VARIABLE,TYPE,NGENES,BETA,BETA_STD,SE,P,FULL_NAME,P_FDR
ABBUD_LIF_SIGNALING_1_UP,SET,39,0.64045,0.029471,0.14415,4.4625e-06,ABBUD_LIF_SIGNALING_1_UP,0.1115392215
GOBP_POSITIVE_REGULATION_OF_...27,SET,5,1.6349,0.026962,0.37462,6.4186e-06,GOBP_POSITIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.1115392215
WP_MAMMARY_GLAND_DEVELOPMENT...4,SET,12,1.127,0.028788,0.26498,1.0593e-05,WP_MAMMARY_GLAND_DEVELOPMENT_PUBERTY_STAGE_2_OF_4,0.122719905
GOCC_INTERMEDIATE_FILAMENT_C...,SET,208,0.27547,0.029139,0.071056,5.311e-05,GOCC_INTERMEDIATE_FILAMENT_CYTOSKELETON,0.2506994
HP_ACNE_INVERSA,SET,11,0.83179,0.020343,0.2152,5.5702e-05,HP_ACNE_INVERSA,0.2506994
HP_COLDNESS,SET,2,2.5353,0.026446,0.65746,5.7767e-05,HP_COLDNESS,0.2506994
HP_HAND_APRAXIA,SET,2,2.5353,0.026446,0.65746,5.7767e-05,HP_HAND_APRAXIA,0.2506994
FAN_OVARY_CL5_HEALTHY_SELECT...,SET,283,0.20226,0.024904,0.052594,6.0308e-05,FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL,0.2506994
HP_OPEN_BITE,SET,54,0.43993,0.023811,0.11524,6.7642e-05,HP_OPEN_BITE,0.2506994
GOBP_DNA_UNWINDING_INVOLVED_...,SET,20,0.70337,0.02319,0.18567,7.6083e-05,GOBP_DNA_UNWINDING_INVOLVED_IN_DNA_REPLICATION,0.2506994
GOCC_GINS_COMPLEX,SET,5,1.4422,0.023784,0.38245,8.161e-05,GOCC_GINS_COMPLEX,0.2506994
BAUS_TFF2_TARGETS_UP,SET,31,0.55612,0.02282,0.14842,8.9803e-05,BAUS_TFF2_TARGETS_UP,0.2506994
HP_DELAYED_ABILITY_TO_CRAWL,SET,8,0.87868,0.018328,0.23802,0.00011175,HP_DELAYED_ABILITY_TO_CRAWL,0.2506994
HP_HEAT_INTOLERANCE,SET,19,0.67116,0.021568,0.18207,0.00011414,HP_HEAT_INTOLERANCE,0.2506994
MIR6752_5P,SET,112,0.30211,0.023512,0.08198,0.00011464,MIR6752_5P,0.2506994
GOMF_RETINOIC_ACID_RESPONSIV...,SET,6,1.2306,0.022231,0.33548,0.00012251,GOMF_RETINOIC_ACID_RESPONSIVE_ELEMENT_BINDING,0.2506994
GROSS_HIF1A_TARGETS_UP,SET,7,1.3987,0.027291,0.38242,0.00012774,GROSS_HIF1A_TARGETS_UP,0.2506994
GAUTAM_EYE_IRIS_CILIARY_BODY...7,SET,89,0.36021,0.025005,0.098599,0.00012984,GAUTAM_EYE_IRIS_CILIARY_BODY_FIBROBLASTS,0.2506994
E2F1_Q3_01,SET,222,0.20403,0.022289,0.056344,0.00014701,E2F1_Q3_01,0.25892475
GSE13522_CTRL_VS_T_CRUZI_Y_S...5,SET,183,0.23125,0.02296,0.063922,0.000149,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_DN,0.25892475
HP_SEMANTIC_DEMENTIA,SET,7,1.1736,0.022899,0.32828,0.00017563,HP_SEMANTIC_DEMENTIA,0.284552784782609
BENNETT_SYSTEMIC_LUPUS_ERYTH...,SET,25,0.64546,0.023789,0.18121,0.0001846,BENNETT_SYSTEMIC_LUPUS_ERYTHEMATOSUS,0.284552784782609
HP_MINICORE_MYOPATHY,SET,8,1.0388,0.021668,0.29207,0.00018831,HP_MINICORE_MYOPATHY,0.284552784782609
HP_EXCESSIVE_BLEEDING_FROM_S...,SET,5,1.4024,0.023128,0.3993,0.00022281,HP_EXCESSIVE_BLEEDING_FROM_SUPERFICIAL_CUTS,0.32265673125
KEGG_SELENOAMINO_ACID_METABO...,SET,23,0.59922,0.021184,0.17193,0.00024648,KEGG_SELENOAMINO_ACID_METABOLISM,0.333265695
REACTOME_MUSCARINIC_ACETYLCH...,SET,5,1.2472,0.020569,0.35847,0.00025192,REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS,0.333265695
GSE29618_BCELL_VS_MDC_DAY7_F...2,SET,169,0.23426,0.02236,0.067803,0.00027583,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_UP,0.333265695
HP_HYPERPIGMENTED_PAPULE,SET,5,1.0707,0.017657,0.31041,0.00028176,HP_HYPERPIGMENTED_PAPULE,0.333265695
KEGG_MEDICUS_VARIANT_ERBB2_O...1,SET,7,1.2043,0.023499,0.34922,0.00028247,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_EGF_JAK_STAT_SIGNALING_PATHWAY,0.333265695
GROSS_HYPOXIA_VIA_ELK3_DN,SET,137,0.27169,0.02337,0.078897,0.00028767,GROSS_HYPOXIA_VIA_ELK3_DN,0.333265695
GOBP_B_CELL_MEDIATED_IMMUNITY,SET,118,0.27307,0.02181,0.08008,0.00032555,GOBP_B_CELL_MEDIATED_IMMUNITY,0.350217957352941
REACTOME_DEFECTIVE_CHST6_CAU...,SET,8,1.0207,0.021291,0.29935,0.00032583,REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1,0.350217957352941
REACTOME_DRUG_ADME,SET,101,0.32614,0.02411,0.096019,0.00034194,REACTOME_DRUG_ADME,0.350217957352941
HP_ACCELERATED_ATHEROSCLEROS...,SET,8,0.97698,0.020379,0.28768,0.00034261,HP_ACCELERATED_ATHEROSCLEROSIS,0.350217957352941
GOBP_ADAPTIVE_IMMUNE_RESPONS...,SET,283,0.18049,0.022224,0.053878,0.00040491,GOBP_ADAPTIVE_IMMUNE_RESPONSE_BASED_ON_SOMATIC_RECOMBINATION_OF_IMMUNE_RECEPTORS_BUILT_FROM_IMMUNOGLOBULIN_SUPERFAMILY_DOMAINS,0.373999446153846
PID_ERBB_NETWORK_PATHWAY,SET,15,0.73449,0.020975,0.21943,0.00040899,PID_ERBB_NETWORK_PATHWAY,0.373999446153846
GSE22601_IMMATURE_CD4_SINGLE...1,SET,180,0.20876,0.020558,0.062457,0.0004161,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.373999446153846
MIR668_3P,SET,54,0.37715,0.020413,0.1129,0.00041897,MIR668_3P,0.373999446153846
GOBP_REGULATION_OF_GRANULOCY...2,SET,15,0.70457,0.02012,0.21095,0.00041968,GOBP_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.373999446153846
HALLMARK_UNFOLDED_PROTEIN_RE...,SET,104,0.26637,0.01998,0.080876,0.00049571,HALLMARK_UNFOLDED_PROTEIN_RESPONSE,0.397952144680851
ATXN7L3_TARGET_GENES,SET,516,0.12549,0.02073,0.03814,0.00050139,ATXN7L3_TARGET_GENES,0.397952144680851
REACTOME_SYNTHESIS_OF_BILE_A...3,SET,14,0.88677,0.024465,0.26995,0.00051101,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_27_HYDROXYCHOLESTEROL,0.397952144680851
HP_CHEST_PAIN,SET,127,0.25298,0.020956,0.077084,0.00051666,HP_CHEST_PAIN,0.397952144680851
GOBP_ERBB2_EGFR_SIGNALING_PA...,SET,8,1.0938,0.022815,0.33365,0.00052343,GOBP_ERBB2_EGFR_SIGNALING_PATHWAY,0.397952144680851
KEGG_MEDICUS_REFERENCE_EGF_E...6,SET,14,0.7534,0.020786,0.23018,0.00053286,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_ERK_SIGNALING_PATHWAY,0.397952144680851
GOCC_JUXTAPARANODE_REGION_OF...,SET,12,0.84548,0.021597,0.25849,0.00053705,GOCC_JUXTAPARANODE_REGION_OF_AXON,0.397952144680851
GOCC_CYTOPLASMIC_STRESS_GRAN...,SET,83,0.2835,0.019009,0.086689,0.00053816,GOCC_CYTOPLASMIC_STRESS_GRANULE,0.397952144680851
GOBP_AMINOGLYCAN_BIOSYNTHETI...,SET,74,0.32268,0.020434,0.098987,0.00055852,GOBP_AMINOGLYCAN_BIOSYNTHETIC_PROCESS,0.402633128571429
GSE6269_HEALTHY_VS_E_COLI_IN...2,SET,157,0.20781,0.019124,0.063839,0.00056766,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_UP,0.402633128571429
LI_CISPLATIN_RESISTANCE_DN,SET,28,0.57265,0.022334,0.17678,0.00060005,LI_CISPLATIN_RESISTANCE_DN,0.412150066363636
GOBP_NEGATIVE_REGULATION_OF_...449,SET,3,1.7344,0.022157,0.53703,0.00062082,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,0.412150066363636
HP_SUDDEN_UNEXPECTED_DEATH_I...,SET,9,0.90134,0.019941,0.27928,0.0006259,HP_SUDDEN_UNEXPECTED_DEATH_IN_EPILEPSY,0.412150066363636
GOMF_PHOSPHATIDYLINOSITOL_5_...,SET,18,0.62519,0.019556,0.19402,0.00063691,GOMF_PHOSPHATIDYLINOSITOL_5_PHOSPHATE_BINDING,0.412150066363636
KEGG_MEDICUS_ENV_FACTOR_BENZ...,SET,11,0.93733,0.022924,0.29118,0.00064412,KEGG_MEDICUS_ENV_FACTOR_BENZO_A_PYRENRE_TO_CYP_MEDIATED_METABOLISM,0.412150066363636
KEGG_LEISHMANIA_INFECTION,SET,63,0.38627,0.022577,0.12013,0.00065223,KEGG_LEISHMANIA_INFECTION,0.412150066363636
GSE29618_BCELL_VS_PDC_DAY7_F...2,SET,165,0.22015,0.020765,0.069402,0.00075813,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_UP,0.441288447727273
SONG_TARGETS_OF_IE86_CMV_PRO...,SET,51,0.37692,0.019828,0.11885,0.00075955,SONG_TARGETS_OF_IE86_CMV_PROTEIN,0.441288447727273
DESERT_EXTRACELLULAR_MATRIX_...,SET,19,0.65531,0.021059,0.20676,0.00076509,DESERT_EXTRACELLULAR_MATRIX_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,0.441288447727273
RODRIGUES_DCC_TARGETS_UP,SET,5,1.1977,0.019753,0.3792,0.00079399,RODRIGUES_DCC_TARGETS_UP,0.441288447727273
GOBP_MIDBRAIN_HINDBRAIN_BOUN...,SET,5,1.2164,0.020061,0.38536,0.00079936,GOBP_MIDBRAIN_HINDBRAIN_BOUNDARY_DEVELOPMENT,0.441288447727273
KEGG_MEDICUS_REFERENCE_IL12_...,SET,10,0.96077,0.022405,0.30446,0.00080192,KEGG_MEDICUS_REFERENCE_IL12_23_TO_JAK_STAT_SIGNALING_PATHWAY,0.441288447727273
HP_SINUS_TACHYCARDIA,SET,27,0.46979,0.017993,0.1491,0.00081516,HP_SINUS_TACHYCARDIA,0.441288447727273
HP_MITRAL_VALVE_PROLAPSE,SET,103,0.26347,0.019669,0.083624,0.00081583,HP_MITRAL_VALVE_PROLAPSE,0.441288447727273
WP_MAMMARY_GLAND_DEVELOPMENT...3,SET,32,0.51766,0.021581,0.16455,0.00082932,WP_MAMMARY_GLAND_DEVELOPMENT_PREGNANCY_AND_LACTATION_STAGE_3_OF_4,0.441288447727273
HP_EPISODIC_HYPERTENSION,SET,5,1.1343,0.018707,0.36062,0.00083052,HP_EPISODIC_HYPERTENSION,0.441288447727273
GOBP_POSITIVE_REGULATION_OF_...195,SET,23,0.55715,0.019697,0.17728,0.00083801,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,0.441288447727273
GSE34156_UNTREATED_VS_24H_NO...4,SET,151,0.21195,0.019133,0.067829,0.00089118,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_UP,0.449498
REACTOME_RECRUITMENT_OF_MITO...,SET,74,0.28281,0.017909,0.0907,0.00091167,REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES,0.449498
HP_PERIAURICULAR_SKIN_PITS,SET,48,0.39504,0.020162,0.1268,0.00091979,HP_PERIAURICULAR_SKIN_PITS,0.449498
GOBP_NEGATIVE_REGULATION_OF_...215,SET,7,1.1874,0.023169,0.3812,0.00092136,GOBP_NEGATIVE_REGULATION_OF_ERAD_PATHWAY,0.449498
HAY_BONE_MARROW_IMMATURE_NEU...,SET,174,0.20353,0.01971,0.065395,0.00092937,HAY_BONE_MARROW_IMMATURE_NEUTROPHIL,0.449498
HP_IMPAIRED_COLLAGEN_INDUCED...,SET,16,0.58303,0.017195,0.18736,0.0009312,HP_IMPAIRED_COLLAGEN_INDUCED_PLATELET_AGGREGATION,0.449498
HOEK_NK_CELL_2011_2012_TIV_A...1,SET,7,0.84637,0.016515,0.27299,0.00096791,HOEK_NK_CELL_2011_2012_TIV_ADULT_1DY_UP,0.460386334459459
GSE32986_CURDLAN_HIGHDOSE_VS...1,SET,187,0.19963,0.020034,0.064466,0.00098025,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.460386334459459
GOBP_LYMPHOCYTE_MEDIATED_IMM...,SET,268,0.17171,0.020584,0.05553,0.00099474,GOBP_LYMPHOCYTE_MEDIATED_IMMUNITY,0.460458019736842
GAUCHER_PBMC_YF_VAX_STAMARIL...5,SET,12,0.75919,0.019393,0.2458,0.0010069,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_DN,0.460458019736842
REACTOME_EGFR_INTERACTS_WITH...,SET,9,0.91924,0.020337,0.29829,0.0010307,REACTOME_EGFR_INTERACTS_WITH_PHOSPHOLIPASE_C_GAMMA,0.46282075
GOBP_REGULATION_OF_VOLTAGE_G...2,SET,6,1.1564,0.020891,0.37553,0.0010387,GOBP_REGULATION_OF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.46282075
AIZARANI_LIVER_C22_RESIDENT_...,SET,26,0.51027,0.019179,0.16618,0.0010697,AIZARANI_LIVER_C22_RESIDENT_B_CELLS_2,0.46745475
REACTOME_RECRUITMENT_OF_NUMA...,SET,87,0.26382,0.018108,0.085965,0.001076,REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES,0.46745475
COLIN_PILOCYTIC_ASTROCYTOMA_...1,SET,26,0.56301,0.021161,0.18422,0.0011223,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_DN,0.481549833333333
HP_HEMANGIOBLASTOMA,SET,18,0.52288,0.016355,0.17164,0.0011596,HP_HEMANGIOBLASTOMA,0.48797675
GSE16385_ROSIGLITAZONE_IFNG_...1,SET,174,0.19339,0.018728,0.063566,0.0011751,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,0.48797675
GOBP_POSITIVE_REGULATION_OF_...317,SET,8,0.87748,0.018303,0.28852,0.0011794,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.48797675
GSE11864_CSF1_IFNG_VS_CSF1_P...1,SET,161,0.2038,0.018991,0.067133,0.0012012,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_DN,0.491149482352941
HP_DEPOSITS_IMMUNOREACTIVE_T...,SET,9,0.87657,0.019393,0.28949,0.0012326,HP_DEPOSITS_IMMUNOREACTIVE_TO_BETA_AMYLOID_PROTEIN,0.491334168539326
HP_FLUSHING,SET,45,0.36001,0.017792,0.11889,0.0012327,HP_FLUSHING,0.491334168539326
GSE21546_SAP1A_KO_VS_SAP1A_K...2,SET,178,0.19355,0.018955,0.064003,0.0012486,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.491334168539326
WP_VITAMIN_A1_AND_A5X_PATHWA...,SET,6,1.019,0.018409,0.33722,0.0012582,WP_VITAMIN_A1_AND_A5X_PATHWAYS,0.491334168539326
GSE2585_THYMIC_MACROPHAGE_VS...2,SET,173,0.19049,0.018394,0.06327,0.0013047,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_UP,0.50383165
MIR758_5P,SET,31,0.43699,0.017932,0.14541,0.001329,MIR758_5P,0.504971857894737
GSE17721_PAM3CSK4_VS_GADIQUI...18,SET,168,0.18961,0.018045,0.063161,0.0013427,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_UP,0.504971857894737
GSE12845_PRE_GC_VS_DARKZONE_...2,SET,174,0.19259,0.01865,0.064196,0.001352,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.504971857894737
HP_MYALGIA,SET,157,0.20145,0.018539,0.067282,0.0013781,HP_MYALGIA,0.504971857894737
MIR6807_3P,SET,128,0.21886,0.018201,0.073109,0.0013803,MIR6807_3P,0.504971857894737
HP_ELEVATED_URINARY_NOREPINE...,SET,18,0.51856,0.01622,0.17404,0.0014451,HP_ELEVATED_URINARY_NOREPINEPHRINE_LEVEL,0.506377274336283
HP_BIFID_NASAL_TIP,SET,13,0.66068,0.017565,0.22197,0.0014598,HP_BIFID_NASAL_TIP,0.506377274336283
GOBP_LEUKOCYTE_MEDIATED_IMMU...,SET,364,0.13884,0.019345,0.046656,0.0014626,GOBP_LEUKOCYTE_MEDIATED_IMMUNITY,0.506377274336283
GOBP_GRANULOCYTE_DIFFERENTIA...,SET,38,0.41531,0.018865,0.13965,0.0014726,GOBP_GRANULOCYTE_DIFFERENTIATION,0.506377274336283
HOLLEMAN_VINCRISTINE_RESISTA...4,SET,36,0.41677,0.018427,0.14034,0.0014924,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP,0.506377274336283
GOMF_MRNA_5_UTR_BINDING,SET,22,0.47551,0.016442,0.16048,0.0015253,GOMF_MRNA_5_UTR_BINDING,0.506377274336283
TIMOFEEVA_GROWTH_STRESS_VIA_...,SET,16,0.64912,0.019144,0.21928,0.0015387,TIMOFEEVA_GROWTH_STRESS_VIA_STAT1_DN,0.506377274336283
HP_SKIN_PIT,SET,62,0.31451,0.018237,0.10627,0.0015422,HP_SKIN_PIT,0.506377274336283
GOCC_CBM_COMPLEX,SET,5,1.0953,0.018064,0.37098,0.0015782,GOCC_CBM_COMPLEX,0.506377274336283
MIR7109_5P,SET,71,0.27878,0.017294,0.094432,0.0015797,MIR7109_5P,0.506377274336283
GOMF_G_PROTEIN_COUPLED_ACETY...,SET,7,0.9398,0.018338,0.31843,0.0015839,GOMF_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.506377274336283
HP_HEMATURIA,SET,164,0.1995,0.018762,0.067612,0.0015871,HP_HEMATURIA,0.506377274336283
GOBP_IRES_DEPENDENT_VIRAL_TR...,SET,10,0.76448,0.017827,0.25972,0.0016247,GOBP_IRES_DEPENDENT_VIRAL_TRANSLATIONAL_INITIATION,0.506377274336283
FRANCO_BLOOD_SANOFI_PASTEUR_...3,SET,24,0.52509,0.018962,0.17846,0.0016305,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_NEGATIVE,0.506377274336283
MIR325,SET,28,0.46955,0.018313,0.15962,0.001634,MIR325,0.506377274336283
E2F1_Q6_01,SET,214,0.16473,0.017672,0.056013,0.0016382,E2F1_Q6_01,0.506377274336283
GSE3982_EFF_MEMORY_CD4_TCELL...2,SET,179,0.18412,0.018082,0.062629,0.0016435,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_UP,0.506377274336283
RUBENSTEIN_SKELETAL_MUSCLE_F...1,SET,154,0.21255,0.019375,0.07231,0.0016464,RUBENSTEIN_SKELETAL_MUSCLE_FAP_CELLS,0.506377274336283
HAY_BONE_MARROW_CD34_POS_MEP,SET,8,0.91145,0.019012,0.31103,0.0016944,HAY_BONE_MARROW_CD34_POS_MEP,0.515431760869565
GOBP_HEPARIN_METABOLIC_PROCE...,SET,17,0.63584,0.019329,0.21713,0.0017055,GOBP_HEPARIN_METABOLIC_PROCESS,0.515431760869565
REACTOME_CIPROFLOXACIN_ADME,SET,5,1.1438,0.018864,0.39098,0.0017216,REACTOME_CIPROFLOXACIN_ADME,0.515812137931035
HP_PREMATURE_SKIN_WRINKLING,SET,61,0.30833,0.017734,0.10557,0.0017481,HP_PREMATURE_SKIN_WRINKLING,0.5179363875
SCHERER_PBMC_APSV_WETVAX_AGE...5,SET,171,0.18453,0.017717,0.06329,0.0017768,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN,0.5179363875
HOWARD_NEUTROPHIL_INACT_MONO...2,SET,358,0.13877,0.019178,0.047622,0.0017866,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.5179363875
E2F_Q3,SET,196,0.16765,0.01722,0.057538,0.0017883,E2F_Q3,0.5179363875
MIR2467_3P,SET,139,0.1997,0.017301,0.068748,0.0018395,MIR2467_3P,0.528362169421488
REACTOME_GLYCOSAMINOGLYCAN_M...,SET,120,0.23191,0.018678,0.079909,0.0018552,REACTOME_GLYCOSAMINOGLYCAN_METABOLISM,0.528503901639344
REACTOME_ROBO_RECEPTORS_BIND...,SET,9,0.72235,0.015981,0.24919,0.001875,REACTOME_ROBO_RECEPTORS_BIND_AKAP5,0.528864592741936
MARIADASON_RESPONSE_TO_BUTYR...2,SET,7,0.9379,0.0183,0.32376,0.0018869,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_2,0.528864592741936
GSE12845_IGD_POS_BLOOD_VS_DA...2,SET,166,0.18402,0.017409,0.063775,0.0019567,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.536638921875
ZHONG_PFC_C6_PLXNA4_POS_EXCI...,SET,6,1.0547,0.019054,0.36555,0.001957,ZHONG_PFC_C6_PLXNA4_POS_EXCITATORY_NEURON,0.536638921875
GSE15930_NAIVE_VS_24H_IN_VIT...3,SET,188,0.16689,0.016793,0.057888,0.0019719,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.536638921875
HP_LINGUAL_DYSTONIA,SET,5,1.0552,0.017402,0.3661,0.0019764,HP_LINGUAL_DYSTONIA,0.536638921875
GSE3982_MEMORY_CD4_TCELL_VS_...5,SET,186,0.17188,0.017203,0.059862,0.0020471,GSE3982_MEMORY_CD4_TCELL_VS_TH2_DN,0.546624595588235
YAMASHITA_LIVER_CANCER_WITH_...2,SET,49,0.32856,0.016942,0.11472,0.0020943,YAMASHITA_LIVER_CANCER_WITH_EPCAM_UP,0.546624595588235
MYLLYKANGAS_AMPLIFICATION_HO...15,SET,6,0.96583,0.017448,0.33735,0.0021009,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_5,0.546624595588235
GSE22935_UNSTIM_VS_48H_MBOVI...4,SET,179,0.17863,0.017543,0.062401,0.0021031,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.546624595588235
GSE5099_CLASSICAL_M1_VS_ALTE...1,SET,146,0.19806,0.017582,0.069193,0.0021045,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_DN,0.546624595588235
MIR4666B,SET,111,0.23938,0.018547,0.083696,0.0021197,MIR4666B,0.546624595588235
REACTOME_DISEASES_OF_DNA_REP...,SET,49,0.32198,0.016603,0.11266,0.0021349,REACTOME_DISEASES_OF_DNA_REPAIR,0.546624595588235
HP_PARAGANGLIOMA,SET,19,0.48138,0.01547,0.16848,0.002139,HP_PARAGANGLIOMA,0.546624595588235
GOBP_MAMMARY_GLAND_ALVEOLUS_...,SET,18,0.62644,0.019595,0.21952,0.0021631,GOBP_MAMMARY_GLAND_ALVEOLUS_DEVELOPMENT,0.54874847080292
GOMF_PHOSPHATIDYLCHOLINE_STE...,SET,6,1.1486,0.02075,0.40331,0.0022029,GOMF_PHOSPHATIDYLCHOLINE_STEROL_O_ACYLTRANSFERASE_ACTIVATOR_ACTIVITY,0.554795576086957
KEGG_MEDICUS_VARIANT_MUTATIO...4,SET,13,0.67295,0.017891,0.23662,0.0022297,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PLCG_ERK_SIGNALING_PATHWAY,0.555043447368421
KEGG_MEDICUS_VARIANT_MUTATIO...80,SET,18,0.51615,0.016145,0.18186,0.0022709,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKAR1A_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.555043447368421
GOCC_GAMMA_TUBULIN_RING_COMP...,SET,8,0.98739,0.020596,0.34875,0.002321,GOCC_GAMMA_TUBULIN_RING_COMPLEX,0.555043447368421
KEGG_MEDICUS_VARIANT_MUTATIO...22,SET,5,1.1193,0.01846,0.39604,0.0023566,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_USP8_TO_EGFR_ERK_ACTH_SIGNALING_PATHWAY,0.555043447368421
E2F1DP1RB_01,SET,208,0.1625,0.017189,0.057573,0.0023851,E2F1DP1RB_01,0.555043447368421
HP_CORNEAL_DYSTROPHY,SET,29,0.47999,0.019051,0.17048,0.0024376,HP_CORNEAL_DYSTROPHY,0.555043447368421
GOBP_TRNA_5_LEADER_REMOVAL,SET,11,0.6266,0.015325,0.22276,0.0024571,GOBP_TRNA_5_LEADER_REMOVAL,0.555043447368421
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...4,SET,7,0.94875,0.018512,0.33754,0.0024737,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_DN,0.555043447368421
HARALAMBIEVA_PBMC_TIV_AGE_50...2,SET,13,0.54666,0.014534,0.19473,0.0025006,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_NEGATIVE,0.555043447368421
GSE6269_HEALTHY_VS_STAPH_PNE...2,SET,165,0.17386,0.016399,0.061941,0.002504,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_UP,0.555043447368421
JOHANSSON_GLIOMAGENESIS_BY_P...2,SET,55,0.3259,0.017802,0.11618,0.0025174,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_UP,0.555043447368421
BALLIF_DEVELOPMENTAL_DISABIL...,SET,13,0.66654,0.017721,0.23763,0.0025189,BALLIF_DEVELOPMENTAL_DISABILITY_P16_P12_DELETION,0.555043447368421
HP_ABNORMAL_PEER_RELATIONSHI...,SET,6,0.94266,0.017029,0.33611,0.0025217,HP_ABNORMAL_PEER_RELATIONSHIPS,0.555043447368421
GOBP_MYELOID_LEUKOCYTE_DIFFE...,SET,219,0.173,0.018772,0.061723,0.0025349,GOBP_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.555043447368421
HASLINGER_B_CLL_WITH_17P13_D...,SET,20,0.50833,0.01676,0.18166,0.0025716,HASLINGER_B_CLL_WITH_17P13_DELETION,0.555043447368421
GOCC_CMG_COMPLEX,SET,11,0.67288,0.016457,0.24064,0.0025877,GOCC_CMG_COMPLEX,0.555043447368421
RICKMAN_METASTASIS_UP,SET,273,0.14351,0.017361,0.05137,0.002608,RICKMAN_METASTASIS_UP,0.555043447368421
chr2q13,SET,14,0.93831,0.025887,0.33604,0.0026198,chr2q13,0.555043447368421
MIR4700_5P,SET,200,0.17172,0.017816,0.061517,0.0026265,MIR4700_5P,0.555043447368421
E2F_Q4_01,SET,211,0.15812,0.016845,0.05666,0.0026324,E2F_Q4_01,0.555043447368421
KEGG_MEDICUS_VARIANT_AMPLIFI...12,SET,11,0.74376,0.01819,0.26653,0.002634,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_CELL_CYCLE_G1_S,0.555043447368421
PAPASPYRIDONOS_UNSTABLE_ATER...1,SET,39,0.36865,0.016964,0.13211,0.0026346,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_DN,0.555043447368421
GOBP_REGULATION_OF_T_HELPER_...3,SET,31,0.4356,0.017875,0.15611,0.0026357,GOBP_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.555043447368421
HE_LIM_SUN_FETAL_LUNG_C1_LAT...4,SET,28,0.49807,0.019426,0.17855,0.002642,HE_LIM_SUN_FETAL_LUNG_C1_LATE_TIP_CELL,0.555043447368421
GOBP_ROSTROCAUDAL_NEURAL_TUB...,SET,8,0.88421,0.018444,0.31742,0.0026738,GOBP_ROSTROCAUDAL_NEURAL_TUBE_PATTERNING,0.555043447368421
MUNSHI_MULTIPLE_MYELOMA_DN,SET,9,0.77672,0.017184,0.27883,0.0026743,MUNSHI_MULTIPLE_MYELOMA_DN,0.555043447368421
GOMF_MYOSIN_II_BINDING,SET,11,0.70655,0.01728,0.25371,0.0026798,GOMF_MYOSIN_II_BINDING,0.555043447368421
HP_IMPACTED_TOOTH,SET,6,1.0469,0.018912,0.37627,0.0027021,HP_IMPACTED_TOOTH,0.555043447368421
DOANE_BREAST_CANCER_ESR1_DN,SET,42,0.40067,0.019132,0.14403,0.0027062,DOANE_BREAST_CANCER_ESR1_DN,0.555043447368421
TRAVAGLINI_LUNG_CD4_NAIVE_T_...,SET,118,0.21876,0.017473,0.078676,0.0027161,TRAVAGLINI_LUNG_CD4_NAIVE_T_CELL,0.555043447368421
GOBP_REGULATION_OF_CHROMATIN...1,SET,10,0.77213,0.018006,0.27775,0.0027218,GOBP_REGULATION_OF_CHROMATIN_BINDING,0.555043447368421
GSE46242_CTRL_VS_EGR2_DELETE...3,SET,162,0.18824,0.017594,0.067717,0.0027232,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_DN,0.555043447368421
HP_ABNORMAL_ALPHA_GRANULES,SET,4,0.95695,0.014116,0.34437,0.0027309,HP_ABNORMAL_ALPHA_GRANULES,0.555043447368421
CAGCAGG_MIR370,SET,138,0.19468,0.016806,0.070179,0.002771,CAGCAGG_MIR370,0.559919215116279
WP_PPAR_SIGNALING,SET,66,0.29003,0.017349,0.10486,0.0028416,WP_PPAR_SIGNALING,0.56692356
MIR4462,SET,13,0.52865,0.014055,0.19119,0.0028486,MIR4462,0.56692356
HP_ABNORMAL_CORTICOSPINAL_TR...,SET,44,0.34253,0.01674,0.12391,0.0028546,HP_ABNORMAL_CORTICOSPINAL_TRACT_MORPHOLOGY,0.56692356
GOBP_AXON_CHOICE_POINT_RECOG...,SET,7,1.0865,0.021201,0.39369,0.0028942,GOBP_AXON_CHOICE_POINT_RECOGNITION,0.570182159685864
E2F_Q3_01,SET,209,0.15797,0.01675,0.057313,0.002926,E2F_Q3_01,0.570182159685864
NAKAMURA_METASTASIS_MODEL_UP,SET,39,0.34896,0.016058,0.12668,0.0029403,NAKAMURA_METASTASIS_MODEL_UP,0.570182159685864
GOBP_ADENYLATE_CYCLASE_INHIB...2,SET,8,0.80913,0.016877,0.29397,0.0029612,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.570182159685864
GAVISH_3CA_METAPROGRAM_CD8_T...9,SET,40,0.37197,0.017334,0.1352,0.0029719,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_2,0.570182159685864
GSE24972_MARGINAL_ZONE_BCELL...3,SET,184,0.17573,0.017495,0.063902,0.0029828,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_UP,0.570182159685864
MIR4447,SET,255,0.14391,0.016833,0.052433,0.0030314,MIR4447,0.570182159685864
HP_EPISODIC_HYPERHIDROSIS,SET,25,0.41445,0.015275,0.15112,0.0030514,HP_EPISODIC_HYPERHIDROSIS,0.570182159685864
PLASARI_TGFB1_TARGETS_10HR_UP,SET,186,0.18447,0.018463,0.067286,0.003061,PLASARI_TGFB1_TARGETS_10HR_UP,0.570182159685864
HP_BRUISING_SUSCEPTIBILITY,SET,162,0.18327,0.01713,0.066894,0.0030776,HP_BRUISING_SUSCEPTIBILITY,0.570182159685864
GOBP_MUCOPOLYSACCHARIDE_META...,SET,86,0.25504,0.017405,0.093094,0.0030788,GOBP_MUCOPOLYSACCHARIDE_METABOLIC_PROCESS,0.570182159685864
HP_PENILE_FRECKLING,SET,5,0.8407,0.013865,0.30702,0.0030913,HP_PENILE_FRECKLING,0.570182159685864
KEGG_PPAR_SIGNALING_PATHWAY,SET,67,0.28643,0.017263,0.1047,0.0031142,KEGG_PPAR_SIGNALING_PATHWAY,0.570182159685864
GSE42021_TREG_PLN_VS_CD24INT...1,SET,184,0.17609,0.017531,0.064369,0.0031164,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_DN,0.570182159685864
GSE10325_LUPUS_BCELL_VS_LUPU...2,SET,161,0.17991,0.016764,0.065788,0.0031258,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_UP,0.570182159685864
GSE15930_NAIVE_VS_24H_IN_VIT...5,SET,189,0.15652,0.015791,0.057254,0.0031335,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_DN,0.570182159685864
ZHANG_ANTIVIRAL_RESPONSE_TO_...2,SET,24,0.49202,0.017768,0.18014,0.0031578,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP,0.571368598445596
MIR425_5P,SET,78,0.26212,0.01704,0.096027,0.0031729,MIR425_5P,0.571368598445596
WAMUNYOKOLI_OVARIAN_CANCER_L...2,SET,255,0.14546,0.017014,0.053392,0.0032248,WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP,0.577721257731959
GAVISH_3CA_METAPROGRAM_EPITH...9,SET,50,0.33538,0.017469,0.12337,0.003283,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI4,0.579613111940299
GOMF_HISTONE_DEACETYLASE_BIN...,SET,103,0.22476,0.016779,0.082699,0.0032884,GOMF_HISTONE_DEACETYLASE_BINDING,0.579613111940299
WP_EXTRAFOLLICULAR_AND_FOLLI...,SET,65,0.31843,0.018903,0.11724,0.0033069,WP_EXTRAFOLLICULAR_AND_FOLLICULAR_B_CELL_ACTIVATION_BY_SARSCOV2,0.579613111940299
VILIMAS_NOTCH1_TARGETS_DN,SET,24,0.52148,0.018832,0.19212,0.0033245,VILIMAS_NOTCH1_TARGETS_DN,0.579613111940299
WP_GLIAL_CELL_DIFFERENTIATION,SET,5,1.0191,0.016806,0.3757,0.0033426,WP_GLIAL_CELL_DIFFERENTIATION,0.579613111940299
GSE27859_MACROPHAGE_VS_CD11C...4,SET,153,0.18788,0.01707,0.06927,0.0033446,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP,0.579613111940299
HP_ABNORMAL_ATRIOVENTRICULAR...3,SET,150,0.19394,0.017449,0.071524,0.0033521,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_MORPHOLOGY,0.579613111940299
FARMER_BREAST_CANCER_CLUSTER...5,SET,19,0.47018,0.01511,0.17353,0.0033728,FARMER_BREAST_CANCER_CLUSTER_5,0.580305267326733
PID_INTEGRIN2_PATHWAY,SET,26,0.5154,0.019371,0.19069,0.0034419,PID_INTEGRIN2_PATHWAY,0.589277017241379
GOBP_OVIDUCT_DEVELOPMENT,SET,6,0.98297,0.017758,0.364,0.0034651,GOBP_OVIDUCT_DEVELOPMENT,0.590025174757282
HP_ABNORMAL_MUSCLE_FIBER_MOR...,SET,234,0.14202,0.015923,0.052633,0.0034872,HP_ABNORMAL_MUSCLE_FIBER_MORPHOLOGY,0.590025174757282
HU_FETAL_RETINA_MULLER,SET,36,0.41167,0.018202,0.15261,0.0034972,HU_FETAL_RETINA_MULLER,0.590025174757282
UROSEVIC_RESPONSE_TO_IMIQUIM...,SET,18,0.54853,0.017158,0.20365,0.0035392,UROSEVIC_RESPONSE_TO_IMIQUIMOD,0.594226550724638
MIR8066,SET,142,0.19176,0.01679,0.071254,0.0035634,MIR8066,0.595183492890995
REACTOME_UNWINDING_OF_DNA,SET,12,0.62219,0.015893,0.23137,0.0035849,REACTOME_UNWINDING_OF_DNA,0.595183492890995
GOBP_POSITIVE_REGULATION_OF_...25,SET,8,0.81233,0.016944,0.30229,0.0036054,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.595183492890995
GOCC_NLRP1_INFLAMMASOME_COMP...,SET,5,1.2371,0.020402,0.46049,0.0036134,GOCC_NLRP1_INFLAMMASOME_COMPLEX,0.595183492890995
GOBP_REGULATION_OF_BONE_RESO...,SET,42,0.38297,0.018286,0.14271,0.0036458,GOBP_REGULATION_OF_BONE_RESORPTION,0.597687636792453
GSE3982_MAC_VS_EFF_MEMORY_CD...2,SET,180,0.16909,0.016652,0.063097,0.003686,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_UP,0.598590247933884
MIR662,SET,5,0.8515,0.014043,0.31782,0.0036935,MIR662,0.598590247933884
GOBP_POSITIVE_REGULATION_OF_...832,SET,16,0.64117,0.01891,0.23981,0.0037552,GOBP_POSITIVE_REGULATION_OF_VASCULAR_PERMEABILITY,0.598590247933884
GSE15930_NAIVE_VS_24H_IN_VIT...1,SET,189,0.15301,0.015437,0.057275,0.0037789,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_DN,0.598590247933884
ZHANG_BREAST_CANCER_PROGENIT...2,SET,397,0.11025,0.016028,0.041341,0.0038319,ZHANG_BREAST_CANCER_PROGENITORS_UP,0.598590247933884
GOBP_REGULATION_OF_PROTEIN_K...4,SET,3,1.5004,0.019167,0.56261,0.0038324,GOBP_REGULATION_OF_PROTEIN_KINASE_C_ACTIVITY,0.598590247933884
GOBP_REGULATION_OF_INTRINSIC...4,SET,15,0.54263,0.015496,0.20373,0.0038705,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.598590247933884
E2F_Q4,SET,212,0.15318,0.016356,0.057527,0.003879,E2F_Q4,0.598590247933884
MIR8071,SET,31,0.38035,0.015607,0.14293,0.0038982,MIR8071,0.598590247933884
BIOCARTA_ION_PATHWAY,SET,5,0.95285,0.015714,0.35809,0.0038997,BIOCARTA_ION_PATHWAY,0.598590247933884
REACTOME_SIGNALING_BY_ERBB2_...2,SET,25,0.41912,0.015447,0.15755,0.0039082,REACTOME_SIGNALING_BY_ERBB2_IN_CANCER,0.598590247933884
GOBP_INTERFERON_BETA_PRODUCT...,SET,50,0.30097,0.015677,0.11319,0.003924,GOBP_INTERFERON_BETA_PRODUCTION,0.598590247933884
RAO_BOUND_BY_SALL4_ISOFORM_A,SET,166,0.17844,0.016881,0.067123,0.00393,RAO_BOUND_BY_SALL4_ISOFORM_A,0.598590247933884
DAUER_STAT3_TARGETS_UP,SET,42,0.37839,0.018068,0.14236,0.0039335,DAUER_STAT3_TARGETS_UP,0.598590247933884
GOBP_AXON_MIDLINE_CHOICE_POI...,SET,5,1.2534,0.020671,0.47179,0.0039487,GOBP_AXON_MIDLINE_CHOICE_POINT_RECOGNITION,0.598590247933884
GSE3982_BCELL_VS_NKCELL_UP,SET,177,0.16441,0.016057,0.061917,0.0039651,GSE3982_BCELL_VS_NKCELL_UP,0.598590247933884
GOMF_PROTEIN_PHOSPHATASE_2B_...,SET,6,0.77006,0.013911,0.29013,0.0039789,GOMF_PROTEIN_PHOSPHATASE_2B_BINDING,0.598590247933884
GSE17721_0.5H_VS_8H_PAM3CSK4...2,SET,181,0.16298,0.016094,0.061409,0.0039812,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_UP,0.598590247933884
MIR217_5P,SET,170,0.16858,0.016138,0.063582,0.0040115,MIR217_5P,0.598590247933884
GSE41978_ID2_KO_VS_BIM_KO_KL...2,SET,186,0.16981,0.016996,0.064082,0.0040294,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,0.598590247933884
HP_ABNORMAL_MESENTERY_MORPHO...,SET,4,0.90025,0.01328,0.3399,0.0040453,HP_ABNORMAL_MESENTERY_MORPHOLOGY,0.598590247933884
GSE7831_1H_VS_4H_INFLUENZA_S...1,SET,186,0.16573,0.016588,0.062589,0.0040528,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_DN,0.598590247933884
BARIS_THYROID_CANCER_DN,SET,52,0.30709,0.016311,0.116,0.004061,BARIS_THYROID_CANCER_DN,0.598590247933884
HP_ELEVATED_URINARY_CATECHOL...,SET,27,0.40919,0.015672,0.15471,0.0040894,HP_ELEVATED_URINARY_CATECHOLAMINE_LEVEL,0.598590247933884
HP_ABNORMAL_PLATELET_AGGREGA...,SET,39,0.34787,0.016008,0.13165,0.0041194,HP_ABNORMAL_PLATELET_AGGREGATION,0.598590247933884
MIR6803_5P,SET,52,0.31147,0.016544,0.11796,0.0041434,MIR6803_5P,0.598590247933884
AP4_Q6_01,SET,233,0.14592,0.016326,0.055286,0.0041562,AP4_Q6_01,0.598590247933884
DORN_ADENOVIRUS_INFECTION_32...2,SET,9,0.73914,0.016352,0.28005,0.0041566,DORN_ADENOVIRUS_INFECTION_32HR_UP,0.598590247933884
GOBP_COMPLEMENT_DEPENDENT_CY...,SET,13,0.67852,0.018039,0.25711,0.0041612,GOBP_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.598590247933884
GOBP_LOCALIZATION_OF_CELL,SET,5,0.99235,0.016366,0.37611,0.004168,GOBP_LOCALIZATION_OF_CELL,0.598590247933884
BIDUS_METASTASIS_DN,SET,131,0.19337,0.016267,0.073434,0.0042322,BIDUS_METASTASIS_DN,0.604623049180328
HP_ABNORMAL_PERIAURICULAR_RE...,SET,95,0.22705,0.016282,0.086257,0.0042448,HP_ABNORMAL_PERIAURICULAR_REGION_MORPHOLOGY,0.604623049180328
REACTOME_C_TYPE_LECTIN_RECEP...,SET,126,0.18647,0.015387,0.070888,0.0042668,REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS,0.604846035294118
HP_RECURRENT_PAROXYSMAL_HEAD...,SET,18,0.45777,0.014319,0.17425,0.0043103,HP_RECURRENT_PAROXYSMAL_HEADACHE,0.604846035294118
GSE2770_IL4_ACT_VS_ACT_CD4_T...1,SET,177,0.16628,0.016239,0.063322,0.0043241,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,0.604846035294118
POU2AF1_TARGET_GENES,SET,664,0.087143,0.016262,0.033188,0.0043266,POU2AF1_TARGET_GENES,0.604846035294118
HP_CEREBRAL_AMYLOID_ANGIOPAT...,SET,5,1.1352,0.018721,0.43251,0.0043408,HP_CEREBRAL_AMYLOID_ANGIOPATHY,0.604846035294118
GOBP_RETINOIC_ACID_RECEPTOR_...,SET,31,0.40462,0.016604,0.15435,0.0043813,GOBP_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.604846035294118
HP_HEPATIC_ENCEPHALOPATHY,SET,19,0.57111,0.018353,0.21802,0.0044064,HP_HEPATIC_ENCEPHALOPATHY,0.604846035294118
WP_IMATINIB_AND_CHRONIC_MYEL...,SET,19,0.52062,0.016731,0.19879,0.0044136,WP_IMATINIB_AND_CHRONIC_MYELOID_LEUKEMIA,0.604846035294118
GOMF_GABA_RECEPTOR_BINDING,SET,17,0.50348,0.015305,0.19229,0.004421,GOMF_GABA_RECEPTOR_BINDING,0.604846035294118
HP_ABNORMAL_CEREBRAL_VASCULA...,SET,307,0.1263,0.016187,0.048241,0.0044243,HP_ABNORMAL_CEREBRAL_VASCULAR_MORPHOLOGY,0.604846035294118
ZHAN_MULTIPLE_MYELOMA_DN,SET,37,0.39519,0.017714,0.151,0.0044378,ZHAN_MULTIPLE_MYELOMA_DN,0.604846035294118
GSE3920_UNTREATED_VS_IFNA_TR...3,SET,179,0.1585,0.015566,0.060668,0.0044968,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_DN,0.609132087548638
HP_GENERALIZED_MYOCLONIC_ATO...,SET,9,0.71498,0.015818,0.27373,0.0045043,HP_GENERALIZED_MYOCLONIC_ATONIC_SEIZURE,0.609132087548638
GAVISH_3CA_METAPROGRAM_B_CEL...8,SET,44,0.35966,0.017577,0.13779,0.0045273,GAVISH_3CA_METAPROGRAM_B_CELLS_MHC_II,0.609869424418605
GOBP_REGULATION_OF_INTRINSIC...2,SET,28,0.41228,0.01608,0.15804,0.0045486,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.610372945945946
GSE9509_LPS_VS_LPS_AND_IL10_...4,SET,168,0.17292,0.016456,0.066389,0.0046029,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_UP,0.611952296577947
HP_INFANTILE_SENSORINEURAL_H...,SET,5,0.92117,0.015192,0.35371,0.0046074,HP_INFANTILE_SENSORINEURAL_HEARING_IMPAIRMENT,0.611952296577947
VERRECCHIA_RESPONSE_TO_TGFB1...2,SET,19,0.53429,0.01717,0.20522,0.0046171,VERRECCHIA_RESPONSE_TO_TGFB1_C2,0.611952296577947
GOBP_PROTEIN_SULFATION,SET,6,0.92094,0.016637,0.35386,0.0046308,GOBP_PROTEIN_SULFATION,0.611952296577947
MIR6751_5P,SET,66,0.27468,0.016431,0.10573,0.0046915,MIR6751_5P,0.61441875
REACTOME_DEFECTIVE_B4GALT1_C...,SET,8,0.7941,0.016564,0.30584,0.004714,REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D,0.61441875
REACTOME_TRANSLESION_SYNTHES...2,SET,16,0.48674,0.014355,0.1876,0.0047402,REACTOME_TRANSLESION_SYNTHESIS_BY_POLK,0.61441875
GOBP_POSITIVE_REGULATION_OF_...680,SET,10,0.79063,0.018437,0.30479,0.0047474,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.61441875
SALL4_TARGET_GENES,SET,1444,0.059241,0.01594,0.022854,0.0047722,SALL4_TARGET_GENES,0.61441875
GSE42088_UNINF_VS_LEISHMANIA...5,SET,178,0.16463,0.016123,0.063531,0.0047835,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_DN,0.61441875
KEGG_MEDICUS_REFERENCE_TLR5_...,SET,15,0.56891,0.016246,0.21963,0.0047982,KEGG_MEDICUS_REFERENCE_TLR5_NFKB_SIGNALING_PATHWAY,0.61441875
MCGARVEY_SILENCED_BY_METHYLA...,SET,41,0.36916,0.017417,0.14257,0.0048123,MCGARVEY_SILENCED_BY_METHYLATION_IN_COLON_CANCER,0.61441875
GSE16385_UNTREATED_VS_12H_IF...2,SET,159,0.17169,0.0159,0.066364,0.0048433,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,0.61441875
PID_S1P_S1P1_PATHWAY,SET,21,0.46418,0.015681,0.17954,0.0048674,PID_S1P_S1P1_PATHWAY,0.61441875
WP_EXTRACELLULAR_VESICLES_IN...,SET,19,0.57302,0.018415,0.2217,0.0048781,WP_EXTRACELLULAR_VESICLES_IN_THE_CROSSTALK_OF_CARDIAC_CELLS,0.61441875
KAMIKUBO_MYELOID_CEBPA_NETWO...,SET,27,0.45476,0.017417,0.17608,0.0049049,KAMIKUBO_MYELOID_CEBPA_NETWORK,0.61441875
GOBP_REGULATION_OF_ADAPTIVE_...,SET,191,0.16692,0.016928,0.064652,0.0049176,GOBP_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.61441875
REACTOME_TERMINATION_OF_O_GL...,SET,21,0.49613,0.016761,0.19219,0.0049232,REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS,0.61441875
chr5q13,SET,51,0.57695,0.03035,0.22357,0.0049345,chr5q13,0.61441875
SEITZ_NEOPLASTIC_TRANSFORMAT...2,SET,67,0.29676,0.017885,0.11503,0.0049458,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_UP,0.61441875
GAVISH_3CA_METAPROGRAM_MACRO...2,SET,47,0.33384,0.016861,0.12942,0.00495,GAVISH_3CA_METAPROGRAM_MACROPHAGES_INTERFERON,0.61441875
GOBP_NEGATIVE_REGULATION_OF_...447,SET,66,0.25964,0.015531,0.10082,0.0050117,GOBP_NEGATIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,0.619785175531915
GOMF_TRANSMEMBRANE_RECEPTOR_...5,SET,16,0.63899,0.018845,0.24824,0.0050289,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.619785175531915
GSE29618_BCELL_VS_PDC_UP,SET,169,0.18063,0.017241,0.070264,0.0050777,GSE29618_BCELL_VS_PDC_UP,0.62358821024735
GOBP_NEGATIVE_REGULATION_OF_...644,SET,8,0.82969,0.017306,0.32307,0.0051159,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,0.625692555737705
GOBP_REGULATION_OF_MYELOID_C...2,SET,186,0.16736,0.016751,0.065259,0.0051703,GOBP_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.625692555737705
MIR6842_5P,SET,143,0.18694,0.016426,0.072904,0.0051739,MIR6842_5P,0.625692555737705
GOBP_PURINE_NUCLEOSIDE_TRANS...,SET,5,1.0213,0.016843,0.39866,0.0052099,GOBP_PURINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,0.625692555737705
UDAYAKUMAR_MED1_TARGETS_DN,SET,212,0.147,0.015697,0.057396,0.0052198,UDAYAKUMAR_MED1_TARGETS_DN,0.625692555737705
GOBP_NEGATIVE_REGULATION_OF_...702,SET,14,0.59634,0.016452,0.23303,0.0052529,GOBP_NEGATIVE_REGULATION_OF_VIRAL_TRANSCRIPTION,0.625692555737705
MAINA_VHL_TARGETS_DN,SET,14,0.64463,0.017785,0.25198,0.0052645,MAINA_VHL_TARGETS_DN,0.625692555737705
E2F_Q6,SET,209,0.14803,0.015696,0.057875,0.0052708,E2F_Q6,0.625692555737705
HP_PAIN,SET,754,0.081153,0.016097,0.031741,0.0052875,HP_PAIN,0.625692555737705
GOBP_NEGATIVE_REGULATION_OF_...19,SET,5,0.95211,0.015702,0.37256,0.0053045,GOBP_NEGATIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.625692555737705
HP_ACNE,SET,60,0.28071,0.016012,0.10992,0.0053317,HP_ACNE,0.625692555737705
GSE9006_TYPE_1_VS_TYPE_2_DIA...1,SET,180,0.15605,0.015367,0.061121,0.0053432,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.625692555737705
HOFMANN_CELL_LYMPHOMA_UP,SET,44,0.31943,0.015611,0.12513,0.0053484,HOFMANN_CELL_LYMPHOMA_UP,0.625692555737705
HP_RETINAL_HAMARTOMA,SET,22,0.40642,0.014053,0.15929,0.0053691,HP_RETINAL_HAMARTOMA,0.625692555737705
WP_NONSMALL_CELL_LUNG_CANCER,SET,71,0.25249,0.015663,0.099031,0.0053965,WP_NONSMALL_CELL_LUNG_CANCER,0.625692555737705
REACTOME_RNA_POLYMERASE_III_...5,SET,21,0.4077,0.013773,0.16013,0.005452,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_TERMINATION,0.625692555737705
CUI_GLUCOSE_DEPRIVATION,SET,53,0.31197,0.016729,0.12253,0.0054523,CUI_GLUCOSE_DEPRIVATION,0.625692555737705
GOBP_INORGANIC_ION_IMPORT_AC...,SET,113,0.21071,0.016471,0.082782,0.0054625,GOBP_INORGANIC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.625692555737705
GOBP_IMMUNE_EFFECTOR_PROCESS,SET,582,0.094874,0.016613,0.037282,0.0054721,GOBP_IMMUNE_EFFECTOR_PROCESS,0.625692555737705
KERLEY_RESPONSE_TO_CISPLATIN...2,SET,44,0.32325,0.015797,0.12706,0.0054821,KERLEY_RESPONSE_TO_CISPLATIN_UP,0.625692555737705
GOMF_ISOPRENOID_BINDING,SET,42,0.39385,0.018806,0.15482,0.0054862,GOMF_ISOPRENOID_BINDING,0.625692555737705
HP_ARACHNOID_HEMANGIOMATOSIS,SET,16,0.4564,0.01346,0.17943,0.0054909,HP_ARACHNOID_HEMANGIOMATOSIS,0.625692555737705
HOLLEMAN_ASPARAGINASE_RESIST...4,SET,24,0.38901,0.014048,0.15306,0.0055233,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_UP,0.626099438110749
GOMF_MHC_CLASS_I_RECEPTOR_AC...,SET,10,0.91165,0.021259,0.35877,0.0055305,GOMF_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.626099438110749
GOBP_POSITIVE_REGULATION_OF_...362,SET,33,0.35512,0.015034,0.13998,0.0055965,GOBP_POSITIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.629807839805825
HP_MACROTHROMBOCYTOPENIA,SET,12,0.64606,0.016503,0.25469,0.0055995,HP_MACROTHROMBOCYTOPENIA,0.629807839805825
GOBP_POSITIVE_REGULATION_OF_...383,SET,5,1.0215,0.016847,0.40298,0.0056275,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.630915362903226
HP_ABNORMALITY_OF_FACIAL_ADI...,SET,10,0.70371,0.01641,0.27781,0.0056574,HP_ABNORMALITY_OF_FACIAL_ADIPOSE_TISSUE,0.631861495192308
KEGG_MEDICUS_VARIANT_MUTATIO...18,SET,17,0.48105,0.014624,0.18998,0.0056723,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKACA_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.631861495192308
REACTOME_DARPP_32_EVENTS,SET,24,0.40313,0.014558,0.15929,0.0056945,REACTOME_DARPP_32_EVENTS,0.632307819488818
HP_EVERSION_OF_LATERAL_THIRD...,SET,4,0.77284,0.0114,0.30569,0.0057371,HP_EVERSION_OF_LATERAL_THIRD_OF_LOWER_EYELIDS,0.63500926910828
GOBP_REGULATION_OF_ALPHA_BET...1,SET,107,0.22337,0.016993,0.088529,0.0058207,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.636809707207207
GOBP_POSITIVE_REGULATION_OF_...592,SET,97,0.22018,0.015953,0.087289,0.0058327,GOBP_POSITIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.636809707207207
YU_MYC_TARGETS_DN,SET,50,0.30646,0.015963,0.1217,0.0059025,YU_MYC_TARGETS_DN,0.636809707207207
HP_IMPAIRED_ADP_INDUCED_PLAT...,SET,18,0.47699,0.01492,0.18946,0.005912,HP_IMPAIRED_ADP_INDUCED_PLATELET_AGGREGATION,0.636809707207207
GOBP_INTERMEDIATE_FILAMENT_B...1,SET,92,0.26618,0.018786,0.10576,0.0059231,GOBP_INTERMEDIATE_FILAMENT_BASED_PROCESS,0.636809707207207
REACTOME_UNFOLDED_PROTEIN_RE...,SET,87,0.21008,0.014419,0.083471,0.0059264,REACTOME_UNFOLDED_PROTEIN_RESPONSE_UPR,0.636809707207207
HP_DISTAL_MUSCLE_WEAKNESS,SET,205,0.14488,0.015215,0.057567,0.005928,HP_DISTAL_MUSCLE_WEAKNESS,0.636809707207207
KEGG_MEDICUS_REFERENCE_EGF_J...,SET,7,1.0388,0.020269,0.41328,0.005981,KEGG_MEDICUS_REFERENCE_EGF_JAK_STAT_SIGNALING_PATHWAY,0.636809707207207
HP_IMPAIRED_ARACHIDONIC_ACID...,SET,7,0.77293,0.015081,0.30768,0.0060045,HP_IMPAIRED_ARACHIDONIC_ACID_INDUCED_PLATELET_AGGREGATION,0.636809707207207
WP_NRF2_PATHWAY,SET,133,0.19732,0.016725,0.078549,0.0060048,WP_NRF2_PATHWAY,0.636809707207207
GAVISH_3CA_METAPROGRAM_MACRO...9,SET,47,0.28715,0.014502,0.11432,0.0060105,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MYC_MITOCHONDRIA,0.636809707207207
REACTOME_MITOTIC_PROMETAPHASE,SET,185,0.15025,0.014998,0.059834,0.0060228,REACTOME_MITOTIC_PROMETAPHASE,0.636809707207207
GOBP_POSITIVE_REGULATION_OF_...59,SET,5,1.1156,0.018399,0.44432,0.0060252,GOBP_POSITIVE_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.636809707207207
GSE37301_HEMATOPOIETIC_STEM_...8,SET,165,0.16335,0.015408,0.065112,0.0060624,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_UP,0.636809707207207
PID_GMCSF_PATHWAY,SET,35,0.35518,0.015485,0.14166,0.0060883,PID_GMCSF_PATHWAY,0.636809707207207
HP_KERATOACANTHOMA,SET,4,0.82001,0.012096,0.32706,0.0060889,HP_KERATOACANTHOMA,0.636809707207207
SHIN_B_CELL_LYMPHOMA_CLUSTER...5,SET,10,0.78302,0.01826,0.31236,0.006096,SHIN_B_CELL_LYMPHOMA_CLUSTER_6,0.636809707207207
GSE45739_NRAS_KO_VS_WT_UNSTI...2,SET,177,0.15654,0.015288,0.062451,0.0060984,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_UP,0.636809707207207
MIR3126_3P,SET,43,0.31968,0.015445,0.12754,0.0061015,MIR3126_3P,0.636809707207207
GOMF_MRNA_BINDING,SET,304,0.11231,0.014324,0.044837,0.0061297,GOMF_MRNA_BINDING,0.637837495508982
HP_SLOWED_SLURRED_SPEECH,SET,6,0.8288,0.014972,0.33125,0.0061793,HP_SLOWED_SLURRED_SPEECH,0.639462379261364
GSE27291_6H_VS_7D_STIM_GAMMA...1,SET,156,0.17398,0.015961,0.069564,0.0061957,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_DN,0.639462379261364
ZHENG_CORD_BLOOD_C4_PUTATIVE...,SET,86,0.23308,0.015906,0.093231,0.0062143,ZHENG_CORD_BLOOD_C4_PUTATIVE_EARLY_ERYTHROID_COMMITMENT,0.639462379261364
E2F1_Q4_01,SET,202,0.14656,0.01528,0.058679,0.0062558,E2F1_Q4_01,0.639462379261364
BOWIE_RESPONSE_TO_EXTRACELLU...,SET,17,0.48618,0.01478,0.19477,0.0062816,BOWIE_RESPONSE_TO_EXTRACELLULAR_MATRIX,0.639462379261364
GOBP_POSITIVE_REGULATION_OF_...186,SET,76,0.24936,0.016002,0.099919,0.0062916,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.639462379261364
KEGG_MEDICUS_VARIANT_AMPLIFI...13,SET,15,0.53574,0.015299,0.21483,0.0063238,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYC_TO_P27_CELL_CYCLE_G1_S,0.639462379261364
GOCC_PLATELET_DENSE_TUBULAR_...1,SET,10,0.62351,0.01454,0.25013,0.0063425,GOCC_PLATELET_DENSE_TUBULAR_NETWORK,0.639462379261364
GOMF_EPOXIDE_HYDROLASE_ACTIV...,SET,8,0.81908,0.017085,0.32881,0.0063729,GOMF_EPOXIDE_HYDROLASE_ACTIVITY,0.639462379261364
GOMF_MHC_CLASS_IB_PROTEIN_BI...,SET,6,0.89789,0.016221,0.36069,0.0064026,GOMF_MHC_CLASS_IB_PROTEIN_BINDING,0.639462379261364
GSE17721_POLYIC_VS_PAM3CSK4_...4,SET,189,0.15003,0.015136,0.060282,0.0064139,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_UP,0.639462379261364
KEGG_PRION_DISEASES,SET,33,0.38886,0.016463,0.15625,0.0064144,KEGG_PRION_DISEASES,0.639462379261364
HP_ABNORMAL_THIRD_TOE_MORPHO...,SET,7,0.89094,0.017384,0.35815,0.0064346,HP_ABNORMAL_THIRD_TOE_MORPHOLOGY,0.639462379261364
MIR493_3P,SET,61,0.2595,0.014925,0.10437,0.0064588,MIR493_3P,0.639462379261364
HP_URINARY_TRACT_NEOPLASM,SET,133,0.18231,0.015453,0.073338,0.0064657,HP_URINARY_TRACT_NEOPLASM,0.639462379261364
GOCC_SMOOTH_ENDOPLASMIC_RETI...1,SET,28,0.39866,0.015548,0.16037,0.0064674,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM,0.639462379261364
PID_NFAT_3PATHWAY,SET,53,0.29162,0.015637,0.11733,0.0064739,PID_NFAT_3PATHWAY,0.639462379261364
REACTOME_ALTERNATIVE_COMPLEM...,SET,4,1.1576,0.017076,0.46577,0.0064765,REACTOME_ALTERNATIVE_COMPLEMENT_ACTIVATION,0.639462379261364
REACTOME_AURKA_ACTIVATION_BY...,SET,67,0.2334,0.014067,0.094024,0.0065297,REACTOME_AURKA_ACTIVATION_BY_TPX2,0.642888735127479
ZHOU_CELL_CYCLE_GENES_IN_IR_...3,SET,79,0.23021,0.015061,0.092909,0.0066142,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_6HR,0.64591244800885
GOBP_MYD88_INDEPENDENT_TOLL_...,SET,16,0.49584,0.014623,0.20012,0.0066167,GOBP_MYD88_INDEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.64591244800885
HP_NEOPLASM_OF_THE_GENITOURI...,SET,213,0.14111,0.015103,0.056968,0.0066285,HP_NEOPLASM_OF_THE_GENITOURINARY_TRACT,0.64591244800885
KEGG_MEDICUS_VARIANT_PAX8_PP...,SET,5,0.94607,0.015602,0.38249,0.0066958,KEGG_MEDICUS_VARIANT_PAX8_PPARG_FUSION_TO_PPARG_MEDIATED_TRANSCRIPTION,0.64591244800885
HP_ATROPHY_DEGENERATION_INVO...3,SET,19,0.45506,0.014624,0.18401,0.0067028,HP_ATROPHY_DEGENERATION_INVOLVING_THE_SPINAL_CORD,0.64591244800885
MYAATNNNNNNNGGC_UNKNOWN,SET,103,0.20904,0.015605,0.084553,0.0067159,MYAATNNNNNNNGGC_UNKNOWN,0.64591244800885
BIOCARTA_MYOSIN_PATHWAY,SET,11,0.72726,0.017787,0.29423,0.0067282,BIOCARTA_MYOSIN_PATHWAY,0.64591244800885
GSE14415_ACT_VS_CTRL_NATURAL...1,SET,157,0.16781,0.015444,0.06792,0.0067467,GSE14415_ACT_VS_CTRL_NATURAL_TREG_DN,0.64591244800885
MIR328_5P,SET,53,0.27927,0.014975,0.11304,0.0067479,MIR328_5P,0.64591244800885
REACTOME_NOD1_2_SIGNALING_PA...,SET,32,0.36026,0.015019,0.1459,0.0067759,REACTOME_NOD1_2_SIGNALING_PATHWAY,0.64591244800885
GOMF_PHOSPHATIDYLINOSITOL_4_...4,SET,27,0.38548,0.014764,0.15632,0.0068362,GOMF_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_BINDING,0.64591244800885
HP_TUBULOINTERSTITIAL_NEPHRI...,SET,19,0.44067,0.014161,0.17877,0.0068554,HP_TUBULOINTERSTITIAL_NEPHRITIS,0.64591244800885
GSE15735_2H_VS_12H_HDAC_INHI...2,SET,188,0.15847,0.015945,0.064305,0.0068679,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_UP,0.64591244800885
HP_ABNORMAL_SYSTEMIC_BLOOD_P...,SET,487,0.097597,0.015675,0.039661,0.0069362,HP_ABNORMAL_SYSTEMIC_BLOOD_PRESSURE,0.64591244800885
GSE3982_NEUTROPHIL_VS_TH2_DN,SET,182,0.14408,0.014267,0.058569,0.0069513,GSE3982_NEUTROPHIL_VS_TH2_DN,0.64591244800885
SREBP1_02,SET,79,0.22133,0.01448,0.089985,0.0069587,SREBP1_02,0.64591244800885
GSE36078_UNTREATED_VS_AD5_T4...2,SET,179,0.15276,0.015002,0.062253,0.0070721,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_UP,0.64591244800885
HP_HYPERTENSION,SET,355,0.11361,0.015636,0.046361,0.0071366,HP_HYPERTENSION,0.64591244800885
KEGG_MEDICUS_REFERENCE_REGUL...7,SET,10,0.57091,0.013313,0.23306,0.0071555,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PATHWAY_ADAPTOR_PROTEINS,0.64591244800885
GOBP_NEGATIVE_REGULATION_OF_...338,SET,52,0.28862,0.015331,0.11793,0.0071976,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.64591244800885
GSE24142_EARLY_THYMIC_PROGEN...9,SET,186,0.1519,0.015204,0.06212,0.0072421,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_DN,0.64591244800885
REACTOME_SIGNALING_BY_NOTCH2,SET,30,0.40059,0.016171,0.16383,0.0072444,REACTOME_SIGNALING_BY_NOTCH2,0.64591244800885
chr14q23,SET,53,0.56371,0.030228,0.23059,0.0072558,chr14q23,0.64591244800885
GSE36527_CD62L_HIGH_VS_CD62L...2,SET,180,0.15351,0.015117,0.062795,0.007256,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_UP,0.64591244800885
KEGG_MEDICUS_VARIANT_EML4_AL...3,SET,13,0.57511,0.01529,0.23534,0.0072726,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PLCG_ERK_SIGNALING_PATHWAY,0.64591244800885
HP_BLUE_SCLERAE,SET,97,0.19989,0.014483,0.081801,0.0072757,HP_BLUE_SCLERAE,0.64591244800885
LXR_DR4_Q3,SET,81,0.23543,0.015595,0.096347,0.0072759,LXR_DR4_Q3,0.64591244800885
HP_ABNORMAL_HEART_VALVE_MORP...,SET,307,0.11996,0.015374,0.049115,0.0072985,HP_ABNORMAL_HEART_VALVE_MORPHOLOGY,0.64591244800885
GSE2124_CTRL_VS_LYMPHOTOXIN_...2,SET,183,0.15617,0.015506,0.06394,0.0072988,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_UP,0.64591244800885
SOBOLEV_PBMC_PANDEMRIX_AGE_1...4,SET,18,0.55105,0.017237,0.22565,0.0073069,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_CORRELATED_WITH_TRANSITIONAL_B_CELLS_UP,0.64591244800885
GOBP_PULMONARY_ARTERY_MORPHO...,SET,6,0.96179,0.017375,0.39403,0.0073306,GOBP_PULMONARY_ARTERY_MORPHOGENESIS,0.64591244800885
GOBP_GLANDULAR_EPITHELIAL_CE...3,SET,8,0.84753,0.017678,0.34723,0.0073313,GOBP_GLANDULAR_EPITHELIAL_CELL_MATURATION,0.64591244800885
BIOCARTA_EEA1_PATHWAY,SET,7,0.72766,0.014198,0.29812,0.0073328,BIOCARTA_EEA1_PATHWAY,0.64591244800885
HP_SUBCUTANEOUS_HEMORRHAGE,SET,234,0.1374,0.015405,0.056372,0.0074011,HP_SUBCUTANEOUS_HEMORRHAGE,0.64591244800885
GOMF_SODIUM_INDEPENDENT_ORGA...,SET,16,0.60149,0.017739,0.24684,0.0074149,GOMF_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.64591244800885
WP_COMPLEMENT_SYSTEM,SET,89,0.23682,0.01644,0.097215,0.0074294,WP_COMPLEMENT_SYSTEM,0.64591244800885
HP_INTRACRANIAL_HEMORRHAGE,SET,141,0.17294,0.015089,0.070997,0.0074328,HP_INTRACRANIAL_HEMORRHAGE,0.64591244800885
REACTOME_AZATHIOPRINE_ADME,SET,21,0.48046,0.016232,0.19737,0.0074657,REACTOME_AZATHIOPRINE_ADME,0.64591244800885
MIR524_3P_MIR525_3P,SET,11,0.61013,0.014922,0.25073,0.0074836,MIR524_3P_MIR525_3P,0.64591244800885
HP_ALZHEIMER_DISEASE,SET,9,0.76644,0.016956,0.31521,0.0075225,HP_ALZHEIMER_DISEASE,0.64591244800885
GSE3982_MEMORY_CD4_TCELL_VS_...6,SET,172,0.15635,0.015054,0.06431,0.00753,GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP,0.64591244800885
GSE9988_LPS_VS_CTRL_TREATED_...2,SET,163,0.17135,0.016065,0.07052,0.0075583,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_UP,0.64591244800885
TOMLINS_METASTASIS_DN,SET,18,0.49774,0.015569,0.20496,0.0075867,TOMLINS_METASTASIS_DN,0.64591244800885
GSE13547_WT_VS_ZFX_KO_BCELL_...5,SET,164,0.16073,0.015115,0.066194,0.0075925,GSE13547_WT_VS_ZFX_KO_BCELL_DN,0.64591244800885
GOBP_ERBB4_SIGNALING_PATHWAY,SET,9,0.68556,0.015167,0.28245,0.0076131,GOBP_ERBB4_SIGNALING_PATHWAY,0.64591244800885
AIZARANI_LIVER_C18_NK_NKT_CE...,SET,110,0.21288,0.01642,0.087719,0.0076208,AIZARANI_LIVER_C18_NK_NKT_CELLS_5,0.64591244800885
GOBP_HEPARIN_BIOSYNTHETIC_PR...,SET,11,0.61812,0.015117,0.25481,0.0076428,GOBP_HEPARIN_BIOSYNTHETIC_PROCESS,0.64591244800885
HP_ABNORMAL_ELECTROPHYSIOLOG...,SET,78,0.23573,0.015324,0.097193,0.0076506,HP_ABNORMAL_ELECTROPHYSIOLOGY_OF_SINOATRIAL_NODE_ORIGIN,0.64591244800885
GENTILE_UV_RESPONSE_CLUSTER_...8,SET,24,0.42611,0.015388,0.17592,0.0077179,GENTILE_UV_RESPONSE_CLUSTER_D9,0.64591244800885
GOBP_MICROTUBULE_NUCLEATION,SET,41,0.28064,0.01324,0.11587,0.0077214,GOBP_MICROTUBULE_NUCLEATION,0.64591244800885
GOBP_METAPHASE_ANAPHASE_TRAN...,SET,6,0.83573,0.015098,0.34507,0.007725,GOBP_METAPHASE_ANAPHASE_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.64591244800885
GOMF_PROTEIN_PHOSPHATASE_1_B...,SET,23,0.40775,0.014415,0.16838,0.00773,GOMF_PROTEIN_PHOSPHATASE_1_BINDING,0.64591244800885
KEGG_MEDICUS_VARIANT_MUTATIO...76,SET,20,0.42543,0.014026,0.17568,0.0077314,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PDE11A_PDE8B_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.64591244800885
KEGG_MEDICUS_REFERENCE_BRANC...,SET,30,0.37641,0.015195,0.15554,0.0077644,KEGG_MEDICUS_REFERENCE_BRANCHING_MICROTUBULE_NUCLEATION,0.64591244800885
HUANG_AML_LSC47,SET,41,0.34091,0.016084,0.14091,0.0077793,HUANG_AML_LSC47,0.64591244800885
GSE2770_IL12_VS_IL4_TREATED_...3,SET,177,0.15137,0.014783,0.062583,0.0077916,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.64591244800885
GSE37416_CTRL_VS_12H_F_TULAR...2,SET,170,0.15948,0.015267,0.065999,0.0078429,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.64591244800885
HP_PRIMARY_PERITONEAL_CARCIN...,SET,13,0.54618,0.014521,0.22604,0.0078448,HP_PRIMARY_PERITONEAL_CARCINOMA,0.64591244800885
GSE8921_3H_VS_24H_TLR1_2_STI...2,SET,175,0.15559,0.01511,0.064391,0.0078453,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_UP,0.64591244800885
HP_MULTIPLE_IMPACTED_TEETH,SET,4,1.1417,0.016841,0.47271,0.0078673,HP_MULTIPLE_IMPACTED_TEETH,0.64591244800885
GOMF_DIACYLGLYCEROL_DEPENDEN...,SET,16,0.51756,0.015264,0.21429,0.0078692,GOMF_DIACYLGLYCEROL_DEPENDENT_SERINE_THREONINE_KINASE_ACTIVITY,0.64591244800885
ESC_V6.5_UP_LATE.V1_DN,SET,162,0.15779,0.014749,0.065347,0.00788,ESC_V6.5_UP_LATE.V1_DN,0.64591244800885
GOMF_SINGLE_STRANDED_DNA_HEL...,SET,23,0.39842,0.014085,0.16502,0.0078866,GOMF_SINGLE_STRANDED_DNA_HELICASE_ACTIVITY,0.64591244800885
GSE17974_CTRL_VS_ACT_IL4_AND...18,SET,172,0.15806,0.015219,0.065469,0.0078872,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_UP,0.64591244800885
GSE23568_ID3_KO_VS_WT_CD8_TC...1,SET,186,0.15141,0.015155,0.062715,0.0078887,GSE23568_ID3_KO_VS_WT_CD8_TCELL_DN,0.64591244800885
KEGG_MEDICUS_REFERENCE_CARDI...,SET,21,0.48565,0.016407,0.20119,0.007896,KEGG_MEDICUS_REFERENCE_CARDIAC_TYPE_VGCC_RYR_SIGNALING,0.64591244800885
GSE11961_GERMINAL_CENTER_BCE...6,SET,181,0.15362,0.01517,0.063654,0.0079076,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,0.64591244800885
WP_ANDROGEN_RECEPTOR_NETWORK...,SET,106,0.20228,0.015317,0.08387,0.0079426,WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER,0.64591244800885
REACTOME_KERATAN_SULFATE_BIO...,SET,28,0.39499,0.015405,0.16382,0.0079566,REACTOME_KERATAN_SULFATE_BIOSYNTHESIS,0.64591244800885
HP_ISOMERISM,SET,4,1.0255,0.015128,0.42543,0.0079681,HP_ISOMERISM,0.64591244800885
GOBP_DNA_TEMPLATED_DNA_REPLI...2,SET,54,0.26789,0.0145,0.11127,0.0080322,GOBP_DNA_TEMPLATED_DNA_REPLICATION_MAINTENANCE_OF_FIDELITY,0.64591244800885
GOBP_REGULATION_OF_MYELOID_L...1,SET,116,0.2059,0.016306,0.085554,0.0080543,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.64591244800885
HP_BCGITIS,SET,10,0.68548,0.015985,0.28487,0.0080623,HP_BCGITIS,0.64591244800885
MIR7515,SET,142,0.1652,0.014465,0.068656,0.0080644,MIR7515,0.64591244800885
GSE369_SOCS3_KO_VS_WT_LIVER_...4,SET,178,0.14341,0.014045,0.059646,0.0081046,GSE369_SOCS3_KO_VS_WT_LIVER_UP,0.64591244800885
GOBP_SODIUM_INDEPENDENT_ORGA...,SET,15,0.63282,0.018071,0.26332,0.0081305,GOBP_SODIUM_INDEPENDENT_ORGANIC_ANION_TRANSPORT,0.64591244800885
GOBP_AMINOGLYCAN_METABOLIC_P...,SET,116,0.1921,0.015213,0.079956,0.0081454,GOBP_AMINOGLYCAN_METABOLIC_PROCESS,0.64591244800885
WP_TH17_CELL_DIFFERENTIATION...,SET,67,0.26404,0.015913,0.10992,0.0081534,WP_TH17_CELL_DIFFERENTIATION_PATHWAY,0.64591244800885
HP_ATROPHY_DEGENERATION_INVO...2,SET,34,0.34491,0.014821,0.14358,0.0081536,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CORTICOSPINAL_TRACTS,0.64591244800885
BIOCARTA_GH_PATHWAY,SET,26,0.4084,0.01535,0.17003,0.008158,BIOCARTA_GH_PATHWAY,0.64591244800885
RODRIGUES_THYROID_CARCINOMA_...1,SET,469,0.094306,0.014871,0.039274,0.0081753,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN,0.64591244800885
GOBP_POSITIVE_REGULATION_OF_...162,SET,9,0.72321,0.016,0.3012,0.0081781,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_BINDING,0.64591244800885
CGTCTTA_MIR208,SET,8,0.74123,0.015461,0.30875,0.0081854,CGTCTTA_MIR208,0.64591244800885
HP_PSEUDOBULBAR_SIGNS,SET,28,0.38141,0.014876,0.15898,0.0082212,HP_PSEUDOBULBAR_SIGNS,0.64591244800885
FAN_OVARY_CL11_MURAL_GRANULO...,SET,387,0.10689,0.015346,0.044568,0.0082409,FAN_OVARY_CL11_MURAL_GRANULOSA_CELL,0.64591244800885
GSE360_L_DONOVANI_VS_M_TUBER...1,SET,183,0.14979,0.014872,0.062462,0.0082472,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_DN,0.64591244800885
KEGG_MEDICUS_REFERENCE_SKELE...,SET,21,0.48539,0.016398,0.20247,0.0082617,KEGG_MEDICUS_REFERENCE_SKELETAL_TYPE_VGCC_RYR_SIGNALING,0.64591244800885
GSE2585_CD80_HIGH_VS_LOW_MTE...1,SET,171,0.15618,0.014995,0.065149,0.008263,GSE2585_CD80_HIGH_VS_LOW_MTEC_DN,0.64591244800885
WINTER_HYPOXIA_DN,SET,42,0.32687,0.015608,0.13637,0.0082699,WINTER_HYPOXIA_DN,0.64591244800885
GSE40225_WT_VS_RIP_B7X_DIABE...2,SET,167,0.15071,0.014301,0.062909,0.0082984,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_UP,0.64591244800885
GOMF_SMALL_RIBOSOMAL_SUBUNIT...,SET,7,0.75953,0.01482,0.31704,0.0082994,GOMF_SMALL_RIBOSOMAL_SUBUNIT_RRNA_BINDING,0.64591244800885
EBAUER_MYOGENIC_TARGETS_OF_P...,SET,43,0.32262,0.015587,0.13468,0.0083051,EBAUER_MYOGENIC_TARGETS_OF_PAX3_FOXO1_FUSION,0.64591244800885
GSE411_UNSTIM_VS_400MIN_IL6_...1,SET,180,0.14638,0.014416,0.061121,0.0083154,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_DN,0.64591244800885
MIR7110_5P,SET,154,0.16819,0.015331,0.070234,0.0083232,MIR7110_5P,0.64591244800885
PUJANA_BREAST_CANCER_LIT_INT...,SET,91,0.19418,0.01363,0.081107,0.0083347,PUJANA_BREAST_CANCER_LIT_INT_NETWORK,0.64591244800885
MIR4329,SET,70,0.24394,0.015026,0.10194,0.0083632,MIR4329,0.64591244800885
WP_RAC1PAK1P38MMP2_PATHWAY,SET,66,0.24556,0.014689,0.10265,0.0083792,WP_RAC1PAK1P38MMP2_PATHWAY,0.64591244800885
GOMF_DNA_BINDING_TRANSCRIPTI...4,SET,263,0.12877,0.015293,0.053832,0.0083836,GOMF_DNA_BINDING_TRANSCRIPTION_REPRESSOR_ACTIVITY,0.64591244800885
HP_INGUINAL_FRECKLING,SET,6,0.67571,0.012207,0.28257,0.0084003,HP_INGUINAL_FRECKLING,0.64591244800885
GOBP_REGULATION_OF_NEUTROPHI...3,SET,8,0.67972,0.014178,0.28452,0.0084515,GOBP_REGULATION_OF_NEUTROPHIL_DEGRANULATION,0.648414751655629
HP_PRIMARY_GONADAL_INSUFFICI...,SET,15,0.52474,0.014985,0.21975,0.0084773,HP_PRIMARY_GONADAL_INSUFFICIENCY,0.648961589207048
COLLIS_PRKDC_REGULATORS,SET,13,0.60341,0.016042,0.25292,0.0085267,COLLIS_PRKDC_REGULATORS,0.650398667763158
QI_PBMC_ZOSTAVAX_AGE_50_75YO...1,SET,6,0.79564,0.014373,0.33353,0.0085335,QI_PBMC_ZOSTAVAX_AGE_50_75YO_1DY_UP,0.650398667763158
RUBENSTEIN_SKELETAL_MUSCLE_F...2,SET,256,0.12988,0.015221,0.054476,0.0085642,RUBENSTEIN_SKELETAL_MUSCLE_FBN1_FAP_CELLS,0.651258725490196
PID_VEGFR1_PATHWAY,SET,26,0.36583,0.01375,0.15354,0.0086,PID_VEGFR1_PATHWAY,0.651258725490196
HP_ELFIN_FACIES,SET,18,0.51151,0.016,0.21469,0.008601,HP_ELFIN_FACIES,0.651258725490196
KORKOLA_YOLK_SAC_TUMOR,SET,53,0.30211,0.0162,0.12685,0.0086208,KORKOLA_YOLK_SAC_TUMOR,0.65133892173913
ACTGCAG_MIR173P,SET,95,0.20463,0.014674,0.085971,0.0086564,ACTGCAG_MIR173P,0.651944006451613
WP_PHOTODYNAMIC_THERAPYINDUC...3,SET,23,0.47443,0.016773,0.19939,0.0086742,WP_PHOTODYNAMIC_THERAPYINDUCED_NFE2L2_NRF2_SURVIVAL_SIGNALING,0.651944006451613
GSE25123_CTRL_VS_IL4_STIM_MA...1,SET,175,0.15261,0.014821,0.064171,0.0087041,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.651944006451613
AIZARANI_LIVER_C34_MHC_II_PO...,SET,118,0.19183,0.015321,0.080687,0.0087215,AIZARANI_LIVER_C34_MHC_II_POS_B_CELLS,0.651944006451613
GOMF_TRNA_SPECIFIC_RIBONUCLE...,SET,13,0.55001,0.014623,0.23135,0.0087226,GOMF_TRNA_SPECIFIC_RIBONUCLEASE_ACTIVITY,0.651944006451613
GOBP_CALCIUM_ION_IMPORT,SET,73,0.23974,0.015079,0.10092,0.0087666,GOBP_CALCIUM_ION_IMPORT,0.653691687366167
HP_RAGGED_RED_MUSCLE_FIBERS,SET,40,0.30002,0.013981,0.12633,0.0087836,HP_RAGGED_RED_MUSCLE_FIBERS,0.653691687366167
REACTOME_SIGNALING_BY_ERBB2_...1,SET,15,0.45554,0.013009,0.19194,0.0088182,REACTOME_SIGNALING_BY_ERBB2_ECD_MUTANTS,0.654864403846154
GSE29618_BCELL_VS_MONOCYTE_UP,SET,160,0.16576,0.015399,0.069905,0.0088701,GSE29618_BCELL_VS_MONOCYTE_UP,0.656825965553236
GOBP_PHOSPHATIDYLSERINE_EXPO...,SET,8,0.6782,0.014147,0.28618,0.0089035,GOBP_PHOSPHATIDYLSERINE_EXPOSURE_ON_APOPTOTIC_CELL_SURFACE,0.656825965553236
GOBP_T_HELPER_17_TYPE_IMMUNE...,SET,45,0.31786,0.015709,0.13418,0.0089245,GOBP_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.656825965553236
HP_SPARSE_LATERAL_EYEBROW,SET,30,0.35117,0.014176,0.14832,0.0089552,HP_SPARSE_LATERAL_EYEBROW,0.656825965553236
GOMF_COMPLEMENT_BINDING,SET,20,0.47911,0.015796,0.20246,0.0089847,GOMF_COMPLEMENT_BINDING,0.656825965553236
HP_ABNORMAL_SWEAT_GLAND_MORP...,SET,18,0.50763,0.015878,0.21458,0.0090043,HP_ABNORMAL_SWEAT_GLAND_MORPHOLOGY,0.656825965553236
PID_ERBB1_RECEPTOR_PROXIMAL_...,SET,34,0.31986,0.013745,0.13523,0.0090139,PID_ERBB1_RECEPTOR_PROXIMAL_PATHWAY,0.656825965553236
GSE24634_IL4_VS_CTRL_TREATED...3,SET,176,0.15371,0.01497,0.065001,0.0090258,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_DN,0.656825965553236
GSE18281_CORTICAL_VS_MEDULLA...2,SET,183,0.15131,0.015023,0.063993,0.0090351,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_UP,0.656825965553236
BOHN_PRIMARY_IMMUNODEFICIENC...1,SET,36,0.32956,0.014571,0.13941,0.0090469,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN,0.656825965553236
GSE2770_TGFB_AND_IL4_VS_IL4_...2,SET,184,0.14569,0.014504,0.061638,0.0090525,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,0.656825965553236
HALMOS_CEBPA_TARGETS_UP,SET,47,0.32128,0.016226,0.136,0.0090833,HALMOS_CEBPA_TARGETS_UP,0.657687690625
MIR637,SET,78,0.2173,0.014126,0.092017,0.0091048,MIR637,0.657763980353635
GSE22935_UNSTIM_VS_24H_MBOVI...3,SET,182,0.14596,0.014453,0.061855,0.009149,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.657763980353635
KEGG_MEDICUS_REFERENCE_P15_C...,SET,13,0.55419,0.014734,0.23528,0.0092564,KEGG_MEDICUS_REFERENCE_P15_CELL_CYCLE_G1_S,0.657763980353635
MODULE_156,SET,16,0.48881,0.014416,0.20772,0.0093113,MODULE_156,0.657763980353635
GOBP_DEDIFFERENTIATION,SET,8,0.82851,0.017282,0.35216,0.0093255,GOBP_DEDIFFERENTIATION,0.657763980353635
GOCC_INHIBITORY_SYNAPSE,SET,13,0.58864,0.01565,0.25022,0.0093292,GOCC_INHIBITORY_SYNAPSE,0.657763980353635
GOBP_POSITIVE_REGULATION_OF_...67,SET,19,0.49767,0.015993,0.21157,0.0093338,GOBP_POSITIVE_REGULATION_OF_BONE_RESORPTION,0.657763980353635
WP_CONSTITUTIVE_ANDROSTANE_R...,SET,29,0.37692,0.01496,0.16024,0.0093374,WP_CONSTITUTIVE_ANDROSTANE_RECEPTOR_PATHWAY,0.657763980353635
DESCARTES_MAIN_FETAL_SLC26A4...,SET,197,0.13163,0.013554,0.055971,0.0093489,DESCARTES_MAIN_FETAL_SLC26A4_PAEP_POSITIVE_CELLS,0.657763980353635
HP_HIP_CONTRACTURE,SET,51,0.2827,0.014871,0.12032,0.0094038,HP_HIP_CONTRACTURE,0.657763980353635
WP_PROSTAGLANDIN_SYNTHESIS_A...,SET,45,0.33661,0.016636,0.14331,0.0094225,WP_PROSTAGLANDIN_SYNTHESIS_AND_REGULATION,0.657763980353635
REACTOME_DEFECTIVE_ST3GAL3_C...,SET,8,0.6868,0.014326,0.29245,0.0094312,REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15,0.657763980353635
GSE9037_CTRL_VS_LPS_4H_STIM_...3,SET,183,0.14846,0.01474,0.063242,0.0094556,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_DN,0.657763980353635
GSE14769_UNSTIM_VS_120MIN_LP...2,SET,184,0.13939,0.013877,0.059379,0.0094562,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_UP,0.657763980353635
GOMF_COMPLEMENT_COMPONENT_C3...,SET,7,0.94001,0.018342,0.4005,0.0094662,GOMF_COMPLEMENT_COMPONENT_C3B_BINDING,0.657763980353635
GARCIA_PINERES_PBMC_HPV_16_L...1,SET,20,0.45759,0.015087,0.195,0.00948,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.657763980353635
REACTOME_SARS_COV_1_ACTIVATE...,SET,34,0.32841,0.014112,0.13996,0.0094831,REACTOME_SARS_COV_1_ACTIVATES_MODULATES_INNATE_IMMUNE_RESPONSES,0.657763980353635
GSE27896_HDAC6_KO_VS_WT_TREG...2,SET,164,0.15218,0.014311,0.064885,0.0095106,GSE27896_HDAC6_KO_VS_WT_TREG_UP,0.657763980353635
WP_GLYCOSAMINOGLYCAN_SYNTHES...,SET,39,0.31964,0.014709,0.13632,0.0095232,WP_GLYCOSAMINOGLYCAN_SYNTHESIS_IN_FIBROBLASTS,0.657763980353635
GOMF_TRANSFERASE_ACTIVITY_TR...5,SET,67,0.25163,0.015165,0.10733,0.0095324,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_SULPHUR_CONTAINING_GROUPS,0.657763980353635
HP_POLYARTICULAR_ARTHROPATHY,SET,18,0.49752,0.015562,0.21226,0.0095456,HP_POLYARTICULAR_ARTHROPATHY,0.657763980353635
GOBP_EMBRYONIC_CAMERA_TYPE_E...1,SET,37,0.34692,0.01555,0.14811,0.0095891,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.657763980353635
MIR744_5P,SET,10,0.60139,0.014024,0.25679,0.0095981,MIR744_5P,0.657763980353635
GNF2_CASP4,SET,21,0.43936,0.014843,0.18764,0.0096082,GNF2_CASP4,0.657763980353635
GOBP_SULFATION,SET,20,0.49566,0.016342,0.21169,0.0096104,GOBP_SULFATION,0.657763980353635
GOBP_POSITIVE_REGULATION_OF_...811,SET,18,0.48013,0.015018,0.20509,0.0096181,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.657763980353635
GSE23695_CD57_POS_VS_NEG_NK_...1,SET,185,0.13765,0.01374,0.058806,0.0096294,GSE23695_CD57_POS_VS_NEG_NK_CELL_DN,0.657763980353635
HP_HAIR_FOLLICLE_NEOPLASM,SET,5,1.0935,0.018033,0.46717,0.0096316,HP_HAIR_FOLLICLE_NEOPLASM,0.657763980353635
WP_SEROTONIN_RECEPTOR_467_AN...,SET,18,0.50668,0.015849,0.21648,0.0096332,WP_SEROTONIN_RECEPTOR_467_AND_NR3C_SIGNALING,0.657763980353635
GOBP_NEGATIVE_REGULATION_OF_...152,SET,8,0.82079,0.017121,0.35106,0.0096985,GOBP_NEGATIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.66092425
GSE13229_MATURE_VS_INTMATURE...2,SET,174,0.15468,0.014979,0.066201,0.0097362,GSE13229_MATURE_VS_INTMATURE_NKCELL_UP,0.661261391601562
GSE3720_VD1_VS_VD2_GAMMADELT...1,SET,184,0.14568,0.014503,0.062351,0.0097415,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_DN,0.661261391601562
GOCC_PTW_PP1_PHOSPHATASE_COM...,SET,7,0.62866,0.012267,0.26919,0.0097679,GOCC_PTW_PP1_PHOSPHATASE_COMPLEX,0.661760944444444
HP_FACIAL_EDEMA,SET,122,0.19005,0.015433,0.081431,0.0098055,HP_FACIAL_EDEMA,0.662931418604651
GSE18893_TCONV_VS_TREG_24H_T...1,SET,169,0.14575,0.013911,0.062476,0.0098346,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_DN,0.662931418604651
CASORELLI_ACUTE_PROMYELOCYTI...2,SET,143,0.16686,0.014661,0.071538,0.0098424,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP,0.662931418604651
HP_PROLONGED_BLEEDING_FOLLOW...2,SET,29,0.39249,0.015578,0.16842,0.0098962,HP_PROLONGED_BLEEDING_FOLLOWING_PROCEDURE,0.664228988439306
GOMF_MRNA_3_UTR_BINDING,SET,98,0.18804,0.013694,0.080697,0.0099049,GOMF_MRNA_3_UTR_BINDING,0.664228988439306
GOCC_KERATIN_FILAMENT,SET,81,0.29859,0.019778,0.12817,0.009919,GOCC_KERATIN_FILAMENT,0.664228988439306
WACKER_HYPOXIA_TARGETS_OF_VHL,SET,11,0.62248,0.015224,0.26746,0.0099778,WACKER_HYPOXIA_TARGETS_OF_VHL,0.666881613461539
KEGG_MEDICUS_REFERENCE_ORIGI...,SET,29,0.32959,0.013082,0.14171,0.010021,KEGG_MEDICUS_REFERENCE_ORIGIN_UNWINDING_AND_ELONGATION,0.667309265267176
GOBP_REGULATION_OF_MONOCYTE_...2,SET,18,0.49796,0.015576,0.21412,0.010026,GOBP_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.667309265267176
GSE42021_CD24INT_VS_CD24LOW_...2,SET,182,0.14839,0.014693,0.063828,0.010047,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_UP,0.667309265267176
GOBP_NEGATIVE_REGULATION_OF_...386,SET,7,0.75091,0.014652,0.32307,0.010061,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.667309265267176
HP_GRANULOCYTIC_HYPERPLASIA,SET,6,0.93387,0.016871,0.40196,0.010087,HP_GRANULOCYTIC_HYPERPLASIA,0.6677594
HP_ABNORMAL_NUMBER_OF_GRANUL...,SET,9,0.65937,0.014588,0.28411,0.010154,HP_ABNORMAL_NUMBER_OF_GRANULOCYTE_PRECURSORS,0.66822893194707
MIR6761_5P,SET,108,0.19096,0.014595,0.082282,0.010156,MIR6761_5P,0.66822893194707
GSE11961_MARGINAL_ZONE_BCELL...3,SET,182,0.14077,0.013939,0.060661,0.010158,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.66822893194707
MIR27B_5P,SET,43,0.29545,0.014274,0.12734,0.010171,MIR27B_5P,0.66822893194707
VERRECCHIA_EARLY_RESPONSE_TO...,SET,52,0.28557,0.015168,0.12316,0.010214,VERRECCHIA_EARLY_RESPONSE_TO_TGFB1,0.668919209039548
DIAZ_CHRONIC_MYELOGENOUS_LEU...1,SET,106,0.19981,0.015131,0.086186,0.01022,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_DN,0.668919209039548
GOCC_ESC_E_Z_COMPLEX,SET,14,0.49656,0.0137,0.21427,0.010246,GOCC_ESC_E_Z_COMPLEX,0.669360394736842
KOYAMA_SEMA3B_TARGETS_DN,SET,319,0.11089,0.014481,0.047884,0.010293,KOYAMA_SEMA3B_TARGETS_DN,0.67116925891182
YAGUE_PRETUMOR_DRUG_RESISTAN...2,SET,7,0.82481,0.016094,0.35635,0.010323,YAGUE_PRETUMOR_DRUG_RESISTANCE_UP,0.671864915730337
MIR1237_5P_MIR4488,SET,12,0.6068,0.0155,0.26229,0.010354,MIR1237_5P_MIR4488,0.672622934579439
MIR3179,SET,117,0.17024,0.01354,0.073613,0.010377,MIR3179,0.672706648044693
BIOCARTA_SLRP_PATHWAY,SET,5,1.254,0.020681,0.54238,0.010394,BIOCARTA_SLRP_PATHWAY,0.672706648044693
GILMORE_CORE_NFKB_PATHWAY,SET,12,0.57004,0.014561,0.24673,0.01044,GILMORE_CORE_NFKB_PATHWAY,0.673878482632541
KEGG_MEDICUS_VARIANT_AML1_ET...,SET,5,0.76154,0.012559,0.32974,0.010462,KEGG_MEDICUS_VARIANT_AML1_ETO_FUSION_TO_PU.1_MEDIATED_TRANSCRIPTION,0.673878482632541
GSE22886_NAIVE_CD4_TCELL_VS_...4,SET,176,0.13984,0.013619,0.060579,0.010492,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_UP,0.673878482632541
MIR4757_5P,SET,55,0.27597,0.015074,0.11962,0.01053,MIR4757_5P,0.673878482632541
REACTOME_TAK1_DEPENDENT_IKK_...,SET,40,0.30093,0.014024,0.13045,0.010537,REACTOME_TAK1_DEPENDENT_IKK_AND_NF_KAPPA_B_ACTIVATION,0.673878482632541
REACTOME_SHC1_EVENTS_IN_EGFR...,SET,14,0.51254,0.014141,0.22224,0.010555,REACTOME_SHC1_EVENTS_IN_EGFR_SIGNALING,0.673878482632541
LEE_BMP2_TARGETS_DN,SET,824,0.06644,0.013749,0.028821,0.010581,LEE_BMP2_TARGETS_DN,0.673878482632541
HP_THIRD_DEGREE_ATRIOVENTRIC...,SET,9,0.59593,0.013184,0.25853,0.010587,HP_THIRD_DEGREE_ATRIOVENTRICULAR_BLOCK,0.673878482632541
GSE13522_WT_VS_IFNAR_KO_SKIN...4,SET,177,0.1453,0.01419,0.063043,0.010595,GSE13522_WT_VS_IFNAR_KO_SKIN_UP,0.673878482632541
GOBP_POSITIVE_REGULATION_OF_...216,SET,5,0.69918,0.011531,0.30341,0.010606,GOBP_POSITIVE_REGULATION_OF_DNA_LIGATION,0.673878482632541
HP_AMYLOIDOSIS,SET,35,0.34688,0.015123,0.15078,0.010712,HP_AMYLOIDOSIS,0.678703743169399
REACTOME_GRB2_SOS_PROVIDES_L...,SET,15,0.53432,0.015258,0.23228,0.010721,REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.678703743169399
REACTOME_SIGNALING_BY_ERBB4,SET,55,0.25198,0.013764,0.10961,0.010761,REACTOME_SIGNALING_BY_ERBB4,0.679997372727273
GSE360_L_MAJOR_VS_B_MALAYI_L...2,SET,177,0.14154,0.013823,0.061637,0.010836,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_UP,0.68313722826087
HP_ABNORMAL_CALCIFICATION_OF...,SET,5,0.99341,0.016383,0.43271,0.01085,HP_ABNORMAL_CALCIFICATION_OF_THE_CARPAL_BONES,0.68313722826087
HP_ABNORMAL_RENAL_PHYSIOLOGY,SET,625,0.077663,0.014076,0.033869,0.010928,HP_ABNORMAL_RENAL_PHYSIOLOGY,0.683452715053763
AIZARANI_LIVER_C38_RESIDENT_...,SET,19,0.47296,0.015199,0.20629,0.01094,AIZARANI_LIVER_C38_RESIDENT_B_CELLS_3,0.683452715053763
HP_ABNORMAL_PULSE,SET,5,0.75547,0.012459,0.32962,0.01096,HP_ABNORMAL_PULSE,0.683452715053763
REACTOME_SHC1_EVENTS_IN_ERBB...1,SET,22,0.40374,0.01396,0.17617,0.010964,REACTOME_SHC1_EVENTS_IN_ERBB2_SIGNALING,0.683452715053763
GOMF_PHOSPHOTRANSFERASE_ACTI...1,SET,21,0.40493,0.01368,0.1767,0.010969,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_FOR_OTHER_SUBSTITUTED_PHOSPHATE_GROUPS,0.683452715053763
YAO_TEMPORAL_RESPONSE_TO_PRO...14,SET,27,0.37397,0.014323,0.1632,0.010973,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5,0.683452715053763
REACTOME_SARS_COV_1_HOST_INT...,SET,85,0.20494,0.013905,0.089485,0.01101,REACTOME_SARS_COV_1_HOST_INTERACTIONS,0.684530500894454
DESCARTES_FETAL_EYE_HORIZONT...,SET,13,0.54284,0.014432,0.23716,0.011046,DESCARTES_FETAL_EYE_HORIZONTAL_CELLS,0.684845432862191
GOMF_CONNEXIN_BINDING,SET,5,0.98755,0.016286,0.43173,0.011091,GOMF_CONNEXIN_BINDING,0.684845432862191
NGO_MALIGNANT_GLIOMA_1P_LOH,SET,13,0.45521,0.012102,0.19903,0.0111,NGO_MALIGNANT_GLIOMA_1P_LOH,0.684845432862191
GSE5455_HEALTHY_VS_TUMOR_BEA...1,SET,179,0.14684,0.01442,0.064243,0.011143,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_DN,0.684845432862191
JI_CARCINOGENESIS_BY_KRAS_AN...1,SET,16,0.5556,0.016386,0.2431,0.011147,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_DN,0.684845432862191
HP_ANTERIOR_OPEN_BITE_MALOCC...,SET,14,0.53561,0.014777,0.23436,0.01115,HP_ANTERIOR_OPEN_BITE_MALOCCLUSION,0.684845432862191
REACTOME_AMYLOID_FIBER_FORMA...,SET,48,0.29844,0.015232,0.13059,0.011153,REACTOME_AMYLOID_FIBER_FORMATION,0.684845432862191
MODULE_313,SET,13,0.50891,0.01353,0.2229,0.011218,MODULE_313,0.685491962457338
GOBP_REGULATION_OF_DEFENSE_R...5,SET,34,0.35066,0.015068,0.15361,0.011228,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS_BY_HOST,0.685491962457338
HP_OPPORTUNISTIC_FUNGAL_INFE...,SET,13,0.53303,0.014171,0.23354,0.01124,HP_OPPORTUNISTIC_FUNGAL_INFECTION,0.685491962457338
HP_MULTIPLE_MYELOMA,SET,7,0.81651,0.015932,0.35789,0.011267,HP_MULTIPLE_MYELOMA,0.685491962457338
HP_INCREASED_MEAN_PLATELET_V...,SET,21,0.45142,0.01525,0.19787,0.01127,HP_INCREASED_MEAN_PLATELET_VOLUME,0.685491962457338
WP_LNCRNA_IN_CANONICAL_WNT_S...,SET,89,0.21286,0.014777,0.093355,0.011305,WP_LNCRNA_IN_CANONICAL_WNT_SIGNALING_AND_COLORECTAL_CANCER,0.685491962457338
HP_CONGESTIVE_HEART_FAILURE,SET,220,0.12861,0.013987,0.056445,0.011353,HP_CONGESTIVE_HEART_FAILURE,0.685491962457338
HP_VERTIGO,SET,136,0.16849,0.01444,0.073986,0.011389,HP_VERTIGO,0.685491962457338
GOBP_TRIF_DEPENDENT_TOLL_LIK...,SET,11,0.55086,0.013472,0.24193,0.011402,GOBP_TRIF_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.685491962457338
GRYDER_PAX3FOXO1_ENHANCERS_K...,SET,412,0.10173,0.015059,0.044693,0.011425,GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN,0.685491962457338
GOMF_LYSOPHOSPHATIDIC_ACID_P...,SET,2,1.6336,0.01704,0.71787,0.01144,GOMF_LYSOPHOSPHATIDIC_ACID_PHOSPHATASE_ACTIVITY,0.685491962457338
BIOCARTA_ERBB4_PATHWAY,SET,7,0.68028,0.013274,0.29897,0.011446,BIOCARTA_ERBB4_PATHWAY,0.685491962457338
MIR7109_3P,SET,60,0.23797,0.013575,0.1046,0.011459,MIR7109_3P,0.685491962457338
GOMF_N_ACETYLGLUCOSAMINE_6_O...,SET,6,0.84575,0.015279,0.37179,0.011465,GOMF_N_ACETYLGLUCOSAMINE_6_O_SULFOTRANSFERASE_ACTIVITY,0.685491962457338
HP_TISSUE_ISCHEMIA,SET,108,0.19575,0.014962,0.086121,0.01152,HP_TISSUE_ISCHEMIA,0.685491962457338
REACTOME_ERBB2_REGULATES_CEL...,SET,15,0.48019,0.013713,0.2113,0.011533,REACTOME_ERBB2_REGULATES_CELL_MOTILITY,0.685491962457338
GOMF_HISTONE_UBIQUITIN_LIGAS...,SET,10,0.59347,0.01384,0.26116,0.011536,GOMF_HISTONE_UBIQUITIN_LIGASE_ACTIVITY,0.685491962457338
GOMF_PHOSPHATIDYLINOSITOL_3_...1,SET,4,0.94036,0.013871,0.41382,0.011538,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.685491962457338
MIR6813_3P,SET,30,0.34665,0.013994,0.15259,0.011555,MIR6813_3P,0.685491962457338
GOBP_REGULATION_OF_ERYTHROCY...,SET,42,0.29318,0.013999,0.12906,0.011558,GOBP_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.685491962457338
HP_OSTEOLYSIS_INVOLVING_BONE...2,SET,20,0.44596,0.014703,0.19647,0.011613,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.68619128164557
GOBP_POSITIVE_REGULATION_OF_...505,SET,97,0.20565,0.014901,0.090647,0.01165,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.68619128164557
GOBP_REGULATION_OF_MRNA_PROC...,SET,117,0.16091,0.012798,0.070969,0.01169,GOBP_REGULATION_OF_MRNA_PROCESSING,0.68619128164557
GSE40274_CTRL_VS_IRF4_TRANSD...2,SET,150,0.1579,0.014206,0.069666,0.011716,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.68619128164557
GSE42088_2H_VS_24H_LEISHMANI...1,SET,173,0.14461,0.013964,0.063861,0.011779,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_DN,0.68619128164557
GOCC_CTF18_RFC_LIKE_COMPLEX,SET,8,0.6318,0.013179,0.27903,0.011784,GOCC_CTF18_RFC_LIKE_COMPLEX,0.68619128164557
HP_ABNORMAL_CHEEK_MORPHOLOGY,SET,231,0.12309,0.013713,0.054374,0.0118,HP_ABNORMAL_CHEEK_MORPHOLOGY,0.68619128164557
GOBP_IMMUNOGLOBULIN_PRODUCTI...2,SET,47,0.26679,0.013474,0.11788,0.011814,GOBP_IMMUNOGLOBULIN_PRODUCTION_INVOLVED_IN_IMMUNOGLOBULIN_MEDIATED_IMMUNE_RESPONSE,0.68619128164557
MIR606,SET,87,0.21033,0.014437,0.092932,0.011815,MIR606,0.68619128164557
PID_LPA4_PATHWAY,SET,14,0.53469,0.014752,0.23637,0.011852,PID_LPA4_PATHWAY,0.68619128164557
CHESLER_BRAIN_QTL_CIS,SET,68,0.23373,0.014191,0.10334,0.011864,CHESLER_BRAIN_QTL_CIS,0.68619128164557
MARSON_FOXP3_TARGETS_UP,SET,61,0.25892,0.014892,0.11451,0.011884,MARSON_FOXP3_TARGETS_UP,0.68619128164557
DESCARTES_FETAL_CEREBELLUM_U...,SET,19,0.47603,0.015298,0.21059,0.011903,DESCARTES_FETAL_CEREBELLUM_UNIPOLAR_BRUSH_CELLS,0.68619128164557
BIOCARTA_PAR1_PATHWAY,SET,19,0.4939,0.015872,0.21856,0.011923,BIOCARTA_PAR1_PATHWAY,0.68619128164557
HP_ARTERIAL_STENOSIS,SET,95,0.20466,0.014676,0.090615,0.011962,HP_ARTERIAL_STENOSIS,0.68619128164557
TAL1BETAITF2_01,SET,237,0.12801,0.014443,0.056686,0.011971,TAL1BETAITF2_01,0.68619128164557
HP_HYPODONTIA,SET,206,0.12747,0.01342,0.056449,0.011973,HP_HYPODONTIA,0.68619128164557
GOBP_RENAL_ABSORPTION,SET,33,0.36897,0.015621,0.16342,0.011982,GOBP_RENAL_ABSORPTION,0.68619128164557
GSE1925_CTRL_VS_IFNG_PRIMED_...6,SET,189,0.14185,0.014311,0.062835,0.011995,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_UP,0.68619128164557
GOMF_PHOSPHATIDYLINOSITOL_3_...7,SET,26,0.34401,0.01293,0.1524,0.012002,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_BINDING,0.68619128164557
TARTE_PLASMA_CELL_VS_B_LYMPH...1,SET,34,0.35406,0.015214,0.15696,0.01205,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN,0.68619128164557
GOCC_CORTICAL_GRANULE,SET,6,0.74581,0.013473,0.33067,0.012058,GOCC_CORTICAL_GRANULE,0.68619128164557
GOBP_PURINE_NUCLEOSIDE_TRIPH...,SET,5,0.82687,0.013636,0.36661,0.012059,GOBP_PURINE_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,0.68619128164557
REACTOME_NUCLEAR_SIGNALING_B...,SET,31,0.32686,0.013413,0.14506,0.012128,REACTOME_NUCLEAR_SIGNALING_BY_ERBB4,0.68619128164557
GOBP_G_PROTEIN_COUPLED_ACETY...,SET,20,0.42911,0.014148,0.19055,0.012169,GOBP_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.68619128164557
REACTOME_RHOT1_GTPASE_CYCLE,SET,5,0.78244,0.012904,0.34747,0.012173,REACTOME_RHOT1_GTPASE_CYCLE,0.68619128164557
GSE9946_LISTERIA_INF_MATURE_...1,SET,100,0.1951,0.014352,0.086646,0.012178,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.68619128164557
HP_OPEN_MOUTH,SET,98,0.18884,0.013753,0.083882,0.012189,HP_OPEN_MOUTH,0.68619128164557
MIR185_5P,SET,267,0.11826,0.01415,0.052593,0.012277,MIR185_5P,0.68619128164557
GOBP_REGULATION_OF_B_CELL_ME...,SET,52,0.2603,0.013826,0.11583,0.012316,GOBP_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.68619128164557
NAKAMURA_ADIPOGENESIS_EARLY_...2,SET,57,0.26486,0.014727,0.11787,0.012325,NAKAMURA_ADIPOGENESIS_EARLY_UP,0.68619128164557
MYLLYKANGAS_AMPLIFICATION_HO...7,SET,6,0.71553,0.012926,0.3185,0.01234,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_21,0.68619128164557
RGAGGAARY_PU1_Q6,SET,462,0.091345,0.014299,0.040667,0.012352,RGAGGAARY_PU1_Q6,0.68619128164557
GSE22601_DOUBLE_NEGATIVE_VS_...2,SET,183,0.14352,0.01425,0.063898,0.012353,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.68619128164557
GOBP_NEGATIVE_REGULATION_OF_...490,SET,5,0.94717,0.01562,0.42186,0.012384,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.68619128164557
ZNF197_TARGET_GENES,SET,504,0.083773,0.013681,0.037313,0.012386,ZNF197_TARGET_GENES,0.68619128164557
GSE30962_PRIMARY_VS_SECONDAR...4,SET,180,0.13421,0.013217,0.059783,0.012391,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_UP,0.68619128164557
HP_GINGIVAL_BLEEDING,SET,52,0.28161,0.014958,0.12546,0.012401,HP_GINGIVAL_BLEEDING,0.68619128164557
GSE37534_GW1929_VS_PIOGLITAZ...2,SET,180,0.14151,0.013936,0.063054,0.012413,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,0.68619128164557
HP_LIVEDO_RETICULARIS,SET,4,0.82556,0.012178,0.36788,0.012419,HP_LIVEDO_RETICULARIS,0.68619128164557
HP_GASTRIC_ULCER,SET,5,0.7731,0.01275,0.34456,0.01243,HP_GASTRIC_ULCER,0.68619128164557
HALLMARK_APOPTOSIS,SET,149,0.15717,0.014094,0.070075,0.012458,HALLMARK_APOPTOSIS,0.68619128164557
GOBP_REGULATION_OF_CALCIUM_I...8,SET,223,0.13237,0.014492,0.05902,0.01246,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.68619128164557
MARSHALL_VIRAL_INFECTION_RES...1,SET,27,0.36486,0.013974,0.16269,0.012464,MARSHALL_VIRAL_INFECTION_RESPONSE_DN,0.68619128164557
HP_CONGENITAL_HIP_DISLOCATION,SET,68,0.22975,0.013949,0.10244,0.012464,HP_CONGENITAL_HIP_DISLOCATION,0.68619128164557
GSE24574_NAIVE_VS_TCONV_CD4_...1,SET,185,0.13106,0.013083,0.058451,0.012478,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN,0.68619128164557
REACTOME_IRAK1_RECRUITS_IKK_...,SET,11,0.59249,0.014491,0.26435,0.01251,REACTOME_IRAK1_RECRUITS_IKK_COMPLEX,0.686864218009479
MIR6729_3P,SET,63,0.23248,0.013588,0.10384,0.012589,MIR6729_3P,0.690111506309148
KEGG_PROSTATE_CANCER,SET,86,0.20529,0.01401,0.091733,0.012621,KEGG_PROSTATE_CANCER,0.690456012931035
PEDRIOLI_MIR31_TARGETS_DN,SET,368,0.10194,0.01428,0.045564,0.01264,PEDRIOLI_MIR31_TARGETS_DN,0.690456012931035
GALIE_TUMOR_ANGIOGENESIS,SET,7,0.78498,0.015317,0.35125,0.012722,GALIE_TUMOR_ANGIOGENESIS,0.690456012931035
GSE14308_TH1_VS_INDUCED_TREG...1,SET,176,0.13474,0.013122,0.060324,0.012762,GSE14308_TH1_VS_INDUCED_TREG_DN,0.690456012931035
ROZANOV_MMP14_TARGETS_SUBSET,SET,32,0.38447,0.016029,0.17216,0.012774,ROZANOV_MMP14_TARGETS_SUBSET,0.690456012931035
KEGG_MEDICUS_REFERENCE_EGF_E...4,SET,16,0.43782,0.012912,0.19607,0.012782,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.690456012931035
GOBP_REGULATION_OF_BINDING_O...,SET,5,0.77391,0.012763,0.34667,0.0128,GOBP_REGULATION_OF_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,0.690456012931035
ZNF774_TARGET_GENES,SET,19,0.40801,0.013112,0.18279,0.012809,ZNF774_TARGET_GENES,0.690456012931035
GOBP_NEGATIVE_REGULATION_OF_...264,SET,8,0.66984,0.013972,0.30053,0.012919,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_DIFFERENTIATION,0.690456012931035
REACTOME_P130CAS_LINKAGE_TO_...,SET,15,0.53277,0.015214,0.23924,0.012984,REACTOME_P130CAS_LINKAGE_TO_MAPK_SIGNALING_FOR_INTEGRINS,0.690456012931035
DESCARTES_MAIN_FETAL_SKELETA...,SET,134,0.16029,0.013637,0.071981,0.012986,DESCARTES_MAIN_FETAL_SKELETAL_MUSCLE_CELLS,0.690456012931035
WP_TCA_CYCLE_NUTRIENT_USE_AN...,SET,5,0.92919,0.015324,0.41731,0.012993,WP_TCA_CYCLE_NUTRIENT_USE_AND_INVASIVENESS_OF_OVARIAN_CANCER,0.690456012931035
MIR7847_3P,SET,65,0.23934,0.014208,0.1075,0.013,MIR7847_3P,0.690456012931035
MIR4682,SET,117,0.1678,0.013346,0.075405,0.013035,MIR4682,0.690456012931035
HP_SMALL_FACE,SET,112,0.18298,0.014241,0.082232,0.01304,HP_SMALL_FACE,0.690456012931035
GOBP_ATTACHMENT_OF_MITOTIC_S...,SET,25,0.35859,0.013216,0.16121,0.013068,GOBP_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.690456012931035
HP_WRIST_FLEXION_CONTRACTURE,SET,33,0.36239,0.015342,0.16293,0.013071,HP_WRIST_FLEXION_CONTRACTURE,0.690456012931035
KEGG_MEDICUS_REFERENCE_DNA_E...,SET,13,0.50896,0.013531,0.22883,0.013073,KEGG_MEDICUS_REFERENCE_DNA_END_RESECTION_AND_RPA_LOADING,0.690456012931035
REACTOME_CYTOSOLIC_SENSORS_O...,SET,57,0.23915,0.013298,0.10752,0.013075,REACTOME_CYTOSOLIC_SENSORS_OF_PATHOGEN_ASSOCIATED_DNA,0.690456012931035
WP_MIRNA_ROLE_IN_IMMUNE_RESP...,SET,33,0.33521,0.014191,0.15075,0.013092,WP_MIRNA_ROLE_IN_IMMUNE_RESPONSE_IN_SEPSIS,0.690456012931035
REACTOME_NOTCH2_INTRACELLULA...,SET,11,0.62525,0.015292,0.28121,0.013101,REACTOME_NOTCH2_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.690456012931035
REACTOME_ERBB2_ACTIVATES_PTK...,SET,13,0.53339,0.014181,0.23998,0.013126,REACTOME_ERBB2_ACTIVATES_PTK6_SIGNALING,0.690456012931035
GOCC_PROTEIN_PHOSPHATASE_TYP...1,SET,18,0.40778,0.012755,0.18354,0.013156,GOCC_PROTEIN_PHOSPHATASE_TYPE_1_COMPLEX,0.690456012931035
EPPERT_LSC_R,SET,36,0.28602,0.012646,0.12881,0.013201,EPPERT_LSC_R,0.690456012931035
HP_ABNORMALITY_OF_VON_WILLEB...,SET,12,0.51826,0.013238,0.23342,0.013206,HP_ABNORMALITY_OF_VON_WILLEBRAND_FACTOR,0.690456012931035
GSE32034_LY6C_HIGH_VS_LOW_RO...2,SET,183,0.13474,0.013378,0.060693,0.013217,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_UP,0.690456012931035
MIR4649_3P,SET,186,0.14249,0.014262,0.064192,0.013224,MIR4649_3P,0.690456012931035
GSE14415_TCONV_VS_FOXP3_KO_I...1,SET,159,0.14263,0.013209,0.064256,0.013224,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_DN,0.690456012931035
PID_TCR_CALCIUM_PATHWAY,SET,27,0.34264,0.013123,0.15439,0.013238,PID_TCR_CALCIUM_PATHWAY,0.690456012931035
GSE43955_TH0_VS_TGFB_IL6_TH1...11,SET,190,0.136,0.013756,0.061308,0.013275,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_DN,0.690456012931035
MIR1277_3P,SET,14,0.49367,0.01362,0.22255,0.013276,MIR1277_3P,0.690456012931035
LAKE_ADULT_KIDNEY_C29_UNKNOW...,SET,77,0.2383,0.015392,0.10745,0.013289,LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2,0.690456012931035
MIR5586_5P,SET,74,0.22726,0.014391,0.10256,0.013354,MIR5586_5P,0.690456012931035
FLECHNER_BIOPSY_KIDNEY_TRANS...4,SET,81,0.20993,0.013906,0.094739,0.013355,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.690456012931035
HP_ABNORMAL_FETAL_GASTROINTE...,SET,17,0.47197,0.014348,0.2131,0.013393,HP_ABNORMAL_FETAL_GASTROINTESTINAL_SYSTEM_MORPHOLOGY,0.690456012931035
GOCC_RIBONUCLEASE_MRP_COMPLEX,SET,8,0.62075,0.012948,0.28028,0.013395,GOCC_RIBONUCLEASE_MRP_COMPLEX,0.690456012931035
FAN_OVARY_CL10_PUTATIVE_EARL...,SET,225,0.11669,0.012831,0.05269,0.013401,FAN_OVARY_CL10_PUTATIVE_EARLY_ATRESIA_GRANULOSA_CELL,0.690456012931035
GGTGAAG_MIR412,SET,55,0.25215,0.013773,0.11387,0.013412,GGTGAAG_MIR412,0.690456012931035
ZIRN_TRETINOIN_RESPONSE_WT1_...1,SET,5,0.84943,0.014008,0.3839,0.013468,ZIRN_TRETINOIN_RESPONSE_WT1_DN,0.690456012931035
GOCC_LATERAL_ELEMENT,SET,13,0.47675,0.012675,0.21549,0.013478,GOCC_LATERAL_ELEMENT,0.690456012931035
REACTOME_PARACETAMOL_ADME,SET,25,0.41665,0.015356,0.18834,0.01348,REACTOME_PARACETAMOL_ADME,0.690456012931035
WP_FERROPTOSIS,SET,56,0.26134,0.014404,0.11818,0.013509,WP_FERROPTOSIS,0.690456012931035
GOBP_POSITIVE_REGULATION_OF_...517,SET,5,0.92859,0.015314,0.42008,0.013542,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.690456012931035
RBM15_TARGET_GENES,SET,141,0.15814,0.013798,0.071572,0.013573,RBM15_TARGET_GENES,0.690456012931035
HP_ANKYLOGLOSSIA,SET,23,0.37186,0.013146,0.16831,0.01358,HP_ANKYLOGLOSSIA,0.690456012931035
GOBP_HEPARAN_SULFATE_PROTEOG...1,SET,32,0.33912,0.014138,0.1535,0.013583,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.690456012931035
BIOCARTA_SPPA_PATHWAY,SET,16,0.5085,0.014997,0.23018,0.013589,BIOCARTA_SPPA_PATHWAY,0.690456012931035
GSE27241_WT_VS_RORGT_KO_TH17...3,SET,166,0.137,0.012961,0.062036,0.013614,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP,0.690456012931035
MORF_CCNI,SET,82,0.19396,0.012927,0.087838,0.013624,MORF_CCNI,0.690456012931035
MYCMAX_02,SET,241,0.1219,0.013867,0.055215,0.01364,MYCMAX_02,0.690456012931035
HP_NEOPLASM_OF_THE_ADRENAL_G...,SET,45,0.273,0.013492,0.1237,0.013664,HP_NEOPLASM_OF_THE_ADRENAL_GLAND,0.690456012931035
PID_ERBB4_PATHWAY,SET,38,0.29077,0.013208,0.13179,0.013684,PID_ERBB4_PATHWAY,0.690456012931035
WP_METAPATHWAY_BIOTRANSFORMA...,SET,173,0.15718,0.015178,0.071255,0.013701,WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II,0.690456012931035
GOBP_NUCLEOTIDE_BINDING_OLIG...1,SET,7,0.7098,0.01385,0.32184,0.013718,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_1_SIGNALING_PATHWAY,0.690456012931035
GOBP_REGULATION_OF_BONE_REMO...,SET,50,0.29048,0.01513,0.13178,0.013761,GOBP_REGULATION_OF_BONE_REMODELING,0.690456012931035
MIR6133,SET,169,0.14084,0.013444,0.063914,0.01378,MIR6133,0.690456012931035
GOCC_BRCA1_A_COMPLEX,SET,5,0.95388,0.015731,0.43286,0.013781,GOCC_BRCA1_A_COMPLEX,0.690456012931035
GOBP_MEIOTIC_CELL_CYCLE_CHEC...,SET,9,0.6697,0.014816,0.30395,0.013792,GOBP_MEIOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.690456012931035
GOCC_PODOSOME,SET,33,0.32389,0.013712,0.14701,0.013797,GOCC_PODOSOME,0.690456012931035
REACTOME_FGFR2_ALTERNATIVE_S...,SET,27,0.33225,0.012725,0.15083,0.013809,REACTOME_FGFR2_ALTERNATIVE_SPLICING,0.690456012931035
MIR6130,SET,164,0.14342,0.013487,0.065112,0.013817,MIR6130,0.690456012931035
GOCC_EXTERNAL_SIDE_OF_APICAL...,SET,6,0.79588,0.014378,0.36138,0.013827,GOCC_EXTERNAL_SIDE_OF_APICAL_PLASMA_MEMBRANE,0.690456012931035
GOBP_RESPONSE_TO_MOLECULE_OF...2,SET,4,0.96094,0.014175,0.4366,0.013876,GOBP_RESPONSE_TO_MOLECULE_OF_FUNGAL_ORIGIN,0.691908723098996
KEGG_MEDICUS_REFERENCE_TRAIP...,SET,14,0.46517,0.012834,0.21142,0.013902,KEGG_MEDICUS_REFERENCE_TRAIP_DEPENDENT_REPLISOME_DISASSEMBLY,0.691922679324894
HP_APLASIA_OF_THE_ULNA,SET,5,1.0471,0.017268,0.47622,0.013954,HP_APLASIA_OF_THE_ULNA,0.691922679324894
GOBP_ALTERNATIVE_MRNA_SPLICI...,SET,67,0.21114,0.012725,0.096073,0.013993,GOBP_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.691922679324894
GOBP_ERBB2_ERBB4_SIGNALING_P...,SET,5,0.88124,0.014533,0.40119,0.014032,GOBP_ERBB2_ERBB4_SIGNALING_PATHWAY,0.691922679324894
GAUCHER_PBMC_YF_VAX_STAMARIL...9,SET,31,0.30881,0.012672,0.1406,0.01404,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_DN,0.691922679324894
HP_LARGE_FACE,SET,225,0.11839,0.013019,0.053914,0.014056,HP_LARGE_FACE,0.691922679324894
REACTOME_SIGNALING_BY_EGFR_I...,SET,24,0.36584,0.013211,0.16661,0.014062,REACTOME_SIGNALING_BY_EGFR_IN_CANCER,0.691922679324894
GOBP_MUCOCILIARY_CLEARANCE,SET,7,0.7572,0.014775,0.34491,0.014074,GOBP_MUCOCILIARY_CLEARANCE,0.691922679324894
GSE1432_CTRL_VS_IFNG_1H_MICR...1,SET,185,0.13429,0.013405,0.061172,0.01408,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN,0.691922679324894
GOMF_MRNA_CDS_BINDING,SET,3,1.0396,0.01328,0.47358,0.014086,GOMF_MRNA_CDS_BINDING,0.691922679324894
WP_ANTIVIRAL_AND_ANTIINFLAMM...,SET,26,0.38207,0.01436,0.1741,0.014104,WP_ANTIVIRAL_AND_ANTIINFLAMMATORY_EFFECTS_OF_NRF2_ON_SARSCOV2_PATHWAY,0.691922679324894
GOBP_REGULATION_OF_RIBOSOME_...,SET,6,0.70535,0.012742,0.32159,0.014148,GOBP_REGULATION_OF_RIBOSOME_BIOGENESIS,0.691922679324894
FAN_OVARY_CL8_MATURE_CUMULUS...,SET,540,0.078222,0.01321,0.035665,0.014151,FAN_OVARY_CL8_MATURE_CUMULUS_GRANULOSA_CELL_2,0.691922679324894
GOBP_RESPONSE_TO_INTERLEUKIN...2,SET,12,0.55495,0.014176,0.25304,0.014155,GOBP_RESPONSE_TO_INTERLEUKIN_12,0.691922679324894
GSE22443_NAIVE_VS_ACT_AND_IL...3,SET,185,0.14023,0.013999,0.064023,0.014254,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_DN,0.694515882352941
HP_ENCEPHALOMALACIA,SET,12,0.61,0.015582,0.2785,0.014258,HP_ENCEPHALOMALACIA,0.694515882352941
GSE22432_MULTIPOTENT_VS_COMM...1,SET,187,0.13304,0.013351,0.060749,0.014268,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_DN,0.694515882352941
WNT_SIGNALING,SET,82,0.21317,0.014207,0.097388,0.014308,WNT_SIGNALING,0.695342702513966
KEGG_MEDICUS_REFERENCE_TGFA_...2,SET,7,0.71151,0.013883,0.32512,0.014325,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY,0.695342702513966
GOBP_CELL_KILLING,SET,204,0.14183,0.014859,0.064884,0.014419,GOBP_CELL_KILLING,0.696399702216067
MIR6515_3P,SET,199,0.13064,0.01352,0.059778,0.014436,MIR6515_3P,0.696399702216067
HP_NEUTROPHILIA,SET,22,0.43044,0.014883,0.197,0.014453,HP_NEUTROPHILIA,0.696399702216067
AR_01,SET,142,0.15485,0.013558,0.070871,0.014455,AR_01,0.696399702216067
GOBP_REGULATION_OF_TRANSCRIP...2,SET,39,0.26284,0.012095,0.1203,0.014455,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.696399702216067
GOBP_RESPONSE_TO_PURINE_CONT...,SET,136,0.16098,0.013796,0.07369,0.014467,GOBP_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.696399702216067
HELLER_SILENCED_BY_METHYLATI...2,SET,239,0.12482,0.014141,0.057194,0.01455,HELLER_SILENCED_BY_METHYLATION_UP,0.696964436038514
GOBP_REGULATION_OF_AMYLOID_B...,SET,17,0.43873,0.013337,0.20108,0.014567,GOBP_REGULATION_OF_AMYLOID_BETA_CLEARANCE,0.696964436038514
MIR197_5P,SET,57,0.24227,0.013471,0.11104,0.014568,MIR197_5P,0.696964436038514
MIR1278,SET,56,0.24404,0.01345,0.11186,0.014572,MIR1278,0.696964436038514
HP_ABNORMAL_OLFACTORY_LOBE_M...,SET,6,0.68845,0.012437,0.31558,0.014579,HP_ABNORMAL_OLFACTORY_LOBE_MORPHOLOGY,0.696964436038514
GSE31082_DP_VS_CD4_SP_THYMOC...2,SET,171,0.13481,0.012943,0.06182,0.014607,GSE31082_DP_VS_CD4_SP_THYMOCYTE_UP,0.697343798076923
GOBP_AMYLOID_BETA_CLEARANCE,SET,36,0.30311,0.013402,0.13923,0.014742,GOBP_AMYLOID_BETA_CLEARANCE,0.699938714859438
PBX1_02,SET,113,0.18569,0.014515,0.085304,0.014755,PBX1_02,0.699938714859438
HP_ABNORMAL_PLATELET_VOLUME,SET,25,0.36524,0.013462,0.16786,0.01479,HP_ABNORMAL_PLATELET_VOLUME,0.699938714859438
REACTOME_PKA_MEDIATED_PHOSPH...2,SET,4,0.82974,0.01224,0.38141,0.014804,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.699938714859438
GOBP_REGULATION_OF_ATPASE_CO...,SET,5,0.66811,0.011018,0.30722,0.014832,GOBP_REGULATION_OF_ATPASE_COUPLED_CALCIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.699938714859438
MIR6512_5P,SET,106,0.17651,0.013366,0.081165,0.014833,MIR6512_5P,0.699938714859438
KEGG_GLYCOSAMINOGLYCAN_BIOSY...2,SET,25,0.37811,0.013936,0.17387,0.014836,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_HEPARAN_SULFATE,0.699938714859438
GSE21033_3H_VS_24H_POLYIC_ST...2,SET,148,0.15146,0.013537,0.069678,0.014869,GSE21033_3H_VS_24H_POLYIC_STIM_DC_UP,0.699938714859438
MIR12115,SET,63,0.2254,0.013174,0.10371,0.014885,MIR12115,0.699938714859438
HP_SMALL_THENAR_EMINENCE,SET,10,0.58647,0.013676,0.26992,0.014906,HP_SMALL_THENAR_EMINENCE,0.699938714859438
GNF2_UBE2I,SET,36,0.29353,0.012978,0.13517,0.01495,GNF2_UBE2I,0.699938714859438
HP_GENERALIZED_ABNORMALITY_O...,SET,945,0.060714,0.013408,0.027961,0.014958,HP_GENERALIZED_ABNORMALITY_OF_SKIN,0.699938714859438
OSAWA_TNF_TARGETS,SET,10,0.55547,0.012953,0.25584,0.014965,OSAWA_TNF_TARGETS,0.699938714859438
GNF2_CD48,SET,30,0.33437,0.013498,0.15403,0.014981,GNF2_CD48,0.699938714859438
HP_UNUSUAL_FUNGAL_INFECTION,SET,103,0.1885,0.014072,0.08686,0.015003,HP_UNUSUAL_FUNGAL_INFECTION,0.699938714859438
BONOME_OVARIAN_CANCER_SURVIV...1,SET,215,0.12533,0.013476,0.057755,0.015007,BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING,0.699938714859438
HP_INFECTION_FOLLOWING_LIVE_...,SET,20,0.428,0.014111,0.19729,0.015032,HP_INFECTION_FOLLOWING_LIVE_VACCINATION,0.699938714859438
REACTOME_DOWNREGULATION_OF_E...2,SET,27,0.34153,0.013081,0.15745,0.015043,REACTOME_DOWNREGULATION_OF_ERBB2_SIGNALING,0.699938714859438
GOBP_NEGATIVE_REGULATION_OF_...68,SET,4,0.91408,0.013484,0.42141,0.015044,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.699938714859438
GOBP_INNER_EAR_RECEPTOR_CELL...2,SET,4,0.94641,0.013961,0.43668,0.015113,GOBP_INNER_EAR_RECEPTOR_CELL_FATE_COMMITMENT,0.700454023904382
GOBP_CORTICAL_ACTIN_CYTOSKEL...,SET,42,0.2754,0.01315,0.12708,0.015119,GOBP_CORTICAL_ACTIN_CYTOSKELETON_ORGANIZATION,0.700454023904382
GSE25087_FETAL_VS_ADULT_TCON...2,SET,174,0.13548,0.013119,0.062524,0.015133,GSE25087_FETAL_VS_ADULT_TCONV_UP,0.700454023904382
FOURATI_BLOOD_TWINRIX_AGE_65...3,SET,4,0.8504,0.012544,0.39249,0.015136,FOURATI_BLOOD_TWINRIX_AGE_65_83YO_POOR_RESPONDERS_VS_RESPONDERS_0DY_NETWORK_INFERENCE_UP,0.700454023904382
REACTOME_RIBAVIRIN_ADME,SET,11,0.63007,0.01541,0.29088,0.015159,REACTOME_RIBAVIRIN_ADME,0.700454023904382
GSE3982_BASOPHIL_VS_TH2_DN,SET,180,0.13391,0.013187,0.061833,0.015176,GSE3982_BASOPHIL_VS_TH2_DN,0.700454023904382
WEINBERGER_BLOOD_TWINRIX_AGE...3,SET,6,0.85447,0.015436,0.39471,0.015208,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_4_POST_BOOSTER_VACC_1DY_POSITIVE,0.701000053050398
GRYDER_PAX3FOXO1_ENHANCERS_I...,SET,942,0.063756,0.014059,0.029477,0.015282,GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS,0.703478026490066
HOLLEMAN_ASPARAGINASE_RESIST...1,SET,22,0.33474,0.011574,0.15485,0.015328,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN,0.704142693823916
GSE18281_CORTICAL_THYMOCYTE_...2,SET,173,0.14613,0.014111,0.067633,0.01537,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_UP,0.704142693823916
MIR4697_5P,SET,14,0.5308,0.014644,0.24571,0.015382,MIR4697_5P,0.704142693823916
MIR4722_5P,SET,127,0.16621,0.013769,0.076941,0.015382,MIR4722_5P,0.704142693823916
MIR4781_5P,SET,5,0.87073,0.01436,0.40315,0.015401,MIR4781_5P,0.704142693823916
GOBERT_CORE_OLIGODENDROCYTE_...,SET,40,0.30124,0.014038,0.13951,0.015418,GOBERT_CORE_OLIGODENDROCYTE_DIFFERENTIATION,0.704142693823916
COULOUARN_TEMPORAL_TGFB1_SIG...2,SET,102,0.18712,0.013901,0.086711,0.01547,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP,0.705590354330709
MIR127_3P,SET,5,1.0008,0.016505,0.46397,0.015506,MIR127_3P,0.705972310209424
GSE30971_WBP7_HET_VS_KO_MACR...2,SET,178,0.13855,0.013569,0.064239,0.015519,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_UP,0.705972310209424
REACTOME_ALK_MUTANTS_BIND_TK...,SET,12,0.49572,0.012663,0.22996,0.015561,REACTOME_ALK_MUTANTS_BIND_TKIS,0.70673025390625
GOBP_CENTRAL_NERVOUS_SYSTEM_...4,SET,4,1.0213,0.015065,0.47394,0.015593,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,0.70673025390625
GOMF_INHIBITORY_MHC_CLASS_I_...,SET,8,0.93485,0.0195,0.43395,0.015616,GOMF_INHIBITORY_MHC_CLASS_I_RECEPTOR_ACTIVITY,0.70673025390625
MIR145_3P,SET,64,0.23134,0.013628,0.10739,0.015617,MIR145_3P,0.70673025390625
GOMF_NUCLEAR_STEROID_RECEPTO...,SET,25,0.3852,0.014197,0.17895,0.015686,GOMF_NUCLEAR_STEROID_RECEPTOR_ACTIVITY,0.708093783958603
MILICIC_FAMILIAL_ADENOMATOUS...2,SET,9,0.6423,0.01421,0.29845,0.015702,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_UP,0.708093783958603
KRIGE_RESPONSE_TO_TOSEDOSTAT...1,SET,912,0.059004,0.012813,0.027422,0.015718,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN,0.708093783958603
GOBP_EARLY_ENDOSOME_TO_RECYC...,SET,7,0.72894,0.014223,0.33889,0.015747,GOBP_EARLY_ENDOSOME_TO_RECYCLING_ENDOSOME_TRANSPORT,0.708093783958603
SCHERER_PBMC_APSV_WETVAX_AGE...6,SET,263,0.11815,0.014032,0.054932,0.015749,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_UP,0.708093783958603
GOBP_INTERMEDIATE_FILAMENT_O...,SET,71,0.29082,0.01804,0.13533,0.015828,GOBP_INTERMEDIATE_FILAMENT_ORGANIZATION,0.708149116564417
GOCC_PLATELET_DENSE_GRANULE_...2,SET,5,0.89739,0.0148,0.41775,0.015858,GOCC_PLATELET_DENSE_GRANULE_MEMBRANE,0.708149116564417
KAPOSI_LIVER_CANCER_MET_DN,SET,5,0.85249,0.014059,0.39687,0.015862,KAPOSI_LIVER_CANCER_MET_DN,0.708149116564417
GOBP_MITOTIC_METAPHASE_CHROM...,SET,62,0.21317,0.01236,0.099286,0.015902,GOBP_MITOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.708149116564417
GSE41867_NAIVE_VS_DAY30_LCMV...4,SET,170,0.14659,0.014033,0.068278,0.015902,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP,0.708149116564417
GOBP_POSITIVE_REGULATION_OF_...646,SET,13,0.51125,0.013592,0.23813,0.015904,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.708149116564417
GOBP_REGULATION_OF_PHOSPHATI...4,SET,5,0.60041,0.0099017,0.27973,0.015927,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.708149116564417
GAUCHER_PBMC_YF_VAX_STAMARIL...7,SET,91,0.18918,0.013279,0.088163,0.015952,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN,0.708149116564417
GOBP_POSITIVE_REGULATION_OF_...33,SET,25,0.3678,0.013556,0.17147,0.015982,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.708149116564417
HP_ABNORMAL_CARPAL_MORPHOLOGY,SET,79,0.20522,0.013426,0.095698,0.016006,HP_ABNORMAL_CARPAL_MORPHOLOGY,0.708149116564417
REACTOME_INTERLEUKIN_4_AND_I...,SET,101,0.20064,0.014833,0.093584,0.016024,REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING,0.708149116564417
GOMF_CYCLIN_DEPENDENT_PROTEI...1,SET,26,0.32618,0.012259,0.15216,0.01604,GOMF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.708149116564417
GOMF_RETINOIC_ACID_BINDING,SET,26,0.46833,0.017602,0.21858,0.016077,GOMF_RETINOIC_ACID_BINDING,0.708149116564417
HP_PHEOCHROMOCYTOMA,SET,28,0.30726,0.011984,0.1435,0.016138,HP_PHEOCHROMOCYTOMA,0.708149116564417
REACTOME_CLEC7A_DECTIN_1_IND...,SET,11,0.47942,0.011725,0.22396,0.016159,REACTOME_CLEC7A_DECTIN_1_INDUCES_NFAT_ACTIVATION,0.708149116564417
HP_ACUTE_CORONARY_SYNDROME,SET,101,0.19412,0.01435,0.090688,0.016165,HP_ACUTE_CORONARY_SYNDROME,0.708149116564417
HP_ENLARGED_NARIS,SET,5,0.80404,0.01326,0.37583,0.01621,HP_ENLARGED_NARIS,0.708149116564417
GOCC_SITE_OF_DNA_DAMAGE,SET,110,0.1572,0.012125,0.073512,0.016247,GOCC_SITE_OF_DNA_DAMAGE,0.708149116564417
WP_ALTERED_GLYCOSYLATION_OF_...,SET,8,0.59005,0.012308,0.27598,0.016264,WP_ALTERED_GLYCOSYLATION_OF_MUC1_IN_TUMOR_MICROENVIRONMENT,0.708149116564417
REACTOME_RHO_GTPASES_ACTIVAT...5,SET,21,0.41732,0.014098,0.19523,0.016282,REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES,0.708149116564417
KEGG_MEDICUS_REFERENCE_PRNP_...,SET,27,0.35523,0.013605,0.16621,0.016296,KEGG_MEDICUS_REFERENCE_PRNP_PI3K_NOX2_SIGNALING_PATHWAY,0.708149116564417
HP_DECREASED_FACIAL_EXPRESSI...,SET,126,0.15903,0.013122,0.074414,0.016301,HP_DECREASED_FACIAL_EXPRESSION,0.708149116564417
HP_BRANCHIAL_ANOMALY,SET,16,0.40293,0.011883,0.18857,0.016317,HP_BRANCHIAL_ANOMALY,0.708149116564417
GOBP_DETECTION_OF_MUSCLE_STR...,SET,7,0.72674,0.01418,0.34015,0.016326,GOBP_DETECTION_OF_MUSCLE_STRETCH,0.708149116564417
GOCC_NUCLEAR_PORE_OUTER_RING,SET,10,0.49625,0.011572,0.23232,0.016342,GOCC_NUCLEAR_PORE_OUTER_RING,0.708149116564417
MIR6885_5P,SET,46,0.26097,0.013039,0.12221,0.016369,MIR6885_5P,0.708149116564417
SEITZ_NEOPLASTIC_TRANSFORMAT...1,SET,30,0.32392,0.013076,0.1517,0.016377,SEITZ_NEOPLASTIC_TRANSFORMATION_BY_8P_DELETION_DN,0.708149116564417
REACTOME_MAP2K_AND_MAPK_ACTI...,SET,38,0.28872,0.013115,0.13528,0.016418,REACTOME_MAP2K_AND_MAPK_ACTIVATION,0.708149116564417
NAKAMURA_METASTASIS,SET,42,0.26689,0.012744,0.12506,0.016427,NAKAMURA_METASTASIS,0.708149116564417
GOCC_SPERM_ANNULUS,SET,2,1.3604,0.014191,0.63757,0.016437,GOCC_SPERM_ANNULUS,0.708149116564417
GSE29618_BCELL_VS_MDC_UP,SET,160,0.14818,0.013765,0.069476,0.016478,GSE29618_BCELL_VS_MDC_UP,0.708149116564417
E2F1_Q3,SET,221,0.11777,0.012836,0.05522,0.016481,E2F1_Q3,0.708149116564417
HP_MONOCYTOPENIA,SET,5,0.97431,0.016068,0.45685,0.016482,HP_MONOCYTOPENIA,0.708149116564417
GOMF_2_OXOGLUTARATE_DEPENDEN...,SET,52,0.22378,0.011886,0.10494,0.016495,GOMF_2_OXOGLUTARATE_DEPENDENT_DIOXYGENASE_ACTIVITY,0.708149116564417
MODULE_180,SET,110,0.1812,0.013976,0.084978,0.016496,MODULE_180,0.708149116564417
chr4p12,SET,15,0.85304,0.02436,0.40016,0.016521,chr4p12,0.708149116564417
GOBP_ECTOPIC_GERM_CELL_PROGR...,SET,17,0.45004,0.013681,0.21114,0.01653,GOBP_ECTOPIC_GERM_CELL_PROGRAMMED_CELL_DEATH,0.708149116564417
GSE35685_CD34POS_CD10NEG_CD6...1,SET,191,0.13351,0.01354,0.062659,0.016559,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_DN,0.708149116564417
GOMF_D1_DOPAMINE_RECEPTOR_BI...,SET,6,0.65327,0.011802,0.30661,0.016565,GOMF_D1_DOPAMINE_RECEPTOR_BINDING,0.708149116564417
GSE21546_WT_VS_ELK1_KO_ANTI_...1,SET,177,0.12801,0.012502,0.060097,0.016587,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.708149116564417
GSE9037_CTRL_VS_LPS_4H_STIM_...4,SET,173,0.13596,0.013128,0.063827,0.01659,GSE9037_CTRL_VS_LPS_4H_STIM_IRAK4_KO_BMDM_UP,0.708149116564417
PAX7_TARGET_GENES,SET,514,0.079798,0.013157,0.03747,0.016606,PAX7_TARGET_GENES,0.708149116564417
HP_ABNORMAL_PYRAMIDAL_TRACT_...,SET,61,0.23203,0.013345,0.10898,0.01663,HP_ABNORMAL_PYRAMIDAL_TRACT_MORPHOLOGY,0.708303492647059
chr8p21,SET,79,0.41556,0.027186,0.19529,0.01668,chr8p21,0.708557605548854
GOBP_REGULATION_OF_MRNA_SPLI...,SET,97,0.16448,0.011918,0.077356,0.016746,GOBP_REGULATION_OF_MRNA_SPLICING_VIA_SPLICEOSOME,0.708557605548854
HP_TOTAL_OPHTHALMOPLEGIA,SET,5,0.76635,0.012638,0.36056,0.016782,HP_TOTAL_OPHTHALMOPLEGIA,0.708557605548854
HP_OVERFRIENDLINESS,SET,23,0.43251,0.015291,0.20351,0.016791,HP_OVERFRIENDLINESS,0.708557605548854
KLF7_TARGET_GENES,SET,736,0.06643,0.013025,0.031263,0.016805,KLF7_TARGET_GENES,0.708557605548854
GOMF_LONG_CHAIN_FATTY_ACYL_C...,SET,12,0.5179,0.013229,0.24376,0.016816,GOMF_LONG_CHAIN_FATTY_ACYL_COA_HYDROLASE_ACTIVITY,0.708557605548854
GAVISH_3CA_MALIGNANT_METAPRO...18,SET,45,0.27953,0.013815,0.13158,0.016828,GAVISH_3CA_MALIGNANT_METAPROGRAM_27_OLIGO_PROGENITOR,0.708557605548854
MODULE_17,SET,319,0.097432,0.012724,0.045868,0.016833,MODULE_17,0.708557605548854
GAVISH_3CA_MALIGNANT_METAPRO...39,SET,41,0.26906,0.012694,0.12669,0.016851,GAVISH_3CA_MALIGNANT_METAPROGRAM_9_UNFOLDED_PROTEIN_RESPONSE,0.708557605548854
HP_RIGHT_AORTIC_ARCH_WITH_MI...,SET,5,0.70385,0.011608,0.3315,0.016875,HP_RIGHT_AORTIC_ARCH_WITH_MIRROR_IMAGE_BRANCHING,0.708557605548854
WP_ACQUIRED_PARTIAL_LIPODYST...,SET,10,0.53972,0.012586,0.25423,0.016886,WP_ACQUIRED_PARTIAL_LIPODYSTROPHY_BARRAQUERSIMONS_SYNDROME,0.708557605548854
REACTOME_REGULATION_OF_FZD_B...,SET,20,0.4333,0.014286,0.20413,0.016898,REACTOME_REGULATION_OF_FZD_BY_UBIQUITINATION,0.708557605548854
WP_EXERCISEINDUCED_CIRCADIAN...,SET,46,0.26757,0.013369,0.12606,0.016901,WP_EXERCISEINDUCED_CIRCADIAN_REGULATION,0.708557605548854
GOBP_POSITIVE_REGULATION_OF_...396,SET,23,0.37992,0.013431,0.17918,0.016996,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.709386802120141
GSE3982_EOSINOPHIL_VS_TH2_UP,SET,174,0.1351,0.013083,0.063751,0.017045,GSE3982_EOSINOPHIL_VS_TH2_UP,0.709386802120141
HP_BROAD_CLAVICLES,SET,10,0.59588,0.013896,0.2812,0.017049,HP_BROAD_CLAVICLES,0.709386802120141
GSE32533_MIR17_KO_VS_MIR17_O...1,SET,176,0.13442,0.013091,0.063443,0.017062,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.709386802120141
GOBP_POSITIVE_REGULATION_OF_...349,SET,233,0.12285,0.013744,0.058014,0.017114,GOBP_POSITIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.709386802120141
MIR5693,SET,78,0.20487,0.013318,0.096749,0.017116,MIR5693,0.709386802120141
MIR1273C,SET,6,0.68793,0.012428,0.32495,0.017137,MIR1273C,0.709386802120141
HP_URETHRAL_VALVE,SET,11,0.52405,0.012817,0.24756,0.017142,HP_URETHRAL_VALVE,0.709386802120141
GAVISH_3CA_METAPROGRAM_FIBRO...12,SET,42,0.30195,0.014418,0.14268,0.017168,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_COMPLEMENT,0.709386802120141
REACTOME_TRANSPORT_OF_BILE_S...,SET,82,0.21186,0.01412,0.10015,0.0172,REACTOME_TRANSPORT_OF_BILE_SALTS_AND_ORGANIC_ACIDS_METAL_IONS_AND_AMINE_COMPOUNDS,0.709386802120141
HP_DELAYED_GROSS_MOTOR_DEVEL...,SET,410,0.087973,0.012992,0.041595,0.017222,HP_DELAYED_GROSS_MOTOR_DEVELOPMENT,0.709386802120141
GSE411_UNSTIM_VS_100MIN_IL6_...4,SET,177,0.1259,0.012296,0.059545,0.017249,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.709386802120141
GSE3982_MAC_VS_TH2_UP,SET,181,0.13515,0.013346,0.063924,0.017251,GSE3982_MAC_VS_TH2_UP,0.709386802120141
GSE18791_UNSTIM_VS_NEWCATSLE...2,SET,186,0.12477,0.012488,0.059021,0.017268,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_UP,0.709386802120141
JEPSEN_SMRT_TARGETS,SET,30,0.33176,0.013393,0.15697,0.017285,JEPSEN_SMRT_TARGETS,0.709386802120141
GOCC_BRCA1_C_COMPLEX,SET,5,0.81584,0.013455,0.38603,0.01729,GOCC_BRCA1_C_COMPLEX,0.709386802120141
HP_PANCREATIC_CALCIFICATION,SET,8,0.70954,0.0148,0.33576,0.017299,HP_PANCREATIC_CALCIFICATION,0.709386802120141
BREUHAHN_GROWTH_FACTOR_SIGNA...,SET,15,0.52826,0.015085,0.25003,0.017316,BREUHAHN_GROWTH_FACTOR_SIGNALING_IN_LIVER_CANCER,0.709386802120141
GSE15930_STIM_VS_STIM_AND_TR...1,SET,177,0.12711,0.012413,0.060161,0.017317,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_DN,0.709386802120141
GOBP_CHROMOSOME_MOVEMENT_TOW...,SET,7,0.61084,0.011919,0.28915,0.017329,GOBP_CHROMOSOME_MOVEMENT_TOWARDS_SPINDLE_POLE,0.709386802120141
GNF2_SMC1L1,SET,23,0.3544,0.012529,0.16788,0.017394,GNF2_SMC1L1,0.709808739742087
GOCC_PORE_COMPLEX,SET,23,0.38411,0.01358,0.18197,0.017402,GOCC_PORE_COMPLEX,0.709808739742087
MIR6744_3P,SET,56,0.25187,0.013882,0.11933,0.017407,MIR6744_3P,0.709808739742087
GSE22601_CD4_SINGLE_POSITIVE...1,SET,180,0.12478,0.012288,0.059127,0.017421,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.709808739742087
BIOCARTA_EGF_PATHWAY,SET,26,0.35127,0.013203,0.1666,0.017505,BIOCARTA_EGF_PATHWAY,0.712396106557377
GOBP_POSITIVE_REGULATION_OF_...350,SET,666,0.071196,0.013305,0.03379,0.017566,GOBP_POSITIVE_REGULATION_OF_IMMUNE_RESPONSE,0.71404249122807
GSE16385_UNTREATED_VS_12H_IF...1,SET,171,0.13075,0.012553,0.062138,0.017689,GSE16385_UNTREATED_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,0.714999094488189
GOBP_POSITIVE_REGULATION_OF_...35,SET,6,0.70419,0.012721,0.33478,0.01772,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.714999094488189
ELLWOOD_MYC_TARGETS_DN,SET,40,0.27955,0.013027,0.13297,0.017768,ELLWOOD_MYC_TARGETS_DN,0.714999094488189
HP_BUTTERFLY_VERTEBRAE,SET,16,0.44019,0.012982,0.20945,0.017799,HP_BUTTERFLY_VERTEBRAE,0.714999094488189
GSE26351_UNSTIM_VS_WNT_PATHW...1,SET,176,0.12996,0.012656,0.061851,0.01782,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.714999094488189
HP_ABNORMAL_MALE_INTERNAL_GE...,SET,69,0.22212,0.013584,0.10573,0.017838,HP_ABNORMAL_MALE_INTERNAL_GENITALIA_MORPHOLOGY,0.714999094488189
GSE22432_UNTREATED_VS_TGFB1_...1,SET,174,0.13021,0.012609,0.061996,0.017858,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_DN,0.714999094488189
ATGCAGT_MIR217,SET,97,0.17248,0.012498,0.082176,0.017917,ATGCAGT_MIR217,0.714999094488189
KIM_GLIS2_TARGETS_UP,SET,81,0.21625,0.014324,0.10303,0.017922,KIM_GLIS2_TARGETS_UP,0.714999094488189
GOBP_REGULATION_OF_MRNA_3_EN...,SET,9,0.53387,0.011811,0.25441,0.01794,GOBP_REGULATION_OF_MRNA_3_END_PROCESSING,0.714999094488189
MIR5584_5P,SET,229,0.11707,0.012986,0.055805,0.017965,MIR5584_5P,0.714999094488189
GSE39820_CTRL_VS_TGFBETA3_IL...4,SET,173,0.12567,0.012135,0.059913,0.017979,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_UP,0.714999094488189
GOBP_REGULATION_OF_VIRAL_TRA...,SET,18,0.45446,0.014215,0.21671,0.018003,GOBP_REGULATION_OF_VIRAL_TRANSCRIPTION,0.714999094488189
HP_LIMITATION_OF_MOVEMENT_AT...,SET,5,0.89783,0.014807,0.42814,0.018003,HP_LIMITATION_OF_MOVEMENT_AT_ANKLES,0.714999094488189
GOCC_DNA_REPLICATION_PREINIT...,SET,13,0.47687,0.012678,0.22745,0.01802,GOCC_DNA_REPLICATION_PREINITIATION_COMPLEX,0.714999094488189
HP_ADDUCTED_THUMB,SET,97,0.18067,0.013091,0.0862,0.01805,HP_ADDUCTED_THUMB,0.714999094488189
NAGASHIMA_EGF_SIGNALING_UP,SET,53,0.26489,0.014204,0.12638,0.018052,NAGASHIMA_EGF_SIGNALING_UP,0.714999094488189
PURBEY_TARGETS_OF_CTBP1_AND_...2,SET,65,0.2114,0.01255,0.10086,0.018052,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_UP,0.714999094488189
GSE37301_COMMON_LYMPHOID_PRO...1,SET,181,0.12816,0.012656,0.06117,0.018083,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_DN,0.714999094488189
STK33_SKM_UP,SET,230,0.11552,0.012842,0.055141,0.018094,STK33_SKM_UP,0.714999094488189
HP_CEREBRAL_HEMORRHAGE,SET,63,0.20726,0.012114,0.098938,0.018097,HP_CEREBRAL_HEMORRHAGE,0.714999094488189
REACTOME_EGFR_DOWNREGULATION,SET,29,0.34362,0.013639,0.16405,0.01811,REACTOME_EGFR_DOWNREGULATION,0.714999094488189
GOBP_REGULATION_OF_BLOOD_BRA...,SET,9,0.69386,0.015351,0.33127,0.018114,GOBP_REGULATION_OF_BLOOD_BRAIN_BARRIER_PERMEABILITY,0.714999094488189
GSE14769_UNSTIM_VS_240MIN_LP...2,SET,181,0.12414,0.012258,0.059268,0.018115,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_UP,0.714999094488189
REACTOME_SYNTHESIS_OF_BILE_A...4,SET,23,0.3983,0.014081,0.1902,0.018131,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_7ALPHA_HYDROXYCHOLESTEROL,0.714999094488189
MIR3187_5P,SET,109,0.1619,0.012431,0.077346,0.018172,MIR3187_5P,0.714999094488189
UZONYI_RESPONSE_TO_LEUKOTRIE...,SET,34,0.35873,0.015415,0.17145,0.018212,UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN,0.714999094488189
REACTOME_WNT5A_DEPENDENT_INT...2,SET,15,0.43653,0.012466,0.20865,0.018221,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4,0.714999094488189
GKCGCNNNNNNNTGAYG_UNKNOWN,SET,54,0.21399,0.011582,0.10228,0.018221,GKCGCNNNNNNNTGAYG_UNKNOWN,0.714999094488189
GSE45365_HEALTHY_VS_MCMV_INF...11,SET,157,0.14405,0.013257,0.068878,0.018252,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_DN,0.714999094488189
MODULE_363,SET,41,0.24891,0.011743,0.11902,0.01826,MODULE_363,0.714999094488189
GOBP_POSITIVE_REGULATION_OF_...198,SET,11,0.52965,0.012954,0.25328,0.018262,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.714999094488189
MIR4510,SET,166,0.13551,0.01282,0.064808,0.018276,MIR4510,0.714999094488189
GOBP_INTERLEUKIN_12_MEDIATED...,SET,9,0.58534,0.01295,0.27999,0.018289,GOBP_INTERLEUKIN_12_MEDIATED_SIGNALING_PATHWAY,0.714999094488189
GOBP_L_LEUCINE_TRANSPORT,SET,10,0.57916,0.013506,0.27713,0.018324,GOBP_L_LEUCINE_TRANSPORT,0.715562494382022
GOBP_CILIARY_BASAL_BODY_ORGA...,SET,5,0.76234,0.012572,0.36519,0.018427,GOBP_CILIARY_BASAL_BODY_ORGANIZATION,0.717234254966887
AIZARANI_LIVER_C8_RESIDENT_B...,SET,30,0.32445,0.013098,0.15545,0.018443,AIZARANI_LIVER_C8_RESIDENT_B_CELLS_1,0.717234254966887
GSE14000_TRANSLATED_RNA_VS_M...3,SET,152,0.14077,0.012748,0.067454,0.018458,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_DN,0.717234254966887
HP_MENORRHAGIA,SET,34,0.31069,0.013351,0.14889,0.018466,HP_MENORRHAGIA,0.717234254966887
chr16q24,SET,72,0.42247,0.02639,0.2025,0.018486,chr16q24,0.717234254966887
HP_DISTAL_LOWER_LIMB_AMYOTRO...,SET,46,0.26641,0.013311,0.12778,0.018549,HP_DISTAL_LOWER_LIMB_AMYOTROPHY,0.717234254966887
DESCARTES_MAIN_FETAL_ACINAR_...,SET,50,0.27456,0.014301,0.1317,0.01855,DESCARTES_MAIN_FETAL_ACINAR_CELLS,0.717234254966887
DEBIASI_APOPTOSIS_BY_REOVIRU...2,SET,272,0.10778,0.013015,0.051706,0.018564,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP,0.717234254966887
HP_SEVERE_LACTIC_ACIDOSIS,SET,11,0.4955,0.012118,0.23775,0.018583,HP_SEVERE_LACTIC_ACIDOSIS,0.717234254966887
WAMUNYOKOLI_OVARIAN_CANCER_G...2,SET,125,0.16074,0.013211,0.077139,0.018595,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_UP,0.717234254966887
GOBP_REGULATION_OF_FERTILIZA...,SET,16,0.44658,0.013171,0.21434,0.018609,GOBP_REGULATION_OF_FERTILIZATION,0.717234254966887
GSE6269_HEALTHY_VS_E_COLI_IN...1,SET,145,0.15299,0.013535,0.07344,0.018623,GSE6269_HEALTHY_VS_E_COLI_INF_PBMC_DN,0.717234254966887
MIR4717_3P,SET,71,0.21685,0.013452,0.10413,0.01866,MIR4717_3P,0.717234254966887
GSE6269_FLU_VS_STREP_PNEUMO_...1,SET,146,0.14564,0.012929,0.06995,0.018677,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_DN,0.717234254966887
GSE37319_WT_VS_RC3H1_KO_CD44...1,SET,122,0.16316,0.013249,0.07837,0.018685,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_DN,0.717234254966887
HP_NARROW_FACE,SET,83,0.19984,0.013399,0.096006,0.018697,HP_NARROW_FACE,0.717234254966887
GSE2197_CPG_DNA_VS_UNTREATED...1,SET,175,0.13125,0.012747,0.063083,0.018739,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_DN,0.718052861080485
GOBP_REGULATION_OF_TRANSLATI...10,SET,4,0.79721,0.01176,0.38328,0.018773,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE_MODULATING_SYNAPTIC_TRANSMISSION,0.718563452643172
REACTOME_DEFECTIVE_C1GALT1C1...,SET,14,0.49811,0.013742,0.23962,0.018828,REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS,0.719181606557377
GOBP_POSITIVE_REGULATION_OF_...543,SET,9,0.68387,0.01513,0.3291,0.018863,GOBP_POSITIVE_REGULATION_OF_NK_T_CELL_ACTIVATION,0.719181606557377
ABDULRAHMAN_KIDNEY_CANCER_VH...,SET,13,0.53816,0.014308,0.259,0.018871,ABDULRAHMAN_KIDNEY_CANCER_VHL_DN,0.719181606557377
MIER1_TARGET_GENES,SET,297,0.10293,0.012978,0.049537,0.018873,MIER1_TARGET_GENES,0.719181606557377
HP_LIMITED_ELBOW_MOVEMENT,SET,145,0.14809,0.013102,0.071306,0.018917,HP_LIMITED_ELBOW_MOVEMENT,0.719181606557377
GOBP_REGULATION_OF_CHOLESTER...1,SET,17,0.42149,0.012813,0.20297,0.018925,GOBP_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,0.719181606557377
NRL_DN.V1_DN,SET,120,0.16529,0.013312,0.079601,0.018934,NRL_DN.V1_DN,0.719181606557377
MENON_FETAL_KIDNEY_2_NEPHRON...,SET,35,0.2979,0.012987,0.14364,0.01905,MENON_FETAL_KIDNEY_2_NEPHRON_PROGENITOR_CELLS,0.722797762008734
GRADE_COLON_VS_RECTAL_CANCER...1,SET,46,0.25108,0.012545,0.1211,0.019076,GRADE_COLON_VS_RECTAL_CANCER_DN,0.722994961832061
HP_AORTIC_REGURGITATION,SET,89,0.1908,0.013245,0.092062,0.019116,HP_AORTIC_REGURGITATION,0.723484506507592
GSE17721_LPS_VS_PAM3CSK4_16H...2,SET,190,0.12282,0.012423,0.059293,0.019171,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_UP,0.723484506507592
GSE17721_LPS_VS_POLYIC_0.5H_...2,SET,181,0.12534,0.012377,0.060511,0.019173,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_UP,0.723484506507592
GOBP_POSITIVE_REGULATION_OF_...503,SET,17,0.43372,0.013185,0.20942,0.019182,GOBP_POSITIVE_REGULATION_OF_MYELINATION,0.723484506507592
GOBP_ZINC_ION_IMPORT_ACROSS_...,SET,10,0.52986,0.012356,0.25586,0.019193,GOBP_ZINC_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.723484506507592
GOBP_MEMBRANE_PROTEIN_PROTEO...,SET,57,0.22391,0.01245,0.10821,0.019271,GOBP_MEMBRANE_PROTEIN_PROTEOLYSIS,0.724970513513513
GOBP_CARDIAC_NEURAL_CREST_CE...2,SET,15,0.52282,0.01493,0.25272,0.01929,GOBP_CARDIAC_NEURAL_CREST_CELL_DIFFERENTIATION_INVOLVED_IN_HEART_DEVELOPMENT,0.724970513513513
E2F_03,SET,218,0.11486,0.012435,0.055522,0.019295,E2F_03,0.724970513513513
GOBP_REGULATION_OF_CELLULAR_...19,SET,24,0.37789,0.013647,0.18275,0.01934,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.725131019417476
GOMF_INTERLEUKIN_12_RECEPTOR...,SET,5,0.97017,0.016,0.4692,0.019341,GOMF_INTERLEUKIN_12_RECEPTOR_BINDING,0.725131019417476
HP_PUNCTATE_OPACIFICATION_OF...,SET,5,0.81037,0.013364,0.39246,0.019476,HP_PUNCTATE_OPACIFICATION_OF_THE_CORNEA,0.729186634615385
HP_PALPITATIONS,SET,102,0.17697,0.013147,0.085752,0.019527,HP_PALPITATIONS,0.729186634615385
HP_ANTENATAL_ONSET,SET,215,0.11629,0.012504,0.056356,0.019538,HP_ANTENATAL_ONSET,0.729186634615385
REACTOME_SLC15A4_TASL_DEPEND...,SET,4,0.77323,0.011406,0.37473,0.019543,REACTOME_SLC15A4_TASL_DEPENDENT_IRF5_ACTIVATION,0.729186634615385
AIZARANI_LIVER_C21_STELLATE_...,SET,176,0.14661,0.014278,0.071065,0.019562,AIZARANI_LIVER_C21_STELLATE_CELLS_1,0.729186634615385
SMID_BREAST_CANCER_RELAPSE_I...8,SET,21,0.4055,0.013699,0.19659,0.019581,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_UP,0.729186634615385
GSE43863_TH1_VS_LY6C_INT_CXC...2,SET,179,0.12431,0.012208,0.06029,0.019615,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.729186634615385
INAMURA_LUNG_CANCER_SCC_DN,SET,13,0.50078,0.013314,0.2429,0.019625,INAMURA_LUNG_CANCER_SCC_DN,0.729186634615385
GOBP_EPIGENETIC_PROGRAMMING_...2,SET,28,0.32092,0.012517,0.15568,0.019638,GOBP_EPIGENETIC_PROGRAMMING_OF_GENE_EXPRESSION,0.729186634615385
HP_NEONATAL_HYPOTONIA,SET,169,0.1317,0.012571,0.063922,0.019688,HP_NEONATAL_HYPOTONIA,0.729632686567164
REACTOME_ANCHORING_OF_THE_BA...,SET,91,0.1656,0.011624,0.080377,0.019692,REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE,0.729632686567164
HP_ENAMEL_HYPOMINERALIZATION,SET,8,0.61474,0.012823,0.29851,0.019737,HP_ENAMEL_HYPOMINERALIZATION,0.729670916313559
GSE21063_CTRL_VS_ANTI_IGM_ST...8,SET,181,0.13199,0.013033,0.064134,0.019804,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_UP,0.729670916313559
GOCC_SPERM_PLASMA_MEMBRANE,SET,14,0.45921,0.012669,0.22314,0.019806,GOCC_SPERM_PLASMA_MEMBRANE,0.729670916313559
RODRIGUES_THYROID_CARCINOMA_...6,SET,14,0.52275,0.014422,0.25403,0.019809,RODRIGUES_THYROID_CARCINOMA_UP,0.729670916313559
HP_NEUROENDOCRINE_NEOPLASM,SET,37,0.26512,0.011883,0.12884,0.019812,HP_NEUROENDOCRINE_NEOPLASM,0.729670916313559
GOBP_POSITIVE_REGULATION_OF_...831,SET,7,0.72649,0.014175,0.35307,0.019819,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.729670916313559
GSE27291_0H_VS_7D_STIM_GAMMA...2,SET,154,0.13307,0.01213,0.064705,0.019869,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP,0.729745247368421
GOBP_AV_NODE_CELL_TO_BUNDLE_...1,SET,13,0.53134,0.014126,0.25838,0.01988,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_COMMUNICATION,0.729745247368421
GOBP_REGULATION_OF_DNA_LIGAT...,SET,6,0.58028,0.010483,0.2823,0.019921,GOBP_REGULATION_OF_DNA_LIGATION,0.729745247368421
GOBP_REGULATION_OF_CARDIAC_M...10,SET,18,0.40677,0.012724,0.19789,0.019923,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_REGULATION_OF_THE_RELEASE_OF_SEQUESTERED_CALCIUM_ION,0.729745247368421
GOBP_REGULATION_OF_CELL_ADHE...2,SET,46,0.26017,0.013,0.1266,0.019942,GOBP_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.729745247368421
LI_INDUCED_T_TO_NATURAL_KILL...1,SET,127,0.15458,0.012805,0.07522,0.019947,LI_INDUCED_T_TO_NATURAL_KILLER_DN,0.729745247368421
WORSCHECH_TUMOR_EVASION_AND_...2,SET,29,0.35136,0.013946,0.17118,0.020062,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP,0.730825408479835
MIR5189_5P,SET,139,0.14241,0.012338,0.069409,0.020102,MIR5189_5P,0.730825408479835
MIR7158_3P,SET,57,0.23766,0.013215,0.11585,0.020124,MIR7158_3P,0.730825408479835
GSE43955_TGFB_IL6_VS_TGFB_IL...4,SET,183,0.12479,0.01239,0.060844,0.020142,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,0.730825408479835
GOBP_DEFENSE_RESPONSE_TO_GRA...1,SET,77,0.22529,0.014552,0.10985,0.020143,GOBP_DEFENSE_RESPONSE_TO_GRAM_NEGATIVE_BACTERIUM,0.730825408479835
GSE9650_GP33_VS_GP276_LCMV_S...1,SET,185,0.1221,0.012188,0.059535,0.02015,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_DN,0.730825408479835
GSE28726_ACT_CD4_TCELL_VS_AC...2,SET,188,0.12063,0.012138,0.05883,0.020167,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP,0.730825408479835
GOCC_HEMOGLOBIN_COMPLEX,SET,8,0.7047,0.014699,0.34371,0.020176,GOCC_HEMOGLOBIN_COMPLEX,0.730825408479835
HP_ABNORMAL_MONOCYTE_COUNT,SET,20,0.37569,0.012387,0.18326,0.020186,HP_ABNORMAL_MONOCYTE_COUNT,0.730825408479835
GOBP_PROTEIN_IMPORT_INTO_MIT...,SET,18,0.37187,0.011632,0.18141,0.020198,GOBP_PROTEIN_IMPORT_INTO_MITOCHONDRIAL_MATRIX,0.730825408479835
SA_PTEN_PATHWAY,SET,17,0.39991,0.012157,0.19518,0.020242,SA_PTEN_PATHWAY,0.730825408479835
GOBP_NEGATIVE_REGULATION_OF_...408,SET,7,0.68035,0.013275,0.33214,0.020269,GOBP_NEGATIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,0.730825408479835
KEGG_MEDICUS_PATHOGEN_HCV_CO...3,SET,5,0.79218,0.013064,0.38676,0.020276,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_PPARA_MEDIATED_TRANSCRIPTION,0.730825408479835
SHIN_B_CELL_LYMPHOMA_CLUSTER...4,SET,18,0.42184,0.013195,0.20597,0.020287,SHIN_B_CELL_LYMPHOMA_CLUSTER_5,0.730825408479835
MIR224_5P,SET,164,0.13134,0.012351,0.064143,0.02031,MIR224_5P,0.730825408479835
LAKE_ADULT_KIDNEY_C15_CONNEC...,SET,156,0.15125,0.013876,0.073873,0.020315,LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE,0.730825408479835
PID_SHP2_PATHWAY,SET,55,0.23909,0.01306,0.1168,0.020334,PID_SHP2_PATHWAY,0.730825408479835
HP_HAMARTOMA_OF_THE_ORBITAL_...,SET,29,0.29116,0.011557,0.14236,0.020421,HP_HAMARTOMA_OF_THE_ORBITAL_REGION,0.732760216718266
REACTOME_GROWTH_HORMONE_RECE...,SET,22,0.42182,0.014586,0.20626,0.02043,REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING,0.732760216718266
RAY_TUMORIGENESIS_BY_ERBB2_C...1,SET,243,0.1153,0.01317,0.056393,0.020457,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN,0.732972201030928
HP_PERIORBITAL_EDEMA,SET,99,0.18456,0.013509,0.090304,0.020495,HP_PERIORBITAL_EDEMA,0.73297943939394
GOBP_RESPONSE_TO_AUDITORY_ST...,SET,32,0.31136,0.012981,0.15236,0.020502,GOBP_RESPONSE_TO_AUDITORY_STIMULUS,0.73297943939394
REACTOME_SIGNALING_BY_RNF43_...,SET,8,0.65265,0.013614,0.31943,0.020526,REACTOME_SIGNALING_BY_RNF43_MUTANTS,0.73297943939394
GSE38696_LIGHT_ZONE_VS_DARK_...1,SET,122,0.15453,0.012548,0.075644,0.020543,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.73297943939394
MIR7114_3P,SET,42,0.25594,0.012221,0.12543,0.020659,MIR7114_3P,0.73297943939394
GSE15930_NAIVE_VS_72H_IN_VIT...7,SET,188,0.11821,0.011895,0.057936,0.020664,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_DN,0.73297943939394
GAVISH_3CA_MALIGNANT_METAPRO...2,SET,38,0.28019,0.012727,0.13734,0.020676,GAVISH_3CA_MALIGNANT_METAPROGRAM_11_TRANSLATION_INITIATION,0.73297943939394
GOBP_REGULATION_OF_LEUKOCYTE...7,SET,226,0.12137,0.013375,0.05951,0.020711,GOBP_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.73297943939394
HP_HOARSE_VOICE,SET,91,0.18157,0.012745,0.089045,0.020726,HP_HOARSE_VOICE,0.73297943939394
HP_THICK_LOWER_LIP_VERMILION,SET,115,0.15871,0.012515,0.077847,0.020748,HP_THICK_LOWER_LIP_VERMILION,0.73297943939394
DANG_REGULATED_BY_MYC_DN,SET,225,0.11459,0.0126,0.056214,0.020763,DANG_REGULATED_BY_MYC_DN,0.73297943939394
HP_DYSGENESIS_OF_THE_HIPPOCA...,SET,15,0.4338,0.012388,0.21282,0.020764,HP_DYSGENESIS_OF_THE_HIPPOCAMPUS,0.73297943939394
GOBP_REGULATION_OF_RRNA_PROC...,SET,15,0.44476,0.012701,0.21823,0.02078,GOBP_REGULATION_OF_RRNA_PROCESSING,0.73297943939394
LAKE_ADULT_KIDNEY_C22_ENDOTH...,SET,135,0.15752,0.013451,0.077291,0.020781,LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES,0.73297943939394
HP_OSTEOLYTIC_DEFECTS_OF_THE...,SET,5,0.72888,0.01202,0.35768,0.020792,HP_OSTEOLYTIC_DEFECTS_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.73297943939394
MIR4471,SET,68,0.20378,0.012372,0.10002,0.020811,MIR4471,0.73297943939394
TCGA_GLIOBLASTOMA_COPY_NUMBE...1,SET,28,0.45302,0.017669,0.22237,0.020822,TCGA_GLIOBLASTOMA_COPY_NUMBER_DN,0.73297943939394
HP_ESOPHORIA,SET,5,0.70392,0.011609,0.34559,0.020839,HP_ESOPHORIA,0.73297943939394
KAECH_NAIVE_VS_MEMORY_CD8_TC...2,SET,184,0.12869,0.012812,0.063195,0.02086,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.73297943939394
MIR4711_3P,SET,73,0.20901,0.013146,0.10265,0.020879,MIR4711_3P,0.73297943939394
GSE15330_MEGAKARYOCYTE_ERYTH...1,SET,174,0.12425,0.012032,0.061042,0.020911,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_DN,0.733358528225806
HP_DIFFICULTY_RUNNING,SET,47,0.2507,0.012662,0.12319,0.020932,HP_DIFFICULTY_RUNNING,0.733358528225806
GSE17974_CTRL_VS_ACT_IL4_AND...13,SET,178,0.1188,0.011634,0.058407,0.020986,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_DN,0.733976698492462
GOCC_NUCLEAR_STRESS_GRANULE,SET,6,0.69676,0.012587,0.34262,0.021002,GOCC_NUCLEAR_STRESS_GRANULE,0.733976698492462
GSE43956_WT_VS_SGK1_KO_TH17_...2,SET,183,0.12734,0.012643,0.062624,0.021013,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_UP,0.733976698492462
GOBP_REGULATION_OF_CELL_PROJ...1,SET,202,0.12402,0.012931,0.061026,0.021067,GOBP_REGULATION_OF_CELL_PROJECTION_ASSEMBLY,0.734468793604651
WP_IL18_SIGNALING,SET,260,0.11179,0.013202,0.055028,0.02111,WP_IL18_SIGNALING,0.734468793604651
GOBP_NEGATIVE_REGULATION_OF_...25,SET,19,0.40187,0.012915,0.19782,0.021111,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.734468793604651
BERENJENO_TRANSFORMED_BY_RHO...3,SET,20,0.39677,0.013081,0.19532,0.021118,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_UP,0.734468793604651
HP_RECURRENT_CUTANEOUS_FUNGA...,SET,53,0.24058,0.012901,0.11851,0.021182,HP_RECURRENT_CUTANEOUS_FUNGAL_INFECTIONS,0.734468793604651
GSE17721_POLYIC_VS_CPG_12H_B...1,SET,183,0.12394,0.012306,0.06111,0.021277,GSE17721_POLYIC_VS_CPG_12H_BMDC_DN,0.734468793604651
HP_HEAD_BANGING,SET,9,0.54651,0.012091,0.26947,0.021282,HP_HEAD_BANGING,0.734468793604651
MIR6781_3P,SET,72,0.19887,0.012423,0.0981,0.021327,MIR6781_3P,0.734468793604651
GOBP_CYTOPLASMIC_MICROTUBULE...,SET,58,0.21699,0.012171,0.10705,0.021337,GOBP_CYTOPLASMIC_MICROTUBULE_ORGANIZATION,0.734468793604651
GOBP_SNRNA_TRANSCRIPTION,SET,20,0.35488,0.0117,0.17508,0.02134,GOBP_SNRNA_TRANSCRIPTION,0.734468793604651
HP_ABNORMAL_ENDOCRINE_MORPHO...,SET,101,0.1681,0.012427,0.082952,0.021363,HP_ABNORMAL_ENDOCRINE_MORPHOLOGY,0.734468793604651
KEGG_MEDICUS_VARIANT_CYP11B1...,SET,31,0.30165,0.012378,0.1489,0.021399,KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.734468793604651
HP_TYPE_1_MUSCLE_FIBER_ATROP...,SET,14,0.4401,0.012142,0.21726,0.021407,HP_TYPE_1_MUSCLE_FIBER_ATROPHY,0.734468793604651
MODULE_286,SET,35,0.2929,0.01277,0.14461,0.021418,MODULE_286,0.734468793604651
HP_ABNORMALITY_OF_HAIR_PIGME...,SET,109,0.16767,0.012874,0.0828,0.021441,HP_ABNORMALITY_OF_HAIR_PIGMENTATION,0.734468793604651
GSE31082_CD4_VS_CD8_SP_THYMO...1,SET,179,0.12419,0.012197,0.061331,0.021442,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_DN,0.734468793604651
REACTOME_CREB3_FACTORS_ACTIV...,SET,8,0.538,0.011222,0.26572,0.021457,REACTOME_CREB3_FACTORS_ACTIVATE_GENES,0.734468793604651
GSE18148_CBFB_KO_VS_WT_TREG_...2,SET,173,0.1307,0.012621,0.064553,0.021458,GSE18148_CBFB_KO_VS_WT_TREG_UP,0.734468793604651
WP_BREAST_CANCER_PATHWAY,SET,149,0.14534,0.013033,0.071819,0.021505,WP_BREAST_CANCER_PATHWAY,0.734468793604651
GOCC_MITOCHONDRIAL_PERMEABIL...,SET,6,0.70078,0.01266,0.34628,0.021506,GOCC_MITOCHONDRIAL_PERMEABILITY_TRANSITION_PORE_COMPLEX,0.734468793604651
LAKE_ADULT_KIDNEY_C6_PROXIMA...,SET,171,0.1355,0.013009,0.066962,0.021518,LAKE_ADULT_KIDNEY_C6_PROXIMAL_TUBULE_EPITHELIAL_CELLS_FIBRINOGEN_POS_S3,0.734468793604651
CHARAFE_BREAST_CANCER_LUMINA...3,SET,425,0.087856,0.013205,0.043423,0.021532,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN,0.734468793604651
MADAN_DPPA4_TARGETS,SET,49,0.24515,0.012641,0.12118,0.02154,MADAN_DPPA4_TARGETS,0.734468793604651
REACTOME_WNT5A_DEPENDENT_INT...1,SET,13,0.46118,0.012261,0.22802,0.021565,REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2,0.734468793604651
SCHERER_PBMC_APSV_WETVAX_AGE...7,SET,20,0.4172,0.013755,0.20632,0.021589,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_DN,0.734468793604651
HP_ABNORMAL_ARTERIAL_PHYSIOL...,SET,154,0.14306,0.01304,0.070761,0.021611,HP_ABNORMAL_ARTERIAL_PHYSIOLOGY,0.734468793604651
GSE27786_ERYTHROBLAST_VS_NEU...2,SET,178,0.12549,0.01229,0.062078,0.021619,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_UP,0.734468793604651
MIR6129,SET,170,0.12955,0.012402,0.064087,0.021624,MIR6129,0.734468793604651
REACTOME_PI3K_EVENTS_IN_ERBB...1,SET,16,0.44244,0.013048,0.21895,0.02166,REACTOME_PI3K_EVENTS_IN_ERBB2_SIGNALING,0.734468793604651
HP_CHRONIC_FURUNCULOSIS,SET,4,0.87387,0.01289,0.43252,0.021678,HP_CHRONIC_FURUNCULOSIS,0.734468793604651
GOBP_NUCLEOLUS_ORGANIZATION,SET,14,0.39048,0.010773,0.19339,0.021745,GOBP_NUCLEOLUS_ORGANIZATION,0.734468793604651
GOBP_POSITIVE_REGULATION_OF_...257,SET,29,0.3262,0.012947,0.16156,0.021749,GOBP_POSITIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,0.734468793604651
HP_ANGINA_PECTORIS,SET,37,0.29842,0.013376,0.1478,0.02175,HP_ANGINA_PECTORIS,0.734468793604651
HP_ANORECTAL_ANOMALY,SET,149,0.14044,0.012594,0.069573,0.021771,HP_ANORECTAL_ANOMALY,0.734468793604651
GSE42021_TCONV_PLN_VS_CD24HI...2,SET,186,0.12636,0.012647,0.062602,0.021781,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_UP,0.734468793604651
BROWNE_HCMV_INFECTION_4HR_UP,SET,47,0.26082,0.013173,0.12926,0.021809,BROWNE_HCMV_INFECTION_4HR_UP,0.734468793604651
GOBP_POSITIVE_REGULATION_OF_...73,SET,8,0.59263,0.012362,0.29369,0.021809,GOBP_POSITIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.734468793604651
MIR6127,SET,185,0.12367,0.012345,0.061307,0.021839,MIR6127,0.734767129719264
REN_BOUND_BY_E2F,SET,53,0.21611,0.011588,0.1072,0.021912,REN_BOUND_BY_E2F,0.734782207421503
HP_ABNORMAL_RELATIONSHIP,SET,11,0.5563,0.013605,0.27596,0.021917,HP_ABNORMAL_RELATIONSHIP,0.734782207421503
MODULE_240,SET,14,0.4392,0.012117,0.21794,0.021944,MODULE_240,0.734782207421503
GOBP_POSITIVE_REGULATION_OF_...398,SET,30,0.31272,0.012624,0.1552,0.021962,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.734782207421503
REACTOME_NR1H2_NR1H3_REGULAT...1,SET,5,0.68355,0.011273,0.33932,0.021987,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_GLUCONEOGENESIS,0.734782207421503
HP_IMPAIRED_RISTOCETIN_INDUC...,SET,8,0.62256,0.012986,0.30912,0.022016,HP_IMPAIRED_RISTOCETIN_INDUCED_PLATELET_AGGREGATION,0.734782207421503
GSE29617_CTRL_VS_DAY3_TIV_FL...2,SET,165,0.1294,0.012205,0.064257,0.022024,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_UP,0.734782207421503
HP_NORMAL_PRESSURE_HYDROCEPH...,SET,5,0.82485,0.013603,0.40966,0.022039,HP_NORMAL_PRESSURE_HYDROCEPHALUS,0.734782207421503
HP_DISPROPORTIONATE_SHORT_ST...,SET,119,0.15875,0.012733,0.078844,0.022041,HP_DISPROPORTIONATE_SHORT_STATURE,0.734782207421503
GOMF_RACEMASE_AND_EPIMERASE_...2,SET,9,0.53999,0.011946,0.26824,0.02206,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY_ACTING_ON_CARBOHYDRATES_AND_DERIVATIVES,0.734782207421503
GOBP_NEGATIVE_REGULATION_OF_...512,SET,9,0.59054,0.013065,0.29344,0.022092,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,0.734782207421503
GOBP_POSITIVE_REGULATION_OF_...664,SET,7,0.62449,0.012185,0.31041,0.022129,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,0.734782207421503
GSE41867_DAY15_EFFECTOR_VS_D...1,SET,182,0.11901,0.011784,0.059176,0.022163,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.734782207421503
REACTOME_GRB2_EVENTS_IN_ERBB...,SET,16,0.41126,0.012129,0.2045,0.022167,REACTOME_GRB2_EVENTS_IN_ERBB2_SIGNALING,0.734782207421503
HP_BROAD_TOE,SET,72,0.19383,0.012108,0.096402,0.022188,HP_BROAD_TOE,0.734782207421503
HP_METACARPOPHALANGEAL_JOINT...,SET,3,1.2396,0.015836,0.61656,0.022198,HP_METACARPOPHALANGEAL_JOINT_CONTRACTURE,0.734782207421503
HP_WEAK_VOICE,SET,24,0.31645,0.011428,0.15741,0.022205,HP_WEAK_VOICE,0.734782207421503
GOBP_ADENINE_TRANSPORT,SET,5,0.84305,0.013903,0.41942,0.02222,GOBP_ADENINE_TRANSPORT,0.734782207421503
GOBP_RESPONSE_TO_TUMOR_CELL,SET,38,0.30361,0.013791,0.15116,0.022303,GOBP_RESPONSE_TO_TUMOR_CELL,0.735163934280639
HP_ABNORMAL_STERNUM_MORPHOLO...,SET,402,0.083097,0.012154,0.041374,0.022305,HP_ABNORMAL_STERNUM_MORPHOLOGY,0.735163934280639
MATSUMIYA_BLOOD_MODIFIED_VAC...1,SET,9,0.61088,0.013515,0.30429,0.022352,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_DN,0.735163934280639
GOMF_GAMMA_AMINOBUTYRIC_ACID...1,SET,5,0.92858,0.015314,0.46257,0.022359,GOMF_GAMMA_AMINOBUTYRIC_ACID_SODIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.735163934280639
WHITESIDE_CISPLATIN_RESISTAN...1,SET,12,0.44251,0.011303,0.22048,0.02238,WHITESIDE_CISPLATIN_RESISTANCE_DN,0.735163934280639
GSE4748_CTRL_VS_CYANOBACTERI...3,SET,178,0.11981,0.011734,0.059699,0.022384,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.735163934280639
REACTOME_SIGNALING_BY_ERBB2,SET,48,0.23222,0.011852,0.11575,0.022424,REACTOME_SIGNALING_BY_ERBB2,0.735163934280639
GOBP_POSITIVE_REGULATION_OF_...688,SET,1685,0.043077,0.012431,0.021473,0.02243,GOBP_POSITIVE_REGULATION_OF_RNA_METABOLIC_PROCESS,0.735163934280639
HP_ABNORMAL_ENDOCARDIUM_MORP...,SET,54,0.24203,0.0131,0.12067,0.022449,HP_ABNORMAL_ENDOCARDIUM_MORPHOLOGY,0.735163934280639
BLANCO_MELO_COVID19_SARS_COV...5,SET,69,0.2177,0.013314,0.10856,0.022469,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN,0.735163934280639
GSE26351_UNSTIM_VS_BMP_PATHW...1,SET,176,0.12655,0.012325,0.063132,0.022512,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,0.735163934280639
MIR8053,SET,5,0.57249,0.0094414,0.28564,0.022531,MIR8053,0.735163934280639
GSE369_SOCS3_KO_VS_IFNG_KO_L...1,SET,181,0.12747,0.012587,0.063617,0.022558,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_DN,0.735163934280639
GSE15659_CD45RA_NEG_CD4_TCEL...5,SET,172,0.12767,0.012293,0.06374,0.022599,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_DN,0.735163934280639
PETROVA_PROX1_TARGETS_DN,SET,55,0.23717,0.012955,0.11844,0.022624,PETROVA_PROX1_TARGETS_DN,0.735163934280639
KEGG_MEDICUS_VARIANT_MUTATIO...52,SET,11,0.50957,0.012463,0.2546,0.022677,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.735163934280639
GSE16385_MONOCYTE_VS_12H_ROS...5,SET,169,0.12244,0.011687,0.061177,0.022681,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,0.735163934280639
KEGG_MEDICUS_REFERENCE_ACTH_...,SET,32,0.29598,0.01234,0.1479,0.022693,KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY,0.735163934280639
GOBP_REGULATION_OF_HEMOPOIES...,SET,385,0.090775,0.013,0.045372,0.022722,GOBP_REGULATION_OF_HEMOPOIESIS,0.735163934280639
BENPORATH_MYC_MAX_TARGETS,SET,687,0.060767,0.011527,0.030374,0.022723,BENPORATH_MYC_MAX_TARGETS,0.735163934280639
GOBP_CELLULAR_RESPONSE_TO_ST...2,SET,193,0.12363,0.012602,0.061826,0.022776,GOBP_CELLULAR_RESPONSE_TO_STEROID_HORMONE_STIMULUS,0.735163934280639
RHEIN_ALL_GLUCOCORTICOID_THE...2,SET,67,0.21225,0.012792,0.1062,0.022832,RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP,0.735163934280639
MODULE_218,SET,18,0.44673,0.013974,0.22354,0.022841,MODULE_218,0.735163934280639
GOBP_NEGATIVE_REGULATION_OF_...141,SET,6,0.73855,0.013342,0.36959,0.022852,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.735163934280639
MIR4725_3P,SET,260,0.10382,0.012261,0.051959,0.022858,MIR4725_3P,0.735163934280639
HP_STEREOTYPICAL_HAND_WRINGI...,SET,20,0.39388,0.012986,0.19715,0.022873,HP_STEREOTYPICAL_HAND_WRINGING,0.735163934280639
HP_CAVERNOUS_HEMANGIOMA,SET,33,0.282,0.011939,0.14123,0.022939,HP_CAVERNOUS_HEMANGIOMA,0.735163934280639
chr10p12,SET,46,0.44412,0.022191,0.22252,0.022984,chr10p12,0.735163934280639
TERAMOTO_OPN_TARGETS_CLUSTER...4,SET,6,0.59749,0.010794,0.29945,0.023013,TERAMOTO_OPN_TARGETS_CLUSTER_5,0.735163934280639
GOBP_REGULATION_OF_TISSUE_RE...,SET,72,0.21276,0.013291,0.10665,0.023027,GOBP_REGULATION_OF_TISSUE_REMODELING,0.735163934280639
GSE27786_ERYTHROBLAST_VS_MON...2,SET,174,0.12487,0.012093,0.062598,0.023037,GSE27786_ERYTHROBLAST_VS_MONO_MAC_UP,0.735163934280639
MODULE_132,SET,13,0.50708,0.013481,0.25425,0.023062,MODULE_132,0.735163934280639
BUCASAS_PBMC_FLUARIX_FLUVIRI...1,SET,6,0.69699,0.012591,0.34965,0.023115,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_3DY_POSITIVE_PREDICTIVE_OF_TITER,0.735163934280639
GOBP_NEGATIVE_REGULATION_OF_...293,SET,16,0.42614,0.012568,0.21378,0.02312,GOBP_NEGATIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.735163934280639
GOBP_INTRACELLULAR_MAGNESIUM...,SET,3,0.96352,0.012309,0.48337,0.023121,GOBP_INTRACELLULAR_MAGNESIUM_ION_HOMEOSTASIS,0.735163934280639
KORKOLA_YOLK_SAC_TUMOR_UP,SET,13,0.54353,0.01445,0.27271,0.023133,KORKOLA_YOLK_SAC_TUMOR_UP,0.735163934280639
HP_MASK_LIKE_FACIES,SET,44,0.23505,0.011487,0.11797,0.023169,HP_MASK_LIKE_FACIES,0.735163934280639
TTGCACT_MIR130A_MIR301_MIR13...,SET,352,0.08965,0.012287,0.045009,0.023204,TTGCACT_MIR130A_MIR301_MIR130B,0.735163934280639
HP_HYPOPLASTIC_PELVIS,SET,14,0.4514,0.012454,0.22667,0.023226,HP_HYPOPLASTIC_PELVIS,0.735163934280639
HP_ABNORMAL_PLATELET_GRANULES,SET,12,0.44121,0.01127,0.22157,0.023235,HP_ABNORMAL_PLATELET_GRANULES,0.735163934280639
GOBP_REGULATION_OF_CD4_POSIT...1,SET,71,0.21406,0.013279,0.10752,0.023259,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.735163934280639
GSE30971_CTRL_VS_LPS_STIM_MA...7,SET,169,0.13233,0.012631,0.066474,0.023263,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_DN,0.735163934280639
GSE6269_FLU_VS_STAPH_AUREUS_...1,SET,146,0.14295,0.012691,0.071829,0.023291,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_DN,0.735163934280639
HP_NODULAR_CHANGES_AFFECTING...,SET,27,0.35745,0.013691,0.17962,0.023298,HP_NODULAR_CHANGES_AFFECTING_THE_EYELIDS,0.735163934280639
GSE40273_GATA1_KO_VS_WT_TREG...2,SET,175,0.12326,0.01197,0.061941,0.023306,GSE40273_GATA1_KO_VS_WT_TREG_UP,0.735163934280639
HP_FOCAL_MOTOR_STATUS_EPILEP...,SET,13,0.47899,0.012735,0.24073,0.023318,HP_FOCAL_MOTOR_STATUS_EPILEPTICUS,0.735163934280639
MIR1224_5P,SET,55,0.21859,0.01194,0.10987,0.023329,MIR1224_5P,0.735163934280639
HP_DEATH_IN_ADULTHOOD,SET,42,0.25295,0.012078,0.12715,0.023335,HP_DEATH_IN_ADULTHOOD,0.735163934280639
GSE44732_UNSTIM_VS_IL27_STIM...1,SET,183,0.12384,0.012296,0.062253,0.02334,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_DN,0.735163934280639
HP_FETAL_ONSET,SET,170,0.12363,0.011835,0.062174,0.023392,HP_FETAL_ONSET,0.735163934280639
GOBP_PURKINJE_MYOCYTE_TO_VEN...,SET,6,0.75373,0.013616,0.37913,0.02341,GOBP_PURKINJE_MYOCYTE_TO_VENTRICULAR_CARDIAC_MUSCLE_CELL_COMMUNICATION,0.735163934280639
MIR12114,SET,37,0.27373,0.01227,0.13772,0.023434,MIR12114,0.735163934280639
DANG_BOUND_BY_MYC,SET,942,0.053263,0.011745,0.026804,0.023462,DANG_BOUND_BY_MYC,0.735163934280639
WEINMANN_ADAPTATION_TO_HYPOX...2,SET,25,0.36444,0.013432,0.18341,0.023467,WEINMANN_ADAPTATION_TO_HYPOXIA_UP,0.735163934280639
GOBP_RESPONSE_TO_VIRUS,SET,369,0.090044,0.01263,0.045324,0.023486,GOBP_RESPONSE_TO_VIRUS,0.735163934280639
GOBP_NEGATIVE_REGULATION_OF_...381,SET,4,0.87918,0.012969,0.4427,0.023528,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CHROMOSOME_SEPARATION,0.735163934280639
WP_IL17_SIGNALING,SET,30,0.32256,0.013021,0.16245,0.02355,WP_IL17_SIGNALING,0.735163934280639
REACTOME_MITOCHONDRIAL_CALCI...,SET,19,0.39517,0.012699,0.19906,0.023572,REACTOME_MITOCHONDRIAL_CALCIUM_ION_TRANSPORT,0.735163934280639
REACTOME_METALLOPROTEASE_DUBS,SET,15,0.4988,0.014244,0.25133,0.0236,REACTOME_METALLOPROTEASE_DUBS,0.735163934280639
GOBP_REGULATION_OF_T_HELPER_...1,SET,22,0.36618,0.012662,0.18456,0.023634,GOBP_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.735163934280639
GOBP_EMBRYONIC_CAMERA_TYPE_E...3,SET,26,0.35258,0.013252,0.17771,0.023637,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_MORPHOGENESIS,0.735163934280639
GOBP_T_CELL_MEDIATED_CYTOTOX...,SET,56,0.25318,0.013954,0.12764,0.023656,GOBP_T_CELL_MEDIATED_CYTOTOXICITY,0.735163934280639
GOBP_INTRINSIC_APOPTOTIC_SIG...2,SET,75,0.18613,0.011866,0.093837,0.023661,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.735163934280639
MORF_JUND,SET,57,0.20996,0.011675,0.10587,0.023684,MORF_JUND,0.735163934280639
GSE17721_PAM3CSK4_VS_CPG_16H...1,SET,176,0.12513,0.012186,0.063101,0.02369,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_DN,0.735163934280639
BIOCARTA_FOSB_PATHWAY,SET,5,0.768,0.012666,0.38731,0.023697,BIOCARTA_FOSB_PATHWAY,0.735163934280639
GOMF_KERATIN_FILAMENT_BINDING,SET,6,0.62894,0.011362,0.31723,0.023712,GOMF_KERATIN_FILAMENT_BINDING,0.735163934280639
GOBP_SNRNA_MODIFICATION,SET,6,0.58913,0.010643,0.29719,0.023726,GOBP_SNRNA_MODIFICATION,0.735163934280639
GOBP_REGULATION_OF_METALLOEN...,SET,4,0.94877,0.013995,0.47864,0.023735,GOBP_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.735163934280639
HP_THORACIC_AORTIC_ANEURYSM,SET,108,0.16336,0.012486,0.082425,0.023753,HP_THORACIC_AORTIC_ANEURYSM,0.735163934280639
KEGG_NOD_LIKE_RECEPTOR_SIGNA...,SET,57,0.2221,0.012349,0.11207,0.023759,KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.735163934280639
GOMF_CALCIUM_DEPENDENT_PROTE...4,SET,5,0.69955,0.011537,0.35307,0.023786,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_REGULATOR_ACTIVITY,0.735163934280639
REACTOME_NUCLEOTIDE_BINDING_...,SET,50,0.23375,0.012175,0.11799,0.023799,REACTOME_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_NLR_SIGNALING_PATHWAYS,0.735163934280639
GOBP_REGULATION_OF_TRANSCRIP...1,SET,8,0.48545,0.010126,0.24507,0.023814,GOBP_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.735163934280639
MYLLYKANGAS_AMPLIFICATION_HO...10,SET,14,0.41087,0.011336,0.20743,0.023818,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_24,0.735163934280639
KEGG_MEDICUS_REFERENCE_HOMOL...1,SET,31,0.25592,0.010502,0.12924,0.023847,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION,0.735405931677019
GOBP_NUCLEOTIDE_BINDING_DOMA...,SET,26,0.32921,0.012374,0.16632,0.023897,GOBP_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.735514221238938
MIR3605_5P,SET,76,0.20016,0.012844,0.10112,0.023898,MIR3605_5P,0.735514221238938
KEGG_MEDICUS_REFERENCE_DNA_R...2,SET,17,0.36853,0.011203,0.18622,0.023914,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_TERMINATION,0.735514221238938
GOBP_PROTEIN_INSERTION_INTO_...7,SET,14,0.43615,0.012033,0.2205,0.023971,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_OUTER_MEMBRANE,0.736615477453581
PER1_TARGET_GENES,SET,21,0.35517,0.011999,0.17964,0.024021,PER1_TARGET_GENES,0.737499871908127
GSE43863_TH1_VS_LY6C_INT_CXC...1,SET,189,0.1202,0.012126,0.060813,0.024055,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.737685415944541
HP_PHONOPHOBIA,SET,22,0.39837,0.013775,0.20166,0.024114,HP_PHONOPHOBIA,0.737685415944541
WP_TRANSSULFURATION_ONECARBO...,SET,63,0.21339,0.012472,0.10802,0.024117,WP_TRANSSULFURATION_ONECARBON_METABOLISM_AND_RELATED_PATHWAYS,0.737685415944541
GOBP_PROTEIN_UNFOLDING,SET,5,0.63066,0.010401,0.31928,0.024128,GOBP_PROTEIN_UNFOLDING,0.737685415944541
GOBP_VIRAL_TRANSLATION,SET,18,0.38148,0.011933,0.19317,0.02415,GOBP_VIRAL_TRANSLATION,0.737685415944541
HP_SEVERE_VARICELLA_ZOSTER_I...,SET,13,0.48824,0.01298,0.24746,0.024254,HP_SEVERE_VARICELLA_ZOSTER_INFECTION,0.737685415944541
HALLMARK_BILE_ACID_METABOLISM,SET,110,0.16644,0.012838,0.084361,0.024255,HALLMARK_BILE_ACID_METABOLISM,0.737685415944541
HP_ABNORMAL_NEPHRON_MORPHOLO...,SET,220,0.11374,0.01237,0.057651,0.024257,HP_ABNORMAL_NEPHRON_MORPHOLOGY,0.737685415944541
GOMF_MOLECULAR_TAG_ACTIVITY,SET,11,0.51344,0.012557,0.26027,0.024274,GOMF_MOLECULAR_TAG_ACTIVITY,0.737685415944541
GOBP_POSITIVE_REGULATION_OF_...256,SET,177,0.13045,0.01274,0.066151,0.024309,GOBP_POSITIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,0.737685415944541
REACTOME_RESPONSE_OF_MTB_TO_...,SET,21,0.3471,0.011726,0.17608,0.024357,REACTOME_RESPONSE_OF_MTB_TO_PHAGOCYTOSIS,0.737685415944541
GOBP_CARDIAC_MUSCLE_CONTRACT...,SET,131,0.15248,0.012828,0.077357,0.024361,GOBP_CARDIAC_MUSCLE_CONTRACTION,0.737685415944541
GSE20727_CTRL_VS_ROS_INH_AND...1,SET,170,0.12216,0.011694,0.061974,0.024363,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,0.737685415944541
GOCC_MULTIMERIC_RIBONUCLEASE...,SET,9,0.53638,0.011867,0.2722,0.024396,GOCC_MULTIMERIC_RIBONUCLEASE_P_COMPLEX,0.737685415944541
GOMF_RIBONUCLEASE_P_ACTIVITY,SET,9,0.53638,0.011867,0.2722,0.024396,GOMF_RIBONUCLEASE_P_ACTIVITY,0.737685415944541
GOMF_RIBONUCLEASE_P_RNA_BIND...,SET,9,0.53638,0.011867,0.2722,0.024396,GOMF_RIBONUCLEASE_P_RNA_BINDING,0.737685415944541
KEGG_MEDICUS_REFERENCE_WNT_S...2,SET,13,0.49648,0.013199,0.25199,0.024412,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_SOST_LRP4,0.737685415944541
GOBP_REGULATION_OF_MONOATOMI...3,SET,302,0.10174,0.012934,0.051665,0.02447,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.737685415944541
HEB_Q6,SET,239,0.10661,0.012078,0.054142,0.024483,HEB_Q6,0.737685415944541
KEGG_MEDICUS_REFERENCE_TLR1_...,SET,18,0.38137,0.011929,0.1937,0.024489,KEGG_MEDICUS_REFERENCE_TLR1_2_4_NFKB_SIGNALING_PATHWAY,0.737685415944541
GOBP_REGULATION_OF_MONOATOMI...4,SET,410,0.087474,0.012919,0.044429,0.024493,GOBP_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.737685415944541
GOBP_POSITIVE_REGULATION_OF_...347,SET,5,0.67152,0.011074,0.34107,0.024494,GOBP_POSITIVE_REGULATION_OF_HYPERSENSITIVITY,0.737685415944541
HP_PILL_ROLLING_TREMOR,SET,4,0.92242,0.013607,0.46875,0.024552,HP_PILL_ROLLING_TREMOR,0.737730811158798
REACTOME_SYNTHESIS_OF_BILE_A...2,SET,13,0.54285,0.014432,0.27589,0.024562,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS_VIA_24_HYDROXYCHOLESTEROL,0.737730811158798
HP_ABNORMAL_RECTUM_MORPHOLOGY,SET,124,0.14856,0.012162,0.075529,0.024601,HP_ABNORMAL_RECTUM_MORPHOLOGY,0.737730811158798
KEGG_GLYCOSPHINGOLIPID_BIOSY...1,SET,15,0.47199,0.013478,0.23996,0.024604,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GANGLIO_SERIES,0.737730811158798
MIR3200_3P,SET,24,0.34982,0.012633,0.1779,0.024633,MIR3200_3P,0.737730811158798
MIR374A_3P,SET,128,0.14894,0.012386,0.075752,0.024645,MIR374A_3P,0.737730811158798
GSE17721_POLYIC_VS_PAM3CSK4_...18,SET,185,0.12471,0.012449,0.063429,0.024649,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_UP,0.737730811158798
GOBP_T_CELL_DIFFERENTIATION_...2,SET,82,0.18879,0.012582,0.096048,0.02468,GOBP_T_CELL_DIFFERENTIATION_IN_THYMUS,0.737730811158798
BOYLAN_MULTIPLE_MYELOMA_D_DN,SET,73,0.20764,0.01306,0.10565,0.024694,BOYLAN_MULTIPLE_MYELOMA_D_DN,0.737730811158798
GOBP_REGULATION_OF_LAMELLIPO...1,SET,32,0.3055,0.012737,0.15547,0.024713,GOBP_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.737730811158798
GOBP_REGULATION_OF_ALPHA_BET...2,SET,70,0.21187,0.01305,0.10783,0.024729,GOBP_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.737730811158798
BIOCARTA_CIRCADIAN_PATHWAY,SET,5,0.84599,0.013952,0.43083,0.024794,BIOCARTA_CIRCADIAN_PATHWAY,0.738236430868167
CHEN_ETV5_TARGETS_TESTIS,SET,21,0.35482,0.011987,0.18071,0.024803,CHEN_ETV5_TARGETS_TESTIS,0.738236430868167
REACTOME_ESTROGEN_DEPENDENT_...2,SET,23,0.38652,0.013665,0.19692,0.024842,REACTOME_ESTROGEN_DEPENDENT_NUCLEAR_EVENTS_DOWNSTREAM_OF_ESR_MEMBRANE_SIGNALING,0.738236430868167
HP_BROAD_DISTAL_PHALANX_OF_T...,SET,5,0.79277,0.013074,0.40393,0.024852,HP_BROAD_DISTAL_PHALANX_OF_THE_TOES,0.738236430868167
RUAN_RESPONSE_TO_TNF_TROGLIT...2,SET,17,0.42322,0.012866,0.21566,0.024861,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_UP,0.738236430868167
HP_EMG_MYOTONIC_DISCHARGES,SET,8,0.56529,0.011791,0.28833,0.024972,HP_EMG_MYOTONIC_DISCHARGES,0.738236430868167
HP_ABNORMAL_PLATELET_FUNCTION,SET,58,0.20852,0.011696,0.10638,0.024997,HP_ABNORMAL_PLATELET_FUNCTION,0.738236430868167
GOBP_B_CELL_ACTIVATION_INVOL...,SET,76,0.18948,0.012159,0.09669,0.025026,GOBP_B_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.738236430868167
GOMF_DNA_INSERTION_OR_DELETI...,SET,6,0.50481,0.0091195,0.25764,0.025043,GOMF_DNA_INSERTION_OR_DELETION_BINDING,0.738236430868167
GOMF_PORIN_ACTIVITY,SET,6,0.73105,0.013207,0.37312,0.025047,GOMF_PORIN_ACTIVITY,0.738236430868167
ACGCACA_MIR210,SET,8,0.56369,0.011758,0.2878,0.025088,ACGCACA_MIR210,0.738236430868167
GOBP_OSTEOCLAST_DIFFERENTIAT...,SET,100,0.18353,0.013501,0.093721,0.025111,GOBP_OSTEOCLAST_DIFFERENTIATION,0.738236430868167
TURASHVILI_BREAST_DUCTAL_CAR...3,SET,60,0.2218,0.012652,0.11328,0.02512,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_DN,0.738236430868167
GSE16266_CTRL_VS_HEATSHOCK_A...1,SET,186,0.11752,0.011762,0.060023,0.025129,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,0.738236430868167
GSE21379_TFH_VS_NON_TFH_SAP_...2,SET,179,0.12063,0.011846,0.061617,0.025141,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_UP,0.738236430868167
GOBP_REGULATORY_NCRNA_MEDIAT...2,SET,16,0.36738,0.010835,0.1877,0.025163,GOBP_REGULATORY_NCRNA_MEDIATED_HETEROCHROMATIN_FORMATION,0.738236430868167
GOMF_CIS_REGULATORY_REGION_S...,SET,1113,0.055085,0.013139,0.028147,0.025177,GOMF_CIS_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.738236430868167
MIR217_3P,SET,83,0.17396,0.011664,0.088892,0.02518,MIR217_3P,0.738236430868167
HP_PREMATURE_THELARCHE,SET,10,0.52256,0.012186,0.26709,0.025214,HP_PREMATURE_THELARCHE,0.738236430868167
GOBP_CELLULAR_RESPONSE_TO_IN...8,SET,78,0.19362,0.012587,0.098996,0.025248,GOBP_CELLULAR_RESPONSE_TO_INTERLEUKIN_1,0.738236430868167
SHEPARD_BMYB_MORPHOLINO_DN,SET,188,0.12021,0.012096,0.061492,0.025305,SHEPARD_BMYB_MORPHOLINO_DN,0.738236430868167
REACTOME_RESOLUTION_OF_D_LOO...1,SET,32,0.27222,0.011349,0.13928,0.025328,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES,0.738236430868167
XU_RESPONSE_TO_TRETINOIN_AND...2,SET,14,0.48971,0.013511,0.25069,0.025392,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP,0.738236430868167
GOCC_PHOSPHATASE_COMPLEX,SET,49,0.21966,0.011327,0.11245,0.025394,GOCC_PHOSPHATASE_COMPLEX,0.738236430868167
KEGG_NATURAL_KILLER_CELL_MED...,SET,121,0.16009,0.012947,0.081967,0.025414,KEGG_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,0.738236430868167
FOURATI_BLOOD_TWINRIX_AGE_65...1,SET,4,0.93981,0.013863,0.48123,0.025421,FOURATI_BLOOD_TWINRIX_AGE_65_81Y0_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_UP,0.738236430868167
MIR885_3P,SET,26,0.30516,0.011469,0.15632,0.025467,MIR885_3P,0.738236430868167
WOOD_EBV_EBNA1_TARGETS_UP,SET,103,0.16973,0.01267,0.086963,0.025492,WOOD_EBV_EBNA1_TARGETS_UP,0.738236430868167
GOMF_DNA_BINDING_TRANSCRIPTI...3,SET,441,0.079284,0.012133,0.040629,0.025511,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.738236430868167
MODULE_392,SET,14,0.41748,0.011518,0.21402,0.025557,MODULE_392,0.738236430868167
REACTOME_HYALURONAN_METABOLI...,SET,17,0.38671,0.011756,0.19826,0.025563,REACTOME_HYALURONAN_METABOLISM,0.738236430868167
HP_RECURRENT_STAPHYLOCOCCAL_...,SET,32,0.30371,0.012662,0.15572,0.025577,HP_RECURRENT_STAPHYLOCOCCAL_INFECTIONS,0.738236430868167
GOBP_ASTROCYTE_DIFFERENTIATI...,SET,79,0.19514,0.012766,0.10007,0.025597,GOBP_ASTROCYTE_DIFFERENTIATION,0.738236430868167
REACTOME_TRANSCRIPTION_OF_E2...1,SET,19,0.352,0.011312,0.18052,0.0256,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_DREAM_COMPLEX,0.738236430868167
PID_S1P_S1P4_PATHWAY,SET,14,0.42296,0.011669,0.21693,0.025609,PID_S1P_S1P4_PATHWAY,0.738236430868167
GOBP_PROTEIN_TRANSMEMBRANE_I...,SET,34,0.27064,0.01163,0.13882,0.025623,GOBP_PROTEIN_TRANSMEMBRANE_IMPORT_INTO_INTRACELLULAR_ORGANELLE,0.738236430868167
HP_CAPILLARY_MALFORMATION,SET,58,0.23079,0.012945,0.11839,0.02563,HP_CAPILLARY_MALFORMATION,0.738236430868167
HP_ABNORMAL_MORPHOLOGY_OF_TH...2,SET,25,0.32916,0.012132,0.16886,0.025637,HP_ABNORMAL_MORPHOLOGY_OF_THE_CHOROIDAL_VASCULATURE,0.738236430868167
GOMF_STRUCTURAL_MOLECULE_ACT...2,SET,12,0.5118,0.013073,0.26268,0.025695,GOMF_STRUCTURAL_MOLECULE_ACTIVITY_CONFERRING_ELASTICITY,0.738236430868167
WP_TYPE_II_INTERFERON_SIGNAL...,SET,35,0.29091,0.012683,0.14935,0.025722,WP_TYPE_II_INTERFERON_SIGNALING,0.738236430868167
MIR3927_5P,SET,35,0.26115,0.011385,0.13408,0.025736,MIR3927_5P,0.738236430868167
GOBP_NEGATIVE_REGULATION_OF_...406,SET,7,0.73152,0.014274,0.37583,0.02581,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.738236430868167
DESCARTES_FETAL_STOMACH_NEUR...,SET,40,0.27587,0.012856,0.14173,0.025811,DESCARTES_FETAL_STOMACH_NEUROENDOCRINE_CELLS,0.738236430868167
GOBP_CELLULAR_RESPONSE_TO_CO...2,SET,13,0.42599,0.011326,0.21897,0.025866,GOBP_CELLULAR_RESPONSE_TO_COLD,0.738236430868167
REACTOME_DISEASES_ASSOCIATED...1,SET,38,0.27981,0.01271,0.14384,0.025879,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM,0.738236430868167
REACTOME_CELL_CYCLE,SET,591,0.065136,0.011491,0.033494,0.025911,REACTOME_CELL_CYCLE,0.738236430868167
GOCC_MULTIVESICULAR_BODY_MEM...,SET,27,0.30766,0.011783,0.15824,0.025938,GOCC_MULTIVESICULAR_BODY_MEMBRANE,0.738236430868167
SASAKI_ADULT_T_CELL_LEUKEMIA,SET,154,0.13037,0.011884,0.067056,0.025943,SASAKI_ADULT_T_CELL_LEUKEMIA,0.738236430868167
SCHEIDEREIT_IKK_INTERACTING_...,SET,52,0.22846,0.012135,0.11751,0.025949,SCHEIDEREIT_IKK_INTERACTING_PROTEINS,0.738236430868167
GSE7219_WT_VS_NIK_NFKB2_KO_D...2,SET,175,0.12655,0.012289,0.065093,0.025952,GSE7219_WT_VS_NIK_NFKB2_KO_DC_UP,0.738236430868167
REACTOME_FASTK_FAMILY_PROTEI...,SET,4,0.90352,0.013328,0.46478,0.025958,REACTOME_FASTK_FAMILY_PROTEINS_REGULATE_PROCESSING_AND_STABILITY_OF_MITOCHONDRIAL_RNAS,0.738236430868167
KEGG_MEDICUS_VARIANT_MUTATIO...86,SET,27,0.30622,0.011728,0.15761,0.026026,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.738236430868167
BIOCARTA_BIOPEPTIDES_PATHWAY,SET,28,0.31914,0.012447,0.1643,0.026048,BIOCARTA_BIOPEPTIDES_PATHWAY,0.738236430868167
GSE17721_LPS_VS_PAM3CSK4_0.5...2,SET,181,0.11793,0.011646,0.060717,0.026055,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_UP,0.738236430868167
PID_MYC_REPRESS_PATHWAY,SET,60,0.20731,0.011826,0.10675,0.026075,PID_MYC_REPRESS_PATHWAY,0.738236430868167
GSE17301_CTRL_VS_48H_ACD3_AC...2,SET,178,0.12083,0.011833,0.062243,0.026123,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_UP,0.738236430868167
WP_GASTRIC_ACID_PRODUCTION,SET,8,0.63523,0.01325,0.3273,0.026149,WP_GASTRIC_ACID_PRODUCTION,0.738236430868167
GSE9006_HEALTHY_VS_TYPE_1_DI...6,SET,169,0.12346,0.011784,0.063614,0.026155,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_UP,0.738236430868167
REACTOME_TYSND1_CLEAVES_PERO...,SET,7,0.59181,0.011548,0.30496,0.026158,REACTOME_TYSND1_CLEAVES_PEROXISOMAL_PROTEINS,0.738236430868167
KEGG_MEDICUS_PATHOGEN_SARS_C...2,SET,12,0.53262,0.013605,0.27452,0.026187,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,0.738236430868167
HE_LIM_SUN_FETAL_LUNG_C2_HSC...2,SET,350,0.087988,0.012026,0.045352,0.026192,HE_LIM_SUN_FETAL_LUNG_C2_HSC_ELP_CELL,0.738236430868167
GOMF_KETOSTEROID_MONOOXYGENA...,SET,5,1.0498,0.017312,0.5411,0.026195,GOMF_KETOSTEROID_MONOOXYGENASE_ACTIVITY,0.738236430868167
HP_ABNORMAL_RENAL_CORPUSCLE_...,SET,165,0.12844,0.012115,0.06622,0.026222,HP_ABNORMAL_RENAL_CORPUSCLE_MORPHOLOGY,0.738236430868167
MARKS_HDAC_TARGETS_DN,SET,14,0.46206,0.012748,0.23825,0.026234,MARKS_HDAC_TARGETS_DN,0.738236430868167
GSE20500_CTRL_VS_RETINOIC_AC...1,SET,174,0.127,0.012299,0.065489,0.026241,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN,0.738236430868167
GOCC_RIBONUCLEOPROTEIN_GRANU...,SET,246,0.099633,0.011449,0.051398,0.026291,GOCC_RIBONUCLEOPROTEIN_GRANULE,0.738236430868167
GOMF_ANTIOXIDANT_ACTIVITY,SET,73,0.19746,0.01242,0.10189,0.026325,GOMF_ANTIOXIDANT_ACTIVITY,0.738236430868167
HP_AORTIC_DISSECTION,SET,37,0.2905,0.013021,0.14996,0.026369,HP_AORTIC_DISSECTION,0.738236430868167
GOBP_REGULATION_OF_ANTIGEN_R...,SET,61,0.20777,0.01195,0.10726,0.02637,GOBP_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.738236430868167
REACTOME_FCERI_MEDIATED_CA_2...,SET,30,0.28314,0.01143,0.14616,0.026373,REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION,0.738236430868167
WP_GASTRIN_SIGNALING,SET,113,0.15856,0.012394,0.081857,0.02638,WP_GASTRIN_SIGNALING,0.738236430868167
HP_ABNORMAL_LOWER_LIP_MORPHO...,SET,208,0.11498,0.012163,0.059364,0.026385,HP_ABNORMAL_LOWER_LIP_MORPHOLOGY,0.738236430868167
GOBP_NEGATIVE_REGULATION_OF_...418,SET,19,0.4021,0.012922,0.2076,0.026386,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CONTRACTION,0.738236430868167
MIR1286,SET,80,0.17793,0.011714,0.091868,0.02639,MIR1286,0.738236430868167
MIR432_5P,SET,87,0.17752,0.012185,0.091658,0.026393,MIR432_5P,0.738236430868167
GSE25123_CTRL_VS_IL4_STIM_PP...1,SET,175,0.12653,0.012288,0.065336,0.026408,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_DN,0.738236430868167
GOBP_INTRACELLULAR_WATER_HOM...,SET,6,0.77017,0.013913,0.39773,0.026416,GOBP_INTRACELLULAR_WATER_HOMEOSTASIS,0.738236430868167
MIR6804_3P,SET,85,0.18411,0.012491,0.09508,0.026421,MIR6804_3P,0.738236430868167
HP_ECCHYMOSIS,SET,54,0.23182,0.012547,0.11972,0.026424,HP_ECCHYMOSIS,0.738236430868167
GOBP_NEGATIVE_REGULATION_OF_...14,SET,14,0.4708,0.012989,0.24319,0.026448,GOBP_NEGATIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.738313445783133
KEGG_MEDICUS_REFERENCE_EGF_E...7,SET,15,0.42155,0.012038,0.2178,0.026472,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.738390337078652
HP_ABNORMAL_LOWER_LIMB_MOTOR...,SET,5,0.71231,0.011747,0.36818,0.026522,HP_ABNORMAL_LOWER_LIMB_MOTOR_EVOKED_POTENTIALS,0.73884910543131
GSE17721_0.5H_VS_4H_POLYIC_B...2,SET,183,0.11187,0.011107,0.057835,0.026549,GSE17721_0.5H_VS_4H_POLYIC_BMDC_UP,0.73884910543131
HP_ABNORMAL_NEUTROPHIL_MORPH...,SET,18,0.42985,0.013446,0.22227,0.026571,HP_ABNORMAL_NEUTROPHIL_MORPHOLOGY,0.73884910543131
GOBP_PROTEIN_LOCALIZATION_TO...32,SET,117,0.14628,0.011634,0.075656,0.026601,GOBP_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.73884910543131
GOMF_UDP_XYLOSYLTRANSFERASE_...,SET,6,0.53732,0.0097069,0.27792,0.026601,GOMF_UDP_XYLOSYLTRANSFERASE_ACTIVITY,0.73884910543131
CHANDRAN_METASTASIS_TOP50_UP,SET,29,0.27813,0.011039,0.14387,0.026616,CHANDRAN_METASTASIS_TOP50_UP,0.73884910543131
GSE13411_PLASMA_CELL_VS_MEMO...2,SET,162,0.12882,0.012041,0.066668,0.026676,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_UP,0.739923687150838
GOBP_POSITIVE_REGULATION_OF_...723,SET,21,0.355,0.011993,0.18382,0.026734,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.739993019762846
GOBP_RESPONSE_TO_ORGANOPHOSP...,SET,123,0.14986,0.012219,0.077602,0.02674,GOBP_RESPONSE_TO_ORGANOPHOSPHORUS,0.739993019762846
DESCARTES_MAIN_FETAL_HORIZON...,SET,26,0.3318,0.012471,0.17191,0.026807,DESCARTES_MAIN_FETAL_HORIZONTAL_CELLS,0.739993019762846
MIR4687_5P,SET,40,0.2558,0.011921,0.13255,0.02682,MIR4687_5P,0.739993019762846
GSE7548_NAIVE_VS_DAY7_PCC_IM...1,SET,184,0.12135,0.012081,0.062882,0.026823,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_DN,0.739993019762846
HP_IMPAIRED_OXIDATIVE_BURST,SET,5,0.8099,0.013357,0.4197,0.026828,HP_IMPAIRED_OXIDATIVE_BURST,0.739993019762846
TAGAACC_MIR182,SET,34,0.26772,0.011504,0.13876,0.026848,TAGAACC_MIR182,0.739993019762846
AACTGGA_MIR145,SET,216,0.10598,0.011422,0.054947,0.026885,AACTGGA_MIR145,0.739993019762846
GOCC_GOLGI_LUMEN,SET,88,0.18594,0.012835,0.096404,0.02689,GOCC_GOLGI_LUMEN,0.739993019762846
WP_EGFEGFR_SIGNALING,SET,155,0.13221,0.01209,0.068551,0.026899,WP_EGFEGFR_SIGNALING,0.739993019762846
GOBP_POSITIVE_REGULATION_OF_...711,SET,15,0.38666,0.011042,0.20051,0.026913,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.739993019762846
TIEN_INTESTINE_PROBIOTICS_6H...2,SET,46,0.23592,0.011788,0.12236,0.026934,TIEN_INTESTINE_PROBIOTICS_6HR_UP,0.739993019762846
PEDERSEN_METASTASIS_BY_ERBB2...1,SET,44,0.24748,0.012095,0.12845,0.027018,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_1,0.740691992125984
GSE42021_CD24HI_VS_CD24INT_T...1,SET,188,0.12254,0.01233,0.063604,0.027026,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_DN,0.740691992125984
REACTOME_MITOTIC_G2_G2_M_PHA...,SET,187,0.1113,0.01117,0.057775,0.027029,REACTOME_MITOTIC_G2_G2_M_PHASES,0.740691992125984
HP_STEROETYPIC_UPPER_EXTREMI...,SET,43,0.24497,0.011835,0.12718,0.027045,HP_STEROETYPIC_UPPER_EXTREMITY_MOVEMENTS,0.740691992125984
MIR4668_3P,SET,277,0.097526,0.011882,0.050639,0.027066,MIR4668_3P,0.740691992125984
HP_ABNORMAL_URINE_PROTEIN_LE...,SET,213,0.11129,0.011911,0.057816,0.027134,HP_ABNORMAL_URINE_PROTEIN_LEVEL,0.741594709347997
GOBP_PHOSPHOLIPASE_C_ACTIVAT...2,SET,8,0.66276,0.013824,0.3444,0.027162,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_ACETYLCHOLINE_RECEPTOR_SIGNALING_PATHWAY,0.741594709347997
GOMF_MONOCARBOXYLIC_ACID_BIN...,SET,83,0.19448,0.01304,0.10106,0.027163,GOMF_MONOCARBOXYLIC_ACID_BINDING,0.741594709347997
GOBP_NEGATIVE_REGULATION_OF_...301,SET,13,0.44054,0.011712,0.22908,0.027242,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_BETA_PRODUCTION,0.743167747252747
GOBP_POSITIVE_REGULATION_OF_...18,SET,67,0.21624,0.013032,0.11256,0.02737,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.746074
MODULE_533,SET,41,0.26164,0.012344,0.13622,0.027392,MODULE_533,0.746088526645768
GAUCHER_PBMC_YF_VAX_STAMARIL...3,SET,12,0.47609,0.012161,0.24808,0.027496,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_DN,0.747937859778598
YYCATTCAWW_UNKNOWN,SET,178,0.12223,0.01197,0.06372,0.027551,YYCATTCAWW_UNKNOWN,0.747937859778598
WP_INFLAMMATORY_BOWEL_DISEAS...,SET,41,0.27333,0.012895,0.14251,0.027562,WP_INFLAMMATORY_BOWEL_DISEASE_SIGNALING,0.747937859778598
MIR4763_3P,SET,228,0.10616,0.01175,0.055353,0.027574,MIR4763_3P,0.747937859778598
GSE17721_PAM3CSK4_VS_CPG_16H...2,SET,177,0.11796,0.011521,0.061528,0.027612,GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP,0.747937859778598
GOCC_GAMMA_TUBULIN_COMPLEX,SET,17,0.39586,0.012034,0.20649,0.027621,GOCC_GAMMA_TUBULIN_COMPLEX,0.747937859778598
GOBP_TRNA_5_END_PROCESSING,SET,13,0.39163,0.010412,0.20429,0.027625,GOBP_TRNA_5_END_PROCESSING,0.747937859778598
KEGG_MEDICUS_REFERENCE_WNT_S...1,SET,18,0.42635,0.013336,0.22245,0.02765,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_LGR_RSPO,0.747937859778598
PID_REG_GR_PATHWAY,SET,80,0.18183,0.01197,0.094886,0.027669,PID_REG_GR_PATHWAY,0.747937859778598
GSE24210_CTRL_VS_IL35_TREATE...1,SET,180,0.11296,0.011124,0.058963,0.027708,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_DN,0.747937859778598
HP_ELBOW_CONTRACTURE,SET,98,0.17042,0.012411,0.088964,0.027714,HP_ELBOW_CONTRACTURE,0.747937859778598
HP_MESOMELIC_ARM_SHORTENING,SET,3,1.14,0.014564,0.59525,0.027742,HP_MESOMELIC_ARM_SHORTENING,0.747937859778598
ZSCAN4_TARGET_GENES,SET,1097,0.051019,0.012087,0.026642,0.027754,ZSCAN4_TARGET_GENES,0.747937859778598
GSE1925_CTRL_VS_IFNG_PRIMED_...1,SET,184,0.1216,0.012106,0.063502,0.027763,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN,0.747937859778598
HP_FOCAL_T2_HYPERINTENSE_BRA...,SET,26,0.26906,0.010113,0.14054,0.027788,HP_FOCAL_T2_HYPERINTENSE_BRAINSTEM_LESION,0.747937859778598
PID_ATR_PATHWAY,SET,38,0.24271,0.011025,0.12688,0.027886,PID_ATR_PATHWAY,0.747937859778598
GSE21033_3H_VS_12H_POLYIC_ST...1,SET,122,0.15226,0.012364,0.079629,0.027942,GSE21033_3H_VS_12H_POLYIC_STIM_DC_DN,0.747937859778598
HP_DIGENIC_INHERITANCE,SET,13,0.48778,0.012968,0.25515,0.027962,HP_DIGENIC_INHERITANCE,0.747937859778598
CAFFAREL_RESPONSE_TO_THC_8HR...1,SET,9,0.45025,0.0099612,0.23554,0.027972,CAFFAREL_RESPONSE_TO_THC_8HR_3_DN,0.747937859778598
KANG_FLUOROURACIL_RESISTANCE...2,SET,19,0.33576,0.01079,0.17566,0.027986,KANG_FLUOROURACIL_RESISTANCE_UP,0.747937859778598
REACTOME_RNA_POLYMERASE_III_...1,SET,16,0.35403,0.010441,0.18524,0.027995,REACTOME_RNA_POLYMERASE_III_CHAIN_ELONGATION,0.747937859778598
GOCC_RNA_POLYMERASE_III_COMP...,SET,16,0.35403,0.010441,0.18524,0.027995,GOCC_RNA_POLYMERASE_III_COMPLEX,0.747937859778598
REACTOME_EXTRA_NUCLEAR_ESTRO...,SET,74,0.19874,0.012586,0.104,0.028013,REACTOME_EXTRA_NUCLEAR_ESTROGEN_SIGNALING,0.747937859778598
GOMF_HISTONE_H2A_UBIQUITIN_L...,SET,6,0.63193,0.011416,0.3307,0.028016,GOMF_HISTONE_H2A_UBIQUITIN_LIGASE_ACTIVITY,0.747937859778598
HP_INCREASED_ENDOMYSIAL_CONN...,SET,27,0.31904,0.012219,0.16696,0.02802,HP_INCREASED_ENDOMYSIAL_CONNECTIVE_TISSUE,0.747937859778598
GSE24972_WT_VS_IRF8_KO_SPLEE...1,SET,178,0.11956,0.011709,0.06258,0.028041,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_DN,0.747937859778598
GSE18281_SUBCAPSULAR_VS_PERI...1,SET,184,0.11888,0.011835,0.062255,0.028103,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_DN,0.747937859778598
KEGG_MEDICUS_REFERENCE_NOD_N...,SET,8,0.50699,0.010575,0.26551,0.028107,KEGG_MEDICUS_REFERENCE_NOD_NFKB_SIGNALING_PATHWAY,0.747937859778598
PALOMERO_GSI_SENSITIVITY_UP,SET,6,0.63827,0.011531,0.33431,0.028123,PALOMERO_GSI_SENSITIVITY_UP,0.747937859778598
T3R_Q6,SET,230,0.10587,0.011769,0.055468,0.028156,T3R_Q6,0.747937859778598
HP_MULTIPLE_ENCHONDROMATOSIS,SET,10,0.49971,0.011653,0.2618,0.028156,HP_MULTIPLE_ENCHONDROMATOSIS,0.747937859778598
PLASARI_TGFB1_SIGNALING_VIA_...1,SET,29,0.3378,0.013408,0.177,0.028176,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_DN,0.747937859778598
GOMF_DNA_TRANSLOCASE_ACTIVITY,SET,2,0.76435,0.0079731,0.40055,0.028187,GOMF_DNA_TRANSLOCASE_ACTIVITY,0.747937859778598
HP_ACHROMATOPSIA,SET,5,0.82428,0.013594,0.4321,0.028228,HP_ACHROMATOPSIA,0.747937859778598
MODULE_121,SET,94,0.18662,0.013312,0.097842,0.028247,MODULE_121,0.747937859778598
MIR3132,SET,62,0.20357,0.011804,0.10675,0.028268,MIR3132,0.747937859778598
BILD_HRAS_ONCOGENIC_SIGNATURE,SET,229,0.1123,0.012457,0.058901,0.028297,BILD_HRAS_ONCOGENIC_SIGNATURE,0.747937859778598
GOBP_LIPID_TRANSPORT_ACROSS_...,SET,6,0.63253,0.011427,0.33195,0.028368,GOBP_LIPID_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,0.747937859778598
BILD_CTNNB1_ONCOGENIC_SIGNAT...,SET,72,0.19106,0.011935,0.10027,0.028377,BILD_CTNNB1_ONCOGENIC_SIGNATURE,0.747937859778598
GOMF_RETINOL_BINDING,SET,14,0.45125,0.012449,0.23686,0.028392,GOMF_RETINOL_BINDING,0.747937859778598
KEGG_MEDICUS_PATHOGEN_ESCHER...8,SET,4,0.76921,0.011347,0.40383,0.028414,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_TIR_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.747937859778598
BIOCARTA_TPO_PATHWAY,SET,24,0.34016,0.012284,0.17861,0.028435,BIOCARTA_TPO_PATHWAY,0.747937859778598
HP_MICROLISSENCEPHALY,SET,5,0.75533,0.012457,0.39664,0.028441,HP_MICROLISSENCEPHALY,0.747937859778598
FAN_EMBRYONIC_CTX_EX_2_EXCIT...,SET,15,0.45068,0.01287,0.23667,0.028448,FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON,0.747937859778598
REACTOME_THE_FATTY_ACID_CYCL...,SET,4,0.72089,0.010634,0.3788,0.028523,REACTOME_THE_FATTY_ACID_CYCLING_MODEL,0.747937859778598
HP_INTERMITTENT_THROMBOCYTOP...,SET,4,0.87951,0.012974,0.46223,0.028545,HP_INTERMITTENT_THROMBOCYTOPENIA,0.747937859778598
HP_MICROANGIOPATHIC_HEMOLYTI...,SET,9,0.56406,0.012479,0.29647,0.028557,HP_MICROANGIOPATHIC_HEMOLYTIC_ANEMIA,0.747937859778598
BACOLOD_RESISTANCE_TO_ALKYLA...1,SET,44,0.25518,0.012471,0.13414,0.02857,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_DN,0.747937859778598
BROWNE_HCMV_INFECTION_2HR_UP,SET,34,0.32109,0.013798,0.16883,0.028605,BROWNE_HCMV_INFECTION_2HR_UP,0.747937859778598
GOMF_NAD_BINDING,SET,55,0.2127,0.011618,0.11187,0.028636,GOMF_NAD_BINDING,0.747937859778598
GSE19374_UNINF_VS_LISTERIA_I...1,SET,182,0.11551,0.011438,0.060773,0.028677,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_DN,0.747937859778598
GSE34205_RSV_VS_FLU_INF_INFA...2,SET,154,0.13123,0.011962,0.069072,0.02873,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_UP,0.747937859778598
GOBP_GDP_METABOLIC_PROCESS,SET,9,0.55832,0.012352,0.29388,0.028735,GOBP_GDP_METABOLIC_PROCESS,0.747937859778598
MIR6847_5P,SET,136,0.13658,0.011705,0.071904,0.028763,MIR6847_5P,0.747937859778598
GOMF_CARD_DOMAIN_BINDING,SET,15,0.39363,0.011241,0.20724,0.028763,GOMF_CARD_DOMAIN_BINDING,0.747937859778598
GSE33424_CD161_HIGH_VS_NEG_C...1,SET,182,0.11944,0.011826,0.062885,0.02877,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_DN,0.747937859778598
GOBP_POSITIVE_REGULATION_OF_...296,SET,1057,0.051453,0.011979,0.027095,0.028793,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION,0.747937859778598
GSE40274_CTRL_VS_FOXP3_AND_X...2,SET,148,0.12267,0.010964,0.064607,0.028804,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.747937859778598
GSE17721_POLYIC_VS_GARDIQUIM...18,SET,185,0.11783,0.011762,0.062057,0.028806,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_UP,0.747937859778598
MIR3619_3P,SET,49,0.26785,0.013812,0.14109,0.028829,MIR3619_3P,0.747937859778598
HP_ARTHRITIS,SET,207,0.11548,0.012186,0.060841,0.028852,HP_ARTHRITIS,0.747937859778598
HP_SPARSE_EYEBROW,SET,121,0.14071,0.01138,0.074136,0.028855,HP_SPARSE_EYEBROW,0.747937859778598
MIR7852_3P,SET,66,0.19497,0.011663,0.10274,0.02887,MIR7852_3P,0.747937859778598
GRAESSMANN_RESPONSE_TO_MC_AN...1,SET,698,0.0594,0.011354,0.031301,0.028876,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN,0.747937859778598
GSE5099_UNSTIM_VS_MCSF_TREAT...4,SET,175,0.11404,0.011075,0.060103,0.028894,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_UP,0.747937859778598
HP_SEROSITIS,SET,88,0.17622,0.012164,0.092878,0.028902,HP_SEROSITIS,0.747937859778598
GOBP_PURINE_CONTAINING_COMPO...4,SET,37,0.28835,0.012925,0.15204,0.028952,GOBP_PURINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,0.747937859778598
MIR4765,SET,44,0.25135,0.012283,0.13253,0.028957,MIR4765,0.747937859778598
MIR3620_3P,SET,58,0.22044,0.012364,0.11624,0.028964,MIR3620_3P,0.747937859778598
GSE2706_UNSTIM_VS_2H_LPS_DC_...1,SET,169,0.13042,0.012449,0.068799,0.02901,GSE2706_UNSTIM_VS_2H_LPS_DC_DN,0.747937859778598
MIR642B_5P,SET,70,0.19763,0.012173,0.10427,0.029032,MIR642B_5P,0.747937859778598
WANG_RESPONSE_TO_GSK3_INHIBI...1,SET,313,0.087623,0.011337,0.046234,0.02904,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN,0.747937859778598
MIR6794_5P,SET,78,0.1789,0.01163,0.094422,0.029078,MIR6794_5P,0.747937859778598
GSE10239_NAIVE_VS_KLRG1HIGH_...1,SET,180,0.11661,0.011483,0.061562,0.029109,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.747937859778598
HP_NEOPLASM_OF_THE_PERIPHERA...,SET,68,0.18268,0.011091,0.096449,0.029119,HP_NEOPLASM_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,0.747937859778598
GOBP_POSITIVE_REGULATION_OF_...689,SET,40,0.23348,0.01088,0.12328,0.029127,GOBP_POSITIVE_REGULATION_OF_RNA_SPLICING,0.747937859778598
GOBP_REGULATION_OF_ALTERNATI...,SET,50,0.20869,0.01087,0.1102,0.029139,GOBP_REGULATION_OF_ALTERNATIVE_MRNA_SPLICING_VIA_SPLICEOSOME,0.747937859778598
HP_LACTICACIDURIA,SET,20,0.35018,0.011545,0.18494,0.029159,HP_LACTICACIDURIA,0.747937859778598
GAVISH_3CA_METAPROGRAM_MACRO...11,SET,41,0.22726,0.010722,0.12002,0.02916,GAVISH_3CA_METAPROGRAM_MACROPHAGES_RESPIRATION,0.747937859778598
GOBP_ACROSOMAL_VESICLE_EXOCY...,SET,9,0.54329,0.01202,0.28704,0.029203,GOBP_ACROSOMAL_VESICLE_EXOCYTOSIS,0.748153840206185
MIR490_5P,SET,39,0.25412,0.011693,0.13428,0.029225,MIR490_5P,0.748153840206185
HP_PREAURICULAR_SKIN_TAG,SET,59,0.2001,0.011319,0.10574,0.029233,HP_PREAURICULAR_SKIN_TAG,0.748153840206185
GOBP_ERAD_PATHWAY,SET,104,0.14945,0.01121,0.078999,0.029267,GOBP_ERAD_PATHWAY,0.748472836644592
GOBP_REGULATION_OF_DNA_DIREC...,SET,9,0.49365,0.010921,0.26106,0.029323,GOBP_REGULATION_OF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,0.749353577205882
GSE6269_E_COLI_VS_STAPH_AURE...2,SET,127,0.14234,0.011792,0.075306,0.029373,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_UP,0.749867769230769
GOBP_DNA_STRAND_INVASION,SET,6,0.57736,0.01043,0.30557,0.029423,GOBP_DNA_STRAND_INVASION,0.749867769230769
MIR4430,SET,128,0.13922,0.011577,0.073684,0.029431,MIR4430,0.749867769230769
GSE43955_10H_VS_30H_ACT_CD4_...4,SET,183,0.11704,0.01162,0.061949,0.029435,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.749867769230769
GOBP_ESTABLISHMENT_OF_PROTEI...6,SET,31,0.26492,0.010871,0.14024,0.029451,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRIAL_MEMBRANE,0.749867769230769
REACTOME_CD209_DC_SIGN_SIGNA...,SET,20,0.34514,0.011379,0.18281,0.029518,REACTOME_CD209_DC_SIGN_SIGNALING,0.750606525547445
HP_DISPROPORTIONATE_TALL_STA...,SET,32,0.27428,0.011435,0.14528,0.029524,HP_DISPROPORTIONATE_TALL_STATURE,0.750606525547445
HP_SEVERELY_REDUCED_LEFT_VEN...,SET,13,0.37155,0.009878,0.19683,0.029547,HP_SEVERELY_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,0.750606525547445
GOBP_POSITIVE_REGULATION_OF_...506,SET,32,0.28797,0.012005,0.15258,0.029571,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.750606525547445
LIANG_SILENCED_BY_METHYLATIO...1,SET,45,0.24757,0.012235,0.13119,0.029588,LIANG_SILENCED_BY_METHYLATION_2,0.750606525547445
GSE37532_TREG_VS_TCONV_PPARG...1,SET,181,0.11189,0.011049,0.059318,0.029638,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_DN,0.750854923469388
GOBP_EMBRYONIC_NEUROCRANIUM_...,SET,8,0.62783,0.013096,0.33285,0.029641,GOBP_EMBRYONIC_NEUROCRANIUM_MORPHOGENESIS,0.750854923469388
HP_GAIT_IMBALANCE,SET,63,0.20524,0.011996,0.10884,0.029673,HP_GAIT_IMBALANCE,0.751118073561544
REACTOME_ATF6_ATF6_ALPHA_ACT...1,SET,11,0.42524,0.0104,0.22564,0.029747,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONES,0.752443220524017
PITX2_Q2,SET,236,0.10823,0.012185,0.057456,0.029812,PITX2_Q2,0.753538952727273
HP_SLENDER_BUILD,SET,23,0.30221,0.010684,0.16052,0.029884,HP_SLENDER_BUILD,0.754362701525054
MURARO_PANCREAS_ACINAR_CELL,SET,660,0.064976,0.01209,0.034515,0.029888,MURARO_PANCREAS_ACINAR_CELL,0.754362701525054
GOBP_OPTIC_CUP_MORPHOGENESIS...,SET,7,0.68704,0.013406,0.36515,0.029959,GOBP_OPTIC_CUP_MORPHOGENESIS_INVOLVED_IN_CAMERA_TYPE_EYE_DEVELOPMENT,0.754374789135097
GOBP_NEGATIVE_REGULATION_OF_...18,SET,23,0.31313,0.01107,0.16646,0.029985,GOBP_NEGATIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.754374789135097
GSE3565_CTRL_VS_LPS_INJECTED...1,SET,155,0.13244,0.012111,0.07041,0.029995,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_DN,0.754374789135097
KEGG_MEDICUS_VARIANT_LMO2_RE...2,SET,5,0.72485,0.011954,0.38537,0.03,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_REPRESSION,0.754374789135097
GOBP_HEPARAN_SULFATE_PROTEOG...3,SET,8,0.5991,0.012497,0.3186,0.030034,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_POLYSACCHARIDE_CHAIN_BIOSYNTHETIC_PROCESS,0.754374789135097
GOMF_PHOSPHATIDYLINOSITOL_3_...14,SET,41,0.24435,0.011528,0.12997,0.030057,GOMF_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BINDING,0.754374789135097
HP_NEUROFIBRILLARY_TANGLES,SET,23,0.36589,0.012935,0.19466,0.030087,HP_NEUROFIBRILLARY_TANGLES,0.754374789135097
GSE2585_AIRE_KO_VS_WT_CD80_H...2,SET,182,0.11389,0.011277,0.060637,0.030182,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP,0.754374789135097
GSE15330_HSC_VS_PRO_BCELL_UP,SET,176,0.11367,0.01107,0.060525,0.03019,GSE15330_HSC_VS_PRO_BCELL_UP,0.754374789135097
ZHENG_CORD_BLOOD_C8_PUTATIVE...,SET,75,0.18914,0.012058,0.10073,0.030213,ZHENG_CORD_BLOOD_C8_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_2,0.754374789135097
GSE6269_FLU_VS_E_COLI_INF_PB...1,SET,122,0.14864,0.01207,0.079158,0.030214,GSE6269_FLU_VS_E_COLI_INF_PBMC_DN,0.754374789135097
MODULE_411,SET,72,0.18573,0.011602,0.098923,0.030233,MODULE_411,0.754374789135097
RUBENSTEIN_SKELETAL_MUSCLE_B...,SET,154,0.12548,0.011438,0.066837,0.030238,RUBENSTEIN_SKELETAL_MUSCLE_B_CELLS,0.754374789135097
NIKOLSKY_BREAST_CANCER_1Q21_...,SET,34,0.39703,0.017061,0.21149,0.030247,NIKOLSKY_BREAST_CANCER_1Q21_AMPLICON,0.754374789135097
GOBP_MEMBRANE_DEPOLARIZATION...2,SET,5,0.78877,0.013008,0.42017,0.030249,GOBP_MEMBRANE_DEPOLARIZATION_DURING_AV_NODE_CELL_ACTION_POTENTIAL,0.754374789135097
GOMF_CARGO_RECEPTOR_ACTIVITY,SET,71,0.18757,0.011636,0.099932,0.030266,GOMF_CARGO_RECEPTOR_ACTIVITY,0.754374789135097
GSE37416_CTRL_VS_24H_F_TULAR...2,SET,166,0.12693,0.012008,0.067625,0.030273,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.754374789135097
HP_RECURRENT_PROTOZOAN_INFEC...,SET,5,0.79074,0.013041,0.42133,0.030283,HP_RECURRENT_PROTOZOAN_INFECTIONS,0.754374789135097
GOBP_CALCIUM_ION_IMPORT_INTO...,SET,5,0.56554,0.0093267,0.3014,0.030309,GOBP_CALCIUM_ION_IMPORT_INTO_SARCOPLASMIC_RETICULUM,0.754374789135097
ROVERSI_GLIOMA_COPY_NUMBER_UP,SET,94,0.20974,0.014961,0.11181,0.03034,ROVERSI_GLIOMA_COPY_NUMBER_UP,0.754374789135097
HP_CHRONIC_ORAL_CANDIDIASIS,SET,26,0.31091,0.011686,0.16577,0.030363,HP_CHRONIC_ORAL_CANDIDIASIS,0.754374789135097
HP_APLASIA_HYPOPLASIA_OF_THE...30,SET,182,0.11537,0.011424,0.061514,0.030366,HP_APLASIA_HYPOPLASIA_OF_THE_EYEBROW,0.754374789135097
SANSOM_WNT_PATHWAY_REQUIRE_M...,SET,60,0.22913,0.01307,0.12222,0.030421,SANSOM_WNT_PATHWAY_REQUIRE_MYC,0.754811124197002
GOBP_REGULATION_OF_ANION_CHA...,SET,5,0.80251,0.013235,0.42808,0.030427,GOBP_REGULATION_OF_ANION_CHANNEL_ACTIVITY,0.754811124197002
GOBP_POSITIVE_REGULATION_OF_...12,SET,116,0.15322,0.012134,0.081769,0.030486,GOBP_POSITIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.755149328358209
RUBENSTEIN_SKELETAL_MUSCLE_N...,SET,198,0.1123,0.011593,0.059942,0.030509,RUBENSTEIN_SKELETAL_MUSCLE_NK_CELLS,0.755149328358209
HP_DEGENERATION_OF_THE_LATER...,SET,19,0.32822,0.010548,0.17522,0.030529,HP_DEGENERATION_OF_THE_LATERAL_CORTICOSPINAL_TRACTS,0.755149328358209
GSE17974_1H_VS_72H_UNTREATED...2,SET,179,0.1146,0.011254,0.061187,0.030548,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.755149328358209
KEGG_MEDICUS_VARIANT_MUTATIO...83,SET,8,0.57679,0.012031,0.30797,0.030551,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROK2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.755149328358209
GSE2405_0H_VS_12H_A_PHAGOCYT...2,SET,185,0.11977,0.011956,0.06396,0.030571,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.755149328358209
MODULE_162,SET,17,0.43145,0.013116,0.23049,0.03062,MODULE_162,0.755822514204545
GSE43863_DAY6_EFF_VS_DAY150_...3,SET,181,0.12369,0.012214,0.066115,0.030695,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_DN,0.756971268551237
GOMF_PROTEIN_DISULFIDE_ISOME...,SET,21,0.34887,0.011786,0.18654,0.030737,GOMF_PROTEIN_DISULFIDE_ISOMERASE_ACTIVITY,0.756971268551237
GSE37301_RAG2_KO_VS_RAG2_AND...1,SET,182,0.11446,0.011334,0.061217,0.030767,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_DN,0.756971268551237
GOBP_BERGMANN_GLIAL_CELL_DIF...,SET,10,0.49935,0.011645,0.26708,0.030775,GOBP_BERGMANN_GLIAL_CELL_DIFFERENTIATION,0.756971268551237
GOMF_TAURINE_TRANSMEMBRANE_T...,SET,5,0.78484,0.012943,0.41984,0.030792,GOMF_TAURINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.756971268551237
GOBP_AV_NODE_CELL_TO_BUNDLE_...2,SET,10,0.56179,0.013101,0.30053,0.030799,GOBP_AV_NODE_CELL_TO_BUNDLE_OF_HIS_CELL_SIGNALING,0.756971268551237
GOBP_REGULATION_OF_CALCIUM_I...6,SET,153,0.13192,0.011986,0.070582,0.030819,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.756971268551237
GUTIERREZ_CHRONIC_LYMPHOCYTI...1,SET,50,0.22829,0.011891,0.12218,0.030858,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,0.757393919491525
CTGRYYYNATT_UNKNOWN,SET,63,0.20089,0.011741,0.10755,0.030893,CTGRYYYNATT_UNKNOWN,0.757717865208186
HP_BILIARY_TRACT_NEOPLASM,SET,15,0.43338,0.012376,0.23209,0.030939,HP_BILIARY_TRACT_NEOPLASM,0.758310962623413
GSE29618_BCELL_VS_MDC_DN,SET,183,0.12136,0.012049,0.065045,0.031046,GSE29618_BCELL_VS_MDC_DN,0.759914039408867
MIR3974,SET,86,0.17935,0.012239,0.096131,0.031055,MIR3974,0.759914039408867
HP_APLASIA_HYPOPLASIA_OF_FAC...,SET,50,0.22414,0.011675,0.12015,0.03107,HP_APLASIA_HYPOPLASIA_OF_FACIAL_BONES,0.759914039408867
GOBP_POSITIVE_REGULATION_OF_...404,SET,134,0.14443,0.012287,0.077463,0.031132,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.760202048780488
GSE42021_CD24HI_VS_CD24INT_T...3,SET,182,0.12131,0.012012,0.06508,0.031165,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_DN,0.760202048780488
WP_NOTCH1_REGULATION_OF_ENDO...,SET,16,0.42981,0.012676,0.2306,0.03118,WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION,0.760202048780488
HP_WOOLLY_HAIR,SET,22,0.355,0.012275,0.19062,0.031284,HP_WOOLLY_HAIR,0.760202048780488
GSE17721_0.5H_VS_12H_POLYIC_...2,SET,180,0.1139,0.011217,0.061158,0.031284,GSE17721_0.5H_VS_12H_POLYIC_BMDC_UP,0.760202048780488
GOMF_INTRACELLULARLY_GATED_C...,SET,18,0.36385,0.011381,0.19538,0.031288,GOMF_INTRACELLULARLY_GATED_CALCIUM_CHANNEL_ACTIVITY,0.760202048780488
HP_GENERALIZED_OSTEOSCLEROSIS,SET,8,0.53808,0.011224,0.28898,0.031308,HP_GENERALIZED_OSTEOSCLEROSIS,0.760202048780488
GSE18791_CTRL_VS_NEWCASTLE_V...20,SET,181,0.11025,0.010887,0.059217,0.03132,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_UP,0.760202048780488
HP_ANDROGEN_INSUFFICIENCY,SET,3,0.864,0.011038,0.46407,0.031324,HP_ANDROGEN_INSUFFICIENCY,0.760202048780488
HP_NUCLEAR_CATARACT,SET,25,0.31588,0.011642,0.16967,0.031327,HP_NUCLEAR_CATARACT,0.760202048780488
GOBP_REGULATION_OF_GOLGI_ORG...,SET,15,0.40528,0.011574,0.21773,0.031349,GOBP_REGULATION_OF_GOLGI_ORGANIZATION,0.760202048780488
REACTOME_NEF_MEDIATED_CD8_DO...,SET,7,0.59803,0.011669,0.32133,0.031373,REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION,0.760202048780488
HP_PELVIC_KIDNEY,SET,30,0.29762,0.012015,0.15993,0.03138,HP_PELVIC_KIDNEY,0.760202048780488
GOBP_POSITIVE_REGULATION_OF_...577,SET,26,0.31215,0.011732,0.16774,0.031388,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.760202048780488
GSE13547_CTRL_VS_ANTI_IGM_ST...8,SET,139,0.12378,0.010724,0.06658,0.031513,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_UP,0.761136911866759
WP_OSTEOPONTIN_SIGNALING,SET,13,0.45791,0.012174,0.24633,0.031528,WP_OSTEOPONTIN_SIGNALING,0.761136911866759
MIR6795_3P,SET,12,0.46527,0.011885,0.2503,0.031534,MIR6795_3P,0.761136911866759
GOBP_DNA_STRAND_RESECTION_IN...,SET,9,0.55678,0.012318,0.29955,0.031544,GOBP_DNA_STRAND_RESECTION_INVOLVED_IN_REPLICATION_FORK_PROCESSING,0.761136911866759
PID_EPHB_FWD_PATHWAY,SET,39,0.24184,0.011129,0.13012,0.031548,PID_EPHB_FWD_PATHWAY,0.761136911866759
KEGG_MEDICUS_REFERENCE_NOTCH...2,SET,6,0.63927,0.011549,0.34397,0.031558,KEGG_MEDICUS_REFERENCE_NOTCH_MESP2_SIGNALING,0.761136911866759
GSE22886_NAIVE_TCELL_VS_NEUT...1,SET,173,0.12764,0.012325,0.068704,0.03161,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_DN,0.761862378640777
HP_ABNORMALITY_OF_THE_PHALAN...2,SET,3,0.94464,0.012068,0.50882,0.031696,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_3RD_TOE,0.763405738045738
GSE9988_LPS_VS_VEHICLE_TREAT...2,SET,162,0.13262,0.012397,0.071467,0.031753,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.76375302739726
REACTOME_HYALURONAN_BIOSYNTH...,SET,5,0.74298,0.012253,0.40038,0.031757,REACTOME_HYALURONAN_BIOSYNTHESIS_AND_EXPORT,0.76375302739726
GNF2_DENR,SET,46,0.20506,0.010246,0.11054,0.031797,GNF2_DENR,0.76375302739726
GOBP_POSITIVE_REGULATION_OF_...351,SET,975,0.052807,0.011836,0.02847,0.031819,GOBP_POSITIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.76375302739726
KEGG_MEDICUS_REFERENCE_GHRHR...,SET,28,0.28878,0.011263,0.15569,0.031821,KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY,0.76375302739726
MIR3922_5P,SET,92,0.1641,0.011581,0.088577,0.031979,MIR3922_5P,0.76375302739726
HP_ABNORMAL_BRAINSTEM_MRI_SI...,SET,31,0.24092,0.0098862,0.13005,0.031988,HP_ABNORMAL_BRAINSTEM_MRI_SIGNAL_INTENSITY,0.76375302739726
PID_BARD1_PATHWAY,SET,28,0.26989,0.010526,0.14569,0.031991,PID_BARD1_PATHWAY,0.76375302739726
HP_CONSTITUTIONAL_SYMPTOM,SET,1128,0.04892,0.011742,0.026409,0.031995,HP_CONSTITUTIONAL_SYMPTOM,0.76375302739726
NAKAYA_MYELOID_DENDRITIC_CEL...3,SET,247,0.095625,0.011011,0.051623,0.031995,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,0.76375302739726
HP_MIXED_HYPO_AND_HYPERPIGME...,SET,10,0.44026,0.010267,0.23771,0.032015,HP_MIXED_HYPO_AND_HYPERPIGMENTATION_OF_THE_SKIN,0.76375302739726
GOMF_PHOSPHATASE_BINDING,SET,176,0.11619,0.011315,0.062736,0.03202,GOMF_PHOSPHATASE_BINDING,0.76375302739726
REACTOME_INNATE_IMMUNE_SYSTEM,SET,962,0.052087,0.011601,0.028126,0.032028,REACTOME_INNATE_IMMUNE_SYSTEM,0.76375302739726
HP_APLASIA_HYPOPLASIA_OF_THE...69,SET,6,0.65339,0.011804,0.35282,0.032028,HP_APLASIA_HYPOPLASIA_OF_THE_SWEAT_GLANDS,0.76375302739726
GOBP_OLFACTORY_BEHAVIOR,SET,11,0.52179,0.012762,0.28186,0.032076,GOBP_OLFACTORY_BEHAVIOR,0.76375302739726
GOBP_SUBSTRATE_ADHESION_DEPE...,SET,97,0.15935,0.011546,0.08608,0.032081,GOBP_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.76375302739726
GOBP_NEUTROPHIL_DIFFERENTIAT...,SET,11,0.49029,0.011991,0.26486,0.032084,GOBP_NEUTROPHIL_DIFFERENTIATION,0.76375302739726
GOMF_EXTRACELLULAR_MATRIX_CO...,SET,10,0.53982,0.012588,0.29167,0.032108,GOMF_EXTRACELLULAR_MATRIX_CONSTITUENT_CONFERRING_ELASTICITY,0.763801190965092
GSE27859_MACROPHAGE_VS_DC_DN,SET,171,0.11952,0.011475,0.064595,0.03214,GSE27859_MACROPHAGE_VS_DC_DN,0.763873564593301
GNF2_PRDX2,SET,27,0.31651,0.012122,0.17107,0.032155,GNF2_PRDX2,0.763873564593301
GSE34205_HEALTHY_VS_RSV_INF_...2,SET,168,0.11684,0.01112,0.063186,0.032221,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_UP,0.764918616803279
GOBP_RENAL_PROTEIN_ABSORPTION,SET,9,0.58827,0.013015,0.31831,0.032302,GOBP_RENAL_PROTEIN_ABSORPTION,0.76631809556314
GSE3982_BCELL_VS_BASOPHIL_UP,SET,164,0.11675,0.010979,0.063206,0.032371,GSE3982_BCELL_VS_BASOPHIL_UP,0.767431176671214
WANG_CLASSIC_ADIPOGENIC_TARG...,SET,27,0.30686,0.011753,0.16619,0.03242,WANG_CLASSIC_ADIPOGENIC_TARGETS_OF_PPARG,0.767490762032086
GOBP_ESTABLISHMENT_OF_LYMPHO...,SET,15,0.40914,0.011684,0.22161,0.032437,GOBP_ESTABLISHMENT_OF_LYMPHOCYTE_POLARITY,0.767490762032086
GOBP_POSITIVE_REGULATION_OF_...201,SET,5,0.76051,0.012542,0.41194,0.032443,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.767490762032086
DELPUECH_FOXO3_TARGETS_DN,SET,34,0.29083,0.012497,0.15756,0.032465,DELPUECH_FOXO3_TARGETS_DN,0.767490762032086
GOBP_STRESS_ACTIVATED_PROTEI...,SET,52,0.21576,0.01146,0.11693,0.032506,GOBP_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.767490762032086
GOBP_LEUKOCYTE_MEDIATED_CYTO...,SET,133,0.1487,0.012604,0.080624,0.032569,GOBP_LEUKOCYTE_MEDIATED_CYTOTOXICITY,0.767490762032086
GSE22432_CDC_VS_COMMON_DC_PR...2,SET,175,0.11765,0.011426,0.06379,0.032573,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_UP,0.767490762032086
HP_RETICULATED_SKIN_PIGMENTA...,SET,5,0.67004,0.01105,0.36342,0.03262,HP_RETICULATED_SKIN_PIGMENTATION,0.767490762032086
GOBP_SOMATIC_DIVERSIFICATION...3,SET,55,0.19508,0.010656,0.10585,0.03267,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNOGLOBULINS,0.767490762032086
GOMF_VOLTAGE_GATED_MONOATOMI...3,SET,11,0.55065,0.013467,0.29878,0.032674,GOMF_VOLTAGE_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.767490762032086
GSE37532_WT_VS_PPARG_KO_VISC...3,SET,180,0.11859,0.011679,0.064352,0.032681,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_DN,0.767490762032086
GOBP_ANTIGEN_RECEPTOR_MEDIAT...,SET,171,0.12178,0.011691,0.066105,0.032735,GOBP_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.767490762032086
TCGATGG_MIR213,SET,5,0.64104,0.010572,0.34804,0.032758,TCGATGG_MIR213,0.767490762032086
HP_MICRORETROGNATHIA,SET,71,0.18548,0.011506,0.10071,0.032766,HP_MICRORETROGNATHIA,0.767490762032086
GOMF_NUCLEOSIDE_TRIPHOSPHATE...,SET,9,0.58164,0.012868,0.31581,0.032767,GOMF_NUCLEOSIDE_TRIPHOSPHATE_DIPHOSPHATASE_ACTIVITY,0.767490762032086
HP_SEVERE_VIRAL_INFECTION,SET,29,0.28317,0.011239,0.15376,0.032775,HP_SEVERE_VIRAL_INFECTION,0.767490762032086
GOMF_IMMUNOGLOBULIN_RECEPTOR...1,SET,12,0.54182,0.01384,0.29424,0.032789,GOMF_IMMUNOGLOBULIN_RECEPTOR_ACTIVITY,0.767490762032086
GSE8921_UNSTIM_VS_TLR1_2_STI...1,SET,181,0.11557,0.011413,0.062773,0.032809,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_DN,0.767490762032086
KIM_WT1_TARGETS_UP,SET,212,0.11176,0.011934,0.060725,0.032858,KIM_WT1_TARGETS_UP,0.767490762032086
REACTOME_INFECTION_WITH_MYCO...,SET,25,0.30268,0.011156,0.16447,0.032868,REACTOME_INFECTION_WITH_MYCOBACTERIUM_TUBERCULOSIS,0.767490762032086
PICCALUGA_ANGIOIMMUNOBLASTIC...2,SET,191,0.1241,0.012585,0.067441,0.032885,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP,0.767490762032086
HP_PECTUS_EXCAVATUM,SET,263,0.093114,0.011059,0.050616,0.032921,HP_PECTUS_EXCAVATUM,0.767490762032086
SAMOLS_TARGETS_OF_KHSV_MIRNA...1,SET,47,0.24772,0.012511,0.13467,0.032933,SAMOLS_TARGETS_OF_KHSV_MIRNAS_DN,0.767490762032086
GOBP_S_ADENOSYLMETHIONINE_ME...,SET,16,0.39722,0.011715,0.21601,0.032971,GOBP_S_ADENOSYLMETHIONINE_METABOLIC_PROCESS,0.767490762032086
GNF2_CD53,SET,52,0.22449,0.011924,0.12209,0.032988,GNF2_CD53,0.767490762032086
GSE11864_CSF1_VS_CSF1_PAM3CY...1,SET,166,0.12083,0.011431,0.065723,0.033006,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_DN,0.767490762032086
GOBP_MALE_SEX_DIFFERENTIATION,SET,158,0.12852,0.011865,0.069912,0.033017,GOBP_MALE_SEX_DIFFERENTIATION,0.767490762032086
REACTOME_ATORVASTATIN_ADME,SET,9,0.55487,0.012276,0.30187,0.033033,REACTOME_ATORVASTATIN_ADME,0.767490762032086
HP_MEGALOCORNEA,SET,42,0.25589,0.012218,0.13921,0.033033,HP_MEGALOCORNEA,0.767490762032086
GOBP_HETEROTYPIC_CELL_CELL_A...,SET,62,0.21326,0.012365,0.11602,0.033036,GOBP_HETEROTYPIC_CELL_CELL_ADHESION,0.767490762032086
ICHIBA_GRAFT_VERSUS_HOST_DIS...4,SET,108,0.15204,0.011621,0.082755,0.033093,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_UP,0.7678538
MIR3190_5P,SET,110,0.14832,0.01144,0.080731,0.033096,MIR3190_5P,0.7678538
HP_MALROTATION_OF_SMALL_BOWEL,SET,8,0.53859,0.011234,0.29321,0.033124,HP_MALROTATION_OF_SMALL_BOWEL,0.7678538
HP_TORTUOUS_CEREBRAL_ARTERIES,SET,5,0.71798,0.011841,0.39092,0.03314,HP_TORTUOUS_CEREBRAL_ARTERIES,0.7678538
MODULE_462,SET,15,0.45459,0.012982,0.2476,0.033189,MODULE_462,0.767914789042821
ZNF394_TARGET_GENES,SET,828,0.054994,0.011407,0.029964,0.033237,ZNF394_TARGET_GENES,0.767914789042821
GOBP_POSITIVE_REGULATION_OF_...459,SET,6,0.72134,0.013031,0.39303,0.033237,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.767914789042821
MIR1285_3P,SET,151,0.12092,0.010915,0.06589,0.03325,MIR1285_3P,0.767914789042821
BLANCO_MELO_INFLUENZA_A_INFE...1,SET,101,0.14335,0.010597,0.078128,0.033277,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_DN,0.767914789042821
MIR3158_3P,SET,35,0.25125,0.010954,0.13694,0.033285,MIR3158_3P,0.767914789042821
REACTOME_MUSCLE_CONTRACTION,SET,194,0.11522,0.011775,0.062819,0.03333,REACTOME_MUSCLE_CONTRACTION,0.767914789042821
GSE2770_UNTREATED_VS_ACT_CD4...5,SET,179,0.1119,0.010989,0.061015,0.033335,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_DN,0.767914789042821
GSE2770_IL12_AND_TGFB_ACT_VS...3,SET,181,0.11038,0.010899,0.060188,0.033347,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_DN,0.767914789042821
chr12p11,SET,31,0.4694,0.019262,0.25611,0.033424,chr12p11,0.767914789042821
GAVISH_3CA_MALIGNANT_METAPRO...11,SET,47,0.2048,0.010343,0.11175,0.033438,GAVISH_3CA_MALIGNANT_METAPROGRAM_20_MYC,0.767914789042821
GOBP_REGULATION_OF_ISOTYPE_S...1,SET,30,0.25752,0.010396,0.14053,0.033446,GOBP_REGULATION_OF_ISOTYPE_SWITCHING,0.767914789042821
GOBP_ENSHEATHMENT_OF_NEURONS,SET,148,0.12812,0.011451,0.069928,0.033472,GOBP_ENSHEATHMENT_OF_NEURONS,0.767914789042821
HP_BROAD_PHALANX_OF_THE_TOES,SET,38,0.25975,0.011799,0.1418,0.033496,HP_BROAD_PHALANX_OF_THE_TOES,0.767914789042821
GSE3565_DUSP1_VS_WT_SPLENOCY...1,SET,164,0.12105,0.011383,0.066089,0.033514,GSE3565_DUSP1_VS_WT_SPLENOCYTES_DN,0.767914789042821
GSE360_L_MAJOR_VS_B_MALAYI_L...4,SET,178,0.11299,0.011066,0.061705,0.033548,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_UP,0.767914789042821
GOCC_SNO_S_RNA_CONTAINING_RI...,SET,19,0.31962,0.010271,0.17457,0.033569,GOCC_SNO_S_RNA_CONTAINING_RIBONUCLEOPROTEIN_COMPLEX,0.767914789042821
HP_ABNORMAL_CIRCULATING_GABA...,SET,6,0.6384,0.011533,0.34874,0.03359,HP_ABNORMAL_CIRCULATING_GABA_CONCENTRATION,0.767914789042821
GOBP_POSITIVE_REGULATION_OF_...797,SET,63,0.18745,0.010956,0.10241,0.033608,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,0.767914789042821
REACTOME_TRANSCRIPTIONAL_REG...12,SET,30,0.30125,0.012161,0.16461,0.033627,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS,0.767914789042821
BIOCARTA_CALCINEURIN_PATHWAY,SET,18,0.35093,0.010977,0.19182,0.033671,BIOCARTA_CALCINEURIN_PATHWAY,0.767914789042821
PARK_APL_PATHOGENESIS_DN,SET,47,0.23721,0.01198,0.12966,0.033678,PARK_APL_PATHOGENESIS_DN,0.767914789042821
GOBP_CHONDROITIN_SULFATE_BIO...,SET,18,0.34722,0.010861,0.18984,0.033708,GOBP_CHONDROITIN_SULFATE_BIOSYNTHETIC_PROCESS,0.767914789042821
HERNANDEZ_ABERRANT_MITOSIS_B...1,SET,18,0.39616,0.012392,0.21664,0.033732,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_DN,0.767914789042821
SASAI_TARGETS_OF_CXCR6_AND_P...1,SET,8,0.62249,0.012984,0.34052,0.033778,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN,0.767914789042821
HP_ABNORMAL_CSF_HOMOVANILLIC...,SET,9,0.53063,0.011739,0.29035,0.033819,HP_ABNORMAL_CSF_HOMOVANILLIC_ACID_CONCENTRATION,0.767914789042821
GOBP_DNA_PROTECTION,SET,5,0.65874,0.010864,0.36071,0.033916,GOBP_DNA_PROTECTION,0.767914789042821
GSE18281_CORTICAL_THYMOCYTE_...1,SET,177,0.10723,0.010473,0.058754,0.033999,GSE18281_CORTICAL_THYMOCYTE_VS_WHOLE_CORTEX_THYMUS_DN,0.767914789042821
MIR6853_5P,SET,6,0.63255,0.011427,0.34661,0.034011,MIR6853_5P,0.767914789042821
KEGG_MEDICUS_REFERENCE_REGUL...6,SET,7,0.4826,0.0094165,0.26445,0.034014,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_MRAS_SHOC2_PP1_HOLOPHOSPHATASE,0.767914789042821
GOBP_REGULATION_OF_SYNAPTIC_...9,SET,17,0.35337,0.010742,0.19364,0.034021,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.767914789042821
HP_GOUT,SET,16,0.35148,0.010366,0.19265,0.034051,HP_GOUT,0.767914789042821
HARALAMBIEVA_PBMC_M_M_R_II_A...3,SET,10,0.51108,0.011918,0.28016,0.034064,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_HIGH_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,0.767914789042821
KEGG_MEDICUS_PATHOGEN_SHIGEL...8,SET,6,0.71691,0.012951,0.39301,0.034072,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPF_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,0.767914789042821
GCNP_SHH_UP_LATE.V1_UP,SET,163,0.11891,0.011149,0.06519,0.034077,GCNP_SHH_UP_LATE.V1_UP,0.767914789042821
GOMF_STRUCTURAL_CONSTITUENT_...10,SET,36,0.31696,0.014014,0.17379,0.0341,GOMF_STRUCTURAL_CONSTITUENT_OF_SKIN_EPIDERMIS,0.767914789042821
GSE40274_FOXP3_VS_FOXP3_AND_...5,SET,119,0.14049,0.011268,0.077036,0.034109,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.767914789042821
REACTOME_SARS_COV_1_INFECTION,SET,129,0.13132,0.010963,0.072032,0.03415,REACTOME_SARS_COV_1_INFECTION,0.767914789042821
PID_IL3_PATHWAY,SET,25,0.30354,0.011188,0.1665,0.034158,PID_IL3_PATHWAY,0.767914789042821
MIR6780B_5P,SET,258,0.095217,0.011202,0.052234,0.034168,MIR6780B_5P,0.767914789042821
MIR216A_5P,SET,118,0.14144,0.011297,0.077612,0.034209,MIR216A_5P,0.767914789042821
GOBP_REGULATION_OF_CALCIUM_I...5,SET,11,0.39924,0.0097643,0.21921,0.034291,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.767914789042821
GOBP_INTRINSIC_APOPTOTIC_SIG...4,SET,41,0.22155,0.010452,0.12166,0.034312,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE_BY_P53_CLASS_MEDIATOR,0.767914789042821
MIR5589_5P,SET,67,0.18495,0.011146,0.10157,0.034326,MIR5589_5P,0.767914789042821
HP_PROSTATE_CANCER,SET,32,0.26964,0.011242,0.1481,0.034335,HP_PROSTATE_CANCER,0.767914789042821
GOBP_GENOMIC_IMPRINTING,SET,17,0.35286,0.010727,0.1939,0.034402,GOBP_GENOMIC_IMPRINTING,0.767914789042821
GOCC_RIBOSOMAL_SUBUNIT,SET,166,0.11191,0.010588,0.061505,0.034422,GOCC_RIBOSOMAL_SUBUNIT,0.767914789042821
GOMF_MOLECULAR_CARRIER_ACTIV...,SET,84,0.15915,0.010735,0.087484,0.034447,GOMF_MOLECULAR_CARRIER_ACTIVITY,0.767914789042821
MIR873_5P,SET,101,0.15528,0.01148,0.085361,0.034453,MIR873_5P,0.767914789042821
HP_ABNORMAL_SEX_DETERMINATION,SET,18,0.38148,0.011932,0.20973,0.034469,HP_ABNORMAL_SEX_DETERMINATION,0.767914789042821
MATTHEWS_AP1_TARGETS,SET,17,0.41275,0.012547,0.22695,0.034488,MATTHEWS_AP1_TARGETS,0.767914789042821
HE_LIM_SUN_FETAL_LUNG_C0_MYL...,SET,110,0.15942,0.012296,0.087656,0.03449,HE_LIM_SUN_FETAL_LUNG_C0_MYL4_POS_SMC_CELL,0.767914789042821
GOBP_REGULATION_OF_GOLGI_TO_...,SET,8,0.5096,0.01063,0.28026,0.034517,GOBP_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.767914789042821
GOBP_NEGATIVE_REGULATION_OF_...148,SET,19,0.33955,0.010912,0.18674,0.034518,GOBP_NEGATIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.767914789042821
GOBP_HYALURONAN_BIOSYNTHETIC...,SET,14,0.41718,0.01151,0.22949,0.034553,GOBP_HYALURONAN_BIOSYNTHETIC_PROCESS,0.767914789042821
GOBP_COMPLEMENT_ACTIVATION_A...,SET,14,0.43268,0.011937,0.23804,0.034563,GOBP_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.767914789042821
PID_IL27_PATHWAY,SET,26,0.30766,0.011564,0.16927,0.034576,PID_IL27_PATHWAY,0.767914789042821
KEGG_CYTOSOLIC_DNA_SENSING_P...,SET,45,0.23314,0.011522,0.1283,0.034605,KEGG_CYTOSOLIC_DNA_SENSING_PATHWAY,0.767914789042821
HP_ABNORMAL_INTERVERTEBRAL_D...,SET,39,0.23394,0.010765,0.12874,0.034612,HP_ABNORMAL_INTERVERTEBRAL_DISK_MORPHOLOGY,0.767914789042821
GOBP_REGULATION_OF_STEM_CELL...2,SET,10,0.48698,0.011356,0.26802,0.03462,GOBP_REGULATION_OF_STEM_CELL_DIVISION,0.767914789042821
GOMF_INTRACELLULARLY_LIGAND_...,SET,30,0.27913,0.011268,0.15364,0.034636,GOMF_INTRACELLULARLY_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.767914789042821
HP_ABNORMALITY_OF_FACIAL_SOF...,SET,458,0.07259,0.011315,0.039965,0.034668,HP_ABNORMALITY_OF_FACIAL_SOFT_TISSUE,0.767914789042821
HP_HEMOLYTIC_UREMIC_SYNDROME,SET,14,0.4354,0.012012,0.23975,0.034693,HP_HEMOLYTIC_UREMIC_SYNDROME,0.767914789042821
GOBP_ENGULFMENT_OF_APOPTOTIC...,SET,15,0.37792,0.010792,0.20817,0.034735,GOBP_ENGULFMENT_OF_APOPTOTIC_CELL,0.767914789042821
GSE3920_UNTREATED_VS_IFNG_TR...3,SET,166,0.12227,0.011568,0.067352,0.034741,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_DN,0.767914789042821
HP_SKIN_NODULE,SET,121,0.14451,0.011687,0.079628,0.034781,HP_SKIN_NODULE,0.767914789042821
GOBP_ECTODERMAL_CELL_DIFFERE...,SET,5,0.78638,0.012969,0.43341,0.034818,GOBP_ECTODERMAL_CELL_DIFFERENTIATION,0.767914789042821
GSE8921_UNSTIM_VS_TLR1_2_STI...8,SET,189,0.11146,0.011244,0.061431,0.03482,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_UP,0.767914789042821
REACTOME_PREDNISONE_ADME,SET,9,0.50902,0.011261,0.28056,0.034824,REACTOME_PREDNISONE_ADME,0.767914789042821
OSWALD_HEMATOPOIETIC_STEM_CE...2,SET,208,0.11005,0.011641,0.060683,0.034881,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP,0.767914789042821
HP_CONGENITAL_POSTERIOR_URET...,SET,8,0.49842,0.010397,0.27484,0.034883,HP_CONGENITAL_POSTERIOR_URETHRAL_VALVE,0.767914789042821
MIR664B_5P,SET,53,0.20918,0.011217,0.11535,0.03489,MIR664B_5P,0.767914789042821
PASQUALUCCI_LYMPHOMA_BY_GC_S...2,SET,262,0.095835,0.011361,0.052852,0.034904,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP,0.767914789042821
GSE3982_MAC_VS_BCELL_UP,SET,178,0.11553,0.011315,0.063727,0.03493,GSE3982_MAC_VS_BCELL_UP,0.767914789042821
KEGG_MEDICUS_PATHOGEN_HCV_CO...2,SET,6,0.59032,0.010664,0.32565,0.034945,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_RXRA_LXRA_MEDIATED_TRANSCRIPTION,0.767914789042821
GOBP_INTRACELLULAR_RECEPTOR_...,SET,335,0.083242,0.011136,0.045921,0.034946,GOBP_INTRACELLULAR_RECEPTOR_SIGNALING_PATHWAY,0.767914789042821
GOMF_VOLTAGE_GATED_CALCIUM_C...1,SET,41,0.25859,0.0122,0.14265,0.034946,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.767914789042821
MIR5187_3P,SET,91,0.15506,0.010884,0.085555,0.034968,MIR5187_3P,0.767914789042821
HP_PROGRESSIVE_PERIPHERAL_NE...,SET,4,0.83265,0.012282,0.45945,0.034979,HP_PROGRESSIVE_PERIPHERAL_NEUROPATHY,0.767914789042821
GOCC_BLOOD_MICROPARTICLE,SET,98,0.16964,0.012354,0.093614,0.034992,GOCC_BLOOD_MICROPARTICLE,0.767914789042821
GOMF_INOSITOL_1_4_5_TRISPHOS...2,SET,11,0.48967,0.011976,0.27022,0.034992,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_BINDING,0.767914789042821
GOCC_HISTONE_METHYLTRANSFERA...,SET,63,0.17686,0.010337,0.097617,0.035019,GOCC_HISTONE_METHYLTRANSFERASE_COMPLEX,0.767914789042821
GARCIA_TARGETS_OF_FLI1_AND_D...2,SET,46,0.19758,0.0098721,0.10908,0.035054,GARCIA_TARGETS_OF_FLI1_AND_DAX1_UP,0.767914789042821
GOMF_PROTEIN_METHYLTRANSFERA...,SET,80,0.16476,0.010847,0.090966,0.03506,GOMF_PROTEIN_METHYLTRANSFERASE_ACTIVITY,0.767914789042821
GOMF_SULFOTRANSFERASE_ACTIVI...,SET,49,0.23566,0.012152,0.13011,0.035061,GOMF_SULFOTRANSFERASE_ACTIVITY,0.767914789042821
BIOCARTA_NEUTROPHIL_PATHWAY,SET,8,0.64668,0.013489,0.35707,0.035074,BIOCARTA_NEUTROPHIL_PATHWAY,0.767914789042821
GSE24814_STAT5_KO_VS_WT_PRE_...1,SET,183,0.10992,0.010914,0.060699,0.035084,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_DN,0.767914789042821
BIOCARTA_FXR_PATHWAY,SET,7,0.57806,0.011279,0.31921,0.035087,BIOCARTA_FXR_PATHWAY,0.767914789042821
GOBP_T_CELL_DIFFERENTIATION,SET,298,0.093266,0.011779,0.051512,0.035113,GOBP_T_CELL_DIFFERENTIATION,0.767995936517913
HP_ENLARGED_THORAX,SET,57,0.19331,0.010749,0.1068,0.035148,HP_ENLARGED_THORAX,0.767995936517913
GOBP_NUCLEOBASE_TRANSPORT,SET,12,0.42546,0.010868,0.23506,0.035157,GOBP_NUCLEOBASE_TRANSPORT,0.767995936517913
MIR3921,SET,135,0.13372,0.011418,0.073901,0.035203,MIR3921,0.768253493408663
WP_PPARALPHA_PATHWAY,SET,26,0.31135,0.011702,0.17209,0.035213,WP_PPARALPHA_PATHWAY,0.768253493408663
GSE22601_IMMATURE_CD4_SINGLE...2,SET,179,0.10722,0.010529,0.059283,0.035271,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.768542915129151
GSE40666_WT_VS_STAT4_KO_CD8_...3,SET,187,0.10986,0.011025,0.060752,0.03529,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.768542915129151
WIERENGA_PML_INTERACTOME,SET,38,0.2373,0.010779,0.13129,0.035359,WIERENGA_PML_INTERACTOME,0.768542915129151
GOBP_MITOTIC_DNA_REPLICATION,SET,15,0.35129,0.010032,0.19438,0.035373,GOBP_MITOTIC_DNA_REPLICATION,0.768542915129151
GSE2405_0H_VS_24H_A_PHAGOCYT...2,SET,188,0.10944,0.011012,0.060565,0.035388,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.768542915129151
GOBP_POSITIVE_REGULATION_OF_...768,SET,31,0.25773,0.010576,0.14263,0.035394,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.768542915129151
GOBP_NEGATIVE_REGULATION_OF_...76,SET,6,0.69785,0.012607,0.3863,0.035427,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,0.768542915129151
HP_ABNORMAL_LYMPH_NODE_MORPH...,SET,228,0.10682,0.011824,0.059135,0.035437,HP_ABNORMAL_LYMPH_NODE_MORPHOLOGY,0.768542915129151
BIOCARTA_NPC_PATHWAY,SET,11,0.4487,0.010974,0.24841,0.035446,BIOCARTA_NPC_PATHWAY,0.768542915129151
NAKAYA_PBMC_FLUAD_IMUVAC_MAL...,SET,18,0.35399,0.011073,0.19602,0.035475,NAKAYA_PBMC_FLUAD_IMUVAC_MALE_AGE_14_27YO_CORRELATED_WITH_HAI_RESPONSE_MF59_ADJUVANTED_AND_NON_1DY_GENES_IN_BTM_M75_POSITIVE,0.768542915129151
GOBP_ACTIVATION_OF_IMMUNE_RE...,SET,485,0.070478,0.011297,0.039027,0.035478,GOBP_ACTIVATION_OF_IMMUNE_RESPONSE,0.768542915129151
GOCC_VACUOLAR_LUMEN,SET,160,0.12356,0.011478,0.068431,0.035498,GOCC_VACUOLAR_LUMEN,0.768542915129151
HP_ABNORMAL_MITOCHONDRIAL_SH...,SET,10,0.46009,0.010729,0.25488,0.035539,HP_ABNORMAL_MITOCHONDRIAL_SHAPE,0.768542915129151
AGCTCCT_MIR28,SET,80,0.16966,0.011169,0.093994,0.035545,AGCTCCT_MIR28,0.768542915129151
MANALO_HYPOXIA_DN,SET,263,0.088232,0.010479,0.048901,0.0356,MANALO_HYPOXIA_DN,0.768542915129151
TERAO_AOX4_TARGETS_SKIN_UP,SET,25,0.28877,0.010643,0.1601,0.035648,TERAO_AOX4_TARGETS_SKIN_UP,0.768542915129151
MIR134_3P,SET,81,0.16973,0.011243,0.094118,0.03567,MIR134_3P,0.768542915129151
BUSSLINGER_DUODENAL_IMMUNE_C...,SET,822,0.053832,0.011127,0.02985,0.03567,BUSSLINGER_DUODENAL_IMMUNE_CELLS,0.768542915129151
MIR6795_5P,SET,120,0.13864,0.011166,0.076881,0.035675,MIR6795_5P,0.768542915129151
RUBENSTEIN_SKELETAL_MUSCLE_T...,SET,157,0.11949,0.010996,0.066286,0.035734,RUBENSTEIN_SKELETAL_MUSCLE_T_CELLS,0.768542915129151
HP_ABNORMALITY_OF_THE_BILIAR...,SET,355,0.081346,0.011196,0.045153,0.035816,HP_ABNORMALITY_OF_THE_BILIARY_SYSTEM,0.768542915129151
JONES_OVARY_MAST_CELL,SET,40,0.25456,0.011863,0.14131,0.035824,JONES_OVARY_MAST_CELL,0.768542915129151
GOBP_RESPONSE_TO_MECHANICAL_...,SET,209,0.10964,0.011625,0.060862,0.035826,GOBP_RESPONSE_TO_MECHANICAL_STIMULUS,0.768542915129151
KEGG_PRIMARY_BILE_ACID_BIOSY...,SET,16,0.40757,0.01202,0.22626,0.035833,KEGG_PRIMARY_BILE_ACID_BIOSYNTHESIS,0.768542915129151
MIR3677_3P,SET,5,0.70352,0.011602,0.39063,0.035863,MIR3677_3P,0.768542915129151
SHEDDEN_LUNG_CANCER_GOOD_SUR...2,SET,182,0.11677,0.011562,0.064837,0.035864,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A4,0.768542915129151
GOBP_ACTIN_POLYMERIZATION_DE...,SET,7,0.56063,0.010939,0.31133,0.03588,GOBP_ACTIN_POLYMERIZATION_DEPENDENT_CELL_MOTILITY,0.768542915129151
HP_UROGENITAL_SINUS_ANOMALY,SET,15,0.41388,0.011819,0.22985,0.035884,HP_UROGENITAL_SINUS_ANOMALY,0.768542915129151
GOCC_AXON_CYTOPLASM,SET,61,0.19768,0.01137,0.10979,0.03589,GOCC_AXON_CYTOPLASM,0.768542915129151
REACTOME_RETINOID_CYCLE_DISE...,SET,11,0.46356,0.011337,0.25747,0.035902,REACTOME_RETINOID_CYCLE_DISEASE_EVENTS,0.768542915129151
GSE25123_CTRL_VS_IL4_AND_ROS...3,SET,185,0.11324,0.011304,0.062914,0.035942,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,0.768542915129151
GSE24026_PD1_LIGATION_VS_CTR...2,SET,180,0.11517,0.011342,0.063987,0.035949,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_UP,0.768542915129151
HOWARD_T_CELL_INACT_MONOV_IN...,SET,41,0.25019,0.011804,0.13901,0.035956,HOWARD_T_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.768542915129151
GOMF_L_LACTATE_DEHYDROGENASE...,SET,5,0.89486,0.014758,0.49752,0.036046,GOMF_L_LACTATE_DEHYDROGENASE_ACTIVITY,0.76995856223176
HP_LONG_NECK,SET,3,0.71218,0.0090982,0.39605,0.036078,HP_LONG_NECK,0.76995856223176
GOCC_WEIBEL_PALADE_BODY,SET,5,0.65255,0.010762,0.36296,0.036109,GOCC_WEIBEL_PALADE_BODY,0.76995856223176
HP_MOON_FACIES,SET,12,0.40679,0.010391,0.2263,0.036131,HP_MOON_FACIES,0.76995856223176
HP_ABNORMAL_MORPHOLOGY_OF_TH...5,SET,43,0.23531,0.011369,0.13091,0.036133,HP_ABNORMAL_MORPHOLOGY_OF_THE_LIMBIC_SYSTEM,0.76995856223176
GOBP_REGULATION_OF_TOOTH_MIN...,SET,10,0.51854,0.012092,0.28857,0.036182,GOBP_REGULATION_OF_TOOTH_MINERALIZATION,0.770050091553455
HP_SHOULDER_CONTRACTURE,SET,8,0.55009,0.011474,0.30621,0.03622,HP_SHOULDER_CONTRACTURE,0.770050091553455
HP_RENOVASCULAR_HYPERTENSION,SET,25,0.30454,0.011224,0.16955,0.03624,HP_RENOVASCULAR_HYPERTENSION,0.770050091553455
GOCC_GRANULAR_COMPONENT,SET,7,0.54897,0.010712,0.30568,0.036266,GOCC_GRANULAR_COMPONENT,0.770050091553455
GSE20198_UNTREATED_VS_IFNA_T...2,SET,186,0.10785,0.010794,0.060054,0.036271,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.770050091553455
GOMF_EXTRACELLULAR_MATRIX_ST...2,SET,19,0.39486,0.012689,0.21992,0.0363,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_COMPRESSION_RESISTANCE,0.770050091553455
KEGG_MEDICUS_REFERENCE_CA2_E...3,SET,24,0.33797,0.012205,0.1883,0.036346,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL,0.770050091553455
AMIT_DELAYED_EARLY_GENES,SET,18,0.38609,0.012077,0.21512,0.036354,AMIT_DELAYED_EARLY_GENES,0.770050091553455
GSE3982_NEUTROPHIL_VS_TH2_UP,SET,181,0.11454,0.01131,0.063819,0.036357,GSE3982_NEUTROPHIL_VS_TH2_UP,0.770050091553455
REACTOME_MITOCHONDRIAL_PROTE...1,SET,78,0.16014,0.01041,0.089267,0.036423,REACTOME_MITOCHONDRIAL_PROTEIN_DEGRADATION,0.770050091553455
GOBP_RESPONSE_TO_FUNGUS,SET,54,0.22039,0.011928,0.12288,0.036457,GOBP_RESPONSE_TO_FUNGUS,0.770050091553455
WANG_NFKB_TARGETS,SET,24,0.30309,0.010945,0.16901,0.036472,WANG_NFKB_TARGETS,0.770050091553455
WP_SPINA_BIFIDA,SET,12,0.40672,0.010389,0.22683,0.03649,WP_SPINA_BIFIDA,0.770050091553455
REACTOME_INFLUENZA_INFECTION,SET,145,0.11869,0.010501,0.066219,0.036544,REACTOME_INFLUENZA_INFECTION,0.770050091553455
WP_ACUTE_MYELOID_LEUKEMIA,SET,65,0.19312,0.011464,0.10779,0.036613,WP_ACUTE_MYELOID_LEUKEMIA,0.770050091553455
REACTOME_SIGNALING_BY_CYTOSO...,SET,17,0.38225,0.01162,0.21339,0.036631,REACTOME_SIGNALING_BY_CYTOSOLIC_FGFR1_FUSION_MUTANTS,0.770050091553455
KEGG_MEDICUS_VARIANT_MUTATIO...1,SET,5,0.71183,0.011739,0.39742,0.036645,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_BRAF_TO_ERK_SIGNALING_PATHWAY,0.770050091553455
chr5q23,SET,35,0.4068,0.017736,0.22713,0.036653,chr5q23,0.770050091553455
GSE5589_UNSTIM_VS_45MIN_LPS_...3,SET,178,0.10734,0.010512,0.059932,0.036657,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_DN,0.770050091553455
MIR6887_5P,SET,120,0.13703,0.011036,0.076517,0.036666,MIR6887_5P,0.770050091553455
DESCARTES_FETAL_PANCREAS_ACI...,SET,68,0.20156,0.012238,0.11257,0.036688,DESCARTES_FETAL_PANCREAS_ACINAR_CELLS,0.770050091553455
GOBP_REGULATION_OF_MICROTUBU...6,SET,16,0.31458,0.0092778,0.17571,0.036705,GOBP_REGULATION_OF_MICROTUBULE_NUCLEATION,0.770050091553455
MIR2682_3P,SET,59,0.19338,0.010939,0.10802,0.036719,MIR2682_3P,0.770050091553455
HP_EMG_AXONAL_ABNORMALITY,SET,14,0.42746,0.011793,0.23887,0.036773,HP_EMG_AXONAL_ABNORMALITY,0.770050091553455
GOBP_L_HISTIDINE_TRANSMEMBRA...,SET,4,0.81414,0.012009,0.45496,0.036776,GOBP_L_HISTIDINE_TRANSMEMBRANE_TRANSPORT,0.770050091553455
GOMF_WIDE_PORE_CHANNEL_ACTIV...,SET,31,0.28625,0.011746,0.16001,0.036823,GOMF_WIDE_PORE_CHANNEL_ACTIVITY,0.770050091553455
HP_GANGRENE,SET,52,0.22566,0.011986,0.12615,0.036834,HP_GANGRENE,0.770050091553455
GOBP_LEUKOCYTE_DIFFERENTIATI...,SET,582,0.067439,0.011809,0.037709,0.036864,GOBP_LEUKOCYTE_DIFFERENTIATION,0.770050091553455
MODULE_136,SET,448,0.070002,0.010795,0.039152,0.036898,MODULE_136,0.770050091553455
GOBP_ERBB2_SIGNALING_PATHWAY,SET,23,0.31999,0.011313,0.17901,0.036931,GOBP_ERBB2_SIGNALING_PATHWAY,0.770050091553455
KEGG_GLYCOSAMINOGLYCAN_BIOSY...1,SET,21,0.30928,0.010449,0.17304,0.036952,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_CHONDROITIN_SULFATE,0.770050091553455
TRAVAGLINI_LUNG_B_CELL,SET,142,0.12932,0.011323,0.072398,0.037037,TRAVAGLINI_LUNG_B_CELL,0.770050091553455
DESCARTES_FETAL_CEREBELLUM_S...,SET,33,0.28733,0.012164,0.16087,0.03705,DESCARTES_FETAL_CEREBELLUM_SLC24A4_PEX5L_POSITIVE_CELLS,0.770050091553455
HP_ABNORMAL_RENAL_INSTERSTIT...,SET,52,0.21141,0.011229,0.11837,0.037058,HP_ABNORMAL_RENAL_INSTERSTITIAL_MORPHOLOGY,0.770050091553455
GSE15659_NAIVE_VS_PTPRC_NEG_...1,SET,170,0.11676,0.011178,0.065377,0.037059,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN,0.770050091553455
HOXA3_01,SET,14,0.4074,0.01124,0.22816,0.037094,HOXA3_01,0.770050091553455
MIR7106_3P,SET,38,0.24355,0.011063,0.13641,0.037107,MIR7106_3P,0.770050091553455
DACH1_TARGET_GENES,SET,742,0.055002,0.010826,0.030813,0.037139,DACH1_TARGET_GENES,0.770050091553455
HP_PANIC_ATTACK,SET,49,0.20165,0.010398,0.11299,0.037158,HP_PANIC_ATTACK,0.770050091553455
HP_ANKYLOSIS,SET,16,0.4098,0.012086,0.22963,0.037173,HP_ANKYLOSIS,0.770050091553455
KORKOLA_EMBRYONIC_CARCINOMA_...2,SET,16,0.41865,0.012347,0.23462,0.037187,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_UP,0.770050091553455
HP_CHRONIC_HEPATITIS_DUE_TO_...,SET,5,0.74912,0.012354,0.41983,0.037195,HP_CHRONIC_HEPATITIS_DUE_TO_CRYPTOSPORIDIUM_INFECTION,0.770050091553455
MIR433_3P,SET,127,0.13764,0.011402,0.077145,0.037203,MIR433_3P,0.770050091553455
GOBP_NUCLEOTIDE_BINDING_OLIG...2,SET,16,0.39819,0.011743,0.22322,0.037235,GOBP_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.770050091553455
GSE42021_TREG_VS_TCONV_PLN_UP,SET,186,0.11434,0.011444,0.064102,0.037248,GSE42021_TREG_VS_TCONV_PLN_UP,0.770050091553455
TSUTSUMI_FBXW8_TARGETS,SET,9,0.47715,0.010556,0.26756,0.037275,TSUTSUMI_FBXW8_TARGETS,0.770050091553455
WEINMANN_ADAPTATION_TO_HYPOX...1,SET,37,0.27061,0.012129,0.15175,0.037281,WEINMANN_ADAPTATION_TO_HYPOXIA_DN,0.770050091553455
CHIARADONNA_NEOPLASTIC_TRANS...4,SET,53,0.21253,0.011396,0.11919,0.037294,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_UP,0.770050091553455
MIR4776_5P,SET,44,0.21936,0.01072,0.12305,0.037326,MIR4776_5P,0.770050091553455
KEGG_MEDICUS_REFERENCE_DEPHO...,SET,12,0.41951,0.010716,0.23533,0.037331,KEGG_MEDICUS_REFERENCE_DEPHOSPHORYLATION_OF_KINETOCHORE,0.770050091553455
HP_LIMB_PAIN,SET,52,0.21844,0.011603,0.12256,0.037356,HP_LIMB_PAIN,0.770050091553455
LEIN_PONS_MARKERS,SET,79,0.17432,0.011404,0.09781,0.037363,LEIN_PONS_MARKERS,0.770050091553455
LEIN_LOCALIZED_TO_DISTAL_AND...,SET,16,0.40428,0.011923,0.22685,0.037371,LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES,0.770050091553455
HP_ABNORMAL_CARDIAC_BIOMARKE...,SET,6,0.69762,0.012603,0.39149,0.037387,HP_ABNORMAL_CARDIAC_BIOMARKER_TEST,0.770050091553455
MODULE_547,SET,11,0.44587,0.010905,0.25027,0.037422,MODULE_547,0.770050091553455
SF1_Q6,SET,236,0.098019,0.011036,0.055023,0.037432,SF1_Q6,0.770050091553455
GOCC_T_TUBULE,SET,52,0.21732,0.011543,0.12204,0.037482,GOCC_T_TUBULE,0.770050091553455
GSE19401_PLN_VS_PEYERS_PATCH...1,SET,186,0.10581,0.01059,0.05942,0.037489,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN,0.770050091553455
GOBP_REGULATION_OF_NEURONAL_...2,SET,53,0.20751,0.011127,0.11654,0.037494,GOBP_REGULATION_OF_NEURONAL_SYNAPTIC_PLASTICITY,0.770050091553455
LEI_HOXC8_TARGETS_UP,SET,11,0.46247,0.011311,0.25973,0.037499,LEI_HOXC8_TARGETS_UP,0.770050091553455
HERNANDEZ_ABERRANT_MITOSIS_B...3,SET,5,0.81634,0.013463,0.4585,0.037507,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_DN,0.770050091553455
GOBP_REGULATION_OF_DNA_DAMAG...1,SET,18,0.33729,0.01055,0.18944,0.037511,GOBP_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,0.770050091553455
GSE17721_CTRL_VS_POLYIC_12H_...1,SET,188,0.10757,0.010824,0.060463,0.03762,GSE17721_CTRL_VS_POLYIC_12H_BMDC_DN,0.771831818181818
GOMF_TRANSCRIPTION_COREGULAT...2,SET,105,0.15137,0.011408,0.085107,0.037666,GOMF_TRANSCRIPTION_COREGULATOR_BINDING,0.771873450087566
DURANTE_ADULT_OLFACTORY_NEUR...14,SET,107,0.15811,0.012029,0.088904,0.037678,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_ENSHEATHING_GLIA,0.771873450087566
GRANDVAUX_IRF3_TARGETS_DN,SET,17,0.39148,0.011901,0.22015,0.037694,GRANDVAUX_IRF3_TARGETS_DN,0.771873450087566
MIR6860,SET,102,0.14115,0.010486,0.079422,0.037777,MIR6860,0.771873450087566
GOCC_TROPONIN_COMPLEX,SET,8,0.56314,0.011746,0.3169,0.037789,GOCC_TROPONIN_COMPLEX,0.771873450087566
DESCARTES_FETAL_KIDNEY_MYELO...,SET,151,0.12893,0.011638,0.072551,0.03779,DESCARTES_FETAL_KIDNEY_MYELOID_CELLS,0.771873450087566
DESCARTES_MAIN_FETAL_SLC24A4...,SET,16,0.42751,0.012608,0.24062,0.03782,DESCARTES_MAIN_FETAL_SLC24A4_PEX5L_POSITIVE_CELLS,0.771873450087566
MARSON_FOXP3_TARGETS_STIMULA...2,SET,29,0.30342,0.012043,0.17078,0.037823,MARSON_FOXP3_TARGETS_STIMULATED_UP,0.771873450087566
GOBP_VASCULAR_TRANSPORT,SET,82,0.18206,0.012134,0.10248,0.03783,GOBP_VASCULAR_TRANSPORT,0.771873450087566
HP_RECURRENT_SKIN_INFECTIONS,SET,122,0.13647,0.011082,0.076843,0.037876,HP_RECURRENT_SKIN_INFECTIONS,0.771873450087566
HP_ABNORMAL_GRANULOCYTOPOIET...,SET,14,0.39819,0.010986,0.22421,0.03788,HP_ABNORMAL_GRANULOCYTOPOIETIC_CELL_MORPHOLOGY,0.771873450087566
GSE17721_LPS_VS_POLYIC_12H_B...2,SET,185,0.10625,0.010606,0.059833,0.037894,GSE17721_LPS_VS_POLYIC_12H_BMDC_UP,0.771873450087566
GOBP_RIBOSOMAL_SMALL_SUBUNIT...1,SET,16,0.35615,0.010504,0.20058,0.037912,GOBP_RIBOSOMAL_SMALL_SUBUNIT_ASSEMBLY,0.771873450087566
GOBP_EMBRYONIC_EYE_MORPHOGEN...,SET,34,0.27933,0.012003,0.15741,0.037999,GOBP_EMBRYONIC_EYE_MORPHOGENESIS,0.771873450087566
GOBP_FUCOSYLATION,SET,16,0.36657,0.010811,0.20661,0.038023,GOBP_FUCOSYLATION,0.771873450087566
DMRT1_TARGET_GENES,SET,329,0.082589,0.010951,0.046551,0.038027,DMRT1_TARGET_GENES,0.771873450087566
LOPEZ_MBD_TARGETS,SET,862,0.049377,0.01044,0.027832,0.038034,LOPEZ_MBD_TARGETS,0.771873450087566
GOBP_MEMBRANE_PROTEIN_ECTODO...,SET,46,0.21265,0.010625,0.11986,0.038036,GOBP_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.771873450087566
RUIZ_TNC_TARGETS_DN,SET,136,0.13072,0.011203,0.073687,0.038044,RUIZ_TNC_TARGETS_DN,0.771873450087566
MIR7153_3P,SET,43,0.22301,0.010774,0.12573,0.038069,MIR7153_3P,0.771905510204082
GSE43955_1H_VS_20H_ACT_CD4_T...3,SET,189,0.11514,0.011615,0.064924,0.03809,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.771905510204082
HP_ECTOPIC_KIDNEY,SET,72,0.17601,0.010995,0.099285,0.038145,HP_ECTOPIC_KIDNEY,0.772569624125874
GOCC_NUCLEAR_ENVELOPE,SET,450,0.069819,0.01079,0.039406,0.038222,GOCC_NUCLEAR_ENVELOPE,0.773678281887012
HP_FETAL_ASCITES,SET,8,0.58338,0.012169,0.32941,0.038289,HP_FETAL_ASCITES,0.774294493891797
KEGG_MEDICUS_VARIANT_MUTATIO...7,SET,29,0.27468,0.010902,0.1551,0.038297,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY,0.774294493891797
HP_DELAYED_ABILITY_TO_ROLL_O...,SET,14,0.34062,0.0093973,0.19244,0.038371,HP_DELAYED_ABILITY_TO_ROLL_OVER,0.774917489843297
HP_ABNORMALITY_OF_DERMAL_MEL...,SET,5,0.69503,0.011462,0.39272,0.038391,HP_ABNORMALITY_OF_DERMAL_MELANOSOMES,0.774917489843297
GOBP_POSITIVE_REGULATION_OF_...176,SET,4,0.84537,0.01247,0.47769,0.038397,GOBP_POSITIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.774917489843297
MIR9898,SET,52,0.20113,0.010683,0.11367,0.038417,MIR9898,0.774917489843297
MODULE_512,SET,36,0.24747,0.010942,0.13991,0.038475,MODULE_512,0.775463386442642
HP_VERTEBRAL_SEGMENTATION_DE...,SET,131,0.12775,0.010747,0.072243,0.038509,HP_VERTEBRAL_SEGMENTATION_DEFECT,0.775463386442642
MIR6790_3P,SET,4,0.85079,0.01255,0.48113,0.038511,MIR6790_3P,0.775463386442642
GOMF_PHOSPHATIDYLINOSITOL_PH...3,SET,162,0.11551,0.010797,0.065337,0.038545,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_BINDING,0.775698595830921
HP_ABNORMAL_BLEEDING,SET,498,0.067063,0.010889,0.037946,0.038596,HP_ABNORMAL_BLEEDING,0.775753284228769
MODULE_329,SET,50,0.21472,0.011184,0.12151,0.038611,MODULE_329,0.775753284228769
HP_GLOMERULOPATHY,SET,31,0.29091,0.011938,0.16464,0.038629,HP_GLOMERULOPATHY,0.775753284228769
GSE27786_NKCELL_VS_ERYTHROBL...1,SET,185,0.10898,0.010878,0.061678,0.038637,GSE27786_NKCELL_VS_ERYTHROBLAST_DN,0.775753284228769
GOBP_POSITIVE_REGULATION_OF_...675,SET,7,0.59819,0.011672,0.33866,0.038678,GOBP_POSITIVE_REGULATION_OF_RESPIRATORY_BURST,0.776128112009238
GOBP_INTRINSIC_APOPTOTIC_SIG...3,SET,98,0.14752,0.010743,0.083531,0.038703,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.776181630121177
MUELLER_PLURINET,SET,278,0.086846,0.0106,0.049185,0.038731,MUELLER_PLURINET,0.776295216262976
GOBP_ISOPRENOID_TRANSPORT,SET,5,0.73332,0.012094,0.41546,0.038784,GOBP_ISOPRENOID_TRANSPORT,0.776314844827586
MIR8089,SET,155,0.12634,0.011553,0.071593,0.03882,MIR8089,0.776314844827586
GSE32986_UNSTIM_VS_CURDLAN_L...2,SET,190,0.10256,0.010374,0.058123,0.038829,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_UP,0.776314844827586
BUSSLINGER_ESOPHAGEAL_DENDRI...,SET,194,0.1115,0.011395,0.063191,0.038832,BUSSLINGER_ESOPHAGEAL_DENDRITIC_CELLS,0.776314844827586
GOBP_L_LEUCINE_IMPORT_ACROSS...,SET,5,0.66849,0.011024,0.37893,0.038862,GOBP_L_LEUCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.776314844827586
KAZMIN_PBMC_P_FALCIPARUM_RTS...2,SET,6,0.71828,0.012976,0.40717,0.038866,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_POSITIVE,0.776314844827586
HADDAD_B_LYMPHOCYTE_PROGENIT...,SET,248,0.099631,0.011495,0.056524,0.03899,HADDAD_B_LYMPHOCYTE_PROGENITOR,0.777004173764906
GSE17721_LPS_VS_CPG_24H_BMDC...2,SET,180,0.10876,0.010711,0.061705,0.03899,GSE17721_LPS_VS_CPG_24H_BMDC_UP,0.777004173764906
GOMF_SODIUM_PROTON_ANTIPORTE...,SET,13,0.4021,0.01069,0.22819,0.039031,GOMF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.777004173764906
WP_AGERAGE_PATHWAY,SET,63,0.1891,0.011052,0.10732,0.039036,WP_AGERAGE_PATHWAY,0.777004173764906
chr1p34,SET,154,0.25102,0.022881,0.14248,0.039062,chr1p34,0.777004173764906
HP_ABNORMAL_PROSTATE_MORPHOL...,SET,38,0.24718,0.011228,0.14032,0.039075,HP_ABNORMAL_PROSTATE_MORPHOLOGY,0.777004173764906
GSE22919_RESTING_VS_IL2_IL12...1,SET,181,0.10625,0.010492,0.060315,0.039078,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_DN,0.777004173764906
MIR193A_3P_MIR193B_3P,SET,79,0.17135,0.01121,0.097284,0.039103,MIR193A_3P_MIR193B_3P,0.777004173764906
KEGG_MEDICUS_REFERENCE_MICRO...3,SET,26,0.30375,0.011416,0.17249,0.039128,KEGG_MEDICUS_REFERENCE_MICROTUBULE_NUCLEATION,0.777004173764906
GOBP_STEROID_HORMONE_MEDIATE...,SET,122,0.13374,0.01086,0.075974,0.039187,GOBP_STEROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.777004173764906
WP_IL4_SIGNALING,SET,50,0.21766,0.011338,0.12367,0.039205,WP_IL4_SIGNALING,0.777004173764906
MAPK3_TARGET_GENES,SET,69,0.17506,0.010706,0.099465,0.039211,MAPK3_TARGET_GENES,0.777004173764906
GOBP_REGULATION_OF_LAMELLIPO...3,SET,43,0.23299,0.011257,0.13239,0.039215,GOBP_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,0.777004173764906
DESCARTES_MAIN_FETAL_RETINAL...1,SET,106,0.15378,0.011645,0.087387,0.039232,DESCARTES_MAIN_FETAL_RETINAL_PIGMENT_CELLS,0.777004173764906
GSE3039_ALPHABETA_CD8_TCELL_...2,SET,178,0.10695,0.010474,0.060776,0.039238,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_UP,0.777004173764906
HP_APPENDICULAR_HYPOTONIA,SET,16,0.40386,0.011911,0.22954,0.039261,HP_APPENDICULAR_HYPOTONIA,0.777004173764906
MODULE_457,SET,10,0.45162,0.010532,0.25672,0.039281,MODULE_457,0.777004173764906
GOMF_DNA_DEMETHYLASE_ACTIVITY,SET,5,0.58002,0.0095655,0.32982,0.039331,GOMF_DNA_DEMETHYLASE_ACTIVITY,0.777004173764906
GOBP_POSITIVE_REGULATION_OF_...454,SET,6,0.64538,0.011659,0.36701,0.039339,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_STEM_CELL_PROLIFERATION,0.777004173764906
GSE27670_CTRL_VS_BLIMP1_TRAN...1,SET,180,0.11348,0.011175,0.06454,0.039355,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_DN,0.777004173764906
KEGG_NON_SMALL_CELL_LUNG_CAN...,SET,53,0.2037,0.010923,0.11586,0.03937,KEGG_NON_SMALL_CELL_LUNG_CANCER,0.777004173764906
HP_HYPERSEGMENTATION_OF_NEUT...,SET,6,0.66946,0.012094,0.38094,0.039435,HP_HYPERSEGMENTATION_OF_NEUTROPHIL_NUCLEI,0.777482952353942
GOBP_NEGATIVE_REGULATION_OF_...396,SET,8,0.5476,0.011422,0.31161,0.039439,GOBP_NEGATIVE_REGULATION_OF_MIRNA_PROCESSING,0.777482952353942
GOBP_NEGATIVE_REGULATION_OF_...315,SET,16,0.36364,0.010725,0.20705,0.039531,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.778799328992072
HP_ABNORMAL_HALLUX_MORPHOLOGY,SET,177,0.11332,0.011067,0.06454,0.039572,HP_ABNORMAL_HALLUX_MORPHOLOGY,0.778799328992072
GSE13229_IMM_VS_MATURE_NKCEL...2,SET,181,0.10885,0.010749,0.061997,0.039573,GSE13229_IMM_VS_MATURE_NKCELL_UP,0.778799328992072
GOCC_ACTIVIN_RECEPTOR_COMPLEX,SET,6,0.5355,0.0096739,0.3052,0.039673,GOCC_ACTIVIN_RECEPTOR_COMPLEX,0.779626890343699
GSE21670_IL6_VS_TGFB_AND_IL6...2,SET,173,0.11337,0.010947,0.064616,0.039677,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,0.779626890343699
GOBP_L_SERINE_BIOSYNTHETIC_P...,SET,6,0.53385,0.0096442,0.30442,0.039752,GOBP_L_SERINE_BIOSYNTHETIC_PROCESS,0.779626890343699
MIR3660,SET,96,0.15161,0.010928,0.08649,0.039818,MIR3660,0.779626890343699
GOBP_LEARNED_VOCALIZATION_BE...,SET,10,0.51826,0.012086,0.29567,0.039823,GOBP_LEARNED_VOCALIZATION_BEHAVIOR_OR_VOCAL_LEARNING,0.779626890343699
HP_ARACHNODACTYLY,SET,109,0.14134,0.010852,0.080634,0.039827,HP_ARACHNODACTYLY,0.779626890343699
HP_PULVERULENT_CATARACT,SET,11,0.47752,0.011679,0.27251,0.039868,HP_PULVERULENT_CATARACT,0.779626890343699
WP_MRNA_VACCINE_ACTIVATION_O...,SET,7,0.4953,0.0096645,0.2827,0.039894,WP_MRNA_VACCINE_ACTIVATION_OF_DENDRITIC_CELL_AND_INDUCTION_OF_IFN1,0.779626890343699
HP_EXERCISE_INDUCED_MYALGIA,SET,31,0.24423,0.010022,0.13944,0.039936,HP_EXERCISE_INDUCED_MYALGIA,0.779626890343699
GSE20727_H2O2_VS_ROS_INHIBIT...1,SET,174,0.11136,0.010784,0.06358,0.039945,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN,0.779626890343699
PID_ANGIOPOIETIN_RECEPTOR_PA...,SET,47,0.21267,0.010741,0.12146,0.039988,PID_ANGIOPOIETIN_RECEPTOR_PATHWAY,0.779626890343699
REACTOME_STAT5_ACTIVATION,SET,7,0.45562,0.0088902,0.26023,0.039995,REACTOME_STAT5_ACTIVATION,0.779626890343699
MIR4782_5P,SET,150,0.12247,0.011019,0.06996,0.040014,MIR4782_5P,0.779626890343699
GSE22886_DAY0_VS_DAY7_MONOCY...2,SET,176,0.11246,0.010952,0.064245,0.04003,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_UP,0.779626890343699
GOBP_REGULATION_OF_CATECHOLA...1,SET,15,0.39011,0.01114,0.22289,0.040046,GOBP_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,0.779626890343699
PAX3_01,SET,19,0.30425,0.0097775,0.17385,0.04006,PAX3_01,0.779626890343699
GSE27786_LIN_NEG_VS_CD8_TCEL...2,SET,179,0.10542,0.010353,0.060243,0.04007,GSE27786_LIN_NEG_VS_CD8_TCELL_UP,0.779626890343699
FAN_OVARY_CL1_GPRC5A_TNFRS12...,SET,343,0.076325,0.010329,0.043621,0.040092,FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL,0.779626890343699
GOBP_ESTABLISHMENT_OF_PLANAR...2,SET,15,0.37616,0.010742,0.215,0.040107,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_OF_EMBRYONIC_EPITHELIUM,0.779626890343699
GOBP_REGULATION_OF_RNA_BINDI...,SET,6,0.56857,0.010271,0.3252,0.040208,GOBP_REGULATION_OF_RNA_BINDING,0.779626890343699
SHEPARD_BMYB_MORPHOLINO_UP,SET,198,0.10157,0.010486,0.058101,0.040222,SHEPARD_BMYB_MORPHOLINO_UP,0.779626890343699
REACTOME_ACTIVATED_TAK1_MEDI...,SET,19,0.35529,0.011418,0.20329,0.040263,REACTOME_ACTIVATED_TAK1_MEDIATES_P38_MAPK_ACTIVATION,0.779626890343699
REACTOME_REGULATION_OF_GLYCO...,SET,11,0.39331,0.0096193,0.22512,0.04032,REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM,0.779626890343699
MIR4651,SET,189,0.11244,0.011343,0.064365,0.040341,MIR4651,0.779626890343699
GOBP_POSITIVE_REGULATION_OF_...71,SET,34,0.24012,0.010318,0.13747,0.040351,GOBP_POSITIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.779626890343699
GSE17721_POLYIC_VS_PAM3CSK4_...14,SET,180,0.10834,0.010669,0.062027,0.040354,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP,0.779626890343699
MEISSNER_NPC_HCP_WITH_H3K4ME...1,SET,330,0.089753,0.011918,0.05139,0.04037,MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.779626890343699
GSE1925_CTRL_VS_24H_IFNG_STI...4,SET,177,0.1097,0.010714,0.062816,0.040379,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_UP,0.779626890343699
GSE360_L_DONOVANI_VS_L_MAJOR...1,SET,178,0.10891,0.010666,0.062368,0.040386,GSE360_L_DONOVANI_VS_L_MAJOR_DC_DN,0.779626890343699
DESCARTES_FETAL_EYE_SKELETAL...,SET,132,0.13232,0.011173,0.075772,0.04039,DESCARTES_FETAL_EYE_SKELETAL_MUSCLE_CELLS,0.779626890343699
HP_PARESIS_OF_EXTENSOR_MUSCL...,SET,6,0.68879,0.012443,0.39444,0.040393,HP_PARESIS_OF_EXTENSOR_MUSCLES_OF_THE_BIG_TOE,0.779626890343699
HP_FEMALE_EXTERNAL_GENITALIA...,SET,14,0.41132,0.011348,0.23556,0.040404,HP_FEMALE_EXTERNAL_GENITALIA_IN_INDIVIDUAL_WITH_46_XY_KARYOTYPE,0.779626890343699
HP_OPPORTUNISTIC_INFECTION,SET,43,0.23299,0.011257,0.13347,0.040446,HP_OPPORTUNISTIC_INFECTION,0.779626890343699
GOMF_EPIDERMAL_GROWTH_FACTOR...,SET,34,0.2555,0.010979,0.1464,0.040483,GOMF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_BINDING,0.779626890343699
GSE14699_NAIVE_VS_ACT_CD8_TC...1,SET,158,0.11725,0.010825,0.067234,0.04059,GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN,0.779626890343699
GSE17721_LPS_VS_POLYIC_16H_B...2,SET,176,0.1037,0.010099,0.059468,0.040604,GSE17721_LPS_VS_POLYIC_16H_BMDC_UP,0.779626890343699
LI_PBMC_MENACTRA_AGE_18_45YO...3,SET,25,0.30525,0.01125,0.17505,0.04061,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.779626890343699
GOBP_POSITIVE_REGULATION_OF_...297,SET,49,0.20702,0.010675,0.11873,0.040625,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.779626890343699
GOBP_POSITIVE_REGULATION_OF_...298,SET,11,0.52321,0.012796,0.30011,0.040642,GOBP_POSITIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_DEMETHYLATION,0.779626890343699
HP_PERCUSSION_MYOTONIA,SET,9,0.48238,0.010672,0.27673,0.040664,HP_PERCUSSION_MYOTONIA,0.779626890343699
REACTOME_RESOLUTION_OF_D_LOO...2,SET,25,0.27431,0.01011,0.15739,0.040688,REACTOME_RESOLUTION_OF_D_LOOP_STRUCTURES_THROUGH_SYNTHESIS_DEPENDENT_STRAND_ANNEALING_SDSA,0.779626890343699
ACTTTAT_MIR1425P,SET,268,0.089028,0.010672,0.051087,0.040704,ACTTTAT_MIR1425P,0.779626890343699
GOBP_LEYDIG_CELL_DIFFERENTIA...,SET,9,0.51684,0.011434,0.29661,0.040718,GOBP_LEYDIG_CELL_DIFFERENTIATION,0.779626890343699
GSE45365_HEALTHY_VS_MCMV_INF...4,SET,160,0.11697,0.010866,0.067132,0.040731,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_DN,0.779626890343699
GOCC_MCM_COMPLEX,SET,11,0.48936,0.011968,0.28088,0.040741,GOCC_MCM_COMPLEX,0.779626890343699
GOBP_POSITIVE_REGULATION_OF_...736,SET,41,0.22325,0.010532,0.12814,0.040742,GOBP_POSITIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.779626890343699
GOBP_DEOXYRIBONUCLEOSIDE_TRI...,SET,9,0.46769,0.010347,0.26847,0.040759,GOBP_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.779626890343699
MIR4776_3P,SET,152,0.12756,0.011553,0.073241,0.040791,MIR4776_3P,0.779626890343699
ZHU_CMV_8_HR_DN,SET,45,0.23617,0.011672,0.1356,0.040798,ZHU_CMV_8_HR_DN,0.779626890343699
GOBP_NEGATIVE_REGULATION_OF_...238,SET,7,0.53133,0.010367,0.30509,0.0408,GOBP_NEGATIVE_REGULATION_OF_FERTILIZATION,0.779626890343699
GTCGATC_MIR3695P,SET,4,0.64502,0.0095147,0.37049,0.040853,GTCGATC_MIR3695P,0.779626890343699
HP_RIDGED_FINGERNAIL,SET,7,0.5253,0.01025,0.30176,0.040871,HP_RIDGED_FINGERNAIL,0.779626890343699
GOBP_POSITIVE_REGULATION_OF_...762,SET,3,1.0468,0.013373,0.60153,0.040915,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.779626890343699
GOBP_EXOCRINE_PANCREAS_DEVEL...,SET,7,0.62455,0.012186,0.35898,0.040958,GOBP_EXOCRINE_PANCREAS_DEVELOPMENT,0.779626890343699
HP_ABNORMAL_NONVERBAL_COMMUN...,SET,89,0.14568,0.010113,0.083753,0.04099,HP_ABNORMAL_NONVERBAL_COMMUNICATIVE_BEHAVIOR,0.779626890343699
GSE12484_HEALTHY_VS_PERIDONT...1,SET,138,0.12485,0.010778,0.071781,0.040994,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_DN,0.779626890343699
MIR509_3P,SET,53,0.19698,0.010563,0.11325,0.040996,MIR509_3P,0.779626890343699
HP_EMG_ABNORMALITY,SET,250,0.092575,0.010723,0.053239,0.041039,HP_EMG_ABNORMALITY,0.779626890343699
GOBP_REGULATION_OF_TRANSLATI...2,SET,10,0.41484,0.0096739,0.23857,0.04104,GOBP_REGULATION_OF_TRANSLATIONAL_ELONGATION,0.779626890343699
GAVISH_3CA_METAPROGRAM_MACRO...13,SET,42,0.22167,0.010585,0.12749,0.041045,GAVISH_3CA_METAPROGRAM_MACROPHAGES_UNFOLDED_PROTEIN_RESPONSE,0.779626890343699
GOBP_POSITIVE_REGULATION_OF_...813,SET,18,0.3616,0.011311,0.20797,0.04105,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.779626890343699
DESCARTES_FETAL_PLACENTA_MEG...,SET,156,0.12083,0.011085,0.069494,0.041052,DESCARTES_FETAL_PLACENTA_MEGAKARYOCYTES,0.779626890343699
GOBP_CHROMOSOME_LOCALIZATION,SET,112,0.13233,0.010298,0.076114,0.041068,GOBP_CHROMOSOME_LOCALIZATION,0.779626890343699
GOBP_NEGATIVE_REGULATION_OF_...336,SET,6,0.70157,0.012674,0.40364,0.041105,GOBP_NEGATIVE_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.779626890343699
GAUSSMANN_MLL_AF4_FUSION_TAR...14,SET,219,0.10222,0.011091,0.058814,0.041118,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_UP,0.779626890343699
GOMF_HAPTOGLOBIN_BINDING,SET,6,0.77777,0.014051,0.44752,0.041118,GOMF_HAPTOGLOBIN_BINDING,0.779626890343699
GSE25123_ROSIGLITAZONE_VS_IL...4,SET,178,0.10634,0.010414,0.061186,0.041118,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,0.779626890343699
HP_NEOPLASM_OF_THE_NERVOUS_S...,SET,184,0.105,0.010454,0.060446,0.041191,HP_NEOPLASM_OF_THE_NERVOUS_SYSTEM,0.780585171755725
HP_PANCREATIC_CYSTS,SET,33,0.23161,0.0098052,0.13338,0.041251,HP_PANCREATIC_CYSTS,0.780739496735582
GOBP_INTERKINETIC_NUCLEAR_MI...,SET,5,0.72754,0.011998,0.41901,0.041262,GOBP_INTERKINETIC_NUCLEAR_MIGRATION,0.780739496735582
HP_BILIARY_TRACT_ABNORMALITY,SET,93,0.15469,0.010976,0.089099,0.041278,HP_BILIARY_TRACT_ABNORMALITY,0.780739496735582
AIZARANI_LIVER_C30_HEPATOCYT...,SET,369,0.075493,0.010589,0.043487,0.041289,AIZARANI_LIVER_C30_HEPATOCYTES_4,0.780739496735582
TIEN_INTESTINE_PROBIOTICS_2H...2,SET,28,0.28305,0.011039,0.16307,0.041312,TIEN_INTESTINE_PROBIOTICS_2HR_UP,0.780749624796085
JIANG_HYPOXIA_CANCER,SET,53,0.20018,0.010734,0.11539,0.041389,JIANG_HYPOXIA_CANCER,0.781223557352198
FORTSCHEGGER_PHF8_TARGETS_DN,SET,685,0.056463,0.010696,0.03255,0.041411,FORTSCHEGGER_PHF8_TARGETS_DN,0.781223557352198
DER_IFN_GAMMA_RESPONSE_UP,SET,67,0.18205,0.010972,0.10498,0.041454,DER_IFN_GAMMA_RESPONSE_UP,0.781223557352198
GOMF_LIPOPOLYSACCHARIDE_BIND...,SET,36,0.26773,0.011837,0.15441,0.041484,GOMF_LIPOPOLYSACCHARIDE_BINDING,0.781223557352198
GOBP_NEGATIVE_REGULATION_OF_...214,SET,35,0.2472,0.010777,0.14261,0.041519,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.781223557352198
GSE40274_CTRL_VS_SATB1_TRANS...1,SET,151,0.11592,0.010464,0.066886,0.041553,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.781223557352198
HP_FETAL_PERICARDIAL_EFFUSION,SET,6,0.50862,0.0091884,0.2935,0.04156,HP_FETAL_PERICARDIAL_EFFUSION,0.781223557352198
GOCC_AZUROPHIL_GRANULE,SET,139,0.12203,0.010572,0.070421,0.041571,GOCC_AZUROPHIL_GRANULE,0.781223557352198
GOBP_ALPHA_BETA_T_CELL_ACTIV...,SET,168,0.12231,0.01164,0.070585,0.041577,GOBP_ALPHA_BETA_T_CELL_ACTIVATION,0.781223557352198
MIR506_5P,SET,118,0.13121,0.01048,0.07575,0.041629,MIR506_5P,0.781223557352198
MODULE_3,SET,362,0.076135,0.010579,0.043958,0.041645,MODULE_3,0.781223557352198
RUBENSTEIN_SKELETAL_MUSCLE_M...,SET,306,0.083515,0.010686,0.048223,0.041658,RUBENSTEIN_SKELETAL_MUSCLE_MYELOID_CELLS,0.781223557352198
REACTOME_NR1H2_NR1H3_REGULAT...3,SET,5,0.52908,0.0087255,0.30556,0.041688,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_TRIGLYCERIDE_LIPOLYSIS_IN_ADIPOSE,0.781223557352198
HP_ESOPHAGEAL_NEOPLASM,SET,27,0.28147,0.01078,0.16256,0.04169,HP_ESOPHAGEAL_NEOPLASM,0.781223557352198
KOBAYASHI_EGFR_SIGNALING_6HR...1,SET,17,0.37978,0.011545,0.21938,0.041725,KOBAYASHI_EGFR_SIGNALING_6HR_DN,0.781223557352198
HP_MALE_REPRODUCTIVE_SYSTEM_...,SET,59,0.19464,0.01101,0.11245,0.041741,HP_MALE_REPRODUCTIVE_SYSTEM_NEOPLASM,0.781223557352198
GSE28726_NAIVE_CD4_TCELL_VS_...2,SET,188,0.1027,0.010334,0.059359,0.041809,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_UP,0.781223557352198
JIANG_MELANOMA_TRM3_CD8,SET,363,0.07603,0.010579,0.04395,0.041833,JIANG_MELANOMA_TRM3_CD8,0.781223557352198
HOLLEMAN_DAUNORUBICIN_B_ALL_...1,SET,12,0.39427,0.010071,0.22798,0.041875,HOLLEMAN_DAUNORUBICIN_B_ALL_DN,0.781223557352198
HP_LIMB_MUSCLE_WEAKNESS,SET,306,0.082908,0.010608,0.047946,0.041895,HP_LIMB_MUSCLE_WEAKNESS,0.781223557352198
SHAFFER_IRF4_TARGETS_IN_ACTI...1,SET,74,0.16996,0.010763,0.098339,0.041974,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE,0.781223557352198
GOBP_NEGATIVE_REGULATION_OF_...65,SET,5,0.50464,0.0083223,0.292,0.041985,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.781223557352198
HP_LOP_EAR,SET,3,0.95274,0.012171,0.5513,0.041986,HP_LOP_EAR,0.781223557352198
KEGG_MEDICUS_PATHOGEN_SALMON...7,SET,8,0.4528,0.0094448,0.2621,0.042042,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_E2_TO_NOD_NFKB_SIGNALING_PATHWAY,0.781223557352198
CAO_BLOOD_FLUZONE_AGE_05_14Y...7,SET,6,0.57261,0.010344,0.3315,0.042063,CAO_BLOOD_FLUZONE_AGE_05_14YO_CORRELATED_WITH_H3N1_HI_TITER_1DY_POSITIVE,0.781223557352198
MIR7850_5P,SET,110,0.14097,0.010873,0.081614,0.042064,MIR7850_5P,0.781223557352198
KEGG_MEDICUS_PATHOGEN_HBV_LH...,SET,11,0.47367,0.011585,0.27423,0.042067,KEGG_MEDICUS_PATHOGEN_HBV_LHBS_TO_PKC_ERK_SIGNALING_PATHWAY,0.781223557352198
GOMF_G_PROTEIN_COUPLED_NEURO...,SET,12,0.43644,0.011148,0.2527,0.042085,GOMF_G_PROTEIN_COUPLED_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.781223557352198
GOCC_CYTOPLASMIC_SIDE_OF_END...1,SET,18,0.29705,0.0092917,0.172,0.04209,GOCC_CYTOPLASMIC_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,0.781223557352198
MODULE_177,SET,95,0.14926,0.010703,0.08647,0.042171,MODULE_177,0.781223557352198
GOMF_TRANSLATION_INITIATION_...2,SET,28,0.25134,0.0098027,0.14563,0.042195,GOMF_TRANSLATION_INITIATION_FACTOR_BINDING,0.781223557352198
GSE17721_0.5H_VS_12H_PAM3CSK...2,SET,182,0.10785,0.010679,0.062506,0.042238,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_UP,0.781223557352198
DESCARTES_MAIN_FETAL_CSH1_CS...,SET,70,0.16057,0.0098908,0.093089,0.042278,DESCARTES_MAIN_FETAL_CSH1_CSH2_POSITIVE_CELLS,0.781223557352198
CACBINDINGPROTEIN_Q6,SET,231,0.095481,0.010637,0.055363,0.042305,CACBINDINGPROTEIN_Q6,0.781223557352198
FAN_EMBRYONIC_CTX_IN_4_INTER...,SET,8,0.56129,0.011708,0.32546,0.042309,FAN_EMBRYONIC_CTX_IN_4_INTERNEURON,0.781223557352198
HP_RIB_SEGMENTATION_ABNORMAL...,SET,11,0.46657,0.011411,0.27055,0.042316,HP_RIB_SEGMENTATION_ABNORMALITIES,0.781223557352198
GOBP_POSITIVE_REGULATION_OF_...99,SET,41,0.24702,0.011654,0.14331,0.042395,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.781223557352198
HP_RECTAL_PROLAPSE,SET,49,0.22307,0.011503,0.12946,0.042446,HP_RECTAL_PROLAPSE,0.781223557352198
HP_SHALLOW_ORBITS,SET,32,0.24831,0.010352,0.14414,0.042482,HP_SHALLOW_ORBITS,0.781223557352198
GSE2706_R848_VS_R848_AND_LPS...1,SET,164,0.11978,0.011264,0.069533,0.042489,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_DN,0.781223557352198
GAVISH_3CA_MALIGNANT_METAPRO...38,SET,46,0.19064,0.0095257,0.11068,0.042498,GAVISH_3CA_MALIGNANT_METAPROGRAM_8_PROTEASOMAL_DEGRADATION,0.781223557352198
DAVICIONI_TARGETS_OF_PAX_FOX...2,SET,233,0.10561,0.011815,0.061318,0.042514,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP,0.781223557352198
WP_GANGLIO_SPHINGOLIPID_META...,SET,13,0.43755,0.011633,0.25408,0.042536,WP_GANGLIO_SPHINGOLIPID_METABOLISM,0.781223557352198
TGACCTTG_SF1_Q6,SET,215,0.10084,0.010843,0.058573,0.042577,TGACCTTG_SF1_Q6,0.781223557352198
ALONSO_METASTASIS_NEURAL_UP,SET,15,0.41184,0.011761,0.23928,0.042622,ALONSO_METASTASIS_NEURAL_UP,0.781223557352198
KEGG_MEDICUS_PATHOGEN_EBV_EB...3,SET,9,0.53542,0.011845,0.3112,0.042678,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00483,0.781223557352198
REACTOME_RESPIRATORY_SYNCYTI...3,SET,16,0.3256,0.0096029,0.18927,0.042692,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_GENOME_REPLICATION_TRANSCRIPTION_AND_TRANSLATION,0.781223557352198
WP_PHOTODYNAMIC_THERAPYINDUC...4,SET,34,0.26537,0.011403,0.15426,0.042702,WP_PHOTODYNAMIC_THERAPYINDUCED_NFKB_SURVIVAL_SIGNALING,0.781223557352198
GSE2405_0H_VS_9H_A_PHAGOCYTO...1,SET,182,0.10274,0.010174,0.059728,0.042707,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.781223557352198
GOMF_CATALYTIC_ACTIVITY_ACTI...2,SET,541,0.058105,0.0098212,0.033779,0.042709,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_NUCLEIC_ACID,0.781223557352198
CUI_DEVELOPING_HEART_C2_CARD...,SET,85,0.16378,0.011113,0.095221,0.042721,CUI_DEVELOPING_HEART_C2_CARDIOMYOCYTE,0.781223557352198
GOBP_ADHESION_OF_SYMBIONT_TO...2,SET,8,0.58529,0.012209,0.34036,0.042756,GOBP_ADHESION_OF_SYMBIONT_TO_HOST_CELL,0.781223557352198
EGR_Q6,SET,250,0.091813,0.010635,0.053395,0.042768,EGR_Q6,0.781223557352198
HOFFMANN_PRE_BI_TO_LARGE_PRE...1,SET,73,0.17618,0.011081,0.10252,0.042868,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN,0.781223557352198
GOBP_IMPORT_ACROSS_PLASMA_ME...,SET,184,0.11244,0.011194,0.065466,0.042948,GOBP_IMPORT_ACROSS_PLASMA_MEMBRANE,0.781223557352198
GOCC_PLATELET_DENSE_TUBULAR_...2,SET,8,0.45979,0.0095906,0.26774,0.042971,GOCC_PLATELET_DENSE_TUBULAR_NETWORK_MEMBRANE,0.781223557352198
SAKAI_CHRONIC_HEPATITIS_VS_L...1,SET,33,0.25826,0.010933,0.15039,0.042974,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_DN,0.781223557352198
REACTOME_SIGNALING_BY_CSF3_G...,SET,27,0.28373,0.010867,0.16523,0.042985,REACTOME_SIGNALING_BY_CSF3_G_CSF,0.781223557352198
BRUNEAU_HEART_GREAT_VESSELS_...,SET,8,0.53034,0.011062,0.30891,0.043017,BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS,0.781223557352198
BIOCARTA_CARDIACEGF_PATHWAY,SET,17,0.37893,0.011519,0.22075,0.043038,BIOCARTA_CARDIACEGF_PATHWAY,0.781223557352198
GSE3720_UNSTIM_VS_PMA_STIM_V...4,SET,148,0.11514,0.01029,0.067083,0.043058,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,0.781223557352198
GSE17974_CTRL_VS_ACT_IL4_AND...10,SET,167,0.11409,0.010826,0.066479,0.043068,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_UP,0.781223557352198
GOCC_NUCLEOLAR_RIBONUCLEASE_...,SET,7,0.52241,0.010193,0.30444,0.043093,GOCC_NUCLEOLAR_RIBONUCLEASE_P_COMPLEX,0.781223557352198
AGTCAGC_MIR345,SET,55,0.17703,0.0096696,0.10317,0.043104,AGTCAGC_MIR345,0.781223557352198
GOBP_POSITIVE_REGULATION_OF_...143,SET,10,0.44928,0.010477,0.26185,0.043112,GOBP_POSITIVE_REGULATION_OF_CELL_SIZE,0.781223557352198
REACTOME_REGULATION_OF_PLK1_...,SET,81,0.14654,0.0097066,0.085434,0.043165,REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION,0.781223557352198
BLUM_RESPONSE_TO_SALIRASIB_UP,SET,221,0.095399,0.010398,0.055622,0.043169,BLUM_RESPONSE_TO_SALIRASIB_UP,0.781223557352198
HP_BRANCHIAL_CYST,SET,4,0.553,0.0081573,0.32245,0.04318,HP_BRANCHIAL_CYST,0.781223557352198
GSE1460_DP_VS_CD4_THYMOCYTE_...1,SET,189,0.11442,0.011543,0.066722,0.043194,GSE1460_DP_VS_CD4_THYMOCYTE_DN,0.781223557352198
HP_ABNORMAL_ORAL_FRENULUM_MO...,SET,58,0.17498,0.0098143,0.10206,0.043231,HP_ABNORMAL_ORAL_FRENULUM_MORPHOLOGY,0.781223557352198
GOCC_ANNULATE_LAMELLAE,SET,5,0.58742,0.0096876,0.34265,0.04324,GOCC_ANNULATE_LAMELLAE,0.781223557352198
GOMF_GUANYLATE_KINASE_ACTIVI...,SET,7,0.56571,0.011038,0.32998,0.043241,GOMF_GUANYLATE_KINASE_ACTIVITY,0.781223557352198
HP_EXERCISE_INDUCED_MUSCLE_S...,SET,7,0.44843,0.0087498,0.26158,0.043248,HP_EXERCISE_INDUCED_MUSCLE_STIFFNESS,0.781223557352198
GOMF_ATP_DEPENDENT_ACTIVITY_...1,SET,109,0.12911,0.009913,0.075314,0.043252,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_DNA,0.781223557352198
GOBP_MECHANOSENSORY_BEHAVIOR,SET,14,0.41493,0.011448,0.24207,0.043261,GOBP_MECHANOSENSORY_BEHAVIOR,0.781223557352198
REACTOME_MIRO_GTPASE_CYCLE,SET,8,0.46085,0.0096128,0.26886,0.043266,REACTOME_MIRO_GTPASE_CYCLE,0.781223557352198
REACTOME_GAP_JUNCTION_ASSEMB...,SET,33,0.27489,0.011638,0.16039,0.043284,REACTOME_GAP_JUNCTION_ASSEMBLY,0.781223557352198
LOPEZ_MESOTELIOMA_SURVIVAL_T...1,SET,7,0.53782,0.010494,0.31387,0.043317,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_DN,0.781223557352198
GSE3982_MAST_CELL_VS_MAC_DN,SET,172,0.11017,0.010608,0.064324,0.04339,GSE3982_MAST_CELL_VS_MAC_DN,0.781223557352198
FLECHNER_PBL_KIDNEY_TRANSPLA...4,SET,57,0.18577,0.01033,0.10849,0.04343,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_UP,0.781223557352198
HP_RENAL_CELL_CARCINOMA,SET,70,0.16976,0.010457,0.099147,0.043433,HP_RENAL_CELL_CARCINOMA,0.781223557352198
MIR6134,SET,122,0.12995,0.010552,0.075895,0.043439,MIR6134,0.781223557352198
GRYDER_PAX3FOXO1_TOP_ENHANCE...,SET,415,0.074484,0.011065,0.043526,0.043525,GRYDER_PAX3FOXO1_TOP_ENHANCERS,0.781223557352198
KEGG_MEDICUS_PATHOGEN_HCMV_U...4,SET,8,0.54802,0.011431,0.32027,0.043538,KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,0.781223557352198
HP_PAPILLARY_THYROID_CARCINO...,SET,24,0.30549,0.011032,0.17856,0.043562,HP_PAPILLARY_THYROID_CARCINOMA,0.781223557352198
GOBP_POSITIVE_REGULATION_OF_...767,SET,6,0.51956,0.009386,0.3037,0.043571,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_GLUCOSE,0.781223557352198
WP_NIPBL_ROLE_IN_DNA_DAMAGE_...,SET,7,0.49767,0.0097106,0.29093,0.043583,WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.781223557352198
DESCARTES_FETAL_STOMACH_GOBL...,SET,16,0.40191,0.011853,0.23499,0.043615,DESCARTES_FETAL_STOMACH_GOBLET_CELLS,0.781223557352198
HP_ABNORMAL_BASOPHIL_MORPHOL...,SET,8,0.55323,0.01154,0.32349,0.043624,HP_ABNORMAL_BASOPHIL_MORPHOLOGY,0.781223557352198
WP_IL3_SIGNALING,SET,46,0.21623,0.010804,0.12644,0.043632,WP_IL3_SIGNALING,0.781223557352198
GOBP_NEGATIVE_REGULATION_OF_...680,SET,10,0.45631,0.010641,0.26688,0.043661,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_17_TYPE_IMMUNE_RESPONSE,0.781223557352198
BIOCARTA_CDMAC_PATHWAY,SET,16,0.39184,0.011556,0.22918,0.043669,BIOCARTA_CDMAC_PATHWAY,0.781223557352198
MIR6090,SET,9,0.50689,0.011214,0.29649,0.043674,MIR6090,0.781223557352198
HP_MITRAL_STENOSIS,SET,21,0.33288,0.011246,0.19475,0.043707,HP_MITRAL_STENOSIS,0.781223557352198
HP_EPISTAXIS,SET,96,0.15806,0.011394,0.092499,0.04375,HP_EPISTAXIS,0.781223557352198
HP_SKIN_ULCER,SET,122,0.1337,0.010857,0.078243,0.043755,HP_SKIN_ULCER,0.781223557352198
CASTELLANO_HRAS_TARGETS_UP,SET,5,0.55117,0.0090898,0.3226,0.043776,CASTELLANO_HRAS_TARGETS_UP,0.781223557352198
SRSF9_TARGET_GENES,SET,613,0.059253,0.010639,0.03468,0.043776,SRSF9_TARGET_GENES,0.781223557352198
GOBP_POSITIVE_REGULATION_OF_...77,SET,9,0.40033,0.0088567,0.23438,0.04382,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.781223557352198
GAUTAM_EYE_IRIS_CILIARY_BODY...5,SET,76,0.16389,0.010517,0.095965,0.043846,GAUTAM_EYE_IRIS_CILIARY_BODY_CRYAA_HIGH_CILIARY_BODY_CELLS,0.781223557352198
GSE8835_HEALTHY_VS_CLL_CD4_T...2,SET,177,0.10876,0.010621,0.063684,0.043849,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_UP,0.781223557352198
ZHONG_PFC_MAJOR_TYPES_EXCITA...,SET,8,0.49286,0.01028,0.28861,0.043858,ZHONG_PFC_MAJOR_TYPES_EXCITATORY_NEURON,0.781223557352198
BIOCARTA_GPCR_PATHWAY,SET,28,0.28063,0.010945,0.16439,0.043904,BIOCARTA_GPCR_PATHWAY,0.781223557352198
HP_IMPAIRED_TEMPERATURE_SENS...,SET,34,0.25954,0.011153,0.15206,0.043933,HP_IMPAIRED_TEMPERATURE_SENSATION,0.781223557352198
GOBP_STEM_CELL_DIVISION,SET,30,0.26741,0.010795,0.15667,0.04394,GOBP_STEM_CELL_DIVISION,0.781223557352198
MIR4303,SET,212,0.10004,0.010682,0.058627,0.043977,MIR4303,0.781223557352198
GOBP_UDP_N_ACETYLGLUCOSAMINE...1,SET,9,0.50752,0.011228,0.29744,0.043985,GOBP_UDP_N_ACETYLGLUCOSAMINE_BIOSYNTHETIC_PROCESS,0.781223557352198
VILIMAS_NOTCH1_TARGETS_UP,SET,50,0.21249,0.011068,0.12455,0.044003,VILIMAS_NOTCH1_TARGETS_UP,0.781223557352198
GOBP_CELL_ACTIVATION_INVOLVE...,SET,280,0.089136,0.010918,0.052256,0.044037,GOBP_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.781223557352198
HP_AGAMMAGLOBULINEMIA,SET,19,0.35369,0.011366,0.20737,0.044052,HP_AGAMMAGLOBULINEMIA,0.781223557352198
MARTORIATI_MDM4_TARGETS_FETA...2,SET,211,0.098537,0.010497,0.057778,0.044065,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP,0.781223557352198
GSE5099_DAY3_VS_DAY7_MCSF_TR...1,SET,144,0.11919,0.010509,0.069888,0.044068,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_DN,0.781223557352198
GOBP_REGULATION_OF_TRANSMEMB...2,SET,420,0.074731,0.011167,0.043822,0.044076,GOBP_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.781223557352198
REACTOME_ONCOGENIC_MAPK_SIGN...,SET,77,0.16342,0.010555,0.09583,0.044078,REACTOME_ONCOGENIC_MAPK_SIGNALING,0.781223557352198
MTHFD1_TARGET_GENES,SET,16,0.33851,0.0099835,0.19851,0.044078,MTHFD1_TARGET_GENES,0.781223557352198
LI_WILMS_TUMOR_VS_FETAL_KIDN...2,SET,170,0.11496,0.011005,0.067421,0.044092,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_UP,0.781223557352198
GESERICK_TERT_TARGETS_DN,SET,21,0.34449,0.011638,0.20204,0.0441,GESERICK_TERT_TARGETS_DN,0.781223557352198
REACTOME_RNA_POLYMERASE_III_...3,SET,26,0.23644,0.0088866,0.13872,0.044155,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_1_PROMOTER,0.781223557352198
GOBP_FOREBRAIN_NEURON_FATE_C...,SET,7,0.65524,0.012785,0.38445,0.044167,GOBP_FOREBRAIN_NEURON_FATE_COMMITMENT,0.781223557352198
REACTOME_PRC2_METHYLATES_HIS...,SET,12,0.4137,0.010567,0.24274,0.044171,REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA,0.781223557352198
HP_TYPE_A_BRACHYDACTYLY,SET,20,0.3319,0.010943,0.19475,0.044182,HP_TYPE_A_BRACHYDACTYLY,0.781223557352198
GOMF_DNA_CLAMP_LOADER_ACTIVI...,SET,9,0.45299,0.010022,0.26583,0.044195,GOMF_DNA_CLAMP_LOADER_ACTIVITY,0.781223557352198
GERHOLD_RESPONSE_TO_TZD_UP,SET,6,0.66256,0.011969,0.38888,0.044221,GERHOLD_RESPONSE_TO_TZD_UP,0.781223557352198
GSE28130_ACTIVATED_VS_INDUCE...2,SET,175,0.11215,0.010891,0.065829,0.044229,GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP,0.781223557352198
GSE13229_IMM_VS_INTMATURE_NK...1,SET,177,0.10355,0.010113,0.060795,0.044269,GSE13229_IMM_VS_INTMATURE_NKCELL_DN,0.781223557352198
BROWNE_INTERFERON_RESPONSIVE...,SET,65,0.1879,0.011155,0.11034,0.044302,BROWNE_INTERFERON_RESPONSIVE_GENES,0.781223557352198
KEGG_MEDICUS_ENV_FACTOR_NICO...2,SET,5,0.78308,0.012914,0.45986,0.044303,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.781223557352198
GOMF_SUPEROXIDE_DISMUTASE_AC...,SET,5,0.6914,0.011402,0.4061,0.044336,GOMF_SUPEROXIDE_DISMUTASE_ACTIVITY,0.781223557352198
HP_NARROW_NARIS,SET,8,0.43887,0.0091543,0.25779,0.044347,HP_NARROW_NARIS,0.781223557352198
REACTOME_CELL_CYCLE_MITOTIC,SET,469,0.063952,0.010085,0.037565,0.044348,REACTOME_CELL_CYCLE_MITOTIC,0.781223557352198
GOBP_CHOLESTEROL_CATABOLIC_P...,SET,9,0.50858,0.011252,0.29878,0.04437,GOBP_CHOLESTEROL_CATABOLIC_PROCESS,0.781223557352198
WP_SELENIUM_MICRONUTRIENT_NE...,SET,70,0.18131,0.011168,0.10652,0.044371,WP_SELENIUM_MICRONUTRIENT_NETWORK,0.781223557352198
WP_NAD_METABOLISM_SIRTUINS_A...,SET,11,0.45738,0.011186,0.26872,0.04438,WP_NAD_METABOLISM_SIRTUINS_AND_AGING,0.781223557352198
GOMF_RIBOSOMAL_SMALL_SUBUNIT...,SET,15,0.34028,0.0097173,0.19993,0.044384,GOMF_RIBOSOMAL_SMALL_SUBUNIT_BINDING,0.781223557352198
MIR330_3P,SET,307,0.087272,0.011185,0.051282,0.044403,MIR330_3P,0.781223557352198
GOBP_REGULATION_OF_NOTCH_SIG...,SET,86,0.15515,0.010588,0.091174,0.044419,GOBP_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.781223557352198
HP_NEOPLASM_OF_HEAD_AND_NECK,SET,35,0.2504,0.010917,0.14716,0.044433,HP_NEOPLASM_OF_HEAD_AND_NECK,0.781223557352198
DEURIG_T_CELL_PROLYMPHOCYTIC...1,SET,282,0.085302,0.010485,0.05014,0.044453,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN,0.781223557352198
GSE4590_SMALL_VS_VPREB_POS_L...2,SET,150,0.11591,0.010429,0.068145,0.044484,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.781223557352198
DURANTE_ADULT_OLFACTORY_NEUR...2,SET,29,0.2777,0.011022,0.16326,0.044484,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_B_CELLS,0.781223557352198
GSE43863_NAIVE_VS_TFH_CD4_EF...2,SET,173,0.10647,0.010281,0.062612,0.044533,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_UP,0.78150552193646
JOHNSTONE_PARVB_TARGETS_2_UP,SET,126,0.12908,0.010651,0.075923,0.044565,JOHNSTONE_PARVB_TARGETS_2_UP,0.78150552193646
GOMF_UREA_TRANSMEMBRANE_TRAN...,SET,7,0.6531,0.012743,0.3842,0.044586,GOMF_UREA_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.78150552193646
HP_FINGERNAIL_DYSPLASIA,SET,16,0.33567,0.0098996,0.19747,0.04459,HP_FINGERNAIL_DYSPLASIA,0.78150552193646
GOBP_POSITIVE_REGULATION_OF_...168,SET,27,0.27728,0.01062,0.16316,0.044624,GOBP_POSITIVE_REGULATION_OF_CILIUM_ASSEMBLY,0.781707217741936
MIR6796_5P,SET,67,0.17213,0.010374,0.1013,0.04466,MIR6796_5P,0.781943727959698
HP_HYPERREFLEXIA_IN_UPPER_LI...,SET,25,0.28644,0.010557,0.16861,0.044683,HP_HYPERREFLEXIA_IN_UPPER_LIMBS,0.7819525
GOBP_REGULATION_OF_ISOMERASE...,SET,7,0.60616,0.011828,0.35695,0.044747,GOBP_REGULATION_OF_ISOMERASE_ACTIVITY,0.782431291937907
ZHU_CMV_8_HR_UP,SET,39,0.24028,0.011057,0.14152,0.044778,ZHU_CMV_8_HR_UP,0.782431291937907
KEGG_GLYCOSAMINOGLYCAN_BIOSY...3,SET,15,0.40836,0.011661,0.24058,0.04482,KEGG_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_KERATAN_SULFATE,0.782431291937907
GOBP_ISOLEUCINE_TRANSPORT,SET,5,0.64258,0.010597,0.37857,0.044821,GOBP_ISOLEUCINE_TRANSPORT,0.782431291937907
GOBP_ALKANESULFONATE_TRANSME...,SET,8,0.58218,0.012144,0.34302,0.044834,GOBP_ALKANESULFONATE_TRANSMEMBRANE_TRANSPORT,0.782431291937907
GSE22886_NAIVE_BCELL_VS_BLOO...2,SET,174,0.10731,0.010391,0.063237,0.04487,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_UP,0.782431291937907
REACTOME_SIGNALING_BY_INTERL...,SET,430,0.070275,0.010623,0.04142,0.044891,REACTOME_SIGNALING_BY_INTERLEUKINS,0.782431291937907
MITSIADES_RESPONSE_TO_APLIDI...2,SET,386,0.072944,0.01046,0.042999,0.044911,MITSIADES_RESPONSE_TO_APLIDIN_UP,0.782431291937907
BIOCARTA_NDKDYNAMIN_PATHWAY,SET,17,0.3475,0.010564,0.20486,0.044924,BIOCARTA_NDKDYNAMIN_PATHWAY,0.782431291937907
GINESTIER_BREAST_CANCER_20Q1...1,SET,158,0.10374,0.0095771,0.061163,0.044942,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN,0.782431291937907
REACTOME_SYNTHESIS_OF_PROSTA...,SET,14,0.36195,0.0099859,0.21342,0.044958,REACTOME_SYNTHESIS_OF_PROSTAGLANDINS_PG_AND_THROMBOXANES_TX,0.782431291937907
GOMF_CATALYTIC_ACTIVITY_ACTI...4,SET,109,0.12465,0.0095706,0.073535,0.045041,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_TRNA,0.782897586462451
GOBP_PROTEIN_TARGETING_TO_MI...,SET,97,0.14044,0.010175,0.082875,0.045089,GOBP_PROTEIN_TARGETING_TO_MITOCHONDRION,0.782897586462451
HAHTOLA_MYCOSIS_FUNGOIDES_CD...2,SET,57,0.20659,0.011487,0.12194,0.04512,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP,0.782897586462451
GOBP_REGULATION_OF_SYNAPTIC_...7,SET,6,0.66881,0.012082,0.39479,0.045134,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CLUSTERING,0.782897586462451
GOBP_REGULATION_OF_RNA_SPLIC...,SET,161,0.10406,0.0096972,0.061441,0.045166,GOBP_REGULATION_OF_RNA_SPLICING,0.782897586462451
MIR646,SET,225,0.093895,0.010325,0.055443,0.045185,MIR646,0.782897586462451
REACTOME_SUPPRESSION_OF_PHAG...,SET,12,0.37899,0.009681,0.2238,0.045193,REACTOME_SUPPRESSION_OF_PHAGOSOMAL_MATURATION,0.782897586462451
GOBP_REGULATION_OF_CELL_DEVE...,SET,765,0.054846,0.010954,0.032389,0.045203,GOBP_REGULATION_OF_CELL_DEVELOPMENT,0.782897586462451
GOBP_MEMBRANE_PROTEIN_INTRAC...,SET,12,0.36982,0.0094467,0.21855,0.04532,GOBP_MEMBRANE_PROTEIN_INTRACELLULAR_DOMAIN_PROTEOLYSIS,0.782897586462451
MIR1324,SET,107,0.13875,0.010556,0.082004,0.04533,MIR1324,0.782897586462451
GOBP_FORMATION_OF_TRANSLATIO...,SET,5,0.50654,0.0083537,0.2994,0.045346,GOBP_FORMATION_OF_TRANSLATION_PREINITIATION_COMPLEX,0.782897586462451
GSE11864_UNTREATED_VS_CSF1_P...2,SET,164,0.107,0.010063,0.063253,0.045363,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_UP,0.782897586462451
HEDENFALK_BREAST_CANCER_BRAC...1,SET,18,0.31194,0.0097574,0.18443,0.045393,HEDENFALK_BREAST_CANCER_BRACX_DN,0.782897586462451
ARID3B_TARGET_GENES,SET,114,0.13561,0.010648,0.080181,0.045394,ARID3B_TARGET_GENES,0.782897586462451
SENESE_HDAC2_TARGETS_DN,SET,111,0.14617,0.011325,0.086424,0.045398,SENESE_HDAC2_TARGETS_DN,0.782897586462451
KEGG_MEDICUS_REFERENCE_P16_C...,SET,10,0.5037,0.011746,0.29783,0.045407,KEGG_MEDICUS_REFERENCE_P16_CELL_CYCLE_G1_S,0.782897586462451
GOBP_HOMOLOGOUS_RECOMBINATION,SET,58,0.17346,0.009729,0.10258,0.045432,GOBP_HOMOLOGOUS_RECOMBINATION,0.782897586462451
GSE46606_DAY1_VS_DAY3_CD40L_...4,SET,186,0.099412,0.0099501,0.058795,0.045444,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_UP,0.782897586462451
RIZ_ERYTHROID_DIFFERENTIATIO...6,SET,25,0.31869,0.011746,0.18851,0.04547,RIZ_ERYTHROID_DIFFERENTIATION_HEMGN,0.782897586462451
WP_FBXL10_ENHANCEMENT_OF_MAP...,SET,10,0.4203,0.0098013,0.24868,0.04551,WP_FBXL10_ENHANCEMENT_OF_MAPERK_SIGNALING_IN_DIFFUSE_LARGE_BCELL_LYMPHOMA,0.782897586462451
DR3_Q4,SET,133,0.12622,0.010698,0.074684,0.045523,DR3_Q4,0.782897586462451
GOBP_NERVE_GROWTH_FACTOR_SIG...,SET,14,0.42153,0.01163,0.24943,0.045524,GOBP_NERVE_GROWTH_FACTOR_SIGNALING_PATHWAY,0.782897586462451
BIOCARTA_TRKA_PATHWAY,SET,14,0.35023,0.0096625,0.20726,0.045539,BIOCARTA_TRKA_PATHWAY,0.782897586462451
REACTOME_TRAF6_MEDIATED_IRF7...2,SET,10,0.44958,0.010484,0.26606,0.045543,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION_IN_TLR7_8_OR_9_SIGNALING,0.782897586462451
REACTOME_RHO_GTPASE_EFFECTORS,SET,244,0.089778,0.010276,0.053132,0.04555,REACTOME_RHO_GTPASE_EFFECTORS,0.782897586462451
GOBP_POSITIVE_REGULATION_OF_...32,SET,8,0.48872,0.010194,0.2893,0.045586,GOBP_POSITIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,0.782897586462451
GOBP_REGULATION_OF_DEVELOPME...2,SET,13,0.41555,0.011048,0.24599,0.045593,GOBP_REGULATION_OF_DEVELOPMENT_HETEROCHRONIC,0.782897586462451
WP_FARNESOID_X_RECEPTOR_PATH...,SET,19,0.34375,0.011047,0.20356,0.045651,WP_FARNESOID_X_RECEPTOR_PATHWAY,0.783237310344827
REACTOME_INTERLEUKIN_23_SIGN...,SET,9,0.4875,0.010785,0.28874,0.045679,REACTOME_INTERLEUKIN_23_SIGNALING,0.783237310344827
HP_CUTIS_LAXA,SET,110,0.13429,0.010358,0.079547,0.045692,HP_CUTIS_LAXA,0.783237310344827
GSE17301_IFNA2_VS_IFNA5_STIM...1,SET,174,0.10847,0.010504,0.064257,0.045711,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN,0.783237310344827
GOMF_MONOATOMIC_ANION_SODIUM...,SET,17,0.39115,0.011891,0.23174,0.045731,GOMF_MONOATOMIC_ANION_SODIUM_SYMPORTER_ACTIVITY,0.783237310344827
GOBP_MAINTENANCE_OF_ORGANELL...,SET,11,0.37168,0.0090902,0.22024,0.045748,GOBP_MAINTENANCE_OF_ORGANELLE_LOCATION,0.783237310344827
HP_EEG_WITH_FOCAL_SPIKE_WAVES,SET,13,0.41645,0.011072,0.24682,0.045786,HP_EEG_WITH_FOCAL_SPIKE_WAVES,0.783501935007386
MEDINA_SMARCA4_TARGETS,SET,35,0.24738,0.010785,0.14666,0.045827,MEDINA_SMARCA4_TARGETS,0.783516036855037
HP_POSTNATAL_MACROCEPHALY,SET,5,0.50987,0.0084086,0.30228,0.045838,HP_POSTNATAL_MACROCEPHALY,0.783516036855037
GOBP_HEPARAN_SULFATE_PROTEOG...2,SET,11,0.48529,0.011869,0.28776,0.045864,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS_ENZYMATIC_MODIFICATION,0.783516036855037
GOCC_TOM_COMPLEX,SET,6,0.56844,0.010269,0.33709,0.045877,GOCC_TOM_COMPLEX,0.783516036855037
GOBP_T_CELL_RECEPTOR_SIGNALI...,SET,127,0.12901,0.010687,0.076528,0.045926,GOBP_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.783635219941349
GSE8921_UNSTIM_0H_VS_TLR1_2_...7,SET,172,0.10761,0.010361,0.063837,0.045936,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_DN,0.783635219941349
WP_LDL_INFLUENCE_ON_CD14_AND...,SET,23,0.30832,0.0109,0.18295,0.045974,WP_LDL_INFLUENCE_ON_CD14_AND_TLR4,0.783635219941349
GOBP_HIGH_DENSITY_LIPOPROTEI...1,SET,12,0.355,0.009068,0.21068,0.045999,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,0.783635219941349
REACTOME_VEGFR2_MEDIATED_CEL...,SET,19,0.31512,0.010127,0.18704,0.046027,REACTOME_VEGFR2_MEDIATED_CELL_PROLIFERATION,0.783635219941349
KEGG_MEDICUS_VARIANT_MUTATIO...34,SET,11,0.46891,0.011468,0.27834,0.046035,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004,0.783635219941349
GSE15930_NAIVE_VS_48H_IN_VIT...3,SET,182,0.099676,0.0098697,0.059186,0.046088,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.783635219941349
WEBER_METHYLATED_ICP_IN_SPER...1,SET,8,0.53054,0.011066,0.31506,0.046109,WEBER_METHYLATED_ICP_IN_SPERM_DN,0.783635219941349
GSE13547_WT_VS_ZFX_KO_BCELL_...3,SET,148,0.11326,0.010122,0.067265,0.046124,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_DN,0.783635219941349
GOBP_POSITIVE_REGULATION_OF_...724,SET,43,0.21539,0.010406,0.12793,0.046127,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.783635219941349
MIR4653_5P,SET,137,0.12365,0.010636,0.073442,0.046132,MIR4653_5P,0.783635219941349
MCBRYAN_PUBERTAL_BREAST_4_5W...1,SET,171,0.11235,0.010786,0.066747,0.046174,MCBRYAN_PUBERTAL_BREAST_4_5WK_DN,0.783965495847582
GSE37534_UNTREATED_VS_GW1929...1,SET,186,0.10098,0.010107,0.060008,0.04621,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.783976643935704
GOCC_AZUROPHIL_GRANULE_LUMEN,SET,81,0.16071,0.010645,0.095524,0.046257,GOCC_AZUROPHIL_GRANULE_LUMEN,0.783976643935704
GOBP_MYELOID_CELL_DIFFERENTI...,SET,393,0.074676,0.010802,0.044391,0.046271,GOBP_MYELOID_CELL_DIFFERENTIATION,0.783976643935704
GOBP_EPOXIDE_METABOLIC_PROCE...,SET,5,0.69948,0.011536,0.41585,0.046289,GOBP_EPOXIDE_METABOLIC_PROCESS,0.783976643935704
GOMF_CO_SMAD_BINDING,SET,9,0.52932,0.01171,0.31471,0.046298,GOMF_CO_SMAD_BINDING,0.783976643935704
GOCC_CHROMAFFIN_GRANULE_MEMB...,SET,9,0.51801,0.01146,0.308,0.04631,GOCC_CHROMAFFIN_GRANULE_MEMBRANE,0.783976643935704
MIR6799_3P,SET,106,0.14944,0.011316,0.088889,0.046374,MIR6799_3P,0.78467788218111
GOBP_GAMMA_AMINOBUTYRIC_ACID...3,SET,8,0.54961,0.011464,0.32704,0.046431,GOBP_GAMMA_AMINOBUTYRIC_ACID_METABOLIC_PROCESS,0.784906114864865
GOBP_NEGATIVE_REGULATION_OF_...438,SET,12,0.44504,0.011368,0.26486,0.04646,GOBP_NEGATIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,0.784906114864865
XPO1_TARGET_GENES,SET,19,0.35131,0.01129,0.20912,0.046488,XPO1_TARGET_GENES,0.784906114864865
GSE1460_INTRATHYMIC_T_PROGEN...1,SET,186,0.11004,0.011014,0.065506,0.046504,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_DN,0.784906114864865
NIKOLSKY_BREAST_CANCER_19P13...,SET,5,0.97999,0.016162,0.58354,0.046547,NIKOLSKY_BREAST_CANCER_19P13_AMPLICON,0.784906114864865
GOBP_MEIOTIC_CHROMOSOME_SEPA...,SET,9,0.40684,0.0090008,0.24232,0.046591,GOBP_MEIOTIC_CHROMOSOME_SEPARATION,0.784906114864865
REACTOME_ACTIVATION_OF_THE_M...,SET,52,0.18536,0.0098456,0.11043,0.046632,REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S,0.784906114864865
GSE15624_3H_VS_6H_HALOFUGINO...2,SET,159,0.11091,0.010271,0.066085,0.046653,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.784906114864865
GOMF_HISTONE_H3K4_MONOMETHYL...,SET,8,0.49212,0.010265,0.29324,0.04666,GOMF_HISTONE_H3K4_MONOMETHYLTRANSFERASE_ACTIVITY,0.784906114864865
GOBP_PROTEOGLYCAN_BIOSYNTHET...,SET,63,0.1827,0.010678,0.10887,0.04667,GOBP_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.784906114864865
KEGG_MEDICUS_REFERENCE_EGF_E...12,SET,15,0.3576,0.010212,0.21315,0.046714,KEGG_MEDICUS_REFERENCE_EGF_ERBB2_RAS_ERK_SIGNALING_PATHWAY,0.784906114864865
GOBP_NEGATIVE_REGULATION_OF_...55,SET,29,0.28632,0.011365,0.17067,0.046721,GOBP_NEGATIVE_REGULATION_OF_B_CELL_ACTIVATION,0.784906114864865
GOBP_TOLL_LIKE_RECEPTOR_SIGN...,SET,68,0.16748,0.010168,0.09984,0.046736,GOBP_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.784906114864865
WANG_RESPONSE_TO_ANDROGEN_UP,SET,28,0.26063,0.010165,0.15541,0.046777,WANG_RESPONSE_TO_ANDROGEN_UP,0.784906114864865
GOBP_MEMBRANE_TO_MEMBRANE_DO...,SET,4,0.7742,0.01142,0.46165,0.04678,GOBP_MEMBRANE_TO_MEMBRANE_DOCKING,0.784906114864865
IZADPANAH_STEM_CELL_ADIPOSE_...2,SET,118,0.13418,0.010717,0.080019,0.04679,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP,0.784906114864865
REACTOME_NONHOMOLOGOUS_END_J...,SET,29,0.23566,0.0093535,0.14053,0.046792,REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ,0.784906114864865
HP_TRIANGULAR_SHAPED_PHALANG...,SET,7,0.60804,0.011864,0.36261,0.046794,HP_TRIANGULAR_SHAPED_PHALANGES_OF_THE_HAND,0.784906114864865
GOBP_INTERLEUKIN_10_MEDIATED...,SET,11,0.55158,0.01349,0.32904,0.046843,GOBP_INTERLEUKIN_10_MEDIATED_SIGNALING_PATHWAY,0.784914412897016
GOBP_LIPOPROTEIN_METABOLIC_P...,SET,127,0.124,0.010272,0.073983,0.046868,GOBP_LIPOPROTEIN_METABOLIC_PROCESS,0.784914412897016
E2F1_Q4,SET,222,0.095243,0.010404,0.056832,0.04689,E2F1_Q4,0.784914412897016
SREBP1_Q6,SET,234,0.091884,0.010302,0.054832,0.046903,SREBP1_Q6,0.784914412897016
HP_SHOULDER_GIRDLE_MUSCLE_WE...,SET,50,0.18815,0.0098005,0.11229,0.046923,HP_SHOULDER_GIRDLE_MUSCLE_WEAKNESS,0.784914412897016
GOBP_PHOTORECEPTOR_CELL_MORP...,SET,4,0.71436,0.010538,0.42637,0.04693,GOBP_PHOTORECEPTOR_CELL_MORPHOGENESIS,0.784914412897016
GOBP_LACTONE_METABOLIC_PROCE...,SET,12,0.44029,0.011247,0.26285,0.046971,GOBP_LACTONE_METABOLIC_PROCESS,0.785222272727273
GSE2585_THYMIC_DC_VS_THYMIC_...1,SET,177,0.10408,0.010164,0.062144,0.047,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_DN,0.785329326923077
GOMF_SODIUM_CHANNEL_ACTIVITY,SET,47,0.22215,0.01122,0.13268,0.047041,GOMF_SODIUM_CHANNEL_ACTIVITY,0.785636691494474
HP_PETECHIAE,SET,55,0.19812,0.010822,0.11835,0.047076,HP_PETECHIAE,0.785843602305475
GSE8678_IL7R_LOW_VS_HIGH_EFF...1,SET,173,0.10582,0.010218,0.063258,0.047196,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_DN,0.786803954044998
GOBP_REGULATION_OF_CALCIUM_I...4,SET,40,0.21936,0.010222,0.13116,0.047226,GOBP_REGULATION_OF_CALCIUM_ION_IMPORT,0.786803954044998
GSE23695_CD57_POS_VS_NEG_NK_...2,SET,185,0.099045,0.0098869,0.059223,0.04723,GSE23695_CD57_POS_VS_NEG_NK_CELL_UP,0.786803954044998
FAN_EMBRYONIC_CTX_IN_3_INTER...,SET,5,0.66149,0.010909,0.39558,0.047251,FAN_EMBRYONIC_CTX_IN_3_INTERNEURON,0.786803954044998
HP_MENOMETRORRHAGIA,SET,5,0.78009,0.012865,0.46651,0.047252,HP_MENOMETRORRHAGIA,0.786803954044998
GOBP_REGULATION_OF_RECEPTOR_...2,SET,11,0.41739,0.010208,0.24964,0.047276,GOBP_REGULATION_OF_RECEPTOR_CATABOLIC_PROCESS,0.786803954044998
GOBP_PURINE_DEOXYRIBONUCLEOS...4,SET,7,0.50082,0.009772,0.29957,0.047292,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,0.786803954044998
GOMF_PROTEIN_ANTIGEN_BINDING,SET,7,0.56637,0.011051,0.33887,0.047335,GOMF_PROTEIN_ANTIGEN_BINDING,0.78714254784689
HP_FIBER_TYPE_GROUPING,SET,10,0.37343,0.0087083,0.22347,0.047364,HP_FIBER_TYPE_GROUPING,0.787248120516499
HP_MUSCLE_WEAKNESS,SET,912,0.046438,0.010085,0.027794,0.047387,HP_MUSCLE_WEAKNESS,0.787253912523901
HP_CONE_SHAPED_METACARPAL_EP...,SET,4,0.66446,0.0098015,0.39778,0.047426,HP_CONE_SHAPED_METACARPAL_EPIPHYSES,0.787525384615385
GSE17974_IL4_AND_ANTI_IL12_V...10,SET,155,0.11433,0.010455,0.068462,0.047475,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_UP,0.787802119331742
DESCARTES_MAIN_FETAL_AFP_ALB...,SET,77,0.16307,0.010533,0.097657,0.047488,DESCARTES_MAIN_FETAL_AFP_ALB_POSITIVE_CELLS,0.787802119331742
GARCIA_PINERES_PBMC_HPV_16_L...5,SET,12,0.41217,0.010528,0.24692,0.047545,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_NEGATIVE,0.787918048141087
GOBP_MIDGUT_DEVELOPMENT,SET,11,0.50282,0.012297,0.30125,0.047557,GOBP_MIDGUT_DEVELOPMENT,0.787918048141087
HP_BULIMIA,SET,5,0.78392,0.012928,0.46968,0.047563,HP_BULIMIA,0.787918048141087
GSE6269_STAPH_AUREUS_VS_STRE...2,SET,146,0.11472,0.010184,0.068751,0.047609,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_UP,0.788278106796117
MIR4489,SET,49,0.19914,0.010269,0.11941,0.047694,MIR4489,0.788278106796117
HP_VENTILATOR_DEPENDENCE_WIT...,SET,4,0.69262,0.010217,0.41538,0.047723,HP_VENTILATOR_DEPENDENCE_WITH_INABILITY_TO_WEAN,0.788278106796117
HP_ABNORMALITY_OF_THE_MUSCUL...2,SET,564,0.058867,0.010153,0.035325,0.04782,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LIMBS,0.788278106796117
CHEOK_RESPONSE_TO_MERCAPTOPU...5,SET,19,0.32934,0.010584,0.19766,0.047843,CHEOK_RESPONSE_TO_MERCAPTOPURINE_DN,0.788278106796117
GOBP_NEGATIVE_REGULATION_OF_...389,SET,2,1.1897,0.01241,0.71403,0.04785,GOBP_NEGATIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.788278106796117
FULLER_PBMC_F_TULARENSIS_VAC...1,SET,19,0.34229,0.011,0.20547,0.047874,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_DN,0.788278106796117
MARTINEZ_RB1_TARGETS_DN,SET,497,0.064254,0.010422,0.038582,0.047926,MARTINEZ_RB1_TARGETS_DN,0.788278106796117
HP_INTERMITTENT_CLAUDICATION,SET,8,0.47575,0.0099236,0.28574,0.047967,HP_INTERMITTENT_CLAUDICATION,0.788278106796117
HP_HYPOPLASTIC_SPLEEN,SET,8,0.51213,0.010682,0.30759,0.047969,HP_HYPOPLASTIC_SPLEEN,0.788278106796117
GOBP_REGULATION_OF_T_HELPER_...2,SET,10,0.47309,0.011032,0.28415,0.047971,GOBP_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.788278106796117
GSE2770_UNTREATED_VS_TGFB_AN...10,SET,131,0.12576,0.010579,0.075547,0.048002,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.788278106796117
GSE20198_IL12_VS_IFNA_TREATE...2,SET,181,0.10249,0.010121,0.061576,0.048021,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.788278106796117
HP_BRUXISM,SET,29,0.25855,0.010262,0.15536,0.048044,HP_BRUXISM,0.788278106796117
GSE27786_NKCELL_VS_ERYTHROBL...2,SET,181,0.10155,0.010028,0.061024,0.04805,GSE27786_NKCELL_VS_ERYTHROBLAST_UP,0.788278106796117
REACTOME_DEFECTIVE_GALNT3_CA...,SET,14,0.39941,0.011019,0.24004,0.04807,REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC,0.788278106796117
GSE36078_WT_VS_IL1R_KO_LUNG_...6,SET,183,0.10504,0.010429,0.063145,0.048116,GSE36078_WT_VS_IL1R_KO_LUNG_DC_UP,0.788278106796117
HP_ABDOMINAL_PAIN,SET,308,0.08265,0.010609,0.049714,0.048214,HP_ABDOMINAL_PAIN,0.788278106796117
GSE17721_LPS_VS_PAM3CSK4_12H...2,SET,188,0.10166,0.010229,0.061159,0.048248,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_UP,0.788278106796117
REACTOME_BH3_ONLY_PROTEINS_A...,SET,9,0.54569,0.012073,0.32844,0.048317,REACTOME_BH3_ONLY_PROTEINS_ASSOCIATE_WITH_AND_INACTIVATE_ANTI_APOPTOTIC_BCL_2_MEMBERS,0.788278106796117
GOBP_REGULATION_OF_T_HELPER_...7,SET,42,0.22567,0.010776,0.13583,0.048325,GOBP_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.788278106796117
chr15q24,SET,57,0.38219,0.021251,0.23007,0.048349,chr15q24,0.788278106796117
KEGG_THYROID_CANCER,SET,29,0.25121,0.0099709,0.15127,0.048393,KEGG_THYROID_CANCER,0.788278106796117
JIANG_MELANOMA_TRM1_CD8,SET,152,0.1201,0.010877,0.072333,0.048425,JIANG_MELANOMA_TRM1_CD8,0.788278106796117
GSE39820_CTRL_VS_TGFBETA1_IL...4,SET,172,0.10543,0.010151,0.063496,0.048427,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP,0.788278106796117
GOMF_PROTEIN_ARGININE_N_METH...,SET,12,0.38187,0.0097546,0.23005,0.048468,GOMF_PROTEIN_ARGININE_N_METHYLTRANSFERASE_ACTIVITY,0.788278106796117
WANG_METASTASIS_OF_BREAST_CA...3,SET,19,0.28452,0.0091434,0.17141,0.048475,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_UP,0.788278106796117
REACTOME_GDP_FUCOSE_BIOSYNTH...,SET,4,0.5885,0.008681,0.35456,0.048484,REACTOME_GDP_FUCOSE_BIOSYNTHESIS,0.788278106796117
HP_PROLONGED_BLEEDING_AFTER_...2,SET,16,0.39438,0.011631,0.23767,0.048529,HP_PROLONGED_BLEEDING_AFTER_SURGERY,0.788278106796117
REACTOME_IRE1ALPHA_ACTIVATES...,SET,47,0.18708,0.0094486,0.11278,0.048583,REACTOME_IRE1ALPHA_ACTIVATES_CHAPERONES,0.788278106796117
KEGG_MEDICUS_VARIANT_MUTATIO...87,SET,5,0.69206,0.011413,0.4172,0.048587,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RUNX1_TO_TRANSCRIPTION,0.788278106796117
GOBP_REGULATION_OF_MATRIX_ME...,SET,5,0.73983,0.012201,0.446,0.048587,GOBP_REGULATION_OF_MATRIX_METALLOPEPTIDASE_SECRETION,0.788278106796117
MIR661,SET,146,0.11722,0.010406,0.070668,0.048595,MIR661,0.788278106796117
HP_CHOLESTEATOMA,SET,10,0.44497,0.010377,0.26828,0.048604,HP_CHOLESTEATOMA,0.788278106796117
HP_STROKE,SET,148,0.11489,0.010268,0.06927,0.048616,HP_STROKE,0.788278106796117
GOBP_UREA_TRANSPORT,SET,10,0.54823,0.012784,0.33057,0.048622,GOBP_UREA_TRANSPORT,0.788278106796117
ACEVEDO_LIVER_CANCER_WITH_H3...4,SET,111,0.14649,0.01135,0.088335,0.048632,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_UP,0.788278106796117
REACTOME_PASSIVE_TRANSPORT_B...,SET,12,0.49572,0.012663,0.29892,0.048634,REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS,0.788278106796117
HP_APLASIA_HYPOPLASIA_OF_THE...47,SET,4,0.79829,0.011776,0.4814,0.048641,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_SEPTUM,0.788278106796117
GOMF_NUCLEOCYTOPLASMIC_CARRI...,SET,30,0.2294,0.0092606,0.13834,0.048642,GOMF_NUCLEOCYTOPLASMIC_CARRIER_ACTIVITY,0.788278106796117
FIGUEROA_AML_METHYLATION_CLU...11,SET,29,0.2616,0.010383,0.15777,0.048658,FIGUEROA_AML_METHYLATION_CLUSTER_6_DN,0.788278106796117
HP_PROXIMAL_MUSCLE_WEAKNESS,SET,219,0.093763,0.010174,0.056551,0.048667,HP_PROXIMAL_MUSCLE_WEAKNESS,0.788278106796117
LAKE_ADULT_KIDNEY_C16_COLLEC...,SET,124,0.13911,0.011388,0.083905,0.048675,LAKE_ADULT_KIDNEY_C16_COLLECTING_SYSTEM_PRINCIPAL_CELLS_CORTEX,0.788278106796117
KEGG_MEDICUS_REFERENCE_NON_C...,SET,6,0.65855,0.011897,0.39724,0.048686,KEGG_MEDICUS_REFERENCE_NON_CANONICAL_INFLAMMASOME_SIGNALING_PATHWAY,0.788278106796117
MIR6892_5P,SET,84,0.15141,0.010213,0.091336,0.048695,MIR6892_5P,0.788278106796117
GOMF_RACEMASE_AND_EPIMERASE_...1,SET,15,0.32482,0.0092759,0.19596,0.04871,GOMF_RACEMASE_AND_EPIMERASE_ACTIVITY,0.788278106796117
HOWLIN_CITED1_TARGETS_2_UP,SET,16,0.33218,0.0097967,0.2004,0.048711,HOWLIN_CITED1_TARGETS_2_UP,0.788278106796117
BOGNI_TREATMENT_RELATED_MYEL...1,SET,31,0.24132,0.0099026,0.1456,0.048721,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN,0.788278106796117
HP_IMPAIRED_NEUTROPHIL_BACTE...,SET,8,0.49089,0.010239,0.29622,0.04875,HP_IMPAIRED_NEUTROPHIL_BACTERICIDAL_ACTIVITY,0.788278106796117
MIR4450,SET,67,0.16152,0.0097347,0.097469,0.048751,MIR4450,0.788278106796117
WP_BENZENE_METABOLISM,SET,5,0.62053,0.010234,0.37454,0.048791,WP_BENZENE_METABOLISM,0.788278106796117
GAVISH_3CA_METAPROGRAM_ENDOT...12,SET,47,0.21477,0.010847,0.12965,0.048812,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_INTERFERON,0.788278106796117
KRIGE_RESPONSE_TO_TOSEDOSTAT...4,SET,795,0.049615,0.010093,0.029952,0.048818,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP,0.788278106796117
GSE26928_NAIVE_VS_EFF_MEMORY...1,SET,169,0.10246,0.00978,0.061865,0.04885,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,0.788278106796117
MIR3652,SET,135,0.11687,0.0099799,0.07058,0.048879,MIR3652,0.788278106796117
WP_DOPAMINERGIC_NEUROGENESIS,SET,28,0.29908,0.011665,0.18066,0.04892,WP_DOPAMINERGIC_NEUROGENESIS,0.788278106796117
GOBP_KERATINOCYTE_MIGRATION,SET,20,0.34391,0.011339,0.20776,0.048933,GOBP_KERATINOCYTE_MIGRATION,0.788278106796117
GAVISH_3CA_MALIGNANT_METAPRO...7,SET,45,0.22894,0.011315,0.13833,0.048967,GAVISH_3CA_MALIGNANT_METAPROGRAM_16_MES_GLIOMA,0.788278106796117
GOBP_L_ALANINE_TRANSMEMBRANE...,SET,4,0.72227,0.010654,0.43641,0.048967,GOBP_L_ALANINE_TRANSMEMBRANE_TRANSPORT,0.788278106796117
GRAHAM_CML_QUIESCENT_VS_NORM...3,SET,37,0.24888,0.011156,0.1504,0.04899,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN,0.788278106796117
HP_CENTRALLY_NUCLEATED_SKELE...,SET,47,0.19681,0.0099396,0.11894,0.049001,HP_CENTRALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,0.788278106796117
HP_APLASIA_HYPOPLASIA_OF_THE...7,SET,58,0.18455,0.010351,0.11155,0.049029,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_FINGER,0.788278106796117
REACTOME_CLEC7A_DECTIN_1_SIG...,SET,94,0.13321,0.0095025,0.080524,0.049038,REACTOME_CLEC7A_DECTIN_1_SIGNALING,0.788278106796117
GAVISH_3CA_METAPROGRAM_ENDOT...15,SET,49,0.20722,0.010685,0.12526,0.04904,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS,0.788278106796117
HP_GLOMERULAR_SCLEROSIS,SET,78,0.15199,0.0098802,0.091882,0.049059,HP_GLOMERULAR_SCLEROSIS,0.788278106796117
GNF2_MYD88,SET,54,0.18833,0.010193,0.11389,0.049107,GNF2_MYD88,0.788506064516129
GOBP_REGULATION_OF_PROTEIN_L...1,SET,10,0.45735,0.010665,0.27659,0.049124,GOBP_REGULATION_OF_PROTEIN_LIPIDATION,0.788506064516129
HASINA_NOL7_TARGETS_DN,SET,13,0.42378,0.011267,0.25637,0.049178,HASINA_NOL7_TARGETS_DN,0.788506064516129
MIR3908,SET,106,0.14451,0.010943,0.087436,0.049198,MIR3908,0.788506064516129
HP_RECURRENT_URINARY_TRACT_I...,SET,144,0.11714,0.010328,0.070882,0.049214,HP_RECURRENT_URINARY_TRACT_INFECTIONS,0.788506064516129
GAUTAM_EYE_CHOROID_SCLERA_MO...,SET,120,0.12573,0.010126,0.076079,0.049219,GAUTAM_EYE_CHOROID_SCLERA_MONOCYTES,0.788506064516129
GSE2706_R848_VS_R848_AND_LPS...4,SET,156,0.11533,0.01058,0.069795,0.049232,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_UP,0.788506064516129
MODULE_404,SET,25,0.30586,0.011273,0.18519,0.049314,MODULE_404,0.788808948458353
ABE_VEGFA_TARGETS_30MIN,SET,26,0.28199,0.010599,0.17074,0.049317,ABE_VEGFA_TARGETS_30MIN,0.788808948458353
GOBP_NEGATIVE_REGULATION_OF_...113,SET,581,0.061412,0.010745,0.037184,0.049319,GOBP_NEGATIVE_REGULATION_OF_CELL_DIFFERENTIATION,0.788808948458353
GOBP_TYPE_I_INTERFERON_PRODU...,SET,107,0.12885,0.0098029,0.078053,0.049395,GOBP_TYPE_I_INTERFERON_PRODUCTION,0.789537724137931
HP_ABNORMAL_SOCIAL_BEHAVIOR,SET,153,0.11152,0.010133,0.067562,0.04941,HP_ABNORMAL_SOCIAL_BEHAVIOR,0.789537724137931
GSE1448_ANTI_VALPHA2_VS_VBET...1,SET,178,0.10641,0.010421,0.064477,0.049447,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_DN,0.789765847886029
GOMF_WNT_PROTEIN_BINDING,SET,30,0.28888,0.011662,0.17507,0.049474,GOMF_WNT_PROTEIN_BINDING,0.789834115755627
REACTOME_SIGNALING_BY_THE_B_...,SET,103,0.12553,0.0093708,0.076101,0.049533,REACTOME_SIGNALING_BY_THE_B_CELL_RECEPTOR_BCR,0.79038569628951
GOBP_CELLULAR_RESPONSE_TO_AC...1,SET,14,0.37282,0.010286,0.22608,0.049574,GOBP_CELLULAR_RESPONSE_TO_ACIDIC_PH,0.79038569628951
GOBP_REGULATION_OF_LEUKOCYTE...6,SET,309,0.084017,0.010802,0.050956,0.049601,GOBP_REGULATION_OF_LEUKOCYTE_DIFFERENTIATION,0.79038569628951
WP_EGFR_TYROSINE_KINASE_INHI...,SET,83,0.16334,0.010952,0.099082,0.049629,WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE,0.79038569628951
GOBP_ANTEROGRADE_AXONAL_TRAN...1,SET,48,0.19943,0.010178,0.12098,0.049634,GOBP_ANTEROGRADE_AXONAL_TRANSPORT,0.79038569628951
GOBP_NEGATIVE_REGULATION_OF_...403,SET,103,0.1435,0.010713,0.087056,0.049645,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.79038569628951
REACTOME_DRUG_MEDIATED_INHIB...,SET,5,0.63792,0.01052,0.38721,0.049737,REACTOME_DRUG_MEDIATED_INHIBITION_OF_CDK4_CDK6_ACTIVITY,0.790861117021277
KEGG_MEDICUS_REFERENCE_DRD1_...,SET,16,0.33182,0.0097861,0.20142,0.04975,KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY,0.790861117021277
RUBENSTEIN_SKELETAL_MUSCLE_P...1,SET,203,0.10356,0.010823,0.062864,0.049755,RUBENSTEIN_SKELETAL_MUSCLE_PCV_ENDOTHELIAL_CELLS,0.790861117021277
GOBP_REGULATION_OF_LYMPHOCYT...5,SET,170,0.11516,0.011024,0.069929,0.049814,GOBP_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,0.790861117021277
GOMF_MONOATOMIC_ANION_MONOAT...,SET,24,0.29749,0.010743,0.18069,0.049851,GOMF_MONOATOMIC_ANION_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.790861117021277
GOCC_SUPRAMOLECULAR_COMPLEX,SET,1253,0.041005,0.010335,0.024909,0.049867,GOCC_SUPRAMOLECULAR_COMPLEX,0.790861117021277
HP_CHEILITIS,SET,48,0.21761,0.011107,0.13219,0.049867,HP_CHEILITIS,0.790861117021277
GOBP_CELL_RECOGNITION,SET,152,0.12116,0.010973,0.073613,0.049897,GOBP_CELL_RECOGNITION,0.790861117021277
GOMF_ATP_DEPENDENT_ACTIVITY,SET,533,0.058795,0.0098663,0.035732,0.049948,GOMF_ATP_DEPENDENT_ACTIVITY,0.790861117021277
HWANG_PROSTATE_CANCER_MARKERS,SET,25,0.27402,0.010099,0.16655,0.049967,HWANG_PROSTATE_CANCER_MARKERS,0.790861117021277
GOBP_REGULATION_OF_T_CELL_DI...,SET,25,0.2847,0.010493,0.17305,0.049972,GOBP_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.790861117021277
HP_ARTERIA_LUSORIA,SET,6,0.65591,0.011849,0.39869,0.04998,HP_ARTERIA_LUSORIA,0.790861117021277
GOMF_SIGNAL_SEQUENCE_BINDING,SET,43,0.19789,0.0095607,0.12032,0.050018,GOMF_SIGNAL_SEQUENCE_BINDING,0.790861117021277
GOCC_RNA_POLYMERASE_II_TRANS...2,SET,14,0.35921,0.0099102,0.21844,0.050058,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REPRESSOR_COMPLEX,0.790861117021277
HP_OVARIAN_CYST,SET,106,0.13779,0.010434,0.083808,0.050089,HP_OVARIAN_CYST,0.790861117021277
GOBP_REGULATION_OF_MYELINATI...,SET,44,0.20875,0.010202,0.12698,0.050098,GOBP_REGULATION_OF_MYELINATION,0.790861117021277
BARX1_TARGET_GENES,SET,1026,0.043464,0.0099786,0.026442,0.05012,BARX1_TARGET_GENES,0.790861117021277
TEL2_Q6,SET,221,0.090902,0.0099079,0.055303,0.050129,TEL2_Q6,0.790861117021277
HP_APLASIA_HYPOPLASIA_OF_THE...67,SET,83,0.14482,0.0097099,0.088111,0.050143,HP_APLASIA_HYPOPLASIA_OF_THE_SPLEEN,0.790861117021277
GOCC_NEUROMUSCULAR_JUNCTION,SET,70,0.16174,0.0099626,0.098457,0.05023,GOCC_NEUROMUSCULAR_JUNCTION,0.790861117021277
KEGG_HEMATOPOIETIC_CELL_LINE...,SET,80,0.1707,0.011237,0.10391,0.050233,KEGG_HEMATOPOIETIC_CELL_LINEAGE,0.790861117021277
GSE12963_UNINF_VS_ENV_AND_NE...1,SET,122,0.12479,0.010134,0.075973,0.050241,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.790861117021277
GOBP_REGULATION_OF_LYMPHOCYT...4,SET,206,0.10082,0.010614,0.061382,0.050248,GOBP_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.790861117021277
GOBP_POSITIVE_REGULATION_OF_...13,SET,6,0.54897,0.0099172,0.33427,0.050275,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.790861117021277
RRAGTTGT_UNKNOWN,SET,228,0.095225,0.01054,0.05799,0.050295,RRAGTTGT_UNKNOWN,0.790861117021277
GOCC_MITOCHONDRIAL_PROTEIN_C...,SET,229,0.085148,0.0094451,0.051857,0.050307,GOCC_MITOCHONDRIAL_PROTEIN_CONTAINING_COMPLEX,0.790861117021277
GOBP_PROTEIN_O_LINKED_FUCOSY...,SET,4,0.58036,0.0085609,0.35353,0.050344,GOBP_PROTEIN_O_LINKED_FUCOSYLATION,0.790861117021277
GSE36392_TYPE_2_MYELOID_VS_N...1,SET,181,0.10126,0.0099988,0.061691,0.050373,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.790861117021277
HP_ABNORMAL_RENAL_CORTEX_MOR...,SET,201,0.098577,0.010252,0.060061,0.05038,HP_ABNORMAL_RENAL_CORTEX_MORPHOLOGY,0.790861117021277
PODAR_RESPONSE_TO_ADAPHOSTIN...1,SET,17,0.37388,0.011366,0.22783,0.0504,PODAR_RESPONSE_TO_ADAPHOSTIN_DN,0.790861117021277
MODULE_567,SET,90,0.13936,0.0097283,0.08492,0.0504,MODULE_567,0.790861117021277
GOBP_CELLULAR_RESPONSE_TO_GL...1,SET,12,0.40448,0.010332,0.24649,0.050408,GOBP_CELLULAR_RESPONSE_TO_GLUCAGON_STIMULUS,0.790861117021277
KARLSSON_TGFB1_TARGETS_UP,SET,113,0.12931,0.010108,0.078837,0.050489,KARLSSON_TGFB1_TARGETS_UP,0.790861117021277
HP_APLASIA_HYPOPLASIA_OF_THE...76,SET,55,0.17564,0.0095938,0.10709,0.050495,HP_APLASIA_HYPOPLASIA_OF_THE_ULNA,0.790861117021277
HP_URETHROVESICAL_OCCLUSION,SET,10,0.41333,0.0096386,0.25202,0.050508,HP_URETHROVESICAL_OCCLUSION,0.790861117021277
HP_PREMATURELY_AGED_APPEARAN...,SET,156,0.10783,0.0098917,0.065747,0.05051,HP_PREMATURELY_AGED_APPEARANCE,0.790861117021277
GOBP_PROTEIN_UFMYLATION,SET,6,0.52465,0.0094779,0.31998,0.050551,GOBP_PROTEIN_UFMYLATION,0.790861117021277
HP_PERIPHERAL_PULMONARY_ARTE...,SET,30,0.25986,0.01049,0.15853,0.050592,HP_PERIPHERAL_PULMONARY_ARTERY_STENOSIS,0.790861117021277
HP_GONADOBLASTOMA,SET,14,0.4043,0.011154,0.24665,0.050599,HP_GONADOBLASTOMA,0.790861117021277
HP_RENAL_INSUFFICIENCY,SET,365,0.072417,0.010103,0.044182,0.050609,HP_RENAL_INSUFFICIENCY,0.790861117021277
MIR1973,SET,6,0.60341,0.010901,0.36827,0.05067,MIR1973,0.790861117021277
SMID_BREAST_CANCER_RELAPSE_I...1,SET,275,0.089787,0.0109,0.054799,0.050672,SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN,0.790861117021277
GOBP_HORMONE_MEDIATED_SIGNAL...,SET,178,0.10419,0.010203,0.06361,0.050732,GOBP_HORMONE_MEDIATED_SIGNALING_PATHWAY,0.790861117021277
GOBP_REGULATION_OF_PHOSPHOLI...1,SET,7,0.55245,0.01078,0.33736,0.050763,GOBP_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.790861117021277
KEGG_MEDICUS_PATHOGEN_HCMV_U...1,SET,26,0.26391,0.009919,0.16117,0.050774,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY,0.790861117021277
GSE9946_MATURE_STIMULATORY_V...3,SET,117,0.13273,0.010556,0.081069,0.050803,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,0.790861117021277
chr2q22,SET,11,0.51993,0.012716,0.31758,0.050804,chr2q22,0.790861117021277
GSE6269_HEALTHY_VS_STAPH_AUR...2,SET,154,0.10937,0.0099691,0.066817,0.050844,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP,0.790861117021277
KEGG_MEDICUS_PATHOGEN_EBV_EB...4,SET,5,0.73451,0.012113,0.44889,0.050898,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_CELL_CYCLE_G1_S_N00484,0.790861117021277
MORF_ATOX1,SET,68,0.15478,0.0093971,0.094592,0.050901,MORF_ATOX1,0.790861117021277
MIR6895_3P,SET,85,0.15546,0.010547,0.095014,0.050915,MIR6895_3P,0.790861117021277
GOBP_CALCIUM_ION_IMPORT_ACRO...,SET,36,0.23078,0.010204,0.14105,0.050918,GOBP_CALCIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.790861117021277
GSE17974_0H_VS_24H_IN_VITRO_...2,SET,162,0.1087,0.01016,0.066442,0.050925,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_UP,0.790861117021277
GOBP_NEGATIVE_REGULATION_OF_...181,SET,14,0.39853,0.010995,0.24361,0.050939,GOBP_NEGATIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,0.790861117021277
PID_NFAT_TFPATHWAY,SET,42,0.22284,0.01064,0.13624,0.050972,PID_NFAT_TFPATHWAY,0.790861117021277
YAATNRNNNYNATT_UNKNOWN,SET,97,0.14703,0.010653,0.089902,0.050993,YAATNRNNNYNATT_UNKNOWN,0.790861117021277
BIOCARTA_ALTERNATIVE_PATHWAY,SET,8,0.47478,0.0099033,0.29042,0.051054,BIOCARTA_ALTERNATIVE_PATHWAY,0.790861117021277
HP_EMG_MYOPATHIC_ABNORMALITI...,SET,116,0.12481,0.0098839,0.076386,0.051151,HP_EMG_MYOPATHIC_ABNORMALITIES,0.790861117021277
GOBP_SYNAPTIC_VESICLE_CLUSTE...,SET,15,0.37981,0.010846,0.23247,0.051159,GOBP_SYNAPTIC_VESICLE_CLUSTERING,0.790861117021277
KEGG_MEDICUS_REFERENCE_METHI...,SET,10,0.499,0.011636,0.30547,0.051187,KEGG_MEDICUS_REFERENCE_METHIONINE_DEGRADATION,0.790861117021277
GSE45365_HEALTHY_VS_MCMV_INF...3,SET,162,0.11114,0.010388,0.068053,0.051233,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_DN,0.790861117021277
HE_LIM_SUN_FETAL_LUNG_C7_PCP...,SET,48,0.21509,0.010978,0.13176,0.051307,HE_LIM_SUN_FETAL_LUNG_C7_PCP4_POS_NEURON_CELL,0.790861117021277
TONKS_TARGETS_OF_RUNX1_RUNX1...5,SET,177,0.11041,0.010783,0.067643,0.051325,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_DN,0.790861117021277
GOBP_INTRACELLULAR_MRNA_LOCA...,SET,15,0.37451,0.010695,0.22945,0.051329,GOBP_INTRACELLULAR_MRNA_LOCALIZATION,0.790861117021277
HONRADO_BREAST_CANCER_BRCA1_...,SET,17,0.34544,0.010501,0.21165,0.051333,HONRADO_BREAST_CANCER_BRCA1_VS_BRCA2,0.790861117021277
HP_ABNORMAL_SCROTAL_RUGATION,SET,4,0.79965,0.011796,0.48995,0.051339,HP_ABNORMAL_SCROTAL_RUGATION,0.790861117021277
GSE21033_1H_VS_12H_POLYIC_ST...1,SET,124,0.1241,0.010159,0.076042,0.051347,GSE21033_1H_VS_12H_POLYIC_STIM_DC_DN,0.790861117021277
GSE16386_IL4_VS_IL4_AND_ROSI...2,SET,181,0.096334,0.0095128,0.059038,0.051378,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_UP,0.790861117021277
DESCARTES_FETAL_INTESTINE_CH...,SET,86,0.16005,0.010923,0.098088,0.05138,DESCARTES_FETAL_INTESTINE_CHROMAFFIN_CELLS,0.790861117021277
GOBP_REGULATION_OF_ODONTOGEN...2,SET,12,0.45037,0.011504,0.27602,0.051385,GOBP_REGULATION_OF_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.790861117021277
REACTOME_CONSTITUTIVE_SIGNAL...5,SET,10,0.36325,0.0084708,0.22265,0.051401,REACTOME_CONSTITUTIVE_SIGNALING_BY_OVEREXPRESSED_ERBB2,0.790861117021277
REACTOME_DNA_METHYLATION,SET,5,0.66782,0.011014,0.40947,0.051461,REACTOME_DNA_METHYLATION,0.790861117021277
GOBP_REGULATION_OF_OSTEOCLAS...1,SET,11,0.44042,0.010771,0.27009,0.051495,GOBP_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.790861117021277
DORN_ADENOVIRUS_INFECTION_48...2,SET,12,0.40532,0.010353,0.24863,0.051539,DORN_ADENOVIRUS_INFECTION_48HR_UP,0.790861117021277
GOCC_CATION_CHANNEL_COMPLEX,SET,195,0.10689,0.010952,0.065579,0.051559,GOCC_CATION_CHANNEL_COMPLEX,0.790861117021277
GOMF_TESTOSTERONE_DEHYDROGEN...2,SET,10,0.41711,0.0097268,0.25592,0.051576,GOMF_TESTOSTERONE_DEHYDROGENASE_NAD_P_ACTIVITY,0.790861117021277
GOMF_UDP_GLUCOSYLTRANSFERASE...,SET,8,0.41157,0.0085849,0.25257,0.051608,GOMF_UDP_GLUCOSYLTRANSFERASE_ACTIVITY,0.790861117021277
HP_SUDDEN_EPISODIC_APNEA,SET,16,0.36535,0.010775,0.22425,0.051649,HP_SUDDEN_EPISODIC_APNEA,0.790861117021277
WP_OPIOID_RECEPTOR_PATHWAYS,SET,41,0.22325,0.010533,0.13704,0.051657,WP_OPIOID_RECEPTOR_PATHWAYS,0.790861117021277
FISCHER_DREAM_TARGETS,SET,861,0.045389,0.0095913,0.027866,0.051681,FISCHER_DREAM_TARGETS,0.790861117021277
PUJANA_XPRSS_INT_NETWORK,SET,155,0.10352,0.0094661,0.063552,0.051685,PUJANA_XPRSS_INT_NETWORK,0.790861117021277
GSE10239_MEMORY_VS_KLRG1HIGH...2,SET,180,0.10137,0.0099827,0.062246,0.051713,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.790861117021277
SCHERER_PBMC_YF_VAX_OR_APSV_...,SET,21,0.31008,0.010475,0.19042,0.051733,SCHERER_PBMC_YF_VAX_OR_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_DN,0.790861117021277
BOQUEST_STEM_CELL_UP,SET,233,0.099963,0.011184,0.061398,0.051759,BOQUEST_STEM_CELL_UP,0.790861117021277
GNF2_FBL,SET,129,0.1126,0.0094007,0.069169,0.051775,GNF2_FBL,0.790861117021277
MODULE_44,SET,292,0.084794,0.010603,0.0521,0.051821,MODULE_44,0.790861117021277
GOBP_CORTICAL_CYTOSKELETON_O...,SET,51,0.18854,0.0099179,0.11586,0.051848,GOBP_CORTICAL_CYTOSKELETON_ORGANIZATION,0.790861117021277
GOBP_RESPONSE_TO_INTERLEUKIN...3,SET,5,0.63899,0.010538,0.39274,0.051879,GOBP_RESPONSE_TO_INTERLEUKIN_13,0.790861117021277
GOBP_NEGATIVE_REGULATION_OF_...376,SET,9,0.50303,0.011129,0.30927,0.051926,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_ACTIVATION,0.790861117021277
HMX1_01,SET,39,0.22979,0.010574,0.14128,0.051932,HMX1_01,0.790861117021277
GOBP_VOLUNTARY_SKELETAL_MUSC...,SET,5,0.51683,0.0085234,0.31781,0.051962,GOBP_VOLUNTARY_SKELETAL_MUSCLE_CONTRACTION,0.790861117021277
GALINDO_IMMUNE_RESPONSE_TO_E...,SET,73,0.16982,0.010681,0.10443,0.051967,GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN,0.790861117021277
HP_IMMUNODEFICIENCY,SET,194,0.10214,0.010439,0.062812,0.051967,HP_IMMUNODEFICIENCY,0.790861117021277
MIR181A_2_3P,SET,99,0.13889,0.010166,0.085417,0.051978,MIR181A_2_3P,0.790861117021277
GOCC_CHROMOSOMAL_REGION,SET,340,0.071668,0.0096572,0.044085,0.052019,GOCC_CHROMOSOMAL_REGION,0.790861117021277
KEGG_MEDICUS_VARIANT_MUTATIO...82,SET,4,0.58407,0.0086156,0.35944,0.052095,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_MGLUR1_SIGNALING_PATHWAY,0.790861117021277
WP_INHIBITION_OF_EXOSOME_BIO...,SET,17,0.29673,0.0090204,0.18266,0.052147,WP_INHIBITION_OF_EXOSOME_BIOGENESIS_AND_SECRETION_BY_MANUMYCIN_A_IN_CRPC_CELLS,0.790861117021277
BOWIE_RESPONSE_TO_TAMOXIFEN,SET,18,0.30363,0.0094974,0.18692,0.052152,BOWIE_RESPONSE_TO_TAMOXIFEN,0.790861117021277
GOCC_GEMINI_OF_COILED_BODIES,SET,9,0.37086,0.0082047,0.22832,0.052166,GOCC_GEMINI_OF_COILED_BODIES,0.790861117021277
GOBP_REGULATION_OF_MITOCHOND...11,SET,7,0.54083,0.010553,0.333,0.052186,GOBP_REGULATION_OF_MITOCHONDRIAL_MRNA_STABILITY,0.790861117021277
GOBP_REGULATION_OF_METALLOPE...,SET,9,0.51675,0.011432,0.31822,0.052209,GOBP_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.790861117021277
GSE23321_CD8_STEM_CELL_MEMOR...6,SET,168,0.10431,0.0099268,0.06424,0.052228,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.790861117021277
HP_RED_HAIR,SET,8,0.4979,0.010386,0.30667,0.052245,HP_RED_HAIR,0.790861117021277
GOMF_LIGAND_GATED_SODIUM_CHA...,SET,16,0.34163,0.010076,0.21045,0.052265,GOMF_LIGAND_GATED_SODIUM_CHANNEL_ACTIVITY,0.790861117021277
GOBP_NUCLEOSIDE_TRANSMEMBRAN...,SET,8,0.52252,0.010899,0.32189,0.052273,GOBP_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORT,0.790861117021277
JIANG_MELANOMA_TRM8_CD4,SET,364,0.073331,0.010217,0.04518,0.052293,JIANG_MELANOMA_TRM8_CD4,0.790861117021277
PETRETTO_HEART_MASS_QTL_CIS_...2,SET,30,0.24526,0.009901,0.15111,0.052299,PETRETTO_HEART_MASS_QTL_CIS_UP,0.790861117021277
GOCC_CALCINEURIN_COMPLEX,SET,6,0.44782,0.00809,0.27596,0.052327,GOCC_CALCINEURIN_COMPLEX,0.790861117021277
WP_IL9_SIGNALING,SET,15,0.4144,0.011834,0.25538,0.052339,WP_IL9_SIGNALING,0.790861117021277
HOFMANN_MYELODYSPLASTIC_SYND...6,SET,19,0.29466,0.0094692,0.18164,0.052385,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_UP,0.790861117021277
REACTOME_CALNEXIN_CALRETICUL...,SET,24,0.27119,0.0097934,0.16723,0.052445,REACTOME_CALNEXIN_CALRETICULIN_CYCLE,0.790861117021277
GOBP_GEPHYRIN_CLUSTERING_INV...,SET,5,0.61378,0.010122,0.3785,0.052451,GOBP_GEPHYRIN_CLUSTERING_INVOLVED_IN_POSTSYNAPTIC_DENSITY_ASSEMBLY,0.790861117021277
HP_LOWER_LIMB_AMYOTROPHY,SET,69,0.16894,0.010332,0.10419,0.052465,HP_LOWER_LIMB_AMYOTROPHY,0.790861117021277
HP_ABNORMALITY_OF_THE_OVARY,SET,216,0.091944,0.0099089,0.056704,0.052466,HP_ABNORMALITY_OF_THE_OVARY,0.790861117021277
HP_SUBCUTANEOUS_NODULE,SET,88,0.1485,0.010251,0.091612,0.052526,HP_SUBCUTANEOUS_NODULE,0.790861117021277
GSE15659_NONSUPPRESSIVE_TCEL...1,SET,170,0.10219,0.0097826,0.06305,0.052541,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_DN,0.790861117021277
GCM_TPT1,SET,60,0.16676,0.0095124,0.10292,0.052602,GCM_TPT1,0.790861117021277
GOBP_REGULATION_OF_RAB_PROTE...,SET,7,0.47918,0.0093499,0.29575,0.052603,GOBP_REGULATION_OF_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.790861117021277
WP_PREGNANE_X_RECEPTOR_PATHW...,SET,31,0.26466,0.01086,0.16337,0.052618,WP_PREGNANE_X_RECEPTOR_PATHWAY,0.790861117021277
LAKE_ADULT_KIDNEY_C2_PODOCYT...,SET,192,0.10582,0.010759,0.065322,0.05263,LAKE_ADULT_KIDNEY_C2_PODOCYTES,0.790861117021277
GSE15139_GMCSF_TREATED_VS_UN...2,SET,180,0.098789,0.0097285,0.060992,0.052655,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_UP,0.790861117021277
REACTOME_HOMOLOGOUS_DNA_PAIR...,SET,41,0.19987,0.0094294,0.12341,0.052671,REACTOME_HOMOLOGOUS_DNA_PAIRING_AND_STRAND_EXCHANGE,0.790861117021277
GSE17721_LPS_VS_PAM3CSK4_24H...2,SET,187,0.096051,0.0096392,0.059318,0.052704,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_UP,0.790861117021277
ZHANG_TARGETS_OF_EWSR1_FLI1_...,SET,83,0.16393,0.010992,0.10125,0.052718,ZHANG_TARGETS_OF_EWSR1_FLI1_FUSION,0.790861117021277
GOBP_INTERLEUKIN_1_MEDIATED_...,SET,29,0.2524,0.010018,0.1559,0.052738,GOBP_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,0.790861117021277
GSE17721_LPS_VS_GARDIQUIMOD_...16,SET,187,0.098467,0.0098816,0.060824,0.052746,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_UP,0.790861117021277
HOLLEMAN_VINCRISTINE_RESISTA...2,SET,25,0.27841,0.010261,0.17201,0.052779,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_UP,0.790861117021277
BCAT.100_UP.V1_UP,SET,45,0.23151,0.011441,0.14305,0.052799,BCAT.100_UP.V1_UP,0.790861117021277
GSE360_DC_VS_MAC_T_GONDII_UP,SET,182,0.10597,0.010493,0.065492,0.05284,GSE360_DC_VS_MAC_T_GONDII_UP,0.790861117021277
REACTOME_PROCESSING_OF_SMDT1,SET,12,0.38388,0.0098058,0.23729,0.052868,REACTOME_PROCESSING_OF_SMDT1,0.790861117021277
KEGG_MEDICUS_REFERENCE_CA2_C...2,SET,12,0.36472,0.0093165,0.22551,0.052917,KEGG_MEDICUS_REFERENCE_CA2_CAM_CN_SIGNALING_PATHWAY,0.790861117021277
GSE411_WT_VS_SOCS3_KO_MACROP...1,SET,185,0.098548,0.0098373,0.060936,0.052923,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN,0.790861117021277
GSE41176_UNSTIM_VS_ANTI_IGM_...2,SET,184,0.10543,0.010496,0.065197,0.052933,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_UP,0.790861117021277
GSE24634_TEFF_VS_TCONV_DAY10...1,SET,186,0.10392,0.010401,0.064264,0.052943,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_DN,0.790861117021277
MODULE_310,SET,19,0.33459,0.010752,0.20692,0.052944,MODULE_310,0.790861117021277
GOBP_ISOTYPE_SWITCHING_TO_IG...2,SET,15,0.35414,0.010113,0.21902,0.052959,GOBP_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.790861117021277
GOBP_DERMATAN_SULFATE_BIOSYN...,SET,5,0.63786,0.010519,0.39454,0.052979,GOBP_DERMATAN_SULFATE_BIOSYNTHETIC_PROCESS,0.790861117021277
GSE1460_CD4_THYMOCYTE_VS_NAI...4,SET,191,0.098527,0.0099918,0.060943,0.052979,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,0.790861117021277
HP_OVERRIDING_AORTA,SET,21,0.33968,0.011476,0.21013,0.052995,HP_OVERRIDING_AORTA,0.790861117021277
CHOI_ATL_CHRONIC_VS_ACUTE_DN,SET,17,0.33315,0.010128,0.20609,0.052996,CHOI_ATL_CHRONIC_VS_ACUTE_DN,0.790861117021277
GOBP_CEREBROSPINAL_FLUID_CIR...,SET,9,0.49111,0.010865,0.3038,0.052996,GOBP_CEREBROSPINAL_FLUID_CIRCULATION,0.790861117021277
GOBP_POSITIVE_REGULATION_OF_...19,SET,50,0.20669,0.010766,0.12786,0.052996,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.790861117021277
GOBP_BONE_REMODELING,SET,89,0.15319,0.010634,0.094782,0.05303,GOBP_BONE_REMODELING,0.790861117021277
GOMF_RRNA_BINDING,SET,56,0.17246,0.0095053,0.10672,0.053058,GOMF_RRNA_BINDING,0.790861117021277
GOBP_POSITIVE_REGULATION_OF_...683,SET,5,0.71242,0.011749,0.44105,0.053132,GOBP_POSITIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.790861117021277
GSE24142_ADULT_VS_FETAL_DN3_...1,SET,182,0.10579,0.010475,0.065491,0.053134,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_DN,0.790861117021277
GSE9946_IMMATURE_VS_MATURE_S...1,SET,124,0.12596,0.010311,0.077998,0.053177,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_DN,0.790861117021277
HP_SPINA_BIFIDA_OCCULTA,SET,68,0.16888,0.010254,0.10461,0.053234,HP_SPINA_BIFIDA_OCCULTA,0.790861117021277
GOBP_REGULATION_OF_B_CELL_RE...,SET,21,0.3007,0.010159,0.18628,0.053252,GOBP_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.790861117021277
HP_LAMELLAR_CATARACT,SET,6,0.55376,0.010004,0.34322,0.053334,HP_LAMELLAR_CATARACT,0.790861117021277
REACTOME_CONSTITUTIVE_SIGNAL...4,SET,18,0.2956,0.0092462,0.18323,0.053348,REACTOME_CONSTITUTIVE_SIGNALING_BY_LIGAND_RESPONSIVE_EGFR_CANCER_VARIANTS,0.790861117021277
GOMF_N_METHYLTRANSFERASE_ACT...,SET,82,0.14235,0.009487,0.088239,0.053358,GOMF_N_METHYLTRANSFERASE_ACTIVITY,0.790861117021277
GSE45365_NK_CELL_VS_CD8A_DC_...4,SET,181,0.099182,0.0097941,0.061482,0.05336,GSE45365_NK_CELL_VS_CD8A_DC_UP,0.790861117021277
GSE26488_WT_VS_HDAC7_DELTAP_...1,SET,184,0.10169,0.010124,0.063045,0.05338,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_DN,0.790861117021277
REACTOME_O_LINKED_GLYCOSYLAT...2,SET,56,0.20023,0.011036,0.12414,0.053385,REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS,0.790861117021277
GSE17721_LPS_VS_CPG_8H_BMDC_...1,SET,167,0.10223,0.0097007,0.063383,0.053389,GSE17721_LPS_VS_CPG_8H_BMDC_DN,0.790861117021277
GOBP_NEGATIVE_REGULATION_OF_...425,SET,49,0.21446,0.011059,0.13298,0.053414,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.790861117021277
LINDSTEDT_DENDRITIC_CELL_MAT...1,SET,61,0.18696,0.010753,0.11593,0.053415,LINDSTEDT_DENDRITIC_CELL_MATURATION_A,0.790861117021277
HP_ELEVATED_CIRCULATING_CALC...,SET,22,0.25148,0.0086957,0.15595,0.053429,HP_ELEVATED_CIRCULATING_CALCITONIN_CONCENTRATION,0.790861117021277
GOBP_ERK1_AND_ERK2_CASCADE,SET,281,0.084941,0.010422,0.052677,0.053436,GOBP_ERK1_AND_ERK2_CASCADE,0.790861117021277
GOMF_POLYSACCHARIDE_BINDING,SET,21,0.31909,0.01078,0.19789,0.053443,GOMF_POLYSACCHARIDE_BINDING,0.790861117021277
BLALOCK_ALZHEIMERS_DISEASE_DN,SET,1103,0.041562,0.0098715,0.025777,0.053447,BLALOCK_ALZHEIMERS_DISEASE_DN,0.790861117021277
REACTOME_CREB_PHOSPHORYLATION,SET,6,0.63605,0.01149,0.39449,0.053454,REACTOME_CREB_PHOSPHORYLATION,0.790861117021277
HP_PROXIMAL_MUSCLE_WEAKNESS_...1,SET,62,0.17254,0.010004,0.10701,0.053456,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_LOWER_LIMBS,0.790861117021277
MIR4797_3P,SET,94,0.13076,0.0093276,0.081103,0.053457,MIR4797_3P,0.790861117021277
GOCC_MITOCHONDRIAL_CRISTA_JU...,SET,4,0.65265,0.0096273,0.40481,0.053462,GOCC_MITOCHONDRIAL_CRISTA_JUNCTION,0.790861117021277
GOMF_LIGAND_GATED_MONOATOMIC...2,SET,132,0.12562,0.010608,0.077921,0.053475,GOMF_LIGAND_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.790861117021277
GOBP_TONIC_SMOOTH_MUSCLE_CON...,SET,11,0.47682,0.011662,0.29585,0.053526,GOBP_TONIC_SMOOTH_MUSCLE_CONTRACTION,0.790923026706231
WP_COMPLEMENT_ACTIVATION,SET,17,0.36227,0.011013,0.2248,0.053545,WP_COMPLEMENT_ACTIVATION,0.790923026706231
MIR4786_5P,SET,85,0.14991,0.010171,0.093041,0.053579,MIR4786_5P,0.790923026706231
GSE45739_UNSTIM_VS_ACD3_ACD2...4,SET,181,0.10268,0.01014,0.063736,0.053595,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_UP,0.790923026706231
GOMF_NUCLEAR_LOCALIZATION_SE...,SET,23,0.2717,0.0096055,0.16867,0.053615,GOMF_NUCLEAR_LOCALIZATION_SEQUENCE_BINDING,0.790923026706231
GSE16522_ANTI_CD3CD28_STIM_V...3,SET,179,0.099069,0.0097292,0.061501,0.053616,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_DN,0.790923026706231
GSE13738_RESTING_VS_BYSTANDE...1,SET,173,0.10494,0.010133,0.065154,0.053643,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,0.790923026706231
MIR5196_3P,SET,60,0.17715,0.010105,0.11001,0.053678,MIR5196_3P,0.790923026706231
HP_LOCALIZED_SKIN_LESION,SET,792,0.049908,0.010135,0.030994,0.053684,HP_LOCALIZED_SKIN_LESION,0.790923026706231
HP_ABNORMAL_SCLERA_MORPHOLOGY,SET,127,0.11557,0.0095737,0.071788,0.053721,HP_ABNORMAL_SCLERA_MORPHOLOGY,0.791132777542373
GOBP_REGULATION_OF_NK_T_CELL...1,SET,11,0.46924,0.011476,0.29155,0.053769,GOBP_REGULATION_OF_NK_T_CELL_ACTIVATION,0.791504275730623
chr11p13,SET,36,0.49983,0.0221,0.31067,0.053834,chr11p13,0.791996292848074
HP_ABNORMAL_SCROTUM_MORPHOLO...,SET,110,0.13498,0.010411,0.083906,0.053848,HP_ABNORMAL_SCROTUM_MORPHOLOGY,0.791996292848074
REACTOME_RESPONSE_TO_ELEVATE...,SET,120,0.1283,0.010333,0.07977,0.053891,REACTOME_RESPONSE_TO_ELEVATED_PLATELET_CYTOSOLIC_CA2,0.792293445431472
MCBRYAN_TERMINAL_END_BUD_DN,SET,6,0.6165,0.011137,0.38339,0.053925,MCBRYAN_TERMINAL_END_BUD_DN,0.792299423076923
GOMF_GTPASE_INHIBITOR_ACTIVI...,SET,12,0.40195,0.010267,0.24998,0.053937,GOMF_GTPASE_INHIBITOR_ACTIVITY,0.792299423076923
LOPEZ_MESOTHELIOMA_SURVIVAL_...6,SET,12,0.41436,0.010584,0.25782,0.054014,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_UP,0.792589235294118
GOBP_RETROTRANSPOSON_SILENCI...,SET,15,0.29697,0.0084805,0.18485,0.054082,GOBP_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.792589235294118
GOMF_PEPTIDE_TRANSMEMBRANE_T...,SET,9,0.48169,0.010657,0.29982,0.054083,GOMF_PEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.792589235294118
GSE17721_CTRL_VS_PAM3CSK4_2H...1,SET,183,0.10368,0.010294,0.064539,0.054103,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_DN,0.792589235294118
LIU_SOX4_TARGETS_UP,SET,126,0.12288,0.010139,0.0765,0.054118,LIU_SOX4_TARGETS_UP,0.792589235294118
HP_HIGH_OUTPUT_CONGESTIVE_HE...,SET,6,0.5641,0.010191,0.35123,0.054137,HP_HIGH_OUTPUT_CONGESTIVE_HEART_FAILURE,0.792589235294118
HP_JOINT_HYPERMOBILITY,SET,476,0.061719,0.0098032,0.038429,0.054141,HP_JOINT_HYPERMOBILITY,0.792589235294118
ACACTGG_MIR199A_MIR199B,SET,140,0.11425,0.0099331,0.07115,0.054179,ACACTGG_MIR199A_MIR199B,0.792589235294118
HP_POSTERIOR_EMBRYOTOXON,SET,46,0.21499,0.010742,0.13391,0.054208,HP_POSTERIOR_EMBRYOTOXON,0.792589235294118
GOBP_POSITIVE_REGULATION_OF_...809,SET,11,0.41204,0.010077,0.25667,0.054223,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_DIFFERENTIATION,0.792589235294118
GOBP_AXONAL_TRANSPORT,SET,62,0.17426,0.010104,0.10855,0.054225,GOBP_AXONAL_TRANSPORT,0.792589235294118
REACTOME_TRANSCRIPTIONAL_REG...1,SET,31,0.22899,0.0093967,0.14267,0.054251,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_E2F6,0.792589235294118
GOCC_SMALL_RIBOSOMAL_SUBUNIT,SET,66,0.15889,0.0095042,0.099003,0.054271,GOCC_SMALL_RIBOSOMAL_SUBUNIT,0.792589235294118
GOCC_CHROMOSOME_CENTROMERIC_...1,SET,2,1.0203,0.010642,0.63575,0.054276,GOCC_CHROMOSOME_CENTROMERIC_CORE_DOMAIN,0.792589235294118
MURARO_PANCREAS_PANCREATIC_P...,SET,134,0.12934,0.011004,0.080651,0.054396,MURARO_PANCREAS_PANCREATIC_POLYPEPTIDE_CELL,0.793601608040201
REACTOME_INTERLEUKIN_12_FAMI...,SET,53,0.18014,0.0096595,0.11233,0.054403,REACTOME_INTERLEUKIN_12_FAMILY_SIGNALING,0.793601608040201
KONDO_HYPOXIA,SET,6,0.54696,0.009881,0.34111,0.054424,KONDO_HYPOXIA,0.793601608040201
MIR4254,SET,92,0.141,0.0099508,0.087946,0.05445,MIR4254,0.793601608040201
MIKKELSEN_NPC_WITH_LCP_H3K27...,SET,7,0.50957,0.0099428,0.31787,0.054467,MIKKELSEN_NPC_WITH_LCP_H3K27ME3,0.793601608040201
GOMF_METAL_CATION_PROTON_ANT...,SET,23,0.28127,0.0099439,0.17549,0.054506,GOMF_METAL_CATION_PROTON_ANTIPORTER_ACTIVITY,0.793601608040201
GOBP_PROTEIN_LOCALIZATION_TO...8,SET,4,0.66344,0.0097864,0.41394,0.054507,GOBP_PROTEIN_LOCALIZATION_TO_CELL_LEADING_EDGE,0.793601608040201
WP_VITAMIN_A_AND_CAROTENOID_...,SET,42,0.21757,0.010389,0.13577,0.054528,WP_VITAMIN_A_AND_CAROTENOID_METABOLISM,0.793601608040201
MIR4716_3P,SET,77,0.15223,0.0098328,0.095063,0.054657,MIR4716_3P,0.794960664993727
HP_APLASIA_HYPOPLASIA_AFFECT...2,SET,127,0.11783,0.0097609,0.07359,0.05468,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_ANTERIOR_SEGMENT_OF_THE_EYE,0.794960664993727
BROCKE_APOPTOSIS_REVERSED_BY...,SET,137,0.11747,0.010104,0.073368,0.05469,BROCKE_APOPTOSIS_REVERSED_BY_IL6,0.794960664993727
REACTOME_ACTIVATION_OF_C3_AN...,SET,4,0.65921,0.009724,0.41178,0.054713,REACTOME_ACTIVATION_OF_C3_AND_C5,0.794962506270903
GSE30083_SP1_VS_SP4_THYMOCYT...1,SET,189,0.099042,0.0099918,0.061894,0.054787,GSE30083_SP1_VS_SP4_THYMOCYTE_DN,0.795451801501251
GOMF_HYALURONONGLUCOSAMINIDA...,SET,6,0.5733,0.010357,0.35832,0.054809,GOMF_HYALURONONGLUCOSAMINIDASE_ACTIVITY,0.795451801501251
MIR6891_3P,SET,62,0.17313,0.010039,0.10822,0.054824,MIR6891_3P,0.795451801501251
HP_ASCENDING_TUBULAR_AORTA_A...,SET,26,0.25652,0.0096416,0.16038,0.054861,HP_ASCENDING_TUBULAR_AORTA_ANEURYSM,0.795451801501251
GOBP_POSITIVE_REGULATION_OF_...569,SET,8,0.4821,0.010056,0.3014,0.054862,GOBP_POSITIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.795451801501251
HP_MUSCLE_FIBER_NECROSIS,SET,10,0.436,0.010167,0.27261,0.054884,HP_MUSCLE_FIBER_NECROSIS,0.795451801501251
DESCARTES_FETAL_LUNG_MYELOID...,SET,143,0.12279,0.010789,0.076802,0.054942,DESCARTES_FETAL_LUNG_MYELOID_CELLS,0.795947425
GSE41867_LCMV_ARMSTRONG_VS_C...4,SET,181,0.095272,0.0094079,0.059597,0.054964,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_UP,0.795947425
KOKKINAKIS_METHIONINE_DEPRIV...1,SET,57,0.18016,0.010018,0.11276,0.055053,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_DN,0.796201514962594
REACTOME_VITAMIN_C_ASCORBATE...,SET,7,0.47766,0.0093203,0.29895,0.055054,REACTOME_VITAMIN_C_ASCORBATE_METABOLISM,0.796201514962594
MODULE_93,SET,173,0.10183,0.0098327,0.06374,0.055082,MODULE_93,0.796201514962594
HP_HYPERHIDROSIS,SET,149,0.10972,0.0098391,0.068683,0.055087,HP_HYPERHIDROSIS,0.796201514962594
HADDAD_T_LYMPHOCYTE_AND_NK_P...1,SET,59,0.18866,0.010672,0.11811,0.055115,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_DN,0.796201514962594
GSE12963_ENV_NEF_VS_ENV_NEF_...1,SET,132,0.11608,0.0098019,0.072676,0.055119,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.796201514962594
GOBP_POSITIVE_REGULATION_OF_...76,SET,23,0.26216,0.0092681,0.16416,0.055148,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.79620414244186
GOCC_SMN_COMPLEX,SET,7,0.44608,0.0087039,0.27936,0.055165,GOCC_SMN_COMPLEX,0.79620414244186
GNF2_CBFB,SET,28,0.24983,0.0097438,0.15648,0.055194,GNF2_CBFB,0.796250029045643
MIR196B_3P,SET,6,0.61431,0.011098,0.38482,0.055214,MIR196B_3P,0.796250029045643
HE_LIM_SUN_FETAL_LUNG_C0_MID...1,SET,58,0.1949,0.010931,0.1221,0.055238,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_1_CELL,0.796252611940298
ZHENG_CORD_BLOOD_C2_PUTATIVE...,SET,86,0.14698,0.01003,0.092093,0.05526,ZHENG_CORD_BLOOD_C2_PUTATIVE_BASOPHIL_EOSINOPHIL_MAST_CELL_PROGENITOR,0.796252611940298
GOMF_NAD_DEPENDENT_HISTONE_D...,SET,5,0.55356,0.0091291,0.34699,0.055331,GOMF_NAD_DEPENDENT_HISTONE_DEACETYLASE_ACTIVITY,0.796945256941566
GOCC_PHAGOPHORE_ASSEMBLY_SIT...,SET,20,0.28593,0.009427,0.17925,0.055355,GOCC_PHAGOPHORE_ASSEMBLY_SITE_MEMBRANE,0.796960656586578
GOBP_DICHOTOMOUS_SUBDIVISION...,SET,8,0.53832,0.011229,0.33759,0.055408,GOBP_DICHOTOMOUS_SUBDIVISION_OF_AN_EPITHELIAL_TERMINAL_UNIT,0.797393391304348
GOBP_ANTIGEN_PROCESSING_AND_...9,SET,7,0.70384,0.013733,0.44154,0.05547,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.797683306451613
GOBP_RETROGRADE_AXONAL_TRANS...,SET,21,0.29243,0.0098792,0.18346,0.055484,GOBP_RETROGRADE_AXONAL_TRANSPORT,0.797683306451613
GOBP_POSITIVE_REGULATION_OF_...141,SET,9,0.50636,0.011202,0.3177,0.055497,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.797683306451613
MODULE_387,SET,48,0.19795,0.010103,0.12424,0.055561,MODULE_387,0.798273069450186
BIOCARTA_HER2_PATHWAY,SET,23,0.28088,0.0099302,0.17632,0.055588,BIOCARTA_HER2_PATHWAY,0.798330966942149
MISIAK_ANAPLASTIC_THYROID_CA...1,SET,17,0.36211,0.011008,0.22738,0.055642,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN,0.798776418835192
GSE7460_FOXP3_MUT_VS_HET_ACT...2,SET,183,0.10142,0.01007,0.0637,0.055681,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_UP,0.798848623607099
MODULE_484,SET,39,0.20398,0.0093862,0.12812,0.055693,MODULE_484,0.798848623607099
KEGG_MEDICUS_VARIANT_TEL_AML...,SET,10,0.45585,0.01063,0.28646,0.055777,KEGG_MEDICUS_VARIANT_TEL_AML1_FUSION_TO_TRANSCRIPTIONAL_REPRESSION,0.799221916426513
HP_FIBULAR_APLASIA,SET,6,0.61265,0.011068,0.38508,0.055816,HP_FIBULAR_APLASIA,0.799221916426513
MIR4497,SET,8,0.53995,0.011263,0.33941,0.055829,MIR4497,0.799221916426513
HP_ABNORMAL_ACTIVITY_OF_MITO...,SET,125,0.10553,0.008673,0.066333,0.055831,HP_ABNORMAL_ACTIVITY_OF_MITOCHONDRIAL_RESPIRATORY_CHAIN,0.799221916426513
WANG_RESPONSE_TO_FORSKOLIN_UP,SET,22,0.2877,0.0099478,0.18087,0.055856,WANG_RESPONSE_TO_FORSKOLIN_UP,0.799221916426513
HP_ABNORMAL_NUMBER_OF_TEETH,SET,356,0.069913,0.0096355,0.043953,0.055857,HP_ABNORMAL_NUMBER_OF_TEETH,0.799221916426513
GOBP_CHONDROITIN_SULFATE_MET...,SET,24,0.26878,0.0097065,0.16906,0.055939,GOBP_CHONDROITIN_SULFATE_METABOLIC_PROCESS,0.799564905505341
GOBP_POSITIVE_REGULATION_OF_...816,SET,25,0.28157,0.010378,0.17711,0.055952,GOBP_POSITIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.799564905505341
MODULE_60,SET,382,0.069921,0.0099752,0.043987,0.05597,MODULE_60,0.799564905505341
GOBP_TOLL_LIKE_RECEPTOR_7_SI...,SET,8,0.52228,0.010894,0.32859,0.055989,GOBP_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.799564905505341
GOBP_NEGATIVE_REGULATION_OF_...314,SET,43,0.21407,0.010342,0.13469,0.055996,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,0.799564905505341
MIR10396A_5P,SET,8,0.46131,0.0096225,0.29031,0.056032,MIR10396A_5P,0.799578920804268
KALMA_E2F1_TARGETS,SET,11,0.35437,0.0086669,0.22303,0.056052,KALMA_E2F1_TARGETS,0.799578920804268
GOBP_REGULATION_OF_AMYLOID_F...,SET,15,0.32418,0.0092574,0.20404,0.056066,GOBP_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.799578920804268
REACTOME_ATF6_ATF6_ALPHA_ACT...2,SET,10,0.3709,0.0086491,0.23352,0.05612,REACTOME_ATF6_ATF6_ALPHA_ACTIVATES_CHAPERONE_GENES,0.79964721680877
GOMF_DEACETYLASE_ACTIVITY,SET,35,0.21857,0.0095291,0.13763,0.05614,GOMF_DEACETYLASE_ACTIVITY,0.79964721680877
MIR152_3P,SET,314,0.076514,0.0099153,0.048207,0.056241,MIR152_3P,0.79964721680877
GOBP_VENOUS_BLOOD_VESSEL_MOR...,SET,9,0.48068,0.010634,0.30287,0.056258,GOBP_VENOUS_BLOOD_VESSEL_MORPHOGENESIS,0.79964721680877
GOBP_CARDIAC_MUSCLE_TISSUE_R...,SET,6,0.52958,0.0095669,0.33374,0.056287,GOBP_CARDIAC_MUSCLE_TISSUE_REGENERATION,0.79964721680877
HP_AV_NODAL_TACHYCARDIA,SET,2,1.0993,0.011467,0.69283,0.056297,HP_AV_NODAL_TACHYCARDIA,0.79964721680877
GOMF_PROTEIN_ARGININE_DEIMIN...,SET,5,0.7194,0.011864,0.4534,0.056302,GOMF_PROTEIN_ARGININE_DEIMINASE_ACTIVITY,0.79964721680877
AMUNDSON_DNA_DAMAGE_RESPONSE...,SET,16,0.31881,0.0094025,0.20093,0.056304,AMUNDSON_DNA_DAMAGE_RESPONSE_TP53,0.79964721680877
GOMF_ENDONUCLEASE_ACTIVITY,SET,111,0.12272,0.0095082,0.077358,0.056335,GOMF_ENDONUCLEASE_ACTIVITY,0.79964721680877
GSE1460_DP_VS_CD4_THYMOCYTE_...2,SET,176,0.098545,0.0095971,0.062125,0.056353,GSE1460_DP_VS_CD4_THYMOCYTE_UP,0.79964721680877
GSE9037_WT_VS_IRAK4_KO_BMDM_...2,SET,179,0.10216,0.010032,0.064405,0.056361,GSE9037_WT_VS_IRAK4_KO_BMDM_UP,0.79964721680877
MODULE_83,SET,281,0.075061,0.00921,0.047337,0.056416,MODULE_83,0.79964721680877
FAN_EMBRYONIC_CTX_BIG_GROUPS...2,SET,131,0.12175,0.010242,0.076812,0.056484,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_IMMUNE,0.79964721680877
GSE20198_IL12_IL18_VS_IFNA_T...1,SET,179,0.096877,0.009514,0.061121,0.056493,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,0.79964721680877
GSE22935_24H_VS_48H_MBOVIS_B...2,SET,178,0.099369,0.0097317,0.062696,0.0565,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.79964721680877
GSE16450_CTRL_VS_IFNA_12H_ST...1,SET,155,0.11013,0.010071,0.069497,0.056536,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.79964721680877
GOBP_SUBTELOMERIC_HETEROCHRO...,SET,6,0.49768,0.0089908,0.31408,0.05654,GOBP_SUBTELOMERIC_HETEROCHROMATIN_FORMATION,0.79964721680877
GSE28783_ANTI_MIR33_VS_UNTRE...2,SET,177,0.099239,0.0096918,0.062631,0.05655,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.79964721680877
DESCARTES_MAIN_FETAL_ANTIGEN...,SET,91,0.1472,0.010332,0.092911,0.056565,DESCARTES_MAIN_FETAL_ANTIGEN_PRESENTING_CELLS,0.79964721680877
GOBP_NUCLEOSIDE_TRIPHOSPHATE...2,SET,12,0.41669,0.010644,0.26301,0.056574,GOBP_NUCLEOSIDE_TRIPHOSPHATE_CATABOLIC_PROCESS,0.79964721680877
GOCC_GOLGI_APPARATUS,SET,1466,0.036303,0.0098355,0.022915,0.056582,GOCC_GOLGI_APPARATUS,0.79964721680877
GOBP_POSITIVE_REGULATION_OF_...426,SET,129,0.12368,0.010325,0.078078,0.056602,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.79964721680877
KRIGE_RESPONSE_TO_TOSEDOSTAT...3,SET,823,0.045274,0.0093635,0.028582,0.056603,KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN,0.79964721680877
GOBP_POSITIVE_REGULATION_OF_...139,SET,320,0.076238,0.0099718,0.048142,0.056652,GOBP_POSITIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.79964721680877
HALLMARK_TNFA_SIGNALING_VIA_...,SET,190,0.10538,0.010659,0.066548,0.056666,HALLMARK_TNFA_SIGNALING_VIA_NFKB,0.79964721680877
REACTOME_RNA_POLYMERASE_III_...2,SET,39,0.18183,0.0083673,0.11483,0.056669,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION,0.79964721680877
HP_TESTICULAR_ATROPHY,SET,9,0.41167,0.0091075,0.26017,0.056803,HP_TESTICULAR_ATROPHY,0.801212769886364
HP_LEFT_SUPERIOR_VENA_CAVA_D...,SET,3,0.78477,0.010026,0.49632,0.056927,HP_LEFT_SUPERIOR_VENA_CAVA_DRAINING_TO_CORONARY_SINUS,0.802425012116317
WP_STRIATED_MUSCLE_CONTRACTI...,SET,37,0.22215,0.0099574,0.14051,0.056941,WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY,0.802425012116317
GSE4984_UNTREATED_VS_GALECTI...1,SET,154,0.1099,0.010017,0.069514,0.056959,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_DN,0.802425012116317
GOMF_DNA_HELICASE_ACTIVITY,SET,55,0.171,0.0093404,0.10819,0.057002,GOMF_DNA_HELICASE_ACTIVITY,0.802425012116317
GOBP_NEGATIVE_REGULATION_OF_...354,SET,5,0.63453,0.010464,0.40149,0.057012,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.802425012116317
REACTOME_PROTON_COUPLED_MONO...,SET,6,0.6019,0.010873,0.38092,0.05705,REACTOME_PROTON_COUPLED_MONOCARBOXYLATE_TRANSPORT,0.802425012116317
GSE23502_WT_VS_HDC_KO_MYELOI...1,SET,186,0.098874,0.0098962,0.062602,0.05713,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_DN,0.802425012116317
GOBP_REGULATION_OF_TRANSCRIP...4,SET,11,0.3606,0.0088191,0.22832,0.057138,GOBP_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.802425012116317
HP_RECURRENT_TONSILLITIS,SET,12,0.41068,0.01049,0.26005,0.05715,HP_RECURRENT_TONSILLITIS,0.802425012116317
chr3q13,SET,80,0.28899,0.019025,0.183,0.057159,chr3q13,0.802425012116317
LEIN_CHOROID_PLEXUS_MARKERS,SET,98,0.13787,0.01004,0.087304,0.05716,LEIN_CHOROID_PLEXUS_MARKERS,0.802425012116317
GOBP_CYTOKINE_PRODUCTION_INV...1,SET,115,0.13105,0.010334,0.082992,0.057166,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,0.802425012116317
GOMF_THREONINE_TYPE_ENDOPEPT...,SET,9,0.4429,0.0097985,0.28059,0.057235,GOMF_THREONINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.803069206701655
GSE46606_IRF4HIGH_VS_WT_CD40...2,SET,177,0.095916,0.0093673,0.060779,0.057279,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.803362245762712
RODRIGUES_THYROID_CARCINOMA_...4,SET,707,0.050504,0.009713,0.032017,0.057361,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN,0.803861717049577
GOBP_CENTRAL_NERVOUS_SYSTEM_...5,SET,35,0.241,0.010507,0.15279,0.057368,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_AXONOGENESIS,0.803861717049577
HP_NEVUS_FLAMMEUS_OF_THE_FOR...,SET,6,0.56919,0.010282,0.36089,0.057384,HP_NEVUS_FLAMMEUS_OF_THE_FOREHEAD,0.803861717049577
HP_FURROWED_TONGUE,SET,38,0.19105,0.008678,0.12115,0.057415,HP_FURROWED_TONGUE,0.803884269323671
GOBP_REGULATION_OF_LONG_TERM...1,SET,23,0.26606,0.0094062,0.16875,0.057444,GOBP_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.803884269323671
GOBP_POSITIVE_REGULATION_OF_...544,SET,57,0.17291,0.0096144,0.10967,0.057455,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.803884269323671
GOBP_REGULATION_OF_COLLAGEN_...2,SET,32,0.25565,0.010658,0.1622,0.057505,GOBP_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.804260070422535
GSE17974_IL4_AND_ANTI_IL12_V...1,SET,135,0.11766,0.010047,0.074686,0.057592,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_DN,0.804757053858521
GSE19888_ADENOSINE_A3R_ACT_V...4,SET,164,0.09982,0.0093872,0.063364,0.057598,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_UP,0.804757053858521
GOBP_CALCIUM_ION_TRANSPORT,SET,396,0.070239,0.010198,0.044589,0.05761,GOBP_CALCIUM_ION_TRANSPORT,0.804757053858521
HP_3_4_TOE_SYNDACTYLY,SET,6,0.57575,0.010401,0.36556,0.057637,HP_3_4_TOE_SYNDACTYLY,0.804810741261551
LI_PBMC_MENACTRA_AGE_18_45YO...4,SET,14,0.37881,0.010451,0.24056,0.057671,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.804962090361446
GOCC_EUCHROMATIN,SET,49,0.18144,0.009356,0.11527,0.057751,GOCC_EUCHROMATIN,0.805339596100278
MIR381_5P,SET,7,0.48947,0.0095507,0.31103,0.057786,MIR381_5P,0.805339596100278
GSE17721_CTRL_VS_POLYIC_12H_...2,SET,178,0.094837,0.0092878,0.060264,0.057788,GSE17721_CTRL_VS_POLYIC_12H_BMDC_UP,0.805339596100278
GOBP_AROMATIC_AMINO_ACID_TRA...,SET,9,0.45707,0.010112,0.29047,0.057804,GOBP_AROMATIC_AMINO_ACID_TRANSPORT,0.805339596100278
GOMF_HISTONE_H3K4_TRIMETHYLT...,SET,10,0.42685,0.0099539,0.27129,0.057825,GOMF_HISTONE_H3K4_TRIMETHYLTRANSFERASE_ACTIVITY,0.805339596100278
WU_HBX_TARGETS_2_UP,SET,21,0.2985,0.010084,0.18981,0.057909,WU_HBX_TARGETS_2_UP,0.805339596100278
GOMF_THIOLESTER_HYDROLASE_AC...,SET,40,0.20798,0.0096921,0.13228,0.057947,GOMF_THIOLESTER_HYDROLASE_ACTIVITY,0.805339596100278
BIOCARTA_PPARA_PATHWAY,SET,52,0.19505,0.01036,0.12407,0.057979,BIOCARTA_PPARA_PATHWAY,0.805339596100278
GOMF_ACTIN_FILAMENT_BINDING,SET,197,0.097029,0.0099916,0.061724,0.057985,GOMF_ACTIN_FILAMENT_BINDING,0.805339596100278
CEBPB_02,SET,237,0.088761,0.010014,0.056475,0.058018,CEBPB_02,0.805339596100278
GOBP_POSITIVE_REGULATION_OF_...624,SET,7,0.52194,0.010184,0.33214,0.058051,GOBP_POSITIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.805339596100278
GSE29164_UNTREATED_VS_CD8_TC...7,SET,178,0.10126,0.0099173,0.064451,0.058079,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_DN,0.805339596100278
GOBP_RENAL_ALBUMIN_ABSORPTION,SET,7,0.5733,0.011186,0.36493,0.058099,GOBP_RENAL_ALBUMIN_ABSORPTION,0.805339596100278
GOBP_TRANSMEMBRANE_TRANSPORT,SET,1410,0.037779,0.010055,0.024048,0.058105,GOBP_TRANSMEMBRANE_TRANSPORT,0.805339596100278
ZNF669_TARGET_GENES,SET,95,0.13835,0.0099209,0.088079,0.058132,ZNF669_TARGET_GENES,0.805339596100278
GOMF_METAL_ION_TRANSMEMBRANE...,SET,426,0.067903,0.010217,0.043238,0.058166,GOMF_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.805339596100278
MIR378G,SET,79,0.14759,0.0096558,0.093984,0.058167,MIR378G,0.805339596100278
GOBP_REGULATION_OF_CARDIAC_M...8,SET,68,0.16317,0.009907,0.10391,0.058182,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.805339596100278
WP_CYTOSOLIC_DNASENSING_PATH...,SET,62,0.16837,0.0097627,0.10723,0.058195,WP_CYTOSOLIC_DNASENSING_PATHWAY,0.805339596100278
PYEON_HPV_POSITIVE_TUMORS_DN,SET,8,0.53334,0.011125,0.3397,0.058212,PYEON_HPV_POSITIVE_TUMORS_DN,0.805339596100278
GSE15330_HSC_VS_MEGAKARYOCYT...4,SET,149,0.1069,0.0095857,0.068085,0.058212,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,0.805339596100278
MIR6878_3P,SET,59,0.17264,0.0097659,0.10997,0.058228,MIR6878_3P,0.805339596100278
GACTGTT_MIR212_MIR132,SET,144,0.10958,0.0096614,0.069802,0.058231,GACTGTT_MIR212_MIR132,0.805339596100278
BARHL1_TARGET_GENES,SET,1040,0.041132,0.0095035,0.026211,0.058301,BARHL1_TARGET_GENES,0.805479561159651
HP_POSTPRANDIAL_HYPERGLYCEMIA,SET,7,0.53408,0.010421,0.34038,0.058325,HP_POSTPRANDIAL_HYPERGLYCEMIA,0.805479561159651
KEGG_ABC_TRANSPORTERS,SET,42,0.21944,0.010478,0.13986,0.058341,KEGG_ABC_TRANSPORTERS,0.805479561159651
BOYLAN_MULTIPLE_MYELOMA_C_CL...1,SET,27,0.29741,0.011391,0.18957,0.058344,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN,0.805479561159651
HP_THROMBOEMBOLISM,SET,91,0.14525,0.010195,0.092585,0.058357,HP_THROMBOEMBOLISM,0.805479561159651
BUCASAS_PBMC_FLUARIX_FLUVIRI...2,SET,18,0.27543,0.0086154,0.17561,0.0584,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_HIGH_RESPONDERS_1DY_TOP_FUNCTIONAL_NETWORK_POSITIVE,0.805502291666667
GOMF_PEPTIDASE_ACTIVATOR_ACT...2,SET,21,0.27843,0.0094061,0.17752,0.058405,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.805502291666667
HP_SMALL_PLACENTA,SET,9,0.48743,0.010784,0.31087,0.058452,HP_SMALL_PLACENTA,0.805538766851705
YGCANTGCR_UNKNOWN,SET,109,0.12502,0.0095993,0.079734,0.058454,YGCANTGCR_UNKNOWN,0.805538766851705
GOBP_POSTSYNAPTIC_MODULATION...,SET,26,0.25593,0.0096194,0.16326,0.058491,GOBP_POSTSYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,0.80555896039604
HP_DENTAL_MALOCCLUSION,SET,127,0.11917,0.0098718,0.076027,0.058513,HP_DENTAL_MALOCCLUSION,0.80555896039604
GOBP_CYCLIC_NUCLEOTIDE_TRANS...,SET,11,0.44428,0.010866,0.28346,0.058525,GOBP_CYCLIC_NUCLEOTIDE_TRANSPORT,0.80555896039604
GSE17721_POLYIC_VS_PAM3CSK4_...3,SET,182,0.097134,0.009618,0.062001,0.058607,GSE17721_POLYIC_VS_PAM3CSK4_12H_BMDC_DN,0.805830731279251
GOCC_RNA_CAP_BINDING_COMPLEX,SET,15,0.30643,0.0087507,0.19566,0.058667,GOCC_RNA_CAP_BINDING_COMPLEX,0.805830731279251
GSE8921_UNSTIM_VS_TLR1_2_STI...7,SET,178,0.095563,0.0093589,0.061025,0.058687,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_6H_DN,0.805830731279251
HP_ABNORMAL_ELASTICITY_OF_SK...,SET,204,0.092601,0.0097016,0.059134,0.058689,HP_ABNORMAL_ELASTICITY_OF_SKIN,0.805830731279251
HP_NARROW_VERTEBRAL_INTERPED...,SET,13,0.34364,0.009136,0.21945,0.058693,HP_NARROW_VERTEBRAL_INTERPEDICULAR_DISTANCE,0.805830731279251
MIR574_3P,SET,5,0.64474,0.010633,0.41179,0.058718,MIR574_3P,0.805830731279251
TOOKER_GEMCITABINE_RESISTANC...1,SET,115,0.12615,0.0099478,0.080578,0.058727,TOOKER_GEMCITABINE_RESISTANCE_DN,0.805830731279251
HP_MYELOPROLIFERATIVE_DISORD...,SET,15,0.35275,0.010073,0.22535,0.05876,HP_MYELOPROLIFERATIVE_DISORDER,0.805830731279251
NIKOLSKY_OVERCONNECTED_IN_BR...,SET,21,0.28776,0.0097214,0.18383,0.058765,NIKOLSKY_OVERCONNECTED_IN_BREAST_CANCER,0.805830731279251
WP_PDGF_PATHWAY,SET,38,0.20707,0.0094058,0.1323,0.058782,WP_PDGF_PATHWAY,0.805830731279251
IRF7_01,SET,224,0.091799,0.010073,0.058672,0.058846,IRF7_01,0.805830731279251
BOQUEST_STEM_CELL_CULTURED_V...1,SET,30,0.25694,0.010372,0.16423,0.058858,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_DN,0.805830731279251
BUSSLINGER_ESOPHAGEAL_PROLIF...,SET,67,0.1667,0.010047,0.10656,0.058874,BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS,0.805830731279251
GSE21360_PRIMARY_VS_TERTIARY...1,SET,180,0.10116,0.0099624,0.06467,0.05888,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.805830731279251
HP_SEVERE_SHORT_LIMB_DWARFISM,SET,5,0.64876,0.010699,0.41488,0.05895,HP_SEVERE_SHORT_LIMB_DWARFISM,0.805830731279251
WP_INTERACTOME_OF_POLYCOMB_R...,SET,15,0.31327,0.0089461,0.20037,0.058975,WP_INTERACTOME_OF_POLYCOMB_REPRESSIVE_COMPLEX_2_PRC2,0.805830731279251
DESCARTES_MAIN_FETAL_VASCULA...,SET,40,0.21504,0.010021,0.13754,0.058986,DESCARTES_MAIN_FETAL_VASCULAR_ENDOTHELIAL_CELLS,0.805830731279251
GSE17721_CTRL_VS_PAM3CSK4_0....2,SET,179,0.094521,0.0092826,0.060479,0.059051,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_UP,0.805830731279251
WP_SULFATASE_AND_AROMATASE_P...,SET,14,0.36891,0.010178,0.2361,0.059091,WP_SULFATASE_AND_AROMATASE_PATHWAY,0.805830731279251
GSE3720_LPS_VS_PMA_STIM_VD1_...1,SET,157,0.1041,0.0095806,0.066634,0.059115,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,0.805830731279251
GSE19825_NAIVE_VS_IL2RALOW_D...2,SET,180,0.10252,0.010096,0.065625,0.059123,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_UP,0.805830731279251
REACTOME_SIGNALING_BY_PTK6,SET,53,0.18641,0.0099961,0.11933,0.059132,REACTOME_SIGNALING_BY_PTK6,0.805830731279251
MODULE_305,SET,19,0.28739,0.0092357,0.18401,0.059169,MODULE_305,0.805830731279251
GOBP_PEPTIDYL_ARGININE_METHY...1,SET,10,0.39179,0.0091364,0.25086,0.059177,GOBP_PEPTIDYL_ARGININE_METHYLATION,0.805830731279251
KEGG_MEDICUS_PATHOGEN_EBV_LM...1,SET,10,0.41117,0.0095884,0.26327,0.059181,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_NFKB_SIGNALING_PATHWAY,0.805830731279251
GSE34156_NOD2_LIGAND_VS_TLR1...2,SET,152,0.10611,0.0096095,0.067956,0.059223,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.805830731279251
GNF2_MCM5,SET,54,0.17446,0.0094427,0.11174,0.059233,GNF2_MCM5,0.805830731279251
GOBP_REGULATION_OF_TOLL_LIKE...6,SET,29,0.2268,0.0090021,0.14529,0.05927,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.805830731279251
GOBP_REGULATION_OF_PEPTIDYL_...5,SET,39,0.21479,0.0098836,0.13761,0.059286,GOBP_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,0.805830731279251
GOBP_MESENCHYMAL_STEM_CELL_P...,SET,7,0.54208,0.010577,0.34731,0.059296,GOBP_MESENCHYMAL_STEM_CELL_PROLIFERATION,0.805830731279251
NUP214_TARGET_GENES,SET,7,0.58399,0.011395,0.37421,0.05932,NUP214_TARGET_GENES,0.805830731279251
GOBP_POSITIVE_REGULATION_OF_...229,SET,10,0.40955,0.0095505,0.26246,0.059342,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.805830731279251
DESCARTES_MAIN_FETAL_URETERI...,SET,27,0.26586,0.010183,0.1704,0.059359,DESCARTES_MAIN_FETAL_URETERIC_BUD_CELLS,0.805830731279251
HP_2_3_TOE_SYNDACTYLY,SET,81,0.14767,0.0097819,0.09466,0.059385,HP_2_3_TOE_SYNDACTYLY,0.805830731279251
SENESE_HDAC3_TARGETS_DN,SET,467,0.062082,0.0097696,0.0398,0.059404,SENESE_HDAC3_TARGETS_DN,0.805830731279251
GOBP_AXO_DENDRITIC_TRANSPORT,SET,74,0.15511,0.0098223,0.099445,0.059419,GOBP_AXO_DENDRITIC_TRANSPORT,0.805830731279251
HP_DYSPHONIA,SET,111,0.12423,0.0096255,0.079659,0.05944,HP_DYSPHONIA,0.805830731279251
GOBP_ERBB4_ERBB4_SIGNALING_P...,SET,6,0.54538,0.0098525,0.34972,0.059449,GOBP_ERBB4_ERBB4_SIGNALING_PATHWAY,0.805830731279251
GOBP_POSITIVE_REGULATION_OF_...274,SET,34,0.22844,0.0098162,0.14648,0.059449,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,0.805830731279251
GARGALOVIC_RESPONSE_TO_OXIDI...24,SET,27,0.25048,0.0095935,0.16067,0.059515,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_UP,0.806410847953216
HES4_TARGET_GENES,SET,490,0.059298,0.0095523,0.038054,0.059597,HES4_TARGET_GENES,0.807207223304754
BROWNE_HCMV_INFECTION_6HR_UP,SET,57,0.1763,0.0098031,0.11322,0.059717,BROWNE_HCMV_INFECTION_6HR_UP,0.807748115577889
GOBP_REGULATION_OF_PANCREATI...,SET,7,0.44765,0.0087345,0.28756,0.059776,GOBP_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.807748115577889
GOBP_SNRNA_TRANSCRIPTION_BY_...1,SET,16,0.29024,0.0085598,0.1865,0.059832,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.807748115577889
GSE15930_NAIVE_VS_72H_IN_VIT...3,SET,183,0.093138,0.0092473,0.059864,0.059883,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_DN,0.807748115577889
MIR4491,SET,67,0.15395,0.0092781,0.098956,0.059895,MIR4491,0.807748115577889
BUSSLINGER_GASTRIC_IMMUNE_CE...,SET,1342,0.036997,0.0096253,0.023781,0.059896,BUSSLINGER_GASTRIC_IMMUNE_CELLS,0.807748115577889
GSE5589_WT_VS_IL10_KO_LPS_ST...3,SET,185,0.09618,0.009601,0.061832,0.059921,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,0.807748115577889
REACTOME_HDR_THROUGH_HOMOLOG...,SET,64,0.14979,0.0088237,0.096302,0.059935,REACTOME_HDR_THROUGH_HOMOLOGOUS_RECOMBINATION_HRR,0.807748115577889
GOBP_POSITIVE_REGULATION_OF_...558,SET,8,0.53678,0.011197,0.34519,0.059982,GOBP_POSITIVE_REGULATION_OF_ODONTOGENESIS,0.807748115577889
MIR612,SET,97,0.12796,0.0092717,0.082292,0.059984,MIR612,0.807748115577889
GOBP_POSITIVE_REGULATION_OF_...764,SET,6,0.55663,0.010056,0.35799,0.06,GOBP_POSITIVE_REGULATION_OF_TOOTH_MINERALIZATION,0.807748115577889
HP_ANIRIDIA,SET,41,0.2031,0.0095819,0.13063,0.060009,HP_ANIRIDIA,0.807748115577889
CALVET_IRINOTECAN_SENSITIVE_...1,SET,4,0.62654,0.0092421,0.403,0.060021,CALVET_IRINOTECAN_SENSITIVE_VS_RESISTANT_UP,0.807748115577889
GOBP_DNA_DAMAGE_RESPONSE,SET,794,0.044885,0.0091255,0.028872,0.060032,GOBP_DNA_DAMAGE_RESPONSE,0.807748115577889
REACTOME_INTERLEUKIN_17_SIGN...,SET,65,0.16918,0.010043,0.10885,0.060065,REACTOME_INTERLEUKIN_17_SIGNALING,0.807748115577889
GOBP_POSITIVE_REGULATION_OF_...825,SET,6,0.56619,0.010228,0.3643,0.060079,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.807748115577889
PID_HIF2PATHWAY,SET,30,0.23036,0.0092995,0.14823,0.060093,PID_HIF2PATHWAY,0.807748115577889
GOBP_ADAPTIVE_IMMUNE_RESPONSE,SET,427,0.069346,0.010446,0.044627,0.060111,GOBP_ADAPTIVE_IMMUNE_RESPONSE,0.807748115577889
GOMF_SOLUTE_PROTON_SYMPORTER...,SET,24,0.28734,0.010377,0.18492,0.060115,GOMF_SOLUTE_PROTON_SYMPORTER_ACTIVITY,0.807748115577889
GOBP_CHAPERONE_MEDIATED_PROT...1,SET,22,0.25119,0.0086855,0.16166,0.060119,GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY,0.807748115577889
ZHENG_CORD_BLOOD_C9_GRANULOC...,SET,90,0.14061,0.0098153,0.090492,0.060125,ZHENG_CORD_BLOOD_C9_GRANULOCYTE_MACROPHAGE_PROGENITOR,0.807748115577889
GOBP_FIBROBLAST_MIGRATION,SET,49,0.19301,0.0099527,0.12423,0.060149,GOBP_FIBROBLAST_MIGRATION,0.807758305641422
REACTOME_METABOLISM_OF_CARBO...,SET,267,0.079916,0.009562,0.051465,0.060241,REACTOME_METABOLISM_OF_CARBOHYDRATES,0.808681326767092
HP_ABNORMAL_RENAL_VASCULAR_M...,SET,24,0.25544,0.0092248,0.16457,0.060318,HP_ABNORMAL_RENAL_VASCULAR_MORPHOLOGY,0.80923751254342
HP_SUPRAVENTRICULAR_ARRHYTHM...,SET,111,0.13425,0.010401,0.086495,0.060329,HP_SUPRAVENTRICULAR_ARRHYTHMIA,0.80923751254342
HP_PROLONGED_BLEEDING_AFTER_...1,SET,21,0.32684,0.011042,0.21064,0.060379,HP_PROLONGED_BLEEDING_AFTER_DENTAL_EXTRACTION,0.809595734953704
HP_FOLLICULAR_HYPERKERATOSIS,SET,26,0.26079,0.0098019,0.1681,0.060408,HP_FOLLICULAR_HYPERKERATOSIS,0.809672209795604
MIR3125,SET,220,0.086022,0.009355,0.055482,0.060526,MIR3125,0.810321252886836
GOBP_GAMMA_AMINOBUTYRIC_ACID...1,SET,6,0.60577,0.010943,0.3907,0.060526,GOBP_GAMMA_AMINOBUTYRIC_ACID_BIOSYNTHETIC_PROCESS,0.810321252886836
MORF_RAGE,SET,136,0.11313,0.0096956,0.072977,0.060553,MORF_RAGE,0.810321252886836
GOBP_CYCLOOXYGENASE_PATHWAY,SET,9,0.41875,0.0092642,0.27013,0.060561,GOBP_CYCLOOXYGENASE_PATHWAY,0.810321252886836
KEGG_MEDICUS_VARIANT_MUTATIO...31,SET,19,0.30463,0.0097897,0.19653,0.060573,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY,0.810321252886836
TERT_TARGET_GENES,SET,72,0.16146,0.010086,0.10418,0.060599,TERT_TARGET_GENES,0.810357154674875
GSE3400_UNTREATED_VS_IFNB_TR...1,SET,154,0.10626,0.0096858,0.068578,0.060644,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN,0.810415513264129
HP_CHRONIC_INFECTION,SET,21,0.29621,0.010007,0.19118,0.06065,HP_CHRONIC_INFECTION,0.810415513264129
WP_PROTEOGLYCAN_BIOSYNTHESIS,SET,17,0.31896,0.0096962,0.20593,0.060715,WP_PROTEOGLYCAN_BIOSYNTHESIS,0.810719540933435
GOBP_REGULATION_OF_RELEASE_O...3,SET,27,0.2607,0.0099849,0.16839,0.060801,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_SARCOPLASMIC_RETICULUM,0.810719540933435
chr3p26,SET,14,0.62581,0.017266,0.40427,0.060821,chr3p26,0.810719540933435
GOBP_POSITIVE_REGULATION_OF_...197,SET,7,0.47556,0.0092791,0.3073,0.060875,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.810719540933435
ACAACCT_MIR453,SET,36,0.21628,0.0095629,0.13977,0.060887,ACAACCT_MIR453,0.810719540933435
GOBP_REGULATION_OF_ESTABLISH...1,SET,13,0.35643,0.0094762,0.23035,0.060897,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PLANAR_POLARITY,0.810719540933435
DESCARTES_MAIN_FETAL_SATB2_L...,SET,77,0.15673,0.010124,0.10129,0.060903,DESCARTES_MAIN_FETAL_SATB2_LRRC7_POSITIVE_CELLS,0.810719540933435
HP_SINGLE_VENTRICLE,SET,8,0.45276,0.009444,0.29265,0.060929,HP_SINGLE_VENTRICLE,0.810719540933435
REACTOME_AGGREPHAGY,SET,38,0.2265,0.010288,0.14641,0.060936,REACTOME_AGGREPHAGY,0.810719540933435
MARKEY_RB1_ACUTE_LOF_UP,SET,215,0.087561,0.0094149,0.056602,0.060946,MARKEY_RB1_ACUTE_LOF_UP,0.810719540933435
GOBP_AMMONIUM_TRANSMEMBRANE_...,SET,13,0.39154,0.01041,0.25311,0.060951,GOBP_AMMONIUM_TRANSMEMBRANE_TRANSPORT,0.810719540933435
WEBER_METHYLATED_HCP_IN_SPER...2,SET,16,0.30229,0.0089154,0.19543,0.060966,WEBER_METHYLATED_HCP_IN_SPERM_UP,0.810719540933435
EHRLICH_ICF_SYNDROM_UP,SET,9,0.42983,0.0095094,0.2779,0.060976,EHRLICH_ICF_SYNDROM_UP,0.810719540933435
MIR4644,SET,274,0.079918,0.009685,0.051681,0.061015,MIR4644,0.810927848948375
WP_COMPLEMENT_AND_COAGULATIO...,SET,52,0.19532,0.010375,0.12633,0.061045,WP_COMPLEMENT_AND_COAGULATION_CASCADES,0.811016427752294
GOBP_NEUTROPHIL_MEDIATED_IMM...,SET,37,0.21305,0.0095497,0.13783,0.061094,GOBP_NEUTROPHIL_MEDIATED_IMMUNITY,0.811219624189241
HP_SEVERE_POSTNATAL_GROWTH_R...,SET,32,0.23936,0.009979,0.15486,0.061108,HP_SEVERE_POSTNATAL_GROWTH_RETARDATION,0.811219624189241
chr14q24,SET,107,0.27027,0.020562,0.17491,0.061162,chr14q24,0.811219624189241
HP_ATLANTOAXIAL_DISLOCATION,SET,6,0.49892,0.0090131,0.32291,0.061176,HP_ATLANTOAXIAL_DISLOCATION,0.811219624189241
LAKE_ADULT_KIDNEY_C17_COLLEC...,SET,225,0.092436,0.010165,0.059828,0.061177,LAKE_ADULT_KIDNEY_C17_COLLECTING_SYSTEM_PCS_STRESSED_DISSOC_SUBSET,0.811219624189241
GOBP_NEGATIVE_REGULATION_OF_...625,SET,4,0.69031,0.010183,0.44693,0.061237,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,0.811261094931921
HP_INTERVERTEBRAL_SPACE_NARR...,SET,6,0.53217,0.0096138,0.34456,0.061243,HP_INTERVERTEBRAL_SPACE_NARROWING,0.811261094931921
GOBP_MONONUCLEAR_CELL_DIFFER...,SET,490,0.063244,0.010188,0.040963,0.06131,GOBP_MONONUCLEAR_CELL_DIFFERENTIATION,0.811261094931921
MIR5685,SET,58,0.16717,0.0093762,0.10828,0.061314,MIR5685,0.811261094931921
GOBP_NEGATIVE_REGULATION_OF_...424,SET,76,0.16122,0.010346,0.10443,0.061324,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_DIFFERENTIATION,0.811261094931921
EGUCHI_CELL_CYCLE_RB1_TARGETS,SET,22,0.27682,0.0095718,0.1794,0.06142,EGUCHI_CELL_CYCLE_RB1_TARGETS,0.811261094931921
CAMPS_COLON_CANCER_COPY_NUMB...1,SET,35,0.24614,0.010731,0.15952,0.061423,CAMPS_COLON_CANCER_COPY_NUMBER_DN,0.811261094931921
MIR5705,SET,5,0.60962,0.010054,0.39513,0.061445,MIR5705,0.811261094931921
TTGCWCAAY_CEBPB_02,SET,60,0.17637,0.010061,0.11432,0.061447,TTGCWCAAY_CEBPB_02,0.811261094931921
BIOCARTA_PDGF_PATHWAY,SET,27,0.25471,0.0097554,0.1651,0.061457,BIOCARTA_PDGF_PATHWAY,0.811261094931921
GSE20198_UNTREATED_VS_IL12_T...2,SET,179,0.091559,0.0089917,0.059351,0.061462,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_UP,0.811261094931921
GSE1448_CTRL_VS_ANTI_VALPHA2...2,SET,178,0.095423,0.0093452,0.061857,0.06147,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_UP,0.811261094931921
MIR5706,SET,150,0.10833,0.0097462,0.070238,0.061515,MIR5706,0.811261094931921
DESCARTES_FETAL_LIVER_HEMATO...,SET,23,0.29496,0.010428,0.1913,0.061559,DESCARTES_FETAL_LIVER_HEMATOPOIETIC_STEM_CELLS,0.811261094931921
MIR4526,SET,94,0.13452,0.009596,0.087266,0.0616,MIR4526,0.811261094931921
GSE7764_IL15_NK_CELL_24H_VS_...2,SET,171,0.094555,0.0090781,0.061341,0.061611,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_UP,0.811261094931921
HP_PULMONARY_LYMPHANGIECTASIA,SET,5,0.68581,0.01131,0.44495,0.06163,HP_PULMONARY_LYMPHANGIECTASIA,0.811261094931921
GOBP_SEX_DETERMINATION,SET,18,0.33489,0.010475,0.21728,0.061637,GOBP_SEX_DETERMINATION,0.811261094931921
VALK_AML_CLUSTER_11,SET,37,0.2316,0.010381,0.15027,0.061644,VALK_AML_CLUSTER_11,0.811261094931921
HP_ABNORMAL_CARTILAGE_MORPHO...,SET,41,0.20932,0.0098756,0.13585,0.061689,HP_ABNORMAL_CARTILAGE_MORPHOLOGY,0.811261094931921
GSE28783_CTRL_ANTI_MIR_VS_UN...2,SET,171,0.097467,0.0093576,0.063257,0.061692,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_UP,0.811261094931921
GOBP_ASTRAL_MICROTUBULE_ORGA...,SET,10,0.40134,0.0093591,0.2605,0.061707,GOBP_ASTRAL_MICROTUBULE_ORGANIZATION,0.811261094931921
LI_PBMC_ZOSTAVAX_AGE_25_40_A...2,SET,7,0.53189,0.010378,0.34525,0.061717,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_3DY_UP,0.811261094931921
GOMF_OXIDATIVE_PHOSPHORYLATI...,SET,4,0.59409,0.0087635,0.38577,0.061789,GOMF_OXIDATIVE_PHOSPHORYLATION_UNCOUPLER_ACTIVITY,0.8114925
GOMF_PHOSPHATIDYLINOSITOL_BI...2,SET,98,0.12991,0.009461,0.084359,0.061793,GOMF_PHOSPHATIDYLINOSITOL_BISPHOSPHATE_BINDING,0.8114925
GOMF_O_PALMITOYLTRANSFERASE_...,SET,5,0.55535,0.0091587,0.36066,0.061814,GOMF_O_PALMITOYLTRANSFERASE_ACTIVITY,0.8114925
HP_VASCULAR_DILATATION,SET,196,0.092778,0.0095298,0.060258,0.061828,HP_VASCULAR_DILATATION,0.8114925
MIR4657,SET,66,0.15489,0.009265,0.10062,0.061879,MIR4657,0.811853237288136
GOBP_MUCUS_SECRETION,SET,19,0.3357,0.010788,0.21814,0.06192,GOBP_MUCUS_SECRETION,0.811853237288136
GSE34156_UNTREATED_VS_24H_NO...3,SET,176,0.10165,0.0098998,0.066068,0.061959,GSE34156_UNTREATED_VS_24H_NOD2_LIGAND_TREATED_MONOCYTE_DN,0.811853237288136
BIOCARTA_TH1TH2_PATHWAY,SET,18,0.31102,0.0097287,0.20216,0.061973,BIOCARTA_TH1TH2_PATHWAY,0.811853237288136
ERWIN_COHEN_BLOOD_VACCINE_TC...1,SET,6,0.50986,0.0092108,0.33146,0.062005,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_DN,0.811853237288136
ABE_VEGFA_TARGETS_2HR,SET,28,0.2562,0.0099922,0.16656,0.062016,ABE_VEGFA_TARGETS_2HR,0.811853237288136
MIR4255,SET,155,0.1068,0.0097668,0.069438,0.062019,MIR4255,0.811853237288136
MIR4737,SET,4,0.68544,0.010111,0.44585,0.062108,MIR4737,0.81218735990974
HP_ABNORMAL_VESTIBULAR_FUNCT...,SET,194,0.095276,0.0097368,0.061978,0.062125,HP_ABNORMAL_VESTIBULAR_FUNCTION,0.81218735990974
GOBP_ANTIGEN_PROCESSING_AND_...1,SET,105,0.13977,0.010535,0.090931,0.062138,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION,0.81218735990974
HP_SINUS_BRADYCARDIA,SET,30,0.25072,0.010121,0.16311,0.062138,HP_SINUS_BRADYCARDIA,0.81218735990974
HP_ABNORMAL_MYELOID_LEUKOCYT...,SET,302,0.074857,0.0095165,0.048712,0.062188,HP_ABNORMAL_MYELOID_LEUKOCYTE_MORPHOLOGY,0.812535315789474
MORF_ACTG1,SET,126,0.11206,0.0092467,0.072933,0.062215,MORF_ACTG1,0.812582609921082
GOBP_REGULATION_OF_NITRIC_OX...2,SET,55,0.18301,0.0099963,0.11917,0.06232,GOBP_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.813399921259843
GOBP_POSITIVE_REGULATION_OF_...338,SET,12,0.48583,0.01241,0.3164,0.062339,GOBP_POSITIVE_REGULATION_OF_HIPPO_SIGNALING,0.813399921259843
KEGG_TIGHT_JUNCTION,SET,125,0.11898,0.0097789,0.077491,0.062348,KEGG_TIGHT_JUNCTION,0.813399921259843
WP_CALCIUM_REGULATION_IN_CAR...,SET,149,0.11177,0.010023,0.072807,0.062377,WP_CALCIUM_REGULATION_IN_CARDIAC_CELLS,0.813399921259843
GSE12366_PLASMA_CELL_VS_MEMO...1,SET,175,0.094497,0.0091769,0.061565,0.062413,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.813399921259843
GOMF_STRUCTURAL_CONSTITUENT_...9,SET,147,0.10014,0.0089203,0.065247,0.062418,GOMF_STRUCTURAL_CONSTITUENT_OF_RIBOSOME,0.813399921259843
GOBP_REGULATION_OF_DNA_TEMPL...1,SET,47,0.18106,0.0091443,0.11806,0.062577,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.815166279985007
GOCC_ENDOCYTIC_VESICLE_LUMEN,SET,21,0.28375,0.0095861,0.18508,0.062626,GOCC_ENDOCYTIC_VESICLE_LUMEN,0.815323662921348
HP_APLASIA_HYPOPLASIA_OF_THE...60,SET,20,0.28804,0.0094966,0.18788,0.062636,HP_APLASIA_HYPOPLASIA_OF_THE_PUBIC_BONE,0.815323662921348
GSE25085_FETAL_LIVER_VS_ADUL...2,SET,166,0.094647,0.0089543,0.061778,0.062765,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,0.816112833395592
GSE41867_DAY8_VS_DAY15_LCMV_...4,SET,182,0.093671,0.0092751,0.061142,0.062767,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,0.816112833395592
BIOCARTA_ECM_PATHWAY,SET,19,0.29169,0.0093736,0.19041,0.062784,BIOCARTA_ECM_PATHWAY,0.816112833395592
GOMF_GLUCURONOSYL_N_ACETYLGA...,SET,6,0.52926,0.0095613,0.34554,0.062806,GOMF_GLUCURONOSYL_N_ACETYLGALACTOSAMINYL_PROTEOGLYCAN_4_BETA_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,0.816112833395592
GOBP_RESPIRATORY_SYSTEM_PROC...,SET,40,0.22014,0.010259,0.14374,0.062837,GOBP_RESPIRATORY_SYSTEM_PROCESS,0.816112833395592
KEGG_ACUTE_MYELOID_LEUKEMIA,SET,54,0.1806,0.0097752,0.11794,0.062847,KEGG_ACUTE_MYELOID_LEUKEMIA,0.816112833395592
GOBP_ISOCITRATE_METABOLIC_PR...,SET,5,0.59629,0.0098338,0.38941,0.062861,GOBP_ISOCITRATE_METABOLIC_PROCESS,0.816112833395592
GAVISH_3CA_MALIGNANT_METAPRO...25,SET,44,0.20406,0.0099726,0.13333,0.062947,GAVISH_3CA_MALIGNANT_METAPROGRAM_33_RBCS,0.816612913870246
HP_FACIAL_HYPOTONIA,SET,41,0.19908,0.0093922,0.13007,0.062948,HP_FACIAL_HYPOTONIA,0.816612913870246
REACTOME_IRAK2_MEDIATED_ACTI...,SET,8,0.5263,0.010978,0.34394,0.06299,REACTOME_IRAK2_MEDIATED_ACTIVATION_OF_TAK1_COMPLEX,0.816612913870246
HP_CERVICAL_KYPHOSIS,SET,8,0.4513,0.0094137,0.29496,0.063011,HP_CERVICAL_KYPHOSIS,0.816612913870246
HP_ABNORMAL_RESPONSE_TO_SOCI...,SET,61,0.17367,0.0099887,0.11351,0.063017,HP_ABNORMAL_RESPONSE_TO_SOCIAL_NORMS,0.816612913870246
HP_ABNORMALITY_OF_COMPLEMENT...,SET,49,0.19313,0.0099591,0.12625,0.063052,HP_ABNORMALITY_OF_COMPLEMENT_SYSTEM,0.816761930674618
REACTOME_TGFBR3_PTM_REGULATI...,SET,9,0.43414,0.0096046,0.28394,0.063144,REACTOME_TGFBR3_PTM_REGULATION,0.817130679448995
ZNF175_TARGET_GENES,SET,627,0.051763,0.0093962,0.033855,0.063149,ZNF175_TARGET_GENES,0.817130679448995
WP_CARDIOMYOCYTE_SIGNALING_C...,SET,31,0.23194,0.0095177,0.1517,0.063151,WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN,0.817130679448995
GOBP_ELASTIC_FIBER_ASSEMBLY,SET,8,0.44234,0.0092267,0.28941,0.06321,GOBP_ELASTIC_FIBER_ASSEMBLY,0.817304314381271
CONCANNON_APOPTOSIS_BY_EPOXO...2,SET,216,0.090541,0.0097577,0.059251,0.063254,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP,0.817304314381271
HP_TONGUE_NODULES,SET,12,0.28785,0.0073527,0.18837,0.063257,HP_TONGUE_NODULES,0.817304314381271
GSE32423_MEMORY_VS_NAIVE_CD8...6,SET,184,0.098183,0.0097747,0.064255,0.063263,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_UP,0.817304314381271
HP_RECURRENT_CUTANEOUS_ABSCE...,SET,6,0.58211,0.010516,0.381,0.063282,HP_RECURRENT_CUTANEOUS_ABSCESS_FORMATION,0.817304314381271
GOBP_CELLULAR_RESPONSE_TO_DE...,SET,27,0.27477,0.010524,0.17988,0.063332,GOBP_CELLULAR_RESPONSE_TO_DEXAMETHASONE_STIMULUS,0.817646233283804
MIR1253,SET,158,0.10528,0.0097198,0.068953,0.063403,MIR1253,0.818124728079911
GOBP_LYMPHOCYTE_MIGRATION_IN...,SET,9,0.4659,0.010307,0.30525,0.063476,GOBP_LYMPHOCYTE_MIGRATION_INTO_LYMPHOID_ORGANS,0.818124728079911
XU_HGF_SIGNALING_NOT_VIA_AKT...2,SET,32,0.23411,0.0097599,0.15338,0.063477,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP,0.818124728079911
WP_UROTENSINIIMEDIATED_SIGNA...,SET,66,0.15976,0.0095563,0.10469,0.063516,WP_UROTENSINIIMEDIATED_SIGNALING,0.818124728079911
GOCC_BASOLATERAL_PLASMA_MEMB...,SET,246,0.087562,0.010062,0.057383,0.063523,GOCC_BASOLATERAL_PLASMA_MEMBRANE,0.818124728079911
GSE9988_ANTI_TREM1_AND_LPS_V...2,SET,165,0.10654,0.01005,0.069841,0.063573,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_UP,0.818124728079911
GSE14000_TRANSLATED_RNA_VS_M...1,SET,162,0.097153,0.0090809,0.06369,0.063589,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_DN,0.818124728079911
GOBP_NEGATIVE_REGULATION_OF_...234,SET,48,0.20389,0.010406,0.13367,0.063603,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,0.818124728079911
MIR6730_5P,SET,120,0.11446,0.0092183,0.075049,0.063624,MIR6730_5P,0.818124728079911
HP_INAPPROPRIATE_CRYING,SET,14,0.34539,0.0095291,0.22647,0.063625,HP_INAPPROPRIATE_CRYING,0.818124728079911
GOBP_ATTACHMENT_OF_SPINDLE_M...,SET,49,0.17578,0.009064,0.11526,0.063628,GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.818124728079911
WP_TLR4_SIGNALING_AND_TOLERA...,SET,26,0.23944,0.0089993,0.15703,0.063661,WP_TLR4_SIGNALING_AND_TOLERANCE,0.818226493530499
GOBP_REGULATION_OF_MEIOTIC_C...2,SET,10,0.39713,0.0092608,0.26047,0.063683,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.818226493530499
GOBP_NEGATIVE_REGULATION_OF_...647,SET,9,0.46633,0.010317,0.30593,0.063726,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.818476396895787
PID_TCR_RAS_PATHWAY,SET,13,0.36055,0.0095858,0.23661,0.063783,PID_TCR_RAS_PATHWAY,0.818905860731437
MODULE_419,SET,30,0.23871,0.0096365,0.15668,0.063816,MODULE_419,0.819026986706056
WP_NODLIKE_RECEPTOR_NLR_SIGN...,SET,7,0.48153,0.0093957,0.31609,0.06384,WP_NODLIKE_RECEPTOR_NLR_SIGNALING,0.819032558139535
HP_TIBIALIS_ANTERIOR_MUSCLE_...,SET,4,0.66421,0.0097978,0.43613,0.063891,HP_TIBIALIS_ANTERIOR_MUSCLE_ATROPHY,0.819126647101981
WP_ENDOPLASMIC_RETICULUM_STR...,SET,44,0.18702,0.0091398,0.12281,0.063901,WP_ENDOPLASMIC_RETICULUM_STRESS_RESPONSE_IN_CORONAVIRUS_INFECTION,0.819126647101981
NFE2L1_TARGET_GENES,SET,1475,0.034093,0.0092627,0.022394,0.063962,NFE2L1_TARGET_GENES,0.819126647101981
GNF2_ICAM3,SET,34,0.21486,0.0092328,0.14115,0.063989,GNF2_ICAM3,0.819126647101981
KEGG_MEDICUS_REFERENCE_GLUTA...,SET,11,0.37571,0.0091889,0.24688,0.06403,KEGG_MEDICUS_REFERENCE_GLUTATHIONE_BIOSYNTHESIS,0.819126647101981
TRAVAGLINI_LUNG_BASOPHIL_MAS...2,SET,425,0.06411,0.0096356,0.042128,0.064039,TRAVAGLINI_LUNG_BASOPHIL_MAST_2_CELL,0.819126647101981
JOHNSTONE_PARVB_TARGETS_2_DN,SET,306,0.076927,0.0098431,0.050551,0.06404,JOHNSTONE_PARVB_TARGETS_2_DN,0.819126647101981
DESCARTES_MAIN_FETAL_INHIBIT...1,SET,25,0.29039,0.010703,0.19083,0.064047,DESCARTES_MAIN_FETAL_INHIBITORY_INTERNEURONS,0.819126647101981
GSE40666_STAT1_KO_VS_STAT4_K...3,SET,145,0.1137,0.010059,0.074733,0.064096,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,0.819126647101981
GOBP_POSITIVE_REGULATION_OF_...303,SET,7,0.54385,0.010612,0.35754,0.064125,GOBP_POSITIVE_REGULATION_OF_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,0.819126647101981
GOBP_LYMPHOCYTE_AGGREGATION,SET,4,0.6849,0.010103,0.45028,0.06413,GOBP_LYMPHOCYTE_AGGREGATION,0.819126647101981
BIOCARTA_P27_PATHWAY,SET,13,0.36523,0.0097102,0.24016,0.064161,BIOCARTA_P27_PATHWAY,0.819126647101981
HP_MITOCHONDRIAL_INHERITANCE,SET,4,0.53263,0.0078568,0.35026,0.064179,HP_MITOCHONDRIAL_INHERITANCE,0.819126647101981
GAVISH_3CA_METAPROGRAM_EPITH...23,SET,46,0.20712,0.010349,0.13621,0.064191,GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS,0.819126647101981
HP_LIMBAL_STEM_CELL_DEFICIEN...,SET,8,0.54538,0.011376,0.35872,0.064219,HP_LIMBAL_STEM_CELL_DEFICIENCY,0.819126647101981
GOCC_PARASPECKLES,SET,7,0.42176,0.0082295,0.27744,0.06424,GOCC_PARASPECKLES,0.819126647101981
WP_PROGERIAASSOCIATED_LIPODY...,SET,21,0.28059,0.0094793,0.18458,0.064248,WP_PROGERIAASSOCIATED_LIPODYSTROPHY,0.819126647101981
GSE24142_EARLY_THYMIC_PROGEN...10,SET,187,0.093297,0.0093628,0.061382,0.064273,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_DN,0.819144889988999
WP_NAD_BIOSYNTHETIC_PATHWAYS,SET,22,0.27844,0.0096276,0.18324,0.064327,WP_NAD_BIOSYNTHETIC_PATHWAYS,0.819532582478006
GOBP_NEGATIVE_REGULATION_OF_...133,SET,11,0.35388,0.0086548,0.23293,0.064358,GOBP_NEGATIVE_REGULATION_OF_CGAS_STING_SIGNALING_PATHWAY,0.819556
KEGG_MEDICUS_REFERENCE_DOUBL...2,SET,11,0.37333,0.0091306,0.24576,0.064376,KEGG_MEDICUS_REFERENCE_DOUBLE_STRAND_BREAK_SIGNALING,0.819556
TIEN_INTESTINE_PROBIOTICS_2H...1,SET,83,0.14328,0.0096071,0.09435,0.064435,TIEN_INTESTINE_PROBIOTICS_2HR_DN,0.819831550841258
MIR3162_3P,SET,20,0.29539,0.0097389,0.19453,0.06446,MIR3162_3P,0.819831550841258
REACTOME_G0_AND_EARLY_G1,SET,27,0.23672,0.0090665,0.15591,0.064481,REACTOME_G0_AND_EARLY_G1,0.819831550841258
GSE34179_THPOK_KO_VS_WT_VA14...1,SET,183,0.096817,0.0096127,0.063771,0.064492,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_DN,0.819831550841258
UNTERMAN_IPF_VS_CTRL_TREG_CE...2,SET,13,0.40362,0.010731,0.26596,0.064569,UNTERMAN_IPF_VS_CTRL_TREG_CELL_UP,0.820273790587377
GOBP_DEFENSE_RESPONSE_TO_TUM...,SET,12,0.3933,0.010047,0.25923,0.064617,GOBP_DEFENSE_RESPONSE_TO_TUMOR_CELL,0.820273790587377
MIR12119,SET,173,0.094977,0.0091712,0.062612,0.064652,MIR12119,0.820273790587377
KEGG_MEDICUS_REFERENCE_RAD51...,SET,10,0.34538,0.0080541,0.22769,0.064655,KEGG_MEDICUS_REFERENCE_RAD51_DSDNA_DESTABILIZATION,0.820273790587377
MIR8058,SET,41,0.21619,0.0102,0.14252,0.064656,MIR8058,0.820273790587377
MODULE_113,SET,96,0.13426,0.0096782,0.088526,0.064686,MODULE_113,0.820273790587377
REACTOME_KERATAN_SULFATE_KER...,SET,36,0.21977,0.0097172,0.14491,0.064692,REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM,0.820273790587377
GOBP_SEX_DIFFERENTIATION,SET,260,0.083678,0.009882,0.055196,0.064765,GOBP_SEX_DIFFERENTIATION,0.820887187839305
MIR4535,SET,26,0.2496,0.0093813,0.16471,0.064849,MIR4535,0.820887187839305
MIR4667_5P,SET,157,0.10829,0.0099655,0.071461,0.064855,MIR4667_5P,0.820887187839305
NABA_MATRISOME_POORLY_METAST...2,SET,12,0.36202,0.0092475,0.23894,0.06488,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,0.820887187839305
HP_INTELLECTUAL_DISABILITY_P...1,SET,87,0.13265,0.0091046,0.087562,0.06491,HP_INTELLECTUAL_DISABILITY_PROFOUND,0.820887187839305
GOBP_BLEB_ASSEMBLY,SET,11,0.42011,0.010275,0.27755,0.065065,GOBP_BLEB_ASSEMBLY,0.820887187839305
KAMMINGA_EZH2_TARGETS,SET,40,0.19391,0.0090363,0.12811,0.065074,KAMMINGA_EZH2_TARGETS,0.820887187839305
KUWANO_RNA_STABILIZED_BY_NO,SET,7,0.58689,0.011451,0.38775,0.065075,KUWANO_RNA_STABILIZED_BY_NO,0.820887187839305
HELLEBREKERS_SILENCED_DURING...,SET,73,0.16307,0.010257,0.10774,0.065087,HELLEBREKERS_SILENCED_DURING_TUMOR_ANGIOGENESIS,0.820887187839305
GSE17721_LPS_VS_PAM3CSK4_1H_...1,SET,190,0.095805,0.0096905,0.063305,0.065099,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_DN,0.820887187839305
GOMF_MELANOCORTIN_RECEPTOR_B...,SET,5,0.56922,0.0093874,0.37612,0.0651,GOMF_MELANOCORTIN_RECEPTOR_BINDING,0.820887187839305
REACTOME_SARS_COV_2_ACTIVATE...,SET,111,0.12013,0.0093077,0.079388,0.065122,REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES,0.820887187839305
AGCATTA_MIR155,SET,124,0.11651,0.009538,0.077002,0.065133,AGCATTA_MIR155,0.820887187839305
HP_MYELIN_OUTFOLDINGS,SET,7,0.46983,0.0091674,0.31052,0.065142,HP_MYELIN_OUTFOLDINGS,0.820887187839305
MIR3139,SET,55,0.17444,0.0095281,0.11529,0.065145,MIR3139,0.820887187839305
GOBP_POSITIVE_REGULATION_OF_...214,SET,16,0.31483,0.009285,0.20808,0.065147,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.820887187839305
HP_NYSTAGMUS_INDUCED_HEAD_NO...,SET,15,0.37893,0.010821,0.25053,0.065211,HP_NYSTAGMUS_INDUCED_HEAD_NODDING,0.820887187839305
HP_ABNORMAL_AORTIC_MORPHOLOGY,SET,351,0.068213,0.0093362,0.045102,0.065225,HP_ABNORMAL_AORTIC_MORPHOLOGY,0.820887187839305
GOBP_REGULATION_OF_CYTOSOLIC...,SET,52,0.19588,0.010404,0.12952,0.065236,GOBP_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,0.820887187839305
GOBP_NUCLEOSIDE_TRANSPORT,SET,10,0.4336,0.010111,0.28674,0.065257,GOBP_NUCLEOSIDE_TRANSPORT,0.820887187839305
HP_INAPPROPRIATE_LAUGHTER,SET,27,0.25156,0.0096348,0.16636,0.065257,HP_INAPPROPRIATE_LAUGHTER,0.820887187839305
GSE40274_CTRL_VS_EOS_TRANSDU...1,SET,134,0.11523,0.0098035,0.076206,0.06526,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.820887187839305
GOBP_PROTEIN_POLYUFMYLATION,SET,5,0.513,0.0084602,0.33938,0.065328,GOBP_PROTEIN_POLYUFMYLATION,0.82144523878437
MIR1224_3P,SET,63,0.15613,0.0091255,0.10335,0.065443,MIR1224_3P,0.822522434924078
HP_ABNORMAL_CIRCLE_OF_WILLIS...,SET,6,0.54267,0.0098035,0.35926,0.065461,HP_ABNORMAL_CIRCLE_OF_WILLIS_MORPHOLOGY,0.822522434924078
GSE7548_DAY7_VS_DAY28_PCC_IM...1,SET,174,0.095623,0.00926,0.063317,0.065502,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,0.822526635379061
GOCC_TUBULAR_ENDOSOME,SET,5,0.5745,0.0094745,0.3805,0.065546,GOCC_TUBULAR_ENDOSOME,0.822526635379061
HP_MITOCHONDRIAL_MYOPATHY,SET,37,0.18632,0.0083517,0.12341,0.065553,HP_MITOCHONDRIAL_MYOPATHY,0.822526635379061
GSE13484_12H_VS_3H_YF17D_VAC...1,SET,178,0.094134,0.009219,0.062349,0.065556,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,0.822526635379061
GOMF_OPSONIN_BINDING,SET,16,0.34451,0.01016,0.22827,0.065636,GOMF_OPSONIN_BINDING,0.822563869704521
GSE34515_CD16_POS_MONOCYTE_V...1,SET,183,0.092777,0.0092116,0.061481,0.065653,GSE34515_CD16_POS_MONOCYTE_VS_DC_DN,0.822563869704521
GSE43955_1H_VS_42H_ACT_CD4_T...1,SET,186,0.093525,0.0093608,0.061997,0.065717,GSE43955_1H_VS_42H_ACT_CD4_TCELL_DN,0.822563869704521
HALLMARK_PEROXISOME,SET,98,0.12707,0.0092539,0.084233,0.065719,HALLMARK_PEROXISOME,0.822563869704521
MIR873_3P,SET,55,0.17195,0.0093923,0.11399,0.065735,MIR873_3P,0.822563869704521
GOBP_REGULATION_OF_CELL_CYCLE,SET,997,0.041029,0.0092933,0.027213,0.065824,GOBP_REGULATION_OF_CELL_CYCLE,0.822563869704521
TRAVAGLINI_LUNG_CAPILLARY_AE...,SET,41,0.20883,0.0098525,0.13852,0.065842,TRAVAGLINI_LUNG_CAPILLARY_AEROCYTE_CELL,0.822563869704521
NAKAYA_PBMC_IMUVAC_MALE_AGE_...,SET,38,0.20716,0.0094101,0.13749,0.06594,NAKAYA_PBMC_IMUVAC_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0DY_PREIMM_TIV_UP,0.822563869704521
GOBP_NEUROMUSCULAR_PROCESS,SET,153,0.10449,0.0094935,0.069346,0.065948,GOBP_NEUROMUSCULAR_PROCESS,0.822563869704521
GSE17974_0H_VS_0.5H_IN_VITRO...2,SET,162,0.097652,0.0091275,0.064825,0.065993,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_UP,0.822563869704521
MIR3173_5P,SET,93,0.13361,0.00948,0.088703,0.066013,MIR3173_5P,0.822563869704521
HP_RELATIVE_MACROCEPHALY,SET,52,0.16876,0.0089641,0.11205,0.066025,HP_RELATIVE_MACROCEPHALY,0.822563869704521
HP_ABNORMAL_CIRCULATING_BETA...,SET,8,0.4608,0.0096118,0.30599,0.066052,HP_ABNORMAL_CIRCULATING_BETA_GLOBULIN_LEVEL,0.822563869704521
MODULE_563,SET,13,0.35389,0.0094085,0.235,0.066057,MODULE_563,0.822563869704521
HP_PROGRESSIVE_FLEXION_CONTR...,SET,6,0.61204,0.011057,0.40663,0.066154,HP_PROGRESSIVE_FLEXION_CONTRACTURES,0.822563869704521
GSE411_WT_VS_SOCS3_KO_MACROP...4,SET,182,0.09129,0.0090394,0.060658,0.066171,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_DN,0.822563869704521
GOCC_SMOOTH_ENDOPLASMIC_RETI...2,SET,7,0.55754,0.010879,0.37048,0.066183,GOCC_SMOOTH_ENDOPLASMIC_RETICULUM_MEMBRANE,0.822563869704521
WP_8Q1123_RB1CC1_COPY_NUMBER...,SET,16,0.31718,0.0093544,0.21077,0.066186,WP_8Q1123_RB1CC1_COPY_NUMBER_VARIATION,0.822563869704521
HP_ABNORMAL_SUBCLAVIAN_ARTER...,SET,10,0.42011,0.0097968,0.27922,0.066224,HP_ABNORMAL_SUBCLAVIAN_ARTERY_MORPHOLOGY,0.822563869704521
HP_ABSENT_TOE,SET,61,0.16307,0.0093788,0.10838,0.066228,HP_ABSENT_TOE,0.822563869704521
HP_ABNORMALITY_OF_THE_ADRENA...,SET,199,0.089968,0.0093109,0.059798,0.066231,HP_ABNORMALITY_OF_THE_ADRENAL_GLANDS,0.822563869704521
BUYTAERT_PHOTODYNAMIC_THERAP...2,SET,759,0.046695,0.0092912,0.031039,0.066248,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP,0.822563869704521
HP_PSEUDOBULBAR_PARALYSIS,SET,20,0.29633,0.0097699,0.19697,0.066249,HP_PSEUDOBULBAR_PARALYSIS,0.822563869704521
GOMF_LIPOPROTEIN_PARTICLE_RE...1,SET,18,0.31917,0.0099836,0.21221,0.066291,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,0.822563869704521
GSE14413_UNSTIM_VS_IFNB_STIM...1,SET,104,0.12742,0.0095575,0.084732,0.066332,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_DN,0.822563869704521
BROWNE_HCMV_INFECTION_1HR_DN,SET,186,0.089882,0.0089962,0.059777,0.066348,BROWNE_HCMV_INFECTION_1HR_DN,0.822563869704521
GOBP_REGULATION_OF_NEURONAL_...1,SET,3,0.84777,0.01083,0.56382,0.066348,GOBP_REGULATION_OF_NEURONAL_ACTION_POTENTIAL,0.822563869704521
GOBP_RESPONSE_TO_TRANSFORMIN...,SET,255,0.082165,0.0096109,0.054649,0.066364,GOBP_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA,0.822563869704521
HP_APLASIA_HYPOPLASIA_OF_THE...32,SET,4,0.66518,0.0098121,0.44253,0.066413,HP_APLASIA_HYPOPLASIA_OF_THE_FALLOPIAN_TUBE,0.822563869704521
BIOCARTA_ACETAMINOPHEN_PATHW...,SET,5,0.61034,0.010065,0.40606,0.06642,BIOCARTA_ACETAMINOPHEN_PATHWAY,0.822563869704521
KAUFFMANN_MELANOMA_RELAPSE_UP,SET,59,0.15497,0.0087663,0.10311,0.066426,KAUFFMANN_MELANOMA_RELAPSE_UP,0.822563869704521
GOBP_UREA_TRANSMEMBRANE_TRAN...,SET,8,0.54098,0.011284,0.35994,0.066432,GOBP_UREA_TRANSMEMBRANE_TRANSPORT,0.822563869704521
GSE2770_UNTREATED_VS_IL4_TRE...5,SET,185,0.091826,0.0091663,0.061097,0.066435,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.822563869704521
GSE15930_STIM_VS_STIM_AND_IL...1,SET,174,0.097241,0.0094167,0.064704,0.066447,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_DN,0.822563869704521
MODULE_139,SET,74,0.15578,0.0098645,0.10366,0.066452,MODULE_139,0.822563869704521
CRX_NRL_DN.V1_DN,SET,112,0.12562,0.0097767,0.083598,0.066466,CRX_NRL_DN.V1_DN,0.822563869704521
CHEN_LVAD_SUPPORT_OF_FAILING...2,SET,88,0.14289,0.0098637,0.095091,0.066472,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP,0.822563869704521
KEGG_MEDICUS_VARIANT_AMPLIFI...3,SET,8,0.49222,0.010267,0.32758,0.066479,KEGG_MEDICUS_VARIANT_AMPLIFIED_CDK4_TO_CELL_CYCLE_G1_S,0.822563869704521
BIOCARTA_EIF4_PATHWAY,SET,24,0.27286,0.0098538,0.1816,0.066482,BIOCARTA_EIF4_PATHWAY,0.822563869704521
HP_SKIN_PICKING,SET,12,0.39068,0.0099795,0.26006,0.066522,HP_SKIN_PICKING,0.82276587544484
HP_ABNORMALITY_OF_THE_MUSCUL...5,SET,243,0.079241,0.0090512,0.052771,0.066609,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_LIMBS,0.823395741201564
GSE5679_PPARG_LIGAND_ROSIGLI...3,SET,181,0.093014,0.009185,0.06195,0.06663,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,0.823395741201564
PTEN_DN.V2_DN,SET,119,0.11842,0.0094977,0.078875,0.066644,PTEN_DN.V2_DN,0.823395741201564
BRUNEAU_SEPTATION_VENTRICULAR,SET,10,0.36354,0.0084776,0.24219,0.06668,BRUNEAU_SEPTATION_VENTRICULAR,0.82354776119403
KEGG_MEDICUS_VARIANT_AMPLIFI...1,SET,6,0.56407,0.01019,0.37591,0.066744,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCND1_TO_CELL_CYCLE_G1_S,0.823798072566372
GSE20366_TREG_VS_NAIVE_CD4_T...3,SET,179,0.096881,0.0095143,0.064578,0.06679,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DN,0.823798072566372
KEGG_AMYOTROPHIC_LATERAL_SCL...,SET,53,0.16792,0.0090044,0.11195,0.066814,KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.823798072566372
GOBP_STRESS_GRANULE_DISASSEM...,SET,7,0.40788,0.0079587,0.27198,0.066855,GOBP_STRESS_GRANULE_DISASSEMBLY,0.823798072566372
GSE22886_DC_VS_MONOCYTE_DN,SET,180,0.095747,0.009429,0.06385,0.066874,GSE22886_DC_VS_MONOCYTE_DN,0.823798072566372
GALE_APL_WITH_FLT3_MUTATED_UP,SET,55,0.16439,0.0089796,0.10964,0.066892,GALE_APL_WITH_FLT3_MUTATED_UP,0.823798072566372
KEGG_MEDICUS_REFERENCE_REGUL...2,SET,9,0.43205,0.0095584,0.28821,0.066935,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION,0.823798072566372
GOBP_REGULATION_OF_ENAMEL_MI...,SET,7,0.50302,0.009815,0.33556,0.066938,GOBP_REGULATION_OF_ENAMEL_MINERALIZATION,0.823798072566372
REACTOME_G2_M_DNA_DAMAGE_CHE...,SET,55,0.16258,0.0088803,0.10845,0.066943,REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT,0.823798072566372
HP_LACK_OF_T_CELL_FUNCTION,SET,7,0.52688,0.010281,0.35151,0.06696,HP_LACK_OF_T_CELL_FUNCTION,0.823798072566372
GSE21927_SPLEEN_C57BL6_VS_4T...1,SET,185,0.091386,0.0091224,0.060969,0.066961,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_DN,0.823798072566372
MORF_FEN1,SET,56,0.15454,0.0085174,0.10312,0.067001,MORF_FEN1,0.823998497876858
MODULE_368,SET,17,0.31769,0.0096576,0.21207,0.067072,MODULE_368,0.824051465725112
MIR6727_3P,SET,102,0.12792,0.0095033,0.08544,0.067179,MIR6727_3P,0.824051465725112
HP_KERATOSIS_PILARIS,SET,34,0.22744,0.0097734,0.15193,0.067202,HP_KERATOSIS_PILARIS,0.824051465725112
GSE7548_DAY7_VS_DAY28_PCC_IM...2,SET,187,0.092986,0.0093316,0.062117,0.067211,GSE7548_DAY7_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,0.824051465725112
GOMF_MONOATOMIC_CATION_TRANS...,SET,580,0.054165,0.0094692,0.036195,0.067272,GOMF_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.824051465725112
GOMF_MISMATCH_REPAIR_COMPLEX...,SET,11,0.33949,0.0083029,0.22692,0.067331,GOMF_MISMATCH_REPAIR_COMPLEX_BINDING,0.824051465725112
HP_PREMATURE_ATRIAL_CONTRACT...,SET,6,0.62291,0.011253,0.41646,0.067374,HP_PREMATURE_ATRIAL_CONTRACTIONS,0.824051465725112
GSE33292_DN3_THYMOCYTE_VS_TC...1,SET,183,0.094677,0.0094002,0.063324,0.067451,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_DN,0.824051465725112
GOBP_CELL_ACTIVATION,SET,1025,0.042275,0.0097012,0.028276,0.067455,GOBP_CELL_ACTIVATION,0.824051465725112
BERENJENO_ROCK_SIGNALING_NOT...1,SET,48,0.18711,0.0095494,0.12515,0.067468,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_DN,0.824051465725112
HTF_01,SET,65,0.14707,0.008731,0.09838,0.067471,HTF_01,0.824051465725112
LMO2COM_02,SET,220,0.086362,0.009392,0.057772,0.067481,LMO2COM_02,0.824051465725112
HP_ABNORMAL_FACIAL_SHAPE,SET,937,0.041289,0.009082,0.027624,0.067506,HP_ABNORMAL_FACIAL_SHAPE,0.824051465725112
GOBP_SYNAPTIC_VESICLE_MEMBRA...,SET,27,0.23067,0.0088349,0.15433,0.06751,GOBP_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,0.824051465725112
REACTOME_ANTIVIRAL_MECHANISM...,SET,135,0.10688,0.0091267,0.071512,0.067515,REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES,0.824051465725112
KEGG_MEDICUS_ENV_FACTOR_META...2,SET,9,0.49499,0.010951,0.33135,0.067618,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_KEAP1_NRF2_SIGNALIG_PATHWAY,0.824051465725112
GOBP_POSITIVE_REGULATION_OF_...508,SET,19,0.26696,0.008579,0.17872,0.067629,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.824051465725112
HP_SKELETAL_MUSCLE_HYPERTROP...,SET,184,0.093566,0.009315,0.062649,0.067664,HP_SKELETAL_MUSCLE_HYPERTROPHY,0.824051465725112
HP_ABNORMAL_FALLOPIAN_TUBE_M...,SET,21,0.25693,0.00868,0.17204,0.067671,HP_ABNORMAL_FALLOPIAN_TUBE_MORPHOLOGY,0.824051465725112
GOMF_EFFLUX_TRANSMEMBRANE_TR...,SET,15,0.32375,0.0092451,0.21679,0.067681,GOMF_EFFLUX_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.824051465725112
GSE26928_NAIVE_VS_CXCR5_POS_...1,SET,166,0.091867,0.0086912,0.061522,0.067698,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_DN,0.824051465725112
CAGTATT_MIR200B_MIR200C_MIR4...,SET,423,0.062744,0.0094086,0.04202,0.067702,CAGTATT_MIR200B_MIR200C_MIR429,0.824051465725112
GSE14308_TH2_VS_TH1_UP,SET,174,0.092752,0.0089819,0.062121,0.067719,GSE14308_TH2_VS_TH1_UP,0.824051465725112
KEGG_MEDICUS_VARIANT_MUTATIO...5,SET,14,0.33328,0.0091948,0.22322,0.067723,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.824051465725112
GOBP_FUCOSE_METABOLIC_PROCESS,SET,15,0.315,0.0089953,0.211,0.067741,GOBP_FUCOSE_METABOLIC_PROCESS,0.824051465725112
MIR6072,SET,72,0.1475,0.009214,0.098811,0.067759,MIR6072,0.824051465725112
IRF1_Q6,SET,248,0.081085,0.0093553,0.054322,0.067769,IRF1_Q6,0.824051465725112
MIR5011_3P,SET,46,0.18687,0.0093373,0.1252,0.067786,MIR5011_3P,0.824051465725112
GSE43955_TH0_VS_TGFB_IL6_TH1...12,SET,177,0.094879,0.009266,0.06358,0.067822,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_4H_UP,0.824051465725112
GOBP_REGULATION_OF_LEUKOCYTE...3,SET,84,0.13878,0.0093605,0.093008,0.067845,GOBP_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,0.824051465725112
GOCC_SPERMATOPROTEASOME_COMP...,SET,5,0.48609,0.0080164,0.32581,0.067865,GOCC_SPERMATOPROTEASOME_COMPLEX,0.824051465725112
GOMF_CERAMIDE_BINDING,SET,17,0.30877,0.0093865,0.20698,0.067886,GOMF_CERAMIDE_BINDING,0.824051465725112
GOBP_OXIDATIVE_DEMETHYLATION,SET,10,0.36822,0.0085868,0.24688,0.067924,GOBP_OXIDATIVE_DEMETHYLATION,0.824051465725112
GOCC_CDC73_PAF1_COMPLEX,SET,6,0.58073,0.010491,0.38945,0.067967,GOCC_CDC73_PAF1_COMPLEX,0.824051465725112
GOBP_NEGATIVE_REGULATION_OF_...472,SET,31,0.24867,0.010204,0.16678,0.06799,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.824051465725112
GOMF_ASPARTIC_ENDOPEPTIDASE_...,SET,8,0.37692,0.0078621,0.25284,0.068024,GOMF_ASPARTIC_ENDOPEPTIDASE_ACTIVITY_INTRAMEMBRANE_CLEAVING,0.824051465725112
REACTOME_ALPHA_PROTEIN_KINAS...,SET,9,0.46711,0.010334,0.31337,0.068041,REACTOME_ALPHA_PROTEIN_KINASE_1_SIGNALING_PATHWAY,0.824051465725112
HP_APLASIA_HYPOPLASIA_OF_THE...58,SET,26,0.25033,0.0094089,0.16796,0.068065,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.824051465725112
HP_ABNORMAL_PULMONARY_ALVEOL...,SET,5,0.67158,0.011075,0.45069,0.068106,HP_ABNORMAL_PULMONARY_ALVEOLAR_SYSTEM_MORPHOLOGY,0.824051465725112
GOMF_PHOSPHATIDYLINOSITOL_3_...4,SET,25,0.23469,0.0086498,0.15754,0.068163,GOMF_PHOSPHATIDYLINOSITOL_3_4_BISPHOSPHATE_BINDING,0.824051465725112
HUANG_GATA2_TARGETS_DN,SET,66,0.15707,0.0093958,0.10547,0.068212,HUANG_GATA2_TARGETS_DN,0.824051465725112
REACTOME_NOTCH2_ACTIVATION_A...,SET,20,0.28995,0.0095595,0.19469,0.068216,REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.824051465725112
GOMF_SINGLE_STRANDED_DNA_BIN...,SET,107,0.11303,0.0085993,0.075899,0.06822,GOMF_SINGLE_STRANDED_DNA_BINDING,0.824051465725112
GOCC_CHOLINERGIC_SYNAPSE,SET,10,0.45255,0.010553,0.30393,0.068253,GOCC_CHOLINERGIC_SYNAPSE,0.824051465725112
MIR4690_3P,SET,57,0.1621,0.0090133,0.10887,0.068259,MIR4690_3P,0.824051465725112
GOCC_CHROMAFFIN_GRANULE,SET,14,0.37861,0.010445,0.25429,0.068265,GOCC_CHROMAFFIN_GRANULE,0.824051465725112
GSE18791_CTRL_VS_NEWCASTLE_V...6,SET,176,0.090052,0.00877,0.060489,0.068289,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_UP,0.824051465725112
GOMF_MAP_KINASE_KINASE_KINAS...2,SET,6,0.5198,0.0093903,0.34917,0.068296,GOMF_MAP_KINASE_KINASE_KINASE_KINASE_ACTIVITY,0.824051465725112
GOBP_DEOXYRIBONUCLEOSIDE_MET...,SET,10,0.43037,0.010036,0.2891,0.068299,GOBP_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.824051465725112
TCTCTCC_MIR185,SET,115,0.12126,0.0095615,0.081456,0.068305,TCTCTCC_MIR185,0.824051465725112
HP_EMG_DECREMENTAL_RESPONSE_...,SET,28,0.22555,0.0087968,0.15153,0.068318,HP_EMG_DECREMENTAL_RESPONSE_OF_COMPOUND_MUSCLE_ACTION_POTENTIAL_TO_REPETITIVE_NERVE_STIMULATION,0.824051465725112
MIR5700,SET,269,0.077559,0.0093142,0.052108,0.068328,MIR5700,0.824051465725112
GOBP_ACTIN_MEDIATED_CELL_CON...,SET,106,0.12803,0.0096951,0.086029,0.068354,GOBP_ACTIN_MEDIATED_CELL_CONTRACTION,0.824051465725112
HP_HYPEREXTENSIBILITY_AT_ELB...,SET,6,0.49855,0.0090064,0.33501,0.068366,HP_HYPEREXTENSIBILITY_AT_ELBOW,0.824051465725112
WP_GLYCINE_METABOLISM_INCLUD...,SET,15,0.29119,0.0083154,0.19568,0.068367,WP_GLYCINE_METABOLISM_INCLUDING_IMDS,0.824051465725112
LAMB_CCND1_TARGETS,SET,18,0.30674,0.0095946,0.20613,0.068379,LAMB_CCND1_TARGETS,0.824051465725112
GTACAGG_MIR486,SET,53,0.16509,0.0088524,0.11097,0.068427,GTACAGG_MIR486,0.824051465725112
GSE37301_CD4_TCELL_VS_GRANUL...2,SET,148,0.10673,0.0095391,0.071746,0.068432,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.824051465725112
GOBP_CELLULAR_OXIDANT_DETOXI...,SET,84,0.13917,0.0093874,0.093561,0.068447,GOBP_CELLULAR_OXIDANT_DETOXIFICATION,0.824051465725112
LEE_LIVER_CANCER_MYC_TGFA_UP,SET,58,0.17888,0.010033,0.12028,0.068492,LEE_LIVER_CANCER_MYC_TGFA_UP,0.824051465725112
GOBP_ISOTYPE_SWITCHING_TO_IG...1,SET,6,0.41591,0.0075135,0.27968,0.068506,GOBP_ISOTYPE_SWITCHING_TO_IGA_ISOTYPES,0.824051465725112
GOBP_TRNA_WOBBLE_BASE_MODIFI...,SET,18,0.27675,0.0086567,0.18614,0.068545,GOBP_TRNA_WOBBLE_BASE_MODIFICATION,0.824051465725112
GSE25502_WT_VS_KLF13_KO_THYM...2,SET,158,0.099584,0.0091935,0.067004,0.068615,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_UP,0.824051465725112
GOMF_SNAP_RECEPTOR_ACTIVITY,SET,35,0.1953,0.0085145,0.13141,0.068624,GOMF_SNAP_RECEPTOR_ACTIVITY,0.824051465725112
GOBERT_OLIGODENDROCYTE_DIFFE...2,SET,525,0.053547,0.0089199,0.03603,0.068625,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP,0.824051465725112
REACTOME_NR1H2_NR1H3_REGULAT...5,SET,5,0.46533,0.0076741,0.31313,0.068641,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_LIMIT_CHOLESTEROL_UPTAKE,0.824051465725112
GSE12198_NK_VS_NK_ACT_EXPANS...1,SET,184,0.088914,0.0088518,0.059837,0.068657,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_DN,0.824051465725112
GOBP_REGULATION_OF_FIBROBLAS...3,SET,35,0.21498,0.0093723,0.14471,0.068702,GOBP_REGULATION_OF_FIBROBLAST_MIGRATION,0.824051465725112
WP_NUCLEOTIDEBINDING_OLIGOME...,SET,37,0.19469,0.0087268,0.13108,0.068736,WP_NUCLEOTIDEBINDING_OLIGOMERIZATION_DOMAIN_NOD_PATHWAY,0.824051465725112
HP_SEVERE_DEMYELINATION_OF_T...,SET,6,0.48856,0.008826,0.32894,0.068747,HP_SEVERE_DEMYELINATION_OF_THE_WHITE_MATTER,0.824051465725112
GSE22886_NAIVE_CD4_TCELL_VS_...6,SET,179,0.091677,0.0090033,0.06173,0.068763,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_UP,0.824051465725112
HP_AUDITORY_HYPERSENSITIVITY,SET,30,0.24519,0.009898,0.1651,0.068769,HP_AUDITORY_HYPERSENSITIVITY,0.824051465725112
GAUTAM_EYE_IRIS_CILIARY_BODY...1,SET,104,0.11716,0.0087879,0.0789,0.068801,GAUTAM_EYE_IRIS_CILIARY_BODY_ACTIVATED_T_CELLS,0.824051465725112
HP_ABNORMAL_CARDIAC_TEST,SET,24,0.27031,0.0097617,0.18206,0.068816,HP_ABNORMAL_CARDIAC_TEST,0.824051465725112
HP_MICROGLOSSIA,SET,17,0.3041,0.0092444,0.20482,0.06882,HP_MICROGLOSSIA,0.824051465725112
WP_BENZOAPYRENE_METABOLISM,SET,9,0.47753,0.010565,0.32165,0.068831,WP_BENZOAPYRENE_METABOLISM,0.824051465725112
GOBP_CARBON_CATABOLITE_REGUL...,SET,7,0.42528,0.0082982,0.28646,0.068831,GOBP_CARBON_CATABOLITE_REGULATION_OF_TRANSCRIPTION,0.824051465725112
JIANG_MELANOMA_TRM5_CD8,SET,180,0.094237,0.0092802,0.063487,0.068868,JIANG_MELANOMA_TRM5_CD8,0.824053364293086
GOBP_CYTOLYSIS_BY_HOST_OF_SY...,SET,6,0.51301,0.0092677,0.34566,0.068894,GOBP_CYTOLYSIS_BY_HOST_OF_SYMBIONT_CELLS,0.824053364293086
MIR4455,SET,100,0.13287,0.0097742,0.089535,0.068912,MIR4455,0.824053364293086
HP_ENLARGED_VESTIBULAR_AQUED...,SET,7,0.48464,0.0094564,0.3266,0.068926,HP_ENLARGED_VESTIBULAR_AQUEDUCT,0.824053364293086
CHEOK_RESPONSE_TO_HD_MTX_DN,SET,19,0.25303,0.0081313,0.17054,0.068953,CHEOK_RESPONSE_TO_HD_MTX_DN,0.824092680536451
KEGG_LONG_TERM_POTENTIATION,SET,66,0.14856,0.0088867,0.10019,0.069067,KEGG_LONG_TERM_POTENTIATION,0.824447280370625
GOBP_REGULATION_OF_SEQUESTER...,SET,15,0.34695,0.0099078,0.23399,0.069073,GOBP_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.824447280370625
TAL1BETAE47_01,SET,225,0.085933,0.0094497,0.057965,0.069112,TAL1BETAE47_01,0.824447280370625
GOMF_RNA_POLYMERASE_III_ACTI...,SET,10,0.33893,0.0079038,0.22862,0.069113,GOMF_RNA_POLYMERASE_III_ACTIVITY,0.824447280370625
GOBP_VESICLE_UNCOATING,SET,9,0.36233,0.0080159,0.24441,0.069118,GOBP_VESICLE_UNCOATING,0.824447280370625
GSE3982_EFF_MEMORY_CD4_TCELL...5,SET,184,0.088695,0.00883,0.059832,0.069125,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_DN,0.824447280370625
HP_FLAT_CORNEA,SET,19,0.32054,0.010301,0.2163,0.069191,HP_FLAT_CORNEA,0.824763801440329
MODULE_152,SET,102,0.11073,0.0082261,0.074724,0.069199,MODULE_152,0.824763801440329
REACTOME_PHASE_2_PLATEAU_PHA...,SET,14,0.34174,0.0094283,0.23069,0.069258,REACTOME_PHASE_2_PLATEAU_PHASE,0.825184021254714
GOBP_REGULATION_OF_DNA_TEMPL...2,SET,15,0.31208,0.0089121,0.21074,0.06933,GOBP_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION_INITIATION,0.825285595278823
GSE14308_TH2_VS_INDUCED_TREG...1,SET,180,0.088466,0.0087119,0.059748,0.069358,GSE14308_TH2_VS_INDUCED_TREG_DN,0.825285595278823
GOBP_NEGATIVE_REGULATION_OF_...90,SET,7,0.5014,0.0097834,0.33866,0.069372,GOBP_NEGATIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.825285595278823
WP_PHOTODYNAMIC_THERAPYINDUC...5,SET,25,0.25285,0.0093192,0.17079,0.069387,WP_PHOTODYNAMIC_THERAPYINDUCED_UNFOLDED_PROTEIN_RESPONSE,0.825285595278823
GNF2_EIF3S6,SET,106,0.11469,0.0086847,0.077471,0.069391,GNF2_EIF3S6,0.825285595278823
MIR215_5P,SET,34,0.22291,0.0095787,0.15059,0.069409,MIR215_5P,0.825285595278823
GOMF_PHOSPHATE_ION_BINDING,SET,8,0.47555,0.0099194,0.32135,0.069465,GOMF_PHOSPHATE_ION_BINDING,0.825615358851675
REACTOME_TFAP2_AP_2_FAMILY_R...2,SET,14,0.37463,0.010336,0.25319,0.069489,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_GROWTH_FACTORS_AND_THEIR_RECEPTORS,0.825615358851675
BEGUM_TARGETS_OF_PAX3_FOXO1_...1,SET,7,0.54859,0.010704,0.37079,0.069508,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_AND_PAX3,0.825615358851675
GCM_ATM,SET,24,0.24337,0.0087886,0.16459,0.069625,GCM_ATM,0.825957573604061
GOBP_DNA_REPAIR_DEPENDENT_CH...,SET,18,0.27476,0.0085943,0.18584,0.069654,GOBP_DNA_REPAIR_DEPENDENT_CHROMATIN_REMODELING,0.825957573604061
HP_CYTOCHROME_C_OXIDASE_NEGA...,SET,26,0.23006,0.0086468,0.15563,0.069683,HP_CYTOCHROME_C_OXIDASE_NEGATIVE_MUSCLE_FIBERS,0.825957573604061
ANDERSEN_LIVER_CANCER_KRT19_...2,SET,33,0.21024,0.0089005,0.14225,0.069716,ANDERSEN_LIVER_CANCER_KRT19_UP,0.825957573604061
GSE40225_WT_VS_RIP_B7X_DIABE...1,SET,169,0.092867,0.0088641,0.062835,0.06972,GSE40225_WT_VS_RIP_B7X_DIABETIC_MOUSE_PANCREATIC_CD8_TCELL_DN,0.825957573604061
SA_REG_CASCADE_OF_CYCLIN_EXPR,SET,13,0.34795,0.0092506,0.23545,0.069741,SA_REG_CASCADE_OF_CYCLIN_EXPR,0.825957573604061
BENPORATH_ES_1,SET,337,0.066498,0.0089217,0.044999,0.069745,BENPORATH_ES_1,0.825957573604061
WP_QUERCETIN_AND_NFKB_AP1_IN...,SET,15,0.34825,0.0099448,0.23569,0.069769,WP_QUERCETIN_AND_NFKB_AP1_INDUCED_APOPTOSIS,0.825957573604061
HAMAI_APOPTOSIS_VIA_TRAIL_UP,SET,596,0.051434,0.0091107,0.034812,0.069785,HAMAI_APOPTOSIS_VIA_TRAIL_UP,0.825957573604061
MIR628_3P,SET,66,0.14013,0.0083826,0.094851,0.06979,MIR628_3P,0.825957573604061
GOMF_HYDROLASE_ACTIVITY_ACTI...8,SET,10,0.44124,0.01029,0.29874,0.069849,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ETHER_BONDS,0.825957573604061
HP_GONADAL_NEOPLASM,SET,100,0.12194,0.0089704,0.082602,0.069944,HP_GONADAL_NEOPLASM,0.825957573604061
GSE14308_TH2_VS_TH17_UP,SET,184,0.091124,0.0090718,0.06173,0.06996,GSE14308_TH2_VS_TH17_UP,0.825957573604061
DANG_MYC_TARGETS_DN,SET,27,0.24964,0.0095612,0.16912,0.069962,DANG_MYC_TARGETS_DN,0.825957573604061
MIR1207_5P,SET,305,0.071572,0.0091433,0.048488,0.069968,MIR1207_5P,0.825957573604061
HP_HYPOPIGMENTATION_OF_HAIR,SET,88,0.13855,0.009564,0.093864,0.069974,HP_HYPOPIGMENTATION_OF_HAIR,0.825957573604061
FEVR_CTNNB1_TARGETS_DN,SET,504,0.054949,0.0089738,0.037234,0.070012,FEVR_CTNNB1_TARGETS_DN,0.825957573604061
GSE23568_CTRL_TRANSDUCED_VS_...2,SET,185,0.09553,0.0095361,0.064734,0.070016,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_UP,0.825957573604061
GSE9037_WT_VS_IRAK4_KO_LPS_1...2,SET,181,0.093625,0.0092453,0.06346,0.070071,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_UP,0.825957573604061
PID_FRA_PATHWAY,SET,35,0.22115,0.0096416,0.14991,0.070079,PID_FRA_PATHWAY,0.825957573604061
GOMF_ASPARTIC_TYPE_ENDOPEPTI...,SET,7,0.50192,0.0097935,0.34024,0.07009,GOMF_ASPARTIC_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.825957573604061
KEGG_MEDICUS_REFERENCE_CITRA...1,SET,8,0.449,0.0093656,0.30439,0.070106,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_FIRST_CARBON_OXIDATION,0.825957573604061
HP_SUDDEN_DEATH,SET,123,0.11905,0.0097066,0.080721,0.070135,HP_SUDDEN_DEATH,0.825957573604061
GARCIA_TARGETS_OF_FLI1_AND_D...1,SET,148,0.097186,0.0086859,0.065899,0.070147,GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN,0.825957573604061
GSE27786_LIN_NEG_VS_NEUTROPH...1,SET,185,0.088028,0.0087872,0.059704,0.070193,GSE27786_LIN_NEG_VS_NEUTROPHIL_DN,0.825957573604061
HP_CHOROIDAL_NEOVASCULARIZAT...,SET,20,0.28879,0.0095215,0.19587,0.070198,HP_CHOROIDAL_NEOVASCULARIZATION,0.825957573604061
GSE21033_CTRL_VS_POLYIC_STIM...4,SET,174,0.094367,0.0091383,0.064006,0.070205,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_UP,0.825957573604061
GOBP_SODIUM_ION_TRANSMEMBRAN...,SET,177,0.1007,0.0098347,0.068305,0.070212,GOBP_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.825957573604061
NFE2L3_TARGET_GENES,SET,10,0.37124,0.0086573,0.25183,0.070226,NFE2L3_TARGET_GENES,0.825957573604061
GOBP_REGULATION_OF_RELEASE_O...2,SET,77,0.15179,0.0098042,0.103,0.0703,GOBP_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,0.82626537
GOBP_RESPONSE_TO_INTERLEUKIN...1,SET,100,0.12962,0.0095352,0.087966,0.070312,GOBP_RESPONSE_TO_INTERLEUKIN_1,0.82626537
CUI_DEVELOPING_HEART_TRABECU...1,SET,161,0.099416,0.009264,0.067484,0.070361,CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE,0.82626537
GSE21546_ELK1_KO_VS_SAP1A_KO...2,SET,176,0.088648,0.0086332,0.060193,0.070421,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,0.82626537
HP_LIVEDO,SET,6,0.41388,0.0074769,0.28105,0.070433,HP_LIVEDO,0.82626537
GOMF_HEPARAN_SULFATE_GLUCOSA...,SET,7,0.55745,0.010877,0.37864,0.070486,GOMF_HEPARAN_SULFATE_GLUCOSAMINE_3_SULFOTRANSFERASE_1_ACTIVITY,0.82626537
GSE7509_UNSTIM_VS_IFNA_STIM_...1,SET,163,0.10129,0.0094969,0.068805,0.070495,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_DN,0.82626537
GOBP_NEGATIVE_REGULATION_OF_...362,SET,35,0.20915,0.0091184,0.14207,0.070499,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.82626537
GOBP_REGULATION_OF_GLUCOCORT...3,SET,5,0.63295,0.010438,0.42996,0.070501,GOBP_REGULATION_OF_GLUCOCORTICOID_RECEPTOR_SIGNALING_PATHWAY,0.82626537
HP_IMPAIRED_EPINEPHRINE_INDU...,SET,9,0.38948,0.0086167,0.26457,0.070506,HP_IMPAIRED_EPINEPHRINE_INDUCED_PLATELET_AGGREGATION,0.82626537
VANDESLUIS_NORMAL_EMBRYOS_DN,SET,19,0.32066,0.010305,0.21789,0.070567,VANDESLUIS_NORMAL_EMBRYOS_DN,0.82626537
HP_HEMOPTYSIS,SET,81,0.15404,0.010203,0.10467,0.070575,HP_HEMOPTYSIS,0.82626537
GOMF_EXOGENOUS_PROTEIN_BINDI...,SET,78,0.15197,0.0098793,0.1033,0.070626,GOMF_EXOGENOUS_PROTEIN_BINDING,0.82626537
GOBP_ALPHA_BETA_T_CELL_DIFFE...,SET,120,0.12226,0.009847,0.083111,0.070642,GOBP_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.82626537
REACTOME_INTERLEUKIN_35_SIGN...,SET,12,0.38924,0.0099426,0.26461,0.070657,REACTOME_INTERLEUKIN_35_SIGNALLING,0.82626537
HP_NEUROINFLAMMATION,SET,18,0.30595,0.00957,0.20804,0.070709,HP_NEUROINFLAMMATION,0.82626537
GSE3982_MAST_CELL_VS_MAC_UP,SET,175,0.09047,0.0087859,0.061527,0.070732,GSE3982_MAST_CELL_VS_MAC_UP,0.82626537
GOMF_HELICASE_ACTIVITY,SET,142,0.098726,0.0086443,0.067158,0.070781,GOMF_HELICASE_ACTIVITY,0.82626537
GSE5542_IFNG_VS_IFNA_AND_IFN...3,SET,174,0.092529,0.0089604,0.062949,0.070803,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,0.82626537
MAP2K1_TARGET_GENES,SET,5,0.49834,0.0082184,0.33906,0.07082,MAP2K1_TARGET_GENES,0.82626537
HP_MACULAR_DRUSEN,SET,6,0.59076,0.010672,0.40198,0.07084,HP_MACULAR_DRUSEN,0.82626537
DELASERNA_TARGETS_OF_MYOD_AN...,SET,10,0.41767,0.0097399,0.28428,0.070899,DELASERNA_TARGETS_OF_MYOD_AND_SMARCA4,0.82626537
GAVISH_3CA_MALIGNANT_METAPRO...16,SET,47,0.2047,0.010338,0.13933,0.070901,GAVISH_3CA_MALIGNANT_METAPROGRAM_25_ASTROCYTES,0.82626537
MIR7155_5P,SET,87,0.12592,0.0086432,0.085711,0.070903,MIR7155_5P,0.82626537
HP_VOCAL_CORD_PARALYSIS,SET,53,0.16257,0.0087172,0.11066,0.070925,HP_VOCAL_CORD_PARALYSIS,0.82626537
KONDO_COLON_CANCER_HCP_WITH_...2,SET,4,0.69949,0.010318,0.47618,0.070934,KONDO_COLON_CANCER_HCP_WITH_H3K27ME3,0.82626537
HP_BIFID_TONGUE,SET,22,0.2413,0.0083434,0.16428,0.070947,HP_BIFID_TONGUE,0.82626537
MODULE_326,SET,13,0.38618,0.010267,0.26293,0.070958,MODULE_326,0.82626537
BIOCARTA_RECK_PATHWAY,SET,8,0.44807,0.0093462,0.30509,0.070976,BIOCARTA_RECK_PATHWAY,0.82626537
GOBP_PROTEOGLYCAN_METABOLIC_...,SET,83,0.1399,0.0093801,0.095283,0.071029,GOBP_PROTEOGLYCAN_METABOLIC_PROCESS,0.82626537
WP_GLUCOCORTICOID_BIOSYNTHES...,SET,14,0.38147,0.010524,0.25983,0.071038,WP_GLUCOCORTICOID_BIOSYNTHESIS,0.82626537
GOBP_LEUKOTRIENE_BIOSYNTHETI...,SET,16,0.33257,0.0098082,0.22653,0.071047,GOBP_LEUKOTRIENE_BIOSYNTHETIC_PROCESS,0.82626537
GOBP_T_CELL_MEDIATED_IMMUNITY,SET,121,0.12655,0.010234,0.086208,0.071067,GOBP_T_CELL_MEDIATED_IMMUNITY,0.82626537
BIOCARTA_PYK2_PATHWAY,SET,27,0.23495,0.0089985,0.16006,0.071085,BIOCARTA_PYK2_PATHWAY,0.82626537
UNTERMAN_IPF_VS_CTRL_DC_DN,SET,6,0.58895,0.010639,0.40128,0.071107,UNTERMAN_IPF_VS_CTRL_DC_DN,0.82626537
GOBP_REGULATION_OF_OSSIFICAT...,SET,111,0.12123,0.0093926,0.082621,0.071159,GOBP_REGULATION_OF_OSSIFICATION,0.82626537
MIR148B_3P,SET,313,0.070805,0.0091611,0.048263,0.071186,MIR148B_3P,0.82626537
WP_HEMATOPOIETIC_STEM_CELL_D...,SET,52,0.18073,0.0095995,0.12321,0.071217,WP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,0.82626537
GOBP_SIGNAL_PEPTIDE_PROCESSI...,SET,13,0.3326,0.0088425,0.22675,0.071224,GOBP_SIGNAL_PEPTIDE_PROCESSING,0.82626537
HELLER_HDAC_TARGETS_SILENCED...1,SET,258,0.079335,0.0093335,0.054095,0.071254,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN,0.82626537
HP_ADENOMATOUS_COLONIC_POLYP...,SET,17,0.26161,0.0079529,0.17841,0.071284,HP_ADENOMATOUS_COLONIC_POLYPOSIS,0.82626537
HP_RECURRENT_GRAM_NEGATIVE_B...,SET,32,0.23223,0.0096819,0.15838,0.071291,HP_RECURRENT_GRAM_NEGATIVE_BACTERIAL_INFECTIONS,0.82626537
GOBP_SYNAPTIC_VESICLE_UNCOAT...,SET,7,0.44306,0.0086451,0.30217,0.071297,GOBP_SYNAPTIC_VESICLE_UNCOATING,0.82626537
GNF2_RBBP6,SET,65,0.13903,0.0082536,0.094829,0.071313,GNF2_RBBP6,0.82626537
HP_BROAD_EYEBROW,SET,23,0.25023,0.0088467,0.17068,0.071322,HP_BROAD_EYEBROW,0.82626537
GNF2_NPM1,SET,65,0.13529,0.0080316,0.092305,0.071371,GNF2_NPM1,0.826502148567621
GOBP_VASCULAR_ENDOTHELIAL_GR...1,SET,34,0.21664,0.0093091,0.14782,0.07139,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.826502148567621
REACTOME_PROCESSING_OF_DNA_D...,SET,57,0.15336,0.0085272,0.10467,0.071444,REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS,0.826851888111888
REACTOME_SHC1_EVENTS_IN_ERBB...2,SET,14,0.30884,0.0085205,0.21083,0.071491,REACTOME_SHC1_EVENTS_IN_ERBB4_SIGNALING,0.826974326194399
HP_LIMB_GIRDLE_MUSCLE_WEAKNE...,SET,86,0.12764,0.0087109,0.087152,0.071527,HP_LIMB_GIRDLE_MUSCLE_WEAKNESS,0.826974326194399
MIR8057,SET,79,0.1342,0.0087797,0.091663,0.071595,MIR8057,0.826974326194399
GOBP_MALATE_METABOLIC_PROCESS,SET,9,0.41606,0.0092048,0.28418,0.071597,GOBP_MALATE_METABOLIC_PROCESS,0.826974326194399
GOBP_LUNG_SACCULE_DEVELOPMENT,SET,10,0.40124,0.0093569,0.27409,0.071616,GOBP_LUNG_SACCULE_DEVELOPMENT,0.826974326194399
MIR4537,SET,6,0.52828,0.0095436,0.36092,0.071645,MIR4537,0.826974326194399
GOBP_PURINE_DEOXYRIBONUCLEOT...2,SET,10,0.38872,0.0090648,0.26563,0.071693,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,0.826974326194399
KEGG_CALCIUM_SIGNALING_PATHW...,SET,167,0.097218,0.0092249,0.066442,0.071716,KEGG_CALCIUM_SIGNALING_PATHWAY,0.826974326194399
WP_NUCLEAR_RECEPTORS,SET,36,0.20828,0.0092091,0.14236,0.071739,WP_NUCLEAR_RECEPTORS,0.826974326194399
KANG_DOXORUBICIN_RESISTANCE_...2,SET,49,0.16839,0.0086833,0.11512,0.071771,KANG_DOXORUBICIN_RESISTANCE_UP,0.826974326194399
BIOCARTA_PLCD_PATHWAY,SET,5,0.66329,0.010939,0.45346,0.07178,BIOCARTA_PLCD_PATHWAY,0.826974326194399
REACTOME_M_PHASE,SET,329,0.065002,0.0086186,0.044448,0.071823,REACTOME_M_PHASE,0.826974326194399
GSE2770_UNTREATED_VS_TGFB_AN...3,SET,176,0.089654,0.0087312,0.061307,0.071828,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,0.826974326194399
GOBP_NEUROTRANSMITTER_RECEPT...5,SET,7,0.52778,0.010298,0.36096,0.071859,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_POSTSYNAPTIC_ENDOSOME_TO_LYSOSOME,0.826974326194399
WP_DEVELOPMENT_AND_HETEROGEN...,SET,32,0.23324,0.0097239,0.15953,0.071873,WP_DEVELOPMENT_AND_HETEROGENEITY_OF_THE_ILC_FAMILY,0.826974326194399
HP_FUSED_CERVICAL_VERTEBRAE,SET,30,0.217,0.0087601,0.14843,0.071884,HP_FUSED_CERVICAL_VERTEBRAE,0.826974326194399
WATANABE_COLON_CANCER_MSI_VS...2,SET,28,0.24166,0.0094253,0.16532,0.071904,WATANABE_COLON_CANCER_MSI_VS_MSS_UP,0.826974326194399
RICHERT_PBMC_HIV_LIPO_5_AGE_...2,SET,5,0.54468,0.0089826,0.3727,0.071959,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_INTERFERON_SUBSET_UP,0.826974326194399
HP_ABNORMAL_MASTOID_MORPHOLO...,SET,10,0.38918,0.0090755,0.26632,0.071976,HP_ABNORMAL_MASTOID_MORPHOLOGY,0.826974326194399
MIR5681B,SET,48,0.17726,0.0090471,0.12131,0.071977,MIR5681B,0.826974326194399
GOMF_CARBOXY_LYASE_ACTIVITY,SET,32,0.21803,0.0090899,0.14922,0.071991,GOMF_CARBOXY_LYASE_ACTIVITY,0.826974326194399
GOBP_CELL_ADHESION_MEDIATED_...,SET,82,0.14159,0.0094367,0.096925,0.072035,GOBP_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.826974326194399
OSMAN_BLADDER_CANCER_UP,SET,363,0.063502,0.0088359,0.043481,0.072092,OSMAN_BLADDER_CANCER_UP,0.826974326194399
HP_RECURRENT_ASPERGILLUS_INF...,SET,22,0.27828,0.0096223,0.19056,0.072104,HP_RECURRENT_ASPERGILLUS_INFECTIONS,0.826974326194399
HP_POOR_WOUND_HEALING,SET,40,0.20169,0.0093988,0.13813,0.072137,HP_POOR_WOUND_HEALING,0.826974326194399
GOBP_INDOLE_CONTAINING_COMPO...1,SET,5,0.5073,0.0083662,0.34745,0.072147,GOBP_INDOLE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,0.826974326194399
AP4_01,SET,235,0.082637,0.0092844,0.056608,0.072181,AP4_01,0.826974326194399
GOBP_PEROXISOME_PROLIFERATOR...,SET,22,0.28776,0.0099499,0.19713,0.072188,GOBP_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.826974326194399
HP_CONCAVE_NASAL_RIDGE,SET,21,0.29196,0.0098634,0.20001,0.072192,HP_CONCAVE_NASAL_RIDGE,0.826974326194399
TFAM_TARGET_GENES,SET,2,0.85547,0.0089235,0.58606,0.072195,TFAM_TARGET_GENES,0.826974326194399
GOMF_ACETYLCHOLINE_RECEPTOR_...1,SET,22,0.27242,0.0094194,0.18663,0.072203,GOMF_ACETYLCHOLINE_RECEPTOR_ACTIVITY,0.826974326194399
REACTOME_CARGO_RECOGNITION_F...,SET,95,0.12878,0.009235,0.088235,0.072216,REACTOME_CARGO_RECOGNITION_FOR_CLATHRIN_MEDIATED_ENDOCYTOSIS,0.826974326194399
MYOCD_TARGET_GENES,SET,1134,0.037703,0.0090719,0.025841,0.072282,MYOCD_TARGET_GENES,0.827143840078973
MODULE_341,SET,74,0.14223,0.0090067,0.09749,0.072305,MODULE_341,0.827143840078973
GOBP_REGULATION_OF_PROTEIN_O...,SET,5,0.55639,0.0091758,0.38138,0.072307,GOBP_REGULATION_OF_PROTEIN_OLIGOMERIZATION,0.827143840078973
HE_LIM_SUN_FETAL_LUNG_C0_LAT...1,SET,103,0.13224,0.0098721,0.090655,0.072326,HE_LIM_SUN_FETAL_LUNG_C0_LATE_AIRWAY_SMC_CELL,0.827143840078973
GOBP_LEUKOCYTE_AGGREGATION,SET,12,0.39672,0.010134,0.27203,0.072377,GOBP_LEUKOCYTE_AGGREGATION,0.827354843495272
HP_PSYCHIC_EPILEPTIC_AURA,SET,10,0.38277,0.008926,0.26257,0.07246,HP_PSYCHIC_EPILEPTIC_AURA,0.827354843495272
GSE43260_BTLA_POS_VS_NEG_INT...1,SET,173,0.093128,0.0089926,0.063884,0.072462,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN,0.827354843495272
GOBP_REGULATION_OF_CELL_KILL...,SET,106,0.13203,0.0099976,0.090574,0.072476,GOBP_REGULATION_OF_CELL_KILLING,0.827354843495272
GOMF_OXIDATIVE_RNA_DEMETHYLA...,SET,5,0.50921,0.0083978,0.34951,0.072574,GOMF_OXIDATIVE_RNA_DEMETHYLASE_ACTIVITY,0.827354843495272
GOBP_VITAMIN_A_METABOLIC_PRO...,SET,8,0.4818,0.01005,0.3308,0.07264,GOBP_VITAMIN_A_METABOLIC_PROCESS,0.827354843495272
TAKADA_GASTRIC_CANCER_COPY_N...1,SET,28,0.27934,0.010895,0.19182,0.072666,TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN,0.827354843495272
MIR23A_5P,SET,30,0.23371,0.0094345,0.16051,0.0727,MIR23A_5P,0.827354843495272
GOMF_SUPEROXIDE_GENERATING_N...1,SET,7,0.49417,0.0096424,0.33943,0.072723,GOMF_SUPEROXIDE_GENERATING_NADPH_OXIDASE_ACTIVATOR_ACTIVITY,0.827354843495272
GOBP_REGULATION_OF_RETINOIC_...,SET,15,0.31435,0.0089769,0.21592,0.072724,GOBP_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.827354843495272
GOCC_ROUGH_ENDOPLASMIC_RETIC...1,SET,52,0.16403,0.0087127,0.11269,0.07277,GOCC_ROUGH_ENDOPLASMIC_RETICULUM,0.827354843495272
GOMF_DNA_APURINIC_OR_APYRIMI...,SET,12,0.32691,0.0083505,0.2246,0.072776,GOMF_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.827354843495272
KEGG_MEDICUS_REFERENCE_TLR4_...,SET,9,0.3775,0.0083516,0.25939,0.072798,KEGG_MEDICUS_REFERENCE_TLR4_IRF3_7_SIGNALING_PATHWAY,0.827354843495272
GOBP_POSITIVE_REGULATION_OF_...129,SET,13,0.34523,0.0091784,0.23723,0.07281,GOBP_POSITIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.827354843495272
HP_CHRONIC_LYMPHOCYTIC_MENIN...,SET,5,0.59763,0.0098559,0.41069,0.072821,HP_CHRONIC_LYMPHOCYTIC_MENINGITIS,0.827354843495272
AP1_Q2_01,SET,247,0.079306,0.0091318,0.054501,0.072826,AP1_Q2_01,0.827354843495272
GOBP_REGULATION_OF_T_CELL_CO...,SET,4,0.65287,0.0096305,0.44868,0.07283,GOBP_REGULATION_OF_T_CELL_COSTIMULATION,0.827354843495272
MOHANKUMAR_HOXA1_TARGETS_UP,SET,366,0.062047,0.0086683,0.042642,0.072834,MOHANKUMAR_HOXA1_TARGETS_UP,0.827354843495272
KEGG_TAURINE_AND_HYPOTAURINE...,SET,10,0.41306,0.0096325,0.28388,0.072837,KEGG_TAURINE_AND_HYPOTAURINE_METABOLISM,0.827354843495272
HP_INTERHEMISPHERIC_CYST,SET,5,0.54991,0.0090689,0.378,0.072872,HP_INTERHEMISPHERIC_CYST,0.827354843495272
GOBP_POSITIVE_REGULATION_OF_...603,SET,121,0.1113,0.0090008,0.076516,0.072905,GOBP_POSITIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.827354843495272
GAUCHER_PBMC_YF_VAX_STAMARIL...11,SET,171,0.095564,0.0091749,0.065706,0.072922,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_DN,0.827354843495272
GOMF_MISFOLDED_PROTEIN_BINDI...,SET,15,0.27591,0.007879,0.18971,0.07293,GOMF_MISFOLDED_PROTEIN_BINDING,0.827354843495272
KRIEG_HYPOXIA_NOT_VIA_KDM3A,SET,665,0.049185,0.0091851,0.03382,0.072936,KRIEG_HYPOXIA_NOT_VIA_KDM3A,0.827354843495272
GOBP_REGULATION_OF_WNT_SIGNA...2,SET,15,0.34127,0.0097457,0.23469,0.072957,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.827354843495272
GOCC_TRANSCRIPTION_REPRESSOR...,SET,73,0.14618,0.0091942,0.10053,0.072976,GOCC_TRANSCRIPTION_REPRESSOR_COMPLEX,0.827354843495272
REACTOME_SIGNALING_BY_MRAS_C...,SET,7,0.40597,0.0079213,0.27924,0.073005,REACTOME_SIGNALING_BY_MRAS_COMPLEX_MUTANTS,0.827354843495272
REACTOME_DOWNSTREAM_SIGNALIN...1,SET,77,0.12576,0.0081233,0.086508,0.073011,REACTOME_DOWNSTREAM_SIGNALING_EVENTS_OF_B_CELL_RECEPTOR_BCR,0.827354843495272
WP_PHYSIOLOGICAL_AND_PATHOLO...,SET,24,0.26074,0.0094159,0.17941,0.07308,WP_PHYSIOLOGICAL_AND_PATHOLOGICAL_HYPERTROPHY_OF_THE_HEART,0.827866818774446
WP_DOPAMINE_METABOLISM,SET,11,0.36191,0.0088514,0.2491,0.073136,WP_DOPAMINE_METABOLISM,0.827935554651919
GSE5142_CTRL_VS_HTERT_TRANSD...1,SET,176,0.091518,0.0089128,0.062991,0.073139,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_DN,0.827935554651919
GSE23925_LIGHT_ZONE_VS_DARK_...2,SET,180,0.092399,0.0090992,0.063611,0.073181,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.827935554651919
GOBP_POSITIVE_REGULATION_OF_...361,SET,20,0.25052,0.0082596,0.17247,0.073183,GOBP_POSITIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,0.827935554651919
GSE9988_LOW_LPS_VS_CTRL_TREA...2,SET,165,0.10214,0.0096343,0.070326,0.073206,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_UP,0.827935554651919
FLETCHER_PBMC_BCG_10W_INFANT...1,SET,235,0.082747,0.0092968,0.05698,0.073229,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_DN,0.827935554651919
GOBP_REGULATION_OF_RNA_POLYM...1,SET,6,0.49661,0.0089714,0.34205,0.073278,GOBP_REGULATION_OF_RNA_POLYMERASE_II_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.828220126829268
KRAS.50_UP.V1_DN,SET,44,0.19161,0.0093641,0.13201,0.073335,KRAS.50_UP.V1_DN,0.828432818181818
PID_AR_PATHWAY,SET,57,0.16443,0.0091432,0.11331,0.073371,PID_AR_PATHWAY,0.828432818181818
HP_PULMONIC_STENOSIS,SET,115,0.11696,0.0092224,0.080594,0.073376,HP_PULMONIC_STENOSIS,0.828432818181818
GOMF_NADPLUS_PROTEIN_ASPARTA...,SET,5,0.53548,0.0088309,0.36906,0.073413,GOMF_NADPLUS_PROTEIN_ASPARTATE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,0.828432818181818
MIR663B,SET,28,0.2273,0.0088651,0.15666,0.073416,MIR663B,0.828432818181818
GSE17721_0.5H_VS_4H_POLYIC_B...1,SET,178,0.091212,0.0089328,0.062884,0.073472,GSE17721_0.5H_VS_4H_POLYIC_BMDC_DN,0.828795637779942
HP_DISPROPORTIONATE_SHORT_LI...,SET,96,0.12856,0.0092669,0.088652,0.07352,HP_DISPROPORTIONATE_SHORT_LIMB_SHORT_STATURE,0.828924781128405
REACTOME_CHAPERONE_MEDIATED_...,SET,19,0.29199,0.0093833,0.20139,0.073552,REACTOME_CHAPERONE_MEDIATED_AUTOPHAGY,0.828924781128405
HU_FETAL_RETINA_RGC,SET,393,0.063154,0.0091357,0.043558,0.073555,HU_FETAL_RETINA_RGC,0.828924781128405
GOBP_COLLATERAL_SPROUTING_IN...,SET,4,0.65092,0.0096017,0.44915,0.073648,GOBP_COLLATERAL_SPROUTING_IN_ABSENCE_OF_INJURY,0.829513779974076
GOBP_CELL_CELL_ADHESION_MEDI...2,SET,17,0.29665,0.0090179,0.2047,0.073655,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.829513779974076
NAB2_TARGET_GENES,SET,1208,0.036027,0.0089276,0.024867,0.073707,NAB2_TARGET_GENES,0.829777031401748
GOBP_PROTEIN_HYDROXYLATION,SET,23,0.23374,0.0082633,0.16136,0.073745,GOBP_PROTEIN_HYDROXYLATION,0.829777031401748
GSE8835_CD4_VS_CD8_TCELL_DN,SET,178,0.09326,0.0091334,0.064385,0.07375,GSE8835_CD4_VS_CD8_TCELL_DN,0.829777031401748
DESCARTES_MAIN_FETAL_PAEP_ME...,SET,109,0.11981,0.0091991,0.082752,0.073846,DESCARTES_MAIN_FETAL_PAEP_MECOM_POSITIVE_CELLS,0.829827327114828
GSE5589_WT_VS_IL10_KO_LPS_AN...4,SET,176,0.0894,0.0087065,0.061755,0.073866,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,0.829827327114828
GOBP_CALCIUM_ION_TRANSMEMBRA...2,SET,311,0.072236,0.0093169,0.049906,0.073894,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.829827327114828
WP_HDAC6_INTERACTIONS_IN_THE...,SET,106,0.11393,0.0086271,0.07873,0.073949,WP_HDAC6_INTERACTIONS_IN_THE_CENTRAL_NERVOUS_SYSTEM,0.829827327114828
GOBP_SMOOTH_MUSCLE_CELL_CHEM...,SET,8,0.44583,0.0092994,0.3081,0.073955,GOBP_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.829827327114828
GSE14769_UNSTIM_VS_240MIN_LP...1,SET,181,0.089643,0.0088521,0.061953,0.073962,GSE14769_UNSTIM_VS_240MIN_LPS_BMDM_DN,0.829827327114828
YAN_ESCAPE_FROM_ANOIKIS,SET,23,0.2484,0.0087819,0.1717,0.074,YAN_ESCAPE_FROM_ANOIKIS,0.829827327114828
GSE21927_BALBC_VS_C57BL6_MON...4,SET,181,0.084589,0.008353,0.058471,0.074003,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP,0.829827327114828
KREPPEL_CD99_TARGETS_DN,SET,7,0.48308,0.009426,0.33399,0.07404,KREPPEL_CD99_TARGETS_DN,0.829827327114828
HP_METHEMOGLOBINEMIA,SET,5,0.55479,0.0091495,0.38357,0.074042,HP_METHEMOGLOBINEMIA,0.829827327114828
GAO_STOMACH_24W_C4_PARIETAL_...,SET,8,0.45739,0.0095407,0.31623,0.074043,GAO_STOMACH_24W_C4_PARIETAL_PROGENITOR,0.829827327114828
KEGG_CIRCADIAN_RHYTHM_MAMMAL,SET,12,0.40406,0.010321,0.27938,0.074063,KEGG_CIRCADIAN_RHYTHM_MAMMAL,0.829827327114828
GSE19772_CTRL_VS_HCMV_INF_MO...3,SET,144,0.10191,0.0089853,0.070471,0.074077,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_DN,0.829827327114828
REACTOME_UPTAKE_AND_FUNCTION...2,SET,6,0.47255,0.0085366,0.32684,0.074123,REACTOME_UPTAKE_AND_FUNCTION_OF_DIPHTHERIA_TOXIN,0.829827327114828
GOMF_ACYL_COA_HYDROLASE_ACTI...,SET,22,0.27237,0.0094179,0.18839,0.074127,GOMF_ACYL_COA_HYDROLASE_ACTIVITY,0.829827327114828
GOBP_POSITIVE_REGULATION_OF_...615,SET,32,0.21294,0.0088776,0.14729,0.074141,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,0.829827327114828
COULOUARN_TEMPORAL_TGFB1_SIG...1,SET,125,0.10782,0.0088617,0.0746,0.074191,COULOUARN_TEMPORAL_TGFB1_SIGNATURE_DN,0.829827327114828
KEGG_GLIOMA,SET,64,0.1573,0.0092662,0.10885,0.074224,KEGG_GLIOMA,0.829827327114828
GOMF_CATALYTIC_ACTIVITY_ACTI...6,SET,341,0.061299,0.0082719,0.04242,0.074231,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_RNA,0.829827327114828
HP_ABNORMALLY_SHAPED_CARPAL_...,SET,7,0.48817,0.0095253,0.33782,0.074232,HP_ABNORMALLY_SHAPED_CARPAL_BONES,0.829827327114828
ZHAN_MULTIPLE_MYELOMA_MS_UP,SET,41,0.21979,0.01037,0.15216,0.074304,ZHAN_MULTIPLE_MYELOMA_MS_UP,0.830365118971061
RIZKI_TUMOR_INVASIVENESS_2D_...1,SET,53,0.16463,0.0088277,0.11398,0.074329,RIZKI_TUMOR_INVASIVENESS_2D_DN,0.8303774975892
WP_GABA_METABOLISM_AKA_GHB,SET,10,0.4235,0.0098759,0.29334,0.074417,WP_GABA_METABOLISM_AKA_GHB,0.83050548
HP_ABNORMALITY_OF_THE_SHOULD...,SET,128,0.10328,0.008589,0.071543,0.074432,HP_ABNORMALITY_OF_THE_SHOULDER_GIRDLE_MUSCULATURE,0.83050548
GOCC_NEURONAL_DENSE_CORE_VES...2,SET,5,0.61986,0.010223,0.42939,0.074435,GOCC_NEURONAL_DENSE_CORE_VESICLE_MEMBRANE,0.83050548
GNF2_TTN,SET,26,0.22297,0.0083806,0.15449,0.074476,GNF2_TTN,0.83050548
CARD_MIR302A_TARGETS,SET,74,0.15345,0.0097173,0.10633,0.074491,CARD_MIR302A_TARGETS,0.83050548
HP_CHIARI_MALFORMATION,SET,91,0.12985,0.0091141,0.08999,0.074533,HP_CHIARI_MALFORMATION,0.83050548
REACTOME_SUPPRESSION_OF_APOP...,SET,7,0.44714,0.0087247,0.30992,0.074552,REACTOME_SUPPRESSION_OF_APOPTOSIS,0.83050548
GSE16450_CTRL_VS_IFNA_12H_ST...2,SET,172,0.095399,0.0091856,0.066124,0.074556,GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP,0.83050548
GOBP_NK_T_CELL_ACTIVATION,SET,13,0.39189,0.010419,0.27164,0.074564,GOBP_NK_T_CELL_ACTIVATION,0.83050548
GOBP_CELL_CYCLE,SET,1476,0.032208,0.0087532,0.022327,0.07458,GOBP_CELL_CYCLE,0.83050548
GOBP_MEDIUM_CHAIN_FATTY_ACID...1,SET,6,0.45467,0.0082138,0.31527,0.074639,GOBP_MEDIUM_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.83050548
JOHNSTONE_PARVB_TARGETS_3_UP,SET,385,0.064022,0.0091686,0.044394,0.074644,JOHNSTONE_PARVB_TARGETS_3_UP,0.83050548
GOBP_PROTEIN_LOCALIZATION_TO...30,SET,17,0.23948,0.0072801,0.16607,0.074654,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.83050548
GOBP_NEGATIVE_REGULATION_OF_...368,SET,6,0.43197,0.0078036,0.29958,0.074675,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.83050548
KEGG_MEDICUS_VARIANT_MUTATIO...8,SET,24,0.24204,0.0087406,0.16803,0.074883,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.832132413738019
MIR4726_3P,SET,65,0.15303,0.0090845,0.10624,0.074885,MIR4726_3P,0.832132413738019
GOMF_SPHINGOSINE_1_PHOSPHATE...2,SET,8,0.45693,0.0095309,0.31727,0.074919,GOMF_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_ACTIVITY,0.832132413738019
REACTOME_HDR_THROUGH_SINGLE_...,SET,36,0.18999,0.0084005,0.13194,0.07494,REACTOME_HDR_THROUGH_SINGLE_STRAND_ANNEALING_SSA,0.832132413738019
GOBP_MACROPHAGE_PROLIFERATION,SET,10,0.42748,0.0099687,0.29686,0.074941,GOBP_MACROPHAGE_PROLIFERATION,0.832132413738019
KASLER_HDAC7_TARGETS_2_DN,SET,31,0.21516,0.0088289,0.14957,0.07515,KASLER_HDAC7_TARGETS_2_DN,0.83392025862069
GOBP_PLASMA_MEMBRANE_REPAIR,SET,27,0.22954,0.0087915,0.15957,0.07515,GOBP_PLASMA_MEMBRANE_REPAIR,0.83392025862069
GSE45739_NRAS_KO_VS_WT_ACD3_...2,SET,180,0.085935,0.0084627,0.059762,0.075233,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_UP,0.834574821257581
FOROUTAN_INTEGRATED_TGFB_EMT...1,SET,70,0.16274,0.010024,0.11319,0.075263,FOROUTAN_INTEGRATED_TGFB_EMT_DN,0.834641214103382
GOMF_L_LEUCINE_TRANSMEMBRANE...,SET,6,0.50936,0.0092017,0.35434,0.075297,GOMF_L_LEUCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.834751909090909
FAN_EMBRYONIC_CTX_BRAIN_B_CE...,SET,84,0.14211,0.0095855,0.098882,0.075341,FAN_EMBRYONIC_CTX_BRAIN_B_CELL,0.834917437858509
GSE29618_PRE_VS_DAY7_POST_TI...2,SET,168,0.099815,0.0094994,0.069465,0.075381,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_UP,0.834917437858509
GSE22886_NAIVE_CD4_TCELL_VS_...2,SET,178,0.087288,0.0085485,0.060748,0.075384,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP,0.834917437858509
WP_COMMON_PATHWAYS_UNDERLYIN...,SET,38,0.20983,0.0095313,0.14609,0.075467,WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION,0.835570431666136
ZNF622_TARGET_GENES,SET,55,0.16298,0.0089026,0.11349,0.075495,ZNF622_TARGET_GENES,0.835591638013372
chr7q32,SET,43,0.35318,0.017063,0.24596,0.075517,chr7q32,0.835591638013372
HP_MYELODYSPLASIA,SET,100,0.11416,0.0083976,0.079509,0.075545,HP_MYELODYSPLASIA,0.835635415340547
HP_ABSENT_OUTER_DYNEIN_ARMS,SET,9,0.38011,0.0084093,0.26479,0.075578,HP_ABSENT_OUTER_DYNEIN_ARMS,0.835734454342985
GOBP_POSTSYNAPTIC_MEMBRANE_O...,SET,36,0.19465,0.0086063,0.13571,0.07575,GOBP_POSTSYNAPTIC_MEMBRANE_ORGANIZATION,0.835983832807571
GSE16385_UNTREATED_VS_12H_IL...2,SET,180,0.091313,0.0089923,0.063665,0.075754,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_UP,0.835983832807571
GSE18893_TCONV_VS_TREG_2H_CU...1,SET,187,0.088837,0.0089153,0.061939,0.075756,GSE18893_TCONV_VS_TREG_2H_CULTURE_DN,0.835983832807571
GOBP_REGULATION_OF_LYMPHANGI...,SET,6,0.55943,0.010106,0.39018,0.075828,GOBP_REGULATION_OF_LYMPHANGIOGENESIS,0.835983832807571
GSE23505_IL6_IL1_VS_IL6_IL1_...1,SET,185,0.089598,0.0089439,0.062496,0.075845,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,0.835983832807571
REACTOME_RHO_GTPASES_ACTIVAT...7,SET,33,0.21394,0.0090574,0.14923,0.075851,REACTOME_RHO_GTPASES_ACTIVATE_PKNS,0.835983832807571
GOMF_CYCLIN_BINDING,SET,33,0.19991,0.0084631,0.13945,0.075869,GOMF_CYCLIN_BINDING,0.835983832807571
HP_ABNORMAL_BRAIN_LACTATE_LE...,SET,23,0.2493,0.0088136,0.17394,0.075897,HP_ABNORMAL_BRAIN_LACTATE_LEVEL_BY_MRS,0.835983832807571
ZNF589_TARGET_GENES,SET,509,0.053968,0.008856,0.037655,0.075904,ZNF589_TARGET_GENES,0.835983832807571
DIRMEIER_LMP1_RESPONSE_EARLY,SET,59,0.16441,0.0093001,0.11471,0.075908,DIRMEIER_LMP1_RESPONSE_EARLY,0.835983832807571
GOBP_POSITIVE_REGULATION_OF_...212,SET,5,0.54385,0.008969,0.37956,0.075961,GOBP_POSITIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.835983832807571
JOHNSTONE_PARVB_TARGETS_3_DN,SET,758,0.043645,0.0086789,0.030464,0.075983,JOHNSTONE_PARVB_TARGETS_3_DN,0.835983832807571
GSE17721_CTRL_VS_PAM3CSK4_1H...1,SET,185,0.091,0.0090838,0.063519,0.075989,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN,0.835983832807571
MODULE_280,SET,44,0.18788,0.0091818,0.13115,0.075993,MODULE_280,0.835983832807571
GOBP_CITRATE_METABOLIC_PROCE...,SET,5,0.56918,0.0093868,0.39732,0.075999,GOBP_CITRATE_METABOLIC_PROCESS,0.835983832807571
CDPCR1_01,SET,117,0.11961,0.0095131,0.083508,0.076032,CDPCR1_01,0.835983832807571
HP_OVARIAN_GONADOBLASTOMA,SET,9,0.41578,0.0091986,0.29037,0.076097,HP_OVARIAN_GONADOBLASTOMA,0.835983832807571
REACTOME_DNA_STRAND_ELONGATI...,SET,31,0.19672,0.0080725,0.13739,0.076105,REACTOME_DNA_STRAND_ELONGATION,0.835983832807571
TTANWNANTGGM_UNKNOWN,SET,55,0.17266,0.0094309,0.12059,0.076115,TTANWNANTGGM_UNKNOWN,0.835983832807571
HP_THORACIC_KYPHOSCOLIOSIS,SET,24,0.21915,0.007914,0.1531,0.076164,HP_THORACIC_KYPHOSCOLIOSIS,0.835983832807571
HP_GENERALIZED_MUSCLE_WEAKNE...,SET,120,0.10943,0.0088132,0.076453,0.076181,HP_GENERALIZED_MUSCLE_WEAKNESS,0.835983832807571
HP_DISTAL_LOWER_LIMB_MUSCLE_...,SET,84,0.13336,0.0089949,0.093179,0.076197,HP_DISTAL_LOWER_LIMB_MUSCLE_WEAKNESS,0.835983832807571
MIR6747_3P,SET,105,0.12027,0.0090643,0.084039,0.076213,MIR6747_3P,0.835983832807571
HP_SWOLLEN_LIP,SET,6,0.58182,0.010511,0.40657,0.076214,HP_SWOLLEN_LIP,0.835983832807571
GOMF_ARP2_3_COMPLEX_BINDING,SET,13,0.32393,0.0086121,0.22636,0.076219,GOMF_ARP2_3_COMPLEX_BINDING,0.835983832807571
GNF2_HLA_C,SET,40,0.19182,0.008939,0.13406,0.076249,GNF2_HLA_C,0.835983832807571
chr3p22,SET,78,0.27668,0.017986,0.19337,0.07625,chr3p22,0.835983832807571
GOBP_INNATE_IMMUNE_RESPONSE_...2,SET,12,0.40257,0.010283,0.28145,0.076322,GOBP_INNATE_IMMUNE_RESPONSE_IN_MUCOSA,0.836244281663516
MIR6780A_5P,SET,203,0.081398,0.0085073,0.056913,0.076336,MIR6780A_5P,0.836244281663516
GSE17721_POLYIC_VS_CPG_6H_BM...2,SET,185,0.086459,0.0086305,0.060457,0.076356,GSE17721_POLYIC_VS_CPG_6H_BMDC_UP,0.836244281663516
NAKAYA_B_CELL_FLUARIX_FLUVIR...1,SET,261,0.069761,0.0082541,0.048785,0.07637,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,0.836244281663516
GOMF_MHC_PROTEIN_COMPLEX_BIN...,SET,30,0.22737,0.0091786,0.15903,0.076404,GOMF_MHC_PROTEIN_COMPLEX_BINDING,0.836261404805915
GOBP_REGULATION_OF_VASCULAR_...2,SET,14,0.33585,0.0092659,0.235,0.076484,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.836261404805915
MIR5697,SET,139,0.098961,0.0085736,0.069246,0.076491,MIR5697,0.836261404805915
GSE10463_CD40L_AND_VA347_VS_...2,SET,167,0.09393,0.0089129,0.065728,0.076502,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_UP,0.836261404805915
AR_02,SET,34,0.20419,0.0087742,0.14288,0.076504,AR_02,0.836261404805915
GOBP_ESTABLISHMENT_OR_MAINTE...3,SET,7,0.39074,0.0076242,0.27346,0.076531,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CYTOSKELETON_POLARITY,0.836261404805915
IRITANI_MAD1_TARGETS_DN,SET,41,0.17837,0.0084151,0.12486,0.076576,IRITANI_MAD1_TARGETS_DN,0.836261404805915
HP_ABNORMAL_PROPORTION_OF_NA...,SET,4,0.69248,0.010215,0.48489,0.076638,HP_ABNORMAL_PROPORTION_OF_NAIVE_T_CELLS,0.836261404805915
ATF2_UP.V1_DN,SET,166,0.097782,0.0092508,0.068472,0.076646,ATF2_UP.V1_DN,0.836261404805915
GOBP_CENTRAL_NERVOUS_SYSTEM_...8,SET,27,0.25352,0.00971,0.17753,0.076649,GOBP_CENTRAL_NERVOUS_SYSTEM_PROJECTION_NEURON_AXONOGENESIS,0.836261404805915
HP_PES_PLANUS,SET,310,0.068369,0.0088041,0.047879,0.076662,HP_PES_PLANUS,0.836261404805915
MODULE_200,SET,27,0.26872,0.010292,0.18821,0.076685,MODULE_200,0.836261404805915
GOBP_SEMI_LUNAR_VALVE_DEVELO...,SET,48,0.19659,0.010034,0.13772,0.076729,GOBP_SEMI_LUNAR_VALVE_DEVELOPMENT,0.836261404805915
GOMF_LOW_DENSITY_LIPOPROTEIN...2,SET,15,0.33395,0.0095365,0.23395,0.076735,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_ACTIVITY,0.836261404805915
GOBP_REGULATION_OF_AMINE_MET...,SET,27,0.23839,0.0091302,0.16703,0.076764,GOBP_REGULATION_OF_AMINE_METABOLIC_PROCESS,0.836261404805915
MIR7160_5P,SET,171,0.092325,0.0088639,0.064704,0.076818,MIR7160_5P,0.836261404805915
MIR4999_3P,SET,35,0.19481,0.008493,0.13655,0.076847,MIR4999_3P,0.836261404805915
CLIMENT_BREAST_CANCER_COPY_N...2,SET,23,0.27558,0.0097426,0.19317,0.076857,CLIMENT_BREAST_CANCER_COPY_NUMBER_UP,0.836261404805915
GOMF_3_PHOSPHOADENOSINE_5_PH...,SET,9,0.40331,0.0089227,0.28271,0.07686,GOMF_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_BINDING,0.836261404805915
GSE20151_CTRL_VS_FUSOBACT_NU...2,SET,178,0.087989,0.0086171,0.061681,0.076869,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_UP,0.836261404805915
HP_SAGITTAL_CRANIOSYNOSTOSIS,SET,23,0.22497,0.0079533,0.15773,0.0769,HP_SAGITTAL_CRANIOSYNOSTOSIS,0.836261404805915
HP_ABNORMALITY_OF_THE_THENAR...,SET,30,0.20815,0.0084028,0.14594,0.076906,HP_ABNORMALITY_OF_THE_THENAR_EMINENCE,0.836261404805915
REACTOME_NGF_STIMULATED_TRAN...,SET,38,0.20353,0.009245,0.14272,0.076936,REACTOME_NGF_STIMULATED_TRANSCRIPTION,0.836261404805915
LI_PBMC_MENACTRA_AGE_18_45YO...8,SET,16,0.32979,0.0097263,0.23136,0.077026,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_NEGATIVE,0.836261404805915
BIOCARTA_PKC_PATHWAY,SET,7,0.51403,0.01003,0.36068,0.077063,BIOCARTA_PKC_PATHWAY,0.836261404805915
BLANCO_MELO_SARS_COV_1_INFEC...1,SET,9,0.42655,0.0094368,0.29931,0.077069,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_DN,0.836261404805915
GSE32986_CURDLAN_HIGHDOSE_VS...2,SET,177,0.0892,0.0087114,0.062596,0.077088,GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,0.836261404805915
HP_ANTEVERTED_EARS,SET,10,0.40713,0.0094941,0.28576,0.077125,HP_ANTEVERTED_EARS,0.836261404805915
NIKOLSKY_BREAST_CANCER_5P15_...,SET,25,0.45062,0.016608,0.31628,0.077126,NIKOLSKY_BREAST_CANCER_5P15_AMPLICON,0.836261404805915
GOBP_MYELOID_DENDRITIC_CELL_...2,SET,6,0.47214,0.0085293,0.33141,0.077143,GOBP_MYELOID_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.836261404805915
HP_ABNORMAL_NOSTRIL_MORPHOLO...,SET,434,0.056404,0.0085646,0.039592,0.077143,HP_ABNORMAL_NOSTRIL_MORPHOLOGY,0.836261404805915
HP_GINGIVAL_OVERGROWTH,SET,110,0.12032,0.0092802,0.084472,0.077185,HP_GINGIVAL_OVERGROWTH,0.836261404805915
GOBP_POSITIVE_REGULATION_OF_...583,SET,5,0.58789,0.0096953,0.4128,0.07721,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_A2_ACTIVITY,0.836261404805915
GOMF_DNA_POLYMERASE_BINDING,SET,19,0.22486,0.0072262,0.15792,0.077246,GOMF_DNA_POLYMERASE_BINDING,0.836261404805915
HP_ABNORMAL_CARDIAC_ATRIUM_M...,SET,518,0.0525,0.0086888,0.036876,0.077277,HP_ABNORMAL_CARDIAC_ATRIUM_MORPHOLOGY,0.836261404805915
PID_IL12_2PATHWAY,SET,61,0.16429,0.009449,0.11541,0.077304,PID_IL12_2PATHWAY,0.836261404805915
HP_LYMPHEDEMA,SET,68,0.14026,0.0085155,0.098531,0.077308,HP_LYMPHEDEMA,0.836261404805915
GOBP_NEGATIVE_REGULATION_OF_...69,SET,56,0.16056,0.0088495,0.11281,0.077336,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.836261404805915
MIR6856_3P,SET,65,0.14392,0.0085435,0.10112,0.077351,MIR6856_3P,0.836261404805915
MIR374C_3P,SET,47,0.18631,0.0094094,0.13093,0.077378,MIR374C_3P,0.836261404805915
GOBP_REGULATION_OF_COMPLEMEN...4,SET,11,0.40651,0.0099421,0.28575,0.077433,GOBP_REGULATION_OF_COMPLEMENT_DEPENDENT_CYTOTOXICITY,0.836261404805915
MIR382_5P,SET,52,0.16392,0.0087068,0.11523,0.077434,MIR382_5P,0.836261404805915
GOMF_NEUROTROPHIN_TRK_RECEPT...,SET,6,0.41335,0.0074672,0.2906,0.077466,GOMF_NEUROTROPHIN_TRK_RECEPTOR_BINDING,0.836261404805915
GOBP_POSTSYNAPTIC_SIGNAL_TRA...,SET,46,0.17136,0.0085621,0.12049,0.077487,GOBP_POSTSYNAPTIC_SIGNAL_TRANSDUCTION,0.836261404805915
GOBP_POSITIVE_REGULATION_OF_...639,SET,5,0.52464,0.0086522,0.36889,0.077489,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,0.836261404805915
GOBP_ESTABLISHMENT_OF_ENDOTH...1,SET,50,0.18209,0.0094846,0.12803,0.077493,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_BARRIER,0.836261404805915
GSE29618_BCELL_VS_MONOCYTE_D...2,SET,169,0.096898,0.0092489,0.068153,0.077556,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_UP,0.836261404805915
GOBP_REGULATION_OF_IMMUNE_EF...,SET,356,0.066707,0.0091937,0.046926,0.077587,GOBP_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,0.836261404805915
GOMF_CDP_ALCOHOL_PHOSPHATIDY...,SET,7,0.4105,0.0080097,0.28878,0.077594,GOMF_CDP_ALCOHOL_PHOSPHATIDYLTRANSFERASE_ACTIVITY,0.836261404805915
GOUYER_TATI_TARGETS_DN,SET,17,0.28687,0.0087205,0.20186,0.077648,GOUYER_TATI_TARGETS_DN,0.836261404805915
GOBP_REGULATION_OF_SYNAPTIC_...4,SET,8,0.35886,0.0074853,0.25252,0.077656,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,0.836261404805915
DURANTE_ADULT_OLFACTORY_NEUR...11,SET,163,0.093602,0.0087757,0.065883,0.077705,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MATURE_NEURONS,0.836261404805915
GOCC_MITOTIC_SPINDLE_MIDZONE,SET,13,0.32246,0.0085731,0.22701,0.077746,GOCC_MITOTIC_SPINDLE_MIDZONE,0.836261404805915
ETS1_B,SET,242,0.076991,0.0087762,0.054202,0.077747,ETS1_B,0.836261404805915
DESCARTES_MAIN_FETAL_LIMBIC_...,SET,6,0.50388,0.0091026,0.35474,0.077751,DESCARTES_MAIN_FETAL_LIMBIC_SYSTEM_NEURONS,0.836261404805915
REACTOME_SARS_COV_2_HOST_INT...,SET,179,0.087516,0.0085947,0.061618,0.07777,REACTOME_SARS_COV_2_HOST_INTERACTIONS,0.836261404805915
GOBP_REGULATION_OF_CD4_POSIT...2,SET,53,0.17438,0.0093506,0.12278,0.077774,GOBP_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.836261404805915
MIR4749_5P,SET,4,0.64296,0.0094844,0.45284,0.077835,MIR4749_5P,0.836261404805915
GOBP_RESPONSE_TO_FATTY_ACID,SET,54,0.18007,0.0097461,0.12684,0.077867,GOBP_RESPONSE_TO_FATTY_ACID,0.836261404805915
HP_PROGRESSIVE_MUSCLE_WEAKNE...,SET,64,0.14768,0.0086996,0.10403,0.077877,HP_PROGRESSIVE_MUSCLE_WEAKNESS,0.836261404805915
HOEK_PBMC_INACTIVATED_INFLUE...6,SET,14,0.32255,0.0088988,0.22724,0.0779,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_UP,0.836261404805915
GOMF_MALATE_DEHYDROGENASE_AC...,SET,8,0.41815,0.008722,0.29459,0.077901,GOMF_MALATE_DEHYDROGENASE_ACTIVITY,0.836261404805915
ZWANG_EGF_PERSISTENTLY_UP,SET,27,0.22576,0.0086468,0.15906,0.077903,ZWANG_EGF_PERSISTENTLY_UP,0.836261404805915
WP_NCRNAS_INVOLVED_IN_WNT_SI...,SET,82,0.1395,0.009297,0.098291,0.077925,WP_NCRNAS_INVOLVED_IN_WNT_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,0.836261404805915
BIOCARTA_AGPCR_PATHWAY,SET,11,0.3776,0.009235,0.26609,0.07795,BIOCARTA_AGPCR_PATHWAY,0.836261404805915
GOBP_POSTREPLICATION_REPAIR,SET,32,0.17747,0.0073988,0.12507,0.077961,GOBP_POSTREPLICATION_REPAIR,0.836261404805915
GSE19923_WT_VS_HEB_AND_E2A_K...1,SET,186,0.088848,0.0088927,0.062628,0.078008,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.836261404805915
GOMF_GLUCOSYLTRANSFERASE_ACT...,SET,16,0.27337,0.0080623,0.19273,0.078044,GOMF_GLUCOSYLTRANSFERASE_ACTIVITY,0.836261404805915
HP_PAROXYSMAL_ATRIAL_FIBRILL...,SET,23,0.26867,0.0094984,0.18944,0.078067,HP_PAROXYSMAL_ATRIAL_FIBRILLATION,0.836261404805915
GOBP_POSITIVE_REGULATION_OF_...829,SET,28,0.23019,0.0089778,0.16232,0.078083,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_PRODUCTION,0.836261404805915
REACTOME_FOXO_MEDIATED_TRANS...3,SET,15,0.31766,0.0090714,0.22402,0.078103,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_DEATH_GENES,0.836261404805915
GSE15330_HSC_VS_GRANULOCYTE_...1,SET,175,0.088316,0.0085767,0.062282,0.078104,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.836261404805915
GOBP_POSITIVE_REGULATION_OF_...175,SET,9,0.4262,0.009429,0.30065,0.078165,GOBP_POSITIVE_REGULATION_OF_COLLATERAL_SPROUTING,0.836420668096843
GSE10273_HIGH_IL7_VS_HIGH_IL...2,SET,182,0.087278,0.0086421,0.061584,0.07822,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.836420668096843
GOBP_POSITIVE_REGULATION_OF_...333,SET,184,0.093738,0.0093321,0.066146,0.078229,GOBP_POSITIVE_REGULATION_OF_HEMOPOIESIS,0.836420668096843
REACTOME_CONSTITUTIVE_SIGNAL...3,SET,15,0.27129,0.007747,0.19145,0.078247,REACTOME_CONSTITUTIVE_SIGNALING_BY_EGFRVIII,0.836420668096843
GOMF_HISTONE_H3K9_TRIMETHYLT...,SET,4,0.63486,0.0093648,0.44805,0.078258,GOMF_HISTONE_H3K9_TRIMETHYLTRANSFERASE_ACTIVITY,0.836420668096843
GSE37301_MULTIPOTENT_PROGENI...4,SET,153,0.09208,0.0083664,0.064992,0.07828,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_UP,0.836420668096843
HUMMEL_BURKITTS_LYMPHOMA_DN,SET,15,0.33855,0.0096679,0.23899,0.078314,HUMMEL_BURKITTS_LYMPHOMA_DN,0.836420668096843
TITF1_Q3,SET,214,0.083363,0.0089429,0.058856,0.078339,TITF1_Q3,0.836420668096843
GOBP_HUMORAL_IMMUNE_RESPONSE...,SET,42,0.20527,0.0098014,0.14494,0.078365,GOBP_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.836420668096843
GSE17580_UNINFECTED_VS_S_MAN...3,SET,175,0.090146,0.0087544,0.063655,0.078373,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_DN,0.836420668096843
GOBP_BONE_RESORPTION,SET,65,0.15675,0.0093055,0.11071,0.078409,GOBP_BONE_RESORPTION,0.836420668096843
GSE1925_3H_VS_24H_IFNG_STIM_...3,SET,181,0.086027,0.008495,0.060761,0.078421,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_DN,0.836420668096843
LFA1_Q6,SET,237,0.078271,0.0088307,0.05529,0.078451,LFA1_Q6,0.836420668096843
GOBP_REGULATION_OF_INTRINSIC...3,SET,35,0.19697,0.0085875,0.13916,0.078478,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.836420668096843
GSE37301_LYMPHOID_PRIMED_MPP...3,SET,189,0.088042,0.0088821,0.062206,0.078494,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.836420668096843
CAO_BLOOD_FLUMIST_AGE_05_14Y...7,SET,9,0.40363,0.0089296,0.28522,0.07852,CAO_BLOOD_FLUMIST_AGE_05_14YO_CORRELATED_WITH_H3N2_VN_TITER_7DY_POSITIVE,0.836420668096843
MCLACHLAN_DENTAL_CARIES_UP,SET,214,0.089346,0.0095847,0.063138,0.078528,MCLACHLAN_DENTAL_CARIES_UP,0.836420668096843
GGAANCGGAANY_UNKNOWN,SET,103,0.10876,0.0081194,0.076887,0.078603,GGAANCGGAANY_UNKNOWN,0.836963010110294
GRESHOCK_CANCER_COPY_NUMBER_...,SET,310,0.068319,0.0087977,0.048302,0.07863,GRESHOCK_CANCER_COPY_NUMBER_UP,0.836994073506891
FULLER_PBMC_F_TULARENSIS_VAC...10,SET,16,0.30445,0.0089791,0.21532,0.078694,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_DN,0.837353762965223
GOBP_POSITIVE_REGULATION_OF_...233,SET,7,0.43877,0.0085613,0.3104,0.078752,GOBP_POSITIVE_REGULATION_OF_ENDOCYTIC_RECYCLING,0.837353762965223
MIKHAYLOVA_OXIDATIVE_STRESS_...2,SET,6,0.54622,0.0098675,0.38642,0.078758,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_UP,0.837353762965223
HP_PENETRATING_FOOT_ULCERS,SET,6,0.46676,0.0084321,0.33026,0.078794,HP_PENETRATING_FOOT_ULCERS,0.837353762965223
HP_CEREBELLAR_HEMISPHERE_HYP...,SET,8,0.36687,0.0076526,0.25967,0.078856,HP_CEREBELLAR_HEMISPHERE_HYPOPLASIA,0.837353762965223
GOBP_KERATINIZATION,SET,72,0.17255,0.010779,0.12217,0.078916,GOBP_KERATINIZATION,0.837353762965223
HP_OLIGODONTIA,SET,52,0.15762,0.008372,0.11159,0.078921,HP_OLIGODONTIA,0.837353762965223
GOBP_CHONDROITIN_SULFATE_PRO...1,SET,23,0.23931,0.0084604,0.16944,0.078932,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.837353762965223
GOBP_METAPHASE_CHROMOSOME_AL...,SET,96,0.11691,0.0084275,0.082781,0.078939,GOBP_METAPHASE_CHROMOSOME_ALIGNMENT,0.837353762965223
GOBP_PODOCYTE_CELL_MIGRATION,SET,7,0.48164,0.0093978,0.34103,0.078939,GOBP_PODOCYTE_CELL_MIGRATION,0.837353762965223
GSE360_CTRL_VS_B_MALAYI_HIGH...4,SET,178,0.086074,0.0084296,0.060946,0.078939,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.837353762965223
HP_EXCESSIVE_WRINKLED_SKIN,SET,36,0.18855,0.0083366,0.13352,0.07897,HP_EXCESSIVE_WRINKLED_SKIN,0.837353762965223
GOMF_PHOSPHATIDYLINOSITOL_TR...2,SET,8,0.37513,0.0078248,0.26566,0.078977,GOMF_PHOSPHATIDYLINOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.837353762965223
GSE21360_SECONDARY_VS_TERTIA...2,SET,180,0.08301,0.0081746,0.058794,0.079002,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,0.837363376029277
MYLLYKANGAS_AMPLIFICATION_HO...17,SET,7,0.48523,0.0094678,0.34379,0.079073,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_7,0.837525298462466
GOBP_INNATE_IMMUNE_RESPONSE,SET,847,0.043002,0.0090162,0.030468,0.079079,GOBP_INNATE_IMMUNE_RESPONSE,0.837525298462466
HP_ABNORMALITY_OF_THE_DORSAL...,SET,5,0.50409,0.0083133,0.35721,0.079103,HP_ABNORMALITY_OF_THE_DORSAL_COLUMN_OF_THE_SPINAL_CORD,0.837525298462466
GOBP_CD4_POSITIVE_ALPHA_BETA...1,SET,112,0.12214,0.0095053,0.086573,0.079164,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.837525298462466
GOMF_HEPARAN_SULFATE_SULFOTR...,SET,14,0.35737,0.0098595,0.25337,0.079208,GOMF_HEPARAN_SULFATE_SULFOTRANSFERASE_ACTIVITY,0.837525298462466
MIR4260,SET,64,0.15018,0.008847,0.10648,0.079211,MIR4260,0.837525298462466
GOBP_REGULATION_OF_CELL_CELL...3,SET,11,0.34302,0.0083893,0.24326,0.079261,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.837525298462466
GOBP_MYELOID_PROGENITOR_CELL...,SET,9,0.36009,0.0079664,0.25538,0.079279,GOBP_MYELOID_PROGENITOR_CELL_DIFFERENTIATION,0.837525298462466
GOBP_POSITIVE_REGULATION_OF_...494,SET,6,0.57407,0.010371,0.40714,0.079279,GOBP_POSITIVE_REGULATION_OF_MUCUS_SECRETION,0.837525298462466
GOBP_REGULATION_OF_CHOLESTER...2,SET,36,0.1901,0.0084052,0.13489,0.079377,GOBP_REGULATION_OF_CHOLESTEROL_EFFLUX,0.837525298462466
GSE32533_WT_VS_MIR17_OVEREXP...1,SET,174,0.094021,0.0091048,0.066717,0.079389,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_DN,0.837525298462466
HP_EMG_IMPAIRED_NEUROMUSCULA...,SET,34,0.20135,0.0086522,0.14288,0.079397,HP_EMG_IMPAIRED_NEUROMUSCULAR_TRANSMISSION,0.837525298462466
GOBP_POSITIVE_REGULATION_OF_...7,SET,7,0.50151,0.0097856,0.3559,0.079409,GOBP_POSITIVE_REGULATION_OF_ACTION_POTENTIAL,0.837525298462466
HP_ABNORMAL_FEMALE_MEIOSIS,SET,6,0.49245,0.0088962,0.34947,0.079409,HP_ABNORMAL_FEMALE_MEIOSIS,0.837525298462466
REACTOME_INTERACTION_WITH_CU...,SET,11,0.34293,0.008387,0.24339,0.07943,REACTOME_INTERACTION_WITH_CUMULUS_CELLS_AND_THE_ZONA_PELLUCIDA,0.837525298462466
ZNF423_TARGET_GENES,SET,844,0.041607,0.0087091,0.029538,0.079485,ZNF423_TARGET_GENES,0.837525298462466
GRAHAM_CML_QUIESCENT_VS_NORM...2,SET,52,0.181,0.0096142,0.12851,0.079502,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.837525298462466
DORN_ADENOVIRUS_INFECTION_12...1,SET,30,0.20381,0.0082277,0.14472,0.079525,DORN_ADENOVIRUS_INFECTION_12HR_DN,0.837525298462466
MIR9903,SET,44,0.17355,0.0084813,0.12326,0.079573,MIR9903,0.837525298462466
HP_ABNORMAL_OVARIAN_MORPHOLO...,SET,158,0.094947,0.0087655,0.067436,0.079578,HP_ABNORMAL_OVARIAN_MORPHOLOGY,0.837525298462466
REACTOME_BUTYROPHILIN_BTN_FA...,SET,12,0.46301,0.011827,0.32886,0.079584,REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS,0.837525298462466
HP_OVARIAN_NEOPLASM,SET,73,0.13095,0.0082367,0.093017,0.079597,HP_OVARIAN_NEOPLASM,0.837525298462466
KEGG_MEDICUS_PATHOGEN_KSHV_V...2,SET,5,0.49938,0.0082356,0.35475,0.079619,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_NFKB_SIGNALING_PATHWAY,0.837525298462466
LIEN_BREAST_CARCINOMA_METAPL...3,SET,73,0.15269,0.0096039,0.10847,0.079623,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_UP,0.837525298462466
GSE18791_CTRL_VS_NEWCASTLE_V...15,SET,167,0.094332,0.008951,0.067017,0.079638,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_DN,0.837525298462466
MIR3678_3P,SET,115,0.11682,0.0092114,0.083,0.07966,MIR3678_3P,0.837525298462466
REACTOME_SIGNALING_BY_BRAF_A...,SET,62,0.15217,0.0088231,0.10813,0.079681,REACTOME_SIGNALING_BY_BRAF_AND_RAF1_FUSIONS,0.837525298462466
KEGG_OOCYTE_MEIOSIS,SET,105,0.11108,0.0083719,0.078965,0.079767,KEGG_OOCYTE_MEIOSIS,0.837525298462466
HP_CONGENITAL_BLINDNESS,SET,8,0.41785,0.0087158,0.29707,0.079784,HP_CONGENITAL_BLINDNESS,0.837525298462466
REACTOME_CYTOKINE_SIGNALING_...,SET,715,0.045945,0.0088841,0.032665,0.079787,REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM,0.837525298462466
GOCC_SITE_OF_DOUBLE_STRAND_B...,SET,85,0.11982,0.0081298,0.085197,0.07981,GOCC_SITE_OF_DOUBLE_STRAND_BREAK,0.837525298462466
MIR593_3P,SET,127,0.10917,0.0090439,0.077632,0.079825,MIR593_3P,0.837525298462466
HP_ABNORMALITY_OF_ABDOMINAL_...,SET,15,0.31625,0.009031,0.2249,0.079844,HP_ABNORMALITY_OF_ABDOMINAL_SITUS,0.837525298462466
WP_TCELL_ACTIVATION_SARSCOV2,SET,86,0.13426,0.0091623,0.095479,0.07985,WP_TCELL_ACTIVATION_SARSCOV2,0.837525298462466
HP_PNEUMOCYSTIS_JIROVECII_PN...,SET,3,0.63318,0.008089,0.45033,0.079863,HP_PNEUMOCYSTIS_JIROVECII_PNEUMONIA,0.837525298462466
GOBP_REELIN_MEDIATED_SIGNALI...,SET,8,0.42172,0.0087966,0.3,0.07991,GOBP_REELIN_MEDIATED_SIGNALING_PATHWAY,0.837525298462466
HP_BROAD_FOREHEAD,SET,167,0.09175,0.0087061,0.065272,0.07992,HP_BROAD_FOREHEAD,0.837525298462466
GOBP_CONSTITUTIVE_HETEROCHRO...,SET,8,0.4057,0.0084625,0.28864,0.079933,GOBP_CONSTITUTIVE_HETEROCHROMATIN_FORMATION,0.837525298462466
GOBP_TRICARBOXYLIC_ACID_CYCLE,SET,28,0.20769,0.0081003,0.1478,0.079987,GOBP_TRICARBOXYLIC_ACID_CYCLE,0.837838512658228
SPIELMAN_LYMPHOBLAST_EUROPEA...3,SET,545,0.049181,0.0083426,0.035006,0.080026,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN,0.837994465200361
HP_MACULAR_PURPURA,SET,79,0.13867,0.0090719,0.098715,0.080057,HP_MACULAR_PURPURA,0.838066576807229
GOBP_SPINAL_CORD_ASSOCIATION...,SET,11,0.42126,0.010303,0.30003,0.080158,GOBP_SPINAL_CORD_ASSOCIATION_NEURON_DIFFERENTIATION,0.838318170072115
HP_PYELONEPHRITIS,SET,20,0.26796,0.0088347,0.19091,0.080226,HP_PYELONEPHRITIS,0.838318170072115
GOBP_UBIQUITIN_DEPENDENT_GLY...,SET,7,0.4737,0.0092429,0.33755,0.080264,GOBP_UBIQUITIN_DEPENDENT_GLYCOPROTEIN_ERAD_PATHWAY,0.838318170072115
GOMF_MANNOSYL_OLIGOSACCHARID...1,SET,7,0.4737,0.0092429,0.33755,0.080264,GOMF_MANNOSYL_OLIGOSACCHARIDE_1_2_ALPHA_MANNOSIDASE_ACTIVITY,0.838318170072115
GOBP_CYSTEINE_METABOLIC_PROC...,SET,10,0.4019,0.0093721,0.28638,0.080265,GOBP_CYSTEINE_METABOLIC_PROCESS,0.838318170072115
GAVISH_3CA_MALIGNANT_METAPRO...27,SET,46,0.19496,0.0097414,0.13893,0.080267,GAVISH_3CA_MALIGNANT_METAPROGRAM_35_HEMATO_RELATED_1,0.838318170072115
GOBP_SIGNAL_TRANSDUCTION_IN_...2,SET,171,0.087503,0.008401,0.062353,0.080268,GOBP_SIGNAL_TRANSDUCTION_IN_RESPONSE_TO_DNA_DAMAGE,0.838318170072115
KEGG_MEDICUS_VARIANT_HRAS_OV...,SET,9,0.41183,0.0091111,0.29347,0.080274,KEGG_MEDICUS_VARIANT_HRAS_OVEREXPRESSION_TO_ERK_SIGNALING_PATHWAY,0.838318170072115
HP_PROTEIN_LOSING_ENTEROPATHY,SET,20,0.26259,0.0086575,0.18722,0.080385,HP_PROTEIN_LOSING_ENTEROPATHY,0.839111574487065
GSE3982_MEMORY_CD4_TCELL_VS_...4,SET,168,0.090698,0.0086317,0.064682,0.080437,GSE3982_MEMORY_CD4_TCELL_VS_TH1_UP,0.839111574487065
HP_STEROETYPIC_MOVEMENTS_OF_...,SET,50,0.1632,0.0085006,0.11641,0.080468,HP_STEROETYPIC_MOVEMENTS_OF_FACE_AND_HEAD,0.839111574487065
ZHAN_MULTIPLE_MYELOMA_HP_UP,SET,39,0.19249,0.0088578,0.13732,0.080504,ZHAN_MULTIPLE_MYELOMA_HP_UP,0.839111574487065
HP_GENERALIZED_LIPODYSTROPHY,SET,8,0.508,0.010596,0.36244,0.080523,HP_GENERALIZED_LIPODYSTROPHY,0.839111574487065
MIR7152_3P,SET,87,0.12165,0.0083496,0.086798,0.080543,MIR7152_3P,0.839111574487065
HP_ABNORMAL_CAROTID_ARTERY_M...,SET,83,0.12994,0.0087127,0.092721,0.080547,HP_ABNORMAL_CAROTID_ARTERY_MORPHOLOGY,0.839111574487065
HP_ABNORMALITY_OF_THE_ELBOW,SET,246,0.074889,0.0086059,0.05344,0.080561,HP_ABNORMALITY_OF_THE_ELBOW,0.839111574487065
GOMF_CALCIUM_ION_TRANSMEMBRA...,SET,135,0.10581,0.0090354,0.075515,0.080581,GOMF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.839111574487065
GSE14350_IL2RB_KO_VS_WT_TREG...2,SET,183,0.086205,0.008559,0.061524,0.080593,GSE14350_IL2RB_KO_VS_WT_TREG_UP,0.839111574487065
GSE8621_UNSTIM_VS_LPS_STIM_M...1,SET,175,0.085691,0.0083218,0.061169,0.08063,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,0.839111574487065
REACTOME_N_GLYCAN_TRIMMING_I...,SET,33,0.20098,0.0085086,0.14347,0.080641,REACTOME_N_GLYCAN_TRIMMING_IN_THE_ER_AND_CALNEXIN_CALRETICULIN_CYCLE,0.839111574487065
HP_TRACHEAL_CALCIFICATION,SET,3,0.74222,0.0094819,0.52993,0.080676,HP_TRACHEAL_CALCIFICATION,0.839111574487065
GSE2706_UNSTIM_VS_8H_LPS_AND...2,SET,176,0.087013,0.008474,0.062138,0.080717,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_UP,0.839111574487065
GSE27786_CD4_VS_CD8_TCELL_DN,SET,176,0.088179,0.0085876,0.062992,0.080791,GSE27786_CD4_VS_CD8_TCELL_DN,0.839111574487065
REACTOME_INTEGRIN_SIGNALING,SET,27,0.22704,0.0086957,0.1622,0.080803,REACTOME_INTEGRIN_SIGNALING,0.839111574487065
MIR4679,SET,141,0.10187,0.008888,0.072775,0.080804,MIR4679,0.839111574487065
GOBP_REGULATION_OF_SHORT_TER...,SET,14,0.33059,0.0091206,0.23618,0.080806,GOBP_REGULATION_OF_SHORT_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.839111574487065
DIRMEIER_LMP1_RESPONSE_LATE_...1,SET,26,0.23295,0.0087554,0.16648,0.080883,DIRMEIER_LMP1_RESPONSE_LATE_DN,0.839111574487065
HP_HAND_MUSCLE_WEAKNESS,SET,43,0.16794,0.0081135,0.12003,0.080906,HP_HAND_MUSCLE_WEAKNESS,0.839111574487065
HP_DEVIATION_OF_THE_2ND_TOE,SET,5,0.61276,0.010105,0.43803,0.080931,HP_DEVIATION_OF_THE_2ND_TOE,0.839111574487065
GOBP_MALE_SEX_DETERMINATION,SET,11,0.38782,0.009485,0.27725,0.080944,GOBP_MALE_SEX_DETERMINATION,0.839111574487065
DESCARTES_FETAL_SPLEEN_ERYTH...,SET,53,0.1661,0.0089066,0.11875,0.080962,DESCARTES_FETAL_SPLEEN_ERYTHROBLASTS,0.839111574487065
GOBP_POSITIVE_REGULATION_OF_...144,SET,119,0.11323,0.0090815,0.080957,0.080972,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.839111574487065
HP_ABNORMALITY_OF_TEMPERATUR...,SET,490,0.054701,0.0088119,0.039111,0.080972,HP_ABNORMALITY_OF_TEMPERATURE_REGULATION,0.839111574487065
MIR24_3P,SET,246,0.074592,0.0085718,0.053339,0.080998,MIR24_3P,0.839111574487065
REACTOME_PROTEIN_LIPOYLATION,SET,10,0.33535,0.0078203,0.23984,0.081032,REACTOME_PROTEIN_LIPOYLATION,0.839111574487065
GOBP_SKELETAL_MUSCLE_SATELLI...3,SET,4,0.66332,0.0097846,0.47456,0.081102,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_MAINTENANCE_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,0.839111574487065
GOBP_POSITIVE_REGULATION_OF_...700,SET,28,0.22963,0.0089559,0.16429,0.08111,GOBP_POSITIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.839111574487065
HP_URETHRAL_OBSTRUCTION,SET,60,0.15641,0.008922,0.11191,0.081127,HP_URETHRAL_OBSTRUCTION,0.839111574487065
HALLMARK_COAGULATION,SET,129,0.11164,0.0093201,0.079881,0.08113,HALLMARK_COAGULATION,0.839111574487065
GSE22601_DOUBLE_NEGATIVE_VS_...6,SET,167,0.091118,0.0086461,0.065204,0.081149,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,0.839111574487065
GOCC_PROTEASOME_CORE_COMPLEX...2,SET,11,0.33149,0.0081072,0.23722,0.08116,GOCC_PROTEASOME_CORE_COMPLEX_BETA_SUBUNIT_COMPLEX,0.839111574487065
GOMF_SECONDARY_ACTIVE_TRANSM...,SET,274,0.074136,0.0089843,0.053062,0.081191,GOMF_SECONDARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.839111574487065
OHM_EMBRYONIC_CARCINOMA_DN,SET,8,0.46707,0.0097425,0.3343,0.081195,OHM_EMBRYONIC_CARCINOMA_DN,0.839111574487065
GOMF_ALDO_KETO_REDUCTASE_NAD...,SET,29,0.24322,0.0096537,0.17413,0.081251,GOMF_ALDO_KETO_REDUCTASE_NADPH_ACTIVITY,0.83932550371471
HP_REDUCED_BRAIN_N_ACETYL_AS...,SET,16,0.26796,0.0079027,0.19185,0.081264,HP_REDUCED_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.83932550371471
MODULE_255,SET,406,0.058545,0.0086049,0.04193,0.081326,MODULE_255,0.839716319073084
GOBP_SOMITE_DEVELOPMENT,SET,74,0.14178,0.0089786,0.10159,0.081416,GOBP_SOMITE_DEVELOPMENT,0.83978279169122
HP_SUPERNUMERARY_CUSP,SET,4,0.58763,0.0086681,0.42117,0.081484,HP_SUPERNUMERARY_CUSP,0.83978279169122
MIR500A_3P,SET,71,0.14659,0.0090932,0.10507,0.081489,MIR500A_3P,0.83978279169122
SHAFFER_IRF4_TARGETS_IN_ACTI...2,SET,58,0.16113,0.0090375,0.1155,0.081507,SHAFFER_IRF4_TARGETS_IN_ACTIVATED_DENDRITIC_CELL,0.83978279169122
GOMF_LIGAND_ACTIVATED_TRANSC...,SET,52,0.16911,0.0089826,0.12123,0.081515,GOMF_LIGAND_ACTIVATED_TRANSCRIPTION_FACTOR_ACTIVITY,0.83978279169122
WP_HEPATITIS_C_AND_HEPATOCEL...,SET,49,0.17705,0.0091297,0.12693,0.081543,WP_HEPATITIS_C_AND_HEPATOCELLULAR_CARCINOMA,0.83978279169122
GOBP_RESPONSE_TO_ENDOPLASMIC...,SET,244,0.072304,0.0082755,0.051847,0.081584,GOBP_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.83978279169122
HP_ARTHROPATHY,SET,41,0.19287,0.0090992,0.1383,0.081588,HP_ARTHROPATHY,0.83978279169122
HP_CARDIOMEGALY,SET,114,0.1096,0.0086052,0.078606,0.081619,HP_CARDIOMEGALY,0.83978279169122
GOBP_POSTSYNAPTIC_MEMBRANE_A...,SET,7,0.40074,0.0078193,0.28746,0.081658,GOBP_POSTSYNAPTIC_MEMBRANE_ASSEMBLY,0.83978279169122
GOMF_DIPHOSPHOTRANSFERASE_AC...,SET,4,0.53976,0.007962,0.38738,0.081761,GOMF_DIPHOSPHOTRANSFERASE_ACTIVITY,0.83978279169122
GSE16385_IFNG_TNF_VS_IL4_STI...4,SET,184,0.087561,0.0087172,0.062842,0.081764,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.83978279169122
HALLMARK_ALLOGRAFT_REJECTION,SET,184,0.090689,0.0090285,0.065097,0.081798,HALLMARK_ALLOGRAFT_REJECTION,0.83978279169122
DESCARTES_FETAL_HEART_ELF3_A...,SET,34,0.20287,0.0087175,0.14563,0.081812,DESCARTES_FETAL_HEART_ELF3_AGBL2_POSITIVE_CELLS,0.83978279169122
KEGG_MEDICUS_VARIANT_AMPLIFI...11,SET,6,0.40566,0.0073283,0.29121,0.081815,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_REPRESSION,0.83978279169122
JECHLINGER_EPITHELIAL_TO_MES...2,SET,66,0.15309,0.0091573,0.1099,0.081825,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.83978279169122
GSE25088_IL4_VS_IL4_AND_ROSI...1,SET,185,0.085795,0.0085643,0.061597,0.081842,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.83978279169122
GOBP_NEGATIVE_REGULATION_OF_...198,SET,6,0.47532,0.0085867,0.34127,0.081853,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_CALCIUM_ION_CONCENTRATION,0.83978279169122
REACTOME_GABA_SYNTHESIS_RELE...,SET,19,0.29517,0.0094854,0.21195,0.081876,REACTOME_GABA_SYNTHESIS_RELEASE_REUPTAKE_AND_DEGRADATION,0.83978279169122
ABBUD_LIF_SIGNALING_2_DN,SET,7,0.52889,0.01032,0.37984,0.08191,ABBUD_LIF_SIGNALING_2_DN,0.83978279169122
MIR148A_3P,SET,315,0.066968,0.0086918,0.048098,0.081922,MIR148A_3P,0.83978279169122
GOCC_CONNEXIN_COMPLEX,SET,18,0.29972,0.0093753,0.21529,0.081941,GOCC_CONNEXIN_COMPLEX,0.83978279169122
GOBP_EGG_ACTIVATION,SET,11,0.34526,0.0084441,0.24802,0.081956,GOBP_EGG_ACTIVATION,0.83978279169122
REACTOME_RUNX3_REGULATES_WNT...,SET,8,0.428,0.0089275,0.30748,0.08198,REACTOME_RUNX3_REGULATES_WNT_SIGNALING,0.83978279169122
HESSON_TUMOR_SUPPRESSOR_CLUS...,SET,8,0.45037,0.0093942,0.32357,0.081986,HESSON_TUMOR_SUPPRESSOR_CLUSTER_3P21_3,0.83978279169122
GOCC_CYTOSOLIC_SMALL_RIBOSOM...,SET,35,0.19261,0.0083972,0.13838,0.081995,GOCC_CYTOSOLIC_SMALL_RIBOSOMAL_SUBUNIT,0.83978279169122
GSE45365_CD8A_DC_VS_CD11B_DC...6,SET,166,0.088998,0.0084198,0.063944,0.082001,GSE45365_CD8A_DC_VS_CD11B_DC_UP,0.83978279169122
TFIII_Q6,SET,201,0.086129,0.0089577,0.061886,0.082009,TFIII_Q6,0.83978279169122
BIOCARTA_GRANULOCYTES_PATHWAY,SET,15,0.30849,0.0088094,0.22172,0.082066,BIOCARTA_GRANULOCYTES_PATHWAY,0.83987156360424
HP_NEOPLASM_OF_THE_ENDOCRINE...,SET,150,0.0949,0.0085383,0.068207,0.082066,HP_NEOPLASM_OF_THE_ENDOCRINE_SYSTEM,0.83987156360424
REACTOME_PLATELET_CALCIUM_HO...,SET,27,0.22668,0.008682,0.16306,0.082249,REACTOME_PLATELET_CALCIUM_HOMEOSTASIS,0.840032508024511
GOMF_INTRONIC_TRANSCRIPTION_...,SET,11,0.38064,0.0093093,0.27385,0.08228,GOMF_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.840032508024511
GOBP_OUTER_DYNEIN_ARM_ASSEMB...,SET,15,0.27226,0.0077748,0.19588,0.082283,GOBP_OUTER_DYNEIN_ARM_ASSEMBLY,0.840032508024511
WP_DENGUE2_INTERACTIONS_WITH...,SET,53,0.17421,0.0093414,0.12534,0.082295,WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES,0.840032508024511
GOCC_TIM23_MITOCHONDRIAL_IMP...,SET,14,0.28403,0.0078362,0.20438,0.082316,GOCC_TIM23_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_TRANSLOCASE_COMPLEX,0.840032508024511
HP_INTESTINAL_HYPOPLASIA,SET,19,0.2622,0.0084262,0.18868,0.082326,HP_INTESTINAL_HYPOPLASIA,0.840032508024511
GSE21774_CD56_BRIGHT_VS_DIM_...1,SET,178,0.087676,0.0085865,0.063115,0.082401,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_DN,0.840032508024511
GOBP_ADENOHYPOPHYSIS_DEVELOP...,SET,16,0.32113,0.0094708,0.23122,0.082446,GOBP_ADENOHYPOPHYSIS_DEVELOPMENT,0.840032508024511
GOMF_L_HISTIDINE_TRANSMEMBRA...,SET,3,0.71498,0.0091339,0.5148,0.082448,GOMF_L_HISTIDINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.840032508024511
REACTOME_NA_CL_DEPENDENT_NEU...,SET,18,0.33138,0.010366,0.23862,0.08246,REACTOME_NA_CL_DEPENDENT_NEUROTRANSMITTER_TRANSPORTERS,0.840032508024511
GSE17974_IL4_AND_ANTI_IL12_V...12,SET,158,0.09907,0.0091461,0.071341,0.082473,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_UP,0.840032508024511
KEGG_MEDICUS_REFERENCE_N_GLY...3,SET,5,0.4257,0.0070205,0.30655,0.082476,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG7_TO_ALG11,0.840032508024511
CHNG_MULTIPLE_MYELOMA_HYPERP...2,SET,50,0.15415,0.0080291,0.11101,0.082487,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP,0.840032508024511
GSE17721_POLYIC_VS_GARDIQUIM...17,SET,180,0.083905,0.0082628,0.060426,0.082493,GSE17721_POLYIC_VS_GARDIQUIMOD_8H_BMDC_DN,0.840032508024511
KEGG_MEDICUS_REFERENCE_TNF_P...,SET,24,0.23114,0.008347,0.16648,0.082517,KEGG_MEDICUS_REFERENCE_TNF_P38_SIGNALING_PATHWAY,0.840032508024511
REACTOME_TRANSCRIPTIONAL_REG...8,SET,36,0.20799,0.0091963,0.14984,0.082557,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_THE_AP_2_TFAP2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.840032508024511
REACTOME_HS_GAG_BIOSYNTHESIS,SET,28,0.24648,0.0096131,0.1776,0.082605,REACTOME_HS_GAG_BIOSYNTHESIS,0.840032508024511
GOMF_SULFURTRANSFERASE_ACTIV...,SET,11,0.34621,0.0084672,0.24949,0.082628,GOMF_SULFURTRANSFERASE_ACTIVITY,0.840032508024511
CAR_WBSCR22,SET,32,0.19003,0.0079225,0.13696,0.082652,CAR_WBSCR22,0.840032508024511
GOCC_RDNA_HETEROCHROMATIN,SET,3,0.50412,0.0064402,0.36333,0.082654,GOCC_RDNA_HETEROCHROMATIN,0.840032508024511
HP_SHORT_UPPER_LIP,SET,9,0.38343,0.0084829,0.27638,0.082681,HP_SHORT_UPPER_LIP,0.840032508024511
HP_HITCHHIKER_THUMB,SET,6,0.40976,0.0074024,0.29539,0.082704,HP_HITCHHIKER_THUMB,0.840032508024511
GSE39820_CTRL_VS_IL1B_IL6_CD...2,SET,171,0.089393,0.0085824,0.064456,0.082749,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_UP,0.840032508024511
MODULE_69,SET,480,0.052235,0.0083305,0.037664,0.082751,MODULE_69,0.840032508024511
GOMF_CYSTEINE_TYPE_ENDOPEPTI...1,SET,5,0.52972,0.008736,0.38199,0.082768,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,0.840032508024511
GSE17721_12H_VS_24H_GARDIQUI...1,SET,175,0.082964,0.0080569,0.059827,0.082773,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_DN,0.840032508024511
HP_COMPLETE_DUPLICATION_OF_P...,SET,11,0.34361,0.0084037,0.2478,0.082782,HP_COMPLETE_DUPLICATION_OF_PHALANX_OF_HAND,0.840032508024511
GOCC_EARLY_ENDOSOME,SET,401,0.058573,0.008557,0.042244,0.082801,GOCC_EARLY_ENDOSOME,0.840032508024511
GOBP_PRODUCTION_OF_MOLECULAR...2,SET,205,0.082409,0.0086547,0.059437,0.082807,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.840032508024511
REACTOME_LYSOSPHINGOLIPID_AN...,SET,9,0.4268,0.0094423,0.30783,0.08281,REACTOME_LYSOSPHINGOLIPID_AND_LPA_RECEPTORS,0.840032508024511
REACTOME_TRANSLESION_SYNTHES...3,SET,36,0.16892,0.0074686,0.12184,0.082831,REACTOME_TRANSLESION_SYNTHESIS_BY_Y_FAMILY_DNA_POLYMERASES_BYPASSES_LESIONS_ON_DNA_TEMPLATE,0.840032508024511
HP_ABNORMAL_CIRCULATING_BRAN...,SET,8,0.40879,0.008527,0.29499,0.082914,HP_ABNORMAL_CIRCULATING_BRANCHED_CHAIN_AMINO_ACID_CONCENTRATION,0.840628958576429
GOMF_GLYCOGEN_BINDING,SET,7,0.47624,0.0092924,0.3439,0.083061,GOMF_GLYCOGEN_BINDING,0.840657675814751
GOMF_DNA_DAMAGE_SENSOR_ACTIV...,SET,20,0.20805,0.0068592,0.15024,0.083074,GOMF_DNA_DAMAGE_SENSOR_ACTIVITY,0.840657675814751
HP_SKIN_TAGS,SET,72,0.13488,0.0084256,0.097437,0.083145,HP_SKIN_TAGS,0.840657675814751
E47_01,SET,233,0.077094,0.0086252,0.055693,0.083146,E47_01,0.840657675814751
GNF2_VAV1,SET,33,0.21137,0.0089487,0.15272,0.08318,GNF2_VAV1,0.840657675814751
SCHERER_PBMC_APSV_WETVAX_AGE...1,SET,31,0.19899,0.0081657,0.1438,0.083208,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_DN,0.840657675814751
HP_ADVANCED_ERUPTION_OF_TEETH,SET,37,0.18481,0.008284,0.13357,0.083241,HP_ADVANCED_ERUPTION_OF_TEETH,0.840657675814751
GSE17974_0H_VS_1H_IN_VITRO_A...2,SET,159,0.091491,0.0084728,0.066137,0.083286,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_UP,0.840657675814751
REACTOME_DECTIN_2_FAMILY,SET,19,0.284,0.0091265,0.20532,0.083311,REACTOME_DECTIN_2_FAMILY,0.840657675814751
REACTOME_SYNTHESIS_OF_PG,SET,8,0.40222,0.0083897,0.29081,0.083327,REACTOME_SYNTHESIS_OF_PG,0.840657675814751
ERWIN_COHEN_PBMC_TC_83_AGE_1...2,SET,14,0.33163,0.0091493,0.2398,0.083354,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_DN,0.840657675814751
PIEPOLI_LGI1_TARGETS_UP,SET,12,0.38999,0.0099618,0.28201,0.083359,PIEPOLI_LGI1_TARGETS_UP,0.840657675814751
NABA_MATRISOME_POORLY_METAST...1,SET,25,0.24262,0.008942,0.17546,0.083384,NABA_MATRISOME_POORLY_METASTATIC_BREAST_CANCER,0.840657675814751
GSE24210_CTRL_VS_IL35_TREATE...2,SET,187,0.086029,0.0086334,0.062238,0.083455,GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP,0.840657675814751
HALLMARK_INTERFERON_GAMMA_RE...,SET,190,0.086921,0.008792,0.062887,0.083465,HALLMARK_INTERFERON_GAMMA_RESPONSE,0.840657675814751
HP_EMBRYONAL_NEOPLASM,SET,73,0.1474,0.0092711,0.10664,0.083466,HP_EMBRYONAL_NEOPLASM,0.840657675814751
STAEGE_EWING_FAMILY_TUMOR,SET,24,0.26954,0.0097337,0.19501,0.083472,STAEGE_EWING_FAMILY_TUMOR,0.840657675814751
KEGG_MEDICUS_VARIANT_MUTATIO...84,SET,8,0.4308,0.008986,0.31175,0.083515,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PROKR2_TO_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.840657675814751
REACTOME_CHONDROITIN_SULFATE...2,SET,45,0.17567,0.0086818,0.12713,0.083522,REACTOME_CHONDROITIN_SULFATE_DERMATAN_SULFATE_METABOLISM,0.840657675814751
GOBP_SNRNA_TRANSCRIPTION_BY_...2,SET,9,0.34703,0.0076774,0.25116,0.083542,GOBP_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.840657675814751
GOBP_MEDIUM_CHAIN_FATTY_ACID...3,SET,15,0.28239,0.008064,0.20442,0.083585,GOBP_MEDIUM_CHAIN_FATTY_ACID_METABOLIC_PROCESS,0.840657675814751
GOBP_DERMATAN_SULFATE_PROTEO...1,SET,8,0.39518,0.008243,0.2861,0.083605,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,0.840657675814751
HP_WRIST_DROP,SET,7,0.46649,0.0091022,0.33776,0.083628,HP_WRIST_DROP,0.840657675814751
HP_ABNORMALITY_OF_THE_HYPOTH...2,SET,7,0.442,0.0086244,0.32006,0.083651,HP_ABNORMALITY_OF_THE_HYPOTHENAR_EMINENCE,0.840657675814751
HP_ABNORMAL_MITOCHONDRIA_IN_...,SET,25,0.20115,0.0074136,0.14568,0.083681,HP_ABNORMAL_MITOCHONDRIA_IN_MUSCLE_TISSUE,0.840657675814751
GOMF_FATTY_ACID_BINDING,SET,45,0.17554,0.0086752,0.12716,0.083727,GOMF_FATTY_ACID_BINDING,0.840657675814751
HP_ABNORMAL_LARGE_INTESTINE_...1,SET,295,0.06853,0.0086122,0.049642,0.083729,HP_ABNORMAL_LARGE_INTESTINE_MORPHOLOGY,0.840657675814751
LEE_LIVER_CANCER_HEPATOBLAST,SET,15,0.32952,0.0094101,0.23882,0.083834,LEE_LIVER_CANCER_HEPATOBLAST,0.840657675814751
GOBP_POSITIVE_REGULATION_OF_...100,SET,33,0.21547,0.009122,0.15619,0.083874,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.840657675814751
GOMF_RNA_ENDONUCLEASE_ACTIVI...1,SET,63,0.1482,0.0086617,0.10743,0.083888,GOMF_RNA_ENDONUCLEASE_ACTIVITY,0.840657675814751
HP_APLASIA_HYPOPLASIA_INVOLV...14,SET,13,0.31499,0.0083743,0.22839,0.083934,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SINUSES,0.840657675814751
MIR5006_5P,SET,109,0.10811,0.0083012,0.078407,0.083977,MIR5006_5P,0.840657675814751
GOBP_TRICARBOXYLIC_ACID_META...,SET,15,0.30436,0.0086916,0.22075,0.083993,GOBP_TRICARBOXYLIC_ACID_METABOLIC_PROCESS,0.840657675814751
HP_HEMOTHORAX,SET,6,0.47483,0.0085778,0.34442,0.084012,HP_HEMOTHORAX,0.840657675814751
HP_SHORT_THORAX,SET,45,0.16539,0.0081736,0.11997,0.084023,HP_SHORT_THORAX,0.840657675814751
GSE12963_UNINF_VS_ENV_AND_NE...4,SET,127,0.1045,0.0086564,0.075812,0.084056,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.840657675814751
GSE20366_CD103_KLRG1_DP_VS_D...2,SET,180,0.086053,0.0084743,0.062438,0.084078,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_UP,0.840657675814751
WP_EICOSANOID_METABOLISM_VIA...3,SET,28,0.21933,0.0085544,0.15915,0.084086,WP_EICOSANOID_METABOLISM_VIA_LIPOOXYGENASES_LOX,0.840657675814751
GSE29618_PRE_VS_DAY7_POST_LA...7,SET,177,0.080004,0.0078133,0.058061,0.084122,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN,0.840657675814751
GOMF_FUCOSYLTRANSFERASE_ACTI...,SET,13,0.34386,0.0091421,0.24961,0.084172,GOMF_FUCOSYLTRANSFERASE_ACTIVITY,0.840657675814751
GSE7219_UNSTIM_VS_LPS_AND_AN...3,SET,185,0.088656,0.0088498,0.064355,0.084173,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_DN,0.840657675814751
GOBP_RESPONSE_TO_INTERLEUKIN...12,SET,5,0.59698,0.0098452,0.43339,0.084193,GOBP_RESPONSE_TO_INTERLEUKIN_9,0.840657675814751
WP_FATTY_ACID_BIOSYNTHESIS,SET,21,0.2385,0.0080573,0.17316,0.084208,WP_FATTY_ACID_BIOSYNTHESIS,0.840657675814751
GOBP_POSITIVE_REGULATION_OF_...717,SET,11,0.36903,0.0090253,0.26792,0.08421,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.840657675814751
GSE14413_UNSTIM_VS_IFNB_STIM...6,SET,123,0.1056,0.0086097,0.076679,0.084245,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_UP,0.840657675814751
GOBP_PROTEIN_IMPORT,SET,9,0.42581,0.0094205,0.30921,0.08425,GOBP_PROTEIN_IMPORT,0.840657675814751
GSE3982_BCELL_VS_TH1_UP,SET,163,0.091368,0.0085663,0.066363,0.084298,GSE3982_BCELL_VS_TH1_UP,0.840657675814751
MIR450A_1_3P,SET,168,0.088964,0.0084667,0.064622,0.084312,MIR450A_1_3P,0.840657675814751
GOMF_AMINO_ACID_MONOATOMIC_C...2,SET,27,0.25677,0.0098345,0.18652,0.084317,GOMF_AMINO_ACID_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.840657675814751
HP_CYSTIC_RENAL_DYSPLASIA,SET,8,0.3799,0.0079243,0.27596,0.08432,HP_CYSTIC_RENAL_DYSPLASIA,0.840657675814751
GOCC_HIGH_DENSITY_LIPOPROTEI...,SET,25,0.24995,0.0092122,0.1816,0.084368,GOCC_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.840657675814751
MURARO_PANCREAS_MESENCHYMAL_...,SET,620,0.049369,0.0089134,0.03587,0.084368,MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL,0.840657675814751
HP_ABNORMALITY_OF_THE_CHIN,SET,336,0.062369,0.0083555,0.045316,0.084374,HP_ABNORMALITY_OF_THE_CHIN,0.840657675814751
REACTOME_SEROTONIN_AND_MELAT...,SET,4,0.55583,0.0081991,0.40391,0.084399,REACTOME_SEROTONIN_AND_MELATONIN_BIOSYNTHESIS,0.840657675814751
REACTOME_INTERLEUKIN_9_SIGNA...,SET,7,0.56337,0.010992,0.4094,0.084408,REACTOME_INTERLEUKIN_9_SIGNALING,0.840657675814751
SOBOLEV_PBMC_PANDEMRIX_AGE_1...8,SET,32,0.2283,0.0095177,0.16591,0.08441,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_1DY_UP,0.840657675814751
GOBP_LYMPHOCYTE_ACTIVATION_I...,SET,194,0.087338,0.0089256,0.063476,0.084433,GOBP_LYMPHOCYTE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.840657675814751
GNF2_INPP5D,SET,39,0.19673,0.0090526,0.14298,0.084434,GNF2_INPP5D,0.840657675814751
HP_SEMILOBAR_HOLOPROSENCEPHA...,SET,7,0.44581,0.0086987,0.32404,0.084453,HP_SEMILOBAR_HOLOPROSENCEPHALY,0.840657675814751
GSE2770_IL12_ACT_VS_ACT_CD4_...3,SET,178,0.083448,0.0081724,0.060655,0.084456,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_DN,0.840657675814751
P300_01,SET,223,0.079551,0.0087093,0.057829,0.084479,P300_01,0.840657675814751
HP_GOWERS_SIGN,SET,68,0.1431,0.0086882,0.10403,0.084493,HP_GOWERS_SIGN,0.840657675814751
GOBP_FEMALE_MEIOSIS_CHROMOSO...,SET,6,0.36362,0.0065689,0.26438,0.084512,GOBP_FEMALE_MEIOSIS_CHROMOSOME_SEGREGATION,0.840657675814751
GOCC_HAPTOGLOBIN_HEMOGLOBIN_...,SET,7,0.53908,0.010519,0.39195,0.084517,GOCC_HAPTOGLOBIN_HEMOGLOBIN_COMPLEX,0.840657675814751
PID_ERBB2_ERBB3_PATHWAY,SET,44,0.16994,0.008305,0.12356,0.08452,PID_ERBB2_ERBB3_PATHWAY,0.840657675814751
REACTOME_PINK1_PRKN_MEDIATED...,SET,29,0.20671,0.0082045,0.15032,0.084552,REACTOME_PINK1_PRKN_MEDIATED_MITOPHAGY,0.840657675814751
HP_EPISODIC_PAIN,SET,38,0.17989,0.0081712,0.13083,0.084575,HP_EPISODIC_PAIN,0.840657675814751
GOBP_POSITIVE_REGULATION_OF_...382,SET,52,0.15779,0.0083813,0.11478,0.084608,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.840657675814751
SCHERER_PBMC_APSV_WETVAX_AGE...9,SET,55,0.17286,0.0094422,0.12574,0.08461,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.840657675814751
SCHERER_PBMC_YF_VAX_AGE_18_4...5,SET,55,0.17286,0.0094422,0.12574,0.08461,SCHERER_PBMC_YF_VAX_AGE_18_40YO_JOINT_TO_VACCINIA_AND_YELLOW_FEVER_UP,0.840657675814751
MILI_PSEUDOPODIA_CHEMOTAXIS_...2,SET,73,0.12309,0.0077421,0.089563,0.084678,MILI_PSEUDOPODIA_CHEMOTAXIS_UP,0.840682410154022
GSE17186_NAIVE_VS_CD21LOW_TR...1,SET,187,0.085442,0.0085746,0.062186,0.084732,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_DN,0.840682410154022
HP_PROLONGED_BLEEDING_FOLLOW...1,SET,11,0.40643,0.00994,0.29581,0.084736,HP_PROLONGED_BLEEDING_FOLLOWING_CIRCUMCISION,0.840682410154022
GOMF_ESTRADIOL_17_BETA_DEHYD...,SET,18,0.28815,0.0090132,0.20973,0.084741,GOMF_ESTRADIOL_17_BETA_DEHYDROGENASE_NAD_P_ACTIVITY,0.840682410154022
ACAWYAAAG_UNKNOWN,SET,91,0.12633,0.0088675,0.091959,0.08476,ACAWYAAAG_UNKNOWN,0.840682410154022
MODULE_453,SET,40,0.17483,0.0081474,0.12727,0.084781,MODULE_453,0.840682410154022
HP_DORSOCERVICAL_FAT_PAD,SET,14,0.28597,0.0078897,0.20819,0.084795,HP_DORSOCERVICAL_FAT_PAD,0.840682410154022
HP_ABNORMAL_MIDFACE_MORPHOLO...,SET,533,0.049645,0.0083308,0.036145,0.084806,HP_ABNORMAL_MIDFACE_MORPHOLOGY,0.840682410154022
GOCC_MULTIVESICULAR_BODY_INT...,SET,6,0.54631,0.0098693,0.39787,0.084872,GOCC_MULTIVESICULAR_BODY_INTERNAL_VESICLE,0.840978109183964
MIR3686,SET,295,0.067815,0.0085224,0.049402,0.084931,MIR3686,0.840978109183964
HP_CORTICAL_CATARACT,SET,10,0.37821,0.0088198,0.27557,0.084969,HP_CORTICAL_CATARACT,0.840978109183964
HUMMERICH_BENIGN_SKIN_TUMOR_...1,SET,19,0.27811,0.0089375,0.20268,0.085008,HUMMERICH_BENIGN_SKIN_TUMOR_DN,0.840978109183964
GSE26912_TUMORICIDAL_VS_CTRL...1,SET,184,0.083031,0.0082662,0.060511,0.085014,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_DN,0.840978109183964
GOBP_L_ASCORBIC_ACID_METABOL...,SET,9,0.39377,0.0087115,0.28699,0.08503,GOBP_L_ASCORBIC_ACID_METABOLIC_PROCESS,0.840978109183964
GSE27786_LIN_NEG_VS_NKCELL_UP,SET,174,0.085774,0.0083062,0.062516,0.085037,GSE27786_LIN_NEG_VS_NKCELL_UP,0.840978109183964
WP_WNT_SIGNALING_AND_PLURIPO...,SET,95,0.12468,0.0089407,0.090886,0.085069,WP_WNT_SIGNALING_AND_PLURIPOTENCY,0.840978109183964
MODULE_1,SET,336,0.068485,0.0091748,0.049925,0.085078,MODULE_1,0.840978109183964
GOBP_REGULATION_OF_APOPTOTIC...1,SET,8,0.41961,0.0087525,0.30591,0.085091,GOBP_REGULATION_OF_APOPTOTIC_CELL_CLEARANCE,0.840978109183964
GSE27786_NKTCELL_VS_ERYTHROB...2,SET,185,0.082803,0.0082656,0.060369,0.085102,GSE27786_NKTCELL_VS_ERYTHROBLAST_UP,0.840978109183964
HP_ABNORMAL_FACTOR_VIII_ACTI...,SET,4,0.55626,0.0082054,0.40569,0.085174,HP_ABNORMAL_FACTOR_VIII_ACTIVITY,0.841193328129435
KANNAN_BLOOD_2012_2013_TIV_A...1,SET,297,0.063902,0.0080574,0.046611,0.085202,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MOS_DN,0.841193328129435
HP_ABNORMAL_CARDIOVASCULAR_S...,SET,1283,0.033295,0.0084843,0.024288,0.08522,HP_ABNORMAL_CARDIOVASCULAR_SYSTEM_PHYSIOLOGY,0.841193328129435
chr2p12,SET,13,0.50316,0.013377,0.3671,0.085255,chr2p12,0.841193328129435
GOBP_NEUROENDOCRINE_CELL_DIF...,SET,16,0.34109,0.01006,0.24886,0.085262,GOBP_NEUROENDOCRINE_CELL_DIFFERENTIATION,0.841193328129435
GOBP_PROTEIN_KINASE_A_SIGNAL...,SET,37,0.20032,0.0089791,0.14616,0.085269,GOBP_PROTEIN_KINASE_A_SIGNALING,0.841193328129435
GSE17974_IL4_AND_ANTI_IL12_V...6,SET,151,0.095894,0.0086562,0.069981,0.085308,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_UP,0.841339256526674
MIR6724_5P,SET,18,0.26642,0.0083337,0.1945,0.085386,MIR6724_5P,0.841869625531915
KEGG_MEDICUS_REFERENCE_LYSOS...,SET,10,0.33222,0.0077472,0.24266,0.085503,KEGG_MEDICUS_REFERENCE_LYSOSOMAL_CA2_RELEASE,0.842712673660335
GSE29949_MICROGLIA_BRAIN_VS_...6,SET,182,0.087095,0.008624,0.063623,0.08552,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,0.842712673660335
GOBP_POSITIVE_REGULATION_OF_...432,SET,22,0.25149,0.0086958,0.18377,0.08559,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,0.842921974504249
SCHWAB_TARGETS_OF_BMYB_POLYM...1,SET,14,0.32757,0.0090375,0.2394,0.085612,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN,0.842921974504249
HP_ABDOMINAL_SITUS_AMBIGUUS,SET,4,0.58665,0.0086537,0.42874,0.085614,HP_ABDOMINAL_SITUS_AMBIGUUS,0.842921974504249
GSE42021_TREG_VS_TCONV_PLN_DN,SET,179,0.086223,0.0084676,0.063031,0.085672,GSE42021_TREG_VS_TCONV_PLN_DN,0.843089032258065
GOBP_RESPONSE_TO_OXYGEN_RADI...,SET,25,0.23155,0.0085342,0.1693,0.085711,GOBP_RESPONSE_TO_OXYGEN_RADICAL,0.843089032258065
MARKS_ACETYLATED_NON_HISTONE...,SET,11,0.35315,0.0086371,0.25823,0.085725,MARKS_ACETYLATED_NON_HISTONE_PROTEINS,0.843089032258065
HP_RENAL_ARTERY_STENOSIS,SET,21,0.24366,0.0082316,0.17817,0.085728,HP_RENAL_ARTERY_STENOSIS,0.843089032258065
MIR4277,SET,116,0.10687,0.0084636,0.078166,0.085783,MIR4277,0.843110903307888
SCHLOSSER_MYC_AND_SERUM_RESP...,SET,31,0.20572,0.0084417,0.15046,0.085785,SCHLOSSER_MYC_AND_SERUM_RESPONSE_SYNERGY,0.843110903307888
BILANGES_SERUM_AND_RAPAMYCIN...,SET,60,0.14295,0.0081542,0.10456,0.085803,BILANGES_SERUM_AND_RAPAMYCIN_SENSITIVE_GENES,0.843110903307888
HP_HYPEREXTENSIBLE_SKIN,SET,60,0.14648,0.0083557,0.10716,0.085834,HP_HYPEREXTENSIBLE_SKIN,0.84317712549463
ACOSTA_PROLIFERATION_INDEPEN...1,SET,106,0.11504,0.0087116,0.084183,0.085886,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_DN,0.843323893280632
MIR4723_5P,SET,194,0.0806,0.008237,0.058988,0.085918,MIR4723_5P,0.843323893280632
MIR4721,SET,64,0.13647,0.008039,0.099877,0.085922,MIR4721,0.843323893280632
REACTOME_INTERLEUKIN_12_SIGN...,SET,43,0.16774,0.0081043,0.12278,0.085946,REACTOME_INTERLEUKIN_12_SIGNALING,0.843323893280632
GOMF_TRANSCRIPTION_FACTOR_BI...,SET,554,0.049877,0.008528,0.036527,0.086057,GOMF_TRANSCRIPTION_FACTOR_BINDING,0.844174720575783
ZHAN_MULTIPLE_MYELOMA_CD1_VS...1,SET,48,0.17798,0.0090836,0.13038,0.086125,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_DN,0.8443847348378
HP_EYE_POKING,SET,5,0.5336,0.0088,0.3909,0.086127,HP_EYE_POKING,0.8443847348378
PID_TRKR_PATHWAY,SET,60,0.14512,0.008278,0.10634,0.086189,PID_TRKR_PATHWAY,0.844425033821871
GOBP_NEGATIVE_REGULATION_OF_...641,SET,11,0.36049,0.0088164,0.26417,0.086196,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_COMPETITIVE_PROMOTER_BINDING,0.844425033821871
GSE40274_CTRL_VS_GATA1_TRANS...1,SET,148,0.093024,0.0083139,0.068171,0.086204,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.844425033821871
MODULE_524,SET,27,0.23389,0.008958,0.17147,0.086288,MODULE_524,0.844883091216216
chr13q12,SET,65,0.26115,0.015503,0.19148,0.086316,chr13q12,0.844883091216216
GSE26030_TH1_VS_TH17_RESTIMU...3,SET,180,0.083897,0.008262,0.061523,0.086345,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_DN,0.844883091216216
PATEL_SKIN_OF_BODY_ZOSTAVAX_...6,SET,260,0.075467,0.0089123,0.055342,0.086348,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_UP,0.844883091216216
IGARASHI_ATF4_TARGETS_DN,SET,88,0.12599,0.0086971,0.092414,0.086399,IGARASHI_ATF4_TARGETS_DN,0.845144172530256
MODULE_306,SET,22,0.22568,0.0078032,0.16556,0.086434,MODULE_306,0.845248640967924
HP_CRANIOFACIAL_ASYMMETRY,SET,5,0.54202,0.0089388,0.39784,0.086544,HP_CRANIOFACIAL_ASYMMETRY,0.846086278481013
HP_HYPOPLASIA_OF_THE_ZYGOMAT...,SET,37,0.19537,0.0087571,0.14343,0.086583,HP_HYPOPLASIA_OF_THE_ZYGOMATIC_BONE,0.84621251474305
HE_LIM_SUN_FETAL_LUNG_C5_CD5...3,SET,588,0.047532,0.0083648,0.034902,0.086628,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_POS_MATURE_B_CELL,0.84621251474305
GOBP_CELLULAR_RESPONSE_TO_SA...1,SET,6,0.46842,0.0084621,0.34397,0.086638,GOBP_CELLULAR_RESPONSE_TO_SALT,0.84621251474305
HP_URETERAL_STENOSIS,SET,29,0.19876,0.0078892,0.14597,0.086664,HP_URETERAL_STENOSIS,0.84621251474305
HP_OSTEOLYSIS_INVOLVING_BONE...1,SET,11,0.37222,0.0091035,0.27341,0.0867,HP_OSTEOLYSIS_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.84621251474305
GOBP_RESPONSE_TO_INTERLEUKIN...9,SET,35,0.193,0.0084141,0.14176,0.086703,GOBP_RESPONSE_TO_INTERLEUKIN_4,0.84621251474305
GSE37301_COMMON_LYMPHOID_PRO...8,SET,166,0.088756,0.0083969,0.065208,0.086746,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.846394505895564
LIU_VAV3_PROSTATE_CARCINOGEN...2,SET,82,0.13397,0.0089285,0.098443,0.086785,LIU_VAV3_PROSTATE_CARCINOGENESIS_UP,0.846537377210216
HP_WIDE_NASAL_BRIDGE,SET,433,0.055398,0.0084023,0.040712,0.08681,HP_WIDE_NASAL_BRIDGE,0.846543644781145
WP_OVERVIEW_OF_NANOPARTICLE_...,SET,19,0.28755,0.0092406,0.21136,0.086852,WP_OVERVIEW_OF_NANOPARTICLE_EFFECTS,0.846715640953717
PID_FOXO_PATHWAY,SET,47,0.17139,0.008656,0.12607,0.086999,PID_FOXO_PATHWAY,0.847431031984691
VERRECCHIA_RESPONSE_TO_TGFB1...1,SET,19,0.27635,0.0088807,0.20329,0.08702,VERRECCHIA_RESPONSE_TO_TGFB1_C1,0.847431031984691
GSE557_WT_VS_I_AB_KO_DC_UP,SET,178,0.081902,0.0080211,0.060258,0.08705,GSE557_WT_VS_I_AB_KO_DC_UP,0.847431031984691
KEGG_MEDICUS_REFERENCE_CHOND...,SET,7,0.44315,0.0086467,0.32613,0.087112,KEGG_MEDICUS_REFERENCE_CHONDROITIN_SULFATE_BIOSYNTHESIS,0.847431031984691
GOMF_ATP_HYDROLYSIS_ACTIVITY,SET,381,0.057156,0.0081436,0.042068,0.087135,GOMF_ATP_HYDROLYSIS_ACTIVITY,0.847431031984691
GSE15271_CXCR4_POS_VS_NEG_GC...2,SET,158,0.086472,0.0079831,0.063657,0.087174,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_UP,0.847431031984691
BIOCARTA_PGC1A_PATHWAY,SET,15,0.2912,0.0083157,0.2144,0.087204,BIOCARTA_PGC1A_PATHWAY,0.847431031984691
GOBP_RESPIRATORY_BURST,SET,30,0.22075,0.0089113,0.16254,0.08722,GOBP_RESPIRATORY_BURST,0.847431031984691
FLOTHO_PEDIATRIC_ALL_THERAPY...2,SET,50,0.1533,0.0079851,0.11294,0.087336,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP,0.847431031984691
GAVISH_3CA_METAPROGRAM_FIBRO...4,SET,38,0.19372,0.0087995,0.14272,0.087352,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_3,0.847431031984691
KEGG_MEDICUS_VARIANT_EGF_OVE...2,SET,14,0.30406,0.0083888,0.22402,0.087355,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.847431031984691
KEGG_SNARE_INTERACTIONS_IN_V...,SET,36,0.17717,0.0078334,0.13058,0.087433,KEGG_SNARE_INTERACTIONS_IN_VESICULAR_TRANSPORT,0.847431031984691
HP_CONGENITAL_HYPOTHYROIDISM,SET,30,0.2126,0.0085824,0.15671,0.087461,HP_CONGENITAL_HYPOTHYROIDISM,0.847431031984691
GOBP_MICROTUBULE_NUCLEATION_...,SET,5,0.51165,0.008438,0.37716,0.087465,GOBP_MICROTUBULE_NUCLEATION_BY_MICROTUBULE_ORGANIZING_CENTER,0.847431031984691
HEDENFALK_BREAST_CANCER_BRAC...2,SET,15,0.2966,0.00847,0.21866,0.087487,HEDENFALK_BREAST_CANCER_BRACX_UP,0.847431031984691
GOBP_POSITIVE_REGULATION_OF_...522,SET,28,0.22893,0.0089286,0.16877,0.087491,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.847431031984691
GOBP_REACTIVE_NITROGEN_SPECI...,SET,74,0.13912,0.0088098,0.10258,0.087516,GOBP_REACTIVE_NITROGEN_SPECIES_METABOLIC_PROCESS,0.847431031984691
GOMF_CARDIOLIPIN_BINDING,SET,10,0.36798,0.0085811,0.27139,0.087577,GOMF_CARDIOLIPIN_BINDING,0.847431031984691
BOYAULT_LIVER_CANCER_SUBCLAS...12,SET,15,0.31711,0.0090557,0.23388,0.087578,BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN,0.847431031984691
GOBP_POSITIVE_REGULATION_OF_...126,SET,428,0.058855,0.0088762,0.043413,0.087606,GOBP_POSITIVE_REGULATION_OF_CELL_DEVELOPMENT,0.847431031984691
GOMF_GLUCURONOSYLTRANSFERASE...,SET,31,0.26554,0.010897,0.19588,0.087619,GOMF_GLUCURONOSYLTRANSFERASE_ACTIVITY,0.847431031984691
LAKE_ADULT_KIDNEY_C13_THICK_...,SET,113,0.11355,0.0088758,0.083771,0.087649,LAKE_ADULT_KIDNEY_C13_THICK_ASCENDING_LIMB,0.847431031984691
REACTOME_SARS_COV_2_MODULATE...2,SET,43,0.16122,0.0077891,0.11901,0.087773,REACTOME_SARS_COV_2_MODULATES_HOST_TRANSLATION_MACHINERY,0.847431031984691
GSE19888_ADENOSINE_A3R_INH_V...6,SET,176,0.084824,0.0082609,0.062619,0.08778,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_UP,0.847431031984691
GOCC_SPERM_HEAD_PLASMA_MEMBR...,SET,6,0.47036,0.0084971,0.34723,0.087782,GOCC_SPERM_HEAD_PLASMA_MEMBRANE,0.847431031984691
RAMJAUN_APOPTOSIS_BY_TGFB1_V...2,SET,6,0.47655,0.008609,0.35182,0.087791,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_UP,0.847431031984691
BIOCARTA_ERK_PATHWAY,SET,26,0.23342,0.0087733,0.17233,0.087796,BIOCARTA_ERK_PATHWAY,0.847431031984691
REACTOME_UPTAKE_OF_DIETARY_C...,SET,9,0.42051,0.0093032,0.31046,0.087799,REACTOME_UPTAKE_OF_DIETARY_COBALAMINS_INTO_ENTEROCYTES,0.847431031984691
GOBP_SULFUR_COMPOUND_BIOSYNT...,SET,155,0.095944,0.0087737,0.070835,0.087802,GOBP_SULFUR_COMPOUND_BIOSYNTHETIC_PROCESS,0.847431031984691
HP_SEVERE_HEARING_IMPAIRMENT,SET,14,0.29144,0.0080406,0.21518,0.087815,HP_SEVERE_HEARING_IMPAIRMENT,0.847431031984691
GOBP_DITERPENOID_BIOSYNTHETI...,SET,10,0.39457,0.0092013,0.29134,0.087823,GOBP_DITERPENOID_BIOSYNTHETIC_PROCESS,0.847431031984691
AP1_Q4_01,SET,241,0.0731,0.0083157,0.05398,0.087846,AP1_Q4_01,0.847431031984691
GOBP_SERINE_FAMILY_AMINO_ACI...1,SET,15,0.2796,0.0079843,0.20648,0.087857,GOBP_SERINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.847431031984691
DESCARTES_FETAL_STOMACH_MESO...,SET,29,0.23211,0.0092129,0.17144,0.087898,DESCARTES_FETAL_STOMACH_MESOTHELIAL_CELLS,0.847431031984691
HEY2_TARGET_GENES,SET,54,0.15343,0.0083042,0.11333,0.087919,HEY2_TARGET_GENES,0.847431031984691
WP_VITAMIN_D_RECEPTOR_PATHWAY,SET,168,0.094455,0.0089892,0.069776,0.087929,WP_VITAMIN_D_RECEPTOR_PATHWAY,0.847431031984691
GSE36888_UNTREATED_VS_IL2_TR...2,SET,168,0.092292,0.0087835,0.068179,0.087929,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_UP,0.847431031984691
GOBP_REGULATION_OF_HETEROTYP...,SET,24,0.24361,0.0087974,0.17998,0.087949,GOBP_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.847431031984691
GOCC_TRANSCRIPTION_REGULATOR...,SET,478,0.052095,0.0082914,0.038496,0.087996,GOCC_TRANSCRIPTION_REGULATOR_COMPLEX,0.847431031984691
REACTOME_GOLGI_CISTERNAE_PER...,SET,14,0.25084,0.0069204,0.18538,0.088021,REACTOME_GOLGI_CISTERNAE_PERICENTRIOLAR_STACK_REORGANIZATION,0.847431031984691
GTF2A2_TARGET_GENES,SET,385,0.059169,0.0084736,0.043732,0.088037,GTF2A2_TARGET_GENES,0.847431031984691
GOBP_POSITIVE_REGULATION_OF_...80,SET,107,0.11388,0.0086637,0.084174,0.088055,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT,0.847431031984691
BERTUCCI_MEDULLARY_VS_DUCTAL...2,SET,173,0.08802,0.0084995,0.065072,0.088092,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP,0.847431031984691
HP_DECREASED_LYMPHOCYTE_PROL...2,SET,27,0.23638,0.0090535,0.17479,0.088137,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_MITOGEN,0.847431031984691
GLI1_UP.V1_DN,SET,16,0.26303,0.0077575,0.19455,0.08819,GLI1_UP.V1_DN,0.847431031984691
MODULE_311,SET,16,0.29789,0.0087854,0.22034,0.088205,MODULE_311,0.847431031984691
NIKOLSKY_BREAST_CANCER_14Q22...,SET,12,0.49279,0.012588,0.36463,0.088278,NIKOLSKY_BREAST_CANCER_14Q22_AMPLICON,0.847431031984691
GOBP_N_ACETYLNEURAMINATE_CAT...,SET,6,0.50969,0.0092078,0.37714,0.08828,GOBP_N_ACETYLNEURAMINATE_CATABOLIC_PROCESS,0.847431031984691
TAYLOR_METHYLATED_IN_ACUTE_L...,SET,66,0.14305,0.0085569,0.10587,0.088324,TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA,0.847431031984691
GOCC_JUNCTIONAL_SARCOPLASMIC...,SET,9,0.42813,0.0094718,0.317,0.088425,GOCC_JUNCTIONAL_SARCOPLASMIC_RETICULUM_MEMBRANE,0.847431031984691
WP_GAMMAGLUTAMYL_CYCLE_FOR_T...,SET,6,0.39435,0.0071241,0.29199,0.088426,WP_GAMMAGLUTAMYL_CYCLE_FOR_THE_BIOSYNTHESIS_AND_DEGRADATION_OF_GLUTATHIONE_INCLUDING_DISEASES,0.847431031984691
REACTOME_METAL_ION_SLC_TRANS...,SET,23,0.22954,0.0081151,0.16996,0.088431,REACTOME_METAL_ION_SLC_TRANSPORTERS,0.847431031984691
GOBP_POSITIVE_REGULATION_OF_...421,SET,5,0.46302,0.007636,0.34285,0.088437,GOBP_POSITIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,0.847431031984691
HP_STATUS_EPILEPTICUS_WITH_P...,SET,24,0.23731,0.00857,0.17572,0.08844,HP_STATUS_EPILEPTICUS_WITH_PROMINENT_MOTOR_SYMPTOMS,0.847431031984691
YEMELYANOV_GR_TARGETS_DN,SET,10,0.36479,0.0085068,0.27013,0.088443,YEMELYANOV_GR_TARGETS_DN,0.847431031984691
GOBP_TELOMERASE_HOLOENZYME_C...,SET,6,0.37392,0.006755,0.27692,0.088468,GOBP_TELOMERASE_HOLOENZYME_COMPLEX_ASSEMBLY,0.847431031984691
GSE22196_HEALTHY_VS_OBESE_MO...1,SET,182,0.084043,0.0083218,0.062245,0.088484,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN,0.847431031984691
GSE2770_UNTREATED_VS_IL12_TR...6,SET,178,0.086624,0.0084835,0.064158,0.088488,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.847431031984691
HP_CYSTATHIONINEMIA,SET,5,0.49271,0.0081257,0.36493,0.08849,HP_CYSTATHIONINEMIA,0.847431031984691
GSE8835_CD4_VS_CD8_TCELL_CLL...1,SET,186,0.08536,0.0085436,0.063244,0.088566,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_DN,0.847431031984691
GGCGGCA_MIR371,SET,5,0.46372,0.0076476,0.34358,0.08857,GGCGGCA_MIR371,0.847431031984691
MIR6870_5P,SET,199,0.079448,0.0082222,0.058866,0.088572,MIR6870_5P,0.847431031984691
MIR7162_3P,SET,201,0.08194,0.0085221,0.060718,0.088594,MIR7162_3P,0.847431031984691
GOCC_PARANODE_REGION_OF_AXON,SET,12,0.34156,0.0087248,0.25311,0.088604,GOCC_PARANODE_REGION_OF_AXON,0.847431031984691
HP_BLUE_IRIDES,SET,50,0.16746,0.0087227,0.1241,0.08861,HP_BLUE_IRIDES,0.847431031984691
GSE5589_LPS_VS_LPS_AND_IL10_...9,SET,177,0.084959,0.0082973,0.062961,0.088613,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,0.847431031984691
DIERICK_SEROTONIN_FUNCTION_G...,SET,7,0.38435,0.0074995,0.28484,0.088622,DIERICK_SEROTONIN_FUNCTION_GENES,0.847431031984691
WANG_TUMOR_INVASIVENESS_UP,SET,362,0.057594,0.008003,0.042684,0.088626,WANG_TUMOR_INVASIVENESS_UP,0.847431031984691
HP_RESPIRATORY_INSUFFICIENCY...,SET,5,0.4555,0.0075119,0.33764,0.088665,HP_RESPIRATORY_INSUFFICIENCY_DUE_TO_DEFECTIVE_CILIARY_CLEARANCE,0.847431031984691
GSE24210_TCONV_VS_TREG_UP,SET,184,0.084507,0.0084131,0.062655,0.088715,GSE24210_TCONV_VS_TREG_UP,0.847431031984691
MIR6838_3P,SET,58,0.14771,0.0082847,0.10952,0.088725,MIR6838_3P,0.847431031984691
GSE24081_CONTROLLER_VS_PROGR...2,SET,178,0.087689,0.0085878,0.065021,0.088739,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_UP,0.847431031984691
HP_NATAL_TOOTH,SET,31,0.20168,0.0082761,0.14956,0.088757,HP_NATAL_TOOTH,0.847431031984691
HP_GRANULOMATOSIS,SET,8,0.49775,0.010383,0.36915,0.08878,HP_GRANULOMATOSIS,0.847431031984691
REACTOME_BIOSYNTHESIS_OF_EPA...,SET,6,0.55066,0.0099478,0.40852,0.088846,REACTOME_BIOSYNTHESIS_OF_EPA_DERIVED_SPMS,0.847431031984691
HP_ATRIAL_FIBRILLATION,SET,79,0.14157,0.0092619,0.10503,0.088852,HP_ATRIAL_FIBRILLATION,0.847431031984691
GOMF_PROTEIN_KINASE_A_REGULA...,SET,24,0.21981,0.007938,0.16309,0.088872,GOMF_PROTEIN_KINASE_A_REGULATORY_SUBUNIT_BINDING,0.847431031984691
HP_ABNORMAL_PARANASAL_SINUS_...,SET,158,0.093292,0.0086126,0.069227,0.088899,HP_ABNORMAL_PARANASAL_SINUS_MORPHOLOGY,0.847431031984691
GSE41867_NAIVE_VS_DAY15_LCMV...2,SET,179,0.079289,0.0077867,0.058841,0.088916,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,0.847431031984691
FRIDMAN_SENESCENCE_UP,SET,75,0.13954,0.0088957,0.10356,0.088924,FRIDMAN_SENESCENCE_UP,0.847431031984691
MEISSNER_BRAIN_HCP_WITH_H3K4...3,SET,1022,0.039849,0.0091318,0.029577,0.088952,MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.847431031984691
GSE22443_NAIVE_VS_ACT_AND_IL...4,SET,188,0.088516,0.0089065,0.065723,0.089032,GSE22443_NAIVE_VS_ACT_AND_IL2_TREATED_CD8_TCELL_UP,0.847431031984691
MIR5088_5P,SET,33,0.20015,0.0084734,0.14863,0.089052,MIR5088_5P,0.847431031984691
GROSS_HYPOXIA_VIA_HIF1A_DN,SET,99,0.11675,0.0085457,0.086709,0.089083,GROSS_HYPOXIA_VIA_HIF1A_DN,0.847431031984691
DESCARTES_MAIN_FETAL_GRANULE...,SET,14,0.31994,0.0088269,0.23762,0.089086,DESCARTES_MAIN_FETAL_GRANULE_NEURONS,0.847431031984691
GOBP_MITOCHONDRIAL_MEMBRANE_...,SET,99,0.10907,0.0079835,0.08101,0.089098,GOBP_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.847431031984691
GSE43955_TH0_VS_TGFB_IL6_TH1...15,SET,190,0.083947,0.0084911,0.06235,0.089098,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_DN,0.847431031984691
MILI_PSEUDOPODIA_CHEMOTAXIS_...1,SET,419,0.053247,0.0079476,0.03955,0.08911,MILI_PSEUDOPODIA_CHEMOTAXIS_DN,0.847431031984691
GSE9006_TYPE_1_DIABETES_AT_D...4,SET,184,0.083159,0.0082789,0.061781,0.089155,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_UP,0.847431031984691
HP_AORTIC_ANEURYSM,SET,152,0.092249,0.0083544,0.068539,0.08917,HP_AORTIC_ANEURYSM,0.847431031984691
REACTOME_GABA_B_RECEPTOR_ACT...,SET,43,0.18469,0.0089231,0.13723,0.089176,REACTOME_GABA_B_RECEPTOR_ACTIVATION,0.847431031984691
GOBP_EPITHELIAL_CELL_MATURAT...,SET,26,0.24862,0.0093446,0.18473,0.08918,GOBP_EPITHELIAL_CELL_MATURATION,0.847431031984691
GSE24210_RESTING_TREG_VS_TCO...1,SET,178,0.080618,0.0078953,0.059904,0.089193,GSE24210_RESTING_TREG_VS_TCONV_DN,0.847431031984691
HP_ABNORMAL_SHOULDER_PHYSIOL...,SET,12,0.35758,0.0091341,0.26583,0.089297,HP_ABNORMAL_SHOULDER_PHYSIOLOGY,0.848187273845313
GSE30971_2H_VS_4H_LPS_STIM_M...4,SET,184,0.082353,0.0081986,0.061238,0.089354,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_UP,0.848496795081967
chr9p13,SET,78,0.27319,0.017759,0.20319,0.089405,chr9p13,0.848749187380497
GOBP_T_HELPER_17_CELL_LINEAG...,SET,19,0.28923,0.0092945,0.21516,0.089445,GOBP_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.848897043965046
GOBP_MAINTENANCE_OF_BLOOD_BR...,SET,37,0.20546,0.0092096,0.15287,0.089473,GOBP_MAINTENANCE_OF_BLOOD_BRAIN_BARRIER,0.848930962325962
GINESTIER_BREAST_CANCER_ZNF2...2,SET,63,0.13747,0.0080348,0.10231,0.089531,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP,0.849142030484486
GOMF_EUKARYOTIC_INITIATION_F...,SET,9,0.32288,0.0071432,0.24037,0.089599,GOMF_EUKARYOTIC_INITIATION_FACTOR_4E_BINDING,0.849142030484486
NEMETH_INFLAMMATORY_RESPONSE...2,SET,76,0.13914,0.0089287,0.10359,0.08963,NEMETH_INFLAMMATORY_RESPONSE_LPS_UP,0.849142030484486
HP_TRANSIENT_ISCHEMIC_ATTACK,SET,53,0.15893,0.0085225,0.11834,0.089641,HP_TRANSIENT_ISCHEMIC_ATTACK,0.849142030484486
HP_ST_SEGMENT_DEPRESSION,SET,13,0.35656,0.0094797,0.26553,0.08967,HP_ST_SEGMENT_DEPRESSION,0.849142030484486
DESCARTES_FETAL_KIDNEY_STROM...,SET,123,0.11127,0.0090721,0.082863,0.089674,DESCARTES_FETAL_KIDNEY_STROMAL_CELLS,0.849142030484486
HP_ACQUIRED_ABNORMAL_HAIR_PA...,SET,34,0.20206,0.0086828,0.1505,0.089712,HP_ACQUIRED_ABNORMAL_HAIR_PATTERN,0.849142030484486
REACTOME_DEADENYLATION_OF_MR...,SET,22,0.24143,0.0083481,0.17985,0.089744,REACTOME_DEADENYLATION_OF_MRNA,0.849142030484486
MIKKELSEN_IPS_LCP_WITH_H3K4M...2,SET,5,0.6032,0.0099477,0.44939,0.089763,MIKKELSEN_IPS_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.849142030484486
WP_SCFA_AND_SKELETAL_MUSCLE_...,SET,6,0.46502,0.0084008,0.34644,0.089763,WP_SCFA_AND_SKELETAL_MUSCLE_SUBSTRATE_METABOLISM,0.849142030484486
HP_FATIGUE,SET,445,0.056579,0.0086966,0.042152,0.089764,HP_FATIGUE,0.849142030484486
REN_ALVEOLAR_RHABDOMYOSARCOM...2,SET,93,0.1243,0.0088194,0.092637,0.089844,REN_ALVEOLAR_RHABDOMYOSARCOMA_UP,0.849667542857143
HP_PELVIC_GIRDLE_MUSCLE_WEAK...,SET,42,0.16034,0.0076562,0.11956,0.089955,HP_PELVIC_GIRDLE_MUSCLE_WEAKNESS,0.849902281368821
MIR1260A_MIR1260B,SET,97,0.11363,0.008233,0.084735,0.089975,MIR1260A_MIR1260B,0.849902281368821
REACTOME_NERVOUS_SYSTEM_DEVE...,SET,533,0.049918,0.0083766,0.037226,0.089978,REACTOME_NERVOUS_SYSTEM_DEVELOPMENT,0.849902281368821
HP_CHOROIDAL_HEMANGIOMA,SET,5,0.44763,0.0073822,0.33387,0.090014,HP_CHOROIDAL_HEMANGIOMA,0.849902281368821
HP_POINTED_CHIN,SET,118,0.10354,0.0082697,0.07723,0.090021,HP_POINTED_CHIN,0.849902281368821
GOBP_SULFUR_AMINO_ACID_BIOSY...,SET,15,0.28817,0.0082293,0.21495,0.090026,GOBP_SULFUR_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.849902281368821
GSE2770_IL12_VS_IL4_TREATED_...6,SET,182,0.081368,0.0080569,0.060697,0.09004,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.849902281368821
GOCC_ORGANELLE_ENVELOPE,SET,1109,0.034036,0.0081045,0.025392,0.090067,GOCC_ORGANELLE_ENVELOPE,0.849926306000543
KEGG_MEDICUS_PATHOGEN_HBV_HB...1,SET,13,0.29571,0.0078618,0.22067,0.090123,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_CREB_MEDIATED_TRANSCRIPTION,0.84999830168204
HP_AMELOGENESIS_IMPERFECTA,SET,31,0.20645,0.0084717,0.15406,0.090124,HP_AMELOGENESIS_IMPERFECTA,0.84999830168204
GSE29617_DAY3_VS_DAY7_TIV_FL...2,SET,168,0.091093,0.0086693,0.067985,0.090148,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,0.84999830168204
MIR30B_5P_MIR30C_5P,SET,713,0.044057,0.0085077,0.032887,0.090187,MIR30B_5P_MIR30C_5P,0.850135390561432
WEINBERGER_BLOOD_TWINRIX_AGE...1,SET,32,0.20757,0.0086538,0.15497,0.090225,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_ANTI_HBS_CONC_PRIMARY_VACC_1DY_SIGNIFICANT,0.850262981290672
GSE37301_COMMON_LYMPHOID_PRO...7,SET,177,0.084509,0.0082533,0.063101,0.09025,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,0.850268026565465
GSE15930_STIM_VS_STIM_AND_TR...6,SET,180,0.079047,0.0077844,0.059041,0.090317,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_UP,0.850668654471545
GOMF_ANNEALING_ACTIVITY,SET,8,0.40446,0.0084366,0.30215,0.090359,GOMF_ANNEALING_ACTIVITY,0.85083366160932
GSE46606_UNSTIM_VS_CD40L_IL2...2,SET,171,0.086395,0.0082946,0.064581,0.090493,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,0.850912162489895
MURAKAMI_UV_RESPONSE_1HR_DN,SET,10,0.35654,0.0083143,0.26656,0.090534,MURAKAMI_UV_RESPONSE_1HR_DN,0.850912162489895
GSE10239_KLRG1INT_VS_KLRG1HI...1,SET,179,0.085007,0.0083483,0.063562,0.090558,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,0.850912162489895
GSE9509_LPS_VS_LPS_AND_IL10_...5,SET,169,0.086206,0.0082283,0.064463,0.090574,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_DN,0.850912162489895
VANHARANTA_UTERINE_FIBROID_DN,SET,59,0.16062,0.0090857,0.12011,0.090582,VANHARANTA_UTERINE_FIBROID_DN,0.850912162489895
GSE17721_CPG_VS_GARDIQUIMOD_...17,SET,183,0.081669,0.0081087,0.061088,0.090636,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_DN,0.850912162489895
GAO_LARGE_INTESTINE_24W_C6_S...,SET,13,0.32906,0.0087486,0.24615,0.090648,GAO_LARGE_INTESTINE_24W_C6_SECRETORY_PROGENITOR,0.850912162489895
GSE27670_CTRL_VS_BLIMP1_TRAN...2,SET,186,0.084264,0.0084339,0.063034,0.090654,GSE27670_CTRL_VS_BLIMP1_TRANSDUCED_GC_BCELL_UP,0.850912162489895
MIR27A_5P,SET,34,0.20502,0.00881,0.15341,0.090713,MIR27A_5P,0.850912162489895
GOMF_MUTSALPHA_COMPLEX_BINDI...,SET,7,0.39483,0.007704,0.29545,0.090721,GOMF_MUTSALPHA_COMPLEX_BINDING,0.850912162489895
PID_TCPTP_PATHWAY,SET,42,0.18723,0.0089401,0.14011,0.09074,PID_TCPTP_PATHWAY,0.850912162489895
HP_APLASIA_HYPOPLASIA_OF_THE...74,SET,37,0.17214,0.007716,0.12883,0.090747,HP_APLASIA_HYPOPLASIA_OF_THE_TONGUE,0.850912162489895
GOBP_POSITIVE_REGULATION_OF_...328,SET,10,0.39061,0.0091089,0.29237,0.090779,GOBP_POSITIVE_REGULATION_OF_HEAT_GENERATION,0.850912162489895
GOBP_CELLULAR_RESPONSE_TO_HO...,SET,568,0.049385,0.0085466,0.036965,0.090782,GOBP_CELLULAR_RESPONSE_TO_HORMONE_STIMULUS,0.850912162489895
PID_TELOMERASE_PATHWAY,SET,64,0.1437,0.0084648,0.10756,0.090786,PID_TELOMERASE_PATHWAY,0.850912162489895
GOCC_CHROMOSOME_CENTROMERIC_...2,SET,219,0.07406,0.0080361,0.055439,0.090801,GOCC_CHROMOSOME_CENTROMERIC_REGION,0.850912162489895
NAKAYA_PBMC_FLUAD_MALE_AGE_1...1,SET,36,0.19503,0.0086232,0.146,0.090818,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_ATIV_UP,0.850912162489895
GOBP_NEGATIVE_REGULATION_OF_...104,SET,11,0.30395,0.0074337,0.22755,0.090828,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,0.850912162489895
REACTOME_MITOCHONDRIAL_IRON_...,SET,12,0.29743,0.0075976,0.22269,0.090846,REACTOME_MITOCHONDRIAL_IRON_SULFUR_CLUSTER_BIOGENESIS,0.850912162489895
PID_IL2_1PATHWAY,SET,54,0.15951,0.0086332,0.11943,0.090857,PID_IL2_1PATHWAY,0.850912162489895
GOBP_MYD88_DEPENDENT_TOLL_LI...,SET,18,0.245,0.0076635,0.18348,0.090905,GOBP_MYD88_DEPENDENT_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.851053122476447
MIR361_5P,SET,152,0.092631,0.008389,0.069383,0.090938,MIR361_5P,0.851053122476447
HP_ABNORMAL_CEREBRAL_ARTERY_...,SET,74,0.13686,0.0086669,0.10253,0.090966,HP_ABNORMAL_CEREBRAL_ARTERY_MORPHOLOGY,0.851053122476447
BLALOCK_ALZHEIMERS_DISEASE_UP,SET,1512,0.029818,0.0081931,0.022338,0.09097,BLALOCK_ALZHEIMERS_DISEASE_UP,0.851053122476447
MODULE_5,SET,401,0.060526,0.0088423,0.04536,0.091052,MODULE_5,0.851525543302851
HP_RESTRICTIVE_CARDIOMYOPATHY,SET,22,0.24681,0.008534,0.18499,0.091081,HP_RESTRICTIVE_CARDIOMYOPATHY,0.851525543302851
MIR640,SET,46,0.15006,0.0074978,0.11248,0.091094,MIR640,0.851525543302851
HE_LIM_SUN_FETAL_LUNG_C4_ILC...1,SET,136,0.10203,0.0087446,0.0765,0.091147,HE_LIM_SUN_FETAL_LUNG_C4_ILC2_CELL,0.851637641129032
KEGG_MEDICUS_REFERENCE_BREAK...,SET,8,0.38982,0.0081311,0.29228,0.091155,KEGG_MEDICUS_REFERENCE_BREAK_INDUCED_REPLICATION,0.851637641129032
HP_ABNORMAL_GLOMERULAR_FILTR...,SET,26,0.2174,0.0081709,0.16304,0.091209,HP_ABNORMAL_GLOMERULAR_FILTRATION_RATE,0.85191314028487
GOMF_HISTONE_MODIFYING_ACTIV...,SET,182,0.079092,0.0078315,0.059338,0.09129,GOMF_HISTONE_MODIFYING_ACTIVITY,0.852265106439596
GOMF_AROMATIC_AMINO_ACID_TRA...,SET,8,0.40326,0.0084116,0.30264,0.091358,GOMF_AROMATIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.852265106439596
HP_LEUKOCYTOSIS,SET,140,0.096083,0.0083539,0.072112,0.091372,HP_LEUKOCYTOSIS,0.852265106439596
REACTOME_FCGAMMA_RECEPTOR_FC...,SET,81,0.12099,0.0080142,0.090805,0.091377,REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS,0.852265106439596
KEGG_MEDICUS_PATHOGEN_SALMON...2,SET,24,0.22281,0.0080462,0.16726,0.091422,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.852265106439596
GSE3982_CENT_MEMORY_CD4_TCEL...4,SET,169,0.085666,0.0081768,0.064312,0.091434,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_UP,0.852265106439596
TERAMOTO_OPN_TARGETS_CLUSTER...6,SET,17,0.29071,0.0088373,0.21826,0.091445,TERAMOTO_OPN_TARGETS_CLUSTER_7,0.852265106439596
ROSS_AML_WITH_AML1_ETO_FUSION,SET,67,0.14781,0.0089082,0.11098,0.091461,ROSS_AML_WITH_AML1_ETO_FUSION,0.852265106439596
GOBP_NEGATIVE_REGULATION_OF_...477,SET,4,0.49295,0.0072715,0.3702,0.091506,GOBP_NEGATIVE_REGULATION_OF_PANCREATIC_JUICE_SECRETION,0.852265106439596
GOCC_SYNAPTONEMAL_STRUCTURE,SET,34,0.17077,0.007338,0.12826,0.091544,GOCC_SYNAPTONEMAL_STRUCTURE,0.852265106439596
GSE37532_TREG_VS_TCONV_CD4_T...1,SET,173,0.084585,0.0081677,0.063534,0.091547,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_DN,0.852265106439596
MIR3194_5P,SET,71,0.13097,0.0081245,0.098383,0.091568,MIR3194_5P,0.852265106439596
ADNP_TARGET_GENES,SET,511,0.049163,0.0080828,0.036934,0.091588,ADNP_TARGET_GENES,0.852265106439596
TOX4_TARGET_GENES,SET,164,0.084566,0.0079526,0.063538,0.09161,TOX4_TARGET_GENES,0.852265106439596
GOBP_REGULATION_OF_T_CELL_ME...1,SET,47,0.18665,0.0094267,0.14027,0.091662,GOBP_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.852265106439596
HP_ESOPHAGEAL_CARCINOMA,SET,13,0.31094,0.0082668,0.23368,0.091667,HP_ESOPHAGEAL_CARCINOMA,0.852265106439596
HP_ABNORMALITY_OF_THE_TARSAL...,SET,113,0.10873,0.0084992,0.081747,0.091761,HP_ABNORMALITY_OF_THE_TARSAL_BONES,0.852265106439596
GOMF_INITIATOR_METHIONYL_AMI...,SET,4,0.5861,0.0086456,0.44077,0.091815,GOMF_INITIATOR_METHIONYL_AMINOPEPTIDASE_ACTIVITY,0.852265106439596
HP_ENCHONDROMA,SET,21,0.23647,0.0079886,0.17784,0.09182,HP_ENCHONDROMA,0.852265106439596
HP_EMBRYONAL_RENAL_NEOPLASM,SET,41,0.19746,0.0093159,0.1485,0.091825,HP_EMBRYONAL_RENAL_NEOPLASM,0.852265106439596
HP_ABNORMAL_ATRIOVENTRICULAR...4,SET,183,0.083834,0.0083236,0.06306,0.091863,HP_ABNORMAL_ATRIOVENTRICULAR_VALVE_PHYSIOLOGY,0.852265106439596
MIR192_5P,SET,32,0.20529,0.0085586,0.15442,0.091865,MIR192_5P,0.852265106439596
HP_GENERALIZED_DYSTONIA,SET,27,0.201,0.0076985,0.15123,0.091919,HP_GENERALIZED_DYSTONIA,0.852265106439596
GSE1460_NAIVE_CD4_TCELL_CORD...2,SET,162,0.083765,0.0078296,0.063031,0.091941,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_UP,0.852265106439596
GOBP_POSITIVE_REGULATION_OF_...655,SET,304,0.064569,0.0082353,0.048595,0.091978,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS,0.852265106439596
REACTOME_SARS_COV_1_MODULATE...,SET,32,0.18807,0.0078407,0.14155,0.091992,REACTOME_SARS_COV_1_MODULATES_HOST_TRANSLATION_MACHINERY,0.852265106439596
HP_TOOTH_MALPOSITION,SET,349,0.060029,0.0081932,0.045184,0.092008,HP_TOOTH_MALPOSITION,0.852265106439596
MIR6813_5P,SET,36,0.16941,0.0074905,0.12752,0.09202,MIR6813_5P,0.852265106439596
GOBP_NEUROTRANSMITTER_GATED_...,SET,16,0.30693,0.0090521,0.23104,0.092022,GOBP_NEUROTRANSMITTER_GATED_ION_CHANNEL_CLUSTERING,0.852265106439596
GOBP_NEGATIVE_REGULATION_OF_...585,SET,2,0.93704,0.0097743,0.70536,0.092024,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.852265106439596
HP_ASYMMETRY_OF_THE_EARS,SET,4,0.48737,0.0071891,0.3669,0.092042,HP_ASYMMETRY_OF_THE_EARS,0.852265106439596
MIR578,SET,168,0.088324,0.0084058,0.066494,0.092046,MIR578,0.852265106439596
GOBP_RESPONSE_TO_COLD,SET,42,0.17174,0.0082007,0.12931,0.092079,GOBP_RESPONSE_TO_COLD,0.852265106439596
EVI1_02,SET,112,0.10755,0.00837,0.080991,0.092112,EVI1_02,0.852265106439596
HP_HYPEREXTENSIBILITY_OF_THE...1,SET,21,0.25898,0.0087491,0.19504,0.09213,HP_HYPEREXTENSIBILITY_OF_THE_FINGER_JOINTS,0.852265106439596
WP_WNT_SIGNALING_IN_KIDNEY_D...,SET,34,0.20587,0.0088464,0.15506,0.092145,WP_WNT_SIGNALING_IN_KIDNEY_DISEASE,0.852265106439596
GSE22935_24H_VS_48H_MBOVIS_B...1,SET,181,0.080205,0.0079201,0.060411,0.092154,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.852265106439596
GSE26495_PD1HIGH_VS_PD1LOW_C...2,SET,166,0.087309,0.00826,0.06577,0.092182,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_UP,0.852297262569832
GOBP_EPITHELIAL_TO_MESENCHYM...1,SET,164,0.090103,0.0084733,0.067891,0.092233,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.852541998670213
GOMF_MHC_CLASS_IB_RECEPTOR_A...,SET,6,0.54005,0.0097561,0.40712,0.092346,GOMF_MHC_CLASS_IB_RECEPTOR_ACTIVITY,0.852868923463983
GOBP_PLANAR_CELL_POLARITY_PA...2,SET,10,0.34219,0.0079796,0.25796,0.092347,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.852868923463983
MIR887_5P,SET,92,0.11931,0.0084205,0.089971,0.092405,MIR887_5P,0.852868923463983
GOBP_POSITIVE_REGULATION_OF_...74,SET,20,0.2301,0.0075864,0.17354,0.092444,GOBP_POSITIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.852868923463983
CASTELLANO_HRAS_AND_NRAS_TAR...2,SET,5,0.49284,0.0081277,0.37175,0.092472,CASTELLANO_HRAS_AND_NRAS_TARGETS_UP,0.852868923463983
PID_WNT_NONCANONICAL_PATHWAY,SET,31,0.19983,0.0081999,0.15073,0.092478,PID_WNT_NONCANONICAL_PATHWAY,0.852868923463983
MODULE_429,SET,14,0.29124,0.0080351,0.2197,0.092486,MODULE_429,0.852868923463983
GSE1432_CTRL_VS_IFNG_24H_MIC...1,SET,182,0.086158,0.0085312,0.065,0.09251,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_DN,0.852868923463983
MANNE_COVID19_NONICU_VS_HEAL...2,SET,131,0.095966,0.0080731,0.072407,0.092531,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_UP,0.852868923463983
LEI_MYB_TARGETS,SET,297,0.066712,0.0084118,0.050339,0.092552,LEI_MYB_TARGETS,0.852868923463983
DESCARTES_MAIN_FETAL_SMOOTH_...,SET,37,0.19104,0.0085632,0.14416,0.092565,DESCARTES_MAIN_FETAL_SMOOTH_MUSCLE_CELLS,0.852868923463983
GSE17721_LPS_VS_POLYIC_1H_BM...2,SET,177,0.084448,0.0082473,0.063741,0.092616,GSE17721_LPS_VS_POLYIC_1H_BMDC_UP,0.852868923463983
KEGG_MEDICUS_REFERENCE_PROK_...,SET,9,0.39158,0.0086632,0.29557,0.092618,KEGG_MEDICUS_REFERENCE_PROK_PRKR_GI_ERK_SIGNALING_PATHWAY,0.852868923463983
GOBP_REGULATION_OF_CYTOKINES...,SET,87,0.11771,0.0080796,0.088858,0.09264,GOBP_REGULATION_OF_CYTOKINESIS,0.852868923463983
GSE24142_EARLY_THYMIC_PROGEN...4,SET,179,0.085578,0.0084043,0.064601,0.092641,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_DN,0.852868923463983
MODULE_431,SET,15,0.31664,0.0090421,0.23904,0.092661,MODULE_431,0.852868923463983
GSE17721_PAM3CSK4_VS_CPG_4H_...1,SET,181,0.085031,0.0083966,0.064229,0.09278,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_DN,0.853603027777778
GOMF_NITRIC_OXIDE_SYNTHASE_B...,SET,10,0.36051,0.0084069,0.27236,0.092823,GOMF_NITRIC_OXIDE_SYNTHASE_BINDING,0.853603027777778
SU_KIDNEY,SET,12,0.34498,0.0088122,0.26064,0.092832,SU_KIDNEY,0.853603027777778
GOBP_POSITIVE_REGULATION_OF_...318,SET,14,0.31178,0.0086017,0.23557,0.092839,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.853603027777778
GSE2770_TGFB_AND_IL4_VS_IL12...1,SET,182,0.08449,0.008366,0.063855,0.0929,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.853937979370537
REACTOME_REGULATION_OF_IFNG_...,SET,13,0.31743,0.0084392,0.24002,0.093007,REACTOME_REGULATION_OF_IFNG_SIGNALING,0.854591117274168
HP_DISPROPORTIONATE_SHORT_TR...,SET,24,0.21847,0.0078897,0.16522,0.093039,HP_DISPROPORTIONATE_SHORT_TRUNK_SHORT_STATURE,0.854591117274168
HP_PROXIMAL_SYMPHALANGISM_OF...,SET,5,0.55597,0.0091689,0.4205,0.093062,HP_PROXIMAL_SYMPHALANGISM_OF_HANDS,0.854591117274168
GSE21360_SECONDARY_VS_QUATER...1,SET,147,0.095197,0.0084797,0.072003,0.09307,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.854591117274168
HP_CARPAL_SYNOSTOSIS,SET,33,0.20352,0.0086161,0.15395,0.093094,HP_CARPAL_SYNOSTOSIS,0.854591117274168
MIR6835_3P,SET,414,0.057761,0.0085709,0.043701,0.09314,MIR6835_3P,0.854787615526802
HP_MISCARRIAGE,SET,32,0.20945,0.0087319,0.1585,0.093196,HP_MISCARRIAGE,0.855075760295671
REACTOME_METABOLISM_OF_INGES...,SET,7,0.47302,0.0092296,0.35803,0.093234,REACTOME_METABOLISM_OF_INGESTED_SEMET_SEC_MESEC_INTO_H2SE,0.85519113528481
TESAR_ALK_TARGETS_HUMAN_ES_5...2,SET,4,0.57741,0.0085174,0.4371,0.09326,TESAR_ALK_TARGETS_HUMAN_ES_5D_UP,0.85519113528481
GOMF_PEPTIDASE_REGULATOR_ACT...,SET,208,0.084193,0.0089059,0.063745,0.093295,GOMF_PEPTIDASE_REGULATOR_ACTIVITY,0.85519113528481
GOMF_K63_LINKED_DEUBIQUITINA...,SET,11,0.30645,0.0074948,0.23203,0.093307,GOMF_K63_LINKED_DEUBIQUITINASE_ACTIVITY,0.85519113528481
GOBP_REGULATION_OF_CALCIUM_I...1,SET,5,0.49937,0.0082354,0.37822,0.093371,GOBP_REGULATION_OF_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.855318993942586
GAVISH_3CA_MALIGNANT_METAPRO...29,SET,42,0.17598,0.008403,0.13329,0.093378,GAVISH_3CA_MALIGNANT_METAPROGRAM_37_HEMATO_RELATED_2,0.855318993942586
HP_BILATERAL_TONIC_CLONIC_SE...2,SET,47,0.15042,0.0075969,0.11396,0.093439,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_FOCAL_ONSET,0.855318993942586
RADAEVA_RESPONSE_TO_IFNA1_UP,SET,46,0.16559,0.0082741,0.12546,0.093444,RADAEVA_RESPONSE_TO_IFNA1_UP,0.855318993942586
KEGG_MEDICUS_PATHOGEN_HCV_CO...1,SET,12,0.34742,0.0088744,0.26322,0.093444,KEGG_MEDICUS_PATHOGEN_HCV_CORE_TO_ERK_SIGNALING_PATHWAY,0.855318993942586
HP_ABNORMAL_BASOPHIL_COUNT,SET,5,0.57909,0.0095502,0.43886,0.0935,HP_ABNORMAL_BASOPHIL_COUNT,0.855606240126382
GSE6259_DEC205_POS_DC_VS_BCE...1,SET,165,0.086092,0.0081206,0.065278,0.093617,GSE6259_DEC205_POS_DC_VS_BCELL_DN,0.856451391155567
WP_INTERFERON_TYPE_I_SIGNALI...,SET,51,0.15545,0.0081774,0.11792,0.093708,WP_INTERFERON_TYPE_I_SIGNALING,0.857006546961326
KEGG_MEDICUS_REFERENCE_ALTER...,SET,5,0.58942,0.0097205,0.44714,0.093727,KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN,0.857006546961326
GOBP_POSITIVE_REGULATION_OF_...456,SET,5,0.5841,0.0096329,0.44328,0.093814,GOBP_POSITIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.857469588807147
HP_SEVERE_EPSTEIN_BARR_VIRUS...,SET,4,0.62618,0.0092368,0.47524,0.093828,HP_SEVERE_EPSTEIN_BARR_VIRUS_INFECTION,0.857469588807147
GOBP_HEPARAN_SULFATE_PROTEOG...5,SET,15,0.32336,0.0092342,0.24545,0.093855,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.857469588807147
GOBP_REGULATION_OF_OSTEOCLAS...2,SET,65,0.15445,0.0091686,0.11726,0.0939,GOBP_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,0.857469588807147
KEGG_MEDICUS_REFERENCE_BILE_...,SET,14,0.30323,0.008366,0.23022,0.093901,KEGG_MEDICUS_REFERENCE_BILE_ACID_BIOSYNTHESIS,0.857469588807147
GOCC_PRESYNAPTIC_CYTOSKELETON,SET,10,0.35177,0.0082032,0.26715,0.093967,GOCC_PRESYNAPTIC_CYTOSKELETON,0.857694623161765
REACTOME_SIGNAL_TRANSDUCTION...,SET,20,0.25843,0.0085204,0.19627,0.093975,REACTOME_SIGNAL_TRANSDUCTION_BY_L1,0.857694623161765
GOBP_NEGATIVE_REGULATION_OF_...584,SET,6,0.47982,0.0086681,0.36453,0.094049,GOBP_NEGATIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.858144656077711
GSE41867_NAIVE_VS_DAY8_LCMV_...1,SET,180,0.080719,0.0079491,0.06135,0.094143,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.85868834689058
BUSSLINGER_DUODENAL_DIFFEREN...,SET,267,0.066607,0.0079696,0.050627,0.094158,BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS,0.85868834689058
REACTOME_ROLE_OF_SECOND_MESS...,SET,9,0.37771,0.0083562,0.28713,0.094186,REACTOME_ROLE_OF_SECOND_MESSENGERS_IN_NETRIN_1_SIGNALING,0.858718370933893
KEGG_MEDICUS_VARIANT_SCRAPIE...5,SET,5,0.55536,0.0091588,0.4223,0.094253,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY,0.859043650980392
MODULE_75,SET,369,0.064512,0.0090488,0.049066,0.094295,MODULE_75,0.859043650980392
GOMF_ALCOHOL_TRANSMEMBRANE_T...,SET,6,0.45486,0.0082171,0.34601,0.094337,GOMF_ALCOHOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.859043650980392
HP_TRUNCUS_ARTERIOSUS,SET,24,0.25198,0.0090998,0.19173,0.094383,HP_TRUNCUS_ARTERIOSUS,0.859043650980392
GOBP_CORTICOSPINAL_TRACT_MOR...,SET,8,0.446,0.0093031,0.33938,0.0944,GOBP_CORTICOSPINAL_TRACT_MORPHOGENESIS,0.859043650980392
GOMF_FOUR_WAY_JUNCTION_HELIC...,SET,6,0.51064,0.0092248,0.38862,0.094439,GOMF_FOUR_WAY_JUNCTION_HELICASE_ACTIVITY,0.859043650980392
MODULE_48,SET,293,0.065036,0.0081459,0.049498,0.094447,MODULE_48,0.859043650980392
REACTOME_NRCAM_INTERACTIONS,SET,6,0.45212,0.0081677,0.34416,0.094483,REACTOME_NRCAM_INTERACTIONS,0.859043650980392
PID_NFKAPPAB_ATYPICAL_PATHWAY,SET,16,0.27153,0.0080081,0.20669,0.094486,PID_NFKAPPAB_ATYPICAL_PATHWAY,0.859043650980392
HP_ABNORMAL_PHAGOCYTOSIS,SET,3,0.6686,0.0085414,0.50903,0.094522,HP_ABNORMAL_PHAGOCYTOSIS,0.859043650980392
GSE14699_DELETIONAL_TOLERANC...1,SET,167,0.084772,0.0080439,0.064541,0.094523,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_DN,0.859043650980392
GOBP_PANCREATIC_JUICE_SECRET...,SET,11,0.3225,0.0078875,0.24556,0.094543,GOBP_PANCREATIC_JUICE_SECRETION,0.859043650980392
GOMF_WATER_TRANSMEMBRANE_TRA...,SET,17,0.32634,0.0099206,0.24848,0.094543,GOMF_WATER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.859043650980392
OHASHI_AURKB_TARGETS,SET,7,0.42572,0.0083067,0.3242,0.094576,OHASHI_AURKB_TARGETS,0.859118891792995
LANDIS_BREAST_CANCER_PROGRES...1,SET,68,0.14508,0.0088084,0.11054,0.094695,LANDIS_BREAST_CANCER_PROGRESSION_DN,0.859859400470219
DURAND_STROMA_NS_UP,SET,161,0.091517,0.0085279,0.069734,0.094707,DURAND_STROMA_NS_UP,0.859859400470219
HP_HYPOVENTILATION,SET,46,0.15421,0.0077051,0.11755,0.094805,HP_HYPOVENTILATION,0.860197584137751
HOEK_MYELOID_DENDRITIC_CELL_...2,SET,16,0.28646,0.0084484,0.21839,0.094822,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_UP,0.860197584137751
GOBP_REGULATION_OF_SMOOTH_MU...1,SET,6,0.44992,0.0081279,0.34303,0.094838,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_CHEMOTAXIS,0.860197584137751
REACTOME_TOLL_LIKE_RECEPTOR_...1,SET,101,0.10917,0.0080707,0.083243,0.094856,REACTOME_TOLL_LIKE_RECEPTOR_9_TLR9_CASCADE,0.860197584137751
SHEN_SMARCA2_TARGETS_UP,SET,389,0.054131,0.0077913,0.041276,0.094868,SHEN_SMARCA2_TARGETS_UP,0.860197584137751
HP_ABNORMALLY_LAX_OR_HYPEREX...,SET,150,0.089466,0.0080494,0.068235,0.094914,HP_ABNORMALLY_LAX_OR_HYPEREXTENSIBLE_SKIN,0.860390211267606
ZNF419_TARGET_GENES,SET,5,0.49362,0.0081407,0.37657,0.094966,ZNF419_TARGET_GENES,0.860637113428944
MULLIGHAN_MLL_SIGNATURE_1_DN,SET,216,0.077774,0.0083817,0.059339,0.094992,MULLIGHAN_MLL_SIGNATURE_1_DN,0.860648321167883
GOMF_ABC_TYPE_TRANSPORTER_AC...,SET,46,0.17372,0.00868,0.13256,0.095032,GOMF_ABC_TYPE_TRANSPORTER_ACTIVITY,0.860786333072713
GSE1460_DP_THYMOCYTE_VS_NAIV...2,SET,170,0.080239,0.0076813,0.061244,0.095079,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.86092143452226
HP_PROGRESSIVE_HEARING_IMPAI...,SET,35,0.18299,0.0079777,0.13969,0.095115,HP_PROGRESSIVE_HEARING_IMPAIRMENT,0.86092143452226
GSE9946_IMMATURE_VS_PROSTAGL...2,SET,139,0.094242,0.0081648,0.071947,0.095125,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,0.86092143452226
DER_IFN_BETA_RESPONSE_UP,SET,98,0.11303,0.0082318,0.0863,0.095146,DER_IFN_BETA_RESPONSE_UP,0.86092143452226
GOBP_DNA_CONFORMATION_CHANGE,SET,83,0.11422,0.0076586,0.087235,0.095212,GOBP_DNA_CONFORMATION_CHANGE,0.861165709090909
ZBTB1_TARGET_GENES,SET,90,0.11332,0.0079103,0.086551,0.09523,ZBTB1_TARGET_GENES,0.861165709090909
HP_NARROW_JAW,SET,13,0.31321,0.0083272,0.23929,0.095287,HP_NARROW_JAW,0.861165709090909
TRAVAGLINI_LUNG_CAPILLARY_IN...2,SET,353,0.058467,0.0080246,0.044673,0.095313,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_2_CELL,0.861165709090909
GSE10239_NAIVE_VS_MEMORY_CD8...2,SET,184,0.078648,0.0078298,0.060101,0.095346,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.861165709090909
HAMAI_APOPTOSIS_VIA_TRAIL_DN,SET,178,0.080801,0.0079132,0.061748,0.095348,HAMAI_APOPTOSIS_VIA_TRAIL_DN,0.861165709090909
GOBP_L_ALANINE_TRANSPORT,SET,10,0.36504,0.0085126,0.27898,0.095361,GOBP_L_ALANINE_TRANSPORT,0.861165709090909
KEGG_MEDICUS_REFERENCE_PRE_I...,SET,27,0.1934,0.0074072,0.14781,0.095375,KEGG_MEDICUS_REFERENCE_PRE_IC_FORMATION,0.861165709090909
KEGG_MEDICUS_REFERENCE_RIG_I...1,SET,20,0.27198,0.0089671,0.20789,0.095396,KEGG_MEDICUS_REFERENCE_RIG_I_IRF7_3_SIGNALING_PATHWAY,0.861165709090909
HP_ABNORMAL_TOE_PHALANX_MORP...,SET,113,0.10192,0.0079669,0.077951,0.095535,HP_ABNORMAL_TOE_PHALANX_MORPHOLOGY,0.861761719844358
GOCC_DNA_REPLICATION_FACTOR_...2,SET,5,0.474,0.0078171,0.36255,0.095546,GOCC_DNA_REPLICATION_FACTOR_C_COMPLEX,0.861761719844358
HP_LOSS_OF_VOICE,SET,6,0.3817,0.0068955,0.292,0.095577,HP_LOSS_OF_VOICE,0.861761719844358
MIR6753_5P,SET,20,0.2539,0.008371,0.19423,0.095585,MIR6753_5P,0.861761719844358
NAKAYA_PBMC_FLUMIST_AGE_18_5...2,SET,30,0.19718,0.0079598,0.15084,0.095586,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_IFN_SUBSET_UP,0.861761719844358
MODULE_378,SET,394,0.055762,0.0080764,0.042664,0.095615,MODULE_378,0.861799617479253
MODULE_229,SET,27,0.21331,0.00817,0.16332,0.095763,MODULE_229,0.861889882459313
HP_ABNORMAL_CIRCULATING_GLOB...,SET,10,0.3684,0.0085909,0.28206,0.095771,HP_ABNORMAL_CIRCULATING_GLOBULIN_CONCENTRATION,0.861889882459313
MODULE_37,SET,428,0.05184,0.0078183,0.039708,0.095861,MODULE_37,0.861889882459313
FOXO3_01,SET,228,0.076866,0.008508,0.058883,0.095888,FOXO3_01,0.861889882459313
GSE45365_WT_VS_IFNAR_KO_CD8A...1,SET,183,0.080046,0.0079475,0.061324,0.095906,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_DN,0.861889882459313
HP_REDUCED_FACTOR_XIII_ACTIV...,SET,6,0.42381,0.0076562,0.32472,0.09593,HP_REDUCED_FACTOR_XIII_ACTIVITY,0.861889882459313
MIR4766_5P,SET,293,0.064888,0.0081273,0.049718,0.095936,MIR4766_5P,0.861889882459313
GOBP_TROPHECTODERMAL_CELL_DI...,SET,19,0.25698,0.0082583,0.19692,0.095954,GOBP_TROPHECTODERMAL_CELL_DIFFERENTIATION,0.861889882459313
YAO_TEMPORAL_RESPONSE_TO_PRO...10,SET,169,0.078972,0.0075379,0.060516,0.095957,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17,0.861889882459313
HP_INCOMPLETE_PARTITION_OF_T...,SET,7,0.3939,0.0076859,0.30185,0.095961,HP_INCOMPLETE_PARTITION_OF_THE_COCHLEA_TYPE_II,0.861889882459313
HP_ABNORMALITY_OF_THE_MUSCUL...1,SET,111,0.09887,0.0076603,0.075771,0.095982,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_HAND,0.861889882459313
SMARCA1_TARGET_GENES,SET,98,0.11186,0.0081466,0.085729,0.095983,SMARCA1_TARGET_GENES,0.861889882459313
ZNF391_TARGET_GENES,SET,752,0.040735,0.0080694,0.031218,0.095983,ZNF391_TARGET_GENES,0.861889882459313
GSE18281_MEDULLARY_THYMOCYTE...2,SET,164,0.083297,0.0078333,0.063839,0.095991,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_UP,0.861889882459313
GOBP_TRANSDIFFERENTIATION,SET,7,0.48485,0.0094605,0.3716,0.095997,GOBP_TRANSDIFFERENTIATION,0.861889882459313
GSE17721_POLYIC_VS_CPG_12H_B...2,SET,178,0.083998,0.0082264,0.064388,0.096028,GSE17721_POLYIC_VS_CPG_12H_BMDC_UP,0.861945542355372
WP_PANCREATIC_ADENOCARCINOMA...,SET,83,0.12192,0.0081744,0.093466,0.09606,WP_PANCREATIC_ADENOCARCINOMA_PATHWAY,0.862010147172734
GOBP_NEGATIVE_REGULATION_OF_...439,SET,147,0.094947,0.0084573,0.072807,0.09611,GOBP_NEGATIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.862042360681115
HP_MONOCYTOSIS,SET,15,0.26087,0.0074496,0.20006,0.096133,HP_MONOCYTOSIS,0.862042360681115
HP_LACRIMATION_ABNORMALITY,SET,76,0.13065,0.0083843,0.1002,0.096138,HP_LACRIMATION_ABNORMALITY,0.862042360681115
GSE15330_WT_VS_IKAROS_KO_MEG...1,SET,184,0.083051,0.0082681,0.063714,0.096213,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.862328773511981
BIOCARTA_BCR_PATHWAY,SET,31,0.19292,0.0079163,0.14803,0.096252,BIOCARTA_BCR_PATHWAY,0.862328773511981
GOBP_MONOATOMIC_CATION_TRANS...1,SET,750,0.042218,0.0083525,0.032394,0.096253,GOBP_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORT,0.862328773511981
GOBP_LEARNING,SET,143,0.094605,0.0083124,0.0726,0.096278,GOBP_LEARNING,0.862328773511981
KOKKINAKIS_METHIONINE_DEPRIV...3,SET,69,0.13081,0.0079997,0.10039,0.096294,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_DN,0.862328773511981
KEGG_SULFUR_METABOLISM,SET,11,0.32978,0.0080654,0.25313,0.096326,KEGG_SULFUR_METABOLISM,0.862393129829985
GOMF_CALCIUM_DEPENDENT_PHOSP...2,SET,52,0.16663,0.0088505,0.12793,0.096381,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPID_BINDING,0.862663315735256
chr13q32,SET,29,0.37854,0.015025,0.29066,0.096407,chr13q32,0.862663962458216
REACTOME_MYD88_INDEPENDENT_T...,SET,103,0.10788,0.0080537,0.082852,0.096444,REACTOME_MYD88_INDEPENDENT_TLR4_CASCADE,0.862663962458216
GOBP_PURINE_NUCLEOBASE_TRANS...,SET,8,0.42988,0.0089668,0.33021,0.096496,GOBP_PURINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORT,0.862663962458216
SMID_BREAST_CANCER_LUMINAL_B...1,SET,494,0.054942,0.0088857,0.042205,0.096504,SMID_BREAST_CANCER_LUMINAL_B_DN,0.862663962458216
GSE11924_TH1_VS_TH17_CD4_TCE...1,SET,186,0.076528,0.0076596,0.058791,0.096521,GSE11924_TH1_VS_TH17_CD4_TCELL_DN,0.862663962458216
BIOCARTA_ARENRF2_PATHWAY,SET,20,0.27073,0.0089259,0.20799,0.09653,BIOCARTA_ARENRF2_PATHWAY,0.862663962458216
GSE2770_IL12_ACT_VS_ACT_CD4_...5,SET,158,0.086165,0.0079547,0.066212,0.096578,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_DN,0.862871051413882
HP_ABNORMAL_VERTEBRAL_MORPHO...,SET,421,0.052707,0.0078853,0.040507,0.096605,HP_ABNORMAL_VERTEBRAL_MORPHOLOGY,0.862890458750964
GSE3982_DC_VS_BCELL_UP,SET,183,0.082971,0.0082379,0.063782,0.096662,GSE3982_DC_VS_BCELL_UP,0.862964953763165
GOBP_RESPIRATORY_CHAIN_COMPL...2,SET,23,0.19252,0.0068063,0.148,0.096663,GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY,0.862964953763165
HP_HYPOPLASTIC_FIFTH_FINGERN...,SET,14,0.30352,0.0083739,0.23342,0.096751,HP_HYPOPLASTIC_FIFTH_FINGERNAIL,0.863123085286301
SCHERER_PBMC_APSV_WETVAX_AGE...8,SET,23,0.23196,0.0082005,0.1784,0.096773,SCHERER_PBMC_APSV_WETVAX_AGE_18_40YO_5_TO_7DY_UP,0.863123085286301
GOCC_COMPACT_MYELIN,SET,13,0.32332,0.0085959,0.24871,0.096808,GOCC_COMPACT_MYELIN,0.863123085286301
GOBP_IMMUNE_RESPONSE_REGULAT...3,SET,478,0.051571,0.008208,0.039671,0.096814,GOBP_IMMUNE_RESPONSE_REGULATING_SIGNALING_PATHWAY,0.863123085286301
GSE17721_4H_VS_24H_POLYIC_BM...1,SET,179,0.077308,0.0075921,0.059474,0.096835,GSE17721_4H_VS_24H_POLYIC_BMDC_DN,0.863123085286301
GOBP_PLASMA_MEMBRANE_PHOSPHO...,SET,24,0.23033,0.0083178,0.17724,0.096894,GOBP_PLASMA_MEMBRANE_PHOSPHOLIPID_SCRAMBLING,0.863123085286301
HP_PERSISTENCE_OF_HEMOGLOBIN...,SET,32,0.18323,0.0076391,0.14103,0.096933,HP_PERSISTENCE_OF_HEMOGLOBIN_F,0.863123085286301
GOCC_EUKARYOTIC_TRANSLATION_...5,SET,13,0.28718,0.007635,0.22106,0.096967,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_4F_COMPLEX,0.863123085286301
GSE3039_CD4_TCELL_VS_B1_BCEL...1,SET,175,0.084711,0.0082266,0.065211,0.096977,GSE3039_CD4_TCELL_VS_B1_BCELL_DN,0.863123085286301
HP_EPIPHORA,SET,22,0.2337,0.0080807,0.17991,0.096985,HP_EPIPHORA,0.863123085286301
AIZARANI_LIVER_C25_KUPFFER_C...,SET,158,0.093629,0.0086437,0.072086,0.097006,AIZARANI_LIVER_C25_KUPFFER_CELLS_4,0.863123085286301
GOBP_RESPONSE_TO_ZINC_ION_ST...,SET,8,0.34668,0.0072314,0.26692,0.097011,GOBP_RESPONSE_TO_ZINC_ION_STARVATION,0.863123085286301
BIOCARTA_KREB_PATHWAY,SET,8,0.43191,0.0090091,0.33255,0.097015,BIOCARTA_KREB_PATHWAY,0.863123085286301
GOBP_HEMIDESMOSOME_ASSEMBLY,SET,6,0.49554,0.008952,0.38156,0.097031,GOBP_HEMIDESMOSOME_ASSEMBLY,0.863123085286301
LIU_NASOPHARYNGEAL_CARCINOMA,SET,62,0.13568,0.0078673,0.10453,0.097142,LIU_NASOPHARYNGEAL_CARCINOMA,0.863123085286301
GOBP_CELL_JUNCTION_MAINTENAN...,SET,41,0.18293,0.0086304,0.14094,0.097162,GOBP_CELL_JUNCTION_MAINTENANCE,0.863123085286301
HP_SECOND_TRIMESTER_ONSET,SET,41,0.16991,0.0080162,0.13092,0.097179,HP_SECOND_TRIMESTER_ONSET,0.863123085286301
HP_ELEVATED_LACTATE_PYRUVATE...,SET,18,0.22461,0.0070257,0.17308,0.097206,HP_ELEVATED_LACTATE_PYRUVATE_RATIO,0.863123085286301
GOBP_URATE_METABOLIC_PROCESS,SET,10,0.36402,0.0084887,0.28058,0.097265,GOBP_URATE_METABOLIC_PROCESS,0.863123085286301
GOBP_SENSORY_PERCEPTION_OF_T...3,SET,5,0.4759,0.0078484,0.36689,0.097303,GOBP_SENSORY_PERCEPTION_OF_TOUCH,0.863123085286301
GOMF_RNA_STEM_LOOP_BINDING,SET,13,0.28338,0.007534,0.21847,0.097305,GOMF_RNA_STEM_LOOP_BINDING,0.863123085286301
GOBP_REGULATION_OF_LEUKOCYTE...1,SET,4,0.60631,0.0089437,0.4677,0.097435,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.863123085286301
GSE339_CD4POS_VS_CD8POS_DC_I...2,SET,183,0.079615,0.0079047,0.061415,0.097438,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_UP,0.863123085286301
GOBP_POSITIVE_REGULATION_OF_...273,SET,18,0.248,0.0077574,0.19132,0.09745,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.863123085286301
KEGG_MEDICUS_REFERENCE_WNT_S...5,SET,44,0.17258,0.008434,0.13315,0.097479,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_PATHWAY,0.863123085286301
REACTOME_TERMINATION_OF_TRAN...,SET,30,0.17552,0.0070857,0.13543,0.097489,REACTOME_TERMINATION_OF_TRANSLESION_DNA_SYNTHESIS,0.863123085286301
MIR151A_5P_MIR151B,SET,10,0.33054,0.007708,0.25519,0.097622,MIR151A_5P_MIR151B,0.863123085286301
MIR486_5P,SET,85,0.11459,0.0077751,0.088491,0.097671,MIR486_5P,0.863123085286301
KIM_RESPONSE_TO_TSA_AND_DECI...1,SET,8,0.34991,0.0072986,0.27021,0.097676,KIM_RESPONSE_TO_TSA_AND_DECITABINE_DN,0.863123085286301
GAVISH_3CA_METAPROGRAM_B_CEL...5,SET,50,0.16128,0.0084005,0.12455,0.097694,GAVISH_3CA_METAPROGRAM_B_CELLS_INTERFERON,0.863123085286301
GOMF_MHC_CLASS_II_PROTEIN_CO...,SET,23,0.24478,0.0086538,0.18904,0.097696,GOMF_MHC_CLASS_II_PROTEIN_COMPLEX_BINDING,0.863123085286301
GSE29618_LAIV_VS_TIV_FLU_VAC...3,SET,170,0.08408,0.0080489,0.064938,0.097707,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_DN,0.863123085286301
HP_ABNORMAL_AORTIC_VALVE_PHY...,SET,148,0.093686,0.0083732,0.072366,0.097734,HP_ABNORMAL_AORTIC_VALVE_PHYSIOLOGY,0.863123085286301
AACWWCAANK_UNKNOWN,SET,132,0.096068,0.0081122,0.074208,0.097742,AACWWCAANK_UNKNOWN,0.863123085286301
GOBP_ORGAN_OR_TISSUE_SPECIFI...,SET,26,0.24027,0.0090306,0.18561,0.097763,GOBP_ORGAN_OR_TISSUE_SPECIFIC_IMMUNE_RESPONSE,0.863123085286301
GSE9650_NAIVE_VS_EFF_CD8_TCE...2,SET,182,0.079484,0.0078703,0.061409,0.097784,GSE9650_NAIVE_VS_EFF_CD8_TCELL_UP,0.863123085286301
NAKAYA_PBMC_FLUMIST_AGE_18_5...6,SET,31,0.19476,0.0079921,0.15048,0.097785,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_UP,0.863123085286301
LINDVALL_IMMORTALIZED_BY_TER...2,SET,59,0.15484,0.0087589,0.11963,0.097787,LINDVALL_IMMORTALIZED_BY_TERT_UP,0.863123085286301
GOBP_CORNEA_DEVELOPMENT_IN_C...,SET,12,0.36714,0.0093782,0.28369,0.097811,GOBP_CORNEA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.863123085286301
MIR9899,SET,4,0.50068,0.0073855,0.38689,0.09782,MIR9899,0.863123085286301
GSE339_CD8POS_VS_CD4CD8DN_DC...2,SET,182,0.079889,0.0079105,0.061736,0.097833,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.863123085286301
GOCC_METHYLTRANSFERASE_COMPL...,SET,92,0.10328,0.007289,0.079825,0.097865,GOCC_METHYLTRANSFERASE_COMPLEX,0.863123085286301
MARZEC_IL2_SIGNALING_UP,SET,109,0.10658,0.0081837,0.082379,0.097871,MARZEC_IL2_SIGNALING_UP,0.863123085286301
SCHAEFFER_PROSTATE_DEVELOPME...1,SET,52,0.1577,0.0083766,0.12191,0.097902,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_DN,0.863123085286301
FAN_OVARY_CL18_B_LYMPHOCYTE,SET,383,0.05493,0.0078465,0.042471,0.097953,FAN_OVARY_CL18_B_LYMPHOCYTE,0.863123085286301
HP_ABNORMALITY_OF_THE_GINGIVA,SET,211,0.077537,0.00826,0.059962,0.097998,HP_ABNORMALITY_OF_THE_GINGIVA,0.863123085286301
GOBP_ANTIBACTERIAL_HUMORAL_R...,SET,48,0.19272,0.0098361,0.14905,0.098019,GOBP_ANTIBACTERIAL_HUMORAL_RESPONSE,0.863123085286301
YIH_RESPONSE_TO_ARSENITE_C5,SET,10,0.45081,0.010513,0.34867,0.098021,YIH_RESPONSE_TO_ARSENITE_C5,0.863123085286301
CTGTTAC_MIR194,SET,92,0.11056,0.0078027,0.08552,0.098048,CTGTTAC_MIR194,0.863123085286301
GSE25123_CTRL_VS_ROSIGLITAZO...2,SET,184,0.07879,0.007844,0.060964,0.098116,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.863123085286301
HP_RETICULAR_HYPERPIGMENTATI...,SET,9,0.3252,0.0071945,0.25166,0.098153,HP_RETICULAR_HYPERPIGMENTATION,0.863123085286301
GSE15215_CD2_POS_VS_NEG_PDC_...1,SET,179,0.075614,0.0074258,0.058536,0.098229,GSE15215_CD2_POS_VS_NEG_PDC_DN,0.863123085286301
MODULE_459,SET,390,0.055406,0.0079849,0.042892,0.09823,MODULE_459,0.863123085286301
HP_CEREBRAL_CAVERNOUS_MALFOR...,SET,5,0.41647,0.0068683,0.32245,0.098258,HP_CEREBRAL_CAVERNOUS_MALFORMATION,0.863123085286301
GSE32901_TH1_VS_TH17_NEG_CD4...1,SET,104,0.10446,0.0078358,0.08088,0.098264,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_DN,0.863123085286301
RAF_UP.V1_UP,SET,176,0.089142,0.0086814,0.069035,0.098314,RAF_UP.V1_UP,0.863123085286301
chr3p25,SET,79,0.2823,0.018468,0.21864,0.098334,chr3p25,0.863123085286301
MODULE_273,SET,40,0.16102,0.0075036,0.12472,0.098352,MODULE_273,0.863123085286301
GOMF_ASPARTIC_TYPE_PEPTIDASE...,SET,25,0.20887,0.0076983,0.16179,0.098357,GOMF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.863123085286301
GOBP_NADPH_OXIDATION,SET,6,0.45892,0.0082904,0.3555,0.098377,GOBP_NADPH_OXIDATION,0.863123085286301
GOBP_BLASTOCYST_FORMATION,SET,45,0.16356,0.0080834,0.12671,0.098387,GOBP_BLASTOCYST_FORMATION,0.863123085286301
MIR6739_3P,SET,174,0.084892,0.0082208,0.065774,0.098419,MIR6739_3P,0.863123085286301
GOBP_NEGATIVE_REGULATION_OF_...209,SET,59,0.15807,0.0089415,0.12247,0.098419,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.863123085286301
HP_LIMITED_ELBOW_EXTENSION,SET,45,0.15637,0.0077282,0.12117,0.098449,HP_LIMITED_ELBOW_EXTENSION,0.863123085286301
GSE15624_CTRL_VS_3H_HALOFUGI...2,SET,147,0.086104,0.0076696,0.066729,0.098475,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_UP,0.863123085286301
HP_ABNORMAL_TRICUSPID_VALVE_...2,SET,72,0.12917,0.0080692,0.10011,0.098477,HP_ABNORMAL_TRICUSPID_VALVE_PHYSIOLOGY,0.863123085286301
GOBP_T_HELPER_17_CELL_DIFFER...,SET,33,0.20232,0.0085653,0.15685,0.098549,GOBP_T_HELPER_17_CELL_DIFFERENTIATION,0.863123085286301
MIR6508_3P,SET,46,0.16606,0.0082972,0.12875,0.098578,MIR6508_3P,0.863123085286301
GOBP_REGULATION_OF_NON_CANON...1,SET,88,0.11421,0.0078843,0.088564,0.098599,GOBP_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.863123085286301
GOBP_MYOSIN_FILAMENT_ORGANIZ...,SET,6,0.42247,0.007632,0.32763,0.09863,GOBP_MYOSIN_FILAMENT_ORGANIZATION,0.863123085286301
RBM34_TARGET_GENES,SET,811,0.038853,0.0079794,0.030134,0.098652,RBM34_TARGET_GENES,0.863123085286301
GSE34156_UNTREATED_VS_24H_TL...2,SET,149,0.091666,0.00822,0.071099,0.098661,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.863123085286301
PRC2_EZH2_UP.V1_DN,SET,169,0.080564,0.0076899,0.062494,0.098682,PRC2_EZH2_UP.V1_DN,0.863123085286301
MIR4470,SET,227,0.072938,0.0080558,0.056593,0.098738,MIR4470,0.863123085286301
HP_ABNORMAL_PLACENTAL_SIZE,SET,14,0.31973,0.008821,0.24809,0.098755,HP_ABNORMAL_PLACENTAL_SIZE,0.863123085286301
GOCC_SIGNAL_PEPTIDASE_COMPLEX,SET,5,0.45261,0.0074644,0.35123,0.098768,GOCC_SIGNAL_PEPTIDASE_COMPLEX,0.863123085286301
HP_AORTIC_ROOT_ANEURYSM,SET,64,0.13534,0.0079726,0.10503,0.098779,HP_AORTIC_ROOT_ANEURYSM,0.863123085286301
GOBP_REGULATION_OF_NON_CANON...2,SET,26,0.2247,0.0084455,0.17441,0.098819,GOBP_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.863123085286301
WP_OXYSTEROLS_DERIVED_FROM_C...,SET,49,0.16555,0.0085367,0.1285,0.098827,WP_OXYSTEROLS_DERIVED_FROM_CHOLESTEROL,0.863123085286301
BURTON_ADIPOGENESIS_PEAK_AT_...1,SET,59,0.14663,0.0082945,0.11382,0.098833,BURTON_ADIPOGENESIS_PEAK_AT_0HR,0.863123085286301
GOMF_E_BOX_BINDING,SET,52,0.17461,0.0092747,0.13554,0.098841,GOMF_E_BOX_BINDING,0.863123085286301
GOBP_CD4_POSITIVE_ALPHA_BETA...4,SET,19,0.27747,0.0089169,0.21544,0.098886,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.863123085286301
GSE27786_LSK_VS_LIN_NEG_CELL...1,SET,179,0.079057,0.0077639,0.061398,0.09895,GSE27786_LSK_VS_LIN_NEG_CELL_DN,0.863123085286301
GOBP_MESENCHYME_DEVELOPMENT,SET,293,0.066934,0.0083836,0.051996,0.099004,GOBP_MESENCHYME_DEVELOPMENT,0.863123085286301
LEIN_OLIGODENDROCYTE_MARKERS,SET,72,0.13374,0.0083545,0.10389,0.099005,LEIN_OLIGODENDROCYTE_MARKERS,0.863123085286301
WP_ESTROGEN_SIGNALING,SET,21,0.23067,0.0077926,0.17919,0.099013,WP_ESTROGEN_SIGNALING,0.863123085286301
GOBP_FAT_PAD_DEVELOPMENT,SET,8,0.38255,0.0079795,0.29719,0.099015,GOBP_FAT_PAD_DEVELOPMENT,0.863123085286301
HP_LOWER_LIMB_PAIN,SET,37,0.18865,0.008456,0.14656,0.099028,HP_LOWER_LIMB_PAIN,0.863123085286301
BIOCARTA_CARM1_PATHWAY,SET,12,0.31729,0.0081047,0.24653,0.099049,BIOCARTA_CARM1_PATHWAY,0.863123085286301
MIR28_5P,SET,43,0.16479,0.0079617,0.12805,0.09906,MIR28_5P,0.863123085286301
GOBP_NEGATIVE_REGULATION_OF_...402,SET,79,0.12671,0.0082894,0.098462,0.099076,GOBP_NEGATIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.863123085286301
GSE29618_LAIV_VS_TIV_FLU_VAC...6,SET,168,0.083884,0.0079832,0.065198,0.099124,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_UP,0.863123085286301
HP_WEAKNESS_OF_MUSCLES_OF_RE...,SET,99,0.10982,0.0080384,0.085365,0.099142,HP_WEAKNESS_OF_MUSCLES_OF_RESPIRATION,0.863123085286301
KONG_E2F1_TARGETS,SET,8,0.3511,0.0073236,0.27295,0.099171,KONG_E2F1_TARGETS,0.863123085286301
HP_ABNORMAL_HEART_VALVE_PHYS...,SET,336,0.060453,0.0080988,0.046999,0.099183,HP_ABNORMAL_HEART_VALVE_PHYSIOLOGY,0.863123085286301
HP_PUNCTATE_CATARACT,SET,14,0.29758,0.0082099,0.23138,0.099208,HP_PUNCTATE_CATARACT,0.863123085286301
GNF2_APEX1,SET,77,0.11342,0.0073262,0.088196,0.099222,GNF2_APEX1,0.863123085286301
PUJANA_BREAST_CANCER_WITH_BR...2,SET,52,0.14245,0.0075662,0.11078,0.099252,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP,0.863123085286301
GOBP_RESPONSE_TO_MANGANESE_I...,SET,16,0.27575,0.0081325,0.21447,0.099279,GOBP_RESPONSE_TO_MANGANESE_ION,0.863123085286301
HOEK_PBMC_INACTIVATED_INFLUE...3,SET,10,0.36474,0.0085055,0.28374,0.099321,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_DN,0.863123085286301
IIZUKA_LIVER_CANCER_PROGRESS...3,SET,8,0.41288,0.0086123,0.32127,0.099376,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_DN,0.863123085286301
GSE17580_UNINFECTED_VS_S_MAN...1,SET,175,0.081277,0.0078931,0.063251,0.099405,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_DN,0.863123085286301
GOBP_NEGATIVE_REGULATION_OF_...677,SET,5,0.52087,0.0085901,0.40536,0.099413,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MIGRATION,0.863123085286301
GOBP_MEMBRANE_DEPOLARIZATION...1,SET,27,0.23376,0.0089531,0.18193,0.099419,GOBP_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.863123085286301
FERNANDEZ_BOUND_BY_MYC,SET,170,0.08304,0.0079494,0.064631,0.099435,FERNANDEZ_BOUND_BY_MYC,0.863123085286301
VANDESLUIS_COMMD1_TARGETS_GR...5,SET,14,0.29997,0.0082758,0.23347,0.09944,VANDESLUIS_COMMD1_TARGETS_GROUP_4_UP,0.863123085286301
REACTOME_SIGNAL_ATTENUATION,SET,10,0.34535,0.0080535,0.26884,0.09947,REACTOME_SIGNAL_ATTENUATION,0.863123085286301
GSE40666_WT_VS_STAT1_KO_CD8_...4,SET,178,0.081464,0.0079781,0.063414,0.09947,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.863123085286301
HP_MICRODONTIA,SET,157,0.087251,0.0080296,0.067937,0.099527,HP_MICRODONTIA,0.863123085286301
GOBP_VESICLE_TETHERING_TO_GO...,SET,5,0.47738,0.0078728,0.3718,0.099587,GOBP_VESICLE_TETHERING_TO_GOLGI,0.863123085286301
MIR551A_MIR551B_3P,SET,5,0.5431,0.0089566,0.42302,0.099603,MIR551A_MIR551B_3P,0.863123085286301
REACTOME_NUCLEAR_EVENTS_KINA...,SET,59,0.14634,0.0082784,0.11406,0.099749,REACTOME_NUCLEAR_EVENTS_KINASE_AND_TRANSCRIPTION_FACTOR_ACTIVATION,0.863123085286301
SANSOM_APC_TARGETS_UP,SET,120,0.10263,0.008266,0.080018,0.099821,SANSOM_APC_TARGETS_UP,0.863123085286301
BLANCO_MELO_HUMAN_PARAINFLUE...1,SET,101,0.10999,0.0081313,0.085756,0.099826,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_DN,0.863123085286301
STTTCRNTTT_IRF_Q6,SET,174,0.086995,0.0084245,0.067827,0.099826,STTTCRNTTT_IRF_Q6,0.863123085286301
GOBP_MEIOTIC_DNA_DOUBLE_STRA...,SET,5,0.59884,0.0098758,0.46703,0.099892,GOBP_MEIOTIC_DNA_DOUBLE_STRAND_BREAK_FORMATION,0.863123085286301
GSE3720_LPS_VS_PMA_STIM_VD2_...1,SET,138,0.095716,0.0082628,0.07466,0.099925,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,0.863123085286301
GOMF_ACTIVIN_BINDING,SET,11,0.32017,0.0078303,0.24977,0.09996,GOMF_ACTIVIN_BINDING,0.863123085286301
GOBP_NEGATIVE_REGULATION_OF_...115,SET,10,0.43019,0.010032,0.33561,0.099962,GOBP_NEGATIVE_REGULATION_OF_CELL_FATE_COMMITMENT,0.863123085286301
GOBP_REGULATION_OF_ANAPHASE_...,SET,5,0.39135,0.0064539,0.30538,0.10002,GOBP_REGULATION_OF_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,0.863123085286301
GOMF_CARBON_CARBON_LYASE_ACT...,SET,50,0.15093,0.0078614,0.1178,0.10006,GOMF_CARBON_CARBON_LYASE_ACTIVITY,0.863123085286301
GSE34156_TLR1_TLR2_LIGAND_VS...2,SET,174,0.084063,0.0081405,0.065611,0.10006,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,0.863123085286301
GOCC_NUCLEAR_ENVELOPE_LUMEN,SET,10,0.36554,0.0085242,0.28539,0.10013,GOCC_NUCLEAR_ENVELOPE_LUMEN,0.863123085286301
GOBP_RESPONSE_TO_CAMP,SET,83,0.11899,0.0079782,0.092915,0.10017,GOBP_RESPONSE_TO_CAMP,0.863123085286301
GSE13484_3H_UNSTIM_VS_YF17D_...1,SET,184,0.082489,0.0082122,0.064417,0.10019,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,0.863123085286301
GOBP_REGULATION_OF_ASPARTIC_...1,SET,6,0.48344,0.0087335,0.37766,0.10027,GOBP_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.863123085286301
GOMF_STRUCTURAL_CONSTITUENT_...2,SET,100,0.11283,0.0082999,0.088144,0.10027,GOMF_STRUCTURAL_CONSTITUENT_OF_CYTOSKELETON,0.863123085286301
HP_MULTIPLE_RENAL_CYSTS,SET,67,0.1377,0.0082987,0.10757,0.10027,HP_MULTIPLE_RENAL_CYSTS,0.863123085286301
HP_SMALL_FOREHEAD,SET,11,0.31449,0.0076915,0.24572,0.10031,HP_SMALL_FOREHEAD,0.863123085286301
GSE4748_LPS_VS_LPS_AND_CYANO...1,SET,143,0.087321,0.0076724,0.068247,0.10037,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,0.863123085286301
MIR4638_3P,SET,56,0.14167,0.007808,0.11073,0.10039,MIR4638_3P,0.863123085286301
HP_ABNORMAL_MEGAKARYOCYTE_MO...,SET,23,0.21879,0.0077351,0.17103,0.10041,HP_ABNORMAL_MEGAKARYOCYTE_MORPHOLOGY,0.863123085286301
GOBP_POSITIVE_REGULATION_OF_...807,SET,17,0.26997,0.0082067,0.21105,0.10042,GOBP_POSITIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.863123085286301
GOBP_PLATELET_DEGRANULATION,SET,7,0.45013,0.008783,0.3519,0.10043,GOBP_PLATELET_DEGRANULATION,0.863123085286301
MANNO_MIDBRAIN_NEUROTYPES_HN...2,SET,262,0.071078,0.0084257,0.055572,0.10046,MANNO_MIDBRAIN_NEUROTYPES_HNBM,0.863123085286301
HP_DOLICHOCEPHALY,SET,196,0.074388,0.0076408,0.058165,0.10047,HP_DOLICHOCEPHALY,0.863123085286301
FAN_EMBRYONIC_CTX_MICROGLIA_2,SET,8,0.40831,0.0085168,0.31932,0.10051,FAN_EMBRYONIC_CTX_MICROGLIA_2,0.863123085286301
HP_GIANT_PLATELETS,SET,10,0.37124,0.0086572,0.29038,0.10055,HP_GIANT_PLATELETS,0.863123085286301
HP_HYPEROXALURIA,SET,6,0.42746,0.0077221,0.33436,0.10056,HP_HYPEROXALURIA,0.863123085286301
GOBP_POSITIVE_REGULATION_OF_...507,SET,58,0.1547,0.0086769,0.12102,0.10057,GOBP_POSITIVE_REGULATION_OF_MYELOID_LEUKOCYTE_DIFFERENTIATION,0.863123085286301
IBRAHIM_NRF2_UP,SET,476,0.048385,0.0076853,0.037859,0.10062,IBRAHIM_NRF2_UP,0.863123085286301
VISALA_AGING_LYMPHOCYTE_UP,SET,6,0.53604,0.0096837,0.41948,0.10066,VISALA_AGING_LYMPHOCYTE_UP,0.863123085286301
E2F5_TARGET_GENES,SET,1007,0.034993,0.0079633,0.027386,0.10067,E2F5_TARGET_GENES,0.863123085286301
GOBP_MYELOID_LEUKOCYTE_MEDIA...,SET,107,0.10489,0.0079803,0.082092,0.10067,GOBP_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.863123085286301
MIR577,SET,300,0.062791,0.0079565,0.049145,0.10069,MIR577,0.863123085286301
GSE6259_33D1_POS_DC_VS_CD4_T...2,SET,161,0.083401,0.0077717,0.065279,0.1007,GSE6259_33D1_POS_DC_VS_CD4_TCELL_UP,0.863123085286301
MIR922,SET,180,0.077453,0.0076274,0.060642,0.10077,MIR922,0.863123085286301
HP_DECREASED_CIRCULATING_BET...,SET,5,0.50695,0.0083604,0.397,0.10082,HP_DECREASED_CIRCULATING_BETA_2_MICROGLOBULIN_LEVEL,0.863123085286301
GOBP_REGULATION_OF_CHOLESTER...3,SET,33,0.19308,0.0081744,0.15122,0.10084,GOBP_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.863123085286301
DESCARTES_FETAL_INTESTINE_MY...,SET,187,0.086865,0.0087173,0.068031,0.10084,DESCARTES_FETAL_INTESTINE_MYELOID_CELLS,0.863123085286301
GOBP_POSITIVE_REGULATION_OF_...616,SET,6,0.38976,0.0070411,0.30526,0.10085,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEACETYLATION,0.863123085286301
MODULE_129,SET,204,0.080847,0.0084702,0.063329,0.10088,MODULE_129,0.863123085286301
POMEROY_MEDULLOBLASTOMA_PROG...2,SET,42,0.15863,0.0075743,0.12427,0.1009,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_UP,0.863123085286301
HP_PALPEBRAL_EDEMA,SET,37,0.17972,0.0080555,0.1408,0.10091,HP_PALPEBRAL_EDEMA,0.863123085286301
GSE10239_NAIVE_VS_DAY4.5_EFF...1,SET,186,0.078074,0.0078144,0.061186,0.10098,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_DN,0.863123085286301
GOMF_NUCLEOBASE_TRANSMEMBRAN...,SET,10,0.3381,0.0078844,0.26498,0.10099,GOMF_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.863123085286301
BLANCO_MELO_COVID19_SARS_COV...10,SET,133,0.097942,0.0083015,0.076762,0.101,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,0.863123085286301
TRAVAGLINI_LUNG_EREG_DENDRIT...,SET,526,0.050283,0.008384,0.039412,0.10101,TRAVAGLINI_LUNG_EREG_DENDRITIC_CELL,0.863123085286301
PRC2_SUZ12_UP.V1_DN,SET,168,0.084764,0.008067,0.066439,0.10102,PRC2_SUZ12_UP.V1_DN,0.863123085286301
GOBP_COLLAGEN_ACTIVATED_TYRO...,SET,9,0.37692,0.0083388,0.29552,0.10108,GOBP_COLLAGEN_ACTIVATED_TYROSINE_KINASE_RECEPTOR_SIGNALING_PATHWAY,0.863123085286301
MATZUK_CUMULUS_EXPANSION,SET,8,0.44928,0.0093715,0.35227,0.10109,MATZUK_CUMULUS_EXPANSION,0.863123085286301
GSE12484_HEALTHY_VS_PERIDONT...2,SET,121,0.10088,0.0081586,0.079112,0.10113,GSE12484_HEALTHY_VS_PERIDONTITIS_NEUTROPHILS_UP,0.863123085286301
GOBP_PURINE_DEOXYRIBONUCLEOT...3,SET,16,0.26928,0.0079417,0.21119,0.10115,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.863123085286301
GSE15324_ELF4_KO_VS_WT_ACTIV...2,SET,180,0.075207,0.0074062,0.058985,0.10116,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_UP,0.863123085286301
MANNO_MIDBRAIN_NEUROTYPES_HD...2,SET,450,0.055315,0.0085488,0.043387,0.10118,MANNO_MIDBRAIN_NEUROTYPES_HDA2,0.863123085286301
GOBP_TYPE_II_HYPERSENSITIVITY,SET,8,0.45365,0.0094627,0.35585,0.10119,GOBP_TYPE_II_HYPERSENSITIVITY,0.863123085286301
GOBP_RESPONSE_TO_YEAST,SET,6,0.49788,0.0089943,0.39057,0.10121,GOBP_RESPONSE_TO_YEAST,0.863123085286301
GSE17580_UNINFECTED_VS_S_MAN...4,SET,186,0.075751,0.0075818,0.059424,0.10121,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TREG_UP,0.863123085286301
GOMF_NEUROTRANSMITTER_TRANSM...,SET,20,0.25898,0.0085384,0.20317,0.10122,GOMF_NEUROTRANSMITTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.863123085286301
MODULE_532,SET,367,0.055972,0.00783,0.043912,0.10123,MODULE_532,0.863123085286301
HP_HAMARTOMA,SET,61,0.12929,0.0074359,0.10144,0.10126,HP_HAMARTOMA,0.863123085286301
GOBP_COLLAGEN_BIOSYNTHETIC_P...,SET,39,0.18891,0.008693,0.14825,0.1013,GOBP_COLLAGEN_BIOSYNTHETIC_PROCESS,0.863123085286301
chr1q22,SET,43,0.28105,0.013578,0.22059,0.10133,chr1q22,0.863123085286301
MIR8074,SET,17,0.2373,0.0072138,0.18626,0.10133,MIR8074,0.863123085286301
HP_ELEVATED_CREATINE_KINASE_...,SET,10,0.32091,0.0074834,0.25189,0.10134,HP_ELEVATED_CREATINE_KINASE_AFTER_EXERCISE,0.863123085286301
GSE2826_WT_VS_BTK_KO_BCELL_UP,SET,182,0.077591,0.0076829,0.060923,0.10141,GSE2826_WT_VS_BTK_KO_BCELL_UP,0.863123085286301
WP_TOLLLIKE_RECEPTOR_SIGNALI...2,SET,27,0.19524,0.0074776,0.1533,0.10142,WP_TOLLLIKE_RECEPTOR_SIGNALING_RELATED_TO_MYD88,0.863123085286301
GOBP_RESPONSE_TO_ACIDIC_PH,SET,25,0.21368,0.0078753,0.16778,0.10142,GOBP_RESPONSE_TO_ACIDIC_PH,0.863123085286301
GSE9960_HEALTHY_VS_GRAM_NEG_...3,SET,176,0.083622,0.0081438,0.065661,0.10142,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_DN,0.863123085286301
GOBP_NEGATIVE_REGULATION_OF_...64,SET,14,0.2598,0.0071675,0.20402,0.10145,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_IMPORT,0.863123085286301
GSE29949_DC_BRAIN_VS_MONOCYT...1,SET,179,0.082038,0.0080567,0.064433,0.10148,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,0.863123085286301
CHEBOTAEV_GR_TARGETS_DN,SET,109,0.10892,0.0083629,0.085547,0.10149,CHEBOTAEV_GR_TARGETS_DN,0.863123085286301
DAZARD_UV_RESPONSE_CLUSTER_G4,SET,17,0.26586,0.008082,0.20882,0.10149,DAZARD_UV_RESPONSE_CLUSTER_G4,0.863123085286301
GOBP_PEPTIDYL_ARGININE_METHY...2,SET,8,0.34751,0.0072487,0.27302,0.10155,GOBP_PEPTIDYL_ARGININE_METHYLATION_TO_ASYMMETRICAL_DIMETHYL_ARGININE,0.863123085286301
GOBP_POSITIVE_REGULATION_OF_...667,SET,50,0.15693,0.0081743,0.1233,0.10155,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.863123085286301
DORN_ADENOVIRUS_INFECTION_24...2,SET,11,0.30169,0.0073785,0.23706,0.10158,DORN_ADENOVIRUS_INFECTION_24HR_UP,0.863123085286301
GOBP_FILOPODIUM_ASSEMBLY,SET,60,0.15398,0.0087836,0.121,0.10159,GOBP_FILOPODIUM_ASSEMBLY,0.863123085286301
GOBP_SOMITOGENESIS,SET,59,0.14456,0.0081774,0.11359,0.10159,GOBP_SOMITOGENESIS,0.863123085286301
HP_LYMPHADENITIS,SET,13,0.28171,0.0074895,0.22137,0.10159,HP_LYMPHADENITIS,0.863123085286301
MIR92A_1_5P,SET,41,0.16859,0.0079537,0.13248,0.10161,MIR92A_1_5P,0.863123085286301
GOMF_POLYOL_TRANSMEMBRANE_TR...,SET,11,0.4026,0.0098463,0.31642,0.10163,GOMF_POLYOL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.863123085286301
REACTOME_VLDL_CLEARANCE,SET,6,0.45935,0.0082982,0.36104,0.10165,REACTOME_VLDL_CLEARANCE,0.863123085286301
WP_MINERALOCORTICOID_BIOSYNT...,SET,14,0.34214,0.0094392,0.26896,0.10168,WP_MINERALOCORTICOID_BIOSYNTHESIS,0.863123085286301
GOCC_CHROMATOID_BODY,SET,12,0.30414,0.007769,0.23909,0.10169,GOCC_CHROMATOID_BODY,0.863123085286301
HP_ACUTE_LEUKEMIA,SET,110,0.10034,0.0077396,0.078901,0.10174,HP_ACUTE_LEUKEMIA,0.863123085286301
TURASHVILI_BREAST_NORMAL_DUC...2,SET,57,0.13807,0.0076772,0.10857,0.10175,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_UP,0.863123085286301
MIR12131,SET,154,0.087327,0.0079602,0.068673,0.10176,MIR12131,0.863123085286301
GOMF_CYCLOSPORIN_A_BINDING,SET,17,0.22989,0.0069885,0.18079,0.10177,GOMF_CYCLOSPORIN_A_BINDING,0.863123085286301
HP_ABNORMAL_ALVEOLAR_RIDGE_M...,SET,38,0.16196,0.0073569,0.12738,0.10178,HP_ABNORMAL_ALVEOLAR_RIDGE_MORPHOLOGY,0.863123085286301
GOBP_LYMPHOCYTE_MIGRATION,SET,96,0.11485,0.0082788,0.090333,0.1018,GOBP_LYMPHOCYTE_MIGRATION,0.863123085286301
WP_TYROBP_CAUSAL_NETWORK_IN_...,SET,56,0.14866,0.0081935,0.11694,0.10183,WP_TYROBP_CAUSAL_NETWORK_IN_MICROGLIA,0.863123085286301
GSE6875_WT_VS_FOXP3_KO_TREG_...1,SET,179,0.080828,0.0079379,0.06359,0.10186,GSE6875_WT_VS_FOXP3_KO_TREG_DN,0.863123085286301
ZHAN_MULTIPLE_MYELOMA_CD1_AN...1,SET,51,0.15879,0.0083532,0.12493,0.10187,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_DN,0.863123085286301
GOBP_CELLULAR_RESPONSE_TO_ATP,SET,16,0.28355,0.0083627,0.22313,0.1019,GOBP_CELLULAR_RESPONSE_TO_ATP,0.863123085286301
HP_BENIGN_NEOPLASM_OF_THE_CE...,SET,100,0.099115,0.0072911,0.07799,0.1019,HP_BENIGN_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,0.863123085286301
HP_HEMIVERTEBRAE,SET,47,0.14509,0.0073278,0.11418,0.10192,HP_HEMIVERTEBRAE,0.863123085286301
HP_EASY_FATIGABILITY,SET,85,0.10677,0.0072444,0.084041,0.10196,HP_EASY_FATIGABILITY,0.863123085286301
HP_PANCREATIC_FIBROSIS,SET,21,0.201,0.0067903,0.15821,0.10198,HP_PANCREATIC_FIBROSIS,0.863123085286301
MIR16_1_3P,SET,173,0.0815,0.0078698,0.064175,0.10206,MIR16_1_3P,0.863123085286301
GSE3982_MAST_CELL_VS_TH1_UP,SET,180,0.080919,0.0079687,0.063717,0.10206,GSE3982_MAST_CELL_VS_TH1_UP,0.863123085286301
STONER_ESOPHAGEAL_CARCINOGEN...2,SET,31,0.18629,0.0076444,0.1467,0.10207,STONER_ESOPHAGEAL_CARCINOGENESIS_UP,0.863123085286301
GOMF_ALPHA_ACTININ_BINDING,SET,28,0.215,0.0083853,0.16932,0.10209,GOMF_ALPHA_ACTININ_BINDING,0.863123085286301
GOBP_NEGATIVE_REGULATION_OF_...119,SET,29,0.20261,0.0080419,0.15958,0.10211,GOBP_NEGATIVE_REGULATION_OF_CELL_KILLING,0.863123085286301
BCAT_BILD_ET_AL_DN,SET,42,0.16063,0.00767,0.12652,0.10212,BCAT_BILD_ET_AL_DN,0.863123085286301
GOBP_RESPONSE_TO_HUMAN_CHORI...,SET,5,0.57297,0.0094493,0.45136,0.10215,GOBP_RESPONSE_TO_HUMAN_CHORIONIC_GONADOTROPIN,0.863123085286301
GOBP_NEGATIVE_REGULATION_OF_...564,SET,39,0.16722,0.0076949,0.13173,0.10216,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.863123085286301
MIR1207_3P,SET,124,0.097616,0.007991,0.076918,0.10221,MIR1207_3P,0.863123085286301
KAAB_HEART_ATRIUM_VS_VENTRIC...2,SET,233,0.073215,0.0081912,0.057696,0.10223,KAAB_HEART_ATRIUM_VS_VENTRICLE_UP,0.863123085286301
GSE43863_NAIVE_VS_MEMORY_TFH...2,SET,179,0.080316,0.0078876,0.063291,0.10223,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_UP,0.863123085286301
GENTLES_LEUKEMIC_STEM_CELL_UP,SET,28,0.22283,0.0086907,0.17561,0.10225,GENTLES_LEUKEMIC_STEM_CELL_UP,0.863123085286301
GOBP_OOCYTE_DIFFERENTIATION,SET,60,0.13671,0.0077982,0.10774,0.10226,GOBP_OOCYTE_DIFFERENTIATION,0.863123085286301
GOMF_VOLTAGE_GATED_SODIUM_CH...1,SET,23,0.24589,0.0086931,0.19382,0.10229,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY,0.863123085286301
HP_HYPERCALCEMIA,SET,63,0.13677,0.007994,0.10782,0.10231,HP_HYPERCALCEMIA,0.863123085286301
MIR5588_3P,SET,41,0.1626,0.0076714,0.12821,0.10237,MIR5588_3P,0.863123085286301
HP_SKIN_VESICLE,SET,24,0.19425,0.007015,0.15319,0.1024,HP_SKIN_VESICLE,0.863123085286301
ZHU_CMV_ALL_DN,SET,109,0.10936,0.008397,0.086252,0.10242,ZHU_CMV_ALL_DN,0.863123085286301
GSE11864_CSF1_IFNG_VS_CSF1_P...2,SET,174,0.079548,0.0077033,0.062764,0.10251,GSE11864_CSF1_IFNG_VS_CSF1_PAM3CYS_IN_MAC_UP,0.863123085286301
BIOCARTA_IRES_PATHWAY,SET,7,0.36732,0.0071671,0.28982,0.10252,BIOCARTA_IRES_PATHWAY,0.863123085286301
HP_ABNORMAL_NASAL_SKELETON_M...,SET,11,0.37615,0.0091994,0.29679,0.10252,HP_ABNORMAL_NASAL_SKELETON_MORPHOLOGY,0.863123085286301
chr8q23,SET,16,0.47111,0.013894,0.37176,0.10255,chr8q23,0.863123085286301
HE_LIM_SUN_FETAL_LUNG_C5_PRO...,SET,407,0.05133,0.0075535,0.040509,0.10256,HE_LIM_SUN_FETAL_LUNG_C5_PRO_B_CELL,0.863123085286301
GOBP_REGULATION_OF_TAU_PROTE...,SET,4,0.52796,0.0077879,0.41667,0.10257,GOBP_REGULATION_OF_TAU_PROTEIN_KINASE_ACTIVITY,0.863123085286301
HP_HIPPOCAMPAL_ATROPHY,SET,5,0.48291,0.0079639,0.38113,0.10258,HP_HIPPOCAMPAL_ATROPHY,0.863123085286301
VETTER_TARGETS_OF_PRKCA_AND_...1,SET,16,0.28788,0.0084903,0.22723,0.1026,VETTER_TARGETS_OF_PRKCA_AND_ETS1_DN,0.863123085286301
PUIFFE_INVASION_INHIBITED_BY...1,SET,134,0.089009,0.0075725,0.070262,0.10262,PUIFFE_INVASION_INHIBITED_BY_ASCITES_DN,0.863123085286301
GOBP_CYTOKINE_PRODUCTION,SET,722,0.041734,0.0081076,0.032948,0.10265,GOBP_CYTOKINE_PRODUCTION,0.863123085286301
GSE5503_MLN_DC_VS_PLN_DC_ACT...1,SET,184,0.077738,0.0077392,0.061377,0.10266,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,0.863123085286301
GOBP_MAGNESIUM_ION_HOMEOSTAS...,SET,10,0.33396,0.0077879,0.2637,0.10269,GOBP_MAGNESIUM_ION_HOMEOSTASIS,0.863123085286301
GOBP_INTRACILIARY_TRANSPORT_...,SET,6,0.44752,0.0080846,0.35339,0.1027,GOBP_INTRACILIARY_TRANSPORT_INVOLVED_IN_CILIUM_ASSEMBLY,0.863123085286301
MIR548Q,SET,43,0.15746,0.0076073,0.12435,0.10273,MIR548Q,0.863123085286301
HP_ABNORMAL_SCAPULA_MORPHOLO...,SET,159,0.081955,0.0075897,0.064727,0.10274,HP_ABNORMAL_SCAPULA_MORPHOLOGY,0.863123085286301
GSE45365_NK_CELL_VS_CD8A_DC_...3,SET,154,0.087148,0.0079438,0.068828,0.10274,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_UP,0.863123085286301
REACTOME_PI3K_EVENTS_IN_ERBB...2,SET,10,0.35464,0.0082701,0.28013,0.10276,REACTOME_PI3K_EVENTS_IN_ERBB4_SIGNALING,0.863123085286301
HP_AXONAL_LOSS,SET,17,0.24577,0.0074711,0.19412,0.10276,HP_AXONAL_LOSS,0.863123085286301
GOBP_RESPONSE_TO_LEUKEMIA_IN...,SET,92,0.11662,0.0082303,0.092125,0.10278,GOBP_RESPONSE_TO_LEUKEMIA_INHIBITORY_FACTOR,0.863123085286301
GOBP_POSITIVE_REGULATION_OF_...847,SET,60,0.14911,0.0085055,0.11779,0.10279,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING,0.863123085286301
SMID_BREAST_CANCER_BASAL_UP,SET,588,0.046725,0.0082227,0.036922,0.10286,SMID_BREAST_CANCER_BASAL_UP,0.863502246376812
chr5q33,SET,63,0.2415,0.014115,0.19091,0.10294,chr5q33,0.863604020221473
HP_VASCULAR_NEOPLASM,SET,143,0.086575,0.0076068,0.068442,0.10295,HP_VASCULAR_NEOPLASM,0.863604020221473
HP_ABNORMAL_SYSTEMIC_ARTERIA...,SET,471,0.049352,0.0077986,0.03902,0.10298,HP_ABNORMAL_SYSTEMIC_ARTERIAL_MORPHOLOGY,0.863604020221473
MIR6828_3P,SET,107,0.10488,0.007979,0.082933,0.10301,MIR6828_3P,0.863604020221473
GOBP_REGULATION_OF_TERMINATI...,SET,5,0.48198,0.0079487,0.38127,0.1031,GOBP_REGULATION_OF_TERMINATION_OF_DNA_TEMPLATED_TRANSCRIPTION,0.863604020221473
GOBP_REGULATION_OF_PEROXISOM...,SET,14,0.32394,0.0089373,0.25627,0.10311,GOBP_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.863604020221473
CHEN_HOXA5_TARGETS_9HR_UP,SET,206,0.075325,0.0079298,0.059594,0.10313,CHEN_HOXA5_TARGETS_9HR_UP,0.863604020221473
GOBP_REGULATION_OF_COLLAGEN_...1,SET,8,0.39835,0.0083092,0.31516,0.10313,GOBP_REGULATION_OF_COLLAGEN_FIBRIL_ORGANIZATION,0.863604020221473
GOBP_INTESTINAL_HEXOSE_ABSOR...,SET,5,0.45009,0.0074228,0.35612,0.10315,GOBP_INTESTINAL_HEXOSE_ABSORPTION,0.863604020221473
GOBP_POSITIVE_REGULATION_OF_...236,SET,13,0.3259,0.0086644,0.25788,0.10317,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.863604020221473
GSE12845_IGD_POS_BLOOD_VS_DA...1,SET,174,0.076017,0.0073614,0.060154,0.10317,GSE12845_IGD_POS_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,0.863604020221473
GOMF_STRUCTURAL_CONSTITUENT_...12,SET,4,0.56558,0.0083429,0.44762,0.1032,GOMF_STRUCTURAL_CONSTITUENT_OF_TOOTH_ENAMEL,0.863604020221473
GSE22589_HEALTHY_VS_HIV_INFE...2,SET,188,0.072312,0.0072761,0.057232,0.10321,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_UP,0.863604020221473
BASSO_B_LYMPHOCYTE_NETWORK,SET,130,0.088254,0.0073961,0.069852,0.10322,BASSO_B_LYMPHOCYTE_NETWORK,0.863604020221473
SENESE_HDAC1_AND_HDAC2_TARGE...1,SET,203,0.077744,0.0081253,0.061546,0.10327,SENESE_HDAC1_AND_HDAC2_TARGETS_DN,0.863807946940727
GOBP_T_HELPER_1_TYPE_IMMUNE_...,SET,47,0.17055,0.0086136,0.13505,0.10333,GOBP_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.863807946940727
MODULE_317,SET,397,0.053646,0.0077988,0.042483,0.10334,MODULE_317,0.863807946940727
HP_ABNORMALITY_OF_MOUTH_SHAPE,SET,240,0.067713,0.0076871,0.053625,0.10336,HP_ABNORMALITY_OF_MOUTH_SHAPE,0.863807946940727
HALLMARK_OXIDATIVE_PHOSPHORY...,SET,169,0.076304,0.0072833,0.060441,0.1034,HALLMARK_OXIDATIVE_PHOSPHORYLATION,0.863807946940727
POMEROY_MEDULLOBLASTOMA_PROG...1,SET,40,0.16459,0.0076701,0.13038,0.10342,POMEROY_MEDULLOBLASTOMA_PROGNOSIS_DN,0.863807946940727
MODULE_514,SET,10,0.30525,0.0071182,0.24185,0.10346,MODULE_514,0.863807946940727
GSE37605_C57BL6_VS_NOD_FOXP3...6,SET,123,0.099361,0.0081012,0.078735,0.10349,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP,0.863807946940727
GSE24142_ADULT_VS_FETAL_DN2_...1,SET,170,0.083107,0.0079558,0.065863,0.10352,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_DN,0.863807946940727
GOBP_DENDRITIC_CELL_DIFFEREN...,SET,46,0.16814,0.0084011,0.13326,0.10353,GOBP_DENDRITIC_CELL_DIFFERENTIATION,0.863807946940727
MODULE_85,SET,47,0.16744,0.0084567,0.13272,0.10355,MODULE_85,0.863807946940727
GOBP_VIRAL_TRANSCRIPTION,SET,50,0.14354,0.0074767,0.11378,0.10356,GOBP_VIRAL_TRANSCRIPTION,0.863807946940727
GOBP_CELL_COMMUNICATION_BY_E...2,SET,26,0.22922,0.0086154,0.18176,0.10364,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.863807946940727
GOBP_RESPONSE_TO_GRAVITY,SET,8,0.3628,0.0075676,0.2877,0.10365,GOBP_RESPONSE_TO_GRAVITY,0.863807946940727
HP_SCLEROSIS_OF_HAND_BONE,SET,11,0.34921,0.0085406,0.27694,0.10367,HP_SCLEROSIS_OF_HAND_BONE,0.863807946940727
HP_ABNORMAL_CIRCULATING_SERI...1,SET,5,0.48574,0.0080106,0.38535,0.10375,HP_ABNORMAL_CIRCULATING_SERINE_CONCENTRATION,0.863807946940727
WP_BMP2WNT4FOXO1_PATHWAY_IN_...,SET,13,0.34662,0.0092154,0.27501,0.10377,WP_BMP2WNT4FOXO1_PATHWAY_IN_PRIMARY_ENDOMETRIAL_STROMAL_CELL_DIFFERENTIATION,0.863807946940727
GOMF_RNA_POLYMERASE_II_SPECI...,SET,318,0.059596,0.007771,0.047289,0.1038,GOMF_RNA_POLYMERASE_II_SPECIFIC_DNA_BINDING_TRANSCRIPTION_FACTOR_BINDING,0.863807946940727
GOBP_NEGATIVE_REGULATION_OF_...452,SET,7,0.38583,0.0075285,0.30617,0.10381,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,0.863807946940727
HSIAO_HOUSEKEEPING_GENES,SET,344,0.055051,0.0074607,0.043689,0.10383,HSIAO_HOUSEKEEPING_GENES,0.863807946940727
GOBP_NEGATIVE_REGULATION_OF_...188,SET,31,0.16915,0.006941,0.13424,0.10383,GOBP_NEGATIVE_REGULATION_OF_DNA_RECOMBINATION,0.863807946940727
GSE25088_ROSIGLITAZONE_VS_IL...1,SET,181,0.076381,0.0075425,0.060617,0.10383,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.863807946940727
MIR6818_3P,SET,108,0.10787,0.0082448,0.085618,0.10386,MIR6818_3P,0.863807946940727
HP_HYPERKERATOTIC_PAPULE,SET,12,0.26321,0.0067235,0.20893,0.10387,HP_HYPERKERATOTIC_PAPULE,0.863807946940727
HP_DECREASED_PATELLAR_REFLEX,SET,9,0.35011,0.0077457,0.27795,0.10391,HP_DECREASED_PATELLAR_REFLEX,0.863807946940727
HP_HYPERMETROPIA,SET,240,0.069089,0.0078433,0.054852,0.10392,HP_HYPERMETROPIA,0.863807946940727
GSE37301_LYMPHOID_PRIMED_MPP...10,SET,185,0.074742,0.007461,0.059342,0.10393,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_UP,0.863807946940727
GSE26343_UNSTIM_VS_LPS_STIM_...2,SET,191,0.078277,0.0079382,0.062155,0.10395,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.863807946940727
HP_CHORIOCAPILLARIS_ATROPHY,SET,8,0.38187,0.0079654,0.30326,0.10398,HP_CHORIOCAPILLARIS_ATROPHY,0.863807946940727
GSE9946_IMMATURE_VS_MATURE_S...2,SET,124,0.091005,0.0074498,0.072272,0.10399,GSE9946_IMMATURE_VS_MATURE_STIMULATORY_DC_UP,0.863807946940727
GOBP_MRNA_CIS_SPLICING_VIA_S...,SET,26,0.19371,0.0072806,0.15388,0.10406,GOBP_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.864064045346062
GOBP_SERINE_FAMILY_AMINO_ACI...3,SET,29,0.18732,0.0074349,0.14885,0.10412,GOBP_SERINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.864064045346062
HP_WADDLING_GAIT,SET,116,0.097527,0.0077235,0.077508,0.10415,HP_WADDLING_GAIT,0.864064045346062
HP_PAROXYSMAL_INVOLUNTARY_EY...,SET,30,0.17691,0.0071417,0.1406,0.10416,HP_PAROXYSMAL_INVOLUNTARY_EYE_MOVEMENTS,0.864064045346062
MIR4433A_3P,SET,53,0.13791,0.0073949,0.10961,0.10417,MIR4433A_3P,0.864064045346062
HP_STREAK_OVARY,SET,31,0.18632,0.0076456,0.14809,0.10417,HP_STREAK_OVARY,0.864064045346062
LAKE_ADULT_KIDNEY_C7_PROXIMA...,SET,129,0.097419,0.008133,0.077454,0.10424,LAKE_ADULT_KIDNEY_C7_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S3,0.864438367931281
VECCHI_GASTRIC_CANCER_EARLY_...2,SET,386,0.05399,0.0077418,0.042953,0.10439,VECCHI_GASTRIC_CANCER_EARLY_UP,0.865120349929544
MYLLYKANGAS_AMPLIFICATION_HO...19,SET,7,0.40716,0.0079446,0.32401,0.10445,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_9,0.865120349929544
KEGG_MEDICUS_REFERENCE_LEWIS...,SET,5,0.55038,0.0090767,0.43803,0.10448,KEGG_MEDICUS_REFERENCE_LEWIS_X_ANTIGEN_BIOSYNTHESIS,0.865120349929544
GOLDRATH_NAIVE_VS_EFF_CD8_TC...2,SET,181,0.075545,0.0074599,0.060123,0.10448,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_UP,0.865120349929544
GOBP_EMBRYONIC_FORELIMB_MORP...,SET,32,0.20782,0.0086643,0.16543,0.10452,GOBP_EMBRYONIC_FORELIMB_MORPHOGENESIS,0.865120349929544
LA_MEN1_TARGETS,SET,21,0.25166,0.0085019,0.20035,0.10455,LA_MEN1_TARGETS,0.865120349929544
RIZ_ERYTHROID_DIFFERENTIATION,SET,74,0.12102,0.0076635,0.096352,0.10457,RIZ_ERYTHROID_DIFFERENTIATION,0.865120349929544
GOCC_EARLY_ENDOSOME_MEMBRANE,SET,175,0.077831,0.0075585,0.061989,0.10465,GOCC_EARLY_ENDOSOME_MEMBRANE,0.865120349929544
GSE360_L_DONOVANI_VS_B_MALAY...2,SET,173,0.08291,0.008006,0.066042,0.10467,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_UP,0.865120349929544
GSE25088_WT_VS_STAT6_KO_MACR...3,SET,176,0.077563,0.0075537,0.061789,0.10469,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_UP,0.865120349929544
BLANCO_MELO_RESPIRATORY_SYNC...2,SET,272,0.069493,0.0083913,0.055364,0.10471,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_UP,0.865120349929544
MIR1185_5P,SET,54,0.1452,0.007859,0.11568,0.10471,MIR1185_5P,0.865120349929544
GOMF_NEUTRAL_L_AMINO_ACID_SO...,SET,8,0.42521,0.0088694,0.3389,0.1048,GOMF_NEUTRAL_L_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.865120349929544
GOMF_TRANSCRIPTION_COACTIVAT...2,SET,40,0.17813,0.0083012,0.142,0.10484,GOMF_TRANSCRIPTION_COACTIVATOR_BINDING,0.865120349929544
HP_RECURRENT_KLEBSIELLA_INFE...,SET,4,0.61541,0.0090779,0.49057,0.10484,HP_RECURRENT_KLEBSIELLA_INFECTIONS,0.865120349929544
GSE19941_IL10_KO_VS_IL10_KO_...1,SET,150,0.082061,0.0073831,0.065416,0.10485,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.865120349929544
GSE16522_MEMORY_VS_NAIVE_ANT...1,SET,183,0.077414,0.0076862,0.06172,0.10488,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_DN,0.865120349929544
GSE7219_WT_VS_NIK_NFKB2_KO_D...1,SET,158,0.085947,0.0079346,0.06854,0.10493,GSE7219_WT_VS_NIK_NFKB2_KO_DC_DN,0.865120349929544
GOMF_NAADP_SENSITIVE_CALCIUM...,SET,5,0.47056,0.0077603,0.37534,0.10498,GOMF_NAADP_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.865120349929544
HP_POSTERIOR_RIB_CUPPING,SET,4,0.53499,0.0078916,0.42674,0.10499,HP_POSTERIOR_RIB_CUPPING,0.865120349929544
GAVISH_3CA_MALIGNANT_METAPRO...13,SET,48,0.15953,0.0081422,0.12726,0.105,GAVISH_3CA_MALIGNANT_METAPROGRAM_22_SECRETED_1,0.865120349929544
VANGURP_PANCREATIC_BETA_CELL,SET,107,0.10738,0.0081693,0.085656,0.105,VANGURP_PANCREATIC_BETA_CELL,0.865120349929544
AP1_Q6,SET,233,0.070707,0.0079106,0.05641,0.10503,AP1_Q6,0.865120349929544
BIOCARTA_NOS1_PATHWAY,SET,21,0.23176,0.0078297,0.18492,0.10506,BIOCARTA_NOS1_PATHWAY,0.865120349929544
HP_WIDE_FEMORAL_METAPHYSIS,SET,6,0.3918,0.007078,0.31262,0.10506,HP_WIDE_FEMORAL_METAPHYSIS,0.865120349929544
GSE41867_LCMV_ARMSTRONG_VS_C...6,SET,174,0.079383,0.0076874,0.063344,0.10507,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_UP,0.865120349929544
GOCC_RIBONUCLEASE_P_COMPLEX,SET,10,0.3156,0.0073596,0.25186,0.1051,GOCC_RIBONUCLEASE_P_COMPLEX,0.865120349929544
MIR339_3P,SET,6,0.41021,0.0074106,0.32739,0.10511,MIR339_3P,0.865120349929544
GOBP_KERATINOCYTE_DEVELOPMENT,SET,13,0.3159,0.0083987,0.25213,0.10512,GOBP_KERATINOCYTE_DEVELOPMENT,0.865120349929544
HP_DIAPHRAGMATIC_PARALYSIS,SET,6,0.4499,0.0081276,0.3591,0.10514,HP_DIAPHRAGMATIC_PARALYSIS,0.865120349929544
BIOCARTA_CREB_PATHWAY,SET,22,0.23399,0.0080906,0.18678,0.10516,BIOCARTA_CREB_PATHWAY,0.865120349929544
GOBP_NEGATIVE_REGULATION_OF_...44,SET,4,0.44466,0.0065592,0.35496,0.10516,GOBP_NEGATIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,0.865120349929544
GSE14769_UNSTIM_VS_20MIN_LPS...1,SET,183,0.077326,0.0076774,0.061725,0.10516,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_DN,0.865120349929544
GOMF_UBIQUITIN_LIGASE_ACTIVA...,SET,9,0.34553,0.0076444,0.27592,0.10524,GOMF_UBIQUITIN_LIGASE_ACTIVATOR_ACTIVITY,0.865120349929544
GSE32986_CURDLAN_LOWDOSE_VS_...3,SET,181,0.074341,0.007341,0.05937,0.10526,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,0.865120349929544
HP_DECREASED_ACTIVITY_OF_MIT...2,SET,86,0.10116,0.0069037,0.080792,0.10527,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_I,0.865120349929544
KEGG_MEDICUS_REFERENCE_PKA_H...,SET,7,0.38242,0.0074619,0.30549,0.10532,KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME,0.865120349929544
GOCC_CAMP_DEPENDENT_PROTEIN_...,SET,7,0.38242,0.0074619,0.30549,0.10532,GOCC_CAMP_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.865120349929544
HP_PERITONITIS,SET,41,0.16603,0.0078333,0.13267,0.10538,HP_PERITONITIS,0.865120349929544
LEE_EARLY_T_LYMPHOCYTE_UP,SET,95,0.10939,0.007844,0.087411,0.1054,LEE_EARLY_T_LYMPHOCYTE_UP,0.865120349929544
HP_MONOCHROMACY,SET,8,0.39187,0.008174,0.31315,0.1054,HP_MONOCHROMACY,0.865120349929544
HP_TEMPORAL_CORTICAL_ATROPHY,SET,17,0.2521,0.0076637,0.20145,0.1054,HP_TEMPORAL_CORTICAL_ATROPHY,0.865120349929544
HP_HERNIA,SET,500,0.047815,0.0077785,0.038214,0.10543,HP_HERNIA,0.865120349929544
GSE32164_RESTING_DIFFERENTIA...2,SET,186,0.077129,0.0077198,0.061662,0.1055,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_UP,0.865120349929544
TONKS_TARGETS_OF_RUNX1_RUNX1...13,SET,21,0.24812,0.0083822,0.19838,0.10552,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_UP,0.865120349929544
HP_ABNORMAL_PLATELET_MEMBRAN...,SET,6,0.44334,0.008009,0.35448,0.10554,HP_ABNORMAL_PLATELET_MEMBRANE_PROTEIN_EXPRESSION,0.865120349929544
HP_CHONDROSARCOMA,SET,7,0.4647,0.0090673,0.37157,0.10554,HP_CHONDROSARCOMA,0.865120349929544
GSE2585_CTEC_VS_THYMIC_DC_DN,SET,188,0.078791,0.0079279,0.063003,0.10555,GSE2585_CTEC_VS_THYMIC_DC_DN,0.865120349929544
GSE3982_MEMORY_CD4_TCELL_VS_...3,SET,186,0.074681,0.0074748,0.059722,0.10557,GSE3982_MEMORY_CD4_TCELL_VS_TH1_DN,0.865120349929544
GOBP_NUCLEAR_MRNA_SURVEILLAN...,SET,10,0.27543,0.0064228,0.22027,0.10558,GOBP_NUCLEAR_MRNA_SURVEILLANCE,0.865120349929544
GSE3039_NKT_CELL_VS_B1_BCELL...1,SET,173,0.081576,0.0078772,0.065247,0.10561,GSE3039_NKT_CELL_VS_B1_BCELL_DN,0.865120349929544
HP_ABNORMAL_MITRAL_VALVE_PHY...,SET,151,0.087188,0.0078704,0.06974,0.10562,HP_ABNORMAL_MITRAL_VALVE_PHYSIOLOGY,0.865120349929544
WP_EICOSANOID_SYNTHESIS,SET,22,0.24792,0.0085725,0.19833,0.10565,WP_EICOSANOID_SYNTHESIS,0.865120349929544
ZNF33A_TARGET_GENES,SET,175,0.078137,0.0075882,0.062524,0.10571,ZNF33A_TARGET_GENES,0.865120349929544
GOBP_CHONDROITIN_SULFATE_PRO...2,SET,29,0.19267,0.0076472,0.15418,0.10572,GOBP_CHONDROITIN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.865120349929544
ZNF322_TARGET_GENES,SET,715,0.038787,0.0075,0.031042,0.10575,ZNF322_TARGET_GENES,0.865120349929544
HP_AGITATION,SET,96,0.10792,0.007779,0.086372,0.10576,HP_AGITATION,0.865120349929544
GOBP_CALCIUM_IMPORT_INTO_THE...,SET,14,0.28609,0.0078929,0.22899,0.10578,GOBP_CALCIUM_IMPORT_INTO_THE_MITOCHONDRION,0.865120349929544
GOMF_STEROID_DEHYDROGENASE_A...1,SET,36,0.18363,0.0081192,0.147,0.10581,GOMF_STEROID_DEHYDROGENASE_ACTIVITY,0.865120349929544
MIR1245A,SET,34,0.1947,0.0083665,0.15588,0.10584,MIR1245A,0.865120349929544
MORF_THRA,SET,46,0.16332,0.0081602,0.13077,0.10587,MORF_THRA,0.865120349929544
GOCC_MIDBODY,SET,186,0.072538,0.0072602,0.058105,0.10595,GOCC_MIDBODY,0.865120349929544
GOBP_POSITIVE_REGULATION_OF_...579,SET,9,0.41625,0.009209,0.33345,0.10596,GOBP_POSITIVE_REGULATION_OF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,0.865120349929544
GSE15750_WT_VS_TRAF6KO_DAY10...1,SET,180,0.083016,0.0081752,0.066505,0.10597,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN,0.865120349929544
GOMF_SALT_TRANSMEMBRANE_TRAN...,SET,9,0.30307,0.0067049,0.2428,0.10598,GOMF_SALT_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.865120349929544
MIR708_5P,SET,44,0.15817,0.00773,0.12672,0.10599,MIR708_5P,0.865120349929544
GOCC_CYTOPLASMIC_SIDE_OF_END...2,SET,6,0.34179,0.0061746,0.27383,0.10599,GOCC_CYTOPLASMIC_SIDE_OF_ENDOSOME_MEMBRANE,0.865120349929544
TENEDINI_MEGAKARYOCYTE_MARKE...,SET,60,0.14161,0.0080779,0.11348,0.10604,TENEDINI_MEGAKARYOCYTE_MARKERS,0.865122112676056
DIDO1_TARGET_GENES,SET,1311,0.029487,0.0075894,0.02363,0.10604,DIDO1_TARGET_GENES,0.865122112676056
HP_SEVERE_FAILURE_TO_THRIVE,SET,16,0.26933,0.0079433,0.21591,0.10613,HP_SEVERE_FAILURE_TO_THRIVE,0.865653168270359
WANG_ESOPHAGUS_CANCER_VS_NOR...2,SET,114,0.10393,0.0081595,0.083331,0.10618,WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP,0.865857789770061
MOOTHA_TCA,SET,14,0.25664,0.0070806,0.20588,0.10629,MOOTHA_TCA,0.866190273876404
HP_DECREASED_COMPOUND_MUSCLE...,SET,13,0.28664,0.0076206,0.22998,0.10633,HP_DECREASED_COMPOUND_MUSCLE_ACTION_POTENTIAL_AMPLITUDE,0.866190273876404
GSE19888_ADENOSINE_A3R_ACT_V...6,SET,178,0.080476,0.0078814,0.064576,0.10635,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_UP,0.866190273876404
JIANG_MELANOMA_TRM4,SET,186,0.08092,0.0080992,0.064935,0.10636,JIANG_MELANOMA_TRM4,0.866190273876404
REACTOME_CILIUM_ASSEMBLY,SET,182,0.07372,0.0072996,0.059175,0.10643,REACTOME_CILIUM_ASSEMBLY,0.866190273876404
HALLMARK_REACTIVE_OXYGEN_SPE...,SET,45,0.16225,0.0080188,0.13025,0.10643,HALLMARK_REACTIVE_OXYGEN_SPECIES_PATHWAY,0.866190273876404
GOBP_POSITIVE_REGULATION_OF_...719,SET,5,0.46284,0.0076329,0.37153,0.10644,GOBP_POSITIVE_REGULATION_OF_SODIUM_PROTON_ANTIPORTER_ACTIVITY,0.866190273876404
BIOCARTA_MONOCYTE_PATHWAY,SET,11,0.36608,0.0089532,0.2939,0.10647,BIOCARTA_MONOCYTE_PATHWAY,0.866190273876404
HP_RECURRENT_HAND_FLAPPING,SET,24,0.20486,0.0073981,0.16447,0.10647,HP_RECURRENT_HAND_FLAPPING,0.866190273876404
GSE37533_PPARG1_FOXP3_VS_FOX...1,SET,189,0.07837,0.0079063,0.062919,0.10647,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.866190273876404
HP_OSTEOPOROSIS,SET,281,0.063936,0.0078449,0.051353,0.10657,HP_OSTEOPOROSIS,0.86680092440908
MIR608,SET,196,0.077887,0.0080003,0.062567,0.1066,MIR608,0.866842068320075
VANDESLUIS_COMMD1_TARGETS_GR...1,SET,15,0.27642,0.0078936,0.22207,0.10663,VANDESLUIS_COMMD1_TARGETS_GROUP_2_UP,0.866883192982456
TESAR_ALK_AND_JAK_TARGETS_MO...2,SET,4,0.51889,0.0076541,0.41699,0.10669,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_UP,0.867168136108513
KEGG_MEDICUS_VARIANT_MUTATIO...89,SET,9,0.29917,0.0066187,0.24054,0.10681,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_TP53_TO_TRANSCRIPTION,0.867536709451575
HP_ENDOCARDITIS,SET,14,0.29531,0.0081475,0.23744,0.10681,HP_ENDOCARDITIS,0.867536709451575
GOBP_ATRIAL_CARDIAC_MUSCLE_C...2,SET,16,0.28952,0.0085386,0.23286,0.10689,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_TO_AV_NODE_CELL_COMMUNICATION,0.867536709451575
CASORELLI_APL_SECONDARY_VS_D...,SET,34,0.19209,0.0082545,0.15451,0.1069,CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP,0.867536709451575
SABATES_COLORECTAL_ADENOMA_UP,SET,127,0.10507,0.0087042,0.084516,0.1069,SABATES_COLORECTAL_ADENOMA_UP,0.867536709451575
HP_URETERAL_OBSTRUCTION,SET,34,0.172,0.0073911,0.13836,0.10692,HP_URETERAL_OBSTRUCTION,0.867536709451575
GOBP_REGULATION_OF_ESTABLISH...6,SET,22,0.22225,0.0076847,0.17879,0.10693,GOBP_REGULATION_OF_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,0.867536709451575
GSE17721_PAM3CSK4_VS_GADIQUI...2,SET,186,0.075959,0.0076027,0.061112,0.10695,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_UP,0.867536709451575
HP_CAROTID_ARTERY_STENOSIS,SET,6,0.41886,0.0075669,0.337,0.10696,HP_CAROTID_ARTERY_STENOSIS,0.867536709451575
GOCC_ORGANELLAR_RIBOSOME,SET,85,0.1046,0.0070971,0.084179,0.10702,GOCC_ORGANELLAR_RIBOSOME,0.867740275186567
GOBP_POSITIVE_REGULATION_OF_...418,SET,8,0.36651,0.0076449,0.29499,0.10704,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_NEURONAL_SYNAPTIC_PLASTICITY,0.867740275186567
GOBP_CELL_CELL_JUNCTION_MAIN...,SET,15,0.29846,0.0085232,0.24024,0.10706,GOBP_CELL_CELL_JUNCTION_MAINTENANCE,0.867740275186567
GSE41867_DAY6_VS_DAY8_LCMV_A...1,SET,187,0.072473,0.007273,0.058353,0.10713,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.867742915309446
HP_ABNORMALITY_OF_THE_ABDOMI...2,SET,467,0.048806,0.0076804,0.039299,0.10714,HP_ABNORMALITY_OF_THE_ABDOMINAL_WALL,0.867742915309446
MIR2681_3P,SET,33,0.17349,0.0073446,0.13972,0.10719,MIR2681_3P,0.867742915309446
HP_LEFT_ANTERIOR_FASCICULAR_...,SET,7,0.4389,0.008564,0.35348,0.10719,HP_LEFT_ANTERIOR_FASCICULAR_BLOCK,0.867742915309446
TIEN_INTESTINE_PROBIOTICS_24...2,SET,514,0.044227,0.007292,0.03562,0.1072,TIEN_INTESTINE_PROBIOTICS_24HR_UP,0.867742915309446
GSE17721_CTRL_VS_CPG_0.5H_BM...2,SET,184,0.076956,0.0076613,0.061987,0.10722,GSE17721_CTRL_VS_CPG_0.5H_BMDC_UP,0.867742915309446
GSE43955_1H_VS_60H_ACT_CD4_T...3,SET,185,0.079542,0.00794,0.064076,0.10724,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.867742915309446
HP_HIGH_FREQUENCY_SENSORINEU...,SET,6,0.40233,0.0072682,0.32414,0.10727,HP_HIGH_FREQUENCY_SENSORINEURAL_HEARING_IMPAIRMENT,0.867742915309446
GSE14769_20MIN_VS_360MIN_LPS...1,SET,178,0.078505,0.0076883,0.063253,0.10729,GSE14769_20MIN_VS_360MIN_LPS_BMDM_DN,0.867742915309446
GSE17721_LPS_VS_POLYIC_6H_BM...1,SET,178,0.078249,0.0076633,0.063052,0.10731,GSE17721_LPS_VS_POLYIC_6H_BMDC_DN,0.867742915309446
REACTOME_NECTIN_NECL_TRANS_H...,SET,3,0.65762,0.0084012,0.53012,0.1074,REACTOME_NECTIN_NECL_TRANS_HETERODIMERIZATION,0.867865853658537
GSE22432_PDC_VS_TGFB1_TREATE...1,SET,176,0.081398,0.0079272,0.065621,0.10742,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_DN,0.867865853658537
GSE37534_UNTREATED_VS_ROSIGL...2,SET,178,0.077224,0.0075629,0.062255,0.10742,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.867865853658537
LI_PBMC_MENOMUNE_A_C_Y_W_135...1,SET,16,0.28035,0.0082681,0.22604,0.10745,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_DN,0.867865853658537
HP_CARDIAC_CONDUCTION_ABNORM...,SET,127,0.093013,0.0077051,0.075003,0.10747,HP_CARDIAC_CONDUCTION_ABNORMALITY,0.867865853658537
LEE_LIVER_CANCER_CIPROFIBRAT...1,SET,63,0.14401,0.0084168,0.11613,0.10749,LEE_LIVER_CANCER_CIPROFIBRATE_DN,0.867865853658537
MENON_FETAL_KIDNEY_8_CONNECT...,SET,223,0.069909,0.0076538,0.056379,0.1075,MENON_FETAL_KIDNEY_8_CONNECTING_TUBULE_CELLS,0.867865853658537
GAUTAM_EYE_IRIS_CILIARY_BODY...13,SET,256,0.065929,0.0077267,0.053189,0.10758,GAUTAM_EYE_IRIS_CILIARY_BODY_PUTATIVE_STEM_CELLS,0.868310009289364
GOBP_CALCIUM_ION_TRANSMEMBRA...1,SET,172,0.083574,0.008047,0.067452,0.10768,GOBP_CALCIUM_ION_TRANSMEMBRANE_IMPORT_INTO_CYTOSOL,0.868915328382455
GOCC_MITOCHONDRIA_ASSOCIATED...,SET,19,0.22896,0.0073578,0.18481,0.10771,GOCC_MITOCHONDRIA_ASSOCIATED_ENDOPLASMIC_RETICULUM_MEMBRANE_CONTACT_SITE,0.868915328382455
MODULE_130,SET,18,0.27167,0.0084978,0.21932,0.10773,MODULE_130,0.868915328382455
GSE3039_NKT_CELL_VS_ALPHABET...1,SET,174,0.078466,0.0075986,0.063379,0.10786,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_DN,0.869519805194805
LEIN_NEURON_MARKERS,SET,57,0.14178,0.0078834,0.11452,0.10787,LEIN_NEURON_MARKERS,0.869519805194805
GSE40666_NAIVE_VS_EFFECTOR_C...4,SET,187,0.078123,0.00784,0.063108,0.10788,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,0.869519805194805
GOBP_ADHESION_OF_SYMBIONT_TO...1,SET,12,0.35702,0.0091198,0.28847,0.10793,GOBP_ADHESION_OF_SYMBIONT_TO_HOST,0.869721110595873
GSE11818_WT_VS_DICER_KO_TREG...1,SET,143,0.083277,0.0073171,0.067306,0.108,GSE11818_WT_VS_DICER_KO_TREG_DN,0.869792755453502
GOBP_MITOCHONDRIAL_CALCIUM_I...2,SET,20,0.24916,0.0082149,0.20146,0.10809,GOBP_MITOCHONDRIAL_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.869792755453502
GSE5960_TH1_VS_ANERGIC_TH1_DN,SET,185,0.074889,0.0074756,0.060568,0.10815,GSE5960_TH1_VS_ANERGIC_TH1_DN,0.869792755453502
MIR1284,SET,214,0.073343,0.0078679,0.059321,0.10817,MIR1284,0.869792755453502
ZWANG_CLASS_3_TRANSIENTLY_IN...,SET,206,0.078308,0.0082439,0.063342,0.10819,ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF,0.869792755453502
GOBP_POSITIVE_REGULATION_OF_...810,SET,8,0.36964,0.0077103,0.29902,0.1082,GOBP_POSITIVE_REGULATION_OF_T_HELPER_17_CELL_LINEAGE_COMMITMENT,0.869792755453502
MIR4722_3P,SET,79,0.11904,0.0077876,0.096302,0.10822,MIR4722_3P,0.869792755453502
MIR6779_3P,SET,64,0.13021,0.0076705,0.10536,0.10825,MIR6779_3P,0.869792755453502
GOBP_RESPONSE_TO_MUSCLE_STRE...,SET,24,0.21416,0.0077339,0.1733,0.10828,GOBP_RESPONSE_TO_MUSCLE_STRETCH,0.869792755453502
MIR7111_5P,SET,189,0.073551,0.0074202,0.059525,0.10831,MIR7111_5P,0.869792755453502
HP_BRANCHIAL_FISTULA,SET,9,0.37391,0.0082722,0.30263,0.10832,HP_BRANCHIAL_FISTULA,0.869792755453502
GOMF_PROTEIN_DISULFIDE_REDUC...,SET,7,0.35752,0.006976,0.28939,0.10835,GOMF_PROTEIN_DISULFIDE_REDUCTASE_NAD_P_H_ACTIVITY,0.869792755453502
GOCC_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.50829,0.0064934,0.41145,0.10836,GOCC_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_COMPLEX,0.869792755453502
GOMF_RIBOSE_PHOSPHATE_DIPHOS...,SET,3,0.50829,0.0064934,0.41145,0.10836,GOMF_RIBOSE_PHOSPHATE_DIPHOSPHOKINASE_ACTIVITY,0.869792755453502
KEGG_MEDICUS_REFERENCE_DOUBL...1,SET,4,0.48932,0.007218,0.39617,0.1084,KEGG_MEDICUS_REFERENCE_DOUBLE_HOLLIDAY_JUNCTION_RESOLUTION,0.869792755453502
MIR519D_5P,SET,220,0.069083,0.0075129,0.055936,0.10842,MIR519D_5P,0.869792755453502
ZF5_01,SET,226,0.06863,0.0075634,0.055583,0.10847,ZF5_01,0.869792755453502
GSE15330_MEGAKARYOCYTE_ERYTH...6,SET,165,0.083878,0.0079117,0.06794,0.1085,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.869792755453502
ABE_VEGFA_TARGETS,SET,15,0.29004,0.0082825,0.23494,0.10851,ABE_VEGFA_TARGETS,0.869792755453502
GSE369_SOCS3_KO_VS_WT_LIVER_...3,SET,187,0.073853,0.0074115,0.059822,0.10851,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_UP,0.869792755453502
GOBP_CARDIAC_NEURAL_CREST_CE...1,SET,12,0.35203,0.0089922,0.28516,0.10852,GOBP_CARDIAC_NEURAL_CREST_CELL_DEVELOPMENT_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,0.869792755453502
KEGG_MEDICUS_PATHOGEN_SHIGEL...9,SET,7,0.371,0.0072391,0.30057,0.10855,KEGG_MEDICUS_PATHOGEN_SHIGELLA_OSPG_TO_TNF_NFKB_SIGNALING_PATHWAY,0.869792755453502
REACTOME_NEGATIVE_REGULATORS...,SET,32,0.18542,0.0077302,0.15024,0.10857,REACTOME_NEGATIVE_REGULATORS_OF_DDX58_IFIH1_SIGNALING,0.869792755453502
GOCC_H3_HISTONE_ACETYLTRANSF...,SET,8,0.36965,0.0077104,0.29951,0.10858,GOCC_H3_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.869792755453502
REACTOME_HOMOLOGY_DIRECTED_R...,SET,96,0.096568,0.006961,0.078257,0.10861,REACTOME_HOMOLOGY_DIRECTED_REPAIR,0.869792755453502
GSE46606_UNSTIM_VS_CD40L_IL2...5,SET,163,0.079401,0.0074443,0.064358,0.10866,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_DN,0.869792755453502
MIR4756_3P,SET,106,0.10167,0.0076986,0.082439,0.10875,MIR4756_3P,0.869792755453502
GOBP_SNRNA_METABOLIC_PROCESS,SET,50,0.13301,0.0069284,0.10787,0.10877,GOBP_SNRNA_METABOLIC_PROCESS,0.869792755453502
CONRAD_GERMLINE_STEM_CELL,SET,8,0.32881,0.0068585,0.26668,0.1088,CONRAD_GERMLINE_STEM_CELL,0.869792755453502
GOBP_REGULATION_OF_CELL_PROJ...2,SET,615,0.043382,0.0078018,0.035186,0.10881,GOBP_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,0.869792755453502
REACTOME_DNA_DAMAGE_BYPASS,SET,44,0.13831,0.0067592,0.11218,0.10882,REACTOME_DNA_DAMAGE_BYPASS,0.869792755453502
MIR6740_5P,SET,58,0.13505,0.0075749,0.10955,0.10882,MIR6740_5P,0.869792755453502
REACTOME_SIGNALING_BY_ACTIVIN,SET,16,0.26347,0.0077704,0.21371,0.10883,REACTOME_SIGNALING_BY_ACTIVIN,0.869792755453502
PPARA_01,SET,31,0.1885,0.0077349,0.1529,0.10883,PPARA_01,0.869792755453502
HP_DERMATOLOGICAL_MANIFESTAT...,SET,301,0.060087,0.0076264,0.048749,0.10887,HP_DERMATOLOGICAL_MANIFESTATIONS_OF_SYSTEMIC_DISORDERS,0.869792755453502
BRACHAT_RESPONSE_TO_CAMPTOTH...1,SET,39,0.1629,0.0074959,0.13216,0.10888,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_DN,0.869792755453502
LIANG_SILENCED_BY_METHYLATIO...2,SET,9,0.35447,0.007842,0.28758,0.10888,LIANG_SILENCED_BY_METHYLATION_DN,0.869792755453502
HP_RENAL_DUPLICATION,SET,31,0.19954,0.0081882,0.16193,0.10894,HP_RENAL_DUPLICATION,0.869792755453502
HP_PILI_TORTI,SET,12,0.29846,0.0076237,0.24223,0.10896,HP_PILI_TORTI,0.869792755453502
GOBP_POST_EMBRYONIC_CAMERA_T...,SET,8,0.41818,0.0087227,0.33944,0.10899,GOBP_POST_EMBRYONIC_CAMERA_TYPE_EYE_DEVELOPMENT,0.869792755453502
GOBP_REGULATION_OF_STEM_CELL...1,SET,80,0.11459,0.0075439,0.093018,0.10899,GOBP_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.869792755453502
HP_SLENDER_TOE,SET,4,0.52431,0.0077341,0.42559,0.10899,HP_SLENDER_TOE,0.869792755453502
GOMF_OXYGEN_CARRIER_ACTIVITY,SET,10,0.40314,0.0094011,0.32729,0.10903,GOMF_OXYGEN_CARRIER_ACTIVITY,0.869912224517906
GOBP_LOCOMOTION_INVOLVED_IN_...,SET,11,0.31645,0.0077395,0.25698,0.10909,GOBP_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,0.87006905634448
HP_FAILURE_OF_ERUPTION_OF_PE...,SET,5,0.5207,0.0085872,0.42288,0.10911,HP_FAILURE_OF_ERUPTION_OF_PERMANENT_TEETH,0.87006905634448
GOBP_HEART_VALVE_FORMATION,SET,15,0.29645,0.0084655,0.24079,0.10914,GOBP_HEART_VALVE_FORMATION,0.87006905634448
GOMF_PHOSPHATIDYLINOSITOL_PH...2,SET,12,0.25396,0.0064872,0.20635,0.10922,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.87006905634448
GOBP_GANGLIOSIDE_BIOSYNTHETI...1,SET,17,0.26968,0.008198,0.21917,0.10927,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS,0.87006905634448
GOBP_REGULATION_OF_CARDIAC_C...,SET,23,0.21762,0.0076935,0.17686,0.10927,GOBP_REGULATION_OF_CARDIAC_CONDUCTION,0.87006905634448
HP_LATE_ONSET_PROXIMAL_MUSCL...,SET,6,0.47205,0.0085278,0.38365,0.10927,HP_LATE_ONSET_PROXIMAL_MUSCLE_WEAKNESS,0.87006905634448
MIR10398_3P,SET,5,0.50111,0.0082641,0.4073,0.10929,MIR10398_3P,0.87006905634448
HP_HYPERCONVEX_FINGERNAILS,SET,6,0.45352,0.0081929,0.3686,0.10929,HP_HYPERCONVEX_FINGERNAILS,0.87006905634448
GSE411_UNSTIM_VS_400MIN_IL6_...3,SET,175,0.079111,0.0076828,0.064302,0.1093,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,0.87006905634448
GOMF_SNARE_BINDING,SET,102,0.099976,0.0074272,0.081273,0.10933,GOMF_SNARE_BINDING,0.870108575681246
GOBP_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.48274,0.0094193,0.39259,0.10943,GOBP_GLYCEROL_TRANSMEMBRANE_TRANSPORT,0.870186359478619
GOMF_GLYCEROL_TRANSMEMBRANE_...,SET,7,0.48274,0.0094193,0.39259,0.10943,GOMF_GLYCEROL_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.870186359478619
PETRETTO_BLOOD_PRESSURE_UP,SET,11,0.30193,0.0073844,0.24557,0.10945,PETRETTO_BLOOD_PRESSURE_UP,0.870186359478619
MIR5196_5P,SET,267,0.063168,0.0075581,0.051379,0.10946,MIR5196_5P,0.870186359478619
GOBP_SEQUESTERING_OF_TRIGLYC...,SET,18,0.26303,0.0082276,0.21395,0.10947,GOBP_SEQUESTERING_OF_TRIGLYCERIDE,0.870186359478619
GOBP_SEMICIRCULAR_CANAL_MORP...,SET,7,0.44332,0.00865,0.36062,0.10949,GOBP_SEMICIRCULAR_CANAL_MORPHOGENESIS,0.870186359478619
HP_HEART_BLOCK,SET,116,0.096606,0.0076506,0.078611,0.10956,HP_HEART_BLOCK,0.870264564770391
HP_NIGHT_SWEATS,SET,10,0.34682,0.0080876,0.28223,0.10957,HP_NIGHT_SWEATS,0.870264564770391
KOYAMA_SEMA3B_TARGETS_UP,SET,223,0.069869,0.0076494,0.056865,0.1096,KOYAMA_SEMA3B_TARGETS_UP,0.870264564770391
HP_KNEE_CLONUS,SET,5,0.47917,0.0079022,0.38998,0.1096,HP_KNEE_CLONUS,0.870264564770391
HP_RECURRENT_BACTERIAL_INFEC...,SET,184,0.078063,0.0077716,0.063582,0.10978,HP_RECURRENT_BACTERIAL_INFECTIONS,0.871454441653345
GOBP_ALPHA_BETA_T_CELL_PROLI...,SET,42,0.17553,0.0083816,0.14298,0.1098,GOBP_ALPHA_BETA_T_CELL_PROLIFERATION,0.871454441653345
GOMF_G_PROTEIN_COUPLED_SEROT...,SET,21,0.23527,0.0079483,0.1917,0.10986,GOMF_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_ACTIVITY,0.871532595297877
GSE24634_NAIVE_CD4_TCELL_VS_...1,SET,187,0.075171,0.0075438,0.061247,0.10986,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_DN,0.871532595297877
GOMF_DIOXYGENASE_ACTIVITY,SET,82,0.11094,0.0073935,0.090409,0.10991,GOMF_DIOXYGENASE_ACTIVITY,0.871730271565495
GSE28726_NAIVE_VS_ACTIVATED_...4,SET,177,0.076823,0.0075027,0.062621,0.10996,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_UP,0.871887522810219
GOBP_PROGRAMMED_CELL_DEATH_I...1,SET,24,0.21793,0.0078702,0.17766,0.10998,GOBP_PROGRAMMED_CELL_DEATH_INVOLVED_IN_CELL_DEVELOPMENT,0.871887522810219
GOBP_POSITIVE_REGULATION_OF_...313,SET,4,0.50904,0.0075088,0.41503,0.11001,GOBP_POSITIVE_REGULATION_OF_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,0.871926465222349
GSE17721_PAM3CSK4_VS_CPG_2H_...2,SET,181,0.078851,0.0077864,0.064307,0.11007,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_UP,0.871937460460913
BIOCARTA_SPRY_PATHWAY,SET,16,0.25448,0.0075053,0.20754,0.11008,BIOCARTA_SPRY_PATHWAY,0.871937460460913
TFCP2_TARGET_GENES,SET,77,0.11538,0.0074524,0.094125,0.11015,TFCP2_TARGET_GENES,0.871937460460913
GOBP_POSITIVE_REGULATION_OF_...666,SET,25,0.22462,0.0082787,0.18325,0.11015,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,0.871937460460913
GOMF_INOSITOL_TETRAKISPHOSPH...2,SET,7,0.38282,0.0074696,0.31232,0.11016,GOMF_INOSITOL_TETRAKISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.871937460460913
GOBP_POSITIVE_REGULATION_OF_...670,SET,40,0.15796,0.0073612,0.12888,0.11018,GOBP_POSITIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.871937460460913
GOBP_PROTEIN_TARGETING,SET,296,0.058889,0.007413,0.048057,0.11022,GOBP_PROTEIN_TARGETING,0.871937460460913
KEGG_MEDICUS_REFERENCE_NUCLE...3,SET,5,0.52892,0.0087229,0.4318,0.11031,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,0.871937460460913
ACTACCT_MIR196A_MIR196B,SET,133,0.091119,0.0077232,0.074398,0.11034,ACTACCT_MIR196A_MIR196B,0.871937460460913
MIR6085,SET,35,0.15756,0.0068693,0.12867,0.11038,MIR6085,0.871937460460913
DESCARTES_MAIN_FETAL_GANGLIO...,SET,19,0.26335,0.0084629,0.2151,0.11042,DESCARTES_MAIN_FETAL_GANGLION_CELLS,0.871937460460913
LU_TUMOR_ENDOTHELIAL_MARKERS...1,SET,4,0.44677,0.0065903,0.36492,0.11043,LU_TUMOR_ENDOTHELIAL_MARKERS_DN,0.871937460460913
GSE21033_CTRL_VS_POLYIC_STIM...9,SET,147,0.080498,0.0071703,0.065763,0.11047,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_DN,0.871937460460913
GOBP_POSITIVE_REGULATION_OF_...547,SET,41,0.16813,0.007932,0.13736,0.11049,GOBP_POSITIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,0.871937460460913
GOMF_THREONINE_TYPE_PEPTIDAS...,SET,16,0.26195,0.0077257,0.21404,0.11051,GOMF_THREONINE_TYPE_PEPTIDASE_ACTIVITY,0.871937460460913
HP_ABNORMAL_MOTOR_EVOKED_POT...,SET,10,0.29837,0.0069579,0.24385,0.11056,HP_ABNORMAL_MOTOR_EVOKED_POTENTIALS,0.871937460460913
GSE29618_PRE_VS_DAY7_POST_TI...6,SET,166,0.078676,0.0074433,0.064302,0.11057,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_UP,0.871937460460913
GOMF_ADENINE_TRANSMEMBRANE_T...,SET,4,0.58937,0.0086938,0.48171,0.11058,GOMF_ADENINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.871937460460913
MIR23B_5P,SET,43,0.16581,0.0080106,0.13555,0.11063,MIR23B_5P,0.871937460460913
KEGG_MEDICUS_VARIANT_MUTATIO...12,SET,9,0.33307,0.0073686,0.27231,0.11065,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_ERK_SIGNALING_PATHWAY,0.871937460460913
MARTINEZ_RB1_AND_TP53_TARGET...1,SET,550,0.04432,0.0075513,0.036237,0.11066,MARTINEZ_RB1_AND_TP53_TARGETS_DN,0.871937460460913
GSE17721_0.5H_VS_24H_PAM3CSK...2,SET,186,0.074552,0.0074618,0.060958,0.11067,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_UP,0.871937460460913
GOBP_SIRNA_MEDIATED_RETROTRA...,SET,10,0.25817,0.0060203,0.21114,0.11073,GOBP_SIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.871937460460913
AIZARANI_LIVER_C2_KUPFFER_CE...,SET,178,0.081213,0.0079535,0.066421,0.11073,AIZARANI_LIVER_C2_KUPFFER_CELLS_1,0.871937460460913
GSE22886_DAY1_VS_DAY7_MONOCY...1,SET,177,0.074242,0.0072506,0.060722,0.11074,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.871937460460913
HOLLEMAN_DAUNORUBICIN_ALL_DN,SET,8,0.35375,0.0073788,0.28936,0.11076,HOLLEMAN_DAUNORUBICIN_ALL_DN,0.871937460460913
GOBP_REGULATION_OF_NON_MOTIL...,SET,9,0.31344,0.0069344,0.25639,0.11077,GOBP_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.871937460460913
GOBP_RECEPTOR_CATABOLIC_PROC...,SET,27,0.19802,0.0075842,0.16199,0.11078,GOBP_RECEPTOR_CATABOLIC_PROCESS,0.871937460460913
EPC1_TARGET_GENES,SET,308,0.058691,0.0075339,0.048014,0.11079,EPC1_TARGET_GENES,0.871937460460913
HP_HYPERAUTOFLUORESCENT_MACU...,SET,11,0.34914,0.0085389,0.28564,0.1108,HP_HYPERAUTOFLUORESCENT_MACULAR_LESION,0.871937460460913
HP_DELAYED_ABILITY_TO_SIT,SET,76,0.11731,0.0075282,0.096004,0.11087,HP_DELAYED_ABILITY_TO_SIT,0.871937460460913
ANDERSON_BLOOD_CN54GP140_ADJ...8,SET,28,0.18824,0.0073419,0.15407,0.11089,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_UP,0.871937460460913
HP_METATARSAL_SYNOSTOSIS,SET,7,0.41971,0.0081895,0.34357,0.11093,HP_METATARSAL_SYNOSTOSIS,0.871937460460913
GSE22601_IMMATURE_CD4_SINGLE...3,SET,184,0.077833,0.0077486,0.063715,0.11094,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.871937460460913
GOBP_MULTICELLULAR_ORGANISMA...5,SET,58,0.13564,0.0076077,0.11104,0.11095,GOBP_MULTICELLULAR_ORGANISMAL_MOVEMENT,0.871937460460913
GSE39820_TGFBETA1_VS_TGFBETA...3,SET,179,0.075782,0.0074423,0.062047,0.11098,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_DN,0.871937460460913
HP_TALIPES_EQUINOVARUS,SET,347,0.056395,0.0076755,0.046176,0.11099,HP_TALIPES_EQUINOVARUS,0.871937460460913
HP_ABNORMAL_FOOT_MORPHOLOGY,SET,1315,0.029603,0.0076299,0.02424,0.111,HP_ABNORMAL_FOOT_MORPHOLOGY,0.871937460460913
COLE_BLOOD_FLUZONE_FLUARIX_A...,SET,7,0.46014,0.0089783,0.37677,0.111,COLE_BLOOD_FLUZONE_FLUARIX_AGE_03_17YO_7DY_DN,0.871937460460913
HP_DELIRIUM,SET,8,0.37362,0.0077932,0.30597,0.11103,HP_DELIRIUM,0.871937460460913
HP_REDUCED_CIRCULATING_GROWT...,SET,10,0.34127,0.0079584,0.27949,0.11104,HP_REDUCED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,0.871937460460913
BIOCARTA_COMP_PATHWAY,SET,15,0.28719,0.0082011,0.23528,0.11113,BIOCARTA_COMP_PATHWAY,0.872282352941176
YBX1_TARGET_GENES,SET,57,0.13224,0.007353,0.10836,0.11116,YBX1_TARGET_GENES,0.872282352941176
CCCNNNNNNAAGWT_UNKNOWN,SET,93,0.10672,0.0075722,0.087458,0.1112,CCCNNNNNNAAGWT_UNKNOWN,0.872282352941176
GOBP_LUNG_VASCULATURE_DEVELO...,SET,9,0.37106,0.0082091,0.30411,0.11121,GOBP_LUNG_VASCULATURE_DEVELOPMENT,0.872282352941176
GOBP_ZINC_ION_IMPORT_INTO_OR...,SET,11,0.29425,0.0071965,0.24118,0.11123,GOBP_ZINC_ION_IMPORT_INTO_ORGANELLE,0.872282352941176
GSE3039_CD4_TCELL_VS_ALPHABE...1,SET,183,0.074529,0.0073998,0.061106,0.1113,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_DN,0.872282352941176
AZARE_NEOPLASTIC_TRANSFORMAT...2,SET,116,0.10234,0.0081046,0.083913,0.11132,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_UP,0.872282352941176
REACTOME_PHOSPHATE_BOND_HYDR...2,SET,7,0.40483,0.0078992,0.33195,0.11132,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NUDT_PROTEINS,0.872282352941176
HP_ABNORMAL_CERVICAL_CURVATU...,SET,11,0.31314,0.0076584,0.25678,0.11134,HP_ABNORMAL_CERVICAL_CURVATURE,0.872282352941176
GOBP_REGULATION_OF_ISOTYPE_S...2,SET,6,0.40575,0.0073299,0.33274,0.11135,GOBP_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGE_ISOTYPES,0.872282352941176
HP_NEONATAL_SEIZURE,SET,8,0.36412,0.0075952,0.29862,0.11136,HP_NEONATAL_SEIZURE,0.872282352941176
GSE25088_CTRL_VS_IL4_STIM_MA...1,SET,174,0.076147,0.007374,0.062468,0.11143,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_DN,0.872343485086342
GOBP_EOSINOPHIL_DIFFERENTIAT...,SET,6,0.43004,0.0077688,0.35285,0.11147,GOBP_EOSINOPHIL_DIFFERENTIATION,0.872343485086342
GOBP_PEPTIDYL_TYROSINE_AUTOP...,SET,16,0.26337,0.0077675,0.21614,0.11152,GOBP_PEPTIDYL_TYROSINE_AUTOPHOSPHORYLATION,0.872343485086342
YTCCCRNNAGGY_UNKNOWN,SET,59,0.13113,0.0074177,0.10765,0.1116,YTCCCRNNAGGY_UNKNOWN,0.872343485086342
KEGG_MEDICUS_VARIANT_LMO2_RE...1,SET,5,0.48599,0.0080148,0.39899,0.11161,KEGG_MEDICUS_VARIANT_LMO2_REARRANGEMENT_TO_TRANSCRIPTIONAL_ACTIVATION,0.872343485086342
BIOCARTA_BARD1_PATHWAY,SET,8,0.32563,0.0067922,0.26739,0.11166,BIOCARTA_BARD1_PATHWAY,0.872343485086342
GSE360_L_DONOVANI_VS_B_MALAY...6,SET,177,0.080079,0.0078207,0.065757,0.11166,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_UP,0.872343485086342
GOMF_VOLTAGE_GATED_CALCIUM_C...2,SET,5,0.50616,0.0083475,0.41571,0.1117,GOMF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.872343485086342
GOCC_ACROSOMAL_MEMBRANE,SET,30,0.21329,0.0086104,0.1752,0.11173,GOCC_ACROSOMAL_MEMBRANE,0.872343485086342
KEGG_FC_GAMMA_R_MEDIATED_PHA...,SET,90,0.11082,0.007736,0.091044,0.11177,KEGG_FC_GAMMA_R_MEDIATED_PHAGOCYTOSIS,0.872343485086342
REACTOME_ACTIVATED_NTRK3_SIG...2,SET,8,0.32262,0.0067294,0.26506,0.11178,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_RAS,0.872343485086342
GSE40068_CXCR5POS_BCL6POS_TF...1,SET,184,0.080412,0.0080055,0.066065,0.11178,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_DN,0.872343485086342
UNTERMAN_PROGRESSIVE_VS_STAB...2,SET,12,0.36463,0.009314,0.29962,0.11182,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_DN,0.872343485086342
GOBP_MEIOTIC_CELL_CYCLE_PROC...1,SET,189,0.069773,0.0070391,0.057343,0.11185,GOBP_MEIOTIC_CELL_CYCLE_PROCESS,0.872343485086342
SUZUKI_RESPONSE_TO_TSA_AND_D...1,SET,20,0.25358,0.0083604,0.2084,0.11186,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A,0.872343485086342
WP_LDLRAD4_AND_WHAT_WE_KNOW_...,SET,7,0.46815,0.0091346,0.38476,0.11186,WP_LDLRAD4_AND_WHAT_WE_KNOW_ABOUT_IT,0.872343485086342
GOBP_RESPONSE_TO_INTERLEUKIN...10,SET,32,0.20003,0.0083395,0.16441,0.11187,GOBP_RESPONSE_TO_INTERLEUKIN_6,0.872343485086342
MIR4299,SET,67,0.12467,0.0075135,0.10247,0.11188,MIR4299,0.872343485086342
GOBP_LIMB_JOINT_MORPHOGENESIS,SET,7,0.4125,0.0080487,0.3391,0.11191,GOBP_LIMB_JOINT_MORPHOGENESIS,0.872343485086342
HP_SHORT_UMBILICAL_CORD,SET,6,0.45411,0.0082035,0.3733,0.11191,HP_SHORT_UMBILICAL_CORD,0.872343485086342
REACTOME_DISEASES_OF_MISMATC...,SET,5,0.33671,0.0055529,0.27681,0.11192,REACTOME_DISEASES_OF_MISMATCH_REPAIR_MMR,0.872343485086342
ACCATTT_MIR522,SET,144,0.083391,0.0073525,0.068554,0.11192,ACCATTT_MIR522,0.872343485086342
GSE40273_EOS_KO_VS_WT_TREG_DN,SET,188,0.074522,0.0074984,0.061284,0.112,GSE40273_EOS_KO_VS_WT_TREG_DN,0.872457989690722
TRAVAGLINI_LUNG_TREM2_DENDRI...,SET,518,0.045828,0.0075845,0.037688,0.112,TRAVAGLINI_LUNG_TREM2_DENDRITIC_CELL,0.872457989690722
GOMF_DNA_DNA_ANNEALING_ACTIV...,SET,7,0.39848,0.0077751,0.32771,0.11201,GOMF_DNA_DNA_ANNEALING_ACTIVITY,0.872457989690722
GSE22886_TH1_VS_TH2_48H_ACT_...1,SET,182,0.076068,0.0075321,0.062573,0.11206,GSE22886_TH1_VS_TH2_48H_ACT_DN,0.872534240591398
MORF_CDC16,SET,63,0.12353,0.0072199,0.10162,0.11207,MORF_CDC16,0.872534240591398
MIR4686,SET,74,0.11442,0.007246,0.094165,0.11216,MIR4686,0.873039372900336
REACTOME_REGULATION_OF_SIGNA...2,SET,9,0.30212,0.0066839,0.24867,0.11221,REACTOME_REGULATION_OF_SIGNALING_BY_NODAL,0.873232993730408
GOBP_NEGATIVE_REGULATION_OF_...109,SET,71,0.12648,0.0078461,0.10412,0.11224,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,0.873270920080591
GOBP_REGULATION_OF_LYMPHOCYT...3,SET,25,0.21402,0.007888,0.17623,0.1123,GOBP_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,0.873462348993289
HP_BROAD_NAIL,SET,8,0.39523,0.008244,0.32548,0.11233,HP_BROAD_NAIL,0.873462348993289
HP_APLASIA_OF_THE_UTERUS,SET,18,0.25446,0.0079594,0.20957,0.11234,HP_APLASIA_OF_THE_UTERUS,0.873462348993289
GOBP_CELLULAR_COMPONENT_MAIN...,SET,65,0.13347,0.0079232,0.10995,0.1124,GOBP_CELLULAR_COMPONENT_MAINTENANCE,0.873733392976963
GSE15330_GRANULOCYTE_MONOCYT...2,SET,178,0.073249,0.0071736,0.060359,0.11247,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_UP,0.874082032647585
GOBP_DEFENSE_RESPONSE_TO_VIR...,SET,280,0.063758,0.0078094,0.052557,0.11255,GOBP_DEFENSE_RESPONSE_TO_VIRUS,0.874421010638298
GAUCHER_PBMC_YF_VAX_STAMARIL...1,SET,96,0.10518,0.0075815,0.08671,0.11258,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_DN,0.874421010638298
GOBP_INTERLEUKIN_8_PRODUCTION,SET,78,0.11976,0.0077852,0.098763,0.11265,GOBP_INTERLEUKIN_8_PRODUCTION,0.874421010638298
GOBP_MESENCHYME_MIGRATION,SET,5,0.46529,0.0076734,0.38378,0.11269,GOBP_MESENCHYME_MIGRATION,0.874421010638298
HP_ABNORMALITY_OF_THE_AXILLA...,SET,52,0.15057,0.0079976,0.1242,0.11271,HP_ABNORMALITY_OF_THE_AXILLARY_HAIR,0.874421010638298
GOBP_REGULATION_OF_ERAD_PATH...,SET,22,0.20136,0.0069625,0.1661,0.11272,GOBP_REGULATION_OF_ERAD_PATHWAY,0.874421010638298
PHONG_TNF_RESPONSE_VIA_P38_C...,SET,214,0.070412,0.0075535,0.0581,0.11278,PHONG_TNF_RESPONSE_VIA_P38_COMPLETE,0.874421010638298
GSE26343_UNSTIM_VS_LPS_STIM_...4,SET,185,0.073377,0.0073247,0.060548,0.11279,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_UP,0.874421010638298
GSE2770_TGFB_AND_IL4_VS_IL4_...3,SET,174,0.0789,0.0076405,0.065105,0.11279,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.874421010638298
GOCC_COPII_COATED_ER_TO_GOLG...,SET,84,0.10907,0.0073566,0.090011,0.11282,GOCC_COPII_COATED_ER_TO_GOLGI_TRANSPORT_VESICLE,0.874421010638298
TBK1.DF_UP,SET,261,0.06478,0.0076646,0.053501,0.11299,TBK1.DF_UP,0.874421010638298
KARAKAS_TGFB1_SIGNALING,SET,18,0.24204,0.0075711,0.19991,0.113,KARAKAS_TGFB1_SIGNALING,0.874421010638298
GSE9006_HEALTHY_VS_TYPE_1_DI...2,SET,179,0.0734,0.0072084,0.060624,0.113,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_UP,0.874421010638298
GOBP_NEGATIVE_REGULATION_OF_...634,SET,21,0.25164,0.0085013,0.20785,0.11301,GOBP_NEGATIVE_REGULATION_OF_TISSUE_REMODELING,0.874421010638298
GOMF_CARBOHYDRATE_PROTON_SYM...,SET,7,0.44387,0.0086609,0.36664,0.11302,GOMF_CARBOHYDRATE_PROTON_SYMPORTER_ACTIVITY,0.874421010638298
GOMF_OXIDOREDUCTASE_ACTIVITY...11,SET,6,0.43737,0.0079012,0.3613,0.11304,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_NAD_OR_NADP_AS_ACCEPTOR,0.874421010638298
GOBP_TELOMERE_ORGANIZATION,SET,147,0.078389,0.0069825,0.064758,0.11305,GOBP_TELOMERE_ORGANIZATION,0.874421010638298
HP_OVOTESTIS,SET,3,0.60307,0.0077042,0.49837,0.11313,HP_OVOTESTIS,0.874421010638298
HP_NECK_MUSCLE_WEAKNESS,SET,84,0.10873,0.0073342,0.089866,0.11316,HP_NECK_MUSCLE_WEAKNESS,0.874421010638298
HOLLEMAN_ASPARAGINASE_RESIST...3,SET,12,0.25397,0.0064874,0.20991,0.11317,HOLLEMAN_ASPARAGINASE_RESISTANCE_B_ALL_DN,0.874421010638298
REACTOME_PLASMA_LIPOPROTEIN_...1,SET,18,0.23088,0.0072218,0.19083,0.11318,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY,0.874421010638298
KEGG_MEDICUS_REFERENCE_WNT5A...,SET,15,0.27361,0.0078133,0.22616,0.11319,KEGG_MEDICUS_REFERENCE_WNT5A_ROR_SIGNALING_PATHWAY,0.874421010638298
GOMF_ACTININ_BINDING,SET,36,0.17894,0.0079116,0.14791,0.11319,GOMF_ACTININ_BINDING,0.874421010638298
HP_SPASTIC_DYSARTHRIA,SET,22,0.20335,0.0070313,0.16809,0.11319,HP_SPASTIC_DYSARTHRIA,0.874421010638298
PID_IL6_7_PATHWAY,SET,43,0.16076,0.0077668,0.13289,0.11321,PID_IL6_7_PATHWAY,0.874421010638298
GSE24574_BCL6_HIGH_VS_LOW_TF...1,SET,182,0.073853,0.0073128,0.061061,0.11325,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_DN,0.874421010638298
GSE22886_UNSTIM_VS_IL15_STIM...1,SET,183,0.072584,0.0072066,0.060028,0.11331,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_DN,0.874421010638298
MIR8059,SET,55,0.13791,0.0075332,0.1141,0.11339,MIR8059,0.874421010638298
GOBP_AMPA_GLUTAMATE_RECEPTOR...,SET,10,0.33679,0.0078539,0.27865,0.1134,GOBP_AMPA_GLUTAMATE_RECEPTOR_CLUSTERING,0.874421010638298
GOBP_DENSE_CORE_GRANULE_EXOC...,SET,10,0.3602,0.0083997,0.29801,0.1134,GOBP_DENSE_CORE_GRANULE_EXOCYTOSIS,0.874421010638298
GOBP_METHIONINE_BIOSYNTHETIC...,SET,12,0.28801,0.007357,0.2383,0.11341,GOBP_METHIONINE_BIOSYNTHETIC_PROCESS,0.874421010638298
GOBP_NEGATIVE_REGULATION_OF_...459,SET,1308,0.029191,0.0075052,0.024152,0.11341,GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.874421010638298
GOBP_MEIOTIC_CELL_CYCLE_PHAS...,SET,13,0.26998,0.0071778,0.22339,0.11343,GOBP_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.874421010638298
HAY_BONE_MARROW_NAIVE_T_CELL,SET,324,0.058771,0.0077342,0.048631,0.11343,HAY_BONE_MARROW_NAIVE_T_CELL,0.874421010638298
KEGG_MEDICUS_REFERENCE_RETRO...,SET,42,0.15223,0.0072686,0.12597,0.11344,KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT,0.874421010638298
WP_VITAMIN_B12_METABOLISM,SET,49,0.15302,0.0078905,0.12664,0.11347,WP_VITAMIN_B12_METABOLISM,0.874421010638298
MARTORIATI_MDM4_TARGETS_NEUR...1,SET,147,0.089209,0.0079463,0.073833,0.11348,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_DN,0.874421010638298
GOBP_NEGATIVE_REGULATION_OF_...468,SET,35,0.17992,0.007844,0.14891,0.11348,GOBP_NEGATIVE_REGULATION_OF_OSSIFICATION,0.874421010638298
KEGG_MEDICUS_VARIANT_SCRAPIE...2,SET,17,0.24821,0.0075453,0.20544,0.1135,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,0.874421010638298
GSE28737_FOLLICULAR_VS_MARGI...2,SET,176,0.076161,0.0074171,0.063044,0.11352,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP,0.874421010638298
WP_SELECTIVE_EXPRESSION_OF_C...,SET,27,0.2129,0.008154,0.17625,0.11355,WP_SELECTIVE_EXPRESSION_OF_CHEMOKINE_RECEPTORS_DURING_TCELL_POLARIZATION,0.874441020543406
GSE12507_PDC_CELL_LINE_VS_IM...2,SET,136,0.086421,0.0074065,0.071562,0.1136,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP,0.874441020543406
GOCC_OUTER_DYNEIN_ARM,SET,10,0.31996,0.0074612,0.26498,0.11364,GOCC_OUTER_DYNEIN_ARM,0.874441020543406
GOBP_LIPOPROTEIN_BIOSYNTHETI...,SET,91,0.1024,0.0071875,0.084836,0.11372,GOBP_LIPOPROTEIN_BIOSYNTHETIC_PROCESS,0.874441020543406
GSE17721_POLYIC_VS_PAM3CSK4_...1,SET,185,0.07408,0.0073948,0.061376,0.11373,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_DN,0.874441020543406
DORSAM_HOXA9_TARGETS_UP,SET,35,0.17488,0.0076244,0.1449,0.11374,DORSAM_HOXA9_TARGETS_UP,0.874441020543406
MORF_TPT1,SET,90,0.10378,0.0072443,0.085985,0.11374,MORF_TPT1,0.874441020543406
HP_ABNORMALITY_OF_PAIN_SENSA...,SET,90,0.10802,0.0075402,0.089498,0.11374,HP_ABNORMALITY_OF_PAIN_SENSATION,0.874441020543406
HP_ABNORMALITY_OF_THE_WRIST,SET,147,0.086828,0.0077342,0.071945,0.11375,HP_ABNORMALITY_OF_THE_WRIST,0.874441020543406
GOBP_NEGATIVE_REGULATION_OF_...66,SET,40,0.15767,0.0073475,0.13069,0.11383,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.874441020543406
GSE15330_GRANULOCYTE_MONOCYT...1,SET,184,0.073742,0.0073414,0.061124,0.11383,GSE15330_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_PRO_BCELL_DN,0.874441020543406
GOBP_T_HELPER_1_CELL_CYTOKIN...,SET,8,0.34651,0.0072279,0.28729,0.11389,GOBP_T_HELPER_1_CELL_CYTOKINE_PRODUCTION,0.874441020543406
GOBP_PANTOTHENATE_METABOLIC_...,SET,7,0.39273,0.0076631,0.32563,0.1139,GOBP_PANTOTHENATE_METABOLIC_PROCESS,0.874441020543406
GSE7852_TREG_VS_TCONV_FAT_DN,SET,183,0.074724,0.0074191,0.061955,0.1139,GSE7852_TREG_VS_TCONV_FAT_DN,0.874441020543406
GSE8621_UNSTIM_VS_LPS_PRIMED...1,SET,188,0.073386,0.0073841,0.060845,0.1139,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,0.874441020543406
HP_SOMATIC_SENSORY_DYSFUNCTI...,SET,379,0.051799,0.0073613,0.042953,0.11393,HP_SOMATIC_SENSORY_DYSFUNCTION,0.874478169169611
GOCC_CONDENSED_CHROMOSOME_CE...,SET,164,0.07649,0.0071932,0.063458,0.11404,GOCC_CONDENSED_CHROMOSOME_CENTROMERIC_REGION,0.875129211746522
HAY_BONE_MARROW_CD34_POS_HSC,SET,96,0.11081,0.0079879,0.091974,0.11414,HAY_BONE_MARROW_CD34_POS_HSC,0.875703245033113
GOBP_NEURON_RECOGNITION,SET,46,0.17531,0.0087597,0.14556,0.11422,GOBP_NEURON_RECOGNITION,0.876043745863667
RUTELLA_RESPONSE_TO_HGF_DN,SET,217,0.070913,0.0076598,0.058886,0.11425,RUTELLA_RESPONSE_TO_HGF_DN,0.876043745863667
GOMF_PHOSPHATIDYLSERINE_BIND...,SET,65,0.13483,0.0080043,0.11196,0.11426,GOMF_PHOSPHATIDYLSERINE_BINDING,0.876043745863667
LU_TUMOR_ANGIOGENESIS_UP,SET,25,0.22977,0.0084686,0.19084,0.1143,LU_TUMOR_ANGIOGENESIS_UP,0.876107652499449
REACTOME_EGR2_AND_SOX10_MEDI...,SET,27,0.20431,0.0078251,0.16973,0.11436,REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION,0.876107652499449
HP_VARIABLE_EXPRESSIVITY,SET,63,0.12505,0.0073088,0.10391,0.1144,HP_VARIABLE_EXPRESSIVITY,0.876107652499449
GOBP_XENOPHAGY,SET,14,0.26062,0.0071904,0.21658,0.11442,GOBP_XENOPHAGY,0.876107652499449
GSE2128_CTRL_VS_MIMETOPE_NEG...4,SET,181,0.077938,0.0076962,0.064764,0.11442,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_UP,0.876107652499449
MODULE_58,SET,17,0.26954,0.0081938,0.224,0.11443,MODULE_58,0.876107652499449
GOBP_NEGATIVE_REGULATION_OF_...398,SET,11,0.32354,0.0079129,0.2689,0.11445,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.876107652499449
GOCC_EXTRINSIC_COMPONENT_OF_...4,SET,22,0.20943,0.0072416,0.17407,0.11447,GOCC_EXTRINSIC_COMPONENT_OF_ORGANELLE_MEMBRANE,0.876107652499449
GSE21546_UNSTIM_VS_ANTI_CD3_...4,SET,160,0.081193,0.0075425,0.067502,0.11453,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_UP,0.876327413679349
REACTOME_SIGNALING_BY_NTRKS,SET,132,0.08862,0.0074833,0.073694,0.11459,REACTOME_SIGNALING_BY_NTRKS,0.876327413679349
MIR6510_5P,SET,78,0.11157,0.0072528,0.092782,0.11459,MIR6510_5P,0.876327413679349
chr19p13,SET,517,0.10119,0.016732,0.084175,0.11465,chr19p13,0.876327413679349
HP_POOR_HEAD_CONTROL,SET,208,0.066501,0.0070344,0.055316,0.11465,HP_POOR_HEAD_CONTROL,0.876327413679349
GSE26351_UNSTIM_VS_WNT_PATHW...2,SET,178,0.072896,0.0071391,0.060635,0.11465,GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,0.876327413679349
GOBP_CELLULAR_RESPONSE_TO_IN...5,SET,196,0.071398,0.0073337,0.0594,0.11469,GOBP_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.87644040237467
MIR6772_3P,SET,66,0.12016,0.007188,0.099984,0.11472,MIR6772_3P,0.87647693998681
GSE46606_UNSTIM_VS_CD40L_IL2...1,SET,185,0.073545,0.0073414,0.061201,0.11475,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,0.876513461538462
GSE411_WT_VS_SOCS3_KO_MACROP...6,SET,178,0.074894,0.0073347,0.062343,0.11482,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_UP,0.876671864740644
HP_CORONARY_ARTERY_ATHEROSCL...,SET,51,0.15007,0.0078941,0.12497,0.11491,HP_CORONARY_ARTERY_ATHEROSCLEROSIS,0.876671864740644
KEGG_MEDICUS_REFERENCE_MACHR...,SET,18,0.24042,0.0075202,0.20021,0.11492,KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY,0.876671864740644
LI_ESTROGENE_BIDIRECTIONAL_E...,SET,85,0.1212,0.0082234,0.10094,0.11494,LI_ESTROGENE_BIDIRECTIONAL_E2_RESPONSE,0.876671864740644
chr11p15,SET,274,0.13393,0.01623,0.11155,0.11495,chr11p15,0.876671864740644
GOBP_NEGATIVE_REGULATION_OF_...380,SET,6,0.43318,0.0078254,0.36078,0.11495,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE_PHASE_TRANSITION,0.876671864740644
CTCTGGA_MIR520A_MIR525,SET,141,0.083398,0.0072767,0.069471,0.11499,CTCTGGA_MIR520A_MIR525,0.876671864740644
HP_HYPEREXTENSIBILITY_OF_THE...2,SET,38,0.15938,0.0072396,0.13278,0.11501,HP_HYPEREXTENSIBILITY_OF_THE_KNEE,0.876671864740644
GOBP_G_PROTEIN_COUPLED_SEROT...,SET,22,0.21649,0.0074858,0.18042,0.11509,GOBP_G_PROTEIN_COUPLED_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.876671864740644
TONKS_TARGETS_OF_RUNX1_RUNX1...8,SET,192,0.073928,0.0075165,0.061612,0.1151,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_UP,0.876671864740644
GOMF_NUCLEAR_EXPORT_SIGNAL_R...,SET,11,0.28213,0.0069002,0.23517,0.11513,GOMF_NUCLEAR_EXPORT_SIGNAL_RECEPTOR_ACTIVITY,0.876671864740644
MIR3668,SET,95,0.10233,0.0073377,0.085292,0.11514,MIR3668,0.876671864740644
HP_INCREASED_SERUM_PYRUVATE,SET,41,0.13851,0.0065347,0.11545,0.11514,HP_INCREASED_SERUM_PYRUVATE,0.876671864740644
GOBP_REGULATION_OF_NUCLEOTID...2,SET,9,0.37794,0.0083613,0.31506,0.11516,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_OLIGOMERIZATION_DOMAIN_CONTAINING_2_SIGNALING_PATHWAY,0.876671864740644
HP_DIFFICULTY_CLIMBING_STAIRS,SET,58,0.1309,0.007342,0.10914,0.1152,HP_DIFFICULTY_CLIMBING_STAIRS,0.876671864740644
INSM2_TARGET_GENES,SET,748,0.037832,0.0074753,0.031545,0.11521,INSM2_TARGET_GENES,0.876671864740644
HP_OSTEOMYELITIS,SET,58,0.14187,0.0079574,0.11831,0.11524,HP_OSTEOMYELITIS,0.876671864740644
GOBP_MIDBRAIN_DEVELOPMENT,SET,81,0.11442,0.0075795,0.095426,0.11525,GOBP_MIDBRAIN_DEVELOPMENT,0.876671864740644
GOBP_REGULATION_OF_GERMINAL_...,SET,8,0.38842,0.008102,0.32392,0.11525,GOBP_REGULATION_OF_GERMINAL_CENTER_FORMATION,0.876671864740644
MIR5698,SET,187,0.072069,0.0072325,0.060112,0.11529,MIR5698,0.876784234135667
HE_LIM_SUN_FETAL_LUNG_C2_PDC...,SET,133,0.090387,0.0076611,0.075403,0.11533,HE_LIM_SUN_FETAL_LUNG_C2_PDC_CELL,0.876896554364472
GSE37416_0H_VS_12H_F_TULAREN...1,SET,178,0.075445,0.0073887,0.062954,0.11539,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.877074082568807
WP_NUCLEAR_RECEPTORS_METAPAT...,SET,300,0.062123,0.0078719,0.051856,0.11546,WP_NUCLEAR_RECEPTORS_METAPATHWAY,0.877074082568807
MIR4472,SET,93,0.10658,0.0075626,0.088966,0.11546,MIR4472,0.877074082568807
GOBP_REGULATION_OF_HEAT_GENE...,SET,13,0.31525,0.0083813,0.26314,0.11546,GOBP_REGULATION_OF_HEAT_GENERATION,0.877074082568807
GSE1460_INTRATHYMIC_T_PROGEN...3,SET,174,0.077319,0.0074875,0.064555,0.11552,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_DN,0.877074082568807
GOCC_ENDOSOME_MEMBRANE,SET,518,0.044142,0.0073055,0.036857,0.11553,GOCC_ENDOSOME_MEMBRANE,0.877074082568807
HP_FRONTAL_BALDING,SET,13,0.27419,0.0072897,0.22893,0.11553,HP_FRONTAL_BALDING,0.877074082568807
chr8p23,SET,42,0.27971,0.013356,0.23358,0.11557,chr8p23,0.877106647020301
GOMF_ATP_DEPENDENT_DNA_DAMAG...,SET,16,0.19736,0.0058207,0.16483,0.11559,GOMF_ATP_DEPENDENT_DNA_DAMAGE_SENSOR_ACTIVITY,0.877106647020301
GOBP_POSITIVE_REGULATION_OF_...91,SET,6,0.40428,0.0073034,0.33767,0.11561,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.877106647020301
KEGG_MEDICUS_REFERENCE_MICRO...1,SET,22,0.22156,0.007661,0.18515,0.11572,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION,0.877182219338092
POOLA_INVASIVE_BREAST_CANCER...2,SET,257,0.067308,0.0079035,0.056251,0.11575,POOLA_INVASIVE_BREAST_CANCER_UP,0.877182219338092
GSE7218_IGM_VS_IGG_SIGNAL_TH...1,SET,161,0.08143,0.0075879,0.068073,0.11581,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_DN,0.877182219338092
MIR6165,SET,111,0.09052,0.0070134,0.075682,0.11584,MIR6165,0.877182219338092
HP_ABNORMAL_DENSE_GRANULES,SET,9,0.3229,0.0071436,0.26997,0.11585,HP_ABNORMAL_DENSE_GRANULES,0.877182219338092
GSE42021_CD24HI_VS_CD24LOW_T...1,SET,183,0.076238,0.0075694,0.063747,0.11587,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_DN,0.877182219338092
HP_SILVER_GRAY_HAIR,SET,6,0.40607,0.0073357,0.33962,0.11593,HP_SILVER_GRAY_HAIR,0.877182219338092
MIR3972,SET,62,0.12411,0.0071962,0.10381,0.11594,MIR3972,0.877182219338092
WP_MONOAMINE_TRANSPORT,SET,30,0.19222,0.0077595,0.16078,0.11595,WP_MONOAMINE_TRANSPORT,0.877182219338092
HP_ABNORMAL_SECOND_TOE_MORPH...,SET,12,0.30773,0.0078607,0.25741,0.11596,HP_ABNORMAL_SECOND_TOE_MORPHOLOGY,0.877182219338092
GSE22601_DOUBLE_POSITIVE_VS_...3,SET,184,0.072672,0.0072349,0.060792,0.11597,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,0.877182219338092
DESCARTES_FETAL_PANCREAS_MYE...,SET,185,0.079616,0.0079474,0.066606,0.11599,DESCARTES_FETAL_PANCREAS_MYELOID_CELLS,0.877182219338092
E2F_Q6_01,SET,207,0.068064,0.0071826,0.056945,0.116,E2F_Q6_01,0.877182219338092
GOBP_RECEPTOR_CLUSTERING,SET,55,0.13281,0.0072543,0.11113,0.11604,GOBP_RECEPTOR_CLUSTERING,0.877182219338092
GSE3691_IFN_PRODUCING_KILLER...2,SET,173,0.073237,0.0070719,0.061284,0.11604,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_UP,0.877182219338092
PID_ERB_GENOMIC_PATHWAY,SET,14,0.27241,0.0075155,0.22799,0.11608,PID_ERB_GENOMIC_PATHWAY,0.877182219338092
GOBP_DEVELOPMENT_OF_PRIMARY_...2,SET,213,0.072346,0.0077431,0.060556,0.11611,GOBP_DEVELOPMENT_OF_PRIMARY_SEXUAL_CHARACTERISTICS,0.877182219338092
GOBP_C_TERMINAL_PROTEIN_AMIN...,SET,16,0.26206,0.0077287,0.21938,0.11614,GOBP_C_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.877182219338092
GARGALOVIC_RESPONSE_TO_OXIDI...11,SET,8,0.43167,0.0090041,0.36139,0.11616,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTGREEN_DN,0.877182219338092
CUI_DEVELOPING_HEART_RIGHT_A...,SET,36,0.17226,0.0076165,0.14423,0.11617,CUI_DEVELOPING_HEART_RIGHT_ATRIAL_CARDIOMYOCYTE,0.877182219338092
GOBP_RESPONSE_TO_ACETYLCHOLI...,SET,44,0.15845,0.0077437,0.13267,0.11618,GOBP_RESPONSE_TO_ACETYLCHOLINE,0.877182219338092
LIM_MAMMARY_LUMINAL_PROGENIT...2,SET,57,0.13767,0.0076547,0.11529,0.11623,LIM_MAMMARY_LUMINAL_PROGENITOR_UP,0.877182219338092
GSE10325_BCELL_VS_MYELOID_UP,SET,170,0.078025,0.0074693,0.06536,0.11629,GSE10325_BCELL_VS_MYELOID_UP,0.877182219338092
GOMF_STEROID_DEHYDROGENASE_A...2,SET,30,0.19305,0.0077932,0.16173,0.11631,GOMF_STEROID_DEHYDROGENASE_ACTIVITY_ACTING_ON_THE_CH_OH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.877182219338092
WP_SMITHMAGENIS_AND_POTOCKIL...,SET,144,0.091072,0.0080296,0.076301,0.11633,WP_SMITHMAGENIS_AND_POTOCKILUPSKI_SYNDROME_COPY_NUMBER_VARIATION,0.877182219338092
HP_TORSADE_DE_POINTES,SET,24,0.21306,0.0076943,0.17854,0.11637,HP_TORSADE_DE_POINTES,0.877182219338092
GAVISH_3CA_METAPROGRAM_MACRO...8,SET,46,0.17243,0.0086154,0.14449,0.11638,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MONOCYTE_SECRETED,0.877182219338092
GOBP_TRNA_PROCESSING,SET,119,0.083626,0.0067072,0.070082,0.11639,GOBP_TRNA_PROCESSING,0.877182219338092
GOMF_RNA_POLYMERASE_II_INTRO...,SET,8,0.38046,0.0079359,0.31886,0.11641,GOMF_RNA_POLYMERASE_II_INTRONIC_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,0.877182219338092
GSE5589_UNSTIM_VS_45MIN_LPS_...1,SET,181,0.071245,0.0070353,0.059722,0.11645,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.877182219338092
GOCC_ER_TO_GOLGI_TRANSPORT_V...,SET,56,0.13303,0.0073318,0.11153,0.11649,GOCC_ER_TO_GOLGI_TRANSPORT_VESICLE_MEMBRANE,0.877182219338092
GSE22886_DAY1_VS_DAY7_MONOCY...2,SET,182,0.075772,0.0075027,0.063531,0.11651,GSE22886_DAY1_VS_DAY7_MONOCYTE_IN_CULTURE_UP,0.877182219338092
BRUECKNER_TARGETS_OF_MIRLET7...2,SET,104,0.10332,0.0077504,0.086639,0.11652,BRUECKNER_TARGETS_OF_MIRLET7A3_UP,0.877182219338092
GOBP_NEGATIVE_REGULATION_OF_...53,SET,18,0.26976,0.0084379,0.2262,0.11653,GOBP_NEGATIVE_REGULATION_OF_BONE_REMODELING,0.877182219338092
GSE2405_HEAT_KILLED_LYSATE_V...3,SET,182,0.07,0.0069313,0.058713,0.11659,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.877182219338092
GOMF_IMMUNOGLOBULIN_BINDING,SET,25,0.21247,0.0078308,0.17822,0.1166,GOMF_IMMUNOGLOBULIN_BINDING,0.877182219338092
GOBP_MAST_CELL_CHEMOTAXIS,SET,11,0.32363,0.0079151,0.27146,0.11661,GOBP_MAST_CELL_CHEMOTAXIS,0.877182219338092
GSE24142_EARLY_THYMIC_PROGEN...11,SET,181,0.078391,0.007741,0.065758,0.11662,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_FETAL_UP,0.877182219338092
GOCC_SARCOLEMMA,SET,136,0.088812,0.0076115,0.074505,0.11663,GOCC_SARCOLEMMA,0.877182219338092
GOCC_SARCOPLASMIC_RETICULUM_...1,SET,9,0.33584,0.0074299,0.28177,0.11666,GOCC_SARCOPLASMIC_RETICULUM_LUMEN,0.877182219338092
GSE3039_ALPHABETA_CD8_TCELL_...4,SET,180,0.074285,0.0073154,0.062325,0.11666,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_UP,0.877182219338092
GSE14308_TH2_VS_NATURAL_TREG...2,SET,168,0.073367,0.0069823,0.061561,0.11668,GSE14308_TH2_VS_NATURAL_TREG_UP,0.877182219338092
GOCC_HAUS_COMPLEX,SET,7,0.3077,0.006004,0.25824,0.11673,GOCC_HAUS_COMPLEX,0.877368328287197
YAMASHITA_SILENCED_BY_METHYL...,SET,7,0.41332,0.0080649,0.34695,0.11677,YAMASHITA_SILENCED_BY_METHYLATION,0.877381992667673
HP_HYPOCHROMIC_MICROCYTIC_AN...,SET,15,0.26876,0.0076749,0.22564,0.11681,HP_HYPOCHROMIC_MICROCYTIC_ANEMIA,0.877381992667673
REACTOME_MECP2_REGULATES_TRA...1,SET,4,0.59056,0.0087113,0.49586,0.11684,REACTOME_MECP2_REGULATES_TRANSCRIPTION_FACTORS,0.877381992667673
GOLDRATH_NAIVE_VS_MEMORY_CD8...2,SET,190,0.072899,0.0073737,0.061209,0.11684,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.877381992667673
GOBP_REGULATION_OF_T_CELL_AP...,SET,39,0.16338,0.0075179,0.13719,0.11686,GOBP_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.877381992667673
GOBP_STEM_CELL_DEVELOPMENT,SET,82,0.11804,0.0078672,0.099143,0.1169,GOBP_STEM_CELL_DEVELOPMENT,0.877381992667673
GOCC_CONTRACTILE_MUSCLE_FIBER,SET,237,0.067076,0.0075677,0.056346,0.11695,GOCC_CONTRACTILE_MUSCLE_FIBER,0.877381992667673
EINAV_INTERFERON_SIGNATURE_I...,SET,27,0.19133,0.007328,0.16075,0.11698,EINAV_INTERFERON_SIGNATURE_IN_CANCER,0.877381992667673
GSE3982_BASOPHIL_VS_NKCELL_UP,SET,177,0.075687,0.0073917,0.063596,0.11701,GSE3982_BASOPHIL_VS_NKCELL_UP,0.877381992667673
GSE17721_POLYIC_VS_CPG_1H_BM...2,SET,189,0.070321,0.0070943,0.059095,0.11704,GSE17721_POLYIC_VS_CPG_1H_BMDC_UP,0.877381992667673
HOFFMANN_SMALL_PRE_BII_TO_IM...1,SET,35,0.16918,0.0073756,0.14218,0.11705,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_DN,0.877381992667673
GOBP_REGULATION_OF_CARDIAC_M...9,SET,23,0.20698,0.0073175,0.17395,0.11706,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,0.877381992667673
GSE39820_CTRL_VS_TGFBETA1_IL...1,SET,183,0.07273,0.0072212,0.061125,0.11706,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_DN,0.877381992667673
REACTOME_RHO_GTPASES_ACTIVAT...1,SET,19,0.22128,0.007111,0.18601,0.11711,REACTOME_RHO_GTPASES_ACTIVATE_CIT,0.877567496765847
HP_THROMBOEMBOLIC_STROKE,SET,69,0.12672,0.0077501,0.10657,0.1172,HP_THROMBOEMBOLIC_STROKE,0.878052597542574
REACTOME_GAB1_SIGNALOSOME,SET,17,0.25218,0.0076661,0.2121,0.11724,REACTOME_GAB1_SIGNALOSOME,0.878162974137931
TONKS_TARGETS_OF_RUNX1_RUNX1...9,SET,42,0.16113,0.0076936,0.13559,0.11735,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINDED_IN_ERYTHROCYTE_UP,0.878346856223176
WP_NF1_COPY_NUMBER_VARIATION...,SET,74,0.12544,0.0079436,0.10555,0.11735,WP_NF1_COPY_NUMBER_VARIATION_SYNDROME,0.878346856223176
HP_MESOMELIA,SET,32,0.16711,0.0069668,0.14063,0.11736,HP_MESOMELIA,0.878346856223176
GAVISH_3CA_METAPROGRAM_EPITH...16,SET,48,0.13957,0.0071232,0.11745,0.11737,GAVISH_3CA_METAPROGRAM_EPITHELIAL_MYC,0.878346856223176
REACTOME_TRANSCRIPTIONAL_REG...14,SET,12,0.30934,0.0079018,0.26039,0.11743,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_TESTIS_DIFFERENTIATION,0.878346856223176
GOBP_PROTEIN_MATURATION,SET,489,0.044599,0.0071773,0.037551,0.11749,GOBP_PROTEIN_MATURATION,0.878346856223176
GOBP_RENAL_SYSTEM_VASCULATUR...1,SET,31,0.20215,0.0082952,0.17022,0.1175,GOBP_RENAL_SYSTEM_VASCULATURE_DEVELOPMENT,0.878346856223176
GOCC_LARGE_RIBOSOMAL_SUBUNIT,SET,103,0.091181,0.0068068,0.076776,0.1175,GOCC_LARGE_RIBOSOMAL_SUBUNIT,0.878346856223176
ABRAMSON_INTERACT_WITH_AIRE,SET,39,0.14148,0.0065102,0.11915,0.11754,ABRAMSON_INTERACT_WITH_AIRE,0.878346856223176
REACTOME_HYALURONAN_UPTAKE_A...,SET,12,0.2709,0.0069197,0.22818,0.11758,REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION,0.878346856223176
GOBP_LIPOPROTEIN_CATABOLIC_P...,SET,15,0.26368,0.0075297,0.22212,0.1176,GOBP_LIPOPROTEIN_CATABOLIC_PROCESS,0.878346856223176
CHICAS_RB1_TARGETS_SENESCENT,SET,506,0.04529,0.0074107,0.038157,0.11763,CHICAS_RB1_TARGETS_SENESCENT,0.878346856223176
GSE6674_UNSTIM_VS_ANTI_IGM_S...1,SET,117,0.093997,0.0074758,0.079196,0.11764,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_DN,0.878346856223176
GAO_LARGE_INTESTINE_ADULT_CE...,SET,289,0.060607,0.0075399,0.051062,0.11764,GAO_LARGE_INTESTINE_ADULT_CE_OLFM4HIGH_STEM_CELL,0.878346856223176
HP_SHORT_PHILTRUM,SET,213,0.067328,0.007206,0.056733,0.11767,HP_SHORT_PHILTRUM,0.878346856223176
GSE21063_3H_VS_16H_ANTI_IGM_...3,SET,182,0.071955,0.0071248,0.060639,0.1177,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_DN,0.878346856223176
GOBP_OOCYTE_MATURATION,SET,30,0.18758,0.0075724,0.15809,0.11771,GOBP_OOCYTE_MATURATION,0.878346856223176
GOMF_NUCLEOSIDE_TRANSMEMBRAN...,SET,10,0.34891,0.0081364,0.29406,0.11772,GOMF_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.878346856223176
BLANCO_MELO_COVID19_BRONCHIA...2,SET,137,0.09298,0.0079977,0.078383,0.11777,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_UP,0.878346856223176
GOCC_OUTER_MITOCHONDRIAL_MEM...,SET,18,0.2195,0.006866,0.18504,0.11777,GOCC_OUTER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.878346856223176
GOBP_NEGATIVE_REGULATION_OF_...195,SET,17,0.21822,0.0066338,0.184,0.11783,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.878605803475649
KEGG_MEDICUS_REFERENCE_PDGF_...3,SET,16,0.25496,0.0075194,0.21501,0.11786,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_RAS_ERK_SIGNALING_PATHWAY,0.878640990990991
MODULE_151,SET,274,0.057277,0.0069412,0.048311,0.1179,MODULE_151,0.878750696976196
GOBP_HUMORAL_IMMUNE_RESPONSE,SET,232,0.076293,0.0085174,0.064363,0.11795,GOBP_HUMORAL_IMMUNE_RESPONSE,0.878856075867981
GSE6269_STAPH_AUREUS_VS_STRE...1,SET,158,0.078872,0.0072814,0.06655,0.11798,GSE6269_STAPH_AUREUS_VS_STREP_PNEUMO_INF_PBMC_DN,0.878856075867981
GOBP_ESTABLISHMENT_OF_PLANAR...1,SET,12,0.27978,0.0071466,0.23608,0.11799,GOBP_ESTABLISHMENT_OF_PLANAR_POLARITY_INVOLVED_IN_NEURAL_TUBE_CLOSURE,0.878856075867981
DESCARTES_FETAL_ADRENAL_SYMP...,SET,90,0.11875,0.0082892,0.10024,0.1181,DESCARTES_FETAL_ADRENAL_SYMPATHOBLASTS,0.879486929505035
GOBP_CELL_CELL_ADHESION_INVO...,SET,11,0.29829,0.0072954,0.25187,0.11815,GOBP_CELL_CELL_ADHESION_INVOLVED_IN_GASTRULATION,0.879670790488432
DELYS_THYROID_CANCER_DN,SET,213,0.075066,0.0080342,0.063398,0.11821,DELYS_THYROID_CANCER_DN,0.87970105973025
HP_NAEVUS_FLAMMEUS_OF_THE_EY...,SET,7,0.36063,0.0070367,0.3046,0.11822,HP_NAEVUS_FLAMMEUS_OF_THE_EYELID,0.87970105973025
GSE10239_KLRG1INT_VS_KLRG1HI...2,SET,183,0.071154,0.0070646,0.0601,0.11823,GSE10239_KLRG1INT_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.87970105973025
GOBP_NUCLEAR_TRANSCRIBED_MRN...3,SET,6,0.38162,0.006894,0.32241,0.11829,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_INDEPENDENT_DECAY,0.87995910744863
GOBP_NEGATIVE_REGULATION_OF_...56,SET,14,0.26277,0.0072495,0.22206,0.11835,GOBP_NEGATIVE_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.879989165775401
GSE5542_IFNG_VS_IFNA_AND_IFN...1,SET,182,0.073235,0.0072516,0.061888,0.11835,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.879989165775401
HP_AGENESIS_OF_CENTRAL_INCIS...,SET,13,0.29359,0.0078056,0.24813,0.11837,HP_AGENESIS_OF_CENTRAL_INCISOR,0.879989165775401
GSE16385_IL4_VS_ROSIGLITAZON...2,SET,174,0.072503,0.0070211,0.061304,0.11848,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.880169636788445
GOMF_TRANSMEMBRANE_RECEPTOR_...1,SET,80,0.12054,0.0079353,0.10193,0.11849,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_KINASE_ACTIVITY,0.880169636788445
KEGG_MEDICUS_REFERENCE_ACTIV...2,SET,23,0.20283,0.0071709,0.17153,0.11851,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119_IN_GERMLINE_GENES,0.880169636788445
TGTGTGA_MIR377,SET,182,0.073257,0.0072537,0.061962,0.11855,TGTGTGA_MIR377,0.880169636788445
MIR4687_3P,SET,76,0.11932,0.0076571,0.10093,0.11858,MIR4687_3P,0.880169636788445
HP_ABNORMAL_T_WAVE,SET,35,0.1737,0.0075727,0.14695,0.11861,HP_ABNORMAL_T_WAVE,0.880169636788445
GSE17721_CTRL_VS_PAM3CSK4_0....1,SET,181,0.073189,0.0072272,0.061926,0.11864,GSE17721_CTRL_VS_PAM3CSK4_0.5H_BMDC_DN,0.880169636788445
TRAVAGLINI_LUNG_MESOTHELIAL_...,SET,581,0.042755,0.0074807,0.036178,0.11865,TRAVAGLINI_LUNG_MESOTHELIAL_CELL,0.880169636788445
GOBP_REGULATION_OF_MONOATOMI...1,SET,6,0.45815,0.0082765,0.38776,0.11871,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORT,0.880169636788445
HP_MENTAL_DETERIORATION,SET,335,0.053768,0.0071927,0.045509,0.11871,HP_MENTAL_DETERIORATION,0.880169636788445
MODULE_18,SET,415,0.049055,0.0072877,0.041528,0.11876,MODULE_18,0.880169636788445
GSE5503_LIVER_DC_VS_MLN_DC_A...2,SET,179,0.074732,0.0073392,0.063267,0.11877,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,0.880169636788445
MIR6852_5P,SET,175,0.074989,0.0072825,0.06349,0.11878,MIR6852_5P,0.880169636788445
HP_ABNORMAL_CIRCULATING_INHI...,SET,6,0.50041,0.00904,0.42381,0.11886,HP_ABNORMAL_CIRCULATING_INHIBIN_B_CONCENTRATION,0.880169636788445
HP_FOLLICULAR_THYROID_CARCIN...,SET,16,0.24025,0.0070856,0.20348,0.11887,HP_FOLLICULAR_THYROID_CARCINOMA,0.880169636788445
HP_STOOPED_POSTURE,SET,8,0.312,0.0065079,0.26427,0.11889,HP_STOOPED_POSTURE,0.880169636788445
GSE16385_MONOCYTE_VS_12H_ROS...2,SET,187,0.072929,0.0073187,0.061778,0.11891,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.880169636788445
NKX22_01,SET,169,0.082364,0.0078617,0.069782,0.11895,NKX22_01,0.880169636788445
GOBP_REGULATION_OF_NUCLEOTID...1,SET,13,0.31134,0.0082775,0.26381,0.11897,GOBP_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.880169636788445
GOBP_REGULATION_OF_TOLL_LIKE...4,SET,4,0.61094,0.009012,0.51772,0.11899,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_7_SIGNALING_PATHWAY,0.880169636788445
GSE30971_WBP7_HET_VS_KO_MACR...6,SET,184,0.073682,0.0073354,0.062446,0.11902,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_UP,0.880169636788445
HP_ABNORMALITY_OF_BLOOD_CIRC...,SET,334,0.055337,0.0073917,0.046899,0.11903,HP_ABNORMALITY_OF_BLOOD_CIRCULATION,0.880169636788445
REACTOME_AUTOPHAGY,SET,145,0.081295,0.0071923,0.068907,0.11905,REACTOME_AUTOPHAGY,0.880169636788445
GOBP_FORELIMB_MORPHOGENESIS,SET,38,0.17736,0.0080564,0.15033,0.11905,GOBP_FORELIMB_MORPHOGENESIS,0.880169636788445
HP_ATLANTOAXIAL_ABNORMALITY,SET,12,0.27022,0.0069024,0.22904,0.11905,HP_ATLANTOAXIAL_ABNORMALITY,0.880169636788445
MODULE_505,SET,16,0.26089,0.0076942,0.22114,0.11906,MODULE_505,0.880169636788445
HP_ABNORMAL_TALUS_MORPHOLOGY,SET,61,0.12476,0.0071754,0.10576,0.11909,HP_ABNORMAL_TALUS_MORPHOLOGY,0.880169636788445
GOMF_NUCLEAR_IMPORT_SIGNAL_R...,SET,19,0.20199,0.0064911,0.17129,0.11916,GOMF_NUCLEAR_IMPORT_SIGNAL_RECEPTOR_ACTIVITY,0.880169636788445
BIOCARTA_BARRESTIN_PATHWAY,SET,11,0.33337,0.0081533,0.28271,0.11917,BIOCARTA_BARRESTIN_PATHWAY,0.880169636788445
TAF9B_TARGET_GENES,SET,397,0.048843,0.0071006,0.041427,0.1192,TAF9B_TARGET_GENES,0.880169636788445
HP_CERVICAL_LYMPHADENOPATHY,SET,9,0.29143,0.0064474,0.24719,0.11922,HP_CERVICAL_LYMPHADENOPATHY,0.880169636788445
GSE17974_CTRL_VS_ACT_IL4_AND...16,SET,161,0.079224,0.0073824,0.067201,0.11922,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_UP,0.880169636788445
HP_PARACENTRAL_SCOTOMA,SET,7,0.42933,0.0083771,0.36418,0.11923,HP_PARACENTRAL_SCOTOMA,0.880169636788445
REACTOME_INTERLEUKIN_15_SIGN...,SET,13,0.28282,0.0075192,0.23997,0.1193,REACTOME_INTERLEUKIN_15_SIGNALING,0.880220640495868
GOBP_REGULATION_OF_MRNA_META...,SET,271,0.058023,0.0069936,0.049236,0.11931,GOBP_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.880220640495868
FOXO4_02,SET,239,0.066176,0.0074972,0.056165,0.11936,FOXO4_02,0.880220640495868
GSE360_L_DONOVANI_VS_M_TUBER...3,SET,188,0.073542,0.0073998,0.062425,0.11939,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_DN,0.880220640495868
LIU_IL13_PRIMING_MODEL,SET,15,0.26474,0.0075602,0.22482,0.11949,LIU_IL13_PRIMING_MODEL,0.880220640495868
GOBP_POSITIVE_REGULATION_OF_...288,SET,26,0.18721,0.0070365,0.15899,0.11951,GOBP_POSITIVE_REGULATION_OF_FOCAL_ADHESION_ASSEMBLY,0.880220640495868
REACTOME_TOXICITY_OF_BOTULIN...,SET,5,0.40682,0.0067092,0.34558,0.11956,REACTOME_TOXICITY_OF_BOTULINUM_TOXIN_TYPE_D_BOTD,0.880220640495868
BIOCARTA_SRCRPTP_PATHWAY,SET,11,0.27502,0.0067262,0.23363,0.11958,BIOCARTA_SRCRPTP_PATHWAY,0.880220640495868
MYLLYKANGAS_AMPLIFICATION_HO...14,SET,5,0.36171,0.0059652,0.30729,0.11959,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_30,0.880220640495868
KEGG_TASTE_TRANSDUCTION,SET,48,0.16354,0.0083466,0.13896,0.11963,KEGG_TASTE_TRANSDUCTION,0.880220640495868
GOBP_POSITIVE_REGULATION_OF_...6,SET,13,0.27677,0.0073582,0.23518,0.11964,GOBP_POSITIVE_REGULATION_OF_ACTIN_NUCLEATION,0.880220640495868
GOBP_DEMETHYLATION,SET,37,0.1603,0.0071852,0.13623,0.11966,GOBP_DEMETHYLATION,0.880220640495868
GOBP_ANTIGEN_PROCESSING_AND_...2,SET,5,0.69729,0.0115,0.5926,0.11967,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_ENDOGENOUS_LIPID_ANTIGEN_VIA_MHC_CLASS_IB,0.880220640495868
GOMF_LIPID_ANTIGEN_BINDING,SET,5,0.69729,0.0115,0.5926,0.11967,GOMF_LIPID_ANTIGEN_BINDING,0.880220640495868
REACTOME_MITOCHONDRIAL_UNCOU...,SET,6,0.38541,0.0069625,0.32764,0.11974,REACTOME_MITOCHONDRIAL_UNCOUPLING,0.880220640495868
GSE557_WT_VS_I_AB_KO_DC_DN,SET,181,0.071944,0.0071044,0.061167,0.11977,GSE557_WT_VS_I_AB_KO_DC_DN,0.880220640495868
GSE1448_CTRL_VS_ANTI_VBETA5_...1,SET,185,0.072225,0.0072097,0.06141,0.11978,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN,0.880220640495868
HP_BROAD_HALLUX_PHALANX,SET,19,0.24367,0.0078305,0.2072,0.11981,HP_BROAD_HALLUX_PHALANX,0.880220640495868
HP_AGENESIS_OF_CEREBELLAR_VE...,SET,16,0.21384,0.0063065,0.18188,0.11987,HP_AGENESIS_OF_CEREBELLAR_VERMIS,0.880220640495868
GOBP_T_CELL_SELECTION,SET,57,0.14415,0.008015,0.12263,0.11991,GOBP_T_CELL_SELECTION,0.880220640495868
ONDER_CDH1_TARGETS_1_UP,SET,123,0.090628,0.0073892,0.077109,0.11994,ONDER_CDH1_TARGETS_1_UP,0.880220640495868
REACTOME_SIGNALING_BY_NUCLEA...,SET,229,0.066958,0.0074275,0.056976,0.11997,REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS,0.880220640495868
GOBP_MEMBRANE_RAFT_LOCALIZAT...,SET,6,0.35746,0.0064577,0.30418,0.11997,GOBP_MEMBRANE_RAFT_LOCALIZATION,0.880220640495868
HP_ORTHOPNEA,SET,68,0.12108,0.0073513,0.10305,0.12002,HP_ORTHOPNEA,0.880220640495868
REACTOME_GLYCOSPHINGOLIPID_B...,SET,19,0.24756,0.0079556,0.21079,0.12012,REACTOME_GLYCOSPHINGOLIPID_BIOSYNTHESIS,0.880220640495868
GOBP_REGULATION_OF_ENDOSOME_...1,SET,4,0.42241,0.006231,0.35967,0.12012,GOBP_REGULATION_OF_ENDOSOME_ORGANIZATION,0.880220640495868
GOBP_NEGATIVE_REGULATION_OF_...178,SET,29,0.16846,0.0066862,0.1435,0.12023,GOBP_NEGATIVE_REGULATION_OF_DEPHOSPHORYLATION,0.880220640495868
GSE20715_0H_VS_48H_OZONE_LUN...2,SET,180,0.074412,0.0073279,0.063391,0.12023,GSE20715_0H_VS_48H_OZONE_LUNG_UP,0.880220640495868
GOBP_ATRIOVENTRICULAR_CANAL_...,SET,13,0.29456,0.0078312,0.25094,0.12024,GOBP_ATRIOVENTRICULAR_CANAL_DEVELOPMENT,0.880220640495868
MODULE_179,SET,421,0.048367,0.007236,0.04121,0.12027,MODULE_179,0.880220640495868
HP_CEREBELLAR_HEMORRHAGE,SET,5,0.51933,0.0085647,0.44256,0.12031,HP_CEREBELLAR_HEMORRHAGE,0.880220640495868
HP_ABSENT_FRONTAL_SINUSES,SET,6,0.35871,0.0064801,0.30571,0.12034,HP_ABSENT_FRONTAL_SINUSES,0.880220640495868
GSE45365_WT_VS_IFNAR_KO_BCEL...4,SET,161,0.073032,0.0068054,0.062266,0.12043,GSE45365_WT_VS_IFNAR_KO_BCELL_UP,0.880220640495868
TSENG_IRS1_TARGETS_DN,SET,112,0.10017,0.0077954,0.085414,0.12047,TSENG_IRS1_TARGETS_DN,0.880220640495868
GOMF_HYDROLASE_ACTIVITY_ACTI...6,SET,11,0.29955,0.007326,0.25544,0.12047,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDINES,0.880220640495868
GSE360_CTRL_VS_M_TUBERCULOSI...3,SET,177,0.072731,0.0071031,0.062034,0.12052,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_DN,0.880220640495868
BYSTRYKH_HEMATOPOIESIS_STEM_...2,SET,142,0.081721,0.0071554,0.069715,0.12056,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_TRANS,0.880220640495868
KEGG_MEDICUS_VARIANT_MUTATIO...63,SET,27,0.17324,0.0066351,0.14779,0.12056,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT,0.880220640495868
REACTOME_TRAF3_DEPENDENT_IRF...,SET,14,0.25169,0.006944,0.2148,0.12065,REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY,0.880220640495868
GOBP_ECTODERM_DEVELOPMENT,SET,19,0.23825,0.0076565,0.20333,0.12066,GOBP_ECTODERM_DEVELOPMENT,0.880220640495868
OCT1_06,SET,223,0.070951,0.0077678,0.060556,0.12068,OCT1_06,0.880220640495868
GOBP_ACTIVATION_OF_JANUS_KIN...,SET,13,0.27137,0.0072148,0.23162,0.12068,GOBP_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.880220640495868
HP_BROAD_FACE,SET,15,0.25813,0.0073713,0.22031,0.12068,HP_BROAD_FACE,0.880220640495868
GSE1432_CTRL_VS_IFNG_6H_MICR...1,SET,183,0.075292,0.0074755,0.064274,0.12072,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_DN,0.880220640495868
NAKAYA_PBMC_FLUARIX_FLUVIRIN...2,SET,564,0.040862,0.0070475,0.034887,0.12075,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_UP,0.880220640495868
GABP_B,SET,240,0.061768,0.0070122,0.052739,0.12077,GABP_B,0.880220640495868
GOBP_MITOCHONDRIAL_CALCIUM_I...1,SET,21,0.21832,0.0073756,0.18644,0.1208,GOBP_MITOCHONDRIAL_CALCIUM_ION_HOMEOSTASIS,0.880220640495868
KEGG_RNA_POLYMERASE,SET,24,0.17935,0.0064767,0.15322,0.1209,KEGG_RNA_POLYMERASE,0.880220640495868
GAUTAM_EYE_IRIS_CILIARY_BODY...14,SET,11,0.28319,0.006926,0.24196,0.12092,GAUTAM_EYE_IRIS_CILIARY_BODY_RIBOSOMAL_GENES_HIGH_FIBROBLASTS,0.880220640495868
NUYTTEN_EZH2_TARGETS_DN,SET,909,0.031812,0.0068976,0.027182,0.12094,NUYTTEN_EZH2_TARGETS_DN,0.880220640495868
REACTOME_SYNTHESIS_OF_BILE_A...1,SET,33,0.18306,0.0077498,0.15643,0.12096,REACTOME_SYNTHESIS_OF_BILE_ACIDS_AND_BILE_SALTS,0.880220640495868
MIR4774_5P,SET,87,0.10322,0.0070851,0.088235,0.12103,MIR4774_5P,0.880220640495868
MIR5787,SET,230,0.065004,0.0072261,0.055568,0.12105,MIR5787,0.880220640495868
INAMURA_LUNG_CANCER_SCC_SUBT...,SET,12,0.24746,0.0063212,0.21156,0.12107,INAMURA_LUNG_CANCER_SCC_SUBTYPES_UP,0.880220640495868
GOBP_NEGATIVE_REGULATION_OF_...572,SET,8,0.35201,0.0073424,0.30094,0.12107,GOBP_NEGATIVE_REGULATION_OF_RETINOIC_ACID_RECEPTOR_SIGNALING_PATHWAY,0.880220640495868
GOBP_REGULATION_OF_PROTEIN_P...2,SET,22,0.21748,0.00752,0.18594,0.12108,GOBP_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,0.880220640495868
REACTOME_INTESTINAL_ABSORPTI...,SET,5,0.48546,0.0080061,0.4151,0.12111,REACTOME_INTESTINAL_ABSORPTION,0.880220640495868
LI_ESTROGENE_NON_MCF7_T47D_E...1,SET,6,0.44404,0.0080218,0.37974,0.12114,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_DN,0.880220640495868
HP_MICROSCOPIC_HEMATURIA,SET,18,0.23677,0.007406,0.20248,0.12114,HP_MICROSCOPIC_HEMATURIA,0.880220640495868
GSE5589_WT_VS_IL10_KO_LPS_AN...5,SET,182,0.072659,0.0071946,0.062144,0.12117,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.880220640495868
MIR8079,SET,30,0.19729,0.0079645,0.16878,0.12122,MIR8079,0.880220640495868
HP_ABNORMAL_EXPERIENCE_OF_RE...,SET,534,0.042882,0.0072025,0.036686,0.12123,HP_ABNORMAL_EXPERIENCE_OF_REALITY,0.880220640495868
REACTOME_PLASMA_LIPOPROTEIN_...3,SET,36,0.16887,0.0074665,0.14447,0.12124,REACTOME_PLASMA_LIPOPROTEIN_CLEARANCE,0.880220640495868
GOCC_VCP_NPL4_UFD1_AAA_ATPAS...,SET,7,0.38906,0.0075914,0.33288,0.12125,GOCC_VCP_NPL4_UFD1_AAA_ATPASE_COMPLEX,0.880220640495868
HP_SPARSE_AXILLARY_HAIR,SET,42,0.16311,0.0077884,0.13956,0.12126,HP_SPARSE_AXILLARY_HAIR,0.880220640495868
ZNF502_TARGET_GENES,SET,25,0.18721,0.0069,0.16019,0.12127,ZNF502_TARGET_GENES,0.880220640495868
BIOCARTA_CXCR4_PATHWAY,SET,19,0.23385,0.007515,0.20011,0.12128,BIOCARTA_CXCR4_PATHWAY,0.880220640495868
HP_HYPEREOSINOPHILIA,SET,5,0.45641,0.007527,0.39054,0.12128,HP_HYPEREOSINOPHILIA,0.880220640495868
HARALAMBIEVA_PBMC_M_M_R_II_A...4,SET,11,0.33616,0.0082215,0.28768,0.1213,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_DN,0.880220640495868
KEGG_B_CELL_RECEPTOR_SIGNALI...,SET,72,0.11663,0.0072854,0.099817,0.12133,KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.880220640495868
GSE16385_ROSIGLITAZONE_IL4_V...1,SET,169,0.078014,0.0074464,0.066771,0.12133,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_DN,0.880220640495868
MIR6847_3P,SET,55,0.12963,0.0070806,0.11095,0.12134,MIR6847_3P,0.880220640495868
REACTOME_SMOOTH_MUSCLE_CONTR...,SET,40,0.15822,0.0073732,0.13544,0.12137,REACTOME_SMOOTH_MUSCLE_CONTRACTION,0.880220640495868
HOEK_MONOCYTE_2011_2012_TIV_...2,SET,7,0.45327,0.0088443,0.38806,0.1214,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_UP,0.880220640495868
KEGG_MEDICUS_VARIANT_EML4_AL...4,SET,11,0.29001,0.0070929,0.24831,0.12142,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.880220640495868
MORF_PRKAR1A,SET,125,0.083526,0.0068649,0.071515,0.12142,MORF_PRKAR1A,0.880220640495868
HP_COCHLEAR_MALFORMATION,SET,8,0.31419,0.0065535,0.26903,0.12144,HP_COCHLEAR_MALFORMATION,0.880220640495868
FRASOR_RESPONSE_TO_SERM_OR_F...1,SET,48,0.13984,0.007137,0.11975,0.12146,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_DN,0.880220640495868
MIR5009_5P,SET,56,0.13905,0.0076639,0.11908,0.12147,MIR5009_5P,0.880220640495868
REACTOME_ION_HOMEOSTASIS,SET,52,0.14001,0.0074368,0.11991,0.1215,REACTOME_ION_HOMEOSTASIS,0.880220640495868
GOMF_GAP_JUNCTION_CHANNEL_AC...2,SET,5,0.48879,0.0080609,0.41866,0.12151,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_CONDUCTION_ELECTRICAL_COUPLING,0.880220640495868
GOBP_NETRIN_ACTIVATED_SIGNAL...,SET,8,0.35482,0.0074012,0.30394,0.12153,GOBP_NETRIN_ACTIVATED_SIGNALING_PATHWAY,0.880220640495868
GSE3982_CENT_MEMORY_CD4_TCEL...6,SET,175,0.075009,0.0072844,0.064256,0.12154,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_UP,0.880220640495868
GSE7460_WT_VS_FOXP3_HET_ACT_...1,SET,183,0.070443,0.0069941,0.060344,0.12154,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_DN,0.880220640495868
MULLIGAN_NTF3_SIGNALING_VIA_...2,SET,20,0.20364,0.006714,0.17446,0.12156,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_UP,0.880220640495868
GSE20366_EX_VIVO_VS_DEC205_C...3,SET,181,0.073411,0.0072492,0.06289,0.12156,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_UP,0.880220640495868
GSE45365_NK_CELL_VS_CD11B_DC...1,SET,184,0.075137,0.0074803,0.064373,0.12157,GSE45365_NK_CELL_VS_CD11B_DC_DN,0.880220640495868
GSE13547_CTRL_VS_ANTI_IGM_ST...7,SET,149,0.079565,0.0071349,0.068171,0.12159,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_2H_DN,0.880220640495868
MACLACHLAN_BRCA1_TARGETS_DN,SET,16,0.23373,0.0068932,0.20027,0.1216,MACLACHLAN_BRCA1_TARGETS_DN,0.880220640495868
REACTOME_REGULATION_OF_FOXO_...,SET,8,0.33957,0.0070831,0.29096,0.1216,REACTOME_REGULATION_OF_FOXO_TRANSCRIPTIONAL_ACTIVITY_BY_ACETYLATION,0.880220640495868
ZF5_B,SET,214,0.069055,0.007408,0.059175,0.12162,ZF5_B,0.880220640495868
FAN_OVARY_CL17_PUTATIVE_APOP...,SET,210,0.064661,0.0068722,0.05541,0.12162,FAN_OVARY_CL17_PUTATIVE_APOPTOTIC_SMOOTH_MUSCLE_CELL,0.880220640495868
MAZR_01,SET,204,0.066534,0.0069707,0.057023,0.12165,MAZR_01,0.880220640495868
KEGG_MEDICUS_REFERENCE_ARL8_...,SET,30,0.17825,0.0071956,0.15281,0.12172,KEGG_MEDICUS_REFERENCE_ARL8_REGULATED_MICROTUBULE_PLUS_END_DIRECTED_TRANSPORT,0.880220640495868
HP_ELBOW_ANKYLOSIS,SET,7,0.40358,0.0078748,0.34605,0.12176,HP_ELBOW_ANKYLOSIS,0.880220640495868
HP_HYDROCELE_TESTIS,SET,35,0.16119,0.0070273,0.13821,0.12176,HP_HYDROCELE_TESTIS,0.880220640495868
MOOTHA_PGC,SET,378,0.048704,0.0069125,0.041762,0.12177,MOOTHA_PGC,0.880220640495868
GOMF_PROTEIN_CARRIER_CHAPERO...,SET,31,0.1691,0.0069388,0.14502,0.12181,GOMF_PROTEIN_CARRIER_CHAPERONE,0.880220640495868
MIR6773_5P,SET,33,0.16454,0.0069658,0.14111,0.12182,MIR6773_5P,0.880220640495868
GOBP_POSITIVE_REGULATION_OF_...455,SET,2,0.75214,0.0078457,0.64507,0.12182,GOBP_POSITIVE_REGULATION_OF_METALLOENDOPEPTIDASE_ACTIVITY,0.880220640495868
BIOCARTA_STAT3_PATHWAY,SET,8,0.40191,0.0083834,0.34474,0.12184,BIOCARTA_STAT3_PATHWAY,0.880220640495868
DAIRKEE_CANCER_PRONE_RESPONS...3,SET,27,0.20049,0.0076788,0.17199,0.12187,DAIRKEE_CANCER_PRONE_RESPONSE_E2,0.880220640495868
HP_ABNORMALITY_OF_SECONDARY_...,SET,71,0.1201,0.0074505,0.10304,0.12189,HP_ABNORMALITY_OF_SECONDARY_SEXUAL_HAIR,0.880220640495868
GSE22501_PERIPHERAL_BLOOD_VS...2,SET,178,0.07586,0.0074293,0.065089,0.12192,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_UP,0.880220640495868
GOMF_ATPASE_COUPLED_INORGANI...,SET,10,0.32263,0.0075236,0.27689,0.12198,GOMF_ATPASE_COUPLED_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.880220640495868
MIR30A_5P,SET,709,0.038427,0.0074003,0.032986,0.12203,MIR30A_5P,0.880220640495868
MIR30D_5P,SET,709,0.038427,0.0074003,0.032986,0.12203,MIR30D_5P,0.880220640495868
MIR30E_5P,SET,709,0.038427,0.0074003,0.032986,0.12203,MIR30E_5P,0.880220640495868
MIR581,SET,73,0.11158,0.0070179,0.095786,0.12205,MIR581,0.880220640495868
GOBP_COLUMNAR_CUBOIDAL_EPITH...3,SET,14,0.27749,0.0076556,0.23826,0.1221,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_MATURATION,0.880220640495868
GSE38697_LIGHT_ZONE_VS_DARK_...1,SET,113,0.09473,0.007405,0.081354,0.12214,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,0.880220640495868
HP_ABNORMAL_SPERMATOGENESIS,SET,134,0.082361,0.0070068,0.070738,0.12216,HP_ABNORMAL_SPERMATOGENESIS,0.880220640495868
TURJANSKI_MAPK7_TARGETS,SET,7,0.41616,0.0081202,0.35749,0.12219,TURJANSKI_MAPK7_TARGETS,0.880220640495868
MIR4661_3P,SET,29,0.17199,0.0068266,0.14774,0.12219,MIR4661_3P,0.880220640495868
BIOCARTA_TERT_PATHWAY,SET,8,0.32204,0.0067173,0.27664,0.1222,BIOCARTA_TERT_PATHWAY,0.880220640495868
LY_AGING_PREMATURE_DN,SET,29,0.1761,0.0069898,0.15131,0.12224,LY_AGING_PREMATURE_DN,0.880220640495868
GOMF_TRANSITION_METAL_ION_TR...,SET,41,0.14108,0.0066562,0.12122,0.12224,GOMF_TRANSITION_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.880220640495868
HP_DECREASED_CIRCULATING_DEH...,SET,7,0.3761,0.0073385,0.32318,0.12227,HP_DECREASED_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.880220640495868
GHANDHI_BYSTANDER_IRRADIATIO...1,SET,11,0.35232,0.0086168,0.30282,0.12232,GHANDHI_BYSTANDER_IRRADIATION_DN,0.880220640495868
BUSSLINGER_ESOPHAGEAL_QUIESC...,SET,70,0.12034,0.0074128,0.10343,0.12232,BUSSLINGER_ESOPHAGEAL_QUIESCENT_BASAL_CELLS,0.880220640495868
REACTOME_SIGNALING_BY_FGFR2,SET,71,0.1143,0.0070907,0.098249,0.12234,REACTOME_SIGNALING_BY_FGFR2,0.880220640495868
HAN_SATB1_TARGETS_DN,SET,346,0.054824,0.0074512,0.047128,0.12236,HAN_SATB1_TARGETS_DN,0.880220640495868
NUNODA_RESPONSE_TO_DASATINIB...1,SET,13,0.264,0.0070188,0.22695,0.12237,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_DN,0.880220640495868
FAN_OVARY_CL6_PUTATIVE_EARLY...,SET,260,0.062964,0.0074357,0.054129,0.12238,FAN_OVARY_CL6_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_2,0.880220640495868
KEGG_MEDICUS_PATHOGEN_HIV_GP...2,SET,17,0.22316,0.006784,0.19188,0.12241,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAQ_PLCB_G_CALCINEURIN,0.880220640495868
GOBP_SNO_S_RNA_METABOLIC_PRO...,SET,11,0.26805,0.0065558,0.23055,0.12249,GOBP_SNO_S_RNA_METABOLIC_PROCESS,0.880220640495868
HP_2_3_TOE_CUTANEOUS_SYNDACT...,SET,13,0.27977,0.007438,0.24063,0.1225,HP_2_3_TOE_CUTANEOUS_SYNDACTYLY,0.880220640495868
GSE17721_POLYIC_VS_PAM3CSK4_...2,SET,180,0.073209,0.0072095,0.06297,0.1225,GSE17721_POLYIC_VS_PAM3CSK4_0.5H_BMDC_UP,0.880220640495868
GOBP_BRANCHED_CHAIN_AMINO_AC...4,SET,13,0.27986,0.0074404,0.24073,0.12251,GOBP_BRANCHED_CHAIN_AMINO_ACID_TRANSPORT,0.880220640495868
GOBP_URATE_TRANSPORT,SET,11,0.29536,0.0072237,0.25412,0.12256,GOBP_URATE_TRANSPORT,0.880220640495868
SOX15_TARGET_GENES,SET,3,0.51527,0.0065826,0.44334,0.12258,SOX15_TARGET_GENES,0.880220640495868
E2F3_UP.V1_UP,SET,175,0.073598,0.0071473,0.063326,0.12258,E2F3_UP.V1_UP,0.880220640495868
WP_SUPPRESSION_OF_HMGB1MEDIA...,SET,8,0.3501,0.0073026,0.30139,0.1227,WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD,0.880608310964278
MIR3145_5P,SET,93,0.097415,0.006912,0.083862,0.1227,MIR3145_5P,0.880608310964278
WP_BIOGENIC_AMINE_SYNTHESIS,SET,13,0.27528,0.0073188,0.23699,0.12271,WP_BIOGENIC_AMINE_SYNTHESIS,0.880608310964278
MENON_FETAL_KIDNEY_4_PODOCYT...,SET,182,0.0735,0.0072778,0.06329,0.12276,MENON_FETAL_KIDNEY_4_PODOCYTES,0.880785260115607
GSE9988_ANTI_TREM1_VS_CTRL_T...2,SET,172,0.081005,0.0077996,0.069761,0.12279,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_UP,0.88081866873065
GSE13306_RA_VS_UNTREATED_MEM...1,SET,170,0.074963,0.0071762,0.064576,0.12286,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_DN,0.881121727963838
GOMF_IMPORTIN_ALPHA_FAMILY_P...,SET,9,0.3917,0.0086658,0.33746,0.12289,GOMF_IMPORTIN_ALPHA_FAMILY_PROTEIN_BINDING,0.881121727963838
FAN_EMBRYONIC_CTX_BIG_GROUPS...7,SET,335,0.056796,0.0075978,0.048943,0.12294,FAN_EMBRYONIC_CTX_BIG_GROUPS_MICROGLIA,0.881121727963838
KEGG_MEDICUS_REFERENCE_HEPAR...1,SET,11,0.31048,0.0075933,0.26758,0.12297,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_BIOSYNTHESIS,0.881121727963838
GOCC_CHROMOCENTER,SET,13,0.26849,0.0071381,0.2314,0.12297,GOCC_CHROMOCENTER,0.881121727963838
CGCAAAA_MIR450,SET,9,0.32833,0.0072639,0.28301,0.12301,CGCAAAA_MIR450,0.881121727963838
HP_ABNORMALITY_OF_CYTOKINE_S...,SET,6,0.44537,0.0080457,0.38396,0.12304,HP_ABNORMALITY_OF_CYTOKINE_SECRETION,0.881121727963838
HP_ABNORMAL_ARACHNOID_MATER_...,SET,48,0.13827,0.0070572,0.11923,0.12309,HP_ABNORMAL_ARACHNOID_MATER_MORPHOLOGY,0.881121727963838
HP_NECK_FLEXOR_WEAKNESS,SET,43,0.13807,0.0066707,0.11905,0.12309,HP_NECK_FLEXOR_WEAKNESS,0.881121727963838
GSE17721_POLYIC_VS_CPG_16H_B...1,SET,180,0.071561,0.0070472,0.061719,0.12314,GSE17721_POLYIC_VS_CPG_16H_BMDC_DN,0.881121727963838
KEGG_MEDICUS_PATHOGEN_HTLV_1...8,SET,5,0.46895,0.0077338,0.4045,0.12317,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SRF_MEDIATED_TRANSCRIPTION,0.881121727963838
GOBP_REGULATION_OF_LYMPHOCYT...6,SET,63,0.12574,0.0073489,0.10846,0.12318,GOBP_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.881121727963838
GSE22935_WT_VS_MYD88_KO_MACR...7,SET,180,0.076597,0.0075431,0.066073,0.12318,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_DN,0.881121727963838
GSE7852_LN_VS_FAT_TCONV_UP,SET,180,0.071737,0.0070645,0.061896,0.12324,GSE7852_LN_VS_FAT_TCONV_UP,0.881121727963838
GOBP_ADENYLATE_CYCLASE_ACTIV...2,SET,9,0.3314,0.0073316,0.28596,0.12326,GOBP_ADENYLATE_CYCLASE_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,0.881121727963838
HP_POSITIONAL_FOOT_DEFORMITY,SET,414,0.049068,0.007281,0.042341,0.12326,HP_POSITIONAL_FOOT_DEFORMITY,0.881121727963838
REACTOME_TERMINAL_PATHWAY_OF...,SET,8,0.35169,0.0073359,0.30349,0.12327,REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT,0.881121727963838
HAY_BONE_MARROW_PRE_DENDRITIC,SET,5,0.46543,0.0076757,0.40171,0.12331,HAY_BONE_MARROW_PRE_DENDRITIC,0.881121727963838
DACOSTA_UV_RESPONSE_VIA_ERCC...5,SET,49,0.14334,0.0073915,0.12375,0.12337,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_UP,0.881121727963838
GOBP_REGULATION_OF_MYOSIN_LI...,SET,7,0.34484,0.0067285,0.29772,0.12338,GOBP_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,0.881121727963838
GSE5589_LPS_AND_IL10_VS_LPS_...4,SET,182,0.071367,0.0070667,0.061615,0.12338,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,0.881121727963838
MIR203A_5P,SET,51,0.13204,0.0069461,0.114,0.12339,MIR203A_5P,0.881121727963838
HP_DRY_HAIR,SET,16,0.24277,0.00716,0.20965,0.12344,HP_DRY_HAIR,0.881297699260477
HP_LATE_FIRST_TRIMESTER_ONSET,SET,7,0.34971,0.0068237,0.30206,0.12349,HP_LATE_FIRST_TRIMESTER_ONSET,0.8814735982748
HP_ABNORMAL_SARCOMERE_MORPHO...,SET,12,0.2823,0.0072111,0.24392,0.12357,HP_ABNORMAL_SARCOMERE_MORPHOLOGY,0.881863521560575
MIR1180_5P,SET,34,0.16012,0.0068806,0.1384,0.12365,MIR1180_5P,0.882253284746459
chr3q27,SET,60,0.27496,0.015685,0.23771,0.1237,chr3q27,0.882302582496413
HP_DUPLICATED_COLLECTING_SYS...,SET,19,0.20812,0.0066881,0.17993,0.12371,HP_DUPLICATED_COLLECTING_SYSTEM,0.882302582496413
GOBP_REGULATION_OF_PLASMA_CE...,SET,6,0.3794,0.006854,0.32808,0.12376,GOBP_REGULATION_OF_PLASMA_CELL_DIFFERENTIATION,0.882302582496413
GSE25085_FETAL_BM_VS_ADULT_B...1,SET,180,0.07407,0.0072942,0.064058,0.12379,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,0.882302582496413
HP_CERVICAL_SPINAL_CORD_ATRO...,SET,5,0.44583,0.0073525,0.38562,0.12382,HP_CERVICAL_SPINAL_CORD_ATROPHY,0.882302582496413
ATGAAGG_MIR205,SET,139,0.081893,0.0070949,0.07084,0.12384,ATGAAGG_MIR205,0.882302582496413
YANAGISAWA_LUNG_CANCER_RECUR...,SET,6,0.40527,0.0073214,0.35058,0.12385,YANAGISAWA_LUNG_CANCER_RECURRENCE,0.882302582496413
GOBP_EPITHELIAL_FLUID_TRANSP...,SET,12,0.30093,0.0076869,0.26034,0.12386,GOBP_EPITHELIAL_FLUID_TRANSPORT,0.882302582496413
LCORL_TARGET_GENES,SET,359,0.050053,0.0069268,0.043315,0.12394,LCORL_TARGET_GENES,0.882653103872157
GSE7219_WT_VS_NIK_NFKB2_KO_L...2,SET,181,0.07788,0.0076905,0.067402,0.12396,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_UP,0.882653103872157
SAKAI_TUMOR_INFILTRATING_MON...1,SET,75,0.10437,0.0066533,0.090341,0.124,SAKAI_TUMOR_INFILTRATING_MONOCYTES_DN,0.882757066775912
JINESH_BLEBBISHIELD_VS_LIVE_...1,SET,241,0.066475,0.0075621,0.057565,0.1241,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_DN,0.883270351810186
FOURNIER_ACINAR_DEVELOPMENT_...2,SET,18,0.25864,0.0080903,0.22401,0.12413,FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP,0.883270351810186
GARGALOVIC_RESPONSE_TO_OXIDI...21,SET,48,0.13668,0.0069761,0.11841,0.12418,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_DN,0.883270351810186
MIR335_5P,SET,105,0.096454,0.0072696,0.083559,0.12419,MIR335_5P,0.883270351810186
MIR511_5P,SET,291,0.057748,0.0072087,0.050029,0.1242,MIR511_5P,0.883270351810186
KEGG_GAP_JUNCTION,SET,84,0.11186,0.0075453,0.096933,0.12425,KEGG_GAP_JUNCTION,0.883270351810186
FRANCO_BLOOD_SANOFI_PASTEUR_...1,SET,14,0.2767,0.0076339,0.23977,0.12425,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_NEGATIVE,0.883270351810186
HP_APLASIA_OF_THE_PHALANGES_...,SET,8,0.32972,0.0068776,0.28576,0.12429,HP_APLASIA_OF_THE_PHALANGES_OF_THE_TOES,0.883374018404908
KEGG_HOMOLOGOUS_RECOMBINATION,SET,25,0.16875,0.0062196,0.14632,0.12439,KEGG_HOMOLOGOUS_RECOMBINATION,0.883575214548427
GOBP_INTERLEUKIN_17_PRODUCTI...,SET,37,0.17738,0.0079508,0.15379,0.12439,GOBP_INTERLEUKIN_17_PRODUCTION,0.883575214548427
GSE40274_FOXP3_VS_FOXP3_AND_...10,SET,185,0.07055,0.0070425,0.061175,0.12441,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.883575214548427
GOMF_ATP_DEPENDENT_CHROMATIN...,SET,33,0.15888,0.0067262,0.13777,0.12442,GOMF_ATP_DEPENDENT_CHROMATIN_REMODELER_ACTIVITY,0.883575214548427
ACEVEDO_LIVER_TUMOR_VS_NORMA...1,SET,241,0.063354,0.007207,0.054963,0.12453,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_DN,0.88409228413962
GOBP_AMYLOID_PRECURSOR_PROTE...2,SET,54,0.12949,0.0070085,0.11235,0.12456,GOBP_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.88409228413962
GOBP_VITAMIN_B6_METABOLIC_PR...,SET,5,0.45364,0.0074813,0.39365,0.12459,GOBP_VITAMIN_B6_METABOLIC_PROCESS,0.88409228413962
MAGRANGEAS_MULTIPLE_MYELOMA_...1,SET,24,0.21156,0.00764,0.18359,0.1246,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_DN,0.88409228413962
GOCC_MITOCHONDRIAL_LARGE_RIB...,SET,53,0.12164,0.0065229,0.10557,0.12462,GOCC_MITOCHONDRIAL_LARGE_RIBOSOMAL_SUBUNIT,0.88409228413962
HP_RADIAL_DEVIATION_OF_THE_2...,SET,6,0.43154,0.0077958,0.37458,0.12466,HP_RADIAL_DEVIATION_OF_THE_2ND_FINGER,0.884195571428571
SCHUETZ_BREAST_CANCER_DUCTAL...2,SET,322,0.057951,0.0076031,0.050324,0.12476,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP,0.884614718482252
GOBP_POSITIVE_REGULATION_OF_...11,SET,7,0.33187,0.0064755,0.28821,0.12477,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.884614718482252
MULLIGHAN_MLL_SIGNATURE_2_DN,SET,255,0.063573,0.0074361,0.05522,0.12482,MULLIGHAN_MLL_SIGNATURE_2_DN,0.884666289731051
HP_CAVUM_SEPTUM_PELLUCIDUM,SET,30,0.17158,0.0069265,0.14904,0.12483,HP_CAVUM_SEPTUM_PELLUCIDUM,0.884666289731051
MIR4271,SET,198,0.068445,0.0070658,0.059465,0.12487,MIR4271,0.884666289731051
CHANG_POU5F1_TARGETS_DN,SET,7,0.42202,0.0082344,0.3667,0.1249,CHANG_POU5F1_TARGETS_DN,0.884666289731051
MIR6778_3P,SET,204,0.064454,0.0067528,0.056008,0.12491,MIR6778_3P,0.884666289731051
HP_PERIPHERAL_OPACIFICATION_...,SET,16,0.2552,0.0075266,0.22177,0.12493,HP_PERIPHERAL_OPACIFICATION_OF_THE_CORNEA,0.884666289731051
WP_TCA_CYCLE_AKA_KREBS_OR_CI...,SET,17,0.21208,0.0064472,0.18445,0.12511,WP_TCA_CYCLE_AKA_KREBS_OR_CITRIC_ACID_CYCLE,0.88562142422398
HP_CHOLESTATIC_LIVER_DISEASE,SET,16,0.25946,0.0076522,0.22574,0.1252,HP_CHOLESTATIC_LIVER_DISEASE,0.88562142422398
GOMF_PHOSPHATIDYLINOSITOL_3_...2,SET,6,0.33139,0.0059866,0.28835,0.12524,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.88562142422398
GOBP_SNRNA_CATABOLIC_PROCESS,SET,4,0.38867,0.0057333,0.33822,0.12525,GOBP_SNRNA_CATABOLIC_PROCESS,0.88562142422398
KEGG_MEDICUS_VARIANT_LRP6_OV...,SET,43,0.15481,0.0074792,0.13472,0.12526,KEGG_MEDICUS_VARIANT_LRP6_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.88562142422398
SENGUPTA_NASOPHARYNGEAL_CARC...2,SET,286,0.060178,0.0074482,0.052384,0.12533,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP,0.88562142422398
REACTOME_FORMATION_OF_THE_PO...,SET,9,0.35528,0.0078601,0.30926,0.12533,REACTOME_FORMATION_OF_THE_POSTERIOR_NEURAL_PLATE,0.88562142422398
GOBP_REGULATION_OF_CILIUM_AS...,SET,89,0.10181,0.0070674,0.088632,0.12536,GOBP_REGULATION_OF_CILIUM_ASSEMBLY,0.88562142422398
HP_BROAD_THUMB,SET,75,0.1133,0.0072228,0.098658,0.12541,HP_BROAD_THUMB,0.88562142422398
GOBP_POSITIVE_REGULATION_OF_...493,SET,29,0.16063,0.0063756,0.13988,0.12543,GOBP_POSITIVE_REGULATION_OF_MRNA_PROCESSING,0.88562142422398
HP_INTERSTITIAL_CARDIAC_FIBR...,SET,9,0.34359,0.0076015,0.29922,0.12543,HP_INTERSTITIAL_CARDIAC_FIBROSIS,0.88562142422398
VALK_AML_CLUSTER_12,SET,24,0.18748,0.0067706,0.16328,0.12544,VALK_AML_CLUSTER_12,0.88562142422398
GOBP_CHEMOSENSORY_BEHAVIOR,SET,19,0.23745,0.0076308,0.20684,0.12549,GOBP_CHEMOSENSORY_BEHAVIOR,0.88562142422398
MIR12125,SET,101,0.095992,0.0070964,0.08362,0.1255,MIR12125,0.88562142422398
GSE22611_MUTANT_NOD2_TRANSDU...1,SET,184,0.0706,0.0070286,0.061505,0.12552,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_DN,0.88562142422398
CHYLA_CBFA2T3_TARGETS_UP,SET,346,0.054159,0.0073607,0.047186,0.12554,CHYLA_CBFA2T3_TARGETS_UP,0.88562142422398
REACTOME_DEFECTIVE_F9_ACTIVA...,SET,5,0.51569,0.0085045,0.44938,0.12558,REACTOME_DEFECTIVE_F9_ACTIVATION,0.88562142422398
HP_OVERLAPPING_FINGERS,SET,29,0.17919,0.0071124,0.15615,0.12558,HP_OVERLAPPING_FINGERS,0.88562142422398
MIR3176,SET,67,0.11241,0.0067744,0.097954,0.12559,MIR3176,0.88562142422398
GOBP_ACTIN_FILAMENT_BASED_MO...,SET,130,0.088157,0.007388,0.076822,0.12559,GOBP_ACTIN_FILAMENT_BASED_MOVEMENT,0.88562142422398
HP_HYPERAUTOFLUORESCENT_RETI...,SET,14,0.29014,0.0080047,0.25285,0.1256,HP_HYPERAUTOFLUORESCENT_RETINAL_LESION,0.88562142422398
MIR3677_5P,SET,24,0.18596,0.0067156,0.16213,0.12571,MIR3677_5P,0.885773703403566
BANP_TARGET_GENES,SET,613,0.038987,0.0070004,0.033995,0.12573,BANP_TARGET_GENES,0.885773703403566
GOMF_ALANINE_TRANSMEMBRANE_T...,SET,14,0.28324,0.0078142,0.24697,0.12573,GOMF_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.885773703403566
GSE3982_NKCELL_VS_TH2_DN,SET,179,0.068664,0.0067432,0.059872,0.12573,GSE3982_NKCELL_VS_TH2_DN,0.885773703403566
GAVISH_3CA_METAPROGRAM_B_CEL...9,SET,36,0.15291,0.0067609,0.13335,0.12577,GAVISH_3CA_METAPROGRAM_B_CELLS_PLASMA,0.885773703403566
GOBP_INFLAMMATORY_CELL_APOPT...,SET,21,0.20677,0.0069853,0.18033,0.12578,GOBP_INFLAMMATORY_CELL_APOPTOTIC_PROCESS,0.885773703403566
GSE42021_TREG_PLN_VS_TREG_PR...1,SET,188,0.073937,0.0074395,0.064487,0.1258,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_DN,0.885773703403566
HP_BROAD_PHILTRUM,SET,42,0.14518,0.0069323,0.12668,0.12589,HP_BROAD_PHILTRUM,0.886118772782503
GOBP_RESPONSE_TO_MURAMYL_DIP...,SET,18,0.20981,0.0065629,0.18308,0.1259,GOBP_RESPONSE_TO_MURAMYL_DIPEPTIDE,0.886118772782503
KEGG_MEDICUS_VARIANT_MUTATIO...47,SET,44,0.14123,0.0069019,0.12327,0.12596,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT,0.886213812993321
BOUDOUKHA_BOUND_BY_IGF2BP2,SET,92,0.098182,0.0069291,0.085698,0.12597,BOUDOUKHA_BOUND_BY_IGF2BP2,0.886213812993321
GOBP_NEGATIVE_REGULATION_OF_...177,SET,6,0.41662,0.0075263,0.36368,0.12599,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,0.886213812993321
GOBP_RESPONSE_TO_THYROXINE,SET,4,0.55491,0.0081855,0.48463,0.12611,GOBP_RESPONSE_TO_THYROXINE,0.886472911214013
PARK_HSC_AND_MULTIPOTENT_PRO...,SET,42,0.13945,0.0066586,0.1218,0.12614,PARK_HSC_AND_MULTIPOTENT_PROGENITORS,0.886472911214013
BAELDE_DIABETIC_NEPHROPATHY_...2,SET,82,0.1117,0.0074444,0.097578,0.12617,BAELDE_DIABETIC_NEPHROPATHY_UP,0.886472911214013
CTAGGAA_MIR384,SET,56,0.12742,0.0070226,0.11134,0.12624,CTAGGAA_MIR384,0.886472911214013
GSE26156_DOUBLE_POSITIVE_VS_...1,SET,185,0.068498,0.0068377,0.059877,0.12632,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,0.886472911214013
GSE6259_FLT3L_INDUCED_DEC205...5,SET,161,0.076189,0.0070996,0.066604,0.12634,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_DN,0.886472911214013
GSE29618_PRE_VS_DAY7_FLU_VAC...2,SET,177,0.073555,0.0071835,0.064306,0.12635,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_UP,0.886472911214013
HP_CEREBELLAR_CALCIFICATIONS,SET,8,0.37674,0.0078583,0.32939,0.12638,HP_CEREBELLAR_CALCIFICATIONS,0.886472911214013
BHAT_ESR1_TARGETS_NOT_VIA_AK...2,SET,201,0.071283,0.0074137,0.062331,0.1264,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_UP,0.886472911214013
GOBP_VESICLE_FUSION_WITH_GOL...,SET,8,0.32335,0.0067446,0.28277,0.12642,GOBP_VESICLE_FUSION_WITH_GOLGI_APPARATUS,0.886472911214013
REACTOME_ER_QUALITY_CONTROL_...,SET,19,0.2181,0.0070089,0.19074,0.12643,REACTOME_ER_QUALITY_CONTROL_COMPARTMENT_ERQC,0.886472911214013
GOBP_RIBOSOME_BIOGENESIS,SET,272,0.053716,0.0064862,0.046977,0.12643,GOBP_RIBOSOME_BIOGENESIS,0.886472911214013
GSE7568_CTRL_VS_24H_TGFB_TRE...1,SET,180,0.074947,0.0073807,0.065561,0.12649,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,0.886472911214013
LEE_CALORIE_RESTRICTION_NEOC...2,SET,66,0.11859,0.0070941,0.10375,0.12651,LEE_CALORIE_RESTRICTION_NEOCORTEX_UP,0.886472911214013
GOBP_REGULATION_OF_NEURON_PR...1,SET,14,0.24313,0.0067079,0.21272,0.12654,GOBP_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,0.886472911214013
MODULE_103,SET,10,0.25977,0.0060578,0.22729,0.12655,MODULE_103,0.886472911214013
KEGG_MEDICUS_VARIANT_MUTATIO...25,SET,16,0.24045,0.0070914,0.2104,0.12657,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_AGE_RAGE_SIGNALING_PATHWAY,0.886472911214013
GOMF_LACTATE_DEHYDROGENASE_A...,SET,6,0.4995,0.0090235,0.4371,0.12658,GOMF_LACTATE_DEHYDROGENASE_ACTIVITY,0.886472911214013
HP_SPLENIC_INFARCTION,SET,6,0.43109,0.0077877,0.37726,0.12659,HP_SPLENIC_INFARCTION,0.886472911214013
KEGG_MEDICUS_ENV_FACTOR_META...3,SET,14,0.23933,0.0066029,0.20945,0.1266,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_NFKB_SIGNALING_PATHWAY,0.886472911214013
GOCC_POTASSIUM_CHANNEL_COMPL...,SET,99,0.10665,0.0078063,0.093359,0.12666,GOCC_POTASSIUM_CHANNEL_COMPLEX,0.886472911214013
HP_DECREASED_ACTIVITY_OF_NAD...,SET,3,0.58163,0.0074304,0.50914,0.12666,HP_DECREASED_ACTIVITY_OF_NADPH_OXIDASE,0.886472911214013
HP_NEOPLASM_OF_THE_EAR,SET,22,0.20658,0.007143,0.18083,0.12666,HP_NEOPLASM_OF_THE_EAR,0.886472911214013
HP_PERIPHERAL_HYPERMYELINATI...,SET,9,0.31954,0.0070693,0.27972,0.12666,HP_PERIPHERAL_HYPERMYELINATION,0.886472911214013
PID_IL23_PATHWAY,SET,37,0.1794,0.0080414,0.15706,0.12668,PID_IL23_PATHWAY,0.886472911214013
GOBP_POSITIVE_REGULATION_OF_...728,SET,34,0.16758,0.0072011,0.14671,0.12669,GOBP_POSITIVE_REGULATION_OF_STEROL_TRANSPORT,0.886472911214013
GSE22886_NAIVE_TCELL_VS_DC_UP,SET,178,0.069518,0.0068082,0.060879,0.12676,GSE22886_NAIVE_TCELL_VS_DC_UP,0.886745602736969
GOBP_NEGATIVE_REGULATION_OF_...586,SET,3,0.65835,0.0084105,0.57661,0.12678,GOBP_NEGATIVE_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.886745602736969
GOBP_NEGATIVE_REGULATION_OF_...364,SET,57,0.13952,0.0077576,0.12222,0.12683,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MEDIATED_IMMUNITY,0.886916830985915
REACTOME_TRANSLATION,SET,256,0.056412,0.0066113,0.049438,0.12693,REACTOME_TRANSLATION,0.887437567893784
HP_DISTAL_AMYOTROPHY,SET,199,0.06623,0.0068542,0.05806,0.127,HP_DISTAL_AMYOTROPHY,0.887475399172087
KEGG_MEDICUS_PATHOGEN_KSHV_L...,SET,7,0.36098,0.0070436,0.31646,0.12701,KEGG_MEDICUS_PATHOGEN_KSHV_LANA_TO_WNT_SIGNALING_PATHWAY,0.887475399172087
HP_SPARSE_OR_ABSENT_EYELASHES,SET,80,0.11126,0.0073247,0.097558,0.12705,HP_SPARSE_OR_ABSENT_EYELASHES,0.887475399172087
GOBP_T_CELL_PROLIFERATION,SET,195,0.072995,0.0074788,0.064009,0.12707,GOBP_T_CELL_PROLIFERATION,0.887475399172087
TRAVAGLINI_LUNG_BRONCHIAL_VE...1,SET,207,0.067732,0.0071475,0.05941,0.12714,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_1_CELL,0.887475399172087
MIR6815_3P,SET,187,0.070135,0.0070384,0.061523,0.12716,MIR6815_3P,0.887475399172087
MIR548AT_3P,SET,56,0.12792,0.0070502,0.11223,0.1272,MIR548AT_3P,0.887475399172087
GOBP_MIDBRAIN_DOPAMINERGIC_N...,SET,15,0.29114,0.008314,0.25545,0.12721,GOBP_MIDBRAIN_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.887475399172087
KEGG_MEDICUS_REFERENCE_BETA_...3,SET,5,0.39834,0.0065693,0.34962,0.12728,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_PEROXISOME_VLCFA,0.887475399172087
GSE43863_DAY6_EFF_VS_DAY150_...6,SET,180,0.075045,0.0073903,0.065871,0.1273,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_UP,0.887475399172087
UNTERMAN_PROGRESSIVE_VS_STAB...3,SET,5,0.46383,0.0076493,0.4072,0.12734,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_CD8T_UP,0.887475399172087
GOBP_POSITIVE_REGULATION_OF_...283,SET,9,0.36068,0.0079795,0.31666,0.12735,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,0.887475399172087
HP_APLASIA_HYPOPLASIA_OF_THE...18,SET,10,0.29868,0.0069652,0.26223,0.12736,HP_APLASIA_HYPOPLASIA_OF_THE_COLON,0.887475399172087
MODULE_148,SET,13,0.30281,0.0080507,0.26587,0.12737,MODULE_148,0.887475399172087
GOBP_NEGATIVE_REGULATION_OF_...196,SET,5,0.40939,0.0067515,0.35946,0.12738,GOBP_NEGATIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.887475399172087
REACTOME_INTERLEUKIN_18_SIGN...,SET,8,0.3719,0.0077574,0.32664,0.12745,REACTOME_INTERLEUKIN_18_SIGNALING,0.887475399172087
FISCHER_G1_S_CELL_CYCLE,SET,172,0.071427,0.0068774,0.062736,0.12746,FISCHER_G1_S_CELL_CYCLE,0.887475399172087
GOBP_NEGATIVE_REGULATION_OF_...357,SET,13,0.28718,0.0076351,0.2523,0.12751,GOBP_NEGATIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,0.887475399172087
GSE28408_LY6G_POS_VS_NEG_DC_...2,SET,175,0.070764,0.0068722,0.062168,0.12751,GSE28408_LY6G_POS_VS_NEG_DC_UP,0.887475399172087
LINDGREN_BLADDER_CANCER_CLUS...3,SET,118,0.091274,0.00729,0.080189,0.12752,LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN,0.887475399172087
GOMF_N6_METHYLADENOSINE_CONT...,SET,11,0.30135,0.0073702,0.26487,0.12762,GOMF_N6_METHYLADENOSINE_CONTAINING_RNA_READER_ACTIVITY,0.887475399172087
REACTOME_INTERLEUKIN_10_SIGN...,SET,43,0.16256,0.007854,0.14289,0.12763,REACTOME_INTERLEUKIN_10_SIGNALING,0.887475399172087
GSE3203_UNTREATED_VS_IFNB_TR...1,SET,186,0.073096,0.0073161,0.064248,0.12763,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_DN,0.887475399172087
REACTOME_DISEASES_OF_BASE_EX...,SET,5,0.438,0.0072234,0.38507,0.12768,REACTOME_DISEASES_OF_BASE_EXCISION_REPAIR,0.887475399172087
HP_ABNORMALITY_OF_FRONTAL_SI...,SET,13,0.25851,0.0068728,0.22734,0.12776,HP_ABNORMALITY_OF_FRONTAL_SINUS,0.887475399172087
GOBP_REGULATION_OF_NUCLEAR_C...,SET,12,0.25031,0.006394,0.22018,0.12781,GOBP_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,0.887475399172087
GOBP_TRNA_METABOLIC_PROCESS,SET,167,0.067471,0.0064022,0.059355,0.12783,GOBP_TRNA_METABOLIC_PROCESS,0.887475399172087
GOBP_HEMOPOIESIS,SET,881,0.034223,0.007311,0.030112,0.12788,GOBP_HEMOPOIESIS,0.887475399172087
GSE21670_TGFB_VS_IL6_TREATED...2,SET,177,0.07172,0.0070043,0.063107,0.12789,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_UP,0.887475399172087
chr9q21,SET,57,0.19664,0.010934,0.17304,0.1279,chr9q21,0.887475399172087
HP_DECREASED_PALMAR_CREASES,SET,5,0.44629,0.00736,0.39272,0.1279,HP_DECREASED_PALMAR_CREASES,0.887475399172087
GSE17721_ALL_VS_24H_PAM3CSK4...2,SET,179,0.071524,0.0070241,0.062954,0.12796,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_UP,0.887475399172087
GOMF_FERROUS_IRON_TRANSMEMBR...,SET,5,0.36963,0.0060958,0.32536,0.12797,GOMF_FERROUS_IRON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.887475399172087
TCCCCAC_MIR491,SET,58,0.11933,0.0066928,0.10505,0.12802,TCCCCAC_MIR491,0.887475399172087
MIZUKAMI_HYPOXIA_DN,SET,6,0.42697,0.0077133,0.37592,0.12803,MIZUKAMI_HYPOXIA_DN,0.887475399172087
GOMF_ANAPHASE_PROMOTING_COMP...,SET,9,0.26994,0.0059721,0.23768,0.12804,GOMF_ANAPHASE_PROMOTING_COMPLEX_BINDING,0.887475399172087
HP_DYSGRAPHIA,SET,52,0.13113,0.006965,0.11546,0.12804,HP_DYSGRAPHIA,0.887475399172087
GOBP_OLFACTORY_BULB_INTERNEU...2,SET,12,0.32482,0.0082971,0.28601,0.12806,GOBP_OLFACTORY_BULB_INTERNEURON_DIFFERENTIATION,0.887475399172087
GOMF_CHLORIDE_CHANNEL_INHIBI...,SET,7,0.33005,0.00644,0.29064,0.12807,GOMF_CHLORIDE_CHANNEL_INHIBITOR_ACTIVITY,0.887475399172087
HP_POSITIVE_ROMBERG_SIGN,SET,26,0.17637,0.006629,0.15532,0.12808,HP_POSITIVE_ROMBERG_SIGN,0.887475399172087
FULLER_PBMC_F_TULARENSIS_VAC...8,SET,30,0.19379,0.007823,0.17066,0.12809,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_DN,0.887475399172087
ZNF766_TARGET_GENES,SET,933,0.031643,0.0069462,0.027869,0.1281,ZNF766_TARGET_GENES,0.887475399172087
HOFMANN_MYELODYSPLASTIC_SYND...3,SET,24,0.19343,0.0069853,0.17038,0.12813,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_DN,0.887475399172087
GAVISH_3CA_MALIGNANT_METAPRO...19,SET,45,0.15632,0.0077256,0.13778,0.12829,GAVISH_3CA_MALIGNANT_METAPROGRAM_28_OLIGO_NORMAL,0.887475399172087
GSE23114_WT_VS_SLE2C1_MOUSE_...1,SET,167,0.075024,0.0071189,0.066127,0.12829,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_DN,0.887475399172087
GOBP_NEGATIVE_REGULATION_OF_...668,SET,39,0.14531,0.0066865,0.12808,0.12831,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_PRODUCTION,0.887475399172087
BRUINS_UVC_RESPONSE_EARLY_LA...,SET,286,0.055131,0.0068235,0.048598,0.12832,BRUINS_UVC_RESPONSE_EARLY_LATE,0.887475399172087
HP_PEPTIC_ULCER,SET,34,0.17937,0.0077077,0.15813,0.12834,HP_PEPTIC_ULCER,0.887475399172087
KEGG_PANCREATIC_CANCER,SET,66,0.1214,0.0072616,0.10704,0.12839,KEGG_PANCREATIC_CANCER,0.887475399172087
HP_ATTACHED_EARLOBE,SET,6,0.41031,0.0074124,0.36185,0.12842,HP_ATTACHED_EARLOBE,0.887475399172087
WP_B_CELL_RECEPTOR_SIGNALING,SET,93,0.098336,0.0069774,0.086727,0.12843,WP_B_CELL_RECEPTOR_SIGNALING,0.887475399172087
AAAGGGA_MIR204_MIR211,SET,211,0.066863,0.0071229,0.058971,0.12844,AAAGGGA_MIR204_MIR211,0.887475399172087
WANG_HCP_PROSTATE_CANCER,SET,100,0.095742,0.007043,0.084456,0.12848,WANG_HCP_PROSTATE_CANCER,0.887475399172087
GSE42021_CD24HI_TREG_VS_CD24...1,SET,187,0.072866,0.0073125,0.064287,0.12852,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_DN,0.887475399172087
REACTOME_TIE2_SIGNALING,SET,18,0.21352,0.0066789,0.18839,0.12853,REACTOME_TIE2_SIGNALING,0.887475399172087
GSE18893_CTRL_VS_TNF_TREATED...5,SET,171,0.071017,0.0068182,0.062658,0.12853,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_DN,0.887475399172087
HP_EMG_SLOW_MOTOR_CONDUCTION,SET,5,0.39461,0.0065078,0.34818,0.12854,HP_EMG_SLOW_MOTOR_CONDUCTION,0.887475399172087
TGCACTG_MIR148A_MIR152_MIR14...,SET,270,0.059398,0.0071463,0.052413,0.12856,TGCACTG_MIR148A_MIR152_MIR148B,0.887475399172087
GSE43955_1H_VS_42H_ACT_CD4_T...4,SET,181,0.070101,0.0069223,0.061865,0.12859,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.887475399172087
SCHLOSSER_MYC_TARGETS_REPRES...,SET,140,0.076145,0.0066204,0.067205,0.12861,SCHLOSSER_MYC_TARGETS_REPRESSED_BY_SERUM,0.887475399172087
GSE13522_WT_VS_IFNG_KO_SKIN_...2,SET,119,0.090474,0.0072564,0.079851,0.12861,GSE13522_WT_VS_IFNG_KO_SKIN_UP,0.887475399172087
GOBP_POSITIVE_REGULATION_OF_...44,SET,37,0.14849,0.0066557,0.13114,0.12877,GOBP_POSITIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.887475399172087
HP_APLASIA_HYPOPLASIA_INVOLV...11,SET,98,0.095422,0.0069493,0.084291,0.12881,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_NOSE,0.887475399172087
GSE19923_HEB_KO_VS_HEB_AND_E...1,SET,191,0.069641,0.0070624,0.061526,0.12885,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.887475399172087
GOBP_REGULATION_OF_RESPIRATO...1,SET,16,0.24641,0.0072672,0.21774,0.12889,GOBP_REGULATION_OF_RESPIRATORY_BURST,0.887475399172087
GOBP_REGULATION_OF_STEROL_TR...,SET,56,0.12721,0.0070113,0.11242,0.12892,GOBP_REGULATION_OF_STEROL_TRANSPORT,0.887475399172087
GOBP_NEURON_NEURON_SYNAPTIC_...,SET,8,0.3589,0.0074862,0.3172,0.12894,GOBP_NEURON_NEURON_SYNAPTIC_TRANSMISSION,0.887475399172087
GOCC_CHROMOSOME_TELOMERIC_RE...1,SET,134,0.076681,0.0065236,0.067784,0.12898,GOCC_CHROMOSOME_TELOMERIC_REGION,0.887475399172087
MIR6793_3P,SET,70,0.1071,0.0065968,0.094674,0.12899,MIR6793_3P,0.887475399172087
REACTOME_PP2A_MEDIATED_DEPHO...,SET,6,0.38628,0.0069782,0.34151,0.12902,REACTOME_PP2A_MEDIATED_DEPHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS,0.887475399172087
CAO_BLOOD_FLUZONE_AGE_05_14Y...6,SET,5,0.37915,0.0062529,0.33523,0.12903,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_UP,0.887475399172087
HP_ABNORMAL_PLEURA_MORPHOLOGY,SET,168,0.077394,0.0073656,0.068442,0.12908,HP_ABNORMAL_PLEURA_MORPHOLOGY,0.887475399172087
ZHONG_PFC_C7_SST_LHX6_POS_PU...,SET,13,0.27718,0.0073692,0.24513,0.12909,ZHONG_PFC_C7_SST_LHX6_POS_PUTATIVE_MIGRATING_INTERNEURON,0.887475399172087
GOMF_NETRIN_RECEPTOR_ACTIVITY,SET,5,0.42213,0.0069617,0.37334,0.1291,GOMF_NETRIN_RECEPTOR_ACTIVITY,0.887475399172087
HP_ALBUMINURIA,SET,22,0.19611,0.0067808,0.17345,0.12911,HP_ALBUMINURIA,0.887475399172087
GOCC_CUL4B_RING_E3_UBIQUITIN...,SET,5,0.34206,0.0056412,0.30264,0.12919,GOCC_CUL4B_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.887475399172087
GOBP_NEGATIVE_REGULATION_OF_...183,SET,122,0.0867,0.0070403,0.076711,0.1292,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.887475399172087
GSE11973_MIR223_KOVS_WT_BONE...2,SET,179,0.073111,0.00718,0.064692,0.12921,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_UP,0.887475399172087
GOCC_RETROMER_COMPLEX,SET,19,0.20011,0.0064307,0.17707,0.12922,GOCC_RETROMER_COMPLEX,0.887475399172087
HP_ABNORMALITY_OF_THE_VOICE,SET,386,0.049085,0.0070384,0.043442,0.12926,HP_ABNORMALITY_OF_THE_VOICE,0.887475399172087
GSE46606_IRF4HIGH_VS_WT_CD40...1,SET,185,0.070503,0.0070378,0.062395,0.12926,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.887475399172087
AP2_Q6,SET,241,0.060553,0.0068884,0.053594,0.12928,AP2_Q6,0.887475399172087
WP_GABA_RECEPTOR_SIGNALING,SET,28,0.20586,0.0080288,0.18221,0.1293,WP_GABA_RECEPTOR_SIGNALING,0.887475399172087
ELF1_Q6,SET,227,0.061142,0.0067529,0.054121,0.12931,ELF1_Q6,0.887475399172087
VANDESLUIS_COMMD1_TARGETS_GR...3,SET,71,0.11301,0.0070106,0.10004,0.12932,VANDESLUIS_COMMD1_TARGETS_GROUP_3_UP,0.887475399172087
GOBP_RESPONSE_TO_POTASSIUM_I...,SET,18,0.24083,0.007533,0.2132,0.12933,GOBP_RESPONSE_TO_POTASSIUM_ION,0.887475399172087
TGCACTT_MIR519C_MIR519B_MIR5...,SET,409,0.047679,0.007033,0.04221,0.12934,TGCACTT_MIR519C_MIR519B_MIR519A,0.887475399172087
HP_TOE_DEFORMITY,SET,112,0.090731,0.0070612,0.080326,0.12934,HP_TOE_DEFORMITY,0.887475399172087
GOBP_KILLING_BY_HOST_OF_SYMB...,SET,23,0.22544,0.00797,0.19959,0.12935,GOBP_KILLING_BY_HOST_OF_SYMBIONT_CELLS,0.887475399172087
GOBP_INTERLEUKIN_2_PRODUCTION,SET,60,0.13377,0.0076308,0.11844,0.12936,GOBP_INTERLEUKIN_2_PRODUCTION,0.887475399172087
GOBP_RRNA_PROCESSING,SET,194,0.062007,0.0063369,0.0549,0.12936,GOBP_RRNA_PROCESSING,0.887475399172087
BUSSLINGER_GASTRIC_LYZ_POSIT...,SET,101,0.097004,0.0071712,0.085887,0.12936,BUSSLINGER_GASTRIC_LYZ_POSITIVE_CELLS,0.887475399172087
GOBP_URINARY_TRACT_SMOOTH_MU...,SET,9,0.34218,0.0075702,0.30299,0.12938,GOBP_URINARY_TRACT_SMOOTH_MUSCLE_CONTRACTION,0.887475399172087
PID_P73PATHWAY,SET,76,0.10156,0.0065176,0.089937,0.1294,PID_P73PATHWAY,0.887475399172087
ZHANG_GATA6_TARGETS_DN,SET,61,0.1266,0.0072815,0.11212,0.12942,ZHANG_GATA6_TARGETS_DN,0.887475399172087
HP_DISTAL_UPPER_LIMB_MUSCLE_...,SET,37,0.16622,0.0074503,0.1472,0.12942,HP_DISTAL_UPPER_LIMB_MUSCLE_WEAKNESS,0.887475399172087
MORF_RAD23A,SET,303,0.05066,0.0064508,0.04487,0.12945,MORF_RAD23A,0.887475399172087
GSE2585_CTEC_VS_THYMIC_MACRO...1,SET,187,0.066649,0.0066886,0.059035,0.12946,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN,0.887475399172087
HP_POSTAXIAL_POLYDACTYLY,SET,123,0.083451,0.006804,0.073925,0.12949,HP_POSTAXIAL_POLYDACTYLY,0.887475399172087
GOCC_GOLGI_MEMBRANE,SET,624,0.038501,0.0069727,0.034111,0.12952,GOCC_GOLGI_MEMBRANE,0.887475399172087
GOBP_INTERLEUKIN_18_MEDIATED...,SET,10,0.3351,0.0078143,0.2969,0.12953,GOBP_INTERLEUKIN_18_MEDIATED_SIGNALING_PATHWAY,0.887475399172087
GOBP_PHOSPHATIDYLINOSITOL_DE...,SET,24,0.16642,0.00601,0.14746,0.12954,GOBP_PHOSPHATIDYLINOSITOL_DEPHOSPHORYLATION,0.887475399172087
GOMF_PHOSPHATIDYLINOSITOL_4_...1,SET,9,0.25841,0.005717,0.22907,0.12964,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.887810482758621
GOMF_PHOSPHATIDYLINOSITOL_4_...3,SET,9,0.25841,0.005717,0.22907,0.12964,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.887810482758621
GSE22611_UNSTIM_VS_6H_MDP_ST...1,SET,174,0.07206,0.0069781,0.063888,0.12969,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.887939935000985
JAZAG_TGFB1_SIGNALING_VIA_SM...2,SET,98,0.094683,0.0068954,0.083954,0.12971,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_UP,0.887939935000985
REACTOME_NR1H2_NR1H3_REGULAT...2,SET,9,0.28892,0.0063919,0.25622,0.12975,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_LINKED_TO_LIPOGENESIS,0.887985805626598
REACTOME_CALCINEURIN_ACTIVAT...,SET,9,0.27681,0.0061239,0.24555,0.12982,REACTOME_CALCINEURIN_ACTIVATES_NFAT,0.887985805626598
BIOCARTA_EICOSANOID_PATHWAY,SET,21,0.22753,0.0076867,0.20185,0.12984,BIOCARTA_EICOSANOID_PATHWAY,0.887985805626598
ZHAN_MULTIPLE_MYELOMA_LB_UP,SET,45,0.15413,0.0076172,0.13674,0.12985,ZHAN_MULTIPLE_MYELOMA_LB_UP,0.887985805626598
REACTOME_SCAVENGING_BY_CLASS...3,SET,6,0.36838,0.0066549,0.32684,0.12986,REACTOME_SCAVENGING_BY_CLASS_F_RECEPTORS,0.887985805626598
REACTOME_NEF_MEDIATED_CD4_DO...,SET,9,0.31515,0.0069722,0.27963,0.12987,REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION,0.887985805626598
REACTOME_ADENYLATE_CYCLASE_I...,SET,14,0.26172,0.0072206,0.23226,0.12991,REACTOME_ADENYLATE_CYCLASE_INHIBITORY_PATHWAY,0.888046637168142
DESCARTES_FETAL_MUSCLE_SMOOT...,SET,67,0.12258,0.0073875,0.10879,0.12993,DESCARTES_FETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,0.888046637168142
GOBP_LYMPHOCYTE_CHEMOTAXIS,SET,42,0.15713,0.0075029,0.13947,0.12996,GOBP_LYMPHOCYTE_CHEMOTAXIS,0.888077034998034
HP_SCAPULAR_WINGING,SET,88,0.097176,0.006708,0.086268,0.13,HP_SCAPULAR_WINGING,0.888160577489688
CAIRO_PML_TARGETS_BOUND_BY_M...1,SET,12,0.29281,0.0074794,0.25999,0.13004,CAIRO_PML_TARGETS_BOUND_BY_MYC_DN,0.888160577489688
REACTOME_SEMA3A_PAK_DEPENDEN...,SET,14,0.25158,0.0069407,0.22341,0.13008,REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION,0.888160577489688
GSE11961_FOLLICULAR_BCELL_VS...3,SET,183,0.06895,0.0068458,0.061238,0.1301,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_DN,0.888160577489688
GSE33424_CD161_INT_VS_NEG_CD...2,SET,181,0.069686,0.0068813,0.061891,0.1301,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP,0.888160577489688
MIR3926,SET,160,0.073026,0.0067839,0.064877,0.13018,MIR3926,0.888532187745483
GOBP_TONGUE_DEVELOPMENT,SET,19,0.24554,0.0078907,0.21818,0.13021,GOBP_TONGUE_DEVELOPMENT,0.888562448458669
CLASPER_LYMPHATIC_VESSELS_DU...1,SET,32,0.19486,0.0081239,0.17321,0.13031,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN,0.888964003925417
HP_CUTANEOUS_FINGER_SYNDACTY...,SET,30,0.17676,0.0071354,0.15713,0.13032,HP_CUTANEOUS_FINGER_SYNDACTYLY,0.888964003925417
HP_SYNOSTOSIS_INVOLVING_BONE...1,SET,26,0.2092,0.0078627,0.18599,0.13035,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_FEET,0.888994162087912
GOBP_NEGATIVE_REGULATION_OF_...261,SET,14,0.26263,0.0072457,0.23357,0.13042,GOBP_NEGATIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.889114676470588
LU_TUMOR_VASCULATURE_DN,SET,8,0.3113,0.0064934,0.2769,0.13046,LU_TUMOR_VASCULATURE_DN,0.889114676470588
HP_ABNORMAL_PULMONARY_VALVE_...2,SET,52,0.12954,0.0068809,0.11523,0.13046,HP_ABNORMAL_PULMONARY_VALVE_MORPHOLOGY,0.889114676470588
REACTOME_MATURATION_OF_TCA_E...,SET,19,0.19369,0.0062245,0.1723,0.13047,REACTOME_MATURATION_OF_TCA_ENZYMES_AND_REGULATION_OF_TCA_CYCLE,0.889114676470588
BRUNEAU_SEPTATION_ATRIAL,SET,5,0.47319,0.0078036,0.42097,0.1305,BRUNEAU_SEPTATION_ATRIAL,0.889144775534209
HP_ANKLE_CONTRACTURE,SET,52,0.131,0.0069581,0.11656,0.13054,HP_ANKLE_CONTRACTURE,0.889204938271605
REACTOME_ACTIVATION_OF_IRF3_...,SET,17,0.21875,0.0066498,0.19465,0.13056,REACTOME_ACTIVATION_OF_IRF3_IRF7_MEDIATED_BY_TBK1_IKK_IKBKE,0.889204938271605
GOCC_SIN3_TYPE_COMPLEX,SET,19,0.21159,0.0067996,0.18832,0.13061,GOCC_SIN3_TYPE_COMPLEX,0.889371189263323
GOBP_CITRULLINE_METABOLIC_PR...,SET,7,0.37831,0.0073816,0.33678,0.13066,GOBP_CITRULLINE_METABOLIC_PROCESS,0.889393176032896
CREB3L2_TARGET_GENES,SET,115,0.090288,0.0071196,0.080384,0.13068,CREB3L2_TARGET_GENES,0.889393176032896
GOBP_CENTRIOLE_ELONGATION,SET,7,0.33421,0.0065211,0.29756,0.13069,GOBP_CENTRIOLE_ELONGATION,0.889393176032896
GOBP_NEURAL_TUBE_PATTERNING,SET,29,0.18956,0.0075239,0.16886,0.13082,GOBP_NEURAL_TUBE_PATTERNING,0.889785120328703
GOBP_REGULATION_OF_NK_T_CELL...2,SET,6,0.44388,0.0080188,0.39543,0.13083,GOBP_REGULATION_OF_NK_T_CELL_DIFFERENTIATION,0.889785120328703
GOMF_CHLORIDE_CHANNEL_REGULA...,SET,13,0.2513,0.0066811,0.22389,0.13084,GOMF_CHLORIDE_CHANNEL_REGULATOR_ACTIVITY,0.889785120328703
GOBP_PYRIMIDINE_DEOXYRIBONUC...1,SET,4,0.46062,0.0067946,0.41037,0.13085,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.889785120328703
VICENT_METASTASIS_UP,SET,13,0.27395,0.0072832,0.24413,0.13091,VICENT_METASTASIS_UP,0.88979865129007
PID_P38_ALPHA_BETA_DOWNSTREA...,SET,37,0.15735,0.0070531,0.14024,0.13093,PID_P38_ALPHA_BETA_DOWNSTREAM_PATHWAY,0.88979865129007
GOMF_SELENIUM_BINDING,SET,6,0.44752,0.0080846,0.39888,0.13095,GOMF_SELENIUM_BINDING,0.88979865129007
REACTOME_CITRIC_ACID_CYCLE_T...,SET,32,0.14849,0.0061907,0.13236,0.13097,REACTOME_CITRIC_ACID_CYCLE_TCA_CYCLE,0.88979865129007
GOCC_NUCLEAR_PORE,SET,87,0.096728,0.0066393,0.086227,0.13098,GOCC_NUCLEAR_PORE,0.88979865129007
GOMF_FAD_BINDING,SET,36,0.15433,0.0068238,0.1376,0.13102,GOMF_FAD_BINDING,0.889896443228454
GAVISH_3CA_METAPROGRAM_FIBRO...14,SET,47,0.14692,0.0074201,0.13101,0.13105,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_INTERFERON,0.88991806640625
HUANG_FOXA2_TARGETS_UP,SET,46,0.15082,0.0075358,0.13451,0.13109,HUANG_FOXA2_TARGETS_UP,0.88991806640625
GSE32255_WT_UNSTIM_VS_JMJD2D...2,SET,159,0.075355,0.0069786,0.067207,0.1311,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,0.88991806640625
GOBP_PROTEIN_LOCALIZATION_TO...47,SET,11,0.27165,0.0066437,0.24232,0.13114,GOBP_PROTEIN_LOCALIZATION_TO_PRESYNAPSE,0.890015758640891
KEGG_MEDICUS_REFERENCE_MODIF...1,SET,6,0.32897,0.0059429,0.29347,0.13117,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_II_SUBUNITS,0.890045558375635
KEGG_RIG_I_LIKE_RECEPTOR_SIG...,SET,61,0.13007,0.0074809,0.11609,0.13127,KEGG_RIG_I_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.890139750584567
DUAN_PRDM5_TARGETS,SET,65,0.12753,0.0075709,0.11383,0.13128,DUAN_PRDM5_TARGETS,0.890139750584567
HP_ABSENT_NIPPLE,SET,9,0.29308,0.0064839,0.2616,0.13129,HP_ABSENT_NIPPLE,0.890139750584567
XBP1_01,SET,113,0.088475,0.0069161,0.078975,0.1313,XBP1_01,0.890139750584567
HOLLEMAN_ASPARAGINASE_RESIST...2,SET,21,0.21324,0.0072038,0.19036,0.13133,HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_UP,0.890139750584567
GOBP_NEGATIVE_REGULATION_OF_...17,SET,13,0.27464,0.0073018,0.24519,0.13134,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.890139750584567
HP_CHILDHOOD_ONSET_SENSORINE...,SET,18,0.23185,0.0072521,0.20702,0.13138,HP_CHILDHOOD_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,0.890139750584567
MIR6884_3P,SET,60,0.12425,0.0070874,0.11095,0.1314,MIR6884_3P,0.890139750584567
REACTOME_KERATAN_SULFATE_DEG...,SET,15,0.24995,0.0071378,0.22324,0.13144,REACTOME_KERATAN_SULFATE_DEGRADATION,0.890139750584567
GSE15930_STIM_VS_STIM_AND_IL...6,SET,181,0.06628,0.006545,0.059198,0.13144,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_UP,0.890139750584567
GOBP_TRANSLATIONAL_TERMINATI...,SET,13,0.26321,0.0069979,0.23519,0.13155,GOBP_TRANSLATIONAL_TERMINATION,0.890453133514986
FARMER_BREAST_CANCER_CLUSTER...3,SET,13,0.30384,0.0080781,0.27152,0.13157,FARMER_BREAST_CANCER_CLUSTER_3,0.890453133514986
GOBP_POSITIVE_REGULATION_OF_...804,SET,63,0.13352,0.0078042,0.11934,0.1316,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.890453133514986
GOBP_CELLULAR_GLUCURONIDATION,SET,19,0.3627,0.011656,0.3242,0.13164,GOBP_CELLULAR_GLUCURONIDATION,0.890453133514986
GOBP_RECOMBINATIONAL_REPAIR,SET,165,0.069145,0.0065221,0.061807,0.13164,GOBP_RECOMBINATIONAL_REPAIR,0.890453133514986
HP_SHORT_COLUMELLA,SET,24,0.18968,0.0068497,0.16955,0.13164,HP_SHORT_COLUMELLA,0.890453133514986
ATGTTAA_MIR302C,SET,217,0.064695,0.0069882,0.057844,0.1317,ATGTTAA_MIR302C,0.890508830341633
HP_ABNORMAL_KNEE_PHYSIOLOGY,SET,78,0.10613,0.0068995,0.094905,0.13172,HP_ABNORMAL_KNEE_PHYSIOLOGY,0.890508830341633
MULLIGAN_NTF3_SIGNALING_VIA_...1,SET,7,0.41325,0.0080633,0.3696,0.13177,MULLIGAN_NTF3_SIGNALING_VIA_INSR_AND_IGF1R_DN,0.890508830341633
YAO_TEMPORAL_RESPONSE_TO_PRO...12,SET,13,0.28879,0.0076778,0.25831,0.13179,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_3,0.890508830341633
ESC_J1_UP_EARLY.V1_DN,SET,155,0.076294,0.0069768,0.068243,0.1318,ESC_J1_UP_EARLY.V1_DN,0.890508830341633
PID_PI3K_PLC_TRK_PATHWAY,SET,36,0.16112,0.007124,0.14413,0.13181,PID_PI3K_PLC_TRK_PATHWAY,0.890508830341633
REACTOME_DISEASES_OF_SIGNAL_...,SET,439,0.044352,0.0067723,0.039685,0.13187,REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS,0.890508830341633
KEGG_MEDICUS_REFERENCE_AVP_V...,SET,9,0.31865,0.0070497,0.28512,0.13188,KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY,0.890508830341633
GSE29949_MICROGLIA_VS_DC_BRA...1,SET,176,0.072489,0.0070595,0.064866,0.13189,GSE29949_MICROGLIA_VS_DC_BRAIN_DN,0.890508830341633
GOCC_SERINE_PROTEASE_INHIBIT...,SET,6,0.45839,0.0082808,0.41023,0.13192,GOCC_SERINE_PROTEASE_INHIBITOR_COMPLEX,0.890508830341633
GOBP_NEGATIVE_REGULATION_OF_...603,SET,11,0.30381,0.0074304,0.272,0.13201,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,0.890508830341633
HP_FIRST_DORSAL_INTEROSSEI_M...,SET,7,0.38763,0.0075635,0.34707,0.13203,HP_FIRST_DORSAL_INTEROSSEI_MUSCLE_WEAKNESS,0.890508830341633
MIR924,SET,44,0.13255,0.0064778,0.11869,0.13205,MIR924,0.890508830341633
GSE24142_DN2_VS_DN3_THYMOCYT...1,SET,180,0.070874,0.0069796,0.063462,0.13205,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN,0.890508830341633
GSE32423_CTRL_VS_IL4_MEMORY_...1,SET,178,0.067715,0.0066317,0.060655,0.13213,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_DN,0.890508830341633
GOCC_DYNEIN_AXONEMAL_PARTICLE,SET,14,0.22978,0.0063394,0.20584,0.13216,GOCC_DYNEIN_AXONEMAL_PARTICLE,0.890508830341633
GOBP_FARNESYL_DIPHOSPHATE_ME...,SET,5,0.38219,0.0063029,0.3424,0.13218,GOBP_FARNESYL_DIPHOSPHATE_METABOLIC_PROCESS,0.890508830341633
HP_ATROPHY_OF_ALVEOLAR_RIDGES,SET,3,0.63934,0.0081676,0.57292,0.13223,HP_ATROPHY_OF_ALVEOLAR_RIDGES,0.890508830341633
WP_IL11_SIGNALING,SET,41,0.15079,0.007114,0.13516,0.13229,WP_IL11_SIGNALING,0.890508830341633
WP_MAMMALIAN_DISORDER_OF_SEX...,SET,24,0.20379,0.0073595,0.18267,0.1323,WP_MAMMALIAN_DISORDER_OF_SEXUAL_DEVELOPMENT,0.890508830341633
GAVISH_3CA_METAPROGRAM_FIBRO...18,SET,43,0.15368,0.0074248,0.13775,0.1323,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II_CYTOKINE,0.890508830341633
REACTOME_SYNTHESIS_OF_15_EIC...,SET,6,0.3932,0.0071033,0.3525,0.13233,REACTOME_SYNTHESIS_OF_15_EICOSATETRAENOIC_ACID_DERIVATIVES,0.890508830341633
KEGG_MEDICUS_VARIANT_MUTATIO...37,SET,17,0.24424,0.0074248,0.21898,0.13235,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_DCTN1_TO_RETROGRADE_AXONAL_TRANSPORT,0.890508830341633
CHEN_HOXA5_TARGETS_9HR_DN,SET,37,0.16265,0.0072907,0.14584,0.13237,CHEN_HOXA5_TARGETS_9HR_DN,0.890508830341633
REACTOME_ERKS_ARE_INACTIVATED,SET,13,0.25496,0.0067785,0.22864,0.1324,REACTOME_ERKS_ARE_INACTIVATED,0.890508830341633
GOBP_POLYKETIDE_METABOLIC_PR...,SET,10,0.37928,0.0088447,0.34014,0.13242,GOBP_POLYKETIDE_METABOLIC_PROCESS,0.890508830341633
GOBP_REGULATION_BY_VIRUS_OF_...,SET,7,0.33416,0.0065202,0.29968,0.13242,GOBP_REGULATION_BY_VIRUS_OF_VIRAL_PROTEIN_LEVELS_IN_HOST_CELL,0.890508830341633
REACTOME_DNA_DOUBLE_STRAND_B...2,SET,38,0.15315,0.0069565,0.13735,0.13244,REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE,0.890508830341633
GOMF_INOSITOL_TRISPHOSPHATE_...,SET,12,0.24013,0.0061339,0.21539,0.13246,GOMF_INOSITOL_TRISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.890508830341633
GSE339_CD4POS_VS_CD4CD8DN_DC...2,SET,189,0.067446,0.0068043,0.060509,0.13251,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_DN,0.890508830341633
HP_SEVERE_TEMPER_TANTRUMS,SET,6,0.40779,0.0073669,0.36587,0.13252,HP_SEVERE_TEMPER_TANTRUMS,0.890508830341633
GOCC_CHROMATIN_SILENCING_COM...,SET,12,0.25223,0.0064429,0.2263,0.13253,GOCC_CHROMATIN_SILENCING_COMPLEX,0.890508830341633
HOEK_NEUTROPHIL_2011_2012_TI...4,SET,7,0.42758,0.0083431,0.38367,0.13255,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_UP,0.890508830341633
ZHONG_PFC_HES1_POS_C1_NPC,SET,6,0.40649,0.0073433,0.36479,0.13258,ZHONG_PFC_HES1_POS_C1_NPC,0.890508830341633
PID_P38_GAMMA_DELTA_PATHWAY,SET,10,0.30796,0.0071815,0.27639,0.1326,PID_P38_GAMMA_DELTA_PATHWAY,0.890508830341633
MIR3916,SET,202,0.063921,0.0066643,0.057373,0.13262,MIR3916,0.890508830341633
BANDRES_RESPONSE_TO_CARMUSTI...5,SET,9,0.33716,0.0074591,0.30266,0.13265,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_DN,0.890508830341633
REACTOME_BINDING_AND_UPTAKE_...,SET,39,0.16077,0.0073978,0.14434,0.13268,REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS,0.890508830341633
GOBP_MESENCHYMAL_STEM_CELL_D...,SET,11,0.30991,0.0075795,0.27823,0.13268,GOBP_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.890508830341633
GOBP_SERINE_FAMILY_AMINO_ACI...2,SET,11,0.26893,0.0065772,0.24144,0.13268,GOBP_SERINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,0.890508830341633
STK33_UP,SET,254,0.059467,0.0069424,0.053394,0.1327,STK33_UP,0.890508830341633
GOBP_RESPONSE_TO_NITRIC_OXIDE,SET,17,0.22816,0.006936,0.20489,0.13274,GOBP_RESPONSE_TO_NITRIC_OXIDE,0.890508830341633
GOBP_REGULATION_OF_INFLAMMAS...,SET,35,0.15855,0.0069125,0.14239,0.13275,GOBP_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.890508830341633
chr9q33,SET,74,0.23204,0.014694,0.2085,0.13288,chr9q33,0.890801916779041
CERIBELLI_GENES_INACTIVE_AND...,SET,29,0.19118,0.0075882,0.17179,0.13289,CERIBELLI_GENES_INACTIVE_AND_BOUND_BY_NFY,0.890801916779041
GOBP_NEGATIVE_REGULATION_OF_...13,SET,4,0.50012,0.0073772,0.44942,0.1329,GOBP_NEGATIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.890801916779041
GSE35685_CD34POS_CD38NEG_VS_...1,SET,188,0.067381,0.0067799,0.060551,0.13291,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_DN,0.890801916779041
GOMF_LIPOPEPTIDE_BINDING,SET,10,0.41424,0.00966,0.3723,0.13293,GOMF_LIPOPEPTIDE_BINDING,0.890801916779041
GOCC_INNER_MITOCHONDRIAL_MEM...,SET,113,0.079087,0.0061822,0.071097,0.13299,GOCC_INNER_MITOCHONDRIAL_MEMBRANE_PROTEIN_COMPLEX,0.890801916779041
GSE37534_UNTREATED_VS_PIOGLI...1,SET,185,0.068493,0.0068371,0.061572,0.13299,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.890801916779041
GSE37301_MULTIPOTENT_PROGENI...12,SET,182,0.068972,0.0068294,0.062011,0.13302,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,0.890801916779041
MIR7976,SET,91,0.095745,0.0067204,0.086093,0.13305,MIR7976,0.890801916779041
GSE35825_UNTREATED_VS_IFNA_S...2,SET,161,0.072154,0.0067236,0.06488,0.13305,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_UP,0.890801916779041
HP_LIMB_GIRDLE_MUSCULAR_DYST...,SET,13,0.25522,0.0067855,0.22952,0.13308,HP_LIMB_GIRDLE_MUSCULAR_DYSTROPHY,0.890831163328197
HP_PULMONARY_HEMORRHAGE,SET,29,0.18591,0.0073788,0.16721,0.13311,HP_PULMONARY_HEMORRHAGE,0.890860398613518
GSE16755_CTRL_VS_IFNA_TREATE...1,SET,174,0.073754,0.0071422,0.066342,0.13314,GSE16755_CTRL_VS_IFNA_TREATED_MAC_DN,0.890889622641509
GOMF_ICOSANOID_TRANSMEMBRANE...,SET,13,0.28103,0.0074717,0.25286,0.1332,GOMF_ICOSANOID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.891119538017324
chr6q23,SET,45,0.26584,0.013138,0.23925,0.13326,chr6q23,0.891349364896074
GSE18791_UNSTIM_VS_NEWCATSLE...5,SET,159,0.073891,0.0068429,0.066517,0.13332,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_DN,0.891541304347826
MODULE_415,SET,11,0.28368,0.006938,0.25538,0.13334,MODULE_415,0.891541304347826
GSE19512_NAUTRAL_VS_INDUCED_...1,SET,173,0.072756,0.0070255,0.06552,0.13341,GSE19512_NAUTRAL_VS_INDUCED_TREG_DN,0.891619719392658
CCAGGTT_MIR490,SET,58,0.11729,0.0065786,0.10563,0.13343,CCAGGTT_MIR490,0.891619719392658
ZBTB44_TARGET_GENES,SET,622,0.038476,0.0069574,0.034654,0.13345,ZBTB44_TARGET_GENES,0.891619719392658
GOBP_AMINO_SUGAR_METABOLIC_P...,SET,38,0.15914,0.0072288,0.14334,0.13346,GOBP_AMINO_SUGAR_METABOLIC_PROCESS,0.891619719392658
GOBP_NEGATIVE_REGULATION_OF_...112,SET,242,0.063242,0.007209,0.056969,0.13348,GOBP_NEGATIVE_REGULATION_OF_CELL_DEVELOPMENT,0.891619719392658
REACTOME_STRIATED_MUSCLE_CON...,SET,35,0.15936,0.0069478,0.14361,0.13358,REACTOME_STRIATED_MUSCLE_CONTRACTION,0.892040549366116
GOBP_NATURAL_KILLER_CELL_MED...2,SET,75,0.11615,0.0074049,0.10468,0.1336,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.892040549366116
GOBP_LYMPHOCYTE_DIFFERENTIAT...,SET,405,0.049826,0.0073146,0.04491,0.13362,GOBP_LYMPHOCYTE_DIFFERENTIATION,0.892040549366116
REACTOME_HDL_ASSEMBLY,SET,7,0.31246,0.0060968,0.28173,0.1337,REACTOME_HDL_ASSEMBLY,0.892089472168906
GOMF_SPHINGOLIPID_TRANSPORTE...,SET,18,0.22154,0.0069296,0.19974,0.1337,GOMF_SPHINGOLIPID_TRANSPORTER_ACTIVITY,0.892089472168906
GOBP_CELLULAR_RESPONSE_TO_OX...5,SET,21,0.20141,0.0068043,0.18161,0.13372,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_RADICAL,0.892089472168906
GOBP_NEGATIVE_REGULATION_OF_...121,SET,8,0.32598,0.0067995,0.29395,0.13373,GOBP_NEGATIVE_REGULATION_OF_CELL_MATURATION,0.892089472168906
GOMF_UNMETHYLATED_CPG_BINDING,SET,9,0.27593,0.0061045,0.24894,0.13385,GOMF_UNMETHYLATED_CPG_BINDING,0.892160317764165
REACTOME_LATE_ENDOSOMAL_MICR...,SET,32,0.16989,0.0070828,0.15329,0.13387,REACTOME_LATE_ENDOSOMAL_MICROAUTOPHAGY,0.892160317764165
REACTOME_PROLACTIN_RECEPTOR_...,SET,14,0.25314,0.006984,0.22846,0.13393,REACTOME_PROLACTIN_RECEPTOR_SIGNALING,0.892160317764165
GSE4535_BM_DERIVED_DC_VS_FOL...1,SET,177,0.068418,0.0066818,0.061749,0.13394,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_DN,0.892160317764165
GOBP_HOMOSERINE_METABOLIC_PR...,SET,3,0.56904,0.0072695,0.51363,0.13396,GOBP_HOMOSERINE_METABOLIC_PROCESS,0.892160317764165
GSE9988_ANTI_TREM1_VS_ANTI_T...1,SET,161,0.078482,0.0073133,0.070848,0.13399,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.892160317764165
GSE2405_0H_VS_24H_A_PHAGOCYT...1,SET,183,0.07138,0.0070871,0.064441,0.13401,GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.892160317764165
GSE32128_INOS_DEPENDENT_VS_I...1,SET,181,0.066918,0.0066081,0.060417,0.13402,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_DN,0.892160317764165
KEGG_MEDICUS_REFERENCE_MDA5_...,SET,21,0.2221,0.0075031,0.20052,0.13403,KEGG_MEDICUS_REFERENCE_MDA5_IRF7_3_SIGNALING_PATHWAY,0.892160317764165
GSE5542_UNTREATED_VS_IFNA_TR...1,SET,168,0.069846,0.0066472,0.063061,0.13403,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,0.892160317764165
GOBP_CELLULAR_RESPONSE_TO_ES...2,SET,18,0.22089,0.0069092,0.19945,0.13406,GOBP_CELLULAR_RESPONSE_TO_ESTROGEN_STIMULUS,0.892160317764165
ZHENG_FOXP3_TARGETS_IN_THYMU...1,SET,12,0.30212,0.0077174,0.27282,0.13407,ZHENG_FOXP3_TARGETS_IN_THYMUS_DN,0.892160317764165
WP_ASPIRIN_AND_MIRNAS,SET,9,0.3557,0.0078693,0.32123,0.13409,WP_ASPIRIN_AND_MIRNAS,0.892160317764165
HP_LOW_BACK_PAIN,SET,13,0.2623,0.0069735,0.23689,0.1341,HP_LOW_BACK_PAIN,0.892160317764165
BURTON_ADIPOGENESIS_PEAK_AT_...4,SET,40,0.15622,0.0072801,0.14112,0.13416,BURTON_ADIPOGENESIS_PEAK_AT_2HR,0.892388669856459
HP_NASOLACRIMAL_DUCT_OBSTRUC...,SET,29,0.1643,0.0065214,0.14849,0.13426,HP_NASOLACRIMAL_DUCT_OBSTRUCTION,0.892534507042254
GSE29949_CD8_NEG_DC_SPLEEN_V...2,SET,176,0.07297,0.0071064,0.06596,0.13431,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_UP,0.892534507042254
GSE11961_MEMORY_BCELL_DAY7_V...6,SET,180,0.069845,0.0068782,0.06314,0.13433,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.892534507042254
MIR6787_5P,SET,24,0.20194,0.0072925,0.18262,0.13442,MIR6787_5P,0.892534507042254
HP_ACUTE_MYELOID_LEUKEMIA,SET,68,0.11235,0.0068215,0.10161,0.13442,HP_ACUTE_MYELOID_LEUKEMIA,0.892534507042254
REACTOME_INTERFERON_SIGNALING,SET,246,0.061679,0.0070879,0.055799,0.13451,REACTOME_INTERFERON_SIGNALING,0.892534507042254
HP_DECREASED_NASAL_NITRIC_OX...,SET,24,0.18806,0.0067914,0.17014,0.13452,HP_DECREASED_NASAL_NITRIC_OXIDE,0.892534507042254
MORF_GSPT1,SET,44,0.12752,0.006232,0.11538,0.13453,MORF_GSPT1,0.892534507042254
GOMF_TYPE_II_TRANSFORMING_GR...,SET,11,0.3155,0.0077162,0.28547,0.13454,GOMF_TYPE_II_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.892534507042254
HP_THIN_EYEBROW,SET,22,0.20017,0.0069213,0.18112,0.13455,HP_THIN_EYEBROW,0.892534507042254
GSE15330_WT_VS_IKAROS_KO_HSC...2,SET,178,0.068782,0.0067361,0.062235,0.13455,GSE15330_WT_VS_IKAROS_KO_HSC_UP,0.892534507042254
GOMF_TESTOSTERONE_17_BETA_DE...,SET,9,0.31134,0.0068879,0.28172,0.13456,GOMF_TESTOSTERONE_17_BETA_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.892534507042254
GSE2706_UNSTIM_VS_8H_LPS_DC_...2,SET,178,0.068235,0.0066825,0.061758,0.13461,GSE2706_UNSTIM_VS_8H_LPS_DC_UP,0.892534507042254
GOBP_POSTSYNAPTIC_DENSITY_PR...,SET,10,0.30486,0.0071093,0.27593,0.13462,GOBP_POSTSYNAPTIC_DENSITY_PROTEIN_95_CLUSTERING,0.892534507042254
GSE14308_INDUCED_VS_NATURAL_...2,SET,178,0.066837,0.0065456,0.060538,0.1348,GSE14308_INDUCED_VS_NATURAL_TREG_UP,0.892534507042254
GSE23321_CENTRAL_VS_EFFECTOR...1,SET,179,0.068125,0.0066904,0.061716,0.13484,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.892534507042254
GSE15659_NAIVE_CD4_TCELL_VS_...6,SET,157,0.072865,0.0067057,0.066016,0.13486,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_UP,0.892534507042254
GSE17721_LPS_VS_GARDIQUIMOD_...4,SET,185,0.068124,0.0068003,0.061721,0.13486,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_UP,0.892534507042254
KEGG_MELANOGENESIS,SET,98,0.097542,0.0071037,0.088378,0.13487,KEGG_MELANOGENESIS,0.892534507042254
HE_LIM_SUN_FETAL_LUNG_C5_CD5...1,SET,46,0.14565,0.0072774,0.13198,0.13489,HE_LIM_SUN_FETAL_LUNG_C5_CD5_NEG_MATURE_B_CELL,0.892534507042254
AGGGCCA_MIR328,SET,68,0.1103,0.006697,0.099976,0.13496,AGGGCCA_MIR328,0.892534507042254
GOBP_NUCLEOLAR_CHROMATIN_ORG...,SET,8,0.28859,0.0060197,0.26164,0.13502,GOBP_NUCLEOLAR_CHROMATIN_ORGANIZATION,0.892534507042254
IK3_01,SET,201,0.068461,0.0071202,0.062075,0.13505,IK3_01,0.892534507042254
HP_ABNORMAL_ORAL_MUCOSA_MORP...,SET,336,0.053297,0.0071401,0.048326,0.13505,HP_ABNORMAL_ORAL_MUCOSA_MORPHOLOGY,0.892534507042254
GSE17721_12H_VS_24H_LPS_BMDC...2,SET,190,0.069324,0.007012,0.062857,0.13505,GSE17721_12H_VS_24H_LPS_BMDC_UP,0.892534507042254
GAVISH_3CA_METAPROGRAM_EPITH...17,SET,38,0.1745,0.0079262,0.15823,0.13507,GAVISH_3CA_METAPROGRAM_EPITHELIAL_NEUROENDOCRINE,0.892534507042254
GOMF_AMMONIUM_TRANSMEMBRANE_...,SET,12,0.28931,0.00739,0.26235,0.13508,GOMF_AMMONIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.892534507042254
GSE2706_UNSTIM_VS_2H_R848_DC...1,SET,173,0.076043,0.0073429,0.06897,0.13512,GSE2706_UNSTIM_VS_2H_R848_DC_DN,0.892534507042254
BONOME_OVARIAN_CANCER_SURVIV...2,SET,453,0.044172,0.0068488,0.040074,0.13518,BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING,0.892534507042254
GOMF_ALCOHOL_DEHYDROGENASE_N...2,SET,23,0.21912,0.0077465,0.19883,0.13523,GOMF_ALCOHOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.892534507042254
GSE7509_DC_VS_MONOCYTE_WITH_...1,SET,185,0.068772,0.006865,0.062406,0.13523,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_DN,0.892534507042254
MIR101_5P,SET,37,0.1472,0.0065979,0.13357,0.13524,MIR101_5P,0.892534507042254
NKX25_01,SET,109,0.092325,0.0070889,0.083804,0.13531,NKX25_01,0.892534507042254
GSE6259_CD4_TCELL_VS_CD8_TCE...2,SET,173,0.073722,0.0071188,0.066923,0.13533,GSE6259_CD4_TCELL_VS_CD8_TCELL_UP,0.892534507042254
GOBP_DOPAMINERGIC_NEURON_DIF...,SET,37,0.17358,0.0077804,0.1576,0.13537,GOBP_DOPAMINERGIC_NEURON_DIFFERENTIATION,0.892534507042254
HP_APLASIA_HYPOPLASIA_OF_THE...43,SET,21,0.21542,0.0072776,0.19559,0.13537,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_5TH_FINGER,0.892534507042254
STEGER_ADIPOGENESIS_DN,SET,22,0.21601,0.0074691,0.19614,0.13538,STEGER_ADIPOGENESIS_DN,0.892534507042254
GOMF_ATPASE_COUPLED_INTRAMEM...,SET,26,0.18568,0.006979,0.16861,0.1354,GOMF_ATPASE_COUPLED_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,0.892534507042254
GOBP_NUCLEIC_ACID_CATABOLIC_...,SET,606,0.0359,0.0064105,0.032601,0.13541,GOBP_NUCLEIC_ACID_CATABOLIC_PROCESS,0.892534507042254
GOBP_REGULATION_OF_GLUCOKINA...,SET,4,0.50918,0.0075109,0.46246,0.13545,GOBP_REGULATION_OF_GLUCOKINASE_ACTIVITY,0.892534507042254
GSE21927_BALBC_VS_C57BL6_MON...3,SET,160,0.071215,0.0066156,0.064693,0.1355,GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_DN,0.892534507042254
GOMF_4_GALACTOSYL_N_ACETYLGL...,SET,6,0.45799,0.0082738,0.4161,0.13552,GOMF_4_GALACTOSYL_N_ACETYLGLUCOSAMINIDE_3_ALPHA_L_FUCOSYLTRANSFERASE_ACTIVITY,0.892534507042254
HP_PREMATURE_CORONARY_ARTERY...,SET,19,0.23148,0.007439,0.21033,0.13555,HP_PREMATURE_CORONARY_ARTERY_ATHEROSCLEROSIS,0.892534507042254
REACTOME_DNA_DAMAGE_RECOGNIT...,SET,35,0.15096,0.0065816,0.13719,0.13559,REACTOME_DNA_DAMAGE_RECOGNITION_IN_GG_NER,0.892534507042254
GOMF_SYNTAXIN_BINDING,SET,59,0.11406,0.0064523,0.10366,0.1356,GOMF_SYNTAXIN_BINDING,0.892534507042254
GSE17721_CTRL_VS_GARDIQUIMOD...9,SET,188,0.067553,0.0067972,0.061392,0.1356,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_DN,0.892534507042254
HAY_BONE_MARROW_CD34_POS_ERP...,SET,10,0.26882,0.0062689,0.24434,0.13563,HAY_BONE_MARROW_CD34_POS_ERP_EARLY,0.892534507042254
GSE28737_BCL6_HET_VS_BCL6_KO...2,SET,179,0.066166,0.0064979,0.060143,0.13564,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP,0.892534507042254
HP_POLYCYSTIC_LIVER_DISEASE,SET,11,0.2693,0.0065864,0.2448,0.13565,HP_POLYCYSTIC_LIVER_DISEASE,0.892534507042254
REACTOME_ELEVATION_OF_CYTOSO...,SET,16,0.23947,0.0070627,0.2177,0.13567,REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS,0.892534507042254
KEGG_MEDICUS_VARIANT_MUTATIO...53,SET,5,0.4028,0.0066428,0.36625,0.13572,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.892534507042254
HALLMARK_SPERMATOGENESIS,SET,126,0.082585,0.0068144,0.07511,0.13578,HALLMARK_SPERMATOGENESIS,0.892534507042254
GOBP_IMMUNE_RESPONSE_REGULAT...1,SET,307,0.055298,0.007087,0.050306,0.13584,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.892534507042254
GOBP_TELOMERE_MAINTENANCE,SET,142,0.072521,0.0063498,0.065974,0.13584,GOBP_TELOMERE_MAINTENANCE,0.892534507042254
BIOCARTA_MEF2D_PATHWAY,SET,18,0.2263,0.0070785,0.20591,0.13589,BIOCARTA_MEF2D_PATHWAY,0.892534507042254
RAY_TARGETS_OF_P210_BCR_ABL_...1,SET,15,0.2523,0.0072048,0.22958,0.1359,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_DN,0.892534507042254
HELLER_HDAC_TARGETS_SILENCED...2,SET,371,0.049995,0.0070312,0.045502,0.13594,HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_UP,0.892534507042254
MORI_MATURE_B_LYMPHOCYTE_UP,SET,80,0.11207,0.0073777,0.10201,0.13598,MORI_MATURE_B_LYMPHOCYTE_UP,0.892534507042254
GOBP_BLOOD_COAGULATION_FIBRI...,SET,14,0.30332,0.0083683,0.27611,0.13599,GOBP_BLOOD_COAGULATION_FIBRIN_CLOT_FORMATION,0.892534507042254
GOBP_VERY_LOW_DENSITY_LIPOPR...2,SET,6,0.38402,0.0069375,0.34957,0.13599,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,0.892534507042254
HP_ABNORMAL_GRANULOCYTE_COUNT,SET,235,0.060054,0.0067471,0.054669,0.136,HP_ABNORMAL_GRANULOCYTE_COUNT,0.892534507042254
GSE13411_IGM_VS_SWITCHED_MEM...1,SET,176,0.0692,0.0067393,0.062996,0.136,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_DN,0.892534507042254
REACTOME_RHO_GTPASES_ACTIVAT...2,SET,129,0.079465,0.0066341,0.072344,0.13602,REACTOME_RHO_GTPASES_ACTIVATE_FORMINS,0.892534507042254
GOMF_AMINO_ACID_SODIUM_SYMPO...,SET,21,0.23521,0.0079461,0.21421,0.1361,GOMF_AMINO_ACID_SODIUM_SYMPORTER_ACTIVITY,0.892534507042254
KEGG_MEDICUS_REFERENCE_ACH_C...2,SET,20,0.19371,0.0063868,0.17643,0.13612,KEGG_MEDICUS_REFERENCE_ACH_CHRN_RAS_ERK_SIGNALING_PATHWAY,0.892534507042254
GOBP_REGULATION_OF_MESENCHYM...2,SET,10,0.3171,0.0073946,0.28881,0.13612,GOBP_REGULATION_OF_MESENCHYMAL_STEM_CELL_DIFFERENTIATION,0.892534507042254
GOBP_POSITIVE_REGULATION_OF_...540,SET,37,0.16135,0.0072324,0.14699,0.13617,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,0.892534507042254
GSE43863_NAIVE_VS_TH1_EFF_CD...1,SET,147,0.078097,0.0069565,0.071147,0.13618,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_DN,0.892534507042254
FERRANDO_TAL1_NEIGHBORS,SET,17,0.22266,0.0067686,0.20288,0.13622,FERRANDO_TAL1_NEIGHBORS,0.892534507042254
REACTOME_FORMYL_PEPTIDE_RECE...,SET,8,0.38885,0.0081109,0.35434,0.13625,REACTOME_FORMYL_PEPTIDE_RECEPTORS_BIND_FORMYL_PEPTIDES_AND_MANY_OTHER_LIGANDS,0.892534507042254
ROSS_AML_WITH_PML_RARA_FUSION,SET,69,0.10729,0.0065618,0.097778,0.13626,ROSS_AML_WITH_PML_RARA_FUSION,0.892534507042254
GAVISH_3CA_METAPROGRAM_EPITH...15,SET,47,0.13779,0.0069593,0.12558,0.13627,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_2,0.892534507042254
GSE36009_UNSTIM_VS_LPS_STIM_...2,SET,174,0.071411,0.0069153,0.065083,0.13628,GSE36009_UNSTIM_VS_LPS_STIM_DC_UP,0.892534507042254
HP_QUADRICEPS_MUSCLE_WEAKNESS,SET,19,0.22567,0.0072521,0.20568,0.13629,HP_QUADRICEPS_MUSCLE_WEAKNESS,0.892534507042254
MIR6846_5P,SET,70,0.11022,0.0067892,0.10046,0.1363,MIR6846_5P,0.892534507042254
ZFHX3_TARGET_GENES,SET,1386,0.025558,0.0067487,0.023297,0.13632,ZFHX3_TARGET_GENES,0.892534507042254
GSE45365_WT_VS_IFNAR_KO_CD11...1,SET,154,0.072592,0.006617,0.06618,0.13635,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_DN,0.892534507042254
GOBP_RESPONSE_TO_GLUCAGON,SET,21,0.20187,0.0068197,0.18406,0.13638,GOBP_RESPONSE_TO_GLUCAGON,0.892534507042254
HP_ABNORMAL_AORTIC_VALVE_MOR...,SET,151,0.075966,0.0068574,0.069268,0.13639,HP_ABNORMAL_AORTIC_VALVE_MORPHOLOGY,0.892534507042254
MIR3622A_5P,SET,37,0.16181,0.0072527,0.14756,0.13642,MIR3622A_5P,0.892534507042254
MCM5_TARGET_GENES,SET,7,0.3407,0.0066477,0.31069,0.13642,MCM5_TARGET_GENES,0.892534507042254
GOMF_CERAMIDE_1_PHOSPHATE_BI...,SET,5,0.37828,0.0062384,0.34496,0.13642,GOMF_CERAMIDE_1_PHOSPHATE_BINDING,0.892534507042254
SHI_SPARC_TARGETS_DN,SET,12,0.29249,0.0074712,0.26676,0.13645,SHI_SPARC_TARGETS_DN,0.892534507042254
GOBP_REGULATION_OF_TRANSLATI...7,SET,8,0.32029,0.0066809,0.29217,0.13649,GOBP_REGULATION_OF_TRANSLATIONAL_TERMINATION,0.892534507042254
GOBP_REGULATION_OF_EPITHELIA...7,SET,100,0.097129,0.007145,0.088619,0.13654,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.892534507042254
HP_C1_C2_SUBLUXATION,SET,5,0.37693,0.0062161,0.3439,0.13654,HP_C1_C2_SUBLUXATION,0.892534507042254
REACTOME_EUKARYOTIC_TRANSLAT...2,SET,108,0.08531,0.0065204,0.077847,0.13658,REACTOME_EUKARYOTIC_TRANSLATION_INITIATION,0.892534507042254
GOBP_DENDRITIC_CELL_CYTOKINE...,SET,17,0.23284,0.0070782,0.21247,0.13658,GOBP_DENDRITIC_CELL_CYTOKINE_PRODUCTION,0.892534507042254
GSE22342_CD11C_HIGH_VS_LOW_D...1,SET,154,0.075076,0.0068434,0.068509,0.13658,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_DN,0.892534507042254
HP_DIFFICULTY_WALKING,SET,277,0.053599,0.0065304,0.048913,0.13659,HP_DIFFICULTY_WALKING,0.892534507042254
GOBP_MYELOID_DENDRITIC_CELL_...3,SET,20,0.22663,0.0074719,0.20683,0.1366,GOBP_MYELOID_DENDRITIC_CELL_DIFFERENTIATION,0.892534507042254
RUAN_RESPONSE_TO_TROGLITAZON...2,SET,24,0.21039,0.0075979,0.19203,0.13663,RUAN_RESPONSE_TO_TROGLITAZONE_UP,0.892534507042254
GOCC_PROTEIN_DNA_COMPLEX,SET,1228,0.027454,0.0068555,0.02506,0.13665,GOCC_PROTEIN_DNA_COMPLEX,0.892534507042254
MIR200A_5P,SET,96,0.090959,0.0065567,0.083035,0.13667,MIR200A_5P,0.892534507042254
GNF2_MBD4,SET,22,0.18404,0.0063637,0.16801,0.13667,GNF2_MBD4,0.892534507042254
CTTGTAT_MIR381,SET,185,0.068513,0.0068391,0.062549,0.13669,CTTGTAT_MIR381,0.892534507042254
chr10p14,SET,15,0.38405,0.010967,0.35066,0.13672,chr10p14,0.892534507042254
FULCHER_INFLAMMATORY_RESPONS...1,SET,405,0.047508,0.0069742,0.04338,0.13673,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN,0.892534507042254
MIR5010_3P,SET,269,0.057068,0.0068534,0.05211,0.13673,MIR5010_3P,0.892534507042254
GSE43863_TFH_VS_LY6C_LOW_CXC...2,SET,185,0.07036,0.0070235,0.06425,0.13675,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.892534507042254
MODULE_24,SET,412,0.048167,0.0071305,0.044002,0.13684,MODULE_24,0.892778832458771
MIR6887_3P,SET,178,0.071397,0.0069923,0.065248,0.13693,MIR6887_3P,0.892778832458771
GOBP_RIBONUCLEOPROTEIN_COMPL...1,SET,398,0.042118,0.0061305,0.038492,0.13694,GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS,0.892778832458771
HP_HYPOMELANOTIC_MACULE,SET,8,0.31276,0.0065238,0.28584,0.13694,HP_HYPOMELANOTIC_MACULE,0.892778832458771
HP_OROPHARYNGEAL_SQUAMOUS_CE...,SET,6,0.36967,0.0066782,0.33787,0.13696,HP_OROPHARYNGEAL_SQUAMOUS_CELL_CARCINOMA,0.892778832458771
WP_TYPE_II_DIABETES_MELLITUS,SET,20,0.21202,0.0069903,0.1938,0.13698,WP_TYPE_II_DIABETES_MELLITUS,0.892778832458771
GOBP_REGULATION_OF_3_UTR_MED...,SET,5,0.46144,0.00761,0.42181,0.13699,GOBP_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,0.892778832458771
GOBP_NEGATIVE_REGULATION_OF_...311,SET,26,0.19289,0.00725,0.17634,0.13701,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,0.892778832458771
HU_FETAL_RETINA_MICROGLIA,SET,338,0.052547,0.0070602,0.048042,0.13704,HU_FETAL_RETINA_MICROGLIA,0.892778832458771
GOBP_REGULATION_OF_AMIDE_MET...,SET,64,0.11051,0.0065099,0.10105,0.13706,GOBP_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.892778832458771
LI_ESTROGENE_MID_E2_RESPONSE...1,SET,40,0.15396,0.0071746,0.14078,0.13707,LI_ESTROGENE_MID_E2_RESPONSE_DN,0.892778832458771
GOBP_MYELOID_LEUKOCYTE_CYTOK...,SET,47,0.13903,0.0070216,0.12717,0.13714,GOBP_MYELOID_LEUKOCYTE_CYTOKINE_PRODUCTION,0.893030310977894
GOBP_CELLULAR_RESPONSE_TO_GR...,SET,24,0.20825,0.0075207,0.1905,0.13716,GOBP_CELLULAR_RESPONSE_TO_GROWTH_HORMONE_STIMULUS,0.893030310977894
GOBP_MRNA_5_SPLICE_SITE_RECO...,SET,6,0.30404,0.0054925,0.27824,0.13727,GOBP_MRNA_5_SPLICE_SITE_RECOGNITION,0.893347147933421
GOBP_HYPOXIA_INDUCIBLE_FACTO...,SET,3,0.59482,0.0075989,0.54451,0.13734,GOBP_HYPOXIA_INDUCIBLE_FACTOR_1ALPHA_SIGNALING_PATHWAY,0.893347147933421
REACTOME_ENOS_ACTIVATION,SET,10,0.2978,0.0069445,0.27266,0.13738,REACTOME_ENOS_ACTIVATION,0.893347147933421
GOBP_MITOCHONDRIAL_TRANSMEMB...,SET,90,0.093313,0.0065138,0.085439,0.13739,GOBP_MITOCHONDRIAL_TRANSMEMBRANE_TRANSPORT,0.893347147933421
REACTOME_ABC_FAMILY_PROTEINS...,SET,97,0.08782,0.0063631,0.080415,0.13741,REACTOME_ABC_FAMILY_PROTEINS_MEDIATED_TRANSPORT,0.893347147933421
GOMF_PHOSPHATIDYLINOSITOL_BI...1,SET,253,0.057033,0.0066453,0.052228,0.13742,GOMF_PHOSPHATIDYLINOSITOL_BINDING,0.893347147933421
GOBP_SKELETAL_MUSCLE_SATELLI...1,SET,9,0.2876,0.0063627,0.26337,0.13743,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_ACTIVATION,0.893347147933421
OLSSON_E2F3_TARGETS_UP,SET,22,0.21892,0.0075697,0.2005,0.13744,OLSSON_E2F3_TARGETS_UP,0.893347147933421
GSE15330_HSC_VS_LYMPHOID_PRI...4,SET,181,0.068173,0.0067319,0.062432,0.13744,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,0.893347147933421
MODULE_511,SET,34,0.15392,0.0066139,0.14099,0.1375,MODULE_511,0.89346825056012
GOMF_PROTEIN_DIMERIZATION_AC...,SET,894,0.031822,0.0068455,0.029159,0.13757,GOMF_PROTEIN_DIMERIZATION_ACTIVITY,0.89346825056012
GSE339_CD8POS_VS_CD4CD8DN_DC...1,SET,185,0.06548,0.0065364,0.060007,0.1376,GSE339_CD8POS_VS_CD4CD8DN_DC_DN,0.89346825056012
GOBP_IMPORT_INTO_THE_MITOCHO...,SET,46,0.12499,0.006245,0.11455,0.13762,GOBP_IMPORT_INTO_THE_MITOCHONDRION,0.89346825056012
KEGG_MEDICUS_REFERENCE_BCR_P...1,SET,16,0.22032,0.0064977,0.20195,0.13765,KEGG_MEDICUS_REFERENCE_BCR_PLCG_CALCINEURIN_SIGNALING_PATHWAY,0.89346825056012
MAINA_HYPOXIA_VHL_TARGETS_UP,SET,6,0.45658,0.0082482,0.41853,0.13766,MAINA_HYPOXIA_VHL_TARGETS_UP,0.89346825056012
GOBP_REGULATION_OF_FAS_SIGNA...,SET,4,0.4281,0.0063149,0.39243,0.13767,GOBP_REGULATION_OF_FAS_SIGNALING_PATHWAY,0.89346825056012
MIR5092,SET,6,0.32718,0.0059106,0.29994,0.13769,MIR5092,0.89346825056012
CP2_02,SET,220,0.062956,0.0068466,0.057716,0.13769,CP2_02,0.89346825056012
HP_INCREASED_CIRCULATING_CRE...,SET,3,0.70611,0.0090206,0.64741,0.13772,HP_INCREASED_CIRCULATING_CREATINE_KINASE_MB_ISOFORM,0.893496098562628
GSE43955_TH0_VS_TGFB_IL6_TH1...2,SET,184,0.068776,0.006847,0.063076,0.13778,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP,0.893718533034714
GOBP_NEGATIVE_REGULATION_OF_...163,SET,23,0.17839,0.0063066,0.16367,0.13788,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.893986994219653
GOBP_NEGATIVE_REGULATION_OF_...525,SET,29,0.16153,0.0064115,0.14822,0.13791,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,0.893986994219653
GOBP_RELAXATION_OF_VASCULAR_...,SET,4,0.47686,0.0070341,0.43757,0.13791,GOBP_RELAXATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE,0.893986994219653
HP_HYPERMOBILITY_OF_INTERPHA...,SET,5,0.43692,0.0072056,0.40097,0.13794,HP_HYPERMOBILITY_OF_INTERPHALANGEAL_JOINTS,0.893986994219653
FAN_EMBRYONIC_CTX_BIG_GROUPS...4,SET,43,0.14916,0.0072064,0.13689,0.13795,FAN_EMBRYONIC_CTX_BIG_GROUPS_EXCITATORY_NEURON,0.893986994219653
GOMF_ACTIVE_TRANSMEMBRANE_TR...,SET,421,0.045254,0.0067703,0.041564,0.13813,GOMF_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.894400724233983
HP_DECREASED_CIRCULATING_COM...1,SET,33,0.16534,0.0069996,0.15185,0.13813,HP_DECREASED_CIRCULATING_COMPLEMENT_C3_CONCENTRATION,0.894400724233983
GSE26928_EFF_MEMORY_VS_CXCR5...2,SET,164,0.071101,0.0066864,0.065303,0.13813,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,0.894400724233983
GOBP_CELLULAR_RESPONSE_TO_EP...,SET,11,0.27819,0.0068036,0.25557,0.13819,GOBP_CELLULAR_RESPONSE_TO_EPINEPHRINE_STIMULUS,0.894400724233983
GOBP_CHORIONIC_TROPHOBLAST_C...1,SET,7,0.41553,0.008108,0.38174,0.13819,GOBP_CHORIONIC_TROPHOBLAST_CELL_DIFFERENTIATION,0.894400724233983
GOCC_GLYCOPROTEIN_IB_IX_V_CO...,SET,4,0.54216,0.0079974,0.49807,0.13819,GOCC_GLYCOPROTEIN_IB_IX_V_COMPLEX,0.894400724233983
KEGG_MEDICUS_REFERENCE_PURIN...2,SET,10,0.28058,0.006543,0.25781,0.13823,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_HYPOXANTHINE_GUANINE_TO_IMP_GMP,0.894400724233983
GOBP_PLASMINOGEN_ACTIVATION,SET,24,0.20548,0.0074205,0.18883,0.13826,GOBP_PLASMINOGEN_ACTIVATION,0.894400724233983
GSE36888_UNTREATED_VS_IL2_TR...5,SET,178,0.066413,0.0065041,0.061032,0.13827,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_DN,0.894400724233983
DESCARTES_FETAL_EYE_PDE11A_F...,SET,16,0.26076,0.0076905,0.23966,0.13829,DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS,0.894400724233983
EGFR_UP.V1_UP,SET,170,0.076766,0.0073488,0.070563,0.13832,EGFR_UP.V1_UP,0.894400724233983
MIR1231,SET,48,0.13889,0.0070884,0.1277,0.13839,MIR1231,0.894400724233983
GSE17721_POLYIC_VS_CPG_0.5H_...1,SET,178,0.066964,0.0065581,0.061571,0.1384,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_DN,0.894400724233983
GSE3720_UNSTIM_VS_PMA_STIM_V...2,SET,158,0.071192,0.0065724,0.065461,0.13841,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,0.894400724233983
MIR877_3P,SET,174,0.069086,0.0066901,0.063551,0.1385,MIR877_3P,0.894400724233983
GSE12198_LOW_IL2_STIM_NK_CEL...1,SET,189,0.066218,0.0066804,0.060914,0.13851,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_DN,0.894400724233983
CBX7_TARGET_GENES,SET,727,0.035172,0.0068556,0.032357,0.13852,CBX7_TARGET_GENES,0.894400724233983
GSE10094_LCMV_VS_LISTERIA_IN...2,SET,175,0.065041,0.0063164,0.059836,0.13853,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_UP,0.894400724233983
GSE6269_HEALTHY_VS_FLU_INF_P...2,SET,153,0.071776,0.0065215,0.066038,0.13855,GSE6269_HEALTHY_VS_FLU_INF_PBMC_UP,0.894400724233983
GOBP_AMINO_ACID_SALVAGE,SET,7,0.40166,0.0078373,0.36959,0.13857,GOBP_AMINO_ACID_SALVAGE,0.894400724233983
ATGTAGC_MIR221_MIR222,SET,130,0.087163,0.0073047,0.080206,0.13858,ATGTAGC_MIR221_MIR222,0.894400724233983
HP_C1_C2_VERTEBRAL_ABNORMALI...,SET,7,0.33,0.0064391,0.30366,0.13858,HP_C1_C2_VERTEBRAL_ABNORMALITY,0.894400724233983
GOBP_REGULATION_OF_GLUCOSE_T...,SET,70,0.11669,0.0071875,0.10739,0.13863,GOBP_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.894557305978463
GOBP_NK_T_CELL_PROLIFERATION,SET,8,0.3667,0.0076489,0.33766,0.13875,GOBP_NK_T_CELL_PROLIFERATION,0.895063808463252
WP_CANCER_PATHWAYS,SET,483,0.043714,0.0069928,0.040255,0.13876,WP_CANCER_PATHWAYS,0.895063808463252
KEGG_MEDICUS_PATHOGEN_EBV_EB...1,SET,10,0.25102,0.0058537,0.2312,0.13881,KEGG_MEDICUS_PATHOGEN_EBV_EBNA1_TO_P53_MEDIATED_TRANSCRIPTION,0.895220179996289
GOMF_MANNOSYL_OLIGOSACCHARID...2,SET,9,0.3218,0.0071193,0.29649,0.13889,GOMF_MANNOSYL_OLIGOSACCHARIDE_MANNOSIDASE_ACTIVITY,0.895569935064935
HP_DILATATION_OF_THE_CEREBRA...,SET,49,0.13511,0.0069671,0.12456,0.13903,HP_DILATATION_OF_THE_CEREBRAL_ARTERY,0.896306371730662
KEGG_MEDICUS_REFERENCE_AREG_...2,SET,14,0.24384,0.0067273,0.22483,0.13907,KEGG_MEDICUS_REFERENCE_AREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.896313157894737
GOBP_NEGATIVE_REGULATION_OF_...201,SET,33,0.17548,0.0074289,0.16182,0.1391,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,0.896313157894737
SNF5_DN.V1_UP,SET,148,0.077655,0.0069404,0.071615,0.13912,SNF5_DN.V1_UP,0.896313157894737
MIR1273H_5P,SET,176,0.06702,0.006527,0.061816,0.13915,MIR1273H_5P,0.896313157894737
REACTOME_SIGNALING_BY_EGFR,SET,51,0.12507,0.0065793,0.11536,0.13916,REACTOME_SIGNALING_BY_EGFR,0.896313157894737
GOBP_CELL_CELL_RECOGNITION,SET,71,0.1089,0.0067553,0.10046,0.13919,GOBP_CELL_CELL_RECOGNITION,0.896340272373541
GOBP_POSITIVE_REGULATION_OF_...101,SET,10,0.34783,0.0081112,0.32091,0.13922,GOBP_POSITIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.896367376806225
GOBP_NEURON_GLIAL_CELL_SIGNA...,SET,5,0.4848,0.0079951,0.4474,0.13928,GOBP_NEURON_GLIAL_CELL_SIGNALING,0.896587590294499
GAVISH_3CA_MALIGNANT_METAPRO...14,SET,49,0.14511,0.0074824,0.13394,0.13932,GAVISH_3CA_MALIGNANT_METAPROGRAM_23_SECRETED_2,0.896600610094287
CHAUHAN_RESPONSE_TO_METHOXYE...1,SET,83,0.099833,0.0066937,0.09216,0.13935,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN,0.896600610094287
GOBP_PROTEIN_LOCALIZATION_TO...35,SET,11,0.21731,0.0053149,0.20063,0.13937,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_BODY,0.896600610094287
GSE3720_VD1_VS_VD2_GAMMADELT...6,SET,178,0.068728,0.0067308,0.063466,0.13943,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_UP,0.896600610094287
GSE4142_PLASMA_CELL_VS_GC_BC...1,SET,177,0.067051,0.0065483,0.061916,0.13943,GSE4142_PLASMA_CELL_VS_GC_BCELL_DN,0.896600610094287
GNF2_PTPN6,SET,41,0.14165,0.006683,0.13082,0.13945,GNF2_PTPN6,0.896600610094287
TRAVAGLINI_LUNG_OLR1_CLASSIC...,SET,654,0.037507,0.0069481,0.034641,0.13947,TRAVAGLINI_LUNG_OLR1_CLASSICAL_MONOCYTE_CELL,0.896600610094287
GSE17721_POLYIC_VS_CPG_8H_BM...2,SET,180,0.066739,0.0065724,0.061653,0.13952,GSE17721_POLYIC_VS_CPG_8H_BMDC_UP,0.896600610094287
HP_ABNORMAL_MUSCLE_FIBER_PRO...,SET,25,0.18675,0.0068828,0.17252,0.13953,HP_ABNORMAL_MUSCLE_FIBER_PROTEIN_EXPRESSION,0.896600610094287
chr21q11,SET,4,0.60457,0.008918,0.55853,0.13954,chr21q11,0.896600610094287
GOMF_HISTONE_H3K14_ACETYLTRA...,SET,9,0.3031,0.0067057,0.28015,0.13965,GOMF_HISTONE_H3K14_ACETYLTRANSFERASE_ACTIVITY,0.897141543438078
GOBP_NEGATIVE_REGULATION_OF_...180,SET,797,0.034619,0.0070511,0.03201,0.13975,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,0.897618046571798
GOMF_PYRUVATE_DEHYDROGENASE_...1,SET,4,0.43027,0.0063469,0.3979,0.13978,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_KINASE_ACTIVITY,0.897644844789357
EPPERT_PROGENITOR,SET,124,0.08003,0.0065513,0.074028,0.13984,EPPERT_PROGENITOR,0.897816109675037
GOBP_NEGATIVE_REGULATION_OF_...79,SET,6,0.38814,0.0070118,0.35905,0.13986,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CONTRACTION,0.897816109675037
BROWN_MYELOID_CELL_DEVELOPME...1,SET,119,0.08421,0.0067541,0.077918,0.13991,BROWN_MYELOID_CELL_DEVELOPMENT_DN,0.897816109675037
REACTOME_PEPTIDE_HORMONE_BIO...,SET,13,0.26715,0.0071024,0.24718,0.13991,REACTOME_PEPTIDE_HORMONE_BIOSYNTHESIS,0.897816109675037
HP_ACUTE_OTITIS_MEDIA,SET,5,0.44989,0.0074194,0.4164,0.13998,HP_ACUTE_OTITIS_MEDIA,0.898062015503876
LEE_LIVER_CANCER_MYC_E2F1_DN,SET,59,0.12794,0.0072375,0.11843,0.14,LEE_LIVER_CANCER_MYC_E2F1_DN,0.898062015503876
GSE15330_MEGAKARYOCYTE_ERYTH...3,SET,181,0.067973,0.0067123,0.062953,0.14013,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.89851576618108
HP_TALIPES_EQUINOVALGUS,SET,13,0.23634,0.0062835,0.2189,0.14014,HP_TALIPES_EQUINOVALGUS,0.89851576618108
GOBP_POLYSACCHARIDE_BIOSYNTH...,SET,60,0.1168,0.0066624,0.10819,0.14019,GOBP_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,0.89851576618108
HP_PEDAL_EDEMA,SET,48,0.13355,0.0068163,0.12373,0.1402,HP_PEDAL_EDEMA,0.89851576618108
GSE2585_CTEC_VS_THYMIC_MACRO...2,SET,183,0.069052,0.0068559,0.063969,0.1402,GSE2585_CTEC_VS_THYMIC_MACROPHAGE_UP,0.89851576618108
PUIFFE_INVASION_INHIBITED_BY...2,SET,65,0.11169,0.0066306,0.1035,0.14026,PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP,0.898734568584071
GOBP_NEGATIVE_REGULATION_OF_...58,SET,13,0.30864,0.0082055,0.28609,0.14034,GOBP_NEGATIVE_REGULATION_OF_B_CELL_MEDIATED_IMMUNITY,0.898915720604497
GSE41176_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.069017,0.0067403,0.063975,0.14034,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_1H_DN,0.898915720604497
GOBP_POSITIVE_REGULATION_OF_...452,SET,8,0.38288,0.0079865,0.35504,0.14043,GOBP_POSITIVE_REGULATION_OF_MEMORY_T_CELL_DIFFERENTIATION,0.89905916375023
HINATA_NFKB_IMMU_INF,SET,15,0.26755,0.0076404,0.2481,0.14043,HINATA_NFKB_IMMU_INF,0.89905916375023
HP_EXANTHEM,SET,20,0.20543,0.0067729,0.19049,0.14044,HP_EXANTHEM,0.89905916375023
REACTOME_METABOLISM_OF_VITAM...,SET,185,0.065893,0.0065776,0.061131,0.14055,REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS,0.899432010679433
GOBP_POSITIVE_REGULATION_OF_...174,SET,22,0.20809,0.0071952,0.19305,0.14055,GOBP_POSITIVE_REGULATION_OF_COLLAGEN_METABOLIC_PROCESS,0.899432010679433
HP_HYPOREFLEXIA_OF_UPPER_LIM...,SET,7,0.39149,0.0076387,0.36329,0.14061,HP_HYPOREFLEXIA_OF_UPPER_LIMBS,0.899499806843267
MORI_PRE_BI_LYMPHOCYTE_UP,SET,73,0.10633,0.0066882,0.098689,0.14064,MORI_PRE_BI_LYMPHOCYTE_UP,0.899499806843267
HALLMARK_P53_PATHWAY,SET,187,0.064315,0.0064543,0.059691,0.14064,HALLMARK_P53_PATHWAY,0.899499806843267
KEGG_MEDICUS_REFERENCE_GLYCO...5,SET,5,0.33358,0.0055012,0.30963,0.14067,KEGG_MEDICUS_REFERENCE_GLYCOSAMINOGLYCAN_BIOSYNTHESIS_LINKAGE_TETRASACCHARIDE,0.899499806843267
GOMF_PLATELET_DERIVED_GROWTH...2,SET,13,0.28686,0.0076264,0.26628,0.14069,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BINDING,0.899499806843267
MIR1202,SET,67,0.10555,0.0063613,0.098044,0.14084,MIR1202,0.900180055147059
MIR7843_5P,SET,86,0.097542,0.0066567,0.090614,0.14087,MIR7843_5P,0.900180055147059
GOMF_RNA_NUCLEASE_ACTIVITY,SET,117,0.081626,0.0064919,0.075836,0.14089,GOMF_RNA_NUCLEASE_ACTIVITY,0.900180055147059
GOBP_NEGATIVE_REGULATION_OF_...78,SET,9,0.33917,0.0075036,0.31512,0.1409,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,0.900180055147059
GOBP_ASTROCYTE_DEVELOPMENT,SET,40,0.14959,0.0069711,0.13901,0.14095,GOBP_ASTROCYTE_DEVELOPMENT,0.900333991913251
SILIGAN_TARGETS_OF_EWS_FLI1_...2,SET,15,0.22925,0.0065466,0.2131,0.14102,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_UP,0.900351587447238
HP_SUNKEN_CHEEKS,SET,5,0.41717,0.0068799,0.3878,0.14103,HP_SUNKEN_CHEEKS,0.900351587447238
HP_HYPOPLASTIC_FRONTAL_SINUS...,SET,6,0.37526,0.0067792,0.34894,0.1411,HP_HYPOPLASTIC_FRONTAL_SINUSES,0.900351587447238
GSE2706_R848_VS_LPS_2H_STIM_...1,SET,145,0.076216,0.006743,0.070871,0.1411,GSE2706_R848_VS_LPS_2H_STIM_DC_DN,0.900351587447238
KEGG_CYSTEINE_AND_METHIONINE...,SET,32,0.17968,0.007491,0.16711,0.14114,KEGG_CYSTEINE_AND_METHIONINE_METABOLISM,0.900351587447238
GOBP_ASTROCYTE_ACTIVATION,SET,23,0.20828,0.0073635,0.19371,0.14115,GOBP_ASTROCYTE_ACTIVATION,0.900351587447238
PUJANA_BRCA_CENTERED_NETWORK,SET,110,0.080109,0.0061789,0.074509,0.14116,PUJANA_BRCA_CENTERED_NETWORK,0.900351587447238
GOMF_HISTONE_METHYLTRANSFERA...1,SET,58,0.11565,0.0064868,0.10757,0.14116,GOMF_HISTONE_METHYLTRANSFERASE_ACTIVITY,0.900351587447238
GOBP_MAINTENANCE_OF_PRESYNAP...,SET,5,0.43308,0.0071422,0.40285,0.14119,GOBP_MAINTENANCE_OF_PRESYNAPTIC_ACTIVE_ZONE_STRUCTURE,0.900377697247707
GOMF_SINGLE_STRANDED_RNA_BIN...,SET,75,0.10378,0.0066158,0.096571,0.14128,GOMF_SINGLE_STRANDED_RNA_BINDING,0.900710911424904
GOBP_SYNAPTIC_TRANSMISSION_C...,SET,32,0.16838,0.0070199,0.1567,0.1413,GOBP_SYNAPTIC_TRANSMISSION_CHOLINERGIC,0.900710911424904
HE_LIM_SUN_FETAL_LUNG_C1_LAT...3,SET,6,0.41435,0.0074854,0.38564,0.14132,HE_LIM_SUN_FETAL_LUNG_C1_LATE_STALK_CELL,0.900710911424904
GOBP_CHOLESTEROL_EFFLUX,SET,56,0.12242,0.0067472,0.11398,0.1414,GOBP_CHOLESTEROL_EFFLUX,0.90075389967045
GAVISH_3CA_METAPROGRAM_MACRO...10,SET,48,0.12551,0.0064056,0.11686,0.14143,GAVISH_3CA_METAPROGRAM_MACROPHAGES_PROTEASOMAL_DEGRADATION,0.90075389967045
GOBP_POSITIVE_REGULATION_OF_...848,SET,5,0.39997,0.0065962,0.37252,0.14149,GOBP_POSITIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,0.90075389967045
ASXL2_TARGET_GENES,SET,38,0.14508,0.0065901,0.13513,0.1415,ASXL2_TARGET_GENES,0.90075389967045
GOBP_TISSUE_HOMEOSTASIS,SET,247,0.061768,0.0071123,0.057533,0.14151,GOBP_TISSUE_HOMEOSTASIS,0.90075389967045
IWANAGA_E2F1_TARGETS_INDUCED...,SET,22,0.18657,0.0064511,0.17379,0.14153,IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM,0.90075389967045
LHX3_01,SET,211,0.067794,0.0072221,0.063151,0.14153,LHX3_01,0.90075389967045
FOURNIER_ACINAR_DEVELOPMENT_...3,SET,264,0.053398,0.0063536,0.049748,0.14156,FOURNIER_ACINAR_DEVELOPMENT_LATE_2,0.90075389967045
MODULE_19,SET,283,0.057704,0.007105,0.053759,0.14156,MODULE_19,0.90075389967045
DBP_Q6,SET,224,0.062401,0.0068469,0.05815,0.14162,DBP_Q6,0.90097073036793
YAGI_AML_WITH_INV_16_TRANSLO...,SET,372,0.046719,0.0065791,0.043547,0.14168,YAGI_AML_WITH_INV_16_TRANSLOCATION,0.901086175663312
GOBP_POSITIVE_REGULATION_OF_...803,SET,4,0.54195,0.0079944,0.50518,0.14169,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.901086175663312
REACTOME_SCAVENGING_OF_HEME_...,SET,10,0.30879,0.0072009,0.28793,0.14177,REACTOME_SCAVENGING_OF_HEME_FROM_PLASMA,0.901429994511526
GOCC_TERTIARY_GRANULE_MEMBRA...,SET,63,0.11415,0.0066716,0.10647,0.14186,GOCC_TERTIARY_GRANULE_MEMBRANE,0.901837259923175
GOBP_3_UTR_MEDIATED_MRNA_DES...,SET,19,0.21295,0.0068434,0.19878,0.14202,GOBP_3_UTR_MEDIATED_MRNA_DESTABILIZATION,0.902511944799854
GOBP_POSITIVE_REGULATION_OF_...735,SET,11,0.25514,0.00624,0.23816,0.14202,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.902511944799854
GOBP_CHAPERONE_MEDIATED_AUTO...,SET,14,0.21142,0.0058329,0.19739,0.14207,GOBP_CHAPERONE_MEDIATED_AUTOPHAGY,0.902511944799854
GOCC_MYOSIN_II_COMPLEX,SET,25,0.1922,0.0070837,0.17944,0.14207,GOCC_MYOSIN_II_COMPLEX,0.902511944799854
GOBP_CELL_SURFACE_RECEPTOR_S...1,SET,7,0.37441,0.0073055,0.34962,0.14212,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_DEVELOPMENT,0.90263212793022
LAKE_ADULT_KIDNEY_C14_DISTAL...,SET,179,0.073127,0.0071815,0.068309,0.1422,LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE,0.90263212793022
HP_ONYCHOGRYPOSIS,SET,27,0.17387,0.0066592,0.16243,0.14222,HP_ONYCHOGRYPOSIS,0.90263212793022
GOBP_NEUTROPHIL_MEDIATED_KIL...1,SET,7,0.41686,0.0081338,0.38957,0.14231,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_GRAM_NEGATIVE_BACTERIUM,0.90263212793022
GOBP_GERMINAL_CENTER_FORMATI...,SET,14,0.24529,0.0067674,0.22926,0.14233,GOBP_GERMINAL_CENTER_FORMATION,0.90263212793022
HOEK_PBMC_INACTIVATED_INFLUE...4,SET,6,0.34236,0.0061849,0.32004,0.14237,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_3DY_UP,0.90263212793022
GOCC_MYOFILAMENT,SET,25,0.17899,0.006597,0.16737,0.14244,GOCC_MYOFILAMENT,0.90263212793022
GOBP_NEGATIVE_REGULATION_OF_...154,SET,11,0.34132,0.0083476,0.31917,0.14245,GOBP_NEGATIVE_REGULATION_OF_COMPLEMENT_ACTIVATION,0.90263212793022
GSE42724_B1_BCELL_VS_PLASMAB...1,SET,181,0.063944,0.0063143,0.059809,0.14251,GSE42724_B1_BCELL_VS_PLASMABLAST_DN,0.90263212793022
GSE16450_IMMATURE_VS_MATURE_...3,SET,177,0.067415,0.0065839,0.063061,0.14253,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_DN,0.90263212793022
MODULE_516,SET,15,0.25816,0.0073722,0.24151,0.14255,MODULE_516,0.90263212793022
GOBP_REGULATION_OF_PHOSPHOLI...7,SET,29,0.16249,0.0064492,0.15203,0.14259,GOBP_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,0.90263212793022
REACTOME_STAT3_NUCLEAR_EVENT...,SET,10,0.32727,0.0076318,0.30628,0.14265,REACTOME_STAT3_NUCLEAR_EVENTS_DOWNSTREAM_OF_ALK_SIGNALING,0.90263212793022
REACTOME_METABOLISM_OF_NITRI...,SET,14,0.2302,0.0063511,0.21545,0.14266,REACTOME_METABOLISM_OF_NITRIC_OXIDE_NOS3_ACTIVATION_AND_REGULATION,0.90263212793022
HP_PENOSCROTAL_HYPOSPADIAS,SET,8,0.33913,0.0070739,0.31746,0.1427,HP_PENOSCROTAL_HYPOSPADIAS,0.90263212793022
CHARAFE_BREAST_CANCER_LUMINA...1,SET,414,0.047269,0.0070141,0.044249,0.14271,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN,0.90263212793022
HP_DELAYED_SOMATOSENSORY_CEN...,SET,3,0.5233,0.0066852,0.48993,0.14274,HP_DELAYED_SOMATOSENSORY_CENTRAL_CONDUCTION_TIME,0.90263212793022
HP_MYOPATHIC_FACIES,SET,46,0.1341,0.0067006,0.12556,0.14276,HP_MYOPATHIC_FACIES,0.90263212793022
WP_FTO_OBESITY_VARIANT_MECHA...,SET,8,0.33825,0.0070554,0.31672,0.14278,WP_FTO_OBESITY_VARIANT_MECHANISM,0.90263212793022
HOLLERN_PAPILLARY_BREAST_TUM...,SET,15,0.24428,0.0069759,0.22875,0.14279,HOLLERN_PAPILLARY_BREAST_TUMOR,0.90263212793022
HP_BICONVEX_VERTEBRAL_BODIES,SET,3,0.49901,0.0063749,0.46728,0.14279,HP_BICONVEX_VERTEBRAL_BODIES,0.90263212793022
CAGGTA_AREB6_01,SET,684,0.03591,0.0067975,0.033629,0.1428,CAGGTA_AREB6_01,0.90263212793022
HP_AIRWAY_OBSTRUCTION,SET,115,0.085686,0.0067567,0.080249,0.14282,HP_AIRWAY_OBSTRUCTION,0.90263212793022
SNAI1_TARGET_GENES,SET,370,0.046083,0.0064724,0.043164,0.14285,SNAI1_TARGET_GENES,0.90263212793022
HP_ABNORMAL_RENAL_TUBULAR_LU...,SET,5,0.42419,0.0069955,0.39731,0.14285,HP_ABNORMAL_RENAL_TUBULAR_LUMEN_MORPHOLOGY,0.90263212793022
GOBP_POSITIVE_REGULATION_OF_...157,SET,26,0.174,0.0065397,0.16298,0.14286,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.90263212793022
GOBP_L_SERINE_METABOLIC_PROC...,SET,11,0.24827,0.0060721,0.23258,0.14289,GOBP_L_SERINE_METABOLIC_PROCESS,0.90263212793022
GOBP_PROTEIN_INSERTION_INTO_...4,SET,4,0.3266,0.0048178,0.30597,0.1429,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE_FROM_INNER_SIDE,0.90263212793022
DESCARTES_FETAL_CEREBELLUM_M...,SET,490,0.043837,0.0070617,0.041068,0.1429,DESCARTES_FETAL_CEREBELLUM_MICROGLIA,0.90263212793022
HP_UNUSUAL_VIRUS_REACTIVATION,SET,21,0.21086,0.0071234,0.19755,0.14291,HP_UNUSUAL_VIRUS_REACTIVATION,0.90263212793022
WP_MFAP5MEDIATED_OVARIAN_CAN...,SET,12,0.26675,0.0068138,0.24992,0.14292,WP_MFAP5MEDIATED_OVARIAN_CANCER_CELL_MOTILITY_AND_INVASIVENESS,0.90263212793022
GOBP_PROTEIN_POLYGLUTAMYLATI...,SET,11,0.29435,0.007199,0.27579,0.14292,GOBP_PROTEIN_POLYGLUTAMYLATION,0.90263212793022
GOBP_POSITIVE_REGULATION_OF_...682,SET,70,0.11558,0.0071192,0.10833,0.14301,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,0.902898448557431
HP_OVERLAPPING_TOE,SET,60,0.11602,0.006618,0.10874,0.14302,HP_OVERLAPPING_TOE,0.902898448557431
GOBP_EMBRYONIC_HEART_TUBE_LE...,SET,5,0.37148,0.0061263,0.34831,0.1431,GOBP_EMBRYONIC_HEART_TUBE_LEFT_RIGHT_PATTERN_FORMATION,0.902898448557431
GOBP_RESPONSE_TO_ATP,SET,31,0.17496,0.0071793,0.16405,0.14311,GOBP_RESPONSE_TO_ATP,0.902898448557431
GOBP_NOTCH_SIGNALING_PATHWAY,SET,164,0.071852,0.006757,0.067375,0.14312,GOBP_NOTCH_SIGNALING_PATHWAY,0.902898448557431
GSE19888_CTRL_VS_T_CELL_MEMB...2,SET,184,0.063526,0.0063244,0.059575,0.14315,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_UP,0.902898448557431
GSE22886_UNSTIM_VS_IL15_STIM...2,SET,171,0.066828,0.006416,0.062675,0.14316,GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP,0.902898448557431
GSE13522_CTRL_VS_T_CRUZI_Y_S...3,SET,117,0.085599,0.006808,0.080283,0.14317,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_DN,0.902898448557431
GOBP_CELL_CYCLE_DNA_REPLICAT...2,SET,4,0.41554,0.0061296,0.38979,0.14321,GOBP_CELL_CYCLE_DNA_REPLICATION_INITIATION,0.902986855950653
REACTOME_HEME_DEGRADATION,SET,15,0.23589,0.0067363,0.22136,0.14329,REACTOME_HEME_DEGRADATION,0.903289635473341
GOBP_N_ACETYLGLUCOSAMINE_MET...,SET,14,0.25397,0.0070067,0.23833,0.14331,GOBP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.903289635473341
GOBP_REGULATION_OF_T_HELPER_...5,SET,31,0.17728,0.0072746,0.16638,0.14334,GOBP_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,0.903314904805077
DESCARTES_FETAL_SPLEEN_STROM...,SET,31,0.18203,0.0074696,0.17087,0.14338,DESCARTES_FETAL_SPLEEN_STROMAL_CELLS,0.903403172588833
GOBP_REGULATION_OF_LIPOPROTE...2,SET,15,0.24813,0.0070859,0.23296,0.14342,GOBP_REGULATION_OF_LIPOPROTEIN_METABOLIC_PROCESS,0.903453642624139
GOBP_POSITIVE_REGULATION_OF_...107,SET,15,0.22784,0.0065064,0.21393,0.14344,GOBP_POSITIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,0.903453642624139
MIR4650_5P,SET,64,0.10813,0.0063696,0.10156,0.14351,MIR4650_5P,0.90347913727618
KANNAN_TP53_TARGETS_UP,SET,56,0.11741,0.0064712,0.11028,0.14352,KANNAN_TP53_TARGETS_UP,0.90347913727618
LUI_THYROID_CANCER_CLUSTER_1,SET,47,0.12772,0.0064503,0.11997,0.14353,LUI_THYROID_CANCER_CLUSTER_1,0.90347913727618
HP_HEMATOLOGICAL_NEOPLASM,SET,277,0.053283,0.0064919,0.050056,0.14356,HP_HEMATOLOGICAL_NEOPLASM,0.90347913727618
GOBP_REPRODUCTIVE_SYSTEM_DEV...,SET,284,0.056342,0.0069494,0.052939,0.14361,GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT,0.90347913727618
HP_ABNORMALITY_OF_THE_DISTAL...1,SET,22,0.19626,0.006786,0.18442,0.14363,HP_ABNORMALITY_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.90347913727618
GOMF_ENDOPEPTIDASE_ACTIVITY,SET,362,0.050069,0.0069573,0.04705,0.14364,GOMF_ENDOPEPTIDASE_ACTIVITY,0.90347913727618
HP_FLAT_FACE,SET,94,0.089903,0.006413,0.084495,0.14367,HP_FLAT_FACE,0.90347913727618
LIU_PROSTATE_CANCER_DN,SET,435,0.045582,0.0069291,0.042844,0.14369,LIU_PROSTATE_CANCER_DN,0.90347913727618
HP_VENOUS_MALFORMATION,SET,11,0.26259,0.0064222,0.24684,0.14372,HP_VENOUS_MALFORMATION,0.90347913727618
HP1SITEFACTOR_Q6,SET,204,0.064813,0.0067904,0.060929,0.14373,HP1SITEFACTOR_Q6,0.90347913727618
GOBP_REGULATION_OF_SUBSTRATE...,SET,58,0.11779,0.0066067,0.11075,0.14377,GOBP_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,0.903567151898734
HP_SPLENIC_RUPTURE,SET,4,0.60984,0.0089958,0.57348,0.1438,HP_SPLENIC_RUPTURE,0.90359229795697
HP_ABNORMAL_RENAL_COLLECTING...,SET,24,0.17475,0.0063109,0.16435,0.14383,HP_ABNORMAL_RENAL_COLLECTING_SYSTEM_MORPHOLOGY,0.903617434924078
REACTOME_REGULATION_OF_LIPID...,SET,114,0.080042,0.0062843,0.075315,0.14395,REACTOME_REGULATION_OF_LIPID_METABOLISM_BY_PPARALPHA,0.903755469314079
MIR380_5P,SET,42,0.14674,0.0070066,0.13809,0.14398,MIR380_5P,0.903755469314079
MODULE_51,SET,36,0.16979,0.0075071,0.15978,0.14399,MODULE_51,0.903755469314079
GNF2_STAT6,SET,73,0.10208,0.0064204,0.09608,0.14403,GNF2_STAT6,0.903755469314079
GOBP_HYALURONAN_METABOLIC_PR...,SET,32,0.15966,0.0066564,0.15029,0.14404,GOBP_HYALURONAN_METABOLIC_PROCESS,0.903755469314079
HP_PERIODONTITIS,SET,33,0.15566,0.00659,0.14653,0.14405,HP_PERIODONTITIS,0.903755469314079
KEGG_MEDICUS_REFERENCE_MICRO...2,SET,19,0.20882,0.0067108,0.19658,0.14406,KEGG_MEDICUS_REFERENCE_MICROTUBULE_DEPOLYMERIZATION_AT_THE_MINUS_ENDS,0.903755469314079
GOBP_REGULATION_OF_LIPID_STO...,SET,50,0.13265,0.0069095,0.12488,0.14406,GOBP_REGULATION_OF_LIPID_STORAGE,0.903755469314079
DACOSTA_LOW_DOSE_UV_RESPONSE...2,SET,11,0.28455,0.0069594,0.268,0.14418,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.904039685658153
HP_LEUKEMIA,SET,162,0.069369,0.006484,0.06535,0.14424,HP_LEUKEMIA,0.904039685658153
GOBP_REGULATION_OF_ENDOTHELI...2,SET,18,0.21356,0.0066801,0.20125,0.14431,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,0.904039685658153
GOBP_DIAPHRAGM_DEVELOPMENT,SET,9,0.32489,0.0071878,0.30618,0.14432,GOBP_DIAPHRAGM_DEVELOPMENT,0.904039685658153
GSE17721_LPS_VS_GARDIQUIMOD_...10,SET,183,0.06695,0.0066473,0.063122,0.14443,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_UP,0.904039685658153
HP_BICARBONATURIA,SET,5,0.35785,0.0059016,0.33747,0.14449,HP_BICARBONATURIA,0.904039685658153
HP_SHORT_TERM_MEMORY_IMPAIRM...,SET,6,0.432,0.0078042,0.40751,0.14455,HP_SHORT_TERM_MEMORY_IMPAIRMENT,0.904039685658153
HP_PROLONGED_PR_INTERVAL,SET,10,0.32296,0.0075314,0.30466,0.14456,HP_PROLONGED_PR_INTERVAL,0.904039685658153
MIR6716_5P,SET,118,0.082847,0.006617,0.078175,0.14463,MIR6716_5P,0.904039685658153
ROYLANCE_BREAST_CANCER_16Q_C...2,SET,59,0.18004,0.010184,0.1699,0.14465,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP,0.904039685658153
GSE19512_NAUTRAL_VS_INDUCED_...2,SET,179,0.068546,0.0067316,0.064689,0.14467,GSE19512_NAUTRAL_VS_INDUCED_TREG_UP,0.904039685658153
GOBP_SEQUESTERING_OF_CALCIUM...,SET,126,0.08334,0.0068768,0.078655,0.14468,GOBP_SEQUESTERING_OF_CALCIUM_ION,0.904039685658153
UNTERMAN_PROGRESSIVE_VS_STAB...4,SET,26,0.21095,0.0079285,0.19911,0.1447,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_MONOCYTE_DN,0.904039685658153
GOBP_PROTEIN_RNA_COMPLEX_DIS...,SET,10,0.24724,0.0057655,0.23346,0.1448,GOBP_PROTEIN_RNA_COMPLEX_DISASSEMBLY,0.904039685658153
HP_QUADRICEPS_MUSCLE_ATROPHY,SET,3,0.56955,0.0072761,0.5378,0.1448,HP_QUADRICEPS_MUSCLE_ATROPHY,0.904039685658153
GOMF_CATALYTIC_ACTIVITY_ACTI...5,SET,225,0.054816,0.0060279,0.051765,0.14482,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_DNA,0.904039685658153
GNF2_CKS2,SET,49,0.12151,0.0062659,0.11477,0.14486,GNF2_CKS2,0.904039685658153
GOBP_NEGATIVE_REGULATION_OF_...659,SET,12,0.25599,0.006539,0.24178,0.14486,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.904039685658153
HP_DECREASED_CIRCULATING_FRE...1,SET,5,0.33309,0.0054932,0.3146,0.14486,HP_DECREASED_CIRCULATING_FREE_T3,0.904039685658153
GOBP_NEGATIVE_REGULATION_OF_...383,SET,6,0.38315,0.0069216,0.3619,0.14487,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,0.904039685658153
GOBP_RESPONSE_TO_UV_B,SET,19,0.19394,0.0062324,0.18319,0.14489,GOBP_RESPONSE_TO_UV_B,0.904039685658153
GOCC_MAIN_AXON,SET,67,0.12058,0.007267,0.11391,0.1449,GOCC_MAIN_AXON,0.904039685658153
HP_ABNORMALITY_OF_PATTERN_VI...,SET,5,0.50116,0.0082649,0.47343,0.1449,HP_ABNORMALITY_OF_PATTERN_VISUAL_EVOKED_POTENTIALS,0.904039685658153
OUYANG_PROSTATE_CANCER_PROGR...1,SET,20,0.20642,0.0068057,0.1951,0.14502,OUYANG_PROSTATE_CANCER_PROGRESSION_DN,0.904039685658153
REACTOME_GASTRIN_CREB_SIGNAL...,SET,17,0.22577,0.0068631,0.21338,0.14502,REACTOME_GASTRIN_CREB_SIGNALLING_PATHWAY_VIA_PKC_AND_MAPK,0.904039685658153
REACTOME_MATURATION_OF_PROTE...,SET,9,0.31264,0.0069167,0.29548,0.14502,REACTOME_MATURATION_OF_PROTEIN_3A,0.904039685658153
GOBP_REGULATION_OF_HYALURONA...,SET,8,0.31541,0.0065791,0.29811,0.14502,GOBP_REGULATION_OF_HYALURONAN_BIOSYNTHETIC_PROCESS,0.904039685658153
MORF_MYC,SET,75,0.10266,0.0065443,0.097027,0.14503,MORF_MYC,0.904039685658153
KEGG_CHRONIC_MYELOID_LEUKEMIA,SET,71,0.10734,0.0066588,0.10147,0.14506,KEGG_CHRONIC_MYELOID_LEUKEMIA,0.904039685658153
HP_ABNORMALITY_OF_SKELETAL_M...2,SET,106,0.08289,0.0062768,0.078359,0.14507,HP_ABNORMALITY_OF_SKELETAL_MUSCLE_FIBER_SIZE,0.904039685658153
GOMF_DOPAMINE_RECEPTOR_BINDI...,SET,13,0.25358,0.0067416,0.23972,0.14508,GOMF_DOPAMINE_RECEPTOR_BINDING,0.904039685658153
MIR495_5P,SET,62,0.11403,0.0066116,0.1078,0.14509,MIR495_5P,0.904039685658153
DAVICIONI_RHABDOMYOSARCOMA_P...2,SET,56,0.1278,0.0070435,0.12083,0.14512,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_UP,0.904039685658153
GOMF_AMINE_TRANSMEMBRANE_TRA...,SET,6,0.41805,0.0075522,0.39536,0.14517,GOMF_AMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.904039685658153
LUI_THYROID_CANCER_CLUSTER_2,SET,43,0.1391,0.0067203,0.13156,0.14519,LUI_THYROID_CANCER_CLUSTER_2,0.904039685658153
RUAN_RESPONSE_TO_TNF_UP,SET,13,0.25863,0.0068759,0.24461,0.1452,RUAN_RESPONSE_TO_TNF_UP,0.904039685658153
GOMF_POTASSIUM_CHANNEL_REGUL...,SET,46,0.13686,0.0068385,0.12948,0.14527,GOMF_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY,0.904039685658153
LAKE_ADULT_KIDNEY_C9_THIN_AS...,SET,246,0.057359,0.0065915,0.05427,0.14528,LAKE_ADULT_KIDNEY_C9_THIN_ASCENDING_LIMB,0.904039685658153
KEGG_CITRATE_CYCLE_TCA_CYCLE,SET,27,0.16093,0.0061635,0.15228,0.14532,KEGG_CITRATE_CYCLE_TCA_CYCLE,0.904039685658153
HP_DISTAL_SENSORY_IMPAIRMENT...,SET,10,0.26776,0.0062441,0.25338,0.14532,HP_DISTAL_SENSORY_IMPAIRMENT_OF_ALL_MODALITIES,0.904039685658153
GOMF_ZINC_ION_TRANSMEMBRANE_...,SET,24,0.16448,0.0059398,0.15565,0.14533,GOMF_ZINC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.904039685658153
HP_POSTERIOR_POLAR_CATARACT,SET,8,0.32872,0.0068567,0.31109,0.14534,HP_POSTERIOR_POLAR_CATARACT,0.904039685658153
REACTOME_MALATE_ASPARTATE_SH...,SET,9,0.26798,0.0059286,0.25363,0.14536,REACTOME_MALATE_ASPARTATE_SHUTTLE,0.904039685658153
chr17q24,SET,32,0.27455,0.011446,0.25986,0.14537,chr17q24,0.904039685658153
HP_ABNORMAL_CIRCULATING_THYR...1,SET,20,0.20578,0.0067846,0.19479,0.14539,HP_ABNORMAL_CIRCULATING_THYROGLOBULIN_CONCENTRATION,0.904039685658153
HP_APLASIA_HYPOPLASIA_OF_THE...4,SET,6,0.41068,0.0074191,0.38879,0.14542,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_FINGER,0.904039685658153
BIOCARTA_FMLP_PATHWAY,SET,32,0.1595,0.0066497,0.15103,0.14547,BIOCARTA_FMLP_PATHWAY,0.904039685658153
GOMF_LYSOPHOSPHATIDIC_ACID_B...,SET,7,0.31317,0.0061106,0.29653,0.14547,GOMF_LYSOPHOSPHATIDIC_ACID_BINDING,0.904039685658153
KEGG_MEDICUS_REFERENCE_P300_...,SET,15,0.23439,0.0066933,0.22195,0.14548,KEGG_MEDICUS_REFERENCE_P300_P21_CELL_CYCLE_G1_S,0.904039685658153
GOCC_ENDOPLASMIC_RETICULUM_G...2,SET,72,0.1017,0.0063528,0.096314,0.14551,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT_MEMBRANE,0.904039685658153
ZHONG_PFC_C5_BCL11B_CALB2_PO...,SET,22,0.20013,0.00692,0.18956,0.14555,ZHONG_PFC_C5_BCL11B_CALB2_POS_INP,0.904039685658153
KDM1B_TARGET_GENES,SET,110,0.08384,0.0064667,0.07942,0.14557,KDM1B_TARGET_GENES,0.904039685658153
GOCC_MYELIN_SHEATH,SET,41,0.13688,0.0064577,0.12967,0.14559,GOCC_MYELIN_SHEATH,0.904039685658153
KEGG_WNT_SIGNALING_PATHWAY,SET,144,0.077274,0.0068132,0.073212,0.14561,KEGG_WNT_SIGNALING_PATHWAY,0.904039685658153
SHAFFER_IRF4_TARGETS_IN_MYEL...,SET,94,0.093424,0.0066642,0.088517,0.14562,SHAFFER_IRF4_TARGETS_IN_MYELOMA_VS_MATURE_B_LYMPHOCYTE,0.904039685658153
HP_SPASTIC_GAIT,SET,69,0.10932,0.006686,0.10358,0.14562,HP_SPASTIC_GAIT,0.904039685658153
HP_HYPERTENSIVE_CRISIS,SET,14,0.2605,0.007187,0.24683,0.14563,HP_HYPERTENSIVE_CRISIS,0.904039685658153
GSE15930_STIM_VS_STIM_AND_IF...4,SET,180,0.065135,0.0064144,0.061716,0.14563,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_UP,0.904039685658153
FRASOR_RESPONSE_TO_SERM_OR_F...2,SET,21,0.19435,0.0065659,0.18416,0.14564,FRASOR_RESPONSE_TO_SERM_OR_FULVESTRANT_UP,0.904039685658153
REACTOME_REGULATION_OF_CHOLE...,SET,53,0.11329,0.0060751,0.10739,0.14573,REACTOME_REGULATION_OF_CHOLESTEROL_BIOSYNTHESIS_BY_SREBP_SREBF,0.904337386181039
REACTOME_ADVANCED_GLYCOSYLAT...,SET,13,0.23426,0.0062281,0.22207,0.14574,REACTOME_ADVANCED_GLYCOSYLATION_ENDPRODUCT_RECEPTOR_SIGNALING,0.904337386181039
GOBP_NEGATIVE_REGULATION_OF_...559,SET,68,0.10827,0.0065734,0.10265,0.14578,GOBP_NEGATIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,0.904424116387005
GOBP_REGULATION_OF_CELLULAR_...7,SET,905,0.029966,0.0064839,0.028418,0.14584,GOBP_REGULATION_OF_CELLULAR_LOCALIZATION,0.904535465738758
NIKOLSKY_BREAST_CANCER_17Q11...,SET,119,0.13777,0.01105,0.13066,0.14585,NIKOLSKY_BREAST_CANCER_17Q11_Q21_AMPLICON,0.904535465738758
GOCC_IMMUNOLOGICAL_SYNAPSE,SET,43,0.13642,0.0065909,0.12946,0.14601,GOCC_IMMUNOLOGICAL_SYNAPSE,0.904702989709014
GOBP_COPPER_ION_TRANSPORT,SET,15,0.22242,0.0063515,0.21115,0.14609,GOBP_COPPER_ION_TRANSPORT,0.904702989709014
KOINUMA_COLON_CANCER_MSI_DN,SET,8,0.3336,0.0069584,0.31672,0.14611,KOINUMA_COLON_CANCER_MSI_DN,0.904702989709014
GOMF_SEROTONIN_RECEPTOR_ACTI...,SET,6,0.44794,0.0080922,0.42528,0.14611,GOMF_SEROTONIN_RECEPTOR_ACTIVITY,0.904702989709014
MODULE_438,SET,64,0.11548,0.0068029,0.10965,0.14613,MODULE_438,0.904702989709014
HP_IRIS_TRANSILLUMINATION_DE...,SET,12,0.28335,0.007238,0.26906,0.14615,HP_IRIS_TRANSILLUMINATION_DEFECT,0.904702989709014
HP_HYPOPLASTIC_FIFTH_TOENAIL,SET,16,0.24427,0.0072042,0.23199,0.14619,HP_HYPOPLASTIC_FIFTH_TOENAIL,0.904702989709014
GOBP_PROTEIN_DE_ADP_RIBOSYLA...,SET,4,0.53158,0.0078413,0.50501,0.14627,GOBP_PROTEIN_DE_ADP_RIBOSYLATION,0.904702989709014
HP_ANGULAR_CHEILITIS,SET,11,0.29306,0.0071674,0.27845,0.1463,HP_ANGULAR_CHEILITIS,0.904702989709014
GSE21670_STAT3_KO_VS_WT_CD4_...6,SET,174,0.071389,0.0069132,0.067834,0.14631,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_DN,0.904702989709014
GSE37416_CTRL_VS_6H_F_TULARE...1,SET,169,0.065937,0.0062937,0.062655,0.14632,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.904702989709014
GSE7460_TREG_VS_TCONV_ACT_DN,SET,173,0.069956,0.0067551,0.066484,0.14635,GSE7460_TREG_VS_TCONV_ACT_DN,0.904702989709014
WANG_THOC1_TARGETS_DN,SET,16,0.23928,0.0070569,0.22744,0.14639,WANG_THOC1_TARGETS_DN,0.904702989709014
GSE35543_IN_VITRO_ITREG_VS_C...1,SET,178,0.066061,0.0064697,0.062802,0.14643,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_DN,0.904702989709014
MIR7973,SET,43,0.13363,0.0064562,0.12705,0.14644,MIR7973,0.904702989709014
GOBP_PROTEIN_LOCALIZATION_TO...36,SET,12,0.24056,0.0061449,0.2287,0.14644,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEAR_ENVELOPE,0.904702989709014
GOCC_CAJAL_BODY,SET,56,0.1071,0.0059026,0.10183,0.14647,GOCC_CAJAL_BODY,0.904702989709014
GSE32986_GMCSF_VS_GMCSF_AND_...1,SET,167,0.07045,0.0066849,0.066991,0.14649,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.904702989709014
THAKAR_PBMC_INACTIVATED_INFL...9,SET,15,0.21556,0.0061558,0.20499,0.1465,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP,0.904702989709014
GOBP_NEGATIVE_REGULATION_OF_...142,SET,10,0.26395,0.0061552,0.25101,0.14651,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_STORAGE,0.904702989709014
MIR4715_5P,SET,39,0.14475,0.0066606,0.13766,0.14652,MIR4715_5P,0.904702989709014
GOBP_ACUTE_PHASE_RESPONSE,SET,44,0.15098,0.0073786,0.14359,0.14653,GOBP_ACUTE_PHASE_RESPONSE,0.904702989709014
HANN_RESISTANCE_TO_BCL2_INHI...1,SET,40,0.15592,0.0072662,0.1483,0.14655,HANN_RESISTANCE_TO_BCL2_INHIBITOR_DN,0.904702989709014
HP_ABNORMAL_MITOCHONDRIAL_MO...,SET,23,0.16393,0.0057955,0.15595,0.1466,HP_ABNORMAL_MITOCHONDRIAL_MORPHOLOGY,0.904702989709014
ZWANG_CLASS_2_TRANSIENTLY_IN...,SET,47,0.13145,0.0066386,0.12505,0.14661,ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF,0.904702989709014
GOMF_OXIDOREDUCTASE_ACTIVITY...18,SET,2,0.5757,0.0060052,0.54773,0.14662,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS_CYTOCHROME_AS_ACCEPTOR,0.904702989709014
GOBP_PROTEIN_DESTABILIZATION,SET,45,0.13503,0.0066734,0.12848,0.14664,GOBP_PROTEIN_DESTABILIZATION,0.904702989709014
GOBP_REGULATION_OF_SERINE_TY...,SET,5,0.43962,0.0072501,0.41832,0.14666,GOBP_REGULATION_OF_SERINE_TYPE_PEPTIDASE_ACTIVITY,0.904702989709014
GSE40274_CTRL_VS_FOXP3_AND_P...1,SET,148,0.070883,0.0063352,0.067453,0.14667,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.904702989709014
GOBP_REGULATION_OF_DOUBLE_ST...3,SET,18,0.20733,0.0064853,0.19732,0.14669,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,0.904702989709014
HALLMARK_PROTEIN_SECRETION,SET,85,0.092364,0.0062668,0.087905,0.1467,HALLMARK_PROTEIN_SECRETION,0.904702989709014
GSE33424_CD161_HIGH_VS_INT_C...2,SET,183,0.068619,0.006813,0.065309,0.14671,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_UP,0.904702989709014
GOBP_ORGANELLE_INHERITANCE,SET,15,0.21497,0.0061389,0.2047,0.14682,GOBP_ORGANELLE_INHERITANCE,0.904775363217576
GOBP_REGULATION_OF_SPHINGOLI...,SET,12,0.21339,0.0054508,0.20319,0.14682,GOBP_REGULATION_OF_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.904775363217576
HP_FEVER,SET,372,0.0471,0.0066327,0.044847,0.14682,HP_FEVER,0.904775363217576
CGCTGCT_MIR503,SET,21,0.18013,0.0060855,0.17157,0.14688,CGCTGCT_MIR503,0.904775363217576
GSE2197_IMMUNOSUPPRESSIVE_DN...1,SET,179,0.063518,0.0062379,0.060498,0.14688,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATEDIN_DC_DN,0.904775363217576
WP_SMC1SMC3_ROLE_IN_DNA_DAMA...,SET,9,0.29475,0.006521,0.28076,0.1469,WP_SMC1SMC3_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME,0.904775363217576
HOWARD_B_CELL_INACT_MONOV_IN...,SET,14,0.23397,0.0064549,0.22287,0.14691,HOWARD_B_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.904775363217576
MIR4505,SET,237,0.057304,0.0064651,0.05459,0.14693,MIR4505,0.904775363217576
MIR4699_5P,SET,95,0.090794,0.0065108,0.086519,0.147,MIR4699_5P,0.905046058458813
BHAT_ESR1_TARGETS_NOT_VIA_AK...1,SET,84,0.1038,0.0070012,0.098962,0.14713,BHAT_ESR1_TARGETS_NOT_VIA_AKT1_DN,0.905240792499558
WP_IL1_AND_MEGAKARYOCYTES_IN...,SET,22,0.20321,0.0070265,0.19378,0.14717,WP_IL1_AND_MEGAKARYOCYTES_IN_OBESITY,0.905240792499558
GOBP_GLUCOSAMINE_CONTAINING_...1,SET,9,0.32792,0.0072548,0.31273,0.14719,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.905240792499558
KEGG_MEDICUS_REFERENCE_SIALY...,SET,6,0.38977,0.0070413,0.37172,0.1472,KEGG_MEDICUS_REFERENCE_SIALYL_LEWIS_X_ANTIGEN_BIOSYNTHESIS,0.905240792499558
GOCC_A_BAND,SET,39,0.13415,0.0061733,0.12794,0.1472,GOCC_A_BAND,0.905240792499558
HP_REDUCED_FACTOR_XII_ACTIVI...,SET,6,0.34033,0.0061482,0.32457,0.1472,HP_REDUCED_FACTOR_XII_ACTIVITY,0.905240792499558
REACTOME_SRP_DEPENDENT_COTRA...,SET,102,0.084236,0.0062579,0.080349,0.14724,REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,0.905240792499558
GCM_ACTG1,SET,109,0.080737,0.0061991,0.077012,0.14724,GCM_ACTG1,0.905240792499558
GSE3720_UNSTIM_VS_PMA_STIM_V...1,SET,112,0.085463,0.0066512,0.081541,0.14731,GSE3720_UNSTIM_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_DN,0.905423647932131
HP_DOWN_SLOPING_SHOULDERS,SET,34,0.15953,0.0068552,0.15224,0.14735,HP_DOWN_SLOPING_SHOULDERS,0.905423647932131
TCF4_Q5,SET,219,0.06421,0.0069672,0.06128,0.14737,TCF4_Q5,0.905423647932131
WP_APOE_AND_MIR146_IN_INFLAM...,SET,7,0.33946,0.0066236,0.324,0.14739,WP_APOE_AND_MIR146_IN_INFLAMMATION_AND_ATHEROSCLEROSIS,0.905423647932131
KEGG_MEDICUS_REFERENCE_C9ORF...,SET,8,0.31009,0.0064682,0.29598,0.1474,KEGG_MEDICUS_REFERENCE_C9ORF72_MEDIATED_AUTOPHAGY_INITIATION,0.905423647932131
GOCC_INNER_ACROSOMAL_MEMBRANE,SET,5,0.44883,0.007402,0.4286,0.14751,GOCC_INNER_ACROSOMAL_MEMBRANE,0.905926126126126
KEGG_TERPENOID_BACKBONE_BIOS...,SET,15,0.19954,0.0056981,0.19058,0.14756,KEGG_TERPENOID_BACKBONE_BIOSYNTHESIS,0.905926126126126
LAKE_ADULT_KIDNEY_C30_IMMUNE...,SET,9,0.32101,0.0071019,0.30661,0.14756,LAKE_ADULT_KIDNEY_C30_IMMUNE_CELLS_MACROPHAGES,0.905926126126126
REACTOME_HDL_CLEARANCE,SET,5,0.40319,0.0066493,0.38527,0.14767,REACTOME_HDL_CLEARANCE,0.906156298517996
LU_IL4_SIGNALING,SET,86,0.093018,0.006348,0.088891,0.14769,LU_IL4_SIGNALING,0.906156298517996
GOMF_CALMODULIN_DEPENDENT_PR...2,SET,5,0.31224,0.0051494,0.29839,0.14769,GOMF_CALMODULIN_DEPENDENT_PROTEIN_PHOSPHATASE_ACTIVITY,0.906156298517996
GOBP_TERPENOID_BIOSYNTHETIC_...,SET,16,0.22556,0.0066524,0.21559,0.14773,GOBP_TERPENOID_BIOSYNTHETIC_PROCESS,0.906156298517996
GSE360_T_GONDII_VS_B_MALAYI_...4,SET,179,0.067937,0.0066718,0.064939,0.14775,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.906156298517996
GOCC_AXON_INITIAL_SEGMENT,SET,21,0.20506,0.0069276,0.19602,0.14776,GOCC_AXON_INITIAL_SEGMENT,0.906156298517996
HP_HBS_HEMOGLOBIN,SET,5,0.43181,0.0071212,0.4128,0.14778,HP_HBS_HEMOGLOBIN,0.906156298517996
GOBP_POSITIVE_REGULATION_OF_...366,SET,26,0.18965,0.0071281,0.18133,0.14782,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.90619539543058
TSUNODA_CISPLATIN_RESISTANCE...2,SET,11,0.29189,0.0071388,0.2792,0.14791,TSUNODA_CISPLATIN_RESISTANCE_UP,0.90619539543058
RAMPON_ENRICHED_LEARNING_ENV...3,SET,21,0.17477,0.0059042,0.1672,0.14795,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_LATE_UP,0.90619539543058
SMIRNOV_RESPONSE_TO_IR_2HR_UP,SET,49,0.12819,0.00661,0.12264,0.14797,SMIRNOV_RESPONSE_TO_IR_2HR_UP,0.90619539543058
MIR3683,SET,5,0.39303,0.0064818,0.37604,0.14797,MIR3683,0.90619539543058
GOBP_DEOXYRIBONUCLEOTIDE_CAT...,SET,28,0.16986,0.0066249,0.16254,0.14801,GOBP_DEOXYRIBONUCLEOTIDE_CATABOLIC_PROCESS,0.90619539543058
MIR6810_3P,SET,69,0.10666,0.0065233,0.10208,0.14803,MIR6810_3P,0.90619539543058
GOBP_RESPONSE_TO_INTERLEUKIN...6,SET,12,0.28816,0.0073609,0.27588,0.14813,GOBP_RESPONSE_TO_INTERLEUKIN_18,0.90619539543058
GSE15330_HSC_VS_MEGAKARYOCYT...3,SET,188,0.063554,0.0063948,0.060847,0.14814,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.90619539543058
MIR4800_5P,SET,23,0.17639,0.0062359,0.16888,0.14815,MIR4800_5P,0.90619539543058
REACTOME_CARDIAC_CONDUCTION,SET,125,0.0827,0.006797,0.079184,0.14816,REACTOME_CARDIAC_CONDUCTION,0.90619539543058
HP_ABNORMAL_SPUTUM,SET,119,0.085134,0.0068282,0.081515,0.14816,HP_ABNORMAL_SPUTUM,0.90619539543058
GSE32423_CTRL_VS_IL7_MEMORY_...2,SET,179,0.068439,0.0067211,0.065548,0.14823,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_UP,0.90619539543058
TESAR_JAK_TARGETS_MOUSE_ES_D...,SET,7,0.37793,0.0073743,0.36199,0.14824,TESAR_JAK_TARGETS_MOUSE_ES_D3_DN,0.90619539543058
GOBP_PROTEIN_RNA_COMPLEX_ORG...,SET,182,0.058239,0.0057667,0.055787,0.14826,GOBP_PROTEIN_RNA_COMPLEX_ORGANIZATION,0.90619539543058
HP_ABNORMAL_PIGMENTATION_OF_...,SET,35,0.1522,0.0066356,0.14581,0.14828,HP_ABNORMAL_PIGMENTATION_OF_THE_ORAL_MUCOSA,0.90619539543058
RODRIGUES_DCC_TARGETS_DN,SET,110,0.083059,0.0064064,0.079585,0.14833,RODRIGUES_DCC_TARGETS_DN,0.90619539543058
GOMF_N_ACETYLLACTOSAMINE_SYN...,SET,5,0.42218,0.0069624,0.40452,0.14833,GOMF_N_ACETYLLACTOSAMINE_SYNTHASE_ACTIVITY,0.90619539543058
GSE17974_IL4_AND_ANTI_IL12_V...17,SET,173,0.067943,0.0065607,0.065102,0.14833,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_DN,0.90619539543058
GSE19888_ADENOSINE_A3R_ACT_V...1,SET,183,0.063897,0.0063441,0.061229,0.14835,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN,0.90619539543058
REACTOME_EPH_EPHRIN_SIGNALING,SET,89,0.096054,0.006668,0.092047,0.14836,REACTOME_EPH_EPHRIN_SIGNALING,0.90619539543058
GSE16451_CTRL_VS_WEST_EQUINE...4,SET,181,0.063622,0.0062826,0.060969,0.14836,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_UP,0.90619539543058
MIR1297,SET,579,0.037432,0.0065385,0.035882,0.14843,MIR1297,0.906217099719101
HOWARD_DENDRITIC_CELL_INACT_...2,SET,140,0.079693,0.0069288,0.076408,0.14849,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.906217099719101
GOCC_SNARE_COMPLEX,SET,48,0.12095,0.0061729,0.11598,0.14851,GOCC_SNARE_COMPLEX,0.906217099719101
GSE5679_CTRL_VS_RARA_AGONIST...2,SET,179,0.062525,0.0061404,0.059955,0.14851,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_UP,0.906217099719101
TIEN_INTESTINE_PROBIOTICS_24...1,SET,192,0.064587,0.0065668,0.061934,0.14852,TIEN_INTESTINE_PROBIOTICS_24HR_DN,0.906217099719101
GOBP_REGULATION_OF_LYMPHOCYT...2,SET,56,0.11856,0.0065342,0.11368,0.14852,GOBP_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.906217099719101
HP_DEFICIT_IN_PHONOLOGIC_SHO...,SET,5,0.47373,0.0078126,0.45447,0.14862,HP_DEFICIT_IN_PHONOLOGIC_SHORT_TERM_MEMORY,0.906668088467615
GOBP_GLYCOPHAGY,SET,11,0.28079,0.0068674,0.26943,0.14867,GOBP_GLYCOPHAGY,0.906813943488943
GOBP_REGULATION_OF_ASTROCYTE...1,SET,5,0.43816,0.0072261,0.42048,0.1487,GOBP_REGULATION_OF_ASTROCYTE_ACTIVATION,0.906837778557642
HP_PSYCHOTIC_EPISODES,SET,15,0.20782,0.0059345,0.19954,0.14884,HP_PSYCHOTIC_EPISODES,0.907532315789474
GOCC_KATANIN_COMPLEX,SET,5,0.45283,0.0074679,0.43494,0.14892,GOCC_KATANIN_COMPLEX,0.907860831433082
GSE2405_HEAT_KILLED_VS_LIVE_...1,SET,173,0.064693,0.0062469,0.062176,0.14906,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,0.908554945633111
GOMF_PROTEIN_HOMODIMERIZATIO...,SET,641,0.035281,0.006473,0.033918,0.14913,GOMF_PROTEIN_HOMODIMERIZATION_ACTIVITY,0.908625460122699
GSE30083_SP3_VS_SP4_THYMOCYT...1,SET,181,0.068268,0.0067413,0.06563,0.14913,GSE30083_SP3_VS_SP4_THYMOCYTE_DN,0.908625460122699
KEGG_MEDICUS_REFERENCE_ORGAN...2,SET,16,0.23049,0.0067976,0.2216,0.14915,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_OUTER_KINETOCHORE,0.908625460122699
GOBP_SEBACEOUS_GLAND_DEVELOP...,SET,10,0.29323,0.0068381,0.28197,0.14919,GOBP_SEBACEOUS_GLAND_DEVELOPMENT,0.908672428596461
GOBP_T_CELL_ANTIGEN_PROCESSI...,SET,4,0.48249,0.0071172,0.464,0.14921,GOBP_T_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,0.908672428596461
REACTOME_PROLONGED_ERK_ACTIV...,SET,14,0.24519,0.0067645,0.23585,0.14928,REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS,0.908901996847084
GOBP_GALACTOSE_TRANSMEMBRANE...,SET,4,0.51761,0.0076353,0.49796,0.1493,GOBP_GALACTOSE_TRANSMEMBRANE_TRANSPORT,0.908901996847084
LEE_METASTASIS_AND_ALTERNATI...1,SET,44,0.13258,0.0064792,0.12757,0.14934,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_DN,0.908986287215412
GOBP_INSULIN_RECEPTOR_SIGNAL...,SET,119,0.078162,0.006269,0.075224,0.1494,GOBP_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.909056476457203
HP_SYNOSTOSIS_OF_CARPAL_BONES,SET,23,0.18336,0.0064823,0.17648,0.14942,HP_SYNOSTOSIS_OF_CARPAL_BONES,0.909056476457203
GAVISH_3CA_METAPROGRAM_EPITH...12,SET,46,0.13508,0.0067493,0.13002,0.14943,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_2,0.909056476457203
HP_ANARTHRIA,SET,15,0.21234,0.0060638,0.20443,0.14947,HP_ANARTHRIA,0.909140680784039
REACTOME_BBSOME_MEDIATED_CAR...,SET,23,0.17647,0.0062389,0.16994,0.14955,REACTOME_BBSOME_MEDIATED_CARGO_TARGETING_TO_CILIUM,0.909369804058782
GOBP_LAMELLIPODIUM_ASSEMBLY,SET,61,0.11651,0.0067011,0.11221,0.14956,GOBP_LAMELLIPODIUM_ASSEMBLY,0.909369804058782
WENG_POR_TARGETS_GLOBAL_UP,SET,18,0.19162,0.005994,0.18462,0.14965,WENG_POR_TARGETS_GLOBAL_UP,0.909681202023726
GOMF_DIPEPTIDE_TRANSMEMBRANE...,SET,5,0.41577,0.0068567,0.40074,0.14976,GOMF_DIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.909681202023726
MODULE_470,SET,15,0.25788,0.0073641,0.24857,0.14977,MODULE_470,0.909681202023726
YAMASHITA_LIVER_CANCER_WITH_...1,SET,15,0.21809,0.0062279,0.21023,0.14979,YAMASHITA_LIVER_CANCER_WITH_EPCAM_DN,0.909681202023726
HP_PERIORBITAL_WRINKLES,SET,4,0.47368,0.0069873,0.45673,0.14985,HP_PERIORBITAL_WRINKLES,0.909681202023726
ZBED5_TARGET_GENES,SET,1307,0.025007,0.0064271,0.024114,0.14987,ZBED5_TARGET_GENES,0.909681202023726
MIR5699_5P,SET,98,0.084827,0.0061777,0.081806,0.14989,MIR5699_5P,0.909681202023726
BIOCARTA_EGFR_SMRTE_PATHWAY,SET,11,0.28325,0.0069276,0.27322,0.14994,BIOCARTA_EGFR_SMRTE_PATHWAY,0.909681202023726
KEGG_MEDICUS_VARIANT_FZD7_OV...,SET,36,0.14772,0.0065312,0.14248,0.14994,KEGG_MEDICUS_VARIANT_FZD7_OVEREXPRESSION_TO_WNT_SIGNALING_PATHWAY,0.909681202023726
GSE21927_SPLENIC_VS_TUMOR_MO...1,SET,178,0.062325,0.0061037,0.060122,0.14996,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN,0.909681202023726
BIOCARTA_PTEN_PATHWAY,SET,18,0.21038,0.0065805,0.20295,0.14997,BIOCARTA_PTEN_PATHWAY,0.909681202023726
ZHENG_GLIOBLASTOMA_PLASTICIT...1,SET,57,0.12614,0.0070138,0.1217,0.14999,ZHENG_GLIOBLASTOMA_PLASTICITY_DN,0.909681202023726
JIANG_TIP30_TARGETS_UP,SET,42,0.14432,0.0068912,0.13924,0.15,JIANG_TIP30_TARGETS_UP,0.909681202023726
DESCARTES_MAIN_FETAL_STROMAL...,SET,11,0.30456,0.0074487,0.29386,0.15001,DESCARTES_MAIN_FETAL_STROMAL_CELLS,0.909681202023726
GOMF_APOLIPOPROTEIN_A_I_BIND...,SET,5,0.39911,0.0065819,0.38511,0.15003,GOMF_APOLIPOPROTEIN_A_I_BINDING,0.909681202023726
GSE15659_NAIVE_CD4_TCELL_VS_...3,SET,175,0.066339,0.0064424,0.064013,0.15003,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,0.909681202023726
GOBP_TRANSCRIPTION_BY_RNA_PO...2,SET,56,0.10207,0.0056258,0.098525,0.1501,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.909686938031592
TRAVAGLINI_LUNG_BASOPHIL_MAS...1,SET,248,0.057241,0.0066042,0.055252,0.15011,TRAVAGLINI_LUNG_BASOPHIL_MAST_1_CELL,0.909686938031592
KEGG_COMPLEMENT_AND_COAGULAT...,SET,61,0.12461,0.0071669,0.12032,0.15019,KEGG_COMPLEMENT_AND_COAGULATION_CASCADES,0.909686938031592
GOBP_ANTERIOR_POSTERIOR_PATT...,SET,200,0.068587,0.0071158,0.066247,0.15027,GOBP_ANTERIOR_POSTERIOR_PATTERN_SPECIFICATION,0.909686938031592
XU_AKT1_TARGETS_6HR,SET,25,0.15964,0.0058839,0.15421,0.15028,XU_AKT1_TARGETS_6HR,0.909686938031592
GSE25088_WT_VS_STAT6_KO_MACR...4,SET,168,0.068273,0.0064976,0.065951,0.15029,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_DN,0.909686938031592
GOBP_EYELID_DEVELOPMENT_IN_C...,SET,13,0.27377,0.0072785,0.26448,0.15031,GOBP_EYELID_DEVELOPMENT_IN_CAMERA_TYPE_EYE,0.909686938031592
MULLIGHAN_NPM1_SIGNATURE_3_UP,SET,290,0.050234,0.0062601,0.048543,0.15038,MULLIGHAN_NPM1_SIGNATURE_3_UP,0.909686938031592
REACTOME_SARS_COV_INFECTIONS,SET,379,0.044107,0.0062681,0.042624,0.15039,REACTOME_SARS_COV_INFECTIONS,0.909686938031592
MIR4710,SET,72,0.10478,0.0065451,0.10125,0.15039,MIR4710,0.909686938031592
BIOCARTA_RAB_PATHWAY,SET,12,0.24407,0.0062345,0.23591,0.15044,BIOCARTA_RAB_PATHWAY,0.909686938031592
GSE10239_NAIVE_VS_KLRG1INT_E...1,SET,184,0.061268,0.0060996,0.059224,0.15046,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_DN,0.909686938031592
GOMF_HISTONE_H4K5_ACETYLTRAN...,SET,11,0.25561,0.0062516,0.24712,0.15049,GOMF_HISTONE_H4K5_ACETYLTRANSFERASE_ACTIVITY,0.909686938031592
GOBP_NEGATIVE_REGULATION_OF_...451,SET,26,0.17143,0.0064434,0.16576,0.15052,GOBP_NEGATIVE_REGULATION_OF_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.909686938031592
GOBP_NEURONAL_SIGNAL_TRANSDU...,SET,6,0.41821,0.007555,0.40437,0.15052,GOBP_NEURONAL_SIGNAL_TRANSDUCTION,0.909686938031592
HP_APLASIA_INVOLVING_BONES_O...2,SET,13,0.24512,0.0065168,0.237,0.15052,HP_APLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,0.909686938031592
GOBP_INTEGRIN_ACTIVATION,SET,26,0.17473,0.0065674,0.16896,0.15054,GOBP_INTEGRIN_ACTIVATION,0.909686938031592
REACTOME_APOPTOSIS_INDUCED_D...,SET,7,0.30705,0.0059912,0.29692,0.15055,REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION,0.909686938031592
GSE22611_NOD2_TRANSD_VS_CTRL...1,SET,114,0.08228,0.00646,0.079567,0.15055,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_DN,0.909686938031592
HP_MUSCLE_ABNORMALITY_RELATE...,SET,63,0.098407,0.0057516,0.09517,0.15057,HP_MUSCLE_ABNORMALITY_RELATED_TO_MITOCHONDRIAL_DYSFUNCTION,0.909686938031592
GOBP_SKELETAL_MUSCLE_CONTRAC...,SET,43,0.13292,0.0064216,0.12856,0.1506,GOBP_SKELETAL_MUSCLE_CONTRACTION,0.909686938031592
GOMF_ESTROGEN_RESPONSE_ELEME...,SET,10,0.31241,0.0072852,0.30222,0.15064,GOMF_ESTROGEN_RESPONSE_ELEMENT_BINDING,0.909686938031592
GOMF_GPI_ANCHOR_BINDING,SET,8,0.29201,0.006091,0.28249,0.15064,GOMF_GPI_ANCHOR_BINDING,0.909686938031592
REACTOME_PRE_NOTCH_PROCESSIN...2,SET,6,0.29148,0.0052656,0.28203,0.15069,REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM,0.909686938031592
GOMF_OXIDOREDUCTASE_ACTIVITY...10,SET,15,0.23125,0.0066037,0.22376,0.1507,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS,0.909686938031592
ZID_01,SET,233,0.056644,0.0063373,0.054816,0.15073,ZID_01,0.909686938031592
GOCC_UBIQUITIN_CONJUGATING_E...,SET,7,0.26518,0.0051742,0.25668,0.15078,GOCC_UBIQUITIN_CONJUGATING_ENZYME_COMPLEX,0.909686938031592
GOBP_CELLULAR_RESPONSE_TO_ET...2,SET,6,0.32371,0.0058479,0.31335,0.15079,GOBP_CELLULAR_RESPONSE_TO_ETHER,0.909686938031592
GOBP_MATURE_CONVENTIONAL_DEN...,SET,5,0.44414,0.0073246,0.42992,0.15079,GOBP_MATURE_CONVENTIONAL_DENDRITIC_CELL_DIFFERENTIATION,0.909686938031592
LEIN_ASTROCYTE_MARKERS,SET,41,0.14202,0.0067003,0.1375,0.15084,LEIN_ASTROCYTE_MARKERS,0.909788046116505
MODULE_59,SET,22,0.20583,0.0071171,0.19938,0.15095,MODULE_59,0.909788046116505
GNF2_SELL,SET,44,0.12784,0.0062474,0.12383,0.15096,GNF2_SELL,0.909788046116505
CEBP_Q2,SET,205,0.062596,0.0065739,0.060636,0.15097,CEBP_Q2,0.909788046116505
GOBP_POSITIVE_REGULATION_OF_...386,SET,22,0.16898,0.0058427,0.16369,0.15097,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING,0.909788046116505
GOBP_CALCINEURIN_MEDIATED_SI...,SET,47,0.12343,0.0062339,0.11957,0.15098,GOBP_CALCINEURIN_MEDIATED_SIGNALING,0.909788046116505
chr4q25,SET,28,0.2947,0.011494,0.28551,0.15099,chr4q25,0.909788046116505
MIR5702,SET,68,0.10587,0.006428,0.10261,0.15109,MIR5702,0.909861931034483
SGCGSSAAA_E2F1DP2_01,SET,147,0.071802,0.0063958,0.069604,0.15114,SGCGSSAAA_E2F1DP2_01,0.909861931034483
HP_MYELOFIBROSIS,SET,11,0.23675,0.0057903,0.22953,0.15117,HP_MYELOFIBROSIS,0.909861931034483
ZHONG_PFC_C7_ORG_UNDERGOING_...,SET,61,0.1192,0.0068557,0.11559,0.15122,ZHONG_PFC_C7_ORG_UNDERGOING_NEURONAL_DIFFERENTIATION,0.909861931034483
GOBP_NEUTROPHIL_DEGRANULATION,SET,13,0.23633,0.0062831,0.22921,0.15126,GOBP_NEUTROPHIL_DEGRANULATION,0.909861931034483
MODULE_138,SET,80,0.10009,0.0065891,0.097085,0.15129,MODULE_138,0.909861931034483
GOCC_DENSE_CORE_GRANULE_MEMB...,SET,7,0.34243,0.0066816,0.33217,0.1513,GOCC_DENSE_CORE_GRANULE_MEMBRANE,0.909861931034483
GOBP_RRNA_METABOLIC_PROCESS,SET,228,0.052725,0.0058359,0.051153,0.15134,GOBP_RRNA_METABOLIC_PROCESS,0.909861931034483
HP_MALABSORPTION,SET,212,0.061196,0.0065344,0.059379,0.15137,HP_MALABSORPTION,0.909861931034483
GOMF_ATP_DEPENDENT_PROTEIN_D...,SET,6,0.34741,0.0062761,0.33712,0.15139,GOMF_ATP_DEPENDENT_PROTEIN_DISAGGREGASE_ACTIVITY,0.909861931034483
GOBP_GRANULOCYTE_MACROPHAGE_...,SET,17,0.22311,0.0067823,0.21654,0.15144,GOBP_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,0.909861931034483
GOMF_PHOSPHATIDYLINOSITOL_3_...6,SET,5,0.30374,0.0050091,0.29483,0.15146,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.909861931034483
KEGG_MEDICUS_REFERENCE_II_BL...,SET,7,0.36945,0.0072088,0.35863,0.15147,KEGG_MEDICUS_REFERENCE_II_BLOOD_GROUP_ANTIGEN_BIOSYNTHESIS,0.909861931034483
REACTOME_SYNTHESIS_OF_UDP_N_...,SET,7,0.35084,0.0068456,0.34057,0.15148,REACTOME_SYNTHESIS_OF_UDP_N_ACETYL_GLUCOSAMINE,0.909861931034483
GSE21063_CTRL_VS_ANTI_IGM_ST...12,SET,173,0.066197,0.0063921,0.064261,0.15148,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP,0.909861931034483
BENPORATH_ES_CORE_NINE,SET,8,0.29589,0.0061718,0.28726,0.1515,BENPORATH_ES_CORE_NINE,0.909861931034483
MIR4747_5P,SET,256,0.05386,0.0063121,0.052289,0.1515,MIR4747_5P,0.909861931034483
HP_HYPOPLASTIC_HIPPOCAMPUS,SET,16,0.21787,0.0064254,0.21152,0.15151,HP_HYPOPLASTIC_HIPPOCAMPUS,0.909861931034483
GOBP_ACTIN_NUCLEATION,SET,45,0.12137,0.0059984,0.11787,0.15158,GOBP_ACTIN_NUCLEATION,0.909861931034483
CHARAFE_BREAST_CANCER_BASAL_...1,SET,50,0.13196,0.0068732,0.12815,0.15159,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_DN,0.909861931034483
GOBP_PROTEIN_PROCESSING,SET,217,0.059197,0.0063942,0.057492,0.15159,GOBP_PROTEIN_PROCESSING,0.909861931034483
GOMF_METAL_CATION_MONOATOMIC...,SET,39,0.13985,0.0064353,0.13582,0.15159,GOMF_METAL_CATION_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.909861931034483
GCATTTG_MIR105,SET,153,0.071819,0.0065254,0.069754,0.15161,GCATTTG_MIR105,0.909861931034483
GSE17186_MEMORY_VS_CD21HIGH_...2,SET,182,0.065518,0.0064875,0.063653,0.15167,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.909861931034483
LEI_HOXC8_TARGETS_DN,SET,17,0.20501,0.006232,0.19918,0.15168,LEI_HOXC8_TARGETS_DN,0.909861931034483
HP_PSEUDOHYPOALDOSTERONISM,SET,6,0.37182,0.006717,0.36134,0.15174,HP_PSEUDOHYPOALDOSTERONISM,0.909861931034483
BUSSLINGER_GASTRIC_IMMATURE_...,SET,156,0.073211,0.0067163,0.071151,0.15176,BUSSLINGER_GASTRIC_IMMATURE_PIT_CELLS,0.909861931034483
GAVIN_FOXP3_TARGETS_CLUSTER_...4,SET,84,0.094973,0.006406,0.092317,0.1518,GAVIN_FOXP3_TARGETS_CLUSTER_P6,0.909861931034483
HP_ABNORMAL_PANCREAS_MORPHOL...,SET,99,0.087992,0.0064406,0.085531,0.1518,HP_ABNORMAL_PANCREAS_MORPHOLOGY,0.909861931034483
GSE25123_WT_VS_PPARG_KO_MACR...8,SET,173,0.071248,0.0068799,0.069256,0.1518,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_UP,0.909861931034483
KEGG_MEDICUS_PATHOGEN_ESCHER...3,SET,16,0.23659,0.0069777,0.23,0.15183,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPG_TO_MICROTUBULE_RHOA_SIGNALING_PATHWAY,0.909861931034483
KEGG_MEDICUS_REFERENCE_CRHR_...,SET,27,0.16529,0.0063308,0.1607,0.15184,KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY,0.909861931034483
GOCC_DNA_DEPENDENT_PROTEIN_K...2,SET,6,0.30728,0.005551,0.29877,0.15187,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_DNA_LIGASE_4_COMPLEX,0.909884821582486
GOBP_ADHERENS_JUNCTION_MAINT...,SET,6,0.38732,0.0069969,0.37664,0.1519,GOBP_ADHERENS_JUNCTION_MAINTENANCE,0.909907704239917
MODULE_109,SET,35,0.15817,0.0068959,0.15387,0.15199,MODULE_109,0.910141699672809
REACTOME_AFLATOXIN_ACTIVATIO...,SET,18,0.20485,0.0064075,0.19929,0.15201,REACTOME_AFLATOXIN_ACTIVATION_AND_DETOXIFICATION,0.910141699672809
GOMF_PRENYLTRANSFERASE_ACTIV...,SET,16,0.20694,0.0061032,0.20135,0.15204,GOMF_PRENYLTRANSFERASE_ACTIVITY,0.910141699672809
GOBP_INFLAMMASOME_MEDIATED_S...,SET,39,0.14083,0.0064803,0.13704,0.15207,GOBP_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,0.910141699672809
GSE46606_UNSTIM_VS_CD40L_IL2...13,SET,180,0.061854,0.0060913,0.060192,0.15207,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,0.910141699672809
HP_ABNORMALITY_OF_CIRCULATIN...1,SET,41,0.1465,0.0069116,0.14262,0.15218,HP_ABNORMALITY_OF_CIRCULATING_FIBRINOGEN,0.910230108173077
GSE36888_STAT5_AB_KNOCKIN_VS...4,SET,170,0.068166,0.0065255,0.066375,0.15222,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_UP,0.910230108173077
KRASNOSELSKAYA_ILF3_TARGETS_...2,SET,37,0.1536,0.0068848,0.14958,0.15225,KRASNOSELSKAYA_ILF3_TARGETS_UP,0.910230108173077
REACTOME_TRNA_MODIFICATION_I...2,SET,38,0.12429,0.0056455,0.12104,0.15226,REACTOME_TRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,0.910230108173077
GOBP_GLYCOLIPID_BIOSYNTHETIC...,SET,74,0.0972,0.0061552,0.09467,0.15228,GOBP_GLYCOLIPID_BIOSYNTHETIC_PROCESS,0.910230108173077
HP_ONYCHOMYCOSIS,SET,20,0.21271,0.0070131,0.20719,0.1523,HP_ONYCHOMYCOSIS,0.910230108173077
SPZ1_01,SET,216,0.058781,0.0063349,0.057259,0.15231,SPZ1_01,0.910230108173077
GSE15735_CTRL_VS_HDAC_INHIBI...3,SET,178,0.06531,0.0063961,0.063617,0.15231,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_DN,0.910230108173077
GSE9946_IMMATURE_VS_LISTERIA...1,SET,112,0.082156,0.0063938,0.080032,0.15233,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_DN,0.910230108173077
GOBP_CELL_ADHESION_INVOLVED_...,SET,7,0.3887,0.0075844,0.3787,0.15236,GOBP_CELL_ADHESION_INVOLVED_IN_HEART_MORPHOGENESIS,0.910230108173077
HP_RIEGER_ANOMALY,SET,11,0.29382,0.0071859,0.28629,0.15239,HP_RIEGER_ANOMALY,0.910230108173077
SUNG_METASTASIS_STROMA_DN,SET,51,0.12368,0.0065061,0.12052,0.15241,SUNG_METASTASIS_STROMA_DN,0.910230108173077
GOBP_MITOTIC_CELL_CYCLE,SET,838,0.029777,0.0062116,0.029026,0.15248,GOBP_MITOTIC_CELL_CYCLE,0.910230108173077
GSE2128_C57BL6_VS_NOD_THYMOC...4,SET,179,0.062962,0.0061833,0.061372,0.15248,GSE2128_C57BL6_VS_NOD_THYMOCYTE_UP,0.910230108173077
MIR548AY_3P,SET,54,0.11673,0.0063179,0.1138,0.15252,MIR548AY_3P,0.910230108173077
REACTOME_PECAM1_INTERACTIONS,SET,11,0.24933,0.0060979,0.24309,0.15253,REACTOME_PECAM1_INTERACTIONS,0.910230108173077
WP_AMINO_ACID_METABOLISM_PAT...,SET,6,0.35261,0.0063699,0.34379,0.15253,WP_AMINO_ACID_METABOLISM_PATHWAY_EXCERPT_HISTIDINE_CATABOLISM_EXTENSION,0.910230108173077
DACOSTA_UV_RESPONSE_VIA_ERCC...7,SET,79,0.099034,0.0064789,0.096602,0.15265,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN,0.910366389365352
PID_IL2_STAT5_PATHWAY,SET,28,0.16103,0.0062806,0.15708,0.15265,PID_IL2_STAT5_PATHWAY,0.910366389365352
GRANDVAUX_IFN_RESPONSE_NOT_V...,SET,14,0.21695,0.0059854,0.21163,0.15266,GRANDVAUX_IFN_RESPONSE_NOT_VIA_IRF3,0.910366389365352
GSE1432_CTRL_VS_IFNG_24H_MIC...2,SET,186,0.063999,0.0064056,0.06244,0.15269,GSE1432_CTRL_VS_IFNG_24H_MICROGLIA_UP,0.910366389365352
GOBP_POSITIVE_REGULATION_OF_...725,SET,44,0.13326,0.0065126,0.13002,0.1527,GOBP_POSITIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,0.910366389365352
GOBP_TOLL_LIKE_RECEPTOR_8_SI...,SET,2,0.73692,0.0076869,0.71901,0.15271,GOBP_TOLL_LIKE_RECEPTOR_8_SIGNALING_PATHWAY,0.910366389365352
GOBP_ATF6_MEDIATED_UNFOLDED_...,SET,8,0.27726,0.0057833,0.27058,0.15276,GOBP_ATF6_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,0.910508283313325
HP_ABNORMAL_MORPHOLOGY_OF_TH...7,SET,496,0.037557,0.006086,0.036663,0.15283,HP_ABNORMAL_MORPHOLOGY_OF_THE_NASAL_ALAE,0.910726258992806
HP_DECREASED_CIRCULATING_COM...3,SET,3,0.53293,0.0068082,0.52035,0.15288,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_B_CONCENTRATION,0.910726258992806
GSE14415_INDUCED_VS_NATURAL_...1,SET,162,0.066615,0.0062265,0.065041,0.15288,GSE14415_INDUCED_VS_NATURAL_TREG_DN,0.910726258992806
ABE_INNER_EAR,SET,39,0.14346,0.0066013,0.14008,0.15291,ABE_INNER_EAR,0.910726258992806
GOBP_DRINKING_BEHAVIOR,SET,8,0.3609,0.0075279,0.35245,0.15293,GOBP_DRINKING_BEHAVIOR,0.910726258992806
PLASARI_TGFB1_SIGNALING_VIA_...4,SET,27,0.16836,0.0064482,0.16444,0.15296,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_UP,0.910726258992806
MIR382_3P,SET,91,0.09041,0.006346,0.08831,0.15298,MIR382_3P,0.910726258992806
MIR3145_3P,SET,206,0.060737,0.0063941,0.059375,0.15317,MIR3145_3P,0.911438133445946
GSE13411_IGM_MEMORY_BCELL_VS...2,SET,178,0.065553,0.0064199,0.064096,0.15323,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_UP,0.911438133445946
PID_INTEGRIN3_PATHWAY,SET,39,0.15881,0.0073079,0.1553,0.15325,PID_INTEGRIN3_PATHWAY,0.911438133445946
GAUTAM_EYE_IRIS_CILIARY_BODY...2,SET,93,0.093425,0.0066289,0.091368,0.15328,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_CELLS,0.911438133445946
REACTOME_REGULATION_OF_BACH1...,SET,10,0.27452,0.0064018,0.26849,0.15329,REACTOME_REGULATION_OF_BACH1_ACTIVITY,0.911438133445946
KEGG_MEDICUS_REFERENCE_RAC_C...,SET,9,0.27259,0.0060305,0.26666,0.15335,KEGG_MEDICUS_REFERENCE_RAC_CDC42_PAK_ERK_SIGNALING_PATHWAY,0.911438133445946
MIR30B_3P,SET,154,0.067255,0.0061305,0.065798,0.15337,MIR30B_3P,0.911438133445946
GOMF_RNA_ENDONUCLEASE_ACTIVI...2,SET,5,0.46891,0.0077331,0.45894,0.15346,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.911438133445946
GOBP_NEGATIVE_REGULATION_OF_...298,SET,7,0.34793,0.0067889,0.34054,0.15347,GOBP_NEGATIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.911438133445946
REACTOME_RNA_POLYMERASE_III_...4,SET,26,0.14539,0.0054645,0.14231,0.15348,REACTOME_RNA_POLYMERASE_III_TRANSCRIPTION_INITIATION_FROM_TYPE_3_PROMOTER,0.911438133445946
GOBP_ALDEHYDE_CATABOLIC_PROC...,SET,13,0.23022,0.0061206,0.22541,0.15356,GOBP_ALDEHYDE_CATABOLIC_PROCESS,0.911438133445946
REACTOME_PHASE_0_RAPID_DEPOL...,SET,31,0.17536,0.0071961,0.17171,0.15357,REACTOME_PHASE_0_RAPID_DEPOLARISATION,0.911438133445946
GSE22886_IL2_VS_IL15_STIM_NK...2,SET,177,0.06945,0.0067826,0.068003,0.15357,GSE22886_IL2_VS_IL15_STIM_NKCELL_UP,0.911438133445946
WHITFIELD_CELL_CYCLE_G1_S,SET,117,0.073324,0.0058316,0.0718,0.15358,WHITFIELD_CELL_CYCLE_G1_S,0.911438133445946
MIR6089,SET,16,0.20926,0.0061715,0.20495,0.15363,MIR6089,0.911438133445946
WONG_MITOCHONDRIA_GENE_MODULE,SET,191,0.057577,0.0058389,0.056397,0.15365,WONG_MITOCHONDRIA_GENE_MODULE,0.911438133445946
GOBP_CELL_MIGRATION_INVOLVED...4,SET,5,0.47585,0.0078476,0.46617,0.15369,GOBP_CELL_MIGRATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,0.911438133445946
GOBP_POSITIVE_REGULATION_OF_...573,SET,152,0.071567,0.0064814,0.070116,0.15371,GOBP_POSITIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,0.911438133445946
GOCC_AZUROPHIL_GRANULE_MEMBR...,SET,51,0.11503,0.0060509,0.11273,0.15377,GOCC_AZUROPHIL_GRANULE_MEMBRANE,0.911438133445946
GSE2706_2H_VS_8H_LPS_STIM_DC...2,SET,178,0.0648,0.0063462,0.06351,0.1538,GSE2706_2H_VS_8H_LPS_STIM_DC_UP,0.911438133445946
GOMF_BIOACTIVE_LIPID_RECEPTO...,SET,13,0.25322,0.0067322,0.24827,0.15389,GOMF_BIOACTIVE_LIPID_RECEPTOR_ACTIVITY,0.911438133445946
MORF_AP3D1,SET,119,0.070314,0.0056395,0.068943,0.1539,MORF_AP3D1,0.911438133445946
MIR3689A_3P_MIR3689B_3P_MIR3...,SET,153,0.067227,0.0061082,0.06592,0.15391,MIR3689A_3P_MIR3689B_3P_MIR3689C,0.911438133445946
HP_MINIMAL_SUBCUTANEOUS_FAT,SET,4,0.45753,0.0067491,0.44866,0.15393,HP_MINIMAL_SUBCUTANEOUS_FAT,0.911438133445946
GOBP_MITOCHONDRIAL_ELECTRON_...3,SET,5,0.3011,0.0049656,0.29529,0.15395,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_SUCCINATE_TO_UBIQUINONE,0.911438133445946
CROONQUIST_IL6_DEPRIVATION_UP,SET,17,0.23541,0.0071562,0.2309,0.15398,CROONQUIST_IL6_DEPRIVATION_UP,0.911438133445946
MIKKELSEN_ES_LCP_WITH_H3K4ME...,SET,7,0.32682,0.0063769,0.32061,0.15402,MIKKELSEN_ES_LCP_WITH_H3K4ME3_AND_H3K27ME3,0.911438133445946
HP_VERTEBRAL_COMPRESSION_FRA...,SET,32,0.14727,0.0061396,0.14447,0.15402,HP_VERTEBRAL_COMPRESSION_FRACTURE,0.911438133445946
HP_DELAYED_FINE_MOTOR_DEVELO...,SET,45,0.12804,0.0063281,0.12562,0.15403,HP_DELAYED_FINE_MOTOR_DEVELOPMENT,0.911438133445946
NAKAYA_PBMC_FLUARIX_FLUVIRIN...4,SET,490,0.037014,0.0059626,0.036318,0.15407,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.911438133445946
GOBP_MUSCULAR_SEPTUM_MORPHOG...,SET,5,0.47414,0.0078193,0.46526,0.15409,GOBP_MUSCULAR_SEPTUM_MORPHOGENESIS,0.911438133445946
HP_CYSTIC_LIVER_DISEASE,SET,40,0.12423,0.0057891,0.12191,0.1541,HP_CYSTIC_LIVER_DISEASE,0.911438133445946
HP_ERUPTION_FAILURE,SET,16,0.21493,0.0063387,0.21092,0.15411,HP_ERUPTION_FAILURE,0.911438133445946
E2F_01,SET,59,0.1078,0.0060978,0.10579,0.15412,E2F_01,0.911438133445946
WP_EICOSANOID_METABOLISM_VIA...1,SET,30,0.16189,0.0065353,0.15891,0.15416,WP_EICOSANOID_METABOLISM_VIA_CYCLOOXYGENASES_COX,0.911438133445946
GOCC_TIM22_MITOCHONDRIAL_IMP...,SET,6,0.34107,0.0061616,0.33482,0.15419,GOCC_TIM22_MITOCHONDRIAL_IMPORT_INNER_MEMBRANE_INSERTION_COMPLEX,0.911438133445946
MIR512_5P,SET,49,0.12001,0.0061882,0.11785,0.15428,MIR512_5P,0.911438133445946
HP_NON_MENDELIAN_INHERITANCE,SET,86,0.09998,0.0068231,0.098194,0.1543,HP_NON_MENDELIAN_INHERITANCE,0.911438133445946
REACTOME_HUR_ELAVL1_BINDS_AN...,SET,8,0.34413,0.0071781,0.33813,0.15441,REACTOME_HUR_ELAVL1_BINDS_AND_STABILIZES_MRNA,0.911438133445946
KYNG_NORMAL_AGING_UP,SET,13,0.23212,0.0061713,0.22809,0.15442,KYNG_NORMAL_AGING_UP,0.911438133445946
GOBP_BRANCHING_INVOLVED_IN_B...,SET,31,0.16825,0.006904,0.16532,0.15442,GOBP_BRANCHING_INVOLVED_IN_BLOOD_VESSEL_MORPHOGENESIS,0.911438133445946
GOBP_PROTEIN_INSERTION_INTO_...6,SET,6,0.28505,0.0051494,0.28012,0.15444,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_MEMBRANE,0.911438133445946
REACTOME_INTERLEUKIN_2_FAMIL...,SET,39,0.15084,0.0069413,0.14828,0.15451,REACTOME_INTERLEUKIN_2_FAMILY_SIGNALING,0.911438133445946
MIR4313,SET,26,0.16498,0.006201,0.16217,0.15451,MIR4313,0.911438133445946
MIR4689,SET,78,0.097012,0.0063065,0.095368,0.15452,MIR4689,0.911438133445946
HP_BCGOSIS,SET,7,0.38377,0.0074881,0.37728,0.15453,HP_BCGOSIS,0.911438133445946
HP_ABNORMAL_FACIAL_EXPRESSION,SET,165,0.066405,0.0062636,0.065288,0.15456,HP_ABNORMAL_FACIAL_EXPRESSION,0.911438133445946
WP_KCNQ2RELATED_EPILEPSIES,SET,19,0.20092,0.0064568,0.1976,0.15463,WP_KCNQ2RELATED_EPILEPSIES,0.911438133445946
MIR6879_5P,SET,99,0.087772,0.0064245,0.086327,0.15465,MIR6879_5P,0.911438133445946
GSE20366_TREG_VS_TCONV_DN,SET,179,0.065674,0.0064497,0.064601,0.15467,GSE20366_TREG_VS_TCONV_DN,0.911438133445946
ZHONG_PFC_MAJOR_TYPES_MICROG...,SET,391,0.045921,0.0066263,0.045172,0.15468,ZHONG_PFC_MAJOR_TYPES_MICROGLIA,0.911438133445946
GOBP_RESPONSE_TO_SODIUM_ARSE...,SET,6,0.34902,0.0063052,0.34335,0.15469,GOBP_RESPONSE_TO_SODIUM_ARSENITE,0.911438133445946
GSE2706_R848_VS_LPS_8H_STIM_...2,SET,141,0.073372,0.0064019,0.07218,0.1547,GSE2706_R848_VS_LPS_8H_STIM_DC_UP,0.911438133445946
GOCC_PLASMA_MEMBRANE_REGION,SET,1187,0.026466,0.006505,0.026038,0.15472,GOCC_PLASMA_MEMBRANE_REGION,0.911438133445946
HP_SCLEROSIS_OF_FINGER_PHALA...,SET,8,0.32656,0.0068116,0.32128,0.15472,HP_SCLEROSIS_OF_FINGER_PHALANX,0.911438133445946
MIR7111_3P,SET,112,0.080865,0.0062933,0.079562,0.15473,MIR7111_3P,0.911438133445946
REACTOME_RESPIRATORY_SYNCYTI...1,SET,106,0.081836,0.006197,0.08052,0.15474,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_PATHWAY,0.911438133445946
HP_GENITAL_NEOPLASM,SET,146,0.070388,0.0062486,0.069259,0.15475,HP_GENITAL_NEOPLASM,0.911438133445946
HP_LIP_PIT,SET,9,0.2955,0.0065374,0.29077,0.15476,HP_LIP_PIT,0.911438133445946
HP_PROGRESSIVE_SPASTIC_PARAP...1,SET,5,0.35784,0.0059014,0.35214,0.15478,HP_PROGRESSIVE_SPASTIC_PARAPARESIS,0.911438133445946
APPIERTO_RESPONSE_TO_FENRETI...1,SET,43,0.12254,0.0059202,0.12061,0.15482,APPIERTO_RESPONSE_TO_FENRETINIDE_DN,0.911438133445946
BIOCARTA_PELP1_PATHWAY,SET,6,0.34228,0.0061833,0.33688,0.15482,BIOCARTA_PELP1_PATHWAY,0.911438133445946
GOBP_CYTOKINE_PRODUCTION_INV...2,SET,57,0.1124,0.0062499,0.11065,0.15485,GOBP_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.911438133445946
HP_ABNORMAL_AUTONOMIC_NERVOU...,SET,121,0.0801,0.0064779,0.078852,0.15486,HP_ABNORMAL_AUTONOMIC_NERVOUS_SYSTEM_PHYSIOLOGY,0.911438133445946
HP_BIFID_SCROTUM,SET,30,0.17201,0.0069437,0.16939,0.15495,HP_BIFID_SCROTUM,0.911438133445946
MIZUKAMI_HYPOXIA_UP,SET,11,0.2881,0.0070462,0.28378,0.155,MIZUKAMI_HYPOXIA_UP,0.911438133445946
REACTOME_2_LTR_CIRCLE_FORMAT...,SET,7,0.31837,0.0062122,0.31366,0.15505,REACTOME_2_LTR_CIRCLE_FORMATION,0.911438133445946
GSE6269_E_COLI_VS_STREP_PNEU...2,SET,145,0.073265,0.0064818,0.072183,0.15506,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_UP,0.911438133445946
GOBP_NON_PROTEINOGENIC_AMINO...1,SET,16,0.22639,0.0066769,0.22305,0.15507,GOBP_NON_PROTEINOGENIC_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.911438133445946
GOMF_METALLOENDOPEPTIDASE_AC...,SET,102,0.089717,0.0066651,0.088407,0.1551,GOMF_METALLOENDOPEPTIDASE_ACTIVITY,0.911438133445946
OCONNOR_PBMC_MENVEO_ACWYVAX_...2,SET,125,0.072228,0.0059363,0.071176,0.15511,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_UP,0.911438133445946
DESCARTES_MAIN_FETAL_LYMPHAT...,SET,64,0.11069,0.0065206,0.10908,0.15511,DESCARTES_MAIN_FETAL_LYMPHATIC_ENDOTHELIAL_CELLS,0.911438133445946
GOBP_DOUBLE_STRAND_BREAK_REP...5,SET,9,0.27578,0.0061012,0.27178,0.15513,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_CLASSICAL_NONHOMOLOGOUS_END_JOINING,0.911438133445946
HP_RENAL_CORTICAL_MICROCYSTS,SET,4,0.40966,0.0060429,0.40376,0.15515,HP_RENAL_CORTICAL_MICROCYSTS,0.911438133445946
MODULE_46,SET,368,0.049864,0.0069849,0.049153,0.15519,MODULE_46,0.911438133445946
GOCC_CENTRIOLAR_SATELLITE,SET,112,0.078373,0.0060994,0.077263,0.15521,GOCC_CENTRIOLAR_SATELLITE,0.911438133445946
LASTOWSKA_NEUROBLASTOMA_COPY...2,SET,169,0.068732,0.0065604,0.067764,0.15523,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_UP,0.911438133445946
GOCC_GROWTH_CONE_MEMBRANE,SET,7,0.34077,0.0066492,0.33597,0.15523,GOCC_GROWTH_CONE_MEMBRANE,0.911438133445946
GUO_HEX_TARGETS_UP,SET,72,0.10306,0.0064377,0.10161,0.15524,GUO_HEX_TARGETS_UP,0.911438133445946
VANLOO_SP3_TARGETS_DN,SET,83,0.087442,0.005863,0.086213,0.15524,VANLOO_SP3_TARGETS_DN,0.911438133445946
MODULE_89,SET,2,0.69648,0.007265,0.68669,0.15524,MODULE_89,0.911438133445946
OCONNOR_PBMC_MENVEO_ACWYVAX_...1,SET,221,0.05725,0.0062399,0.056448,0.15525,OCONNOR_PBMC_MENVEO_ACWYVAX_AGE_30_70YO_7DY_AFTER_SECOND_DOSE_VS_7DY_AFTER_FIRST_DOSE_DN,0.911438133445946
KIM_PTEN_TARGETS_DN,SET,4,0.3944,0.0058178,0.38903,0.15534,KIM_PTEN_TARGETS_DN,0.911453687141411
GOCC_FILOPODIUM_TIP,SET,16,0.22281,0.0065712,0.2198,0.15537,GOCC_FILOPODIUM_TIP,0.911453687141411
MORI_PLASMA_CELL_DN,SET,34,0.15127,0.0065002,0.14923,0.15538,MORI_PLASMA_CELL_DN,0.911453687141411
GOBP_PHOSPHOLIPID_DEPHOSPHOR...,SET,27,0.14412,0.0055198,0.14218,0.15538,GOBP_PHOSPHOLIPID_DEPHOSPHORYLATION,0.911453687141411
RIZ_ERYTHROID_DIFFERENTIATIO...5,SET,36,0.15839,0.0070033,0.15628,0.15541,RIZ_ERYTHROID_DIFFERENTIATION_HBZ,0.911453687141411
GOBP_GUANINE_NUCLEOTIDE_TRAN...,SET,11,0.29042,0.0071029,0.28655,0.15541,GOBP_GUANINE_NUCLEOTIDE_TRANSPORT,0.911453687141411
GSE29618_MONOCYTE_VS_MDC_DAY...1,SET,171,0.068075,0.0065358,0.067207,0.15556,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_DN,0.912179483718576
GOBP_OSTEOCLAST_FUSION,SET,6,0.37663,0.0068038,0.37197,0.15566,GOBP_OSTEOCLAST_FUSION,0.912516587957497
chr18p11,SET,63,0.21315,0.012458,0.21053,0.15567,chr18p11,0.912516587957497
GSE6259_BCELL_VS_CD8_TCELL_UP,SET,174,0.069781,0.0067575,0.068937,0.15572,GSE6259_BCELL_VS_CD8_TCELL_UP,0.912523811530681
REACTOME_DISINHIBITION_OF_SN...,SET,5,0.35471,0.0058498,0.35045,0.15574,REACTOME_DISINHIBITION_OF_SNARE_FORMATION,0.912523811530681
GOBP_LEUKOTRIENE_SIGNALING_P...,SET,4,0.38542,0.0056853,0.3808,0.15575,GOBP_LEUKOTRIENE_SIGNALING_PATHWAY,0.912523811530681
GOBP_SENSORY_PERCEPTION_OF_S...2,SET,9,0.29011,0.0064182,0.28674,0.15583,GOBP_SENSORY_PERCEPTION_OF_SOUR_TASTE,0.912681385642738
GOBP_NEGATIVE_REGULATION_OF_...617,SET,7,0.34121,0.0066577,0.3373,0.15588,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.912681385642738
REACTOME_TRANSPORT_OF_SMALL_...,SET,688,0.033689,0.0063949,0.033305,0.15589,REACTOME_TRANSPORT_OF_SMALL_MOLECULES,0.912681385642738
GOBP_FC_RECEPTOR_MEDIATED_IN...,SET,5,0.44328,0.0073104,0.43824,0.1559,GOBP_FC_RECEPTOR_MEDIATED_INHIBITORY_SIGNALING_PATHWAY,0.912681385642738
GOBP_NEGATIVE_REGULATION_OF_...642,SET,7,0.24054,0.0046935,0.23783,0.15592,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.912681385642738
HP_CYANOTIC_EPISODE,SET,7,0.3709,0.0072371,0.36675,0.15594,HP_CYANOTIC_EPISODE,0.912681385642738
REACTOME_CYCLIN_A_CDK2_ASSOC...,SET,82,0.085739,0.0057141,0.08479,0.15597,REACTOME_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY,0.912681385642738
ZNF486_TARGET_GENES,SET,160,0.068201,0.0063356,0.067453,0.15599,ZNF486_TARGET_GENES,0.912681385642738
HP_PANCREATIC_PSEUDOCYST,SET,4,0.47059,0.0069417,0.46557,0.15606,HP_PANCREATIC_PSEUDOCYST,0.912681385642738
MIR615_5P,SET,37,0.15041,0.0067419,0.14885,0.15613,MIR615_5P,0.912681385642738
GOBP_NEUROTRANSMITTER_RECEPT...2,SET,22,0.18862,0.0065221,0.18667,0.15614,GOBP_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,0.912681385642738
HP_UNUSUAL_INFECTION,SET,918,0.029133,0.0063462,0.028831,0.15614,HP_UNUSUAL_INFECTION,0.912681385642738
GOBP_IMMUNE_RESPONSE_TO_TUMO...,SET,24,0.19761,0.0071361,0.19558,0.15616,GOBP_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.912681385642738
REACTOME_BIOSYNTHESIS_OF_MAR...1,SET,8,0.29946,0.0062464,0.29646,0.15622,REACTOME_BIOSYNTHESIS_OF_MARESINS,0.912681385642738
GOBP_POSITIVE_REGULATION_OF_...461,SET,6,0.27798,0.0050219,0.27521,0.15624,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_NUCLEATION,0.912681385642738
GOMF_HISTONE_DEUBIQUITINASE_...,SET,7,0.24007,0.0046843,0.2377,0.15626,GOMF_HISTONE_DEUBIQUITINASE_ACTIVITY,0.912681385642738
MIKKELSEN_ES_LCP_WITH_H3K27M...,SET,12,0.25556,0.006528,0.25307,0.15629,MIKKELSEN_ES_LCP_WITH_H3K27ME3,0.912681385642738
GOBP_REGULATION_OF_PROTEIN_N...,SET,18,0.19128,0.0059832,0.18943,0.1563,GOBP_REGULATION_OF_PROTEIN_NEDDYLATION,0.912681385642738
GOBP_ACTIN_FILAMENT_SEVERING,SET,16,0.21883,0.0064537,0.21671,0.15631,GOBP_ACTIN_FILAMENT_SEVERING,0.912681385642738
GSE22229_RENAL_TRANSPLANT_IM...1,SET,183,0.063943,0.0063487,0.063326,0.15632,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_DN,0.912681385642738
GOBP_URINARY_BLADDER_SMOOTH_...,SET,7,0.34128,0.0066591,0.338,0.15633,GOBP_URINARY_BLADDER_SMOOTH_MUSCLE_CONTRACTION,0.912681385642738
HP_AORTIC_ARCH_ANEURYSM,SET,37,0.15265,0.0068424,0.15124,0.15641,HP_AORTIC_ARCH_ANEURYSM,0.912681385642738
MCBRYAN_PUBERTAL_BREAST_5_6W...2,SET,115,0.082676,0.0065193,0.081923,0.15645,MCBRYAN_PUBERTAL_BREAST_5_6WK_UP,0.912681385642738
HP_ANURIA,SET,11,0.28519,0.006975,0.2826,0.15645,HP_ANURIA,0.912681385642738
GOBP_ANTIGEN_PROCESSING_AND_...11,SET,36,0.15213,0.0067266,0.15076,0.15646,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,0.912681385642738
GSE25088_CTRL_VS_IL4_AND_ROS...4,SET,172,0.060199,0.0057963,0.059679,0.15656,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,0.912681385642738
GOBP_RIBOSOMAL_SMALL_SUBUNIT...2,SET,93,0.084694,0.0060094,0.083969,0.15658,GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS,0.912681385642738
REACTOME_VLDLR_INTERNALISATI...,SET,15,0.21094,0.0060236,0.20914,0.15659,REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION,0.912681385642738
WP_SMALL_LIGAND_GPCRS,SET,18,0.22364,0.0069953,0.22173,0.15659,WP_SMALL_LIGAND_GPCRS,0.912681385642738
GSE22103_UNSTIM_VS_LPS_STIM_...2,SET,189,0.060603,0.0061139,0.060116,0.15671,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP,0.912681385642738
CETS1P54_01,SET,250,0.050947,0.0059014,0.05054,0.15672,CETS1P54_01,0.912681385642738
GSE29618_MONOCYTE_VS_MDC_DN,SET,170,0.067836,0.0064939,0.067294,0.15672,GSE29618_MONOCYTE_VS_MDC_DN,0.912681385642738
WP_GANGLIO_SERIES_SPHINGOLIP...,SET,13,0.25364,0.0067434,0.25162,0.15673,WP_GANGLIO_SERIES_SPHINGOLIPID_METABOLISM,0.912681385642738
GOBP_FEVER_GENERATION,SET,11,0.29431,0.0071979,0.292,0.15676,GOBP_FEVER_GENERATION,0.912681385642738
HE_LIM_SUN_FETAL_LUNG_C4_ILC...2,SET,68,0.11043,0.0067048,0.10958,0.15679,HE_LIM_SUN_FETAL_LUNG_C4_ILC3_CELL,0.912681385642738
LIU_VAV3_PROSTATE_CARCINOGEN...1,SET,14,0.24442,0.0067432,0.24255,0.15681,LIU_VAV3_PROSTATE_CARCINOGENESIS_DN,0.912681385642738
DESCARTES_FETAL_STOMACH_SQUA...,SET,60,0.11791,0.0067261,0.11703,0.15685,DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS,0.912681385642738
GOBP_POSITIVE_REGULATION_OF_...285,SET,14,0.2278,0.0062848,0.22614,0.15689,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_MIGRATION,0.912681385642738
PID_HIF1A_PATHWAY,SET,15,0.19695,0.0056242,0.19553,0.15691,PID_HIF1A_PATHWAY,0.912681385642738
GOBP_NEGATIVE_REGULATION_OF_...323,SET,19,0.2008,0.006453,0.19942,0.15699,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_BY_P53_CLASS_MEDIATOR,0.912681385642738
BIOCARTA_FCER1_PATHWAY,SET,37,0.14004,0.006277,0.13909,0.15701,BIOCARTA_FCER1_PATHWAY,0.912681385642738
REACTOME_TICAM1_DEPENDENT_AC...,SET,12,0.244,0.0062327,0.24234,0.15701,REACTOME_TICAM1_DEPENDENT_ACTIVATION_OF_IRF3_IRF7,0.912681385642738
GOBP_NEGATIVE_REGULATION_OF_...670,SET,23,0.17968,0.0063524,0.17851,0.15708,GOBP_NEGATIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.912681385642738
BIOCARTA_NO1_PATHWAY,SET,28,0.17453,0.0068071,0.17341,0.1571,BIOCARTA_NO1_PATHWAY,0.912681385642738
HP_SPINAL_DYSRAPHISM,SET,129,0.074494,0.0062191,0.074018,0.15711,HP_SPINAL_DYSRAPHISM,0.912681385642738
BAE_BRCA1_TARGETS_DN,SET,29,0.16163,0.0064154,0.1606,0.15712,BAE_BRCA1_TARGETS_DN,0.912681385642738
HP_NON_SMALL_CELL_LUNG_CARCI...,SET,22,0.17046,0.0058941,0.16938,0.15712,HP_NON_SMALL_CELL_LUNG_CARCINOMA,0.912681385642738
GSE15324_NAIVE_VS_ACTIVATED_...3,SET,185,0.060093,0.0059986,0.059714,0.15713,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_DN,0.912681385642738
GOBP_REGULATION_OF_MACROPHAG...2,SET,9,0.25438,0.0056277,0.25281,0.15716,GOBP_REGULATION_OF_MACROPHAGE_APOPTOTIC_PROCESS,0.912681385642738
GOCC_NUCLEOLUS,SET,908,0.027526,0.0059651,0.027356,0.15716,GOCC_NUCLEOLUS,0.912681385642738
GOMF_UBIQUITIN_BINDING,SET,94,0.086993,0.0062054,0.086479,0.15723,GOMF_UBIQUITIN_BINDING,0.912681385642738
GSE37416_0H_VS_48H_F_TULAREN...1,SET,168,0.062806,0.0059773,0.062438,0.15724,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.912681385642738
WAKABAYASHI_ADIPOGENESIS_PPA...1,SET,28,0.16105,0.0062812,0.16011,0.15725,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_36HR,0.912681385642738
GSE12001_MIR223_KO_VS_WT_NEU...2,SET,150,0.069426,0.0062463,0.069021,0.15725,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_UP,0.912681385642738
MIR6836_5P,SET,115,0.079432,0.0062635,0.078974,0.15726,MIR6836_5P,0.912681385642738
HP_ABNORMALITY_OF_MUSCLE_SIZE,SET,635,0.03391,0.0061932,0.033718,0.15729,HP_ABNORMALITY_OF_MUSCLE_SIZE,0.912681385642738
BIOCARTA_LAIR_PATHWAY,SET,17,0.21614,0.0065704,0.21492,0.1573,BIOCARTA_LAIR_PATHWAY,0.912681385642738
WP_CELLS_AND_MOLECULES_INVOL...,SET,17,0.21614,0.0065704,0.21492,0.1573,WP_CELLS_AND_MOLECULES_INVOLVED_IN_LOCAL_ACUTE_INFLAMMATORY_RESPONSE,0.912681385642738
GOBP_AMP_CATABOLIC_PROCESS,SET,5,0.40626,0.0066999,0.4041,0.15737,GOBP_AMP_CATABOLIC_PROCESS,0.912731809841535
GSE17186_CD21LOW_VS_CD21HIGH...3,SET,185,0.063659,0.0063546,0.063323,0.15738,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,0.912731809841535
PODAR_RESPONSE_TO_ADAPHOSTIN...2,SET,127,0.079671,0.0065999,0.079266,0.15743,PODAR_RESPONSE_TO_ADAPHOSTIN_UP,0.912731809841535
GSE7460_FOXP3_MUT_VS_WT_ACT_...2,SET,182,0.064521,0.0063887,0.064193,0.15743,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP,0.912731809841535
HP_ABNORMAL_SPINAL_CORD_MORP...,SET,274,0.051346,0.0062224,0.051087,0.15744,HP_ABNORMAL_SPINAL_CORD_MORPHOLOGY,0.912731809841535
GOBP_PROTEIN_NEDDYLATION,SET,27,0.15143,0.0057998,0.15069,0.15748,GOBP_PROTEIN_NEDDYLATION,0.91281144096064
GSE45365_CD8A_DC_VS_CD11B_DC...3,SET,142,0.073673,0.0064507,0.073323,0.15751,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_DN,0.912833091545773
NERF_Q2,SET,228,0.056328,0.0062348,0.056077,0.15758,NERF_Q2,0.913086512170724
GOMF_LIGAND_GATED_CALCIUM_CH...,SET,30,0.15813,0.0063834,0.15744,0.15761,GOMF_LIGAND_GATED_CALCIUM_CHANNEL_ACTIVITY,0.913108109684947
GSE1740_UNSTIM_VS_IFNA_STIMU...4,SET,165,0.06908,0.0065159,0.068803,0.15769,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_UP,0.913419325
REACTOME_EGFR_TRANSACTIVATIO...,SET,9,0.27456,0.0060742,0.2736,0.15781,REACTOME_EGFR_TRANSACTIVATION_BY_GASTRIN,0.913962097983669
REACTOME_PKR_MEDIATED_SIGNAL...,SET,65,0.10445,0.0062008,0.1041,0.15784,REACTOME_PKR_MEDIATED_SIGNALING,0.913983538820393
WP_BLOOD_CLOTTING_CASCADE,SET,20,0.2163,0.0071314,0.21561,0.15789,WP_BLOOD_CLOTTING_CASCADE,0.914032778425171
GOMF_HISTONE_H3K36_DEMETHYLA...,SET,7,0.28767,0.0056132,0.28679,0.15791,GOMF_HISTONE_H3K36_DEMETHYLASE_ACTIVITY,0.914032778425171
GOBP_LACTATE_TRANSMEMBRANE_T...,SET,8,0.33001,0.0068836,0.32905,0.15796,GOBP_LACTATE_TRANSMEMBRANE_TRANSPORT,0.914032778425171
DER_IFN_ALPHA_RESPONSE_UP,SET,72,0.10023,0.0062611,0.099943,0.15797,DER_IFN_ALPHA_RESPONSE_UP,0.914032778425171
GOBP_NADH_OXIDATION,SET,6,0.31827,0.0057495,0.31737,0.15798,GOBP_NADH_OXIDATION,0.914032778425171
GSE22196_HEALTHY_VS_OBESE_MO...2,SET,180,0.064413,0.0063432,0.064246,0.15804,GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_UP,0.914057649685743
REACTOME_MAPK1_ERK2_ACTIVATI...,SET,9,0.30323,0.0067084,0.30252,0.1581,REACTOME_MAPK1_ERK2_ACTIVATION,0.914057649685743
GSE17721_POLYIC_VS_PAM3CSK4_...8,SET,184,0.058774,0.0058513,0.058662,0.1582,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_UP,0.914057649685743
GSE45739_UNSTIM_VS_ACD3_ACD2...2,SET,171,0.062395,0.0059904,0.062285,0.15823,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_UP,0.914057649685743
GSE3982_MAST_CELL_VS_TH2_UP,SET,181,0.063422,0.0062628,0.063322,0.15828,GSE3982_MAST_CELL_VS_TH2_UP,0.914057649685743
BIOCARTA_AKT_PATHWAY,SET,20,0.1878,0.0061919,0.18753,0.15831,BIOCARTA_AKT_PATHWAY,0.914057649685743
KEGG_MEDICUS_REFERENCE_PDL_P...,SET,8,0.31841,0.0066416,0.31798,0.15834,KEGG_MEDICUS_REFERENCE_PDL_PD1_SHP_PI3K_SIGNALING_PATHWAY,0.914057649685743
HP_PROMINENT_OCCIPUT,SET,50,0.1115,0.005808,0.11137,0.15836,HP_PROMINENT_OCCIPUT,0.914057649685743
KYNG_WERNER_SYNDROM_DN,SET,18,0.20455,0.0063984,0.20433,0.15839,KYNG_WERNER_SYNDROM_DN,0.914057649685743
GOBP_REGULATION_OF_NK_T_CELL...3,SET,7,0.35611,0.0069485,0.35571,0.15839,GOBP_REGULATION_OF_NK_T_CELL_PROLIFERATION,0.914057649685743
HP_AXONAL_DEGENERATION_REGEN...,SET,9,0.27076,0.0059901,0.2705,0.15843,HP_AXONAL_DEGENERATION_REGENERATION,0.914057649685743
GOBP_REGULATION_OF_AMYLOID_P...,SET,42,0.12952,0.0061843,0.12941,0.15846,GOBP_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.914057649685743
GOMF_PIRNA_BINDING,SET,5,0.41241,0.0068014,0.4121,0.15848,GOMF_PIRNA_BINDING,0.914057649685743
KEGG_CARDIAC_MUSCLE_CONTRACT...,SET,68,0.10281,0.0062418,0.10274,0.15851,KEGG_CARDIAC_MUSCLE_CONTRACTION,0.914057649685743
GOMF_INORGANIC_MOLECULAR_ENT...,SET,659,0.034346,0.006386,0.034325,0.15852,GOMF_INORGANIC_MOLECULAR_ENTITY_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.914057649685743
MIR5087,SET,85,0.093962,0.0063752,0.093932,0.15858,MIR5087,0.914057649685743
HP_PREAXIAL_FOOT_POLYDACTYLY,SET,16,0.20732,0.0061143,0.20725,0.15858,HP_PREAXIAL_FOOT_POLYDACTYLY,0.914057649685743
KEGG_MEDICUS_REFERENCE_P4_PR...2,SET,15,0.21698,0.0061962,0.21699,0.15867,KEGG_MEDICUS_REFERENCE_P4_PR_RAS_ERK_SIGNALING_PATHWAY,0.914057649685743
GSE36527_CD62L_HIGH_CD69_NEG...1,SET,180,0.064664,0.0063679,0.06467,0.15869,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_DN,0.914057649685743
GOBP_REGULATION_OF_TRANSLATI...4,SET,76,0.08882,0.0056998,0.088839,0.15871,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION,0.914057649685743
E2F1DP1_01,SET,209,0.059149,0.0062716,0.059168,0.15874,E2F1DP1_01,0.914057649685743
E2F1DP2_01,SET,209,0.059149,0.0062716,0.059168,0.15874,E2F1DP2_01,0.914057649685743
E2F4DP2_01,SET,209,0.059149,0.0062716,0.059168,0.15874,E2F4DP2_01,0.914057649685743
E2F_02,SET,209,0.059149,0.0062716,0.059168,0.15874,E2F_02,0.914057649685743
REACTOME_SELECTIVE_AUTOPHAGY,SET,81,0.094883,0.0062851,0.094918,0.15875,REACTOME_SELECTIVE_AUTOPHAGY,0.914057649685743
HESS_TARGETS_OF_HOXA9_AND_ME...1,SET,79,0.10054,0.0065772,0.10059,0.15878,HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN,0.914057649685743
WP_7Q1123_DISTAL_COPY_NUMBER...,SET,21,0.20223,0.0068318,0.20236,0.15882,WP_7Q1123_DISTAL_COPY_NUMBER_VARIATION,0.914057649685743
HP_CHOLESTASIS,SET,257,0.052451,0.0061589,0.052486,0.15883,HP_CHOLESTASIS,0.914057649685743
GOBP_NUCLEOBASE_CONTAINING_C...,SET,207,0.055565,0.0058636,0.055608,0.15885,GOBP_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,0.914057649685743
HP_ABNORMAL_VASCULAR_PHYSIOL...,SET,285,0.050889,0.0062878,0.050932,0.15886,HP_ABNORMAL_VASCULAR_PHYSIOLOGY,0.914057649685743
GOBP_REGULATION_OF_CD8_POSIT...1,SET,19,0.21138,0.006793,0.21158,0.15889,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.914057649685743
LI_WILMS_TUMOR_VS_FETAL_KIDN...3,SET,46,0.14045,0.0070177,0.14058,0.1589,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_DN,0.914057649685743
GSE360_CTRL_VS_L_MAJOR_MAC_UP,SET,182,0.05968,0.0059094,0.05974,0.1589,GSE360_CTRL_VS_L_MAJOR_MAC_UP,0.914057649685743
DESCARTES_FETAL_MUSCLE_MEGAK...,SET,195,0.059964,0.0061437,0.060034,0.15895,DESCARTES_FETAL_MUSCLE_MEGAKARYOCYTES,0.914057649685743
GOMF_ALL_TRANS_RETINOL_DEHYD...,SET,13,0.24463,0.0065039,0.24494,0.15896,GOMF_ALL_TRANS_RETINOL_DEHYDROGENASE_NADPPLUS_ACTIVITY,0.914057649685743
MODULE_395,SET,12,0.2363,0.0060361,0.23663,0.15899,MODULE_395,0.914057649685743
GSE4590_LARGE_PRE_BCELL_VS_V...2,SET,160,0.069527,0.0064588,0.069624,0.159,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,0.914057649685743
LIANG_SILENCED_BY_METHYLATIO...3,SET,26,0.18662,0.0070143,0.18689,0.15901,LIANG_SILENCED_BY_METHYLATION_UP,0.914057649685743
MIR1295B_3P,SET,18,0.22357,0.0069933,0.22389,0.15901,MIR1295B_3P,0.914057649685743
REACTOME_TOLL_LIKE_RECEPTOR_...3,SET,108,0.082226,0.0062846,0.082362,0.15906,REACTOME_TOLL_LIKE_RECEPTOR_TLR1_TLR2_CASCADE,0.914157638888889
MIR200B_5P,SET,95,0.083153,0.0059628,0.083296,0.15908,MIR200B_5P,0.914157638888889
RBM17_TARGET_GENES,SET,5,0.34809,0.0057406,0.34874,0.15911,RBM17_TARGET_GENES,0.914161470539693
GOCC_CLATHRIN_COATED_ENDOCYT...2,SET,67,0.11129,0.0067073,0.11155,0.15922,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE_MEMBRANE,0.914161470539693
HP_BREAST_CARCINOMA,SET,68,0.095539,0.0058006,0.095763,0.15923,HP_BREAST_CARCINOMA,0.914161470539693
GSE33425_CD8_ALPHAALPHA_VS_A...2,SET,187,0.061042,0.0061258,0.06119,0.15925,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,0.914161470539693
BIOCARTA_RACCYCD_PATHWAY,SET,25,0.16568,0.0061065,0.1661,0.15927,BIOCARTA_RACCYCD_PATHWAY,0.914161470539693
GOMF_ENOYL_COA_HYDRATASE_ACT...,SET,11,0.28416,0.0069498,0.28488,0.15927,GOMF_ENOYL_COA_HYDRATASE_ACTIVITY,0.914161470539693
GOMF_DNA_BINDING_BENDING,SET,17,0.21887,0.0066533,0.21948,0.15934,GOMF_DNA_BINDING_BENDING,0.914161470539693
FOROUTAN_TGFB_EMT_DN,SET,102,0.090464,0.0067206,0.090721,0.15935,FOROUTAN_TGFB_EMT_DN,0.914161470539693
TRAVAGLINI_LUNG_FIBROMYOCYTE...,SET,21,0.2075,0.00701,0.20809,0.15935,TRAVAGLINI_LUNG_FIBROMYOCYTE_CELL,0.914161470539693
MORF_NME2,SET,137,0.067764,0.0058288,0.067964,0.15937,MORF_NME2,0.914161470539693
MATSUMIYA_PBMC_MODIFIED_VACC...4,SET,81,0.093376,0.0061853,0.093651,0.15937,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_MVA85A_6HR_UP,0.914161470539693
MIR6732_5P,SET,25,0.16783,0.0061857,0.16835,0.15941,MIR6732_5P,0.914240024752475
GSE24142_EARLY_THYMIC_PROGEN...8,SET,186,0.062145,0.00622,0.062359,0.1595,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_UP,0.914512303278689
GOCC_TRIGLYCERIDE_RICH_PLASM...,SET,18,0.22237,0.0069556,0.22316,0.15952,GOCC_TRIGLYCERIDE_RICH_PLASMA_LIPOPROTEIN_PARTICLE,0.914512303278689
LENAOUR_DENDRITIC_CELL_MATUR...1,SET,115,0.080708,0.0063642,0.081013,0.15957,LENAOUR_DENDRITIC_CELL_MATURATION_DN,0.914512303278689
GOBP_POSITIVE_REGULATION_OF_...179,SET,13,0.23737,0.0063108,0.23832,0.15962,GOBP_POSITIVE_REGULATION_OF_CREB_TRANSCRIPTION_FACTOR_ACTIVITY,0.914512303278689
ROVERSI_GLIOMA_LOH_REGIONS,SET,45,0.16291,0.0080511,0.16356,0.15963,ROVERSI_GLIOMA_LOH_REGIONS,0.914512303278689
REACTOME_REGULATION_OF_CDH11...2,SET,10,0.29441,0.0068654,0.29558,0.15963,REACTOME_REGULATION_OF_CDH11_GENE_TRANSCRIPTION,0.914512303278689
GOBP_POSITIVE_REGULATION_OF_...640,SET,24,0.17469,0.0063084,0.1754,0.15965,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MATURATION,0.914512303278689
GAVISH_3CA_METAPROGRAM_CD4_T...4,SET,47,0.11257,0.0056851,0.11304,0.15968,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_GLYCOLYSIS_MYC,0.914512303278689
GOBP_NEGATIVE_REGULATION_OF_...462,SET,26,0.15368,0.0057763,0.15435,0.15971,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,0.914512303278689
HP_COMPLETE_OR_NEAR_COMPLETE...1,SET,7,0.37905,0.0073961,0.38078,0.15977,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,0.914512303278689
MIR7154_5P,SET,239,0.055201,0.0062537,0.055466,0.15982,MIR7154_5P,0.914512303278689
TTTGCAG_MIR518A2,SET,188,0.06182,0.0062203,0.062117,0.15982,TTTGCAG_MIR518A2,0.914512303278689
HP_ABNORMAL_CURVATURE_OF_THE...,SET,1027,0.026164,0.0060095,0.026289,0.15982,HP_ABNORMAL_CURVATURE_OF_THE_VERTEBRAL_COLUMN,0.914512303278689
GOMF_SNRNA_BINDING,SET,44,0.10583,0.0051718,0.10639,0.15994,GOMF_SNRNA_BINDING,0.914512303278689
WP_VEGFAVEGFR2_SIGNALING,SET,404,0.04242,0.0062198,0.04265,0.15997,WP_VEGFAVEGFR2_SIGNALING,0.914512303278689
FINETTI_BREAST_CANCERS_KINOM...2,SET,15,0.20826,0.0059473,0.20941,0.15999,FINETTI_BREAST_CANCERS_KINOME_GRAY,0.914512303278689
WANG_METHYLATED_IN_BREAST_CA...,SET,34,0.15261,0.0065577,0.15346,0.16002,WANG_METHYLATED_IN_BREAST_CANCER,0.914512303278689
HP_RESTING_TREMOR,SET,45,0.12083,0.0059715,0.12151,0.16003,HP_RESTING_TREMOR,0.914512303278689
GOBP_RESPONSE_TO_GLYCOPROTEIN,SET,11,0.27888,0.0068205,0.28049,0.16006,GOBP_RESPONSE_TO_GLYCOPROTEIN,0.914512303278689
GSE41176_UNSTIM_VS_ANTI_IGM_...7,SET,175,0.062339,0.006054,0.062706,0.16008,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN,0.914512303278689
GSE17721_POLYIC_VS_CPG_1H_BM...1,SET,183,0.060676,0.0060244,0.061041,0.16011,GSE17721_POLYIC_VS_CPG_1H_BMDC_DN,0.914512303278689
DESCARTES_FETAL_EYE_CORNEAL_...,SET,222,0.061032,0.0066671,0.0614,0.16012,DESCARTES_FETAL_EYE_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,0.914512303278689
HP_RETINAL_ARTERIOLAR_TORTUO...,SET,27,0.1854,0.007101,0.18656,0.16016,HP_RETINAL_ARTERIOLAR_TORTUOSITY,0.914512303278689
GSE5542_IFNA_VS_IFNA_AND_IFN...2,SET,183,0.062296,0.0061852,0.062699,0.16022,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.914512303278689
GOBP_NEGATIVE_REGULATION_OF_...653,SET,108,0.083123,0.0063532,0.083667,0.16024,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,0.914512303278689
GOBP_PHOTOPERIODISM,SET,26,0.16012,0.0060181,0.16117,0.16024,GOBP_PHOTOPERIODISM,0.914512303278689
GOMF_INOSITOL_PHOSPHATE_PHOS...,SET,18,0.17889,0.0055955,0.18007,0.16025,GOMF_INOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.914512303278689
WENG_POR_TARGETS_LIVER_UP,SET,41,0.13399,0.0063216,0.13489,0.16028,WENG_POR_TARGETS_LIVER_UP,0.914512303278689
WP_MALE_STEROID_HORMONES_IN_...,SET,13,0.23838,0.0063377,0.23998,0.16028,WP_MALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,0.914512303278689
GSE16266_LPS_VS_HEATSHOCK_AN...2,SET,182,0.064057,0.0063428,0.064499,0.16033,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,0.914512303278689
HP_RECURRENT_PANCREATITIS,SET,11,0.30311,0.0074132,0.30522,0.16034,HP_RECURRENT_PANCREATITIS,0.914512303278689
HP_LARYNGOTRACHEOMALACIA,SET,7,0.3232,0.0063062,0.32545,0.16035,HP_LARYNGOTRACHEOMALACIA,0.914512303278689
GSE17974_CTRL_VS_ACT_IL4_AND...7,SET,176,0.0587,0.0057166,0.059112,0.16036,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_DN,0.914512303278689
GSE3720_VD1_VS_VD2_GAMMADELT...4,SET,172,0.063329,0.0060977,0.063775,0.16036,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_UP,0.914512303278689
MIR6132,SET,119,0.076994,0.0061753,0.077554,0.16042,MIR6132,0.914512303278689
GOBP_POSITIVE_REGULATION_OF_...172,SET,8,0.32935,0.0068699,0.33181,0.16046,GOBP_POSITIVE_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.914512303278689
GOBP_REGULATION_OF_COA_TRANS...,SET,8,0.32935,0.0068699,0.33181,0.16046,GOBP_REGULATION_OF_COA_TRANSFERASE_ACTIVITY,0.914512303278689
SIMBULAN_UV_RESPONSE_IMMORTA...,SET,31,0.1517,0.0062252,0.15285,0.16049,SIMBULAN_UV_RESPONSE_IMMORTALIZED_DN,0.914512303278689
MIR492,SET,23,0.16703,0.005905,0.1683,0.1605,MIR492,0.914512303278689
GOBP_RESPONSE_TO_FOLLICLE_ST...,SET,15,0.24243,0.006923,0.24428,0.16051,GOBP_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE,0.914512303278689
GOMF_MEMBRANE_INSERTASE_ACTI...,SET,14,0.21249,0.0058624,0.21416,0.16056,GOMF_MEMBRANE_INSERTASE_ACTIVITY,0.914611258603736
GSE17721_POLYIC_VS_PAM3CSK4_...7,SET,175,0.065262,0.0063378,0.06578,0.16058,GSE17721_POLYIC_VS_PAM3CSK4_1H_BMDC_DN,0.914611258603736
CUI_DEVELOPING_HEART_CARDIAC...,SET,100,0.087004,0.0064002,0.087707,0.16061,CUI_DEVELOPING_HEART_CARDIAC_FIBROBLASTS,0.914632238243487
GOBP_GLANDULAR_EPITHELIAL_CE...1,SET,33,0.15725,0.0066572,0.15855,0.16066,GOBP_GLANDULAR_EPITHELIAL_CELL_DEVELOPMENT,0.914722021276596
GOBP_POSITIVE_REGULATION_OF_...686,SET,4,0.3692,0.0054461,0.37237,0.16073,GOBP_POSITIVE_REGULATION_OF_RNA_BINDING,0.914722021276596
GOCC_CCR4_NOT_CORE_COMPLEX,SET,5,0.3261,0.005378,0.32895,0.16077,GOCC_CCR4_NOT_CORE_COMPLEX,0.914722021276596
GSE18791_CTRL_VS_NEWCASTLE_V...18,SET,178,0.059663,0.0058431,0.060186,0.16077,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_UP,0.914722021276596
NAGASHIMA_NRG1_SIGNALING_UP,SET,166,0.068915,0.0065199,0.069531,0.16081,NAGASHIMA_NRG1_SIGNALING_UP,0.914722021276596
GOMF_N_ACYLSPHINGOSINE_AMIDO...,SET,7,0.35984,0.0070213,0.36305,0.16081,GOMF_N_ACYLSPHINGOSINE_AMIDOHYDROLASE_ACTIVITY,0.914722021276596
HP_ABNORMALITY_OF_LYSOSOMAL_...,SET,8,0.31462,0.0065626,0.31742,0.16081,HP_ABNORMALITY_OF_LYSOSOMAL_METABOLISM,0.914722021276596
GOCC_SECRETORY_GRANULE_MEMBR...,SET,291,0.05076,0.0063363,0.051222,0.16086,GOCC_SECRETORY_GRANULE_MEMBRANE,0.91477836514929
GOCC_TRANS_GOLGI_NETWORK_MEM...,SET,95,0.085772,0.0061506,0.086573,0.16091,GOCC_TRANS_GOLGI_NETWORK_MEMBRANE,0.91477836514929
GOBP_SODIUM_ION_IMPORT_ACROS...,SET,22,0.17754,0.0061388,0.17921,0.16092,GOBP_SODIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.91477836514929
GOCC_FHF_COMPLEX,SET,4,0.36808,0.0054296,0.37156,0.16094,GOCC_FHF_COMPLEX,0.91477836514929
REACTOME_DOWNREGULATION_OF_T...,SET,25,0.15564,0.0057362,0.15713,0.16097,REACTOME_DOWNREGULATION_OF_TGF_BETA_RECEPTOR_SIGNALING,0.91477836514929
GOBP_ABSCISSION,SET,5,0.32525,0.0053639,0.3285,0.16107,GOBP_ABSCISSION,0.91477836514929
GOBP_TRANSCRIPTION_BY_RNA_PO...1,SET,58,0.098811,0.0055421,0.099812,0.1611,GOBP_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.91477836514929
GOMF_TRANSMEMBRANE_RECEPTOR_...6,SET,62,0.11695,0.0067809,0.11813,0.16111,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.91477836514929
NRF2_Q4,SET,227,0.05571,0.006153,0.056306,0.16124,NRF2_Q4,0.91477836514929
GSE37416_CTRL_VS_12H_F_TULAR...1,SET,175,0.059535,0.0057816,0.060172,0.16124,GSE37416_CTRL_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.91477836514929
GGCACTT_MIR519E,SET,109,0.079605,0.0061122,0.080463,0.16126,GGCACTT_MIR519E,0.91477836514929
GSE22140_GERMFREE_VS_SPF_MOU...1,SET,187,0.061534,0.0061753,0.062199,0.16126,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN,0.91477836514929
CHEOK_RESPONSE_TO_MERCAPTOPU...2,SET,4,0.44661,0.0065879,0.45145,0.16127,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_UP,0.91477836514929
GSE24634_NAIVE_CD4_TCELL_VS_...7,SET,178,0.059086,0.0057866,0.059732,0.16129,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_DN,0.91477836514929
KEGG_MEDICUS_PATHOGEN_SALMON...1,SET,6,0.3405,0.0061512,0.34423,0.1613,KEGG_MEDICUS_PATHOGEN_SALMONELLA_AVRA_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.91477836514929
GOBP_REGULATION_OF_HEXOKINAS...,SET,5,0.41731,0.0068821,0.42188,0.1613,GOBP_REGULATION_OF_HEXOKINASE_ACTIVITY,0.91477836514929
HP_HYPERACUSIS,SET,23,0.18683,0.0066052,0.18889,0.16131,HP_HYPERACUSIS,0.91477836514929
GSE21546_WT_VS_SAP1A_KO_DP_T...2,SET,176,0.064564,0.0062878,0.065274,0.16131,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_UP,0.91477836514929
GSE1791_CTRL_VS_NEUROMEDINU_...5,SET,168,0.06207,0.0059072,0.062756,0.16132,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_DN,0.91477836514929
GOBP_DERMATAN_SULFATE_METABO...,SET,8,0.30176,0.0062944,0.30517,0.16138,GOBP_DERMATAN_SULFATE_METABOLIC_PROCESS,0.91480771484375
HP_ABNORMAL_FORM_OF_THE_VERT...,SET,307,0.046698,0.0059848,0.047235,0.16143,HP_ABNORMAL_FORM_OF_THE_VERTEBRAL_BODIES,0.91480771484375
WHN_B,SET,229,0.055786,0.0061882,0.056431,0.16144,WHN_B,0.91480771484375
TRAVAGLINI_LUNG_ADVENTITIAL_...,SET,279,0.054603,0.0066763,0.055244,0.16149,TRAVAGLINI_LUNG_ADVENTITIAL_FIBROBLAST_CELL,0.91480771484375
WP_GENE_REGULATORY_NETWORK_M...,SET,11,0.25012,0.0061171,0.25308,0.16151,WP_GENE_REGULATORY_NETWORK_MODELING_SOMITOGENESIS,0.91480771484375
NAKAYA_PBMC_FLUMIST_AGE_18_5...3,SET,504,0.036371,0.0059398,0.036801,0.16151,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_UP,0.91480771484375
GOCC_DENDRITIC_SPINE_MEMBRANE,SET,14,0.22362,0.0061696,0.22628,0.16152,GOCC_DENDRITIC_SPINE_MEMBRANE,0.91480771484375
PID_AMB2_NEUTROPHILS_PATHWAY,SET,40,0.13568,0.0063231,0.13732,0.16157,PID_AMB2_NEUTROPHILS_PATHWAY,0.91480771484375
REACTOME_CONSTITUTIVE_SIGNAL...1,SET,82,0.098064,0.0065356,0.09927,0.16162,REACTOME_CONSTITUTIVE_SIGNALING_BY_ABERRANT_PI3K_IN_CANCER,0.91480771484375
ZNF407_TARGET_GENES,SET,1554,0.022052,0.0061352,0.022324,0.16162,ZNF407_TARGET_GENES,0.91480771484375
MODULE_163,SET,489,0.03883,0.006249,0.039312,0.16165,MODULE_163,0.91480771484375
E47_02,SET,222,0.058769,0.0064199,0.05951,0.16169,E47_02,0.91480771484375
WP_SEROTONIN_HTR1_GROUP_AND_...,SET,36,0.15163,0.0067044,0.15356,0.16171,WP_SEROTONIN_HTR1_GROUP_AND_FOS_PATHWAY,0.91480771484375
MIR892A,SET,117,0.081078,0.0064484,0.082109,0.16172,MIR892A,0.91480771484375
GSE6092_CTRL_VS_BORRELIA_BIR...1,SET,140,0.070573,0.006136,0.071471,0.16172,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_DN,0.91480771484375
KEGG_MEDICUS_REFERENCE_BETA_...2,SET,10,0.25914,0.006043,0.26247,0.16175,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION_ACYL_COA_SYNTHESIS,0.914828519121237
GAUTAM_EYE_CHOROID_SCLERA_FI...,SET,185,0.06221,0.0062099,0.063025,0.16181,GAUTAM_EYE_CHOROID_SCLERA_FIBROBLASTS,0.914911668563994
REACTOME_NEGATIVE_FEEDBACK_R...,SET,6,0.34443,0.0062223,0.34902,0.16186,REACTOME_NEGATIVE_FEEDBACK_REGULATION_OF_MAPK_PATHWAY,0.914911668563994
HP_PES_VALGUS,SET,48,0.12518,0.0063889,0.12684,0.16186,HP_PES_VALGUS,0.914911668563994
GOMF_NEUROTROPHIN_RECEPTOR_B...,SET,11,0.23539,0.0057571,0.23854,0.16187,GOMF_NEUROTROPHIN_RECEPTOR_BINDING,0.914911668563994
HP_CEREBRAL_INCLUSION_BODIES,SET,45,0.12629,0.0062413,0.12804,0.162,HP_CEREBRAL_INCLUSION_BODIES,0.915483806587701
GOBP_G_QUADRUPLEX_DNA_UNWIND...,SET,7,0.3145,0.0061365,0.31898,0.16209,GOBP_G_QUADRUPLEX_DNA_UNWINDING,0.915483806587701
REACTOME_NETRIN_1_SIGNALING,SET,42,0.12803,0.0061136,0.12991,0.16218,REACTOME_NETRIN_1_SIGNALING,0.915483806587701
GOBP_NEGATIVE_REGULATION_OF_...528,SET,32,0.14113,0.0058837,0.14322,0.16222,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,0.915483806587701
GSE37605_FOXP3_FUSION_GFP_VS...4,SET,171,0.06312,0.00606,0.064054,0.16222,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_UP,0.915483806587701
CASTELLANO_NRAS_TARGETS_UP,SET,67,0.10779,0.0064962,0.10939,0.16224,CASTELLANO_NRAS_TARGETS_UP,0.915483806587701
MIR4490,SET,95,0.085823,0.0061543,0.087101,0.16224,MIR4490,0.915483806587701
TRAVAGLINI_LUNG_NEUTROPHIL_C...,SET,294,0.049031,0.0061515,0.049763,0.16225,TRAVAGLINI_LUNG_NEUTROPHIL_CELL,0.915483806587701
KEGG_MEDICUS_REFERENCE_GLUCO...,SET,5,0.33101,0.005459,0.33597,0.16226,KEGG_MEDICUS_REFERENCE_GLUCONEOGENESIS,0.915483806587701
REACTOME_PIWI_INTERACTING_RN...,SET,29,0.12818,0.0050875,0.1301,0.16227,REACTOME_PIWI_INTERACTING_RNA_PIRNA_BIOGENESIS,0.915483806587701
MIR8088,SET,5,0.34157,0.0056331,0.34672,0.16228,MIR8088,0.915483806587701
REACTOME_VLDL_ASSEMBLY,SET,5,0.31286,0.0051596,0.3176,0.1623,REACTOME_VLDL_ASSEMBLY,0.915483806587701
GOMF_HISTONE_H3_METHYLTRANSF...,SET,40,0.12776,0.0059538,0.12971,0.16232,GOMF_HISTONE_H3_METHYLTRANSFERASE_ACTIVITY,0.915483806587701
GOLDRATH_EFF_VS_MEMORY_CD8_T...1,SET,186,0.060309,0.0060363,0.061232,0.16234,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_DN,0.915483806587701
GOBP_REGULATION_OF_MEMBRANE_...6,SET,16,0.18191,0.0053649,0.18476,0.16243,GOBP_REGULATION_OF_MEMBRANE_LIPID_METABOLIC_PROCESS,0.915725550874919
HP_TETRALOGY_OF_FALLOT,SET,156,0.067218,0.0061665,0.068292,0.1625,HP_TETRALOGY_OF_FALLOT,0.915725550874919
WP_2Q37_COPY_NUMBER_VARIATIO...,SET,124,0.097431,0.0079759,0.098997,0.16252,WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME,0.915725550874919
GAVISH_3CA_METAPROGRAM_ENDOT...13,SET,49,0.1277,0.0065849,0.12977,0.16255,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NF_KB,0.915725550874919
GOCC_STRIATED_MUSCLE_THIN_FI...,SET,21,0.18092,0.0061121,0.18387,0.16258,GOCC_STRIATED_MUSCLE_THIN_FILAMENT,0.915725550874919
GSE40274_CTRL_VS_LEF1_TRANSD...1,SET,156,0.063289,0.005806,0.064325,0.16259,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.915725550874919
GOMF_NATURAL_KILLER_CELL_LEC...,SET,8,0.35909,0.0074902,0.36498,0.1626,GOMF_NATURAL_KILLER_CELL_LECTIN_LIKE_RECEPTOR_BINDING,0.915725550874919
GOBP_NEGATIVE_REGULATION_OF_...182,SET,28,0.16757,0.0065355,0.17032,0.16261,GOBP_NEGATIVE_REGULATION_OF_DNA_BINDING,0.915725550874919
REACTOME_RHO_GTPASES_ACTIVAT...6,SET,19,0.18419,0.0059191,0.18723,0.16262,REACTOME_RHO_GTPASES_ACTIVATE_PAKS,0.915725550874919
SARTIPY_NORMAL_AT_INSULIN_RE...2,SET,27,0.16234,0.0062175,0.16506,0.16269,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_UP,0.91587925170068
GSE10325_CD4_TCELL_VS_MYELOI...1,SET,179,0.065191,0.0064022,0.066287,0.1627,GSE10325_CD4_TCELL_VS_MYELOID_DN,0.91587925170068
KRAS.600_UP.V1_UP,SET,249,0.058181,0.006726,0.059175,0.16276,KRAS.600_UP.V1_UP,0.915884555609519
HP_DECREASED_MINIATURE_ENDPL...,SET,13,0.19856,0.005279,0.20197,0.16278,HP_DECREASED_MINIATURE_ENDPLATE_POTENTIALS,0.915884555609519
GSE22886_UNSTIM_VS_IL2_STIM_...1,SET,185,0.056754,0.0056654,0.057729,0.16278,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_DN,0.915884555609519
HP_ABNORMAL_5TH_METACARPAL_M...,SET,17,0.20645,0.0062759,0.21004,0.16284,HP_ABNORMAL_5TH_METACARPAL_MORPHOLOGY,0.915925586664509
GSE37416_CTRL_VS_6H_F_TULARE...2,SET,164,0.063443,0.0059662,0.064548,0.16284,GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.915925586664509
VDR_Q3,SET,213,0.057589,0.0061636,0.058605,0.16289,VDR_Q3,0.916033271375465
HP_HIP_FLEXOR_WEAKNESS,SET,15,0.1877,0.0053599,0.19106,0.16296,HP_HIP_FLEXOR_WEAKNESS,0.916033271375465
GOBP_MULTIVESICULAR_BODY_SOR...,SET,45,0.11545,0.0057057,0.11755,0.16302,GOBP_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.916033271375465
NEWMAN_ERCC6_TARGETS_DN,SET,33,0.15824,0.0066994,0.16113,0.16304,NEWMAN_ERCC6_TARGETS_DN,0.916033271375465
GOBP_POSITIVE_REGULATION_OF_...546,SET,6,0.33045,0.0059697,0.3365,0.16305,GOBP_POSITIVE_REGULATION_OF_NON_MOTILE_CILIUM_ASSEMBLY,0.916033271375465
GSE24634_IL4_VS_CTRL_TREATED...7,SET,176,0.06424,0.0062562,0.06542,0.16306,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_DN,0.916033271375465
GOBP_POSITIVE_REGULATION_OF_...387,SET,11,0.23896,0.0058444,0.24336,0.16307,GOBP_POSITIVE_REGULATION_OF_ISOTYPE_SWITCHING_TO_IGG_ISOTYPES,0.916033271375465
HP_CEREBRAL_BERRY_ANEURYSM,SET,6,0.34006,0.0061432,0.34631,0.16307,HP_CEREBRAL_BERRY_ANEURYSM,0.916033271375465
WP_IRONSULFUR_CLUSTER_BIOGEN...,SET,13,0.22861,0.0060778,0.23286,0.16312,WP_IRONSULFUR_CLUSTER_BIOGENESIS,0.916130344158992
MIR6858_5P,SET,56,0.11181,0.0061622,0.11389,0.16314,MIR6858_5P,0.916130344158992
chr4p16,SET,93,0.16011,0.011361,0.16314,0.16319,chr4p16,0.916263077544426
REACTOME_OAS_ANTIVIRAL_RESPO...,SET,7,0.41914,0.0081784,0.42715,0.16324,REACTOME_OAS_ANTIVIRAL_RESPONSE,0.916395768050396
GOMF_P_TYPE_CALCIUM_TRANSPOR...,SET,8,0.25915,0.0054055,0.26421,0.16334,GOMF_P_TYPE_CALCIUM_TRANSPORTER_ACTIVITY,0.916511731170708
GOMF_DNA_METHYLTRANSFERASE_A...,SET,7,0.35195,0.0068673,0.35886,0.16337,GOMF_DNA_METHYLTRANSFERASE_ACTIVITY,0.916511731170708
BIOCARTA_PLATELETAPP_PATHWAY,SET,11,0.29162,0.0071322,0.29741,0.16342,BIOCARTA_PLATELETAPP_PATHWAY,0.916511731170708
QI_PBMC_ZOSTAVAX_AGE_50_75YO...2,SET,35,0.1346,0.0058683,0.13728,0.16342,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_28D_PEAK_T_CELL_RESPONSE_14DY_NEGATIVE,0.916511731170708
HP_LIPOATROPHY,SET,71,0.10277,0.006375,0.10482,0.16346,HP_LIPOATROPHY,0.916511731170708
STEARMAN_TUMOR_FIELD_EFFECT_...,SET,35,0.14249,0.0062122,0.14539,0.16353,STEARMAN_TUMOR_FIELD_EFFECT_UP,0.916511731170708
HP_ABNORMALITY_OF_THE_HAMATE...,SET,9,0.26809,0.0059311,0.27357,0.16355,HP_ABNORMALITY_OF_THE_HAMATE_BONE,0.916511731170708
GOMF_SINGLE_STRANDED_DNA_3_5...,SET,6,0.30077,0.0054335,0.30696,0.16359,GOMF_SINGLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,0.916511731170708
HP_VACUOLATED_LYMPHOCYTES,SET,11,0.26257,0.0064217,0.26798,0.1636,HP_VACUOLATED_LYMPHOCYTES,0.916511731170708
MIR3679_5P,SET,71,0.096366,0.0059779,0.098374,0.16365,MIR3679_5P,0.916511731170708
HP_ABNORMALITY_OF_NEUTROPHILS,SET,231,0.053741,0.005987,0.054868,0.16368,HP_ABNORMALITY_OF_NEUTROPHILS,0.916511731170708
HP_DECREASED_ACTIVITY_OF_MIT...3,SET,13,0.19366,0.0051487,0.19772,0.16368,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_II,0.916511731170708
GOBP_POSITIVE_REGULATION_OF_...486,SET,9,0.30622,0.0067747,0.31268,0.16371,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_DIFFERENTIATION,0.916511731170708
GSE29949_CD8_NEG_DC_SPLEEN_V...3,SET,179,0.062842,0.0061715,0.064168,0.16371,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN,0.916511731170708
BURTON_ADIPOGENESIS_PEAK_AT_...2,SET,39,0.12351,0.0056837,0.12614,0.16375,BURTON_ADIPOGENESIS_PEAK_AT_16HR,0.916511731170708
GSE28737_BCL6_HET_VS_BCL6_KO...1,SET,185,0.060439,0.0060332,0.061729,0.16377,GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_DN,0.916511731170708
GOBP_CELLULAR_RESPONSE_TO_FA...,SET,32,0.15681,0.0065374,0.16018,0.1638,GOBP_CELLULAR_RESPONSE_TO_FATTY_ACID,0.916511731170708
GSE17301_ACD3_ACD28_VS_ACD3_...2,SET,171,0.060183,0.0057781,0.06148,0.16382,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_UP,0.916511731170708
GOBP_NON_MOTILE_CILIUM_ASSEM...,SET,60,0.10353,0.0059054,0.10576,0.16384,GOBP_NON_MOTILE_CILIUM_ASSEMBLY,0.916511731170708
GOCC_PROTEIN_LIPID_COMPLEX,SET,37,0.14758,0.0066148,0.15078,0.16386,GOCC_PROTEIN_LIPID_COMPLEX,0.916511731170708
GSE42088_UNINF_VS_LEISHMANIA...6,SET,183,0.061481,0.0061042,0.062818,0.16387,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_4H_UP,0.916511731170708
GSE20754_WT_VS_TCF1_KO_MEMOR...2,SET,188,0.056801,0.0057153,0.058049,0.16392,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_UP,0.916511731170708
REACTOME_SNRNP_ASSEMBLY,SET,49,0.10701,0.005518,0.10937,0.16395,REACTOME_SNRNP_ASSEMBLY,0.916511731170708
JOHNSTONE_PARVB_TARGETS_1_DN,SET,56,0.11104,0.0061202,0.1135,0.16396,JOHNSTONE_PARVB_TARGETS_1_DN,0.916511731170708
HP_ABNORMAL_CSF_PROTEIN_CONC...,SET,45,0.12771,0.0063115,0.13054,0.16396,HP_ABNORMAL_CSF_PROTEIN_CONCENTRATION,0.916511731170708
HP_PROMINENT_FOREHEAD,SET,221,0.053647,0.0058472,0.054839,0.16398,HP_PROMINENT_FOREHEAD,0.916511731170708
GSE14308_TH17_VS_INDUCED_TRE...2,SET,178,0.058538,0.0057329,0.059855,0.16405,GSE14308_TH17_VS_INDUCED_TREG_UP,0.916511731170708
MIR580_5P,SET,210,0.057076,0.006066,0.058371,0.16409,MIR580_5P,0.916511731170708
GOBP_POSITIVE_REGULATION_OF_...581,SET,24,0.17555,0.0063397,0.17954,0.16409,GOBP_POSITIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.916511731170708
REACTOME_DEX_H_BOX_HELICASES...,SET,7,0.30686,0.0059874,0.31384,0.1641,REACTOME_DEX_H_BOX_HELICASES_ACTIVATE_TYPE_I_IFN_AND_INFLAMMATORY_CYTOKINES_PRODUCTION,0.916511731170708
REACTOME_SIGNALING_BY_RETINO...,SET,40,0.13952,0.006502,0.14271,0.16412,REACTOME_SIGNALING_BY_RETINOIC_ACID,0.916511731170708
GNF2_DNM1,SET,68,0.10601,0.0064366,0.10844,0.16413,GNF2_DNM1,0.916511731170708
MARTINEZ_TP53_TARGETS_DN,SET,553,0.035392,0.006046,0.036203,0.16415,MARTINEZ_TP53_TARGETS_DN,0.916511731170708
HP_PATCHY_ALOPECIA,SET,19,0.21288,0.006841,0.2178,0.1642,HP_PATCHY_ALOPECIA,0.916511731170708
GOBP_SULFUR_AMINO_ACID_METAB...,SET,30,0.1587,0.0064064,0.16238,0.16421,GOBP_SULFUR_AMINO_ACID_METABOLIC_PROCESS,0.916511731170708
GOMF_INTRAMOLECULAR_OXIDORED...3,SET,15,0.20816,0.0059442,0.21298,0.16421,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_TRANSPOSING_C_C_BONDS,0.916511731170708
GOMF_CARBOHYDRATE_MONOATOMIC...,SET,16,0.20876,0.0061568,0.2137,0.16432,GOMF_CARBOHYDRATE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.916597617901829
AGCACTT_MIR93_MIR302A_MIR302...,SET,318,0.046567,0.0060722,0.047671,0.16433,AGCACTT_MIR93_MIR302A_MIR302B_MIR302C_MIR302D_MIR372_MIR373_MIR520E_MIR520A_MIR526B_MIR520B_MIR520C_MIR520D,0.916597617901829
HP_SPASTIC_PARAPARESIS,SET,49,0.10671,0.0055028,0.10925,0.16435,HP_SPASTIC_PARAPARESIS,0.916597617901829
GNF2_FEN1,SET,54,0.1034,0.0055967,0.10587,0.16438,GNF2_FEN1,0.916597617901829
GSE36888_UNTREATED_VS_IL2_TR...9,SET,164,0.065375,0.0061479,0.066938,0.16438,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_DN,0.916597617901829
GOBP_DERMATAN_SULFATE_PROTEO...2,SET,11,0.2402,0.0058746,0.24595,0.16439,GOBP_DERMATAN_SULFATE_PROTEOGLYCAN_METABOLIC_PROCESS,0.916597617901829
GSE5589_WT_VS_IL10_KO_LPS_ST...2,SET,140,0.066266,0.0057615,0.067858,0.16441,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,0.916597617901829
GSE26030_TH1_VS_TH17_RESTIMU...2,SET,175,0.062928,0.0061111,0.064448,0.16444,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP,0.916617834803528
LBP1_Q6,SET,211,0.057492,0.0061247,0.058944,0.16469,LBP1_Q6,0.916802416653374
GOMF_TRIPEPTIDE_TRANSMEMBRAN...,SET,9,0.27791,0.0061483,0.28492,0.16469,GOMF_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.916802416653374
KEGG_MEDICUS_REFERENCE_P27_C...,SET,14,0.21958,0.0060581,0.22514,0.16471,KEGG_MEDICUS_REFERENCE_P27_CELL_CYCLE_G1_S,0.916802416653374
REACTOME_SEALING_OF_THE_NUCL...,SET,29,0.14895,0.005912,0.15274,0.16474,REACTOME_SEALING_OF_THE_NUCLEAR_ENVELOPE_NE_BY_ESCRT_III,0.916802416653374
GSE11961_MEMORY_BCELL_DAY7_V...2,SET,180,0.060689,0.0059766,0.062232,0.16474,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,0.916802416653374
GOBP_THYROID_HORMONE_TRANSPO...,SET,10,0.26553,0.0061921,0.27234,0.16478,GOBP_THYROID_HORMONE_TRANSPORT,0.916802416653374
SCHAEFFER_PROSTATE_DEVELOPME...10,SET,6,0.35722,0.0064532,0.36639,0.1648,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_UP,0.916802416653374
GOBP_GLYCOSIDE_METABOLIC_PRO...,SET,19,0.20972,0.0067395,0.21511,0.1648,GOBP_GLYCOSIDE_METABOLIC_PROCESS,0.916802416653374
MIR4636,SET,3,0.65969,0.0084276,0.67691,0.1649,MIR4636,0.916802416653374
GOBP_NEGATIVE_REGULATION_OF_...633,SET,9,0.27081,0.0059912,0.27791,0.16492,GOBP_NEGATIVE_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,0.916802416653374
GOBP_POSITIVE_REGULATION_OF_...846,SET,8,0.33059,0.0068958,0.3393,0.16495,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.916802416653374
GOMF_PROTEIN_TYROSINE_KINASE...1,SET,29,0.16855,0.0066899,0.17299,0.16495,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,0.916802416653374
MIR3922_3P,SET,89,0.0825,0.0057271,0.084677,0.16496,MIR3922_3P,0.916802416653374
HP_HYPERPLASTIC_CALLUS_FORMA...,SET,5,0.38564,0.0063599,0.39581,0.16496,HP_HYPERPLASTIC_CALLUS_FORMATION,0.916802416653374
DAVICIONI_PAX_FOXO1_SIGNATUR...2,SET,52,0.12391,0.0065818,0.12719,0.16498,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP,0.916802416653374
KEGG_MEDICUS_REFERENCE_EGF_E...2,SET,13,0.22413,0.0059588,0.23007,0.16499,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_NFKB_SIGNALING_PATHWAY,0.916802416653374
MIR34C_3P,SET,58,0.10662,0.00598,0.10945,0.165,MIR34C_3P,0.916802416653374
HARALAMBIEVA_PBMC_FLUARIX_AG...1,SET,377,0.04334,0.0061433,0.044498,0.16504,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_NEGATIVE,0.916802416653374
GOMF_PROMOTER_ENHANCER_LOOP_...,SET,4,0.4003,0.0059048,0.41105,0.16507,GOMF_PROMOTER_ENHANCER_LOOP_ANCHORING_ACTIVITY,0.916802416653374
GOBP_NEGATIVE_REGULATION_OF_...390,SET,4,0.44514,0.0065662,0.45713,0.1651,GOBP_NEGATIVE_REGULATION_OF_METALLOPEPTIDASE_ACTIVITY,0.916802416653374
GOBP_ROUNDABOUT_SIGNALING_PA...,SET,5,0.40653,0.0067043,0.41749,0.1651,GOBP_ROUNDABOUT_SIGNALING_PATHWAY,0.916802416653374
GOBP_RESPONSE_TO_LIGHT_STIMU...,SET,289,0.047869,0.0059552,0.049163,0.16512,GOBP_RESPONSE_TO_LIGHT_STIMULUS,0.916802416653374
SCHERER_PBMC_APSV_WETVAX_AGE...2,SET,57,0.10981,0.0061058,0.11279,0.16513,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_2_TO_4DY_UP,0.916802416653374
GOMF_TRANSCRIPTION_ELONGATIO...,SET,7,0.32736,0.0063876,0.33628,0.16516,GOMF_TRANSCRIPTION_ELONGATION_FACTOR_ACTIVITY,0.916802416653374
GNF2_BNIP2,SET,32,0.13215,0.0055092,0.13578,0.16522,GNF2_BNIP2,0.916802416653374
HE_LIM_SUN_FETAL_LUNG_C3_DEF...1,SET,23,0.16804,0.0059409,0.17268,0.16524,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROBLAST,0.916802416653374
RUBENSTEIN_SKELETAL_MUSCLE_S...2,SET,377,0.040643,0.005761,0.041764,0.16524,RUBENSTEIN_SKELETAL_MUSCLE_SMOOTH_MUSCLE_CELLS,0.916802416653374
REACTOME_RESOLUTION_OF_SISTE...,SET,113,0.075512,0.0059027,0.077604,0.16527,REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION,0.916802416653374
REACTOME_ISG15_ANTIVIRAL_MEC...,SET,70,0.093128,0.0057364,0.095709,0.16528,REACTOME_ISG15_ANTIVIRAL_MECHANISM,0.916802416653374
HP_ABNORMAL_CIRCULATING_LEPT...,SET,12,0.25032,0.0063941,0.25728,0.1653,HP_ABNORMAL_CIRCULATING_LEPTIN_CONCENTRATION,0.916802416653374
GOBP_TACHYKININ_RECEPTOR_SIG...,SET,7,0.30888,0.006027,0.31748,0.16531,GOBP_TACHYKININ_RECEPTOR_SIGNALING_PATHWAY,0.916802416653374
GOBP_ALANINE_TRANSPORT,SET,16,0.2262,0.0066711,0.23251,0.16532,GOBP_ALANINE_TRANSPORT,0.916802416653374
GOBP_POSITIVE_REGULATION_OF_...9,SET,7,0.24814,0.0048417,0.2551,0.16536,GOBP_POSITIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,0.916802416653374
GOMF_ALDEHYDE_LYASE_ACTIVITY,SET,9,0.24874,0.005503,0.25573,0.16537,GOMF_ALDEHYDE_LYASE_ACTIVITY,0.916802416653374
MODULE_95,SET,485,0.038372,0.0061506,0.039464,0.16545,MODULE_95,0.916953396587466
HP_MICROVESICULAR_HEPATIC_ST...,SET,19,0.17573,0.0056474,0.18074,0.16545,HP_MICROVESICULAR_HEPATIC_STEATOSIS,0.916953396587466
MANNO_MIDBRAIN_NEUROTYPES_HDA,SET,435,0.043091,0.0065504,0.044328,0.16551,MANNO_MIDBRAIN_NEUROTYPES_HDA,0.917139676339286
GOBP_NEGATIVE_REGULATION_OF_...305,SET,13,0.25224,0.0067061,0.25954,0.16557,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_17_PRODUCTION,0.917144294820717
GSE3982_MAC_VS_BASOPHIL_UP,SET,182,0.060215,0.0059624,0.061963,0.16558,GSE3982_MAC_VS_BASOPHIL_UP,0.917144294820717
HP_ABNORMAL_MACROPHAGE_MORPH...,SET,42,0.14027,0.0066977,0.14434,0.16559,HP_ABNORMAL_MACROPHAGE_MORPHOLOGY,0.917144294820717
GOBP_REGULATION_OF_NEURAL_PR...,SET,96,0.09024,0.0065048,0.092874,0.16562,GOBP_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.917164292543021
GSE32533_MIR17_KO_VS_MIR17_O...2,SET,180,0.060203,0.0059287,0.061972,0.16566,GSE32533_MIR17_KO_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.917239652700335
MIR455_3P,SET,84,0.089958,0.0060677,0.092634,0.16575,MIR455_3P,0.917591788786238
GSE40685_NAIVE_CD4_TCELL_VS_...3,SET,180,0.061715,0.0060776,0.063579,0.16586,GSE40685_NAIVE_CD4_TCELL_VS_TREG_DN,0.917889877641824
WP_CYTOSINE_METHYLATION,SET,7,0.33887,0.006612,0.34912,0.16587,WP_CYTOSINE_METHYLATION,0.917889877641824
FUNG_IL2_SIGNALING_2,SET,12,0.2354,0.006013,0.24258,0.16593,FUNG_IL2_SIGNALING_2,0.917889877641824
RICKMAN_HEAD_AND_NECK_CANCER...2,SET,33,0.15324,0.0064875,0.15798,0.16603,RICKMAN_HEAD_AND_NECK_CANCER_B,0.917889877641824
PSMB5_TARGET_GENES,SET,196,0.059547,0.0061164,0.061399,0.16607,PSMB5_TARGET_GENES,0.917889877641824
GSE21546_UNSTIM_VS_ANTI_CD3_...6,SET,147,0.07016,0.0062495,0.072349,0.16609,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.917889877641824
LAKE_ADULT_KIDNEY_C20_COLLEC...,SET,139,0.071631,0.0062058,0.073866,0.16609,LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX,0.917889877641824
GSE3203_INFLUENZA_INF_VS_IFN...1,SET,172,0.062555,0.0060231,0.064507,0.1661,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_DN,0.917889877641824
HP_PUNCTATE_KERATITIS,SET,5,0.43274,0.0071366,0.44631,0.16613,HP_PUNCTATE_KERATITIS,0.917889877641824
chr16p11,SET,88,0.18785,0.012967,0.19376,0.16615,chr16p11,0.917889877641824
HP_MALIGNANT_GENITOURINARY_T...,SET,33,0.12755,0.0054,0.13156,0.16615,HP_MALIGNANT_GENITOURINARY_TRACT_TUMOR,0.917889877641824
GSE26030_UNSTIM_VS_RESTIM_TH...2,SET,163,0.067391,0.0063183,0.069512,0.16615,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_UP,0.917889877641824
REACTOME_ACTIVATION_OF_MATRI...,SET,30,0.17091,0.0068993,0.1763,0.16617,REACTOME_ACTIVATION_OF_MATRIX_METALLOPROTEINASES,0.917889877641824
HP_ABNORMAL_U_WAVE,SET,5,0.42346,0.0069836,0.43683,0.16618,HP_ABNORMAL_U_WAVE,0.917889877641824
HP_ONION_BULB_FORMATION,SET,27,0.15812,0.006056,0.16313,0.1662,HP_ONION_BULB_FORMATION,0.917889877641824
IVANOVA_HEMATOPOIESIS_STEM_C...3,SET,201,0.058438,0.0060778,0.060298,0.16624,IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM,0.917894123252859
PARK_HSC_VS_MULTIPOTENT_PROG...2,SET,16,0.19536,0.0057617,0.2016,0.16626,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP,0.917894123252859
MIR6824_3P,SET,99,0.079745,0.005837,0.082297,0.16628,MIR6824_3P,0.917894123252859
GOBP_REGULATION_OF_LIGASE_AC...,SET,5,0.29221,0.0048191,0.30161,0.16632,GOBP_REGULATION_OF_LIGASE_ACTIVITY,0.917902602348461
HP_ABNORMAL_LACRIMAL_DUCT_MO...,SET,41,0.12114,0.0057154,0.12505,0.16634,HP_ABNORMAL_LACRIMAL_DUCT_MORPHOLOGY,0.917902602348461
GOMF_PYRUVATE_DEHYDROGENASE_...2,SET,5,0.36781,0.0060659,0.37977,0.1664,GOMF_PYRUVATE_DEHYDROGENASE_ACETYL_TRANSFERRING_PHOSPHATASE_ACTIVITY,0.917902602348461
WEBER_METHYLATED_IN_COLON_CA...,SET,18,0.20928,0.0065462,0.2161,0.16641,WEBER_METHYLATED_IN_COLON_CANCER,0.917902602348461
WP_MELANOMA,SET,66,0.098601,0.0058981,0.10182,0.16643,WP_MELANOMA,0.917902602348461
CAGNWMCNNNGAC_UNKNOWN,SET,79,0.095763,0.0062649,0.098892,0.16644,CAGNWMCNNNGAC_UNKNOWN,0.917902602348461
BAKER_HEMATOPOESIS_STAT5_TAR...,SET,7,0.35995,0.0070233,0.37179,0.1665,BAKER_HEMATOPOESIS_STAT5_TARGETS,0.918087815326035
MIR766_5P,SET,196,0.059337,0.0060948,0.061301,0.16654,MIR766_5P,0.918162706218274
WP_ERK_PATHWAY_IN_HUNTINGTON...,SET,16,0.22559,0.0066531,0.23311,0.1666,WP_ERK_PATHWAY_IN_HUNTINGTONS_DISEASE,0.918312416745956
GOBP_REGULATION_OF_T_CELL_RE...,SET,43,0.12398,0.0059899,0.12813,0.16662,GOBP_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,0.918312416745956
GOMF_CARNITINE_O_ACYLTRANSFE...,SET,6,0.28574,0.005162,0.2955,0.16678,GOMF_CARNITINE_O_ACYLTRANSFERASE_ACTIVITY,0.918804020895995
GSE43863_NAIVE_VS_LY6C_LOW_C...1,SET,173,0.059534,0.0057487,0.061581,0.16684,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_DN,0.918804020895995
HP_PERSISTENT_BLEEDING_AFTER...,SET,12,0.25667,0.0065563,0.26552,0.16686,HP_PERSISTENT_BLEEDING_AFTER_TRAUMA,0.918804020895995
ROSS_AML_OF_FAB_M7_TYPE,SET,63,0.10314,0.0060285,0.10671,0.16688,ROSS_AML_OF_FAB_M7_TYPE,0.918804020895995
MUELLER_METHYLATED_IN_GLIOBL...,SET,35,0.13467,0.0058713,0.13933,0.16689,MUELLER_METHYLATED_IN_GLIOBLASTOMA,0.918804020895995
GOBP_POSITIVE_REGULATION_OF_...843,SET,6,0.36046,0.0065117,0.37301,0.16694,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.918804020895995
GNF2_ST13,SET,57,0.098081,0.0054537,0.1015,0.16695,GNF2_ST13,0.918804020895995
MIR3613_5P,SET,64,0.1055,0.0062146,0.10918,0.16696,MIR3613_5P,0.918804020895995
GSE12707_AT16L1_HYPOMORPH_VS...2,SET,111,0.080114,0.0062071,0.082909,0.16696,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_UP,0.918804020895995
AMIT_EGF_RESPONSE_240_MCF10A,SET,21,0.20075,0.0067821,0.20779,0.167,AMIT_EGF_RESPONSE_240_MCF10A,0.918804020895995
GSE21927_SPLENIC_C26GM_TUMOR...3,SET,162,0.063121,0.0059,0.065335,0.167,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_DN,0.918804020895995
GOMF_NUCLEASE_ACTIVITY,SET,197,0.05539,0.0057038,0.057343,0.16704,GOMF_NUCLEASE_ACTIVITY,0.918862808544304
BUSSLINGER_DUODENAL_STEM_CEL...,SET,281,0.049785,0.0061087,0.051548,0.16708,BUSSLINGER_DUODENAL_STEM_CELLS,0.918862808544304
GOBP_KINETOCHORE_ORGANIZATION,SET,20,0.18004,0.0059359,0.18642,0.16709,GOBP_KINETOCHORE_ORGANIZATION,0.918862808544304
RIZKI_TUMOR_INVASIVENESS_3D_...1,SET,243,0.052402,0.0059855,0.054273,0.16715,RIZKI_TUMOR_INVASIVENESS_3D_DN,0.918937529119428
GOBP_GROWTH_INVOLVED_IN_HEAR...,SET,4,0.48589,0.0071674,0.50334,0.1672,GOBP_GROWTH_INVOLVED_IN_HEART_MORPHOGENESIS,0.918937529119428
MIR7845_5P,SET,55,0.10649,0.0058168,0.11034,0.16724,MIR7845_5P,0.918937529119428
EBAUER_TARGETS_OF_PAX3_FOXO1...1,SET,46,0.1249,0.0062406,0.12943,0.16729,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.918937529119428
SHEPARD_BMYB_TARGETS,SET,71,0.097868,0.0060711,0.10142,0.16729,SHEPARD_BMYB_TARGETS,0.918937529119428
MIR155_5P,SET,215,0.058052,0.0062419,0.060163,0.1673,MIR155_5P,0.918937529119428
ZSCAN31_TARGET_GENES,SET,746,0.030473,0.0060134,0.031584,0.16733,ZSCAN31_TARGET_GENES,0.918937529119428
GOBP_MONOATOMIC_ION_TRANSMEM...,SET,904,0.028867,0.0062427,0.029939,0.16748,GOBP_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.918937529119428
WP_RIBOFLAVIN_AND_COQ_DISORD...,SET,13,0.19785,0.00526,0.20521,0.1675,WP_RIBOFLAVIN_AND_COQ_DISORDERS,0.918937529119428
DACOSTA_UV_RESPONSE_VIA_ERCC...4,SET,78,0.092469,0.0060112,0.095935,0.16756,DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN,0.918937529119428
GOMF_FUCOSE_BINDING,SET,8,0.30074,0.0062731,0.31203,0.16758,GOMF_FUCOSE_BINDING,0.918937529119428
HP_SHORT_LINGUAL_FRENULUM,SET,11,0.21697,0.0053064,0.22519,0.16766,HP_SHORT_LINGUAL_FRENULUM,0.918937529119428
HP_HYPOHIDROSIS_OR_HYPERHIDR...,SET,210,0.056444,0.0059989,0.058593,0.1677,HP_HYPOHIDROSIS_OR_HYPERHIDROSIS,0.918937529119428
REACTOME_RHO_GTPASES_ACTIVAT...9,SET,19,0.1873,0.006019,0.19445,0.16772,REACTOME_RHO_GTPASES_ACTIVATE_ROCKS,0.918937529119428
BLANCO_MELO_BRONCHIAL_EPITHE...2,SET,579,0.03614,0.0063128,0.03753,0.16779,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP,0.918937529119428
MIR589_5P,SET,77,0.091596,0.0059163,0.09512,0.16779,MIR589_5P,0.918937529119428
GSE29164_DAY3_VS_DAY7_UNTREA...2,SET,163,0.062034,0.0058161,0.064419,0.16779,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_UP,0.918937529119428
BHAT_ESR1_TARGETS_VIA_AKT1_UP,SET,264,0.052567,0.0062548,0.054595,0.16782,BHAT_ESR1_TARGETS_VIA_AKT1_UP,0.918937529119428
GOBP_SECRETION_OF_LYSOSOMAL_...,SET,6,0.28519,0.0051521,0.29623,0.16785,GOBP_SECRETION_OF_LYSOSOMAL_ENZYMES,0.918937529119428
HP_MODERATE_MYOPIA,SET,3,0.48753,0.0062282,0.50641,0.16785,HP_MODERATE_MYOPIA,0.918937529119428
CUI_DEVELOPING_HEART_C6_EPIC...,SET,178,0.065036,0.0063692,0.067586,0.16796,CUI_DEVELOPING_HEART_C6_EPICARDIAL_CELL,0.918937529119428
HP_PITUITARY_DWARFISM,SET,9,0.28785,0.0063683,0.29916,0.16798,HP_PITUITARY_DWARFISM,0.918937529119428
GOBP_POSITIVE_REGULATION_OF_...519,SET,10,0.28828,0.0067226,0.29968,0.16804,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,0.918937529119428
GOMF_ALPHA_1_3_FUCOSYLTRANSF...,SET,8,0.33034,0.0068906,0.34343,0.16805,GOMF_ALPHA_1_3_FUCOSYLTRANSFERASE_ACTIVITY,0.918937529119428
ESC_V6.5_UP_EARLY.V1_DN,SET,149,0.069532,0.0062352,0.072285,0.16805,ESC_V6.5_UP_EARLY.V1_DN,0.918937529119428
WP_ATM_SIGNALING,SET,36,0.11989,0.0053008,0.12464,0.16806,WP_ATM_SIGNALING,0.918937529119428
TRAVAGLINI_LUNG_CLUB_CELL,SET,102,0.085473,0.0063498,0.08887,0.16809,TRAVAGLINI_LUNG_CLUB_CELL,0.918937529119428
IIZUKA_LIVER_CANCER_EARLY_RE...,SET,11,0.26854,0.0065677,0.2793,0.16816,IIZUKA_LIVER_CANCER_EARLY_RECURRENCE,0.918937529119428
REACTOME_DNA_DOUBLE_STRAND_B...1,SET,126,0.066553,0.0054916,0.06922,0.16816,REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR,0.918937529119428
GOCC_CANONICAL_INFLAMMASOME_...,SET,16,0.23258,0.0068593,0.2419,0.16816,GOCC_CANONICAL_INFLAMMASOME_COMPLEX,0.918937529119428
GSE37301_LYMPHOID_PRIMED_MPP...6,SET,180,0.05913,0.005823,0.061502,0.16817,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_UP,0.918937529119428
KEGG_BIOSYNTHESIS_OF_UNSATUR...,SET,22,0.18655,0.0064502,0.19403,0.16818,KEGG_BIOSYNTHESIS_OF_UNSATURATED_FATTY_ACIDS,0.918937529119428
MODULE_98,SET,368,0.039622,0.0055502,0.041234,0.16831,MODULE_98,0.918937529119428
ATACTGT_MIR144,SET,181,0.061438,0.0060669,0.063953,0.16837,ATACTGT_MIR144,0.918937529119428
GOMF_NADP_BINDING,SET,50,0.11165,0.0058157,0.11623,0.16838,GOMF_NADP_BINDING,0.918937529119428
HP_CONGENITAL_DIAPHRAGMATIC_...,SET,79,0.092322,0.0060398,0.096108,0.16838,HP_CONGENITAL_DIAPHRAGMATIC_HERNIA,0.918937529119428
SHETH_LIVER_CANCER_VS_TXNIP_...2,SET,152,0.067443,0.006108,0.070213,0.1684,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM2,0.918937529119428
GOBP_POSITIVE_REGULATION_OF_...211,SET,68,0.094334,0.0057274,0.098272,0.16855,GOBP_POSITIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.918937529119428
GOBP_LYMPHANGIOGENESIS,SET,17,0.19777,0.006012,0.20604,0.16857,GOBP_LYMPHANGIOGENESIS,0.918937529119428
KEGG_MEDICUS_REFERENCE_EREG_...2,SET,14,0.21561,0.0059486,0.22464,0.16858,KEGG_MEDICUS_REFERENCE_EREG_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.918937529119428
GOBP_NERVOUS_SYSTEM_PROCESS,SET,1294,0.025857,0.0066151,0.02694,0.16859,GOBP_NERVOUS_SYSTEM_PROCESS,0.918937529119428
GOCC_ALPHA_DNA_POLYMERASE_PR...,SET,4,0.34426,0.0050781,0.35868,0.16859,GOCC_ALPHA_DNA_POLYMERASE_PRIMASE_COMPLEX,0.918937529119428
WALLACE_JAK2_TARGETS_UP,SET,19,0.16011,0.0051452,0.16682,0.1686,WALLACE_JAK2_TARGETS_UP,0.918937529119428
MIR3202,SET,229,0.051513,0.0057141,0.053673,0.1686,MIR3202,0.918937529119428
GOBP_POSITIVE_REGULATION_OF_...676,SET,350,0.043276,0.0059149,0.045101,0.16865,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,0.918937529119428
HP_ABNORMAL_CIRCULATING_LEUC...,SET,4,0.39495,0.005826,0.41165,0.16867,HP_ABNORMAL_CIRCULATING_LEUCINE_CONCENTRATION,0.918937529119428
chr11q23,SET,107,0.15418,0.01173,0.16072,0.1687,chr11q23,0.918937529119428
REACTOME_PEXOPHAGY,SET,9,0.29146,0.0064481,0.30385,0.16873,REACTOME_PEXOPHAGY,0.918937529119428
GOCC_NUCLEOSOME,SET,37,0.12782,0.0057291,0.13326,0.16875,GOCC_NUCLEOSOME,0.918937529119428
HP_OLIGOSACCHARIDURIA,SET,9,0.25271,0.0055909,0.26351,0.16878,HP_OLIGOSACCHARIDURIA,0.918937529119428
GOBP_REGULATION_OF_PEPTIDE_T...,SET,187,0.06177,0.0061989,0.064412,0.16879,GOBP_REGULATION_OF_PEPTIDE_TRANSPORT,0.918937529119428
HALLMARK_E2F_TARGETS,SET,188,0.055081,0.0055422,0.057439,0.1688,HALLMARK_E2F_TARGETS,0.918937529119428
HP_ABNORMAL_PERICARDIUM_MORP...,SET,71,0.099328,0.0061617,0.10358,0.16881,HP_ABNORMAL_PERICARDIUM_MORPHOLOGY,0.918937529119428
GOBP_MONOATOMIC_ION_TRANSPORT,SET,1105,0.026221,0.0062331,0.027346,0.16882,GOBP_MONOATOMIC_ION_TRANSPORT,0.918937529119428
MIR4703_5P,SET,225,0.056339,0.0061954,0.05876,0.16883,MIR4703_5P,0.918937529119428
GOBP_MESENCHYMAL_CELL_DIFFER...1,SET,237,0.055162,0.0062236,0.057531,0.16883,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION,0.918937529119428
FIGUEROA_AML_METHYLATION_CLU...9,SET,42,0.1442,0.0068855,0.1504,0.16885,FIGUEROA_AML_METHYLATION_CLUSTER_5_DN,0.918937529119428
GOBP_ORGANELLE_DISASSEMBLY,SET,153,0.061805,0.0056156,0.064464,0.16885,GOBP_ORGANELLE_DISASSEMBLY,0.918937529119428
GOBP_MITOCHONDRIAL_RIBOSOME_...,SET,11,0.23227,0.0056805,0.24227,0.16886,GOBP_MITOCHONDRIAL_RIBOSOME_ASSEMBLY,0.918937529119428
WILCOX_RESPONSE_TO_PROGESTER...2,SET,136,0.068584,0.0058778,0.07156,0.16893,WILCOX_RESPONSE_TO_PROGESTERONE_UP,0.918937529119428
FERRARI_RESPONSE_TO_FENRETIN...2,SET,20,0.21117,0.0069624,0.22037,0.16897,FERRARI_RESPONSE_TO_FENRETINIDE_UP,0.918937529119428
MIR4673,SET,129,0.070926,0.0059212,0.074049,0.16908,MIR4673,0.918937529119428
HP_ABDOMINAL_SITUS_INVERSUS,SET,12,0.23027,0.0058819,0.2404,0.16908,HP_ABDOMINAL_SITUS_INVERSUS,0.918937529119428
BIOCARTA_CYTOKINE_PATHWAY,SET,19,0.2007,0.0064498,0.20957,0.16912,BIOCARTA_CYTOKINE_PATHWAY,0.918937529119428
HP_RIGHT_BUNDLE_BRANCH_BLOCK,SET,50,0.11143,0.0058044,0.11636,0.16912,HP_RIGHT_BUNDLE_BRANCH_BLOCK,0.918937529119428
HP_ABNORMAL_THROMBOSIS,SET,185,0.062534,0.0062423,0.065305,0.16914,HP_ABNORMAL_THROMBOSIS,0.918937529119428
HOX13_01,SET,42,0.13006,0.0062104,0.13584,0.16916,HOX13_01,0.918937529119428
GSE7852_TREG_VS_TCONV_LN_DN,SET,182,0.062961,0.0062342,0.065754,0.16916,GSE7852_TREG_VS_TCONV_LN_DN,0.918937529119428
GOMF_RDNA_BINDING,SET,8,0.25637,0.0053476,0.26777,0.16918,GOMF_RDNA_BINDING,0.918937529119428
BLANCO_MELO_COVID19_BRONCHIA...1,SET,49,0.12469,0.0064298,0.13025,0.16921,BLANCO_MELO_COVID19_BRONCHIAL_EPITHELIAL_CELLS_SARS_COV_2_INFECTION_DN,0.918937529119428
REACTOME_EICOSANOIDS,SET,12,0.2767,0.007068,0.28906,0.16923,REACTOME_EICOSANOIDS,0.918937529119428
WP_NICOTINE_EFFECT_ON_DOPAMI...,SET,21,0.17415,0.0058833,0.18193,0.16923,WP_NICOTINE_EFFECT_ON_DOPAMINERGIC_NEURONS,0.918937529119428
GRAHAM_NORMAL_QUIESCENT_VS_N...2,SET,54,0.11794,0.0063834,0.12323,0.16927,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP,0.918937529119428
GOBP_B_CELL_APOPTOTIC_PROCESS,SET,24,0.17271,0.0062372,0.18046,0.16927,GOBP_B_CELL_APOPTOTIC_PROCESS,0.918937529119428
GOMF_HISTONE_CHAPERONE_ACTIV...,SET,12,0.21631,0.0055253,0.2261,0.16937,GOMF_HISTONE_CHAPERONE_ACTIVITY,0.918937529119428
GOMF_L_ASCORBIC_ACID_BINDING,SET,20,0.17628,0.0058119,0.18427,0.16938,GOMF_L_ASCORBIC_ACID_BINDING,0.918937529119428
HP_DISTURBED_PERCEPTION_WITH...,SET,35,0.12753,0.0055601,0.13332,0.16939,HP_DISTURBED_PERCEPTION_WITH_A_STIMULUS,0.918937529119428
BURTON_ADIPOGENESIS_9,SET,73,0.09816,0.006174,0.10262,0.1694,BURTON_ADIPOGENESIS_9,0.918937529119428
GSE24210_IL35_TREATED_VS_UNT...2,SET,174,0.060387,0.0058478,0.063128,0.1694,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_UP,0.918937529119428
GOBP_INOSINE_METABOLIC_PROCE...,SET,4,0.46853,0.0069112,0.48983,0.16941,GOBP_INOSINE_METABOLIC_PROCESS,0.918937529119428
TGACCTY_ERR1_Q2,SET,936,0.027125,0.0059634,0.028373,0.16954,TGACCTY_ERR1_Q2,0.918937529119428
HP_OVERFOLDING_OF_THE_SUPERI...,SET,4,0.40807,0.0060194,0.42689,0.16956,HP_OVERFOLDING_OF_THE_SUPERIOR_HELICES,0.918937529119428
MORF_ESPL1,SET,54,0.098318,0.0053214,0.10286,0.16958,MORF_ESPL1,0.918937529119428
GOBP_POSITIVE_REGULATION_OF_...78,SET,77,0.095198,0.0061489,0.099596,0.16958,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT,0.918937529119428
GOBP_SERTOLI_CELL_DIFFERENTI...,SET,17,0.18885,0.0057408,0.1976,0.16962,GOBP_SERTOLI_CELL_DIFFERENTIATION,0.918937529119428
ADDYA_ERYTHROID_DIFFERENTIAT...,SET,69,0.10758,0.0065794,0.11258,0.16964,ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN,0.918937529119428
REACTOME_EUKARYOTIC_TRANSLAT...1,SET,85,0.083854,0.0056894,0.087747,0.16964,REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION,0.918937529119428
HP_UPPER_LIMB_MUSCLE_WEAKNESS,SET,131,0.070828,0.0059583,0.074131,0.16968,HP_UPPER_LIMB_MUSCLE_WEAKNESS,0.918937529119428
AGARWAL_AKT_PATHWAY_TARGETS,SET,10,0.29689,0.0069233,0.31081,0.16974,AGARWAL_AKT_PATHWAY_TARGETS,0.918937529119428
HP_LIMITED_ELBOW_FLEXION,SET,10,0.28289,0.0065969,0.29616,0.16975,HP_LIMITED_ELBOW_FLEXION,0.918937529119428
GOCC_LAMELLIPODIUM,SET,187,0.058302,0.0058509,0.061041,0.16976,GOCC_LAMELLIPODIUM,0.918937529119428
GSE33513_TCF7_KO_VS_HET_EARL...1,SET,181,0.058147,0.005742,0.060879,0.16976,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_DN,0.918937529119428
AAAGACA_MIR511,SET,185,0.060123,0.0060017,0.06295,0.16977,AAAGACA_MIR511,0.918937529119428
GSE25146_UNSTIM_VS_HELIOBACT...1,SET,149,0.064158,0.0057533,0.067178,0.16979,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN,0.918937529119428
HP_PROGRESSIVE_SPASTIC_PARAP...2,SET,26,0.15044,0.0056542,0.15753,0.16981,HP_PROGRESSIVE_SPASTIC_PARAPLEGIA,0.918937529119428
GOBP_POSITIVE_REGULATION_OF_...477,SET,13,0.20788,0.0055269,0.21771,0.16983,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CYTOKINESIS,0.918937529119428
OUYANG_PROSTATE_CANCER_PROGR...2,SET,18,0.19302,0.0060376,0.20216,0.16985,OUYANG_PROSTATE_CANCER_PROGRESSION_UP,0.918937529119428
GOBP_NEURON_PROJECTION_MAINT...,SET,10,0.22892,0.0053382,0.23976,0.16985,GOBP_NEURON_PROJECTION_MAINTENANCE,0.918937529119428
GOBP_HYALURONAN_CATABOLIC_PR...,SET,15,0.2031,0.0058,0.21274,0.16987,GOBP_HYALURONAN_CATABOLIC_PROCESS,0.918937529119428
HP_NEUROMA,SET,6,0.28478,0.0051447,0.29841,0.16996,HP_NEUROMA,0.918937529119428
HP_INTRAVENTRICULAR_HEMORRHA...,SET,7,0.3298,0.0064351,0.34562,0.16999,HP_INTRAVENTRICULAR_HEMORRHAGE,0.918937529119428
HP_4_5_TOE_SYNDACTYLY,SET,8,0.31328,0.0065347,0.32832,0.17,HP_4_5_TOE_SYNDACTYLY,0.918937529119428
MIR660_5P,SET,68,0.099776,0.0060578,0.10457,0.17001,MIR660_5P,0.918937529119428
GAUTAM_EYE_CORNEA_ELF3_HIGH_...,SET,134,0.07023,0.0059749,0.073608,0.17002,GAUTAM_EYE_CORNEA_ELF3_HIGH_EPITHELIAL_CELLS,0.918937529119428
KEGG_MEDICUS_REFERENCE_TRANS...3,SET,72,0.091414,0.0057104,0.095815,0.17003,KEGG_MEDICUS_REFERENCE_TRANSLATION_INITIATION,0.918937529119428
GOBP_CD4_POSITIVE_ALPHA_BETA...3,SET,90,0.091709,0.0064018,0.096129,0.17004,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.918937529119428
CREB_Q3,SET,238,0.052226,0.0059046,0.054749,0.17007,CREB_Q3,0.918937529119428
REACTOME_EXTRINSIC_PATHWAY_O...,SET,4,0.47455,0.007,0.49755,0.17011,REACTOME_EXTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,0.918937529119428
REACTOME_ACTIVATION_OF_BAD_A...,SET,15,0.20672,0.0059034,0.21676,0.17012,REACTOME_ACTIVATION_OF_BAD_AND_TRANSLOCATION_TO_MITOCHONDRIA,0.918937529119428
GSE27786_LSK_VS_CD8_TCELL_UP,SET,168,0.060934,0.0057991,0.063891,0.17012,GSE27786_LSK_VS_CD8_TCELL_UP,0.918937529119428
SCIAN_CELL_CYCLE_TARGETS_OF_...2,SET,8,0.2686,0.0056028,0.28166,0.17013,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_UP,0.918937529119428
GOBP_MORPHOGENESIS_OF_AN_EPI...2,SET,22,0.18753,0.0064842,0.19664,0.17013,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_FOLD,0.918937529119428
GOBP_POSITIVE_REGULATION_OF_...3,SET,57,0.10767,0.0059868,0.11293,0.17019,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,0.918937529119428
HU_GENOTOXIC_DAMAGE_4HR,SET,34,0.13248,0.0056927,0.13896,0.17022,HU_GENOTOXIC_DAMAGE_4HR,0.918937529119428
HP_ABNORMAL_RESPONSE_TO_INSU...,SET,8,0.29457,0.0061444,0.30899,0.17022,HP_ABNORMAL_RESPONSE_TO_INSULIN_TOLERANCE_TEST,0.918937529119428
MTOR_UP.N4.V1_DN,SET,155,0.06295,0.0057565,0.066033,0.17022,MTOR_UP.N4.V1_DN,0.918937529119428
MODULE_68,SET,26,0.1731,0.0065062,0.18159,0.17024,MODULE_68,0.918937529119428
HP_EPILEPTIC_AURA,SET,20,0.18218,0.0060064,0.19111,0.17024,HP_EPILEPTIC_AURA,0.918937529119428
MALONEY_RESPONSE_TO_17AAG_DN,SET,66,0.091865,0.0054951,0.096373,0.17025,MALONEY_RESPONSE_TO_17AAG_DN,0.918937529119428
MIR6764_3P,SET,98,0.078673,0.0057295,0.082553,0.1703,MIR6764_3P,0.919047955390335
GOCC_ENDODEOXYRIBONUCLEASE_C...,SET,5,0.34811,0.0057409,0.36537,0.17036,GOCC_ENDODEOXYRIBONUCLEASE_COMPLEX,0.919047955390335
GOMF_LIM_DOMAIN_BINDING,SET,5,0.37876,0.0062465,0.39758,0.17038,GOMF_LIM_DOMAIN_BINDING,0.919047955390335
MIR874_3P,SET,49,0.10801,0.0055695,0.1134,0.17043,MIR874_3P,0.919047955390335
GOBP_REGULATION_OF_RECEPTOR_...8,SET,101,0.083797,0.0061949,0.087975,0.17043,GOBP_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.919047955390335
HP_NEOPLASM_OF_THE_RECTUM,SET,46,0.11191,0.0055918,0.1175,0.17045,HP_NEOPLASM_OF_THE_RECTUM,0.919047955390335
GOCC_PLATELET_ALPHA_GRANULE_...1,SET,59,0.10821,0.0061213,0.11362,0.17046,GOCC_PLATELET_ALPHA_GRANULE_LUMEN,0.919047955390335
HP_PROLONGED_QTC_INTERVAL,SET,28,0.16185,0.0063126,0.16999,0.17053,HP_PROLONGED_QTC_INTERVAL,0.919047955390335
KEGG_MEDICUS_REFERENCE_THYRO...,SET,8,0.27206,0.0056749,0.28578,0.17055,KEGG_MEDICUS_REFERENCE_THYROID_HORMONE_SIGNALING_PATHWAY,0.919047955390335
MIR6894_5P,SET,38,0.12396,0.0056306,0.13022,0.17058,MIR6894_5P,0.919047955390335
GOMF_GROWTH_FACTOR_ACTIVITY,SET,145,0.070186,0.0062094,0.073735,0.17059,GOMF_GROWTH_FACTOR_ACTIVITY,0.919047955390335
GSE22140_GERMFREE_VS_SPF_MOU...2,SET,185,0.060128,0.0060022,0.063171,0.1706,GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_UP,0.919047955390335
GOMF_NADPLUS_BINDING,SET,18,0.18628,0.0058267,0.19576,0.17067,GOMF_NADPLUS_BINDING,0.919047955390335
GOBP_REGULATION_OF_SYNAPTIC_...13,SET,22,0.1622,0.0056085,0.17048,0.17069,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,0.919047955390335
GOCC_H4_H2A_HISTONE_ACETYLTR...,SET,26,0.15303,0.0057516,0.16085,0.17071,GOCC_H4_H2A_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.919047955390335
MIR5687,SET,16,0.2033,0.0059959,0.2137,0.17072,MIR5687,0.919047955390335
DESCARTES_MAIN_FETAL_INTESTI...,SET,71,0.096702,0.0059988,0.10165,0.17072,DESCARTES_MAIN_FETAL_INTESTINAL_EPITHELIAL_CELLS,0.919047955390335
WP_15Q25_COPY_NUMBER_VARIATI...,SET,42,0.13628,0.006507,0.14327,0.17076,WP_15Q25_COPY_NUMBER_VARIATION,0.919051555968416
GSE2706_UNSTIM_VS_2H_LPS_AND...1,SET,170,0.065973,0.0063156,0.069366,0.17079,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_DN,0.919051555968416
GOCC_AUTOPHAGOSOME_MEMBRANE,SET,49,0.108,0.0055693,0.11357,0.1708,GOCC_AUTOPHAGOSOME_MEMBRANE,0.919051555968416
YAO_TEMPORAL_RESPONSE_TO_PRO...17,SET,46,0.11839,0.0059155,0.1245,0.17083,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_8,0.919055153203343
GOBP_CORONARY_ARTERY_MORPHOG...,SET,8,0.31366,0.0065425,0.32989,0.17086,GOBP_CORONARY_ARTERY_MORPHOGENESIS,0.919055153203343
GOCC_ORGANELLE_INNER_MEMBRANE,SET,466,0.035456,0.0055737,0.037294,0.17088,GOCC_ORGANELLE_INNER_MEMBRANE,0.919055153203343
GOBP_LEUKOCYTE_MIGRATION_INV...,SET,19,0.18905,0.0060752,0.19889,0.17094,GOBP_LEUKOCYTE_MIGRATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.919195945945946
GOBP_ICOSANOID_BIOSYNTHETIC_...,SET,50,0.11172,0.0058194,0.11756,0.17097,GOBP_ICOSANOID_BIOSYNTHETIC_PROCESS,0.919195945945946
MIR138_1_3P,SET,79,0.088051,0.0057604,0.09267,0.17102,MIR138_1_3P,0.919195945945946
GSE3565_CTRL_VS_LPS_INJECTED...3,SET,155,0.064687,0.0059154,0.068095,0.17107,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_DN,0.919195945945946
GOMF_PROTEIN_CONTAINING_COMP...1,SET,1562,0.021137,0.0058944,0.022257,0.17114,GOMF_PROTEIN_CONTAINING_COMPLEX_BINDING,0.919195945945946
GOBP_RECEPTOR_DIFFUSION_TRAP...,SET,10,0.27214,0.0063461,0.28656,0.17115,GOBP_RECEPTOR_DIFFUSION_TRAPPING,0.919195945945946
GSE45739_NRAS_KO_VS_WT_UNSTI...1,SET,169,0.062109,0.0059283,0.065407,0.17117,GSE45739_NRAS_KO_VS_WT_UNSTIM_CD4_TCELL_DN,0.919195945945946
MORF_BUB1B,SET,56,0.10312,0.0056832,0.1086,0.17119,MORF_BUB1B,0.919195945945946
GOBP_DNA_TEMPLATED_DNA_REPLI...1,SET,154,0.061617,0.0056166,0.064898,0.1712,GOBP_DNA_TEMPLATED_DNA_REPLICATION,0.919195945945946
GOBP_NEUROFILAMENT_CYTOSKELE...,SET,10,0.24288,0.0056639,0.25581,0.1712,GOBP_NEUROFILAMENT_CYTOSKELETON_ORGANIZATION,0.919195945945946
GOMF_NUCLEOSIDE_KINASE_ACTIV...,SET,9,0.24236,0.0053619,0.2553,0.17123,GOMF_NUCLEOSIDE_KINASE_ACTIVITY,0.919195945945946
GSE17721_PAM3CSK4_VS_GADIQUI...4,SET,176,0.05415,0.0052735,0.05704,0.17123,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_UP,0.919195945945946
HP_OVARIAN_CARCINOMA,SET,14,0.2195,0.0060559,0.23124,0.17125,HP_OVARIAN_CARCINOMA,0.919195945945946
KYNG_RESPONSE_TO_H2O2_VIA_ER...2,SET,39,0.12548,0.0057742,0.13224,0.17134,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_DN,0.919537013588635
HELLER_HDAC_TARGETS_DN,SET,266,0.050677,0.0060524,0.053424,0.17142,HELLER_HDAC_TARGETS_DN,0.919614952410193
GSE2770_IL12_VS_TGFB_AND_IL1...4,SET,180,0.061539,0.0060603,0.064884,0.17146,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,0.919614952410193
HP_PHIMOSIS,SET,9,0.25453,0.005631,0.2684,0.17149,HP_PHIMOSIS,0.919614952410193
KEGG_MEDICUS_REFERENCE_TGFA_...3,SET,14,0.21253,0.0058636,0.22414,0.17151,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.919614952410193
BIOCARTA_NTHI_PATHWAY,SET,23,0.1806,0.0063849,0.19049,0.17155,BIOCARTA_NTHI_PATHWAY,0.919614952410193
GOCC_DOPAMINERGIC_SYNAPSE,SET,13,0.21749,0.0057822,0.2294,0.17155,GOCC_DOPAMINERGIC_SYNAPSE,0.919614952410193
GOBP_REGULATION_OF_GONAD_DEV...,SET,12,0.25177,0.0064312,0.26558,0.17157,GOBP_REGULATION_OF_GONAD_DEVELOPMENT,0.919614952410193
GOBP_RESPONSE_TO_SORBITOL,SET,6,0.35304,0.0063777,0.37248,0.17162,GOBP_RESPONSE_TO_SORBITOL,0.919614952410193
GSE33162_UNTREATED_VS_4H_LPS...2,SET,183,0.058997,0.0058577,0.06225,0.17163,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_UP,0.919614952410193
GOMF_METALLOENDOPEPTIDASE_IN...,SET,13,0.21866,0.0058134,0.23074,0.17166,GOMF_METALLOENDOPEPTIDASE_INHIBITOR_ACTIVITY,0.919614952410193
GOBP_CELLULAR_RESPONSE_TO_LA...,SET,7,0.29682,0.0057916,0.31325,0.17168,GOBP_CELLULAR_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.919614952410193
CAO_BLOOD_FLUMIST_AGE_05_14Y...3,SET,7,0.33983,0.0066308,0.35868,0.17171,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_DN,0.919614952410193
KEGG_MEDICUS_PATHOGEN_EBV_EB...5,SET,11,0.2612,0.0063882,0.27581,0.17182,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00264,0.919614952410193
HP_ABNORMALITY_OF_THE_HEPATI...,SET,84,0.087852,0.0059256,0.092768,0.17183,HP_ABNORMALITY_OF_THE_HEPATIC_VASCULATURE,0.919614952410193
HP_TALL_STATURE,SET,147,0.063948,0.0056962,0.067538,0.17186,HP_TALL_STATURE,0.919614952410193
KEGG_MEDICUS_VARIANT_AMPLIFI...2,SET,6,0.39508,0.0071373,0.41737,0.17193,KEGG_MEDICUS_VARIANT_AMPLIFIED_CCNE_TO_CELL_CYCLE_G1_S,0.919614952410193
MORF_ZNF10,SET,46,0.12285,0.0061384,0.1298,0.17197,MORF_ZNF10,0.919614952410193
JI_RESPONSE_TO_FSH_UP,SET,57,0.10206,0.0056747,0.10784,0.17198,JI_RESPONSE_TO_FSH_UP,0.919614952410193
GOBP_NEGATIVE_REGULATION_OF_...683,SET,16,0.21302,0.0062826,0.22511,0.172,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_CELL_DIFFERENTIATION,0.919614952410193
HP_UNDERFOLDED_HELIX,SET,4,0.4626,0.0068239,0.48885,0.172,HP_UNDERFOLDED_HELIX,0.919614952410193
INAMURA_LUNG_CANCER_SCC_UP,SET,11,0.24631,0.006024,0.26036,0.17207,INAMURA_LUNG_CANCER_SCC_UP,0.919614952410193
DESCARTES_MAIN_FETAL_UNIPOLA...,SET,22,0.18533,0.0064082,0.1959,0.17207,DESCARTES_MAIN_FETAL_UNIPOLAR_BRUSH_CELLS,0.919614952410193
MIR4782_3P,SET,140,0.065874,0.0057274,0.069646,0.17212,MIR4782_3P,0.919614952410193
GOBP_PROPRIOCEPTION,SET,4,0.43903,0.0064761,0.46418,0.17213,GOBP_PROPRIOCEPTION,0.919614952410193
GOBP_POSITIVE_REGULATION_OF_...769,SET,1153,0.024475,0.0059349,0.025882,0.17217,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.919614952410193
GSE22611_UNSTIM_VS_2H_MDP_ST...2,SET,177,0.057802,0.005645,0.061124,0.17217,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.919614952410193
HP_ANGULATED_MUSCLE_FIBERS,SET,5,0.35526,0.0058589,0.37573,0.1722,HP_ANGULATED_MUSCLE_FIBERS,0.919614952410193
MYLLYKANGAS_AMPLIFICATION_HO...12,SET,10,0.26346,0.0061439,0.27867,0.17222,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_27,0.919614952410193
IRX3_TARGET_GENES,SET,45,0.12,0.0059306,0.12693,0.17223,IRX3_TARGET_GENES,0.919614952410193
MIR328_3P,SET,39,0.12844,0.0059103,0.13587,0.17226,MIR328_3P,0.919614952410193
KEGG_DRUG_METABOLISM_OTHER_E...,SET,48,0.13684,0.006984,0.14476,0.17227,KEGG_DRUG_METABOLISM_OTHER_ENZYMES,0.919614952410193
MIR133A_3P_MIR133B,SET,222,0.052023,0.0056829,0.055037,0.17228,MIR133A_3P_MIR133B,0.919614952410193
HP_LARGE_HANDS,SET,29,0.13519,0.0053659,0.14302,0.17228,HP_LARGE_HANDS,0.919614952410193
HP_ABNORMALITY_OF_THE_TONSILS,SET,29,0.15545,0.0061699,0.16447,0.1723,HP_ABNORMALITY_OF_THE_TONSILS,0.919614952410193
HP_ERYTHEMATOUS_PAPULE,SET,10,0.19968,0.0046564,0.21128,0.17231,HP_ERYTHEMATOUS_PAPULE,0.919614952410193
GOBP_ADENOSINE_TRANSPORT,SET,5,0.38996,0.0064311,0.41266,0.17234,GOBP_ADENOSINE_TRANSPORT,0.919614952410193
BIOCARTA_HBX_PATHWAY,SET,7,0.28138,0.0054903,0.29777,0.17235,BIOCARTA_HBX_PATHWAY,0.919614952410193
GSE13485_CTRL_VS_DAY3_YF17D_...1,SET,179,0.059316,0.0058252,0.062773,0.17236,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_DN,0.919614952410193
GOBP_REGULATION_OF_PROTEIN_U...,SET,165,0.061664,0.0058164,0.065278,0.17243,GOBP_REGULATION_OF_PROTEIN_UBIQUITINATION,0.919831578947368
GOBP_B_CELL_RECEPTOR_SIGNALI...,SET,58,0.11065,0.006206,0.11715,0.17246,GOBP_B_CELL_RECEPTOR_SIGNALING_PATHWAY,0.919831578947368
ZHAN_MULTIPLE_MYELOMA_SPIKED,SET,20,0.19179,0.0063234,0.20307,0.17248,ZHAN_MULTIPLE_MYELOMA_SPIKED,0.919831578947368
HP_SEX_REVERSAL,SET,11,0.26508,0.0064831,0.28077,0.17256,HP_SEX_REVERSAL,0.920117029763731
GSE25123_CTRL_VS_IL4_AND_ROS...2,SET,186,0.057462,0.0057513,0.060881,0.17263,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.920349079613438
GOCC_EUKARYOTIC_TRANSLATION_...4,SET,7,0.28724,0.0056046,0.30444,0.17272,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX_EIF3M,0.920358021877849
GSE9006_TYPE_1_DIABETES_AT_D...3,SET,172,0.058016,0.0055861,0.061512,0.1728,GSE9006_TYPE_1_DIABETES_AT_DX_VS_4MONTH_POST_DX_PBMC_DN,0.920358021877849
GOBP_NEGATIVE_REGULATION_OF_...489,SET,4,0.44952,0.0066308,0.47665,0.17283,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,0.920358021877849
TAKEDA_TARGETS_OF_NUP98_HOXA...10,SET,145,0.072802,0.0064409,0.077217,0.17289,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP,0.920358021877849
HP_ABNORMALITY_OF_URINARY_UR...,SET,11,0.22936,0.0056094,0.24332,0.17294,HP_ABNORMALITY_OF_URINARY_URIC_ACID_LEVEL,0.920358021877849
GOBP_REGULATION_OF_STRESS_AC...,SET,36,0.13139,0.0058091,0.13941,0.17299,GOBP_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.920358021877849
GSE5542_UNTREATED_VS_IFNA_AN...1,SET,179,0.057233,0.0056206,0.060729,0.17299,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,0.920358021877849
GOMF_MONOATOMIC_CATION_CHANN...,SET,302,0.049241,0.0062599,0.052252,0.17301,GOMF_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.920358021877849
GSE9650_EFFECTOR_VS_MEMORY_C...2,SET,183,0.056702,0.0056297,0.060169,0.17301,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_UP,0.920358021877849
GOBP_PROTEIN_LIPOYLATION,SET,5,0.33317,0.0054945,0.35364,0.17308,GOBP_PROTEIN_LIPOYLATION,0.920358021877849
CONCANNON_APOPTOSIS_BY_EPOXO...1,SET,146,0.068569,0.0060871,0.072788,0.17309,CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN,0.920358021877849
MIR488_3P,SET,168,0.05951,0.0056636,0.063174,0.1731,MIR488_3P,0.920358021877849
KANG_DOXORUBICIN_RESISTANCE_...1,SET,16,0.20804,0.0061356,0.22093,0.17319,KANG_DOXORUBICIN_RESISTANCE_DN,0.920358021877849
PROVENZANI_METASTASIS_DN,SET,135,0.069272,0.0059151,0.073582,0.17325,PROVENZANI_METASTASIS_DN,0.920358021877849
KEGG_MEDICUS_VARIANT_MUTATIO...41,SET,13,0.20455,0.0054383,0.21729,0.17326,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_CREB_MEDIATED_TRANSCRIPTION,0.920358021877849
GOMF_THYROID_HORMONE_TRANSME...,SET,7,0.31065,0.0060614,0.33003,0.17329,GOMF_THYROID_HORMONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.920358021877849
REACTOME_Z_DECAY_DEGRADATION...,SET,10,0.24299,0.0056664,0.25816,0.1733,REACTOME_Z_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_ZYGOTICALLY_EXPRESSED_FACTORS,0.920358021877849
GOBP_REGULATION_OF_MITOTIC_C...4,SET,16,0.18467,0.0054464,0.19621,0.17331,GOBP_REGULATION_OF_MITOTIC_CYTOKINESIS,0.920358021877849
GOBP_POSITIVE_REGULATION_OF_...79,SET,28,0.15834,0.0061755,0.16825,0.17334,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.920358021877849
CUI_DEVELOPING_HEART_TRABECU...2,SET,99,0.081029,0.005931,0.086103,0.17334,CUI_DEVELOPING_HEART_TRABECULAR_VENTRICULAR_CARDIOMYOCYTE,0.920358021877849
GAVISH_3CA_METAPROGRAM_CD8_T...8,SET,44,0.1311,0.006407,0.13933,0.17337,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_MEMORY_NAIVE_1,0.920358021877849
HILLION_HMGA1_TARGETS,SET,75,0.093508,0.0059612,0.099392,0.17341,HILLION_HMGA1_TARGETS,0.920358021877849
KEGG_MEDICUS_REFERENCE_CITRA...2,SET,10,0.22481,0.0052426,0.23897,0.17342,KEGG_MEDICUS_REFERENCE_CITRATE_CYCLE_SECOND_CARBON_OXIDATION_2,0.920358021877849
GOCC_TETRASPANIN_ENRICHED_MI...,SET,10,0.26174,0.0061036,0.27826,0.17345,GOCC_TETRASPANIN_ENRICHED_MICRODOMAIN,0.920358021877849
MIR6886_5P,SET,8,0.30102,0.006279,0.3201,0.17351,MIR6886_5P,0.920358021877849
HP_ALVEOLAR_RIDGE_OVERGROWTH,SET,11,0.22915,0.0056044,0.24367,0.17351,HP_ALVEOLAR_RIDGE_OVERGROWTH,0.920358021877849
HP_ATRIAL_STANDSTILL,SET,6,0.35672,0.0064443,0.37933,0.17351,HP_ATRIAL_STANDSTILL,0.920358021877849
MIR1825,SET,149,0.065098,0.0058375,0.069227,0.17352,MIR1825,0.920358021877849
GOBP_SYNAPTIC_VESICLE_PRIMING,SET,19,0.16245,0.0052203,0.17275,0.17352,GOBP_SYNAPTIC_VESICLE_PRIMING,0.920358021877849
HP_ABNORMAL_ST_SEGMENT,SET,38,0.13418,0.0060948,0.14269,0.17353,HP_ABNORMAL_ST_SEGMENT,0.920358021877849
GOMF_STAT_FAMILY_PROTEIN_BIN...,SET,10,0.24822,0.0057885,0.26398,0.17354,GOMF_STAT_FAMILY_PROTEIN_BINDING,0.920358021877849
HP_ABNORMALITY_OF_THE_PULMON...1,SET,119,0.074219,0.0059528,0.07894,0.17356,HP_ABNORMALITY_OF_THE_PULMONARY_ARTERY,0.920358021877849
GOBP_INTERFERON_ALPHA_PRODUC...,SET,26,0.14435,0.0054255,0.15354,0.17357,GOBP_INTERFERON_ALPHA_PRODUCTION,0.920358021877849
WP_IRON_METABOLISM_IN_PLACEN...,SET,12,0.24597,0.006283,0.26167,0.17362,WP_IRON_METABOLISM_IN_PLACENTA,0.920358021877849
GOCC_RIBOSOME,SET,210,0.05068,0.0053862,0.053916,0.17362,GOCC_RIBOSOME,0.920358021877849
MIR1913,SET,139,0.063989,0.0055438,0.068088,0.17367,MIR1913,0.920358021877849
GOMF_RAGE_RECEPTOR_BINDING,SET,10,0.27224,0.0063486,0.28972,0.1737,GOMF_RAGE_RECEPTOR_BINDING,0.920358021877849
GOMF_FLOPPASE_ACTIVITY,SET,15,0.21208,0.0060564,0.22574,0.17374,GOMF_FLOPPASE_ACTIVITY,0.920358021877849
GOMF_PROCOLLAGEN_PROLINE_DIO...,SET,8,0.23108,0.00482,0.24598,0.17376,GOMF_PROCOLLAGEN_PROLINE_DIOXYGENASE_ACTIVITY,0.920358021877849
GSE17721_PAM3CSK4_VS_CPG_0.5...1,SET,181,0.056074,0.0055372,0.059696,0.17379,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_DN,0.920358021877849
GOBP_SULFUR_COMPOUND_METABOL...,SET,291,0.048559,0.0060617,0.0517,0.1738,GOBP_SULFUR_COMPOUND_METABOLIC_PROCESS,0.920358021877849
MIR12129,SET,131,0.071559,0.0060199,0.076203,0.17385,MIR12129,0.920358021877849
GOMF_HYDROLASE_ACTIVITY_ACTI...1,SET,716,0.029829,0.0057717,0.031766,0.17386,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES,0.920358021877849
HP_HYPERALDOSTERONISM,SET,30,0.16037,0.0064738,0.17084,0.17396,HP_HYPERALDOSTERONISM,0.920358021877849
HP_ABNORMALITY_OF_THE_UPPER_...4,SET,1281,0.022776,0.0057997,0.024268,0.174,HP_ABNORMALITY_OF_THE_UPPER_URINARY_TRACT,0.920358021877849
BARRIER_CANCER_RELAPSE_TUMOR...2,SET,15,0.19876,0.0056759,0.21179,0.17401,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_UP,0.920358021877849
HP_CORTICAL_SCLEROSIS,SET,5,0.36295,0.0059856,0.38676,0.17402,HP_CORTICAL_SCLEROSIS,0.920358021877849
GOBP_POSITIVE_REGULATION_OF_...614,SET,178,0.057769,0.0056576,0.061576,0.17408,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.920358021877849
GOBP_REGULATION_OF_MEMBRANE_...5,SET,58,0.10565,0.0059258,0.11262,0.1741,GOBP_REGULATION_OF_MEMBRANE_LIPID_DISTRIBUTION,0.920358021877849
GSE43955_1H_VS_60H_ACT_CD4_T...4,SET,186,0.055629,0.0055678,0.0593,0.17411,GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,0.920358021877849
BUSSLINGER_GASTRIC_PPP1R1B_P...,SET,114,0.073254,0.0057514,0.078093,0.17412,BUSSLINGER_GASTRIC_PPP1R1B_POSITIVE_CELLS,0.920358021877849
GOBP_EMBRYONIC_APPENDAGE_MOR...,SET,116,0.080195,0.006351,0.085497,0.17413,GOBP_EMBRYONIC_APPENDAGE_MORPHOGENESIS,0.920358021877849
KEGG_PROXIMAL_TUBULE_BICARBO...,SET,21,0.17887,0.0060429,0.19071,0.17414,KEGG_PROXIMAL_TUBULE_BICARBONATE_RECLAMATION,0.920358021877849
GOBP_REGULATION_OF_CELLULAR_...13,SET,70,0.092116,0.005674,0.098217,0.17416,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.920358021877849
GOMF_GAP_JUNCTION_CHANNEL_AC...1,SET,21,0.188,0.0063511,0.20045,0.17416,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY,0.920358021877849
HP_SPONDYLOLISTHESIS,SET,19,0.18242,0.0058623,0.19453,0.17419,HP_SPONDYLOLISTHESIS,0.920358021877849
GSE17721_CPG_VS_GARDIQUIMOD_...13,SET,177,0.058759,0.0057385,0.062663,0.1742,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_DN,0.920358021877849
GOBP_POSITIVE_REGULATION_OF_...399,SET,23,0.16933,0.0059863,0.18058,0.17421,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.920358021877849
HP_ABNORMAL_UMBILICAL_STUMP_...,SET,8,0.30776,0.0064194,0.32822,0.17421,HP_ABNORMAL_UMBILICAL_STUMP_BLEEDING,0.920358021877849
GOBP_REGULATION_OF_NATURAL_K...4,SET,8,0.29507,0.0061549,0.31475,0.17426,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.920358021877849
OUILLETTE_CLL_13Q14_DELETION...2,SET,70,0.086754,0.0053438,0.092544,0.17427,OUILLETTE_CLL_13Q14_DELETION_UP,0.920358021877849
HP_INTERVERTEBRAL_DISK_DEGEN...,SET,6,0.34208,0.0061798,0.36493,0.17429,HP_INTERVERTEBRAL_DISK_DEGENERATION,0.920358021877849
GSE34006_WT_VS_A2AR_KO_TREG_...1,SET,182,0.060538,0.0059944,0.064587,0.1743,GSE34006_WT_VS_A2AR_KO_TREG_DN,0.920358021877849
KEGG_MEDICUS_REFERENCE_E2_ER...,SET,22,0.16009,0.0055354,0.17081,0.17433,KEGG_MEDICUS_REFERENCE_E2_ER_RAS_ERK_SIGNALING_PATHWAY,0.92037659881513
KEGG_MEDICUS_REFERENCE_ANTER...,SET,23,0.16281,0.005756,0.17376,0.17439,KEGG_MEDICUS_REFERENCE_ANTEROGRADE_AXONAL_TRANSPORT,0.920466514806378
KEGG_MEDICUS_VARIANT_AMPLIFI...10,SET,6,0.32157,0.0058092,0.34321,0.1744,KEGG_MEDICUS_VARIANT_AMPLIFIED_MYCN_TO_TRANSCRIPTIONAL_ACTIVATION,0.920466514806378
GAZDA_DIAMOND_BLACKFAN_ANEMI...3,SET,31,0.14329,0.0058798,0.15296,0.17444,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_DN,0.920537837837838
PATEL_SKIN_OF_BODY_ZOSTAVAX_...4,SET,91,0.084252,0.0059137,0.089959,0.1745,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_DN,0.920664696509863
REACTOME_RESPIRATORY_SYNCYTI...2,SET,21,0.17818,0.0060194,0.19027,0.17453,REACTOME_RESPIRATORY_SYNCYTIAL_VIRUS_RSV_ATTACHMENT_AND_ENTRY,0.920664696509863
REACTOME_CREB1_PHOSPHORYLATI...2,SET,11,0.2491,0.0060922,0.26604,0.17456,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE,0.920664696509863
BIOCARTA_ERK5_PATHWAY,SET,14,0.20514,0.0056596,0.2191,0.17457,BIOCARTA_ERK5_PATHWAY,0.920664696509863
GOBP_ALLANTOIN_METABOLIC_PRO...,SET,9,0.29219,0.0064643,0.31218,0.17465,GOBP_ALLANTOIN_METABOLIC_PROCESS,0.920757179681577
KEGG_MEDICUS_PATHOGEN_HCMV_U...3,SET,33,0.13905,0.0058868,0.14857,0.17467,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNB_G_RHO_SIGNALING_PATHWAY,0.920757179681577
GOMF_ATP_DEPENDENT_PEPTIDASE...,SET,7,0.24926,0.0048635,0.26635,0.17469,GOMF_ATP_DEPENDENT_PEPTIDASE_ACTIVITY,0.920757179681577
KEGG_MEDICUS_VARIANT_MUTATIO...66,SET,12,0.22888,0.0058465,0.24459,0.1747,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY,0.920757179681577
GOBP_LEUKOCYTE_ADHESION_TO_A...,SET,5,0.39883,0.0065773,0.42623,0.17472,GOBP_LEUKOCYTE_ADHESION_TO_ARTERIAL_ENDOTHELIAL_CELL,0.920757179681577
REACTOME_NONSENSE_MEDIATED_D...,SET,103,0.074571,0.0055668,0.079708,0.17476,REACTOME_NONSENSE_MEDIATED_DECAY_NMD,0.920766145833333
GSE32533_WT_VS_MIR17_KO_ACT_...1,SET,179,0.057331,0.0056302,0.061295,0.17482,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_DN,0.920766145833333
HP_LARGE_SELLA_TURCICA,SET,14,0.21394,0.0059023,0.22874,0.17483,HP_LARGE_SELLA_TURCICA,0.920766145833333
ICHIBA_GRAFT_VERSUS_HOST_DIS...3,SET,41,0.13054,0.0061585,0.13962,0.17492,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_D7_DN,0.920766145833333
MIR6779_5P,SET,158,0.061065,0.0056375,0.065318,0.17493,MIR6779_5P,0.920766145833333
HP_ABNORMAL_GLOMERULAR_MESAN...,SET,45,0.11804,0.0058335,0.12629,0.17499,HP_ABNORMAL_GLOMERULAR_MESANGIUM_MORPHOLOGY,0.920766145833333
AIZARANI_LIVER_C23_KUPFFER_C...,SET,196,0.059072,0.0060676,0.063212,0.17503,AIZARANI_LIVER_C23_KUPFFER_CELLS_3,0.920766145833333
HP_ABNORMAL_NATURAL_KILLER_C...,SET,38,0.12369,0.0056187,0.13237,0.17504,HP_ABNORMAL_NATURAL_KILLER_CELL_MORPHOLOGY,0.920766145833333
SHAFFER_IRF4_MULTIPLE_MYELOM...,SET,33,0.14603,0.0061822,0.15628,0.17505,SHAFFER_IRF4_MULTIPLE_MYELOMA_PROGRAM,0.920766145833333
HP_AUTOIMMUNE_ANTIBODY_POSIT...,SET,148,0.067897,0.0060683,0.072661,0.17505,HP_AUTOIMMUNE_ANTIBODY_POSITIVITY,0.920766145833333
HP_LIPODYSTROPHY,SET,114,0.074503,0.0058494,0.079737,0.17507,HP_LIPODYSTROPHY,0.920766145833333
PRC1_BMI_UP.V1_DN,SET,155,0.062683,0.0057321,0.067102,0.17512,PRC1_BMI_UP.V1_DN,0.920766145833333
HP_CRANIAL_ASYMMETRY,SET,15,0.20314,0.005801,0.21749,0.17516,HP_CRANIAL_ASYMMETRY,0.920766145833333
GSE40274_GATA1_VS_FOXP3_AND_...1,SET,183,0.059273,0.005885,0.063468,0.17518,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.920766145833333
HP_ABNORMALITY_OF_GLOBE_LOCA...,SET,965,0.025461,0.0056789,0.027263,0.17519,HP_ABNORMALITY_OF_GLOBE_LOCATION,0.920766145833333
MIR6884_5P,SET,132,0.067182,0.0056731,0.071945,0.17521,MIR6884_5P,0.920766145833333
HP_EXPRESSIVE_LANGUAGE_DELAY,SET,50,0.10476,0.0054566,0.11219,0.17521,HP_EXPRESSIVE_LANGUAGE_DELAY,0.920766145833333
TONKS_TARGETS_OF_RUNX1_RUNX1...2,SET,143,0.07159,0.0062902,0.076668,0.17522,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP,0.920766145833333
GSE37301_MULTIPOTENT_PROGENI...2,SET,148,0.067875,0.0060663,0.072702,0.17526,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_UP,0.920766145833333
GOCC_MYOSIN_COMPLEX,SET,55,0.11315,0.0061807,0.12122,0.1753,GOCC_MYOSIN_COMPLEX,0.920766145833333
GOBP_REGULATION_OF_TRANSLATI...1,SET,334,0.042321,0.0056531,0.045351,0.17536,GOBP_REGULATION_OF_TRANSLATION,0.920766145833333
chr6p25,SET,31,0.23203,0.0095213,0.24868,0.1754,chr6p25,0.920766145833333
REN_ALVEOLAR_RHABDOMYOSARCOM...1,SET,369,0.041953,0.0058845,0.044965,0.17542,REN_ALVEOLAR_RHABDOMYOSARCOMA_DN,0.920766145833333
HP_ABSENT_PUBIC_HAIR,SET,8,0.29666,0.0061879,0.31797,0.17542,HP_ABSENT_PUBIC_HAIR,0.920766145833333
KEGG_MEDICUS_REFERENCE_REGUL...14,SET,8,0.2306,0.00481,0.24718,0.17544,KEGG_MEDICUS_REFERENCE_REGULATION_OF_SERCA,0.920766145833333
MIR6502_3P,SET,50,0.11078,0.0057702,0.11875,0.17545,MIR6502_3P,0.920766145833333
GSE12366_GC_VS_NAIVE_BCELL_DN,SET,171,0.061793,0.0059326,0.066248,0.17548,GSE12366_GC_VS_NAIVE_BCELL_DN,0.920766145833333
REACTOME_SIGNALING_BY_FGFR,SET,86,0.085118,0.0058088,0.091257,0.17549,REACTOME_SIGNALING_BY_FGFR,0.920766145833333
GOMF_ENONE_REDUCTASE_ACTIVITY,SET,5,0.3638,0.0059997,0.39004,0.17549,GOMF_ENONE_REDUCTASE_ACTIVITY,0.920766145833333
GOCC_PERINUCLEOLAR_COMPARTME...,SET,5,0.38452,0.0063414,0.41234,0.17554,GOCC_PERINUCLEOLAR_COMPARTMENT,0.920889464150943
GSE41978_ID2_KO_VS_ID2_KO_AN...1,SET,188,0.055548,0.0055892,0.059587,0.17562,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.920997012673506
KEGG_MEDICUS_VARIANT_MUTATIO...6,SET,15,0.20427,0.0058332,0.21913,0.17563,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_FGFR3_TO_RAS_ERK_SIGNALING_PATHWAY,0.920997012673506
GOBP_NEGATIVE_REGULATION_OF_...258,SET,17,0.20016,0.0060848,0.21473,0.17564,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,0.920997012673506
HP_HYPOPLASTIC_PUBIC_RAMUS,SET,6,0.33542,0.0060595,0.36003,0.17576,HP_HYPOPLASTIC_PUBIC_RAMUS,0.92148722280887
GOBP_RNA_LOCALIZATION,SET,180,0.053464,0.005265,0.057396,0.1758,GOBP_RNA_LOCALIZATION,0.921489626055489
GOBP_TRIPEPTIDE_TRANSMEMBRAN...,SET,10,0.256,0.0059699,0.27485,0.17583,GOBP_TRIPEPTIDE_TRANSMEMBRANE_TRANSPORT,0.921489626055489
GOBP_FOREBRAIN_NEUROBLAST_DI...,SET,6,0.35279,0.0063733,0.37879,0.17584,GOBP_FOREBRAIN_NEUROBLAST_DIVISION,0.921489626055489
TAKEDA_TARGETS_OF_NUP98_HOXA...6,SET,168,0.066133,0.0062939,0.071035,0.17593,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP,0.921735709978897
ZNF488_TARGET_GENES,SET,25,0.15492,0.0057098,0.16641,0.17594,ZNF488_TARGET_GENES,0.921735709978897
GSE24292_WT_VS_PPARG_KO_MACR...2,SET,185,0.058456,0.0058352,0.062807,0.17601,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP,0.921860929496836
GOCC_LYSOSOMAL_LUMEN,SET,89,0.08497,0.0058985,0.091309,0.17604,GOCC_LYSOSOMAL_LUMEN,0.921860929496836
HP_SIMPLE_FEBRILE_SEIZURE,SET,25,0.17027,0.0062754,0.18298,0.17606,HP_SIMPLE_FEBRILE_SEIZURE,0.921860929496836
GOMF_RETINAL_DEHYDROGENASE_A...,SET,9,0.31884,0.0070539,0.34267,0.17607,GOMF_RETINAL_DEHYDROGENASE_ACTIVITY,0.921860929496836
MIR563,SET,30,0.14758,0.0059574,0.15866,0.17615,MIR563,0.92203832429991
FU_INTERACT_WITH_ALKBH8,SET,13,0.17786,0.0047285,0.19124,0.17619,FU_INTERACT_WITH_ALKBH8,0.92203832429991
GSE15930_NAIVE_VS_72H_IN_VIT...5,SET,182,0.057393,0.0056829,0.061712,0.17619,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,0.92203832429991
GOBP_AORTIC_VALVE_MORPHOGENE...,SET,39,0.1429,0.0065755,0.15366,0.17621,GOBP_AORTIC_VALVE_MORPHOGENESIS,0.92203832429991
GSE24634_TEFF_VS_TCONV_DAY5_...1,SET,174,0.05838,0.0056534,0.062788,0.17624,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_DN,0.922056480505796
GOBP_AMYLOID_BETA_CLEARANCE_...1,SET,8,0.26472,0.0055218,0.28475,0.17627,GOBP_AMYLOID_BETA_CLEARANCE_BY_CELLULAR_CATABOLIC_PROCESS,0.922074631246237
WP_PDGFRBETA_PATHWAY,SET,28,0.15256,0.0059502,0.16412,0.1763,WP_PDGFRBETA_PATHWAY,0.922092776523702
ERWIN_COHEN_BLOOD_VACCINE_TC...3,SET,5,0.33615,0.0055436,0.36168,0.17635,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_DN,0.922129050699564
HP_OPTIC_DISC_DRUSEN,SET,12,0.23209,0.0059284,0.24973,0.17636,HP_OPTIC_DISC_DRUSEN,0.922129050699564
GSE22886_NEUTROPHIL_VS_DC_UP,SET,164,0.065138,0.0061256,0.070122,0.17647,GSE22886_NEUTROPHIL_VS_DC_UP,0.922380369480324
ZHAN_EARLY_DIFFERENTIATION_G...1,SET,41,0.13018,0.0061418,0.14017,0.17652,ZHAN_EARLY_DIFFERENTIATION_GENES_DN,0.922380369480324
DURANTE_ADULT_OLFACTORY_NEUR...15,SET,18,0.20554,0.0064293,0.22132,0.17652,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS,0.922380369480324
REACTOME_TRNA_PROCESSING,SET,96,0.072979,0.0052606,0.078581,0.17653,REACTOME_TRNA_PROCESSING,0.922380369480324
GSE29164_CD8_TCELL_VS_CD8_TC...4,SET,174,0.058109,0.0056272,0.06258,0.17657,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,0.922380369480324
GAVISH_3CA_METAPROGRAM_FIBRO...22,SET,48,0.11715,0.0059792,0.12621,0.17664,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_STRESS,0.922380369480324
GOMF_U2_SNRNA_BINDING,SET,5,0.31901,0.0052609,0.34366,0.17664,GOMF_U2_SNRNA_BINDING,0.922380369480324
HP_PRIMITIVE_REFLEX,SET,24,0.15757,0.0056903,0.16976,0.17666,HP_PRIMITIVE_REFLEX,0.922380369480324
GOCC_MICOS_COMPLEX,SET,5,0.31335,0.0051677,0.33761,0.17667,GOCC_MICOS_COMPLEX,0.922380369480324
GOBP_DEFENSE_RESPONSE_TO_OTH...,SET,1094,0.025377,0.0060042,0.027343,0.17669,GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM,0.922380369480324
MXD1_TARGET_GENES,SET,504,0.034649,0.0056585,0.037335,0.1767,MXD1_TARGET_GENES,0.922380369480324
GOBP_SARCOMERE_ORGANIZATION,SET,50,0.11005,0.0057323,0.11863,0.1768,GOBP_SARCOMERE_ORGANIZATION,0.922763778345097
GOCC_L_TYPE_VOLTAGE_GATED_CA...,SET,12,0.2552,0.0065187,0.27516,0.17685,GOCC_L_TYPE_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,0.922799774808587
MIR4660,SET,124,0.07,0.0057303,0.075477,0.17686,MIR4660,0.922799774808587
REACTOME_SYNTHESIS_OF_DIPHTH...,SET,8,0.24206,0.0050491,0.26104,0.17689,REACTOME_SYNTHESIS_OF_DIPHTHAMIDE_EEF2,0.922817764935455
HP_ANKLE_WEAKNESS,SET,17,0.16716,0.0050816,0.1803,0.17693,HP_ANKLE_WEAKNESS,0.922887910850968
GOBP_CALCIUM_ION_TRANSMEMBRA...3,SET,17,0.20589,0.0062588,0.22215,0.17702,GOBP_CALCIUM_ION_TRANSMEMBRANE_TRANSPORT_VIA_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL,0.923096952949963
HHEX_TARGET_GENES,SET,825,0.027059,0.0056027,0.0292,0.17705,HHEX_TARGET_GENES,0.923096952949963
TET1_TARGET_GENES,SET,1072,0.024234,0.0056795,0.026151,0.17706,TET1_TARGET_GENES,0.923096952949963
GOBP_PROTEIN_TRANSMEMBRANE_T...,SET,69,0.092708,0.0056697,0.10011,0.17721,GOBP_PROTEIN_TRANSMEMBRANE_TRANSPORT,0.923096952949963
REACTOME_AMINO_ACID_TRANSPOR...,SET,30,0.15324,0.0061863,0.16548,0.17722,REACTOME_AMINO_ACID_TRANSPORT_ACROSS_THE_PLASMA_MEMBRANE,0.923096952949963
GSE2585_CD80_HIGH_VS_LOW_MTE...2,SET,179,0.059588,0.0058519,0.064354,0.17725,GSE2585_CD80_HIGH_VS_LOW_MTEC_UP,0.923096952949963
GSE3920_IFNA_VS_IFNB_TREATED...2,SET,159,0.063217,0.0058544,0.06828,0.17727,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,0.923096952949963
HP_ABNORMAL_FETAL_PHYSIOLOGY,SET,261,0.048403,0.005727,0.052284,0.17729,HP_ABNORMAL_FETAL_PHYSIOLOGY,0.923096952949963
GSE43863_TFH_VS_LY6C_LOW_CXC...1,SET,175,0.062173,0.0060378,0.067158,0.17729,GSE43863_TFH_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,0.923096952949963
GSE17974_2.5H_VS_72H_IL4_AND...2,SET,178,0.055101,0.0053963,0.059523,0.1773,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.923096952949963
GOMF_THIOREDOXIN_DISULFIDE_R...,SET,6,0.31219,0.0056398,0.33725,0.17731,GOMF_THIOREDOXIN_DISULFIDE_REDUCTASE_NADPH_ACTIVITY,0.923096952949963
MEBARKI_HCC_PROGENITOR_WNT_U...2,SET,72,0.10096,0.006307,0.10908,0.17734,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT,0.923096952949963
GOBP_CELL_DIVISION,SET,578,0.032024,0.005589,0.034605,0.17738,GOBP_CELL_DIVISION,0.923096952949963
GSE36476_YOUNG_VS_OLD_DONOR_...5,SET,173,0.059061,0.0057031,0.063827,0.1774,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_DN,0.923096952949963
GOBP_CELL_SUBSTRATE_ADHESION,SET,333,0.04397,0.0058647,0.047526,0.17744,GOBP_CELL_SUBSTRATE_ADHESION,0.923096952949963
MIR377_5P,SET,50,0.10867,0.0056604,0.1175,0.17752,MIR377_5P,0.923096952949963
MIR494_3P,SET,346,0.042901,0.0058307,0.046386,0.17752,MIR494_3P,0.923096952949963
GSE22886_NAIVE_CD4_TCELL_VS_...17,SET,185,0.053739,0.0053643,0.058103,0.17752,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_DN,0.923096952949963
GOBP_APOPTOTIC_MITOCHONDRIAL...,SET,94,0.081131,0.0057873,0.087727,0.17754,GOBP_APOPTOTIC_MITOCHONDRIAL_CHANGES,0.923096952949963
HP_HALLUCINATIONS,SET,146,0.06228,0.0055289,0.067368,0.17762,HP_HALLUCINATIONS,0.923096952949963
MIR3940_5P,SET,33,0.12165,0.0051499,0.13158,0.17763,MIR3940_5P,0.923096952949963
GOBP_REGULATION_OF_ACTIVATIO...,SET,8,0.28425,0.0059292,0.30754,0.17768,GOBP_REGULATION_OF_ACTIVATION_OF_JANUS_KINASE_ACTIVITY,0.923096952949963
HP_ELEVATED_CIRCULATING_FOLL...,SET,46,0.11112,0.0055524,0.12024,0.17769,HP_ELEVATED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_LEVEL,0.923096952949963
GSE26669_CTRL_VS_COSTIM_BLOC...4,SET,184,0.055536,0.0055289,0.060099,0.17773,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_UP,0.923096952949963
IIZUKA_LIVER_CANCER_PROGRESS...5,SET,15,0.19212,0.0054862,0.20791,0.17774,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_DN,0.923096952949963
REACTOME_MITOPHAGY,SET,35,0.12701,0.0055373,0.13746,0.17775,REACTOME_MITOPHAGY,0.923096952949963
GOMF_UBIQUITIN_PROTEIN_TRANS...1,SET,15,0.20288,0.0057936,0.21957,0.17776,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVATOR_ACTIVITY,0.923096952949963
GOBP_REGULATION_OF_ESTABLISH...4,SET,43,0.1136,0.0054886,0.12296,0.17777,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.923096952949963
GOBP_CELLULAR_RESPONSE_TO_HI...,SET,6,0.33192,0.0059962,0.35928,0.17779,GOBP_CELLULAR_RESPONSE_TO_HISTAMINE,0.923096952949963
GOBP_PROTEIN_DEPALMITOYLATION,SET,8,0.26836,0.0055978,0.29049,0.17779,GOBP_PROTEIN_DEPALMITOYLATION,0.923096952949963
ANDERSON_BLOOD_CN54GP140_ADJ...2,SET,63,0.099624,0.0058227,0.10784,0.1778,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_UP,0.923096952949963
FREAC2_01,SET,235,0.053553,0.0060168,0.057974,0.17782,FREAC2_01,0.923096952949963
MIR597_3P,SET,100,0.077815,0.0057243,0.08427,0.1779,MIR597_3P,0.923150500149298
GSE23505_UNTREATED_VS_4DAY_I...3,SET,184,0.054285,0.0054044,0.058791,0.17791,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,0.923150500149298
GSE36476_CTRL_VS_TSST_ACT_16...3,SET,185,0.05545,0.0055351,0.060051,0.17791,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_DN,0.923150500149298
HP_LOSS_OF_SUBCUTANEOUS_ADIP...,SET,9,0.26931,0.0059581,0.29174,0.17798,HP_LOSS_OF_SUBCUTANEOUS_ADIPOSE_TISSUE_IN_LIMBS,0.923375862068965
GOMF_PHOSPHOLIPID_BINDING,SET,446,0.037804,0.0058171,0.040966,0.17806,GOMF_PHOSPHOLIPID_BINDING,0.923653029850746
TCCAGAG_MIR518C,SET,137,0.072933,0.0062734,0.07906,0.17814,TCCAGAG_MIR518C,0.923908912655972
GOBP_NEGATIVE_REGULATION_OF_...495,SET,34,0.13659,0.0058694,0.14808,0.17817,GOBP_NEGATIVE_REGULATION_OF_PLASMA_MEMBRANE_BOUNDED_CELL_PROJECTION_ASSEMBLY,0.923908912655972
HP_SYNDACTYLY,SET,346,0.041858,0.0056889,0.045388,0.17821,HP_SYNDACTYLY,0.923908912655972
FINETTI_BREAST_CANCERS_KINOM...1,SET,20,0.17,0.005605,0.18437,0.17825,FINETTI_BREAST_CANCERS_KINOME_BLUE,0.923908912655972
WP_OSTEOARTHRITIC_CHONDROCYT...,SET,48,0.11712,0.0059777,0.12703,0.17826,WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY,0.923908912655972
MCBRYAN_PUBERTAL_TGFB1_TARGE...1,SET,59,0.10981,0.0062118,0.11913,0.17832,MCBRYAN_PUBERTAL_TGFB1_TARGETS_DN,0.923908912655972
BIOCARTA_INSULIN_PATHWAY,SET,20,0.17045,0.0056196,0.18492,0.17834,BIOCARTA_INSULIN_PATHWAY,0.923908912655972
FULCHER_INFLAMMATORY_RESPONS...2,SET,525,0.035711,0.0059488,0.038747,0.17836,FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP,0.923908912655972
KEGG_MEDICUS_VARIANT_MUTATIO...74,SET,7,0.2922,0.0057014,0.31703,0.17836,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_OPTN_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,0.923908912655972
KYNG_RESPONSE_TO_H2O2,SET,64,0.096254,0.0056701,0.10445,0.17839,KYNG_RESPONSE_TO_H2O2,0.923908912655972
HOLLERN_EMT_BREAST_TUMOR_DN,SET,117,0.073504,0.0058459,0.079771,0.17842,HOLLERN_EMT_BREAST_TUMOR_DN,0.923908912655972
GOBP_MUSCLE_CONTRACTION,SET,328,0.044344,0.0058708,0.04813,0.17844,GOBP_MUSCLE_CONTRACTION,0.923908912655972
HP_AORTIC_VALVE_CALCIFICATION,SET,8,0.30565,0.0063755,0.33183,0.1785,HP_AORTIC_VALVE_CALCIFICATION,0.923908912655972
HP_THENAR_MUSCLE_WEAKNESS,SET,4,0.44188,0.0065182,0.4798,0.17854,HP_THENAR_MUSCLE_WEAKNESS,0.923908912655972
DESCARTES_FETAL_LIVER_HEPATO...,SET,382,0.043215,0.0061651,0.04693,0.17857,DESCARTES_FETAL_LIVER_HEPATOBLASTS,0.923908912655972
ZNF563_TARGET_GENES,SET,473,0.03599,0.0056989,0.039092,0.17862,ZNF563_TARGET_GENES,0.923908912655972
MIR5002_3P,SET,41,0.11617,0.0054809,0.12619,0.17863,MIR5002_3P,0.923908912655972
MODULE_223,SET,132,0.074173,0.0062634,0.080576,0.17865,MODULE_223,0.923908912655972
HINATA_NFKB_TARGETS_KERATINO...2,SET,84,0.087851,0.0059256,0.095447,0.17868,HINATA_NFKB_TARGETS_KERATINOCYTE_UP,0.923908912655972
GOBP_LYMPHOCYTE_ACTIVATION,SET,728,0.030655,0.0059791,0.033305,0.17868,GOBP_LYMPHOCYTE_ACTIVATION,0.923908912655972
GOMF_C3HC4_TYPE_RING_FINGER_...,SET,6,0.30278,0.0054699,0.32902,0.17872,GOMF_C3HC4_TYPE_RING_FINGER_DOMAIN_BINDING,0.923908912655972
REACTOME_AEROBIC_RESPIRATION...,SET,209,0.048646,0.0051579,0.052872,0.17878,REACTOME_AEROBIC_RESPIRATION_AND_RESPIRATORY_ELECTRON_TRANSPORT,0.923908912655972
GSE360_DC_VS_MAC_M_TUBERCULO...2,SET,179,0.058251,0.0057207,0.063314,0.17878,GSE360_DC_VS_MAC_M_TUBERCULOSIS_UP,0.923908912655972
TANG_SENESCENCE_TP53_TARGETS...1,SET,51,0.1146,0.0060284,0.12457,0.1788,TANG_SENESCENCE_TP53_TARGETS_DN,0.923908912655972
HP_ABNORMAL_PULMONARY_VALVE_...3,SET,137,0.067654,0.0058193,0.073543,0.17881,HP_ABNORMAL_PULMONARY_VALVE_PHYSIOLOGY,0.923908912655972
HP_LONG_EAR,SET,6,0.28423,0.0051348,0.30902,0.17885,HP_LONG_EAR,0.923908912655972
GSE21774_CD62L_POS_CD56_DIM_...2,SET,183,0.058562,0.0058145,0.063672,0.17886,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,0.923908912655972
ALX4_TARGET_GENES,SET,23,0.16897,0.0059737,0.18373,0.17888,ALX4_TARGET_GENES,0.923908912655972
CREBP1_Q2,SET,231,0.050883,0.0056686,0.055335,0.17891,CREBP1_Q2,0.923908912655972
MIR33A_5P_MIR33B_5P,SET,106,0.077659,0.0058807,0.084462,0.17893,MIR33A_5P_MIR33B_5P,0.923908912655972
ZNF837_TARGET_GENES,SET,5,0.36643,0.006043,0.39853,0.17894,ZNF837_TARGET_GENES,0.923908912655972
REACTOME_SELENOAMINO_ACID_ME...,SET,99,0.076227,0.0055794,0.082914,0.17896,REACTOME_SELENOAMINO_ACID_METABOLISM,0.923908912655972
MIR6888_3P,SET,87,0.082838,0.0056859,0.090121,0.17901,MIR6888_3P,0.923915696817914
THUM_SYSTOLIC_HEART_FAILURE_...1,SET,190,0.055893,0.0056535,0.060822,0.17906,THUM_SYSTOLIC_HEART_FAILURE_DN,0.923915696817914
MIR4635,SET,120,0.070493,0.0056774,0.076714,0.17908,MIR4635,0.923915696817914
CAFFAREL_RESPONSE_TO_THC_24H...1,SET,12,0.23048,0.0058873,0.25085,0.17911,CAFFAREL_RESPONSE_TO_THC_24HR_3_DN,0.923915696817914
chr11p11,SET,62,0.19755,0.011454,0.21506,0.17916,chr11p11,0.923915696817914
HP_EXAGGERATED_CUPID_S_BOW,SET,31,0.13486,0.0055338,0.14684,0.17922,HP_EXAGGERATED_CUPID_S_BOW,0.923915696817914
GOCC_SPECIFIC_GRANULE_MEMBRA...,SET,84,0.083586,0.0056379,0.091021,0.17923,GOCC_SPECIFIC_GRANULE_MEMBRANE,0.923915696817914
MIR6873_5P,SET,94,0.081761,0.0058323,0.089041,0.17925,MIR6873_5P,0.923915696817914
GSE10239_MEMORY_VS_DAY4.5_EF...2,SET,187,0.055794,0.0055992,0.060764,0.17926,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP,0.923915696817914
HP_DECREASED_LYMPHOCYTE_PROL...1,SET,9,0.2935,0.0064934,0.31969,0.17929,HP_DECREASED_LYMPHOCYTE_PROLIFERATION_IN_RESPONSE_TO_ANTI_CD3,0.923915696817914
GAVISH_3CA_MALIGNANT_METAPRO...37,SET,37,0.12999,0.0058264,0.14164,0.17938,GAVISH_3CA_MALIGNANT_METAPROGRAM_7_STRESS_IN_VITRO,0.923915696817914
GOBP_NEGATIVE_REGULATION_OF_...638,SET,18,0.16932,0.0052961,0.18449,0.17939,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.923915696817914
GOCC_POLE_PLASM,SET,23,0.14524,0.0051346,0.15826,0.17939,GOCC_POLE_PLASM,0.923915696817914
HP_HYPOPLASIA_OF_THE_VAGINA,SET,13,0.22296,0.0059276,0.24297,0.17941,HP_HYPOPLASIA_OF_THE_VAGINA,0.923915696817914
FIGUEROA_AML_METHYLATION_CLU...7,SET,14,0.2169,0.0059839,0.23642,0.17946,FIGUEROA_AML_METHYLATION_CLUSTER_4_DN,0.923915696817914
GOBP_ERROR_PRONE_TRANSLESION...,SET,12,0.18651,0.0047643,0.2033,0.17946,GOBP_ERROR_PRONE_TRANSLESION_SYNTHESIS,0.923915696817914
GOMF_MONOATOMIC_ION_TRANSMEM...,SET,687,0.030837,0.0058495,0.033612,0.17946,GOMF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.923915696817914
GOMF_CALCIUM_MONOATOMIC_CATI...,SET,13,0.24319,0.0064655,0.2651,0.17948,GOMF_CALCIUM_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,0.923915696817914
GOBP_IRON_ION_TRANSMEMBRANE_...,SET,18,0.1715,0.0053646,0.187,0.17955,GOBP_IRON_ION_TRANSMEMBRANE_TRANSPORT,0.923915696817914
GENTILE_UV_LOW_DOSE_DN,SET,59,0.10736,0.0060728,0.11707,0.17957,GENTILE_UV_LOW_DOSE_DN,0.923915696817914
HP_KYPHOSCOLIOSIS,SET,164,0.05949,0.0055945,0.064883,0.17961,HP_KYPHOSCOLIOSIS,0.923915696817914
WINTER_HYPOXIA_METAGENE,SET,216,0.055693,0.006002,0.060748,0.17963,WINTER_HYPOXIA_METAGENE,0.923915696817914
GOBP_INTERLEUKIN_27_MEDIATED...,SET,7,0.30474,0.0059461,0.33245,0.17967,GOBP_INTERLEUKIN_27_MEDIATED_SIGNALING_PATHWAY,0.923915696817914
GOMF_AMIDE_TRANSMEMBRANE_TRA...,SET,34,0.13784,0.0059232,0.15039,0.1797,GOMF_AMIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.923915696817914
MYC_UP.V1_DN,SET,145,0.064441,0.0057012,0.070312,0.17971,MYC_UP.V1_DN,0.923915696817914
GOBP_WOUND_HEALING_INVOLVED_...,SET,7,0.33266,0.0064909,0.36298,0.17972,GOBP_WOUND_HEALING_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.923915696817914
GSE9006_HEALTHY_VS_TYPE_1_DI...5,SET,178,0.061586,0.0060314,0.067231,0.17983,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_AT_DX_DN,0.923915696817914
GOMF_TRANSCRIPTION_REGULATOR...2,SET,1783,0.020595,0.0060956,0.022484,0.17985,GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY,0.923915696817914
PID_FOXM1_PATHWAY,SET,39,0.12322,0.0056702,0.13453,0.17986,PID_FOXM1_PATHWAY,0.923915696817914
GOBP_MHC_CLASS_I_BIOSYNTHETI...,SET,8,0.32017,0.0066783,0.34962,0.1799,GOBP_MHC_CLASS_I_BIOSYNTHETIC_PROCESS,0.923915696817914
GOBP_MONOUBIQUITINATED_PROTE...,SET,8,0.25964,0.0054158,0.28356,0.17993,GOBP_MONOUBIQUITINATED_PROTEIN_DEUBIQUITINATION,0.923915696817914
GOBP_REGULATION_OF_PLASMINOG...,SET,17,0.19315,0.0058716,0.21095,0.17994,GOBP_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.923915696817914
GSE3337_CTRL_VS_16H_IFNG_IN_...1,SET,181,0.05695,0.0056237,0.0622,0.17994,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_DN,0.923915696817914
KEGG_MEDICUS_VARIANT_MUTATIO...39,SET,25,0.1536,0.0056613,0.16777,0.17995,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.923915696817914
GSE17721_PAM3CSK4_VS_CPG_12H...2,SET,174,0.055837,0.0054072,0.060989,0.17996,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_UP,0.923915696817914
ZNF8_TARGET_GENES,SET,786,0.027951,0.0056552,0.030534,0.18,ZNF8_TARGET_GENES,0.923915696817914
HP_GASTROINTESTINAL_ULCER,SET,46,0.12025,0.0060086,0.13139,0.18004,HP_GASTROINTESTINAL_ULCER,0.923915696817914
MIR4281,SET,19,0.19014,0.0061104,0.20782,0.18012,MIR4281,0.923915696817914
KIM_GERMINAL_CENTER_T_HELPER...2,SET,57,0.10811,0.0060111,0.11817,0.18014,KIM_GERMINAL_CENTER_T_HELPER_UP,0.923915696817914
GSE27786_LIN_NEG_VS_NKTCELL_...2,SET,179,0.053966,0.0052998,0.058991,0.18015,GSE27786_LIN_NEG_VS_NKTCELL_UP,0.923915696817914
MIKKELSEN_PLURIPOTENT_STATE_...2,SET,8,0.25251,0.0052671,0.27603,0.18016,MIKKELSEN_PLURIPOTENT_STATE_UP,0.923915696817914
KEGG_MEDICUS_REFERENCE_CX3CR...,SET,17,0.19139,0.0058182,0.20923,0.18016,KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY,0.923915696817914
HP_ABNORMALITY_OF_MASSETER_M...,SET,5,0.3518,0.0058018,0.38457,0.18016,HP_ABNORMALITY_OF_MASSETER_MUSCLE,0.923915696817914
GOMF_RNA_CAP_BINDING,SET,17,0.16035,0.0048745,0.17533,0.18022,GOMF_RNA_CAP_BINDING,0.923915696817914
WP_7OXOC_AND_7BETAHC_PATHWAYS,SET,25,0.16065,0.005921,0.17567,0.18024,WP_7OXOC_AND_7BETAHC_PATHWAYS,0.923915696817914
GOBP_REGULATION_OF_RESPONSE_...12,SET,20,0.1961,0.0064655,0.21449,0.18029,GOBP_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,0.923915696817914
WP_NONGENOMIC_ACTIONS_OF_125...,SET,70,0.096305,0.0059321,0.10535,0.18032,WP_NONGENOMIC_ACTIONS_OF_125_DIHYDROXYVITAMIN_D3,0.923915696817914
MIR520G_5P,SET,53,0.10749,0.005764,0.11759,0.18033,MIR520G_5P,0.923915696817914
GOBP_ESTABLISHMENT_OF_PIGMEN...,SET,21,0.17897,0.0060461,0.19578,0.18033,GOBP_ESTABLISHMENT_OF_PIGMENT_GRANULE_LOCALIZATION,0.923915696817914
GSE21063_WT_VS_NFATC1_KO_16H...2,SET,176,0.056611,0.0055132,0.061928,0.18033,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_UP,0.923915696817914
GOBP_CELLULAR_RESPONSE_TO_SO...,SET,5,0.3319,0.0054736,0.36311,0.18035,GOBP_CELLULAR_RESPONSE_TO_SODIUM_ARSENITE,0.923915696817914
MIR1911_3P,SET,42,0.1227,0.0058588,0.13424,0.18036,MIR1911_3P,0.923915696817914
GOBP_CELLULAR_RESPONSE_TO_CA...4,SET,49,0.11241,0.0057966,0.123,0.18038,GOBP_CELLULAR_RESPONSE_TO_CAMP,0.923915696817914
GAVISH_3CA_METAPROGRAM_CD8_T...5,SET,48,0.10339,0.0052766,0.11313,0.1804,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_GLYCOLYSIS_MYC,0.923915696817914
WANG_METASTASIS_OF_BREAST_CA...1,SET,13,0.20917,0.0055611,0.22892,0.18043,WANG_METASTASIS_OF_BREAST_CANCER,0.923915696817914
BIOCARTA_AMAN_PATHWAY,SET,15,0.21393,0.0061091,0.23414,0.18045,BIOCARTA_AMAN_PATHWAY,0.923915696817914
GOBP_HEART_PROCESS,SET,240,0.05306,0.0060236,0.058096,0.18054,GOBP_HEART_PROCESS,0.924225176626435
REACTOME_SLC_MEDIATED_TRANSM...,SET,235,0.052487,0.005897,0.05749,0.18063,REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT,0.924225176626435
GOBP_PEPTIDYL_TYROSINE_DEPHO...2,SET,7,0.30687,0.0059877,0.33612,0.18064,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION_INVOLVED_IN_INACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,0.924225176626435
HP_URETEROPELVIC_JUNCTION_OB...,SET,20,0.15046,0.0049605,0.1648,0.18065,HP_URETEROPELVIC_JUNCTION_OBSTRUCTION,0.924225176626435
GSE25088_WT_VS_STAT6_KO_MACR...5,SET,183,0.053946,0.0053561,0.059093,0.18065,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_AND_IL4_STIM_UP,0.924225176626435
GOBP_VIRAL_GENE_EXPRESSION,SET,98,0.075594,0.0055053,0.082812,0.18067,GOBP_VIRAL_GENE_EXPRESSION,0.924225176626435
LIU_CMYB_TARGETS_UP,SET,147,0.066675,0.005939,0.073066,0.18075,LIU_CMYB_TARGETS_UP,0.924312266509781
MNX1_TARGET_GENES,SET,8,0.27311,0.0056967,0.29931,0.18077,MNX1_TARGET_GENES,0.924312266509781
GOBP_POSITIVE_REGULATION_OF_...669,SET,51,0.11245,0.0059153,0.12325,0.18079,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,0.924312266509781
GSE9650_NAIVE_VS_MEMORY_CD8_...2,SET,184,0.056755,0.0056502,0.062207,0.1808,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_UP,0.924312266509781
MIR124_5P,SET,102,0.074749,0.0055531,0.081937,0.18082,MIR124_5P,0.924312266509781
GOBP_POSITIVE_REGULATION_OF_...364,SET,42,0.12857,0.006139,0.14095,0.18085,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,0.924329669117647
GSE17721_LPS_VS_POLYIC_16H_B...1,SET,190,0.056742,0.0057394,0.062214,0.18088,GSE17721_LPS_VS_POLYIC_16H_BMDC_DN,0.924347066607852
GSE17186_CD21LOW_VS_CD21HIGH...2,SET,184,0.055321,0.0055075,0.060681,0.18098,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,0.92450240193918
GOBP_THALAMUS_DEVELOPMENT,SET,10,0.2629,0.0061308,0.28841,0.18101,GOBP_THALAMUS_DEVELOPMENT,0.92450240193918
GSE40685_NAIVE_CD4_TCELL_VS_...4,SET,164,0.057969,0.0054515,0.063595,0.18101,GSE40685_NAIVE_CD4_TCELL_VS_TREG_UP,0.92450240193918
GOBP_ANTERIOR_POSTERIOR_AXON...,SET,7,0.32707,0.0063818,0.35887,0.18105,GOBP_ANTERIOR_POSTERIOR_AXON_GUIDANCE,0.92450240193918
GOBP_METHYLATION,SET,180,0.052643,0.0051842,0.057763,0.18106,GOBP_METHYLATION,0.92450240193918
GOCC_NEUROFIBRILLARY_TANGLE,SET,5,0.43971,0.0072515,0.4825,0.18107,GOCC_NEUROFIBRILLARY_TANGLE,0.92450240193918
HP_TESTICULAR_DYSGENESIS,SET,10,0.25808,0.0060182,0.28324,0.18111,HP_TESTICULAR_DYSGENESIS,0.92457080640423
GSE7768_OVA_WITH_LPS_VS_OVA_...2,SET,156,0.060188,0.0055216,0.066086,0.18122,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,0.924996489939786
GOBP_NON_LYTIC_VIRAL_RELEASE,SET,14,0.1948,0.0053742,0.21391,0.18125,GOBP_NON_LYTIC_VIRAL_RELEASE,0.925013766519824
BACH1_01,SET,238,0.050977,0.0057633,0.05599,0.18129,BACH1_01,0.925048304462713
HP_MEMBRANOPROLIFERATIVE_GLO...,SET,9,0.26602,0.0058853,0.2922,0.18131,HP_MEMBRANOPROLIFERATIVE_GLOMERULONEPHRITIS,0.925048304462713
GOCC_NUCLEAR_OUTER_MEMBRANE,SET,26,0.14366,0.0053996,0.15785,0.18138,GOCC_NUCLEAR_OUTER_MEMBRANE,0.925134560657181
GOBP_BUNDLE_OF_HIS_CELL_TO_P...2,SET,7,0.34399,0.006712,0.37799,0.1814,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_SIGNALING,0.925134560657181
GOBP_POSITIVE_REGULATION_OF_...554,SET,7,0.31935,0.0062312,0.35097,0.18144,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BINDING_DOMAIN_LEUCINE_RICH_REPEAT_CONTAINING_RECEPTOR_SIGNALING_PATHWAY,0.925134560657181
ABRAHAM_ALPC_VS_MULTIPLE_MYE...2,SET,25,0.17091,0.0062993,0.18785,0.18145,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_UP,0.925134560657181
HP_TYPE_2_MUSCLE_FIBER_PREDO...,SET,9,0.24638,0.0054508,0.27079,0.18146,HP_TYPE_2_MUSCLE_FIBER_PREDOMINANCE,0.925134560657181
REACTOME_SIGNALING_BY_RECEPT...,SET,509,0.035113,0.0057619,0.038604,0.18153,REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES,0.925254427503299
REACTOME_INHIBITION_OF_REPLI...,SET,11,0.22808,0.0055782,0.25076,0.18154,REACTOME_INHIBITION_OF_REPLICATION_INITIATION_OF_DAMAGED_DNA_BY_RB1_E2F1,0.925254427503299
HP_PARALYSIS,SET,146,0.06356,0.0056424,0.069893,0.18158,HP_PARALYSIS,0.925254427503299
HP_ABNORMAL_CIRCULATING_C_RE...,SET,59,0.10283,0.005817,0.11309,0.18159,HP_ABNORMAL_CIRCULATING_C_REACTIVE_PROTEIN_CONCENTRATION,0.925254427503299
SCHAEFFER_PROSTATE_DEVELOPME...6,SET,142,0.064361,0.0056354,0.070788,0.18162,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_UP,0.925271635883905
HAY_BONE_MARROW_CD34_POS_LYM...,SET,7,0.3359,0.0065541,0.36949,0.18166,HAY_BONE_MARROW_CD34_POS_LYMPHOID_UNK,0.925339777224095
AIZARANI_LIVER_C4_EPCAM_POS_...,SET,178,0.062027,0.0060746,0.068238,0.18169,AIZARANI_LIVER_C4_EPCAM_POS_BILE_DUCT_CELLS_1,0.925356968053927
GSE2935_UV_INACTIVATED_VS_LI...2,SET,163,0.063507,0.0059541,0.069883,0.18174,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_UP,0.925476
REACTOME_PYROPTOSIS,SET,26,0.16378,0.0061558,0.18029,0.18182,REACTOME_PYROPTOSIS,0.925714912922582
TTCNRGNNNNTTC_HSF_Q6,SET,137,0.065971,0.0056745,0.072636,0.18188,TTCNRGNNNNTTC_HSF_Q6,0.925714912922582
PID_TGFBR_PATHWAY,SET,52,0.1077,0.0057208,0.11861,0.18192,PID_TGFBR_PATHWAY,0.925714912922582
ENGELMANN_CANCER_PROGENITORS...2,SET,46,0.12126,0.0060587,0.13354,0.18194,ENGELMANN_CANCER_PROGENITORS_UP,0.925714912922582
HP_SOFT_SKIN,SET,40,0.12596,0.0058698,0.13873,0.18195,HP_SOFT_SKIN,0.925714912922582
HP_HETEROTAXY,SET,21,0.16835,0.0056874,0.18544,0.18199,HP_HETEROTAXY,0.925714912922582
HP_MACROSCOPIC_HEMATURIA,SET,8,0.30304,0.0063211,0.33381,0.18199,HP_MACROSCOPIC_HEMATURIA,0.925714912922582
GOBP_THREONINE_METABOLIC_PRO...,SET,4,0.39424,0.0058154,0.43428,0.182,GOBP_THREONINE_METABOLIC_PROCESS,0.925714912922582
GSE37416_0H_VS_6H_F_TULARENS...1,SET,182,0.05656,0.0056004,0.062327,0.18208,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.925952895583504
PID_PS1_PATHWAY,SET,42,0.12204,0.0058274,0.1345,0.18212,PID_PS1_PATHWAY,0.925952895583504
GOCC_CELL_BODY_FIBER,SET,8,0.30058,0.0062696,0.33129,0.18213,GOCC_CELL_BODY_FIBER,0.925952895583504
GOMF_ADENOSINE_3_5_BISPHOSPH...,SET,5,0.3425,0.0056484,0.37754,0.18216,GOMF_ADENOSINE_3_5_BISPHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.925952895583504
GARGALOVIC_RESPONSE_TO_OXIDI...12,SET,11,0.21658,0.0052969,0.23875,0.18218,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_UP,0.925952895583504
HP_ABNORMAL_FINGERNAIL_MORPH...,SET,173,0.057874,0.0055885,0.063824,0.18227,HP_ABNORMAL_FINGERNAIL_MORPHOLOGY,0.926274872057318
GOMF_INOSITOL_1_4_5_TRISPHOS...1,SET,6,0.27293,0.0049306,0.30111,0.18236,GOMF_INOSITOL_1_4_5_TRISPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.926293662587413
HP_DECREASED_EOSINOPHIL_COUNT,SET,8,0.27979,0.0058361,0.3087,0.18238,HP_DECREASED_EOSINOPHIL_COUNT,0.926293662587413
LEE_DIFFERENTIATING_T_LYMPHO...,SET,170,0.056998,0.0054564,0.062896,0.18241,LEE_DIFFERENTIATING_T_LYMPHOCYTE,0.926293662587413
GOCC_MULTIVESICULAR_BODY,SET,61,0.10042,0.0057755,0.11082,0.18244,GOCC_MULTIVESICULAR_BODY,0.926293662587413
REACTOME_REGULATION_OF_EXPRE...,SET,154,0.058286,0.005313,0.064334,0.18247,REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS,0.926293662587413
WCTCNATGGY_UNKNOWN,SET,69,0.089869,0.0054961,0.099213,0.18252,WCTCNATGGY_UNKNOWN,0.926293662587413
BIOCARTA_CBL_PATHWAY,SET,11,0.23732,0.0058042,0.26206,0.18258,BIOCARTA_CBL_PATHWAY,0.926293662587413
GOBP_POSITIVE_REGULATION_OF_...232,SET,4,0.38407,0.0056654,0.42417,0.18262,GOBP_POSITIVE_REGULATION_OF_ENAMEL_MINERALIZATION,0.926293662587413
MIR6769A_3P,SET,17,0.2011,0.0061133,0.22211,0.18263,MIR6769A_3P,0.926293662587413
HP_EVERTED_LOWER_LIP_VERMILI...,SET,117,0.07326,0.0058265,0.080917,0.18264,HP_EVERTED_LOWER_LIP_VERMILION,0.926293662587413
LI_PBMC_MENACTRA_AGE_18_45YO...1,SET,8,0.28343,0.0059119,0.31306,0.18265,LI_PBMC_MENACTRA_AGE_18_45YO_7DY_UP,0.926293662587413
WAMUNYOKOLI_OVARIAN_CANCER_L...1,SET,173,0.060127,0.005806,0.066416,0.18266,WAMUNYOKOLI_OVARIAN_CANCER_LMP_DN,0.926293662587413
SNIP1_TARGET_GENES,SET,593,0.031327,0.0055356,0.034607,0.18268,SNIP1_TARGET_GENES,0.926293662587413
HP_DIMPLE_CHIN,SET,14,0.22539,0.0062183,0.24899,0.18269,HP_DIMPLE_CHIN,0.926293662587413
CEBP_C,SET,184,0.056624,0.0056372,0.062559,0.18271,CEBP_C,0.926293662587413
GSE17721_CTRL_VS_GARDIQUIMOD...7,SET,181,0.052141,0.0051489,0.057611,0.18272,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_DN,0.926293662587413
GOBP_PURINE_NUCLEOTIDE_TRANS...,SET,38,0.1359,0.0061729,0.15019,0.18278,GOBP_PURINE_NUCLEOTIDE_TRANSPORT,0.926293662587413
GOBP_REGULATION_OF_ADENYLATE...1,SET,19,0.173,0.0055596,0.1912,0.18278,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.926293662587413
HP_INCREASED_T_CELL_COUNT,SET,4,0.42752,0.0063064,0.47251,0.1828,HP_INCREASED_T_CELL_COUNT,0.926293662587413
ANDERSEN_LIVER_CANCER_KRT19_...1,SET,70,0.092306,0.0056857,0.10205,0.18286,ANDERSEN_LIVER_CANCER_KRT19_DN,0.926293662587413
MIR554,SET,16,0.18764,0.0055341,0.20746,0.18288,MIR554,0.926293662587413
GAUSSMANN_MLL_AF4_FUSION_TAR...9,SET,17,0.19877,0.0060424,0.21978,0.18289,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_DN,0.926293662587413
GOBP_TRANSFORMING_GROWTH_FAC...4,SET,196,0.056052,0.0057574,0.061976,0.1829,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.926293662587413
GOBP_POSITIVE_REGULATION_OF_...305,SET,17,0.17628,0.0053587,0.19493,0.18292,GOBP_POSITIVE_REGULATION_OF_GLUCONEOGENESIS,0.926293662587413
GOTTWEIN_TARGETS_OF_KSHV_MIR...,SET,59,0.10053,0.0056868,0.11118,0.18294,GOTTWEIN_TARGETS_OF_KSHV_MIR_K12_11,0.926293662587413
REACTOME_SIGNALING_BY_CSF1_M...,SET,29,0.13625,0.0054081,0.15073,0.18302,REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS,0.926428794057676
GOBP_ESTABLISHMENT_OF_BLOOD_...2,SET,4,0.41758,0.0061598,0.46196,0.18302,GOBP_ESTABLISHMENT_OF_BLOOD_RETINAL_BARRIER,0.926428794057676
ATF3_Q6,SET,229,0.051071,0.0056651,0.056515,0.18309,ATF3_Q6,0.92651349287169
GOBP_MICROTUBULE_POLYMERIZAT...1,SET,87,0.076412,0.0052448,0.084573,0.18314,GOBP_MICROTUBULE_POLYMERIZATION,0.92651349287169
GOBP_NEGATIVE_REGULATION_OF_...160,SET,7,0.27678,0.0054006,0.30644,0.18321,GOBP_NEGATIVE_REGULATION_OF_CYTOKINESIS,0.92651349287169
MODULE_249,SET,21,0.15582,0.0052642,0.17253,0.18322,MODULE_249,0.92651349287169
KEGG_MEDICUS_REFERENCE_WNT_S...4,SET,27,0.15766,0.0060383,0.17457,0.18323,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_INHIBITOR,0.92651349287169
GOBP_PULMONARY_VALVE_DEVELOP...,SET,24,0.18246,0.0065893,0.20203,0.18323,GOBP_PULMONARY_VALVE_DEVELOPMENT,0.92651349287169
WP_LIVER_X_RECEPTOR_PATHWAY,SET,10,0.24927,0.005813,0.27602,0.18324,WP_LIVER_X_RECEPTOR_PATHWAY,0.92651349287169
MODULE_307,SET,21,0.15507,0.0052389,0.17172,0.18325,MODULE_307,0.92651349287169
MIR6830_5P,SET,163,0.060832,0.0057033,0.067374,0.1833,MIR6830_5P,0.926582551256136
VANGURP_PANCREATIC_GAMMA_CELL,SET,41,0.13521,0.0063789,0.14976,0.18332,VANGURP_PANCREATIC_GAMMA_CELL,0.926582551256136
HP_NARROW_PELVIS_BONE,SET,7,0.28446,0.0055505,0.31526,0.18345,HP_NARROW_PELVIS_BONE,0.926582551256136
GOCC_MHC_CLASS_I_PEPTIDE_LOA...,SET,8,0.25159,0.0052479,0.27887,0.18348,GOCC_MHC_CLASS_I_PEPTIDE_LOADING_COMPLEX,0.926582551256136
BIOCARTA_NKT_PATHWAY,SET,24,0.16346,0.0059031,0.18119,0.18349,BIOCARTA_NKT_PATHWAY,0.926582551256136
GOBP_DEOXYRIBONUCLEOSIDE_CAT...,SET,6,0.36817,0.006651,0.40808,0.18349,GOBP_DEOXYRIBONUCLEOSIDE_CATABOLIC_PROCESS,0.926582551256136
HP_ELEVATED_TOTAL_SERUM_TRYP...,SET,6,0.31543,0.0056984,0.34973,0.18356,HP_ELEVATED_TOTAL_SERUM_TRYPTASE,0.926582551256136
PID_UPA_UPAR_PATHWAY,SET,42,0.1327,0.0063363,0.14715,0.18359,PID_UPA_UPAR_PATHWAY,0.926582551256136
SCHAEFFER_PROSTATE_DEVELOPME...13,SET,10,0.25055,0.0058427,0.27787,0.18362,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_UP,0.926582551256136
REACTOME_TRAFFICKING_OF_GLUR...,SET,15,0.20857,0.005956,0.23131,0.18362,REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS,0.926582551256136
GOBP_SARCOPLASMIC_RETICULUM_...,SET,38,0.12233,0.0055568,0.13567,0.18362,GOBP_SARCOPLASMIC_RETICULUM_CALCIUM_ION_TRANSPORT,0.926582551256136
HP_CALF_MUSCLE_HYPERTROPHY,SET,42,0.12032,0.0057451,0.13348,0.18369,HP_CALF_MUSCLE_HYPERTROPHY,0.926582551256136
GAVISH_3CA_METAPROGRAM_B_CEL...12,SET,44,0.12956,0.0063314,0.14375,0.18372,GAVISH_3CA_METAPROGRAM_B_CELLS_STRESS,0.926582551256136
DESCARTES_FETAL_PANCREAS_ISL...,SET,117,0.078838,0.0062702,0.08748,0.18374,DESCARTES_FETAL_PANCREAS_ISLET_ENDOCRINE_CELLS,0.926582551256136
GOBP_POSITIVE_REGULATION_OF_...559,SET,28,0.1674,0.0065289,0.18576,0.18376,GOBP_POSITIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.926582551256136
GOMF_MICROTUBULE_MINUS_END_B...,SET,12,0.20518,0.0052412,0.2277,0.18377,GOMF_MICROTUBULE_MINUS_END_BINDING,0.926582551256136
GSE13738_TCR_VS_BYSTANDER_AC...2,SET,178,0.056497,0.005533,0.062722,0.18387,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,0.926582551256136
CUI_DEVELOPING_HEART_C1_5TH_...,SET,73,0.089392,0.0056226,0.099245,0.18387,CUI_DEVELOPING_HEART_C1_5TH_WEEK_CARDIAC_CELLS,0.926582551256136
ZNF26_TARGET_GENES,SET,20,0.16051,0.005292,0.1782,0.18388,ZNF26_TARGET_GENES,0.926582551256136
HP_PERICARDITIS,SET,33,0.14012,0.0059323,0.15559,0.18391,HP_PERICARDITIS,0.926582551256136
GOCC_CILIARY_ROOTLET,SET,12,0.22073,0.0056382,0.24513,0.18394,GOCC_CILIARY_ROOTLET,0.926582551256136
MODULE_160,SET,2,0.54361,0.0056704,0.60378,0.18397,MODULE_160,0.926582551256136
REACTOME_PURINE_CATABOLISM,SET,17,0.19675,0.0059811,0.21853,0.18398,REACTOME_PURINE_CATABOLISM,0.926582551256136
GOMF_NUCLEAR_THYROID_HORMONE...,SET,27,0.1355,0.0051896,0.15053,0.18403,GOMF_NUCLEAR_THYROID_HORMONE_RECEPTOR_BINDING,0.926582551256136
MIR4695_5P,SET,80,0.082491,0.0054305,0.091645,0.18404,MIR4695_5P,0.926582551256136
HP_GASTROINTESTINAL_HEMORRHA...,SET,154,0.062343,0.0056828,0.069263,0.18404,HP_GASTROINTESTINAL_HEMORRHAGE,0.926582551256136
GSE30971_CTRL_VS_LPS_STIM_MA...6,SET,168,0.066166,0.006297,0.073513,0.18405,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_UP,0.926582551256136
RCGCANGCGY_NRF1_Q6,SET,852,0.025187,0.0052958,0.02799,0.1841,RCGCANGCGY_NRF1_Q6,0.926582551256136
KEGG_MEDICUS_PATHOGEN_HPV_E7...2,SET,7,0.31771,0.0061992,0.35309,0.18412,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_P27_CELL_CYCLE_G1_S,0.926582551256136
HP_ABNORMAL_STERNAL_OSSIFICA...,SET,11,0.2177,0.0053242,0.24194,0.18412,HP_ABNORMAL_STERNAL_OSSIFICATION,0.926582551256136
EHLERS_ANEUPLOIDY_DN,SET,10,0.26074,0.0060804,0.28978,0.18413,EHLERS_ANEUPLOIDY_DN,0.926582551256136
MIR6719_3P,SET,110,0.076766,0.0059211,0.085325,0.18415,MIR6719_3P,0.926582551256136
HP_BILATERAL_TONIC_CLONIC_SE...1,SET,322,0.04158,0.0054552,0.046223,0.18419,HP_BILATERAL_TONIC_CLONIC_SEIZURE,0.926582551256136
LOPEZ_TRANSLATION_VIA_FN1_SI...,SET,34,0.13548,0.0058219,0.15063,0.18422,LOPEZ_TRANSLATION_VIA_FN1_SIGNALING,0.926582551256136
GSE36527_CD69_NEG_VS_POS_TRE...2,SET,188,0.057691,0.0058049,0.064154,0.18426,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_UP,0.926582551256136
MIR6826_5P,SET,34,0.12487,0.0053657,0.13888,0.18431,MIR6826_5P,0.926582551256136
HP_IRREGULAR_MENSTRUATION,SET,58,0.098035,0.0054985,0.10904,0.18432,HP_IRREGULAR_MENSTRUATION,0.926582551256136
CASTELLANO_HRAS_AND_NRAS_TAR...1,SET,7,0.30052,0.0058638,0.3343,0.18435,CASTELLANO_HRAS_AND_NRAS_TARGETS_DN,0.926582551256136
GSE4590_LARGE_PRE_BCELL_VS_V...1,SET,172,0.059485,0.0057276,0.066178,0.18437,GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.926582551256136
HP_ABNORMAL_OPTICAL_COHERENC...,SET,18,0.18803,0.0058814,0.20924,0.18443,HP_ABNORMAL_OPTICAL_COHERENCE_TOMOGRAPHY,0.926582551256136
HE_LIM_SUN_FETAL_LUNG_C5_CD5...2,SET,142,0.06704,0.00587,0.074611,0.18446,HE_LIM_SUN_FETAL_LUNG_C5_CD5_POS_CCL22_NEG_MATURE_B_CELL,0.926582551256136
CHEN_METABOLIC_SYNDROM_NETWO...,SET,1123,0.023844,0.005711,0.02654,0.18449,CHEN_METABOLIC_SYNDROM_NETWORK,0.926582551256136
GOBP_REGULATION_OF_PATTERN_R...,SET,149,0.059899,0.0053714,0.066672,0.18449,GOBP_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.926582551256136
GSE9988_ANTI_TREM1_VS_LOW_LP...1,SET,174,0.05973,0.0057842,0.066487,0.1845,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_DN,0.926582551256136
FOXF2_TARGET_GENES,SET,7,0.26754,0.0052203,0.29788,0.18455,FOXF2_TARGET_GENES,0.926582551256136
KEGG_MEDICUS_REFERENCE_NODAL...,SET,8,0.22999,0.0047974,0.25609,0.18457,KEGG_MEDICUS_REFERENCE_NODAL_SIGNALING_PATHWAY,0.926582551256136
GOBP_REGULATION_OF_MULTICELL...1,SET,1271,0.022971,0.0058282,0.025577,0.18457,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISMAL_DEVELOPMENT,0.926582551256136
HP_IMPAIRED_DISTAL_VIBRATION...,SET,47,0.10813,0.0054609,0.12039,0.18457,HP_IMPAIRED_DISTAL_VIBRATION_SENSATION,0.926582551256136
GOBP_CGAS_STING_SIGNALING_PA...,SET,15,0.17499,0.0049972,0.19486,0.18459,GOBP_CGAS_STING_SIGNALING_PATHWAY,0.926582551256136
HP_XANTHOMATOSIS,SET,38,0.13353,0.0060655,0.14873,0.18464,HP_XANTHOMATOSIS,0.926582551256136
GSE19888_CTRL_VS_TCELL_MEMBR...2,SET,171,0.057376,0.0055086,0.063905,0.18464,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_UP,0.926582551256136
GSE21670_IL6_VS_TGFB_AND_IL6...1,SET,188,0.05464,0.0054979,0.06086,0.18465,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.926582551256136
GSE19941_LPS_VS_LPS_AND_IL10...2,SET,161,0.057658,0.0053728,0.064259,0.18479,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.926583395656551
MYLLYKANGAS_AMPLIFICATION_HO...4,SET,18,0.1637,0.0051206,0.18251,0.18488,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_17,0.926583395656551
GSE360_HIGH_DOSE_B_MALAYI_VS...2,SET,176,0.056056,0.0054592,0.062498,0.18488,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.926583395656551
GOBP_RENAL_SODIUM_ION_ABSORP...,SET,12,0.24168,0.0061735,0.26951,0.18493,GOBP_RENAL_SODIUM_ION_ABSORPTION,0.926583395656551
GOBP_NEGATIVE_REGULATION_OF_...24,SET,6,0.32761,0.0059184,0.36536,0.18495,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,0.926583395656551
HP_FIRST_DEGREE_ATRIOVENTRIC...,SET,42,0.12293,0.00587,0.13713,0.18501,HP_FIRST_DEGREE_ATRIOVENTRICULAR_BLOCK,0.926583395656551
MIR4486,SET,34,0.12018,0.0051642,0.13407,0.18502,MIR4486,0.926583395656551
HP_GIANT_CELL_HEPATITIS,SET,5,0.36278,0.0059828,0.40471,0.18503,HP_GIANT_CELL_HEPATITIS,0.926583395656551
GSE2770_IL12_AND_TGFB_VS_IL4...6,SET,178,0.054764,0.0053633,0.061094,0.18503,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,0.926583395656551
GOBP_REGULATION_OF_PROTEIN_A...2,SET,5,0.27507,0.0045364,0.30687,0.18504,GOBP_REGULATION_OF_PROTEIN_ADP_RIBOSYLATION,0.926583395656551
HP_CHOANAL_STENOSIS,SET,25,0.1549,0.005709,0.17281,0.18504,HP_CHOANAL_STENOSIS,0.926583395656551
KEGG_MEDICUS_VARIANT_ESR1_PO...,SET,5,0.39249,0.0064729,0.43792,0.18506,KEGG_MEDICUS_VARIANT_ESR1_POSITIVE_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.926583395656551
GSE36476_YOUNG_VS_OLD_DONOR_...2,SET,174,0.056923,0.0055124,0.063512,0.18506,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_UP,0.926583395656551
KEGG_LEUKOCYTE_TRANSENDOTHEL...,SET,108,0.076221,0.0058257,0.085062,0.18511,KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION,0.926583395656551
GSE17721_12H_VS_24H_POLYIC_B...2,SET,179,0.056678,0.0055662,0.063254,0.18512,GSE17721_12H_VS_24H_POLYIC_BMDC_UP,0.926583395656551
GOBP_REGULATION_OF_NEUTROPHI...2,SET,29,0.15044,0.0059712,0.16796,0.18521,GOBP_REGULATION_OF_NEUTROPHIL_CHEMOTAXIS,0.926583395656551
HP_RECURRENT_FEVER,SET,85,0.082005,0.005564,0.091579,0.18528,HP_RECURRENT_FEVER,0.926583395656551
HP_APLASIA_HYPOPLASIA_OF_THE...55,SET,6,0.29075,0.0052525,0.32471,0.18529,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HALLUX,0.926583395656551
VERNELL_RETINOBLASTOMA_PATHW...1,SET,19,0.17465,0.0056125,0.19506,0.1853,VERNELL_RETINOBLASTOMA_PATHWAY_DN,0.926583395656551
GOBP_CELLULAR_RESPONSE_TO_CA...2,SET,10,0.23081,0.0053823,0.25778,0.1853,GOBP_CELLULAR_RESPONSE_TO_CAFFEINE,0.926583395656551
HP_ABNORMAL_METABOLIC_BRAIN_...,SET,46,0.10602,0.0052973,0.11841,0.1853,HP_ABNORMAL_METABOLIC_BRAIN_IMAGING_BY_MRS,0.926583395656551
GSE17721_POLYIC_VS_CPG_24H_B...1,SET,181,0.055528,0.0054833,0.062016,0.1853,GSE17721_POLYIC_VS_CPG_24H_BMDC_DN,0.926583395656551
GOBP_REGULATION_OF_COMPLEMEN...1,SET,17,0.21143,0.0064273,0.23616,0.18532,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION,0.926583395656551
GOBP_RESPONSE_TO_HYDROXYUREA,SET,9,0.2339,0.0051748,0.26126,0.18532,GOBP_RESPONSE_TO_HYDROXYUREA,0.926583395656551
MIR219A_5P,SET,141,0.062103,0.0054186,0.069371,0.18534,MIR219A_5P,0.926583395656551
MIR576_5P,SET,313,0.043794,0.0056662,0.048923,0.18536,MIR576_5P,0.926583395656551
HP_PULMONARY_INFILTRATES,SET,52,0.11404,0.0060573,0.1274,0.18537,HP_PULMONARY_INFILTRATES,0.926583395656551
MIR548S,SET,119,0.066449,0.0053296,0.074246,0.1854,MIR548S,0.926600086281277
HP_ABNORMAL_ZYGOMATIC_BONE_M...,SET,206,0.052222,0.0054977,0.058365,0.18547,HP_ABNORMAL_ZYGOMATIC_BONE_MORPHOLOGY,0.926816657081237
HP_ABNORMAL_ASCENDING_AORTA_...,SET,26,0.16006,0.0060158,0.17894,0.18554,HP_ABNORMAL_ASCENDING_AORTA_MORPHOLOGY,0.926883237534128
HP_RADIAL_DEVIATION_OF_FINGER,SET,43,0.11213,0.0054171,0.12536,0.18556,HP_RADIAL_DEVIATION_OF_FINGER,0.926883237534128
FOXD2_TARGET_GENES,SET,994,0.023975,0.0054228,0.026807,0.18557,FOXD2_TARGET_GENES,0.926883237534128
TRAVAGLINI_LUNG_MYELOID_DEND...,SET,17,0.18661,0.0056729,0.20868,0.18559,TRAVAGLINI_LUNG_MYELOID_DENDRITIC_TYPE_1_CELL,0.926883237534128
GOBP_RAB_PROTEIN_SIGNAL_TRAN...,SET,17,0.17295,0.0052577,0.19343,0.18563,GOBP_RAB_PROTEIN_SIGNAL_TRANSDUCTION,0.926916499066226
chr19q12,SET,9,0.35568,0.007869,0.39783,0.18565,chr19q12,0.926916499066226
GOBP_UTERUS_MORPHOGENESIS,SET,6,0.29467,0.0053233,0.3297,0.18573,GOBP_UTERUS_MORPHOGENESIS,0.927016262205629
HP_NEUROPATHIC_ARTHROPATHY,SET,5,0.3008,0.0049607,0.33658,0.18575,HP_NEUROPATHIC_ARTHROPATHY,0.927016262205629
HP_TROPHIC_CHANGES_RELATED_T...,SET,5,0.3008,0.0049607,0.33658,0.18575,HP_TROPHIC_CHANGES_RELATED_TO_PAIN,0.927016262205629
ZHENG_CORD_BLOOD_C10_MULTILY...,SET,81,0.08763,0.0058046,0.098064,0.18578,ZHENG_CORD_BLOOD_C10_MULTILYMPHOID_PROGENITOR,0.927032864321608
KEGG_MEDICUS_PATHOGEN_EBV_EB...7,SET,10,0.20935,0.0048819,0.23435,0.18585,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P53_MEDIATED_TRANSCRIPTION,0.927115939428735
HP_CYANOSIS,SET,100,0.077214,0.00568,0.086436,0.18585,HP_CYANOSIS,0.927115939428735
GAVISH_3CA_METAPROGRAM_B_CEL...6,SET,43,0.11766,0.0056845,0.13174,0.18591,GAVISH_3CA_METAPROGRAM_B_CELLS_MEMORY,0.927148346219931
NRSF_01,SET,93,0.081746,0.0058002,0.091539,0.18593,NRSF_01,0.927148346219931
GOBP_MITOTIC_DNA_INTEGRITY_C...,SET,79,0.078385,0.005128,0.087815,0.18604,GOBP_MITOTIC_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.927148346219931
GOMF_ALL_TRANS_RETINAL_BINDI...,SET,5,0.34577,0.0057024,0.38738,0.18604,GOMF_ALL_TRANS_RETINAL_BINDING,0.927148346219931
GSE26488_CTRL_VS_PEPTIDE_INJ...1,SET,178,0.056712,0.005554,0.063538,0.18605,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_DN,0.927148346219931
LI_CYTIDINE_ANALOGS_CYCTOTOX...,SET,14,0.1944,0.0053632,0.21781,0.18607,LI_CYTIDINE_ANALOGS_CYCTOTOXICITY,0.927148346219931
MIR1269A_MIR1269B,SET,48,0.13814,0.0070504,0.15478,0.18607,MIR1269A_MIR1269B,0.927148346219931
MIR4522,SET,52,0.10786,0.0057289,0.12087,0.18612,MIR4522,0.927148346219931
GOBP_ONE_CARBON_COMPOUND_TRA...,SET,22,0.19546,0.0067584,0.21906,0.18613,GOBP_ONE_CARBON_COMPOUND_TRANSPORT,0.927148346219931
GSE22313_HEALTHY_VS_SLE_MOUS...1,SET,179,0.055825,0.0054823,0.062567,0.18614,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_DN,0.927148346219931
GOBP_POSITIVE_REGULATION_OF_...4,SET,9,0.26454,0.0058527,0.29653,0.18617,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,0.927148346219931
GOMF_RETINAL_BINDING,SET,17,0.18887,0.0057414,0.21173,0.18619,GOMF_RETINAL_BINDING,0.927148346219931
BILANGES_RAPAMYCIN_SENSITIVE...1,SET,35,0.12325,0.0053733,0.13817,0.18621,BILANGES_RAPAMYCIN_SENSITIVE_GENES,0.927148346219931
GOBP_REGULATION_OF_PRODUCTIO...,SET,171,0.058158,0.0055836,0.065216,0.18626,GOBP_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,0.927148346219931
GOBP_WATER_SOLUBLE_VITAMIN_B...,SET,11,0.23012,0.0056281,0.25808,0.18629,GOBP_WATER_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,0.927148346219931
HP_VASCULAR_TORTUOSITY,SET,21,0.16616,0.0056134,0.18636,0.1863,HP_VASCULAR_TORTUOSITY,0.927148346219931
GOBP_FUNGIFORM_PAPILLA_MORPH...,SET,4,0.41789,0.0061643,0.46869,0.18631,GOBP_FUNGIFORM_PAPILLA_MORPHOGENESIS,0.927148346219931
HP_SUBARACHNOID_HEMORRHAGE,SET,36,0.13294,0.0058777,0.14915,0.1864,HP_SUBARACHNOID_HEMORRHAGE,0.927375468350838
GOBP_CONSTITUTIVE_SECRETORY_...,SET,7,0.29068,0.0056719,0.3262,0.18643,GOBP_CONSTITUTIVE_SECRETORY_PATHWAY,0.927375468350838
MIR6805_5P,SET,40,0.11145,0.0051937,0.12508,0.18646,MIR6805_5P,0.927375468350838
KRAS.DF.V1_UP,SET,176,0.058888,0.005735,0.06611,0.18654,KRAS.DF.V1_UP,0.927375468350838
GOBP_REGULATION_OF_BIOMINERA...,SET,89,0.082672,0.005739,0.092843,0.18662,GOBP_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.927375468350838
IKEDA_MIR1_TARGETS_DN,SET,6,0.33976,0.0061378,0.3816,0.18664,IKEDA_MIR1_TARGETS_DN,0.927375468350838
BIOCARTA_EDG1_PATHWAY,SET,22,0.17055,0.0058971,0.19155,0.18664,BIOCARTA_EDG1_PATHWAY,0.927375468350838
GOBP_PROGESTERONE_RECEPTOR_S...,SET,10,0.24587,0.0057336,0.27614,0.18664,GOBP_PROGESTERONE_RECEPTOR_SIGNALING_PATHWAY,0.927375468350838
GOBP_RENAL_SODIUM_ION_TRANSP...,SET,14,0.22352,0.0061667,0.25104,0.18664,GOBP_RENAL_SODIUM_ION_TRANSPORT,0.927375468350838
HP_HYPOREFLEXIA_OF_LOWER_LIM...,SET,33,0.133,0.0056306,0.1494,0.18667,HP_HYPOREFLEXIA_OF_LOWER_LIMBS,0.927375468350838
ZHONG_PFC_C6_DLX5_GAD1_GAD2_...,SET,13,0.22412,0.0059585,0.25178,0.1867,ZHONG_PFC_C6_DLX5_GAD1_GAD2_POS_INTERNEURON,0.927375468350838
BIOCARTA_GATA3_PATHWAY,SET,14,0.21222,0.0058549,0.23843,0.18672,BIOCARTA_GATA3_PATHWAY,0.927375468350838
GSE9988_LPS_VS_LOW_LPS_MONOC...2,SET,137,0.06496,0.0055875,0.072988,0.18674,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_UP,0.927375468350838
GSE15930_STIM_VS_STIM_AND_IF...1,SET,178,0.057014,0.0055836,0.064093,0.18686,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_DN,0.927375468350838
DESCARTES_FETAL_CEREBELLUM_V...,SET,507,0.036298,0.005945,0.040812,0.1869,DESCARTES_FETAL_CEREBELLUM_VASCULAR_ENDOTHELIAL_CELLS,0.927375468350838
GSE6259_DEC205_POS_DC_VS_BCE...2,SET,139,0.067569,0.0058539,0.075987,0.18695,GSE6259_DEC205_POS_DC_VS_BCELL_UP,0.927375468350838
HP_PERONEAL_MUSCLE_WEAKNESS,SET,8,0.27907,0.0058211,0.31389,0.18698,HP_PERONEAL_MUSCLE_WEAKNESS,0.927375468350838
HP_DECREASED_FERTILITY,SET,312,0.041552,0.0053677,0.046741,0.18701,HP_DECREASED_FERTILITY,0.927375468350838
WP_VASOPRESSINREGULATED_WATE...,SET,43,0.11107,0.0053662,0.12497,0.18706,WP_VASOPRESSINREGULATED_WATER_REABSORPTION,0.927375468350838
KEGG_MEDICUS_VARIANT_MUTATIO...33,SET,13,0.22375,0.0059486,0.25175,0.18707,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM,0.927375468350838
HP_SPONTANEOUS_PAIN_SENSATION,SET,5,0.35497,0.0058541,0.39947,0.18711,HP_SPONTANEOUS_PAIN_SENSATION,0.927375468350838
HP_TRICEPS_WEAKNESS,SET,17,0.16169,0.0049152,0.18199,0.18715,HP_TRICEPS_WEAKNESS,0.927375468350838
GOMF_TRANSCRIPTION_COACTIVAT...1,SET,251,0.046172,0.0053588,0.05197,0.18716,GOMF_TRANSCRIPTION_COACTIVATOR_ACTIVITY,0.927375468350838
GOMF_THYROID_HORMONE_BINDING,SET,6,0.33998,0.0061419,0.38277,0.18722,GOMF_THYROID_HORMONE_BINDING,0.927375468350838
GOMF_PHOSPHATIDYLCHOLINE_FLO...,SET,8,0.28,0.0058406,0.31527,0.18724,GOMF_PHOSPHATIDYLCHOLINE_FLOPPASE_ACTIVITY,0.927375468350838
KEGG_MEDICUS_PATHOGEN_HPV_E5...2,SET,13,0.20414,0.0054272,0.22993,0.18733,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_EGFR_RAS_ERK_SIGNALING_PATHWAY,0.927375468350838
GOBP_XENOBIOTIC_TRANSPORT,SET,47,0.11547,0.0058319,0.1301,0.18739,GOBP_XENOBIOTIC_TRANSPORT,0.927375468350838
GOBP_MAST_CELL_DIFFERENTIATI...,SET,6,0.34549,0.0062413,0.38926,0.1874,GOBP_MAST_CELL_DIFFERENTIATION,0.927375468350838
WP_INTEGRATED_CANCER_PATHWAY,SET,43,0.11185,0.0054037,0.12604,0.18743,WP_INTEGRATED_CANCER_PATHWAY,0.927375468350838
GOBP_NEGATIVE_REGULATION_OF_...701,SET,85,0.088623,0.006013,0.099873,0.18745,GOBP_NEGATIVE_REGULATION_OF_VIRAL_PROCESS,0.927375468350838
GOBP_TONGUE_MORPHOGENESIS,SET,9,0.27928,0.0061786,0.31476,0.18747,GOBP_TONGUE_MORPHOGENESIS,0.927375468350838
GSE34205_HEALTHY_VS_FLU_INF_...2,SET,173,0.055011,0.005312,0.062001,0.18748,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_UP,0.927375468350838
GOBP_IMMUNOLOGICAL_MEMORY_PR...,SET,18,0.2019,0.0063152,0.22758,0.18751,GOBP_IMMUNOLOGICAL_MEMORY_PROCESS,0.927375468350838
GSE41978_KLRG1_HIGH_VS_LOW_E...1,SET,179,0.053652,0.005269,0.060477,0.18751,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_DN,0.927375468350838
HP_GENERALIZED_CLONIC_SEIZURE,SET,28,0.14639,0.0057094,0.16503,0.18754,HP_GENERALIZED_CLONIC_SEIZURE,0.927375468350838
PID_EPHA2_FWD_PATHWAY,SET,19,0.16671,0.0053575,0.18797,0.18756,PID_EPHA2_FWD_PATHWAY,0.927375468350838
GOBP_LIPID_STORAGE,SET,87,0.085328,0.0058568,0.09622,0.1876,GOBP_LIPID_STORAGE,0.927375468350838
KEGG_HISTIDINE_METABOLISM,SET,26,0.14163,0.0053232,0.15974,0.18765,KEGG_HISTIDINE_METABOLISM,0.927375468350838
MIR331_3P,SET,59,0.10444,0.0059081,0.1178,0.18765,MIR331_3P,0.927375468350838
GOBP_INTERLEUKIN_6_MEDIATED_...,SET,18,0.19621,0.0061373,0.22131,0.18766,GOBP_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,0.927375468350838
GOBP_OXYGEN_TRANSPORT,SET,11,0.27743,0.0067852,0.31294,0.18767,GOBP_OXYGEN_TRANSPORT,0.927375468350838
HP_ABNORMALITY_OF_THE_PERIOR...,SET,229,0.05105,0.0056628,0.057585,0.18767,HP_ABNORMALITY_OF_THE_PERIORBITAL_REGION,0.927375468350838
HP_PARADOXICAL_INCREASED_COR...,SET,14,0.2018,0.0055675,0.22768,0.18773,HP_PARADOXICAL_INCREASED_CORTISOL_SECRETION_ON_DEXAMETHASONE_SUPPRESSION_TEST,0.927375468350838
HOEK_MONOCYTE_2011_2012_TIV_...6,SET,5,0.33969,0.005602,0.38329,0.18775,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_UP,0.927375468350838
GOMF_STRUCTURAL_CONSTITUENT_...4,SET,40,0.11473,0.0053465,0.12946,0.18776,GOMF_STRUCTURAL_CONSTITUENT_OF_MUSCLE,0.927375468350838
GSE22886_NAIVE_CD8_TCELL_VS_...9,SET,184,0.055718,0.005547,0.062875,0.18777,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_DN,0.927375468350838
GOBP_STRIATED_MUSCLE_CONTRAC...,SET,173,0.058357,0.0056351,0.065863,0.1878,GOBP_STRIATED_MUSCLE_CONTRACTION,0.927375468350838
GOMF_TRANSFERRIN_RECEPTOR_BI...,SET,9,0.23389,0.0051745,0.26398,0.18781,GOMF_TRANSFERRIN_RECEPTOR_BINDING,0.927375468350838
GOMF_PROTEIN_LYSINE_DEACETYL...,SET,21,0.15495,0.0052347,0.17491,0.18784,GOMF_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.927375468350838
GOBP_CELLULAR_RESPONSE_TO_PO...,SET,12,0.23773,0.0060725,0.26836,0.18785,GOBP_CELLULAR_RESPONSE_TO_POTASSIUM_ION,0.927375468350838
BUYTAERT_PHOTODYNAMIC_THERAP...1,SET,578,0.030624,0.0053448,0.034572,0.18786,BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_DN,0.927375468350838
ACTGTGA_MIR27A_MIR27B,SET,436,0.036988,0.005629,0.041757,0.18787,ACTGTGA_MIR27A_MIR27B,0.927375468350838
GSE5589_WT_VS_IL10_KO_LPS_AN...3,SET,183,0.053899,0.0053515,0.060856,0.1879,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.927375468350838
TESAR_ALK_TARGETS_EPISC_4D_UP,SET,5,0.34005,0.005608,0.38396,0.18791,TESAR_ALK_TARGETS_EPISC_4D_UP,0.927375468350838
BIOCARTA_TERC_PATHWAY,SET,6,0.28645,0.0051748,0.32343,0.18791,BIOCARTA_TERC_PATHWAY,0.927375468350838
KEGG_MEDICUS_PATHOGEN_HPV_E6...3,SET,13,0.20334,0.0054061,0.22961,0.18792,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382,0.927375468350838
GOBP_REGULATION_OF_ENDOPLASM...3,SET,27,0.14949,0.0057254,0.1688,0.18792,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.927375468350838
GOMF_UDP_GALACTOSE_BETA_N_AC...,SET,12,0.23442,0.0059879,0.26474,0.18796,GOMF_UDP_GALACTOSE_BETA_N_ACETYLGLUCOSAMINE_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.927375468350838
GSE17721_PAM3CSK4_VS_GADIQUI...8,SET,181,0.057872,0.0057147,0.065358,0.18796,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_UP,0.927375468350838
GOBP_CILIUM_DISASSEMBLY,SET,5,0.32696,0.0053921,0.36932,0.188,GOBP_CILIUM_DISASSEMBLY,0.927375468350838
GOBP_NEGATIVE_REGULATION_OF_...33,SET,3,0.46739,0.005971,0.52795,0.188,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_ACTIVATION,0.927375468350838
REACTOME_SERINE_BIOSYNTHESIS,SET,9,0.22919,0.0050705,0.25889,0.18801,REACTOME_SERINE_BIOSYNTHESIS,0.927375468350838
GOBP_POSITIVE_REGULATION_OF_...644,SET,5,0.29659,0.0048913,0.33508,0.18805,GOBP_POSITIVE_REGULATION_OF_PROTEIN_NEDDYLATION,0.927387573964497
GSE40441_NRP1_POS_INDUCED_TR...2,SET,184,0.058452,0.0058191,0.06605,0.1881,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_UP,0.927387573964497
GSE12845_IGD_NEG_BLOOD_VS_DA...2,SET,162,0.058692,0.0054859,0.066327,0.18811,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_UP,0.927387573964497
HP_HYPOPLASIA_OF_THE_MUSCULA...,SET,20,0.18577,0.0061248,0.20997,0.18815,HP_HYPOPLASIA_OF_THE_MUSCULATURE,0.927387573964497
GSE8921_UNSTIM_0H_VS_TLR1_2_...2,SET,188,0.053292,0.0053623,0.060245,0.18819,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_UP,0.927387573964497
GOBP_COLLATERAL_SPROUTING,SET,25,0.15401,0.0056761,0.1741,0.1882,GOBP_COLLATERAL_SPROUTING,0.927387573964497
GSE13306_TREG_VS_TCONV_SPLEE...1,SET,177,0.057422,0.005608,0.064934,0.18827,GSE13306_TREG_VS_TCONV_SPLEEN_DN,0.927387573964497
NKX2_2_TARGET_GENES,SET,1062,0.022834,0.0053278,0.025822,0.18828,NKX2_2_TARGET_GENES,0.927387573964497
GOMF_HISTONE_H3K4_METHYLTRAN...,SET,18,0.17343,0.0054249,0.19617,0.18833,GOMF_HISTONE_H3K4_METHYLTRANSFERASE_ACTIVITY,0.927387573964497
DAZARD_UV_RESPONSE_CLUSTER_G...2,SET,17,0.20648,0.0062769,0.2336,0.18837,DAZARD_UV_RESPONSE_CLUSTER_G28,0.927387573964497
JOSEPH_RESPONSE_TO_SODIUM_BU...2,SET,26,0.14208,0.0053403,0.16075,0.18838,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_UP,0.927387573964497
GSE25085_FETAL_LIVER_VS_FETA...2,SET,181,0.05221,0.0051557,0.059073,0.1884,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_UP,0.927387573964497
GOCC_GOLGI_CIS_CISTERNA,SET,15,0.18716,0.0053446,0.21177,0.18842,GOCC_GOLGI_CIS_CISTERNA,0.927387573964497
HP_UNDETECTABLE_LIGHT_ADAPTE...,SET,6,0.35111,0.0063428,0.39729,0.18842,HP_UNDETECTABLE_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.927387573964497
GOCC_TRNA_METHYLTRANSFERASE_...,SET,6,0.23984,0.0043327,0.27141,0.18844,GOCC_TRNA_METHYLTRANSFERASE_COMPLEX,0.927387573964497
HP_DECREASED_CORNEAL_SENSATI...,SET,5,0.37949,0.0062585,0.42956,0.1885,HP_DECREASED_CORNEAL_SENSATION,0.927387573964497
GOMF_AMINOACYL_TRNA_HYDROLAS...,SET,4,0.28255,0.004168,0.31984,0.18851,GOMF_AMINOACYL_TRNA_HYDROLASE_ACTIVITY,0.927387573964497
GOBP_NEGATIVE_REGULATION_OF_...350,SET,21,0.16567,0.0055968,0.18755,0.18854,GOBP_NEGATIVE_REGULATION_OF_LIPID_STORAGE,0.927387573964497
LEONARD_HYPOXIA,SET,38,0.11815,0.0053669,0.13377,0.18856,LEONARD_HYPOXIA,0.927387573964497
MIR6791_5P,SET,152,0.060507,0.0054797,0.068505,0.18856,MIR6791_5P,0.927387573964497
GSE27241_CTRL_VS_DIGOXIN_TRE...2,SET,146,0.062251,0.0055263,0.070493,0.1886,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,0.927387573964497
GOBP_DNA_RECOMBINATION,SET,284,0.042187,0.0052035,0.047773,0.18861,GOBP_DNA_RECOMBINATION,0.927387573964497
GSE21670_UNTREATED_VS_IL6_TR...3,SET,180,0.054296,0.0053469,0.061502,0.18867,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,0.927387573964497
CGTSACG_PAX3_B,SET,141,0.064786,0.0056527,0.073389,0.18868,CGTSACG_PAX3_B,0.927387573964497
PASTURAL_RIZ1_TARGETS_UP,SET,8,0.22289,0.0046492,0.25255,0.18875,PASTURAL_RIZ1_TARGETS_UP,0.927387573964497
GOBP_SUCCINATE_METABOLIC_PRO...,SET,7,0.30999,0.0060486,0.35124,0.18875,GOBP_SUCCINATE_METABOLIC_PROCESS,0.927387573964497
REACTOME_SODIUM_PROTON_EXCHA...,SET,7,0.28114,0.0054856,0.31862,0.18879,REACTOME_SODIUM_PROTON_EXCHANGERS,0.927387573964497
GOBP_IP_10_PRODUCTION,SET,4,0.41353,0.0061,0.46871,0.18882,GOBP_IP_10_PRODUCTION,0.927387573964497
REACTOME_EPH_EPHRIN_MEDIATED...,SET,49,0.1124,0.0057957,0.12743,0.18888,REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS,0.927387573964497
HP_ABNORMALITY_OF_NEUTROPHIL...,SET,14,0.19416,0.0053566,0.22012,0.18888,HP_ABNORMALITY_OF_NEUTROPHIL_PHYSIOLOGY,0.927387573964497
HP_PAPILLARY_RENAL_CELL_CARC...,SET,8,0.30341,0.0063288,0.34401,0.1889,HP_PAPILLARY_RENAL_CELL_CARCINOMA,0.927387573964497
GNF2_DAP3,SET,105,0.065934,0.0049693,0.074761,0.18891,GNF2_DAP3,0.927387573964497
HP_ABNORMAL_TOE_MORPHOLOGY,SET,627,0.030101,0.005464,0.034137,0.18896,HP_ABNORMAL_TOE_MORPHOLOGY,0.927387573964497
GSE3982_EOSINOPHIL_VS_CENT_M...1,SET,178,0.053905,0.0052792,0.061137,0.18897,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.927387573964497
CROMER_METASTASIS_UP,SET,59,0.098334,0.0055625,0.11153,0.18899,CROMER_METASTASIS_UP,0.927387573964497
WP_WNT_SIGNALING_WP363,SET,51,0.10512,0.0055296,0.11923,0.18899,WP_WNT_SIGNALING_WP363,0.927387573964497
HP_SUPRAVALVULAR_AORTIC_STEN...,SET,26,0.16921,0.0063599,0.19196,0.18903,HP_SUPRAVALVULAR_AORTIC_STENOSIS,0.927387573964497
HP_CLEFT_SOFT_PALATE,SET,49,0.10053,0.0051837,0.11406,0.18908,HP_CLEFT_SOFT_PALATE,0.927387573964497
KASLER_HDAC7_TARGETS_1_DN,SET,16,0.19643,0.0057931,0.22293,0.18914,KASLER_HDAC7_TARGETS_1_DN,0.927387573964497
MIR429,SET,457,0.036654,0.0057076,0.041602,0.18915,MIR429,0.927387573964497
WP_DEREGULATION_OF_RAB_AND_R...,SET,14,0.17598,0.0048552,0.1998,0.18922,WP_DEREGULATION_OF_RAB_AND_RAB_EFFECTOR_GENES_IN_BLADDER_CANCER,0.927387573964497
MODULE_573,SET,24,0.1562,0.005641,0.17735,0.18922,MODULE_573,0.927387573964497
GSE13484_UNSTIM_VS_12H_YF17D...2,SET,185,0.053602,0.0053507,0.060864,0.18925,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_UP,0.927387573964497
HP_INCREASED_NUCHAL_TRANSLUC...,SET,46,0.11504,0.0057481,0.13065,0.18929,HP_INCREASED_NUCHAL_TRANSLUCENCY,0.927387573964497
FAELT_B_CLL_WITH_VH_REARRANG...1,SET,43,0.10989,0.005309,0.12482,0.18933,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN,0.927387573964497
REACTOME_ACETYLCHOLINE_NEURO...,SET,16,0.20764,0.0061238,0.23585,0.18933,REACTOME_ACETYLCHOLINE_NEUROTRANSMITTER_RELEASE_CYCLE,0.927387573964497
chr17q11,SET,76,0.18807,0.012069,0.21364,0.18935,chr17q11,0.927387573964497
GOBP_REGULATION_OF_IMMUNE_RE...,SET,834,0.026945,0.0056081,0.030608,0.18935,GOBP_REGULATION_OF_IMMUNE_RESPONSE,0.927387573964497
GOBP_THYMUS_DEVELOPMENT,SET,47,0.11239,0.0056764,0.12767,0.18935,GOBP_THYMUS_DEVELOPMENT,0.927387573964497
GOBP_POSITIVE_REGULATION_OF_...802,SET,37,0.15014,0.0067298,0.17056,0.18936,GOBP_POSITIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.927387573964497
HP_ABNORMAL_PERIPHERAL_ACTIO...,SET,37,0.12341,0.0055314,0.1402,0.18939,HP_ABNORMAL_PERIPHERAL_ACTION_POTENTIAL_AMPLITUDE,0.927387573964497
GOMF_RIBONUCLEOPROTEIN_COMPL...,SET,142,0.058366,0.0051105,0.066317,0.1894,GOMF_RIBONUCLEOPROTEIN_COMPLEX_BINDING,0.927387573964497
GOBP_HEPATIC_STELLATE_CELL_A...,SET,9,0.27058,0.0059861,0.30751,0.18946,GOBP_HEPATIC_STELLATE_CELL_ACTIVATION,0.927420042253521
HP_HYPERECHOGENIC_PANCREAS,SET,4,0.35215,0.0051945,0.40021,0.18946,HP_HYPERECHOGENIC_PANCREAS,0.927420042253521
REACTOME_BINDING_OF_TCF_LEF_...,SET,8,0.27399,0.0057152,0.31149,0.18954,REACTOME_BINDING_OF_TCF_LEF_CTNNB1_TO_TARGET_GENE_PROMOTERS,0.927680988593156
HP_NEOPLASM_OF_THE_LARGE_INT...,SET,108,0.069776,0.0053331,0.079343,0.18959,HP_NEOPLASM_OF_THE_LARGE_INTESTINE,0.927711051818565
GSE6259_33D1_POS_DC_VS_CD8_T...2,SET,122,0.067401,0.0054732,0.076647,0.18961,GSE6259_33D1_POS_DC_VS_CD8_TCELL_UP,0.927711051818565
REACTOME_MAPK3_ERK1_ACTIVATI...,SET,10,0.25679,0.0059881,0.29206,0.18964,REACTOME_MAPK3_ERK1_ACTIVATION,0.927711051818565
REACTOME_VITAMIN_B5_PANTOTHE...,SET,19,0.15549,0.004997,0.17687,0.18967,REACTOME_VITAMIN_B5_PANTOTHENATE_METABOLISM,0.927711051818565
FXR1_TARGET_GENES,SET,980,0.023551,0.0052912,0.02679,0.18969,FXR1_TARGET_GENES,0.927711051818565
NABA_PROTEOGLYCANS,SET,33,0.15029,0.0063627,0.17102,0.18977,NABA_PROTEOGLYCANS,0.927711051818565
GOBP_CENTRAL_NERVOUS_SYSTEM_...6,SET,76,0.09358,0.0060052,0.10649,0.18977,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DEVELOPMENT,0.927711051818565
GOBP_NEGATIVE_REGULATION_OF_...269,SET,10,0.2282,0.0053215,0.25972,0.18981,GOBP_NEGATIVE_REGULATION_OF_HEART_RATE,0.927711051818565
GOBP_SYNAPTIC_VESICLE_CYTOSK...,SET,18,0.17716,0.0055415,0.20169,0.18988,GOBP_SYNAPTIC_VESICLE_CYTOSKELETAL_TRANSPORT,0.927711051818565
HP_BONE_MARROW_HYPERCELLULAR...,SET,28,0.15003,0.0058517,0.17082,0.18989,HP_BONE_MARROW_HYPERCELLULARITY,0.927711051818565
GSE3203_UNTREATED_VS_IFNB_TR...2,SET,169,0.055707,0.0053173,0.063431,0.18991,GSE3203_UNTREATED_VS_IFNB_TREATED_LN_BCELL_UP,0.927711051818565
HP_HYPEROPIC_ASTIGMATISM,SET,5,0.29205,0.0048164,0.33256,0.18993,HP_HYPEROPIC_ASTIGMATISM,0.927711051818565
GOMF_TAU_PROTEIN_BINDING,SET,42,0.10771,0.0051429,0.12266,0.18995,GOMF_TAU_PROTEIN_BINDING,0.927711051818565
GOMF_PROLINE_SODIUM_SYMPORTE...,SET,5,0.40426,0.0066669,0.46042,0.18997,GOMF_PROLINE_SODIUM_SYMPORTER_ACTIVITY,0.927711051818565
CDP_01,SET,88,0.087444,0.0060363,0.099601,0.18999,CDP_01,0.927711051818565
GSE1460_CORD_VS_ADULT_BLOOD_...2,SET,165,0.056795,0.0053572,0.06469,0.18999,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP,0.927711051818565
GOBP_SODIUM_ION_TRANSPORT,SET,232,0.052828,0.0058978,0.060183,0.19003,GOBP_SODIUM_ION_TRANSPORT,0.927711051818565
GSE18893_TCONV_VS_TREG_24H_T...2,SET,175,0.052579,0.0051062,0.059906,0.19006,GSE18893_TCONV_VS_TREG_24H_TNF_STIM_UP,0.927711051818565
BURTON_ADIPOGENESIS_PEAK_AT_...5,SET,38,0.12785,0.0058072,0.14567,0.19007,BURTON_ADIPOGENESIS_PEAK_AT_8HR,0.927711051818565
GOBP_B_CELL_CHEMOTAXIS,SET,8,0.29762,0.0062081,0.33912,0.19008,GOBP_B_CELL_CHEMOTAXIS,0.927711051818565
KLEIN_PRIMARY_EFFUSION_LYMPH...1,SET,50,0.11278,0.0058743,0.12853,0.19013,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN,0.927724076406381
GOBP_POSITIVE_REGULATION_OF_...727,SET,24,0.15806,0.0057081,0.18017,0.19017,GOBP_POSITIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,0.927724076406381
MIR4762_5P,SET,128,0.065442,0.0054423,0.074599,0.19018,MIR4762_5P,0.927724076406381
DESCARTES_MAIN_FETAL_LYMPHOI...,SET,116,0.073931,0.0058549,0.084289,0.19022,DESCARTES_MAIN_FETAL_LYMPHOID_CELLS,0.927724076406381
GAO_LARGE_INTESTINE_ADULT_CG...,SET,42,0.1235,0.0058971,0.14084,0.19029,GAO_LARGE_INTESTINE_ADULT_CG_GOBLET_CELL_SUBTYPE_2,0.927724076406381
MIR601,SET,34,0.12758,0.0054821,0.1455,0.1903,MIR601,0.927724076406381
GOBP_APOPTOTIC_CELL_CLEARANCE,SET,46,0.11094,0.0055431,0.12653,0.19031,GOBP_APOPTOTIC_CELL_CLEARANCE,0.927724076406381
GOBP_MACROPHAGE_APOPTOTIC_PR...,SET,12,0.18958,0.0048426,0.21623,0.19031,GOBP_MACROPHAGE_APOPTOTIC_PROCESS,0.927724076406381
HP_MANDIBULAR_PROGNATHIA,SET,174,0.054119,0.0052408,0.061729,0.19033,HP_MANDIBULAR_PROGNATHIA,0.927724076406381
GOBP_MONOCYTE_DIFFERENTIATION,SET,32,0.14132,0.0058918,0.16125,0.19041,GOBP_MONOCYTE_DIFFERENTIATION,0.927724076406381
HP_REDUCED_SYSTOLIC_FUNCTION,SET,21,0.1701,0.0057466,0.19409,0.19041,HP_REDUCED_SYSTOLIC_FUNCTION,0.927724076406381
GOCC_CALYX_OF_HELD,SET,17,0.191,0.0058064,0.21796,0.19044,GOCC_CALYX_OF_HELD,0.927724076406381
GOBP_IMPORT_INTO_CELL,SET,847,0.026472,0.0055504,0.030212,0.19046,GOBP_IMPORT_INTO_CELL,0.927724076406381
GSE19941_UNSTIM_VS_LPS_STIM_...3,SET,174,0.056647,0.0054856,0.064654,0.19048,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,0.927724076406381
NABA_MATRISOME_PRIMARY_METAS...,SET,54,0.11074,0.005994,0.12642,0.19053,NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR,0.927724076406381
HP_HYPERKALEMIA,SET,35,0.13463,0.0058694,0.15371,0.19056,HP_HYPERKALEMIA,0.927724076406381
GSE37416_12H_VS_24H_F_TULARE...2,SET,181,0.054729,0.0054044,0.062485,0.19056,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.927724076406381
GSE22025_PROGESTERONE_VS_TGF...2,SET,177,0.055412,0.0054116,0.063284,0.19063,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.927724076406381
GSE37532_TREG_VS_TCONV_PPARG...4,SET,187,0.053458,0.0053648,0.061054,0.19063,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,0.927724076406381
PATEL_SKIN_OF_BODY_ZOSTAVAX_...5,SET,28,0.15584,0.0060779,0.17799,0.19065,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_6HR_TOP_30_DEG_UP,0.927724076406381
MIR4503,SET,248,0.047566,0.0054879,0.054332,0.19067,MIR4503,0.927724076406381
MANNO_MIDBRAIN_NEUROTYPES_HD...1,SET,516,0.03544,0.0058542,0.040485,0.19069,MANNO_MIDBRAIN_NEUROTYPES_HDA1,0.927724076406381
MIR6894_3P,SET,62,0.093796,0.0054386,0.10716,0.19071,MIR6894_3P,0.927724076406381
HP_UNCONJUGATED_HYPERBILIRUB...,SET,11,0.20639,0.0050476,0.23582,0.19074,HP_UNCONJUGATED_HYPERBILIRUBINEMIA,0.927724076406381
GSE13411_NAIVE_VS_SWITCHED_M...1,SET,178,0.053958,0.0052843,0.061654,0.19075,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_DN,0.927724076406381
GOBP_GLOMERULUS_DEVELOPMENT,SET,68,0.10012,0.0060786,0.11441,0.19078,GOBP_GLOMERULUS_DEVELOPMENT,0.927740156709109
GNF2_GLTSCR2,SET,30,0.12831,0.0051796,0.14669,0.19088,GNF2_GLTSCR2,0.927818781407035
KEGG_MEDICUS_REFERENCE_TLR3_...3,SET,9,0.25542,0.0056507,0.29206,0.19092,KEGG_MEDICUS_REFERENCE_TLR3_NFKB_SIGNALING_PATHWAY,0.927818781407035
HAY_BONE_MARROW_EARLY_ERYTHR...,SET,82,0.080479,0.0053636,0.092034,0.19094,HAY_BONE_MARROW_EARLY_ERYTHROBLAST,0.927818781407035
GOCC_XY_BODY,SET,14,0.19247,0.00531,0.22013,0.19097,GOCC_XY_BODY,0.927818781407035
GOMF_ABC_TYPE_XENOBIOTIC_TRA...,SET,14,0.21559,0.005948,0.24658,0.19098,GOMF_ABC_TYPE_XENOBIOTIC_TRANSPORTER_ACTIVITY,0.927818781407035
GUILLAUMOND_KLF10_TARGETS_DN,SET,27,0.14157,0.0054222,0.16195,0.19102,GUILLAUMOND_KLF10_TARGETS_DN,0.927818781407035
GOBP_APOLIPOPROTEIN_A_I_MEDI...,SET,5,0.33757,0.0055671,0.38616,0.19102,GOBP_APOLIPOPROTEIN_A_I_MEDIATED_SIGNALING_PATHWAY,0.927818781407035
HP_LARGE_INTESTINAL_POLYPOSIS,SET,31,0.12082,0.0049576,0.1382,0.19102,HP_LARGE_INTESTINAL_POLYPOSIS,0.927818781407035
HP_BOWEL_DIVERTICULOSIS,SET,32,0.128,0.0053366,0.14646,0.19107,HP_BOWEL_DIVERTICULOSIS,0.927818781407035
KEGG_VASOPRESSIN_REGULATED_W...,SET,42,0.11,0.0052526,0.1259,0.19114,KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION,0.927818781407035
GOMF_ACETYLATION_DEPENDENT_P...,SET,25,0.14479,0.0053365,0.16572,0.19114,GOMF_ACETYLATION_DEPENDENT_PROTEIN_BINDING,0.927818781407035
GOMF_TRANSFERASE_ACTIVITY_TR...3,SET,178,0.051366,0.0050305,0.05879,0.19114,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ONE_CARBON_GROUPS,0.927818781407035
REACTOME_SIGNALING_BY_NODAL,SET,19,0.1679,0.0053958,0.19218,0.19115,REACTOME_SIGNALING_BY_NODAL,0.927818781407035
GSE19888_ADENOSINE_A3R_INH_V...1,SET,179,0.055685,0.0054687,0.063745,0.19119,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_DN,0.927818781407035
MCCLUNG_DELTA_FOSB_TARGETS_8...,SET,45,0.10734,0.005305,0.1229,0.19122,MCCLUNG_DELTA_FOSB_TARGETS_8WK,0.927818781407035
GNF2_MYL2,SET,32,0.13524,0.005638,0.15485,0.19125,GNF2_MYL2,0.927818781407035
GOCC_SPERM_HEAD,SET,17,0.17306,0.0052609,0.19817,0.19125,GOCC_SPERM_HEAD,0.927818781407035
REACTOME_INCRETIN_SYNTHESIS_...,SET,23,0.15633,0.0055268,0.17911,0.19139,REACTOME_INCRETIN_SYNTHESIS_SECRETION_AND_INACTIVATION,0.928139026597967
GOBP_MODULATION_OF_INHIBITOR...,SET,7,0.31481,0.0061427,0.36069,0.19139,GOBP_MODULATION_OF_INHIBITORY_POSTSYNAPTIC_POTENTIAL,0.928139026597967
GOBP_MRNA_3_SPLICE_SITE_RECO...,SET,6,0.29662,0.0053586,0.33993,0.19144,GOBP_MRNA_3_SPLICE_SITE_RECOGNITION,0.928139026597967
GOMF_NFAT_PROTEIN_BINDING,SET,5,0.31961,0.005271,0.36627,0.19144,GOMF_NFAT_PROTEIN_BINDING,0.928139026597967
HP_DIGITAL_FLEXOR_TENOSYNOVI...,SET,7,0.29492,0.0057546,0.33801,0.19146,HP_DIGITAL_FLEXOR_TENOSYNOVITIS,0.928139026597967
GOBP_POSITIVE_REGULATION_OF_...771,SET,48,0.096397,0.0049199,0.11049,0.19149,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_II,0.928139026597967
GSE25087_TREG_VS_TCONV_FETUS...2,SET,175,0.055152,0.005356,0.06322,0.19151,GSE25087_TREG_VS_TCONV_FETUS_UP,0.928139026597967
GSE1460_NAIVE_CD4_TCELL_ADUL...1,SET,182,0.054219,0.0053687,0.062162,0.19155,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.928139026597967
GOBP_REGULATION_OF_MEIOTIC_C...1,SET,63,0.090763,0.0053048,0.10408,0.1916,GOBP_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.928139026597967
GOBP_PRODUCTION_OF_MOLECULAR...1,SET,84,0.080348,0.0054195,0.092165,0.19167,GOBP_PRODUCTION_OF_MOLECULAR_MEDIATOR_INVOLVED_IN_INFLAMMATORY_RESPONSE,0.928139026597967
DAWSON_METHYLATED_IN_LYMPHOM...,SET,55,0.11763,0.0064254,0.13494,0.19168,DAWSON_METHYLATED_IN_LYMPHOMA_TCL1,0.928139026597967
GOBP_PROTEIN_LOCALIZATION_TO...38,SET,12,0.17067,0.0043597,0.19579,0.19169,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOPLASM,0.928139026597967
WP_HIPPOYAP_SIGNALING,SET,22,0.15452,0.005343,0.17728,0.19171,WP_HIPPOYAP_SIGNALING,0.928139026597967
HP_ABNORMALITY_OF_THE_DENTIT...,SET,875,0.025012,0.005326,0.028698,0.19173,HP_ABNORMALITY_OF_THE_DENTITION,0.928139026597967
GOBP_SKELETAL_MYOFIBRIL_ASSE...,SET,10,0.23625,0.0055094,0.27111,0.19176,GOBP_SKELETAL_MYOFIBRIL_ASSEMBLY,0.928139026597967
HP_FRONTAL_POLYMICROGYRIA,SET,5,0.36037,0.0059431,0.41353,0.19176,HP_FRONTAL_POLYMICROGYRIA,0.928139026597967
GSE41867_NAIVE_VS_DAY30_LCMV...3,SET,180,0.051349,0.0050567,0.058926,0.19177,GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_DN,0.928139026597967
GSE37533_PPARG2_FOXP3_VS_FOX...1,SET,182,0.055536,0.0054991,0.063744,0.19182,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.928170910483085
GOBP_ENDOPLASMIC_RETICULUM_T...1,SET,25,0.13111,0.0048324,0.1505,0.19183,GOBP_ENDOPLASMIC_RETICULUM_TO_CYTOSOL_TRANSPORT,0.928170910483085
GOBP_REGULATION_OF_LIPID_BIO...,SET,162,0.058319,0.0054511,0.066961,0.1919,GOBP_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,0.928347891440501
MIR6766_3P,SET,139,0.060711,0.0052598,0.069714,0.19192,MIR6766_3P,0.928347891440501
HP_INGUINAL_HERNIA,SET,265,0.04557,0.0054323,0.052339,0.19197,HP_INGUINAL_HERNIA,0.928460527414417
MIR4716_5P,SET,107,0.06894,0.0052449,0.079199,0.19203,MIR4716_5P,0.928621490190622
GOCC_MITOCHONDRIAL_SMALL_RIB...,SET,31,0.12314,0.0050531,0.14149,0.19206,GOCC_MITOCHONDRIAL_SMALL_RIBOSOMAL_SUBUNIT,0.928637353923205
NABA_MATRISOME_HIGHLY_METAST...2,SET,26,0.1351,0.0050777,0.15528,0.19215,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED,0.928860700389105
GOBP_FOREBRAIN_DORSAL_VENTRA...,SET,7,0.32763,0.0063928,0.37662,0.19218,GOBP_FOREBRAIN_DORSAL_VENTRAL_PATTERN_FORMATION,0.928860700389105
REACTOME_CELL_CYCLE_CHECKPOI...,SET,241,0.044549,0.0050678,0.051214,0.1922,REACTOME_CELL_CYCLE_CHECKPOINTS,0.928860700389105
GOBP_PEPTIDYL_ARGININE_MODIF...,SET,13,0.18402,0.0048924,0.21163,0.19229,GOBP_PEPTIDYL_ARGININE_MODIFICATION,0.928860700389105
THAKAR_PBMC_INACTIVATED_INFL...4,SET,115,0.067741,0.0053417,0.077906,0.19229,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_UP,0.928860700389105
REACTOME_TRANSCRIPTION_OF_E2...2,SET,16,0.17594,0.0051888,0.20236,0.19231,REACTOME_TRANSCRIPTION_OF_E2F_TARGETS_UNDER_NEGATIVE_CONTROL_BY_P107_RBL1_AND_P130_RBL2_IN_COMPLEX_WITH_HDAC1,0.928860700389105
GOBP_NEGATIVE_REGULATION_OF_...324,SET,28,0.14162,0.0055234,0.16288,0.19231,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,0.928860700389105
REACTOME_OPIOID_SIGNALLING,SET,88,0.079327,0.0054759,0.091242,0.19232,REACTOME_OPIOID_SIGNALLING,0.928860700389105
GOBP_TRANS_SYNAPTIC_SIGNALIN...4,SET,9,0.28547,0.0063155,0.3284,0.19236,GOBP_TRANS_SYNAPTIC_SIGNALING_MODULATING_SYNAPTIC_TRANSMISSION,0.928924802000834
GOBP_VOLUNTARY_MUSCULOSKELET...,SET,7,0.25381,0.0049523,0.29208,0.19244,GOBP_VOLUNTARY_MUSCULOSKELETAL_MOVEMENT,0.929182022784107
GOMF_OLIGOPEPTIDE_TRANSMEMBR...,SET,14,0.20117,0.0055502,0.23162,0.19255,GOMF_OLIGOPEPTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.92943258971872
MAFG_TARGET_GENES,SET,1315,0.020693,0.0053334,0.023829,0.1926,MAFG_TARGET_GENES,0.92943258971872
GSE11864_CSF1_VS_CSF1_IFNG_I...2,SET,161,0.05674,0.0052872,0.065344,0.19262,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_UP,0.92943258971872
GOBP_KINETOCHORE_ASSEMBLY,SET,16,0.17286,0.0050981,0.19915,0.1927,GOBP_KINETOCHORE_ASSEMBLY,0.92943258971872
GOBP_ADRENAL_GLAND_DEVELOPME...,SET,26,0.15867,0.0059636,0.1828,0.19271,GOBP_ADRENAL_GLAND_DEVELOPMENT,0.92943258971872
BIOCARTA_IL6_PATHWAY,SET,20,0.168,0.0055388,0.19359,0.19275,BIOCARTA_IL6_PATHWAY,0.92943258971872
GOBP_VACUOLE_FUSION,SET,12,0.19893,0.0050815,0.22925,0.19277,GOBP_VACUOLE_FUSION,0.92943258971872
HP_ULNAR_DEVIATION_OF_FINGER,SET,33,0.13163,0.0055726,0.1517,0.19278,HP_ULNAR_DEVIATION_OF_FINGER,0.92943258971872
GOMF_DNA_BINDING_TRANSCRIPTI...2,SET,1331,0.023365,0.0060559,0.026928,0.19279,GOMF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.92943258971872
GOBP_UDP_N_ACETYLGLUCOSAMINE...2,SET,14,0.20197,0.0055721,0.23284,0.19286,GOBP_UDP_N_ACETYLGLUCOSAMINE_METABOLIC_PROCESS,0.92943258971872
MODULE_377,SET,10,0.24336,0.0056752,0.28059,0.19288,MODULE_377,0.92943258971872
GOBP_POSITIVE_REGULATION_OF_...316,SET,24,0.1585,0.005724,0.18275,0.19289,GOBP_POSITIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.92943258971872
OSMAN_BLADDER_CANCER_DN,SET,353,0.036785,0.0050488,0.042414,0.1929,OSMAN_BLADDER_CANCER_DN,0.92943258971872
HP_DENTAL_CROWDING,SET,119,0.067144,0.0053853,0.077418,0.1929,HP_DENTAL_CROWDING,0.92943258971872
REACTOME_MODULATION_BY_MTB_O...,SET,6,0.35,0.0063229,0.4036,0.19292,REACTOME_MODULATION_BY_MTB_OF_HOST_IMMUNE_SYSTEM,0.92943258971872
KEGG_REGULATION_OF_ACTIN_CYT...,SET,196,0.053761,0.0055221,0.061996,0.19293,KEGG_REGULATION_OF_ACTIN_CYTOSKELETON,0.92943258971872
GOMF_ATP_DEPENDENT_PROTEIN_F...,SET,31,0.1204,0.0049405,0.13886,0.19297,GOMF_ATP_DEPENDENT_PROTEIN_FOLDING_CHAPERONE,0.92943258971872
RIGGI_EWING_SARCOMA_PROGENIT...1,SET,172,0.061804,0.0059508,0.07129,0.19299,RIGGI_EWING_SARCOMA_PROGENITOR_DN,0.92943258971872
GOMF_INSULIN_BINDING,SET,5,0.30908,0.0050972,0.35653,0.193,GOMF_INSULIN_BINDING,0.92943258971872
GSE20715_0H_VS_48H_OZONE_LUN...1,SET,189,0.051317,0.0051771,0.059221,0.1931,GSE20715_0H_VS_48H_OZONE_LUNG_DN,0.929663851677945
REACTOME_ABACAVIR_TRANSMEMBR...,SET,5,0.38344,0.0063236,0.44259,0.19315,REACTOME_ABACAVIR_TRANSMEMBRANE_TRANSPORT,0.929663851677945
GOCC_CHAPERONIN_CONTAINING_T...,SET,10,0.19373,0.0045177,0.22362,0.19316,GOCC_CHAPERONIN_CONTAINING_T_COMPLEX,0.929663851677945
GOBP_CARBOHYDRATE_DERIVATIVE...4,SET,88,0.080451,0.0055535,0.092889,0.19322,GOBP_CARBOHYDRATE_DERIVATIVE_TRANSPORT,0.929663851677945
DESCARTES_MAIN_FETAL_STELLAT...,SET,44,0.11992,0.0058605,0.13851,0.19331,DESCARTES_MAIN_FETAL_STELLATE_CELLS,0.929663851677945
GOMF_STRUCTURAL_MOLECULE_ACT...1,SET,651,0.030018,0.0055486,0.034676,0.19334,GOMF_STRUCTURAL_MOLECULE_ACTIVITY,0.929663851677945
GOBP_INTERSTRAND_CROSS_LINK_...,SET,34,0.10752,0.0046201,0.12421,0.19336,GOBP_INTERSTRAND_CROSS_LINK_REPAIR,0.929663851677945
AMIT_EGF_RESPONSE_40_MCF10A,SET,15,0.20215,0.0057728,0.23355,0.19337,AMIT_EGF_RESPONSE_40_MCF10A,0.929663851677945
FERRANDO_HOX11_NEIGHBORS,SET,22,0.16437,0.0056836,0.18991,0.19338,FERRANDO_HOX11_NEIGHBORS,0.929663851677945
LEF1_Q2,SET,212,0.052853,0.0056436,0.061072,0.19341,LEF1_Q2,0.929663851677945
HP_MACROCYTIC_ANEMIA,SET,63,0.092422,0.0054018,0.1068,0.19342,HP_MACROCYTIC_ANEMIA,0.929663851677945
HP_PHOCOMELIA,SET,7,0.29268,0.0057109,0.33824,0.19344,HP_PHOCOMELIA,0.929663851677945
GOCC_COHESIN_COMPLEX,SET,8,0.24436,0.005097,0.28241,0.19345,GOCC_COHESIN_COMPLEX,0.929663851677945
DESCARTES_FETAL_EYE_MICROGLIA,SET,127,0.067034,0.005553,0.077477,0.19347,DESCARTES_FETAL_EYE_MICROGLIA,0.929663851677945
WP_SOMATROPH_AXIS_GH_AND_ITS...,SET,6,0.29482,0.005326,0.34084,0.19353,WP_SOMATROPH_AXIS_GH_AND_ITS_RELATIONSHIP_TO_DIETARY_RESTRICTION_AND_AGING,0.929663851677945
WANG_TARGETS_OF_MLL_CBP_FUSI...2,SET,43,0.11046,0.0053368,0.12773,0.19357,WANG_TARGETS_OF_MLL_CBP_FUSION_UP,0.929663851677945
WP_EMBRYONIC_STEM_CELL_PLURI...,SET,108,0.074378,0.0056848,0.086013,0.1936,WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS,0.929663851677945
HP_BILATERAL_COXA_VALGA,SET,13,0.22436,0.0059649,0.25946,0.1936,HP_BILATERAL_COXA_VALGA,0.929663851677945
GSE36476_YOUNG_VS_OLD_DONOR_...7,SET,166,0.059464,0.0056257,0.068776,0.19363,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN,0.929663851677945
GNF2_ELAC2,SET,40,0.10278,0.0047895,0.11889,0.19366,GNF2_ELAC2,0.929663851677945
FRANCO_BLOOD_SANOFI_PASTEUR_...5,SET,19,0.1557,0.0050037,0.18011,0.19367,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_NEGATIVE,0.929663851677945
GOBP_DNA_DAMAGE_RESPONSE_SIG...3,SET,15,0.18418,0.0052595,0.21306,0.19368,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_RESULTING_IN_TRANSCRIPTION,0.929663851677945
DESCARTES_FETAL_LUNG_MESOTHE...,SET,83,0.087155,0.0058437,0.10082,0.19368,DESCARTES_FETAL_LUNG_MESOTHELIAL_CELLS,0.929663851677945
PETRETTO_LEFT_VENTRICLE_MASS...2,SET,5,0.37859,0.0062436,0.43799,0.19369,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_UP,0.929663851677945
GSE28726_NAIVE_VS_ACTIVATED_...6,SET,181,0.051142,0.0050502,0.05919,0.19379,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_UP,0.929818424317618
BACH2_01,SET,242,0.046823,0.0053374,0.054202,0.19384,BACH2_01,0.929818424317618
HE_LIM_SUN_FETAL_LUNG_C2_GMP...,SET,33,0.13777,0.0058326,0.15949,0.19385,HE_LIM_SUN_FETAL_LUNG_C2_GMP_CELL,0.929818424317618
GOCC_TRANSPORT_VESICLE,SET,397,0.037345,0.0054291,0.043236,0.19387,GOCC_TRANSPORT_VESICLE,0.929818424317618
GOBP_IRON_ION_IMPORT_ACROSS_...,SET,4,0.32622,0.004812,0.37773,0.1939,GOBP_IRON_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,0.929818424317618
GSE16385_IFNG_TNF_VS_ROSIGLI...2,SET,160,0.056383,0.0052378,0.065284,0.1939,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,0.929818424317618
GSE21670_IL6_VS_TGFB_AND_IL6...4,SET,187,0.048798,0.0048972,0.056509,0.19392,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,0.929818424317618
HP_RETROBULBAR_OPTIC_NEURITIS,SET,15,0.20723,0.0059178,0.24003,0.19398,HP_RETROBULBAR_OPTIC_NEURITIS,0.929818424317618
MIR7113_5P,SET,136,0.062852,0.0053866,0.07281,0.19401,MIR7113_5P,0.929818424317618
HP_SYNOSTOSIS_OF_METACARPALS...,SET,15,0.18683,0.0053352,0.21642,0.19401,HP_SYNOSTOSIS_OF_METACARPALS_METATARSALS,0.929818424317618
AHR_Q5,SET,195,0.053037,0.005434,0.061452,0.19406,AHR_Q5,0.929818424317618
WP_TYPE_I_INTERFERON_INDUCTI...,SET,28,0.13544,0.0052823,0.15693,0.19407,WP_TYPE_I_INTERFERON_INDUCTION_AND_SIGNALING_DURING_SARSCOV2_INFECTION,0.929818424317618
GOBP_NEGATIVE_REGULATION_OF_...63,SET,4,0.42581,0.0062812,0.49341,0.19407,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.929818424317618
KEGG_MEDICUS_REFERENCE_CYTOK...,SET,42,0.12516,0.0059761,0.14506,0.19413,KEGG_MEDICUS_REFERENCE_CYTOKINE_JAK_STAT_SIGNALING_PATHWAY,0.929977691247415
GOBP_NEGATIVE_REGULATION_OF_...91,SET,104,0.069512,0.0052141,0.080576,0.19416,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,0.929993219404631
HP_ABNORMALITY_OF_TUMOR_NECR...,SET,5,0.35452,0.0058466,0.411,0.19419,HP_ABNORMALITY_OF_TUMOR_NECROSIS_FACTOR_SECRETION,0.930008743282348
GOBP_NEGATIVE_REGULATION_OF_...359,SET,6,0.29342,0.0053007,0.3403,0.19429,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_ACTIVITY,0.930086298540347
GOCC_BRISC_COMPLEX,SET,3,0.41905,0.0053534,0.48602,0.19429,GOCC_BRISC_COMPLEX,0.930086298540347
GTTTGTT_MIR495,SET,228,0.049123,0.0054372,0.056979,0.19432,GTTTGTT_MIR495,0.930086298540347
MURATA_VIRULENCE_OF_H_PILORI,SET,20,0.17386,0.005732,0.20168,0.19434,MURATA_VIRULENCE_OF_H_PILORI,0.930086298540347
HP_EUTHYROID_GOITER,SET,4,0.36306,0.0053555,0.42117,0.19434,HP_EUTHYROID_GOITER,0.930086298540347
GOBP_IMMUNOLOGICAL_SYNAPSE_F...,SET,16,0.19076,0.0056261,0.22136,0.19441,GOBP_IMMUNOLOGICAL_SYNAPSE_FORMATION,0.930293205287071
BUSSLINGER_GASTRIC_MATURE_PI...,SET,208,0.05314,0.0056211,0.06168,0.19447,BUSSLINGER_GASTRIC_MATURE_PIT_CELLS,0.930371975223675
GSE2706_UNSTIM_VS_8H_R848_DC...1,SET,175,0.059792,0.0058066,0.069401,0.19448,GSE2706_UNSTIM_VS_8H_R848_DC_DN,0.930371975223675
GSE19198_6H_VS_24H_IL21_TREA...1,SET,177,0.054869,0.0053586,0.063709,0.19456,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN,0.930626589595376
HP_HYPOPLASIA_OF_THE_EAR_CAR...,SET,10,0.20034,0.0046718,0.23273,0.19467,HP_HYPOPLASIA_OF_THE_EAR_CARTILAGE,0.930944331315355
KEGG_MEDICUS_PATHOGEN_KSHV_M...2,SET,6,0.33777,0.0061019,0.39239,0.19468,KEGG_MEDICUS_PATHOGEN_KSHV_MIR2_TO_CELL_SURFACE_MOLECULE_ENDOCYTOSIS,0.930944331315355
HP_SHUFFLING_GAIT,SET,30,0.12938,0.0052229,0.15034,0.19475,HP_SHUFFLING_GAIT,0.931043065843621
HP_2_HYDROXYGLUTARATE_ACIDUR...,SET,5,0.36062,0.0059472,0.41926,0.19486,HP_2_HYDROXYGLUTARATE_ACIDURIA,0.931043065843621
FEKIR_HEPARG_SPHERE_VS_HEPAR...2,SET,95,0.076736,0.0055027,0.089216,0.19487,FEKIR_HEPARG_SPHERE_VS_HEPARG_UP,0.931043065843621
HP_NEONATAL_ASPHYXIA,SET,12,0.20807,0.005315,0.24194,0.1949,HP_NEONATAL_ASPHYXIA,0.931043065843621
GSE41867_DAY8_EFFECTOR_VS_DA...3,SET,186,0.052349,0.0052396,0.060873,0.19491,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,0.931043065843621
GSE28737_FOLLICULAR_VS_MARGI...1,SET,184,0.052978,0.0052742,0.061618,0.19496,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_DN,0.931043065843621
GOBP_NOREPINEPHRINE_METABOLI...,SET,10,0.26804,0.0062505,0.31177,0.19497,GOBP_NOREPINEPHRINE_METABOLIC_PROCESS,0.931043065843621
HP_AORTIC_ATHEROSCLEROTIC_LE...,SET,9,0.28048,0.0062051,0.32631,0.19502,HP_AORTIC_ATHEROSCLEROTIC_LESION,0.931043065843621
GOBP_MACROMOLECULE_DEPALMITO...,SET,14,0.19631,0.0054162,0.2284,0.19503,GOBP_MACROMOLECULE_DEPALMITOYLATION,0.931043065843621
GOMF_PALMITOYL_HYDROLASE_ACT...,SET,14,0.19631,0.0054162,0.2284,0.19503,GOMF_PALMITOYL_HYDROLASE_ACTIVITY,0.931043065843621
GOBP_REGULATION_OF_POST_TRAN...,SET,211,0.048643,0.0051819,0.056601,0.19507,GOBP_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.931043065843621
MIR4796_3P,SET,224,0.048881,0.0053634,0.056881,0.19508,MIR4796_3P,0.931043065843621
GOBP_POSITIVE_REGULATION_OF_...830,SET,14,0.20716,0.0057154,0.24106,0.19508,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,0.931043065843621
GOMF_DNA_DNA_TETHERING_ACTIV...,SET,5,0.2925,0.0048238,0.34043,0.19512,GOMF_DNA_DNA_TETHERING_ACTIVITY,0.931043065843621
REACTOME_GPER1_SIGNALING,SET,45,0.10804,0.0053397,0.12576,0.19515,REACTOME_GPER1_SIGNALING,0.931043065843621
BOYAULT_LIVER_CANCER_SUBCLAS...15,SET,19,0.17317,0.0055649,0.20159,0.19517,BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN,0.931043065843621
HP_DIMINISHED_MOVEMENT,SET,72,0.081354,0.005082,0.094729,0.19523,HP_DIMINISHED_MOVEMENT,0.931043065843621
AP1_C,SET,249,0.045571,0.0052682,0.05307,0.19526,AP1_C,0.931043065843621
GOMF_AMINO_ACID_PROTON_SYMPO...,SET,6,0.32702,0.0059077,0.38086,0.19527,GOMF_AMINO_ACID_PROTON_SYMPORTER_ACTIVITY,0.931043065843621
GSE2585_CD80_HIGH_VS_LOW_AIR...1,SET,183,0.054511,0.0054122,0.063485,0.19527,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_DN,0.931043065843621
MIR6859_5P,SET,189,0.050927,0.0051378,0.059312,0.19528,MIR6859_5P,0.931043065843621
GOMF_CALCIUM_DEPENDENT_PROTE...3,SET,7,0.20628,0.0040249,0.24024,0.19529,GOMF_CALCIUM_DEPENDENT_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.931043065843621
AML_Q6,SET,238,0.047224,0.005339,0.05501,0.19533,AML_Q6,0.931106041695241
REACTOME_RRNA_PROCESSING,SET,177,0.050456,0.0049276,0.058793,0.1954,REACTOME_RRNA_PROCESSING,0.931184286301933
HP_RECURRENT_BACTERIAL_SKIN_...,SET,23,0.15557,0.0054999,0.18128,0.1954,HP_RECURRENT_BACTERIAL_SKIN_INFECTIONS,0.931184286301933
MIR4640_5P,SET,118,0.062823,0.0050176,0.073217,0.19544,MIR4640_5P,0.931197759353159
HP_SYNOSTOSIS_OF_CARPALS_TAR...,SET,42,0.11897,0.0056809,0.13867,0.19546,HP_SYNOSTOSIS_OF_CARPALS_TARSALS,0.931197759353159
ZHAN_VARIABLE_EARLY_DIFFEREN...2,SET,17,0.18104,0.0055036,0.21104,0.19549,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_UP,0.931197759353159
REACTOME_MITOCHONDRIAL_TRANS...,SET,90,0.070269,0.0049052,0.081918,0.19551,REACTOME_MITOCHONDRIAL_TRANSLATION,0.931197759353159
GOCC_PCG_PROTEIN_COMPLEX,SET,44,0.10498,0.0051303,0.1224,0.19554,GOCC_PCG_PROTEIN_COMPLEX,0.931213030967388
GOCC_NEUROFILAMENT,SET,10,0.26182,0.0061056,0.30544,0.19567,GOCC_NEUROFILAMENT,0.931694401148482
HP_ABNORMAL_BLOOD_POTASSIUM_...,SET,105,0.074247,0.0055959,0.086625,0.1957,HP_ABNORMAL_BLOOD_POTASSIUM_CONCENTRATION,0.931694401148482
GOBP_REGULATION_OF_LIPID_LOC...,SET,154,0.060152,0.0054831,0.070198,0.19576,GOBP_REGULATION_OF_LIPID_LOCALIZATION,0.931694401148482
HP_DELAYED_ERUPTION_OF_TEETH,SET,153,0.05921,0.0053798,0.06911,0.1958,HP_DELAYED_ERUPTION_OF_TEETH,0.931694401148482
BIOCARTA_PLC_PATHWAY,SET,9,0.24456,0.0054105,0.28551,0.19585,BIOCARTA_PLC_PATHWAY,0.931694401148482
HALLMARK_PI3K_AKT_MTOR_SIGNA...,SET,102,0.067429,0.0050093,0.078729,0.19588,HALLMARK_PI3K_AKT_MTOR_SIGNALING,0.931694401148482
GOBP_NEURAL_PLATE_MORPHOGENE...,SET,4,0.29151,0.0043001,0.34038,0.19589,GOBP_NEURAL_PLATE_MORPHOGENESIS,0.931694401148482
REACTOME_GLYCINE_DEGRADATION,SET,7,0.22571,0.0044041,0.26358,0.19591,REACTOME_GLYCINE_DEGRADATION,0.931694401148482
REACTOME_FC_EPSILON_RECEPTOR...,SET,125,0.0603,0.004956,0.070423,0.19593,REACTOME_FC_EPSILON_RECEPTOR_FCERI_SIGNALING,0.931694401148482
REACTOME_REDUCTION_OF_CYTOSO...,SET,11,0.21115,0.005164,0.2466,0.19595,REACTOME_REDUCTION_OF_CYTOSOLIC_CA_LEVELS,0.931694401148482
GOBP_CYTOPLASMIC_PATTERN_REC...,SET,148,0.057747,0.0051611,0.067444,0.19595,GOBP_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.931694401148482
GOBP_COBALAMIN_METABOLIC_PRO...,SET,9,0.24299,0.0053757,0.28382,0.19597,GOBP_COBALAMIN_METABOLIC_PROCESS,0.931694401148482
LMTK3_TARGET_GENES,SET,426,0.035595,0.005356,0.04159,0.19605,LMTK3_TARGET_GENES,0.931694401148482
MODULE_213,SET,75,0.087132,0.0055547,0.10181,0.19605,MODULE_213,0.931694401148482
ATF1_Q6,SET,219,0.05178,0.0056185,0.060504,0.19606,ATF1_Q6,0.931694401148482
GOCC_BETA_CATENIN_DESTRUCTIO...,SET,12,0.20834,0.0053218,0.24346,0.19607,GOCC_BETA_CATENIN_DESTRUCTION_COMPLEX,0.931694401148482
HP_CEREBRAL_PALSY,SET,157,0.057447,0.0052868,0.067161,0.19618,HP_CEREBRAL_PALSY,0.931792308741306
HP_NEOPLASM_OF_THE_PANCREAS,SET,86,0.076202,0.0052004,0.0891,0.19621,HP_NEOPLASM_OF_THE_PANCREAS,0.931792308741306
MORF_PPP1CC,SET,146,0.056424,0.005009,0.065981,0.19624,MORF_PPP1CC,0.931792308741306
GOBP_RESPONSE_TO_PROSTAGLAND...2,SET,5,0.40456,0.0066719,0.47313,0.19626,GOBP_RESPONSE_TO_PROSTAGLANDIN_D,0.931792308741306
GSE17974_IL4_AND_ANTI_IL12_V...2,SET,149,0.056177,0.0050376,0.065712,0.19631,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_0.5H_ACT_CD4_TCELL_UP,0.931792308741306
HP_PALMAR_PITS,SET,8,0.18985,0.0039601,0.22209,0.19633,HP_PALMAR_PITS,0.931792308741306
HE_LIM_SUN_FETAL_LUNG_C7_MID...,SET,237,0.050639,0.0057132,0.059251,0.19638,HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL,0.931792308741306
HEBERT_MATRISOME_TNBC_BONE_B...1,SET,13,0.21746,0.0057816,0.2545,0.19642,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LIVER_LUNG_METASTASTASES,0.931792308741306
HP_CRANIOFACIAL_DISPROPORTION,SET,6,0.29296,0.0052924,0.34289,0.19645,HP_CRANIOFACIAL_DISPROPORTION,0.931792308741306
GOMF_C_ACETYLTRANSFERASE_ACT...,SET,7,0.23694,0.0046233,0.27733,0.19646,GOMF_C_ACETYLTRANSFERASE_ACTIVITY,0.931792308741306
KEGG_MEDICUS_VARIANT_IGF2_OV...,SET,14,0.19438,0.0053627,0.22752,0.19647,KEGG_MEDICUS_VARIANT_IGF2_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,0.931792308741306
CAMP_UP.V1_DN,SET,178,0.054256,0.0053136,0.063516,0.1965,CAMP_UP.V1_DN,0.931792308741306
WP_INFLUENCE_OF_LAMINOPATHIE...,SET,33,0.12613,0.0053397,0.14767,0.19652,WP_INFLUENCE_OF_LAMINOPATHIES_ON_WNT_SIGNALING,0.931792308741306
HP_LIMB_TREMOR,SET,20,0.16898,0.0055711,0.19783,0.19652,HP_LIMB_TREMOR,0.931792308741306
GSE46242_TH1_VS_ANERGIC_TH1_...1,SET,158,0.057179,0.0052788,0.06695,0.19654,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_DN,0.931792308741306
NFAT_Q4_01,SET,243,0.04838,0.0055261,0.056653,0.19657,NFAT_Q4_01,0.931792308741306
GSE37605_FOXP3_FUSION_GFP_VS...1,SET,157,0.058993,0.0054291,0.069082,0.19657,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_DN,0.931792308741306
GOCC_RNA_POLYMERASE_II_CORE_...,SET,13,0.17617,0.0046837,0.20631,0.19659,GOCC_RNA_POLYMERASE_II_CORE_COMPLEX,0.931792308741306
URS_ADIPOCYTE_DIFFERENTIATIO...1,SET,31,0.13734,0.0056359,0.16085,0.1966,URS_ADIPOCYTE_DIFFERENTIATION_DN,0.931792308741306
MIR4511,SET,139,0.061365,0.0053164,0.07188,0.19664,MIR4511,0.931805376857026
REACTOME_DEFECTIVE_EXT2_CAUS...,SET,12,0.2337,0.0059697,0.27379,0.19667,REACTOME_DEFECTIVE_EXT2_CAUSES_EXOSTOSES_2,0.931805376857026
RAO_BOUND_BY_SALL4_ISOFORM_B,SET,463,0.034553,0.0054148,0.040484,0.19669,RAO_BOUND_BY_SALL4_ISOFORM_B,0.931805376857026
GSE46606_IRF4HIGH_VS_IRF4MID...3,SET,181,0.055122,0.0054432,0.064585,0.19671,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.931805376857026
GSE19888_NO_PRETREAT_VS_ADEN...1,SET,179,0.052218,0.0051282,0.061202,0.19678,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_DN,0.931958674993212
WEIGEL_OXIDATIVE_STRESS_BY_H...2,SET,59,0.098282,0.0055596,0.11526,0.19691,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_TBH,0.931958674993212
HP_PREDOMINANTLY_LOWER_LIMB_...,SET,8,0.26164,0.0054574,0.30685,0.19693,HP_PREDOMINANTLY_LOWER_LIMB_LYMPHEDEMA,0.931958674993212
GOBP_DOUBLE_STRAND_BREAK_REP...4,SET,12,0.20239,0.0051699,0.23739,0.19696,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_BREAK_INDUCED_REPLICATION,0.931958674993212
GOBP_RESPONSE_TO_NITROSATIVE...,SET,10,0.21884,0.0051033,0.25669,0.19696,GOBP_RESPONSE_TO_NITROSATIVE_STRESS,0.931958674993212
REACTOME_SIGNALING_BY_MODERA...,SET,42,0.11164,0.0053306,0.13097,0.19701,REACTOME_SIGNALING_BY_MODERATE_KINASE_ACTIVITY_BRAF_MUTANTS,0.931958674993212
HP_THROMBOCYTOSIS,SET,55,0.092748,0.0050661,0.10881,0.19701,HP_THROMBOCYTOSIS,0.931958674993212
REACTOME_BILE_ACID_AND_BILE_...,SET,44,0.11425,0.0055832,0.13404,0.19703,REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM,0.931958674993212
GOBP_NEGATIVE_REGULATION_OF_...312,SET,6,0.36269,0.006552,0.42555,0.19703,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,0.931958674993212
GSE37336_LY6C_POS_VS_NEG_NAI...1,SET,141,0.06184,0.0053957,0.072561,0.19705,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_DN,0.931958674993212
GOBP_DOUBLE_STRAND_BREAK_REP...2,SET,7,0.2426,0.0047337,0.28469,0.19707,GOBP_DOUBLE_STRAND_BREAK_REPAIR_INVOLVED_IN_MEIOTIC_RECOMBINATION,0.931958674993212
HP_ABNORMAL_TRAGUS_MORPHOLOGY,SET,11,0.20417,0.0049934,0.23963,0.1971,HP_ABNORMAL_TRAGUS_MORPHOLOGY,0.931958674993212
GOBP_ANTIGEN_PROCESSING_AND_...7,SET,8,0.22704,0.0047358,0.26647,0.19711,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_I,0.931958674993212
MOOTHA_GLUCONEOGENESIS,SET,27,0.12628,0.0048365,0.14823,0.19714,MOOTHA_GLUCONEOGENESIS,0.931958674993212
HP_ANTIMITOCHONDRIAL_ANTIBOD...,SET,11,0.25953,0.0063474,0.30466,0.19715,HP_ANTIMITOCHONDRIAL_ANTIBODY_POSITIVITY,0.931958674993212
HP_ABSENT_EARLOBE,SET,20,0.15334,0.0050557,0.18005,0.1972,HP_ABSENT_EARLOBE,0.931958674993212
MORF_ACP1,SET,198,0.046954,0.0048472,0.055137,0.19723,MORF_ACP1,0.931958674993212
GOBP_NEGATIVE_REGULATION_OF_...504,SET,26,0.15657,0.0058848,0.18393,0.19732,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,0.931958674993212
HOFFMANN_LARGE_TO_SMALL_PRE_...2,SET,142,0.057438,0.0050292,0.067478,0.19733,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_UP,0.931958674993212
GOBP_REGULATION_OF_FEMALE_GO...,SET,7,0.29863,0.0058269,0.35083,0.19733,GOBP_REGULATION_OF_FEMALE_GONAD_DEVELOPMENT,0.931958674993212
HP_NARROW_NOSE,SET,21,0.1612,0.0054457,0.18938,0.19734,HP_NARROW_NOSE,0.931958674993212
GOMF_AMP_ACTIVATED_PROTEIN_K...,SET,8,0.24723,0.0051569,0.29046,0.19735,GOMF_AMP_ACTIVATED_PROTEIN_KINASE_ACTIVITY,0.931958674993212
GSE21546_ELK1_KO_VS_SAP1A_KO...3,SET,180,0.050434,0.0049666,0.059259,0.19737,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,0.931958674993212
GSE27241_CTRL_VS_DIGOXIN_TRE...1,SET,176,0.054806,0.0053374,0.064402,0.19739,GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,0.931958674993212
GOMF_OXIDOREDUCTASE_ACTIVITY...16,SET,50,0.089338,0.0046534,0.105,0.19743,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_QUINONE_OR_SIMILAR_COMPOUND_AS_ACCEPTOR,0.931958674993212
GOBP_CORONARY_VASCULATURE_MO...,SET,17,0.18568,0.0056445,0.21824,0.19745,GOBP_CORONARY_VASCULATURE_MORPHOGENESIS,0.931958674993212
MIR5190,SET,121,0.066808,0.0054029,0.078532,0.19747,MIR5190,0.931958674993212
GSE41176_UNSTIM_VS_ANTI_IGM_...16,SET,161,0.054477,0.0050764,0.064044,0.1975,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_UP,0.931958674993212
YAMANAKA_GLIOBLASTOMA_SURVIV...2,SET,9,0.25484,0.005638,0.29963,0.19752,YAMANAKA_GLIOBLASTOMA_SURVIVAL_UP,0.931958674993212
GOBP_BLOOD_COAGULATION_INTRI...,SET,6,0.3494,0.006312,0.41086,0.19755,GOBP_BLOOD_COAGULATION_INTRINSIC_PATHWAY,0.931973700285055
REACTOME_RESPONSE_OF_EIF2AK4...,SET,91,0.073233,0.0051403,0.086126,0.19758,REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY,0.931988721498371
YAO_TEMPORAL_RESPONSE_TO_PRO...7,SET,132,0.060759,0.0051307,0.071471,0.19763,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_14,0.932063766445138
HP_HYPOKINESIA,SET,46,0.097209,0.0048571,0.11435,0.19765,HP_HYPOKINESIA,0.932063766445138
HANN_RESISTANCE_TO_BCL2_INHI...2,SET,30,0.14274,0.0057623,0.16795,0.19769,HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP,0.932063766445138
WP_MITOCHONDRIAL_COMPLEX_IV_...,SET,28,0.11583,0.0045177,0.1363,0.19772,WP_MITOCHONDRIAL_COMPLEX_IV_ASSEMBLY,0.932063766445138
HP_ABNORMALITY_OF_THE_URETHRA,SET,375,0.036275,0.0051285,0.042689,0.19773,HP_ABNORMALITY_OF_THE_URETHRA,0.932063766445138
GOBP_NEGATIVE_REGULATION_OF_...575,SET,1112,0.022255,0.0053059,0.026193,0.19777,GOBP_NEGATIVE_REGULATION_OF_RNA_BIOSYNTHETIC_PROCESS,0.932125895036615
chr6q15,SET,23,0.24253,0.0085743,0.28554,0.19784,chr6q15,0.932170841805612
CROONQUIST_STROMAL_STIMULATI...2,SET,49,0.11462,0.0059102,0.13496,0.19786,CROONQUIST_STROMAL_STIMULATION_UP,0.932170841805612
GOMF_HISTONE_H3K27ME2_H3K27M...,SET,2,0.45202,0.0047151,0.53221,0.19786,GOMF_HISTONE_H3K27ME2_H3K27ME3_DEMETHYLASE_ACTIVITY,0.932170841805612
GOBP_RETINAL_GANGLION_CELL_A...,SET,22,0.16916,0.0058491,0.1992,0.19789,GOBP_RETINAL_GANGLION_CELL_AXON_GUIDANCE,0.932185815939279
HP_EXCESSIVE_SHYNESS,SET,8,0.21326,0.0044484,0.25118,0.19794,HP_EXCESSIVE_SHYNESS,0.93221575203252
GOBP_RELAXATION_OF_MUSCLE,SET,31,0.1355,0.0055604,0.15961,0.19795,GOBP_RELAXATION_OF_MUSCLE,0.93221575203252
GSE21546_ELK1_KO_VS_SAP1A_KO...4,SET,172,0.053562,0.0051573,0.063106,0.19801,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,0.932245671904633
GSE21546_UNSTIM_VS_ANTI_CD3_...1,SET,170,0.051501,0.0049301,0.060678,0.19801,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.932245671904633
REACTOME_ACTIVATION_OF_THE_T...,SET,11,0.22079,0.0053999,0.26021,0.19808,REACTOME_ACTIVATION_OF_THE_TFAP2_AP_2_FAMILY_OF_TRANSCRIPTION_FACTORS,0.93244892320195
GOMF_HISTONE_ACETYLTRANSFERA...,SET,23,0.15308,0.0054118,0.18044,0.19812,GOMF_HISTONE_ACETYLTRANSFERASE_BINDING,0.932510915492958
GSE22140_GERMFREE_VS_SPF_ART...1,SET,175,0.052865,0.0051339,0.062356,0.19828,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_DN,0.933137630331754
GOBP_POSITIVE_REGULATION_OF_...594,SET,12,0.2352,0.0060079,0.27756,0.19839,GOBP_POSITIVE_REGULATION_OF_PLATELET_ACTIVATION,0.933257828316912
GOBP_REGULATION_OF_SEROTONIN...,SET,6,0.302,0.0054557,0.3564,0.1984,GOBP_REGULATION_OF_SEROTONIN_SECRETION,0.933257828316912
GOBP_OLIGOPEPTIDE_IMPORT_ACR...,SET,5,0.34315,0.0056592,0.40501,0.19843,GOBP_OLIGOPEPTIDE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.933257828316912
GOBP_REGULATION_OF_MRNA_CIS_...,SET,3,0.36439,0.0046551,0.43009,0.19843,GOBP_REGULATION_OF_MRNA_CIS_SPLICING_VIA_SPLICEOSOME,0.933257828316912
GOBP_MAINTENANCE_OF_SYNAPSE_...,SET,24,0.15255,0.0055091,0.18006,0.19844,GOBP_MAINTENANCE_OF_SYNAPSE_STRUCTURE,0.933257828316912
MIKKELSEN_NPC_HCP_WITH_H3K27...,SET,330,0.043965,0.0058381,0.051917,0.19855,MIKKELSEN_NPC_HCP_WITH_H3K27ME3,0.933257828316912
GOBP_GLYCINE_IMPORT_ACROSS_P...,SET,5,0.37723,0.0062212,0.44556,0.1986,GOBP_GLYCINE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.933257828316912
GOBP_OUTER_EAR_MORPHOGENESIS,SET,8,0.2619,0.005463,0.30934,0.1986,GOBP_OUTER_EAR_MORPHOGENESIS,0.933257828316912
KEGG_MEDICUS_VARIANT_MUTATIO...35,SET,8,0.26468,0.0055208,0.31265,0.19863,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006,0.933257828316912
BIOCARTA_VOBESITY_PATHWAY,SET,8,0.28644,0.0059749,0.33838,0.19864,BIOCARTA_VOBESITY_PATHWAY,0.933257828316912
E2F4DP1_01,SET,209,0.049846,0.0052852,0.05891,0.19874,E2F4DP1_01,0.933257828316912
MIR4507,SET,34,0.10909,0.0046877,0.12894,0.19877,MIR4507,0.933257828316912
GOBP_NEGATIVE_REGULATION_OF_...580,SET,5,0.32355,0.0053359,0.38244,0.19878,GOBP_NEGATIVE_REGULATION_OF_SATELLITE_CELL_DIFFERENTIATION,0.933257828316912
GOBP_REGULATION_OF_SUPEROXID...1,SET,20,0.17049,0.005621,0.20158,0.19885,GOBP_REGULATION_OF_SUPEROXIDE_ANION_GENERATION,0.933257828316912
HP_ATHETOSIS,SET,139,0.060743,0.0052625,0.071825,0.19887,HP_ATHETOSIS,0.933257828316912
GOBP_REGULATION_OF_INSULIN_R...,SET,65,0.084471,0.0050146,0.099891,0.19888,GOBP_REGULATION_OF_INSULIN_RECEPTOR_SIGNALING_PATHWAY,0.933257828316912
GSE24671_CTRL_VS_SENDAI_VIRU...1,SET,177,0.049914,0.0048747,0.059032,0.19891,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,0.933257828316912
GOBP_3_PHOSPHOADENOSINE_5_PH...,SET,15,0.20683,0.0059063,0.24462,0.19892,GOBP_3_PHOSPHOADENOSINE_5_PHOSPHOSULFATE_METABOLIC_PROCESS,0.933257828316912
KEGG_CHEMOKINE_SIGNALING_PAT...,SET,176,0.056643,0.0055163,0.066995,0.19893,KEGG_CHEMOKINE_SIGNALING_PATHWAY,0.933257828316912
GSE4590_SMALL_VS_VPREB_POS_L...1,SET,139,0.061614,0.005338,0.072876,0.19893,GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.933257828316912
MENON_FETAL_KIDNEY_5_PROXIMA...,SET,89,0.079596,0.0055255,0.094143,0.19893,MENON_FETAL_KIDNEY_5_PROXIMAL_TUBULE_CELLS,0.933257828316912
GOBP_NEGATIVE_REGULATION_OF_...130,SET,7,0.27452,0.0053565,0.32471,0.19894,GOBP_NEGATIVE_REGULATION_OF_CENTRIOLE_REPLICATION,0.933257828316912
GOBP_SMOOTH_MUSCLE_CELL_APOP...,SET,29,0.12832,0.0050934,0.15179,0.19894,GOBP_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.933257828316912
GOBP_POSITIVE_REGULATION_OF_...114,SET,453,0.035895,0.0055655,0.04246,0.19895,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION,0.933257828316912
HP_BUNDLE_BRANCH_BLOCK,SET,68,0.084432,0.0051262,0.099903,0.19902,HP_BUNDLE_BRANCH_BLOCK,0.933407949029126
PID_SMAD2_3PATHWAY,SET,16,0.18713,0.005519,0.22144,0.19904,PID_SMAD2_3PATHWAY,0.933407949029126
GOCC_EKC_KEOPS_COMPLEX,SET,3,0.3994,0.0051024,0.47268,0.19907,GOCC_EKC_KEOPS_COMPLEX,0.933407949029126
GNF2_PCNA,SET,64,0.086176,0.0050764,0.10201,0.19913,GNF2_PCNA,0.933407949029126
GOBP_REGULATION_OF_NUCLEAR_T...2,SET,11,0.20347,0.0049764,0.24091,0.19917,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,0.933407949029126
GOCC_DYSTROGLYCAN_COMPLEX,SET,7,0.23453,0.0045761,0.27768,0.19917,GOCC_DYSTROGLYCAN_COMPLEX,0.933407949029126
GSE24142_DN2_VS_DN3_THYMOCYT...3,SET,186,0.053413,0.0053461,0.06324,0.19917,GSE24142_DN2_VS_DN3_THYMOCYTE_DN,0.933407949029126
BREDEMEYER_RAG_SIGNALING_VIA...2,SET,46,0.1136,0.0056763,0.13452,0.19921,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_UP,0.93346953620062
REACTOME_SYNTHESIS_SECRETION...2,SET,20,0.16796,0.0055378,0.19894,0.19926,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCAGON_LIKE_PEPTIDE_1_GLP_1,0.933577959018603
MIR6783_3P,SET,185,0.051902,0.005181,0.061481,0.19929,MIR6783_3P,0.933589915117219
HP_SUPRAVENTRICULAR_TACHYCAR...,SET,51,0.10851,0.0057081,0.12857,0.19935,HP_SUPRAVENTRICULAR_TACHYCARDIA,0.933589915117219
GOBP_CELLULAR_RESPONSE_TO_SA...2,SET,14,0.19495,0.0053786,0.23102,0.19937,GOBP_CELLULAR_RESPONSE_TO_SALT_STRESS,0.933589915117219
GOBP_VESICLE_FUSION_TO_PLASM...,SET,23,0.14204,0.0050214,0.16831,0.19937,GOBP_VESICLE_FUSION_TO_PLASMA_MEMBRANE,0.933589915117219
BLALOCK_ALZHEIMERS_DISEASE_I...2,SET,350,0.037365,0.0051069,0.044281,0.1994,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP,0.93360460730163
HP_CRANIOFACIAL_DYSOSTOSIS,SET,8,0.23348,0.0048701,0.27678,0.19946,HP_CRANIOFACIAL_DYSOSTOSIS,0.933680787878788
FAN_OVARY_CL3_MATURE_CUMULUS...,SET,200,0.05136,0.0053285,0.060887,0.19947,FAN_OVARY_CL3_MATURE_CUMULUS_GRANULOSA_CELL_1,0.933680787878788
GOBP_LACTATE_METABOLIC_PROCE...,SET,16,0.17206,0.0050746,0.20406,0.19956,GOBP_LACTATE_METABOLIC_PROCESS,0.933850518378888
GSE12198_CTRL_VS_LOW_IL2_STI...1,SET,192,0.049626,0.0050456,0.058854,0.19956,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_DN,0.933850518378888
GAVISH_3CA_MALIGNANT_METAPRO...12,SET,38,0.10135,0.0046037,0.12024,0.19964,GAVISH_3CA_MALIGNANT_METAPROGRAM_21_RESPIRATION,0.934099111470113
GOBP_POSITIVE_REGULATION_OF_...171,SET,30,0.13146,0.0053068,0.15603,0.19975,GOBP_POSITIVE_REGULATION_OF_COAGULATION,0.934110470257235
GOBP_REGULATION_OF_FATTY_ACI...2,SET,41,0.10482,0.0049453,0.12441,0.19975,GOBP_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.934110470257235
MIR3127_3P,SET,95,0.068577,0.0049176,0.081396,0.19976,MIR3127_3P,0.934110470257235
chr7p22,SET,67,0.19282,0.011621,0.22889,0.19979,chr7p22,0.934110470257235
GOBP_PULMONARY_VALVE_MORPHOG...,SET,20,0.18682,0.0061593,0.22179,0.19981,GOBP_PULMONARY_VALVE_MORPHOGENESIS,0.934110470257235
HP_PLEURAL_EFFUSION,SET,78,0.082379,0.0053553,0.097814,0.19984,HP_PLEURAL_EFFUSION,0.934110470257235
GSE13547_WT_VS_ZFX_KO_BCELL_...2,SET,125,0.0683,0.0056135,0.081112,0.19989,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_UP,0.934110470257235
HP_ABNORMAL_AMPLITUDE_OF_DAR...,SET,14,0.19639,0.0054182,0.23324,0.1999,HP_ABNORMAL_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM,0.934110470257235
VALK_AML_WITH_EVI1,SET,22,0.16795,0.0058071,0.19948,0.19992,VALK_AML_WITH_EVI1,0.934110470257235
HP_ESOPHAGEAL_STRICTURE,SET,19,0.16027,0.0051504,0.1904,0.19997,HP_ESOPHAGEAL_STRICTURE,0.934110470257235
GSE19401_NAIVE_VS_IMMUNIZED_...2,SET,186,0.053655,0.0053702,0.063756,0.20002,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP,0.934110470257235
NFXL1_TARGET_GENES,SET,341,0.039376,0.0053136,0.046792,0.20003,NFXL1_TARGET_GENES,0.934110470257235
KEGG_MEDICUS_REFERENCE_CENPE...,SET,12,0.19374,0.0049489,0.23023,0.20004,KEGG_MEDICUS_REFERENCE_CENPE_INTERACTION_WITH_NDC80_COMPLEX,0.934110470257235
GSE11961_PLASMA_CELL_DAY7_VS...3,SET,177,0.053617,0.0052363,0.063726,0.20008,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,0.934110470257235
GOMF_CULLIN_FAMILY_PROTEIN_B...,SET,21,0.14391,0.0048619,0.17108,0.20012,GOMF_CULLIN_FAMILY_PROTEIN_BINDING,0.934110470257235
GOBP_POSITIVE_REGULATION_OF_...817,SET,92,0.073684,0.0052002,0.087621,0.2002,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.934110470257235
GOMF_PENTOSYLTRANSFERASE_ACT...,SET,47,0.099993,0.0050501,0.11891,0.2002,GOMF_PENTOSYLTRANSFERASE_ACTIVITY,0.934110470257235
GSE3982_BASOPHIL_VS_CENT_MEM...1,SET,172,0.052917,0.0050951,0.062927,0.2002,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.934110470257235
DESCARTES_FETAL_ADRENAL_MEGA...,SET,86,0.077261,0.0052727,0.091897,0.20025,DESCARTES_FETAL_ADRENAL_MEGAKARYOCYTES,0.934110470257235
HAN_SATB1_TARGETS_UP,SET,388,0.037754,0.0054272,0.044908,0.20027,HAN_SATB1_TARGETS_UP,0.934110470257235
GOBP_PROTEIN_HISTIDYL_MODIFI...,SET,7,0.23102,0.0045078,0.27483,0.20029,GOBP_PROTEIN_HISTIDYL_MODIFICATION_TO_DIPHTHAMIDE,0.934110470257235
GSE15330_LYMPHOID_MULTIPOTEN...7,SET,149,0.058583,0.0052533,0.069697,0.20031,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP,0.934110470257235
GOBP_O_GLYCAN_PROCESSING,SET,41,0.12025,0.005673,0.14307,0.20034,GOBP_O_GLYCAN_PROCESSING,0.934110470257235
THAKAR_PBMC_INACTIVATED_INFL...10,SET,127,0.062595,0.0051853,0.074484,0.20035,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_DN,0.934110470257235
GOTZMANN_EPITHELIAL_TO_MESEN...2,SET,65,0.091235,0.0054161,0.1086,0.20043,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP,0.934110470257235
KEGG_MEDICUS_VARIANT_MUTATIO...88,SET,11,0.21434,0.0052422,0.25515,0.20045,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY,0.934110470257235
GOBP_MINERALOCORTICOID_SECRE...,SET,7,0.30285,0.0059093,0.36052,0.20045,GOBP_MINERALOCORTICOID_SECRETION,0.934110470257235
LU_AGING_BRAIN_DN,SET,139,0.059886,0.0051883,0.071293,0.20046,LU_AGING_BRAIN_DN,0.934110470257235
GOBP_RRNA_MODIFICATION,SET,25,0.12186,0.0044912,0.14508,0.20048,GOBP_RRNA_MODIFICATION,0.934110470257235
GOBP_MYELIN_MAINTENANCE,SET,15,0.18395,0.005253,0.21901,0.20049,GOBP_MYELIN_MAINTENANCE,0.934110470257235
HP_ABNORMALITY_OF_THE_GLABEL...,SET,22,0.15256,0.0052752,0.18169,0.20055,HP_ABNORMALITY_OF_THE_GLABELLA,0.934110470257235
GOBP_POSITIVE_REGULATION_OF_...75,SET,13,0.19681,0.0052326,0.2344,0.20056,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.934110470257235
HALLMARK_ESTROGEN_RESPONSE_E...,SET,187,0.055556,0.0055753,0.066169,0.20057,HALLMARK_ESTROGEN_RESPONSE_EARLY,0.934110470257235
REACTOME_GABA_RECEPTOR_ACTIV...,SET,57,0.10309,0.0057321,0.1228,0.20059,REACTOME_GABA_RECEPTOR_ACTIVATION,0.934110470257235
GOBP_GLUCOSAMINE_CONTAINING_...2,SET,21,0.16094,0.0054371,0.19172,0.20061,GOBP_GLUCOSAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,0.934110470257235
GOBP_NEGATIVE_REGULATION_OF_...461,SET,18,0.15005,0.0046934,0.17874,0.20061,GOBP_NEGATIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,0.934110470257235
GUTIERREZ_WALDENSTROEMS_MACR...1,SET,8,0.27863,0.0058118,0.33206,0.20072,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN,0.934119127292196
OUILLETTE_CLL_13Q14_DELETION...1,SET,47,0.10702,0.0054051,0.12756,0.20074,OUILLETTE_CLL_13Q14_DELETION_DN,0.934119127292196
HP_ABNORMAL_SUBARACHNOID_SPA...,SET,70,0.084996,0.0052355,0.10131,0.20075,HP_ABNORMAL_SUBARACHNOID_SPACE_MORPHOLOGY,0.934119127292196
HOELZEL_NF1_TARGETS_UP,SET,115,0.070963,0.0055957,0.08459,0.20076,HOELZEL_NF1_TARGETS_UP,0.934119127292196
HP_ACUTE_HEPATIC_FAILURE,SET,31,0.119,0.0048833,0.14187,0.20079,HP_ACUTE_HEPATIC_FAILURE,0.934119127292196
MODY_HIPPOCAMPUS_PRENATAL,SET,42,0.10139,0.0048415,0.12088,0.2008,MODY_HIPPOCAMPUS_PRENATAL,0.934119127292196
GSE18893_CTRL_VS_TNF_TREATED...4,SET,182,0.050139,0.0049647,0.059775,0.2008,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_UP,0.934119127292196
GOBP_EMBRYONIC_CAMERA_TYPE_E...2,SET,11,0.23016,0.0056291,0.27444,0.20083,GOBP_EMBRYONIC_CAMERA_TYPE_EYE_FORMATION,0.934133652301927
REACTOME_REGULATION_OF_NF_KA...,SET,16,0.16487,0.0048624,0.19664,0.2009,REACTOME_REGULATION_OF_NF_KAPPA_B_SIGNALING,0.934249001814882
GOMF_INTRAMEMBRANE_LIPID_TRA...,SET,41,0.11499,0.0054252,0.13726,0.20109,GOMF_INTRAMEMBRANE_LIPID_TRANSPORTER_ACTIVITY,0.934249001814882
WP_ATM_SIGNALING_IN_DEVELOPM...,SET,43,0.10137,0.0048976,0.12106,0.2012,WP_ATM_SIGNALING_IN_DEVELOPMENT_AND_DISEASE,0.934249001814882
MODULE_80,SET,32,0.14104,0.00588,0.16846,0.20124,MODULE_80,0.934249001814882
GOBP_T_CELL_ACTIVATION,SET,528,0.032982,0.0055095,0.0394,0.20127,GOBP_T_CELL_ACTIVATION,0.934249001814882
NADELLA_PRKAR1A_TARGETS_DN,SET,7,0.26187,0.0051096,0.31284,0.20128,NADELLA_PRKAR1A_TARGETS_DN,0.934249001814882
GOBP_MIDBODY_ABSCISSION,SET,17,0.16743,0.0050898,0.20003,0.20129,GOBP_MIDBODY_ABSCISSION,0.934249001814882
HP_GERM_CELL_NEOPLASIA,SET,40,0.11325,0.0052776,0.13532,0.20132,HP_GERM_CELL_NEOPLASIA,0.934249001814882
GOBP_BILE_ACID_BIOSYNTHETIC_...,SET,36,0.12042,0.0053243,0.14389,0.20133,GOBP_BILE_ACID_BIOSYNTHETIC_PROCESS,0.934249001814882
MIR6760_5P,SET,105,0.069317,0.0052243,0.082832,0.20135,MIR6760_5P,0.934249001814882
DESCARTES_FETAL_THYMUS_STROM...,SET,116,0.071784,0.0056849,0.085793,0.20138,DESCARTES_FETAL_THYMUS_STROMAL_CELLS,0.934249001814882
GOMF_SCAVENGER_RECEPTOR_ACTI...,SET,25,0.14369,0.0052959,0.17174,0.20139,GOMF_SCAVENGER_RECEPTOR_ACTIVITY,0.934249001814882
PHF21A_TARGET_GENES,SET,224,0.04778,0.0052426,0.057109,0.2014,PHF21A_TARGET_GENES,0.934249001814882
GOMF_DEOXYNUCLEOSIDE_KINASE_...,SET,5,0.30022,0.0049512,0.35884,0.2014,GOMF_DEOXYNUCLEOSIDE_KINASE_ACTIVITY,0.934249001814882
GSE17721_LPS_VS_GARDIQUIMOD_...6,SET,187,0.050908,0.0051089,0.060847,0.2014,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_UP,0.934249001814882
GSE17721_CTRL_VS_GARDIQUIMOD...2,SET,185,0.051511,0.0051419,0.061579,0.20144,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_UP,0.934249001814882
ZHU_SKIL_TARGETS_UP,SET,19,0.18469,0.0059352,0.22081,0.20146,ZHU_SKIL_TARGETS_UP,0.934249001814882
HP_UNDERDEVELOPED_SUPRAORBIT...,SET,55,0.099831,0.005453,0.11936,0.20148,HP_UNDERDEVELOPED_SUPRAORBITAL_RIDGES,0.934249001814882
GOBP_REGULATION_OF_ACTIN_FIL...1,SET,39,0.11101,0.0051084,0.13276,0.20152,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_MOVEMENT,0.934249001814882
HALLMARK_MYOGENESIS,SET,191,0.053201,0.0053952,0.06363,0.20155,HALLMARK_MYOGENESIS,0.934249001814882
PID_RET_PATHWAY,SET,39,0.11198,0.005153,0.13394,0.20156,PID_RET_PATHWAY,0.934249001814882
GSE37533_UNTREATED_VS_PIOGLI...1,SET,150,0.056785,0.005109,0.06792,0.20157,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_DN,0.934249001814882
GOBP_ETHER_BIOSYNTHETIC_PROC...,SET,11,0.22041,0.0053907,0.26367,0.2016,GOBP_ETHER_BIOSYNTHETIC_PROCESS,0.934249001814882
HP_ERYSIPELAS,SET,11,0.22476,0.005497,0.26887,0.2016,HP_ERYSIPELAS,0.934249001814882
GSE8921_UNSTIM_0H_VS_TLR1_2_...5,SET,186,0.051944,0.005199,0.062145,0.20163,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_DN,0.934249001814882
DESCARTES_MAIN_FETAL_CORNEAL...,SET,219,0.046797,0.0050778,0.055995,0.20166,DESCARTES_MAIN_FETAL_CORNEAL_AND_CONJUNCTIVAL_EPITHELIAL_CELLS,0.934249001814882
GOBP_MAINTENANCE_OF_DNA_REPE...,SET,7,0.24387,0.0047584,0.29181,0.20167,GOBP_MAINTENANCE_OF_DNA_REPEAT_ELEMENTS,0.934249001814882
GOBP_REGULATION_OF_MEMBRANE_...9,SET,25,0.14087,0.005192,0.16857,0.20167,GOBP_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,0.934249001814882
MODULE_416,SET,22,0.15337,0.0053032,0.18359,0.20176,MODULE_416,0.934249001814882
WP_STEROID_HORMONE_PRECURSOR...,SET,9,0.25055,0.005543,0.30001,0.20182,WP_STEROID_HORMONE_PRECURSOR_BIOSYNTHESIS,0.934249001814882
GOBP_CHONDROBLAST_DIFFERENTI...,SET,4,0.33833,0.0049907,0.40516,0.20185,GOBP_CHONDROBLAST_DIFFERENTIATION,0.934249001814882
YRTCANNRCGC_UNKNOWN,SET,61,0.087165,0.0050133,0.10439,0.20186,YRTCANNRCGC_UNKNOWN,0.934249001814882
HP_ABNORMAL_PHALANGEAL_JOINT...,SET,194,0.050977,0.0052096,0.06105,0.20186,HP_ABNORMAL_PHALANGEAL_JOINT_MORPHOLOGY_OF_THE_HAND,0.934249001814882
HP_CHOLANGITIS,SET,18,0.16538,0.0051732,0.19807,0.20187,HP_CHOLANGITIS,0.934249001814882
GOMF_TRANSLATION_ACTIVATOR_A...,SET,9,0.22672,0.0050159,0.27164,0.20197,GOMF_TRANSLATION_ACTIVATOR_ACTIVITY,0.934249001814882
HP_WORMIAN_BONES,SET,53,0.095688,0.0051311,0.11465,0.20197,HP_WORMIAN_BONES,0.934249001814882
HP_RIGHT_AORTIC_ARCH,SET,20,0.15098,0.0049777,0.1809,0.20198,HP_RIGHT_AORTIC_ARCH,0.934249001814882
HDAC4_TARGET_GENES,SET,517,0.032097,0.0053071,0.03846,0.20199,HDAC4_TARGET_GENES,0.934249001814882
XU_AKT1_TARGETS_48HR,SET,9,0.2398,0.0053053,0.28736,0.20201,XU_AKT1_TARGETS_48HR,0.934249001814882
CHUNG_BLISTER_CYTOTOXICITY_UP,SET,120,0.062897,0.0050656,0.075388,0.20206,CHUNG_BLISTER_CYTOTOXICITY_UP,0.934249001814882
GOBP_T_HELPER_1_CELL_DIFFERE...,SET,23,0.15807,0.0055884,0.18946,0.20206,GOBP_T_HELPER_1_CELL_DIFFERENTIATION,0.934249001814882
IZADPANAH_STEM_CELL_ADIPOSE_...1,SET,97,0.074561,0.0054024,0.089383,0.2021,IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_DN,0.934249001814882
REACTOME_FORMATION_OF_TUBULI...,SET,24,0.13782,0.0049772,0.16522,0.2021,REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC,0.934249001814882
HP_GLOSSITIS,SET,10,0.24468,0.0057059,0.2934,0.20216,HP_GLOSSITIS,0.934249001814882
NICK_RESPONSE_TO_PROC_TREATM...2,SET,4,0.3549,0.0052351,0.42572,0.20225,NICK_RESPONSE_TO_PROC_TREATMENT_UP,0.934249001814882
HP_ANTERIOR_CREASES_OF_EARLO...,SET,3,0.37144,0.0047452,0.44563,0.20228,HP_ANTERIOR_CREASES_OF_EARLOBE,0.934249001814882
GNF2_LYN,SET,23,0.15026,0.0053123,0.18033,0.20235,GNF2_LYN,0.934249001814882
GSE25085_FETAL_LIVER_VS_FETA...1,SET,183,0.054416,0.0054028,0.065313,0.20238,GSE25085_FETAL_LIVER_VS_FETAL_BM_SP4_THYMIC_IMPLANT_DN,0.934249001814882
E2F1_Q6,SET,207,0.048773,0.0051468,0.05854,0.20239,E2F1_Q6,0.934249001814882
GOBP_CLATHRIN_COATED_VESICLE...,SET,7,0.2587,0.0050478,0.31051,0.20239,GOBP_CLATHRIN_COATED_VESICLE_CARGO_LOADING,0.934249001814882
FAN_OVARY_CL9_PUTATIVE_APOPT...,SET,329,0.038412,0.0050931,0.046116,0.20245,FAN_OVARY_CL9_PUTATIVE_APOPTOTIC_ENDOTHELIAL_CELL,0.934249001814882
GSE17721_POLYIC_VS_CPG_0.5H_...2,SET,184,0.051277,0.0051049,0.061582,0.20252,GSE17721_POLYIC_VS_CPG_0.5H_BMDC_UP,0.934249001814882
GSE40274_CTRL_VS_FOXP3_AND_S...1,SET,138,0.059956,0.0051758,0.07201,0.20254,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.934249001814882
MORF_RAB5A,SET,85,0.066189,0.0044908,0.079502,0.20256,MORF_RAB5A,0.934249001814882
GOBP_NEGATIVE_REGULATION_OF_...87,SET,30,0.13734,0.0055441,0.16498,0.20258,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.934249001814882
HP_NEGATIVISM,SET,10,0.22131,0.0051608,0.26585,0.20259,HP_NEGATIVISM,0.934249001814882
GOBP_CD8_POSITIVE_ALPHA_BETA...1,SET,26,0.14883,0.0055937,0.17881,0.20263,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,0.934249001814882
GSE9988_ANTI_TREM1_VS_VEHICL...2,SET,166,0.059181,0.0055989,0.071129,0.2027,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_UP,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...268,SET,28,0.13074,0.0050992,0.15716,0.20274,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,0.934249001814882
MIR371B_3P,SET,36,0.12397,0.0054812,0.14903,0.20276,MIR371B_3P,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...697,SET,9,0.25381,0.0056151,0.30514,0.20277,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_TRIGLYCERIDE,0.934249001814882
HP_HOMOCYSTINURIA,SET,9,0.22602,0.0050005,0.27174,0.20278,HP_HOMOCYSTINURIA,0.934249001814882
GSE6566_STRONG_VS_WEAK_DC_ST...1,SET,156,0.055078,0.0050528,0.066232,0.20282,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_DN,0.934249001814882
HP_THICKENED_CORTEX_OF_LONG_...,SET,14,0.19019,0.0052472,0.22873,0.20284,HP_THICKENED_CORTEX_OF_LONG_BONES,0.934249001814882
MIR592,SET,70,0.083404,0.0051374,0.10031,0.20285,MIR592,0.934249001814882
GOBP_NEGATIVE_REGULATION_OF_...89,SET,9,0.24449,0.0054089,0.29405,0.20287,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.934249001814882
GOBP_REGULATION_OF_MACROPHAG...8,SET,6,0.31132,0.0056241,0.37443,0.20287,GOBP_REGULATION_OF_MACROPHAGE_PROLIFERATION,0.934249001814882
SNIJDERS_AMPLIFIED_IN_HEAD_A...,SET,37,0.12916,0.0057894,0.15539,0.20294,SNIJDERS_AMPLIFIED_IN_HEAD_AND_NECK_TUMORS,0.934249001814882
GOBP_RESPONSE_TO_NITROGEN_CO...,SET,992,0.023031,0.0052043,0.027709,0.20294,GOBP_RESPONSE_TO_NITROGEN_COMPOUND,0.934249001814882
ZHANG_BREAST_CANCER_PROGENIT...1,SET,131,0.06106,0.0051367,0.073465,0.20295,ZHANG_BREAST_CANCER_PROGENITORS_DN,0.934249001814882
GOBP_REGULATION_OF_MAST_CELL...2,SET,4,0.36388,0.0053677,0.43781,0.20295,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.934249001814882
GOMF_LAMININ_BINDING,SET,28,0.13308,0.0051905,0.16015,0.20299,GOMF_LAMININ_BINDING,0.934249001814882
GOBP_INHIBITION_OF_NEUROEPIT...,SET,6,0.27526,0.0049727,0.33131,0.20304,GOBP_INHIBITION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,0.934249001814882
GOBP_RESPONSE_TO_2_3_7_8_TET...,SET,5,0.38048,0.0062747,0.45812,0.20313,GOBP_RESPONSE_TO_2_3_7_8_TETRACHLORODIBENZODIOXINE,0.934249001814882
ZHAN_MULTIPLE_MYELOMA_CD1_AN...2,SET,78,0.077136,0.0050144,0.092883,0.20314,ZHAN_MULTIPLE_MYELOMA_CD1_AND_CD2_UP,0.934249001814882
GOBP_NUCLEAR_PORE_LOCALIZATI...,SET,5,0.32129,0.0052986,0.38688,0.20314,GOBP_NUCLEAR_PORE_LOCALIZATION,0.934249001814882
WP_HYPERTROPHY_MODEL,SET,19,0.17092,0.0054927,0.20582,0.20315,WP_HYPERTROPHY_MODEL,0.934249001814882
HP_ABNORMAL_CARDIAC_EXERCISE...,SET,19,0.16713,0.0053709,0.20126,0.20315,HP_ABNORMAL_CARDIAC_EXERCISE_STRESS_TEST,0.934249001814882
GSE5589_WT_VS_IL10_KO_LPS_AN...2,SET,140,0.056468,0.0049096,0.068,0.20316,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.934249001814882
WP_MIRNA_REGULATION_OF_DNA_D...,SET,67,0.078841,0.0047516,0.094946,0.20317,WP_MIRNA_REGULATION_OF_DNA_DAMAGE_RESPONSE,0.934249001814882
GOBP_TERMINAL_BUTTON_ORGANIZ...,SET,6,0.30988,0.005598,0.37318,0.20317,GOBP_TERMINAL_BUTTON_ORGANIZATION,0.934249001814882
XU_HGF_TARGETS_REPRESSED_BY_...1,SET,81,0.07706,0.0051045,0.092804,0.20318,XU_HGF_TARGETS_REPRESSED_BY_AKT1_DN,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...41,SET,5,0.33472,0.00552,0.40328,0.20328,GOBP_POSITIVE_REGULATION_OF_ASPARTIC_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.934249001814882
HP_ABNORMAL_ERYTHROCYTE_ADEN...,SET,22,0.13705,0.0047389,0.16513,0.20328,HP_ABNORMAL_ERYTHROCYTE_ADENOSINE_DEAMINASE_ACTIVITY,0.934249001814882
SREBP_Q3,SET,229,0.046383,0.0051451,0.055888,0.2033,SREBP_Q3,0.934249001814882
GOMF_TYPE_I_TRANSFORMING_GRO...,SET,11,0.23825,0.0058269,0.2871,0.20331,GOMF_TYPE_I_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.934249001814882
GOBP_REGULATION_OF_MUCUS_SEC...,SET,9,0.26825,0.0059346,0.32327,0.20333,GOBP_REGULATION_OF_MUCUS_SECRETION,0.934249001814882
GOMF_ADP_RIBOSE_DIPHOSPHATAS...,SET,6,0.29261,0.005286,0.35261,0.20333,GOMF_ADP_RIBOSE_DIPHOSPHATASE_ACTIVITY,0.934249001814882
GOBP_LEUKOTRIENE_TRANSPORT,SET,7,0.27469,0.0053597,0.33107,0.20336,GOBP_LEUKOTRIENE_TRANSPORT,0.934249001814882
NAKAMURA_METASTASIS_MODEL_DN,SET,43,0.11295,0.005457,0.13616,0.20341,NAKAMURA_METASTASIS_MODEL_DN,0.934249001814882
GOBP_STEROID_CATABOLIC_PROCE...,SET,24,0.14915,0.0053861,0.17985,0.20348,GOBP_STEROID_CATABOLIC_PROCESS,0.934249001814882
GOBP_GANGLIOSIDE_METABOLIC_P...,SET,28,0.13821,0.0053904,0.16667,0.2035,GOBP_GANGLIOSIDE_METABOLIC_PROCESS,0.934249001814882
LET_7A_2_3P,SET,265,0.043559,0.0051926,0.052538,0.20353,LET_7A_2_3P,0.934249001814882
LET_7G_3P,SET,265,0.043559,0.0051926,0.052538,0.20353,LET_7G_3P,0.934249001814882
RAO_BOUND_BY_SALL4,SET,205,0.049785,0.0052285,0.060052,0.20355,RAO_BOUND_BY_SALL4,0.934249001814882
WP_MITOCHONDRIAL_COMPLEX_I_A...,SET,45,0.088033,0.0043507,0.10619,0.20355,WP_MITOCHONDRIAL_COMPLEX_I_ASSEMBLY_MODEL_OXPHOS_SYSTEM,0.934249001814882
MIR631,SET,48,0.10424,0.00532,0.12574,0.20356,MIR631,0.934249001814882
GOBP_ACTIVATION_OF_INNATE_IM...,SET,266,0.042296,0.0050514,0.051041,0.20365,GOBP_ACTIVATION_OF_INNATE_IMMUNE_RESPONSE,0.934249001814882
GOBP_SUPPRESSION_OF_VIRAL_RE...,SET,14,0.19997,0.005517,0.24138,0.20372,GOBP_SUPPRESSION_OF_VIRAL_RELEASE_BY_HOST,0.934249001814882
GOBP_CELLULAR_RESPONSE_TO_CG...,SET,7,0.24786,0.0048363,0.29927,0.20378,GOBP_CELLULAR_RESPONSE_TO_CGMP,0.934249001814882
GOCC_MITOTIC_SPINDLE_POLE,SET,36,0.11261,0.0049788,0.13597,0.2038,GOCC_MITOTIC_SPINDLE_POLE,0.934249001814882
GOBP_TELOMERASE_RNA_LOCALIZA...,SET,18,0.14737,0.0046096,0.17795,0.20381,GOBP_TELOMERASE_RNA_LOCALIZATION,0.934249001814882
GOBP_REGULATION_OF_DEPHOSPHO...,SET,92,0.070679,0.0049881,0.085359,0.20384,GOBP_REGULATION_OF_DEPHOSPHORYLATION,0.934249001814882
GOBP_CHROMOSOME_ATTACHMENT_T...,SET,4,0.30423,0.0044877,0.36747,0.20387,GOBP_CHROMOSOME_ATTACHMENT_TO_THE_NUCLEAR_ENVELOPE,0.934249001814882
HP_ASTROCYTOMA,SET,22,0.13775,0.0047629,0.16638,0.20387,HP_ASTROCYTOMA,0.934249001814882
SHIN_B_CELL_LYMPHOMA_CLUSTER...3,SET,27,0.14824,0.0056776,0.17911,0.20394,SHIN_B_CELL_LYMPHOMA_CLUSTER_3,0.934249001814882
GOBP_NEUTROPHIL_APOPTOTIC_PR...,SET,7,0.30912,0.0060317,0.37351,0.20395,GOBP_NEUTROPHIL_APOPTOTIC_PROCESS,0.934249001814882
HP_TARSAL_SYNOSTOSIS,SET,21,0.17044,0.005758,0.20599,0.204,HP_TARSAL_SYNOSTOSIS,0.934249001814882
GOBP_MICROGLIA_DIFFERENTIATI...,SET,11,0.22388,0.0054754,0.2706,0.20403,GOBP_MICROGLIA_DIFFERENTIATION,0.934249001814882
MIR323B_3P,SET,56,0.090277,0.0049756,0.10912,0.20404,MIR323B_3P,0.934249001814882
GOMF_PHOSPHOTRANSFERASE_ACTI...3,SET,34,0.11517,0.0049491,0.13922,0.20406,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR,0.934249001814882
REACTOME_SYNTHESIS_SECRETION...3,SET,12,0.19627,0.0050136,0.23729,0.20408,REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLUCOSE_DEPENDENT_INSULINOTROPIC_POLYPEPTIDE_GIP,0.934249001814882
MYLLYKANGAS_AMPLIFICATION_HO...13,SET,8,0.27068,0.005646,0.32727,0.20411,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_29,0.934249001814882
GSE17721_POLYIC_VS_GARDIQUIM...15,SET,184,0.048969,0.0048751,0.059209,0.20411,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_DN,0.934249001814882
GSE17580_TREG_VS_TEFF_UP,SET,182,0.050898,0.0050398,0.061544,0.20412,GSE17580_TREG_VS_TEFF_UP,0.934249001814882
GSE24142_ADULT_VS_FETAL_EARL...1,SET,177,0.053838,0.0052579,0.065108,0.20415,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_DN,0.934249001814882
GSE28237_FOLLICULAR_VS_LATE_...1,SET,177,0.051148,0.0049952,0.061863,0.20418,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_DN,0.934249001814882
GCTGAGT_MIR5125P,SET,42,0.10592,0.0050576,0.12815,0.20425,GCTGAGT_MIR5125P,0.934249001814882
REACTOME_RUNX1_REGULATES_EXP...,SET,5,0.33818,0.0055771,0.40915,0.20426,REACTOME_RUNX1_REGULATES_EXPRESSION_OF_COMPONENTS_OF_TIGHT_JUNCTIONS,0.934249001814882
GOMF_STRUCTURAL_CONSTITUENT_...1,SET,3,0.41487,0.0053,0.50195,0.20426,GOMF_STRUCTURAL_CONSTITUENT_OF_CHROMATIN,0.934249001814882
GOMF_11_CIS_RETINAL_BINDING,SET,7,0.27586,0.0053826,0.33377,0.20427,GOMF_11_CIS_RETINAL_BINDING,0.934249001814882
HP_JAUNDICE,SET,200,0.048821,0.005065,0.059069,0.20427,HP_JAUNDICE,0.934249001814882
GSE15330_LYMPHOID_MULTIPOTEN...6,SET,164,0.057099,0.0053697,0.06909,0.20428,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,0.934249001814882
REACTOME_OTHER_SEMAPHORIN_IN...,SET,18,0.18212,0.0056966,0.22038,0.2043,REACTOME_OTHER_SEMAPHORIN_INTERACTIONS,0.934249001814882
MIR708_3P,SET,102,0.070758,0.0052566,0.085656,0.20439,MIR708_3P,0.934249001814882
GOBP_PSYCHOMOTOR_BEHAVIOR,SET,3,0.48459,0.0061907,0.5868,0.20446,GOBP_PSYCHOMOTOR_BEHAVIOR,0.934249001814882
MODULE_244,SET,172,0.050099,0.0048239,0.060677,0.2045,MODULE_244,0.934249001814882
WALLACE_PROSTATE_CANCER_DN,SET,5,0.34862,0.0057494,0.42227,0.20452,WALLACE_PROSTATE_CANCER_DN,0.934249001814882
MODULE_67,SET,199,0.048373,0.0050062,0.058611,0.2046,MODULE_67,0.934249001814882
GSE7400_CTRL_VS_CSF3_IN_VIVO...2,SET,176,0.049502,0.0048209,0.059984,0.20462,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_UP,0.934249001814882
GSE339_EX_VIVO_VS_IN_CULTURE...1,SET,180,0.052002,0.005121,0.063019,0.20464,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_DN,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...833,SET,4,0.29498,0.0043512,0.35762,0.20474,GOBP_POSITIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,0.934249001814882
HU_FETAL_RETINA_RPE,SET,253,0.047601,0.0055464,0.057726,0.2048,HU_FETAL_RETINA_RPE,0.934249001814882
ZNF85_TARGET_GENES,SET,252,0.043421,0.0050494,0.05266,0.20482,ZNF85_TARGET_GENES,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...691,SET,13,0.19931,0.0052989,0.24172,0.20482,GOBP_POSITIVE_REGULATION_OF_RUFFLE_ASSEMBLY,0.934249001814882
HP_PALLOR,SET,140,0.057402,0.0049908,0.069617,0.20482,HP_PALLOR,0.934249001814882
KEGG_PYRUVATE_METABOLISM,SET,38,0.10532,0.0047841,0.12775,0.20484,KEGG_PYRUVATE_METABOLISM,0.934249001814882
CSHL1_TARGET_GENES,SET,178,0.051804,0.0050734,0.062837,0.20485,CSHL1_TARGET_GENES,0.934249001814882
GREENBAUM_E2A_TARGETS_DN,SET,17,0.15886,0.0048291,0.19271,0.20488,GREENBAUM_E2A_TARGETS_DN,0.934249001814882
HP_PERIPHERAL_ARTERIAL_STENO...,SET,31,0.13588,0.0055756,0.16487,0.20493,HP_PERIPHERAL_ARTERIAL_STENOSIS,0.934249001814882
GSE23308_WT_VS_MINERALCORTIC...3,SET,189,0.053422,0.0053894,0.064821,0.20493,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN,0.934249001814882
VECCHI_GASTRIC_CANCER_EARLY_...1,SET,306,0.0435,0.005566,0.052789,0.20496,VECCHI_GASTRIC_CANCER_EARLY_DN,0.934249001814882
GOBP_REGULATION_OF_T_CELL_ME...3,SET,94,0.079572,0.0056761,0.096569,0.20498,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,0.934249001814882
GSE1740_UNSTIM_VS_IFNA_STIMU...3,SET,166,0.052732,0.0049888,0.064019,0.20506,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_IFNG_DERIVED_MACROPHAGE_DN,0.934249001814882
GOBP_AMYLOID_FIBRIL_FORMATION,SET,35,0.11936,0.0052037,0.14494,0.20512,GOBP_AMYLOID_FIBRIL_FORMATION,0.934249001814882
GOBP_TRIPEPTIDE_TRANSPORT,SET,11,0.21914,0.0053596,0.26612,0.20513,GOBP_TRIPEPTIDE_TRANSPORT,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...117,SET,305,0.043017,0.0054954,0.052246,0.20516,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION,0.934249001814882
GOBP_PURINE_DEOXYRIBONUCLEOS...1,SET,5,0.36605,0.0060368,0.44464,0.20519,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_METABOLIC_PROCESS,0.934249001814882
GOMF_CYCLIN_DEPENDENT_PROTEI...2,SET,14,0.16719,0.0046125,0.20309,0.20519,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,0.934249001814882
HP_ABNORMAL_CIRCULATING_CREA...2,SET,49,0.098475,0.0050779,0.11963,0.20521,HP_ABNORMAL_CIRCULATING_CREATININE_CONCENTRATION,0.934249001814882
GSE360_DC_VS_MAC_L_DONOVANI_...1,SET,175,0.051027,0.0049554,0.061988,0.20521,GSE360_DC_VS_MAC_L_DONOVANI_DN,0.934249001814882
DESCARTES_FETAL_PANCREAS_SMO...,SET,30,0.1374,0.0055468,0.16695,0.20525,DESCARTES_FETAL_PANCREAS_SMOOTH_MUSCLE_CELLS,0.934249001814882
GENTILE_UV_LOW_DOSE_UP,SET,23,0.14692,0.005194,0.17857,0.20533,GENTILE_UV_LOW_DOSE_UP,0.934249001814882
HP_ABNORMAL_PENIS_MORPHOLOGY,SET,559,0.029099,0.0049972,0.035368,0.20533,HP_ABNORMAL_PENIS_MORPHOLOGY,0.934249001814882
MIR302A_3P_MIR302B_3P_MIR302...,SET,323,0.038522,0.0050617,0.046832,0.20539,MIR302A_3P_MIR302B_3P_MIR302C_3P_MIR302D_3P,0.934249001814882
REACTOME_SARS_COV_2_INFECTION,SET,269,0.041646,0.0050013,0.050634,0.20541,REACTOME_SARS_COV_2_INFECTION,0.934249001814882
GAGCCTG_MIR484,SET,96,0.070012,0.0050467,0.085134,0.20544,GAGCCTG_MIR484,0.934249001814882
GOBP_NEUTROPHIL_ACTIVATION_I...,SET,20,0.15313,0.0050486,0.1862,0.20544,GOBP_NEUTROPHIL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.934249001814882
GOBP_REGULATION_OF_CILIUM_BE...2,SET,9,0.22093,0.0048877,0.26873,0.20551,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY_INVOLVED_IN_CILIARY_MOTILITY,0.934249001814882
TAVAZOIE_METASTASIS,SET,87,0.076182,0.005229,0.092689,0.20557,TAVAZOIE_METASTASIS,0.934249001814882
PID_ARF_3PATHWAY,SET,19,0.15081,0.0048466,0.18351,0.20559,PID_ARF_3PATHWAY,0.934249001814882
GSE22886_NAIVE_BCELL_VS_BM_P...2,SET,178,0.049868,0.0048838,0.060679,0.20559,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_UP,0.934249001814882
chr7p14,SET,54,0.14725,0.0079697,0.17917,0.2056,chr7p14,0.934249001814882
WP_CHOLESTASIS,SET,19,0.17596,0.0056545,0.21411,0.2056,WP_CHOLESTASIS,0.934249001814882
GSE15330_HSC_VS_MEGAKARYOCYT...1,SET,150,0.055656,0.0050074,0.067732,0.20563,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,0.934249001814882
MODULE_292,SET,120,0.06533,0.0052617,0.079517,0.20566,MODULE_292,0.934249001814882
HARALAMBIEVA_PBMC_FLUARIX_AG...5,SET,11,0.20229,0.0049474,0.24626,0.2057,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_NEGATIVE,0.934249001814882
DESCARTES_FETAL_THYMUS_VASCU...,SET,113,0.07062,0.0055204,0.085984,0.20574,DESCARTES_FETAL_THYMUS_VASCULAR_ENDOTHELIAL_CELLS,0.934249001814882
GOBP_NEGATIVE_REGULATION_OF_...500,SET,11,0.21779,0.0053265,0.26518,0.20575,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,0.934249001814882
GSE39152_BRAIN_VS_SPLEEN_CD1...1,SET,186,0.049617,0.0049661,0.06042,0.20577,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_DN,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...778,SET,112,0.062238,0.0048437,0.0758,0.20581,GOBP_POSITIVE_REGULATION_OF_TRANSLATION,0.934249001814882
HP_FETAL_DISTRESS,SET,52,0.090159,0.0047889,0.10981,0.20581,HP_FETAL_DISTRESS,0.934249001814882
ONDER_CDH1_SIGNALING_VIA_CTN...,SET,79,0.087997,0.0057568,0.10718,0.20582,ONDER_CDH1_SIGNALING_VIA_CTNNB1,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...773,SET,9,0.21905,0.0048462,0.26681,0.20582,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NUCLEOLAR_LARGE_RRNA_BY_RNA_POLYMERASE_I,0.934249001814882
DESCARTES_FETAL_INTESTINE_EN...1,SET,46,0.11102,0.0055475,0.13524,0.20585,DESCARTES_FETAL_INTESTINE_ENS_GLIA,0.934249001814882
MIR508_3P,SET,94,0.07182,0.0051231,0.087515,0.20593,MIR508_3P,0.934249001814882
HP_MALE_PSEUDOHERMAPHRODITISM,SET,36,0.1098,0.0048546,0.1338,0.20594,HP_MALE_PSEUDOHERMAPHRODITISM,0.934249001814882
GOBP_DETECTION_OF_MECHANICAL...3,SET,14,0.19561,0.0053966,0.23838,0.20595,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.934249001814882
MANNO_MIDBRAIN_NEUROTYPES_HR...1,SET,316,0.041662,0.0054157,0.050775,0.20597,MANNO_MIDBRAIN_NEUROTYPES_HRGL1,0.934249001814882
TESAR_ALK_TARGETS_EPISC_3D_UP,SET,5,0.31627,0.0052159,0.38549,0.20599,TESAR_ALK_TARGETS_EPISC_3D_UP,0.934249001814882
BURTON_ADIPOGENESIS_7,SET,41,0.1163,0.0054868,0.14177,0.20602,BURTON_ADIPOGENESIS_7,0.934249001814882
CAGCTG_AP4_Q5,SET,1354,0.019845,0.0051841,0.024193,0.20603,CAGCTG_AP4_Q5,0.934249001814882
chr1q23,SET,130,0.12688,0.010634,0.15472,0.20608,chr1q23,0.934249001814882
MIR5088_3P,SET,121,0.062818,0.0050802,0.076599,0.20609,MIR5088_3P,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...500,SET,46,0.1055,0.0052712,0.12865,0.20611,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CONTRACTION,0.934249001814882
GSE40274_CTRL_VS_IRF4_TRANSD...1,SET,151,0.055994,0.0050545,0.068295,0.20615,GSE40274_CTRL_VS_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.934249001814882
WP_PRIMARY_OVARIAN_INSUFFICI...,SET,159,0.052886,0.0048977,0.064515,0.20619,WP_PRIMARY_OVARIAN_INSUFFICIENCY,0.934249001814882
GOBP_REGULATION_OF_DEFENSE_R...4,SET,52,0.096009,0.0050996,0.11714,0.20622,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,0.934249001814882
HP_RECURRENT_PATELLAR_DISLOC...,SET,3,0.45358,0.0057945,0.55347,0.20625,HP_RECURRENT_PATELLAR_DISLOCATION,0.934249001814882
GOBP_COMMISSURAL_NEURON_AXON...,SET,13,0.20811,0.0055329,0.25396,0.20627,GOBP_COMMISSURAL_NEURON_AXON_GUIDANCE,0.934249001814882
HP_ABNORMAL_DELIVERY,SET,87,0.07178,0.0049268,0.0876,0.20628,HP_ABNORMAL_DELIVERY,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...359,SET,11,0.22169,0.005422,0.2706,0.20632,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_ACTIVATION,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...482,SET,132,0.06353,0.0053646,0.077566,0.20639,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORT,0.934249001814882
GOBP_CYTOKINESIS,SET,164,0.051719,0.0048636,0.063151,0.20641,GOBP_CYTOKINESIS,0.934249001814882
GSE14000_4H_VS_16H_LPS_DC_TR...2,SET,170,0.054239,0.0051923,0.066237,0.20644,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_UP,0.934249001814882
GOMF_PROCOLLAGEN_PROLINE_4_D...,SET,5,0.22626,0.0037315,0.27633,0.20645,GOMF_PROCOLLAGEN_PROLINE_4_DIOXYGENASE_ACTIVITY,0.934249001814882
UNTERMAN_PROGRESSIVE_VS_STAB...6,SET,8,0.27926,0.0058251,0.34106,0.20646,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_UP,0.934249001814882
PID_RETINOIC_ACID_PATHWAY,SET,30,0.12446,0.0050241,0.15201,0.20648,PID_RETINOIC_ACID_PATHWAY,0.934249001814882
KEGG_MEDICUS_VARIANT_NOTCH_O...,SET,16,0.17974,0.0053009,0.21954,0.20649,KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY,0.934249001814882
MIR146A_3P,SET,197,0.050288,0.0051784,0.061436,0.20653,MIR146A_3P,0.934249001814882
VALK_AML_WITH_T_8_21_TRANSLO...,SET,4,0.38545,0.0056858,0.47094,0.20655,VALK_AML_WITH_T_8_21_TRANSLOCATION,0.934249001814882
GSE17974_0H_VS_72H_IN_VITRO_...2,SET,163,0.056098,0.0052595,0.068541,0.20656,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_UP,0.934249001814882
REACTOME_TRANSPORT_OF_CONNEX...,SET,18,0.18154,0.0056785,0.2219,0.20665,REACTOME_TRANSPORT_OF_CONNEXONS_TO_THE_PLASMA_MEMBRANE,0.934249001814882
WP_STEROID_BIOSYNTHESIS,SET,10,0.22672,0.0052869,0.27713,0.20666,WP_STEROID_BIOSYNTHESIS,0.934249001814882
GOMF_GAMMA_AMINOBUTYRIC_ACID...2,SET,7,0.31826,0.0062099,0.38903,0.20666,GOMF_GAMMA_AMINOBUTYRIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.934249001814882
NABA_MATRISOME_HIGHLY_METAST...1,SET,37,0.10817,0.0048483,0.13224,0.20669,NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER,0.934249001814882
GOBP_HOMOCYSTEINE_METABOLIC_...,SET,11,0.19577,0.004788,0.23934,0.20669,GOBP_HOMOCYSTEINE_METABOLIC_PROCESS,0.934249001814882
KEGG_MEDICUS_ENV_FACTOR_IRON...,SET,18,0.17973,0.0056218,0.21974,0.20671,KEGG_MEDICUS_ENV_FACTOR_IRON_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.934249001814882
GOBP_MAST_CELL_MIGRATION,SET,14,0.19759,0.0054513,0.24159,0.20672,GOBP_MAST_CELL_MIGRATION,0.934249001814882
KEGG_MEDICUS_REFERENCE_FE_TF...,SET,7,0.26789,0.0052272,0.32756,0.20673,KEGG_MEDICUS_REFERENCE_FE_TF_TRANSPORT,0.934249001814882
HP_PALMOPLANTAR_CUTIS_LAXA,SET,8,0.23466,0.0048948,0.28693,0.20673,HP_PALMOPLANTAR_CUTIS_LAXA,0.934249001814882
HP_FUNCTIONAL_MOTOR_DEFICIT,SET,450,0.031778,0.0049112,0.038859,0.20675,HP_FUNCTIONAL_MOTOR_DEFICIT,0.934249001814882
GSE13411_NAIVE_VS_IGM_MEMORY...1,SET,183,0.050175,0.0049817,0.061356,0.20675,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.934249001814882
GSE44649_WT_VS_MIR155_KO_NAI...1,SET,188,0.053281,0.0053612,0.065166,0.20679,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_DN,0.934249001814882
GOCC_HETEROCHROMATIN,SET,69,0.08197,0.005013,0.10026,0.20681,GOCC_HETEROCHROMATIN,0.934249001814882
HP_POLLAKISURIA,SET,7,0.26919,0.0052525,0.32934,0.20687,HP_POLLAKISURIA,0.934249001814882
HP_SHORT_5TH_TOE,SET,5,0.33511,0.0055265,0.41004,0.2069,HP_SHORT_5TH_TOE,0.934249001814882
GOBP_CELLULAR_RESPONSE_TO_ES...1,SET,36,0.12204,0.005396,0.14937,0.20696,GOBP_CELLULAR_RESPONSE_TO_ESTRADIOL_STIMULUS,0.934249001814882
REACTOME_INTERLEUKIN_1_SIGNA...,SET,108,0.061696,0.0047155,0.075514,0.20697,REACTOME_INTERLEUKIN_1_SIGNALING,0.934249001814882
GOBP_REGULATION_OF_PROTEIN_K...2,SET,12,0.20885,0.0053349,0.25563,0.20697,GOBP_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,0.934249001814882
GSE9988_LOW_LPS_VS_ANTI_TREM...2,SET,176,0.052474,0.0051104,0.064231,0.20698,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,0.934249001814882
REICHERT_G1S_REGULATORS_AS_P...,SET,8,0.2186,0.0045597,0.26762,0.20702,REICHERT_G1S_REGULATORS_AS_PI3K_TARGETS,0.934249001814882
HP_HIGH_FOREHEAD,SET,261,0.041827,0.004949,0.051209,0.20703,HP_HIGH_FOREHEAD,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...223,SET,57,0.0836,0.0046485,0.10237,0.20706,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,0.934249001814882
GOMF_MUTLALPHA_COMPLEX_BINDI...,SET,7,0.23711,0.0046266,0.29034,0.20706,GOMF_MUTLALPHA_COMPLEX_BINDING,0.934249001814882
GOBP_NEGATIVE_REGULATION_BY_...3,SET,14,0.18056,0.0049816,0.22111,0.20707,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,0.934249001814882
HP_INCREASED_MUSCLE_FATIGUAB...,SET,16,0.16902,0.0049849,0.20697,0.20707,HP_INCREASED_MUSCLE_FATIGUABILITY,0.934249001814882
LIEN_BREAST_CARCINOMA_METAPL...1,SET,32,0.13133,0.0054754,0.16086,0.20713,LIEN_BREAST_CARCINOMA_METAPLASTIC,0.934249001814882
REACTOME_JNK_C_JUN_KINASES_P...,SET,18,0.17125,0.0053568,0.2098,0.20717,REACTOME_JNK_C_JUN_KINASES_PHOSPHORYLATION_AND_ACTIVATION_MEDIATED_BY_ACTIVATED_HUMAN_TAK1,0.934249001814882
GOBP_NEGATIVE_REGULATION_OF_...47,SET,20,0.15236,0.0050233,0.18667,0.2072,GOBP_NEGATIVE_REGULATION_OF_BLOOD_CIRCULATION,0.934249001814882
GSE3920_UNTREATED_VS_IFNA_TR...4,SET,159,0.055033,0.0050965,0.067434,0.20723,GSE3920_UNTREATED_VS_IFNA_TREATED_FIBROBLAST_UP,0.934249001814882
GSE3982_DC_VS_EFF_MEMORY_CD4...2,SET,187,0.050607,0.0050786,0.062013,0.20724,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_UP,0.934249001814882
GOBP_POSITIVE_REGULATION_OF_...26,SET,19,0.15784,0.0050725,0.19343,0.20725,GOBP_POSITIVE_REGULATION_OF_AMYLOID_BETA_FORMATION,0.934249001814882
MIR100_5P_MIR99A_5P_MIR99B_5P,SET,17,0.17905,0.0054431,0.21948,0.20731,MIR100_5P_MIR99A_5P_MIR99B_5P,0.934249001814882
GSE45365_CD8A_DC_VS_CD11B_DC...2,SET,167,0.053083,0.0050369,0.065075,0.20734,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_DN,0.934249001814882
WP_MIRNA_REGULATION_OF_P53_P...,SET,24,0.14078,0.0050838,0.17259,0.20735,WP_MIRNA_REGULATION_OF_P53_PATHWAY_IN_PROSTATE_CANCER,0.934249001814882
GOBP_HEART_VALVE_DEVELOPMENT,SET,72,0.09021,0.0056352,0.1106,0.20735,GOBP_HEART_VALVE_DEVELOPMENT,0.934249001814882
GOBP_STEM_CELL_FATE_SPECIFIC...,SET,6,0.33924,0.0061284,0.41591,0.20735,GOBP_STEM_CELL_FATE_SPECIFICATION,0.934249001814882
GSE19825_NAIVE_VS_IL2RALOW_D...1,SET,179,0.047846,0.0046988,0.058658,0.20735,GSE19825_NAIVE_VS_IL2RALOW_DAY3_EFF_CD8_TCELL_DN,0.934249001814882
BIOCARTA_AT1R_PATHWAY,SET,26,0.13525,0.0050832,0.16581,0.20736,BIOCARTA_AT1R_PATHWAY,0.934249001814882
GOBP_REGULATION_OF_BILE_ACID...1,SET,11,0.22864,0.0055918,0.28031,0.20736,GOBP_REGULATION_OF_BILE_ACID_BIOSYNTHETIC_PROCESS,0.934249001814882
GSE24142_EARLY_THYMIC_PROGEN...3,SET,183,0.050863,0.00505,0.062359,0.20736,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_DN,0.934249001814882
LOCKWOOD_AMPLIFIED_IN_LUNG_C...,SET,203,0.052712,0.0055092,0.064641,0.20741,LOCKWOOD_AMPLIFIED_IN_LUNG_CANCER,0.93435314970836
REACTOME_RMTS_METHYLATE_HIST...,SET,29,0.13181,0.0052318,0.16168,0.20746,REACTOME_RMTS_METHYLATE_HISTONE_ARGININES,0.934457270606532
MODULE_448,SET,40,0.099257,0.0046255,0.12178,0.20752,MODULE_448,0.934483255284141
GOCC_ENDONUCLEASE_COMPLEX,SET,35,0.11477,0.0050036,0.14082,0.20754,GOCC_ENDONUCLEASE_COMPLEX,0.934483255284141
HP_FOCAL_CLONIC_SEIZURE,SET,39,0.10849,0.0049922,0.13315,0.2076,HP_FOCAL_CLONIC_SEIZURE,0.934483255284141
MIR6735_5P,SET,92,0.072121,0.0050899,0.088544,0.20768,MIR6735_5P,0.934483255284141
GSE22935_WT_VS_MYD88_KO_MACR...4,SET,180,0.048376,0.004764,0.059397,0.2077,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_UP,0.934483255284141
GOBP_PROSTANOID_METABOLIC_PR...,SET,45,0.10257,0.0050692,0.12595,0.20772,GOBP_PROSTANOID_METABOLIC_PROCESS,0.934483255284141
GOBP_ESTABLISHMENT_OF_BLOOD_...1,SET,14,0.1903,0.0052503,0.23373,0.20777,GOBP_ESTABLISHMENT_OF_BLOOD_BRAIN_BARRIER,0.934483255284141
GSE3982_CENT_MEMORY_CD4_TCEL...2,SET,176,0.05119,0.0049853,0.062886,0.20782,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_UP,0.934483255284141
HP_EOSINOPHILIA,SET,52,0.097282,0.0051672,0.11956,0.20791,HP_EOSINOPHILIA,0.934483255284141
KEGG_STEROID_HORMONE_BIOSYNT...,SET,52,0.11265,0.0059833,0.13846,0.20796,KEGG_STEROID_HORMONE_BIOSYNTHESIS,0.934483255284141
MIR2116_5P,SET,133,0.057837,0.0049023,0.071092,0.20796,MIR2116_5P,0.934483255284141
GOCC_NUCLEAR_MEMBRANE,SET,282,0.040339,0.0049583,0.049602,0.20804,GOCC_NUCLEAR_MEMBRANE,0.934483255284141
HP_ZONULAR_CATARACT,SET,47,0.10251,0.0051772,0.12607,0.20808,HP_ZONULAR_CATARACT,0.934483255284141
GOBP_SOMITE_ROSTRAL_CAUDAL_A...,SET,9,0.22223,0.0049164,0.27332,0.2081,GOBP_SOMITE_ROSTRAL_CAUDAL_AXIS_SPECIFICATION,0.934483255284141
GSE13485_DAY1_VS_DAY21_YF17D...1,SET,165,0.048883,0.0046108,0.060122,0.2081,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_DN,0.934483255284141
MODULE_318,SET,27,0.1241,0.0047532,0.15265,0.20811,MODULE_318,0.934483255284141
HP_ABNORMALITY_OF_THE_MALE_G...,SET,1026,0.021602,0.0049594,0.026571,0.20812,HP_ABNORMALITY_OF_THE_MALE_GENITALIA,0.934483255284141
GOBP_REGULATION_OF_MEMBRANE_...10,SET,33,0.12662,0.0053607,0.15576,0.20814,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION,0.934483255284141
GOBP_REGULATION_OF_CELL_SHAPE,SET,125,0.063314,0.0052037,0.077901,0.20819,GOBP_REGULATION_OF_CELL_SHAPE,0.934483255284141
GSE40493_BCL6_KO_VS_WT_TREG_...2,SET,167,0.051211,0.0048594,0.063027,0.20825,GSE40493_BCL6_KO_VS_WT_TREG_UP,0.934483255284141
GSE5099_UNSTIM_VS_MCSF_TREAT...2,SET,177,0.049308,0.0048155,0.060693,0.20828,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_UP,0.934483255284141
MIR374A_5P,SET,396,0.036261,0.005265,0.044637,0.2083,MIR374A_5P,0.934483255284141
MIR8082,SET,104,0.065864,0.0049405,0.081083,0.20831,MIR8082,0.934483255284141
GOBP_ISOPRENOID_BIOSYNTHETIC...,SET,28,0.12805,0.0049941,0.15766,0.20835,GOBP_ISOPRENOID_BIOSYNTHETIC_PROCESS,0.934483255284141
ZHENG_IL22_SIGNALING_UP,SET,53,0.10115,0.0054242,0.12458,0.20841,ZHENG_IL22_SIGNALING_UP,0.934483255284141
VERHAAK_AML_WITH_NPM1_MUTATE...1,SET,224,0.049507,0.0054321,0.060981,0.20844,VERHAAK_AML_WITH_NPM1_MUTATED_DN,0.934483255284141
WP_INITIATION_OF_TRANSCRIPTI...,SET,31,0.11218,0.0046034,0.13818,0.20844,WP_INITIATION_OF_TRANSCRIPTION_AND_TRANSLATION_ELONGATION_AT_THE_HIV1_LTR,0.934483255284141
HP_RECURRENT_RESPIRATORY_INF...,SET,545,0.030485,0.0051712,0.037551,0.20845,HP_RECURRENT_RESPIRATORY_INFECTIONS,0.934483255284141
REACTOME_POSTMITOTIC_NUCLEAR...,SET,26,0.12666,0.0047606,0.15606,0.20851,REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION,0.934483255284141
MIR223_3P,SET,112,0.064327,0.0050063,0.079266,0.20853,MIR223_3P,0.934483255284141
MIR4531,SET,303,0.04064,0.005175,0.050079,0.20854,MIR4531,0.934483255284141
GOCC_BARR_BODY,SET,2,0.56077,0.0058495,0.69102,0.20854,GOCC_BARR_BODY,0.934483255284141
REACTOME_FOLDING_OF_ACTIN_BY...,SET,10,0.18121,0.0042258,0.22331,0.20855,REACTOME_FOLDING_OF_ACTIN_BY_CCT_TRIC,0.934483255284141
GGCAGTG_MIR3243P,SET,87,0.071153,0.0048839,0.087685,0.20855,GGCAGTG_MIR3243P,0.934483255284141
GSE36888_UNTREATED_VS_IL2_TR...4,SET,182,0.051922,0.0051412,0.064008,0.20863,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_UP,0.934483255284141
GSE6269_HEALTHY_VS_STAPH_PNE...1,SET,152,0.057113,0.0051724,0.070419,0.20867,GSE6269_HEALTHY_VS_STAPH_PNEUMO_INF_PBMC_DN,0.934483255284141
HP_THIN_NAIL,SET,13,0.19073,0.0050708,0.23522,0.20873,HP_THIN_NAIL,0.934483255284141
HP_HEPATIC_CALCIFICATION,SET,5,0.3272,0.0053962,0.40356,0.20875,HP_HEPATIC_CALCIFICATION,0.934483255284141
GSE27786_LIN_NEG_VS_MONO_MAC...2,SET,181,0.047219,0.0046628,0.05824,0.20876,GSE27786_LIN_NEG_VS_MONO_MAC_UP,0.934483255284141
REACTOME_RELEASE_OF_APOPTOTI...,SET,5,0.29502,0.0048653,0.36392,0.20878,REACTOME_RELEASE_OF_APOPTOTIC_FACTORS_FROM_THE_MITOCHONDRIA,0.934483255284141
HP_FOOT_DORSIFLEXOR_WEAKNESS,SET,128,0.060032,0.0049924,0.074051,0.20878,HP_FOOT_DORSIFLEXOR_WEAKNESS,0.934483255284141
GOBP_RESPONSE_TO_NERVE_GROWT...,SET,51,0.098689,0.0051915,0.12176,0.20882,GOBP_RESPONSE_TO_NERVE_GROWTH_FACTOR,0.934483255284141
ITO_PTTG1_TARGETS_UP,SET,11,0.24124,0.0059001,0.29771,0.20888,ITO_PTTG1_TARGETS_UP,0.934483255284141
GOCC_AXOLEMMA,SET,15,0.20526,0.0058616,0.25331,0.20888,GOCC_AXOLEMMA,0.934483255284141
GOBP_PROTEIN_DEGLYCOSYLATION,SET,14,0.18608,0.0051338,0.22966,0.2089,GOBP_PROTEIN_DEGLYCOSYLATION,0.934483255284141
HP_REDUCED_LEFT_VENTRICULAR_...,SET,55,0.090211,0.0049275,0.11134,0.20892,HP_REDUCED_LEFT_VENTRICULAR_EJECTION_FRACTION,0.934483255284141
GOBP_OBSERVATIONAL_LEARNING,SET,7,0.25058,0.0048893,0.30933,0.20896,GOBP_OBSERVATIONAL_LEARNING,0.934483255284141
HP_ABNORMAL_CERVICAL_SPINE_M...,SET,19,0.16573,0.0053258,0.2046,0.20897,HP_ABNORMAL_CERVICAL_SPINE_MORPHOLOGY,0.934483255284141
GOBP_REGULATION_OF_STEROID_B...,SET,69,0.088116,0.0053889,0.10879,0.20898,GOBP_REGULATION_OF_STEROID_BIOSYNTHETIC_PROCESS,0.934483255284141
GOBP_POSITIVE_REGULATION_OF_...332,SET,6,0.28549,0.0051575,0.35252,0.20902,GOBP_POSITIVE_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,0.934483255284141
GOBP_STEROL_BIOSYNTHETIC_PRO...,SET,54,0.089391,0.0048383,0.1104,0.20907,GOBP_STEROL_BIOSYNTHETIC_PROCESS,0.934483255284141
MZF1_01,SET,222,0.045214,0.0049391,0.055849,0.2091,MZF1_01,0.934483255284141
REACTOME_SIGNALING_BY_ALK_IN...,SET,86,0.073001,0.0049819,0.090177,0.20911,REACTOME_SIGNALING_BY_ALK_IN_CANCER,0.934483255284141
ZNF236_TARGET_GENES,SET,212,0.046157,0.0049286,0.057018,0.20911,ZNF236_TARGET_GENES,0.934483255284141
GOBP_INTERLEUKIN_6_PRODUCTION,SET,136,0.06121,0.0052459,0.075615,0.20912,GOBP_INTERLEUKIN_6_PRODUCTION,0.934483255284141
BIOCARTA_ATRBRCA_PATHWAY,SET,21,0.13196,0.0044581,0.16308,0.20921,BIOCARTA_ATRBRCA_PATHWAY,0.934483255284141
KEGG_PATHWAYS_IN_CANCER,SET,311,0.040085,0.0051701,0.049537,0.20921,KEGG_PATHWAYS_IN_CANCER,0.934483255284141
GOBP_POSITIVE_REGULATION_OF_...355,SET,11,0.19754,0.0048313,0.24417,0.20925,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,0.934483255284141
REACTOME_ACTIVATION_OF_GENE_...,SET,41,0.096286,0.0045427,0.11909,0.20941,REACTOME_ACTIVATION_OF_GENE_EXPRESSION_BY_SREBF_SREBP,0.934483255284141
HP_ABNORMAL_ATRIOVENTRICULAR...1,SET,87,0.075382,0.0051741,0.09324,0.20941,HP_ABNORMAL_ATRIOVENTRICULAR_CONDUCTION,0.934483255284141
SASSON_RESPONSE_TO_GONADOTRO...2,SET,76,0.075895,0.0048704,0.093902,0.20948,SASSON_RESPONSE_TO_GONADOTROPHINS_UP,0.934483255284141
GOMF_L_ALANINE_TRANSMEMBRANE...,SET,9,0.23545,0.0052089,0.29134,0.2095,GOMF_L_ALANINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.934483255284141
GSE28737_WT_VS_BCL6_HET_FOLL...2,SET,183,0.050248,0.004989,0.062174,0.2095,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_UP,0.934483255284141
AZARE_STAT3_TARGETS,SET,23,0.14447,0.0051075,0.17877,0.20951,AZARE_STAT3_TARGETS,0.934483255284141
GSE17974_IL4_AND_ANTI_IL12_V...15,SET,173,0.052851,0.0051034,0.065403,0.20953,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_DN,0.934483255284141
GSE2770_UNTREATED_VS_ACT_CD4...4,SET,171,0.05021,0.0048206,0.062138,0.20954,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_UP,0.934483255284141
GOBP_POSITIVE_REGULATION_OF_...158,SET,13,0.19401,0.005158,0.24011,0.20955,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_METABOLIC_PROCESS,0.934483255284141
HP_RECURRENT_CANDIDA_INFECTI...,SET,17,0.18061,0.0054903,0.22354,0.20957,HP_RECURRENT_CANDIDA_INFECTIONS,0.934483255284141
VECCHI_GASTRIC_CANCER_ADVANC...2,SET,155,0.06049,0.0055316,0.074888,0.20963,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP,0.934483255284141
GOBP_ANTIGEN_PROCESSING_AND_...3,SET,30,0.14573,0.0058831,0.18044,0.20965,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_ANTIGEN,0.934483255284141
GOMF_PRIMARY_MIRNA_BINDING,SET,9,0.21212,0.0046928,0.26263,0.20965,GOMF_PRIMARY_MIRNA_BINDING,0.934483255284141
GOBP_MITOPHAGY,SET,57,0.086571,0.0048136,0.1072,0.20967,GOBP_MITOPHAGY,0.934483255284141
KEGG_MEDICUS_PATHOGEN_HCMV_G...1,SET,14,0.18149,0.005007,0.22476,0.20971,KEGG_MEDICUS_PATHOGEN_HCMV_GB_TO_PDGFR_RAS_ERK_SIGNALING_PATHWAY,0.934483255284141
GOBP_ESTABLISHMENT_OF_RNA_LO...,SET,143,0.051673,0.0045402,0.063999,0.20972,GOBP_ESTABLISHMENT_OF_RNA_LOCALIZATION,0.934483255284141
GOMF_TRANSPORTER_ACTIVITY,SET,1110,0.021652,0.0051579,0.026817,0.20972,GOMF_TRANSPORTER_ACTIVITY,0.934483255284141
GSE6269_HEALTHY_VS_FLU_INF_P...1,SET,143,0.056184,0.0049365,0.069615,0.20982,GSE6269_HEALTHY_VS_FLU_INF_PBMC_DN,0.934483255284141
HP_LYMPHANGIOMA,SET,11,0.22619,0.005532,0.28033,0.20988,HP_LYMPHANGIOMA,0.934483255284141
MIR4292,SET,143,0.056774,0.0049884,0.070368,0.20989,MIR4292,0.934483255284141
GSE46606_IRF4HIGH_VS_WT_CD40...3,SET,183,0.050031,0.0049674,0.06201,0.20989,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,0.934483255284141
GSE13485_CTRL_VS_DAY1_YF17D_...1,SET,132,0.061622,0.0052035,0.076409,0.20999,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_DN,0.934483255284141
GOBP_REGULATION_OF_LENS_FIBE...,SET,8,0.26825,0.0055954,0.33263,0.21,GOBP_REGULATION_OF_LENS_FIBER_CELL_DIFFERENTIATION,0.934483255284141
HP_HYPERTELORISM,SET,721,0.025318,0.0049153,0.031395,0.21,HP_HYPERTELORISM,0.934483255284141
GSE9946_MATURE_STIMULATORY_V...1,SET,114,0.064363,0.0050533,0.079819,0.21002,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_DN,0.934483255284141
REACTOME_GAP_JUNCTION_TRAFFI...,SET,46,0.10783,0.0053878,0.13375,0.21008,REACTOME_GAP_JUNCTION_TRAFFICKING_AND_REGULATION,0.934483255284141
GSE26559_TCF1_KO_VS_WT_LIN_N...1,SET,174,0.050934,0.0049323,0.063191,0.21012,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN,0.934483255284141
REACTOME_ANDROGEN_BIOSYNTHES...,SET,11,0.21184,0.005181,0.26286,0.21015,REACTOME_ANDROGEN_BIOSYNTHESIS,0.934483255284141
HP_ABNORMAL_CD4_CD8_RATIO,SET,17,0.16843,0.0051201,0.20899,0.21016,HP_ABNORMAL_CD4_CD8_RATIO,0.934483255284141
WP_ARYLAMINE_METABOLISM,SET,6,0.36384,0.0065729,0.4515,0.21017,WP_ARYLAMINE_METABOLISM,0.934483255284141
HP_NEOPLASM_OF_THE_HEART,SET,15,0.16668,0.0047598,0.20684,0.21017,HP_NEOPLASM_OF_THE_HEART,0.934483255284141
PID_S1P_META_PATHWAY,SET,21,0.15351,0.0051862,0.19053,0.2102,PID_S1P_META_PATHWAY,0.934483255284141
GOBP_POSITIVE_REGULATION_OF_...145,SET,31,0.1192,0.0048914,0.14795,0.21021,GOBP_POSITIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,0.934483255284141
MYLLYKANGAS_AMPLIFICATION_HO...1,SET,11,0.2003,0.0048989,0.24868,0.21028,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12,0.934483255284141
BROWNE_HCMV_INFECTION_8HR_DN,SET,40,0.11364,0.0052955,0.14109,0.21029,BROWNE_HCMV_INFECTION_8HR_DN,0.934483255284141
GOBP_REGULATION_OF_MITOTIC_C...1,SET,472,0.031372,0.0049626,0.038952,0.2103,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE,0.934483255284141
BASSO_CD40_SIGNALING_UP,SET,95,0.073295,0.0052559,0.091011,0.21032,BASSO_CD40_SIGNALING_UP,0.934483255284141
GOBP_AMINO_SUGAR_CATABOLIC_P...,SET,14,0.20101,0.0055456,0.24964,0.21036,GOBP_AMINO_SUGAR_CATABOLIC_PROCESS,0.934483255284141
SA_B_CELL_RECEPTOR_COMPLEXES,SET,22,0.14298,0.0049439,0.17759,0.21038,SA_B_CELL_RECEPTOR_COMPLEXES,0.934483255284141
GOBP_PEROXISOME_ORGANIZATION,SET,30,0.12194,0.0049225,0.15148,0.21042,GOBP_PEROXISOME_ORGANIZATION,0.934483255284141
MIR6086,SET,49,0.095329,0.0049157,0.11844,0.21046,MIR6086,0.934483255284141
WP_CHROMOSOMAL_AND_MICROSATE...,SET,72,0.078633,0.004912,0.097704,0.21047,WP_CHROMOSOMAL_AND_MICROSATELLITE_INSTABILITY_IN_COLORECTAL_CANCER,0.934483255284141
TCF11_01,SET,225,0.046004,0.0050589,0.057163,0.21047,TCF11_01,0.934483255284141
GOBP_REGULATION_OF_PROTEIN_S...1,SET,246,0.044852,0.0051542,0.05573,0.21047,GOBP_REGULATION_OF_PROTEIN_SECRETION,0.934483255284141
GSE17721_LPS_VS_CPG_8H_BMDC_...2,SET,186,0.050239,0.0050284,0.062426,0.21048,GSE17721_LPS_VS_CPG_8H_BMDC_UP,0.934483255284141
HP_PROGRESSIVE_SPASTIC_QUADR...,SET,11,0.21319,0.0052141,0.26492,0.21049,HP_PROGRESSIVE_SPASTIC_QUADRIPLEGIA,0.934483255284141
GOMF_IRON_ION_TRANSMEMBRANE_...,SET,9,0.21454,0.0047464,0.26661,0.2105,GOMF_IRON_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.934483255284141
HP_REACTIVE_HYPOGLYCEMIA,SET,7,0.23454,0.0045764,0.29151,0.21054,HP_REACTIVE_HYPOGLYCEMIA,0.934483255284141
LINDGREN_BLADDER_CANCER_CLUS...1,SET,348,0.037029,0.0050468,0.046029,0.21057,LINDGREN_BLADDER_CANCER_CLUSTER_1_DN,0.934483255284141
GSE22432_MULTIPOTENT_PROGENI...2,SET,183,0.05048,0.005012,0.06276,0.21061,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_UP,0.934483255284141
CHNG_MULTIPLE_MYELOMA_HYPERP...1,SET,28,0.11763,0.0045877,0.14627,0.21065,CHNG_MULTIPLE_MYELOMA_HYPERPLOID_DN,0.934483255284141
MODULE_99,SET,325,0.041031,0.0054078,0.051024,0.21066,MODULE_99,0.934483255284141
ZHOU_PANCREATIC_BETA_CELL,SET,11,0.2368,0.0057914,0.29451,0.21069,ZHOU_PANCREATIC_BETA_CELL,0.934483255284141
GOCC_SPERM_MITOCHONDRIAL_SHE...,SET,6,0.27075,0.0048911,0.33677,0.21072,GOCC_SPERM_MITOCHONDRIAL_SHEATH,0.934483255284141
NRF1_Q6,SET,231,0.043252,0.0048185,0.053802,0.21073,NRF1_Q6,0.934483255284141
REACTOME_RUNX1_REGULATES_TRA...3,SET,8,0.23329,0.0048662,0.29021,0.21074,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_KERATINOCYTES,0.934483255284141
REACTOME_ESR_MEDIATED_SIGNAL...,SET,157,0.054694,0.0050335,0.068048,0.21077,REACTOME_ESR_MEDIATED_SIGNALING,0.934483255284141
HP_ABNORMAL_ANTERIOR_HORN_CE...,SET,18,0.16032,0.0050148,0.19952,0.21084,HP_ABNORMAL_ANTERIOR_HORN_CELL_MORPHOLOGY,0.934483255284141
GOBP_CELLULAR_RESPONSE_TO_TO...2,SET,116,0.065479,0.0051856,0.081521,0.21093,GOBP_CELLULAR_RESPONSE_TO_TOXIC_SUBSTANCE,0.934483255284141
GOBP_NEGATIVE_REGULATION_OF_...263,SET,4,0.39614,0.0058435,0.49318,0.21093,GOBP_NEGATIVE_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,0.934483255284141
GOBP_CARDIAC_NEURAL_CREST_CE...3,SET,10,0.24852,0.0057954,0.30943,0.21095,GOBP_CARDIAC_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_OUTFLOW_TRACT_MORPHOGENESIS,0.934483255284141
MIR4705,SET,111,0.065982,0.0051122,0.082158,0.21096,MIR4705,0.934483255284141
GOBP_FACE_DEVELOPMENT,SET,49,0.099878,0.0051502,0.12438,0.21099,GOBP_FACE_DEVELOPMENT,0.934483255284141
HP_ABNORMAL_LOCALIZATION_OF_...,SET,202,0.046672,0.004866,0.05813,0.21102,HP_ABNORMAL_LOCALIZATION_OF_KIDNEY,0.934483255284141
GOBP_NEGATIVE_REGULATION_OF_...174,SET,9,0.2461,0.0054446,0.30653,0.21103,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_APOPTOTIC_PROCESS,0.934483255284141
MIR29B_2_5P,SET,199,0.047859,0.004953,0.059614,0.21104,MIR29B_2_5P,0.934483255284141
MIR3160_3P,SET,66,0.084954,0.0050818,0.10582,0.21105,MIR3160_3P,0.934483255284141
ZNF331_TARGET_GENES,SET,270,0.041646,0.0050105,0.051885,0.21109,ZNF331_TARGET_GENES,0.934483255284141
GOBP_EMBRYONIC_CRANIAL_SKELE...,SET,42,0.11068,0.0052848,0.13789,0.2111,GOBP_EMBRYONIC_CRANIAL_SKELETON_MORPHOGENESIS,0.934483255284141
HP_TENDON_RUPTURE,SET,5,0.32028,0.005282,0.39913,0.21115,HP_TENDON_RUPTURE,0.934483255284141
GSE21927_SPLEEN_VS_BONE_MARR...1,SET,164,0.05377,0.0050565,0.067018,0.21119,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_DN,0.934483255284141
POS_HISTAMINE_RESPONSE_NETWO...,SET,27,0.13342,0.0051101,0.16633,0.21124,POS_HISTAMINE_RESPONSE_NETWORK,0.934483255284141
GOMF_ALDOSE_REDUCTASE_NADPH_...,SET,12,0.25605,0.0065405,0.3192,0.21124,GOMF_ALDOSE_REDUCTASE_NADPH_ACTIVITY,0.934483255284141
GOMF_PEPTIDYL_PROLINE_DIOXYG...,SET,12,0.16704,0.0042668,0.20823,0.21124,GOMF_PEPTIDYL_PROLINE_DIOXYGENASE_ACTIVITY,0.934483255284141
BIOCARTA_SET_PATHWAY,SET,10,0.24846,0.0057939,0.30991,0.21137,BIOCARTA_SET_PATHWAY,0.934483255284141
HP_SUPRANUCLEAR_GAZE_PALSY,SET,49,0.095582,0.0049287,0.11922,0.21137,HP_SUPRANUCLEAR_GAZE_PALSY,0.934483255284141
GSE21927_C26GM_VS_4T1_TUMOR_...1,SET,176,0.048954,0.0047676,0.061069,0.21139,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,0.934483255284141
KEGG_PANTOTHENATE_AND_COA_BI...,SET,16,0.16854,0.0049706,0.21026,0.2114,KEGG_PANTOTHENATE_AND_COA_BIOSYNTHESIS,0.934483255284141
GOBP_REGULATION_OF_NEUROTRAN...1,SET,40,0.11222,0.0052297,0.14001,0.21142,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.934483255284141
GSE34006_A2AR_KO_VS_A2AR_AGO...2,SET,190,0.051102,0.0051689,0.063758,0.21142,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_UP,0.934483255284141
chr13q33,SET,18,0.24195,0.0075681,0.30194,0.21148,chr13q33,0.934483255284141
GOCC_PARALLEL_FIBER_TO_PURKI...,SET,17,0.16016,0.0048689,0.19988,0.21149,GOCC_PARALLEL_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.934483255284141
POOLA_INVASIVE_BREAST_CANCER...1,SET,123,0.062754,0.0051165,0.078348,0.21158,POOLA_INVASIVE_BREAST_CANCER_DN,0.934483255284141
GSE14308_TH17_VS_NATURAL_TRE...1,SET,180,0.048491,0.0047753,0.060544,0.21159,GSE14308_TH17_VS_NATURAL_TREG_DN,0.934483255284141
MIR26B_5P,SET,455,0.03228,0.0050157,0.040309,0.21163,MIR26B_5P,0.934483255284141
DESCARTES_FETAL_PANCREAS_STR...,SET,16,0.18002,0.0053093,0.2248,0.21163,DESCARTES_FETAL_PANCREAS_STROMAL_CELLS,0.934483255284141
GARCIA_PINERES_PBMC_HPV_16_L...4,SET,305,0.03947,0.0050422,0.049292,0.21165,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_UP,0.934483255284141
GOBP_NEUTROPHIL_MEDIATED_KIL...2,SET,13,0.21866,0.0058134,0.27312,0.21169,GOBP_NEUTROPHIL_MEDIATED_KILLING_OF_SYMBIONT_CELL,0.934483255284141
GOBP_DOUBLE_STRAND_BREAK_REP...1,SET,272,0.039214,0.0047351,0.048983,0.2117,GOBP_DOUBLE_STRAND_BREAK_REPAIR,0.934483255284141
GOBP_LIPID_DROPLET_DISASSEMB...,SET,6,0.25965,0.0046907,0.32434,0.2117,GOBP_LIPID_DROPLET_DISASSEMBLY,0.934483255284141
GSE43955_10H_VS_30H_ACT_CD4_...3,SET,182,0.051167,0.0050665,0.063933,0.21177,GSE43955_10H_VS_30H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.934483255284141
STAMBOLSKY_TARGETS_OF_MUTATE...2,SET,45,0.10134,0.0050085,0.12663,0.21178,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_UP,0.934483255284141
HP_POLYDACTYLY,SET,228,0.044549,0.004931,0.055668,0.21178,HP_POLYDACTYLY,0.934483255284141
ZNF512B_TARGET_GENES,SET,176,0.053521,0.0052123,0.066881,0.21179,ZNF512B_TARGET_GENES,0.934483255284141
HP_DECREASED_ACTIVITY_OF_MIT...1,SET,8,0.20528,0.0042819,0.25654,0.21181,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_ATP_SYNTHASE_COMPLEX,0.934483255284141
BASSO_HAIRY_CELL_LEUKEMIA_UP,SET,74,0.082218,0.0052065,0.10276,0.21183,BASSO_HAIRY_CELL_LEUKEMIA_UP,0.934483255284141
KEGG_MEDICUS_PATHOGEN_KSHV_V...1,SET,6,0.30392,0.0054903,0.37988,0.21185,KEGG_MEDICUS_PATHOGEN_KSHV_VCYCLIN_TO_CELL_CYCLE_G1_S,0.934483255284141
GSE16385_UNTREATED_VS_12H_IL...1,SET,171,0.050741,0.0048715,0.063425,0.21186,GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN,0.934483255284141
GOMF_S_METHYLTRANSFERASE_ACT...,SET,8,0.283,0.005903,0.35377,0.21188,GOMF_S_METHYLTRANSFERASE_ACTIVITY,0.934483255284141
GSE36009_WT_VS_NLRP10_KO_DC_...3,SET,186,0.048113,0.0048156,0.060146,0.21188,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_UP,0.934483255284141
KIM_MYCL1_AMPLIFICATION_TARG...1,SET,18,0.15801,0.0049426,0.19754,0.21189,KIM_MYCL1_AMPLIFICATION_TARGETS_DN,0.934483255284141
MIR7853_5P,SET,198,0.048432,0.0049998,0.060549,0.21189,MIR7853_5P,0.934483255284141
GOMF_RNA_2_O_METHYLTRANSFERA...,SET,6,0.23251,0.0042004,0.29072,0.21192,GOMF_RNA_2_O_METHYLTRANSFERASE_ACTIVITY,0.934483255284141
GSE9988_LOW_LPS_VS_VEHICLE_T...2,SET,164,0.057168,0.0053761,0.071483,0.21193,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_UP,0.934483255284141
GOCC_POSTSYNAPTIC_ACTIN_CYTO...,SET,8,0.22826,0.0047613,0.28543,0.21194,GOCC_POSTSYNAPTIC_ACTIN_CYTOSKELETON,0.934483255284141
GOBP_EPITHELIAL_CELL_DEVELOP...,SET,205,0.050367,0.0052897,0.062986,0.21196,GOBP_EPITHELIAL_CELL_DEVELOPMENT,0.934483255284141
HP_BREECH_PRESENTATION,SET,49,0.091741,0.0047307,0.11473,0.21196,HP_BREECH_PRESENTATION,0.934483255284141
GOBP_CHONDROCYTE_PROLIFERATI...,SET,23,0.14409,0.0050942,0.1802,0.21197,GOBP_CHONDROCYTE_PROLIFERATION,0.934483255284141
HP_THORACIC_SCOLIOSIS,SET,54,0.086766,0.0046962,0.10852,0.212,HP_THORACIC_SCOLIOSIS,0.934483255284141
GRAHAM_CML_DIVIDING_VS_NORMA...3,SET,77,0.081817,0.0052847,0.10236,0.21206,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN,0.934483255284141
FAELT_B_CLL_WITH_VH3_21_UP,SET,39,0.0987,0.0045418,0.1235,0.2121,FAELT_B_CLL_WITH_VH3_21_UP,0.934483255284141
KEGG_MEDICUS_VARIANT_MUTATIO...11,SET,13,0.18376,0.0048854,0.22994,0.21211,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_RAS_ERK_SIGNALING_PATHWAY,0.934483255284141
GOBP_POSITIVE_REGULATION_OF_...786,SET,75,0.080412,0.0051263,0.10063,0.21212,GOBP_POSITIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,0.934483255284141
MODULE_81,SET,18,0.14979,0.0046855,0.18746,0.21213,MODULE_81,0.934483255284141
GOBP_REGULATION_OF_B_CELL_AC...,SET,116,0.062719,0.004967,0.078502,0.21216,GOBP_REGULATION_OF_B_CELL_ACTIVATION,0.934483255284141
MIR6834_3P,SET,42,0.10118,0.0048312,0.12666,0.2122,MIR6834_3P,0.934483255284141
GOBP_POSITIVE_REGULATION_OF_...282,SET,7,0.28684,0.0055969,0.35912,0.21223,GOBP_POSITIVE_REGULATION_OF_FEVER_GENERATION,0.934483255284141
GSE24142_EARLY_THYMIC_PROGEN...2,SET,183,0.052017,0.0051646,0.065135,0.21226,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_UP,0.934483255284141
REACTOME_DOPAMINE_CLEARANCE_...,SET,3,0.51267,0.0065494,0.64202,0.21229,REACTOME_DOPAMINE_CLEARANCE_FROM_THE_SYNAPTIC_CLEFT,0.934483255284141
PID_ATM_PATHWAY,SET,29,0.11984,0.0047567,0.1501,0.21232,PID_ATM_PATHWAY,0.934483255284141
GOBP_HYDROCARBON_METABOLIC_P...,SET,7,0.26331,0.0051378,0.32984,0.21235,GOBP_HYDROCARBON_METABOLIC_PROCESS,0.934483255284141
GCGNNANTTCC_UNKNOWN,SET,115,0.060766,0.0047916,0.076131,0.21239,GCGNNANTTCC_UNKNOWN,0.934483255284141
GSE360_CTRL_VS_L_DONOVANI_DC...1,SET,181,0.052097,0.0051445,0.065271,0.21239,GSE360_CTRL_VS_L_DONOVANI_DC_DN,0.934483255284141
MIR194_3P,SET,81,0.077597,0.00514,0.09722,0.2124,MIR194_3P,0.934483255284141
chr11q11,SET,10,0.31953,0.0074513,0.40041,0.21244,chr11q11,0.934483255284141
WP_LNCRNAMEDIATED_MECHANISMS...,SET,6,0.27681,0.0050007,0.34688,0.21244,WP_LNCRNAMEDIATED_MECHANISMS_OF_THERAPEUTIC_RESISTANCE,0.934483255284141
ZHONG_PFC_C2_THY1_POS_OPC,SET,22,0.15964,0.00552,0.20005,0.21244,ZHONG_PFC_C2_THY1_POS_OPC,0.934483255284141
GSE360_CTRL_VS_L_MAJOR_MAC_DN,SET,171,0.050078,0.0048079,0.062769,0.2125,GSE360_CTRL_VS_L_MAJOR_MAC_DN,0.934518451327433
GSE46242_TH1_VS_ANERGIC_TH1_...2,SET,168,0.051553,0.0049063,0.064625,0.21252,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_UP,0.934518451327433
LEE_AGING_NEOCORTEX_UP,SET,72,0.081221,0.0050737,0.10184,0.21258,LEE_AGING_NEOCORTEX_UP,0.934518451327433
VANHARANTA_UTERINE_FIBROID_UP,SET,39,0.11062,0.0050904,0.13872,0.21261,VANHARANTA_UTERINE_FIBROID_UP,0.934518451327433
GOBP_CARNITINE_METABOLIC_PRO...,SET,11,0.18565,0.0045405,0.23286,0.21265,GOBP_CARNITINE_METABOLIC_PROCESS,0.934518451327433
HP_FOAMY_URINE,SET,29,0.1271,0.0050446,0.15942,0.21266,HP_FOAMY_URINE,0.934518451327433
WANG_RESPONSE_TO_GSK3_INHIBI...2,SET,310,0.038054,0.0049004,0.047734,0.21267,WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_UP,0.934518451327433
BIOCARTA_TFF_PATHWAY,SET,24,0.1396,0.0050412,0.17511,0.21267,BIOCARTA_TFF_PATHWAY,0.934518451327433
HP_CEREBELLAR_DENTATE_NUCLEU...,SET,5,0.33398,0.0055079,0.41897,0.21269,HP_CEREBELLAR_DENTATE_NUCLEUS_CALCIFICATION,0.934518451327433
HP_ABNORMAL_EARLOBE_MORPHOLO...,SET,107,0.064269,0.0048895,0.080633,0.21272,HP_ABNORMAL_EARLOBE_MORPHOLOGY,0.934532119833144
WP_IMMUNE_RESPONSE_TO_TUBERC...,SET,22,0.1408,0.0048685,0.17672,0.2128,WP_IMMUNE_RESPONSE_TO_TUBERCULOSIS,0.934586759317751
GOBP_REGULATION_OF_TETRAPYRR...,SET,7,0.26815,0.0052322,0.33656,0.21281,GOBP_REGULATION_OF_TETRAPYRROLE_METABOLIC_PROCESS,0.934586759317751
HP_NORMOCHROMIC_ANEMIA,SET,33,0.10807,0.0045752,0.13564,0.21282,HP_NORMOCHROMIC_ANEMIA,0.934586759317751
GSE40274_XBP1_VS_FOXP3_AND_X...1,SET,180,0.047329,0.0046609,0.059411,0.21284,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.934586759317751
GOMF_WNT_RECEPTOR_ACTIVITY,SET,16,0.19338,0.0057033,0.24284,0.21292,GOMF_WNT_RECEPTOR_ACTIVITY,0.934624738038127
HP_SPONDYLOEPIMETAPHYSEAL_DY...,SET,15,0.17073,0.0048755,0.21439,0.21292,HP_SPONDYLOEPIMETAPHYSEAL_DYSPLASIA,0.934624738038127
GOBP_MAST_CELL_CYTOKINE_PROD...,SET,6,0.29811,0.0053855,0.37437,0.21293,GOBP_MAST_CELL_CYTOKINE_PRODUCTION,0.934624738038127
GSE10273_LOW_IL7_VS_HIGH_IL7...2,SET,176,0.049799,0.0048498,0.062552,0.21299,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_UP,0.934624738038127
GSE19888_ADENOSINE_A3R_INH_V...2,SET,173,0.049788,0.0048076,0.062538,0.21299,GSE19888_ADENOSINE_A3R_INH_VS_ACT_IN_MAST_CELL_UP,0.934624738038127
GOBP_INTRACELLULAR_IRON_ION_...,SET,60,0.085459,0.0048748,0.10735,0.21301,GOBP_INTRACELLULAR_IRON_ION_HOMEOSTASIS,0.934624738038127
PAX4_01,SET,247,0.042334,0.0048746,0.053199,0.21309,PAX4_01,0.934797217314488
GOBP_GLYCOPROTEIN_METABOLIC_...,SET,344,0.037212,0.0050431,0.046767,0.21311,GOBP_GLYCOPROTEIN_METABOLIC_PROCESS,0.934797217314488
HP_EPIDERMAL_HYPERKERATOSIS,SET,11,0.21746,0.0053184,0.27331,0.21313,HP_EPIDERMAL_HYPERKERATOSIS,0.934797217314488
GOBP_REGULATION_OF_DENDRITIC...5,SET,12,0.20537,0.0052459,0.25815,0.21316,GOBP_REGULATION_OF_DENDRITIC_SPINE_MAINTENANCE,0.934810826498423
MORF_SART1,SET,58,0.079468,0.0044572,0.099921,0.21322,MORF_SART1,0.934955980317941
HP_MINIMAL_CHANGE_GLOMERULON...,SET,34,0.11992,0.0051529,0.15084,0.21331,HP_MINIMAL_CHANGE_GLOMERULONEPHRITIS,0.935158501513623
GOBP_EMBRYONIC_HEART_TUBE_DE...,SET,82,0.074895,0.0049915,0.094213,0.21332,GOBP_EMBRYONIC_HEART_TUBE_DEVELOPMENT,0.935158501513623
KEGG_MEDICUS_VARIANT_CDH1_RE...,SET,8,0.22918,0.0047805,0.28834,0.21336,KEGG_MEDICUS_VARIANT_CDH1_REDUCED_EXPRESSION_TO_BETA_CATENIN_SIGNALING_PATHWAY,0.935215891032917
GOCC_VESICLE_LUMEN,SET,301,0.039526,0.0050167,0.049747,0.21344,GOCC_VESICLE_LUMEN,0.935330626654898
GSE1791_CTRL_VS_NEUROMEDINU_...2,SET,170,0.049983,0.0047848,0.062906,0.21344,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_UP,0.935330626654898
KEGG_MEDICUS_REFERENCE_FLT3L...1,SET,14,0.16671,0.0045994,0.20986,0.2135,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_ERK_SIGNALING_PATHWAY,0.935475605143722
UNTERMAN_PROGRESSIVE_VS_STAB...5,SET,8,0.26607,0.0055499,0.33518,0.21366,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_NK_CELL_DN,0.935788991056808
HP_UNBALANCED_ATRIOVENTRICUL...,SET,5,0.29436,0.0048545,0.37088,0.21369,HP_UNBALANCED_ATRIOVENTRICULAR_CANAL_DEFECT,0.935788991056808
GOBP_LATE_ENDOSOME_TO_VACUOL...2,SET,26,0.11854,0.0044553,0.14936,0.2137,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.935788991056808
GSE21670_STAT3_KO_VS_WT_CD4_...4,SET,175,0.052888,0.0051362,0.066639,0.21371,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_DN,0.935788991056808
SERVITJA_ISLET_HNF1A_TARGETS...1,SET,100,0.070981,0.0052215,0.089456,0.21376,SERVITJA_ISLET_HNF1A_TARGETS_DN,0.935788991056808
REACTOME_HCMV_LATE_EVENTS,SET,51,0.086292,0.0045393,0.10875,0.21376,REACTOME_HCMV_LATE_EVENTS,0.935788991056808
GSE36392_MAC_VS_NEUTROPHIL_I...1,SET,186,0.051904,0.005195,0.065415,0.21376,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,0.935788991056808
GSE9239_CTRL_VS_TNF_INHIBITO...1,SET,177,0.047094,0.0045992,0.059378,0.21386,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN,0.936108853904282
HP_APNEIC_EPISODES_PRECIPITA...,SET,11,0.20825,0.0050932,0.2627,0.21397,HP_APNEIC_EPISODES_PRECIPITATED_BY_ILLNESS_FATIGUE_STRESS,0.93614203673418
DELASERNA_MYOD_TARGETS_DN,SET,49,0.10343,0.0053336,0.13051,0.21402,DELASERNA_MYOD_TARGETS_DN,0.93614203673418
SESTO_RESPONSE_TO_UV_C4,SET,20,0.13959,0.0046021,0.17612,0.21402,SESTO_RESPONSE_TO_UV_C4,0.93614203673418
GOMF_ISOCITRATE_DEHYDROGENAS...,SET,4,0.34078,0.0050268,0.42999,0.21403,GOMF_ISOCITRATE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,0.93614203673418
KEGG_VASCULAR_SMOOTH_MUSCLE_...,SET,109,0.065771,0.00505,0.082997,0.21405,KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION,0.93614203673418
GOBP_T_CELL_MIGRATION,SET,63,0.088629,0.0051801,0.11185,0.21407,GOBP_T_CELL_MIGRATION,0.93614203673418
GOBP_DIENCEPHALON_DEVELOPMENT,SET,71,0.088832,0.0055106,0.11211,0.21409,GOBP_DIENCEPHALON_DEVELOPMENT,0.93614203673418
HP_HYPOKALEMIA,SET,74,0.081017,0.0051304,0.10226,0.21411,HP_HYPOKALEMIA,0.93614203673418
GSE37534_UNTREATED_VS_ROSIGL...1,SET,182,0.05087,0.005037,0.064207,0.21411,GSE37534_UNTREATED_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,0.93614203673418
DESCARTES_FETAL_KIDNEY_ERYTH...,SET,129,0.060079,0.0050156,0.075849,0.21416,DESCARTES_FETAL_KIDNEY_ERYTHROBLASTS,0.936242867924528
MIR7844_5P,SET,139,0.056404,0.0048866,0.071222,0.2142,MIR7844_5P,0.936283006412674
GOBP_PRIMARY_AMINO_COMPOUND_...1,SET,6,0.22078,0.0039884,0.27883,0.21424,GOBP_PRIMARY_AMINO_COMPOUND_BIOSYNTHETIC_PROCESS,0.936283006412674
GOBP_MONOATOMIC_CATION_TRANS...2,SET,917,0.023509,0.0051186,0.029692,0.21425,GOBP_MONOATOMIC_CATION_TRANSPORT,0.936283006412674
MODULE_107,SET,74,0.081389,0.005154,0.10284,0.21436,MODULE_107,0.936615575109994
GSE42724_NAIVE_BCELL_VS_PLAS...2,SET,181,0.050552,0.004992,0.063883,0.21438,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_UP,0.936615575109994
GOMF_POTASSIUM_CHANNEL_INHIB...,SET,5,0.3046,0.0050234,0.38507,0.21447,GOMF_POTASSIUM_CHANNEL_INHIBITOR_ACTIVITY,0.936786566976627
GOBP_REGULATION_OF_MITOPHAGY,SET,33,0.11359,0.0048089,0.14361,0.21449,GOBP_REGULATION_OF_MITOPHAGY,0.936786566976627
GOCC_BLEB,SET,9,0.22784,0.0050407,0.28808,0.2145,GOCC_BLEB,0.936786566976627
LAKE_ADULT_KIDNEY_C19_COLLEC...,SET,288,0.038485,0.0047797,0.048671,0.21456,LAKE_ADULT_KIDNEY_C19_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_MEDULLA,0.936856827889447
HIRSCH_CELLULAR_TRANSFORMATI...2,SET,228,0.045005,0.0049815,0.056919,0.21457,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP,0.936856827889447
GSE7831_UNSTIM_VS_CPG_STIM_P...4,SET,185,0.048201,0.0048115,0.060968,0.2146,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_UP,0.936870116819495
HP_DEJA_VU_AURA,SET,7,0.24597,0.0047995,0.31123,0.21468,HP_DEJA_VU_AURA,0.937010508474576
HP_SPHEROPHAKIA,SET,5,0.30518,0.005033,0.38619,0.2147,HP_SPHEROPHAKIA,0.937010508474576
GOBP_TRANSLATION,SET,579,0.026685,0.0046612,0.033774,0.21474,GOBP_TRANSLATION,0.937010508474576
GSE24574_BCL6_LOW_TFH_VS_TCO...1,SET,180,0.048035,0.0047304,0.060797,0.21474,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_DN,0.937010508474576
GENTILE_UV_RESPONSE_CLUSTER_...7,SET,36,0.11511,0.0050897,0.14572,0.21477,GENTILE_UV_RESPONSE_CLUSTER_D8,0.937023769771529
GOBP_NEGATIVE_REGULATION_OF_...189,SET,29,0.11332,0.0044978,0.14348,0.21484,GOBP_NEGATIVE_REGULATION_OF_DNA_REPAIR,0.937072914837577
GSE25088_CTRL_VS_ROSIGLITAZO...1,SET,138,0.055589,0.0047988,0.070387,0.21484,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,0.937072914837577
MIR616_5P,SET,856,0.023189,0.0048866,0.029369,0.21489,MIR616_5P,0.937072914837577
GOBP_CELL_PROJECTION_ASSEMBLY,SET,537,0.029009,0.0048856,0.036744,0.21492,GOBP_CELL_PROJECTION_ASSEMBLY,0.937072914837577
HP_POLYCYTHEMIA,SET,22,0.14316,0.0049502,0.18137,0.21496,HP_POLYCYTHEMIA,0.937072914837577
HP_LOBULATED_TONGUE,SET,15,0.14252,0.00407,0.18056,0.21497,HP_LOBULATED_TONGUE,0.937072914837577
GSE40274_FOXP3_VS_FOXP3_AND_...11,SET,184,0.049293,0.0049073,0.06245,0.21497,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.937072914837577
GOBP_4FE_4S_CLUSTER_ASSEMBLY,SET,4,0.30943,0.0045644,0.39221,0.21508,GOBP_4FE_4S_CLUSTER_ASSEMBLY,0.937306786339755
GOBP_POSITIVE_REGULATION_OF_...523,SET,61,0.094113,0.0054129,0.11931,0.21511,GOBP_POSITIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.937306786339755
GOBP_NEGATIVE_REGULATION_OF_...100,SET,14,0.18972,0.0052342,0.24054,0.21514,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.937306786339755
IKEDA_MIR133_TARGETS_DN,SET,6,0.33549,0.0060608,0.42568,0.21531,IKEDA_MIR133_TARGETS_DN,0.937306786339755
GOBP_NEURAL_FOLD_FORMATION,SET,7,0.24396,0.0047601,0.30953,0.21531,GOBP_NEURAL_FOLD_FORMATION,0.937306786339755
CAHOY_ASTROGLIAL,SET,89,0.07266,0.005044,0.092219,0.21538,CAHOY_ASTROGLIAL,0.937306786339755
TERAO_AOX4_TARGETS_HG_DN,SET,6,0.29896,0.0054008,0.37944,0.21539,TERAO_AOX4_TARGETS_HG_DN,0.937306786339755
GAVISH_3CA_METAPROGRAM_CD4_T...7,SET,38,0.10636,0.0048315,0.135,0.21539,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_2,0.937306786339755
GOMF_GLYCEROPHOSPHOLIPID_FLI...,SET,12,0.20376,0.0052048,0.25863,0.2154,GOMF_GLYCEROPHOSPHOLIPID_FLIPPASE_ACTIVITY,0.937306786339755
GOBP_AUTOCRINE_SIGNALING,SET,7,0.2841,0.0055435,0.36063,0.21541,GOBP_AUTOCRINE_SIGNALING,0.937306786339755
HP_FOOT_JOINT_CONTRACTURE,SET,123,0.059342,0.0048383,0.075328,0.21542,HP_FOOT_JOINT_CONTRACTURE,0.937306786339755
HP_HIGH_FREQUENCY_HEARING_IM...,SET,5,0.33904,0.0055913,0.43037,0.21542,HP_HIGH_FREQUENCY_HEARING_IMPAIRMENT,0.937306786339755
HP_MYOPATHY,SET,280,0.038912,0.0047661,0.049395,0.21542,HP_MYOPATHY,0.937306786339755
KEGG_DNA_REPLICATION,SET,34,0.10279,0.0044169,0.13049,0.21544,KEGG_DNA_REPLICATION,0.937306786339755
GOCC_SMN_SM_PROTEIN_COMPLEX,SET,14,0.15775,0.0043521,0.20031,0.2155,GOCC_SMN_SM_PROTEIN_COMPLEX,0.937306786339755
HP_ABNORMALITY_OF_FIBRINOLYS...,SET,4,0.2584,0.0038117,0.32814,0.21551,HP_ABNORMALITY_OF_FIBRINOLYSIS,0.937306786339755
GOBP_TRNA_THIO_MODIFICATION,SET,5,0.29876,0.004927,0.37941,0.21552,GOBP_TRNA_THIO_MODIFICATION,0.937306786339755
GOBP_POSITIVE_REGULATION_OF_...39,SET,7,0.2394,0.0046712,0.30406,0.21554,GOBP_POSITIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,0.937306786339755
GSE11386_NAIVE_VS_MEMORY_BCE...2,SET,160,0.04988,0.0046337,0.063358,0.21557,GSE11386_NAIVE_VS_MEMORY_BCELL_UP,0.937306786339755
GOBP_MAGNESIUM_ION_TRANSPORT,SET,14,0.17733,0.0048923,0.22525,0.21558,GOBP_MAGNESIUM_ION_TRANSPORT,0.937306786339755
REACTOME_NETRIN_MEDIATED_REP...,SET,8,0.23679,0.0049392,0.30081,0.21559,REACTOME_NETRIN_MEDIATED_REPULSION_SIGNALS,0.937306786339755
KIM_HYPOXIA,SET,15,0.17374,0.0049615,0.22077,0.21565,KIM_HYPOXIA,0.937450375234522
BLANCO_MELO_BETA_INTERFERON_...1,SET,183,0.050331,0.0049972,0.063969,0.21571,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_DN,0.937516125
GOBP_RESPONSE_TO_RADIATION,SET,391,0.033225,0.0047943,0.042233,0.21573,GOBP_RESPONSE_TO_RADIATION,0.937516125
BIOCARTA_MAL_PATHWAY,SET,19,0.14745,0.0047386,0.18745,0.21575,BIOCARTA_MAL_PATHWAY,0.937516125
GOBP_REGULATION_OF_PEPTIDYL_...3,SET,7,0.22814,0.0044514,0.29007,0.21579,GOBP_REGULATION_OF_PEPTIDYL_SERINE_DEPHOSPHORYLATION,0.937516125
IRITANI_MAD1_TARGETS_UP,SET,12,0.20791,0.0053109,0.26436,0.2158,IRITANI_MAD1_TARGETS_UP,0.937516125
GOBP_REGULATION_OF_INSULIN_S...1,SET,157,0.054684,0.0050326,0.069555,0.21588,GOBP_REGULATION_OF_INSULIN_SECRETION,0.937716133466633
GSE22313_HEALTHY_VS_SLE_MOUS...2,SET,164,0.05151,0.004844,0.065523,0.2159,GSE22313_HEALTHY_VS_SLE_MOUSE_CD4_TCELL_UP,0.937716133466633
GOBP_PEPTIDYL_PROLINE_MODIFI...,SET,29,0.10804,0.0042884,0.13747,0.21596,GOBP_PEPTIDYL_PROLINE_MODIFICATION,0.937859527677121
GOBP_COMPLEMENT_ACTIVATION_C...,SET,29,0.14059,0.0055801,0.17891,0.216,GOBP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.937885708931918
HP_TESTICULAR_ADRENAL_REST_T...,SET,8,0.24439,0.0050976,0.31103,0.21602,HP_TESTICULAR_ADRENAL_REST_TUMOR,0.937885708931918
GSE40274_FOXP3_VS_FOXP3_AND_...4,SET,183,0.050595,0.0050234,0.0644,0.21605,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.93789879465401
SWEET_KRAS_TARGETS_DN,SET,56,0.095345,0.0052549,0.12138,0.21608,SWEET_KRAS_TARGETS_DN,0.937911877107531
BIOCARTA_MTOR_PATHWAY,SET,21,0.14855,0.0050186,0.18914,0.21611,BIOCARTA_MTOR_PATHWAY,0.937924956293706
HP_BLEEDING_WITH_MINOR_OR_NO...,SET,7,0.2656,0.0051824,0.33821,0.21614,HP_BLEEDING_WITH_MINOR_OR_NO_TRAUMA,0.937938032213759
HP_ABNORMAL_PREPUTIUM_MORPHO...,SET,30,0.10886,0.0043944,0.13864,0.21618,HP_ABNORMAL_PREPUTIUM_MORPHOLOGY,0.937994494382023
GOBP_OLFACTORY_NERVE_DEVELOP...,SET,6,0.29184,0.0052722,0.37174,0.21621,GOBP_OLFACTORY_NERVE_DEVELOPMENT,0.938007558357259
PID_SYNDECAN_3_PATHWAY,SET,15,0.1726,0.0049289,0.22004,0.2164,PID_SYNDECAN_3_PATHWAY,0.938315646046396
GOCC_CCAAT_BINDING_FACTOR_CO...,SET,5,0.26559,0.00438,0.33858,0.21641,GOCC_CCAAT_BINDING_FACTOR_COMPLEX,0.938315646046396
GSE7460_FOXP3_MUT_VS_WT_ACT_...1,SET,184,0.048287,0.0048072,0.061566,0.21643,GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_DN,0.938315646046396
MURARO_PANCREAS_DUCTAL_CELL,SET,1167,0.020903,0.0050972,0.026653,0.21645,MURARO_PANCREAS_DUCTAL_CELL,0.938315646046396
GOCC_BRUSH_BORDER,SET,100,0.065069,0.0047866,0.082973,0.21646,GOCC_BRUSH_BORDER,0.938315646046396
HP_FEW_CAFE_AU_LAIT_SPOTS,SET,6,0.27457,0.0049602,0.35011,0.21646,HP_FEW_CAFE_AU_LAIT_SPOTS,0.938315646046396
RAMJAUN_APOPTOSIS_BY_TGFB1_V...1,SET,8,0.25747,0.0053705,0.32832,0.21647,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_MAPK1_DN,0.938315646046396
KLF14_TARGET_GENES,SET,204,0.046381,0.0048593,0.059153,0.2165,KLF14_TARGET_GENES,0.938328656939768
BURTON_ADIPOGENESIS_6,SET,176,0.048797,0.0047523,0.062251,0.21656,BURTON_ADIPOGENESIS_6,0.938423987286551
GOMF_ENDOPEPTIDASE_REGULATOR...,SET,168,0.057082,0.0054324,0.072835,0.21661,GOMF_ENDOPEPTIDASE_REGULATOR_ACTIVITY,0.938423987286551
MIR191_5P,SET,19,0.14568,0.0046814,0.18589,0.21662,MIR191_5P,0.938423987286551
GSE17186_CD21LOW_VS_CD21HIGH...4,SET,183,0.050677,0.0050316,0.064668,0.21663,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,0.938423987286551
AIZARANI_LIVER_C20_LSECS_3,SET,271,0.042386,0.0051088,0.054096,0.21666,AIZARANI_LIVER_C20_LSECS_3,0.938436976570289
HP_GASTROINTESTINAL_INFARCTI...,SET,13,0.19832,0.0052725,0.25321,0.21676,HP_GASTROINTESTINAL_INFARCTIONS,0.938753121495327
GOBP_RESPONSE_TO_CGMP,SET,8,0.22412,0.0046749,0.28625,0.21683,GOBP_RESPONSE_TO_CGMP,0.938939278594568
GOMF_LACTATE_TRANSMEMBRANE_T...,SET,6,0.30759,0.0055567,0.3929,0.21686,GOMF_LACTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.938952198828952
GOMF_CYCLIC_NUCLEOTIDE_ACTIV...,SET,10,0.21414,0.0049938,0.27357,0.21689,GOMF_CYCLIC_NUCLEOTIDE_ACTIVATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.938965115844544
GOBP_REGULATION_OF_PHOSPHATI...3,SET,4,0.3319,0.0048958,0.42426,0.21703,GOBP_REGULATION_OF_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,0.939254199328108
GSE16385_UNTREATED_VS_12H_RO...2,SET,183,0.048825,0.0048477,0.062417,0.21704,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_UP,0.939254199328108
FIGUEROA_AML_METHYLATION_CLU...5,SET,35,0.11792,0.0051408,0.15076,0.21708,FIGUEROA_AML_METHYLATION_CLUSTER_3_DN,0.939254199328108
HAY_BONE_MARROW_CD34_POS_PRE...1,SET,80,0.079324,0.0052221,0.10143,0.2171,HAY_BONE_MARROW_CD34_POS_PRE_B,0.939254199328108
KEGG_MEDICUS_REFERENCE_PURIN...1,SET,11,0.19523,0.0047748,0.24969,0.21714,KEGG_MEDICUS_REFERENCE_PURINE_SALVAGE_PATHWAY_ADENINE_TO_AMP,0.939254199328108
MIR6846_3P,SET,23,0.14248,0.0050371,0.18224,0.21717,MIR6846_3P,0.939254199328108
GOBP_XENOBIOTIC_TRANSPORT_AC...,SET,6,0.30402,0.0054922,0.3889,0.21719,GOBP_XENOBIOTIC_TRANSPORT_ACROSS_BLOOD_BRAIN_BARRIER,0.939254199328108
HP_ABSENT_THUMBNAIL,SET,16,0.16616,0.0049005,0.21256,0.2172,HP_ABSENT_THUMBNAIL,0.939254199328108
HP_TOE_SYNDACTYLY,SET,199,0.046496,0.0048119,0.05948,0.2172,HP_TOE_SYNDACTYLY,0.939254199328108
GSE5142_HTERT_TRANSDUCED_VS_...2,SET,177,0.046253,0.0045171,0.059176,0.21723,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_UP,0.939267062702165
GSE9650_NAIVE_VS_EXHAUSTED_C...2,SET,182,0.045929,0.0045478,0.058785,0.21732,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_UP,0.939456245339299
GSE17721_0.5H_VS_12H_POLYIC_...1,SET,186,0.047462,0.0047504,0.06076,0.21737,GSE17721_0.5H_VS_12H_POLYIC_BMDC_DN,0.939456245339299
GSE26669_CTRL_VS_COSTIM_BLOC...1,SET,174,0.049974,0.0048394,0.063976,0.21737,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_DN,0.939456245339299
GOMF_ATP_DEPENDENT_ACTIVITY_...2,SET,71,0.073064,0.0045324,0.093554,0.21741,GOMF_ATP_DEPENDENT_ACTIVITY_ACTING_ON_RNA,0.939456245339299
GOBP_REGULATION_OF_NODAL_SIG...,SET,7,0.29111,0.0056803,0.37279,0.21743,GOBP_REGULATION_OF_NODAL_SIGNALING_PATHWAY,0.939456245339299
GOBP_NEURON_FATE_DETERMINATI...,SET,8,0.27549,0.0057464,0.35283,0.21746,GOBP_NEURON_FATE_DETERMINATION,0.939456245339299
GSE45365_NK_CELL_VS_CD8_TCEL...3,SET,183,0.048475,0.004813,0.062088,0.21748,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_UP,0.939456245339299
WP_CHOLESTEROL_BIOSYNTHESIS_...1,SET,14,0.15394,0.0042472,0.19718,0.21749,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,0.939456245339299
MODULE_198,SET,289,0.036584,0.0045513,0.046867,0.21753,MODULE_198,0.939512259227041
HP_DEEP_PLANTAR_CREASES,SET,19,0.14789,0.0047526,0.18949,0.21756,HP_DEEP_PLANTAR_CREASES,0.939525074552684
GAO_LARGE_INTESTINE_24W_C10_...,SET,55,0.085461,0.0046681,0.10955,0.21768,GAO_LARGE_INTESTINE_24W_C10_ENTEROCYTE,0.939926500186359
chr9q31,SET,55,0.15762,0.0086098,0.20209,0.21771,chr9q31,0.939939260869565
GOBP_REGULATION_OF_MEMBRANE_...2,SET,5,0.33108,0.0054601,0.42461,0.21778,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_ACTION_POTENTIAL,0.940041232315711
GOBP_POSITIVE_REGULATION_OF_...135,SET,9,0.22796,0.0050432,0.29239,0.21781,GOBP_POSITIVE_REGULATION_OF_CELL_MATURATION,0.940041232315711
GOBP_HYDROGEN_SULFIDE_METABO...,SET,4,0.31907,0.0047066,0.40927,0.21782,GOBP_HYDROGEN_SULFIDE_METABOLIC_PROCESS,0.940041232315711
GSE14308_NAIVE_CD4_TCELL_VS_...3,SET,182,0.04833,0.0047856,0.062012,0.21789,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN,0.940041232315711
MODULE_183,SET,62,0.076054,0.0044098,0.097592,0.21791,MODULE_183,0.940041232315711
LEE_AGING_NEOCORTEX_DN,SET,62,0.08142,0.004721,0.1045,0.21794,LEE_AGING_NEOCORTEX_DN,0.940041232315711
GOBP_POSITIVE_REGULATION_OF_...593,SET,7,0.25838,0.0050415,0.33159,0.21794,GOBP_POSITIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,0.940041232315711
GOBP_MITOTIC_INTRA_S_DNA_DAM...,SET,16,0.1436,0.0042351,0.1843,0.21795,GOBP_MITOTIC_INTRA_S_DNA_DAMAGE_CHECKPOINT_SIGNALING,0.940041232315711
MIR4645_5P,SET,103,0.064092,0.0047845,0.082271,0.21799,MIR4645_5P,0.940097090209703
GSE10239_NAIVE_VS_KLRG1HIGH_...2,SET,187,0.047844,0.0048014,0.061441,0.21808,GSE10239_NAIVE_VS_KLRG1HIGH_EFF_CD8_TCELL_UP,0.940368535980149
GOBP_ENDOSOME_TO_LYSOSOME_TR...2,SET,17,0.14871,0.0045208,0.19102,0.21813,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.940467454410123
GSE43955_1H_VS_60H_ACT_CD4_T...1,SET,182,0.049717,0.0049228,0.063873,0.21818,GSE43955_1H_VS_60H_ACT_CD4_TCELL_DN,0.940535904750093
BILANGES_RAPAMYCIN_SENSITIVE...2,SET,59,0.079972,0.0045238,0.10275,0.2182,BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2,0.940535904750093
GSE3337_CTRL_VS_16H_IFNG_IN_...2,SET,181,0.049926,0.0049301,0.064187,0.21835,GSE3337_CTRL_VS_16H_IFNG_IN_CD8POS_DC_UP,0.941042557937787
GSE20715_WT_VS_TLR4_KO_6H_OZ...1,SET,177,0.050057,0.0048886,0.064381,0.21844,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_DN,0.941042557937787
DE_YY1_TARGETS_DN,SET,88,0.07138,0.0049274,0.091815,0.21846,DE_YY1_TARGETS_DN,0.941042557937787
GOBP_NEGATIVE_REGULATION_OF_...5,SET,6,0.30259,0.0054664,0.38923,0.21846,GOBP_NEGATIVE_REGULATION_OF_ACTION_POTENTIAL,0.941042557937787
GOBP_PEPTIDYL_TYROSINE_MODIF...,SET,248,0.043325,0.0049987,0.055728,0.21846,GOBP_PEPTIDYL_TYROSINE_MODIFICATION,0.941042557937787
GSE8835_CD4_VS_CD8_TCELL_CLL...2,SET,189,0.049327,0.0049764,0.063457,0.21848,GSE8835_CD4_VS_CD8_TCELL_CLL_PATIENT_UP,0.941042557937787
KRIGE_RESPONSE_TO_TOSEDOSTAT...2,SET,645,0.026041,0.004792,0.033506,0.21852,KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP,0.941098215613383
GOMF_ADP_D_RIBOSE_MODIFICATI...,SET,4,0.28174,0.0041559,0.36257,0.21857,GOMF_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.941105480554867
GSE21670_STAT3_KO_VS_WT_CD4_...7,SET,180,0.046225,0.0045521,0.059496,0.2186,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_TREATED_UP,0.941105480554867
HP_APLASIA_HYPOPLASIA_OF_THE...21,SET,108,0.064426,0.0049242,0.082928,0.21861,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,0.941105480554867
REACTOME_ACTIVATED_NOTCH1_TR...,SET,29,0.11713,0.0046491,0.15078,0.21863,REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS,0.941105480554867
GNF2_MSN,SET,20,0.14296,0.0047135,0.18405,0.21866,GNF2_MSN,0.941118055727554
GOBP_AMELOGENESIS,SET,23,0.13974,0.0049403,0.17998,0.21875,GOBP_AMELOGENESIS,0.941261716738197
GOMF_INTRAMOLECULAR_OXIDORED...1,SET,51,0.088551,0.0046582,0.11406,0.21878,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY,0.941261716738197
GNF2_HCK,SET,86,0.07434,0.0050733,0.095772,0.21882,GNF2_HCK,0.941261716738197
GOCC_GAP_JUNCTION,SET,27,0.13546,0.0051882,0.17456,0.21887,GOCC_GAP_JUNCTION,0.941261716738197
GSE17301_CTRL_VS_48H_ACD3_AC...1,SET,174,0.048499,0.0046966,0.0625,0.21888,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA2_STIM_CD8_TCELL_DN,0.941261716738197
GOCC_SEROTONIN_RECEPTOR_COMP...,SET,5,0.36653,0.0060447,0.47247,0.21894,GOCC_SEROTONIN_RECEPTOR_COMPLEX,0.941261716738197
GOMF_SEROTONIN_GATED_MONOATO...,SET,5,0.36653,0.0060447,0.47247,0.21894,GOMF_SEROTONIN_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.941261716738197
GOBP_TRANS_SYNAPTIC_SIGNALIN...1,SET,4,0.37454,0.0055248,0.48282,0.21896,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_BDNF,0.941261716738197
GSE37533_UNTREATED_VS_PIOGLI...2,SET,149,0.052665,0.0047227,0.06791,0.21902,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP,0.941261716738197
MIR1252_5P,SET,294,0.037923,0.0047579,0.048905,0.21905,MIR1252_5P,0.941261716738197
REACTOME_SYNTHESIS_OF_PIPS_A...2,SET,5,0.30324,0.005001,0.39115,0.2191,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_ER_MEMBRANE,0.941261716738197
GOBP_CHORION_DEVELOPMENT,SET,10,0.23284,0.0054298,0.30035,0.21911,GOBP_CHORION_DEVELOPMENT,0.941261716738197
REACTOME_PREVENTION_OF_PHAGO...,SET,8,0.2238,0.0046682,0.2887,0.21912,REACTOME_PREVENTION_OF_PHAGOSOMAL_LYSOSOMAL_FUSION,0.941261716738197
HP_ATROPHIC_SCARS,SET,33,0.11581,0.0049027,0.1494,0.21913,HP_ATROPHIC_SCARS,0.941261716738197
GOBP_POSITIVE_REGULATION_OF_...110,SET,24,0.13478,0.0048672,0.17388,0.21914,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,0.941261716738197
HP_FUNCTIONAL_ABNORMALITY_OF...1,SET,228,0.04243,0.0046965,0.054754,0.2192,HP_FUNCTIONAL_ABNORMALITY_OF_MALE_INTERNAL_GENITALIA,0.941261716738197
HP_ABNORMAL_ISCHIUM_MORPHOLO...,SET,24,0.13067,0.0047187,0.16864,0.21923,HP_ABNORMAL_ISCHIUM_MORPHOLOGY,0.941261716738197
HP_UPPER_AIRWAY_OBSTRUCTION,SET,15,0.18161,0.0051861,0.2344,0.21924,HP_UPPER_AIRWAY_OBSTRUCTION,0.941261716738197
GSE21927_SPLEEN_VS_C26GM_TUM...2,SET,137,0.058331,0.0050173,0.075297,0.21927,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_UP,0.941261716738197
HP_NECROTIZING_ENTEROCOLITIS,SET,6,0.24724,0.0044665,0.31919,0.21929,HP_NECROTIZING_ENTEROCOLITIS,0.941261716738197
REACTOME_SHC_RELATED_EVENTS_...,SET,9,0.20368,0.0045062,0.26303,0.21936,REACTOME_SHC_RELATED_EVENTS_TRIGGERED_BY_IGF1R,0.941261716738197
MODULE_114,SET,290,0.036306,0.0045244,0.046888,0.21938,MODULE_114,0.941261716738197
BIOCARTA_EIF_PATHWAY,SET,13,0.1644,0.0043708,0.21235,0.21941,BIOCARTA_EIF_PATHWAY,0.941261716738197
GOCC_ENDOPLASMIC_RETICULUM_Q...,SET,15,0.15924,0.0045473,0.2057,0.21943,GOCC_ENDOPLASMIC_RETICULUM_QUALITY_CONTROL_COMPARTMENT,0.941261716738197
HP_ABNORMAL_FOVEAL_MORPHOLOG...,SET,6,0.28438,0.0051373,0.36736,0.21944,HP_ABNORMAL_FOVEAL_MORPHOLOGY_ON_MACULAR_OCT,0.941261716738197
GOBP_PORE_COMPLEX_ASSEMBLY,SET,18,0.15084,0.0047182,0.19487,0.21946,GOBP_PORE_COMPLEX_ASSEMBLY,0.941261716738197
GOMF_3_HYDROXYACYL_COA_DEHYD...1,SET,7,0.3108,0.0060644,0.40157,0.21948,GOMF_3_HYDROXYACYL_COA_DEHYDRATASE_ACTIVITY,0.941261716738197
GOMF_NITRITE_REDUCTASE_ACTIV...,SET,5,0.31685,0.0052253,0.40944,0.21951,GOMF_NITRITE_REDUCTASE_ACTIVITY,0.941261716738197
GOMF_ARYL_SULFOTRANSFERASE_A...,SET,7,0.31424,0.0061315,0.40612,0.21954,GOMF_ARYL_SULFOTRANSFERASE_ACTIVITY,0.941261716738197
WP_SPHINGOLIPID_METABOLISM_I...2,SET,27,0.13706,0.0052493,0.17714,0.21956,WP_SPHINGOLIPID_METABOLISM_IN_SENESCENCE,0.941261716738197
GOBP_REGULATION_OF_PHOSPHATA...,SET,50,0.090684,0.0047235,0.11721,0.21956,GOBP_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.941261716738197
WP_PROLACTIN_SIGNALING,SET,72,0.080514,0.0050295,0.10407,0.21957,WP_PROLACTIN_SIGNALING,0.941261716738197
HP_CEPHALOHEMATOMA,SET,9,0.23211,0.005135,0.30007,0.21961,HP_CEPHALOHEMATOMA,0.941261716738197
GOBP_REGULATION_OF_STEM_CELL...3,SET,67,0.077658,0.0046803,0.1004,0.21963,GOBP_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.941261716738197
HP_OCCIPITAL_CORTICAL_ATROPHY,SET,5,0.39847,0.0065715,0.51533,0.21969,HP_OCCIPITAL_CORTICAL_ATROPHY,0.941261716738197
GSE32533_WT_VS_MIR17_OVEREXP...2,SET,171,0.049107,0.0047147,0.063514,0.21971,GSE32533_WT_VS_MIR17_OVEREXPRESS_ACT_CD4_TCELL_UP,0.941261716738197
PATEL_SKIN_OF_BODY_ZOSTAVAX_...2,SET,33,0.11373,0.0048147,0.14713,0.21977,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_DN,0.941261716738197
HP_APLASIA_HYPOPLASIA_OF_THE...22,SET,13,0.17965,0.0047761,0.23244,0.21981,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.941261716738197
GOBP_CHOLINE_TRANSPORT,SET,9,0.22953,0.0050781,0.29703,0.21983,GOBP_CHOLINE_TRANSPORT,0.941261716738197
GOBP_EPIGENETIC_REGULATION_O...,SET,210,0.043708,0.0046453,0.056565,0.21985,GOBP_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,0.941261716738197
HP_CARDIAC_VALVE_CALCIFICATI...,SET,11,0.22385,0.0054747,0.28978,0.21992,HP_CARDIAC_VALVE_CALCIFICATION,0.941261716738197
BIOCARTA_PDZS_PATHWAY,SET,15,0.17566,0.0050162,0.22744,0.21996,BIOCARTA_PDZS_PATHWAY,0.941261716738197
HP_ABNORMAL_SELLA_TURCICA_MO...,SET,37,0.1021,0.0045764,0.13224,0.22004,HP_ABNORMAL_SELLA_TURCICA_MORPHOLOGY,0.941261716738197
HP_INTERPHALANGEAL_JOINT_ERO...,SET,7,0.2597,0.0050674,0.33639,0.22005,HP_INTERPHALANGEAL_JOINT_EROSIONS,0.941261716738197
HP_UPPER_LIMB_PAIN,SET,8,0.24116,0.0050304,0.31242,0.22009,HP_UPPER_LIMB_PAIN,0.941261716738197
GSE25088_IL4_VS_IL4_AND_ROSI...4,SET,177,0.0502,0.0049026,0.065035,0.22009,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.941261716738197
GOBP_INTERLEUKIN_17A_MEDIATE...,SET,6,0.30206,0.0054567,0.39133,0.2201,GOBP_INTERLEUKIN_17A_MEDIATED_SIGNALING_PATHWAY,0.941261716738197
GSE19941_IL10_KO_VS_IL10_KO_...5,SET,179,0.049779,0.0048886,0.064491,0.2201,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_DN,0.941261716738197
GSE42021_CD24HI_VS_CD24LOW_T...2,SET,178,0.049187,0.0048171,0.063727,0.22011,GSE42021_CD24HI_VS_CD24LOW_TCONV_THYMUS_UP,0.941261716738197
GOBP_LYMPH_NODE_DEVELOPMENT,SET,19,0.15403,0.00495,0.19957,0.22012,GOBP_LYMPH_NODE_DEVELOPMENT,0.941261716738197
TAKAO_RESPONSE_TO_UVB_RADIAT...2,SET,71,0.072646,0.0045065,0.094166,0.22022,TAKAO_RESPONSE_TO_UVB_RADIATION_UP,0.941261716738197
GOBP_NEGATIVE_REGULATION_OF_...648,SET,89,0.069934,0.0048547,0.090666,0.22026,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_SIGNALING_PATHWAY,0.941261716738197
GOMF_ABC_TYPE_GLUTATHIONE_S_...,SET,8,0.24303,0.0050693,0.31509,0.22027,GOMF_ABC_TYPE_GLUTATHIONE_S_CONJUGATE_TRANSPORTER_ACTIVITY,0.941261716738197
GOBP_TESTOSTERONE_BIOSYNTHET...,SET,10,0.20178,0.0047054,0.26164,0.22029,GOBP_TESTOSTERONE_BIOSYNTHETIC_PROCESS,0.941261716738197
REACTOME_METABOLISM_OF_FAT_S...,SET,45,0.10266,0.0050737,0.13312,0.2203,REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS,0.941261716738197
SASAKI_TARGETS_OF_TP73_AND_T...,SET,11,0.20845,0.0050982,0.27031,0.22031,SASAKI_TARGETS_OF_TP73_AND_TP63,0.941261716738197
PHB2_TARGET_GENES,SET,149,0.051836,0.0046483,0.06722,0.22032,PHB2_TARGET_GENES,0.941261716738197
GSE6259_33D1_POS_DC_VS_CD4_T...1,SET,165,0.049925,0.0047091,0.06475,0.22035,GSE6259_33D1_POS_DC_VS_CD4_TCELL_DN,0.941261716738197
GSE37301_MULTIPOTENT_PROGENI...8,SET,146,0.052105,0.0046256,0.067582,0.22036,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP,0.941261716738197
GOBP_CELLULAR_LIPID_BIOSYNTH...,SET,11,0.20385,0.0049857,0.26444,0.22039,GOBP_CELLULAR_LIPID_BIOSYNTHETIC_PROCESS,0.941261716738197
GSE3203_HEALTHY_VS_INFLUENZA...2,SET,178,0.049127,0.0048112,0.063728,0.22039,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_UP,0.941261716738197
MIR548AT_5P,SET,313,0.037106,0.0048009,0.048148,0.22046,MIR548AT_5P,0.941261716738197
GOBP_NEGATIVE_REGULATION_OF_...608,SET,26,0.12891,0.0048451,0.1673,0.2205,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_DIFFERENTIATION,0.941261716738197
GOBP_SKELETAL_MUSCLE_SATELLI...4,SET,16,0.14521,0.0042825,0.18846,0.22051,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,0.941261716738197
GOBP_NEGATIVE_REGULATION_OF_...502,SET,21,0.15969,0.0053949,0.20727,0.22052,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,0.941261716738197
GOBP_COMMON_BILE_DUCT_DEVELO...,SET,5,0.30087,0.0049618,0.3906,0.22057,GOBP_COMMON_BILE_DUCT_DEVELOPMENT,0.941261716738197
HP_ABNORMAL_EXTEROCEPTIVE_SE...,SET,219,0.043886,0.0047619,0.056981,0.2206,HP_ABNORMAL_EXTEROCEPTIVE_SENSATION,0.941261716738197
GOBP_AMINO_SUGAR_BIOSYNTHETI...,SET,11,0.19823,0.0048482,0.25741,0.22062,GOBP_AMINO_SUGAR_BIOSYNTHETIC_PROCESS,0.941261716738197
KOBAYASHI_EGFR_SIGNALING_24H...1,SET,240,0.040355,0.0045813,0.052414,0.22068,KOBAYASHI_EGFR_SIGNALING_24HR_DN,0.941261716738197
HP_CONSTIPATION,SET,388,0.033715,0.0048467,0.043796,0.22071,HP_CONSTIPATION,0.941261716738197
HP_SUBDURAL_HEMORRHAGE,SET,12,0.19696,0.005031,0.25584,0.22071,HP_SUBDURAL_HEMORRHAGE,0.941261716738197
HP_HIP_DYSPLASIA,SET,207,0.044894,0.0047375,0.058322,0.22073,HP_HIP_DYSPLASIA,0.941261716738197
HP_SEVERE_EXPRESSIVE_LANGUAG...,SET,9,0.21738,0.0048092,0.28241,0.22073,HP_SEVERE_EXPRESSIVE_LANGUAGE_DELAY,0.941261716738197
GOMF_MAGNESIUM_ION_TRANSMEMB...,SET,13,0.17749,0.0047187,0.2306,0.22075,GOMF_MAGNESIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.941261716738197
GSE40274_CTRL_VS_FOXP3_AND_P...2,SET,152,0.053327,0.0048295,0.069301,0.2208,GSE40274_CTRL_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.941261716738197
GOMF_ATPASE_BINDING,SET,78,0.077472,0.0050363,0.10068,0.22081,GOMF_ATPASE_BINDING,0.941261716738197
HP_SUBUNGUAL_HYPERKERATOSIS,SET,6,0.26908,0.0048609,0.34971,0.22082,HP_SUBUNGUAL_HYPERKERATOSIS,0.941261716738197
LEIN_MEDULLA_MARKERS,SET,76,0.075245,0.0048287,0.097796,0.22083,LEIN_MEDULLA_MARKERS,0.941261716738197
TCF1P_Q6,SET,239,0.042925,0.0048631,0.055793,0.22084,TCF1P_Q6,0.941261716738197
GOBP_REGULATION_OF_TRIGLYCER...3,SET,39,0.10113,0.0046535,0.13145,0.22086,GOBP_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.941261716738197
ROPERO_HDAC2_TARGETS,SET,98,0.065585,0.0047763,0.085302,0.22099,ROPERO_HDAC2_TARGETS,0.941399963293772
GOBP_POSITIVE_REGULATION_OF_...323,SET,29,0.11898,0.0047224,0.15475,0.221,GOBP_POSITIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.941399963293772
HP_MULTIPLE_LENTIGINES,SET,15,0.15413,0.0044013,0.20049,0.22102,HP_MULTIPLE_LENTIGINES,0.941399963293772
TRAVAGLINI_LUNG_GOBLET_CELL,SET,138,0.057277,0.0049445,0.074504,0.22102,TRAVAGLINI_LUNG_GOBLET_CELL,0.941399963293772
GSE8621_UNSTIM_VS_LPS_PRIMED...4,SET,176,0.048242,0.0046982,0.062765,0.22107,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_UP,0.941399963293772
HP_DYSESTHESIA,SET,16,0.17555,0.0051773,0.22847,0.22114,HP_DYSESTHESIA,0.941399963293772
GSE19923_WT_VS_HEB_AND_E2A_K...2,SET,182,0.046242,0.0045788,0.06019,0.22117,GSE19923_WT_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.941399963293772
MCGOWAN_RSP6_TARGETS_UP,SET,20,0.15039,0.0049585,0.19578,0.22119,MCGOWAN_RSP6_TARGETS_UP,0.941399963293772
GSE27786_NKCELL_VS_NEUTROPHI...2,SET,184,0.045846,0.0045642,0.059682,0.2212,GSE27786_NKCELL_VS_NEUTROPHIL_UP,0.941399963293772
MIR105_5P,SET,198,0.0465,0.0048004,0.060542,0.22123,MIR105_5P,0.941399963293772
HP_APLASIA_OF_THE_MIDDLE_PHA...,SET,7,0.23889,0.0046612,0.31103,0.22123,HP_APLASIA_OF_THE_MIDDLE_PHALANX_OF_THE_HAND,0.941399963293772
REACTOME_INTERLEUKIN_3_INTER...,SET,43,0.10072,0.0048662,0.13116,0.22126,REACTOME_INTERLEUKIN_3_INTERLEUKIN_5_AND_GM_CSF_SIGNALING,0.941399963293772
GOBP_PYRIMIDINE_NUCLEOSIDE_B...,SET,4,0.29401,0.0043369,0.38285,0.22127,GOBP_PYRIMIDINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,0.941399963293772
HAHTOLA_CTCL_PATHOGENESIS,SET,15,0.17834,0.0050927,0.23225,0.22129,HAHTOLA_CTCL_PATHOGENESIS,0.941399963293772
GSE12366_PLASMA_CELL_VS_NAIV...1,SET,170,0.047883,0.0045838,0.062365,0.22131,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN,0.941399963293772
GSE45365_HEALTHY_VS_MCMV_INF...2,SET,184,0.044979,0.0044779,0.058597,0.22137,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_UP,0.941399963293772
GNF2_ANK1,SET,61,0.084349,0.0048514,0.10989,0.22138,GNF2_ANK1,0.941399963293772
GNF2_SPTB,SET,61,0.084349,0.0048514,0.10989,0.22138,GNF2_SPTB,0.941399963293772
NAKAYA_PBMC_FLUMIST_AGE_18_5...1,SET,615,0.025997,0.0046754,0.03388,0.22144,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN,0.94150976146789
HP_AUDITORY_HALLUCINATION,SET,16,0.15195,0.0044812,0.19803,0.22146,HP_AUDITORY_HALLUCINATION,0.94150976146789
MIR3161,SET,69,0.084551,0.0051709,0.11021,0.2215,MIR3161,0.941564640410959
HP_HYPOPLASTIC_ISCHIA,SET,16,0.15828,0.004668,0.20635,0.22154,HP_HYPOPLASTIC_ISCHIA,0.941619505931271
GSE40666_UNTREATED_VS_IFNA_S...4,SET,186,0.049661,0.0049706,0.06476,0.22159,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_UP,0.941686703753515
chr16q21,SET,37,0.19473,0.0087286,0.25396,0.22161,chr16q21,0.941686703753515
FAN_EMBRYONIC_CTX_BRAIN_NAIV...,SET,139,0.057595,0.0049898,0.075145,0.22171,FAN_EMBRYONIC_CTX_BRAIN_NAIVE_LIKE_T_CELL,0.941893632363725
HALLMARK_ANDROGEN_RESPONSE,SET,94,0.069042,0.004925,0.090083,0.22172,HALLMARK_ANDROGEN_RESPONSE,0.941893632363725
GOBP_GLYCOSPHINGOLIPID_BIOSY...,SET,38,0.11166,0.0050721,0.1457,0.22174,GOBP_GLYCOSPHINGOLIPID_BIOSYNTHETIC_PROCESS,0.941893632363725
HP_SMALL_JOINT_HYPERMOBILTY,SET,52,0.090304,0.0047966,0.11787,0.22181,HP_SMALL_JOINT_HYPERMOBILTY,0.942057947464875
REACTOME_MITOTIC_PROPHASE,SET,77,0.069817,0.0045096,0.091148,0.22185,REACTOME_MITOTIC_PROPHASE,0.942057947464875
HP_LIMITED_WRIST_MOVEMENT,SET,12,0.19072,0.0048719,0.24901,0.22186,HP_LIMITED_WRIST_MOVEMENT,0.942057947464875
HP_EPILEPTIC_ENCEPHALOPATHY,SET,105,0.063017,0.0047495,0.082289,0.2219,HP_EPILEPTIC_ENCEPHALOPATHY,0.942112692401661
ATF5_TARGET_GENES,SET,349,0.033618,0.0045883,0.043916,0.22199,ATF5_TARGET_GENES,0.942158206409163
MIR373_3P,SET,295,0.037415,0.004702,0.048889,0.22205,MIR373_3P,0.942158206409163
HP_RENAL_STEATOSIS,SET,10,0.23642,0.0055133,0.30893,0.22205,HP_RENAL_STEATOSIS,0.942158206409163
HP_AXONAL_REGENERATION,SET,6,0.29872,0.0053964,0.39045,0.22212,HP_AXONAL_REGENERATION,0.942158206409163
VECCHI_GASTRIC_CANCER_ADVANC...1,SET,132,0.056671,0.0047854,0.074084,0.22216,VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_DN,0.942158206409163
MIR1252_3P,SET,270,0.041054,0.0049392,0.05367,0.22216,MIR1252_3P,0.942158206409163
SOBOLEV_PBMC_PANDEMRIX_AGE_1...6,SET,5,0.32735,0.0053986,0.42802,0.2222,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_LOW_VS_MEDIUM_HIGH_ADVERSE_EVENT_SUBJECTS_0DY_DN,0.942158206409163
MODULE_101,SET,10,0.22519,0.0052512,0.29447,0.22223,MODULE_101,0.942158206409163
GOBP_EMBRYONIC_VISCEROCRANIU...,SET,9,0.22875,0.0050607,0.29916,0.22225,GOBP_EMBRYONIC_VISCEROCRANIUM_MORPHOGENESIS,0.942158206409163
GNF2_PAK2,SET,25,0.12217,0.0045027,0.1598,0.22228,GNF2_PAK2,0.942158206409163
KRIGE_AMINO_ACID_DEPRIVATION,SET,24,0.14891,0.0053775,0.19479,0.2223,KRIGE_AMINO_ACID_DEPRIVATION,0.942158206409163
GSE27786_NKCELL_VS_MONO_MAC_...2,SET,179,0.045948,0.0045124,0.060129,0.22239,GSE27786_NKCELL_VS_MONO_MAC_UP,0.942158206409163
WP_SOMATIC_SEX_DETERMINATION,SET,13,0.18503,0.0049192,0.24214,0.2224,WP_SOMATIC_SEX_DETERMINATION,0.942158206409163
HP_ABNORMAL_MUSCLE_FIBER_TYP...,SET,76,0.067694,0.0043441,0.08859,0.2224,HP_ABNORMAL_MUSCLE_FIBER_TYPE_DISTRIBUTION,0.942158206409163
GSE17721_0.5H_VS_12H_CPG_BMD...1,SET,186,0.046712,0.0046753,0.061129,0.2224,GSE17721_0.5H_VS_12H_CPG_BMDC_DN,0.942158206409163
CHEMELLO_SOLEUS_VS_EDL_MYOFI...2,SET,16,0.15985,0.0047143,0.20922,0.22244,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_UP,0.942158206409163
GOBP_RIBOSOME_ASSEMBLY,SET,51,0.085639,0.004505,0.11209,0.22244,GOBP_RIBOSOME_ASSEMBLY,0.942158206409163
GOMF_MINUS_END_DIRECTED_MICR...,SET,17,0.14762,0.0044877,0.19324,0.22246,GOMF_MINUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,0.942158206409163
MIR6808_3P,SET,37,0.10806,0.0048434,0.14145,0.22247,MIR6808_3P,0.942158206409163
GOBP_PEPTIDE_MODIFICATION,SET,5,0.29165,0.0048097,0.38179,0.22247,GOBP_PEPTIDE_MODIFICATION,0.942158206409163
GOBP_REGULATION_OF_RUFFLE_AS...,SET,29,0.12917,0.0051268,0.1691,0.22248,GOBP_REGULATION_OF_RUFFLE_ASSEMBLY,0.942158206409163
WP_WNT_SIGNALING_WP428,SET,109,0.064063,0.0049189,0.083932,0.22265,WP_WNT_SIGNALING_WP428,0.942379779099405
GOCC_CELL_SUBSTRATE_JUNCTION,SET,411,0.031871,0.0047124,0.041756,0.22266,GOCC_CELL_SUBSTRATE_JUNCTION,0.942379779099405
HP_SKIN_APPENDAGE_NEOPLASM,SET,16,0.15895,0.0046877,0.20829,0.22271,HP_SKIN_APPENDAGE_NEOPLASM,0.942379779099405
GOBP_REGULATION_OF_TRIGLYCER...1,SET,18,0.13969,0.0043694,0.18308,0.22274,GOBP_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.942379779099405
GOBP_POSITIVE_REGULATION_OF_...363,SET,37,0.11887,0.005328,0.1558,0.22275,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.942379779099405
LEE_RECENT_THYMIC_EMIGRANT,SET,197,0.046573,0.0047958,0.061047,0.22277,LEE_RECENT_THYMIC_EMIGRANT,0.942379779099405
SIRNA_EIF4GI_DN,SET,84,0.072062,0.0048606,0.094458,0.22277,SIRNA_EIF4GI_DN,0.942379779099405
HP_DEVIATION_OF_TOES,SET,103,0.065748,0.0049082,0.086203,0.22282,HP_DEVIATION_OF_TOES,0.942379779099405
GSE5589_IL6_KO_VS_IL10_KO_LP...2,SET,179,0.046488,0.0045654,0.060953,0.22283,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,0.942379779099405
DESCARTES_FETAL_LIVER_ERYTHR...,SET,55,0.0886,0.0048396,0.11618,0.22286,DESCARTES_FETAL_LIVER_ERYTHROBLASTS,0.942379779099405
GOBP_RESPONSE_TO_PHENYLPROPA...,SET,4,0.37393,0.0055159,0.49042,0.22289,GOBP_RESPONSE_TO_PHENYLPROPANOID,0.942379779099405
KEGG_MEDICUS_REFERENCE_LPA_G...1,SET,12,0.18251,0.004662,0.23948,0.223,KEGG_MEDICUS_REFERENCE_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,0.942379779099405
MIR875_5P,SET,49,0.09252,0.0047708,0.1214,0.223,MIR875_5P,0.942379779099405
GOMF_LONG_CHAIN_FATTY_ACID_B...,SET,16,0.15077,0.0044467,0.19784,0.223,GOMF_LONG_CHAIN_FATTY_ACID_BINDING,0.942379779099405
GOBP_REGULATION_OF_COAGULATI...,SET,73,0.079976,0.0050303,0.10494,0.22301,GOBP_REGULATION_OF_COAGULATION,0.942379779099405
GOBP_REGULATION_OF_REPRODUCT...,SET,187,0.047795,0.0047965,0.062738,0.22309,GOBP_REGULATION_OF_REPRODUCTIVE_PROCESS,0.942379779099405
SA_G1_AND_S_PHASES,SET,15,0.17027,0.0048625,0.22352,0.2231,SA_G1_AND_S_PHASES,0.942379779099405
GOBP_MITRAL_VALVE_DEVELOPMENT,SET,14,0.18898,0.0052139,0.24808,0.2231,GOBP_MITRAL_VALVE_DEVELOPMENT,0.942379779099405
GSE46606_DAY1_VS_DAY3_CD40L_...2,SET,155,0.054945,0.0050246,0.072132,0.22311,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_UP,0.942379779099405
GOBP_REGULATION_OF_CENTRIOLE...,SET,22,0.13319,0.0046052,0.17488,0.22315,GOBP_REGULATION_OF_CENTRIOLE_REPLICATION,0.942379779099405
KEGG_ALZHEIMERS_DISEASE,SET,139,0.049943,0.0043269,0.065581,0.22317,KEGG_ALZHEIMERS_DISEASE,0.942379779099405
GOMF_HIGH_VOLTAGE_GATED_CALC...,SET,13,0.18987,0.0050478,0.24931,0.22317,GOMF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,0.942379779099405
KEGG_MEDICUS_REFERENCE_AGE_R...,SET,15,0.16365,0.0046734,0.21493,0.22321,KEGG_MEDICUS_REFERENCE_AGE_RAGE_SIGNALING_PATHWAY,0.942379779099405
GOBP_RETINA_HOMEOSTASIS,SET,53,0.092907,0.0049819,0.12203,0.22323,GOBP_RETINA_HOMEOSTASIS,0.942379779099405
HP_CHRONIC_AXONAL_NEUROPATHY,SET,7,0.28586,0.0055778,0.37549,0.22324,HP_CHRONIC_AXONAL_NEUROPATHY,0.942379779099405
GOMF_CENTROMERIC_DNA_BINDING,SET,6,0.23857,0.0043097,0.31339,0.22326,GOMF_CENTROMERIC_DNA_BINDING,0.942379779099405
HP_LARYNGEAL_STRIDOR,SET,4,0.32809,0.0048397,0.43103,0.22328,HP_LARYNGEAL_STRIDOR,0.942379779099405
HP_MYOCARDIAL_FIBROSIS,SET,17,0.16219,0.0049303,0.2131,0.22331,HP_MYOCARDIAL_FIBROSIS,0.942379779099405
GCM_SIRT2,SET,40,0.099463,0.0046351,0.13072,0.22336,GCM_SIRT2,0.942379779099405
GOBP_REGULATION_OF_DNA_DAMAG...3,SET,6,0.25409,0.0045903,0.33395,0.22337,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.942379779099405
MSX1_01,SET,158,0.054751,0.0050545,0.071963,0.22339,MSX1_01,0.942379779099405
BIOCARTA_HIF_PATHWAY,SET,15,0.16051,0.0045836,0.21098,0.2234,BIOCARTA_HIF_PATHWAY,0.942379779099405
GSE41867_NAIVE_VS_DAY30_LCMV...1,SET,175,0.0462,0.0044867,0.060748,0.22348,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_DN,0.942572806698216
REACTOME_TRANS_GOLGI_NETWORK...,SET,65,0.074275,0.0044093,0.097674,0.2235,REACTOME_TRANS_GOLGI_NETWORK_VESICLE_BUDDING,0.942572806698216
MODULE_87,SET,41,0.099285,0.0046841,0.13059,0.22355,MODULE_87,0.942586246366279
CREIGHTON_AKT1_SIGNALING_VIA...2,SET,32,0.10609,0.0044231,0.13957,0.22358,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_UP,0.942586246366279
chr3q26,SET,61,0.16344,0.0094006,0.21509,0.22367,chr3q26,0.942586246366279
BASSO_CD40_SIGNALING_DN,SET,64,0.082815,0.0048784,0.10899,0.22367,BASSO_CD40_SIGNALING_DN,0.942586246366279
HP_ABNORMALITY_OF_INTRACRANI...,SET,82,0.068179,0.0045439,0.089731,0.22369,HP_ABNORMALITY_OF_INTRACRANIAL_PRESSURE,0.942586246366279
GOBP_CELL_CYCLE_PROCESS,SET,1143,0.019091,0.0046105,0.025127,0.2237,GOBP_CELL_CYCLE_PROCESS,0.942586246366279
GSE22443_IL2_VS_IL12_TREATED...2,SET,185,0.047696,0.0047612,0.062782,0.22372,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_UP,0.942586246366279
HP_NEOPLASM_OF_THE_EYE,SET,47,0.082534,0.0041684,0.10864,0.22373,HP_NEOPLASM_OF_THE_EYE,0.942586246366279
SUZUKI_RESPONSE_TO_TSA,SET,15,0.1697,0.0048462,0.22343,0.22377,SUZUKI_RESPONSE_TO_TSA,0.942586246366279
HP_ABNORMAL_HEART_SOUND,SET,39,0.1074,0.004942,0.14144,0.22383,HP_ABNORMAL_HEART_SOUND,0.942586246366279
NUNODA_RESPONSE_TO_DASATINIB...2,SET,29,0.11303,0.0044865,0.14887,0.22385,NUNODA_RESPONSE_TO_DASATINIB_IMATINIB_UP,0.942586246366279
ATF6_TARGET_GENES,SET,865,0.022092,0.0046786,0.029099,0.22387,ATF6_TARGET_GENES,0.942586246366279
GSE2770_UNTREATED_VS_TGFB_AN...5,SET,178,0.046721,0.0045756,0.06154,0.22387,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,0.942586246366279
SAGIV_CD24_TARGETS_UP,SET,21,0.1496,0.0050538,0.19707,0.22391,SAGIV_CD24_TARGETS_UP,0.942586246366279
TORCHIA_TARGETS_OF_EWSR1_FLI...3,SET,18,0.16115,0.0050407,0.21229,0.22391,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_UP,0.942586246366279
chr9p24,SET,33,0.1885,0.0079804,0.24838,0.22395,chr9p24,0.942640456582294
GOMF_PROTEIN_KINASE_B_BINDING,SET,10,0.19668,0.0045865,0.25924,0.22403,GOMF_PROTEIN_KINASE_B_BINDING,0.94274304647785
BIOCARTA_EPO_PATHWAY,SET,17,0.15846,0.004817,0.20887,0.22404,BIOCARTA_EPO_PATHWAY,0.94274304647785
HAN_JNK_SINGALING_DN,SET,36,0.11602,0.0051299,0.15295,0.22406,HAN_JNK_SINGALING_DN,0.94274304647785
GOMF_PHOSPHATIDYLGLYCEROL_BI...,SET,14,0.17634,0.004865,0.23249,0.22409,GOMF_PHOSPHATIDYLGLYCEROL_BINDING,0.94274304647785
ZNF112_TARGET_GENES,SET,3,0.38676,0.0049409,0.50996,0.22411,ZNF112_TARGET_GENES,0.94274304647785
BIOCARTA_ATM_PATHWAY,SET,19,0.13862,0.0044548,0.18284,0.22418,BIOCARTA_ATM_PATHWAY,0.942923381338497
HP_ABNORMAL_UMBILICUS_MORPHO...,SET,265,0.039775,0.0047416,0.052523,0.22444,HP_ABNORMAL_UMBILICUS_MORPHOLOGY,0.943719100719424
DURANTE_ADULT_OLFACTORY_NEUR...9,SET,73,0.08378,0.0052696,0.11064,0.22446,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MACROPHAGES,0.943719100719424
WP_FOLATEALCOHOL_AND_CANCER_...,SET,8,0.23244,0.0048485,0.30705,0.22452,WP_FOLATEALCOHOL_AND_CANCER_PATHWAY_HYPOTHESES,0.943719100719424
GSE10240_CTRL_VS_IL22_STIM_P...2,SET,182,0.047962,0.0047491,0.063356,0.22452,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.943719100719424
WP_COVID19_THROMBOSIS_AND_AN...,SET,7,0.30002,0.005854,0.39637,0.22456,WP_COVID19_THROMBOSIS_AND_ANTICOAGULATION,0.943719100719424
MORF_HDAC1,SET,225,0.039228,0.0043137,0.051843,0.22463,MORF_HDAC1,0.943719100719424
WEIGEL_OXIDATIVE_STRESS_BY_H...1,SET,31,0.1108,0.0045466,0.14644,0.22464,WEIGEL_OXIDATIVE_STRESS_BY_HNE_AND_H2O2,0.943719100719424
GR_Q6_01,SET,247,0.041912,0.004826,0.055399,0.22466,GR_Q6_01,0.943719100719424
HP_PULMONARY_ARTERY_STENOSIS,SET,66,0.080167,0.0047954,0.10597,0.22467,HP_PULMONARY_ARTERY_STENOSIS,0.943719100719424
GOMF_TRACE_AMINE_RECEPTOR_AC...,SET,6,0.39588,0.0071517,0.52357,0.22479,GOMF_TRACE_AMINE_RECEPTOR_ACTIVITY,0.943719100719424
GOBP_REGULATION_OF_SYNAPTIC_...8,SET,12,0.17287,0.0044159,0.2287,0.22486,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_CYCLE,0.943719100719424
HOWLIN_CITED1_TARGETS_2_DN,SET,15,0.18305,0.0052272,0.24224,0.22494,HOWLIN_CITED1_TARGETS_2_DN,0.943719100719424
GSE30083_SP1_VS_SP3_THYMOCYT...2,SET,178,0.049649,0.0048623,0.065719,0.22499,GSE30083_SP1_VS_SP3_THYMOCYTE_UP,0.943719100719424
HP_NEOPLASM_OF_THE_COLON,SET,77,0.070304,0.004541,0.093077,0.22503,HP_NEOPLASM_OF_THE_COLON,0.943719100719424
MARSON_BOUND_BY_FOXP3_STIMUL...,SET,880,0.022221,0.0047445,0.02942,0.22504,MARSON_BOUND_BY_FOXP3_STIMULATED,0.943719100719424
WENG_POR_TARGETS_GLOBAL_DN,SET,23,0.13864,0.0049015,0.18358,0.22507,WENG_POR_TARGETS_GLOBAL_DN,0.943719100719424
KEGG_MEDICUS_VARIANT_MUTATIO...2,SET,24,0.12959,0.0046799,0.17163,0.22511,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_CACNA1D_H_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.943719100719424
MODULE_335,SET,14,0.18845,0.0051991,0.24961,0.22514,MODULE_335,0.943719100719424
HP_PROXIMAL_MUSCLE_WEAKNESS_...2,SET,54,0.084274,0.0045613,0.11163,0.22514,HP_PROXIMAL_MUSCLE_WEAKNESS_IN_UPPER_LIMBS,0.943719100719424
NIKOLSKY_BREAST_CANCER_20Q11...,SET,31,0.19276,0.0079101,0.25538,0.22519,NIKOLSKY_BREAST_CANCER_20Q11_AMPLICON,0.943719100719424
GSE12003_4D_VS_8D_CULTURE_BM...2,SET,153,0.050861,0.0046212,0.067386,0.2252,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_UP,0.943719100719424
HP_DOUBLE_AORTIC_ARCH,SET,5,0.26877,0.0044324,0.35612,0.22522,HP_DOUBLE_AORTIC_ARCH,0.943719100719424
GSE2405_HEAT_KILLED_VS_LIVE_...3,SET,183,0.047362,0.0047024,0.062759,0.22523,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_DN,0.943719100719424
GOBP_REGULATION_OF_VASCULAR_...1,SET,2,0.48332,0.0050416,0.64048,0.22524,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEDIFFERENTIATION,0.943719100719424
SCHWAB_TARGETS_OF_BMYB_POLYM...2,SET,12,0.18021,0.0046033,0.23882,0.22525,SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_UP,0.943719100719424
SHARMA_PILOCYTIC_ASTROCYTOMA...2,SET,26,0.14346,0.0053918,0.19011,0.22525,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_UP,0.943719100719424
GOCC_PML_BODY,SET,99,0.062637,0.0045847,0.083038,0.22534,GOCC_PML_BODY,0.943719100719424
GSE16385_ROSIGLITAZONE_VS_UN...1,SET,188,0.042757,0.0043022,0.056684,0.22534,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_DN,0.943719100719424
SOBOLEV_PBMC_PANDEMRIX_AGE_1...1,SET,15,0.17308,0.0049425,0.22951,0.22539,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_1DY_UP,0.943719100719424
REACTOME_TICAM1_TRAF6_DEPEND...,SET,9,0.24994,0.0055296,0.33144,0.2254,REACTOME_TICAM1_TRAF6_DEPENDENT_INDUCTION_OF_TAK1_COMPLEX,0.943719100719424
REACTOME_SUMOYLATION_OF_INTR...,SET,28,0.12097,0.0047179,0.16042,0.22542,REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS,0.943719100719424
HP_ECHOGENIC_FETAL_BOWEL,SET,5,0.27185,0.0044832,0.36053,0.22542,HP_ECHOGENIC_FETAL_BOWEL,0.943719100719424
HOOI_ST7_TARGETS_DN,SET,95,0.070718,0.0050711,0.093808,0.22547,HOOI_ST7_TARGETS_DN,0.943719100719424
GSE9006_HEALTHY_VS_TYPE_2_DI...1,SET,179,0.047669,0.0046814,0.063247,0.22552,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_DN,0.943719100719424
DANG_MYC_TARGETS_UP,SET,118,0.056899,0.0045445,0.075502,0.22555,DANG_MYC_TARGETS_UP,0.943719100719424
HP_ABNORMAL_CIRCULATING_CARB...1,SET,55,0.077431,0.0042295,0.10279,0.22563,HP_ABNORMAL_CIRCULATING_CARBOHYDRATE_CONCENTRATION,0.943719100719424
MIR4482_3P,SET,427,0.031713,0.0047773,0.042101,0.22566,MIR4482_3P,0.943719100719424
REACTOME_RUNX1_REGULATES_TRA...2,SET,66,0.071188,0.0042583,0.094516,0.22567,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS,0.943719100719424
GOBP_RESPONSE_TO_HEPATOCYTE_...,SET,17,0.1723,0.0052377,0.2288,0.22572,GOBP_RESPONSE_TO_HEPATOCYTE_GROWTH_FACTOR,0.943719100719424
DESCARTES_FETAL_PLACENTA_STR...,SET,56,0.096437,0.0053151,0.12807,0.22572,DESCARTES_FETAL_PLACENTA_STROMAL_CELLS,0.943719100719424
GOBP_RENAL_WATER_HOMEOSTASIS,SET,24,0.14108,0.0050948,0.18736,0.22573,GOBP_RENAL_WATER_HOMEOSTASIS,0.943719100719424
GSE22886_TH1_VS_TH2_48H_ACT_...2,SET,177,0.049926,0.0048759,0.06631,0.22575,GSE22886_TH1_VS_TH2_48H_ACT_UP,0.943719100719424
ATM_TARGET_GENES,SET,11,0.21232,0.0051928,0.28203,0.22578,ATM_TARGET_GENES,0.943719100719424
HOFFMANN_IMMATURE_TO_MATURE_...2,SET,36,0.11481,0.0050765,0.15255,0.22584,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_UP,0.943719100719424
PURBEY_TARGETS_OF_CTBP1_NOT_...2,SET,262,0.038127,0.0045197,0.050665,0.22587,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_UP,0.943719100719424
HP_ABNORMAL_CRY,SET,54,0.087288,0.0047245,0.11599,0.22587,HP_ABNORMAL_CRY,0.943719100719424
REACTOME_SPRY_REGULATION_OF_...,SET,15,0.16444,0.004696,0.21853,0.22588,REACTOME_SPRY_REGULATION_OF_FGF_SIGNALING,0.943719100719424
GOBP_REVERSE_CHOLESTEROL_TRA...,SET,17,0.16374,0.0049776,0.21761,0.22589,GOBP_REVERSE_CHOLESTEROL_TRANSPORT,0.943719100719424
GOMF_OXIDOREDUCTASE_ACTIVITY,SET,653,0.025199,0.0046648,0.033497,0.22594,GOMF_OXIDOREDUCTASE_ACTIVITY,0.943719100719424
GOBP_CALCIUM_ION_REGULATED_E...1,SET,62,0.082095,0.0047601,0.10913,0.22596,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS,0.943719100719424
HP_DESCENDING_AORTIC_DISSECT...,SET,20,0.15042,0.0049592,0.2,0.22601,HP_DESCENDING_AORTIC_DISSECTION,0.943719100719424
GSE3982_MAST_CELL_VS_NKCELL_...2,SET,176,0.047653,0.0046409,0.063368,0.22603,GSE3982_MAST_CELL_VS_NKCELL_UP,0.943719100719424
GOMF_DNA_SECONDARY_STRUCTURE...,SET,34,0.10398,0.004468,0.13827,0.22604,GOMF_DNA_SECONDARY_STRUCTURE_BINDING,0.943719100719424
chr2p14,SET,17,0.19573,0.00595,0.26031,0.22605,chr2p14,0.943719100719424
IK2_01,SET,238,0.042449,0.0047992,0.056457,0.22606,IK2_01,0.943719100719424
FAN_EMBRYONIC_CTX_EX_1_EXCIT...,SET,5,0.25716,0.004241,0.34201,0.22606,FAN_EMBRYONIC_CTX_EX_1_EXCITATORY_NEURON,0.943719100719424
GSE16522_ANTI_CD3CD28_STIM_V...1,SET,175,0.045627,0.004431,0.060684,0.22607,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_DN,0.943719100719424
GOMF_POLY_PYRIMIDINE_TRACT_B...,SET,25,0.12661,0.0046664,0.16841,0.22609,GOMF_POLY_PYRIMIDINE_TRACT_BINDING,0.943719100719424
GSE12198_NK_VS_NK_ACT_EXPANS...2,SET,182,0.048368,0.0047893,0.06435,0.22614,GSE12198_NK_VS_NK_ACT_EXPANSION_SYSTEM_DERIVED_NK_CELL_UP,0.943719100719424
GOMF_DELTA_CATENIN_BINDING,SET,9,0.22762,0.0050358,0.3029,0.22619,GOMF_DELTA_CATENIN_BINDING,0.943719100719424
GSE42088_2H_VS_24H_LEISHMANI...2,SET,176,0.048424,0.0047159,0.064438,0.22619,GSE42088_2H_VS_24H_LEISHMANIA_INF_DC_UP,0.943719100719424
DESCARTES_FETAL_MUSCLE_LYMPH...1,SET,56,0.091662,0.0050519,0.12198,0.22619,DESCARTES_FETAL_MUSCLE_LYMPHATIC_ENDOTHELIAL_CELLS,0.943719100719424
GOBP_NEGATIVE_REGULATION_OF_...431,SET,15,0.16813,0.0048013,0.22378,0.22623,GOBP_NEGATIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.943719100719424
GOCC_SPERM_FIBROUS_SHEATH,SET,5,0.30969,0.0051072,0.41221,0.22625,GOCC_SPERM_FIBROUS_SHEATH,0.943719100719424
GOBP_CONNECTIVE_TISSUE_REPLA...2,SET,5,0.31522,0.0051986,0.41962,0.22627,GOBP_CONNECTIVE_TISSUE_REPLACEMENT_INVOLVED_IN_INFLAMMATORY_RESPONSE_WOUND_HEALING,0.943719100719424
MODULE_433,SET,59,0.095041,0.0053762,0.12653,0.22628,MODULE_433,0.943719100719424
GSE11961_FOLLICULAR_BCELL_VS...4,SET,177,0.047175,0.0046072,0.062804,0.22629,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,0.943719100719424
SYATTGTG_UNKNOWN,SET,205,0.046235,0.0048557,0.061556,0.2263,SYATTGTG_UNKNOWN,0.943719100719424
GOBP_NEGATIVE_REGULATION_OF_...672,SET,45,0.10072,0.0049776,0.1341,0.2263,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION,0.943719100719424
GOMF_PHOTORECEPTOR_ACTIVITY,SET,13,0.17997,0.0047848,0.23965,0.22634,GOMF_PHOTORECEPTOR_ACTIVITY,0.943719100719424
GOBP_CARDIAC_CHAMBER_FORMATI...,SET,11,0.22573,0.0055207,0.30059,0.22635,GOBP_CARDIAC_CHAMBER_FORMATION,0.943719100719424
WP_CANNABINOID_RECEPTOR_SIGN...,SET,29,0.11987,0.0047579,0.15964,0.22636,WP_CANNABINOID_RECEPTOR_SIGNALING,0.943719100719424
MCBRYAN_PUBERTAL_BREAST_3_4W...2,SET,193,0.048868,0.0049814,0.065099,0.22643,MCBRYAN_PUBERTAL_BREAST_3_4WK_UP,0.943719100719424
HP_LOCALIZED_OSTEOPOROSIS,SET,19,0.13758,0.0044212,0.18327,0.22643,HP_LOCALIZED_OSTEOPOROSIS,0.943719100719424
MODULE_332,SET,42,0.095686,0.0045689,0.12748,0.22645,MODULE_332,0.943719100719424
GOBP_CELLULAR_METABOLIC_COMP...,SET,30,0.12476,0.0050364,0.16621,0.22645,GOBP_CELLULAR_METABOLIC_COMPOUND_SALVAGE,0.943719100719424
WANG_CISPLATIN_RESPONSE_AND_...1,SET,207,0.043231,0.004562,0.057597,0.22646,WANG_CISPLATIN_RESPONSE_AND_XPC_DN,0.943719100719424
HP_NASOGASTRIC_TUBE_FEEDING_...,SET,34,0.10831,0.004654,0.14433,0.22651,HP_NASOGASTRIC_TUBE_FEEDING_IN_INFANCY,0.943814296846901
GOCC_NODE_OF_RANVIER,SET,16,0.1766,0.0052083,0.23539,0.22656,GOCC_NODE_OF_RANVIER,0.943909470151043
GOBP_MEIOTIC_CELL_CYCLE,SET,249,0.037563,0.0043425,0.05008,0.22661,GOBP_MEIOTIC_CELL_CYCLE,0.94396706500956
BARIS_THYROID_CANCER_UP,SET,23,0.11796,0.0041703,0.1573,0.22666,BARIS_THYROID_CANCER_UP,0.94396706500956
GOBP_NEGATIVE_REGULATION_OF_...663,SET,57,0.089026,0.0049501,0.11876,0.22674,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,0.94396706500956
chr2q37,SET,107,0.12413,0.0094438,0.1656,0.22675,chr2q37,0.94396706500956
HP_DEMENTIA,SET,188,0.046374,0.0046661,0.061879,0.22681,HP_DEMENTIA,0.94396706500956
GSE360_L_MAJOR_VS_B_MALAYI_H...4,SET,181,0.048076,0.0047474,0.064152,0.22681,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_UP,0.94396706500956
REACTOME_ZINC_EFFLUX_AND_COM...,SET,5,0.29531,0.0048701,0.39408,0.22683,REACTOME_ZINC_EFFLUX_AND_COMPARTMENTALIZATION_BY_THE_SLC30_FAMILY,0.94396706500956
GSE22935_WT_VS_MYD88_KO_MACR...5,SET,175,0.047944,0.0046561,0.063983,0.22683,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_DN,0.94396706500956
KEGG_MEDICUS_PATHOGEN_HPV_E7...1,SET,6,0.29281,0.0052898,0.39079,0.22685,KEGG_MEDICUS_PATHOGEN_HPV_E7_TO_CELL_CYCLE_G1_S,0.94396706500956
MIR657,SET,68,0.073029,0.0044339,0.097473,0.22687,MIR657,0.94396706500956
GSE360_LOW_DOSE_B_MALAYI_VS_...2,SET,184,0.044884,0.0044684,0.059928,0.22694,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP,0.94396706500956
GSE3720_VD1_VS_VD2_GAMMADELT...5,SET,180,0.044936,0.0044252,0.059999,0.22695,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_PMA_STIM_DN,0.94396706500956
GSE15750_DAY6_VS_DAY10_EFF_C...2,SET,179,0.044749,0.0043946,0.059752,0.22696,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_UP,0.94396706500956
VALK_AML_CLUSTER_1,SET,26,0.13633,0.0051242,0.1821,0.22703,VALK_AML_CLUSTER_1,0.94396706500956
HP_LEFT_VENTRICULAR_SYSTOLIC...,SET,81,0.069431,0.0045991,0.092744,0.22705,HP_LEFT_VENTRICULAR_SYSTOLIC_DYSFUNCTION,0.94396706500956
GOMF_PROTEIN_TRANSMEMBRANE_T...,SET,25,0.11869,0.0043745,0.15857,0.22708,GOMF_PROTEIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.94396706500956
AMBROSINI_FLAVOPIRIDOL_TREAT...,SET,99,0.061394,0.0044938,0.082023,0.22709,AMBROSINI_FLAVOPIRIDOL_TREATMENT_TP53,0.94396706500956
GOBP_DETOXIFICATION,SET,130,0.058352,0.0048902,0.077987,0.22717,GOBP_DETOXIFICATION,0.94396706500956
HP_DELAYED_ABILITY_TO_WALK,SET,253,0.039036,0.0045484,0.052172,0.22717,HP_DELAYED_ABILITY_TO_WALK,0.94396706500956
GOBP_CELLULAR_RESPONSE_TO_TE...1,SET,5,0.28181,0.0046475,0.37668,0.22719,GOBP_CELLULAR_RESPONSE_TO_TEMPERATURE_STIMULUS,0.94396706500956
HP_BROAD_NASAL_TIP,SET,133,0.052371,0.0044389,0.070001,0.22719,HP_BROAD_NASAL_TIP,0.94396706500956
chr1q31,SET,30,0.17244,0.0069612,0.23052,0.22722,chr1q31,0.94396706500956
GOBP_NUCLEOTIDE_TRANSMEMBRAN...,SET,28,0.13044,0.0050874,0.1744,0.22725,GOBP_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORT,0.94396706500956
GOBP_AXO_DENDRITIC_PROTEIN_T...,SET,9,0.21579,0.0047741,0.28852,0.22726,GOBP_AXO_DENDRITIC_PROTEIN_TRANSPORT,0.94396706500956
FAN_OVARY_CL15_SMALL_ANTRAL_...,SET,552,0.027219,0.0046458,0.036393,0.22726,FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL,0.94396706500956
MIR10525_3P,SET,55,0.089475,0.0048873,0.11964,0.22728,MIR10525_3P,0.94396706500956
GOBP_MYELOID_DENDRITIC_CELL_...1,SET,27,0.1339,0.0051285,0.1791,0.22734,GOBP_MYELOID_DENDRITIC_CELL_ACTIVATION,0.944103441271358
GSE36888_UNTREATED_VS_IL2_TR...1,SET,181,0.047075,0.0046486,0.062973,0.22737,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_17H_DN,0.944115215053763
GSE43863_TFH_VS_LY6C_INT_CXC...1,SET,182,0.048783,0.0048304,0.065268,0.22741,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_DN,0.944168504360292
KESHELAVA_MULTIPLE_DRUG_RESI...,SET,66,0.07223,0.0043206,0.096666,0.22747,KESHELAVA_MULTIPLE_DRUG_RESISTANCE,0.944233536366893
GSE23321_CD8_STEM_CELL_MEMOR...5,SET,178,0.04647,0.004551,0.062193,0.22748,GSE23321_CD8_STEM_CELL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.944233536366893
HAY_BONE_MARROW_PRO_B,SET,255,0.038859,0.0045453,0.052019,0.22753,HAY_BONE_MARROW_PRO_B,0.94432829591593
HP_HAIR_PULLING,SET,7,0.27713,0.0054075,0.3713,0.22772,HP_HAIR_PULLING,0.944590216486262
HP_OOCYTE_ARREST_AT_METAPHAS...,SET,5,0.28526,0.0047045,0.38221,0.22773,HP_OOCYTE_ARREST_AT_METAPHASE_I,0.944590216486262
MODULE_360,SET,12,0.2023,0.0051676,0.2711,0.22777,MODULE_360,0.944590216486262
HP_DECREASED_ACTIVITY_OF_MIT...5,SET,60,0.071167,0.0040596,0.095388,0.22781,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_IV,0.944590216486262
KEGG_MEDICUS_REFERENCE_PROMO...,SET,21,0.1398,0.004723,0.18746,0.2279,KEGG_MEDICUS_REFERENCE_PROMOTION_OF_MICROTUBULE_GROWTH,0.944590216486262
GOBP_SMOOTHENED_SIGNALING_PA...2,SET,5,0.28842,0.0047566,0.38674,0.22791,GOBP_SMOOTHENED_SIGNALING_PATHWAY_INVOLVED_IN_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,0.944590216486262
GOBP_NITRIC_OXIDE_TRANSPORT,SET,3,0.43928,0.0056119,0.58913,0.22794,GOBP_NITRIC_OXIDE_TRANSPORT,0.944590216486262
GOBP_T_CELL_DIFFERENTIATION_...1,SET,81,0.075268,0.0049858,0.10095,0.22796,GOBP_T_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.944590216486262
LI_ESTROGENE_T47D_E2_RESPONS...1,SET,33,0.12444,0.0052683,0.16694,0.22802,LI_ESTROGENE_T47D_E2_RESPONSE_DN,0.944590216486262
JONES_OVARY_ENDOTHELIAL,SET,145,0.056753,0.005021,0.076161,0.22809,JONES_OVARY_ENDOTHELIAL,0.944590216486262
MODULE_264,SET,10,0.19357,0.0045139,0.25981,0.22813,MODULE_264,0.944590216486262
GOMF_CCR1_CHEMOKINE_RECEPTOR...,SET,5,0.28582,0.0047136,0.38367,0.22815,GOMF_CCR1_CHEMOKINE_RECEPTOR_BINDING,0.944590216486262
HP_ENLARGED_INTERPHALANGEAL_...,SET,5,0.27142,0.0044762,0.36435,0.22816,HP_ENLARGED_INTERPHALANGEAL_JOINTS,0.944590216486262
GOBP_REGULATION_OF_LIPID_MET...,SET,282,0.038207,0.0046963,0.051294,0.22818,GOBP_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.944590216486262
MIR4306,SET,429,0.0308,0.0046504,0.041353,0.2282,MIR4306,0.944590216486262
YIH_RESPONSE_TO_ARSENITE_C3,SET,26,0.13313,0.0050038,0.17876,0.22822,YIH_RESPONSE_TO_ARSENITE_C3,0.944590216486262
GSE14769_UNSTIM_VS_360MIN_LP...2,SET,175,0.044652,0.0043363,0.059966,0.22826,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_UP,0.944590216486262
GSE11864_CSF1_PAM3CYS_VS_CSF...2,SET,166,0.049146,0.0046496,0.066022,0.22832,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.944590216486262
HP_SEVERE_MUSCULAR_HYPOTONIA,SET,58,0.076685,0.0043011,0.10302,0.22833,HP_SEVERE_MUSCULAR_HYPOTONIA,0.944590216486262
CREIGHTON_ENDOCRINE_THERAPY_...1,SET,445,0.030807,0.0047352,0.041388,0.22834,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1,0.944590216486262
HP_EPILEPSIA_PARTIALIS_CONTI...,SET,8,0.22959,0.004789,0.30848,0.22836,HP_EPILEPSIA_PARTIALIS_CONTINUA,0.944590216486262
chr8q22,SET,62,0.14961,0.008675,0.20102,0.22837,chr8q22,0.944590216486262
GOCC_SUPRAMOLECULAR_POLYMER,SET,924,0.021878,0.0047805,0.029395,0.22837,GOCC_SUPRAMOLECULAR_POLYMER,0.944590216486262
WP_CALCIUM_MEDIATED_TCELL_AP...,SET,20,0.13604,0.0044851,0.18281,0.2284,WP_CALCIUM_MEDIATED_TCELL_APOPTOSIS_INVOLVED_IN_INCLUSION_BODY_MYOSITIS,0.944590216486262
GSE24492_LYVE_NEG_VS_POS_MAC...1,SET,177,0.047702,0.0046586,0.064105,0.22841,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_DN,0.944590216486262
GSE2405_0H_VS_9H_A_PHAGOCYTO...2,SET,176,0.0466,0.0045383,0.062629,0.22843,GSE2405_0H_VS_9H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,0.944590216486262
LXR_Q3,SET,74,0.072411,0.0045855,0.097334,0.22846,LXR_Q3,0.944590216486262
GOBP_AUTOSOME_GENOMIC_IMPRIN...,SET,5,0.27208,0.004487,0.36572,0.22846,GOBP_AUTOSOME_GENOMIC_IMPRINTING,0.944590216486262
MIR4480,SET,49,0.089243,0.0046018,0.11996,0.22847,MIR4480,0.944590216486262
HP_ABNORMAL_IMMUNE_SYSTEM_MO...,SET,589,0.02629,0.0046304,0.035341,0.22847,HP_ABNORMAL_IMMUNE_SYSTEM_MORPHOLOGY,0.944590216486262
MATZUK_SPERMATOCYTE,SET,67,0.071444,0.0043058,0.096044,0.22848,MATZUK_SPERMATOCYTE,0.944590216486262
GOCC_CELL_SURFACE,SET,818,0.02462,0.0050771,0.033098,0.22849,GOCC_CELL_SURFACE,0.944590216486262
GSE40274_FOXP3_VS_FOXP3_AND_...13,SET,164,0.04745,0.0044622,0.06379,0.22849,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.944590216486262
REACTOME_REGULATION_OF_PYRUV...2,SET,29,0.11863,0.0047084,0.15953,0.22856,REACTOME_REGULATION_OF_PYRUVATE_METABOLISM,0.944737531216554
GOBP_REGULATION_OF_FEVER_GEN...,SET,9,0.23924,0.0052927,0.32175,0.22858,GOBP_REGULATION_OF_FEVER_GENERATION,0.944737531216554
GOBP_CYCLIC_GMP_AMP_TRANSMEM...,SET,8,0.24931,0.0052003,0.33533,0.22861,GOBP_CYCLIC_GMP_AMP_TRANSMEMBRANE_IMPORT_ACROSS_PLASMA_MEMBRANE,0.944749173602854
GSE4142_PLASMA_CELL_VS_GC_BC...2,SET,181,0.044938,0.0044376,0.060456,0.22865,GSE4142_PLASMA_CELL_VS_GC_BCELL_UP,0.944771267371422
GOBP_REGULATION_OF_B_CELL_AP...,SET,18,0.15206,0.0047565,0.20459,0.22867,GOBP_REGULATION_OF_B_CELL_APOPTOTIC_PROCESS,0.944771267371422
MIR5580_3P,SET,222,0.042731,0.0046678,0.057501,0.22871,MIR5580_3P,0.944771267371422
KEGG_MEDICUS_PATHOGEN_HCMV_U...6,SET,19,0.13978,0.0044918,0.18813,0.22876,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,0.944771267371422
GOBP_POSITIVE_REGULATION_OF_...799,SET,14,0.17405,0.0048018,0.23428,0.22877,GOBP_POSITIVE_REGULATION_OF_T_CELL_APOPTOTIC_PROCESS,0.944771267371422
GSE339_CD4POS_VS_CD8POS_DC_DN,SET,185,0.045386,0.0045305,0.061106,0.22883,GSE339_CD4POS_VS_CD8POS_DC_DN,0.944771267371422
HP_RECURRENT_ACUTE_RESPIRATO...,SET,11,0.18539,0.004534,0.24963,0.22885,HP_RECURRENT_ACUTE_RESPIRATORY_TRACT_INFECTION,0.944771267371422
GSE1460_DP_THYMOCYTE_VS_NAIV...3,SET,173,0.049346,0.004765,0.066448,0.22886,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,0.944771267371422
HALLMARK_MTORC1_SIGNALING,SET,185,0.04479,0.004471,0.060314,0.22886,HALLMARK_MTORC1_SIGNALING,0.944771267371422
OCT1_07,SET,143,0.055422,0.0048696,0.074658,0.22894,OCT1_07,0.944971200427452
HP_HORIZONTAL_RIBS,SET,15,0.14799,0.004226,0.19938,0.22898,HP_HORIZONTAL_RIBS,0.944971200427452
MIR675_3P,SET,56,0.086887,0.0047888,0.11707,0.22899,MIR675_3P,0.944971200427452
GCM_PTPRU,SET,50,0.083644,0.0043568,0.11274,0.22907,GCM_PTPRU,0.945005982195846
GOBP_MEIOSIS_I_CELL_CYCLE_PR...,SET,120,0.052349,0.0042161,0.070558,0.22907,GOBP_MEIOSIS_I_CELL_CYCLE_PROCESS,0.945005982195846
BIOCARTA_CLASSIC_PATHWAY,SET,10,0.20515,0.0047841,0.27652,0.22908,BIOCARTA_CLASSIC_PATHWAY,0.945005982195846
GOCC_DENSE_CORE_GRANULE,SET,38,0.10871,0.0049382,0.14655,0.22911,GOCC_DENSE_CORE_GRANULE,0.945017570614764
OSADA_ASCL1_TARGETS_UP,SET,43,0.10102,0.0048804,0.13623,0.2292,OSADA_ASCL1_TARGETS_UP,0.945276610893556
BORCZUK_MALIGNANT_MESOTHELIO...1,SET,86,0.065901,0.0044974,0.088919,0.22931,BORCZUK_MALIGNANT_MESOTHELIOMA_DN,0.945588343813026
GOBP_GLYCOPROTEIN_BIOSYNTHET...,SET,289,0.037809,0.0047037,0.051018,0.22933,GOBP_GLYCOPROTEIN_BIOSYNTHETIC_PROCESS,0.945588343813026
GOBP_PROTEIN_DEGLUTAMYLATION,SET,7,0.26475,0.0051659,0.35735,0.22939,GOBP_PROTEIN_DEGLUTAMYLATION,0.945597990992059
GSE19198_1H_VS_24H_IL21_TREA...1,SET,182,0.048162,0.0047689,0.065017,0.22943,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_DN,0.945597990992059
RICKMAN_TUMOR_DIFFERENTIATED...3,SET,101,0.062835,0.0046452,0.084841,0.22947,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_DN,0.945597990992059
REACTOME_LEUKOTRIENE_RECEPTO...,SET,4,0.27652,0.004079,0.37338,0.22947,REACTOME_LEUKOTRIENE_RECEPTORS,0.945597990992059
HP_CRANIAL_NERVE_COMPRESSION,SET,49,0.083668,0.0043144,0.11299,0.22951,HP_CRANIAL_NERVE_COMPRESSION,0.945597990992059
KEGG_MEDICUS_REFERENCE_REGUL...5,SET,6,0.29866,0.0053953,0.40336,0.22952,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_PAI,0.945597990992059
GOBP_NEGATIVE_REGULATION_OF_...23,SET,11,0.17676,0.004323,0.23873,0.22953,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_FIBRIL_FORMATION,0.945597990992059
KIM_WT1_TARGETS_8HR_UP,SET,159,0.049818,0.0046136,0.067291,0.22955,KIM_WT1_TARGETS_8HR_UP,0.945597990992059
GSE22432_UNTREATED_VS_TGFB1_...2,SET,186,0.044979,0.0045019,0.060772,0.22962,GSE22432_UNTREATED_VS_TGFB1_TREATED_COMMON_DC_PROGENITOR_UP,0.945607619893428
GOBP_RESPONSE_TO_HORMONE,SET,816,0.022939,0.004725,0.030999,0.22965,GOBP_RESPONSE_TO_HORMONE,0.945607619893428
GSE40274_FOXP3_VS_FOXP3_AND_...16,SET,134,0.053893,0.0045849,0.072833,0.22967,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.945607619893428
GSE33424_CD161_HIGH_VS_NEG_C...2,SET,189,0.04734,0.0047759,0.063983,0.22969,GSE33424_CD161_HIGH_VS_NEG_CD8_TCELL_UP,0.945607619893428
GOBP_REGULATION_OF_G2_MI_TRA...,SET,4,0.29101,0.0042927,0.3934,0.22974,GOBP_REGULATION_OF_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,0.945607619893428
WP_DYRK1A_INVOLVEMENT_REGARD...,SET,59,0.08116,0.004591,0.10973,0.22976,WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT,0.945607619893428
GALE_APL_WITH_FLT3_MUTATED_DN,SET,13,0.17052,0.0045334,0.23055,0.22977,GALE_APL_WITH_FLT3_MUTATED_DN,0.945607619893428
REACTOME_CHONDROITIN_SULFATE...1,SET,18,0.14986,0.0046876,0.20262,0.22977,REACTOME_CHONDROITIN_SULFATE_BIOSYNTHESIS,0.945607619893428
WIERENGA_STAT5A_TARGETS_DN,SET,175,0.049306,0.0047883,0.066674,0.2298,WIERENGA_STAT5A_TARGETS_DN,0.945619109637698
NPAT_TARGET_GENES,SET,190,0.045054,0.0045572,0.06095,0.2299,NPAT_TARGET_GENES,0.945818102734051
GOBP_DNA_ALKYLATION_REPAIR,SET,11,0.16302,0.0039869,0.22055,0.22991,GOBP_DNA_ALKYLATION_REPAIR,0.945818102734051
REACTOME_IKBA_VARIANT_LEADS_...,SET,6,0.24153,0.0043633,0.32679,0.22993,REACTOME_IKBA_VARIANT_LEADS_TO_EDA_ID,0.945818102734051
GSE4748_CTRL_VS_LPS_AND_CYAN...2,SET,180,0.046717,0.0046006,0.063229,0.23,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.94592326943557
MCCABE_HOXC6_TARGETS_UP,SET,7,0.22139,0.0043198,0.29966,0.23001,MCCABE_HOXC6_TARGETS_UP,0.94592326943557
GOBP_SISTER_CHROMATID_COHESI...,SET,42,0.090397,0.0043164,0.1224,0.2301,GOBP_SISTER_CHROMATID_COHESION,0.94596686362562
HP_SALIVARY_GLAND_NEOPLASM,SET,12,0.15625,0.0039912,0.21159,0.23012,HP_SALIVARY_GLAND_NEOPLASM,0.94596686362562
WP_GLUTATHIONE_METABOLISM,SET,16,0.14914,0.0043985,0.20203,0.2302,WP_GLUTATHIONE_METABOLISM,0.94596686362562
HP_INCREASED_VERTEBRAL_HEIGHT,SET,10,0.17754,0.0041402,0.2405,0.2302,HP_INCREASED_VERTEBRAL_HEIGHT,0.94596686362562
GSE4984_LPS_VS_VEHICLE_CTRL_...2,SET,168,0.047085,0.0044811,0.063791,0.23023,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_UP,0.94596686362562
REACTOME_ANTIGEN_ACTIVATES_B...,SET,27,0.11644,0.0044598,0.15778,0.23025,REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS,0.94596686362562
GOBP_IMMATURE_B_CELL_DIFFERE...,SET,12,0.18941,0.0048384,0.25668,0.23028,GOBP_IMMATURE_B_CELL_DIFFERENTIATION,0.94596686362562
GSE24574_NAIVE_VS_TCONV_CD4_...2,SET,181,0.04785,0.0047251,0.064842,0.23028,GSE24574_NAIVE_VS_TCONV_CD4_TCELL_UP,0.94596686362562
GOBP_REGULATION_OF_RESPONSE_...4,SET,74,0.068459,0.0043352,0.092776,0.23029,GOBP_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.94596686362562
KEGG_MEDICUS_PATHOGEN_KSHV_K...,SET,7,0.21864,0.0042662,0.29632,0.23031,KEGG_MEDICUS_PATHOGEN_KSHV_K15_TO_TNF_NFKB_SIGNALING_PATHWAY,0.94596686362562
GOMF_NADPH_BINDING,SET,16,0.13742,0.0040527,0.18624,0.23032,GOMF_NADPH_BINDING,0.94596686362562
MORF_RFC5,SET,72,0.069334,0.0043311,0.094036,0.23047,MORF_RFC5,0.945967163915094
MORF_PPP1CA,SET,145,0.04671,0.0041325,0.06336,0.2305,MORF_PPP1CA,0.945967163915094
GSE37301_PRO_BCELL_VS_GRANUL...1,SET,161,0.048813,0.0045486,0.066213,0.23051,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.945967163915094
REACTOME_TRANSLATION_OF_REPL...,SET,14,0.16447,0.0045376,0.22312,0.23052,REACTOME_TRANSLATION_OF_REPLICASE_AND_ASSEMBLY_OF_THE_REPLICATION_TRANSCRIPTION_COMPLEX,0.945967163915094
BIOCARTA_IGF1R_PATHWAY,SET,23,0.13208,0.0046695,0.17919,0.23054,BIOCARTA_IGF1R_PATHWAY,0.945967163915094
HP_POLYGENIC_INHERITANCE,SET,32,0.11552,0.0048162,0.15674,0.23056,HP_POLYGENIC_INHERITANCE,0.945967163915094
WAKABAYASHI_ADIPOGENESIS_PPA...3,SET,143,0.05311,0.0046664,0.072078,0.23062,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_36HR,0.945967163915094
WOOD_EBV_EBNA1_TARGETS_DN,SET,43,0.097531,0.004712,0.13237,0.23062,WOOD_EBV_EBNA1_TARGETS_DN,0.945967163915094
GSE3982_NEUTROPHIL_VS_CENT_M...1,SET,183,0.042661,0.0042357,0.057903,0.23064,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_DN,0.945967163915094
GAUSSMANN_MLL_AF4_FUSION_TAR...12,SET,166,0.051254,0.0048489,0.06957,0.23065,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_UP,0.945967163915094
GSE3920_IFNA_VS_IFNG_TREATED...3,SET,172,0.048573,0.0046769,0.065936,0.23066,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_DN,0.945967163915094
REACTOME_ADENYLATE_CYCLASE_A...,SET,10,0.20809,0.0048526,0.28248,0.23067,REACTOME_ADENYLATE_CYCLASE_ACTIVATING_PATHWAY,0.945967163915094
GOBP_REGULATION_OF_MYELOID_L...2,SET,52,0.084997,0.0045147,0.11539,0.23068,GOBP_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,0.945967163915094
HP_HYPOPLASIA_OF_THE_FOVEA,SET,25,0.13296,0.0049004,0.18055,0.23075,HP_HYPOPLASIA_OF_THE_FOVEA,0.945967163915094
GSE46606_DAY1_VS_DAY3_CD40L_...7,SET,179,0.04542,0.0044605,0.061678,0.23075,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_DN,0.945967163915094
BOHN_PRIMARY_IMMUNODEFICIENC...2,SET,44,0.09882,0.0048294,0.13422,0.2308,BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_UP,0.945967163915094
GOBP_REGULATION_OF_CELL_MORP...,SET,222,0.042354,0.0046267,0.057527,0.2308,GOBP_REGULATION_OF_CELL_MORPHOGENESIS,0.945967163915094
REACTOME_MAP3K8_TPL2_DEPENDE...,SET,14,0.16344,0.0045093,0.22201,0.23081,REACTOME_MAP3K8_TPL2_DEPENDENT_MAPK1_3_ACTIVATION,0.945967163915094
HP_SIMPLIFIED_GYRAL_PATTERN,SET,78,0.068622,0.0044609,0.09329,0.231,HP_SIMPLIFIED_GYRAL_PATTERN,0.946260296017855
GARY_CD5_TARGETS_DN,SET,396,0.029303,0.0042547,0.03984,0.23102,GARY_CD5_TARGETS_DN,0.946260296017855
TAVOR_CEBPA_TARGETS_DN,SET,29,0.12226,0.0048527,0.16623,0.23102,TAVOR_CEBPA_TARGETS_DN,0.946260296017855
HE_LIM_SUN_FETAL_LUNG_C3_PRI...,SET,100,0.062295,0.0045825,0.084732,0.23111,HE_LIM_SUN_FETAL_LUNG_C3_PRIMITIVE_ERYTHROCYTE,0.946260296017855
WP_NOTCH_SIGNALING_WP268,SET,45,0.08817,0.0043575,0.11994,0.23114,WP_NOTCH_SIGNALING_WP268,0.946260296017855
GOBP_HYDROGEN_PEROXIDE_BIOSY...,SET,14,0.17807,0.0049128,0.24224,0.23114,GOBP_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,0.946260296017855
GAZDA_DIAMOND_BLACKFAN_ANEMI...1,SET,404,0.029655,0.0043481,0.040341,0.23115,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN,0.946260296017855
GOBP_T_FOLLICULAR_HELPER_CEL...,SET,7,0.22793,0.0044474,0.31008,0.23115,GOBP_T_FOLLICULAR_HELPER_CELL_DIFFERENTIATION,0.946260296017855
GSE29618_LAIV_VS_TIV_FLU_VAC...5,SET,173,0.045856,0.004428,0.062386,0.23116,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MONOCYTE_DN,0.946260296017855
HP_CENTRAL_HYPOVENTILATION,SET,11,0.20789,0.0050844,0.28285,0.23119,HP_CENTRAL_HYPOVENTILATION,0.946260296017855
WP_MICRORNA_FOR_TARGETING_CA...,SET,7,0.22915,0.0044712,0.31184,0.23123,WP_MICRORNA_FOR_TARGETING_CANCER_GROWTH_AND_VASCULARIZATION_IN_GLIOBLASTOMA,0.946260296017855
HP_CEREBRAL_CORTICAL_ATROPHY,SET,278,0.036384,0.0044408,0.049514,0.23123,HP_CEREBRAL_CORTICAL_ATROPHY,0.946260296017855
REACTOME_DNA_REPLICATION_INI...,SET,7,0.18889,0.0036856,0.25708,0.23125,REACTOME_DNA_REPLICATION_INITIATION,0.946260296017855
GOBP_REGULATION_OF_HEPATIC_S...,SET,7,0.25806,0.0050352,0.35124,0.23127,GOBP_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.946260296017855
GOBP_RNA_GUANINE_N7_METHYLAT...,SET,4,0.24792,0.003657,0.33769,0.23143,GOBP_RNA_GUANINE_N7_METHYLATION,0.946260296017855
HP_AMBIGUOUS_GENITALIA_MALE,SET,11,0.19256,0.0047094,0.26229,0.23143,HP_AMBIGUOUS_GENITALIA_MALE,0.946260296017855
REACTOME_A_TETRASACCHARIDE_L...,SET,23,0.13269,0.0046909,0.18074,0.23144,REACTOME_A_TETRASACCHARIDE_LINKER_SEQUENCE_IS_REQUIRED_FOR_GAG_SYNTHESIS,0.946260296017855
MIR153_3P,SET,308,0.036619,0.0047005,0.04988,0.23144,MIR153_3P,0.946260296017855
BIOCARTA_MET_PATHWAY,SET,32,0.114,0.0047526,0.1553,0.23146,BIOCARTA_MET_PATHWAY,0.946260296017855
GSE3982_MAC_VS_NKCELL_UP,SET,180,0.04747,0.0046748,0.064671,0.23147,GSE3982_MAC_VS_NKCELL_UP,0.946260296017855
HP_ABNORMALITY_OF_THE_THYROI...,SET,462,0.029558,0.0046271,0.04027,0.23148,HP_ABNORMALITY_OF_THE_THYROID_GLAND,0.946260296017855
HP_RETROGNATHIA,SET,308,0.03447,0.0044248,0.046982,0.23157,HP_RETROGNATHIA,0.946260296017855
PEA3_Q6,SET,242,0.041442,0.004724,0.056487,0.23158,PEA3_Q6,0.946260296017855
KEGG_MEDICUS_REFERENCE_IGG_F...,SET,9,0.21645,0.0047887,0.29509,0.23163,KEGG_MEDICUS_REFERENCE_IGG_FCGR_RAC_SIGNALING_PATHWAY,0.946260296017855
HP_NODULAR_GOITER,SET,11,0.20431,0.0049968,0.27855,0.23164,HP_NODULAR_GOITER,0.946260296017855
GSE24142_DN2_VS_DN3_THYMOCYT...4,SET,186,0.046148,0.0046189,0.062932,0.23169,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_DN,0.946260296017855
HOLLEMAN_VINCRISTINE_RESISTA...1,SET,19,0.14196,0.004562,0.19359,0.2317,HOLLEMAN_VINCRISTINE_RESISTANCE_ALL_DN,0.946260296017855
GOBP_POSITIVE_REGULATION_OF_...46,SET,11,0.1668,0.0040794,0.22748,0.23171,GOBP_POSITIVE_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,0.946260296017855
HP_ABNORMAL_FOURTH_TOE_MORPH...,SET,8,0.24398,0.0050892,0.33277,0.23173,HP_ABNORMAL_FOURTH_TOE_MORPHOLOGY,0.946260296017855
SCHLOSSER_SERUM_RESPONSE_DN,SET,636,0.024448,0.0044685,0.033348,0.23175,SCHLOSSER_SERUM_RESPONSE_DN,0.946260296017855
REACTOME_ENDOGENOUS_STEROLS,SET,24,0.13213,0.0047716,0.18024,0.23176,REACTOME_ENDOGENOUS_STEROLS,0.946260296017855
GSE18804_SPLEEN_MACROPHAGE_V...2,SET,170,0.048758,0.0046676,0.066515,0.23177,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP,0.946260296017855
BIOCARTA_INTEGRIN_PATHWAY,SET,34,0.10653,0.0045778,0.14534,0.23178,BIOCARTA_INTEGRIN_PATHWAY,0.946260296017855
GSE13493_DP_VS_CD4INTCD8POS_...2,SET,178,0.045418,0.004448,0.061974,0.23183,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_UP,0.946353259337562
REACTOME_DERMATAN_SULFATE_BI...,SET,10,0.20579,0.0047989,0.28103,0.23201,REACTOME_DERMATAN_SULFATE_BIOSYNTHESIS,0.946765696172811
GOBP_NEGATIVE_REGULATION_OF_...626,SET,4,0.31175,0.0045986,0.42577,0.23203,GOBP_NEGATIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,0.946765696172811
KEGG_MEDICUS_VARIANT_MUTATIO...9,SET,25,0.12353,0.0045529,0.16872,0.23204,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KCNJ5_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.946765696172811
GSE32986_UNSTIM_VS_GMCSF_AND...4,SET,180,0.043261,0.0042602,0.059086,0.23204,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.946765696172811
GSE3982_CTRL_VS_LPS_1H_NEUTR...1,SET,174,0.04533,0.0043897,0.061931,0.23211,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_DN,0.946940139687757
GOBP_NEGATIVE_REGULATION_OF_...643,SET,810,0.022409,0.0045995,0.03062,0.23214,GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.946944280183034
MODULE_62,SET,67,0.064363,0.003879,0.087974,0.23221,MODULE_62,0.946944280183034
chr1q44,SET,56,0.14133,0.0077895,0.19319,0.23222,chr1q44,0.946944280183034
MORF_NPM1,SET,147,0.04836,0.0043077,0.066106,0.23222,MORF_NPM1,0.946944280183034
REACTOME_METABOLISM_OF_STERO...2,SET,33,0.1122,0.0047501,0.1534,0.23226,REACTOME_METABOLISM_OF_STEROID_HORMONES,0.946996281088691
GOBP_NEGATIVE_REGULATION_OF_...10,SET,60,0.08666,0.0049434,0.11849,0.23229,GOBP_NEGATIVE_REGULATION_OF_ADAPTIVE_IMMUNE_RESPONSE,0.947007501466276
GSE3920_UNTREATED_VS_IFNG_TR...2,SET,137,0.053021,0.0045606,0.072517,0.23235,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.947015709598031
GOBP_IMMUNE_SYSTEM_DEVELOPME...,SET,182,0.045783,0.0045333,0.062624,0.23237,GOBP_IMMUNE_SYSTEM_DEVELOPMENT,0.947015709598031
GOBP_REGULATION_OF_ASPARTIC_...2,SET,7,0.25549,0.0049852,0.34949,0.23238,GOBP_REGULATION_OF_ASPARTIC_TYPE_PEPTIDASE_ACTIVITY,0.947015709598031
GSE46606_DAY1_VS_DAY3_CD40L_...3,SET,177,0.04637,0.0045286,0.063439,0.23241,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4HIGH_BCELL_DN,0.947015709598031
GSE15330_WT_VS_IKAROS_KO_LYM...2,SET,188,0.043405,0.0043675,0.059387,0.23243,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_UP,0.947015709598031
MODULE_424,SET,17,0.15417,0.0046867,0.21097,0.23247,MODULE_424,0.947015709598031
GOBP_REGULATION_OF_LEUKOCYTE...2,SET,30,0.11937,0.0048187,0.16338,0.23251,GOBP_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,0.947015709598031
HOEK_T_CELL_2011_2012_TIV_AD...5,SET,2,0.35783,0.0037326,0.48975,0.23251,HOEK_T_CELL_2011_2012_TIV_ADULT_7DY_UP,0.947015709598031
XU_GH1_AUTOCRINE_TARGETS_DN,SET,117,0.058608,0.0046613,0.080255,0.23262,XU_GH1_AUTOCRINE_TARGETS_DN,0.947334331068416
GSE23114_WT_VS_SLE2C1_MOUSE_...3,SET,181,0.045284,0.0044717,0.062019,0.23265,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_DN,0.947334331068416
GOMF_DEMETHYLASE_ACTIVITY,SET,33,0.09849,0.0041696,0.1349,0.23267,GOMF_DEMETHYLASE_ACTIVITY,0.947334331068416
GSE14308_TH17_VS_NATURAL_TRE...2,SET,180,0.04485,0.0044167,0.06145,0.23274,GSE14308_TH17_VS_NATURAL_TREG_UP,0.94743807097681
HP_ABSENCE_OF_STOMACH_BUBBLE...,SET,5,0.28672,0.0047285,0.39286,0.23275,HP_ABSENCE_OF_STOMACH_BUBBLE_ON_FETAL_SONOGRAPHY,0.94743807097681
GOBP_GLIAL_CELL_DEVELOPMENT,SET,126,0.05577,0.0046018,0.076454,0.23287,GOBP_GLIAL_CELL_DEVELOPMENT,0.947612673753066
HP_REDUNDANT_SKIN,SET,79,0.069971,0.0045776,0.095935,0.23289,HP_REDUNDANT_SKIN,0.947612673753066
HP_LARGE_EARLOBE,SET,28,0.11339,0.0044225,0.15548,0.23291,HP_LARGE_EARLOBE,0.947612673753066
GOBP_MONOCYTE_ACTIVATION,SET,12,0.1832,0.0046796,0.25121,0.23292,GOBP_MONOCYTE_ACTIVATION,0.947612673753066
GNF2_TYK2,SET,28,0.10557,0.0041175,0.14477,0.23293,GNF2_TYK2,0.947612673753066
HP_PORPHYRINURIA,SET,7,0.21998,0.0042924,0.3017,0.23296,HP_PORPHYRINURIA,0.947612673753066
GOBP_REGULATION_OF_STRIATED_...2,SET,87,0.066872,0.00459,0.09176,0.23308,GOBP_REGULATION_OF_STRIATED_MUSCLE_CONTRACTION,0.947612673753066
BRACHAT_RESPONSE_TO_METHOTRE...1,SET,23,0.12066,0.0042657,0.16563,0.23316,BRACHAT_RESPONSE_TO_METHOTREXATE_DN,0.947612673753066
ZNF584_TARGET_GENES,SET,284,0.036511,0.0045034,0.050119,0.23316,ZNF584_TARGET_GENES,0.947612673753066
HP_APLASIA_HYPOPLASIA_INVOLV...5,SET,90,0.062546,0.0043661,0.085856,0.23316,HP_APLASIA_HYPOPLASIA_INVOLVING_FOREARM_BONES,0.947612673753066
MIR6780A_3P,SET,138,0.053242,0.0045962,0.073098,0.2332,MIR6780A_3P,0.947612673753066
GOBP_NEGATIVE_REGULATION_OF_...6,SET,13,0.17232,0.0045814,0.23659,0.2332,GOBP_NEGATIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,0.947612673753066
GOBP_STEROL_METABOLIC_PROCESS,SET,140,0.05237,0.0045533,0.071914,0.23324,GOBP_STEROL_METABOLIC_PROCESS,0.947612673753066
HP_ABNORMAL_MORPHOLOGY_OF_TH...10,SET,28,0.10827,0.0042228,0.14869,0.23325,HP_ABNORMAL_MORPHOLOGY_OF_THE_VESTIBULE_OF_THE_INNER_EAR,0.947612673753066
GSE13522_CTRL_VS_T_CRUZI_Y_S...8,SET,146,0.050279,0.0044635,0.069056,0.23328,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_UP,0.947612673753066
GOMF_HISTONE_H2A_DEUBIQUITIN...,SET,5,0.21652,0.0035708,0.29739,0.23329,GOMF_HISTONE_H2A_DEUBIQUITINASE_ACTIVITY,0.947612673753066
MIR4658,SET,44,0.10054,0.0049135,0.13811,0.23331,MIR4658,0.947612673753066
MIR9851_5P,SET,103,0.058663,0.0043793,0.080584,0.23332,MIR9851_5P,0.947612673753066
MIR194_5P,SET,179,0.046505,0.0045671,0.06389,0.23334,MIR194_5P,0.947612673753066
MYLLYKANGAS_AMPLIFICATION_HO...8,SET,9,0.21518,0.0047604,0.29566,0.23338,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_22,0.947612673753066
RREB1_01,SET,191,0.044096,0.0044719,0.060601,0.23342,RREB1_01,0.947612673753066
GOBP_DEFENSE_RESPONSE_TO_GRA...2,SET,92,0.067945,0.0047951,0.093374,0.23342,GOBP_DEFENSE_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.947612673753066
HP_IMMOTILE_SPERM,SET,14,0.16602,0.0045805,0.22816,0.23342,HP_IMMOTILE_SPERM,0.947612673753066
BURTON_ADIPOGENESIS_11,SET,47,0.088826,0.0044861,0.12209,0.23346,BURTON_ADIPOGENESIS_11,0.947664365802383
MIR135A_2_3P,SET,48,0.080247,0.0040956,0.11038,0.23361,MIR135A_2_3P,0.947977898973402
MIR135B_3P,SET,48,0.080247,0.0040956,0.11038,0.23361,MIR135B_3P,0.947977898973402
KEGG_MEDICUS_REFERENCE_GENE_...,SET,26,0.11996,0.0045088,0.16506,0.23369,KEGG_MEDICUS_REFERENCE_GENE_SILENCING_BY_METHYLATION_OF_H3K27_AND_UBIQUITINATION_OF_H2AK119,0.947977898973402
GOBP_NEGATIVE_REGULATION_OF_...161,SET,265,0.039011,0.0046505,0.05368,0.2337,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.947977898973402
REACTOME_CYCLIN_D_ASSOCIATED...,SET,45,0.092697,0.0045812,0.12757,0.23372,REACTOME_CYCLIN_D_ASSOCIATED_EVENTS_IN_G1,0.947977898973402
KENNEDY_PBMC_DRYVAX_AGE_18_4...,SET,32,0.10787,0.004497,0.14846,0.23375,KENNEDY_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_DN,0.947977898973402
WP_FOLATE_METABOLISM,SET,66,0.078587,0.0047009,0.10817,0.23376,WP_FOLATE_METABOLISM,0.947977898973402
GNF2_ITGB2,SET,51,0.085697,0.004508,0.11796,0.23377,GNF2_ITGB2,0.947977898973402
KEGG_MEDICUS_PATHOGEN_KSHV_V...4,SET,31,0.1141,0.004682,0.15706,0.23379,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_ERK_SIGNALING_PATHWAY,0.947977898973402
HP_EXERTIONAL_DYSPNEA,SET,134,0.053073,0.0045152,0.073064,0.23381,HP_EXERTIONAL_DYSPNEA,0.947977898973402
GOBP_RNA_MODIFICATION,SET,145,0.046832,0.0041433,0.064502,0.23391,GOBP_RNA_MODIFICATION,0.948272722500875
BIOCARTA_ERAD_PATHWAY,SET,19,0.12839,0.0041259,0.17697,0.23408,BIOCARTA_ERAD_PATHWAY,0.948714283216783
GOMF_PHOSPHATIDYLINOSITOL_3_...3,SET,35,0.099636,0.0043438,0.13734,0.23409,GOMF_PHOSPHATIDYLINOSITOL_3_4_5_TRISPHOSPHATE_BINDING,0.948714283216783
KMT2D_TARGET_GENES,SET,586,0.025731,0.0045207,0.035476,0.23414,KMT2D_TARGET_GENES,0.948714283216783
WATANABE_ULCERATIVE_COLITIS_...1,SET,14,0.16716,0.0046118,0.23049,0.23416,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_DN,0.948714283216783
HP_ABNORMAL_URINE_OSMOLALITY,SET,6,0.28841,0.0052101,0.39769,0.23417,HP_ABNORMAL_URINE_OSMOLALITY,0.948714283216783
HP_ABNORMAL_PERIPHERAL_NERVO...1,SET,360,0.031656,0.0043869,0.043657,0.23419,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_MORPHOLOGY,0.948714283216783
GOBP_POSITIVE_REGULATION_OF_...259,SET,32,0.10206,0.0042551,0.14076,0.23421,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,0.948714283216783
GOBP_CELL_COMMUNICATION_BY_E...1,SET,33,0.1164,0.0049278,0.16058,0.23427,GOBP_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.948776672104405
GSE2128_C57BL6_VS_NOD_CD4CD8...1,SET,187,0.044203,0.004436,0.060983,0.23428,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_DN,0.948776672104405
GSE10240_CTRL_VS_IL22_STIM_P...1,SET,175,0.043354,0.0042103,0.059821,0.23431,GSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.948787609227543
GSE14026_TH1_VS_TH17_UP,SET,178,0.046252,0.0045297,0.063854,0.23443,GSE14026_TH1_VS_TH17_UP,0.949043092220025
GOBP_XENOBIOTIC_GLUCURONIDAT...,SET,6,0.35968,0.0064977,0.49665,0.23447,GOBP_XENOBIOTIC_GLUCURONIDATION,0.949043092220025
GSE32034_UNTREATED_VS_ROSIGL...3,SET,166,0.049204,0.004655,0.067961,0.23454,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_DN,0.949043092220025
GOMF_S_ADENOSYLMETHIONINE_DE...,SET,133,0.048707,0.0041284,0.067283,0.23456,GOMF_S_ADENOSYLMETHIONINE_DEPENDENT_METHYLTRANSFERASE_ACTIVITY,0.949043092220025
GOBP_PHAGOLYSOSOME_ASSEMBLY,SET,17,0.16259,0.0049426,0.22465,0.23462,GOBP_PHAGOLYSOSOME_ASSEMBLY,0.949043092220025
GSE26343_UNSTIM_VS_LPS_STIM_...3,SET,188,0.046124,0.004641,0.063732,0.23463,GSE26343_UNSTIM_VS_LPS_STIM_NFAT5_KO_MACROPHAGE_DN,0.949043092220025
GOMF_BH_DOMAIN_BINDING,SET,10,0.20252,0.0047226,0.27985,0.23464,GOMF_BH_DOMAIN_BINDING,0.949043092220025
MODULE_33,SET,346,0.034694,0.0047152,0.047951,0.23468,MODULE_33,0.949043092220025
REACTOME_ORGANIC_ANION_TRANS...1,SET,5,0.2545,0.0041972,0.35183,0.23473,REACTOME_ORGANIC_ANION_TRANSPORT,0.949043092220025
HP_ABNORMAL_CONNECTION_OF_TH...,SET,234,0.040198,0.0045068,0.05557,0.23473,HP_ABNORMAL_CONNECTION_OF_THE_CARDIAC_SEGMENTS,0.949043092220025
GOBP_POSITIVE_REGULATION_OF_...690,SET,9,0.21435,0.0047421,0.29638,0.23477,GOBP_POSITIVE_REGULATION_OF_RRNA_PROCESSING,0.949043092220025
GOBP_COLLAGEN_METABOLIC_PROC...,SET,90,0.070264,0.0049049,0.097157,0.23478,GOBP_COLLAGEN_METABOLIC_PROCESS,0.949043092220025
HP_BILATERAL_SUPERIOR_VENA_C...,SET,8,0.2161,0.0045076,0.29882,0.23479,HP_BILATERAL_SUPERIOR_VENA_CAVA,0.949043092220025
HP_AZOOSPERMIA,SET,105,0.057507,0.0043342,0.079525,0.2348,HP_AZOOSPERMIA,0.949043092220025
GSE2770_UNTREATED_VS_IL4_TRE...1,SET,179,0.041975,0.0041222,0.058044,0.2348,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.949043092220025
GSE21546_SAP1A_KO_VS_SAP1A_K...1,SET,190,0.045207,0.0045726,0.062517,0.23481,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,0.949043092220025
MIR3674,SET,123,0.055153,0.0044968,0.076292,0.23487,MIR3674,0.949058684302123
CROONQUIST_NRAS_SIGNALING_DN,SET,68,0.068985,0.0041884,0.09543,0.23488,CROONQUIST_NRAS_SIGNALING_DN,0.949058684302123
HP_ABNORMAL_MAST_CELL_MORPHO...,SET,8,0.22222,0.0046353,0.30744,0.2349,HP_ABNORMAL_MAST_CELL_MORPHOLOGY,0.949058684302123
HP_LARGE_PLACENTA,SET,6,0.26884,0.0048567,0.37207,0.23498,HP_LARGE_PLACENTA,0.949058684302123
GOBP_METANEPHRIC_GLOMERULUS_...2,SET,9,0.24675,0.005459,0.34153,0.235,GOBP_METANEPHRIC_GLOMERULUS_VASCULATURE_DEVELOPMENT,0.949058684302123
GOMF_UBIQUITIN_LIKE_PROTEIN_...1,SET,112,0.056002,0.0043584,0.077517,0.23501,GOMF_UBIQUITIN_LIKE_PROTEIN_BINDING,0.949058684302123
REACTOME_RECYCLING_PATHWAY_O...,SET,40,0.10026,0.0046722,0.13882,0.23508,REACTOME_RECYCLING_PATHWAY_OF_L1,0.949058684302123
MANNO_MIDBRAIN_NEUROTYPES_HM...,SET,525,0.027948,0.0046556,0.038699,0.23509,MANNO_MIDBRAIN_NEUROTYPES_HMGL,0.949058684302123
HP_MICROPHALLUS,SET,14,0.17363,0.0047903,0.24047,0.23514,HP_MICROPHALLUS,0.949058684302123
GOBP_TYPE_II_INTERFERON_PROD...,SET,108,0.064373,0.0049201,0.089172,0.23518,GOBP_TYPE_II_INTERFERON_PRODUCTION,0.949058684302123
WP_KREBS_CYCLE_DISORDERS,SET,13,0.17692,0.0047036,0.24507,0.23519,WP_KREBS_CYCLE_DISORDERS,0.949058684302123
GOBP_POSITIVE_REGULATION_OF_...483,SET,184,0.047397,0.0047186,0.065657,0.23519,GOBP_POSITIVE_REGULATION_OF_MONOATOMIC_ION_TRANSPORT,0.949058684302123
FLORIO_HUMAN_NEOCORTEX,SET,28,0.12255,0.0047797,0.16978,0.23521,FLORIO_HUMAN_NEOCORTEX,0.949058684302123
KEGG_MEDICUS_REFERENCE_EGF_E...10,SET,11,0.18775,0.0045918,0.26016,0.23525,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RALGDS_SIGNALING_PATHWAY,0.949058684302123
GOBP_RESPONSE_TO_ESTROGEN,SET,64,0.076798,0.004524,0.10641,0.23525,GOBP_RESPONSE_TO_ESTROGEN,0.949058684302123
HP_OSTEOCHONDRITIS_DISSECANS,SET,7,0.24413,0.0047635,0.33834,0.23529,HP_OSTEOCHONDRITIS_DISSECANS,0.949058684302123
GSE12392_WT_VS_IFNB_KO_CD8A_...3,SET,184,0.04568,0.0045477,0.063313,0.23531,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_DN,0.949058684302123
GSE3982_MAST_CELL_VS_NEUTROP...2,SET,180,0.041696,0.0041061,0.057798,0.23533,GSE3982_MAST_CELL_VS_NEUTROPHIL_UP,0.949058684302123
HP_JOINT_SUBLUXATION,SET,26,0.11941,0.004488,0.16553,0.23534,HP_JOINT_SUBLUXATION,0.949058684302123
GSE13493_CD4INTCD8POS_VS_CD8...2,SET,168,0.045382,0.004319,0.062915,0.23536,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_UP,0.949058684302123
HP_RING_SCOTOMA,SET,5,0.25124,0.0041434,0.34851,0.23549,HP_RING_SCOTOMA,0.949416670530953
HP_PAPULE,SET,92,0.061547,0.0043436,0.085386,0.23552,HP_PAPULE,0.949416670530953
REACTOME_PTK6_REGULATES_CELL...,SET,6,0.25035,0.0045227,0.34745,0.2356,REACTOME_PTK6_REGULATES_CELL_CYCLE,0.949416670530953
GOBP_OUTFLOW_TRACT_MORPHOGEN...,SET,75,0.079649,0.0050776,0.11054,0.2356,GOBP_OUTFLOW_TRACT_MORPHOGENESIS,0.949416670530953
GOBP_G_PROTEIN_COUPLED_RECEP...4,SET,9,0.2007,0.0044402,0.27856,0.23562,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_HEART_PROCESS,0.949416670530953
HP_INTRAMUSCULAR_HEMATOMA,SET,7,0.24246,0.004731,0.33655,0.23563,HP_INTRAMUSCULAR_HEMATOMA,0.949416670530953
HP_URETERAL_DUPLICATION,SET,41,0.087846,0.0041444,0.12194,0.23564,HP_URETERAL_DUPLICATION,0.949416670530953
GOMF_DNA_BINDING_TRANSCRIPTI...1,SET,442,0.030055,0.0046045,0.041729,0.2357,GOMF_DNA_BINDING_TRANSCRIPTION_ACTIVATOR_ACTIVITY,0.94952329138767
GOBP_RESPONSE_TO_OXIDATIVE_S...,SET,357,0.032804,0.0045274,0.045576,0.23584,GOBP_RESPONSE_TO_OXIDATIVE_STRESS,0.94952329138767
GSE26023_PHD3_KO_VS_WT_NEUTR...2,SET,171,0.047005,0.0045129,0.065313,0.23586,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_UP,0.94952329138767
GSE46606_IRF4_KO_VS_WT_CD40L...2,SET,170,0.048275,0.0046213,0.067098,0.23593,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_UP,0.94952329138767
GSE30971_WBP7_HET_VS_KO_MACR...1,SET,184,0.048396,0.004818,0.067273,0.23595,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_2H_LPS_STIM_DN,0.94952329138767
GSE17721_POLYIC_VS_GARDIQUIM...9,SET,176,0.044395,0.0043236,0.061732,0.23603,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_DN,0.94952329138767
WP_15Q112_COPY_NUMBER_VARIAT...,SET,4,0.2925,0.0043147,0.40677,0.23605,WP_15Q112_COPY_NUMBER_VARIATION_SYNDROME,0.94952329138767
GOCC_EQUATORIAL_MICROTUBULE_...,SET,4,0.2925,0.0043147,0.40677,0.23605,GOCC_EQUATORIAL_MICROTUBULE_ORGANIZING_CENTER,0.94952329138767
GSE4590_SMALL_VS_LARGE_PRE_B...1,SET,139,0.052967,0.0045889,0.07366,0.23605,GSE4590_SMALL_VS_LARGE_PRE_BCELL_DN,0.94952329138767
MODULE_32,SET,210,0.039092,0.0041547,0.054368,0.23607,MODULE_32,0.94952329138767
MIR4316,SET,131,0.052276,0.0043977,0.072707,0.23608,MIR4316,0.94952329138767
REACTOME_DDX58_IFIH1_MEDIATE...,SET,74,0.073057,0.0046264,0.10163,0.23611,REACTOME_DDX58_IFIH1_MEDIATED_INDUCTION_OF_INTERFERON_ALPHA_BETA,0.94952329138767
GSE21360_NAIVE_VS_TERTIARY_M...1,SET,178,0.04445,0.0043532,0.061833,0.23611,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_DN,0.94952329138767
VALK_AML_CLUSTER_4,SET,25,0.12798,0.0047169,0.17808,0.23618,VALK_AML_CLUSTER_4,0.94952329138767
MIR6834_5P,SET,53,0.083242,0.0044637,0.11584,0.2362,MIR6834_5P,0.94952329138767
HP_ABNORMAL_HYPOTHALAMUS_MOR...,SET,19,0.11958,0.0038427,0.16643,0.23623,HP_ABNORMAL_HYPOTHALAMUS_MORPHOLOGY,0.94952329138767
MIR4266,SET,74,0.067478,0.0042731,0.09394,0.23629,MIR4266,0.94952329138767
GSE360_CTRL_VS_L_DONOVANI_MA...1,SET,175,0.04557,0.0044254,0.063444,0.2363,GSE360_CTRL_VS_L_DONOVANI_MAC_DN,0.94952329138767
WEST_ADRENOCORTICAL_TUMOR_DN,SET,480,0.028277,0.0045096,0.039371,0.23632,WEST_ADRENOCORTICAL_TUMOR_DN,0.94952329138767
GOBP_NUCLEOLAR_LARGE_RRNA_TR...,SET,19,0.13462,0.0043261,0.18744,0.23632,GOBP_NUCLEOLAR_LARGE_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_I,0.94952329138767
HP_APLASIA_HYPOPLASIA_OF_THE...42,SET,5,0.23005,0.003794,0.32032,0.23632,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.94952329138767
NEUROG3_TARGET_GENES,SET,15,0.14784,0.0042218,0.20586,0.23633,NEUROG3_TARGET_GENES,0.94952329138767
HP_ABNORMAL_CIRCULATING_FREE...3,SET,7,0.19943,0.0038914,0.2777,0.23633,HP_ABNORMAL_CIRCULATING_FREE_T4_CONCENTRATION,0.94952329138767
ZHANG_PROLIFERATING_VS_QUIES...,SET,45,0.092245,0.0045588,0.12848,0.2364,ZHANG_PROLIFERATING_VS_QUIESCENT,0.94952329138767
MODULE_471,SET,9,0.21105,0.0046691,0.29397,0.23641,MODULE_471,0.94952329138767
REACTOME_SIGNALING_BY_NTRK3_...,SET,17,0.13134,0.0039926,0.18296,0.23643,REACTOME_SIGNALING_BY_NTRK3_TRKC,0.94952329138767
AIZARANI_LIVER_C28_NK_NKT_CE...,SET,85,0.068219,0.0046286,0.095049,0.23647,AIZARANI_LIVER_C28_NK_NKT_CELLS_6,0.94952329138767
VART_KSHV_INFECTION_ANGIOGEN...2,SET,152,0.053754,0.0048682,0.074909,0.23651,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP,0.94952329138767
KEGG_MEDICUS_REFERENCE_ACTIV...1,SET,16,0.14126,0.0041662,0.19688,0.23654,KEGG_MEDICUS_REFERENCE_ACTIVATION_OF_PRC2.2_BY_UBIQUITINATION_OF_H2AK119,0.94952329138767
HP_DECREASED_CIRCULATING_FRE...2,SET,4,0.25825,0.0038095,0.35999,0.23657,HP_DECREASED_CIRCULATING_FREE_T4_CONCENTRATION,0.94952329138767
GSE2770_IL12_AND_TGFB_VS_IL4...4,SET,182,0.044726,0.0044287,0.062347,0.23657,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,0.94952329138767
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...2,SET,727,0.022889,0.0044614,0.03191,0.2366,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN,0.94952329138767
SOTIRIOU_BREAST_CANCER_GRADE...2,SET,137,0.048947,0.0042101,0.068244,0.23662,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_UP,0.94952329138767
GOMF_MOLECULAR_ADAPTOR_ACTIV...,SET,1032,0.018749,0.0043163,0.026143,0.23663,GOMF_MOLECULAR_ADAPTOR_ACTIVITY,0.94952329138767
HP_ABNORMAL_SACRUM_MORPHOLOGY,SET,139,0.052413,0.0045409,0.07308,0.23663,HP_ABNORMAL_SACRUM_MORPHOLOGY,0.94952329138767
GOMF_HISTONE_H4_ACETYLTRANSF...,SET,21,0.11408,0.003854,0.15908,0.23665,GOMF_HISTONE_H4_ACETYLTRANSFERASE_ACTIVITY,0.94952329138767
MIR10401_3P,SET,6,0.22963,0.0041483,0.32025,0.23668,MIR10401_3P,0.949534041325176
SCHOEN_NFKB_SIGNALING,SET,32,0.12369,0.0051569,0.17261,0.23681,SCHOEN_NFKB_SIGNALING,0.949879126773561
HP_RESPIRATORY_PARALYSIS,SET,7,0.26157,0.0051038,0.36507,0.23684,HP_RESPIRATORY_PARALYSIS,0.949879126773561
GOBP_GLOMERULAR_MESANGIAL_CE...2,SET,12,0.20099,0.005134,0.28058,0.2369,GOBP_GLOMERULAR_MESANGIAL_CELL_PROLIFERATION,0.949879126773561
GOBP_REGULATION_OF_RIBONUCLE...,SET,9,0.22841,0.0050532,0.3189,0.23692,GOBP_REGULATION_OF_RIBONUCLEASE_ACTIVITY,0.949879126773561
GTAAGAT_MIR200A,SET,44,0.093175,0.0045535,0.13009,0.23693,GTAAGAT_MIR200A,0.949879126773561
OVOL3_TARGET_GENES,SET,392,0.029853,0.0043131,0.041682,0.23693,OVOL3_TARGET_GENES,0.949879126773561
GOBP_POSITIVE_REGULATION_OF_...374,SET,10,0.19561,0.0045615,0.27316,0.23697,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.94992991349481
GOMF_PHOSPHATIDYLINOSITOL_PH...4,SET,23,0.11135,0.0039367,0.15555,0.23704,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_PHOSPHATASE_ACTIVITY,0.950100934148311
GSE3039_NKT_CELL_VS_B1_BCELL...2,SET,176,0.044339,0.0043181,0.061944,0.23707,GSE3039_NKT_CELL_VS_B1_BCELL_UP,0.950111606319188
MODULE_432,SET,13,0.15259,0.0040567,0.21322,0.23711,MODULE_432,0.950154270401107
REACTOME_STAT5_ACTIVATION_DO...,SET,10,0.17399,0.0040574,0.24319,0.23717,REACTOME_STAT5_ACTIVATION_DOWNSTREAM_OF_FLT3_ITD_MUTANTS,0.950154270401107
HP_SHORT_FACE,SET,17,0.15385,0.0046768,0.21505,0.23718,HP_SHORT_FACE,0.950154270401107
HP_APLASIA_OF_THE_DISTAL_PHA...,SET,5,0.24256,0.0040003,0.33907,0.23719,HP_APLASIA_OF_THE_DISTAL_PHALANGES_OF_THE_TOES,0.950154270401107
GSE46606_IRF4_KO_VS_WT_CD40L...4,SET,176,0.048045,0.004679,0.067207,0.23734,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_UP,0.95031892171514
REACTOME_ORGANELLE_BIOGENESI...,SET,250,0.036538,0.0042323,0.051113,0.23736,REACTOME_ORGANELLE_BIOGENESIS_AND_MAINTENANCE,0.95031892171514
GOBP_NEGATIVE_REGULATION_OF_...83,SET,308,0.033416,0.0042894,0.046747,0.23736,GOBP_NEGATIVE_REGULATION_OF_CATABOLIC_PROCESS,0.95031892171514
WP_CHOLESTEROL_SYNTHESIS_DIS...,SET,17,0.13301,0.0040433,0.18611,0.23741,WP_CHOLESTEROL_SYNTHESIS_DISORDERS,0.95031892171514
NADLER_OBESITY_DN,SET,47,0.087101,0.004399,0.12188,0.23742,NADLER_OBESITY_DN,0.95031892171514
HP_HYPERURICOSURIA,SET,8,0.19192,0.0040032,0.26855,0.23742,HP_HYPERURICOSURIA,0.95031892171514
MIR182_5P,SET,506,0.027479,0.0044963,0.038454,0.23743,MIR182_5P,0.95031892171514
GOMF_PHOSPHATIDYLINOSITOL_3_...8,SET,11,0.15299,0.0037416,0.21414,0.23748,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.95031892171514
GSE6674_ANTI_IGM_VS_PL2_3_ST...1,SET,176,0.044019,0.0042869,0.061625,0.23752,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_DN,0.95031892171514
REACTOME_RHOBTB3_ATPASE_CYCLE,SET,8,0.20474,0.0042707,0.28668,0.23756,REACTOME_RHOBTB3_ATPASE_CYCLE,0.95031892171514
GRUETZMANN_PANCREATIC_CANCER...2,SET,331,0.034017,0.0045238,0.047642,0.23762,GRUETZMANN_PANCREATIC_CANCER_UP,0.95031892171514
WP_NANOPARTICLEMEDIATED_ACTI...,SET,28,0.12018,0.0046871,0.16833,0.23765,WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING,0.95031892171514
GSE7831_UNSTIM_VS_CPG_STIM_P...1,SET,175,0.045496,0.0044183,0.063729,0.23765,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN,0.95031892171514
WP_INCLUSION_BODY_MYOSITIS,SET,10,0.18848,0.0043952,0.26406,0.23769,WP_INCLUSION_BODY_MYOSITIS,0.95031892171514
MIR4731_5P,SET,238,0.038433,0.0043451,0.053859,0.23775,MIR4731_5P,0.95031892171514
GOMF_ISOMERASE_ACTIVITY,SET,158,0.04455,0.0041128,0.062434,0.23776,GOMF_ISOMERASE_ACTIVITY,0.95031892171514
GOMF_OXYGEN_BINDING,SET,28,0.12684,0.0049471,0.17777,0.23777,GOMF_OXYGEN_BINDING,0.95031892171514
KUNINGER_IGF1_VS_PDGFB_TARGE...1,SET,41,0.099585,0.0046983,0.13959,0.2378,KUNINGER_IGF1_VS_PDGFB_TARGETS_DN,0.95031892171514
GSE7348_UNSTIM_VS_LPS_STIM_M...2,SET,141,0.048268,0.0042115,0.067661,0.23781,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,0.95031892171514
GSE34156_NOD2_LIGAND_VS_TLR1...4,SET,186,0.045526,0.0045567,0.063824,0.23783,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,0.95031892171514
HASLINGER_B_CLL_WITH_11Q23_D...,SET,20,0.12478,0.0041138,0.17494,0.23785,HASLINGER_B_CLL_WITH_11Q23_DELETION,0.95031892171514
HP_CONVULSIVE_STATUS_EPILEPT...,SET,6,0.22971,0.0041497,0.32205,0.23785,HP_CONVULSIVE_STATUS_EPILEPTICUS,0.95031892171514
GOBP_SUPRAMOLECULAR_FIBER_OR...,SET,776,0.022515,0.0045278,0.031568,0.23786,GOBP_SUPRAMOLECULAR_FIBER_ORGANIZATION,0.95031892171514
GOBP_NATURAL_KILLER_CELL_MED...1,SET,9,0.21336,0.0047203,0.29938,0.23803,GOBP_NATURAL_KILLER_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.950552842866988
GSE369_IFNG_KO_VS_WT_LIVER_DN,SET,171,0.043122,0.00414,0.060507,0.23803,GSE369_IFNG_KO_VS_WT_LIVER_DN,0.950552842866988
GOBP_TELOMERE_TETHERING_AT_N...,SET,3,0.29145,0.0037233,0.40903,0.23807,GOBP_TELOMERE_TETHERING_AT_NUCLEAR_PERIPHERY,0.950552842866988
NOTCH_DN.V1_UP,SET,157,0.048937,0.0045037,0.068681,0.23807,NOTCH_DN.V1_UP,0.950552842866988
TRAVAGLINI_LUNG_LIPOFIBROBLA...,SET,138,0.054918,0.0047408,0.077074,0.23807,TRAVAGLINI_LUNG_LIPOFIBROBLAST_CELL,0.950552842866988
MOSERLE_IFNA_RESPONSE,SET,30,0.12948,0.0052269,0.18174,0.2381,MOSERLE_IFNA_RESPONSE,0.950552842866988
GSE17301_ACD3_ACD28_VS_ACD3_...1,SET,183,0.043462,0.0043152,0.061007,0.23811,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA2_STIM_CD8_TCELL_DN,0.950552842866988
WP_ULCERATIVE_COLITIS_SIGNAL...,SET,16,0.15566,0.0045909,0.21857,0.23818,WP_ULCERATIVE_COLITIS_SIGNALING,0.950681942215088
chr6q24,SET,32,0.20138,0.0083955,0.28278,0.2382,chr6q24,0.950681942215088
GOCC_DNA_DEPENDENT_PROTEIN_K...1,SET,5,0.25695,0.0042375,0.36096,0.23828,GOCC_DNA_DEPENDENT_PROTEIN_KINASE_COMPLEX,0.950681942215088
GOBP_REGULATION_OF_SNRNA_TRA...,SET,5,0.22628,0.0037317,0.31789,0.23829,GOBP_REGULATION_OF_SNRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_II,0.950681942215088
TGTATGA_MIR4853P,SET,146,0.049351,0.0043811,0.069332,0.2383,TGTATGA_MIR4853P,0.950681942215088
GOBP_NEGATIVE_REGULATION_OF_...122,SET,15,0.15569,0.004446,0.21879,0.23836,GOBP_NEGATIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.950681942215088
HOXC6_TARGET_GENES,SET,949,0.019646,0.0043475,0.02761,0.23837,HOXC6_TARGET_GENES,0.950681942215088
ZNF362_TARGET_GENES,SET,489,0.026515,0.0042671,0.037269,0.23841,ZNF362_TARGET_GENES,0.950681942215088
GSE26030_TH1_VS_TH17_RESTIMU...4,SET,187,0.042982,0.0043134,0.060419,0.23842,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY5_POST_POLARIZATION_UP,0.950681942215088
NUTT_GBM_VS_AO_GLIOMA_UP,SET,41,0.096556,0.0045554,0.13574,0.23844,NUTT_GBM_VS_AO_GLIOMA_UP,0.950681942215088
CRX_DN.V1_UP,SET,120,0.054841,0.0044169,0.077115,0.2385,CRX_DN.V1_UP,0.950681942215088
HP_TERATOMA,SET,12,0.16396,0.0041882,0.23057,0.23851,HP_TERATOMA,0.950681942215088
GOMF_CYTOSKELETAL_MOTOR_ACTI...,SET,112,0.056824,0.0044223,0.079914,0.23853,GOMF_CYTOSKELETAL_MOTOR_ACTIVITY,0.950681942215088
GOBP_GLOMERULAR_MESANGIAL_CE...1,SET,4,0.29209,0.0043086,0.41081,0.23854,GOBP_GLOMERULAR_MESANGIAL_CELL_DEVELOPMENT,0.950681942215088
GSE40274_CTRL_VS_FOXP3_TRANS...2,SET,182,0.043095,0.0042672,0.060617,0.23856,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.950681942215088
GOMF_CATALYTIC_ACTIVITY_ACTI...3,SET,16,0.12352,0.0036429,0.17375,0.23858,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_RRNA,0.950681942215088
HP_ABNORMAL_CIRCULATING_THYR...2,SET,31,0.10785,0.0044256,0.15181,0.23873,HP_ABNORMAL_CIRCULATING_THYROID_HORMONE_CONCENTRATION,0.951170600710765
GOMF_PEPTIDASE_ACTIVATOR_ACT...1,SET,52,0.080549,0.0042785,0.11346,0.23888,GOMF_PEPTIDASE_ACTIVATOR_ACTIVITY,0.951461927131072
GSE32423_CTRL_VS_IL7_IL4_MEM...2,SET,182,0.04437,0.0043934,0.062499,0.23888,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,0.951461927131072
GOMF_FATTY_ACID_OMEGA_HYDROX...,SET,7,0.26174,0.0051072,0.36875,0.23892,GOMF_FATTY_ACID_OMEGA_HYDROXYLASE_ACTIVITY,0.951461927131072
HP_NONPROGRESSIVE,SET,18,0.13709,0.0042883,0.19317,0.23894,HP_NONPROGRESSIVE,0.951461927131072
GSE40274_LEF1_VS_FOXP3_AND_L...2,SET,182,0.045397,0.0044951,0.063964,0.23894,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.951461927131072
VISALA_RESPONSE_TO_HEAT_SHOC...1,SET,12,0.17391,0.0044424,0.2451,0.23899,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_DN,0.951501068937922
PID_PDGFRA_PATHWAY,SET,21,0.13208,0.0044622,0.18622,0.23908,PID_PDGFRA_PATHWAY,0.951501068937922
MIR1270,SET,72,0.073331,0.0045808,0.1034,0.2391,MIR1270,0.951501068937922
GSE19888_ADENOSINE_A3R_INH_V...8,SET,183,0.044208,0.0043893,0.06234,0.23912,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.951501068937922
HP_AGENESIS_OF_PERMANENT_TEE...,SET,19,0.12879,0.0041389,0.18164,0.23915,HP_AGENESIS_OF_PERMANENT_TEETH,0.951501068937922
YAGUE_PRETUMOR_DRUG_RESISTAN...1,SET,12,0.17857,0.0045613,0.25188,0.23919,YAGUE_PRETUMOR_DRUG_RESISTANCE_DN,0.951501068937922
HASINA_NOL7_TARGETS_UP,SET,10,0.2036,0.0047479,0.2872,0.2392,HASINA_NOL7_TARGETS_UP,0.951501068937922
GSE7831_UNSTIM_VS_INFLUENZA_...1,SET,182,0.045224,0.004478,0.063808,0.23924,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_DN,0.951501068937922
GSE18893_CTRL_VS_TNF_TREATED...8,SET,179,0.044581,0.0043781,0.062907,0.23927,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_UP,0.951501068937922
MALIK_REPRESSED_BY_ESTROGEN,SET,13,0.17795,0.004731,0.25114,0.2393,MALIK_REPRESSED_BY_ESTROGEN,0.951501068937922
GOBP_NEGATIVE_REGULATION_OF_...433,SET,21,0.134,0.0045271,0.18912,0.23931,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.951501068937922
GOBP_MONOSACCHARIDE_TRANSMEM...,SET,110,0.058452,0.0045085,0.082505,0.23933,GOBP_MONOSACCHARIDE_TRANSMEMBRANE_TRANSPORT,0.951501068937922
HP_EEG_WITH_MULTIFOCAL_SLOW_...,SET,49,0.080569,0.0041546,0.11373,0.23934,HP_EEG_WITH_MULTIFOCAL_SLOW_ACTIVITY,0.951501068937922
SHIRAISHI_PLZF_TARGETS_DN,SET,9,0.21468,0.0047495,0.30313,0.23941,SHIRAISHI_PLZF_TARGETS_DN,0.951501068937922
HP_ABNORMAL_BRAIN_N_ACETYL_A...,SET,19,0.12588,0.0040451,0.17775,0.23942,HP_ABNORMAL_BRAIN_N_ACETYL_ASPARTATE_LEVEL_BY_MRS,0.951501068937922
GSE36527_CD62L_HIGH_CD69_NEG...2,SET,180,0.043316,0.0042657,0.061171,0.23944,GSE36527_CD62L_HIGH_CD69_NEG_VS_CD62L_LOW_CD69_POS_TREG_KLRG1_NEG_UP,0.951501068937922
HP_MOVEMENT_ABNORMALITY_OF_T...,SET,15,0.15357,0.0043855,0.21689,0.23945,HP_MOVEMENT_ABNORMALITY_OF_THE_TONGUE,0.951501068937922
HP_APLASIA_HYPOPLASIA_OF_THE...77,SET,70,0.073278,0.0045137,0.1035,0.23947,HP_APLASIA_HYPOPLASIA_OF_THE_UTERUS,0.951501068937922
OVSYANNIKOVA_PBMC_FLUARIX_AG...3,SET,17,0.13015,0.0039563,0.18381,0.23947,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,0.951501068937922
FAN_OVARY_CL7_ANGEIOGENIC_EN...,SET,224,0.042478,0.0046609,0.060006,0.23951,FAN_OVARY_CL7_ANGEIOGENIC_ENDOTHELIAL_CELL,0.951551217421125
GSE9037_CTRL_VS_LPS_1H_STIM_...3,SET,175,0.046208,0.0044874,0.065308,0.23962,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_DN,0.951762081572032
GOBP_TRNA_MODIFICATION,SET,83,0.05937,0.0039807,0.083915,0.23963,GOBP_TRNA_MODIFICATION,0.951762081572032
GSE29949_CD8_POS_DC_SPLEEN_V...3,SET,176,0.04525,0.0044068,0.063962,0.23965,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,0.951762081572032
GSE42724_B1_BCELL_VS_PLASMAB...2,SET,184,0.042337,0.0042149,0.059853,0.23968,GSE42724_B1_BCELL_VS_PLASMABLAST_UP,0.951762081572032
GSE3920_UNTREATED_VS_IFNG_TR...1,SET,174,0.044037,0.0042645,0.062262,0.2397,GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,0.951762081572032
PEPPER_CHRONIC_LYMPHOCYTIC_L...2,SET,29,0.11687,0.0046386,0.16539,0.23991,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.952378303826385
GOBP_POSITIVE_REGULATION_OF_...20,SET,24,0.14042,0.0050709,0.19872,0.23991,GOBP_POSITIVE_REGULATION_OF_ALPHA_BETA_T_CELL_PROLIFERATION,0.952378303826385
GSE5679_PPARG_LIGAND_ROSIGLI...4,SET,178,0.044543,0.0043623,0.06306,0.23999,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,0.952557673860911
HP_PROPTOSIS,SET,257,0.036467,0.004282,0.051632,0.24001,HP_PROPTOSIS,0.952557673860911
HP_DISCOID_LUPUS_RASH,SET,28,0.1221,0.0047622,0.17292,0.24006,HP_DISCOID_LUPUS_RASH,0.952604390049977
WP_CHEMOKINE_SIGNALING,SET,157,0.049313,0.0045382,0.069859,0.24013,WP_CHEMOKINE_SIGNALING,0.952604390049977
GSE20715_0H_VS_48H_OZONE_TLR...1,SET,190,0.042398,0.0042885,0.060066,0.24014,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_DN,0.952604390049977
GOBP_POSITIVE_REGULATION_OF_...369,SET,56,0.08242,0.0045426,0.11682,0.24025,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,0.952604390049977
GOBP_NEGATIVE_REGULATION_OF_...222,SET,8,0.2088,0.0043553,0.29598,0.24027,GOBP_NEGATIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.952604390049977
GSE21379_WT_VS_SAP_KO_CD4_TC...2,SET,185,0.043136,0.0043059,0.061149,0.24028,GSE21379_WT_VS_SAP_KO_CD4_TCELL_UP,0.952604390049977
HP_HYPOAMYLASEMIA,SET,4,0.26818,0.0039559,0.38022,0.24031,HP_HYPOAMYLASEMIA,0.952604390049977
REACTOME_LIGAND_RECEPTOR_INT...,SET,8,0.23734,0.0049505,0.33655,0.24034,REACTOME_LIGAND_RECEPTOR_INTERACTIONS,0.952604390049977
GOMF_ACROSIN_BINDING,SET,5,0.2429,0.0040058,0.34447,0.24037,GOMF_ACROSIN_BINDING,0.952604390049977
HP_ABNORMAL_NASOLACRIMAL_SYS...,SET,63,0.071284,0.0041663,0.1011,0.24038,HP_ABNORMAL_NASOLACRIMAL_SYSTEM_MORPHOLOGY,0.952604390049977
MARTINEZ_RESPONSE_TO_TRABECT...2,SET,254,0.035444,0.0041378,0.050282,0.24044,MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN,0.952604390049977
HP_JOINT_HEMORRHAGE,SET,14,0.16985,0.0046859,0.24098,0.24047,HP_JOINT_HEMORRHAGE,0.952604390049977
WP_CONTROL_OF_IMMUNE_TOLERAN...,SET,13,0.17429,0.0046338,0.24731,0.24048,WP_CONTROL_OF_IMMUNE_TOLERANCE_BY_VASOACTIVE_INTESTINAL_PEPTIDE,0.952604390049977
MILI_PSEUDOPODIA,SET,41,0.083588,0.0039436,0.11861,0.2405,MILI_PSEUDOPODIA,0.952604390049977
GOMF_BUBBLE_DNA_BINDING,SET,8,0.22714,0.0047379,0.32237,0.24054,GOMF_BUBBLE_DNA_BINDING,0.952604390049977
MODULE_454,SET,10,0.20872,0.0048673,0.29629,0.24058,MODULE_454,0.952604390049977
GOBP_NEGATIVE_REGULATION_OF_...114,SET,14,0.1689,0.0046599,0.23976,0.24058,GOBP_NEGATIVE_REGULATION_OF_CELL_DIVISION,0.952604390049977
GOBP_PROTEIN_IMPORT_INTO_PER...1,SET,13,0.16223,0.0043131,0.23031,0.24059,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX,0.952604390049977
GOCC_PI_BODY,SET,9,0.16923,0.0037439,0.24026,0.24061,GOCC_PI_BODY,0.952604390049977
GOBP_POSITIVE_REGULATION_OF_...637,SET,91,0.059612,0.0041842,0.084661,0.24068,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.952604390049977
MIR3160_5P,SET,188,0.045052,0.0045331,0.063996,0.24073,MIR3160_5P,0.952604390049977
TGCCAAR_NF1_Q6,SET,640,0.024365,0.0044668,0.034623,0.24081,TGCCAAR_NF1_Q6,0.952604390049977
GOBP_PURINE_NUCLEOTIDE_SALVA...,SET,10,0.19238,0.0044861,0.2734,0.24083,GOBP_PURINE_NUCLEOTIDE_SALVAGE,0.952604390049977
GOBP_REGULATION_OF_RESTING_M...,SET,10,0.18928,0.0044139,0.26899,0.24083,GOBP_REGULATION_OF_RESTING_MEMBRANE_POTENTIAL,0.952604390049977
GOBP_CELLULAR_RESPONSE_TO_FO...,SET,9,0.23683,0.0052394,0.33659,0.24084,GOBP_CELLULAR_RESPONSE_TO_FOLLICLE_STIMULATING_HORMONE_STIMULUS,0.952604390049977
REACTOME_DETOXIFICATION_OF_R...,SET,33,0.099944,0.0042312,0.14205,0.24085,REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES,0.952604390049977
FAC1_01,SET,189,0.04562,0.0046024,0.064838,0.24085,FAC1_01,0.952604390049977
GOBP_NEGATIVE_REGULATION_OF_...131,SET,11,0.18753,0.0045865,0.26654,0.24085,GOBP_NEGATIVE_REGULATION_OF_CENTROSOME_DUPLICATION,0.952604390049977
HP_BREATHING_DYSREGULATION,SET,19,0.13043,0.0041916,0.18541,0.24088,HP_BREATHING_DYSREGULATION,0.952604390049977
GOMF_OXIDIZED_DNA_BINDING,SET,11,0.16697,0.0040835,0.23735,0.24089,GOMF_OXIDIZED_DNA_BINDING,0.952604390049977
GSE17721_0.5H_VS_4H_CPG_BMDC...1,SET,188,0.043904,0.0044176,0.062424,0.24093,GSE17721_0.5H_VS_4H_CPG_BMDC_DN,0.952604390049977
GOCC_ACTIN_CYTOSKELETON,SET,481,0.027845,0.0044453,0.039601,0.24099,GOCC_ACTIN_CYTOSKELETON,0.952604390049977
GOBP_MRNA_3_END_PROCESSING,SET,36,0.089879,0.003974,0.12783,0.241,GOBP_MRNA_3_END_PROCESSING,0.952604390049977
GSE30962_ACUTE_VS_CHRONIC_LC...3,SET,185,0.04497,0.004489,0.063962,0.24101,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_DN,0.952604390049977
GOCC_ATG12_ATG5_ATG16_COMPLEX,SET,6,0.27453,0.0049594,0.39059,0.24108,GOCC_ATG12_ATG5_ATG16_COMPLEX,0.952604390049977
MIR4727_5P,SET,103,0.059698,0.0044566,0.08495,0.24111,MIR4727_5P,0.952604390049977
HP_COARSE_FACIAL_FEATURES,SET,191,0.041913,0.0042504,0.059651,0.24115,HP_COARSE_FACIAL_FEATURES,0.952604390049977
REACTOME_DEFECTS_OF_CONTACT_...,SET,14,0.17286,0.0047692,0.24604,0.24116,REACTOME_DEFECTS_OF_CONTACT_ACTIVATION_SYSTEM_CAS_AND_KALLIKREIN_KININ_SYSTEM_KKS,0.952604390049977
GOBP_EMBRYONIC_DIGIT_MORPHOG...,SET,53,0.087675,0.0047014,0.12481,0.24119,GOBP_EMBRYONIC_DIGIT_MORPHOGENESIS,0.952604390049977
HALLMARK_G2M_CHECKPOINT,SET,182,0.04278,0.004236,0.060899,0.2412,HALLMARK_G2M_CHECKPOINT,0.952604390049977
HP_PRENATAL_MOVEMENT_ABNORMA...,SET,211,0.041526,0.0044237,0.05912,0.24122,HP_PRENATAL_MOVEMENT_ABNORMALITY,0.952604390049977
DESCARTES_MAIN_FETAL_THYMOCY...,SET,70,0.075287,0.0046375,0.1072,0.24124,DESCARTES_MAIN_FETAL_THYMOCYTES,0.952604390049977
GOBP_MEDIUM_CHAIN_FATTY_ACYL...,SET,6,0.24835,0.0044864,0.35362,0.24125,GOBP_MEDIUM_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,0.952604390049977
MANN_RESPONSE_TO_AMIFOSTINE_...1,SET,9,0.16293,0.0036045,0.232,0.24126,MANN_RESPONSE_TO_AMIFOSTINE_DN,0.952604390049977
GOCC_CONTRACTILE_RING,SET,11,0.15633,0.0038235,0.22264,0.24129,GOCC_CONTRACTILE_RING,0.952604390049977
CHIARADONNA_NEOPLASTIC_TRANS...6,SET,113,0.056703,0.0044325,0.080762,0.24131,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_UP,0.952604390049977
HP_RENAL_FIBROSIS,SET,15,0.15104,0.0043131,0.21512,0.24131,HP_RENAL_FIBROSIS,0.952604390049977
GOBP_REGULATION_OF_PRESYNAPT...2,SET,28,0.12439,0.0048516,0.17721,0.24136,GOBP_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,0.952693560477002
GOBP_GOLGI_TO_PLASMA_MEMBRAN...2,SET,61,0.072621,0.0041768,0.10348,0.24141,GOBP_GOLGI_TO_PLASMA_MEMBRANE_TRANSPORT,0.952756182643222
GNF2_RFC4,SET,57,0.070868,0.0039405,0.101,0.24146,GNF2_RFC4,0.952756182643222
GOBP_PROTEIN_INSERTION_INTO_...2,SET,9,0.18547,0.0041032,0.26436,0.24147,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE_BY_STOP_TRANSFER_MEMBRANE_ANCHOR_SEQUENCE,0.952756182643222
GOBP_POSITIVE_REGULATION_OF_...801,SET,10,0.19788,0.0046145,0.28211,0.24152,GOBP_POSITIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,0.952756182643222
GOBP_IMMUNOLOGICAL_MEMORY_FO...,SET,13,0.1872,0.004977,0.26697,0.24159,GOBP_IMMUNOLOGICAL_MEMORY_FORMATION_PROCESS,0.952756182643222
GOBP_NEGATIVE_REGULATION_OF_...156,SET,20,0.12943,0.0042675,0.18459,0.24159,GOBP_NEGATIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.952756182643222
SABATES_COLORECTAL_ADENOMA_S...1,SET,11,0.16698,0.0040839,0.23815,0.2416,SABATES_COLORECTAL_ADENOMA_SIZE_DN,0.952756182643222
MIR3128,SET,114,0.053564,0.0042055,0.076406,0.24164,MIR3128,0.952756182643222
REACTOME_MITOTIC_SPINDLE_CHE...,SET,104,0.054828,0.0041127,0.078213,0.24165,REACTOME_MITOTIC_SPINDLE_CHECKPOINT,0.952756182643222
GOBP_LEUKOCYTE_CELL_CELL_ADH...,SET,384,0.032955,0.0047134,0.047009,0.24165,GOBP_LEUKOCYTE_CELL_CELL_ADHESION,0.952756182643222
GOBP_DNA_REPLICATION_SYNTHES...,SET,6,0.22066,0.0039862,0.31485,0.24171,GOBP_DNA_REPLICATION_SYNTHESIS_OF_PRIMER,0.952815991833957
GAURNIER_PSMD4_TARGETS,SET,64,0.081681,0.0048116,0.11655,0.24172,GAURNIER_PSMD4_TARGETS,0.952815991833957
GSE30971_CTRL_VS_LPS_STIM_MA...8,SET,173,0.049921,0.0048205,0.071243,0.24175,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_4H_UP,0.952826179405761
REACTOME_RET_SIGNALING,SET,40,0.090325,0.0042092,0.12893,0.24179,REACTOME_RET_SIGNALING,0.952875773897267
HP_CONJUNCTIVAL_ICTERUS,SET,6,0.23993,0.0043343,0.34253,0.24183,HP_CONJUNCTIVAL_ICTERUS,0.952925357142857
REACTOME_THE_CANONICAL_RETIN...,SET,22,0.12842,0.0044403,0.18339,0.2419,REACTOME_THE_CANONICAL_RETINOID_CYCLE_IN_RODS_TWILIGHT_VISION,0.953034648078885
GSE17721_LPS_VS_PAM3CSK4_4H_...2,SET,189,0.043093,0.0043474,0.061549,0.24192,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_UP,0.953034648078885
PHONG_TNF_TARGETS_UP,SET,61,0.086969,0.005002,0.12423,0.24194,PHONG_TNF_TARGETS_UP,0.953034648078885
GOBP_RESPONSE_TO_LAMINAR_FLU...,SET,14,0.16383,0.0045198,0.23407,0.242,GOBP_RESPONSE_TO_LAMINAR_FLUID_SHEAR_STRESS,0.953162964641886
REACTOME_ORGANIC_ANION_TRANS...2,SET,12,0.17811,0.0045496,0.25456,0.24207,REACTOME_ORGANIC_ANION_TRANSPORTERS,0.953330634560906
GOCC_CENTROSOME,SET,667,0.022348,0.0041794,0.03195,0.24213,GOCC_CENTROSOME,0.953429619349722
HP_FASCICULATIONS,SET,123,0.052824,0.0043069,0.075524,0.24215,HP_FASCICULATIONS,0.953429619349722
MIR5591_3P,SET,41,0.092571,0.0043674,0.13239,0.2422,MIR5591_3P,0.953489194699286
HP_TINNITUS,SET,65,0.070576,0.0041897,0.10094,0.24222,HP_TINNITUS,0.953489194699286
HEIDENBLAD_AMPLICON_8Q24_UP,SET,35,0.090881,0.0039622,0.13004,0.24231,HEIDENBLAD_AMPLICON_8Q24_UP,0.953678139430116
BUSSLINGER_GASTRIC_PREZYMOGE...,SET,57,0.082275,0.0045748,0.11777,0.24241,BUSSLINGER_GASTRIC_PREZYMOGENIC_CELLS,0.953678139430116
GOMF_FLIPPASE_ACTIVITY,SET,15,0.15366,0.0043879,0.21996,0.24242,GOMF_FLIPPASE_ACTIVITY,0.953678139430116
HP_AUTOPHAGIC_VACUOLES,SET,8,0.20809,0.0043406,0.29789,0.24242,HP_AUTOPHAGIC_VACUOLES,0.953678139430116
HP_INCREASED_CIRCULATING_INT...3,SET,11,0.18395,0.0044988,0.26336,0.24245,HP_INCREASED_CIRCULATING_INTERLEUKIN_6_CONCENTRATION,0.953678139430116
HP_LARYNGOMALACIA,SET,77,0.066923,0.0043226,0.095814,0.24245,HP_LARYNGOMALACIA,0.953678139430116
WP_IRINOTECAN_PATHWAY,SET,12,0.1715,0.0043807,0.24562,0.24252,WP_IRINOTECAN_PATHWAY,0.953678139430116
HP_ORCHITIS,SET,14,0.17344,0.004785,0.24846,0.24257,HP_ORCHITIS,0.953678139430116
HP_APLASIA_HYPOPLASIA_OF_THE...37,SET,25,0.12347,0.0045508,0.17691,0.24261,HP_APLASIA_HYPOPLASIA_OF_THE_HUMERUS,0.953678139430116
GOBP_RESPONSE_TO_CYCLOHEXIMI...,SET,5,0.29439,0.0048551,0.4219,0.24266,GOBP_RESPONSE_TO_CYCLOHEXIMIDE,0.953678139430116
OCT_C,SET,220,0.041454,0.0045082,0.059416,0.24269,OCT_C,0.953678139430116
GOBP_POSITIVE_REGULATION_OF_...595,SET,12,0.1959,0.005004,0.2808,0.24271,GOBP_POSITIVE_REGULATION_OF_PLATELET_AGGREGATION,0.953678139430116
GSE4590_PRE_BCELL_VS_LARGE_P...1,SET,147,0.04659,0.00415,0.066795,0.24275,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_DN,0.953678139430116
GOBP_SERTOLI_CELL_PROLIFERAT...,SET,5,0.22841,0.0037668,0.32749,0.24276,GOBP_SERTOLI_CELL_PROLIFERATION,0.953678139430116
MANNO_MIDBRAIN_NEUROTYPES_HN...3,SET,287,0.03711,0.004601,0.053206,0.24276,MANNO_MIDBRAIN_NEUROTYPES_HNBML1,0.953678139430116
GOBP_RESPONSE_TO_PEPTIDOGLYC...,SET,11,0.17636,0.0043132,0.2529,0.24281,GOBP_RESPONSE_TO_PEPTIDOGLYCAN,0.953678139430116
AMIT_EGF_RESPONSE_120_MCF10A,SET,38,0.1027,0.004665,0.14729,0.24282,AMIT_EGF_RESPONSE_120_MCF10A,0.953678139430116
MIR7704,SET,5,0.28639,0.0047231,0.41076,0.24284,MIR7704,0.953678139430116
MCBRYAN_TERMINAL_END_BUD_UP,SET,12,0.18037,0.0046074,0.25872,0.24285,MCBRYAN_TERMINAL_END_BUD_UP,0.953678139430116
HP_LOSS_OF_AMBULATION,SET,114,0.052771,0.0041432,0.075697,0.24286,HP_LOSS_OF_AMBULATION,0.953678139430116
GOMF_BRANCHED_CHAIN_AMINO_AC...,SET,9,0.20009,0.0044266,0.28703,0.24288,GOMF_BRANCHED_CHAIN_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.953678139430116
GSE14908_RESTING_VS_HDM_STIM...2,SET,177,0.041684,0.004071,0.059809,0.24292,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP,0.953678139430116
GSE41867_LCMV_ARMSTRONG_VS_C...1,SET,141,0.05032,0.0043906,0.0722,0.24292,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN,0.953678139430116
GOBP_NEGATIVE_REGULATION_OF_...281,SET,14,0.19481,0.0053746,0.27952,0.24293,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,0.953678139430116
GSE27786_LSK_VS_CD4_TCELL_UP,SET,172,0.043975,0.0042342,0.063106,0.24296,GSE27786_LSK_VS_CD4_TCELL_UP,0.953678139430116
HP_PHYSICAL_URTICARIA,SET,14,0.16226,0.0044767,0.23291,0.243,HP_PHYSICAL_URTICARIA,0.953678139430116
GOBP_MITOTIC_G1_S_TRANSITION...,SET,30,0.1051,0.0042428,0.15089,0.24305,GOBP_MITOTIC_G1_S_TRANSITION_CHECKPOINT_SIGNALING,0.953678139430116
GOCC_GATOR2_COMPLEX,SET,8,0.18488,0.0038563,0.26548,0.2431,GOCC_GATOR2_COMPLEX,0.953678139430116
DESCARTES_MAIN_FETAL_AMACRIN...,SET,16,0.15714,0.0046344,0.22573,0.24318,DESCARTES_MAIN_FETAL_AMACRINE_CELLS,0.953678139430116
WP_RENINANGIOTENSINALDOSTERO...,SET,43,0.090029,0.0043496,0.12934,0.2432,WP_RENINANGIOTENSINALDOSTERONE_SYSTEM_RAAS,0.953678139430116
ZNF260_TARGET_GENES,SET,668,0.023412,0.0043816,0.033642,0.24324,ZNF260_TARGET_GENES,0.953678139430116
GOMF_INTEGRIN_BINDING,SET,145,0.051232,0.0045325,0.073629,0.24328,GOMF_INTEGRIN_BINDING,0.953678139430116
YAGI_AML_WITH_T_9_11_TRANSLO...,SET,116,0.055155,0.004368,0.079274,0.2433,YAGI_AML_WITH_T_9_11_TRANSLOCATION,0.953678139430116
REACTOME_DEFECTIVE_B4GALT7_C...,SET,17,0.15693,0.0047705,0.2256,0.24334,REACTOME_DEFECTIVE_B4GALT7_CAUSES_EDS_PROGEROID_TYPE,0.953678139430116
GSE41867_DAY6_EFFECTOR_VS_DA...1,SET,181,0.041732,0.004121,0.060003,0.24337,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,0.953678139430116
STAT6_01,SET,238,0.039361,0.0044501,0.056601,0.2434,STAT6_01,0.953678139430116
GOBP_REGULATION_OF_COMPLEMEN...2,SET,3,0.3771,0.0048174,0.5423,0.24342,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_ALTERNATIVE_PATHWAY,0.953678139430116
GSE45365_WT_VS_IFNAR_KO_CD11...2,SET,151,0.049609,0.0044781,0.071348,0.24343,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_DN,0.953678139430116
HP_ABNORMAL_FINGER_PHALANX_M...,SET,578,0.024616,0.0042962,0.035404,0.24344,HP_ABNORMAL_FINGER_PHALANX_MORPHOLOGY,0.953678139430116
KEGG_MEDICUS_REFERENCE_GLYCO...4,SET,21,0.113,0.0038175,0.16255,0.24347,KEGG_MEDICUS_REFERENCE_GLYCOLYSIS,0.953678139430116
GOBP_RESPONSE_TO_ETHER,SET,15,0.15658,0.0044715,0.2253,0.24353,GOBP_RESPONSE_TO_ETHER,0.953678139430116
ZA_UNIPROT_Q9UM89_UNREVIEWED...,SET,60,0.077515,0.0044217,0.11155,0.24356,ZA_UNIPROT_Q9UM89_UNREVIEWED_GENES_TARGET_GENES,0.953678139430116
GOMF_HEXOSAMINIDASE_ACTIVITY,SET,12,0.16682,0.0042613,0.24008,0.24358,GOMF_HEXOSAMINIDASE_ACTIVITY,0.953678139430116
GSE5542_UNTREATED_VS_IFNA_AN...4,SET,163,0.044983,0.0042174,0.064739,0.24358,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,0.953678139430116
GOBP_CELLULAR_RESPONSE_TO_PU...,SET,13,0.16411,0.004363,0.2362,0.2436,GOBP_CELLULAR_RESPONSE_TO_PURINE_CONTAINING_COMPOUND,0.953678139430116
GOCC_CALCIUM_CHANNEL_COMPLEX,SET,63,0.075166,0.0043933,0.10819,0.2436,GOCC_CALCIUM_CHANNEL_COMPLEX,0.953678139430116
GSE33292_DN3_THYMOCYTE_VS_TC...3,SET,137,0.051631,0.0044411,0.074314,0.24361,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_DN,0.953678139430116
GSE2770_IL12_ACT_VS_ACT_CD4_...6,SET,170,0.043503,0.0041645,0.062621,0.24363,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_6H_UP,0.953678139430116
GOBP_RESPONSE_TO_BLUE_LIGHT,SET,6,0.23029,0.0041603,0.33152,0.24364,GOBP_RESPONSE_TO_BLUE_LIGHT,0.953678139430116
GOBP_UBIQUINONE_METABOLIC_PR...,SET,16,0.12831,0.0037842,0.18471,0.24364,GOBP_UBIQUINONE_METABOLIC_PROCESS,0.953678139430116
HP_ULNAR_CLAW,SET,9,0.21675,0.0047953,0.31213,0.24371,HP_ULNAR_CLAW,0.953844712837838
HP_RESTRICTIVE_BEHAVIOR,SET,12,0.16866,0.0043082,0.24295,0.24378,HP_RESTRICTIVE_BEHAVIOR,0.954011248733251
GOBP_PROTEIN_PEPTIDYL_PROLYL...,SET,17,0.13121,0.0039888,0.18913,0.24392,GOBP_PROTEIN_PEPTIDYL_PROLYL_ISOMERIZATION,0.954295796758947
GSE11924_TH1_VS_TH2_CD4_TCEL...2,SET,192,0.040202,0.0040875,0.057962,0.24397,GSE11924_TH1_VS_TH2_CD4_TCELL_UP,0.954295796758947
GOBP_CORNIFICATION,SET,9,0.23094,0.0051091,0.33297,0.24398,GOBP_CORNIFICATION,0.954295796758947
KEGG_MEDICUS_REFERENCE_KINET...1,SET,22,0.12003,0.0041502,0.17306,0.24399,KEGG_MEDICUS_REFERENCE_KINETOCHORE_FIBER_ORGANIZATION,0.954295796758947
HP_FINGER_APLASIA,SET,77,0.064291,0.0041526,0.092701,0.24399,HP_FINGER_APLASIA,0.954295796758947
GOBP_MUSCLE_CELL_CELLULAR_HO...,SET,21,0.12174,0.0041126,0.17556,0.24403,GOBP_MUSCLE_CELL_CELLULAR_HOMEOSTASIS,0.954315678442844
GSE41176_UNSTIM_VS_ANTI_IGM_...3,SET,180,0.04379,0.0043124,0.063158,0.24405,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_DN,0.954315678442844
HP_EPIDERMOID_CYST,SET,15,0.13699,0.0039118,0.19762,0.24411,HP_EPIDERMOID_CYST,0.954374645669291
LAKE_ADULT_KIDNEY_C4_PROXIMA...,SET,159,0.051087,0.0047311,0.073705,0.24412,LAKE_ADULT_KIDNEY_C4_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S2,0.954374645669291
GOBP_GLIAL_CELL_FATE_COMMITM...,SET,13,0.18451,0.0049055,0.26627,0.24417,GOBP_GLIAL_CELL_FATE_COMMITMENT,0.954462754470813
GOMF_ACTIN_MONOMER_BINDING,SET,21,0.12404,0.0041906,0.17906,0.24424,GOMF_ACTIN_MONOMER_BINDING,0.954560750028112
ASTON_MAJOR_DEPRESSIVE_DISOR...1,SET,146,0.048457,0.0043017,0.069953,0.24425,ASTON_MAJOR_DEPRESSIVE_DISORDER_DN,0.954560750028112
HP_MESANGIAL_HYPERCELLULARITY,SET,6,0.23802,0.0042999,0.34368,0.2443,HP_MESANGIAL_HYPERCELLULARITY,0.954648808185293
GOBP_MALE_GENITALIA_DEVELOPM...,SET,23,0.135,0.0047728,0.19503,0.24441,GOBP_MALE_GENITALIA_DEVELOPMENT,0.954971281618887
RYCACNNRNNRNCAG_UNKNOWN,SET,63,0.073291,0.0042836,0.1059,0.24445,RYCACNNRNNRNCAG_UNKNOWN,0.955020205710432
HP_ABSENT_PATELLAR_REFLEXES,SET,11,0.18827,0.0046045,0.27211,0.24451,HP_ABSENT_PATELLAR_REFLEXES,0.955049747162602
DLX6_TARGET_GENES,SET,451,0.026598,0.0041152,0.038445,0.24452,DLX6_TARGET_GENES,0.955049747162602
HP_MYELOID_LEUKEMIA,SET,30,0.10614,0.0042848,0.15343,0.24454,HP_MYELOID_LEUKEMIA,0.955049747162602
BIOCARTA_LYMPHOCYTE_PATHWAY,SET,9,0.22917,0.00507,0.33134,0.24459,BIOCARTA_LYMPHOCYTE_PATHWAY,0.955118599820346
GSE41867_DAY8_VS_DAY15_LCMV_...3,SET,179,0.039834,0.0039119,0.057602,0.24462,GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.955118599820346
REACTOME_INTERFERON_ALPHA_BE...,SET,72,0.073744,0.0046066,0.10667,0.24468,REACTOME_INTERFERON_ALPHA_BETA_SIGNALING,0.955118599820346
MIR1279,SET,167,0.046558,0.0044179,0.067364,0.24474,MIR1279,0.955118599820346
GOBP_HEART_DEVELOPMENT,SET,557,0.025788,0.0044208,0.037312,0.24474,GOBP_HEART_DEVELOPMENT,0.955118599820346
HP_UNILATERAL_PRIMARY_PULMON...,SET,3,0.28666,0.0036622,0.41477,0.24474,HP_UNILATERAL_PRIMARY_PULMONARY_DYSGENESIS,0.955118599820346
HP_LINEAR_ARRAYS_OF_MACULAR_...,SET,5,0.27765,0.0045789,0.40174,0.24475,HP_LINEAR_ARRAYS_OF_MACULAR_HYPERKERATOSES_IN_FLEXURAL_AREAS,0.955118599820346
REACTOME_TRAF6_MEDIATED_INDU...,SET,14,0.16855,0.0046502,0.24394,0.2448,REACTOME_TRAF6_MEDIATED_INDUCTION_OF_TAK1_COMPLEX_WITHIN_TLR4_COMPLEX,0.955138252132914
FRANCO_BLOOD_SANOFI_PASTEUR_...6,SET,119,0.05511,0.0044201,0.079764,0.24481,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_1DY_POSITIVE,0.955138252132914
ACEVEDO_LIVER_CANCER_WITH_H3...2,SET,229,0.04365,0.0048419,0.063197,0.24488,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_UP,0.955284721131186
HP_FRONTOTEMPORAL_DEMENTIA,SET,51,0.080497,0.0042345,0.11656,0.24492,HP_FRONTOTEMPORAL_DEMENTIA,0.955284721131186
HOEGERKORP_CD44_TARGETS_DIRE...1,SET,11,0.16925,0.0041394,0.24509,0.24493,HOEGERKORP_CD44_TARGETS_DIRECT_DN,0.955284721131186
GSE28726_NAIVE_CD4_TCELL_VS_...3,SET,173,0.044045,0.0042531,0.06381,0.24502,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_DN,0.955431091541396
GSE21927_UNTREATED_VS_GMCSF_...4,SET,154,0.046331,0.0042233,0.067123,0.24503,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_UP,0.955431091541396
HP_PROMINENT_EAR_HELIX,SET,6,0.27339,0.0049389,0.39612,0.24505,HP_PROMINENT_EAR_HELIX,0.955431091541396
BROWNE_HCMV_INFECTION_8HR_UP,SET,92,0.061087,0.0043111,0.088537,0.24511,BROWNE_HCMV_INFECTION_8HR_UP,0.955548251513114
GOCC_POSTSYNAPTIC_ENDOSOME_M...,SET,4,0.2634,0.0038854,0.38186,0.24517,GOCC_POSTSYNAPTIC_ENDOSOME_MEMBRANE,0.955548251513114
MIKKELSEN_MEF_ICP_WITH_H3K27...,SET,187,0.043984,0.004414,0.063785,0.24524,MIKKELSEN_MEF_ICP_WITH_H3K27ME3,0.955548251513114
MIR6868_5P,SET,111,0.054901,0.0042537,0.07962,0.24525,MIR6868_5P,0.955548251513114
HP_TRANSIENT_NEUTROPENIA,SET,7,0.18899,0.0036877,0.27412,0.24527,HP_TRANSIENT_NEUTROPENIA,0.955548251513114
GOMF_OXIDOREDUCTASE_ACTIVITY...27,SET,51,0.085623,0.0045041,0.12419,0.24528,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PEROXIDE_AS_ACCEPTOR,0.955548251513114
WP_EFFECT_OF_PROGERIN_ON_GEN...,SET,20,0.13123,0.0043266,0.19035,0.24529,WP_EFFECT_OF_PROGERIN_ON_GENES_INVOLVED_IN_PROGERIA,0.955548251513114
HP_CENTRAL_SCOTOMA,SET,36,0.096955,0.0042868,0.14064,0.2453,HP_CENTRAL_SCOTOMA,0.955548251513114
GOMF_RNA_POLYMERASE_BINDING,SET,56,0.079828,0.0043997,0.11583,0.24536,GOMF_RNA_POLYMERASE_BINDING,0.955674862714334
GOBP_PROGESTERONE_METABOLIC_...,SET,15,0.1568,0.0044776,0.22755,0.2454,GOBP_PROGESTERONE_METABOLIC_PROCESS,0.955704120940649
KEGG_MEDICUS_VARIANT_MUTATIO...70,SET,10,0.17914,0.0041774,0.26002,0.24543,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_AXIN_TO_WNT_SIGNALING_PATHWAY,0.955704120940649
GOBP_RESPONSE_TO_STEROID_HOR...,SET,310,0.034174,0.0044006,0.049621,0.24551,GOBP_RESPONSE_TO_STEROID_HORMONE,0.955704120940649
GOMF_CIS_TRANS_ISOMERASE_ACT...,SET,37,0.085405,0.0038281,0.12402,0.24552,GOMF_CIS_TRANS_ISOMERASE_ACTIVITY,0.955704120940649
LAKE_ADULT_KIDNEY_C23_ENDOTH...,SET,115,0.055862,0.004405,0.081116,0.24552,LAKE_ADULT_KIDNEY_C23_ENDOTHELIAL_CELLS_AVR,0.955704120940649
GOBP_REGULATION_OF_ODONTOBLA...,SET,10,0.21186,0.0049405,0.30769,0.24555,GOBP_REGULATION_OF_ODONTOBLAST_DIFFERENTIATION,0.955704120940649
GOBP_PROTEIN_DEUBIQUITINATIO...,SET,5,0.25677,0.0042345,0.37291,0.24556,GOBP_PROTEIN_DEUBIQUITINATION_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.955704120940649
GOBP_MATURE_B_CELL_DIFFERENT...2,SET,30,0.11274,0.004551,0.16376,0.2456,GOBP_MATURE_B_CELL_DIFFERENTIATION_INVOLVED_IN_IMMUNE_RESPONSE,0.955752771246221
DESCARTES_MAIN_FETAL_METANEP...,SET,25,0.13617,0.0050188,0.19785,0.24565,DESCARTES_MAIN_FETAL_METANEPHRIC_CELLS,0.955840321316614
HP_ABNORMAL_TONGUE_MORPHOLOGY,SET,333,0.031676,0.0042249,0.046034,0.2457,HP_ABNORMAL_TONGUE_MORPHOLOGY,0.95585975486904
REACTOME_REGULATION_OF_CYTOS...,SET,7,0.20273,0.0039557,0.29463,0.24571,REACTOME_REGULATION_OF_CYTOSKELETAL_REMODELING_AND_CELL_SPREADING_BY_IPP_COMPLEX_COMPONENTS,0.95585975486904
GOBP_NEGATIVE_REGULATION_OF_...217,SET,59,0.077774,0.0043995,0.11307,0.24579,GOBP_NEGATIVE_REGULATION_OF_ERK1_AND_ERK2_CASCADE,0.955995859444942
HP_PROGRESSIVE_GAIT_ATAXIA,SET,26,0.11306,0.0042495,0.16439,0.2458,HP_PROGRESSIVE_GAIT_ATAXIA,0.955995859444942
GOBP_COLLAGEN_ACTIVATED_SIGN...,SET,13,0.1755,0.0046659,0.25525,0.24586,GOBP_COLLAGEN_ACTIVATED_SIGNALING_PATHWAY,0.956122222222222
GOCC_MONOATOMIC_ION_CHANNEL_...,SET,319,0.035454,0.0046302,0.051578,0.24592,GOCC_MONOATOMIC_ION_CHANNEL_COMPLEX,0.956248556724099
HP_MUSCLE_FIBER_INCLUSION_BO...,SET,36,0.094784,0.0041908,0.13792,0.24598,HP_MUSCLE_FIBER_INCLUSION_BODIES,0.956374862960063
GOMF_ORGANIC_HYDROXY_COMPOUN...,SET,52,0.08828,0.0046891,0.12851,0.24606,GOMF_ORGANIC_HYDROXY_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.956403234636872
GOBP_NEGATIVE_REGULATION_OF_...273,SET,107,0.06114,0.0046514,0.089005,0.24607,GOBP_NEGATIVE_REGULATION_OF_HEMOPOIESIS,0.956403234636872
BLANCO_MELO_COVID19_SARS_COV...12,SET,139,0.052268,0.0045283,0.076095,0.24609,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_UP,0.956403234636872
TTGCCAA_MIR182,SET,298,0.035282,0.004456,0.051369,0.2461,TTGCCAA_MIR182,0.956403234636872
REACTOME_ACTIVATION_OF_ANTER...,SET,60,0.073527,0.0041942,0.10709,0.24617,REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS,0.956403234636872
WP_ALTERNATIVE_PATHWAY_OF_FE...,SET,11,0.17902,0.0043782,0.26072,0.24617,WP_ALTERNATIVE_PATHWAY_OF_FETAL_ANDROGEN_SYNTHESIS,0.956403234636872
MODULE_203,SET,3,0.34404,0.0043951,0.50109,0.24618,MODULE_203,0.956403234636872
GSE43955_1H_VS_42H_ACT_CD4_T...3,SET,182,0.042702,0.0042282,0.062203,0.24621,GSE43955_1H_VS_42H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.956403234636872
KEGG_VIBRIO_CHOLERAE_INFECTI...,SET,50,0.081732,0.0042572,0.11908,0.24624,KEGG_VIBRIO_CHOLERAE_INFECTION,0.956403234636872
BROWNE_HCMV_INFECTION_10HR_DN,SET,52,0.084339,0.0044798,0.1229,0.24628,BROWNE_HCMV_INFECTION_10HR_DN,0.956403234636872
HP_LEFT_BUNDLE_BRANCH_BLOCK,SET,18,0.14324,0.0044804,0.20874,0.24629,HP_LEFT_BUNDLE_BRANCH_BLOCK,0.956403234636872
GOBP_EXTRACELLULAR_MATRIX_CE...,SET,4,0.3319,0.0048958,0.48376,0.24634,GOBP_EXTRACELLULAR_MATRIX_CELL_SIGNALING,0.956430939904114
FULLER_PBMC_F_TULARENSIS_VAC...7,SET,42,0.093172,0.0044489,0.13582,0.24636,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_UP,0.956430939904114
GSE9650_EXHAUSTED_VS_MEMORY_...1,SET,187,0.041765,0.0041913,0.060888,0.24639,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_DN,0.956430939904114
PEREZ_TP63_TARGETS,SET,309,0.034773,0.0044707,0.050703,0.24642,PEREZ_TP63_TARGETS,0.956430939904114
GOCC_MITOCHONDRIAL_RESPIRATO...,SET,12,0.14397,0.0036775,0.20997,0.24647,GOCC_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_III,0.956430939904114
GSE15659_NAIVE_CD4_TCELL_VS_...2,SET,160,0.045421,0.0042194,0.066262,0.24653,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_UP,0.956430939904114
MIR485_5P,SET,127,0.050001,0.004142,0.072947,0.24654,MIR485_5P,0.956430939904114
GNF2_TAL1,SET,61,0.073982,0.0042551,0.10794,0.24655,GNF2_TAL1,0.956430939904114
HP_CHRONIC_LYMPHATIC_LEUKEMIA,SET,14,0.16046,0.004427,0.23413,0.24657,HP_CHRONIC_LYMPHATIC_LEUKEMIA,0.956430939904114
MIR4684_5P,SET,156,0.044941,0.0041228,0.06559,0.24662,MIR4684_5P,0.956430939904114
STEGMEIER_PREMITOTIC_CELL_CY...,SET,11,0.16891,0.0041311,0.24666,0.24674,STEGMEIER_PREMITOTIC_CELL_CYCLE_REGULATORS,0.956430939904114
GOBP_DNA_SYNTHESIS_INVOLVED_...,SET,38,0.078909,0.0035843,0.11523,0.24674,GOBP_DNA_SYNTHESIS_INVOLVED_IN_DNA_REPAIR,0.956430939904114
CHANDRAN_METASTASIS_UP,SET,176,0.043991,0.0042842,0.064241,0.24675,CHANDRAN_METASTASIS_UP,0.956430939904114
GOBP_DEFENSE_RESPONSE_TO_FUN...,SET,44,0.092868,0.0045385,0.13562,0.24676,GOBP_DEFENSE_RESPONSE_TO_FUNGUS,0.956430939904114
GOBP_RESPONSE_TO_L_PHENYLALA...,SET,5,0.29778,0.0049108,0.43487,0.24676,GOBP_RESPONSE_TO_L_PHENYLALANINE_DERIVATIVE,0.956430939904114
BANG_VERTEPORFIN_ENDOMETRIAL...2,SET,16,0.15795,0.0046583,0.23071,0.2468,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_UP,0.956430939904114
HP_DEVIATION_OF_THE_2ND_FING...,SET,19,0.13224,0.0042496,0.19316,0.2468,HP_DEVIATION_OF_THE_2ND_FINGER,0.956430939904114
HP_ABNORMALITY_OF_THE_PULMON...2,SET,185,0.042898,0.0042822,0.062663,0.24681,HP_ABNORMALITY_OF_THE_PULMONARY_VASCULATURE,0.956430939904114
GOBP_NEGATIVE_REGULATION_OF_...576,SET,72,0.06658,0.0041591,0.097262,0.24682,GOBP_NEGATIVE_REGULATION_OF_RNA_CATABOLIC_PROCESS,0.956430939904114
WP_BDNFTRKB_SIGNALING,SET,33,0.099377,0.0042072,0.14519,0.24685,WP_BDNFTRKB_SIGNALING,0.956440551839465
GOBP_POSITIVE_REGULATION_OF_...69,SET,74,0.065124,0.004124,0.095183,0.24693,GOBP_POSITIVE_REGULATION_OF_B_CELL_ACTIVATION,0.956614718011592
HP_SKELETAL_MUSCLE_ATROPHY,SET,497,0.025643,0.0041595,0.037484,0.24695,HP_SKELETAL_MUSCLE_ATROPHY,0.956614718011592
HP_CHRONIC_FATIGUE,SET,24,0.13034,0.0047069,0.19056,0.247,HP_CHRONIC_FATIGUE,0.956701771982615
GOBP_PROLINE_TRANSMEMBRANE_T...,SET,9,0.2171,0.004803,0.3175,0.24706,GOBP_PROLINE_TRANSMEMBRANE_TRANSPORT,0.956807937834225
DESCARTES_MAIN_FETAL_ERYTHRO...,SET,194,0.040901,0.0041799,0.059825,0.2471,DESCARTES_MAIN_FETAL_ERYTHROBLASTS,0.956807937834225
MIR7977,SET,207,0.040053,0.0042267,0.058589,0.24711,MIR7977,0.956807937834225
GSE20727_H2O2_VS_ROS_INHIBIT...2,SET,173,0.043474,0.0041979,0.063615,0.24719,GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP,0.956943194475384
HP_ELEVATED_CIRCULATING_LONG...,SET,3,0.27605,0.0035265,0.40396,0.2472,HP_ELEVATED_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,0.956943194475384
HP_ABNORMALITY_OF_SALIVATION,SET,178,0.044184,0.0043272,0.06468,0.24727,HP_ABNORMALITY_OF_SALIVATION,0.957020056780227
ZNF512_TARGET_GENES,SET,327,0.032105,0.0042441,0.047003,0.2473,ZNF512_TARGET_GENES,0.957020056780227
GOBP_TRANSLATIONAL_INITIATION,SET,106,0.05058,0.0038301,0.074056,0.24731,GOBP_TRANSLATIONAL_INITIATION,0.957020056780227
GOBP_REGULATION_OF_CALCINEUR...,SET,40,0.086852,0.0040474,0.12718,0.24733,GOBP_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,0.957020056780227
MORF_IL4,SET,162,0.046643,0.0043597,0.068329,0.24743,MORF_IL4,0.957057597330367
GOCC_LATE_ENDOSOME_LUMEN,SET,7,0.22826,0.0044539,0.33446,0.24747,GOCC_LATE_ENDOSOME_LUMEN,0.957057597330367
MIR4726_5P,SET,89,0.057127,0.0039657,0.083706,0.24748,MIR4726_5P,0.957057597330367
HP_GEOGRAPHIC_ATROPHY,SET,5,0.2531,0.0041741,0.37087,0.24748,HP_GEOGRAPHIC_ATROPHY,0.957057597330367
STEIN_ESRRA_TARGETS_UP,SET,345,0.030661,0.0041613,0.044933,0.2475,STEIN_ESRRA_TARGETS_UP,0.957057597330367
GOBP_RESPIRATORY_BURST_INVOL...1,SET,14,0.16588,0.0045764,0.2431,0.24752,GOBP_RESPIRATORY_BURST_INVOLVED_IN_DEFENSE_RESPONSE,0.957057597330367
GSE10325_LUPUS_CD4_TCELL_VS_...4,SET,172,0.044447,0.0042796,0.065148,0.24755,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_UP,0.957057597330367
MIR1178_5P,SET,32,0.10484,0.0043708,0.15368,0.24756,MIR1178_5P,0.957057597330367
GAVISH_3CA_METAPROGRAM_FIBRO...5,SET,43,0.077958,0.0037664,0.11433,0.24767,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_4,0.957131262480586
GSE18804_SPLEEN_MACROPHAGE_V...1,SET,170,0.043637,0.0041774,0.064,0.24767,GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_DN,0.957131262480586
MIR4697_3P,SET,99,0.056397,0.004128,0.08273,0.24772,MIR4697_3P,0.957131262480586
GNF2_BUB3,SET,26,0.10031,0.0037703,0.14715,0.24772,GNF2_BUB3,0.957131262480586
BERENJENO_TRANSFORMED_BY_RHO...2,SET,27,0.11417,0.0043725,0.16753,0.24779,BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN,0.957131262480586
GOBP_HISTAMINE_METABOLIC_PRO...,SET,6,0.28177,0.0050902,0.41351,0.24781,GOBP_HISTAMINE_METABOLIC_PROCESS,0.957131262480586
GOBP_TRACHEA_FORMATION,SET,7,0.2576,0.0050264,0.37813,0.24786,GOBP_TRACHEA_FORMATION,0.957131262480586
SIMBULAN_UV_RESPONSE_NORMAL_...2,SET,9,0.20207,0.0044704,0.29662,0.24787,SIMBULAN_UV_RESPONSE_NORMAL_UP,0.957131262480586
LEE_NAIVE_T_LYMPHOCYTE,SET,16,0.1566,0.0046184,0.22988,0.24788,LEE_NAIVE_T_LYMPHOCYTE,0.957131262480586
HP_CESSATION_OF_HEAD_GROWTH,SET,6,0.25058,0.0045269,0.36791,0.24791,HP_CESSATION_OF_HEAD_GROWTH,0.957131262480586
GAVISH_3CA_METAPROGRAM_B_CEL...7,SET,48,0.078088,0.0039854,0.11467,0.24795,GAVISH_3CA_METAPROGRAM_B_CELLS_METABOLISM_MYC,0.957131262480586
GOBP_REGULATION_OF_DNA_RECOM...,SET,112,0.049835,0.0038784,0.073181,0.24795,GOBP_REGULATION_OF_DNA_RECOMBINATION,0.957131262480586
GOCC_AMPA_GLUTAMATE_RECEPTOR...,SET,23,0.12798,0.0045247,0.18796,0.24797,GOCC_AMPA_GLUTAMATE_RECEPTOR_COMPLEX,0.957131262480586
GOMF_INOSITOL_POLYPHOSPHATE_...,SET,6,0.21639,0.0039092,0.31783,0.24799,GOMF_INOSITOL_POLYPHOSPHATE_5_PHOSPHATASE_ACTIVITY,0.957131262480586
GOBP_POSITIVE_REGULATION_OF_...650,SET,27,0.10544,0.0040384,0.15488,0.248,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,0.957131262480586
GOBP_INTRACELLULAR_CORTICOST...,SET,12,0.17236,0.0044027,0.25321,0.24804,GOBP_INTRACELLULAR_CORTICOSTEROID_RECEPTOR_SIGNALING_PATHWAY,0.957131262480586
GSE27786_NEUTROPHIL_VS_MONO_...2,SET,176,0.043098,0.0041973,0.063331,0.24809,GSE27786_NEUTROPHIL_VS_MONO_MAC_UP,0.957131262480586
HP_ATYPICAL_NEVI_IN_NON_SUN_...,SET,5,0.22486,0.0037083,0.33047,0.24812,HP_ATYPICAL_NEVI_IN_NON_SUN_EXPOSED_AREAS,0.957131262480586
BIOCARTA_IGF1MTOR_PATHWAY,SET,18,0.14715,0.0046028,0.21627,0.24813,BIOCARTA_IGF1MTOR_PATHWAY,0.957131262480586
GOCC_ENDOSOME_LUMEN,SET,37,0.098156,0.0043997,0.14431,0.24819,GOCC_ENDOSOME_LUMEN,0.957131262480586
ZSCAN30_TARGET_GENES,SET,1382,0.016291,0.004296,0.023952,0.24822,ZSCAN30_TARGET_GENES,0.957131262480586
IRF1_01,SET,225,0.039962,0.0043945,0.058758,0.24822,IRF1_01,0.957131262480586
GSE8868_SPLEEN_VS_INTESTINE_...2,SET,175,0.042255,0.0041035,0.06213,0.24823,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_UP,0.957131262480586
MIR6848_5P,SET,70,0.069335,0.0042708,0.10196,0.24824,MIR6848_5P,0.957131262480586
XU_CREBBP_TARGETS_UP,SET,20,0.12009,0.0039595,0.17668,0.24835,XU_CREBBP_TARGETS_UP,0.957449168053245
GOBP_MAINTENANCE_OF_CELL_NUM...,SET,170,0.043868,0.0041994,0.064555,0.2484,GOBP_MAINTENANCE_OF_CELL_NUMBER,0.957535714285714
REACTOME_ARMS_MEDIATED_ACTIV...,SET,7,0.22754,0.0044397,0.33509,0.24856,REACTOME_ARMS_MEDIATED_ACTIVATION,0.95804622379949
TRAVAGLINI_LUNG_PLASMACYTOID...,SET,101,0.060238,0.0044532,0.088726,0.2486,TRAVAGLINI_LUNG_PLASMACYTOID_DENDRITIC_CELL,0.958094145043247
PETRETTO_LEFT_VENTRICLE_MASS...1,SET,9,0.20292,0.0044894,0.29895,0.24864,PETRETTO_LEFT_VENTRICLE_MASS_QTL_CIS_DN,0.958102482544608
KEGG_MEDICUS_REFERENCE_KITLG...2,SET,14,0.15224,0.0042002,0.22434,0.2487,KEGG_MEDICUS_REFERENCE_KITLG_KIT_RAS_ERK_SIGNALING_PATHWAY,0.958102482544608
PID_BCR_5PATHWAY,SET,59,0.074583,0.004219,0.10991,0.2487,PID_BCR_5PATHWAY,0.958102482544608
GOMF_PROTEIN_FOLDING_CHAPERO...1,SET,62,0.069862,0.0040508,0.10296,0.24872,GOMF_PROTEIN_FOLDING_CHAPERONE,0.958102482544608
GSE13306_RA_VS_UNTREATED_TCO...2,SET,183,0.041166,0.0040873,0.060675,0.24874,GSE13306_RA_VS_UNTREATED_TCONV_UP,0.958102482544608
REACTOME_CLEC7A_INFLAMMASOME...,SET,5,0.26195,0.0043199,0.38653,0.24899,REACTOME_CLEC7A_INFLAMMASOME_PATHWAY,0.958710931800597
GOCC_MICROTUBULE_ORGANIZING_...1,SET,780,0.020136,0.0040591,0.029713,0.249,GOCC_MICROTUBULE_ORGANIZING_CENTER,0.958710931800597
GOBP_RADIAL_GLIA_GUIDED_PYRA...,SET,6,0.24334,0.0043959,0.35912,0.24902,GOBP_RADIAL_GLIA_GUIDED_PYRAMIDAL_NEURON_MIGRATION,0.958710931800597
GOBP_REGULATION_OF_SODIUM_IO...2,SET,42,0.097497,0.0046554,0.14393,0.24908,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.958710931800597
GOBP_NEGATIVE_REGULATION_OF_...15,SET,42,0.094242,0.0045,0.13913,0.2491,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_ACTIVATION,0.958710931800597
CRX_DN.V1_DN,SET,122,0.054804,0.0044502,0.080924,0.24914,CRX_DN.V1_DN,0.958710931800597
PCGF1_TARGET_GENES,SET,456,0.02738,0.0042589,0.040433,0.24915,PCGF1_TARGET_GENES,0.958710931800597
HP_DECREASED_URINARY_POTASSI...,SET,4,0.32346,0.0047714,0.47766,0.24915,HP_DECREASED_URINARY_POTASSIUM,0.958710931800597
REACTOME_NUCLEAR_ENVELOPE_NE...,SET,71,0.065357,0.0040543,0.096545,0.24922,REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY,0.958710931800597
WP_SMALL_CELL_LUNG_CANCER,SET,93,0.057963,0.0041127,0.08563,0.24924,WP_SMALL_CELL_LUNG_CANCER,0.958710931800597
GOBP_POSITIVE_REGULATION_OF_...671,SET,20,0.13616,0.0044892,0.20116,0.24925,GOBP_POSITIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.958710931800597
GOBP_NEGATIVE_REGULATION_OF_...430,SET,5,0.22437,0.0037002,0.33152,0.24927,GOBP_NEGATIVE_REGULATION_OF_MYOSIN_LIGHT_CHAIN_PHOSPHATASE_ACTIVITY,0.958710931800597
HP_ABNORMAL_AORTIC_VALVE_CUS...,SET,101,0.058817,0.0043482,0.08692,0.24931,HP_ABNORMAL_AORTIC_VALVE_CUSP_MORPHOLOGY,0.958710931800597
GOBP_NEGATIVE_REGULATION_OF_...651,SET,21,0.10558,0.003567,0.15604,0.24932,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.958710931800597
HP_VERTEBRAL_CLEFTING,SET,35,0.095706,0.0041725,0.14148,0.24938,HP_VERTEBRAL_CLEFTING,0.958710931800597
HP_ABNORMAL_CARDIAC_VENTRICU...,SET,142,0.048576,0.0042533,0.071815,0.24939,HP_ABNORMAL_CARDIAC_VENTRICULAR_FUNCTION,0.958710931800597
GOBP_DOUBLE_STRAND_BREAK_REP...8,SET,8,0.1432,0.002987,0.21171,0.2494,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SYNTHESIS_DEPENDENT_STRAND_ANNEALING,0.958710931800597
HP_PROMINENT_EYELASHES,SET,14,0.15381,0.0042435,0.22745,0.24945,HP_PROMINENT_EYELASHES,0.958710931800597
HOEK_NK_CELL_2011_2012_TIV_A...3,SET,13,0.17553,0.0046667,0.25957,0.24945,HOEK_NK_CELL_2011_2012_TIV_ADULT_7DY_UP,0.958710931800597
GOBP_PURINE_CONTAINING_COMPO...3,SET,14,0.16335,0.0045068,0.24166,0.24953,GOBP_PURINE_CONTAINING_COMPOUND_SALVAGE,0.958710931800597
GOMF_PHOSPHATIDYLINOSITOL_MO...,SET,11,0.16029,0.0039203,0.23713,0.24953,GOMF_PHOSPHATIDYLINOSITOL_MONOPHOSPHATE_PHOSPHATASE_ACTIVITY,0.958710931800597
GSE25088_CTRL_VS_IL4_STIM_ST...1,SET,155,0.045524,0.004163,0.067347,0.24954,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_DN,0.958710931800597
GOBP_REGULATION_OF_VASCULAR_...6,SET,9,0.18486,0.0040897,0.27349,0.24955,GOBP_REGULATION_OF_VASCULAR_WOUND_HEALING,0.958710931800597
DESCARTES_FETAL_SPLEEN_VASCU...,SET,41,0.098024,0.0046246,0.14503,0.24956,DESCARTES_FETAL_SPLEEN_VASCULAR_ENDOTHELIAL_CELLS,0.958710931800597
AAACCAC_MIR140,SET,98,0.058271,0.0042437,0.086241,0.24963,AAACCAC_MIR140,0.958856388490795
GSE17721_CTRL_VS_GARDIQUIMOD...1,SET,176,0.040942,0.0039872,0.06061,0.24969,GSE17721_CTRL_VS_GARDIQUIMOD_0.5H_BMDC_DN,0.958856388490795
GOBP_NEGATIVE_REGULATION_OF_...471,SET,5,0.28377,0.0046798,0.42016,0.24972,GOBP_NEGATIVE_REGULATION_OF_OSTEOCLAST_DEVELOPMENT,0.958856388490795
GOMF_FRUCTOSE_BINDING,SET,6,0.18117,0.0032728,0.26825,0.24972,GOMF_FRUCTOSE_BINDING,0.958856388490795
GOBP_CELL_MIGRATION_INVOLVED...3,SET,6,0.2845,0.0051396,0.42133,0.24976,GOBP_CELL_MIGRATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.958856388490795
GSE22601_DOUBLE_NEGATIVE_VS_...5,SET,184,0.039712,0.0039535,0.058827,0.24982,GSE22601_DOUBLE_NEGATIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,0.958856388490795
PID_ENDOTHELIN_PATHWAY,SET,62,0.076947,0.0044616,0.11399,0.24983,PID_ENDOTHELIN_PATHWAY,0.958856388490795
GSE41867_DAY8_EFFECTOR_VS_DA...2,SET,174,0.042372,0.0041032,0.062782,0.24987,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,0.958856388490795
GOBP_PIGMENT_ACCUMULATION,SET,11,0.17928,0.0043846,0.26565,0.24989,GOBP_PIGMENT_ACCUMULATION,0.958856388490795
STEARMAN_LUNG_CANCER_EARLY_V...1,SET,56,0.078051,0.0043018,0.11567,0.24991,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_DN,0.958856388490795
GSE17721_PAM3CSK4_VS_GADIQUI...3,SET,194,0.040415,0.0041302,0.059894,0.24991,GSE17721_PAM3CSK4_VS_GADIQUIMOD_12H_BMDC_DN,0.958856388490795
GOBP_OXALOACETATE_METABOLIC_...,SET,9,0.17153,0.0037949,0.2543,0.24999,GOBP_OXALOACETATE_METABOLIC_PROCESS,0.958856388490795
WP_MEVALONATE_PATHWAY,SET,7,0.17191,0.0033544,0.25489,0.25002,WP_MEVALONATE_PATHWAY,0.958856388490795
GOBP_FEMALE_MEIOTIC_NUCLEAR_...,SET,32,0.096013,0.0040028,0.14236,0.25002,GOBP_FEMALE_MEIOTIC_NUCLEAR_DIVISION,0.958856388490795
BIOCARTA_P53_PATHWAY,SET,16,0.14603,0.0043066,0.21655,0.25006,BIOCARTA_P53_PATHWAY,0.958856388490795
MOOTHA_GLYCOLYSIS,SET,17,0.11286,0.0034308,0.16739,0.25009,MOOTHA_GLYCOLYSIS,0.958856388490795
KEGG_MEDICUS_REFERENCE_RIG_I...2,SET,17,0.17297,0.005258,0.25659,0.25013,KEGG_MEDICUS_REFERENCE_RIG_I_NFKB_SIGNALING_PATHWAY,0.958856388490795
MODULE_345,SET,110,0.05531,0.0042661,0.082059,0.25015,MODULE_345,0.958856388490795
REACTOME_ZINC_TRANSPORTERS,SET,15,0.13737,0.0039227,0.20382,0.25017,REACTOME_ZINC_TRANSPORTERS,0.958856388490795
GOBP_POSITIVE_REGULATION_OF_...65,SET,32,0.10777,0.0044929,0.15994,0.25023,GOBP_POSITIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,0.958856388490795
MIR942_5P,SET,194,0.040522,0.0041412,0.060146,0.25025,MIR942_5P,0.958856388490795
HP_ABNORMAL_NASAL_SEPTUM_MOR...,SET,15,0.16148,0.0046113,0.2397,0.25026,HP_ABNORMAL_NASAL_SEPTUM_MORPHOLOGY,0.958856388490795
GSE28726_NAIVE_CD4_TCELL_VS_...1,SET,184,0.041819,0.0041632,0.062073,0.25026,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_NKTCELL_DN,0.958856388490795
GSE3982_EOSINOPHIL_VS_EFF_ME...1,SET,171,0.042734,0.0041028,0.063434,0.25026,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,0.958856388490795
KEGG_MEDICUS_REFERENCE_SEROT...,SET,3,0.33966,0.0043392,0.50425,0.25029,KEGG_MEDICUS_REFERENCE_SEROTONIN_METABOLISM,0.958865625
GOBP_EPIGENETIC_PROGRAMMING_...1,SET,12,0.16922,0.0043225,0.25125,0.25032,GOBP_EPIGENETIC_PROGRAMMING_IN_THE_ZYGOTIC_PRONUCLEI,0.958874859473162
WP_AFLATOXIN_B1_METABOLISM,SET,6,0.24439,0.0044149,0.36291,0.25035,WP_AFLATOXIN_B1_METABOLISM,0.958884091910954
GOMF_INTERMEDIATE_FILAMENT_B...,SET,10,0.17201,0.0040113,0.25556,0.25045,GOMF_INTERMEDIATE_FILAMENT_BINDING,0.958981246644475
PTEN_DN.V1_DN,SET,151,0.048865,0.004411,0.072618,0.25051,PTEN_DN.V1_DN,0.958981246644475
GOMF_AXON_GUIDANCE_RECEPTOR_...,SET,10,0.19508,0.0045492,0.28997,0.25055,GOMF_AXON_GUIDANCE_RECEPTOR_ACTIVITY,0.958981246644475
GOBP_AGGRESOME_ASSEMBLY,SET,4,0.26358,0.0038881,0.39184,0.25058,GOBP_AGGRESOME_ASSEMBLY,0.958981246644475
HP_PROXIMAL_TUBULOPATHY,SET,35,0.084177,0.0036699,0.12516,0.25061,HP_PROXIMAL_TUBULOPATHY,0.958981246644475
GOBP_INNER_CELL_MASS_CELL_DI...,SET,8,0.23811,0.0049667,0.35408,0.25064,GOBP_INNER_CELL_MASS_CELL_DIFFERENTIATION,0.958981246644475
GSE27786_CD8_TCELL_VS_NKTCEL...2,SET,176,0.041099,0.0040026,0.061129,0.25069,GSE27786_CD8_TCELL_VS_NKTCELL_UP,0.958981246644475
WP_KIT_RECEPTOR_SIGNALING,SET,56,0.080407,0.0044317,0.11965,0.25079,WP_KIT_RECEPTOR_SIGNALING,0.958981246644475
REACTOME_REGULATION_OF_MITF_...2,SET,17,0.12939,0.0039333,0.19256,0.25082,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_CELL_CYCLE_AND_PROLIFERATION,0.958981246644475
GOCC_IGG_IMMUNOGLOBULIN_COMP...,SET,2,0.47097,0.0049127,0.70105,0.25086,GOCC_IGG_IMMUNOGLOBULIN_COMPLEX,0.958981246644475
HP_DEEP_PALMAR_CREASE,SET,28,0.1025,0.0039977,0.1526,0.25089,HP_DEEP_PALMAR_CREASE,0.958981246644475
KEGG_MEDICUS_REFERENCE_CHOLE...,SET,11,0.15603,0.0038161,0.23234,0.25093,KEGG_MEDICUS_REFERENCE_CHOLESTEROL_BIOSYNTHESIS,0.958981246644475
KEGG_MEDICUS_REFERENCE_GF_RT...2,SET,89,0.065457,0.004544,0.097466,0.25093,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY,0.958981246644475
HP_NEONATAL_ONSET,SET,427,0.027162,0.0040917,0.040445,0.25093,HP_NEONATAL_ONSET,0.958981246644475
GOBP_GLYCOLIPID_TRANSPORT,SET,8,0.19342,0.0040344,0.28802,0.25094,GOBP_GLYCOLIPID_TRANSPORT,0.958981246644475
HP_ECTODERMAL_DYSPLASIA,SET,23,0.11883,0.0042011,0.17697,0.25096,HP_ECTODERMAL_DYSPLASIA,0.958981246644475
STAT5A_04,SET,188,0.042812,0.0043078,0.063822,0.25118,STAT5A_04,0.958981246644475
WP_17P133_YWHAE_COPY_NUMBER_...,SET,21,0.12286,0.0041506,0.18319,0.25122,WP_17P133_YWHAE_COPY_NUMBER_VARIATION,0.958981246644475
GOMF_PYRIMIDINE_NUCLEOTIDE_B...,SET,5,0.21551,0.0035541,0.3214,0.25126,GOMF_PYRIMIDINE_NUCLEOTIDE_BINDING,0.958981246644475
YANG_BREAST_CANCER_ESR1_BULK...1,SET,22,0.1257,0.0043463,0.18747,0.25128,YANG_BREAST_CANCER_ESR1_BULK_DN,0.958981246644475
GSE2706_LPS_VS_R848_AND_LPS_...3,SET,159,0.046888,0.0043422,0.069931,0.25128,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_DN,0.958981246644475
GOBP_CONNECTIVE_TISSUE_DEVEL...,SET,260,0.0366,0.0043223,0.054596,0.25131,GOBP_CONNECTIVE_TISSUE_DEVELOPMENT,0.958981246644475
HP_FETAL_PLEURAL_EFFUSION,SET,5,0.2502,0.0041262,0.37324,0.25132,HP_FETAL_PLEURAL_EFFUSION,0.958981246644475
MIR26A_5P,SET,455,0.027021,0.0041985,0.040312,0.25134,MIR26A_5P,0.958981246644475
BILD_E2F3_ONCOGENIC_SIGNATURE,SET,223,0.038125,0.004174,0.056881,0.25135,BILD_E2F3_ONCOGENIC_SIGNATURE,0.958981246644475
GSE3982_MAST_CELL_VS_DC_DN,SET,179,0.044182,0.004339,0.065916,0.25135,GSE3982_MAST_CELL_VS_DC_DN,0.958981246644475
HP_ABNORMALITY_OF_THE_EPIPHY...2,SET,6,0.24076,0.0043495,0.35925,0.25138,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_FEET,0.958981246644475
GOBP_REPLICATION_BORN_DOUBLE...,SET,6,0.20232,0.0036549,0.30192,0.2514,GOBP_REPLICATION_BORN_DOUBLE_STRAND_BREAK_REPAIR_VIA_SISTER_CHROMATID_EXCHANGE,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...315,SET,8,0.22748,0.004745,0.33957,0.25146,GOBP_POSITIVE_REGULATION_OF_GONAD_DEVELOPMENT,0.958981246644475
MORF_EPHA7,SET,125,0.051526,0.0042349,0.076936,0.25152,MORF_EPHA7,0.958981246644475
GSE3982_BASOPHIL_VS_TH2_UP,SET,172,0.043254,0.0041647,0.064583,0.25152,GSE3982_BASOPHIL_VS_TH2_UP,0.958981246644475
AACYNNNNTTCCS_UNKNOWN,SET,88,0.061955,0.0042768,0.092519,0.25155,AACYNNNNTTCCS_UNKNOWN,0.958981246644475
GOBP_ACTIN_MYOSIN_FILAMENT_S...,SET,15,0.14888,0.0042515,0.22239,0.25161,GOBP_ACTIN_MYOSIN_FILAMENT_SLIDING,0.958981246644475
GSE19888_ADENOSINE_A3R_INH_V...4,SET,184,0.043206,0.0043014,0.064545,0.25163,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_UP,0.958981246644475
GSE9316_CD4_TCELL_BALBC_VS_T...1,SET,180,0.043321,0.0042661,0.064718,0.25163,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_DN,0.958981246644475
LY_AGING_OLD_DN,SET,53,0.068142,0.0036539,0.10182,0.25167,LY_AGING_OLD_DN,0.958981246644475
MIR7161_5P,SET,177,0.044515,0.0043474,0.066524,0.2517,MIR7161_5P,0.958981246644475
HP_HYPOPLASIA_OF_OLFACTORY_T...,SET,8,0.14772,0.0030812,0.22077,0.25172,HP_HYPOPLASIA_OF_OLFACTORY_TRACT,0.958981246644475
MIR6074,SET,249,0.037313,0.0043136,0.055784,0.25179,MIR6074,0.958981246644475
HP_ABNORMAL_ARM_SPAN,SET,11,0.16265,0.0039781,0.24318,0.25179,HP_ABNORMAL_ARM_SPAN,0.958981246644475
HP_PECTUS_EXCAVATUM_OF_INFER...,SET,5,0.21557,0.0035551,0.32228,0.25179,HP_PECTUS_EXCAVATUM_OF_INFERIOR_STERNUM,0.958981246644475
GOBP_POST_GOLGI_VESICLE_MEDI...,SET,103,0.052651,0.0039305,0.078743,0.25187,GOBP_POST_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.958981246644475
CHESLER_BRAIN_D6MIT150_QTL_T...,SET,9,0.19813,0.0043834,0.29635,0.25189,CHESLER_BRAIN_D6MIT150_QTL_TRANS,0.958981246644475
GOCC_TRNA_SPLICING_LIGASE_CO...,SET,7,0.21378,0.0041713,0.31978,0.25191,GOCC_TRNA_SPLICING_LIGASE_COMPLEX,0.958981246644475
MIR663A,SET,17,0.14296,0.0043458,0.21387,0.25193,MIR663A,0.958981246644475
GOBP_IRIS_MORPHOGENESIS,SET,9,0.21453,0.0047461,0.32094,0.25193,GOBP_IRIS_MORPHOGENESIS,0.958981246644475
GOMF_G_PROTEIN_ALPHA_SUBUNIT...,SET,29,0.10848,0.0043058,0.16234,0.25199,GOMF_G_PROTEIN_ALPHA_SUBUNIT_BINDING,0.958981246644475
LEE_LIVER_CANCER_MYC_DN,SET,56,0.086642,0.0047753,0.1297,0.25206,LEE_LIVER_CANCER_MYC_DN,0.958981246644475
GSE24210_IL35_TREATED_VS_RES...1,SET,181,0.043894,0.0043344,0.065705,0.25206,GSE24210_IL35_TREATED_VS_RESTING_TREG_DN,0.958981246644475
GSE27786_CD4_TCELL_VS_NKCELL...1,SET,180,0.041465,0.0040834,0.062091,0.25213,GSE27786_CD4_TCELL_VS_NKCELL_DN,0.958981246644475
GOBP_REGULATION_OF_TRANSLATI...9,SET,7,0.20266,0.0039543,0.30348,0.25214,GOBP_REGULATION_OF_TRANSLATION_AT_SYNAPSE,0.958981246644475
WP_AFFECTED_PATHWAYS_IN_DUCH...,SET,67,0.07335,0.0044206,0.10986,0.25217,WP_AFFECTED_PATHWAYS_IN_DUCHENNE_MUSCULAR_DYSTROPHY,0.958981246644475
GERHOLD_ADIPOGENESIS_UP,SET,47,0.085969,0.0043418,0.12876,0.25219,GERHOLD_ADIPOGENESIS_UP,0.958981246644475
GSE11818_WT_VS_DICER_KO_TREG...2,SET,129,0.054012,0.0045092,0.0809,0.25219,GSE11818_WT_VS_DICER_KO_TREG_UP,0.958981246644475
HP_LEG_MUSCLE_STIFFNESS,SET,14,0.14129,0.0038981,0.21167,0.25223,HP_LEG_MUSCLE_STIFFNESS,0.958981246644475
GSE29164_DAY3_VS_DAY7_CD8_TC...2,SET,178,0.040696,0.0039856,0.060971,0.25224,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP,0.958981246644475
GOBP_REGULATION_OF_PROTEIN_T...1,SET,72,0.064254,0.0040138,0.096273,0.25226,GOBP_REGULATION_OF_PROTEIN_TARGETING,0.958981246644475
MARTIN_VIRAL_GPCR_SIGNALING_...1,SET,47,0.084424,0.0042638,0.12652,0.2523,MARTIN_VIRAL_GPCR_SIGNALING_DN,0.958981246644475
WP_TYPE_I_COLLAGEN_SYNTHESIS...,SET,31,0.10121,0.0041532,0.15169,0.25233,WP_TYPE_I_COLLAGEN_SYNTHESIS_IN_THE_CONTEXT_OF_OSTEOGENESIS_IMPERFECTA,0.958981246644475
KORKOLA_EMBRYONAL_CARCINOMA,SET,8,0.20361,0.0042472,0.30521,0.25235,KORKOLA_EMBRYONAL_CARCINOMA,0.958981246644475
GOBP_PHOSPHOLIPID_EFFLUX,SET,14,0.15481,0.0042711,0.23208,0.25237,GOBP_PHOSPHOLIPID_EFFLUX,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...185,SET,455,0.027472,0.0042686,0.041193,0.25242,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...812,SET,6,0.2666,0.0048161,0.39981,0.25245,GOBP_POSITIVE_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,0.958981246644475
GSE1740_UNSTIM_VS_IFNA_STIMU...1,SET,159,0.044855,0.004154,0.067267,0.25245,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_DN,0.958981246644475
HP_OPPORTUNISTIC_BACTERIAL_I...,SET,22,0.1269,0.004388,0.19035,0.25249,HP_OPPORTUNISTIC_BACTERIAL_INFECTION,0.958981246644475
MCCABE_BOUND_BY_HOXC6,SET,356,0.030437,0.0041949,0.045663,0.25253,MCCABE_BOUND_BY_HOXC6,0.958981246644475
HP_RESTLESSNESS,SET,128,0.050661,0.0042131,0.076014,0.25256,HP_RESTLESSNESS,0.958981246644475
GSE39022_LN_VS_SPLEEN_DC_UP,SET,181,0.041158,0.0040642,0.061771,0.25262,GSE39022_LN_VS_SPLEEN_DC_UP,0.958981246644475
MIR3199,SET,41,0.083428,0.003936,0.12522,0.25263,MIR3199,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...731,SET,49,0.081962,0.0042264,0.12305,0.25269,GOBP_POSITIVE_REGULATION_OF_STRESS_FIBER_ASSEMBLY,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...425,SET,19,0.12863,0.0041336,0.19317,0.25274,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_CHEMOTAXIS,0.958981246644475
WP_STING_PATHWAY_IN_KAWASAKI...,SET,18,0.13035,0.0040773,0.19578,0.25277,WP_STING_PATHWAY_IN_KAWASAKILIKE_DISEASE_AND_COVID19,0.958981246644475
GSE24210_TCONV_VS_TREG_DN,SET,176,0.041054,0.0039982,0.061665,0.25278,GSE24210_TCONV_VS_TREG_DN,0.958981246644475
HP_INCREASED_ARM_SPAN,SET,7,0.1879,0.0036663,0.28224,0.25279,HP_INCREASED_ARM_SPAN,0.958981246644475
PID_NFKAPPAB_CANONICAL_PATHW...,SET,21,0.12944,0.0043729,0.19444,0.2528,PID_NFKAPPAB_CANONICAL_PATHWAY,0.958981246644475
HOLLEMAN_VINCRISTINE_RESISTA...3,SET,16,0.13615,0.0040155,0.20456,0.25284,HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_DN,0.958981246644475
HP_HYPERMAGNESEMIA,SET,7,0.21932,0.0042795,0.32955,0.25286,HP_HYPERMAGNESEMIA,0.958981246644475
AP1_Q4,SET,251,0.036098,0.0041896,0.054254,0.25292,AP1_Q4,0.958981246644475
HP_PROGRESSIVE_PSYCHOMOTOR_D...,SET,12,0.15719,0.0040153,0.23634,0.253,HP_PROGRESSIVE_PSYCHOMOTOR_DETERIORATION,0.958981246644475
GYORFFY_DOXORUBICIN_RESISTAN...,SET,34,0.094988,0.0040817,0.14284,0.25304,GYORFFY_DOXORUBICIN_RESISTANCE,0.958981246644475
GOBP_AMINO_ACID_NEUROTRANSMI...,SET,10,0.20839,0.0048595,0.31343,0.25307,GOBP_AMINO_ACID_NEUROTRANSMITTER_REUPTAKE,0.958981246644475
HP_APLASIA_HYPOPLASIA_OF_FIN...,SET,314,0.031742,0.0041134,0.047743,0.25307,HP_APLASIA_HYPOPLASIA_OF_FINGERS,0.958981246644475
IKEDA_MIR1_TARGETS_UP,SET,53,0.076941,0.0041258,0.11574,0.25309,IKEDA_MIR1_TARGETS_UP,0.958981246644475
GSE46606_IRF4MID_VS_WT_CD40L...2,SET,171,0.041321,0.0039671,0.062153,0.25309,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,0.958981246644475
GOBP_ENDOTHELIAL_CELL_DEVELO...,SET,64,0.074749,0.0044033,0.11246,0.25313,GOBP_ENDOTHELIAL_CELL_DEVELOPMENT,0.958981246644475
GOMF_UBIQUITIN_CONJUGATING_E...,SET,28,0.10606,0.0041364,0.15956,0.25314,GOMF_UBIQUITIN_CONJUGATING_ENZYME_BINDING,0.958981246644475
HP_PATELLAR_SUBLUXATION,SET,5,0.29485,0.0048625,0.44368,0.25317,HP_PATELLAR_SUBLUXATION,0.958981246644475
KEGG_MEDICUS_REFERENCE_IGF_I...2,SET,15,0.14722,0.004204,0.22154,0.25318,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_RAS_ERK_SIGNALING_PATHWAY,0.958981246644475
GOCC_GOLGI_APPARATUS_SUBCOMP...,SET,330,0.03009,0.0039957,0.045284,0.25319,GOCC_GOLGI_APPARATUS_SUBCOMPARTMENT,0.958981246644475
MIR542_3P,SET,125,0.050892,0.0041827,0.07661,0.25326,MIR542_3P,0.958981246644475
GOBP_NEGATIVE_REGULATION_OF_...210,SET,46,0.091924,0.0045931,0.13841,0.25331,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.958981246644475
GOBP_MRNA_SPLICE_SITE_RECOGN...,SET,30,0.093619,0.0037793,0.14097,0.25332,GOBP_MRNA_SPLICE_SITE_RECOGNITION,0.958981246644475
GOBP_NEURONAL_DENSE_CORE_VES...,SET,7,0.23726,0.0046294,0.35727,0.25332,GOBP_NEURONAL_DENSE_CORE_VESICLE_EXOCYTOSIS,0.958981246644475
HP_EEG_WITH_IRREGULAR_GENERA...,SET,11,0.17735,0.0043374,0.26707,0.25334,HP_EEG_WITH_IRREGULAR_GENERALIZED_SPIKE_AND_WAVE_COMPLEXES,0.958981246644475
GOMF_G_QUADRUPLEX_DNA_BINDING,SET,11,0.16799,0.0041086,0.253,0.25335,GOMF_G_QUADRUPLEX_DNA_BINDING,0.958981246644475
GOBP_REGULATION_OF_ER_TO_GOL...,SET,10,0.16766,0.0039098,0.25252,0.25337,GOBP_REGULATION_OF_ER_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.958981246644475
MIR7159_5P,SET,323,0.032466,0.004266,0.048901,0.25338,MIR7159_5P,0.958981246644475
BOYAULT_LIVER_CANCER_SUBCLAS...14,SET,27,0.12406,0.0047515,0.18687,0.25339,BOYAULT_LIVER_CANCER_SUBCLASS_G5_DN,0.958981246644475
MIR6514_5P,SET,47,0.08832,0.0044606,0.13304,0.2534,MIR6514_5P,0.958981246644475
GOBP_CELLULAR_RESPONSE_TO_PE...2,SET,293,0.033338,0.0041757,0.050223,0.25341,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE_HORMONE_STIMULUS,0.958981246644475
HP_ABNORMALITY_OF_THE_TONGUE,SET,409,0.027599,0.0040711,0.041577,0.25341,HP_ABNORMALITY_OF_THE_TONGUE,0.958981246644475
MODULE_331,SET,69,0.064555,0.003948,0.097272,0.25346,MODULE_331,0.958981246644475
GSE21670_UNTREATED_VS_IL6_TR...1,SET,183,0.040143,0.0039856,0.060486,0.25346,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_DN,0.958981246644475
HOXA4_Q2,SET,244,0.037536,0.0042961,0.056565,0.25348,HOXA4_Q2,0.958981246644475
BLUM_RESPONSE_TO_SALIRASIB_DN,SET,308,0.031156,0.0039993,0.046959,0.25352,BLUM_RESPONSE_TO_SALIRASIB_DN,0.958981246644475
HP_FAILURE_TO_THRIVE_IN_INFA...,SET,108,0.053872,0.0041175,0.081206,0.25354,HP_FAILURE_TO_THRIVE_IN_INFANCY,0.958981246644475
METHYLCYTOSINE_DIOXYGENASE_T...,SET,117,0.048695,0.0038729,0.073409,0.25356,METHYLCYTOSINE_DIOXYGENASE_TET_UNIPROT_A0A023HHK9_UNREVIEWED_TARGET_GENES,0.958981246644475
GOMF_AMYLOID_BETA_BINDING,SET,81,0.067125,0.0044464,0.1012,0.25358,GOMF_AMYLOID_BETA_BINDING,0.958981246644475
HP_UPPER_LIMB_JOINT_CONTRACT...,SET,300,0.033097,0.0041938,0.049917,0.25366,HP_UPPER_LIMB_JOINT_CONTRACTURE,0.958981246644475
GOBP_GONADAL_MESODERM_DEVELO...,SET,2,0.42851,0.0044699,0.64631,0.25367,GOBP_GONADAL_MESODERM_DEVELOPMENT,0.958981246644475
GOCC_RADIAL_SPOKE_HEAD,SET,5,0.248,0.00409,0.37406,0.25367,GOCC_RADIAL_SPOKE_HEAD,0.958981246644475
GOCC_VACUOLAR_MEMBRANE,SET,438,0.026247,0.0040034,0.0396,0.25373,GOCC_VACUOLAR_MEMBRANE,0.958981246644475
WP_TYPE_2_PAPILLARY_RENAL_CE...,SET,31,0.10005,0.0041056,0.15099,0.25378,WP_TYPE_2_PAPILLARY_RENAL_CELL_CARCINOMA,0.958981246644475
GSE42021_TREG_PLN_VS_CD24INT...2,SET,183,0.042508,0.0042205,0.064149,0.25378,GSE42021_TREG_PLN_VS_CD24INT_TREG_THYMUS_UP,0.958981246644475
HE_LIM_SUN_FETAL_LUNG_C0_MID...2,SET,168,0.046501,0.0044255,0.070178,0.25379,HE_LIM_SUN_FETAL_LUNG_C0_MID_AIRWAY_SMC_2_CELL,0.958981246644475
RORA_TARGET_GENES,SET,214,0.037205,0.0039913,0.056156,0.25382,RORA_TARGET_GENES,0.958981246644475
MIR4633_3P_MIR6500_5P,SET,32,0.096174,0.0040095,0.14522,0.25391,MIR4633_3P_MIR6500_5P,0.958981246644475
GOMF_ORGANIC_CATION_TRANSMEM...,SET,75,0.068715,0.0043806,0.1038,0.25399,GOMF_ORGANIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.958981246644475
GOCC_CENTRAL_ELEMENT,SET,7,0.19417,0.0037886,0.29334,0.25402,GOCC_CENTRAL_ELEMENT,0.958981246644475
HP_ERLENMEYER_FLASK_DEFORMIT...,SET,8,0.21496,0.0044838,0.32477,0.25403,HP_ERLENMEYER_FLASK_DEFORMITY_OF_THE_FEMURS,0.958981246644475
HP_DEVIATION_OF_THE_4TH_FING...,SET,8,0.21743,0.0045354,0.32852,0.25404,HP_DEVIATION_OF_THE_4TH_FINGER,0.958981246644475
BROWNE_HCMV_INFECTION_48HR_DN,SET,425,0.02699,0.0040566,0.040797,0.25412,BROWNE_HCMV_INFECTION_48HR_DN,0.958981246644475
GOBP_ANTIVIRAL_INNATE_IMMUNE...,SET,49,0.076261,0.0039324,0.11529,0.25416,GOBP_ANTIVIRAL_INNATE_IMMUNE_RESPONSE,0.958981246644475
MIR200B_3P,SET,448,0.027784,0.0042846,0.042026,0.25427,MIR200B_3P,0.958981246644475
MIR200C_3P,SET,448,0.027784,0.0042846,0.042026,0.25427,MIR200C_3P,0.958981246644475
KEGG_HUNTINGTONS_DISEASE,SET,153,0.041134,0.0037374,0.062221,0.25428,KEGG_HUNTINGTONS_DISEASE,0.958981246644475
WP_TGIF_DISRUPTION_OF_SHH_SI...,SET,9,0.19344,0.0042795,0.29266,0.25432,WP_TGIF_DISRUPTION_OF_SHH_SIGNALING,0.958981246644475
HP_UPPER_LIMB_POSTURAL_TREMOR,SET,10,0.20033,0.0046715,0.30308,0.25432,HP_UPPER_LIMB_POSTURAL_TREMOR,0.958981246644475
KEGG_ALDOSTERONE_REGULATED_S...,SET,39,0.09817,0.0045174,0.14855,0.25435,KEGG_ALDOSTERONE_REGULATED_SODIUM_REABSORPTION,0.958981246644475
GOMF_U6_SNRNA_BINDING,SET,14,0.12721,0.0035097,0.19252,0.25438,GOMF_U6_SNRNA_BINDING,0.958981246644475
GOCC_PINOSOME,SET,7,0.22465,0.0043834,0.33998,0.25439,GOCC_PINOSOME,0.958981246644475
GOBP_COENZYME_A_BIOSYNTHETIC...,SET,10,0.15585,0.0036343,0.23594,0.25446,GOBP_COENZYME_A_BIOSYNTHETIC_PROCESS,0.958981246644475
GSE25088_WT_VS_STAT6_KO_MACR...7,SET,167,0.039368,0.0037356,0.0596,0.25446,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,0.958981246644475
REACTOME_RETROGRADE_NEUROTRO...,SET,14,0.14459,0.0039891,0.2189,0.25447,REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING,0.958981246644475
WP_MYD88_DISTINCT_INPUTOUTPU...,SET,15,0.16459,0.0047002,0.24919,0.25447,WP_MYD88_DISTINCT_INPUTOUTPUT_PATHWAY,0.958981246644475
MIR6501_5P,SET,65,0.071329,0.0042344,0.108,0.25448,MIR6501_5P,0.958981246644475
FARMER_BREAST_CANCER_BASAL_V...,SET,292,0.032832,0.0041053,0.049719,0.25452,FARMER_BREAST_CANCER_BASAL_VS_LULMINAL,0.958981246644475
YUAN_ZNF143_PARTNERS,SET,20,0.1207,0.0039795,0.18283,0.25457,YUAN_ZNF143_PARTNERS,0.958981246644475
GOBP_TRANSLESION_SYNTHESIS,SET,24,0.093214,0.0033662,0.14131,0.25474,GOBP_TRANSLESION_SYNTHESIS,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...40,SET,6,0.2516,0.0045452,0.3815,0.25479,GOBP_POSITIVE_REGULATION_OF_ARTERY_MORPHOGENESIS,0.958981246644475
GOBP_REGULATION_OF_ARTERY_MO...,SET,6,0.2516,0.0045452,0.3815,0.25479,GOBP_REGULATION_OF_ARTERY_MORPHOGENESIS,0.958981246644475
MIR10400_3P_MIR4674,SET,34,0.098343,0.0042259,0.14913,0.25481,MIR10400_3P_MIR4674,0.958981246644475
MIR3167,SET,96,0.058367,0.0042073,0.088508,0.25481,MIR3167,0.958981246644475
GOMF_THIOL_OXIDASE_ACTIVITY,SET,4,0.22332,0.0032942,0.33868,0.25483,GOMF_THIOL_OXIDASE_ACTIVITY,0.958981246644475
REACTOME_RESPIRATORY_ELECTRO...,SET,135,0.041392,0.0035344,0.062778,0.25485,REACTOME_RESPIRATORY_ELECTRON_TRANSPORT,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...224,SET,66,0.063241,0.003783,0.09594,0.2549,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,0.958981246644475
GSE28726_ACT_CD4_TCELL_VS_AC...4,SET,183,0.040091,0.0039805,0.06082,0.2549,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP,0.958981246644475
GOBP_POSITIVE_REGULATION_OF_...82,SET,56,0.076178,0.0041985,0.11559,0.25494,GOBP_POSITIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,0.958981246644475
GOMF_RNA_7_METHYLGUANOSINE_C...,SET,11,0.14202,0.0034733,0.2155,0.25495,GOMF_RNA_7_METHYLGUANOSINE_CAP_BINDING,0.958981246644475
GSE26928_EFF_MEM_VS_CENTR_ME...2,SET,165,0.043562,0.0041089,0.066105,0.25496,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_UP,0.958981246644475
HIF1_Q5,SET,227,0.037624,0.0041555,0.057099,0.25498,HIF1_Q5,0.958981246644475
HP_URINARY_URGENCY,SET,43,0.081532,0.003939,0.12375,0.255,HP_URINARY_URGENCY,0.958981246644475
GSE41867_LCMV_ARMSTRONG_VS_C...5,SET,178,0.040359,0.0039525,0.061256,0.255,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY8_EFFECTOR_CD8_TCELL_DN,0.958981246644475
HP_POLYCYSTIC_KIDNEY_DYSPLAS...,SET,48,0.08073,0.0041203,0.12254,0.25502,HP_POLYCYSTIC_KIDNEY_DYSPLASIA,0.958981246644475
GAVISH_3CA_METAPROGRAM_EPITH...8,SET,49,0.080683,0.0041605,0.12248,0.25503,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3,0.958981246644475
GOBP_ESTABLISHMENT_OR_MAINTE...1,SET,51,0.082076,0.0043175,0.12459,0.25503,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_BIPOLAR_CELL_POLARITY,0.958981246644475
GSE11924_TFH_VS_TH2_CD4_TCEL...1,SET,176,0.040798,0.0039732,0.061931,0.25503,GSE11924_TFH_VS_TH2_CD4_TCELL_DN,0.958981246644475
HP_ABNORMAL_EOSINOPHIL_MORPH...,SET,65,0.070155,0.0041647,0.1065,0.25504,HP_ABNORMAL_EOSINOPHIL_MORPHOLOGY,0.958981246644475
GOBP_IMMUNE_COMPLEX_CLEARANCE,SET,5,0.28645,0.004724,0.4349,0.25506,GOBP_IMMUNE_COMPLEX_CLEARANCE,0.958981246644475
WP_SOMITOGENESIS_IN_THE_CONT...,SET,9,0.18261,0.00404,0.27734,0.25514,WP_SOMITOGENESIS_IN_THE_CONTEXT_OF_SPONDYLOCOSTAL_DYSOSTOSIS,0.958981246644475
MODULE_6,SET,382,0.030525,0.0043547,0.046364,0.25516,MODULE_6,0.958981246644475
GOBP_RRNA_METHYLATION,SET,17,0.11029,0.0033526,0.16755,0.2552,GOBP_RRNA_METHYLATION,0.958981246644475
HP_SLENDER_FINGER,SET,130,0.048125,0.0040331,0.073122,0.25523,HP_SLENDER_FINGER,0.958981246644475
MIR4730,SET,6,0.24665,0.0044558,0.37485,0.25527,MIR4730,0.958981246644475
GOMF_POTASSIUM_PROTON_ANTIPO...,SET,12,0.16119,0.0041173,0.24495,0.25527,GOMF_POTASSIUM_PROTON_ANTIPORTER_ACTIVITY,0.958981246644475
KEGG_ANTIGEN_PROCESSING_AND_...,SET,72,0.075234,0.0046997,0.11434,0.25528,KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION,0.958981246644475
FAN_EMBRYONIC_CTX_IN_6_INTER...,SET,4,0.3158,0.0046583,0.47995,0.25528,FAN_EMBRYONIC_CTX_IN_6_INTERNEURON,0.958981246644475
OCT1_03,SET,206,0.039444,0.0041524,0.059948,0.25529,OCT1_03,0.958981246644475
GSE1925_CTRL_VS_IFNG_PRIMED_...2,SET,180,0.041068,0.0040443,0.062418,0.25529,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_UP,0.958981246644475
WP_MESODERMAL_COMMITMENT_PAT...,SET,132,0.050634,0.0042756,0.076993,0.25539,WP_MESODERMAL_COMMITMENT_PATHWAY,0.958981246644475
GAVISH_3CA_METAPROGRAM_MACRO...3,SET,45,0.087281,0.0043135,0.13273,0.2554,GAVISH_3CA_METAPROGRAM_MACROPHAGES_LIPID_ASSOCIATED,0.958981246644475
YAGI_AML_FAB_MARKERS,SET,179,0.042612,0.0041848,0.064801,0.25541,YAGI_AML_FAB_MARKERS,0.958981246644475
HP_SYNOSTOSIS_INVOLVING_BONE...2,SET,43,0.087491,0.0042269,0.13306,0.25543,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_HAND,0.958981246644475
HP_WIDE_NASAL_RIDGE,SET,8,0.15145,0.0031591,0.23034,0.25543,HP_WIDE_NASAL_RIDGE,0.958981246644475
HP_PARIETAL_BOSSING,SET,8,0.1659,0.0034605,0.25233,0.25544,HP_PARIETAL_BOSSING,0.958981246644475
GSE2770_TGFB_AND_IL4_VS_IL4_...1,SET,178,0.041913,0.0041047,0.063753,0.25546,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.958981246644475
DBP_TARGET_GENES,SET,1183,0.016477,0.0040436,0.025069,0.25551,DBP_TARGET_GENES,0.958981246644475
MODULE_165,SET,77,0.068066,0.0043965,0.10359,0.25557,MODULE_165,0.958981246644475
GOBP_CARDIAC_MUSCLE_CELL_CON...,SET,78,0.06695,0.0043522,0.10191,0.25562,GOBP_CARDIAC_MUSCLE_CELL_CONTRACTION,0.958981246644475
GSE38696_LIGHT_ZONE_VS_DARK_...2,SET,165,0.04062,0.0038314,0.061836,0.25563,GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,0.958981246644475
RAFFEL_VEGFA_TARGETS_DN,SET,5,0.25005,0.0041237,0.38067,0.25564,RAFFEL_VEGFA_TARGETS_DN,0.958981246644475
GOMF_ORGANIC_ACID_BINDING,SET,189,0.043183,0.0043565,0.06575,0.25567,GOMF_ORGANIC_ACID_BINDING,0.958981246644475
GSE22886_DAY0_VS_DAY7_MONOCY...1,SET,183,0.040673,0.0040383,0.06193,0.25567,GSE22886_DAY0_VS_DAY7_MONOCYTE_IN_CULTURE_DN,0.958981246644475
FIGUEROA_AML_METHYLATION_CLU...3,SET,8,0.20699,0.0043175,0.31518,0.25569,FIGUEROA_AML_METHYLATION_CLUSTER_2_DN,0.958981246644475
REACTOME_REGULATION_OF_INNAT...,SET,13,0.15568,0.0041391,0.23707,0.25569,REACTOME_REGULATION_OF_INNATE_IMMUNE_RESPONSES_TO_CYTOSOLIC_DNA,0.958981246644475
GOMF_OXIDOREDUCTASE_ACTIVITY...12,SET,4,0.32436,0.0047846,0.49396,0.25571,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_METAL_IONS_OXYGEN_AS_ACCEPTOR,0.958981246644475
ZBTB5_TARGET_GENES,SET,396,0.028513,0.0041401,0.043432,0.25575,ZBTB5_TARGET_GENES,0.958981246644475
GOCC_UNIPLEX_COMPLEX,SET,5,0.28777,0.0047458,0.43832,0.25575,GOCC_UNIPLEX_COMPLEX,0.958981246644475
GOBP_DEFENSE_RESPONSE,SET,1632,0.015048,0.0042805,0.022926,0.25579,GOBP_DEFENSE_RESPONSE,0.958981246644475
GSE17721_CTRL_VS_PAM3CSK4_1H...2,SET,178,0.03891,0.0038106,0.059288,0.25582,GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_UP,0.958981246644475
GSE11961_UNSTIM_VS_ANTI_IGM_...1,SET,177,0.041983,0.0041001,0.063978,0.25585,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_DN,0.958981246644475
MIR933,SET,6,0.25578,0.0046207,0.38981,0.25586,MIR933,0.958981246644475
GOCC_MISMATCH_REPAIR_COMPLEX,SET,7,0.16149,0.003151,0.2461,0.25586,GOCC_MISMATCH_REPAIR_COMPLEX,0.958981246644475
BCAT_GDS748_UP,SET,45,0.087971,0.0043476,0.13409,0.2559,BCAT_GDS748_UP,0.958981246644475
KEGG_VEGF_SIGNALING_PATHWAY,SET,76,0.063398,0.0040684,0.096668,0.25597,KEGG_VEGF_SIGNALING_PATHWAY,0.958981246644475
GOBP_NEGATIVE_REGULATION_OF_...518,SET,25,0.10051,0.0037045,0.15326,0.25598,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.958981246644475
HP_TENDON_XANTHOMATOSIS,SET,15,0.16441,0.004695,0.25086,0.25611,HP_TENDON_XANTHOMATOSIS,0.958981246644475
GOBP_REGULATION_OF_IRON_ION_...1,SET,3,0.28046,0.0035829,0.42801,0.25615,GOBP_REGULATION_OF_IRON_ION_TRANSMEMBRANE_TRANSPORT,0.958981246644475
WP_ENDODERM_DIFFERENTIATION,SET,130,0.05136,0.0043043,0.078389,0.25617,WP_ENDODERM_DIFFERENTIATION,0.958981246644475
RUVBL2_TARGET_GENES,SET,29,0.10066,0.0039954,0.15366,0.25621,RUVBL2_TARGET_GENES,0.958981246644475
HP_HYPOPLASIA_OF_THE_COCHLEA,SET,8,0.19593,0.0040868,0.29909,0.25621,HP_HYPOPLASIA_OF_THE_COCHLEA,0.958981246644475
RUBENSTEIN_SKELETAL_MUSCLE_S...1,SET,266,0.0336,0.0040129,0.051294,0.25622,RUBENSTEIN_SKELETAL_MUSCLE_SATELLITE_CELLS,0.958981246644475
WANG_LMO4_TARGETS_DN,SET,320,0.029363,0.0038406,0.044831,0.25625,WANG_LMO4_TARGETS_DN,0.958981246644475
ACCTGTTG_UNKNOWN,SET,144,0.04763,0.0041995,0.072722,0.25625,ACCTGTTG_UNKNOWN,0.958981246644475
GOBP_REGULATION_OF_HEART_MOR...,SET,8,0.24535,0.0051177,0.37459,0.25625,GOBP_REGULATION_OF_HEART_MORPHOGENESIS,0.958981246644475
MIR6790_5P,SET,46,0.088886,0.0044413,0.13572,0.25626,MIR6790_5P,0.958981246644475
GSE360_T_GONDII_VS_B_MALAYI_...1,SET,187,0.040476,0.004062,0.061805,0.25627,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.958981246644475
REACTOME_DEADENYLATION_DEPEN...,SET,49,0.07387,0.0038091,0.1128,0.25628,REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY,0.958981246644475
GOMF_MRNA_METHYLTRANSFERASE_...,SET,12,0.13638,0.0034836,0.20826,0.25629,GOMF_MRNA_METHYLTRANSFERASE_ACTIVITY,0.958981246644475
GOBP_APOPTOTIC_PROCESS,SET,1731,0.013965,0.0040791,0.021329,0.25632,GOBP_APOPTOTIC_PROCESS,0.958981246644475
GOBP_NEGATIVE_REGULATION_OF_...614,SET,7,0.23813,0.0046464,0.36377,0.25637,GOBP_NEGATIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.958981246644475
GSE22935_UNSTIM_VS_48H_MBOVI...1,SET,180,0.041094,0.0040468,0.062783,0.25639,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_DN,0.958981246644475
HP_ABNORMAL_VASCULAR_MORPHOL...,SET,1015,0.017784,0.0040622,0.027171,0.2564,HP_ABNORMAL_VASCULAR_MORPHOLOGY,0.958981246644475
HP_GENERALIZED_JOINT_HYPERMO...,SET,46,0.082592,0.0041268,0.12621,0.25643,HP_GENERALIZED_JOINT_HYPERMOBILITY,0.958981246644475
SA_FAS_SIGNALING,SET,9,0.18864,0.0041734,0.28827,0.25644,SA_FAS_SIGNALING,0.958981246644475
GOBP_ENDOPLASMIC_RETICULUM_C...,SET,23,0.11589,0.004097,0.1771,0.25644,GOBP_ENDOPLASMIC_RETICULUM_CALCIUM_ION_HOMEOSTASIS,0.958981246644475
HP_ABNORMAL_NASAL_BONE_MORPH...,SET,9,0.21529,0.004763,0.32909,0.25649,HP_ABNORMAL_NASAL_BONE_MORPHOLOGY,0.958981246644475
GSE3982_BASOPHIL_VS_TH1_DN,SET,175,0.040689,0.0039515,0.062203,0.25652,GSE3982_BASOPHIL_VS_TH1_DN,0.958981246644475
GOBP_PARAXIAL_MESODERM_DEVEL...,SET,17,0.13586,0.0041301,0.20774,0.25656,GOBP_PARAXIAL_MESODERM_DEVELOPMENT,0.958981246644475
HP_ABNORMALITY_OF_HAIR_GROWTH,SET,29,0.10054,0.0039904,0.15372,0.25656,HP_ABNORMALITY_OF_HAIR_GROWTH,0.958981246644475
SEIDEN_ONCOGENESIS_BY_MET,SET,79,0.06021,0.003939,0.092069,0.25657,SEIDEN_ONCOGENESIS_BY_MET,0.958981246644475
MIR617,SET,57,0.07081,0.0039373,0.10831,0.25664,MIR617,0.958981246644475
WP_MAPK_AND_NFKB_SIGNALING_I...,SET,11,0.16928,0.0041401,0.25895,0.25665,WP_MAPK_AND_NFKB_SIGNALING_INHIBITED_BY_YERSINIA_YOPJ,0.958981246644475
HP_DIAPHRAGMATIC_WEAKNESS,SET,16,0.14678,0.0043288,0.22456,0.25668,HP_DIAPHRAGMATIC_WEAKNESS,0.958981246644475
GOBP_LAMELLIPODIUM_ORGANIZAT...,SET,79,0.062791,0.0041078,0.096082,0.25672,GOBP_LAMELLIPODIUM_ORGANIZATION,0.958981246644475
MIZUSHIMA_AUTOPHAGOSOME_FORM...,SET,12,0.14411,0.0036812,0.22053,0.25673,MIZUSHIMA_AUTOPHAGOSOME_FORMATION,0.958981246644475
GSE22432_MULTIPOTENT_VS_COMM...2,SET,174,0.039821,0.0038562,0.060941,0.25675,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_DN,0.958981246644475
GOMF_GUANYLATE_CYCLASE_REGUL...,SET,7,0.24546,0.0047894,0.37568,0.25676,GOMF_GUANYLATE_CYCLASE_REGULATOR_ACTIVITY,0.958981246644475
GSE21927_SPLEEN_VS_BONE_MARR...2,SET,168,0.042492,0.004044,0.065035,0.25676,GSE21927_SPLEEN_VS_BONE_MARROW_MONOCYTE_BALBC_UP,0.958981246644475
GOBP_MEMBRANE_ORGANIZATION,SET,723,0.020631,0.0040106,0.031577,0.25677,GOBP_MEMBRANE_ORGANIZATION,0.958981246644475
HP_ACROMESOMELIA,SET,5,0.2124,0.0035028,0.3251,0.25678,HP_ACROMESOMELIA,0.958981246644475
GSE17721_LPS_VS_GARDIQUIMOD_...9,SET,176,0.040207,0.0039157,0.061557,0.25683,GSE17721_LPS_VS_GARDIQUIMOD_24H_BMDC_DN,0.958981246644475
HP_MOYAMOYA_PHENOMENON,SET,12,0.15106,0.0038587,0.23139,0.25693,HP_MOYAMOYA_PHENOMENON,0.958981246644475
CUI_DEVELOPING_HEART_C7_MAST...,SET,135,0.049512,0.0042278,0.075839,0.25693,CUI_DEVELOPING_HEART_C7_MAST_CELL,0.958981246644475
GOBP_TRANSPOSITION,SET,35,0.086948,0.0037907,0.13319,0.25694,GOBP_TRANSPOSITION,0.958981246644475
REACTOME_TOLL_LIKE_RECEPTOR_...2,SET,159,0.044453,0.0041167,0.068096,0.25695,REACTOME_TOLL_LIKE_RECEPTOR_CASCADES,0.958981246644475
WP_CHRONIC_HYPERGLYCEMIA_IMP...,SET,43,0.094821,0.0045811,0.14526,0.25696,WP_CHRONIC_HYPERGLYCEMIA_IMPAIRMENT_OF_NEURON_FUNCTION,0.958981246644475
REACTOME_LIPID_PARTICLE_ORGA...,SET,6,0.24457,0.0044182,0.37469,0.25697,REACTOME_LIPID_PARTICLE_ORGANIZATION,0.958981246644475
MORF_JAG1,SET,91,0.059254,0.0041591,0.09078,0.25697,MORF_JAG1,0.958981246644475
MORF_RPA2,SET,174,0.038893,0.0037664,0.059602,0.25703,MORF_RPA2,0.959102174146446
chr2p23,SET,84,0.11578,0.0078095,0.17749,0.2571,chr2p23,0.95926038647343
HP_SPRENGEL_ANOMALY,SET,43,0.079491,0.0038404,0.12188,0.25713,HP_SPRENGEL_ANOMALY,0.959269337698583
GOMF_FOUR_WAY_JUNCTION_DNA_B...,SET,16,0.12929,0.003813,0.19832,0.25723,GOMF_FOUR_WAY_JUNCTION_DNA_BINDING,0.959436429491307
HP_CONGENITAL_HYPOPLASTIC_AN...,SET,4,0.25385,0.0037446,0.38939,0.25723,HP_CONGENITAL_HYPOPLASTIC_ANEMIA,0.959436429491307
GOBP_ATRIAL_CARDIAC_MUSCLE_C...1,SET,8,0.21387,0.0044611,0.32828,0.25737,GOBP_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.959772977294532
GATA1_04,SET,222,0.038775,0.0042357,0.059531,0.25742,GATA1_04,0.959772977294532
GOMF_ALPHA_N_ACETYLGALACTOSA...,SET,6,0.26201,0.0047332,0.40232,0.25745,GOMF_ALPHA_N_ACETYLGALACTOSAMINIDE_ALPHA_2_6_SIALYLTRANSFERASE_ACTIVITY,0.959772977294532
MIR345_5P,SET,40,0.089352,0.0041639,0.13721,0.25746,MIR345_5P,0.959772977294532
HP_IMPAIRED_PAIN_SENSATION,SET,65,0.067966,0.0040347,0.10437,0.25746,HP_IMPAIRED_PAIN_SENSATION,0.959772977294532
GOBP_IMMUNOGLOBULIN_PRODUCTI...1,SET,91,0.054521,0.0038269,0.083768,0.25758,GOBP_IMMUNOGLOBULIN_PRODUCTION,0.959772977294532
GOCC_TRANSPORTER_COMPLEX,SET,428,0.02763,0.004167,0.042458,0.2576,GOCC_TRANSPORTER_COMPLEX,0.959772977294532
HP_DEVIATION_OF_THE_HALLUX,SET,75,0.067073,0.0042759,0.10309,0.25764,HP_DEVIATION_OF_THE_HALLUX,0.959772977294532
GSE22611_NOD2_TRANSDUCED_VS_...1,SET,173,0.038857,0.0037521,0.05973,0.25767,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_DN,0.959772977294532
BIOCARTA_PRC2_PATHWAY,SET,12,0.17712,0.0045242,0.27229,0.2577,BIOCARTA_PRC2_PATHWAY,0.959772977294532
HP_PROLONGED_BLEEDING_TIME,SET,46,0.080147,0.0040046,0.12323,0.25773,HP_PROLONGED_BLEEDING_TIME,0.959772977294532
GOBP_REGULATION_OF_SKELETAL_...5,SET,16,0.13213,0.0038969,0.20322,0.25778,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION,0.959772977294532
KEGG_MEDICUS_REFERENCE_EARLY...,SET,8,0.17504,0.0036511,0.26925,0.25782,KEGG_MEDICUS_REFERENCE_EARLY_ENDOSOMAL_FUSION,0.959772977294532
HP_POLYNEUROPATHY,SET,45,0.081074,0.0040068,0.12473,0.25786,HP_POLYNEUROPATHY,0.959772977294532
GSE43863_TFH_VS_LY6C_INT_CXC...2,SET,183,0.039802,0.0039518,0.061241,0.25787,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_EFFECTOR_CD4_TCELL_UP,0.959772977294532
GOBP_CALCIUM_MEDIATED_SIGNAL...,SET,214,0.039323,0.0042184,0.060504,0.25788,GOBP_CALCIUM_MEDIATED_SIGNALING,0.959772977294532
STAT5A_01,SET,227,0.037673,0.0041608,0.05797,0.25789,STAT5A_01,0.959772977294532
HP_SPOTTY_HYPOPIGMENTATION,SET,7,0.21232,0.0041427,0.32672,0.2579,HP_SPOTTY_HYPOPIGMENTATION,0.959772977294532
HEBERT_MATRISOME_TNBC_LIVER_...,SET,13,0.16392,0.0043581,0.25239,0.25802,HEBERT_MATRISOME_TNBC_LIVER_METASTASIS,0.959772977294532
GSE17974_0H_VS_48H_IN_VITRO_...2,SET,164,0.044251,0.0041614,0.068177,0.25815,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP,0.959772977294532
GSE15659_NAIVE_CD4_TCELL_VS_...1,SET,168,0.042065,0.0040033,0.064815,0.25817,GSE15659_NAIVE_CD4_TCELL_VS_ACTIVATED_TREG_DN,0.959772977294532
GSE19888_CTRL_VS_A3R_INHIBIT...2,SET,179,0.038235,0.0037549,0.058916,0.25818,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_UP,0.959772977294532
HP_PYODERMA_GANGRENOSUM,SET,11,0.16501,0.0040358,0.25438,0.25827,HP_PYODERMA_GANGRENOSUM,0.959772977294532
GOBP_PROTEIN_O_LINKED_GLYCOS...1,SET,87,0.059719,0.004099,0.092072,0.2583,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION,0.959772977294532
MIR643,SET,58,0.071165,0.0039915,0.10973,0.25832,MIR643,0.959772977294532
GOBP_NUCLEOTIDE_SUGAR_BIOSYN...,SET,16,0.13027,0.0038421,0.20087,0.25832,GOBP_NUCLEOTIDE_SUGAR_BIOSYNTHETIC_PROCESS,0.959772977294532
GSE13485_DAY3_VS_DAY7_YF17D_...2,SET,151,0.043082,0.003889,0.066433,0.25833,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_UP,0.959772977294532
MIR4436B_3P,SET,97,0.055365,0.0040115,0.085387,0.25837,MIR4436B_3P,0.959772977294532
HP_PROGRESSIVE_LEUKOENCEPHAL...,SET,4,0.26752,0.0039462,0.41268,0.25842,HP_PROGRESSIVE_LEUKOENCEPHALOPATHY,0.959772977294532
GSE1740_MCSF_VS_MCSF_AND_IFN...2,SET,161,0.043562,0.0040593,0.067204,0.25843,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_UP,0.959772977294532
GOBP_FUNGIFORM_PAPILLA_DEVEL...,SET,5,0.25509,0.0042069,0.39357,0.25845,GOBP_FUNGIFORM_PAPILLA_DEVELOPMENT,0.959772977294532
GOBP_SKELETAL_MUSCLE_SATELLI...2,SET,11,0.15861,0.0038791,0.24472,0.25845,GOBP_SKELETAL_MUSCLE_SATELLITE_CELL_DIFFERENTIATION,0.959772977294532
KEGG_MEDICUS_REFERENCE_RAB7_...,SET,40,0.087346,0.0040704,0.13477,0.25846,KEGG_MEDICUS_REFERENCE_RAB7_REGULATED_MICROTUBULE_MINUS_END_DIRECTED_TRANSPORT,0.959772977294532
GOBP_POSITIVE_REGULATION_OF_...512,SET,13,0.16086,0.0042767,0.24822,0.25847,GOBP_POSITIVE_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.959772977294532
GOMF_CARBON_SULFUR_LYASE_ACT...,SET,10,0.18145,0.0042314,0.27999,0.25847,GOMF_CARBON_SULFUR_LYASE_ACTIVITY,0.959772977294532
TRAVAGLINI_LUNG_ALVEOLAR_FIB...,SET,149,0.047765,0.0042833,0.073712,0.2585,TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL,0.959772977294532
HP_IVORY_EPIPHYSES_OF_THE_PH...,SET,6,0.23747,0.0042899,0.3665,0.25852,HP_IVORY_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,0.959772977294532
GOMF_VITAMIN_B6_BINDING,SET,48,0.08209,0.0041897,0.12671,0.25855,GOMF_VITAMIN_B6_BINDING,0.959772977294532
GOBP_POSITIVE_REGULATION_OF_...28,SET,24,0.11423,0.004125,0.17633,0.25856,GOBP_POSITIVE_REGULATION_OF_AMYLOID_PRECURSOR_PROTEIN_CATABOLIC_PROCESS,0.959772977294532
GOBP_REGULATION_OF_CORE_PROM...,SET,5,0.24148,0.0039824,0.37281,0.25858,GOBP_REGULATION_OF_CORE_PROMOTER_BINDING,0.959772977294532
GOMF_PROTEIN_RNA_ADAPTOR_ACT...,SET,18,0.12785,0.0039992,0.19739,0.25858,GOMF_PROTEIN_RNA_ADAPTOR_ACTIVITY,0.959772977294532
GOBP_AMYLOID_BETA_METABOLIC_...,SET,52,0.07472,0.0039688,0.11536,0.25859,GOBP_AMYLOID_BETA_METABOLIC_PROCESS,0.959772977294532
HP_FOLLICULITIS,SET,7,0.25304,0.0049373,0.39067,0.25859,HP_FOLLICULITIS,0.959772977294532
GOCC_I_BAND,SET,137,0.048007,0.0041293,0.074123,0.2586,GOCC_I_BAND,0.959772977294532
DCA_UP.V1_DN,SET,165,0.04136,0.0039013,0.063863,0.25861,DCA_UP.V1_DN,0.959772977294532
MATZUK_MEIOTIC_AND_DNA_REPAIR,SET,35,0.078383,0.0034173,0.12104,0.25863,MATZUK_MEIOTIC_AND_DNA_REPAIR,0.959772977294532
GOMF_SINGLE_STRANDED_DNA_EXO...,SET,10,0.14974,0.0034918,0.23123,0.25863,GOMF_SINGLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,0.959772977294532
GSE3982_DC_VS_CENT_MEMORY_CD...1,SET,165,0.04262,0.0040201,0.065824,0.25867,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_DN,0.959772977294532
GSE43955_1H_VS_10H_ACT_CD4_T...1,SET,186,0.039579,0.0039615,0.061135,0.25869,GSE43955_1H_VS_10H_ACT_CD4_TCELL_DN,0.959772977294532
GNF2_CDH11,SET,24,0.13135,0.0047434,0.20291,0.25871,GNF2_CDH11,0.959772977294532
HP_LACRIMAL_DUCT_STENOSIS,SET,13,0.14867,0.0039525,0.22973,0.25878,HP_LACRIMAL_DUCT_STENOSIS,0.959772977294532
REACTOME_ONCOGENE_INDUCED_SE...,SET,32,0.10142,0.0042282,0.15674,0.25881,REACTOME_ONCOGENE_INDUCED_SENESCENCE,0.959772977294532
GOBP_POSITIVE_REGULATION_OF_...393,SET,15,0.1527,0.0043607,0.23604,0.25884,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,0.959772977294532
ZHOU_INFLAMMATORY_RESPONSE_L...3,SET,337,0.031358,0.0042072,0.048501,0.25896,ZHOU_INFLAMMATORY_RESPONSE_LPS_UP,0.959772977294532
KEGG_PEROXISOME,SET,74,0.061971,0.0039244,0.095844,0.25896,KEGG_PEROXISOME,0.959772977294532
GOBP_CELLULAR_RESPONSE_TO_RE...1,SET,14,0.15224,0.0042002,0.23546,0.25896,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_NITROGEN_SPECIES,0.959772977294532
GOBP_RIBOFLAVIN_TRANSPORT,SET,6,0.23991,0.004334,0.37106,0.25897,GOBP_RIBOFLAVIN_TRANSPORT,0.959772977294532
GOMF_RIBOFLAVIN_TRANSMEMBRAN...,SET,6,0.23991,0.004334,0.37106,0.25897,GOMF_RIBOFLAVIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.959772977294532
GOBP_EPITHELIAL_CELL_MORPHOG...,SET,30,0.10684,0.0043129,0.16525,0.25898,GOBP_EPITHELIAL_CELL_MORPHOGENESIS,0.959772977294532
GACAATC_MIR219,SET,134,0.048043,0.0040873,0.074327,0.25902,GACAATC_MIR219,0.959772977294532
GOTZMANN_EPITHELIAL_TO_MESEN...1,SET,192,0.039451,0.0040111,0.061036,0.25903,GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,0.959772977294532
MIR6079,SET,135,0.046959,0.0040098,0.072659,0.25905,MIR6079,0.959772977294532
GOBP_REGULATION_OF_OOCYTE_MA...,SET,7,0.19198,0.0037459,0.29705,0.25906,GOBP_REGULATION_OF_OOCYTE_MATURATION,0.959772977294532
GSE13306_LAMINA_PROPRIA_VS_S...1,SET,186,0.04111,0.0041147,0.063633,0.25913,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_DN,0.959880610288636
HALLMARK_MYC_TARGETS_V1,SET,182,0.036554,0.0036195,0.056588,0.25916,HALLMARK_MYC_TARGETS_V1,0.959880610288636
HP_JAW_HYPERREFLEXIA,SET,39,0.082137,0.0037796,0.12722,0.25927,HP_JAW_HYPERREFLEXIA,0.959880610288636
IWANAGA_CARCINOGENESIS_BY_KR...1,SET,115,0.051197,0.0040371,0.079308,0.25929,IWANAGA_CARCINOGENESIS_BY_KRAS_DN,0.959880610288636
EMX1_TARGET_GENES,SET,183,0.04037,0.0040082,0.062538,0.2593,EMX1_TARGET_GENES,0.959880610288636
SPIELMAN_LYMPHOBLAST_EUROPEA...2,SET,12,0.15023,0.0038375,0.23274,0.25931,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_UP,0.959880610288636
GOBP_VIRAL_RNA_GENOME_REPLIC...,SET,24,0.1262,0.0045573,0.19551,0.25931,GOBP_VIRAL_RNA_GENOME_REPLICATION,0.959880610288636
HP_ABNORMAL_THALAMUS_MORPHOL...,SET,53,0.069011,0.0037006,0.10691,0.25931,HP_ABNORMAL_THALAMUS_MORPHOLOGY,0.959880610288636
REACTOME_TRAFFICKING_OF_MYRI...,SET,4,0.25266,0.0037271,0.39193,0.25958,REACTOME_TRAFFICKING_OF_MYRISTOYLATED_PROTEINS_TO_THE_CILIUM,0.960229842043889
ZNF426_TARGET_GENES,SET,121,0.046851,0.0037889,0.072688,0.25961,ZNF426_TARGET_GENES,0.960229842043889
HP_ABNORMALITY_OF_UPPER_LIMB...,SET,489,0.024988,0.0040213,0.038768,0.25962,HP_ABNORMALITY_OF_UPPER_LIMB_JOINT,0.960229842043889
GOMF_ATP_DEPENDENT_DNA_DNA_A...,SET,4,0.25848,0.0038128,0.40105,0.25963,GOMF_ATP_DEPENDENT_DNA_DNA_ANNEALING_ACTIVITY,0.960229842043889
NOUSHMEHR_GBM_SILENCED_BY_ME...,SET,45,0.084079,0.0041553,0.13046,0.25964,NOUSHMEHR_GBM_SILENCED_BY_METHYLATION,0.960229842043889
HP_ABNORMAL_SACROILIAC_JOINT...,SET,6,0.26685,0.0048207,0.41407,0.25965,HP_ABNORMAL_SACROILIAC_JOINT_MORPHOLOGY,0.960229842043889
HP_HYPERKINETIC_MOVEMENTS,SET,35,0.093207,0.0040636,0.14463,0.25965,HP_HYPERKINETIC_MOVEMENTS,0.960229842043889
GOMF_FERROUS_IRON_BINDING,SET,23,0.10645,0.0037633,0.1652,0.25967,GOMF_FERROUS_IRON_BINDING,0.960229842043889
PID_IL2_PI3K_PATHWAY,SET,33,0.092785,0.0039281,0.14404,0.25974,PID_IL2_PI3K_PATHWAY,0.960229842043889
HP_GENERALIZED_HYPOPIGMENTAT...2,SET,45,0.082616,0.004083,0.12826,0.25975,HP_GENERALIZED_HYPOPIGMENTATION_OF_HAIR,0.960229842043889
MIR4691_3P,SET,90,0.057709,0.0040284,0.089609,0.25979,MIR4691_3P,0.960229842043889
GOBP_REGULATION_OF_INTEGRIN_...1,SET,17,0.13704,0.0041659,0.2128,0.2598,GOBP_REGULATION_OF_INTEGRIN_ACTIVATION,0.960229842043889
chr18q22,SET,23,0.19029,0.0067272,0.29552,0.25983,chr18q22,0.960229842043889
SMID_BREAST_CANCER_RELAPSE_I...6,SET,6,0.2376,0.0042923,0.36909,0.25987,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_UP,0.960229842043889
GOMF_HISTONE_H3K9_METHYLTRAN...,SET,12,0.15413,0.0039371,0.23943,0.25987,GOMF_HISTONE_H3K9_METHYLTRANSFERASE_ACTIVITY,0.960229842043889
XU_HGF_SIGNALING_NOT_VIA_AKT...3,SET,23,0.12158,0.0042983,0.18887,0.25988,XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR,0.960229842043889
GSE28737_WT_VS_BCL6_HET_MARG...2,SET,173,0.041181,0.0039766,0.063971,0.25988,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_UP,0.960229842043889
GSE40274_FOXP3_VS_FOXP3_AND_...3,SET,183,0.038543,0.0038268,0.059898,0.25996,GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.960229842043889
GOBP_ADIPOSE_TISSUE_DEVELOPM...,SET,55,0.073524,0.0040161,0.11427,0.25998,GOBP_ADIPOSE_TISSUE_DEVELOPMENT,0.960229842043889
GOBP_SYNOVIOCYTE_PROLIFERATI...,SET,2,0.36289,0.0037853,0.56412,0.26002,GOBP_SYNOVIOCYTE_PROLIFERATION,0.960229842043889
CAO_BLOOD_FLUZONE_AGE_05_14Y...2,SET,5,0.24815,0.0040925,0.38581,0.26005,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_UP,0.960229842043889
HP_ABNORMALITY_OF_BLOOD_AND_...,SET,1319,0.015394,0.0039732,0.023935,0.26007,HP_ABNORMALITY_OF_BLOOD_AND_BLOOD_FORMING_TISSUES,0.960229842043889
KEGG_NON_HOMOLOGOUS_END_JOIN...,SET,12,0.13142,0.003357,0.20438,0.26011,KEGG_NON_HOMOLOGOUS_END_JOINING,0.960229842043889
GOBP_ZINC_ION_TRANSPORT,SET,29,0.094338,0.0037444,0.14671,0.26011,GOBP_ZINC_ION_TRANSPORT,0.960229842043889
GOCC_ACTIN_FILAMENT_BUNDLE,SET,85,0.060586,0.0041107,0.09426,0.26019,GOCC_ACTIN_FILAMENT_BUNDLE,0.960229842043889
HP_MORNING_GLORY_ANOMALY,SET,6,0.2517,0.004547,0.39159,0.26019,HP_MORNING_GLORY_ANOMALY,0.960229842043889
GOCC_BOX_C_D_RNP_COMPLEX,SET,4,0.23714,0.003498,0.36894,0.2602,GOCC_BOX_C_D_RNP_COMPLEX,0.960229842043889
STOSSI_RESPONSE_TO_ESTRADIOL,SET,37,0.096351,0.0043187,0.14992,0.26022,STOSSI_RESPONSE_TO_ESTRADIOL,0.960229842043889
chr17q22,SET,42,0.14273,0.0068151,0.22213,0.26026,chr17q22,0.960229842043889
WP_MITOCHONDRIAL_FATTY_ACID_...3,SET,5,0.22447,0.0037019,0.34942,0.2603,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_PATHWAY,0.960229842043889
GSE45365_NK_CELL_VS_CD11B_DC...3,SET,186,0.039479,0.0039514,0.061488,0.26042,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_UP,0.960229842043889
HP_TRUE_HERMAPHRODITISM,SET,20,0.10807,0.0035629,0.16832,0.26043,HP_TRUE_HERMAPHRODITISM,0.960229842043889
GOCC_MRE11_COMPLEX,SET,3,0.27853,0.0035582,0.43388,0.26046,GOCC_MRE11_COMPLEX,0.960229842043889
GSE14415_INDUCED_TREG_VS_FOX...4,SET,149,0.043443,0.0038957,0.067676,0.26046,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_UP,0.960229842043889
GSE19401_RETINOIC_ACID_VS_RE...2,SET,177,0.042314,0.0041324,0.065914,0.26046,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,0.960229842043889
TEAD2_TARGET_GENES,SET,1172,0.016389,0.0040044,0.025532,0.26048,TEAD2_TARGET_GENES,0.960229842043889
SANA_RESPONSE_TO_IFNG_UP,SET,68,0.06638,0.0040302,0.10343,0.2605,SANA_RESPONSE_TO_IFNG_UP,0.960229842043889
GOBP_NEGATIVE_REGULATION_OF_...99,SET,4,0.28991,0.0042764,0.45176,0.26053,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.960229842043889
GOBP_SECRETION_BY_TISSUE,SET,46,0.085422,0.0042682,0.13312,0.26054,GOBP_SECRETION_BY_TISSUE,0.960229842043889
LAKE_ADULT_KIDNEY_C1_EPITHEL...,SET,27,0.10661,0.0040833,0.16614,0.26054,LAKE_ADULT_KIDNEY_C1_EPITHELIAL_CELLS_UNASSIGNED,0.960229842043889
GSE15930_NAIVE_VS_72H_IN_VIT...1,SET,182,0.038804,0.0038423,0.060483,0.26058,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_DN,0.960229842043889
GSE4748_CYANOBACTERIUM_LPSLI...2,SET,166,0.043465,0.0041121,0.067753,0.2606,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,0.960229842043889
MIKKELSEN_MEF_HCP_WITH_H3_UN...,SET,185,0.04153,0.0041457,0.064742,0.26061,MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED,0.960229842043889
HP_PAPILLARY_CYSTADENOMA_OF_...,SET,5,0.25957,0.0042808,0.40466,0.26062,HP_PAPILLARY_CYSTADENOMA_OF_THE_EPIDIDYMIS,0.960229842043889
HP_ABNORMAL_FACIAL_SKELETON_...,SET,1162,0.01609,0.0039157,0.025089,0.26067,HP_ABNORMAL_FACIAL_SKELETON_MORPHOLOGY,0.960247313195549
GOBP_COPII_COATED_VESICLE_CA...,SET,18,0.11546,0.0036117,0.18005,0.26068,GOBP_COPII_COATED_VESICLE_CARGO_LOADING,0.960247313195549
GOMF_ANTIPORTER_ACTIVITY,SET,126,0.047472,0.0039171,0.074053,0.26075,GOMF_ANTIPORTER_ACTIVITY,0.96040337537092
REACTOME_RAB_GEFS_EXCHANGE_G...,SET,82,0.058526,0.0039005,0.091317,0.26079,REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS,0.960448919148034
GSE22589_HEALTHY_VS_SIV_INFE...1,SET,186,0.040488,0.0040525,0.063195,0.26087,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_DN,0.960473046378653
GOBP_REGULATION_OF_THYMOCYTE...,SET,13,0.14977,0.0039819,0.2338,0.26089,GOBP_REGULATION_OF_THYMOCYTE_APOPTOTIC_PROCESS,0.960473046378653
BIOCARTA_IGF1_PATHWAY,SET,20,0.11993,0.0039542,0.18723,0.26091,BIOCARTA_IGF1_PATHWAY,0.960473046378653
GOMF_PRE_MRNA_5_SPLICE_SITE_...,SET,2,0.29936,0.0031226,0.46733,0.26091,GOMF_PRE_MRNA_5_SPLICE_SITE_BINDING,0.960473046378653
GOMF_TRANSMEMBRANE_RECEPTOR_...3,SET,18,0.12729,0.0039817,0.19875,0.26094,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,0.960473046378653
HP_LEFT_VENTRICULAR_DIASTOLI...,SET,7,0.20473,0.0039948,0.31971,0.26097,HP_LEFT_VENTRICULAR_DIASTOLIC_DYSFUNCTION,0.960473046378653
WP_TROP2_REGULATORY_SIGNALING,SET,48,0.08084,0.0041259,0.12625,0.26099,WP_TROP2_REGULATORY_SIGNALING,0.960473046378653
KEGG_MEDICUS_REFERENCE_EP_NE...,SET,15,0.14046,0.0040111,0.21944,0.26106,KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY,0.960628935944944
GARGALOVIC_RESPONSE_TO_OXIDI...18,SET,16,0.14501,0.0042767,0.2266,0.26112,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_UP,0.960691765453006
GSE17721_POLYIC_VS_GARDIQUIM...11,SET,184,0.039228,0.0039053,0.06131,0.26115,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_DN,0.960691765453006
HP_HYPOPLASIA_OF_THE_RADIUS,SET,38,0.081317,0.0036937,0.1271,0.26116,HP_HYPOPLASIA_OF_THE_RADIUS,0.960691765453006
GSE20484_MCSG_VS_CXCL4_MONOC...1,SET,174,0.04018,0.003891,0.062822,0.26122,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_DN,0.960810784209969
STEIN_ESRRA_TARGETS_RESPONSI...1,SET,39,0.089647,0.0041252,0.14023,0.26132,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_DN,0.960947069403301
GOMF_GAP_JUNCTION_CHANNEL_AC...3,SET,8,0.21687,0.0045237,0.33927,0.26134,GOMF_GAP_JUNCTION_CHANNEL_ACTIVITY_INVOLVED_IN_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.960947069403301
HP_ELEVATED_BRAIN_CHOLINE_LE...,SET,8,0.16797,0.0035036,0.26277,0.26134,HP_ELEVATED_BRAIN_CHOLINE_LEVEL_BY_MRS,0.960947069403301
GOBP_TETRAHYDROFOLATE_INTERC...,SET,9,0.15552,0.0034406,0.24338,0.26142,GOBP_TETRAHYDROFOLATE_INTERCONVERSION,0.961139543002221
GOBP_NEUTROPHIL_CHEMOTAXIS,SET,78,0.066151,0.0043003,0.10355,0.26147,GOBP_NEUTROPHIL_CHEMOTAXIS,0.961221689232071
GSE37301_HEMATOPOIETIC_STEM_...2,SET,167,0.04193,0.0039787,0.065654,0.26153,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP,0.961340576414595
MIR378A_5P,SET,120,0.05019,0.0040423,0.078608,0.26158,MIR378A_5P,0.961422684010152
FAN_OVARY_CL14_MATURE_SMOOTH...,SET,268,0.033267,0.0039878,0.052112,0.26162,FAN_OVARY_CL14_MATURE_SMOOTH_MUSCLE_CELL,0.961457029598309
BIOCARTA_IL3_PATHWAY,SET,13,0.15571,0.0041397,0.24399,0.26168,BIOCARTA_IL3_PATHWAY,0.961457029598309
GSE3982_MAST_CELL_VS_EFF_MEM...2,SET,178,0.041121,0.0040272,0.064434,0.26168,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_UP,0.961457029598309
HP_MICROGRAPHIA,SET,13,0.14376,0.0038219,0.22528,0.2617,HP_MICROGRAPHIA,0.961457029598309
REACTOME_TRIGLYCERIDE_CATABO...,SET,23,0.11407,0.0040326,0.17878,0.26173,REACTOME_TRIGLYCERIDE_CATABOLISM,0.961465611457563
GSE17721_0.5H_VS_8H_LPS_BMDC...2,SET,189,0.038939,0.0039283,0.061043,0.26178,GSE17721_0.5H_VS_8H_LPS_BMDC_UP,0.961547653772987
HEIDENBLAD_AMPLIFIED_IN_SOFT...,SET,13,0.14309,0.0038043,0.22443,0.26188,HEIDENBLAD_AMPLIFIED_IN_SOFT_TISSUE_CANCER,0.961616166842661
GOBP_DETECTION_OF_MOLECULE_O...,SET,12,0.1687,0.0043093,0.26463,0.2619,GOBP_DETECTION_OF_MOLECULE_OF_BACTERIAL_ORIGIN,0.961616166842661
KEGG_MEDICUS_REFERENCE_NUCLE...1,SET,27,0.095386,0.0036533,0.14969,0.26199,KEGG_MEDICUS_REFERENCE_NUCLEAR_EXPORT_OF_MRNA,0.961616166842661
GOBP_REGULATION_OF_PHOSPHOLI...9,SET,15,0.1341,0.0038294,0.21045,0.262,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSPORT,0.961616166842661
GARCIA_PINERES_PBMC_HPV_16_L...7,SET,125,0.049158,0.0040403,0.077149,0.262,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_DN,0.961616166842661
NAKAYA_PBMC_FLUMIST_AGE_18_5...7,SET,1367,0.014359,0.0037676,0.022535,0.262,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_UP,0.961616166842661
BENPORATH_ES_2,SET,32,0.08826,0.0036796,0.13852,0.26201,BENPORATH_ES_2,0.961616166842661
GSE36476_YOUNG_VS_OLD_DONOR_...8,SET,167,0.042091,0.003994,0.066062,0.26202,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_UP,0.961616166842661
LAKE_ADULT_KIDNEY_C24_ENDOTH...,SET,144,0.047964,0.0042289,0.075319,0.26213,LAKE_ADULT_KIDNEY_C24_ENDOTHELIAL_CELLS_AEA_AND_DVR,0.961757902511078
MODULE_509,SET,12,0.14564,0.0037202,0.22877,0.26219,MODULE_509,0.961757902511078
HP_KYPHOSIS,SET,380,0.026914,0.0038297,0.042277,0.2622,HP_KYPHOSIS,0.961757902511078
HP_ABNORMALITY_THIGH_MUSCULA...,SET,15,0.14938,0.0042658,0.23469,0.26222,HP_ABNORMALITY_THIGH_MUSCULATURE_MORPHOLOGY,0.961757902511078
LEE_LIVER_CANCER_SURVIVAL_DN,SET,165,0.041423,0.0039072,0.065079,0.26223,LEE_LIVER_CANCER_SURVIVAL_DN,0.961757902511078
GOMF_RNA_POLYMERASE_ACTIVITY,SET,28,0.088286,0.0034433,0.13871,0.26224,GOMF_RNA_POLYMERASE_ACTIVITY,0.961757902511078
GSE1925_CTRL_VS_3H_IFNG_STIM...3,SET,177,0.043154,0.0042145,0.067811,0.26227,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_DN,0.961757902511078
GSE27786_NKCELL_VS_NKTCELL_DN,SET,182,0.039924,0.0039531,0.062738,0.26228,GSE27786_NKCELL_VS_NKTCELL_DN,0.961757902511078
HP_PYRIDOXINE_RESPONSIVE_SID...,SET,22,0.1011,0.0034957,0.1589,0.26231,HP_PYRIDOXINE_RESPONSIVE_SIDEROBLASTIC_ANEMIA,0.961766436332946
GSE22886_DAY0_VS_DAY1_MONOCY...1,SET,185,0.040237,0.0040165,0.063252,0.26235,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_DN,0.961811629746836
GOBP_QUINONE_METABOLIC_PROCE...,SET,21,0.10453,0.0035313,0.16438,0.26243,GOBP_QUINONE_METABOLIC_PROCESS,0.962003443729564
MODULE_444,SET,17,0.14711,0.0044721,0.23146,0.26252,MODULE_444,0.96216705156596
GOBP_ADENYLATE_CYCLASE_INHIB...4,SET,77,0.065982,0.0042619,0.10382,0.26253,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.96216705156596
MIR6775_3P,SET,69,0.065662,0.0040157,0.10334,0.2626,MIR6775_3P,0.962322121467735
GSE360_DC_VS_MAC_DN,SET,171,0.040717,0.0039092,0.064115,0.2627,GSE360_DC_VS_MAC_DN,0.962420791609571
STANELLE_E2F1_TARGETS,SET,26,0.10612,0.0039887,0.16712,0.26271,STANELLE_E2F1_TARGETS,0.962420791609571
KEGG_MEDICUS_REFERENCE_ASSEM...,SET,17,0.11459,0.0034835,0.18045,0.26271,KEGG_MEDICUS_REFERENCE_ASSEMBLY_AND_TRAFFICKING_OF_TELOMERASE,0.962420791609571
GOBP_PROSTANOID_BIOSYNTHETIC...,SET,27,0.10078,0.00386,0.15875,0.26277,GOBP_PROSTANOID_BIOSYNTHETIC_PROCESS,0.962426438053097
WENG_POR_DOSAGE,SET,22,0.12271,0.0042429,0.19333,0.26281,WENG_POR_DOSAGE,0.962426438053097
RODRIGUES_THYROID_CARCINOMA_...3,SET,73,0.068534,0.0043107,0.10798,0.26282,RODRIGUES_THYROID_CARCINOMA_DN,0.962426438053097
NAKAYA_PBMC_FLUMIST_AGE_18_5...4,SET,765,0.019516,0.0038979,0.030752,0.26284,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_DN,0.962426438053097
GOMF_TRAIL_BINDING,SET,5,0.29566,0.004876,0.4659,0.26285,GOMF_TRAIL_BINDING,0.962426438053097
WP_MAPK_PATHWAY_IN_CONGENITA...,SET,14,0.14383,0.0039682,0.22669,0.26288,WP_MAPK_PATHWAY_IN_CONGENITAL_THYROID_CANCER,0.96243488886548
GOBP_N_TERMINAL_PROTEIN_AMIN...2,SET,24,0.10251,0.0037018,0.1616,0.26294,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_MODIFICATION,0.962553159890457
BIOCARTA_CCR3_PATHWAY,SET,18,0.13346,0.0041747,0.21051,0.26305,BIOCARTA_CCR3_PATHWAY,0.962592444491213
GSE41867_NAIVE_VS_DAY30_LCMV...2,SET,182,0.036601,0.0036242,0.057735,0.26306,GSE41867_NAIVE_VS_DAY30_LCMV_ARMSTRONG_MEMORY_CD8_TCELL_UP,0.962592444491213
GSE10239_NAIVE_VS_KLRG1INT_E...2,SET,181,0.038515,0.0038033,0.060761,0.26309,GSE10239_NAIVE_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.962592444491213
GSE1791_CTRL_VS_NEUROMEDINU_...1,SET,162,0.042819,0.0040023,0.067556,0.2631,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_0.8H_DN,0.962592444491213
GSE30153_LUPUS_VS_HEALTHY_DO...1,SET,180,0.04141,0.004078,0.065335,0.26311,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_DN,0.962592444491213
MIR4738_3P,SET,163,0.042399,0.0039752,0.066916,0.26317,MIR4738_3P,0.962592444491213
GOBP_RESPONSE_TO_RAPAMYCIN,SET,4,0.27774,0.004097,0.43835,0.26317,GOBP_RESPONSE_TO_RAPAMYCIN,0.962592444491213
KEGG_MEDICUS_REFERENCE_CA2_C...3,SET,11,0.17513,0.0042831,0.27642,0.26319,KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY,0.962592444491213
GOBP_ANTIFUNGAL_INNATE_IMMUN...,SET,14,0.13576,0.0037456,0.2143,0.2632,GOBP_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,0.962592444491213
GOCC_SM_LIKE_PROTEIN_FAMILY_...,SET,78,0.051733,0.003363,0.081675,0.26324,GOCC_SM_LIKE_PROTEIN_FAMILY_COMPLEX,0.962609289847449
CHESLER_BRAIN_HIGHEST_GENETI...,SET,36,0.090552,0.0040037,0.14297,0.26326,CHESLER_BRAIN_HIGHEST_GENETIC_VARIANCE,0.962609289847449
GSE34156_UNTREATED_VS_6H_TLR...2,SET,172,0.042662,0.0041077,0.067389,0.26335,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,0.962716058470922
GSE7509_UNSTIM_VS_FCGRIIB_ST...1,SET,159,0.043509,0.0040293,0.068729,0.26336,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_DN,0.962716058470922
NABA_ECM_REGULATORS,SET,229,0.039075,0.0043344,0.061735,0.26339,NABA_ECM_REGULATORS,0.962716058470922
HP_ANGIOEDEMA,SET,12,0.18092,0.0046215,0.28585,0.2634,HP_ANGIOEDEMA,0.962716058470922
GOBP_SYNAPTIC_VESICLE_COATING,SET,5,0.23089,0.0038077,0.36491,0.26346,GOBP_SYNAPTIC_VESICLE_COATING,0.962834100946372
HP_SLENDER_LONG_BONE,SET,46,0.071716,0.0035834,0.11338,0.26353,HP_SLENDER_LONG_BONE,0.962856288746454
HP_TENTED_UPPER_LIP_VERMILION,SET,101,0.050503,0.0037335,0.079846,0.26353,HP_TENTED_UPPER_LIP_VERMILION,0.962856288746454
REACTOME_SEPARATION_OF_SISTE...,SET,174,0.038269,0.003706,0.060518,0.26358,REACTOME_SEPARATION_OF_SISTER_CHROMATIDS,0.962856288746454
GSE43863_LY6C_INT_CXCR5POS_V...2,SET,181,0.041562,0.0041042,0.065733,0.2636,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.962856288746454
KEGG_MEDICUS_VARIANT_AMPLIFI...16,SET,13,0.14565,0.0038722,0.23038,0.26364,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.962856288746454
GOMF_OLFACTORY_RECEPTOR_BIND...,SET,6,0.24182,0.0043685,0.38251,0.26364,GOMF_OLFACTORY_RECEPTOR_BINDING,0.962856288746454
REACTOME_HEPARAN_SULFATE_HEP...,SET,52,0.077644,0.0041242,0.12283,0.26366,REACTOME_HEPARAN_SULFATE_HEPARIN_HS_GAG_METABOLISM,0.962856288746454
GOBP_REGULATION_OF_ALCOHOL_B...,SET,45,0.082634,0.0040839,0.13075,0.2637,GOBP_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,0.962901187224207
KEGG_MEDICUS_REFERENCE_PTH_P...,SET,15,0.14132,0.0040356,0.22371,0.26379,KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY,0.96295979527559
GOBP_REGULATED_EXOCYTOSIS,SET,210,0.036534,0.0038828,0.057836,0.2638,GOBP_REGULATED_EXOCYTOSIS,0.96295979527559
GSE45739_NRAS_KO_VS_WT_ACD3_...1,SET,166,0.040304,0.0038131,0.06383,0.26388,GSE45739_NRAS_KO_VS_WT_ACD3_ACD28_STIM_CD4_TCELL_DN,0.96295979527559
GOBP_GLYCOSIDE_CATABOLIC_PRO...,SET,7,0.19161,0.0037387,0.30346,0.26389,GOBP_GLYCOSIDE_CATABOLIC_PROCESS,0.96295979527559
GSE21546_WT_VS_ELK1_KO_DP_TH...2,SET,183,0.03888,0.0038603,0.061578,0.26389,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP,0.96295979527559
REACTOME_FCERI_MEDIATED_NF_K...,SET,76,0.056955,0.0036549,0.090206,0.2639,REACTOME_FCERI_MEDIATED_NF_KB_ACTIVATION,0.96295979527559
GSE17721_POLYIC_VS_CPG_16H_B...2,SET,184,0.038224,0.0038054,0.060544,0.26391,GSE17721_POLYIC_VS_CPG_16H_BMDC_UP,0.96295979527559
SCHAEFFER_PROSTATE_DEVELOPME...7,SET,9,0.16901,0.0037392,0.26774,0.26394,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_DN,0.962968160823011
GOMF_COLLAGEN_BINDING,SET,67,0.069123,0.0041659,0.10953,0.26399,GOMF_COLLAGEN_BINDING,0.962998568281938
GSE9006_HEALTHY_VS_TYPE_1_DI...4,SET,183,0.039288,0.0039008,0.062262,0.26402,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_UP,0.962998568281938
GOBP_REGULATION_OF_PLATELET_...1,SET,51,0.082565,0.0043433,0.1309,0.2641,GOBP_REGULATION_OF_PLATELET_ACTIVATION,0.962998568281938
GOMF_INWARD_RECTIFIER_POTASS...,SET,26,0.11827,0.0044453,0.18752,0.26411,GOMF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,0.962998568281938
GOMF_CUPRIC_ION_BINDING,SET,5,0.23375,0.0038549,0.37062,0.26412,GOMF_CUPRIC_ION_BINDING,0.962998568281938
LEE_DOUBLE_POLAR_THYMOCYTE,SET,24,0.12462,0.0045004,0.19762,0.26415,LEE_DOUBLE_POLAR_THYMOCYTE,0.962998568281938
GOBP_LEUKOTRIENE_METABOLIC_P...,SET,29,0.10388,0.0041232,0.16474,0.26416,GOBP_LEUKOTRIENE_METABOLIC_PROCESS,0.962998568281938
COLE_BLOOD_FLUMIST_QUADRIVAL...,SET,5,0.28709,0.0047346,0.45529,0.26417,COLE_BLOOD_FLUMIST_QUADRIVALENT_AGE_03_17YO_7DY_UP,0.962998568281938
GOBP_NEURAL_PLATE_DEVELOPMENT,SET,7,0.1788,0.0034888,0.28371,0.26428,GOBP_NEURAL_PLATE_DEVELOPMENT,0.963298521237546
GOCC_CLATHRIN_COATED_ENDOCYT...1,SET,85,0.062816,0.004262,0.099731,0.2644,GOCC_CLATHRIN_COATED_ENDOCYTIC_VESICLE,0.963421276595745
HP_ABNORMAL_PROPORTION_OF_CD...2,SET,39,0.083431,0.0038392,0.13247,0.26441,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_T_CELLS,0.963421276595745
GOBP_MEIOTIC_CHROMOSOME_SEGR...,SET,79,0.056128,0.0036719,0.089121,0.26442,GOBP_MEIOTIC_CHROMOSOME_SEGREGATION,0.963421276595745
GOBP_ESTABLISHMENT_OF_SERTOL...,SET,4,0.22284,0.0032871,0.35385,0.26443,GOBP_ESTABLISHMENT_OF_SERTOLI_CELL_BARRIER,0.963421276595745
SHAFFER_IRF4_TARGETS_IN_PLAS...,SET,65,0.070868,0.004207,0.11256,0.26447,SHAFFER_IRF4_TARGETS_IN_PLASMA_CELL_VS_MATURE_B_LYMPHOCYTE,0.963421276595745
GSE46606_IRF4_KO_VS_WT_CD40L...1,SET,168,0.039993,0.0038061,0.063522,0.26448,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_1DAY_STIMULATED_BCELL_DN,0.963421276595745
MIR1912_3P,SET,80,0.058962,0.0038816,0.093674,0.26454,MIR1912_3P,0.96345954973822
HP_ABNORMAL_4TH_METACARPAL_M...,SET,14,0.15523,0.0042827,0.24665,0.26455,HP_ABNORMAL_4TH_METACARPAL_MORPHOLOGY,0.96345954973822
REACTOME_COPII_MEDIATED_VESI...,SET,66,0.062221,0.0037219,0.098877,0.26459,REACTOME_COPII_MEDIATED_VESICLE_TRANSPORT,0.96345954973822
MILI_PSEUDOPODIA_HAPTOTAXIS_...2,SET,452,0.02407,0.003728,0.038267,0.26468,MILI_PSEUDOPODIA_HAPTOTAXIS_UP,0.96345954973822
GOBP_POSITIVE_REGULATION_OF_...795,SET,71,0.067935,0.0042142,0.108,0.26468,GOBP_POSITIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,0.96345954973822
HP_ABNORMAL_BONE_MARROW_CELL...,SET,199,0.037094,0.0038389,0.058977,0.2647,HP_ABNORMAL_BONE_MARROW_CELL_MORPHOLOGY,0.96345954973822
GSE22611_UNSTIM_VS_2H_MDP_ST...1,SET,171,0.037877,0.0036365,0.060227,0.26471,GSE22611_UNSTIM_VS_2H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,0.96345954973822
GOMF_PHOSPHATIDYLINOSITOL_3_...10,SET,24,0.12018,0.0043402,0.19112,0.26473,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_BINDING,0.96345954973822
DARWICHE_SKIN_TUMOR_PROMOTER...2,SET,128,0.047321,0.0039353,0.075253,0.26474,DARWICHE_SKIN_TUMOR_PROMOTER_UP,0.96345954973822
GSE18281_SUBCAPSULAR_CORTICA...2,SET,189,0.03786,0.0038195,0.060258,0.26491,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.963853091650973
GSE411_100MIN_VS_400MIN_IL6_...4,SET,187,0.036981,0.0037112,0.058867,0.26493,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.963853091650973
DESCARTES_FETAL_STOMACH_MYEL...,SET,65,0.070949,0.0042119,0.11294,0.26494,DESCARTES_FETAL_STOMACH_MYELOID_CELLS,0.963853091650973
MIR3140_3P,SET,207,0.037852,0.0039945,0.06026,0.26496,MIR3140_3P,0.963853091650973
GOBP_SOMATIC_DIVERSIFICATION...1,SET,66,0.061069,0.003653,0.097269,0.26506,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS,0.963853091650973
HP_FOOT_ACROOSTEOLYSIS,SET,7,0.20517,0.0040033,0.32679,0.26506,HP_FOOT_ACROOSTEOLYSIS,0.963853091650973
PID_S1P_S1P2_PATHWAY,SET,23,0.11439,0.0040441,0.18221,0.26507,PID_S1P_S1P2_PATHWAY,0.963853091650973
MIR6849_5P,SET,28,0.10925,0.0042611,0.17403,0.26507,MIR6849_5P,0.963853091650973
GOBP_PROTEIN_EXPORT_FROM_NUC...,SET,58,0.065664,0.0036829,0.10461,0.26511,GOBP_PROTEIN_EXPORT_FROM_NUCLEUS,0.963897693273355
GOCC_GOLGI_STACK,SET,125,0.04678,0.0038448,0.074559,0.26519,GOCC_GOLGI_STACK,0.964059570128648
GSE17721_PAM3CSK4_VS_GADIQUI...13,SET,181,0.038904,0.0038417,0.062011,0.26521,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_DN,0.964059570128648
GOBP_RUFFLE_ORGANIZATION,SET,53,0.076188,0.0040854,0.12147,0.26526,GOBP_RUFFLE_ORGANIZATION,0.964140483162518
WP_FATTY_ACIDS_AND_LIPOPROTE...,SET,359,0.028099,0.0038886,0.04481,0.26531,WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES,0.964221379274286
HP_ABNORMAL_NEUTROPHIL_COUNT,SET,197,0.037168,0.0038273,0.059299,0.2654,HP_ABNORMAL_NEUTROPHIL_COUNT,0.964447616060226
GOBP_LYMPH_VESSEL_MORPHOGENE...,SET,21,0.11697,0.0039516,0.18664,0.26543,GOBP_LYMPH_VESSEL_MORPHOGENESIS,0.964455791949817
GOBP_PROTEIN_RETENTION_IN_GO...,SET,5,0.25961,0.0042814,0.41433,0.26547,GOBP_PROTEIN_RETENTION_IN_GOLGI_APPARATUS,0.964500297930169
JONES_OVARY_T_CELL,SET,83,0.06279,0.00421,0.10022,0.2655,JONES_OVARY_T_CELL,0.964508466603951
GOMF_FLAP_ENDONUCLEASE_ACTIV...,SET,6,0.19016,0.0034352,0.30356,0.26553,GOMF_FLAP_ENDONUCLEASE_ACTIVITY,0.964516633570234
HP_THICKENED_CALVARIA,SET,32,0.090477,0.003772,0.14447,0.26557,HP_THICKENED_CALVARIA,0.964532962382445
GOBP_REGULATION_OF_CELL_CYCL...5,SET,665,0.020482,0.003825,0.032709,0.26559,GOBP_REGULATION_OF_CELL_CYCLE_PROCESS,0.964532962382445
GOBP_POSITIVE_REGULATION_OF_...51,SET,68,0.067275,0.0040845,0.10748,0.26569,GOBP_POSITIVE_REGULATION_OF_AXONOGENESIS,0.964767138529043
HP_CLINODACTYLY_OF_THE_2ND_F...,SET,8,0.21029,0.0043864,0.336,0.26571,HP_CLINODACTYLY_OF_THE_2ND_FINGER,0.964767138529043
GOBP_APPENDAGE_MORPHOGENESIS,SET,139,0.04874,0.0042226,0.077905,0.26578,GOBP_APPENDAGE_MORPHOGENESIS,0.96486517252163
GOBP_POSITIVE_REGULATION_OF_...458,SET,14,0.14287,0.0039416,0.2285,0.26591,GOBP_POSITIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.96486517252163
HP_MESOMELIC_LEG_SHORTENING,SET,5,0.24153,0.0039832,0.38632,0.26593,HP_MESOMELIC_LEG_SHORTENING,0.96486517252163
THEILGAARD_NEUTROPHIL_AT_SKI...1,SET,213,0.034996,0.0037455,0.055991,0.26598,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN,0.96486517252163
GSE40274_CTRL_VS_FOXP3_AND_H...2,SET,187,0.03778,0.0037914,0.060454,0.26601,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.96486517252163
HP_LIMITATION_OF_KNEE_MOBILI...,SET,30,0.10088,0.0040723,0.16143,0.26602,HP_LIMITATION_OF_KNEE_MOBILITY,0.96486517252163
MIR4711_5P,SET,94,0.053601,0.0038235,0.085786,0.26605,MIR4711_5P,0.96486517252163
GOBP_THYMOCYTE_APOPTOTIC_PRO...,SET,19,0.12497,0.0040161,0.20004,0.26608,GOBP_THYMOCYTE_APOPTOTIC_PROCESS,0.96486517252163
REACTOME_SARS_COV_2_TARGETS_...2,SET,3,0.3596,0.0045939,0.57578,0.26614,REACTOME_SARS_COV_2_TARGETS_PDZ_PROTEINS_IN_CELL_CELL_JUNCTION,0.96486517252163
MIR106A_3P,SET,99,0.0563,0.0041209,0.09015,0.26615,MIR106A_3P,0.96486517252163
WP_DDX1_AS_A_REGULATORY_COMP...,SET,6,0.19049,0.0034413,0.30506,0.26617,WP_DDX1_AS_A_REGULATORY_COMPONENT_OF_THE_DROSHA_MICROPROCESSOR,0.96486517252163
LI_ESTROGENE_META_E2_RESPONS...1,SET,22,0.11787,0.0040755,0.18877,0.26619,LI_ESTROGENE_META_E2_RESPONSE_DN,0.96486517252163
REACTOME_SIGNALING_BY_RHO_GT...,SET,608,0.021388,0.0038252,0.034255,0.26619,REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3,0.96486517252163
MODULE_528,SET,10,0.17623,0.0041095,0.28225,0.2662,MODULE_528,0.96486517252163
HP_ABNORMALITY_OF_BONE_MINER...,SET,572,0.022263,0.003866,0.03566,0.26621,HP_ABNORMALITY_OF_BONE_MINERAL_DENSITY,0.96486517252163
AREB6_03,SET,242,0.035187,0.004011,0.056374,0.26626,AREB6_03,0.96486517252163
HP_FULL_CHEEKS,SET,132,0.043874,0.0037048,0.070292,0.26626,HP_FULL_CHEEKS,0.96486517252163
MIR298,SET,170,0.040515,0.0038785,0.064913,0.26627,MIR298,0.96486517252163
CHAUHAN_RESPONSE_TO_METHOXYE...2,SET,41,0.074133,0.0034975,0.11878,0.26628,CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_UP,0.96486517252163
GSE32164_ALTERNATIVELY_ACT_M...2,SET,180,0.038803,0.0038212,0.062181,0.26631,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_UP,0.96486517252163
GOBP_DAMP_METABOLIC_PROCESS,SET,7,0.20991,0.0040957,0.33639,0.26632,GOBP_DAMP_METABOLIC_PROCESS,0.96486517252163
MARTIN_VIRAL_GPCR_SIGNALING_...2,SET,82,0.058838,0.0039213,0.09432,0.26638,MARTIN_VIRAL_GPCR_SIGNALING_UP,0.964981957473421
PID_S1P_S1P3_PATHWAY,SET,29,0.10364,0.0041137,0.16618,0.26642,PID_S1P_S1P3_PATHWAY,0.964998145060442
PARENT_MTOR_SIGNALING_DN,SET,41,0.085646,0.0040407,0.13734,0.26644,PARENT_MTOR_SIGNALING_DN,0.964998145060442
GOMF_ATPASE_COUPLED_TRANSMEM...,SET,91,0.05661,0.0039735,0.090801,0.2665,GOMF_ATPASE_COUPLED_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.965038584522446
GSE41867_LCMV_ARMSTRONG_VS_C...3,SET,187,0.035839,0.0035966,0.057497,0.26654,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY6_EFFECTOR_CD8_TCELL_DN,0.965038584522446
GSE2770_UNTREATED_VS_TGFB_AN...7,SET,181,0.038574,0.0038091,0.061891,0.26656,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.965038584522446
MIR146B_3P,SET,62,0.067139,0.0038929,0.10773,0.26657,MIR146B_3P,0.965038584522446
GAUTAM_EYE_CORNEA_MELANOCYTES,SET,235,0.032999,0.0037074,0.052954,0.26659,GAUTAM_EYE_CORNEA_MELANOCYTES,0.965038584522446
SUZUKI_AMPLIFIED_IN_ORAL_CAN...,SET,17,0.14299,0.0043468,0.22949,0.26662,SUZUKI_AMPLIFIED_IN_ORAL_CANCER,0.965046667360967
GTGCCAA_MIR96,SET,276,0.032095,0.0039034,0.051526,0.26668,GTGCCAA_MIR96,0.965163323961262
ERWIN_COHEN_PBMC_TC_83_AGE_1...3,SET,16,0.14371,0.0042384,0.23076,0.26672,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NON_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,0.965179458615304
GOMF_SODIUM_ION_TRANSMEMBRAN...,SET,156,0.044776,0.0041076,0.071905,0.26674,GOMF_SODIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.965179458615304
GOBP_MITOTIC_G2_M_TRANSITION...,SET,46,0.071489,0.003572,0.11484,0.26681,GOBP_MITOTIC_G2_M_TRANSITION_CHECKPOINT,0.965231763297595
HP_BROAD_FOOT,SET,26,0.10924,0.0041059,0.17549,0.26681,HP_BROAD_FOOT,0.965231763297595
GOBP_POSITIVE_REGULATION_OF_...335,SET,10,0.1582,0.0036892,0.25428,0.26692,GOBP_POSITIVE_REGULATION_OF_HEPATOCYTE_PROLIFERATION,0.965251981485334
GOBP_RESPIRATORY_GASEOUS_EXC...,SET,72,0.065584,0.0040969,0.10541,0.26692,GOBP_RESPIRATORY_GASEOUS_EXCHANGE_BY_RESPIRATORY_SYSTEM,0.965251981485334
MIR630,SET,71,0.061734,0.0038296,0.099241,0.26696,MIR630,0.965251981485334
GOCC_SODIUM_CHANNEL_COMPLEX,SET,24,0.12221,0.0044134,0.19647,0.26696,GOCC_SODIUM_CHANNEL_COMPLEX,0.965251981485334
MIR548AS_3P,SET,241,0.033512,0.0038122,0.053876,0.26697,MIR548AS_3P,0.965251981485334
GOBP_TISSUE_REMODELING,SET,166,0.042947,0.0040631,0.069051,0.26699,GOBP_TISSUE_REMODELING,0.965251981485334
BIOCARTA_LONGEVITY_PATHWAY,SET,15,0.14146,0.0040395,0.22746,0.26701,BIOCARTA_LONGEVITY_PATHWAY,0.965251981485334
GSE27786_BCELL_VS_ERYTHROBLA...1,SET,178,0.040266,0.0039434,0.064783,0.26712,GSE27786_BCELL_VS_ERYTHROBLAST_DN,0.965296290523691
HP_CHRONIC_PANCREATITIS,SET,4,0.25322,0.0037352,0.40744,0.26714,HP_CHRONIC_PANCREATITIS,0.965296290523691
chr7q11,SET,71,0.11421,0.0070848,0.18382,0.2672,chr7q11,0.965296290523691
GSE34179_THPOK_KO_VS_WT_VA14...2,SET,187,0.036893,0.0037024,0.059382,0.26721,GSE34179_THPOK_KO_VS_WT_VA14I_NKTCELL_UP,0.965296290523691
HP_APLASIA_HYPOPLASIA_OF_THE...2,SET,15,0.1363,0.0038922,0.21943,0.26726,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_FINGER,0.965296290523691
HP_CANDIDA_ESOPHAGITIS,SET,5,0.23624,0.003896,0.38034,0.26726,HP_CANDIDA_ESOPHAGITIS,0.965296290523691
HP_HEPATOBLASTOMA,SET,21,0.12423,0.004197,0.20002,0.26727,HP_HEPATOBLASTOMA,0.965296290523691
GSE1460_INTRATHYMIC_T_PROGEN...5,SET,171,0.041184,0.003954,0.066314,0.26729,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.965296290523691
PID_NCADHERIN_PATHWAY,SET,33,0.092535,0.0039175,0.149,0.2673,PID_NCADHERIN_PATHWAY,0.965296290523691
MIR4755_3P,SET,133,0.045132,0.0038254,0.072674,0.2673,MIR4755_3P,0.965296290523691
CAR_TNFRSF25,SET,29,0.098263,0.0039002,0.15829,0.26738,CAR_TNFRSF25,0.965484872727273
HP_POSTURAL_INSTABILITY,SET,74,0.060936,0.0038588,0.09821,0.26748,HP_POSTURAL_INSTABILITY,0.965681164383562
GSE37533_PPARG1_FOXP3_VS_PPA...1,SET,183,0.037492,0.0037225,0.06043,0.26749,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_DN,0.965681164383562
GSE22103_UNSTIM_VS_LPS_STIM_...1,SET,178,0.039326,0.0038514,0.063406,0.26756,GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_DN,0.965681164383562
TRAVAGLINI_LUNG_NONCLASSICAL...,SET,171,0.04207,0.004039,0.067838,0.26758,TRAVAGLINI_LUNG_NONCLASSICAL_MONOCYTE_CELL,0.965681164383562
GOBP_REGULATION_OF_COMPLEMEN...3,SET,9,0.2238,0.0049513,0.3609,0.26759,GOBP_REGULATION_OF_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY,0.965681164383562
GAUTAM_EYE_IRIS_CILIARY_BODY...3,SET,316,0.028325,0.003682,0.045688,0.26764,GAUTAM_EYE_IRIS_CILIARY_BODY_CILIARY_BODY_ENDOTHELIAL_CELLS,0.965681164383562
UNTERMAN_IPF_VS_CTRL_MONOCYT...1,SET,19,0.13787,0.0044306,0.22245,0.2677,UNTERMAN_IPF_VS_CTRL_MONOCYTE_DN,0.965681164383562
PURWIN_A375_MEWO_COMMON_SOX1...,SET,25,0.10351,0.003815,0.16701,0.26771,PURWIN_A375_MEWO_COMMON_SOX10_TARGETS,0.965681164383562
GOBP_NEUTRAL_LIPID_BIOSYNTHE...,SET,45,0.076269,0.0037693,0.12306,0.26771,GOBP_NEUTRAL_LIPID_BIOSYNTHETIC_PROCESS,0.965681164383562
HP_COLOR_VISION_TEST_ABNORMA...,SET,9,0.20053,0.0044365,0.32359,0.26772,HP_COLOR_VISION_TEST_ABNORMALITY,0.965681164383562
COBLL1_TARGET_GENES,SET,115,0.046063,0.0036323,0.074334,0.26774,COBLL1_TARGET_GENES,0.965681164383562
GSE2770_UNTREATED_VS_TGFB_AN...6,SET,176,0.036583,0.0035627,0.059047,0.26778,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,0.96572521531597
GOBP_NEUTROPHIL_MEDIATED_CYT...,SET,15,0.15244,0.004353,0.24607,0.26781,GOBP_NEUTROPHIL_MEDIATED_CYTOTOXICITY,0.965733196721311
GOBP_DENDRITIC_TRANSPORT_OF_...,SET,5,0.22799,0.00376,0.36835,0.26798,GOBP_DENDRITIC_TRANSPORT_OF_RIBONUCLEOPROTEIN_COMPLEX,0.966005225505443
GSE32255_WT_UNSTIM_VS_JMJD2D...1,SET,155,0.041732,0.0038163,0.067433,0.268,GSE32255_WT_UNSTIM_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,0.966005225505443
JINESH_BLEBBISHIELD_TO_IMMUN...1,SET,343,0.030187,0.0040852,0.048786,0.26804,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_DN,0.966005225505443
GOMF_BETA_2_MICROGLOBULIN_BI...,SET,8,0.19512,0.0040701,0.31535,0.26804,GOMF_BETA_2_MICROGLOBULIN_BINDING,0.966005225505443
GOMF_ACETYLCHOLINE_RECEPTOR_...2,SET,11,0.17001,0.0041579,0.27478,0.26806,GOMF_ACETYLCHOLINE_RECEPTOR_BINDING,0.966005225505443
WP_EV_RELEASE_FROM_CARDIAC_C...,SET,7,0.22998,0.0044875,0.37175,0.26808,WP_EV_RELEASE_FROM_CARDIAC_CELLS_AND_THEIR_FUNCTIONAL_EFFECTS,0.966005225505443
HP_LOWER_LIMB_MUSCLE_WEAKNESS,SET,196,0.037254,0.0038266,0.06022,0.26808,HP_LOWER_LIMB_MUSCLE_WEAKNESS,0.966005225505443
PARK_OSTEOBLAST_DIFFERENTIAT...1,SET,6,0.2638,0.0047656,0.42647,0.26811,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_DN,0.9660131712627
GOBP_REGULATION_OF_CELLULAR_...18,SET,137,0.0459,0.0039481,0.074221,0.26815,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,0.96605714211672
MEISSNER_BRAIN_HCP_WITH_H3K4...2,SET,54,0.072802,0.0039404,0.11774,0.26818,MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3,0.966065080845771
HP_ABNORMALITY_OF_THE_PROXIM...1,SET,4,0.26188,0.003863,0.42379,0.26831,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_5TH_FINGER,0.96636468303294
MIR6759_5P,SET,56,0.071858,0.0039605,0.11631,0.26835,MIR6759_5P,0.96636468303294
GSE5589_WT_VS_IL6_KO_LPS_AND...3,SET,178,0.03832,0.0037528,0.062037,0.26839,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,0.96636468303294
MIR7110_3P,SET,366,0.028713,0.0040113,0.046486,0.2684,MIR7110_3P,0.96636468303294
GSE25088_ROSIGLITAZONE_VS_IL...3,SET,178,0.038932,0.0038128,0.063035,0.26842,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,0.96636468303294
HP_MALAR_FLATTENING,SET,175,0.038922,0.0037798,0.063023,0.26843,HP_MALAR_FLATTENING,0.96636468303294
GOBP_GALACTOSYLCERAMIDE_BIOS...,SET,6,0.22541,0.004072,0.36506,0.26847,GOBP_GALACTOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.966388381484933
GSE411_WT_VS_SOCS3_KO_MACROP...3,SET,187,0.035554,0.003568,0.057589,0.2685,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_UP,0.966388381484933
GAVISH_3CA_MALIGNANT_METAPRO...34,SET,36,0.080233,0.0035475,0.12997,0.26852,GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED,0.966388381484933
HP_ABSENT_HAIR,SET,56,0.072829,0.004014,0.11801,0.26857,HP_ABSENT_HAIR,0.966391875388118
REACTOME_RAS_PROCESSING,SET,21,0.11055,0.0037347,0.17914,0.26859,REACTOME_RAS_PROCESSING,0.966391875388118
MIR373_5P,SET,852,0.018184,0.0038233,0.029474,0.26864,MIR373_5P,0.966391875388118
SHIPP_DLBCL_VS_FOLLICULAR_LY...2,SET,44,0.078643,0.0038433,0.12748,0.26866,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_UP,0.966391875388118
HP_PANCREATIC_ADENOCARCINOMA,SET,35,0.085028,0.003707,0.13784,0.26866,HP_PANCREATIC_ADENOCARCINOMA,0.966391875388118
GSE43955_TH0_VS_TGFB_IL6_TH1...8,SET,191,0.039634,0.0040193,0.064263,0.2687,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_UP,0.966413688939378
GOBP_EXTRACELLULAR_MATRIX_DI...,SET,58,0.071239,0.0039956,0.11556,0.2688,GOBP_EXTRACELLULAR_MATRIX_DISASSEMBLY,0.966413688939378
WP_KALLMANN_SYNDROME,SET,23,0.10846,0.0038343,0.17595,0.26881,WP_KALLMANN_SYNDROME,0.966413688939378
HP_MACROCEPHALY,SET,375,0.026356,0.0037261,0.042762,0.26884,HP_MACROCEPHALY,0.966413688939378
GOMF_PHOSPHATIDYLSERINE_FLOP...,SET,8,0.18572,0.003874,0.30135,0.26885,GOMF_PHOSPHATIDYLSERINE_FLOPPASE_ACTIVITY,0.966413688939378
HP_APLASIA_OF_THE_NASAL_BONE,SET,5,0.29487,0.0048629,0.47844,0.26885,HP_APLASIA_OF_THE_NASAL_BONE,0.966413688939378
GOBP_REGULATION_OF_IRON_ION_...2,SET,6,0.19534,0.0035289,0.317,0.26888,GOBP_REGULATION_OF_IRON_ION_TRANSPORT,0.966413688939378
GOMF_HISTONE_H3K9ME2_H3K9ME3...,SET,5,0.27404,0.0045194,0.44481,0.26892,GOMF_HISTONE_H3K9ME2_H3K9ME3_DEMETHYLASE_ACTIVITY,0.966413688939378
MIR5000_5P,SET,91,0.052876,0.0037114,0.085859,0.269,MIR5000_5P,0.966413688939378
HP_REDUCED_FORCED_VITAL_CAPA...,SET,34,0.084154,0.0036162,0.13666,0.26901,HP_REDUCED_FORCED_VITAL_CAPACITY,0.966413688939378
BIOCARTA_AMI_PATHWAY,SET,18,0.1348,0.0042166,0.219,0.2691,BIOCARTA_AMI_PATHWAY,0.966413688939378
GOBP_LYSOSOMAL_MEMBRANE_ORGA...,SET,15,0.13409,0.0038291,0.21783,0.2691,GOBP_LYSOSOMAL_MEMBRANE_ORGANIZATION,0.966413688939378
MIR4763_5P,SET,54,0.066775,0.0036142,0.10849,0.26911,MIR4763_5P,0.966413688939378
GOBP_REGULATION_OF_CILIUM_DE...,SET,27,0.101,0.0038682,0.16411,0.26914,GOBP_REGULATION_OF_CILIUM_DEPENDENT_CELL_MOTILITY,0.966413688939378
NABA_MATRISOME_ASSOCIATED,SET,698,0.022571,0.0043143,0.036677,0.26915,NABA_MATRISOME_ASSOCIATED,0.966413688939378
GSE12963_UNINF_VS_ENV_AND_NE...3,SET,129,0.046319,0.0038669,0.075273,0.26917,GSE12963_UNINF_VS_ENV_AND_NEF_DEFICIENT_HIV1_INF_CD4_TCELL_DN,0.966413688939378
GNF2_ANP32B,SET,34,0.086141,0.0037016,0.14,0.26919,GNF2_ANP32B,0.966413688939378
GOBP_PROPIONATE_METABOLIC_PR...,SET,4,0.24221,0.0035728,0.39364,0.26919,GOBP_PROPIONATE_METABOLIC_PROCESS,0.966413688939378
HP_PURE_RED_CELL_APLASIA,SET,25,0.097253,0.0035844,0.15807,0.2692,HP_PURE_RED_CELL_APLASIA,0.966413688939378
GOCC_CYTOSOLIC_RIBOSOME,SET,102,0.048234,0.0035833,0.078411,0.26924,GOCC_CYTOSOLIC_RIBOSOME,0.966413688939378
HP_MEDIAN_CLEFT_PALATE,SET,24,0.10974,0.003963,0.17841,0.26925,HP_MEDIAN_CLEFT_PALATE,0.966413688939378
GOBP_REGULATION_OF_ANTIFUNGA...,SET,4,0.22885,0.0033757,0.37216,0.26931,GOBP_REGULATION_OF_ANTIFUNGAL_INNATE_IMMUNE_RESPONSE,0.966529228624535
NIKOLSKY_BREAST_CANCER_16Q24...,SET,50,0.13577,0.0070718,0.22095,0.26945,NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON,0.96687879389313
STK33_SKM_DN,SET,239,0.034176,0.0038719,0.055635,0.26951,STK33_SKM_DN,0.96687879389313
HP_TIP_TOE_GAIT,SET,75,0.059413,0.0037876,0.096751,0.26958,HP_TIP_TOE_GAIT,0.96687879389313
GSE2585_THYMIC_DC_VS_MTEC_DN,SET,177,0.039326,0.0038406,0.06406,0.26965,GSE2585_THYMIC_DC_VS_MTEC_DN,0.96687879389313
GOBP_MYOBLAST_MIGRATION,SET,12,0.1471,0.0037575,0.23964,0.26966,GOBP_MYOBLAST_MIGRATION,0.96687879389313
GSE30971_2H_VS_4H_LPS_STIM_M...3,SET,176,0.03943,0.00384,0.064235,0.26967,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_KO_DN,0.96687879389313
THILLAINADESAN_ZNF217_TARGET...2,SET,38,0.081529,0.0037033,0.13289,0.26978,THILLAINADESAN_ZNF217_TARGETS_UP,0.96687879389313
UBE2I_TARGET_GENES,SET,70,0.061874,0.0038113,0.10086,0.26978,UBE2I_TARGET_GENES,0.96687879389313
SASSON_RESPONSE_TO_FORSKOLIN...1,SET,84,0.054583,0.0036817,0.088976,0.26979,SASSON_RESPONSE_TO_FORSKOLIN_DN,0.96687879389313
GSE17721_PAM3CSK4_VS_CPG_24H...2,SET,177,0.03752,0.0036643,0.061173,0.26983,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_UP,0.96687879389313
REACTOME_INTERLEUKIN_1_FAMIL...,SET,143,0.041799,0.0036726,0.068164,0.26987,REACTOME_INTERLEUKIN_1_FAMILY_SIGNALING,0.96687879389313
HP_HIGH_PITCHED_CRY,SET,5,0.21252,0.0035048,0.34658,0.26988,HP_HIGH_PITCHED_CRY,0.96687879389313
REACTOME_NEUROTOXICITY_OF_CL...,SET,10,0.1558,0.0036331,0.25411,0.26991,REACTOME_NEUROTOXICITY_OF_CLOSTRIDIUM_TOXINS,0.96687879389313
MODULE_9,SET,112,0.048046,0.0037392,0.078368,0.26991,MODULE_9,0.96687879389313
HP_ABNORMAL_SPINAL_CORD_PHYS...,SET,8,0.18716,0.0039039,0.30527,0.26991,HP_ABNORMAL_SPINAL_CORD_PHYSIOLOGY,0.96687879389313
MODULE_29,SET,24,0.096855,0.0034977,0.15804,0.26999,MODULE_29,0.96687879389313
MODULE_226,SET,27,0.097292,0.0037263,0.15876,0.27,MODULE_226,0.96687879389313
GOBP_PROTEIN_PALMITOYLATION,SET,28,0.093307,0.0036392,0.15228,0.27003,GOBP_PROTEIN_PALMITOYLATION,0.96687879389313
GOBP_CELL_CYCLE_DNA_REPLICAT...1,SET,41,0.074214,0.0035013,0.12113,0.27004,GOBP_CELL_CYCLE_DNA_REPLICATION,0.96687879389313
GOBP_MRNA_TRANSPORT,SET,112,0.045501,0.0035411,0.074269,0.27006,GOBP_MRNA_TRANSPORT,0.96687879389313
GOBP_GERMINAL_CENTER_B_CELL_...,SET,8,0.21967,0.004582,0.35862,0.2701,GOBP_GERMINAL_CENTER_B_CELL_DIFFERENTIATION,0.96687879389313
HP_3_4_FINGER_SYNDACTYLY,SET,10,0.18068,0.0042134,0.29499,0.27011,HP_3_4_FINGER_SYNDACTYLY,0.96687879389313
GOMF_DISULFIDE_OXIDOREDUCTAS...,SET,37,0.082071,0.0036787,0.13401,0.27013,GOMF_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.96687879389313
HIF1_Q3,SET,211,0.036085,0.0038441,0.058938,0.27019,HIF1_Q3,0.96687879389313
GOBP_REGULATION_OF_ODONTOGEN...1,SET,19,0.13438,0.0043185,0.21951,0.27021,GOBP_REGULATION_OF_ODONTOGENESIS,0.96687879389313
AIZARANI_LIVER_C17_HEPATOCYT...,SET,99,0.056038,0.0041017,0.091537,0.27021,AIZARANI_LIVER_C17_HEPATOCYTES_3,0.96687879389313
ZHONG_PFC_MAJOR_TYPES_OPC,SET,86,0.060716,0.0041436,0.099185,0.27022,ZHONG_PFC_MAJOR_TYPES_OPC,0.96687879389313
HP_WEAK_CRY,SET,44,0.07887,0.0038544,0.12886,0.27026,HP_WEAK_CRY,0.96687879389313
GOBP_SHORT_CHAIN_FATTY_ACID_...1,SET,7,0.21357,0.0041672,0.34901,0.27029,GOBP_SHORT_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,0.96687879389313
BIOCARTA_RNAPOL3_PATHWAY,SET,7,0.14243,0.0027791,0.23282,0.27035,BIOCARTA_RNAPOL3_PATHWAY,0.96687879389313
ALTEMEIER_RESPONSE_TO_LPS_WI...,SET,114,0.051489,0.0040425,0.084169,0.27036,ALTEMEIER_RESPONSE_TO_LPS_WITH_MECHANICAL_VENTILATION,0.96687879389313
GOMF_CLATHRIN_HEAVY_CHAIN_BI...,SET,11,0.16177,0.0039563,0.26449,0.2704,GOMF_CLATHRIN_HEAVY_CHAIN_BINDING,0.96687879389313
JAATINEN_HEMATOPOIETIC_STEM_...2,SET,274,0.03295,0.0039931,0.053875,0.27041,JAATINEN_HEMATOPOIETIC_STEM_CELL_UP,0.96687879389313
HP_NEPHRITIS,SET,113,0.049836,0.0038957,0.081501,0.27044,HP_NEPHRITIS,0.96687879389313
HO_LIVER_CANCER_VASCULAR_INV...,SET,12,0.16273,0.0041569,0.2662,0.27049,HO_LIVER_CANCER_VASCULAR_INVASION,0.96687879389313
KINSEY_TARGETS_OF_EWSR1_FLII...2,SET,1155,0.015263,0.003704,0.024975,0.27056,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP,0.96687879389313
HP_THICK_NASAL_ALAE,SET,34,0.088407,0.0037989,0.14466,0.27056,HP_THICK_NASAL_ALAE,0.96687879389313
RICKMAN_TUMOR_DIFFERENTIATED...5,SET,356,0.028068,0.0038684,0.04595,0.27066,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN,0.96687879389313
GSE23114_PERITONEAL_CAVITY_B...1,SET,183,0.036221,0.0035963,0.059299,0.27066,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN,0.96687879389313
WP_CANONICAL_NFKB_PATHWAY,SET,7,0.18926,0.0036929,0.30985,0.27067,WP_CANONICAL_NFKB_PATHWAY,0.96687879389313
GSE17721_CTRL_VS_LPS_6H_BMDC...2,SET,179,0.037408,0.0036737,0.06125,0.27069,GSE17721_CTRL_VS_LPS_6H_BMDC_UP,0.96687879389313
MYCMAX_B,SET,245,0.033434,0.0038344,0.054751,0.27072,MYCMAX_B,0.96687879389313
MIR6809_3P,SET,504,0.024143,0.0039429,0.039539,0.27073,MIR6809_3P,0.96687879389313
CHEMNITZ_RESPONSE_TO_PROSTAG...1,SET,348,0.028246,0.0038497,0.046265,0.27076,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN,0.96687879389313
REACTOME_ACETYLCHOLINE_INHIB...,SET,5,0.27372,0.0045141,0.44836,0.27077,REACTOME_ACETYLCHOLINE_INHIBITS_CONTRACTION_OF_OUTER_HAIR_CELLS,0.96687879389313
BROWN_MYELOID_CELL_DEVELOPME...2,SET,147,0.044589,0.0039717,0.073051,0.27081,BROWN_MYELOID_CELL_DEVELOPMENT_UP,0.96687879389313
GSE17974_1.5H_VS_72H_IL4_AND...2,SET,173,0.039637,0.0038274,0.064955,0.27086,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.96687879389313
HP_SUBRETINAL_DEPOSITS,SET,6,0.23329,0.0042144,0.38234,0.27089,HP_SUBRETINAL_DEPOSITS,0.96687879389313
REACTOME_YAP1_AND_WWTR1_TAZ_...,SET,14,0.14758,0.0040716,0.24208,0.27105,REACTOME_YAP1_AND_WWTR1_TAZ_STIMULATED_GENE_EXPRESSION,0.96687879389313
GOMF_UDP_GLYCOSYLTRANSFERASE...,SET,132,0.048983,0.0041363,0.080348,0.27105,GOMF_UDP_GLYCOSYLTRANSFERASE_ACTIVITY,0.96687879389313
GSE23502_BM_VS_COLON_TUMOR_H...1,SET,187,0.037538,0.0037671,0.061574,0.27105,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,0.96687879389313
GOBP_POSITIVE_REGULATION_OF_...800,SET,25,0.10666,0.0039309,0.17497,0.27107,GOBP_POSITIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,0.96687879389313
WP_GLP1_SECRETION_FROM_INTES...,SET,5,0.27284,0.0044996,0.44762,0.27109,WP_GLP1_SECRETION_FROM_INTESTINE_TO_PORTAL_VEIN,0.96687879389313
MODULE_53,SET,361,0.027105,0.0037612,0.044473,0.27111,MODULE_53,0.96687879389313
HP_ABNORMAL_CALF_MUSCULATURE...,SET,60,0.066439,0.0037899,0.10901,0.27112,HP_ABNORMAL_CALF_MUSCULATURE_MORPHOLOGY,0.96687879389313
GOBP_DENDRITIC_TRANSPORT,SET,12,0.14811,0.0037832,0.24313,0.27121,GOBP_DENDRITIC_TRANSPORT,0.96687879389313
GOBP_SKELETAL_MUSCLE_ACETYLC...,SET,11,0.12793,0.0031289,0.21004,0.27124,GOBP_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,0.96687879389313
GTCAACC_MIR3805P,SET,20,0.12435,0.0040999,0.20418,0.27126,GTCAACC_MIR3805P,0.96687879389313
WP_ENDOMETRIAL_CANCER,SET,61,0.064302,0.0036983,0.10559,0.27127,WP_ENDOMETRIAL_CANCER,0.96687879389313
GOBP_NODAL_SIGNALING_PATHWAY,SET,16,0.13992,0.0041267,0.22977,0.27127,GOBP_NODAL_SIGNALING_PATHWAY,0.96687879389313
HP_APLASIA_HYPOPLASIA_OF_THE...66,SET,178,0.037988,0.0037203,0.062386,0.2713,HP_APLASIA_HYPOPLASIA_OF_THE_SKIN,0.96687879389313
PID_HDAC_CLASSIII_PATHWAY,SET,23,0.10729,0.0037932,0.17622,0.27131,PID_HDAC_CLASSIII_PATHWAY,0.96687879389313
MIR1229_5P,SET,30,0.10182,0.0041103,0.16723,0.27132,MIR1229_5P,0.96687879389313
HP_CONJUGATED_HYPERBILIRUBIN...,SET,34,0.097488,0.0041892,0.16015,0.27136,HP_CONJUGATED_HYPERBILIRUBINEMIA,0.96687879389313
WP_PLEURAL_MESOTHELIOMA,SET,419,0.026566,0.0039652,0.043669,0.27148,WP_PLEURAL_MESOTHELIOMA,0.96687879389313
GOBP_PROTEIN_LOCALIZATION_TO...45,SET,5,0.24878,0.0041029,0.40898,0.2715,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE_RAFT,0.96687879389313
STAT3_01,SET,21,0.10555,0.0035658,0.17356,0.27155,STAT3_01,0.96687879389313
MORF_ESR1,SET,159,0.039871,0.0036924,0.065563,0.27156,MORF_ESR1,0.96687879389313
GOMF_CHROMATIN_DNA_BINDING,SET,95,0.05403,0.0038745,0.088849,0.27156,GOMF_CHROMATIN_DNA_BINDING,0.96687879389313
chr14q11,SET,91,0.10809,0.0075867,0.17777,0.27159,chr14q11,0.96687879389313
GOMF_KINETOCHORE_BINDING,SET,6,0.20491,0.0037017,0.337,0.27159,GOMF_KINETOCHORE_BINDING,0.96687879389313
MORF_GNB1,SET,273,0.029777,0.0036021,0.048984,0.27163,MORF_GNB1,0.96687879389313
GOBP_PHOSPHATIDYLSERINE_META...,SET,22,0.11144,0.0038531,0.18332,0.27164,GOBP_PHOSPHATIDYLSERINE_METABOLIC_PROCESS,0.96687879389313
GOBP_ENDOCYTOSIS_INVOLVED_IN...,SET,11,0.15402,0.003767,0.2534,0.27165,GOBP_ENDOCYTOSIS_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,0.96687879389313
GOBP_REGULATION_OF_MEIOSIS_I,SET,5,0.2098,0.00346,0.34519,0.27167,GOBP_REGULATION_OF_MEIOSIS_I,0.96687879389313
HP_GRANULOCYTOPENIA,SET,6,0.2041,0.0036871,0.33586,0.2717,HP_GRANULOCYTOPENIA,0.96687879389313
KEGG_MEDICUS_VARIANT_MUTATIO...62,SET,6,0.21625,0.0039066,0.35599,0.27178,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_PERK_ATF4_SIGNALING_PATHWAY,0.96687879389313
MORF_BMI1,SET,74,0.055817,0.0035346,0.091895,0.2718,MORF_BMI1,0.96687879389313
GOBP_POSITIVE_REGULATION_OF_...411,SET,104,0.05231,0.0039238,0.086127,0.27181,GOBP_POSITIVE_REGULATION_OF_LIPID_LOCALIZATION,0.96687879389313
GOBP_ACROSOME_REACTION,SET,39,0.084171,0.0038732,0.13861,0.27184,GOBP_ACROSOME_REACTION,0.96687879389313
GSE15330_LYMPHOID_MULTIPOTEN...1,SET,181,0.036795,0.0036335,0.060593,0.27185,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,0.96687879389313
REACTOME_COMPLEX_III_ASSEMBLY,SET,22,0.095629,0.0033066,0.1575,0.27188,REACTOME_COMPLEX_III_ASSEMBLY,0.96687879389313
GOBP_PROTEIN_LOCALIZATION_TO...48,SET,11,0.14596,0.0035698,0.24046,0.27193,GOBP_PROTEIN_LOCALIZATION_TO_SITE_OF_DOUBLE_STRAND_BREAK,0.96687879389313
GOBP_CELLULAR_RESPONSE_TO_OR...1,SET,483,0.024271,0.0038826,0.039991,0.27196,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,0.96687879389313
GOBP_NEGATIVE_REGULATION_OF_...542,SET,63,0.065933,0.0038536,0.10865,0.27198,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.96687879389313
MENON_FETAL_KIDNEY_1_EMBRYON...,SET,83,0.055375,0.0037128,0.09127,0.27202,MENON_FETAL_KIDNEY_1_EMBRYONIC_RED_BLOOD_CELLS,0.96687879389313
GSE360_CTRL_VS_L_DONOVANI_DC...2,SET,179,0.037223,0.0036555,0.061354,0.27203,GSE360_CTRL_VS_L_DONOVANI_DC_UP,0.96687879389313
GOBP_RRNA_BASE_METHYLATION,SET,6,0.19359,0.0034972,0.3191,0.27204,GOBP_RRNA_BASE_METHYLATION,0.96687879389313
PID_AURORA_B_PATHWAY,SET,36,0.083115,0.0036749,0.13702,0.27206,PID_AURORA_B_PATHWAY,0.96687879389313
WP_RETT_SYNDROME,SET,41,0.080412,0.0037937,0.13256,0.27206,WP_RETT_SYNDROME,0.96687879389313
GOMF_RNA_POLYMERASE_II_CTD_H...1,SET,10,0.15297,0.0035673,0.25218,0.27206,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_KINASE_ACTIVITY,0.96687879389313
FUJIWARA_PARK2_HEPATOCYTE_PR...2,SET,12,0.17134,0.0043768,0.28251,0.2721,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_UP,0.96687879389313
FOROUTAN_TGFB_EMT_UP,SET,185,0.040156,0.0040085,0.066228,0.27215,FOROUTAN_TGFB_EMT_UP,0.96687879389313
GOBP_SPLICEOSOMAL_CONFORMATI...,SET,4,0.20996,0.0030971,0.34627,0.27215,GOBP_SPLICEOSOMAL_CONFORMATIONAL_CHANGES_TO_GENERATE_CATALYTIC_CONFORMATION,0.96687879389313
HP_ABNORMAL_BLOOD_INORGANIC_...,SET,160,0.041982,0.0039,0.069247,0.27217,HP_ABNORMAL_BLOOD_INORGANIC_CATION_CONCENTRATION,0.96687879389313
HP_LONG_PALPEBRAL_FISSURE,SET,62,0.058639,0.0034001,0.096723,0.27218,HP_LONG_PALPEBRAL_FISSURE,0.96687879389313
MIR3928_3P,SET,84,0.053535,0.0036109,0.088331,0.27224,MIR3928_3P,0.96687879389313
ZNF768_TARGET_GENES,SET,1015,0.016595,0.0037906,0.027387,0.27228,ZNF768_TARGET_GENES,0.96687879389313
HP_CALCINOSIS,SET,11,0.1714,0.0041919,0.2829,0.2723,HP_CALCINOSIS,0.96687879389313
KEGG_MEDICUS_ENV_FACTOR_NNK_...5,SET,5,0.26144,0.0043116,0.43161,0.27235,KEGG_MEDICUS_ENV_FACTOR_NNK_TO_DNA_ADDUCTS,0.96687879389313
HP_RETICULOCYTOPENIA,SET,32,0.084192,0.00351,0.13899,0.27235,HP_RETICULOCYTOPENIA,0.96687879389313
WP_METABOLIC_PATHWAYS_OF_FIB...,SET,32,0.087671,0.003655,0.14475,0.27237,WP_METABOLIC_PATHWAYS_OF_FIBROBLASTS,0.96687879389313
KEGG_MEDICUS_REFERENCE_TSH_T...,SET,29,0.093318,0.0037039,0.15414,0.27245,KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY,0.96687879389313
GOMF_PHOSPHODIESTERASE_I_ACT...,SET,5,0.23442,0.0038659,0.38723,0.27247,GOMF_PHOSPHODIESTERASE_I_ACTIVITY,0.96687879389313
MIR548N,SET,554,0.022151,0.0037875,0.036599,0.27251,MIR548N,0.96687879389313
GOBP_NEGATIVE_REGULATION_OF_...334,SET,3,0.32422,0.0041419,0.53574,0.27254,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ASSEMBLY,0.96687879389313
HP_SCAPHOCEPHALY,SET,38,0.082699,0.0037565,0.13669,0.27259,HP_SCAPHOCEPHALY,0.96687879389313
GOBP_COBALT_ION_TRANSPORT,SET,6,0.21486,0.0038815,0.35516,0.2726,GOBP_COBALT_ION_TRANSPORT,0.96687879389313
GSE10325_BCELL_VS_LUPUS_BCEL...2,SET,163,0.039974,0.0037478,0.06608,0.27262,GSE10325_BCELL_VS_LUPUS_BCELL_UP,0.96687879389313
REACTOME_ERYTHROPOIETIN_ACTI...3,SET,14,0.13432,0.0037058,0.22206,0.27263,REACTOME_ERYTHROPOIETIN_ACTIVATES_RAS,0.96687879389313
MARTIN_NFKB_TARGETS_UP,SET,41,0.087086,0.0041086,0.14399,0.27266,MARTIN_NFKB_TARGETS_UP,0.96687879389313
GOMF_OXIDOREDUCTASE_ACTIVITY...32,SET,31,0.085571,0.0035114,0.14149,0.27266,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,0.96687879389313
IK1_01,SET,253,0.032895,0.0038328,0.054397,0.27269,IK1_01,0.96687879389313
MIR3934_5P,SET,55,0.067845,0.0037058,0.1122,0.2727,MIR3934_5P,0.96687879389313
GOBP_ENUCLEATE_ERYTHROCYTE_M...,SET,3,0.36606,0.0046764,0.60537,0.2727,GOBP_ENUCLEATE_ERYTHROCYTE_MATURATION,0.96687879389313
GSE14000_TRANSLATED_RNA_VS_M...6,SET,178,0.037233,0.0036464,0.06161,0.27282,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_UP,0.96687879389313
WP_CHOLESTEROL_BIOSYNTHESIS_...2,SET,106,0.04914,0.0037211,0.081324,0.27284,WP_CHOLESTEROL_BIOSYNTHESIS_PATHWAY_IN_HEPATOCYTES,0.96687879389313
LINDGREN_BLADDER_CANCER_CLUS...5,SET,343,0.029642,0.0040115,0.049061,0.27286,LINDGREN_BLADDER_CANCER_CLUSTER_2B,0.96687879389313
HE_LIM_SUN_FETAL_LUNG_C0_INT...2,SET,9,0.19073,0.0042197,0.31571,0.27288,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_FIBROBLAST,0.96687879389313
GSE18791_CTRL_VS_NEWCASTLE_V...2,SET,178,0.035779,0.003504,0.059227,0.27289,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_UP,0.96687879389313
CAO_BLOOD_FLUMIST_AGE_05_14Y...5,SET,7,0.18051,0.0035222,0.2988,0.27289,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_DN,0.96687879389313
GOBP_SOMATOSTATIN_RECEPTOR_S...,SET,6,0.20354,0.003677,0.33696,0.27291,GOBP_SOMATOSTATIN_RECEPTOR_SIGNALING_PATHWAY,0.96687879389313
WP_MICROTUBULE_CYTOSKELETON_...,SET,48,0.068717,0.0035072,0.11377,0.27292,WP_MICROTUBULE_CYTOSKELETON_REGULATION,0.96687879389313
GOBP_DIAPEDESIS,SET,6,0.22682,0.0040976,0.37553,0.27293,GOBP_DIAPEDESIS,0.96687879389313
PELLICCIOTTA_HDAC_IN_ANTIGEN...1,SET,49,0.067494,0.0034804,0.11177,0.27297,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_DN,0.96687879389313
GOCC_MICROTUBULE_MINUS_END,SET,6,0.26324,0.0047555,0.43593,0.27298,GOCC_MICROTUBULE_MINUS_END,0.96687879389313
HP_PHONIC_TICS,SET,5,0.21446,0.0035368,0.35525,0.27303,HP_PHONIC_TICS,0.96687879389313
KEGG_MEDICUS_REFERENCE_LIGHT...,SET,9,0.16014,0.0035429,0.26535,0.27309,KEGG_MEDICUS_REFERENCE_LIGHT_HVEM_NFKB_SIGNALING_PATHWAY,0.96687879389313
REACTOME_FOXO_MEDIATED_TRANS...2,SET,16,0.13928,0.0041077,0.23078,0.27309,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_CELL_CYCLE_GENES,0.96687879389313
GOMF_NAD_DEPENDENT_PROTEIN_L...,SET,7,0.17592,0.0034325,0.29152,0.27311,GOMF_NAD_DEPENDENT_PROTEIN_LYSINE_DEACETYLASE_ACTIVITY,0.96687879389313
GSE14769_UNSTIM_VS_60MIN_LPS...1,SET,189,0.038988,0.0039333,0.064614,0.27313,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_DN,0.96687879389313
GSE22886_NAIVE_BCELL_VS_DC_UP,SET,153,0.041743,0.0037927,0.069186,0.27315,GSE22886_NAIVE_BCELL_VS_DC_UP,0.96687879389313
GSE360_CTRL_VS_B_MALAYI_HIGH...1,SET,177,0.038151,0.0037259,0.063245,0.27318,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_DN,0.96687879389313
GOBP_EMBRYONIC_HEART_TUBE_MO...,SET,70,0.060658,0.0037363,0.10057,0.27322,GOBP_EMBRYONIC_HEART_TUBE_MORPHOGENESIS,0.96687879389313
GOBP_NEGATIVE_REGULATION_OF_...678,SET,65,0.068807,0.0040847,0.11409,0.27322,GOBP_NEGATIVE_REGULATION_OF_T_CELL_PROLIFERATION,0.96687879389313
HP_LIMB_HYPERTONIA,SET,143,0.040784,0.0035835,0.06763,0.27324,HP_LIMB_HYPERTONIA,0.96687879389313
KEGG_MEDICUS_REFERENCE_RECRU...,SET,9,0.19271,0.0042633,0.31957,0.27325,KEGG_MEDICUS_REFERENCE_RECRUITMENT_AND_FORMATION_OF_THE_MCC,0.96687879389313
GOCC_BBSOME,SET,8,0.17923,0.0037385,0.29733,0.27332,GOCC_BBSOME,0.96687879389313
BIOCARTA_NGF_PATHWAY,SET,19,0.11522,0.0037027,0.19114,0.27333,BIOCARTA_NGF_PATHWAY,0.96687879389313
GOCC_BOX_H_ACA_RNP_COMPLEX,SET,3,0.24074,0.0030755,0.39937,0.27333,GOCC_BOX_H_ACA_RNP_COMPLEX,0.96687879389313
GOCC_BOX_H_ACA_TELOMERASE_RN...,SET,3,0.24074,0.0030755,0.39937,0.27333,GOCC_BOX_H_ACA_TELOMERASE_RNP_COMPLEX,0.96687879389313
BIOCARTA_IL10_PATHWAY,SET,13,0.14859,0.0039505,0.24671,0.2735,BIOCARTA_IL10_PATHWAY,0.966937656075525
REACTOME_DISPLACEMENT_OF_DNA...,SET,9,0.1627,0.0035994,0.27017,0.27352,REACTOME_DISPLACEMENT_OF_DNA_GLYCOSYLASE_BY_APEX1,0.966937656075525
CUI_DEVELOPING_HEART_5TH_WEE...2,SET,64,0.067511,0.0039769,0.1121,0.27352,CUI_DEVELOPING_HEART_5TH_WEEK_VENTRICULAR_CARDIOMYOCYTE,0.966937656075525
GSE23505_UNTREATED_VS_4DAY_I...6,SET,171,0.035659,0.0034236,0.059237,0.2736,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_UP,0.966937656075525
WILCOX_RESPONSE_TO_PROGESTER...1,SET,57,0.070363,0.0039124,0.1169,0.27363,WILCOX_RESPONSE_TO_PROGESTERONE_DN,0.966937656075525
MODULE_70,SET,39,0.082935,0.0038163,0.1378,0.27364,MODULE_70,0.966937656075525
GSE18281_PERIMEDULLARY_CORTI...4,SET,187,0.036703,0.0036833,0.061011,0.27373,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.966937656075525
GOBP_POSITIVE_REGULATION_OF_...412,SET,111,0.049227,0.003814,0.081832,0.27374,GOBP_POSITIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,0.966937656075525
GOMF_RECEPTOR_TYROSINE_KINAS...,SET,76,0.054405,0.0034913,0.090454,0.27377,GOMF_RECEPTOR_TYROSINE_KINASE_BINDING,0.966937656075525
OHASHI_AURKA_TARGETS,SET,5,0.20369,0.0033592,0.33868,0.27379,OHASHI_AURKA_TARGETS,0.966937656075525
GSE17721_LPS_VS_CPG_16H_BMDC...1,SET,184,0.034557,0.0034403,0.057469,0.27382,GSE17721_LPS_VS_CPG_16H_BMDC_DN,0.966937656075525
GOBP_REGULATION_OF_CYCLIN_DE...,SET,73,0.057442,0.003613,0.09553,0.27383,GOBP_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,0.966937656075525
MIR6782_5P,SET,37,0.082628,0.0037036,0.13742,0.27384,MIR6782_5P,0.966937656075525
GOBP_T_CELL_CHEMOTAXIS,SET,24,0.10754,0.0038836,0.17887,0.27385,GOBP_T_CELL_CHEMOTAXIS,0.966937656075525
GOBP_MEMBRANE_DEPOLARIZATION...3,SET,21,0.12388,0.004185,0.20608,0.27388,GOBP_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.966937656075525
BUSSLINGER_GASTRIC_NECK_CELLS,SET,34,0.094492,0.0040604,0.15719,0.27388,BUSSLINGER_GASTRIC_NECK_CELLS,0.966937656075525
GOBP_NEGATIVE_REGULATION_OF_...411,SET,83,0.053518,0.0035884,0.089047,0.27392,GOBP_NEGATIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,0.966937656075525
QUEREC_MODEL_PBMC_YF_17D_VAC...1,SET,46,0.072275,0.0036113,0.12027,0.27394,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_PREDICTIVE,0.966937656075525
REACTOME_RELEASE_OF_HH_NP_FR...,SET,8,0.1691,0.0035271,0.2814,0.27396,REACTOME_RELEASE_OF_HH_NP_FROM_THE_SECRETING_CELL,0.966937656075525
HP_LATERAL_VENTRICLE_DILATAT...,SET,75,0.056635,0.0036105,0.094263,0.27398,HP_LATERAL_VENTRICLE_DILATATION,0.966937656075525
GOCC_SPHERICAL_HIGH_DENSITY_...,SET,8,0.17749,0.0037022,0.29544,0.274,GOCC_SPHERICAL_HIGH_DENSITY_LIPOPROTEIN_PARTICLE,0.966937656075525
HUI_MAPK14_TARGETS_UP,SET,18,0.12171,0.0038069,0.20261,0.27402,HUI_MAPK14_TARGETS_UP,0.966937656075525
GOBP_POST_TRANSCRIPTIONAL_RE...,SET,466,0.02326,0.0036565,0.038723,0.27404,GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION,0.966937656075525
GOMF_OXIDOREDUCTASE_ACTIVITY...21,SET,38,0.084969,0.0038596,0.14146,0.27404,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_NAD_P_H_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.966937656075525
GOBP_REGULATION_OF_ADIPOSE_T...,SET,14,0.13742,0.0037912,0.22879,0.27405,GOBP_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,0.966937656075525
ATGTCAC_MIR489,SET,77,0.060794,0.0039268,0.10123,0.27407,ATGTCAC_MIR489,0.966937656075525
REACTOME_NR1H2_NR1H3_REGULAT...4,SET,9,0.14293,0.0031622,0.23832,0.27434,REACTOME_NR1H2_NR1H3_REGULATE_GENE_EXPRESSION_TO_CONTROL_BILE_ACID_HOMEOSTASIS,0.967771914958393
KEGG_MEDICUS_VARIANT_BCR_ABL...2,SET,13,0.13617,0.0036202,0.2271,0.27439,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.967771914958393
GSE15330_HSC_VS_GRANULOCYTE_...4,SET,185,0.035073,0.003501,0.058492,0.27439,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.967771914958393
GOBP_CHORIONIC_TROPHOBLAST_C...2,SET,5,0.22702,0.003744,0.3787,0.27443,GOBP_CHORIONIC_TROPHOBLAST_CELL_PROLIFERATION,0.967787109375
GOMF_TRANSPORTER_ACTIVATOR_A...,SET,7,0.18515,0.0036127,0.30888,0.27445,GOMF_TRANSPORTER_ACTIVATOR_ACTIVITY,0.967787109375
HP_AMEGAKARYOCYTIC_THROMBOCY...,SET,6,0.19106,0.0034515,0.31881,0.27449,HP_AMEGAKARYOCYTIC_THROMBOCYTOPENIA,0.967802297626293
TRAVAGLINI_LUNG_CAPILLARY_IN...1,SET,150,0.044906,0.0040402,0.074938,0.27451,TRAVAGLINI_LUNG_CAPILLARY_INTERMEDIATE_1_CELL,0.967802297626293
GOMF_OXYGEN_SENSOR_ACTIVITY,SET,5,0.17719,0.0029222,0.29574,0.27454,GOMF_OXYGEN_SENSOR_ACTIVITY,0.96780988944112
GSE37532_WT_VS_PPARG_KO_VISC...2,SET,173,0.037684,0.0036388,0.062928,0.27464,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_UP,0.968064219066937
MIR7156_3P,SET,89,0.052513,0.0036454,0.087735,0.27474,MIR7156_3P,0.968187579811493
GOBP_POSITIVE_REGULATION_OF_...445,SET,26,0.10111,0.0038004,0.16894,0.27475,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,0.968187579811493
MANNE_COVID19_COMBINED_COHOR...2,SET,162,0.039177,0.0036619,0.065464,0.27477,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_UP,0.968187579811493
DESCARTES_FETAL_HEART_SMOOTH...,SET,36,0.09081,0.0040151,0.15178,0.27483,DESCARTES_FETAL_HEART_SMOOTH_MUSCLE_CELLS,0.968187579811493
GSE10211_UV_INACT_SENDAI_VS_...2,SET,141,0.041891,0.0036551,0.070021,0.27484,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_UP,0.968187579811493
GOBP_REGULATION_OF_CARDIAC_M...6,SET,25,0.10594,0.0039044,0.17709,0.27485,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.968187579811493
HP_ESOPHAGEAL_STENOSIS,SET,29,0.089993,0.0035719,0.15045,0.27487,HP_ESOPHAGEAL_STENOSIS,0.968187579811493
HP_DIFFUSE_ALVEOLAR_HEMORRHA...,SET,16,0.13123,0.0038704,0.21947,0.27493,HP_DIFFUSE_ALVEOLAR_HEMORRHAGE,0.968288172424273
DAZARD_UV_RESPONSE_CLUSTER_G3,SET,13,0.13942,0.0037068,0.23323,0.27499,DAZARD_UV_RESPONSE_CLUSTER_G3,0.968288172424273
HP_REDUCED_FEV1_FVC_RATIO,SET,7,0.18981,0.0037036,0.31751,0.27499,HP_REDUCED_FEV1_FVC_RATIO,0.968288172424273
KEGG_MEDICUS_PATHOGEN_SHIGEL...3,SET,9,0.1795,0.0039711,0.3003,0.27501,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAB_C_D_TO_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,0.968288172424273
REACTOME_EARLY_SARS_COV_2_IN...,SET,34,0.087699,0.0037685,0.14675,0.27505,REACTOME_EARLY_SARS_COV_2_INFECTION_EVENTS,0.968330910656402
GOBP_POSITIVE_REGULATION_OF_...376,SET,58,0.068887,0.0038637,0.11531,0.27512,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_8_PRODUCTION,0.96845155965161
GOMF_TRNA_BINDING,SET,62,0.05667,0.0032859,0.09487,0.27514,GOMF_TRNA_BINDING,0.96845155965161
HP_DOWNTURNED_CORNERS_OF_MOU...,SET,150,0.040708,0.0036626,0.068179,0.27523,HP_DOWNTURNED_CORNERS_OF_MOUTH,0.968477530466311
HALLMARK_HEME_METABOLISM,SET,179,0.037563,0.0036889,0.062925,0.27528,HALLMARK_HEME_METABOLISM,0.968477530466311
GOCC_CATALYTIC_STEP_1_SPLICE...,SET,10,0.13517,0.0031521,0.22648,0.27531,GOCC_CATALYTIC_STEP_1_SPLICEOSOME,0.968477530466311
WP_MIRNAS_INVOLVED_IN_DNA_DA...,SET,14,0.13967,0.0038534,0.23406,0.27535,WP_MIRNAS_INVOLVED_IN_DNA_DAMAGE_RESPONSE,0.968477530466311
GSE26669_CD4_VS_CD8_TCELL_IN...3,SET,179,0.036987,0.0036323,0.062011,0.27544,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_DN,0.968477530466311
GSE21927_GMCSF_IL6_VS_GMCSF_...2,SET,144,0.039958,0.003523,0.066997,0.27545,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,0.968477530466311
MIR6741_3P,SET,5,0.21805,0.003596,0.36569,0.2755,MIR6741_3P,0.968477530466311
HP_DECREASED_SERUM_LEPTIN,SET,11,0.16315,0.0039902,0.27367,0.27554,HP_DECREASED_SERUM_LEPTIN,0.968477530466311
GOMF_BH3_DOMAIN_BINDING,SET,5,0.24261,0.0040011,0.40701,0.27556,GOMF_BH3_DOMAIN_BINDING,0.968477530466311
REACTOME_NEGATIVE_REGULATION...11,SET,5,0.19177,0.0031626,0.32175,0.27558,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS,0.968477530466311
GOMF_INTRACELLULARLY_CGMP_AC...,SET,6,0.20632,0.0037272,0.34626,0.27564,GOMF_INTRACELLULARLY_CGMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,0.968477530466311
MIR144_5P,SET,47,0.070886,0.0035801,0.11898,0.27567,MIR144_5P,0.968477530466311
GOBP_PENETRATION_OF_ZONA_PEL...,SET,9,0.17039,0.0037697,0.28606,0.27571,GOBP_PENETRATION_OF_ZONA_PELLUCIDA,0.968477530466311
MIR3664_3P,SET,141,0.040696,0.0035508,0.06833,0.27573,MIR3664_3P,0.968477530466311
GOMF_WD40_REPEAT_DOMAIN_BIND...,SET,4,0.22604,0.0033343,0.37958,0.27576,GOMF_WD40_REPEAT_DOMAIN_BINDING,0.968477530466311
HP_PERINEAL_FISTULA,SET,12,0.14014,0.0035797,0.23534,0.27577,HP_PERINEAL_FISTULA,0.968477530466311
HP_SMALL_FORAMEN_MAGNUM,SET,11,0.13932,0.0034073,0.23401,0.27581,HP_SMALL_FORAMEN_MAGNUM,0.968477530466311
RORIE_TARGETS_OF_EWSR1_FLI1_...2,SET,24,0.11934,0.0043096,0.20047,0.27583,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.968477530466311
GOBP_PHAGOSOME_LYSOSOME_FUSI...,SET,13,0.14898,0.0039609,0.25032,0.27587,GOBP_PHAGOSOME_LYSOSOME_FUSION,0.968477530466311
KEGG_MEDICUS_REFERENCE_AUTOP...6,SET,16,0.11786,0.0034759,0.19804,0.27588,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_MTORC1_PI3KC3_C1,0.968477530466311
HP_CERVICAL_SUBLUXATION,SET,8,0.17156,0.0035785,0.28828,0.27589,HP_CERVICAL_SUBLUXATION,0.968477530466311
MIR7114_5P,SET,136,0.04379,0.0037529,0.073587,0.2759,MIR7114_5P,0.968477530466311
GOBP_VISUAL_BEHAVIOR,SET,53,0.071558,0.0038372,0.12025,0.2759,GOBP_VISUAL_BEHAVIOR,0.968477530466311
GOMF_SULFATE_TRANSMEMBRANE_T...,SET,15,0.12885,0.0036796,0.21658,0.27594,GOMF_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.968477530466311
HP_SENSORY_AXONAL_NEUROPATHY,SET,36,0.080688,0.0035676,0.13562,0.27594,HP_SENSORY_AXONAL_NEUROPATHY,0.968477530466311
HP_HYPOPLASTIC_ANEMIA,SET,6,0.17544,0.0031694,0.29492,0.27597,HP_HYPOPLASTIC_ANEMIA,0.968477530466311
THRAP3_TARGET_GENES,SET,19,0.12169,0.0039107,0.20458,0.27598,THRAP3_TARGET_GENES,0.968477530466311
GSE3920_IFNA_VS_IFNG_TREATED...4,SET,161,0.038893,0.0036242,0.065405,0.27604,GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP,0.968477530466311
MIR6866_3P,SET,66,0.062018,0.0037098,0.10431,0.27608,MIR6866_3P,0.968477530466311
GOBP_CARBOHYDRATE_TRANSPORT,SET,126,0.046182,0.0038107,0.077678,0.27608,GOBP_CARBOHYDRATE_TRANSPORT,0.968477530466311
GOBP_FRUCTOSE_1_6_BISPHOSPHA...,SET,9,0.14239,0.0031503,0.23962,0.27618,GOBP_FRUCTOSE_1_6_BISPHOSPHATE_METABOLIC_PROCESS,0.968477530466311
REACTOME_DEFECTIVE_FACTOR_VI...,SET,5,0.22844,0.0037674,0.38449,0.27621,REACTOME_DEFECTIVE_FACTOR_VIII_CAUSES_HEMOPHILIA_A,0.968477530466311
TIEN_INTESTINE_PROBIOTICS_6H...1,SET,159,0.038877,0.0036003,0.06545,0.27626,TIEN_INTESTINE_PROBIOTICS_6HR_DN,0.968477530466311
HP_ABSENT_AXILLARY_HAIR,SET,12,0.15124,0.0038633,0.25463,0.27627,HP_ABSENT_AXILLARY_HAIR,0.968477530466311
GOBP_SEROTONIN_METABOLIC_PRO...,SET,10,0.16719,0.0038989,0.28153,0.2763,GOBP_SEROTONIN_METABOLIC_PROCESS,0.968477530466311
GOBP_NOTOCHORD_MORPHOGENESIS,SET,6,0.21723,0.0039243,0.36579,0.27631,GOBP_NOTOCHORD_MORPHOGENESIS,0.968477530466311
GOLDRATH_HOMEOSTATIC_PROLIFE...,SET,134,0.042994,0.0036577,0.072402,0.27632,GOLDRATH_HOMEOSTATIC_PROLIFERATION,0.968477530466311
HP_INCREASED_DENSITY_OF_LONG...,SET,11,0.16756,0.0040981,0.28227,0.27638,HP_INCREASED_DENSITY_OF_LONG_BONES,0.968477530466311
GOCC_SARCOPLASMIC_RETICULUM_...2,SET,42,0.074615,0.0035628,0.12572,0.27642,GOCC_SARCOPLASMIC_RETICULUM_MEMBRANE,0.968477530466311
GOBP_SPERMINE_METABOLIC_PROC...,SET,4,0.23122,0.0034107,0.38959,0.27643,GOBP_SPERMINE_METABOLIC_PROCESS,0.968477530466311
REACTOME_S_PHASE,SET,155,0.036713,0.0033572,0.061883,0.27651,REACTOME_S_PHASE,0.968477530466311
HP_ATYPICAL_SCARRING_OF_SKIN,SET,64,0.064258,0.0037853,0.10832,0.27652,HP_ATYPICAL_SCARRING_OF_SKIN,0.968477530466311
ETS_Q4,SET,228,0.033079,0.0036615,0.055766,0.27653,ETS_Q4,0.968477530466311
HP_RENAL_HYPOPLASIA,SET,116,0.046907,0.0037148,0.079078,0.27653,HP_RENAL_HYPOPLASIA,0.968477530466311
FARMER_BREAST_CANCER_CLUSTER...2,SET,32,0.090474,0.0037719,0.15252,0.27654,FARMER_BREAST_CANCER_CLUSTER_2,0.968477530466311
HP_ABNORMAL_EPIDIDYMIS_MORPH...,SET,10,0.16192,0.003776,0.27298,0.27654,HP_ABNORMAL_EPIDIDYMIS_MORPHOLOGY,0.968477530466311
GSE17721_CTRL_VS_PAM3CSK4_12...1,SET,185,0.036606,0.0036541,0.061714,0.27654,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_DN,0.968477530466311
KEGG_MEDICUS_VARIANT_MUTATIO...72,SET,5,0.21991,0.0036267,0.37088,0.27662,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ERBB4_TO_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,0.968477530466311
GOBP_CORTICOSTEROID_HORMONE_...,SET,18,0.12328,0.0038563,0.20797,0.27666,GOBP_CORTICOSTEROID_HORMONE_SECRETION,0.968477530466311
GOBP_RESPONSE_TO_THYROGLOBUL...,SET,5,0.25652,0.0042304,0.43271,0.27666,GOBP_RESPONSE_TO_THYROGLOBULIN_TRIIODOTHYRONINE,0.968477530466311
REACTOME_SIGNALING_BY_ROBO_R...,SET,198,0.033827,0.0034921,0.057067,0.27667,REACTOME_SIGNALING_BY_ROBO_RECEPTORS,0.968477530466311
ZNF20_TARGET_GENES,SET,5,0.20597,0.0033968,0.34748,0.27668,ZNF20_TARGET_GENES,0.968477530466311
GOBP_NOTCH_RECEPTOR_PROCESSI...,SET,8,0.16157,0.0033703,0.27259,0.27668,GOBP_NOTCH_RECEPTOR_PROCESSING,0.968477530466311
HP_TACHYCARDIA,SET,134,0.044524,0.0037879,0.075114,0.27668,HP_TACHYCARDIA,0.968477530466311
CUI_DEVELOPING_HEART_C9_B_T_...,SET,133,0.04502,0.0038159,0.075952,0.27668,CUI_DEVELOPING_HEART_C9_B_T_CELL,0.968477530466311
ZHU_CMV_24_HR_DN,SET,78,0.060915,0.0039599,0.10281,0.27675,ZHU_CMV_24_HR_DN,0.968549849003423
MEISSNER_NPC_ICP_WITH_H3_UNM...,SET,20,0.11672,0.0038481,0.19704,0.27682,MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED,0.968549849003423
GOCC_CONDENSED_CHROMOSOME,SET,250,0.030401,0.0035214,0.051327,0.27683,GOCC_CONDENSED_CHROMOSOME,0.968549849003423
WP_SEROTONIN_RECEPTOR_2_AND_...,SET,18,0.11649,0.0036438,0.19668,0.27684,WP_SEROTONIN_RECEPTOR_2_AND_ELKSRFGATA4_SIGNALING,0.968549849003423
HP_CONGENITAL_FINGER_FLEXION...,SET,11,0.16339,0.0039961,0.27587,0.27684,HP_CONGENITAL_FINGER_FLEXION_CONTRACTURES,0.968549849003423
HP_RECURRENT_HAEMOPHILUS_INF...,SET,22,0.11561,0.0039974,0.19531,0.27696,HP_RECURRENT_HAEMOPHILUS_INFLUENZAE_INFECTIONS,0.968809616545894
SCHLESINGER_METHYLATED_IN_CO...,SET,10,0.17672,0.004121,0.29857,0.27697,SCHLESINGER_METHYLATED_IN_COLON_CANCER,0.968809616545894
WP_ZINC_HOMEOSTASIS,SET,36,0.082854,0.0036633,0.14001,0.27701,WP_ZINC_HOMEOSTASIS,0.968836234797467
REACTOME_DEFECTS_OF_PLATELET...,SET,8,0.18588,0.0038772,0.31422,0.27708,REACTOME_DEFECTS_OF_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,0.968836234797467
HP_RIGHT_ATRIAL_ENLARGEMENT,SET,23,0.11159,0.0039452,0.1887,0.27714,HP_RIGHT_ATRIAL_ENLARGEMENT,0.968836234797467
HP_ABNORMAL_BLOOD_CHLORIDE_C...,SET,10,0.1747,0.004074,0.29544,0.27715,HP_ABNORMAL_BLOOD_CHLORIDE_CONCENTRATION,0.968836234797467
GSE3982_NEUTROPHIL_VS_TH1_UP,SET,171,0.038704,0.0037159,0.065455,0.27716,GSE3982_NEUTROPHIL_VS_TH1_UP,0.968836234797467
REACTOME_RUNX3_REGULATES_P14...,SET,10,0.14724,0.0034336,0.24909,0.27723,REACTOME_RUNX3_REGULATES_P14_ARF,0.968836234797467
MIR6879_3P,SET,41,0.080703,0.0038074,0.13653,0.27723,MIR6879_3P,0.968836234797467
HP_ABNORMALITY_OF_THROMBOCYT...,SET,426,0.024398,0.0036711,0.041282,0.27726,HP_ABNORMALITY_OF_THROMBOCYTES,0.968836234797467
GOBP_MAINTENANCE_OF_CENTROSO...,SET,5,0.17538,0.0028922,0.29677,0.27728,GOBP_MAINTENANCE_OF_CENTROSOME_LOCATION,0.968836234797467
HP_MEGACYSTIS,SET,9,0.17835,0.0039456,0.30181,0.27729,HP_MEGACYSTIS,0.968836234797467
GSE3982_DC_VS_TH2_UP,SET,181,0.038521,0.0038039,0.065195,0.27731,GSE3982_DC_VS_TH2_UP,0.968836234797467
GSE12507_PDC_CELL_LINE_VS_IM...1,SET,119,0.046806,0.003754,0.079222,0.27733,GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_DN,0.968836234797467
GOBP_RRNA_TRANSCRIPTION,SET,33,0.08204,0.0034732,0.13887,0.27734,GOBP_RRNA_TRANSCRIPTION,0.968836234797467
HP_STARING_GAZE,SET,20,0.10903,0.0035947,0.18462,0.27741,HP_STARING_GAZE,0.968983371859297
GOBP_POSITIVE_REGULATION_OF_...608,SET,69,0.058325,0.003567,0.098803,0.27749,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,0.969082805907173
GOBP_LYMPHOCYTE_ANERGY,SET,7,0.18746,0.0036578,0.31763,0.27754,GOBP_LYMPHOCYTE_ANERGY,0.969082805907173
BOYLAN_MULTIPLE_MYELOMA_C_D_...2,SET,125,0.043555,0.0035798,0.073805,0.27755,BOYLAN_MULTIPLE_MYELOMA_C_D_UP,0.969082805907173
HP_ABNORMALITY_OF_THE_PANCRE...,SET,284,0.029901,0.0036881,0.050669,0.27755,HP_ABNORMALITY_OF_THE_PANCREAS,0.969082805907173
chr12q24,SET,200,0.081824,0.0084891,0.13872,0.27764,chr12q24,0.969299668508287
GSE15330_HSC_VS_LYMPHOID_PRI...3,SET,181,0.036421,0.0035966,0.06176,0.27769,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_UP,0.96931632202369
MIR8052,SET,40,0.075032,0.0034966,0.12726,0.27774,MIR8052,0.96931632202369
GSE24574_BCL6_HIGH_VS_LOW_TF...2,SET,183,0.037573,0.0037305,0.063736,0.27776,GSE24574_BCL6_HIGH_VS_LOW_TFH_CD4_TCELL_UP,0.96931632202369
GSE22611_NOD2_VS_MUTANT_NOD2...2,SET,170,0.036667,0.0035101,0.062204,0.27778,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,0.96931632202369
DEMAGALHAES_AGING_DN,SET,13,0.13542,0.0036004,0.2298,0.27783,DEMAGALHAES_AGING_DN,0.96931632202369
PID_E2F_PATHWAY,SET,70,0.058901,0.0036281,0.099954,0.27784,PID_E2F_PATHWAY,0.96931632202369
GOBP_REGULATION_OF_CELL_FATE...1,SET,38,0.082433,0.0037444,0.13989,0.27784,GOBP_REGULATION_OF_CELL_FATE_COMMITMENT,0.96931632202369
chr7q21,SET,73,0.10725,0.0067457,0.18205,0.2779,chr7q21,0.969331041750301
HELLER_HDAC_TARGETS_UP,SET,252,0.031056,0.0036115,0.052718,0.2779,HELLER_HDAC_TARGETS_UP,0.969331041750301
HP_BLADDER_DIVERTICULUM,SET,29,0.10058,0.0039922,0.17081,0.27799,HP_BLADDER_DIVERTICULUM,0.969494419374248
GOBP_POSITIVE_REGULATION_OF_...368,SET,6,0.24943,0.0045061,0.42374,0.27805,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,0.969494419374248
KEGG_MEDICUS_PATHOGEN_EBV_EB...6,SET,9,0.17903,0.0039607,0.3042,0.2781,KEGG_MEDICUS_PATHOGEN_EBV_EBNA3C_TO_P27_CELL_CYCLE_G1_S_N00482,0.969494419374248
GSE7568_IL4_TGFB_DEXAMETHASO...1,SET,160,0.037537,0.003487,0.063785,0.27811,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_DN,0.969494419374248
MIR6862_5P,SET,44,0.079572,0.0038887,0.13523,0.27813,MIR6862_5P,0.969494419374248
HP_ABNORMAL_URINE_HORMONE_LE...,SET,16,0.1254,0.0036983,0.21312,0.27814,HP_ABNORMAL_URINE_HORMONE_LEVEL,0.969494419374248
GSE26495_NAIVE_VS_PD1HIGH_CD...2,SET,151,0.041456,0.0037422,0.070461,0.27815,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP,0.969494419374248
FOSTER_KDM1A_TARGETS_UP,SET,225,0.035315,0.0038835,0.060029,0.27817,FOSTER_KDM1A_TARGETS_UP,0.969494419374248
TRAVAGLINI_LUNG_SEROUS_CELL,SET,86,0.056012,0.0038225,0.095234,0.27822,TRAVAGLINI_LUNG_SEROUS_CELL,0.969571452922892
GOBP_RENAL_VESICLE_FORMATION,SET,8,0.18717,0.0039041,0.31828,0.27825,GOBP_RENAL_VESICLE_FORMATION,0.969578779827552
ATAACCT_MIR154,SET,59,0.059537,0.0033679,0.10126,0.27828,ATAACCT_MIR154,0.969586105263158
GOBP_DENDRITIC_SPINE_MAINTEN...,SET,21,0.11357,0.0038368,0.19321,0.27834,GOBP_DENDRITIC_SPINE_MAINTENANCE,0.969677736019242
MIR1301_3P_MIR5047,SET,105,0.049068,0.0036982,0.083495,0.27838,MIR1301_3P_MIR5047,0.969677736019242
KEGG_MEDICUS_VARIANT_MUTATIO...56,SET,24,0.10035,0.0036239,0.17077,0.27839,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.969677736019242
GOBP_RESPONSE_TO_EPINEPHRINE,SET,14,0.13599,0.0037519,0.23148,0.27844,GOBP_RESPONSE_TO_EPINEPHRINE,0.969754704880249
GOCC_HEMIDESMOSOME,SET,7,0.2099,0.0040955,0.3574,0.27851,GOCC_HEMIDESMOSOME,0.969894908421262
GOCC_NF_KAPPAB_COMPLEX,SET,5,0.22538,0.0037169,0.38384,0.27855,GOCC_NF_KAPPAB_COMPLEX,0.969894908421262
GOBP_PROTEIN_HOMOTETRAMERIZA...,SET,60,0.063948,0.0036478,0.10896,0.27864,GOBP_PROTEIN_HOMOTETRAMERIZATION,0.969894908421262
GOMF_MAGNESIUM_ION_BINDING,SET,209,0.033611,0.0035637,0.057279,0.27868,GOMF_MAGNESIUM_ION_BINDING,0.969894908421262
WP_CATABOLISM_OF_SKELETAL_MU...,SET,39,0.080496,0.0037041,0.13721,0.27871,WP_CATABOLISM_OF_SKELETAL_MUSCLE_IN_CACHEXIA,0.969894908421262
LAKE_ADULT_KIDNEY_C12_THICK_...,SET,328,0.027346,0.0036204,0.046617,0.27874,LAKE_ADULT_KIDNEY_C12_THICK_ASCENDING_LIMB,0.969894908421262
GOBP_PROTEIN_LOCALIZATION_TO...27,SET,5,0.20573,0.0033929,0.35074,0.27875,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_MEMBRANE,0.969894908421262
HP_SCLEROCORNEA,SET,43,0.072478,0.0035017,0.12356,0.27875,HP_SCLEROCORNEA,0.969894908421262
GSE26495_NAIVE_VS_PD1LOW_CD8...2,SET,153,0.040413,0.0036719,0.068934,0.27886,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_UP,0.969894908421262
MIR4681,SET,5,0.18421,0.003038,0.31436,0.27894,MIR4681,0.969894908421262
HP_PULMONARY_ARTERY_ATRESIA,SET,29,0.092448,0.0036694,0.15779,0.27897,HP_PULMONARY_ARTERY_ATRESIA,0.969894908421262
GOBP_PROTEIN_C_LINKED_GLYCOS...,SET,4,0.2715,0.0040049,0.46347,0.27901,GOBP_PROTEIN_C_LINKED_GLYCOSYLATION,0.969894908421262
HP_CRANIOFACIAL_OSTEOSCLEROS...,SET,13,0.13048,0.0034689,0.22279,0.27906,HP_CRANIOFACIAL_OSTEOSCLEROSIS,0.969894908421262
HP_SPINAL_RIGIDITY,SET,54,0.067161,0.0036351,0.11469,0.27908,HP_SPINAL_RIGIDITY,0.969894908421262
HP_ELEVATED_CIRCULATING_CATE...,SET,12,0.14853,0.003794,0.25367,0.2791,HP_ELEVATED_CIRCULATING_CATECHOLAMINE_LEVEL,0.969894908421262
GOBP_REGULATION_OF_GLIAL_CEL...2,SET,74,0.064593,0.0040904,0.11034,0.27915,GOBP_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.969894908421262
MIR2467_5P,SET,102,0.048323,0.0035899,0.082553,0.27916,MIR2467_5P,0.969894908421262
GOMF_DYNEIN_LIGHT_INTERMEDIA...,SET,28,0.085432,0.003332,0.14595,0.27916,GOMF_DYNEIN_LIGHT_INTERMEDIATE_CHAIN_BINDING,0.969894908421262
GOMF_TPR_DOMAIN_BINDING,SET,7,0.14513,0.0028317,0.248,0.27922,GOMF_TPR_DOMAIN_BINDING,0.969894908421262
NAKAMURA_ALVEOLAR_EPITHELIUM,SET,5,0.23109,0.0038111,0.39503,0.27928,NAKAMURA_ALVEOLAR_EPITHELIUM,0.969894908421262
GOBP_T_HELPER_CELL_LINEAGE_C...,SET,23,0.11439,0.0040441,0.19556,0.27929,GOBP_T_HELPER_CELL_LINEAGE_COMMITMENT,0.969894908421262
WAKABAYASHI_ADIPOGENESIS_PPA...4,SET,781,0.018211,0.0036735,0.031143,0.27936,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D,0.969894908421262
WP_PREIMPLANTATION_EMBRYO,SET,54,0.070148,0.0037968,0.11996,0.27936,WP_PREIMPLANTATION_EMBRYO,0.969894908421262
HP_ABSCESS,SET,61,0.066413,0.0038198,0.11359,0.27938,HP_ABSCESS,0.969894908421262
CHASSOT_SKIN_WOUND,SET,9,0.18752,0.0041487,0.32077,0.27941,CHASSOT_SKIN_WOUND,0.969894908421262
HP_HYPERTONIC_DEHYDRATION,SET,4,0.28405,0.00419,0.48598,0.27945,HP_HYPERTONIC_DEHYDRATION,0.969894908421262
GOBP_NEGATIVE_REGULATION_OF_...342,SET,67,0.066025,0.0039792,0.11297,0.27947,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MEDIATED_IMMUNITY,0.969894908421262
GOMF_K63_LINKED_POLYUBIQUITI...,SET,22,0.094439,0.0032655,0.16159,0.27947,GOMF_K63_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,0.969894908421262
GTCTACC_MIR379,SET,22,0.11431,0.0039526,0.19563,0.2795,GTCTACC_MIR379,0.969894908421262
HP_DECREASED_CIRCULATING_COM...2,SET,27,0.099229,0.0038005,0.16984,0.27953,HP_DECREASED_CIRCULATING_COMPLEMENT_C4_CONCENTRATION,0.969894908421262
GSE22601_DOUBLE_NEGATIVE_VS_...7,SET,164,0.03872,0.0036413,0.066277,0.27954,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_DN,0.969894908421262
GOBP_POSITIVE_REGULATION_OF_...118,SET,10,0.14292,0.0033328,0.24464,0.27955,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.969894908421262
ONGUSAHA_BRCA1_TARGETS_UP,SET,11,0.16463,0.0040263,0.28189,0.27961,ONGUSAHA_BRCA1_TARGETS_UP,0.969894908421262
HP_APLASIA_HYPOPLASIA_OF_TOE,SET,112,0.046503,0.0036191,0.079643,0.27965,HP_APLASIA_HYPOPLASIA_OF_TOE,0.969894908421262
REACTOME_METABOLISM_OF_WATER...,SET,120,0.04367,0.0035172,0.074805,0.27968,REACTOME_METABOLISM_OF_WATER_SOLUBLE_VITAMINS_AND_COFACTORS,0.969894908421262
GOBP_AORTA_MORPHOGENESIS,SET,33,0.094099,0.0039837,0.1612,0.2797,GOBP_AORTA_MORPHOGENESIS,0.969894908421262
GOBP_LOCOMOTORY_EXPLORATION_...,SET,15,0.13456,0.0038426,0.23052,0.2797,GOBP_LOCOMOTORY_EXPLORATION_BEHAVIOR,0.969894908421262
GOBP_GLOMERULAR_MESANGIUM_DE...,SET,16,0.13505,0.0039829,0.23136,0.27971,GOBP_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.969894908421262
GOBP_ORGANELLE_FISSION,SET,450,0.022318,0.0034491,0.038253,0.27981,GOBP_ORGANELLE_FISSION,0.969894908421262
MIR7706,SET,10,0.16737,0.003903,0.28693,0.27984,MIR7706,0.969894908421262
MIR1204,SET,6,0.20743,0.0037473,0.35564,0.27986,MIR1204,0.969894908421262
GOBP_PEPTIDYL_PROLINE_HYDROX...2,SET,8,0.13314,0.0027772,0.22831,0.2799,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION_TO_4_HYDROXY_L_PROLINE,0.969894908421262
GOMF_PEPTIDYL_PROLINE_4_DIOX...,SET,8,0.13314,0.0027772,0.22831,0.2799,GOMF_PEPTIDYL_PROLINE_4_DIOXYGENASE_ACTIVITY,0.969894908421262
GOBP_T_TUBULE_ORGANIZATION,SET,6,0.18886,0.0034119,0.32399,0.27998,GOBP_T_TUBULE_ORGANIZATION,0.969894908421262
BIOCARTA_ERBB3_PATHWAY,SET,5,0.25629,0.0042266,0.43969,0.27999,BIOCARTA_ERBB3_PATHWAY,0.969894908421262
MIR219B_3P,SET,54,0.066153,0.0035805,0.11349,0.27999,MIR219B_3P,0.969894908421262
HP_CHYLOTHORAX,SET,16,0.11865,0.0034993,0.20356,0.27999,HP_CHYLOTHORAX,0.969894908421262
GSE17721_LPS_VS_CPG_12H_BMDC...2,SET,178,0.037622,0.0036845,0.064552,0.28001,GSE17721_LPS_VS_CPG_12H_BMDC_UP,0.969894908421262
GSE31622_WT_VS_KLF3_KO_BCELL...2,SET,178,0.036055,0.003531,0.061873,0.28004,GSE31622_WT_VS_KLF3_KO_BCELL_UP,0.969894908421262
TORCHIA_TARGETS_OF_EWSR1_FLI...4,SET,241,0.032888,0.0037413,0.056444,0.28006,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP,0.969894908421262
ZNF138_TARGET_GENES,SET,3,0.24264,0.0030998,0.41643,0.28006,ZNF138_TARGET_GENES,0.969894908421262
GOBP_REGULATION_OF_CD40_SIGN...,SET,6,0.16644,0.0030067,0.28563,0.28006,GOBP_REGULATION_OF_CD40_SIGNALING_PATHWAY,0.969894908421262
HP_ABNORMALITY_OF_THE_DIAPHR...,SET,101,0.048264,0.003568,0.082843,0.28009,HP_ABNORMALITY_OF_THE_DIAPHRAGM,0.969894908421262
MIR6864_3P,SET,39,0.077782,0.0035792,0.13355,0.28015,MIR6864_3P,0.969894908421262
REACTOME_FORMATION_OF_INCISI...,SET,38,0.06725,0.0030547,0.11548,0.28017,REACTOME_FORMATION_OF_INCISION_COMPLEX_IN_GG_NER,0.969894908421262
KEGG_RIBOSOME,SET,79,0.053538,0.0035025,0.091938,0.28018,KEGG_RIBOSOME,0.969894908421262
GOMF_ACYLTRANSFERASE_ACTIVIT...1,SET,5,0.22677,0.0037398,0.38949,0.28021,GOMF_ACYLTRANSFERASE_ACTIVITY_ACYL_GROUPS_CONVERTED_INTO_ALKYL_ON_TRANSFER,0.969894908421262
NKX25_02,SET,232,0.034155,0.0038131,0.058664,0.28022,NKX25_02,0.969894908421262
GOBP_C21_STEROID_HORMONE_MET...,SET,35,0.092855,0.0040482,0.15949,0.28022,GOBP_C21_STEROID_HORMONE_METABOLIC_PROCESS,0.969894908421262
GOBP_REGULATION_OF_ENDOTHELI...5,SET,5,0.25586,0.0042196,0.43947,0.28022,GOBP_REGULATION_OF_ENDOTHELIAL_TUBE_MORPHOGENESIS,0.969894908421262
GSE22935_24H_VS_48H_MBOVIS_B...3,SET,179,0.037071,0.0036406,0.063676,0.28023,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,0.969894908421262
GSE3920_UNTREATED_VS_IFNA_TR...1,SET,146,0.041226,0.0036598,0.070817,0.28024,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_DN,0.969894908421262
GSE17721_LPS_VS_GARDIQUIMOD_...17,SET,182,0.035685,0.0035335,0.061314,0.28028,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_DN,0.969894908421262
GSE20151_CTRL_VS_FUSOBACT_NU...1,SET,174,0.036363,0.0035214,0.062485,0.2803,GSE20151_CTRL_VS_FUSOBACT_NUCLEATUM_NEUTROPHIL_DN,0.969894908421262
RBL1_TARGET_GENES,SET,36,0.080533,0.0035607,0.13841,0.28034,RBL1_TARGET_GENES,0.969894908421262
GSE14769_40MIN_VS_360MIN_LPS...1,SET,189,0.034305,0.0034608,0.05896,0.28035,GSE14769_40MIN_VS_360MIN_LPS_BMDM_DN,0.969894908421262
GSE22025_UNTREATED_VS_PROGES...2,SET,181,0.036827,0.0036366,0.063296,0.28035,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_UP,0.969894908421262
BIOCARTA_NKCELLS_PATHWAY,SET,18,0.12048,0.0037687,0.20714,0.2804,BIOCARTA_NKCELLS_PATHWAY,0.969971334726784
GSE2585_CTEC_VS_MTEC_THYMUS_...1,SET,188,0.036292,0.0036517,0.062424,0.2805,GSE2585_CTEC_VS_MTEC_THYMUS_DN,0.970096776119403
IGF1R_TARGET_GENES,SET,2,0.40382,0.0042123,0.69467,0.28052,IGF1R_TARGET_GENES,0.970096776119403
AKT_UP.V1_DN,SET,178,0.037846,0.0037064,0.065106,0.28052,AKT_UP.V1_DN,0.970096776119403
GOBP_T_CELL_ACTIVATION_INVOL...,SET,117,0.0496,0.0039448,0.085362,0.28061,GOBP_T_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,0.970311466520744
WP_TOLLLIKE_RECEPTOR_SIGNALI...1,SET,95,0.054049,0.0038758,0.093057,0.28068,WP_TOLLLIKE_RECEPTOR_SIGNALING,0.970456963788301
HP_ABNORMALITY_OF_THE_ACHILL...,SET,50,0.070877,0.0036918,0.12205,0.28072,HP_ABNORMALITY_OF_THE_ACHILLES_TENDON,0.970481900138696
GOBP_TRNA_3_END_PROCESSING,SET,6,0.16002,0.0028908,0.27565,0.28079,GOBP_TRNA_3_END_PROCESSING,0.970481900138696
IL15_UP.V1_DN,SET,157,0.039425,0.0036283,0.067953,0.2809,IL15_UP.V1_DN,0.970481900138696
GOCC_RAGULATOR_COMPLEX,SET,6,0.1643,0.0029681,0.28323,0.28094,GOCC_RAGULATOR_COMPLEX,0.970481900138696
GOBP_GLYCOSYL_COMPOUND_CATAB...,SET,31,0.10161,0.0041697,0.17523,0.281,GOBP_GLYCOSYL_COMPOUND_CATABOLIC_PROCESS,0.970481900138696
GSE31082_DN_VS_CD8_SP_THYMOC...2,SET,176,0.034752,0.0033844,0.059943,0.28105,GSE31082_DN_VS_CD8_SP_THYMOCYTE_UP,0.970481900138696
GSE15324_ELF4_KO_VS_WT_NAIVE...1,SET,175,0.037554,0.003647,0.064783,0.28107,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_DN,0.970481900138696
TOMLINS_PROSTATE_CANCER_DN,SET,36,0.083961,0.0037123,0.14485,0.28108,TOMLINS_PROSTATE_CANCER_DN,0.970481900138696
MGGAAGTG_GABP_B,SET,699,0.018292,0.0034989,0.031558,0.28108,MGGAAGTG_GABP_B,0.970481900138696
HP_ALBINISM,SET,18,0.12287,0.0038434,0.21201,0.28111,HP_ALBINISM,0.970481900138696
GOMF_PEPTIDOGLYCAN_BINDING,SET,18,0.12662,0.0039607,0.21852,0.28115,GOMF_PEPTIDOGLYCAN_BINDING,0.970481900138696
REACTOME_O_LINKED_GLYCOSYLAT...1,SET,100,0.053494,0.0039351,0.092344,0.2812,REACTOME_O_LINKED_GLYCOSYLATION,0.970481900138696
HOWARD_DENDRITIC_CELL_INACT_...1,SET,39,0.083048,0.0038216,0.14337,0.28121,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.970481900138696
REACTOME_NICOTINAMIDE_SALVAG...,SET,17,0.11666,0.0035464,0.2014,0.28122,REACTOME_NICOTINAMIDE_SALVAGING,0.970481900138696
HP_BROAD_FEMORAL_NECK,SET,16,0.11617,0.0034262,0.20064,0.28129,HP_BROAD_FEMORAL_NECK,0.970481900138696
GOBP_VASCULAR_ASSOCIATED_SMO...2,SET,11,0.1405,0.0034361,0.24266,0.28131,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DEVELOPMENT,0.970481900138696
GOBP_POSITIVE_REGULATION_OF_...466,SET,9,0.15857,0.003508,0.27391,0.28133,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_CALCIUM_ION_CONCENTRATION,0.970481900138696
GOCC_CELL_LEADING_EDGE,SET,399,0.024575,0.0035815,0.042452,0.28133,GOCC_CELL_LEADING_EDGE,0.970481900138696
HP_ABNORMAL_INTRAHEPATIC_BIL...,SET,28,0.095684,0.0037319,0.16528,0.28133,HP_ABNORMAL_INTRAHEPATIC_BILE_DUCT_MORPHOLOGY,0.970481900138696
GOBP_MEMBRANE_REPOLARIZATION...2,SET,5,0.24772,0.0040853,0.42795,0.28135,GOBP_MEMBRANE_REPOLARIZATION_DURING_ATRIAL_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,0.970481900138696
HP_BROAD_METATARSAL,SET,12,0.14319,0.0036576,0.24737,0.28135,HP_BROAD_METATARSAL,0.970481900138696
PANAPASA_BLOOD_FLUENZ_AGE_03...2,SET,9,0.18083,0.0040007,0.3125,0.28141,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_6DY_7DY_UP,0.970481900138696
ONDER_CDH1_TARGETS_2_DN,SET,445,0.02524,0.0038796,0.043619,0.28142,ONDER_CDH1_TARGETS_2_DN,0.970481900138696
GSE11057_NAIVE_CD4_VS_PBMC_C...2,SET,163,0.03722,0.0034896,0.064328,0.28143,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_UP,0.970481900138696
GSE21033_CTRL_VS_POLYIC_STIM...1,SET,177,0.036537,0.0035683,0.063155,0.28146,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_DN,0.970481900138696
MIR623,SET,107,0.046302,0.0035226,0.080056,0.28151,MIR623,0.970481900138696
GOBP_B_CELL_ACTIVATION,SET,245,0.032599,0.0037386,0.056373,0.28154,GOBP_B_CELL_ACTIVATION,0.970481900138696
BIOCARTA_TCR_PATHWAY,SET,43,0.072695,0.0035121,0.12571,0.28155,BIOCARTA_TCR_PATHWAY,0.970481900138696
GOMF_OLEATE_TRANSMEMBRANE_TR...,SET,6,0.19086,0.0034479,0.33007,0.28155,GOMF_OLEATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.970481900138696
GOMF_POLY_A_BINDING,SET,21,0.1091,0.0036857,0.1887,0.28158,GOMF_POLY_A_BINDING,0.970481900138696
GOBP_POSITIVE_REGULATION_OF_...606,SET,6,0.23608,0.0042648,0.40834,0.28159,GOBP_POSITIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,0.970481900138696
HP_LUPUS_ANTICOAGULANT,SET,4,0.27159,0.0040063,0.4699,0.28164,HP_LUPUS_ANTICOAGULANT,0.970481900138696
HP_HEMOPHAGOCYTOSIS,SET,19,0.11938,0.0038365,0.20659,0.28168,HP_HEMOPHAGOCYTOSIS,0.970481900138696
GOMF_CALCIUM_SENSITIVE_GUANY...,SET,5,0.24665,0.0040677,0.42688,0.2817,GOMF_CALCIUM_SENSITIVE_GUANYLATE_CYCLASE_ACTIVATOR_ACTIVITY,0.970481900138696
HP_RECURRENT_ABSCESS_FORMATI...,SET,16,0.1418,0.0041821,0.24543,0.28171,HP_RECURRENT_ABSCESS_FORMATION,0.970481900138696
ZNF7_TARGET_GENES,SET,680,0.019355,0.0036534,0.033502,0.28173,ZNF7_TARGET_GENES,0.970481900138696
GSE16385_ROSIGLITAZONE_IFNG_...2,SET,185,0.036562,0.0036497,0.063299,0.28177,GSE16385_ROSIGLITAZONE_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_UP,0.970481900138696
GOCC_ATG1_ULK1_KINASE_COMPLEX,SET,9,0.16971,0.0037547,0.29385,0.28178,GOCC_ATG1_ULK1_KINASE_COMPLEX,0.970481900138696
HP_ABNORMAL_LYMPHOCYTE_PROLI...,SET,39,0.078603,0.003617,0.13612,0.28182,HP_ABNORMAL_LYMPHOCYTE_PROLIFERATION,0.970481900138696
BEGUM_TARGETS_OF_PAX3_FOXO1_...2,SET,46,0.07897,0.0039458,0.13677,0.28185,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_DN,0.970481900138696
KOHN_EMT_MESENCHYMAL,SET,14,0.12758,0.0035197,0.22097,0.28186,KOHN_EMT_MESENCHYMAL,0.970481900138696
GOMF_IRON_ION_BINDING,SET,139,0.043364,0.0037569,0.075109,0.28186,GOMF_IRON_ION_BINDING,0.970481900138696
GOBP_ENAMEL_MINERALIZATION,SET,18,0.11736,0.0036709,0.20331,0.28189,GOBP_ENAMEL_MINERALIZATION,0.970489049034175
REACTOME_REGULATION_OF_TLR_B...,SET,20,0.12718,0.0041931,0.22038,0.28194,REACTOME_REGULATION_OF_TLR_BY_ENDOGENOUS_LIGAND,0.970565045562599
HP_POST_PARTUM_HEMORRHAGE,SET,13,0.14427,0.0038356,0.25014,0.28205,HP_POST_PARTUM_HEMORRHAGE,0.970759709026128
MIR624_3P,SET,90,0.051933,0.0036252,0.090049,0.28207,MIR624_3P,0.970759709026128
REACTOME_DOWNSTREAM_SIGNAL_T...,SET,29,0.089178,0.0035396,0.15468,0.28213,REACTOME_DOWNSTREAM_SIGNAL_TRANSDUCTION,0.970759709026128
GGGTGGRR_PAX4_03,SET,1158,0.014893,0.0036186,0.025837,0.28217,GGGTGGRR_PAX4_03,0.970759709026128
GOMF_COLLAGEN_RECEPTOR_ACTIV...,SET,6,0.19547,0.0035312,0.33911,0.28217,GOMF_COLLAGEN_RECEPTOR_ACTIVITY,0.970759709026128
HP_SCLEROSIS_OF_SKULL_BASE,SET,13,0.15096,0.0040135,0.26191,0.28218,HP_SCLEROSIS_OF_SKULL_BASE,0.970759709026128
MIR376C_3P,SET,138,0.041274,0.003563,0.071613,0.2822,MIR376C_3P,0.970759709026128
GOMF_PROTEIN_CONTAINING_COMP...2,SET,15,0.1259,0.0035952,0.21847,0.28222,GOMF_PROTEIN_CONTAINING_COMPLEX_DESTABILIZING_ACTIVITY,0.970759709026128
MORF_GPX4,SET,47,0.067645,0.0034164,0.11741,0.28226,MORF_GPX4,0.970801217219198
BIOCARTA_NUCLEARRS_PATHWAY,SET,34,0.085081,0.003656,0.14774,0.28235,BIOCARTA_NUCLEARRS_PATHWAY,0.971014669503265
MIR210_3P,SET,10,0.14837,0.0034599,0.25767,0.28238,MIR210_3P,0.971021757197982
GOBP_OPTIC_NERVE_DEVELOPMENT,SET,20,0.11312,0.0037296,0.19656,0.28248,GOBP_OPTIC_NERVE_DEVELOPMENT,0.971269529085873
GOMF_ACETYLTRANSFERASE_ACTIV...,SET,88,0.047608,0.0032864,0.082751,0.28254,GOMF_ACETYLTRANSFERASE_ACTIVITY,0.971379730932832
GOBP_PRESYNAPTIC_MEMBRANE_OR...,SET,6,0.17972,0.0032467,0.31243,0.28257,GOBP_PRESYNAPTIC_MEMBRANE_ORGANIZATION,0.97138678041543
GOBP_REGULATION_OF_BONE_MINE...1,SET,70,0.059885,0.0036887,0.10414,0.28263,GOBP_REGULATION_OF_BONE_MINERALIZATION,0.97149694886757
GOCC_TRANSPORT_VESICLE_MEMBR...,SET,221,0.032684,0.0035624,0.056909,0.28288,GOCC_TRANSPORT_VESICLE_MEMBRANE,0.971753643364929
LOPEZ_MESOTHELIOMA_SURVIVAL_...5,SET,7,0.18276,0.0035661,0.31823,0.28289,LOPEZ_MESOTHELIOMA_SURVIVAL_WORST_VS_BEST_DN,0.971753643364929
MODULE_259,SET,41,0.081396,0.0038402,0.14174,0.28289,MODULE_259,0.971753643364929
REACTOME_DEGRADATION_OF_DVL,SET,54,0.058228,0.0031516,0.10142,0.28295,REACTOME_DEGRADATION_OF_DVL,0.971753643364929
MIR6801_5P,SET,97,0.051183,0.0037086,0.089152,0.28295,MIR6801_5P,0.971753643364929
GSE21670_TGFB_VS_TGFB_AND_IL...1,SET,175,0.035358,0.0034337,0.061589,0.28296,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_DN,0.971753643364929
GSE18791_CTRL_VS_NEWCASTLE_V...19,SET,179,0.037259,0.003659,0.064908,0.28298,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_8H_DN,0.971753643364929
GOMF_3_HYDROXYACYL_COA_DEHYD...2,SET,5,0.22493,0.0037094,0.39186,0.28299,GOMF_3_HYDROXYACYL_COA_DEHYDROGENASE_ACTIVITY,0.971753643364929
WP_NUCLEAR_RECEPTORS_IN_LIPI...,SET,33,0.085785,0.0036318,0.14949,0.28304,WP_NUCLEAR_RECEPTORS_IN_LIPID_METABOLISM_AND_TOXICITY,0.971753643364929
GOBP_PROTEIN_CONTAINING_COMP...1,SET,1375,0.013087,0.0034431,0.022807,0.28305,GOBP_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,0.971753643364929
HUNSBERGER_EXERCISE_REGULATE...,SET,28,0.098463,0.0038403,0.17161,0.28306,HUNSBERGER_EXERCISE_REGULATED_GENES,0.971753643364929
GOBP_MATURE_B_CELL_DIFFERENT...1,SET,35,0.087422,0.0038114,0.15237,0.28307,GOBP_MATURE_B_CELL_DIFFERENTIATION,0.971753643364929
ZBED4_TARGET_GENES,SET,248,0.029929,0.0034531,0.052173,0.2831,ZBED4_TARGET_GENES,0.971753643364929
GOMF_TRNA_CYTIDINE_METHYLTRA...,SET,9,0.14863,0.0032883,0.25914,0.28314,GOMF_TRNA_CYTIDINE_METHYLTRANSFERASE_ACTIVITY,0.971753643364929
GSE17721_CTRL_VS_GARDIQUIMOD...11,SET,180,0.035918,0.0035371,0.062631,0.28316,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_DN,0.971753643364929
GSE36891_UNSTIM_VS_PAM_TLR2_...2,SET,174,0.037545,0.0036358,0.065468,0.28316,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,0.971753643364929
MIR4701_5P,SET,107,0.048123,0.0036611,0.083921,0.28318,MIR4701_5P,0.971753643364929
GOBP_REGULATION_OF_MACROPHAG...5,SET,23,0.11267,0.0039832,0.19655,0.28325,GOBP_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.971871819526627
ZNF529_TARGET_GENES,SET,33,0.078639,0.0033292,0.13723,0.28331,ZNF529_TARGET_GENES,0.971871819526627
REACTOME_FOXO_MEDIATED_TRANS...1,SET,63,0.063708,0.0037235,0.11118,0.28332,REACTOME_FOXO_MEDIATED_TRANSCRIPTION,0.971871819526627
GOBP_DIACYLGLYCEROL_BIOSYNTH...,SET,9,0.17608,0.0038955,0.30735,0.28336,GOBP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.971871819526627
CYCLIN_D1_UP.V1_UP,SET,170,0.037851,0.0036235,0.066069,0.28336,CYCLIN_D1_UP.V1_UP,0.971871819526627
ZNF318_TARGET_GENES,SET,826,0.017015,0.0035251,0.029709,0.28342,ZNF318_TARGET_GENES,0.971871819526627
GOMF_G_PROTEIN_COUPLED_RECEP...3,SET,4,0.20723,0.0030568,0.36191,0.28346,GOMF_G_PROTEIN_COUPLED_RECEPTOR_KINASE_ACTIVITY,0.971871819526627
REACTOME_PCP_CE_PATHWAY,SET,88,0.048191,0.0033266,0.084176,0.2835,REACTOME_PCP_CE_PATHWAY,0.971871819526627
TAFAZZIN_TARGET_GENES,SET,368,0.025149,0.0035229,0.043936,0.28353,TAFAZZIN_TARGET_GENES,0.971871819526627
HP_FEMUR_FRACTURE,SET,5,0.17477,0.0028822,0.30533,0.28353,HP_FEMUR_FRACTURE,0.971871819526627
HP_EARLY_ONSET_OF_SEXUAL_MAT...,SET,150,0.040864,0.0036766,0.071394,0.28354,HP_EARLY_ONSET_OF_SEXUAL_MATURATION,0.971871819526627
GSE20715_0H_VS_6H_OZONE_LUNG...2,SET,182,0.036208,0.0035853,0.063265,0.28355,GSE20715_0H_VS_6H_OZONE_LUNG_UP,0.971871819526627
HP_APLASIA_HYPOPLASIA_OF_THE...79,SET,43,0.074403,0.0035946,0.13011,0.28371,HP_APLASIA_HYPOPLASIA_OF_THE_VAGINA,0.972058718125431
GOBP_POSITIVE_REGULATION_OF_...264,SET,72,0.055275,0.0034529,0.096668,0.28373,GOBP_POSITIVE_REGULATION_OF_EXOCYTOSIS,0.972058718125431
GOMF_OXIDOREDUCTASE_ACTIVITY...19,SET,164,0.038609,0.0036308,0.067534,0.28376,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN,0.972058718125431
HP_DECREASED_BODY_MASS_INDEX,SET,20,0.11613,0.0038289,0.20317,0.2838,HP_DECREASED_BODY_MASS_INDEX,0.972058718125431
HP_THORACIC_AORTA_CALCIFICAT...,SET,5,0.24514,0.0040428,0.42895,0.28384,HP_THORACIC_AORTA_CALCIFICATION,0.972058718125431
GSE15330_HSC_VS_GRANULOCYTE_...2,SET,174,0.035003,0.0033896,0.061248,0.28384,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.972058718125431
GOBP_IMMUNE_RESPONSE_INHIBIT...1,SET,8,0.18848,0.0039315,0.32997,0.28393,GOBP_IMMUNE_RESPONSE_INHIBITING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.972058718125431
GOBP_REGULATION_OF_ENDOCYTIC...,SET,18,0.11511,0.0036005,0.20153,0.28395,GOBP_REGULATION_OF_ENDOCYTIC_RECYCLING,0.972058718125431
GOBP_HIGH_DENSITY_LIPOPROTEI...3,SET,17,0.12856,0.0039082,0.2251,0.28396,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,0.972058718125431
MEK_UP.V1_UP,SET,177,0.038422,0.0037524,0.06728,0.28398,MEK_UP.V1_UP,0.972058718125431
STEINER_ERYTHROCYTE_MEMBRANE...,SET,14,0.12598,0.0034758,0.22065,0.28402,STEINER_ERYTHROCYTE_MEMBRANE_GENES,0.972058718125431
TCTATGA_MIR376A_MIR376B,SET,79,0.05406,0.0035366,0.094687,0.28403,TCTATGA_MIR376A_MIR376B,0.972058718125431
KEGG_MEDICUS_REFERENCE_NOTCH...1,SET,9,0.1679,0.0037146,0.29414,0.28406,KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION,0.972058718125431
LI_PBMC_MENACTRA_AGE_18_45YO...2,SET,15,0.13279,0.003792,0.23262,0.28406,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_DT_ANTIBODY_CORRELATION_PROFILE_3DY_DN,0.972058718125431
UNTERMAN_IPF_VS_CTRL_TREG_CE...1,SET,16,0.13943,0.004112,0.24427,0.28407,UNTERMAN_IPF_VS_CTRL_TREG_CELL_DN,0.972058718125431
HP_INCREASED_LAXITY_OF_FINGE...,SET,5,0.24661,0.0040669,0.43204,0.28407,HP_INCREASED_LAXITY_OF_FINGERS,0.972058718125431
MORF_MTA1,SET,93,0.046833,0.003323,0.08205,0.28408,MORF_MTA1,0.972058718125431
GSE32901_NAIVE_VS_TH17_NEG_C...1,SET,112,0.046913,0.003651,0.082266,0.28426,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_DN,0.972578883638512
MODULE_71,SET,19,0.12367,0.0039744,0.21694,0.28431,MODULE_71,0.972654203169603
HP_PNEUMOTHORAX,SET,72,0.059175,0.0036965,0.10388,0.28445,HP_PNEUMOTHORAX,0.972989530650399
GSE9037_CTRL_VS_LPS_1H_STIM_...4,SET,185,0.033649,0.003359,0.059078,0.28449,GSE9037_CTRL_VS_LPS_1H_STIM_IRAK4_KO_BMDM_UP,0.972989530650399
GOBP_RESPONSE_TO_GRAM_POSITI...,SET,6,0.1927,0.0034812,0.33834,0.2845,GOBP_RESPONSE_TO_GRAM_POSITIVE_BACTERIUM,0.972989530650399
MIR524_5P,SET,853,0.017148,0.0036074,0.030111,0.28452,MIR524_5P,0.972989530650399
WP_RANKLRANK_SIGNALING,SET,54,0.064447,0.0034882,0.11321,0.28459,WP_RANKLRANK_SIGNALING,0.973037929515419
GOBP_RESPONSE_TO_CELL_CYCLE_...,SET,7,0.18083,0.0035285,0.31778,0.28466,GOBP_RESPONSE_TO_CELL_CYCLE_CHECKPOINT_SIGNALING,0.973037929515419
GSE17974_0H_VS_24H_IN_VITRO_...1,SET,178,0.033064,0.0032381,0.058126,0.28474,GSE17974_0H_VS_24H_IN_VITRO_ACT_CD4_TCELL_DN,0.973037929515419
GOBP_MAINTENANCE_OF_LOCATION...,SET,210,0.033812,0.0035935,0.059448,0.28476,GOBP_MAINTENANCE_OF_LOCATION_IN_CELL,0.973037929515419
RIZ_ERYTHROID_DIFFERENTIATIO...2,SET,38,0.079723,0.0036213,0.1402,0.2848,RIZ_ERYTHROID_DIFFERENTIATION_6HR,0.973037929515419
GSE17721_CTRL_VS_GARDIQUIMOD...5,SET,183,0.035603,0.003535,0.06263,0.28486,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_DN,0.973037929515419
MARKEY_RB1_CHRONIC_LOF_DN,SET,108,0.049107,0.0037533,0.086403,0.2849,MARKEY_RB1_CHRONIC_LOF_DN,0.973037929515419
GSE13547_2H_VS_12_H_ANTI_IGM...3,SET,154,0.039152,0.0035688,0.068885,0.2849,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_DN,0.973037929515419
KEGG_MEDICUS_REFERENCE_MITOC...,SET,52,0.055398,0.0029425,0.097474,0.28491,KEGG_MEDICUS_REFERENCE_MITOCHONDRIAL_COMPLEX_UCP1_IN_THERMOGENESIS,0.973037929515419
HE_LIM_SUN_FETAL_LUNG_C5_LAR...,SET,1182,0.013613,0.0033393,0.023955,0.28493,HE_LIM_SUN_FETAL_LUNG_C5_LARGE_PRE_B_CELL,0.973037929515419
GSE14000_UNSTIM_VS_16H_LPS_D...1,SET,174,0.035945,0.0034809,0.063263,0.28496,GSE14000_UNSTIM_VS_16H_LPS_DC_DN,0.973037929515419
GSE2770_UNTREATED_VS_ACT_CD4...1,SET,181,0.034116,0.0033689,0.060058,0.285,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN,0.973037929515419
WP_VITAMIN_DSENSITIVE_CALCIU...,SET,34,0.08444,0.0036285,0.1487,0.28506,WP_VITAMIN_DSENSITIVE_CALCIUM_SIGNALING_IN_DEPRESSION,0.973037929515419
KEGG_MEDICUS_REFERENCE_MYOST...,SET,8,0.1711,0.003569,0.30131,0.28507,KEGG_MEDICUS_REFERENCE_MYOSTATIN_SIGNALING_PATHWAY,0.973037929515419
GSE6674_ANTI_IGM_VS_PL2_3_ST...2,SET,178,0.034091,0.0033387,0.06004,0.28509,GSE6674_ANTI_IGM_VS_PL2_3_STIM_BCELL_UP,0.973037929515419
HP_EMG_POSITIVE_SHARP_WAVES,SET,9,0.17464,0.0038637,0.30761,0.28511,HP_EMG_POSITIVE_SHARP_WAVES,0.973037929515419
MIR185_3P,SET,138,0.041414,0.0035751,0.072954,0.28513,MIR185_3P,0.973037929515419
KEGG_MEDICUS_VARIANT_MUTATIO...16,SET,14,0.12648,0.0034895,0.22285,0.28517,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_RAS_ERK_SIGNALING_PATHWAY,0.973037929515419
CREIGHTON_ENDOCRINE_THERAPY_...4,SET,266,0.030404,0.0036311,0.053584,0.28523,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_4,0.973037929515419
MIR3065_3P,SET,234,0.031006,0.0034763,0.054664,0.28529,MIR3065_3P,0.973037929515419
HP_ABNORMAL_CIRCULATING_PROL...,SET,19,0.10226,0.0032861,0.18031,0.28532,HP_ABNORMAL_CIRCULATING_PROLINE_CONCENTRATION,0.973037929515419
GOMF_ERBB_3_CLASS_RECEPTOR_B...,SET,5,0.21772,0.0035906,0.38392,0.28533,GOMF_ERBB_3_CLASS_RECEPTOR_BINDING,0.973037929515419
GOBP_TETRAPYRROLE_CATABOLIC_...,SET,13,0.1323,0.0035174,0.23334,0.28536,GOBP_TETRAPYRROLE_CATABOLIC_PROCESS,0.973037929515419
HP_PERINEAL_HYPOSPADIAS,SET,4,0.22497,0.0033186,0.39683,0.28539,HP_PERINEAL_HYPOSPADIAS,0.973037929515419
MIR203B_3P,SET,88,0.052785,0.0036437,0.093115,0.2854,MIR203B_3P,0.973037929515419
GOBP_NEGATIVE_REGULATION_OF_...422,SET,9,0.15271,0.0033784,0.26947,0.28547,GOBP_NEGATIVE_REGULATION_OF_MYELINATION,0.973037929515419
MODULE_39,SET,9,0.15573,0.0034454,0.27485,0.28549,MODULE_39,0.973037929515419
HP_ALACRIMA,SET,17,0.11173,0.0033965,0.19718,0.28549,HP_ALACRIMA,0.973037929515419
GOBP_NEGATIVE_REGULATION_OF_...136,SET,4,0.24158,0.0035635,0.42643,0.28553,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,0.973037929515419
GOBP_MEMBRANE_INVAGINATION,SET,65,0.061048,0.0036241,0.10777,0.28555,GOBP_MEMBRANE_INVAGINATION,0.973037929515419
KRAS.LUNG_UP.V1_UP,SET,122,0.046307,0.0037602,0.081748,0.28555,KRAS.LUNG_UP.V1_UP,0.973037929515419
GSE17974_CTRL_VS_ACT_IL4_AND...12,SET,156,0.039858,0.0036565,0.07037,0.28556,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_UP,0.973037929515419
GSE11961_PLASMA_CELL_DAY7_VS...4,SET,175,0.036235,0.0035189,0.063977,0.28557,GSE11961_PLASMA_CELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.973037929515419
REACTOME_NFE2L2_REGULATING_T...,SET,11,0.15296,0.0037409,0.27009,0.28559,REACTOME_NFE2L2_REGULATING_TUMORIGENIC_GENES,0.973037929515419
HP_ABNORMAL_CIRCULATING_DEHY...,SET,15,0.12597,0.0035973,0.22244,0.28559,HP_ABNORMAL_CIRCULATING_DEHYDROEPIANDROSTERONE_CONCENTRATION,0.973037929515419
GOCC_IGA_IMMUNOGLOBULIN_COMP...1,SET,2,0.3693,0.0038522,0.65245,0.28569,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX,0.973037929515419
GOCC_IGA_IMMUNOGLOBULIN_COMP...2,SET,2,0.3693,0.0038522,0.65245,0.28569,GOCC_IGA_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,0.973037929515419
COATES_MACROPHAGE_M1_VS_M2_UP,SET,80,0.056565,0.0037238,0.099943,0.28571,COATES_MACROPHAGE_M1_VS_M2_UP,0.973037929515419
HP_CARDIOGENIC_SHOCK,SET,6,0.18316,0.0033088,0.32366,0.28573,HP_CARDIOGENIC_SHOCK,0.973037929515419
GOBP_ENDOCARDIAL_CUSHION_TO_...,SET,6,0.21062,0.0038049,0.37221,0.28575,GOBP_ENDOCARDIAL_CUSHION_TO_MESENCHYMAL_TRANSITION,0.973037929515419
WP_DUAL_HIJACK_MODEL_OF_VIF_...,SET,5,0.21748,0.0035866,0.38437,0.28577,WP_DUAL_HIJACK_MODEL_OF_VIF_IN_HIV_INFECTION,0.973037929515419
MODULE_430,SET,52,0.063439,0.0033696,0.11212,0.28577,MODULE_430,0.973037929515419
GOBP_PIGMENT_CATABOLIC_PROCE...,SET,11,0.14931,0.0036516,0.26395,0.28582,GOBP_PIGMENT_CATABOLIC_PROCESS,0.973037929515419
GOBP_DEFENSE_RESPONSE_TO_BAC...,SET,274,0.032156,0.0038969,0.056854,0.28584,GOBP_DEFENSE_RESPONSE_TO_BACTERIUM,0.973037929515419
GOMF_K48_LINKED_DEUBIQUITINA...,SET,10,0.1364,0.0031808,0.24122,0.28588,GOMF_K48_LINKED_DEUBIQUITINASE_ACTIVITY,0.973037929515419
MIR6777_3P,SET,45,0.072283,0.0035723,0.12785,0.28591,MIR6777_3P,0.973037929515419
GAVISH_3CA_METAPROGRAM_MACRO...12,SET,48,0.076416,0.0039001,0.13516,0.28592,GAVISH_3CA_METAPROGRAM_MACROPHAGES_STRESS_HSP,0.973037929515419
FAELT_B_CLL_WITH_VH_REARRANG...2,SET,45,0.073039,0.0036097,0.1292,0.28594,FAELT_B_CLL_WITH_VH_REARRANGEMENTS_UP,0.973037929515419
HP_REFRACTORY_ANEMIA,SET,6,0.21132,0.0038175,0.37383,0.28594,HP_REFRACTORY_ANEMIA,0.973037929515419
TGACATY_UNKNOWN,SET,614,0.020142,0.0036196,0.035634,0.28595,TGACATY_UNKNOWN,0.973037929515419
GOBP_REGULATION_OF_CELL_CELL...1,SET,461,0.023906,0.0037384,0.042299,0.28598,GOBP_REGULATION_OF_CELL_CELL_ADHESION,0.973037929515419
GOBP_HEART_VALVE_MORPHOGENES...,SET,60,0.069425,0.0039603,0.12284,0.28599,GOBP_HEART_VALVE_MORPHOGENESIS,0.973037929515419
HP_RECURRENT_JOINT_DISLOCATI...,SET,10,0.15978,0.0037259,0.28276,0.28602,HP_RECURRENT_JOINT_DISLOCATION,0.973044743539546
GOMF_HIGH_DENSITY_LIPOPROTEI...,SET,11,0.16213,0.0039651,0.28696,0.28605,GOMF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,0.973051556229813
REACTOME_SEMA4D_INDUCED_CELL...,SET,20,0.10582,0.003489,0.18734,0.28608,REACTOME_SEMA4D_INDUCED_CELL_MIGRATION_AND_GROWTH_CONE_COLLAPSE,0.973058367586612
GSE22025_UNTREATED_VS_TGFB1_...4,SET,185,0.036598,0.0036533,0.064814,0.28616,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_UP,0.973235228495939
GSE17721_LPS_VS_POLYIC_24H_B...1,SET,178,0.035655,0.0034918,0.063159,0.2862,GSE17721_LPS_VS_POLYIC_24H_BMDC_DN,0.97327602739726
GSE16385_ROSIGLITAZONE_IL4_V...2,SET,184,0.034393,0.003424,0.060934,0.28624,GSE16385_ROSIGLITAZONE_IL4_VS_IFNG_TNF_STIM_MACROPHAGE_UP,0.973316818315233
DESCARTES_FETAL_CEREBRUM_MIC...,SET,364,0.026857,0.003742,0.047591,0.28627,DESCARTES_FETAL_CEREBRUM_MICROGLIA,0.973323601056545
HP_HYPOPLASTIC_ILIAC_WING,SET,27,0.096539,0.0036975,0.17113,0.28634,HP_HYPOPLASTIC_ILIAC_WING,0.973371156103286
ANDERSON_BLOOD_CN54GP140_ADJ...9,SET,5,0.25324,0.0041764,0.44893,0.28634,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_HIGH_IGM_RESPONDERS_3DY_7D_DN,0.973371156103286
MIR1293,SET,55,0.067363,0.0036795,0.11949,0.28647,MIR1293,0.973376658560311
GOMF_TASTE_RECEPTOR_ACTIVITY,SET,28,0.10794,0.00421,0.1915,0.28649,GOMF_TASTE_RECEPTOR_ACTIVITY,0.973376658560311
GOBP_TRANSITION_METAL_ION_TR...,SET,89,0.048884,0.0033935,0.08674,0.28653,GOBP_TRANSITION_METAL_ION_TRANSPORT,0.973376658560311
KEGG_MEDICUS_REFERENCE_HORMO...,SET,17,0.13061,0.0039705,0.23177,0.28654,KEGG_MEDICUS_REFERENCE_HORMONE_LIKE_CYTOKINE_TO_JAK_STAT_SIGNALING_PATHWAY,0.973376658560311
GOBP_ASPARTATE_FAMILY_AMINO_...3,SET,41,0.073439,0.0034648,0.13032,0.28654,GOBP_ASPARTATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,0.973376658560311
BLANCO_MELO_BRONCHIAL_EPITHE...3,SET,69,0.05849,0.0035771,0.10381,0.28658,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_DN,0.973376658560311
GOBP_DORSAL_AORTA_MORPHOGENE...,SET,8,0.18858,0.0039336,0.33484,0.28665,GOBP_DORSAL_AORTA_MORPHOGENESIS,0.973376658560311
LIN_MELANOMA_COPY_NUMBER_UP,SET,65,0.062741,0.0037246,0.11144,0.28672,LIN_MELANOMA_COPY_NUMBER_UP,0.973376658560311
GSE25846_IL10_POS_VS_NEG_CD8...1,SET,176,0.03382,0.0032937,0.060077,0.28674,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_DN,0.973376658560311
GOBP_SYMBIONT_ENTRY_INTO_HOST,SET,154,0.040432,0.0036855,0.071829,0.28676,GOBP_SYMBIONT_ENTRY_INTO_HOST,0.973376658560311
DACOSTA_ERCC3_ALLELE_XPCS_VS...2,SET,26,0.099694,0.003747,0.17718,0.28683,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_UP,0.973376658560311
GOMF_7SK_SNRNA_BINDING,SET,9,0.12845,0.0028417,0.2283,0.28685,GOMF_7SK_SNRNA_BINDING,0.973376658560311
GOBP_FATTY_ACID_OMEGA_OXIDAT...,SET,5,0.25927,0.0042758,0.46084,0.28686,GOBP_FATTY_ACID_OMEGA_OXIDATION,0.973376658560311
GSE39864_WT_VS_GATA3_KO_TREG...2,SET,188,0.035813,0.0036036,0.063661,0.28687,GSE39864_WT_VS_GATA3_KO_TREG_UP,0.973376658560311
GSE22282_HYPOXIA_VS_NORMOXIA...2,SET,174,0.035392,0.0034273,0.062914,0.28688,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_UP,0.973376658560311
GOBP_ORGANELLE_MEMBRANE_FUSI...,SET,114,0.04299,0.0033753,0.076438,0.28692,GOBP_ORGANELLE_MEMBRANE_FUSION,0.973376658560311
MIR376A_5P,SET,56,0.064639,0.0035626,0.11496,0.28697,MIR376A_5P,0.973376658560311
GSE42021_TCONV_PLN_VS_CD24HI...1,SET,181,0.03558,0.0035135,0.063286,0.28699,GSE42021_TCONV_PLN_VS_CD24HI_TCONV_THYMUS_DN,0.973376658560311
LAU_APOPTOSIS_CDKN2A_DN,SET,5,0.19047,0.0031412,0.33885,0.28702,LAU_APOPTOSIS_CDKN2A_DN,0.973376658560311
GOBP_REGULATION_OF_CDC42_PRO...,SET,8,0.19242,0.0040137,0.34234,0.28703,GOBP_REGULATION_OF_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,0.973376658560311
DASU_IL6_SIGNALING_SCAR_UP,SET,30,0.086559,0.0034943,0.15401,0.28705,DASU_IL6_SIGNALING_SCAR_UP,0.973376658560311
WP_DISORDERS_OF_BILE_ACID_SY...,SET,29,0.092264,0.0036621,0.1642,0.2871,WP_DISORDERS_OF_BILE_ACID_SYNTHESIS_AND_BILIARY_TRANSPORT,0.973376658560311
GOBP_POSITIVE_REGULATION_OF_...427,SET,39,0.078718,0.0036223,0.14012,0.28713,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.973376658560311
GSE17974_0.5H_VS_72H_UNTREAT...2,SET,160,0.03723,0.0034585,0.066275,0.28715,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,0.973376658560311
HP_ECLAMPSIA,SET,7,0.19693,0.0038425,0.35061,0.28717,HP_ECLAMPSIA,0.973376658560311
GOMF_GROWTH_HORMONE_RECEPTOR...,SET,8,0.18853,0.0039326,0.33574,0.28721,GOMF_GROWTH_HORMONE_RECEPTOR_BINDING,0.973376658560311
GOBP_PROTEIN_HOMOOLIGOMERIZA...,SET,190,0.035408,0.0035815,0.063058,0.28723,GOBP_PROTEIN_HOMOOLIGOMERIZATION,0.973376658560311
HP_MOTTLED_PIGMENTATION,SET,8,0.18155,0.0037869,0.32341,0.28728,HP_MOTTLED_PIGMENTATION,0.973376658560311
MIR619_3P,SET,53,0.066637,0.0035733,0.11874,0.28733,MIR619_3P,0.973376658560311
HP_MEGALOBLASTIC_ANEMIA,SET,17,0.1182,0.003593,0.21061,0.28733,HP_MEGALOBLASTIC_ANEMIA,0.973376658560311
LU_EZH2_TARGETS_UP,SET,253,0.02806,0.0032695,0.050001,0.28734,LU_EZH2_TARGETS_UP,0.973376658560311
BURTON_ADIPOGENESIS_2,SET,70,0.057846,0.0035632,0.10312,0.28741,BURTON_ADIPOGENESIS_2,0.973376658560311
KAPOSI_LIVER_CANCER_MET_UP,SET,18,0.10924,0.003417,0.19474,0.28741,KAPOSI_LIVER_CANCER_MET_UP,0.973376658560311
GOBP_RESPONSE_TO_SALT_STRESS,SET,24,0.09711,0.0035069,0.17316,0.28747,GOBP_RESPONSE_TO_SALT_STRESS,0.973376658560311
MIR588,SET,108,0.046899,0.0035846,0.083634,0.28748,MIR588,0.973376658560311
GOBP_REGULATION_OF_PROTEIN_K...1,SET,6,0.19012,0.0034345,0.33903,0.28748,GOBP_REGULATION_OF_PROTEIN_K48_LINKED_UBIQUITINATION,0.973376658560311
GSE27786_NKCELL_VS_NEUTROPHI...1,SET,180,0.035508,0.0034967,0.063319,0.28748,GSE27786_NKCELL_VS_NEUTROPHIL_DN,0.973376658560311
GSE19888_ADENOSINE_A3R_INH_P...1,SET,181,0.034648,0.0034215,0.061797,0.28751,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN,0.973376658560311
HP_UNILATERAL_CRYPTORCHIDISM,SET,11,0.15008,0.0036706,0.26772,0.28754,HP_UNILATERAL_CRYPTORCHIDISM,0.973376658560311
MIR1283,SET,435,0.023217,0.0035293,0.041417,0.28755,MIR1283,0.973376658560311
GOMF_MITOCHONDRION_TARGETING...,SET,5,0.18949,0.003125,0.33803,0.28755,GOMF_MITOCHONDRION_TARGETING_SEQUENCE_BINDING,0.973376658560311
HP_ABNORMALITY_OF_SKELETAL_M...1,SET,358,0.024479,0.0033831,0.043671,0.28756,HP_ABNORMALITY_OF_SKELETAL_MATURATION,0.973376658560311
GOBP_NEGATIVE_REGULATION_OF_...501,SET,75,0.054946,0.0035028,0.098031,0.28757,GOBP_NEGATIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.973376658560311
MIR665,SET,122,0.041366,0.0033591,0.073806,0.28758,MIR665,0.973376658560311
GOBP_DECIDUALIZATION,SET,24,0.097921,0.0035362,0.17476,0.28763,GOBP_DECIDUALIZATION,0.973376658560311
GOBP_MATURATION_OF_SSU_RRNA_...,SET,30,0.084103,0.0033951,0.1501,0.28763,GOBP_MATURATION_OF_SSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.973376658560311
MIR4796_5P,SET,89,0.052291,0.00363,0.093361,0.28771,MIR4796_5P,0.973376658560311
GOBP_TRYPTOPHAN_TRANSPORT,SET,5,0.21137,0.0034859,0.37742,0.28773,GOBP_TRYPTOPHAN_TRANSPORT,0.973376658560311
HP_ABNORMAL_CORONARY_ARTERY_...1,SET,68,0.059395,0.0036061,0.10607,0.28776,HP_ABNORMAL_CORONARY_ARTERY_MORPHOLOGY,0.973376658560311
HP_INCREASED_PROPORTION_OF_C...,SET,6,0.19244,0.0034765,0.34374,0.2878,HP_INCREASED_PROPORTION_OF_CD25_MAST_CELLS,0.973376658560311
BIOCARTA_SARS_PATHWAY,SET,7,0.17993,0.0035108,0.32151,0.28787,BIOCARTA_SARS_PATHWAY,0.973376658560311
GSE1460_CD4_THYMOCYTE_VS_NAI...2,SET,182,0.0356,0.003525,0.063611,0.28787,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,0.973376658560311
GSE40274_FOXP3_VS_FOXP3_AND_...15,SET,151,0.038606,0.0034849,0.068989,0.28788,GSE40274_FOXP3_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.973376658560311
IVANOVA_HEMATOPOIESIS_EARLY_...,SET,404,0.023189,0.0034,0.04144,0.28789,IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR,0.973376658560311
IBRAHIM_NRF1_UP,SET,390,0.023315,0.0033601,0.041671,0.28791,IBRAHIM_NRF1_UP,0.973376658560311
GOBP_SPHINGOID_BIOSYNTHETIC_...,SET,13,0.13707,0.0036443,0.24498,0.28791,GOBP_SPHINGOID_BIOSYNTHETIC_PROCESS,0.973376658560311
SANCHEZ_MDM2_TARGETS,SET,9,0.15863,0.0035095,0.28363,0.28798,SANCHEZ_MDM2_TARGETS,0.973491538611165
GOBP_RESPONSE_TO_CAFFEINE,SET,14,0.12261,0.0033826,0.21923,0.288,GOBP_RESPONSE_TO_CAFFEINE,0.973491538611165
GAUSSMANN_MLL_AF4_FUSION_TAR...3,SET,6,0.21598,0.0039017,0.38634,0.28807,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN,0.973599449180956
MIR6871_5P,SET,51,0.074418,0.0039147,0.13317,0.28814,MIR6871_5P,0.973599449180956
HP_SHIELD_CHEST,SET,14,0.11545,0.0031851,0.20661,0.28817,HP_SHIELD_CHEST,0.973599449180956
MIR3129_5P,SET,144,0.038862,0.0034264,0.069588,0.28827,MIR3129_5P,0.973599449180956
GOMF_MOLECULAR_CONDENSATE_SC...,SET,33,0.07412,0.0031379,0.13272,0.28827,GOMF_MOLECULAR_CONDENSATE_SCAFFOLD_ACTIVITY,0.973599449180956
MIR450B_5P,SET,421,0.02365,0.0035382,0.042356,0.2883,MIR450B_5P,0.973599449180956
CAR_MLANA,SET,40,0.071654,0.0033391,0.12833,0.28831,CAR_MLANA,0.973599449180956
GOBP_NEGATIVE_REGULATION_OF_...689,SET,8,0.17172,0.0035819,0.30755,0.28831,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.973599449180956
MIR371B_5P,SET,856,0.016414,0.0034589,0.0294,0.28832,MIR371B_5P,0.973599449180956
GSE45837_WT_VS_GFI1_KO_PDC_DN,SET,175,0.033493,0.0032526,0.059995,0.28833,GSE45837_WT_VS_GFI1_KO_PDC_DN,0.973599449180956
HP_TRACHEOESOPHAGEAL_FISTULA,SET,82,0.051283,0.0034178,0.09188,0.28837,HP_TRACHEOESOPHAGEAL_FISTULA,0.973599449180956
CHENG_RESPONSE_TO_NICKEL_ACE...,SET,40,0.066803,0.0031131,0.11969,0.28838,CHENG_RESPONSE_TO_NICKEL_ACETATE,0.973599449180956
GOBP_HEAT_ACCLIMATION,SET,5,0.22412,0.0036961,0.40174,0.28847,GOBP_HEAT_ACCLIMATION,0.973599449180956
GOBP_POSITIVE_REGULATION_OF_...758,SET,10,0.1542,0.0035959,0.27644,0.28849,GOBP_POSITIVE_REGULATION_OF_TOLERANCE_INDUCTION,0.973599449180956
WP_16P112_PROXIMAL_DELETION_...,SET,68,0.065715,0.0039898,0.11785,0.28855,WP_16P112_PROXIMAL_DELETION_SYNDROME,0.973599449180956
GOBP_SIGNAL_TRANSDUCTION_INV...,SET,23,0.10452,0.0036952,0.18745,0.28856,GOBP_SIGNAL_TRANSDUCTION_INVOLVED_IN_REGULATION_OF_GENE_EXPRESSION,0.973599449180956
GCM_NPM1,SET,104,0.042477,0.0031862,0.076222,0.28867,GCM_NPM1,0.973599449180956
HP_ABNORMALITY_IRIS_MORPHOLO...,SET,404,0.023838,0.0034953,0.042779,0.28868,HP_ABNORMALITY_IRIS_MORPHOLOGY,0.973599449180956
GOBP_TOLL_LIKE_RECEPTOR_3_SI...,SET,28,0.084536,0.0032971,0.15171,0.2887,GOBP_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,0.973599449180956
GOBP_TRNA_TRANSCRIPTION,SET,13,0.1042,0.0027704,0.18703,0.28872,GOBP_TRNA_TRANSCRIPTION,0.973599449180956
HP_PECTUS_CARINATUM,SET,158,0.036347,0.0033556,0.065251,0.28875,HP_PECTUS_CARINATUM,0.973599449180956
GSE10147_IL3_VS_IL3_AND_CPG_...1,SET,147,0.037014,0.003297,0.066465,0.2888,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_DN,0.973599449180956
WU_HBX_TARGETS_1_DN,SET,22,0.10597,0.0036642,0.19033,0.28885,WU_HBX_TARGETS_1_DN,0.973599449180956
KEGG_MEDICUS_VARIANT_LOSS_OF...1,SET,8,0.18495,0.0038578,0.33219,0.28885,KEGG_MEDICUS_VARIANT_LOSS_OF_CDKN1B_TO_P27_CELL_CYCLE_G1_S,0.973599449180956
GOBP_POSITIVE_REGULATION_OF_...21,SET,28,0.087928,0.0034294,0.15793,0.28885,GOBP_POSITIVE_REGULATION_OF_AMIDE_METABOLIC_PROCESS,0.973599449180956
GOCC_SPECIFIC_GRANULE_LUMEN,SET,57,0.065579,0.0036464,0.11784,0.28893,GOCC_SPECIFIC_GRANULE_LUMEN,0.973599449180956
GAVISH_3CA_MALIGNANT_METAPRO...35,SET,41,0.067101,0.0031657,0.12058,0.28894,GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN,0.973599449180956
HP_DECREASED_AMPLITUDE_OF_SE...,SET,24,0.097032,0.0035041,0.17437,0.28895,HP_DECREASED_AMPLITUDE_OF_SENSORY_ACTION_POTENTIALS,0.973599449180956
HP_THYMUS_HYPERPLASIA,SET,6,0.17629,0.0031848,0.31687,0.28899,HP_THYMUS_HYPERPLASIA,0.973599449180956
GSE3982_EOSINOPHIL_VS_TH1_UP,SET,178,0.034907,0.0034186,0.062743,0.28899,GSE3982_EOSINOPHIL_VS_TH1_UP,0.973599449180956
GOBP_ALDEHYDE_BIOSYNTHETIC_P...,SET,17,0.12453,0.0037858,0.22386,0.289,GOBP_ALDEHYDE_BIOSYNTHETIC_PROCESS,0.973599449180956
GOBP_RESPONSE_TO_ENDOGENOUS_...,SET,1524,0.012882,0.0035525,0.023163,0.28905,GOBP_RESPONSE_TO_ENDOGENOUS_STIMULUS,0.973599449180956
ICHIBA_GRAFT_VERSUS_HOST_DIS...2,SET,130,0.041969,0.0035172,0.075512,0.28918,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP,0.973599449180956
HP_ABNORMALITY_OF_FOVEAL_PIG...,SET,6,0.21749,0.0039291,0.39135,0.28919,HP_ABNORMALITY_OF_FOVEAL_PIGMENTATION,0.973599449180956
GOCC_CCR4_NOT_COMPLEX,SET,15,0.11821,0.0033757,0.21272,0.28921,GOCC_CCR4_NOT_COMPLEX,0.973599449180956
HP_HYPERCONVEX_NAIL,SET,16,0.12112,0.0035722,0.21798,0.28923,HP_HYPERCONVEX_NAIL,0.973599449180956
HP_REDUCED_FORCED_EXPIRATORY...,SET,27,0.090548,0.003468,0.16298,0.28925,HP_REDUCED_FORCED_EXPIRATORY_VOLUME_IN_ONE_SECOND,0.973599449180956
GOBP_METALLO_SULFUR_CLUSTER_...,SET,21,0.097932,0.0033085,0.17628,0.28926,GOBP_METALLO_SULFUR_CLUSTER_ASSEMBLY,0.973599449180956
NIKOLSKY_BREAST_CANCER_8P12_...,SET,50,0.11939,0.0062189,0.21491,0.28927,NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON,0.973599449180956
ZHONG_PFC_C4_UNKNOWN_INP,SET,81,0.053129,0.0035193,0.095648,0.28929,ZHONG_PFC_C4_UNKNOWN_INP,0.973599449180956
MIR199A_3P_MIR199B_3P,SET,145,0.038643,0.0034188,0.069571,0.2893,MIR199A_3P_MIR199B_3P,0.973599449180956
HP_ABSENT_VAS_DEFERENS,SET,19,0.11599,0.0037275,0.20884,0.28931,HP_ABSENT_VAS_DEFERENS,0.973599449180956
GOBP_SPLICEOSOMAL_SNRNP_ASSE...,SET,37,0.066285,0.0029711,0.11936,0.28933,GOBP_SPLICEOSOMAL_SNRNP_ASSEMBLY,0.973599449180956
GAUTAM_EYE_CORNEA_TGFBI_HIGH...,SET,102,0.047453,0.0035253,0.085448,0.28933,GAUTAM_EYE_CORNEA_TGFBI_HIGH_EPITHELIAL_CELLS,0.973599449180956
REACTOME_THE_ROLE_OF_GTSE1_I...,SET,73,0.049512,0.0031142,0.089159,0.28934,REACTOME_THE_ROLE_OF_GTSE1_IN_G2_M_PROGRESSION_AFTER_G2_CHECKPOINT,0.973599449180956
HP_BLEPHAROCHALASIS,SET,6,0.21106,0.0038128,0.38016,0.28939,HP_BLEPHAROCHALASIS,0.973599449180956
ZAMORA_NOS2_TARGETS_DN,SET,76,0.053885,0.0034579,0.097091,0.28945,ZAMORA_NOS2_TARGETS_DN,0.973599449180956
GSE17974_CTRL_VS_ACT_IL4_AND...9,SET,173,0.033771,0.003261,0.060875,0.28953,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_2H_CD4_TCELL_DN,0.973599449180956
HP_ABNORMAL_CARDIOMYOCYTE_MO...,SET,15,0.1108,0.003164,0.19975,0.28956,HP_ABNORMAL_CARDIOMYOCYTE_MORPHOLOGY,0.973599449180956
GSE22886_NAIVE_TCELL_VS_MONO...2,SET,177,0.034696,0.0033885,0.062577,0.28964,GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP,0.973599449180956
GSE40274_CTRL_VS_HELIOS_TRAN...1,SET,163,0.035895,0.0033654,0.06474,0.28964,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.973599449180956
HP_ABNORMALITY_OF_THE_URETER,SET,328,0.025843,0.0034214,0.046614,0.28966,HP_ABNORMALITY_OF_THE_URETER,0.973599449180956
HP_EEG_WITH_ABNORMALLY_SLOW_...,SET,86,0.04786,0.0032662,0.086358,0.28972,HP_EEG_WITH_ABNORMALLY_SLOW_FREQUENCIES,0.973599449180956
MIR5590_5P,SET,106,0.044897,0.0033998,0.081022,0.28975,MIR5590_5P,0.973599449180956
GOBP_ADAPTIVE_IMMUNE_MEMORY_...,SET,5,0.24142,0.0039814,0.43573,0.28977,GOBP_ADAPTIVE_IMMUNE_MEMORY_RESPONSE,0.973599449180956
GOMF_POU_DOMAIN_BINDING,SET,2,0.4027,0.0042006,0.72701,0.28982,GOMF_POU_DOMAIN_BINDING,0.973599449180956
GSE45365_HEALTHY_VS_MCMV_INF...9,SET,172,0.035025,0.0033724,0.063231,0.28982,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_UP,0.973599449180956
GOBP_POSITIVE_REGULATION_OF_...751,SET,14,0.10897,0.0030065,0.19679,0.28988,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_RNA_LOCALIZATION_TO_CAJAL_BODY,0.973599449180956
GSE20198_UNTREATED_VS_IL12_I...1,SET,176,0.033117,0.0032252,0.059806,0.28988,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,0.973599449180956
MIR3691_5P,SET,40,0.073876,0.0034427,0.13345,0.28993,MIR3691_5P,0.973599449180956
MIR6873_3P,SET,340,0.026284,0.0035417,0.047481,0.28994,MIR6873_3P,0.973599449180956
GOBP_BIOLOGICAL_PROCESS_INVO...2,SET,107,0.045023,0.0034253,0.081358,0.29,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_SYMBIONT,0.973599449180956
GOBP_REGULATION_OF_VENTRICUL...3,SET,22,0.10412,0.0036002,0.18817,0.29002,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,0.973599449180956
HP_GOITER,SET,54,0.064099,0.0034693,0.11584,0.29002,HP_GOITER,0.973599449180956
MIR6821_3P,SET,47,0.064766,0.003271,0.11705,0.29003,MIR6821_3P,0.973599449180956
GOBP_MITOTIC_SPINDLE_ASSEMBLY,SET,68,0.052142,0.0031658,0.09425,0.29006,GOBP_MITOTIC_SPINDLE_ASSEMBLY,0.973599449180956
chr2p21,SET,35,0.13696,0.0059713,0.2476,0.29008,chr2p21,0.973599449180956
HP_NEPHROGENIC_DIABETES_INSI...,SET,7,0.19237,0.0037536,0.34776,0.29008,HP_NEPHROGENIC_DIABETES_INSIPIDUS,0.973599449180956
MIR4253,SET,45,0.073121,0.0036137,0.13224,0.29016,MIR4253,0.973599449180956
MODULE_361,SET,127,0.04172,0.003456,0.075513,0.29031,MODULE_361,0.973599449180956
HP_MASTOIDITIS,SET,7,0.17928,0.0034982,0.32459,0.29036,HP_MASTOIDITIS,0.973599449180956
REACTOME_VIRAL_MESSENGER_RNA...,SET,42,0.066838,0.0031915,0.12101,0.29037,REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS,0.973599449180956
MODULE_248,SET,117,0.044237,0.0035183,0.080098,0.29038,MODULE_248,0.973599449180956
BROWNE_HCMV_INFECTION_4HR_DN,SET,227,0.030775,0.003399,0.055735,0.29042,BROWNE_HCMV_INFECTION_4HR_DN,0.973599449180956
SAKAI_CHRONIC_HEPATITIS_VS_L...2,SET,79,0.047678,0.0031192,0.086368,0.29047,SAKAI_CHRONIC_HEPATITIS_VS_LIVER_CANCER_UP,0.973599449180956
HP_ABNORMAL_NUMBER_OF_DENSE_...,SET,7,0.16803,0.0032786,0.30439,0.29048,HP_ABNORMAL_NUMBER_OF_DENSE_GRANULES,0.973599449180956
GSE9988_LPS_VS_LPS_AND_ANTI_...1,SET,170,0.03667,0.0035104,0.066435,0.29049,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_DN,0.973599449180956
GSE15659_RESTING_TREG_VS_NON...1,SET,172,0.034851,0.0033556,0.063142,0.2905,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_DN,0.973599449180956
GSE13411_PLASMA_CELL_VS_MEMO...1,SET,175,0.035231,0.0034214,0.063854,0.29057,GSE13411_PLASMA_CELL_VS_MEMORY_BCELL_DN,0.973599449180956
GOBP_TERTIARY_ALCOHOL_METABO...,SET,22,0.11587,0.0040064,0.2101,0.29065,GOBP_TERTIARY_ALCOHOL_METABOLIC_PROCESS,0.973599449180956
REACTOME_INTERFERON_GAMMA_SI...,SET,90,0.052937,0.0036954,0.095993,0.29066,REACTOME_INTERFERON_GAMMA_SIGNALING,0.973599449180956
GOBP_NAD_TRANSPORT,SET,5,0.22479,0.0037072,0.40765,0.29067,GOBP_NAD_TRANSPORT,0.973599449180956
HP_EXCESSIVE_SALIVATION,SET,106,0.045884,0.0034746,0.083211,0.29068,HP_EXCESSIVE_SALIVATION,0.973599449180956
MIR381_3P,SET,407,0.023322,0.003432,0.042297,0.29069,MIR381_3P,0.973599449180956
HP_MIXED_HEARING_IMPAIRMENT,SET,32,0.083969,0.0035007,0.15233,0.29074,HP_MIXED_HEARING_IMPAIRMENT,0.973599449180956
GOBP_PROTEIN_POLYMERIZATION,SET,253,0.028969,0.0033754,0.052558,0.29076,GOBP_PROTEIN_POLYMERIZATION,0.973599449180956
CUI_DEVELOPING_HEART_C3_FIBR...,SET,103,0.050353,0.0037589,0.091386,0.29082,CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL,0.973599449180956
GOBP_AXONEMAL_CENTRAL_APPARA...,SET,5,0.20744,0.0034211,0.37651,0.29083,GOBP_AXONEMAL_CENTRAL_APPARATUS_ASSEMBLY,0.973599449180956
HAY_BONE_MARROW_ERYTHROBLAST,SET,1136,0.013458,0.0032409,0.024429,0.29085,HAY_BONE_MARROW_ERYTHROBLAST,0.973599449180956
GOCC_ACTIN_FILAMENT,SET,105,0.045935,0.003462,0.08339,0.29087,GOCC_ACTIN_FILAMENT,0.973599449180956
GSE4142_GC_BCELL_VS_MEMORY_B...1,SET,180,0.032423,0.003193,0.058861,0.29087,GSE4142_GC_BCELL_VS_MEMORY_BCELL_DN,0.973599449180956
GOBP_AMYGDALA_DEVELOPMENT,SET,5,0.2008,0.0033115,0.36455,0.29088,GOBP_AMYGDALA_DEVELOPMENT,0.973599449180956
REACTOME_SIGNALING_BY_FGFR_I...,SET,61,0.058512,0.0033653,0.10628,0.29097,REACTOME_SIGNALING_BY_FGFR_IN_DISEASE,0.973599449180956
GOMF_O_ACETYLTRANSFERASE_ACT...,SET,9,0.15695,0.0034722,0.28509,0.29099,GOMF_O_ACETYLTRANSFERASE_ACTIVITY,0.973599449180956
GOBP_REGULATION_OF_MALE_GONA...,SET,8,0.18134,0.0037824,0.32949,0.29104,GOBP_REGULATION_OF_MALE_GONAD_DEVELOPMENT,0.973599449180956
GOBP_PYRAMIDAL_NEURON_DIFFER...,SET,12,0.13716,0.0035037,0.24924,0.29105,GOBP_PYRAMIDAL_NEURON_DIFFERENTIATION,0.973599449180956
ROETH_TERT_TARGETS_UP,SET,14,0.13765,0.0037976,0.25013,0.29106,ROETH_TERT_TARGETS_UP,0.973599449180956
GAL_LEUKEMIC_STEM_CELL_UP,SET,110,0.044783,0.0034542,0.081402,0.29111,GAL_LEUKEMIC_STEM_CELL_UP,0.973599449180956
MORF_PAX7,SET,242,0.03075,0.0035052,0.0559,0.29113,MORF_PAX7,0.973599449180956
chr1q41,SET,31,0.14008,0.005748,0.25466,0.29114,chr1q41,0.973599449180956
MANNO_MIDBRAIN_NEUROTYPES_HP...1,SET,703,0.018682,0.0035832,0.033967,0.29116,MANNO_MIDBRAIN_NEUROTYPES_HPERIC,0.973599449180956
BOYAULT_LIVER_CANCER_SUBCLAS...8,SET,10,0.15016,0.0035016,0.27302,0.29117,BOYAULT_LIVER_CANCER_SUBCLASS_G23_DN,0.973599449180956
GOBP_SEROTONIN_RECEPTOR_SIGN...,SET,8,0.18267,0.0038104,0.33216,0.29118,GOBP_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,0.973599449180956
GOBP_GANGLIOSIDE_BIOSYNTHETI...2,SET,6,0.1756,0.0031722,0.31931,0.29119,GOBP_GANGLIOSIDE_BIOSYNTHETIC_PROCESS_VIA_LACTOSYLCERAMIDE,0.973599449180956
GOBP_POSITIVE_REGULATION_OF_...330,SET,6,0.16674,0.0030121,0.30326,0.29123,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,0.973599449180956
HP_SMALL_ANTERIOR_FONTANELLE,SET,6,0.18251,0.003297,0.33199,0.29125,HP_SMALL_ANTERIOR_FONTANELLE,0.973599449180956
GOBP_DNA_DAMAGE_RESPONSE_SIG...1,SET,67,0.057473,0.0034638,0.10457,0.29129,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.973599449180956
GOBP_DNA_INTEGRITY_CHECKPOIN...,SET,125,0.038387,0.003155,0.069863,0.29135,GOBP_DNA_INTEGRITY_CHECKPOINT_SIGNALING,0.973599449180956
BURTON_ADIPOGENESIS_1,SET,28,0.09325,0.0036369,0.16973,0.29137,BURTON_ADIPOGENESIS_1,0.973599449180956
BIOCARTA_RHO_PATHWAY,SET,18,0.10519,0.0032903,0.19147,0.29138,BIOCARTA_RHO_PATHWAY,0.973599449180956
HP_CHRONIC_PULMONARY_OBSTRUC...,SET,30,0.092775,0.0037452,0.1689,0.2914,HP_CHRONIC_PULMONARY_OBSTRUCTION,0.973599449180956
GOBP_SIGNAL_TRANSDUCTION_BY_...,SET,159,0.036239,0.003356,0.065974,0.29141,GOBP_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.973599449180956
GOBP_VESICLE_TRANSPORT_ALONG...2,SET,43,0.069321,0.0033491,0.1262,0.29141,GOBP_VESICLE_TRANSPORT_ALONG_MICROTUBULE,0.973599449180956
GOBP_ENDOSOME_TRANSPORT_VIA_...,SET,39,0.068015,0.0031298,0.12383,0.29142,GOBP_ENDOSOME_TRANSPORT_VIA_MULTIVESICULAR_BODY_SORTING_PATHWAY,0.973599449180956
HP_DELAYED_ERUPTION_OF_PERMA...,SET,32,0.083928,0.003499,0.15282,0.29143,HP_DELAYED_ERUPTION_OF_PERMANENT_TEETH,0.973599449180956
MIR6845_5P,SET,57,0.06156,0.003423,0.1121,0.29145,MIR6845_5P,0.973599449180956
HP_HYPOMETHIONINEMIA,SET,8,0.15486,0.0032301,0.28202,0.29147,HP_HYPOMETHIONINEMIA,0.973599449180956
HP_MUSCLE_FIBER_TUBULAR_INCL...,SET,7,0.17197,0.0033554,0.31317,0.29147,HP_MUSCLE_FIBER_TUBULAR_INCLUSIONS,0.973599449180956
GOMF_SIGNALING_RECEPTOR_BIND...,SET,1327,0.013814,0.0035755,0.02516,0.29148,GOMF_SIGNALING_RECEPTOR_BINDING,0.973599449180956
GOBP_REGULATION_OF_HEART_RAT...2,SET,5,0.22713,0.0037457,0.41372,0.29151,GOBP_REGULATION_OF_HEART_RATE_BY_CHEMICAL_SIGNAL,0.973599449180956
GOBP_REGULATION_OF_MULTICELL...2,SET,61,0.065521,0.0037685,0.11936,0.29152,GOBP_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,0.973599449180956
GOBP_NEUTROPHIL_EXTRAVASATION,SET,9,0.17538,0.0038801,0.31954,0.29155,GOBP_NEUTROPHIL_EXTRAVASATION,0.973599449180956
HP_RADIAL_DEVIATION_OF_THE_H...2,SET,51,0.06475,0.0034061,0.11799,0.29158,HP_RADIAL_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,0.973599449180956
GSE43957_UNTREATED_VS_NACL_T...2,SET,181,0.034122,0.0033695,0.062176,0.29158,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,0.973599449180956
GSE43955_TH0_VS_TGFB_IL6_TH1...14,SET,183,0.034162,0.0033918,0.062263,0.29162,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP,0.973599449180956
MIR10B_3P,SET,72,0.055125,0.0034435,0.10048,0.29164,MIR10B_3P,0.973599449180956
MIR2861,SET,83,0.059429,0.0039847,0.10836,0.29169,MIR2861,0.973599449180956
REACTOME_GENE_AND_PROTEIN_EX...,SET,35,0.074038,0.0032278,0.13502,0.29174,REACTOME_GENE_AND_PROTEIN_EXPRESSION_BY_JAK_STAT_SIGNALING_AFTER_INTERLEUKIN_12_STIMULATION,0.973599449180956
FOROUTAN_PRODRANK_TGFB_EMT_DN,SET,76,0.056387,0.0036184,0.10285,0.29178,FOROUTAN_PRODRANK_TGFB_EMT_DN,0.973599449180956
BIOCARTA_VIP_PATHWAY,SET,26,0.093359,0.0035089,0.17035,0.29184,BIOCARTA_VIP_PATHWAY,0.973599449180956
GSE7460_CTRL_VS_TGFB_TREATED...1,SET,185,0.03443,0.0034369,0.06284,0.29188,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_DN,0.973599449180956
SCHMIDT_POR_TARGETS_IN_LIMB_...1,SET,8,0.17281,0.0036047,0.31564,0.29202,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_DN,0.973599449180956
GAUTAM_EYE_CORNEA_FIBROBLASTS,SET,147,0.038181,0.003401,0.069746,0.29204,GAUTAM_EYE_CORNEA_FIBROBLASTS,0.973599449180956
HP_PREMATURE_VENTRICULAR_CON...,SET,27,0.097388,0.00373,0.1779,0.29205,HP_PREMATURE_VENTRICULAR_CONTRACTION,0.973599449180956
MIKKELSEN_MCV6_LCP_WITH_H3K4...,SET,146,0.039526,0.0035088,0.072213,0.29207,MIKKELSEN_MCV6_LCP_WITH_H3K4ME3,0.973599449180956
ZHENG_CORD_BLOOD_C7_PUTATIVE...,SET,81,0.05213,0.0034531,0.095274,0.29214,ZHENG_CORD_BLOOD_C7_PUTATIVE_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_1,0.973599449180956
BARRIER_CANCER_RELAPSE_NORMA...2,SET,29,0.083388,0.0033098,0.15243,0.29217,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_UP,0.973599449180956
GOBP_WATER_SOLUBLE_VITAMIN_M...,SET,58,0.058097,0.0032585,0.1062,0.29217,GOBP_WATER_SOLUBLE_VITAMIN_METABOLIC_PROCESS,0.973599449180956
MIR141_5P,SET,91,0.048634,0.0034137,0.088902,0.29218,MIR141_5P,0.973599449180956
HP_NON_MEDULLARY_THYROID_CAR...,SET,6,0.20952,0.0037849,0.38308,0.29222,HP_NON_MEDULLARY_THYROID_CARCINOMA,0.973599449180956
MODULE_243,SET,71,0.053809,0.003338,0.098425,0.29229,MODULE_243,0.973599449180956
GAJATE_RESPONSE_TO_TRABECTED...2,SET,59,0.062961,0.0035615,0.11517,0.2923,GAJATE_RESPONSE_TO_TRABECTEDIN_UP,0.973599449180956
MIR1343_3P,SET,144,0.038468,0.0033917,0.070366,0.2923,MIR1343_3P,0.973599449180956
DORMOY_ELAVL1_TARGETS,SET,17,0.11513,0.0034998,0.21062,0.29232,DORMOY_ELAVL1_TARGETS,0.973599449180956
HP_FOCAL_NON_MOTOR_SEIZURE,SET,37,0.076959,0.0034496,0.14079,0.29232,HP_FOCAL_NON_MOTOR_SEIZURE,0.973599449180956
REACTOME_HSP90_CHAPERONE_CYC...,SET,53,0.062183,0.0033344,0.11377,0.29234,REACTOME_HSP90_CHAPERONE_CYCLE_FOR_STEROID_HORMONE_RECEPTORS_SHR_IN_THE_PRESENCE_OF_LIGAND,0.973599449180956
KEGG_MEDICUS_REFERENCE_GH_JA...,SET,7,0.20733,0.0040454,0.37936,0.29235,KEGG_MEDICUS_REFERENCE_GH_JAK_STAT_SIGNALING_PATHWAY,0.973599449180956
PCGF6_TARGET_GENES,SET,64,0.05333,0.0031416,0.097577,0.29235,PCGF6_TARGET_GENES,0.973599449180956
GOBP_REGULATION_OF_T_CELL_MI...,SET,44,0.071271,0.003483,0.13041,0.29236,GOBP_REGULATION_OF_T_CELL_MIGRATION,0.973599449180956
HP_LOWER_EYELID_COLOBOMA,SET,10,0.13351,0.0031133,0.2443,0.29237,HP_LOWER_EYELID_COLOBOMA,0.973599449180956
GSE45881_CXCR6HI_VS_CXCR1LO_...1,SET,185,0.033907,0.0033846,0.062054,0.2924,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_DN,0.973599449180956
GOMF_AMINE_BINDING,SET,12,0.13343,0.0034082,0.24421,0.29241,GOMF_AMINE_BINDING,0.973599449180956
HP_COLORECTAL_POLYPOSIS,SET,23,0.090221,0.0031896,0.16513,0.29241,HP_COLORECTAL_POLYPOSIS,0.973599449180956
HP_DISTAL_SENSORY_IMPAIRMENT,SET,117,0.040622,0.0032308,0.074351,0.29241,HP_DISTAL_SENSORY_IMPAIRMENT,0.973599449180956
HOEK_T_CELL_2011_2012_TIV_AD...2,SET,8,0.15573,0.0032483,0.28502,0.29241,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_UP,0.973599449180956
MIR3919,SET,278,0.027822,0.0033958,0.050925,0.29242,MIR3919,0.973599449180956
HP_HYDROURETER,SET,65,0.057159,0.0033932,0.10463,0.29243,HP_HYDROURETER,0.973599449180956
GSE44649_WT_VS_MIR155_KO_ACT...1,SET,182,0.033378,0.003305,0.061122,0.29251,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_DN,0.973659178397012
HP_SCHWANNOMA,SET,11,0.12704,0.0031071,0.23267,0.29253,HP_SCHWANNOMA,0.973659178397012
GOBP_REGULATION_OF_EXECUTION...,SET,22,0.1057,0.0036549,0.19361,0.29255,GOBP_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,0.973659178397012
HP_SPARSE_EYELASHES,SET,61,0.060466,0.0034777,0.11076,0.29256,HP_SPARSE_EYELASHES,0.973659178397012
GSE24634_TREG_VS_TCONV_POST_...2,SET,180,0.03333,0.0032822,0.061068,0.29261,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_UP,0.973731206995413
DESCARTES_FETAL_STOMACH_ENS_...1,SET,42,0.077643,0.0037074,0.14232,0.2927,DESCARTES_FETAL_STOMACH_ENS_GLIA,0.973731206995413
REACTOME_CELLULAR_RESPONSE_T...5,SET,140,0.037619,0.0032708,0.068973,0.29274,REACTOME_CELLULAR_RESPONSE_TO_STARVATION,0.973731206995413
GSE36826_WT_VS_IL1R_KO_SKIN_...2,SET,176,0.036137,0.0035193,0.066271,0.29278,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_DN,0.973731206995413
chr13q14,SET,81,0.10478,0.0069408,0.19217,0.29279,chr13q14,0.973731206995413
GSE18281_CORTEX_VS_MEDULLA_T...1,SET,160,0.036824,0.0034209,0.067543,0.29281,GSE18281_CORTEX_VS_MEDULLA_THYMUS_DN,0.973731206995413
REACTOME_NOTCH4_ACTIVATION_A...,SET,10,0.14798,0.0034509,0.27146,0.29283,REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,0.973731206995413
REACTOME_NUCLEAR_RECEPTOR_TR...,SET,50,0.066447,0.0034611,0.1219,0.29285,REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY,0.973731206995413
MIR193A_5P,SET,36,0.078283,0.0034612,0.14364,0.29289,MIR193A_5P,0.973731206995413
GOBP_MANGANESE_ION_TRANSPORT,SET,11,0.13384,0.0032734,0.2456,0.29289,GOBP_MANGANESE_ION_TRANSPORT,0.973731206995413
WP_PHASE_I_BIOTRANSFORMATION...,SET,8,0.18969,0.0039567,0.34809,0.2929,WP_PHASE_I_BIOTRANSFORMATIONS_NONP450,0.973731206995413
GOBP_PROTEIN_DEPHOSPHORYLATI...,SET,187,0.03278,0.0032896,0.060176,0.29297,GOBP_PROTEIN_DEPHOSPHORYLATION,0.973731206995413
GOBP_DORSAL_AORTA_DEVELOPMENT,SET,10,0.16547,0.0038587,0.30382,0.293,GOBP_DORSAL_AORTA_DEVELOPMENT,0.973731206995413
GSE24142_EARLY_THYMIC_PROGEN...7,SET,180,0.033741,0.0033228,0.061976,0.29308,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_ADULT_DN,0.973731206995413
HP_APLASIA_HYPOPLASIA_OF_THE...27,SET,47,0.066971,0.0033824,0.12303,0.2931,HP_APLASIA_HYPOPLASIA_OF_THE_EARLOBES,0.973731206995413
CUI_DEVELOPING_HEART_LEFT_AT...,SET,16,0.12352,0.0036428,0.22692,0.29312,CUI_DEVELOPING_HEART_LEFT_ATRIAL_CARDIOMYOCYTE,0.973731206995413
GOBP_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.2444,0.0036052,0.44907,0.29314,GOBP_NAD_TRANSMEMBRANE_TRANSPORT,0.973731206995413
GOMF_NAD_TRANSMEMBRANE_TRANS...,SET,4,0.2444,0.0036052,0.44907,0.29314,GOMF_NAD_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.973731206995413
BLANCO_MELO_COVID19_SARS_COV...3,SET,373,0.024479,0.0034517,0.044981,0.29315,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP,0.973731206995413
GOCC_SCHMIDT_LANTERMAN_INCIS...,SET,10,0.15197,0.0035438,0.27926,0.29316,GOCC_SCHMIDT_LANTERMAN_INCISURE,0.973731206995413
GSE15330_MEGAKARYOCYTE_ERYTH...2,SET,188,0.033999,0.003421,0.06248,0.29317,GSE15330_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_VS_PRO_BCELL_UP,0.973731206995413
REACTOME_MYOCLONIC_EPILEPSY_...,SET,8,0.15743,0.0032839,0.28938,0.29321,REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA,0.973771003344482
PID_CIRCADIAN_PATHWAY,SET,13,0.13158,0.0034983,0.24196,0.29328,PID_CIRCADIAN_PATHWAY,0.973850573230152
HALLMARK_CHOLESTEROL_HOMEOST...,SET,69,0.053198,0.0032535,0.097823,0.29329,HALLMARK_CHOLESTEROL_HOMEOSTASIS,0.973850573230152
GSE17974_CTRL_VS_ACT_IL4_AND...3,SET,178,0.032493,0.0031822,0.059779,0.29338,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_DN,0.974056352693924
chr1p36,SET,326,0.054254,0.0071614,0.099906,0.29355,chr1p36,0.974214794311349
TONKS_TARGETS_OF_RUNX1_RUNX1...1,SET,16,0.11576,0.003414,0.21317,0.29356,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_DN,0.974214794311349
REACTOME_METABOLISM_OF_STERO...1,SET,146,0.037679,0.0033449,0.069392,0.29357,REACTOME_METABOLISM_OF_STEROIDS,0.974214794311349
DUTERTRE_ESTRADIOL_RESPONSE_...4,SET,209,0.031591,0.0033496,0.058196,0.29363,DUTERTRE_ESTRADIOL_RESPONSE_6HR_UP,0.974214794311349
ZC3H11A_TARGET_GENES,SET,747,0.016913,0.0033398,0.031159,0.29363,ZC3H11A_TARGET_GENES,0.974214794311349
THEILGAARD_NEUTROPHIL_AT_SKI...2,SET,73,0.056417,0.0035485,0.10396,0.29367,THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP,0.974214794311349
GOBP_ENDOCARDIAL_CUSHION_FUS...,SET,4,0.27243,0.0040186,0.50199,0.29367,GOBP_ENDOCARDIAL_CUSHION_FUSION,0.974214794311349
GOMF_HYALURONIC_ACID_BINDING,SET,24,0.099588,0.0035964,0.1835,0.29367,GOMF_HYALURONIC_ACID_BINDING,0.974214794311349
REACTOME_SIGNALING_BY_TGFBR3,SET,44,0.071024,0.003471,0.13088,0.29368,REACTOME_SIGNALING_BY_TGFBR3,0.974214794311349
AMUNDSON_RESPONSE_TO_ARSENITE,SET,195,0.032822,0.0033629,0.060504,0.29375,AMUNDSON_RESPONSE_TO_ARSENITE,0.97433330472103
GOBP_NEURON_REMODELING,SET,15,0.13138,0.0037518,0.24227,0.29381,GOBP_NEURON_REMODELING,0.97433330472103
GOBP_REGULATION_OF_RETROGRAD...1,SET,12,0.12353,0.0031553,0.22779,0.29382,GOBP_REGULATION_OF_RETROGRADE_PROTEIN_TRANSPORT_ER_TO_CYTOSOL,0.97433330472103
GOBP_NEGATIVE_REGULATION_OF_...413,SET,1003,0.015448,0.0035089,0.028489,0.29383,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,0.97433330472103
HP_ABNORMAL_MORPHOLOGY_OF_UL...,SET,140,0.038964,0.0033877,0.071877,0.29388,HP_ABNORMAL_MORPHOLOGY_OF_ULNA,0.97433330472103
GOMF_GLUTATHIONE_PEROXIDASE_...,SET,21,0.1054,0.0035607,0.19447,0.29392,GOMF_GLUTATHIONE_PEROXIDASE_ACTIVITY,0.97433330472103
HP_ONYCHOGRYPOSIS_OF_FINGERN...,SET,9,0.13586,0.0030058,0.25068,0.29392,HP_ONYCHOGRYPOSIS_OF_FINGERNAIL,0.97433330472103
HP_ABNORMAL_UVEA_MORPHOLOGY,SET,523,0.02067,0.0034368,0.038142,0.29394,HP_ABNORMAL_UVEA_MORPHOLOGY,0.97433330472103
GSE16522_ANTI_CD3CD28_STIM_V...2,SET,186,0.032614,0.0032643,0.060197,0.29398,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_MEMORY_CD8_TCELL_UP,0.974372963951936
HP_CUTANEOUS_ABSCESS,SET,23,0.09598,0.0033932,0.17722,0.29405,HP_CUTANEOUS_ABSCESS,0.974412009149828
REACTOME_ANTIGEN_PROCESSING_...1,SET,97,0.043281,0.003136,0.079928,0.29408,REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION,0.974412009149828
BIOCARTA_ETS_PATHWAY,SET,17,0.11969,0.0036384,0.22106,0.29411,BIOCARTA_ETS_PATHWAY,0.974412009149828
HP_RETINAL_PIGMENT_EPITHELIA...2,SET,39,0.075216,0.0034612,0.13893,0.29412,HP_RETINAL_PIGMENT_EPITHELIAL_MOTTLING,0.974412009149828
OZEN_MIR125B1_TARGETS,SET,22,0.098814,0.0034167,0.18255,0.29416,OZEN_MIR125B1_TARGETS,0.974412009149828
MIR921,SET,57,0.064022,0.0035599,0.11828,0.29416,MIR921,0.974412009149828
HP_CELLULAR_IMMUNODEFICIENCY,SET,33,0.075926,0.0032144,0.14034,0.29425,HP_CELLULAR_IMMUNODEFICIENCY,0.974557489994282
GOBP_PROTEIN_MATURATION_BY_P...,SET,6,0.17697,0.0031969,0.32712,0.29426,GOBP_PROTEIN_MATURATION_BY_PROTEIN_FOLDING,0.974557489994282
GOBP_POSITIVE_REGULATION_OF_...334,SET,5,0.20505,0.0033817,0.37921,0.29434,GOBP_POSITIVE_REGULATION_OF_HEPATIC_STELLATE_CELL_ACTIVATION,0.974729556931872
GOMF_PHOSPHATASE_REGULATOR_A...,SET,93,0.045701,0.0032427,0.084535,0.29439,GOMF_PHOSPHATASE_REGULATOR_ACTIVITY,0.974802253239329
HALLMARK_ANGIOGENESIS,SET,35,0.086474,0.00377,0.16002,0.29447,HALLMARK_ANGIOGENESIS,0.974804751948299
GSE17721_LPS_VS_GARDIQUIMOD_...5,SET,180,0.033999,0.0033481,0.06293,0.29451,GSE17721_LPS_VS_GARDIQUIMOD_16H_BMDC_DN,0.974804751948299
GSE26343_WT_VS_NFAT5_KO_MACR...3,SET,189,0.03333,0.0033625,0.061709,0.29456,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_UP,0.974804751948299
BIOCARTA_PS1_PATHWAY,SET,13,0.10901,0.0028983,0.20193,0.29465,BIOCARTA_PS1_PATHWAY,0.974804751948299
GAVISH_3CA_METAPROGRAM_CD4_T...5,SET,47,0.067039,0.0033858,0.12418,0.29466,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_INTERFERON,0.974804751948299
MODULE_115,SET,25,0.084796,0.0031253,0.15714,0.29473,MODULE_115,0.974804751948299
GOCC_EUKARYOTIC_TRANSLATION_...2,SET,3,0.26244,0.0033527,0.48633,0.29473,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2_COMPLEX,0.974804751948299
BEGUM_TARGETS_OF_PAX3_FOXO1_...3,SET,54,0.068591,0.0037125,0.12712,0.29474,BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.974804751948299
GSE30971_WBP7_HET_VS_KO_MACR...4,SET,178,0.03441,0.0033699,0.063776,0.29476,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_UP,0.974804751948299
HP_ABNORMALITY_OF_THE_LYMPHA...,SET,694,0.017564,0.003348,0.032557,0.29478,HP_ABNORMALITY_OF_THE_LYMPHATIC_SYSTEM,0.974804751948299
HP_HYPERLORDOSIS,SET,184,0.033474,0.0033325,0.062055,0.2948,HP_HYPERLORDOSIS,0.974804751948299
MIR620,SET,69,0.057109,0.0034926,0.10588,0.29482,MIR620,0.974804751948299
REACTOME_BUDDING_AND_MATURAT...,SET,27,0.082751,0.0031694,0.15343,0.29483,REACTOME_BUDDING_AND_MATURATION_OF_HIV_VIRION,0.974804751948299
MIR938,SET,69,0.050755,0.003104,0.094112,0.29484,MIR938,0.974804751948299
GOMF_RS_DOMAIN_BINDING,SET,4,0.18775,0.0027695,0.34825,0.29491,GOMF_RS_DOMAIN_BINDING,0.974804751948299
REACTOME_COOPERATION_OF_PREF...,SET,30,0.077008,0.0031087,0.14287,0.29494,REACTOME_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT_IN_ACTIN_AND_TUBULIN_FOLDING,0.974804751948299
GOBP_URONIC_ACID_METABOLIC_P...,SET,24,0.13472,0.0048652,0.24996,0.29495,GOBP_URONIC_ACID_METABOLIC_PROCESS,0.974804751948299
GSE3982_MAST_CELL_VS_BCELL_UP,SET,180,0.035009,0.0034477,0.064953,0.29495,GSE3982_MAST_CELL_VS_BCELL_UP,0.974804751948299
GOMF_TRNA_METHYLTRANSFERASE_...,SET,30,0.071801,0.0028985,0.13323,0.29497,GOMF_TRNA_METHYLTRANSFERASE_ACTIVITY,0.974804751948299
KEGG_MEDICUS_VARIANT_MUTATIO...68,SET,22,0.096305,0.00333,0.17872,0.29499,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP2B3_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.974804751948299
LEE_NEURAL_CREST_STEM_CELL_DN,SET,103,0.048289,0.0036048,0.089615,0.295,LEE_NEURAL_CREST_STEM_CELL_DN,0.974804751948299
GSE23308_WT_VS_MINERALCORTIC...4,SET,187,0.031897,0.0032011,0.059216,0.29506,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_UP,0.974804751948299
GOCC_PHAGOCYTIC_CUP,SET,26,0.089082,0.0033482,0.16539,0.29508,GOCC_PHAGOCYTIC_CUP,0.974804751948299
HP_SQUARED_ILIAC_BONES,SET,11,0.13226,0.0032346,0.24555,0.29508,HP_SQUARED_ILIAC_BONES,0.974804751948299
GSE43955_TGFB_IL6_VS_TGFB_IL...3,SET,180,0.033907,0.003339,0.062962,0.29511,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,0.974804751948299
GOMF_O_ACYLTRANSFERASE_ACTIV...,SET,47,0.067363,0.0034022,0.12509,0.29512,GOMF_O_ACYLTRANSFERASE_ACTIVITY,0.974804751948299
GSE2770_IL12_ACT_VS_ACT_CD4_...4,SET,181,0.032695,0.0032286,0.06076,0.29526,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_48H_UP,0.974902169578428
BURTON_ADIPOGENESIS_3,SET,95,0.044581,0.0031969,0.082856,0.29527,BURTON_ADIPOGENESIS_3,0.974902169578428
GSE17721_CTRL_VS_LPS_1H_BMDC...2,SET,177,0.033165,0.0032389,0.061642,0.29528,GSE17721_CTRL_VS_LPS_1H_BMDC_UP,0.974902169578428
ACTAYRNNNCCCR_UNKNOWN,SET,411,0.022321,0.0033004,0.041501,0.29534,ACTAYRNNNCCCR_UNKNOWN,0.974902169578428
GSE22886_IGM_MEMORY_BCELL_VS...3,SET,178,0.033544,0.0032851,0.062382,0.29539,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,0.974902169578428
REACTOME_GAMMA_CARBOXYLATION...1,SET,51,0.060344,0.0031743,0.11223,0.2954,REACTOME_GAMMA_CARBOXYLATION_HYPUSINYLATION_HYDROXYLATION_AND_ARYLSULFATASE_ACTIVATION,0.974902169578428
GSE39820_CTRL_VS_IL1B_IL6_IL...1,SET,186,0.033833,0.0033863,0.062924,0.2954,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_DN,0.974902169578428
GOBP_MESODERMAL_CELL_MIGRATI...,SET,5,0.22044,0.0036355,0.41003,0.29542,GOBP_MESODERMAL_CELL_MIGRATION,0.974902169578428
GSE17974_CTRL_VS_ACT_IL4_AND...4,SET,159,0.037387,0.0034624,0.069546,0.29543,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_12H_CD4_TCELL_UP,0.974902169578428
DESCARTES_MAIN_FETAL_MESANGI...,SET,16,0.12193,0.0035959,0.2268,0.29543,DESCARTES_MAIN_FETAL_MESANGIAL_CELLS,0.974902169578428
HP_DOWNSLANTED_PALPEBRAL_FIS...,SET,428,0.021609,0.0032589,0.040201,0.29546,HP_DOWNSLANTED_PALPEBRAL_FISSURES,0.974908601538023
GSE30971_WBP7_HET_VS_KO_MACR...3,SET,174,0.034443,0.0033354,0.064097,0.29551,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_4H_LPS_STIM_DN,0.97492146179402
HP_ABNORMALITY_OF_THE_FOREHE...,SET,1026,0.014099,0.0032368,0.026237,0.29552,HP_ABNORMALITY_OF_THE_FOREHEAD,0.97492146179402
HP_ELEVATED_SERUM_11_DEOXYCO...,SET,9,0.16304,0.003607,0.30362,0.29564,HP_ELEVATED_SERUM_11_DEOXYCORTISOL,0.975224772209567
GOBP_REGULATION_OF_LIPID_KIN...,SET,8,0.17982,0.0037508,0.33504,0.29574,GOBP_REGULATION_OF_LIPID_KINASE_ACTIVITY,0.975462057511626
HP_SECUNDUM_ATRIAL_SEPTAL_DE...,SET,38,0.074839,0.0033994,0.1395,0.29582,HP_SECUNDUM_ATRIAL_SEPTAL_DEFECT,0.975573740392827
REACTOME_OREXIN_AND_NEUROPEP...,SET,6,0.22945,0.004145,0.42772,0.29583,REACTOME_OREXIN_AND_NEUROPEPTIDES_FF_AND_QRFP_BIND_TO_THEIR_RESPECTIVE_RECEPTORS,0.975573740392827
PEART_HDAC_PROLIFERATION_CLU...2,SET,51,0.063695,0.0033506,0.11878,0.29589,PEART_HDAC_PROLIFERATION_CLUSTER_UP,0.975679027514231
HP_ANTERIOR_SYNECHIAE_OF_THE...,SET,13,0.1434,0.0038124,0.26744,0.29592,HP_ANTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,0.975685380893653
HP_PAPILLEDEMA,SET,26,0.088913,0.0033418,0.16596,0.29607,HP_PAPILLEDEMA,0.976027734041544
REACTOME_ENDOSOMAL_SORTING_C...,SET,30,0.076659,0.0030946,0.1431,0.29608,REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT,0.976027734041544
GSE23505_UNTREATED_VS_4DAY_I...2,SET,185,0.033562,0.0033502,0.062673,0.29615,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,0.976038995260664
GOBP_POSTSYNAPSE_ASSEMBLY,SET,41,0.072136,0.0034033,0.13474,0.2962,GOBP_POSTSYNAPSE_ASSEMBLY,0.976038995260664
GSE22886_NAIVE_VS_IGM_MEMORY...1,SET,176,0.0345,0.0033599,0.064444,0.29621,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_DN,0.976038995260664
GOBP_LEUKOCYTE_APOPTOTIC_PRO...,SET,112,0.043055,0.0033507,0.080451,0.29627,GOBP_LEUKOCYTE_APOPTOTIC_PROCESS,0.976038995260664
HP_AREFLEXIA,SET,271,0.026824,0.0032331,0.050123,0.29627,HP_AREFLEXIA,0.976038995260664
MIR6870_3P,SET,42,0.067319,0.0032144,0.1258,0.29628,MIR6870_3P,0.976038995260664
GOBP_CARDIAC_PACEMAKER_CELL_...1,SET,9,0.16477,0.0036452,0.3079,0.29628,GOBP_CARDIAC_PACEMAKER_CELL_DEVELOPMENT,0.976038995260664
GSE20500_CTRL_VS_RETINOIC_AC...2,SET,174,0.032092,0.0031078,0.059994,0.29636,GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_UP,0.97613010233087
THEODOROU_MAMMARY_TUMORIGENE...,SET,27,0.099628,0.0038158,0.18628,0.29638,THEODOROU_MAMMARY_TUMORIGENESIS,0.97613010233087
GAVISH_3CA_METAPROGRAM_MACRO...5,SET,47,0.070626,0.0035669,0.13206,0.2964,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_2,0.97613010233087
SIG_BCR_SIGNALING_PATHWAY,SET,45,0.066583,0.0032906,0.12452,0.29642,SIG_BCR_SIGNALING_PATHWAY,0.97613010233087
WP_MICRORNAS_IN_CARDIOMYOCYT...,SET,81,0.050488,0.0033443,0.094443,0.29647,WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY,0.97620225959261
GOBP_POSITIVE_REGULATION_OF_...828,SET,17,0.10755,0.0032695,0.20122,0.2965,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.976208554376658
GOBP_NEGATIVE_REGULATION_OF_...34,SET,12,0.13452,0.0034362,0.25178,0.29658,GOBP_NEGATIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.976368588591429
HP_APLASIA_OF_THE_PECTORALIS...,SET,4,0.24428,0.0036033,0.45752,0.29671,HP_APLASIA_OF_THE_PECTORALIS_MAJOR_MUSCLE,0.976368588591429
WP_CORTICOTROPINRELEASING_HO...,SET,89,0.049128,0.0034104,0.092029,0.29673,WP_CORTICOTROPINRELEASING_HORMONE_SIGNALING,0.976368588591429
HP_SYNOSTOSIS_INVOLVING_BONE...3,SET,106,0.045029,0.0034098,0.084357,0.29675,HP_SYNOSTOSIS_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.976368588591429
HP_LARYNGEAL_CARCINOMA,SET,12,0.11206,0.0028626,0.20996,0.29676,HP_LARYNGEAL_CARCINOMA,0.976368588591429
MIR10A_3P,SET,20,0.099555,0.0032823,0.18657,0.29681,MIR10A_3P,0.976368588591429
KEGG_MEDICUS_REFERENCE_NUCLE...2,SET,11,0.14297,0.0034966,0.26796,0.29683,KEGG_MEDICUS_REFERENCE_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,0.976368588591429
GSE24972_MARGINAL_ZONE_BCELL...1,SET,179,0.034017,0.0033407,0.063756,0.29683,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_DN,0.976368588591429
REACTOME_ARACHIDONIC_ACID_ME...,SET,56,0.063214,0.0034841,0.1185,0.29686,REACTOME_ARACHIDONIC_ACID_METABOLISM,0.976368588591429
NPM1_TARGET_GENES,SET,280,0.026152,0.0032033,0.049037,0.29691,NPM1_TARGET_GENES,0.976368588591429
GSE17301_CTRL_VS_48H_ACD3_AC...3,SET,186,0.032173,0.0032201,0.060324,0.29691,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN,0.976368588591429
GOBP_REGULATION_OF_PROTEOLYS...2,SET,197,0.03153,0.0032468,0.05913,0.29694,GOBP_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.976368588591429
KEGG_MEDICUS_VARIANT_LOSS_OF...4,SET,12,0.14093,0.0035999,0.26434,0.29697,KEGG_MEDICUS_VARIANT_LOSS_OF_VHL_TO_HIF_1_SIGNALING_PATHWAY,0.976368588591429
MIR4432,SET,62,0.055782,0.0032344,0.10463,0.29697,MIR4432,0.976368588591429
GOBP_NEGATIVE_REGULATION_OF_...50,SET,7,0.17713,0.0034562,0.33223,0.29697,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,0.976368588591429
REACTOME_SYNTHESIS_OF_PIPS_A...5,SET,48,0.063,0.0032154,0.11818,0.297,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_PLASMA_MEMBRANE,0.976374858115778
GOBP_INTERLEUKIN_5_PRODUCTION,SET,19,0.10841,0.0034839,0.20345,0.29707,GOBP_INTERLEUKIN_5_PRODUCTION,0.976420261963306
GOBP_NEGATIVE_REGULATION_OF_...497,SET,18,0.11357,0.0035524,0.21313,0.29707,GOBP_NEGATIVE_REGULATION_OF_PLATELET_ACTIVATION,0.976420261963306
BIOCARTA_CCR5_PATHWAY,SET,17,0.11775,0.0035796,0.22108,0.29715,BIOCARTA_CCR5_PATHWAY,0.976568626803735
GSE3982_BCELL_VS_CENT_MEMORY...2,SET,177,0.03328,0.0032502,0.062503,0.29721,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.976568626803735
WP_WNTBETACATENIN_SIGNALING_...1,SET,4,0.25262,0.0037264,0.47457,0.29726,WP_WNTBETACATENIN_SIGNALING_INHIBITORS_IN_CURRENT_AND_PAST_CLINICAL_TRIALS,0.976568626803735
GOMF_NUCLEOSIDE_BINDING,SET,8,0.15976,0.0033324,0.30014,0.29726,GOMF_NUCLEOSIDE_BINDING,0.976568626803735
HP_TYPE_I_DIABETES_MELLITUS,SET,51,0.064551,0.0033957,0.12129,0.29729,HP_TYPE_I_DIABETES_MELLITUS,0.976568626803735
BOSCO_EPITHELIAL_DIFFERENTIA...,SET,60,0.06383,0.0036411,0.11994,0.2973,BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE,0.976568626803735
GOBP_NEGATIVE_REGULATION_OF_...12,SET,14,0.11964,0.0033007,0.22487,0.29736,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.976568626803735
GOCC_SMALL_NUCLEAR_RIBONUCLE...,SET,70,0.045487,0.0028019,0.085515,0.29739,GOCC_SMALL_NUCLEAR_RIBONUCLEOPROTEIN_COMPLEX,0.976568626803735
OSMAN_BLOOD_CHAD63_KH_AGE_18...1,SET,1468,0.012393,0.0033598,0.023304,0.29743,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_DN,0.976568626803735
CAFFAREL_RESPONSE_TO_THC_24H...4,SET,29,0.072872,0.0028924,0.13703,0.29744,CAFFAREL_RESPONSE_TO_THC_24HR_5_UP,0.976568626803735
REACTOME_NS1_MEDIATED_EFFECT...,SET,39,0.064763,0.0029801,0.1218,0.29746,REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS,0.976568626803735
ZNF404_TARGET_GENES,SET,17,0.098849,0.0030049,0.18592,0.29748,ZNF404_TARGET_GENES,0.976568626803735
GOMF_NUCLEAR_RECEPTOR_BINDING,SET,126,0.039387,0.00325,0.07409,0.2975,GOMF_NUCLEAR_RECEPTOR_BINDING,0.976568626803735
GAVISH_3CA_MALIGNANT_METAPRO...5,SET,46,0.069628,0.003479,0.13099,0.29751,GAVISH_3CA_MALIGNANT_METAPROGRAM_14_EMT_3,0.976568626803735
GOCC_PHAGOLYSOSOME,SET,7,0.15881,0.0030988,0.2988,0.29754,GOCC_PHAGOLYSOSOME,0.976568626803735
HP_POSTERIOR_PITUITARY_DYSGE...,SET,22,0.094115,0.0032542,0.17713,0.2976,HP_POSTERIOR_PITUITARY_DYSGENESIS,0.976568626803735
PID_TXA2PATHWAY,SET,52,0.064584,0.0034305,0.12159,0.29765,PID_TXA2PATHWAY,0.976568626803735
GAO_LARGE_INTESTINE_24W_C4_P...,SET,5,0.20882,0.0034438,0.39315,0.29766,GAO_LARGE_INTESTINE_24W_C4_PROM1LOW_PROGENITOR,0.976568626803735
HP_HYPERGLUTAMINEMIA,SET,8,0.13322,0.0027787,0.25082,0.29767,HP_HYPERGLUTAMINEMIA,0.976568626803735
GOBP_L_METHIONINE_SALVAGE_FR...,SET,5,0.22775,0.003756,0.42891,0.29771,GOBP_L_METHIONINE_SALVAGE_FROM_METHYLTHIOADENOSINE,0.976568626803735
HP_HYPERTROPHIC_CARDIOMYOPAT...,SET,243,0.027679,0.0031616,0.052141,0.29776,HP_HYPERTROPHIC_CARDIOMYOPATHY,0.976568626803735
GOMF_POTASSIUM_ION_TRANSMEMB...,SET,156,0.039482,0.003622,0.0744,0.29783,GOMF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976568626803735
GOBP_INNER_MITOCHONDRIAL_MEM...,SET,35,0.070297,0.0030647,0.13248,0.29784,GOBP_INNER_MITOCHONDRIAL_MEMBRANE_ORGANIZATION,0.976568626803735
ZNF667_TARGET_GENES,SET,120,0.040323,0.0032476,0.075997,0.29786,ZNF667_TARGET_GENES,0.976568626803735
KEGG_MEDICUS_REFERENCE_TIGHT...,SET,34,0.079468,0.0034148,0.14979,0.29788,KEGG_MEDICUS_REFERENCE_TIGHT_JUNCTION_ACTIN_SIGNALING_PATHWAY,0.976568626803735
HP_PROXIMAL_FEMORAL_EPIPHYSI...,SET,7,0.15509,0.0030262,0.29236,0.29789,HP_PROXIMAL_FEMORAL_EPIPHYSIOLYSIS,0.976568626803735
GSE25123_WT_VS_PPARG_KO_MACR...3,SET,162,0.034368,0.0032124,0.064793,0.29791,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_UP,0.976568626803735
MED16_TARGET_GENES,SET,19,0.10964,0.0035234,0.20672,0.29793,MED16_TARGET_GENES,0.976568626803735
HP_THICK_VERMILION_BORDER,SET,226,0.028697,0.0031626,0.054108,0.29793,HP_THICK_VERMILION_BORDER,0.976568626803735
GOCC_PLATELET_ALPHA_GRANULE,SET,81,0.052639,0.0034868,0.099323,0.29807,GOCC_PLATELET_ALPHA_GRANULE,0.976935387589589
GOBP_REGULATION_OF_LYSOSOME_...1,SET,12,0.12883,0.0032909,0.24331,0.29824,GOBP_REGULATION_OF_LYSOSOME_ORGANIZATION,0.976975347773317
GSE25123_ROSIGLITAZONE_VS_IL...1,SET,105,0.042959,0.0032377,0.081137,0.29825,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,0.976975347773317
GAJATE_RESPONSE_TO_TRABECTED...1,SET,16,0.12307,0.0036296,0.23247,0.29827,GAJATE_RESPONSE_TO_TRABECTEDIN_DN,0.976975347773317
GOMF_RNA_METHYLTRANSFERASE_A...,SET,53,0.051501,0.0027616,0.097282,0.29827,GOMF_RNA_METHYLTRANSFERASE_ACTIVITY,0.976975347773317
REACTOME_CARGO_TRAFFICKING_T...,SET,49,0.061035,0.0031473,0.1153,0.29828,REACTOME_CARGO_TRAFFICKING_TO_THE_PERICILIARY_MEMBRANE,0.976975347773317
GSE15930_STIM_VS_STIM_AND_IF...2,SET,176,0.031807,0.0030976,0.060085,0.29828,GSE15930_STIM_VS_STIM_AND_IFNAB_24H_CD8_T_CELL_UP,0.976975347773317
GOBP_NEGATIVE_REGULATION_OF_...80,SET,18,0.10982,0.0034352,0.20751,0.29832,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_GROWTH,0.976975347773317
BRUINS_UVC_RESPONSE_VIA_TP53...2,SET,493,0.020142,0.0032544,0.038064,0.29835,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B,0.976975347773317
GSE22935_WT_VS_MYD88_KO_MACR...3,SET,182,0.032816,0.0032493,0.062014,0.29835,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_24H_MBOVIS_BCG_STIM_DN,0.976975347773317
MEBARKI_HCC_PROGENITOR_WNT_U...3,SET,39,0.081708,0.0037599,0.15448,0.29843,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,0.976975347773317
GOBP_PITUITARY_GLAND_DEVELOP...,SET,39,0.080587,0.0037083,0.15243,0.29851,GOBP_PITUITARY_GLAND_DEVELOPMENT,0.976975347773317
ATGCACG_MIR517B,SET,18,0.11124,0.0034794,0.21042,0.29853,ATGCACG_MIR517B,0.976975347773317
GOBP_NEGATIVE_REGULATION_OF_...529,SET,5,0.15744,0.0025965,0.2979,0.29858,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MICROTUBULE,0.976975347773317
KEGG_AMINOACYL_TRNA_BIOSYNTH...,SET,22,0.089606,0.0030983,0.16959,0.29862,KEGG_AMINOACYL_TRNA_BIOSYNTHESIS,0.976975347773317
GOMF_FATTY_ACID_TRANSMEMBRAN...,SET,18,0.10372,0.0032445,0.19642,0.29872,GOMF_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976975347773317
REACTOME_FLT3_SIGNALING_THRO...,SET,6,0.16752,0.0030264,0.31725,0.29873,REACTOME_FLT3_SIGNALING_THROUGH_SRC_FAMILY_KINASES,0.976975347773317
MIR3059_5P,SET,275,0.027017,0.00328,0.051172,0.29877,MIR3059_5P,0.976975347773317
HP_CRANIAL_NERVE_PARALYSIS,SET,258,0.027788,0.0032691,0.052637,0.29878,HP_CRANIAL_NERVE_PARALYSIS,0.976975347773317
MIR1908_5P,SET,16,0.11538,0.0034028,0.21856,0.29879,MIR1908_5P,0.976975347773317
MIR624_5P,SET,97,0.044922,0.0032549,0.085134,0.29887,MIR624_5P,0.976975347773317
FAN_OVARY_CL13_MONOCYTE_MACR...,SET,411,0.022195,0.0032817,0.042068,0.29889,FAN_OVARY_CL13_MONOCYTE_MACROPHAGE,0.976975347773317
GOBP_MHC_CLASS_II_BIOSYNTHET...,SET,19,0.10579,0.0033996,0.20055,0.29892,GOBP_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,0.976975347773317
HP_HEPATIC_BRIDGING_FIBROSIS,SET,9,0.14379,0.0031811,0.27259,0.29893,HP_HEPATIC_BRIDGING_FIBROSIS,0.976975347773317
HP_MACROGLOSSIA,SET,134,0.038471,0.0032729,0.07293,0.29893,HP_MACROGLOSSIA,0.976975347773317
HP_BROAD_METACARPALS,SET,17,0.1173,0.0035659,0.2224,0.29895,HP_BROAD_METACARPALS,0.976975347773317
HP_DERMAL_TRANSLUCENCY,SET,25,0.094749,0.0034921,0.17967,0.29898,HP_DERMAL_TRANSLUCENCY,0.976975347773317
MODULE_323,SET,52,0.056937,0.0030243,0.10798,0.299,MODULE_323,0.976975347773317
BIOCARTA_NOTCH_PATHWAY,SET,6,0.15472,0.002795,0.29348,0.29903,BIOCARTA_NOTCH_PATHWAY,0.976975347773317
GOBP_RNA_STABILIZATION,SET,60,0.056759,0.0032377,0.10769,0.29908,GOBP_RNA_STABILIZATION,0.976975347773317
REACTOME_FGFR1_MUTANT_RECEPT...,SET,30,0.086063,0.0034743,0.16332,0.29911,REACTOME_FGFR1_MUTANT_RECEPTOR_ACTIVATION,0.976975347773317
GOBP_POSITIVE_REGULATION_OF_...584,SET,38,0.075734,0.0034401,0.14379,0.2992,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,0.976975347773317
GOMF_COMPLEMENT_COMPONENT_C1...,SET,7,0.16738,0.003266,0.31779,0.29921,GOMF_COMPLEMENT_COMPONENT_C1Q_COMPLEX_BINDING,0.976975347773317
MIR4632_5P,SET,91,0.047269,0.0033178,0.089787,0.29929,MIR4632_5P,0.976975347773317
HP_NEOPLASM_OF_THE_GALLBLADD...,SET,6,0.18787,0.0033939,0.35705,0.29939,HP_NEOPLASM_OF_THE_GALLBLADDER,0.976975347773317
GOMF_MACROMOLECULE_TRANSMEMB...,SET,30,0.075317,0.0030405,0.14318,0.29944,GOMF_MACROMOLECULE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.976975347773317
HP_ERYTHROID_HYPOPLASIA,SET,26,0.081395,0.0030592,0.15476,0.29947,HP_ERYTHROID_HYPOPLASIA,0.976975347773317
GSE2770_IL4_ACT_VS_ACT_CD4_T...5,SET,173,0.031925,0.0030828,0.060702,0.29947,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,0.976975347773317
REACTOME_BETA_OXIDATION_OF_D...,SET,6,0.16225,0.0029311,0.30853,0.29948,REACTOME_BETA_OXIDATION_OF_DECANOYL_COA_TO_OCTANOYL_COA_COA,0.976975347773317
GOBP_REGULATION_OF_GASTRIC_A...,SET,6,0.1744,0.0031506,0.33163,0.29949,GOBP_REGULATION_OF_GASTRIC_ACID_SECRETION,0.976975347773317
GOBP_BIOLOGICAL_PHASE,SET,11,0.13877,0.0033938,0.26389,0.2995,GOBP_BIOLOGICAL_PHASE,0.976975347773317
HP_ABNORMAL_MATERNAL_SERUM_S...,SET,6,0.19962,0.0036062,0.37962,0.29951,HP_ABNORMAL_MATERNAL_SERUM_SCREENING,0.976975347773317
GOBP_REGULATION_OF_DNA_CATAB...,SET,10,0.14117,0.0032921,0.26854,0.29955,GOBP_REGULATION_OF_DNA_CATABOLIC_PROCESS,0.976975347773317
GOMF_HEMOGLOBIN_BINDING,SET,8,0.185,0.0038588,0.35195,0.29958,GOMF_HEMOGLOBIN_BINDING,0.976975347773317
HP_METRORRHAGIA,SET,15,0.11905,0.0033996,0.22656,0.29963,HP_METRORRHAGIA,0.976975347773317
BASSO_HAIRY_CELL_LEUKEMIA_DN,SET,4,0.23401,0.0034519,0.44537,0.29964,BASSO_HAIRY_CELL_LEUKEMIA_DN,0.976975347773317
WP_AIRWAY_SMOOTH_MUSCLE_CELL...,SET,15,0.11714,0.0033452,0.22294,0.29964,WP_AIRWAY_SMOOTH_MUSCLE_CELL_CONTRACTION,0.976975347773317
MORF_PSMC1,SET,170,0.030335,0.002904,0.057733,0.29964,MORF_PSMC1,0.976975347773317
GOCC_ACETYLCHOLINE_GATED_CHA...,SET,16,0.11938,0.0035209,0.22735,0.29975,GOCC_ACETYLCHOLINE_GATED_CHANNEL_COMPLEX,0.976975347773317
HP_ABNORMAL_POSTERIOR_SEGMEN...,SET,41,0.073302,0.0034583,0.13964,0.29982,HP_ABNORMAL_POSTERIOR_SEGMENT_IMAGING,0.976975347773317
GSE24210_IL35_TREATED_VS_UNT...1,SET,183,0.033461,0.0033222,0.063748,0.29983,GSE24210_IL35_TREATED_VS_UNTREATED_TCONV_CD4_TCELL_DN,0.976975347773317
GOBP_WNT_SIGNALING_PATHWAY_P...,SET,48,0.065009,0.0033179,0.12387,0.29986,GOBP_WNT_SIGNALING_PATHWAY_PLANAR_CELL_POLARITY_PATHWAY,0.976975347773317
HP_NEPHROTIC_SYNDROME,SET,118,0.040231,0.0032132,0.076668,0.29989,HP_NEPHROTIC_SYNDROME,0.976975347773317
MIR339_5P,SET,65,0.054537,0.0032376,0.10395,0.29992,MIR339_5P,0.976975347773317
HP_ABSENT_THUMB,SET,51,0.057153,0.0030065,0.10896,0.29995,HP_ABSENT_THUMB,0.976975347773317
HP_ABNORMALITY_OF_FLUID_REGU...,SET,706,0.017405,0.0033451,0.033185,0.29997,HP_ABNORMALITY_OF_FLUID_REGULATION,0.976975347773317
MAGRANGEAS_MULTIPLE_MYELOMA_...3,SET,22,0.092754,0.0032072,0.17685,0.29998,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_DN,0.976975347773317
REACTOME_REGULATION_OF_RAS_B...,SET,64,0.049925,0.0029409,0.095231,0.30006,REACTOME_REGULATION_OF_RAS_BY_GAPS,0.976975347773317
HATADA_METHYLATED_IN_LUNG_CA...1,SET,31,0.085906,0.0035251,0.16388,0.30007,HATADA_METHYLATED_IN_LUNG_CANCER_DN,0.976975347773317
chr16q22,SET,105,0.090708,0.0068365,0.17305,0.30008,chr16q22,0.976975347773317
GOBP_INTEGRIN_MEDIATED_SIGNA...,SET,102,0.045266,0.0033628,0.086353,0.30008,GOBP_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,0.976975347773317
GOBP_POSITIVE_REGULATION_BY_...2,SET,20,0.099639,0.0032851,0.19012,0.30011,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.976975347773317
NEBEN_AML_WITH_FLT3_OR_NRAS_...2,SET,7,0.17097,0.0033359,0.32626,0.30013,NEBEN_AML_WITH_FLT3_OR_NRAS_UP,0.976975347773317
GOBP_PROTEIN_DNA_COVALENT_CR...,SET,8,0.12893,0.0026893,0.24604,0.30013,GOBP_PROTEIN_DNA_COVALENT_CROSS_LINKING_REPAIR,0.976975347773317
HP_DECREASED_URINE_OUTPUT,SET,24,0.096401,0.0034813,0.18395,0.30013,HP_DECREASED_URINE_OUTPUT,0.976975347773317
HP_LAGOPHTHALMOS,SET,12,0.11404,0.0029131,0.21764,0.30015,HP_LAGOPHTHALMOS,0.976975347773317
GSE17974_0H_VS_2H_IN_VITRO_A...2,SET,166,0.033984,0.0032151,0.064863,0.30017,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_UP,0.976975347773317
BIOCARTA_SAM68_PATHWAY,SET,6,0.18398,0.0033236,0.35119,0.30019,BIOCARTA_SAM68_PATHWAY,0.976975347773317
HP_MYOKYMIA,SET,18,0.092229,0.0028849,0.17607,0.30021,HP_MYOKYMIA,0.976975347773317
BOYAULT_LIVER_CANCER_SUBCLAS...9,SET,46,0.06099,0.0030474,0.11645,0.30024,BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP,0.976975347773317
GOBP_REGULATION_OF_PRE_MIRNA...,SET,5,0.19289,0.003181,0.36838,0.30028,GOBP_REGULATION_OF_PRE_MIRNA_PROCESSING,0.976975347773317
GOCC_EXTRINSIC_COMPONENT_OF_...10,SET,11,0.14021,0.0034292,0.26784,0.30032,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_VESICLE_MEMBRANE,0.976975347773317
HP_HEMANGIOMATOSIS,SET,19,0.10359,0.003329,0.19788,0.30032,HP_HEMANGIOMATOSIS,0.976975347773317
GOBP_POSITIVE_REGULATION_OF_...336,SET,14,0.12697,0.0035029,0.24259,0.30036,GOBP_POSITIVE_REGULATION_OF_HETEROTYPIC_CELL_CELL_ADHESION,0.976975347773317
KEGG_MEDICUS_REFERENCE_BMP_S...1,SET,20,0.098661,0.0032528,0.18852,0.30037,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY,0.976975347773317
HP_MATERNAL_HYPERTENSION,SET,7,0.17438,0.0034026,0.3332,0.30037,HP_MATERNAL_HYPERTENSION,0.976975347773317
REACTOME_ORGANIC_CATION_ANIO...,SET,15,0.1216,0.0034725,0.23239,0.3004,REACTOME_ORGANIC_CATION_ANION_ZWITTERION_TRANSPORT,0.976975347773317
MIR4760_5P,SET,181,0.03441,0.0033979,0.065767,0.30042,MIR4760_5P,0.976975347773317
KEGG_MEDICUS_REFERENCE_REGUL...13,SET,4,0.23476,0.003463,0.44872,0.30043,KEGG_MEDICUS_REFERENCE_REGULATION_OF_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY_NLRP3_INHIBITION,0.976975347773317
GOBP_NEGATIVE_REGULATION_OF_...82,SET,26,0.092288,0.0034687,0.17642,0.30046,GOBP_NEGATIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,0.976975347773317
GOBP_PEPTIDYL_METHIONINE_MOD...,SET,11,0.13123,0.0032095,0.25094,0.30051,GOBP_PEPTIDYL_METHIONINE_MODIFICATION,0.976975347773317
GOBP_METHIONINE_METABOLIC_PR...,SET,15,0.11538,0.0032948,0.22066,0.30053,GOBP_METHIONINE_METABOLIC_PROCESS,0.976975347773317
GOMF_NUCLEOSIDE_DIPHOSPHATE_...2,SET,17,0.10531,0.0032014,0.20143,0.30055,GOMF_NUCLEOSIDE_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,0.976975347773317
WEBER_METHYLATED_LCP_IN_FIBR...2,SET,11,0.13146,0.0032152,0.2515,0.30059,WEBER_METHYLATED_LCP_IN_FIBROBLAST_UP,0.976975347773317
TURASHVILI_BREAST_DUCTAL_CAR...1,SET,173,0.035467,0.0034248,0.067854,0.3006,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_DN,0.976975347773317
GNF2_TDG,SET,33,0.068668,0.0029071,0.13141,0.30065,GNF2_TDG,0.976975347773317
GSE22886_NAIVE_TCELL_VS_DC_DN,SET,189,0.032343,0.0032629,0.061904,0.30067,GSE22886_NAIVE_TCELL_VS_DC_DN,0.976975347773317
SENESE_HDAC1_AND_HDAC2_TARGE...2,SET,212,0.031584,0.0033725,0.060459,0.3007,SENESE_HDAC1_AND_HDAC2_TARGETS_UP,0.976975347773317
UBN1_TARGET_GENES,SET,1414,0.012118,0.0032295,0.023202,0.30073,UBN1_TARGET_GENES,0.976975347773317
HP_GENERALIZED_HYPERKERATOSIS,SET,13,0.1128,0.002999,0.21597,0.30073,HP_GENERALIZED_HYPERKERATOSIS,0.976975347773317
RUTELLA_RESPONSE_TO_CSF2RB_A...1,SET,295,0.026862,0.0033757,0.051434,0.30075,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN,0.976975347773317
HP_LIMB_JOINT_CONTRACTURE,SET,399,0.022523,0.0032824,0.04313,0.30076,HP_LIMB_JOINT_CONTRACTURE,0.976975347773317
GAVISH_3CA_MALIGNANT_METAPRO...33,SET,50,0.069193,0.0036041,0.13252,0.3008,GAVISH_3CA_MALIGNANT_METAPROGRAM_40_PDAC_RELATED,0.976975347773317
GOBP_REGULATION_OF_HIPPO_SIG...,SET,36,0.079118,0.0034982,0.15153,0.3008,GOBP_REGULATION_OF_HIPPO_SIGNALING,0.976975347773317
GSE43863_TH1_VS_LY6C_INT_CXC...3,SET,177,0.033468,0.0032685,0.064101,0.3008,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,0.976975347773317
GSE3982_NEUTROPHIL_VS_NKCELL...1,SET,176,0.0315,0.0030677,0.060355,0.30087,GSE3982_NEUTROPHIL_VS_NKCELL_DN,0.976975347773317
GOCC_EXOCYTIC_VESICLE,SET,217,0.030724,0.0033187,0.058875,0.30089,GOCC_EXOCYTIC_VESICLE,0.976975347773317
GOBP_DENTATE_GYRUS_DEVELOPME...,SET,23,0.095432,0.0033739,0.18293,0.30095,GOBP_DENTATE_GYRUS_DEVELOPMENT,0.976975347773317
REACTOME_BASIGIN_INTERACTIONS,SET,24,0.09451,0.003413,0.1812,0.30098,REACTOME_BASIGIN_INTERACTIONS,0.976975347773317
GSE18791_UNSTIM_VS_NEWCATSLE...1,SET,171,0.034464,0.0033088,0.066076,0.30098,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_10H_DN,0.976975347773317
GSE13522_CTRL_VS_T_CRUZI_Y_S...6,SET,184,0.033743,0.0033593,0.064697,0.30099,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNAR_KO_UP,0.976975347773317
GOBP_PEROXISOME_FISSION,SET,8,0.15487,0.0032305,0.29698,0.30101,GOBP_PEROXISOME_FISSION,0.976975347773317
GOBP_NEGATIVE_REGULATION_OF_...657,SET,3,0.24794,0.0031674,0.47552,0.30104,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.976975347773317
GOMF_PROTEIN_PHOSPHATASE_BIN...,SET,136,0.037217,0.0031896,0.071376,0.30104,GOMF_PROTEIN_PHOSPHATASE_BINDING,0.976975347773317
chr10q22,SET,85,0.090294,0.0061263,0.17318,0.30105,chr10q22,0.976975347773317
MIR363_3P,SET,385,0.022899,0.0032794,0.043929,0.30109,MIR363_3P,0.976975347773317
LMX1B_TARGET_GENES,SET,21,0.098383,0.0033237,0.18873,0.30109,LMX1B_TARGET_GENES,0.976975347773317
DESCARTES_FETAL_PLACENTA_VAS...,SET,85,0.051698,0.0035077,0.099176,0.30109,DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS,0.976975347773317
GSE4984_UNTREATED_VS_GALECTI...2,SET,170,0.033937,0.0032488,0.065125,0.30115,GSE4984_UNTREATED_VS_GALECTIN1_TREATED_DC_UP,0.977078813480209
REACTOME_FORMATION_OF_FIBRIN...,SET,36,0.079212,0.0035023,0.15205,0.3012,REACTOME_FORMATION_OF_FIBRIN_CLOT_CLOTTING_CASCADE,0.977149817978157
GOBP_PLASMA_CELL_DIFFERENTIA...,SET,9,0.14477,0.0032028,0.278,0.30127,GOBP_PLASMA_CELL_DIFFERENTIATION,0.977285686951652
HP_CALCIFICATION_OF_CARTILAGE,SET,11,0.1478,0.0036146,0.28386,0.3013,HP_CALCIFICATION_OF_CARTILAGE,0.977291787214186
HP_ABNORMAL_PERITONEUM_MORPH...,SET,59,0.059008,0.003338,0.11337,0.30136,HP_ABNORMAL_PERITONEUM_MORPHOLOGY,0.977338590604027
MIR4741,SET,41,0.066469,0.0031359,0.12771,0.30138,MIR4741,0.977338590604027
MIR3618,SET,88,0.047601,0.0032859,0.091471,0.3014,MIR3618,0.977338590604027
KEGG_NOTCH_SIGNALING_PATHWAY,SET,46,0.060641,0.00303,0.11658,0.30147,KEGG_NOTCH_SIGNALING_PATHWAY,0.977338590604027
GOMF_LIPID_BINDING,SET,790,0.016381,0.0033224,0.031493,0.30148,GOMF_LIPID_BINDING,0.977338590604027
TBX3_TARGET_GENES,SET,628,0.017725,0.0032201,0.034093,0.30157,TBX3_TARGET_GENES,0.977338590604027
GSE9037_CTRL_VS_LPS_1H_STIM_...1,SET,177,0.033056,0.0032283,0.063581,0.30157,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_DN,0.977338590604027
HP_ABNORMALITY_OF_THE_VERTEB...1,SET,1337,0.012113,0.003146,0.0233,0.30158,HP_ABNORMALITY_OF_THE_VERTEBRAL_COLUMN,0.977338590604027
HP_LATE_YOUNG_ADULT_ONSET,SET,42,0.065401,0.0031229,0.12582,0.30161,HP_LATE_YOUNG_ADULT_ONSET,0.977338590604027
GSE19888_ADENOSINE_A3R_INH_P...4,SET,186,0.033276,0.0033305,0.064031,0.30165,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_UP,0.977338590604027
chr3q23,SET,27,0.14948,0.005725,0.28765,0.30166,chr3q23,0.977338590604027
HP_ACCESSORY_ORAL_FRENULUM,SET,16,0.10568,0.0031166,0.20336,0.30166,HP_ACCESSORY_ORAL_FRENULUM,0.977338590604027
GOBP_REGULATION_OF_POSTSYNAP...8,SET,5,0.22025,0.0036323,0.42391,0.30168,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,0.977338590604027
HP_APLASIA_HYPOPLASIA_OF_THE...31,SET,41,0.066589,0.0031416,0.12818,0.30172,HP_APLASIA_HYPOPLASIA_OF_THE_EYELID,0.977377071488489
SABATES_COLORECTAL_ADENOMA_S...2,SET,15,0.10708,0.0030578,0.20618,0.30176,SABATES_COLORECTAL_ADENOMA_SIZE_UP,0.977389236790607
REACTOME_ACTIVATION_OF_SMO,SET,17,0.1079,0.0032802,0.20779,0.30178,REACTOME_ACTIVATION_OF_SMO,0.977389236790607
GOBP_CELL_MIGRATION_INVOLVED...1,SET,13,0.11953,0.0031779,0.23025,0.30183,GOBP_CELL_MIGRATION_INVOLVED_IN_GASTRULATION,0.977460086656728
HP_ACRAL_OVERGROWTH,SET,3,0.20498,0.0026187,0.39504,0.30192,HP_ACRAL_OVERGROWTH,0.977593611473272
HP_SEVERE_CYTOMEGALOVIRUS_IN...,SET,10,0.13799,0.0032179,0.26604,0.30199,HP_SEVERE_CYTOMEGALOVIRUS_INFECTION,0.977593611473272
GOCC_MLL3_4_COMPLEX,SET,10,0.12469,0.0029077,0.24044,0.30203,GOCC_MLL3_4_COMPLEX,0.977593611473272
ACOSTA_PROLIFERATION_INDEPEN...2,SET,77,0.047736,0.0030833,0.092056,0.30204,ACOSTA_PROLIFERATION_INDEPENDENT_MYC_TARGETS_UP,0.977593611473272
WAKABAYASHI_ADIPOGENESIS_PPA...5,SET,132,0.03716,0.0031379,0.071661,0.30204,WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_WITH_H4K20ME1_MARK,0.977593611473272
HP_NASAL_DYSARTHRIA,SET,29,0.080571,0.003198,0.15537,0.30204,HP_NASAL_DYSARTHRIA,0.977593611473272
GSE15330_LYMPHOID_MULTIPOTEN...2,SET,187,0.031596,0.0031709,0.060954,0.30211,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,0.97761783652951
GSE17721_CTRL_VS_CPG_2H_BMDC...1,SET,189,0.032975,0.0033267,0.063623,0.30213,GSE17721_CTRL_VS_CPG_2H_BMDC_DN,0.97761783652951
HP_ABNORMAL_LYMPHATIC_VESSEL...,SET,16,0.10943,0.0032275,0.21116,0.30215,HP_ABNORMAL_LYMPHATIC_VESSEL_MORPHOLOGY,0.97761783652951
GOBP_POSITIVE_REGULATION_OF_...204,SET,49,0.063703,0.0032849,0.12293,0.30216,GOBP_POSITIVE_REGULATION_OF_DEPHOSPHORYLATION,0.97761783652951
REACTOME_ABERRANT_REGULATION...2,SET,17,0.11238,0.0034163,0.217,0.30228,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_G1_S_TRANSITION_IN_CANCER_DUE_TO_RB1_DEFECTS,0.977660186994139
GSE19923_E2A_KO_VS_E2A_AND_H...2,SET,194,0.030707,0.0031381,0.059294,0.30228,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_UP,0.977660186994139
HP_DIAPHYSEAL_DYSPLASIA,SET,5,0.19296,0.0031823,0.37262,0.30229,HP_DIAPHYSEAL_DYSPLASIA,0.977660186994139
GSE22045_TREG_VS_TCONV_DN,SET,157,0.034491,0.0031742,0.066606,0.30229,GSE22045_TREG_VS_TCONV_DN,0.977660186994139
WP_HISTONE_MODIFICATIONS,SET,35,0.068789,0.002999,0.1329,0.30237,WP_HISTONE_MODIFICATIONS,0.977660186994139
GOCC_CILIARY_BASAL_BODY,SET,144,0.035911,0.0031662,0.069379,0.30237,GOCC_CILIARY_BASAL_BODY,0.977660186994139
GSE12366_GC_BCELL_VS_PLASMA_...2,SET,171,0.032116,0.0030834,0.062049,0.30237,GSE12366_GC_BCELL_VS_PLASMA_CELL_UP,0.977660186994139
KEGG_MEDICUS_REFERENCE_FE3_F...,SET,5,0.21152,0.0034883,0.40898,0.30251,KEGG_MEDICUS_REFERENCE_FE3_FERRITIN_TRANSPORT,0.977916631021016
GSE19941_LPS_VS_LPS_AND_IL10...4,SET,183,0.032721,0.0032488,0.063287,0.30257,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.977916631021016
GSE37532_VISCERAL_ADIPOSE_TI...1,SET,89,0.046667,0.0032396,0.090258,0.30257,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_DN,0.977916631021016
WP_TCA_CYCLE_IN_SENESCENCE,SET,9,0.15803,0.0034962,0.30567,0.30258,WP_TCA_CYCLE_IN_SENESCENCE,0.977916631021016
SEF1_C,SET,5,0.20098,0.0033144,0.38876,0.30259,SEF1_C,0.977916631021016
NIKOLSKY_BREAST_CANCER_8Q12_...,SET,124,0.067846,0.005554,0.1313,0.30268,NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON,0.977934684391559
WANG_METASTASIS_OF_BREAST_CA...2,SET,29,0.083611,0.0033186,0.16181,0.30268,WANG_METASTASIS_OF_BREAST_CANCER_ESR1_DN,0.977934684391559
GTGGGTGK_UNKNOWN,SET,265,0.027589,0.0032888,0.053393,0.30268,GTGGGTGK_UNKNOWN,0.977934684391559
HP_HAMSTRING_CONTRACTURES,SET,5,0.19958,0.0032915,0.3864,0.30275,HP_HAMSTRING_CONTRACTURES,0.978059070305273
GSE17721_PAM3CSK4_VS_GADIQUI...7,SET,178,0.032576,0.0031903,0.063098,0.30283,GSE17721_PAM3CSK4_VS_GADIQUIMOD_1H_BMDC_DN,0.978059070305273
GOBP_RESPONSE_TO_LECTIN,SET,20,0.10924,0.0036016,0.21164,0.30288,GOBP_RESPONSE_TO_LECTIN,0.978059070305273
CAIRO_HEPATOBLASTOMA_CLASSES...2,SET,559,0.017518,0.0030083,0.033955,0.30296,CAIRO_HEPATOBLASTOMA_CLASSES_UP,0.978059070305273
WP_PRION_DISEASE_PATHWAY,SET,31,0.079876,0.0032777,0.15482,0.30296,WP_PRION_DISEASE_PATHWAY,0.978059070305273
GOBP_NEGATIVE_REGULATION_OF_...367,SET,14,0.12053,0.0033253,0.2337,0.30302,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,0.978059070305273
GOCC_FANCONI_ANAEMIA_NUCLEAR...,SET,7,0.14136,0.0027583,0.27416,0.30307,GOCC_FANCONI_ANAEMIA_NUCLEAR_COMPLEX,0.978059070305273
HP_INSULIN_RESISTANCE,SET,104,0.044905,0.0033684,0.087102,0.30309,HP_INSULIN_RESISTANCE,0.978059070305273
REACTOME_COMPLEMENT_CASCADE,SET,49,0.072137,0.0037198,0.13995,0.30312,REACTOME_COMPLEMENT_CASCADE,0.978059070305273
ZNF610_TARGET_GENES,SET,708,0.016415,0.0031591,0.031859,0.3032,ZNF610_TARGET_GENES,0.978059070305273
STAT1_01,SET,62,0.054224,0.0031441,0.10525,0.3032,STAT1_01,0.978059070305273
GOBP_SERTOLI_CELL_DEVELOPMENT,SET,12,0.12031,0.0030732,0.23353,0.30322,GOBP_SERTOLI_CELL_DEVELOPMENT,0.978059070305273
GOMF_ANKYRIN_BINDING,SET,19,0.10728,0.0034475,0.20826,0.30323,GOMF_ANKYRIN_BINDING,0.978059070305273
REACTOME_P75NTR_SIGNALS_VIA_...,SET,14,0.12437,0.0034314,0.24145,0.30324,REACTOME_P75NTR_SIGNALS_VIA_NF_KB,0.978059070305273
HP_LOWER_LIMB_JOINT_CONTRACT...,SET,197,0.03134,0.0032273,0.060848,0.30326,HP_LOWER_LIMB_JOINT_CONTRACTURE,0.978059070305273
GOBP_THYROID_STIMULATING_HOR...,SET,6,0.18755,0.0033881,0.36415,0.30327,GOBP_THYROID_STIMULATING_HORMONE_SECRETING_CELL_DIFFERENTIATION,0.978059070305273
GOMF_L_PROLINE_TRANSMEMBRANE...,SET,7,0.18396,0.0035894,0.35722,0.30329,GOMF_L_PROLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.978059070305273
BIOCARTA_MHC_PATHWAY,SET,10,0.16705,0.0038955,0.32442,0.30331,BIOCARTA_MHC_PATHWAY,0.978059070305273
HP_ABNORMAL_CIRCULATING_FREE...2,SET,7,0.14755,0.0028791,0.28661,0.30334,HP_ABNORMAL_CIRCULATING_FREE_T3_CONCENTRATION,0.978059070305273
HP_HYPERCHLOREMIC_ACIDOSIS,SET,13,0.11752,0.0031244,0.22833,0.30339,HP_HYPERCHLOREMIC_ACIDOSIS,0.978059070305273
GSE9509_10MIN_VS_30MIN_LPS_A...2,SET,162,0.032365,0.0030252,0.062889,0.3034,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,0.978059070305273
GOMF_BHLH_TRANSCRIPTION_FACT...,SET,31,0.079632,0.0032677,0.15474,0.30341,GOMF_BHLH_TRANSCRIPTION_FACTOR_BINDING,0.978059070305273
MIR12118,SET,90,0.044414,0.0031004,0.086316,0.30344,MIR12118,0.978059070305273
MIR7108_3P,SET,12,0.12913,0.0032984,0.25098,0.30346,MIR7108_3P,0.978059070305273
NIKOLSKY_MUTATED_AND_AMPLIFI...,SET,87,0.045589,0.0031292,0.08866,0.30356,NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER,0.978059070305273
GOBP_CELL_PROLIFERATION_INVO...2,SET,21,0.10758,0.0036344,0.20928,0.30361,GOBP_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,0.978059070305273
HP_ABNORMAL_DENTAL_ROOT_MORP...,SET,47,0.062697,0.0031665,0.12197,0.30362,HP_ABNORMAL_DENTAL_ROOT_MORPHOLOGY,0.978059070305273
MIR6877_3P,SET,31,0.076888,0.0031551,0.14963,0.30368,MIR6877_3P,0.978059070305273
GOBP_C_TERMINAL_PROTEIN_LIPI...,SET,8,0.14836,0.0030947,0.28872,0.30368,GOBP_C_TERMINAL_PROTEIN_LIPIDATION,0.978059070305273
GERHOLD_ADIPOGENESIS_DN,SET,58,0.059109,0.0033153,0.11505,0.30371,GERHOLD_ADIPOGENESIS_DN,0.978059070305273
MATZUK_SPERMATOZOA,SET,105,0.041771,0.0031482,0.081316,0.30374,MATZUK_SPERMATOZOA,0.978059070305273
chr3q12,SET,22,0.15053,0.005205,0.29306,0.30375,chr3q12,0.978059070305273
GOCC_MEIOTIC_COHESIN_COMPLEX,SET,6,0.15314,0.0027664,0.29814,0.30376,GOCC_MEIOTIC_COHESIN_COMPLEX,0.978059070305273
OCT1_B,SET,225,0.030687,0.0033745,0.059753,0.30378,OCT1_B,0.978059070305273
CORRE_MULTIPLE_MYELOMA_UP,SET,64,0.057597,0.0033929,0.11218,0.30383,CORRE_MULTIPLE_MYELOMA_UP,0.978059070305273
MIR3173_3P,SET,90,0.044021,0.0030729,0.085751,0.30385,MIR3173_3P,0.978059070305273
GOBP_SEQUESTERING_OF_ACTIN_M...,SET,6,0.18046,0.00326,0.35153,0.30386,GOBP_SEQUESTERING_OF_ACTIN_MONOMERS,0.978059070305273
GSE40274_CTRL_VS_FOXP3_AND_L...1,SET,148,0.035132,0.0031399,0.06845,0.30389,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.978059070305273
MIR548L,SET,334,0.02401,0.0032072,0.046784,0.3039,MIR548L,0.978059070305273
HOXB4_TARGET_GENES,SET,931,0.013904,0.003049,0.027095,0.30393,HOXB4_TARGET_GENES,0.978059070305273
HP_ABNORMAL_METACARPAL_EPIPH...,SET,16,0.10964,0.0032336,0.21366,0.30393,HP_ABNORMAL_METACARPAL_EPIPHYSIS_MORPHOLOGY,0.978059070305273
HP_DIAPHRAGMATIC_EVENTRATION,SET,18,0.095971,0.0030019,0.18704,0.30394,HP_DIAPHRAGMATIC_EVENTRATION,0.978059070305273
KEGG_MEDICUS_REFERENCE_GPI_A...,SET,23,0.080976,0.0028628,0.15785,0.30398,KEGG_MEDICUS_REFERENCE_GPI_ANCHOR_BIOSYNTHESIS,0.978059070305273
HP_LOW_SET_EARS,SET,768,0.015698,0.0031413,0.030602,0.30398,HP_LOW_SET_EARS,0.978059070305273
WP_JOUBERT_SYNDROME,SET,69,0.048541,0.0029686,0.094635,0.304,WP_JOUBERT_SYNDROME,0.978059070305273
HP_SPOTTY_HYPERPIGMENTATION,SET,9,0.13958,0.0030879,0.27214,0.30402,HP_SPOTTY_HYPERPIGMENTATION,0.978059070305273
GOCC_PIP_BODY,SET,5,0.15439,0.0025462,0.30111,0.30407,GOCC_PIP_BODY,0.978059070305273
MIR6763_5P,SET,93,0.043994,0.0031215,0.085841,0.30415,MIR6763_5P,0.978059070305273
GSE40685_NAIVE_CD4_TCELL_VS_...1,SET,171,0.03421,0.0032844,0.066755,0.30416,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_DN,0.978059070305273
REACTOME_M_DECAY_DEGRADATION...,SET,31,0.076531,0.0031405,0.14934,0.30417,REACTOME_M_DECAY_DEGRADATION_OF_MATERNAL_MRNAS_BY_MATERNALLY_STORED_FACTORS,0.978059070305273
GOMF_ANDROSTAN_3_ALPHA_17_BE...,SET,8,0.18278,0.0038127,0.35668,0.30417,GOMF_ANDROSTAN_3_ALPHA_17_BETA_DIOL_DEHYDROGENASE_ACTIVITY,0.978059070305273
HP_APLASIA_HYPOPLASIA_OF_THE...61,SET,74,0.047877,0.0030318,0.093436,0.30419,HP_APLASIA_HYPOPLASIA_OF_THE_RADIUS,0.978059070305273
DESCARTES_FETAL_HEART_SCHWAN...,SET,47,0.065367,0.0033014,0.12759,0.30421,DESCARTES_FETAL_HEART_SCHWANN_CELLS,0.978059070305273
ATTACAT_MIR3803P,SET,87,0.047893,0.0032873,0.09351,0.30427,ATTACAT_MIR3803P,0.978161488298955
GOBP_ALANINE_METABOLIC_PROCE...,SET,5,0.19496,0.0032152,0.38088,0.30438,GOBP_ALANINE_METABOLIC_PROCESS,0.97842461154273
GOBP_POSITIVE_REGULATION_OF_...424,SET,17,0.11255,0.0034215,0.21999,0.30446,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_APOPTOTIC_PROCESS,0.978430536451169
LIAO_HAVE_SOX4_BINDING_SITES,SET,40,0.066067,0.0030788,0.12916,0.3045,LIAO_HAVE_SOX4_BINDING_SITES,0.978430536451169
HP_ROUND_FACE,SET,95,0.043177,0.0030962,0.084465,0.30462,HP_ROUND_FACE,0.978430536451169
GSE37533_UNTREATED_VS_PIOGLI...4,SET,182,0.032396,0.0032078,0.063399,0.30468,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,0.978430536451169
GOBP_POSITIVE_REGULATION_OF_...539,SET,127,0.038412,0.003182,0.075206,0.30477,GOBP_POSITIVE_REGULATION_OF_NF_KAPPAB_TRANSCRIPTION_FACTOR_ACTIVITY,0.978430536451169
GOBP_POSITIVE_REGULATION_OF_...730,SET,20,0.08766,0.0028901,0.17169,0.30483,GOBP_POSITIVE_REGULATION_OF_STRESS_ACTIVATED_PROTEIN_KINASE_SIGNALING_CASCADE,0.978430536451169
GSE7509_DC_VS_MONOCYTE_DN,SET,186,0.031265,0.0031293,0.061236,0.30483,GSE7509_DC_VS_MONOCYTE_DN,0.978430536451169
GOBP_REGULATION_OF_DNA_DAMAG...2,SET,33,0.077006,0.0032601,0.15086,0.30487,GOBP_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.978430536451169
HP_HYPOPLASTIC_TOENAILS,SET,75,0.049858,0.0031784,0.097674,0.30487,HP_HYPOPLASTIC_TOENAILS,0.978430536451169
GOBP_POSITIVE_REGULATION_OF_...745,SET,6,0.17199,0.003107,0.33695,0.30488,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_ENDOCYTOSIS,0.978430536451169
GOMF_UBIQUITIN_LIKE_MODIFIER...,SET,9,0.11532,0.0025512,0.22594,0.3049,GOMF_UBIQUITIN_LIKE_MODIFIER_ACTIVATING_ENZYME_ACTIVITY,0.978430536451169
GSE31082_DP_VS_CD8_SP_THYMOC...1,SET,179,0.032321,0.0031741,0.06334,0.30493,GSE31082_DP_VS_CD8_SP_THYMOCYTE_DN,0.978430536451169
GOCC_CYCLIN_DEPENDENT_PROTEI...,SET,51,0.054807,0.0028831,0.10741,0.30494,GOCC_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,0.978430536451169
HP_AXIAL_MUSCLE_WEAKNESS,SET,39,0.069014,0.0031757,0.1353,0.305,HP_AXIAL_MUSCLE_WEAKNESS,0.978430536451169
REACTOME_SIGNALING_BY_PDGF,SET,57,0.058891,0.0032745,0.11547,0.30502,REACTOME_SIGNALING_BY_PDGF,0.978430536451169
GOBP_REGULATION_OF_CELL_COMM...1,SET,16,0.1268,0.0037397,0.24871,0.30509,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING,0.978430536451169
GSE29618_PRE_VS_DAY7_POST_TI...5,SET,172,0.029924,0.0028812,0.058709,0.30513,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MONOCYTE_DN,0.978430536451169
ZHONG_PFC_MAJOR_TYPES_ASTROC...,SET,299,0.026336,0.0033317,0.05169,0.3052,ZHONG_PFC_MAJOR_TYPES_ASTROCYTES,0.978430536451169
GOCC_CYTOSOLIC_LARGE_RIBOSOM...,SET,50,0.056975,0.0029677,0.11185,0.30524,GOCC_CYTOSOLIC_LARGE_RIBOSOMAL_SUBUNIT,0.978430536451169
GOMF_EXCITATORY_EXTRACELLULA...,SET,34,0.080502,0.0034593,0.15804,0.30525,GOMF_EXCITATORY_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,0.978430536451169
HP_EPICANTHUS,SET,527,0.018412,0.0030727,0.036147,0.30525,HP_EPICANTHUS,0.978430536451169
GSE5589_LPS_AND_IL10_VS_LPS_...2,SET,178,0.032885,0.0032206,0.064574,0.30529,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,0.978430536451169
HP_ABNORMAL_DENTIN_MORPHOLOGY,SET,21,0.091682,0.0030973,0.18004,0.3053,HP_ABNORMAL_DENTIN_MORPHOLOGY,0.978430536451169
GSE28726_NAIVE_VS_ACTIVATED_...5,SET,177,0.032697,0.0031932,0.06421,0.3053,GSE28726_NAIVE_VS_ACTIVATED_VA24NEG_NKTCELL_DN,0.978430536451169
MIR891A_3P,SET,119,0.04081,0.0032732,0.080159,0.30534,MIR891A_3P,0.978430536451169
GOMF_ACTIVIN_RECEPTOR_ACTIVI...1,SET,9,0.13732,0.003038,0.26975,0.30536,GOMF_ACTIVIN_RECEPTOR_ACTIVITY,0.978430536451169
HP_VOCAL_CORD_PARESIS,SET,14,0.11626,0.0032074,0.22838,0.30536,HP_VOCAL_CORD_PARESIS,0.978430536451169
MIR409_3P,SET,88,0.046877,0.0032359,0.092096,0.30538,MIR409_3P,0.978430536451169
TGCTGCT_MIR15A_MIR16_MIR15B_...,SET,555,0.018126,0.003102,0.035616,0.3054,TGCTGCT_MIR15A_MIR16_MIR15B_MIR195_MIR424_MIR497,0.978430536451169
GOBP_LIPID_DROPLET_ORGANIZAT...,SET,33,0.077424,0.0032778,0.15213,0.3054,GOBP_LIPID_DROPLET_ORGANIZATION,0.978430536451169
MODULE_298,SET,26,0.091312,0.003432,0.17952,0.30551,MODULE_298,0.978430536451169
GOMF_XENOBIOTIC_TRANSMEMBRAN...,SET,32,0.081733,0.0034075,0.16073,0.30555,GOMF_XENOBIOTIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.978430536451169
GSE3982_EOSINOPHIL_VS_NKCELL...2,SET,179,0.032369,0.0031789,0.063653,0.30555,GSE3982_EOSINOPHIL_VS_NKCELL_UP,0.978430536451169
REACTOME_PLASMA_LIPOPROTEIN_...2,SET,71,0.051414,0.0031894,0.10113,0.30559,REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY_REMODELING_AND_CLEARANCE,0.978430536451169
KEGG_TOLL_LIKE_RECEPTOR_SIGN...,SET,95,0.047007,0.0033708,0.092488,0.30564,KEGG_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,0.978430536451169
GOBP_RELAXATION_OF_SMOOTH_MU...,SET,6,0.18777,0.0033922,0.36947,0.30565,GOBP_RELAXATION_OF_SMOOTH_MUSCLE,0.978430536451169
MIR8065,SET,134,0.034876,0.0029671,0.068638,0.30569,MIR8065,0.978430536451169
ZNF19_TARGET_GENES,SET,10,0.12743,0.0029716,0.25084,0.30573,ZNF19_TARGET_GENES,0.978430536451169
MIR297,SET,130,0.039071,0.0032743,0.076922,0.30575,MIR297,0.978430536451169
MIR300,SET,406,0.021567,0.0031699,0.04246,0.30575,MIR300,0.978430536451169
GOMF_D_LOOP_DNA_BINDING,SET,5,0.23234,0.0038317,0.45746,0.30577,GOMF_D_LOOP_DNA_BINDING,0.978430536451169
GOBP_SYNAPTIC_VESICLE_LOCALI...,SET,53,0.059131,0.0031708,0.11646,0.30582,GOBP_SYNAPTIC_VESICLE_LOCALIZATION,0.978430536451169
REACTOME_INTERACTIONS_OF_REV...,SET,35,0.067725,0.0029526,0.13342,0.30587,REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS,0.978430536451169
GOBP_GTP_BIOSYNTHETIC_PROCESS,SET,10,0.13729,0.0032015,0.27048,0.30588,GOBP_GTP_BIOSYNTHETIC_PROCESS,0.978430536451169
HP_BROAD_LONG_BONES,SET,128,0.038462,0.0031986,0.075785,0.3059,HP_BROAD_LONG_BONES,0.978430536451169
HP_EDEMA_OF_THE_DORSUM_OF_FE...,SET,4,0.20158,0.0029735,0.39719,0.3059,HP_EDEMA_OF_THE_DORSUM_OF_FEET,0.978430536451169
HP_ABNORMAL_3RD_FINGER_MORPH...,SET,24,0.09267,0.0033466,0.18261,0.30592,HP_ABNORMAL_3RD_FINGER_MORPHOLOGY,0.978430536451169
MIR4263,SET,240,0.027965,0.0031748,0.055117,0.30595,MIR4263,0.978430536451169
GOBP_VASCULAR_ASSOCIATED_SMO...6,SET,24,0.092927,0.0033558,0.18317,0.30596,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,0.978430536451169
GSE23308_CTRL_VS_CORTICOSTER...3,SET,185,0.0307,0.0030645,0.060513,0.30597,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_UP,0.978430536451169
HOQUE_METHYLATED_IN_CANCER,SET,56,0.059578,0.0032836,0.11745,0.30599,HOQUE_METHYLATED_IN_CANCER,0.978430536451169
GOMF_PYRIMIDINE_NUCLEOBASE_T...,SET,7,0.17897,0.003492,0.35282,0.306,GOMF_PYRIMIDINE_NUCLEOBASE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.978430536451169
chr7p11,SET,14,0.16894,0.0046608,0.3331,0.30602,chr7p11,0.978430536451169
GOBP_BASE_EXCISION_REPAIR_AP...,SET,12,0.11795,0.0030129,0.23261,0.30605,GOBP_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,0.978430536451169
GSE15330_LYMPHOID_MULTIPOTEN...4,SET,180,0.031565,0.0031084,0.062248,0.30605,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,0.978430536451169
GOBP_LACRIMAL_GLAND_DEVELOPM...,SET,7,0.17201,0.0033563,0.33937,0.30613,GOBP_LACRIMAL_GLAND_DEVELOPMENT,0.978430536451169
NIKOLSKY_BREAST_CANCER_22Q13...,SET,16,0.16506,0.0048681,0.32571,0.30616,NIKOLSKY_BREAST_CANCER_22Q13_AMPLICON,0.978430536451169
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...2,SET,6,0.15814,0.0028568,0.31208,0.30618,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_I_PROTEIN_COMPLEX,0.978430536451169
GOBP_POSITIVE_REGULATION_OF_...344,SET,7,0.17485,0.0034118,0.34509,0.30619,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.978430536451169
GSE26559_TCF1_KO_VS_WT_LIN_N...2,SET,183,0.032295,0.0032065,0.063755,0.30624,GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_UP,0.978430536451169
GOMF_INTERLEUKIN_1_BINDING,SET,8,0.15904,0.0033173,0.31399,0.30626,GOMF_INTERLEUKIN_1_BINDING,0.978430536451169
HP_ABSENT_FACIAL_HAIR,SET,33,0.079258,0.0033554,0.15653,0.30631,HP_ABSENT_FACIAL_HAIR,0.978430536451169
GSE29618_PRE_VS_DAY7_FLU_VAC...3,SET,178,0.030424,0.0029796,0.060093,0.30633,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_DN,0.978430536451169
KEGG_MEDICUS_REFERENCE_IL1_I...2,SET,15,0.1212,0.0034611,0.23942,0.30635,KEGG_MEDICUS_REFERENCE_IL1_IL1R_P38_SIGNALING_PATHWAY,0.978430536451169
GSE5542_IFNG_VS_IFNA_AND_IFN...2,SET,179,0.030404,0.0029859,0.060063,0.30636,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,0.978430536451169
GSE10240_CTRL_VS_IL17_STIM_P...2,SET,177,0.032702,0.0031937,0.064609,0.30638,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.978430536451169
MARCHINI_TRABECTEDIN_RESISTA...1,SET,43,0.066136,0.0031952,0.13069,0.30641,MARCHINI_TRABECTEDIN_RESISTANCE_DN,0.978430536451169
MIR4639_5P,SET,86,0.047518,0.0032429,0.0939,0.30641,MIR4639_5P,0.978430536451169
PID_CONE_PATHWAY,SET,20,0.10078,0.0033226,0.19915,0.30642,PID_CONE_PATHWAY,0.978430536451169
GSE36078_WT_VS_IL1R_KO_LUNG_...1,SET,184,0.03309,0.0032943,0.065392,0.30642,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_DN,0.978430536451169
CTIP_DN.V1_DN,SET,115,0.040941,0.0032284,0.08093,0.30647,CTIP_DN.V1_DN,0.978430536451169
GOBP_REGULATION_OF_LIPID_TRA...1,SET,125,0.03866,0.0031774,0.076461,0.30657,GOBP_REGULATION_OF_LIPID_TRANSPORT,0.978430536451169
LI_ESTROGENE_T47D_E2_RESPONS...2,SET,56,0.061907,0.003412,0.12245,0.30659,LI_ESTROGENE_T47D_E2_RESPONSE_UP,0.978430536451169
GOBP_NUCLEAR_BODY_ORGANIZATI...,SET,15,0.098517,0.0028133,0.19487,0.30659,GOBP_NUCLEAR_BODY_ORGANIZATION,0.978430536451169
HP_APLASIA_HYPOPLASIA_INVOLV...4,SET,479,0.019813,0.0031566,0.039192,0.30659,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,0.978430536451169
GSE17721_LPS_VS_POLYIC_4H_BM...1,SET,174,0.030497,0.0029533,0.060342,0.30664,GSE17721_LPS_VS_POLYIC_4H_BMDC_DN,0.978430536451169
GOBP_POSITIVE_REGULATION_OF_...434,SET,15,0.11951,0.0034128,0.23647,0.30665,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,0.978430536451169
HP_ORAL_AVERSION,SET,16,0.10972,0.003236,0.21716,0.30669,HP_ORAL_AVERSION,0.978430536451169
WELCH_GATA1_TARGETS,SET,21,0.094558,0.0031945,0.18718,0.30672,WELCH_GATA1_TARGETS,0.978430536451169
HP_CUBITUS_VALGUS,SET,45,0.060343,0.0029822,0.11945,0.30673,HP_CUBITUS_VALGUS,0.978430536451169
AGGGCAG_MIR18A,SET,130,0.038706,0.0032437,0.076642,0.30678,AGGGCAG_MIR18A,0.978430536451169
GOBP_EXECUTION_PHASE_OF_APOP...,SET,77,0.048918,0.0031596,0.096896,0.30684,GOBP_EXECUTION_PHASE_OF_APOPTOSIS,0.978430536451169
GOBP_GLIAL_CELL_FATE_SPECIFI...,SET,7,0.18494,0.0036085,0.36632,0.30684,GOBP_GLIAL_CELL_FATE_SPECIFICATION,0.978430536451169
HP_ABNORMAL_PR_INTERVAL,SET,17,0.11267,0.0034251,0.22321,0.30686,HP_ABNORMAL_PR_INTERVAL,0.978430536451169
REACTOME_NTRK2_ACTIVATES_RAC1,SET,5,0.18736,0.0030899,0.37126,0.3069,REACTOME_NTRK2_ACTIVATES_RAC1,0.978430536451169
PEDRIOLI_MIR31_TARGETS_UP,SET,190,0.031389,0.003175,0.062201,0.30691,PEDRIOLI_MIR31_TARGETS_UP,0.978430536451169
GOMF_MHC_PROTEIN_BINDING,SET,26,0.084173,0.0031637,0.1668,0.30691,GOMF_MHC_PROTEIN_BINDING,0.978430536451169
GOBP_POST_TRANSLATIONAL_PROT...2,SET,14,0.10788,0.0029763,0.21379,0.30692,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_ENDOPLASMIC_RETICULUM_MEMBRANE,0.978430536451169
DR4_Q2,SET,228,0.028368,0.00314,0.056223,0.30694,DR4_Q2,0.978430536451169
GOBP_INTERLEUKIN_4_MEDIATED_...,SET,9,0.13311,0.0029448,0.26383,0.30695,GOBP_INTERLEUKIN_4_MEDIATED_SIGNALING_PATHWAY,0.978430536451169
GSE11924_TH1_VS_TH2_CD4_TCEL...1,SET,178,0.032408,0.0031739,0.064243,0.30697,GSE11924_TH1_VS_TH2_CD4_TCELL_DN,0.978430536451169
GOBP_DEOXYRIBONUCLEOTIDE_MET...,SET,42,0.066082,0.0031553,0.13101,0.30699,GOBP_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,0.978430536451169
REACTOME_SIGNALING_BY_NOTCH1...3,SET,7,0.143,0.0027903,0.28352,0.307,REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT,0.978430536451169
KEGG_MEDICUS_REFERENCE_NON_H...,SET,13,0.097046,0.0025801,0.19245,0.30704,KEGG_MEDICUS_REFERENCE_NON_HOMOLOGOUS_END_JOINING,0.978468292682927
LANDEMAINE_LUNG_METASTASIS,SET,20,0.1003,0.0033069,0.19898,0.3071,LANDEMAINE_LUNG_METASTASIS,0.978549660830507
GOMF_PROTEIN_TYROSINE_KINASE...2,SET,140,0.038457,0.0033436,0.076306,0.30714,GOMF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.978549660830507
HP_CHRONIC_KIDNEY_DISEASE,SET,178,0.03106,0.0030418,0.061632,0.30715,HP_CHRONIC_KIDNEY_DISEASE,0.978549660830507
GSE17721_LPS_VS_PAM3CSK4_12H...1,SET,179,0.03105,0.0030493,0.061642,0.30723,GSE17721_LPS_VS_PAM3CSK4_12H_BMDC_DN,0.978630984237537
MIR3688_5P,SET,126,0.038556,0.0031814,0.076556,0.30726,MIR3688_5P,0.978630984237537
GOMF_SIGNAL_RECOGNITION_PART...,SET,7,0.1367,0.0026673,0.27142,0.30726,GOMF_SIGNAL_RECOGNITION_PARTICLE_BINDING,0.978630984237537
MEISSNER_ES_ICP_WITH_H3K4ME3...,SET,11,0.13319,0.0032573,0.26452,0.30731,MEISSNER_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,0.978700545221296
GOBP_NEGATIVE_REGULATION_OF_...88,SET,20,0.10213,0.0033673,0.20293,0.30738,GOBP_NEGATIVE_REGULATION_OF_CD4_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,0.978775945945946
KEGG_MEDICUS_REFERENCE_MDM2_...1,SET,13,0.1262,0.0033552,0.25077,0.30739,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00066,0.978775945945946
GOBP_ENDOSOME_TO_LYSOSOME_TR...1,SET,68,0.05173,0.0031407,0.10282,0.30745,GOBP_ENDOSOME_TO_LYSOSOME_TRANSPORT,0.978877313118358
GOBP_CELLULAR_RESPONSE_TO_GL...2,SET,53,0.062198,0.0033352,0.12366,0.30749,GOBP_CELLULAR_RESPONSE_TO_GLUCOCORTICOID_STIMULUS,0.978914990381973
GOCC_IMMUNOGLOBULIN_COMPLEX,SET,10,0.15311,0.0035704,0.3045,0.30755,GOCC_IMMUNOGLOBULIN_COMPLEX,0.978958494367616
HP_MALIGNANT_HYPERTHERMIA,SET,25,0.083695,0.0030847,0.16647,0.30756,HP_MALIGNANT_HYPERTHERMIA,0.978958494367616
GOBP_GOLGI_TO_ENDOSOME_TRANS...,SET,15,0.10272,0.0029332,0.20435,0.30761,GOBP_GOLGI_TO_ENDOSOME_TRANSPORT,0.978961661327231
REACTOME_ATF4_ACTIVATES_GENE...,SET,26,0.079117,0.0029736,0.15742,0.30763,REACTOME_ATF4_ACTIVATES_GENES_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.978961661327231
MIR4534,SET,146,0.034415,0.0030551,0.068499,0.30769,MIR4534,0.978961661327231
GNF2_PCAF,SET,31,0.076309,0.0031313,0.1519,0.30771,GNF2_PCAF,0.978961661327231
ETF_Q6,SET,111,0.040755,0.0031577,0.081131,0.30772,ETF_Q6,0.978961661327231
GOBP_ANTIGEN_PROCESSING_AND_...14,SET,24,0.10884,0.0039303,0.21668,0.30773,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_VIA_MHC_CLASS_IB,0.978961661327231
GOBP_REGULATION_OF_MUSCLE_CO...,SET,154,0.034895,0.0031808,0.069507,0.30783,GOBP_REGULATION_OF_MUSCLE_CONTRACTION,0.979014531749657
NABA_MATRISOME_METASTATIC_CO...,SET,26,0.09449,0.0035514,0.18826,0.30787,NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS,0.979014531749657
HP_ABNORMAL_PUTAMEN_MORPHOLO...,SET,5,0.19728,0.0032536,0.39309,0.30788,HP_ABNORMAL_PUTAMEN_MORPHOLOGY,0.979014531749657
GOMF_HISTONE_H4K16_ACETYLTRA...,SET,8,0.1401,0.0029223,0.27924,0.30793,GOMF_HISTONE_H4K16_ACETYLTRANSFERASE_ACTIVITY,0.979014531749657
MIKKELSEN_DEDIFFERENTIATED_S...2,SET,6,0.18734,0.0033843,0.3734,0.30794,MIKKELSEN_DEDIFFERENTIATED_STATE_UP,0.979014531749657
GOBP_POSITIVE_REGULATION_OF_...413,SET,24,0.09246,0.003339,0.18429,0.30794,GOBP_POSITIVE_REGULATION_OF_LIPID_STORAGE,0.979014531749657
REACTOME_INACTIVATION_OF_CSF...,SET,22,0.10532,0.0036417,0.20994,0.30795,REACTOME_INACTIVATION_OF_CSF3_G_CSF_SIGNALING,0.979014531749657
GOBP_POSITIVE_REGULATION_OF_...578,SET,147,0.036173,0.0032221,0.07214,0.30804,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,0.979014531749657
REACTOME_GLUCOSE_METABOLISM,SET,77,0.044574,0.0028791,0.088906,0.30806,REACTOME_GLUCOSE_METABOLISM,0.979014531749657
REACTOME_RAC1_GTPASE_CYCLE,SET,167,0.033641,0.0031922,0.067118,0.30811,REACTOME_RAC1_GTPASE_CYCLE,0.979014531749657
GSE40274_CTRL_VS_FOXP3_TRANS...1,SET,182,0.032136,0.003182,0.064115,0.30811,GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.979014531749657
HP_ABNORMAL_UPPER_LIMB_BONE_...,SET,398,0.021571,0.0031398,0.043043,0.30813,HP_ABNORMAL_UPPER_LIMB_BONE_MORPHOLOGY,0.979014531749657
REACTOME_LEISHMANIA_INFECTION,SET,152,0.033558,0.0030392,0.066981,0.30819,REACTOME_LEISHMANIA_INFECTION,0.979014531749657
GOBP_ERK5_CASCADE,SET,3,0.22357,0.0028561,0.44626,0.3082,GOBP_ERK5_CASCADE,0.979014531749657
MODULE_557,SET,9,0.16446,0.0036384,0.32834,0.30823,MODULE_557,0.979014531749657
REACTOME_CLATHRIN_MEDIATED_E...,SET,134,0.036489,0.0031043,0.072863,0.30826,REACTOME_CLATHRIN_MEDIATED_ENDOCYTOSIS,0.979014531749657
GOBP_PATTERN_SPECIFICATION_P...,SET,433,0.021961,0.0033309,0.043854,0.30827,GOBP_PATTERN_SPECIFICATION_PROCESS,0.979014531749657
HP_POLAR_CATARACT,SET,15,0.11793,0.0033677,0.2355,0.30827,HP_POLAR_CATARACT,0.979014531749657
KEGG_MEDICUS_REFERENCE_AUTOP...3,SET,5,0.17952,0.0029606,0.35855,0.3083,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TRANS_SNARE,0.979014531749657
REACTOME_COMPLEX_I_BIOGENESIS,SET,56,0.049059,0.0027039,0.09799,0.30831,REACTOME_COMPLEX_I_BIOGENESIS,0.979014531749657
GOMF_PHOSPHATIDYLINOSITOL_3_...9,SET,6,0.19377,0.0035005,0.38711,0.30834,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVATOR_ACTIVITY,0.979020345331628
GSE22103_UNSTIM_VS_GMCSF_AND...1,SET,188,0.029132,0.0029313,0.058223,0.30842,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,0.979164750205498
MORF_MBD4,SET,75,0.043651,0.0027828,0.087266,0.30847,MORF_MBD4,0.979164750205498
GOMF_GLUTATHIONE_DISULFIDE_O...,SET,5,0.20836,0.0034362,0.41656,0.30847,GOMF_GLUTATHIONE_DISULFIDE_OXIDOREDUCTASE_ACTIVITY,0.979164750205498
GSE3400_UNTREATED_VS_IFNB_TR...2,SET,167,0.031969,0.0030335,0.063933,0.30853,GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_UP,0.979265767123288
MIR514B_5P,SET,167,0.032848,0.0031169,0.065705,0.30856,MIR514B_5P,0.979271555109122
HP_REDUCED_SUBCUTANEOUS_ADIP...,SET,30,0.079322,0.0032021,0.15871,0.30862,HP_REDUCED_SUBCUTANEOUS_ADIPOSE_TISSUE,0.979280324876802
RUTELLA_RESPONSE_TO_HGF_VS_C...2,SET,373,0.022858,0.0032231,0.045744,0.30865,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP,0.979280324876802
GSE1460_NAIVE_CD4_TCELL_CORD...1,SET,173,0.031799,0.0030706,0.063645,0.30867,GSE1460_NAIVE_CD4_TCELL_CORD_BLOOD_VS_THYMIC_STROMAL_CELL_DN,0.979280324876802
REACTOME_SEMA3A_PLEXIN_REPUL...,SET,13,0.12195,0.0032422,0.24412,0.3087,REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION,0.979280324876802
MIR585_5P,SET,119,0.039877,0.0031983,0.079847,0.30875,MIR585_5P,0.979280324876802
HP_NAIL_PITS,SET,9,0.14846,0.0032844,0.29727,0.30875,HP_NAIL_PITS,0.979280324876802
GSE3982_MAC_VS_NEUTROPHIL_UP,SET,181,0.030242,0.0029864,0.060562,0.30876,GSE3982_MAC_VS_NEUTROPHIL_UP,0.979280324876802
GSE7460_CD8_TCELL_VS_CD4_TCE...2,SET,173,0.032287,0.0031177,0.064666,0.30879,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_UP,0.979286107309061
ZNF211_TARGET_GENES,SET,2,0.20346,0.0021223,0.40773,0.30889,ZNF211_TARGET_GENES,0.979427400382967
MARIADASON_RESPONSE_TO_BUTYR...5,SET,40,0.070023,0.0032632,0.14038,0.30896,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_6,0.979427400382967
GOMF_ACYL_COA_OXIDASE_ACTIVI...,SET,7,0.14295,0.0027893,0.2866,0.30897,GOMF_ACYL_COA_OXIDASE_ACTIVITY,0.979427400382967
HE_LIM_SUN_FETAL_LUNG_C3_DEF...3,SET,102,0.041477,0.0030813,0.08316,0.30898,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_RETICULOCYTE,0.979427400382967
KEGG_MEDICUS_VARIANT_MUTATIO...67,SET,25,0.084315,0.0031075,0.16909,0.30902,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATP1A1_TO_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,0.979427400382967
GSE45365_HEALTHY_VS_MCMV_INF...10,SET,182,0.029641,0.002935,0.059447,0.30903,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_UP,0.979427400382967
EBAUER_TARGETS_OF_PAX3_FOXO1...2,SET,172,0.033469,0.0032225,0.067128,0.30904,EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_UP,0.979427400382967
GSE16451_IMMATURE_VS_MATURE_...2,SET,181,0.031233,0.0030842,0.062651,0.30906,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_UP,0.979427400382967
REACTOME_MITOTIC_G1_PHASE_AN...,SET,143,0.032578,0.0028624,0.065395,0.30918,REACTOME_MITOTIC_G1_PHASE_AND_G1_S_TRANSITION,0.979459090909091
MIR1323,SET,285,0.025478,0.003148,0.051143,0.30918,MIR1323,0.979459090909091
MODULE_202,SET,26,0.085348,0.0032078,0.17132,0.30918,MODULE_202,0.979459090909091
LUCAS_HNF4A_TARGETS_DN,SET,7,0.20777,0.004054,0.41723,0.30926,LUCAS_HNF4A_TARGETS_DN,0.979459090909091
HP_ABNORMAL_PERIFOLLICULAR_M...,SET,5,0.25273,0.004168,0.50766,0.3093,HP_ABNORMAL_PERIFOLLICULAR_MORPHOLOGY,0.979459090909091
GOBP_PREPULSE_INHIBITION,SET,13,0.11443,0.0030422,0.2299,0.30934,GOBP_PREPULSE_INHIBITION,0.979459090909091
HP_NEPHROPATHY,SET,82,0.046495,0.0030987,0.093431,0.30937,HP_NEPHROPATHY,0.979459090909091
GSE3982_NEUTROPHIL_VS_BASOPH...1,SET,172,0.030677,0.0029537,0.061643,0.30937,GSE3982_NEUTROPHIL_VS_BASOPHIL_DN,0.979459090909091
GOBP_REGULATION_OF_POLYSACCH...1,SET,33,0.073938,0.0031302,0.1486,0.3094,GOBP_REGULATION_OF_POLYSACCHARIDE_BIOSYNTHETIC_PROCESS,0.979459090909091
GOBP_VIRAL_LIFE_CYCLE,SET,298,0.025311,0.0031968,0.050882,0.30944,GOBP_VIRAL_LIFE_CYCLE,0.979459090909091
MIR302E,SET,444,0.020092,0.003085,0.040404,0.30949,MIR302E,0.979459090909091
GOBP_REGULATION_OF_NERVOUS_S...2,SET,107,0.042198,0.0032104,0.084859,0.3095,GOBP_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,0.979459090909091
chr4p14,SET,29,0.14265,0.005662,0.28688,0.30951,chr4p14,0.979459090909091
GOMF_PEPTIDE_ALPHA_N_ACETYLT...,SET,6,0.14155,0.0025571,0.28467,0.30952,GOMF_PEPTIDE_ALPHA_N_ACETYLTRANSFERASE_ACTIVITY,0.979459090909091
GSE25890_CTRL_VS_IL33_IL7_TR...1,SET,185,0.030162,0.0030108,0.060671,0.30955,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN,0.979459090909091
GOMF_GTPASE_ACTIVATOR_ACTIVI...,SET,240,0.02723,0.0030913,0.054787,0.30959,GOMF_GTPASE_ACTIVATOR_ACTIVITY,0.979459090909091
GSE22025_UNTREATED_VS_TGFB1_...2,SET,178,0.032199,0.0031534,0.064793,0.30961,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,0.979459090909091
GSE6259_33D1_POS_VS_DEC205_P...2,SET,159,0.033681,0.0031192,0.067792,0.30966,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_UP,0.979459090909091
MIR367_5P,SET,67,0.049214,0.002966,0.099071,0.30968,MIR367_5P,0.979459090909091
GSE4590_PRE_BCELL_VS_SMALL_P...1,SET,109,0.038742,0.0029747,0.077989,0.30968,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_DN,0.979459090909091
HP_INCREASED_SERUM_ESTRADIOL,SET,8,0.14662,0.0030583,0.29515,0.30969,HP_INCREASED_SERUM_ESTRADIOL,0.979459090909091
DESCARTES_FETAL_PLACENTA_MYE...,SET,125,0.040131,0.0032984,0.08079,0.30969,DESCARTES_FETAL_PLACENTA_MYELOID_CELLS,0.979459090909091
GOBP_COMPLEMENT_RECEPTOR_MED...,SET,13,0.13361,0.0035523,0.26904,0.30973,GOBP_COMPLEMENT_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,0.979496464968153
HP_ANISOPOIKILOCYTOSIS,SET,9,0.15064,0.0033327,0.30341,0.30978,HP_ANISOPOIKILOCYTOSIS,0.979539574235808
GOBP_PURINE_NUCLEOSIDE_CATAB...,SET,7,0.1815,0.0035415,0.36561,0.3098,GOBP_PURINE_NUCLEOSIDE_CATABOLIC_PROCESS,0.979539574235808
GOMF_ENZYME_SUBSTRATE_ADAPTO...,SET,65,0.053275,0.0031626,0.10736,0.30988,GOMF_ENZYME_SUBSTRATE_ADAPTOR_ACTIVITY,0.979631132589164
GSE3982_MAST_CELL_VS_CENT_ME...2,SET,185,0.030141,0.0030087,0.060753,0.30991,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP,0.979631132589164
RODRIGUES_NTN1_TARGETS_DN,SET,149,0.035174,0.0031542,0.070932,0.30999,RODRIGUES_NTN1_TARGETS_DN,0.979631132589164
GOMF_UBIQUINONE_BINDING,SET,5,0.15103,0.0024907,0.30464,0.31003,GOMF_UBIQUINONE_BINDING,0.979631132589164
HP_ABNORMAL_CIRCULATING_T4_C...,SET,24,0.086936,0.0031395,0.17536,0.31003,HP_ABNORMAL_CIRCULATING_T4_CONCENTRATION,0.979631132589164
QIU_PBMC_HEPTATITIS_B_SURFAC...1,SET,15,0.11912,0.0034018,0.24031,0.31005,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0DY_UP,0.979631132589164
GOMF_HISTONE_H3K36_TRIMETHYL...,SET,4,0.17675,0.0026072,0.35657,0.31006,GOMF_HISTONE_H3K36_TRIMETHYLTRANSFERASE_ACTIVITY,0.979631132589164
MIR1909_5P,SET,34,0.068805,0.0029566,0.13881,0.31007,MIR1909_5P,0.979631132589164
HP_APLASIA_HYPOPLASIA_OF_THE...36,SET,32,0.076987,0.0032096,0.15536,0.31011,HP_APLASIA_HYPOPLASIA_OF_THE_HALLUX,0.979631132589164
GOBP_NEGATIVE_REGULATION_OF_...436,SET,24,0.085143,0.0030747,0.17182,0.31012,GOBP_NEGATIVE_REGULATION_OF_NEURAL_PRECURSOR_CELL_PROLIFERATION,0.979631132589164
GOMF_N_ACETYLGALACTOSAMINE_4...,SET,5,0.17152,0.0028287,0.34624,0.31016,GOMF_N_ACETYLGALACTOSAMINE_4_O_SULFOTRANSFERASE_ACTIVITY,0.979631132589164
WP_EPO_RECEPTOR_SIGNALING,SET,26,0.08871,0.0033342,0.1791,0.31019,WP_EPO_RECEPTOR_SIGNALING,0.979631132589164
HP_ULCERATIVE_COLITIS,SET,13,0.12312,0.0032733,0.24872,0.3103,HP_ULCERATIVE_COLITIS,0.979631132589164
HP_HYPOMIMIC_FACE,SET,35,0.070064,0.0030546,0.14163,0.3104,HP_HYPOMIMIC_FACE,0.979631132589164
GOMF_TRANSFORMING_GROWTH_FAC...4,SET,26,0.089244,0.0033543,0.18041,0.31042,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_BINDING,0.979631132589164
KEGG_MEDICUS_REFERENCE_WNT_S...3,SET,17,0.10754,0.0032691,0.21741,0.31043,KEGG_MEDICUS_REFERENCE_WNT_SIGNALING_MODULATION_WNT_ACYLATION,0.979631132589164
DUNNE_TARGETS_OF_AML1_MTG8_F...2,SET,49,0.063568,0.0032779,0.12852,0.31044,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_UP,0.979631132589164
GOBP_GMP_SALVAGE,SET,4,0.19631,0.0028957,0.39692,0.31045,GOBP_GMP_SALVAGE,0.979631132589164
GSE33292_DN3_THYMOCYTE_VS_TC...4,SET,184,0.031025,0.0030887,0.06273,0.31045,GSE33292_DN3_THYMOCYTE_VS_TCF1_KO_TCELL_LYMPHOMA_UP,0.979631132589164
GOBP_GOLGI_RIBBON_FORMATION,SET,11,0.12006,0.0029363,0.24278,0.31047,GOBP_GOLGI_RIBBON_FORMATION,0.979631132589164
MIR6756_3P,SET,92,0.041031,0.0028957,0.08298,0.31049,MIR6756_3P,0.979631132589164
HP_ABNORMAL_MENINGEAL_MORPHO...,SET,177,0.03128,0.0030548,0.063262,0.3105,HP_ABNORMAL_MENINGEAL_MORPHOLOGY,0.979631132589164
HP_DELAYED_PUBERTY,SET,177,0.03153,0.0030792,0.063785,0.31055,HP_DELAYED_PUBERTY,0.979631132589164
GOMF_CARBON_OXYGEN_LYASE_ACT...,SET,69,0.051008,0.0031195,0.10321,0.31057,GOMF_CARBON_OXYGEN_LYASE_ACTIVITY,0.979631132589164
KORKOLA_TERATOMA,SET,38,0.070637,0.0032086,0.14293,0.31058,KORKOLA_TERATOMA,0.979631132589164
GCM_MAP1B,SET,62,0.052897,0.0030671,0.10704,0.31059,GCM_MAP1B,0.979631132589164
GSE41978_ID2_KO_VS_BIM_KO_KL...1,SET,180,0.03072,0.0030253,0.062162,0.31059,GSE41978_ID2_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,0.979631132589164
GOMF_DOUBLE_STRANDED_RNA_BIN...,SET,69,0.048857,0.002988,0.098909,0.31067,GOMF_DOUBLE_STRANDED_RNA_BINDING,0.979688271828815
HP_BROAD_PALM,SET,24,0.083823,0.0030271,0.16971,0.31069,HP_BROAD_PALM,0.979688271828815
GSE3203_WT_VS_IFNAR1_KO_INFL...1,SET,186,0.030613,0.003064,0.061993,0.31072,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_DN,0.979688271828815
HOWARD_NEUTROPHIL_INACT_MONO...1,SET,102,0.041884,0.0031116,0.084835,0.31076,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,0.979688271828815
AGGCACT_MIR5153P,SET,80,0.047888,0.0031526,0.097017,0.31079,AGGCACT_MIR5153P,0.979688271828815
REACTOME_GLUCURONIDATION,SET,23,0.124,0.0043838,0.25129,0.31085,REACTOME_GLUCURONIDATION,0.979688271828815
GSE34006_A2AR_KO_VS_A2AR_AGO...1,SET,188,0.029337,0.0029519,0.059452,0.31085,GSE34006_A2AR_KO_VS_A2AR_AGONIST_TREATED_TREG_DN,0.979688271828815
GOBP_PRESYNAPTIC_ACTIVE_ZONE...,SET,7,0.17346,0.0033846,0.3516,0.31089,GOBP_PRESYNAPTIC_ACTIVE_ZONE_ORGANIZATION,0.979688271828815
GSE17721_LPS_VS_CPG_12H_BMDC...1,SET,177,0.031283,0.0030552,0.063412,0.31089,GSE17721_LPS_VS_CPG_12H_BMDC_DN,0.979688271828815
LI_PBMC_ZOSTAVAX_AGE_25_40_A...1,SET,7,0.14836,0.0028948,0.30073,0.31089,LI_PBMC_ZOSTAVAX_AGE_25_40_AND_60_79YO_1DY_UP,0.979688271828815
GSE30971_WBP7_HET_VS_KO_MACR...5,SET,179,0.03398,0.0033371,0.068895,0.31093,GSE30971_WBP7_HET_VS_KO_MACROPHAGE_DN,0.979725489573889
MEISSNER_NPC_HCP_WITH_H3_UNM...,SET,489,0.019649,0.0031622,0.039855,0.311,MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED,0.979785496148618
HP_PERSISTENCE_OF_PRIMARY_TE...,SET,22,0.082459,0.0028512,0.16732,0.31107,HP_PERSISTENCE_OF_PRIMARY_TEETH,0.979785496148618
REACTOME_CELL_SURFACE_INTERA...,SET,131,0.039883,0.0033551,0.080932,0.31108,REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL,0.979785496148618
FARMER_BREAST_CANCER_APOCRIN...2,SET,290,0.025229,0.003144,0.051198,0.31109,FARMER_BREAST_CANCER_APOCRINE_VS_LUMINAL,0.979785496148618
GOBP_ARTICULAR_CARTILAGE_DEV...,SET,5,0.17159,0.0028297,0.34821,0.31109,GOBP_ARTICULAR_CARTILAGE_DEVELOPMENT,0.979785496148618
GOBP_NUCLEOTIDE_TRANSPORT,SET,44,0.068055,0.0033259,0.13815,0.31115,GOBP_NUCLEOTIDE_TRANSPORT,0.979859866811634
GOCC_U5_SNRNP,SET,19,0.082693,0.0026574,0.16789,0.31117,GOCC_U5_SNRNP,0.979859866811634
MIR6883_5P,SET,373,0.021476,0.0030283,0.043638,0.31131,MIR6883_5P,0.979999746491625
GOBP_SEMICIRCULAR_CANAL_DEVE...,SET,9,0.1578,0.0034911,0.32069,0.31134,GOBP_SEMICIRCULAR_CANAL_DEVELOPMENT,0.979999746491625
FARMER_BREAST_CANCER_CLUSTER...4,SET,18,0.10836,0.0033893,0.22022,0.31135,FARMER_BREAST_CANCER_CLUSTER_4,0.979999746491625
GOBP_SKELETAL_MUSCLE_CELL_PR...,SET,23,0.08269,0.0029234,0.1681,0.3114,GOBP_SKELETAL_MUSCLE_CELL_PROLIFERATION,0.979999746491625
HP_LEG_DYSTONIA,SET,7,0.14977,0.0029223,0.30448,0.3114,HP_LEG_DYSTONIA,0.979999746491625
GOBP_REGULATION_OF_INNATE_IM...,SET,396,0.020868,0.00303,0.04243,0.31142,GOBP_REGULATION_OF_INNATE_IMMUNE_RESPONSE,0.979999746491625
GOCC_MUSCLE_MYOSIN_COMPLEX,SET,14,0.12816,0.0035359,0.26057,0.31142,GOCC_MUSCLE_MYOSIN_COMPLEX,0.979999746491625
HP_FOCAL_HEMICLONIC_SEIZURE,SET,23,0.0899,0.0031783,0.18281,0.31144,HP_FOCAL_HEMICLONIC_SEIZURE,0.979999746491625
REACTOME_NICOTINATE_METABOLI...,SET,29,0.076407,0.0030327,0.1554,0.31148,REACTOME_NICOTINATE_METABOLISM,0.980011088983434
MIR3150A_3P,SET,86,0.043698,0.0029821,0.088887,0.3115,MIR3150A_3P,0.980011088983434
REACTOME_G2_M_CHECKPOINTS,SET,125,0.034228,0.0028132,0.069647,0.31156,REACTOME_G2_M_CHECKPOINTS,0.980022427368993
GSE10240_IL22_VS_IL22_AND_IL...1,SET,187,0.029003,0.0029106,0.059015,0.31156,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,0.980022427368993
KOBAYASHI_EGFR_SIGNALING_24H...2,SET,84,0.04523,0.0030508,0.092111,0.3117,KOBAYASHI_EGFR_SIGNALING_24HR_UP,0.980339362279512
MIR6765_3P,SET,88,0.043663,0.0030141,0.088947,0.31176,MIR6765_3P,0.980339362279512
GSE11057_CD4_EFF_MEM_VS_PBMC...1,SET,183,0.031732,0.0031505,0.064659,0.3118,GSE11057_CD4_EFF_MEM_VS_PBMC_DN,0.980339362279512
MIR296_3P,SET,28,0.076423,0.0029806,0.15573,0.31181,MIR296_3P,0.980339362279512
HP_URINARY_BLADDER_SPHINCTER...,SET,28,0.071848,0.0028022,0.1464,0.31181,HP_URINARY_BLADDER_SPHINCTER_DYSFUNCTION,0.980339362279512
GSE23502_WT_VS_HDC_KO_MYELOI...2,SET,179,0.029644,0.0029112,0.060415,0.31183,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP,0.980339362279512
HP_SHOULDER_PAIN,SET,6,0.19672,0.0035538,0.40113,0.31192,HP_SHOULDER_PAIN,0.980430379746835
HP_FLEXION_CONTRACTURE_OF_DI...,SET,276,0.025148,0.0030585,0.051281,0.31193,HP_FLEXION_CONTRACTURE_OF_DIGIT,0.980430379746835
WP_SPINAL_CORD_INJURY,SET,116,0.041924,0.0033202,0.085506,0.31196,WP_SPINAL_CORD_INJURY,0.980430379746835
BIOCARTA_IL22BP_PATHWAY,SET,9,0.1778,0.0039336,0.36267,0.31198,BIOCARTA_IL22BP_PATHWAY,0.980430379746835
GSE16450_IMMATURE_VS_MATURE_...4,SET,182,0.03024,0.0029943,0.061688,0.312,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_6H_IFNA_STIM_UP,0.980430379746835
GOMF_NADH_DEHYDROGENASE_ACTI...,SET,8,0.13125,0.0027377,0.26783,0.31206,GOMF_NADH_DEHYDROGENASE_ACTIVITY,0.980530268510985
ZNF704_TARGET_GENES,SET,61,0.051742,0.0029759,0.10563,0.31213,ZNF704_TARGET_GENES,0.980661557584524
SANDERSON_PPARA_TARGETS,SET,15,0.098082,0.0028009,0.20043,0.3123,SANDERSON_PPARA_TARGETS,0.981083821145533
MIR10397_3P,SET,42,0.06617,0.0031596,0.13534,0.31245,MIR10397_3P,0.981083821145533
GOBP_CALCIUM_ION_EXPORT_ACRO...,SET,9,0.15506,0.0034304,0.31715,0.31246,GOBP_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.981083821145533
MIR455_5P,SET,82,0.045786,0.0030515,0.093656,0.31247,MIR455_5P,0.981083821145533
GOBP_DEOXYRIBONUCLEOSIDE_MON...3,SET,24,0.084973,0.0030686,0.17382,0.31247,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,0.981083821145533
IKEDA_MIR30_TARGETS_UP,SET,110,0.04029,0.0031076,0.082429,0.3125,IKEDA_MIR30_TARGETS_UP,0.981083821145533
GSE17322_CD103_POS_VS_CD11B_...1,SET,173,0.03035,0.0029307,0.062117,0.31257,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_DN,0.981083821145533
MONNIER_POSTRADIATION_TUMOR_...1,SET,335,0.022516,0.003012,0.046092,0.3126,MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN,0.981083821145533
WP_MAPK_SIGNALING,SET,235,0.02794,0.0031391,0.057195,0.3126,WP_MAPK_SIGNALING,0.981083821145533
GSE36095_WT_VS_HDAC9_KO_TREG...2,SET,167,0.031436,0.002983,0.064353,0.3126,GSE36095_WT_VS_HDAC9_KO_TREG_UP,0.981083821145533
GSE32423_MEMORY_VS_NAIVE_CD8...3,SET,178,0.030583,0.0029951,0.062628,0.31266,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_DN,0.981083821145533
FLECHNER_PBL_KIDNEY_TRANSPLA...3,SET,50,0.056813,0.0029593,0.11636,0.31269,FLECHNER_PBL_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,0.981083821145533
KEGG_MEDICUS_REFERENCE_ATR_S...,SET,11,0.11111,0.0027174,0.22762,0.31273,KEGG_MEDICUS_REFERENCE_ATR_SIGNALING,0.981083821145533
GGATTA_PITX2_Q2,SET,522,0.019179,0.003186,0.039292,0.31273,GGATTA_PITX2_Q2,0.981083821145533
HP_ABNORMAL_FRONTALIS_MUSCLE...,SET,10,0.14576,0.003399,0.29879,0.31284,HP_ABNORMAL_FRONTALIS_MUSCLE_PHYSIOLOGY,0.981083821145533
HP_EPISODIC_RESPIRATORY_DIST...,SET,10,0.14576,0.003399,0.29879,0.31284,HP_EPISODIC_RESPIRATORY_DISTRESS,0.981083821145533
WP_BRAINDERIVED_NEUROTROPHIC...,SET,135,0.037628,0.0032131,0.077137,0.31285,WP_BRAINDERIVED_NEUROTROPHIC_FACTOR_BDNF_SIGNALING,0.981083821145533
WP_EBSTEINBARR_VIRUS_LMP1_SI...,SET,21,0.083532,0.002822,0.17128,0.31289,WP_EBSTEINBARR_VIRUS_LMP1_SIGNALING,0.981083821145533
GSE9988_ANTI_TREM1_VS_LPS_MO...1,SET,176,0.032426,0.0031579,0.066498,0.31291,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_DN,0.981083821145533
MARCHINI_TRABECTEDIN_RESISTA...2,SET,16,0.10333,0.0030476,0.21197,0.31296,MARCHINI_TRABECTEDIN_RESISTANCE_UP,0.981083821145533
WP_5Q35_COPY_NUMBER_VARIATION,SET,97,0.045307,0.0032828,0.09294,0.31296,WP_5Q35_COPY_NUMBER_VARIATION,0.981083821145533
FULLER_PBMC_F_TULARENSIS_VAC...6,SET,31,0.081563,0.0033469,0.16733,0.31298,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_192HR_DN,0.981083821145533
HP_ECTOPIC_ANTERIOR_PITUITAR...,SET,8,0.14828,0.003093,0.30426,0.31301,HP_ECTOPIC_ANTERIOR_PITUITARY_GLAND,0.981083821145533
BIOCARTA_LECTIN_PATHWAY,SET,10,0.12668,0.0029541,0.25998,0.31304,BIOCARTA_LECTIN_PATHWAY,0.981083821145533
WP_RUBINSTEINTAYBI_SYNDROME_1,SET,14,0.11322,0.0031236,0.23235,0.31304,WP_RUBINSTEINTAYBI_SYNDROME_1,0.981083821145533
HP_HETEROPHORIA,SET,11,0.11621,0.0028421,0.23854,0.31308,HP_HETEROPHORIA,0.981083821145533
KAECH_DAY15_EFF_VS_MEMORY_CD...1,SET,182,0.030183,0.0029886,0.06197,0.31311,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_DN,0.981083821145533
HP_SHORT_PROXIMAL_PHALANX_OF...,SET,7,0.15678,0.003059,0.32193,0.31314,HP_SHORT_PROXIMAL_PHALANX_OF_FINGER,0.981083821145533
GSE17301_CTRL_VS_48H_IFNA2_S...1,SET,163,0.031624,0.002965,0.064938,0.31314,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_DN,0.981083821145533
HP_SPORADIC,SET,86,0.046312,0.0031606,0.095169,0.31326,HP_SPORADIC,0.981083821145533
REACTOME_TP53_REGULATES_TRAN...1,SET,20,0.090849,0.0029953,0.18671,0.31328,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_ADDITIONAL_CELL_CYCLE_GENES_WHOSE_EXACT_ROLE_IN_THE_P53_PATHWAY_REMAIN_UNCERTAIN,0.981083821145533
GOMF_PALMITOYLTRANSFERASE_AC...,SET,35,0.067012,0.0029215,0.13775,0.31332,GOMF_PALMITOYLTRANSFERASE_ACTIVITY,0.981083821145533
HP_CAFE_AU_LAIT_SPOT,SET,120,0.034952,0.002815,0.071849,0.31332,HP_CAFE_AU_LAIT_SPOT,0.981083821145533
WP_NETWORK_MAP_OF_SARSCOV2_S...,SET,204,0.029926,0.0031353,0.06152,0.31333,WP_NETWORK_MAP_OF_SARSCOV2_SIGNALING,0.981083821145533
MIR6864_5P,SET,77,0.048075,0.0031052,0.098838,0.31335,MIR6864_5P,0.981083821145533
GSE41867_DAY6_VS_DAY15_LCMV_...3,SET,142,0.034926,0.0030581,0.071816,0.31337,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,0.981083821145533
MIR1228_3P,SET,70,0.049978,0.0030785,0.10278,0.31339,MIR1228_3P,0.981083821145533
GOBP_REGULATION_OF_IMMUNE_SY...,SET,1406,0.01172,0.0031152,0.024104,0.3134,GOBP_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,0.981083821145533
GOBP_MYELOID_CELL_HOMEOSTASIS,SET,163,0.032223,0.0030211,0.066274,0.31341,GOBP_MYELOID_CELL_HOMEOSTASIS,0.981083821145533
MATZUK_MALE_REPRODUCTION_SER...,SET,25,0.080805,0.0029782,0.1662,0.31342,MATZUK_MALE_REPRODUCTION_SERTOLI,0.981083821145533
ZHAN_LATE_DIFFERENTIATION_GE...1,SET,14,0.10216,0.0028184,0.21012,0.31343,ZHAN_LATE_DIFFERENTIATION_GENES_DN,0.981083821145533
GSE8921_UNSTIM_VS_TLR1_2_STI...5,SET,183,0.030211,0.0029996,0.062151,0.31345,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_DN,0.981083821145533
GSE16385_MONOCYTE_VS_12H_ROS...1,SET,175,0.031021,0.0030126,0.063842,0.31352,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.98109686825054
GOBP_REGULATION_OF_GENE_SILE...,SET,25,0.083333,0.0030713,0.17151,0.31353,GOBP_REGULATION_OF_GENE_SILENCING_BY_REGULATORY_NCRNA,0.98109686825054
MODULE_124,SET,92,0.039267,0.0027712,0.080837,0.31357,MODULE_124,0.98109686825054
HP_ABNORMALITY_OF_THE_SUPRAO...,SET,87,0.045648,0.0031332,0.093997,0.31362,HP_ABNORMALITY_OF_THE_SUPRAORBITAL_RIDGES,0.98109686825054
GSE17721_4_VS_24H_CPG_BMDC_UP,SET,177,0.031568,0.003083,0.065005,0.31362,GSE17721_4_VS_24H_CPG_BMDC_UP,0.98109686825054
GOBP_PROTEIN_LOCALIZATION_TO...20,SET,59,0.047886,0.0027088,0.098619,0.31364,GOBP_PROTEIN_LOCALIZATION_TO_CYTOSKELETON,0.98109686825054
GOBP_CELLULAR_RESPONSE_TO_PH,SET,25,0.081804,0.003015,0.16849,0.31366,GOBP_CELLULAR_RESPONSE_TO_PH,0.98109686825054
GOBP_N_ACETYLNEURAMINATE_MET...,SET,11,0.13093,0.0032022,0.26971,0.31368,GOBP_N_ACETYLNEURAMINATE_METABOLIC_PROCESS,0.98109686825054
GSE5099_CLASSICAL_M1_VS_ALTE...2,SET,178,0.031062,0.0030421,0.064003,0.31373,GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP,0.981135619210361
GSE3039_ALPHABETA_CD8_TCELL_...3,SET,184,0.029242,0.0029112,0.060282,0.31381,GSE3039_ALPHABETA_CD8_TCELL_VS_B2_BCELL_DN,0.981135619210361
HP_HYPERPIGMENTATION_OF_THE_...1,SET,6,0.17453,0.003153,0.35983,0.31383,HP_HYPERPIGMENTATION_OF_THE_FUNDUS,0.981135619210361
GOBP_POSITIVE_REGULATION_OF_...652,SET,19,0.094258,0.0030291,0.19436,0.31385,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,0.981135619210361
GOBP_CENTROMERE_COMPLEX_ASSE...,SET,26,0.0787,0.002958,0.16228,0.31386,GOBP_CENTROMERE_COMPLEX_ASSEMBLY,0.981135619210361
GOBP_DORSAL_VENTRAL_PATTERN_...,SET,88,0.047023,0.003246,0.096972,0.31387,GOBP_DORSAL_VENTRAL_PATTERN_FORMATION,0.981135619210361
GOBP_GLYCOSYLCERAMIDE_BIOSYN...,SET,8,0.14634,0.0030525,0.30183,0.31389,GOBP_GLYCOSYLCERAMIDE_BIOSYNTHETIC_PROCESS,0.981135619210361
MOREIRA_RESPONSE_TO_TSA_DN,SET,18,0.098615,0.0030846,0.20348,0.31397,MOREIRA_RESPONSE_TO_TSA_DN,0.981297423561151
GSE29617_CTRL_VS_TIV_FLU_VAC...2,SET,163,0.032691,0.0030649,0.067479,0.31403,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP,0.981369064942064
GOMF_PROTEIN_SERINE_THREONIN...5,SET,90,0.04104,0.0028648,0.084727,0.31406,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,0.981369064942064
FERRANDO_T_ALL_WITH_MLL_ENL_...2,SET,77,0.048211,0.003114,0.099541,0.31408,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP,0.981369064942064
GRAESSMANN_APOPTOSIS_BY_DOXO...1,SET,1596,0.010386,0.0029246,0.021453,0.31415,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN,0.981369064942064
GOBP_CELLULAR_RESPONSE_TO_TE...2,SET,8,0.12855,0.0026814,0.26565,0.31423,GOBP_CELLULAR_RESPONSE_TO_TESTOSTERONE_STIMULUS,0.981369064942064
PID_RXR_VDR_PATHWAY,SET,26,0.078878,0.0029647,0.16308,0.31431,PID_RXR_VDR_PATHWAY,0.981369064942064
GOCC_MYOSIN_FILAMENT,SET,24,0.092434,0.003338,0.1911,0.31431,GOCC_MYOSIN_FILAMENT,0.981369064942064
KEGG_MEDICUS_PATHOGEN_HPV_E6...1,SET,12,0.1233,0.0031496,0.25494,0.31432,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380,0.981369064942064
GOBP_PROTEIN_LIPID_COMPLEX_A...,SET,28,0.075855,0.0029585,0.15684,0.31432,GOBP_PROTEIN_LIPID_COMPLEX_ASSEMBLY,0.981369064942064
HP_HEPATIC_CYSTS,SET,23,0.081943,0.002897,0.16943,0.31432,HP_HEPATIC_CYSTS,0.981369064942064
REACTOME_DUAL_INCISION_IN_GG...,SET,38,0.056877,0.0025836,0.11762,0.31435,REACTOME_DUAL_INCISION_IN_GG_NER,0.981369064942064
RUAN_RESPONSE_TO_TNF_DN,SET,76,0.048615,0.0031197,0.10054,0.31436,RUAN_RESPONSE_TO_TNF_DN,0.981369064942064
GOBP_COENZYME_A_METABOLIC_PR...,SET,18,0.087252,0.0027292,0.18044,0.31436,GOBP_COENZYME_A_METABOLIC_PROCESS,0.981369064942064
GOBP_RENAL_WATER_ABSORPTION,SET,6,0.18688,0.0033761,0.38673,0.31447,GOBP_RENAL_WATER_ABSORPTION,0.9814276109368
GOBP_DEVELOPMENTAL_PROCESS_I...,SET,869,0.014091,0.0029906,0.029163,0.31449,GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION,0.9814276109368
WP_TRANSCRIPTION_FACTORS_REG...,SET,8,0.12841,0.0026786,0.26589,0.31456,WP_TRANSCRIPTION_FACTORS_REGULATE_MIRNAS_RELATED_TO_CARDIAC_HYPERTROPHY,0.9814276109368
MIR5571_3P,SET,39,0.064867,0.0029849,0.13432,0.31458,MIR5571_3P,0.9814276109368
GOBP_VIRAL_PROCESS,SET,397,0.021098,0.0030671,0.04369,0.31459,GOBP_VIRAL_PROCESS,0.9814276109368
GOBP_CILIUM_ORGANIZATION,SET,369,0.020518,0.0028779,0.042494,0.31461,GOBP_CILIUM_ORGANIZATION,0.9814276109368
REACTOME_IONOTROPIC_ACTIVITY...,SET,9,0.14115,0.0031227,0.29237,0.31463,REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS,0.9814276109368
GSE19888_CTRL_VS_A3R_ACTIVAT...1,SET,171,0.031681,0.0030416,0.065626,0.31464,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_DN,0.9814276109368
GSE7218_UNSTIM_VS_ANTIGEN_ST...3,SET,104,0.04014,0.0030109,0.083163,0.31467,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_DN,0.9814276109368
GOCC_SPECIFIC_GRANULE,SET,148,0.03371,0.0030128,0.069876,0.31475,GOCC_SPECIFIC_GRANULE,0.9814276109368
HE_LIM_SUN_FETAL_LUNG_C5_DEL...,SET,3,0.26048,0.0033276,0.54,0.31478,HE_LIM_SUN_FETAL_LUNG_C5_DELTA_SMALL_PRE_B_CELL,0.9814276109368
GOBP_CELL_SURFACE_RECEPTOR_P...1,SET,333,0.023117,0.0030834,0.047928,0.31479,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.9814276109368
HAHTOLA_MYCOSIS_FUNGOIDES_SK...1,SET,26,0.083159,0.0031256,0.17243,0.3148,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_DN,0.9814276109368
ZFP28_TARGET_GENES,SET,69,0.048439,0.0029624,0.10049,0.31489,ZFP28_TARGET_GENES,0.9814276109368
HP_MATERNAL_AUTOIMMUNE_DISEA...,SET,14,0.10901,0.0030075,0.22614,0.31489,HP_MATERNAL_AUTOIMMUNE_DISEASE,0.9814276109368
MIR4659A_3P_MIR4659B_3P,SET,609,0.016934,0.003031,0.035134,0.31491,MIR4659A_3P_MIR4659B_3P,0.9814276109368
GOMF_CLASS_I_DNA_APURINIC_OR...,SET,8,0.13778,0.002874,0.28587,0.31492,GOMF_CLASS_I_DNA_APURINIC_OR_APYRIMIDINIC_SITE_ENDONUCLEASE_ACTIVITY,0.9814276109368
HP_NONTUBERCULOUS_MYCOBACTER...,SET,19,0.096437,0.0030991,0.20011,0.31493,HP_NONTUBERCULOUS_MYCOBACTERIAL_PULMONARY_INFECTION,0.9814276109368
GENTILE_UV_RESPONSE_CLUSTER_...5,SET,33,0.068657,0.0029066,0.14247,0.31495,GENTILE_UV_RESPONSE_CLUSTER_D6,0.9814276109368
GSE18791_UNSTIM_VS_NEWCATSLE...3,SET,154,0.033693,0.0030712,0.069936,0.31499,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_DN,0.9814276109368
REACTOME_THE_RETINOID_CYCLE_...,SET,3,0.30557,0.0039037,0.63433,0.315,REACTOME_THE_RETINOID_CYCLE_IN_CONES_DAYLIGHT_VISION,0.9814276109368
HE_LIM_SUN_FETAL_LUNG_C0_ALV...,SET,7,0.17893,0.0034912,0.37142,0.315,HE_LIM_SUN_FETAL_LUNG_C0_ALVEOLAR_FIBROBLAST,0.9814276109368
MIR3681_5P,SET,31,0.078533,0.0032226,0.16308,0.31506,MIR3681_5P,0.981449556411865
GOMF_OXIDOREDUCTASE_ACTIVITY...5,SET,9,0.12081,0.0026728,0.2509,0.31507,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,0.981449556411865
HP_LONG_TOE,SET,38,0.065182,0.0029608,0.13539,0.31511,HP_LONG_TOE,0.981449556411865
GOMF_INOSITOL_1_3_4_5_TETRAK...,SET,5,0.18216,0.0030041,0.3784,0.31512,GOMF_INOSITOL_1_3_4_5_TETRAKISPHOSPHATE_BINDING,0.981449556411865
GSE2405_HEAT_KILLED_VS_LIVE_...4,SET,178,0.02853,0.0027941,0.059313,0.31526,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,0.98147946905016
TGCTTTG_MIR330,SET,297,0.023585,0.0029738,0.04904,0.31529,TGCTTTG_MIR330,0.98147946905016
MIR1251_3P,SET,140,0.035655,0.0031,0.074159,0.31533,MIR1251_3P,0.98147946905016
OVSYANNIKOVA_PBMC_FLUARIX_AG...7,SET,6,0.15773,0.0028494,0.32807,0.31534,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_DN,0.98147946905016
GSE45365_HEALTHY_VS_MCMV_INF...6,SET,154,0.031675,0.0028873,0.065903,0.31539,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_UP,0.98147946905016
MARTIN_NFKB_TARGETS_DN,SET,10,0.12339,0.0028775,0.25681,0.31545,MARTIN_NFKB_TARGETS_DN,0.98147946905016
GOBP_REGULATION_OF_AXON_EXTE...2,SET,15,0.10892,0.0031105,0.22676,0.31549,GOBP_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.98147946905016
MIR659_3P,SET,204,0.029112,0.00305,0.060608,0.3155,MIR659_3P,0.98147946905016
GSE5960_TH1_VS_ANERGIC_TH1_UP,SET,183,0.029601,0.0029389,0.061625,0.3155,GSE5960_TH1_VS_ANERGIC_TH1_UP,0.98147946905016
GOBP_HIS_PURKINJE_SYSTEM_DEV...,SET,7,0.19124,0.0037315,0.39817,0.31551,GOBP_HIS_PURKINJE_SYSTEM_DEVELOPMENT,0.98147946905016
KIM_MYCN_AMPLIFICATION_TARGE...1,SET,98,0.041793,0.0030436,0.087016,0.31552,KIM_MYCN_AMPLIFICATION_TARGETS_DN,0.98147946905016
SENGUPTA_NASOPHARYNGEAL_CARC...4,SET,362,0.022196,0.0030842,0.046215,0.31552,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP,0.98147946905016
KEGG_MEDICUS_VARIANT_AMPLIFI...8,SET,12,0.12419,0.0031722,0.25858,0.31553,KEGG_MEDICUS_VARIANT_AMPLIFIED_MDM2_TO_P21_CELL_CYCLE_G1_S,0.98147946905016
HP_INTELLECTUAL_DISABILITY_P...2,SET,31,0.062095,0.0025481,0.12935,0.31559,HP_INTELLECTUAL_DISABILITY_PROGRESSIVE,0.98147946905016
GOBP_CORPUS_CALLOSUM_DEVELOP...,SET,25,0.084624,0.003119,0.17631,0.31562,GOBP_CORPUS_CALLOSUM_DEVELOPMENT,0.98147946905016
HP_DECREASED_PROPORTION_OF_N...,SET,3,0.2724,0.00348,0.56752,0.31562,HP_DECREASED_PROPORTION_OF_NAIVE_T_CELLS,0.98147946905016
MARTINELLI_IMMATURE_NEUTROPH...2,SET,8,0.16669,0.003477,0.34745,0.3157,MARTINELLI_IMMATURE_NEUTROPHIL_UP,0.98147946905016
GSE22886_NAIVE_TCELL_VS_NKCE...2,SET,173,0.03099,0.0029925,0.064609,0.31574,GSE22886_NAIVE_TCELL_VS_NKCELL_UP,0.98147946905016
HP_DYSURIA,SET,14,0.10377,0.0028628,0.2164,0.3158,HP_DYSURIA,0.98147946905016
GSE37605_TREG_VS_TCONV_C57BL...2,SET,122,0.038739,0.0031457,0.080801,0.31582,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_UP,0.98147946905016
PID_EPHA_FWDPATHWAY,SET,34,0.073267,0.0031484,0.15284,0.31583,PID_EPHA_FWDPATHWAY,0.98147946905016
HP_OCULAR_FLUTTER,SET,5,0.20003,0.0032988,0.41726,0.31584,HP_OCULAR_FLUTTER,0.98147946905016
GOMF_S_ACYLTRANSFERASE_ACTIV...,SET,28,0.070764,0.0027599,0.14763,0.31585,GOMF_S_ACYLTRANSFERASE_ACTIVITY,0.98147946905016
GSE22886_NAIVE_CD4_TCELL_VS_...10,SET,171,0.029884,0.0028691,0.062349,0.31587,GSE22886_NAIVE_CD4_TCELL_VS_DC_UP,0.98147946905016
GOBP_VIRION_ASSEMBLY,SET,34,0.065156,0.0027998,0.13595,0.31588,GOBP_VIRION_ASSEMBLY,0.98147946905016
MIR4668_5P,SET,425,0.019823,0.0029793,0.04137,0.31592,MIR4668_5P,0.98147946905016
GSE20366_EX_VIVO_VS_HOMEOSTA...4,SET,187,0.02807,0.002817,0.058618,0.31602,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_UP,0.98147946905016
CAVARD_LIVER_CANCER_MALIGNAN...,SET,28,0.082872,0.0032322,0.17312,0.31608,CAVARD_LIVER_CANCER_MALIGNANT_VS_BENIGN,0.98147946905016
GNF2_MYL3,SET,31,0.076995,0.0031595,0.16084,0.31608,GNF2_MYL3,0.98147946905016
GOBP_PHAGOCYTOSIS_ENGULFMENT,SET,49,0.061047,0.0031479,0.12753,0.31609,GOBP_PHAGOCYTOSIS_ENGULFMENT,0.98147946905016
HP_RESPIRATORY_TRACT_INFECTI...,SET,681,0.016003,0.0030228,0.033449,0.31618,HP_RESPIRATORY_TRACT_INFECTION,0.98147946905016
MODULE_116,SET,13,0.10947,0.0029104,0.22887,0.31622,MODULE_116,0.98147946905016
MZF1_02,SET,220,0.02745,0.0029853,0.057411,0.31628,MZF1_02,0.98147946905016
GOCC_ENDOPLASMIC_RETICULUM_P...3,SET,111,0.036846,0.0028548,0.077061,0.31628,GOCC_ENDOPLASMIC_RETICULUM_PROTEIN_CONTAINING_COMPLEX,0.98147946905016
WP_AMYOTROPHIC_LATERAL_SCLER...,SET,37,0.062727,0.0028116,0.13121,0.31631,WP_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS,0.98147946905016
GOMF_TUMOR_NECROSIS_FACTOR_R...2,SET,28,0.080202,0.003128,0.16777,0.31632,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_BINDING,0.98147946905016
GSE45365_NK_CELL_VS_BCELL_MC...2,SET,181,0.030289,0.002991,0.063373,0.31635,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_UP,0.98147946905016
GOBP_SPHINGOMYELIN_BIOSYNTHE...,SET,11,0.1154,0.0028224,0.24148,0.31636,GOBP_SPHINGOMYELIN_BIOSYNTHETIC_PROCESS,0.98147946905016
HP_VERY_LOW_VISUAL_ACUITY,SET,5,0.1948,0.0032125,0.40766,0.31638,HP_VERY_LOW_VISUAL_ACUITY,0.98147946905016
GSE23321_CENTRAL_MEMORY_VS_N...1,SET,180,0.030492,0.0030027,0.063827,0.31643,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_DN,0.98147946905016
GOBP_REGULATION_OF_KILLING_O...,SET,9,0.15319,0.0033892,0.32077,0.31648,GOBP_REGULATION_OF_KILLING_OF_CELLS_OF_ANOTHER_ORGANISM,0.98147946905016
GSE3691_CONVENTIONAL_VS_PLAS...2,SET,188,0.029449,0.0029632,0.061667,0.31649,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_UP,0.98147946905016
GOBP_PHOTOTRANSDUCTION,SET,40,0.065737,0.0030634,0.1377,0.31655,GOBP_PHOTOTRANSDUCTION,0.98147946905016
MIR7106_5P,SET,325,0.022126,0.0029161,0.046351,0.31656,MIR7106_5P,0.98147946905016
HP_ABNORMAL_Z_DISK_MORPHOLOGY,SET,8,0.13612,0.0028393,0.28518,0.31657,HP_ABNORMAL_Z_DISK_MORPHOLOGY,0.98147946905016
AMIT_EGF_RESPONSE_40_HELA,SET,41,0.067101,0.0031657,0.14059,0.31658,AMIT_EGF_RESPONSE_40_HELA,0.98147946905016
GOMF_UNFOLDED_PROTEIN_BINDING,SET,107,0.035131,0.0026727,0.073615,0.3166,GOMF_UNFOLDED_PROTEIN_BINDING,0.98147946905016
MODULE_52,SET,394,0.021012,0.0030434,0.044039,0.31664,MODULE_52,0.98147946905016
GOMF_TRANSFORMING_GROWTH_FAC...1,SET,23,0.090382,0.0031953,0.18944,0.31665,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_BINDING,0.98147946905016
GOBP_REGULATION_OF_VIRAL_PRO...,SET,154,0.034748,0.0031674,0.072892,0.31679,GOBP_REGULATION_OF_VIRAL_PROCESS,0.98147946905016
HP_HIGH_PALATE,SET,672,0.015347,0.0028805,0.032198,0.31681,HP_HIGH_PALATE,0.98147946905016
REACTOME_TRANSCRIPTIONAL_REG...4,SET,171,0.030287,0.0029078,0.063545,0.31682,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1,0.98147946905016
MIR4708_5P,SET,80,0.043161,0.0028414,0.090594,0.31689,MIR4708_5P,0.98147946905016
GSE27786_LSK_VS_NKTCELL_UP,SET,174,0.030027,0.0029078,0.063028,0.31689,GSE27786_LSK_VS_NKTCELL_UP,0.98147946905016
GSE16385_UNTREATED_VS_12H_RO...4,SET,186,0.02822,0.0028245,0.059242,0.31691,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,0.98147946905016
MODULE_301,SET,136,0.034867,0.0029882,0.073197,0.31692,MODULE_301,0.98147946905016
KEGG_MEDICUS_PATHOGEN_HIV_NE...,SET,12,0.1101,0.0028124,0.23124,0.31699,KEGG_MEDICUS_PATHOGEN_HIV_NEF_TO_TNF_NFKB_SIGNALING_PATHWAY,0.98147946905016
GOMF_G_QUADRUPLEX_RNA_BINDING,SET,6,0.16175,0.0029221,0.33975,0.31701,GOMF_G_QUADRUPLEX_RNA_BINDING,0.98147946905016
DAZARD_RESPONSE_TO_UV_NHEK_UP,SET,190,0.029246,0.0029582,0.061441,0.31704,DAZARD_RESPONSE_TO_UV_NHEK_UP,0.98147946905016
GOMF_IGG_RECEPTOR_ACTIVITY,SET,6,0.20932,0.0037815,0.43975,0.31704,GOMF_IGG_RECEPTOR_ACTIVITY,0.98147946905016
HP_BROAD_PHALANGES_OF_THE_HA...,SET,94,0.042141,0.003006,0.088538,0.31705,HP_BROAD_PHALANGES_OF_THE_HAND,0.98147946905016
GOMF_ENDONUCLEASE_ACTIVITY_A...1,SET,15,0.10522,0.0030048,0.22108,0.31706,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_3_PHOSPHOMONOESTERS,0.98147946905016
GOCC_ENDOPLASMIC_RETICULUM_L...,SET,285,0.024554,0.0030339,0.051596,0.31708,GOCC_ENDOPLASMIC_RETICULUM_LUMEN,0.98147946905016
chr12q13,SET,248,0.061933,0.0071456,0.13016,0.3171,chr12q13,0.98147946905016
MIR4272,SET,180,0.029096,0.0028654,0.061148,0.3171,MIR4272,0.98147946905016
GSE9960_HEALTHY_VS_GRAM_POS_...1,SET,166,0.031442,0.0029747,0.066079,0.3171,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_DN,0.98147946905016
GOBP_ANTIMICROBIAL_HUMORAL_R...,SET,128,0.042238,0.0035126,0.088812,0.31719,GOBP_ANTIMICROBIAL_HUMORAL_RESPONSE,0.98147946905016
GOBP_INTRACELLULAR_ESTROGEN_...,SET,45,0.056785,0.0028064,0.1194,0.31719,GOBP_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,0.98147946905016
GSE2706_LPS_VS_R848_AND_LPS_...4,SET,166,0.03045,0.0028808,0.064042,0.31723,GSE2706_LPS_VS_R848_AND_LPS_8H_STIM_DC_UP,0.98147946905016
MIR4709_5P,SET,94,0.043307,0.0030892,0.091088,0.31724,MIR4709_5P,0.98147946905016
GNF2_IGF1,SET,26,0.082712,0.0031088,0.17399,0.31726,GNF2_IGF1,0.98147946905016
GSE19401_PAM2CSK4_VS_RETINOI...4,SET,179,0.029677,0.0029144,0.062429,0.31726,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,0.98147946905016
GSE40666_WT_VS_STAT4_KO_CD8_...2,SET,148,0.034353,0.0030703,0.072277,0.31729,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_UP,0.98147946905016
TAGGTCA_MIR192_MIR215,SET,36,0.066499,0.0029402,0.13998,0.31738,TAGGTCA_MIR192_MIR215,0.98147946905016
GOBP_CELLULAR_RESPONSE_TO_LI...1,SET,106,0.037039,0.0028048,0.077969,0.31738,GOBP_CELLULAR_RESPONSE_TO_LIGHT_STIMULUS,0.98147946905016
GOMF_RNA_POLYMERASE_CORE_ENZ...,SET,40,0.065503,0.0030525,0.13789,0.31738,GOMF_RNA_POLYMERASE_CORE_ENZYME_BINDING,0.98147946905016
GSE2706_UNSTIM_VS_8H_LPS_AND...1,SET,174,0.032192,0.0031174,0.067765,0.31738,GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN,0.98147946905016
GOBP_REGULATION_OF_MAST_CELL...1,SET,16,0.10576,0.0031192,0.22265,0.3174,GOBP_REGULATION_OF_MAST_CELL_ACTIVATION,0.98147946905016
HP_ABNORMAL_THUMB_MORPHOLOGY,SET,344,0.021243,0.0028789,0.044726,0.31741,HP_ABNORMAL_THUMB_MORPHOLOGY,0.98147946905016
REACTOME_TRANSLESION_SYNTHES...1,SET,17,0.084349,0.0025642,0.1776,0.31742,REACTOME_TRANSLESION_SYNTHESIS_BY_POLH,0.98147946905016
ALK_DN.V1_UP,SET,122,0.038126,0.0030959,0.080282,0.31743,ALK_DN.V1_UP,0.98147946905016
GOCC_CONE_PHOTORECEPTOR_OUTE...,SET,7,0.18842,0.0036764,0.39684,0.31747,GOCC_CONE_PHOTORECEPTOR_OUTER_SEGMENT,0.98147946905016
GOCC_AXONAL_GROWTH_CONE,SET,23,0.086388,0.0030541,0.18196,0.31748,GOCC_AXONAL_GROWTH_CONE,0.98147946905016
WP_LACTO_SERIES_SPHINGOLIPID...,SET,6,0.16941,0.0030604,0.3569,0.31752,WP_LACTO_SERIES_SPHINGOLIPID_METABOLISM,0.98147946905016
GOBP_TRANS_SYNAPTIC_SIGNALIN...2,SET,7,0.1698,0.0033131,0.35775,0.31753,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.98147946905016
HOFT_CD4_POSITIVE_ALPHA_BETA...3,SET,3,0.19973,0.0025516,0.42124,0.3177,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_DN,0.981493920464543
KEGG_MEDICUS_REFERENCE_AHR_S...,SET,8,0.14813,0.0030898,0.31247,0.31773,KEGG_MEDICUS_REFERENCE_AHR_SIGNALING_PATHWAY,0.981493920464543
REACTOME_ADORA2B_MEDIATED_AN...,SET,42,0.06243,0.002981,0.1317,0.31774,REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION,0.981493920464543
GOBP_KETONE_BIOSYNTHETIC_PRO...,SET,42,0.060146,0.0028719,0.1269,0.31777,GOBP_KETONE_BIOSYNTHETIC_PROCESS,0.981493920464543
HP_ABNORMAL_FINGER_FLEXION_C...,SET,19,0.097186,0.0031232,0.20521,0.3179,HP_ABNORMAL_FINGER_FLEXION_CREASE,0.981493920464543
KIM_MYC_AMPLIFICATION_TARGET...2,SET,170,0.030353,0.0029057,0.064095,0.31791,KIM_MYC_AMPLIFICATION_TARGETS_UP,0.981493920464543
MARKEY_RB1_ACUTE_LOF_DN,SET,211,0.028416,0.0030272,0.060017,0.31794,MARKEY_RB1_ACUTE_LOF_DN,0.981493920464543
MIR6717_5P,SET,4,0.19494,0.0028756,0.41186,0.31799,MIR6717_5P,0.981493920464543
HP_MECHANICAL_ILEUS,SET,21,0.09463,0.0031969,0.20002,0.31807,HP_MECHANICAL_ILEUS,0.981493920464543
HP_LEUKODYSTROPHY,SET,83,0.040332,0.0027042,0.085257,0.31809,HP_LEUKODYSTROPHY,0.981493920464543
WP_ONCOSTATIN_M_SIGNALING,SET,63,0.055144,0.003223,0.11659,0.31812,WP_ONCOSTATIN_M_SIGNALING,0.981493920464543
DACOSTA_ERCC3_ALLELE_XPCS_VS...1,SET,31,0.072029,0.0029557,0.15232,0.31815,DACOSTA_ERCC3_ALLELE_XPCS_VS_TTD_DN,0.981493920464543
GOCC_POLYMERIC_CYTOSKELETAL_...,SET,687,0.016009,0.0030368,0.03386,0.31818,GOCC_POLYMERIC_CYTOSKELETAL_FIBER,0.981493920464543
HP_RED_GREEN_DYSCHROMATOPSIA,SET,8,0.13495,0.0028149,0.28543,0.31818,HP_RED_GREEN_DYSCHROMATOPSIA,0.981493920464543
HP_DECREASED_CIRCULATING_REN...,SET,11,0.12025,0.0029409,0.25439,0.31822,HP_DECREASED_CIRCULATING_RENIN_LEVEL,0.981493920464543
GSE17186_MEMORY_VS_NAIVE_BCE...2,SET,169,0.030721,0.0029324,0.065015,0.31828,GSE17186_MEMORY_VS_NAIVE_BCELL_UP,0.981493920464543
GOMF_GDP_BINDING,SET,70,0.047934,0.0029526,0.10145,0.31829,GOMF_GDP_BINDING,0.981493920464543
GOBP_REGULATION_OF_MAST_CELL...3,SET,7,0.15223,0.0029703,0.32222,0.31831,GOBP_REGULATION_OF_MAST_CELL_CHEMOTAXIS,0.981493920464543
REACTOME_SENSING_OF_DNA_DOUB...,SET,5,0.15387,0.0025376,0.32572,0.31833,REACTOME_SENSING_OF_DNA_DOUBLE_STRAND_BREAKS,0.981493920464543
WP_PARKINUBIQUITIN_PROTEASOM...,SET,64,0.047106,0.0027749,0.099745,0.31837,WP_PARKINUBIQUITIN_PROTEASOMAL_SYSTEM_PATHWAY,0.981493920464543
GOBP_POSITIVE_REGULATION_OF_...601,SET,18,0.09377,0.0029331,0.19855,0.31837,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.981493920464543
GSE369_PRE_VS_POST_IL6_INJEC...5,SET,185,0.028301,0.0028251,0.059938,0.3184,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_DN,0.981493920464543
MIR520D_5P,SET,852,0.014212,0.0029882,0.030101,0.31842,MIR520D_5P,0.981493920464543
GSE17721_CTRL_VS_PAM3CSK4_24...2,SET,186,0.029406,0.0029432,0.062291,0.31844,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_UP,0.981493920464543
HP_ABNORMALITY_OF_THE_LARYNX,SET,192,0.028817,0.00293,0.061055,0.31847,HP_ABNORMALITY_OF_THE_LARYNX,0.981493920464543
GOBP_REGULATION_OF_OLIGODEND...,SET,46,0.068402,0.0034178,0.14494,0.31849,GOBP_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,0.981493920464543
GSE37533_PPARG1_FOXP3_VS_PPA...2,SET,190,0.029904,0.0030248,0.063365,0.31849,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,0.981493920464543
ZHAN_MULTIPLE_MYELOMA_HP_DN,SET,38,0.062994,0.0028614,0.13351,0.31853,ZHAN_MULTIPLE_MYELOMA_HP_DN,0.981493920464543
chr4q13,SET,70,0.097699,0.006018,0.20709,0.31854,chr4q13,0.981493920464543
HP_PULMONARY_VENOUS_HYPERTEN...,SET,9,0.13643,0.0030182,0.28921,0.31857,HP_PULMONARY_VENOUS_HYPERTENSION,0.981493920464543
GOBP_REVERSIBLE_DIFFERENTIAT...,SET,5,0.20117,0.0033176,0.42658,0.31861,GOBP_REVERSIBLE_DIFFERENTIATION,0.981493920464543
REACTOME_INTERLEUKIN_RECEPTO...,SET,23,0.08457,0.0029898,0.17933,0.31862,REACTOME_INTERLEUKIN_RECEPTOR_SHC_SIGNALING,0.981493920464543
GOBP_HEAT_GENERATION,SET,18,0.10793,0.0033761,0.22892,0.31865,GOBP_HEAT_GENERATION,0.981493920464543
GOBP_VASCULAR_ASSOCIATED_SMO...3,SET,28,0.077044,0.0030049,0.16341,0.31865,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.981493920464543
WP_HEPATOCYTE_GROWTH_FACTOR_...,SET,33,0.071691,0.0030351,0.15207,0.31867,WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING,0.981493920464543
GOBP_ACTIVATED_T_CELL_PROLIF...,SET,42,0.066085,0.0031555,0.14019,0.31868,GOBP_ACTIVATED_T_CELL_PROLIFERATION,0.981493920464543
GSE18281_PERIMEDULLARY_CORTI...1,SET,170,0.030507,0.0029204,0.064715,0.31868,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,0.981493920464543
GOBP_MITOTIC_CELL_CYCLE_CHEC...,SET,134,0.03241,0.0027573,0.068754,0.31869,GOBP_MITOTIC_CELL_CYCLE_CHECKPOINT_SIGNALING,0.981493920464543
WP_PAFAH1B1_COPY_NUMBER_VARI...,SET,10,0.11227,0.002618,0.2382,0.31872,WP_PAFAH1B1_COPY_NUMBER_VARIATION,0.981493920464543
MIR424_3P,SET,34,0.064494,0.0027714,0.13688,0.31877,MIR424_3P,0.981493920464543
GOBP_URIDINE_TRANSMEMBRANE_T...,SET,6,0.17659,0.0031902,0.37481,0.31877,GOBP_URIDINE_TRANSMEMBRANE_TRANSPORT,0.981493920464543
GAUTAM_EYE_IRIS_CILIARY_BODY...4,SET,83,0.04397,0.0029482,0.093332,0.31878,GAUTAM_EYE_IRIS_CILIARY_BODY_COL9A1_HIGH_CILIARY_BODY_CELLS,0.981493920464543
WP_PHOTODYNAMIC_THERAPYINDUC...1,SET,49,0.060366,0.0031128,0.12817,0.31883,WP_PHOTODYNAMIC_THERAPYINDUCED_AP1_SURVIVAL_SIGNALING,0.981493920464543
DESCARTES_FETAL_SPLEEN_MEGAK...,SET,88,0.043638,0.0030123,0.09268,0.31888,DESCARTES_FETAL_SPLEEN_MEGAKARYOCYTES,0.981493920464543
WP_CHOLESTEROL_METABOLISM_WI...,SET,44,0.056109,0.0027421,0.11918,0.3189,WP_CHOLESTEROL_METABOLISM_WITH_BLOCH_AND_KANDUTSCHRUSSELL_PATHWAYS,0.981493920464543
REACTOME_SIGNALING_BY_FLT3_I...,SET,16,0.090629,0.0026729,0.19259,0.31898,REACTOME_SIGNALING_BY_FLT3_ITD_AND_TKD_MUTANTS,0.981493920464543
BANDRES_RESPONSE_TO_CARMUSTI...7,SET,28,0.078087,0.0030455,0.16602,0.31906,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_DN,0.981493920464543
HP_ABNORMAL_BRANCHING_PATTER...,SET,26,0.076413,0.002872,0.16246,0.31906,HP_ABNORMAL_BRANCHING_PATTERN_OF_THE_AORTIC_ARCH,0.981493920464543
MIR520D_3P,SET,303,0.022595,0.0028772,0.048046,0.31908,MIR520D_3P,0.981493920464543
HP_STEROID_RESISTANT_NEPHROT...,SET,14,0.097383,0.0026867,0.20708,0.31909,HP_STEROID_RESISTANT_NEPHROTIC_SYNDROME,0.981493920464543
WU_SILENCED_BY_METHYLATION_I...,SET,46,0.06708,0.0033517,0.14267,0.31912,WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER,0.981493920464543
HP_DIFFUSE_MESANGIAL_SCLEROS...,SET,38,0.064267,0.0029193,0.13673,0.31916,HP_DIFFUSE_MESANGIAL_SCLEROSIS,0.981493920464543
GSE40274_SATB1_VS_FOXP3_AND_...2,SET,155,0.030765,0.0028134,0.065458,0.31918,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.981493920464543
GSE23321_CD8_STEM_CELL_MEMOR...3,SET,180,0.029113,0.002867,0.061945,0.31919,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_DN,0.981493920464543
DESCARTES_FETAL_SPLEEN_AFP_A...,SET,172,0.031804,0.0030623,0.067678,0.3192,DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS,0.981493920464543
REACTOME_NEUROFASCIN_INTERAC...,SET,6,0.16615,0.0030015,0.3536,0.31922,REACTOME_NEUROFASCIN_INTERACTIONS,0.981493920464543
TCCCRNNRTGC_UNKNOWN,SET,189,0.027633,0.0027877,0.058812,0.31924,TCCCRNNRTGC_UNKNOWN,0.981493920464543
GSE19941_UNSTIM_VS_LPS_STIM_...2,SET,178,0.030184,0.0029561,0.064272,0.31931,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP,0.981493920464543
GOBP_COPPER_ION_IMPORT,SET,6,0.15564,0.0028116,0.33145,0.31934,GOBP_COPPER_ION_IMPORT,0.981493920464543
GSE42021_CD24HI_VS_CD24LOW_T...4,SET,171,0.030023,0.0028824,0.063947,0.31936,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP,0.981493920464543
MORF_JAK3,SET,90,0.041893,0.0029244,0.089233,0.31937,MORF_JAK3,0.981493920464543
HP_PROMINENT_NOSE,SET,86,0.041471,0.0028302,0.088359,0.31942,HP_PROMINENT_NOSE,0.981493920464543
MIR6874_3P,SET,70,0.046544,0.0028669,0.099192,0.31946,MIR6874_3P,0.981493920464543
REACTOME_TIGHT_JUNCTION_INTE...,SET,27,0.082056,0.0031428,0.17489,0.31947,REACTOME_TIGHT_JUNCTION_INTERACTIONS,0.981493920464543
GOBP_NEGATIVE_REGULATION_OF_...593,SET,6,0.16671,0.0030116,0.35532,0.31947,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,0.981493920464543
GOBP_RIBOFLAVIN_METABOLIC_PR...,SET,5,0.17827,0.0029399,0.37994,0.31947,GOBP_RIBOFLAVIN_METABOLIC_PROCESS,0.981493920464543
HP_LOSS_OF_SPEECH,SET,45,0.058877,0.0029097,0.12549,0.31947,HP_LOSS_OF_SPEECH,0.981493920464543
GOBP_NEGATIVE_REGULATION_OF_...348,SET,43,0.060217,0.0029092,0.12836,0.31949,GOBP_NEGATIVE_REGULATION_OF_LIPID_LOCALIZATION,0.981493920464543
REACTOME_WAX_AND_PLASMALOGEN...,SET,5,0.1877,0.0030955,0.40017,0.31952,REACTOME_WAX_AND_PLASMALOGEN_BIOSYNTHESIS,0.981493920464543
GOBP_REGULATION_OF_CELL_ACTI...,SET,580,0.017518,0.0030625,0.037349,0.31953,GOBP_REGULATION_OF_CELL_ACTIVATION,0.981493920464543
HP_CORNEAL_GUTTATA,SET,6,0.17356,0.0031354,0.37009,0.31955,HP_CORNEAL_GUTTATA,0.981493920464543
ZAMORA_NOS2_TARGETS_UP,SET,51,0.054727,0.0028789,0.11671,0.31957,ZAMORA_NOS2_TARGETS_UP,0.981493920464543
HP_NORMOCYTIC_ANEMIA,SET,15,0.094829,0.002708,0.2023,0.31963,HP_NORMOCYTIC_ANEMIA,0.981493920464543
POMEROY_MEDULLOBLASTOMA_DESM...2,SET,56,0.050581,0.0027878,0.10795,0.31969,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_UP,0.981493920464543
BIOCARTA_IFNG_PATHWAY,SET,6,0.17738,0.0032044,0.37858,0.3197,BIOCARTA_IFNG_PATHWAY,0.981493920464543
MIR149_5P,SET,133,0.032974,0.0027949,0.070378,0.31971,MIR149_5P,0.981493920464543
GOBP_POSITIVE_REGULATION_OF_...30,SET,4,0.14493,0.0021379,0.30937,0.31973,GOBP_POSITIVE_REGULATION_OF_ANOIKIS,0.981493920464543
DOANE_BREAST_CANCER_ESR1_UP,SET,102,0.041411,0.0030764,0.088402,0.31974,DOANE_BREAST_CANCER_ESR1_UP,0.981493920464543
FUJIWARA_PARK2_IN_LIVER_CANC...2,SET,8,0.14415,0.0030068,0.30784,0.3198,FUJIWARA_PARK2_IN_LIVER_CANCER_UP,0.981493920464543
GOBP_ASSOCIATIVE_LEARNING,SET,82,0.045724,0.0030473,0.097659,0.31982,GOBP_ASSOCIATIVE_LEARNING,0.981493920464543
GOBP_REGULATION_OF_TYPE_B_PA...1,SET,8,0.14987,0.003126,0.32012,0.31984,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.981493920464543
GAVISH_3CA_METAPROGRAM_CD8_T...11,SET,40,0.060988,0.0028421,0.1303,0.31988,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_1,0.981493920464543
MULLIGHAN_NPM1_MUTATED_SIGNA...2,SET,234,0.025567,0.0028664,0.054639,0.31992,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP,0.981493920464543
DARWICHE_PAPILLOMA_RISK_LOW_...1,SET,153,0.031086,0.0028244,0.066445,0.31995,DARWICHE_PAPILLOMA_RISK_LOW_DN,0.981493920464543
GOMF_GAMMA_TUBULIN_BINDING,SET,28,0.074678,0.0029126,0.15966,0.31999,GOMF_GAMMA_TUBULIN_BINDING,0.981493920464543
NR4A2_TARGET_GENES,SET,4,0.21734,0.003206,0.46477,0.32003,NR4A2_TARGET_GENES,0.981493920464543
MARIADASON_REGULATED_BY_HIST...2,SET,55,0.054078,0.0029539,0.11566,0.32005,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_UP,0.981493920464543
MIR6773_3P,SET,96,0.041394,0.0029839,0.08855,0.32009,MIR6773_3P,0.981493920464543
MIR367_3P,SET,386,0.020499,0.0029394,0.043889,0.32023,MIR367_3P,0.981493920464543
KEGG_MEDICUS_VARIANT_MUTATIO...29,SET,15,0.091974,0.0026265,0.19694,0.32024,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,0.981493920464543
BUSSLINGER_GASTRIC_ISTHMUS_C...,SET,428,0.019124,0.0028842,0.040953,0.32026,BUSSLINGER_GASTRIC_ISTHMUS_CELLS,0.981493920464543
HP_PHOTOSENSITIVE_MYOCLONIC_...,SET,7,0.1595,0.0031122,0.34168,0.32032,HP_PHOTOSENSITIVE_MYOCLONIC_SEIZURE,0.981493920464543
WU_HBX_TARGETS_3_UP,SET,18,0.097101,0.0030373,0.20807,0.32037,WU_HBX_TARGETS_3_UP,0.981493920464543
GOMF_CELL_ADHESION_MEDIATOR_...,SET,64,0.054458,0.003208,0.11669,0.32037,GOMF_CELL_ADHESION_MEDIATOR_ACTIVITY,0.981493920464543
BENITEZ_GBM_PROTEASOME_INHIB...,SET,45,0.059931,0.0029619,0.12844,0.3204,BENITEZ_GBM_PROTEASOME_INHIBITION_RESPONSE,0.981493920464543
HP_KNEE_CONTRACTURE,SET,98,0.040998,0.0029858,0.087869,0.3204,HP_KNEE_CONTRACTURE,0.981493920464543
HP_ABNORMALITY_OF_THE_AUTONO...,SET,269,0.023761,0.0028535,0.05093,0.32042,HP_ABNORMALITY_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,0.981493920464543
GOBP_MULTIVESICULAR_BODY_ORG...,SET,32,0.06422,0.0026773,0.13768,0.32045,GOBP_MULTIVESICULAR_BODY_ORGANIZATION,0.981493920464543
VANTVEER_BREAST_CANCER_METAS...2,SET,41,0.064262,0.0030318,0.13779,0.32048,VANTVEER_BREAST_CANCER_METASTASIS_UP,0.981493920464543
GOBP_POSITIVE_REGULATION_OF_...222,SET,13,0.10621,0.0028238,0.2278,0.32052,GOBP_POSITIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,0.981493920464543
HP_ABNORMAL_SPERM_MOTILITY,SET,93,0.039418,0.0027969,0.084552,0.32054,HP_ABNORMAL_SPERM_MOTILITY,0.981493920464543
MIR582_3P,SET,83,0.043364,0.0029075,0.093028,0.32056,MIR582_3P,0.981493920464543
GOCC_RUFFLE,SET,172,0.029949,0.0028836,0.064251,0.32057,GOCC_RUFFLE,0.981493920464543
WP_FOXA2_PATHWAY,SET,21,0.091489,0.0030908,0.19629,0.32058,WP_FOXA2_PATHWAY,0.981493920464543
STEGER_ADIPOGENESIS_UP,SET,21,0.091833,0.0031024,0.19708,0.32062,STEGER_ADIPOGENESIS_UP,0.981493920464543
MODULE_207,SET,207,0.027498,0.0029018,0.059017,0.32063,MODULE_207,0.981493920464543
GOMF_POTASSIUM_CHLORIDE_SYMP...,SET,9,0.12594,0.0027862,0.27029,0.32063,GOMF_POTASSIUM_CHLORIDE_SYMPORTER_ACTIVITY,0.981493920464543
WP_H19_RBE2F1_AND_CDKBETACAT...,SET,13,0.11429,0.0030386,0.24532,0.32065,WP_H19_RBE2F1_AND_CDKBETACATENIN_IN_COLORECTAL_CANCER,0.981493920464543
RIEGE_DELTANP63_DIRECT_TARGE...,SET,130,0.034879,0.002923,0.07488,0.32068,RIEGE_DELTANP63_DIRECT_TARGETS_UP,0.981493920464543
REACTOME_PERK_REGULATES_GENE...,SET,30,0.068311,0.0027576,0.14665,0.32068,REACTOME_PERK_REGULATES_GENE_EXPRESSION,0.981493920464543
GSE46468_LUNG_INNATE_LYMPHOI...1,SET,178,0.028052,0.0027473,0.060228,0.3207,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_DN,0.981493920464543
GOMF_ADENYL_NUCLEOTIDE_BINDI...,SET,1501,0.010411,0.0028512,0.022355,0.32071,GOMF_ADENYL_NUCLEOTIDE_BINDING,0.981493920464543
GGAMTNNNNNTCCY_UNKNOWN,SET,107,0.035718,0.0027174,0.076704,0.32073,GGAMTNNNNNTCCY_UNKNOWN,0.981493920464543
CALVET_IRINOTECAN_SENSITIVE_...3,SET,5,0.18343,0.003025,0.3941,0.32081,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_UP,0.981493920464543
WP_FIBRIN_COMPLEMENT_RECEPTO...,SET,41,0.063348,0.0029887,0.13613,0.32084,WP_FIBRIN_COMPLEMENT_RECEPTOR_3_SIGNALING,0.981493920464543
PID_ERA_GENOMIC_PATHWAY,SET,61,0.050911,0.0029282,0.10942,0.32086,PID_ERA_GENOMIC_PATHWAY,0.981493920464543
GOBP_POSITIVE_REGULATION_OF_...794,SET,18,0.10048,0.003143,0.21595,0.32086,GOBP_POSITIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,0.981493920464543
GSE7509_DC_VS_MONOCYTE_UP,SET,182,0.029067,0.0028782,0.062495,0.32093,GSE7509_DC_VS_MONOCYTE_UP,0.981493920464543
GOCC_RIBONUCLEOPROTEIN_COMPL...,SET,619,0.014772,0.002665,0.031764,0.32094,GOCC_RIBONUCLEOPROTEIN_COMPLEX,0.981493920464543
DESCARTES_FETAL_EYE_RETINAL_...1,SET,63,0.053943,0.0031528,0.116,0.32095,DESCARTES_FETAL_EYE_RETINAL_PIGMENT_CELLS,0.981493920464543
HARALAMBIEVA_PBMC_TIV_AGE_50...3,SET,13,0.1033,0.0027465,0.22214,0.32096,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_3DY_POSITIVE,0.981493920464543
YAO_TEMPORAL_RESPONSE_TO_PRO...6,SET,146,0.029886,0.0026531,0.064275,0.32098,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13,0.981493920464543
GOMF_PROTEASOME_BINDING,SET,16,0.085259,0.0025145,0.18339,0.32101,GOMF_PROTEASOME_BINDING,0.98149930060702
MONTERO_THYROID_CANCER_POOR_...2,SET,12,0.11945,0.0030512,0.25706,0.32108,MONTERO_THYROID_CANCER_POOR_SURVIVAL_UP,0.981540628023573
BIOCARTA_VITCB_PATHWAY,SET,8,0.12153,0.0025349,0.26153,0.32108,BIOCARTA_VITCB_PATHWAY,0.981540628023573
GOBP_MARGINAL_ZONE_B_CELL_DI...,SET,8,0.14067,0.0029342,0.30279,0.32112,GOBP_MARGINAL_ZONE_B_CELL_DIFFERENTIATION,0.981576569920844
HP_THIRD_TRIMESTER_ONSET,SET,41,0.05811,0.0027416,0.12513,0.32118,HP_THIRD_TRIMESTER_ONSET,0.981673634684724
GOCC_MITOCHONDRIAL_ENVELOPE,SET,686,0.0146,0.0027675,0.031461,0.32131,GOCC_MITOCHONDRIAL_ENVELOPE,0.981809670619236
chr8p11,SET,50,0.10107,0.0052646,0.21785,0.32134,chr8p11,0.981809670619236
HP_PERONEAL_MUSCLE_ATROPHY,SET,10,0.13726,0.0032009,0.2959,0.32137,HP_PERONEAL_MUSCLE_ATROPHY,0.981809670619236
GOMF_NUCLEAR_RECEPTOR_COACTI...,SET,51,0.052597,0.0027668,0.11339,0.32139,GOMF_NUCLEAR_RECEPTOR_COACTIVATOR_ACTIVITY,0.981809670619236
AKL_HTLV1_INFECTION_UP,SET,24,0.074404,0.0026869,0.16047,0.32144,AKL_HTLV1_INFECTION_UP,0.981809670619236
HP_ABNORMALITY_OF_DENTAL_ERU...,SET,209,0.027121,0.0028756,0.058513,0.32151,HP_ABNORMALITY_OF_DENTAL_ERUPTION,0.981809670619236
REACTOME_CELLULAR_RESPONSE_T...1,SET,191,0.027193,0.0027577,0.058677,0.32153,REACTOME_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,0.981809670619236
GHANDHI_DIRECT_IRRADIATION_DN,SET,32,0.07594,0.003166,0.16391,0.32157,GHANDHI_DIRECT_IRRADIATION_DN,0.981809670619236
YAO_TEMPORAL_RESPONSE_TO_PRO...4,SET,86,0.039209,0.0026758,0.084626,0.32157,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_11,0.981809670619236
GOBP_ACTIN_FILAMENT_NETWORK_...,SET,6,0.1717,0.0031019,0.3706,0.32157,GOBP_ACTIN_FILAMENT_NETWORK_FORMATION,0.981809670619236
GOBP_PROLINE_TRANSPORT,SET,11,0.12769,0.0031229,0.27562,0.32158,GOBP_PROLINE_TRANSPORT,0.981809670619236
BIOCARTA_EXTRINSIC_PATHWAY,SET,13,0.11856,0.003152,0.25592,0.32159,BIOCARTA_EXTRINSIC_PATHWAY,0.981809670619236
WP_ONECARBON_METABOLISM,SET,29,0.067804,0.0026912,0.14638,0.32161,WP_ONECARBON_METABOLISM,0.981809670619236
KEGG_EPITHELIAL_CELL_SIGNALI...,SET,65,0.046396,0.0027543,0.10017,0.32162,KEGG_EPITHELIAL_CELL_SIGNALING_IN_HELICOBACTER_PYLORI_INFECTION,0.981809670619236
GOMF_INSULIN_LIKE_GROWTH_FAC...4,SET,16,0.11077,0.0032669,0.2392,0.32165,GOMF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_BINDING,0.981815014052345
GSE17721_CPG_VS_GARDIQUIMOD_...12,SET,183,0.029309,0.00291,0.063306,0.32169,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_UP,0.981850878194432
GOBP_L_PROLINE_TRANSMEMBRANE...,SET,3,0.24095,0.0030781,0.52082,0.32182,GOBP_L_PROLINE_TRANSMEMBRANE_TRANSPORT,0.981961344500965
HP_MEMORY_IMPAIRMENT,SET,130,0.033571,0.0028134,0.072575,0.32184,HP_MEMORY_IMPAIRMENT,0.981961344500965
GSE2770_IL12_AND_TGFB_VS_IL4...5,SET,175,0.031354,0.0030449,0.067787,0.32185,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.981961344500965
GSE45365_NK_CELL_VS_CD11B_DC...2,SET,178,0.029113,0.0028512,0.062941,0.32185,GSE45365_NK_CELL_VS_CD11B_DC_MCMV_INFECTION_DN,0.981961344500965
MIR92A_2_5P,SET,193,0.02791,0.002845,0.060362,0.32191,MIR92A_2_5P,0.981961344500965
GOBP_ENDOCRINE_SYSTEM_DEVELO...,SET,130,0.037325,0.003128,0.080747,0.32196,GOBP_ENDOCRINE_SYSTEM_DEVELOPMENT,0.981961344500965
GOMF_HISTONE_H3_KINASE_ACTIV...,SET,10,0.12439,0.0029007,0.26913,0.32198,GOMF_HISTONE_H3_KINASE_ACTIVITY,0.981961344500965
GSE45365_NK_CELL_VS_BCELL_UP,SET,186,0.028433,0.0028459,0.061547,0.32205,GSE45365_NK_CELL_VS_BCELL_UP,0.981961344500965
GSE21380_TFH_VS_GERMINAL_CEN...1,SET,179,0.027696,0.0027199,0.05996,0.32208,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,0.981961344500965
MIR1291,SET,97,0.040438,0.00293,0.087557,0.3221,MIR1291,0.981961344500965
GOMF_POTASSIUM_CHANNEL_ACTIV...2,SET,122,0.039253,0.0031875,0.084999,0.32211,GOMF_POTASSIUM_CHANNEL_ACTIVITY,0.981961344500965
HP_SCLEROSING_CHOLANGITIS,SET,10,0.13786,0.0032147,0.29852,0.32212,HP_SCLEROSING_CHOLANGITIS,0.981961344500965
GSE13946_CTRL_VS_DSS_COLITIS...2,SET,163,0.032189,0.0030179,0.069709,0.32213,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_UP,0.981961344500965
HP_MILD_POSTNATAL_GROWTH_RET...,SET,16,0.10119,0.0029843,0.21915,0.32214,HP_MILD_POSTNATAL_GROWTH_RETARDATION,0.981961344500965
REACTOME_ADP_SIGNALLING_THRO...2,SET,22,0.084883,0.002935,0.18385,0.32215,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_12,0.981961344500965
FLECHNER_BIOPSY_KIDNEY_TRANS...2,SET,509,0.017157,0.0028154,0.037176,0.32222,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,0.982018414131673
GAVISH_3CA_MALIGNANT_METAPRO...40,SET,45,0.057441,0.0028388,0.12448,0.32224,GAVISH_3CA_MALIGNANT_METAPROGRAM_METAPROGRAM_6_HYPOXIA,0.982018414131673
GSE45365_HEALTHY_VS_MCMV_INF...5,SET,160,0.031089,0.0028881,0.067394,0.32229,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD11B_DC_IFNAR_KO_UP,0.982018414131673
WP_NOVEL_INTRACELLULAR_COMPO...,SET,54,0.052694,0.002852,0.11424,0.32231,WP_NOVEL_INTRACELLULAR_COMPONENTS_OF_RIGILIKE_RECEPTOR_PATHWAY,0.982018414131673
WP_TRANSCRIPTION_FACTOR_REGU...,SET,21,0.098458,0.0033262,0.21346,0.32231,WP_TRANSCRIPTION_FACTOR_REGULATION_IN_ADIPOGENESIS,0.982018414131673
GOBP_BIOLOGICAL_PROCESS_INVO...5,SET,287,0.023635,0.0029303,0.051249,0.32234,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,0.982023728962132
REACTOME_VITAMIN_B2_RIBOFLAV...,SET,7,0.15052,0.0029369,0.3266,0.32245,REACTOME_VITAMIN_B2_RIBOFLAVIN_METABOLISM,0.982186656441718
GOBP_RESPONSE_TO_UV_A,SET,13,0.12297,0.0032692,0.26681,0.32245,GOBP_RESPONSE_TO_UV_A,0.982186656441718
CHUANG_OXIDATIVE_STRESS_RESP...1,SET,10,0.10304,0.0024028,0.22368,0.32252,CHUANG_OXIDATIVE_STRESS_RESPONSE_DN,0.9822012335958
REACTOME_RUNX1_AND_FOXP3_CON...,SET,9,0.1423,0.0031483,0.30902,0.32258,REACTOME_RUNX1_AND_FOXP3_CONTROL_THE_DEVELOPMENT_OF_REGULATORY_T_LYMPHOCYTES_TREGS,0.9822012335958
STEIN_ESRRA_TARGETS_RESPONSI...2,SET,26,0.076447,0.0028733,0.16607,0.32264,STEIN_ESRRA_TARGETS_RESPONSIVE_TO_ESTROGEN_UP,0.9822012335958
BIOCARTA_S1P_PATHWAY,SET,7,0.13647,0.0026629,0.29657,0.3227,BIOCARTA_S1P_PATHWAY,0.9822012335958
GSE7509_DC_VS_MONOCYTE_WITH_...2,SET,182,0.028534,0.0028254,0.062014,0.32271,GSE7509_DC_VS_MONOCYTE_WITH_FCGRIIB_STIM_UP,0.9822012335958
REACTOME_RUNX1_REGULATES_TRA...5,SET,5,0.18589,0.0030656,0.40412,0.32277,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_INTERLEUKIN_SIGNALING,0.9822012335958
KEGG_MEDICUS_REFERENCE_ORGAN...1,SET,14,0.10876,0.0030006,0.23646,0.32278,KEGG_MEDICUS_REFERENCE_ORGANIZATION_OF_THE_INNER_KINETOCHORE,0.9822012335958
WP_MITOCHONDRIAL_IMMUNE_RESP...,SET,23,0.076002,0.0026869,0.16524,0.32278,WP_MITOCHONDRIAL_IMMUNE_RESPONSE_TO_SARSCOV2,0.9822012335958
BUCASAS_PBMC_FLUARIX_FLUVIRI...3,SET,5,0.17893,0.0029509,0.38909,0.32281,BUCASAS_PBMC_FLUARIX_FLUVIRIN_CAUCASIAN_MALE_AGE_18_40YO_LOW_RESPONDERS_1DY_POSITIVE_PREDICTIVE_OF_TITER,0.9822012335958
GOBP_MINERALOCORTICOID_METAB...,SET,14,0.12169,0.0033572,0.26463,0.32282,GOBP_MINERALOCORTICOID_METABOLIC_PROCESS,0.9822012335958
GOBP_POSITIVE_REGULATION_OF_...38,SET,123,0.036349,0.0029636,0.079065,0.32286,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,0.9822012335958
SESTO_RESPONSE_TO_UV_C3,SET,19,0.088964,0.0028589,0.19355,0.32289,SESTO_RESPONSE_TO_UV_C3,0.9822012335958
MODULE_575,SET,12,0.12407,0.0031691,0.26995,0.32291,MODULE_575,0.9822012335958
GSE10239_MEMORY_VS_KLRG1INT_...2,SET,179,0.029197,0.0028673,0.06355,0.32297,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_UP,0.9822012335958
GSE11864_CSF1_VS_CSF1_IFNG_P...2,SET,167,0.027954,0.0026526,0.060845,0.32297,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,0.9822012335958
KEGG_MEDICUS_VARIANT_TRK_FUS...,SET,10,0.11592,0.0027032,0.25233,0.32298,KEGG_MEDICUS_VARIANT_TRK_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.9822012335958
REACTOME_RHOG_GTPASE_CYCLE,SET,68,0.049493,0.0030049,0.10775,0.323,REACTOME_RHOG_GTPASE_CYCLE,0.9822012335958
HP_CHRONIC_HEPATITIS,SET,9,0.13593,0.0030073,0.29594,0.323,HP_CHRONIC_HEPATITIS,0.9822012335958
GSE2585_AIRE_KO_VS_WT_CD80_H...1,SET,181,0.028782,0.0028421,0.062668,0.32302,GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_DN,0.9822012335958
VANGURP_PANCREATIC_ALPHA_CELL,SET,38,0.068888,0.0031291,0.14999,0.32302,VANGURP_PANCREATIC_ALPHA_CELL,0.9822012335958
REACTOME_SEMAPHORIN_INTERACT...,SET,61,0.05101,0.0029339,0.11112,0.32309,REACTOME_SEMAPHORIN_INTERACTIONS,0.982328138395591
CTACCTC_LET7A_LET7B_LET7C_LE...,SET,352,0.020797,0.0028505,0.045321,0.32316,CTACCTC_LET7A_LET7B_LET7C_LET7D_LET7E_LET7F_MIR98_LET7G_LET7I,0.982429887168722
NEUROD2_TARGET_GENES,SET,5,0.17463,0.00288,0.38061,0.32318,NEUROD2_TARGET_GENES,0.982429887168722
WP_MFAP5_EFFECT_ON_PERMEABIL...,SET,17,0.098174,0.0029844,0.21411,0.32329,WP_MFAP5_EFFECT_ON_PERMEABILITY_AND_MOTILITY_OF_ENDOTHELIAL_CELLS_VIA_CYTOSKELETON_REARRANGEMENT,0.982622780935724
REACTOME_RECOGNITION_OF_DNA_...,SET,28,0.0692,0.0026989,0.15093,0.3233,REACTOME_RECOGNITION_OF_DNA_DAMAGE_BY_PCNA_CONTAINING_REPLICATION_COMPLEX,0.982622780935724
HP_ABNORMAL_CSF_LACTATE_CONC...,SET,82,0.039224,0.0026141,0.085583,0.32337,HP_ABNORMAL_CSF_LACTATE_CONCENTRATION,0.9826238834018
GOMF_PROTEIN_GLUTAMIC_ACID_L...,SET,9,0.13745,0.003041,0.29996,0.32339,GOMF_PROTEIN_GLUTAMIC_ACID_LIGASE_ACTIVITY,0.9826238834018
GOBP_CRISTAE_FORMATION,SET,15,0.1007,0.0028755,0.21979,0.32342,GOBP_CRISTAE_FORMATION,0.9826238834018
chr2p24,SET,26,0.1283,0.0048222,0.28008,0.32345,chr2p24,0.9826238834018
VALK_AML_CLUSTER_8,SET,23,0.08288,0.0029301,0.18093,0.32345,VALK_AML_CLUSTER_8,0.9826238834018
GOBP_POSITIVE_REGULATION_OF_...481,SET,1057,0.01249,0.0029079,0.027269,0.32347,GOBP_POSITIVE_REGULATION_OF_MOLECULAR_FUNCTION,0.9826238834018
GOBP_MICROGLIAL_CELL_PROLIFE...,SET,7,0.16486,0.0032169,0.36003,0.32351,GOBP_MICROGLIAL_CELL_PROLIFERATION,0.982659504457263
GOBP_REGULATION_OF_SIGNAL_TR...,SET,95,0.039314,0.0028192,0.08591,0.32362,GOBP_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,0.982672141236034
HARRIS_HYPOXIA,SET,74,0.048826,0.003092,0.10672,0.32365,HARRIS_HYPOXIA,0.982672141236034
GOBP_BILE_ACID_METABOLIC_PRO...,SET,49,0.05831,0.0030068,0.12745,0.32365,GOBP_BILE_ACID_METABOLIC_PROCESS,0.982672141236034
GOMF_GANGLIOSIDE_BINDING,SET,5,0.19424,0.0032033,0.42456,0.32366,GOMF_GANGLIOSIDE_BINDING,0.982672141236034
GOMF_CCR5_CHEMOKINE_RECEPTOR...,SET,7,0.16001,0.0031221,0.34982,0.3237,GOMF_CCR5_CHEMOKINE_RECEPTOR_BINDING,0.982672141236034
PAX_Q6,SET,227,0.027215,0.0030058,0.059506,0.32372,PAX_Q6,0.982672141236034
GOBP_REGULATION_OF_VASCULAR_...5,SET,45,0.061796,0.003054,0.13519,0.3238,GOBP_REGULATION_OF_VASCULAR_PERMEABILITY,0.982672141236034
HP_WIDE_MOUTH,SET,188,0.027725,0.0027897,0.060661,0.32382,HP_WIDE_MOUTH,0.982672141236034
MARSON_BOUND_BY_E2F4_UNSTIMU...,SET,613,0.016,0.0028729,0.03501,0.32383,MARSON_BOUND_BY_E2F4_UNSTIMULATED,0.982672141236034
HP_ABNORMAL_LEUKOCYTE_COUNT,SET,436,0.018519,0.0028184,0.04053,0.32386,HP_ABNORMAL_LEUKOCYTE_COUNT,0.982672141236034
GOBP_CHIASMA_ASSEMBLY,SET,6,0.13157,0.0023768,0.28796,0.32387,GOBP_CHIASMA_ASSEMBLY,0.982672141236034
GOBP_POSITIVE_REGULATION_OF_...423,SET,4,0.17573,0.0025921,0.38466,0.3239,GOBP_POSITIVE_REGULATION_OF_LYMPHOCYTE_ANERGY,0.982672141236034
HP_SKIN_RASH,SET,148,0.033188,0.0029661,0.072647,0.3239,HP_SKIN_RASH,0.982672141236034
BRACHAT_RESPONSE_TO_METHOTRE...2,SET,18,0.081593,0.0025522,0.17862,0.32391,BRACHAT_RESPONSE_TO_METHOTREXATE_UP,0.982672141236034
GOCC_INTERCELLULAR_BRIDGE,SET,83,0.040412,0.0027096,0.088488,0.32395,GOCC_INTERCELLULAR_BRIDGE,0.982707711442786
GOMF_TESTOSTERONE_DEHYDROGEN...1,SET,7,0.13628,0.0026592,0.2987,0.32411,GOMF_TESTOSTERONE_DEHYDROGENASE_NADPLUS_ACTIVITY,0.982829785938044
JIANG_AGING_HYPOTHALAMUS_UP,SET,39,0.058436,0.002689,0.12809,0.32412,JIANG_AGING_HYPOTHALAMUS_UP,0.982829785938044
HP_DYSGYRIA,SET,7,0.1414,0.002759,0.30995,0.32413,HP_DYSGYRIA,0.982829785938044
HP_GENERALIZED_AMYLOID_DEPOS...,SET,6,0.16295,0.0029437,0.35724,0.32415,HP_GENERALIZED_AMYLOID_DEPOSITION,0.982829785938044
GOBP_P_BODY_ASSEMBLY,SET,21,0.077629,0.0026225,0.17025,0.32421,GOBP_P_BODY_ASSEMBLY,0.982829785938044
LHX3_TARGET_GENES,SET,18,0.096798,0.0030278,0.21235,0.32426,LHX3_TARGET_GENES,0.982829785938044
GOBP_MITOCHONDRIAL_TRANSLATI...1,SET,122,0.031571,0.0025637,0.06927,0.32428,GOBP_MITOCHONDRIAL_TRANSLATION,0.982829785938044
GSE2128_C57BL6_VS_NOD_THYMOC...3,SET,183,0.028806,0.00286,0.063227,0.32435,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_UP,0.982829785938044
HAY_BONE_MARROW_EOSINOPHIL,SET,41,0.060712,0.0028643,0.13328,0.32437,HAY_BONE_MARROW_EOSINOPHIL,0.982829785938044
GOBP_NEGATIVE_REGULATION_OF_...706,SET,10,0.13566,0.0031635,0.29784,0.32438,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,0.982829785938044
HP_ABSENCE_OF_SECONDARY_SEX_...,SET,40,0.064174,0.0029906,0.1409,0.3244,HP_ABSENCE_OF_SECONDARY_SEX_CHARACTERISTICS,0.982829785938044
GOBP_RETROGRADE_TRANS_SYNAPT...2,SET,5,0.18777,0.0030967,0.41234,0.32442,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING_BY_LIPID,0.982829785938044
GOMF_MONOAMINE_TRANSMEMBRANE...,SET,12,0.12232,0.0031245,0.26869,0.32447,GOMF_MONOAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.982829785938044
MIR513C_5P,SET,164,0.029961,0.0028176,0.065828,0.3245,MIR513C_5P,0.982829785938044
GSE37301_COMMON_LYMPHOID_PRO...5,SET,177,0.027773,0.0027124,0.061022,0.32451,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_DN,0.982829785938044
GSE14000_TRANSLATED_RNA_VS_M...4,SET,174,0.027347,0.0026483,0.060089,0.32452,GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP,0.982829785938044
GOMF_DNA_N_GLYCOSYLASE_ACTIV...,SET,14,0.097534,0.0026909,0.21435,0.32455,GOMF_DNA_N_GLYCOSYLASE_ACTIVITY,0.982829785938044
HP_PROGRESSIVE_NEUROLOGIC_DE...,SET,62,0.046129,0.0026747,0.10139,0.32458,HP_PROGRESSIVE_NEUROLOGIC_DETERIORATION,0.982829785938044
GOBP_DISRUPTION_OF_CELLULAR_...,SET,3,0.28895,0.0036914,0.63517,0.32459,GOBP_DISRUPTION_OF_CELLULAR_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.982829785938044
MIR596,SET,29,0.070807,0.0028104,0.15569,0.32463,MIR596,0.982829785938044
GOMF_INTERLEUKIN_17_RECEPTOR...,SET,8,0.14644,0.0030547,0.32201,0.32463,GOMF_INTERLEUKIN_17_RECEPTOR_ACTIVITY,0.982829785938044
BROWNE_HCMV_INFECTION_1HR_UP,SET,47,0.057686,0.0029134,0.12685,0.32465,BROWNE_HCMV_INFECTION_1HR_UP,0.982829785938044
HP_AXIAL_DYSTONIA,SET,15,0.095644,0.0027313,0.2104,0.3247,HP_AXIAL_DYSTONIA,0.982829785938044
MIR6729_5P,SET,9,0.11466,0.0025367,0.25229,0.32474,MIR6729_5P,0.982829785938044
GSE19888_ADENOSINE_A3R_ACT_V...5,SET,160,0.028621,0.0026588,0.062981,0.32476,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_IN_MAST_CELL_DN,0.982829785938044
GOBP_CELLULAR_RESPONSE_TO_VA...,SET,61,0.052961,0.003046,0.11657,0.3248,GOBP_CELLULAR_RESPONSE_TO_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_STIMULUS,0.982829785938044
GSE41176_UNSTIM_VS_ANTI_IGM_...14,SET,179,0.028275,0.0027768,0.062241,0.32482,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_UP,0.982829785938044
GOBP_REGULATION_OF_GAMMA_AMI...,SET,8,0.1494,0.0031163,0.32889,0.32483,GOBP_REGULATION_OF_GAMMA_AMINOBUTYRIC_ACID_SECRETION,0.982829785938044
GSE39382_IL3_VS_IL3_IL33_TRE...1,SET,177,0.029647,0.0028954,0.065275,0.32485,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_DN,0.982829785938044
HP_PREMATURE_RUPTURE_OF_MEMB...,SET,15,0.089393,0.0025528,0.19688,0.3249,HP_PREMATURE_RUPTURE_OF_MEMBRANES,0.982829785938044
MIR676_5P,SET,141,0.033407,0.0029148,0.07358,0.32491,MIR676_5P,0.982829785938044
GOMF_OXIDOREDUCTASE_ACTIVITY...6,SET,127,0.036751,0.0030445,0.080945,0.32491,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OH_GROUP_OF_DONORS,0.982829785938044
HP_PSEUDOEPIPHYSES,SET,17,0.09722,0.0029554,0.21418,0.32495,HP_PSEUDOEPIPHYSES,0.982829785938044
GOBP_POSITIVE_REGULATION_OF_...408,SET,48,0.057332,0.0029261,0.12632,0.32496,GOBP_POSITIVE_REGULATION_OF_LIPASE_ACTIVITY,0.982829785938044
GOBP_REGULATION_OF_APOPTOTIC...2,SET,9,0.12947,0.0028642,0.28528,0.32498,GOBP_REGULATION_OF_APOPTOTIC_DNA_FRAGMENTATION,0.982829785938044
LAKE_ADULT_KIDNEY_C3_PROXIMA...,SET,194,0.028928,0.0029564,0.063778,0.32507,LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2,0.982866201408818
HP_Y_SHAPED_METACARPALS,SET,12,0.089257,0.00228,0.19681,0.32509,HP_Y_SHAPED_METACARPALS,0.982866201408818
GSE9960_GRAM_NEG_VS_GRAM_NEG...2,SET,151,0.030899,0.0027892,0.068154,0.32514,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,0.982866201408818
GOBP_POSITIVE_REGULATION_OF_...685,SET,9,0.1203,0.0026616,0.26538,0.32516,GOBP_POSITIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,0.982866201408818
REACTOME_NEUTROPHIL_DEGRANUL...,SET,439,0.018686,0.0028533,0.041229,0.32519,REACTOME_NEUTROPHIL_DEGRANULATION,0.982866201408818
WP_AMINO_ACID_METABOLISM_IN_...,SET,7,0.14728,0.0028737,0.32494,0.32519,WP_AMINO_ACID_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,0.982866201408818
GOBP_REGULATION_OF_FILOPODIU...,SET,41,0.06495,0.0030643,0.1433,0.32519,GOBP_REGULATION_OF_FILOPODIUM_ASSEMBLY,0.982866201408818
GSE32986_GMCSF_VS_GMCSF_AND_...4,SET,171,0.029049,0.002789,0.064109,0.32523,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,0.98290162173913
chr5q11,SET,34,0.11533,0.0049561,0.25471,0.32534,chr5q11,0.982903522411397
GSE43863_TH1_VS_TFH_MEMORY_C...2,SET,179,0.027815,0.0027317,0.061425,0.32534,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_UP,0.982903522411397
LEE_LIVER_CANCER_DENA_DN,SET,71,0.045694,0.0028346,0.10093,0.32538,LEE_LIVER_CANCER_DENA_DN,0.982903522411397
HP_HYPERKERATOSIS,SET,212,0.026129,0.0027901,0.057717,0.32538,HP_HYPERKERATOSIS,0.982903522411397
GOBP_DEOXYRIBONUCLEOSIDE_MON...1,SET,8,0.12361,0.0025784,0.27316,0.32545,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.982903522411397
AP1FJ_Q2,SET,248,0.024942,0.0028777,0.055121,0.32546,AP1FJ_Q2,0.982903522411397
GSE10325_CD4_TCELL_VS_LUPUS_...2,SET,183,0.027664,0.0027467,0.061146,0.32548,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_UP,0.982903522411397
GOBP_CELLULAR_RESPONSE_TO_AM...2,SET,40,0.06483,0.0030211,0.14331,0.3255,GOBP_CELLULAR_RESPONSE_TO_AMYLOID_BETA,0.982903522411397
POS_RESPONSE_TO_HISTAMINE_UP,SET,11,0.10657,0.0026064,0.23562,0.32553,POS_RESPONSE_TO_HISTAMINE_UP,0.982903522411397
REACTOME_PARASITE_INFECTION,SET,56,0.049133,0.002708,0.10864,0.32555,REACTOME_PARASITE_INFECTION,0.982903522411397
GOMF_CYCLASE_REGULATOR_ACTIV...,SET,15,0.10633,0.0030365,0.23513,0.32555,GOMF_CYCLASE_REGULATOR_ACTIVITY,0.982903522411397
DAZARD_UV_RESPONSE_CLUSTER_G2,SET,25,0.08283,0.0030528,0.18318,0.32557,DAZARD_UV_RESPONSE_CLUSTER_G2,0.982903522411397
GSE22140_HEALTHY_VS_ARTHRITI...4,SET,178,0.028067,0.0027488,0.062087,0.32561,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_UP,0.982904027020005
GOBP_METANEPHRIC_GLOMERULAR_...,SET,5,0.20378,0.0033607,0.4509,0.32566,GOBP_METANEPHRIC_GLOMERULAR_MESANGIUM_DEVELOPMENT,0.982904027020005
MIR4693_5P,SET,100,0.038488,0.0028312,0.08519,0.32571,MIR4693_5P,0.982904027020005
WP_OMEGA6FATTY_ACIDS_IN_SENE...,SET,55,0.053071,0.0028989,0.11747,0.32572,WP_OMEGA6FATTY_ACIDS_IN_SENESCENCE,0.982904027020005
REACTOME_TRANSPORT_OF_FATTY_...,SET,8,0.12841,0.0026786,0.28433,0.32577,REACTOME_TRANSPORT_OF_FATTY_ACIDS,0.982904027020005
GOBP_NEGATIVE_REGULATION_OF_...287,SET,4,0.18595,0.0027429,0.41179,0.3258,GOBP_NEGATIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,0.982904027020005
HP_PLEURITIS,SET,26,0.08216,0.003088,0.18195,0.3258,HP_PLEURITIS,0.982904027020005
MIR7703,SET,101,0.038158,0.0028209,0.08454,0.32587,MIR7703,0.982904027020005
GOBP_CELLULAR_RESPONSE_TO_KE...,SET,97,0.040297,0.0029198,0.089303,0.32591,GOBP_CELLULAR_RESPONSE_TO_KETONE,0.982904027020005
HP_APLASIA_HYPOPLASIA_OF_THE...56,SET,200,0.027591,0.0028625,0.061164,0.32596,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_HAND,0.982904027020005
HP_MUSCLE_FIBER_CYTOPLASMATI...,SET,29,0.069617,0.0027632,0.15432,0.32596,HP_MUSCLE_FIBER_CYTOPLASMATIC_INCLUSION_BODIES,0.982904027020005
MIR2110,SET,160,0.029622,0.0027518,0.06569,0.32602,MIR2110,0.982904027020005
GOBP_MITOCHONDRIAL_TRANSPORT,SET,164,0.028833,0.0027114,0.063945,0.32604,GOBP_MITOCHONDRIAL_TRANSPORT,0.982904027020005
GOBP_SHORT_TERM_MEMORY,SET,10,0.11606,0.0027065,0.25745,0.32607,GOBP_SHORT_TERM_MEMORY,0.982904027020005
E12_Q6,SET,245,0.024257,0.0027819,0.053812,0.32608,E12_Q6,0.982904027020005
WP_ADIPOGENESIS,SET,125,0.036499,0.0029998,0.080986,0.32611,WP_ADIPOGENESIS,0.982904027020005
MIR5583_5P,SET,93,0.040628,0.0028827,0.090161,0.32614,MIR5583_5P,0.982904027020005
GSE14769_UNSTIM_VS_80MIN_LPS...1,SET,188,0.029879,0.0030065,0.066332,0.3262,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_DN,0.982904027020005
GOBP_PIGMENT_GRANULE_MATURAT...,SET,10,0.12443,0.0029017,0.27626,0.32621,GOBP_PIGMENT_GRANULE_MATURATION,0.982904027020005
BIOCARTA_RANMS_PATHWAY,SET,10,0.1151,0.0026841,0.25565,0.32627,BIOCARTA_RANMS_PATHWAY,0.982904027020005
GOBP_ATTACHMENT_OF_GPI_ANCHO...,SET,6,0.12704,0.0022949,0.28216,0.32628,GOBP_ATTACHMENT_OF_GPI_ANCHOR_TO_PROTEIN,0.982904027020005
GOBP_NATURAL_KILLER_CELL_DEG...,SET,10,0.11743,0.0027384,0.26083,0.32628,GOBP_NATURAL_KILLER_CELL_DEGRANULATION,0.982904027020005
HEBERT_MATRISOME_TNBC_BRAIN_...2,SET,9,0.13208,0.0029221,0.29343,0.32631,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS_TUMOR_CELL_DERIVED,0.982904027020005
WP_METABOLISM_OF_SPHINGOLIPI...,SET,21,0.086733,0.0029301,0.19271,0.32633,WP_METABOLISM_OF_SPHINGOLIPIDS_IN_ER_AND_GOLGI_APPARATUS,0.982904027020005
PARK_TRETINOIN_RESPONSE_AND_...2,SET,20,0.093835,0.0030937,0.2085,0.32634,PARK_TRETINOIN_RESPONSE_AND_RARA_PLZF_FUSION,0.982904027020005
GOBP_RECEPTOR_METABOLIC_PROC...,SET,67,0.045273,0.0027285,0.10062,0.32638,GOBP_RECEPTOR_METABOLIC_PROCESS,0.982904027020005
MIR1468_5P,SET,14,0.097461,0.0026889,0.21662,0.32639,MIR1468_5P,0.982904027020005
HP_ANTI_ACETYLCHOLINE_RECEPT...,SET,21,0.082543,0.0027886,0.18349,0.32641,HP_ANTI_ACETYLCHOLINE_RECEPTOR_ANTIBODY_POSITIVITY,0.982904027020005
HOEK_T_CELL_2011_2012_TIV_AD...1,SET,4,0.19934,0.0029405,0.44323,0.32645,HOEK_T_CELL_2011_2012_TIV_ADULT_1DY_DN,0.982904027020005
GSE19923_WT_VS_HEB_KO_DP_THY...1,SET,180,0.027527,0.0027108,0.06121,0.32646,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_DN,0.982904027020005
HP_SUBMUCOUS_CLEFT_SOFT_PALA...,SET,9,0.11883,0.002629,0.26432,0.32651,HP_SUBMUCOUS_CLEFT_SOFT_PALATE,0.982904027020005
HE_LIM_SUN_FETAL_LUNG_C7_PRO...,SET,909,0.012523,0.0027153,0.027857,0.32652,HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL,0.982904027020005
HP_NEOPLASM_OF_THE_MALE_EXTE...,SET,32,0.072351,0.0030164,0.16095,0.32653,HP_NEOPLASM_OF_THE_MALE_EXTERNAL_GENITALIA,0.982904027020005
REACTOME_DNA_REPLICATION,SET,122,0.030775,0.002499,0.068475,0.32656,REACTOME_DNA_REPLICATION,0.982904027020005
GOBP_MEIOTIC_METAPHASE_CHROM...,SET,3,0.20456,0.0026133,0.45514,0.32656,GOBP_MEIOTIC_METAPHASE_CHROMOSOME_ALIGNMENT,0.982904027020005
GOBP_NEGATIVE_REGULATION_OF_...251,SET,24,0.086081,0.0031086,0.19159,0.32661,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.982969392968479
RASHI_RESPONSE_TO_IONIZING_R...5,SET,126,0.033186,0.0027383,0.073892,0.32668,RASHI_RESPONSE_TO_IONIZING_RADIATION_5,0.983045069690936
GOBP_POSITIVE_REGULATION_OF_...679,SET,576,0.016254,0.0028321,0.036201,0.32672,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,0.983045069690936
GSE3982_DC_VS_NEUTROPHIL_UP,SET,181,0.028006,0.0027655,0.062372,0.32672,GSE3982_DC_VS_NEUTROPHIL_UP,0.983045069690936
GOBP_PML_BODY_ORGANIZATION,SET,6,0.1503,0.0027152,0.33482,0.32676,GOBP_PML_BODY_ORGANIZATION,0.983080315096953
GOBP_POSITIVE_REGULATION_OF_...87,SET,9,0.14878,0.0032916,0.33157,0.32682,GOBP_POSITIVE_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.983175720592054
MIR655_3P,SET,382,0.020018,0.0028557,0.044639,0.32692,MIR655_3P,0.983346668685645
HP_ADENOMA_SEBACEUM,SET,26,0.067674,0.0025435,0.15092,0.32694,HP_ADENOMA_SEBACEUM,0.983346668685645
GOBP_POSITIVE_REGULATION_OF_...443,SET,12,0.10479,0.0026767,0.23375,0.32697,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,0.983346668685645
GOBP_REGULATION_OF_PROTEOLYS...1,SET,528,0.0169,0.0028231,0.037702,0.32699,GOBP_REGULATION_OF_PROTEOLYSIS,0.983346668685645
GSE360_T_GONDII_VS_B_MALAYI_...7,SET,184,0.026917,0.0026797,0.060061,0.32702,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_DN,0.983351799619311
GOMF_UBIQUITIN_LIKE_PROTEIN_...5,SET,291,0.021682,0.0027066,0.048394,0.32707,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_BINDING,0.983362058823529
PEDERSEN_METASTASIS_BY_ERBB2...4,SET,11,0.1267,0.0030988,0.28281,0.32708,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_5,0.983362058823529
GSE17721_LPS_VS_PAM3CSK4_4H_...1,SET,188,0.025043,0.0025198,0.055929,0.32717,GSE17721_LPS_VS_PAM3CSK4_4H_BMDC_DN,0.983386040193203
GSE5589_WT_VS_IL6_KO_LPS_AND...5,SET,178,0.028404,0.0027817,0.063447,0.3272,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,0.983386040193203
GSE13411_NAIVE_BCELL_VS_PLAS...1,SET,166,0.029156,0.0027584,0.06514,0.32722,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_DN,0.983386040193203
ZHENG_FOXP3_TARGETS_UP,SET,24,0.082058,0.0029633,0.18346,0.32734,ZHENG_FOXP3_TARGETS_UP,0.983386040193203
HP_FOCAL_TONIC_SEIZURE,SET,28,0.072504,0.0028278,0.1621,0.32734,HP_FOCAL_TONIC_SEIZURE,0.983386040193203
GOCC_EGG_COAT,SET,5,0.14828,0.0024455,0.33158,0.32737,GOCC_EGG_COAT,0.983386040193203
GSE20727_CTRL_VS_H2O2_TREATE...2,SET,179,0.027438,0.0026946,0.061369,0.3274,GSE20727_CTRL_VS_H2O2_TREATED_DC_UP,0.983386040193203
GSE32255_UNSTIM_VS_4H_LPS_ST...2,SET,172,0.029447,0.0028353,0.065874,0.32743,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_UP,0.983386040193203
GOBP_REGULATION_OF_DOUBLE_ST...2,SET,68,0.041887,0.0025432,0.093766,0.32754,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.983386040193203
GSE3982_MAC_VS_CENT_MEMORY_C...2,SET,179,0.027121,0.0026635,0.060722,0.32757,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_UP,0.983386040193203
HP_APLASIA_HYPOPLASIA_OF_THE...51,SET,17,0.091792,0.0027904,0.20555,0.3276,HP_APLASIA_HYPOPLASIA_OF_THE_PALMAR_CREASES,0.983386040193203
GOCC_CILIARY_BASE,SET,35,0.061796,0.0026941,0.13842,0.32764,GOCC_CILIARY_BASE,0.983386040193203
GSE43863_NAIVE_VS_MEMORY_TFH...1,SET,183,0.027641,0.0027444,0.061922,0.32766,GSE43863_NAIVE_VS_MEMORY_TFH_CD4_TCELL_D150_LCMV_DN,0.983386040193203
GOBP_NEGATIVE_REGULATION_OF_...140,SET,5,0.16559,0.0027308,0.371,0.32768,GOBP_NEGATIVE_REGULATION_OF_CHOLESTEROL_EFFLUX,0.983386040193203
GOBP_MONOTERPENOID_METABOLIC...,SET,6,0.13954,0.0025209,0.3127,0.32771,GOBP_MONOTERPENOID_METABOLIC_PROCESS,0.983386040193203
BIOCARTA_MPR_PATHWAY,SET,21,0.082708,0.0027942,0.18537,0.32774,BIOCARTA_MPR_PATHWAY,0.983386040193203
GOBP_NUCLEOSIDE_MONOPHOSPHAT...1,SET,36,0.061729,0.0027293,0.13836,0.32775,GOBP_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,0.983386040193203
GOBP_POSITIVE_REGULATION_OF_...487,SET,5,0.16202,0.002672,0.36318,0.32776,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.983386040193203
GSE27786_CD4_TCELL_VS_MONO_M...1,SET,180,0.027932,0.0027507,0.062616,0.32777,GSE27786_CD4_TCELL_VS_MONO_MAC_DN,0.983386040193203
REACTOME_INTERLEUKIN_27_SIGN...,SET,11,0.11867,0.0029023,0.26604,0.32778,REACTOME_INTERLEUKIN_27_SIGNALING,0.983386040193203
FAN_EMBRYONIC_CTX_BRAIN_EFFE...,SET,116,0.036792,0.0029137,0.082492,0.3278,FAN_EMBRYONIC_CTX_BRAIN_EFFECTOR_T_CELL,0.983386040193203
GOBP_NEGATIVE_REGULATION_OF_...434,SET,124,0.034657,0.002837,0.077707,0.32781,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,0.983386040193203
GSE10147_IL3_VS_IL3_AND_HIVP...1,SET,131,0.034233,0.0028798,0.076765,0.32782,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_DN,0.983386040193203
ZHAN_MULTIPLE_MYELOMA_MF_DN,SET,40,0.061047,0.0028448,0.1369,0.32784,ZHAN_MULTIPLE_MYELOMA_MF_DN,0.983386040193203
GSE7764_IL15_NK_CELL_24H_VS_...1,SET,176,0.027713,0.0026989,0.062154,0.32785,GSE7764_IL15_NK_CELL_24H_VS_SPLENOCYTE_DN,0.983386040193203
HP_ECLABION,SET,147,0.031951,0.002846,0.071664,0.32786,HP_ECLABION,0.983386040193203
GOBP_APPENDAGE_DEVELOPMENT,SET,173,0.030274,0.0029233,0.067914,0.32789,GOBP_APPENDAGE_DEVELOPMENT,0.983386040193203
PUJANA_ATM_PCC_NETWORK,SET,1244,0.010648,0.0026749,0.023893,0.32792,PUJANA_ATM_PCC_NETWORK,0.983386040193203
AIZARANI_LIVER_C9_LSECS_1,SET,280,0.023863,0.0029229,0.053568,0.32799,AIZARANI_LIVER_C9_LSECS_1,0.983386040193203
GOBP_REGULATION_OF_NATURAL_K...5,SET,49,0.057982,0.0029898,0.13017,0.32801,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,0.983386040193203
BIOCARTA_CD40_PATHWAY,SET,12,0.11274,0.0028799,0.25317,0.32804,BIOCARTA_CD40_PATHWAY,0.983386040193203
GOBP_HARD_PALATE_DEVELOPMENT,SET,8,0.16494,0.0034405,0.37039,0.32805,GOBP_HARD_PALATE_DEVELOPMENT,0.983386040193203
GOBP_POSITIVE_REGULATION_OF_...270,SET,9,0.12043,0.0026643,0.27044,0.32805,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,0.983386040193203
HP_HEADACHE,SET,298,0.022024,0.0027816,0.049456,0.32805,HP_HEADACHE,0.983386040193203
GOBP_POSITIVE_REGULATION_OF_...645,SET,81,0.040327,0.0026713,0.090591,0.3281,GOBP_POSITIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,0.983401371044236
MIR3159,SET,84,0.043085,0.0029061,0.096804,0.32814,MIR3159,0.983401371044236
GSE7460_CD8_TCELL_VS_CD4_TCE...1,SET,191,0.027566,0.0027955,0.061936,0.32814,GSE7460_CD8_TCELL_VS_CD4_TCELL_ACT_DN,0.983401371044236
MCCOLLUM_GELDANAMYCIN_RESIST...1,SET,7,0.15099,0.0029462,0.33941,0.32821,MCCOLLUM_GELDANAMYCIN_RESISTANCE_DN,0.983526345059493
FOROUTAN_PRODRANK_TGFB_EMT_UP,SET,178,0.029897,0.002928,0.067215,0.32824,FOROUTAN_PRODRANK_TGFB_EMT_UP,0.983531442365721
KANG_IMMORTALIZED_BY_TERT_UP,SET,82,0.043239,0.0028817,0.097311,0.3284,KANG_IMMORTALIZED_BY_TERT_UP,0.983607796624763
HP_ABNORMALITY_OF_THE_COMMON...,SET,61,0.049536,0.0028491,0.1115,0.32843,HP_ABNORMALITY_OF_THE_COMMON_COAGULATION_PATHWAY,0.983607796624763
GSE3982_EOSINOPHIL_VS_MAC_UP,SET,173,0.028486,0.0027507,0.064133,0.32846,GSE3982_EOSINOPHIL_VS_MAC_UP,0.983607796624763
GOMF_DYNEIN_INTERMEDIATE_CHA...,SET,31,0.065771,0.0026989,0.14812,0.32851,GOMF_DYNEIN_INTERMEDIATE_CHAIN_BINDING,0.983607796624763
MIR8061,SET,150,0.03185,0.0028656,0.071736,0.32853,MIR8061,0.983607796624763
KEGG_MEDICUS_REFERENCE_COMMO...,SET,7,0.14094,0.00275,0.31753,0.32858,KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION,0.983607796624763
GOCC_MEMBRANE_ATTACK_COMPLEX,SET,7,0.14094,0.00275,0.31753,0.32858,GOCC_MEMBRANE_ATTACK_COMPLEX,0.983607796624763
GOBP_LOW_DENSITY_LIPOPROTEIN...3,SET,6,0.16666,0.0030107,0.37551,0.32859,GOBP_LOW_DENSITY_LIPOPROTEIN_RECEPTOR_PARTICLE_METABOLIC_PROCESS,0.983607796624763
GOCC_ARP2_3_PROTEIN_COMPLEX,SET,9,0.11459,0.0025352,0.25819,0.32859,GOCC_ARP2_3_PROTEIN_COMPLEX,0.983607796624763
HUMMERICH_MALIGNANT_SKIN_TUM...1,SET,19,0.085011,0.0027319,0.19155,0.3286,HUMMERICH_MALIGNANT_SKIN_TUMOR_DN,0.983607796624763
REACTOME_P75NTR_RECRUITS_SIG...,SET,11,0.12116,0.0029632,0.27301,0.3286,REACTOME_P75NTR_RECRUITS_SIGNALLING_COMPLEXES,0.983607796624763
MIR3672,SET,41,0.058061,0.0027393,0.13087,0.32865,MIR3672,0.983607796624763
GOMF_CLATHRIN_BINDING,SET,53,0.051366,0.0027544,0.11579,0.32866,GOMF_CLATHRIN_BINDING,0.983607796624763
ELF2_TARGET_GENES,SET,1233,0.010874,0.0027204,0.024516,0.32869,ELF2_TARGET_GENES,0.983607796624763
GSE360_CTRL_VS_T_GONDII_DC_DN,SET,176,0.029543,0.0028772,0.06661,0.32869,GSE360_CTRL_VS_T_GONDII_DC_DN,0.983607796624763
HP_ELEVATED_SERUM_ACID_PHOSP...,SET,5,0.17398,0.0028693,0.39235,0.32872,HP_ELEVATED_SERUM_ACID_PHOSPHATASE,0.983612879896685
GOBP_SNO_S_RNA_PROCESSING,SET,9,0.10768,0.0023823,0.24286,0.32875,GOBP_SNO_S_RNA_PROCESSING,0.983617962293388
REACTOME_GRB7_EVENTS_IN_ERBB...,SET,5,0.18227,0.0030059,0.41125,0.32881,REACTOME_GRB7_EVENTS_IN_ERBB2_SIGNALING,0.983628124462042
HP_ENLARGED_KIDNEY,SET,41,0.057383,0.0027073,0.12947,0.32881,HP_ENLARGED_KIDNEY,0.983628124462042
CUX1_TARGET_GENES,SET,664,0.014623,0.0027287,0.033007,0.32888,CUX1_TARGET_GENES,0.983728012048193
GOMF_MYOSIN_PHOSPHATASE_ACTI...,SET,69,0.043428,0.0026559,0.098043,0.3289,GOMF_MYOSIN_PHOSPHATASE_ACTIVITY,0.983728012048193
GOBP_MEMBRANE_FUSION,SET,166,0.028752,0.0027201,0.06493,0.32895,GOBP_MEMBRANE_FUSION,0.983792896480509
MIR2115_3P,SET,215,0.026211,0.0028183,0.059202,0.32898,MIR2115_3P,0.983797960764068
GSE14350_IL2RB_KO_VS_WT_TEFF...1,SET,184,0.027192,0.0027071,0.06145,0.32906,GSE14350_IL2RB_KO_VS_WT_TEFF_DN,0.983952533769251
GOBP_PRIMITIVE_ERYTHROCYTE_D...,SET,4,0.22102,0.0032602,0.49975,0.32916,GOBP_PRIMITIVE_ERYTHROCYTE_DIFFERENTIATION,0.984166878871301
KEGG_DORSO_VENTRAL_AXIS_FORM...,SET,24,0.078492,0.0028346,0.17754,0.32921,KEGG_DORSO_VENTRAL_AXIS_FORMATION,0.984231703225806
GSE17721_0.5H_VS_12H_LPS_BMD...1,SET,185,0.026642,0.0026595,0.060274,0.32924,GSE17721_0.5H_VS_12H_LPS_BMDC_DN,0.984236728023396
GSE11864_UNTREATED_VS_CSF1_I...6,SET,167,0.028089,0.0026653,0.063568,0.32929,GSE11864_UNTREATED_VS_CSF1_IN_MAC_UP,0.984301535219747
MIR3129_3P,SET,94,0.039675,0.0028302,0.089817,0.32934,MIR3129_3P,0.9843115702124
GOBP_ACTIVATION_OF_CYSTEINE_...2,SET,68,0.047088,0.0028589,0.10661,0.32935,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,0.9843115702124
GSE22935_UNSTIM_VS_12H_MBOVI...2,SET,181,0.026763,0.0026428,0.06061,0.32941,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_UP,0.984406238177128
BUSSLINGER_DUODENAL_EARLY_IM...,SET,99,0.037433,0.0027399,0.084796,0.32945,BUSSLINGER_DUODENAL_EARLY_IMMATURE_ENTEROCYTES,0.984441127160176
GNF2_MCL1,SET,49,0.052549,0.0027097,0.11909,0.32952,GNF2_MCL1,0.984565646492435
HP_HIGH_PITCHED_VOICE,SET,41,0.059082,0.0027874,0.13397,0.32961,HP_HIGH_PITCHED_VOICE,0.984645350635957
HP_VEGETATIVE_STATE,SET,9,0.11912,0.0026354,0.27013,0.32962,HP_VEGETATIVE_STATE,0.984645350635957
GOBP_NEGATIVE_REGULATION_BY_...1,SET,8,0.1131,0.0023591,0.25651,0.32964,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,0.984645350635957
GOMF_EXTRACELLULARLY_ATP_GAT...,SET,7,0.15175,0.002961,0.34421,0.32966,GOMF_EXTRACELLULARLY_ATP_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.984645350635957
GSE11864_CSF1_IFNG_VS_CSF1_I...1,SET,167,0.028157,0.0026718,0.063891,0.32971,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,0.984710067027584
HP_INFERTILITY,SET,248,0.023176,0.0026739,0.052617,0.3298,HP_INFERTILITY,0.984774746650635
GOBP_CELLULAR_RESPONSE_TO_UV...2,SET,10,0.11584,0.0027013,0.26303,0.32983,GOBP_CELLULAR_RESPONSE_TO_UV_B,0.984774746650635
GOBP_MYELOID_LEUKOCYTE_ACTIV...,SET,224,0.026097,0.0028635,0.059264,0.32984,GOBP_MYELOID_LEUKOCYTE_ACTIVATION,0.984774746650635
MIR6076,SET,49,0.055709,0.0028727,0.12653,0.32987,MIR6076,0.984774746650635
DURANTE_ADULT_OLFACTORY_NEUR...5,SET,103,0.039181,0.0029249,0.088994,0.32988,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_DENDRITIC_CELLS,0.984774746650635
GOBP_SPECIFICATION_OF_SYMMET...,SET,131,0.032293,0.0027166,0.073367,0.32991,GOBP_SPECIFICATION_OF_SYMMETRY,0.984774746650635
GOBP_POSITIVE_REGULATION_OF_...299,SET,45,0.063065,0.0031168,0.14329,0.32993,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_DIFFERENTIATION,0.984774746650635
GOMF_NOTCH_BINDING,SET,22,0.074022,0.0025595,0.16827,0.33001,GOMF_NOTCH_BINDING,0.984928943752684
MIR556_5P,SET,39,0.05863,0.0026979,0.13331,0.33004,MIR556_5P,0.98493390005152
ZNF528_TARGET_GENES,SET,597,0.015287,0.0027101,0.034777,0.33012,ZNF528_TARGET_GENES,0.985008434200361
PID_NETRIN_PATHWAY,SET,32,0.06459,0.0026928,0.14695,0.33014,PID_NETRIN_PATHWAY,0.985008434200361
GAO_LARGE_INTESTINE_ADULT_CH...,SET,92,0.035746,0.0025228,0.081333,0.33015,GAO_LARGE_INTESTINE_ADULT_CH_MKI67HIGH_CELLS,0.985008434200361
GOCC_POSTSYNAPTIC_ENDOCYTIC_...,SET,5,0.17792,0.0029342,0.4049,0.33018,GOCC_POSTSYNAPTIC_ENDOCYTIC_ZONE,0.985013381974249
MODULE_188,SET,118,0.034503,0.0027558,0.078582,0.33031,MODULE_188,0.985087683334763
JONES_OVARY_STROMAL,SET,135,0.033956,0.0028995,0.077347,0.33033,JONES_OVARY_STROMAL,0.985087683334763
GSE3982_EFF_MEMORY_VS_CENT_M...2,SET,174,0.028224,0.0027331,0.064298,0.33035,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_UP,0.985087683334763
GOCC_PROTEIN_FOLDING_CHAPERO...,SET,40,0.051087,0.0023807,0.1164,0.33037,GOCC_PROTEIN_FOLDING_CHAPERONE_COMPLEX,0.985087683334763
MIR4677_5P,SET,233,0.024614,0.0027538,0.056099,0.33042,MIR4677_5P,0.985087683334763
WINNEPENNINCKX_MELANOMA_META...1,SET,38,0.062998,0.0028616,0.14359,0.33043,WINNEPENNINCKX_MELANOMA_METASTASIS_DN,0.985087683334763
HP_DEEP_PHILTRUM,SET,63,0.046455,0.0027152,0.10588,0.33043,HP_DEEP_PHILTRUM,0.985087683334763
chr2q33,SET,74,0.083326,0.0052767,0.18994,0.33044,chr2q33,0.985087683334763
GOBP_ENDONUCLEOLYTIC_CLEAVAG...2,SET,9,0.12014,0.0026579,0.27389,0.33046,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_ITS1_TO_SEPARATE_SSU_RRNA_FROM_5_8S_RRNA_AND_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.985087683334763
GOMF_PRERIBOSOME_BINDING,SET,6,0.16497,0.0029802,0.37616,0.33049,GOMF_PRERIBOSOME_BINDING,0.985092620068611
WP_IRON_METABOLISM_DISORDERS,SET,15,0.096703,0.0027615,0.22057,0.33054,WP_IRON_METABOLISM_DISORDERS,0.98515716490867
GOBP_BARBED_END_ACTIN_FILAME...,SET,21,0.079712,0.0026929,0.18192,0.33064,GOBP_BARBED_END_ACTIN_FILAMENT_CAPPING,0.985296056579511
HP_VERY_LONG_CHAIN_FATTY_ACI...,SET,15,0.09375,0.0026772,0.21399,0.33066,HP_VERY_LONG_CHAIN_FATTY_ACID_ACCUMULATION,0.985296056579511
GSE42088_UNINF_VS_LEISHMANIA...2,SET,183,0.027801,0.0027603,0.063466,0.33068,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_UP,0.985296056579511
HP_SYNOSTOSIS_OF_JOINTS,SET,171,0.028555,0.0027415,0.065196,0.3307,HP_SYNOSTOSIS_OF_JOINTS,0.985296056579511
GSE11961_MARGINAL_ZONE_BCELL...5,SET,185,0.026782,0.0026734,0.061166,0.33075,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_DN,0.985360556317504
HP_ABNORMAL_SYNAPTIC_TRANSMI...,SET,111,0.035025,0.0027137,0.080048,0.33086,HP_ABNORMAL_SYNAPTIC_TRANSMISSION_AT_THE_NEUROMUSCULAR_JUNCTION,0.985603779892003
GSE16385_IFNG_TNF_VS_UNSTIM_...2,SET,154,0.028641,0.0026107,0.065487,0.33093,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,0.985667273116438
GSE18281_PERIMEDULLARY_CORTI...2,SET,186,0.026288,0.0026311,0.060125,0.33098,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP,0.985667273116438
HP_EXERCISE_INDUCED_MUSCLE_C...,SET,14,0.086544,0.0023877,0.19799,0.33101,HP_EXERCISE_INDUCED_MUSCLE_CRAMPS,0.985667273116438
GSE7460_TCONV_VS_TREG_THYMUS...1,SET,185,0.028104,0.0028054,0.064302,0.33104,GSE7460_TCONV_VS_TREG_THYMUS_DN,0.985667273116438
GOBP_SUPEROXIDE_ANION_GENERA...,SET,36,0.065838,0.002911,0.15068,0.33108,GOBP_SUPEROXIDE_ANION_GENERATION,0.985667273116438
GSE18281_SUBCAPSULAR_CORTICA...4,SET,188,0.025241,0.0025397,0.057766,0.33108,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP,0.985667273116438
FOURNIER_ACINAR_DEVELOPMENT_...1,SET,6,0.16556,0.0029908,0.37912,0.33117,FOURNIER_ACINAR_DEVELOPMENT_EARLY_DN,0.985667273116438
GOBP_REGULATION_OF_CENTROMER...2,SET,4,0.18737,0.0027639,0.42917,0.33121,GOBP_REGULATION_OF_CENTROMERIC_SISTER_CHROMATID_COHESION,0.985667273116438
HP_DYNEIN_ARM_DEFECT_OF_RESP...,SET,14,0.086056,0.0023742,0.19711,0.33121,HP_DYNEIN_ARM_DEFECT_OF_RESPIRATORY_MOTILE_CILIA,0.985667273116438
GSE13484_UNSTIM_VS_12H_YF17D...1,SET,177,0.026724,0.00261,0.061217,0.33122,GSE13484_UNSTIM_VS_12H_YF17D_VACCINE_STIM_PBMC_DN,0.985667273116438
DELACROIX_RAR_BOUND_ES,SET,411,0.018664,0.0027596,0.042758,0.33124,DELACROIX_RAR_BOUND_ES,0.985667273116438
KEGG_MEDICUS_VARIANT_DUPLICA...2,SET,13,0.099856,0.0026548,0.22876,0.33124,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_ERK_SIGNALING_PATHWAY,0.985667273116438
GOMF_CALCIUM_CHANNEL_INHIBIT...,SET,12,0.11262,0.0028767,0.25802,0.33125,GOMF_CALCIUM_CHANNEL_INHIBITOR_ACTIVITY,0.985667273116438
HP_SUPERNUMERARY_TOOTH,SET,44,0.056625,0.0027673,0.12981,0.33134,HP_SUPERNUMERARY_TOOTH,0.985782494454871
REACTOME_NUCLEAR_IMPORT_OF_R...,SET,32,0.061543,0.0025658,0.14111,0.33137,REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN,0.985782494454871
GSE27786_CD4_TCELL_VS_NEUTRO...1,SET,181,0.027727,0.002738,0.063597,0.33143,GSE27786_CD4_TCELL_VS_NEUTROPHIL_DN,0.985782494454871
GOBP_RECEPTOR_LOCALIZATION_T...1,SET,4,0.17552,0.0025891,0.40267,0.33146,GOBP_RECEPTOR_LOCALIZATION_TO_NON_MOTILE_CILIUM,0.985782494454871
HP_ABNORMALITY_OF_THYROID_PH...,SET,347,0.020073,0.002732,0.046056,0.33148,HP_ABNORMALITY_OF_THYROID_PHYSIOLOGY,0.985782494454871
HP_OVERGROWTH,SET,37,0.057904,0.0025955,0.13287,0.33149,HP_OVERGROWTH,0.985782494454871
GSE21063_WT_VS_NFATC1_KO_16H...1,SET,164,0.031686,0.0029798,0.072717,0.33151,GSE21063_WT_VS_NFATC1_KO_16H_ANTI_IGM_STIM_BCELL_DN,0.985782494454871
REACTOME_ERYTHROCYTES_TAKE_U...2,SET,7,0.14879,0.0029031,0.34147,0.33152,REACTOME_ERYTHROCYTES_TAKE_UP_OXYGEN_AND_RELEASE_CARBON_DIOXIDE,0.985782494454871
KEGG_DILATED_CARDIOMYOPATHY,SET,85,0.041436,0.0028114,0.09514,0.33159,KEGG_DILATED_CARDIOMYOPATHY,0.985782494454871
HP_DISPLACEMENT_OF_THE_URETH...,SET,315,0.020115,0.0026108,0.046201,0.33164,HP_DISPLACEMENT_OF_THE_URETHRAL_MEATUS,0.985782494454871
GSE14308_TH1_VS_TH17_DN,SET,176,0.026271,0.0025585,0.060359,0.33169,GSE14308_TH1_VS_TH17_DN,0.985782494454871
GOBP_FC_RECEPTOR_SIGNALING_P...,SET,53,0.054391,0.0029166,0.12504,0.33179,GOBP_FC_RECEPTOR_SIGNALING_PATHWAY,0.985782494454871
GOBP_REGULATION_OF_T_HELPER_...4,SET,11,0.12312,0.0030111,0.28304,0.33179,GOBP_REGULATION_OF_T_HELPER_1_CELL_DIFFERENTIATION,0.985782494454871
GOBP_NEGATIVE_REGULATION_OF_...365,SET,14,0.096824,0.0026713,0.22263,0.33182,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_MIGRATION,0.985782494454871
MIR6806_5P,SET,63,0.045821,0.0026781,0.10536,0.33183,MIR6806_5P,0.985782494454871
GOMF_INOSITOL_BISPHOSPHATE_P...,SET,7,0.12775,0.0024928,0.29382,0.33186,GOMF_INOSITOL_BISPHOSPHATE_PHOSPHATASE_ACTIVITY,0.985782494454871
GOBP_POSITIVE_REGULATION_OF_...133,SET,70,0.05097,0.0031396,0.11723,0.33187,GOBP_POSITIVE_REGULATION_OF_CELL_KILLING,0.985782494454871
HP_REDUCED_ANTIGEN_SPECIFIC_...,SET,8,0.12316,0.002569,0.28328,0.33187,HP_REDUCED_ANTIGEN_SPECIFIC_T_CELL_PROLIFERATION,0.985782494454871
GSE9316_IL6_KO_VS_IFNG_KO_IN...1,SET,188,0.027489,0.0027659,0.063258,0.33195,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_DN,0.985782494454871
GOBP_RESPONSE_TO_INSULIN,SET,251,0.023107,0.0026818,0.053182,0.33197,GOBP_RESPONSE_TO_INSULIN,0.985782494454871
MIR3123,SET,229,0.024871,0.0027588,0.057244,0.33198,MIR3123,0.985782494454871
REACTOME_MAPK_FAMILY_SIGNALI...,SET,308,0.020769,0.002666,0.047812,0.33201,REACTOME_MAPK_FAMILY_SIGNALING_CASCADES,0.985782494454871
GOBP_IRON_IMPORT_INTO_CELL,SET,9,0.11397,0.0025214,0.26239,0.33202,GOBP_IRON_IMPORT_INTO_CELL,0.985782494454871
GOBP_NEGATIVE_REGULATION_OF_...102,SET,197,0.027877,0.0028706,0.064179,0.33202,GOBP_NEGATIVE_REGULATION_OF_CELL_ACTIVATION,0.985782494454871
chr13q34,SET,34,0.10663,0.0045821,0.24556,0.33206,chr13q34,0.985782494454871
GOBP_ENDOTHELIUM_DEVELOPMENT,SET,129,0.034455,0.0028764,0.079371,0.33211,GOBP_ENDOTHELIUM_DEVELOPMENT,0.985782494454871
HP_NECK_PAIN,SET,5,0.17874,0.0029477,0.41175,0.33211,HP_NECK_PAIN,0.985782494454871
HU_GENOTOXIC_DAMAGE_24HR,SET,31,0.063101,0.0025893,0.14538,0.33214,HU_GENOTOXIC_DAMAGE_24HR,0.985782494454871
HP_FATIGABLE_WEAKNESS_OF_SKE...,SET,42,0.053021,0.0025317,0.12217,0.33214,HP_FATIGABLE_WEAKNESS_OF_SKELETAL_MUSCLES,0.985782494454871
ZNF292_TARGET_GENES,SET,21,0.074735,0.0025248,0.17226,0.3322,ZNF292_TARGET_GENES,0.985782494454871
HP_ABNORMALITY_OF_THE_ABDOMI...1,SET,1202,0.010806,0.0026715,0.024913,0.33224,HP_ABNORMALITY_OF_THE_ABDOMINAL_ORGANS,0.985782494454871
GSE1460_DP_THYMOCYTE_VS_THYM...1,SET,174,0.026658,0.0025816,0.06147,0.33226,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,0.985782494454871
HP_SENILE_PLAQUES,SET,11,0.11196,0.0027381,0.25817,0.33227,HP_SENILE_PLAQUES,0.985782494454871
GOCC_MICROVESICLE,SET,8,0.13847,0.0028883,0.31942,0.33233,GOCC_MICROVESICLE,0.985782494454871
WP_TRYPTOPHAN_CATABOLISM_LEA...,SET,16,0.095062,0.0028036,0.2193,0.33234,WP_TRYPTOPHAN_CATABOLISM_LEADING_TO_NAD_PRODUCTION,0.985782494454871
GOMF_CAMP_DEPENDENT_PROTEIN_...2,SET,10,0.11765,0.0027435,0.27144,0.33236,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_INHIBITOR_ACTIVITY,0.985782494454871
AIZARANI_LIVER_C7_EPCAM_POS_...,SET,206,0.027513,0.0028964,0.063482,0.33236,AIZARANI_LIVER_C7_EPCAM_POS_BILE_DUCT_CELLS_2,0.985782494454871
PID_IL12_STAT4_PATHWAY,SET,32,0.065772,0.0027421,0.15182,0.33243,PID_IL12_STAT4_PATHWAY,0.985782494454871
GOBP_AMYLOID_PRECURSOR_PROTE...3,SET,71,0.042521,0.0026377,0.098154,0.33243,GOBP_AMYLOID_PRECURSOR_PROTEIN_METABOLIC_PROCESS,0.985782494454871
GOBP_CONNECTIVE_TISSUE_REPLA...1,SET,11,0.11095,0.0027136,0.25615,0.33245,GOBP_CONNECTIVE_TISSUE_REPLACEMENT,0.985782494454871
MIR580_3P,SET,190,0.026826,0.0027134,0.061943,0.33248,MIR580_3P,0.985782494454871
GSE17301_IFNA2_VS_IFNA5_STIM...2,SET,176,0.027308,0.0026594,0.063055,0.33248,GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP,0.985782494454871
GOBP_POSITIVE_REGULATION_OF_...716,SET,15,0.10099,0.002884,0.2333,0.33255,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.985905932781711
ELVIDGE_HYPOXIA_BY_DMOG_DN,SET,52,0.049021,0.0026038,0.11329,0.33262,ELVIDGE_HYPOXIA_BY_DMOG_DN,0.985945253731343
ZSCAN18_TARGET_GENES,SET,33,0.064386,0.0027258,0.1488,0.33262,ZSCAN18_TARGET_GENES,0.985945253731343
GOBP_RESPONSE_TO_CALCIUM_ION,SET,124,0.034028,0.0027856,0.078667,0.33267,GOBP_RESPONSE_TO_CALCIUM_ION,0.986008711217184
REACTOME_LOSS_OF_FUNCTION_OF...2,SET,7,0.13485,0.0026312,0.3119,0.33275,REACTOME_LOSS_OF_FUNCTION_OF_SMAD2_3_IN_CANCER,0.986008711217184
MIR190A_5P,SET,105,0.037229,0.0028059,0.086112,0.33275,MIR190A_5P,0.986008711217184
BYSTRYKH_HEMATOPOIESIS_STEM_...6,SET,121,0.031522,0.0025492,0.072923,0.33278,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_CIS,0.986008711217184
GOBP_RESPONSE_TO_ODORANT,SET,5,0.17581,0.0028994,0.40679,0.33281,GOBP_RESPONSE_TO_ODORANT,0.986008711217184
DING_LUNG_CANCER_BY_MUTATION...,SET,20,0.087307,0.0028785,0.20204,0.33283,DING_LUNG_CANCER_BY_MUTATION_RATE,0.986008711217184
GOMF_NUCLEAR_ANDROGEN_RECEPT...,SET,25,0.066034,0.0024338,0.15282,0.33284,GOMF_NUCLEAR_ANDROGEN_RECEPTOR_BINDING,0.986008711217184
HP_MICROMELIA,SET,86,0.037952,0.00259,0.087857,0.33288,HP_MICROMELIA,0.986036993358311
GOMF_INSULIN_RECEPTOR_SUBSTR...,SET,13,0.10311,0.0027413,0.23883,0.33297,GOMF_INSULIN_RECEPTOR_SUBSTRATE_BINDING,0.986036993358311
HP_ABNORMALITY_OF_THE_DIENCE...,SET,122,0.031844,0.0025858,0.073769,0.333,HP_ABNORMALITY_OF_THE_DIENCEPHALON,0.986036993358311
WP_DISRUPTION_OF_POSTSYNAPTI...,SET,29,0.06962,0.0027633,0.16132,0.33303,WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV,0.986036993358311
GOBP_SENSORY_PERCEPTION_OF_P...,SET,73,0.045179,0.0028417,0.1047,0.33305,GOBP_SENSORY_PERCEPTION_OF_PAIN,0.986036993358311
GOBP_TOLL_SIGNALING_PATHWAY,SET,11,0.10884,0.002662,0.25224,0.33305,GOBP_TOLL_SIGNALING_PATHWAY,0.986036993358311
MANNO_MIDBRAIN_NEUROTYPES_HP...3,SET,284,0.022064,0.0027214,0.051138,0.33307,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPL,0.986036993358311
HP_CONGENITAL_MALFORMATION_O...2,SET,76,0.041279,0.0026489,0.095685,0.33309,HP_CONGENITAL_MALFORMATION_OF_THE_RIGHT_HEART,0.986036993358311
ZAIDI_OSTEOBLAST_TRANSCRIPTI...,SET,13,0.11267,0.0029954,0.26125,0.33314,ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS,0.986036993358311
GOBP_POSITIVE_T_CELL_SELECTI...,SET,44,0.059834,0.0029241,0.13874,0.33314,GOBP_POSITIVE_T_CELL_SELECTION,0.986036993358311
HP_ABNORMAL_EYELASH_MORPHOLO...,SET,250,0.023262,0.0026946,0.053949,0.33317,HP_ABNORMAL_EYELASH_MORPHOLOGY,0.986036993358311
HP_CORNEAL_STROMAL_EDEMA,SET,11,0.12264,0.0029994,0.28446,0.33319,HP_CORNEAL_STROMAL_EDEMA,0.986036993358311
BILANGES_SERUM_SENSITIVE_VIA...2,SET,24,0.072271,0.0026099,0.16772,0.33327,BILANGES_SERUM_SENSITIVE_VIA_TSC2,0.986189770114942
MIR4781_3P,SET,35,0.058588,0.0025543,0.136,0.33331,MIR4781_3P,0.986224165673421
HOXB6_TARGET_GENES,SET,514,0.015792,0.0026038,0.036668,0.33335,HOXB6_TARGET_GENES,0.986258555375841
NFY_Q6_01,SET,231,0.023775,0.0026486,0.055239,0.33345,NFY_Q6_01,0.986361689361702
GSE39820_TGFBETA1_VS_TGFBETA...1,SET,184,0.026499,0.0026381,0.061567,0.33345,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_DN,0.986361689361702
WP_CANCER_IMMUNOTHERAPY_BY_C...,SET,12,0.1109,0.0028329,0.2577,0.33347,WP_CANCER_IMMUNOTHERAPY_BY_CTLA4_BLOCKADE,0.986361689361702
GSE18791_UNSTIM_VS_NEWCATSLE...9,SET,172,0.028632,0.0027568,0.066556,0.33353,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_DN,0.986410413476263
KEGG_MEDICUS_PATHOGEN_HIV_GP...4,SET,13,0.097042,0.00258,0.2256,0.33355,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_TNF_NFKB_SIGNALING_PATHWAY,0.986410413476263
MIR4690_5P,SET,68,0.046066,0.0027968,0.10713,0.3336,MIR4690_5P,0.986410413476263
GSE4590_PRE_BCELL_VS_SMALL_P...2,SET,136,0.030862,0.002645,0.07177,0.3336,GSE4590_PRE_BCELL_VS_SMALL_PRE_BCELL_UP,0.986410413476263
MODULE_289,SET,117,0.036707,0.0029194,0.085401,0.33367,MODULE_289,0.98647910854032
MIR22_5P,SET,127,0.031863,0.0026395,0.074137,0.33368,MIR22_5P,0.98647910854032
HP_ABNORMAL_JUDGMENT,SET,438,0.017301,0.0026389,0.040265,0.33372,HP_ABNORMAL_JUDGMENT,0.986513447307987
HP_SMALL_BOWEL_DIVERTICULA,SET,5,0.1616,0.0026651,0.37619,0.33375,HP_SMALL_BOWEL_DIVERTICULA,0.986518221636333
ZHAN_MULTIPLE_MYELOMA_SUBGRO...,SET,30,0.058303,0.0023536,0.13576,0.3338,ZHAN_MULTIPLE_MYELOMA_SUBGROUPS,0.986557321428571
GSE7509_FCGRIIB_VS_TNFA_IL1B...2,SET,157,0.027138,0.0024975,0.063202,0.33382,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,0.986557321428571
GOBP_STEM_CELL_DIFFERENTIATI...,SET,229,0.024604,0.0027293,0.057327,0.33389,GOBP_STEM_CELL_DIFFERENTIATION,0.986625956469988
GOMF_GLYCEROL_CHANNEL_ACTIVI...,SET,5,0.20237,0.0033374,0.47154,0.3339,GOMF_GLYCEROL_CHANNEL_ACTIVITY,0.986625956469988
GSE15330_LYMPHOID_MULTIPOTEN...10,SET,182,0.02643,0.0026171,0.061675,0.33413,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_UP,0.986716310160428
HP_ABNORMAL_CORNEAL_REFLEX,SET,11,0.10254,0.0025079,0.2393,0.33414,HP_ABNORMAL_CORNEAL_REFLEX,0.986716310160428
GOCC_MIB_COMPLEX,SET,9,0.11067,0.0024484,0.25828,0.33415,GOCC_MIB_COMPLEX,0.986716310160428
GNF2_CDC27,SET,56,0.048669,0.0026824,0.11361,0.33419,GNF2_CDC27,0.986716310160428
HP_ABNORMAL_SWEAT_HOMEOSTASIS,SET,28,0.074714,0.002914,0.17441,0.33419,HP_ABNORMAL_SWEAT_HOMEOSTASIS,0.986716310160428
GOBP_CIRCULATORY_SYSTEM_PROC...,SET,566,0.016472,0.0028457,0.038456,0.33421,GOBP_CIRCULATORY_SYSTEM_PROCESS,0.986716310160428
GOBP_PEPTIDE_TRANSPORT,SET,244,0.023979,0.0027445,0.055985,0.33422,GOBP_PEPTIDE_TRANSPORT,0.986716310160428
GSE369_PRE_VS_POST_IL6_INJEC...4,SET,178,0.027928,0.0027352,0.065209,0.33422,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_UP,0.986716310160428
GOMF_MISMATCHED_DNA_BINDING,SET,14,0.074131,0.0020452,0.17314,0.33427,GOMF_MISMATCHED_DNA_BINDING,0.986716310160428
HP_GASTROINTESTINAL_EOSINOPH...,SET,14,0.10101,0.0027867,0.23594,0.33429,HP_GASTROINTESTINAL_EOSINOPHILIA,0.986716310160428
GNF2_PECAM1,SET,48,0.055077,0.002811,0.12866,0.3343,GNF2_PECAM1,0.986716310160428
HINATA_NFKB_MATRIX,SET,10,0.12163,0.0028363,0.28412,0.3343,HINATA_NFKB_MATRIX,0.986716310160428
GSE2706_UNSTIM_VS_8H_LPS_DC_...1,SET,171,0.028285,0.0027156,0.066089,0.33433,GSE2706_UNSTIM_VS_8H_LPS_DC_DN,0.986716310160428
GSE360_T_GONDII_VS_B_MALAYI_...3,SET,180,0.026413,0.0026011,0.061731,0.33437,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_MAC_DN,0.986716310160428
REACTOME_BMAL1_CLOCK_NPAS2_A...,SET,23,0.080695,0.0028528,0.18865,0.33442,REACTOME_BMAL1_CLOCK_NPAS2_ACTIVATES_CIRCADIAN_GENE_EXPRESSION,0.986716310160428
MIR4696,SET,91,0.03742,0.0026266,0.087482,0.33442,MIR4696,0.986716310160428
DESCARTES_MAIN_FETAL_EPICARD...,SET,38,0.06514,0.0029589,0.15231,0.33444,DESCARTES_MAIN_FETAL_EPICARDIAL_FAT_CELLS,0.986716310160428
GSE13887_HEALTHY_VS_LUPUS_RE...2,SET,104,0.036842,0.0027635,0.086148,0.33445,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_UP,0.986716310160428
PID_WNT_CANONICAL_PATHWAY,SET,20,0.073343,0.0024181,0.17152,0.33447,PID_WNT_CANONICAL_PATHWAY,0.986716310160428
GOBP_GLIAL_CELL_DIFFERENTIAT...,SET,247,0.024012,0.0027649,0.056182,0.33455,GOBP_GLIAL_CELL_DIFFERENTIATION,0.986868549482261
GOMF_COA_TRANSFERASE_ACTIVITY,SET,5,0.1746,0.0028794,0.4086,0.33458,GOMF_COA_TRANSFERASE_ACTIVITY,0.986873283544089
GOBP_DOUBLE_STRAND_BREAK_REP...3,SET,8,0.10495,0.0021891,0.24566,0.33461,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_ALTERNATIVE_NONHOMOLOGOUS_END_JOINING,0.986878016802444
GSE22033_UNTREATED_VS_MRL24_...2,SET,178,0.025624,0.0025095,0.060017,0.33471,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_UP,0.98691834815756
GOBP_LYMPHOCYTE_COSTIMULATION,SET,44,0.057258,0.0027982,0.13414,0.33474,GOBP_LYMPHOCYTE_COSTIMULATION,0.98691834815756
DLX2_TARGET_GENES,SET,217,0.025177,0.0027195,0.059002,0.33479,DLX2_TARGET_GENES,0.98691834815756
GOBP_SECRETORY_GRANULE_ORGAN...,SET,61,0.046638,0.0026824,0.10929,0.33479,GOBP_SECRETORY_GRANULE_ORGANIZATION,0.98691834815756
HP_AVASCULAR_NECROSIS,SET,83,0.040061,0.0026861,0.0939,0.33483,HP_AVASCULAR_NECROSIS,0.98691834815756
GOMF_OXIDOREDUCTASE_ACTIVITY...4,SET,10,0.10664,0.0024869,0.25007,0.33489,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_NAD_P_AS_ACCEPTOR,0.98691834815756
GOBP_REGULATION_OF_SULFUR_ME...,SET,12,0.11322,0.002892,0.2655,0.3349,GOBP_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.98691834815756
GOBP_WATER_TRANSPORT,SET,25,0.08332,0.0030709,0.19541,0.33492,GOBP_WATER_TRANSPORT,0.98691834815756
GSE3920_IFNA_VS_IFNG_TREATED...2,SET,154,0.028756,0.0026212,0.067479,0.335,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,0.98691834815756
NME2_TARGET_GENES,SET,53,0.051141,0.0027423,0.12001,0.33501,NME2_TARGET_GENES,0.98691834815756
GOCC_POSTSYNAPTIC_CYTOSKELET...,SET,13,0.095552,0.0025404,0.22423,0.33501,GOCC_POSTSYNAPTIC_CYTOSKELETON,0.98691834815756
GOBP_POSITIVE_REGULATION_OF_...718,SET,28,0.074213,0.0028945,0.17418,0.33503,GOBP_POSITIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,0.98691834815756
BIOCARTA_ETC_PATHWAY,SET,7,0.12154,0.0023714,0.28527,0.33504,BIOCARTA_ETC_PATHWAY,0.98691834815756
HSD17B8_TARGET_GENES,SET,518,0.01639,0.0027126,0.038471,0.33504,HSD17B8_TARGET_GENES,0.98691834815756
AIZARANI_LIVER_C11_HEPATOCYT...,SET,277,0.023212,0.0028281,0.054494,0.33507,AIZARANI_LIVER_C11_HEPATOCYTES_1,0.98691834815756
MIR4744,SET,155,0.028384,0.0025956,0.066655,0.33512,MIR4744,0.98691834815756
GOMF_PROTON_TRANSMEMBRANE_TR...,SET,143,0.028184,0.0024764,0.066192,0.33513,GOMF_PROTON_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.98691834815756
GOBP_ISG15_PROTEIN_CONJUGATI...,SET,6,0.14167,0.0025594,0.33278,0.33515,GOBP_ISG15_PROTEIN_CONJUGATION,0.98691834815756
MIR550A_3_5P_MIR550A_5P,SET,67,0.045435,0.0027382,0.10674,0.33518,MIR550A_3_5P_MIR550A_5P,0.98691834815756
CSR_EARLY_UP.V1_UP,SET,143,0.029519,0.0025937,0.06936,0.33521,CSR_EARLY_UP.V1_UP,0.98691834815756
GSE14000_TRANSLATED_RNA_VS_M...2,SET,146,0.02964,0.0026312,0.069651,0.33522,GSE14000_TRANSLATED_RNA_VS_MRNA_16H_LPS_DC_UP,0.98691834815756
REACTOME_SOMITOGENESIS,SET,52,0.044838,0.0023816,0.1054,0.33527,REACTOME_SOMITOGENESIS,0.986981945620871
HP_EMPHYSEMA,SET,63,0.044622,0.002608,0.10505,0.33551,HP_EMPHYSEMA,0.987341916243655
MIR92A_3P,SET,435,0.017526,0.0026642,0.041278,0.33557,MIR92A_3P,0.987341916243655
HP_SYMPHALANGISM_AFFECTING_T...,SET,16,0.093755,0.0027651,0.22081,0.33557,HP_SYMPHALANGISM_AFFECTING_THE_PHALANGES_OF_THE_HAND,0.987341916243655
GOBP_REGULATION_OF_CARDIAC_M...5,SET,7,0.12826,0.0025027,0.30211,0.33558,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_MEMBRANE_POTENTIAL,0.987341916243655
GSE7568_CTRL_VS_3H_TGFB_TREA...2,SET,139,0.031681,0.0027448,0.07462,0.33558,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,0.987341916243655
GSE15659_NAIVE_CD4_TCELL_VS_...5,SET,171,0.026838,0.0025767,0.063219,0.33559,GSE15659_NAIVE_CD4_TCELL_VS_RESTING_TREG_DN,0.987341916243655
GOBP_POSITIVE_REGULATION_OF_...286,SET,53,0.052354,0.0028073,0.12338,0.33567,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.987341916243655
GSE5589_LPS_VS_LPS_AND_IL10_...6,SET,184,0.025394,0.0025281,0.059848,0.33567,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP,0.987341916243655
GOMF_U1_SNRNA_BINDING,SET,8,0.10791,0.0022508,0.25437,0.33571,GOMF_U1_SNRNA_BINDING,0.987341916243655
DESCARTES_FETAL_MUSCLE_ERYTH...,SET,101,0.033971,0.0025114,0.080089,0.33572,DESCARTES_FETAL_MUSCLE_ERYTHROBLASTS,0.987341916243655
GOCC_CLATHRIN_SCULPTED_GAMMA...,SET,8,0.14117,0.0029447,0.33283,0.33573,GOCC_CLATHRIN_SCULPTED_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT_VESICLE,0.987341916243655
GSE43955_1H_VS_42H_ACT_CD4_T...2,SET,180,0.025678,0.0025287,0.060546,0.33574,GSE43955_1H_VS_42H_ACT_CD4_TCELL_UP,0.987341916243655
REACTOME_PEPTIDE_HORMONE_MET...,SET,81,0.04161,0.0027563,0.098126,0.33577,REACTOME_PEPTIDE_HORMONE_METABOLISM,0.987341916243655
GSE21360_PRIMARY_VS_QUATERNA...1,SET,180,0.025117,0.0024734,0.05924,0.33579,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,0.987341916243655
AR_03,SET,54,0.047708,0.0025822,0.11262,0.33592,AR_03,0.987586461681611
HP_IMPAIRED_CORTISOL_RESPONS...,SET,5,0.17511,0.0028878,0.41337,0.33593,HP_IMPAIRED_CORTISOL_RESPONSE_TO_INSULIN_STIMULATION_TEST,0.987586461681611
GOMF_CYSTEINE_TYPE_ENDOPEPTI...2,SET,80,0.039904,0.0026269,0.094226,0.33597,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,0.987620515097691
GSE24671_CTRL_VS_SENDAI_VIRU...2,SET,146,0.029842,0.0026492,0.070504,0.33605,GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,0.987722640791476
GOMF_HEMOGLOBIN_ALPHA_BINDING,SET,4,0.24324,0.003588,0.57472,0.33607,GOMF_HEMOGLOBIN_ALPHA_BINDING,0.987722640791476
GTGTGAG_MIR342,SET,56,0.046766,0.0025775,0.11052,0.33609,GTGTGAG_MIR342,0.987722640791476
GSE11924_TFH_VS_TH1_CD4_TCEL...2,SET,186,0.025481,0.0025504,0.060234,0.33614,GSE11924_TFH_VS_TH1_CD4_TCELL_UP,0.987786057326456
GSE14769_UNSTIM_VS_20MIN_LPS...2,SET,174,0.026949,0.0026097,0.063782,0.33633,GSE14769_UNSTIM_VS_20MIN_LPS_BMDM_UP,0.987808902561527
GOMF_NF_KAPPAB_BINDING,SET,28,0.061703,0.0024066,0.14605,0.33634,GOMF_NF_KAPPAB_BINDING,0.987808902561527
GSE7460_CTRL_VS_TGFB_TREATED...4,SET,192,0.024223,0.0024628,0.057373,0.33644,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_UP,0.987808902561527
TCF11MAFG_01,SET,182,0.026675,0.0026413,0.063207,0.3365,TCF11MAFG_01,0.987808902561527
HP_RIGHT_VENTRICULAR_DILATAT...,SET,17,0.094923,0.0028856,0.22494,0.33652,HP_RIGHT_VENTRICULAR_DILATATION,0.987808902561527
GOBP_L_PROLINE_BIOSYNTHETIC_...,SET,5,0.17995,0.0029676,0.42646,0.33653,GOBP_L_PROLINE_BIOSYNTHETIC_PROCESS,0.987808902561527
BIOCARTA_BARR_MAPK_PATHWAY,SET,13,0.11122,0.002957,0.2638,0.33665,BIOCARTA_BARR_MAPK_PATHWAY,0.987808902561527
MIR4665_5P,SET,137,0.031682,0.0027251,0.075162,0.33669,MIR4665_5P,0.987808902561527
GSE19888_CTRL_VS_A3R_ACT_TRE...2,SET,185,0.025609,0.0025564,0.060783,0.33676,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_UP,0.987808902561527
GSE17580_UNINFECTED_VS_S_MAN...2,SET,187,0.025956,0.0026048,0.061609,0.33677,GSE17580_UNINFECTED_VS_S_MANSONI_INF_TEFF_UP,0.987808902561527
GSE15330_HSC_VS_GRANULOCYTE_...3,SET,173,0.027312,0.0026373,0.064843,0.33681,GSE15330_HSC_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,0.987808902561527
KEGG_MEDICUS_VARIANT_RET_FUS...,SET,10,0.10769,0.0025112,0.25577,0.33687,KEGG_MEDICUS_VARIANT_RET_FUSION_KINASE_TO_RAS_ERK_SIGNALING_PATHWAY,0.987808902561527
WP_OSTEOBLAST_SIGNALING,SET,13,0.10916,0.0029021,0.25929,0.33688,WP_OSTEOBLAST_SIGNALING,0.987808902561527
GOBP_REGULATION_OF_ANIMAL_OR...2,SET,82,0.042045,0.0028021,0.099902,0.33693,GOBP_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,0.987808902561527
HP_ABNORMAL_SYNOVIAL_MEMBRAN...,SET,15,0.09229,0.0026355,0.21929,0.33693,HP_ABNORMAL_SYNOVIAL_MEMBRANE_MORPHOLOGY,0.987808902561527
HP_CARCINOMA,SET,6,0.12899,0.0023303,0.30655,0.33696,HP_CARCINOMA,0.987808902561527
GSE25088_CTRL_VS_ROSIGLITAZO...3,SET,183,0.02525,0.002507,0.060034,0.33702,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,0.987808902561527
GOBP_PROTEIN_LOCALIZATION_TO...7,SET,98,0.036688,0.0026719,0.087234,0.33704,GOBP_PROTEIN_LOCALIZATION_TO_CELL_JUNCTION,0.987808902561527
ZNF92_TARGET_GENES,SET,1106,0.011079,0.0026348,0.026353,0.3371,ZNF92_TARGET_GENES,0.987808902561527
GOBP_IRON_ION_TRANSPORT,SET,48,0.051413,0.002624,0.12231,0.33712,GOBP_IRON_ION_TRANSPORT,0.987808902561527
GSE6090_UNSTIM_VS_DC_SIGN_ST...1,SET,129,0.032787,0.0027372,0.078001,0.33712,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_DN,0.987808902561527
KEGG_GLYOXYLATE_AND_DICARBOX...,SET,16,0.086673,0.0025562,0.20632,0.33722,KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM,0.987808902561527
HP_ABNORMALITY_OF_THE_ANTERI...1,SET,6,0.13241,0.002392,0.31523,0.33723,HP_ABNORMALITY_OF_THE_ANTERIOR_COMMISSURE,0.987808902561527
GSE5542_UNTREATED_VS_IFNA_TR...3,SET,171,0.026469,0.0025412,0.063025,0.33725,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,0.987808902561527
GOMF_SOMATOSTATIN_RECEPTOR_A...,SET,5,0.14924,0.0024612,0.35542,0.33728,GOMF_SOMATOSTATIN_RECEPTOR_ACTIVITY,0.987808902561527
REACTOME_BIOSYNTHESIS_OF_MAR...2,SET,6,0.13772,0.0024879,0.328,0.33729,REACTOME_BIOSYNTHESIS_OF_MARESIN_LIKE_SPMS,0.987808902561527
HP_PSYCHOSIS,SET,94,0.037291,0.0026601,0.088832,0.33732,HP_PSYCHOSIS,0.987808902561527
GOBP_NEGATIVE_REGULATION_OF_...635,SET,6,0.15474,0.0027955,0.36867,0.33734,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.987808902561527
MIR10393_3P,SET,96,0.037497,0.002703,0.089341,0.33735,MIR10393_3P,0.987808902561527
chr12q21,SET,59,0.084915,0.0048034,0.20234,0.33737,chr12q21,0.987808902561527
HUANG_DASATINIB_RESISTANCE_DN,SET,66,0.047181,0.0028223,0.11243,0.33737,HUANG_DASATINIB_RESISTANCE_DN,0.987808902561527
GOMF_TRANSCRIPTION_COREGULAT...1,SET,452,0.016238,0.002515,0.038694,0.33737,GOMF_TRANSCRIPTION_COREGULATOR_ACTIVITY,0.987808902561527
DESCARTES_FETAL_ADRENAL_SLC2...,SET,33,0.063076,0.0026704,0.15033,0.3374,DESCARTES_FETAL_ADRENAL_SLC26A4_PAEP_POSITIVE_CELLS,0.987808902561527
MIR6762_5P,SET,55,0.04777,0.0026093,0.11386,0.33741,MIR6762_5P,0.987808902561527
GOBP_DICARBOXYLIC_ACID_BIOSY...,SET,12,0.11018,0.0028145,0.26261,0.33741,GOBP_DICARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,0.987808902561527
HP_ABNORMAL_LACRIMAL_GLAND_M...,SET,9,0.12622,0.0027924,0.3009,0.33744,HP_ABNORMAL_LACRIMAL_GLAND_MORPHOLOGY,0.987808902561527
GOBP_REGULATION_OF_PROTEIN_C...1,SET,318,0.019525,0.002546,0.046555,0.33747,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.987808902561527
IBRAHIM_NRF3_DOWN,SET,13,0.087241,0.0023194,0.20805,0.33749,IBRAHIM_NRF3_DOWN,0.987808902561527
REACTOME_SUMOYLATION_OF_RNA_...,SET,44,0.050698,0.0024776,0.12093,0.33752,REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS,0.987808902561527
MIR4646_3P,SET,54,0.04974,0.0026922,0.11865,0.33754,MIR4646_3P,0.987808902561527
GNF2_HMMR,SET,47,0.050972,0.0025743,0.12161,0.33756,GNF2_HMMR,0.987808902561527
CHUNG_BLISTER_CYTOTOXICITY_DN,SET,40,0.056944,0.0026536,0.13591,0.33762,CHUNG_BLISTER_CYTOTOXICITY_DN,0.987808902561527
HP_ABNORMAL_2ND_METACARPAL_M...,SET,6,0.16134,0.0029147,0.38512,0.33763,HP_ABNORMAL_2ND_METACARPAL_MORPHOLOGY,0.987808902561527
GOBP_INNER_CELL_MASS_CELL_PR...,SET,14,0.085115,0.0023482,0.2032,0.33766,GOBP_INNER_CELL_MASS_CELL_PROLIFERATION,0.987808902561527
MIR6728_5P,SET,66,0.042899,0.0025661,0.10243,0.33767,MIR6728_5P,0.987808902561527
GOMF_RRNA_ADENINE_METHYLTRAN...,SET,7,0.1031,0.0020118,0.24621,0.33769,GOMF_RRNA_ADENINE_METHYLTRANSFERASE_ACTIVITY,0.987808902561527
GOMF_ARYLSULFATASE_ACTIVITY,SET,9,0.12293,0.0027196,0.2936,0.33772,GOMF_ARYLSULFATASE_ACTIVITY,0.987808902561527
REACTOME_INTERLEUKIN_6_SIGNA...,SET,11,0.11149,0.0027266,0.2663,0.33774,REACTOME_INTERLEUKIN_6_SIGNALING,0.987808902561527
GOBP_CELL_MATURATION,SET,188,0.026802,0.0026968,0.064036,0.33778,GOBP_CELL_MATURATION,0.987808902561527
GOMF_AMINO_ACID_BINDING,SET,43,0.056322,0.0027211,0.13461,0.33783,GOMF_AMINO_ACID_BINDING,0.987808902561527
chr3p14,SET,47,0.10755,0.0054318,0.25713,0.33787,chr3p14,0.987808902561527
LAIHO_COLORECTAL_CANCER_SERR...1,SET,67,0.04208,0.0025361,0.10063,0.33792,LAIHO_COLORECTAL_CANCER_SERRATED_DN,0.987808902561527
GSE18791_CTRL_VS_NEWCASTLE_V...14,SET,165,0.026763,0.0025244,0.064011,0.33794,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_UP,0.987808902561527
MIR1197,SET,84,0.037237,0.0025116,0.089071,0.33795,MIR1197,0.987808902561527
LAKE_ADULT_KIDNEY_C18_COLLEC...,SET,295,0.020573,0.0025854,0.049212,0.33796,LAKE_ADULT_KIDNEY_C18_COLLECTING_DUCT_PRINCIPAL_CELLS_MEDULLA,0.987808902561527
LAIHO_COLORECTAL_CANCER_SERR...2,SET,103,0.033233,0.0024809,0.079519,0.338,LAIHO_COLORECTAL_CANCER_SERRATED_UP,0.987808902561527
HP_RHIZOMELIA,SET,59,0.047604,0.0026929,0.11391,0.33801,HP_RHIZOMELIA,0.987808902561527
GSE18804_SPLEEN_MACROPHAGE_V...4,SET,183,0.026203,0.0026016,0.062723,0.33806,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_UP,0.987808902561527
MIR759,SET,65,0.048341,0.0028697,0.11572,0.33808,MIR759,0.987808902561527
GOBP_POSITIVE_REGULATION_OF_...653,SET,90,0.03595,0.0025096,0.086072,0.33809,GOBP_POSITIVE_REGULATION_OF_PROTEIN_UBIQUITINATION,0.987808902561527
HP_INCREASED_GLUTAMINE_FAMIL...,SET,5,0.13483,0.0022236,0.32287,0.33812,HP_INCREASED_GLUTAMINE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,0.987808902561527
GNF2_CENPF,SET,57,0.046798,0.0026021,0.11207,0.33813,GNF2_CENPF,0.987808902561527
HP_APLASIA_HYPOPLASIA_OF_THE...24,SET,4,0.16261,0.0023987,0.38944,0.33814,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,0.987808902561527
RB_DN.V1_DN,SET,109,0.035248,0.0027064,0.084429,0.33816,RB_DN.V1_DN,0.987808902561527
GOMF_PROTEIN_TYROSINE_KINASE...4,SET,5,0.17101,0.0028203,0.40965,0.33817,GOMF_PROTEIN_TYROSINE_KINASE_INHIBITOR_ACTIVITY,0.987808902561527
GOBP_LATE_ENDOSOME_TO_VACUOL...1,SET,36,0.054101,0.002392,0.12962,0.3382,GOBP_LATE_ENDOSOME_TO_VACUOLE_TRANSPORT,0.987808902561527
GSE2770_IL12_VS_TGFB_AND_IL1...1,SET,145,0.02993,0.0026479,0.071718,0.33822,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,0.987808902561527
HP_ABSENT_SPERM_FLAGELLA,SET,23,0.067621,0.0023906,0.16204,0.33823,HP_ABSENT_SPERM_FLAGELLA,0.987808902561527
REACTOME_ABACAVIR_ADME,SET,9,0.13858,0.0030658,0.33211,0.33825,REACTOME_ABACAVIR_ADME,0.987808902561527
GSE32423_IL7_VS_IL7_IL4_MEMO...1,SET,180,0.024701,0.0024325,0.0592,0.33825,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,0.987808902561527
REACTOME_SIRT1_NEGATIVELY_RE...,SET,7,0.10985,0.0021434,0.26331,0.33828,REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION,0.987808902561527
KAZMIN_PBMC_P_FALCIPARUM_RTS...3,SET,9,0.13258,0.002933,0.31789,0.33832,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_UNKN_AGE_IMM_WITH_ARR_VS_IMM_BY_RRR_PRIMARY_IMMUNIZ_WITH_RECOMB_ADENOVIRUS_35_1DY_UP,0.987808902561527
GSE19401_UNSTIM_VS_PAM2CSK4_...1,SET,183,0.026202,0.0026015,0.062838,0.33835,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_DN,0.987808902561527
chr5q34,SET,12,0.15219,0.0038875,0.36506,0.33839,chr5q34,0.987808902561527
KRAS.50_UP.V1_UP,SET,44,0.058766,0.0028719,0.14108,0.33851,KRAS.50_UP.V1_UP,0.987808902561527
GOBP_CELL_PROLIFERATION_IN_F...,SET,25,0.07675,0.0028287,0.18427,0.33852,GOBP_CELL_PROLIFERATION_IN_FOREBRAIN,0.987808902561527
PID_ALPHA_SYNUCLEIN_PATHWAY,SET,30,0.064218,0.0025924,0.15421,0.33855,PID_ALPHA_SYNUCLEIN_PATHWAY,0.987808902561527
GOCC_SYMMETRIC_SYNAPSE,SET,7,0.13819,0.0026965,0.33188,0.33856,GOCC_SYMMETRIC_SYNAPSE,0.987808902561527
GSE12392_IFNAR_KO_VS_IFNB_KO...2,SET,177,0.025801,0.0025197,0.061971,0.33858,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP,0.987808902561527
PURWIN_A375_SOX10_TARGETS,SET,43,0.053478,0.0025837,0.12849,0.33863,PURWIN_A375_SOX10_TARGETS,0.987808902561527
WP_GLYCOSPHINGOLIPID_METABOL...,SET,19,0.084496,0.0027154,0.20303,0.33864,WP_GLYCOSPHINGOLIPID_METABOLISM,0.987808902561527
MTOR_UP.V1_UP,SET,155,0.027646,0.0025281,0.066429,0.33865,MTOR_UP.V1_UP,0.987808902561527
GSE45365_WT_VS_IFNAR_KO_BCEL...3,SET,150,0.027624,0.0024854,0.066396,0.33869,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_UP,0.987808902561527
chr6q12,SET,5,0.24551,0.0040489,0.59025,0.33873,chr6q12,0.987808902561527
GOMF_STORE_OPERATED_CALCIUM_...,SET,9,0.12439,0.0027521,0.29929,0.33884,GOMF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,0.987808902561527
UNTERMAN_IPF_VS_CTRL_CD4T_DN,SET,9,0.13862,0.0030667,0.33364,0.3389,UNTERMAN_IPF_VS_CTRL_CD4T_DN,0.987808902561527
REACTOME_SIGNALING_BY_NOTCH1...1,SET,14,0.094951,0.0026196,0.22855,0.33891,REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER,0.987808902561527
GOBP_RESPONSE_TO_AMYLOID_BETA,SET,50,0.054303,0.0028285,0.13075,0.33896,GOBP_RESPONSE_TO_AMYLOID_BETA,0.987808902561527
GSE20727_CTRL_VS_DNFB_ALLERG...1,SET,165,0.026916,0.0025389,0.06481,0.33896,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_DN,0.987808902561527
BYSTRYKH_HEMATOPOIESIS_STEM_...1,SET,64,0.038763,0.0022834,0.093347,0.33898,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_AND_BRAIN_QTL_CIS,0.987808902561527
GOBP_POSITIVE_REGULATION_OF_...352,SET,44,0.049558,0.0024219,0.11934,0.33898,GOBP_POSITIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,0.987808902561527
SCHAEFFER_PROSTATE_DEVELOPME...15,SET,10,0.13162,0.0030694,0.31705,0.33902,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_UP,0.987808902561527
GSE11864_CSF1_VS_CSF1_IFNG_I...1,SET,168,0.02655,0.0025268,0.06396,0.33903,GSE11864_CSF1_VS_CSF1_IFNG_IN_MAC_DN,0.987808902561527
GOBP_REGULATION_OF_DNA_BIOSY...,SET,111,0.032693,0.002533,0.078765,0.33905,GOBP_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,0.987808902561527
GOBP_SUBSTRATE_DEPENDENT_CEL...2,SET,7,0.12875,0.0025121,0.31023,0.33907,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION_CELL_EXTENSION,0.987808902561527
HP_RIMMED_VACUOLES,SET,38,0.054203,0.0024621,0.13063,0.33909,HP_RIMMED_VACUOLES,0.987808902561527
WP_ARYL_HYDROCARBON_RECEPTOR...2,SET,45,0.052746,0.0026068,0.12712,0.3391,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873,0.987808902561527
GOBP_ADULT_HEART_DEVELOPMENT,SET,13,0.10483,0.0027871,0.25268,0.33912,GOBP_ADULT_HEART_DEVELOPMENT,0.987808902561527
MIR4473,SET,79,0.038311,0.0025063,0.092386,0.33919,MIR4473,0.987808902561527
QUINTENS_EMBRYONIC_BRAIN_RES...,SET,73,0.040753,0.0025633,0.098318,0.33926,QUINTENS_EMBRYONIC_BRAIN_RESPONSE_TO_IR,0.987808902561527
GOMF_LIGASE_ACTIVITY_FORMING...3,SET,22,0.068319,0.0023623,0.16485,0.33928,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_OXYGEN_BONDS,0.987808902561527
MIR4485_5P,SET,7,0.13265,0.0025883,0.3201,0.3393,MIR4485_5P,0.987808902561527
BIOCARTA_FIBRINOLYSIS_PATHWAY,SET,12,0.11994,0.0030637,0.28949,0.33933,BIOCARTA_FIBRINOLYSIS_PATHWAY,0.987808902561527
GHANDHI_BYSTANDER_IRRADIATIO...2,SET,72,0.045793,0.0028606,0.11054,0.33934,GHANDHI_BYSTANDER_IRRADIATION_UP,0.987808902561527
PTTG1_TARGET_GENES,SET,55,0.045729,0.0024978,0.11038,0.33934,PTTG1_TARGET_GENES,0.987808902561527
GOBP_DETECTION_OF_OTHER_ORGA...,SET,17,0.088443,0.0026886,0.21351,0.33936,GOBP_DETECTION_OF_OTHER_ORGANISM,0.987808902561527
GERY_CEBP_TARGETS,SET,118,0.035299,0.0028193,0.085226,0.33938,GERY_CEBP_TARGETS,0.987808902561527
HP_ABNORMALITY_OF_THE_MIDDLE...3,SET,10,0.10499,0.0024482,0.25349,0.33938,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANGES_OF_THE_TOES,0.987808902561527
GSE36078_UNTREATED_VS_AD5_IN...2,SET,182,0.025231,0.0024983,0.060926,0.3394,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP,0.987808902561527
ARHGAP35_TARGET_GENES,SET,87,0.036422,0.0025,0.08796,0.33941,ARHGAP35_TARGET_GENES,0.987808902561527
GOBP_REGULATION_OF_SKELETAL_...12,SET,7,0.13218,0.002579,0.31921,0.33941,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.987808902561527
GOMF_CALCIUM_INDUCED_CALCIUM...,SET,6,0.13458,0.0024312,0.32504,0.33942,GOMF_CALCIUM_INDUCED_CALCIUM_RELEASE_ACTIVITY,0.987808902561527
KAAB_FAILED_HEART_VENTRICLE_...,SET,37,0.058684,0.0026304,0.14174,0.33943,KAAB_FAILED_HEART_VENTRICLE_DN,0.987808902561527
GSE3039_ALPHAALPHA_CD8_TCELL...3,SET,182,0.026548,0.0026287,0.064126,0.33944,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_DN,0.987808902561527
HP_ABNORMAL_SIZE_OF_THE_PALP...,SET,259,0.021139,0.0024917,0.051069,0.33946,HP_ABNORMAL_SIZE_OF_THE_PALPEBRAL_FISSURES,0.987808902561527
GOCC_EXTRINSIC_COMPONENT_OF_...3,SET,6,0.12777,0.0023082,0.30873,0.33949,GOCC_EXTRINSIC_COMPONENT_OF_MITOCHONDRIAL_INNER_MEMBRANE,0.987808902561527
GOCC_VACUOLE,SET,773,0.012602,0.0025295,0.03045,0.3395,GOCC_VACUOLE,0.987808902561527
REACTOME_IRON_UPTAKE_AND_TRA...,SET,53,0.049355,0.0026465,0.11927,0.33951,REACTOME_IRON_UPTAKE_AND_TRANSPORT,0.987808902561527
GOCC_CLATHRIN_COATED_VESICLE...,SET,124,0.032548,0.0026644,0.078666,0.33953,GOCC_CLATHRIN_COATED_VESICLE_MEMBRANE,0.987808902561527
MODULE_349,SET,17,0.092319,0.0028064,0.22334,0.33968,MODULE_349,0.988143160003339
GSE16385_UNTREATED_VS_12H_RO...1,SET,173,0.02583,0.0024942,0.062521,0.33976,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IFNG_TNF_TREATED_MACROPHAGE_DN,0.988143160003339
GSE2770_UNTREATED_VS_TGFB_AN...11,SET,116,0.031001,0.0024551,0.075071,0.33982,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_DN,0.988143160003339
MORI_IMMATURE_B_LYMPHOCYTE_UP,SET,46,0.052592,0.0026278,0.12737,0.33984,MORI_IMMATURE_B_LYMPHOCYTE_UP,0.988143160003339
GOBP_GLYCOSYL_COMPOUND_METAB...,SET,75,0.043402,0.0027669,0.10515,0.33989,GOBP_GLYCOSYL_COMPOUND_METABOLIC_PROCESS,0.988143160003339
HP_VENTRICULAR_ARRHYTHMIA,SET,188,0.025584,0.0025743,0.061982,0.33989,HP_VENTRICULAR_ARRHYTHMIA,0.988143160003339
GOBP_NEGATIVE_REGULATION_OF_...579,SET,9,0.13113,0.002901,0.31781,0.33995,GOBP_NEGATIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,0.988143160003339
CHYLA_CBFA2T3_TARGETS_DN,SET,213,0.023681,0.0025345,0.057404,0.33998,CHYLA_CBFA2T3_TARGETS_DN,0.988143160003339
DEBOSSCHER_NFKB_TARGETS_REPR...,SET,21,0.079864,0.002698,0.19364,0.34001,DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS,0.988143160003339
GOBP_POSITIVE_REGULATION_OF_...599,SET,111,0.031347,0.0024288,0.076031,0.34006,GOBP_POSITIVE_REGULATION_OF_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,0.988143160003339
GOBP_GASTRULATION_WITH_MOUTH...,SET,23,0.066983,0.0023681,0.16248,0.34007,GOBP_GASTRULATION_WITH_MOUTH_FORMING_SECOND,0.988143160003339
GOBP_SYNAPTIC_VESICLE_RECYCL...1,SET,74,0.039512,0.0025021,0.09584,0.34008,GOBP_SYNAPTIC_VESICLE_RECYCLING,0.988143160003339
HP_HIP_DISLOCATION,SET,226,0.022657,0.002497,0.054962,0.34009,HP_HIP_DISLOCATION,0.988143160003339
GOCC_BASAL_PART_OF_CELL,SET,297,0.021332,0.0026897,0.051764,0.34014,GOCC_BASAL_PART_OF_CELL,0.988143160003339
HP_COLOR_VISION_DEFECT,SET,133,0.030574,0.0025915,0.074225,0.3402,HP_COLOR_VISION_DEFECT,0.988143160003339
GOBP_FLUID_TRANSPORT,SET,35,0.066538,0.0029009,0.16154,0.34021,GOBP_FLUID_TRANSPORT,0.988143160003339
WP_IL26_SIGNALING,SET,44,0.057923,0.0028307,0.14066,0.34025,WP_IL26_SIGNALING,0.988143160003339
PID_AP1_PATHWAY,SET,68,0.044981,0.002731,0.10926,0.34029,PID_AP1_PATHWAY,0.988143160003339
GOBP_ESTABLISHMENT_OF_PROTEI...8,SET,18,0.080531,0.002519,0.19569,0.34035,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PEROXISOME,0.988143160003339
GOBP_ORGANOPHOSPHATE_ESTER_T...,SET,144,0.02952,0.0026027,0.071733,0.34035,GOBP_ORGANOPHOSPHATE_ESTER_TRANSPORT,0.988143160003339
MODULE_530,SET,15,0.090292,0.0025784,0.21952,0.34042,MODULE_530,0.988143160003339
HP_ABNORMALITY_OF_FACIAL_MUS...,SET,291,0.02027,0.0025304,0.049283,0.34043,HP_ABNORMALITY_OF_FACIAL_MUSCULATURE,0.988143160003339
GOBP_PROTEIN_LOCALIZATION_TO...4,SET,4,0.19521,0.0028795,0.47465,0.34044,GOBP_PROTEIN_LOCALIZATION_TO_BICELLULAR_TIGHT_JUNCTION,0.988143160003339
REACTOME_NFE2L2_REGULATING_A...,SET,19,0.082275,0.002644,0.20006,0.34045,REACTOME_NFE2L2_REGULATING_ANTI_OXIDANT_DETOXIFICATION_ENZYMES,0.988143160003339
HP_RAYNAUD_PHENOMENON,SET,41,0.0569,0.0026844,0.13839,0.34049,HP_RAYNAUD_PHENOMENON,0.988143160003339
GSE22935_WT_VS_MYD88_KO_MACR...2,SET,188,0.024907,0.0025061,0.060586,0.3405,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_UP,0.988143160003339
GOMF_PHOSPHATIDYLINOSITOL_3_...5,SET,8,0.10902,0.0022741,0.26521,0.34051,GOMF_PHOSPHATIDYLINOSITOL_3_5_BISPHOSPHATE_3_PHOSPHATASE_ACTIVITY,0.988143160003339
REACTOME_SCF_SKP2_MEDIATED_D...,SET,57,0.041341,0.0022987,0.10058,0.34052,REACTOME_SCF_SKP2_MEDIATED_DEGRADATION_OF_P27_P21,0.988143160003339
MIR496,SET,95,0.03674,0.0026346,0.089387,0.34053,MIR496,0.988143160003339
GSE1740_MCSF_VS_MCSF_AND_IFN...3,SET,146,0.028703,0.0025481,0.069844,0.34055,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_DN,0.988143160003339
GALLUZZI_PREVENT_MITOCHONDIA...,SET,14,0.10006,0.0027605,0.24351,0.34058,GALLUZZI_PREVENT_MITOCHONDIAL_PERMEABILIZATION,0.988143160003339
UDAYAKUMAR_MED1_TARGETS_UP,SET,118,0.031008,0.0024766,0.075475,0.3406,UDAYAKUMAR_MED1_TARGETS_UP,0.988143160003339
HOLLEMAN_PREDNISOLONE_RESIST...2,SET,16,0.071595,0.0021115,0.1743,0.34063,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_UP,0.988143160003339
HP_ANASARCA,SET,9,0.094875,0.002099,0.23097,0.34063,HP_ANASARCA,0.988143160003339
GOBP_FATTY_ACID_BETA_OXIDATI...3,SET,12,0.091209,0.0023298,0.22207,0.34064,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_OXIDASE,0.988143160003339
WP_PHYSICOCHEMICAL_FEATURES_...,SET,62,0.043861,0.0025432,0.10683,0.3407,WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS,0.988210264541434
GOMF_MODIFIED_AMINO_ACID_BIN...,SET,91,0.038066,0.0026719,0.09273,0.34072,GOMF_MODIFIED_AMINO_ACID_BINDING,0.988210264541434
GOCC_SPINDLE_MIDZONE,SET,35,0.057193,0.0024934,0.13942,0.34082,GOCC_SPINDLE_MIDZONE,0.988294796511628
MIR188_5P,SET,65,0.043339,0.0025728,0.10565,0.34083,MIR188_5P,0.988294796511628
MIR4717_5P,SET,94,0.034667,0.0024729,0.084534,0.34087,MIR4717_5P,0.988294796511628
GNF2_CDC2,SET,58,0.045558,0.0025552,0.11111,0.3409,GNF2_CDC2,0.988294796511628
MIR5691_MIR6805_3P,SET,144,0.029658,0.0026149,0.07234,0.34091,MIR5691_MIR6805_3P,0.988294796511628
GOBP_POSITIVE_REGULATION_OF_...656,SET,115,0.031271,0.0024659,0.076307,0.34097,GOBP_POSITIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,0.988294796511628
KEGG_MEDICUS_PATHOGEN_ESCHER...1,SET,14,0.086998,0.0024002,0.21232,0.341,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY,0.988294796511628
GOBP_SUCKLING_BEHAVIOR,SET,11,0.10241,0.0025046,0.25001,0.34104,GOBP_SUCKLING_BEHAVIOR,0.988294796511628
HP_BROAD_FIRST_METATARSAL,SET,5,0.16232,0.002677,0.39628,0.34105,HP_BROAD_FIRST_METATARSAL,0.988294796511628
GOMF_NUCLEOSIDE_MONOPHOSPHAT...,SET,19,0.079635,0.0025591,0.19447,0.34109,GOMF_NUCLEOSIDE_MONOPHOSPHATE_KINASE_ACTIVITY,0.988294796511628
DESCARTES_MAIN_FETAL_GOBLET_...,SET,37,0.064344,0.0028841,0.15715,0.34111,DESCARTES_MAIN_FETAL_GOBLET_CELLS,0.988294796511628
GOBP_REGULATION_OF_DNA_BINDI...2,SET,320,0.019562,0.0025586,0.047794,0.34117,GOBP_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.988294796511628
LIU_SMARCA4_TARGETS,SET,44,0.057091,0.00279,0.13951,0.34119,LIU_SMARCA4_TARGETS,0.988294796511628
HP_ABSENT_SPEECH,SET,364,0.017745,0.0024724,0.043362,0.34119,HP_ABSENT_SPEECH,0.988294796511628
GOBP_RRNA_PSEUDOURIDINE_SYNT...,SET,7,0.11981,0.0023377,0.29284,0.34123,GOBP_RRNA_PSEUDOURIDINE_SYNTHESIS,0.988294796511628
HP_BRADYCARDIA,SET,90,0.037223,0.0025984,0.09101,0.34127,HP_BRADYCARDIA,0.988294796511628
GOBP_POSITIVE_REGULATION_OF_...636,SET,5,0.1708,0.0028168,0.41776,0.34133,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,0.988294796511628
GOBP_MESANGIAL_CELL_DEVELOPM...,SET,5,0.15625,0.0025768,0.38223,0.34135,GOBP_MESANGIAL_CELL_DEVELOPMENT,0.988294796511628
HP_ANODONTIA,SET,13,0.089476,0.0023788,0.2189,0.34136,HP_ANODONTIA,0.988294796511628
GOBP_POSITIVE_REGULATION_OF_...790,SET,20,0.071423,0.0023548,0.17476,0.34139,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_METABOLIC_PROCESS,0.988294796511628
TRAVAGLINI_LUNG_PROLIFERATIN...2,SET,874,0.01168,0.0024857,0.028582,0.3414,TRAVAGLINI_LUNG_PROLIFERATING_MACROPHAGE_CELL,0.988294796511628
GOBP_POSITIVE_REGULATION_OF_...449,SET,38,0.053613,0.0024353,0.13127,0.34149,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,0.988294796511628
GSE40274_FOXP3_VS_FOXP3_AND_...6,SET,138,0.030056,0.0025946,0.073594,0.34149,GSE40274_FOXP3_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.988294796511628
GOBP_POSITIVE_REGULATION_OF_...148,SET,6,0.12778,0.0023084,0.3131,0.3416,GOBP_POSITIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,0.988294796511628
WATANABE_COLON_CANCER_MSI_VS...1,SET,53,0.049668,0.0026634,0.12173,0.34164,WATANABE_COLON_CANCER_MSI_VS_MSS_DN,0.988294796511628
REACTOME_SYNTHESIS_OF_DNA,SET,116,0.028747,0.0022766,0.070465,0.34165,REACTOME_SYNTHESIS_OF_DNA,0.988294796511628
HP_INCREASED_CIRCULATING_IGM...,SET,32,0.063319,0.0026398,0.15521,0.34166,HP_INCREASED_CIRCULATING_IGM_LEVEL,0.988294796511628
GOBP_PEPTIDYL_SERINE_MODIFIC...,SET,256,0.021692,0.0025422,0.053181,0.34168,GOBP_PEPTIDYL_SERINE_MODIFICATION,0.988294796511628
GOBP_COPPER_ION_TRANSMEMBRAN...,SET,7,0.11697,0.0022822,0.2868,0.3417,GOBP_COPPER_ION_TRANSMEMBRANE_TRANSPORT,0.988294796511628
GSE9316_IL6_KO_VS_IFNG_KO_IN...2,SET,184,0.025539,0.0025426,0.062623,0.3417,GSE9316_IL6_KO_VS_IFNG_KO_INVIVO_EXPANDED_CD4_TCELL_UP,0.988294796511628
MA_RAT_AGING_UP,SET,96,0.036408,0.0026245,0.089292,0.34173,MA_RAT_AGING_UP,0.988294796511628
GSE28737_WT_VS_BCL6_HET_FOLL...1,SET,178,0.024902,0.0024388,0.061092,0.34178,GSE28737_WT_VS_BCL6_HET_FOLLICULAR_BCELL_DN,0.988294796511628
HP_APLASIA_INVOLVING_BONES_O...1,SET,22,0.075315,0.0026042,0.18478,0.34179,HP_APLASIA_INVOLVING_BONES_OF_THE_EXTREMITIES,0.988294796511628
MODULE_159,SET,69,0.037698,0.0023055,0.092498,0.3418,MODULE_159,0.988294796511628
GOBP_SPLICEOSOMAL_COMPLEX_AS...,SET,68,0.035687,0.0021667,0.087572,0.34182,GOBP_SPLICEOSOMAL_COMPLEX_ASSEMBLY,0.988294796511628
KANG_IMMORTALIZED_BY_TERT_DN,SET,95,0.037912,0.0027187,0.093048,0.34184,KANG_IMMORTALIZED_BY_TERT_DN,0.988294796511628
GSE46606_DAY1_VS_DAY3_CD40L_...1,SET,175,0.025609,0.002487,0.062886,0.34192,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_BCELL_DN,0.988294796511628
GOBP_NEGATIVE_REGULATION_BY_...2,SET,13,0.087596,0.0023288,0.21511,0.34193,GOBP_NEGATIVE_REGULATION_BY_HOST_OF_VIRAL_PROCESS,0.988294796511628
GOBP_NEGATIVE_REGULATION_OF_...200,SET,13,0.095439,0.0025374,0.23442,0.34196,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.988294796511628
HP_NAUSEA,SET,91,0.035254,0.0024745,0.08659,0.34196,HP_NAUSEA,0.988294796511628
GOCC_NUCLEAR_PORE_CENTRAL_TR...,SET,5,0.14642,0.0024147,0.35969,0.34198,GOCC_NUCLEAR_PORE_CENTRAL_TRANSPORT_CHANNEL,0.988294796511628
MIR3126_5P,SET,59,0.043883,0.0024823,0.10781,0.34199,MIR3126_5P,0.988294796511628
HP_MODERATELY_REDUCED_VISUAL...,SET,7,0.14285,0.0027873,0.35102,0.34202,HP_MODERATELY_REDUCED_VISUAL_ACUITY,0.988294796511628
KIM_LIVER_CANCER_POOR_SURVIV...2,SET,21,0.077034,0.0026024,0.1893,0.34203,KIM_LIVER_CANCER_POOR_SURVIVAL_UP,0.988294796511628
GOBP_POSITIVE_REGULATION_OF_...659,SET,10,0.097535,0.0022745,0.23977,0.34208,GOBP_POSITIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,0.988294796511628
GOBP_DNA_MODIFICATION,SET,38,0.057946,0.0026321,0.14247,0.34211,GOBP_DNA_MODIFICATION,0.988294796511628
MIR4252,SET,86,0.038231,0.0026091,0.094011,0.34213,MIR4252,0.988294796511628
GSE17974_IL4_AND_ANTI_IL12_V...3,SET,168,0.027516,0.0026187,0.067664,0.34213,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_DN,0.988294796511628
MIR520A_3P,SET,304,0.019499,0.002487,0.047977,0.34222,MIR520A_3P,0.988294796511628
GSE4590_PRE_BCELL_VS_VPREB_P...1,SET,147,0.026293,0.002342,0.064701,0.34224,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN,0.988294796511628
REACTOME_NEGATIVE_EPIGENETIC...,SET,44,0.046073,0.0022516,0.1134,0.34227,REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,0.988294796511628
GOCC_PRERIBOSOME_SMALL_SUBUN...,SET,14,0.083107,0.0022929,0.20456,0.34227,GOCC_PRERIBOSOME_SMALL_SUBUNIT_PRECURSOR,0.988294796511628
GSE39110_UNTREATED_VS_IL2_TR...3,SET,186,0.02711,0.0027134,0.066743,0.34231,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_DN,0.988294796511628
MORF_CCNF,SET,72,0.0371,0.0023176,0.091365,0.34235,MORF_CCNF,0.988294796511628
GOMF_OXIDOREDUCTASE_ACTIVITY...2,SET,51,0.047615,0.0025048,0.11726,0.34235,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS,0.988294796511628
MIR6787_3P,SET,90,0.036463,0.0025454,0.089811,0.34237,MIR6787_3P,0.988294796511628
GOBP_CELLULAR_RESPONSE_TO_BR...,SET,10,0.11517,0.0026857,0.28365,0.34237,GOBP_CELLULAR_RESPONSE_TO_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_STIMULUS,0.988294796511628
GSE23925_LIGHT_ZONE_VS_NAIVE...2,SET,181,0.026258,0.0025929,0.064693,0.34242,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_UP,0.988296705619095
SMIRNOV_CIRCULATING_ENDOTHEL...2,SET,145,0.029758,0.0026327,0.073322,0.34243,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP,0.988296705619095
GOMF_HISTONE_H3K9_MONOMETHYL...,SET,6,0.1299,0.0023467,0.32014,0.34246,GOMF_HISTONE_H3K9_MONOMETHYLTRANSFERASE_ACTIVITY,0.988296705619095
MIR515_3P,SET,61,0.044079,0.0025352,0.10872,0.34258,MIR515_3P,0.988296705619095
CEBPA_01,SET,223,0.023938,0.0026208,0.059049,0.34259,CEBPA_01,0.988296705619095
BIOCARTA_NFAT_PATHWAY,SET,50,0.049991,0.0026039,0.12334,0.34263,BIOCARTA_NFAT_PATHWAY,0.988296705619095
HP_SCLEROTIC_VERTEBRAL_ENDPL...,SET,5,0.17206,0.0028376,0.42455,0.34264,HP_SCLEROTIC_VERTEBRAL_ENDPLATES,0.988296705619095
JAZAG_TGFB1_SIGNALING_VIA_SM...1,SET,59,0.04373,0.0024737,0.10791,0.34265,JAZAG_TGFB1_SIGNALING_VIA_SMAD4_DN,0.988296705619095
MIR1225_5P,SET,25,0.066721,0.0024591,0.16468,0.34269,MIR1225_5P,0.988296705619095
GOBP_SENSORY_PERCEPTION_OF_S...1,SET,331,0.026727,0.0035543,0.066013,0.34279,GOBP_SENSORY_PERCEPTION_OF_SMELL,0.988296705619095
HP_CARDIOVASCULAR_CALCIFICAT...,SET,36,0.061475,0.0027181,0.15184,0.34279,HP_CARDIOVASCULAR_CALCIFICATION,0.988296705619095
NAKAYA_PLASMACYTOID_DENDRITI...4,SET,1082,0.010204,0.0024018,0.025204,0.34279,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,0.988296705619095
GOBP_REGULATION_OF_CELL_COMM...2,SET,12,0.1155,0.0029502,0.28529,0.3428,GOBP_REGULATION_OF_CELL_COMMUNICATION_BY_ELECTRICAL_COUPLING_INVOLVED_IN_CARDIAC_CONDUCTION,0.988296705619095
ALONSO_METASTASIS_EMT_DN,SET,5,0.18541,0.0030577,0.45807,0.34283,ALONSO_METASTASIS_EMT_DN,0.988296705619095
GOBP_KERATAN_SULFATE_METABOL...,SET,18,0.083724,0.0026188,0.20687,0.34284,GOBP_KERATAN_SULFATE_METABOLIC_PROCESS,0.988296705619095
GOBP_REGULATION_OF_AXONOGENE...,SET,125,0.031287,0.0025715,0.07731,0.34285,GOBP_REGULATION_OF_AXONOGENESIS,0.988296705619095
HEBERT_MATRISOME_TNBC_BONE_B...2,SET,7,0.13766,0.0026861,0.3402,0.34287,HEBERT_MATRISOME_TNBC_BONE_BRAIN_LUNG_LIVER_METASTASTASES_TUMOR_CELL_DERIVED,0.988296705619095
HP_URETHRAL_STENOSIS,SET,49,0.050844,0.0026218,0.1257,0.34293,HP_URETHRAL_STENOSIS,0.988296705619095
MEISSNER_BRAIN_HCP_WITH_H3K2...,SET,253,0.023819,0.0027753,0.058891,0.34294,MEISSNER_BRAIN_HCP_WITH_H3K27ME3,0.988296705619095
HP_LOBAR_HOLOPROSENCEPHALY,SET,23,0.063039,0.0022286,0.15592,0.34299,HP_LOBAR_HOLOPROSENCEPHALY,0.988296705619095
HP_SPARSE_HAIR,SET,332,0.018675,0.0024872,0.046202,0.34303,HP_SPARSE_HAIR,0.988296705619095
HP_THYROID_DEFECT_IN_OXIDATI...,SET,6,0.13943,0.0025188,0.34494,0.34303,HP_THYROID_DEFECT_IN_OXIDATION_AND_ORGANIFICATION_OF_IODIDE,0.988296705619095
DELLA_RESPONSE_TO_TSA_AND_BU...,SET,20,0.075237,0.0024806,0.18617,0.34306,DELLA_RESPONSE_TO_TSA_AND_BUTYRATE,0.988296705619095
HP_ELEVATED_MATERNAL_CIRCULA...,SET,4,0.18821,0.0027763,0.46577,0.34308,HP_ELEVATED_MATERNAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,0.988296705619095
MODULE_362,SET,19,0.088838,0.0028549,0.2199,0.34311,MODULE_362,0.988296705619095
HP_VERTEBRAL_ARCH_ANOMALY,SET,16,0.077812,0.0022949,0.19261,0.34311,HP_VERTEBRAL_ARCH_ANOMALY,0.988296705619095
GOBP_DISRUPTION_OF_ANATOMICA...,SET,81,0.041562,0.0027531,0.10294,0.3432,GOBP_DISRUPTION_OF_ANATOMICAL_STRUCTURE_IN_ANOTHER_ORGANISM,0.988474020054695
MIR6516_5P,SET,172,0.025758,0.0024801,0.063852,0.34333,MIR6516_5P,0.988476485369215
GOBP_MEIOTIC_CELL_CYCLE_PROC...2,SET,6,0.13834,0.0024991,0.34309,0.3434,GOBP_MEIOTIC_CELL_CYCLE_PROCESS_INVOLVED_IN_OOCYTE_MATURATION,0.988476485369215
GOBP_REGULATION_OF_CELL_CELL...2,SET,19,0.074895,0.0024068,0.18583,0.34346,GOBP_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,0.988476485369215
MIR3675_3P,SET,78,0.040695,0.0026455,0.10099,0.34349,MIR3675_3P,0.988476485369215
GOBP_SKELETAL_MUSCLE_FIBER_D...,SET,11,0.11004,0.0026912,0.27308,0.3435,GOBP_SKELETAL_MUSCLE_FIBER_DIFFERENTIATION,0.988476485369215
REACTOME_MET_RECEPTOR_ACTIVA...,SET,6,0.14619,0.002641,0.36288,0.34352,REACTOME_MET_RECEPTOR_ACTIVATION,0.988476485369215
JIANG_MELANOMA_TRM9_CD8,SET,459,0.015993,0.0024956,0.039702,0.34355,JIANG_MELANOMA_TRM9_CD8,0.988476485369215
GOBP_NON_MEMBRANE_BOUNDED_OR...,SET,385,0.016582,0.0023747,0.041172,0.34357,GOBP_NON_MEMBRANE_BOUNDED_ORGANELLE_ASSEMBLY,0.988476485369215
GOMF_2_ACYLGLYCEROL_O_ACYLTR...,SET,6,0.14933,0.0026977,0.37094,0.34363,GOMF_2_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,0.988476485369215
GOBP_CELLULAR_RESPONSE_TO_NI...3,SET,11,0.10293,0.0025173,0.25569,0.34364,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_LEVELS,0.988476485369215
GSE3982_BASOPHIL_VS_CENT_MEM...2,SET,176,0.025327,0.0024666,0.06292,0.34365,GSE3982_BASOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,0.988476485369215
FARDIN_HYPOXIA_9,SET,7,0.1216,0.0023726,0.30217,0.34369,FARDIN_HYPOXIA_9,0.988476485369215
WIERENGA_STAT5A_TARGETS_GROU...2,SET,50,0.052639,0.0027418,0.13082,0.3437,WIERENGA_STAT5A_TARGETS_GROUP2,0.988476485369215
HP_WHITE_FORELOCK,SET,14,0.10021,0.0027647,0.24904,0.3437,HP_WHITE_FORELOCK,0.988476485369215
MANNO_MIDBRAIN_NEUROTYPES_HE...,SET,806,0.012881,0.0026377,0.032014,0.34371,MANNO_MIDBRAIN_NEUROTYPES_HENDO,0.988476485369215
GOCC_VESICLE_MEMBRANE,SET,1142,0.010422,0.0025158,0.025902,0.34372,GOCC_VESICLE_MEMBRANE,0.988476485369215
GSE15735_CTRL_VS_HDAC_INHIBI...2,SET,179,0.024495,0.0024055,0.060896,0.34376,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_UP,0.988476485369215
GOBP_RANDOM_INACTIVATION_OF_...,SET,6,0.14618,0.0026408,0.36348,0.34378,GOBP_RANDOM_INACTIVATION_OF_X_CHROMOSOME,0.988476485369215
GSE37301_HEMATOPOIETIC_STEM_...9,SET,152,0.027267,0.0024694,0.067797,0.34378,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_DN,0.988476485369215
GOBP_DETECTION_OF_STIMULUS_I...2,SET,27,0.067895,0.0026004,0.16885,0.3438,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,0.988476485369215
HP_HYPOPLASTIC_SACRUM,SET,6,0.13036,0.002355,0.32439,0.3439,HP_HYPOPLASTIC_SACRUM,0.988476485369215
GOMF_FMN_BINDING,SET,15,0.087408,0.0024961,0.21753,0.34391,GOMF_FMN_BINDING,0.988476485369215
ACEVEDO_LIVER_CANCER_WITH_H3...1,SET,141,0.030585,0.0026686,0.076128,0.34394,ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN,0.988476485369215
HOUNKPE_HOUSEKEEPING_GENES,SET,1054,0.0099036,0.0023027,0.024656,0.34396,HOUNKPE_HOUSEKEEPING_GENES,0.988476485369215
GOBP_RECEPTOR_MEDIATED_ENDOC...1,SET,242,0.021901,0.0024966,0.054525,0.34396,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS,0.988476485369215
GOBP_DICARBOXYLIC_ACID_METAB...,SET,89,0.035195,0.0024432,0.087643,0.344,GOBP_DICARBOXYLIC_ACID_METABOLIC_PROCESS,0.988476485369215
MIR561_3P,SET,437,0.016785,0.0025573,0.041819,0.34407,MIR561_3P,0.988476485369215
GSE12839_CTRL_VS_IL12_TREATE...2,SET,135,0.028929,0.0024702,0.072071,0.34407,GSE12839_CTRL_VS_IL12_TREATED_PBMC_UP,0.988476485369215
GOBP_LONG_CHAIN_FATTY_ACID_B...,SET,25,0.072739,0.0026809,0.18125,0.34409,GOBP_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.988476485369215
REACTOME_RHOC_GTPASE_CYCLE,SET,68,0.0429,0.0026046,0.10692,0.34412,REACTOME_RHOC_GTPASE_CYCLE,0.988476485369215
TCGA_GLIOBLASTOMA_MUTATED,SET,8,0.12771,0.0026638,0.3183,0.34413,TCGA_GLIOBLASTOMA_MUTATED,0.988476485369215
REACTOME_DOWNREGULATION_OF_S...,SET,28,0.063867,0.0024909,0.15918,0.34413,REACTOME_DOWNREGULATION_OF_SMAD2_3_SMAD4_TRANSCRIPTIONAL_ACTIVITY,0.988476485369215
GSE36527_CD62L_HIGH_VS_CD62L...1,SET,188,0.024714,0.0024868,0.061607,0.34415,GSE36527_CD62L_HIGH_VS_CD62L_LOW_TREG_CD69_NEG_KLRG1_NEG_DN,0.988476485369215
GOBP_PHOSPHOLIPID_TRANSPORT,SET,95,0.034521,0.0024755,0.086082,0.3442,GOBP_PHOSPHOLIPID_TRANSPORT,0.988476485369215
GAO_LARGE_INTESTINE_ADULT_CI...,SET,307,0.020372,0.0026109,0.050842,0.34432,GAO_LARGE_INTESTINE_ADULT_CI_MESENCHYMAL_CELLS,0.988476485369215
GOBP_CELLULAR_RESPONSE_TO_LE...1,SET,4,0.2011,0.0029664,0.50195,0.34435,GOBP_CELLULAR_RESPONSE_TO_LEAD_ION,0.988476485369215
HP_MULTIPLE_BLADDER_DIVERTIC...,SET,4,0.17274,0.002548,0.43117,0.34435,HP_MULTIPLE_BLADDER_DIVERTICULA,0.988476485369215
MIR4451,SET,133,0.028945,0.0024534,0.072312,0.34448,MIR4451,0.988476485369215
HP_BARREL_SHAPED_CHEST,SET,20,0.076712,0.0025292,0.19165,0.34448,HP_BARREL_SHAPED_CHEST,0.988476485369215
GOBP_GLYCOPROTEIN_CATABOLIC_...,SET,31,0.066965,0.0027479,0.16733,0.34451,GOBP_GLYCOPROTEIN_CATABOLIC_PROCESS,0.988476485369215
HP_SANDAL_GAP,SET,87,0.037452,0.0025706,0.093586,0.34451,HP_SANDAL_GAP,0.988476485369215
HP_LIMB_GIRDLE_MUSCLE_ATROPHY,SET,31,0.057739,0.0023693,0.1443,0.34453,HP_LIMB_GIRDLE_MUSCLE_ATROPHY,0.988476485369215
GSE17721_LPS_VS_GARDIQUIMOD_...3,SET,180,0.024542,0.0024169,0.061345,0.34456,GSE17721_LPS_VS_GARDIQUIMOD_12H_BMDC_DN,0.988476485369215
MIR6728_3P,SET,134,0.029331,0.0024953,0.073353,0.34463,MIR6728_3P,0.988476485369215
HP_ABNORMAL_MORPHOLOGY_OF_TH...1,SET,52,0.04599,0.0024428,0.11506,0.34469,HP_ABNORMAL_MORPHOLOGY_OF_THE_ABDOMINAL_MUSCULATURE,0.988476485369215
HP_ABNORMAL_FRONTAL_BONE_MOR...,SET,365,0.016969,0.0023674,0.042461,0.34472,HP_ABNORMAL_FRONTAL_BONE_MORPHOLOGY,0.988476485369215
TCTGATC_MIR383,SET,46,0.050829,0.0025397,0.1272,0.34473,TCTGATC_MIR383,0.988476485369215
GSE21360_TERTIARY_VS_QUATERN...2,SET,173,0.026591,0.0025677,0.066569,0.34478,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,0.988476485369215
WP_PURINE_METABOLISM,SET,10,0.11684,0.0027246,0.29253,0.3448,WP_PURINE_METABOLISM,0.988476485369215
GOCC_NUCLEAR_CYCLIN_DEPENDEN...,SET,13,0.077884,0.0020706,0.19511,0.34489,GOCC_NUCLEAR_CYCLIN_DEPENDENT_PROTEIN_KINASE_HOLOENZYME_COMPLEX,0.988476485369215
KEGG_MEDICUS_VARIANT_MUTATIO...73,SET,14,0.088064,0.0024296,0.22067,0.34492,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_FGF17_TO_RAS_ERK_SIGNALING_PATHWAY,0.988476485369215
GOBP_PROTEIN_LOCALIZATION_TO...18,SET,14,0.098797,0.0027257,0.2476,0.34494,GOBP_PROTEIN_LOCALIZATION_TO_CONDENSED_CHROMOSOME,0.988476485369215
NICK_RESPONSE_TO_PROC_TREATM...1,SET,23,0.062265,0.0022013,0.15607,0.34496,NICK_RESPONSE_TO_PROC_TREATMENT_DN,0.988476485369215
GOMF_NUCLEOBASE_CONTAINING_C...1,SET,40,0.053011,0.0024704,0.13287,0.34496,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_KINASE_ACTIVITY,0.988476485369215
HP_FOCAL_EMOTIONAL_SEIZURE,SET,17,0.082752,0.0025156,0.20748,0.34501,HP_FOCAL_EMOTIONAL_SEIZURE,0.988476485369215
GSE22886_IGA_VS_IGM_MEMORY_B...1,SET,186,0.024673,0.0024695,0.061871,0.34503,GSE22886_IGA_VS_IGM_MEMORY_BCELL_DN,0.988476485369215
HP_SMALL_PITUITARY_GLAND,SET,12,0.09969,0.0025465,0.25029,0.34521,HP_SMALL_PITUITARY_GLAND,0.988476485369215
MIR374B_5P,SET,343,0.019056,0.0025788,0.047849,0.34523,MIR374B_5P,0.988476485369215
NABA_MATRISOME,SET,950,0.012465,0.0027598,0.031303,0.34524,NABA_MATRISOME,0.988476485369215
BIOCARTA_IL5_PATHWAY,SET,9,0.11924,0.002638,0.29947,0.34526,BIOCARTA_IL5_PATHWAY,0.988476485369215
PGF_UP.V1_UP,SET,167,0.026862,0.0025489,0.067465,0.34526,PGF_UP.V1_UP,0.988476485369215
HP_APLASIA_HYPOPLASIA_INVOLV...6,SET,15,0.086653,0.0024745,0.21766,0.34528,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CARPAL_BONES,0.988476485369215
ZHONG_RESPONSE_TO_AZACITIDIN...2,SET,150,0.026999,0.0024292,0.067838,0.34532,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_UP,0.988476485369215
WP_GLP1_IN_PANCREATIC_ISLET_...,SET,7,0.14767,0.0028813,0.37103,0.34532,WP_GLP1_IN_PANCREATIC_ISLET_CELLS,0.988476485369215
IGARASHI_ATF4_TARGETS_UP,SET,4,0.2237,0.0032997,0.56234,0.34539,IGARASHI_ATF4_TARGETS_UP,0.988476485369215
GOBP_REGULATION_OF_T_CELL_ME...2,SET,10,0.12924,0.0030138,0.32508,0.34548,GOBP_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.988476485369215
ATAAGCT_MIR21,SET,111,0.03126,0.002422,0.078646,0.34551,ATAAGCT_MIR21,0.988476485369215
HP_UNSTEADY_GAIT,SET,169,0.025112,0.002397,0.063185,0.34552,HP_UNSTEADY_GAIT,0.988476485369215
GSE14308_NAIVE_CD4_TCELL_VS_...2,SET,178,0.024697,0.0024187,0.062163,0.34558,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP,0.988476485369215
GSE16385_IFNG_TNF_VS_IL4_STI...2,SET,174,0.024509,0.0023735,0.061695,0.34559,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...62,SET,7,0.13568,0.0026475,0.34157,0.3456,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,0.988476485369215
GOCC_NUCLEOLAR_EXOSOME_RNASE...,SET,9,0.093151,0.0020608,0.23449,0.3456,GOCC_NUCLEOLAR_EXOSOME_RNASE_COMPLEX,0.988476485369215
GOBP_CELLULAR_RESPONSE_TO_EX...2,SET,72,0.042614,0.002662,0.10728,0.34561,GOBP_CELLULAR_RESPONSE_TO_EXTERNAL_STIMULUS,0.988476485369215
MIR129_1_3P_MIR129_2_3P,SET,120,0.02981,0.0024008,0.075053,0.34562,MIR129_1_3P_MIR129_2_3P,0.988476485369215
GSE12963_ENV_NEF_VS_ENV_NEF_...2,SET,117,0.029676,0.0023602,0.07475,0.34568,GSE12963_ENV_NEF_VS_ENV_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,0.988476485369215
GOMF_GLYCEROL_3_PHOSPHATE_O_...,SET,3,0.21654,0.0027664,0.54545,0.34569,GOMF_GLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,0.988476485369215
GSE1925_CTRL_VS_24H_IFNG_STI...1,SET,186,0.024445,0.0024467,0.061587,0.34571,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,0.988476485369215
SP1_01,SET,216,0.022916,0.0024696,0.057736,0.34572,SP1_01,0.988476485369215
CP2_01,SET,238,0.021711,0.0024545,0.05471,0.34575,CP2_01,0.988476485369215
GOBP_CEREBELLAR_PURKINJE_CEL...2,SET,12,0.098015,0.0025037,0.24708,0.3458,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_FORMATION,0.988476485369215
GOBP_QUINOLINATE_METABOLIC_P...,SET,5,0.1593,0.0026271,0.40162,0.34582,GOBP_QUINOLINATE_METABOLIC_PROCESS,0.988476485369215
HP_PNEUMONIA,SET,275,0.020312,0.002466,0.051211,0.34582,HP_PNEUMONIA,0.988476485369215
GSE36888_STAT5_AB_KNOCKIN_VS...5,SET,181,0.024185,0.0023883,0.061017,0.34592,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_DN,0.988476485369215
HP_SEVERE_COMBINED_IMMUNODEF...,SET,19,0.08002,0.0025715,0.20191,0.34593,HP_SEVERE_COMBINED_IMMUNODEFICIENCY,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...254,SET,39,0.056337,0.0025924,0.14216,0.34594,GOBP_NEGATIVE_REGULATION_OF_GLIOGENESIS,0.988476485369215
MIR3682_3P,SET,72,0.039848,0.0024892,0.10055,0.34595,MIR3682_3P,0.988476485369215
REACTOME_POLYMERASE_SWITCHING,SET,13,0.083908,0.0022308,0.21188,0.34605,REACTOME_POLYMERASE_SWITCHING,0.988476485369215
GOBP_INTERLEUKIN_10_PRODUCTI...,SET,52,0.05148,0.0027344,0.13001,0.34607,GOBP_INTERLEUKIN_10_PRODUCTION,0.988476485369215
MODULE_186,SET,19,0.082174,0.0026407,0.20756,0.34609,MODULE_186,0.988476485369215
MIR32_5P,SET,434,0.01639,0.0024886,0.041407,0.34612,MIR32_5P,0.988476485369215
GSE22601_DOUBLE_NEGATIVE_VS_...8,SET,172,0.024302,0.00234,0.061407,0.34614,GSE22601_DOUBLE_NEGATIVE_VS_IMMATURE_CD4_SP_THYMOCYTE_UP,0.988476485369215
GSE46468_LUNG_INNATE_LYMPHOI...2,SET,164,0.02442,0.0022964,0.0617,0.34614,GSE46468_LUNG_INNATE_LYMPHOID_CELL_VS_SPLEEN_CD4_TCELL_UP,0.988476485369215
HP_METOPIC_SYNOSTOSIS,SET,23,0.058548,0.0020699,0.14795,0.34616,HP_METOPIC_SYNOSTOSIS,0.988476485369215
GOBP_5_PHOSPHORIBOSE_1_DIPHO...,SET,4,0.14964,0.0022074,0.37823,0.34619,GOBP_5_PHOSPHORIBOSE_1_DIPHOSPHATE_METABOLIC_PROCESS,0.988476485369215
HP_POLYHYDRAMNIOS,SET,263,0.020468,0.0024309,0.051739,0.3462,HP_POLYHYDRAMNIOS,0.988476485369215
HP_SHORT_CLAVICLES,SET,29,0.060774,0.0024122,0.1538,0.34637,HP_SHORT_CLAVICLES,0.988476485369215
GSE3720_UNSTIM_VS_LPS_STIM_V...4,SET,143,0.028355,0.0024914,0.07177,0.34639,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_UP,0.988476485369215
CHEBOTAEV_GR_TARGETS_UP,SET,76,0.040132,0.0025753,0.1016,0.34642,CHEBOTAEV_GR_TARGETS_UP,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...164,SET,48,0.04517,0.0023054,0.11436,0.34643,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,0.988476485369215
GOBP_REGULATION_OF_BEHAVIOR,SET,71,0.043822,0.0027184,0.11096,0.34644,GOBP_REGULATION_OF_BEHAVIOR,0.988476485369215
GOMF_SEQUENCE_SPECIFIC_DNA_B...,SET,1525,0.0096101,0.0026509,0.024335,0.34646,GOMF_SEQUENCE_SPECIFIC_DNA_BINDING,0.988476485369215
YAGI_AML_WITH_11Q23_REARRANG...,SET,305,0.019192,0.0024517,0.048609,0.34649,YAGI_AML_WITH_11Q23_REARRANGED,0.988476485369215
KEGG_MEDICUS_ENV_FACTOR_PHIP...,SET,3,0.21386,0.002732,0.5418,0.34653,KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS,0.988476485369215
GSE21927_SPLENIC_C26GM_TUMOR...1,SET,162,0.025382,0.0023725,0.064312,0.34655,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_DN,0.988476485369215
ZNF165_TARGET_GENES,SET,67,0.039837,0.0024009,0.10097,0.3466,ZNF165_TARGET_GENES,0.988476485369215
HP_PURPURA,SET,117,0.031935,0.0025399,0.080951,0.34661,HP_PURPURA,0.988476485369215
MIR4465,SET,395,0.016975,0.0024616,0.043041,0.34665,MIR4465,0.988476485369215
GSE26030_TH1_VS_TH17_RESTIMU...1,SET,181,0.024091,0.002379,0.061084,0.34665,GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_DN,0.988476485369215
HP_ABNORMAL_LEFT_VENTRICULAR...,SET,26,0.067939,0.0025535,0.1723,0.34668,HP_ABNORMAL_LEFT_VENTRICULAR_OUTFLOW_TRACT_MORPHOLOGY,0.988476485369215
ATF_01,SET,240,0.021814,0.0024764,0.055357,0.34677,ATF_01,0.988476485369215
SMID_BREAST_CANCER_ERBB2_UP,SET,127,0.029591,0.0024513,0.075124,0.34683,SMID_BREAST_CANCER_ERBB2_UP,0.988476485369215
KEGG_VIRAL_MYOCARDITIS,SET,64,0.044517,0.0026224,0.11302,0.34683,KEGG_VIRAL_MYOCARDITIS,0.988476485369215
MOOTHA_VOXPHOS,SET,68,0.034621,0.002102,0.087899,0.34684,MOOTHA_VOXPHOS,0.988476485369215
MIR1295B_5P,SET,69,0.039431,0.0024115,0.10012,0.34686,MIR1295B_5P,0.988476485369215
GSE8685_IL15_ACT_IL2_STARVED...2,SET,149,0.028121,0.0025217,0.071405,0.34686,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,0.988476485369215
chr5p12,SET,12,0.15431,0.0039417,0.39194,0.3469,chr5p12,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...132,SET,5,0.11484,0.0018939,0.29181,0.34696,GOBP_NEGATIVE_REGULATION_OF_CERAMIDE_BIOSYNTHETIC_PROCESS,0.988476485369215
KEGG_MEDICUS_REFERENCE_TYPE_...2,SET,20,0.084463,0.0027847,0.21465,0.34698,KEGG_MEDICUS_REFERENCE_TYPE_I_IFN_SIGNALING_PATHWAY,0.988476485369215
MIR190B_5P,SET,104,0.034098,0.0025577,0.086667,0.347,MIR190B_5P,0.988476485369215
GOBP_PARACRINE_SIGNALING,SET,6,0.14833,0.0026796,0.37701,0.347,GOBP_PARACRINE_SIGNALING,0.988476485369215
GOBP_REGULATION_OF_PROTEIN_C...3,SET,13,0.082445,0.0021919,0.20955,0.347,GOBP_REGULATION_OF_PROTEIN_COMPLEX_STABILITY,0.988476485369215
TOMLINS_METASTASIS_UP,SET,14,0.093593,0.0025821,0.23792,0.34702,TOMLINS_METASTASIS_UP,0.988476485369215
REACTOME_MET_ACTIVATES_RAS_S...,SET,10,0.095701,0.0022317,0.24334,0.34706,REACTOME_MET_ACTIVATES_RAS_SIGNALING,0.988476485369215
MIR4280,SET,43,0.051114,0.0024695,0.12997,0.34706,MIR4280,0.988476485369215
GOBP_TRANSPORT_OF_VIRUS,SET,20,0.075085,0.0024755,0.19091,0.34706,GOBP_TRANSPORT_OF_VIRUS,0.988476485369215
GSE3982_DC_VS_NEUTROPHIL_DN,SET,172,0.025297,0.0024358,0.064323,0.34706,GSE3982_DC_VS_NEUTROPHIL_DN,0.988476485369215
GOBP_REGULATION_OF_PROTEIN_D...2,SET,69,0.039424,0.002411,0.10035,0.34722,GOBP_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,0.988476485369215
GOMF_RNA_POLYMERASE_II_ACTIV...,SET,9,0.0909,0.002011,0.23139,0.34722,GOMF_RNA_POLYMERASE_II_ACTIVITY,0.988476485369215
CHAF1A_TARGET_GENES,SET,79,0.038391,0.0025116,0.097735,0.34723,CHAF1A_TARGET_GENES,0.988476485369215
GSE22886_NAIVE_CD8_TCELL_VS_...10,SET,175,0.024779,0.0024064,0.063114,0.34731,GSE22886_NAIVE_CD8_TCELL_VS_NKCELL_UP,0.988476485369215
GOMF_PHOSPHATIDYLSERINE_FLIP...,SET,4,0.15634,0.0023061,0.39848,0.34741,GOMF_PHOSPHATIDYLSERINE_FLIPPASE_ACTIVITY,0.988476485369215
REACTOME_NEGATIVE_REGULATION...13,SET,116,0.031981,0.0025327,0.081528,0.34743,REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK,0.988476485369215
GOBP_PROTEIN_IMPORT_INTO_PER...2,SET,5,0.14234,0.0023475,0.36304,0.3475,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_RECEPTOR_RECYCLING,0.988476485369215
REACTOME_BETA_CATENIN_INDEPE...,SET,142,0.026407,0.0023122,0.067355,0.34751,REACTOME_BETA_CATENIN_INDEPENDENT_WNT_SIGNALING,0.988476485369215
GOCC_PRESYNAPTIC_MEMBRANE,SET,159,0.028444,0.0026341,0.072562,0.34753,GOCC_PRESYNAPTIC_MEMBRANE,0.988476485369215
WP_ETHER_LIPID_BIOSYNTHESIS,SET,19,0.07616,0.0024475,0.1944,0.34762,WP_ETHER_LIPID_BIOSYNTHESIS,0.988476485369215
REACTOME_CD28_DEPENDENT_VAV1...,SET,11,0.097549,0.0023858,0.24904,0.34764,REACTOME_CD28_DEPENDENT_VAV1_PATHWAY,0.988476485369215
HP_ELEVATED_CIRCULATING_LUTE...,SET,35,0.053838,0.0023472,0.13752,0.34771,HP_ELEVATED_CIRCULATING_LUTEINIZING_HORMONE_LEVEL,0.988476485369215
KEGG_MEDICUS_PATHOGEN_HCMV_U...5,SET,13,0.096631,0.0025691,0.24683,0.34772,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNA12_13_RHO_SIGNALING_PATHWAY,0.988476485369215
HP_PARTIAL_ALBINISM,SET,9,0.11948,0.0026434,0.30521,0.34772,HP_PARTIAL_ALBINISM,0.988476485369215
GOMF_PEPTIDE_BINDING,SET,234,0.02313,0.0025932,0.059087,0.34774,GOMF_PEPTIDE_BINDING,0.988476485369215
HP_LUPUS_NEPHRITIS,SET,25,0.070754,0.0026077,0.18077,0.34776,HP_LUPUS_NEPHRITIS,0.988476485369215
KEGG_MEDICUS_REFERENCE_GLYCO...1,SET,5,0.13159,0.0021702,0.33625,0.34777,KEGG_MEDICUS_REFERENCE_GLYCOGEN_BIOSYNTHESIS,0.988476485369215
CCANNAGRKGGC_UNKNOWN,SET,106,0.032827,0.0024858,0.083881,0.34777,CCANNAGRKGGC_UNKNOWN,0.988476485369215
GOBP_REGULATION_OF_XENOPHAGY,SET,9,0.097048,0.002147,0.24801,0.34778,GOBP_REGULATION_OF_XENOPHAGY,0.988476485369215
GOBP_DNA_BIOSYNTHETIC_PROCESS,SET,177,0.023024,0.0022486,0.05885,0.34781,GOBP_DNA_BIOSYNTHETIC_PROCESS,0.988476485369215
ACATTCC_MIR1_MIR206,SET,279,0.019767,0.0024169,0.050526,0.34782,ACATTCC_MIR1_MIR206,0.988476485369215
MAYBURD_RESPONSE_TO_L663536_...1,SET,51,0.042734,0.002248,0.10924,0.34783,MAYBURD_RESPONSE_TO_L663536_DN,0.988476485369215
GOBP_REGULATION_OF_PROTEIN_D...4,SET,9,0.097812,0.0021639,0.25008,0.34786,GOBP_REGULATION_OF_PROTEIN_DEUBIQUITINATION,0.988476485369215
GOBP_ANAPHASE_PROMOTING_COMP...,SET,22,0.063263,0.0021875,0.16177,0.34787,GOBP_ANAPHASE_PROMOTING_COMPLEX_DEPENDENT_CATABOLIC_PROCESS,0.988476485369215
PID_MTOR_4PATHWAY,SET,67,0.04054,0.0024432,0.10368,0.34789,PID_MTOR_4PATHWAY,0.988476485369215
HP_ABDOMINAL_AORTIC_ANEURYSM,SET,22,0.075833,0.0026221,0.19394,0.34789,HP_ABDOMINAL_AORTIC_ANEURYSM,0.988476485369215
GOBP_CELLULAR_RESPONSE_TO_MA...3,SET,9,0.10425,0.0023063,0.26675,0.34797,GOBP_CELLULAR_RESPONSE_TO_MANGANESE_ION,0.988476485369215
GOBP_GLOMERULAR_EPITHELIUM_D...,SET,25,0.075304,0.0027754,0.1928,0.34805,GOBP_GLOMERULAR_EPITHELIUM_DEVELOPMENT,0.988476485369215
REACTOME_FORMATION_OF_AXIAL_...,SET,13,0.098595,0.0026213,0.25247,0.34808,REACTOME_FORMATION_OF_AXIAL_MESODERM,0.988476485369215
ALONSO_METASTASIS_UP,SET,175,0.024457,0.0023751,0.06264,0.34811,ALONSO_METASTASIS_UP,0.988476485369215
KYNG_DNA_DAMAGE_BY_GAMMA_AND...,SET,74,0.038466,0.0024359,0.09852,0.34811,KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION,0.988476485369215
HP_FAIR_HAIR,SET,17,0.084933,0.0025819,0.21755,0.34812,HP_FAIR_HAIR,0.988476485369215
GOMF_HISTONE_BINDING,SET,204,0.02236,0.0023426,0.05729,0.34816,GOMF_HISTONE_BINDING,0.988476485369215
GSE40274_FOXP3_VS_FOXP3_AND_...8,SET,176,0.025315,0.0024653,0.064865,0.34817,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.988476485369215
MIR155_3P,SET,85,0.035058,0.0023786,0.089835,0.34818,MIR155_3P,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...609,SET,22,0.071347,0.002467,0.18289,0.34823,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_POPULATION_MAINTENANCE,0.988476485369215
GOBP_EPITHELIUM_DEVELOPMENT,SET,1134,0.010742,0.0025846,0.027537,0.34824,GOBP_EPITHELIUM_DEVELOPMENT,0.988476485369215
WP_RAS_SIGNALING,SET,174,0.025095,0.0024302,0.064345,0.34827,WP_RAS_SIGNALING,0.988476485369215
GOCC_MALE_GERM_CELL_NUCLEUS,SET,48,0.043716,0.0022312,0.11212,0.3483,GOCC_MALE_GERM_CELL_NUCLEUS,0.988476485369215
HP_STRIDOR,SET,45,0.049139,0.0024285,0.12608,0.34837,HP_STRIDOR,0.988476485369215
GSE45365_BCELL_VS_CD8_TCELL_...2,SET,149,0.028069,0.0025171,0.072044,0.34841,GSE45365_BCELL_VS_CD8_TCELL_UP,0.988476485369215
GOBP_REGULATION_OF_SPONTANEO...,SET,5,0.14979,0.0024703,0.38457,0.34846,GOBP_REGULATION_OF_SPONTANEOUS_SYNAPTIC_TRANSMISSION,0.988476485369215
GSE360_L_DONOVANI_VS_L_MAJOR...3,SET,177,0.024322,0.0023754,0.062452,0.34847,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_DN,0.988476485369215
GOBP_NEURAL_CREST_CELL_DIFFE...,SET,87,0.038168,0.0026198,0.098052,0.34854,GOBP_NEURAL_CREST_CELL_DIFFERENTIATION,0.988476485369215
REACTOME_UCH_PROTEINASES,SET,80,0.035045,0.0023071,0.090056,0.34859,REACTOME_UCH_PROTEINASES,0.988476485369215
WP_VITAMIN_D_IN_INFLAMMATORY...,SET,20,0.073347,0.0024182,0.1885,0.3486,WP_VITAMIN_D_IN_INFLAMMATORY_DISEASES,0.988476485369215
MIR4515,SET,38,0.053735,0.0024408,0.13813,0.34863,MIR4515,0.988476485369215
KEGG_MEDICUS_REFERENCE_EGF_E...5,SET,15,0.088465,0.0025263,0.22741,0.34864,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PLCG_CAMK_SIGNALING_PATHWAY,0.988476485369215
GOCC_CUL4_RING_E3_UBIQUITIN_...,SET,31,0.057141,0.0023448,0.14689,0.34864,GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.988476485369215
GOBP_AXON_ENSHEATHMENT_IN_CE...,SET,23,0.070883,0.0025059,0.18223,0.34865,GOBP_AXON_ENSHEATHMENT_IN_CENTRAL_NERVOUS_SYSTEM,0.988476485369215
CARRILLOREIXACH_HEPATOBLASTO...4,SET,736,0.01266,0.0024822,0.032548,0.34866,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP,0.988476485369215
MISSIAGLIA_REGULATED_BY_METH...2,SET,109,0.03292,0.0025277,0.08466,0.3487,MISSIAGLIA_REGULATED_BY_METHYLATION_UP,0.988476485369215
HP_EYELID_COLOBOMA,SET,34,0.05403,0.0023217,0.13896,0.34871,HP_EYELID_COLOBOMA,0.988476485369215
HOSHIDA_LIVER_CANCER_SUBCLAS...1,SET,216,0.02236,0.0024097,0.057517,0.34873,HOSHIDA_LIVER_CANCER_SUBCLASS_S1,0.988476485369215
GOBP_POSITIVE_REGULATION_OF_...219,SET,65,0.038876,0.0023078,0.10004,0.34879,GOBP_POSITIVE_REGULATION_OF_DNA_RECOMBINATION,0.988476485369215
GOBP_CALCIUM_ACTIVATED_PHOSP...,SET,5,0.15795,0.0026048,0.40669,0.34888,GOBP_CALCIUM_ACTIVATED_PHOSPHOLIPID_SCRAMBLING,0.988476485369215
GOBP_SULFUR_COMPOUND_TRANSPO...,SET,60,0.042809,0.002442,0.11026,0.34891,GOBP_SULFUR_COMPOUND_TRANSPORT,0.988476485369215
GOBP_REGULATION_OF_SODIUM_IO...1,SET,52,0.049603,0.0026347,0.12779,0.34895,GOBP_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,0.988476485369215
KEGG_MEDICUS_REFERENCE_ESTAB...,SET,5,0.13451,0.0022184,0.3466,0.34898,KEGG_MEDICUS_REFERENCE_ESTABLISHMENT_OF_COHESION,0.988476485369215
ZNF513_TARGET_GENES,SET,614,0.013669,0.0024563,0.035227,0.349,ZNF513_TARGET_GENES,0.988476485369215
MIR4328,SET,518,0.014805,0.0024502,0.038157,0.34901,MIR4328,0.988476485369215
GOBP_BRANCHING_INVOLVED_IN_L...,SET,12,0.10177,0.0025995,0.2623,0.34902,GOBP_BRANCHING_INVOLVED_IN_LABYRINTHINE_LAYER_MORPHOGENESIS,0.988476485369215
GOBP_REGULATION_OF_HORMONE_M...,SET,38,0.054867,0.0024923,0.14146,0.34906,GOBP_REGULATION_OF_HORMONE_METABOLIC_PROCESS,0.988476485369215
REACTOME_DEFECTIVE_CFTR_CAUS...,SET,58,0.038138,0.002139,0.098341,0.34908,REACTOME_DEFECTIVE_CFTR_CAUSES_CYSTIC_FIBROSIS,0.988476485369215
MIR518D_5P_MIR518F_5P_MIR520...,SET,85,0.034533,0.002343,0.089045,0.34908,MIR518D_5P_MIR518F_5P_MIR520C_5P_MIR526A_5P,0.988476485369215
GSE3337_CTRL_VS_4H_IFNG_IN_C...2,SET,185,0.024253,0.002421,0.062541,0.34909,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_UP,0.988476485369215
REACTOME_SIGNALING_BY_NOTCH4,SET,77,0.034021,0.0021975,0.087741,0.3491,REACTOME_SIGNALING_BY_NOTCH4,0.988476485369215
GOBP_NATURAL_KILLER_CELL_CYT...,SET,8,0.12797,0.0026694,0.33005,0.3491,GOBP_NATURAL_KILLER_CELL_CYTOKINE_PRODUCTION,0.988476485369215
MDM2_TARGET_GENES,SET,9,0.093865,0.0020766,0.24229,0.34923,MDM2_TARGET_GENES,0.988476485369215
GOMF_ARMADILLO_REPEAT_DOMAIN...,SET,8,0.10429,0.0021754,0.26931,0.34929,GOMF_ARMADILLO_REPEAT_DOMAIN_BINDING,0.988476485369215
NAKAYA_MYELOID_DENDRITIC_CEL...2,SET,355,0.016813,0.0023141,0.043419,0.34929,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.988476485369215
HP_MYOCLONIC_ABSENCE_SEIZURE,SET,14,0.089363,0.0024655,0.23078,0.3493,HP_MYOCLONIC_ABSENCE_SEIZURE,0.988476485369215
WONG_ADULT_TISSUE_STEM_MODULE,SET,660,0.013566,0.0025243,0.035046,0.34934,WONG_ADULT_TISSUE_STEM_MODULE,0.988476485369215
HP_ABNORMAL_PERISTALSIS,SET,21,0.069725,0.0023555,0.18013,0.34935,HP_ABNORMAL_PERISTALSIS,0.988476485369215
MIR188_3P,SET,139,0.027132,0.0023506,0.070109,0.34938,MIR188_3P,0.988476485369215
MIR553,SET,10,0.096149,0.0022422,0.24852,0.34942,MIR553,0.988476485369215
YAMASHITA_METHYLATED_IN_PROS...,SET,59,0.045216,0.0025578,0.11689,0.34944,YAMASHITA_METHYLATED_IN_PROSTATE_CANCER,0.988476485369215
UEDA_PERIFERAL_CLOCK,SET,157,0.026825,0.0024687,0.06935,0.34945,UEDA_PERIFERAL_CLOCK,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...556,SET,5,0.15739,0.0025956,0.40689,0.34945,GOBP_NEGATIVE_REGULATION_OF_REGULATORY_T_CELL_DIFFERENTIATION,0.988476485369215
GOBP_POSITIVE_REGULATION_OF_...130,SET,137,0.028491,0.0024506,0.073657,0.34945,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH,0.988476485369215
GNATENKO_PLATELET_SIGNATURE,SET,34,0.057052,0.0024516,0.14754,0.3495,GNATENKO_PLATELET_SIGNATURE,0.988476485369215
GOBP_MITOTIC_CYTOKINESIS,SET,88,0.032018,0.0022102,0.0828,0.3495,GOBP_MITOTIC_CYTOKINESIS,0.988476485369215
HP_PRURITUS,SET,140,0.028077,0.0024411,0.072611,0.3495,HP_PRURITUS,0.988476485369215
REACTOME_REPRESSION_OF_WNT_T...,SET,13,0.09586,0.0025486,0.24795,0.34952,REACTOME_REPRESSION_OF_WNT_TARGET_GENES,0.988476485369215
REACTOME_ORC1_REMOVAL_FROM_C...,SET,68,0.035391,0.0021487,0.091566,0.34956,REACTOME_ORC1_REMOVAL_FROM_CHROMATIN,0.988476485369215
GOMF_4_IRON_4_SULFUR_CLUSTER...,SET,44,0.048959,0.0023927,0.12668,0.34958,GOMF_4_IRON_4_SULFUR_CLUSTER_BINDING,0.988476485369215
GSE2770_UNTREATED_VS_TGFB_AN...9,SET,184,0.023926,0.002382,0.061916,0.34959,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_48H_DN,0.988476485369215
REACTOME_ACTIVATED_NTRK2_SIG...3,SET,7,0.12603,0.0024591,0.32617,0.34961,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FYN,0.988476485369215
NAKAYA_MONOCYTE_FLUARIX_FLUV...2,SET,75,0.036503,0.0023271,0.094485,0.34962,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.988476485369215
GOBP_VASCULOGENESIS_INVOLVED...,SET,4,0.19364,0.0028563,0.50128,0.34964,GOBP_VASCULOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,0.988476485369215
HP_INCREASED_CIRCULATING_LAC...1,SET,180,0.021878,0.0021545,0.056635,0.34964,HP_INCREASED_CIRCULATING_LACTATE_CONCENTRATION,0.988476485369215
GOBP_REGULATION_OF_ASTROCYTE...2,SET,27,0.068009,0.0026048,0.17608,0.34966,GOBP_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,0.988476485369215
HP_DELAYED_EARLY_CHILDHOOD_S...,SET,20,0.068533,0.0022595,0.17746,0.34968,HP_DELAYED_EARLY_CHILDHOOD_SOCIAL_MILESTONE_DEVELOPMENT,0.988476485369215
GOBP_REGULATION_OF_PROTEIN_K...5,SET,18,0.082815,0.0025904,0.21447,0.3497,GOBP_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,0.988476485369215
MIR1225_3P,SET,56,0.044716,0.0024645,0.11581,0.34971,MIR1225_3P,0.988476485369215
GOBP_POSITIVE_REGULATION_OF_...513,SET,21,0.076449,0.0025827,0.198,0.34971,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,0.988476485369215
MIR143_5P,SET,120,0.030303,0.0024406,0.078489,0.34972,MIR143_5P,0.988476485369215
HP_COARCTATION_OF_AORTA,SET,128,0.028237,0.0023483,0.073168,0.34978,HP_COARCTATION_OF_AORTA,0.988476485369215
HP_FATIGABLE_WEAKNESS_OF_RES...,SET,57,0.04159,0.0023126,0.10778,0.34979,HP_FATIGABLE_WEAKNESS_OF_RESPIRATORY_MUSCLES,0.988476485369215
MIR6871_3P,SET,116,0.031665,0.0025077,0.082083,0.34984,MIR6871_3P,0.988476485369215
MIR4302,SET,115,0.030671,0.0024185,0.079511,0.34985,MIR4302,0.988476485369215
HP_DEVELOPMENTAL_REGRESSION,SET,360,0.016735,0.0023192,0.043389,0.34986,HP_DEVELOPMENTAL_REGRESSION,0.988476485369215
HP_EBSTEIN_ANOMALY_OF_THE_TR...,SET,5,0.16615,0.0027401,0.43091,0.34991,HP_EBSTEIN_ANOMALY_OF_THE_TRICUSPID_VALVE,0.988476485369215
JONES_OVARY_MACROPHAGE,SET,215,0.023791,0.0025581,0.061704,0.34991,JONES_OVARY_MACROPHAGE,0.988476485369215
MIR450A_2_3P,SET,115,0.030683,0.0024195,0.079587,0.34992,MIR450A_2_3P,0.988476485369215
KEGG_MEDICUS_VARIANT_MUTATIO...42,SET,5,0.12518,0.0020645,0.32473,0.34994,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,0.988476485369215
HP_J_SHAPED_SELLA_TURCICA,SET,12,0.090775,0.0023187,0.23554,0.34997,HP_J_SHAPED_SELLA_TURCICA,0.988476485369215
PID_IGF1_PATHWAY,SET,28,0.064072,0.0024989,0.16629,0.35001,PID_IGF1_PATHWAY,0.988476485369215
GOBP_MUSCLE_CELL_DEVELOPMENT,SET,185,0.024059,0.0024016,0.062442,0.35001,GOBP_MUSCLE_CELL_DEVELOPMENT,0.988476485369215
HP_CALCIFIC_STIPPLING,SET,3,0.22803,0.0029131,0.59184,0.35001,HP_CALCIFIC_STIPPLING,0.988476485369215
GOBP_LIPID_DROPLET_FORMATION,SET,12,0.095033,0.0024275,0.24674,0.35007,GOBP_LIPID_DROPLET_FORMATION,0.988476485369215
REACTOME_TRANSPORT_OF_THE_SL...,SET,33,0.051211,0.0021681,0.133,0.35011,REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA,0.988476485369215
GOMF_ACETYL_COA_C_ACYLTRANSF...,SET,7,0.1087,0.002121,0.28237,0.35014,GOMF_ACETYL_COA_C_ACYLTRANSFERASE_ACTIVITY,0.988476485369215
GOMF_HISTONE_H4_METHYLTRANSF...,SET,13,0.091574,0.0024346,0.23788,0.35014,GOMF_HISTONE_H4_METHYLTRANSFERASE_ACTIVITY,0.988476485369215
GOBP_DETECTION_OF_EXTERNAL_B...,SET,23,0.070609,0.0024963,0.18352,0.35021,GOBP_DETECTION_OF_EXTERNAL_BIOTIC_STIMULUS,0.988476485369215
GSE2585_AIRE_KO_VS_WT_CD80_L...2,SET,165,0.025797,0.0024333,0.06705,0.35022,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_UP,0.988476485369215
GOCC_MICROBODY_MEMBRANE,SET,57,0.041847,0.0023268,0.10878,0.35023,GOCC_MICROBODY_MEMBRANE,0.988476485369215
ZNF2_TARGET_GENES,SET,941,0.010689,0.002356,0.027792,0.35026,ZNF2_TARGET_GENES,0.988476485369215
REACTOME_N_GLYCAN_ANTENNAE_E...1,SET,15,0.093463,0.002669,0.24302,0.35028,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION,0.988476485369215
GAVISH_3CA_METAPROGRAM_EPITH...1,SET,48,0.05152,0.0026295,0.134,0.35032,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ALVEOLAR,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...674,SET,10,0.095352,0.0022236,0.24813,0.35039,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_CYTOTOXICITY,0.988476485369215
MIR190B_3P,SET,124,0.028709,0.0023502,0.074735,0.35044,MIR190B_3P,0.988476485369215
NAKAMURA_ADIPOGENESIS_LATE_UP,SET,93,0.032435,0.0023014,0.084451,0.35047,NAKAMURA_ADIPOGENESIS_LATE_UP,0.988476485369215
MIR1539,SET,5,0.14624,0.0024117,0.3808,0.35048,MIR1539,0.988476485369215
MODULE_321,SET,107,0.033026,0.0025126,0.086008,0.3505,MODULE_321,0.988476485369215
GOBP_CYTOSKELETON_DEPENDENT_...1,SET,103,0.02937,0.0021925,0.076491,0.3505,GOBP_CYTOSKELETON_DEPENDENT_CYTOKINESIS,0.988476485369215
HP_ABNORMAL_CARDIAC_SEPTUM_M...,SET,657,0.012596,0.0023386,0.032804,0.3505,HP_ABNORMAL_CARDIAC_SEPTUM_MORPHOLOGY,0.988476485369215
GOBP_NEGATIVE_REGULATION_OF_...313,SET,7,0.129,0.002517,0.33601,0.35052,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_5_PRODUCTION,0.988476485369215
PID_TOLL_ENDOGENOUS_PATHWAY,SET,21,0.071392,0.0024119,0.18606,0.3506,PID_TOLL_ENDOGENOUS_PATHWAY,0.988476485369215
GSE22589_HEALTHY_VS_SIV_INFE...2,SET,177,0.02367,0.0023116,0.061696,0.35062,GSE22589_HEALTHY_VS_SIV_INFECTED_DC_UP,0.988476485369215
GOBP_NON_CANONICAL_NF_KAPPAB...,SET,114,0.030243,0.0023745,0.078833,0.35063,GOBP_NON_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,0.988476485369215
GSE37416_0H_VS_12H_F_TULAREN...2,SET,169,0.025161,0.0024017,0.065601,0.35066,GSE37416_0H_VS_12H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.988476485369215
DEBIASI_APOPTOSIS_BY_REOVIRU...1,SET,246,0.020263,0.0023285,0.05285,0.35072,DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN,0.988476485369215
KEGG_MEDICUS_REFERENCE_TESTO...,SET,11,0.09505,0.0023247,0.24795,0.35074,KEGG_MEDICUS_REFERENCE_TESTOSTERONE_BIOSYNTHESIS,0.988476485369215
GAVISH_3CA_METAPROGRAM_EPITH...2,SET,42,0.052529,0.0025082,0.13703,0.35074,GAVISH_3CA_METAPROGRAM_EPITHELIAL_ANDROGEN_PROSTATE,0.988476485369215
GSE2770_IL4_ACT_VS_ACT_CD4_T...4,SET,178,0.023945,0.002345,0.062483,0.35078,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,0.988476485369215
LINDGREN_BLADDER_CANCER_HIGH...,SET,47,0.050013,0.0025259,0.13057,0.35084,LINDGREN_BLADDER_CANCER_HIGH_RECURRENCE,0.988476485369215
GOMF_THIAMINE_PYROPHOSPHATE_...,SET,6,0.13562,0.0024499,0.35406,0.35085,GOMF_THIAMINE_PYROPHOSPHATE_BINDING,0.988476485369215
HP_ABNORMALITY_OF_HAND_JOINT...,SET,43,0.050648,0.002447,0.13224,0.35086,HP_ABNORMALITY_OF_HAND_JOINT_MOBILITY,0.988476485369215
GOBP_RESPONSE_TO_KETONE,SET,201,0.023928,0.0024886,0.062475,0.35087,GOBP_RESPONSE_TO_KETONE,0.988476485369215
GSE19825_NAIVE_VS_IL2RAHIGH_...1,SET,180,0.023098,0.0022746,0.060311,0.35087,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,0.988476485369215
MORF_PRKDC,SET,168,0.023603,0.0022463,0.061634,0.35088,MORF_PRKDC,0.988476485369215
GOBP_ENDONUCLEOLYTIC_CLEAVAG...3,SET,16,0.078958,0.0023287,0.20618,0.35088,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,0.988476485369215
GOBP_PURINE_RIBONUCLEOSIDE_C...,SET,5,0.16774,0.0027663,0.43802,0.35088,GOBP_PURINE_RIBONUCLEOSIDE_CATABOLIC_PROCESS,0.988476485369215
REACTOME_PHASE_3_RAPID_REPOL...,SET,8,0.1138,0.0023737,0.29729,0.35094,REACTOME_PHASE_3_RAPID_REPOLARISATION,0.988565383368455
BLANCO_MELO_BETA_INTERFERON_...2,SET,338,0.018872,0.0025357,0.049328,0.35101,BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP,0.988578530913216
GOBP_TRIGLYCERIDE_RICH_LIPOP...1,SET,7,0.13015,0.0025396,0.34021,0.35102,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_CLEARANCE,0.988578530913216
GSE17974_IL4_AND_ANTI_IL12_V...5,SET,139,0.028011,0.0024268,0.073224,0.35103,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_1H_ACT_CD4_TCELL_DN,0.988578530913216
GSE22886_TCELL_VS_BCELL_NAIV...2,SET,182,0.023294,0.0023066,0.060953,0.35117,GSE22886_TCELL_VS_BCELL_NAIVE_UP,0.988816915100454
PID_P75_NTR_PATHWAY,SET,59,0.041854,0.0023676,0.10954,0.3512,PID_P75_NTR_PATHWAY,0.988816915100454
MIR1250_5P,SET,6,0.11922,0.0021538,0.31204,0.3512,MIR1250_5P,0.988816915100454
PID_MAPK_TRK_PATHWAY,SET,33,0.057393,0.0024298,0.1503,0.35128,PID_MAPK_TRK_PATHWAY,0.988962041312272
DESCARTES_FETAL_KIDNEY_LYMPH...,SET,150,0.028405,0.0025557,0.074429,0.35137,DESCARTES_FETAL_KIDNEY_LYMPHOID_CELLS,0.988964329663212
TURASHVILI_BREAST_NORMAL_DUC...1,SET,5,0.13439,0.0022162,0.35217,0.35138,TURASHVILI_BREAST_NORMAL_DUCTAL_VS_LOBULAR_DN,0.988964329663212
BIOCARTA_KERATINOCYTE_PATHWAY,SET,46,0.049589,0.0024778,0.12995,0.35138,BIOCARTA_KERATINOCYTE_PATHWAY,0.988964329663212
PID_CMYB_PATHWAY,SET,78,0.037198,0.0024181,0.097506,0.35142,PID_CMYB_PATHWAY,0.988964329663212
GAUTAM_EYE_IRIS_CILIARY_BODY...6,SET,68,0.036181,0.0021967,0.094847,0.35143,GAUTAM_EYE_IRIS_CILIARY_BODY_CYTOTOXIC_T_CELLS,0.988964329663212
GOBP_MAINTENANCE_OF_LOCATION,SET,312,0.018841,0.0024338,0.049405,0.35147,GOBP_MAINTENANCE_OF_LOCATION,0.988964329663212
ZHENG_RESPONSE_TO_ARSENITE_UP,SET,14,0.10346,0.0028545,0.27132,0.35148,ZHENG_RESPONSE_TO_ARSENITE_UP,0.988964329663212
GSE3982_DC_VS_NEUTROPHIL_LPS...2,SET,176,0.022937,0.0022338,0.060166,0.35152,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_UP,0.988996810491379
KAN_RESPONSE_TO_ARSENIC_TRIO...,SET,108,0.034235,0.0026166,0.089828,0.35156,KAN_RESPONSE_TO_ARSENIC_TRIOXIDE,0.989029286061195
PTEN_DN.V1_UP,SET,163,0.026463,0.0024811,0.069472,0.35163,PTEN_DN.V1_UP,0.989122349465847
GRAHAM_CML_QUIESCENT_VS_CML_...2,SET,23,0.078517,0.0027758,0.20615,0.35165,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP,0.989122349465847
MORF_CSNK2B,SET,251,0.018974,0.0022021,0.049833,0.3517,MORF_CSNK2B,0.989182932750668
BAKER_HEMATOPOIESIS_STAT3_TA...,SET,14,0.091508,0.0025246,0.24055,0.35182,BAKER_HEMATOPOIESIS_STAT3_TARGETS,0.989440370610131
JAZAG_TGFB1_SIGNALING_UP,SET,93,0.031605,0.0022425,0.08312,0.35189,JAZAG_TGFB1_SIGNALING_UP,0.989557160773525
GAUSSMANN_MLL_AF4_FUSION_TAR...10,SET,90,0.035635,0.0024875,0.093767,0.35196,GAUSSMANN_MLL_AF4_FUSION_TARGETS_E_UP,0.989604373484236
GSE1432_1H_VS_24H_IFNG_MICRO...1,SET,181,0.024156,0.0023854,0.063572,0.35198,GSE1432_1H_VS_24H_IFNG_MICROGLIA_DN,0.989604373484236
GSE43863_NAIVE_VS_MEMORY_TH1...2,SET,153,0.026601,0.0024169,0.070012,0.352,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_UP,0.989604373484236
MIR6788_3P,SET,3,0.17357,0.0022174,0.45704,0.35206,MIR6788_3P,0.989604373484236
GOBP_REGULATION_OF_NEUROMUSC...,SET,7,0.12456,0.0024305,0.32802,0.35207,GOBP_REGULATION_OF_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,0.989604373484236
ANDERSON_BLOOD_CN54GP140_ADJ...10,SET,5,0.1476,0.0024342,0.38883,0.35213,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_LOW_IGM_RESPONDERS_6HY_1DY_UP,0.989604373484236
DESCARTES_FETAL_ADRENAL_ERYT...,SET,84,0.035723,0.0024095,0.094129,0.35216,DESCARTES_FETAL_ADRENAL_ERYTHROBLASTS,0.989604373484236
KEGG_MEDICUS_PATHOGEN_SALMON...6,SET,5,0.11949,0.0019706,0.31488,0.35217,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOG_SIGNALING_PATHWAY,0.989604373484236
GOBP_POSITIVE_REGULATION_OF_...217,SET,271,0.019002,0.0022903,0.050084,0.35219,GOBP_POSITIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,0.989604373484236
HP_ABNORMAL_CSF_PYRUVATE_FAM...,SET,5,0.15051,0.0024822,0.39671,0.3522,HP_ABNORMAL_CSF_PYRUVATE_FAMILY_AMINO_ACID_CONCENTRATION,0.989604373484236
GOBP_POSITIVE_REGULATION_OF_...193,SET,450,0.015436,0.0023857,0.040693,0.35222,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE,0.989604373484236
GOMF_FRIZZLED_BINDING,SET,35,0.054843,0.002391,0.14466,0.3523,GOMF_FRIZZLED_BINDING,0.989640557125555
HP_VERTEBRAL_FUSION,SET,63,0.039205,0.0022914,0.10344,0.35235,HP_VERTEBRAL_FUSION,0.989640557125555
GSE9988_LOW_LPS_VS_ANTI_TREM...1,SET,171,0.024958,0.0023962,0.065865,0.35237,GSE9988_LOW_LPS_VS_ANTI_TREM1_AND_LPS_MONOCYTE_DN,0.989640557125555
REACTOME_ACTIVATED_NTRK3_SIG...1,SET,6,0.14853,0.0026832,0.39203,0.35239,REACTOME_ACTIVATED_NTRK3_SIGNALS_THROUGH_PI3K,0.989640557125555
HP_ABNORMAL_NASAL_MUCOSA_MOR...,SET,69,0.038106,0.0023305,0.10058,0.3524,HP_ABNORMAL_NASAL_MUCOSA_MORPHOLOGY,0.989640557125555
GOBP_POSITIVE_REGULATION_OF_...779,SET,22,0.061954,0.0021422,0.16358,0.35244,GOBP_POSITIVE_REGULATION_OF_TRANSLATIONAL_INITIATION,0.989640557125555
GOMF_ARYLESTERASE_ACTIVITY,SET,6,0.16451,0.0029719,0.43444,0.35247,GOMF_ARYLESTERASE_ACTIVITY,0.989640557125555
GOCC_NUCLEAR_UBIQUITIN_LIGAS...,SET,42,0.046306,0.0022111,0.1223,0.35249,GOCC_NUCLEAR_UBIQUITIN_LIGASE_COMPLEX,0.989640557125555
GOBP_POTASSIUM_ION_TRANSPORT,SET,227,0.023232,0.0025659,0.061368,0.35251,GOBP_POTASSIUM_ION_TRANSPORT,0.989640557125555
GOBP_CONVERGENT_EXTENSION_IN...3,SET,5,0.12643,0.0020851,0.33411,0.35256,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_ORGANOGENESIS,0.989640557125555
REACTOME_TRANSPORT_OF_MATURE...1,SET,40,0.044998,0.002097,0.11895,0.3526,REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS,0.989640557125555
GSE1460_DP_THYMOCYTE_VS_THYM...2,SET,169,0.023891,0.0022804,0.063155,0.35261,GSE1460_DP_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,0.989640557125555
REACTOME_OLFACTORY_SIGNALING...,SET,316,0.025706,0.0033416,0.067974,0.35265,REACTOME_OLFACTORY_SIGNALING_PATHWAY,0.989640557125555
KEGG_MEDICUS_REFERENCE_TNF_N...,SET,14,0.081922,0.0022602,0.21663,0.35266,KEGG_MEDICUS_REFERENCE_TNF_NFKB_SIGNALING_PATHWAY,0.989640557125555
HP_GENERALIZED_AMYOTROPHY,SET,78,0.033578,0.0021828,0.088795,0.35266,HP_GENERALIZED_AMYOTROPHY,0.989640557125555
HP_MUSCLE_FIBER_ATROPHY,SET,61,0.039153,0.0022519,0.1037,0.35288,HP_MUSCLE_FIBER_ATROPHY,0.98997737531122
MODULE_500,SET,28,0.060222,0.0023488,0.15951,0.35289,MODULE_500,0.98997737531122
GSE19772_CTRL_VS_HCMV_INF_MO...4,SET,182,0.023612,0.002338,0.062555,0.35292,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_UP,0.98997737531122
BAUS_TFF2_TARGETS_DN,SET,11,0.1066,0.0026072,0.2825,0.35296,BAUS_TFF2_TARGETS_DN,0.98997737531122
CHESLER_BRAIN_D6MIT150_QTL_C...,SET,3,0.18281,0.0023354,0.48459,0.353,CHESLER_BRAIN_D6MIT150_QTL_CIS,0.98997737531122
GSE27786_BCELL_VS_NKCELL_UP,SET,180,0.022434,0.0022093,0.059468,0.353,GSE27786_BCELL_VS_NKCELL_UP,0.98997737531122
GSE1448_CTRL_VS_ANTI_VBETA5_...2,SET,187,0.023844,0.0023929,0.063216,0.35302,GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_UP,0.98997737531122
WP_HEMATOPOIETIC_STEM_CELL_G...,SET,19,0.077392,0.0024871,0.2053,0.3531,WP_HEMATOPOIETIC_STEM_CELL_GENE_REGULATION_BY_GABP_ALPHABETA_COMPLEX,0.98997737531122
GOMF_TRANSLATION_ELONGATION_...,SET,18,0.065561,0.0020507,0.17397,0.35314,GOMF_TRANSLATION_ELONGATION_FACTOR_ACTIVITY,0.98997737531122
MIR92B_3P,SET,432,0.015631,0.0023682,0.041505,0.35323,MIR92B_3P,0.98997737531122
MODULE_119,SET,130,0.026641,0.0022326,0.070739,0.35324,MODULE_119,0.98997737531122
FAN_EMBRYONIC_CTX_ASTROCYTE_2,SET,139,0.030066,0.0026048,0.079856,0.35327,FAN_EMBRYONIC_CTX_ASTROCYTE_2,0.98997737531122
GOMF_MINOR_GROOVE_OF_ADENINE...,SET,8,0.11278,0.0023525,0.29957,0.35328,GOMF_MINOR_GROOVE_OF_ADENINE_THYMINE_RICH_DNA_BINDING,0.98997737531122
HU_FETAL_RETINA_FIBROBLAST,SET,337,0.018779,0.0025195,0.049895,0.35332,HU_FETAL_RETINA_FIBROBLAST,0.98997737531122
VERNELL_RETINOBLASTOMA_PATHW...2,SET,68,0.037057,0.0022499,0.098481,0.35335,VERNELL_RETINOBLASTOMA_PATHWAY_UP,0.98997737531122
GOBP_INTRACELLULAR_TRIGLYCER...,SET,9,0.098967,0.0021895,0.26309,0.35339,GOBP_INTRACELLULAR_TRIGLYCERIDE_HOMEOSTASIS,0.98997737531122
HP_CUTANEOUS_ANERGY,SET,6,0.13767,0.0024871,0.36611,0.35344,HP_CUTANEOUS_ANERGY,0.98997737531122
PID_ERBB1_DOWNSTREAM_PATHWAY,SET,102,0.031694,0.0023545,0.084308,0.35349,PID_ERBB1_DOWNSTREAM_PATHWAY,0.98997737531122
GOBP_REGULATION_OF_CELLULAR_...5,SET,37,0.054676,0.0024508,0.14545,0.35349,GOBP_REGULATION_OF_CELLULAR_EXTRAVASATION,0.98997737531122
MIR409_5P,SET,35,0.050494,0.0022014,0.13436,0.35353,MIR409_5P,0.98997737531122
GOBP_REGULATION_OF_ATP_BIOSY...,SET,11,0.089258,0.002183,0.2375,0.35353,GOBP_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.98997737531122
GOBP_STEM_CELL_FATE_COMMITME...,SET,10,0.1188,0.0027705,0.31621,0.35357,GOBP_STEM_CELL_FATE_COMMITMENT,0.98997737531122
HP_ABNORMAL_HUMERUS_MORPHOLO...,SET,14,0.08012,0.0022104,0.21328,0.35359,HP_ABNORMAL_HUMERUS_MORPHOLOGY,0.98997737531122
GOBP_POSITIVE_REGULATION_OF_...444,SET,10,0.10383,0.0024213,0.27642,0.3536,GOBP_POSITIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,0.98997737531122
GOBP_REGULATION_OF_REGULATED...,SET,104,0.030691,0.0023022,0.081723,0.35363,GOBP_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,0.98997737531122
GOBP_VASCULAR_PROCESS_IN_CIR...,SET,254,0.021742,0.0025382,0.057912,0.35368,GOBP_VASCULAR_PROCESS_IN_CIRCULATORY_SYSTEM,0.98997737531122
GOBP_REGULATION_OF_ADIPONECT...,SET,7,0.1266,0.0024702,0.33725,0.35369,GOBP_REGULATION_OF_ADIPONECTIN_SECRETION,0.98997737531122
REACTOME_ACTIVATION_OF_ATR_I...,SET,37,0.0468,0.0020977,0.12469,0.35371,REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS,0.98997737531122
HP_INABILITY_TO_WALK,SET,327,0.016987,0.0022455,0.045261,0.35372,HP_INABILITY_TO_WALK,0.98997737531122
REACTOME_GLUCAGON_LIKE_PEPTI...,SET,42,0.049704,0.0023734,0.13247,0.35375,REACTOME_GLUCAGON_LIKE_PEPTIDE_1_GLP1_REGULATES_INSULIN_SECRETION,0.98997737531122
GOMF_CROSSOVER_JUNCTION_DNA_...,SET,7,0.10765,0.0021004,0.28695,0.35378,GOMF_CROSSOVER_JUNCTION_DNA_ENDONUCLEASE_ACTIVITY,0.98997737531122
PPARGC1A_TARGET_GENES,SET,79,0.034795,0.0022763,0.092803,0.35386,PPARGC1A_TARGET_GENES,0.98997737531122
REACTOME_PRESYNAPTIC_DEPOLAR...,SET,11,0.10054,0.0024588,0.2682,0.35389,REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING,0.98997737531122
GOBP_MACROPHAGE_ACTIVATION,SET,103,0.0338,0.0025233,0.090184,0.35391,GOBP_MACROPHAGE_ACTIVATION,0.98997737531122
MODULE_219,SET,21,0.067788,0.0022901,0.18089,0.35393,MODULE_219,0.98997737531122
HP_MYOTONIA,SET,28,0.060789,0.0023709,0.16222,0.35393,HP_MYOTONIA,0.98997737531122
GSE44649_NAIVE_VS_ACTIVATED_...4,SET,186,0.023351,0.0023372,0.062313,0.35393,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,0.98997737531122
REACTOME_PTK6_EXPRESSION,SET,5,0.14034,0.0023144,0.37467,0.354,REACTOME_PTK6_EXPRESSION,0.98997737531122
SOX5_01,SET,236,0.02126,0.0023936,0.056772,0.35403,SOX5_01,0.98997737531122
HP_TRACHEAL_STENOSIS,SET,25,0.063339,0.0023345,0.1692,0.35408,HP_TRACHEAL_STENOSIS,0.98997737531122
HP_UPPER_LIMB_UNDERGROWTH,SET,78,0.033485,0.0021768,0.089465,0.3541,HP_UPPER_LIMB_UNDERGROWTH,0.98997737531122
WP_NITRIC_OXIDE_METABOLISM_I...,SET,13,0.090734,0.0024123,0.24246,0.35412,WP_NITRIC_OXIDE_METABOLISM_IN_CYSTIC_FIBROSIS,0.98997737531122
GOBP_RECEPTOR_MEDIATED_VIRIO...,SET,5,0.16163,0.0026656,0.43198,0.35414,GOBP_RECEPTOR_MEDIATED_VIRION_ATTACHMENT_TO_HOST_CELL,0.98997737531122
GOBP_CELLULAR_RESPONSE_TO_ST...5,SET,1637,0.007935,0.0022602,0.021209,0.35416,GOBP_CELLULAR_RESPONSE_TO_STRESS,0.98997737531122
REACTOME_SIGNALING_BY_FGFR2_...1,SET,19,0.064663,0.002078,0.17292,0.35422,REACTOME_SIGNALING_BY_FGFR2_IIIA_TM,0.98997737531122
REACTOME_BACTERIAL_INFECTION...,SET,67,0.038253,0.0023054,0.10233,0.35427,REACTOME_BACTERIAL_INFECTION_PATHWAYS,0.98997737531122
HP_APLASIA_HYPOPLASIA_OF_THE...78,SET,27,0.054412,0.002084,0.14556,0.35427,HP_APLASIA_HYPOPLASIA_OF_THE_UVULA,0.98997737531122
KEGG_MEDICUS_REFERENCE_V_D_J...,SET,12,0.077232,0.0019728,0.20666,0.35431,KEGG_MEDICUS_REFERENCE_V_D_J_RECOMBINATION,0.98997737531122
MIR130B_5P,SET,175,0.02448,0.0023774,0.065506,0.35431,MIR130B_5P,0.98997737531122
MIR520B_3P_MIR520C_3P_MIR520...,SET,302,0.018053,0.002295,0.048319,0.35435,MIR520B_3P_MIR520C_3P_MIR520E_3P,0.98997737531122
GCM_TINF2,SET,38,0.04689,0.0021299,0.1255,0.35435,GCM_TINF2,0.98997737531122
HP_BABINSKI_SIGN,SET,255,0.019346,0.0022629,0.051781,0.35435,HP_BABINSKI_SIGN,0.98997737531122
MORF_RBM8A,SET,77,0.035382,0.0022854,0.094737,0.3544,MORF_RBM8A,0.98997737531122
HP_ABNORMAL_HAND_BONE_OSSIFI...,SET,34,0.053034,0.0022789,0.14203,0.35443,HP_ABNORMAL_HAND_BONE_OSSIFICATION,0.98997737531122
GOBP_SYNAPTIC_VESICLE_EXOCYT...,SET,90,0.032587,0.0022748,0.087289,0.35446,GOBP_SYNAPTIC_VESICLE_EXOCYTOSIS,0.98997737531122
REACTOME_CELL_EXTRACELLULAR_...,SET,16,0.079533,0.0023456,0.21309,0.35449,REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS,0.98997737531122
GOMF_TELOMERASE_RNA_BINDING,SET,20,0.066846,0.0022039,0.1791,0.35449,GOMF_TELOMERASE_RNA_BINDING,0.98997737531122
REACTOME_REGULATION_OF_GENE_...3,SET,8,0.1301,0.0027137,0.34863,0.35451,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_EARLY_PANCREATIC_PRECURSOR_CELLS,0.98997737531122
MODULE_199,SET,52,0.04782,0.00254,0.12815,0.35452,MODULE_199,0.98997737531122
GOMF_INTERFERON_RECEPTOR_ACT...,SET,5,0.15162,0.0025005,0.40636,0.35453,GOMF_INTERFERON_RECEPTOR_ACTIVITY,0.98997737531122
GSE39820_TGFBETA3_IL6_VS_TGF...1,SET,179,0.022374,0.0021973,0.06,0.35461,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_DN,0.98997737531122
GSE43955_1H_VS_20H_ACT_CD4_T...1,SET,183,0.023965,0.0023794,0.064266,0.35461,GSE43955_1H_VS_20H_ACT_CD4_TCELL_DN,0.98997737531122
WU_HBX_TARGETS_1_UP,SET,13,0.087889,0.0023366,0.23575,0.35465,WU_HBX_TARGETS_1_UP,0.98997737531122
LY_AGING_MIDDLE_DN,SET,15,0.071302,0.0020361,0.19127,0.35466,LY_AGING_MIDDLE_DN,0.98997737531122
HP_NEUTROPENIA_IN_PRESENCE_O...,SET,21,0.07018,0.0023709,0.18827,0.35466,HP_NEUTROPENIA_IN_PRESENCE_OF_ANTI_NEUTROPIL_ANTIBODIES,0.98997737531122
DESCARTES_FETAL_STOMACH_LYMP...2,SET,68,0.039468,0.0023963,0.10587,0.35466,DESCARTES_FETAL_STOMACH_LYMPHOID_CELLS,0.98997737531122
REACTOME_INTEGRATION_OF_PROV...,SET,9,0.094757,0.0020964,0.25446,0.3548,REACTOME_INTEGRATION_OF_PROVIRUS,0.990285948787928
GSE360_L_MAJOR_VS_T_GONDII_D...1,SET,176,0.023291,0.0022683,0.062565,0.35485,GSE360_L_MAJOR_VS_T_GONDII_DC_DN,0.990285948787928
HP_NEOPLASM,SET,880,0.010779,0.0023015,0.02896,0.35487,HP_NEOPLASM,0.990285948787928
GOBP_ENDOCYTOSIS,SET,646,0.012662,0.0023318,0.034029,0.35491,GOBP_ENDOCYTOSIS,0.990285948787928
WP_SERINE_METABOLISM,SET,8,0.093459,0.0019494,0.25126,0.35496,WP_SERINE_METABOLISM,0.990285948787928
GSE24026_PD1_LIGATION_VS_CTR...1,SET,182,0.023019,0.0022792,0.061885,0.35497,GSE24026_PD1_LIGATION_VS_CTRL_IN_ACT_TCELL_LINE_DN,0.990285948787928
GSE39556_CD8A_DC_VS_NK_CELL_...4,SET,182,0.023416,0.0023186,0.062955,0.35497,GSE39556_CD8A_DC_VS_NK_CELL_UP,0.990285948787928
GOCC_SEH1_ASSOCIATED_COMPLEX,SET,12,0.086201,0.0022019,0.23184,0.35502,GOCC_SEH1_ASSOCIATED_COMPLEX,0.99034594269203
GOBP_REGULATION_OF_NUCLEOCYT...,SET,108,0.029588,0.0022614,0.079611,0.35508,GOBP_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,0.990418502768194
GSE13738_RESTING_VS_TCR_ACTI...1,SET,178,0.023092,0.0022615,0.06216,0.35513,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_DN,0.990418502768194
KEGG_MEDICUS_VARIANT_AMPLIFI...7,SET,14,0.081643,0.0022524,0.2198,0.35515,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_RAS_ERK_SIGNALING_PATHWAY,0.990418502768194
GOMF_3_5_DNA_HELICASE_ACTIVI...,SET,14,0.083263,0.0022972,0.22417,0.35516,GOMF_3_5_DNA_HELICASE_ACTIVITY,0.990418502768194
HP_FLAT_ACETABULAR_ROOF,SET,26,0.058962,0.0022161,0.15887,0.35527,HP_FLAT_ACETABULAR_ROOF,0.990545259584664
GOBP_OXALATE_TRANSPORT,SET,11,0.093312,0.0022821,0.25152,0.35532,GOBP_OXALATE_TRANSPORT,0.990545259584664
HE_LIM_SUN_FETAL_LUNG_C3_AER...,SET,84,0.036434,0.0024575,0.098265,0.3554,HE_LIM_SUN_FETAL_LUNG_C3_AEROCYTE,0.990545259584664
REACTOME_DEVELOPMENTAL_BIOLO...,SET,1245,0.0096577,0.002427,0.026052,0.35543,REACTOME_DEVELOPMENTAL_BIOLOGY,0.990545259584664
WP_LEPTIN_SIGNALING,SET,74,0.037211,0.0023564,0.1004,0.35545,WP_LEPTIN_SIGNALING,0.990545259584664
HP_COUGH,SET,136,0.027261,0.0023364,0.073553,0.35546,HP_COUGH,0.990545259584664
SETLUR_PROSTATE_CANCER_TMPRS...2,SET,66,0.038459,0.0023005,0.10378,0.35548,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_UP,0.990545259584664
VARELA_ZMPSTE24_TARGETS_UP,SET,40,0.050117,0.0023355,0.13527,0.35551,VARELA_ZMPSTE24_TARGETS_UP,0.990545259584664
KEGG_MEDICUS_REFERENCE_DEUBI...,SET,21,0.071877,0.0024282,0.19403,0.35553,KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119,0.990545259584664
GSE17301_CTRL_VS_48H_ACD3_AC...5,SET,178,0.023941,0.0023446,0.064626,0.35553,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_DN,0.990545259584664
MIR6822_3P,SET,49,0.04178,0.0021544,0.11279,0.35554,MIR6822_3P,0.990545259584664
GOBP_MATURATION_OF_SSU_RRNA,SET,47,0.045322,0.002289,0.12237,0.35555,GOBP_MATURATION_OF_SSU_RRNA,0.990545259584664
MEISSNER_NPC_HCP_WITH_H3K4ME...2,SET,140,0.02812,0.0024449,0.075972,0.35564,MEISSNER_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,0.990545259584664
GOBP_POSITIVE_REGULATION_OF_...754,SET,37,0.047114,0.0021118,0.12729,0.35565,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.990545259584664
ZBTB18_TARGET_GENES,SET,672,0.012005,0.0022532,0.032465,0.35577,ZBTB18_TARGET_GENES,0.990545259584664
HP_MYOFIBRILLAR_MYOPATHY,SET,10,0.10418,0.0024294,0.28178,0.3558,HP_MYOFIBRILLAR_MYOPATHY,0.990545259584664
GSE12845_IGD_NEG_BLOOD_VS_NA...1,SET,182,0.022773,0.002255,0.061596,0.3558,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.990545259584664
GOMF_NUCLEAR_VITAMIN_D_RECEP...,SET,13,0.077227,0.0020532,0.20895,0.35584,GOMF_NUCLEAR_VITAMIN_D_RECEPTOR_BINDING,0.990545259584664
MIR4284,SET,99,0.030515,0.0022336,0.082619,0.35594,MIR4284,0.990545259584664
GSE31082_DN_VS_CD4_SP_THYMOC...1,SET,181,0.022553,0.002227,0.06106,0.35594,GSE31082_DN_VS_CD4_SP_THYMOCYTE_DN,0.990545259584664
REACTOME_NEUROTRANSMITTER_CL...,SET,9,0.10649,0.0023559,0.2884,0.35597,REACTOME_NEUROTRANSMITTER_CLEARANCE,0.990545259584664
HP_SOFT_DOUGHY_SKIN,SET,12,0.093574,0.0023903,0.25342,0.35597,HP_SOFT_DOUGHY_SKIN,0.990545259584664
GAVISH_3CA_MALIGNANT_METAPRO...8,SET,44,0.049475,0.0024179,0.134,0.35598,GAVISH_3CA_MALIGNANT_METAPROGRAM_17_INTERFERON_MHC_II_1,0.990545259584664
GSE7852_TREG_VS_TCONV_LN_UP,SET,177,0.024458,0.0023886,0.066242,0.35598,GSE7852_TREG_VS_TCONV_LN_UP,0.990545259584664
MIR5089_3P,SET,62,0.039145,0.0022698,0.10604,0.356,MIR5089_3P,0.990545259584664
GSE26912_TUMORICIDAL_VS_CTRL...2,SET,187,0.023399,0.0023482,0.063421,0.35608,GSE26912_TUMORICIDAL_VS_CTRL_MACROPHAGE_UP,0.990545259584664
chr3q25,SET,61,0.075186,0.0043243,0.2038,0.35609,chr3q25,0.990545259584664
GOMF_OXIDOREDUCTASE_ACTIVITY...22,SET,4,0.16657,0.002457,0.45148,0.35609,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_ASCORBATE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,0.990545259584664
GOBP_PROTEIN_DENEDDYLATION,SET,11,0.086276,0.0021101,0.23387,0.3561,GOBP_PROTEIN_DENEDDYLATION,0.990545259584664
REACTOME_MAPK_TARGETS_NUCLEA...,SET,29,0.060559,0.0024037,0.16417,0.35611,REACTOME_MAPK_TARGETS_NUCLEAR_EVENTS_MEDIATED_BY_MAP_KINASES,0.990545259584664
MODULE_545,SET,18,0.073749,0.0023068,0.19994,0.35612,MODULE_545,0.990545259584664
GSE6269_FLU_VS_STREP_PNEUMO_...2,SET,162,0.024029,0.002246,0.065155,0.35614,GSE6269_FLU_VS_STREP_PNEUMO_INF_PBMC_UP,0.990545259584664
GSE17721_12H_VS_24H_PAM3CSK4...1,SET,185,0.022584,0.0022544,0.061246,0.35616,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_DN,0.990545259584664
HP_ACCELERATED_SKELETAL_MATU...,SET,63,0.040836,0.0023867,0.11079,0.35622,HP_ACCELERATED_SKELETAL_MATURATION,0.990545259584664
BOQUEST_STEM_CELL_CULTURED_V...2,SET,385,0.017371,0.0024878,0.047148,0.35627,BOQUEST_STEM_CELL_CULTURED_VS_FRESH_UP,0.990545259584664
MIR4475,SET,58,0.040147,0.0022518,0.10901,0.35633,MIR4475,0.990545259584664
HP_SHORT_FOOT,SET,111,0.030884,0.0023929,0.083874,0.35636,HP_SHORT_FOOT,0.990545259584664
HP_RECTAL_ABSCESS,SET,7,0.13919,0.0027158,0.37814,0.35641,HP_RECTAL_ABSCESS,0.990545259584664
HP_ABNORMAL_MUSCLE_FIBER_ALP...,SET,9,0.10133,0.0022417,0.27531,0.35642,HP_ABNORMAL_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,0.990545259584664
WP_MBDNF_AND_PROBDNF_REGULAT...,SET,35,0.058894,0.0025676,0.16004,0.35644,WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION,0.990545259584664
SHARMA_ASTROCYTOMA_WITH_NF1_...,SET,4,0.15722,0.0023192,0.42736,0.35648,SHARMA_ASTROCYTOMA_WITH_NF1_SYNDROM,0.990545259584664
GSE37532_TREG_VS_TCONV_CD4_T...3,SET,149,0.023739,0.0021288,0.064527,0.35648,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,0.990545259584664
GOBP_CELLULAR_RESPONSE_TO_CO...4,SET,62,0.042272,0.0024511,0.11491,0.35649,GOBP_CELLULAR_RESPONSE_TO_CORTICOSTEROID_STIMULUS,0.990545259584664
MIR206,SET,340,0.017078,0.0023012,0.046448,0.35656,MIR206,0.990545259584664
HP_RENAL_AMYLOIDOSIS,SET,11,0.093781,0.0022936,0.25506,0.35656,HP_RENAL_AMYLOIDOSIS,0.990545259584664
REACTOME_GLUTATHIONE_SYNTHES...,SET,12,0.085584,0.0021862,0.23283,0.35659,REACTOME_GLUTATHIONE_SYNTHESIS_AND_RECYCLING,0.990545259584664
SAGIV_CD24_TARGETS_DN,SET,44,0.047148,0.0023041,0.1283,0.35664,SAGIV_CD24_TARGETS_DN,0.990545259584664
HP_ABNORMAL_TRACHEOBRONCHIAL...,SET,330,0.017207,0.0022849,0.046829,0.35665,HP_ABNORMAL_TRACHEOBRONCHIAL_MORPHOLOGY,0.990545259584664
GOBP_GASTRO_INTESTINAL_SYSTE...,SET,12,0.087146,0.0022261,0.23722,0.35667,GOBP_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,0.990545259584664
HP_INCREASED_CIRCULATING_IGA...,SET,26,0.064911,0.0024397,0.17673,0.3567,HP_INCREASED_CIRCULATING_IGA_LEVEL,0.990545259584664
HE_LIM_SUN_FETAL_LUNG_C0_LAT...2,SET,632,0.012936,0.0023573,0.035233,0.35675,HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL,0.990545259584664
MIR598_5P,SET,4,0.16139,0.0023807,0.43964,0.35677,MIR598_5P,0.990545259584664
GSE9960_HEALTHY_VS_SEPSIS_PB...1,SET,139,0.027237,0.0023597,0.074193,0.35677,GSE9960_HEALTHY_VS_SEPSIS_PBMC_DN,0.990545259584664
GOBP_ERYTHROCYTE_HOMEOSTASIS,SET,133,0.026679,0.0022613,0.072679,0.35678,GOBP_ERYTHROCYTE_HOMEOSTASIS,0.990545259584664
GOBP_APOPTOTIC_PROCESS_INVOL...1,SET,37,0.052061,0.0023335,0.14185,0.35681,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,0.990545259584664
DARWICHE_PAPILLOMA_RISK_HIGH...1,SET,164,0.023522,0.002212,0.064099,0.35683,DARWICHE_PAPILLOMA_RISK_HIGH_DN,0.990545259584664
KEGG_MEDICUS_ENV_FACTOR_ZN_T...,SET,18,0.081157,0.0025386,0.22117,0.35683,KEGG_MEDICUS_ENV_FACTOR_ZN_TO_ANTEROGRADE_AXONAL_TRANSPORT,0.990545259584664
PASQUALUCCI_LYMPHOMA_BY_GC_S...1,SET,156,0.025571,0.0023458,0.069713,0.35689,PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN,0.990559039840637
PID_HNF3B_PATHWAY,SET,43,0.050622,0.0024457,0.13802,0.3569,PID_HNF3B_PATHWAY,0.990559039840637
KAUFFMANN_DNA_REPAIR_GENES,SET,208,0.019253,0.0020366,0.052526,0.35698,KAUFFMANN_DNA_REPAIR_GENES,0.990559039840637
GSE23568_CTRL_VS_ID3_TRANSDU...1,SET,178,0.022529,0.0022064,0.061493,0.35705,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_DN,0.990559039840637
FUJIWARA_PARK2_IN_LIVER_CANC...1,SET,5,0.15164,0.0025008,0.41396,0.35707,FUJIWARA_PARK2_IN_LIVER_CANCER_DN,0.990559039840637
HP_SERTOLI_CELL_NEOPLASM,SET,5,0.13951,0.0023008,0.381,0.35712,HP_SERTOLI_CELL_NEOPLASM,0.990559039840637
REACTOME_SIGNALING_BY_NTRK2_...,SET,25,0.057622,0.0021238,0.15741,0.35716,REACTOME_SIGNALING_BY_NTRK2_TRKB,0.990559039840637
GOBP_REGULATION_OF_CELL_SIZE,SET,157,0.025238,0.0023227,0.068957,0.35718,GOBP_REGULATION_OF_CELL_SIZE,0.990559039840637
chr13q31,SET,9,0.14226,0.0031472,0.3888,0.35723,chr13q31,0.990559039840637
WRN_TARGET_GENES,SET,10,0.099234,0.0023141,0.27137,0.35731,WRN_TARGET_GENES,0.990559039840637
GSE18893_TCONV_VS_TREG_24H_C...1,SET,179,0.024347,0.0023911,0.066589,0.35732,GSE18893_TCONV_VS_TREG_24H_CULTURE_DN,0.990559039840637
GOMF_GTP_DEPENDENT_PROTEIN_B...,SET,20,0.075936,0.0025036,0.2077,0.35733,GOMF_GTP_DEPENDENT_PROTEIN_BINDING,0.990559039840637
AFFAR_YY1_TARGETS_DN,SET,237,0.020089,0.0022665,0.05497,0.35739,AFFAR_YY1_TARGETS_DN,0.990559039840637
GOBP_PEPTIDYL_GLUTAMIC_ACID_...,SET,25,0.064559,0.0023794,0.17665,0.35739,GOBP_PEPTIDYL_GLUTAMIC_ACID_MODIFICATION,0.990559039840637
MIR6857_3P,SET,68,0.038967,0.0023658,0.10664,0.35741,MIR6857_3P,0.990559039840637
GOCC_ELASTIC_FIBER,SET,4,0.16257,0.002398,0.44509,0.35747,GOCC_ELASTIC_FIBER,0.990559039840637
HP_ELEVATED_MEAN_ARTERIAL_PR...,SET,10,0.098286,0.002292,0.26917,0.35751,HP_ELEVATED_MEAN_ARTERIAL_PRESSURE,0.990559039840637
PRAMOONJAGO_SOX4_TARGETS_DN,SET,46,0.04335,0.002166,0.11873,0.35752,PRAMOONJAGO_SOX4_TARGETS_DN,0.990559039840637
HP_CORPUS_CALLOSUM_ATROPHY,SET,37,0.048686,0.0021823,0.13336,0.35754,HP_CORPUS_CALLOSUM_ATROPHY,0.990559039840637
HP_ABNORMAL_CIRCULATING_SERI...2,SET,30,0.05622,0.0022695,0.15402,0.35755,HP_ABNORMAL_CIRCULATING_SERINE_FAMILY_AMINO_ACID_CONCENTRATION,0.990559039840637
GOBP_POSITIVE_REGULATION_OF_...58,SET,48,0.045359,0.002315,0.12428,0.35756,GOBP_POSITIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,0.990559039840637
GOCC_FIBRINOGEN_COMPLEX,SET,8,0.11723,0.0024453,0.32119,0.35756,GOCC_FIBRINOGEN_COMPLEX,0.990559039840637
CROONQUIST_NRAS_VS_STROMAL_S...1,SET,86,0.033781,0.0023054,0.092567,0.35758,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_DN,0.990559039840637
YAO_TEMPORAL_RESPONSE_TO_PRO...15,SET,71,0.040044,0.0024841,0.10974,0.35759,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_6,0.990559039840637
GSE22935_24H_VS_48H_MBOVIS_B...4,SET,183,0.022529,0.0022368,0.061739,0.35759,GSE22935_24H_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,0.990559039840637
VILLANUEVA_LIVER_CANCER_KRT1...2,SET,152,0.023983,0.002172,0.065733,0.35761,VILLANUEVA_LIVER_CANCER_KRT19_UP,0.990559039840637
DESCARTES_FETAL_ADRENAL_SCHW...,SET,108,0.032715,0.0025005,0.08967,0.35762,DESCARTES_FETAL_ADRENAL_SCHWANN_CELLS,0.990559039840637
SUMI_HNF4A_TARGETS,SET,28,0.062388,0.0024333,0.17103,0.35764,SUMI_HNF4A_TARGETS,0.990559039840637
MIR4484,SET,31,0.054772,0.0022475,0.1502,0.35769,MIR4484,0.990559039840637
MATSUMIYA_PBMC_MODIFIED_VACC...2,SET,9,0.10326,0.0022846,0.2832,0.35769,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_HIGH_RESPONDERS_VS_LOW_RESPONDERS_0DY_UP,0.990559039840637
GOBP_METANEPHRIC_PART_OF_URE...,SET,6,0.14757,0.002666,0.40492,0.35776,GOBP_METANEPHRIC_PART_OF_URETERIC_BUD_DEVELOPMENT,0.990673954266592
GAUCHER_PBMC_YF_VAX_STAMARIL...10,SET,44,0.046944,0.0022941,0.12887,0.35783,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_60DY_UP,0.990788850382409
MIR6840_3P,SET,154,0.024299,0.0022149,0.066718,0.35786,MIR6840_3P,0.990792981757349
GSE1432_1H_VS_24H_IFNG_MICRO...2,SET,188,0.023231,0.0023376,0.063823,0.35793,GSE1432_1H_VS_24H_IFNG_MICROGLIA_UP,0.99085660692951
SCHLESINGER_METHYLATED_DE_NO...,SET,80,0.037165,0.0024466,0.10211,0.35794,SCHLESINGER_METHYLATED_DE_NOVO_IN_CANCER,0.99085660692951
HP_WEBBED_NECK,SET,104,0.029043,0.0021785,0.079915,0.35815,HP_WEBBED_NECK,0.990883705765408
HP_ABNORMAL_FUNDUS_AUTOFLUOR...,SET,26,0.064055,0.0024075,0.17628,0.35817,HP_ABNORMAL_FUNDUS_AUTOFLUORESCENCE_IMAGING,0.990883705765408
GOBP_GLUCOSE_IMPORT_IN_RESPO...,SET,5,0.10127,0.0016701,0.27873,0.35818,GOBP_GLUCOSE_IMPORT_IN_RESPONSE_TO_INSULIN_STIMULUS,0.990883705765408
HP_ANAL_FISSURE,SET,4,0.12072,0.0017807,0.33226,0.35818,HP_ANAL_FISSURE,0.990883705765408
LIM_MAMMARY_LUMINAL_PROGENIT...1,SET,14,0.089146,0.0024595,0.2454,0.35821,LIM_MAMMARY_LUMINAL_PROGENITOR_DN,0.990883705765408
PRMT5_TARGET_GENES,SET,64,0.037559,0.0022125,0.1034,0.35822,PRMT5_TARGET_GENES,0.990883705765408
GSE17721_LPS_VS_POLYIC_12H_B...1,SET,187,0.021788,0.0021866,0.059993,0.35824,GSE17721_LPS_VS_POLYIC_12H_BMDC_DN,0.990883705765408
GSE45382_UNTREATED_VS_TGFB_T...1,SET,167,0.023169,0.0021985,0.0638,0.35825,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_DN,0.990883705765408
HAY_BONE_MARROW_CD34_POS_GRAN,SET,24,0.064711,0.0023369,0.17827,0.35831,HAY_BONE_MARROW_CD34_POS_GRAN,0.990883705765408
GNF2_RAB3A,SET,34,0.055938,0.0024037,0.15412,0.35833,GNF2_RAB3A,0.990883705765408
GOCC_ENDOLYSOSOME,SET,26,0.058947,0.0022155,0.16243,0.35834,GOCC_ENDOLYSOSOME,0.990883705765408
GOBP_REGULATION_OF_HELICASE_...,SET,9,0.08278,0.0018314,0.22814,0.35836,GOBP_REGULATION_OF_HELICASE_ACTIVITY,0.990883705765408
MEBARKI_HCC_PROGENITOR_WNT_D...1,SET,54,0.042715,0.0023119,0.11776,0.35841,MEBARKI_HCC_PROGENITOR_WNT_DN_BLOCKED_BY_FZD8CRD,0.990883705765408
HOLLERN_EMT_BREAST_TUMOR_UP,SET,128,0.02763,0.0022978,0.076193,0.35844,HOLLERN_EMT_BREAST_TUMOR_UP,0.990883705765408
HP_RESTRICTIVE_VENTILATORY_D...,SET,90,0.032499,0.0022687,0.08962,0.35844,HP_RESTRICTIVE_VENTILATORY_DEFECT,0.990883705765408
WP_NPHP1_DELETION_SYNDROME,SET,10,0.10552,0.0024606,0.2911,0.3585,WP_NPHP1_DELETION_SYNDROME,0.990883705765408
MIR500B_3P,SET,76,0.036045,0.0023131,0.099443,0.3585,MIR500B_3P,0.990883705765408
HP_ABNORMALITY_OF_CONNECTIVE...,SET,1351,0.0085718,0.002237,0.023647,0.3585,HP_ABNORMALITY_OF_CONNECTIVE_TISSUE,0.990883705765408
SU_SALIVARY_GLAND,SET,10,0.10151,0.0023673,0.28008,0.35851,SU_SALIVARY_GLAND,0.990883705765408
HASLINGER_B_CLL_WITH_6Q21_DE...,SET,11,0.085872,0.0021002,0.23693,0.35852,HASLINGER_B_CLL_WITH_6Q21_DELETION,0.990883705765408
REACTOME_REGULATION_OF_PTEN_...2,SET,7,0.13598,0.0026532,0.37548,0.35862,REACTOME_REGULATION_OF_PTEN_LOCALIZATION,0.990966395159414
GSE33425_CD161_HIGH_VS_INT_C...2,SET,186,0.022529,0.0022549,0.062223,0.35865,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_UP,0.990966395159414
HP_UPPER_LIMB_HYPERTONIA,SET,9,0.1038,0.0022964,0.28669,0.35866,HP_UPPER_LIMB_HYPERTONIA,0.990966395159414
GOBP_MESENCHYMAL_CELL_MIGRAT...,SET,57,0.043232,0.0024039,0.11949,0.35875,GOBP_MESENCHYMAL_CELL_MIGRATION,0.990966395159414
MIR6891_5P,SET,109,0.028437,0.0021834,0.078658,0.35886,MIR6891_5P,0.990966395159414
GOBP_FAS_SIGNALING_PATHWAY,SET,6,0.11378,0.0020555,0.31476,0.35887,GOBP_FAS_SIGNALING_PATHWAY,0.990966395159414
HAHTOLA_MYCOSIS_FUNGOIDES_SK...2,SET,163,0.023403,0.0021941,0.064747,0.35888,HAHTOLA_MYCOSIS_FUNGOIDES_SKIN_UP,0.990966395159414
GSE23502_BM_VS_COLON_TUMOR_M...2,SET,184,0.02427,0.0024162,0.067145,0.35888,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,0.990966395159414
GOBP_MITOTIC_NUCLEAR_DIVISION,SET,265,0.018009,0.0021468,0.049826,0.35889,GOBP_MITOTIC_NUCLEAR_DIVISION,0.990966395159414
HP_RECURRENT_NEISSERIAL_INFE...,SET,7,0.11239,0.002193,0.31106,0.35893,HP_RECURRENT_NEISSERIAL_INFECTIONS,0.990966395159414
GOMF_LYASE_ACTIVITY,SET,179,0.023409,0.0022989,0.064795,0.35895,GOMF_LYASE_ACTIVITY,0.990966395159414
KEGG_MEDICUS_REFERENCE_AMH_S...,SET,9,0.10358,0.0022916,0.28674,0.35897,KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY,0.990966395159414
GOCC_EXON_EXON_JUNCTION_COMP...,SET,16,0.072711,0.0021444,0.20138,0.35903,GOCC_EXON_EXON_JUNCTION_COMPLEX,0.990966395159414
HP_INCREASED_CIRCULATING_ANT...,SET,93,0.032384,0.0022978,0.089705,0.35905,HP_INCREASED_CIRCULATING_ANTIBODY_LEVEL,0.990966395159414
HP_LEUKOPENIA,SET,129,0.025996,0.0021703,0.072013,0.35905,HP_LEUKOPENIA,0.990966395159414
HP_DECREASED_CIRCULATING_MET...,SET,8,0.11406,0.0023791,0.31602,0.35908,HP_DECREASED_CIRCULATING_METHYLCOBALAMIN_CONCENTRATION,0.990966395159414
PUJANA_BRCA2_PCC_NETWORK,SET,394,0.014507,0.0021011,0.040196,0.35909,PUJANA_BRCA2_PCC_NETWORK,0.990966395159414
FAN_EMBRYONIC_CTX_IN_1_INTER...,SET,10,0.10845,0.002529,0.30066,0.35916,FAN_EMBRYONIC_CTX_IN_1_INTERNEURON,0.990966395159414
GOCC_GABA_ERGIC_SYNAPSE,SET,69,0.040653,0.0024862,0.11281,0.35929,GOCC_GABA_ERGIC_SYNAPSE,0.990966395159414
HE_LIM_SUN_FETAL_LUNG_C7_TM4...2,SET,107,0.031083,0.0023648,0.086268,0.35931,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_PENK_POS_NEURON_CELL,0.990966395159414
GSE24634_TREG_VS_TCONV_POST_...1,SET,189,0.023265,0.0023471,0.064583,0.35934,GSE24634_TREG_VS_TCONV_POST_DAY10_IL4_CONVERSION_DN,0.990966395159414
GERHOLD_RESPONSE_TO_TZD_DN,SET,12,0.1041,0.002659,0.28904,0.35937,GERHOLD_RESPONSE_TO_TZD_DN,0.990966395159414
GOBP_REGULATION_OF_ATP_DEPEN...,SET,58,0.038904,0.002182,0.10803,0.35938,GOBP_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,0.990966395159414
GSE18893_CTRL_VS_TNF_TREATED...6,SET,182,0.022241,0.0022023,0.061762,0.35938,GSE18893_CTRL_VS_TNF_TREATED_TREG_24H_UP,0.990966395159414
GOBP_PROTEIN_ACTIVATION_CASC...,SET,18,0.084696,0.0026493,0.23522,0.3594,GOBP_PROTEIN_ACTIVATION_CASCADE,0.990966395159414
MODULE_320,SET,19,0.072787,0.0023391,0.20219,0.35943,MODULE_320,0.990966395159414
HALLMARK_UV_RESPONSE_DN,SET,136,0.028534,0.0024454,0.079267,0.35944,HALLMARK_UV_RESPONSE_DN,0.990966395159414
REACTOME_SIGNALING_BY_FGFR1_...,SET,37,0.050156,0.0022481,0.13945,0.35955,REACTOME_SIGNALING_BY_FGFR1_IN_DISEASE,0.990966395159414
HP_NEOPLASM_BY_HISTOLOGY,SET,331,0.0165,0.0021943,0.045877,0.35955,HP_NEOPLASM_BY_HISTOLOGY,0.990966395159414
GSE26156_DOUBLE_POSITIVE_VS_...2,SET,178,0.022882,0.0022409,0.063655,0.35962,GSE26156_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,0.990966395159414
PID_INTEGRIN_A4B1_PATHWAY,SET,32,0.052827,0.0022024,0.147,0.35966,PID_INTEGRIN_A4B1_PATHWAY,0.990966395159414
GAGACTG_MIR452,SET,88,0.032261,0.002227,0.089791,0.35969,GAGACTG_MIR452,0.990966395159414
DURANTE_ADULT_OLFACTORY_NEUR...24,SET,46,0.050471,0.0025218,0.1406,0.35981,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_SUSTENTACULAR_CELLS,0.990966395159414
WP_EFFECT_OF_INTESTINAL_MICR...,SET,8,0.10824,0.0022578,0.30158,0.35983,WP_EFFECT_OF_INTESTINAL_MICROBIOME_ON_ANTICOAGULANT_RESPONSE_OF_VITAMIN_K_ANTAGONISTS,0.990966395159414
BREDEMEYER_RAG_SIGNALING_NOT...2,SET,59,0.039769,0.0022496,0.11081,0.35984,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP,0.990966395159414
GOBP_REGULATION_OF_PROTON_TR...,SET,12,0.088454,0.0022595,0.2465,0.35986,GOBP_REGULATION_OF_PROTON_TRANSPORT,0.990966395159414
GSE27241_WT_VS_RORGT_KO_TH17...2,SET,164,0.023817,0.0022398,0.066372,0.35986,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_DN,0.990966395159414
REACTOME_HEMOSTASIS,SET,570,0.013531,0.0023456,0.037715,0.35989,REACTOME_HEMOSTASIS,0.990966395159414
GSE13485_DAY1_VS_DAY7_YF17D_...1,SET,180,0.022189,0.0021851,0.061852,0.35989,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_DN,0.990966395159414
HP_ABNORMAL_LARYNX_MORPHOLOGY,SET,130,0.026855,0.0022505,0.07486,0.3599,HP_ABNORMAL_LARYNX_MORPHOLOGY,0.990966395159414
GOBP_REGULATION_OF_PROTEIN_L...7,SET,11,0.071904,0.0017586,0.20063,0.36003,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,0.990966395159414
GOBP_BIOMINERAL_TISSUE_DEVEL...,SET,161,0.025096,0.0023386,0.070037,0.36005,GOBP_BIOMINERAL_TISSUE_DEVELOPMENT,0.990966395159414
MORF_RAD21,SET,158,0.021485,0.0019835,0.05999,0.36012,MORF_RAD21,0.990966395159414
GSE43863_DAY6_EFF_VS_DAY150_...1,SET,175,0.022792,0.0022134,0.063639,0.36012,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_DN,0.990966395159414
GOBP_REGULATION_OF_DEFENSE_R...3,SET,5,0.11973,0.0019746,0.33444,0.36017,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_FUNGUS,0.990966395159414
MIR451B,SET,150,0.025538,0.0022977,0.071344,0.36019,MIR451B,0.990966395159414
HP_APLASIA_HYPOPLASIA_OF_THE...72,SET,23,0.063133,0.002232,0.17649,0.36028,HP_APLASIA_HYPOPLASIA_OF_THE_THYROID_GLAND,0.990966395159414
HP_SPASTIC_TETRAPLEGIA,SET,109,0.028839,0.0022143,0.080631,0.3603,HP_SPASTIC_TETRAPLEGIA,0.990966395159414
GSE22886_IGM_MEMORY_BCELL_VS...4,SET,180,0.022399,0.0022058,0.062636,0.36032,GSE22886_IGM_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,0.990966395159414
MIR4638_5P,SET,5,0.12092,0.0019942,0.3382,0.36034,MIR4638_5P,0.990966395159414
CARDOSO_RESPONSE_TO_GAMMA_RA...,SET,11,0.078679,0.0019243,0.22011,0.36038,CARDOSO_RESPONSE_TO_GAMMA_RADIATION_AND_3AB,0.990966395159414
REACTOME_DNA_REPAIR,SET,264,0.016653,0.0019814,0.0466,0.36042,REACTOME_DNA_REPAIR,0.990966395159414
REACTOME_SIGNALING_BY_NOTCH3,SET,46,0.043571,0.002177,0.122,0.36049,REACTOME_SIGNALING_BY_NOTCH3,0.990966395159414
HP_INTRAUTERINE_GROWTH_RETAR...,SET,547,0.012538,0.0021305,0.035111,0.36051,HP_INTRAUTERINE_GROWTH_RETARDATION,0.990966395159414
DESCARTES_MAIN_FETAL_OLIGODE...,SET,40,0.052388,0.0024414,0.1467,0.36051,DESCARTES_MAIN_FETAL_OLIGODENDROCYTES,0.990966395159414
GOMF_ANGIOTENSIN_RECEPTOR_BI...,SET,9,0.1089,0.0024093,0.30508,0.36056,GOMF_ANGIOTENSIN_RECEPTOR_BINDING,0.990966395159414
HP_NARROW_NASAL_RIDGE,SET,19,0.070289,0.0022588,0.19702,0.36064,HP_NARROW_NASAL_RIDGE,0.990966395159414
HAY_BONE_MARROW_FOLLICULAR_B...,SET,125,0.028456,0.0023387,0.079796,0.3607,HAY_BONE_MARROW_FOLLICULAR_B_CELL,0.990966395159414
REACTOME_NUCLEOTIDE_EXCISION...,SET,103,0.02596,0.0019379,0.072827,0.36075,REACTOME_NUCLEOTIDE_EXCISION_REPAIR,0.990966395159414
GOBP_RESPONSE_TO_PROSTAGLAND...1,SET,31,0.060865,0.0024976,0.17078,0.36078,GOBP_RESPONSE_TO_PROSTAGLANDIN,0.990966395159414
MIR7152_5P,SET,223,0.020772,0.0022741,0.05829,0.36079,MIR7152_5P,0.990966395159414
CAVIN1_TARGET_GENES,SET,62,0.036166,0.002097,0.1015,0.3608,CAVIN1_TARGET_GENES,0.990966395159414
GOBP_LEUKOCYTE_CHEMOTAXIS,SET,219,0.022109,0.002399,0.062056,0.36082,GOBP_LEUKOCYTE_CHEMOTAXIS,0.990966395159414
GOBP_PIRNA_MEDIATED_RETROTRA...,SET,5,0.11734,0.0019352,0.32939,0.36083,GOBP_PIRNA_MEDIATED_RETROTRANSPOSON_SILENCING_BY_HETEROCHROMATIN_FORMATION,0.990966395159414
GOBP_CELLULAR_RESPONSE_TO_NI...2,SET,587,0.01275,0.0022419,0.035795,0.36085,GOBP_CELLULAR_RESPONSE_TO_NITROGEN_COMPOUND,0.990966395159414
ESC_J1_UP_LATE.V1_DN,SET,151,0.024757,0.0022348,0.069535,0.36091,ESC_J1_UP_LATE.V1_DN,0.990966395159414
GOBP_REGULATION_OF_NEURON_AP...,SET,220,0.021104,0.0022951,0.059281,0.36092,GOBP_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,0.990966395159414
HP_FOCAL_AUTOMATISM_SEIZURE,SET,12,0.08537,0.0021807,0.2398,0.36092,HP_FOCAL_AUTOMATISM_SEIZURE,0.990966395159414
GSE24634_IL4_VS_CTRL_TREATED...1,SET,180,0.022481,0.0022139,0.063158,0.36094,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_DN,0.990966395159414
KEGG_MEDICUS_REFERENCE_EGF_E...3,SET,9,0.10371,0.0022944,0.29137,0.36095,KEGG_MEDICUS_REFERENCE_EGF_EGFR_PI3K_SIGNALING_PATHWAY,0.990966395159414
MIR4296,SET,65,0.037665,0.002236,0.10587,0.36101,MIR4296,0.990966395159414
YORDY_RECIPROCAL_REGULATION_...2,SET,20,0.069728,0.0022989,0.19606,0.36105,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_UP,0.990966395159414
GOBP_REGULATION_OF_FIBROBLAS...4,SET,87,0.032827,0.0022532,0.092318,0.36108,GOBP_REGULATION_OF_FIBROBLAST_PROLIFERATION,0.990966395159414
HP_ABNORMAL_MORPHOLOGY_OF_MY...,SET,19,0.069698,0.0022398,0.19617,0.36119,HP_ABNORMAL_MORPHOLOGY_OF_MYOCARDIAL_TRABECULAE,0.990966395159414
GOBP_BONE_CELL_DEVELOPMENT,SET,18,0.076652,0.0023976,0.21584,0.36125,GOBP_BONE_CELL_DEVELOPMENT,0.990966395159414
HP_MILDLY_ELEVATED_CREATINE_...,SET,53,0.039801,0.0021343,0.11208,0.36126,HP_MILDLY_ELEVATED_CREATINE_KINASE,0.990966395159414
HP_APLASIA_HYPOPLASIA_OF_THE...5,SET,3,0.20428,0.0026096,0.57531,0.36127,HP_APLASIA_HYPOPLASIA_OF_THE_3RD_METACARPAL,0.990966395159414
REACTOME_FLT3_SIGNALING_IN_D...,SET,27,0.053576,0.002052,0.15093,0.36131,REACTOME_FLT3_SIGNALING_IN_DISEASE,0.990966395159414
HP_MACULAR_DYSTROPHY,SET,18,0.070292,0.0021987,0.19808,0.36134,HP_MACULAR_DYSTROPHY,0.990966395159414
GSE6259_FLT3L_INDUCED_33D1_P...3,SET,149,0.02367,0.0021226,0.0667,0.36134,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_DN,0.990966395159414
GSE22589_SIV_VS_HIV_AND_SIV_...1,SET,181,0.021702,0.0021431,0.06118,0.3614,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_DN,0.990966395159414
BYSTRYKH_HEMATOPOIESIS_STEM_...8,SET,7,0.12995,0.0025356,0.36639,0.36142,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_RUNX1,0.990966395159414
RB_DN.V1_UP,SET,111,0.027114,0.0021008,0.076486,0.36148,RB_DN.V1_UP,0.990966395159414
GOBP_ANTIBACTERIAL_INNATE_IM...,SET,8,0.10714,0.0022349,0.30233,0.36152,GOBP_ANTIBACTERIAL_INNATE_IMMUNE_RESPONSE,0.990966395159414
CROMER_TUMORIGENESIS_DN,SET,46,0.04612,0.0023044,0.13015,0.36154,CROMER_TUMORIGENESIS_DN,0.990966395159414
HP_DERMAL_ATROPHY,SET,90,0.030703,0.0021433,0.086655,0.36155,HP_DERMAL_ATROPHY,0.990966395159414
GOBP_REGULATION_OF_MEIOTIC_N...,SET,32,0.052962,0.002208,0.14952,0.36159,GOBP_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.990966395159414
GOCC_3M_COMPLEX,SET,5,0.11587,0.0019109,0.32726,0.36165,GOCC_3M_COMPLEX,0.990966395159414
GOMF_HISTONE_KINASE_ACTIVITY,SET,21,0.066018,0.0022303,0.18654,0.3617,GOMF_HISTONE_KINASE_ACTIVITY,0.990966395159414
GSE23925_LIGHT_ZONE_VS_NAIVE...1,SET,174,0.022019,0.0021323,0.062216,0.36171,GSE23925_LIGHT_ZONE_VS_NAIVE_BCELL_DN,0.990966395159414
HP_DEMYELINATING_MOTOR_NEURO...,SET,5,0.15039,0.0024801,0.42504,0.36174,HP_DEMYELINATING_MOTOR_NEUROPATHY,0.990966395159414
GSE43260_BTLA_POS_VS_NEG_INT...2,SET,182,0.022195,0.0021977,0.062729,0.36174,GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_UP,0.990966395159414
REICHERT_MITOSIS_LIN9_TARGETS,SET,25,0.055242,0.002036,0.15614,0.36175,REICHERT_MITOSIS_LIN9_TARGETS,0.990966395159414
GSE12003_MIR223_KO_VS_WT_BM_...1,SET,187,0.022316,0.0022396,0.06308,0.36176,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_DN,0.990966395159414
GOMF_CD4_RECEPTOR_BINDING,SET,7,0.12284,0.0023969,0.34741,0.36183,GOMF_CD4_RECEPTOR_BINDING,0.990966395159414
GOBP_POSITIVE_REGULATION_OF_...397,SET,7,0.10864,0.0021198,0.30741,0.3619,GOBP_POSITIVE_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,0.990966395159414
HP_CLEFT_PALATE,SET,510,0.013144,0.0021589,0.037202,0.36193,HP_CLEFT_PALATE,0.990966395159414
MIR573,SET,86,0.032471,0.002216,0.091932,0.36197,MIR573,0.990966395159414
HP_MICROCEPHALIC_SPERM_HEAD,SET,2,0.22976,0.0023967,0.65049,0.36197,HP_MICROCEPHALIC_SPERM_HEAD,0.990966395159414
GSE14308_TH1_VS_NAIVE_CD4_TC...1,SET,176,0.022117,0.002154,0.062626,0.36199,GSE14308_TH1_VS_NAIVE_CD4_TCELL_DN,0.990966395159414
GSE9509_10MIN_VS_30MIN_LPS_A...1,SET,142,0.025314,0.0022165,0.071684,0.36199,GSE9509_10MIN_VS_30MIN_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,0.990966395159414
HP_BRITTLE_HAIR,SET,41,0.043031,0.0020302,0.12189,0.36203,HP_BRITTLE_HAIR,0.990966395159414
BROWNE_HCMV_INFECTION_20HR_DN,SET,90,0.033061,0.0023078,0.093735,0.36216,BROWNE_HCMV_INFECTION_20HR_DN,0.990966395159414
TANAKA_METHYLATED_IN_ESOPHAG...,SET,97,0.035614,0.0025805,0.10102,0.36221,TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA,0.990966395159414
VALK_AML_CLUSTER_10,SET,28,0.059531,0.0023218,0.16887,0.36222,VALK_AML_CLUSTER_10,0.990966395159414
HP_FULMINANT_HEPATIC_FAILURE,SET,5,0.11752,0.001938,0.33342,0.36225,HP_FULMINANT_HEPATIC_FAILURE,0.990966395159414
GOMF_CHOLINE_TRANSMEMBRANE_T...,SET,7,0.12569,0.0024526,0.35668,0.36227,GOMF_CHOLINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.990966395159414
REACTOME_L1CAM_INTERACTIONS,SET,108,0.030334,0.0023184,0.086085,0.36228,REACTOME_L1CAM_INTERACTIONS,0.990966395159414
GOBP_REGULATION_OF_PROTEIN_D...1,SET,25,0.053578,0.0019747,0.15205,0.36228,GOBP_REGULATION_OF_PROTEIN_DEACETYLATION,0.990966395159414
REACTOME_ENHANCED_BINDING_OF...,SET,7,0.12572,0.0024531,0.35682,0.3623,REACTOME_ENHANCED_BINDING_OF_GP1BA_VARIANT_TO_VWF_MULTIMER_COLLAGEN,0.990966395159414
HOXA13_TARGET_GENES,SET,39,0.045288,0.002084,0.1286,0.36236,HOXA13_TARGET_GENES,0.990966395159414
GOBP_PEROXISOMAL_TRANSPORT,SET,19,0.06426,0.0020651,0.18247,0.36236,GOBP_PEROXISOMAL_TRANSPORT,0.990966395159414
REACTOME_HISTIDINE_CATABOLISM,SET,7,0.11732,0.0022892,0.33316,0.36237,REACTOME_HISTIDINE_CATABOLISM,0.990966395159414
GOBP_ARTERIAL_ENDOTHELIAL_CE...,SET,6,0.13247,0.0023931,0.37623,0.36238,GOBP_ARTERIAL_ENDOTHELIAL_CELL_DIFFERENTIATION,0.990966395159414
MIR29A_3P,SET,396,0.015715,0.0022818,0.044636,0.36239,MIR29A_3P,0.990966395159414
GOBP_RETINOIC_ACID_METABOLIC...,SET,33,0.060375,0.002556,0.17155,0.36244,GOBP_RETINOIC_ACID_METABOLIC_PROCESS,0.990966395159414
GOBP_PROTEIN_AUTO_ADP_RIBOSY...,SET,11,0.093562,0.0022883,0.26589,0.36247,GOBP_PROTEIN_AUTO_ADP_RIBOSYLATION,0.990966395159414
HP_ABNORMAL_LIGHT_ADAPTED_EL...,SET,9,0.11474,0.0025385,0.32619,0.36251,HP_ABNORMAL_LIGHT_ADAPTED_ELECTRORETINOGRAM,0.990966395159414
MORF_SOD1,SET,243,0.017448,0.001993,0.049628,0.36258,MORF_SOD1,0.990966395159414
GOBP_7_METHYLGUANOSINE_RNA_C...,SET,5,0.10557,0.001741,0.30031,0.3626,GOBP_7_METHYLGUANOSINE_RNA_CAPPING,0.990966395159414
GOBP_RETICULOPHAGY,SET,17,0.069151,0.0021021,0.19671,0.3626,GOBP_RETICULOPHAGY,0.990966395159414
MODULE_521,SET,35,0.055842,0.0024346,0.15886,0.36261,MODULE_521,0.990966395159414
JINESH_BLEBBISHIELD_TO_IMMUN...2,SET,341,0.017059,0.002302,0.048538,0.36263,JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP,0.990966395159414
GOBP_ACTIN_CROSSLINK_FORMATI...,SET,13,0.090245,0.0023993,0.25689,0.36268,GOBP_ACTIN_CROSSLINK_FORMATION,0.990966395159414
HP_LOWER_LIMB_HYPERREFLEXIA,SET,72,0.034144,0.0021329,0.097198,0.36269,HP_LOWER_LIMB_HYPERREFLEXIA,0.990966395159414
GSE2770_TGFB_AND_IL4_ACT_VS_...1,SET,176,0.021982,0.0021408,0.062575,0.36269,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN,0.990966395159414
GOBP_NEGATIVE_REGULATION_OF_...486,SET,19,0.060382,0.0019404,0.17191,0.3627,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATASE_ACTIVITY,0.990966395159414
GSE25123_WT_VS_PPARG_KO_MACR...6,SET,149,0.024122,0.0021631,0.068681,0.36271,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,0.990966395159414
CEBPDELTA_Q6,SET,217,0.020539,0.0022186,0.058511,0.36278,CEBPDELTA_Q6,0.990966395159414
HP_ABNORMAL_GLYCOSPHINGOLIPI...,SET,6,0.13176,0.0023803,0.37538,0.36279,HP_ABNORMAL_GLYCOSPHINGOLIPID_METABOLISM,0.990966395159414
GSE5589_UNSTIM_VS_180MIN_LPS...1,SET,184,0.02098,0.0020887,0.059786,0.36282,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_DN,0.990966395159414
GOCC_SMALL_SUBUNIT_PROCESSOME,SET,63,0.035027,0.0020472,0.099828,0.36284,GOCC_SMALL_SUBUNIT_PROCESSOME,0.990966395159414
BIOCARTA_FLUMAZENIL_PATHWAY,SET,8,0.11423,0.0023828,0.32561,0.36286,BIOCARTA_FLUMAZENIL_PATHWAY,0.990966395159414
GOBP_REGULATION_OF_PHOSPHOLI...3,SET,5,0.15458,0.0025492,0.441,0.36298,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,0.990966395159414
SWEET_LUNG_CANCER_KRAS_UP,SET,427,0.014465,0.002179,0.041275,0.363,SWEET_LUNG_CANCER_KRAS_UP,0.990966395159414
GOBP_REGULATION_OF_EPITHELIA...1,SET,97,0.032654,0.002366,0.093181,0.36301,GOBP_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,0.990966395159414
SCHERER_PBMC_APSV_WETVAX_AGE...3,SET,130,0.025515,0.0021383,0.072823,0.36303,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_DN,0.990966395159414
GOBP_REGULATION_OF_HUMORAL_I...2,SET,17,0.085792,0.002608,0.24499,0.3631,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,0.990966395159414
RHODES_CANCER_META_SIGNATURE,SET,58,0.036542,0.0020495,0.10438,0.36315,RHODES_CANCER_META_SIGNATURE,0.990966395159414
KEGG_MEDICUS_REFERENCE_ACTIV...3,SET,8,0.096602,0.002015,0.27597,0.36315,KEGG_MEDICUS_REFERENCE_ACTIVIN_SIGNALING_PATHWAY,0.990966395159414
GSE40274_IRF4_VS_FOXP3_AND_I...1,SET,102,0.030841,0.0022912,0.088142,0.36321,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.990966395159414
GOBP_REGULATION_OF_NEUTROPHI...4,SET,4,0.15778,0.0023274,0.451,0.36323,GOBP_REGULATION_OF_NEUTROPHIL_EXTRAVASATION,0.990966395159414
GOBP_TYPE_B_PANCREATIC_CELL_...1,SET,10,0.10683,0.0024911,0.30538,0.36324,GOBP_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,0.990966395159414
HP_DECREASED_MEAN_CORPUSCULA...1,SET,5,0.1539,0.0025381,0.43999,0.36325,HP_DECREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,0.990966395159414
GSE27786_CD8_TCELL_VS_ERYTHR...2,SET,182,0.020283,0.0020084,0.057987,0.36325,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_UP,0.990966395159414
GOBP_LUNG_MORPHOGENESIS,SET,54,0.04251,0.0023008,0.12163,0.36335,GOBP_LUNG_MORPHOGENESIS,0.990966395159414
GOBP_DETERMINATION_OF_ADULT_...,SET,31,0.052273,0.002145,0.1496,0.36339,GOBP_DETERMINATION_OF_ADULT_LIFESPAN,0.990966395159414
HP_CONTRACTURE_OF_THE_PROXIM...1,SET,6,0.12321,0.0022258,0.3527,0.36342,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_3RD_FINGER,0.990966395159414
GOBP_CYTOCHROME_COMPLEX_ASSE...,SET,32,0.04529,0.0018881,0.12965,0.36343,GOBP_CYTOCHROME_COMPLEX_ASSEMBLY,0.990966395159414
GOBP_REGULATION_OF_UNSATURAT...,SET,10,0.085838,0.0020017,0.24575,0.36344,GOBP_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,0.990966395159414
HP_ABNORMAL_LARYNX_PHYSIOLOGY,SET,43,0.044018,0.0021267,0.12607,0.36349,HP_ABNORMAL_LARYNX_PHYSIOLOGY,0.990966395159414
REACTOME_SARS_COV_1_TARGETS_...,SET,16,0.077174,0.002276,0.22107,0.36351,REACTOME_SARS_COV_1_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,0.990966395159414
HALLMARK_APICAL_SURFACE,SET,39,0.049504,0.002278,0.14182,0.36352,HALLMARK_APICAL_SURFACE,0.990966395159414
HOWARD_NEUTROPHIL_INACT_MONO...4,SET,113,0.028663,0.0022406,0.082134,0.36355,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,0.990966395159414
GOCC_ORGANELLE_SUBCOMPARTMENT,SET,1359,0.0082673,0.0021634,0.023692,0.36356,GOCC_ORGANELLE_SUBCOMPARTMENT,0.990966395159414
GSE20152_SPHK1_KO_VS_HTNFA_O...1,SET,177,0.020842,0.0020354,0.059729,0.36357,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN,0.990966395159414
BLANCO_MELO_BRONCHIAL_EPITHE...1,SET,159,0.022474,0.0020813,0.064413,0.36358,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_DN,0.990966395159414
MIR4283,SET,186,0.021529,0.0021548,0.06171,0.36359,MIR4283,0.990966395159414
GSE22886_NAIVE_TCELL_VS_NKCE...1,SET,181,0.020932,0.002067,0.059997,0.36359,GSE22886_NAIVE_TCELL_VS_NKCELL_DN,0.990966395159414
HP_SACROCOCCYGEAL_TERATOMA,SET,5,0.12424,0.002049,0.35615,0.3636,HP_SACROCOCCYGEAL_TERATOMA,0.990966395159414
HP_WOLFF_PARKINSON_WHITE_SYN...,SET,15,0.070866,0.0020237,0.20315,0.36361,HP_WOLFF_PARKINSON_WHITE_SYNDROME,0.990966395159414
HP_DEFORMED_TARSAL_BONES,SET,13,0.095118,0.0025288,0.27272,0.36363,HP_DEFORMED_TARSAL_BONES,0.990966395159414
HP_OSTEOCHONDROSIS,SET,12,0.087173,0.0022267,0.24993,0.36363,HP_OSTEOCHONDROSIS,0.990966395159414
GSE28726_ACT_CD4_TCELL_VS_AC...1,SET,177,0.022057,0.0021541,0.063273,0.3637,GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_DN,0.990966395159414
GOBP_DORSAL_VENTRAL_AXIS_SPE...,SET,14,0.088098,0.0024305,0.25275,0.36371,GOBP_DORSAL_VENTRAL_AXIS_SPECIFICATION,0.990966395159414
GOBP_PEPTIDYL_LYSINE_HYDROXY...,SET,8,0.10891,0.0022718,0.31249,0.36372,GOBP_PEPTIDYL_LYSINE_HYDROXYLATION,0.990966395159414
REACTOME_ACTIVATION_OF_BH3_O...,SET,30,0.057033,0.0023024,0.16368,0.36375,REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS,0.990966395159414
HP_ENLARGED_OVARIES,SET,16,0.07236,0.0021341,0.20776,0.36382,HP_ENLARGED_OVARIES,0.990966395159414
GOBP_SYNAPTIC_ASSEMBLY_AT_NE...,SET,8,0.099453,0.0020745,0.28564,0.36385,GOBP_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,0.990966395159414
MIR4468,SET,107,0.028448,0.0021643,0.081712,0.36387,MIR4468,0.990966395159414
GOBP_RESPONSE_TO_ALKALOID,SET,97,0.030082,0.0021796,0.086463,0.36395,GOBP_RESPONSE_TO_ALKALOID,0.990966395159414
MIR3936,SET,30,0.050932,0.002056,0.14646,0.36402,MIR3936,0.990966395159414
GOBP_MACROMOLECULE_DEACYLATI...,SET,53,0.038035,0.0020395,0.10939,0.36403,GOBP_MACROMOLECULE_DEACYLATION,0.990966395159414
GOMF_CYCLASE_ACTIVATOR_ACTIV...,SET,11,0.10316,0.0025231,0.29672,0.36404,GOMF_CYCLASE_ACTIVATOR_ACTIVITY,0.990966395159414
GOBP_BONE_MINERALIZATION,SET,113,0.028887,0.0022581,0.083108,0.36408,GOBP_BONE_MINERALIZATION,0.990966395159414
MODULE_346,SET,17,0.07713,0.0023447,0.22193,0.36409,MODULE_346,0.990966395159414
GOBP_ARTERY_MORPHOGENESIS,SET,69,0.039358,0.002407,0.11325,0.3641,GOBP_ARTERY_MORPHOGENESIS,0.990966395159414
HP_ABNORMAL_FEAR_INDUCED_BEH...,SET,7,0.099805,0.0019474,0.28757,0.36427,HP_ABNORMAL_FEAR_INDUCED_BEHAVIOR,0.990966395159414
GOBP_REGULATION_OF_SODIUM_DE...,SET,5,0.13718,0.0022623,0.39534,0.3643,GOBP_REGULATION_OF_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,0.990966395159414
REACTOME_KILLING_MECHANISMS,SET,11,0.082041,0.0020065,0.23646,0.36431,REACTOME_KILLING_MECHANISMS,0.990966395159414
HP_PERIPHERAL_DEMYELINATION,SET,40,0.045621,0.002126,0.13149,0.36432,HP_PERIPHERAL_DEMYELINATION,0.990966395159414
GOBP_RENAL_SYSTEM_PROCESS,SET,117,0.028747,0.0022863,0.082868,0.36434,GOBP_RENAL_SYSTEM_PROCESS,0.990966395159414
TURASHVILI_BREAST_CARCINOMA_...2,SET,21,0.06784,0.0022919,0.19571,0.36443,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP,0.990966395159414
WP_TYPE_III_INTERFERON_SIGNA...,SET,10,0.088791,0.0020706,0.25618,0.36445,WP_TYPE_III_INTERFERON_SIGNALING,0.990966395159414
MODULE_102,SET,16,0.070534,0.0020802,0.20356,0.36448,MODULE_102,0.990966395159414
GAVISH_3CA_METAPROGRAM_EPITH...18,SET,47,0.048925,0.0024709,0.14125,0.36453,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_1,0.990966395159414
GOBP_MICROTUBULE_BASED_MOVEM...,SET,367,0.014859,0.0020786,0.04291,0.36457,GOBP_MICROTUBULE_BASED_MOVEMENT,0.990966395159414
GOBP_POSITIVE_REGULATION_OF_...357,SET,81,0.032492,0.0021523,0.093857,0.3646,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION,0.990966395159414
MEBARKI_HCC_PROGENITOR_WNT_D...2,SET,25,0.065122,0.0024002,0.18812,0.36461,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT,0.990966395159414
GOBP_REGULATION_OF_ASYMMETRI...,SET,5,0.15822,0.0026092,0.45709,0.36462,GOBP_REGULATION_OF_ASYMMETRIC_CELL_DIVISION,0.990966395159414
RODWELL_AGING_KIDNEY_UP,SET,422,0.014778,0.0022135,0.042711,0.36467,RODWELL_AGING_KIDNEY_UP,0.990966395159414
BIOCARTA_CB1R_PATHWAY,SET,7,0.1103,0.0021523,0.31888,0.36471,BIOCARTA_CB1R_PATHWAY,0.990966395159414
GOMF_5S_RRNA_BINDING,SET,8,0.10209,0.0021294,0.29512,0.36471,GOMF_5S_RRNA_BINDING,0.990966395159414
MCBRYAN_PUBERTAL_BREAST_6_7W...1,SET,71,0.035409,0.0021965,0.10238,0.36473,MCBRYAN_PUBERTAL_BREAST_6_7WK_DN,0.990966395159414
GSE11961_GERMINAL_CENTER_BCE...4,SET,176,0.021985,0.0021411,0.063573,0.36474,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_UP,0.990966395159414
HP_NEVUS,SET,153,0.023082,0.0020972,0.066791,0.36483,HP_NEVUS,0.990966395159414
GSE23308_CTRL_VS_CORTICOSTER...4,SET,188,0.020303,0.0020429,0.05875,0.36483,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_UP,0.990966395159414
HP_TEMPOROMANDIBULAR_JOINT_A...,SET,4,0.13526,0.0019952,0.39149,0.36486,HP_TEMPOROMANDIBULAR_JOINT_ANKYLOSIS,0.990966395159414
MIR320E,SET,60,0.038243,0.0021815,0.1107,0.36488,MIR320E,0.990966395159414
GSE32423_IL7_VS_IL7_IL4_NAIV...1,SET,173,0.021669,0.0020924,0.062724,0.36488,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_DN,0.990966395159414
GOBP_CHROMOSOME_ORGANIZATION,SET,543,0.011962,0.0020256,0.034631,0.36489,GOBP_CHROMOSOME_ORGANIZATION,0.990966395159414
GSE42724_MEMORY_VS_B1_BCELL_...2,SET,185,0.020362,0.0020326,0.058948,0.36489,GSE42724_MEMORY_VS_B1_BCELL_UP,0.990966395159414
MIR1972,SET,88,0.030047,0.0020742,0.087025,0.36495,MIR1972,0.990966395159414
GOCC_MEDIATOR_COMPLEX,SET,34,0.046185,0.0019846,0.13377,0.36495,GOCC_MEDIATOR_COMPLEX,0.990966395159414
REACTOME_KERATINIZATION,SET,183,0.030058,0.0029843,0.087071,0.36497,REACTOME_KERATINIZATION,0.990966395159414
GOBP_MICROTUBULE_SEVERING,SET,9,0.086489,0.0019134,0.25055,0.36498,GOBP_MICROTUBULE_SEVERING,0.990966395159414
GSE13484_3H_UNSTIM_VS_YF17D_...2,SET,185,0.020815,0.0020778,0.060303,0.36498,GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,0.990966395159414
ANDERSON_BLOOD_CN54GP140_ADJ...6,SET,31,0.052069,0.0021366,0.15084,0.36498,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_UP,0.990966395159414
GOBP_TRANSCYTOSIS,SET,21,0.064142,0.0021669,0.18587,0.36501,GOBP_TRANSCYTOSIS,0.990966395159414
BIOCARTA_VEGF_PATHWAY,SET,24,0.056818,0.0020519,0.16468,0.36504,BIOCARTA_VEGF_PATHWAY,0.990966395159414
GOBP_POSITIVE_REGULATION_OF_...526,SET,226,0.020524,0.0022619,0.05952,0.36511,GOBP_POSITIVE_REGULATION_OF_NEUROGENESIS,0.990966395159414
MEBARKI_HCC_PROGENITOR_FZD8C...2,SET,477,0.01312,0.0020861,0.038056,0.36514,MEBARKI_HCC_PROGENITOR_FZD8CRD_UP,0.990966395159414
MODULE_111,SET,140,0.024533,0.002133,0.071164,0.36515,MODULE_111,0.990966395159414
KEGG_MEDICUS_PATHOGEN_ESCHER...5,SET,14,0.074431,0.0020535,0.216,0.3652,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY,0.990966395159414
HP_HYPOTHALAMIC_HAMARTOMA,SET,14,0.063549,0.0017532,0.18444,0.36522,HP_HYPOTHALAMIC_HAMARTOMA,0.990966395159414
HP_APLASIA_HYPOPLASIA_OF_THE...50,SET,85,0.03109,0.0021094,0.090254,0.36525,HP_APLASIA_HYPOPLASIA_OF_THE_OVARY,0.990966395159414
REACTOME_TICAM1_RIP1_MEDIATE...,SET,17,0.076581,0.002328,0.22239,0.36529,REACTOME_TICAM1_RIP1_MEDIATED_IKK_COMPLEX_RECRUITMENT,0.990966395159414
ER_Q6,SET,246,0.018879,0.0021696,0.054828,0.3653,ER_Q6,0.990966395159414
GOBP_REGULATION_OF_MONOCYTE_...3,SET,6,0.11773,0.0021268,0.34202,0.36534,GOBP_REGULATION_OF_MONOCYTE_EXTRAVASATION,0.990966395159414
KEGG_MEDICUS_REFERENCE_TYPE_...1,SET,18,0.087507,0.0027372,0.25427,0.36537,KEGG_MEDICUS_REFERENCE_TYPE_II_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,0.990966395159414
GOBP_ENDOPLASMIC_RETICULUM_U...,SET,70,0.033971,0.0020925,0.098755,0.36543,GOBP_ENDOPLASMIC_RETICULUM_UNFOLDED_PROTEIN_RESPONSE,0.990966395159414
REACTOME_DISEASES_OF_HEMOSTA...,SET,17,0.075448,0.0022936,0.21947,0.36551,REACTOME_DISEASES_OF_HEMOSTASIS,0.990966395159414
KEGG_MEDICUS_REFERENCE_ANTIG...2,SET,12,0.085643,0.0021876,0.24914,0.36552,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,0.990966395159414
GSE360_L_MAJOR_VS_M_TUBERCUL...2,SET,169,0.02233,0.0021314,0.064958,0.36552,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_UP,0.990966395159414
HP_ABNORMALITY_OF_THE_ACOUST...,SET,4,0.15558,0.0022949,0.45266,0.36554,HP_ABNORMALITY_OF_THE_ACOUSTIC_REFLEX,0.990966395159414
HP_ABNORMAL_MIDDLE_EAR_REFLE...,SET,4,0.15558,0.0022949,0.45266,0.36554,HP_ABNORMAL_MIDDLE_EAR_REFLEXES,0.990966395159414
MURARO_PANCREAS_ALPHA_CELL,SET,471,0.013968,0.0022072,0.04064,0.36554,MURARO_PANCREAS_ALPHA_CELL,0.990966395159414
GOBP_POSITIVE_REGULATION_OF_...401,SET,258,0.019642,0.0023108,0.057156,0.36555,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,0.990966395159414
WP_FOCAL_ADHESION,SET,190,0.021906,0.0022158,0.063747,0.36556,WP_FOCAL_ADHESION,0.990966395159414
GOMF_MOLECULAR_SEQUESTERING_...,SET,41,0.045901,0.0021655,0.13358,0.36556,GOMF_MOLECULAR_SEQUESTERING_ACTIVITY,0.990966395159414
YGCGYRCGC_UNKNOWN,SET,287,0.016444,0.0020387,0.047877,0.36563,YGCGYRCGC_UNKNOWN,0.990966395159414
STARK_HYPPOCAMPUS_22Q11_DELE...2,SET,46,0.043667,0.0021819,0.12717,0.36566,STARK_HYPPOCAMPUS_22Q11_DELETION_UP,0.990966395159414
MIR222_3P,SET,158,0.02378,0.0021954,0.069258,0.36567,MIR222_3P,0.990966395159414
VIETOR_IFRD1_TARGETS,SET,20,0.068503,0.0022585,0.19962,0.36574,VIETOR_IFRD1_TARGETS,0.990966395159414
GOCC_TRANS_GOLGI_NETWORK_TRA...1,SET,35,0.04794,0.00209,0.13973,0.36577,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE,0.990966395159414
HP_ABNORMAL_BLOOD_MONOVALENT...,SET,140,0.025717,0.0022359,0.075018,0.36587,HP_ABNORMAL_BLOOD_MONOVALENT_INORGANIC_CATION_CONCENTRATION,0.990966395159414
GAVISH_3CA_METAPROGRAM_EPITH...20,SET,48,0.041835,0.0021352,0.12206,0.36589,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_3,0.990966395159414
GOCC_CKM_COMPLEX,SET,4,0.11395,0.0016809,0.33249,0.36591,GOCC_CKM_COMPLEX,0.990966395159414
SAUL_SEN_MAYO,SET,123,0.029781,0.0024281,0.086931,0.36596,SAUL_SEN_MAYO,0.990966395159414
REACTOME_UPTAKE_AND_ACTIONS_...,SET,28,0.055295,0.0021566,0.16141,0.36596,REACTOME_UPTAKE_AND_ACTIONS_OF_BACTERIAL_TOXINS,0.990966395159414
GOCC_ORIGIN_RECOGNITION_COMP...,SET,8,0.082466,0.0017201,0.24079,0.366,GOCC_ORIGIN_RECOGNITION_COMPLEX,0.990966395159414
GSE12366_GC_VS_MEMORY_BCELL_...1,SET,180,0.021563,0.0021235,0.06296,0.366,GSE12366_GC_VS_MEMORY_BCELL_DN,0.990966395159414
GOBP_TAURINE_METABOLIC_PROCE...,SET,9,0.1095,0.0024226,0.31978,0.36601,GOBP_TAURINE_METABOLIC_PROCESS,0.990966395159414
HP_ABNORMALLY_OSSIFIED_VERTE...,SET,19,0.06605,0.0021226,0.19288,0.36601,HP_ABNORMALLY_OSSIFIED_VERTEBRAE,0.990966395159414
GSE6259_FLT3L_INDUCED_33D1_P...2,SET,177,0.021009,0.0020518,0.061356,0.36602,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_UP,0.990966395159414
MCDOWELL_ACUTE_LUNG_INJURY_DN,SET,41,0.045755,0.0021586,0.13363,0.36603,MCDOWELL_ACUTE_LUNG_INJURY_DN,0.990966395159414
REACTOME_TRNA_MODIFICATION_I...1,SET,7,0.090256,0.0017611,0.26367,0.36606,REACTOME_TRNA_MODIFICATION_IN_THE_MITOCHONDRION,0.990966395159414
HP_ABNORMAL_URETER_MORPHOLOGY,SET,136,0.024211,0.0020749,0.070782,0.36616,HP_ABNORMAL_URETER_MORPHOLOGY,0.990966395159414
GSE20715_0H_VS_6H_OZONE_LUNG...1,SET,186,0.021156,0.0021175,0.06185,0.36616,GSE20715_0H_VS_6H_OZONE_LUNG_DN,0.990966395159414
GOBP_NUCLEUS_ORGANIZATION,SET,132,0.023663,0.0019981,0.069199,0.3662,GOBP_NUCLEUS_ORGANIZATION,0.990966395159414
HP_AORTOPULMONARY_COLLATERAL...,SET,14,0.085635,0.0023626,0.25045,0.36621,HP_AORTOPULMONARY_COLLATERAL_ARTERIES,0.990966395159414
REACTOME_NF_KB_IS_ACTIVATED_...,SET,11,0.09064,0.0022168,0.26513,0.36623,REACTOME_NF_KB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL,0.990966395159414
GSE43955_TH0_VS_TGFB_IL6_IL2...1,SET,188,0.021204,0.0021335,0.062027,0.36623,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,0.990966395159414
GSE24634_TEFF_VS_TCONV_DAY7_...1,SET,183,0.022417,0.0022257,0.065578,0.36624,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_DN,0.990966395159414
AHR_01,SET,54,0.038147,0.0020647,0.1116,0.36625,AHR_01,0.990966395159414
GSE19198_1H_VS_6H_IL21_TREAT...2,SET,145,0.024774,0.0021918,0.072485,0.36626,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_UP,0.990966395159414
HP_JUVENILE_CATARACT,SET,10,0.084228,0.0019642,0.24653,0.36631,HP_JUVENILE_CATARACT,0.990966395159414
HP_HYPOARGININEMIA,SET,6,0.10857,0.0019613,0.31797,0.36639,HP_HYPOARGININEMIA,0.990966395159414
REACTOME_CIRCADIAN_CLOCK,SET,64,0.036836,0.0021699,0.10791,0.36642,REACTOME_CIRCADIAN_CLOCK,0.990966395159414
GOCC_BLOC_COMPLEX,SET,19,0.065889,0.0021174,0.19304,0.36643,GOCC_BLOC_COMPLEX,0.990966395159414
GSE27670_CTRL_VS_LMP1_TRANSD...2,SET,181,0.021639,0.0021368,0.063397,0.36643,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_UP,0.990966395159414
GOBP_POSITIVE_REGULATION_OF_...405,SET,141,0.025201,0.0021989,0.073858,0.36647,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,0.990966395159414
HP_EPISODIC_TACHYPNEA,SET,48,0.0359,0.0018323,0.10522,0.36648,HP_EPISODIC_TACHYPNEA,0.990966395159414
MIR4445_3P,SET,9,0.089593,0.0019821,0.26262,0.3665,MIR4445_3P,0.990966395159414
HP_EPIDURAL_HEMORRHAGE,SET,5,0.1674,0.0027608,0.49091,0.36655,HP_EPIDURAL_HEMORRHAGE,0.990966395159414
HP_ANAPHYLACTIC_SHOCK,SET,8,0.10523,0.0021949,0.30872,0.36661,HP_ANAPHYLACTIC_SHOCK,0.990966395159414
HP_ABSENT_HAND,SET,17,0.074255,0.0022573,0.21789,0.36663,HP_ABSENT_HAND,0.990966395159414
PEDERSEN_METASTASIS_BY_ERBB2...2,SET,17,0.077464,0.0023549,0.22734,0.36665,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_3,0.990966395159414
GOBP_EPIDERMAL_CELL_FATE_SPE...,SET,5,0.14055,0.0023179,0.41248,0.36665,GOBP_EPIDERMAL_CELL_FATE_SPECIFICATION,0.990966395159414
HP_ABNORMALITY_OF_THE_UMBILI...,SET,62,0.037242,0.0021594,0.10929,0.36665,HP_ABNORMALITY_OF_THE_UMBILICAL_CORD,0.990966395159414
GSE17721_POLYIC_VS_CPG_8H_BM...1,SET,181,0.020726,0.0020466,0.060825,0.36665,GSE17721_POLYIC_VS_CPG_8H_BMDC_DN,0.990966395159414
MIR520G_3P_MIR520H,SET,182,0.02107,0.0020864,0.061844,0.36666,MIR520G_3P_MIR520H,0.990966395159414
MYC_Q2,SET,180,0.02188,0.0021547,0.064224,0.36667,MYC_Q2,0.990966395159414
XIE_LT_HSC_S1PR3_OE_UP,SET,26,0.064783,0.0024349,0.19017,0.36669,XIE_LT_HSC_S1PR3_OE_UP,0.990966395159414
MODULE_26,SET,187,0.020943,0.0021017,0.061479,0.36669,MODULE_26,0.990966395159414
HP_PAIN_INSENSITIVITY,SET,26,0.056483,0.0021229,0.16582,0.36669,HP_PAIN_INSENSITIVITY,0.990966395159414
GSE33162_HDAC3_KO_VS_HDAC3_K...2,SET,181,0.02023,0.0019976,0.059398,0.36671,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_UP,0.990966395159414
GSE9037_WT_VS_IRAK4_KO_LPS_1...1,SET,172,0.022446,0.0021612,0.065936,0.36677,GSE9037_WT_VS_IRAK4_KO_LPS_1H_STIM_BMDM_DN,0.990966395159414
MIR4494,SET,52,0.039405,0.002093,0.11576,0.36678,MIR4494,0.990966395159414
MIR652_3P,SET,4,0.1648,0.002431,0.48418,0.36679,MIR652_3P,0.990966395159414
CAGTCAC_MIR134,SET,48,0.041013,0.0020932,0.12051,0.3668,CAGTCAC_MIR134,0.990966395159414
FOXE1_TARGET_GENES,SET,567,0.012323,0.0021309,0.036207,0.3668,FOXE1_TARGET_GENES,0.990966395159414
NR0B1_TARGET_GENES,SET,278,0.017681,0.0021581,0.051956,0.36681,NR0B1_TARGET_GENES,0.990966395159414
GOBP_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.11372,0.0016775,0.33417,0.36681,GOBP_FRUCTOSE_2_6_BISPHOSPHATE_METABOLIC_PROCESS,0.990966395159414
GOMF_FRUCTOSE_2_6_BISPHOSPHA...,SET,4,0.11372,0.0016775,0.33417,0.36681,GOMF_FRUCTOSE_2_6_BISPHOSPHATE_2_PHOSPHATASE_ACTIVITY,0.990966395159414
MIR450B_3P,SET,42,0.043442,0.0020743,0.12767,0.36683,MIR450B_3P,0.990966395159414
GSE2770_IL12_VS_IL4_TREATED_...1,SET,151,0.023887,0.0021562,0.070245,0.36691,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,0.990966395159414
GOBP_MULTI_CILIATED_EPITHELI...,SET,8,0.10345,0.0021578,0.30426,0.36693,GOBP_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,0.990966395159414
GSE11961_MARGINAL_ZONE_BCELL...9,SET,176,0.021351,0.0020793,0.062798,0.36693,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_DN,0.990966395159414
MIR29B_3P_MIR29C_3P,SET,396,0.015183,0.0022045,0.044657,0.36694,MIR29B_3P_MIR29C_3P,0.990966395159414
WP_GLUCURONIDATION,SET,24,0.08191,0.002958,0.24104,0.367,WP_GLUCURONIDATION,0.990966395159414
MIR3675_5P,SET,30,0.049721,0.0020072,0.14632,0.367,MIR3675_5P,0.990966395159414
GSE19198_CTRL_VS_IL21_TREATE...2,SET,149,0.023615,0.0021177,0.069506,0.36702,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_UP,0.990966395159414
GOBP_HEMATOPOIETIC_OR_LYMPHO...,SET,97,0.030024,0.0021754,0.088371,0.36703,GOBP_HEMATOPOIETIC_OR_LYMPHOID_ORGAN_DEVELOPMENT,0.990966395159414
HALLMARK_UV_RESPONSE_UP,SET,149,0.023227,0.0020828,0.068406,0.3671,HALLMARK_UV_RESPONSE_UP,0.990966395159414
STREICHER_LSM1_TARGETS_UP,SET,40,0.046744,0.0021783,0.13768,0.36711,STREICHER_LSM1_TARGETS_UP,0.990966395159414
REACTOME_TRNA_PROCESSING_IN_...2,SET,53,0.037334,0.0020019,0.10997,0.36712,REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS,0.990966395159414
GSE2585_CTEC_VS_MTEC_THYMUS_...2,SET,176,0.021523,0.0020961,0.0634,0.36712,GSE2585_CTEC_VS_MTEC_THYMUS_UP,0.990966395159414
TSAI_DNAJB4_TARGETS_UP,SET,12,0.083061,0.0021217,0.24468,0.36713,TSAI_DNAJB4_TARGETS_UP,0.990966395159414
GAVISH_3CA_METAPROGRAM_CD8_T...4,SET,46,0.043574,0.0021772,0.12844,0.36721,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_DYSFUNCTION,0.990966395159414
GCM_APEX1,SET,102,0.025958,0.0019284,0.076528,0.36723,GCM_APEX1,0.990966395159414
GOBP_POSITIVE_REGULATION_OF_...815,SET,7,0.10972,0.0021409,0.32346,0.36723,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,0.990966395159414
CUI_DEVELOPING_HEART_VASCULA...,SET,179,0.022572,0.0022167,0.066564,0.36727,CUI_DEVELOPING_HEART_VASCULAR_ENDOTHELIAL_CELL,0.990966395159414
GOBP_INFLAMMATORY_RESPONSE,SET,780,0.011096,0.0022368,0.032726,0.36729,GOBP_INFLAMMATORY_RESPONSE,0.990966395159414
MORF_MAP2K2,SET,116,0.024443,0.0019358,0.07214,0.36737,MORF_MAP2K2,0.990966395159414
GSE37416_CTRL_VS_48H_F_TULAR...2,SET,167,0.022195,0.002106,0.065504,0.36737,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.990966395159414
GOBP_EMBRYO_IMPLANTATION,SET,50,0.0413,0.0021512,0.12192,0.3674,GOBP_EMBRYO_IMPLANTATION,0.990966395159414
NAKAMURA_TUMOR_ZONE_PERIPHER...1,SET,550,0.01252,0.0021332,0.036969,0.36743,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN,0.990966395159414
HP_ABNORMAL_MUSCLE_FIBER_MER...,SET,4,0.13637,0.0020117,0.40273,0.36745,HP_ABNORMAL_MUSCLE_FIBER_MEROSIN_EXPRESSION,0.990966395159414
GOMF_STRUCTURAL_CONSTITUENT_...6,SET,22,0.056246,0.0019448,0.16612,0.36746,GOMF_STRUCTURAL_CONSTITUENT_OF_NUCLEAR_PORE,0.990966395159414
HALLMARK_KRAS_SIGNALING_UP,SET,186,0.022922,0.0022943,0.067705,0.36747,HALLMARK_KRAS_SIGNALING_UP,0.990966395159414
GSE14415_NATURAL_TREG_VS_TCO...1,SET,168,0.021136,0.0020115,0.062434,0.36748,GSE14415_NATURAL_TREG_VS_TCONV_DN,0.990966395159414
GOBP_NUCLEOPHAGY,SET,21,0.062504,0.0021116,0.18464,0.36749,GOBP_NUCLEOPHAGY,0.990966395159414
REACTOME_ERK_MAPK_TARGETS,SET,20,0.065533,0.0021606,0.19363,0.36752,REACTOME_ERK_MAPK_TARGETS,0.990966395159414
GSE17721_LPS_VS_GARDIQUIMOD_...8,SET,187,0.02069,0.0020764,0.061143,0.36754,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_UP,0.990966395159414
REACTOME_NOTCH3_INTRACELLULA...,SET,24,0.057125,0.0020629,0.16885,0.36756,REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,0.990966395159414
FEKIR_HEPARG_SIDE_POP_VS_HEP...1,SET,77,0.032093,0.0020729,0.094961,0.3677,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_DN,0.991217020864035
GSE29618_PRE_VS_DAY7_POST_LA...2,SET,182,0.020899,0.0020694,0.061843,0.36771,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_UP,0.991217020864035
GSE46606_DAY1_VS_DAY3_CD40L_...5,SET,180,0.020962,0.0020643,0.062067,0.36778,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_DN,0.991235845332095
GOCC_ESCRT_COMPLEX,SET,29,0.050829,0.0020175,0.15053,0.36781,GOCC_ESCRT_COMPLEX,0.991235845332095
GOBP_POSITIVE_REGULATION_OF_...826,SET,14,0.089867,0.0024793,0.26617,0.36782,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,0.991235845332095
HP_BILATERAL_CLEFT_LIP,SET,12,0.093447,0.002387,0.27682,0.36785,HP_BILATERAL_CLEFT_LIP,0.991235845332095
MIR518E_5P_MIR519A_5P_MIR519...,SET,82,0.03065,0.0020427,0.090824,0.36788,MIR518E_5P_MIR519A_5P_MIR519B_5P_MIR519C_5P_MIR522_5P_MIR523_5P,0.991235845332095
MARIADASON_REGULATED_BY_HIST...1,SET,37,0.048733,0.0021844,0.14443,0.36791,MARIADASON_REGULATED_BY_HISTONE_ACETYLATION_DN,0.991235845332095
GSE3982_EFF_MEMORY_CD4_TCELL...3,SET,181,0.020783,0.0020523,0.061641,0.368,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_DN,0.991235845332095
MIR3915,SET,197,0.020123,0.0020722,0.059687,0.36801,MIR3915,0.991235845332095
GSE19923_E2A_KO_VS_HEB_AND_E...1,SET,163,0.023333,0.0021876,0.069283,0.36814,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_DN,0.991235845332095
E2F2_TARGET_GENES,SET,1188,0.0083447,0.0020519,0.024784,0.36817,E2F2_TARGET_GENES,0.991235845332095
GSE339_CD8POS_VS_CD4CD8DN_DC...3,SET,185,0.020542,0.0020506,0.061009,0.36817,GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,0.991235845332095
HP_ANTI_THYROID_ANTIBODY_POS...,SET,10,0.090278,0.0021053,0.26816,0.36819,HP_ANTI_THYROID_ANTIBODY_POSITIVITY,0.991235845332095
GSE360_L_MAJOR_VS_T_GONDII_M...2,SET,179,0.02169,0.0021301,0.06443,0.36819,GSE360_L_MAJOR_VS_T_GONDII_MAC_UP,0.991235845332095
GSE4984_GALECTIN1_VS_LPS_STI...1,SET,156,0.022173,0.0020341,0.065866,0.3682,GSE4984_GALECTIN1_VS_LPS_STIM_DC_DN,0.991235845332095
GOMF_ATP_DEPENDENT_PROTEIN_B...,SET,6,0.11016,0.00199,0.32743,0.36828,GOMF_ATP_DEPENDENT_PROTEIN_BINDING,0.991235845332095
HP_ABSENT_TESTIS,SET,24,0.051393,0.0018559,0.15276,0.36828,HP_ABSENT_TESTIS,0.991235845332095
ZFP82_TARGET_GENES,SET,25,0.053102,0.0019571,0.15787,0.3683,ZFP82_TARGET_GENES,0.991235845332095
PID_ALK1_PATHWAY,SET,24,0.05548,0.0020035,0.16497,0.36832,PID_ALK1_PATHWAY,0.991235845332095
HP_ABNORMAL_VENTRICULAR_SEPT...,SET,429,0.013585,0.0020512,0.040394,0.36832,HP_ABNORMAL_VENTRICULAR_SEPTUM_MORPHOLOGY,0.991235845332095
ANASTASSIOU_MULTICANCER_INVA...,SET,61,0.040574,0.0023336,0.12066,0.36833,ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE,0.991235845332095
GSE7548_NAIVE_VS_DAY7_PCC_IM...2,SET,184,0.019799,0.0019711,0.058878,0.36833,GSE7548_NAIVE_VS_DAY7_PCC_IMMUNIZATION_CD4_TCELL_UP,0.991235845332095
GOBP_MONOACYLGLYCEROL_BIOSYN...,SET,7,0.1096,0.0021385,0.32608,0.3684,GOBP_MONOACYLGLYCEROL_BIOSYNTHETIC_PROCESS,0.991235845332095
DESCARTES_FETAL_PLACENTA_PAE...,SET,132,0.02621,0.0022132,0.077983,0.3684,DESCARTES_FETAL_PLACENTA_PAEP_MECOM_POSITIVE_CELLS,0.991235845332095
CHANDRAN_METASTASIS_DN,SET,288,0.017245,0.0021418,0.051317,0.36841,CHANDRAN_METASTASIS_DN,0.991235845332095
HP_RETINAL_HEMORRHAGE,SET,26,0.056289,0.0021156,0.16751,0.36843,HP_RETINAL_HEMORRHAGE,0.991235845332095
GOBP_CELLULAR_RESPONSE_TO_FR...,SET,5,0.11312,0.0018655,0.33686,0.36851,GOBP_CELLULAR_RESPONSE_TO_FRUCTOSE_STIMULUS,0.991374336248936
GOBP_LUNG_GROWTH,SET,5,0.1555,0.0025644,0.46317,0.36854,GOBP_LUNG_GROWTH,0.99137830495356
HP_INCREASED_CIRCULATING_THY...,SET,8,0.11066,0.0023082,0.32972,0.36859,HP_INCREASED_CIRCULATING_THYROGLOBULIN_CONCENTRATION,0.991386240520043
GOMF_DNA_ENDONUCLEASE_ACTIVI...2,SET,9,0.08889,0.0019666,0.26489,0.3686,GOMF_DNA_ENDONUCLEASE_ACTIVITY_PRODUCING_3_PHOSPHOMONOESTERS,0.991386240520043
GSE5589_LPS_AND_IL10_VS_LPS_...1,SET,178,0.021101,0.0020665,0.06291,0.36866,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,0.991470889112435
WP_EICOSANOID_METABOLISM_VIA...2,SET,9,0.095016,0.0021021,0.28354,0.36877,WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY,0.991552354988399
HP_ABNORMALITY_OF_THE_PREMAX...,SET,11,0.084386,0.0020638,0.25186,0.36879,HP_ABNORMALITY_OF_THE_PREMAXILLA,0.991552354988399
MODULE_220,SET,310,0.017427,0.0022441,0.05203,0.36884,MODULE_220,0.991552354988399
GOBP_SEMINIFEROUS_TUBULE_DEV...,SET,13,0.080664,0.0021445,0.24083,0.36884,GOBP_SEMINIFEROUS_TUBULE_DEVELOPMENT,0.991552354988399
HP_TRIPHALANGEAL_THUMB,SET,64,0.033116,0.0019508,0.098876,0.36884,HP_TRIPHALANGEAL_THUMB,0.991552354988399
HP_LIMITED_HIP_MOVEMENT,SET,22,0.062845,0.002173,0.18769,0.36887,HP_LIMITED_HIP_MOVEMENT,0.991552354988399
GOBP_REGULATION_OF_GLUCOCORT...4,SET,10,0.089594,0.0020893,0.2676,0.36889,GOBP_REGULATION_OF_GLUCOCORTICOID_SECRETION,0.991552354988399
REACTOME_ZINC_INFLUX_INTO_CE...,SET,10,0.079685,0.0018582,0.23813,0.36895,REACTOME_ZINC_INFLUX_INTO_CELLS_BY_THE_SLC39_GENE_FAMILY,0.991636938365169
RODRIGUES_NTN1_AND_DCC_TARGE...,SET,29,0.05501,0.0021834,0.16451,0.36905,RODRIGUES_NTN1_AND_DCC_TARGETS,0.991806065877986
GSE9006_1MONTH_VS_4MONTH_POS...1,SET,169,0.022199,0.0021189,0.066399,0.36907,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_DN,0.991806065877986
GREENBAUM_E2A_TARGETS_UP,SET,27,0.053472,0.002048,0.16,0.36912,GREENBAUM_E2A_TARGETS_UP,0.991814568845619
GSE36888_UNTREATED_VS_IL2_TR...12,SET,167,0.022903,0.0021732,0.068566,0.36918,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_UP,0.991814568845619
BIOCARTA_WNT_PATHWAY,SET,23,0.058998,0.0020858,0.17673,0.36925,BIOCARTA_WNT_PATHWAY,0.991814568845619
HP_CHIARI_TYPE_I_MALFORMATION,SET,41,0.043353,0.0020453,0.12989,0.36928,HP_CHIARI_TYPE_I_MALFORMATION,0.991814568845619
GOMF_ACTIVE_MONOATOMIC_ION_T...,SET,261,0.017089,0.002022,0.051206,0.36929,GOMF_ACTIVE_MONOATOMIC_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.991814568845619
STAMBOLSKY_TARGETS_OF_MUTATE...1,SET,47,0.041418,0.0020918,0.12411,0.3693,STAMBOLSKY_TARGETS_OF_MUTATED_TP53_DN,0.991814568845619
DESCARTES_FETAL_SPLEEN_MESOT...,SET,177,0.02232,0.0021798,0.066883,0.3693,DESCARTES_FETAL_SPLEEN_MESOTHELIAL_CELLS,0.991814568845619
STANHILL_HRAS_TRANSFROMATION...,SET,5,0.15361,0.0025334,0.46035,0.36931,STANHILL_HRAS_TRANSFROMATION_UP,0.991814568845619
GSE14308_TH1_VS_NATURAL_TREG...2,SET,176,0.020408,0.0019875,0.06117,0.36933,GSE14308_TH1_VS_NATURAL_TREG_UP,0.991814568845619
MODULE_22,SET,31,0.041756,0.0017134,0.12522,0.36939,MODULE_22,0.991849273794808
GOBP_POSITIVE_REGULATION_OF_...228,SET,38,0.045256,0.0020557,0.13572,0.3694,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR_VIA_HOMOLOGOUS_RECOMBINATION,0.991849273794808
HP_TIBIALIS_MUSCLE_WEAKNESS,SET,6,0.11635,0.0021019,0.34914,0.36947,HP_TIBIALIS_MUSCLE_WEAKNESS,0.991960590961761
KAECH_NAIVE_VS_DAY8_EFF_CD8_...2,SET,185,0.020083,0.0020047,0.060284,0.36952,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_UP,0.992018198671404
MIR548AL,SET,10,0.084746,0.0019762,0.25447,0.36956,MIR548AL,0.992026019462465
HP_GLOMERULONEPHRITIS,SET,86,0.031406,0.0021433,0.094322,0.36958,HP_GLOMERULONEPHRITIS,0.992026019462465
GOCC_PERINUCLEAR_REGION_OF_C...,SET,669,0.010904,0.0020421,0.032766,0.36965,GOCC_PERINUCLEAR_REGION_OF_CYTOPLASM,0.992087513513513
GOBP_POSITIVE_REGULATION_OF_...772,SET,7,0.11712,0.0022852,0.35195,0.36966,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_OF_NOTCH_RECEPTOR_TARGET,0.992087513513513
GSE32533_WT_VS_MIR17_KO_ACT_...2,SET,179,0.021323,0.0020941,0.064101,0.3697,GSE32533_WT_VS_MIR17_KO_ACT_CD4_TCELL_UP,0.992118253416725
REACTOME_BETA_OXIDATION_OF_P...,SET,9,0.082043,0.0018151,0.24675,0.36976,REACTOME_BETA_OXIDATION_OF_PRISTANOYL_COA,0.992202655960469
REACTOME_RAB_REGULATION_OF_T...,SET,111,0.025345,0.0019637,0.076251,0.3698,REACTOME_RAB_REGULATION_OF_TRAFFICKING,0.992233382228055
HP_FINGER_SWELLING,SET,4,0.18345,0.0027061,0.55251,0.36993,HP_FINGER_SWELLING,0.992386942429387
GSE7460_CTRL_VS_FOXP3_OVEREX...2,SET,171,0.021036,0.0020196,0.063351,0.36993,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_UP,0.992386942429387
GSE27859_DC_VS_CD11C_INT_F48...3,SET,183,0.019337,0.0019199,0.058249,0.36996,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN,0.992386942429387
GOBP_OLFACTORY_BULB_INTERNEU...1,SET,7,0.12312,0.0024023,0.37092,0.36998,GOBP_OLFACTORY_BULB_INTERNEURON_DEVELOPMENT,0.992386942429387
GOBP_REGULATION_OF_SYNAPTIC_...10,SET,37,0.046289,0.0020748,0.13948,0.37,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_EXOCYTOSIS,0.992386942429387
GSE19198_CTRL_VS_IL21_TREATE...3,SET,186,0.020411,0.0020429,0.061527,0.37005,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_DN,0.992394699074074
HEBERT_MATRISOME_TNBC_BRAIN_...1,SET,23,0.062274,0.0022016,0.18774,0.37006,HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS,0.992394699074074
LI_PBMC_MENACTRA_AGE_18_45YO...5,SET,30,0.054239,0.0021896,0.16368,0.37018,LI_PBMC_MENACTRA_AGE_18_45YO_ANTI_POLYSACCHARIDE_ANTIBODY_CORRELATION_PROFILE_3DY_UP,0.992475716818252
GSE29618_BCELL_VS_MONOCYTE_DN,SET,179,0.021523,0.0021137,0.064957,0.3702,GSE29618_BCELL_VS_MONOCYTE_DN,0.992475716818252
HP_ABNORMAL_RENAL_TUBULE_MOR...,SET,74,0.032442,0.0020544,0.097939,0.37023,HP_ABNORMAL_RENAL_TUBULE_MORPHOLOGY,0.992475716818252
HP_ACEPHALIC_SPERMATOZOA,SET,7,0.11484,0.0022407,0.34671,0.37024,HP_ACEPHALIC_SPERMATOZOA,0.992475716818252
HP_APLASIA_CUTIS_CONGENITA_O...1,SET,19,0.061237,0.0019679,0.18498,0.3703,HP_APLASIA_CUTIS_CONGENITA_OF_SCALP,0.992475716818252
WP_CYTOPLASMIC_RIBOSOMAL_PRO...,SET,78,0.030481,0.0019815,0.092079,0.37031,WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS,0.992475716818252
GOBP_S_ADENOSYLMETHIONINE_CY...,SET,7,0.11002,0.0021467,0.33236,0.37032,GOBP_S_ADENOSYLMETHIONINE_CYCLE,0.992475716818252
GOBP_NEGATIVE_REGULATION_OF_...344,SET,88,0.032457,0.0022405,0.098068,0.37034,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,0.992475716818252
GOBP_CYTOPLASMIC_TRANSLATION...2,SET,37,0.03911,0.001753,0.11821,0.37037,GOBP_CYTOPLASMIC_TRANSLATIONAL_INITIATION,0.992475716818252
HP_ABNORMALITY_OF_PRIMARY_TE...,SET,70,0.032515,0.0020028,0.098325,0.37044,HP_ABNORMALITY_OF_PRIMARY_TEETH,0.992475716818252
REACTOME_THYROXINE_BIOSYNTHE...,SET,10,0.097737,0.0022792,0.29559,0.37045,REACTOME_THYROXINE_BIOSYNTHESIS,0.992475716818252
VALK_AML_CLUSTER_2,SET,26,0.063058,0.0023701,0.19073,0.37047,VALK_AML_CLUSTER_2,0.992475716818252
HP_BULBAR_SIGNS,SET,32,0.046819,0.0019519,0.14161,0.37047,HP_BULBAR_SIGNS,0.992475716818252
GSE10240_IL17_VS_IL17_AND_IL...2,SET,180,0.02015,0.0019844,0.060959,0.37049,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,0.992475716818252
GSE15624_3H_VS_6H_HALOFUGINO...1,SET,135,0.024286,0.0020737,0.073511,0.37056,GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,0.992586728323699
GOBP_ANTIGEN_PROCESSING_AND_...5,SET,45,0.046066,0.0022767,0.13947,0.37059,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_ANTIGEN,0.992590586467324
FAN_EMBRYONIC_CTX_IN_2_INTER...,SET,7,0.1035,0.0020194,0.31362,0.3707,FAN_EMBRYONIC_CTX_IN_2_INTERNEURON,0.992758980582524
HP_CEREBELLAR_VERMIS_ATROPHY,SET,49,0.038686,0.0019948,0.11724,0.37071,HP_CEREBELLAR_VERMIS_ATROPHY,0.992758980582524
GOBP_VASCULAR_WOUND_HEALING,SET,18,0.068441,0.0021408,0.20766,0.37086,GOBP_VASCULAR_WOUND_HEALING,0.993084159026119
GOBP_GLYOXYLATE_METABOLIC_PR...,SET,8,0.10223,0.0021324,0.31046,0.37097,GOBP_GLYOXYLATE_METABOLIC_PROCESS,0.993137640535962
HP_GENERALIZED_HYPERTRICHOSIS,SET,8,0.10204,0.0021284,0.30998,0.37101,HP_GENERALIZED_HYPERTRICHOSIS,0.993137640535962
KEGG_MEDICUS_REFERENCE_EGF_E...11,SET,11,0.078564,0.0019215,0.23872,0.37104,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_RASSF1_SIGNALING_PATHWAY,0.993137640535962
REACTOME_SIGNALING_BY_ALK,SET,26,0.057189,0.0021495,0.1738,0.37106,REACTOME_SIGNALING_BY_ALK,0.993137640535962
GSE36891_POLYIC_TLR3_VS_PAM_...1,SET,146,0.022219,0.0019725,0.06753,0.37107,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,0.993137640535962
MODULE_204,SET,79,0.030301,0.0019823,0.092104,0.37108,MODULE_204,0.993137640535962
GOCC_GOLGI_CISTERNA_MEMBRANE,SET,74,0.032248,0.0020421,0.09802,0.37108,GOCC_GOLGI_CISTERNA_MEMBRANE,0.993137640535962
GOMF_GLYCOLIPID_MANNOSYLTRAN...,SET,5,0.09825,0.0016203,0.29874,0.37113,GOMF_GLYCOLIPID_MANNOSYLTRANSFERASE_ACTIVITY,0.993194975744976
HP_LARGE_JOINT_HYPERMOBILTY,SET,6,0.11291,0.0020397,0.34344,0.37118,HP_LARGE_JOINT_HYPERMOBILTY,0.993210203217612
MIR4719,SET,456,0.01332,0.002072,0.040535,0.37123,MIR4719,0.993210203217612
GOBP_ATRIOVENTRICULAR_VALVE_...1,SET,29,0.05762,0.002287,0.17536,0.37124,GOBP_ATRIOVENTRICULAR_VALVE_DEVELOPMENT,0.993210203217612
HP_AKINESIA,SET,37,0.04515,0.0020238,0.13742,0.37125,HP_AKINESIA,0.993210203217612
GSE13946_CTRL_VS_DSS_COLITIS...1,SET,157,0.022002,0.0020248,0.067018,0.37134,GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN,0.993324809512815
WP_DNA_DAMAGE_RESPONSE,SET,65,0.031684,0.0018809,0.096513,0.37135,WP_DNA_DAMAGE_RESPONSE,0.993324809512815
GOBP_COCHLEA_MORPHOGENESIS,SET,22,0.061002,0.0021093,0.18588,0.37139,GOBP_COCHLEA_MORPHOGENESIS,0.993355352470371
HP_NARROW_PALM,SET,13,0.081397,0.002164,0.24814,0.37145,HP_NARROW_PALM,0.993439380530973
GOCC_FAR_SIN_STRIPAK_COMPLEX,SET,16,0.069411,0.0020471,0.2117,0.37151,GOCC_FAR_SIN_STRIPAK_COMPLEX,0.993523395660203
GOBP_POSITIVE_REGULATION_OF_...706,SET,5,0.11954,0.0019714,0.36474,0.37156,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_REGENERATION,0.99358065707471
GOBP_HINDBRAIN_TANGENTIAL_CE...,SET,5,0.12267,0.002023,0.37439,0.37159,GOBP_HINDBRAIN_TANGENTIAL_CELL_MIGRATION,0.993584432220341
HP_SHORT_NAIL,SET,13,0.07483,0.0019894,0.22856,0.37168,HP_SHORT_NAIL,0.993630027685919
WHITFIELD_CELL_CYCLE_M_G1,SET,115,0.025716,0.0020278,0.078558,0.3717,WHITFIELD_CELL_CYCLE_M_G1,0.993630027685919
GSE5542_IFNG_VS_IFNA_TREATED...4,SET,176,0.01968,0.0019166,0.060121,0.37171,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,0.993630027685919
GOBP_SENSORY_PERCEPTION_OF_C...,SET,403,0.018715,0.0027408,0.05719,0.37174,GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS,0.993630027685919
ZNF433_TARGET_GENES,SET,46,0.038794,0.0019384,0.11855,0.37175,ZNF433_TARGET_GENES,0.993630027685919
GSE45365_NK_CELL_VS_BCELL_DN,SET,127,0.025348,0.0020998,0.077518,0.37184,GSE45365_NK_CELL_VS_BCELL_DN,0.99374782140936
LIN_TUMOR_ESCAPE_FROM_IMMUNE...,SET,17,0.068639,0.0020866,0.21,0.37189,LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK,0.99374782140936
GOBP_MEMBRANE_RAFT_ORGANIZAT...,SET,24,0.055566,0.0020066,0.17,0.37189,GOBP_MEMBRANE_RAFT_ORGANIZATION,0.99374782140936
LIEN_BREAST_CARCINOMA_METAPL...2,SET,104,0.026685,0.0020017,0.081669,0.37193,LIEN_BREAST_CARCINOMA_METAPLASTIC_VS_DUCTAL_DN,0.99374782140936
GSE22919_RESTING_VS_IL2_IL12...2,SET,181,0.01901,0.0018772,0.058206,0.37199,GSE22919_RESTING_VS_IL2_IL12_IL15_STIM_NK_CELL_UP,0.99374782140936
GOCC_H4_HISTONE_ACETYLTRANSF...,SET,37,0.042407,0.0019008,0.12987,0.37201,GOCC_H4_HISTONE_ACETYLTRANSFERASE_COMPLEX,0.99374782140936
GSE13485_PRE_VS_POST_YF17D_V...1,SET,179,0.020451,0.0020084,0.062655,0.37206,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN,0.99374782140936
HP_MULTIPLE_PRENATAL_FRACTUR...,SET,16,0.065561,0.0019336,0.20087,0.37207,HP_MULTIPLE_PRENATAL_FRACTURES,0.99374782140936
GSE9988_ANTI_TREM1_VS_LPS_MO...2,SET,173,0.020822,0.0020106,0.063794,0.37207,GSE9988_ANTI_TREM1_VS_LPS_MONOCYTE_UP,0.99374782140936
GSE4748_CTRL_VS_CYANOBACTERI...2,SET,181,0.019761,0.0019513,0.060552,0.37208,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_UP,0.99374782140936
GOCC_CUL4A_RING_E3_UBIQUITIN...,SET,12,0.075551,0.0019299,0.23165,0.37216,GOCC_CUL4A_RING_E3_UBIQUITIN_LIGASE_COMPLEX,0.99386964738419
GOBP_POSITIVE_REGULATION_OF_...346,SET,413,0.014352,0.0021271,0.044024,0.37222,GOBP_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY,0.99386964738419
HP_GLOMUS_JUGULAR_TUMOR,SET,5,0.09185,0.0015148,0.28176,0.37222,HP_GLOMUS_JUGULAR_TUMOR,0.99386964738419
NAKAYA_B_CELL_FLUARIX_FLUVIR...2,SET,321,0.014417,0.0018886,0.044234,0.37224,NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,0.99386964738419
GSE4142_NAIVE_VS_MEMORY_BCEL...2,SET,184,0.020972,0.0020878,0.064362,0.37228,GSE4142_NAIVE_VS_MEMORY_BCELL_UP,0.993900092180058
GSE32034_UNTREATED_VS_ROSIGL...2,SET,178,0.021231,0.0020792,0.06518,0.37232,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_UP,0.993930532298948
GSE5679_RARA_AGONIST_AM580_V...2,SET,182,0.021011,0.0020804,0.064542,0.37239,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_UP,0.993945496429394
REACTOME_REGULATION_OF_LOCAL...,SET,11,0.084867,0.0020756,0.26081,0.37244,REACTOME_REGULATION_OF_LOCALIZATION_OF_FOXO_TRANSCRIPTION_FACTORS,0.993945496429394
GOBP_LUTEOLYSIS,SET,6,0.13193,0.0023834,0.40544,0.37244,GOBP_LUTEOLYSIS,0.993945496429394
HP_REDUCED_TENDON_REFLEXES,SET,521,0.011729,0.0019465,0.036043,0.37244,HP_REDUCED_TENDON_REFLEXES,0.993945496429394
GOBP_SPERM_MITOCHONDRIAL_SHE...,SET,6,0.12596,0.0022755,0.38731,0.37251,GOBP_SPERM_MITOCHONDRIAL_SHEATH_ASSEMBLY,0.994033024952015
GOCC_HFE_TRANSFERRIN_RECEPTO...,SET,7,0.10595,0.0020673,0.32583,0.37253,GOCC_HFE_TRANSFERRIN_RECEPTOR_COMPLEX,0.994033024952015
GOMF_R_SMAD_BINDING,SET,25,0.055619,0.0020499,0.1711,0.37257,GOMF_R_SMAD_BINDING,0.9940634385076
GSE17186_BLOOD_VS_CORD_BLOOD...5,SET,175,0.019772,0.0019202,0.060855,0.37263,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_DN,0.994099528735632
GOBP_ANTEROGRADE_AXONAL_TRAN...2,SET,6,0.1113,0.0020106,0.34263,0.37265,GOBP_ANTEROGRADE_AXONAL_TRANSPORT_OF_MITOCHONDRION,0.994099528735632
GOCC_NURD_COMPLEX,SET,14,0.066721,0.0018408,0.20549,0.37271,GOCC_NURD_COMPLEX,0.994099528735632
HORTON_SREBF_TARGETS,SET,24,0.051724,0.0018679,0.15936,0.37275,HORTON_SREBF_TARGETS,0.994099528735632
chr2p11,SET,44,0.093098,0.0045497,0.28697,0.37282,chr2p11,0.994099528735632
KORKOLA_CHORIOCARCINOMA_DN,SET,8,0.111,0.0023153,0.34219,0.37283,KORKOLA_CHORIOCARCINOMA_DN,0.994099528735632
GSE18203_CTRL_VS_INTRATUMORA...1,SET,176,0.020786,0.0020243,0.064082,0.37283,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_DN,0.994099528735632
GOMF_CHONDROITIN_SULFOTRANSF...,SET,5,0.11519,0.0018997,0.35515,0.37284,GOMF_CHONDROITIN_SULFOTRANSFERASE_ACTIVITY,0.994099528735632
GSE339_CD4POS_VS_CD8POS_DC_I...1,SET,181,0.019423,0.001918,0.059911,0.37289,GSE339_CD4POS_VS_CD8POS_DC_IN_CULTURE_DN,0.994099528735632
HP_ABNORMALITY_OF_LOWER_EYEL...,SET,5,0.12913,0.0021296,0.39851,0.37295,HP_ABNORMALITY_OF_LOWER_EYELASHES,0.994099528735632
GOMF_OLIGOPEPTIDE_BINDING,SET,10,0.086613,0.0020198,0.26729,0.37296,GOMF_OLIGOPEPTIDE_BINDING,0.994099528735632
HP_SHORT_CHIN,SET,56,0.036236,0.0019972,0.11185,0.37298,HP_SHORT_CHIN,0.994099528735632
GSE11924_TFH_VS_TH2_CD4_TCEL...2,SET,183,0.019056,0.0018921,0.05882,0.37298,GSE11924_TFH_VS_TH2_CD4_TCELL_UP,0.994099528735632
TAKAYAMA_BOUND_BY_AR,SET,10,0.086914,0.0020268,0.2683,0.37299,TAKAYAMA_BOUND_BY_AR,0.994099528735632
GOBP_NEGATIVE_REGULATION_OF_...519,SET,10,0.080118,0.0018683,0.24741,0.37304,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,0.994099528735632
GOBP_REGULATION_OF_MAST_CELL...4,SET,25,0.055823,0.0020574,0.17241,0.37305,GOBP_REGULATION_OF_MAST_CELL_DEGRANULATION,0.994099528735632
MIR548G_3P,SET,216,0.018443,0.0019876,0.056977,0.37309,MIR548G_3P,0.994099528735632
GCAAAAA_MIR129,SET,171,0.020919,0.0020084,0.064637,0.37311,GCAAAAA_MIR129,0.994099528735632
GOCC_TRANS_GOLGI_NETWORK,SET,228,0.017638,0.0019523,0.054519,0.37315,GOCC_TRANS_GOLGI_NETWORK,0.994099528735632
GOBP_NON_PROTEINOGENIC_AMINO...3,SET,68,0.032595,0.001979,0.10082,0.37324,GOBP_NON_PROTEINOGENIC_AMINO_ACID_METABOLIC_PROCESS,0.994099528735632
GSE14415_INDUCED_TREG_VS_TCO...2,SET,158,0.02079,0.0019193,0.064308,0.37324,GSE14415_INDUCED_TREG_VS_TCONV_UP,0.994099528735632
SCHLINGEMANN_SKIN_CARCINOGEN...1,SET,24,0.051759,0.0018691,0.16011,0.37325,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_DN,0.994099528735632
MIR3189_3P,SET,69,0.031813,0.0019456,0.098422,0.37326,MIR3189_3P,0.994099528735632
WP_COVID19_AND_ENDOTHELIAL_C...,SET,5,0.1393,0.0022973,0.431,0.37327,WP_COVID19_AND_ENDOTHELIAL_CELL_SENESCENCE,0.994099528735632
MIR299_5P,SET,134,0.024688,0.0021004,0.076409,0.37331,MIR299_5P,0.99412987893648
GOMF_ATP_GATED_ION_CHANNEL_A...,SET,9,0.093097,0.0020596,0.28826,0.37336,GOMF_ATP_GATED_ION_CHANNEL_ACTIVITY,0.994186852589642
MIR384,SET,109,0.025544,0.0019613,0.079111,0.37339,MIR384,0.994190565387267
HP_COMPENSATED_HYPOTHYROIDISM,SET,9,0.091925,0.0020337,0.28518,0.3736,HP_COMPENSATED_HYPOTHYROIDISM,0.994650563002681
GSE29618_BCELL_VS_PDC_DN,SET,177,0.021204,0.0020708,0.065792,0.37362,GSE29618_BCELL_VS_PDC_DN,0.994650563002681
GSE16385_MONOCYTE_VS_12H_ROS...3,SET,187,0.019244,0.0019312,0.059794,0.37379,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,0.99496532041957
GOMF_PRE_MIRNA_BINDING,SET,9,0.091194,0.0020175,0.28341,0.37381,GOMF_PRE_MIRNA_BINDING,0.99496532041957
GSE19941_UNSTIM_VS_LPS_STIM_...4,SET,182,0.019605,0.0019413,0.060937,0.37383,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,0.99496532041957
HP_ABSENT_DISTAL_INTERPHALAN...,SET,7,0.10194,0.0019891,0.31702,0.37389,HP_ABSENT_DISTAL_INTERPHALANGEAL_CREASES,0.99496532041957
GOBP_HYDROGEN_PEROXIDE_METAB...,SET,46,0.042445,0.0021208,0.13202,0.37391,GOBP_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,0.99496532041957
GOBP_PROTEIN_DELIPIDATION,SET,4,0.12321,0.0018174,0.3832,0.37391,GOBP_PROTEIN_DELIPIDATION,0.99496532041957
HP_ABNORMAL_EPIDERMAL_MORPHO...,SET,87,0.028673,0.001968,0.089238,0.37399,HP_ABNORMAL_EPIDERMAL_MORPHOLOGY,0.995102009646302
GSE42088_UNINF_VS_LEISHMANIA...3,SET,178,0.020924,0.0020492,0.065206,0.37415,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_DN,0.995198818265259
HP_ABNORMAL_OCCIPITAL_BONE_M...,SET,103,0.025147,0.0018772,0.078404,0.37421,HP_ABNORMAL_OCCIPITAL_BONE_MORPHOLOGY,0.995198818265259
HP_ABNORMAL_NASAL_TIP_MORPHO...,SET,324,0.014603,0.0019217,0.045549,0.37426,HP_ABNORMAL_NASAL_TIP_MORPHOLOGY,0.995198818265259
MYOD_01,SET,232,0.018262,0.0020388,0.056973,0.37428,MYOD_01,0.995198818265259
GOBP_CD40_SIGNALING_PATHWAY,SET,13,0.069251,0.0018411,0.21608,0.3743,GOBP_CD40_SIGNALING_PATHWAY,0.995198818265259
GSE2770_IL12_AND_TGFB_ACT_VS...2,SET,174,0.019792,0.0019167,0.061758,0.3743,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP,0.995198818265259
HP_GLOMERULAR_DEPOSITS,SET,18,0.060185,0.0018826,0.1878,0.37431,HP_GLOMERULAR_DEPOSITS,0.995198818265259
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...7,SET,90,0.028826,0.0020122,0.089971,0.37434,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GT_200_VS_LTE_200_1DY_DN,0.995198818265259
GENTILE_RESPONSE_CLUSTER_D3,SET,51,0.037376,0.0019662,0.11667,0.37435,GENTILE_RESPONSE_CLUSTER_D3,0.995198818265259
GSE17721_ALL_VS_24H_PAM3CSK4...1,SET,174,0.019612,0.0018992,0.061223,0.37436,GSE17721_ALL_VS_24H_PAM3CSK4_BMDC_DN,0.995198818265259
MIR301A_5P,SET,75,0.031306,0.0019957,0.097738,0.37437,MIR301A_5P,0.995198818265259
MIR301B_5P,SET,75,0.031306,0.0019957,0.097738,0.37437,MIR301B_5P,0.995198818265259
GOBP_MULTICELLULAR_ORGANISM_...,SET,136,0.02433,0.0020852,0.075993,0.37442,GOBP_MULTICELLULAR_ORGANISM_GROWTH,0.995206076017131
GOBP_MONOATOMIC_ANION_HOMEOS...,SET,20,0.061785,0.0020371,0.19299,0.37443,GOBP_MONOATOMIC_ANION_HOMEOSTASIS,0.995206076017131
MIR6756_5P,SET,242,0.017776,0.0020263,0.055569,0.37452,MIR6756_5P,0.995248373424971
PID_PRL_SIGNALING_EVENTS_PAT...,SET,23,0.056909,0.0020119,0.17792,0.37454,PID_PRL_SIGNALING_EVENTS_PATHWAY,0.995248373424971
GOBP_SYNAPSE_PRUNING,SET,14,0.086468,0.0023856,0.27034,0.37454,GOBP_SYNAPSE_PRUNING,0.995248373424971
HP_ABNORMAL_ESOPHAGUS_MORPHO...,SET,207,0.019025,0.0020076,0.059515,0.37461,HP_ABNORMAL_ESOPHAGUS_MORPHOLOGY,0.995248373424971
PID_TCR_PATHWAY,SET,59,0.032935,0.001863,0.1031,0.3747,PID_TCR_PATHWAY,0.995248373424971
REACTOME_METAL_SEQUESTRATION...,SET,6,0.1264,0.0022834,0.39579,0.37473,REACTOME_METAL_SEQUESTRATION_BY_ANTIMICROBIAL_PROTEINS,0.995248373424971
HP_ABNORMALLY_FOLDED_HELIX,SET,71,0.032531,0.002018,0.10186,0.37473,HP_ABNORMALLY_FOLDED_HELIX,0.995248373424971
GSE22527_ANTI_CD3_INVIVO_VS_...1,SET,178,0.018741,0.0018354,0.058689,0.37474,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN,0.995248373424971
GOCC_BCL_2_FAMILY_PROTEIN_CO...,SET,10,0.094256,0.002198,0.29524,0.37477,GOCC_BCL_2_FAMILY_PROTEIN_COMPLEX,0.995248373424971
HP_CENTRAL_Y_SHAPED_METACARP...,SET,8,0.069875,0.0014575,0.21893,0.3748,HP_CENTRAL_Y_SHAPED_METACARPAL,0.995248373424971
GOBP_NEGATIVE_REGULATION_OF_...42,SET,8,0.099072,0.0020665,0.31044,0.37482,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,0.995248373424971
CENPT_TARGET_GENES,SET,49,0.038434,0.0019819,0.12044,0.37483,CENPT_TARGET_GENES,0.995248373424971
GOCC_9PLUS2_MOTILE_CILIUM,SET,158,0.021308,0.0019671,0.066786,0.37485,GOCC_9PLUS2_MOTILE_CILIUM,0.995248373424971
ZHANG_INTERFERON_RESPONSE,SET,23,0.062958,0.0022258,0.1974,0.37489,ZHANG_INTERFERON_RESPONSE,0.995248373424971
UNTERMAN_IPF_VS_CTRL_CD8T_UP,SET,2,0.19885,0.0020743,0.62363,0.37492,UNTERMAN_IPF_VS_CTRL_CD8T_UP,0.995248373424971
HP_NEOPLASM_OF_THE_BREAST,SET,95,0.026138,0.0018743,0.081976,0.37492,HP_NEOPLASM_OF_THE_BREAST,0.995248373424971
HP_BIPARIETAL_NARROWING,SET,60,0.030531,0.0017416,0.095774,0.37495,HP_BIPARIETAL_NARROWING,0.995248373424971
PRDM12_TARGET_GENES,SET,93,0.026745,0.0018977,0.083915,0.37497,PRDM12_TARGET_GENES,0.995248373424971
MIR4516,SET,272,0.016328,0.0019716,0.051236,0.37499,MIR4516,0.995248373424971
BIOCARTA_SM_PATHWAY,SET,13,0.068146,0.0018118,0.21402,0.37509,BIOCARTA_SM_PATHWAY,0.995289380868769
GOBP_TYPE_B_PANCREATIC_CELL_...2,SET,22,0.060625,0.0020962,0.19041,0.37509,GOBP_TYPE_B_PANCREATIC_CELL_DEVELOPMENT,0.995289380868769
GSE21927_SPLEEN_C57BL6_VS_4T...2,SET,182,0.018947,0.0018761,0.059508,0.3751,GSE21927_SPLEEN_C57BL6_VS_4T1_TUMOR_BALBC_MONOCYTES_UP,0.995289380868769
GOBP_PEPTIDYL_PROLINE_HYDROX...1,SET,11,0.068459,0.0016743,0.21506,0.37512,GOBP_PEPTIDYL_PROLINE_HYDROXYLATION,0.995289380868769
KEGG_MEDICUS_PATHOGEN_ESCHER...6,SET,13,0.067531,0.0017954,0.21238,0.37526,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY,0.995304430379747
HP_APLASIA_HYPOPLASIA_OF_THE...28,SET,12,0.079134,0.0020214,0.2489,0.37527,HP_APLASIA_HYPOPLASIA_OF_THE_EPIGLOTTIS,0.995304430379747
GOBP_REGULATION_OF_CD4_POSIT...3,SET,4,0.14446,0.002131,0.45448,0.3753,GOBP_REGULATION_OF_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,0.995304430379747
GR_Q6,SET,234,0.018131,0.0020328,0.057059,0.37534,GR_Q6,0.995304430379747
GOCC_MYELIN_SHEATH_ADAXONAL_...,SET,5,0.10654,0.0017571,0.33537,0.37536,GOCC_MYELIN_SHEATH_ADAXONAL_REGION,0.995304430379747
GOBP_REGULATION_OF_AGGREPHAGY,SET,7,0.10061,0.0019631,0.31674,0.37538,GOBP_REGULATION_OF_AGGREPHAGY,0.995304430379747
GSE46606_UNSTIM_VS_CD40L_IL2...7,SET,180,0.020013,0.0019708,0.063028,0.37543,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN,0.995304430379747
AP4_Q6,SET,199,0.019113,0.001978,0.060213,0.37546,AP4_Q6,0.995304430379747
DURANTE_ADULT_OLFACTORY_NEUR...10,SET,66,0.03689,0.0022067,0.11627,0.37552,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MAST_CELLS,0.995304430379747
KEGG_MEDICUS_REFERENCE_CA2_P...2,SET,14,0.06999,0.001931,0.22061,0.37553,KEGG_MEDICUS_REFERENCE_CA2_PYK2_RAS_ERK_SIGNALING_PATHWAY,0.995304430379747
GSE1460_CD4_THYMOCYTE_VS_NAI...1,SET,174,0.020392,0.0019747,0.064291,0.37555,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,0.995304430379747
GOBP_REGULATION_OF_SUPEROXID...2,SET,27,0.053291,0.0020411,0.16806,0.37558,GOBP_REGULATION_OF_SUPEROXIDE_METABOLIC_PROCESS,0.995304430379747
GSE3982_CTRL_VS_LPS_48H_DC_DN,SET,180,0.021024,0.0020704,0.0663,0.37558,GSE3982_CTRL_VS_LPS_48H_DC_DN,0.995304430379747
SETLUR_PROSTATE_CANCER_TMPRS...1,SET,16,0.069879,0.0020609,0.22042,0.37561,SETLUR_PROSTATE_CANCER_TMPRSS2_ERG_FUSION_DN,0.995304430379747
GOBP_NEGATIVE_REGULATION_OF_...302,SET,17,0.071706,0.0021798,0.22621,0.37563,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_10_PRODUCTION,0.995304430379747
GSE9988_ANTI_TREM1_AND_LPS_V...4,SET,162,0.02274,0.0021255,0.071793,0.37572,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_UP,0.995304430379747
MIR590_5P,SET,118,0.024712,0.0019738,0.078041,0.37575,MIR590_5P,0.995304430379747
GSE21033_CTRL_VS_POLYIC_STIM...6,SET,142,0.022858,0.0020014,0.072216,0.3758,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_UP,0.995304430379747
MANNO_MIDBRAIN_NEUROTYPES_HR...5,SET,502,0.01266,0.0020635,0.04,0.37581,MANNO_MIDBRAIN_NEUROTYPES_HRGL3,0.995304430379747
KEGG_MEDICUS_REFERENCE_KEAP1...,SET,20,0.073764,0.002432,0.23311,0.37584,KEGG_MEDICUS_REFERENCE_KEAP1_NRF2_SIGNALING_PATHWAY,0.995304430379747
MOLENAAR_TARGETS_OF_CCND1_AN...2,SET,58,0.033602,0.0018847,0.10622,0.37587,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP,0.995304430379747
SALVADOR_MARTIN_PEDIATRIC_TB...2,SET,19,0.065505,0.0021051,0.20709,0.37588,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP,0.995304430379747
REACTOME_GLUTATHIONE_CONJUGA...,SET,32,0.051972,0.0021668,0.16431,0.37588,REACTOME_GLUTATHIONE_CONJUGATION,0.995304430379747
GOMF_ALKANE_1_MONOOXYGENASE_...,SET,5,0.12473,0.0020569,0.39451,0.37594,GOMF_ALKANE_1_MONOOXYGENASE_ACTIVITY,0.995304430379747
GOBP_REGULATION_OF_CALCIUM_I...3,SET,5,0.13873,0.0022879,0.43888,0.37596,GOBP_REGULATION_OF_CALCIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,0.995304430379747
PEREZ_TP53_AND_TP63_TARGETS,SET,178,0.021071,0.0020636,0.066669,0.37598,PEREZ_TP53_AND_TP63_TARGETS,0.995304430379747
KOINUMA_TARGETS_OF_SMAD2_OR_...,SET,773,0.0099515,0.0019975,0.031492,0.376,KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3,0.995304430379747
MIR105_3P,SET,4,0.1628,0.0024014,0.51517,0.376,MIR105_3P,0.995304430379747
MIR494_5P,SET,38,0.041538,0.0018868,0.13152,0.37606,MIR494_5P,0.995304430379747
ZNF140_TARGET_GENES,SET,551,0.011268,0.0019215,0.035685,0.3761,ZNF140_TARGET_GENES,0.995304430379747
GOBP_GRANULOCYTE_CHEMOTAXIS,SET,118,0.02725,0.0021764,0.086315,0.37612,GOBP_GRANULOCYTE_CHEMOTAXIS,0.995304430379747
GOBP_ASPARTATE_FAMILY_AMINO_...1,SET,21,0.060863,0.0020562,0.19282,0.37614,GOBP_ASPARTATE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,0.995304430379747
GOBP_ENDOPLASMIC_RETICULUM_T...2,SET,126,0.022174,0.0018297,0.070266,0.37617,GOBP_ENDOPLASMIC_RETICULUM_TO_GOLGI_VESICLE_MEDIATED_TRANSPORT,0.995304430379747
HP_ABDOMINAL_CRAMPS,SET,7,0.090239,0.0017608,0.28595,0.37617,HP_ABDOMINAL_CRAMPS,0.995304430379747
PID_DNA_PK_PATHWAY,SET,16,0.05515,0.0016265,0.1748,0.37619,PID_DNA_PK_PATHWAY,0.995304430379747
MORF_BUB3,SET,242,0.01582,0.0018034,0.050141,0.37619,MORF_BUB3,0.995304430379747
GOBP_CARDIAC_LEFT_VENTRICLE_...,SET,16,0.072912,0.0021503,0.23123,0.37626,GOBP_CARDIAC_LEFT_VENTRICLE_MORPHOGENESIS,0.995304430379747
MODULE_145,SET,95,0.027662,0.0019837,0.087735,0.37627,MODULE_145,0.995304430379747
MIR4423_5P,SET,26,0.054409,0.002045,0.17259,0.37628,MIR4423_5P,0.995304430379747
LEIN_LOCALIZED_TO_PROXIMAL_D...,SET,31,0.047481,0.0019484,0.1507,0.37635,LEIN_LOCALIZED_TO_PROXIMAL_DENDRITES,0.995304430379747
KEGG_AXON_GUIDANCE,SET,122,0.024832,0.0020164,0.07881,0.37635,KEGG_AXON_GUIDANCE,0.995304430379747
MIR5006_3P,SET,334,0.015206,0.0020311,0.048286,0.37642,MIR5006_3P,0.995304430379747
GAVISH_3CA_METAPROGRAM_FIBRO...20,SET,48,0.038974,0.0019891,0.12382,0.37648,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PERICYTE_LIKE,0.995304430379747
GSE6259_FLT3L_INDUCED_DEC205...6,SET,134,0.022749,0.0019353,0.072279,0.37648,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD8_TCELL_UP,0.995304430379747
HMCES_TARGET_GENES,SET,6,0.09883,0.0017854,0.31402,0.37649,HMCES_TARGET_GENES,0.995304430379747
GOBP_CELLULAR_COMPONENT_DISA...1,SET,481,0.011893,0.0018987,0.037804,0.37653,GOBP_CELLULAR_COMPONENT_DISASSEMBLY,0.995304430379747
BROWNE_HCMV_INFECTION_18HR_DN,SET,167,0.020961,0.001989,0.066651,0.37657,BROWNE_HCMV_INFECTION_18HR_DN,0.995304430379747
HP_MYOCARDITIS,SET,6,0.12745,0.0023024,0.40553,0.37666,HP_MYOCARDITIS,0.995304430379747
MIR621,SET,30,0.0504,0.0020346,0.16051,0.37676,MIR621,0.995304430379747
HP_SEA_BLUE_HISTIOCYTOSIS,SET,5,0.14758,0.0024338,0.47,0.37677,HP_SEA_BLUE_HISTIOCYTOSIS,0.995304430379747
GSE17721_LPS_VS_POLYIC_8H_BM...1,SET,177,0.019396,0.0018943,0.061784,0.37678,GSE17721_LPS_VS_POLYIC_8H_BMDC_DN,0.995304430379747
CREB_Q2,SET,238,0.01755,0.0019842,0.055922,0.37682,CREB_Q2,0.995304430379747
HE_LIM_SUN_FETAL_LUNG_C5_LAT...,SET,25,0.055889,0.0020599,0.17807,0.37682,HE_LIM_SUN_FETAL_LUNG_C5_LATE_PRO_B_CELL,0.995304430379747
ZHAN_MULTIPLE_MYELOMA_PR_DN,SET,45,0.042822,0.0021163,0.13645,0.37683,ZHAN_MULTIPLE_MYELOMA_PR_DN,0.995304430379747
AHRARNT_01,SET,129,0.024275,0.0020266,0.077366,0.37685,AHRARNT_01,0.995304430379747
HP_ABNORMAL_UPPER_LIMB_EPIPH...,SET,54,0.036882,0.0019963,0.11757,0.37687,HP_ABNORMAL_UPPER_LIMB_EPIPHYSIS_MORPHOLOGY,0.995304430379747
PLASARI_TGFB1_TARGETS_1HR_DN,SET,4,0.15029,0.0022169,0.47916,0.3769,PLASARI_TGFB1_TARGETS_1HR_DN,0.995304430379747
GSE17721_LPS_VS_CPG_16H_BMDC...2,SET,183,0.019455,0.0019316,0.062036,0.37691,GSE17721_LPS_VS_CPG_16H_BMDC_UP,0.995304430379747
GSE13306_TREG_VS_TCONV_LAMIN...2,SET,182,0.020087,0.0019889,0.064081,0.37697,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_UP,0.995304430379747
GOMF_ANTIGEN_BINDING,SET,63,0.038262,0.0022363,0.1221,0.377,GOMF_ANTIGEN_BINDING,0.995304430379747
GSE20366_TREG_VS_NAIVE_CD4_T...5,SET,179,0.01981,0.0019455,0.063217,0.37701,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_UP,0.995304430379747
GOBP_MULTINUCLEAR_OSTEOCLAST...,SET,8,0.10189,0.0021253,0.32521,0.37703,GOBP_MULTINUCLEAR_OSTEOCLAST_DIFFERENTIATION,0.995304430379747
GOBP_T_CELL_MEDIATED_IMMUNE_...,SET,11,0.096912,0.0023702,0.30939,0.37705,GOBP_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,0.995304430379747
KEGG_MEDICUS_PATHOGEN_SHIGEL...6,SET,5,0.093665,0.0015447,0.29921,0.37713,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGB1_TO_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,0.995304430379747
GOCC_POLAR_MICROTUBULE,SET,5,0.11148,0.0018385,0.35617,0.37714,GOCC_POLAR_MICROTUBULE,0.995304430379747
GOBP_CYTOSOL_TO_ENDOPLASMIC_...,SET,4,0.12293,0.0018134,0.39277,0.37715,GOBP_CYTOSOL_TO_ENDOPLASMIC_RETICULUM_TRANSPORT,0.995304430379747
GOBP_MICROTUBULE_BASED_PROTE...,SET,14,0.072652,0.0020044,0.23214,0.37715,GOBP_MICROTUBULE_BASED_PROTEIN_TRANSPORT,0.995304430379747
REACTOME_GLOBAL_GENOME_NUCLE...,SET,79,0.026113,0.0017083,0.083444,0.37716,REACTOME_GLOBAL_GENOME_NUCLEOTIDE_EXCISION_REPAIR_GG_NER,0.995304430379747
GGTAACC_MIR4095P,SET,28,0.049217,0.0019195,0.15743,0.37728,GGTAACC_MIR4095P,0.995304430379747
GOBP_POSITIVE_REGULATION_OF_...712,SET,16,0.065398,0.0019288,0.2092,0.37729,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,0.995304430379747
HP_CHIN_WITH_HORIZONTAL_CREA...,SET,8,0.11084,0.0023121,0.35464,0.37731,HP_CHIN_WITH_HORIZONTAL_CREASE,0.995304430379747
HOEK_T_CELL_2011_2012_TIV_AD...4,SET,9,0.08613,0.0019055,0.27555,0.37731,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_UP,0.995304430379747
GSE2405_S_AUREUS_VS_A_PHAGOC...1,SET,189,0.018292,0.0018453,0.058539,0.37734,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN,0.995304430379747
THUM_MIR21_TARGETS_HEART_DIS...1,SET,7,0.12948,0.0025263,0.41441,0.37736,THUM_MIR21_TARGETS_HEART_DISEASE_DN,0.995304430379747
GSE20198_IL12_IL18_VS_IFNA_T...2,SET,186,0.018432,0.0018448,0.058999,0.37737,GSE20198_IL12_IL18_VS_IFNA_TREATED_ACT_CD4_TCELL_UP,0.995304430379747
GSE28783_CTRL_ANTI_MIR_VS_UN...1,SET,182,0.020034,0.0019838,0.064131,0.37737,GSE28783_CTRL_ANTI_MIR_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,0.995304430379747
GOBP_REGULATION_OF_WOUND_HEA...1,SET,126,0.024667,0.0020353,0.079011,0.37745,GOBP_REGULATION_OF_WOUND_HEALING,0.995304430379747
KEGG_MEDICUS_REFERENCE_TRANS...2,SET,28,0.042297,0.0016497,0.1355,0.37746,KEGG_MEDICUS_REFERENCE_TRANSCRIPTION_COUPLED_NER,0.995304430379747
GSE22229_RENAL_TRANSPLANT_IM...2,SET,185,0.018824,0.0018791,0.06031,0.37747,GSE22229_RENAL_TRANSPLANT_IMMUNOSUPP_THERAPY_VS_HEALTHY_PBMC_UP,0.995304430379747
KEGG_GLYCOSYLPHOSPHATIDYLINO...,SET,24,0.047341,0.0017096,0.15169,0.37749,KEGG_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI_ANCHOR_BIOSYNTHESIS,0.995304430379747
GOMF_SOLUTE_MONOATOMIC_CATIO...,SET,114,0.025688,0.0020169,0.082319,0.3775,GOMF_SOLUTE_MONOATOMIC_CATION_SYMPORTER_ACTIVITY,0.995304430379747
GOMF_VOLTAGE_GATED_CHANNEL_A...,SET,165,0.022357,0.0021088,0.071665,0.37754,GOMF_VOLTAGE_GATED_CHANNEL_ACTIVITY,0.995304430379747
HOEK_NK_CELL_2011_2012_TIV_7...,SET,14,0.066216,0.0018268,0.21229,0.37755,HOEK_NK_CELL_2011_2012_TIV_7D_VS_0DY_ADULT_7D_DN,0.995304430379747
MIR4755_5P,SET,333,0.015072,0.0020103,0.048359,0.37765,MIR4755_5P,0.995304430379747
GOBP_ORGANIC_ACID_BIOSYNTHET...,SET,303,0.015459,0.0019685,0.049602,0.37765,GOBP_ORGANIC_ACID_BIOSYNTHETIC_PROCESS,0.995304430379747
HP_ABNORMAL_LEFT_ATRIUM_MORP...,SET,22,0.056627,0.001958,0.18177,0.3777,HP_ABNORMAL_LEFT_ATRIUM_MORPHOLOGY,0.995304430379747
GSE41176_UNSTIM_VS_ANTI_IGM_...10,SET,170,0.018978,0.0018168,0.060932,0.37772,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_UP,0.995304430379747
REACTOME_GENE_SILENCING_BY_R...,SET,77,0.027433,0.0017719,0.08808,0.37773,REACTOME_GENE_SILENCING_BY_RNA,0.995304430379747
GOBP_SEXUAL_REPRODUCTION,SET,923,0.0086742,0.0018944,0.027859,0.37776,GOBP_SEXUAL_REPRODUCTION,0.995304430379747
HP_CHILDHOOD_ONSET_TRUNCAL_O...,SET,30,0.047758,0.0019279,0.15342,0.37779,HP_CHILDHOOD_ONSET_TRUNCAL_OBESITY,0.995304430379747
CERVERA_SDHB_TARGETS_2,SET,102,0.028134,0.0020901,0.090426,0.37785,CERVERA_SDHB_TARGETS_2,0.995304430379747
DELACROIX_RARG_BOUND_MEF,SET,345,0.014606,0.0019823,0.046973,0.37792,DELACROIX_RARG_BOUND_MEF,0.995304430379747
GOBP_GLANDULAR_EPITHELIAL_CE...2,SET,68,0.034626,0.0021023,0.1114,0.37797,GOBP_GLANDULAR_EPITHELIAL_CELL_DIFFERENTIATION,0.995304430379747
GOMF_MYOSIN_HEAVY_CHAIN_BIND...,SET,13,0.069716,0.0018535,0.2243,0.37797,GOMF_MYOSIN_HEAVY_CHAIN_BINDING,0.995304430379747
MANNO_MIDBRAIN_NEUROTYPES_HO...2,SET,324,0.015662,0.0020611,0.050388,0.37797,MANNO_MIDBRAIN_NEUROTYPES_HOPC,0.995304430379747
SCHERER_PBMC_YF_VAX_AGE_18_4...4,SET,10,0.084335,0.0019667,0.27134,0.37798,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_UP,0.995304430379747
MODULE_439,SET,20,0.053923,0.0017778,0.17351,0.37799,MODULE_439,0.995304430379747
ACEVEDO_LIVER_TUMOR_VS_NORMA...2,SET,753,0.0093917,0.0018617,0.030244,0.37808,ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP,0.995304430379747
HP_PENDULAR_NYSTAGMUS,SET,37,0.04349,0.0019493,0.14006,0.37809,HP_PENDULAR_NYSTAGMUS,0.995304430379747
IKEDA_MIR133_TARGETS_UP,SET,40,0.038882,0.001812,0.12524,0.37811,IKEDA_MIR133_TARGETS_UP,0.995304430379747
GOBP_INSULIN_METABOLIC_PROCE...,SET,15,0.071139,0.0020315,0.22916,0.37812,GOBP_INSULIN_METABOLIC_PROCESS,0.995304430379747
NIKOLSKY_BREAST_CANCER_17Q21...,SET,305,0.025846,0.0033017,0.083289,0.37816,NIKOLSKY_BREAST_CANCER_17Q21_Q25_AMPLICON,0.995304430379747
MIR7153_5P,SET,103,0.02536,0.0018931,0.081734,0.37818,MIR7153_5P,0.995304430379747
KEGG_MEDICUS_PATHOGEN_HIV_GP...3,SET,26,0.05318,0.0019988,0.17144,0.37821,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.995304430379747
HP_INCREASED_MUSCLE_LIPID_CO...,SET,33,0.045551,0.0019284,0.14692,0.37826,HP_INCREASED_MUSCLE_LIPID_CONTENT,0.995304430379747
GOBP_REGULATION_OF_GLIOGENES...,SET,101,0.027926,0.0020645,0.090095,0.3783,GOBP_REGULATION_OF_GLIOGENESIS,0.995304430379747
MIR3117_5P,SET,54,0.034594,0.0018724,0.11166,0.37835,MIR3117_5P,0.995304430379747
GOBP_TRNA_SURVEILLANCE,SET,8,0.084793,0.0017687,0.27373,0.37837,GOBP_TRNA_SURVEILLANCE,0.995304430379747
HP_HAND_POLYDACTYLY,SET,149,0.021012,0.0018842,0.067881,0.37846,HP_HAND_POLYDACTYLY,0.995304430379747
HP_NEOPLASM_OF_THE_INNER_EAR,SET,8,0.096633,0.0020156,0.31219,0.37846,HP_NEOPLASM_OF_THE_INNER_EAR,0.995304430379747
HP_LIMB_UNDERGROWTH,SET,220,0.017529,0.0019064,0.05664,0.37848,HP_LIMB_UNDERGROWTH,0.995304430379747
GOBP_ODONTOGENESIS_OF_DENTIN...,SET,87,0.029742,0.0020415,0.096118,0.3785,GOBP_ODONTOGENESIS_OF_DENTIN_CONTAINING_TOOTH,0.995304430379747
GOBP_INNATE_IMMUNE_RESPONSE_...1,SET,88,0.028464,0.0019648,0.092067,0.3786,GOBP_INNATE_IMMUNE_RESPONSE_ACTIVATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY,0.995304430379747
GOBP_CELL_VOLUME_HOMEOSTASIS,SET,34,0.045281,0.0019458,0.14648,0.37861,GOBP_CELL_VOLUME_HOMEOSTASIS,0.995304430379747
DUTERTRE_ESTRADIOL_RESPONSE_...2,SET,297,0.014638,0.0018457,0.047364,0.37864,DUTERTRE_ESTRADIOL_RESPONSE_24HR_UP,0.995304430379747
GOMF_MICROFILAMENT_MOTOR_ACT...,SET,37,0.04648,0.0020834,0.1504,0.37864,GOMF_MICROFILAMENT_MOTOR_ACTIVITY,0.995304430379747
HP_ANHIDROSIS,SET,29,0.051195,0.002032,0.16575,0.37871,HP_ANHIDROSIS,0.995304430379747
MIR6852_3P,SET,134,0.022816,0.0019411,0.073899,0.37876,MIR6852_3P,0.995304430379747
HP_PROMINENT_ANTIHELIX,SET,13,0.070337,0.00187,0.22782,0.37876,HP_PROMINENT_ANTIHELIX,0.995304430379747
GOBP_NEGATIVE_REGULATION_OF_...595,SET,20,0.065263,0.0021517,0.21151,0.37883,GOBP_NEGATIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,0.995304430379747
GOBP_DEPHOSPHORYLATION,SET,243,0.016092,0.001838,0.052165,0.37886,GOBP_DEPHOSPHORYLATION,0.995304430379747
GOBP_PROTON_TRANSPORTING_V_T...,SET,6,0.10057,0.0018168,0.32601,0.37886,GOBP_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,0.995304430379747
HP_HIATUS_HERNIA,SET,32,0.044941,0.0018736,0.14569,0.37887,HP_HIATUS_HERNIA,0.995304430379747
GOBP_REGULATION_OF_NMDA_RECE...,SET,14,0.070308,0.0019397,0.22795,0.37888,GOBP_REGULATION_OF_NMDA_RECEPTOR_ACTIVITY,0.995304430379747
SARRIO_EPITHELIAL_MESENCHYMA...2,SET,159,0.019878,0.0018409,0.064453,0.37889,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_UP,0.995304430379747
AGTCTTA_MIR499,SET,68,0.030938,0.0018784,0.10032,0.37889,AGTCTTA_MIR499,0.995304430379747
HP_TEMPORAL_PATTERN,SET,18,0.056878,0.0017791,0.18453,0.37895,HP_TEMPORAL_PATTERN,0.995304430379747
WP_TAMOXIFEN_METABOLISM,SET,21,0.060672,0.0020497,0.19688,0.37898,WP_TAMOXIFEN_METABOLISM,0.995304430379747
GOBP_POSITIVE_REGULATION_OF_...253,SET,7,0.094723,0.0018483,0.30749,0.37902,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TUBE_FORMATION,0.995304430379747
HP_IMPAIRED_OROPHARYNGEAL_SW...,SET,12,0.075735,0.0019346,0.24586,0.37903,HP_IMPAIRED_OROPHARYNGEAL_SWALLOW_RESPONSE,0.995304430379747
GSE43863_NAIVE_VS_TH1_EFF_CD...2,SET,165,0.020289,0.0019138,0.06587,0.37903,GSE43863_NAIVE_VS_TH1_EFF_CD4_TCELL_D6_LCMV_UP,0.995304430379747
GOBP_TRIGLYCERIDE_BIOSYNTHET...,SET,37,0.041677,0.0018681,0.13534,0.37906,GOBP_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.995304430379747
LUI_THYROID_CANCER_PAX8_PPAR...2,SET,44,0.037506,0.0018329,0.12183,0.3791,LUI_THYROID_CANCER_PAX8_PPARG_UP,0.995304430379747
HP_ABNORMAL_JAW_MORPHOLOGY,SET,987,0.008318,0.0018751,0.027023,0.37912,HP_ABNORMAL_JAW_MORPHOLOGY,0.995304430379747
HP_FATTY_REPLACEMENT_OF_SKEL...,SET,33,0.041018,0.0017365,0.13328,0.37914,HP_FATTY_REPLACEMENT_OF_SKELETAL_MUSCLE,0.995304430379747
GSE12845_IGD_POS_BLOOD_VS_NA...1,SET,187,0.018624,0.001869,0.060516,0.37914,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN,0.995304430379747
REACTOME_MASTL_FACILITATES_M...,SET,10,0.074962,0.0017481,0.24363,0.37916,REACTOME_MASTL_FACILITATES_MITOTIC_PROGRESSION,0.995304430379747
HP_ABNORMAL_RESPIRATORY_SYST...,SET,1273,0.0075803,0.0019247,0.024637,0.37916,HP_ABNORMAL_RESPIRATORY_SYSTEM_MORPHOLOGY,0.995304430379747
MIR10395_5P,SET,66,0.033858,0.0020253,0.11008,0.3792,MIR10395_5P,0.995304430379747
HP_FOCAL_AUTONOMIC_SEIZURE,SET,11,0.076818,0.0018787,0.24976,0.37921,HP_FOCAL_AUTONOMIC_SEIZURE,0.995304430379747
GOBP_NUCLEOTIDE_SALVAGE,SET,16,0.066926,0.0019738,0.21762,0.37922,GOBP_NUCLEOTIDE_SALVAGE,0.995304430379747
XIE_ST_HSC_S1PR3_OE_UP,SET,176,0.021384,0.0020826,0.069561,0.37926,XIE_ST_HSC_S1PR3_OE_UP,0.995304430379747
GOMF_ACETYLCHOLINE_GATED_MON...,SET,16,0.069478,0.0020491,0.22602,0.37927,GOMF_ACETYLCHOLINE_GATED_MONOATOMIC_CATION_SELECTIVE_CHANNEL_ACTIVITY,0.995304430379747
GOBP_ESTABLISHMENT_OF_TISSUE...,SET,35,0.045296,0.0019748,0.14738,0.37929,GOBP_ESTABLISHMENT_OF_TISSUE_POLARITY,0.995304430379747
GSE13547_CTRL_VS_ANTI_IGM_ST...2,SET,174,0.018928,0.001833,0.061638,0.37939,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_UP,0.995304430379747
WP_ENTEROCYTE_CHOLESTEROL_ME...,SET,34,0.040687,0.0017484,0.13256,0.37945,WP_ENTEROCYTE_CHOLESTEROL_METABOLISM,0.995304430379747
GNF2_CASP1,SET,102,0.026239,0.0019493,0.085517,0.37949,GNF2_CASP1,0.995304430379747
GOBP_POSITIVE_REGULATION_OF_...210,SET,199,0.018722,0.0019375,0.061022,0.3795,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING_TRANSCRIPTION_FACTOR_ACTIVITY,0.995304430379747
LEE_LIVER_CANCER_E2F1_DN,SET,59,0.035994,0.0020361,0.11736,0.37953,LEE_LIVER_CANCER_E2F1_DN,0.995304430379747
HP_LONG_HALLUX,SET,20,0.056572,0.0018652,0.18445,0.37953,HP_LONG_HALLUX,0.995304430379747
PID_RAS_PATHWAY,SET,29,0.045587,0.0018094,0.14865,0.37955,PID_RAS_PATHWAY,0.995304430379747
GSE4142_NAIVE_VS_GC_BCELL_DN,SET,179,0.018314,0.0017985,0.059735,0.37958,GSE4142_NAIVE_VS_GC_BCELL_DN,0.995304430379747
GOBP_CIRCULATORY_SYSTEM_DEVE...,SET,1047,0.0085186,0.0019744,0.027804,0.37966,GOBP_CIRCULATORY_SYSTEM_DEVELOPMENT,0.995304430379747
GSE10500_ARTHRITIC_SYNOVIAL_...1,SET,125,0.023029,0.0018928,0.075172,0.37967,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_DN,0.995304430379747
ZSCAN2_TARGET_GENES,SET,677,0.010285,0.0019372,0.033574,0.37968,ZSCAN2_TARGET_GENES,0.995304430379747
PBX1_01,SET,234,0.017665,0.0019805,0.05767,0.37969,PBX1_01,0.995304430379747
GOMF_LONG_CHAIN_FATTY_ACID_C...,SET,14,0.065931,0.001819,0.21529,0.37971,GOMF_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,0.995304430379747
GOCC_KINETOCHORE_MICROTUBULE,SET,19,0.054191,0.0017415,0.17696,0.37972,GOCC_KINETOCHORE_MICROTUBULE,0.995304430379747
GSE5589_WT_VS_IL10_KO_LPS_ST...1,SET,134,0.023768,0.002022,0.077636,0.37975,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,0.995304430379747
MARSON_FOXP3_TARGETS_DN,SET,48,0.041056,0.0020954,0.13416,0.3798,MARSON_FOXP3_TARGETS_DN,0.995304430379747
GSE14026_TH1_VS_TH17_DN,SET,179,0.018872,0.0018534,0.061678,0.37981,GSE14026_TH1_VS_TH17_DN,0.995304430379747
REACTOME_SIGNALLING_TO_ERKS,SET,34,0.043651,0.0018757,0.14269,0.37984,REACTOME_SIGNALLING_TO_ERKS,0.995304430379747
GOBP_POSITIVE_REGULATION_OF_...261,SET,31,0.047101,0.0019328,0.15406,0.37991,GOBP_POSITIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,0.995304430379747
KEGG_MEDICUS_REFERENCE_DYNEI...,SET,29,0.046053,0.0018279,0.15067,0.37994,KEGG_MEDICUS_REFERENCE_DYNEIN_RECRUITMENT_TO_THE_KINETOCHORE,0.995304430379747
HP_DECREASED_THALAMIC_VOLUME,SET,9,0.079804,0.0017655,0.26113,0.37995,HP_DECREASED_THALAMIC_VOLUME,0.995304430379747
GSE17301_ACD3_ACD28_VS_ACD3_...4,SET,176,0.018973,0.0018478,0.062085,0.37996,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_UP,0.995304430379747
GOBP_POSITIVE_REGULATION_OF_...709,SET,128,0.023368,0.0019433,0.076485,0.37998,GOBP_POSITIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,0.995304430379747
GOBP_REGULATION_OF_CORTICOST...,SET,16,0.067666,0.0019956,0.22146,0.37998,GOBP_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,0.995304430379747
SATO_SILENCED_EPIGENETICALLY...,SET,39,0.041721,0.0019199,0.13657,0.38,SATO_SILENCED_EPIGENETICALLY_IN_PANCREATIC_CANCER,0.995304430379747
GOBP_POSITIVE_REGULATION_OF_...380,SET,9,0.086558,0.001915,0.28334,0.38,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,0.995304430379747
HP_FUNCTIONAL_ABNORMALITY_OF...4,SET,330,0.013887,0.0018441,0.04548,0.38005,HP_FUNCTIONAL_ABNORMALITY_OF_THE_MIDDLE_EAR,0.995304430379747
GOCC_COMMITMENT_COMPLEX,SET,5,0.083215,0.0013724,0.27258,0.38007,GOCC_COMMITMENT_COMPLEX,0.995304430379747
GOBP_POSITIVE_REGULATION_OF_...737,SET,5,0.12032,0.0019843,0.39414,0.38008,GOBP_POSITIVE_REGULATION_OF_SULFUR_METABOLIC_PROCESS,0.995304430379747
MIR25_3P,SET,380,0.013482,0.0019184,0.044219,0.38023,MIR25_3P,0.99562221426957
JIANG_TIP30_TARGETS_DN,SET,22,0.061588,0.0021295,0.20215,0.38031,JIANG_TIP30_TARGETS_DN,0.995639923181202
GSE17721_CTRL_VS_GARDIQUIMOD...13,SET,184,0.018935,0.0018851,0.062173,0.38035,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_DN,0.995639923181202
GSE25677_R848_VS_MPL_AND_R84...2,SET,134,0.02179,0.0018538,0.071544,0.38035,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_UP,0.995639923181202
E2A_Q2,SET,220,0.016922,0.0018403,0.055569,0.38036,E2A_Q2,0.995639923181202
REACTOME_ELASTIC_FIBRE_FORMA...,SET,42,0.041929,0.0020021,0.1377,0.38038,REACTOME_ELASTIC_FIBRE_FORMATION,0.995639923181202
GOBP_MEMBRANE_DEPOLARIZATION...4,SET,5,0.12081,0.0019924,0.39711,0.38048,GOBP_MEMBRANE_DEPOLARIZATION_DURING_SA_NODE_CELL_ACTION_POTENTIAL,0.995826673695308
GOBP_VACUOLAR_TRANSMEMBRANE_...,SET,8,0.089802,0.0018732,0.29558,0.38064,GOBP_VACUOLAR_TRANSMEMBRANE_TRANSPORT,0.995952868421053
FUJIWARA_PARK2_HEPATOCYTE_PR...1,SET,7,0.10786,0.0021045,0.35511,0.38067,FUJIWARA_PARK2_HEPATOCYTE_PROLIFERATION_DN,0.995952868421053
HP_MICROTIA_FIRST_DEGREE,SET,4,0.15477,0.0022829,0.50955,0.38067,HP_MICROTIA_FIRST_DEGREE,0.995952868421053
GOBP_SEGMENTATION,SET,93,0.027498,0.0019511,0.090548,0.38068,GOBP_SEGMENTATION,0.995952868421053
GOBP_REGULATION_OF_DOUBLE_ST...1,SET,119,0.022371,0.0017943,0.073683,0.38071,GOBP_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,0.995952868421053
UNTERMAN_IPF_VS_CTRL_NK_CELL...1,SET,8,0.10164,0.00212,0.33486,0.38075,UNTERMAN_IPF_VS_CTRL_NK_CELL_DN,0.995952868421053
MIR374C_5P,SET,381,0.013564,0.0019326,0.044691,0.38075,MIR374C_5P,0.995952868421053
GSE7852_LN_VS_THYMUS_TCONV_UP,SET,177,0.019762,0.00193,0.06514,0.3808,GSE7852_LN_VS_THYMUS_TCONV_UP,0.995952868421053
GOBP_PROTEIN_LOCALIZATION_TO...39,SET,297,0.014572,0.0018374,0.048073,0.3809,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS,0.995952868421053
GOBP_NEGATIVE_REGULATION_OF_...126,SET,8,0.092927,0.0019383,0.30663,0.38092,GOBP_NEGATIVE_REGULATION_OF_CELL_SIZE,0.995952868421053
HP_ABNORMAL_HALLUX_PHALANX_M...,SET,37,0.04036,0.0018091,0.13323,0.38097,HP_ABNORMAL_HALLUX_PHALANX_MORPHOLOGY,0.995952868421053
RICKMAN_HEAD_AND_NECK_CANCER...5,SET,75,0.031625,0.0020161,0.10441,0.38099,RICKMAN_HEAD_AND_NECK_CANCER_E,0.995952868421053
HOEK_NK_CELL_2011_2012_TIV_A...2,SET,12,0.070452,0.0017996,0.23261,0.38099,HOEK_NK_CELL_2011_2012_TIV_ADULT_3DY_UP,0.995952868421053
MIR876_3P,SET,80,0.029721,0.0019566,0.098166,0.38104,MIR876_3P,0.995952868421053
GOMF_2_IRON_2_SULFUR_CLUSTER...,SET,23,0.045147,0.0015961,0.14913,0.38105,GOMF_2_IRON_2_SULFUR_CLUSTER_BINDING,0.995952868421053
HP_SPASTIC_PARAPLEGIA,SET,95,0.026102,0.0018718,0.086221,0.38105,HP_SPASTIC_PARAPLEGIA,0.995952868421053
KEGG_MEDICUS_REFERENCE_PLASM...,SET,8,0.095074,0.0019831,0.31418,0.3811,KEGG_MEDICUS_REFERENCE_PLASMIN_MEDIATED_ACTIVATION_OF_LATENT_TGF_BETA,0.995952868421053
GSE37605_TREG_VS_TCONV_NOD_F...2,SET,133,0.02317,0.0019638,0.076568,0.3811,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP,0.995952868421053
GOBP_PROTEIN_LOCALIZATION_TO...25,SET,350,0.01406,0.0019217,0.046468,0.38111,GOBP_PROTEIN_LOCALIZATION_TO_EXTRACELLULAR_REGION,0.995952868421053
REACTOME_SYNTHESIS_OF_GLYCOS...,SET,17,0.057422,0.0017456,0.1898,0.38113,REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI,0.995952868421053
GSE40274_CTRL_VS_EOS_TRANSDU...2,SET,158,0.020126,0.0018581,0.066529,0.38113,GSE40274_CTRL_VS_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.995952868421053
HP_APLASIA_OF_THE_2ND_FINGER,SET,4,0.1319,0.0019457,0.43624,0.38119,HP_APLASIA_OF_THE_2ND_FINGER,0.996034768062552
GNF2_CD33,SET,43,0.041416,0.002001,0.13708,0.38128,GNF2_CD33,0.996142451915909
HP_SPINAL_MUSCULAR_ATROPHY,SET,51,0.033937,0.0017852,0.11239,0.38134,HP_SPINAL_MUSCULAR_ATROPHY,0.996142451915909
MIR411_5P,SET,44,0.036792,0.001798,0.12193,0.38143,MIR411_5P,0.996142451915909
HP_ABNORMAL_DESCEMET_MEMBRAN...,SET,14,0.076986,0.002124,0.25514,0.38143,HP_ABNORMAL_DESCEMET_MEMBRANE_MORPHOLOGY,0.996142451915909
HEN1_02,SET,184,0.018343,0.0018261,0.060806,0.38146,HEN1_02,0.996142451915909
MODULE_316,SET,63,0.034187,0.0019982,0.11334,0.38147,MODULE_316,0.996142451915909
GOBP_PROTEIN_FOLDING,SET,200,0.016893,0.0017526,0.056014,0.38148,GOBP_PROTEIN_FOLDING,0.996142451915909
HP_PREMATURE_GRAYING_OF_HAIR,SET,46,0.036216,0.0018096,0.12014,0.38154,HP_PREMATURE_GRAYING_OF_HAIR,0.996142451915909
MIR6755_3P,SET,72,0.030321,0.001894,0.10062,0.38158,MIR6755_3P,0.996142451915909
REACTOME_MOLYBDENUM_COFACTOR...,SET,6,0.11235,0.0020296,0.37298,0.38162,REACTOME_MOLYBDENUM_COFACTOR_BIOSYNTHESIS,0.996142451915909
GOBP_PROSTHETIC_GROUP_METABO...,SET,6,0.11235,0.0020296,0.37298,0.38162,GOBP_PROSTHETIC_GROUP_METABOLIC_PROCESS,0.996142451915909
REACTOME_STABILIZATION_OF_P53,SET,53,0.031305,0.0016787,0.104,0.3817,REACTOME_STABILIZATION_OF_P53,0.996142451915909
GSE11057_NAIVE_VS_MEMORY_CD4...2,SET,158,0.021238,0.0019607,0.070598,0.38177,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_UP,0.996142451915909
GOBP_PEPTIDYL_THREONINE_DEPH...,SET,17,0.063029,0.001916,0.20966,0.38185,GOBP_PEPTIDYL_THREONINE_DEPHOSPHORYLATION,0.996142451915909
GOBP_TRANSFORMING_GROWTH_FAC...3,SET,31,0.049093,0.0020145,0.16343,0.38194,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.996142451915909
GSE14308_TH17_VS_NAIVE_CD4_T...2,SET,179,0.018422,0.0018092,0.061337,0.38196,GSE14308_TH17_VS_NAIVE_CD4_TCELL_UP,0.996142451915909
GOCC_PROTEASE_INHIBITOR_COMP...,SET,8,0.099615,0.0020778,0.33174,0.38198,GOCC_PROTEASE_INHIBITOR_COMPLEX,0.996142451915909
GSE41867_NAIVE_VS_DAY8_LCMV_...6,SET,182,0.017164,0.0016995,0.057159,0.38198,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,0.996142451915909
HILLION_HMGA1B_TARGETS,SET,78,0.029552,0.0019211,0.098438,0.38201,HILLION_HMGA1B_TARGETS,0.996142451915909
GSE28726_NAIVE_VS_ACTIVATED_...2,SET,173,0.019569,0.0018897,0.065189,0.38202,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_UP,0.996142451915909
KAT5_TARGET_GENES,SET,709,0.0093844,0.0018073,0.031275,0.38207,KAT5_TARGET_GENES,0.996142451915909
HP_HALITOSIS,SET,6,0.10931,0.0019748,0.36441,0.3821,HP_HALITOSIS,0.996142451915909
GSE12845_IGD_POS_BLOOD_VS_PR...2,SET,170,0.019181,0.0018362,0.063959,0.38213,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,0.996142451915909
GOBP_NEGATIVE_REGULATION_OF_...467,SET,26,0.052129,0.0019593,0.17389,0.38218,GOBP_NEGATIVE_REGULATION_OF_ORGAN_GROWTH,0.996142451915909
GSE21546_UNSTIM_VS_ANTI_CD3_...3,SET,145,0.021699,0.0019198,0.072387,0.38218,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_ELK1_KO_DP_THYMOCYTES_DN,0.996142451915909
chr10q11,SET,45,0.067844,0.0033529,0.22636,0.3822,chr10q11,0.996142451915909
HP_COXA_VALGA,SET,82,0.028215,0.0018804,0.094146,0.38221,HP_COXA_VALGA,0.996142451915909
HP_LIVER_ABSCESS,SET,7,0.10062,0.0019632,0.33576,0.38222,HP_LIVER_ABSCESS,0.996142451915909
FOXJ2_TARGET_GENES,SET,439,0.012046,0.0018394,0.040247,0.38236,FOXJ2_TARGET_GENES,0.996142451915909
HP_DIAPHYSEAL_SCLEROSIS,SET,9,0.092422,0.0020447,0.30884,0.38238,HP_DIAPHYSEAL_SCLEROSIS,0.996142451915909
GOBP_PROTEIN_LOCALIZATION_TO...19,SET,7,0.091132,0.0017782,0.30459,0.3824,GOBP_PROTEIN_LOCALIZATION_TO_CYTOPLASMIC_STRESS_GRANULE,0.996142451915909
DESCARTES_FETAL_MUSCLE_LYMPH...2,SET,96,0.025674,0.0018507,0.08581,0.3824,DESCARTES_FETAL_MUSCLE_LYMPHOID_CELLS,0.996142451915909
GOMF_SULFUR_COMPOUND_TRANSME...,SET,59,0.032574,0.0018426,0.1089,0.38243,GOMF_SULFUR_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.996142451915909
chr19p12,SET,29,0.075675,0.0030036,0.25306,0.38246,chr19p12,0.996142451915909
GOBP_POSITIVE_REGULATION_BY_...3,SET,17,0.054316,0.0016512,0.18164,0.38246,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_TRANSCRIPTION,0.996142451915909
GOBP_STEROID_BIOSYNTHETIC_PR...,SET,167,0.019927,0.0018908,0.066669,0.38252,GOBP_STEROID_BIOSYNTHETIC_PROCESS,0.996142451915909
GCM_Q2,SET,213,0.017829,0.0019082,0.059658,0.38253,GCM_Q2,0.996142451915909
GOBP_POSITIVE_REGULATION_OF_...788,SET,8,0.087651,0.0018283,0.29331,0.38253,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,0.996142451915909
MIR4257,SET,120,0.022036,0.0017747,0.073763,0.38257,MIR4257,0.996142451915909
GOBP_POSITIVE_REGULATION_OF_...678,SET,35,0.03926,0.0017116,0.13143,0.38259,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,0.996142451915909
HP_TALIPES_CALCANEOVALGUS,SET,13,0.068828,0.0018299,0.23043,0.38259,HP_TALIPES_CALCANEOVALGUS,0.996142451915909
GSE39152_SPLEEN_CD103_NEG_VS...2,SET,187,0.018161,0.0018225,0.060805,0.3826,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_UP,0.996142451915909
GOBP_NEGATIVE_REGULATION_OF_...652,SET,137,0.022406,0.0019272,0.075031,0.38262,GOBP_NEGATIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,0.996142451915909
KEGG_MEDICUS_REFERENCE_TLR2_...,SET,25,0.053789,0.0019825,0.18021,0.38267,KEGG_MEDICUS_REFERENCE_TLR2_4_MAPK_SIGNALING_PATHWAY,0.996142451915909
GOBP_NEGATIVE_REGULATION_OF_...412,SET,20,0.049362,0.0016274,0.16539,0.38268,GOBP_NEGATIVE_REGULATION_OF_MRNA_PROCESSING,0.996142451915909
GOBP_POSITIVE_REGULATION_OF_...777,SET,16,0.066956,0.0019747,0.22436,0.38269,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA_PRODUCTION,0.996142451915909
GOCC_LAMIN_FILAMENT,SET,5,0.10541,0.0017384,0.35321,0.38269,GOCC_LAMIN_FILAMENT,0.996142451915909
GOBP_CELLULAR_RESPONSE_TO_AN...2,SET,11,0.079579,0.0019463,0.26681,0.38276,GOBP_CELLULAR_RESPONSE_TO_ANTIBIOTIC,0.996142451915909
GOMF_O_METHYLTRANSFERASE_ACT...,SET,17,0.053041,0.0016124,0.17784,0.38276,GOMF_O_METHYLTRANSFERASE_ACTIVITY,0.996142451915909
MILICIC_FAMILIAL_ADENOMATOUS...1,SET,9,0.092678,0.0020504,0.31081,0.38278,MILICIC_FAMILIAL_ADENOMATOUS_POLYPOSIS_DN,0.996142451915909
MIR4433B_5P,SET,51,0.037667,0.0019814,0.12636,0.38282,MIR4433B_5P,0.996142451915909
MORF_RFC4,SET,132,0.020681,0.0017463,0.06938,0.38282,MORF_RFC4,0.996142451915909
ODONNELL_TFRC_TARGETS_UP,SET,329,0.013949,0.0018495,0.046817,0.38288,ODONNELL_TFRC_TARGETS_UP,0.996142451915909
GOBP_POSITIVE_REGULATION_OF_...618,SET,15,0.067706,0.0019335,0.22731,0.38291,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,0.996142451915909
GOBP_POSITIVE_REGULATION_OF_...808,SET,8,0.089664,0.0018703,0.30106,0.38292,GOBP_POSITIVE_REGULATION_OF_T_CELL_TOLERANCE_INDUCTION,0.996142451915909
GOBP_REGULATION_OF_MYOTUBE_D...,SET,40,0.042332,0.0019727,0.14214,0.38292,GOBP_REGULATION_OF_MYOTUBE_DIFFERENTIATION,0.996142451915909
GSE2770_TGFB_AND_IL4_VS_IL4_...5,SET,171,0.0188,0.001805,0.06316,0.38298,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,0.996142451915909
BIOCARTA_FREE_PATHWAY,SET,9,0.076003,0.0016814,0.2555,0.38306,BIOCARTA_FREE_PATHWAY,0.996142451915909
BROWNE_HCMV_INFECTION_10HR_UP,SET,90,0.025556,0.001784,0.085934,0.38308,BROWNE_HCMV_INFECTION_10HR_UP,0.996142451915909
ANDERSON_BLOOD_CN54GP140_ADJ...4,SET,25,0.048588,0.0017908,0.16339,0.38309,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_UP,0.996142451915909
HP_ANTINUCLEAR_ANTIBODY_POSI...,SET,62,0.034212,0.0019837,0.11511,0.38315,HP_ANTINUCLEAR_ANTIBODY_POSITIVITY,0.996142451915909
GOMF_DAMAGED_DNA_BINDING,SET,71,0.026067,0.001617,0.087723,0.38318,GOMF_DAMAGED_DNA_BINDING,0.996142451915909
HP_GLUCOSE_INTOLERANCE,SET,421,0.012467,0.0018651,0.04196,0.38319,HP_GLUCOSE_INTOLERANCE,0.996142451915909
MIR6819_3P,SET,32,0.04389,0.0018298,0.14778,0.38324,MIR6819_3P,0.996142451915909
GOBP_RESPONSE_TO_UV,SET,142,0.020022,0.0017531,0.067415,0.38324,GOBP_RESPONSE_TO_UV,0.996142451915909
GOMF_VITAMIN_BINDING,SET,133,0.022199,0.0018816,0.074761,0.38326,GOMF_VITAMIN_BINDING,0.996142451915909
GSE25088_WT_VS_STAT6_KO_MACR...8,SET,166,0.018939,0.0017918,0.063811,0.38331,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_UP,0.996142451915909
GSE3982_MEMORY_CD4_TCELL_VS_...1,SET,174,0.018655,0.0018065,0.062886,0.38337,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_DN,0.996142451915909
GOBP_PROSTATE_GLAND_GROWTH,SET,10,0.094435,0.0022022,0.31836,0.38338,GOBP_PROSTATE_GLAND_GROWTH,0.996142451915909
GSE21380_TFH_VS_GERMINAL_CEN...2,SET,184,0.018947,0.0018862,0.063904,0.38343,GSE21380_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,0.996142451915909
HP_EPILEPTIC_SPASM,SET,167,0.01924,0.0018256,0.064908,0.38346,HP_EPILEPTIC_SPASM,0.996142451915909
CART1_01,SET,201,0.018961,0.001972,0.063992,0.3835,CART1_01,0.996142451915909
GOBP_CELLULAR_RESPONSE_TO_ET...1,SET,12,0.071407,0.001824,0.24101,0.38351,GOBP_CELLULAR_RESPONSE_TO_ETHANOL,0.996142451915909
GSE8685_IL2_ACT_IL2_STARVED_...1,SET,181,0.018565,0.0018332,0.062662,0.38352,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,0.996142451915909
MIR609,SET,30,0.044855,0.0018107,0.15142,0.38353,MIR609,0.996142451915909
REACTOME_NUCLEOTIDE_CATABOLI...,SET,35,0.044079,0.0019217,0.14881,0.38354,REACTOME_NUCLEOTIDE_CATABOLISM,0.996142451915909
HP_ABSENT_STERNAL_OSSIFICATI...,SET,5,0.096057,0.0015841,0.32431,0.38355,HP_ABSENT_STERNAL_OSSIFICATION,0.996142451915909
KAYO_CALORIE_RESTRICTION_MUS...1,SET,77,0.026466,0.0017095,0.089376,0.38357,KAYO_CALORIE_RESTRICTION_MUSCLE_DN,0.996142451915909
GOBP_MEMBRANE_LIPID_BIOSYNTH...,SET,143,0.020942,0.00184,0.070728,0.38358,GOBP_MEMBRANE_LIPID_BIOSYNTHETIC_PROCESS,0.996142451915909
GOBP_REGULATION_OF_ENDOPLASM...1,SET,29,0.042668,0.0016936,0.14411,0.38358,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.996142451915909
GOBP_NEGATIVE_REGULATION_OF_...514,SET,101,0.024052,0.0017781,0.081253,0.38361,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,0.996142451915909
MIR1275,SET,258,0.016033,0.0018863,0.054176,0.38364,MIR1275,0.996142451915909
GOBP_VASCULAR_ENDOTHELIAL_GR...4,SET,40,0.04243,0.0019773,0.14344,0.38369,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_SIGNALING_PATHWAY,0.996142451915909
WP_METABOLISM_OF_ALPHALINOLE...,SET,6,0.11453,0.0020689,0.38718,0.3837,WP_METABOLISM_OF_ALPHALINOLENIC_ACID,0.996142451915909
GOBP_COLUMNAR_CUBOIDAL_EPITH...1,SET,49,0.038445,0.0019824,0.13,0.38372,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DEVELOPMENT,0.996142451915909
GSE43863_TH1_VS_TFH_EFFECTOR...2,SET,187,0.018505,0.0018571,0.062608,0.38378,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_UP,0.996142451915909
GOBP_MORPHOGENESIS_OF_AN_END...,SET,16,0.065439,0.00193,0.22144,0.3838,GOBP_MORPHOGENESIS_OF_AN_ENDOTHELIUM,0.996142451915909
GOMF_N_ACETYLLACTOSAMINIDE_B...,SET,6,0.1251,0.0022599,0.42331,0.3838,GOMF_N_ACETYLLACTOSAMINIDE_BETA_1_3_N_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,0.996142451915909
GOMF_PASSIVE_TRANSMEMBRANE_T...,SET,454,0.012731,0.001976,0.043098,0.38385,GOMF_PASSIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,0.996142451915909
HP_ATOPIC_DERMATITIS,SET,35,0.043275,0.0018867,0.1465,0.38385,HP_ATOPIC_DERMATITIS,0.996142451915909
COLLER_MYC_TARGETS_UP,SET,23,0.052936,0.0018715,0.17925,0.38387,COLLER_MYC_TARGETS_UP,0.996142451915909
KEGG_MEDICUS_ENV_FACTOR_META...4,SET,11,0.074473,0.0018214,0.25227,0.38392,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_RAS_ERK_SIGNALING_PATHWAY,0.996142451915909
WP_4P163_COPY_NUMBER_VARIATI...,SET,27,0.044652,0.0017102,0.15125,0.38392,WP_4P163_COPY_NUMBER_VARIATION,0.996142451915909
BIOCARTA_RARRXR_PATHWAY,SET,7,0.085578,0.0016698,0.28994,0.38394,BIOCARTA_RARRXR_PATHWAY,0.996142451915909
WP_ARACHIDONATE_EPOXYGENASE_...,SET,7,0.083223,0.0016239,0.28212,0.384,WP_ARACHIDONATE_EPOXYGENASE_EPOXIDE_HYDROLASE,0.996142451915909
DORSEY_GAB2_TARGETS,SET,27,0.052344,0.0020048,0.17753,0.38406,DORSEY_GAB2_TARGETS,0.996142451915909
WP_DNA_IRDAMAGE_AND_CELLULAR...,SET,74,0.026053,0.0016498,0.088368,0.38406,WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR,0.996142451915909
HP_ABNORMAL_CIRCULATING_AMYL...,SET,6,0.096514,0.0017436,0.3274,0.38408,HP_ABNORMAL_CIRCULATING_AMYLASE_CONCENTRATION,0.996142451915909
GSE17974_0.5H_VS_72H_IL4_AND...2,SET,178,0.01849,0.0018108,0.062782,0.38418,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP,0.996142451915909
GOCC_GOLGI_CISTERNA,SET,96,0.025755,0.0018565,0.08745,0.38419,GOCC_GOLGI_CISTERNA,0.996142451915909
MIR103B,SET,36,0.040452,0.0017886,0.13739,0.38422,MIR103B,0.996142451915909
WP_INTERLEUKIN1_IL1_STRUCTUR...,SET,46,0.036954,0.0018464,0.12557,0.38427,WP_INTERLEUKIN1_IL1_STRUCTURAL_PATHWAY,0.996142451915909
HP_DECREASED_CIRCULATING_TOT...2,SET,8,0.095443,0.0019908,0.32434,0.38428,HP_DECREASED_CIRCULATING_TOTAL_IGG,0.996142451915909
CUI_DEVELOPING_HEART_COMPACT...2,SET,58,0.035962,0.002017,0.12227,0.38433,CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE,0.996142451915909
GOBP_CARDIAC_SEPTUM_DEVELOPM...,SET,104,0.025773,0.0019332,0.087637,0.38435,GOBP_CARDIAC_SEPTUM_DEVELOPMENT,0.996142451915909
HP_STATUS_EPILEPTICUS,SET,182,0.018197,0.0018019,0.061888,0.38437,HP_STATUS_EPILEPTICUS,0.996142451915909
GSE339_EX_VIVO_VS_IN_CULTURE...6,SET,183,0.017754,0.0017627,0.060383,0.38437,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_UP,0.996142451915909
GOBP_IMMUNOGLOBULIN_V_D_J_RE...,SET,7,0.087046,0.0016984,0.29613,0.3844,GOBP_IMMUNOGLOBULIN_V_D_J_RECOMBINATION,0.996142451915909
WP_GALANIN_RECEPTOR_PATHWAY,SET,21,0.056703,0.0019156,0.19294,0.38442,WP_GALANIN_RECEPTOR_PATHWAY,0.996142451915909
AMIT_EGF_RESPONSE_60_MCF10A,SET,36,0.043266,0.001913,0.14722,0.38443,AMIT_EGF_RESPONSE_60_MCF10A,0.996142451915909
HAY_BONE_MARROW_CD34_POS_CLP,SET,7,0.10885,0.0021238,0.3704,0.38443,HAY_BONE_MARROW_CD34_POS_CLP,0.996142451915909
GOCC_EXORIBONUCLEASE_COMPLEX,SET,22,0.045561,0.0015754,0.15508,0.38446,GOCC_EXORIBONUCLEASE_COMPLEX,0.996142451915909
GSE2585_AIRE_KO_VS_WT_CD80_L...1,SET,193,0.017859,0.0018204,0.060792,0.38447,GSE2585_AIRE_KO_VS_WT_CD80_LOW_MTEC_DN,0.996142451915909
GSE8835_HEALTHY_VS_CLL_CD8_T...2,SET,183,0.017929,0.0017801,0.061047,0.3845,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_UP,0.996145918747671
GOMF_HSP90_PROTEIN_BINDING,SET,38,0.038667,0.0017564,0.13173,0.38456,GOMF_HSP90_PROTEIN_BINDING,0.996156316142495
GOBP_REGULATION_OF_CELL_SUBS...1,SET,202,0.01793,0.0018693,0.061088,0.38457,GOBP_REGULATION_OF_CELL_SUBSTRATE_ADHESION,0.996156316142495
GOCC_SYNAPTIC_MEMBRANE,SET,369,0.013714,0.0019236,0.046734,0.38459,GOCC_SYNAPTIC_MEMBRANE,0.996156316142495
GOMF_VOLTAGE_GATED_MONOATOMI...2,SET,139,0.023237,0.0020132,0.079272,0.38471,GOMF_VOLTAGE_GATED_MONOATOMIC_CATION_CHANNEL_ACTIVITY,0.996190940571939
chr11q13,SET,240,0.033599,0.0038144,0.11464,0.38473,chr11q13,0.996190940571939
GOCC_NEUROTRANSMITTER_RECEPT...,SET,43,0.040615,0.0019622,0.13862,0.38476,GOCC_NEUROTRANSMITTER_RECEPTOR_COMPLEX,0.996190940571939
REACTOME_REGULATION_OF_ENDOG...2,SET,47,0.034373,0.001736,0.11734,0.38478,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS,0.996190940571939
GOBP_SEPTUM_PRIMUM_DEVELOPME...,SET,4,0.13534,0.0019964,0.4621,0.38481,GOBP_SEPTUM_PRIMUM_DEVELOPMENT,0.996190940571939
REACTOME_IKK_COMPLEX_RECRUIT...,SET,21,0.056682,0.0019149,0.19361,0.38485,REACTOME_IKK_COMPLEX_RECRUITMENT_MEDIATED_BY_RIP1,0.996190940571939
MIR6849_3P,SET,68,0.030032,0.0018234,0.10259,0.38486,MIR6849_3P,0.996190940571939
MIR4274,SET,51,0.035056,0.0018441,0.11978,0.38489,MIR4274,0.996190940571939
GSE34515_CD16_NEG_MONOCYTE_V...1,SET,176,0.017723,0.001726,0.060555,0.38489,GSE34515_CD16_NEG_MONOCYTE_VS_DC_DN,0.996190940571939
GSE40274_HELIOS_VS_FOXP3_AND...1,SET,179,0.018115,0.001779,0.061894,0.38489,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,0.996190940571939
GSE360_LOW_DOSE_B_MALAYI_VS_...3,SET,181,0.018064,0.0017837,0.061766,0.38497,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,0.996253071253071
GOBP_BIOLOGICAL_PROCESS_INVO...3,SET,1528,0.0067912,0.001875,0.023225,0.38499,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS,0.996253071253071
GOBP_AMELOBLAST_DIFFERENTIAT...,SET,5,0.13035,0.0021497,0.44582,0.385,GOBP_AMELOBLAST_DIFFERENTIATION,0.996253071253071
GOCC_CEREBELLAR_CLIMBING_FIB...,SET,7,0.10839,0.002115,0.37106,0.3851,GOCC_CEREBELLAR_CLIMBING_FIBER_TO_PURKINJE_CELL_SYNAPSE,0.996266885001861
HP_HAMARTOMA_OF_TONGUE,SET,21,0.046727,0.0015786,0.15997,0.38511,HP_HAMARTOMA_OF_TONGUE,0.996266885001861
RATTENBACHER_BOUND_BY_CELF1,SET,365,0.012894,0.0017989,0.044147,0.38512,RATTENBACHER_BOUND_BY_CELF1,0.996266885001861
HP_YELLOW_BROWN_DISCOLORATIO...,SET,14,0.067207,0.0018542,0.23012,0.38512,HP_YELLOW_BROWN_DISCOLORATION_OF_THE_TEETH,0.996266885001861
GSE6259_33D1_POS_VS_DEC205_P...3,SET,179,0.019416,0.0019067,0.066513,0.38518,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_DN,0.996347938374516
GSE19198_CTRL_VS_IL21_TREATE...6,SET,172,0.019428,0.0018707,0.066582,0.38522,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_UP,0.996377249386024
REACTOME_PRE_NOTCH_EXPRESSIO...,SET,48,0.033623,0.001716,0.1153,0.38529,REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING,0.996435858322792
GAO_LARGE_INTESTINE_ADULT_CA...,SET,260,0.016257,0.0019199,0.055751,0.3853,GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS,0.996435858322792
GOBP_LYMPH_VESSEL_DEVELOPMENT,SET,29,0.047391,0.001881,0.16263,0.38537,GOBP_LYMPH_VESSEL_DEVELOPMENT,0.996542734375
PARK_APL_PATHOGENESIS_UP,SET,14,0.069056,0.0019052,0.23725,0.3855,PARK_APL_PATHOGENESIS_UP,0.996637430271476
ZNF202_TARGET_GENES,SET,64,0.030842,0.0018168,0.10596,0.3855,ZNF202_TARGET_GENES,0.996637430271476
GSE6259_DEC205_POS_DC_VS_CD4...2,SET,180,0.018054,0.0017779,0.062031,0.38551,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_UP,0.996637430271476
GROSS_HYPOXIA_VIA_ELK3_AND_H...2,SET,125,0.023012,0.0018913,0.079092,0.38555,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP,0.996637430271476
HP_SHORT_STEPPED_SHUFFLING_G...,SET,14,0.060129,0.0016589,0.20666,0.38555,HP_SHORT_STEPPED_SHUFFLING_GAIT,0.996637430271476
WIELAND_UP_BY_HBV_INFECTION,SET,93,0.026064,0.0018494,0.089721,0.38572,WIELAND_UP_BY_HBV_INFECTION,0.996940124832813
WP_HOSTPATHOGEN_INTERACTION_...3,SET,30,0.045726,0.0018459,0.1575,0.38578,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_INTERFERON_INDUCTION,0.996940124832813
MIR369_3P,SET,276,0.015144,0.0018419,0.052162,0.38578,MIR369_3P,0.996940124832813
GSE3920_UNTREATED_VS_IFNG_TR...4,SET,156,0.01951,0.0017898,0.067234,0.38584,GSE3920_UNTREATED_VS_IFNG_TREATED_FIBROBLAST_UP,0.996940124832813
MODULE_131,SET,31,0.045754,0.0018775,0.15768,0.38585,MODULE_131,0.996940124832813
GOBP_ANTIMICROBIAL_HUMORAL_I...,SET,90,0.030408,0.0021227,0.10481,0.38586,GOBP_ANTIMICROBIAL_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_ANTIMICROBIAL_PEPTIDE,0.996940124832813
WP_FOLLICLE_STIMULATING_HORM...,SET,26,0.050168,0.0018856,0.17296,0.38589,WP_FOLLICLE_STIMULATING_HORMONE_FSH_SIGNALING,0.996940124832813
MIR1256,SET,64,0.031131,0.0018339,0.10741,0.38597,MIR1256,0.996940124832813
MIR149_3P,SET,397,0.012309,0.0017894,0.042465,0.38597,MIR149_3P,0.996940124832813
MIR1912_5P,SET,73,0.029739,0.0018705,0.10262,0.38599,MIR1912_5P,0.996940124832813
GOMF_CYCLASE_INHIBITOR_ACTIV...,SET,4,0.11167,0.0016473,0.38546,0.38602,GOMF_CYCLASE_INHIBITOR_ACTIVITY,0.996940124832813
GOBP_STRIATED_MUSCLE_CELL_DE...,SET,77,0.027689,0.0017884,0.095582,0.38603,GOBP_STRIATED_MUSCLE_CELL_DEVELOPMENT,0.996940124832813
GOMF_MANNOSIDASE_ACTIVITY,SET,15,0.065233,0.0018628,0.22521,0.38604,GOMF_MANNOSIDASE_ACTIVITY,0.996940124832813
GSE360_CTRL_VS_B_MALAYI_LOW_...1,SET,177,0.018643,0.0018207,0.064433,0.38616,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_DN,0.997153484398217
GOBP_NEGATIVE_REGULATION_OF_...57,SET,6,0.11466,0.0020714,0.39634,0.38618,GOBP_NEGATIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,0.997153484398217
HP_DECREASED_CORNEAL_REFLEX,SET,9,0.07335,0.0016228,0.25378,0.38628,HP_DECREASED_CORNEAL_REFLEX,0.997270254010695
HP_RECURRENT_CORNEAL_EROSIONS,SET,11,0.077496,0.0018953,0.26819,0.38631,HP_RECURRENT_CORNEAL_EROSIONS,0.997270254010695
WP_JAKSTAT_SIGNALING_IN_THE_...,SET,34,0.043663,0.0018762,0.15112,0.38632,WP_JAKSTAT_SIGNALING_IN_THE_REGULATION_OF_BETA_CELLS,0.997270254010695
GOBP_REGULATION_OF_TRANSCRIP...3,SET,27,0.042921,0.0016439,0.14858,0.38634,GOBP_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,0.997270254010695
MODULE_105,SET,188,0.01724,0.0017347,0.05981,0.38658,MODULE_105,0.997695440205429
GOBP_CATECHOL_CONTAINING_COM...2,SET,5,0.12657,0.0020874,0.4392,0.3866,GOBP_CATECHOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,0.997695440205429
GSE21774_CD62L_POS_CD56_BRIG...1,SET,173,0.018925,0.0018274,0.065669,0.38661,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,0.997695440205429
chr7q35,SET,17,0.093084,0.0028297,0.32311,0.38664,chr7q35,0.997695440205429
GSE29617_DAY3_VS_DAY7_TIV_FL...1,SET,151,0.018471,0.0016673,0.064149,0.3867,GSE29617_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,0.997695440205429
HP_LOWER_LIMB_HYPERTONIA,SET,32,0.040818,0.0017017,0.14178,0.38672,HP_LOWER_LIMB_HYPERTONIA,0.997695440205429
GSE17186_BLOOD_VS_CORD_BLOOD...3,SET,182,0.017768,0.0017593,0.061723,0.38673,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_DN,0.997695440205429
MODULE_208,SET,108,0.024468,0.0018701,0.085006,0.38674,MODULE_208,0.997695440205429
GOBP_POSITIVE_REGULATION_OF_...787,SET,12,0.062731,0.0016024,0.21803,0.38678,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_BIOSYNTHETIC_PROCESS,0.997695440205429
SHIN_B_CELL_LYMPHOMA_CLUSTER...7,SET,36,0.039389,0.0017416,0.137,0.38687,SHIN_B_CELL_LYMPHOMA_CLUSTER_8,0.997695440205429
MENON_FETAL_KIDNEY_10_IMMUNE...,SET,71,0.029449,0.0018268,0.10246,0.3869,MENON_FETAL_KIDNEY_10_IMMUNE_CELLS,0.997695440205429
GSE6674_UNSTIM_VS_PL2_3_STIM...1,SET,152,0.01887,0.001709,0.065746,0.38705,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_DN,0.997695440205429
GSE15767_MED_VS_SCS_MAC_LN_DN,SET,180,0.017846,0.0017574,0.062231,0.38715,GSE15767_MED_VS_SCS_MAC_LN_DN,0.997695440205429
GSE36392_EOSINOPHIL_VS_MAC_I...1,SET,177,0.01756,0.0017149,0.061234,0.38715,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_DN,0.997695440205429
GOBP_NUCLEAR_PORE_ORGANIZATI...,SET,15,0.057301,0.0016363,0.19988,0.38718,GOBP_NUCLEAR_PORE_ORGANIZATION,0.997695440205429
GSE35825_UNTREATED_VS_IFNG_S...2,SET,188,0.018961,0.0019079,0.066176,0.38724,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_UP,0.997695440205429
IM_SREBF1A_TARGETS,SET,5,0.1012,0.0016689,0.3533,0.38727,IM_SREBF1A_TARGETS,0.997695440205429
HP_APLASIA_CUTIS_CONGENITA_O...2,SET,6,0.10196,0.0018419,0.35596,0.38727,HP_APLASIA_CUTIS_CONGENITA_ON_TRUNK_OR_LIMBS,0.997695440205429
GUTIERREZ_CHRONIC_LYMPHOCYTI...2,SET,11,0.07888,0.0019292,0.2755,0.38732,GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_UP,0.997695440205429
WP_OREXIN_RECEPTOR_PATHWAY,SET,189,0.019295,0.0019466,0.067397,0.38733,WP_OREXIN_RECEPTOR_PATHWAY,0.997695440205429
GOBP_CELLULAR_RESPONSE_TO_RA...,SET,161,0.018347,0.0017097,0.064086,0.38733,GOBP_CELLULAR_RESPONSE_TO_RADIATION,0.997695440205429
HP_RECTOVAGINAL_FISTULA,SET,20,0.053742,0.0017719,0.18772,0.38733,HP_RECTOVAGINAL_FISTULA,0.997695440205429
MODULE_90,SET,3,0.11543,0.0014747,0.40334,0.38737,MODULE_90,0.997695440205429
GOBP_BEHAVIORAL_RESPONSE_TO_...2,SET,9,0.088703,0.0019624,0.31012,0.38743,GOBP_BEHAVIORAL_RESPONSE_TO_ETHANOL,0.997695440205429
BRUINS_UVC_RESPONSE_MIDDLE,SET,92,0.023524,0.0016602,0.082294,0.3875,BRUINS_UVC_RESPONSE_MIDDLE,0.997695440205429
GOCC_ATP_BINDING_CASSETTE_AB...,SET,6,0.10586,0.0019123,0.37044,0.38753,GOCC_ATP_BINDING_CASSETTE_ABC_TRANSPORTER_COMPLEX,0.997695440205429
HP_SKELETAL_MYOPATHY,SET,9,0.070828,0.001567,0.24794,0.38757,HP_SKELETAL_MYOPATHY,0.997695440205429
GOBP_NEGATIVE_REGULATION_OF_...239,SET,13,0.065514,0.0017418,0.22938,0.38759,GOBP_NEGATIVE_REGULATION_OF_FIBRINOLYSIS,0.997695440205429
MIR3671,SET,571,0.010296,0.0017864,0.036053,0.3876,MIR3671,0.997695440205429
MIR4802_3P,SET,153,0.021028,0.0019106,0.073631,0.3876,MIR4802_3P,0.997695440205429
REACTOME_DEFECTIVE_FACTOR_IX...,SET,7,0.10198,0.0019898,0.3571,0.38761,REACTOME_DEFECTIVE_FACTOR_IX_CAUSES_HEMOPHILIA_B,0.997695440205429
HP_LOW_1_MINUTE_APGAR_SCORE,SET,6,0.12067,0.00218,0.42283,0.38767,HP_LOW_1_MINUTE_APGAR_SCORE,0.997695440205429
GSE35543_IN_VIVO_NTREG_VS_CO...1,SET,179,0.018464,0.0018133,0.064695,0.38767,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN,0.997695440205429
GSE14000_TRANSLATED_RNA_VS_M...5,SET,161,0.01843,0.0017173,0.064583,0.38768,GSE14000_TRANSLATED_RNA_VS_MRNA_DC_DN,0.997695440205429
HP_EXCESSIVE_WRINKLING_OF_PA...,SET,11,0.069238,0.0016934,0.2427,0.38772,HP_EXCESSIVE_WRINKLING_OF_PALMAR_SKIN,0.997695440205429
HOWARD_MONOCYTE_INACT_MONOV_...2,SET,203,0.018449,0.0019281,0.064676,0.38773,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,0.997695440205429
GOMF_UBIQUITIN_LIKE_PROTEIN_...3,SET,34,0.039173,0.0016833,0.13737,0.38776,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_BINDING,0.997695440205429
GSE25088_ROSIGLITAZONE_VS_IL...4,SET,165,0.018526,0.0017474,0.064992,0.38781,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_UP,0.997695440205429
GOMF_SOLUTE_POTASSIUM_ANTIPO...,SET,17,0.061817,0.0018792,0.21693,0.38784,GOMF_SOLUTE_POTASSIUM_ANTIPORTER_ACTIVITY,0.997695440205429
chr22q12,SET,107,0.049619,0.003775,0.17437,0.38799,chr22q12,0.997695440205429
GOMF_TRNA_GUANINE_METHYLTRAN...,SET,11,0.062854,0.0015372,0.22087,0.38799,GOMF_TRNA_GUANINE_METHYLTRANSFERASE_ACTIVITY,0.997695440205429
MORF_DNMT1,SET,104,0.02174,0.0016307,0.076429,0.38804,MORF_DNMT1,0.997695440205429
ZHOU_TNF_SIGNALING_4HR,SET,42,0.03572,0.0017056,0.12562,0.38807,ZHOU_TNF_SIGNALING_4HR,0.997695440205429
GOBP_NEGATIVE_REGULATION_OF_...248,SET,128,0.020349,0.0016923,0.071565,0.38807,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_EPIGENETIC,0.997695440205429
GSE11864_UNTREATED_VS_CSF1_I...2,SET,165,0.018348,0.0017306,0.064555,0.38812,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_UP,0.997695440205429
GSE24634_IL4_VS_CTRL_TREATED...5,SET,183,0.018618,0.0018485,0.065542,0.38818,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_DN,0.997695440205429
GOBP_ENTERIC_NERVOUS_SYSTEM_...,SET,11,0.073253,0.0017916,0.2579,0.38819,GOBP_ENTERIC_NERVOUS_SYSTEM_DEVELOPMENT,0.997695440205429
GOBP_GLOSSOPHARYNGEAL_NERVE_...,SET,5,0.091811,0.0015141,0.32324,0.3882,GOBP_GLOSSOPHARYNGEAL_NERVE_DEVELOPMENT,0.997695440205429
GSE15930_STIM_VS_STIM_AND_IF...3,SET,190,0.017319,0.0017518,0.061002,0.38824,GSE15930_STIM_VS_STIM_AND_IFNAB_48H_CD8_T_CELL_DN,0.997695440205429
LIU_SOX4_TARGETS_DN,SET,286,0.014089,0.0017438,0.049628,0.38825,LIU_SOX4_TARGETS_DN,0.997695440205429
GOBP_STOMACH_DEVELOPMENT,SET,5,0.11945,0.0019699,0.42099,0.38831,GOBP_STOMACH_DEVELOPMENT,0.997695440205429
HP_GENERALIZED_HYPOPIGMENTAT...1,SET,28,0.049587,0.001934,0.17477,0.38831,HP_GENERALIZED_HYPOPIGMENTATION,0.997695440205429
SHI_SPARC_TARGETS_UP,SET,24,0.050516,0.0018243,0.17806,0.38832,SHI_SPARC_TARGETS_UP,0.997695440205429
MIR125B_5P,SET,298,0.013785,0.001741,0.048608,0.38836,MIR125B_5P,0.997695440205429
GSE11961_FOLLICULAR_BCELL_VS...9,SET,179,0.017556,0.0017242,0.061925,0.38839,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_DN,0.997695440205429
MORF_RAD54L,SET,91,0.02344,0.0016453,0.08271,0.38843,MORF_RAD54L,0.997695440205429
GOBP_VASCULAR_ASSOCIATED_SMO...1,SET,11,0.072896,0.0017828,0.25726,0.38846,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,0.997695440205429
GOBP_REGULATION_OF_MACROPHAG...1,SET,54,0.035125,0.0019011,0.12399,0.38848,GOBP_REGULATION_OF_MACROPHAGE_ACTIVATION,0.997695440205429
GSE6269_FLU_VS_STAPH_AUREUS_...2,SET,172,0.017553,0.0016901,0.061974,0.3885,GSE6269_FLU_VS_STAPH_AUREUS_INF_PBMC_UP,0.997695440205429
MIR6758_5P,SET,99,0.023716,0.0017359,0.083756,0.38853,MIR6758_5P,0.997695440205429
GSE28783_ANTI_MIR33_VS_CTRL_...2,SET,184,0.018473,0.0018391,0.06525,0.38854,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_UP,0.997695440205429
GOBP_MISMATCH_REPAIR,SET,31,0.037777,0.0015502,0.13345,0.38856,GOBP_MISMATCH_REPAIR,0.997695440205429
MIR6839_3P,SET,146,0.020197,0.0017929,0.071357,0.38857,MIR6839_3P,0.997695440205429
GOBP_REGULATION_OF_PROTEASOM...1,SET,164,0.018099,0.0017021,0.063987,0.38864,GOBP_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,0.997695440205429
HP_ABNORMAL_ANTIHELIX_MORPHO...,SET,36,0.039223,0.0017342,0.13881,0.38876,HP_ABNORMAL_ANTIHELIX_MORPHOLOGY,0.997695440205429
GSE32901_TH1_VS_TH17_ENRICHE...2,SET,160,0.01865,0.0017325,0.066004,0.38876,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_UP,0.997695440205429
MIR1537_5P,SET,109,0.023483,0.0018031,0.08312,0.38877,MIR1537_5P,0.997695440205429
HP_COMPLETE_ATRIOVENTRICULAR...,SET,16,0.054719,0.0016138,0.19369,0.38878,HP_COMPLETE_ATRIOVENTRICULAR_CANAL_DEFECT,0.997695440205429
LUDWICZEK_TREATING_IRON_OVER...,SET,7,0.104,0.0020293,0.36816,0.38879,LUDWICZEK_TREATING_IRON_OVERLOAD,0.997695440205429
HP_MOLAR_TOOTH_SIGN_ON_MRI,SET,37,0.033901,0.0015196,0.12007,0.38884,HP_MOLAR_TOOTH_SIGN_ON_MRI,0.997695440205429
GOBP_CARDIAC_ATRIUM_DEVELOPM...,SET,34,0.046293,0.0019893,0.16402,0.38888,GOBP_CARDIAC_ATRIUM_DEVELOPMENT,0.997695440205429
MORF_RAB6A,SET,60,0.030906,0.001763,0.10959,0.38896,MORF_RAB6A,0.997695440205429
HP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,8,0.078313,0.0016335,0.27778,0.389,HP_MULTIPLE_EPIPHYSEAL_DYSPLASIA,0.997695440205429
GSE11924_TFH_VS_TH17_CD4_TCE...2,SET,177,0.01658,0.0016192,0.058806,0.389,GSE11924_TFH_VS_TH17_CD4_TCELL_UP,0.997695440205429
GSE16450_CTRL_VS_IFNA_6H_STI...1,SET,157,0.019126,0.0017601,0.067845,0.38901,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_DN,0.997695440205429
HARALAMBIEVA_PBMC_FLUARIX_AG...9,SET,318,0.013275,0.001731,0.047094,0.38902,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_POSITIVE,0.997695440205429
BIOCARTA_HES_PATHWAY,SET,11,0.068104,0.0016656,0.24174,0.38908,BIOCARTA_HES_PATHWAY,0.997695440205429
HP_INEFFECTIVE_ESOPHAGEAL_PE...,SET,14,0.062468,0.0017234,0.22178,0.3891,HP_INEFFECTIVE_ESOPHAGEAL_PERISTALSIS,0.997695440205429
GOMF_PLATELET_DERIVED_GROWTH...1,SET,11,0.083886,0.0020516,0.29784,0.38911,GOMF_PLATELET_DERIVED_GROWTH_FACTOR_BINDING,0.997695440205429
HP_NEONATAL_ALLOIMMUNE_THROM...,SET,14,0.064922,0.0017911,0.23058,0.38914,HP_NEONATAL_ALLOIMMUNE_THROMBOCYTOPENIA,0.997695440205429
CHEN_HOXA5_TARGETS_6HR_DN,SET,4,0.12157,0.0017932,0.4318,0.38915,CHEN_HOXA5_TARGETS_6HR_DN,0.997695440205429
GOBP_POSITIVE_REGULATION_OF_...260,SET,9,0.06363,0.0014077,0.22603,0.38916,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,0.997695440205429
HP_ABNORMAL_CIRCULATING_RENIN,SET,29,0.048243,0.0019148,0.17136,0.38916,HP_ABNORMAL_CIRCULATING_RENIN,0.997695440205429
HP_APLASIA_HYPOPLASIA_OF_THE...48,SET,43,0.034688,0.0016759,0.12327,0.3892,HP_APLASIA_HYPOPLASIA_OF_THE_NIPPLES,0.997695440205429
HP_ANTERIOR_PITUITARY_AGENES...,SET,10,0.081708,0.0019054,0.29047,0.38925,HP_ANTERIOR_PITUITARY_AGENESIS,0.997695440205429
GSE43863_TH1_VS_LY6C_LOW_CXC...2,SET,180,0.016694,0.001644,0.059357,0.38926,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_UP,0.997695440205429
GSE46606_IRF4HIGH_VS_IRF4MID...4,SET,178,0.01634,0.0016003,0.058115,0.38929,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,0.997695440205429
GOCC_WASH_COMPLEX,SET,7,0.07891,0.0015397,0.28066,0.3893,GOCC_WASH_COMPLEX,0.997695440205429
GSE7852_TREG_VS_TCONV_DN,SET,178,0.018576,0.0018192,0.066075,0.38931,GSE7852_TREG_VS_TCONV_DN,0.997695440205429
WP_PATHWAYS_OF_NUCLEIC_ACID_...,SET,13,0.064507,0.001715,0.2295,0.38933,WP_PATHWAYS_OF_NUCLEIC_ACID_METABOLISM_AND_INNATE_IMMUNE_SENSING,0.997695440205429
MIR9_3P,SET,308,0.013656,0.001753,0.048586,0.38933,MIR9_3P,0.997695440205429
REACTOME_ACTIVATED_NTRK2_SIG...5,SET,9,0.072428,0.0016024,0.2577,0.38934,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_RAS,0.997695440205429
chr9p22,SET,20,0.1098,0.0036202,0.39076,0.38936,chr9p22,0.997695440205429
GOBP_FUSED_ANTRUM_STAGE,SET,6,0.1044,0.0018861,0.37162,0.38938,GOBP_FUSED_ANTRUM_STAGE,0.997695440205429
GOBP_POSITIVE_REGULATION_OF_...329,SET,6,0.080159,0.0014481,0.28539,0.38941,GOBP_POSITIVE_REGULATION_OF_HELICASE_ACTIVITY,0.997695440205429
HP_PERIVENTRICULAR_WHITE_MAT...,SET,29,0.042622,0.0016917,0.15175,0.38941,HP_PERIVENTRICULAR_WHITE_MATTER_HYPERINTENSITIES,0.997695440205429
LINDVALL_IMMORTALIZED_BY_TER...1,SET,64,0.031576,0.0018601,0.11244,0.38942,LINDVALL_IMMORTALIZED_BY_TERT_DN,0.997695440205429
ZFP37_TARGET_GENES,SET,4,0.1399,0.0020637,0.49817,0.38942,ZFP37_TARGET_GENES,0.997695440205429
MIR4740_5P,SET,61,0.034914,0.0020081,0.12436,0.38945,MIR4740_5P,0.997695440205429
GOBP_MEIOTIC_CHROMOSOME_COND...,SET,6,0.078191,0.0014125,0.27884,0.38958,GOBP_MEIOTIC_CHROMOSOME_CONDENSATION,0.997695440205429
GOBP_GOLGI_VESICLE_BUDDING,SET,10,0.062341,0.0014538,0.22238,0.38961,GOBP_GOLGI_VESICLE_BUDDING,0.997695440205429
GSE1112_HY_CD8AB_VS_HY_CD8AA...2,SET,160,0.019059,0.0017705,0.067996,0.38963,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,0.997695440205429
REACTOME_TP53_REGULATES_TRAN...8,SET,14,0.065229,0.0017996,0.23276,0.38965,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G1_CELL_CYCLE_ARREST,0.997695440205429
GOCC_MITOTIC_SPINDLE_MICROTU...,SET,13,0.05253,0.0013966,0.18749,0.38967,GOCC_MITOTIC_SPINDLE_MICROTUBULE,0.997695440205429
MIR199A_5P,SET,166,0.01773,0.0016773,0.063298,0.3897,MIR199A_5P,0.997695440205429
GOBP_POLY_N_ACETYLLACTOSAMIN...,SET,9,0.083178,0.0018402,0.29704,0.38973,GOBP_POLY_N_ACETYLLACTOSAMINE_METABOLIC_PROCESS,0.997695440205429
HP_PRIMARY_HYPERALDOSTERONISM,SET,10,0.08699,0.0020286,0.31072,0.38975,HP_PRIMARY_HYPERALDOSTERONISM,0.997695440205429
HP_SPASTIC_ATAXIA,SET,18,0.050658,0.0015846,0.18101,0.3898,HP_SPASTIC_ATAXIA,0.997695440205429
SCHERER_PBMC_YF_VAX_AGE_18_4...2,SET,317,0.013464,0.0017529,0.048125,0.38983,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_UP,0.997695440205429
ROZANOV_MMP14_TARGETS_UP,SET,242,0.016167,0.0018429,0.057802,0.38986,ROZANOV_MMP14_TARGETS_UP,0.997695440205429
GOBP_CHOLANGIOCYTE_PROLIFERA...,SET,4,0.11383,0.0016791,0.4071,0.38989,GOBP_CHOLANGIOCYTE_PROLIFERATION,0.997695440205429
CHOI_ATL_STAGE_PREDICTOR,SET,39,0.038157,0.0017559,0.1365,0.38992,CHOI_ATL_STAGE_PREDICTOR,0.997695440205429
GOMF_TYPE_2_FIBROBLAST_GROWT...,SET,5,0.12932,0.0021326,0.46277,0.38996,GOMF_TYPE_2_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,0.997695440205429
HP_OPTIC_NEUROPATHY,SET,46,0.032698,0.0016338,0.11704,0.38998,HP_OPTIC_NEUROPATHY,0.997695440205429
HP_GLANDULAR_HYPOSPADIAS,SET,4,0.11552,0.001704,0.41356,0.39,HP_GLANDULAR_HYPOSPADIAS,0.997695440205429
GSE37416_12H_VS_48H_F_TULARE...2,SET,182,0.017576,0.0017403,0.062923,0.39,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,0.997695440205429
GOBP_PLATELET_DENSE_GRANULE_...,SET,24,0.048628,0.0017561,0.17422,0.39008,GOBP_PLATELET_DENSE_GRANULE_ORGANIZATION,0.997695440205429
HP_DELAYED_MYELINATION,SET,245,0.014465,0.0016589,0.051845,0.39012,HP_DELAYED_MYELINATION,0.997695440205429
MIR4694_5P,SET,34,0.041656,0.00179,0.14933,0.39014,MIR4694_5P,0.997695440205429
HP_INTERRUPTED_INFERIOR_VENA...,SET,5,0.083899,0.0013836,0.30078,0.39015,HP_INTERRUPTED_INFERIOR_VENA_CAVA_WITH_AZYGOUS_CONTINUATION,0.997695440205429
MIR372_3P,SET,304,0.013468,0.0017177,0.048288,0.39016,MIR372_3P,0.997695440205429
GOBP_NEGATIVE_REGULATION_OF_...363,SET,54,0.034468,0.0018656,0.1236,0.39018,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_DIFFERENTIATION,0.997695440205429
GOBP_REGULATION_OF_CARDIAC_E...,SET,11,0.081796,0.0020005,0.29343,0.39022,GOBP_REGULATION_OF_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,0.997695440205429
HP_DECREASED_LACRIMATION,SET,26,0.047171,0.001773,0.16928,0.39025,HP_DECREASED_LACRIMATION,0.997695440205429
GOBP_TOLL_LIKE_RECEPTOR_2_SI...,SET,16,0.060471,0.0017834,0.21703,0.39026,GOBP_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,0.997695440205429
PLASARI_NFIC_TARGETS_BASAL_DN,SET,20,0.059736,0.0019695,0.2144,0.39027,PLASARI_NFIC_TARGETS_BASAL_DN,0.997695440205429
TONKS_TARGETS_OF_RUNX1_RUNX1...7,SET,53,0.03583,0.0019213,0.1286,0.39027,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_MONOCYTE_DN,0.997695440205429
HP_STAGE_5_CHRONIC_KIDNEY_DI...,SET,124,0.020668,0.0016919,0.07418,0.39027,HP_STAGE_5_CHRONIC_KIDNEY_DISEASE,0.997695440205429
FAN_OVARY_CL4_T_LYMPHOCYTE_N...,SET,212,0.016023,0.0017109,0.057507,0.39027,FAN_OVARY_CL4_T_LYMPHOCYTE_NK_CELL_1,0.997695440205429
GSE39152_SPLEEN_CD103_NEG_VS...1,SET,189,0.017269,0.0017422,0.062015,0.39033,GSE39152_SPLEEN_CD103_NEG_VS_BRAIN_CD103_POS_MEMORY_CD8_TCELL_DN,0.997695440205429
AREB6_02,SET,237,0.015623,0.0017626,0.056115,0.39035,AREB6_02,0.997695440205429
HP_ABNORMAL_SUBSTANTIA_NIGRA...,SET,18,0.051844,0.0016217,0.18631,0.39041,HP_ABNORMAL_SUBSTANTIA_NIGRA_MORPHOLOGY,0.997695440205429
DESCARTES_MAIN_FETAL_ISLET_E...,SET,51,0.035366,0.0018604,0.1271,0.39041,DESCARTES_MAIN_FETAL_ISLET_ENDOCRINE_CELLS,0.997695440205429
GOCC_COPII_VESICLE_COAT,SET,16,0.053638,0.0015819,0.19283,0.39045,GOCC_COPII_VESICLE_COAT,0.997695440205429
MEISSNER_BRAIN_HCP_WITH_H3_U...,SET,31,0.03984,0.0016348,0.14325,0.39046,MEISSNER_BRAIN_HCP_WITH_H3_UNMETHYLATED,0.997695440205429
TBPL1_TARGET_GENES,SET,136,0.020409,0.0017491,0.07338,0.39046,TBPL1_TARGET_GENES,0.997695440205429
HP_BULBOUS_NOSE,SET,176,0.017311,0.0016859,0.062251,0.39047,HP_BULBOUS_NOSE,0.997695440205429
HP_HYPOAUTOFLUORESCENT_RETIN...,SET,5,0.12527,0.0020659,0.45054,0.39049,HP_HYPOAUTOFLUORESCENT_RETINAL_LESION,0.997695440205429
GSE27786_CD8_TCELL_VS_MONO_M...1,SET,179,0.016807,0.0016506,0.060466,0.39052,GSE27786_CD8_TCELL_VS_MONO_MAC_DN,0.997695440205429
GOBP_NOREPINEPHRINE_BIOSYNTH...,SET,6,0.11043,0.001995,0.3973,0.39053,GOBP_NOREPINEPHRINE_BIOSYNTHETIC_PROCESS,0.997695440205429
MIR584_5P,SET,79,0.026224,0.0017156,0.094405,0.39059,MIR584_5P,0.997695440205429
chr8q13,SET,31,0.096677,0.0039671,0.34806,0.3906,chr8q13,0.997695440205429
RNTCANNRNNYNATTW_UNKNOWN,SET,58,0.031431,0.0017629,0.11319,0.39063,RNTCANNRNNYNATTW_UNKNOWN,0.997695440205429
GRAHAM_CML_QUIESCENT_VS_NORM...1,SET,9,0.090439,0.0020008,0.32587,0.39069,GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_DN,0.997695440205429
CACTTTG_MIR520G_MIR520H,SET,215,0.0167,0.0017956,0.060193,0.39072,CACTTTG_MIR520G_MIR520H,0.997695440205429
GOBP_STRESS_INDUCED_PREMATUR...,SET,7,0.073968,0.0014433,0.26663,0.39073,GOBP_STRESS_INDUCED_PREMATURE_SENESCENCE,0.997695440205429
GOBP_RESPONSE_TO_TOPOLOGICAL...,SET,144,0.019071,0.0016814,0.068753,0.39075,GOBP_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,0.997695440205429
KEGG_MEDICUS_PATHOGEN_HTLV_1...6,SET,8,0.08585,0.0017907,0.30976,0.39084,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00498,0.997695440205429
BIOCARTA_DC_PATHWAY,SET,16,0.066021,0.0019471,0.23837,0.3909,BIOCARTA_DC_PATHWAY,0.997695440205429
GOBP_MULTICELLULAR_ORGANISMA...4,SET,33,0.044443,0.0018815,0.16049,0.39092,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_WATER_HOMEOSTASIS,0.997695440205429
MODULE_262,SET,19,0.065343,0.0020999,0.23604,0.39096,MODULE_262,0.997695440205429
HP_ABNORMAL_METACARPAL_MORPH...,SET,196,0.016944,0.0017404,0.061261,0.39105,HP_ABNORMAL_METACARPAL_MORPHOLOGY,0.997695440205429
GSE13411_IGM_MEMORY_BCELL_VS...1,SET,174,0.017231,0.0016686,0.062302,0.39106,GSE13411_IGM_MEMORY_BCELL_VS_PLASMA_CELL_DN,0.997695440205429
HP_PROGRESSIVE_PROXIMAL_MUSC...,SET,21,0.050708,0.0017131,0.18338,0.39107,HP_PROGRESSIVE_PROXIMAL_MUSCLE_WEAKNESS,0.997695440205429
GOBP_NEGATIVE_REGULATION_OF_...533,SET,362,0.012427,0.0017268,0.044956,0.39111,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,0.997695440205429
GSE12392_WT_VS_IFNAR_KO_CD8A...2,SET,174,0.017428,0.0016877,0.063051,0.39112,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_UP,0.997695440205429
GOBP_VASCULAR_ENDOTHELIAL_CE...,SET,25,0.046482,0.0017132,0.1682,0.39114,GOBP_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,0.997695440205429
HP_ABNORMAL_ASTROCYTE_MORPHO...,SET,45,0.033977,0.0016792,0.12297,0.39116,HP_ABNORMAL_ASTROCYTE_MORPHOLOGY,0.997695440205429
GSE411_UNSTIM_VS_400MIN_IL6_...4,SET,188,0.016561,0.0016664,0.059937,0.39116,GSE411_UNSTIM_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_UP,0.997695440205429
GOBP_COGNITION,SET,291,0.014118,0.0017624,0.051105,0.39117,GOBP_COGNITION,0.997695440205429
HOFFMANN_PRE_BI_TO_LARGE_PRE...2,SET,26,0.043462,0.0016335,0.15739,0.39122,HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_UP,0.997695440205429
GSE22045_TREG_VS_TCONV_UP,SET,153,0.019135,0.0017386,0.069304,0.39123,GSE22045_TREG_VS_TCONV_UP,0.997695440205429
ZHAN_LATE_DIFFERENTIATION_GE...2,SET,29,0.044358,0.0017606,0.16067,0.39124,ZHAN_LATE_DIFFERENTIATION_GENES_UP,0.997695440205429
GOBP_PROLACTIN_SECRETION,SET,5,0.11628,0.0019176,0.42118,0.39125,GOBP_PROLACTIN_SECRETION,0.997695440205429
HP_3_METHYLGLUTACONIC_ACIDUR...,SET,17,0.055805,0.0016964,0.20214,0.39125,HP_3_METHYLGLUTACONIC_ACIDURIA,0.997695440205429
MIKKELSEN_MCV6_HCP_WITH_H3K2...,SET,412,0.012567,0.0018603,0.045528,0.39127,MIKKELSEN_MCV6_HCP_WITH_H3K27ME3,0.997695440205429
HP_MOLLUSCOID_PSEUDOTUMORS,SET,6,0.10883,0.0019661,0.39462,0.39136,HP_MOLLUSCOID_PSEUDOTUMORS,0.997804016285211
GOBP_NEURONAL_ACTION_POTENTI...1,SET,33,0.043303,0.0018333,0.15703,0.39137,GOBP_NEURONAL_ACTION_POTENTIAL,0.997804016285211
GOBP_DEOXYRIBONUCLEOSIDE_DIP...,SET,5,0.1025,0.0016904,0.37195,0.39144,GOBP_DEOXYRIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,0.997861577673464
GOBP_REGULATION_OF_CHOLESTER...4,SET,17,0.056667,0.0017226,0.20566,0.39145,GOBP_REGULATION_OF_CHOLESTEROL_STORAGE,0.997861577673464
GSE12198_LOW_IL2_STIM_NK_CEL...2,SET,184,0.016016,0.0015945,0.058207,0.3916,GSE12198_LOW_IL2_STIM_NK_CELL_VS_HIGH_IL2_STIM_NK_CELL_UP,0.997923906833663
GOBP_CENTRAL_NERVOUS_SYSTEM_...7,SET,163,0.020087,0.0018833,0.07304,0.39165,GOBP_CENTRAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,0.997923906833663
MCCABE_HOXC6_TARGETS_DN,SET,18,0.057621,0.0018024,0.20952,0.39166,MCCABE_HOXC6_TARGETS_DN,0.997923906833663
RIZ_ERYTHROID_DIFFERENTIATIO...4,SET,39,0.037478,0.0017246,0.13633,0.39169,RIZ_ERYTHROID_DIFFERENTIATION_CCNE1,0.997923906833663
MODULE_191,SET,19,0.063703,0.0020472,0.23187,0.39176,MODULE_191,0.997923906833663
HP_ABNORMAL_PUBIC_BONE_MORPH...,SET,39,0.037666,0.0017332,0.13712,0.39177,HP_ABNORMAL_PUBIC_BONE_MORPHOLOGY,0.997923906833663
KEGG_MEDICUS_REFERENCE_CXCR4...5,SET,26,0.047501,0.0017853,0.17295,0.3918,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_RAC_SIGNALING_PATHWAY,0.997923906833663
chr3q21,SET,62,0.049169,0.002851,0.17908,0.39183,chr3q21,0.997923906833663
GSE43955_1H_VS_10H_ACT_CD4_T...3,SET,182,0.017096,0.0016928,0.062291,0.39187,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,0.997923906833663
AMIT_EGF_RESPONSE_20_MCF10A,SET,11,0.06732,0.0016464,0.24533,0.39189,AMIT_EGF_RESPONSE_20_MCF10A,0.997923906833663
GSE45365_HEALTHY_VS_MCMV_INF...7,SET,181,0.017192,0.0016977,0.062654,0.39189,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_DN,0.997923906833663
GSE8621_UNSTIM_VS_LPS_PRIMED...3,SET,179,0.016228,0.0015937,0.059167,0.39193,GSE8621_UNSTIM_VS_LPS_PRIMED_UNSTIM_MACROPHAGE_DN,0.997923906833663
MIR1915_5P,SET,42,0.038355,0.0018314,0.13986,0.39195,MIR1915_5P,0.997923906833663
GSE41867_DAY6_VS_DAY15_LCMV_...1,SET,169,0.017193,0.0016411,0.062694,0.39195,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,0.997923906833663
chr15q26,SET,67,0.056402,0.0033992,0.2057,0.39197,chr15q26,0.997923906833663
GOBP_PYRIMIDINE_RIBONUCLEOTI...1,SET,21,0.04961,0.001676,0.18095,0.39198,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,0.997923906833663
KEGG_MEDICUS_REFERENCE_TRANS...1,SET,11,0.06778,0.0016577,0.2473,0.39201,KEGG_MEDICUS_REFERENCE_TRANSCRIPTIONAL_ACTIVATION_BY_ACETYLATION_OF_H3K27,0.997923906833663
GOCC_PARANODAL_JUNCTION,SET,8,0.07488,0.0015619,0.27318,0.39201,GOCC_PARANODAL_JUNCTION,0.997923906833663
GSE9006_TYPE_1_DIABETES_AT_D...2,SET,182,0.016309,0.0016149,0.059511,0.39202,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP,0.997923906833663
HP_INTERMITTENT_EPISODES_OF_...,SET,13,0.071558,0.0019024,0.26124,0.39208,HP_INTERMITTENT_EPISODES_OF_RESPIRATORY_INSUFFICIENCY_DUE_TO_MUSCLE_WEAKNESS,0.997959182776801
GOBP_POSITIVE_REGULATION_OF_...446,SET,17,0.057966,0.0017621,0.21169,0.39211,GOBP_POSITIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,0.997959182776801
GSE18893_TCONV_VS_TREG_24H_C...2,SET,189,0.017112,0.0017263,0.062495,0.39212,GSE18893_TCONV_VS_TREG_24H_CULTURE_UP,0.997959182776801
FUNG_IL2_TARGETS_WITH_STAT5_...2,SET,9,0.084755,0.0018751,0.30968,0.39216,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES_T1,0.99796572704642
HP_MENINGITIS,SET,65,0.02979,0.0017685,0.10886,0.39218,HP_MENINGITIS,0.99796572704642
GSE32901_NAIVE_VS_TH1_CD4_TC...1,SET,152,0.018774,0.0017003,0.068625,0.39221,GSE32901_NAIVE_VS_TH1_CD4_TCELL_DN,0.997968998462552
CHENG_TAF7L_TARGETS,SET,4,0.10604,0.0015643,0.38775,0.39224,CHENG_TAF7L_TARGETS,0.997972269399707
LEE_CALORIE_RESTRICTION_NEOC...1,SET,60,0.028034,0.0015992,0.10259,0.39233,LEE_CALORIE_RESTRICTION_NEOCORTEX_DN,0.998070175310446
PID_EPO_PATHWAY,SET,31,0.041378,0.0016979,0.15159,0.39244,PID_EPO_PATHWAY,0.998070175310446
HP_LONG_FINGERS,SET,246,0.014306,0.0016439,0.05241,0.39245,HP_LONG_FINGERS,0.998070175310446
REACTOME_IFNG_SIGNALING_ACTI...,SET,8,0.084791,0.0017686,0.31087,0.39252,REACTOME_IFNG_SIGNALING_ACTIVATES_MAPKS,0.998070175310446
GSE17721_CTRL_VS_LPS_4H_BMDC...1,SET,181,0.016955,0.0016742,0.062159,0.39252,GSE17721_CTRL_VS_LPS_4H_BMDC_DN,0.998070175310446
GSE15930_NAIVE_VS_48H_IN_VIT...2,SET,182,0.017419,0.0017248,0.063866,0.39253,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_UP,0.998070175310446
GSE3982_BCELL_VS_TH1_DN,SET,176,0.01756,0.0017101,0.064404,0.39256,GSE3982_BCELL_VS_TH1_DN,0.998070175310446
REACTOME_PKA_ACTIVATION_IN_G...,SET,17,0.057019,0.0017333,0.20917,0.39258,REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING,0.998070175310446
GOBP_POSITIVE_REGULATION_OF_...470,SET,34,0.037807,0.0016246,0.13872,0.3926,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,0.998070175310446
HP_PERIVENTRICULAR_LEUKOMALA...,SET,38,0.034769,0.0015793,0.12765,0.39267,HP_PERIVENTRICULAR_LEUKOMALACIA,0.998070175310446
GOMF_PHOSPHATIDYLINOSITOL_4_...2,SET,75,0.026976,0.0017197,0.09905,0.39268,GOMF_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_BINDING,0.998070175310446
HP_REFLEX_SEIZURE,SET,19,0.053939,0.0017334,0.19826,0.39279,HP_REFLEX_SEIZURE,0.998070175310446
GSE17721_PAM3CSK4_VS_CPG_4H_...2,SET,177,0.016523,0.0016137,0.060749,0.39282,GSE17721_PAM3CSK4_VS_CPG_4H_BMDC_UP,0.998070175310446
GOBP_PERICYTE_CELL_DIFFERENT...,SET,10,0.07396,0.0017247,0.27201,0.39285,GOBP_PERICYTE_CELL_DIFFERENTIATION,0.998070175310446
GOCC_MON1_CCZ1_COMPLEX,SET,4,0.11446,0.0016884,0.421,0.39286,GOCC_MON1_CCZ1_COMPLEX,0.998070175310446
WU_ALZHEIMER_DISEASE_DN,SET,17,0.05687,0.0017288,0.2092,0.39287,WU_ALZHEIMER_DISEASE_DN,0.998070175310446
MIR4650_3P,SET,119,0.021383,0.001715,0.078676,0.39289,MIR4650_3P,0.998070175310446
BIOCARTA_MRP_PATHWAY,SET,6,0.10507,0.0018981,0.38668,0.39292,BIOCARTA_MRP_PATHWAY,0.998070175310446
SMID_BREAST_CANCER_LUMINAL_A...1,SET,16,0.05463,0.0016112,0.20107,0.39293,SMID_BREAST_CANCER_LUMINAL_A_DN,0.998070175310446
YY1_Q6,SET,221,0.015232,0.0016602,0.056065,0.39294,YY1_Q6,0.998070175310446
MIR378B,SET,37,0.034962,0.0015671,0.12872,0.39296,MIR378B,0.998070175310446
REACTOME_REGULATION_OF_HMOX1...,SET,5,0.096234,0.0015871,0.35461,0.39305,REACTOME_REGULATION_OF_HMOX1_EXPRESSION_AND_ACTIVITY,0.998070175310446
GSE37416_CTRL_VS_48H_F_TULAR...1,SET,168,0.016301,0.0015514,0.06007,0.39305,GSE37416_CTRL_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,0.998070175310446
JIANG_MELANOMA_TRM2_CD8,SET,127,0.022059,0.0018274,0.081305,0.39308,JIANG_MELANOMA_TRM2_CD8,0.998070175310446
MORF_LMO1,SET,48,0.03388,0.0017292,0.1249,0.39309,MORF_LMO1,0.998070175310446
GSE17301_CTRL_VS_48H_ACD3_AC...6,SET,177,0.017058,0.0016659,0.06288,0.39309,GSE17301_CTRL_VS_48H_ACD3_ACD28_STIM_CD8_TCELL_UP,0.998070175310446
HP_LEFT_VENTRICULAR_NONCOMPA...,SET,9,0.086024,0.0019031,0.31718,0.39311,HP_LEFT_VENTRICULAR_NONCOMPACTION_CARDIOMYOPATHY,0.998070175310446
WP_PHOTODYNAMIC_THERAPYINDUC...2,SET,34,0.039567,0.0017003,0.1459,0.39312,WP_PHOTODYNAMIC_THERAPYINDUCED_HIF1_SURVIVAL_SIGNALING,0.998070175310446
GSE17721_LPS_VS_CPG_2H_BMDC_...2,SET,183,0.017107,0.0016985,0.063086,0.39313,GSE17721_LPS_VS_CPG_2H_BMDC_UP,0.998070175310446
WP_ESTROGEN_RECEPTOR_PATHWAY,SET,13,0.068485,0.0018208,0.25256,0.39314,WP_ESTROGEN_RECEPTOR_PATHWAY,0.998070175310446
HP_FETAL_NECK_ANOMALY,SET,92,0.023988,0.0016929,0.088497,0.39317,HP_FETAL_NECK_ANOMALY,0.998070899759773
GOBP_RESPONSE_TO_ACTINOMYCIN...,SET,5,0.097154,0.0016022,0.35868,0.39325,GOBP_RESPONSE_TO_ACTINOMYCIN_D,0.998070899759773
DAZARD_RESPONSE_TO_UV_SCC_DN,SET,110,0.021848,0.0016852,0.080704,0.3933,DAZARD_RESPONSE_TO_UV_SCC_DN,0.998070899759773
GOBP_DIET_INDUCED_THERMOGENE...,SET,13,0.065777,0.0017488,0.24316,0.39339,GOBP_DIET_INDUCED_THERMOGENESIS,0.998070899759773
GAVISH_3CA_METAPROGRAM_FIBRO...16,SET,46,0.036392,0.0018183,0.13456,0.39341,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_METAL_RESPONSE,0.998070899759773
REACTOME_SEMA4D_IN_SEMAPHORI...,SET,24,0.04648,0.0016785,0.17194,0.39345,REACTOME_SEMA4D_IN_SEMAPHORIN_SIGNALING,0.998070899759773
GALI_TP53_TARGETS_APOPTOTIC_...2,SET,8,0.08831,0.001842,0.32674,0.39348,GALI_TP53_TARGETS_APOPTOTIC_UP,0.998070899759773
WP_ANGIOGENESIS,SET,24,0.048288,0.0017438,0.17867,0.39348,WP_ANGIOGENESIS,0.998070899759773
GSE22103_UNSTIM_VS_GMCSF_AND...2,SET,185,0.01608,0.0016052,0.059498,0.39348,GSE22103_UNSTIM_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,0.998070899759773
chr4q23,SET,18,0.084515,0.0026436,0.31287,0.39353,chr4q23,0.998070899759773
GOBP_REGULATION_OF_AUTOPHAGY...1,SET,39,0.035299,0.0016243,0.13076,0.3936,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,0.998070899759773
GOBP_NEGATIVE_REGULATION_OF_...646,SET,6,0.10322,0.0018648,0.38252,0.39364,GOBP_NEGATIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,0.998070899759773
MIR4483,SET,85,0.025603,0.0017371,0.09496,0.39373,MIR4483,0.998070899759773
HP_RETINAL_HOLE,SET,5,0.10197,0.0016817,0.37837,0.39377,HP_RETINAL_HOLE,0.998070899759773
GOBP_CITRULLINE_BIOSYNTHETIC...,SET,4,0.11735,0.0017311,0.43549,0.39378,GOBP_CITRULLINE_BIOSYNTHETIC_PROCESS,0.998070899759773
WORSCHECH_TUMOR_REJECTION_DN,SET,8,0.077705,0.0016208,0.28838,0.39379,WORSCHECH_TUMOR_REJECTION_DN,0.998070899759773
GOBP_POSITIVE_REGULATION_OF_...183,SET,6,0.089424,0.0016155,0.33187,0.39379,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,0.998070899759773
HP_INCREASED_INTRAMYOCELLULA...,SET,18,0.054347,0.0017,0.20171,0.3938,HP_INCREASED_INTRAMYOCELLULAR_LIPID_DROPLETS,0.998070899759773
GOBP_GLOMERULAR_EPITHELIAL_C...,SET,12,0.070772,0.0018078,0.26275,0.39383,GOBP_GLOMERULAR_EPITHELIAL_CELL_DEVELOPMENT,0.998070899759773
GSE22527_ANTI_CD3_INVIVO_VS_...2,SET,176,0.017299,0.0016847,0.064224,0.39383,GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_UP,0.998070899759773
GOMF_SEROTONIN_BINDING,SET,10,0.075966,0.0017715,0.2821,0.39386,GOMF_SEROTONIN_BINDING,0.998070899759773
MIR3907,SET,49,0.033226,0.0017133,0.12342,0.39389,MIR3907,0.998070899759773
GSE17721_POLYIC_VS_PAM3CSK4_...6,SET,187,0.016099,0.0016156,0.059809,0.3939,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_UP,0.998070899759773
MORF_PDCD1,SET,64,0.029506,0.0017382,0.10968,0.39396,MORF_PDCD1,0.998070899759773
GOBP_LYTIC_VACUOLE_ORGANIZAT...,SET,98,0.022458,0.0016355,0.083479,0.39396,GOBP_LYTIC_VACUOLE_ORGANIZATION,0.998070899759773
GSE40274_CTRL_VS_GATA1_TRANS...2,SET,128,0.019581,0.0016284,0.072826,0.39401,GSE40274_CTRL_VS_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,0.998070899759773
GOMF_HYDROLASE_ACTIVITY_HYDR...1,SET,37,0.041108,0.0018426,0.15289,0.39402,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_N_GLYCOSYL_COMPOUNDS,0.998070899759773
GSE3982_DC_VS_MAC_UP,SET,174,0.016853,0.001632,0.062692,0.39404,GSE3982_DC_VS_MAC_UP,0.998070899759773
VERRECCHIA_RESPONSE_TO_TGFB1...5,SET,20,0.05251,0.0017313,0.1954,0.39407,VERRECCHIA_RESPONSE_TO_TGFB1_C5,0.998070899759773
ZNF595_TARGET_GENES,SET,99,0.022473,0.0016449,0.083623,0.39407,ZNF595_TARGET_GENES,0.998070899759773
HP_ABSENCE_OF_RENAL_CORTICOM...,SET,6,0.10802,0.0019514,0.40198,0.39408,HP_ABSENCE_OF_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,0.998070899759773
KEGG_MEDICUS_REFERENCE_TLR3_...2,SET,16,0.069551,0.0020512,0.2589,0.39411,KEGG_MEDICUS_REFERENCE_TLR3_IRF7_SIGNALING_PATHWAY,0.998070899759773
HP_DELUSION,SET,28,0.044193,0.0017236,0.1646,0.39416,HP_DELUSION,0.998070899759773
GOBP_DNA_METABOLIC_PROCESS,SET,870,0.0074486,0.0015818,0.027753,0.3942,GOBP_DNA_METABOLIC_PROCESS,0.998070899759773
LOPEZ_MESOTHELIOMA_SURVIVAL_...3,SET,7,0.088175,0.0017205,0.32855,0.39421,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_UP,0.998070899759773
BOYAULT_LIVER_CANCER_SUBCLAS...11,SET,177,0.016386,0.0016002,0.061072,0.39424,BOYAULT_LIVER_CANCER_SUBCLASS_G3_UP,0.998070899759773
GSE42724_NAIVE_VS_B1_BCELL_DN,SET,170,0.016451,0.0015749,0.061338,0.39427,GSE42724_NAIVE_VS_B1_BCELL_DN,0.998070899759773
MIR603,SET,150,0.01861,0.0016744,0.069408,0.3943,MIR603,0.998070899759773
GOBP_LIVER_REGENERATION,SET,30,0.040877,0.0016501,0.15249,0.39433,GOBP_LIVER_REGENERATION,0.998070899759773
HP_FINE_HAIR,SET,69,0.026719,0.001634,0.099691,0.39435,HP_FINE_HAIR,0.998070899759773
GOMF_PROSTAGLANDIN_E_RECEPTO...,SET,5,0.11628,0.0019177,0.43404,0.39439,GOMF_PROSTAGLANDIN_E_RECEPTOR_ACTIVITY,0.998070899759773
GSE10325_BCELL_VS_LUPUS_BCEL...1,SET,186,0.01652,0.0016535,0.061666,0.39439,GSE10325_BCELL_VS_LUPUS_BCELL_DN,0.998070899759773
GSE46606_UNSTIM_VS_CD40L_IL2...10,SET,187,0.015807,0.0015863,0.059026,0.39443,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,0.998070899759773
MIR5692B_MIR5692C,SET,373,0.012371,0.0017444,0.0462,0.39444,MIR5692B_MIR5692C,0.998070899759773
GSE19888_CTRL_VS_A3R_ACT_TRE...1,SET,178,0.016615,0.0016272,0.062069,0.39447,GSE19888_CTRL_VS_A3R_ACT_TREATED_MAST_CELL_PRETREATED_WITH_A3R_INH_DN,0.998070899759773
GOBP_TYPE_2_IMMUNE_RESPONSE,SET,42,0.037615,0.0017961,0.14054,0.39449,GOBP_TYPE_2_IMMUNE_RESPONSE,0.998070899759773
HP_ABNORMALITY_OF_THE_FIRST_...,SET,11,0.067776,0.0016576,0.25324,0.39449,HP_ABNORMALITY_OF_THE_FIRST_METATARSAL_BONE,0.998070899759773
GOBP_CYTOCHROME_METABOLIC_PR...,SET,5,0.11086,0.0018283,0.41477,0.39463,GOBP_CYTOCHROME_METABOLIC_PROCESS,0.998092307692308
GSE39152_BRAIN_VS_SPLEEN_CD1...2,SET,179,0.016996,0.0016691,0.063593,0.39464,GSE39152_BRAIN_VS_SPLEEN_CD103_NEG_MEMORY_CD8_TCELL_UP,0.998092307692308
GOCC_EMC_COMPLEX,SET,8,0.075869,0.0015825,0.28395,0.39466,GOCC_EMC_COMPLEX,0.998092307692308
NFY_C,SET,212,0.015724,0.001679,0.058869,0.3947,NFY_C,0.998092307692308
GOCC_PROTEIN_KINASE_COMPLEX,SET,135,0.018052,0.0015414,0.067594,0.39471,GOCC_PROTEIN_KINASE_COMPLEX,0.998092307692308
HLF_01,SET,228,0.015183,0.0016806,0.056853,0.39472,HLF_01,0.998092307692308
KANG_CISPLATIN_RESISTANCE_UP,SET,18,0.052415,0.0016395,0.19632,0.39474,KANG_CISPLATIN_RESISTANCE_UP,0.998092307692308
HP_CHOANAL_ATRESIA,SET,107,0.020989,0.0015968,0.078613,0.39474,HP_CHOANAL_ATRESIA,0.998092307692308
GOBP_HEMATOPOIETIC_STEM_CELL...3,SET,9,0.071538,0.0015827,0.26809,0.3948,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...407,SET,13,0.064638,0.0017185,0.24234,0.39484,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,0.998092307692308
GSE26290_CTRL_VS_AKT_INHIBIT...1,SET,181,0.017162,0.0016948,0.064349,0.39485,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,0.998092307692308
GSE10325_CD4_TCELL_VS_BCELL_...2,SET,175,0.017644,0.0017135,0.066249,0.39499,GSE10325_CD4_TCELL_VS_BCELL_UP,0.998092307692308
GOBP_SOMATIC_DIVERSIFICATION...2,SET,13,0.052499,0.0013957,0.19722,0.39504,GOBP_SOMATIC_DIVERSIFICATION_OF_IMMUNE_RECEPTORS_VIA_SOMATIC_MUTATION,0.998092307692308
KEGG_MEDICUS_REFERENCE_TLR7_...2,SET,15,0.069577,0.0019869,0.26162,0.39514,KEGG_MEDICUS_REFERENCE_TLR7_9_IRF7_SIGNALING_PATHWAY,0.998092307692308
HP_ADRENAL_HYPERPLASIA,SET,23,0.049303,0.001743,0.18539,0.39514,HP_ADRENAL_HYPERPLASIA,0.998092307692308
HP_INTERMEDIATE_YOUNG_ADULT_...,SET,19,0.049146,0.0015793,0.18487,0.39518,HP_INTERMEDIATE_YOUNG_ADULT_ONSET,0.998092307692308
HP_IMPAIRED_TANDEM_GAIT,SET,9,0.08682,0.0019208,0.32663,0.3952,HP_IMPAIRED_TANDEM_GAIT,0.998092307692308
GSE2405_0H_VS_1.5H_A_PHAGOCY...1,SET,181,0.015424,0.0015231,0.058043,0.39522,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,0.998092307692308
YAGI_AML_WITH_T_8_21_TRANSLO...,SET,326,0.012542,0.0016555,0.047202,0.39523,YAGI_AML_WITH_T_8_21_TRANSLOCATION,0.998092307692308
GOBP_PHAGOCYTOSIS_RECOGNITION,SET,27,0.048008,0.0018387,0.18069,0.39524,GOBP_PHAGOCYTOSIS_RECOGNITION,0.998092307692308
GOBP_CHAPERONE_MEDIATED_PROT...2,SET,72,0.024405,0.0015245,0.091874,0.39526,GOBP_CHAPERONE_MEDIATED_PROTEIN_FOLDING,0.998092307692308
HP_LOWER_EXTREMITY_JOINT_DIS...,SET,271,0.013545,0.0016325,0.051007,0.3953,HP_LOWER_EXTREMITY_JOINT_DISLOCATION,0.998092307692308
GOMF_CARBOXYLESTERASE_ACTIVI...,SET,6,0.094539,0.0017079,0.35608,0.39531,GOMF_CARBOXYLESTERASE_ACTIVITY,0.998092307692308
GOBP_ENDOCRINE_HORMONE_SECRE...,SET,54,0.032782,0.0017743,0.12356,0.39539,GOBP_ENDOCRINE_HORMONE_SECRETION,0.998092307692308
GSE22935_WT_VS_MYD88_KO_MACR...8,SET,181,0.017038,0.0016825,0.064242,0.39542,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_UP,0.998092307692308
HP_ABNORMAL_EPIGLOTTIS_MORPH...,SET,20,0.049414,0.0016292,0.18633,0.39543,HP_ABNORMAL_EPIGLOTTIS_MORPHOLOGY,0.998092307692308
GOBP_CARTILAGE_CONDENSATION,SET,18,0.058224,0.0018212,0.21957,0.39544,GOBP_CARTILAGE_CONDENSATION,0.998092307692308
BIOCARTA_NFKB_PATHWAY,SET,20,0.05254,0.0017322,0.19815,0.39545,BIOCARTA_NFKB_PATHWAY,0.998092307692308
HALLMARK_INFLAMMATORY_RESPON...,SET,190,0.017507,0.0017708,0.066061,0.3955,HALLMARK_INFLAMMATORY_RESPONSE,0.998092307692308
GOBP_MODULATION_BY_SYMBIONT_...,SET,53,0.033011,0.0017702,0.12467,0.39558,GOBP_MODULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...43,SET,8,0.078761,0.0016429,0.29751,0.39561,GOBP_POSITIVE_REGULATION_OF_ATP_BIOSYNTHETIC_PROCESS,0.998092307692308
HP_BOWED_HUMERUS,SET,7,0.081947,0.001599,0.30958,0.39562,HP_BOWED_HUMERUS,0.998092307692308
MIR3150B_3P,SET,137,0.018867,0.0016228,0.071319,0.39568,MIR3150B_3P,0.998092307692308
GSE27786_CD4_VS_CD8_TCELL_UP,SET,188,0.016077,0.0016177,0.060776,0.39569,GSE27786_CD4_VS_CD8_TCELL_UP,0.998092307692308
GOBP_CD8_POSITIVE_ALPHA_BETA...3,SET,7,0.087204,0.0017015,0.3297,0.3957,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_PROLIFERATION,0.998092307692308
MCCLUNG_COCAIN_REWARD_4WK,SET,68,0.027751,0.0016849,0.10495,0.39573,MCCLUNG_COCAIN_REWARD_4WK,0.998092307692308
MCGOWAN_RSP6_TARGETS_DN,SET,4,0.11178,0.0016489,0.42274,0.39573,MCGOWAN_RSP6_TARGETS_DN,0.998092307692308
MODULE_519,SET,15,0.059035,0.0016858,0.22329,0.39574,MODULE_519,0.998092307692308
DACOSTA_UV_RESPONSE_VIA_ERCC...1,SET,436,0.010856,0.001652,0.041062,0.39575,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN,0.998092307692308
HP_ENURESIS_NOCTURNA,SET,10,0.072255,0.0016849,0.27332,0.39576,HP_ENURESIS_NOCTURNA,0.998092307692308
HP_DILATATED_INTERNAL_AUDITO...,SET,3,0.16305,0.002083,0.61738,0.39585,HP_DILATATED_INTERNAL_AUDITORY_CANAL,0.998092307692308
GSE8515_IL1_VS_IL6_4H_STIM_M...2,SET,177,0.01688,0.0016486,0.063927,0.39587,GSE8515_IL1_VS_IL6_4H_STIM_MAC_UP,0.998092307692308
MIR4453,SET,24,0.050221,0.0018136,0.19037,0.39597,MIR4453,0.998092307692308
MODULE_238,SET,141,0.019,0.0016578,0.072056,0.39601,MODULE_238,0.998092307692308
YU_MYC_TARGETS_UP,SET,41,0.033861,0.0015975,0.12848,0.39606,YU_MYC_TARGETS_UP,0.998092307692308
HP_KERATAN_SULFATE_EXCRETION...,SET,5,0.095845,0.0015806,0.3637,0.39607,HP_KERATAN_SULFATE_EXCRETION_IN_URINE,0.998092307692308
HP_KNEE_DISLOCATION,SET,13,0.05901,0.0015688,0.22392,0.39607,HP_KNEE_DISLOCATION,0.998092307692308
WP_NEPHROTIC_SYNDROME,SET,42,0.035004,0.0016714,0.13285,0.39609,WP_NEPHROTIC_SYNDROME,0.998092307692308
REACTOME_ROLE_OF_PHOSPHOLIPI...,SET,23,0.045998,0.0016262,0.17459,0.3961,REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...542,SET,16,0.065096,0.0019198,0.24725,0.39617,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,0.998092307692308
HP_POLYMORPHIC_VENTRICULAR_T...,SET,6,0.10636,0.0019215,0.40399,0.39617,HP_POLYMORPHIC_VENTRICULAR_TACHYCARDIA,0.998092307692308
CAGNYGKNAAA_UNKNOWN,SET,70,0.027241,0.001678,0.1035,0.3962,CAGNYGKNAAA_UNKNOWN,0.998092307692308
PID_PDGFRB_PATHWAY,SET,124,0.0198,0.0016208,0.075232,0.39621,PID_PDGFRB_PATHWAY,0.998092307692308
REACTOME_APOBEC3G_MEDIATED_R...,SET,5,0.097635,0.0016102,0.37112,0.39624,REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV_1_INFECTION,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...215,SET,5,0.096396,0.0015897,0.36642,0.39625,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_TRANSCRIPTION_OF_P21_CLASS_MEDIATOR,0.998092307692308
GOMF_LNCRNA_BINDING,SET,17,0.048221,0.0014659,0.1833,0.39625,GOMF_LNCRNA_BINDING,0.998092307692308
GOBP_CD4_POSITIVE_ALPHA_BETA...2,SET,19,0.05265,0.001692,0.2002,0.39628,GOBP_CD4_POSITIVE_ALPHA_BETA_T_CELL_CYTOKINE_PRODUCTION,0.998092307692308
MIR19A_5P,SET,161,0.018373,0.001712,0.069879,0.39631,MIR19A_5P,0.998092307692308
REACTOME_ABC_TRANSPORTER_DIS...,SET,74,0.023896,0.0015133,0.090898,0.39632,REACTOME_ABC_TRANSPORTER_DISORDERS,0.998092307692308
GOBP_POSTSYNAPTIC_SPECIALIZA...2,SET,45,0.034291,0.0016947,0.13048,0.39635,GOBP_POSTSYNAPTIC_SPECIALIZATION_ORGANIZATION,0.998092307692308
GOBP_RESPONSE_TO_REACTIVE_OX...,SET,180,0.017164,0.0016902,0.065325,0.39638,GOBP_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,0.998092307692308
HP_ABNORMALITY_OF_CHROMOSOME...1,SET,13,0.066849,0.0017773,0.25445,0.39638,HP_ABNORMALITY_OF_CHROMOSOME_SEGREGATION,0.998092307692308
WEI_MYCN_TARGETS_WITH_E_BOX,SET,723,0.0081111,0.0015768,0.030881,0.39641,WEI_MYCN_TARGETS_WITH_E_BOX,0.998092307692308
GOBP_ELASTIN_CATABOLIC_PROCE...,SET,4,0.12803,0.0018885,0.48764,0.39645,GOBP_ELASTIN_CATABOLIC_PROCESS,0.998092307692308
GSE24210_IL35_TREATED_VS_RES...2,SET,178,0.017329,0.0016971,0.066024,0.39648,GSE24210_IL35_TREATED_VS_RESTING_TREG_UP,0.998092307692308
INGRAM_SHH_TARGETS_UP,SET,113,0.022483,0.0017575,0.085692,0.39652,INGRAM_SHH_TARGETS_UP,0.998092307692308
CHANDRAN_METASTASIS_TOP50_DN,SET,35,0.038664,0.0016856,0.14744,0.39657,CHANDRAN_METASTASIS_TOP50_DN,0.998092307692308
HP_REDUCED_SOCIAL_RECIPROCITY,SET,52,0.028886,0.0015343,0.11016,0.39658,HP_REDUCED_SOCIAL_RECIPROCITY,0.998092307692308
GOBP_GOLGI_ORGANIZATION,SET,136,0.01789,0.0015332,0.068247,0.39661,GOBP_GOLGI_ORGANIZATION,0.998092307692308
GOBP_RELEASE_OF_CYTOCHROME_C...,SET,52,0.03174,0.0016859,0.12111,0.39664,GOBP_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,0.998092307692308
REACTOME_DAP12_SIGNALING,SET,27,0.040405,0.0015475,0.15421,0.39666,REACTOME_DAP12_SIGNALING,0.998092307692308
HP_ABNORMALITY_OF_THE_LEYDIG...,SET,12,0.062939,0.0016077,0.24023,0.39666,HP_ABNORMALITY_OF_THE_LEYDIG_CELLS,0.998092307692308
LEE_LIVER_CANCER_MYC_TGFA_DN,SET,57,0.030744,0.0017095,0.11738,0.39669,LEE_LIVER_CANCER_MYC_TGFA_DN,0.998092307692308
PICCALUGA_ANGIOIMMUNOBLASTIC...1,SET,117,0.021672,0.0017236,0.082764,0.39672,PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN,0.998092307692308
HP_APLASIA_HYPOPLASIA_OF_THE...25,SET,7,0.094679,0.0018474,0.36169,0.39675,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,0.998092307692308
WP_WNTBETACATENIN_SIGNALING_...2,SET,25,0.047371,0.0017459,0.18116,0.39686,WP_WNTBETACATENIN_SIGNALING_IN_LEUKEMIA,0.998092307692308
GOBP_PHOSPHATIDYLETHANOLAMIN...2,SET,9,0.077388,0.0017121,0.29606,0.39689,GOBP_PHOSPHATIDYLETHANOLAMINE_BIOSYNTHETIC_PROCESS,0.998092307692308
AP2_Q6_01,SET,248,0.013777,0.0015896,0.052729,0.39694,AP2_Q6_01,0.998092307692308
CMYB_01,SET,232,0.014298,0.0015963,0.054761,0.39701,CMYB_01,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...574,SET,106,0.021919,0.0016598,0.083953,0.39701,GOBP_POSITIVE_REGULATION_OF_PEPTIDE_SECRETION,0.998092307692308
ZNF250_TARGET_GENES,SET,444,0.010373,0.0015927,0.039755,0.39707,ZNF250_TARGET_GENES,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...64,SET,2,0.12296,0.0012826,0.47136,0.3971,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_REMODELING,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...294,SET,5,0.093823,0.0015473,0.35968,0.3971,GOBP_POSITIVE_REGULATION_OF_GASTRO_INTESTINAL_SYSTEM_SMOOTH_MUSCLE_CONTRACTION,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...414,SET,82,0.02492,0.0016609,0.095532,0.3971,GOBP_POSITIVE_REGULATION_OF_LIPID_TRANSPORT,0.998092307692308
PXR_Q2,SET,241,0.014384,0.0016363,0.055162,0.39714,PXR_Q2,0.998092307692308
GOMF_HYDROLASE_ACTIVITY_ACTI...2,SET,128,0.019576,0.001628,0.075104,0.39718,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS,0.998092307692308
HP_ABNORMAL_DENTAL_MORPHOLOGY,SET,255,0.013995,0.001637,0.053706,0.3972,HP_ABNORMAL_DENTAL_MORPHOLOGY,0.998092307692308
HP_ABNORMAL_MORPHOLOGY_OF_MU...,SET,4,0.09421,0.0013897,0.36152,0.3972,HP_ABNORMAL_MORPHOLOGY_OF_MUSCULATURE_OF_PHARYNX,0.998092307692308
HP_ABNORMAL_VOCAL_CORD_MORPH...,SET,4,0.09421,0.0013897,0.36152,0.3972,HP_ABNORMAL_VOCAL_CORD_MORPHOLOGY,0.998092307692308
GOBP_EPITHELIAL_CELL_DIFFERE...3,SET,10,0.078476,0.00183,0.30135,0.39727,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,0.998092307692308
GOCC_SEX_CHROMOSOME,SET,26,0.040132,0.0015084,0.1541,0.39727,GOCC_SEX_CHROMOSOME,0.998092307692308
MIR519E_3P,SET,60,0.028485,0.0016249,0.10939,0.39728,MIR519E_3P,0.998092307692308
GSE339_EX_VIVO_VS_IN_CULTURE...3,SET,180,0.016257,0.0016009,0.062443,0.3973,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_DN,0.998092307692308
DESCARTES_FETAL_THYMUS_ANTIG...,SET,152,0.019066,0.0017267,0.073229,0.3973,DESCARTES_FETAL_THYMUS_ANTIGEN_PRESENTING_CELLS,0.998092307692308
REACTOME_CHREBP_ACTIVATES_ME...,SET,8,0.067481,0.0014076,0.25924,0.39732,REACTOME_CHREBP_ACTIVATES_METABOLIC_GENE_EXPRESSION,0.998092307692308
SRY_02,SET,229,0.015296,0.0016967,0.058768,0.39733,SRY_02,0.998092307692308
GOBP_REGULATION_OF_MICROTUBU...7,SET,56,0.02749,0.0015151,0.10565,0.39736,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION,0.998092307692308
MIR890,SET,88,0.024048,0.00166,0.092444,0.39738,MIR890,0.998092307692308
GOBP_POSITIVE_REGULATION_OF_...342,SET,136,0.019566,0.0016768,0.075219,0.39739,GOBP_POSITIVE_REGULATION_OF_HORMONE_SECRETION,0.998092307692308
REACTOME_RIP_MEDIATED_NFKB_A...,SET,16,0.056709,0.0016725,0.21805,0.39741,REACTOME_RIP_MEDIATED_NFKB_ACTIVATION_VIA_ZBP1,0.998092307692308
REACTOME_CELLULAR_RESPONSE_T...3,SET,70,0.023876,0.0014707,0.091834,0.39744,REACTOME_CELLULAR_RESPONSE_TO_HYPOXIA,0.998092307692308
MIR3659,SET,73,0.026003,0.0016355,0.10005,0.39747,MIR3659,0.998092307692308
GSE27786_NEUTROPHIL_VS_MONO_...1,SET,179,0.015593,0.0015313,0.060004,0.39749,GSE27786_NEUTROPHIL_VS_MONO_MAC_DN,0.998092307692308
GSE11924_TFH_VS_TH17_CD4_TCE...1,SET,180,0.015856,0.0015614,0.06103,0.39751,GSE11924_TFH_VS_TH17_CD4_TCELL_DN,0.998092307692308
MORF_CDK2,SET,67,0.023871,0.0014387,0.091918,0.39755,MORF_CDK2,0.998092307692308
GOBP_CELLULAR_RESPONSE_TO_NI...4,SET,6,0.079019,0.0014275,0.30429,0.39756,GOBP_CELLULAR_RESPONSE_TO_NITROSATIVE_STRESS,0.998092307692308
MIR10396B_5P,SET,19,0.052526,0.001688,0.20235,0.3976,MIR10396B_5P,0.998092307692308
GSE24574_BCL6_LOW_TFH_VS_NAI...1,SET,171,0.017299,0.0016608,0.066646,0.3976,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_DN,0.998092307692308
CTTTGA_LEF1_Q2,SET,1088,0.0072067,0.0017007,0.027792,0.3977,CTTTGA_LEF1_Q2,0.998155368618673
KEGG_MEDICUS_REFERENCE_LOADI...,SET,7,0.073535,0.0014348,0.28367,0.39773,KEGG_MEDICUS_REFERENCE_LOADING_OF_THE_SMC5_SMC6_COMPLEX,0.998155368618673
TURJANSKI_MAPK1_AND_MAPK2_TA...,SET,11,0.072626,0.0017762,0.28019,0.39774,TURJANSKI_MAPK1_AND_MAPK2_TARGETS,0.998155368618673
GOBP_LIPOSACCHARIDE_METABOLI...,SET,103,0.021049,0.0015714,0.081207,0.39774,GOBP_LIPOSACCHARIDE_METABOLIC_PROCESS,0.998155368618673
KIM_LRRC3B_TARGETS,SET,29,0.039853,0.0015818,0.15382,0.39778,KIM_LRRC3B_TARGETS,0.998183675090253
GOMF_MACROLIDE_BINDING,SET,12,0.054623,0.0013953,0.21092,0.39783,GOMF_MACROLIDE_BINDING,0.998237069525666
KEGG_MEDICUS_ENV_FACTOR_DCE_...,SET,15,0.074545,0.0021288,0.28795,0.39786,KEGG_MEDICUS_ENV_FACTOR_DCE_TO_DNA_ADDUCTS,0.998240275772452
GOBP_POSITIVE_REGULATION_OF_...275,SET,13,0.061296,0.0016296,0.23705,0.39798,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_OXIDATION,0.998297384937239
GSE32986_UNSTIM_VS_GMCSF_AND...1,SET,168,0.017112,0.0016286,0.066183,0.39799,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,0.998297384937239
GOBP_NEGATIVE_REGULATION_OF_...172,SET,8,0.074817,0.0015606,0.28938,0.398,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,0.998297384937239
GSE33424_CD161_INT_VS_NEG_CD...1,SET,181,0.015812,0.0015614,0.061203,0.39807,GSE33424_CD161_INT_VS_NEG_CD8_TCELL_DN,0.998297384937239
GSE2197_IMMUNOSUPPRESSIVE_DN...2,SET,179,0.016431,0.0016137,0.063607,0.39808,GSE2197_IMMUNOSUPPRESSIVE_DNA_VS_UNTREATED_IN_DC_UP,0.998297384937239
LAKE_ADULT_KIDNEY_C21_COLLEC...,SET,98,0.023438,0.0017069,0.090749,0.3981,LAKE_ADULT_KIDNEY_C21_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_B,0.998297384937239
GOBP_CELLULAR_RESPONSE_TO_XE...,SET,187,0.01715,0.0017211,0.066408,0.39811,GOBP_CELLULAR_RESPONSE_TO_XENOBIOTIC_STIMULUS,0.998297384937239
MORI_EMU_MYC_LYMPHOMA_BY_ONS...2,SET,104,0.020585,0.0015441,0.07972,0.39812,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP,0.998297384937239
HP_ABNORMAL_COAGULATION_FACT...,SET,5,0.11229,0.0018518,0.43497,0.39815,HP_ABNORMAL_COAGULATION_FACTOR_V_ACTIVITY,0.998297384937239
VANASSE_BCL2_TARGETS_UP,SET,29,0.043382,0.0017219,0.16809,0.39817,VANASSE_BCL2_TARGETS_UP,0.998297384937239
MIR199B_5P,SET,165,0.016361,0.0015432,0.063435,0.39824,MIR199B_5P,0.998338440181726
MIR19B_1_5P_MIR19B_2_5P,SET,160,0.018071,0.0016787,0.070098,0.39829,MIR19B_1_5P_MIR19B_2_5P,0.998338440181726
REACTOME_PROGRAMMED_CELL_DEA...,SET,193,0.015249,0.0015544,0.059167,0.39831,REACTOME_PROGRAMMED_CELL_DEATH,0.998338440181726
GOCC_VOLTAGE_GATED_SODIUM_CH...,SET,14,0.069362,0.0019136,0.26913,0.39831,GOCC_VOLTAGE_GATED_SODIUM_CHANNEL_COMPLEX,0.998338440181726
GOBP_CELLULAR_RESPONSE_TO_AL...3,SET,7,0.089568,0.0017477,0.34759,0.39833,GOBP_CELLULAR_RESPONSE_TO_ALDOSTERONE,0.998338440181726
GOBP_POSITIVE_REGULATION_OF_...113,SET,343,0.012423,0.0016812,0.048237,0.39838,GOBP_POSITIVE_REGULATION_OF_CELL_ACTIVATION,0.998344830196842
GOBP_TELOMERE_MAINTENANCE_VI...3,SET,74,0.023295,0.0014752,0.090456,0.39839,GOBP_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,0.998344830196842
GOBP_HYPERSENSITIVITY,SET,15,0.063632,0.0018171,0.2472,0.39843,GOBP_HYPERSENSITIVITY,0.998360797174571
ACEVEDO_NORMAL_TISSUE_ADJACE...2,SET,154,0.016562,0.0015097,0.064377,0.39849,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_UP,0.998360797174571
HP_CHRONIC_SINUSITIS,SET,57,0.027503,0.0015293,0.1069,0.39849,HP_CHRONIC_SINUSITIS,0.998360797174571
MIR3158_5P,SET,154,0.017349,0.0015815,0.067456,0.39852,MIR3158_5P,0.998360797174571
ZMYND11_TARGET_GENES,SET,34,0.037091,0.0015938,0.14425,0.39854,ZMYND11_TARGET_GENES,0.998360797174571
GSE22611_NOD2_TRANSDUCED_VS_...2,SET,166,0.016953,0.0016039,0.065968,0.3986,GSE22611_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_2H_UP,0.998417274430672
NAKAYA_PBMC_FLUARIX_FLUVIRIN...5,SET,315,0.011898,0.0015443,0.046311,0.39862,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE,0.998417274430672
HP_ABNORMAL_SERUM_BICARBONAT...,SET,5,0.098161,0.0016188,0.38242,0.39871,HP_ABNORMAL_SERUM_BICARBONATE_CONCENTRATION,0.998439577180725
GSE39382_IL3_VS_IL3_IL33_TRE...2,SET,182,0.015569,0.0015416,0.060684,0.39876,GSE39382_IL3_VS_IL3_IL33_TREATED_MAST_CELL_UP,0.998439577180725
WP_NAD_METABOLISM,SET,15,0.053745,0.0015348,0.20951,0.39877,WP_NAD_METABOLISM,0.998439577180725
GOBP_POSITIVE_REGULATION_OF_...370,SET,66,0.027566,0.0016489,0.10745,0.39877,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,0.998439577180725
MORF_UBE2A,SET,39,0.031814,0.0014639,0.12405,0.3988,MORF_UBE2A,0.998439577180725
REACTOME_SUMOYLATION_OF_DNA_...1,SET,70,0.025076,0.0015446,0.097792,0.39882,REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS,0.998439577180725
GOMF_ROUNDABOUT_BINDING,SET,8,0.085825,0.0017902,0.33475,0.39883,GOMF_ROUNDABOUT_BINDING,0.998439577180725
GOMF_LEUCINE_ZIPPER_DOMAIN_B...,SET,10,0.071552,0.0016686,0.27922,0.39888,GOMF_LEUCINE_ZIPPER_DOMAIN_BINDING,0.998492826274849
JISON_SICKLE_CELL_DISEASE_DN,SET,167,0.016152,0.0015327,0.063123,0.39902,JISON_SICKLE_CELL_DISEASE_DN,0.998499593349647
ATGTACA_MIR493,SET,294,0.01284,0.0016109,0.050181,0.39902,ATGTACA_MIR493,0.998499593349647
GOBP_REGULATION_OF_EATING_BE...,SET,7,0.095191,0.0018574,0.37205,0.39903,GOBP_REGULATION_OF_EATING_BEHAVIOR,0.998499593349647
GOBP_BONE_DEVELOPMENT,SET,196,0.016328,0.0016771,0.063829,0.39905,GOBP_BONE_DEVELOPMENT,0.998499593349647
HP_FLANK_PAIN,SET,14,0.057751,0.0015933,0.22575,0.39905,HP_FLANK_PAIN,0.998499593349647
GCANCTGNY_MYOD_Q6,SET,845,0.0076765,0.0016077,0.030011,0.39906,GCANCTGNY_MYOD_Q6,0.998499593349647
MIR12126,SET,34,0.03893,0.0016729,0.15231,0.39913,MIR12126,0.998499593349647
GOBP_GAMMA_AMINOBUTYRIC_ACID...6,SET,19,0.055706,0.0017902,0.21801,0.39916,GOBP_GAMMA_AMINOBUTYRIC_ACID_TRANSPORT,0.998499593349647
GSE20727_CTRL_VS_ROS_INH_AND...2,SET,167,0.016314,0.0015481,0.063847,0.39916,GSE20727_CTRL_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,0.998499593349647
GOBP_CELLULAR_RESPONSE_TO_PA...,SET,8,0.076401,0.0015936,0.29903,0.39917,GOBP_CELLULAR_RESPONSE_TO_PARATHYROID_HORMONE_STIMULUS,0.998499593349647
MIR4675,SET,38,0.033771,0.001534,0.13227,0.39924,MIR4675,0.998580980138169
GSE4748_CTRL_VS_CYANOBACTERI...1,SET,176,0.01642,0.0015992,0.064325,0.39926,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN,0.998580980138169
GOBP_NEGATIVE_REGULATION_OF_...199,SET,17,0.049183,0.0014951,0.19275,0.3993,GOBP_NEGATIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.998609160250414
REACTOME_G_ALPHA_Q_SIGNALLIN...,SET,203,0.01628,0.0017015,0.063885,0.39943,REACTOME_G_ALPHA_Q_SIGNALLING_EVENTS,0.998619678253375
HP_HYPERPLASIA_OF_MIDFACE,SET,4,0.13212,0.001949,0.51909,0.39954,HP_HYPERPLASIA_OF_MIDFACE,0.998619678253375
HP_APLASIA_CUTIS_CONGENITA,SET,37,0.034319,0.0015383,0.13484,0.39955,HP_APLASIA_CUTIS_CONGENITA,0.998619678253375
GOCC_ENDOPLASMIC_RETICULUM_T...2,SET,4,0.098429,0.0014519,0.38713,0.39965,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_MEMBRANE,0.998619678253375
GOBP_RNA_CATABOLIC_PROCESS,SET,264,0.012783,0.001521,0.050278,0.39966,GOBP_RNA_CATABOLIC_PROCESS,0.998619678253375
KEGG_ARACHIDONIC_ACID_METABO...,SET,58,0.031195,0.0017497,0.12272,0.39967,KEGG_ARACHIDONIC_ACID_METABOLISM,0.998619678253375
HP_COR_PULMONALE,SET,10,0.068673,0.0016014,0.27024,0.3997,HP_COR_PULMONALE,0.998619678253375
WP_FGFR3_SIGNALING_IN_CHONDR...,SET,27,0.043407,0.0016625,0.17082,0.39971,WP_FGFR3_SIGNALING_IN_CHONDROCYTE_PROLIFERATION_AND_TERMINAL_DIFFERENTIATION,0.998619678253375
GSE2770_TGFB_AND_IL4_ACT_VS_...6,SET,177,0.015698,0.0015331,0.061789,0.39973,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,0.998619678253375
GOBP_POSITIVE_REGULATION_OF_...565,SET,50,0.030504,0.0015889,0.1201,0.39975,GOBP_POSITIVE_REGULATION_OF_OSSIFICATION,0.998619678253375
GOBP_RNA_METHYLATION,SET,66,0.022825,0.0013653,0.08988,0.39977,GOBP_RNA_METHYLATION,0.998619678253375
MIR4288,SET,144,0.018654,0.0016447,0.073462,0.39978,MIR4288,0.998619678253375
BUSSLINGER_DUODENAL_TRANSIT_...,SET,162,0.016321,0.0015256,0.064286,0.39979,BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS,0.998619678253375
HP_IMPAIRED_LYMPHOCYTE_TRANS...,SET,11,0.066636,0.0016297,0.26249,0.3998,HP_IMPAIRED_LYMPHOCYTE_TRANSFORMATION_WITH_PHYTOHEMAGGLUTININ,0.998619678253375
GOBP_INTERCELLULAR_TRANSPORT,SET,10,0.075565,0.0017621,0.29769,0.39981,GOBP_INTERCELLULAR_TRANSPORT,0.998619678253375
GSE13173_UNTREATED_VS_IL12_T...1,SET,117,0.019295,0.0015346,0.076057,0.39987,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_DN,0.998619678253375
HOLLEMAN_PREDNISOLONE_RESIST...4,SET,16,0.048456,0.0014291,0.19102,0.39988,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_UP,0.998619678253375
REACTOME_TRAF6_MEDIATED_NF_K...,SET,23,0.044595,0.0015766,0.1758,0.39988,REACTOME_TRAF6_MEDIATED_NF_KB_ACTIVATION,0.998619678253375
WP_LTF_DANGER_SIGNAL_RESPONS...,SET,18,0.054653,0.0017095,0.21553,0.39991,WP_LTF_DANGER_SIGNAL_RESPONSE_PATHWAY,0.998619678253375
GOCC_PHAGOCYTIC_VESICLE_LUMEN,SET,5,0.094176,0.0015531,0.37143,0.39992,GOCC_PHAGOCYTIC_VESICLE_LUMEN,0.998619678253375
GOBP_RETINAL_METABOLIC_PROCE...,SET,18,0.054649,0.0017094,0.21566,0.39998,GOBP_RETINAL_METABOLIC_PROCESS,0.998619678253375
MORF_SNRP70,SET,59,0.024102,0.0013634,0.095119,0.39999,MORF_SNRP70,0.998619678253375
KEGG_MEDICUS_REFERENCE_PDGF_...2,SET,17,0.054985,0.0016715,0.21706,0.40001,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PLCG_CAMK_SIGNALING_PATHWAY,0.998619678253375
HP_OVERWEIGHT,SET,42,0.032513,0.0015525,0.12838,0.40004,HP_OVERWEIGHT,0.998619678253375
GOMF_BETA_1_3_GALACTOSYLTRAN...,SET,14,0.062118,0.0017138,0.24533,0.40006,GOMF_BETA_1_3_GALACTOSYLTRANSFERASE_ACTIVITY,0.998619678253375
GSE37301_LYMPHOID_PRIMED_MPP...9,SET,170,0.01632,0.0015623,0.064471,0.40008,GSE37301_LYMPHOID_PRIMED_MPP_VS_RAG2_KO_NK_CELL_DN,0.998619678253375
GSE43863_TH1_VS_LY6C_INT_CXC...4,SET,187,0.015459,0.0015514,0.061065,0.40008,GSE43863_TH1_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,0.998619678253375
HP_GENERALIZED_HYPERPIGMENTA...,SET,37,0.033852,0.0015174,0.13377,0.40011,HP_GENERALIZED_HYPERPIGMENTATION,0.99862284021544
MIR3689D,SET,88,0.022286,0.0015384,0.088117,0.40017,MIR3689D,0.998657276708788
PID_SYNDECAN_2_PATHWAY,SET,31,0.039076,0.0016035,0.15455,0.4002,PID_SYNDECAN_2_PATHWAY,0.998657276708788
AIZARANI_LIVER_C14_HEPATOCYT...,SET,211,0.015883,0.0016921,0.062829,0.40021,AIZARANI_LIVER_C14_HEPATOCYTES_2,0.998657276708788
GSE29618_PRE_VS_DAY7_FLU_VAC...5,SET,180,0.014842,0.0014616,0.058782,0.40033,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_DN,0.99888499892311
GOBP_AMIDE_TRANSPORT,SET,295,0.012913,0.0016229,0.051158,0.40036,GOBP_AMIDE_TRANSPORT,0.998888140703518
MIR4519,SET,73,0.024108,0.0015164,0.095571,0.40042,MIR4519,0.998897563338836
MANNO_MIDBRAIN_NEUROTYPES_HN...4,SET,413,0.011293,0.0016737,0.044772,0.40043,MANNO_MIDBRAIN_NEUROTYPES_HNBML5,0.998897563338836
HP_DIASTASIS_RECTI,SET,21,0.045893,0.0015504,0.18197,0.40045,HP_DIASTASIS_RECTI,0.998897563338836
GOBP_PROTEIN_KINASE_C_SIGNAL...,SET,35,0.037747,0.0016457,0.14972,0.40048,GOBP_PROTEIN_KINASE_C_SIGNALING,0.998897740477728
GSE42021_TREG_PLN_VS_CD24LO_...1,SET,181,0.016151,0.0015949,0.064101,0.40054,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_DN,0.998897740477728
GOMF_TRANSPORTER_INHIBITOR_A...,SET,38,0.036154,0.0016423,0.14352,0.40055,GOMF_TRANSPORTER_INHIBITOR_ACTIVITY,0.998897740477728
HP_COGWHEEL_RIGIDITY,SET,25,0.045771,0.0016869,0.18179,0.40061,HP_COGWHEEL_RIGIDITY,0.998897740477728
HP_OSTEOPENIA,SET,288,0.012452,0.0015465,0.04946,0.40061,HP_OSTEOPENIA,0.998897740477728
MIR378H,SET,39,0.031328,0.0014416,0.12448,0.40065,MIR378H,0.998897740477728
PETRETTO_CARDIAC_HYPERTROPHY,SET,32,0.037707,0.001572,0.14988,0.40068,PETRETTO_CARDIAC_HYPERTROPHY,0.998897740477728
GSE37301_MULTIPOTENT_PROGENI...3,SET,187,0.014969,0.0015022,0.059501,0.40068,GSE37301_MULTIPOTENT_PROGENITOR_VS_COMMON_LYMPHOID_PROGENITOR_DN,0.998897740477728
GOBP_BONE_MATURATION,SET,24,0.045147,0.0016304,0.17953,0.40073,GOBP_BONE_MATURATION,0.998950735188639
REACTOME_ESTROGEN_BIOSYNTHES...,SET,6,0.083978,0.0015171,0.33409,0.40077,REACTOME_ESTROGEN_BIOSYNTHESIS,0.998960136249552
MIR2909,SET,47,0.029214,0.0014755,0.11627,0.40081,MIR2909,0.998960136249552
IGLESIAS_E2F_TARGETS_UP,SET,136,0.019383,0.0016612,0.077151,0.40082,IGLESIAS_E2F_TARGETS_UP,0.998960136249552
MODULE_209,SET,83,0.024052,0.0016127,0.095804,0.40089,MODULE_209,0.998997580471718
ZHENG_CORD_BLOOD_C6_HSC_MULT...,SET,81,0.025664,0.0017,0.10225,0.40091,ZHENG_CORD_BLOOD_C6_HSC_MULTIPOTENT_PROGENITOR,0.998997580471718
FOROUTAN_INTEGRATED_TGFB_EMT...2,SET,116,0.021128,0.0016732,0.084205,0.40094,FOROUTAN_INTEGRATED_TGFB_EMT_UP,0.998997580471718
CHESLER_BRAIN_QTL_TRANS,SET,6,0.090642,0.0016375,0.36127,0.40095,CHESLER_BRAIN_QTL_TRANS,0.998997580471718
GOBP_REGULATION_OF_EPITHELIA...2,SET,144,0.019307,0.0017022,0.076992,0.401,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,0.999001414487784
HALLMARK_TGF_BETA_SIGNALING,SET,52,0.029745,0.0015799,0.11865,0.40102,HALLMARK_TGF_BETA_SIGNALING,0.999001414487784
HP_ABNORMALITY_OF_THE_PALPEB...,SET,738,0.0077314,0.0015178,0.030849,0.40106,HP_ABNORMALITY_OF_THE_PALPEBRAL_FISSURES,0.999001414487784
HP_ATROPHY_DEGENERATION_AFFE...3,SET,593,0.0084237,0.0014885,0.033625,0.4011,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CEREBRUM,0.999001414487784
HAY_BONE_MARROW_NEUTROPHIL,SET,397,0.011075,0.0016101,0.04423,0.40114,HAY_BONE_MARROW_NEUTROPHIL,0.999001414487784
ALK_DN.V1_DN,SET,129,0.019284,0.0016099,0.077046,0.40118,ALK_DN.V1_DN,0.999001414487784
CTCAAGA_MIR526B,SET,61,0.026233,0.0015088,0.10484,0.40121,CTCAAGA_MIR526B,0.999001414487784
KCCGNSWTTT_UNKNOWN,SET,96,0.020573,0.001483,0.082286,0.40129,KCCGNSWTTT_UNKNOWN,0.999001414487784
GSE36888_STAT5_AB_KNOCKIN_VS...1,SET,177,0.016297,0.0015916,0.065188,0.40129,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_DN,0.999001414487784
GOMF_MRF_BINDING,SET,5,0.096783,0.0015961,0.38745,0.40137,GOMF_MRF_BINDING,0.999001414487784
GOBP_POSITIVE_REGULATION_OF_...235,SET,9,0.061335,0.0013569,0.24565,0.40142,GOBP_POSITIVE_REGULATION_OF_ENDOPLASMIC_RETICULUM_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,0.999001414487784
GSE7348_UNSTIM_VS_TOLERIZED_...2,SET,147,0.016121,0.001436,0.064594,0.40146,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,0.999001414487784
HP_HYPERNATREMIA,SET,8,0.082101,0.0017125,0.32917,0.40152,HP_HYPERNATREMIA,0.999001414487784
GSE19923_HEB_KO_VS_HEB_AND_E...2,SET,177,0.01566,0.0015294,0.06281,0.40155,GSE19923_HEB_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,0.999001414487784
GOBP_DUCTUS_ARTERIOSUS_CLOSU...,SET,5,0.10862,0.0017913,0.43567,0.40156,GOBP_DUCTUS_ARTERIOSUS_CLOSURE,0.999001414487784
GOCC_NEURON_PROJECTION_MEMBR...,SET,56,0.0294,0.0016204,0.11796,0.40159,GOCC_NEURON_PROJECTION_MEMBRANE,0.999001414487784
HP_CLUMSINESS,SET,84,0.022624,0.001526,0.090782,0.4016,HP_CLUMSINESS,0.999001414487784
GOMF_CYCLOHYDROLASE_ACTIVITY,SET,5,0.094787,0.0015632,0.38043,0.40162,GOMF_CYCLOHYDROLASE_ACTIVITY,0.999001414487784
WP_ESTROGEN_METABOLISM_WP5276,SET,23,0.045378,0.0016043,0.18221,0.40166,WP_ESTROGEN_METABOLISM_WP5276,0.999001414487784
HP_EXOSTOSES,SET,18,0.051464,0.0016098,0.20663,0.40166,HP_EXOSTOSES,0.999001414487784
WP_THYROID_STIMULATING_HORMO...,SET,66,0.028357,0.0016962,0.11388,0.40168,WP_THYROID_STIMULATING_HORMONE_TSH_SIGNALING,0.999001414487784
GOMF_LRR_DOMAIN_BINDING,SET,15,0.055496,0.0015848,0.22294,0.40171,GOMF_LRR_DOMAIN_BINDING,0.999001414487784
HP_INFLAMMATION_OF_THE_LARGE...,SET,104,0.021088,0.0015818,0.084805,0.40181,HP_INFLAMMATION_OF_THE_LARGE_INTESTINE,0.999001414487784
YAO_HOXA10_TARGETS_VIA_PROGE...2,SET,76,0.025453,0.0016334,0.10238,0.40183,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP,0.999001414487784
ARNT_01,SET,238,0.013842,0.0015649,0.055695,0.40187,ARNT_01,0.999001414487784
ZNF781_TARGET_GENES,SET,121,0.018004,0.001456,0.072467,0.4019,ZNF781_TARGET_GENES,0.999001414487784
GSE17721_POLYIC_VS_PAM3CSK4_...15,SET,178,0.014719,0.0014415,0.059275,0.40195,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_DN,0.999001414487784
MIR939_3P,SET,138,0.017113,0.0014773,0.068949,0.402,MIR939_3P,0.999001414487784
DACOSTA_UV_RESPONSE_VIA_ERCC...8,SET,22,0.043134,0.0014914,0.17384,0.40202,DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_UP,0.999001414487784
HP_BRADYKINESIA,SET,95,0.02085,0.0014952,0.084043,0.40203,HP_BRADYKINESIA,0.999001414487784
RAMASWAMY_METASTASIS_UP,SET,60,0.026752,0.001526,0.10784,0.40204,RAMASWAMY_METASTASIS_UP,0.999001414487784
GOMF_LYSOPHOSPHATIDIC_ACID_R...,SET,4,0.10758,0.0015869,0.43363,0.40204,GOMF_LYSOPHOSPHATIDIC_ACID_RECEPTOR_ACTIVITY,0.999001414487784
WP_PROSTAGLANDIN_SIGNALING,SET,32,0.040156,0.0016741,0.1619,0.40206,WP_PROSTAGLANDIN_SIGNALING,0.999001414487784
MIR3684,SET,30,0.039134,0.0015798,0.15782,0.40208,MIR3684,0.999001414487784
HP_FOCAL_T2_HYPERINTENSE_BAS...,SET,23,0.041335,0.0014613,0.16671,0.40209,HP_FOCAL_T2_HYPERINTENSE_BASAL_GANGLIA_LESION,0.999001414487784
HP_DYSMENORRHEA,SET,12,0.061977,0.0015831,0.25004,0.40212,HP_DYSMENORRHEA,0.999001414487784
MIR4780,SET,38,0.033621,0.0015272,0.13573,0.40219,MIR4780,0.999001414487784
GOBP_MRNA_TRANSCRIPTION,SET,46,0.028177,0.0014079,0.11378,0.4022,GOBP_MRNA_TRANSCRIPTION,0.999001414487784
REACTOME_PROCESSING_OF_INTRO...,SET,19,0.040801,0.0013112,0.1648,0.40223,REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS,0.999001414487784
GOCC_MITOCHONDRION,SET,1452,0.0055045,0.0014848,0.022232,0.40223,GOCC_MITOCHONDRION,0.999001414487784
KASLER_HDAC7_TARGETS_2_UP,SET,5,0.12055,0.001988,0.48703,0.40226,KASLER_HDAC7_TARGETS_2_UP,0.999001414487784
GOBP_RESPONSE_TO_FOLIC_ACID,SET,9,0.069228,0.0015316,0.27969,0.40226,GOBP_RESPONSE_TO_FOLIC_ACID,0.999001414487784
REACTOME_FORMATION_OF_THE_CO...,SET,120,0.024591,0.0019806,0.099393,0.40229,REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE,0.999001414487784
ACAACTT_MIR382,SET,62,0.025922,0.0015031,0.10478,0.4023,ACAACTT_MIR382,0.999001414487784
GSE36078_UNTREATED_VS_AD5_IN...1,SET,183,0.01503,0.0014922,0.060756,0.40231,GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_DN,0.999001414487784
REACTOME_EPHB_MEDIATED_FORWA...,SET,41,0.032832,0.001549,0.13276,0.40234,REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING,0.999001414487784
GOBP_GPI_ANCHOR_METABOLIC_PR...,SET,30,0.033369,0.0013471,0.13493,0.40234,GOBP_GPI_ANCHOR_METABOLIC_PROCESS,0.999001414487784
GOBP_POSITIVE_REGULATION_OF_...312,SET,24,0.041896,0.001513,0.16943,0.40235,GOBP_POSITIVE_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,0.999001414487784
DESCARTES_FETAL_EYE_STROMAL_...,SET,81,0.025742,0.0017051,0.10412,0.40236,DESCARTES_FETAL_EYE_STROMAL_CELLS,0.999001414487784
CCAATNNSNNNGCG_UNKNOWN,SET,53,0.030476,0.0016342,0.12331,0.4024,CCAATNNSNNNGCG_UNKNOWN,0.999029359239946
MIR3661,SET,62,0.027148,0.0015741,0.10992,0.40247,MIR3661,0.999110059995715
GSE20715_WT_VS_TLR4_KO_48H_O...1,SET,176,0.014899,0.001451,0.060344,0.40249,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_DN,0.999110059995715
SOBOLEV_PBMC_PANDEMRIX_AGE_1...3,SET,28,0.040465,0.0015782,0.16394,0.40252,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_CORRELATED_WITH_AGE_1DY_POSITIVE,0.999113169547208
GOBP_RESOLUTION_OF_MEIOTIC_R...,SET,13,0.055648,0.0014795,0.2258,0.40267,GOBP_RESOLUTION_OF_MEIOTIC_RECOMBINATION_INTERMEDIATES,0.999367566409597
GOBP_NUCLEOSIDE_BISPHOSPHATE...2,SET,11,0.064377,0.0015745,0.26126,0.40268,GOBP_NUCLEOSIDE_BISPHOSPHATE_CATABOLIC_PROCESS,0.999367566409597
WP_TRANSCRIPTIONAL_ACTIVATIO...,SET,15,0.055345,0.0015805,0.22486,0.40279,WP_TRANSCRIPTIONAL_ACTIVATION_BY_NRF2_IN_RESPONSE_TO_PHYTOCHEMICALS,0.999407823542009
GOBP_INTERLEUKIN_1_PRODUCTION,SET,104,0.021384,0.0016041,0.086879,0.40279,GOBP_INTERLEUKIN_1_PRODUCTION,0.999407823542009
GSE29618_PRE_VS_DAY7_FLU_VAC...6,SET,170,0.016114,0.0015426,0.065482,0.40281,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MONOCYTE_UP,0.999407823542009
HP_SLOW_SACCADIC_EYE_MOVEMEN...,SET,34,0.033277,0.0014299,0.13525,0.40283,HP_SLOW_SACCADIC_EYE_MOVEMENTS,0.999407823542009
GOBP_FOLLICLE_STIMULATING_HO...,SET,8,0.085485,0.0017831,0.3475,0.40284,GOBP_FOLLICLE_STIMULATING_HORMONE_SECRETION,0.999407823542009
MIR4712_5P,SET,92,0.022089,0.0015589,0.089831,0.40288,MIR4712_5P,0.999435717344754
MIR4759,SET,46,0.029032,0.0014506,0.11818,0.40297,MIR4759,0.999587634715581
KEGG_MEDICUS_REFERENCE_CLASS...,SET,4,0.1256,0.0018527,0.51194,0.4031,KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,0.999649521940778
GOBP_ELASTIN_METABOLIC_PROCE...,SET,7,0.091367,0.0017828,0.37241,0.4031,GOBP_ELASTIN_METABOLIC_PROCESS,0.999649521940778
GSE13306_RA_VS_UNTREATED_TRE...1,SET,190,0.01541,0.0015587,0.062816,0.4031,GSE13306_RA_VS_UNTREATED_TREG_DN,0.999649521940778
HP_INCREASED_LDL_CHOLESTEROL...,SET,31,0.040059,0.0016438,0.1633,0.40311,HP_INCREASED_LDL_CHOLESTEROL_CONCENTRATION,0.999649521940778
STAT_01,SET,233,0.01388,0.0015529,0.056629,0.40319,STAT_01,0.999714436519258
FIRESTEIN_CTNNB1_PATHWAY,SET,26,0.041778,0.0015702,0.17053,0.40323,FIRESTEIN_CTNNB1_PATHWAY,0.999714436519258
GOBP_REGULATION_OF_CELL_MATU...,SET,22,0.04528,0.0015657,0.18482,0.40323,GOBP_REGULATION_OF_CELL_MATURATION,0.999714436519258
HP_ABNORMAL_RESPIRATORY_EPIT...,SET,23,0.038381,0.0013569,0.15671,0.40326,HP_ABNORMAL_RESPIRATORY_EPITHELIUM_MORPHOLOGY,0.999714436519258
EHLERS_ANEUPLOIDY_UP,SET,35,0.032464,0.0014153,0.13258,0.40328,EHLERS_ANEUPLOIDY_UP,0.999714436519258
GOBP_NUCLEAR_PORE_COMPLEX_AS...,SET,11,0.056914,0.001392,0.23254,0.40333,GOBP_NUCLEAR_PORE_COMPLEX_ASSEMBLY,0.999767074388417
MODULE_388,SET,16,0.044913,0.0013246,0.18357,0.40336,MODULE_388,0.999770132648695
HP_VASCULAR_SKIN_ABNORMALITY,SET,514,0.009107,0.0015015,0.037233,0.40339,HP_VASCULAR_SKIN_ABNORMALITY,0.999773190472795
GSE45365_CD8A_DC_VS_CD11B_DC...1,SET,173,0.01571,0.001517,0.064298,0.40349,GSE45365_CD8A_DC_VS_CD11B_DC_DN,0.999838023952096
HP_DIAPHYSEAL_UNDERTUBULATION,SET,13,0.053437,0.0014207,0.21882,0.40353,HP_DIAPHYSEAL_UNDERTUBULATION,0.999838023952096
GOMF_FIBRINOGEN_BINDING,SET,6,0.08909,0.0016094,0.36486,0.40355,GOMF_FIBRINOGEN_BINDING,0.999838023952096
GOBP_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.078698,0.0012979,0.32233,0.40356,GOBP_CERAMIDE_1_PHOSPHATE_TRANSPORT,0.999838023952096
GOMF_CERAMIDE_1_PHOSPHATE_TR...,SET,5,0.078698,0.0012979,0.32233,0.40356,GOMF_CERAMIDE_1_PHOSPHATE_TRANSFER_ACTIVITY,0.999838023952096
FONTAINE_THYROID_TUMOR_UNCER...1,SET,26,0.042641,0.0016027,0.17489,0.40368,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_DN,1
MIR122B_3P,SET,124,0.018935,0.0015501,0.0777,0.40374,MIR122B_3P,1
GOCC_CENTRIOLE,SET,144,0.01644,0.0014495,0.067462,0.40374,GOCC_CENTRIOLE,1
CHAMP1_TARGET_GENES,SET,145,0.016614,0.0014699,0.068185,0.40375,CHAMP1_TARGET_GENES,1
GOBP_CHROMOSOME_ORGANIZATION...,SET,55,0.02444,0.001335,0.10037,0.40381,GOBP_CHROMOSOME_ORGANIZATION_INVOLVED_IN_MEIOTIC_CELL_CYCLE,1
GOBP_VIRAL_BUDDING,SET,25,0.038797,0.0014299,0.15951,0.40392,GOBP_VIRAL_BUDDING,1
GOBP_FATTY_ACYL_COA_CATABOLI...,SET,5,0.087803,0.001448,0.36107,0.40394,GOBP_FATTY_ACYL_COA_CATABOLIC_PROCESS,1
GOBP_PYRIMIDINE_CONTAINING_C...4,SET,7,0.078954,0.0015406,0.32475,0.40396,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_SALVAGE,1
GOCC_PERICENTRIC_HETEROCHROM...,SET,27,0.041468,0.0015882,0.1706,0.40398,GOCC_PERICENTRIC_HETEROCHROMATIN,1
GSE369_SOCS3_KO_VS_WT_LIVER_...2,SET,182,0.015399,0.0015248,0.063364,0.40399,GSE369_SOCS3_KO_VS_WT_LIVER_POST_IL6_INJECTION_DN,1
GOBP_MONOACYLGLYCEROL_METABO...,SET,14,0.053757,0.0014831,0.22121,0.404,GOBP_MONOACYLGLYCEROL_METABOLIC_PROCESS,1
GSE40274_CTRL_VS_HELIOS_TRAN...2,SET,146,0.017507,0.0015542,0.072132,0.40411,GSE40274_CTRL_VS_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
BIOCARTA_STRESS_PATHWAY,SET,23,0.042911,0.001517,0.17681,0.40412,BIOCARTA_STRESS_PATHWAY,1
GRADE_COLON_AND_RECTAL_CANCE...2,SET,256,0.012216,0.0014317,0.050354,0.40416,GRADE_COLON_AND_RECTAL_CANCER_UP,1
MIR22_3P,SET,126,0.018341,0.0015134,0.07562,0.40418,MIR22_3P,1
GOBP_LATERAL_VENTRICLE_DEVEL...,SET,12,0.056783,0.0014505,0.23422,0.40422,GOBP_LATERAL_VENTRICLE_DEVELOPMENT,1
GOBP_REGULATION_OF_CHEMOKINE...,SET,9,0.064124,0.0014186,0.26463,0.40427,GOBP_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,1
LE_EGR2_TARGETS_UP,SET,103,0.019643,0.0014664,0.081104,0.40432,LE_EGR2_TARGETS_UP,1
AAAGGAT_MIR501,SET,111,0.019603,0.0015188,0.080938,0.40432,AAAGGAT_MIR501,1
GOBP_INTERLEUKIN_1_ALPHA_PRO...,SET,8,0.08888,0.0018539,0.36701,0.40432,GOBP_INTERLEUKIN_1_ALPHA_PRODUCTION,1
HP_REDUCED_AMPLITUDE_OF_DARK...,SET,12,0.060133,0.001536,0.24843,0.40437,HP_REDUCED_AMPLITUDE_OF_DARK_ADAPTED_BRIGHT_FLASH_ELECTRORETINOGRAM_A_WAVE,1
GSE22886_IGM_MEMORY_BCELL_VS...1,SET,175,0.015112,0.0014676,0.062437,0.40438,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
GOBP_REGULATION_OF_PROTEIN_M...1,SET,62,0.025679,0.0014889,0.10613,0.40441,GOBP_REGULATION_OF_PROTEIN_MATURATION,1
GSE17721_CTRL_VS_CPG_0.5H_BM...1,SET,181,0.01515,0.001496,0.062664,0.40448,GSE17721_CTRL_VS_CPG_0.5H_BMDC_DN,1
GOBP_MONOCARBOXYLIC_ACID_BIO...,SET,204,0.014635,0.0015333,0.060549,0.4045,GOBP_MONOCARBOXYLIC_ACID_BIOSYNTHETIC_PROCESS,1
HP_STOMATOCYTOSIS,SET,12,0.066245,0.0016922,0.27425,0.40457,HP_STOMATOCYTOSIS,1
MIR122B_5P,SET,195,0.014355,0.0014708,0.05945,0.4046,MIR122B_5P,1
GOBP_REGULATION_OF_VITAMIN_M...,SET,12,0.058548,0.0014955,0.24257,0.40464,GOBP_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
HOEK_MONOCYTE_2011_2012_TIV_...1,SET,13,0.055612,0.0014785,0.23051,0.40468,HOEK_MONOCYTE_2011_2012_TIV_ADULT_1DY_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...46,SET,7,0.096408,0.0018811,0.39983,0.40473,HP_APLASIA_HYPOPLASIA_OF_THE_NASAL_BONE,1
REACTOME_MOLECULES_ASSOCIATE...,SET,35,0.035976,0.0015685,0.14929,0.40479,REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES,1
GOBP_CELL_SUBSTRATE_JUNCTION...2,SET,100,0.020172,0.0014839,0.083719,0.4048,GOBP_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
GNF2_CKS1B,SET,36,0.031352,0.0013862,0.13016,0.40483,GNF2_CKS1B,1
GOBP_REGULATION_OF_INTRACELL...1,SET,29,0.03686,0.001463,0.15303,0.40483,GOBP_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_PEPTIDASE_ACTIVITY,SET,534,0.0091498,0.0015368,0.037994,0.40485,GOMF_PEPTIDASE_ACTIVITY,1
MODULE_327,SET,21,0.045842,0.0015487,0.19044,0.40489,MODULE_327,1
GSE28408_LY6G_POS_VS_NEG_DC_...1,SET,176,0.014489,0.0014111,0.060217,0.40493,GSE28408_LY6G_POS_VS_NEG_DC_DN,1
HOFT_CD4_POSITIVE_ALPHA_BETA...6,SET,39,0.031185,0.001435,0.12961,0.40493,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,1
REACTOME_RSK_ACTIVATION,SET,5,0.099836,0.0016465,0.41499,0.40494,REACTOME_RSK_ACTIVATION,1
GOCC_DERLIN_1_RETROTRANSLOCA...,SET,7,0.069042,0.0013472,0.28699,0.40494,GOCC_DERLIN_1_RETROTRANSLOCATION_COMPLEX,1
HP_IRREGULAR_HYPERPIGMENTATI...,SET,211,0.013333,0.0014203,0.055473,0.40503,HP_IRREGULAR_HYPERPIGMENTATION,1
GOBP_MYELOID_CELL_ACTIVATION...,SET,91,0.021551,0.0015127,0.089716,0.40509,GOBP_MYELOID_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
GOMF_CARBOHYDRATE_TRANSMEMBR...,SET,36,0.036326,0.0016061,0.15123,0.40509,GOMF_CARBOHYDRATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_NON_CANONICAL_WNT_SIGNA...,SET,68,0.025608,0.0015548,0.10664,0.40511,GOBP_NON_CANONICAL_WNT_SIGNALING_PATHWAY,1
GSE17721_CTRL_VS_LPS_6H_BMDC...1,SET,184,0.014974,0.0014907,0.062359,0.40512,GSE17721_CTRL_VS_LPS_6H_BMDC_DN,1
MIR548AD_3P,SET,23,0.042049,0.0014866,0.17514,0.40513,MIR548AD_3P,1
MULLIGHAN_NPM1_MUTATED_SIGNA...4,SET,114,0.018885,0.0014827,0.078731,0.40522,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP,1
GCM_CSNK2B,SET,85,0.019539,0.0013257,0.081459,0.40522,GCM_CSNK2B,1
MISHRA_CARCINOMA_ASSOCIATED_...2,SET,22,0.047493,0.0016422,0.19807,0.40525,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_UP,1
GOBP_REGULATION_OF_COLLATERA...,SET,18,0.052044,0.0016279,0.21712,0.40528,GOBP_REGULATION_OF_COLLATERAL_SPROUTING,1
ZHONG_PFC_C2_SOX5_BCL11B_POS...,SET,24,0.045182,0.0016316,0.18856,0.40532,ZHONG_PFC_C2_SOX5_BCL11B_POS_EXCITATORY_NEURON,1
GOCC_SYNAPTIC_VESICLE_MEMBRA...,SET,124,0.018579,0.0015209,0.07755,0.40533,GOCC_SYNAPTIC_VESICLE_MEMBRANE,1
CUI_DEVELOPING_HEART_C5_VALV...,SET,184,0.016136,0.0016064,0.06736,0.40534,CUI_DEVELOPING_HEART_C5_VALVAR_CELL,1
GCGCCTT_MIR525_MIR524,SET,15,0.048004,0.0013708,0.20047,0.40538,GCGCCTT_MIR525_MIR524,1
GSE39820_TGFBETA1_IL6_VS_TGF...2,SET,185,0.014474,0.0014448,0.060449,0.40538,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP,1
GSE17721_CTRL_VS_GARDIQUIMOD...6,SET,188,0.01406,0.0014148,0.058724,0.40539,GSE17721_CTRL_VS_GARDIQUIMOD_1H_BMDC_UP,1
GOBP_REGULATION_OF_STEROID_H...2,SET,22,0.04601,0.0015909,0.19221,0.40541,GOBP_REGULATION_OF_STEROID_HORMONE_SECRETION,1
UNTERMAN_IPF_VS_CTRL_CD8T_DN,SET,2,0.16288,0.001699,0.68062,0.40543,UNTERMAN_IPF_VS_CTRL_CD8T_DN,1
GOBP_POST_EMBRYONIC_DEVELOPM...,SET,80,0.022773,0.0014992,0.095163,0.40544,GOBP_POST_EMBRYONIC_DEVELOPMENT,1
WANG_RESPONSE_TO_FORSKOLIN_DN,SET,9,0.061994,0.0013715,0.25913,0.40546,WANG_RESPONSE_TO_FORSKOLIN_DN,1
ZNF169_TARGET_GENES,SET,35,0.031711,0.0013825,0.13254,0.40546,ZNF169_TARGET_GENES,1
KUNINGER_IGF1_VS_PDGFB_TARGE...2,SET,75,0.023558,0.0015019,0.098508,0.4055,KUNINGER_IGF1_VS_PDGFB_TARGETS_UP,1
GSE360_L_DONOVANI_VS_B_MALAY...7,SET,179,0.014855,0.0014588,0.062171,0.40558,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
MORF_DEAF1,SET,46,0.028608,0.0014294,0.11975,0.40559,MORF_DEAF1,1
YANG_BREAST_CANCER_ESR1_BULK...2,SET,25,0.036141,0.001332,0.1513,0.40561,YANG_BREAST_CANCER_ESR1_BULK_UP,1
GOMF_TRANSPORTER_REGULATOR_A...,SET,141,0.017758,0.0015494,0.074388,0.40566,GOMF_TRANSPORTER_REGULATOR_ACTIVITY,1
HP_ABNORMAL_DISTAL_PHALANX_M...,SET,146,0.016791,0.0014906,0.070419,0.40577,HP_ABNORMAL_DISTAL_PHALANX_MORPHOLOGY_OF_FINGER,1
KEGG_MAPK_SIGNALING_PATHWAY,SET,256,0.013022,0.0015261,0.054646,0.40582,KEGG_MAPK_SIGNALING_PATHWAY,1
REACTOME_RHO_GTPASES_ACTIVAT...10,SET,33,0.031893,0.0013502,0.13384,0.40583,REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES,1
NABA_SECRETED_FACTORS,SET,318,0.013013,0.0016968,0.05462,0.40585,NABA_SECRETED_FACTORS,1
GSE21063_WT_VS_NFATC1_KO_3H_...2,SET,184,0.014247,0.0014184,0.059809,0.40586,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_UP,1
HP_JOINT_CONTRACTURE_OF_THE_...2,SET,14,0.052949,0.0014608,0.2224,0.40591,HP_JOINT_CONTRACTURE_OF_THE_5TH_FINGER,1
MODULE_174,SET,89,0.022766,0.0015804,0.095652,0.40594,MODULE_174,1
GSE15930_NAIVE_VS_48H_IN_VIT...1,SET,183,0.013855,0.0013756,0.058233,0.40597,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_CD8_TCELL_DN,1
WP_PATHWAYS_AFFECTED_IN_ADEN...,SET,56,0.02517,0.0013873,0.10585,0.40602,WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA,1
GOBP_NEGATIVE_REGULATION_OF_...698,SET,22,0.047404,0.0016391,0.19935,0.40602,GOBP_NEGATIVE_REGULATION_OF_VIRAL_ENTRY_INTO_HOST_CELL,1
HP_ABNORMAL_OOCYTE_MORPHOLOGY,SET,6,0.077512,0.0014003,0.32614,0.40607,HP_ABNORMAL_OOCYTE_MORPHOLOGY,1
MIR125A_5P,SET,300,0.011514,0.0014589,0.048453,0.40609,MIR125A_5P,1
HP_ABNORMALITY_OF_THE_URINAR...,SET,990,0.006458,0.0014579,0.027192,0.40614,HP_ABNORMALITY_OF_THE_URINARY_SYSTEM_PHYSIOLOGY,1
GOBP_UBIQUITIN_DEPENDENT_PRO...1,SET,12,0.056171,0.0014348,0.23655,0.40615,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_C_END_DEGRON_RULE_PATHWAY,1
GOBP_REGULATION_OF_EXTRACELL...4,SET,61,0.026698,0.0015356,0.11244,0.40616,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
GSE25846_IL10_POS_VS_NEG_CD8...2,SET,175,0.015134,0.0014697,0.063789,0.40623,GSE25846_IL10_POS_VS_NEG_CD8_TCELL_DAY7_POST_CORONAVIRUS_BRAIN_UP,1
GOBP_NATURAL_KILLER_CELL_CHE...,SET,10,0.070819,0.0016515,0.2986,0.40627,GOBP_NATURAL_KILLER_CELL_CHEMOTAXIS,1
GOBP_ARP2_3_COMPLEX_MEDIATED...,SET,33,0.032577,0.0013792,0.1374,0.40629,GOBP_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
KEGG_TYPE_II_DIABETES_MELLIT...,SET,46,0.031582,0.001578,0.13323,0.40631,KEGG_TYPE_II_DIABETES_MELLITUS,1
GOBP_RELEASE_OF_SEQUESTERED_...,SET,34,0.034721,0.001492,0.1465,0.40633,GOBP_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL_BY_ENDOPLASMIC_RETICULUM,1
GOBP_REGULATION_OF_SODIUM_IO...3,SET,76,0.024975,0.0016027,0.10546,0.4064,GOBP_REGULATION_OF_SODIUM_ION_TRANSPORT,1
HP_EPIRETINAL_MEMBRANE,SET,12,0.059669,0.0015242,0.25205,0.40643,HP_EPIRETINAL_MEMBRANE,1
NIKOLSKY_BREAST_CANCER_20P13...,SET,7,0.10208,0.0019917,0.43125,0.40645,NIKOLSKY_BREAST_CANCER_20P13_AMPLICON,1
MIR1304_5P,SET,121,0.017869,0.0014451,0.075504,0.40646,MIR1304_5P,1
HP_REDUCED_PROGRESSIVE_SPERM...,SET,15,0.044523,0.0012714,0.18825,0.40652,HP_REDUCED_PROGRESSIVE_SPERM_MOTILITY,1
GOBP_POSITIVE_REGULATION_OF_...146,SET,4,0.10639,0.0015693,0.4499,0.40654,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_ELONGATION,1
MOREIRA_RESPONSE_TO_TSA_UP,SET,25,0.039493,0.0014556,0.1671,0.40658,MOREIRA_RESPONSE_TO_TSA_UP,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...4,SET,42,0.0334,0.0015948,0.14136,0.40661,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_POSITIVE,1
FIGUEROA_AML_METHYLATION_CLU...2,SET,105,0.01974,0.0014877,0.083576,0.40665,FIGUEROA_AML_METHYLATION_CLUSTER_1_UP,1
IRF5_TARGET_GENES,SET,654,0.0077298,0.001432,0.032754,0.40672,IRF5_TARGET_GENES,1
DUTERTRE_ESTRADIOL_RESPONSE_...1,SET,475,0.0098498,0.0015629,0.041748,0.40674,DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN,1
chr17p12,SET,22,0.067792,0.0023441,0.28737,0.40675,chr17p12,1
REACTOME_BETA_OXIDATION_OF_V...,SET,10,0.063601,0.0014831,0.26963,0.40677,REACTOME_BETA_OXIDATION_OF_VERY_LONG_CHAIN_FATTY_ACIDS,1
chr14q32,SET,129,0.035111,0.0029312,0.1489,0.4068,chr14q32,1
GOBP_FIBROBLAST_ACTIVATION,SET,15,0.058053,0.0016578,0.24624,0.40681,GOBP_FIBROBLAST_ACTIVATION,1
GSE17721_12H_VS_24H_POLYIC_B...1,SET,180,0.014353,0.0014134,0.060882,0.40682,GSE17721_12H_VS_24H_POLYIC_BMDC_DN,1
GSE42021_TCONV_PLN_VS_CD24IN...2,SET,177,0.015104,0.0014751,0.064082,0.40684,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...484,SET,7,0.073225,0.0014288,0.31072,0.40685,GOBP_NEGATIVE_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
HOSHIDA_LIVER_CANCER_SUBCLAS...3,SET,243,0.012791,0.001461,0.054303,0.40689,HOSHIDA_LIVER_CANCER_SUBCLASS_S3,1
BIOCARTA_DREAM_PATHWAY,SET,13,0.064036,0.0017025,0.27198,0.40693,BIOCARTA_DREAM_PATHWAY,1
HP_ABNORMAL_FORAMEN_MAGNUM_M...,SET,16,0.046287,0.0013651,0.19668,0.40697,HP_ABNORMAL_FORAMEN_MAGNUM_MORPHOLOGY,1
HP_DUPLICATION_OF_RENAL_PELV...,SET,3,0.13804,0.0017634,0.58663,0.40699,HP_DUPLICATION_OF_RENAL_PELVIS,1
KYNG_DNA_DAMAGE_BY_4NQO_OR_G...,SET,15,0.049581,0.0014159,0.21075,0.40701,KYNG_DNA_DAMAGE_BY_4NQO_OR_GAMMA_RADIATION,1
DESCARTES_FETAL_PLACENTA_EXT...,SET,60,0.026678,0.0015218,0.11341,0.40702,DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS,1
GOBP_NEGATIVE_REGULATION_OF_...346,SET,54,0.026944,0.0014583,0.11462,0.40708,GOBP_NEGATIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
MIR6732_3P,SET,87,0.020233,0.0013887,0.08614,0.40715,MIR6732_3P,1
HP_UNUSUAL_SKIN_INFECTION,SET,7,0.066857,0.0013045,0.28469,0.40717,HP_UNUSUAL_SKIN_INFECTION,1
WP_PEROXIREDOXIN_2_INDUCED_O...,SET,8,0.075767,0.0015804,0.32329,0.40735,WP_PEROXIREDOXIN_2_INDUCED_OVARIAN_FAILURE,1
MIR548M,SET,172,0.014799,0.0014249,0.063147,0.40736,MIR548M,1
GSE9601_UNTREATED_VS_NFKB_IN...1,SET,162,0.015223,0.0014229,0.064958,0.40736,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,1
HOEK_PBMC_INACTIVATED_INFLUE...2,SET,2,0.12627,0.0013172,0.53891,0.40737,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_UP,1
GOCC_EXTRINSIC_COMPONENT_OF_...1,SET,47,0.029832,0.0015067,0.12739,0.40742,GOCC_EXTRINSIC_COMPONENT_OF_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,1
FIRESTEIN_PROLIFERATION,SET,150,0.015686,0.0014113,0.067014,0.40746,FIRESTEIN_PROLIFERATION,1
REACTOME_ZYGOTIC_GENOME_ACTI...,SET,13,0.054614,0.001452,0.23333,0.40747,REACTOME_ZYGOTIC_GENOME_ACTIVATION_ZGA,1
TERAO_AOX4_TARGETS_HG_UP,SET,27,0.037769,0.0014466,0.16148,0.40753,TERAO_AOX4_TARGETS_HG_UP,1
MODULE_247,SET,35,0.036846,0.0016064,0.15755,0.40755,MODULE_247,1
MIR152_5P,SET,74,0.023541,0.0014907,0.10071,0.40759,MIR152_5P,1
GOBP_POSITIVE_REGULATION_OF_...657,SET,12,0.056102,0.0014331,0.24,0.40759,GOBP_POSITIVE_REGULATION_OF_PSEUDOPODIUM_ASSEMBLY,1
GSE24634_TEFF_VS_TCONV_DAY7_...2,SET,181,0.013929,0.0013755,0.059606,0.40761,GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP,1
MIR6069,SET,26,0.036445,0.0013698,0.15604,0.40766,MIR6069,1
GSE17721_CPG_VS_GARDIQUIMOD_...7,SET,182,0.01403,0.0013892,0.06008,0.40768,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_DN,1
GOCC_NUCLEAR_EXOSOME_RNASE_C...,SET,14,0.045772,0.0012628,0.19605,0.4077,GOCC_NUCLEAR_EXOSOME_RNASE_COMPLEX,1
JISON_SICKLE_CELL_DISEASE_UP,SET,165,0.015573,0.0014689,0.06673,0.40774,JISON_SICKLE_CELL_DISEASE_UP,1
HP_AMBIGUOUS_GENITALIA,SET,109,0.018542,0.0014237,0.079461,0.40775,HP_AMBIGUOUS_GENITALIA,1
GSE27092_WT_VS_HDAC7_PHOSPHO...2,SET,185,0.014787,0.001476,0.063366,0.40775,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_UP,1
GOBP_REGULATION_OF_VENTRICUL...2,SET,7,0.0914,0.0017834,0.39188,0.40779,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,1
GOMF_3_BETA_HYDROXY_DELTA5_S...,SET,5,0.096204,0.0015866,0.41253,0.4078,GOMF_3_BETA_HYDROXY_DELTA5_STEROID_DEHYDROGENASE_ACTIVITY,1
BIOCARTA_CDC42RAC_PATHWAY,SET,8,0.062326,0.0013,0.26738,0.40784,BIOCARTA_CDC42RAC_PATHWAY,1
GSE37301_CD4_TCELL_VS_RAG2_K...1,SET,165,0.014726,0.001389,0.063182,0.40785,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...518,SET,31,0.039782,0.0016325,0.17076,0.40789,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_IMMUNITY,1
LENAOUR_DENDRITIC_CELL_MATUR...2,SET,110,0.020058,0.0015471,0.086132,0.40793,LENAOUR_DENDRITIC_CELL_MATURATION_UP,1
GOBP_MICROGLIAL_CELL_MEDIATE...,SET,5,0.087945,0.0014504,0.37786,0.40798,GOBP_MICROGLIAL_CELL_MEDIATED_CYTOTOXICITY,1
GAUTAM_EYE_IRIS_CILIARY_BODY...17,SET,104,0.02012,0.0015092,0.08647,0.40801,GAUTAM_EYE_IRIS_CILIARY_BODY_WIF1_HIGH_FIBROBLASTS,1
FLECHNER_BIOPSY_KIDNEY_TRANS...3,SET,504,0.0089314,0.0014586,0.038393,0.40802,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN,1
HP_VASCULAR_CALCIFICATION,SET,31,0.038072,0.0015623,0.1637,0.40805,HP_VASCULAR_CALCIFICATION,1
MIR567,SET,95,0.020119,0.0014427,0.086544,0.40809,MIR567,1
KEGG_MEDICUS_REFERENCE_GF_RT...1,SET,81,0.024395,0.001616,0.10502,0.40816,KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY,1
PID_BETA_CATENIN_DEG_PATHWAY,SET,17,0.043275,0.0013155,0.18647,0.40824,PID_BETA_CATENIN_DEG_PATHWAY,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...4,SET,25,0.043748,0.0016124,0.18852,0.40825,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_2_UP,1
GSE369_PRE_VS_POST_IL6_INJEC...6,SET,175,0.015039,0.0014605,0.064808,0.40825,GSE369_PRE_VS_POST_IL6_INJECTION_SOCS3_KO_LIVER_UP,1
GOMF_METAL_CLUSTER_BINDING,SET,69,0.02225,0.0013608,0.095892,0.40826,GOMF_METAL_CLUSTER_BINDING,1
GSE22886_NAIVE_VS_MEMORY_TCE...1,SET,183,0.014459,0.0014356,0.062324,0.40827,GSE22886_NAIVE_VS_MEMORY_TCELL_DN,1
GOMF_SERINE_TYPE_ENDOPEPTIDA...,SET,92,0.023741,0.0016755,0.10251,0.40843,GOMF_SERINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
MIR4270,SET,164,0.014972,0.001408,0.064667,0.40846,MIR4270,1
BIOCARTA_NO2IL12_PATHWAY,SET,14,0.056734,0.0015652,0.2451,0.40848,BIOCARTA_NO2IL12_PATHWAY,1
HP_POOR_SPEECH,SET,167,0.014461,0.0013722,0.062486,0.40849,HP_POOR_SPEECH,1
GOMF_APOLIPOPROTEIN_BINDING,SET,17,0.047458,0.0014427,0.20508,0.4085,GOMF_APOLIPOPROTEIN_BINDING,1
GOBP_NUCLEOSIDE_METABOLIC_PR...,SET,50,0.030455,0.0015863,0.13162,0.40851,GOBP_NUCLEOSIDE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_L...4,SET,38,0.031111,0.0014132,0.1345,0.40854,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
HP_EPISODIC_FLACCID_WEAKNESS,SET,5,0.099251,0.0016368,0.42922,0.40857,HP_EPISODIC_FLACCID_WEAKNESS,1
HP_HYPOGLYCEMIC_SEIZURES,SET,23,0.043672,0.0015439,0.18894,0.40861,HP_HYPOGLYCEMIC_SEIZURES,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...3,SET,6,0.071164,0.0012856,0.30795,0.40863,KEGG_MEDICUS_PATHOGEN_KSHV_VFLIP_TO_TNF_NFKB_SIGNALING_PATHWAY,1
HP_WHITE_HAIR,SET,21,0.042182,0.001425,0.18259,0.40865,HP_WHITE_HAIR,1
GOBP_REGULATION_OF_POSTSYNAP...6,SET,83,0.021576,0.0014467,0.093424,0.40868,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_NEUROTRANSMITTER_RECEPTOR_LEVELS,1
HP_PROGRESSIVE_DISTAL_MUSCLE...,SET,14,0.05135,0.0014167,0.22245,0.40872,HP_PROGRESSIVE_DISTAL_MUSCLE_WEAKNESS,1
MIR21_5P,SET,133,0.017093,0.0014488,0.074063,0.40874,MIR21_5P,1
GOBP_REGULATION_OF_MICROVILL...1,SET,6,0.088448,0.0015978,0.38333,0.40876,GOBP_REGULATION_OF_MICROVILLUS_ASSEMBLY,1
HP_POSTTERM_PREGNANCY,SET,5,0.1046,0.0017251,0.45333,0.40876,HP_POSTTERM_PREGNANCY,1
KEGG_MEDICUS_REFERENCE_ERK_R...,SET,4,0.10529,0.0015531,0.45656,0.40881,KEGG_MEDICUS_REFERENCE_ERK_RSK_SIGNALING,1
AGGTGCA_MIR500,SET,82,0.02118,0.0014116,0.091868,0.40883,AGGTGCA_MIR500,1
GOCC_BLOC_1_COMPLEX,SET,14,0.052527,0.0014492,0.2279,0.40886,GOCC_BLOC_1_COMPLEX,1
GOBP_AUTOPHAGY_OF_MITOCHONDR...,SET,91,0.01964,0.0013785,0.085233,0.40888,GOBP_AUTOPHAGY_OF_MITOCHONDRION,1
WANG_CISPLATIN_RESPONSE_AND_...2,SET,159,0.015834,0.0014664,0.068773,0.40896,WANG_CISPLATIN_RESPONSE_AND_XPC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...567,SET,9,0.070737,0.001565,0.30778,0.40911,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,1
GOBP_CALCIUM_INDEPENDENT_CEL...,SET,22,0.044281,0.0015311,0.19286,0.4092,GOBP_CALCIUM_INDEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,1
MODULE_436,SET,118,0.018559,0.0014823,0.080875,0.40925,MODULE_436,1
GSE40666_UNTREATED_VS_IFNA_S...6,SET,153,0.015801,0.0014357,0.068897,0.4093,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_UP,1
GOMF_MYOSIN_V_BINDING,SET,16,0.051901,0.0015307,0.22633,0.40931,GOMF_MYOSIN_V_BINDING,1
REACTOME_METABOLISM_OF_AMINE...,SET,17,0.049458,0.0015035,0.21571,0.40933,REACTOME_METABOLISM_OF_AMINE_DERIVED_HORMONES,1
WP_HYPOTHESIZED_PATHWAYS_IN_...,SET,23,0.041824,0.0014786,0.18247,0.40936,WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE,1
GOBP_NEGATIVE_REGULATION_OF_...371,SET,13,0.054219,0.0014415,0.23655,0.40936,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
GSE26495_PD1HIGH_VS_PD1LOW_C...1,SET,148,0.015547,0.0013895,0.067869,0.40941,GSE26495_PD1HIGH_VS_PD1LOW_CD8_TCELL_DN,1
HP_ABNORMAL_ORAL_PHYSIOLOGY,SET,286,0.011689,0.0014468,0.051043,0.40943,HP_ABNORMAL_ORAL_PHYSIOLOGY,1
MIR5739,SET,6,0.071104,0.0012845,0.31066,0.40948,MIR5739,1
GOBP_DETECTION_OF_CALCIUM_ION,SET,13,0.055817,0.001484,0.24401,0.40953,GOBP_DETECTION_OF_CALCIUM_ION,1
GOBP_DETECTION_OF_MECHANICAL...1,SET,51,0.028091,0.0014777,0.12282,0.40954,GOBP_DETECTION_OF_MECHANICAL_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...591,SET,7,0.073511,0.0014344,0.32138,0.40954,GOBP_POSITIVE_REGULATION_OF_PINOCYTOSIS,1
GSE11924_TFH_VS_TH1_CD4_TCEL...1,SET,174,0.014407,0.0013952,0.063005,0.40956,GSE11924_TFH_VS_TH1_CD4_TCELL_DN,1
GOBP_PLASMA_MEMBRANE_FUSION,SET,25,0.041942,0.0015458,0.18347,0.40959,GOBP_PLASMA_MEMBRANE_FUSION,1
HP_RETINAL_DYSPLASIA,SET,18,0.044002,0.0013764,0.19249,0.40959,HP_RETINAL_DYSPLASIA,1
GOBP_WNT_SIGNALING_PATHWAY,SET,416,0.0099923,0.0014862,0.043718,0.40961,GOBP_WNT_SIGNALING_PATHWAY,1
MIR569,SET,69,0.023995,0.0014675,0.10501,0.40963,MIR569,1
GOBP_REGULATION_OF_DNA_TEMPL...4,SET,79,0.020331,0.0013301,0.089064,0.40972,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
REACTOME_PYRUVATE_METABOLISM,SET,44,0.030593,0.0014951,0.13409,0.40976,REACTOME_PYRUVATE_METABOLISM,1
MENON_FETAL_KIDNEY_6_COLLECT...,SET,84,0.022565,0.001522,0.098914,0.40978,MENON_FETAL_KIDNEY_6_COLLECTING_DUCT_CELLS,1
JONES_OVARY_NK_CELL,SET,80,0.023125,0.0015223,0.10145,0.40985,JONES_OVARY_NK_CELL,1
GOBP_POSITIVE_REGULATION_OF_...672,SET,23,0.042401,0.001499,0.18616,0.40992,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,1
MANNO_MIDBRAIN_NEUROTYPES_HR...2,SET,513,0.0090677,0.0014937,0.039816,0.40992,MANNO_MIDBRAIN_NEUROTYPES_HRGL2A,1
GOBP_PROTEIN_KINASE_C_ACTIVA...,SET,24,0.039619,0.0014308,0.17405,0.40997,GOBP_PROTEIN_KINASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
MATTIOLI_MGUS_VS_PCL,SET,91,0.020003,0.001404,0.087884,0.40998,MATTIOLI_MGUS_VS_PCL,1
GOBP_MITOTIC_NUCLEAR_MEMBRAN...1,SET,8,0.064341,0.0013421,0.28272,0.40999,GOBP_MITOTIC_NUCLEAR_MEMBRANE_DISASSEMBLY,1
GOBP_REGULATION_OF_ACTIVIN_R...,SET,26,0.038144,0.0014336,0.16773,0.41005,GOBP_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_PROTECTION_FROM_NATURAL...,SET,6,0.086215,0.0015575,0.37924,0.41008,GOBP_PROTECTION_FROM_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...3,SET,64,0.023503,0.0013845,0.10345,0.41013,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5,1
GOBP_HEPATOCYTE_GROWTH_FACTO...,SET,11,0.060441,0.0014782,0.26639,0.41026,GOBP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE29618_PRE_VS_DAY7_POST_TI...8,SET,176,0.014136,0.0013766,0.062321,0.41028,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP,1
HP_EXERCISE_INDUCED_MUSCLE_F...,SET,9,0.060996,0.0013494,0.26905,0.41033,HP_EXERCISE_INDUCED_MUSCLE_FATIGUE,1
HP_ABNORMAL_BRONCHUS_MORPHOL...,SET,186,0.01404,0.0014053,0.061937,0.41034,HP_ABNORMAL_BRONCHUS_MORPHOLOGY,1
HP_ABNORMAL_NASAL_BRIDGE_MOR...,SET,882,0.0064826,0.0013856,0.028611,0.41038,HP_ABNORMAL_NASAL_BRIDGE_MORPHOLOGY,1
GSE36888_UNTREATED_VS_IL2_TR...8,SET,170,0.014521,0.0013901,0.06409,0.41038,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_UP,1
HP_PROLONGED_QT_INTERVAL,SET,45,0.029782,0.0014718,0.13147,0.4104,HP_PROLONGED_QT_INTERVAL,1
GSE37301_HEMATOPOIETIC_STEM_...3,SET,186,0.014736,0.0014749,0.065105,0.41047,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN,1
HP_ABNORMAL_AFFECT,SET,37,0.034828,0.0015611,0.15407,0.41058,HP_ABNORMAL_AFFECT,1
TAANNYSGCG_UNKNOWN,SET,73,0.022742,0.0014304,0.10067,0.41064,TAANNYSGCG_UNKNOWN,1
GOBP_PYROPTOSIS,SET,33,0.034112,0.0014442,0.15104,0.41066,GOBP_PYROPTOSIS,1
HP_SKIN_DIMPLE,SET,102,0.019517,0.0014499,0.08644,0.41069,HP_SKIN_DIMPLE,1
GOCC_ENDOPLASMIC_RETICULUM_G...1,SET,121,0.016793,0.0013581,0.074427,0.41074,GOCC_ENDOPLASMIC_RETICULUM_GOLGI_INTERMEDIATE_COMPARTMENT,1
GSE29615_CTRL_VS_DAY3_LAIV_I...1,SET,153,0.014627,0.001329,0.064827,0.41074,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_DN,1
REACTOME_FATTY_ACID_METABOLI...,SET,167,0.014944,0.0014181,0.066238,0.41075,REACTOME_FATTY_ACID_METABOLISM,1
MIR4504,SET,142,0.016277,0.0014252,0.072267,0.4109,MIR4504,1
GOCC_MITOCHONDRIAL_CRISTA,SET,6,0.087014,0.0015719,0.38661,0.41096,GOCC_MITOCHONDRIAL_CRISTA,1
BARRIER_COLON_CANCER_RECURRE...1,SET,16,0.046397,0.0013683,0.20618,0.41098,BARRIER_COLON_CANCER_RECURRENCE_DN,1
KYNG_ENVIRONMENTAL_STRESS_RE...1,SET,16,0.047244,0.0013933,0.21021,0.41109,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_DN,1
MIR7158_5P,SET,63,0.023666,0.0013832,0.10532,0.4111,MIR7158_5P,1
GOBP_CELLULAR_PROCESS_INVOLV...,SET,356,0.0099463,0.0013708,0.044275,0.41113,GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM,1
GSE26928_CENTR_MEMORY_VS_CXC...2,SET,159,0.014923,0.001382,0.066445,0.41115,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_UP,1
HP_ABNORMAL_CAPILLARY_PHYSIO...,SET,8,0.069073,0.0014408,0.30757,0.41116,HP_ABNORMAL_CAPILLARY_PHYSIOLOGY,1
GOBP_REGULATION_OF_CELL_SUBS...2,SET,65,0.022872,0.0013578,0.10186,0.41117,GOBP_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
WP_SULFATION_BIOTRANSFORMATI...,SET,14,0.058801,0.0016223,0.26198,0.41121,WP_SULFATION_BIOTRANSFORMATION_REACTION,1
GOBP_COPI_COATED_VESICLE_BUD...,SET,6,0.055353,0.00099997,0.24672,0.41124,GOBP_COPI_COATED_VESICLE_BUDDING,1
GSE9946_IMMATURE_VS_LISTERIA...2,SET,118,0.017501,0.0013978,0.078043,0.41128,GSE9946_IMMATURE_VS_LISTERIA_INF_MATURE_DC_UP,1
GOBP_AUDITORY_RECEPTOR_CELL_...2,SET,19,0.045496,0.0014621,0.20289,0.41129,GOBP_AUDITORY_RECEPTOR_CELL_MORPHOGENESIS,1
REACTOME_GLUTAMATE_AND_GLUTA...,SET,10,0.060995,0.0014224,0.27205,0.4113,REACTOME_GLUTAMATE_AND_GLUTAMINE_METABOLISM,1
MIR6736_3P,SET,113,0.018116,0.0014161,0.080809,0.41131,MIR6736_3P,1
HP_BILATERAL_PTOSIS,SET,63,0.023966,0.0014008,0.10691,0.41131,HP_BILATERAL_PTOSIS,1
GSE31082_DN_VS_DP_THYMOCYTE_...1,SET,184,0.013524,0.0013464,0.060324,0.41131,GSE31082_DN_VS_DP_THYMOCYTE_DN,1
DARWICHE_SQUAMOUS_CELL_CARCI...2,SET,136,0.016511,0.001415,0.073661,0.41132,DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP,1
REACTOME_NADE_MODULATES_DEAT...,SET,5,0.09996,0.0016485,0.44593,0.41132,REACTOME_NADE_MODULATES_DEATH_SIGNALLING,1
KEGG_MEDICUS_PATHOGEN_HPV_E6...2,SET,12,0.057046,0.0014572,0.25463,0.41136,KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381,1
HP_ACETABULAR_SPURS,SET,5,0.084554,0.0013944,0.37744,0.41137,HP_ACETABULAR_SPURS,1
GOBP_ORGANELLE_FUSION,SET,152,0.015031,0.0013613,0.067161,0.41145,GOBP_ORGANELLE_FUSION,1
BIOCARTA_P53HYPOXIA_PATHWAY,SET,20,0.042045,0.0013862,0.18786,0.41146,BIOCARTA_P53HYPOXIA_PATHWAY,1
MCCLUNG_CREB1_TARGETS_UP,SET,91,0.021064,0.0014785,0.094146,0.41148,MCCLUNG_CREB1_TARGETS_UP,1
GOBP_CHRONIC_INFLAMMATORY_RE...,SET,18,0.046019,0.0014395,0.20571,0.41149,GOBP_CHRONIC_INFLAMMATORY_RESPONSE,1
REACTOME_TRANSPORT_OF_ORGANI...,SET,10,0.068333,0.0015935,0.30548,0.4115,REACTOME_TRANSPORT_OF_ORGANIC_ANIONS,1
QI_PLASMACYTOMA_UP,SET,246,0.012662,0.0014551,0.056621,0.41152,QI_PLASMACYTOMA_UP,1
GOBP_POSITIVE_REGULATION_OF_...696,SET,13,0.056184,0.0014937,0.25132,0.41155,GOBP_POSITIVE_REGULATION_OF_SEQUESTERING_OF_CALCIUM_ION,1
GOBP_ANDROGEN_CATABOLIC_PROC...,SET,5,0.08558,0.0014114,0.38339,0.41168,GOBP_ANDROGEN_CATABOLIC_PROCESS,1
HP_ABNORMAL_2ND_FINGER_MORPH...,SET,37,0.031099,0.001394,0.13948,0.41178,HP_ABNORMAL_2ND_FINGER_MORPHOLOGY,1
GOBP_ESTABLISHMENT_OF_GOLGI_...,SET,6,0.078498,0.0014181,0.35222,0.41182,GOBP_ESTABLISHMENT_OF_GOLGI_LOCALIZATION,1
GSE9601_UNTREATED_VS_NFKB_IN...2,SET,145,0.01625,0.0014377,0.072926,0.41183,GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
GOBP_REGULATION_OF_ESTABLISH...5,SET,5,0.089355,0.0014736,0.40111,0.41186,GOBP_REGULATION_OF_ESTABLISHMENT_OF_T_CELL_POLARITY,1
GAO_STOMACH_24W_C2_TFF2POS_M...,SET,6,0.093549,0.00169,0.42009,0.41189,GAO_STOMACH_24W_C2_TFF2POS_MULTIPOTENT_PROGENITOR,1
BLANCO_MELO_BRONCHIAL_EPITHE...4,SET,124,0.017065,0.001397,0.076724,0.41199,BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_INFECTION_UP,1
WP_MATRIX_METALLOPROTEINASES,SET,28,0.039447,0.0015385,0.17735,0.41199,WP_MATRIX_METALLOPROTEINASES,1
GOBP_VESICLE_ORGANIZATION,SET,337,0.010006,0.0013425,0.044998,0.41201,GOBP_VESICLE_ORGANIZATION,1
HP_ABNORMAL_CIRCULATING_PHEN...,SET,9,0.067718,0.0014982,0.30455,0.41202,HP_ABNORMAL_CIRCULATING_PHENYLALANINE_CONCENTRATION,1
ZNF10_TARGET_GENES,SET,643,0.007371,0.0013544,0.033167,0.41207,ZNF10_TARGET_GENES,1
GOBP_ESTROGEN_METABOLIC_PROC...,SET,37,0.03264,0.001463,0.14687,0.41207,GOBP_ESTROGEN_METABOLIC_PROCESS,1
MIR323A_3P,SET,206,0.013169,0.0013864,0.059266,0.41208,MIR323A_3P,1
MIR6854_3P,SET,10,0.06427,0.0014988,0.28933,0.4121,MIR6854_3P,1
MODULE_540,SET,10,0.068178,0.0015899,0.30694,0.41211,MODULE_540,1
MSX1_TARGET_GENES,SET,167,0.01468,0.001393,0.066125,0.41215,MSX1_TARGET_GENES,1
GOBP_INTERLEUKIN_11_MEDIATED...,SET,6,0.07883,0.0014241,0.35525,0.4122,GOBP_INTERLEUKIN_11_MEDIATED_SIGNALING_PATHWAY,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...2,SET,11,0.063137,0.0015442,0.28459,0.41222,LOPEZ_MESOTHELIOMA_SURVIVAL_OVERALL_DN,1
GSE1925_CTRL_VS_3H_IFNG_STIM...2,SET,155,0.014777,0.0013513,0.066606,0.41222,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
DESCARTES_FETAL_LUNG_LYMPHOI...,SET,118,0.018404,0.0014699,0.08299,0.41225,DESCARTES_FETAL_LUNG_LYMPHOID_CELLS,1
HP_ARTERIAL_THROMBOSIS,SET,29,0.035208,0.0013974,0.15904,0.4124,HP_ARTERIAL_THROMBOSIS,1
GOMF_UBIQUITIN_UBIQUITIN_LIG...,SET,13,0.044792,0.0011908,0.20237,0.41242,GOMF_UBIQUITIN_UBIQUITIN_LIGASE_ACTIVITY,1
GSE3994_WT_VS_PAC1_KO_ACTIVA...1,SET,189,0.013729,0.001385,0.062059,0.41246,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_DN,1
REACTOME_SUMO_IS_CONJUGATED_...,SET,5,0.065889,0.0010866,0.29788,0.41247,REACTOME_SUMO_IS_CONJUGATED_TO_E1_UBA2_SAE1,1
GOBP_DEOXYRIBONUCLEOSIDE_MON...2,SET,14,0.05327,0.0014697,0.24106,0.41255,GOBP_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
REACTOME_NUCLEAR_EVENTS_MEDI...,SET,92,0.018732,0.001322,0.08477,0.41256,REACTOME_NUCLEAR_EVENTS_MEDIATED_BY_NFE2L2,1
MIR4273,SET,94,0.018942,0.0013512,0.085753,0.41259,MIR4273,1
MIR1302,SET,63,0.022161,0.0012952,0.10035,0.41261,MIR1302,1
GOMF_UBIQUITIN_PROTEIN_TRANS...3,SET,30,0.035979,0.0014524,0.16295,0.41263,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_REGULATOR_ACTIVITY,1
GOCC_IMMUNOGLOBULIN_COMPLEX_...,SET,3,0.13495,0.0017239,0.6114,0.41266,GOCC_IMMUNOGLOBULIN_COMPLEX_CIRCULATING,1
GOBP_REGULATION_OF_POTASSIUM...4,SET,87,0.021559,0.0014798,0.097716,0.41269,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
GOCC_FILTRATION_DIAPHRAGM,SET,9,0.066699,0.0014756,0.30237,0.41271,GOCC_FILTRATION_DIAPHRAGM,1
GSE6259_FLT3L_INDUCED_VS_WT_...1,SET,145,0.016344,0.001446,0.074108,0.41273,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_DN,1
FUKUSHIMA_TNFSF11_TARGETS,SET,16,0.050803,0.0014983,0.2304,0.41274,FUKUSHIMA_TNFSF11_TARGETS,1
GOMF_N_ACETYLTRANSFERASE_ACT...,SET,61,0.021974,0.0012638,0.09965,0.41274,GOMF_N_ACETYLTRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...106,SET,1025,0.0060282,0.0013833,0.027347,0.41277,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...508,SET,2,0.086155,0.0008987,0.39093,0.41279,GOBP_NEGATIVE_REGULATION_OF_PROSTAGLANDIN_BIOSYNTHETIC_PROCESS,1
HP_ANEMIA_OF_INADEQUATE_PROD...,SET,174,0.013637,0.0013206,0.061889,0.4128,HP_ANEMIA_OF_INADEQUATE_PRODUCTION,1
GOMF_CALCIUM_SODIUM_ANTIPORT...,SET,10,0.065865,0.001536,0.29895,0.41281,GOMF_CALCIUM_SODIUM_ANTIPORTER_ACTIVITY,1
REACTOME_CROSSLINKING_OF_COL...,SET,16,0.05352,0.0015784,0.24294,0.41282,REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS,1
GSE17974_1H_VS_72H_UNTREATED...1,SET,178,0.01272,0.0012457,0.05774,0.41282,GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...514,SET,5,0.086581,0.0014279,0.39324,0.41287,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,1
GSE360_DC_VS_MAC_M_TUBERCULO...1,SET,180,0.013972,0.001376,0.063458,0.41287,GSE360_DC_VS_MAC_M_TUBERCULOSIS_DN,1
GOBP_MEMBRANE_BIOGENESIS,SET,60,0.023042,0.0013144,0.10468,0.41289,GOBP_MEMBRANE_BIOGENESIS,1
HP_BONE_MARROW_MATURATION_AR...,SET,6,0.074104,0.0013387,0.33684,0.41294,HP_BONE_MARROW_MATURATION_ARREST,1
GOBP_GANGLION_DEVELOPMENT,SET,16,0.051226,0.0015108,0.23287,0.41295,GOBP_GANGLION_DEVELOPMENT,1
REACTOME_HEDGEHOG_LIGAND_BIO...,SET,62,0.020675,0.0011988,0.094022,0.41298,REACTOME_HEDGEHOG_LIGAND_BIOGENESIS,1
KEGG_TGF_BETA_SIGNALING_PATH...,SET,84,0.02039,0.0013753,0.092741,0.41299,KEGG_TGF_BETA_SIGNALING_PATHWAY,1
GSE46606_UNSTIM_VS_CD40L_IL2...8,SET,184,0.01265,0.0012594,0.057537,0.41299,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...318,SET,32,0.031527,0.0013144,0.14343,0.41301,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
GSE22501_PERIPHERAL_BLOOD_VS...1,SET,175,0.01431,0.0013897,0.065101,0.41301,GSE22501_PERIPHERAL_BLOOD_VS_CORD_BLOOD_TREG_DN,1
GOBP_GLUTATHIONE_CATABOLIC_P...,SET,7,0.070086,0.0013675,0.31893,0.41303,GOBP_GLUTATHIONE_CATABOLIC_PROCESS,1
GOBP_DNA_LIGATION,SET,16,0.037775,0.0011141,0.17192,0.41304,GOBP_DNA_LIGATION,1
MIR653_3P,SET,121,0.016499,0.0013343,0.075096,0.41305,MIR653_3P,1
BAELDE_DIABETIC_NEPHROPATHY_...1,SET,402,0.0095972,0.0014038,0.043688,0.41306,BAELDE_DIABETIC_NEPHROPATHY_DN,1
GSE15324_NAIVE_VS_ACTIVATED_...4,SET,184,0.013196,0.0013138,0.060068,0.41306,GSE15324_NAIVE_VS_ACTIVATED_ELF4_KO_CD8_TCELL_UP,1
GSE3982_CTRL_VS_LPS_1H_NEUTR...2,SET,170,0.013663,0.001308,0.062197,0.41306,GSE3982_CTRL_VS_LPS_1H_NEUTROPHIL_UP,1
REACTOME_RORA_ACTIVATES_GENE...,SET,17,0.044738,0.00136,0.20374,0.4131,REACTOME_RORA_ACTIVATES_GENE_EXPRESSION,1
DURANTE_ADULT_OLFACTORY_NEUR...18,SET,11,0.059355,0.0014516,0.2704,0.41313,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PLASMA_CELLS,1
GOMF_LIGAND_GATED_CHANNEL_AC...,SET,177,0.015019,0.0014668,0.06844,0.41315,GOMF_LIGAND_GATED_CHANNEL_ACTIVITY,1
HP_ARM_DYSTONIA,SET,12,0.051319,0.0013109,0.23386,0.41315,HP_ARM_DYSTONIA,1
TRAVAGLINI_LUNG_MYOFIBROBLAS...,SET,60,0.026597,0.0015172,0.12126,0.41319,TRAVAGLINI_LUNG_MYOFIBROBLAST_CELL,1
GSE7460_FOXP3_MUT_VS_WT_ACT_...4,SET,180,0.013886,0.0013675,0.063312,0.4132,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_UP,1
GSE18791_CTRL_VS_NEWCASTLE_V...10,SET,186,0.012557,0.0012568,0.057271,0.41323,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...360,SET,17,0.044277,0.001346,0.20207,0.41328,GOBP_NEGATIVE_REGULATION_OF_LYASE_ACTIVITY,1
REACTOME_DAP12_INTERACTIONS,SET,36,0.029461,0.0013026,0.13446,0.41329,REACTOME_DAP12_INTERACTIONS,1
FAN_OVARY_CL2_PUTATIVE_EARLY...,SET,83,0.021335,0.0014305,0.097401,0.41331,FAN_OVARY_CL2_PUTATIVE_EARLY_ATRETIC_FOLLICLE_THECAL_CELL_1,1
MIR548AV_5P_MIR548K,SET,267,0.011344,0.0013573,0.05184,0.41339,MIR548AV_5P_MIR548K,1
GSE14413_UNSTIM_VS_IFNB_STIM...2,SET,110,0.017861,0.0013776,0.081644,0.41342,GSE14413_UNSTIM_VS_IFNB_STIM_L929_CELLS_UP,1
GSE28737_BCL6_HET_VS_BCL6_KO...4,SET,184,0.014175,0.0014112,0.064808,0.41343,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,1
HP_VERTICAL_SUPRANUCLEAR_GAZ...,SET,26,0.036323,0.0013652,0.16609,0.41344,HP_VERTICAL_SUPRANUCLEAR_GAZE_PALSY,1
REACTOME_DEGRADATION_OF_GLI1...,SET,57,0.021243,0.0011812,0.097173,0.41348,REACTOME_DEGRADATION_OF_GLI1_BY_THE_PROTEASOME,1
GOBP_MONONUCLEAR_CELL_MIGRAT...,SET,203,0.013608,0.0014223,0.062273,0.41351,GOBP_MONONUCLEAR_CELL_MIGRATION,1
GOBP_CELLULAR_RESPONSE_TO_AB...,SET,308,0.010487,0.0013462,0.048018,0.41356,GOBP_CELLULAR_RESPONSE_TO_ABIOTIC_STIMULUS,1
HE_LIM_SUN_FETAL_LUNG_C4_T_A...,SET,66,0.023297,0.0013936,0.10677,0.41364,HE_LIM_SUN_FETAL_LUNG_C4_T_ALPHA_BETA_ENTRY_CELL,1
WP_SARSCOV2_ALTERING_ANGIOGE...,SET,4,0.10807,0.0015941,0.49535,0.41365,WP_SARSCOV2_ALTERING_ANGIOGENESIS_VIA_NRP1,1
FONTAINE_FOLLICULAR_THYROID_...1,SET,62,0.023957,0.0013891,0.10993,0.41374,FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN,1
GSE8835_CD4_VS_CD8_TCELL_UP,SET,179,0.013246,0.0013009,0.060779,0.41374,GSE8835_CD4_VS_CD8_TCELL_UP,1
GSE4748_CTRL_VS_LPS_STIM_DC_...1,SET,182,0.013686,0.0013552,0.062809,0.41375,GSE4748_CTRL_VS_LPS_STIM_DC_3H_DN,1
F10_TARGET_GENES,SET,211,0.012964,0.0013811,0.05954,0.41382,F10_TARGET_GENES,1
HP_ASYMMETRY_OF_THE_THORAX,SET,6,0.071207,0.0012864,0.32715,0.41385,HP_ASYMMETRY_OF_THE_THORAX,1
MIR10523_5P,SET,216,0.01275,0.001374,0.058588,0.41386,MIR10523_5P,1
IL21_UP.V1_DN,SET,157,0.015369,0.0014144,0.07067,0.41392,IL21_UP.V1_DN,1
HP_ABNORMALITY_OF_THE_MIDDLE...4,SET,12,0.054853,0.0014012,0.25233,0.41395,HP_ABNORMALITY_OF_THE_MIDDLE_PHALANX_OF_THE_2ND_FINGER,1
GOBP_RESPONSE_TO_SODIUM_PHOS...,SET,9,0.06876,0.0015212,0.31649,0.41401,GOBP_RESPONSE_TO_SODIUM_PHOSPHATE,1
MIR3192_3P,SET,75,0.021358,0.0013616,0.098336,0.41403,MIR3192_3P,1
WP_FLUOROACETIC_ACID_TOXICITY,SET,6,0.062657,0.0011319,0.28858,0.41406,WP_FLUOROACETIC_ACID_TOXICITY,1
EVI1_05,SET,161,0.014993,0.0013971,0.069057,0.41406,EVI1_05,1
GSE11961_FOLLICULAR_BCELL_VS...6,SET,180,0.013799,0.0013589,0.063604,0.41412,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_UP,1
HP_DUPLICATION_OF_BONES_INVO...,SET,193,0.012873,0.0013122,0.059348,0.41414,HP_DUPLICATION_OF_BONES_INVOLVING_THE_UPPER_EXTREMITIES,1
GOBP_POSITIVE_REGULATION_OF_...63,SET,8,0.076182,0.0015891,0.35125,0.41415,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
HP_LACRIMAL_DUCT_APLASIA,SET,9,0.060051,0.0013285,0.27709,0.41421,HP_LACRIMAL_DUCT_APLASIA,1
REACTOME_COBALAMIN_CBL_VITAM...,SET,20,0.040986,0.0013513,0.18917,0.41424,REACTOME_COBALAMIN_CBL_VITAMIN_B12_TRANSPORT_AND_METABOLISM,1
WP_MITOCHONDRIAL_COMPLEX_III...,SET,15,0.040081,0.0011446,0.18502,0.41425,WP_MITOCHONDRIAL_COMPLEX_III_ASSEMBLY,1
MORF_PCNA,SET,71,0.019759,0.0012257,0.091273,0.41431,MORF_PCNA,1
HP_OROMANDIBULAR_DYSTONIA,SET,18,0.038797,0.0012136,0.17923,0.41431,HP_OROMANDIBULAR_DYSTONIA,1
WP_EFFECTS_OF_NITRIC_OXIDE,SET,6,0.081641,0.0014749,0.37752,0.4144,WP_EFFECTS_OF_NITRIC_OXIDE,1
MAGRANGEAS_MULTIPLE_MYELOMA_...4,SET,38,0.032704,0.0014855,0.15126,0.41441,MAGRANGEAS_MULTIPLE_MYELOMA_IGLL_VS_IGLK_UP,1
GOMF_NADH_DEHYDROGENASE_UBIQ...,SET,33,0.026459,0.0011202,0.12242,0.41444,GOMF_NADH_DEHYDROGENASE_UBIQUINONE_ACTIVITY,1
REACTOME_REGULATION_OF_GENE_...1,SET,11,0.056148,0.0013732,0.25994,0.41449,REACTOME_REGULATION_OF_GENE_EXPRESSION_BY_HYPOXIA_INDUCIBLE_FACTOR,1
GSE26030_UNSTIM_VS_RESTIM_TH...1,SET,178,0.013514,0.0013235,0.062582,0.41452,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY15_POST_POLARIZATION_DN,1
GSE8685_IL2_STARVED_VS_IL21_...2,SET,182,0.013235,0.0013105,0.061361,0.41462,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,1
KRAS.600.LUNG.BREAST_UP.V1_UP,SET,248,0.012659,0.0014606,0.058699,0.41463,KRAS.600.LUNG.BREAST_UP.V1_UP,1
HP_MEGAKARYOCYTE_DYSPLASIA,SET,4,0.095313,0.001406,0.44202,0.41464,HP_MEGAKARYOCYTE_DYSPLASIA,1
GOBP_PROTEIN_TARGETING_TO_PE...,SET,9,0.058539,0.0012951,0.27152,0.41465,GOBP_PROTEIN_TARGETING_TO_PEROXISOME,1
GOBP_RESPONSE_TO_GROWTH_HORM...,SET,35,0.033128,0.0014443,0.15365,0.41465,GOBP_RESPONSE_TO_GROWTH_HORMONE,1
PRDM5_TARGET_GENES,SET,79,0.020537,0.0013435,0.095272,0.41467,PRDM5_TARGET_GENES,1
REACTOME_CA2_PATHWAY,SET,62,0.023166,0.0013432,0.10755,0.41473,REACTOME_CA2_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...51,SET,9,0.050901,0.0011261,0.23633,0.41474,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
GOBP_RESPONSE_TO_LIPOTEICHOI...,SET,10,0.056085,0.0013079,0.26039,0.41474,GOBP_RESPONSE_TO_LIPOTEICHOIC_ACID,1
MIR146B_5P,SET,102,0.017596,0.0013072,0.081761,0.4148,MIR146B_5P,1
GOBP_COMPLEMENT_ACTIVATION,SET,46,0.031091,0.0015535,0.1445,0.41482,GOBP_COMPLEMENT_ACTIVATION,1
GOBP_REGULATION_OF_GRANULOCY...1,SET,47,0.027503,0.001389,0.12789,0.41486,GOBP_REGULATION_OF_GRANULOCYTE_CHEMOTAXIS,1
KONDO_PROSTATE_CANCER_WITH_H...,SET,178,0.014864,0.0014557,0.06912,0.41487,KONDO_PROSTATE_CANCER_WITH_H3K27ME3,1
GOBP_MOTOR_LEARNING,SET,8,0.069807,0.0014561,0.32474,0.4149,GOBP_MOTOR_LEARNING,1
HP_ARTHRALGIA,SET,178,0.01426,0.0013966,0.066441,0.41503,HP_ARTHRALGIA,1
GSE37301_COMMON_LYMPHOID_PRO...3,SET,170,0.013938,0.0013343,0.064979,0.41508,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,1
PTPRA_TARGET_GENES,SET,94,0.018757,0.001338,0.087454,0.41509,PTPRA_TARGET_GENES,1
GOBP_PHOTORECEPTOR_CELL_OUTE...,SET,12,0.049663,0.0012686,0.23155,0.41509,GOBP_PHOTORECEPTOR_CELL_OUTER_SEGMENT_ORGANIZATION,1
MIR676_3P,SET,47,0.026022,0.0013142,0.12137,0.41512,MIR676_3P,1
GOBP_NEGATIVE_REGULATION_OF_...503,SET,17,0.049154,0.0014943,0.22943,0.41518,GOBP_NEGATIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR8068,SET,353,0.009889,0.0013573,0.046177,0.41521,MIR8068,1
HP_SMOOTH_TONGUE,SET,5,0.089709,0.0014794,0.41888,0.41521,HP_SMOOTH_TONGUE,1
HP_RIGIDITY,SET,185,0.012874,0.0012851,0.060117,0.41522,HP_RIGIDITY,1
HP_HYPERESTHESIA,SET,9,0.059495,0.0013162,0.27789,0.41524,HP_HYPERESTHESIA,1
MIR10392_3P,SET,5,0.076392,0.0012598,0.3569,0.41526,MIR10392_3P,1
GSE15767_MED_VS_SCS_MAC_LN_UP,SET,176,0.014305,0.0013931,0.06684,0.41527,GSE15767_MED_VS_SCS_MAC_LN_UP,1
GOBP_DNA_CATABOLIC_PROCESS,SET,27,0.034516,0.001322,0.16135,0.41531,GOBP_DNA_CATABOLIC_PROCESS,1
LET_7E_3P,SET,4,0.097494,0.0014381,0.45581,0.41532,LET_7E_3P,1
HP_RADIAL_HEAD_SUBLUXATION,SET,7,0.071262,0.0013905,0.33324,0.41534,HP_RADIAL_HEAD_SUBLUXATION,1
GOBP_LEUKOCYTE_PROLIFERATION,SET,323,0.01076,0.0014138,0.050338,0.41537,GOBP_LEUKOCYTE_PROLIFERATION,1
GOBP_PERIPHERAL_NERVOUS_SYST...5,SET,14,0.051594,0.0014234,0.24139,0.41538,GOBP_PERIPHERAL_NERVOUS_SYSTEM_NEURON_DIFFERENTIATION,1
GOBP_REGULATION_OF_CALCIUM_I...2,SET,29,0.033621,0.0013345,0.15739,0.41542,GOBP_REGULATION_OF_CALCIUM_ION_DEPENDENT_EXOCYTOSIS,1
GOBP_VENOUS_BLOOD_VESSEL_DEV...,SET,16,0.047184,0.0013916,0.22086,0.41542,GOBP_VENOUS_BLOOD_VESSEL_DEVELOPMENT,1
BOYLAN_MULTIPLE_MYELOMA_C_CL...2,SET,35,0.029808,0.0012996,0.13955,0.41543,BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_UP,1
HP_PAROXYSMAL_DYSKINESIA,SET,15,0.045764,0.0013069,0.21435,0.41547,HP_PAROXYSMAL_DYSKINESIA,1
GOBP_REGULATION_OF_CEREBELLA...,SET,9,0.062544,0.0013837,0.29304,0.4155,GOBP_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,1
HP_FRONTAL_CORTICAL_ATROPHY,SET,10,0.05823,0.0013579,0.27286,0.41551,HP_FRONTAL_CORTICAL_ATROPHY,1
GOBP_MESANGIAL_CELL_DIFFEREN...,SET,6,0.076119,0.0013751,0.35675,0.41552,GOBP_MESANGIAL_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_TOLL_SIGN...,SET,5,0.079492,0.001311,0.37272,0.41556,GOBP_REGULATION_OF_TOLL_SIGNALING_PATHWAY,1
GOBP_T_CELL_CYTOKINE_PRODUCT...,SET,36,0.031462,0.0013911,0.14764,0.41563,GOBP_T_CELL_CYTOKINE_PRODUCTION,1
MEBARKI_HCC_PROGENITOR_WNT_DN,SET,72,0.022081,0.0013793,0.10373,0.41572,MEBARKI_HCC_PROGENITOR_WNT_DN,1
HP_RECURRENT_MYCOBACTERIAL_I...,SET,48,0.02523,0.0012877,0.11853,0.41572,HP_RECURRENT_MYCOBACTERIAL_INFECTIONS,1
WP_IL2_SIGNALING,SET,41,0.028721,0.001355,0.13502,0.41577,WP_IL2_SIGNALING,1
HP_DEFORMED_SELLA_TURCICA,SET,18,0.038446,0.0012026,0.18086,0.41583,HP_DEFORMED_SELLA_TURCICA,1
GOBP_B_CELL_HOMEOSTASIS,SET,30,0.034457,0.001391,0.16213,0.41585,GOBP_B_CELL_HOMEOSTASIS,1
GOBP_MEIOTIC_ATTACHMENT_OF_T...,SET,2,0.097822,0.0010204,0.4603,0.41585,GOBP_MEIOTIC_ATTACHMENT_OF_TELOMERE_TO_NUCLEAR_ENVELOPE,1
HP_FIFTH_FINGER_DISTAL_PHALA...,SET,27,0.034015,0.0013028,0.16011,0.41588,HP_FIFTH_FINGER_DISTAL_PHALANX_CLINODACTYLY,1
REACTOME_TRANSFERRIN_ENDOCYT...,SET,29,0.033545,0.0013315,0.15795,0.41591,REACTOME_TRANSFERRIN_ENDOCYTOSIS_AND_RECYCLING,1
GOBP_NEGATIVE_REGULATION_OF_...688,SET,3,0.12075,0.0015426,0.56858,0.41591,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
CHIARADONNA_NEOPLASTIC_TRANS...5,SET,130,0.016062,0.0013461,0.075645,0.41592,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN,1
GCGSCMNTTT_UNKNOWN,SET,62,0.021779,0.0012628,0.10259,0.41594,GCGSCMNTTT_UNKNOWN,1
GOBP_POSITIVE_REGULATION_OF_...496,SET,30,0.035064,0.0014155,0.16518,0.41595,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,1
WP_SARSCOV2_B117_VARIANT_ANT...,SET,7,0.064736,0.0012631,0.30506,0.41597,WP_SARSCOV2_B117_VARIANT_ANTAGONISES_INNATE_IMMUNE_ACTIVATION,1
GOMF_NEUROPEPTIDE_RECEPTOR_A...,SET,42,0.030907,0.0014758,0.14576,0.41604,GOMF_NEUROPEPTIDE_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_REPRODUCTIVE_SYS...,SET,1236,0.0051847,0.0012985,0.024462,0.41608,HP_ABNORMAL_REPRODUCTIVE_SYSTEM_MORPHOLOGY,1
MODULE_236,SET,17,0.045225,0.0013748,0.21345,0.4161,MODULE_236,1
AAGCAAT_MIR137,SET,198,0.013317,0.0013747,0.062893,0.41616,AAGCAAT_MIR137,1
MIR4793_5P,SET,58,0.023312,0.0013075,0.11014,0.41619,MIR4793_5P,1
TONKS_TARGETS_OF_RUNX1_RUNX1...6,SET,167,0.014393,0.0013657,0.068011,0.4162,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP,1
HP_FATIGUABLE_WEAKNESS_OF_PR...,SET,21,0.038756,0.0013093,0.18316,0.41622,HP_FATIGUABLE_WEAKNESS_OF_PROXIMAL_LIMB_MUSCLES,1
GOBP_RNA_3_END_PROCESSING,SET,76,0.017987,0.0011543,0.085049,0.41625,GOBP_RNA_3_END_PROCESSING,1
HP_APLASIA_HYPOPLASIA_OF_THE...9,SET,32,0.030992,0.0012921,0.14659,0.41628,HP_APLASIA_HYPOPLASIA_OF_THE_ABDOMINAL_WALL_MUSCULATURE,1
chr20q12,SET,7,0.12254,0.0023911,0.57983,0.41631,chr20q12,1
GSE5589_WT_VS_IL6_KO_LPS_STI...2,SET,119,0.015755,0.0012636,0.074598,0.41637,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_UP,1
HP_ALVEOLAR_CELL_CARCINOMA,SET,17,0.042803,0.0013012,0.20271,0.41638,HP_ALVEOLAR_CELL_CARCINOMA,1
GOBP_RADIAL_GLIAL_CELL_DIFFE...,SET,14,0.052649,0.0014525,0.24934,0.41639,GOBP_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
GSE13484_UNSTIM_VS_YF17D_VAC...1,SET,188,0.013356,0.0013439,0.063263,0.4164,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
DESCARTES_FETAL_STOMACH_PARI...,SET,36,0.031708,0.0014019,0.15018,0.4164,DESCARTES_FETAL_STOMACH_PARIETAL_AND_CHIEF_CELLS,1
GSE31082_DP_VS_CD4_SP_THYMOC...1,SET,176,0.013373,0.0013024,0.063392,0.41646,GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN,1
MIR6509_3P,SET,123,0.015895,0.001296,0.075378,0.41649,MIR6509_3P,1
GAVISH_3CA_METAPROGRAM_ENDOT...4,SET,48,0.028197,0.0014391,0.1338,0.41655,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_2,1
GOMF_VASCULAR_ENDOTHELIAL_GR...1,SET,4,0.11031,0.0016271,0.52346,0.41655,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_BINDING,1
HP_THICKENED_NUCHAL_SKIN_FOLD,SET,49,0.023972,0.0012361,0.11386,0.41662,HP_THICKENED_NUCHAL_SKIN_FOLD,1
MODULE_562,SET,20,0.045725,0.0015076,0.21728,0.41666,MODULE_562,1
MIR6820_3P,SET,88,0.01885,0.0013012,0.0896,0.41669,MIR6820_3P,1
GOCC_MOTILE_CILIUM,SET,229,0.011588,0.0012854,0.055108,0.41673,GOCC_MOTILE_CILIUM,1
HP_MYOCLONIC_STATUS_EPILEPTI...,SET,5,0.087236,0.0014387,0.41507,0.41677,HP_MYOCLONIC_STATUS_EPILEPTICUS,1
HP_LARYNGEAL_DYSTONIA,SET,13,0.047259,0.0012565,0.22491,0.41679,HP_LARYNGEAL_DYSTONIA,1
GNF2_FGR,SET,30,0.031766,0.0012823,0.15128,0.41684,GNF2_FGR,1
GOBP_POSITIVE_REGULATION_OF_...824,SET,8,0.060573,0.0012635,0.28848,0.41684,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOMF_IMMUNOGLOBULIN_RECEPTOR...2,SET,9,0.065756,0.0014548,0.31314,0.41684,GOMF_IMMUNOGLOBULIN_RECEPTOR_BINDING,1
HP_APLASIA_HYPOPLASIA_INVOLV...12,SET,64,0.022584,0.0013303,0.10756,0.41685,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_PELVIS,1
LEF1_Q6,SET,241,0.012109,0.0013775,0.057693,0.41688,LEF1_Q6,1
HP_FUNDUS_ATROPHY,SET,3,0.13574,0.0017341,0.64686,0.41689,HP_FUNDUS_ATROPHY,1
GSE36078_WT_VS_IL1R_KO_LUNG_...5,SET,176,0.013007,0.0012668,0.061993,0.4169,GSE36078_WT_VS_IL1R_KO_LUNG_DC_DN,1
REACTOME_EPHA_MEDIATED_GROWT...,SET,29,0.035233,0.0013985,0.16796,0.41692,REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE,1
GOBP_KERATINOCYTE_DIFFERENTI...,SET,161,0.016112,0.0015014,0.076847,0.41697,GOBP_KERATINOCYTE_DIFFERENTIATION,1
HP_DIFFICULTY_IN_TONGUE_MOVE...,SET,12,0.05202,0.0013288,0.24819,0.41699,HP_DIFFICULTY_IN_TONGUE_MOVEMENTS,1
REACTOME_CYTOPROTECTION_BY_H...,SET,51,0.023545,0.0012386,0.11238,0.41702,REACTOME_CYTOPROTECTION_BY_HMOX1,1
MIR4663,SET,61,0.022951,0.00132,0.10953,0.41702,MIR4663,1
MIR1272,SET,80,0.019289,0.0012698,0.092065,0.41703,MIR1272,1
GOCC_PLASMA_MEMBRANE_RAFT,SET,106,0.017672,0.0013382,0.084347,0.41703,GOCC_PLASMA_MEMBRANE_RAFT,1
GOBP_SPERM_EGG_RECOGNITION,SET,49,0.024559,0.0012664,0.11727,0.41706,GOBP_SPERM_EGG_RECOGNITION,1
HP_HASHIMOTO_THYROIDITIS,SET,15,0.045062,0.0012868,0.21521,0.41708,HP_HASHIMOTO_THYROIDITIS,1
GOMF_DISORDERED_DOMAIN_SPECI...,SET,27,0.03515,0.0013462,0.16792,0.4171,GOMF_DISORDERED_DOMAIN_SPECIFIC_BINDING,1
MIR1_3P,SET,337,0.0097406,0.0013068,0.046545,0.41712,MIR1_3P,1
GSE19888_ADENOSINE_A3R_ACT_V...2,SET,166,0.012586,0.0011907,0.060147,0.41713,GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_UP,1
GSE24634_IL4_VS_CTRL_TREATED...4,SET,184,0.013267,0.0013208,0.063436,0.41717,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY3_UP,1
LEIN_MIDBRAIN_MARKERS,SET,68,0.022491,0.0013655,0.10755,0.41718,LEIN_MIDBRAIN_MARKERS,1
MIR5195_3P,SET,290,0.010605,0.0013216,0.050715,0.41718,MIR5195_3P,1
GOBP_NEGATIVE_REGULATION_OF_...326,SET,50,0.026892,0.0014007,0.1286,0.41718,GOBP_NEGATIVE_REGULATION_OF_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_MITOCHONDRIAL_ELECTRON_...1,SET,16,0.040096,0.0011825,0.19176,0.41719,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_CYTOCHROME_C_TO_OXYGEN,1
GOBP_REGULATION_OF_CELLULAR_...2,SET,416,0.0086018,0.0012794,0.041142,0.41719,GOBP_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,1
GOBP_GOLGI_TO_PLASMA_MEMBRAN...1,SET,40,0.027722,0.0012919,0.13273,0.41728,GOBP_GOLGI_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
OISHI_CHOLANGIOMA_STEM_CELL_...2,SET,324,0.0094224,0.00124,0.045132,0.41731,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP,1
ZHONG_PFC_C3_HOPX_POS_OPC,SET,7,0.06317,0.0012326,0.30279,0.41737,ZHONG_PFC_C3_HOPX_POS_OPC,1
GOCC_MSL_COMPLEX,SET,3,0.074631,0.00095341,0.3582,0.41748,GOCC_MSL_COMPLEX,1
REACTOME_ANTIGEN_PRESENTATIO...,SET,28,0.032884,0.0012825,0.15794,0.41754,REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC,1
MIR548AO_5P_MIR548AX,SET,152,0.014776,0.0013382,0.071025,0.4176,MIR548AO_5P_MIR548AX,1
GOBP_AMMONIUM_HOMEOSTASIS,SET,5,0.096335,0.0015887,0.46303,0.4176,GOBP_AMMONIUM_HOMEOSTASIS,1
GOBP_POSITIVE_REGULATION_OF_...744,SET,33,0.03324,0.0014072,0.15978,0.4176,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GOBP_ASTROCYTE_CELL_MIGRATION,SET,9,0.063358,0.0014017,0.30457,0.41761,GOBP_ASTROCYTE_CELL_MIGRATION,1
HP_ABNORMALITY_OF_CARDIOVASC...,SET,494,0.0079753,0.0012898,0.038341,0.41761,HP_ABNORMALITY_OF_CARDIOVASCULAR_SYSTEM_ELECTROPHYSIOLOGY,1
GOBP_SENSORY_PERCEPTION_OF_L...,SET,201,0.013238,0.0013768,0.06365,0.41762,GOBP_SENSORY_PERCEPTION_OF_LIGHT_STIMULUS,1
GOBP_NK_T_CELL_DIFFERENTIATI...,SET,11,0.056659,0.0013857,0.27253,0.41766,GOBP_NK_T_CELL_DIFFERENTIATION,1
HP_FACIAL_PARALYSIS,SET,10,0.061837,0.001442,0.29746,0.41766,HP_FACIAL_PARALYSIS,1
GOCC_CEREBELLAR_MOSSY_FIBER,SET,7,0.066689,0.0013013,0.32106,0.41773,GOCC_CEREBELLAR_MOSSY_FIBER,1
FLORIO_NEOCORTEX_BASAL_RADIA...2,SET,339,0.010065,0.0013543,0.048463,0.41774,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP,1
HP_ABNORMAL_LABIA_MINORA_MOR...,SET,34,0.031353,0.0013473,0.15096,0.41774,HP_ABNORMAL_LABIA_MINORA_MORPHOLOGY,1
SEAVEY_EPITHELIOID_HEMANGIOE...,SET,87,0.020029,0.0013747,0.096454,0.41775,SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA,1
MIR4474_5P,SET,44,0.027468,0.0013424,0.13229,0.41776,MIR4474_5P,1
MORF_TNFRSF25,SET,244,0.011342,0.0012982,0.054628,0.41776,MORF_TNFRSF25,1
GNF2_HAT1,SET,45,0.025153,0.0012431,0.12128,0.41785,GNF2_HAT1,1
HP_DEVIATION_OF_THE_3RD_FING...,SET,10,0.05657,0.0013192,0.27296,0.41791,HP_DEVIATION_OF_THE_3RD_FINGER,1
GOBP_DENDRITIC_CELL_APOPTOTI...,SET,12,0.055528,0.0014184,0.26797,0.41792,GOBP_DENDRITIC_CELL_APOPTOTIC_PROCESS,1
GOCC_NONHOMOLOGOUS_END_JOINI...,SET,7,0.058422,0.0011399,0.28193,0.41792,GOCC_NONHOMOLOGOUS_END_JOINING_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...665,SET,6,0.083809,0.001514,0.40467,0.41796,GOBP_NEGATIVE_REGULATION_OF_TYPE_B_PANCREATIC_CELL_APOPTOTIC_PROCESS,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...1,SET,35,0.029353,0.0012797,0.14174,0.41797,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_DN,1
HP_INTRA_EPIDERMAL_BLISTERING,SET,6,0.065519,0.0011836,0.31638,0.41797,HP_INTRA_EPIDERMAL_BLISTERING,1
GSE30971_2H_VS_4H_LPS_STIM_M...2,SET,160,0.013274,0.0012331,0.0641,0.41797,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...5,SET,13,0.044607,0.0011859,0.2157,0.41808,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BROWN_UP,1
WP_HORMONAL_CONTROL_OF_PUBER...,SET,5,0.085903,0.0014167,0.41544,0.41809,WP_HORMONAL_CONTROL_OF_PUBERTAL_GROWTH_SPURT,1
CTACTGT_MIR199A,SET,172,0.013277,0.0012784,0.064237,0.41813,CTACTGT_MIR199A,1
MODULE_287,SET,47,0.027128,0.0013701,0.13125,0.41813,MODULE_287,1
REACTOME_REGULATED_NECROSIS,SET,54,0.023924,0.0012949,0.11593,0.41825,REACTOME_REGULATED_NECROSIS,1
HP_INCREASED_SULFUR_AMINO_AC...,SET,15,0.048028,0.0013715,0.23273,0.41825,HP_INCREASED_SULFUR_AMINO_ACID_LEVEL_IN_URINE,1
GOCC_M_BAND,SET,27,0.031858,0.0012202,0.15449,0.41831,GOCC_M_BAND,1
GOBP_EXTRAEMBRYONIC_MEMBRANE...,SET,13,0.054479,0.0014484,0.26424,0.41833,GOBP_EXTRAEMBRYONIC_MEMBRANE_DEVELOPMENT,1
GAVISH_3CA_MALIGNANT_METAPRO...1,SET,41,0.028869,0.001362,0.14006,0.41835,GAVISH_3CA_MALIGNANT_METAPROGRAM_10_PROTEIN_MATURATION,1
GOMF_OPSONIN_RECEPTOR_ACTIVI...,SET,4,0.1001,0.0014766,0.48567,0.41836,GOMF_OPSONIN_RECEPTOR_ACTIVITY,1
HP_LOW_SERUM_CALCITRIOL,SET,7,0.06971,0.0013602,0.33832,0.41838,HP_LOW_SERUM_CALCITRIOL,1
TRAVAGLINI_LUNG_CD4_MEMORY_E...,SET,63,0.023706,0.0013856,0.11507,0.41839,TRAVAGLINI_LUNG_CD4_MEMORY_EFFECTOR_T_CELL,1
GOBP_CENTROMERIC_SISTER_CHRO...,SET,9,0.056845,0.0012576,0.27594,0.4184,GOBP_CENTROMERIC_SISTER_CHROMATID_COHESION,1
MIR645,SET,35,0.027912,0.0012169,0.13551,0.41841,MIR645,1
GSE26488_CTRL_VS_PEPTIDE_INJ...3,SET,172,0.013707,0.0013198,0.066554,0.41841,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_DN,1
REACTOME_TGFBR3_REGULATES_TG...,SET,8,0.06466,0.0013487,0.314,0.41843,REACTOME_TGFBR3_REGULATES_TGF_BETA_SIGNALING,1
chr20p12,SET,39,0.047363,0.0021795,0.23018,0.41849,chr20p12,1
HP_HEPATITIS,SET,82,0.020297,0.0013527,0.098658,0.4185,HP_HEPATITIS,1
MORF_XPC,SET,53,0.020884,0.0011199,0.10156,0.41854,MORF_XPC,1
HE_LIM_SUN_FETAL_LUNG_C7_LAT...,SET,90,0.01933,0.0013493,0.093996,0.41854,HE_LIM_SUN_FETAL_LUNG_C7_LATE_SCHWANN_CELL,1
REACTOME_CA2_ACTIVATED_K_CHA...,SET,9,0.062653,0.0013861,0.30502,0.41863,REACTOME_CA2_ACTIVATED_K_CHANNELS,1
GOCC_ENDOLYSOSOME_MEMBRANE,SET,17,0.042348,0.0012874,0.20619,0.41864,GOCC_ENDOLYSOSOME_MEMBRANE,1
GOMF_GLUTATHIONE_TRANSMEMBRA...,SET,7,0.064304,0.0012547,0.31334,0.4187,GOMF_GLUTATHIONE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
JIANG_AGING_CEREBRAL_CORTEX_...1,SET,44,0.026379,0.0012891,0.12859,0.41873,JIANG_AGING_CEREBRAL_CORTEX_DN,1
GOBP_POSITIVE_REGULATION_OF_...254,SET,15,0.038651,0.0011037,0.1884,0.41873,GOBP_POSITIVE_REGULATION_OF_ERAD_PATHWAY,1
PARK_TRETINOIN_RESPONSE_AND_...1,SET,27,0.034717,0.0013297,0.16942,0.41882,PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION,1
GOBP_RIBOSOMAL_LARGE_SUBUNIT...1,SET,19,0.036509,0.0011733,0.17817,0.41882,GOBP_RIBOSOMAL_LARGE_SUBUNIT_ASSEMBLY,1
HONMA_DOCETAXEL_RESISTANCE,SET,32,0.033076,0.0013789,0.16147,0.41885,HONMA_DOCETAXEL_RESISTANCE,1
GOBP_CRANIAL_GANGLION_DEVELO...,SET,4,0.09364,0.0013813,0.45736,0.41889,GOBP_CRANIAL_GANGLION_DEVELOPMENT,1
HP_ABNORMAL_PREIMPLANTATION_...,SET,6,0.059378,0.0010727,0.29002,0.41889,HP_ABNORMAL_PREIMPLANTATION_EMBRYONIC_DEVELOPMENT,1
GSE17721_LPS_VS_POLYIC_24H_B...2,SET,173,0.012442,0.0012015,0.060775,0.41889,GSE17721_LPS_VS_POLYIC_24H_BMDC_UP,1
REACTOME_PLATELET_AGGREGATIO...,SET,39,0.028299,0.0013022,0.1383,0.41893,REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION,1
GOMF_PHOSPHOFRUCTOKINASE_ACT...,SET,6,0.053334,0.00096349,0.26074,0.41896,GOMF_PHOSPHOFRUCTOKINASE_ACTIVITY,1
MIR6801_3P,SET,48,0.025096,0.0012809,0.12272,0.41899,MIR6801_3P,1
WP_OMEGA3_OMEGA6_FATTY_ACID_...,SET,14,0.051029,0.0014079,0.24957,0.419,WP_OMEGA3_OMEGA6_FATTY_ACID_SYNTHESIS,1
MODULE_172,SET,91,0.018793,0.0013191,0.091922,0.41901,MODULE_172,1
GOCC_AGGRESOME,SET,30,0.030155,0.0012173,0.14752,0.41902,GOCC_AGGRESOME,1
RP58_01,SET,191,0.012797,0.0012978,0.062636,0.41905,RP58_01,1
chr12p13,SET,133,0.034998,0.0029664,0.17136,0.41909,chr12p13,1
GOBP_CARBOHYDRATE_DERIVATIVE...1,SET,569,0.0072667,0.0012586,0.03559,0.41911,GOBP_CARBOHYDRATE_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
GSE36095_WT_VS_HDAC9_KO_TREG...1,SET,109,0.016519,0.0012684,0.080926,0.41913,GSE36095_WT_VS_HDAC9_KO_TREG_DN,1
HP_URETHRAL_DIVERTICULUM,SET,4,0.090967,0.0013419,0.44581,0.41916,HP_URETHRAL_DIVERTICULUM,1
GSE14000_UNSTIM_VS_4H_LPS_DC...2,SET,178,0.013636,0.0013354,0.066838,0.41918,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_DN,1
HP_ABNORMAL_CIRCULATING_ANTI...,SET,8,0.053904,0.0011244,0.26451,0.41926,HP_ABNORMAL_CIRCULATING_ANTIMULLERIAN_HORMONE_CONCENTRATION,1
GOBP_REGULATION_OF_PERK_MEDI...,SET,12,0.051889,0.0013255,0.25477,0.41931,GOBP_REGULATION_OF_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
GSE32986_CURDLAN_LOWDOSE_VS_...4,SET,179,0.012333,0.0012112,0.060585,0.41935,GSE32986_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_UP,1
MEISSNER_NPC_ICP_WITH_H3K4ME3,SET,17,0.037094,0.0011276,0.18229,0.41938,MEISSNER_NPC_ICP_WITH_H3K4ME3,1
KORKOLA_EMBRYONAL_CARCINOMA_...1,SET,9,0.06665,0.0014745,0.32764,0.4194,KORKOLA_EMBRYONAL_CARCINOMA_DN,1
GSE12366_PLASMA_CELL_VS_MEMO...2,SET,168,0.013243,0.0012603,0.065093,0.4194,GSE12366_PLASMA_CELL_VS_MEMORY_BCELL_UP,1
STK33_DN,SET,237,0.011257,0.00127,0.05535,0.41942,STK33_DN,1
GCM_IL6ST,SET,52,0.023586,0.0012528,0.11598,0.41943,GCM_IL6ST,1
GARGALOVIC_RESPONSE_TO_OXIDI...20,SET,10,0.059684,0.0013918,0.29364,0.41947,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TAN_DN,1
GOBP_UV_DAMAGE_EXCISION_REPA...,SET,11,0.04027,0.00098488,0.19818,0.41949,GOBP_UV_DAMAGE_EXCISION_REPAIR,1
HP_ADRENAL_OVERACTIVITY,SET,49,0.02637,0.0013598,0.12983,0.41952,HP_ADRENAL_OVERACTIVITY,1
GSE21927_SPLEEN_MONOCYTE_VS_...2,SET,151,0.012976,0.0011713,0.0639,0.41954,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_UP,1
GOBP_MITOCHONDRIAL_PROTEIN_C...,SET,9,0.049232,0.0010892,0.24274,0.41964,GOBP_MITOCHONDRIAL_PROTEIN_CATABOLIC_PROCESS,1
MANNO_MIDBRAIN_NEUROTYPES_HG...,SET,972,0.0058903,0.0013183,0.029041,0.41964,MANNO_MIDBRAIN_NEUROTYPES_HGABA,1
HP_CONFUSION,SET,69,0.0204,0.0012476,0.10062,0.41967,HP_CONFUSION,1
NIKOLSKY_BREAST_CANCER_15Q26...,SET,17,0.064316,0.0019552,0.31725,0.41968,NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON,1
ILK_TARGET_GENES,SET,15,0.040687,0.0011619,0.20079,0.41971,ILK_TARGET_GENES,1
GARGALOVIC_RESPONSE_TO_OXIDI...3,SET,59,0.021367,0.0012087,0.10548,0.41973,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN,1
NAKAMURA_TUMOR_ZONE_PERIPHER...2,SET,249,0.01059,0.0012242,0.052292,0.41976,NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP,1
GOMF_BITTER_TASTE_RECEPTOR_A...,SET,22,0.048493,0.0016767,0.23976,0.41986,GOMF_BITTER_TASTE_RECEPTOR_ACTIVITY,1
GOBP_TOLL_LIKE_RECEPTOR_4_SI...,SET,56,0.022189,0.0012229,0.10982,0.41994,GOBP_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
REACTOME_METABOLISM_OF_RNA,SET,647,0.0062132,0.001145,0.030766,0.41998,REACTOME_METABOLISM_OF_RNA,1
HP_PRIMARY_HYPOTHYROIDISM,SET,6,0.059622,0.0010771,0.29525,0.41998,HP_PRIMARY_HYPOTHYROIDISM,1
HP_HYPERTHYROIDISM,SET,30,0.032536,0.0013134,0.16115,0.42,HP_HYPERTHYROIDISM,1
GOBP_REGULATION_OF_GLUTAMATE...2,SET,6,0.074542,0.0013466,0.36928,0.42002,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
CERVERA_SDHB_TARGETS_1_DN,SET,34,0.030505,0.0013108,0.15117,0.42004,CERVERA_SDHB_TARGETS_1_DN,1
WP_DNA_MISMATCH_REPAIR,SET,23,0.030572,0.0010808,0.15152,0.42005,WP_DNA_MISMATCH_REPAIR,1
GGATCCG_MIR127,SET,9,0.065562,0.0014505,0.32523,0.42012,GGATCCG_MIR127,1
HP_ABNORMAL_CIRCULATING_ALPH...,SET,30,0.032886,0.0013276,0.16312,0.42012,HP_ABNORMAL_CIRCULATING_ALPHA_FETOPROTEIN_CONCENTRATION,1
chr18q12,SET,43,0.046885,0.0022651,0.23267,0.42015,chr18q12,1
FLETCHER_PBMC_BCG_10W_INFANT...2,SET,119,0.017614,0.0014127,0.087414,0.42016,FLETCHER_PBMC_BCG_10W_INFANT_BCG_STIMULATED_VS_UNSTIMULATED_10W_UP,1
REACTOME_INTERLEUKIN_21_SIGN...,SET,9,0.068396,0.0015132,0.33961,0.4202,REACTOME_INTERLEUKIN_21_SIGNALING,1
GSE17721_POLYIC_VS_GARDIQUIM...4,SET,181,0.012096,0.0011944,0.060065,0.4202,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_UP,1
GOCC_NUCLEAR_PROTEIN_CONTAIN...,SET,1121,0.0049254,0.0011787,0.02446,0.42021,GOCC_NUCLEAR_PROTEIN_CONTAINING_COMPLEX,1
HP_WEAKNESS_OF_FACIAL_MUSCUL...,SET,210,0.011588,0.0012316,0.05755,0.42021,HP_WEAKNESS_OF_FACIAL_MUSCULATURE,1
GSE24574_BCL6_LOW_TFH_VS_TCO...2,SET,168,0.013598,0.0012941,0.067548,0.42023,GSE24574_BCL6_LOW_TFH_VS_TCONV_CD4_TCELL_UP,1
WP_UNFOLDED_PROTEIN_RESPONSE,SET,22,0.036894,0.0012757,0.18331,0.42025,WP_UNFOLDED_PROTEIN_RESPONSE,1
GOBP_DETECTION_OF_VIRUS,SET,5,0.069175,0.0011408,0.34392,0.4203,GOBP_DETECTION_OF_VIRUS,1
REACTOME_GLYOXYLATE_METABOLI...,SET,19,0.037662,0.0012103,0.18727,0.42031,REACTOME_GLYOXYLATE_METABOLISM_AND_GLYCINE_DEGRADATION,1
HP_BELL_SHAPED_THORAX,SET,32,0.03164,0.0013191,0.15734,0.42031,HP_BELL_SHAPED_THORAX,1
GSE41867_DAY15_EFFECTOR_VS_D...2,SET,189,0.012097,0.0012204,0.060163,0.42033,GSE41867_DAY15_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,1
ROYLANCE_BREAST_CANCER_16Q_C...1,SET,24,0.050255,0.0018149,0.25019,0.4204,ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_DN,1
REACTOME_SOS_MEDIATED_SIGNAL...,SET,7,0.05987,0.0011682,0.2983,0.42047,REACTOME_SOS_MEDIATED_SIGNALLING,1
GOBP_NEGATIVE_REGULATION_OF_...409,SET,7,0.068877,0.0013439,0.34322,0.42048,GOBP_NEGATIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
HEIDENBLAD_AMPLICON_8Q24_DN,SET,38,0.029081,0.0013209,0.14493,0.42049,HEIDENBLAD_AMPLICON_8Q24_DN,1
GOMF_CALCIUM_CHANNEL_REGULAT...,SET,47,0.026628,0.0013448,0.13271,0.42049,GOMF_CALCIUM_CHANNEL_REGULATOR_ACTIVITY,1
CLAUS_PGR_POSITIVE_MENINGIOM...1,SET,12,0.05685,0.0014522,0.28365,0.42058,CLAUS_PGR_POSITIVE_MENINGIOMA_DN,1
MIR1298_5P,SET,40,0.025275,0.0011778,0.12612,0.42059,MIR1298_5P,1
GOBP_REGULATION_OF_T_HELPER_...6,SET,12,0.052122,0.0013314,0.26017,0.42061,GOBP_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
HP_DYSKINESIA,SET,172,0.01241,0.0011949,0.061964,0.42063,HP_DYSKINESIA,1
GSE24142_EARLY_THYMIC_PROGEN...1,SET,183,0.012439,0.0012351,0.062106,0.42063,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_ADULT_DN,1
HP_DECREASED_FERTILITY_IN_MA...,SET,183,0.012,0.0011914,0.059957,0.42069,HP_DECREASED_FERTILITY_IN_MALES,1
WP_HEPATITIS_B_INFECTION,SET,141,0.014568,0.0012711,0.072813,0.42071,WP_HEPATITIS_B_INFECTION,1
NMYC_01,SET,258,0.010371,0.0012201,0.051855,0.42074,NMYC_01,1
BRUINS_UVC_RESPONSE_VIA_TP53...1,SET,815,0.0060914,0.001254,0.03047,0.42077,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_A,1
MIR365A_3P_MIR365B_3P,SET,106,0.016606,0.0012575,0.083076,0.42078,MIR365A_3P_MIR365B_3P,1
GOBP_DIRECT_OSSIFICATION,SET,7,0.062692,0.0012233,0.31384,0.42084,GOBP_DIRECT_OSSIFICATION,1
HP_STOMATITIS,SET,66,0.021915,0.0013109,0.10978,0.42089,HP_STOMATITIS,1
MIR625_5P,SET,190,0.012199,0.0012339,0.061124,0.42091,MIR625_5P,1
GNF2_SPI1,SET,34,0.030029,0.0012904,0.15057,0.42097,GNF2_SPI1,1
GSE22025_UNTREATED_VS_TGFB1_...1,SET,174,0.012818,0.0012413,0.064306,0.42101,GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
NOURUZI_NEPC_ASCL1_TARGETS,SET,124,0.016557,0.0013554,0.083135,0.42107,NOURUZI_NEPC_ASCL1_TARGETS,1
GOBP_COLLAGEN_CATABOLIC_PROC...,SET,39,0.029694,0.0013664,0.14918,0.42111,GOBP_COLLAGEN_CATABOLIC_PROCESS,1
GSE43863_TH1_VS_TFH_EFFECTOR...1,SET,173,0.012784,0.0012345,0.064244,0.42113,GSE43863_TH1_VS_TFH_EFFECTOR_CD4_TCELL_DN,1
GOBP_AMINOGLYCOSIDE_ANTIBIOT...,SET,10,0.068168,0.0015897,0.34259,0.42114,GOBP_AMINOGLYCOSIDE_ANTIBIOTIC_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_PEPTIDYL_...6,SET,200,0.012241,0.0012699,0.061526,0.42115,GOBP_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,1
HOXA10_TARGET_GENES,SET,205,0.011025,0.0011579,0.055438,0.42118,HOXA10_TARGET_GENES,1
GSE7831_UNSTIM_VS_CPG_STIM_P...3,SET,178,0.012444,0.0012187,0.062584,0.4212,GSE7831_UNSTIM_VS_CPG_STIM_PDC_4H_DN,1
GOBP_DETOXIFICATION_OF_NITRO...,SET,2,0.13608,0.0014194,0.6846,0.42122,GOBP_DETOXIFICATION_OF_NITROGEN_COMPOUND,1
GSE360_CTRL_VS_L_MAJOR_DC_DN,SET,181,0.01294,0.0012778,0.065102,0.42122,GSE360_CTRL_VS_L_MAJOR_DC_DN,1
HP_ABNORMALITY_OF_MOUTH_SIZE,SET,373,0.0087539,0.0012344,0.044054,0.42125,HP_ABNORMALITY_OF_MOUTH_SIZE,1
HP_MESOAXIAL_POLYDACTYLY,SET,18,0.03548,0.0011098,0.17868,0.4213,HP_MESOAXIAL_POLYDACTYLY,1
GOBP_NEGATIVE_REGULATION_OF_...481,SET,23,0.031842,0.0011257,0.16037,0.42131,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
GOBP_MITOTIC_CELL_CYCLE_PROC...,SET,701,0.0062694,0.0012008,0.031587,0.42134,GOBP_MITOTIC_CELL_CYCLE_PROCESS,1
GSE3920_UNTREATED_VS_IFNB_TR...1,SET,157,0.013031,0.0011993,0.06569,0.42138,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,1
MORF_PDPK1,SET,66,0.019992,0.0011959,0.1008,0.42139,MORF_PDPK1,1
HP_NEOPLASM_OF_THE_TRACHEOBR...,SET,19,0.038629,0.0012414,0.19481,0.42141,HP_NEOPLASM_OF_THE_TRACHEOBRONCHIAL_SYSTEM,1
HP_SPARSE_BODY_HAIR,SET,57,0.024151,0.0013429,0.1218,0.42141,HP_SPARSE_BODY_HAIR,1
FUNG_IL2_TARGETS_WITH_STAT5_...1,SET,6,0.073681,0.0013311,0.37162,0.42142,FUNG_IL2_TARGETS_WITH_STAT5_BINDING_SITES,1
AREB6_01,SET,248,0.0109,0.0012576,0.054976,0.42142,AREB6_01,1
GOBP_POSITIVE_REGULATION_OF_...267,SET,6,0.064669,0.0011683,0.32639,0.42147,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,1
GCM_DDX5,SET,59,0.020919,0.0011833,0.1056,0.42148,GCM_DDX5,1
GOBP_HISTONE_MRNA_CATABOLIC_...,SET,11,0.042575,0.0010413,0.21503,0.42152,GOBP_HISTONE_MRNA_CATABOLIC_PROCESS,1
GOCC_PHOSPHOLIPID_TRANSLOCAT...,SET,13,0.045636,0.0012133,0.23054,0.42154,GOCC_PHOSPHOLIPID_TRANSLOCATING_ATPASE_COMPLEX,1
HP_ABNORMALITY_OF_IMMUNE_SYS...,SET,1562,0.0044228,0.0012334,0.022343,0.42154,HP_ABNORMALITY_OF_IMMUNE_SYSTEM_PHYSIOLOGY,1
MIR3685,SET,166,0.012693,0.0012009,0.064204,0.42164,MIR3685,1
KEGG_MEDICUS_REFERENCE_ANXA2...,SET,5,0.082185,0.0013554,0.41603,0.4217,KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON,1
STK33_NOMO_DN,SET,233,0.011035,0.0012346,0.055956,0.42183,STK33_NOMO_DN,1
GSE1791_CTRL_VS_NEUROMEDINU_...4,SET,173,0.012578,0.0012146,0.063791,0.42185,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_UP,1
GSE360_HIGH_DOSE_B_MALAYI_VS...4,SET,187,0.011589,0.001163,0.058831,0.42192,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,1
HP_VENTRICULAR_ESCAPE_RHYTHM,SET,8,0.061442,0.0012816,0.31198,0.42194,HP_VENTRICULAR_ESCAPE_RHYTHM,1
GOBP_INTRACELLULAR_SPHINGOLI...,SET,5,0.061199,0.0010093,0.31086,0.42197,GOBP_INTRACELLULAR_SPHINGOLIPID_HOMEOSTASIS,1
HP_APLASTIC_HYPOPLASTIC_LACR...,SET,8,0.063285,0.0013201,0.32159,0.422,HP_APLASTIC_HYPOPLASTIC_LACRIMAL_GLANDS,1
HP_MITRAL_VALVE_CALCIFICATION,SET,7,0.068693,0.0013404,0.34907,0.422,HP_MITRAL_VALVE_CALCIFICATION,1
HP_ABNORMAL_CRANIAL_NERVE_MO...,SET,71,0.019472,0.0012079,0.09899,0.42203,HP_ABNORMAL_CRANIAL_NERVE_MORPHOLOGY,1
HP_BROAD_FINGER,SET,113,0.015586,0.0012183,0.079342,0.42214,HP_BROAD_FINGER,1
GOBP_EMBRYONIC_SKELETAL_SYST...1,SET,121,0.017085,0.0013817,0.087014,0.42217,GOBP_EMBRYONIC_SKELETAL_SYSTEM_DEVELOPMENT,1
HP_FOCAL_SEGMENTAL_GLOMERULO...,SET,51,0.022973,0.0012085,0.11704,0.4222,HP_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS,1
GOBP_POSITIVE_REGULATION_OF_...600,SET,32,0.030816,0.0012847,0.15706,0.42222,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...442,SET,5,0.071391,0.0011774,0.36394,0.42224,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_CHEMOTAXIS,1
KYNG_NORMAL_AGING_DN,SET,16,0.042235,0.0012456,0.21546,0.4223,KYNG_NORMAL_AGING_DN,1
GOBP_ACTIVATION_OF_CYSTEINE_...3,SET,5,0.063113,0.0010408,0.32206,0.42232,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS_BY_CYTOCHROME_C,1
GSE40666_NAIVE_VS_EFFECTOR_C...3,SET,179,0.011923,0.0011709,0.060855,0.42233,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
GGCCAGT_MIR193A_MIR193B,SET,84,0.017523,0.001182,0.089519,0.4224,GGCCAGT_MIR193A_MIR193B,1
HP_ABNORMAL_LEUKOCYTE_ENZYME...,SET,6,0.069393,0.0012536,0.35463,0.42243,HP_ABNORMAL_LEUKOCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
DESCARTES_FETAL_INTESTINE_ME...,SET,67,0.020644,0.0012442,0.1056,0.42251,DESCARTES_FETAL_INTESTINE_MESOTHELIAL_CELLS,1
MATSUMIYA_PBMC_MODIFIED_VACC...6,SET,9,0.056462,0.0012491,0.28907,0.42257,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_BCG_PRIMED_28DY_UP,1
HP_ABNORMALITY_ON_PULMONARY_...,SET,167,0.012616,0.0011972,0.064619,0.4226,HP_ABNORMALITY_ON_PULMONARY_FUNCTION_TESTING,1
RAFFEL_VEGFA_TARGETS_UP,SET,9,0.058632,0.0012971,0.30039,0.42262,RAFFEL_VEGFA_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...339,SET,17,0.043673,0.0013276,0.22379,0.42264,GOBP_POSITIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
GSE17721_LPS_VS_CPG_1H_BMDC_...1,SET,192,0.011873,0.0012072,0.060853,0.42265,GSE17721_LPS_VS_CPG_1H_BMDC_DN,1
GSE20715_WT_VS_TLR4_KO_LUNG_...2,SET,179,0.012213,0.0011994,0.062596,0.42265,GSE20715_WT_VS_TLR4_KO_LUNG_UP,1
BIOCARTA_TUBBY_PATHWAY,SET,4,0.095496,0.0014087,0.48967,0.42269,BIOCARTA_TUBBY_PATHWAY,1
GTGACGY_E4F1_Q6,SET,591,0.0068318,0.0012052,0.03504,0.42271,GTGACGY_E4F1_Q6,1
GOBP_POSITIVE_REGULATION_OF_...120,SET,300,0.0096506,0.0012229,0.049496,0.42271,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE,1
WEST_ADRENOCORTICAL_CARCINOM...2,SET,16,0.041375,0.0012203,0.21223,0.42272,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP,1
ZHU_CMV_ALL_UP,SET,102,0.016193,0.001203,0.083081,0.42273,ZHU_CMV_ALL_UP,1
MIR4787_5P,SET,6,0.073207,0.0013225,0.37557,0.42273,MIR4787_5P,1
HP_SEPTO_OPTIC_DYSPLASIA,SET,18,0.041903,0.0013107,0.2152,0.42281,HP_SEPTO_OPTIC_DYSPLASIA,1
GOBP_PHOSPHATIDYLINOSITOL_3_...1,SET,275,0.010376,0.0012597,0.053401,0.42297,GOBP_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...687,SET,4,0.091691,0.0013525,0.47207,0.423,GOBP_NEGATIVE_REGULATION_OF_URINE_VOLUME,1
WP_IL10_ANTIINFLAMMATORY_SIG...,SET,12,0.045383,0.0011593,0.23372,0.42302,WP_IL10_ANTIINFLAMMATORY_SIGNALING,1
GOBP_INTRACELLULAR_ZINC_ION_...,SET,34,0.030804,0.0013237,0.15876,0.42308,GOBP_INTRACELLULAR_ZINC_ION_HOMEOSTASIS,1
MIR6863,SET,8,0.058514,0.0012205,0.30184,0.42314,MIR6863,1
GOBP_NEGATIVE_REGULATION_OF_...294,SET,150,0.014044,0.0012635,0.072454,0.42316,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,1
GOBP_REGULATION_OF_HORMONE_S...,SET,243,0.011127,0.0012709,0.057439,0.4232,GOBP_REGULATION_OF_HORMONE_SECRETION,1
LI_WILMS_TUMOR_ANAPLASTIC_UP,SET,17,0.036434,0.0011076,0.18813,0.42322,LI_WILMS_TUMOR_ANAPLASTIC_UP,1
PAX8_01,SET,33,0.029263,0.0012389,0.15112,0.42323,PAX8_01,1
MIR145_5P,SET,285,0.0098747,0.0012201,0.051047,0.42331,MIR145_5P,1
HP_OSTEOSARCOMA,SET,32,0.02819,0.0011753,0.14586,0.42337,HP_OSTEOSARCOMA,1
MOOTHA_HUMAN_MITODB_6_2002,SET,382,0.0081844,0.0011676,0.042367,0.42341,MOOTHA_HUMAN_MITODB_6_2002,1
REACTOME_G2_PHASE,SET,5,0.077948,0.0012855,0.40353,0.42342,REACTOME_G2_PHASE,1
KEGG_MEDICUS_REFERENCE_FSHR_...,SET,16,0.042691,0.001259,0.22115,0.42346,KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY,1
HP_DILATATION_OF_THE_BLADDER,SET,11,0.053523,0.001309,0.2773,0.42347,HP_DILATATION_OF_THE_BLADDER,1
GSE43955_TH0_VS_TGFB_IL6_TH1...1,SET,180,0.012326,0.0012138,0.063888,0.42351,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_DN,1
GOBP_ENDOSOME_ORGANIZATION,SET,86,0.016479,0.0011246,0.085506,0.42359,GOBP_ENDOSOME_ORGANIZATION,1
GOBP_REGULATION_OF_GLYCOGEN_...2,SET,6,0.064773,0.0011701,0.33608,0.42359,GOBP_REGULATION_OF_GLYCOGEN_CATABOLIC_PROCESS,1
REACTOME_RHOB_GTPASE_CYCLE,SET,65,0.02026,0.0012027,0.10514,0.4236,REACTOME_RHOB_GTPASE_CYCLE,1
WP_TCELL_RECEPTOR_SIGNALING,SET,87,0.017394,0.0011939,0.090397,0.42371,WP_TCELL_RECEPTOR_SIGNALING,1
HP_ABNORMAL_BLOOD_ION_CONCEN...,SET,321,0.0093953,0.0012308,0.04883,0.42371,HP_ABNORMAL_BLOOD_ION_CONCENTRATION,1
GSE11961_GERMINAL_CENTER_BCE...1,SET,178,0.012103,0.0011853,0.062956,0.42378,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
ZHANG_RESPONSE_TO_CANTHARIDI...1,SET,60,0.019358,0.0011042,0.10078,0.42384,ZHANG_RESPONSE_TO_CANTHARIDIN_DN,1
WP_COVID19_STRUCTURAL_COVERA...,SET,19,0.036674,0.0011786,0.19092,0.42384,WP_COVID19_STRUCTURAL_COVERAGE_MAP,1
GOBP_RNA_5_END_PROCESSING,SET,32,0.024245,0.0010108,0.12622,0.42384,GOBP_RNA_5_END_PROCESSING,1
GOBP_TERPENOID_METABOLIC_PRO...,SET,96,0.018484,0.0013324,0.096259,0.42386,GOBP_TERPENOID_METABOLIC_PROCESS,1
GOCC_FILOPODIUM,SET,92,0.017358,0.001225,0.090404,0.42387,GOCC_FILOPODIUM,1
GOBP_LIPID_DROPLET_FUSION,SET,5,0.085562,0.0014111,0.44588,0.42391,GOBP_LIPID_DROPLET_FUSION,1
GSE7219_UNSTIM_VS_LPS_AND_AN...4,SET,168,0.012527,0.0011922,0.065297,0.42393,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_NIK_NFKB2_KO_DC_UP,1
HP_URINARY_RETENTION,SET,24,0.036325,0.0013118,0.18952,0.424,HP_URINARY_RETENTION,1
GOBP_RESPIRATORY_BURST_INVOL...2,SET,9,0.057078,0.0012628,0.2979,0.42403,GOBP_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
SANSOM_APC_MYC_TARGETS,SET,223,0.010305,0.0011282,0.053795,0.42404,SANSOM_APC_MYC_TARGETS,1
BIOCARTA_NPP1_PATHWAY,SET,8,0.065368,0.0013635,0.34155,0.42411,BIOCARTA_NPP1_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...747,SET,8,0.056617,0.001181,0.29618,0.4242,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_RECYCLING,1
MA_MYELOID_DIFFERENTIATION_DN,SET,40,0.025467,0.0011868,0.13326,0.42422,MA_MYELOID_DIFFERENTIATION_DN,1
GOBP_MACROMOLECULE_METHYLATI...,SET,104,0.014059,0.0010546,0.073601,0.42426,GOBP_MACROMOLECULE_METHYLATION,1
WP_DEVELOPMENT_OF_PULMONARY_...,SET,13,0.045913,0.0012207,0.24053,0.42431,WP_DEVELOPMENT_OF_PULMONARY_DENDRITIC_CELLS_AND_MACROPHAGE_SUBSETS,1
WP_TRANSCRIPTIONAL_CASCADE_R...,SET,12,0.054552,0.0013935,0.28579,0.42431,WP_TRANSCRIPTIONAL_CASCADE_REGULATING_ADIPOGENESIS,1
HP_ABNORMAL_ENERGY_EXPENDITU...,SET,12,0.049959,0.0012762,0.26175,0.42431,HP_ABNORMAL_ENERGY_EXPENDITURE,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...3,SET,13,0.043639,0.0011602,0.22866,0.42432,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_RAS_ERK_SIGNALING_PATHWAY,1
BIOCARTA_CREM_PATHWAY,SET,6,0.077536,0.0014007,0.40634,0.42434,BIOCARTA_CREM_PATHWAY,1
GSE7852_THYMUS_VS_FAT_TCONV_...2,SET,178,0.011867,0.0011622,0.062203,0.42435,GSE7852_THYMUS_VS_FAT_TCONV_UP,1
GSE5589_UNSTIM_VS_45MIN_LPS_...5,SET,182,0.011178,0.0011068,0.058608,0.42437,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_DN,1
HP_RETINAL_ARTERIAL_TORTUOSI...,SET,3,0.075097,0.00095938,0.3938,0.42438,HP_RETINAL_ARTERIAL_TORTUOSITY,1
CASTELLANO_NRAS_TARGETS_DN,SET,13,0.047616,0.0012659,0.24971,0.42439,CASTELLANO_NRAS_TARGETS_DN,1
GOMF_ANKYRIN_REPEAT_BINDING,SET,6,0.05654,0.0010214,0.29652,0.42439,GOMF_ANKYRIN_REPEAT_BINDING,1
SCHLESINGER_H3K27ME3_IN_NORM...,SET,26,0.038412,0.0014437,0.20182,0.42453,SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER,1
GOBP_SPERM_EJACULATION,SET,6,0.059122,0.001068,0.3108,0.42457,GOBP_SPERM_EJACULATION,1
GOCC_HOST_CELLULAR_COMPONENT,SET,9,0.053313,0.0011795,0.28042,0.42461,GOCC_HOST_CELLULAR_COMPONENT,1
WIEMANN_TELOMERE_SHORTENING_...1,SET,5,0.0592,0.00097631,0.31156,0.42465,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_DN,1
HP_RIGHT_VENTRICULAR_HYPERTR...,SET,25,0.029961,0.0011043,0.15772,0.42467,HP_RIGHT_VENTRICULAR_HYPERTROPHY,1
REACTOME_SUMOYLATION_OF_DNA_...2,SET,15,0.042653,0.001218,0.22463,0.4247,REACTOME_SUMOYLATION_OF_DNA_METHYLATION_PROTEINS,1
GOBP_POSITIVE_REGULATION_OF_...538,SET,27,0.033433,0.0012805,0.17612,0.42472,GOBP_POSITIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
GSE4984_GALECTIN1_VS_LPS_STI...2,SET,144,0.012735,0.0011228,0.06715,0.4248,GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP,1
GOBP_NEURAL_PRECURSOR_CELL_P...,SET,157,0.0134,0.0012332,0.070685,0.42482,GOBP_NEURAL_PRECURSOR_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_HIGH_VOLT...,SET,8,0.062657,0.0013069,0.3305,0.42482,GOBP_REGULATION_OF_HIGH_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GSE13887_ACT_CD4_VS_NO_TREAT...1,SET,119,0.015135,0.0012139,0.079861,0.42484,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_DN,1
HP_ORAL_CAVITY_BLEEDING,SET,19,0.039428,0.001267,0.20823,0.42491,HP_ORAL_CAVITY_BLEEDING,1
GAVISH_3CA_MALIGNANT_METAPRO...9,SET,41,0.027099,0.0012785,0.14327,0.42499,GAVISH_3CA_MALIGNANT_METAPROGRAM_18_INTERFERON_MHC_II_2,1
GOBP_PLACENTA_DEVELOPMENT,SET,142,0.013862,0.0012138,0.073301,0.425,GOBP_PLACENTA_DEVELOPMENT,1
HP_PROMINENT_DIGIT_PAD,SET,35,0.026664,0.0011625,0.141,0.42501,HP_PROMINENT_DIGIT_PAD,1
GSE24634_TREG_VS_TCONV_POST_...3,SET,180,0.012075,0.0011891,0.063857,0.42501,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_DN,1
MIR6081,SET,97,0.016413,0.0011892,0.086813,0.42502,MIR6081,1
PPAR_DR1_Q2,SET,235,0.010357,0.0011637,0.054786,0.42503,PPAR_DR1_Q2,1
GOBP_POSITIVE_REGULATION_OF_...658,SET,5,0.077514,0.0012783,0.41021,0.42506,GOBP_POSITIVE_REGULATION_OF_PYROPTOSIS,1
GOBP_REGULATION_OF_DNA_TOPOI...,SET,5,0.08027,0.0013238,0.42513,0.42512,GOBP_REGULATION_OF_DNA_TOPOISOMERASE_ATP_HYDROLYZING_ACTIVITY,1
GSE37605_TREG_VS_TCONV_C57BL...3,SET,136,0.013027,0.0011164,0.069016,0.42514,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_DN,1
GOMF_MONOATOMIC_ION_GATED_CH...,SET,30,0.031173,0.0012584,0.16522,0.42517,GOMF_MONOATOMIC_ION_GATED_CHANNEL_ACTIVITY,1
PHONG_TNF_RESPONSE_NOT_VIA_P...,SET,325,0.0095595,0.0012599,0.05067,0.42518,PHONG_TNF_RESPONSE_NOT_VIA_P38,1
GOBP_NUCLEAR_ENVELOPE_ORGANI...,SET,54,0.02086,0.0011291,0.11068,0.42526,GOBP_NUCLEAR_ENVELOPE_ORGANIZATION,1
GOBP_PROSTAGLANDIN_TRANSPORT,SET,29,0.033582,0.0013329,0.17819,0.42526,GOBP_PROSTAGLANDIN_TRANSPORT,1
YAO_HOXA10_TARGETS_VIA_PROGE...1,SET,18,0.044224,0.0013833,0.23471,0.42527,YAO_HOXA10_TARGETS_VIA_PROGESTERONE_DN,1
GOBP_FOREBRAIN_NEURON_DEVELO...,SET,21,0.037414,0.001264,0.19854,0.42527,GOBP_FOREBRAIN_NEURON_DEVELOPMENT,1
GSE27786_CD4_TCELL_VS_MONO_M...2,SET,176,0.011189,0.0010897,0.059414,0.42531,GSE27786_CD4_TCELL_VS_MONO_MAC_UP,1
HP_INFECTIOUS_ENCEPHALITIS,SET,39,0.026405,0.0012151,0.14026,0.42534,HP_INFECTIOUS_ENCEPHALITIS,1
KEGG_MEDICUS_REFERENCE_GATOR...,SET,13,0.04298,0.0011427,0.22835,0.42535,KEGG_MEDICUS_REFERENCE_GATOR1_MTORC1_SIGNALING_PATHWAY,1
MCCOLLUM_GELDANAMYCIN_RESIST...2,SET,9,0.057212,0.0012657,0.30401,0.42536,MCCOLLUM_GELDANAMYCIN_RESISTANCE_UP,1
HP_ABNORMALITY_OF_BODY_MASS_...,SET,25,0.034167,0.0012593,0.18154,0.42536,HP_ABNORMALITY_OF_BODY_MASS_INDEX,1
GOBP_METHYLGLYOXAL_METABOLIC...,SET,4,0.064812,0.00095605,0.34464,0.42542,GOBP_METHYLGLYOXAL_METABOLIC_PROCESS,1
HP_ELEVATED_URINARY_DELTA_AM...,SET,5,0.083202,0.0013721,0.44251,0.42543,HP_ELEVATED_URINARY_DELTA_AMINOLEVULINIC_ACID,1
HUANG_GATA2_TARGETS_UP,SET,141,0.013701,0.0011955,0.072906,0.42547,HUANG_GATA2_TARGETS_UP,1
JOHNSTONE_PARVB_TARGETS_1_UP,SET,6,0.067931,0.0012272,0.36161,0.4255,JOHNSTONE_PARVB_TARGETS_1_UP,1
GOBP_POSITIVE_REGULATION_OF_...53,SET,7,0.063245,0.001234,0.33677,0.42552,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION_INVOLVED_IN_AXON_GUIDANCE,1
HP_ABNORMAL_FIFTH_TOE_MORPHO...,SET,83,0.016941,0.0011359,0.090207,0.42552,HP_ABNORMAL_FIFTH_TOE_MORPHOLOGY,1
MIR6775_5P,SET,4,0.089317,0.0013175,0.47569,0.42553,MIR6775_5P,1
GOCC_GTPASE_COMPLEX,SET,38,0.026333,0.0011961,0.14026,0.42554,GOCC_GTPASE_COMPLEX,1
GSE7831_UNSTIM_VS_CPG_STIM_P...2,SET,180,0.011787,0.0011607,0.062807,0.42557,GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_UP,1
GOBP_NEURON_PROJECTION_EXTEN...2,SET,19,0.03867,0.0012427,0.20611,0.42559,GOBP_NEURON_PROJECTION_EXTENSION_INVOLVED_IN_NEURON_PROJECTION_GUIDANCE,1
MIR6804_5P,SET,66,0.018785,0.0011236,0.10019,0.42564,MIR6804_5P,1
HP_CHOREA,SET,202,0.011061,0.0011532,0.059006,0.42565,HP_CHOREA,1
EHRLICH_ICF_SYNDROM_DN,SET,12,0.047354,0.0012096,0.25264,0.42566,EHRLICH_ICF_SYNDROM_DN,1
GOCC_SET1C_COMPASS_COMPLEX,SET,14,0.04065,0.0011215,0.21695,0.42569,GOCC_SET1C_COMPASS_COMPLEX,1
BIOCARTA_CDK5_PATHWAY,SET,13,0.045938,0.0012213,0.24521,0.4257,BIOCARTA_CDK5_PATHWAY,1
HP_TALL_CHIN,SET,5,0.061068,0.0010071,0.32612,0.42573,HP_TALL_CHIN,1
HP_FOCAL_T2_HYPERINTENSE_THA...,SET,14,0.037704,0.0010402,0.20144,0.42576,HP_FOCAL_T2_HYPERINTENSE_THALAMIC_LESION,1
GSE30083_SP1_VS_SP2_THYMOCYT...2,SET,178,0.012011,0.0011763,0.064165,0.42576,GSE30083_SP1_VS_SP2_THYMOCYTE_UP,1
HP_SHORT_TOE,SET,89,0.016696,0.001159,0.089251,0.4258,HP_SHORT_TOE,1
GOBP_NEGATIVE_REGULATION_OF_...137,SET,6,0.056258,0.0010163,0.30081,0.42582,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_MEDIATED_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...699,SET,51,0.023994,0.0012622,0.12833,0.42584,GOBP_NEGATIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,1
MIR208B_5P,SET,232,0.01043,0.0011644,0.055802,0.42587,MIR208B_5P,1
GOBP_ESTROGEN_BIOSYNTHETIC_P...,SET,11,0.046084,0.0011271,0.24686,0.42596,GOBP_ESTROGEN_BIOSYNTHETIC_PROCESS,1
HP_PAROXYSMAL_VENTRICULAR_TA...,SET,26,0.031158,0.0011711,0.1669,0.42596,HP_PAROXYSMAL_VENTRICULAR_TACHYCARDIA,1
GCM_ANP32B,SET,31,0.026661,0.001094,0.14316,0.42613,GCM_ANP32B,1
GOBP_GLUTATHIONE_TRANSMEMBRA...,SET,8,0.055872,0.0011654,0.30009,0.42615,GOBP_GLUTATHIONE_TRANSMEMBRANE_TRANSPORT,1
HP_HYPOPLASIA_OF_THE_PHALANG...,SET,6,0.059529,0.0010754,0.32,0.42621,HP_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_TOES,1
GSE1448_CTRL_VS_ANTI_VALPHA2...1,SET,182,0.011497,0.0011384,0.061803,0.42621,GSE1448_CTRL_VS_ANTI_VALPHA2_DP_THYMOCYTE_DN,1
HP_DIALEPTIC_SEIZURE,SET,221,0.010575,0.0011526,0.056885,0.42626,HP_DIALEPTIC_SEIZURE,1
HP_STIFF_SKIN,SET,6,0.068859,0.001244,0.37049,0.42628,HP_STIFF_SKIN,1
MIR6768_5P,SET,186,0.011683,0.0011694,0.062868,0.42629,MIR6768_5P,1
APPEL_IMATINIB_RESPONSE,SET,30,0.030323,0.0012241,0.16321,0.42631,APPEL_IMATINIB_RESPONSE,1
HP_CAUDATE_ATROPHY,SET,11,0.050005,0.001223,0.26921,0.42632,HP_CAUDATE_ATROPHY,1
KEGG_MEDICUS_REFERENCE_COPII...,SET,12,0.039995,0.0010216,0.21533,0.42633,KEGG_MEDICUS_REFERENCE_COPII_VESICLE_FORMATION,1
GOBP_NEGATIVE_REGULATION_OF_...143,SET,21,0.037537,0.0012681,0.2021,0.42633,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
GSE22282_HYPOXIA_VS_NORMOXIA...1,SET,178,0.012025,0.0011776,0.064741,0.42633,GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN,1
HP_ERYTHROCYTE_INCLUSION_BOD...,SET,6,0.057664,0.0010417,0.31077,0.4264,HP_ERYTHROCYTE_INCLUSION_BODIES,1
MIR181A_3P,SET,7,0.063912,0.0012471,0.3445,0.42641,MIR181A_3P,1
GOBP_POSITIVE_REGULATION_OF_...409,SET,79,0.017547,0.0011479,0.094605,0.42643,GOBP_POSITIVE_REGULATION_OF_LIPID_BIOSYNTHETIC_PROCESS,1
GAZIN_EPIGENETIC_SILENCING_B...,SET,25,0.032038,0.0011808,0.17275,0.42644,GAZIN_EPIGENETIC_SILENCING_BY_KRAS,1
GOBP_POSITIVE_REGULATION_OF_...495,SET,1506,0.0043795,0.0012012,0.023625,0.42647,GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS,1
REACTOME_TP53_REGULATES_TRAN...6,SET,57,0.01711,0.00095138,0.092321,0.42649,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DNA_REPAIR_GENES,1
GOBP_REGULATION_OF_CHEMOTAXIS,SET,193,0.011894,0.0012124,0.064197,0.42651,GOBP_REGULATION_OF_CHEMOTAXIS,1
HP_ABSENT_FINGERNAIL,SET,35,0.025615,0.0011168,0.13827,0.42652,HP_ABSENT_FINGERNAIL,1
GOBP_DORSAL_SPINAL_CORD_DEVE...,SET,19,0.042227,0.001357,0.22802,0.42654,GOBP_DORSAL_SPINAL_CORD_DEVELOPMENT,1
MIR3182,SET,238,0.010317,0.0011664,0.055726,0.42656,MIR3182,1
MIR378F,SET,36,0.024027,0.0010623,0.12992,0.42664,MIR378F,1
GSE33425_CD161_HIGH_VS_NEG_C...2,SET,184,0.011697,0.0011645,0.063254,0.42665,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_UP,1
E2F3_UP.V1_DN,SET,132,0.013247,0.0011186,0.071717,0.42673,E2F3_UP.V1_DN,1
REACTOME_ASSEMBLY_OF_THE_ORC...,SET,9,0.042316,0.00093619,0.22912,0.42674,REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION,1
GOBP_REGULATION_OF_CELL_DIFF...,SET,1406,0.0044531,0.0011836,0.024119,0.42676,GOBP_REGULATION_OF_CELL_DIFFERENTIATION,1
HP_SCARRING,SET,88,0.016853,0.0011634,0.091308,0.42678,HP_SCARRING,1
GCCATNTTG_YY1_Q6,SET,385,0.0076657,0.0010978,0.041543,0.4268,GCCATNTTG_YY1_Q6,1
REACTOME_MEIOTIC_RECOMBINATI...,SET,26,0.027879,0.0010478,0.1511,0.42681,REACTOME_MEIOTIC_RECOMBINATION,1
MIR5572,SET,70,0.01908,0.0011752,0.10345,0.42684,MIR5572,1
GOBP_INSULIN_LIKE_GROWTH_FAC...,SET,48,0.023518,0.0012003,0.1276,0.42688,GOBP_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE19401_UNSTIM_VS_RETINOIC_...2,SET,177,0.011043,0.0010785,0.059954,0.42693,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
GOMF_5ALPHA_ANDROSTANE_3BETA...,SET,6,0.073292,0.001324,0.39807,0.42696,GOMF_5ALPHA_ANDROSTANE_3BETA_17BETA_DIOL_DEHYDROGENASE_ACTIVITY,1
HP_ABNORMAL_RETICULOCYTE_MOR...,SET,73,0.017669,0.0011114,0.095992,0.42698,HP_ABNORMAL_RETICULOCYTE_MORPHOLOGY,1
GOMF_GTPASE_ACTIVATING_PROTE...,SET,11,0.047706,0.0011668,0.25923,0.42699,GOMF_GTPASE_ACTIVATING_PROTEIN_BINDING,1
GOBP_REGULATION_OF_MEMBRANE_...3,SET,4,0.086241,0.0012721,0.46867,0.427,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GOBP_SULFATE_TRANSPORT,SET,16,0.038845,0.0011456,0.21122,0.42704,GOBP_SULFATE_TRANSPORT,1
GOMF_KINASE_ACTIVITY,SET,682,0.0059226,0.0011195,0.032206,0.42705,GOMF_KINASE_ACTIVITY,1
GAO_ESOPHAGUS_25W_C1_CILIATE...,SET,375,0.0078723,0.001113,0.042808,0.42705,GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS,1
DESCARTES_FETAL_KIDNEY_VASCU...,SET,79,0.018419,0.001205,0.10017,0.42706,DESCARTES_FETAL_KIDNEY_VASCULAR_ENDOTHELIAL_CELLS,1
APPIERTO_RESPONSE_TO_FENRETI...2,SET,37,0.02298,0.00103,0.12505,0.4271,APPIERTO_RESPONSE_TO_FENRETINIDE_UP,1
SHEDDEN_LUNG_CANCER_POOR_SUR...,SET,417,0.0075487,0.0011241,0.041078,0.4271,SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6,1
RAMPON_ENRICHED_LEARNING_ENV...1,SET,10,0.05331,0.0012432,0.29041,0.42718,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_DN,1
GOBP_REGULATION_OF_PROTEIN_L...13,SET,137,0.012717,0.0010938,0.069318,0.42722,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
HP_CAPILLARY_FRAGILITY,SET,6,0.063485,0.0011469,0.34628,0.42727,HP_CAPILLARY_FRAGILITY,1
GSE41867_MEMORY_VS_EXHAUSTED...1,SET,180,0.01128,0.0011109,0.061557,0.4273,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_DN,1
GSE15659_CD45RA_NEG_CD4_TCEL...1,SET,164,0.011825,0.001112,0.064562,0.42734,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_DN,1
GOBP_REGULATION_OF_REGULATOR...,SET,15,0.039198,0.0011194,0.21409,0.42736,GOBP_REGULATION_OF_REGULATORY_NCRNA_PROCESSING,1
MIR203B_5P,SET,64,0.019193,0.0011306,0.10484,0.42737,MIR203B_5P,1
ZHU_CMV_24_HR_UP,SET,79,0.016949,0.0011088,0.092613,0.4274,ZHU_CMV_24_HR_UP,1
HP_ABNORMALITY_OF_JAW_MUSCLES,SET,26,0.028904,0.0010864,0.158,0.42742,HP_ABNORMALITY_OF_JAW_MUSCLES,1
GOBP_SEROTONERGIC_NEURON_AXO...,SET,5,0.064171,0.0010583,0.35086,0.42744,GOBP_SEROTONERGIC_NEURON_AXON_GUIDANCE,1
NIKOLSKY_BREAST_CANCER_7P22_...,SET,37,0.045453,0.0020374,0.24862,0.42747,NIKOLSKY_BREAST_CANCER_7P22_AMPLICON,1
GOBP_PRESYNAPSE_ORGANIZATION,SET,46,0.02428,0.0012132,0.13283,0.42748,GOBP_PRESYNAPSE_ORGANIZATION,1
HOLLERN_MICROACINAR_BREAST_T...2,SET,40,0.025299,0.0011789,0.13841,0.42749,HOLLERN_MICROACINAR_BREAST_TUMOR_UP,1
DESCARTES_MAIN_FETAL_CARDIOM...,SET,24,0.032129,0.0011603,0.17581,0.4275,DESCARTES_MAIN_FETAL_CARDIOMYOCYTES,1
HP_EQUINUS_CALCANEUS,SET,8,0.061656,0.0012861,0.33751,0.42753,HP_EQUINUS_CALCANEUS,1
FXR_Q3,SET,102,0.016178,0.0012019,0.088579,0.42754,FXR_Q3,1
HP_ABNORMAL_BLOOD_UREA_NITRO...,SET,17,0.036739,0.0011168,0.20124,0.42757,HP_ABNORMAL_BLOOD_UREA_NITROGEN_CONCENTRATION,1
GSE360_L_DONOVANI_VS_B_MALAY...5,SET,181,0.011169,0.0011029,0.061263,0.42767,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN,1
WP_MOLYBDENUM_COFACTOR_MOCO_...,SET,6,0.065976,0.0011919,0.36207,0.42771,WP_MOLYBDENUM_COFACTOR_MOCO_BIOSYNTHESIS,1
GSE27786_LSK_VS_CD8_TCELL_DN,SET,182,0.011061,0.0010953,0.060704,0.42771,GSE27786_LSK_VS_CD8_TCELL_DN,1
HALLMARK_NOTCH_SIGNALING,SET,31,0.027375,0.0011233,0.15044,0.4278,HALLMARK_NOTCH_SIGNALING,1
GSE14386_UNTREATED_VS_IFNA_T...2,SET,126,0.014115,0.0011647,0.077608,0.42784,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_UP,1
GOCC_AXONEMAL_DYNEIN_COMPLEX,SET,18,0.033005,0.0010324,0.18154,0.42787,GOCC_AXONEMAL_DYNEIN_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...150,SET,52,0.022749,0.0012084,0.1252,0.42791,GOBP_NEGATIVE_REGULATION_OF_COAGULATION,1
GOMF_PROLINE_RICH_REGION_BIN...,SET,16,0.041059,0.0012109,0.22596,0.42791,GOMF_PROLINE_RICH_REGION_BINDING,1
MIR1292_5P,SET,15,0.038583,0.0011018,0.21244,0.42794,MIR1292_5P,1
GOBP_LIPOPOLYSACCHARIDE_MEDI...,SET,54,0.021668,0.0011728,0.11929,0.42794,GOBP_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
MIR6882_5P,SET,154,0.012188,0.001111,0.067118,0.42795,MIR6882_5P,1
HP_VITREOUS_FLOATERS,SET,11,0.047777,0.0011685,0.26308,0.42795,HP_VITREOUS_FLOATERS,1
KEGG_MEDICUS_REFERENCE_HIF_1...,SET,9,0.054083,0.0011965,0.2979,0.42797,KEGG_MEDICUS_REFERENCE_HIF_1_SIGNALING_PATHWAY,1
GSE17974_0H_VS_4H_IN_VITRO_A...2,SET,168,0.012031,0.001145,0.066276,0.42798,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_UP,1
GOMF_3_5_DNA_EXONUCLEASE_ACT...,SET,13,0.041313,0.0010984,0.22776,0.42803,GOMF_3_5_DNA_EXONUCLEASE_ACTIVITY,1
YTATTTTNR_MEF2_02,SET,627,0.0063546,0.0011535,0.035034,0.42804,YTATTTTNR_MEF2_02,1
REACTOME_SMAD2_SMAD3_SMAD4_H...,SET,35,0.024788,0.0010807,0.13673,0.42807,REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION,1
MIR4533,SET,303,0.0086001,0.0010951,0.047436,0.42807,MIR4533,1
SP3_Q3,SET,212,0.010563,0.0011279,0.058266,0.42807,SP3_Q3,1
ZNF697_TARGET_GENES,SET,121,0.013168,0.001065,0.072646,0.42808,ZNF697_TARGET_GENES,1
MIR3617_5P,SET,232,0.010036,0.0011205,0.05541,0.42813,MIR3617_5P,1
GSE12845_IGD_NEG_BLOOD_VS_NA...2,SET,173,0.011134,0.0010751,0.061478,0.42814,GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,1
REACTOME_TP53_REGULATES_TRAN...3,SET,48,0.021666,0.0011058,0.11965,0.42815,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_GENES,1
HP_DECREASED_CERVICAL_SPINE_...2,SET,11,0.044347,0.0010846,0.24488,0.42815,HP_DECREASED_CERVICAL_SPINE_MOBILITY,1
REACTOME_REGULATED_PROTEOLYS...,SET,10,0.045108,0.0010519,0.24921,0.42818,REACTOME_REGULATED_PROTEOLYSIS_OF_P75NTR,1
MIR520F_5P,SET,182,0.011564,0.001145,0.063911,0.42821,MIR520F_5P,1
GOCC_DNA_POLYMERASE_COMPLEX,SET,19,0.030487,0.00097971,0.16852,0.42822,GOCC_DNA_POLYMERASE_COMPLEX,1
E4F1_Q6,SET,255,0.0096584,0.0011297,0.053401,0.42824,E4F1_Q6,1
HP_HEMIMEGALENCEPHALY,SET,14,0.042302,0.0011671,0.23417,0.42832,HP_HEMIMEGALENCEPHALY,1
GOBP_REGULATION_OF_SYNAPSE_M...,SET,21,0.034607,0.0011691,0.19171,0.42837,GOBP_REGULATION_OF_SYNAPSE_MATURATION,1
GOMF_DIACYLGLYCEROL_O_ACYLTR...,SET,5,0.075146,0.0012393,0.4163,0.42838,GOMF_DIACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,1
GSE360_T_GONDII_VS_M_TUBERCU...1,SET,184,0.01149,0.0011439,0.063669,0.42839,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_DN,1
LINDGREN_BLADDER_CANCER_WITH...,SET,103,0.014807,0.0011054,0.082071,0.42841,LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q,1
GOBP_PURINE_DEOXYRIBONUCLEOT...1,SET,5,0.065451,0.0010794,0.36285,0.42843,GOBP_PURINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
HP_PROTRUDING_EAR,SET,168,0.011328,0.0010781,0.062856,0.42849,HP_PROTRUDING_EAR,1
MIR8070,SET,116,0.014894,0.0011795,0.082658,0.42851,MIR8070,1
HP_APLASIA_HYPOPLASIA_INVOLV...9,SET,119,0.014265,0.0011441,0.079204,0.42854,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_METACARPAL_BONES,1
AIZARANI_LIVER_C10_MVECS_1,SET,245,0.010789,0.0012373,0.059904,0.42854,AIZARANI_LIVER_C10_MVECS_1,1
KEGG_MEDICUS_ENV_FACTOR_E2_T...1,SET,7,0.060444,0.0011794,0.33597,0.42861,KEGG_MEDICUS_ENV_FACTOR_E2_TO_NUCLEAR_INITIATED_ESTROGEN_SIGNALING_PATHWAY,1
HP_PROGRESSIVE_VISUAL_FIELD_...,SET,13,0.041444,0.0011018,0.23038,0.42862,HP_PROGRESSIVE_VISUAL_FIELD_DEFECTS,1
GOMF_PURINE_NUCLEOTIDE_BINDI...,SET,1797,0.0037044,0.0011003,0.020623,0.42872,GOMF_PURINE_NUCLEOTIDE_BINDING,1
PID_CD8_TCR_PATHWAY,SET,51,0.020705,0.0010892,0.11531,0.42875,PID_CD8_TCR_PATHWAY,1
GOBP_ESTABLISHMENT_OR_MAINTE...2,SET,211,0.010626,0.001132,0.059241,0.42882,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_CELL_POLARITY,1
KEGG_BLADDER_CANCER,SET,40,0.024229,0.0011291,0.13517,0.42887,KEGG_BLADDER_CANCER,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...2,SET,120,0.013739,0.0011065,0.076645,0.42887,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_UP,1
GSE31082_DP_VS_CD8_SP_THYMOC...2,SET,180,0.010702,0.0010539,0.059865,0.42906,GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP,1
MORF_DEK,SET,237,0.0089558,0.0010104,0.050107,0.42907,MORF_DEK,1
GSE45365_WT_VS_IFNAR_KO_CD8A...4,SET,174,0.011485,0.0011122,0.064278,0.4291,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_UP,1
REACTOME_DEFECTIVE_CHSY1_CAU...,SET,7,0.062386,0.0012173,0.34921,0.42911,REACTOME_DEFECTIVE_CHSY1_CAUSES_TPBS,1
DESCARTES_MAIN_FETAL_ADRENOC...,SET,62,0.019738,0.0011445,0.11049,0.42911,DESCARTES_MAIN_FETAL_ADRENOCORTICAL_CELLS,1
GOBP_PROTEIN_INSERTION_INTO_...5,SET,10,0.043845,0.0010224,0.24567,0.42918,GOBP_PROTEIN_INSERTION_INTO_MITOCHONDRIAL_INNER_MEMBRANE,1
GOBP_NADH_DEHYDROGENASE_COMP...,SET,48,0.019067,0.00097314,0.10694,0.42925,GOBP_NADH_DEHYDROGENASE_COMPLEX_ASSEMBLY,1
FINAK_BREAST_CANCER_SDPP_SIG...,SET,20,0.038344,0.0012642,0.21512,0.42927,FINAK_BREAST_CANCER_SDPP_SIGNATURE,1
GOBP_NEGATIVE_REGULATION_OF_...420,SET,9,0.055063,0.0012182,0.30909,0.42931,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,1
HP_ABNORMAL_RIGHT_VENTRICULA...,SET,19,0.034961,0.0011235,0.19628,0.42932,HP_ABNORMAL_RIGHT_VENTRICULAR_FUNCTION,1
REACTOME_INSERTION_OF_TAIL_A...,SET,18,0.033758,0.0010559,0.18958,0.42934,REACTOME_INSERTION_OF_TAIL_ANCHORED_PROTEINS_INTO_THE_ENDOPLASMIC_RETICULUM_MEMBRANE,1
MIR146A_5P,SET,103,0.014493,0.0010819,0.081399,0.42934,MIR146A_5P,1
STAT1_03,SET,239,0.0098263,0.0011132,0.055189,0.42934,STAT1_03,1
GSE22935_UNSTIM_VS_12H_MBOVI...3,SET,181,0.010753,0.0010619,0.060435,0.42939,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GSE21063_WT_VS_NFATC1_KO_BCE...1,SET,181,0.010379,0.0010249,0.058361,0.42943,GSE21063_WT_VS_NFATC1_KO_BCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_APO...1,SET,13,0.042734,0.0011361,0.24032,0.42943,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M1_MACROPHAGE_CELL,1
REACTOME_SENSORY_PERCEPTION_...1,SET,6,0.071097,0.0012844,0.39989,0.42944,REACTOME_SENSORY_PERCEPTION_OF_SALTY_TASTE,1
GOBP_MEMORY,SET,118,0.01395,0.0011142,0.078458,0.42944,GOBP_MEMORY,1
HP_BILATERAL_CRYPTORCHIDISM,SET,43,0.020209,0.00097636,0.1137,0.42947,HP_BILATERAL_CRYPTORCHIDISM,1
GSE36078_WT_VS_IL1R_KO_LUNG_...3,SET,180,0.011347,0.0011174,0.063848,0.42947,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_DN,1
GSE39556_UNTREATED_VS_3H_POL...3,SET,179,0.01141,0.0011206,0.064227,0.4295,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_DN,1
GOBP_REGULATION_OF_BINDING,SET,206,0.010632,0.0011193,0.059865,0.42952,GOBP_REGULATION_OF_BINDING,1
KEGG_MEDICUS_REFERENCE_GF_RT...3,SET,87,0.017732,0.0012171,0.099885,0.42955,KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY,1
MIR1290,SET,241,0.0097771,0.0011122,0.05509,0.42957,MIR1290,1
GOMF_ARACHIDONATE_COA_LIGASE...,SET,10,0.046189,0.0010771,0.26037,0.4296,GOMF_ARACHIDONATE_COA_LIGASE_ACTIVITY,1
HP_SMALL_SCROTUM,SET,51,0.022256,0.0011708,0.12552,0.42963,HP_SMALL_SCROTUM,1
chr12q23,SET,68,0.035004,0.0021252,0.19749,0.42966,chr12q23,1
GOBP_NUCLEOBASE_CONTAINING_S...1,SET,15,0.039795,0.0011364,0.22453,0.42966,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,1
CSR_LATE_UP.V1_UP,SET,154,0.012091,0.0011022,0.068311,0.42975,CSR_LATE_UP.V1_UP,1
KYNG_ENVIRONMENTAL_STRESS_RE...2,SET,12,0.041601,0.0010627,0.23551,0.42989,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_OLD,1
GOBP_2_OXOGLUTARATE_METABOLI...,SET,16,0.03594,0.0010599,0.20345,0.42989,GOBP_2_OXOGLUTARATE_METABOLIC_PROCESS,1
GOCC_EUKARYOTIC_TRANSLATION_...3,SET,13,0.037302,0.00099173,0.21147,0.42999,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_3_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...643,SET,4,0.077614,0.0011449,0.44033,0.43004,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,1
GOBP_NEGATIVE_REGULATION_OF_...444,SET,5,0.05429,0.00089533,0.30801,0.43005,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,1
GSE10325_MYELOID_VS_LUPUS_MY...1,SET,185,0.011055,0.0011035,0.062724,0.43005,GSE10325_MYELOID_VS_LUPUS_MYELOID_DN,1
GOMF_HISTONE_DECROTONYLASE_A...,SET,4,0.070394,0.0010384,0.39958,0.43008,GOMF_HISTONE_DECROTONYLASE_ACTIVITY,1
HP_COLD_INDUCED_MUSCLE_CRAMPS,SET,6,0.066193,0.0011958,0.37596,0.43012,HP_COLD_INDUCED_MUSCLE_CRAMPS,1
GSE29618_BCELL_VS_MDC_DAY7_F...1,SET,183,0.011293,0.0011213,0.064143,0.43012,GSE29618_BCELL_VS_MDC_DAY7_FLU_VACCINE_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...42,SET,15,0.037227,0.0010631,0.21152,0.43015,GOBP_PROTEIN_LOCALIZATION_TO_PHAGOPHORE_ASSEMBLY_SITE,1
HP_PARANOIA,SET,20,0.031248,0.0010302,0.17754,0.43015,HP_PARANOIA,1
GSE12392_CD8A_POS_VS_NEG_SPL...4,SET,188,0.010453,0.0010518,0.059414,0.43017,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_UP,1
GSE411_100MIN_VS_400MIN_IL6_...3,SET,183,0.010535,0.001046,0.059879,0.43017,GSE411_100MIN_VS_400MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
HP_ABNORMAL_FINGER_MORPHOLOGY,SET,1056,0.0046291,0.0010772,0.026324,0.43021,HP_ABNORMAL_FINGER_MORPHOLOGY,1
HP_HYPOSEGMENTATION_OF_NEUTR...,SET,6,0.063212,0.0011419,0.35952,0.43022,HP_HYPOSEGMENTATION_OF_NEUTROPHIL_NUCLEI,1
GOBP_VITAMIN_D3_METABOLIC_PR...,SET,7,0.050691,0.0009891,0.28837,0.43023,GOBP_VITAMIN_D3_METABOLIC_PROCESS,1
HP_INCREASED_CIRCULATING_REN...,SET,18,0.039646,0.0012401,0.22554,0.43023,HP_INCREASED_CIRCULATING_RENIN_LEVEL,1
HP_SPONDYLOLYSIS,SET,5,0.063617,0.0010491,0.36192,0.43024,HP_SPONDYLOLYSIS,1
HP_PREAXIAL_POLYDACTYLY,SET,73,0.016152,0.0010159,0.091927,0.43027,HP_PREAXIAL_POLYDACTYLY,1
GNF2_SMC2L1,SET,32,0.026729,0.0011143,0.15219,0.43029,GNF2_SMC2L1,1
GOMF_EXTRACELLULAR_MATRIX_BI...,SET,61,0.020208,0.0011623,0.11509,0.43031,GOMF_EXTRACELLULAR_MATRIX_BINDING,1
HP_EYELID_APRAXIA,SET,5,0.063535,0.0010478,0.36201,0.43034,HP_EYELID_APRAXIA,1
REACTOME_SIGNALING_BY_FGFR4,SET,39,0.023546,0.0010835,0.13417,0.43035,REACTOME_SIGNALING_BY_FGFR4,1
HP_PREMATURE_PUBARCHE,SET,13,0.045819,0.0012182,0.26119,0.43037,HP_PREMATURE_PUBARCHE,1
GSE9006_HEALTHY_VS_TYPE_1_DI...3,SET,176,0.010279,0.0010011,0.058608,0.43039,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_4MONTH_POST_DX_DN,1
NOJIMA_SFRP2_TARGETS_UP,SET,29,0.029311,0.0011634,0.16719,0.43042,NOJIMA_SFRP2_TARGETS_UP,1
LI_ESTROGENE_MCF7_E2_RESPONS...1,SET,35,0.02794,0.0012181,0.15945,0.43045,LI_ESTROGENE_MCF7_E2_RESPONSE_DN,1
GOBP_OLEFINIC_COMPOUND_BIOSY...,SET,26,0.030336,0.0011402,0.17323,0.43049,GOBP_OLEFINIC_COMPOUND_BIOSYNTHETIC_PROCESS,1
HP_ECTRODACTYLY,SET,66,0.019006,0.0011369,0.1086,0.43054,HP_ECTRODACTYLY,1
JINESH_BLEBBISHIELD_VS_LIVE_...2,SET,304,0.0082983,0.0010584,0.047432,0.43056,JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP,1
HP_DISSEMINATED_INTRAVASCULA...,SET,25,0.0293,0.0010799,0.16754,0.43059,HP_DISSEMINATED_INTRAVASCULAR_COAGULATION,1
RUTELLA_RESPONSE_TO_CSF2RB_A...2,SET,301,0.0087833,0.0011148,0.050231,0.4306,RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_UP,1
GOMF_TOXIN_TRANSMEMBRANE_TRA...,SET,9,0.055864,0.0012359,0.31955,0.43061,GOMF_TOXIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_UCHL1...,SET,4,0.095333,0.0014063,0.54561,0.43065,KEGG_MEDICUS_REFERENCE_UCHL1_MEDIATED_HYDROLYSIS,1
GOMF_INSULIN_RECEPTOR_BINDING,SET,21,0.034868,0.001178,0.19966,0.43068,GOMF_INSULIN_RECEPTOR_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...16,SET,25,0.031646,0.0011664,0.18143,0.43077,GOBP_NEGATIVE_REGULATION_OF_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GSE17721_POLYIC_VS_GARDIQUIM...3,SET,183,0.010363,0.0010289,0.059473,0.43083,GSE17721_POLYIC_VS_GARDIQUIMOD_12H_BMDC_DN,1
NIKOLSKY_BREAST_CANCER_19Q13...2,SET,7,0.083391,0.0016271,0.47915,0.43092,NIKOLSKY_BREAST_CANCER_19Q13.4_AMPLICON,1
HP_INSIDIOUS_ONSET,SET,15,0.03456,0.0009869,0.1986,0.43093,HP_INSIDIOUS_ONSET,1
GOBP_ACTIVATION_OF_GTPASE_AC...,SET,81,0.016562,0.0010971,0.0952,0.43094,GOBP_ACTIVATION_OF_GTPASE_ACTIVITY,1
GOBP_MYELIN_ASSEMBLY,SET,23,0.031339,0.0011079,0.18018,0.43096,GOBP_MYELIN_ASSEMBLY,1
REACTOME_TRANSPORT_AND_SYNTH...,SET,6,0.063071,0.0011394,0.36274,0.43098,REACTOME_TRANSPORT_AND_SYNTHESIS_OF_PAPS,1
GOBP_DOUBLE_STRAND_BREAK_REP...6,SET,58,0.017165,0.00096272,0.098713,0.43098,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_NONHOMOLOGOUS_END_JOINING,1
REACTOME_ATTACHMENT_OF_GPI_A...,SET,7,0.047214,0.00092125,0.27187,0.43107,REACTOME_ATTACHMENT_OF_GPI_ANCHOR_TO_UPAR,1
AAGWWRNYGGC_UNKNOWN,SET,111,0.013588,0.0010528,0.078247,0.43107,AAGWWRNYGGC_UNKNOWN,1
HP_ABNORMAL_FOOT_BONE_OSSIFI...,SET,9,0.046803,0.0010354,0.2695,0.43107,HP_ABNORMAL_FOOT_BONE_OSSIFICATION,1
MIR6861_3P,SET,45,0.021313,0.0010533,0.12295,0.43119,MIR6861_3P,1
HP_EEG_WITH_FOCAL_EPILEPTIFO...,SET,108,0.014502,0.0011084,0.083662,0.43119,HP_EEG_WITH_FOCAL_EPILEPTIFORM_DISCHARGES,1
HP_NEOPLASM_OF_THE_LARYNX,SET,18,0.031919,0.00099841,0.1843,0.43125,HP_NEOPLASM_OF_THE_LARYNX,1
MODULE_252,SET,227,0.0091614,0.0010119,0.052946,0.43131,MODULE_252,1
MIR4456,SET,119,0.013043,0.0010461,0.075409,0.43134,MIR4456,1
GOBP_DE_NOVO_PYRIMIDINE_NUCL...,SET,6,0.056042,0.0010124,0.32403,0.43135,GOBP_DE_NOVO_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
GSE12845_IGD_NEG_BLOOD_VS_PR...2,SET,169,0.010749,0.001026,0.062193,0.43139,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_UP,1
MIR122_5P,SET,82,0.01544,0.001029,0.089369,0.43142,MIR122_5P,1
GOBP_REGULATION_OF_TRANSLATI...8,SET,5,0.069583,0.0011475,0.40296,0.43145,GOBP_REGULATION_OF_TRANSLATION_AT_POSTSYNAPSE,1
TBX1_TARGET_GENES,SET,166,0.011007,0.0010413,0.06376,0.43147,TBX1_TARGET_GENES,1
HP_ELEVATED_HEPATIC_IRON_CON...,SET,11,0.044494,0.0010882,0.25808,0.43156,HP_ELEVATED_HEPATIC_IRON_CONCENTRATION,1
DAUER_STAT3_TARGETS_DN,SET,46,0.022385,0.0011185,0.12987,0.43158,DAUER_STAT3_TARGETS_DN,1
GOBP_MICROAUTOPHAGY,SET,22,0.029522,0.0010208,0.17153,0.43168,GOBP_MICROAUTOPHAGY,1
REACTOME_PTK6_PROMOTES_HIF1A...,SET,6,0.063937,0.001155,0.37157,0.43169,REACTOME_PTK6_PROMOTES_HIF1A_STABILIZATION,1
GOBP_CELLULAR_RESPONSE_TO_CA...3,SET,69,0.018303,0.0011193,0.1064,0.43171,GOBP_CELLULAR_RESPONSE_TO_CALCIUM_ION,1
GOBP_POSITIVE_REGULATION_OF_...287,SET,25,0.031488,0.0011605,0.1831,0.43173,GOBP_POSITIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...755,SET,5,0.070753,0.0011668,0.41141,0.43173,GOBP_POSITIVE_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
CCACACA_MIR147,SET,56,0.018624,0.0010265,0.10836,0.43177,CCACACA_MIR147,1
GOBP_ENDOCARDIUM_MORPHOGENES...,SET,6,0.069986,0.0012643,0.40725,0.43178,GOBP_ENDOCARDIUM_MORPHOGENESIS,1
MIR651_5P,SET,107,0.014226,0.0010823,0.082855,0.43184,MIR651_5P,1
RAMPON_ENRICHED_LEARNING_ENV...2,SET,14,0.036241,0.00099987,0.21115,0.43186,RAMPON_ENRICHED_LEARNING_ENVIRONMENT_EARLY_UP,1
MIR3165,SET,33,0.02417,0.0010233,0.14083,0.43187,MIR3165,1
GOCC_PRERIBOSOME,SET,94,0.013811,0.0009852,0.080505,0.43189,GOCC_PRERIBOSOME,1
HP_PROMINENT_VEINS_ON_TRUNK,SET,5,0.055511,0.00091547,0.32356,0.43189,HP_PROMINENT_VEINS_ON_TRUNK,1
GOMF_SUMO_POLYMER_BINDING,SET,5,0.05886,0.00097069,0.3431,0.4319,GOMF_SUMO_POLYMER_BINDING,1
ZNF146_TARGET_GENES,SET,889,0.0049264,0.0010569,0.028733,0.43193,ZNF146_TARGET_GENES,1
GOBP_CELL_PROLIFERATION_IN_H...,SET,13,0.040333,0.0010723,0.2354,0.43198,GOBP_CELL_PROLIFERATION_IN_HINDBRAIN,1
HP_NORMAL_INTERICTAL_EEG,SET,6,0.059687,0.0010783,0.34836,0.43198,HP_NORMAL_INTERICTAL_EEG,1
GSE24634_TREG_VS_TCONV_POST_...6,SET,179,0.010336,0.0010151,0.060392,0.43205,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_UP,1
WP_PYRIMIDINE_METABOLISM,SET,75,0.015828,0.001009,0.092564,0.43212,WP_PYRIMIDINE_METABOLISM,1
GOBP_APOPTOTIC_DNA_FRAGMENTA...,SET,18,0.034363,0.0010749,0.20107,0.43215,GOBP_APOPTOTIC_DNA_FRAGMENTATION,1
GOBP_POSITIVE_REGULATION_OF_...308,SET,40,0.024186,0.0011271,0.14169,0.43223,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_TRANSMEMBRANE_TRANSPORT,1
HP_MEDIASTINAL_LYMPHADENOPAT...,SET,24,0.031515,0.0011381,0.18488,0.43232,HP_MEDIASTINAL_LYMPHADENOPATHY,1
GOBP_CERAMIDE_BIOSYNTHETIC_P...,SET,66,0.018069,0.0010808,0.1061,0.43239,GOBP_CERAMIDE_BIOSYNTHETIC_PROCESS,1
GOBP_MACROPHAGE_CYTOKINE_PRO...,SET,35,0.025153,0.0010966,0.14783,0.43245,GOBP_MACROPHAGE_CYTOKINE_PRODUCTION,1
GOBP_PYRIMIDINE_NUCLEOBASE_B...,SET,7,0.050065,0.00097687,0.29432,0.43246,GOBP_PYRIMIDINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
GAANYNYGACNY_UNKNOWN,SET,65,0.017886,0.0010618,0.10517,0.43248,GAANYNYGACNY_UNKNOWN,1
GOBP_ANATOMICAL_STRUCTURE_RE...,SET,15,0.038386,0.0010962,0.22572,0.43248,GOBP_ANATOMICAL_STRUCTURE_REGRESSION,1
CACTGTG_MIR128A_MIR128B,SET,306,0.0082303,0.0010531,0.048476,0.43259,CACTGTG_MIR128A_MIR128B,1
chr10p15,SET,30,0.042262,0.0017061,0.24917,0.43266,chr10p15,1
KEGG_MEDICUS_REFERENCE_EGF_E...9,SET,15,0.036509,0.0010426,0.21537,0.43269,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY,1
BIOCARTA_HDAC_PATHWAY,SET,25,0.029265,0.0010786,0.17302,0.43285,BIOCARTA_HDAC_PATHWAY,1
GOBP_REGULATION_OF_NATURAL_K...6,SET,12,0.046704,0.001193,0.27626,0.43288,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_PROLIFERATION,1
GSE9006_HEALTHY_VS_TYPE_1_DI...1,SET,171,0.010664,0.0010238,0.063128,0.43293,GSE9006_HEALTHY_VS_TYPE_1_DIABETES_PBMC_1MONTH_POST_DX_DN,1
RICKMAN_TUMOR_DIFFERENTIATED...4,SET,97,0.01454,0.0010535,0.086104,0.43295,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP,1
MIR6875_5P,SET,62,0.01774,0.0010286,0.10505,0.43295,MIR6875_5P,1
GOBP_FORMATION_OF_CYTOPLASMI...,SET,13,0.036187,0.00096208,0.21443,0.43299,GOBP_FORMATION_OF_CYTOPLASMIC_TRANSLATION_INITIATION_COMPLEX,1
NABA_ECM_AFFILIATED,SET,151,0.013152,0.0011872,0.077953,0.43301,NABA_ECM_AFFILIATED,1
GOBP_SPONTANEOUS_SYNAPTIC_TR...,SET,13,0.042616,0.001133,0.25279,0.43306,GOBP_SPONTANEOUS_SYNAPTIC_TRANSMISSION,1
HP_VIRAL_HEPATITIS,SET,13,0.040376,0.0010734,0.23949,0.43306,HP_VIRAL_HEPATITIS,1
GOCC_DYNEIN_COMPLEX,SET,43,0.020293,0.0009804,0.12047,0.43312,GOCC_DYNEIN_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...549,SET,59,0.019623,0.00111,0.11653,0.43314,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_DIVISION,1
HP_ABNORMAL_CIRCULATING_ANDR...2,SET,11,0.044343,0.0010845,0.26335,0.43314,HP_ABNORMAL_CIRCULATING_ANDROSTENEDIONE_CONCENTRATION,1
CASORELLI_ACUTE_PROMYELOCYTI...1,SET,591,0.0056933,0.0010044,0.033827,0.43317,CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN,1
DESCARTES_MAIN_FETAL_PDE11A_...,SET,37,0.026634,0.0011938,0.15824,0.43317,DESCARTES_MAIN_FETAL_PDE11A_FAM19A2_POSITIVE_CELLS,1
HP_PLETHORA,SET,12,0.041477,0.0010595,0.24651,0.43319,HP_PLETHORA,1
HP_ABSENT_INNER_AND_OUTER_DY...,SET,3,0.072552,0.00092686,0.4314,0.43322,HP_ABSENT_INNER_AND_OUTER_DYNEIN_ARMS,1
REACTOME_PREGNENOLONE_BIOSYN...,SET,10,0.047532,0.0011084,0.28276,0.43325,REACTOME_PREGNENOLONE_BIOSYNTHESIS,1
PIONTEK_PKD1_TARGETS_UP,SET,39,0.022621,0.0010409,0.13467,0.4333,PIONTEK_PKD1_TARGETS_UP,1
KEGG_SYSTEMIC_LUPUS_ERYTHEMA...,SET,48,0.021818,0.0011135,0.12993,0.43333,KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
RYBP_TARGET_GENES,SET,1411,0.0040178,0.0010697,0.023928,0.43333,RYBP_TARGET_GENES,1
HP_POSTAXIAL_HAND_POLYDACTYLY,SET,78,0.015322,0.00099603,0.09126,0.43334,HP_POSTAXIAL_HAND_POLYDACTYLY,1
HP_ABNORMAL_CIRCULATING_ASPA...,SET,22,0.031874,0.0011021,0.18988,0.43335,HP_ABNORMAL_CIRCULATING_ASPARTATE_FAMILY_AMINO_ACID_CONCENTRATION,1
MIR4680_5P,SET,58,0.018303,0.0010266,0.10907,0.43336,MIR4680_5P,1
GOBP_HYPOTHALAMUS_DEVELOPMENT,SET,25,0.031606,0.0011649,0.18855,0.43344,GOBP_HYPOTHALAMUS_DEVELOPMENT,1
HP_THENAR_MUSCLE_ATROPHY,SET,13,0.032987,0.000877,0.19683,0.43345,HP_THENAR_MUSCLE_ATROPHY,1
GOMF_BICARBONATE_TRANSMEMBRA...,SET,31,0.02455,0.0010074,0.14656,0.43348,GOMF_BICARBONATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR12132,SET,134,0.011827,0.0010062,0.070657,0.43353,MIR12132,1
WP_BILE_ACID_SYNTHESIS_AND_E...,SET,12,0.04631,0.001183,0.27672,0.43355,WP_BILE_ACID_SYNTHESIS_AND_ENTEROHEPATIC_CIRCULATION,1
HP_STENOSIS_OF_THE_EXTERNAL_...,SET,32,0.025507,0.0010634,0.15248,0.43357,HP_STENOSIS_OF_THE_EXTERNAL_AUDITORY_CANAL,1
GOBP_STEROID_HORMONE_SECRETI...,SET,26,0.02979,0.0011197,0.17812,0.43359,GOBP_STEROID_HORMONE_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...243,SET,8,0.049107,0.0010243,0.29396,0.43366,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_MIGRATION,1
HP_ABNORMAL_NASAL_MORPHOLOGY,SET,1289,0.003957,0.0010105,0.023686,0.43366,HP_ABNORMAL_NASAL_MORPHOLOGY,1
GOBP_REGULATION_OF_SECONDARY...1,SET,8,0.053695,0.00112,0.32179,0.43374,GOBP_REGULATION_OF_SECONDARY_HEART_FIELD_CARDIOBLAST_PROLIFERATION,1
ESC_V6.5_UP_LATE.V1_UP,SET,162,0.011728,0.0010963,0.070293,0.43375,ESC_V6.5_UP_LATE.V1_UP,1
GOCC_MICROBODY,SET,132,0.012029,0.0010158,0.07217,0.43381,GOCC_MICROBODY,1
GSE36826_NORMAL_VS_STAPH_AUR...3,SET,187,0.010341,0.0010378,0.062037,0.43381,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_DN,1
MIR1205,SET,160,0.011079,0.0010292,0.066504,0.43384,MIR1205,1
HP_ULNAR_DEVIATION_OF_THE_WR...,SET,19,0.037156,0.001194,0.22309,0.43386,HP_ULNAR_DEVIATION_OF_THE_WRIST,1
GOBP_PEPTIDYL_SERINE_DEPHOSP...,SET,14,0.03375,0.00093112,0.20271,0.43389,GOBP_PEPTIDYL_SERINE_DEPHOSPHORYLATION,1
GSE21546_UNSTIM_VS_ANTI_CD3_...2,SET,163,0.011253,0.001055,0.067609,0.43391,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
ZZZ3_TARGET_GENES,SET,234,0.0089425,0.0010026,0.053772,0.43396,ZZZ3_TARGET_GENES,1
GOBP_HISTIDINE_METABOLIC_PRO...,SET,8,0.051455,0.0010733,0.30955,0.43399,GOBP_HISTIDINE_METABOLIC_PROCESS,1
GOBP_T_CELL_EXTRAVASATION,SET,11,0.044245,0.0010821,0.26618,0.43399,GOBP_T_CELL_EXTRAVASATION,1
GOBP_INNER_EAR_RECEPTOR_CELL...3,SET,32,0.026159,0.0010906,0.15775,0.43415,GOBP_INNER_EAR_RECEPTOR_CELL_STEREOCILIUM_ORGANIZATION,1
GOBP_REGULATION_OF_GROWTH_HO...,SET,6,0.060773,0.0010979,0.36688,0.43422,GOBP_REGULATION_OF_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...621,SET,11,0.050541,0.0012361,0.30526,0.43425,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ORGANIZATION,1
DESCARTES_FETAL_HEART_EPICAR...,SET,90,0.015727,0.0010979,0.095029,0.43428,DESCARTES_FETAL_HEART_EPICARDIAL_FAT_CELLS,1
BYSTRYKH_HEMATOPOIESIS_STEM_...5,SET,8,0.050044,0.0010439,0.30255,0.43431,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_IL3RA,1
HP_PERIPHERAL_AXONAL_NEUROPA...,SET,152,0.011146,0.0010094,0.067408,0.43433,HP_PERIPHERAL_AXONAL_NEUROPATHY,1
GOBP_GAS_TRANSPORT,SET,18,0.039075,0.0012222,0.23662,0.43442,GOBP_GAS_TRANSPORT,1
MIR4709_3P,SET,148,0.011467,0.0010249,0.069456,0.43443,MIR4709_3P,1
GOMF_RNA_POLYMERASE_III_TRAN...,SET,8,0.041479,0.00086521,0.25126,0.43444,GOMF_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
MIR215_3P,SET,119,0.012973,0.0010405,0.078639,0.43449,MIR215_3P,1
GOMF_TAU_PROTEIN_KINASE_ACTI...,SET,22,0.026744,0.00092474,0.16219,0.43452,GOMF_TAU_PROTEIN_KINASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...279,SET,12,0.043248,0.0011047,0.26249,0.43457,GOBP_NEGATIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
HP_OLIGOZOOSPERMIA,SET,43,0.020035,0.00096797,0.12161,0.43457,HP_OLIGOZOOSPERMIA,1
GOMF_NUCLEOSOME_BINDING,SET,52,0.018614,0.00098868,0.11301,0.43459,GOMF_NUCLEOSOME_BINDING,1
HP_ABNORMAL_LIP_MORPHOLOGY,SET,1049,0.0043551,0.0010103,0.026471,0.43466,HP_ABNORMAL_LIP_MORPHOLOGY,1
GOBP_CORTISOL_BIOSYNTHETIC_P...,SET,10,0.050869,0.0011862,0.30931,0.43468,GOBP_CORTISOL_BIOSYNTHETIC_PROCESS,1
DESCARTES_FETAL_STOMACH_LYMP...1,SET,19,0.035219,0.0011318,0.21411,0.43468,DESCARTES_FETAL_STOMACH_LYMPHATIC_ENDOTHELIAL_CELLS,1
SHEPARD_CRASH_AND_BURN_MUTAN...1,SET,179,0.010648,0.0010457,0.064747,0.43469,SHEPARD_CRASH_AND_BURN_MUTANT_DN,1
HP_DEVELOPMENTAL_GLAUCOMA,SET,64,0.017504,0.0010311,0.1065,0.43473,HP_DEVELOPMENTAL_GLAUCOMA,1
GAVISH_3CA_METAPROGRAM_ENDOT...6,SET,42,0.023885,0.0011405,0.14545,0.43478,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_4,1
GSE20715_WT_VS_TLR4_KO_24H_O...1,SET,181,0.0099356,0.00098113,0.060501,0.43478,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_DN,1
WP_MACROPHAGESTIMULATING_PRO...,SET,104,0.014546,0.0010911,0.088604,0.4348,WP_MACROPHAGESTIMULATING_PROTEIN_MSP_SIGNALING,1
GOBP_REGULATION_OF_CORTISOL_...,SET,7,0.05687,0.0011097,0.34649,0.43481,GOBP_REGULATION_OF_CORTISOL_BIOSYNTHETIC_PROCESS,1
GSE25088_CTRL_VS_IL4_AND_ROS...2,SET,160,0.011224,0.0010427,0.068395,0.43482,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
HP_TYPIFIED_BY_SOMATIC_MOSAI...,SET,162,0.011171,0.0010441,0.068087,0.43484,HP_TYPIFIED_BY_SOMATIC_MOSAICISM,1
GOBP_PURINE_DEOXYRIBONUCLEOS...2,SET,6,0.058927,0.0010645,0.3592,0.43485,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GOCC_ENDOCYTIC_VESICLE,SET,315,0.0081387,0.0010563,0.049613,0.43485,GOCC_ENDOCYTIC_VESICLE,1
RODWELL_AGING_KIDNEY_NO_BLOO...2,SET,196,0.010435,0.0010718,0.063644,0.43488,RODWELL_AGING_KIDNEY_NO_BLOOD_UP,1
REACTOME_INTERLEUKIN_20_FAMI...,SET,26,0.029543,0.0011104,0.1804,0.43496,REACTOME_INTERLEUKIN_20_FAMILY_SIGNALING,1
FAN_EMBRYONIC_CTX_NSC_1,SET,16,0.037587,0.0011085,0.22964,0.43499,FAN_EMBRYONIC_CTX_NSC_1,1
WP_GROWTH_FACTORS_AND_HORMON...,SET,26,0.026501,0.00099605,0.16199,0.43502,WP_GROWTH_FACTORS_AND_HORMONES_IN_BETA_CELL_PROLIFERATION,1
MODULE_42,SET,24,0.023055,0.00083257,0.14106,0.43509,MODULE_42,1
GOBP_REGULATION_OF_LAMELLIPO...2,SET,11,0.040735,0.00099625,0.24929,0.4351,GOBP_REGULATION_OF_LAMELLIPODIUM_MORPHOGENESIS,1
chr5q32,SET,44,0.038533,0.0018831,0.23615,0.43519,chr5q32,1
CLAUS_PGR_POSITIVE_MENINGIOM...2,SET,8,0.044668,0.00093172,0.27377,0.4352,CLAUS_PGR_POSITIVE_MENINGIOMA_UP,1
HP_XEROSTOMIA,SET,52,0.019239,0.0010219,0.11792,0.4352,HP_XEROSTOMIA,1
GSE14769_40MIN_VS_360MIN_LPS...2,SET,179,0.0097184,0.00095441,0.059626,0.43526,GSE14769_40MIN_VS_360MIN_LPS_BMDM_UP,1
GSE5589_LPS_VS_LPS_AND_IL10_...10,SET,180,0.010307,0.001015,0.063236,0.43526,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
GSE40443_INDUCED_VS_TOTAL_TR...1,SET,180,0.010324,0.0010167,0.063407,0.43533,GSE40443_INDUCED_VS_TOTAL_TREG_DN,1
REACTOME_INWARDLY_RECTIFYING...,SET,35,0.025712,0.001121,0.15798,0.43536,REACTOME_INWARDLY_RECTIFYING_K_CHANNELS,1
GSE27859_MACROPHAGE_VS_CD11C...3,SET,178,0.010416,0.0010201,0.064021,0.43538,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_DN,1
NKX62_Q2,SET,220,0.0099351,0.0010805,0.061075,0.43539,NKX62_Q2,1
HP_ABNORMAL_PALATE_MORPHOLOGY,SET,991,0.0043793,0.00098912,0.026971,0.43551,HP_ABNORMAL_PALATE_MORPHOLOGY,1
HP_ABNORMAL_PERIPHERAL_MYELI...,SET,92,0.013843,0.00097694,0.085279,0.43553,HP_ABNORMAL_PERIPHERAL_MYELINATION,1
GOBP_HETEROCHROMATIN_FORMATI...,SET,95,0.013535,0.00097057,0.08344,0.43557,GOBP_HETEROCHROMATIN_FORMATION,1
GOCC_ANAPHASE_PROMOTING_COMP...,SET,21,0.026858,0.00090735,0.16564,0.4356,GOCC_ANAPHASE_PROMOTING_COMPLEX,1
KEGG_MEDICUS_VARIANT_FUS_DDI...,SET,5,0.069887,0.0011526,0.43111,0.43561,KEGG_MEDICUS_VARIANT_FUS_DDIT3_FUSION_TO_NFKB_MEDIATED_TRANSCRIPTION,1
GOBP_MODULATION_OF_EXCITATOR...,SET,46,0.020586,0.0010286,0.12698,0.43561,GOBP_MODULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
GOBP_INTERLEUKIN_12_PRODUCTI...,SET,61,0.018366,0.0010563,0.11331,0.43562,GOBP_INTERLEUKIN_12_PRODUCTION,1
WP_DISORDERS_OF_GALACTOSE_ME...,SET,12,0.037985,0.00097028,0.23447,0.43565,WP_DISORDERS_OF_GALACTOSE_METABOLISM,1
GOBP_VESICLE_BUDDING_FROM_ME...,SET,82,0.014036,0.00093545,0.086664,0.43567,GOBP_VESICLE_BUDDING_FROM_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...220,SET,7,0.051327,0.0010015,0.31694,0.43568,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MITOCHONDRION,1
HP_DYSPAREUNIA,SET,34,0.025135,0.0010801,0.15522,0.43568,HP_DYSPAREUNIA,1
GSE3982_EOSINOPHIL_VS_BASOPH...1,SET,177,0.010027,0.00097929,0.061919,0.43568,GSE3982_EOSINOPHIL_VS_BASOPHIL_DN,1
GOBP_PROLINE_METABOLIC_PROCE...,SET,9,0.052653,0.0011649,0.32536,0.43572,GOBP_PROLINE_METABOLIC_PROCESS,1
HP_ORAL_ULCER,SET,57,0.018671,0.0010382,0.11537,0.43572,HP_ORAL_ULCER,1
GSE19888_CTRL_VS_TCELL_MEMBR...1,SET,185,0.010142,0.0010124,0.062665,0.43572,GSE19888_CTRL_VS_TCELL_MEMBRANES_ACT_MAST_CELL_PRETREAT_A3R_INH_DN,1
REACTOME_GLYCOGEN_SYNTHESIS,SET,12,0.038306,0.00097849,0.23749,0.43593,REACTOME_GLYCOGEN_SYNTHESIS,1
GOCC_SARCOPLASMIC_RETICULUM,SET,73,0.015644,0.00098398,0.097004,0.43594,GOCC_SARCOPLASMIC_RETICULUM,1
GSE39864_WT_VS_GATA3_KO_TREG...1,SET,180,0.00973,0.00095819,0.060335,0.43594,GSE39864_WT_VS_GATA3_KO_TREG_DN,1
SCHRAETS_MLL_TARGETS_UP,SET,29,0.028145,0.0011171,0.1747,0.43601,SCHRAETS_MLL_TARGETS_UP,1
HP_APLASIA_HYPOPLASIA_INVOLV...7,SET,4,0.063499,0.00093668,0.39472,0.4361,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_CORTICOSPINAL_TRACTS,1
HP_STEATORRHEA,SET,61,0.018323,0.0010539,0.11395,0.43613,HP_STEATORRHEA,1
GSE6875_TCONV_VS_FOXP3_KO_TR...1,SET,177,0.0099372,0.00097048,0.061801,0.43613,GSE6875_TCONV_VS_FOXP3_KO_TREG_DN,1
HP_STAPES_ANKYLOSIS,SET,6,0.059772,0.0010798,0.37202,0.43618,HP_STAPES_ANKYLOSIS,1
SMAD4_Q6,SET,223,0.0093735,0.0010262,0.058467,0.43632,SMAD4_Q6,1
MANNO_MIDBRAIN_NEUROTYPES_BA...,SET,64,0.015174,0.00089388,0.094699,0.43635,MANNO_MIDBRAIN_NEUROTYPES_BASAL,1
GRAHAM_CML_QUIESCENT_VS_CML_...1,SET,10,0.049418,0.0011524,0.30868,0.4364,GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...8,SET,28,0.025339,0.00098826,0.15848,0.43649,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_15,1
MIR378E,SET,37,0.020557,0.00092144,0.12865,0.43652,MIR378E,1
GSE43956_WT_VS_SGK1_KO_TH17_...1,SET,180,0.010354,0.0010196,0.064822,0.43655,GSE43956_WT_VS_SGK1_KO_TH17_DIFFERENTIATED_CD4_TCELL_DN,1
PANGAS_TUMOR_SUPPRESSION_BY_...2,SET,118,0.012832,0.0010249,0.080351,0.43656,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP,1
GOCC_MICROTUBULE_ASSOCIATED_...,SET,139,0.010628,0.00092077,0.06656,0.43657,GOCC_MICROTUBULE_ASSOCIATED_COMPLEX,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...4,SET,13,0.040472,0.001076,0.25351,0.43658,GOBP_GAMMA_AMINOBUTYRIC_ACID_SECRETION,1
chr16q12,SET,35,0.039616,0.0017271,0.24831,0.43662,chr16q12,1
GOBP_RNA_TEMPLATED_DNA_BIOSY...,SET,66,0.015517,0.00092817,0.097292,0.43664,GOBP_RNA_TEMPLATED_DNA_BIOSYNTHETIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_VI...1,SET,70,0.017379,0.0010705,0.10914,0.43674,GOBP_CELLULAR_RESPONSE_TO_VIRUS,1
KEGG_MEDICUS_VARIANT_CDX2_OV...,SET,5,0.070529,0.0011631,0.44299,0.43675,KEGG_MEDICUS_VARIANT_CDX2_OVEREXPRESSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
MIR4677_3P,SET,120,0.012566,0.0010121,0.078954,0.43677,MIR4677_3P,1
GOMF_HISTONE_H3K9ME_H3K9ME2_...,SET,4,0.060721,0.00089569,0.38148,0.43677,GOMF_HISTONE_H3K9ME_H3K9ME2_DEMETHYLASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...137,SET,32,0.022717,0.00094709,0.14275,0.43678,GOBP_POSITIVE_REGULATION_OF_CELL_MORPHOGENESIS,1
GOBP_CILIUM_OR_FLAGELLUM_DEP...,SET,149,0.010579,0.00094864,0.066608,0.43691,GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY,1
H1_6_TARGET_GENES,SET,406,0.0067911,0.00099814,0.042767,0.43692,H1_6_TARGET_GENES,1
WP_PROSTAGLANDIN_AND_LEUKOTR...1,SET,29,0.026849,0.0010657,0.16924,0.43697,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5122,1
GSE14350_TREG_VS_TEFF_DN,SET,186,0.0099569,0.00099658,0.062758,0.43697,GSE14350_TREG_VS_TEFF_DN,1
GOBP_REGULATION_OF_NEUROGENE...,SET,346,0.0075517,0.0010263,0.047604,0.43698,GOBP_REGULATION_OF_NEUROGENESIS,1
RUTELLA_RESPONSE_TO_HGF_VS_C...1,SET,223,0.0092796,0.0010159,0.058507,0.43699,RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN,1
HP_EPIPHYSEAL_STIPPLING,SET,30,0.024719,0.00099789,0.15585,0.43699,HP_EPIPHYSEAL_STIPPLING,1
GOBP_GLYCOSYLCERAMIDE_METABO...,SET,16,0.033912,0.0010001,0.21389,0.43701,GOBP_GLYCOSYLCERAMIDE_METABOLIC_PROCESS,1
GOBP_GLUCOSYLCERAMIDE_CATABO...,SET,4,0.075182,0.001109,0.47422,0.43702,GOBP_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,1
GAUTAM_EYE_IRIS_CILIARY_BODY...16,SET,228,0.0085715,0.00094875,0.05407,0.43702,GAUTAM_EYE_IRIS_CILIARY_BODY_SMOOTH_MUSCLE_CELLS,1
GOBP_SKELETAL_MUSCLE_THIN_FI...,SET,7,0.052913,0.0010324,0.33387,0.43704,GOBP_SKELETAL_MUSCLE_THIN_FILAMENT_ASSEMBLY,1
HE_LIM_SUN_FETAL_LUNG_C3_DEF...2,SET,23,0.027943,0.00098789,0.17642,0.43707,HE_LIM_SUN_FETAL_LUNG_C3_DEFINITIVE_ERYTHROCYTE,1
GOBP_NEGATIVE_REGULATION_OF_...588,SET,25,0.027099,0.00099877,0.1711,0.43708,GOBP_NEGATIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,1
GOBP_PEPTIDYL_L_CYSTEINE_S_P...,SET,21,0.028333,0.00095716,0.17903,0.43713,GOBP_PEPTIDYL_L_CYSTEINE_S_PALMITOYLATION,1
ZNF548_TARGET_GENES,SET,45,0.021213,0.0010484,0.13416,0.43718,ZNF548_TARGET_GENES,1
HP_CROSSED_FUSED_RENAL_ECTOP...,SET,9,0.039403,0.00087174,0.24936,0.43722,HP_CROSSED_FUSED_RENAL_ECTOPIA,1
HP_MUSCULAR_DYSTROPHY,SET,69,0.015775,0.00096476,0.099823,0.43722,HP_MUSCULAR_DYSTROPHY,1
GOBP_PRIMARY_AMINO_COMPOUND_...2,SET,13,0.033712,0.00089629,0.21387,0.43738,GOBP_PRIMARY_AMINO_COMPOUND_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...59,SET,15,0.037881,0.0010818,0.24038,0.43739,GOBP_NEGATIVE_REGULATION_OF_B_CELL_PROLIFERATION,1
GOMF_NADPLUS_PROTEIN_ADP_RIB...,SET,28,0.024399,0.00095161,0.15482,0.43739,GOMF_NADPLUS_PROTEIN_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
HP_CHRONIC_LEUKEMIA,SET,23,0.027858,0.00098486,0.17679,0.4374,HP_CHRONIC_LEUKEMIA,1
HP_APLASIA_HYPOPLASIA_OF_THE...17,SET,43,0.019068,0.00092126,0.12105,0.43742,HP_APLASIA_HYPOPLASIA_OF_THE_CLAVICLES,1
S8_01,SET,230,0.0093326,0.0010375,0.05926,0.43743,S8_01,1
SKP2_TARGET_GENES,SET,50,0.018697,0.00097387,0.11873,0.43744,SKP2_TARGET_GENES,1
GSE15930_NAIVE_VS_72H_IN_VIT...8,SET,185,0.0092384,0.0009222,0.058681,0.43745,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_TRICHOSTATINA_CD8_TCELL_UP,1
MIR3914,SET,50,0.01948,0.0010146,0.12375,0.43746,MIR3914,1
GSE24634_NAIVE_CD4_TCELL_VS_...6,SET,184,0.0095997,0.0009557,0.061005,0.43748,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_UP,1
HP_MILD_HEARING_IMPAIRMENT,SET,7,0.043638,0.00085147,0.27749,0.43752,HP_MILD_HEARING_IMPAIRMENT,1
GOBP_CELL_ADHESION,SET,1402,0.0039529,0.0010493,0.02515,0.43755,GOBP_CELL_ADHESION,1
SEKI_INFLAMMATORY_RESPONSE_L...2,SET,72,0.017441,0.0010895,0.11104,0.4376,SEKI_INFLAMMATORY_RESPONSE_LPS_UP,1
GOBP_10_FORMYLTETRAHYDROFOLA...,SET,5,0.060248,0.0009936,0.38367,0.43761,GOBP_10_FORMYLTETRAHYDROFOLATE_METABOLIC_PROCESS,1
HP_RECURRENT_EAR_INFECTIONS,SET,16,0.034283,0.0010111,0.21834,0.43762,HP_RECURRENT_EAR_INFECTIONS,1
DESCARTES_FETAL_CEREBELLUM_I...,SET,24,0.03126,0.0011289,0.19909,0.43762,DESCARTES_FETAL_CEREBELLUM_INHIBITORY_INTERNEURONS,1
GOMF_L_AMINO_ACID_TRANSMEMBR...,SET,62,0.017532,0.0010166,0.11175,0.43767,GOMF_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_TRANSCRIPTION_REGULATOR...1,SET,5,0.069742,0.0011502,0.44452,0.43767,GOMF_TRANSCRIPTION_REGULATOR_ACTIVATOR_ACTIVITY,1
GSE32255_WT_VS_JMJD2D_KNOCKD...2,SET,129,0.012032,0.0010045,0.076711,0.43768,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_UP,1
FOXO1_02,SET,233,0.0089755,0.0010042,0.057228,0.43769,FOXO1_02,1
GOMF_CORECEPTOR_ACTIVITY,SET,52,0.018882,0.0010029,0.12049,0.43774,GOMF_CORECEPTOR_ACTIVITY,1
DESCARTES_MAIN_FETAL_STC2_TL...,SET,16,0.035837,0.0010569,0.22873,0.43775,DESCARTES_MAIN_FETAL_STC2_TLX1_POSITIVE_CELLS,1
GOBP_SENSORY_PERCEPTION_OF_T...1,SET,65,0.018252,0.0010835,0.11653,0.43777,GOBP_SENSORY_PERCEPTION_OF_TASTE,1
REACTOME_AQUAPORIN_MEDIATED_...,SET,50,0.020088,0.0010463,0.12835,0.43782,REACTOME_AQUAPORIN_MEDIATED_TRANSPORT,1
HP_EXUDATIVE_VITREORETINOPAT...,SET,7,0.051416,0.0010032,0.32853,0.43782,HP_EXUDATIVE_VITREORETINOPATHY,1
GOBP_ICOSANOID_CATABOLIC_PRO...,SET,9,0.042403,0.00093811,0.27098,0.43783,GOBP_ICOSANOID_CATABOLIC_PROCESS,1
DESCARTES_FETAL_PANCREAS_MES...,SET,63,0.017352,0.0010142,0.1111,0.43794,DESCARTES_FETAL_PANCREAS_MESOTHELIAL_CELLS,1
GOBP_VIRAL_TRANSLATIONAL_TER...,SET,5,0.053382,0.00088035,0.34184,0.43795,GOBP_VIRAL_TRANSLATIONAL_TERMINATION_REINITIATION,1
MIR3138,SET,65,0.016464,0.00097739,0.10547,0.43798,MIR3138,1
GRATIAS_RETINOBLASTOMA_16Q24,SET,17,0.038782,0.0011789,0.24848,0.43799,GRATIAS_RETINOBLASTOMA_16Q24,1
GOCC_SPLICEOSOMAL_TRI_SNRNP_...,SET,36,0.018149,0.00080244,0.11628,0.43799,GOCC_SPLICEOSOMAL_TRI_SNRNP_COMPLEX,1
GOBP_RESPONSE_TO_PHORBOL_13_...,SET,8,0.04621,0.00096388,0.29648,0.43807,GOBP_RESPONSE_TO_PHORBOL_13_ACETATE_12_MYRISTATE,1
HP_CAROTID_ARTERY_DILATATION,SET,23,0.028367,0.0010029,0.18204,0.43809,HP_CAROTID_ARTERY_DILATATION,1
MATZUK_CENTRAL_FOR_FEMALE_FE...,SET,29,0.023679,0.00093984,0.15201,0.43811,MATZUK_CENTRAL_FOR_FEMALE_FERTILITY,1
GOBP_POSITIVE_REGULATION_OF_...70,SET,15,0.031766,0.00090713,0.20401,0.43813,GOBP_POSITIVE_REGULATION_OF_B_CELL_DIFFERENTIATION,1
MIR2054,SET,148,0.011117,0.0009936,0.071439,0.43817,MIR2054,1
HP_RECTAL_FISTULA,SET,23,0.027188,0.00096119,0.17478,0.43819,HP_RECTAL_FISTULA,1
GOCC_PAR_POLARITY_COMPLEX,SET,6,0.058546,0.0010576,0.3764,0.4382,GOCC_PAR_POLARITY_COMPLEX,1
GOBP_CELLULAR_RESPONSE_TO_GA...,SET,23,0.026407,0.00093356,0.16995,0.43826,GOBP_CELLULAR_RESPONSE_TO_GAMMA_RADIATION,1
REACTOME_ANTIMICROBIAL_PEPTI...,SET,74,0.018776,0.001189,0.12085,0.43827,REACTOME_ANTIMICROBIAL_PEPTIDES,1
GOBP_MITOTIC_CHROMOSOME_COND...,SET,17,0.026789,0.00081436,0.17263,0.43834,GOBP_MITOTIC_CHROMOSOME_CONDENSATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...11,SET,80,0.014205,0.00093516,0.09165,0.43841,HP_APLASIA_HYPOPLASIA_OF_THE_BRAINSTEM,1
HP_ABNORMAL_COCHLEA_MORPHOLO...,SET,27,0.024137,0.00092447,0.15609,0.43856,HP_ABNORMAL_COCHLEA_MORPHOLOGY,1
MODULE_254,SET,59,0.01675,0.00094749,0.10836,0.43858,MODULE_254,1
MIR1271_3P,SET,65,0.016836,0.00099945,0.10894,0.43859,MIR1271_3P,1
KEGG_MISMATCH_REPAIR,SET,22,0.024436,0.00084494,0.15826,0.43864,KEGG_MISMATCH_REPAIR,1
GOBP_POSITIVE_REGULATION_OF_...805,SET,32,0.023359,0.00097387,0.15126,0.43864,GOBP_POSITIVE_REGULATION_OF_T_CELL_MIGRATION,1
GOBP_COP9_SIGNALOSOME_ASSEMB...,SET,5,0.060687,0.0010008,0.39306,0.43865,GOBP_COP9_SIGNALOSOME_ASSEMBLY,1
HP_FLAT_FOREHEAD,SET,15,0.033535,0.00095766,0.21738,0.4387,HP_FLAT_FOREHEAD,1
GSE22443_NAIVE_VS_ACT_AND_IL...2,SET,186,0.0093714,0.00093798,0.060789,0.43874,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_UP,1
GOBP_PURINE_RIBONUCLEOTIDE_S...,SET,7,0.050595,0.00098722,0.32833,0.43877,GOBP_PURINE_RIBONUCLEOTIDE_SALVAGE,1
GSE14308_TH1_VS_TH17_UP,SET,177,0.0096759,0.00094497,0.062789,0.43877,GSE14308_TH1_VS_TH17_UP,1
GOBP_POSITIVE_REGULATION_OF_...343,SET,20,0.031883,0.0010512,0.207,0.4388,GOBP_POSITIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,1
AMIT_EGF_RESPONSE_60_HELA,SET,42,0.020094,0.00095949,0.13057,0.43885,AMIT_EGF_RESPONSE_60_HELA,1
GOBP_ANTIGEN_PROCESSING_AND_...10,SET,64,0.018043,0.0010629,0.11732,0.43889,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,1
MODULE_315,SET,16,0.033074,0.00097542,0.21529,0.43895,MODULE_315,1
HP_CLUBBING_OF_TOES,SET,28,0.022213,0.00086636,0.14464,0.43897,HP_CLUBBING_OF_TOES,1
GOBP_NEUROEPITHELIAL_CELL_DI...,SET,42,0.022026,0.0010517,0.14348,0.439,GOBP_NEUROEPITHELIAL_CELL_DIFFERENTIATION,1
WP_BLADDER_CANCER,SET,39,0.021177,0.0009745,0.13797,0.43901,WP_BLADDER_CANCER,1
GSE21360_NAIVE_VS_QUATERNARY...1,SET,181,0.0093863,0.00092688,0.061183,0.43904,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
GOBP_IMP_SALVAGE,SET,4,0.06782,0.0010004,0.44227,0.43906,GOBP_IMP_SALVAGE,1
GOBP_REGULATION_OF_CELL_ADHE...1,SET,738,0.0050759,0.00099651,0.033098,0.43906,GOBP_REGULATION_OF_CELL_ADHESION,1
NKX2_8_TARGET_GENES,SET,31,0.025505,0.0010466,0.1666,0.43917,NKX2_8_TARGET_GENES,1
MODULE_47,SET,208,0.0096438,0.0010201,0.063064,0.43923,MODULE_47,1
GOBP_REGULATION_OF_CELL_PROL...1,SET,15,0.036741,0.0010492,0.24037,0.43926,GOBP_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
RASHI_NFKB1_TARGETS,SET,17,0.033975,0.0010328,0.22243,0.4393,RASHI_NFKB1_TARGETS,1
GOBP_MITOTIC_CYTOKINETIC_PRO...,SET,31,0.022145,0.00090871,0.14498,0.4393,GOBP_MITOTIC_CYTOKINETIC_PROCESS,1
GSE33292_DN3_THYMOCYTE_VS_TC...2,SET,154,0.0094618,0.00086247,0.062003,0.43936,GSE33292_DN3_THYMOCYTE_VS_TCELL_LYMPHOMA_FROM_TCF1_KO_UP,1
GSE3982_MAST_CELL_VS_BASOPHI...1,SET,172,0.0097711,0.00094082,0.0641,0.43942,GSE3982_MAST_CELL_VS_BASOPHIL_DN,1
DARWICHE_SQUAMOUS_CELL_CARCI...1,SET,165,0.0098071,0.00092504,0.064347,0.43943,DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN,1
GOBP_REGULATION_OF_POTASSIUM...3,SET,45,0.020155,0.00099608,0.13234,0.43948,GOBP_REGULATION_OF_POTASSIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_MITOCHONDRIAL_FATTY...1,SET,35,0.020952,0.00091346,0.1376,0.43949,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION,1
HP_APLASIA_OF_THE_SEMICIRCUL...,SET,16,0.028622,0.00084412,0.18893,0.43979,HP_APLASIA_OF_THE_SEMICIRCULAR_CANAL,1
GOBP_NUCLEAR_EXPORT,SET,153,0.00958,0.00087043,0.063247,0.4398,GOBP_NUCLEAR_EXPORT,1
GOBP_SOMATOTROPIN_SECRETING_...,SET,5,0.065869,0.0010863,0.43551,0.43989,GOBP_SOMATOTROPIN_SECRETING_CELL_DIFFERENTIATION,1
GOBP_PROTEOLYSIS_INVOLVED_IN...,SET,698,0.0047463,0.00090723,0.031387,0.4399,GOBP_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,1
HP_SHORT_PALPEBRAL_FISSURE,SET,107,0.011891,0.00090463,0.078637,0.43991,HP_SHORT_PALPEBRAL_FISSURE,1
HP_ABNORMAL_PELVIS_BONE_MORP...,SET,18,0.029871,0.00093437,0.19765,0.43994,HP_ABNORMAL_PELVIS_BONE_MORPHOLOGY,1
GOCC_AXONEMAL_A_TUBULE_INNER...,SET,9,0.04748,0.0010504,0.31436,0.43997,GOCC_AXONEMAL_A_TUBULE_INNER_SHEATH,1
GOBP_NEGATIVE_REGULATION_OF_...491,SET,333,0.0069999,0.00093365,0.046379,0.44002,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,1
WANG_NEOPLASTIC_TRANSFORMATI...,SET,17,0.036976,0.0011241,0.24526,0.44008,WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC,1
GOCC_CLATHRIN_COAT_OF_COATED...,SET,18,0.02935,0.00091807,0.19474,0.4401,GOCC_CLATHRIN_COAT_OF_COATED_PIT,1
REACTOME_RHOA_GTPASE_CYCLE,SET,138,0.011056,0.00095443,0.073393,0.44013,REACTOME_RHOA_GTPASE_CYCLE,1
GOBP_CELLULAR_RESPONSE_TO_HY...3,SET,4,0.064018,0.00094432,0.42507,0.44015,GOBP_CELLULAR_RESPONSE_TO_HYPEROXIA,1
MIR6857_5P,SET,73,0.014121,0.00088816,0.093874,0.44022,MIR6857_5P,1
LAKE_ADULT_KIDNEY_C27_VASCUL...,SET,145,0.011419,0.0010103,0.075957,0.44025,LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES,1
GSE5589_IL6_KO_VS_IL10_KO_LP...9,SET,180,0.0094112,0.00092679,0.062631,0.44028,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_DN,1
GOMF_PHOSPHATIDYLETHANOLAMIN...2,SET,5,0.059118,0.00097495,0.39355,0.4403,GOMF_PHOSPHATIDYLETHANOLAMINE_FLIPPASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_BCR_P...2,SET,7,0.048767,0.00095155,0.32475,0.44032,KEGG_MEDICUS_REFERENCE_BCR_PLCG_ITPR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CYTOPLASM...4,SET,7,0.039071,0.00076236,0.26024,0.44033,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
YTAAYNGCT_UNKNOWN,SET,130,0.012016,0.001007,0.08007,0.44035,YTAAYNGCT_UNKNOWN,1
GSE21927_GMCSF_IL6_VS_GMCSF_...1,SET,181,0.0088056,0.00086954,0.058685,0.44036,GSE21927_GMCSF_IL6_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
BIOCARTA_STEM_PATHWAY,SET,15,0.03412,0.00097435,0.22785,0.44048,BIOCARTA_STEM_PATHWAY,1
GOBP_AXONEMAL_DYNEIN_COMPLEX...,SET,26,0.022177,0.00083355,0.14823,0.44054,GOBP_AXONEMAL_DYNEIN_COMPLEX_ASSEMBLY,1
GOCC_EARLY_PHAGOSOME,SET,12,0.037003,0.00094519,0.24733,0.44054,GOCC_EARLY_PHAGOSOME,1
GOBP_CELL_CELL_SIGNALING_INV...,SET,30,0.025476,0.0010284,0.17043,0.44059,GOBP_CELL_CELL_SIGNALING_INVOLVED_IN_CARDIAC_CONDUCTION,1
BROWNE_HCMV_INFECTION_48HR_UP,SET,168,0.0096094,0.00091453,0.064609,0.44088,BROWNE_HCMV_INFECTION_48HR_UP,1
GRAHAM_CML_DIVIDING_VS_NORMA...4,SET,170,0.0094489,0.00090454,0.063537,0.44089,GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_UP,1
REACTOME_METABOLISM_OF_COFAC...,SET,22,0.024472,0.00084617,0.16458,0.4409,REACTOME_METABOLISM_OF_COFACTORS,1
WP_THYMIC_STROMAL_LYMPHOPOIE...,SET,45,0.019602,0.00096875,0.13187,0.44092,WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...602,SET,45,0.020531,0.0010147,0.1383,0.44099,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
GSE7400_CTRL_VS_CSF3_IN_VIVO...1,SET,175,0.0094513,0.00091785,0.063678,0.44101,GSE7400_CTRL_VS_CSF3_IN_VIVO_TREATED_PBMC_DN,1
HOFFMANN_LARGE_TO_SMALL_PRE_...1,SET,61,0.015964,0.00091816,0.10761,0.44104,HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN,1
GSE5503_LIVER_DC_VS_SPLEEN_D...2,SET,182,0.0094057,0.00093134,0.063457,0.44108,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
MIR10394_5P,SET,162,0.0097638,0.00091263,0.065875,0.44109,MIR10394_5P,1
GOBP_EMBRYONIC_AXIS_SPECIFIC...,SET,35,0.021142,0.00092172,0.14289,0.44119,GOBP_EMBRYONIC_AXIS_SPECIFICATION,1
HP_PACE_OF_PROGRESSION,SET,401,0.006138,0.00089671,0.041486,0.44119,HP_PACE_OF_PROGRESSION,1
HP_CHOLANGIOCARCINOMA,SET,8,0.045555,0.00095022,0.30804,0.44122,HP_CHOLANGIOCARCINOMA,1
GOBP_REGULATION_OF_PHOSPHOLI...2,SET,46,0.019375,0.00096809,0.13111,0.44126,GOBP_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,1
HP_TALIPES_VALGUS,SET,17,0.031535,0.00095865,0.21382,0.44137,HP_TALIPES_VALGUS,1
GAUSSMANN_MLL_AF4_FUSION_TAR...2,SET,165,0.010082,0.00095093,0.068359,0.44138,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_UP,1
MIR486_3P,SET,152,0.010006,0.00090617,0.067869,0.4414,MIR486_3P,1
RUBENSTEIN_SKELETAL_MUSCLE_P...2,SET,116,0.01195,0.00094633,0.081061,0.4414,RUBENSTEIN_SKELETAL_MUSCLE_PERICYTES,1
GOBP_TRANSEPITHELIAL_TRANSPO...,SET,35,0.022706,0.00098993,0.1541,0.44143,GOBP_TRANSEPITHELIAL_TRANSPORT,1
GOBP_DEVELOPMENT_OF_PRIMARY_...1,SET,101,0.013159,0.00097278,0.089325,0.44144,GOBP_DEVELOPMENT_OF_PRIMARY_FEMALE_SEXUAL_CHARACTERISTICS,1
HP_ABNORMALITY_OF_THUMB_PHAL...,SET,171,0.0093527,0.00089793,0.063489,0.44144,HP_ABNORMALITY_OF_THUMB_PHALANX,1
ZHU_SKIL_TARGETS_DN,SET,9,0.042696,0.00094459,0.28992,0.44146,ZHU_SKIL_TARGETS_DN,1
ROSS_AML_WITH_CBFB_MYH11_FUS...,SET,45,0.019502,0.0009638,0.13245,0.44147,ROSS_AML_WITH_CBFB_MYH11_FUSION,1
MIR3164,SET,93,0.01278,0.00090679,0.086795,0.44147,MIR3164,1
HP_ABNORMAL_CIRCULATING_LONG...,SET,16,0.030116,0.00088819,0.20458,0.44148,HP_ABNORMAL_CIRCULATING_LONG_CHAIN_FATTY_ACID_CONCENTRATION,1
GSE33374_CD8_ALPHAALPHA_VS_A...2,SET,187,0.009193,0.00092257,0.062455,0.44149,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_UP,1
CDPCR3_01,SET,50,0.019537,0.0010176,0.13275,0.4415,CDPCR3_01,1
GOBP_INTRINSIC_APOPTOTIC_SIG...5,SET,58,0.01541,0.00086431,0.10471,0.4415,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
SATO_SILENCED_BY_METHYLATION...2,SET,41,0.020263,0.000956,0.13774,0.44152,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_2,1
BRUECKNER_TARGETS_OF_MIRLET7...1,SET,72,0.015602,0.00097463,0.10611,0.44155,BRUECKNER_TARGETS_OF_MIRLET7A3_DN,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...7,SET,30,0.022909,0.0009248,0.15585,0.44157,KEGG_MEDICUS_PATHOGEN_HCMV_US28_TO_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,1
MIR4463,SET,75,0.014056,0.00089607,0.095638,0.44158,MIR4463,1
HP_HYPERGALACTOSEMIA,SET,6,0.050018,0.00090358,0.34031,0.44158,HP_HYPERGALACTOSEMIA,1
MIR3690,SET,52,0.017074,0.00090692,0.11622,0.4416,MIR3690,1
ATGGYGGA_UNKNOWN,SET,85,0.013374,0.00090743,0.091044,0.44161,ATGGYGGA_UNKNOWN,1
GOBP_MEMBRANE_DISASSEMBLY,SET,12,0.034758,0.00088785,0.23664,0.44161,GOBP_MEMBRANE_DISASSEMBLY,1
MIR6797_5P,SET,181,0.0093731,0.00092558,0.063826,0.44162,MIR6797_5P,1
HP_APLASTIC_HYPOPLASTIC_TOEN...,SET,105,0.01182,0.00089083,0.080483,0.44162,HP_APLASTIC_HYPOPLASTIC_TOENAIL,1
GOBP_FOREGUT_MORPHOGENESIS,SET,10,0.040119,0.00093556,0.2739,0.44178,GOBP_FOREGUT_MORPHOGENESIS,1
MIR422A,SET,37,0.01881,0.00084314,0.12859,0.44185,MIR422A,1
HP_FOCAL_IMPAIRED_AWARENESS_...,SET,113,0.011878,0.00092849,0.081213,0.44186,HP_FOCAL_IMPAIRED_AWARENESS_SEIZURE,1
GTCTTCC_MIR7,SET,155,0.0099579,0.00091061,0.068107,0.44188,GTCTTCC_MIR7,1
GOBP_CAVEOLA_ASSEMBLY,SET,6,0.055282,0.00099868,0.37816,0.44189,GOBP_CAVEOLA_ASSEMBLY,1
WP_EPAC1_AND_PKA_REDUCTION_O...,SET,8,0.044907,0.00093671,0.3074,0.44193,WP_EPAC1_AND_PKA_REDUCTION_OF_RETINAL_INFLAMMATION,1
PID_FAK_PATHWAY,SET,57,0.01585,0.00088129,0.1086,0.44198,PID_FAK_PATHWAY,1
GOMF_IMMUNE_RECEPTOR_ACTIVITY,SET,131,0.012647,0.0010639,0.086851,0.44211,GOMF_IMMUNE_RECEPTOR_ACTIVITY,1
GSE557_WT_VS_CIITA_KO_DC_DN,SET,186,0.0092847,0.0009293,0.063787,0.44214,GSE557_WT_VS_CIITA_KO_DC_DN,1
GSE7831_CPG_VS_INFLUENZA_STI...2,SET,181,0.0088478,0.0008737,0.060825,0.44217,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_UP,1
GSE34217_MIR17_92_OVEREXPRES...2,SET,122,0.011287,0.00091651,0.077599,0.44218,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_UP,1
HP_DRUSEN,SET,26,0.025172,0.0009461,0.17318,0.44222,HP_DRUSEN,1
GOBP_REGULATION_OF_NEURON_PR...2,SET,404,0.006321,0.0009268,0.043537,0.44228,GOBP_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,1
GOCC_NEURONAL_DENSE_CORE_VES...1,SET,25,0.02666,0.00098261,0.18379,0.44233,GOCC_NEURONAL_DENSE_CORE_VESICLE,1
GARCIA_PINERES_PBMC_HPV_16_L...8,SET,238,0.0085544,0.00096714,0.058991,0.44235,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_STIMULATED_VS_UNSTIMULATED_0DY_VACCINATION_INDEPENDENT_UP,1
GOBP_REGULATION_OF_NADP_META...,SET,8,0.043646,0.0009104,0.30105,0.44236,GOBP_REGULATION_OF_NADP_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_IGF_I...3,SET,13,0.033128,0.00088075,0.22865,0.4424,KEGG_MEDICUS_REFERENCE_IGF_IGFR_PI3K_NFKB_SIGNALING_PATHWAY,1
GOCC_F_ACTIN_CAPPING_PROTEIN...,SET,8,0.040651,0.00084793,0.28095,0.44248,GOCC_F_ACTIN_CAPPING_PROTEIN_COMPLEX,1
GSE18791_CTRL_VS_NEWCASTLE_V...17,SET,176,0.0095494,0.00093,0.066037,0.44251,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_6H_DN,1
GOBP_REPLICATIVE_SENESCENCE,SET,16,0.028134,0.00082974,0.19461,0.44253,GOBP_REPLICATIVE_SENESCENCE,1
GOBP_CD4_POSITIVE_OR_CD8_POS...,SET,29,0.025037,0.00099376,0.17325,0.44255,GOBP_CD4_POSITIVE_OR_CD8_POSITIVE_ALPHA_BETA_T_CELL_LINEAGE_COMMITMENT,1
GOBP_POSITIVE_REGULATION_OF_...783,SET,185,0.0094032,0.00093865,0.065083,0.44256,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_TRANSPORT,1
HP_ABNORMAL_UPPER_MOTOR_NEUR...,SET,14,0.029675,0.00081871,0.20559,0.44262,HP_ABNORMAL_UPPER_MOTOR_NEURON_MORPHOLOGY,1
HP_PERSONALITY_CHANGES,SET,33,0.020164,0.00085364,0.13977,0.44265,HP_PERSONALITY_CHANGES,1
GOMF_TRANSCRIPTION_COREPRESS...2,SET,42,0.018916,0.00090321,0.13114,0.44266,GOMF_TRANSCRIPTION_COREPRESSOR_BINDING,1
GOBP_REGULATION_OF_ARACHIDON...,SET,7,0.043635,0.00085142,0.30264,0.44268,GOBP_REGULATION_OF_ARACHIDONIC_ACID_SECRETION,1
HP_ANTERIOR_UVEITIS,SET,15,0.031956,0.00091256,0.22217,0.44282,HP_ANTERIOR_UVEITIS,1
GSE38304_MYC_NEG_VS_POS_GC_B...2,SET,184,0.0092723,0.0009231,0.064498,0.44285,GSE38304_MYC_NEG_VS_POS_GC_BCELL_UP,1
GOCC_OUTER_MEMBRANE,SET,208,0.0082804,0.00087589,0.057608,0.44286,GOCC_OUTER_MEMBRANE,1
MIR33B_3P,SET,60,0.015717,0.00089656,0.10937,0.44287,MIR33B_3P,1
HARALAMBIEVA_PBMC_FLUARIX_AG...4,SET,15,0.034627,0.00098884,0.24095,0.44287,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_POSITIVE,1
GSE10239_NAIVE_VS_MEMORY_CD8...1,SET,181,0.0088697,0.00087587,0.061746,0.44289,GSE10239_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
HP_LONG_THUMB,SET,7,0.047079,0.0009186,0.32827,0.44298,HP_LONG_THUMB,1
REACTOME_PRESYNAPTIC_NICOTIN...,SET,12,0.038118,0.00097369,0.26597,0.44302,REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1
MIR3614_3P,SET,58,0.015369,0.00086198,0.10735,0.44308,MIR3614_3P,1
GOBP_REGULATION_OF_FLAGELLAT...,SET,18,0.029634,0.00092695,0.20712,0.44312,GOBP_REGULATION_OF_FLAGELLATED_SPERM_MOTILITY,1
GOCC_PRESYNAPTIC_CYTOSOL,SET,12,0.03497,0.00089327,0.24444,0.44312,GOCC_PRESYNAPTIC_CYTOSOL,1
GOBP_PYRUVATE_METABOLIC_PROC...,SET,109,0.011104,0.00085259,0.077642,0.44314,GOBP_PYRUVATE_METABOLIC_PROCESS,1
HP_CHRONIC_OTITIS_MEDIA,SET,136,0.010559,0.00090489,0.07383,0.44314,HP_CHRONIC_OTITIS_MEDIA,1
CYCLIN_D1_UP.V1_DN,SET,175,0.0089786,0.00087194,0.062781,0.44314,CYCLIN_D1_UP.V1_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...5,SET,70,0.014584,0.00089835,0.10205,0.44318,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_12,1
KEGG_MEDICUS_REFERENCE_TNFSF...,SET,5,0.061415,0.0010128,0.4297,0.44318,KEGG_MEDICUS_REFERENCE_TNFSF10_RIPK1_3_SIGNALING_PATHWAY,1
GOMF_CCR3_CHEMOKINE_RECEPTOR...,SET,4,0.062882,0.00092757,0.4402,0.44321,GOMF_CCR3_CHEMOKINE_RECEPTOR_BINDING,1
GOCC_NUCLEAR_LAMINA,SET,10,0.035895,0.00083705,0.25132,0.44322,GOCC_NUCLEAR_LAMINA,1
GOBP_ENDODERMAL_CELL_FATE_CO...,SET,14,0.037398,0.0010318,0.26189,0.44323,GOBP_ENDODERMAL_CELL_FATE_COMMITMENT,1
VETTER_TARGETS_OF_PRKCA_AND_...2,SET,16,0.031235,0.0009212,0.21882,0.44325,VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP,1
GOBP_MITOCHONDRIAL_ELECTRON_...4,SET,12,0.031076,0.0007938,0.21812,0.44335,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_UBIQUINOL_TO_CYTOCHROME_C,1
KEGG_STEROID_BIOSYNTHESIS,SET,15,0.028967,0.00082721,0.20378,0.44348,KEGG_STEROID_BIOSYNTHESIS,1
GSE21546_WT_VS_SAP1A_KO_DP_T...1,SET,156,0.0097711,0.00089638,0.068768,0.44351,GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN,1
GSE43863_NAIVE_VS_MEMORY_TH1...1,SET,140,0.0099113,0.00086173,0.069765,0.44351,GSE43863_NAIVE_VS_MEMORY_TH1_CD4_TCELL_D150_LCMV_DN,1
HP_CALCIUM_NEPHROLITHIASIS,SET,18,0.027195,0.00085066,0.19183,0.44363,HP_CALCIUM_NEPHROLITHIASIS,1
GOBP_CELLULAR_COMPONENT_DISA...2,SET,31,0.0214,0.00087815,0.15098,0.44364,GOBP_CELLULAR_COMPONENT_DISASSEMBLY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...496,SET,8,0.043403,0.00090534,0.3062,0.44364,GOBP_NEGATIVE_REGULATION_OF_PLASMINOGEN_ACTIVATION,1
REACTOME_MRNA_EDITING_C_TO_U...,SET,7,0.053403,0.001042,0.37697,0.44367,REACTOME_MRNA_EDITING_C_TO_U_CONVERSION,1
chr1p22,SET,59,0.029654,0.0016775,0.20944,0.4437,chr1p22,1
MIR376A_2_5P,SET,59,0.015971,0.00090344,0.11281,0.44371,MIR376A_2_5P,1
MORF_AP2M1,SET,194,0.0079232,0.00080972,0.055984,0.44373,MORF_AP2M1,1
REACTOME_CRISTAE_FORMATION,SET,9,0.035901,0.00079426,0.25394,0.44379,REACTOME_CRISTAE_FORMATION,1
KEGG_MEDICUS_PATHOGEN_YERSIN...1,SET,5,0.054515,0.00089904,0.3858,0.44382,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPH_TO_TCR_NFAT_SIGNALING_PATHWAY,1
ZNF843_TARGET_GENES,SET,677,0.0047335,0.00089159,0.033507,0.44383,ZNF843_TARGET_GENES,1
HORIUCHI_WTAP_TARGETS_DN,SET,284,0.0068766,0.00084819,0.048697,0.44385,HORIUCHI_WTAP_TARGETS_DN,1
HP_TRICUSPID_STENOSIS,SET,6,0.052708,0.00095218,0.37337,0.44387,HP_TRICUSPID_STENOSIS,1
GSE7764_IL15_TREATED_VS_CTRL...1,SET,181,0.0091521,0.00090376,0.064893,0.44392,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_DN,1
MIR4520_5P,SET,6,0.051283,0.00092643,0.36432,0.44403,MIR4520_5P,1
HP_ABNORMALITY_OF_THE_HUMERUS,SET,54,0.016922,0.00091593,0.12034,0.44409,HP_ABNORMALITY_OF_THE_HUMERUS,1
GOBP_CYTOSKELETON_ORGANIZATI...,SET,1361,0.0033429,0.00087535,0.02378,0.4441,GOBP_CYTOSKELETON_ORGANIZATION,1
WP_LINOLEIC_ACID_METABOLISM_...,SET,5,0.058083,0.00095789,0.41384,0.44419,WP_LINOLEIC_ACID_METABOLISM_AFFECTED_BY_SARSCOV2,1
GOBP_NEURONAL_ION_CHANNEL_CL...,SET,12,0.034361,0.00087773,0.24482,0.44419,GOBP_NEURONAL_ION_CHANNEL_CLUSTERING,1
GOCC_TRANSLATION_PREINITIATI...,SET,15,0.028154,0.00080397,0.20064,0.4442,GOCC_TRANSLATION_PREINITIATION_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...281,SET,5,0.056301,0.00092849,0.40136,0.44422,GOBP_POSITIVE_REGULATION_OF_FERTILIZATION,1
GOBP_REGULATION_OF_CARBOHYDR...2,SET,58,0.01455,0.00081605,0.10372,0.44422,GOBP_REGULATION_OF_CARBOHYDRATE_CATABOLIC_PROCESS,1
GSE17721_LPS_VS_PAM3CSK4_2H_...2,SET,184,0.0090365,0.00089962,0.064471,0.44427,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_UP,1
HP_LOW_SET_POSTERIORLY_ROTAT...,SET,216,0.0079481,0.00085657,0.056758,0.44432,HP_LOW_SET_POSTERIORLY_ROTATED_EARS,1
GOCC_EPSILON_DNA_POLYMERASE_...,SET,5,0.045875,0.00075656,0.32779,0.44435,GOCC_EPSILON_DNA_POLYMERASE_COMPLEX,1
GSE6674_ANTI_IGM_VS_CPG_STIM...1,SET,179,0.0086035,0.00084492,0.061489,0.44436,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_DN,1
GOBP_NEUROTROPHIN_SIGNALING_...,SET,38,0.018742,0.00085133,0.134,0.44438,GOBP_NEUROTROPHIN_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...385,SET,7,0.052291,0.0010203,0.37439,0.44446,GOBP_POSITIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
HP_ABNORMAL_PYRAMIDAL_SIGN,SET,383,0.0058743,0.00083911,0.042063,0.44447,HP_ABNORMAL_PYRAMIDAL_SIGN,1
PID_AVB3_OPN_PATHWAY,SET,31,0.022795,0.00093538,0.16336,0.44451,PID_AVB3_OPN_PATHWAY,1
GOMF_SCAFFOLD_PROTEIN_BINDING,SET,65,0.014774,0.00087703,0.10601,0.44458,GOMF_SCAFFOLD_PROTEIN_BINDING,1
HP_URETHRAL_ATRESIA,SET,22,0.022719,0.00078555,0.16301,0.44458,HP_URETHRAL_ATRESIA,1
MIR6880_5P,SET,87,0.012596,0.00086455,0.090404,0.4446,MIR6880_5P,1
BENPORATH_MYC_TARGETS_WITH_E...,SET,201,0.0082777,0.00086092,0.059438,0.44462,BENPORATH_MYC_TARGETS_WITH_EBOX,1
FOURATI_BLOOD_TWINRIX_AGE_25...2,SET,407,0.0059823,0.00088032,0.042963,0.44463,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_UP,1
MIR4784,SET,138,0.0098924,0.00085397,0.071085,0.44466,MIR4784,1
GSE8685_IL2_ACT_IL2_STARVED_...3,SET,127,0.010462,0.00086668,0.075197,0.44467,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
JNK_DN.V1_UP,SET,161,0.0096638,0.00090051,0.06947,0.44468,JNK_DN.V1_UP,1
GSE35435_RESTING_VS_IL4_TREA...1,SET,170,0.0088684,0.00084897,0.06375,0.44468,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_DN,1
GOBP_IMMUNE_RESPONSE_REGULAT...2,SET,21,0.027628,0.00093336,0.19886,0.44475,GOBP_IMMUNE_RESPONSE_REGULATING_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_INVOLVED_IN_PHAGOCYTOSIS,1
HP_LOW_APGAR_SCORE,SET,9,0.04313,0.00095418,0.31056,0.44477,HP_LOW_APGAR_SCORE,1
GSE13485_DAY1_VS_DAY3_YF17D_...1,SET,182,0.0081734,0.00080932,0.058856,0.44478,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN,1
TCGA_GLIOBLASTOMA_COPY_NUMBE...2,SET,67,0.018867,0.001137,0.13593,0.4448,TCGA_GLIOBLASTOMA_COPY_NUMBER_UP,1
REACTOME_COMMON_PATHWAY_OF_F...,SET,21,0.027408,0.00092594,0.19756,0.44483,REACTOME_COMMON_PATHWAY_OF_FIBRIN_CLOT_FORMATION,1
PBRM1_TARGET_GENES,SET,5,0.062368,0.0010286,0.44969,0.44485,PBRM1_TARGET_GENES,1
REACTOME_ADRENALINE_NORADREN...,SET,28,0.023341,0.00091034,0.16848,0.44491,REACTOME_ADRENALINE_NORADRENALINE_INHIBITS_INSULIN_SECRETION,1
GENTILE_UV_HIGH_DOSE_UP,SET,17,0.031391,0.00095426,0.22672,0.44494,GENTILE_UV_HIGH_DOSE_UP,1
REACTOME_NR1H2_AND_NR1H3_MED...,SET,46,0.017437,0.00087127,0.126,0.44497,REACTOME_NR1H2_AND_NR1H3_MEDIATED_SIGNALING,1
HP_ABSENT_TIBIA,SET,5,0.058692,0.00096793,0.4242,0.44498,HP_ABSENT_TIBIA,1
GOMF_PHOSPHOLIPASE_D_ACTIVITY,SET,6,0.042834,0.00077381,0.30987,0.44503,GOMF_PHOSPHOLIPASE_D_ACTIVITY,1
GOBP_N_TERMINAL_PROTEIN_AMIN...1,SET,13,0.029736,0.00079057,0.2152,0.44505,GOBP_N_TERMINAL_PROTEIN_AMINO_ACID_ACETYLATION,1
GOBP_ATRIAL_SEPTUM_DEVELOPME...,SET,21,0.028916,0.00097686,0.20935,0.44507,GOBP_ATRIAL_SEPTUM_DEVELOPMENT,1
GOBP_HYALOID_VASCULAR_PLEXUS...,SET,7,0.049681,0.00096938,0.35966,0.44507,GOBP_HYALOID_VASCULAR_PLEXUS_REGRESSION,1
GNF2_SMC4L1,SET,80,0.012206,0.00080355,0.088449,0.44512,GNF2_SMC4L1,1
MARKEY_RB1_CHRONIC_LOF_UP,SET,106,0.011238,0.000851,0.081447,0.44513,MARKEY_RB1_CHRONIC_LOF_UP,1
GOBP_T_HELPER_2_CELL_DIFFERE...,SET,18,0.029662,0.00092783,0.21497,0.44513,GOBP_T_HELPER_2_CELL_DIFFERENTIATION,1
REACTOME_SULFUR_AMINO_ACID_M...,SET,26,0.024691,0.000928,0.17897,0.44514,REACTOME_SULFUR_AMINO_ACID_METABOLISM,1
WP_ATR_SIGNALING,SET,11,0.030686,0.00075048,0.2226,0.44518,WP_ATR_SIGNALING,1
GOBP_KERATINOCYTE_APOPTOTIC_...,SET,7,0.045378,0.00088542,0.32923,0.44519,GOBP_KERATINOCYTE_APOPTOTIC_PROCESS,1
GOMF_RNA_POLYMERASE_III_TYPE...,SET,6,0.039085,0.00070607,0.28359,0.44519,GOMF_RNA_POLYMERASE_III_TYPE_3_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,1
HP_PROGEROID_FACIAL_APPEARAN...,SET,29,0.020644,0.00081938,0.14984,0.44521,HP_PROGEROID_FACIAL_APPEARANCE,1
MODULE_233,SET,21,0.023432,0.00079162,0.17012,0.44522,MODULE_233,1
WP_NETRINUNC5B_SIGNALING,SET,48,0.017259,0.00088085,0.12534,0.44524,WP_NETRINUNC5B_SIGNALING,1
REACTOME_CHOLESTEROL_BIOSYNT...,SET,24,0.020588,0.0007435,0.15002,0.44542,REACTOME_CHOLESTEROL_BIOSYNTHESIS,1
REACTOME_G1_S_DNA_DAMAGE_CHE...,SET,64,0.013004,0.00076603,0.094797,0.44545,REACTOME_G1_S_DNA_DAMAGE_CHECKPOINTS,1
GCM_ERBB2IP,SET,59,0.014693,0.00083115,0.10713,0.44546,GCM_ERBB2IP,1
HP_RENAL_CORTICAL_CYSTS,SET,16,0.027976,0.00082508,0.20409,0.44549,HP_RENAL_CORTICAL_CYSTS,1
GOBP_LEUKOCYTE_ACTIVATION_IN...,SET,48,0.018284,0.0009332,0.13357,0.44556,GOBP_LEUKOCYTE_ACTIVATION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GOBP_NEGATIVE_REGULATION_OF_...589,SET,27,0.02265,0.00086752,0.16556,0.44559,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
GOBP_4_HYDROXYPROLINE_METABO...,SET,12,0.02845,0.00072672,0.208,0.4456,GOBP_4_HYDROXYPROLINE_METABOLIC_PROCESS,1
GSE11057_CD4_CENT_MEM_VS_PBM...2,SET,178,0.0086713,0.00084922,0.063537,0.44572,GSE11057_CD4_CENT_MEM_VS_PBMC_UP,1
GSE29949_MICROGLIA_VS_DC_BRA...2,SET,185,0.0083897,0.00083748,0.061499,0.44575,GSE29949_MICROGLIA_VS_DC_BRAIN_UP,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...1,SET,108,0.010503,0.00080276,0.077015,0.44576,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS,1
GNF2_SPRR1B,SET,23,0.026266,0.00092859,0.19271,0.44579,GNF2_SPRR1B,1
GOBP_DETECTION_OF_BACTERIUM,SET,15,0.0305,0.00087099,0.22375,0.44579,GOBP_DETECTION_OF_BACTERIUM,1
GAVISH_3CA_METAPROGRAM_MACRO...7,SET,46,0.017912,0.00089498,0.13147,0.44582,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MES_GLYCOLYSIS,1
GSE26343_UNSTIM_VS_LPS_STIM_...1,SET,182,0.0081322,0.00080523,0.059699,0.44582,GSE26343_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,1
GOBP_PROTEIN_TETRAMERIZATION,SET,91,0.011812,0.00082909,0.086818,0.44589,GOBP_PROTEIN_TETRAMERIZATION,1
KEGG_FC_EPSILON_RI_SIGNALING...,SET,78,0.013547,0.00088064,0.099602,0.44591,KEGG_FC_EPSILON_RI_SIGNALING_PATHWAY,1
GOMF_ICOSANOID_RECEPTOR_ACTI...,SET,14,0.031815,0.00087775,0.23414,0.44596,GOMF_ICOSANOID_RECEPTOR_ACTIVITY,1
SENESE_HDAC3_TARGETS_UP,SET,437,0.005676,0.00086477,0.041849,0.44606,SENESE_HDAC3_TARGETS_UP,1
GNF2_TM4SF2,SET,23,0.025187,0.00089043,0.18585,0.4461,GNF2_TM4SF2,1
HP_RENAL_CYST,SET,245,0.0073571,0.00084375,0.054288,0.4461,HP_RENAL_CYST,1
KEGG_MEDICUS_REFERENCE_LESIO...,SET,12,0.026565,0.00067857,0.19612,0.44613,KEGG_MEDICUS_REFERENCE_LESION_BYPASS_BY_TLS_AND_DSB_FORMATION,1
BIOCARTA_BARRESTIN_SRC_PATHW...,SET,16,0.031527,0.00092982,0.23286,0.44615,BIOCARTA_BARRESTIN_SRC_PATHWAY,1
HP_INTESTINAL_MALROTATION,SET,126,0.010174,0.0008395,0.075137,0.44615,HP_INTESTINAL_MALROTATION,1
GSE22601_DOUBLE_POSITIVE_VS_...1,SET,183,0.0081406,0.00080826,0.060142,0.44617,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,1
HP_ABSENT_TOENAIL,SET,17,0.025808,0.00078453,0.19081,0.44621,HP_ABSENT_TOENAIL,1
MSX2_TARGET_GENES,SET,15,0.029472,0.00084163,0.21797,0.44622,MSX2_TARGET_GENES,1
HP_HORIZONTAL_NYSTAGMUS,SET,102,0.011076,0.00082285,0.081919,0.44622,HP_HORIZONTAL_NYSTAGMUS,1
GSE3982_CTRL_VS_LPS_4H_MAC_DN,SET,187,0.0085891,0.00086196,0.06357,0.44626,GSE3982_CTRL_VS_LPS_4H_MAC_DN,1
GOBP_DETERMINATION_OF_DORSAL...,SET,10,0.037602,0.00087686,0.27836,0.44627,GOBP_DETERMINATION_OF_DORSAL_VENTRAL_ASYMMETRY,1
MIR208A_5P,SET,228,0.0075912,0.00084024,0.056217,0.44629,MIR208A_5P,1
HP_FOCAL_MOTOR_SEIZURE,SET,100,0.011388,0.00083769,0.084396,0.44633,HP_FOCAL_MOTOR_SEIZURE,1
PID_HEDGEHOG_GLI_PATHWAY,SET,46,0.016367,0.00081779,0.12152,0.44643,PID_HEDGEHOG_GLI_PATHWAY,1
GOBP_CARDIAC_EPITHELIAL_TO_M...,SET,36,0.020888,0.00092356,0.1551,0.44643,GOBP_CARDIAC_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
GOCC_B_CELL_RECEPTOR_COMPLEX,SET,5,0.05465,0.00090126,0.40571,0.44643,GOCC_B_CELL_RECEPTOR_COMPLEX,1
DESCARTES_FETAL_ADRENAL_CHRO...,SET,75,0.014559,0.00092814,0.10822,0.44649,DESCARTES_FETAL_ADRENAL_CHROMAFFIN_CELLS,1
GOMF_ATP_ADP_ANTIPORTER_ACTI...,SET,3,0.063241,0.00080791,0.47012,0.4465,GOMF_ATP_ADP_ANTIPORTER_ACTIVITY,1
MIR4704_5P,SET,55,0.01518,0.00082916,0.11294,0.44654,MIR4704_5P,1
MODULE_478,SET,18,0.026488,0.00082853,0.19708,0.44654,MODULE_478,1
GOBP_CELLULAR_RESPONSE_TO_LI...2,SET,557,0.0050535,0.00086631,0.037624,0.44658,GOBP_CELLULAR_RESPONSE_TO_LIPID,1
HAHTOLA_MYCOSIS_FUNGOIDES_DN,SET,13,0.032486,0.00086368,0.24198,0.4466,HAHTOLA_MYCOSIS_FUNGOIDES_DN,1
REACTOME_RAP1_SIGNALLING,SET,16,0.02781,0.00082019,0.20715,0.4466,REACTOME_RAP1_SIGNALLING,1
GOBP_DENDRITE_SELF_AVOIDANCE,SET,14,0.035996,0.00099311,0.26819,0.44661,GOBP_DENDRITE_SELF_AVOIDANCE,1
chr5q22,SET,26,0.045468,0.0017089,0.3388,0.44662,chr5q22,1
MIR4742_5P,SET,169,0.0090149,0.00086047,0.067174,0.44662,MIR4742_5P,1
REACTOME_ASPIRIN_ADME,SET,41,0.02138,0.0010087,0.15944,0.44667,REACTOME_ASPIRIN_ADME,1
MORF_LCAT,SET,118,0.010808,0.00086325,0.080621,0.44668,MORF_LCAT,1
ZNF524_TARGET_GENES,SET,277,0.0066233,0.00080697,0.04942,0.44669,ZNF524_TARGET_GENES,1
GOMF_TROPOMYOSIN_BINDING,SET,14,0.028374,0.00078282,0.21182,0.44672,GOMF_TROPOMYOSIN_BINDING,1
MANNO_MIDBRAIN_NEUROTYPES_HP...5,SET,269,0.0071639,0.00086033,0.053497,0.44674,MANNO_MIDBRAIN_NEUROTYPES_HPROGM,1
REACTOME_G1_S_SPECIFIC_TRANS...,SET,28,0.020038,0.00078151,0.14967,0.44675,REACTOME_G1_S_SPECIFIC_TRANSCRIPTION,1
GAVIN_FOXP3_TARGETS_CLUSTER_...5,SET,82,0.012925,0.00086141,0.096604,0.44678,GAVIN_FOXP3_TARGETS_CLUSTER_P7,1
GOBP_NEGATIVE_REGULATION_OF_...353,SET,5,0.057273,0.00094453,0.42811,0.44679,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,1
REACTOME_MTORC1_MEDIATED_SIG...,SET,23,0.022714,0.00080303,0.16986,0.44681,REACTOME_MTORC1_MEDIATED_SIGNALLING,1
GOBP_LUTEINIZATION,SET,11,0.037821,0.000925,0.28303,0.44685,GOBP_LUTEINIZATION,1
ZNF34_TARGET_GENES,SET,213,0.0075548,0.00080858,0.056562,0.44687,ZNF34_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_CXCL1...,SET,18,0.027101,0.00084771,0.20328,0.44697,KEGG_MEDICUS_REFERENCE_CXCL12_CXCR4_PKC_ERK_SIGNALING_PATHAWAY,1
HP_FRECKLING,SET,46,0.014634,0.00073122,0.10978,0.44697,HP_FRECKLING,1
GSE8515_CTRL_VS_IL1_4H_STIM_...1,SET,174,0.0083855,0.00081204,0.062893,0.44697,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_DN,1
HP_DECREASED_SIZE_OF_NERVE_T...,SET,15,0.025863,0.00073857,0.19411,0.447,HP_DECREASED_SIZE_OF_NERVE_TERMINALS,1
HP_CALF_MUSCLE_PSEUDOHYPERTR...,SET,15,0.026105,0.00074547,0.19595,0.44701,HP_CALF_MUSCLE_PSEUDOHYPERTROPHY,1
MIR549A_5P,SET,43,0.017648,0.00085264,0.1325,0.44702,MIR549A_5P,1
DESCARTES_FETAL_EYE_BIPOLAR_...,SET,19,0.02966,0.00095314,0.22292,0.44708,DESCARTES_FETAL_EYE_BIPOLAR_CELLS,1
GOBP_REGULATION_OF_T_CELL_CH...,SET,15,0.02824,0.00080644,0.21235,0.4471,GOBP_REGULATION_OF_T_CELL_CHEMOTAXIS,1
GNF2_MSH6,SET,29,0.018082,0.00071769,0.13607,0.44714,GNF2_MSH6,1
GSE32128_INOS_DEPENDENT_VS_I...2,SET,186,0.0082249,0.00082322,0.061899,0.44715,GSE32128_INOS_DEPENDENT_VS_INOS_INDEPENDENT_ACTIVATED_TCELL_UP,1
GOBP_GLUCOCORTICOID_SECRETION,SET,11,0.033913,0.00082941,0.25531,0.44716,GOBP_GLUCOCORTICOID_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...52,SET,15,0.02971,0.00084843,0.2238,0.44719,GOBP_NEGATIVE_REGULATION_OF_BONE_MINERALIZATION,1
GOBP_POSITIVE_REGULATION_OF_...752,SET,17,0.026467,0.00080458,0.19942,0.44721,GOBP_POSITIVE_REGULATION_OF_TELOMERE_CAPPING,1
FARDIN_HYPOXIA_11,SET,28,0.020839,0.00081275,0.15709,0.44723,FARDIN_HYPOXIA_11,1
GOBP_NEGATIVE_REGULATION_OF_...385,SET,12,0.032323,0.00082567,0.24397,0.4473,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_POTENTIAL,1
GOCC_ACTOMYOSIN,SET,86,0.012473,0.00085122,0.094165,0.44731,GOCC_ACTOMYOSIN,1
GOBP_REGULATION_OF_SOMITOGEN...,SET,6,0.049546,0.00089507,0.37413,0.44732,GOBP_REGULATION_OF_SOMITOGENESIS,1
SPIRA_SMOKERS_LUNG_CANCER_UP,SET,36,0.019176,0.00084787,0.14494,0.44737,SPIRA_SMOKERS_LUNG_CANCER_UP,1
GOBP_SINGLE_STRAND_BREAK_REP...,SET,11,0.029919,0.00073173,0.22614,0.44737,GOBP_SINGLE_STRAND_BREAK_REPAIR,1
REACTOME_ESTROGEN_STIMULATED...,SET,6,0.042765,0.00077257,0.32327,0.44738,REACTOME_ESTROGEN_STIMULATED_SIGNALING_THROUGH_PRKCZ,1
SOX11_TARGET_GENES,SET,35,0.018725,0.00081638,0.14155,0.44738,SOX11_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...329,SET,12,0.02943,0.00075175,0.22283,0.44746,GOBP_NEGATIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,1
HP_MODERATE_ALBUMINURIA,SET,10,0.037684,0.00087878,0.28548,0.44749,HP_MODERATE_ALBUMINURIA,1
HP_NEOPLASM_OF_THE_SMALL_INT...,SET,18,0.023803,0.00074455,0.18032,0.44749,HP_NEOPLASM_OF_THE_SMALL_INTESTINE,1
GOBP_POSITIVE_REGULATION_OF_...384,SET,6,0.043547,0.0007867,0.33002,0.44751,GOBP_POSITIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_DNA_DAMAGE,1
REACTOME_HIV_ELONGATION_ARRE...,SET,29,0.017511,0.00069502,0.13274,0.44752,REACTOME_HIV_ELONGATION_ARREST_AND_RECOVERY,1
GOBP_XENOBIOTIC_TRANSMEMBRAN...,SET,17,0.028064,0.00085312,0.21271,0.44752,GOBP_XENOBIOTIC_TRANSMEMBRANE_TRANSPORT,1
HP_ANOMIC_APHASIA,SET,6,0.044689,0.00080731,0.33873,0.44752,HP_ANOMIC_APHASIA,1
GOMF_PROTEIN_TRANSPORTER_ACT...,SET,37,0.017566,0.00078737,0.13331,0.44759,GOMF_PROTEIN_TRANSPORTER_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_CONDE...,SET,19,0.023247,0.00074705,0.17664,0.44765,KEGG_MEDICUS_REFERENCE_CONDENSIN_LOADING,1
GNF2_MMP1,SET,32,0.022791,0.00095016,0.17317,0.44765,GNF2_MMP1,1
GOBP_MESODERM_MORPHOGENESIS,SET,68,0.013957,0.0008474,0.10609,0.44767,GOBP_MESODERM_MORPHOGENESIS,1
MAML1_TARGET_GENES,SET,212,0.0078326,0.00083637,0.059622,0.44774,MAML1_TARGET_GENES,1
GSE36392_MAC_VS_NEUTROPHIL_I...2,SET,186,0.0079127,0.00079198,0.060234,0.44774,GSE36392_MAC_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,1
MIR3169,SET,54,0.01512,0.00081837,0.11513,0.44776,MIR3169,1
GOMF_OXALATE_TRANSMEMBRANE_T...,SET,9,0.035882,0.00079384,0.27333,0.44778,GOMF_OXALATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
CCTGCTG_MIR214,SET,218,0.0070705,0.00076547,0.053897,0.44781,CCTGCTG_MIR214,1
MIR4538,SET,25,0.024337,0.00089697,0.18556,0.44783,MIR4538,1
GOBP_NEGATIVE_REGULATION_OF_...450,SET,5,0.058541,0.00096544,0.44683,0.44788,GOBP_NEGATIVE_REGULATION_OF_NODAL_SIGNALING_PATHWAY,1
GOBP_SYNAPTIC_VESICLE_ENDOSO...,SET,8,0.037787,0.00078819,0.28847,0.44789,GOBP_SYNAPTIC_VESICLE_ENDOSOMAL_PROCESSING,1
GOBP_REGULATION_OF_KETONE_BI...,SET,19,0.025623,0.00082342,0.19591,0.44797,GOBP_REGULATION_OF_KETONE_BIOSYNTHETIC_PROCESS,1
REACTOME_LGI_ADAM_INTERACTIO...,SET,14,0.030008,0.00082788,0.22969,0.44803,REACTOME_LGI_ADAM_INTERACTIONS,1
GOBP_NEGATIVE_REGULATION_OF_...70,SET,21,0.024183,0.00081699,0.18513,0.44804,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
DESCARTES_FETAL_LUNG_NEUROEN...,SET,76,0.013897,0.00089182,0.10651,0.4481,DESCARTES_FETAL_LUNG_NEUROENDOCRINE_CELLS,1
GOBP_RIBOSOME_DISASSEMBLY,SET,32,0.017795,0.00074187,0.13645,0.44812,GOBP_RIBOSOME_DISASSEMBLY,1
MIR4746_5P,SET,8,0.034239,0.00071418,0.26272,0.44816,MIR4746_5P,1
GOBP_ANATOMICAL_STRUCTURE_MA...,SET,247,0.0073159,0.0008424,0.056139,0.44816,GOBP_ANATOMICAL_STRUCTURE_MATURATION,1
GOBP_REGULATION_OF_CELLULAR_...6,SET,123,0.0099881,0.00081436,0.076683,0.44818,GOBP_REGULATION_OF_CELLULAR_KETONE_METABOLIC_PROCESS,1
GOBP_NEUROMUSCULAR_PROCESS_C...2,SET,16,0.02701,0.0007966,0.20744,0.4482,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_POSTURE,1
GOMF_ACETYLESTERASE_ACTIVITY,SET,5,0.045032,0.00074265,0.34598,0.44822,GOMF_ACETYLESTERASE_ACTIVITY,1
HP_ADULT_ONSET_SENSORINEURAL...,SET,5,0.06017,0.00099231,0.46226,0.44822,HP_ADULT_ONSET_SENSORINEURAL_HEARING_IMPAIRMENT,1
GSE15330_HSC_VS_PRO_BCELL_DN,SET,177,0.0077316,0.00075508,0.059397,0.44822,GSE15330_HSC_VS_PRO_BCELL_DN,1
GSE2770_IL12_VS_IL4_TREATED_...2,SET,129,0.009191,0.00076731,0.070625,0.44823,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
GOMF_NUCLEOSIDE_DIPHOSPHATE_...1,SET,17,0.025653,0.00077984,0.1972,0.44825,GOMF_NUCLEOSIDE_DIPHOSPHATE_KINASE_ACTIVITY,1
BUSSLINGER_GASTRIC_G_CELLS,SET,88,0.013049,0.00090078,0.10047,0.44833,BUSSLINGER_GASTRIC_G_CELLS,1
GOBP_OSSIFICATION,SET,382,0.0058669,0.00083699,0.045178,0.44834,GOBP_OSSIFICATION,1
GOMF_INTRACELLULARLY_CAMP_AC...,SET,8,0.038293,0.00079875,0.29491,0.44834,GOMF_INTRACELLULARLY_CAMP_ACTIVATED_CATION_CHANNEL_ACTIVITY,1
TGCACGA_MIR517A_MIR517C,SET,17,0.025222,0.00076674,0.19435,0.44837,TGCACGA_MIR517A_MIR517C,1
WP_SEROTONIN_TRANSPORTER_ACT...,SET,10,0.034474,0.00080393,0.26617,0.44847,WP_SEROTONIN_TRANSPORTER_ACTIVITY,1
LU_AGING_BRAIN_UP,SET,235,0.0074552,0.0008376,0.057563,0.44848,LU_AGING_BRAIN_UP,1
GSE5679_CTRL_VS_PPARG_LIGAND...1,SET,178,0.00834,0.00081677,0.064397,0.44848,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN,1
GOBP_REGULATION_OF_PROTEIN_L...11,SET,166,0.0083816,0.00079296,0.064877,0.4486,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
MIR1233_5P,SET,94,0.010547,0.00075235,0.081665,0.44862,MIR1233_5P,1
GOMF_MEDIUM_CHAIN_FATTY_ACID...,SET,9,0.042069,0.00093072,0.32636,0.44872,GOMF_MEDIUM_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
REACTOME_NEGATIVE_REGULATION...1,SET,10,0.035007,0.00081634,0.27163,0.44873,REACTOME_NEGATIVE_REGULATION_OF_ACTIVITY_OF_TFAP2_AP_2_FAMILY_TRANSCRIPTION_FACTORS,1
SCIBETTA_KDM5B_TARGETS_DN,SET,75,0.012227,0.00077948,0.094909,0.44875,SCIBETTA_KDM5B_TARGETS_DN,1
CHEN_NEUROBLASTOMA_COPY_NUMB...,SET,48,0.017932,0.00091523,0.13946,0.44884,CHEN_NEUROBLASTOMA_COPY_NUMBER_GAINS,1
KUROKAWA_LIVER_CANCER_EARLY_...1,SET,6,0.059256,0.0010705,0.46076,0.44884,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN,1
HP_INCREASED_BONE_MINERAL_DE...,SET,95,0.011469,0.00082247,0.089236,0.44887,HP_INCREASED_BONE_MINERAL_DENSITY,1
KORKOLA_CORRELATED_WITH_POU5...,SET,26,0.022834,0.00085824,0.17779,0.4489,KORKOLA_CORRELATED_WITH_POU5F1,1
HP_RHABDOMYOLYSIS,SET,37,0.016452,0.00073742,0.12808,0.4489,HP_RHABDOMYOLYSIS,1
GOBP_NEGATIVE_REGULATION_OF_...155,SET,15,0.028279,0.00080756,0.22035,0.44894,GOBP_NEGATIVE_REGULATION_OF_CYCLASE_ACTIVITY,1
HP_NONCOMPACTION_CARDIOMYOPA...,SET,15,0.029099,0.00083098,0.22674,0.44894,HP_NONCOMPACTION_CARDIOMYOPATHY,1
GOBP_DORSAL_ROOT_GANGLION_DE...,SET,7,0.047456,0.00092596,0.37003,0.44898,GOBP_DORSAL_ROOT_GANGLION_DEVELOPMENT,1
GOCC_GPI_ANCHOR_TRANSAMIDASE...,SET,5,0.03996,0.00065901,0.31209,0.44906,GOCC_GPI_ANCHOR_TRANSAMIDASE_COMPLEX,1
AIZARANI_LIVER_C39_EPCAM_POS...,SET,177,0.0086395,0.00084375,0.06748,0.44906,AIZARANI_LIVER_C39_EPCAM_POS_BILE_DUCT_CELLS_4,1
GSE37605_NOD_VS_C57BL6_IRES_...1,SET,143,0.0090761,0.00079746,0.070921,0.44909,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_DN,1
MIR6844,SET,306,0.0061833,0.00079118,0.048352,0.44912,MIR6844,1
GOBP_POSITIVE_REGULATION_OF_...184,SET,46,0.016379,0.00081841,0.12808,0.44912,GOBP_POSITIVE_REGULATION_OF_CYTOKINESIS,1
REACTOME_BIOSYNTHESIS_OF_SPE...,SET,19,0.026137,0.00083993,0.20464,0.44918,REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS,1
HP_MACROCEPHALY_AT_BIRTH,SET,8,0.040043,0.00083524,0.31346,0.44918,HP_MACROCEPHALY_AT_BIRTH,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...1,SET,36,0.021505,0.00095085,0.16842,0.4492,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_NAIVE_NOT_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
GOBP_OLIGOSACCHARIDE_CATABOL...,SET,16,0.0276,0.00081398,0.21624,0.44922,GOBP_OLIGOSACCHARIDE_CATABOLIC_PROCESS,1
YEGNASUBRAMANIAN_PROSTATE_CA...,SET,100,0.011053,0.00081308,0.08662,0.44923,YEGNASUBRAMANIAN_PROSTATE_CANCER,1
HP_LIMITATION_OF_JOINT_MOBIL...,SET,370,0.0057408,0.0008063,0.045012,0.44926,HP_LIMITATION_OF_JOINT_MOBILITY,1
GOBP_SEROTONIN_SECRETION,SET,9,0.037279,0.00082474,0.29252,0.4493,GOBP_SEROTONIN_SECRETION,1
GSE369_IFNG_KO_VS_WT_LIVER_UP,SET,179,0.0079918,0.00078485,0.062768,0.44934,GSE369_IFNG_KO_VS_WT_LIVER_UP,1
GSE17721_PAM3CSK4_VS_CPG_8H_...2,SET,182,0.0078369,0.00077599,0.061602,0.44938,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_UP,1
MEF2D_TARGET_GENES,SET,475,0.0049481,0.00078512,0.038943,0.44945,MEF2D_TARGET_GENES,1
REACTOME_MATERNAL_TO_ZYGOTIC...,SET,58,0.013836,0.00077603,0.10892,0.44946,REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,1
GOBP_FEMALE_GAMETE_GENERATION,SET,145,0.0087187,0.00077136,0.068719,0.44952,GOBP_FEMALE_GAMETE_GENERATION,1
REACTOME_KINESINS,SET,57,0.013861,0.00077075,0.10934,0.44956,REACTOME_KINESINS,1
GOBP_REGULATION_OF_TRIGLYCER...2,SET,13,0.029037,0.00077198,0.22909,0.44957,GOBP_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_OF_THE...53,SET,27,0.0216,0.0008273,0.17079,0.44968,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_FINGER,1
HP_SYMPHALANGISM_OF_MIDDLE_P...1,SET,4,0.060888,0.00089815,0.48177,0.44971,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_5TH_FINGER,1
GSE11924_TH2_VS_TH17_CD4_TCE...1,SET,184,0.0078969,0.00078618,0.062544,0.44976,GSE11924_TH2_VS_TH17_CD4_TCELL_DN,1
HP_SPINAL_CORD_LESION,SET,41,0.015496,0.00073107,0.12277,0.44978,HP_SPINAL_CORD_LESION,1
MIR4771,SET,48,0.01516,0.00077373,0.12024,0.44983,MIR4771,1
GOBP_CELL_PROLIFERATION_INVO...1,SET,17,0.028836,0.00087659,0.22876,0.44985,GOBP_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,1
GOBP_MAST_CELL_ACTIVATION_IN...,SET,52,0.015063,0.00080008,0.1195,0.44985,GOBP_MAST_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
FOXQ1_TARGET_GENES,SET,34,0.01967,0.00084523,0.15617,0.44989,FOXQ1_TARGET_GENES,1
GSE15330_LYMPHOID_MULTIPOTEN...3,SET,176,0.0077175,0.00075159,0.06128,0.44989,GSE15330_LYMPHOID_MULTIPOTENT_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
GOBP_POST_EMBRYONIC_ANIMAL_M...,SET,4,0.052229,0.00077043,0.41488,0.44991,GOBP_POST_EMBRYONIC_ANIMAL_MORPHOGENESIS,1
HP_BUDD_CHIARI_SYNDROME,SET,7,0.044116,0.0008608,0.35081,0.44996,HP_BUDD_CHIARI_SYNDROME,1
KORKOLA_EMBRYONIC_CARCINOMA_...1,SET,19,0.024577,0.0007898,0.19564,0.45002,KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN,1
GSE29618_MONOCYTE_VS_PDC_DAY...2,SET,186,0.0080212,0.00080284,0.064017,0.45014,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP,1
GOCC_COLLAGEN_CONTAINING_EXT...,SET,393,0.0057099,0.00082598,0.045586,0.45016,GOCC_COLLAGEN_CONTAINING_EXTRACELLULAR_MATRIX,1
WANG_BARRETTS_ESOPHAGUS_DN,SET,24,0.02352,0.00084936,0.18802,0.45023,WANG_BARRETTS_ESOPHAGUS_DN,1
GOBP_MICROTUBULE_POLYMERIZAT...2,SET,124,0.0088233,0.00072229,0.070571,0.45025,GOBP_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
GAVISH_3CA_METAPROGRAM_CD4_T...6,SET,44,0.017264,0.00084371,0.13826,0.45032,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_NAIVE_1,1
DOUGLAS_BMI1_TARGETS_UP,SET,513,0.004753,0.00078292,0.038086,0.45034,DOUGLAS_BMI1_TARGETS_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...71,SET,36,0.018675,0.0008257,0.1497,0.45036,HP_APLASIA_HYPOPLASIA_OF_THE_THYMUS,1
MIKKELSEN_IPS_WITH_HCP_H3K27...,SET,97,0.012094,0.0008763,0.097003,0.45039,MIKKELSEN_IPS_WITH_HCP_H3K27ME3,1
DESCARTES_FETAL_EYE_VASCULAR...,SET,81,0.012627,0.00083642,0.10128,0.45039,DESCARTES_FETAL_EYE_VASCULAR_ENDOTHELIAL_CELLS,1
HP_RECURRENT_SPONTANEOUS_ABO...,SET,11,0.032429,0.00079312,0.26045,0.45046,HP_RECURRENT_SPONTANEOUS_ABORTION,1
GSE22935_WT_VS_MYD88_KO_MACR...1,SET,187,0.0077663,0.00077938,0.06245,0.45052,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_12H_MBOVIS_BCG_STIM_DN,1
ZSCAN5C_TARGET_GENES,SET,111,0.010164,0.0007875,0.081806,0.45056,ZSCAN5C_TARGET_GENES,1
GSE10239_MEMORY_VS_KLRG1INT_...1,SET,184,0.0074237,0.00073907,0.059796,0.4506,GSE10239_MEMORY_VS_KLRG1INT_EFF_CD8_TCELL_DN,1
HP_PSORIASIFORM_DERMATITIS,SET,28,0.021894,0.00085391,0.17643,0.45062,HP_PSORIASIFORM_DERMATITIS,1
GSE19825_IL2RALOW_VS_IL2RAHI...2,SET,173,0.0076705,0.00074069,0.06184,0.45064,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,1
GOBP_REGULATION_OF_NEURON_MA...,SET,8,0.038594,0.00080503,0.3112,0.45065,GOBP_REGULATION_OF_NEURON_MATURATION,1
GOBP_PLASMA_MEMBRANE_ORGANIZ...,SET,149,0.0086759,0.000778,0.069975,0.45066,GOBP_PLASMA_MEMBRANE_ORGANIZATION,1
chr4q27,SET,14,0.041799,0.0011532,0.33792,0.45078,chr4q27,1
GSE34156_NOD2_LIGAND_VS_NOD2...4,SET,161,0.0076552,0.00071334,0.061895,0.45079,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,1
TONKS_TARGETS_OF_RUNX1_RUNX1...4,SET,47,0.015662,0.00079099,0.12678,0.45084,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_UP,1
GOBP_PRIMARY_MIRNA_PROCESSING,SET,18,0.022008,0.00068839,0.17834,0.4509,GOBP_PRIMARY_MIRNA_PROCESSING,1
WP_AUTOSOMAL_RECESSIVE_OSTEO...,SET,11,0.032232,0.00078831,0.26131,0.45092,WP_AUTOSOMAL_RECESSIVE_OSTEOPETROSIS_PATHWAYS,1
DACOSTA_UV_RESPONSE_VIA_ERCC...6,SET,287,0.0059244,0.00073452,0.048053,0.45094,DACOSTA_UV_RESPONSE_VIA_ERCC3_UP,1
ZEILSTRA_CD44_TARGETS_UP,SET,8,0.03927,0.00081912,0.31854,0.45094,ZEILSTRA_CD44_TARGETS_UP,1
GOBP_CELL_MIGRATION_INVOLVED...2,SET,19,0.027314,0.00087775,0.22158,0.45095,GOBP_CELL_MIGRATION_INVOLVED_IN_HEART_DEVELOPMENT,1
HP_OSTEOPETROSIS,SET,17,0.027793,0.00084489,0.22547,0.45095,HP_OSTEOPETROSIS,1
LINDGREN_BLADDER_CANCER_CLUS...7,SET,288,0.0059752,0.00074209,0.048484,0.45096,LINDGREN_BLADDER_CANCER_CLUSTER_3_UP,1
GOBP_REGULATION_OF_PROTEIN_L...15,SET,16,0.025257,0.00074488,0.20498,0.45097,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
GSE37416_CTRL_VS_3H_F_TULARE...1,SET,176,0.0075908,0.00073926,0.061692,0.45104,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
HP_EARLY_SATIETY,SET,6,0.040038,0.00072329,0.32557,0.45106,HP_EARLY_SATIETY,1
GOCC_GLYCOSYLPHOSPHATIDYLINO...,SET,6,0.040936,0.00073951,0.33293,0.45107,GOCC_GLYCOSYLPHOSPHATIDYLINOSITOL_N_ACETYLGLUCOSAMINYLTRANSFERASE_GPI_GNT_COMPLEX,1
GOBP_SHORT_CHAIN_FATTY_ACID_...2,SET,15,0.026195,0.00074804,0.2133,0.45113,GOBP_SHORT_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
GSE22432_PDC_VS_TGFB1_TREATE...2,SET,168,0.007503,0.00071406,0.06113,0.45116,GSE22432_PDC_VS_TGFB1_TREATEDCOMMON_DC_PROGENITOR_UP,1
GOBP_CHOLESTEROL_STORAGE,SET,23,0.022512,0.00079589,0.18354,0.45119,GOBP_CHOLESTEROL_STORAGE,1
GSE37605_C57BL6_VS_NOD_FOXP3...5,SET,149,0.0084242,0.00075543,0.068703,0.45121,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_DN,1
GSE29949_MICROGLIA_BRAIN_VS_...5,SET,182,0.007459,0.00073857,0.060852,0.45122,GSE29949_MICROGLIA_BRAIN_VS_MONOCYTE_BONE_MARROW_DN,1
TONKS_TARGETS_OF_RUNX1_RUNX1...12,SET,9,0.037966,0.00083994,0.30989,0.45125,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_MONOCYTE_DN,1
GOBP_CELL_FATE_COMMITMENT_IN...2,SET,11,0.032794,0.00080205,0.26774,0.45126,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_PATTERN_SPECIFICATION,1
NAKAJIMA_EOSINOPHIL,SET,22,0.024994,0.00086421,0.20412,0.45127,NAKAJIMA_EOSINOPHIL,1
GOBP_POSITIVE_REGULATION_OF_...188,SET,6,0.041652,0.00075246,0.34047,0.45132,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
GSE13493_DP_VS_CD8POS_THYMOC...2,SET,172,0.0077362,0.00074489,0.063364,0.45141,GSE13493_DP_VS_CD8POS_THYMOCYTE_UP,1
MIR6513_5P,SET,88,0.011056,0.00076317,0.090591,0.45143,MIR6513_5P,1
YAP1_UP,SET,40,0.015309,0.00071342,0.12545,0.45144,YAP1_UP,1
MIR378A_3P_MIR378C_MIR378D_M...,SET,38,0.01551,0.00070452,0.12736,0.45154,MIR378A_3P_MIR378C_MIR378D_MIR378I,1
BRAUNE_GEIST_20_GENE_NOTCH_S...,SET,20,0.025185,0.00083035,0.20695,0.45157,BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER,1
GSE40274_CTRL_VS_FOXP3_AND_E...2,SET,157,0.0083596,0.00076933,0.068763,0.45162,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GCM_BCL2L1,SET,33,0.016007,0.00067766,0.13169,0.45163,GCM_BCL2L1,1
MIR4720_3P,SET,106,0.010113,0.00076576,0.083271,0.45167,MIR4720_3P,1
GSE11961_FOLLICULAR_BCELL_VS...7,SET,178,0.007574,0.00074176,0.062524,0.45179,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_DN,1
HEIDENBLAD_AMPLIFIED_IN_PANC...,SET,53,0.014352,0.00076961,0.11858,0.45183,HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER,1
WP_NEOLACTO_SERIES_SPHINGOLI...,SET,11,0.031252,0.00076432,0.25818,0.45183,WP_NEOLACTO_SERIES_SPHINGOLIPID_METABOLISM,1
GOBP_REGULATION_OF_TYPE_2_IM...,SET,34,0.018672,0.00080234,0.15432,0.45185,GOBP_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
MODULE_201,SET,48,0.015203,0.00077593,0.12568,0.45186,MODULE_201,1
KEGG_MEDICUS_REFERENCE_HOMOL...2,SET,12,0.02901,0.00074103,0.23991,0.45188,KEGG_MEDICUS_REFERENCE_HOMOLOGOUS_RECOMBINATION_IN_ICLR,1
GOMF_ENZYME_ACTIVATOR_ACTIVI...,SET,543,0.0044366,0.00075124,0.036705,0.4519,GOMF_ENZYME_ACTIVATOR_ACTIVITY,1
FUNG_IL2_SIGNALING_1,SET,9,0.033673,0.00074496,0.27865,0.45191,FUNG_IL2_SIGNALING_1,1
GSE5679_CTRL_VS_PPARG_LIGAND...4,SET,179,0.0070177,0.00068918,0.058123,0.45195,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_UP,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...2,SET,95,0.011184,0.00080202,0.092897,0.45209,HE_LIM_SUN_FETAL_LUNG_C2_ADC_2_CELL,1
HP_PROTRACTED_DIARRHEA,SET,13,0.027687,0.00073611,0.23009,0.45211,HP_PROTRACTED_DIARRHEA,1
HP_CHRONIC_HEMOLYTIC_ANEMIA,SET,5,0.046369,0.0007647,0.38563,0.45215,HP_CHRONIC_HEMOLYTIC_ANEMIA,1
GOBP_SEQUESTERING_OF_METAL_I...,SET,9,0.035422,0.00078365,0.29475,0.45217,GOBP_SEQUESTERING_OF_METAL_ION,1
KEGG_MEDICUS_VARIANT_MUTATIO...49,SET,17,0.024317,0.00073923,0.20256,0.45222,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM,1
GOMF_SINGLE_STRANDED_DNA_5_3...,SET,5,0.040403,0.00066631,0.33657,0.45223,GOMF_SINGLE_STRANDED_DNA_5_3_DNA_EXONUCLEASE_ACTIVITY,1
GOBP_REGULATION_OF_TOLERANCE...,SET,17,0.026789,0.00081435,0.22328,0.45225,GOBP_REGULATION_OF_TOLERANCE_INDUCTION,1
HP_FOCAL_SENSORY_SEIZURE,SET,15,0.025875,0.00073892,0.21575,0.45227,HP_FOCAL_SENSORY_SEIZURE,1
HP_OLIVOPONTOCEREBELLAR_HYPO...,SET,12,0.025003,0.00063868,0.2086,0.4523,HP_OLIVOPONTOCEREBELLAR_HYPOPLASIA,1
MIR5008_3P,SET,151,0.0082933,0.00074863,0.06921,0.45231,MIR5008_3P,1
HP_SPONTANEOUS_HEMOLYTIC_CRI...,SET,7,0.033853,0.00066055,0.28271,0.45234,HP_SPONTANEOUS_HEMOLYTIC_CRISES,1
GSE42724_NAIVE_VS_B1_BCELL_UP,SET,182,0.0074,0.00073273,0.06181,0.45235,GSE42724_NAIVE_VS_B1_BCELL_UP,1
TNCATNTCCYR_UNKNOWN,SET,119,0.0092709,0.00074357,0.077473,0.45237,TNCATNTCCYR_UNKNOWN,1
GAVISH_3CA_MALIGNANT_METAPRO...17,SET,38,0.018237,0.0008284,0.15239,0.45237,GAVISH_3CA_MALIGNANT_METAPROGRAM_26_NPC_GLIOMA,1
REACTOME_RUNX1_REGULATES_TRA...4,SET,7,0.036164,0.00070563,0.30228,0.45239,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_MYELOID_CELLS,1
GGCNKCCATNK_UNKNOWN,SET,111,0.0091198,0.00070659,0.076259,0.4524,GGCNKCCATNK_UNKNOWN,1
KEGG_MEDICUS_REFERENCE_GLOBA...,SET,16,0.019648,0.00057946,0.1643,0.45241,KEGG_MEDICUS_REFERENCE_GLOBAL_GENOME_NER,1
GSE20366_TREG_VS_NAIVE_CD4_T...2,SET,186,0.0074268,0.00074334,0.062121,0.45242,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_UP,1
GSE37532_VISCERAL_ADIPOSE_TI...2,SET,148,0.0077833,0.00069563,0.065126,0.45244,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TCONV_CD4_TCELL_UP,1
GAVISH_3CA_METAPROGRAM_MACRO...1,SET,41,0.016157,0.00076226,0.13524,0.45245,GAVISH_3CA_METAPROGRAM_MACROPHAGES_CELL_CYCLE,1
GOBP_SEX_CHROMOSOME_DOSAGE_C...,SET,13,0.028625,0.00076102,0.2399,0.45251,GOBP_SEX_CHROMOSOME_DOSAGE_COMPENSATION,1
GOBP_PIGMENT_GRANULE_LOCALIZ...,SET,23,0.021635,0.00076486,0.18145,0.45255,GOBP_PIGMENT_GRANULE_LOCALIZATION,1
GSE2770_IL12_VS_IL4_TREATED_...4,SET,182,0.0070794,0.00070098,0.059484,0.45263,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...6,SET,11,0.03047,0.00074521,0.25616,0.45266,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
GOBP_POSITIVE_REGULATION_OF_...818,SET,9,0.028306,0.00062623,0.23804,0.45267,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,1
GSE46606_IRF4MID_VS_WT_CD40L...3,SET,186,0.007032,0.00070382,0.059133,0.45267,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,1
NELSON_RESPONSE_TO_ANDROGEN_...2,SET,75,0.012128,0.00077318,0.102,0.45268,NELSON_RESPONSE_TO_ANDROGEN_UP,1
GOMF_TRANSLATION_TERMINATION...,SET,4,0.045834,0.0006761,0.38546,0.45268,GOMF_TRANSLATION_TERMINATION_FACTOR_ACTIVITY,1
MURARO_PANCREAS_BETA_CELL,SET,858,0.0035555,0.00075007,0.029902,0.45268,MURARO_PANCREAS_BETA_CELL,1
VART_KSHV_INFECTION_ANGIOGEN...1,SET,124,0.0096734,0.00079188,0.081393,0.4527,VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN,1
GOBP_PROTEIN_COMPLEX_OLIGOME...,SET,250,0.0065216,0.00075542,0.054878,0.4527,GOBP_PROTEIN_COMPLEX_OLIGOMERIZATION,1
WP_TRANSSULFURATION_PATHWAY,SET,9,0.040028,0.00088555,0.33705,0.45273,WP_TRANSSULFURATION_PATHWAY,1
HP_PROLONGED_NEONATAL_JAUNDI...,SET,63,0.012495,0.00073032,0.10526,0.45275,HP_PROLONGED_NEONATAL_JAUNDICE,1
GOMF_UBIQUITIN_MODIFIED_HIST...,SET,7,0.036109,0.00070456,0.3043,0.45277,GOMF_UBIQUITIN_MODIFIED_HISTONE_READER_ACTIVITY,1
HP_FINGER_SYMPHALANGISM,SET,11,0.032321,0.00079048,0.27244,0.45278,HP_FINGER_SYMPHALANGISM,1
GSE25123_ROSIGLITAZONE_VS_IL...3,SET,175,0.0074701,0.00072545,0.063055,0.45285,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,1
MIR4477A,SET,329,0.0054997,0.00072921,0.046439,0.45287,MIR4477A,1
GOBP_POSITIVE_REGULATION_OF_...545,SET,14,0.030176,0.00083253,0.25508,0.45292,GOBP_POSITIVE_REGULATION_OF_NON_CANONICAL_WNT_SIGNALING_PATHWAY,1
MIR7154_3P,SET,57,0.013352,0.0007424,0.11293,0.45294,MIR7154_3P,1
CROMER_METASTASIS_DN,SET,74,0.011588,0.00073382,0.098019,0.45295,CROMER_METASTASIS_DN,1
GOBP_ANTEROGRADE_DENDRITIC_T...1,SET,9,0.032891,0.00072767,0.27856,0.453,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT,1
GOBP_CELLULAR_RESPONSE_TO_IN...4,SET,8,0.036162,0.0007543,0.30709,0.45313,GOBP_CELLULAR_RESPONSE_TO_INSULIN_LIKE_GROWTH_FACTOR_STIMULUS,1
GSE46025_WT_VS_FOXO1_KO_KLRG...2,SET,166,0.0075078,0.00071029,0.063812,0.45317,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_UP,1
HP_CALCIFICATION_OF_THE_AORTA,SET,21,0.023733,0.00080178,0.20175,0.45318,HP_CALCIFICATION_OF_THE_AORTA,1
MIR3116,SET,87,0.01038,0.00071246,0.08828,0.4532,MIR3116,1
GSE1925_CTRL_VS_IFNG_PRIMED_...3,SET,115,0.0095155,0.00075033,0.080921,0.4532,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_DN,1
REACTOME_CASPASE_ACTIVATION_...2,SET,9,0.034279,0.00075837,0.29161,0.45321,REACTOME_CASPASE_ACTIVATION_VIA_DEPENDENCE_RECEPTORS_IN_THE_ABSENCE_OF_LIGAND,1
GSE11057_PBMC_VS_MEM_CD4_TCE...1,SET,164,0.0078425,0.00073751,0.06672,0.45322,GSE11057_PBMC_VS_MEM_CD4_TCELL_DN,1
HP_URIC_ACID_NEPHROLITHIASIS,SET,11,0.028027,0.00068545,0.23851,0.45323,HP_URIC_ACID_NEPHROLITHIASIS,1
HP_ABNORMAL_EAR_MORPHOLOGY,SET,1421,0.0026904,0.00071859,0.02293,0.4533,HP_ABNORMAL_EAR_MORPHOLOGY,1
GSE557_CIITA_KO_VS_I_AB_KO_D...2,SET,180,0.0071913,0.00070818,0.06134,0.45334,GSE557_CIITA_KO_VS_I_AB_KO_DC_UP,1
HP_RETINAL_VASCULAR_TORTUOSI...,SET,38,0.017384,0.00078965,0.14835,0.45336,HP_RETINAL_VASCULAR_TORTUOSITY,1
GOBP_MITOCHONDRIAL_ADP_TRANS...,SET,3,0.052227,0.00066721,0.44591,0.45338,GOBP_MITOCHONDRIAL_ADP_TRANSMEMBRANE_TRANSPORT,1
KEGG_MEDICUS_PATHOGEN_HBV_HB...2,SET,5,0.05054,0.00083348,0.43181,0.45341,KEGG_MEDICUS_PATHOGEN_HBV_HBX_TO_ERK_SIGNALING_PATHWAY,1
HP_INTERNALLY_NUCLEATED_SKEL...,SET,6,0.043572,0.00078714,0.37229,0.45342,HP_INTERNALLY_NUCLEATED_SKELETAL_MUSCLE_FIBERS,1
GOCC_KAINATE_SELECTIVE_GLUTA...,SET,5,0.046122,0.00076064,0.39422,0.45343,GOCC_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,1
GOMF_KAINATE_SELECTIVE_GLUTA...,SET,5,0.046122,0.00076064,0.39422,0.45343,GOMF_KAINATE_SELECTIVE_GLUTAMATE_RECEPTOR_ACTIVITY,1
MORF_RRM1,SET,89,0.0094798,0.00065808,0.081043,0.45344,MORF_RRM1,1
GOMF_GLYCINE_BINDING,SET,10,0.034329,0.00080053,0.29406,0.45353,GOMF_GLYCINE_BINDING,1
SALVADOR_MARTIN_PEDIATRIC_TB...1,SET,21,0.022176,0.00074919,0.19003,0.45355,SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_POST_TREATMENT_UP,1
GOBP_NUCLEAR_MEMBRANE_REASSE...,SET,25,0.019016,0.00070085,0.16312,0.4536,GOBP_NUCLEAR_MEMBRANE_REASSEMBLY,1
GOBP_INDUCTION_OF_BACTERIAL_...,SET,5,0.054464,0.00089821,0.46748,0.45363,GOBP_INDUCTION_OF_BACTERIAL_AGGLUTINATION,1
KEGG_MEDICUS_REFERENCE_TRAPP...,SET,8,0.031958,0.0006666,0.27441,0.45364,KEGG_MEDICUS_REFERENCE_TRAPPI_RAB1_SIGNALING_PATHWAY,1
REACTOME_APOPTOTIC_EXECUTION...,SET,43,0.014905,0.0007201,0.12799,0.45365,REACTOME_APOPTOTIC_EXECUTION_PHASE,1
GOBP_THYMOCYTE_MIGRATION,SET,7,0.040755,0.00079522,0.35008,0.45366,GOBP_THYMOCYTE_MIGRATION,1
GSE41176_WT_VS_TAK1_KO_ANTI_...6,SET,175,0.0073907,0.00071774,0.063541,0.4537,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_UP,1
GSE40273_XBP1_KO_VS_WT_TREG_...1,SET,184,0.0073307,0.00072981,0.063058,0.45373,GSE40273_XBP1_KO_VS_WT_TREG_DN,1
ZNF157_TARGET_GENES,SET,58,0.012869,0.00072179,0.11072,0.45374,ZNF157_TARGET_GENES,1
ZHENG_CORD_BLOOD_C3_MEGAKARY...,SET,90,0.010107,0.0007055,0.087059,0.45379,ZHENG_CORD_BLOOD_C3_MEGAKARYOCYTE_ERYTHROID_PROGENITOR,1
GAVISH_3CA_METAPROGRAM_EPITH...21,SET,34,0.015967,0.00068612,0.13769,0.45384,GAVISH_3CA_METAPROGRAM_EPITHELIAL_RESPIRATION,1
RYAAAKNNNNNNTTGW_UNKNOWN,SET,74,0.011978,0.00075849,0.1033,0.45385,RYAAAKNNNNNNTTGW_UNKNOWN,1
KYNG_WERNER_SYNDROM_UP,SET,11,0.028378,0.00069404,0.24525,0.45394,KYNG_WERNER_SYNDROM_UP,1
GOBP_POSITIVE_REGULATION_OF_...820,SET,7,0.038353,0.00074834,0.33147,0.45394,GOBP_POSITIVE_REGULATION_OF_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GSE3920_IFNB_VS_IFNG_TREATED...1,SET,158,0.007238,0.00066821,0.062593,0.45397,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...520,SET,6,0.038814,0.00070119,0.33584,0.454,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,1
AIZARANI_LIVER_C33_STELLATE_...,SET,117,0.009725,0.00077345,0.08417,0.45401,AIZARANI_LIVER_C33_STELLATE_CELLS_2,1
KEGG_MEDICUS_REFERENCE_CXCR4...3,SET,21,0.020277,0.00068503,0.17571,0.45407,KEGG_MEDICUS_REFERENCE_CXCR4_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,1
HP_POSTERIORLY_ROTATED_EARS,SET,397,0.0048385,0.0007034,0.041941,0.45408,HP_POSTERIORLY_ROTATED_EARS,1
WP_NEPHROGENESIS,SET,18,0.02483,0.00077669,0.21531,0.4541,WP_NEPHROGENESIS,1
HP_ATROPHY_DEGENERATION_AFFE...2,SET,752,0.0034526,0.00068396,0.029957,0.45412,HP_ATROPHY_DEGENERATION_AFFECTING_THE_CENTRAL_NERVOUS_SYSTEM,1
MIR4477B,SET,242,0.0062274,0.00070986,0.054098,0.45418,MIR4477B,1
HP_ABNORMALITY_OF_LENS_SHAPE,SET,15,0.026444,0.00075516,0.22973,0.45418,HP_ABNORMALITY_OF_LENS_SHAPE,1
SCHLOSSER_SERUM_RESPONSE_UP,SET,116,0.0089945,0.00071231,0.078161,0.45419,SCHLOSSER_SERUM_RESPONSE_UP,1
GCM_LTK,SET,41,0.014285,0.00067396,0.12413,0.45419,GCM_LTK,1
HP_NEVUS_SEBACEOUS,SET,5,0.038913,0.00064175,0.33855,0.45425,HP_NEVUS_SEBACEOUS,1
GSE17721_LPS_VS_CPG_24H_BMDC...1,SET,190,0.0068331,0.00069116,0.059539,0.45432,GSE17721_LPS_VS_CPG_24H_BMDC_DN,1
MIR412_3P,SET,67,0.012223,0.00073666,0.10661,0.45436,MIR412_3P,1
GOBP_COPII_COATED_VESICLE_BU...,SET,42,0.013603,0.00064953,0.11868,0.45438,GOBP_COPII_COATED_VESICLE_BUDDING,1
GOBP_ISOPRENOID_METABOLIC_PR...,SET,129,0.0089587,0.00074791,0.078238,0.45442,GOBP_ISOPRENOID_METABOLIC_PROCESS,1
HP_PROSTATITIS,SET,6,0.050185,0.0009066,0.4383,0.45442,HP_PROSTATITIS,1
MIR551B_5P,SET,451,0.004775,0.00073876,0.041718,0.45444,MIR551B_5P,1
GOBP_AXONAL_FASCICULATION,SET,20,0.024125,0.00079542,0.21084,0.45445,GOBP_AXONAL_FASCICULATION,1
GOBP_CARDIOBLAST_PROLIFERATI...,SET,9,0.0352,0.00077874,0.30759,0.45445,GOBP_CARDIOBLAST_PROLIFERATION,1
ZNF592_TARGET_GENES,SET,1472,0.0026092,0.00070824,0.022823,0.45449,ZNF592_TARGET_GENES,1
GSE17301_CTRL_VS_48H_IFNA2_S...2,SET,182,0.0070914,0.00070218,0.062057,0.45451,GSE17301_CTRL_VS_48H_IFNA2_STIM_CD8_TCELL_UP,1
WP_NAD_BIOSYNTHESIS_II_FROM_...,SET,8,0.033925,0.00070764,0.29819,0.45471,WP_NAD_BIOSYNTHESIS_II_FROM_TRYPTOPHAN,1
HP_ABNORMAL_DISTAL_FEMORAL_M...,SET,5,0.045451,0.00074957,0.39947,0.45471,HP_ABNORMAL_DISTAL_FEMORAL_METAPHYSIS_MORPHOLOGY,1
GOBP_MODULATION_BY_HOST_OF_S...,SET,79,0.010403,0.00068058,0.091488,0.45473,GOBP_MODULATION_BY_HOST_OF_SYMBIONT_PROCESS,1
HP_EXTRAPYRAMIDAL_MUSCULAR_R...,SET,13,0.028342,0.0007535,0.24937,0.45476,HP_EXTRAPYRAMIDAL_MUSCULAR_RIGIDITY,1
HP_DEVIATION_OF_THE_4TH_TOE,SET,4,0.054861,0.00080926,0.48321,0.4548,HP_DEVIATION_OF_THE_4TH_TOE,1
NAKAYA_MONOCYTE_FLUMIST_AGE_...1,SET,237,0.0061174,0.00069018,0.0539,0.45482,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_DN,1
LE_NEURONAL_DIFFERENTIATION_...2,SET,17,0.022246,0.00067625,0.19617,0.45486,LE_NEURONAL_DIFFERENTIATION_UP,1
GSE25502_WT_VS_KLF13_KO_THYM...1,SET,154,0.0080637,0.00073504,0.071119,0.45486,GSE25502_WT_VS_KLF13_KO_THYMIC_MEMORY_LIKE_CD8_TCELL_DN,1
GSE2770_UNTREATED_VS_TGFB_AN...8,SET,177,0.006924,0.00067621,0.061065,0.45486,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
chr7q22,SET,121,0.018815,0.0015216,0.16601,0.45488,chr7q22,1
GARY_CD5_TARGETS_UP,SET,417,0.0045647,0.00067973,0.04027,0.45488,GARY_CD5_TARGETS_UP,1
GOBP_REGULATION_OF_CATABOLIC...,SET,917,0.0031798,0.00069232,0.028137,0.45501,GOBP_REGULATION_OF_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_MONOATOMI...2,SET,13,0.027247,0.0007244,0.2415,0.45509,GOBP_REGULATION_OF_MONOATOMIC_ANION_TRANSPORT,1
GSE17301_IFNA2_VS_IFNA2_AND_...2,SET,183,0.0068688,0.00068198,0.060881,0.45509,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP,1
NABA_ECM_GLYCOPROTEINS,SET,177,0.0076299,0.00074515,0.067654,0.4551,NABA_ECM_GLYCOPROTEINS,1
HP_FAVORABLE_RESPONSE_OF_WEA...,SET,4,0.048754,0.00071917,0.43252,0.45513,HP_FAVORABLE_RESPONSE_OF_WEAKNESS_TO_ACETYLCHOLINE_ESTERASE_INHIBITORS,1
HP_HISTIOCYTOSIS,SET,6,0.040856,0.00073807,0.3628,0.45517,HP_HISTIOCYTOSIS,1
GOMF_AMINOPEPTIDASE_ACTIVITY,SET,36,0.016163,0.00071462,0.14397,0.45531,GOMF_AMINOPEPTIDASE_ACTIVITY,1
WP_ROS_IN_COVID19_ENDOTHELIA...,SET,6,0.042915,0.00077526,0.38288,0.45538,WP_ROS_IN_COVID19_ENDOTHELIAL_DYSFUNCTION,1
GOBP_ENTEROENDOCRINE_CELL_DI...,SET,33,0.017818,0.00075435,0.159,0.45539,GOBP_ENTEROENDOCRINE_CELL_DIFFERENTIATION,1
WAKASUGI_HAVE_ZNF143_BINDING...,SET,51,0.011431,0.0006013,0.10203,0.4554,WAKASUGI_HAVE_ZNF143_BINDING_SITES,1
NKX61_01,SET,215,0.0068348,0.0007349,0.061023,0.45541,NKX61_01,1
MIR6833_3P,SET,375,0.0049371,0.00069799,0.044086,0.45542,MIR6833_3P,1
ABBUD_LIF_SIGNALING_1_DN,SET,21,0.022079,0.00074589,0.19724,0.45544,ABBUD_LIF_SIGNALING_1_DN,1
REACTOME_INTRA_GOLGI_TRAFFIC,SET,43,0.014427,0.00069702,0.1289,0.45544,REACTOME_INTRA_GOLGI_TRAFFIC,1
HP_MALFORMATION_OF_THE_HEPAT...,SET,8,0.027566,0.00057499,0.24672,0.45552,HP_MALFORMATION_OF_THE_HEPATIC_DUCTAL_PLATE,1
REACTOME_NEGATIVE_REGULATION...7,SET,40,0.014979,0.00069803,0.13408,0.45553,REACTOME_NEGATIVE_REGULATION_OF_MAPK_PATHWAY,1
GNF2_MLH1,SET,36,0.013855,0.0006126,0.12417,0.45558,GNF2_MLH1,1
REACTOME_NF_KB_ACTIVATION_TH...,SET,11,0.029031,0.00071001,0.26053,0.45564,REACTOME_NF_KB_ACTIVATION_THROUGH_FADD_RIP_1_PATHWAY_MEDIATED_BY_CASPASE_8_AND_10,1
GSE17721_POLYIC_VS_PAM3CSK4_...12,SET,183,0.0066792,0.00066315,0.059963,0.45566,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP,1
JACKSON_DNMT1_TARGETS_UP,SET,80,0.01077,0.00070902,0.096739,0.45568,JACKSON_DNMT1_TARGETS_UP,1
GSE17721_LPS_VS_CPG_1H_BMDC_...2,SET,180,0.0066497,0.00065485,0.059766,0.4557,GSE17721_LPS_VS_CPG_1H_BMDC_UP,1
GSE25123_IL4_VS_IL4_AND_ROSI...3,SET,170,0.0074534,0.00071351,0.067104,0.45578,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_DN,1
DURANTE_ADULT_OLFACTORY_NEUR...8,SET,128,0.0086658,0.00072067,0.078109,0.45583,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS,1
GOBP_REGULATION_OF_CD8_POSIT...2,SET,8,0.034722,0.00072426,0.3133,0.45588,GOBP_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOCC_OXIDOREDUCTASE_COMPLEX,SET,102,0.0082391,0.00061208,0.074417,0.45592,GOCC_OXIDOREDUCTASE_COMPLEX,1
HP_LOSS_OF_EYELASHES,SET,4,0.040229,0.00059341,0.36338,0.45593,HP_LOSS_OF_EYELASHES,1
GOBP_NATURAL_KILLER_CELL_PRO...,SET,14,0.028026,0.00077322,0.25362,0.456,GOBP_NATURAL_KILLER_CELL_PROLIFERATION,1
GNF2_RFC3,SET,39,0.014021,0.00064521,0.1271,0.45608,GNF2_RFC3,1
HP_ILEUS,SET,29,0.018453,0.00073244,0.16731,0.45609,HP_ILEUS,1
MIR618,SET,59,0.011516,0.00065145,0.10445,0.4561,MIR618,1
GOBP_SMOOTH_MUSCLE_CELL_MATR...,SET,6,0.037731,0.00068163,0.34264,0.45616,GOBP_SMOOTH_MUSCLE_CELL_MATRIX_ADHESION,1
GSE411_WT_VS_SOCS3_KO_MACROP...5,SET,184,0.0072621,0.00072298,0.065975,0.45618,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_400MIN_UP,1
REACTOME_DOWNREGULATION_OF_E...1,SET,12,0.027068,0.00069142,0.24597,0.45619,REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING,1
KEGG_MEDICUS_REFERENCE_HGF_M...2,SET,14,0.024691,0.0006812,0.22449,0.45621,KEGG_MEDICUS_REFERENCE_HGF_MET_RAS_ERK_SIGNALING_PATHWAY,1
MIR3177_3P,SET,8,0.036674,0.00076498,0.33358,0.45623,MIR3177_3P,1
GSE27786_NKTCELL_VS_ERYTHROB...1,SET,186,0.0069205,0.00069267,0.062961,0.45624,GSE27786_NKTCELL_VS_ERYTHROBLAST_DN,1
GSE5589_UNSTIM_VS_45MIN_LPS_...2,SET,182,0.0066954,0.00066297,0.060913,0.45624,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,1
HU_ANGIOGENESIS_DN,SET,32,0.015663,0.000653,0.14255,0.45625,HU_ANGIOGENESIS_DN,1
HP_INTESTINAL_FISTULA,SET,29,0.016696,0.00066267,0.15206,0.45629,HP_INTESTINAL_FISTULA,1
MIR1288_3P,SET,36,0.015705,0.00069439,0.14327,0.45636,MIR1288_3P,1
NAKAYA_PBMC_FLUAD_MALE_AGE_1...3,SET,17,0.025553,0.00077678,0.2331,0.45636,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_UP,1
GOBP_NEGATIVE_REGULATION_OF_...97,SET,41,0.013901,0.00065585,0.12686,0.45637,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_INSULIN_STIMULUS,1
HP_SLOW_DECREASE_IN_VISUAL_A...,SET,24,0.01852,0.00066879,0.16923,0.45643,HP_SLOW_DECREASE_IN_VISUAL_ACUITY,1
HP_PARONYCHIA,SET,16,0.023883,0.00070437,0.21828,0.45644,HP_PARONYCHIA,1
GSE1460_INTRATHYMIC_T_PROGEN...4,SET,171,0.0071727,0.00068864,0.06557,0.45645,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_DP_THYMOCYTE_UP,1
GOBP_POSITIVE_REGULATION_OF_...301,SET,19,0.022008,0.00070725,0.20123,0.45646,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...454,SET,35,0.015593,0.00067981,0.14277,0.45652,GOBP_NEGATIVE_REGULATION_OF_NOTCH_SIGNALING_PATHWAY,1
GOBP_PEPTIDYL_LYSINE_DEACETY...,SET,5,0.038942,0.00064222,0.35713,0.45658,GOBP_PEPTIDYL_LYSINE_DEACETYLATION,1
GOBP_AUTOPHAGOSOME_MEMBRANE_...,SET,7,0.027648,0.00053947,0.25382,0.45663,GOBP_AUTOPHAGOSOME_MEMBRANE_DOCKING,1
HP_PAROXYSMAL_BURSTS_OF_LAUG...,SET,9,0.029701,0.00065709,0.27271,0.45664,HP_PAROXYSMAL_BURSTS_OF_LAUGHTER,1
TGFB_UP.V1_DN,SET,172,0.0072034,0.00069358,0.066153,0.45665,TGFB_UP.V1_DN,1
MODULE_197,SET,169,0.0071905,0.00068634,0.066056,0.45666,MODULE_197,1
HP_THIN_LOWER_LIP_VERMILION,SET,5,0.044992,0.000742,0.41356,0.45668,HP_THIN_LOWER_LIP_VERMILION,1
MCBRYAN_PUBERTAL_BREAST_5_6W...1,SET,119,0.007955,0.00063804,0.073154,0.4567,MCBRYAN_PUBERTAL_BREAST_5_6WK_DN,1
HP_ABNORMAL_EYELID_MORPHOLOGY,SET,1180,0.0026891,0.00065913,0.024787,0.4568,HP_ABNORMAL_EYELID_MORPHOLOGY,1
MATZUK_PREOVULATORY_FOLLICLE,SET,9,0.035733,0.00079054,0.3296,0.45684,MATZUK_PREOVULATORY_FOLLICLE,1
GSE37533_UNTREATED_VS_PIOGLI...6,SET,129,0.0080306,0.00067043,0.074179,0.4569,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_UP,1
HP_NEONATAL_SHORT_LIMB_SHORT...,SET,13,0.025717,0.00068371,0.23775,0.45693,HP_NEONATAL_SHORT_LIMB_SHORT_STATURE,1
HP_ABNORMAL_MITOCHONDRIAL_NU...,SET,6,0.029934,0.00054077,0.27735,0.45703,HP_ABNORMAL_MITOCHONDRIAL_NUMBER,1
NIKOLSKY_BREAST_CANCER_10Q22...,SET,8,0.041481,0.00086524,0.38445,0.45704,NIKOLSKY_BREAST_CANCER_10Q22_AMPLICON,1
GOMF_DYNEIN_HEAVY_CHAIN_BIND...,SET,12,0.022958,0.00058645,0.21277,0.45704,GOMF_DYNEIN_HEAVY_CHAIN_BINDING,1
HP_NEONATAL_OMPHALITIS,SET,10,0.033576,0.00078298,0.31129,0.45705,HP_NEONATAL_OMPHALITIS,1
GOMF_COPPER_ION_TRANSMEMBRAN...,SET,6,0.03387,0.00061187,0.31406,0.45706,GOMF_COPPER_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_CD4_T...10,SET,46,0.013252,0.00066212,0.12297,0.45709,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_UNASSIGNED,1
HP_HYPOPLASIA_OF_THE_EPIGLOT...,SET,9,0.031788,0.00070326,0.29501,0.4571,HP_HYPOPLASIA_OF_THE_EPIGLOTTIS,1
HP_PULMONARY_EMBOLISM,SET,35,0.015619,0.00068094,0.14499,0.45711,HP_PULMONARY_EMBOLISM,1
HP_FACIAL_ERYTHEMA,SET,11,0.029207,0.00071433,0.27118,0.45712,HP_FACIAL_ERYTHEMA,1
GOBP_POSITIVE_REGULATION_OF_...262,SET,14,0.02655,0.00073248,0.24659,0.45713,GOBP_POSITIVE_REGULATION_OF_EXECUTION_PHASE_OF_APOPTOSIS,1
HP_ABNORMALITY_OF_THE_COAGUL...,SET,136,0.0076932,0.00065933,0.071534,0.45718,HP_ABNORMALITY_OF_THE_COAGULATION_CASCADE,1
GOBP_REGULATION_OF_MITOCHOND...16,SET,136,0.0078453,0.00067237,0.073034,0.45723,GOBP_REGULATION_OF_MITOCHONDRION_ORGANIZATION,1
GOBP_SINOATRIAL_NODE_CELL_DI...,SET,6,0.042495,0.00076768,0.39615,0.45729,GOBP_SINOATRIAL_NODE_CELL_DIFFERENTIATION,1
MODULE_77,SET,27,0.014718,0.00056369,0.1374,0.45735,MODULE_77,1
REACTOME_INFECTIOUS_DISEASE,SET,889,0.002944,0.00063163,0.027504,0.45738,REACTOME_INFECTIOUS_DISEASE,1
GOBP_REGULATION_OF_PRO_B_CEL...,SET,8,0.033287,0.00069434,0.31163,0.45747,GOBP_REGULATION_OF_PRO_B_CELL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...251,SET,9,0.034764,0.0007691,0.32553,0.45748,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_WOUND_HEALING,1
GSE22611_MUTANT_NOD2_VS_CTRL...1,SET,161,0.0070826,0.00065998,0.066317,0.45748,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,1
HP_ACUTE_ENCEPHALOPATHY,SET,10,0.029915,0.00069761,0.28043,0.45752,HP_ACUTE_ENCEPHALOPATHY,1
MATSUMIYA_BLOOD_MODIFIED_VAC...2,SET,13,0.023854,0.00063419,0.22369,0.45754,MATSUMIYA_BLOOD_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_1DY_UP,1
KYNG_ENVIRONMENTAL_STRESS_RE...4,SET,29,0.015771,0.00062599,0.14797,0.45756,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_OLD,1
WP_HIPPO_SIGNALING_REGULATION,SET,98,0.009633,0.00070154,0.090388,0.45756,WP_HIPPO_SIGNALING_REGULATION,1
DESCARTES_FETAL_HEART_LYMPHA...,SET,28,0.018753,0.00073142,0.17634,0.45765,DESCARTES_FETAL_HEART_LYMPHATIC_ENDOTHELIAL_CELLS,1
KEGG_RETINOL_METABOLISM,SET,60,0.014942,0.00085234,0.14055,0.45767,KEGG_RETINOL_METABOLISM,1
BORLAK_LIVER_CANCER_EGF_UP,SET,49,0.013483,0.00069526,0.1269,0.45769,BORLAK_LIVER_CANCER_EGF_UP,1
KEGG_MEDICUS_REFERENCE_AUTOP...5,SET,12,0.025696,0.00065638,0.24198,0.45772,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_LC3_II_FORMATION,1
IVANOVA_HEMATOPOIESIS_STEM_C...1,SET,179,0.0068194,0.00066971,0.064254,0.45774,IVANOVA_HEMATOPOIESIS_STEM_CELL,1
HP_ABNORMALITY_OF_THE_MITOCH...,SET,190,0.0058844,0.0005952,0.055476,0.45776,HP_ABNORMALITY_OF_THE_MITOCHONDRION,1
GOBP_ALDITOL_PHOSPHATE_METAB...,SET,9,0.032574,0.00072065,0.30753,0.45782,GOBP_ALDITOL_PHOSPHATE_METABOLIC_PROCESS,1
GOBP_CHAPERONE_COFACTOR_DEPE...,SET,30,0.014993,0.00060524,0.14173,0.45788,GOBP_CHAPERONE_COFACTOR_DEPENDENT_PROTEIN_REFOLDING,1
GSE1460_INTRATHYMIC_T_PROGEN...2,SET,173,0.006562,0.00063364,0.062075,0.45791,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_CD4_THYMOCYTE_UP,1
MIR324_3P,SET,71,0.0099725,0.00061863,0.094532,0.45799,MIR324_3P,1
HOXA9_DN.V1_UP,SET,172,0.0072046,0.0006937,0.068406,0.45806,HOXA9_DN.V1_UP,1
MIR139_3P,SET,14,0.025306,0.00069818,0.24036,0.45808,MIR139_3P,1
BIOCARTA_AGR_PATHWAY,SET,29,0.016779,0.00066597,0.15943,0.45809,BIOCARTA_AGR_PATHWAY,1
MIR6807_5P,SET,53,0.011952,0.00064089,0.11363,0.45812,MIR6807_5P,1
GOMF_IONOTROPIC_GLUTAMATE_RE...,SET,23,0.018294,0.00064674,0.17406,0.45815,GOMF_IONOTROPIC_GLUTAMATE_RECEPTOR_BINDING,1
GOBP_ALKALOID_METABOLIC_PROC...,SET,7,0.030556,0.00059622,0.29081,0.45816,GOBP_ALKALOID_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...335,SET,5,0.039463,0.00065081,0.37594,0.4582,GOBP_NEGATIVE_REGULATION_OF_LAMELLIPODIUM_ORGANIZATION,1
GOBP_DE_NOVO_NAD_BIOSYNTHETI...,SET,8,0.033649,0.00070187,0.3207,0.45822,GOBP_DE_NOVO_NAD_BIOSYNTHETIC_PROCESS,1
GOBP_NEPHRON_DEVELOPMENT,SET,150,0.0078751,0.00070853,0.075073,0.45823,GOBP_NEPHRON_DEVELOPMENT,1
HP_APLASIA_HYPOPLASIA_INVOLV...13,SET,3,0.061809,0.00078961,0.58943,0.45824,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SHOULDER_MUSCULATURE,1
HP_ABNORMAL_THYROID_MORPHOLO...,SET,166,0.0069134,0.00065406,0.066042,0.45831,HP_ABNORMAL_THYROID_MORPHOLOGY,1
HP_INCREASED_CIRCULATING_INS...,SET,5,0.035263,0.00058154,0.33678,0.45831,HP_INCREASED_CIRCULATING_INSULIN_LIKE_GROWTH_FACTOR_1_CONCENTRATION,1
GSE15659_CD45RA_NEG_CD4_TCEL...3,SET,172,0.0066064,0.0006361,0.063137,0.45833,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_DN,1
GOBP_MATERNAL_PROCESS_INVOLV...1,SET,52,0.012591,0.00066876,0.12055,0.45841,GOBP_MATERNAL_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,1
REACTOME_MULTIFUNCTIONAL_ANI...,SET,9,0.029215,0.00064633,0.28011,0.45847,REACTOME_MULTIFUNCTIONAL_ANION_EXCHANGERS,1
MIR6502_5P,SET,51,0.011964,0.00062936,0.11472,0.45847,MIR6502_5P,1
GSE9960_HEALTHY_VS_GRAM_NEG_...4,SET,186,0.006355,0.00063607,0.06096,0.45849,GSE9960_HEALTHY_VS_GRAM_NEG_SEPSIS_PBMC_UP,1
MIR548AZ_5P,SET,393,0.0046259,0.00066918,0.044419,0.45853,MIR548AZ_5P,1
GOBP_POSITIVE_REGULATION_OF_...516,SET,25,0.019451,0.00071688,0.18676,0.45853,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_MEDIATED_CYTOTOXICITY,1
GOBP_ADENOSINE_METABOLIC_PRO...,SET,9,0.034347,0.00075988,0.33011,0.45857,GOBP_ADENOSINE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_ENDODERMA...,SET,6,0.043019,0.00077715,0.41375,0.4586,GOBP_REGULATION_OF_ENDODERMAL_CELL_DIFFERENTIATION,1
DESCARTES_FETAL_CEREBELLUM_P...,SET,43,0.014585,0.00070466,0.14031,0.4586,DESCARTES_FETAL_CEREBELLUM_PURKINJE_NEURONS,1
GSE5503_PLN_DC_VS_SPLEEN_DC_...2,SET,186,0.0063111,0.00063167,0.06078,0.45865,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...119,SET,6,0.033992,0.00061407,0.32745,0.45866,GOBP_POSITIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
GOMF_PRE_MRNA_3_SPLICE_SITE_...,SET,3,0.047643,0.00060864,0.45959,0.45872,GOMF_PRE_MRNA_3_SPLICE_SITE_BINDING,1
BRF2_TARGET_GENES,SET,7,0.030263,0.00059049,0.29202,0.45873,BRF2_TARGET_GENES,1
GSE17974_CTRL_VS_ACT_IL4_AND...6,SET,173,0.0066461,0.00064176,0.064123,0.45873,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_UP,1
GSE45365_WT_VS_IFNAR_KO_CD11...3,SET,167,0.0065025,0.00061701,0.062761,0.45874,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_MCMV_INFECTION_UP,1
REACTOME_TRANSPORT_OF_INORGA...,SET,103,0.0090533,0.00067584,0.087402,0.45875,REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES,1
CHO_NR4A1_TARGETS,SET,29,0.017625,0.00069956,0.17025,0.45878,CHO_NR4A1_TARGETS,1
MORI_LARGE_PRE_BII_LYMPHOCYT...1,SET,53,0.012518,0.00067127,0.12099,0.4588,MORI_LARGE_PRE_BII_LYMPHOCYTE_DN,1
BCAT_GDS748_DN,SET,40,0.01336,0.00062259,0.12918,0.45882,BCAT_GDS748_DN,1
HP_HYPOPLASTIC_LABIA_MINORA,SET,28,0.016849,0.00065715,0.16319,0.45888,HP_HYPOPLASTIC_LABIA_MINORA,1
GOBP_PROTEIN_DEMETHYLATION,SET,8,0.024556,0.00051221,0.23805,0.45892,GOBP_PROTEIN_DEMETHYLATION,1
GOBP_REGULATION_OF_SYSTEMIC_...3,SET,6,0.040171,0.00072569,0.38961,0.45894,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_ENDOTHELIN,1
REACTOME_REELIN_SIGNALLING_P...,SET,4,0.046777,0.00069001,0.4543,0.459,REACTOME_REELIN_SIGNALLING_PATHWAY,1
MODULE_372,SET,20,0.019137,0.00063093,0.18587,0.459,MODULE_372,1
HP_SPONTANEOUS_RECURRENT_EPI...,SET,13,0.025775,0.00068527,0.25041,0.45901,HP_SPONTANEOUS_RECURRENT_EPISTAXIS,1
GOMF_DELAYED_RECTIFIER_POTAS...,SET,27,0.019607,0.00075095,0.19054,0.45902,GOMF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
GOMF_PRE_MRNA_BINDING,SET,36,0.013034,0.0005763,0.1267,0.45903,GOMF_PRE_MRNA_BINDING,1
MIR641,SET,232,0.0056765,0.00063374,0.055189,0.45904,MIR641,1
HP_INTERMITTENT_HYPERVENTILA...,SET,3,0.054566,0.00069709,0.53079,0.45906,HP_INTERMITTENT_HYPERVENTILATION,1
HP_PILOMATRIXOMA,SET,7,0.034161,0.00066656,0.33254,0.45909,HP_PILOMATRIXOMA,1
GSE13173_UNTREATED_VS_IL12_T...2,SET,113,0.0082262,0.00064304,0.080093,0.4591,GSE13173_UNTREATED_VS_IL12_TREATED_ACT_CD8_TCELL_UP,1
REACTOME_DISEASES_OF_IMMUNE_...,SET,29,0.016787,0.00066632,0.16366,0.45915,REACTOME_DISEASES_OF_IMMUNE_SYSTEM,1
GSE26290_CTRL_VS_AKT_INHIBIT...2,SET,174,0.0067795,0.00065652,0.066088,0.45915,GSE26290_CTRL_VS_AKT_INHIBITOR_TREATED_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,1
REACTOME_SYNTHESIS_OF_PIPS_A...4,SET,10,0.022647,0.00052811,0.22095,0.45918,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_LATE_ENDOSOME_MEMBRANE,1
DESCARTES_MAIN_FETAL_ASTROCY...,SET,33,0.016104,0.00068176,0.15717,0.4592,DESCARTES_MAIN_FETAL_ASTROCYTES,1
GSE22103_LPS_VS_GMCSF_AND_IF...1,SET,188,0.0060876,0.00061254,0.059519,0.45927,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN,1
DESCARTES_FETAL_CEREBRUM_MEG...,SET,313,0.0049243,0.00063713,0.048143,0.45927,DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES,1
REACTOME_HSF1_ACTIVATION,SET,28,0.015769,0.00061501,0.15432,0.45931,REACTOME_HSF1_ACTIVATION,1
HP_INCREASED_SERUM_TESTOSTER...,SET,10,0.028179,0.00065713,0.2762,0.45937,HP_INCREASED_SERUM_TESTOSTERONE_LEVEL,1
GOBP_PYRAMIDAL_NEURON_DEVELO...,SET,9,0.029808,0.00065945,0.29263,0.45943,GOBP_PYRAMIDAL_NEURON_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...38,SET,82,0.0091444,0.00060944,0.089815,0.45945,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY,1
HP_SHORTENING_OF_ALL_PHALANG...,SET,6,0.031807,0.00057459,0.31255,0.45947,HP_SHORTENING_OF_ALL_PHALANGES_OF_THE_TOES,1
GOBP_REGULATION_OF_FOCAL_ADH...,SET,6,0.037651,0.00068017,0.3703,0.45951,GOBP_REGULATION_OF_FOCAL_ADHESION_DISASSEMBLY,1
REACTOME_CARBOXYTERMINAL_POS...,SET,41,0.014292,0.00067425,0.14061,0.45952,REACTOME_CARBOXYTERMINAL_POST_TRANSLATIONAL_MODIFICATIONS_OF_TUBULIN,1
KEGG_MEDICUS_REFERENCE_NOTCH...4,SET,13,0.024229,0.00064416,0.23861,0.45956,KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY,1
ACEVEDO_METHYLATED_IN_LIVER_...,SET,684,0.003635,0.00068807,0.035834,0.4596,ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN,1
MIR4731_3P,SET,203,0.0063715,0.00066592,0.06285,0.45963,MIR4731_3P,1
HP_DEFICIENT_EXCISION_OF_UV_...,SET,5,0.032203,0.00053108,0.31804,0.45968,HP_DEFICIENT_EXCISION_OF_UV_INDUCED_PYRIMIDINE_DIMERS_IN_DNA,1
chr2p13,SET,81,0.022161,0.0014679,0.21892,0.45969,chr2p13,1
KEGG_RNA_DEGRADATION,SET,49,0.011511,0.00059356,0.11396,0.45977,KEGG_RNA_DEGRADATION,1
REACTOME_PHYSIOLOGICAL_FACTO...,SET,14,0.023602,0.00065117,0.23444,0.4599,REACTOME_PHYSIOLOGICAL_FACTORS,1
PAX5_02,SET,16,0.020674,0.00060971,0.20535,0.4599,PAX5_02,1
ZHONG_RESPONSE_TO_AZACITIDIN...1,SET,58,0.010445,0.00058581,0.10375,0.45991,ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN,1
GOBP_RECOGNITION_OF_APOPTOTI...,SET,7,0.034895,0.00068087,0.34702,0.45995,GOBP_RECOGNITION_OF_APOPTOTIC_CELL,1
GSE13547_2H_VS_12_H_ANTI_IGM...1,SET,165,0.0061822,0.00058313,0.061632,0.46005,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_DN,1
MARTORIATI_MDM4_TARGETS_FETA...1,SET,467,0.0038986,0.00061351,0.038931,0.46012,MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN,1
STAT1_02,SET,233,0.0054369,0.00060828,0.054314,0.46013,STAT1_02,1
REACTOME_STING_MEDIATED_INDU...,SET,13,0.020998,0.00055826,0.20981,0.46014,REACTOME_STING_MEDIATED_INDUCTION_OF_HOST_IMMUNE_RESPONSES,1
KEGG_MEDICUS_VARIANT_TMPRSS2...,SET,7,0.036051,0.00070343,0.36029,0.46015,KEGG_MEDICUS_VARIANT_TMPRSS2_ERG_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
BIOCARTA_MCALPAIN_PATHWAY,SET,18,0.021265,0.00066515,0.21275,0.46019,BIOCARTA_MCALPAIN_PATHWAY,1
GSE36826_NORMAL_VS_STAPH_AUR...4,SET,175,0.0061525,0.0005975,0.061582,0.46021,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP,1
HADDAD_T_LYMPHOCYTE_AND_NK_P...2,SET,73,0.01062,0.000668,0.10634,0.46022,HADDAD_T_LYMPHOCYTE_AND_NK_PROGENITOR_UP,1
HP_RHEUMATOID_ARTHRITIS,SET,20,0.020012,0.00065979,0.20039,0.46023,HP_RHEUMATOID_ARTHRITIS,1
GOBP_THYMIC_T_CELL_SELECTION,SET,24,0.018408,0.00066475,0.18481,0.46033,GOBP_THYMIC_T_CELL_SELECTION,1
GSE3039_CD4_TCELL_VS_B2_BCEL...1,SET,181,0.0063156,0.00062366,0.063413,0.46033,GSE3039_CD4_TCELL_VS_B2_BCELL_DN,1
KEGG_MELANOMA,SET,68,0.011079,0.00067266,0.11127,0.46034,KEGG_MELANOMA,1
GOBP_PHOSPHATIDYLSERINE_ACYL...,SET,8,0.032985,0.00068803,0.33154,0.46037,GOBP_PHOSPHATIDYLSERINE_ACYL_CHAIN_REMODELING,1
GSE7852_TREG_VS_TCONV_THYMUS...2,SET,182,0.0063812,0.00063186,0.064195,0.46041,GSE7852_TREG_VS_TCONV_THYMUS_UP,1
GOBP_CRANIAL_NERVE_DEVELOPME...,SET,61,0.011412,0.00065639,0.11489,0.46044,GOBP_CRANIAL_NERVE_DEVELOPMENT,1
GSE43863_DAY6_EFF_VS_DAY150_...5,SET,184,0.0065542,0.0006525,0.066031,0.46047,GSE43863_DAY6_EFF_VS_DAY150_MEM_TH1_CD4_TCELL_DN,1
REACTOME_SIGNALING_BY_MST1,SET,5,0.033721,0.00055612,0.34004,0.4605,REACTOME_SIGNALING_BY_MST1,1
ZNF493_TARGET_GENES,SET,6,0.034163,0.00061716,0.34482,0.46054,ZNF493_TARGET_GENES,1
GSE17721_LPS_VS_CPG_2H_BMDC_...1,SET,181,0.0061322,0.00060554,0.062016,0.46062,GSE17721_LPS_VS_CPG_2H_BMDC_DN,1
GSE40274_FOXP3_VS_FOXP3_AND_...14,SET,117,0.0082481,0.00065599,0.083502,0.46066,GSE40274_FOXP3_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
MISIAK_ANAPLASTIC_THYROID_CA...2,SET,44,0.013148,0.00064256,0.13337,0.46073,MISIAK_ANAPLASTIC_THYROID_CARCINOMA_UP,1
GSE6259_33D1_POS_VS_DEC205_P...1,SET,156,0.006805,0.00062428,0.069131,0.46079,GSE6259_33D1_POS_VS_DEC205_POS_FLT3L_INDUCED_SPLENIC_DC_DN,1
REACTOME_HOST_INTERACTIONS_O...,SET,121,0.0069486,0.00056195,0.07065,0.46083,REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS,1
MEBARKI_HCC_PROGENITOR_WNT_D...3,SET,18,0.021122,0.0006607,0.21498,0.46087,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_DEPENDENT_BLOCKED_BY_FZD8CRD,1
HP_ABNORMAL_CIRCULATING_GLYC...,SET,27,0.016081,0.00061592,0.16387,0.46091,HP_ABNORMAL_CIRCULATING_GLYCINE_CONCENTRATION,1
GOBP_MATING_BEHAVIOR,SET,36,0.01476,0.0006526,0.15059,0.46096,GOBP_MATING_BEHAVIOR,1
HP_DELAYED_PROXIMAL_FEMORAL_...,SET,16,0.020373,0.00060086,0.20798,0.46098,HP_DELAYED_PROXIMAL_FEMORAL_EPIPHYSEAL_OSSIFICATION,1
TGGAAA_NFAT_Q4_01,SET,1695,0.0021726,0.00062863,0.022191,0.461,TGGAAA_NFAT_Q4_01,1
GOBP_CELLULAR_RESPONSE_TO_MA...1,SET,13,0.026575,0.00070652,0.27139,0.461,GOBP_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,1
GSE21063_CTRL_VS_ANTI_IGM_ST...6,SET,140,0.007385,0.00064208,0.075416,0.461,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_UP,1
GSE27241_WT_CTRL_VS_DIGOXIN_...2,SET,161,0.0066684,0.00062139,0.068104,0.461,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,1
REACTOME_SPHINGOLIPID_DE_NOV...,SET,36,0.013801,0.0006102,0.14143,0.46113,REACTOME_SPHINGOLIPID_DE_NOVO_BIOSYNTHESIS,1
HP_OMPHALOCELE,SET,67,0.01011,0.00060931,0.10381,0.46121,HP_OMPHALOCELE,1
GSE15735_CTRL_VS_HDAC_INHIBI...1,SET,185,0.0060696,0.00060588,0.062336,0.46122,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_12H_DN,1
ROSTY_CERVICAL_CANCER_PROLIF...,SET,130,0.0066575,0.00055793,0.068415,0.46124,ROSTY_CERVICAL_CANCER_PROLIFERATION_CLUSTER,1
ZHENG_GLIOBLASTOMA_PLASTICIT...2,SET,227,0.0056055,0.00061911,0.057718,0.46132,ZHENG_GLIOBLASTOMA_PLASTICITY_UP,1
GSE45365_CD8A_DC_VS_CD11B_DC...4,SET,151,0.0066537,0.00060062,0.068557,0.46134,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_MCMV_INFECTION_UP,1
GOMF_ACYLTRANSFERASE_ACTIVIT...2,SET,199,0.0056062,0.00058019,0.057768,0.46135,GOMF_ACYLTRANSFERASE_ACTIVITY_TRANSFERRING_GROUPS_OTHER_THAN_AMINO_ACYL_GROUPS,1
DESCARTES_FETAL_PANCREAS_ERY...,SET,107,0.0080143,0.00060972,0.082752,0.46142,DESCARTES_FETAL_PANCREAS_ERYTHROBLASTS,1
KEGG_MEDICUS_REFERENCE_ELECT...3,SET,14,0.019431,0.00053607,0.20063,0.46143,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_IV,1
HP_CENTROCECAL_SCOTOMA,SET,3,0.037371,0.00047742,0.38622,0.46146,HP_CENTROCECAL_SCOTOMA,1
GOBP_POSITIVE_REGULATION_OF_...555,SET,12,0.024684,0.00063052,0.25555,0.46153,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOMF_MHC_CLASS_I_PROTEIN_BIN...,SET,15,0.020551,0.00058686,0.21339,0.46164,GOMF_MHC_CLASS_I_PROTEIN_BINDING,1
GOBP_ENTRAINMENT_OF_CIRCADIA...,SET,27,0.015759,0.00060356,0.16387,0.46169,GOBP_ENTRAINMENT_OF_CIRCADIAN_CLOCK,1
ZHAN_V2_LATE_DIFFERENTIATION...,SET,36,0.013734,0.00060724,0.14283,0.4617,ZHAN_V2_LATE_DIFFERENTIATION_GENES,1
GOBP_REGULATION_OF_RESPONSE_...1,SET,475,0.0037717,0.00059847,0.03923,0.4617,GOBP_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
GAVISH_3CA_METAPROGRAM_FIBRO...21,SET,45,0.012793,0.00063225,0.13309,0.46171,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_PI16_POS,1
GSE24574_BCL6_HIGH_TFH_VS_TF...1,SET,185,0.0060897,0.00060789,0.063354,0.46171,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_DN,1
GAVISH_3CA_METAPROGRAM_MACRO...6,SET,43,0.013776,0.00066557,0.1434,0.46173,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_3,1
GOBP_REGULATION_OF_AMPA_RECE...,SET,19,0.019395,0.00062326,0.20188,0.46173,GOBP_REGULATION_OF_AMPA_RECEPTOR_ACTIVITY,1
HP_MULTIPLE_EXOSTOSES,SET,7,0.032565,0.0006354,0.3389,0.46173,HP_MULTIPLE_EXOSTOSES,1
GSE8835_HEALTHY_VS_CLL_CD8_T...1,SET,181,0.0059745,0.00058997,0.062285,0.46179,GSE8835_HEALTHY_VS_CLL_CD8_TCELL_DN,1
GOBP_RESPONSE_TO_DSRNA,SET,49,0.012491,0.00064413,0.13058,0.4619,GOBP_RESPONSE_TO_DSRNA,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...8,SET,37,0.013051,0.00058498,0.13666,0.46196,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_REGULATOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
HP_KNEE_JOINT_HYPERMOBILITY,SET,5,0.040544,0.00066864,0.42485,0.46199,HP_KNEE_JOINT_HYPERMOBILITY,1
SETD1A_TARGET_GENES,SET,1214,0.0023654,0.00058752,0.024821,0.46204,SETD1A_TARGET_GENES,1
MEF2_Q6_01,SET,221,0.005596,0.00060993,0.058723,0.46204,MEF2_Q6_01,1
STAT4_01,SET,250,0.0051925,0.00060146,0.054492,0.46204,STAT4_01,1
GSE34156_TLR1_TLR2_LIGAND_VS...1,SET,176,0.0059252,0.00057705,0.062228,0.46207,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
GOMF_SMAD_BINDING,SET,74,0.0096827,0.00061316,0.10171,0.46208,GOMF_SMAD_BINDING,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...2,SET,10,0.025444,0.00059333,0.26773,0.46214,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAA_TO_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,1
HP_RENAL_POTASSIUM_WASTING,SET,6,0.037504,0.00067752,0.39463,0.46214,HP_RENAL_POTASSIUM_WASTING,1
PATIL_LIVER_CANCER,SET,586,0.003275,0.00057539,0.034526,0.46221,PATIL_LIVER_CANCER,1
GSE26669_CTRL_VS_COSTIM_BLOC...3,SET,179,0.0058337,0.00057291,0.061526,0.46223,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD8_TCELL_DN,1
GOBP_CARDIAC_MYOFIBRIL_ASSEM...,SET,19,0.018489,0.00059415,0.19506,0.46224,GOBP_CARDIAC_MYOFIBRIL_ASSEMBLY,1
HP_CEREBELLAR_CORTICAL_ATROP...,SET,5,0.03584,0.00059105,0.3788,0.46231,HP_CEREBELLAR_CORTICAL_ATROPHY,1
HP_TEMPORAL_OPTIC_DISC_PALLOR,SET,7,0.031466,0.00061398,0.33274,0.46233,HP_TEMPORAL_OPTIC_DISC_PALLOR,1
MARIADASON_RESPONSE_TO_BUTYR...3,SET,9,0.028259,0.00062518,0.29902,0.46236,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_8,1
ZHOU_CELL_CYCLE_GENES_IN_IR_...1,SET,116,0.007144,0.00056576,0.075641,0.46238,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_24HR,1
GOBP_POSITIVE_REGULATION_OF_...284,SET,8,0.02916,0.00060825,0.30929,0.46244,GOBP_POSITIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
MIR5195_5P,SET,18,0.020423,0.00063882,0.21683,0.46248,MIR5195_5P,1
GOBP_GLUTATHIONE_TRANSPORT,SET,9,0.027198,0.00060172,0.28883,0.46249,GOBP_GLUTATHIONE_TRANSPORT,1
GOBP_SPINDLE_ASSEMBLY,SET,119,0.0066527,0.00053358,0.070807,0.46257,GOBP_SPINDLE_ASSEMBLY,1
GOCC_EXTRINSIC_COMPONENT_OF_...7,SET,4,0.026566,0.00039188,0.28277,0.46257,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GAVISH_3CA_METAPROGRAM_ENDOT...14,SET,46,0.013116,0.00065538,0.13973,0.46261,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING,1
MODULE_11,SET,496,0.0037829,0.000613,0.040327,0.46263,MODULE_11,1
ZSCAN5B_TARGET_GENES,SET,48,0.011724,0.00059835,0.12505,0.46265,ZSCAN5B_TARGET_GENES,1
HP_NEOPLASM_OF_THE_SKELETAL_...,SET,97,0.0078185,0.0005665,0.083425,0.46267,HP_NEOPLASM_OF_THE_SKELETAL_SYSTEM,1
GOBP_RESPONSE_TO_DEXAMETHASO...,SET,42,0.013195,0.00063005,0.14099,0.46272,GOBP_RESPONSE_TO_DEXAMETHASONE,1
GOCC_NUCLEAR_BODY,SET,748,0.0027961,0.00055249,0.029875,0.46272,GOCC_NUCLEAR_BODY,1
FOXD3_TARGET_GENES,SET,29,0.015059,0.00059773,0.16115,0.46277,FOXD3_TARGET_GENES,1
CTGCAGY_UNKNOWN,SET,678,0.0031504,0.00059383,0.033749,0.46281,CTGCAGY_UNKNOWN,1
MORF_SKP1A,SET,179,0.0052582,0.00051639,0.056357,0.46283,MORF_SKP1A,1
GOBP_REGULATION_OF_ATRIAL_CA...2,SET,5,0.037958,0.000626,0.4068,0.46283,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,1
GOBP_GERM_CELL_PROLIFERATION,SET,10,0.022308,0.00052021,0.2392,0.46285,GOBP_GERM_CELL_PROLIFERATION,1
GOCC_POSTSYNAPTIC_MEMBRANE,SET,257,0.00527,0.00061882,0.056649,0.46294,GOCC_POSTSYNAPTIC_MEMBRANE,1
REACTOME_BLOOD_GROUP_SYSTEMS...,SET,21,0.018338,0.00061952,0.19728,0.46297,REACTOME_BLOOD_GROUP_SYSTEMS_BIOSYNTHESIS,1
MIR210_5P,SET,49,0.010909,0.00056254,0.11737,0.46297,MIR210_5P,1
DASU_IL6_SIGNALING_SCAR_DN,SET,13,0.023852,0.00063413,0.25666,0.46298,DASU_IL6_SIGNALING_SCAR_DN,1
WP_2Q211_COPY_NUMBER_VARIATI...,SET,15,0.023139,0.00066078,0.24951,0.46306,WP_2Q211_COPY_NUMBER_VARIATION_SYNDROME,1
GSE17974_0H_VS_12H_IN_VITRO_...1,SET,176,0.0056321,0.00054849,0.060742,0.46306,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_DN,1
HP_SYNCOPE,SET,116,0.0077844,0.00061648,0.084081,0.46312,HP_SYNCOPE,1
MIR548AH_5P,SET,321,0.0044369,0.00058123,0.048048,0.46321,MIR548AH_5P,1
BIOCARTA_CELLCYCLE_PATHWAY,SET,23,0.016104,0.00056932,0.17448,0.46323,BIOCARTA_CELLCYCLE_PATHWAY,1
EGFR_TARGET_GENES,SET,20,0.017755,0.00058539,0.1925,0.46326,EGFR_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...10,SET,26,0.016003,0.00060149,0.17355,0.46326,GOBP_POSITIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...81,SET,13,0.023307,0.00061965,0.25296,0.46329,GOBP_POSITIVE_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
GOBP_RESPIRATORY_CHAIN_COMPL...1,SET,8,0.024909,0.00051958,0.27079,0.46336,GOBP_RESPIRATORY_CHAIN_COMPLEX_III_ASSEMBLY,1
GOBP_TRANSMISSION_OF_NERVE_I...,SET,71,0.0097856,0.00060704,0.10641,0.46336,GOBP_TRANSMISSION_OF_NERVE_IMPULSE,1
GSE20366_CD103_POS_VS_NEG_TR...2,SET,179,0.0059671,0.00058601,0.064935,0.46339,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_UP,1
GOBP_POSITIVE_REGULATION_OF_...181,SET,14,0.020046,0.00055305,0.21834,0.46342,GOBP_POSITIVE_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
HP_VEIN_OF_GALEN_ANEURYSMAL_...,SET,5,0.033065,0.00054529,0.36063,0.46347,HP_VEIN_OF_GALEN_ANEURYSMAL_MALFORMATION,1
GOMF_CYCLIN_DEPENDENT_PROTEI...4,SET,45,0.010807,0.00053408,0.11794,0.4635,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_REGULATOR_ACTIVITY,1
GOMF_TRANSLATION_REGULATOR_A...1,SET,115,0.0066787,0.00052665,0.072893,0.4635,GOMF_TRANSLATION_REGULATOR_ACTIVITY,1
GSE9601_UNTREATED_VS_PI3K_IN...1,SET,131,0.0066411,0.00055868,0.072591,0.46355,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...182,SET,120,0.0071014,0.00057194,0.077677,0.46358,GOBP_POSITIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GOMF_NEUREGULIN_BINDING,SET,5,0.035852,0.00059125,0.39249,0.46361,GOMF_NEUREGULIN_BINDING,1
MIR5008_5P,SET,78,0.0083015,0.00053966,0.090898,0.46362,MIR5008_5P,1
MIR770_5P,SET,93,0.008028,0.00056962,0.087959,0.46364,MIR770_5P,1
GOBP_PREASSEMBLY_OF_GPI_ANCH...,SET,7,0.025532,0.00049818,0.27994,0.46367,GOBP_PREASSEMBLY_OF_GPI_ANCHOR_IN_ER_MEMBRANE,1
GOMF_TRANSFERASE_ACTIVITY_TR...4,SET,822,0.0026408,0.00054585,0.028971,0.46369,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,1
MODULE_20,SET,77,0.0082972,0.00053592,0.091191,0.46375,MODULE_20,1
GOBP_VENTRICULAR_CARDIAC_MUS...4,SET,27,0.01566,0.00059978,0.17221,0.46377,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,1
GOBP_REGULATION_OF_NERVOUS_S...1,SET,417,0.0039589,0.00058951,0.043601,0.46383,GOBP_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,1
GOBP_AMINO_ACID_BIOSYNTHETIC...,SET,71,0.0091818,0.00056958,0.10119,0.46385,GOBP_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
ODONNELL_TARGETS_OF_MYC_AND_...2,SET,68,0.0092855,0.00056376,0.10235,0.46386,ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP,1
GRAHAM_CML_DIVIDING_VS_NORMA...1,SET,9,0.030667,0.00067845,0.33816,0.46387,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_DN,1
GSE41176_WT_VS_TAK1_KO_UNSTI...2,SET,178,0.0056995,0.00055818,0.062851,0.46387,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_UP,1
MORF_EIF4A2,SET,128,0.0062393,0.00051887,0.068828,0.46389,MORF_EIF4A2,1
HP_OPTIC_DISC_PALLOR,SET,216,0.0050775,0.0005472,0.056076,0.46393,HP_OPTIC_DISC_PALLOR,1
HP_ABNORMAL_BONE_STRUCTURE,SET,737,0.0028558,0.0005603,0.031597,0.46399,HP_ABNORMAL_BONE_STRUCTURE,1
MCBRYAN_PUBERTAL_BREAST_4_5W...2,SET,242,0.0053557,0.0006105,0.059319,0.46403,MCBRYAN_PUBERTAL_BREAST_4_5WK_UP,1
HP_CELIAC_DISEASE,SET,52,0.011109,0.00059007,0.12303,0.46403,HP_CELIAC_DISEASE,1
GOBP_NEGATIVE_REGULATION_OF_...598,SET,31,0.012492,0.00051259,0.13864,0.4641,GOBP_NEGATIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,1
HP_SCLERODACTYLY,SET,5,0.036004,0.00059376,0.39964,0.46411,HP_SCLERODACTYLY,1
GAVIN_FOXP3_TARGETS_CLUSTER_...2,SET,147,0.0064534,0.00057483,0.071708,0.46415,GAVIN_FOXP3_TARGETS_CLUSTER_P3,1
GSE46606_UNSTIM_VS_CD40L_IL2...15,SET,168,0.0054746,0.00052102,0.060878,0.46417,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_DN,1
GSE22886_NAIVE_CD8_TCELL_VS_...1,SET,185,0.0055416,0.00055318,0.061668,0.4642,GSE22886_NAIVE_CD8_TCELL_VS_DC_DN,1
GOBP_LEUKOTRIENE_D4_BIOSYNTH...,SET,5,0.03543,0.0005843,0.39434,0.46421,GOBP_LEUKOTRIENE_D4_BIOSYNTHETIC_PROCESS,1
GOMF_GLUTATHIONE_HYDROLASE_A...,SET,5,0.03543,0.0005843,0.39434,0.46421,GOMF_GLUTATHIONE_HYDROLASE_ACTIVITY,1
GSE5589_LPS_VS_LPS_AND_IL6_S...2,SET,180,0.0057333,0.0005646,0.063938,0.46428,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
MIR3144_3P,SET,56,0.0096606,0.00053245,0.10794,0.46434,MIR3144_3P,1
GSE360_L_DONOVANI_VS_L_MAJOR...2,SET,181,0.0055923,0.00055223,0.062497,0.46435,GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP,1
GOBP_OXYGEN_METABOLIC_PROCESS,SET,6,0.030307,0.00054751,0.33889,0.46437,GOBP_OXYGEN_METABOLIC_PROCESS,1
GSE40274_FOXP3_VS_FOXP3_AND_...1,SET,180,0.0053443,0.00052629,0.059774,0.46438,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_AR...,SET,16,0.018407,0.00054288,0.20593,0.46439,GOBP_CELLULAR_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,1
HP_VERTICAL_NYSTAGMUS,SET,21,0.015789,0.00053341,0.1771,0.46448,HP_VERTICAL_NYSTAGMUS,1
GAVISH_3CA_METAPROGRAM_ENDOT...2,SET,47,0.011837,0.00059782,0.13279,0.46449,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_COAGULATION,1
GOBP_POSITIVE_REGULATION_OF_...524,SET,37,0.013729,0.00061536,0.15408,0.4645,GOBP_POSITIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
MORF_MSH2,SET,58,0.0086467,0.00048497,0.097195,0.46456,MORF_MSH2,1
GOBP_MANCHETTE_ASSEMBLY,SET,8,0.024033,0.00050129,0.2706,0.46462,GOBP_MANCHETTE_ASSEMBLY,1
MIR4320,SET,48,0.011496,0.00058671,0.1295,0.46463,MIR4320,1
GSE3982_NEUTROPHIL_VS_BCELL_...1,SET,182,0.005237,0.00051856,0.059048,0.46466,GSE3982_NEUTROPHIL_VS_BCELL_DN,1
GSE36826_WT_VS_IL1R_KO_SKIN_...4,SET,181,0.0056469,0.00055762,0.063711,0.46469,GSE36826_WT_VS_IL1R_KO_SKIN_UP,1
GOBP_PIRNA_PROCESSING,SET,21,0.013956,0.00047148,0.15772,0.46475,GOBP_PIRNA_PROCESSING,1
WP_POSTCOVID_NEUROINFLAMMATI...,SET,20,0.018419,0.00060729,0.20823,0.46476,WP_POSTCOVID_NEUROINFLAMMATION,1
GOCC_GLYCINERGIC_SYNAPSE,SET,7,0.030282,0.00059088,0.34427,0.46495,GOCC_GLYCINERGIC_SYNAPSE,1
MIR144_3P,SET,451,0.0036483,0.00056445,0.041502,0.46498,MIR144_3P,1
GOMF_ADP_BINDING,SET,32,0.012743,0.00053126,0.14506,0.465,GOMF_ADP_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...492,SET,125,0.0064424,0.00052949,0.07339,0.46503,GOBP_POSITIVE_REGULATION_OF_MRNA_METABOLIC_PROCESS,1
GSE17721_CTRL_VS_GARDIQUIMOD...14,SET,185,0.0053106,0.00053011,0.06051,0.46503,GSE17721_CTRL_VS_GARDIQUIMOD_6H_BMDC_UP,1
GSE5589_LPS_AND_IL10_VS_LPS_...5,SET,184,0.0055604,0.00055357,0.063375,0.46504,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
BIOCARTA_INTRINSIC_PATHWAY,SET,19,0.019046,0.00061205,0.21748,0.46511,BIOCARTA_INTRINSIC_PATHWAY,1
HP_HORSESHOE_KIDNEY,SET,122,0.0064736,0.00052567,0.074019,0.46515,HP_HORSESHOE_KIDNEY,1
GOCC_DENDRITIC_GROWTH_CONE,SET,7,0.025483,0.00049724,0.29169,0.46519,GOCC_DENDRITIC_GROWTH_CONE,1
GSE41867_NAIVE_VS_EFFECTOR_C...2,SET,187,0.0050262,0.0005044,0.0576,0.46523,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,1
HP_HEMERALOPIA,SET,8,0.026889,0.00056086,0.30824,0.46524,HP_HEMERALOPIA,1
GOBP_ATP_TRANSPORT,SET,19,0.018531,0.0005955,0.21271,0.46529,GOBP_ATP_TRANSPORT,1
MORI_IMMATURE_B_LYMPHOCYTE_DN,SET,86,0.0075046,0.00051215,0.086297,0.46535,MORI_IMMATURE_B_LYMPHOCYTE_DN,1
HP_APLASIA_INVOLVING_BONES_O...3,SET,15,0.01912,0.000546,0.21989,0.46535,HP_APLASIA_INVOLVING_BONES_OF_THE_UPPER_LIMBS,1
HP_SPHEROCYTOSIS,SET,8,0.026703,0.00055698,0.30708,0.46535,HP_SPHEROCYTOSIS,1
GSE40274_CTRL_VS_FOXP3_AND_L...2,SET,153,0.0062701,0.0005697,0.072128,0.46536,GSE40274_CTRL_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_PERIPHERAL_NERVOUS_SYST...3,SET,83,0.0082783,0.00055506,0.095309,0.46539,GOBP_PERIPHERAL_NERVOUS_SYSTEM_DEVELOPMENT,1
REACTOME_RAF_INDEPENDENT_MAP...,SET,22,0.017301,0.00059823,0.19922,0.4654,REACTOME_RAF_INDEPENDENT_MAPK1_3_ACTIVATION,1
MED25_TARGET_GENES,SET,76,0.0082798,0.00053133,0.095399,0.46542,MED25_TARGET_GENES,1
GSE17721_LPS_VS_GARDIQUIMOD_...13,SET,176,0.0052578,0.00051205,0.060589,0.46542,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_DN,1
GOBP_RESPONSE_TO_TYPE_III_IN...,SET,11,0.024655,0.00060299,0.28415,0.46543,GOBP_RESPONSE_TO_TYPE_III_INTERFERON,1
GSE7460_CTRL_VS_TGFB_TREATED...3,SET,182,0.0054452,0.00053917,0.062824,0.46547,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_HET_TCONV_DN,1
GOCC_HIPPOCAMPAL_MOSSY_FIBER...,SET,41,0.011832,0.00055821,0.13677,0.46553,GOCC_HIPPOCAMPAL_MOSSY_FIBER_TO_CA3_SYNAPSE,1
BIOCARTA_HCMV_PATHWAY,SET,17,0.019591,0.00059555,0.22663,0.46556,BIOCARTA_HCMV_PATHWAY,1
MIR3942_5P,SET,197,0.0054589,0.00056213,0.063154,0.46556,MIR3942_5P,1
MIR568,SET,239,0.0048328,0.00054751,0.055908,0.46556,MIR568,1
GOBP_RENAL_CONTROL_OF_PERIPH...,SET,4,0.034043,0.00050218,0.39398,0.46557,GOBP_RENAL_CONTROL_OF_PERIPHERAL_VASCULAR_RESISTANCE_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GSE10240_IL17_VS_IL17_AND_IL...1,SET,187,0.0053901,0.00054092,0.062392,0.46558,GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
HP_SNORING,SET,6,0.029687,0.00053631,0.34434,0.46565,HP_SNORING,1
GSE28449_WT_VS_LRF_KO_GERMIN...1,SET,171,0.0056778,0.00054511,0.065863,0.46565,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_DN,1
GOMF_TRANSMEMBRANE_RECEPTOR_...7,SET,17,0.016629,0.0005055,0.19314,0.46569,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ADAPTOR_ACTIVITY,1
BIOCARTA_GABA_PATHWAY,SET,9,0.024907,0.00055102,0.28996,0.46577,BIOCARTA_GABA_PATHWAY,1
GOCC_TRAMP_COMPLEX,SET,2,0.043625,0.00045506,0.50858,0.46582,GOCC_TRAMP_COMPLEX,1
GSE12392_CD8A_POS_VS_NEG_SPL...2,SET,189,0.0052218,0.0005268,0.060868,0.46582,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_UP,1
HP_RENAL_SALT_WASTING,SET,20,0.017825,0.00058769,0.20796,0.46585,HP_RENAL_SALT_WASTING,1
GOMF_SHORT_CHAIN_CARBOXYLEST...,SET,6,0.027841,0.00050295,0.32526,0.46589,GOMF_SHORT_CHAIN_CARBOXYLESTERASE_ACTIVITY,1
REN_MIF_TARGETS_DN,SET,5,0.032953,0.00054345,0.38573,0.46596,REN_MIF_TARGETS_DN,1
GOBP_MYOTUBE_DIFFERENTIATION...,SET,7,0.031479,0.00061423,0.36912,0.46602,GOBP_MYOTUBE_DIFFERENTIATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
GOBP_CARDIAC_CONDUCTION_SYST...,SET,36,0.013431,0.00059384,0.15782,0.46609,GOBP_CARDIAC_CONDUCTION_SYSTEM_DEVELOPMENT,1
HP_ABNORMAL_CIRCULATING_ALBU...,SET,108,0.0067744,0.00051777,0.079599,0.46609,HP_ABNORMAL_CIRCULATING_ALBUMIN_CONCENTRATION,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...2,SET,24,0.016012,0.00057823,0.18819,0.4661,GOBP_LONG_CHAIN_FATTY_ACYL_COA_METABOLIC_PROCESS,1
ITO_PTTG1_TARGETS_DN,SET,9,0.02392,0.00052918,0.2812,0.46611,ITO_PTTG1_TARGETS_DN,1
HP_PANCREATIC_APLASIA,SET,6,0.030259,0.00054664,0.35616,0.46615,HP_PANCREATIC_APLASIA,1
GOBP_BIOLOGICAL_PROCESS_INVO...1,SET,190,0.0053999,0.0005462,0.063658,0.4662,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERACTION_WITH_HOST,1
HASEGAWA_TUMORIGENESIS_BY_RE...,SET,9,0.022201,0.00049115,0.26194,0.46623,HASEGAWA_TUMORIGENESIS_BY_RET_C634R,1
MIR4714_5P,SET,93,0.0074308,0.00052725,0.087854,0.4663,MIR4714_5P,1
HP_THINNING_OF_DESCEMET_MEMB...,SET,6,0.034383,0.00062113,0.40674,0.46632,HP_THINNING_OF_DESCEMET_MEMBRANE,1
KEGG_MEDICUS_VARIANT_SCRAPIE...4,SET,16,0.018199,0.00053673,0.21545,0.46634,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM,1
GOCC_ROD_PHOTORECEPTOR_OUTER...,SET,7,0.025862,0.00050462,0.30614,0.46634,GOCC_ROD_PHOTORECEPTOR_OUTER_SEGMENT,1
MIR3616_5P,SET,84,0.007845,0.00052915,0.092935,0.46636,MIR3616_5P,1
MIR1265,SET,40,0.011076,0.00051617,0.13147,0.46643,MIR1265,1
WEBER_METHYLATED_HCP_IN_FIBR...1,SET,38,0.010863,0.00049342,0.12931,0.46653,WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN,1
GSE41867_NAIVE_VS_DAY6_LCMV_...4,SET,185,0.0050145,0.00050056,0.059712,0.46654,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_UP,1
WP_LET7_INHIBITION_OF_ES_CEL...,SET,6,0.034524,0.00062368,0.41124,0.46655,WP_LET7_INHIBITION_OF_ES_CELL_REPROGRAMMING,1
GSE17721_0.5H_VS_4H_GARDIQUI...2,SET,172,0.0051018,0.00049123,0.060816,0.46657,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_UP,1
GOBP_TAXIS,SET,423,0.0037294,0.00055924,0.04449,0.4666,GOBP_TAXIS,1
FULLER_PBMC_F_TULARENSIS_VAC...11,SET,57,0.010232,0.00056893,0.12207,0.4666,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_48HR_UP,1
GOBP_NEGATIVE_REGULATION_OF_...67,SET,21,0.01578,0.00053311,0.18862,0.46666,GOBP_NEGATIVE_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_TYPE_I_PNEUMOCYTE_DIFFE...,SET,8,0.027235,0.00056808,0.32584,0.46669,GOBP_TYPE_I_PNEUMOCYTE_DIFFERENTIATION,1
HP_COLOBOMA,SET,207,0.0048436,0.00051113,0.057976,0.46671,HP_COLOBOMA,1
GOBP_APICAL_PROTEIN_LOCALIZA...,SET,14,0.017911,0.00049416,0.21444,0.46672,GOBP_APICAL_PROTEIN_LOCALIZATION,1
GSE22886_NAIVE_CD4_TCELL_VS_...14,SET,172,0.0054131,0.00052121,0.064808,0.46672,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_UP,1
COUP_01,SET,235,0.0045464,0.00051079,0.054552,0.46679,COUP_01,1
GOBP_GLYCERALDEHYDE_3_PHOSPH...,SET,11,0.019273,0.00047136,0.23142,0.46681,GOBP_GLYCERALDEHYDE_3_PHOSPHATE_METABOLIC_PROCESS,1
HP_ST_SEGMENT_ELEVATION,SET,24,0.014487,0.00052318,0.17399,0.46682,HP_ST_SEGMENT_ELEVATION,1
GSE45365_NK_CELL_VS_BCELL_MC...1,SET,172,0.005481,0.00052774,0.065903,0.46686,GSE45365_NK_CELL_VS_BCELL_MCMV_INFECTION_DN,1
REACTOME_HDL_REMODELING,SET,10,0.022224,0.00051826,0.26742,0.46688,REACTOME_HDL_REMODELING,1
GOMF_PYRIMIDINE_NUCLEOSIDE_T...,SET,8,0.027612,0.00057596,0.33274,0.46693,GOMF_PYRIMIDINE_NUCLEOSIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE4984_UNTREATED_VS_LPS_TRE...1,SET,156,0.0055265,0.00050699,0.066786,0.46703,GSE4984_UNTREATED_VS_LPS_TREATED_DC_DN,1
BRN2_01,SET,210,0.0049412,0.00052516,0.059799,0.46707,BRN2_01,1
GOBP_REGULATION_OF_SKELETAL_...4,SET,14,0.018158,0.00050096,0.21976,0.46708,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,1
GSE18893_CTRL_VS_TNF_TREATED...7,SET,179,0.0051674,0.00050747,0.062551,0.46708,GSE18893_CTRL_VS_TNF_TREATED_TREG_2H_DN,1
MIR767_5P,SET,174,0.0053672,0.00051975,0.06507,0.46713,MIR767_5P,1
HP_SENSORY_SEEKING,SET,24,0.014336,0.00051773,0.17407,0.46718,HP_SENSORY_SEEKING,1
CAATGCA_MIR33,SET,88,0.0071621,0.0004944,0.087135,0.46725,CAATGCA_MIR33,1
MIR4760_3P,SET,249,0.0045171,0.0005222,0.05498,0.46726,MIR4760_3P,1
MIR128_3P,SET,409,0.0035377,0.00052184,0.043077,0.46727,MIR128_3P,1
BIOCARTA_IL12_PATHWAY,SET,18,0.016696,0.00052224,0.20334,0.46728,BIOCARTA_IL12_PATHWAY,1
HP_ABNORMALITY_OF_THE_EPIPHY...1,SET,5,0.031427,0.00051828,0.38299,0.4673,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_DISTAL_PHALANX_OF_FINGER,1
MYOD_Q6,SET,227,0.0045822,0.00050609,0.055876,0.46732,MYOD_Q6,1
GOBP_ANTIGEN_PROCESSING_AND_...4,SET,23,0.016108,0.00056947,0.19644,0.46732,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_ENDOGENOUS_PEPTIDE_ANTIGEN,1
GOBP_REGULATION_OF_KERATINOC...3,SET,44,0.01151,0.00056247,0.14039,0.46733,GOBP_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
HP_POSTAXIAL_FOOT_POLYDACTYLY,SET,63,0.008367,0.00048903,0.10212,0.46735,HP_POSTAXIAL_FOOT_POLYDACTYLY,1
GSE27786_BCELL_VS_ERYTHROBLA...2,SET,179,0.0049036,0.00048156,0.059946,0.4674,GSE27786_BCELL_VS_ERYTHROBLAST_UP,1
KEGG_CYTOKINE_CYTOKINE_RECEP...,SET,245,0.0050897,0.00058371,0.062359,0.46748,KEGG_CYTOKINE_CYTOKINE_RECEPTOR_INTERACTION,1
GOMF_DNA_EXONUCLEASE_ACTIVITY,SET,23,0.013413,0.00047419,0.16437,0.46748,GOMF_DNA_EXONUCLEASE_ACTIVITY,1
NAISHIRO_CTNNB1_TARGETS_WITH...,SET,8,0.027032,0.00056385,0.33132,0.46749,NAISHIRO_CTNNB1_TARGETS_WITH_LEF1_MOTIF,1
JIANG_MELANOMA_TRM6_CD8,SET,122,0.0059224,0.00048091,0.072627,0.4675,JIANG_MELANOMA_TRM6_CD8,1
MODULE_14,SET,13,0.021503,0.00057167,0.26368,0.4675,MODULE_14,1
GNF2_CCNA2,SET,64,0.0083976,0.00049468,0.10309,0.46754,GNF2_CCNA2,1
GOBP_CELLULAR_RESPONSE_TO_NI...1,SET,9,0.023959,0.00053005,0.29438,0.46757,GOBP_CELLULAR_RESPONSE_TO_NICOTINE,1
GOBP_B_CELL_DIFFERENTIATION,SET,140,0.0062264,0.00054135,0.076594,0.46761,GOBP_B_CELL_DIFFERENTIATION,1
MODULE_25,SET,13,0.015093,0.00040126,0.18579,0.46763,MODULE_25,1
GSE22589_HEALTHY_VS_HIV_AND_...1,SET,171,0.0049764,0.00047777,0.061255,0.46763,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_DN,1
GSE21033_CTRL_VS_POLYIC_STIM...8,SET,179,0.0048081,0.00047219,0.05921,0.46764,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_UP,1
HP_LYMPHANGIECTASIS,SET,10,0.022051,0.00051422,0.27184,0.46767,HP_LYMPHANGIECTASIS,1
GSE39820_CTRL_VS_TGFBETA3_IL...2,SET,177,0.0049599,0.00048439,0.061173,0.46769,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_UP,1
REACTOME_MRNA_SPLICING_MINOR...,SET,48,0.0083452,0.00042592,0.10304,0.46772,REACTOME_MRNA_SPLICING_MINOR_PATHWAY,1
HP_PROMINENCE_OF_THE_PREMAXI...,SET,7,0.024158,0.00047137,0.29873,0.46777,HP_PROMINENCE_OF_THE_PREMAXILLA,1
KEGG_MEDICUS_REFERENCE_REGUL...1,SET,4,0.048129,0.00070995,0.59691,0.46787,KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR,1
GOBP_NEUROINFLAMMATORY_RESPO...,SET,75,0.0086379,0.00055067,0.10715,0.46787,GOBP_NEUROINFLAMMATORY_RESPONSE,1
CAIRO_LIVER_DEVELOPMENT_DN,SET,204,0.0049248,0.00051597,0.061126,0.46789,CAIRO_LIVER_DEVELOPMENT_DN,1
PID_P53_REGULATION_PATHWAY,SET,55,0.0090236,0.00049289,0.11211,0.46792,PID_P53_REGULATION_PATHWAY,1
KEGG_MEDICUS_VARIANT_EGF_OVE...1,SET,8,0.024321,0.0005073,0.30223,0.46793,KEGG_MEDICUS_VARIANT_EGF_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
KAECH_NAIVE_VS_DAY15_EFF_CD8...2,SET,177,0.0049602,0.00048442,0.061631,0.46793,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_UP,1
GSE15271_CXCR4_POS_VS_NEG_GC...1,SET,164,0.0053516,0.00050327,0.066516,0.46794,GSE15271_CXCR4_POS_VS_NEG_GC_BCELL_DN,1
GSE17186_NAIVE_VS_CD21LOW_TR...4,SET,184,0.005113,0.00050903,0.063583,0.46795,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...485,SET,19,0.016412,0.00052742,0.20465,0.46804,GOBP_NEGATIVE_REGULATION_OF_PHAGOCYTOSIS,1
HP_ABNORMALITY_OF_THE_MUSCUL...3,SET,89,0.0071663,0.00049748,0.089452,0.46807,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_LOWER_LIMBS,1
GSE5589_LPS_VS_LPS_AND_IL10_...4,SET,177,0.0050375,0.00049197,0.062904,0.46809,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_UP,1
GOCC_CYTOPLASMIC_SIDE_OF_ROU...,SET,4,0.029016,0.00042802,0.36284,0.46813,GOCC_CYTOPLASMIC_SIDE_OF_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,1
GOCC_NUCLEAR_RNA_EXPORT_FACT...,SET,2,0.037802,0.00039432,0.47308,0.46816,GOCC_NUCLEAR_RNA_EXPORT_FACTOR_COMPLEX,1
GOMF_PHOSPHATIDYLINOSITOL_3_...13,SET,10,0.019867,0.0004633,0.24873,0.46817,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_MRNA_CATA...,SET,170,0.0051073,0.00048892,0.064067,0.46823,GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS,1
GSE37532_WT_VS_PPARG_KO_LN_T...1,SET,166,0.0051036,0.00048283,0.064117,0.46828,GSE37532_WT_VS_PPARG_KO_LN_TCONV_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...3,SET,9,0.024531,0.00054271,0.30832,0.46829,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_16,1
GOMF_P53_BINDING,SET,64,0.0084974,0.00050056,0.10681,0.46829,GOMF_P53_BINDING,1
AIGNER_ZEB1_TARGETS,SET,33,0.012833,0.00054331,0.16136,0.46831,AIGNER_ZEB1_TARGETS,1
VERHAAK_AML_WITH_NPM1_MUTATE...2,SET,168,0.0057544,0.00054765,0.072406,0.46833,VERHAAK_AML_WITH_NPM1_MUTATED_UP,1
GSE40685_TREG_VS_FOXP3_KO_TR...1,SET,182,0.0049904,0.00049414,0.062826,0.46834,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_DN,1
REACTOME_HCMV_INFECTION,SET,91,0.0068256,0.0004791,0.085975,0.46836,REACTOME_HCMV_INFECTION,1
GSE369_PRE_VS_POST_IL6_INJEC...3,SET,193,0.0048008,0.00048938,0.060562,0.46841,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_WT_LIVER_DN,1
HP_CONGENITAL_STATIONARY_NIG...,SET,18,0.016268,0.00050885,0.20542,0.46844,HP_CONGENITAL_STATIONARY_NIGHT_BLINDNESS,1
HP_INCREASED_PULMONARY_VASCU...,SET,13,0.021146,0.00056219,0.26727,0.46847,HP_INCREASED_PULMONARY_VASCULAR_RESISTANCE,1
GSE20715_WT_VS_TLR4_KO_48H_O...2,SET,178,0.0050081,0.00049047,0.063354,0.4685,GSE20715_WT_VS_TLR4_KO_48H_OZONE_LUNG_UP,1
TRAVAGLINI_LUNG_ALVEOLAR_EPI...1,SET,363,0.0037,0.00051483,0.046889,0.46855,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL,1
REACTOME_FBXW7_MUTANTS_AND_N...,SET,5,0.027036,0.00044587,0.3429,0.46858,REACTOME_FBXW7_MUTANTS_AND_NOTCH1_IN_CANCER,1
WANG_ESOPHAGUS_CANCER_PROGRE...,SET,9,0.02418,0.00053494,0.30761,0.46867,WANG_ESOPHAGUS_CANCER_PROGRESSION_UP,1
GOMF_TAP_BINDING,SET,7,0.02567,0.00050088,0.32673,0.46869,GOMF_TAP_BINDING,1
CORDENONSI_YAP_CONSERVED_SIG...,SET,52,0.010099,0.00053643,0.12854,0.46869,CORDENONSI_YAP_CONSERVED_SIGNATURE,1
HP_2_4_TOE_CUTANEOUS_SYNDACT...,SET,4,0.039547,0.00058336,0.50451,0.46876,HP_2_4_TOE_CUTANEOUS_SYNDACTYLY,1
HP_ABNORMALITY_OF_THE_PUBIC_...,SET,52,0.0092113,0.00048927,0.11765,0.4688,HP_ABNORMALITY_OF_THE_PUBIC_HAIR,1
GOBP_REGULATION_OF_ANGIOTENS...,SET,8,0.025194,0.00052552,0.32203,0.46882,GOBP_REGULATION_OF_ANGIOTENSIN_LEVELS_IN_BLOOD,1
GSE13411_NAIVE_BCELL_VS_PLAS...2,SET,169,0.005131,0.00048975,0.065595,0.46883,GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP,1
GSE25087_TREG_VS_TCONV_FETUS...1,SET,162,0.0051633,0.00048261,0.066028,0.46884,GSE25087_TREG_VS_TCONV_FETUS_DN,1
FULLER_PBMC_F_TULARENSIS_VAC...9,SET,43,0.010191,0.00049237,0.13034,0.46884,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_336HR_UP,1
REACTOME_TNFR1_INDUCED_NF_KA...,SET,27,0.012512,0.00047921,0.16028,0.46889,REACTOME_TNFR1_INDUCED_NF_KAPPA_B_SIGNALING_PATHWAY,1
GSE6674_UNSTIM_VS_ANTI_IGM_S...2,SET,150,0.0049796,0.00044802,0.063814,0.4689,GSE6674_UNSTIM_VS_ANTI_IGM_STIM_BCELL_UP,1
WGGAATGY_TEF1_Q6,SET,331,0.0037921,0.00050429,0.048621,0.46892,WGGAATGY_TEF1_Q6,1
HP_ANKLE_PAIN,SET,5,0.030005,0.00049483,0.38483,0.46893,HP_ANKLE_PAIN,1
GSE21546_UNSTIM_VS_ANTI_CD3_...7,SET,132,0.0058493,0.00049393,0.075067,0.46895,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_DN,1
HP_NEONATAL_DEATH,SET,82,0.0068383,0.00045574,0.08782,0.46897,HP_NEONATAL_DEATH,1
MORF_IL9,SET,86,0.0072572,0.00049527,0.0934,0.46903,MORF_IL9,1
GOBP_POSITIVE_REGULATION_OF_...48,SET,7,0.022731,0.00044354,0.29285,0.46907,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,1
LANDIS_ERBB2_BREAST_TUMORS_6...1,SET,36,0.011743,0.00051919,0.15145,0.4691,LANDIS_ERBB2_BREAST_TUMORS_65_DN,1
GOBP_POSITIVE_REGULATION_OF_...234,SET,143,0.005715,0.00050214,0.073713,0.4691,GOBP_POSITIVE_REGULATION_OF_ENDOCYTOSIS,1
WP_CEREBRAL_ORGANIC_ACIDURIA...,SET,8,0.021937,0.00045758,0.28304,0.46911,WP_CEREBRAL_ORGANIC_ACIDURIAS_INCLUDING_DISEASES,1
GSE17721_LPS_VS_CPG_6H_BMDC_...1,SET,181,0.0047666,0.00047069,0.061504,0.46911,GSE17721_LPS_VS_CPG_6H_BMDC_DN,1
GOBP_RESPONSE_TO_HISTAMINE,SET,10,0.022132,0.0005161,0.28594,0.46915,GOBP_RESPONSE_TO_HISTAMINE,1
HP_PRENATAL_DEATH,SET,61,0.0086873,0.00049965,0.1123,0.46917,HP_PRENATAL_DEATH,1
GSE36476_CTRL_VS_TSST_ACT_40...3,SET,181,0.0045462,0.00044893,0.058796,0.46918,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_DN,1
HP_ABNORMAL_CIRCULATING_AROM...,SET,18,0.016032,0.00050147,0.20759,0.46922,HP_ABNORMAL_CIRCULATING_AROMATIC_AMINO_ACID_CONCENTRATION,1
HP_ABNORMAL_MIDDLE_PHALANX_M...,SET,58,0.0086945,0.00048765,0.11277,0.46927,HP_ABNORMAL_MIDDLE_PHALANX_MORPHOLOGY_OF_THE_HAND,1
AHRARNT_02,SET,14,0.017147,0.00047308,0.22257,0.46929,AHRARNT_02,1
HP_WEIGHT_LOSS,SET,351,0.003501,0.00047918,0.045513,0.46934,HP_WEIGHT_LOSS,1
GOCC_CELL_TRAILING_EDGE,SET,14,0.017329,0.0004781,0.2257,0.4694,GOCC_CELL_TRAILING_EDGE,1
GSE6092_UNSTIM_VS_IFNG_STIM_...4,SET,179,0.0045363,0.00044549,0.059204,0.46946,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_UP,1
GOBP_OOGENESIS,SET,100,0.0064097,0.00047151,0.083684,0.46947,GOBP_OOGENESIS,1
GSE3982_CTRL_VS_PMA_STIM_EOS...2,SET,173,0.004759,0.00045954,0.062127,0.46947,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_UP,1
HP_DECREASED_FERTILITY_IN_FE...,SET,87,0.0066814,0.0004586,0.087258,0.46948,HP_DECREASED_FERTILITY_IN_FEMALES,1
HP_ABNORMALITY_OF_THE_INNER_...,SET,79,0.0072263,0.00047275,0.094553,0.46954,HP_ABNORMALITY_OF_THE_INNER_EAR,1
DIAZ_CHRONIC_MYELOGENOUS_LEU...2,SET,1273,0.0017997,0.00045695,0.023579,0.46958,DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP,1
GSE360_L_DONOVANI_VS_T_GONDI...2,SET,184,0.00486,0.00048383,0.063727,0.46961,GSE360_L_DONOVANI_VS_T_GONDII_DC_UP,1
GOBP_REGULATION_OF_POLYSACCH...2,SET,39,0.010351,0.0004763,0.13639,0.46975,GOBP_REGULATION_OF_POLYSACCHARIDE_METABOLIC_PROCESS,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...4,SET,35,0.010317,0.00044979,0.13603,0.46977,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
HP_ABNORMALITY_OF_THE_EPIPHY...3,SET,5,0.029928,0.00049357,0.39466,0.46978,HP_ABNORMALITY_OF_THE_EPIPHYSES_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
MORF_FBL,SET,125,0.0052657,0.00043278,0.069606,0.46985,MORF_FBL,1
MIR510_5P,SET,59,0.0079898,0.00045196,0.1058,0.4699,MIR510_5P,1
HP_LIMITED_KNEE_EXTENSION,SET,17,0.016671,0.00050679,0.22106,0.46994,HP_LIMITED_KNEE_EXTENSION,1
GSE2770_IL12_AND_TGFB_ACT_VS...5,SET,181,0.0045888,0.00045314,0.060835,0.46994,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN,1
HP_CONE_CONE_ROD_DYSTROPHY,SET,52,0.0086119,0.00045743,0.1148,0.4701,HP_CONE_CONE_ROD_DYSTROPHY,1
DESCARTES_FETAL_PANCREAS_ENS...1,SET,58,0.008778,0.00049234,0.11702,0.4701,DESCARTES_FETAL_PANCREAS_ENS_GLIA,1
GAVISH_3CA_MALIGNANT_METAPRO...36,SET,48,0.0098393,0.00050218,0.1312,0.47011,GAVISH_3CA_MALIGNANT_METAPROGRAM_5_STRESS,1
HP_PRODUCTIVE_COUGH,SET,56,0.0081345,0.00044833,0.10861,0.47015,HP_PRODUCTIVE_COUGH,1
REACTOME_MECP2_REGULATES_NEU...,SET,16,0.017637,0.00052016,0.23616,0.47023,REACTOME_MECP2_REGULATES_NEURONAL_RECEPTORS_AND_CHANNELS,1
GOBP_ANAGEN,SET,5,0.03134,0.00051684,0.4198,0.47025,GOBP_ANAGEN,1
HP_ABNORMALITY_OF_THE_NECK,SET,611,0.0025389,0.00045517,0.034045,0.47028,HP_ABNORMALITY_OF_THE_NECK,1
HP_RETINAL_COLOBOMA,SET,37,0.010155,0.00045518,0.13623,0.47029,HP_RETINAL_COLOBOMA,1
GOMF_OXIDOREDUCTASE_ACTIVITY...33,SET,10,0.018925,0.00044133,0.25417,0.47032,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
WP_ACETAMINOPHEN_IN_ANALGESI...,SET,9,0.023392,0.00051751,0.31419,0.47033,WP_ACETAMINOPHEN_IN_ANALGESIA_AND_ANTIPYRESIS,1
GOMF_UBIQUITIN_LIKE_LIGASE_S...,SET,53,0.0088771,0.00047602,0.11952,0.4704,GOMF_UBIQUITIN_LIKE_LIGASE_SUBSTRATE_ADAPTOR_ACTIVITY,1
HP_MYELOPATHY,SET,13,0.01728,0.0004594,0.23352,0.47051,HP_MYELOPATHY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...9,SET,8,0.018195,0.00037952,0.24687,0.47063,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_DIPHENOLS_AND_RELATED_SUBSTANCES_AS_DONORS,1
GOBP_POSITIVE_REGULATION_OF_...109,SET,13,0.016399,0.00043597,0.2227,0.47065,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPIRATION,1
GSE17721_12H_VS_24H_GARDIQUI...2,SET,178,0.0046626,0.00045663,0.063431,0.4707,GSE17721_12H_VS_24H_GARDIQUIMOD_BMDC_UP,1
GSE3982_NEUTROPHIL_VS_EFF_ME...1,SET,181,0.0042288,0.00041759,0.057583,0.47073,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,1
GOBP_PROTEIN_AUTOPROCESSING,SET,26,0.012121,0.00045556,0.16515,0.47075,GOBP_PROTEIN_AUTOPROCESSING,1
GOBP_POSITIVE_REGULATION_OF_...227,SET,80,0.0069738,0.0004591,0.095314,0.47084,GOBP_POSITIVE_REGULATION_OF_DOUBLE_STRAND_BREAK_REPAIR,1
KAECH_DAY8_EFF_VS_MEMORY_CD8...2,SET,183,0.0043555,0.00043244,0.059584,0.47086,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_UP,1
ONDER_CDH1_TARGETS_1_DN,SET,157,0.0048934,0.00045033,0.066963,0.47087,ONDER_CDH1_TARGETS_1_DN,1
REACTOME_FGFR3B_LIGAND_BINDI...,SET,7,0.027515,0.00053687,0.37642,0.47087,REACTOME_FGFR3B_LIGAND_BINDING_AND_ACTIVATION,1
MIR34A_3P,SET,64,0.0078639,0.00046324,0.10766,0.47089,MIR34A_3P,1
WP_G_PROTEIN_SIGNALING,SET,90,0.0066113,0.00046151,0.090622,0.47092,WP_G_PROTEIN_SIGNALING,1
GSE34156_UNTREATED_VS_6H_NOD...1,SET,146,0.0050763,0.00045064,0.069717,0.47098,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
NAKAMURA_CANCER_MICROENVIRON...1,SET,40,0.0089045,0.00041496,0.12255,0.47104,NAKAMURA_CANCER_MICROENVIRONMENT_DN,1
RAY_ALZHEIMERS_DISEASE,SET,13,0.017316,0.00046037,0.23928,0.47115,RAY_ALZHEIMERS_DISEASE,1
HP_HAMMERTOE,SET,52,0.0085883,0.00045618,0.11869,0.47116,HP_HAMMERTOE,1
GSE26488_CTRL_VS_PEPTIDE_INJ...2,SET,188,0.0046818,0.00047108,0.064811,0.47121,GSE26488_CTRL_VS_PEPTIDE_INJECTION_HDAC7_DELTAP_TG_OT2_THYMOCYTE_UP,1
GSE5542_IFNG_VS_IFNA_AND_IFN...4,SET,167,0.0045491,0.00043166,0.062979,0.47121,GSE5542_IFNG_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
GOBP_REGULATION_OF_MITOTIC_S...2,SET,22,0.011161,0.00038592,0.15472,0.47125,GOBP_REGULATION_OF_MITOTIC_SPINDLE_ASSEMBLY,1
GSE9960_HEALTHY_VS_GRAM_POS_...2,SET,165,0.0043608,0.00041133,0.060593,0.47131,GSE9960_HEALTHY_VS_GRAM_POS_SEPSIS_PBMC_UP,1
HP_FALLS,SET,38,0.010397,0.00047228,0.14448,0.47132,HP_FALLS,1
GOBP_N_GLYCAN_PROCESSING,SET,17,0.015051,0.00045755,0.20935,0.47134,GOBP_N_GLYCAN_PROCESSING,1
GSE19941_UNSTIM_VS_LPS_STIM_...1,SET,177,0.0046165,0.00045085,0.064232,0.47135,GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_DN,1
DESCARTES_FETAL_LUNG_MEGAKAR...,SET,133,0.0054558,0.00046243,0.075912,0.47135,DESCARTES_FETAL_LUNG_MEGAKARYOCYTES,1
GSE20198_IL12_VS_IL12_IL18_T...2,SET,175,0.0043909,0.00042641,0.061115,0.47136,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,1
BOYAULT_LIVER_CANCER_SUBCLAS...7,SET,27,0.013029,0.00049901,0.18141,0.47137,BOYAULT_LIVER_CANCER_SUBCLASS_G2,1
HP_DACRYOCYSTITIS,SET,7,0.023464,0.00045783,0.32711,0.47141,HP_DACRYOCYSTITIS,1
HP_CALVARIAL_OSTEOSCLEROSIS,SET,7,0.020708,0.00040405,0.28912,0.47145,HP_CALVARIAL_OSTEOSCLEROSIS,1
NFKBIA_TARGET_GENES,SET,967,0.0019981,0.0004461,0.027944,0.4715,NFKBIA_TARGET_GENES,1
HP_ULNAR_DEVIATION_OF_THE_HA...2,SET,58,0.0082804,0.00046443,0.11581,0.4715,HP_ULNAR_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
KORKOLA_SEMINOMA_UP,SET,29,0.013563,0.00053832,0.18991,0.47153,KORKOLA_SEMINOMA_UP,1
MODULE_211,SET,11,0.023035,0.00056338,0.32272,0.47155,MODULE_211,1
KEGG_MEDICUS_REFERENCE_BMP_H...1,SET,11,0.018187,0.00044479,0.255,0.47157,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY,1
HP_ABNORMAL_HEMOGLOBIN_CONCE...,SET,17,0.01396,0.00042438,0.19617,0.47163,HP_ABNORMAL_HEMOGLOBIN_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...150,SET,5,0.026397,0.00043533,0.37159,0.47168,GOBP_POSITIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
GOMF_DNA_RNA_HYBRID_BINDING,SET,5,0.024027,0.00039625,0.33813,0.47168,GOMF_DNA_RNA_HYBRID_BINDING,1
HP_ABNORMAL_PELVIC_GIRDLE_BO...,SET,548,0.0025809,0.00043896,0.036342,0.47169,HP_ABNORMAL_PELVIC_GIRDLE_BONE_MORPHOLOGY,1
HAY_BONE_MARROW_PLATELET,SET,217,0.0041195,0.00044498,0.058031,0.4717,HAY_BONE_MARROW_PLATELET,1
GOBP_ENDOCARDIAL_CUSHION_FOR...,SET,30,0.012645,0.00051048,0.17822,0.47172,GOBP_ENDOCARDIAL_CUSHION_FORMATION,1
GSE17721_CTRL_VS_CPG_24H_BMD...1,SET,183,0.0043176,0.00042868,0.060857,0.47172,GSE17721_CTRL_VS_CPG_24H_BMDC_DN,1
GOBP_REGULATION_OF_BRANCHING...3,SET,9,0.020118,0.00044508,0.28368,0.47173,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
LE_SKI_TARGETS_UP,SET,17,0.014989,0.00045566,0.21155,0.47176,LE_SKI_TARGETS_UP,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...8,SET,135,0.0050983,0.00043534,0.072055,0.4718,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_POSITIVE,1
HP_VASCULITIS_BY_ANATOMICAL_...,SET,14,0.015836,0.00043689,0.22403,0.47182,HP_VASCULITIS_BY_ANATOMICAL_SITE,1
GOBP_RNA_SPLICING_VIA_ENDONU...,SET,13,0.016992,0.00045176,0.24063,0.47185,GOBP_RNA_SPLICING_VIA_ENDONUCLEOLYTIC_CLEAVAGE_AND_LIGATION,1
GOBP_NEGATIVE_REGULATION_OF_...660,SET,5,0.025713,0.00042405,0.36438,0.47187,GOBP_NEGATIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,1
GOBP_B_CELL_PROLIFERATION_IN...,SET,6,0.027686,0.00050016,0.39316,0.47193,GOBP_B_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_VENTRICULAR_TACHYCARDIA,SET,62,0.0078822,0.00045704,0.11194,0.47193,HP_VENTRICULAR_TACHYCARDIA,1
GSE36078_UNTREATED_VS_AD5_IN...4,SET,185,0.0044454,0.00044375,0.06316,0.47195,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_UP,1
MIR1287_3P,SET,31,0.0096586,0.00039634,0.1374,0.47198,MIR1287_3P,1
GSE7764_NKCELL_VS_SPLENOCYTE...2,SET,184,0.0044911,0.00044711,0.063925,0.472,GSE7764_NKCELL_VS_SPLENOCYTE_UP,1
ZNF16_TARGET_GENES,SET,66,0.0077239,0.00046203,0.11002,0.47202,ZNF16_TARGET_GENES,1
SIG_INSULIN_RECEPTOR_PATHWAY...,SET,48,0.0088615,0.00045227,0.12646,0.47207,SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES,1
REACTOME_TRANSCRIPTIONAL_REG...15,SET,79,0.0063551,0.00041575,0.090779,0.47209,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_WHITE_ADIPOCYTE_DIFFERENTIATION,1
GSE24634_IL4_VS_CTRL_TREATED...2,SET,174,0.0045397,0.00043961,0.064961,0.47214,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY10_UP,1
GSE360_CTRL_VS_M_TUBERCULOSI...1,SET,184,0.0044658,0.00044459,0.064031,0.4722,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_DN,1
GOBP_REPRODUCTIVE_BEHAVIOR,SET,44,0.0096648,0.00047232,0.13862,0.47221,GOBP_REPRODUCTIVE_BEHAVIOR,1
GOCC_MEMBRANE_PROTEIN_COMPLEX,SET,1153,0.001795,0.00043527,0.025835,0.4723,GOCC_MEMBRANE_PROTEIN_COMPLEX,1
GSE2706_2H_VS_8H_R848_AND_LP...2,SET,174,0.0042662,0.00041313,0.061495,0.47235,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...365,SET,14,0.015547,0.00042892,0.22481,0.47243,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,1
GOCC_INTERCHROMATIN_GRANULE,SET,5,0.020995,0.00034624,0.30444,0.47251,GOCC_INTERCHROMATIN_GRANULE,1
GSE2405_0H_VS_1.5H_A_PHAGOCY...2,SET,189,0.0043887,0.00044275,0.06366,0.47252,GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
GSE17721_LPS_VS_GARDIQUIMOD_...7,SET,181,0.0042681,0.00042146,0.061977,0.47255,GSE17721_LPS_VS_GARDIQUIMOD_1H_BMDC_DN,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...5,SET,9,0.020054,0.00044367,0.29158,0.47258,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_P21_CELL_CYCLE_G1_S_N00497,1
GOBP_LIPID_EXPORT_FROM_CELL,SET,49,0.0089497,0.00046149,0.1302,0.4726,GOBP_LIPID_EXPORT_FROM_CELL,1
GOCC_PERINEURONAL_NET,SET,10,0.021455,0.00050031,0.31229,0.47261,GOCC_PERINEURONAL_NET,1
GNF2_RAN,SET,78,0.0057796,0.00037572,0.084243,0.47265,GNF2_RAN,1
GOBP_REGULATION_OF_LIPASE_AC...,SET,61,0.0077901,0.00044805,0.11353,0.47265,GOBP_REGULATION_OF_LIPASE_ACTIVITY,1
GOBP_MITOTIC_SISTER_CHROMATI...2,SET,3,0.027719,0.00035411,0.40461,0.47269,GOBP_MITOTIC_SISTER_CHROMATID_COHESION_CENTROMERIC,1
GSE30083_SP2_VS_SP4_THYMOCYT...1,SET,186,0.0042815,0.00042853,0.062936,0.47288,GSE30083_SP2_VS_SP4_THYMOCYTE_DN,1
GSE4984_GALECTIN1_VS_VEHICLE...2,SET,164,0.0042371,0.00039845,0.062278,0.47288,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_UP,1
ZHONG_PFC_C1_ASTROCYTE,SET,27,0.010794,0.00041343,0.15869,0.47288,ZHONG_PFC_C1_ASTROCYTE,1
GOBP_PARATHYROID_GLAND_DEVEL...,SET,7,0.021292,0.00041545,0.31352,0.47293,GOBP_PARATHYROID_GLAND_DEVELOPMENT,1
GSE27786_BCELL_VS_CD8_TCELL_...2,SET,185,0.0040711,0.00040639,0.059952,0.47293,GSE27786_BCELL_VS_CD8_TCELL_UP,1
GOBP_CELL_SURFACE_PATTERN_RE...,SET,71,0.006821,0.00042313,0.10052,0.47295,GOBP_CELL_SURFACE_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
GSE17301_CTRL_VS_48H_ACD3_AC...4,SET,176,0.0041912,0.00040818,0.061884,0.473,GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP,1
GSE40274_CTRL_VS_FOXP3_AND_S...2,SET,150,0.0045008,0.00040494,0.066485,0.47301,GSE40274_CTRL_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE1112_OT1_VS_HY_CD8AB_THYM...2,SET,180,0.0041507,0.00040875,0.06139,0.47305,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_UP,1
GSE27786_LIN_NEG_VS_CD8_TCEL...1,SET,185,0.0042177,0.00042103,0.062383,0.47305,GSE27786_LIN_NEG_VS_CD8_TCELL_DN,1
GSE33162_UNTREATED_VS_4H_LPS...3,SET,186,0.004282,0.00042858,0.063331,0.47305,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN,1
QI_HYPOXIA_TARGETS_OF_HIF1A_...,SET,32,0.010416,0.00043425,0.15411,0.47306,QI_HYPOXIA_TARGETS_OF_HIF1A_AND_FOXA2,1
MIR132_3P,SET,173,0.0042722,0.00041254,0.063323,0.47311,MIR132_3P,1
MIR8054,SET,268,0.0034801,0.00041716,0.051621,0.47313,MIR8054,1
GSE22886_NAIVE_VS_MEMORY_TCE...2,SET,175,0.004189,0.00040681,0.062388,0.47323,GSE22886_NAIVE_VS_MEMORY_TCELL_UP,1
MODULE_237,SET,54,0.0075605,0.00040921,0.11262,0.47324,MODULE_237,1
GSE13229_IMM_VS_MATURE_NKCEL...1,SET,183,0.0041823,0.00041524,0.062329,0.47325,GSE13229_IMM_VS_MATURE_NKCELL_DN,1
GOMF_TYPE_1_FIBROBLAST_GROWT...,SET,5,0.028497,0.00046997,0.42507,0.47327,GOMF_TYPE_1_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
GSE21379_TFH_VS_NON_TFH_CD4_...1,SET,176,0.0044185,0.00043031,0.065965,0.4733,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_DN,1
GOBP_CYTOPLASMIC_TRANSLATION,SET,142,0.0043973,0.00038502,0.065783,0.47335,GOBP_CYTOPLASMIC_TRANSLATION,1
GOBP_POSITIVE_REGULATION_OF_...105,SET,459,0.0026374,0.00041156,0.03947,0.47336,GOBP_POSITIVE_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,1
HP_LACTOSE_INTOLERANCE,SET,5,0.026621,0.00043903,0.39855,0.47337,HP_LACTOSE_INTOLERANCE,1
WONG_ENDMETRIUM_CANCER_DN,SET,69,0.0075199,0.00045989,0.11262,0.47338,WONG_ENDMETRIUM_CANCER_DN,1
GOBP_REGULATION_OF_TORC2_SIG...,SET,4,0.027486,0.00040544,0.41184,0.4734,GOBP_REGULATION_OF_TORC2_SIGNALING,1
HP_DECREASED_SPECIFIC_ANTIBO...3,SET,13,0.017637,0.00046891,0.26443,0.47341,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_VACCINE,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...4,SET,109,0.0054004,0.00041466,0.080951,0.47341,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGM_BCELL_UP,1
GSE8515_CTRL_VS_IL6_4H_STIM_...2,SET,179,0.0041753,0.00041004,0.0627,0.47345,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_UP,1
HP_ABNORMAL_RETINAL_VASCULAR...,SET,227,0.003723,0.00041119,0.055949,0.47347,HP_ABNORMAL_RETINAL_VASCULAR_MORPHOLOGY,1
HP_BICONCAVE_VERTEBRAL_BODIES,SET,21,0.012217,0.00041272,0.18354,0.47347,HP_BICONCAVE_VERTEBRAL_BODIES,1
HP_ABNORMAL_5TH_FINGER_PHALA...,SET,54,0.0077114,0.00041738,0.11592,0.47348,HP_ABNORMAL_5TH_FINGER_PHALANX_MORPHOLOGY,1
GSE14350_TREG_VS_TEFF_IN_IL2...2,SET,183,0.0039746,0.00039462,0.059855,0.47353,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_UP,1
HP_ABNORMAL_GASTROINTESTINAL...1,SET,87,0.006016,0.00041293,0.090621,0.47354,HP_ABNORMAL_GASTROINTESTINAL_MOTILITY,1
KUROZUMI_RESPONSE_TO_ONCOCYT...1,SET,41,0.009555,0.00045079,0.14412,0.47357,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS,1
WP_NEUROINFLAMMATION,SET,11,0.019215,0.00046995,0.29007,0.47359,WP_NEUROINFLAMMATION,1
GSE17721_0.5H_VS_4H_PAM3CSK4...2,SET,181,0.0041153,0.00040638,0.062133,0.4736,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_UP,1
GOBP_GOLGI_LUMEN_ACIDIFICATI...,SET,9,0.016968,0.00037539,0.25659,0.47364,GOBP_GOLGI_LUMEN_ACIDIFICATION,1
GOBP_CARDIAC_MUSCLE_CELL_MEM...,SET,36,0.00982,0.00043419,0.14876,0.47368,GOBP_CARDIAC_MUSCLE_CELL_MEMBRANE_REPOLARIZATION,1
GOBP_GERM_CELL_MIGRATION,SET,9,0.020992,0.00046442,0.31789,0.47368,GOBP_GERM_CELL_MIGRATION,1
GARGALOVIC_RESPONSE_TO_OXIDI...16,SET,9,0.020305,0.00044921,0.30806,0.47372,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PURPLE_DN,1
MMS_MOUSE_LYMPH_HIGH_4HRS_UP,SET,28,0.0098569,0.00038444,0.14965,0.47374,MMS_MOUSE_LYMPH_HIGH_4HRS_UP,1
GOBP_REGULATION_OF_FEMALE_RE...,SET,8,0.022195,0.00046296,0.33715,0.47376,GOBP_REGULATION_OF_FEMALE_RECEPTIVITY,1
GOBP_PURINE_NUCLEOSIDE_METAB...,SET,24,0.013172,0.00047569,0.2002,0.47377,GOBP_PURINE_NUCLEOSIDE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...134,SET,55,0.0075799,0.00041403,0.11524,0.47378,GOBP_POSITIVE_REGULATION_OF_CELL_MATRIX_ADHESION,1
HP_EQUINOVARUS_DEFORMITY,SET,13,0.017043,0.00045311,0.26044,0.47391,HP_EQUINOVARUS_DEFORMITY,1
HP_HYPERSPLENISM,SET,20,0.012587,0.00041499,0.19271,0.47396,HP_HYPERSPLENISM,1
HP_ABNORMAL_ANATOMIC_LOCATIO...,SET,127,0.0045611,0.00037784,0.069873,0.47398,HP_ABNORMAL_ANATOMIC_LOCATION_OF_THE_HEART,1
HP_PSEUDOEPIPHYSES_OF_THE_PH...,SET,5,0.027365,0.00045129,0.41931,0.47398,HP_PSEUDOEPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,1
HP_PITUITARY_ADENOMA,SET,51,0.0072417,0.00038094,0.11112,0.47402,HP_PITUITARY_ADENOMA,1
GSE5589_WT_VS_IL10_KO_LPS_ST...4,SET,179,0.0039837,0.00039123,0.061133,0.47402,GSE5589_WT_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
GOBP_BUD_ELONGATION_INVOLVED...,SET,7,0.023934,0.00046701,0.36749,0.47404,GOBP_BUD_ELONGATION_INVOLVED_IN_LUNG_BRANCHING,1
GOBP_REGULATION_OF_GLUCOCORT...2,SET,11,0.016073,0.0003931,0.24685,0.47404,GOBP_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,1
GOBP_ATRIOVENTRICULAR_NODE_D...,SET,9,0.019282,0.00042659,0.29619,0.47405,GOBP_ATRIOVENTRICULAR_NODE_DEVELOPMENT,1
REACTOME_TRIGLYCERIDE_METABO...,SET,35,0.0096013,0.00041859,0.14786,0.47411,REACTOME_TRIGLYCERIDE_METABOLISM,1
GOBP_POSITIVE_REGULATION_OF_...521,SET,270,0.003576,0.00043023,0.055065,0.47411,GOBP_POSITIVE_REGULATION_OF_NERVOUS_SYSTEM_DEVELOPMENT,1
HP_BLURRED_VISION,SET,33,0.0098462,0.00041684,0.15185,0.47415,HP_BLURRED_VISION,1
GSE27786_BCELL_VS_NKTCELL_DN,SET,178,0.004159,0.00040731,0.064184,0.47417,GSE27786_BCELL_VS_NKTCELL_DN,1
GSE5589_WT_VS_IL6_KO_LPS_AND...6,SET,180,0.0042341,0.00041697,0.065402,0.47419,GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
MIR655_5P,SET,75,0.0066379,0.00042317,0.10262,0.47421,MIR655_5P,1
MIR376A_3P_MIR376B_3P,SET,133,0.0045462,0.00038533,0.070497,0.47429,MIR376A_3P_MIR376B_3P,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...4,SET,636,0.0021838,0.00039915,0.033961,0.47436,HP_ABNORMAL_MORPHOLOGY_OF_THE_GREAT_VESSELS,1
GOBP_NEGATIVE_REGULATION_OF_...382,SET,9,0.018799,0.00041589,0.29238,0.47437,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_NUCLEAR_DIVISION,1
HOWARD_PBMC_INACT_MONOV_INFL...2,SET,334,0.0032383,0.00043256,0.050379,0.47437,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_UP,1
GOMF_PHOSPHOSERINE_RESIDUE_B...,SET,10,0.017695,0.00041264,0.27567,0.47441,GOMF_PHOSPHOSERINE_RESIDUE_BINDING,1
HP_ABNORMALITY_OF_THE_MIDDLE...1,SET,544,0.0023579,0.00039962,0.036793,0.47445,HP_ABNORMALITY_OF_THE_MIDDLE_EAR,1
TESAR_ALK_TARGETS_HUMAN_ES_4...,SET,4,0.026116,0.00038523,0.40819,0.47449,TESAR_ALK_TARGETS_HUMAN_ES_4D_DN,1
GOBP_TAIL_ANCHORED_MEMBRANE_...,SET,12,0.013633,0.00034824,0.21371,0.47457,GOBP_TAIL_ANCHORED_MEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
WGTTNNNNNAAA_UNKNOWN,SET,484,0.0026065,0.00041738,0.040881,0.47458,WGTTNNNNNAAA_UNKNOWN,1
YOSHIMURA_MAPK8_TARGETS_UP,SET,1186,0.0016704,0.0004104,0.026214,0.4746,YOSHIMURA_MAPK8_TARGETS_UP,1
GOMF_METAL_ION_SEQUESTERING_...,SET,5,0.025694,0.00042374,0.40358,0.47462,GOMF_METAL_ION_SEQUESTERING_ACTIVITY,1
MODULE_325,SET,53,0.0072499,0.00038876,0.11423,0.4747,MODULE_325,1
GOBP_TRANSCRIPTION_INITIATIO...1,SET,8,0.015515,0.00032362,0.24459,0.47471,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_III_PROMOTER,1
WP_OVARIAN_INFERTILITY,SET,38,0.0085378,0.00038782,0.13468,0.47473,WP_OVARIAN_INFERTILITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...24,SET,9,0.020677,0.00045744,0.32628,0.47474,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_IRON_SULFUR_PROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
MODULE_50,SET,13,0.011977,0.00031841,0.18989,0.47486,MODULE_50,1
WAGNER_APO2_SENSITIVITY,SET,25,0.011719,0.00043191,0.18622,0.47491,WAGNER_APO2_SENSITIVITY,1
HP_SIDEROBLASTIC_ANEMIA,SET,32,0.008382,0.00034945,0.13316,0.47491,HP_SIDEROBLASTIC_ANEMIA,1
KATSANOU_ELAVL1_TARGETS_DN,SET,133,0.0047951,0.00040643,0.076269,0.47494,KATSANOU_ELAVL1_TARGETS_DN,1
HP_ABSENT_HYPOPLASTIC_PARANA...,SET,5,0.025845,0.00042623,0.41112,0.47494,HP_ABSENT_HYPOPLASTIC_PARANASAL_SINUSES,1
REACTOME_GLYCOGEN_STORAGE_DI...,SET,13,0.014423,0.00038344,0.22968,0.47497,REACTOME_GLYCOGEN_STORAGE_DISEASES,1
LAKE_ADULT_KIDNEY_C10_THIN_A...,SET,317,0.0029931,0.00038968,0.047787,0.47503,LAKE_ADULT_KIDNEY_C10_THIN_ASCENDING_LIMB,1
WELCSH_BRCA1_TARGETS_DN,SET,125,0.0044385,0.00036479,0.070935,0.47505,WELCSH_BRCA1_TARGETS_DN,1
HP_SHORT_MANDIBULAR_RAMI,SET,6,0.021822,0.00039422,0.34898,0.47507,HP_SHORT_MANDIBULAR_RAMI,1
BIOCARTA_IFNA_PATHWAY,SET,9,0.017655,0.00039058,0.28272,0.4751,BIOCARTA_IFNA_PATHWAY,1
IIZUKA_LIVER_CANCER_PROGRESS...4,SET,24,0.010277,0.00037113,0.16474,0.47513,IIZUKA_LIVER_CANCER_PROGRESSION_G2_G3_UP,1
GOBP_REGULATION_OF_DNA_DEMET...,SET,4,0.025553,0.00037693,0.41113,0.47522,GOBP_REGULATION_OF_DNA_DEMETHYLATION,1
GOBP_POSITIVE_REGULATION_OF_...654,SET,5,0.024655,0.00040661,0.39699,0.47524,GOBP_POSITIVE_REGULATION_OF_PROTEOGLYCAN_BIOSYNTHETIC_PROCESS,1
GOBP_RESPONSE_TO_PH,SET,38,0.0085252,0.00038724,0.13732,0.47525,GOBP_RESPONSE_TO_PH,1
GOBP_GLIAL_CELL_ACTIVATION,SET,53,0.007814,0.00041901,0.12613,0.4753,GOBP_GLIAL_CELL_ACTIVATION,1
VISALA_RESPONSE_TO_HEAT_SHOC...2,SET,14,0.013235,0.00036513,0.21378,0.47532,VISALA_RESPONSE_TO_HEAT_SHOCK_AND_AGING_UP,1
GSE360_LOW_DOSE_B_MALAYI_VS_...1,SET,184,0.0038906,0.00038733,0.062933,0.47535,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,1
WP_GENES_TARGETED_BY_MIRNAS_...,SET,11,0.017336,0.000424,0.28058,0.47537,WP_GENES_TARGETED_BY_MIRNAS_IN_ADIPOCYTES,1
GOBP_CARDIAC_CONDUCTION,SET,91,0.0058772,0.00041253,0.095303,0.47541,GOBP_CARDIAC_CONDUCTION,1
GOMF_CELL_CELL_ADHESION_MEDI...,SET,50,0.0082362,0.000429,0.13365,0.47543,GOMF_CELL_CELL_ADHESION_MEDIATOR_ACTIVITY,1
chr17p11,SET,61,0.011272,0.0006483,0.18309,0.47546,chr17p11,1
GOBP_PROTEIN_DEACETYLATION,SET,37,0.0078409,0.00035145,0.12765,0.47551,GOBP_PROTEIN_DEACETYLATION,1
MOOTHA_MITOCHONDRIA,SET,397,0.0025637,0.00037269,0.04185,0.47558,MOOTHA_MITOCHONDRIA,1
GOBP_NEGATIVE_REGULATION_OF_...594,SET,5,0.021535,0.00035515,0.35161,0.47558,GOBP_NEGATIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_PROLIFERATION,1
GOBP_PROTEOLYSIS,SET,1454,0.0014233,0.00038416,0.02324,0.47558,GOBP_PROTEOLYSIS,1
CUI_DEVELOPING_HEART_C8_MACR...,SET,248,0.0034805,0.00040156,0.056886,0.47561,CUI_DEVELOPING_HEART_C8_MACROPHAGE,1
GSE22886_CD8_VS_CD4_NAIVE_TC...2,SET,176,0.00371,0.00036131,0.060698,0.47563,GSE22886_CD8_VS_CD4_NAIVE_TCELL_UP,1
GOCC_CILIARY_TRANSITION_FIBER,SET,8,0.018345,0.00038266,0.30085,0.47569,GOCC_CILIARY_TRANSITION_FIBER,1
GSE22033_UNTREATED_VS_ROSIGL...1,SET,176,0.0039052,0.00038032,0.064116,0.47572,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_DN,1
GSE9946_IMMATURE_VS_PROSTAGL...1,SET,124,0.0045736,0.0003744,0.07509,0.47572,GSE9946_IMMATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN,1
GSE39820_CTRL_VS_TGFBETA3_IL...1,SET,182,0.003758,0.0003721,0.061726,0.47573,GSE39820_CTRL_VS_TGFBETA3_IL6_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...482,SET,16,0.013333,0.00039323,0.21909,0.47574,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_THREONINE_PHOSPHORYLATION,1
REACTOME_HYDROLYSIS_OF_LPC,SET,9,0.018013,0.00039851,0.29629,0.47576,REACTOME_HYDROLYSIS_OF_LPC,1
GOBP_TRNA_AMINOACYLATION_FOR...,SET,7,0.017217,0.00033593,0.28325,0.47577,GOBP_TRNA_AMINOACYLATION_FOR_MITOCHONDRIAL_PROTEIN_TRANSLATION,1
MODULE_474,SET,13,0.016001,0.00042542,0.26427,0.47586,MODULE_474,1
REACTOME_ORGANIC_CATION_TRAN...,SET,10,0.018736,0.00043691,0.30952,0.47587,REACTOME_ORGANIC_CATION_TRANSPORT,1
GOCC_EXTERNAL_ENCAPSULATING_...,SET,520,0.0024174,0.00040082,0.039953,0.47588,GOCC_EXTERNAL_ENCAPSULATING_STRUCTURE,1
MIR1255B_2_3P,SET,78,0.0054601,0.00035495,0.090344,0.4759,MIR1255B_2_3P,1
GOBP_HAIR_CYCLE_PHASE,SET,9,0.017561,0.00038852,0.29113,0.47595,GOBP_HAIR_CYCLE_PHASE,1
HP_ABNORMAL_NASOLABIAL_REGIO...,SET,17,0.011249,0.00034195,0.18665,0.47597,HP_ABNORMAL_NASOLABIAL_REGION_MORPHOLOGY,1
WP_NAD_METABOLISM_IN_ONCOGEN...,SET,22,0.010555,0.00036496,0.1752,0.47598,WP_NAD_METABOLISM_IN_ONCOGENEINDUCED_SENESCENCE_AND_MITOCHONDRIAL_DYSFUNCTIONASSOCIATED_SENESCENCE,1
HP_APLASIA_HYPOPLASIA_OF_THE...6,SET,4,0.027921,0.00041186,0.46349,0.47598,HP_APLASIA_HYPOPLASIA_OF_THE_4TH_FINGER,1
TCCGTCC_MIR184,SET,12,0.01562,0.00039899,0.25994,0.47604,TCCGTCC_MIR184,1
HP_MEDIAL_FLARING_OF_THE_EYE...,SET,35,0.0083259,0.00036299,0.1396,0.47622,HP_MEDIAL_FLARING_OF_THE_EYEBROW,1
GSE4748_CTRL_VS_CYANOBACTERI...4,SET,188,0.003578,0.00036001,0.060068,0.47625,GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,1
HP_AGANGLIONIC_MEGACOLON,SET,132,0.0041835,0.00035326,0.070281,0.47627,HP_AGANGLIONIC_MEGACOLON,1
DONATO_CELL_CYCLE_TRETINOIN,SET,6,0.023278,0.00042052,0.39238,0.47635,DONATO_CELL_CYCLE_TRETINOIN,1
HP_ABNORMAL_SEMICIRCULAR_CAN...,SET,21,0.0099254,0.00033531,0.16733,0.47635,HP_ABNORMAL_SEMICIRCULAR_CANAL_MORPHOLOGY,1
MORF_FRK,SET,98,0.0051181,0.00037274,0.086403,0.47638,MORF_FRK,1
CHANG_POU5F1_TARGETS_UP,SET,13,0.015339,0.00040781,0.25928,0.47641,CHANG_POU5F1_TARGETS_UP,1
REACTOME_SIGNALING_BY_FLT3_F...,SET,19,0.010751,0.0003455,0.18169,0.47641,REACTOME_SIGNALING_BY_FLT3_FUSION_PROTEINS,1
NAKAMURA_BRONCHIAL_AND_BRONC...,SET,5,0.022412,0.00036961,0.37917,0.47643,NAKAMURA_BRONCHIAL_AND_BRONCHIOLAR_EPITHELIA,1
WP_IL19_SIGNALING,SET,28,0.0096291,0.00037555,0.16308,0.47646,WP_IL19_SIGNALING,1
KEGG_MEDICUS_REFERENCE_AUTOP...8,SET,9,0.015609,0.00034533,0.26507,0.47652,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PI3P_SYNTHESIS_BY_PI3KC3_C1,1
GOBP_ACTOMYOSIN_CONTRACTILE_...,SET,10,0.015215,0.00035481,0.25868,0.47655,GOBP_ACTOMYOSIN_CONTRACTILE_RING_ORGANIZATION,1
TSAI_RESPONSE_TO_RADIATION_T...,SET,28,0.010611,0.00041386,0.18057,0.47657,TSAI_RESPONSE_TO_RADIATION_THERAPY,1
HP_RENAL_INTERSTITIAL_FIBROS...,SET,6,0.018258,0.00032984,0.31186,0.47666,HP_RENAL_INTERSTITIAL_FIBROSIS,1
GOBP_POSITIVE_REGULATION_OF_...302,SET,68,0.0064975,0.00039449,0.11115,0.47669,GOBP_POSITIVE_REGULATION_OF_GLIOGENESIS,1
GOCC_PIGMENT_GRANULE,SET,107,0.0047083,0.0003582,0.080539,0.47669,GOCC_PIGMENT_GRANULE,1
PETROVA_ENDOTHELIUM_LYMPHATI...1,SET,154,0.0042027,0.00038309,0.071935,0.47671,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN,1
HP_DELAYED_UMBILICAL_CORD_SE...,SET,5,0.027483,0.00045324,0.47138,0.47675,HP_DELAYED_UMBILICAL_CORD_SEPARATION,1
WANG_RESPONSE_TO_BEXAROTENE_...1,SET,28,0.0096725,0.00037725,0.16604,0.47677,WANG_RESPONSE_TO_BEXAROTENE_DN,1
MORF_PRDX3,SET,72,0.0053789,0.000336,0.092393,0.47679,MORF_PRDX3,1
HP_CONCENTRIC_HYPERTROPHIC_C...,SET,7,0.020524,0.00040048,0.35267,0.4768,HP_CONCENTRIC_HYPERTROPHIC_CARDIOMYOPATHY,1
GSE32034_LY6C_HIGH_VS_LOW_MO...1,SET,188,0.0034446,0.0003466,0.059314,0.47684,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_DN,1
HP_DEPRESSED_NASAL_TIP,SET,22,0.01085,0.00037516,0.18709,0.47688,HP_DEPRESSED_NASAL_TIP,1
GOBP_NEGATIVE_REGULATION_OF_...230,SET,18,0.010744,0.00033607,0.18545,0.4769,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GSE3039_B2_VS_B1_BCELL_UP,SET,186,0.0035161,0.00035192,0.060706,0.47691,GSE3039_B2_VS_B1_BCELL_UP,1
BERENJENO_ROCK_SIGNALING_NOT...2,SET,28,0.009351,0.00036471,0.16162,0.47693,BERENJENO_ROCK_SIGNALING_NOT_VIA_RHOA_UP,1
GSE46606_IRF4_KO_VS_WT_UNSTI...2,SET,186,0.0034883,0.00034914,0.060502,0.47701,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_UP,1
GSE36826_WT_VS_IL1R_KO_SKIN_...1,SET,170,0.0036554,0.00034993,0.063428,0.47702,GSE36826_WT_VS_IL1R_KO_SKIN_DN,1
GOBP_MEMBRANE_REPOLARIZATION,SET,48,0.0075111,0.00038335,0.13043,0.47704,GOBP_MEMBRANE_REPOLARIZATION,1
GOBP_REGULATION_OF_SYNAPTIC_...1,SET,5,0.022791,0.00037586,0.39623,0.47707,GOBP_REGULATION_OF_SYNAPTIC_ASSEMBLY_AT_NEUROMUSCULAR_JUNCTION,1
WP_CLASSICAL_PATHWAY_OF_STER...,SET,16,0.013176,0.00038858,0.2298,0.47714,WP_CLASSICAL_PATHWAY_OF_STEROIDOGENESIS_WITH_GLUCOCORTICOID_AND_MINERALOCORTICOID_METABOLISM,1
WP_ETHANOL_METABOLISM_PRODUC...,SET,9,0.017076,0.00037778,0.29802,0.47715,WP_ETHANOL_METABOLISM_PRODUCTION_OF_ROS_BY_CYP2E1,1
GSE22935_UNSTIM_VS_48H_MBOVI...3,SET,177,0.003653,0.00035676,0.063738,0.47715,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN,1
GOBP_REGULATION_OF_SKELETAL_...9,SET,11,0.013812,0.0003378,0.24186,0.47723,GOBP_REGULATION_OF_SKELETAL_MUSCLE_SATELLITE_CELL_PROLIFERATION,1
GOBP_POSITIVE_REGULATION_OF_...238,SET,13,0.014589,0.00038786,0.25576,0.47726,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,1
HP_DEATH_IN_ADOLESCENCE,SET,21,0.010796,0.00036471,0.18943,0.47728,HP_DEATH_IN_ADOLESCENCE,1
MIR5690,SET,110,0.0047123,0.00036347,0.082747,0.47729,MIR5690,1
GOBP_INTERLEUKIN_3_MEDIATED_...,SET,6,0.022733,0.00041067,0.40048,0.47737,GOBP_INTERLEUKIN_3_MEDIATED_SIGNALING_PATHWAY,1
HP_BIFID_URETER,SET,4,0.02323,0.00034266,0.40951,0.47738,HP_BIFID_URETER,1
HP_HYPOPIGMENTATION_OF_THE_S...,SET,180,0.0034509,0.00033984,0.060867,0.47739,HP_HYPOPIGMENTATION_OF_THE_SKIN,1
REACTOME_SARS_COV_2_TARGETS_...1,SET,12,0.014778,0.00037748,0.26076,0.4774,REACTOME_SARS_COV_2_TARGETS_HOST_INTRACELLULAR_SIGNALLING_AND_REGULATORY_PATHWAYS,1
BIOCARTA_ACH_PATHWAY,SET,14,0.01311,0.0003617,0.23142,0.47741,BIOCARTA_ACH_PATHWAY,1
HP_POLYCLONAL_ELEVATION_OF_I...,SET,6,0.017567,0.00031735,0.31031,0.47743,HP_POLYCLONAL_ELEVATION_OF_IGM,1
GAO_SMALL_INTESTINE_24W_C4_E...,SET,87,0.0052539,0.00036062,0.092921,0.47746,GAO_SMALL_INTESTINE_24W_C4_ENTEROCYTE_PROGENITOR_SUBTYPE_2,1
GSE21063_CTRL_VS_ANTI_IGM_ST...9,SET,164,0.0036783,0.00034591,0.06516,0.47749,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_DN,1
TERAMOTO_OPN_TARGETS_CLUSTER...7,SET,8,0.016339,0.00034082,0.28989,0.47753,TERAMOTO_OPN_TARGETS_CLUSTER_8,1
GOMF_HISTONE_H4K12_ACETYLTRA...,SET,12,0.012968,0.00033125,0.23033,0.47755,GOMF_HISTONE_H4K12_ACETYLTRANSFERASE_ACTIVITY,1
GOCC_PROTEASOME_REGULATORY_P...2,SET,7,0.016309,0.00031822,0.29247,0.47777,GOCC_PROTEASOME_REGULATORY_PARTICLE_LID_SUBCOMPLEX,1
GOCC_MLL1_2_COMPLEX,SET,29,0.0076441,0.0003034,0.13763,0.47785,GOCC_MLL1_2_COMPLEX,1
GOBP_REGULATION_OF_PLASMA_ME...2,SET,6,0.020568,0.00037156,0.37048,0.47786,GOBP_REGULATION_OF_PLASMA_MEMBRANE_REPAIR,1
GOMF_ADENYLATE_CYCLASE_REGUL...,SET,8,0.016741,0.0003492,0.30147,0.47786,GOMF_ADENYLATE_CYCLASE_REGULATOR_ACTIVITY,1
MIR3920,SET,123,0.0043004,0.00035062,0.07748,0.47787,MIR3920,1
HP_ABNORMAL_RESPONSE_TO_GLUC...,SET,4,0.025956,0.00038288,0.46783,0.47788,HP_ABNORMAL_RESPONSE_TO_GLUCAGON_STIMULATION_TEST,1
GSE557_CIITA_KO_VS_I_AB_KO_D...1,SET,183,0.0032745,0.00032512,0.059337,0.478,GSE557_CIITA_KO_VS_I_AB_KO_DC_DN,1
BHATTACHARYA_EMBRYONIC_STEM_...,SET,76,0.0050396,0.0003234,0.091373,0.47801,BHATTACHARYA_EMBRYONIC_STEM_CELL,1
MIR8069,SET,57,0.0063789,0.00035469,0.11609,0.47809,MIR8069,1
GAVISH_3CA_METAPROGRAM_B_CEL...4,SET,45,0.0067672,0.00033444,0.12313,0.47809,GAVISH_3CA_METAPROGRAM_B_CELLS_HSP_STRESS,1
GOBP_PROTEIN_HEXAMERIZATION,SET,8,0.015491,0.00032313,0.28231,0.47812,GOBP_PROTEIN_HEXAMERIZATION,1
GOMF_SIALYLTRANSFERASE_ACTIV...,SET,21,0.010725,0.00036233,0.19592,0.47817,GOMF_SIALYLTRANSFERASE_ACTIVITY,1
HP_EPIPHYSEAL_DYSPLASIA,SET,28,0.0085208,0.00033233,0.15579,0.47819,HP_EPIPHYSEAL_DYSPLASIA,1
GSE17974_0.5H_VS_72H_UNTREAT...1,SET,172,0.0032702,0.00031487,0.059881,0.47822,GSE17974_0.5H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
HP_ELEVATED_URINARY_COLLAGEN...,SET,5,0.020025,0.00033025,0.36682,0.47823,HP_ELEVATED_URINARY_COLLAGEN_DEGRADATION_PRODUCTS,1
GOCC_NLRP3_INFLAMMASOME_COMP...,SET,6,0.018696,0.00033776,0.34369,0.47831,GOCC_NLRP3_INFLAMMASOME_COMPLEX,1
BOYLAN_MULTIPLE_MYELOMA_C_DN,SET,53,0.006851,0.00036737,0.12666,0.47843,BOYLAN_MULTIPLE_MYELOMA_C_DN,1
HP_ABNORMAL_GAMMA_GLUTAMYLTR...,SET,41,0.0071249,0.00033614,0.13173,0.47843,HP_ABNORMAL_GAMMA_GLUTAMYLTRANSFERASE_LEVEL,1
GSE14415_INDUCED_TREG_VS_FOX...1,SET,160,0.0036879,0.0003426,0.068169,0.47843,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_DN,1
GOBP_MITOTIC_SISTER_CHROMATI...3,SET,178,0.0032387,0.00031718,0.059923,0.47845,GOBP_MITOTIC_SISTER_CHROMATID_SEGREGATION,1
ABBUD_LIF_SIGNALING_2_UP,SET,13,0.013666,0.00036333,0.25312,0.47847,ABBUD_LIF_SIGNALING_2_UP,1
HP_ABNORMAL_CLAVICLE_MORPHOL...,SET,94,0.0046076,0.00032868,0.085549,0.47852,HP_ABNORMAL_CLAVICLE_MORPHOLOGY,1
GSE12003_MIR223_KO_VS_WT_BM_...4,SET,105,0.0044302,0.0003339,0.082262,0.47853,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_UP,1
SINGH_NFE2L2_TARGETS,SET,13,0.012885,0.00034258,0.2395,0.47855,SINGH_NFE2L2_TARGETS,1
GSE8621_LPS_PRIMED_UNSTIM_VS...2,SET,175,0.0033347,0.00032385,0.062045,0.47857,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...6,SET,8,0.019526,0.00040728,0.36333,0.47857,FAN_EMBRYONIC_CTX_BIG_GROUPS_INHIBITORY,1
GSE2770_IL12_AND_TGFB_ACT_VS...1,SET,167,0.003588,0.00034046,0.066793,0.47858,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_DN,1
SIX1_TARGET_GENES,SET,292,0.0027137,0.00033932,0.050547,0.47859,SIX1_TARGET_GENES,1
HP_DEVELOPMENTAL_STAGNATION,SET,16,0.012236,0.00036087,0.22785,0.47859,HP_DEVELOPMENTAL_STAGNATION,1
GOMF_MICROTUBULE_MOTOR_ACTIV...,SET,68,0.0052998,0.00032177,0.098924,0.47864,GOMF_MICROTUBULE_MOTOR_ACTIVITY,1
GOBP_SKELETAL_MUSCLE_ORGAN_D...,SET,169,0.0035974,0.00034337,0.067378,0.47871,GOBP_SKELETAL_MUSCLE_ORGAN_DEVELOPMENT,1
SMIRNOV_RESPONSE_TO_IR_6HR_DN,SET,104,0.0044986,0.00033744,0.084297,0.47872,SMIRNOV_RESPONSE_TO_IR_6HR_DN,1
CACGTG_MYC_Q2,SET,933,0.0015123,0.00033197,0.028412,0.47878,CACGTG_MYC_Q2,1
GSE25088_CTRL_VS_ROSIGLITAZO...2,SET,183,0.00334,0.00033162,0.062839,0.47881,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP,1
REACTOME_DEGRADATION_OF_CYST...,SET,14,0.012572,0.00034684,0.2367,0.47882,REACTOME_DEGRADATION_OF_CYSTEINE_AND_HOMOCYSTEINE,1
GOBP_NAIL_DEVELOPMENT,SET,11,0.015025,0.00036746,0.28285,0.47882,GOBP_NAIL_DEVELOPMENT,1
HP_ABNORMALITY_OF_HUMORAL_IM...,SET,280,0.0026954,0.00033015,0.05098,0.47892,HP_ABNORMALITY_OF_HUMORAL_IMMUNITY,1
REACTOME_TFAP2A_ACTS_AS_A_TR...,SET,5,0.021659,0.0003572,0.41001,0.47894,REACTOME_TFAP2A_ACTS_AS_A_TRANSCRIPTIONAL_REPRESSOR_DURING_RETINOIC_ACID_INDUCED_CELL_DIFFERENTIATION,1
GSE10325_LUPUS_CD4_TCELL_VS_...1,SET,166,0.0036959,0.00034965,0.070109,0.47898,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_DN,1
XU_GH1_EXOGENOUS_TARGETS_DN,SET,90,0.004618,0.00032237,0.087694,0.479,XU_GH1_EXOGENOUS_TARGETS_DN,1
GOBP_PURINE_NUCLEOSIDE_BIOSY...,SET,9,0.016004,0.00035407,0.30434,0.47903,GOBP_PURINE_NUCLEOSIDE_BIOSYNTHETIC_PROCESS,1
HP_CONICAL_INCISOR,SET,34,0.0079887,0.00034328,0.15193,0.47903,HP_CONICAL_INCISOR,1
HP_PECTORAL_MUSCLE_HYPOPLASI...,SET,7,0.017537,0.00034219,0.3335,0.47903,HP_PECTORAL_MUSCLE_HYPOPLASIA_APLASIA,1
BEIER_GLIOMA_STEM_CELL_UP,SET,35,0.0081726,0.0003563,0.15572,0.47907,BEIER_GLIOMA_STEM_CELL_UP,1
GOBP_CILIUM_MOVEMENT,SET,172,0.0032549,0.0003134,0.062086,0.47909,GOBP_CILIUM_MOVEMENT,1
GSE25087_TREG_VS_TCONV_ADULT...1,SET,164,0.0034424,0.00032372,0.065806,0.47914,GSE25087_TREG_VS_TCONV_ADULT_DN,1
HP_BULL_S_EYE_MACULOPATHY,SET,9,0.014906,0.00032978,0.28502,0.47915,HP_BULL_S_EYE_MACULOPATHY,1
HP_MACULE,SET,209,0.0028914,0.00030658,0.055305,0.47915,HP_MACULE,1
MAHADEVAN_GIST_MORPHOLOGICAL...,SET,14,0.012834,0.00035409,0.24602,0.4792,MAHADEVAN_GIST_MORPHOLOGICAL_SWITCH,1
HP_SUBEPENDYMAL_CYSTS,SET,8,0.014516,0.00030278,0.27881,0.47924,HP_SUBEPENDYMAL_CYSTS,1
KEGG_MEDICUS_PATHOGEN_ESCHER...4,SET,5,0.021707,0.00035798,0.41707,0.47925,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPJ_TO_IGG_FCGR_RAC_SIGNALING_PATHWAY,1
GOBP_MAINTENANCE_OF_POSTSYNA...,SET,8,0.015329,0.00031975,0.2946,0.47925,GOBP_MAINTENANCE_OF_POSTSYNAPTIC_SPECIALIZATION_STRUCTURE,1
HP_PATELLAR_DISLOCATION,SET,56,0.0062693,0.00034553,0.12062,0.47927,HP_PATELLAR_DISLOCATION,1
HP_ADRENAL_HYPOPLASIA,SET,28,0.0082691,0.00032251,0.15913,0.47928,HP_ADRENAL_HYPOPLASIA,1
REACTOME_NOTCH4_INTRACELLULA...,SET,19,0.0095915,0.00030823,0.18475,0.4793,REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
EIF4E_DN,SET,90,0.0046537,0.00032486,0.089706,0.47931,EIF4E_DN,1
KRISHNAN_FURIN_TARGETS_UP,SET,8,0.016102,0.00033587,0.31074,0.47934,KRISHNAN_FURIN_TARGETS_UP,1
GSE18281_SUBCAPSULAR_CORTICA...3,SET,172,0.0033633,0.00032384,0.064977,0.47936,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...597,SET,97,0.0044543,0.00032275,0.086301,0.47942,GOBP_NEGATIVE_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,1
GSE2405_HEAT_KILLED_LYSATE_V...1,SET,182,0.003207,0.00031755,0.062141,0.47942,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_DN,1
GSE15930_STIM_VS_STIM_AND_TR...5,SET,181,0.0032448,0.00032042,0.063487,0.47962,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_72H_CD8_T_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...399,SET,214,0.0029088,0.00031205,0.056942,0.47963,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,1
GOBP_TISSUE_REGENERATION,SET,69,0.0054451,0.00033301,0.10659,0.47963,GOBP_TISSUE_REGENERATION,1
HP_JOINT_CONTRACTURE_OF_THE_...3,SET,237,0.0028483,0.00032135,0.055777,0.47964,HP_JOINT_CONTRACTURE_OF_THE_HAND,1
GOBP_REGULATION_OF_ESTABLISH...2,SET,489,0.0019545,0.00031455,0.038316,0.47966,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
GOBP_GLUCOSYLCERAMIDE_METABO...,SET,7,0.017034,0.00033238,0.33449,0.47969,GOBP_GLUCOSYLCERAMIDE_METABOLIC_PROCESS,1
GSE41176_WT_VS_TAK1_KO_ANTI_...2,SET,183,0.0031507,0.00031283,0.061885,0.4797,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_UP,1
GSE6259_DEC205_POS_DC_VS_CD8...1,SET,140,0.0035363,0.00030747,0.069776,0.47979,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN,1
HP_DIABETES_INSIPIDUS,SET,53,0.0060637,0.00032516,0.12007,0.47986,HP_DIABETES_INSIPIDUS,1
GOBP_R_LOOP_PROCESSING,SET,8,0.01244,0.00025949,0.24662,0.47988,GOBP_R_LOOP_PROCESSING,1
HP_DEEP_SET_NAILS,SET,6,0.015901,0.00028725,0.31541,0.4799,HP_DEEP_SET_NAILS,1
PETRETTO_HEART_MASS_QTL_CIS_...1,SET,24,0.0083053,0.00029993,0.1655,0.47999,PETRETTO_HEART_MASS_QTL_CIS_DN,1
ZHANG_RESPONSE_TO_CANTHARIDI...2,SET,14,0.011852,0.00032699,0.23621,0.47999,ZHANG_RESPONSE_TO_CANTHARIDIN_UP,1
GOBP_NEGATIVE_REGULATION_OF_...554,SET,23,0.007974,0.00028191,0.15896,0.48,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,1
GSE34205_HEALTHY_VS_FLU_INF_...1,SET,175,0.0032964,0.00032013,0.065797,0.48002,GSE34205_HEALTHY_VS_FLU_INF_INFANT_PBMC_DN,1
MIR7159_3P,SET,199,0.0030063,0.00031112,0.060048,0.48004,MIR7159_3P,1
HP_GLUCOCORTOCOID_INSENSITIV...,SET,5,0.020563,0.00033911,0.41107,0.48005,HP_GLUCOCORTOCOID_INSENSITIVE_PRIMARY_HYPERALDOSTERONISM,1
GOBP_POSITIVE_REGULATION_OF_...632,SET,7,0.016425,0.00032049,0.32866,0.48007,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,1
REACTOME_UBIQUINOL_BIOSYNTHE...,SET,10,0.011814,0.0002755,0.23655,0.48008,REACTOME_UBIQUINOL_BIOSYNTHESIS,1
GOBP_CARDIAC_CELL_DEVELOPMENT,SET,82,0.0047829,0.00031876,0.095809,0.48009,GOBP_CARDIAC_CELL_DEVELOPMENT,1
GSE19198_CTRL_VS_IL21_TREATE...5,SET,176,0.0031689,0.00030862,0.063663,0.48015,GSE19198_CTRL_VS_IL21_TREATED_TCELL_6H_DN,1
GOBP_PROTEIN_K29_LINKED_DEUB...,SET,4,0.020027,0.00029542,0.40252,0.48016,GOBP_PROTEIN_K29_LINKED_DEUBIQUITINATION,1
GOBP_RESPONSE_TO_ELECTRICAL_...,SET,41,0.0067469,0.00031831,0.13564,0.48016,GOBP_RESPONSE_TO_ELECTRICAL_STIMULUS,1
WP_GLYOXYLATE_METABOLISM,SET,11,0.012993,0.00031777,0.26135,0.48017,WP_GLYOXYLATE_METABOLISM,1
GOBP_VACUOLAR_PROTON_TRANSPO...,SET,5,0.017078,0.00028165,0.34345,0.48017,GOBP_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX_ASSEMBLY,1
REACTOME_EXPORT_OF_VIRAL_RIB...,SET,31,0.0071833,0.00029476,0.14454,0.48018,REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS,1
KEGG_OLFACTORY_TRANSDUCTION,SET,320,0.0032378,0.00042349,0.065184,0.48019,KEGG_OLFACTORY_TRANSDUCTION,1
DROSHA_TARGET_GENES,SET,36,0.006767,0.0002992,0.13623,0.48019,DROSHA_TARGET_GENES,1
HP_ABNORMALITY_OF_CORNEAL_SI...,SET,145,0.0035331,0.00031258,0.071323,0.48025,HP_ABNORMALITY_OF_CORNEAL_SIZE,1
CUI_DEVELOPING_HEART_VALVAR_...,SET,126,0.0040944,0.00033785,0.083212,0.48038,CUI_DEVELOPING_HEART_VALVAR_ENDOTHELIAL_CELL,1
EGR1_01,SET,242,0.0026441,0.0003014,0.053849,0.48042,EGR1_01,1
WP_KLEEFSTRA_SYNDROME,SET,26,0.0084425,0.00031732,0.17216,0.48044,WP_KLEEFSTRA_SYNDROME,1
HP_THIN_CLAVICLES,SET,6,0.017977,0.00032477,0.3665,0.48044,HP_THIN_CLAVICLES,1
RANKIN_ANGIOGENIC_TARGETS_OF...1,SET,8,0.017345,0.0003618,0.35372,0.48045,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_DN,1
GSE2770_TGFB_AND_IL4_VS_IL4_...4,SET,177,0.00304,0.00029689,0.062058,0.48047,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GOBP_CELLULAR_RESPONSE_TO_RE...2,SET,136,0.0036444,0.00031234,0.074528,0.4805,GOBP_CELLULAR_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
GOBP_NEGATIVE_REGULATION_OF_...218,SET,8,0.013846,0.00028882,0.28421,0.48057,GOBP_NEGATIVE_REGULATION_OF_ERYTHROCYTE_DIFFERENTIATION,1
KEGG_MEDICUS_VARIANT_LOSS_OF...2,SET,5,0.018383,0.00030316,0.37759,0.48059,KEGG_MEDICUS_VARIANT_LOSS_OF_NKX3_1_TO_PI3K_SIGNALING_PATHWAY,1
GSE360_L_MAJOR_VS_M_TUBERCUL...4,SET,172,0.0032386,0.00031183,0.066527,0.48059,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_UP,1
GOBP_PROTEIN_TARGETING_TO_LY...,SET,29,0.0071184,0.00028254,0.14667,0.48065,GOBP_PROTEIN_TARGETING_TO_LYSOSOME,1
GOBP_DETECTION_OF_MECHANICAL...2,SET,33,0.0076079,0.00032209,0.15707,0.48068,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,1
GOBP_NEGATIVE_REGULATION_OF_...110,SET,59,0.004943,0.00027961,0.10204,0.48068,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
GOCC_OMEGASOME,SET,4,0.015778,0.00023274,0.32594,0.4807,GOCC_OMEGASOME,1
GOMF_FERRIC_IRON_BINDING,SET,8,0.01582,0.00032998,0.32771,0.48075,GOMF_FERRIC_IRON_BINDING,1
HP_LISSENCEPHALY,SET,166,0.0031244,0.00029559,0.06477,0.48076,HP_LISSENCEPHALY,1
DURCHDEWALD_SKIN_CARCINOGENE...2,SET,74,0.0048024,0.00030412,0.09964,0.48078,DURCHDEWALD_SKIN_CARCINOGENESIS_UP,1
REACTOME_PHASE_II_CONJUGATIO...,SET,99,0.0047239,0.00034577,0.098097,0.4808,REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS,1
GSE22443_NAIVE_VS_ACT_AND_IL...1,SET,185,0.0029525,0.00029473,0.061421,0.48083,GSE22443_NAIVE_VS_ACT_AND_IL12_TREATED_CD8_TCELL_DN,1
GOBP_ORGANELLE_ASSEMBLY,SET,914,0.0013263,0.00028831,0.02761,0.48084,GOBP_ORGANELLE_ASSEMBLY,1
CHEN_LVAD_SUPPORT_OF_FAILING...1,SET,42,0.006767,0.00032312,0.14106,0.48087,CHEN_LVAD_SUPPORT_OF_FAILING_HEART_DN,1
PID_CD8_TCR_DOWNSTREAM_PATHW...,SET,61,0.0056303,0.00032383,0.11753,0.4809,PID_CD8_TCR_DOWNSTREAM_PATHWAY,1
GSE32901_NAIVE_VS_TH1_CD4_TC...2,SET,113,0.0039009,0.00030493,0.081443,0.4809,GSE32901_NAIVE_VS_TH1_CD4_TCELL_UP,1
PETRETTO_BLOOD_PRESSURE_DN,SET,7,0.016199,0.00031607,0.33855,0.48092,PETRETTO_BLOOD_PRESSURE_DN,1
GSE12845_NAIVE_VS_PRE_GC_TON...1,SET,175,0.0028946,0.0002811,0.060483,0.48092,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_DN,1
GRAESSMANN_APOPTOSIS_BY_DOXO...2,SET,1057,0.0012669,0.00029497,0.0267,0.48108,GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP,1
GSE26351_WNT_VS_BMP_PATHWAY_...2,SET,182,0.0029553,0.00029263,0.062369,0.4811,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...13,SET,21,0.0090488,0.0003057,0.19114,0.48112,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_CENTROMERIC_REGION,1
CAHOY_ASTROCYTIC,SET,94,0.0042972,0.00030653,0.090932,0.48115,CAHOY_ASTROCYTIC,1
chr5p15,SET,52,0.009491,0.00050412,0.20088,0.48116,chr5p15,1
GAVISH_3CA_MALIGNANT_METAPRO...24,SET,44,0.0060762,0.00029695,0.12862,0.48116,GAVISH_3CA_MALIGNANT_METAPROGRAM_32_SKIN_PIGMENTATION,1
HP_PAINLESS_FRACTURES_DUE_TO...,SET,7,0.013657,0.00026647,0.28931,0.48118,HP_PAINLESS_FRACTURES_DUE_TO_INJURY,1
SFMBT1_TARGET_GENES,SET,1310,0.001141,0.00029357,0.024201,0.4812,SFMBT1_TARGET_GENES,1
GOBP_MESENCHYMAL_CELL_PROLIF...1,SET,42,0.0070728,0.00033772,0.15038,0.48124,GOBP_MESENCHYMAL_CELL_PROLIFERATION,1
GOBP_SCARNA_LOCALIZATION_TO_...,SET,4,0.015387,0.00022698,0.32713,0.48124,GOBP_SCARNA_LOCALIZATION_TO_CAJAL_BODY,1
REACTOME_GOLGI_ASSOCIATED_VE...,SET,50,0.0054056,0.00028156,0.11504,0.48126,REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS,1
GOBP_FLAVONOID_GLUCURONIDATI...,SET,5,0.040164,0.00066238,0.85579,0.48128,GOBP_FLAVONOID_GLUCURONIDATION,1
GSE20727_DNFB_ALLERGEN_VS_RO...1,SET,188,0.0028641,0.00028818,0.061261,0.48136,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
KOHN_EMT_EPITHELIAL,SET,22,0.0089252,0.00030861,0.19107,0.48137,KOHN_EMT_EPITHELIAL,1
GSE22886_CD4_TCELL_VS_BCELL_...2,SET,183,0.0028228,0.00028027,0.060492,0.48139,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_UP,1
MIR3679_3P,SET,145,0.0032439,0.00028699,0.069582,0.48141,MIR3679_3P,1
HP_APLASIA_HYPOPLASIA_INVOLV...1,SET,236,0.0025932,0.00029196,0.055796,0.48147,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_FEET,1
HP_PES_CAVUS,SET,252,0.002479,0.00028828,0.053407,0.48149,HP_PES_CAVUS,1
GOBP_CARDIAC_MUSCLE_CELL_ACT...2,SET,57,0.0058916,0.00032759,0.12712,0.48152,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_CONTRACTION,1
GSE43955_10H_VS_60H_ACT_CD4_...3,SET,184,0.0030117,0.00029983,0.065007,0.48152,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN,1
GOCC_NLS_DEPENDENT_PROTEIN_N...,SET,10,0.011054,0.00025777,0.23966,0.48161,GOCC_NLS_DEPENDENT_PROTEIN_NUCLEAR_IMPORT_COMPLEX,1
GOBP_SPERMATID_NUCLEUS_DIFFE...,SET,22,0.008149,0.00028177,0.17686,0.48163,GOBP_SPERMATID_NUCLEUS_DIFFERENTIATION,1
OCT1_04,SET,201,0.002942,0.00030598,0.06389,0.48164,OCT1_04,1
GSE17721_0.5H_VS_12H_LPS_BMD...2,SET,174,0.0027981,0.00027097,0.060888,0.48167,GSE17721_0.5H_VS_12H_LPS_BMDC_UP,1
HP_WHITE_LESION_OF_THE_ORAL_...,SET,26,0.0080655,0.00030314,0.17564,0.48169,HP_WHITE_LESION_OF_THE_ORAL_MUCOSA,1
GSE37416_0H_VS_3H_F_TULARENS...1,SET,182,0.0028113,0.00027836,0.06133,0.48172,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOMF_ADP_TRANSMEMBRANE_TRANS...,SET,9,0.013803,0.00030538,0.30189,0.48177,GOMF_ADP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_JUVENILE_ONSET,SET,598,0.001574,0.00027925,0.034497,0.4818,HP_JUVENILE_ONSET,1
HP_DECREASED_CIRCULATING_TER...,SET,6,0.015508,0.00028016,0.34056,0.48184,HP_DECREASED_CIRCULATING_TERMINAL_COMPLEMENT_COMPONENT_CONCENTRATION,1
HP_DIGESTIVE_SYSTEM_NEOPLASM,SET,343,0.0021003,0.00028423,0.046113,0.48184,HP_DIGESTIVE_SYSTEM_NEOPLASM,1
GSE13887_RESTING_VS_NO_TREAT...1,SET,93,0.0040803,0.00028952,0.089725,0.48186,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_DN,1
WP_WHITE_FAT_CELL_DIFFERENTI...,SET,31,0.0075862,0.0003113,0.16691,0.48187,WP_WHITE_FAT_CELL_DIFFERENTIATION,1
GSE33162_HDAC3_KO_VS_HDAC3_K...1,SET,184,0.0028983,0.00028854,0.063839,0.48189,GSE33162_HDAC3_KO_VS_HDAC3_KO_4H_LPS_STIM_MACROPHAGE_DN,1
KEGG_PENTOSE_AND_GLUCURONATE...,SET,26,0.0098599,0.00037059,0.2174,0.48191,KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS,1
HP_DECREASED_CIRCULATING_TOT...1,SET,7,0.016142,0.00031497,0.35583,0.48191,HP_DECREASED_CIRCULATING_TOTAL_IGA,1
HOWARD_DENDRITIC_CELL_INACT_...3,SET,9,0.014395,0.00031846,0.31761,0.48193,HOWARD_DENDRITIC_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,1
FULLER_PBMC_F_TULARENSIS_VAC...5,SET,54,0.0055742,0.0003017,0.12321,0.48196,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_UP,1
HP_ABNORMAL_OSSIFICATION_INV...,SET,23,0.0077418,0.0002737,0.17139,0.48199,HP_ABNORMAL_OSSIFICATION_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,1
GARCIA_PINERES_PBMC_HPV_16_L...6,SET,20,0.0091503,0.00030168,0.20285,0.48201,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_7MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
HP_REDUCED_NATURAL_KILLER_CE...2,SET,24,0.0076697,0.00027697,0.1703,0.48204,HP_REDUCED_NATURAL_KILLER_CELL_COUNT,1
KEGG_MEDICUS_PATHOGEN_SALMON...8,SET,19,0.0079623,0.00025588,0.17705,0.48206,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_MUSCLE_INAC...,SET,9,0.013973,0.00030913,0.31076,0.48207,GOBP_RESPONSE_TO_MUSCLE_INACTIVITY,1
SANSOM_APC_TARGETS_REQUIRE_M...,SET,210,0.0024439,0.00025974,0.054578,0.48214,SANSOM_APC_TARGETS_REQUIRE_MYC,1
GOBP_REGULATION_OF_CARDIAC_M...3,SET,7,0.012165,0.00023736,0.2717,0.48214,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_INVOLVED_IN_REGULATION_OF_CONTRACTION,1
GOMF_TRANSLATION_INITIATION_...1,SET,43,0.0053783,0.00025984,0.12013,0.48214,GOMF_TRANSLATION_INITIATION_FACTOR_ACTIVITY,1
HP_SHORT_NOSE,SET,276,0.0022488,0.0002735,0.050261,0.48216,HP_SHORT_NOSE,1
GSE3982_CENT_MEMORY_CD4_TCEL...5,SET,184,0.0026155,0.00026039,0.0585,0.48217,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH2_DN,1
DESCARTES_FETAL_MUSCLE_SKELE...,SET,181,0.0028521,0.00028164,0.064054,0.48224,DESCARTES_FETAL_MUSCLE_SKELETAL_MUSCLE_CELLS,1
GOBP_RNA_EXPORT_FROM_NUCLEUS,SET,80,0.0038454,0.00025315,0.086743,0.48232,GOBP_RNA_EXPORT_FROM_NUCLEUS,1
REACTOME_DISSOLUTION_OF_FIBR...,SET,13,0.011331,0.00030124,0.25578,0.48233,REACTOME_DISSOLUTION_OF_FIBRIN_CLOT,1
GOBP_UTP_BIOSYNTHETIC_PROCESS,SET,9,0.012848,0.00028424,0.29024,0.48235,GOBP_UTP_BIOSYNTHETIC_PROCESS,1
GSE38681_WT_VS_LYL1_KO_LYMPH...1,SET,191,0.0027524,0.00027912,0.06238,0.4824,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,1
MIR3198,SET,43,0.0054866,0.00026507,0.12479,0.48247,MIR3198,1
MIR6766_5P,SET,225,0.0025163,0.00027671,0.057249,0.48247,MIR6766_5P,1
MIR593_5P,SET,146,0.0030608,0.00027172,0.069829,0.48252,MIR593_5P,1
REACTOME_WNT_LIGAND_BIOGENES...,SET,24,0.0081044,0.00029267,0.18497,0.48253,REACTOME_WNT_LIGAND_BIOGENESIS_AND_TRAFFICKING,1
GOMF_MANGANESE_ION_TRANSMEMB...,SET,9,0.011521,0.00025488,0.26348,0.48256,GOMF_MANGANESE_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE37532_WT_VS_PPARG_KO_LN_T...3,SET,107,0.0037036,0.00028177,0.084792,0.48258,GSE37532_WT_VS_PPARG_KO_LN_TREG_DN,1
VANHARANTA_UTERINE_FIBROID_W...1,SET,35,0.0065436,0.00028528,0.14999,0.4826,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_DN,1
BOYLAN_MULTIPLE_MYELOMA_PCA1...1,SET,8,0.013754,0.0002869,0.3159,0.48264,BOYLAN_MULTIPLE_MYELOMA_PCA1_DN,1
GOBP_POSITIVE_REGULATION_OF_...272,SET,9,0.012104,0.00026778,0.27832,0.48266,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,1
GOBP_REGULATION_OF_EXTRACELL...2,SET,9,0.014241,0.00031506,0.32767,0.48267,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,1
GOMF_LIGASE_ACTIVITY_FORMING...4,SET,38,0.0056162,0.00025511,0.12951,0.48271,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_SULFUR_BONDS,1
GSE46606_DAY1_VS_DAY3_CD40L_...8,SET,184,0.0026876,0.00026757,0.062074,0.48273,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4_KO_BCELL_UP,1
HP_DYSDIADOCHOKINESIS,SET,49,0.0048047,0.00024776,0.11103,0.48274,HP_DYSDIADOCHOKINESIS,1
HP_ABNORMAL_PARIETAL_BONE_MO...,SET,28,0.0063982,0.00024954,0.14805,0.48276,HP_ABNORMAL_PARIETAL_BONE_MORPHOLOGY,1
WP_PTF1A_RELATED_REGULATORY_...,SET,11,0.012223,0.00029893,0.2832,0.48279,WP_PTF1A_RELATED_REGULATORY_PATHWAY,1
CUI_TCF21_TARGETS_2_UP,SET,390,0.0018842,0.00027155,0.043751,0.48282,CUI_TCF21_TARGETS_2_UP,1
HP_RHINITIS,SET,97,0.0035649,0.0002583,0.083015,0.48287,HP_RHINITIS,1
GOBP_RESPONSE_TO_SALT,SET,22,0.0080976,0.00027999,0.18931,0.48294,GOBP_RESPONSE_TO_SALT,1
MIR4762_3P,SET,242,0.0023862,0.000272,0.055854,0.48296,MIR4762_3P,1
GSE21063_CTRL_VS_ANTI_IGM_ST...7,SET,175,0.0026204,0.00025448,0.061347,0.48296,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_16H_DN,1
HE_LIM_SUN_FETAL_LUNG_C4_CD1...,SET,16,0.010752,0.00031709,0.2517,0.48296,HE_LIM_SUN_FETAL_LUNG_C4_CD16_POS_NK_CELL,1
GSE41978_WT_VS_ID2_KO_KLRG1_...2,SET,187,0.0026731,0.00026826,0.062912,0.48305,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
GOMF_NEUROTROPHIN_RECEPTOR_A...,SET,5,0.017657,0.0002912,0.41599,0.48307,GOMF_NEUROTROPHIN_RECEPTOR_ACTIVITY,1
GSE17186_MEMORY_VS_CD21LOW_T...1,SET,179,0.0025939,0.00025474,0.061412,0.48315,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_DN,1
GOBP_SINOATRIAL_NODE_CELL_DE...,SET,5,0.018314,0.00030202,0.43371,0.48316,GOBP_SINOATRIAL_NODE_CELL_DEVELOPMENT,1
GLI4_TARGET_GENES,SET,664,0.001388,0.00025901,0.032919,0.48318,GLI4_TARGET_GENES,1
MIR1246,SET,47,0.0051794,0.00026158,0.12304,0.48321,MIR1246,1
ZNF708_TARGET_GENES,SET,72,0.00402,0.00025112,0.095623,0.48323,ZNF708_TARGET_GENES,1
HP_SEVERELY_REDUCED_VISUAL_A...,SET,39,0.0057889,0.00026638,0.13777,0.48324,HP_SEVERELY_REDUCED_VISUAL_ACUITY,1
MODULE_342,SET,194,0.0026736,0.00027323,0.0639,0.48331,MODULE_342,1
HP_APLASIA_HYPOPLASIA_OF_THE...41,SET,51,0.0050236,0.00026426,0.12037,0.48335,HP_APLASIA_HYPOPLASIA_OF_THE_MIDDLE_PHALANGES_OF_THE_HAND,1
MIR516B_5P,SET,114,0.003124,0.00024527,0.074872,0.48336,MIR516B_5P,1
HP_GASTROINTESTINAL_OBSTRUCT...,SET,85,0.0040417,0.00027422,0.096849,0.48336,HP_GASTROINTESTINAL_OBSTRUCTION,1
GOBP_ENDOCARDIAL_CUSHION_DEV...,SET,52,0.0055765,0.0002962,0.13409,0.48341,GOBP_ENDOCARDIAL_CUSHION_DEVELOPMENT,1
AMIT_SERUM_RESPONSE_60_MCF10A,SET,54,0.0054443,0.00029467,0.13096,0.48342,AMIT_SERUM_RESPONSE_60_MCF10A,1
chr17q21,SET,271,0.0048871,0.00058904,0.11773,0.48344,chr17q21,1
HP_PREAXIAL_HAND_POLYDACTYLY,SET,53,0.0044159,0.00023679,0.10635,0.48344,HP_PREAXIAL_HAND_POLYDACTYLY,1
LHX4_TARGET_GENES,SET,5,0.013935,0.00022981,0.33572,0.48345,LHX4_TARGET_GENES,1
GSE5099_MONOCYTE_VS_CLASSICA...2,SET,174,0.0025271,0.00024472,0.061392,0.48358,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_UP,1
GOBP_ENDOCARDIAL_CELL_DIFFER...,SET,6,0.016176,0.00029222,0.39352,0.48361,GOBP_ENDOCARDIAL_CELL_DIFFERENTIATION,1
GOBP_STEM_CELL_PROLIFERATION,SET,107,0.003417,0.00025996,0.083233,0.48363,GOBP_STEM_CELL_PROLIFERATION,1
GOBP_DIGESTIVE_TRACT_MORPHOG...,SET,48,0.0053627,0.0002737,0.13083,0.48365,GOBP_DIGESTIVE_TRACT_MORPHOGENESIS,1
MIR216A_3P,SET,409,0.0017664,0.00026056,0.043133,0.48367,MIR216A_3P,1
GOMF_PROTEIN_KINASE_A_BINDING,SET,49,0.0048156,0.00024832,0.11793,0.48371,GOMF_PROTEIN_KINASE_A_BINDING,1
GOMF_SODIUM_ION_BINDING,SET,8,0.011801,0.00024616,0.28923,0.48373,GOMF_SODIUM_ION_BINDING,1
MIR3059_3P,SET,47,0.0045899,0.00023181,0.1127,0.48376,MIR3059_3P,1
PKCA_DN.V1_UP,SET,143,0.0028692,0.0002521,0.070523,0.48377,PKCA_DN.V1_UP,1
GOCC_AP_2_ADAPTOR_COMPLEX,SET,11,0.010768,0.00026336,0.26521,0.48381,GOCC_AP_2_ADAPTOR_COMPLEX,1
HP_SICK_SINUS_SYNDROME,SET,27,0.0069557,0.0002664,0.17209,0.48388,HP_SICK_SINUS_SYNDROME,1
GOBP_POSITIVE_REGULATION_OF_...834,SET,156,0.0028815,0.00026434,0.071399,0.4839,GOBP_POSITIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,1
KEGG_MEDICUS_PATHOGEN_ARSENI...,SET,6,0.011557,0.00020878,0.28647,0.48391,KEGG_MEDICUS_PATHOGEN_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_II,1
HP_PROGRESSIVE_PTOSIS,SET,4,0.014595,0.00021528,0.36244,0.48394,HP_PROGRESSIVE_PTOSIS,1
MENON_FETAL_KIDNEY_7_LOOPOF_...,SET,210,0.0022452,0.00023863,0.056153,0.48405,MENON_FETAL_KIDNEY_7_LOOPOF_HENLE_CELLS_DISTAL,1
WP_NONHOMOLOGOUS_END_JOINING,SET,10,0.0089179,0.00020796,0.2237,0.4841,WP_NONHOMOLOGOUS_END_JOINING,1
KYNG_ENVIRONMENTAL_STRESS_RE...7,SET,12,0.0099193,0.00025338,0.24903,0.48411,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_WS,1
REACTOME_POTASSIUM_CHANNELS,SET,102,0.0037201,0.00027636,0.093561,0.48414,REACTOME_POTASSIUM_CHANNELS,1
GOCC_NUCLEOCYTOPLASMIC_TRANS...,SET,12,0.0087834,0.00022436,0.2213,0.48417,GOCC_NUCLEOCYTOPLASMIC_TRANSPORT_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...15,SET,10,0.010539,0.00024576,0.2658,0.48419,GOBP_POSITIVE_REGULATION_OF_ADIPOSE_TISSUE_DEVELOPMENT,1
GOMF_DEAMINASE_ACTIVITY,SET,29,0.0070469,0.0002797,0.17777,0.48419,GOMF_DEAMINASE_ACTIVITY,1
LIN_APC_TARGETS,SET,63,0.004196,0.00024524,0.10597,0.48421,LIN_APC_TARGETS,1
RODWELL_AGING_KIDNEY_NO_BLOO...1,SET,127,0.003116,0.00025812,0.078694,0.48421,RODWELL_AGING_KIDNEY_NO_BLOOD_DN,1
HP_REDUCED_SPERM_MOTILITY,SET,58,0.004199,0.00023551,0.10604,0.48421,HP_REDUCED_SPERM_MOTILITY,1
GOBP_REGULATION_OF_HISTAMINE...,SET,6,0.01376,0.00024858,0.34831,0.48424,GOBP_REGULATION_OF_HISTAMINE_SECRETION_BY_MAST_CELL,1
HP_ANOREXIA,SET,107,0.0033998,0.00025865,0.086038,0.48424,HP_ANOREXIA,1
HP_RETINAL_PERFORATION,SET,10,0.010822,0.00025237,0.27387,0.48424,HP_RETINAL_PERFORATION,1
HP_FALCIFORM_RETINAL_FOLD,SET,5,0.015502,0.00025565,0.3926,0.48425,HP_FALCIFORM_RETINAL_FOLD,1
HP_ABNORMALITY_OF_EXOCRINE_P...,SET,66,0.0042207,0.00025247,0.10739,0.48433,HP_ABNORMALITY_OF_EXOCRINE_PANCREAS_PHYSIOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...649,SET,118,0.0029793,0.00023795,0.075954,0.48436,GOBP_NEGATIVE_REGULATION_OF_TRANSLATION,1
SIRNA_EIF4GI_UP,SET,84,0.0034177,0.00023053,0.087208,0.48437,SIRNA_EIF4GI_UP,1
GSE22886_NAIVE_CD4_TCELL_VS_...18,SET,181,0.0024016,0.00023716,0.061298,0.48437,GSE22886_NAIVE_CD4_TCELL_VS_NKCELL_UP,1
KIM_ALL_DISORDERS_CALB1_CORR...2,SET,497,0.0014836,0.00024064,0.037892,0.48438,KIM_ALL_DISORDERS_CALB1_CORR_UP,1
HP_ADENOCARCINOMA_OF_THE_COL...,SET,30,0.0054268,0.00021907,0.13883,0.48441,HP_ADENOCARCINOMA_OF_THE_COLON,1
BIOCARTA_TEL_PATHWAY,SET,17,0.0082155,0.00024974,0.21083,0.48446,BIOCARTA_TEL_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...419,SET,27,0.0067773,0.00025957,0.17445,0.48451,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,1
GOBP_REGULATION_OF_RELAXATIO...1,SET,6,0.013909,0.00025127,0.35832,0.48452,GOBP_REGULATION_OF_RELAXATION_OF_CARDIAC_MUSCLE,1
ZHAN_MULTIPLE_MYELOMA_LB_DN,SET,35,0.0055314,0.00024115,0.1428,0.48455,ZHAN_MULTIPLE_MYELOMA_LB_DN,1
MIR626,SET,51,0.0047813,0.00025152,0.1236,0.48457,MIR626,1
HP_ABNORMAL_LUNG_MORPHOLOGY,SET,1069,0.0010365,0.00024259,0.026799,0.48458,HP_ABNORMAL_LUNG_MORPHOLOGY,1
MIR6800_5P,SET,42,0.004785,0.00022848,0.12395,0.4846,MIR6800_5P,1
HP_LIMITED_HIP_EXTENSION,SET,5,0.01582,0.0002609,0.40984,0.4846,HP_LIMITED_HIP_EXTENSION,1
BOYAULT_LIVER_CANCER_SUBCLAS...4,SET,38,0.0051496,0.00023391,0.13374,0.48464,BOYAULT_LIVER_CANCER_SUBCLASS_G12_UP,1
WP_CYTOKINES_AND_INFLAMMATOR...,SET,25,0.0069823,0.00025734,0.18236,0.48473,WP_CYTOKINES_AND_INFLAMMATORY_RESPONSE,1
WP_CELLTYPE_DEPENDENT_SELECT...,SET,13,0.01003,0.00026667,0.2636,0.48482,WP_CELLTYPE_DEPENDENT_SELECTIVITY_OF_CCK2R_SIGNALING,1
REACTOME_MITOTIC_METAPHASE_A...,SET,217,0.0020647,0.00022302,0.05428,0.48483,REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE,1
GOBP_OOCYTE_CONSTRUCTION,SET,8,0.0096243,0.00020075,0.25311,0.48483,GOBP_OOCYTE_CONSTRUCTION,1
GSE21670_UNTREATED_VS_TGFB_I...4,SET,180,0.0023415,0.00023059,0.061607,0.48484,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_TCR_P...,SET,19,0.0072313,0.00023238,0.19079,0.48488,KEGG_MEDICUS_REFERENCE_TCR_PLCG_ITPR_SIGNALING_PATHWAY,1
HP_PERIORBITAL_FULLNESS,SET,34,0.005095,0.00021894,0.13468,0.48491,HP_PERIORBITAL_FULLNESS,1
REACTOME_CLASS_B_2_SECRETIN_...,SET,90,0.0036559,0.00025521,0.09677,0.48493,REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS,1
CAGGGTC_MIR504,SET,69,0.0038748,0.00023697,0.10252,0.48493,CAGGGTC_MIR504,1
HP_IRIS_COLOBOMA,SET,150,0.0025691,0.00023115,0.06798,0.48493,HP_IRIS_COLOBOMA,1
GOBP_MESODERM_DEVELOPMENT,SET,117,0.0030562,0.00024307,0.08098,0.48495,GOBP_MESODERM_DEVELOPMENT,1
HP_ABNORMAL_SHOULDER_MORPHOL...,SET,79,0.0037351,0.00024436,0.09897,0.48495,HP_ABNORMAL_SHOULDER_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_LHCGR...,SET,16,0.0082741,0.00024402,0.21961,0.48497,KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY,1
DNMT1_TARGET_GENES,SET,173,0.0023713,0.00022898,0.063003,0.48499,DNMT1_TARGET_GENES,1
COWLING_MYCN_TARGETS,SET,38,0.0054086,0.00024568,0.14385,0.485,COWLING_MYCN_TARGETS,1
HP_ENLARGED_CISTERNA_MAGNA,SET,52,0.0040262,0.00021385,0.10762,0.48508,HP_ENLARGED_CISTERNA_MAGNA,1
HP_ABNORMAL_BOWMAN_CAPSULE_M...,SET,9,0.010767,0.00023821,0.2886,0.48512,HP_ABNORMAL_BOWMAN_CAPSULE_MORPHOLOGY,1
MIR6776_3P,SET,57,0.0042757,0.00023774,0.1149,0.48516,MIR6776_3P,1
NFAT_Q6,SET,217,0.0022338,0.00024128,0.060282,0.48522,NFAT_Q6,1
GOCC_EUKARYOTIC_48S_PREINITI...,SET,13,0.0078879,0.00020971,0.21369,0.48528,GOCC_EUKARYOTIC_48S_PREINITIATION_COMPLEX,1
HP_BONE_PAIN,SET,82,0.0035934,0.00023949,0.097555,0.48531,HP_BONE_PAIN,1
GSE17974_IL4_AND_ANTI_IL12_V...11,SET,164,0.0024606,0.0002314,0.06695,0.48534,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_48H_ACT_CD4_TCELL_DN,1
GOBP_REGULATION_OF_HEMOGLOBI...,SET,8,0.010703,0.00022325,0.29142,0.48535,GOBP_REGULATION_OF_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,1
GSE1432_6H_VS_24H_IFNG_MICRO...1,SET,179,0.0022101,0.00021704,0.060176,0.48535,GSE1432_6H_VS_24H_IFNG_MICROGLIA_DN,1
GOBP_NEGATIVE_REGULATION_OF_...226,SET,13,0.0095198,0.00025309,0.25936,0.48536,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ORGANIZATION,1
HP_SHORT_MIDDLE_PHALANX_OF_T...1,SET,7,0.011837,0.00023097,0.32277,0.48537,HP_SHORT_MIDDLE_PHALANX_OF_THE_2ND_FINGER,1
HP_CORNEAL_ULCERATION,SET,18,0.0071434,0.00022344,0.19516,0.4854,HP_CORNEAL_ULCERATION,1
LIU_TARGETS_OF_VMYB_VS_CMYB_...2,SET,15,0.0082929,0.00023682,0.22663,0.48541,LIU_TARGETS_OF_VMYB_VS_CMYB_UP,1
SCHAEFFER_PROSTATE_DEVELOPME...11,SET,5,0.014509,0.00023927,0.39654,0.48541,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3,1
GOBP_NEGATIVE_REGULATION_OF_...211,SET,63,0.0040587,0.00023722,0.11111,0.48543,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,1
HP_RECURRENT_VIRAL_INFECTIONS,SET,54,0.0042281,0.00022885,0.1158,0.48544,HP_RECURRENT_VIRAL_INFECTIONS,1
GOBP_REGULATION_OF_IMMUNOGLO...,SET,62,0.0036523,0.00021177,0.1001,0.48545,GOBP_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,1
CHIANG_LIVER_CANCER_SUBCLASS...10,SET,80,0.0036254,0.00023866,0.099449,0.48546,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_UP,1
KORKOLA_SEMINOMA_DN,SET,8,0.012907,0.00026922,0.35423,0.48547,KORKOLA_SEMINOMA_DN,1
MIR587,SET,338,0.0017421,0.00023407,0.047817,0.48547,MIR587,1
YANG_BCL3_TARGETS_UP,SET,308,0.0017694,0.00022713,0.048596,0.48548,YANG_BCL3_TARGETS_UP,1
GOBP_RETROGRADE_NEURONAL_DEN...,SET,4,0.015749,0.00023232,0.43319,0.4855,GOBP_RETROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,1
KRAS.300_UP.V1_UP,SET,127,0.0030318,0.00025115,0.083675,0.48555,KRAS.300_UP.V1_UP,1
GOCC_PLATELET_DENSE_GRANULE,SET,19,0.0069041,0.00022187,0.19118,0.4856,GOCC_PLATELET_DENSE_GRANULE,1
GSE30971_CTRL_VS_LPS_STIM_MA...3,SET,170,0.0021652,0.00020727,0.060027,0.48561,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_DN,1
HP_YELLOW_WHITE_LESIONS_OF_T...2,SET,56,0.0041988,0.00023142,0.11648,0.48562,HP_YELLOW_WHITE_LESIONS_OF_THE_RETINA,1
GOBP_NUCLEUS_LOCALIZATION,SET,31,0.0053418,0.0002192,0.14852,0.48565,GOBP_NUCLEUS_LOCALIZATION,1
GOBP_POSITIVE_REGULATION_OF_...45,SET,29,0.005769,0.00022898,0.16051,0.48566,GOBP_POSITIVE_REGULATION_OF_ATP_METABOLIC_PROCESS,1
GAUTAM_EYE_CORNEA_MONOCYTES,SET,218,0.0019662,0.00021286,0.054712,0.48567,GAUTAM_EYE_CORNEA_MONOCYTES,1
GOBP_PSEUDOURIDINE_SYNTHESIS,SET,17,0.0066241,0.00020137,0.18452,0.48568,GOBP_PSEUDOURIDINE_SYNTHESIS,1
GOBP_POSITIVE_REGULATION_OF_...377,SET,4,0.014908,0.00021991,0.41588,0.4857,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
GOMF_INOSITOL_PHOSPHATE_KINA...,SET,11,0.0078374,0.00019168,0.21868,0.48571,GOMF_INOSITOL_PHOSPHATE_KINASE_ACTIVITY,1
GOBP_REGULATION_OF_DENDRITE_...1,SET,90,0.0032861,0.00022939,0.091769,0.48572,GOBP_REGULATION_OF_DENDRITE_DEVELOPMENT,1
GSE10147_IL3_VS_IL3_AND_HIVP...2,SET,151,0.0023293,0.00021027,0.065343,0.48578,GSE10147_IL3_VS_IL3_AND_HIVP17_STIM_PDC_UP,1
IIZUKA_LIVER_CANCER_PROGRESS...2,SET,12,0.0090814,0.00023197,0.25567,0.48583,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_UP,1
GOBP_KERATINOCYTE_PROLIFERAT...,SET,56,0.0043377,0.00023907,0.12214,0.48584,GOBP_KERATINOCYTE_PROLIFERATION,1
GOBP_NLS_BEARING_PROTEIN_IMP...,SET,18,0.0070605,0.00022085,0.19889,0.48584,GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS,1
WP_HOMOLOGOUS_RECOMBINATION,SET,12,0.0075104,0.00019185,0.21183,0.48586,WP_HOMOLOGOUS_RECOMBINATION,1
HP_DESMOID_TUMORS,SET,6,0.012531,0.00022637,0.35407,0.48588,HP_DESMOID_TUMORS,1
GSE22886_NAIVE_VS_IGG_IGA_ME...2,SET,169,0.002287,0.0002183,0.064629,0.48589,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_UP,1
GSE34006_UNTREATED_VS_A2AR_A...1,SET,182,0.0022755,0.00022532,0.064344,0.48589,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_DN,1
GSE37532_VISCERAL_ADIPOSE_TI...7,SET,139,0.0024499,0.00021225,0.069305,0.4859,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN,1
REACTOME_CHROMOSOME_MAINTENA...,SET,83,0.0030856,0.00020689,0.087759,0.48598,REACTOME_CHROMOSOME_MAINTENANCE,1
WP_TCA_CYCLE_AND_DEFICIENCY_...,SET,15,0.0076591,0.00021872,0.21782,0.48598,WP_TCA_CYCLE_AND_DEFICIENCY_OF_PYRUVATE_DEHYDROGENASE_COMPLEX_PDHC,1
GSE26890_CXCR1_NEG_VS_POS_EF...1,SET,177,0.0021082,0.00020589,0.059979,0.48598,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_DN,1
HP_NOCTURNAL_HYPOVENTILATION,SET,15,0.006834,0.00019516,0.19456,0.48599,HP_NOCTURNAL_HYPOVENTILATION,1
GOZGIT_ESR1_TARGETS_UP,SET,130,0.0026627,0.00022315,0.075842,0.486,GOZGIT_ESR1_TARGETS_UP,1
REACTOME_METABOLISM_OF_PORPH...,SET,26,0.0057873,0.00021752,0.16505,0.48601,REACTOME_METABOLISM_OF_PORPHYRINS,1
GOMF_DEAD_H_BOX_RNA_HELICASE...,SET,8,0.011778,0.00024568,0.33788,0.4861,GOMF_DEAD_H_BOX_RNA_HELICASE_BINDING,1
TASOR_TARGET_GENES,SET,209,0.0020656,0.00021902,0.059312,0.48611,TASOR_TARGET_GENES,1
REACTOME_INTERACTIONS_OF_VPR...,SET,33,0.0047234,0.00019997,0.13577,0.48612,REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS,1
GSE23984_CTRL_VS_HYPOCALEMIC...1,SET,168,0.0022764,0.00021664,0.065539,0.48615,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN,1
GSE3982_DC_VS_MAC_LPS_STIM_DN,SET,173,0.0022955,0.00022166,0.066269,0.48618,GSE3982_DC_VS_MAC_LPS_STIM_DN,1
GOBP_REGULATION_OF_ENDOSOME_...2,SET,9,0.0097487,0.00021567,0.28182,0.4862,GOBP_REGULATION_OF_ENDOSOME_SIZE,1
HP_ABNORMAL_HELIX_MORPHOLOGY,SET,151,0.0023786,0.00021471,0.069283,0.48631,HP_ABNORMAL_HELIX_MORPHOLOGY,1
REACTOME_DAG_AND_IP3_SIGNALI...,SET,39,0.0048608,0.00022368,0.14171,0.48632,REACTOME_DAG_AND_IP3_SIGNALING,1
KEGG_PROTEASOME,SET,43,0.0039037,0.0001886,0.11421,0.48637,KEGG_PROTEASOME,1
REACTOME_PROTEIN_LOCALIZATION,SET,144,0.0023178,0.00020436,0.067862,0.48638,REACTOME_PROTEIN_LOCALIZATION,1
GOBP_CELLULAR_RESPONSE_TO_UV...1,SET,10,0.010584,0.00024681,0.31232,0.48648,GOBP_CELLULAR_RESPONSE_TO_UV_A,1
REACTOME_TRANSCRIPTIONAL_REG...7,SET,45,0.0039607,0.00019574,0.1172,0.48652,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS,1
GOBP_PROTEIN_K63_LINKED_DEUB...,SET,21,0.0058298,0.00019695,0.17252,0.48652,GOBP_PROTEIN_K63_LINKED_DEUBIQUITINATION,1
GOBP_ANATOMICAL_STRUCTURE_FO...,SET,1097,0.00090824,0.00021517,0.026937,0.48655,GOBP_ANATOMICAL_STRUCTURE_FORMATION_INVOLVED_IN_MORPHOGENESIS,1
GOBP_SULFUR_AMINO_ACID_CATAB...,SET,9,0.0098117,0.00021707,0.29171,0.48658,GOBP_SULFUR_AMINO_ACID_CATABOLIC_PROCESS,1
REACTOME_HORMONE_LIGAND_BIND...,SET,12,0.0082812,0.00021154,0.24962,0.48677,REACTOME_HORMONE_LIGAND_BINDING_RECEPTORS,1
GOBP_CELL_SURFACE_RECEPTOR_S...2,SET,167,0.0022893,0.00021723,0.069143,0.48679,GOBP_CELL_SURFACE_RECEPTOR_SIGNALING_PATHWAY_VIA_STAT,1
CARRILLOREIXACH_HEPATOBLASTO...3,SET,157,0.0023949,0.0002204,0.072473,0.48682,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP,1
MIR548O_3P,SET,250,0.0017867,0.00020696,0.054283,0.48687,MIR548O_3P,1
GSE360_L_MAJOR_VS_M_TUBERCUL...1,SET,168,0.0021519,0.0002048,0.066213,0.48704,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_DC_DN,1
HP_ABNORMALITY_OF_THE_UPPER_...3,SET,443,0.0013276,0.00020361,0.040899,0.48705,HP_ABNORMALITY_OF_THE_UPPER_RESPIRATORY_TRACT,1
GOBP_POSITIVE_REGULATION_OF_...647,SET,140,0.0023686,0.00020594,0.073,0.48706,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...372,SET,33,0.0053099,0.0002248,0.16387,0.48708,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_2_PRODUCTION,1
BIOCARTA_RELA_PATHWAY,SET,14,0.0073967,0.00020407,0.22882,0.48711,BIOCARTA_RELA_PATHWAY,1
BERTUCCI_MEDULLARY_VS_DUCTAL...1,SET,153,0.0022484,0.00020429,0.06974,0.48714,BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_DN,1
REACTOME_GAP_FILLING_DNA_REP...,SET,24,0.0048382,0.00017472,0.15044,0.48717,REACTOME_GAP_FILLING_DNA_REPAIR_SYNTHESIS_AND_LIGATION_IN_GG_NER,1
GOMF_G_PROTEIN_COUPLED_AMINE...,SET,38,0.0049115,0.0002231,0.15268,0.48717,GOMF_G_PROTEIN_COUPLED_AMINE_RECEPTOR_ACTIVITY,1
ROSS_ACUTE_MYELOID_LEUKEMIA_...,SET,77,0.0033731,0.00021787,0.105,0.48719,ROSS_ACUTE_MYELOID_LEUKEMIA_CBF,1
GSE5503_MLN_DC_VS_SPLEEN_DC_...1,SET,179,0.0019601,0.00019249,0.061182,0.48722,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...582,SET,5,0.012068,0.00019901,0.37789,0.48726,GOBP_NEGATIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_SPEECH_DISCRIMIN...,SET,4,0.012413,0.0001831,0.39008,0.48731,HP_ABNORMAL_SPEECH_DISCRIMINATION,1
DESCARTES_MAIN_FETAL_PARIETA...,SET,92,0.0027029,0.00019075,0.085373,0.48737,DESCARTES_MAIN_FETAL_PARIETAL_AND_CHIEF_CELLS,1
GSE32423_IL7_VS_IL7_IL4_MEMO...2,SET,188,0.0019021,0.00019139,0.06012,0.48738,GSE32423_IL7_VS_IL7_IL4_MEMORY_CD8_TCELL_UP,1
BIOCARTA_LIS1_PATHWAY,SET,18,0.0061195,0.00019142,0.19379,0.4874,BIOCARTA_LIS1_PATHWAY,1
GNF2_RRM1,SET,85,0.0027168,0.00018433,0.086233,0.48743,GNF2_RRM1,1
HP_FRAGMENTED_EPIPHYSES,SET,5,0.013508,0.00022278,0.42861,0.48743,HP_FRAGMENTED_EPIPHYSES,1
KAYO_CALORIE_RESTRICTION_MUS...2,SET,89,0.0027869,0.00019346,0.088601,0.48745,KAYO_CALORIE_RESTRICTION_MUSCLE_UP,1
REACTOME_MRNA_DECAY_BY_3_TO_...,SET,12,0.0063007,0.00016094,0.2003,0.48745,REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE,1
GOBP_CONDITIONED_PLACE_PREFE...,SET,5,0.012093,0.00019943,0.38504,0.48747,GOBP_CONDITIONED_PLACE_PREFERENCE,1
GOBP_RESPONSE_TO_MACROPHAGE_...,SET,16,0.0075374,0.0002223,0.24036,0.48749,GOBP_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR,1
GOBP_NEGATIVE_REGULATION_OF_...675,SET,5,0.014495,0.00023904,0.4624,0.4875,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNE_RESPONSE_TO_TUMOR_CELL,1
STEIN_ESRRA_TARGETS,SET,473,0.0012134,0.00019213,0.038735,0.48751,STEIN_ESRRA_TARGETS,1
GSE36078_UNTREATED_VS_AD5_T4...3,SET,181,0.0019744,0.00019497,0.063244,0.48755,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_DN,1
GOBP_AXIAL_MESODERM_DEVELOPM...,SET,7,0.0083875,0.00016366,0.26917,0.48757,GOBP_AXIAL_MESODERM_DEVELOPMENT,1
HP_ABNORMAL_DELAYED_HYPERSEN...,SET,10,0.0084519,0.0001971,0.27215,0.48761,HP_ABNORMAL_DELAYED_HYPERSENSITIVITY_SKIN_TEST,1
HP_ABNORMALITY_OF_COAGULATION,SET,201,0.0018093,0.00018818,0.058335,0.48763,HP_ABNORMALITY_OF_COAGULATION,1
HBZ_TARGET_GENES,SET,837,0.00091394,0.00019055,0.029612,0.48769,HBZ_TARGET_GENES,1
MIR20A_5P,SET,623,0.0010645,0.00019263,0.034541,0.48771,MIR20A_5P,1
LAMB3_TARGET_GENES,SET,5,0.011194,0.0001846,0.36328,0.48771,LAMB3_TARGET_GENES,1
HP_CROHN_S_DISEASE,SET,13,0.0087841,0.00023354,0.28508,0.48771,HP_CROHN_S_DISEASE,1
HP_EEG_WITH_FOCAL_SHARP_SLOW...,SET,12,0.0074878,0.00019127,0.24342,0.48773,HP_EEG_WITH_FOCAL_SHARP_SLOW_WAVES,1
GSE5679_CTRL_VS_PPARG_LIGAND...2,SET,179,0.0020668,0.00020297,0.067204,0.48773,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_UP,1
GOBP_N_TERMINAL_PEPTIDYL_MET...,SET,5,0.010653,0.00017568,0.3472,0.48776,GOBP_N_TERMINAL_PEPTIDYL_METHIONINE_ACETYLATION,1
GSE22611_NOD2_TRANSD_VS_CTRL...2,SET,165,0.0019379,0.00018279,0.063135,0.48776,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_2H_UP,1
GSE22140_HEALTHY_VS_ARTHRITI...1,SET,188,0.001948,0.00019601,0.063632,0.48779,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...617,SET,39,0.004258,0.00019594,0.1395,0.48782,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEPHOSPHORYLATION,1
MOOTHA_GLYCOGEN_METABOLISM,SET,18,0.0055823,0.00017461,0.18295,0.48783,MOOTHA_GLYCOGEN_METABOLISM,1
ZNF776_TARGET_GENES,SET,6,0.0091469,0.00016524,0.30279,0.48795,ZNF776_TARGET_GENES,1
STAT3_02,SET,138,0.0021822,0.00018838,0.072308,0.48796,STAT3_02,1
WP_MITOCHONDRIAL_COMPLEX_II_...,SET,8,0.0074337,0.00015506,0.24664,0.48798,WP_MITOCHONDRIAL_COMPLEX_II_ASSEMBLY,1
MIR6511A_3P_MIR6511B_3P,SET,55,0.0032661,0.0001784,0.10869,0.48801,MIR6511A_3P_MIR6511B_3P,1
GOBP_ATRIOVENTRICULAR_VALVE_...2,SET,8,0.0099592,0.00020774,0.33179,0.48803,GOBP_ATRIOVENTRICULAR_VALVE_FORMATION,1
REACTOME_CELLULAR_RESPONSES_...,SET,700,0.0009524,0.00018229,0.031758,0.48804,REACTOME_CELLULAR_RESPONSES_TO_STIMULI,1
MIR370_3P,SET,88,0.0026097,0.00018015,0.087314,0.48808,MIR370_3P,1
RIGGINS_TAMOXIFEN_RESISTANCE...1,SET,202,0.0019223,0.00020042,0.064409,0.4881,RIGGINS_TAMOXIFEN_RESISTANCE_DN,1
LIU_CMYB_TARGETS_DN,SET,6,0.0084128,0.00015198,0.28223,0.48811,LIU_CMYB_TARGETS_DN,1
GOBP_REGULATION_OF_KERATINOC...2,SET,14,0.0077403,0.00021355,0.2602,0.48813,GOBP_REGULATION_OF_KERATINOCYTE_MIGRATION,1
MIR200C_5P,SET,58,0.0034358,0.0001927,0.11588,0.48817,MIR200C_5P,1
HP_ABNORMAL_FULL_FIELD_ELECT...,SET,55,0.0036226,0.00019787,0.12288,0.48824,HP_ABNORMAL_FULL_FIELD_ELECTRORETINOGRAM,1
MIR943,SET,47,0.003715,0.00018762,0.12646,0.48828,MIR943,1
AIZARANI_LIVER_C24_EPCAM_POS...,SET,174,0.0020321,0.00019678,0.069208,0.48829,AIZARANI_LIVER_C24_EPCAM_POS_BILE_DUCT_CELLS_3,1
MIR136_3P,SET,8,0.0083539,0.00017425,0.2852,0.48832,MIR136_3P,1
GOBP_OLIGODENDROCYTE_DEVELOP...,SET,44,0.003843,0.00018781,0.1312,0.48832,GOBP_OLIGODENDROCYTE_DEVELOPMENT,1
GOBP_REGULATION_OF_PRIMARY_M...,SET,5,0.012324,0.00020324,0.42125,0.48833,GOBP_REGULATION_OF_PRIMARY_MIRNA_PROCESSING,1
HP_APLASIA_HYPOPLASIA_OF_THE...49,SET,100,0.0023484,0.00017275,0.080326,0.48834,HP_APLASIA_HYPOPLASIA_OF_THE_OPTIC_NERVE,1
TACGGGT_MIR99A_MIR100_MIR99B,SET,23,0.0056137,0.00019846,0.19221,0.48835,TACGGGT_MIR99A_MIR100_MIR99B,1
MIR148B_5P,SET,70,0.0028615,0.00017626,0.098688,0.48843,MIR148B_5P,1
GOBP_VIRAL_RELEASE_FROM_HOST...,SET,28,0.0043401,0.00016927,0.14973,0.48844,GOBP_VIRAL_RELEASE_FROM_HOST_CELL,1
HP_WIDOW_S_PEAK,SET,14,0.0064969,0.00017924,0.2251,0.48849,HP_WIDOW_S_PEAK,1
GOBP_LENS_FIBER_CELL_DIFFERE...,SET,34,0.0044915,0.00019301,0.15583,0.4885,GOBP_LENS_FIBER_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_HEMATOPOI...1,SET,41,0.0036085,0.00017024,0.1253,0.48851,GOBP_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
HP_ABNORMALITY_OF_THE_LIVER,SET,986,0.00079109,0.00017825,0.027468,0.48851,HP_ABNORMALITY_OF_THE_LIVER,1
TGTTTAC_MIR30A5P_MIR30C_MIR3...,SET,530,0.0010842,0.00018145,0.037675,0.48852,TGTTTAC_MIR30A5P_MIR30C_MIR30D_MIR30B_MIR30E5P,1
GSE28737_WT_VS_BCL6_HET_MARG...1,SET,180,0.0017598,0.0001733,0.061484,0.48858,GSE28737_WT_VS_BCL6_HET_MARGINAL_ZONE_BCELL_DN,1
GOMF_OXIDOREDUCTASE_ACTIVITY...7,SET,11,0.0070432,0.00017226,0.24737,0.48864,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS,1
GOBP_CELL_PROLIFERATION_IN_M...,SET,7,0.0096508,0.00018831,0.33959,0.48866,GOBP_CELL_PROLIFERATION_IN_MIDBRAIN,1
KEGG_MEDICUS_REFERENCE_TSC1_...,SET,11,0.0070448,0.00017229,0.24863,0.4887,KEGG_MEDICUS_REFERENCE_TSC1_2_MTORC1_SIGNALING_PATHWAY,1
MARIADASON_RESPONSE_TO_CURCU...1,SET,22,0.0047293,0.00016353,0.16702,0.48871,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_5,1
GSE23568_ID3_KO_VS_WT_CD8_TC...2,SET,173,0.001767,0.00017063,0.062473,0.48872,GSE23568_ID3_KO_VS_WT_CD8_TCELL_UP,1
GARCIA_PINERES_PBMC_HPV_16_L...2,SET,21,0.0051834,0.00017511,0.18369,0.48874,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_12MO_CORRELATED_WITH_ANTIBODY_RESPONSE_POSITIVE,1
GSE5503_MLN_DC_VS_PLN_DC_ACT...2,SET,179,0.001738,0.00017068,0.061742,0.48877,GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
CHOP_01,SET,207,0.0017021,0.00017962,0.060772,0.48883,CHOP_01,1
MIR613,SET,289,0.0013979,0.00017391,0.050062,0.48886,MIR613,1
BIERIE_INFLAMMATORY_RESPONSE...,SET,5,0.013131,0.00021655,0.47183,0.4889,BIERIE_INFLAMMATORY_RESPONSE_TGFB1,1
REACTOME_DEFECTS_IN_COBALAMI...,SET,12,0.0063897,0.00016322,0.22953,0.4889,REACTOME_DEFECTS_IN_COBALAMIN_B12_METABOLISM,1
HP_JUVENILE_RHEUMATOID_ARTHR...,SET,5,0.010302,0.0001699,0.37012,0.4889,HP_JUVENILE_RHEUMATOID_ARTHRITIS,1
HP_APLASIA_HYPOPLASIA_OF_THE...75,SET,8,0.0075346,0.00015716,0.27114,0.48892,HP_APLASIA_HYPOPLASIA_OF_THE_TRAGUS,1
REACTOME_ABC_TRANSPORTERS_IN...,SET,17,0.0059133,0.00017976,0.21362,0.48896,REACTOME_ABC_TRANSPORTERS_IN_LIPID_HOMEOSTASIS,1
MANALO_HYPOXIA_UP,SET,184,0.0018248,0.00018167,0.066106,0.48899,MANALO_HYPOXIA_UP,1
MIR6856_5P,SET,93,0.0023861,0.0001693,0.086537,0.489,MIR6856_5P,1
GSE42021_CD24HI_TREG_VS_CD24...2,SET,179,0.0016335,0.00016042,0.059377,0.48903,GSE42021_CD24HI_TREG_VS_CD24HI_TCONV_THYMUS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...345,SET,11,0.0077632,0.00018987,0.28318,0.48906,GOBP_NEGATIVE_REGULATION_OF_LIPASE_ACTIVITY,1
GOBP_DNA_DOUBLE_STRAND_BREAK...,SET,19,0.0049129,0.00015788,0.18048,0.48914,GOBP_DNA_DOUBLE_STRAND_BREAK_PROCESSING,1
GOBP_NEGATIVE_REGULATION_OF_...392,SET,6,0.010022,0.00018105,0.36954,0.48918,GOBP_NEGATIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,1
HP_LONG_EYELASHES,SET,115,0.0020963,0.0001653,0.077369,0.48919,HP_LONG_EYELASHES,1
GAVISH_3CA_METAPROGRAM_FIBRO...6,SET,47,0.0035805,0.00018083,0.13255,0.48922,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_5,1
GOMF_HISTONE_H2AX_KINASE_ACT...,SET,5,0.0098566,0.00016255,0.36519,0.48923,GOMF_HISTONE_H2AX_KINASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...419,SET,6,0.010893,0.00019679,0.40496,0.48927,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,1
GOBP_CARDIAC_ATRIUM_MORPHOGE...,SET,26,0.0050483,0.00018974,0.18792,0.48928,GOBP_CARDIAC_ATRIUM_MORPHOGENESIS,1
GSE2405_0H_VS_3H_A_PHAGOCYTO...2,SET,188,0.001767,0.0001778,0.065816,0.48929,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
MUNSHI_MULTIPLE_MYELOMA_UP,SET,71,0.0026578,0.00016488,0.099492,0.48934,MUNSHI_MULTIPLE_MYELOMA_UP,1
GOBP_MONOCARBOXYLIC_ACID_MET...,SET,589,0.00095996,0.00016907,0.035998,0.48936,GOBP_MONOCARBOXYLIC_ACID_METABOLIC_PROCESS,1
GSE8621_UNSTIM_VS_LPS_PRIMED...2,SET,180,0.0016435,0.00016184,0.061706,0.48938,GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,1
GOBP_PROTEIN_GERANYLGERANYLA...,SET,6,0.0084774,0.00015315,0.31969,0.48942,GOBP_PROTEIN_GERANYLGERANYLATION,1
KEGG_MEDICUS_VARIANT_ERBB2_O...2,SET,12,0.0064135,0.00016383,0.24307,0.48948,KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...379,SET,17,0.0055177,0.00016773,0.20928,0.48948,GOBP_NEGATIVE_REGULATION_OF_MEIOTIC_CELL_CYCLE,1
BLANCO_MELO_INFLUENZA_A_INFE...2,SET,37,0.003736,0.00016746,0.14187,0.4895,BLANCO_MELO_INFLUENZA_A_INFECTION_A594_CELLS_UP,1
SENESE_HDAC1_TARGETS_UP,SET,398,0.001133,0.00016491,0.043023,0.4895,SENESE_HDAC1_TARGETS_UP,1
GOBP_METANEPHRIC_NEPHRON_TUB...1,SET,6,0.010729,0.00019383,0.40835,0.48952,GOBP_METANEPHRIC_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
GOBP_RESPONSE_TO_TOXIC_SUBST...,SET,226,0.0015443,0.00017019,0.058791,0.48952,GOBP_RESPONSE_TO_TOXIC_SUBSTANCE,1
GOBP_PROTEIN_SIDE_CHAIN_DEGL...,SET,5,0.011622,0.00019167,0.44324,0.48954,GOBP_PROTEIN_SIDE_CHAIN_DEGLUTAMYLATION,1
GOBP_LYMPHOCYTE_APOPTOTIC_PR...,SET,78,0.0025447,0.00016543,0.097322,0.48957,GOBP_LYMPHOCYTE_APOPTOTIC_PROCESS,1
GOCC_INNER_KINETOCHORE,SET,14,0.0059822,0.00016504,0.22925,0.48959,GOCC_INNER_KINETOCHORE,1
CAHOY_NEURONAL,SET,97,0.0024822,0.00017985,0.095089,0.48959,CAHOY_NEURONAL,1
GOMF_L_LEUCINE_BINDING,SET,6,0.007853,0.00014187,0.30337,0.48967,GOMF_L_LEUCINE_BINDING,1
HP_VENOUS_THROMBOSIS,SET,74,0.002616,0.00016566,0.10128,0.4897,HP_VENOUS_THROMBOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...45,SET,97,0.0022038,0.00015968,0.085724,0.48975,GOBP_NEGATIVE_REGULATION_OF_BINDING,1
HP_EPISCLERITIS,SET,4,0.012484,0.00018415,0.4885,0.48981,HP_EPISCLERITIS,1
GOBP_NEGATIVE_REGULATION_OF_...391,SET,5,0.010733,0.00017701,0.42113,0.48983,GOBP_NEGATIVE_REGULATION_OF_MHC_CLASS_II_BIOSYNTHETIC_PROCESS,1
MIR1262,SET,44,0.0029787,0.00014557,0.1187,0.48999,MIR1262,1
XU_RESPONSE_TO_TRETINOIN_AND...1,SET,13,0.005967,0.00015864,0.23838,0.49002,XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_DN,1
HP_THICK_CORPUS_CALLOSUM,SET,15,0.0048701,0.00013907,0.19474,0.49002,HP_THICK_CORPUS_CALLOSUM,1
HAY_BONE_MARROW_MONOCYTE,SET,195,0.001551,0.00015891,0.062307,0.49007,HAY_BONE_MARROW_MONOCYTE,1
GOBP_PROTEIN_K11_LINKED_DEUB...,SET,9,0.0061923,0.000137,0.2515,0.49018,GOBP_PROTEIN_K11_LINKED_DEUBIQUITINATION,1
GOCC_ROUGH_ENDOPLASMIC_RETIC...2,SET,20,0.0045867,0.00015122,0.18697,0.49021,GOCC_ROUGH_ENDOPLASMIC_RETICULUM_MEMBRANE,1
GOCC_SPINDLE_MICROTUBULE,SET,76,0.0021987,0.00014109,0.089694,0.49022,GOCC_SPINDLE_MICROTUBULE,1
GOBP_EPIGENETIC_PROGRAMING_O...,SET,4,0.010642,0.00015697,0.4345,0.49023,GOBP_EPIGENETIC_PROGRAMING_OF_MALE_PRONUCLEUS,1
REACTOME_GLUCAGON_SIGNALING_...,SET,33,0.0036837,0.00015595,0.15067,0.49025,REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION,1
WP_16P112_DISTAL_DELETION_SY...,SET,31,0.0041252,0.00016928,0.16875,0.49025,WP_16P112_DISTAL_DELETION_SYNDROME,1
GOBP_POTASSIUM_ION_IMPORT_AC...,SET,44,0.003544,0.0001732,0.14501,0.49025,GOBP_POTASSIUM_ION_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_PROTEIN_SERINE_THREONIN...4,SET,36,0.0035141,0.00015537,0.14375,0.49025,GOMF_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,1
BENPORATH_PROLIFERATION,SET,135,0.0017426,0.0001488,0.071452,0.49027,BENPORATH_PROLIFERATION,1
GSE17721_0.5H_VS_24H_CPG_BMD...2,SET,182,0.0015236,0.00015086,0.062539,0.49028,GSE17721_0.5H_VS_24H_CPG_BMDC_UP,1
GOMF_PRIMARY_ACTIVE_TRANSMEM...,SET,143,0.0016163,0.00014202,0.06652,0.49031,GOMF_PRIMARY_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GNF2_RAP1B,SET,32,0.0035772,0.00014913,0.14746,0.49032,GNF2_RAP1B,1
HP_APLASIA_HYPOPLASIA_OF_THE...64,SET,16,0.004996,0.00014734,0.207,0.49037,HP_APLASIA_HYPOPLASIA_OF_THE_SACRUM,1
GOMF_CAMP_DEPENDENT_PROTEIN_...1,SET,5,0.0073236,0.00012078,0.30371,0.49038,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_MISMA...,SET,26,0.0034213,0.00012859,0.14217,0.4904,KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR,1
GSE14350_IL2RB_KO_VS_WT_TREG...1,SET,181,0.0015167,0.00014977,0.063092,0.49041,GSE14350_IL2RB_KO_VS_WT_TREG_DN,1
GOMF_SPECTRIN_BINDING,SET,26,0.0042551,0.00015993,0.17739,0.49043,GOMF_SPECTRIN_BINDING,1
GOBP_TELOMERE_MAINTENANCE_VI...2,SET,9,0.0062038,0.00013725,0.26189,0.49055,GOBP_TELOMERE_MAINTENANCE_VIA_SEMI_CONSERVATIVE_REPLICATION,1
GOBP_POSITIVE_REGULATION_OF_...340,SET,8,0.0072909,0.00015208,0.30805,0.49056,GOBP_POSITIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
KAECH_DAY15_EFF_VS_MEMORY_CD...2,SET,186,0.0014694,0.00014707,0.062279,0.49059,KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP,1
GSE41867_NAIVE_VS_DAY6_LCMV_...2,SET,177,0.0014716,0.00014372,0.062659,0.49063,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
HP_NEOPLASM_OF_THE_RESPIRATO...,SET,74,0.0022761,0.00014414,0.097069,0.49065,HP_NEOPLASM_OF_THE_RESPIRATORY_SYSTEM,1
GOBP_PRO_B_CELL_DIFFERENTIAT...,SET,12,0.0059357,0.00015162,0.25367,0.49067,GOBP_PRO_B_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_PRL_J...,SET,5,0.011809,0.00019475,0.51195,0.4908,KEGG_MEDICUS_REFERENCE_PRL_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_GLYCOSPHINGOLIPID_METAB...,SET,62,0.0026179,0.0001518,0.11377,0.49082,GOBP_GLYCOSPHINGOLIPID_METABOLIC_PROCESS,1
HP_DEPRESSED_NASAL_BRIDGE,SET,527,0.00083619,0.00013955,0.036547,0.49087,HP_DEPRESSED_NASAL_BRIDGE,1
GOBP_NEGATIVE_REGULATION_OF_...221,SET,9,0.0064426,0.00014253,0.28372,0.49094,GOBP_NEGATIVE_REGULATION_OF_EXCITATORY_POSTSYNAPTIC_POTENTIAL,1
HP_EXSTROPHY,SET,6,0.0080951,0.00014624,0.35738,0.49096,HP_EXSTROPHY,1
HP_ANGIOKERATOMA,SET,5,0.0079657,0.00013137,0.35397,0.49102,HP_ANGIOKERATOMA,1
MODULE_408,SET,18,0.0046611,0.0001458,0.20753,0.49104,MODULE_408,1
WP_APOPTOSISRELATED_NETWORK_...,SET,52,0.0027776,0.00014753,0.12485,0.49113,WP_APOPTOSISRELATED_NETWORK_DUE_TO_ALTERED_NOTCH3_IN_OVARIAN_CANCER,1
MIR3115,SET,33,0.0030001,0.00012701,0.13518,0.49115,MIR3115,1
HP_PARAPARESIS,SET,67,0.0021233,0.00012796,0.09621,0.4912,HP_PARAPARESIS,1
HP_CHORIORETINAL_DYSPLASIA,SET,14,0.0049579,0.00013678,0.22512,0.49121,HP_CHORIORETINAL_DYSPLASIA,1
RAY_TARGETS_OF_P210_BCR_ABL_...2,SET,12,0.0059251,0.00015135,0.26909,0.49122,RAY_TARGETS_OF_P210_BCR_ABL_FUSION_UP,1
KYNG_ENVIRONMENTAL_STRESS_RE...5,SET,28,0.003156,0.00012309,0.14409,0.49126,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS,1
HP_CUTANEOUS_CYST,SET,21,0.0038063,0.00012859,0.17374,0.49126,HP_CUTANEOUS_CYST,1
GOBP_POSITIVE_REGULATION_OF_...164,SET,8,0.0053989,0.00011262,0.24666,0.49127,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_CONDENSATION,1
GOBP_REGULATION_OF_SKELETAL_...3,SET,18,0.0041144,0.0001287,0.18794,0.49127,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GOCC_CONDENSIN_COMPLEX,SET,8,0.0053989,0.00011262,0.24666,0.49127,GOCC_CONDENSIN_COMPLEX,1
MIR4493,SET,88,0.0018648,0.00012873,0.085793,0.49133,MIR4493,1
GSE3982_NEUTROPHIL_VS_TH1_DN,SET,179,0.001299,0.00012757,0.059822,0.49134,GSE3982_NEUTROPHIL_VS_TH1_DN,1
GOBP_PROTEIN_CATABOLIC_PROCE...1,SET,911,0.00060296,0.00013087,0.027924,0.49139,GOBP_PROTEIN_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_ATTACHMEN...2,SET,22,0.003596,0.00012434,0.16688,0.4914,GOBP_REGULATION_OF_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GSE15930_STIM_VS_STIM_AND_IF...6,SET,171,0.0013727,0.00013179,0.064561,0.49152,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_UP,1
HP_INCREASED_OVERBITE,SET,8,0.0067264,0.0001403,0.31662,0.49153,HP_INCREASED_OVERBITE,1
GOBP_PROXIMAL_DISTAL_PATTERN...2,SET,5,0.0099473,0.00016405,0.4696,0.49155,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION_INVOLVED_IN_NEPHRON_DEVELOPMENT,1
chr15q11,SET,8,0.0085662,0.00017868,0.40576,0.49158,chr15q11,1
GOBP_PROTEIN_IMPORT_INTO_PER...4,SET,5,0.0075219,0.00012405,0.35676,0.49159,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MEMBRANE,1
chr11q12,SET,178,0.0030406,0.00029778,0.14464,0.49161,chr11q12,1
REACTOME_PI5P_REGULATES_TP53...,SET,8,0.0064701,0.00013496,0.30766,0.49161,REACTOME_PI5P_REGULATES_TP53_ACETYLATION,1
WP_VITAMIN_B12_DISORDERS,SET,11,0.0050489,0.00012348,0.24023,0.49162,WP_VITAMIN_B12_DISORDERS,1
GOMF_SYNDECAN_BINDING,SET,5,0.0088104,0.0001453,0.41917,0.49162,GOMF_SYNDECAN_BINDING,1
KAT2A_TARGET_GENES,SET,902,0.00059792,0.00012917,0.028615,0.49166,KAT2A_TARGET_GENES,1
MIR591,SET,44,0.002643,0.00012916,0.12654,0.49167,MIR591,1
HP_TRANSPOSITION_OF_THE_GREA...,SET,68,0.0020694,0.00012564,0.099169,0.49168,HP_TRANSPOSITION_OF_THE_GREAT_ARTERIES,1
GSE14308_TH1_VS_NATURAL_TREG...1,SET,181,0.0012611,0.00012453,0.060697,0.49171,GSE14308_TH1_VS_NATURAL_TREG_DN,1
KEGG_MEDICUS_REFERENCE_KINET...2,SET,19,0.00442,0.00014204,0.21286,0.49172,KEGG_MEDICUS_REFERENCE_KINETOCHORE_MICROTUBULE_ATTACHMENT,1
GOBP_POSITIVE_REGULATION_OF_...478,SET,43,0.0028623,0.00013829,0.13812,0.49173,GOBP_POSITIVE_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
ZNF490_TARGET_GENES,SET,335,0.00094003,0.00012575,0.045618,0.49178,ZNF490_TARGET_GENES,1
REACTOME_WNT_MEDIATED_ACTIVA...,SET,8,0.0055208,0.00011516,0.26811,0.49179,REACTOME_WNT_MEDIATED_ACTIVATION_OF_DVL,1
GOBP_RESPONSE_TO_WATER_DEPRI...,SET,5,0.0069788,0.00011509,0.34071,0.49183,GOBP_RESPONSE_TO_WATER_DEPRIVATION,1
GOBP_MONOACYLGLYCEROL_CATABO...,SET,7,0.006148,0.00011996,0.30109,0.49185,GOBP_MONOACYLGLYCEROL_CATABOLIC_PROCESS,1
HP_PURSED_LIPS,SET,4,0.010005,0.00014759,0.49105,0.49187,HP_PURSED_LIPS,1
REACTOME_PLATELET_ACTIVATION...,SET,246,0.001137,0.00013066,0.05603,0.4919,REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION,1
BIOCARTA_CACAM_PATHWAY,SET,9,0.0064294,0.00014224,0.31929,0.49197,BIOCARTA_CACAM_PATHWAY,1
GOBP_REGULATION_OF_SPERM_CAP...,SET,4,0.0093155,0.00013741,0.46291,0.49197,GOBP_REGULATION_OF_SPERM_CAPACITATION,1
REACTOME_TRYPTOPHAN_CATABOLI...,SET,12,0.0051643,0.00013192,0.25692,0.49198,REACTOME_TRYPTOPHAN_CATABOLISM,1
GOBP_FC_EPSILON_RECEPTOR_SIG...,SET,24,0.0035729,0.00012903,0.17821,0.492,GOBP_FC_EPSILON_RECEPTOR_SIGNALING_PATHWAY,1
GSE22025_UNTREATED_VS_TGFB1_...3,SET,184,0.0012754,0.00012698,0.063701,0.49201,GSE22025_UNTREATED_VS_TGFB1_TREATED_CD4_TCELL_DN,1
WP_SUDDEN_INFANT_DEATH_SYNDR...,SET,148,0.0015232,0.00013614,0.076123,0.49202,WP_SUDDEN_INFANT_DEATH_SYNDROME_SIDS_SUSCEPTIBILITY_PATHWAYS,1
XU_HGF_TARGETS_INDUCED_BY_AK...2,SET,13,0.0050531,0.00013434,0.25338,0.49204,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_UP,1
GOBP_SOMATIC_STEM_CELL_DIVIS...,SET,11,0.00543,0.0001328,0.27589,0.49215,GOBP_SOMATIC_STEM_CELL_DIVISION,1
MIR6785_5P,SET,470,0.00076462,0.0001207,0.038905,0.49216,MIR6785_5P,1
GSE24142_EARLY_THYMIC_PROGEN...12,SET,185,0.0012696,0.00012674,0.0646,0.49216,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN3_THYMOCYTE_UP,1
MIR7975,SET,37,0.0025599,0.00011474,0.13053,0.49218,MIR7975,1
KEGG_MEDICUS_REFERENCE_VGCC_...,SET,20,0.0038185,0.0001259,0.19504,0.49219,KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY,1
REACTOME_PEROXISOMAL_PROTEIN...,SET,60,0.0021428,0.00012223,0.10991,0.49222,REACTOME_PEROXISOMAL_PROTEIN_IMPORT,1
REACTOME_THE_ACTIVATION_OF_A...,SET,8,0.0054172,0.000113,0.27855,0.49224,REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES,1
GOBP_CALCIUM_ION_HOMEOSTASIS,SET,303,0.0010115,0.0001288,0.052083,0.49225,GOBP_CALCIUM_ION_HOMEOSTASIS,1
GSE37301_LYMPHOID_PRIMED_MPP...7,SET,168,0.0012565,0.00011958,0.064762,0.49226,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN,1
GOBP_NEURAL_CREST_FORMATION,SET,15,0.0045082,0.00012874,0.23267,0.49227,GOBP_NEURAL_CREST_FORMATION,1
MIR6885_3P,SET,364,0.00088614,0.00012347,0.045966,0.49231,MIR6885_3P,1
MIR6742_3P,SET,94,0.0015937,0.00011369,0.083812,0.49241,MIR6742_3P,1
REACTOME_DEFECTIVE_CHST14_CA...,SET,7,0.0065221,0.00012726,0.34463,0.49245,REACTOME_DEFECTIVE_CHST14_CAUSES_EDS_MUSCULOCONTRACTURAL_TYPE,1
JOHANSSON_BRAIN_CANCER_EARLY...1,SET,41,0.0024782,0.00011692,0.13126,0.49247,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_DN,1
HP_PROPORTIONATE_SHORT_STATU...,SET,130,0.0013633,0.00011425,0.072253,0.49247,HP_PROPORTIONATE_SHORT_STATURE,1
GSE17974_IL4_AND_ANTI_IL12_V...13,SET,153,0.0013509,0.00012274,0.071858,0.4925,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_DN,1
ZHENG_FOXP3_TARGETS_IN_T_LYM...1,SET,34,0.0028887,0.00012413,0.15416,0.49253,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN,1
BIOCARTA_PITX2_PATHWAY,SET,15,0.0038084,0.00010875,0.20385,0.49255,BIOCARTA_PITX2_PATHWAY,1
SRF_01,SET,45,0.0024583,0.00012149,0.13203,0.49257,SRF_01,1
GOBP_ENDONUCLEOLYTIC_CLEAVAG...1,SET,7,0.0055262,0.00010783,0.29727,0.49258,GOBP_ENDONUCLEOLYTIC_CLEAVAGE_IN_5_ETS_OF_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
LEE_INTRATHYMIC_T_PROGENITOR,SET,17,0.0040093,0.00012188,0.21594,0.49259,LEE_INTRATHYMIC_T_PROGENITOR,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...3,SET,430,0.00077362,0.00011694,0.041906,0.49264,FAN_EMBRYONIC_CTX_BIG_GROUPS_CAJAL_RETZIUS,1
GOBP_CARDIAC_PACEMAKER_CELL_...2,SET,11,0.0051998,0.00012717,0.28301,0.49267,GOBP_CARDIAC_PACEMAKER_CELL_DIFFERENTIATION,1
AP2_Q3,SET,231,0.00099002,0.00011029,0.054177,0.49271,AP2_Q3,1
GOBP_PROTON_TRANSPORTING_TWO...,SET,11,0.0045817,0.00011206,0.25076,0.49271,GOBP_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_ASSEMBLY,1
HOFFMANN_SMALL_PRE_BII_TO_IM...2,SET,62,0.0020951,0.00012148,0.11506,0.49274,HOFFMANN_SMALL_PRE_BII_TO_IMMATURE_B_LYMPHOCYTE_UP,1
HP_GRAVES_DISEASE,SET,3,0.0099423,0.00012701,0.5475,0.49276,HP_GRAVES_DISEASE,1
GOBP_REGULATION_OF_TOLL_LIKE...1,SET,11,0.0046887,0.00011467,0.25982,0.4928,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,1
HP_ABNORMAL_IRIS_PIGMENTATION,SET,131,0.0013942,0.00011728,0.077663,0.49284,HP_ABNORMAL_IRIS_PIGMENTATION,1
GOBP_ZYMOGEN_ACTIVATION,SET,51,0.0022041,0.00011595,0.12308,0.49286,GOBP_ZYMOGEN_ACTIVATION,1
XU_HGF_TARGETS_INDUCED_BY_AK...3,SET,15,0.003831,0.0001094,0.2155,0.49291,XU_HGF_TARGETS_INDUCED_BY_AKT1_6HR,1
GOMF_METALLOAMINOPEPTIDASE_A...,SET,23,0.0033786,0.00011944,0.19004,0.49291,GOMF_METALLOAMINOPEPTIDASE_ACTIVITY,1
GOBP_RIBONUCLEOSIDE_MONOPHOS...2,SET,14,0.0042978,0.00011857,0.24598,0.49303,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
HP_ABNORMAL_CSF_GLYCINE_CONC...,SET,8,0.0047502,9.9083e-05,0.27234,0.49304,HP_ABNORMAL_CSF_GLYCINE_CONCENTRATION,1
GOBP_UBIQUITIN_DEPENDENT_PRO...2,SET,34,0.0023282,0.00010004,0.13371,0.49305,GOBP_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,1
WP_NRF2ARE_REGULATION,SET,23,0.003111,0.00010998,0.17955,0.49309,WP_NRF2ARE_REGULATION,1
MORF_PSMC2,SET,101,0.0013113,9.6943e-05,0.075737,0.49309,MORF_PSMC2,1
HP_PSYCHOTIC_MENTATION,SET,15,0.0033266,9.4996e-05,0.19271,0.49311,HP_PSYCHOTIC_MENTATION,1
GSE40655_FOXO1_KO_VS_WT_NTRE...2,SET,178,0.0010372,0.00010158,0.060165,0.49312,GSE40655_FOXO1_KO_VS_WT_NTREG_UP,1
GOBP_POSITIVE_REGULATION_OF_...674,SET,85,0.0016294,0.00011056,0.095008,0.49316,GOBP_POSITIVE_REGULATION_OF_REPRODUCTIVE_PROCESS,1
MIR139_5P,SET,145,0.0012247,0.00010835,0.071756,0.49319,MIR139_5P,1
GOBP_FOREBRAIN_MORPHOGENESIS,SET,13,0.0042149,0.00011206,0.24695,0.49319,GOBP_FOREBRAIN_MORPHOGENESIS,1
HP_SOCIAL_AND_OCCUPATIONAL_D...,SET,14,0.0040198,0.0001109,0.23594,0.4932,HP_SOCIAL_AND_OCCUPATIONAL_DETERIORATION,1
KAMIKUBO_MYELOID_MN1_NETWORK,SET,18,0.0034758,0.00010872,0.20586,0.49326,KAMIKUBO_MYELOID_MN1_NETWORK,1
HP_MEGAKARYOCYTOPENIA,SET,6,0.0056166,0.00010146,0.33409,0.49329,HP_MEGAKARYOCYTOPENIA,1
GSE13411_SWITCHED_MEMORY_BCE...1,SET,160,0.0011366,0.00010558,0.068069,0.49334,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_DN,1
HP_BILIARY_CIRRHOSIS,SET,19,0.0034382,0.00011049,0.20724,0.49338,HP_BILIARY_CIRRHOSIS,1
HP_SMALL_INTESTINAL_POLYPOSIS,SET,5,0.0055035,9.0762e-05,0.33389,0.49342,HP_SMALL_INTESTINAL_POLYPOSIS,1
GOBP_PYRIMIDINE_NUCLEOSIDE_M...1,SET,22,0.0032437,0.00011216,0.19856,0.49348,GOBP_PYRIMIDINE_NUCLEOSIDE_METABOLIC_PROCESS,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...2,SET,18,0.0034933,0.00010927,0.21457,0.49351,GOBP_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GSE40274_CTRL_VS_FOXP3_AND_H...1,SET,172,0.0010259,9.8781e-05,0.063051,0.49351,GSE40274_CTRL_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_REGULATION_OF_ACTIN_NUC...,SET,27,0.0024304,9.3085e-05,0.14974,0.49353,GOBP_REGULATION_OF_ACTIN_NUCLEATION,1
REACTOME_SIGNALING_BY_TGF_BE...2,SET,8,0.0048175,0.00010049,0.29829,0.49356,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX_IN_CANCER,1
LANDIS_ERBB2_BREAST_TUMORS_3...1,SET,141,0.0011571,0.00010096,0.073768,0.49374,LANDIS_ERBB2_BREAST_TUMORS_324_DN,1
GOBP_COBALAMIN_TRANSPORT,SET,8,0.0046122,9.6205e-05,0.29384,0.49374,GOBP_COBALAMIN_TRANSPORT,1
GARGALOVIC_RESPONSE_TO_OXIDI...6,SET,15,0.0030776,8.7886e-05,0.19691,0.49377,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP,1
GSE13484_UNSTIM_VS_3H_YF17D_...1,SET,180,0.00096534,9.5065e-05,0.062021,0.49379,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN,1
HP_ABNORMALITY_OF_THE_GALLBL...,SET,99,0.0013494,9.8771e-05,0.086831,0.4938,HP_ABNORMALITY_OF_THE_GALLBLADDER,1
REACTOME_AUF1_HNRNP_D0_BINDS...,SET,52,0.0016613,8.8241e-05,0.10708,0.49381,REACTOME_AUF1_HNRNP_D0_BINDS_AND_DESTABILIZES_MRNA,1
HP_MALAR_RASH,SET,29,0.0025761,0.00010225,0.16606,0.49381,HP_MALAR_RASH,1
MIR7_5P,SET,241,0.0008588,9.7696e-05,0.055524,0.49383,MIR7_5P,1
GOBP_DORSAL_VENTRAL_NEURAL_T...,SET,16,0.003348,9.8742e-05,0.21687,0.49384,GOBP_DORSAL_VENTRAL_NEURAL_TUBE_PATTERNING,1
REACTOME_RRNA_MODIFICATION_I...1,SET,4,0.0051009,7.5244e-05,0.33184,0.49387,REACTOME_RRNA_MODIFICATION_IN_THE_MITOCHONDRION,1
HUPER_BREAST_BASAL_VS_LUMINA...1,SET,54,0.0020021,0.00010837,0.13064,0.49389,HUPER_BREAST_BASAL_VS_LUMINAL_DN,1
BIOCARTA_MELANOCYTE_PATHWAY,SET,7,0.0057873,0.00011292,0.37772,0.49389,BIOCARTA_MELANOCYTE_PATHWAY,1
DESCARTES_FETAL_PLACENTA_IGF...,SET,94,0.0014125,0.00010076,0.093032,0.49394,DESCARTES_FETAL_PLACENTA_IGFBP1_DKK1_POSITIVE_CELLS,1
GOBP_SMAD_PROTEIN_SIGNAL_TRA...,SET,76,0.0015815,0.00010149,0.10536,0.49401,GOBP_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE40277_GATA1_AND_SATB1_TRA...1,SET,181,0.00093992,9.2815e-05,0.062652,0.49402,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,1
GOBP_EARLY_ENDOSOME_TO_GOLGI...,SET,16,0.0032123,9.4739e-05,0.21485,0.49404,GOBP_EARLY_ENDOSOME_TO_GOLGI_TRANSPORT,1
GOCC_SWR1_COMPLEX,SET,13,0.0029269,7.7814e-05,0.19581,0.49404,GOCC_SWR1_COMPLEX,1
GSE26669_CTRL_VS_COSTIM_BLOC...2,SET,186,0.0008941,8.9489e-05,0.059876,0.49404,GSE26669_CTRL_VS_COSTIM_BLOCK_MLR_CD4_TCELL_UP,1
GSE19941_LPS_VS_LPS_AND_IL10...3,SET,178,0.00093015,9.1094e-05,0.06262,0.49407,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,1
GCM_CBFB,SET,63,0.0014404,8.4189e-05,0.098546,0.49417,GCM_CBFB,1
GSE28737_BCL6_HET_VS_BCL6_KO...3,SET,186,0.00086825,8.6903e-05,0.059387,0.49417,GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,1
MODULE_312,SET,46,0.0017659,8.8233e-05,0.12136,0.4942,MODULE_312,1
MIR503_5P,SET,95,0.0012738,9.1342e-05,0.087788,0.49421,MIR503_5P,1
REACTOME_CATION_COUPLED_CHLO...,SET,7,0.0045829,8.9423e-05,0.31637,0.49422,REACTOME_CATION_COUPLED_CHLORIDE_COTRANSPORTERS,1
HP_DECREASED_HIP_ABDUCTION,SET,7,0.0046015,8.9786e-05,0.3185,0.49424,HP_DECREASED_HIP_ABDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...161,SET,8,0.0045355,9.4605e-05,0.31607,0.49428,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,1
HE_LIM_SUN_FETAL_LUNG_C7_MFN...,SET,17,0.0030806,9.3648e-05,0.21537,0.49429,HE_LIM_SUN_FETAL_LUNG_C7_MFNG_POS_DBH_POS_NEURON_CELL,1
GSE25123_CTRL_VS_ROSIGLITAZO...3,SET,178,0.00089146,8.7305e-05,0.062444,0.4943,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...440,SET,68,0.001585,9.623e-05,0.11163,0.49434,GOBP_NEGATIVE_REGULATION_OF_NEURON_DIFFERENTIATION,1
GSE2405_HEAT_KILLED_VS_LIVE_...2,SET,174,0.00091503,8.861e-05,0.065369,0.49442,GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,1
HP_DYSCHROMATOPSIA,SET,29,0.0021981,8.7247e-05,0.15916,0.49449,HP_DYSCHROMATOPSIA,1
GOMF_PROTEIN_ARGININE_OMEGA_...2,SET,5,0.0051336,8.4662e-05,0.37355,0.49452,GOMF_PROTEIN_ARGININE_OMEGA_N_MONOMETHYLTRANSFERASE_ACTIVITY,1
GOBP_CYTOKINETIC_PROCESS,SET,46,0.0016354,8.1714e-05,0.11934,0.49453,GOBP_CYTOKINETIC_PROCESS,1
GOBP_CLEARANCE_OF_FOREIGN_IN...,SET,6,0.0064533,0.00011658,0.47125,0.49454,GOBP_CLEARANCE_OF_FOREIGN_INTRACELLULAR_NUCLEIC_ACIDS,1
REACTOME_TYPE_I_HEMIDESMOSOM...,SET,11,0.0034119,8.3446e-05,0.25222,0.4946,REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY,1
REACTOME_TELOMERE_MAINTENANCE,SET,61,0.0013066,7.5151e-05,0.097779,0.49467,REACTOME_TELOMERE_MAINTENANCE,1
MIR548V,SET,124,0.001014,8.3011e-05,0.07633,0.4947,MIR548V,1
GOBP_INTERLEUKIN_13_PRODUCTI...,SET,21,0.002509,8.476e-05,0.18883,0.4947,GOBP_INTERLEUKIN_13_PRODUCTION,1
GOBP_MACROMOLECULE_CATABOLIC...,SET,1247,0.00031786,7.9937e-05,0.024018,0.49472,GOBP_MACROMOLECULE_CATABOLIC_PROCESS,1
chr13q13,SET,31,0.0035871,0.0001472,0.27227,0.49474,chr13q13,1
WP_SPHINGOLIPID_PATHWAY,SET,27,0.002176,8.3341e-05,0.16652,0.49479,WP_SPHINGOLIPID_PATHWAY,1
MIR4803,SET,411,0.00055769,8.246e-05,0.042962,0.49482,MIR4803,1
ZHAN_MULTIPLE_MYELOMA_CD1_DN,SET,40,0.0017589,8.1967e-05,0.13613,0.49485,ZHAN_MULTIPLE_MYELOMA_CD1_DN,1
HP_AMYOTROPHIC_LATERAL_SCLER...,SET,48,0.0014955,7.6327e-05,0.1159,0.49485,HP_AMYOTROPHIC_LATERAL_SCLEROSIS,1
HP_HYPERLIPIDEMIA,SET,138,0.0009625,8.3089e-05,0.074774,0.49486,HP_HYPERLIPIDEMIA,1
REACTOME_PTK6_REGULATES_RHO_...,SET,14,0.002657,7.3305e-05,0.20725,0.49489,REACTOME_PTK6_REGULATES_RHO_GTPASES_RAS_GTPASE_AND_MAP_KINASES,1
AIZARANI_LIVER_C32_MVECS_3,SET,121,0.0010549,8.5312e-05,0.082864,0.49492,AIZARANI_LIVER_C32_MVECS_3,1
REACTOME_GLUCONEOGENESIS,SET,21,0.0021092,7.1256e-05,0.16744,0.49497,REACTOME_GLUCONEOGENESIS,1
GOBP_REGULATION_OF_EXTRACELL...3,SET,13,0.0028168,7.4889e-05,0.22382,0.49498,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,1
GSE29618_PRE_VS_DAY7_POST_LA...1,SET,175,0.00080854,7.8521e-05,0.064987,0.49504,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_BCELL_DN,1
GSE11961_MARGINAL_ZONE_BCELL...2,SET,179,0.00074197,7.2866e-05,0.059843,0.49505,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOBP_INTRACELLULAR_MONOATOMI...,SET,10,0.0035538,8.2872e-05,0.28774,0.49507,GOBP_INTRACELLULAR_MONOATOMIC_ANION_HOMEOSTASIS,1
PAF1_TARGET_GENES,SET,55,0.0014322,7.8227e-05,0.11629,0.49509,PAF1_TARGET_GENES,1
MILI_PSEUDOPODIA_HAPTOTAXIS_...1,SET,632,0.00040023,7.2931e-05,0.03351,0.49524,MILI_PSEUDOPODIA_HAPTOTAXIS_DN,1
GOCC_CYTOSOLIC_PROTEASOME_CO...,SET,5,0.0035555,5.8636e-05,0.2984,0.49525,GOCC_CYTOSOLIC_PROTEASOME_COMPLEX,1
GOMF_BETA_GLUCOSIDASE_ACTIVI...,SET,5,0.0044579,7.3519e-05,0.3821,0.49535,GOMF_BETA_GLUCOSIDASE_ACTIVITY,1
GOBP_COLLAGEN_FIBRIL_ORGANIZ...,SET,63,0.0013299,7.7729e-05,0.11492,0.49538,GOBP_COLLAGEN_FIBRIL_ORGANIZATION,1
GOBP_RESPONSE_TO_CORTICOSTER...2,SET,15,0.0026387,7.5352e-05,0.22886,0.4954,GOBP_RESPONSE_TO_CORTICOSTERONE,1
HP_PHARYNGITIS,SET,15,0.0025206,7.1981e-05,0.22326,0.4955,HP_PHARYNGITIS,1
HP_ACUTE_KIDNEY_INJURY,SET,34,0.0016072,6.9064e-05,0.14408,0.49555,HP_ACUTE_KIDNEY_INJURY,1
HP_NASOGASTRIC_TUBE_FEEDING,SET,34,0.001557,6.6904e-05,0.14026,0.49557,HP_NASOGASTRIC_TUBE_FEEDING,1
REACTOME_HIGHLY_SODIUM_PERME...,SET,7,0.0032024,6.2485e-05,0.29488,0.49567,REACTOME_HIGHLY_SODIUM_PERMEABLE_POSTSYNAPTIC_ACETYLCHOLINE_NICOTINIC_RECEPTORS,1
CROMER_TUMORIGENESIS_UP,SET,53,0.0014423,7.7339e-05,0.13533,0.49575,CROMER_TUMORIGENESIS_UP,1
GSE41176_UNSTIM_VS_ANTI_IGM_...9,SET,175,0.00066709,6.4783e-05,0.062586,0.49575,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_1H_DN,1
GOBP_MITOCHONDRION_DISTRIBUT...,SET,18,0.0021484,6.72e-05,0.20492,0.49582,GOBP_MITOCHONDRION_DISTRIBUTION,1
MODULE_447,SET,35,0.0014504,6.3234e-05,0.1392,0.49584,MODULE_447,1
KEGG_MEDICUS_REFERENCE_LPAR_...,SET,22,0.0019009,6.5728e-05,0.18436,0.49589,KEGG_MEDICUS_REFERENCE_LPAR_GNB_G_RHO_SIGNALING_PATHWAY,1
GOBP_AMINO_ACID_IMPORT_ACROS...,SET,45,0.0013497,6.6704e-05,0.13234,0.49593,GOBP_AMINO_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
POMEROY_MEDULLOBLASTOMA_DESM...1,SET,52,0.0012612,6.6988e-05,0.12601,0.49601,POMEROY_MEDULLOBLASTOMA_DESMOPLASIC_VS_CLASSIC_DN,1
NAKAYA_B_CELL_FLUMIST_AGE_18...2,SET,416,0.00040106,5.9651e-05,0.040342,0.49603,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP,1
HP_ACHOLIC_STOOLS,SET,8,0.0034461,7.1882e-05,0.34742,0.49604,HP_ACHOLIC_STOOLS,1
GSE3994_WT_VS_PAC1_KO_ACTIVA...2,SET,187,0.00063974,6.4202e-05,0.064723,0.49606,GSE3994_WT_VS_PAC1_KO_ACTIVATED_MAST_CELL_UP,1
MIR4312,SET,42,0.0012943,6.1802e-05,0.13243,0.4961,MIR4312,1
MIR586,SET,256,0.00051802,6.071e-05,0.053586,0.49614,MIR586,1
KEGG_PARKINSONS_DISEASE,SET,92,0.00074891,5.2853e-05,0.078216,0.49618,KEGG_PARKINSONS_DISEASE,1
HP_SCLERODERMA,SET,11,0.0025296,6.1867e-05,0.26438,0.49618,HP_SCLERODERMA,1
GSE41867_DAY6_VS_DAY15_LCMV_...2,SET,161,0.00068555,6.3882e-05,0.072211,0.49621,GSE41867_DAY6_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
WP_CHOLESTEROL_BIOSYNTHESIS_...3,SET,5,0.0031395,5.1775e-05,0.33124,0.49622,WP_CHOLESTEROL_BIOSYNTHESIS_WITH_SKELETAL_DYSPLASIAS,1
GOMF_CARBONYL_REDUCTASE_NADP...,SET,9,0.0028961,6.4071e-05,0.309,0.49626,GOMF_CARBONYL_REDUCTASE_NADPH_ACTIVITY,1
GOMF_CHITIN_BINDING,SET,8,0.0029453,6.1436e-05,0.32056,0.49633,GOMF_CHITIN_BINDING,1
MIR4524A_5P,SET,221,0.00052139,5.6829e-05,0.057285,0.49637,MIR4524A_5P,1
MIR4524B_5P,SET,221,0.00052139,5.6829e-05,0.057285,0.49637,MIR4524B_5P,1
GSE360_T_GONDII_VS_B_MALAYI_...6,SET,174,0.00059151,5.7281e-05,0.066315,0.49644,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_UP,1
MATZUK_IMPLANTATION_AND_UTER...,SET,18,0.0018195,5.6914e-05,0.20751,0.4965,MATZUK_IMPLANTATION_AND_UTERINE,1
MIR1255A_MIR1255B_5P,SET,65,0.00088989,5.2828e-05,0.1026,0.49654,MIR1255A_MIR1255B_5P,1
GOBP_POSTSYNAPTIC_SPECIALIZA...1,SET,29,0.0014091,5.5929e-05,0.16231,0.49654,GOBP_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,1
MATZUK_MATERNAL_EFFECT,SET,7,0.0027446,5.3554e-05,0.31974,0.49658,MATZUK_MATERNAL_EFFECT,1
HP_ACRAL_ULCERATION,SET,8,0.0024972,5.2088e-05,0.29336,0.4966,HP_ACRAL_ULCERATION,1
MIR221_3P,SET,161,0.00056745,5.2878e-05,0.06859,0.4967,MIR221_3P,1
GOBP_POSITIVE_REGULATION_OF_...587,SET,5,0.0029677,4.8943e-05,0.36763,0.49678,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...30,SET,7,0.0025694,5.0135e-05,0.32359,0.49683,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...5,SET,9,0.0023912,5.2902e-05,0.30089,0.49683,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_HIGH_VS_LOW_RESPONDERS_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_TRANSIENT_UP,1
GOBP_HOMEOSTASIS_OF_NUMBER_O...2,SET,33,0.001197,5.0678e-05,0.15359,0.49689,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS_WITHIN_A_TISSUE,1
BIOCARTA_IL4_PATHWAY,SET,10,0.0021361,4.9813e-05,0.27461,0.4969,BIOCARTA_IL4_PATHWAY,1
GOBP_CERAMIDE_METABOLIC_PROC...,SET,99,0.00065064,4.7624e-05,0.087065,0.49702,GOBP_CERAMIDE_METABOLIC_PROCESS,1
GSE360_L_DONOVANI_VS_T_GONDI...1,SET,169,0.00047448,4.529e-05,0.063994,0.49704,GSE360_L_DONOVANI_VS_T_GONDII_DC_DN,1
GSE15330_HSC_VS_LYMPHOID_PRI...1,SET,164,0.00049549,4.6596e-05,0.067361,0.49707,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...352,SET,13,0.0016812,4.4698e-05,0.23159,0.4971,GOBP_NEGATIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
ROVERSI_GLIOMA_COPY_NUMBER_DN,SET,51,0.0010436,5.49e-05,0.14843,0.4972,ROVERSI_GLIOMA_COPY_NUMBER_DN,1
GOBP_NEGATIVE_REGULATION_OF_...591,SET,13,0.0018746,4.9838e-05,0.26672,0.4972,GOBP_NEGATIVE_REGULATION_OF_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,1
GOBP_NEGATIVE_REGULATION_OF_...671,SET,10,0.0020003,4.6647e-05,0.28872,0.49724,GOBP_NEGATIVE_REGULATION_OF_T_CELL_CYTOKINE_PRODUCTION,1
HP_INCREASED_INFLAMMATORY_RE...,SET,1104,0.000182,4.3245e-05,0.026264,0.49724,HP_INCREASED_INFLAMMATORY_RESPONSE,1
GOMF_GLUTAMATE_BINDING,SET,8,0.0023144,4.8275e-05,0.33885,0.49728,GOMF_GLUTAMATE_BINDING,1
REACTOME_THROMBIN_SIGNALLING...,SET,32,0.0010712,4.4659e-05,0.15979,0.49733,REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS,1
GAVISH_3CA_METAPROGRAM_EPITH...14,SET,45,0.00089486,4.4225e-05,0.13487,0.49735,GAVISH_3CA_METAPROGRAM_EPITHELIAL_METABOLISM_KIDNEY_1,1
GOBP_TUBULIN_DEACETYLATION,SET,18,0.0011782,3.6853e-05,0.17822,0.49736,GOBP_TUBULIN_DEACETYLATION,1
HP_TONGUE_THRUSTING,SET,13,0.0014427,3.8357e-05,0.22441,0.49744,HP_TONGUE_THRUSTING,1
GSE21063_3H_VS_16H_ANTI_IGM_...1,SET,168,0.00038287,3.6438e-05,0.059593,0.49744,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN,1
REACTOME_FIBRONECTIN_MATRIX_...,SET,6,0.0023645,4.2715e-05,0.38266,0.49753,REACTOME_FIBRONECTIN_MATRIX_FORMATION,1
HU_FETAL_RETINA_HORIZONTAL,SET,34,0.00094997,4.0821e-05,0.15338,0.49753,HU_FETAL_RETINA_HORIZONTAL,1
IVANOVSKA_MIR106B_TARGETS,SET,82,0.00052505,3.4992e-05,0.087105,0.4976,IVANOVSKA_MIR106B_TARGETS,1
GOBP_REGULATION_OF_RECEPTOR_...3,SET,14,0.0012925,3.566e-05,0.21871,0.49764,GOBP_REGULATION_OF_RECEPTOR_CLUSTERING,1
HP_CEREBRAL_VISUAL_IMPAIRMENT,SET,140,0.00039616,3.4444e-05,0.068756,0.4977,HP_CEREBRAL_VISUAL_IMPAIRMENT,1
GOCC_CLATHRIN_SCULPTED_VESIC...,SET,12,0.0015392,3.9318e-05,0.26953,0.49772,GOCC_CLATHRIN_SCULPTED_VESICLE,1
MORF_CDH4,SET,115,0.00045767,3.6089e-05,0.081433,0.49776,MORF_CDH4,1
FERRANDO_LYL1_NEIGHBORS,SET,15,0.0013528,3.863e-05,0.24231,0.49777,FERRANDO_LYL1_NEIGHBORS,1
GOBP_NEURONAL_ACTION_POTENTI...2,SET,10,0.0015208,3.5463e-05,0.27326,0.49778,GOBP_NEURONAL_ACTION_POTENTIAL_PROPAGATION,1
CREB_Q2_01,SET,206,0.00031032,3.2669e-05,0.058644,0.49789,CREB_Q2_01,1
GOBP_SYNAPTIC_TRANSMISSION_D...,SET,27,0.00083464,3.1967e-05,0.15902,0.49791,GOBP_SYNAPTIC_TRANSMISSION_DOPAMINERGIC,1
GOBP_NEGATIVE_REGULATION_OF_...540,SET,5,0.0021014,3.4656e-05,0.40274,0.49792,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MITOCHONDRION,1
HP_DELAYED_ERUPTION_OF_PRIMA...,SET,14,0.0010732,2.9608e-05,0.21043,0.49797,HP_DELAYED_ERUPTION_OF_PRIMARY_TEETH,1
SWEET_LUNG_CANCER_KRAS_DN,SET,387,0.00023216,3.3332e-05,0.046866,0.49802,SWEET_LUNG_CANCER_KRAS_DN,1
WOTTON_RUNX_TARGETS_DN,SET,26,0.00089549,3.3657e-05,0.18286,0.49805,WOTTON_RUNX_TARGETS_DN,1
WP_MELATONIN_METABOLISM_AND_...,SET,31,0.00073943,3.0342e-05,0.15528,0.4981,WP_MELATONIN_METABOLISM_AND_EFFECTS,1
GSE21063_CTRL_VS_ANTI_IGM_ST...2,SET,180,0.00029016,2.8574e-05,0.06191,0.49813,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP,1
GSE6259_BCELL_VS_CD4_TCELL_UP,SET,154,0.00030916,2.8181e-05,0.066382,0.49814,GSE6259_BCELL_VS_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...320,SET,32,0.00065639,2.7365e-05,0.15042,0.49826,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...319,SET,220,0.00025218,2.7425e-05,0.058588,0.49828,GOBP_POSITIVE_REGULATION_OF_GROWTH,1
GOLDRATH_NAIVE_VS_MEMORY_CD8...1,SET,183,0.00026888,2.6696e-05,0.064545,0.49834,GOLDRATH_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
ZHOU_INFLAMMATORY_RESPONSE_F...2,SET,427,0.00017569,2.6466e-05,0.042458,0.49835,ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP,1
GOBP_BONE_MARROW_DEVELOPMENT,SET,9,0.0012044,2.6647e-05,0.29364,0.49836,GOBP_BONE_MARROW_DEVELOPMENT,1
HP_PERIMEMBRANOUS_VENTRICULA...,SET,23,0.00076762,2.7138e-05,0.18746,0.49837,HP_PERIMEMBRANOUS_VENTRICULAR_SEPTAL_DEFECT,1
GOBP_NUCLEOBASE_CONTAINING_S...2,SET,28,0.00075741,2.954e-05,0.19243,0.49843,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_CATABOLIC_PROCESS,1
GSE37534_GW1929_VS_ROSIGLITA...2,SET,150,0.00025525,2.2965e-05,0.066717,0.49847,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,1
GOMF_VASCULAR_ENDOTHELIAL_GR...2,SET,9,0.0011327,2.5059e-05,0.30379,0.49851,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_BINDING,1
GSE43863_NAIVE_VS_LY6C_INT_C...1,SET,146,0.00026202,2.326e-05,0.07172,0.49854,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_DN,1
MIR6503_5P,SET,52,0.00041587,2.2089e-05,0.11689,0.49858,MIR6503_5P,1
GOBP_POSITIVE_REGULATION_OF_...415,SET,10,0.00098722,2.3021e-05,0.28037,0.4986,GOBP_POSITIVE_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
GSE13485_CTRL_VS_DAY21_YF17D...2,SET,177,0.00020477,1.9998e-05,0.059859,0.49864,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
GOBP_REGULATION_OF_VERY_LOW_...1,SET,4,0.0012608,1.8598e-05,0.38774,0.4987,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
MIR6501_3P,SET,132,0.00023622,1.9947e-05,0.074898,0.49874,MIR6501_3P,1
GOBP_MALE_MEIOTIC_NUCLEAR_DI...,SET,49,0.00034843,1.7967e-05,0.10991,0.49874,GOBP_MALE_MEIOTIC_NUCLEAR_DIVISION,1
GOBP_PROTEIN_HETEROTETRAMERI...,SET,15,0.00060901,1.7391e-05,0.19348,0.49874,GOBP_PROTEIN_HETEROTETRAMERIZATION,1
GOMF_1_ACYLGLYCEROPHOSPHOCHO...,SET,6,0.0011738,2.1205e-05,0.3949,0.49881,GOMF_1_ACYLGLYCEROPHOSPHOCHOLINE_O_ACYLTRANSFERASE_ACTIVITY,1
PLASARI_NFIC_TARGETS_BASAL_UP,SET,28,0.0005335,2.0808e-05,0.18048,0.49882,PLASARI_NFIC_TARGETS_BASAL_UP,1
GSE12845_IGD_NEG_BLOOD_VS_DA...1,SET,182,0.00015873,1.5717e-05,0.05854,0.49892,GSE12845_IGD_NEG_BLOOD_VS_DARKZONE_GC_TONSIL_BCELL_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...19,SET,13,0.000697,1.8531e-05,0.26215,0.49894,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_SALMON_DN,1
HOWARD_NEUTROPHIL_INACT_MONO...3,SET,8,0.00066604,1.3893e-05,0.28357,0.49906,HOWARD_NEUTROPHIL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_DN,1
MIR711,SET,36,0.00031249,1.3817e-05,0.1373,0.49909,MIR711,1
HP_WIDE_INTERMAMILLARY_DISTA...,SET,103,0.00017417,1.3002e-05,0.080735,0.49914,HP_WIDE_INTERMAMILLARY_DISTANCE,1
GAVISH_3CA_METAPROGRAM_FIBRO...15,SET,44,0.00030977,1.5139e-05,0.14725,0.49916,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_LIPID_METABOLISM,1
GOCC_PRESYNAPSE,SET,524,8.0654e-05,1.3423e-05,0.038276,0.49916,GOCC_PRESYNAPSE,1
BRUINS_UVC_RESPONSE_LATE,SET,1032,5.3711e-05,1.2365e-05,0.026033,0.49918,BRUINS_UVC_RESPONSE_LATE,1
SHEPARD_CRASH_AND_BURN_MUTAN...2,SET,187,0.00012311,1.2355e-05,0.062497,0.49921,SHEPARD_CRASH_AND_BURN_MUTANT_UP,1
GOCC_SYNAPTOBREVIN_2_SNAP_25...,SET,5,0.00073263,1.2082e-05,0.37154,0.49921,GOCC_SYNAPTOBREVIN_2_SNAP_25_SYNTAXIN_1A_COMPLEX,1
GOCC_LAMELLIPODIUM_MEMBRANE,SET,22,0.00034921,1.2075e-05,0.18923,0.49926,GOCC_LAMELLIPODIUM_MEMBRANE,1
GOBP_REGULATION_OF_CALCIUM_M...,SET,92,0.00016292,1.1498e-05,0.08966,0.49928,GOBP_REGULATION_OF_CALCIUM_MEDIATED_SIGNALING,1
HP_ABNORMAL_LIVER_ENZYME_ACT...,SET,11,0.00042958,1.0506e-05,0.23757,0.49928,HP_ABNORMAL_LIVER_ENZYME_ACTIVITY_OR_CONCENTRATION,1
MIR9851_3P,SET,161,0.00011323,1.0551e-05,0.066245,0.49932,MIR9851_3P,1
MORF_CD8A,SET,111,0.00014626,1.1332e-05,0.085394,0.49932,MORF_CD8A,1
PLASARI_TGFB1_TARGETS_1HR_UP,SET,33,0.00026263,1.1118e-05,0.16461,0.49936,PLASARI_TGFB1_TARGETS_1HR_UP,1
GOBP_NEGATIVE_REGULATION_OF_...60,SET,7,0.00055011,1.0734e-05,0.34214,0.49936,GOBP_NEGATIVE_REGULATION_OF_B_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_FLAVONOID_METABOLIC_PRO...,SET,11,0.00048713,1.1914e-05,0.32484,0.4994,GOBP_FLAVONOID_METABOLIC_PROCESS,1
HP_ABNORMAL_CAUDATE_NUCLEUS_...,SET,19,0.00028871,9.2779e-06,0.19707,0.49942,HP_ABNORMAL_CAUDATE_NUCLEUS_MORPHOLOGY,1
BLANCO_MELO_MERS_COV_INFECTI...1,SET,31,0.00021304,8.7422e-06,0.16206,0.49948,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_DN,1
GOBP_INDUCTION_OF_POSITIVE_C...,SET,13,0.0003443,9.1536e-06,0.26585,0.49948,GOBP_INDUCTION_OF_POSITIVE_CHEMOTAXIS,1
HP_ABNORMAL_CIRCULATING_ARGI...,SET,8,0.00034334,7.1616e-06,0.28202,0.49951,HP_ABNORMAL_CIRCULATING_ARGININE_CONCENTRATION,1
HP_BRONCHIECTASIS,SET,154,8.0947e-05,7.3785e-06,0.069233,0.49953,HP_BRONCHIECTASIS,1
MIR487B_3P,SET,9,0.00031783,7.0315e-06,0.29821,0.49957,MIR487B_3P,1
GOMF_ACETYLCHOLINE_RECEPTOR_...3,SET,7,0.00040294,7.8623e-06,0.37703,0.49957,GOMF_ACETYLCHOLINE_RECEPTOR_INHIBITOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...169,SET,13,0.00027218,7.2362e-06,0.26151,0.49958,GOBP_POSITIVE_REGULATION_OF_CILIUM_MOVEMENT,1
KEGG_MEDICUS_REFERENCE_FLCN_...,SET,13,0.0002241,5.9579e-06,0.21695,0.49959,KEGG_MEDICUS_REFERENCE_FLCN_MTORC1_SIGNALING_PATHWAY,1
HP_CHILDHOOD_ONSET,SET,774,3.1384e-05,6.3034e-06,0.030663,0.49959,HP_CHILDHOOD_ONSET,1
GSE12963_UNINF_VS_ENV_AND_NE...2,SET,119,7.4904e-05,6.0076e-06,0.07612,0.49961,GSE12963_UNINF_VS_ENV_AND_NEF_AND_VPR_DEFICIENT_HIV1_INF_CD4_TCELL_UP,1
GOMF_PHOSPHATIDIC_ACID_TRANS...,SET,5,0.00036108,5.9547e-06,0.38513,0.49963,GOMF_PHOSPHATIDIC_ACID_TRANSFER_ACTIVITY,1
GSE22886_NAIVE_CD8_TCELL_VS_...7,SET,171,6.6342e-05,6.3694e-06,0.071278,0.49963,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_DN,1
HP_ABNORMAL_HIP_JOINT_MORPHO...,SET,336,3.6852e-05,4.9371e-06,0.045659,0.49968,HP_ABNORMAL_HIP_JOINT_MORPHOLOGY,1
REACTOME_INITIATION_OF_NUCLE...,SET,18,0.00014049,4.3945e-06,0.18414,0.4997,REACTOME_INITIATION_OF_NUCLEAR_ENVELOPE_NE_REFORMATION,1
KEGG_MEDICUS_REFERENCE_COHES...3,SET,14,0.00015476,4.2696e-06,0.21096,0.49971,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_PROPHASE,1
HP_HYPOPLASTIC_AORTIC_ARCH,SET,11,0.00016513,4.0385e-06,0.25609,0.49974,HP_HYPOPLASTIC_AORTIC_ARCH,1
GOMF_MYRISTOYLTRANSFERASE_AC...,SET,10,0.00012595,2.9372e-06,0.23191,0.49978,GOMF_MYRISTOYLTRANSFERASE_ACTIVITY,1
GOBP_REGULATION_OF_INSULIN_S...2,SET,51,5.5038e-05,2.8952e-06,0.11742,0.49981,GOBP_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
GOMF_NUCLEOTIDE_RECEPTOR_ACT...,SET,17,0.00011855,3.6039e-06,0.24419,0.49981,GOMF_NUCLEOTIDE_RECEPTOR_ACTIVITY,1
GOBP_REGULATION_OF_TRANSMEMB...1,SET,247,2.3933e-05,2.7558e-06,0.056427,0.49983,GOBP_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,1
HP_KETOACIDOSIS,SET,35,5.4721e-05,2.3857e-06,0.14746,0.49985,HP_KETOACIDOSIS,1
GOBP_RESPONSE_TO_COCAINE,SET,54,4.2695e-05,2.3109e-06,0.12053,0.49986,GOBP_RESPONSE_TO_COCAINE,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...4,SET,13,6.4556e-05,1.7163e-06,0.22773,0.49989,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY,1
GOBP_NEUTROPHIL_MIGRATION,SET,96,2.2487e-05,1.6209e-06,0.093466,0.4999,GOBP_NEUTROPHIL_MIGRATION,1
HP_LACK_OF_SKIN_ELASTICITY,SET,56,2.9157e-05,1.607e-06,0.11586,0.4999,HP_LACK_OF_SKIN_ELASTICITY,1
GSE21379_TFH_VS_NON_TFH_SAP_...1,SET,172,1.6041e-05,1.5445e-06,0.064824,0.4999,GSE21379_TFH_VS_NON_TFH_SAP_KO_CD4_TCELL_DN,1
MIKKELSEN_MEF_LCP_WITH_H3K4M...,SET,112,1.7593e-05,1.3692e-06,0.081338,0.49991,MIKKELSEN_MEF_LCP_WITH_H3K4ME3,1
GOBP_CELLULAR_COMPONENT_ASSE...,SET,130,1.0228e-05,8.5714e-07,0.072395,0.49994,GOBP_CELLULAR_COMPONENT_ASSEMBLY_INVOLVED_IN_MORPHOGENESIS,1
GSE37605_TREG_VS_TCONV_C57BL...4,SET,114,-2.3894e-06,-1.876e-07,0.07973,0.50001,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_IRES_GFP_UP,1
GOBP_RESPONSE_TO_LIPID,SET,853,-1.9501e-06,-4.1025e-07,0.030832,0.50003,GOBP_RESPONSE_TO_LIPID,1
GSE3691_IFN_PRODUCING_KILLER...3,SET,176,-1.7397e-05,-1.6943e-06,0.06257,0.50011,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN,1
REACTOME_E2F_MEDIATED_REGULA...,SET,20,-7.9103e-05,-2.608e-06,0.17138,0.50018,REACTOME_E2F_MEDIATED_REGULATION_OF_DNA_REPLICATION,1
GOBP_RUFFLE_ASSEMBLY,SET,42,-6.9405e-05,-3.314e-06,0.13788,0.5002,GOBP_RUFFLE_ASSEMBLY,1
GSE360_CTRL_VS_T_GONDII_MAC_...1,SET,179,-3.7523e-05,-3.685e-06,0.062214,0.50024,GSE360_CTRL_VS_T_GONDII_MAC_DN,1
GSE40274_CTRL_VS_FOXP3_AND_I...1,SET,148,-4.6298e-05,-4.1378e-06,0.066888,0.50028,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_MUSCLE_FIBRILLATION,SET,58,-8.0037e-05,-4.4891e-06,0.10954,0.50029,HP_MUSCLE_FIBRILLATION,1
GOBP_LEUKOCYTE_ADHESION_TO_V...,SET,47,-0.00012434,-6.2798e-06,0.13283,0.50037,GOBP_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,1
GOCC_DENDRITE_MEMBRANE,SET,37,-0.0001826,-8.1849e-06,0.14189,0.50051,GOCC_DENDRITE_MEMBRANE,1
HP_LABIAL_HYPERTROPHY,SET,7,-0.00049185,-9.597e-06,0.37709,0.50052,HP_LABIAL_HYPERTROPHY,1
HP_SEVERE_INFECTION,SET,61,-0.00014772,-8.4962e-06,0.10892,0.50054,HP_SEVERE_INFECTION,1
COLLIS_PRKDC_SUBSTRATES,SET,15,-0.00029246,-8.3516e-06,0.20423,0.50057,COLLIS_PRKDC_SUBSTRATES,1
GHO_ATF5_TARGETS_DN,SET,16,-0.00033026,-9.7402e-06,0.22533,0.50058,GHO_ATF5_TARGETS_DN,1
MODULE_149,SET,34,-0.00019704,-8.4672e-06,0.13274,0.50059,MODULE_149,1
GOMF_PROTEIN_SERINE_THREONIN...2,SET,392,-6.2086e-05,-8.97e-06,0.041851,0.50059,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
REACTOME_RAS_SIGNALING_DOWNS...,SET,7,-0.00049284,-9.6164e-06,0.30085,0.50065,REACTOME_RAS_SIGNALING_DOWNSTREAM_OF_NF1_LOSS_OF_FUNCTION_VARIANTS,1
GOCC_MICROTUBULE_END,SET,33,-0.00023906,-1.0121e-05,0.14495,0.50066,GOCC_MICROTUBULE_END,1
GCM_PFN1,SET,44,-0.00020617,-1.0076e-05,0.12038,0.50068,GCM_PFN1,1
GSE37532_TREG_VS_TCONV_CD4_T...2,SET,181,-0.00010689,-1.0556e-05,0.060586,0.5007,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_LN_UP,1
GSE17721_CTRL_VS_LPS_1H_BMDC...1,SET,181,-0.00012088,-1.1937e-05,0.064153,0.50075,GSE17721_CTRL_VS_LPS_1H_BMDC_DN,1
GSE25123_CTRL_VS_IL4_STIM_MA...2,SET,177,-0.0001172,-1.1446e-05,0.062653,0.50075,GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_UP,1
REACTOME_SIGNALING_BY_LTK_IN...,SET,7,-0.00064014,-1.249e-05,0.33482,0.50076,REACTOME_SIGNALING_BY_LTK_IN_CANCER,1
GOBP_CELL_COMMUNICATION_INVO...,SET,55,-0.00024033,-1.3127e-05,0.12662,0.50076,GOBP_CELL_COMMUNICATION_INVOLVED_IN_CARDIAC_CONDUCTION,1
HP_MECKEL_DIVERTICULUM,SET,25,-0.00032315,-1.191e-05,0.1524,0.50085,HP_MECKEL_DIVERTICULUM,1
GOBP_POSITIVE_REGULATION_OF_...402,SET,89,-0.00020504,-1.4234e-05,0.093663,0.50087,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
GSE27241_WT_VS_RORGT_KO_TH17...1,SET,152,-0.00013916,-1.2603e-05,0.063597,0.50087,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_DN,1
MIR342_5P,SET,57,-0.00024969,-1.3884e-05,0.10888,0.50091,MIR342_5P,1
OUELLET_OVARIAN_CANCER_INVAS...1,SET,11,-0.00069331,-1.6956e-05,0.29387,0.50094,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1
HP_ASCITES,SET,125,-0.00018429,-1.5147e-05,0.077807,0.50094,HP_ASCITES,1
GSE3982_NKCELL_VS_TH1_UP,SET,172,-0.00017266,-1.6624e-05,0.066961,0.50103,GSE3982_NKCELL_VS_TH1_UP,1
GOBP_DNA_DEMETHYLATION,SET,18,-0.00062024,-1.9401e-05,0.23865,0.50104,GOBP_DNA_DEMETHYLATION,1
GOBP_RESPONSE_TO_PROGESTERONE,SET,42,-0.00038733,-1.8495e-05,0.13102,0.50118,GOBP_RESPONSE_TO_PROGESTERONE,1
MIR4769_3P,SET,97,-0.00025822,-1.871e-05,0.085964,0.5012,MIR4769_3P,1
KIM_WT1_TARGETS_8HR_DN,SET,113,-0.00023435,-1.8319e-05,0.076512,0.50122,KIM_WT1_TARGETS_8HR_DN,1
REACTOME_TACHYKININ_RECEPTOR...,SET,5,-0.0012233,-2.0174e-05,0.39816,0.50123,REACTOME_TACHYKININ_RECEPTORS_BIND_TACHYKININS,1
GOBP_HOMOLOGOUS_CHROMOSOME_S...,SET,56,-0.00032665,-1.8004e-05,0.10355,0.50126,GOBP_HOMOLOGOUS_CHROMOSOME_SEGREGATION,1
GOBP_GAMETE_GENERATION,SET,676,-0.00010686,-2.0114e-05,0.031995,0.50133,GOBP_GAMETE_GENERATION,1
AKT_UP_MTOR_DN.V1_DN,SET,173,-0.00021513,-2.0773e-05,0.064473,0.50133,AKT_UP_MTOR_DN.V1_DN,1
GSE21670_UNTREATED_VS_TGFB_I...1,SET,160,-0.00022752,-2.1136e-05,0.06715,0.50135,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN,1
MYB_Q5_01,SET,247,-0.00019337,-2.2266e-05,0.05416,0.50142,MYB_Q5_01,1
HE_PTEN_TARGETS_DN,SET,7,-0.0013052,-2.5467e-05,0.36018,0.50145,HE_PTEN_TARGETS_DN,1
HP_POROKERATOSIS,SET,7,-0.0010965,-2.1395e-05,0.30101,0.50145,HP_POROKERATOSIS,1
chr6p23,SET,7,-0.0014342,-2.7984e-05,0.38379,0.50149,chr6p23,1
GOBP_EPITHELIAL_CELL_DIFFERE...2,SET,46,-0.00053813,-2.6888e-05,0.14116,0.50152,GOBP_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
MIR597_5P,SET,72,-0.00037621,-2.3501e-05,0.097246,0.50154,MIR597_5P,1
HP_POSTERIOR_FOSSA_CYST,SET,15,-0.00088477,-2.5266e-05,0.22303,0.50158,HP_POSTERIOR_FOSSA_CYST,1
REACTOME_SYNTHESIS_SECRETION...1,SET,18,-0.00083438,-2.6099e-05,0.2057,0.50162,REACTOME_SYNTHESIS_SECRETION_AND_DEACYLATION_OF_GHRELIN,1
GSE5099_MONOCYTE_VS_ALTERNAT...2,SET,143,-0.00028369,-2.4926e-05,0.069899,0.50162,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_UP,1
JIANG_MELANOMA_TRM7_CD8,SET,78,-0.00039297,-2.5546e-05,0.094906,0.50165,JIANG_MELANOMA_TRM7_CD8,1
GSE11057_CD4_EFF_MEM_VS_PBMC...2,SET,175,-0.00026901,-2.6125e-05,0.063267,0.5017,GSE11057_CD4_EFF_MEM_VS_PBMC_UP,1
GAVISH_3CA_METAPROGRAM_FIBRO...7,SET,48,-0.00056769,-2.8973e-05,0.13143,0.50172,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_6,1
GOBP_REGULATION_OF_ACTION_PO...,SET,52,-0.00054924,-2.9174e-05,0.12714,0.50172,GOBP_REGULATION_OF_ACTION_POTENTIAL,1
DURANTE_ADULT_OLFACTORY_NEUR...19,SET,119,-0.00033251,-2.6669e-05,0.075636,0.50175,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS,1
GOBP_GLUTATHIONE_METABOLIC_P...,SET,46,-0.00057907,-2.8934e-05,0.13072,0.50177,GOBP_GLUTATHIONE_METABOLIC_PROCESS,1
RASHI_RESPONSE_TO_IONIZING_R...1,SET,36,-0.00066657,-2.9472e-05,0.14181,0.50188,RASHI_RESPONSE_TO_IONIZING_RADIATION_1,1
GSE25088_CTRL_VS_IL4_STIM_ST...2,SET,156,-0.00032631,-2.9935e-05,0.067935,0.50192,GSE25088_CTRL_VS_IL4_STIM_STAT6_KO_MACROPHAGE_UP,1
HP_ENLARGED_CEREBELLUM,SET,6,-0.0017181,-3.1037e-05,0.34775,0.50197,HP_ENLARGED_CEREBELLUM,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...3,SET,13,-0.0012788,-3.3999e-05,0.25309,0.50202,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_3,1
GOCC_MICROTUBULE_PLUS_END,SET,24,-0.00083199,-3.0045e-05,0.1606,0.50207,GOCC_MICROTUBULE_PLUS_END,1
GOMF_LEUKOTRIENE_C4_GAMMA_GL...,SET,4,-0.0022152,-3.2677e-05,0.42614,0.50207,GOMF_LEUKOTRIENE_C4_GAMMA_GLUTAMYL_TRANSFERASE_ACTIVITY,1
MPHOSPH8_TARGET_GENES,SET,7,-0.0017113,-3.3391e-05,0.32693,0.50209,MPHOSPH8_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_MEVAL...,SET,12,-0.001106,-2.8252e-05,0.20875,0.50211,KEGG_MEDICUS_REFERENCE_MEVALONATE_PATHWAY,1
GSE2770_TGFB_AND_IL4_VS_IL4_...6,SET,162,-0.00033248,-3.1077e-05,0.062682,0.50212,GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
MANNO_MIDBRAIN_NEUROTYPES_HRN,SET,300,-0.00028022,-3.5508e-05,0.052718,0.50212,MANNO_MIDBRAIN_NEUROTYPES_HRN,1
WP_11P112_COPY_NUMBER_VARIAT...,SET,52,-0.00072474,-3.8495e-05,0.13456,0.50215,WP_11P112_COPY_NUMBER_VARIATION_SYNDROME,1
ARGGGTTAA_UNKNOWN,SET,111,-0.00046027,-3.5661e-05,0.084641,0.50217,ARGGGTTAA_UNKNOWN,1
GOBP_NEURON_MATURATION,SET,46,-0.00071793,-3.5872e-05,0.13137,0.50218,GOBP_NEURON_MATURATION,1
HP_SINGLE_LINEAGE_MYELODYSPL...,SET,5,-0.0019702,-3.2492e-05,0.34808,0.50226,HP_SINGLE_LINEAGE_MYELODYSPLASIA,1
HP_CORONARY_ARTERY_STENOSIS,SET,6,-0.0018773,-3.3913e-05,0.32547,0.5023,HP_CORONARY_ARTERY_STENOSIS,1
GOCC_ELONGATOR_HOLOENZYME_CO...,SET,5,-0.0022334,-3.6832e-05,0.38543,0.50231,GOCC_ELONGATOR_HOLOENZYME_COMPLEX,1
GOBP_BINDING_OF_SPERM_TO_ZON...,SET,38,-0.00075803,-3.4432e-05,0.13006,0.50233,GOBP_BINDING_OF_SPERM_TO_ZONA_PELLUCIDA,1
DLX4_TARGET_GENES,SET,689,-0.00018878,-3.5859e-05,0.032174,0.50234,DLX4_TARGET_GENES,1
GOCC_POLYPRENYL_DIPHOSPHATE_...,SET,10,-0.0014641,-3.4142e-05,0.2496,0.50234,GOCC_POLYPRENYL_DIPHOSPHATE_SYNTHASE_COMPLEX,1
GSE43863_NAIVE_VS_TFH_CD4_EF...1,SET,149,-0.0004183,-3.751e-05,0.071196,0.50234,GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN,1
HP_PRIMARY_CONGENITAL_GLAUCO...,SET,6,-0.002092,-3.7792e-05,0.35271,0.50237,HP_PRIMARY_CONGENITAL_GLAUCOMA,1
HE_LIM_SUN_FETAL_LUNG_C2_HSC...1,SET,1385,-0.0001387,-3.6613e-05,0.022767,0.50243,HE_LIM_SUN_FETAL_LUNG_C2_HSC_CELL,1
MEBARKI_HCC_PROGENITOR_WNT_U...1,SET,107,-0.00056543,-4.3017e-05,0.089346,0.50252,MEBARKI_HCC_PROGENITOR_WNT_UP_BLOCKED_BY_FZD8CRD,1
GOBP_CARBOHYDRATE_BIOSYNTHET...,SET,186,-0.00040288,-4.0324e-05,0.061982,0.50259,GOBP_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,1
PID_FCER1_PATHWAY,SET,56,-0.00073388,-4.0448e-05,0.11023,0.50266,PID_FCER1_PATHWAY,1
FXR_IR1_Q6,SET,105,-0.00057113,-4.3045e-05,0.08544,0.50267,FXR_IR1_Q6,1
GOBP_ORGANONITROGEN_COMPOUND...1,SET,1503,-0.00015269,-4.1842e-05,0.022355,0.50272,GOBP_ORGANONITROGEN_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOBP_TOOTH_MINERALIZATION,SET,28,-0.0011409,-4.4499e-05,0.16719,0.50272,GOBP_TOOTH_MINERALIZATION,1
GOBP_POSITIVE_REGULATION_OF_...607,SET,96,-0.00056037,-4.0393e-05,0.081761,0.50273,GOBP_POSITIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,1
PID_ANTHRAX_PATHWAY,SET,17,-0.0014532,-4.4176e-05,0.21022,0.50276,PID_ANTHRAX_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_TO...1,SET,95,-0.00059074,-4.2362e-05,0.085071,0.50277,GOBP_CELLULAR_RESPONSE_TO_TOPOLOGICALLY_INCORRECT_PROTEIN,1
GSE17721_0.5H_VS_8H_CPG_BMDC...2,SET,188,-0.00041602,-4.186e-05,0.059893,0.50277,GSE17721_0.5H_VS_8H_CPG_BMDC_UP,1
FAELT_B_CLL_WITH_VH3_21_DN,SET,44,-0.00089159,-4.3572e-05,0.12714,0.5028,FAELT_B_CLL_WITH_VH3_21_DN,1
HP_DELAYED_OSSIFICATION_OF_C...,SET,15,-0.0014064,-4.0163e-05,0.20004,0.5028,HP_DELAYED_OSSIFICATION_OF_CARPAL_BONES,1
GOBP_PHARYNGEAL_SYSTEM_DEVEL...,SET,29,-0.0012848,-5.0996e-05,0.17969,0.50285,GOBP_PHARYNGEAL_SYSTEM_DEVELOPMENT,1
GOBP_RNA_SPLICING_VIA_TRANSE...,SET,270,-0.0003366,-4.0497e-05,0.046373,0.5029,GOBP_RNA_SPLICING_VIA_TRANSESTERIFICATION_REACTIONS,1
MIR4713_5P,SET,140,-0.00051182,-4.45e-05,0.070203,0.50291,MIR4713_5P,1
GOBP_CELL_AGGREGATION,SET,22,-0.0014565,-5.036e-05,0.19916,0.50292,GOBP_CELL_AGGREGATION,1
HP_ABNORMALITY_OF_CANINE,SET,16,-0.001633,-4.816e-05,0.21621,0.50301,HP_ABNORMALITY_OF_CANINE,1
GOCC_MITOTIC_SPINDLE_ASTRAL_...,SET,7,-0.0023586,-4.6022e-05,0.31132,0.50302,GOCC_MITOTIC_SPINDLE_ASTRAL_MICROTUBULE,1
GSE3691_CONVENTIONAL_VS_PLAS...1,SET,182,-0.00047573,-4.7106e-05,0.062747,0.50302,GSE3691_CONVENTIONAL_VS_PLASMACYTOID_DC_SPLEEN_DN,1
REACTOME_MITOCHONDRIAL_PROTE...2,SET,54,-0.00083849,-4.5383e-05,0.10648,0.50314,REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT,1
GOBP_REGULATION_OF_EXOCYTOSIS,SET,155,-0.00053652,-4.9063e-05,0.067819,0.50316,GOBP_REGULATION_OF_EXOCYTOSIS,1
WP_P38_MAPK_SIGNALING,SET,33,-0.0011542,-4.8863e-05,0.1449,0.50318,WP_P38_MAPK_SIGNALING,1
GOBP_REGULATION_OF_PROGRAMME...1,SET,1349,-0.00019254,-5.0213e-05,0.023993,0.5032,GOBP_REGULATION_OF_PROGRAMMED_CELL_DEATH,1
GSE369_SOCS3_KO_VS_WT_LIVER_...1,SET,184,-0.00048393,-4.8178e-05,0.060303,0.5032,GSE369_SOCS3_KO_VS_WT_LIVER_DN,1
GSE23568_CTRL_VS_ID3_TRANSDU...2,SET,183,-0.00048585,-4.8239e-05,0.060226,0.50322,GSE23568_CTRL_VS_ID3_TRANSDUCED_CD8_TCELL_UP,1
chr4q35,SET,36,-0.0020829,-9.2093e-05,0.25693,0.50323,chr4q35,1
GOBP_CARTILAGE_DEVELOPMENT,SET,187,-0.00053074,-5.3262e-05,0.064592,0.50328,GOBP_CARTILAGE_DEVELOPMENT,1
GSE26488_WT_VS_HDAC7_DELTAP_...2,SET,184,-0.00053737,-5.3497e-05,0.065245,0.50329,GSE26488_WT_VS_HDAC7_DELTAP_TG_OT2_THYMOCYTE_WITH_PEPTIDE_INJECTION_UP,1
GOBP_RESPONSE_TO_PEPTIDE_HOR...,SET,405,-0.00036305,-5.3295e-05,0.042983,0.50337,GOBP_RESPONSE_TO_PEPTIDE_HORMONE,1
HP_RIB_FUSION,SET,45,-0.0010741,-5.3082e-05,0.127,0.50337,HP_RIB_FUSION,1
GSE43955_TGFB_IL6_VS_TGFB_IL...1,SET,176,-0.00056414,-5.4941e-05,0.06663,0.50338,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_DN,1
GOMF_HYDROLASE_ACTIVITY_ACTI...5,SET,69,-0.00084047,-5.14e-05,0.098452,0.50341,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_LINEAR_AMIDES,1
HP_ABNORMAL_SKIN_ADNEXA_MORP...,SET,1293,-0.00020394,-5.2156e-05,0.023832,0.50341,HP_ABNORMAL_SKIN_ADNEXA_MORPHOLOGY,1
HP_ABDOMINAL_COLIC,SET,5,-0.0037219,-6.1381e-05,0.43232,0.50343,HP_ABDOMINAL_COLIC,1
GOMF_DNA_NUCLEASE_ACTIVITY,SET,59,-0.00089445,-5.0597e-05,0.1034,0.50345,GOMF_DNA_NUCLEASE_ACTIVITY,1
HP_PERICARDIAL_EFFUSION,SET,39,-0.001177,-5.4161e-05,0.13518,0.50347,HP_PERICARDIAL_EFFUSION,1
MIR1287_5P,SET,58,-0.00093777,-5.2597e-05,0.10765,0.50348,MIR1287_5P,1
chr2q36,SET,34,-0.0022649,-9.7326e-05,0.25564,0.50353,chr2q36,1
GOMF_VITAMIN_TRANSMEMBRANE_T...,SET,33,-0.0013325,-5.6412e-05,0.14882,0.50357,GOMF_VITAMIN_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOCC_PROTEASOME_ACCESSORY_CO...,SET,23,-0.0014141,-4.9995e-05,0.15666,0.5036,GOCC_PROTEASOME_ACCESSORY_COMPLEX,1
MOTAMED_RESPONSE_TO_ANDROGEN...1,SET,6,-0.0030327,-5.4787e-05,0.33219,0.50364,MOTAMED_RESPONSE_TO_ANDROGEN_DN,1
GOBP_REGULATION_OF_NATURAL_K...2,SET,8,-0.003015,-6.2889e-05,0.32958,0.50365,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_CHEMOTAXIS,1
REACTOME_MITOCHONDRIAL_RNA_D...,SET,10,-0.0022644,-5.2806e-05,0.24697,0.50366,REACTOME_MITOCHONDRIAL_RNA_DEGRADATION,1
GOBP_NEGATIVE_REGULATION_OF_...49,SET,32,-0.0014126,-5.8894e-05,0.15272,0.50369,GOBP_NEGATIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,1
HP_NEONATAL_RESPIRATORY_DIST...,SET,136,-0.00065578,-5.6202e-05,0.070721,0.5037,HP_NEONATAL_RESPIRATORY_DISTRESS,1
SPIELMAN_LYMPHOBLAST_EUROPEA...4,SET,430,-0.00035906,-5.4275e-05,0.038638,0.50371,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP,1
HP_SCOTOMA,SET,69,-0.00097052,-5.9354e-05,0.10325,0.50375,HP_SCOTOMA,1
SMN1_SMN2_TARGET_GENES,SET,628,-0.00031887,-5.7928e-05,0.033385,0.50381,SMN1_SMN2_TARGET_GENES,1
GOCC_CARDIAC_MYOFIBRIL,SET,6,-0.0035006,-6.324e-05,0.35632,0.50392,GOCC_CARDIAC_MYOFIBRIL,1
KEGG_MEDICUS_REFERENCE_REGUL...8,SET,19,-0.0021344,-6.8592e-05,0.21506,0.50396,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_PTP,1
HP_SHALLOW_ACETABULAR_FOSSAE,SET,10,-0.0025335,-5.908e-05,0.25271,0.504,HP_SHALLOW_ACETABULAR_FOSSAE,1
PAX8_B,SET,91,-0.00092944,-6.5239e-05,0.092294,0.50402,PAX8_B,1
GARGALOVIC_RESPONSE_TO_OXIDI...23,SET,22,-0.001861,-6.4347e-05,0.1833,0.50405,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_YELLOW_DN,1
GOMF_PROTEIN_KINASE_ACTIVITY,SET,534,-0.00037422,-6.2855e-05,0.036634,0.50408,GOMF_PROTEIN_KINASE_ACTIVITY,1
GOBP_REGULATION_OF_SYSTEMIC_...6,SET,20,-0.002153,-7.0983e-05,0.20735,0.50414,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_RENIN_ANGIOTENSIN,1
GOBP_CELLULAR_RESPONSE_TO_AL...4,SET,36,-0.0014912,-6.5931e-05,0.14336,0.50415,GOBP_CELLULAR_RESPONSE_TO_ALKALOID,1
HP_CENTRAL_APNEA,SET,37,-0.0014017,-6.2829e-05,0.13297,0.50421,HP_CENTRAL_APNEA,1
HP_GENERALIZED_AMINOACIDURIA,SET,14,-0.0024575,-6.78e-05,0.23229,0.50422,HP_GENERALIZED_AMINOACIDURIA,1
MODULE_16,SET,462,-0.00041846,-6.5508e-05,0.039398,0.50424,MODULE_16,1
GOBP_POSITIVE_REGULATION_OF_...628,SET,451,-0.00042111,-6.5153e-05,0.039332,0.50427,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION,1
MTOR_UP.N4.V1_UP,SET,175,-0.00069475,-6.747e-05,0.063277,0.50438,MTOR_UP.N4.V1_UP,1
GSE18791_CTRL_VS_NEWCASTLE_V...13,SET,142,-0.00079045,-6.921e-05,0.071669,0.5044,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_2H_DN,1
GOBP_POSITIVE_REGULATION_OF_...258,SET,307,-0.00052037,-6.669e-05,0.047098,0.50441,GOBP_POSITIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
REACTOME_PLATELET_HOMEOSTASIS,SET,81,-0.0010707,-7.0926e-05,0.096506,0.50443,REACTOME_PLATELET_HOMEOSTASIS,1
GOCC_TRANSCRIPTION_PREINITIA...,SET,13,-0.0024827,-6.6007e-05,0.22307,0.50444,GOCC_TRANSCRIPTION_PREINITIATION_COMPLEX,1
SESTO_RESPONSE_TO_UV_C6,SET,36,-0.0016759,-7.4099e-05,0.14833,0.50451,SESTO_RESPONSE_TO_UV_C6,1
HP_CNS_DEMYELINATION,SET,45,-0.0014089,-6.9629e-05,0.12356,0.50455,HP_CNS_DEMYELINATION,1
GOBP_EPITHELIAL_CELL_DIFFERE...1,SET,681,-0.00041313,-7.8037e-05,0.036111,0.50456,GOBP_EPITHELIAL_CELL_DIFFERENTIATION,1
SMID_BREAST_CANCER_RELAPSE_I...7,SET,37,-0.0016698,-7.4845e-05,0.14585,0.50457,SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN,1
GOBP_POSITIVE_REGULATION_OF_...300,SET,11,-0.0032082,-7.8464e-05,0.2801,0.50457,GOBP_POSITIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,1
MIR10396A_3P_MIR10396B_3P,SET,4,-0.005963,-8.796e-05,0.51239,0.50464,MIR10396A_3P_MIR10396B_3P,1
GSE7764_NKCELL_VS_SPLENOCYTE...1,SET,189,-0.0007168,-7.2314e-05,0.061604,0.50464,GSE7764_NKCELL_VS_SPLENOCYTE_DN,1
GSE360_CTRL_VS_M_TUBERCULOSI...4,SET,179,-0.00070086,-6.8829e-05,0.05993,0.50467,GSE360_CTRL_VS_M_TUBERCULOSIS_MAC_UP,1
GOBP_FEMALE_SEX_DIFFERENTIAT...,SET,116,-0.00098549,-7.8045e-05,0.083806,0.50469,GOBP_FEMALE_SEX_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...753,SET,66,-0.0011384,-6.8097e-05,0.096412,0.50471,GOBP_POSITIVE_REGULATION_OF_TELOMERE_MAINTENANCE,1
GOBP_INTERMEDIATE_FILAMENT_B...2,SET,7,-0.0043153,-8.4201e-05,0.3625,0.50475,GOBP_INTERMEDIATE_FILAMENT_BUNDLE_ASSEMBLY,1
HP_INFANTILE_MUSCULAR_HYPOTO...,SET,177,-0.00077244,-7.5438e-05,0.063825,0.50483,HP_INFANTILE_MUSCULAR_HYPOTONIA,1
GOBP_CELLULAR_RESPONSE_TO_WA...,SET,6,-0.0044613,-8.0595e-05,0.36748,0.50484,GOBP_CELLULAR_RESPONSE_TO_WATER_STIMULUS,1
HP_FETAL_AKINESIA_SEQUENCE,SET,32,-0.0018214,-7.5936e-05,0.14972,0.50485,HP_FETAL_AKINESIA_SEQUENCE,1
REACTOME_SUMO_IS_TRANSFERRED...,SET,7,-0.0033308,-6.499e-05,0.27057,0.50491,REACTOME_SUMO_IS_TRANSFERRED_FROM_E1_TO_E2_UBE2I_UBC9,1
MIR1229_3P,SET,75,-0.0011476,-7.3157e-05,0.092795,0.50493,MIR1229_3P,1
HP_ABNORMAL_LDL_CHOLESTEROL_...,SET,42,-0.0016842,-8.0418e-05,0.13609,0.50494,HP_ABNORMAL_LDL_CHOLESTEROL_CONCENTRATION,1
GOBP_REGULATION_OF_PROTEIN_T...2,SET,31,-0.0018356,-7.5323e-05,0.14805,0.50495,GOBP_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,1
HP_CORNEAL_NEOVASCULARIZATION,SET,23,-0.0024635,-8.7094e-05,0.19782,0.50497,HP_CORNEAL_NEOVASCULARIZATION,1
GOBP_REGULATION_OF_EPITHELIA...8,SET,6,-0.0049121,-8.8738e-05,0.38862,0.50504,GOBP_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,1
GOBP_EXTRACELLULAR_VESICLE_B...,SET,24,-0.0021216,-7.6617e-05,0.16751,0.50505,GOBP_EXTRACELLULAR_VESICLE_BIOGENESIS,1
BIOCARTA_TGFB_PATHWAY,SET,19,-0.0024956,-8.0198e-05,0.19636,0.50507,BIOCARTA_TGFB_PATHWAY,1
GSE2128_C57BL6_VS_NOD_THYMOC...2,SET,181,-0.00080925,-7.9912e-05,0.063624,0.50507,GSE2128_C57BL6_VS_NOD_THYMOCYTE_MIMETOPE_NEGATIVE_SELECTION_DN,1
GSE24292_WT_VS_PPARG_KO_MACR...1,SET,178,-0.00077913,-7.6304e-05,0.061256,0.50507,GSE24292_WT_VS_PPARG_KO_MACROPHAGE_DN,1
GCM_VAV1,SET,40,-0.0015744,-7.3369e-05,0.12325,0.5051,GCM_VAV1,1
GSE11864_CSF1_IFNG_VS_CSF1_I...2,SET,174,-0.00082799,-8.0182e-05,0.064593,0.50511,GSE11864_CSF1_IFNG_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,1
GOBP_RESPONSE_TO_REDOX_STATE,SET,12,-0.0031618,-8.0764e-05,0.24619,0.50512,GOBP_RESPONSE_TO_REDOX_STATE,1
MIR548U,SET,142,-0.00098165,-8.5952e-05,0.075211,0.50521,MIR548U,1
GOBP_BASIC_AMINO_ACID_TRANSP...,SET,20,-0.0026051,-8.5891e-05,0.19906,0.50522,GOBP_BASIC_AMINO_ACID_TRANSPORT,1
HOEK_B_CELL_2011_2012_TIV_AD...4,SET,6,-0.0051887,-9.3734e-05,0.39139,0.50529,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_DN,1
GSE22140_HEALTHY_VS_ARTHRITI...2,SET,175,-0.00082151,-7.978e-05,0.061832,0.5053,GSE22140_HEALTHY_VS_ARTHRITIC_GERMFREE_MOUSE_CD4_TCELL_UP,1
MIR644A,SET,56,-0.0015612,-8.6048e-05,0.11602,0.50537,MIR644A,1
GOBP_NEGATIVE_REGULATION_OF_...282,SET,10,-0.0046814,-0.00010917,0.34701,0.50538,GOBP_NEGATIVE_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE_MEDIATED_BY_CIRCULATING_IMMUNOGLOBULIN,1
KEGG_MEDICUS_REFERENCE_IL6_F...,SET,25,-0.0023174,-8.5412e-05,0.17092,0.50541,KEGG_MEDICUS_REFERENCE_IL6_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_SERINE_TRANSPORT,SET,9,-0.0036447,-8.0633e-05,0.2683,0.50542,GOBP_SERINE_TRANSPORT,1
GOBP_REGULATION_OF_NEUTROPHI...6,SET,37,-0.0020545,-9.2087e-05,0.14933,0.50549,GOBP_REGULATION_OF_NEUTROPHIL_MIGRATION,1
GSE11961_MARGINAL_ZONE_BCELL...4,SET,180,-0.00087616,-8.6282e-05,0.063363,0.50552,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
HP_UTERINE_LEIOMYOMA,SET,8,-0.004365,-9.1049e-05,0.31472,0.50553,HP_UTERINE_LEIOMYOMA,1
MIR549A_3P,SET,69,-0.001449,-8.8614e-05,0.1041,0.50555,MIR549A_3P,1
MARKS_HDAC_TARGETS_UP,SET,20,-0.0028054,-9.2495e-05,0.20081,0.50557,MARKS_HDAC_TARGETS_UP,1
REACTOME_FACTORS_INVOLVED_IN...,SET,144,-0.0010156,-8.9544e-05,0.072714,0.50557,REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION,1
AIYAR_COBRA1_TARGETS_DN,SET,27,-0.0023121,-8.8554e-05,0.16408,0.50562,AIYAR_COBRA1_TARGETS_DN,1
GOMF_EPHRIN_RECEPTOR_BINDING,SET,26,-0.0023766,-8.9326e-05,0.16655,0.50569,GOMF_EPHRIN_RECEPTOR_BINDING,1
HP_IMPAIRED_NEUTROPHIL_CHEMO...,SET,7,-0.0045745,-8.9258e-05,0.31956,0.50571,HP_IMPAIRED_NEUTROPHIL_CHEMOTAXIS,1
GOMF_CYCLIC_NUCLEOTIDE_DEPEN...,SET,7,-0.0039831,-7.7719e-05,0.27793,0.50572,GOMF_CYCLIC_NUCLEOTIDE_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
DURANTE_ADULT_OLFACTORY_NEUR...17,SET,70,-0.0016115,-9.9265e-05,0.11237,0.50572,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_PERICYTES,1
GSE27786_ERYTHROBLAST_VS_MON...1,SET,184,-0.00086225,-8.5841e-05,0.059788,0.50575,GSE27786_ERYTHROBLAST_VS_MONO_MAC_DN,1
HP_BROAD_ISCHIA,SET,5,-0.0058614,-9.6664e-05,0.40614,0.50576,HP_BROAD_ISCHIA,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...1,SET,8,-0.0041359,-8.627e-05,0.28646,0.50576,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_DN,1
GOMF_SEQUENCE_SPECIFIC_MRNA_...,SET,11,-0.0032513,-7.9517e-05,0.22401,0.50579,GOMF_SEQUENCE_SPECIFIC_MRNA_BINDING,1
HP_MULTIPLE_CAFE_AU_LAIT_SPO...,SET,61,-0.0014516,-8.3489e-05,0.099323,0.50583,HP_MULTIPLE_CAFE_AU_LAIT_SPOTS,1
GSE17580_TREG_VS_TEFF_S_MANS...2,SET,180,-0.00092707,-9.1295e-05,0.063274,0.50584,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_UP,1
GOBP_POSITIVE_REGULATION_OF_...354,SET,137,-0.0011422,-9.8244e-05,0.077904,0.50585,GOBP_POSITIVE_REGULATION_OF_INFLAMMATORY_RESPONSE,1
REACTOME_NUCLEOTIDE_SALVAGE,SET,21,-0.0027422,-9.2641e-05,0.18612,0.50588,REACTOME_NUCLEOTIDE_SALVAGE,1
GOMF_CHEMOREPELLENT_ACTIVITY,SET,28,-0.0025041,-9.7663e-05,0.16923,0.5059,GOMF_CHEMOREPELLENT_ACTIVITY,1
GOCC_GLYCOGEN_GRANULE,SET,6,-0.0046703,-8.437e-05,0.31491,0.50592,GOCC_GLYCOGEN_GRANULE,1
GOBP_LIPOPROTEIN_LOCALIZATION,SET,19,-0.0026356,-8.4699e-05,0.17689,0.50594,GOBP_LIPOPROTEIN_LOCALIZATION,1
chr8q11,SET,19,-0.0049115,-0.00015783,0.32936,0.50595,chr8q11,1
HP_IMPAIRED_VIBRATION_SENSAT...2,SET,46,-0.0018273,-9.13e-05,0.12196,0.50598,HP_IMPAIRED_VIBRATION_SENSATION_IN_THE_LOWER_LIMBS,1
MIR3191_3P,SET,21,-0.0026777,-9.0461e-05,0.17812,0.506,MIR3191_3P,1
REACTOME_ACTIVATED_PKN1_STIM...,SET,6,-0.0055038,-9.9427e-05,0.364,0.50603,REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3,1
GSE19941_UNSTIM_VS_LPS_AND_I...2,SET,185,-0.00097424,-9.7251e-05,0.064435,0.50603,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_UP,1
REACTOME_REGULATION_OF_TBK1_...1,SET,13,-0.0040013,-0.00010638,0.25577,0.50624,REACTOME_REGULATION_OF_TBK1_IKK_IKBKE_MEDIATED_ACTIVATION_OF_IRF3_IRF7,1
GSE25088_CTRL_VS_IL4_AND_ROS...3,SET,152,-0.0010566,-9.5691e-05,0.067427,0.50625,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DN,1
HP_UPGAZE_PALSY,SET,11,-0.0041111,-0.00010054,0.2599,0.50631,HP_UPGAZE_PALSY,1
MIR449B_3P,SET,110,-0.0013219,-0.00010196,0.082661,0.50638,MIR449B_3P,1
GSE5099_MONOCYTE_VS_ALTERNAT...1,SET,166,-0.00097484,-9.2227e-05,0.060893,0.50639,GSE5099_MONOCYTE_VS_ALTERNATIVE_M2_MACROPHAGE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...546,SET,21,-0.0031422,-0.00010615,0.19521,0.50642,GOBP_NEGATIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_APLASIA_HYPOPLASIA_OF_THE...39,SET,14,-0.0036352,-0.00010029,0.22587,0.50642,HP_APLASIA_HYPOPLASIA_OF_THE_LENS,1
GOBP_POSITIVE_REGULATION_OF_...511,SET,11,-0.0040662,-9.9447e-05,0.25133,0.50645,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,1
GSE2706_UNSTIM_VS_2H_R848_DC...2,SET,172,-0.00097208,-9.3598e-05,0.060084,0.50645,GSE2706_UNSTIM_VS_2H_R848_DC_UP,1
DELACROIX_RAR_TARGETS_UP,SET,44,-0.0023325,-0.00011399,0.14375,0.50647,DELACROIX_RAR_TARGETS_UP,1
REACTOME_SIGNALING_BY_FGFR1,SET,50,-0.0019759,-0.00010292,0.1218,0.50647,REACTOME_SIGNALING_BY_FGFR1,1
DESCARTES_MAIN_FETAL_MUC13_D...,SET,48,-0.0020036,-0.00010226,0.123,0.5065,DESCARTES_MAIN_FETAL_MUC13_DMBT1_POSITIVE_CELLS,1
PR_01,SET,134,-0.0012245,-0.00010417,0.074881,0.50652,PR_01,1
GOBP_POSITIVE_REGULATION_OF_...403,SET,21,-0.0028035,-9.4713e-05,0.1712,0.50653,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,1
HP_MUSCLE_SPASM,SET,148,-0.0011353,-0.00010146,0.068619,0.5066,HP_MUSCLE_SPASM,1
ZSCAN21_TARGET_GENES,SET,393,-0.00069478,-0.00010051,0.041955,0.50661,ZSCAN21_TARGET_GENES,1
TAKEDA_TARGETS_OF_NUP98_HOXA...7,SET,42,-0.0022278,-0.00010638,0.13353,0.50666,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_DN,1
HP_WRIST_HYPERMOBILITY,SET,7,-0.0059631,-0.00011635,0.35696,0.50666,HP_WRIST_HYPERMOBILITY,1
GSE26290_WT_VS_PDK1_KO_ANTI_...1,SET,169,-0.0010224,-9.7592e-05,0.060865,0.5067,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN,1
GSE29614_CTRL_VS_TIV_FLU_VAC...2,SET,148,-0.0012291,-0.00010985,0.072775,0.50674,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_UP,1
MIR126_5P,SET,405,-0.00073311,-0.00010762,0.043146,0.50678,MIR126_5P,1
HP_ELLIPTOCYTOSIS,SET,8,-0.005223,-0.00010895,0.3069,0.50679,HP_ELLIPTOCYTOSIS,1
REACTOME_DUAL_INCISION_IN_TC...,SET,60,-0.0016036,-9.1476e-05,0.094028,0.5068,REACTOME_DUAL_INCISION_IN_TC_NER,1
HP_SEVERE_SHORT_STATURE,SET,96,-0.0014338,-0.00010336,0.084016,0.50681,HP_SEVERE_SHORT_STATURE,1
GAVISH_3CA_METAPROGRAM_CD8_T...7,SET,48,-0.0021575,-0.00011011,0.12523,0.50687,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_INTERFERON,1
GOBP_EPITHELIAL_CELL_APOPTOT...,SET,128,-0.0013733,-0.00011421,0.079591,0.50688,GOBP_EPITHELIAL_CELL_APOPTOTIC_PROCESS,1
KEGG_FOCAL_ADHESION,SET,190,-0.001107,-0.00011197,0.063787,0.50692,KEGG_FOCAL_ADHESION,1
GOBP_NEGATIVE_REGULATION_OF_...620,SET,8,-0.0063641,-0.00013275,0.36636,0.50693,GOBP_NEGATIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,1
MIR5094,SET,85,-0.001618,-0.00010978,0.092736,0.50696,MIR5094,1
HP_SPASTIC_HYPERACTIVE_BLADD...,SET,9,-0.0051752,-0.00011449,0.29587,0.50698,HP_SPASTIC_HYPERACTIVE_BLADDER,1
MIR4276,SET,243,-0.00095355,-0.00010892,0.054422,0.50699,MIR4276,1
GCM_CASP2,SET,26,-0.0027572,-0.00010363,0.15723,0.507,GCM_CASP2,1
MORF_PPP2R4,SET,44,-0.0020384,-9.9619e-05,0.11603,0.50701,MORF_PPP2R4,1
HE_LIM_SUN_FETAL_LUNG_C3_ART...,SET,259,-0.00099477,-0.00011725,0.056318,0.50705,HE_LIM_SUN_FETAL_LUNG_C3_ARTERIAL_ENDOTHELIAL_CELL,1
MIR627_3P,SET,423,-0.0007475,-0.00011209,0.042179,0.50707,MIR627_3P,1
DESCARTES_MAIN_FETAL_IGFBP1_...,SET,128,-0.0013735,-0.00011423,0.077368,0.50708,DESCARTES_MAIN_FETAL_IGFBP1_DKK1_POSITIVE_CELLS,1
GOBP_GRANULOCYTE_COLONY_STIM...2,SET,5,-0.006166,-0.00010169,0.34713,0.50709,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,1
TRAVAGLINI_LUNG_BRONCHIAL_VE...2,SET,243,-0.001009,-0.00011525,0.056627,0.50711,TRAVAGLINI_LUNG_BRONCHIAL_VESSEL_2_CELL,1
BIOCARTA_MCM_PATHWAY,SET,18,-0.0033859,-0.00010591,0.18908,0.50714,BIOCARTA_MCM_PATHWAY,1
GOBP_PHOTORECEPTOR_CELL_MAIN...,SET,43,-0.0024009,-0.00011599,0.1342,0.50714,GOBP_PHOTORECEPTOR_CELL_MAINTENANCE,1
GOBP_REGULATION_OF_SECRETION,SET,560,-0.00066671,-0.00011459,0.03722,0.50715,GOBP_REGULATION_OF_SECRETION,1
HP_ABNORMAL_PERIVENTRICULAR_...,SET,116,-0.0013333,-0.00010559,0.074342,0.50715,HP_ABNORMAL_PERIVENTRICULAR_WHITE_MATTER_MORPHOLOGY,1
REACTOME_PENTOSE_PHOSPHATE_P...,SET,12,-0.0047044,-0.00012017,0.26226,0.50716,REACTOME_PENTOSE_PHOSPHATE_PATHWAY,1
GOMF_RRNA_CYTOSINE_METHYLTRA...,SET,4,-0.0071389,-0.00010531,0.39709,0.50717,GOMF_RRNA_CYTOSINE_METHYLTRANSFERASE_ACTIVITY,1
MULLIGHAN_MLL_SIGNATURE_1_UP,SET,353,-0.00079926,-0.0001097,0.044228,0.50721,MULLIGHAN_MLL_SIGNATURE_1_UP,1
GOCC_MICROBODY_LUMEN,SET,50,-0.002203,-0.00011475,0.12191,0.50721,GOCC_MICROBODY_LUMEN,1
GSE41867_NAIVE_VS_DAY15_LCMV...1,SET,180,-0.0011011,-0.00010844,0.060735,0.50723,GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
MIR4724_3P,SET,78,-0.001628,-0.00010583,0.089283,0.50727,MIR4724_3P,1
STAT5A_02,SET,124,-0.0014264,-0.00011677,0.078204,0.50728,STAT5A_02,1
GSE11367_CTRL_VS_IL17_TREATE...2,SET,119,-0.0014607,-0.00011716,0.079706,0.50731,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_UP,1
REACTOME_FCGR3A_MEDIATED_IL1...,SET,37,-0.0026058,-0.0001168,0.14148,0.50735,REACTOME_FCGR3A_MEDIATED_IL10_SYNTHESIS,1
GSE42021_CD24INT_TREG_VS_CD2...2,SET,178,-0.0011014,-0.00010787,0.059327,0.50741,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_UP,1
chr13q21,SET,11,-0.0075447,-0.00018452,0.40361,0.50746,chr13q21,1
KEGG_MEDICUS_VARIANT_MUTATIO...43,SET,11,-0.0041314,-0.00010104,0.21922,0.50752,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_ELECTRON_TRANSFER_IN_COMPLEX_III,1
WP_HAIR_FOLLICLE_DEVELOPMENT...1,SET,86,-0.0019424,-0.00013256,0.10241,0.50757,WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3,1
HP_THICK_UPPER_LIP_VERMILION,SET,20,-0.0038075,-0.00012553,0.20029,0.50758,HP_THICK_UPPER_LIP_VERMILION,1
KEGG_ENDOMETRIAL_CANCER,SET,50,-0.0022474,-0.00011706,0.11814,0.50759,KEGG_ENDOMETRIAL_CANCER,1
HP_SPIDER_HEMANGIOMA,SET,5,-0.0070644,-0.0001165,0.36885,0.50764,HP_SPIDER_HEMANGIOMA,1
HP_PERIVENTRICULAR_CYSTS,SET,12,-0.0049019,-0.00012521,0.25507,0.50767,HP_PERIVENTRICULAR_CYSTS,1
GOBP_CRANIAL_SKELETAL_SYSTEM...,SET,67,-0.0021479,-0.00012945,0.11152,0.50768,GOBP_CRANIAL_SKELETAL_SYSTEM_DEVELOPMENT,1
GOBP_NERVE_DEVELOPMENT,SET,92,-0.0018398,-0.00012984,0.095428,0.50769,GOBP_NERVE_DEVELOPMENT,1
HP_NASAL_REGURGITATION,SET,13,-0.004806,-0.00012777,0.24896,0.5077,HP_NASAL_REGURGITATION,1
GOMF_PHOSPHOPROTEIN_PHOSPHAT...,SET,159,-0.0012767,-0.00011823,0.065733,0.50775,GOMF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,1
GOBP_PURINE_DEOXYRIBONUCLEOS...3,SET,11,-0.0050728,-0.00012407,0.25911,0.50781,GOBP_PURINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GOBP_RIBONUCLEOSIDE_MONOPHOS...1,SET,29,-0.0030505,-0.00012108,0.1557,0.50782,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HALLMARK_INTERFERON_ALPHA_RE...,SET,93,-0.0016851,-0.00011956,0.085879,0.50783,HALLMARK_INTERFERON_ALPHA_RESPONSE,1
REACTOME_SIGNALLING_TO_P38_V...,SET,5,-0.0062234,-0.00010263,0.31616,0.50785,REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN,1
GSE22886_NAIVE_VS_IGM_MEMORY...2,SET,173,-0.001264,-0.00012206,0.063901,0.50789,GSE22886_NAIVE_VS_IGM_MEMORY_BCELL_UP,1
REACTOME_P2Y_RECEPTORS,SET,9,-0.0065048,-0.00014391,0.32828,0.5079,REACTOME_P2Y_RECEPTORS,1
GOBP_LEUKOTRIENE_D4_METABOLI...,SET,7,-0.0063433,-0.00012377,0.32021,0.5079,GOBP_LEUKOTRIENE_D4_METABOLIC_PROCESS,1
BRACHAT_RESPONSE_TO_CISPLATIN,SET,20,-0.003694,-0.00012179,0.18639,0.50791,BRACHAT_RESPONSE_TO_CISPLATIN,1
GAVISH_3CA_METAPROGRAM_EPITH...13,SET,43,-0.0028939,-0.00013981,0.14593,0.50791,GAVISH_3CA_METAPROGRAM_EPITHELIAL_INTERFERON_MHC,1
GOBP_MITOTIC_G2_DNA_DAMAGE_C...,SET,29,-0.0027676,-0.00010985,0.13955,0.50791,GOBP_MITOTIC_G2_DNA_DAMAGE_CHECKPOINT_SIGNALING,1
ZSCAN5DP_TARGET_GENES,SET,1195,-0.00049902,-0.00012304,0.025086,0.50794,ZSCAN5DP_TARGET_GENES,1
MIR3157_5P,SET,97,-0.0016746,-0.00012134,0.08401,0.50795,MIR3157_5P,1
GOMF_PROTEIN_GERANYLGERANYLT...,SET,4,-0.0076369,-0.00011265,0.38213,0.50797,GOMF_PROTEIN_GERANYLGERANYLTRANSFERASE_ACTIVITY,1
HP_VISUAL_HALLUCINATION,SET,21,-0.0035735,-0.00012072,0.17863,0.50798,HP_VISUAL_HALLUCINATION,1
FEKIR_HEPARG_SPHERE_VS_HEPAR...1,SET,34,-0.0030961,-0.00013304,0.15381,0.50803,FEKIR_HEPARG_SPHERE_VS_HEPARG_DN,1
GOBP_STEROID_METABOLIC_PROCE...,SET,301,-0.001031,-0.00013086,0.051066,0.50805,GOBP_STEROID_METABOLIC_PROCESS,1
HP_CORNEAL_SCARRING,SET,19,-0.0037468,-0.00012041,0.18572,0.50805,HP_CORNEAL_SCARRING,1
GSE9650_EFFECTOR_VS_EXHAUSTE...2,SET,183,-0.0011995,-0.0001191,0.059213,0.50808,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_UP,1
GOCC_PROTEIN_PHOSPHATASE_4_C...,SET,3,-0.008414,-0.00010749,0.41457,0.5081,GOCC_PROTEIN_PHOSPHATASE_4_COMPLEX,1
GNF2_KPNB1,SET,65,-0.0019593,-0.00011631,0.096397,0.50811,GNF2_KPNB1,1
HP_FINGER_SYNDACTYLY,SET,177,-0.0012733,-0.00012435,0.062373,0.50814,HP_FINGER_SYNDACTYLY,1
WONG_ENDOMETRIAL_CANCER_LATE,SET,7,-0.0073211,-0.00014285,0.35683,0.50818,WONG_ENDOMETRIAL_CANCER_LATE,1
GOBP_ACTIN_FILAMENT_BASED_PR...,SET,755,-0.00065714,-0.00013043,0.031928,0.50821,GOBP_ACTIN_FILAMENT_BASED_PROCESS,1
MIR326,SET,115,-0.0016623,-0.00013108,0.08053,0.50823,MIR326,1
GSE24726_WT_VS_E2_2_KO_PDC_D...3,SET,177,-0.0012255,-0.00011969,0.059378,0.50823,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_UP,1
MIR5689,SET,137,-0.0015337,-0.00013192,0.074159,0.50825,MIR5689,1
GOBP_GAP_JUNCTION_MEDIATED_I...,SET,6,-0.0086204,-0.00015573,0.41644,0.50826,GOBP_GAP_JUNCTION_MEDIATED_INTERCELLULAR_TRANSPORT,1
WENG_POR_TARGETS_LIVER_DN,SET,22,-0.0042341,-0.0001464,0.20428,0.50827,WENG_POR_TARGETS_LIVER_DN,1
YATGNWAAT_OCT_C,SET,315,-0.00105,-0.00013628,0.050645,0.50827,YATGNWAAT_OCT_C,1
GOBP_LATE_ENDOSOME_TO_LYSOSO...,SET,21,-0.0037972,-0.00012828,0.18291,0.50828,GOBP_LATE_ENDOSOME_TO_LYSOSOME_TRANSPORT,1
MIR4801,SET,242,-0.0011871,-0.00013532,0.056684,0.50835,MIR4801,1
HP_ABNORMAL_FETAL_PULMONARY_...,SET,8,-0.0065196,-0.00013599,0.31159,0.50835,HP_ABNORMAL_FETAL_PULMONARY_MORPHOLOGY,1
FOSTER_KDM1A_TARGETS_DN,SET,186,-0.0012078,-0.00012089,0.057539,0.50837,FOSTER_KDM1A_TARGETS_DN,1
REACTOME_SYNTHESIS_OF_PYROPH...,SET,8,-0.0053432,-0.00011145,0.25351,0.50841,REACTOME_SYNTHESIS_OF_PYROPHOSPHATES_IN_THE_CYTOSOL,1
BHAT_ESR1_TARGETS_VIA_AKT1_DN,SET,79,-0.0021807,-0.00014266,0.10273,0.50847,BHAT_ESR1_TARGETS_VIA_AKT1_DN,1
WANG_LSD1_TARGETS_UP,SET,21,-0.0042104,-0.00014224,0.19802,0.50848,WANG_LSD1_TARGETS_UP,1
REACTOME_PYRIMIDINE_SALVAGE,SET,10,-0.0057205,-0.0001334,0.26557,0.50859,REACTOME_PYRIMIDINE_SALVAGE,1
GSE360_DC_VS_MAC_B_MALAYI_LO...2,SET,177,-0.0013146,-0.00012839,0.06032,0.50869,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_UP,1
GOBP_POSITIVE_REGULATION_OF_...743,SET,15,-0.0049442,-0.00014119,0.22392,0.50881,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
GSE1460_CD4_THYMOCYTE_VS_THY...2,SET,177,-0.0013577,-0.0001326,0.06138,0.50882,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_UP,1
GSE34515_CD16_NEG_VS_POS_MON...2,SET,181,-0.001423,-0.00014051,0.06426,0.50883,GSE34515_CD16_NEG_VS_POS_MONOCYTE_UP,1
GOBP_ORGANIC_ACID_METABOLIC_...,SET,857,-0.00066072,-0.00013931,0.029821,0.50884,GOBP_ORGANIC_ACID_METABOLIC_PROCESS,1
GSE28737_WT_VS_BCL6_KO_MARGI...1,SET,174,-0.001384,-0.00013402,0.061974,0.50891,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_DN,1
GOCC_CHYLOMICRON,SET,13,-0.0059397,-0.00015791,0.26394,0.50898,GOCC_CHYLOMICRON,1
ZHONG_PFC_C1_NEUROD1_POS_EXC...,SET,25,-0.0042648,-0.00015719,0.18884,0.50901,ZHONG_PFC_C1_NEUROD1_POS_EXCITATORY_NEURON,1
GSE29618_PRE_VS_DAY7_POST_LA...6,SET,182,-0.0013838,-0.00013702,0.06114,0.50903,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_UP,1
LOPEZ_MBD_TARGETS_IMPRINTED_...,SET,3,-0.0092468,-0.00011813,0.40801,0.50904,LOPEZ_MBD_TARGETS_IMPRINTED_AND_X_LINKED,1
HP_PROMINENT_UMBILICUS,SET,5,-0.010267,-0.00016932,0.45111,0.50908,HP_PROMINENT_UMBILICUS,1
AEBP2_TARGET_GENES,SET,990,-0.00062192,-0.0001404,0.027249,0.5091,AEBP2_TARGET_GENES,1
GSE22601_DOUBLE_NEGATIVE_VS_...1,SET,179,-0.0014038,-0.00013787,0.061139,0.50916,GSE22601_DOUBLE_NEGATIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_DN,1
MIR874_5P,SET,55,-0.0025095,-0.00013707,0.10871,0.50921,MIR874_5P,1
GSE11961_MARGINAL_ZONE_BCELL...10,SET,185,-0.001404,-0.00014015,0.060783,0.50921,GSE11961_MARGINAL_ZONE_BCELL_VS_PLASMA_CELL_DAY7_UP,1
DARWICHE_PAPILLOMA_RISK_HIGH...2,SET,137,-0.0017174,-0.00014772,0.074033,0.50925,DARWICHE_PAPILLOMA_RISK_HIGH_UP,1
GOBP_COLUMNAR_CUBOIDAL_EPITH...2,SET,119,-0.0019683,-0.00015787,0.084305,0.50931,GOBP_COLUMNAR_CUBOIDAL_EPITHELIAL_CELL_DIFFERENTIATION,1
MIR101_3P,SET,418,-0.00099822,-0.00014882,0.042627,0.50934,MIR101_3P,1
GOBP_INSULIN_PROCESSING,SET,7,-0.0076216,-0.00014871,0.32538,0.50934,GOBP_INSULIN_PROCESSING,1
HOXA9_DN.V1_DN,SET,165,-0.0015667,-0.00014778,0.066929,0.50934,HOXA9_DN.V1_DN,1
YRCCAKNNGNCGC_UNKNOWN,SET,60,-0.0026517,-0.00015126,0.11294,0.50937,YRCCAKNNGNCGC_UNKNOWN,1
WP_CELL_DIFFERENTIATION_INDEX,SET,12,-0.0064036,-0.00016357,0.27164,0.5094,WP_CELL_DIFFERENTIATION_INDEX,1
GSE2706_LPS_VS_R848_AND_LPS_...2,SET,146,-0.0016121,-0.00014311,0.068248,0.50942,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_UP,1
GSE23925_DARK_ZONE_VS_NAIVE_...1,SET,188,-0.0014485,-0.00014574,0.060969,0.50948,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_DN,1
REACTOME_OTHER_INTERLEUKIN_S...,SET,24,-0.0042234,-0.00015252,0.1774,0.5095,REACTOME_OTHER_INTERLEUKIN_SIGNALING,1
GOBP_PERIPHERAL_NERVOUS_SYST...2,SET,8,-0.0081056,-0.00016907,0.34042,0.5095,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_REGENERATION,1
GSE19888_CTRL_VS_A3R_ACTIVAT...2,SET,179,-0.0013538,-0.00013295,0.056331,0.50959,GSE19888_CTRL_VS_A3R_ACTIVATION_MAST_CELL_UP,1
GOBP_RESPONSE_TO_TESTOSTERONE,SET,39,-0.0031635,-0.00014557,0.13151,0.5096,GOBP_RESPONSE_TO_TESTOSTERONE,1
GOBP_VACUOLAR_LOCALIZATION,SET,75,-0.002353,-0.00015,0.097758,0.5096,GOBP_VACUOLAR_LOCALIZATION,1
GSE41176_UNSTIM_VS_ANTI_IGM_...8,SET,184,-0.0014871,-0.00014804,0.061732,0.50961,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_UP,1
GOBP_MITOTIC_SPINDLE_ORGANIZ...,SET,124,-0.0016955,-0.00013879,0.070208,0.50963,GOBP_MITOTIC_SPINDLE_ORGANIZATION,1
GSE14415_INDUCED_TREG_VS_FOX...2,SET,124,-0.0019308,-0.00015806,0.079833,0.50965,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_DN,1
QIU_PBMC_HEPTATITIS_B_SURFAC...5,SET,12,-0.0063947,-0.00016335,0.26447,0.50965,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_35DY_UP,1
CAFFAREL_RESPONSE_TO_THC_24H...2,SET,8,-0.006483,-0.00013523,0.2673,0.50967,CAFFAREL_RESPONSE_TO_THC_24HR_3_UP,1
GSE13485_CTRL_VS_DAY1_YF17D_...2,SET,179,-0.0013745,-0.00013499,0.056675,0.50967,GSE13485_CTRL_VS_DAY1_YF17D_VACCINE_PBMC_UP,1
ANDERSEN_CHOLANGIOCARCINOMA_...1,SET,58,-0.0027721,-0.00015548,0.11412,0.50969,ANDERSEN_CHOLANGIOCARCINOMA_CLASS1,1
HP_FOOT_OLIGODACTYLY,SET,10,-0.005689,-0.00013266,0.23304,0.50974,HP_FOOT_OLIGODACTYLY,1
HP_MUSCLE_STIFFNESS,SET,74,-0.0022863,-0.00014478,0.093653,0.50974,HP_MUSCLE_STIFFNESS,1
GOBP_SATELLITE_CELL_ACTIVATI...,SET,6,-0.007541,-0.00013623,0.30864,0.50975,GOBP_SATELLITE_CELL_ACTIVATION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
GOBP_RESPONSE_TO_FORSKOLIN,SET,13,-0.0065504,-0.00017415,0.26727,0.50978,GOBP_RESPONSE_TO_FORSKOLIN,1
GSE5455_EX_VIVO_VS_POST_24H_...1,SET,181,-0.0014957,-0.0001477,0.060779,0.50982,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_DN,1
GOBP_PROTOPORPHYRINOGEN_IX_B...,SET,8,-0.0072013,-0.00015021,0.29222,0.50983,GOBP_PROTOPORPHYRINOGEN_IX_BIOSYNTHETIC_PROCESS,1
REACTOME_CHYLOMICRON_CLEARAN...,SET,5,-0.010497,-0.00017311,0.42187,0.50993,REACTOME_CHYLOMICRON_CLEARANCE,1
HP_NON_MIDLINE_CLEFT_PALATE,SET,26,-0.0043849,-0.00016481,0.17511,0.50999,HP_NON_MIDLINE_CLEFT_PALATE,1
GOBP_REGULATION_OF_PHOSPHOLI...6,SET,7,-0.0085783,-0.00016738,0.34156,0.51002,GOBP_REGULATION_OF_PHOSPHOLIPID_CATABOLIC_PROCESS,1
GOBP_MEMBRANE_DEPOLARIZATION,SET,85,-0.0025112,-0.00017038,0.099835,0.51003,GOBP_MEMBRANE_DEPOLARIZATION,1
KEGG_MEDICUS_REFERENCE_ELECT...2,SET,10,-0.0057761,-0.0001347,0.22725,0.51014,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_III,1
HP_DILATATION_OF_THE_VENTRIC...,SET,9,-0.007196,-0.0001592,0.28283,0.51015,HP_DILATATION_OF_THE_VENTRICULAR_CAVITY,1
MIR342_3P,SET,111,-0.001995,-0.00015457,0.078291,0.51016,MIR342_3P,1
GOBP_REGULATION_OF_PRESYNAPS...,SET,28,-0.0047443,-0.00018504,0.18617,0.51017,GOBP_REGULATION_OF_PRESYNAPSE_ORGANIZATION,1
GSE28726_NAIVE_CD4_TCELL_VS_...4,SET,184,-0.0015188,-0.00015121,0.059485,0.51019,GSE28726_NAIVE_CD4_TCELL_VS_NAIVE_VA24NEG_NKTCELL_UP,1
GSE36476_CTRL_VS_TSST_ACT_40...1,SET,181,-0.0014767,-0.00014582,0.057748,0.5102,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_DN,1
MIR4529_5P,SET,45,-0.0032463,-0.00016044,0.1266,0.51023,MIR4529_5P,1
MIR1827,SET,359,-0.0011485,-0.00015894,0.044605,0.51027,MIR1827,1
MIR526B_3P,SET,565,-0.00094442,-0.00016302,0.036348,0.51036,MIR526B_3P,1
WP_2Q112_COPY_NUMBER_VARIATI...,SET,32,-0.0050459,-0.00021037,0.19407,0.51037,WP_2Q112_COPY_NUMBER_VARIATION_SYNDROME,1
GOCC_CLEAVAGE_FURROW,SET,50,-0.0030703,-0.00015992,0.11811,0.51037,GOCC_CLEAVAGE_FURROW,1
HP_TRISMUS,SET,13,-0.0059194,-0.00015738,0.22703,0.5104,HP_TRISMUS,1
HMGA1_TARGET_GENES,SET,703,-0.0008528,-0.00016357,0.032669,0.51041,HMGA1_TARGET_GENES,1
REACTOME_GLUCOCORTICOID_BIOS...,SET,10,-0.0076811,-0.00017912,0.29333,0.51045,REACTOME_GLUCOCORTICOID_BIOSYNTHESIS,1
GOBP_POSITIVE_REGULATION_OF_...588,SET,15,-0.0062841,-0.00017945,0.23988,0.51045,GOBP_POSITIVE_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,1
GOMF_PROTEIN_SERINE_THREONIN...6,SET,11,-0.0061495,-0.0001504,0.23413,0.51048,GOMF_PROTEIN_SERINE_THREONINE_PHOSPHATASE_INHIBITOR_ACTIVITY,1
GOBP_ESCRT_COMPLEX_DISASSEMB...,SET,10,-0.0059957,-0.00013982,0.22775,0.5105,GOBP_ESCRT_COMPLEX_DISASSEMBLY,1
REACTOME_LRR_FLII_INTERACTIN...,SET,5,-0.0092828,-0.00015309,0.35221,0.51051,REACTOME_LRR_FLII_INTERACTING_PROTEIN_1_LRRFIP1_ACTIVATES_TYPE_I_IFN_PRODUCTION,1
GSE25085_FETAL_BM_VS_ADULT_B...2,SET,187,-0.0016619,-0.00016678,0.063101,0.51051,GSE25085_FETAL_BM_VS_ADULT_BM_SP4_THYMIC_IMPLANT_UP,1
GOBP_POST_TRANSLATIONAL_PROT...1,SET,871,-0.00075506,-0.00016043,0.028417,0.5106,GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
REACTOME_EXTENSION_OF_TELOME...,SET,48,-0.002976,-0.00015189,0.1119,0.51061,REACTOME_EXTENSION_OF_TELOMERES,1
GSE11057_NAIVE_VS_CENT_MEMOR...1,SET,183,-0.0016825,-0.00016705,0.063066,0.51064,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,1
SIX4_TARGET_GENES,SET,33,-0.0037058,-0.00015689,0.13881,0.51065,SIX4_TARGET_GENES,1
ZWANG_EGF_INTERVAL_DN,SET,185,-0.0016609,-0.00016579,0.062034,0.51068,ZWANG_EGF_INTERVAL_DN,1
HP_ABNORMAL_ERYTHROCYTE_SEDI...,SET,57,-0.0032199,-0.00017904,0.11976,0.51072,HP_ABNORMAL_ERYTHROCYTE_SEDIMENTATION_RATE,1
HP_ABNORMAL_SIZE_OF_THE_DENT...,SET,14,-0.006668,-0.00018396,0.24594,0.51081,HP_ABNORMAL_SIZE_OF_THE_DENTAL_ROOT,1
HP_MUSCLE_FIBER_SPLITTING,SET,19,-0.005018,-0.00016126,0.1848,0.51083,HP_MUSCLE_FIBER_SPLITTING,1
ONKEN_UVEAL_MELANOMA_DN,SET,475,-0.0010943,-0.00017363,0.040248,0.51085,ONKEN_UVEAL_MELANOMA_DN,1
GSE5455_HEALTHY_VS_TUMOR_BEA...3,SET,183,-0.0017535,-0.0001741,0.06439,0.51086,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_DN,1
GOCC_AP_TYPE_MEMBRANE_COAT_A...,SET,39,-0.003544,-0.00016308,0.12915,0.51095,GOCC_AP_TYPE_MEMBRANE_COAT_ADAPTOR_COMPLEX,1
DESCARTES_FETAL_LIVER_VASCUL...,SET,102,-0.0024596,-0.00018272,0.089629,0.51095,DESCARTES_FETAL_LIVER_VASCULAR_ENDOTHELIAL_CELLS,1
HP_DELAYED_CNS_MYELINATION,SET,171,-0.0017204,-0.00016517,0.062566,0.51097,HP_DELAYED_CNS_MYELINATION,1
REACTOME_SUMOYLATION,SET,163,-0.0018006,-0.00016881,0.065113,0.51103,REACTOME_SUMOYLATION,1
REACTOME_DECTIN_1_MEDIATED_N...,SET,59,-0.0027516,-0.00015565,0.098793,0.51111,REACTOME_DECTIN_1_MEDIATED_NONCANONICAL_NF_KB_SIGNALING,1
GOBP_PIGMENT_CELL_DIFFERENTI...,SET,34,-0.0043646,-0.00018755,0.15652,0.51112,GOBP_PIGMENT_CELL_DIFFERENTIATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...59,SET,15,-0.0059747,-0.00017062,0.21293,0.51119,HP_APLASIA_HYPOPLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
GSE36476_CTRL_VS_TSST_ACT_16...4,SET,173,-0.0018273,-0.00017645,0.064841,0.51124,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_YOUNG_UP,1
MELLMAN_TUT1_TARGETS_UP,SET,19,-0.0054295,-0.00017448,0.19247,0.51125,MELLMAN_TUT1_TARGETS_UP,1
GOMF_NITRIC_OXIDE_SYNTHASE_R...,SET,7,-0.0088449,-0.00017258,0.31249,0.51129,GOMF_NITRIC_OXIDE_SYNTHASE_REGULATOR_ACTIVITY,1
GOBP_REGULATION_OF_BILE_ACID...2,SET,14,-0.0070336,-0.00019405,0.24836,0.5113,GOBP_REGULATION_OF_BILE_ACID_METABOLIC_PROCESS,1
HP_INCREASED_NUMBER_OF_SKIN_...,SET,6,-0.0095115,-0.00017183,0.33582,0.5113,HP_INCREASED_NUMBER_OF_SKIN_FOLDS,1
KEGG_SMALL_CELL_LUNG_CANCER,SET,80,-0.0026864,-0.00017685,0.094701,0.51132,KEGG_SMALL_CELL_LUNG_CANCER,1
MIR4319,SET,406,-0.0011819,-0.00017372,0.041612,0.51133,MIR4319,1
GSE17721_PAM3CSK4_VS_GADIQUI...9,SET,186,-0.0017065,-0.00017081,0.060082,0.51133,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_DN,1
HP_DECREASED_CIRCULATING_VIT...1,SET,8,-0.009917,-0.00020686,0.34859,0.51135,HP_DECREASED_CIRCULATING_VITAMIN_B12_CONCENTRATION,1
KEGG_MEDICUS_REFERENCE_EGF_E...1,SET,21,-0.0049502,-0.00016723,0.17321,0.5114,KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY,1
GOMF_BASIC_AMINO_ACID_TRANSM...,SET,16,-0.0064497,-0.00019022,0.22488,0.51144,GOMF_BASIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HNF4ALPHA_Q6,SET,236,-0.0015761,-0.00017745,0.054862,0.51146,HNF4ALPHA_Q6,1
REACTOME_MITOTIC_TELOPHASE_C...,SET,10,-0.0073769,-0.00017203,0.25646,0.51147,REACTOME_MITOTIC_TELOPHASE_CYTOKINESIS,1
REACTOME_ZBP1_DAI_MEDIATED_I...,SET,20,-0.005265,-0.00017359,0.18264,0.5115,REACTOME_ZBP1_DAI_MEDIATED_INDUCTION_OF_TYPE_I_IFNS,1
MORF_WNT1,SET,93,-0.0026073,-0.000185,0.090422,0.5115,MORF_WNT1,1
GSE17721_4H_VS_24H_POLYIC_BM...2,SET,179,-0.001817,-0.00017845,0.062828,0.51154,GSE17721_4H_VS_24H_POLYIC_BMDC_UP,1
GOCC_LUMENAL_SIDE_OF_ENDOPLA...,SET,29,-0.0045638,-0.00018114,0.15708,0.51159,GOCC_LUMENAL_SIDE_OF_ENDOPLASMIC_RETICULUM_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...309,SET,6,-0.0091328,-0.00016499,0.31328,0.51163,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,1
MIR3913_3P,SET,73,-0.0029627,-0.00018635,0.10155,0.51164,MIR3913_3P,1
GOBP_EXCITATORY_SYNAPSE_ASSE...,SET,34,-0.0045769,-0.00019667,0.15646,0.51167,GOBP_EXCITATORY_SYNAPSE_ASSEMBLY,1
WP_INTERACTIONS_BETWEEN_IMMU...,SET,24,-0.0053953,-0.00019484,0.1843,0.51168,WP_INTERACTIONS_BETWEEN_IMMUNE_CELLS_AND_MICRORNAS_IN_TUMOR_MICROENVIRONMENT,1
GSE25087_FETAL_VS_ADULT_TREG...1,SET,157,-0.0019711,-0.0001814,0.067262,0.51169,GSE25087_FETAL_VS_ADULT_TREG_DN,1
HP_ESOPHAGEAL_ULCERATION,SET,7,-0.0087476,-0.00017068,0.29806,0.51171,HP_ESOPHAGEAL_ULCERATION,1
GOCC_UBIQUINONE_BIOSYNTHESIS...,SET,6,-0.0082238,-0.00014857,0.27925,0.51175,GOCC_UBIQUINONE_BIOSYNTHESIS_COMPLEX,1
GSE360_CTRL_VS_T_GONDII_MAC_...2,SET,180,-0.0017781,-0.0001751,0.060333,0.51176,GSE360_CTRL_VS_T_GONDII_MAC_UP,1
REACTOME_RHO_GTPASES_ACTIVAT...3,SET,29,-0.0048564,-0.00019276,0.16444,0.51178,REACTOME_RHO_GTPASES_ACTIVATE_IQGAPS,1
GOCC_NADPH_OXIDASE_COMPLEX,SET,13,-0.0070225,-0.0001867,0.23767,0.51179,GOCC_NADPH_OXIDASE_COMPLEX,1
GAVISH_3CA_METAPROGRAM_CD8_T...2,SET,42,-0.0034592,-0.00016518,0.11691,0.5118,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN,1
GSE20727_CTRL_VS_ROS_INHIBIT...1,SET,180,-0.0018175,-0.00017898,0.061305,0.51183,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_DN,1
GOBP_TELOMERE_MAINTENANCE_VI...1,SET,14,-0.0053454,-0.00014747,0.17996,0.51185,GOBP_TELOMERE_MAINTENANCE_VIA_RECOMBINATION,1
HP_THICKENED_HELICES,SET,43,-0.0036035,-0.0001741,0.12118,0.51186,HP_THICKENED_HELICES,1
MIR3135B,SET,97,-0.0025579,-0.00018533,0.085918,0.51188,MIR3135B,1
XU_RESPONSE_TO_TRETINOIN_UP,SET,13,-0.0075771,-0.00020145,0.25399,0.5119,XU_RESPONSE_TO_TRETINOIN_UP,1
GOBP_HINDGUT_DEVELOPMENT,SET,8,-0.010896,-0.00022727,0.36529,0.5119,GOBP_HINDGUT_DEVELOPMENT,1
GOBP_NEUROMUSCULAR_SYNAPTIC_...,SET,26,-0.0050195,-0.00018866,0.16827,0.5119,GOBP_NEUROMUSCULAR_SYNAPTIC_TRANSMISSION,1
HP_LYMPHOMA,SET,112,-0.0024358,-0.00018957,0.081002,0.51199,HP_LYMPHOMA,1
HP_AUTISM,SET,216,-0.0017571,-0.00018937,0.058411,0.512,HP_AUTISM,1
GOBP_POSITIVE_REGULATION_OF_...474,SET,12,-0.0071081,-0.00018157,0.23582,0.51202,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY,1
MIR3143,SET,412,-0.001272,-0.0001883,0.042167,0.51203,MIR3143,1
SHETH_LIVER_CANCER_VS_TXNIP_...5,SET,96,-0.0027162,-0.00019579,0.089938,0.51205,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5,1
GOBP_REGULATION_OF_NEUROTRAN...2,SET,8,-0.0090918,-0.00018964,0.30054,0.51207,GOBP_REGULATION_OF_NEUROTRANSMITTER_RECEPTOR_LOCALIZATION_TO_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GEISS_RESPONSE_TO_DSRNA_UP,SET,37,-0.0041161,-0.0001845,0.13545,0.51212,GEISS_RESPONSE_TO_DSRNA_UP,1
HE_LIM_SUN_FETAL_LUNG_C3_VEN...,SET,76,-0.0030948,-0.0001986,0.10181,0.51213,HE_LIM_SUN_FETAL_LUNG_C3_VENOUS_ENDOTHELIAL_CELL,1
GOBP_GLUCOSE_IMPORT,SET,68,-0.0031978,-0.00019415,0.10507,0.51214,GOBP_GLUCOSE_IMPORT,1
VALK_AML_WITH_FLT3_ITD,SET,36,-0.0046954,-0.00020761,0.15353,0.5122,VALK_AML_WITH_FLT3_ITD,1
GOBP_CELL_CYCLE_CHECKPOINT_S...,SET,180,-0.0018186,-0.00017909,0.059459,0.5122,GOBP_CELL_CYCLE_CHECKPOINT_SIGNALING,1
GATA4_Q3,SET,224,-0.0018272,-0.00020049,0.059423,0.51226,GATA4_Q3,1
HP_NEOPLASM_OF_THE_THYROID_G...,SET,87,-0.002774,-0.0001904,0.08952,0.51236,HP_NEOPLASM_OF_THE_THYROID_GLAND,1
GOMF_3_KETO_STEROL_REDUCTASE...,SET,5,-0.011884,-0.00019598,0.38269,0.51239,GOMF_3_KETO_STEROL_REDUCTASE_ACTIVITY,1
HP_SMALL_FOR_GESTATIONAL_AGE,SET,226,-0.001747,-0.00019253,0.055626,0.51253,HP_SMALL_FOR_GESTATIONAL_AGE,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...4,SET,150,-0.0020266,-0.00018234,0.06408,0.51261,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_UP,1
KEGG_MEDICUS_REFERENCE_REGUL...12,SET,25,-0.0058507,-0.00021563,0.1845,0.51265,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL,1
REACTOME_ERYTHROPOIETIN_ACTI...2,SET,7,-0.010615,-0.00020713,0.33464,0.51265,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOLIPASE_C_GAMMA_PLCG,1
GOBP_PLASMA_MEMBRANE_TO_ENDO...,SET,8,-0.0093161,-0.00019432,0.29302,0.51268,GOBP_PLASMA_MEMBRANE_TO_ENDOSOME_TRANSPORT,1
GSE5589_IL6_KO_VS_IL10_KO_LP...5,SET,179,-0.0020142,-0.00019781,0.063362,0.51268,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
GOBP_REGULATION_OF_PROTEIN_L...14,SET,102,-0.0026087,-0.0001938,0.081986,0.51269,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
LOPEZ_MESOTELIOMA_SURVIVAL_T...2,SET,10,-0.0088515,-0.00020641,0.27811,0.5127,LOPEZ_MESOTELIOMA_SURVIVAL_TIME_UP,1
HP_FACIAL_DIPLEGIA,SET,39,-0.0042234,-0.00019435,0.13205,0.51276,HP_FACIAL_DIPLEGIA,1
GOBP_NEURON_PROJECTION_ARBOR...,SET,32,-0.0046434,-0.00019358,0.14484,0.51279,GOBP_NEURON_PROJECTION_ARBORIZATION,1
HP_RECEPTIVE_LANGUAGE_DELAY,SET,13,-0.0071713,-0.00019066,0.22354,0.5128,HP_RECEPTIVE_LANGUAGE_DELAY,1
LIM_MAMMARY_STEM_CELL_UP,SET,430,-0.0013832,-0.00020908,0.043032,0.51282,LIM_MAMMARY_STEM_CELL_UP,1
HP_LARGE_FOR_GESTATIONAL_AGE,SET,49,-0.0038535,-0.00019871,0.11989,0.51282,HP_LARGE_FOR_GESTATIONAL_AGE,1
KEGG_GLYCINE_SERINE_AND_THRE...,SET,27,-0.0052358,-0.00020053,0.16227,0.51287,KEGG_GLYCINE_SERINE_AND_THREONINE_METABOLISM,1
GSE37605_NOD_VS_C57BL6_IRES_...2,SET,140,-0.0023569,-0.00020492,0.073063,0.51287,GSE37605_NOD_VS_C57BL6_IRES_GFP_TREG_UP,1
GOBP_SA_NODE_CELL_TO_ATRIAL_...1,SET,11,-0.0089337,-0.00021849,0.27603,0.51291,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_COMMUNICATION,1
HP_ABNORMAL_MUSCLE_GLYCOGEN_...,SET,10,-0.0075431,-0.0001759,0.23154,0.51299,HP_ABNORMAL_MUSCLE_GLYCOGEN_CONTENT,1
GSE46606_IRF4MID_VS_WT_CD40L...1,SET,185,-0.0021964,-0.00021925,0.067224,0.51303,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
HP_ECTOPIA_PUPILLAE,SET,21,-0.0066375,-0.00022424,0.20264,0.51306,HP_ECTOPIA_PUPILLAE,1
HP_HYPERCAPNIA,SET,12,-0.0085719,-0.00021896,0.25943,0.51318,HP_HYPERCAPNIA,1
WATANABE_RECTAL_CANCER_RADIO...1,SET,89,-0.0030541,-0.00021201,0.092244,0.51321,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...515,SET,5,-0.01319,-0.00021752,0.39618,0.51328,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
TSENG_IRS1_TARGETS_UP,SET,94,-0.0029249,-0.00020864,0.087687,0.5133,TSENG_IRS1_TARGETS_UP,1
HP_ABNORMALITY_OF_SUBCUTANEO...,SET,60,-0.0036282,-0.00020696,0.10839,0.51335,HP_ABNORMALITY_OF_SUBCUTANEOUS_FAT_TISSUE,1
DAIRKEE_CANCER_PRONE_RESPONS...1,SET,50,-0.0037654,-0.00019613,0.11237,0.51337,DAIRKEE_CANCER_PRONE_RESPONSE_BPA,1
MIR4444,SET,5,-0.012221,-0.00020155,0.3626,0.51344,MIR4444,1
DESCARTES_FETAL_ADRENAL_MYEL...,SET,151,-0.0025093,-0.00022651,0.074339,0.51346,DESCARTES_FETAL_ADRENAL_MYELOID_CELLS,1
REACTOME_TRANSCRIPTIONAL_REG...11,SET,30,-0.0051351,-0.0002073,0.15199,0.51348,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_BROWN_AND_BEIGE_ADIPOCYTE_DIFFERENTIATION,1
GOMF_AMINO_ACID_TRANSMEMBRAN...,SET,91,-0.0031872,-0.00022371,0.093459,0.5136,GOMF_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
RAX2_TARGET_GENES,SET,62,-0.003789,-0.0002197,0.11083,0.51364,RAX2_TARGET_GENES,1
HP_PROFOUND_GLOBAL_DEVELOPME...,SET,59,-0.0037006,-0.00020933,0.10784,0.51369,HP_PROFOUND_GLOBAL_DEVELOPMENTAL_DELAY,1
CIITA_TARGET_GENES,SET,973,-0.00093579,-0.00020954,0.027238,0.5137,CIITA_TARGET_GENES,1
GOBP_REGULATION_OF_GLYCOGEN_...1,SET,25,-0.0058853,-0.00021691,0.17114,0.51372,GOBP_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
GSE43955_1H_VS_60H_ACT_CD4_T...2,SET,184,-0.0021756,-0.00021659,0.062887,0.5138,GSE43955_1H_VS_60H_ACT_CD4_TCELL_UP,1
KAUFFMANN_DNA_REPLICATION_GE...,SET,135,-0.0024269,-0.00020723,0.070107,0.51381,KAUFFMANN_DNA_REPLICATION_GENES,1
HALLMARK_FATTY_ACID_METABOLI...,SET,145,-0.0023697,-0.00020965,0.068444,0.51381,HALLMARK_FATTY_ACID_METABOLISM,1
GOMF_DOPAMINE_BINDING,SET,6,-0.013929,-0.00025162,0.39999,0.51389,GOMF_DOPAMINE_BINDING,1
KORKOLA_TERATOMA_UP,SET,13,-0.0090609,-0.00024089,0.25916,0.51395,KORKOLA_TERATOMA_UP,1
REACTOME_SUMOYLATION_OF_CHRO...,SET,53,-0.0039749,-0.00021315,0.11369,0.51395,REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS,1
MIR6823_5P,SET,64,-0.0036366,-0.00021422,0.10401,0.51395,MIR6823_5P,1
SCHERER_PBMC_YF_VAX_AGE_18_4...3,SET,17,-0.0075463,-0.0002294,0.21442,0.51404,SCHERER_PBMC_YF_VAX_AGE_18_40YO_ANYD_DN,1
MODULE_206,SET,144,-0.0024354,-0.00021472,0.068927,0.51409,MODULE_206,1
BONOME_OVARIAN_CANCER_POOR_S...2,SET,28,-0.0057716,-0.0002251,0.16318,0.51411,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_UP,1
GOBP_CAMERA_TYPE_EYE_MORPHOG...,SET,127,-0.0028168,-0.00023335,0.079647,0.51411,GOBP_CAMERA_TYPE_EYE_MORPHOGENESIS,1
chr4q24,SET,24,-0.011513,-0.00041578,0.32507,0.51413,chr4q24,1
GSE11973_MIR223_KOVS_WT_BONE...1,SET,154,-0.0023573,-0.00021487,0.066547,0.51413,GSE11973_MIR223_KOVS_WT_BONE_MARROW_NEUTROPHIL_DN,1
HP_BLEPHAROPHIMOSIS,SET,111,-0.0029348,-0.00022738,0.08274,0.51415,HP_BLEPHAROPHIMOSIS,1
GOCC_ENDOPLASMIC_RETICULUM_C...,SET,11,-0.0080302,-0.0001964,0.22615,0.51416,GOCC_ENDOPLASMIC_RETICULUM_CHAPERONE_COMPLEX,1
GSE15930_NAIVE_VS_48H_IN_VIT...5,SET,179,-0.0021164,-0.00020785,0.059592,0.51417,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...8,SET,11,-0.0093672,-0.00022909,0.26269,0.51422,HP_APLASIA_HYPOPLASIA_OF_THE_5TH_METACARPAL,1
KEGG_MEDICUS_VARIANT_MUTATIO...75,SET,11,-0.0086632,-0.00021188,0.24246,0.51425,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_P62_TO_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
HP_TRACTIONAL_RETINAL_DETACH...,SET,7,-0.012812,-0.00024999,0.35702,0.51431,HP_TRACTIONAL_RETINAL_DETACHMENT,1
KEGG_PATHOGENIC_ESCHERICHIA_...,SET,53,-0.0041395,-0.00022197,0.11457,0.51441,KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,1
WP_PATHOGENIC_ESCHERICHIA_CO...,SET,53,-0.0041395,-0.00022197,0.11457,0.51441,WP_PATHOGENIC_ESCHERICHIA_COLI_INFECTION,1
KEGG_GLYCOSPHINGOLIPID_BIOSY...3,SET,26,-0.0064722,-0.00024326,0.17836,0.51447,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_LACTO_AND_NEOLACTO_SERIES,1
HP_ABNORMALITY_OF_CHROMOSOME...2,SET,49,-0.0040427,-0.00020846,0.11106,0.51452,HP_ABNORMALITY_OF_CHROMOSOME_STABILITY,1
GSE17974_CTRL_VS_ACT_IL4_AND...2,SET,131,-0.0025836,-0.00021734,0.070942,0.51453,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_UP,1
GRANDVAUX_IRF3_TARGETS_UP,SET,13,-0.0088304,-0.00023477,0.24158,0.51458,GRANDVAUX_IRF3_TARGETS_UP,1
GOBP_SYMPATHETIC_NEURON_PROJ...,SET,5,-0.014419,-0.00023779,0.39411,0.51459,GOBP_SYMPATHETIC_NEURON_PROJECTION_EXTENSION,1
GOMF_ENDONUCLEASE_ACTIVITY_A...2,SET,33,-0.0054292,-0.00022985,0.1482,0.51461,GOMF_ENDONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
GOBP_REGULATION_OF_MITOCHOND...15,SET,23,-0.0058375,-0.00020638,0.1593,0.51462,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
HP_ABNORMAL_CORNEAL_STROMA_M...,SET,96,-0.003209,-0.00023131,0.087511,0.51463,HP_ABNORMAL_CORNEAL_STROMA_MORPHOLOGY,1
GOBP_REGULATION_OF_TRANSCRIP...5,SET,29,-0.0061117,-0.00024258,0.16653,0.51464,GOBP_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
GOBP_STRIATED_MUSCLE_CELL_PR...,SET,67,-0.0039573,-0.0002385,0.10784,0.51464,GOBP_STRIATED_MUSCLE_CELL_PROLIFERATION,1
GSE20198_UNTREATED_VS_IFNA_T...1,SET,175,-0.0021821,-0.00021191,0.059443,0.51464,GSE20198_UNTREATED_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,1
HP_HAND_CLENCHING,SET,27,-0.0056278,-0.00021555,0.15225,0.51474,HP_HAND_CLENCHING,1
SUZUKI_RESPONSE_TO_TSA_AND_D...2,SET,15,-0.0087398,-0.00024958,0.23618,0.51476,SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B,1
REACTOME_ABORTIVE_ELONGATION...,SET,23,-0.0055704,-0.00019693,0.15051,0.51476,REACTOME_ABORTIVE_ELONGATION_OF_HIV_1_TRANSCRIPT_IN_THE_ABSENCE_OF_TAT,1
MODULE_537,SET,17,-0.0076204,-0.00023166,0.2058,0.51477,MODULE_537,1
MIR323A_5P,SET,40,-0.0045035,-0.00020987,0.12155,0.51478,MIR323A_5P,1
GOBP_LEUKOCYTE_CHEMOTAXIS_IN...,SET,8,-0.012303,-0.00025663,0.33175,0.51479,GOBP_LEUKOCYTE_CHEMOTAXIS_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GSE9316_CD4_TCELL_BALBC_VS_T...2,SET,178,-0.0023317,-0.00022836,0.062413,0.5149,GSE9316_CD4_TCELL_BALBC_VS_TH17_ENRI_CD4_TCELL_SKG_PMA_IONO_STIM_FR4NEG_UP,1
NR1I2_TARGET_GENES,SET,270,-0.0018515,-0.00022276,0.049483,0.51492,NR1I2_TARGET_GENES,1
BONOME_OVARIAN_CANCER_POOR_S...1,SET,19,-0.0065764,-0.00021134,0.17489,0.515,BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN,1
JIANG_VHL_TARGETS,SET,77,-0.0034909,-0.00022548,0.09268,0.51502,JIANG_VHL_TARGETS,1
MASSARWEH_TAMOXIFEN_RESISTAN...2,SET,510,-0.0014491,-0.00023802,0.038489,0.51502,MASSARWEH_TAMOXIFEN_RESISTANCE_UP,1
REACTOME_REGULATION_OF_MRNA_...,SET,83,-0.0032692,-0.0002192,0.08681,0.51502,REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS,1
HP_HYPNOPOMPIC_HALLUCINATION,SET,6,-0.014217,-0.00025683,0.37686,0.51505,HP_HYPNOPOMPIC_HALLUCINATION,1
ESC_V6.5_UP_EARLY.V1_UP,SET,154,-0.0026194,-0.00023876,0.06937,0.51506,ESC_V6.5_UP_EARLY.V1_UP,1
GSE21670_UNTREATED_VS_TGFB_T...3,SET,180,-0.0024275,-0.00023906,0.064078,0.51511,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_DN,1
GOBP_CELL_MATRIX_ADHESION,SET,225,-0.0021823,-0.00023998,0.057573,0.51512,GOBP_CELL_MATRIX_ADHESION,1
MORF_DDX11,SET,145,-0.0025248,-0.00022337,0.066577,0.51513,MORF_DDX11,1
HP_TOOTH_ABSCESS,SET,6,-0.014865,-0.00026854,0.39172,0.51514,HP_TOOTH_ABSCESS,1
GOBP_NEURON_APOPTOTIC_PROCESS,SET,263,-0.0020391,-0.00024218,0.053449,0.51522,GOBP_NEURON_APOPTOTIC_PROCESS,1
KEGG_MEDICUS_ENV_FACTOR_NICO...1,SET,11,-0.0096458,-0.00023591,0.25224,0.51525,KEGG_MEDICUS_ENV_FACTOR_NICOTINE_NNK_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...66,SET,40,-0.0052345,-0.00024393,0.1368,0.51526,GOBP_POSITIVE_REGULATION_OF_BONE_MINERALIZATION,1
HP_NEMALINE_BODIES,SET,19,-0.0073015,-0.00023464,0.19021,0.51531,HP_NEMALINE_BODIES,1
GOBP_MESENDODERM_DEVELOPMENT,SET,9,-0.010963,-0.00024253,0.28463,0.51536,GOBP_MESENDODERM_DEVELOPMENT,1
MORF_RUNX1,SET,139,-0.0027063,-0.00023446,0.070108,0.5154,MORF_RUNX1,1
HP_SPASTIC_TETRAPARESIS,SET,60,-0.0041497,-0.00023672,0.10719,0.51544,HP_SPASTIC_TETRAPARESIS,1
BUSSLINGER_GASTRIC_METALLOTH...,SET,91,-0.0036035,-0.00025293,0.092802,0.51549,BUSSLINGER_GASTRIC_METALLOTHIONEIN_CELLS,1
MAGRANGEAS_MULTIPLE_MYELOMA_...2,SET,16,-0.0082997,-0.00024478,0.21344,0.51551,MAGRANGEAS_MULTIPLE_MYELOMA_IGG_VS_IGA_UP,1
GOMF_PROTEIN_CYSTEINE_S_STEA...,SET,6,-0.012824,-0.00023166,0.32928,0.51553,GOMF_PROTEIN_CYSTEINE_S_STEAROYLTRANSFERASE_ACTIVITY,1
HP_AREFLEXIA_OF_UPPER_LIMBS,SET,7,-0.013839,-0.00027003,0.35474,0.51556,HP_AREFLEXIA_OF_UPPER_LIMBS,1
GSE17721_4_VS_24H_GARDIQUIMO...2,SET,179,-0.0024785,-0.0002434,0.063457,0.51558,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_UP,1
HP_ANONYCHIA,SET,60,-0.0042771,-0.00024398,0.10944,0.51559,HP_ANONYCHIA,1
GOMF_GATED_CHANNEL_ACTIVITY,SET,301,-0.0020739,-0.00026322,0.052921,0.51563,GOMF_GATED_CHANNEL_ACTIVITY,1
GOBP_CAP_DEPENDENT_TRANSLATI...,SET,7,-0.0099328,-0.00019381,0.25267,0.51568,GOBP_CAP_DEPENDENT_TRANSLATIONAL_INITIATION,1
GSE29618_PRE_VS_DAY7_POST_TI...4,SET,180,-0.0024468,-0.00024096,0.062168,0.5157,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_UP,1
GOBP_THYROID_GLAND_DEVELOPME...,SET,30,-0.0063094,-0.0002547,0.15962,0.51576,GOBP_THYROID_GLAND_DEVELOPMENT,1
GSE8868_SPLEEN_VS_INTESTINE_...1,SET,178,-0.0024716,-0.00024205,0.062312,0.51582,GSE8868_SPLEEN_VS_INTESTINE_CD11B_POS_CD11C_NEG_DC_DN,1
GOBP_RNA_DECAPPING,SET,17,-0.0083472,-0.00025375,0.20985,0.51586,GOBP_RNA_DECAPPING,1
GSE32901_NAIVE_VS_TH17_NEG_C...2,SET,157,-0.002653,-0.00024416,0.06642,0.51593,GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP,1
GSE21927_SPLEEN_VS_C26GM_TUM...1,SET,162,-0.002632,-0.00024601,0.065829,0.51595,GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN,1
GSE13484_12H_VS_3H_YF17D_VAC...2,SET,174,-0.0025069,-0.00024277,0.062455,0.51601,GSE13484_12H_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,1
HP_RECURRENT_INTRAPULMONARY_...,SET,7,-0.016341,-0.00031884,0.40633,0.51604,HP_RECURRENT_INTRAPULMONARY_HEMORRHAGE,1
HP_ABNORMAL_CHOROID_MORPHOLO...,SET,170,-0.0026701,-0.0002556,0.066318,0.51606,HP_ABNORMAL_CHOROID_MORPHOLOGY,1
HP_APHTHOUS_ULCER,SET,6,-0.015825,-0.00028589,0.39269,0.51607,HP_APHTHOUS_ULCER,1
PITX1_TARGET_GENES,SET,290,-0.0019794,-0.00024667,0.048973,0.51612,PITX1_TARGET_GENES,1
GOBP_PROTEIN_LOCALIZATION_TO...15,SET,11,-0.0092221,-0.00022555,0.22799,0.51613,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_MEMBRANE,1
GSE10325_LUPUS_CD4_TCELL_VS_...3,SET,183,-0.0026724,-0.00026534,0.065945,0.51616,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_MYELOID_DN,1
chr10q21,SET,41,-0.0099543,-0.00046963,0.24535,0.51618,chr10q21,1
MODULE_8,SET,396,-0.0017017,-0.00024708,0.041862,0.51621,MODULE_8,1
REACTOME_RUNX1_REGULATES_EST...,SET,6,-0.015141,-0.00027352,0.37143,0.51626,REACTOME_RUNX1_REGULATES_ESTROGEN_RECEPTOR_MEDIATED_TRANSCRIPTION,1
GOCC_PHAGOPHORE_ASSEMBLY_SITE,SET,35,-0.0057577,-0.00025102,0.14083,0.51631,GOCC_PHAGOPHORE_ASSEMBLY_SITE,1
GSE7596_AKT_TRANSD_VS_CTRL_C...2,SET,147,-0.0027651,-0.0002463,0.067618,0.51631,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_UP,1
GSE2770_TGFB_AND_IL4_ACT_VS_...2,SET,163,-0.0026299,-0.00024657,0.06405,0.51638,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,1
REACTOME_OPSINS,SET,7,-0.012421,-0.00024236,0.30182,0.51641,REACTOME_OPSINS,1
GOBP_RESPONSE_TO_ANTIBIOTIC,SET,36,-0.005717,-0.00025278,0.13841,0.51647,GOBP_RESPONSE_TO_ANTIBIOTIC,1
GOBP_RETINAL_CONE_CELL_DEVEL...,SET,11,-0.011725,-0.00028676,0.28377,0.51648,GOBP_RETINAL_CONE_CELL_DEVELOPMENT,1
GOBP_CELL_DIFFERENTIATION_IN...4,SET,3,-0.023535,-0.00030067,0.56904,0.5165,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_PHENOTYPIC_SWITCHING,1
MORF_CASP10,SET,109,-0.0032662,-0.00025078,0.078824,0.51653,MORF_CASP10,1
HP_ABNORMALITY_OF_THE_OUTER_...,SET,1117,-0.0010656,-0.00025459,0.025563,0.51662,HP_ABNORMALITY_OF_THE_OUTER_EAR,1
SNF5_DN.V1_DN,SET,136,-0.0032365,-0.00027738,0.077515,0.51665,SNF5_DN.V1_DN,1
GOBP_CELLULAR_RESPONSE_TO_BI...,SET,232,-0.0024516,-0.0002737,0.058343,0.51676,GOBP_CELLULAR_RESPONSE_TO_BIOTIC_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...627,SET,9,-0.013076,-0.0002893,0.31123,0.51676,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_C_SIGNALING,1
GSE6259_DEC205_POS_DC_VS_CD4...1,SET,181,-0.0025486,-0.00025167,0.060643,0.51676,GSE6259_DEC205_POS_DC_VS_CD4_TCELL_DN,1
HP_ASTHENIA,SET,8,-0.012577,-0.00026235,0.29805,0.51683,HP_ASTHENIA,1
GOMF_CHROMO_SHADOW_DOMAIN_BI...,SET,5,-0.014467,-0.00023859,0.34197,0.51687,GOMF_CHROMO_SHADOW_DOMAIN_BINDING,1
KEGG_METABOLISM_OF_XENOBIOTI...,SET,65,-0.0059463,-0.000353,0.14015,0.51692,KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450,1
REACTOME_FORMATION_OF_PARAXI...,SET,63,-0.0040428,-0.00023629,0.09531,0.51692,REACTOME_FORMATION_OF_PARAXIAL_MESODERM,1
HP_NEOPLASM_OF_THE_ORAL_CAVI...,SET,63,-0.0041356,-0.00024171,0.097385,0.51694,HP_NEOPLASM_OF_THE_ORAL_CAVITY,1
GSE41176_WT_VS_TAK1_KO_ANTI_...7,SET,183,-0.0026321,-0.00026133,0.061915,0.51695,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_DN,1
REACTOME_TNF_RECEPTOR_SUPERF...,SET,16,-0.0097231,-0.00028676,0.22865,0.51696,REACTOME_TNF_RECEPTOR_SUPERFAMILY_TNFSF_MEMBERS_MEDIATING_NON_CANONICAL_NF_KB_PATHWAY,1
GOBP_AMINO_ACID_BETAINE_META...,SET,16,-0.0090072,-0.00026564,0.21175,0.51696,GOBP_AMINO_ACID_BETAINE_METABOLIC_PROCESS,1
PID_ER_NONGENOMIC_PATHWAY,SET,39,-0.0055612,-0.0002559,0.12984,0.51708,PID_ER_NONGENOMIC_PATHWAY,1
GOCC_MRNA_CLEAVAGE_AND_POLYA...,SET,17,-0.0076357,-0.00023212,0.17823,0.51709,GOCC_MRNA_CLEAVAGE_AND_POLYADENYLATION_SPECIFICITY_FACTOR_COMPLEX,1
HP_ACUTE_LYMPHOBLASTIC_LEUKE...,SET,40,-0.005703,-0.00026577,0.13226,0.5172,HP_ACUTE_LYMPHOBLASTIC_LEUKEMIA,1
REACTOME_POU5F1_OCT4_SOX2_NA...1,SET,10,-0.01251,-0.00029172,0.28967,0.51722,REACTOME_POU5F1_OCT4_SOX2_NANOG_ACTIVATE_GENES_RELATED_TO_PROLIFERATION,1
GOMF_STRUCTURAL_CONSTITUENT_...5,SET,9,-0.013494,-0.00029854,0.31252,0.51722,GOMF_STRUCTURAL_CONSTITUENT_OF_MYELIN_SHEATH,1
GOMF_BMP_RECEPTOR_ACTIVITY,SET,7,-0.013562,-0.00026462,0.3124,0.51731,GOMF_BMP_RECEPTOR_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C6_MUC...,SET,49,-0.0056314,-0.00029038,0.12972,0.51731,HE_LIM_SUN_FETAL_LUNG_C6_MUC16_POS_CILIATED_CELL,1
GOBP_REGULATION_OF_RESPIRATO...2,SET,7,-0.014754,-0.00028788,0.3394,0.51734,GOBP_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GOMF_SYMPORTER_ACTIVITY,SET,144,-0.0032721,-0.0002885,0.075,0.5174,GOMF_SYMPORTER_ACTIVITY,1
REACTOME_ACTIVATION_OF_THE_P...2,SET,31,-0.0058541,-0.00024022,0.13389,0.51744,REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX,1
GOBP_REGULATION_OF_MEMBRANE_...7,SET,61,-0.0046059,-0.00026491,0.10518,0.51746,GOBP_REGULATION_OF_MEMBRANE_PERMEABILITY,1
GSE10273_HIGH_VS_LOW_IL7_TRE...2,SET,171,-0.0027508,-0.0002641,0.062787,0.51747,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_UP,1
HARALAMBIEVA_PBMC_FLUARIX_AG...6,SET,14,-0.011518,-0.00031777,0.26294,0.51747,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LEUK_MIGR_MAPK_ACT_CYTOK_SIG_DIAB_OF_THE_YNG_POSITIVE,1
MIR211_3P,SET,75,-0.0043973,-0.00028033,0.10025,0.51749,MIR211_3P,1
REACTOME_REGULATION_OF_RUNX1...,SET,17,-0.0091783,-0.00027901,0.20889,0.51752,REACTOME_REGULATION_OF_RUNX1_EXPRESSION_AND_ACTIVITY,1
GOBP_NUCLEAR_MEMBRANE_ORGANI...,SET,44,-0.0053818,-0.00026301,0.12238,0.51754,GOBP_NUCLEAR_MEMBRANE_ORGANIZATION,1
GOBP_GLUCAN_BIOSYNTHETIC_PRO...,SET,40,-0.0057132,-0.00026624,0.12979,0.51755,GOBP_GLUCAN_BIOSYNTHETIC_PROCESS,1
MIR1180_3P,SET,6,-0.015685,-0.00028336,0.35519,0.51761,MIR1180_3P,1
GOCC_FLEMMING_BODY,SET,34,-0.0061008,-0.00026216,0.1381,0.51762,GOCC_FLEMMING_BODY,1
HP_RECTAL_POLYPOSIS,SET,5,-0.017508,-0.00028873,0.39557,0.51765,HP_RECTAL_POLYPOSIS,1
PDGF_ERK_DN.V1_UP,SET,126,-0.0031022,-0.00025598,0.070091,0.51765,PDGF_ERK_DN.V1_UP,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...2,SET,178,-0.0026734,-0.00026182,0.060323,0.51767,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_UP,1
REACTOME_MET_ACTIVATES_RAP1_...,SET,11,-0.012371,-0.00030257,0.27911,0.51768,REACTOME_MET_ACTIVATES_RAP1_AND_RAC1,1
MODULE_94,SET,342,-0.0021075,-0.0002848,0.047446,0.51771,MODULE_94,1
GOCC_NEURON_PROJECTION_CYTOP...,SET,83,-0.0041132,-0.00027579,0.092617,0.51771,GOCC_NEURON_PROJECTION_CYTOPLASM,1
HP_TRIANGULAR_MOUTH,SET,19,-0.0074045,-0.00023795,0.16657,0.51773,HP_TRIANGULAR_MOUTH,1
GOCC_PHAGOCYTIC_VESICLE,SET,126,-0.0033133,-0.0002734,0.074179,0.51781,GOCC_PHAGOCYTIC_VESICLE,1
GOBP_HORMONE_BIOSYNTHETIC_PR...,SET,64,-0.0048825,-0.00028762,0.10866,0.51792,GOBP_HORMONE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_DNA_TEMPL...3,SET,94,-0.003645,-0.00026,0.081029,0.51794,GOBP_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
MITSIADES_RESPONSE_TO_APLIDI...1,SET,229,-0.0024456,-0.00027128,0.054301,0.51796,MITSIADES_RESPONSE_TO_APLIDIN_DN,1
HP_ABNORMAL_LATERAL_VENTRICL...,SET,104,-0.0036006,-0.00027009,0.079948,0.51796,HP_ABNORMAL_LATERAL_VENTRICLE_MORPHOLOGY,1
GSE21063_WT_VS_NFATC1_KO_8H_...1,SET,180,-0.002769,-0.00027269,0.061482,0.51796,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_DN,1
KEGG_MEDICUS_VARIANT_SCRAPIE...3,SET,6,-0.016931,-0.00030586,0.37462,0.51802,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_PERK_ATF4_SIGNALING_PATHWAY,1
HP_RENAL_MALROTATION,SET,6,-0.016373,-0.00029579,0.36201,0.51804,HP_RENAL_MALROTATION,1
GSE10239_NAIVE_VS_DAY4.5_EFF...2,SET,187,-0.0028741,-0.00028844,0.063356,0.51809,GSE10239_NAIVE_VS_DAY4.5_EFF_CD8_TCELL_UP,1
GSE2405_0H_VS_6H_A_PHAGOCYTO...2,SET,171,-0.0027581,-0.0002648,0.060719,0.51812,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP,1
chr14q21,SET,33,-0.010795,-0.00045703,0.23739,0.51814,chr14q21,1
GOBP_CARDIAC_SEPTUM_MORPHOGE...,SET,68,-0.0053364,-0.00032399,0.11672,0.51823,GOBP_CARDIAC_SEPTUM_MORPHOGENESIS,1
GOBP_REGULATION_OF_SMAD_PROT...,SET,59,-0.0055098,-0.00031167,0.12051,0.51823,GOBP_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_T_CELL_TOLERANCE_INDUCT...,SET,14,-0.011072,-0.00030547,0.24189,0.51825,GOBP_T_CELL_TOLERANCE_INDUCTION,1
HP_GLOSSOPTOSIS,SET,25,-0.0075909,-0.00027977,0.16576,0.51826,HP_GLOSSOPTOSIS,1
TAKEDA_TARGETS_OF_NUP98_HOXA...2,SET,171,-0.0032684,-0.00031379,0.071019,0.51835,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_UP,1
MODULE_451,SET,30,-0.0067065,-0.00027073,0.14565,0.51836,MODULE_451,1
GOBP_DEVELOPMENTAL_MATURATION,SET,310,-0.0023038,-0.00029667,0.04995,0.51839,GOBP_DEVELOPMENTAL_MATURATION,1
GSE40685_TREG_VS_FOXP3_KO_TR...2,SET,172,-0.0030979,-0.00029829,0.067186,0.51839,GSE40685_TREG_VS_FOXP3_KO_TREG_PRECURSOR_UP,1
GOBP_PROTEIN_INSERTION_INTO_...3,SET,40,-0.0059148,-0.00027564,0.12815,0.51841,GOBP_PROTEIN_INSERTION_INTO_MEMBRANE,1
REACTOME_G_BETA_GAMMA_SIGNAL...1,SET,19,-0.009086,-0.00029199,0.19668,0.51842,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_CDC42,1
GOMF_RNA_ENDONUCLEASE_ACTIVI...3,SET,27,-0.007956,-0.00030472,0.17213,0.51843,GOMF_RNA_ENDONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
GOBP_CELLULAR_RESPONSE_TO_UV,SET,81,-0.0041035,-0.00027182,0.088712,0.51845,GOBP_CELLULAR_RESPONSE_TO_UV,1
GOBP_POSITIVE_REGULATION_OF_...598,SET,11,-0.012226,-0.00029901,0.26414,0.51846,GOBP_POSITIVE_REGULATION_OF_POST_TRANSCRIPTIONAL_GENE_SILENCING,1
HP_PROGRESSIVE_DISTAL_MUSCUL...,SET,37,-0.0061204,-0.00027433,0.13184,0.51851,HP_PROGRESSIVE_DISTAL_MUSCULAR_ATROPHY,1
HP_REDUCED_VITAL_CAPACITY,SET,26,-0.0070079,-0.00026339,0.15076,0.51854,HP_REDUCED_VITAL_CAPACITY,1
HP_CALCIFICATION_OF_FALX_CER...,SET,7,-0.01354,-0.00026419,0.29073,0.51857,HP_CALCIFICATION_OF_FALX_CEREBRI,1
GOBP_ACTIN_FILAMENT_DEPOLYME...,SET,54,-0.0052056,-0.00028175,0.11171,0.51858,GOBP_ACTIN_FILAMENT_DEPOLYMERIZATION,1
GOBP_SNRNA_TRANSPORT,SET,5,-0.015415,-0.00025421,0.33024,0.51861,GOBP_SNRNA_TRANSPORT,1
GSE21063_CTRL_VS_ANTI_IGM_ST...5,SET,178,-0.0029905,-0.00029287,0.063872,0.51867,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_8H_DN,1
BERENJENO_TRANSFORMED_BY_RHO...5,SET,8,-0.016455,-0.00034323,0.35,0.51875,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_UP,1
REACTOME_PEROXISOMAL_LIPID_M...,SET,28,-0.0071611,-0.0002793,0.15223,0.51876,REACTOME_PEROXISOMAL_LIPID_METABOLISM,1
GOBP_EMBRYO_DEVELOPMENT_ENDI...,SET,642,-0.0016192,-0.00029729,0.034323,0.51881,GOBP_EMBRYO_DEVELOPMENT_ENDING_IN_BIRTH_OR_EGG_HATCHING,1
HP_APLASIA_HYPOPLASIA_AFFECT...3,SET,418,-0.0019504,-0.00029078,0.041358,0.51881,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_EYE,1
MIR1258,SET,57,-0.0053687,-0.00029852,0.11365,0.51884,MIR1258,1
TORCHIA_TARGETS_OF_EWSR1_FLI...1,SET,291,-0.0024541,-0.00030635,0.051891,0.51886,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1
GOBP_SUGAR_MEDIATED_SIGNALIN...,SET,9,-0.013926,-0.00030808,0.29445,0.51886,GOBP_SUGAR_MEDIATED_SIGNALING_PATHWAY,1
GATGKMRGCG_UNKNOWN,SET,60,-0.0051912,-0.00029612,0.10973,0.51887,GATGKMRGCG_UNKNOWN,1
HP_ABNORMAL_INTERNAL_GENITAL...,SET,467,-0.001872,-0.00029459,0.039552,0.51887,HP_ABNORMAL_INTERNAL_GENITALIA,1
HP_CORNEAL_EROSION,SET,40,-0.0066204,-0.00030852,0.13953,0.51892,HP_CORNEAL_EROSION,1
MEBARKI_HCC_PROGENITOR_WNT_U...4,SET,21,-0.0095746,-0.00032346,0.20157,0.51894,MEBARKI_HCC_PROGENITOR_WNT_UP_CTNNB1_INDEPENDENT,1
WILSON_PROTEASES_AT_TUMOR_BO...2,SET,20,-0.0081688,-0.00026933,0.172,0.51894,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_UP,1
HP_ABNORMAL_SERUM_ESTRADIOL,SET,59,-0.0051144,-0.00028931,0.10757,0.51896,HP_ABNORMAL_SERUM_ESTRADIOL,1
GOBP_NEGATIVE_REGULATION_OF_...421,SET,12,-0.01205,-0.0003078,0.25297,0.519,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
HP_AIRWAY_HYPERRESPONSIVENESS,SET,8,-0.015529,-0.00032391,0.32448,0.51908,HP_AIRWAY_HYPERRESPONSIVENESS,1
GOBP_PHOSPHATIDYLGLYCEROL_BI...,SET,9,-0.014466,-0.00032004,0.30216,0.51909,GOBP_PHOSPHATIDYLGLYCEROL_BIOSYNTHETIC_PROCESS,1
GOBP_PROGESTERONE_BIOSYNTHET...,SET,5,-0.016833,-0.00027761,0.35132,0.51911,GOBP_PROGESTERONE_BIOSYNTHETIC_PROCESS,1
GSE17974_IL4_AND_ANTI_IL12_V...4,SET,167,-0.0031894,-0.00030264,0.06656,0.51911,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_12H_ACT_CD4_TCELL_UP,1
PID_NECTIN_PATHWAY,SET,26,-0.0082807,-0.00031123,0.1726,0.51913,PID_NECTIN_PATHWAY,1
WHITEHURST_PACLITAXEL_SENSIT...,SET,31,-0.0066534,-0.00027302,0.13865,0.51914,WHITEHURST_PACLITAXEL_SENSITIVITY,1
GSE36009_UNSTIM_VS_LPS_STIM_...3,SET,169,-0.0029261,-0.0002793,0.060903,0.51916,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_DN,1
GSE26928_NAIVE_VS_EFF_MEMORY...2,SET,156,-0.0032216,-0.00029554,0.066937,0.51919,GSE26928_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_RTK_P...,SET,53,-0.0060518,-0.00032452,0.12571,0.5192,KEGG_MEDICUS_REFERENCE_RTK_PLCG_ITPR_SIGNALING_PATHWAY,1
MIR6827_3P,SET,72,-0.0047345,-0.00029575,0.098247,0.51922,MIR6827_3P,1
HP_FEMALE_INFERTILITY,SET,69,-0.0047238,-0.00028889,0.097452,0.51933,HP_FEMALE_INFERTILITY,1
GSE32423_CTRL_VS_IL4_MEMORY_...2,SET,176,-0.0030741,-0.00029938,0.063333,0.51936,GSE32423_CTRL_VS_IL4_MEMORY_CD8_TCELL_UP,1
REACTOME_NR1H3_NR1H2_REGULAT...,SET,36,-0.0067589,-0.00029884,0.13915,0.51937,REACTOME_NR1H3_NR1H2_REGULATE_GENE_EXPRESSION_LINKED_TO_CHOLESTEROL_TRANSPORT_AND_EFFLUX,1
GOBP_POSITIVE_REGULATION_OF_...568,SET,28,-0.0087292,-0.00034045,0.17968,0.51937,GOBP_POSITIVE_REGULATION_OF_OSTEOCLAST_DIFFERENTIATION,1
FOXC1_TARGET_GENES,SET,59,-0.0054677,-0.0003093,0.11248,0.51938,FOXC1_TARGET_GENES,1
GOBP_RRNA_3_END_PROCESSING,SET,10,-0.010519,-0.0002453,0.21635,0.51939,GOBP_RRNA_3_END_PROCESSING,1
NR5A1_TARGET_GENES,SET,11,-0.012299,-0.00030079,0.25283,0.5194,NR5A1_TARGET_GENES,1
REACTOME_IRAK4_DEFICIENCY_TL...,SET,17,-0.010253,-0.0003117,0.21071,0.51941,REACTOME_IRAK4_DEFICIENCY_TLR2_4,1
HP_RETROCOLLIS,SET,8,-0.01349,-0.00028139,0.27678,0.51944,HP_RETROCOLLIS,1
BIOCARTA_SKP2E2F_PATHWAY,SET,10,-0.013838,-0.00032271,0.2836,0.51946,BIOCARTA_SKP2E2F_PATHWAY,1
HP_RECURRENT_ASPIRATION_PNEU...,SET,23,-0.0084155,-0.00029752,0.17239,0.51947,HP_RECURRENT_ASPIRATION_PNEUMONIA,1
GOBP_POSITIVE_REGULATION_OF_...557,SET,34,-0.007403,-0.00031812,0.15115,0.51953,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,1
PID_IL8_CXCR1_PATHWAY,SET,27,-0.0079847,-0.00030582,0.16284,0.51955,PID_IL8_CXCR1_PATHWAY,1
SIMBULAN_PARP1_TARGETS_UP,SET,27,-0.0087057,-0.00033343,0.17729,0.51958,SIMBULAN_PARP1_TARGETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...29,SET,29,-0.0075746,-0.00030064,0.15416,0.51959,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_RECEPTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_CARDIAC_MUSCLE_CELL_FAT...,SET,7,-0.018166,-0.00035446,0.36965,0.5196,GOBP_CARDIAC_MUSCLE_CELL_FATE_COMMITMENT,1
MORF_UNG,SET,65,-0.0046538,-0.00027627,0.094505,0.51964,MORF_UNG,1
GOMF_PROTEIN_CARBOXYL_O_METH...,SET,6,-0.015843,-0.00028621,0.32155,0.51965,GOMF_PROTEIN_CARBOXYL_O_METHYLTRANSFERASE_ACTIVITY,1
BROWNE_HCMV_INFECTION_14HR_UP,SET,138,-0.0033504,-0.00028922,0.067852,0.51969,BROWNE_HCMV_INFECTION_14HR_UP,1
MIR6799_5P,SET,131,-0.0035507,-0.0002987,0.071901,0.51969,MIR6799_5P,1
GSE6269_HEALTHY_VS_STAPH_AUR...1,SET,145,-0.0034608,-0.00030618,0.069698,0.5198,GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_DN,1
HP_CYSTIC_HYGROMA,SET,50,-0.0055674,-0.00028999,0.11207,0.51981,HP_CYSTIC_HYGROMA,1
GOBP_CONVERGENT_EXTENSION,SET,15,-0.010808,-0.00030863,0.21668,0.51989,GOBP_CONVERGENT_EXTENSION,1
GSE20754_WT_VS_TCF1_KO_MEMOR...1,SET,179,-0.0031934,-0.00031361,0.06398,0.5199,GSE20754_WT_VS_TCF1_KO_MEMORY_CD8_TCELL_DN,1
GOBP_MEDIUM_CHAIN_FATTY_ACID...2,SET,5,-0.016383,-0.00027018,0.32799,0.51992,GOBP_MEDIUM_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,1
REACTOME_SUMOYLATION_OF_DNA_...3,SET,43,-0.0060583,-0.0002927,0.12124,0.51993,REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS,1
GOBP_CIRCADIAN_REGULATION_OF...,SET,62,-0.0055128,-0.00031965,0.10983,0.52002,GOBP_CIRCADIAN_REGULATION_OF_GENE_EXPRESSION,1
HU_GENOTOXIN_ACTION_DIRECT_V...2,SET,37,-0.0071074,-0.00031858,0.14152,0.52003,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_4HR,1
GSE31082_DN_VS_CD8_SP_THYMOC...1,SET,188,-0.0030382,-0.00030571,0.060486,0.52003,GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN,1
HP_FOCAL_WHITE_MATTER_LESIONS,SET,13,-0.011406,-0.00030325,0.22679,0.52006,HP_FOCAL_WHITE_MATTER_LESIONS,1
AP1_01,SET,235,-0.0028272,-0.00031763,0.056053,0.52011,AP1_01,1
GOBP_FORMATE_METABOLIC_PROCE...,SET,6,-0.018925,-0.00034188,0.37454,0.52015,GOBP_FORMATE_METABOLIC_PROCESS,1
GSE13887_RESTING_VS_ACT_CD4_...1,SET,116,-0.0038198,-0.0003025,0.075584,0.52015,GSE13887_RESTING_VS_ACT_CD4_TCELL_DN,1
REACTOME_REMOVAL_OF_AMINOTER...,SET,8,-0.015196,-0.00031697,0.29983,0.52021,REACTOME_REMOVAL_OF_AMINOTERMINAL_PROPEPTIDES_FROM_GAMMA_CARBOXYLATED_PROTEINS,1
MIR4795_5P,SET,62,-0.0054791,-0.00031769,0.10763,0.5203,MIR4795_5P,1
TOYOTA_TARGETS_OF_MIR34B_AND...,SET,400,-0.0020566,-0.00030008,0.040283,0.52036,TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C,1
REACTOME_INTERLEUKIN_37_SIGN...,SET,19,-0.0090218,-0.00028992,0.17635,0.5204,REACTOME_INTERLEUKIN_37_SIGNALING,1
GSE7852_TREG_VS_TCONV_THYMUS...1,SET,178,-0.0032459,-0.00031789,0.063335,0.52044,GSE7852_TREG_VS_TCONV_THYMUS_DN,1
GOBP_N_TERMINAL_PROTEIN_LIPI...,SET,6,-0.017951,-0.00032429,0.34965,0.52047,GOBP_N_TERMINAL_PROTEIN_LIPIDATION,1
MIR4437,SET,97,-0.0044321,-0.00032113,0.086064,0.52054,MIR4437,1
HP_ABNORMAL_CORPUS_STRIATUM_...,SET,35,-0.0069557,-0.00030325,0.13491,0.52056,HP_ABNORMAL_CORPUS_STRIATUM_MORPHOLOGY,1
HP_SEESAW_NYSTAGMUS,SET,6,-0.018637,-0.00033667,0.36143,0.52056,HP_SEESAW_NYSTAGMUS,1
PAX3_B,SET,83,-0.0050395,-0.0003379,0.097507,0.52061,PAX3_B,1
MORF_CTBP1,SET,155,-0.0031762,-0.00029045,0.061187,0.5207,MORF_CTBP1,1
MIR6866_5P,SET,67,-0.0055327,-0.00033344,0.10654,0.52071,MIR6866_5P,1
MIR1245B_5P,SET,53,-0.0059069,-0.00031675,0.11364,0.52073,MIR1245B_5P,1
HOEK_T_CELL_2011_2012_TIV_AD...3,SET,8,-0.017917,-0.00037373,0.34467,0.52073,HOEK_T_CELL_2011_2012_TIV_ADULT_3DY_DN,1
HP_ELEVATED_CIRCULATING_PHYT...,SET,14,-0.011667,-0.00032188,0.22409,0.52076,HP_ELEVATED_CIRCULATING_PHYTANIC_ACID_CONCENTRATION,1
REACTOME_DOWNSTREAM_SIGNALIN...5,SET,26,-0.008312,-0.00031241,0.15952,0.52078,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR4,1
MIR1468_3P,SET,589,-0.0018696,-0.00032929,0.035862,0.52079,MIR1468_3P,1
MORF_THPO,SET,109,-0.0043787,-0.0003362,0.08385,0.52082,MORF_THPO,1
HP_GAIT_DISTURBANCE,SET,1053,-0.0013701,-0.00031841,0.026244,0.52082,HP_GAIT_DISTURBANCE,1
GSE3982_EOSINOPHIL_VS_BASOPH...2,SET,173,-0.0033679,-0.00032521,0.064514,0.52082,GSE3982_EOSINOPHIL_VS_BASOPHIL_UP,1
YANG_BREAST_CANCER_ESR1_DN,SET,21,-0.010437,-0.00035259,0.19976,0.52083,YANG_BREAST_CANCER_ESR1_DN,1
HP_ABNORMAL_FETAL_CARDIOVASC...,SET,46,-0.0063282,-0.00031619,0.12099,0.52086,HP_ABNORMAL_FETAL_CARDIOVASCULAR_MORPHOLOGY,1
GOBP_CALCIUM_ION_TRANSPORT_I...,SET,28,-0.00904,-0.00035258,0.17261,0.52088,GOBP_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
GSE29949_CD8_NEG_DC_SPLEEN_V...1,SET,175,-0.0033859,-0.00032882,0.06441,0.52096,GSE29949_CD8_NEG_DC_SPLEEN_VS_CD8_POS_DC_SPLEEN_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...4,SET,204,-0.0033248,-0.00034834,0.063212,0.52097,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_3_CELL,1
ZHONG_SECRETOME_OF_LUNG_CANC...1,SET,63,-0.0057214,-0.0003344,0.10849,0.52103,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_ENDOTHELIUM,1
MIR892B,SET,71,-0.0053735,-0.00033334,0.10188,0.52103,MIR892B,1
GSE11961_GERMINAL_CENTER_BCE...5,SET,183,-0.0032919,-0.00032685,0.062422,0.52103,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,1
GSE14415_TCONV_VS_FOXP3_KO_I...2,SET,151,-0.0035618,-0.00032152,0.067384,0.52108,GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP,1
GOBP_NEGATIVE_REGULATION_OF_...61,SET,15,-0.011441,-0.00032671,0.21599,0.52112,GOBP_NEGATIVE_REGULATION_OF_CALCINEURIN_MEDIATED_SIGNALING,1
GOCC_PROTON_TRANSPORTING_TWO...3,SET,10,-0.012618,-0.00029424,0.2382,0.52112,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_PROTON_TRANSPORTING_DOMAIN,1
GOCC_PROTON_TRANSPORTING_V_T...2,SET,10,-0.012618,-0.00029424,0.2382,0.52112,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,1
GSE360_CTRL_VS_M_TUBERCULOSI...2,SET,185,-0.0033146,-0.00033087,0.062526,0.52114,GSE360_CTRL_VS_M_TUBERCULOSIS_DC_UP,1
GSE15735_CTRL_VS_HDAC_INHIBI...4,SET,178,-0.0034781,-0.00034062,0.065384,0.52121,GSE15735_CTRL_VS_HDAC_INHIBITOR_TREATED_CD4_TCELL_2H_UP,1
GSE46606_IRF4HIGH_VS_IRF4MID...2,SET,185,-0.0032755,-0.00032697,0.061456,0.52125,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
HALMOS_CEBPA_TARGETS_DN,SET,40,-0.007987,-0.0003722,0.14968,0.52128,HALMOS_CEBPA_TARGETS_DN,1
GSE30083_SP2_VS_SP4_THYMOCYT...2,SET,183,-0.0034744,-0.00034496,0.064863,0.52136,GSE30083_SP2_VS_SP4_THYMOCYTE_UP,1
GSE20366_CD103_POS_VS_CD103_...1,SET,179,-0.0033831,-0.00033224,0.063121,0.52137,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_DN,1
GOBP_POSITIVE_REGULATION_OF_...353,SET,18,-0.010556,-0.00033019,0.19625,0.52145,GOBP_POSITIVE_REGULATION_OF_INFLAMMASOME_MEDIATED_SIGNALING_PATHWAY,1
GOBP_THYROID_HORMONE_MEDIATE...,SET,7,-0.0192,-0.00037462,0.35657,0.52147,GOBP_THYROID_HORMONE_MEDIATED_SIGNALING_PATHWAY,1
HP_CATAPLEXY,SET,10,-0.01476,-0.00034419,0.27393,0.52148,HP_CATAPLEXY,1
ARNT2_TARGET_GENES,SET,552,-0.0019082,-0.00032569,0.035403,0.52149,ARNT2_TARGET_GENES,1
MIR4530,SET,133,-0.0040134,-0.00034017,0.07435,0.52152,MIR4530,1
HP_INTELLECTUAL_DISABILITY_M...1,SET,289,-0.0026971,-0.00033554,0.049968,0.52152,HP_INTELLECTUAL_DISABILITY_MILD,1
REACTOME_ACYL_CHAIN_REMODELL...5,SET,20,-0.010983,-0.00036212,0.20341,0.52153,REACTOME_ACYL_CHAIN_REMODELLING_OF_PS,1
GOCC_CIS_GOLGI_NETWORK_MEMBR...,SET,10,-0.013634,-0.00031794,0.25246,0.52153,GOCC_CIS_GOLGI_NETWORK_MEMBRANE,1
ARID5B_TARGET_GENES,SET,725,-0.0017089,-0.00033264,0.031629,0.52154,ARID5B_TARGET_GENES,1
HP_SHORTENED_PR_INTERVAL,SET,6,-0.019255,-0.00034785,0.35611,0.52156,HP_SHORTENED_PR_INTERVAL,1
GOBP_ESTABLISHMENT_OF_MITOTI...2,SET,40,-0.0071516,-0.00033327,0.13201,0.5216,GOBP_ESTABLISHMENT_OF_MITOTIC_SPINDLE_LOCALIZATION,1
NIKOLSKY_BREAST_CANCER_19Q13...1,SET,21,-0.016301,-0.0005507,0.30072,0.52161,NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON,1
GOBP_MITOTIC_RECOMBINATION,SET,24,-0.007521,-0.0002716,0.13877,0.52161,GOBP_MITOTIC_RECOMBINATION,1
HP_HYPOPLASTIC_FINGERNAIL,SET,46,-0.0072029,-0.0003599,0.13272,0.52164,HP_HYPOPLASTIC_FINGERNAIL,1
GOCC_BASEMENT_MEMBRANE_COLLA...,SET,6,-0.020465,-0.00036971,0.37672,0.52166,GOCC_BASEMENT_MEMBRANE_COLLAGEN_TRIMER,1
GLASS_IGF2BP1_CLIP_TARGETS_K...,SET,105,-0.0043471,-0.00032764,0.079898,0.52169,GLASS_IGF2BP1_CLIP_TARGETS_KNOCKDOWN_DN,1
GSE32034_LY6C_HIGH_VS_LOW_RO...1,SET,183,-0.0035176,-0.00034925,0.06466,0.52169,GSE32034_LY6C_HIGH_VS_LOW_ROSIGLIZATONE_TREATED_MONOCYTE_DN,1
REACTOME_CROSS_PRESENTATION_...2,SET,47,-0.0058606,-0.00029599,0.10768,0.5217,REACTOME_CROSS_PRESENTATION_OF_SOLUBLE_EXOGENOUS_ANTIGENS_ENDOSOMES,1
GSE41867_MEMORY_VS_EXHAUSTED...2,SET,186,-0.0033813,-0.00033844,0.061626,0.52188,GSE41867_MEMORY_VS_EXHAUSTED_CD8_TCELL_DAY30_LCMV_UP,1
WONG_EMBRYONIC_STEM_CELL_CORE,SET,309,-0.0024912,-0.00032029,0.045232,0.52196,WONG_EMBRYONIC_STEM_CELL_CORE,1
MIR3121_3P,SET,590,-0.0019526,-0.00034419,0.035429,0.52198,MIR3121_3P,1
HP_APLASIA_HYPOPLASIA_OF_THE...26,SET,186,-0.003285,-0.0003288,0.059449,0.52203,HP_APLASIA_HYPOPLASIA_OF_THE_EAR,1
GOBP_RESPONSE_TO_PARATHYROID...,SET,10,-0.014937,-0.00034833,0.26918,0.52213,GOBP_RESPONSE_TO_PARATHYROID_HORMONE,1
GOMF_DYNACTIN_BINDING,SET,11,-0.013065,-0.00031953,0.2344,0.52222,GOMF_DYNACTIN_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...679,SET,22,-0.0096383,-0.00033327,0.17263,0.52226,GOBP_NEGATIVE_REGULATION_OF_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
NAKAYA_PLASMACYTOID_DENDRITI...3,SET,806,-0.0016899,-0.00034604,0.030274,0.52226,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
GOBP_TUMOR_NECROSIS_FACTOR_S...,SET,162,-0.0038969,-0.00036425,0.069769,0.52227,GOBP_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,1
GSE13547_WT_VS_ZFX_KO_BCELL_...4,SET,158,-0.0036504,-0.00033701,0.06522,0.52232,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_2H_UP,1
GOCC_METHYLOSOME,SET,13,-0.012104,-0.00032181,0.21602,0.52234,GOCC_METHYLOSOME,1
REACTOME_CYTOSOLIC_SULFONATI...,SET,21,-0.011028,-0.00037257,0.19675,0.52235,REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES,1
GRAHAM_NORMAL_QUIESCENT_VS_N...1,SET,84,-0.0049634,-0.00033479,0.088151,0.52245,GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_DN,1
GSE5589_WT_VS_IL6_KO_LPS_AND...1,SET,134,-0.004064,-0.00034575,0.07174,0.52259,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,1
REACTOME_ALPHA_LINOLENIC_OME...,SET,12,-0.014023,-0.00035819,0.24727,0.52261,REACTOME_ALPHA_LINOLENIC_OMEGA3_AND_LINOLEIC_OMEGA6_ACID_METABOLISM,1
GOBP_PROSTAGLANDIN_SECRETION,SET,18,-0.013383,-0.00041862,0.23589,0.52262,GOBP_PROSTAGLANDIN_SECRETION,1
GOMF_SMALL_MOLECULE_SENSOR_A...,SET,44,-0.0063985,-0.0003127,0.11257,0.52266,GOMF_SMALL_MOLECULE_SENSOR_ACTIVITY,1
GOMF_TOXIC_SUBSTANCE_BINDING,SET,10,-0.016224,-0.00037834,0.28465,0.52273,GOMF_TOXIC_SUBSTANCE_BINDING,1
chr6q26,SET,6,-0.025888,-0.00046768,0.45394,0.52274,chr6q26,1
GSE12707_AT16L1_HYPOMORPH_VS...1,SET,114,-0.0044687,-0.00035085,0.078317,0.52275,GSE12707_AT16L1_HYPOMORPH_VS_WT_THYMUS_DN,1
WWTAAGGC_UNKNOWN,SET,130,-0.0044505,-0.00037297,0.077925,0.52277,WWTAAGGC_UNKNOWN,1
KEGG_MEDICUS_REFERENCE_NOTCH...3,SET,10,-0.014105,-0.00032893,0.24688,0.52278,KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION,1
GOBP_N_ACYLPHOSPHATIDYLETHAN...,SET,4,-0.024669,-0.00036389,0.43008,0.52287,GOBP_N_ACYLPHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,1
MIR374B_3P,SET,128,-0.0044164,-0.00036728,0.076838,0.52292,MIR374B_3P,1
HP_PERIPHERAL_HYPOMYELINATION,SET,9,-0.014296,-0.00031628,0.24867,0.52292,HP_PERIPHERAL_HYPOMYELINATION,1
HP_THORACOLUMBAR_KYPHOSCOLIO...,SET,6,-0.020707,-0.00037408,0.35999,0.52293,HP_THORACOLUMBAR_KYPHOSCOLIOSIS,1
GSE1460_CD4_THYMOCYTE_VS_THY...1,SET,174,-0.0037917,-0.00036718,0.065918,0.52293,GSE1460_CD4_THYMOCYTE_VS_THYMIC_STROMAL_CELL_DN,1
GSE360_L_DONOVANI_VS_B_MALAY...1,SET,178,-0.0035804,-0.00035065,0.06222,0.52294,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN,1
PID_AR_NONGENOMIC_PATHWAY,SET,30,-0.0082116,-0.00033149,0.14261,0.52296,PID_AR_NONGENOMIC_PATHWAY,1
HP_APLASIA_HYPOPLASIA_OF_THE...54,SET,3,-0.029515,-0.00037705,0.51264,0.52296,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_5TH_TOE,1
HOXC13_TARGET_GENES,SET,95,-0.004842,-0.00034722,0.084041,0.52297,HOXC13_TARGET_GENES,1
GOBP_FATTY_ACID_DERIVATIVE_C...,SET,17,-0.011666,-0.00035462,0.20219,0.523,GOBP_FATTY_ACID_DERIVATIVE_CATABOLIC_PROCESS,1
HP_LONG_PHILTRUM,SET,371,-0.0025073,-0.00035261,0.043444,0.52301,HP_LONG_PHILTRUM,1
MODULE_552,SET,7,-0.017479,-0.00034105,0.3028,0.52302,MODULE_552,1
GSE22601_DOUBLE_NEGATIVE_VS_...3,SET,165,-0.00382,-0.00036032,0.066152,0.52302,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_DN,1
HP_MIDFACE_RETRUSION,SET,253,-0.0029877,-0.00034811,0.051692,0.52304,HP_MIDFACE_RETRUSION,1
GOBP_REGULATION_OF_B_CELL_DI...,SET,31,-0.0088706,-0.000364,0.15336,0.52306,GOBP_REGULATION_OF_B_CELL_DIFFERENTIATION,1
HP_DISTAL_UPPER_LIMB_AMYOTRO...,SET,58,-0.0062838,-0.00035244,0.10855,0.52308,HP_DISTAL_UPPER_LIMB_AMYOTROPHY,1
HP_EMG_CHRONIC_DENERVATION_S...,SET,25,-0.0093113,-0.00034318,0.16029,0.52316,HP_EMG_CHRONIC_DENERVATION_SIGNS,1
MIR4315,SET,3,-0.027068,-0.0003458,0.46572,0.52317,MIR4315,1
HARALAMBIEVA_PBMC_M_M_R_II_A...6,SET,40,-0.0085304,-0.00039752,0.14663,0.52319,HARALAMBIEVA_PBMC_M_M_R_II_AGE_13_16YO_STIMULATED_VS_UNSTIMULATED_3_TO_7YR_POST_TOP_DEG_UP,1
ZHENG_FOXP3_TARGETS_IN_T_LYM...2,SET,12,-0.013719,-0.00035043,0.23555,0.52322,ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_UP,1
MIR3193,SET,7,-0.018576,-0.00036246,0.3184,0.52326,MIR3193,1
HP_FRAGMENTED_ELASTIC_FIBERS...,SET,9,-0.014838,-0.00032827,0.25418,0.52328,HP_FRAGMENTED_ELASTIC_FIBERS_IN_THE_DERMIS,1
HP_INTESTINAL_POLYP,SET,63,-0.00605,-0.00035361,0.10362,0.52328,HP_INTESTINAL_POLYP,1
WP_ENDOCHONDRAL_OSSIFICATION,SET,63,-0.0067948,-0.00039714,0.11622,0.52331,WP_ENDOCHONDRAL_OSSIFICATION,1
WP_ENDOCHONDRAL_OSSIFICATION...,SET,63,-0.0067948,-0.00039714,0.11622,0.52331,WP_ENDOCHONDRAL_OSSIFICATION_WITH_SKELETAL_DYSPLASIAS,1
TSUNODA_CISPLATIN_RESISTANCE...1,SET,43,-0.0078869,-0.00038104,0.13485,0.52332,TSUNODA_CISPLATIN_RESISTANCE_DN,1
HP_ABNORMALITY_OF_THE_PHILTR...,SET,621,-0.0019598,-0.0003541,0.0335,0.52333,HP_ABNORMALITY_OF_THE_PHILTRUM,1
HP_ABNORMAL_NASAL_BASE_NORPH...,SET,24,-0.0099537,-0.00035946,0.17011,0.52333,HP_ABNORMAL_NASAL_BASE_NORPHOLOGY,1
MORF_PTPN11,SET,93,-0.0047127,-0.00033438,0.080508,0.52334,MORF_PTPN11,1
GOBP_PYRIMIDINE_NUCLEOSIDE_D...1,SET,6,-0.018445,-0.00033321,0.31398,0.52342,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...474,SET,9,-0.017201,-0.00038054,0.29222,0.52347,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_PEPTIDYL_...4,SET,106,-0.0049865,-0.0003776,0.084633,0.52349,GOBP_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
MIR942_3P,SET,104,-0.0048493,-0.00036375,0.082259,0.5235,MIR942_3P,1
GSE14415_NATURAL_TREG_VS_FOX...2,SET,141,-0.004113,-0.00035887,0.069741,0.52351,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_UP,1
REACTOME_TANDEM_PORE_DOMAIN_...,SET,12,-0.015474,-0.00039528,0.26195,0.52355,REACTOME_TANDEM_PORE_DOMAIN_POTASSIUM_CHANNELS,1
REACTOME_TRANSPORT_OF_VITAMI...,SET,38,-0.0079829,-0.00036261,0.13505,0.52357,REACTOME_TRANSPORT_OF_VITAMINS_NUCLEOSIDES_AND_RELATED_MOLECULES,1
GOBP_NEGATIVE_REGULATION_OF_...308,SET,29,-0.0094191,-0.00037386,0.15927,0.52358,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_BETA_PRODUCTION,1
GAVISH_3CA_METAPROGRAM_MACRO...4,SET,46,-0.0079122,-0.00039534,0.13365,0.5236,GAVISH_3CA_METAPROGRAM_MACROPHAGES_MAC_1,1
WIZ_TARGET_GENES,SET,14,-0.012073,-0.00033307,0.20333,0.52367,WIZ_TARGET_GENES,1
TRAVAGLINI_LUNG_CILIATED_CELL,SET,953,-0.0016261,-0.00036057,0.027378,0.52368,TRAVAGLINI_LUNG_CILIATED_CELL,1
MIR4691_5P,SET,119,-0.0046908,-0.00037622,0.078938,0.52369,MIR4691_5P,1
PALOMERO_GSI_SENSITIVITY_DN,SET,3,-0.031884,-0.00040732,0.53455,0.52378,PALOMERO_GSI_SENSITIVITY_DN,1
GSE13484_UNSTIM_VS_3H_YF17D_...2,SET,179,-0.0034706,-0.00034084,0.058055,0.52384,GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP,1
GOBP_ATRIAL_SEPTUM_MORPHOGEN...,SET,13,-0.015928,-0.00042346,0.26562,0.52391,GOBP_ATRIAL_SEPTUM_MORPHOGENESIS,1
GOBP_INDOLE_CONTAINING_COMPO...3,SET,22,-0.011782,-0.00040739,0.19577,0.52399,GOBP_INDOLE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_LIMITED_EXTRAOCULAR_MOVEM...,SET,14,-0.013079,-0.00036083,0.21728,0.524,HP_LIMITED_EXTRAOCULAR_MOVEMENTS,1
GSE33513_TCF7_KO_VS_HET_EARL...2,SET,178,-0.0040298,-0.00039465,0.066714,0.52408,GSE33513_TCF7_KO_VS_HET_EARLY_THYMIC_PROGENITOR_UP,1
MARTENS_BOUND_BY_PML_RARA_FU...,SET,412,-0.0025208,-0.00037317,0.041718,0.52409,MARTENS_BOUND_BY_PML_RARA_FUSION,1
chr6p21,SET,271,-0.0070271,-0.00084698,0.11614,0.52412,chr6p21,1
MIR3134,SET,59,-0.0064291,-0.00036368,0.10628,0.52412,MIR3134,1
KEGG_MEDICUS_VARIANT_MUTATIO...60,SET,39,-0.0072172,-0.00033211,0.11898,0.52418,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
HP_ABNORMALITY_OF_THE_ORBITA...,SET,1410,-0.0013858,-0.00036883,0.022842,0.52419,HP_ABNORMALITY_OF_THE_ORBITAL_REGION,1
CADWELL_ATG16L1_TARGETS_UP,SET,94,-0.0055406,-0.00039522,0.091231,0.52421,CADWELL_ATG16L1_TARGETS_UP,1
SETBP1_TARGET_GENES,SET,149,-0.004255,-0.00038156,0.069807,0.5243,SETBP1_TARGET_GENES,1
LINDSTEDT_DENDRITIC_CELL_MAT...4,SET,60,-0.0067185,-0.00038324,0.11018,0.52431,LINDSTEDT_DENDRITIC_CELL_MATURATION_D,1
chr4p15,SET,46,-0.015286,-0.00076377,0.25031,0.52435,chr4p15,1
GOBP_POSITIVE_REGULATION_OF_...420,SET,22,-0.011245,-0.0003888,0.184,0.52436,GOBP_POSITIVE_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
REACTOME_MRNA_CAPPING,SET,28,-0.0082422,-0.00032146,0.13469,0.5244,REACTOME_MRNA_CAPPING,1
GSE18893_TCONV_VS_TREG_2H_TN...2,SET,185,-0.0037105,-0.00037039,0.060617,0.5244,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_UP,1
GOMF_GLYCOSYLTRANSFERASE_ACT...,SET,254,-0.0034112,-0.00039824,0.055708,0.52441,GOMF_GLYCOSYLTRANSFERASE_ACTIVITY,1
GOBP_MALE_MEIOSIS_I,SET,25,-0.0096291,-0.00035489,0.15718,0.52442,GOBP_MALE_MEIOSIS_I,1
HP_LETHAL_SKELETAL_DYSPLASIA,SET,8,-0.016404,-0.00034217,0.26787,0.52442,HP_LETHAL_SKELETAL_DYSPLASIA,1
PID_ALK2_PATHWAY,SET,10,-0.016939,-0.00039502,0.27629,0.52444,PID_ALK2_PATHWAY,1
GOBP_REGULATION_OF_TESTOSTER...,SET,6,-0.023122,-0.0004177,0.37668,0.52447,GOBP_REGULATION_OF_TESTOSTERONE_BIOSYNTHETIC_PROCESS,1
GSE17721_POLYIC_VS_GARDIQUIM...10,SET,185,-0.0038109,-0.00038042,0.062071,0.52448,GSE17721_POLYIC_VS_GARDIQUIMOD_24H_BMDC_UP,1
GSE37416_CTRL_VS_0H_F_TULARE...1,SET,133,-0.0045561,-0.00038617,0.074164,0.52449,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_HYDROGEN_PEROXIDE_CATAB...,SET,26,-0.011094,-0.00041699,0.18048,0.52451,GOBP_HYDROGEN_PEROXIDE_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...155,SET,136,-0.0046792,-0.00040102,0.076124,0.52451,GOBP_POSITIVE_REGULATION_OF_CHEMOTAXIS,1
WEBER_METHYLATED_ICP_IN_FIBR...,SET,16,-0.012481,-0.00036809,0.20284,0.52453,WEBER_METHYLATED_ICP_IN_FIBROBLAST,1
GOMF_SYNTAXIN_1_BINDING,SET,19,-0.011845,-0.00038066,0.19243,0.52454,GOMF_SYNTAXIN_1_BINDING,1
SCHEIDEREIT_IKK_TARGETS,SET,17,-0.013948,-0.00042401,0.22651,0.52455,SCHEIDEREIT_IKK_TARGETS,1
GOBP_NEGATIVE_REGULATION_OF_...521,SET,15,-0.012999,-0.00037121,0.21046,0.52462,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
MIR29A_5P,SET,183,-0.003863,-0.00038354,0.062519,0.52463,MIR29A_5P,1
MIR378J,SET,70,-0.0065366,-0.00040263,0.10578,0.52464,MIR378J,1
GSE12845_NAIVE_VS_DARKZONE_G...1,SET,176,-0.0036562,-0.00035607,0.058942,0.52473,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_DN,1
GNF2_H2AFX,SET,29,-0.0099339,-0.00039429,0.15991,0.52477,GNF2_H2AFX,1
GOMF_FK506_BINDING,SET,10,-0.014172,-0.00033048,0.22809,0.52477,GOMF_FK506_BINDING,1
MODULE_488,SET,29,-0.01086,-0.00043104,0.17459,0.5248,MODULE_488,1
MIYAGAWA_TARGETS_OF_EWSR1_ET...1,SET,204,-0.0041201,-0.00043166,0.066013,0.52488,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN,1
JONES_OVARY_OOCYTE,SET,64,-0.00634,-0.00037348,0.10151,0.5249,JONES_OVARY_OOCYTE,1
WP_STATIN_INHIBITION_OF_CHOL...,SET,29,-0.010385,-0.00041219,0.16584,0.52496,WP_STATIN_INHIBITION_OF_CHOLESTEROL_PRODUCTION,1
GOBP_NEGATIVE_REGULATION_OF_...107,SET,9,-0.017883,-0.00039564,0.28566,0.52496,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,1
REACTOME_INTERLEUKIN_2_SIGNA...,SET,11,-0.017139,-0.00041918,0.27365,0.52497,REACTOME_INTERLEUKIN_2_SIGNALING,1
HP_SPLANCHNIC_VEIN_THROMBOSIS,SET,22,-0.011712,-0.00040496,0.18591,0.52511,HP_SPLANCHNIC_VEIN_THROMBOSIS,1
GSE17721_0.5H_VS_12H_GARDIQU...2,SET,184,-0.0036816,-0.00036652,0.05839,0.52514,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_UP,1
TAGCTTT_MIR9,SET,210,-0.0036464,-0.00038754,0.057769,0.52516,TAGCTTT_MIR9,1
HP_HYPERPIGMENTATION_OF_THE_...2,SET,290,-0.0030058,-0.00037457,0.047612,0.52517,HP_HYPERPIGMENTATION_OF_THE_SKIN,1
STARK_PREFRONTAL_CORTEX_22Q1...1,SET,448,-0.0024026,-0.00037051,0.037957,0.52523,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN,1
GOBP_L_ALPHA_AMINO_ACID_TRAN...,SET,66,-0.0068765,-0.00041134,0.10834,0.5253,GOBP_L_ALPHA_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
GOBP_PHOSPHATIDYLETHANOLAMIN...1,SET,7,-0.022392,-0.00043692,0.3527,0.52531,GOBP_PHOSPHATIDYLETHANOLAMINE_ACYL_CHAIN_REMODELING,1
GOBP_REGULATION_PROTEIN_CATA...,SET,4,-0.022388,-0.00033025,0.3507,0.52545,GOBP_REGULATION_PROTEIN_CATABOLIC_PROCESS_AT_SYNAPSE,1
MODULE_181,SET,270,-0.0033197,-0.0003994,0.05196,0.52547,MODULE_181,1
WP_MEASLES_VIRUS_INFECTION,SET,123,-0.0052232,-0.00042586,0.081635,0.52551,WP_MEASLES_VIRUS_INFECTION,1
KEGG_MEDICUS_VARIANT_MET_OVE...,SET,13,-0.014748,-0.00039208,0.22952,0.52562,KEGG_MEDICUS_VARIANT_MET_OVEREXPRESSION_TO_RAS_ERK_SIGNALING_PATHWAY,1
SKIL_TARGET_GENES,SET,1479,-0.0014865,-0.00040435,0.023118,0.52563,SKIL_TARGET_GENES,1
GOBP_CHITIN_METABOLIC_PROCESS,SET,6,-0.023948,-0.00043263,0.37241,0.52564,GOBP_CHITIN_METABOLIC_PROCESS,1
GOMF_CHITINASE_ACTIVITY,SET,6,-0.023948,-0.00043263,0.37241,0.52564,GOMF_CHITINASE_ACTIVITY,1
REACTOME_ACETYLCHOLINE_BINDI...,SET,14,-0.01586,-0.00043756,0.24624,0.52568,REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS,1
GSE9988_ANTI_TREM1_VS_LOW_LP...2,SET,174,-0.0041354,-0.00040046,0.064173,0.52569,GSE9988_ANTI_TREM1_VS_LOW_LPS_MONOCYTE_UP,1
GOCC_ESCRT_I_COMPLEX,SET,12,-0.01546,-0.00039492,0.23948,0.52574,GOCC_ESCRT_I_COMPLEX,1
MIR4308,SET,133,-0.0047033,-0.00039865,0.07281,0.52575,MIR4308,1
HSF4_TARGET_GENES,SET,5,-0.023474,-0.00038712,0.36327,0.52576,HSF4_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...605,SET,14,-0.016463,-0.00045421,0.25461,0.52578,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSPORT,1
MYB_Q6,SET,228,-0.0036427,-0.00040319,0.056263,0.52581,MYB_Q6,1
GOBP_CYTOLYSIS,SET,6,-0.029022,-0.00052429,0.44778,0.52584,GOBP_CYTOLYSIS,1
GSE21360_NAIVE_VS_PRIMARY_ME...2,SET,159,-0.0044559,-0.00041265,0.068688,0.52586,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_UP,1
HP_DELAYED_MENARCHE,SET,23,-0.010353,-0.00036602,0.15925,0.52592,HP_DELAYED_MENARCHE,1
WP_MIRNA_BIOGENESIS,SET,6,-0.021139,-0.00038188,0.32487,0.52594,WP_MIRNA_BIOGENESIS,1
MIR1288_5P,SET,46,-0.008819,-0.00044065,0.13549,0.52595,MIR1288_5P,1
HP_SQUARE_FACE,SET,11,-0.018353,-0.00044885,0.28138,0.526,HP_SQUARE_FACE,1
GAUSSMANN_MLL_AF4_FUSION_TAR...6,SET,157,-0.0042508,-0.0003912,0.065057,0.52605,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_UP,1
REACTOME_SIGNALING_BY_ERYTHR...,SET,25,-0.011267,-0.00041525,0.1722,0.52608,REACTOME_SIGNALING_BY_ERYTHROPOIETIN,1
KEGG_MEDICUS_REFERENCE_IL10_...,SET,13,-0.018252,-0.00048524,0.27853,0.52612,KEGG_MEDICUS_REFERENCE_IL10_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,1
REACTOME_RND1_GTPASE_CYCLE,SET,41,-0.0088015,-0.00041524,0.13426,0.52613,REACTOME_RND1_GTPASE_CYCLE,1
GSE24142_DN2_VS_DN3_THYMOCYT...6,SET,184,-0.0041245,-0.00041061,0.062929,0.52613,GSE24142_DN2_VS_DN3_THYMOCYTE_UP,1
GSE11961_PLASMA_CELL_DAY7_VS...2,SET,179,-0.0041133,-0.00040396,0.062624,0.52618,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
GOBP_REGULATION_OF_GLUCOSE_I...,SET,52,-0.0082587,-0.00043867,0.12568,0.5262,GOBP_REGULATION_OF_GLUCOSE_IMPORT,1
NABA_MATRISOME_HGSOC_OMENTAL...,SET,57,-0.0079977,-0.0004447,0.1216,0.52622,NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS,1
WILLIAMS_ESR1_TARGETS_DN,SET,6,-0.022021,-0.00039781,0.33399,0.52628,WILLIAMS_ESR1_TARGETS_DN,1
HP_ABNORMAL_RETINAL_NERVE_FI...,SET,5,-0.02342,-0.00038623,0.35515,0.52629,HP_ABNORMAL_RETINAL_NERVE_FIBER_LAYER_MORPHOLOGY,1
GSE36392_TYPE_2_MYELOID_VS_M...2,SET,183,-0.0043971,-0.00043658,0.066636,0.52631,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_UP,1
YIH_RESPONSE_TO_ARSENITE_C4,SET,16,-0.013499,-0.00039811,0.20422,0.52635,YIH_RESPONSE_TO_ARSENITE_C4,1
GSE9650_EFFECTOR_VS_MEMORY_C...1,SET,184,-0.0040839,-0.00040657,0.061766,0.52636,GSE9650_EFFECTOR_VS_MEMORY_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...52,SET,31,-0.0098515,-0.00040425,0.14882,0.52639,GOBP_POSITIVE_REGULATION_OF_AXON_EXTENSION,1
MCBRYAN_PUBERTAL_BREAST_6_7W...2,SET,177,-0.004086,-0.00039905,0.061696,0.5264,MCBRYAN_PUBERTAL_BREAST_6_7WK_UP,1
MAZ_Q6,SET,179,-0.0041206,-0.00040467,0.062202,0.52641,MAZ_Q6,1
HP_CONGENITAL_MUSCULAR_TORTI...,SET,6,-0.02376,-0.00042923,0.35839,0.52643,HP_CONGENITAL_MUSCULAR_TORTICOLLIS,1
GOBP_REGULATION_OF_BIOLOGICA...,SET,59,-0.0078748,-0.00044546,0.11869,0.52645,GOBP_REGULATION_OF_BIOLOGICAL_PROCESS_INVOLVED_IN_SYMBIOTIC_INTERACTION,1
GOCC_PROTEASOME_CORE_COMPLEX,SET,20,-0.010858,-0.00035798,0.16359,0.52646,GOCC_PROTEASOME_CORE_COMPLEX,1
GOBP_REGULATION_OF_TELOMERE_...4,SET,57,-0.007064,-0.00039278,0.1063,0.52649,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
HP_HEMIPARESIS,SET,79,-0.0066114,-0.00043252,0.099351,0.52653,HP_HEMIPARESIS,1
GOBP_MYOBLAST_FUSION_INVOLVE...,SET,3,-0.038292,-0.00048919,0.57514,0.52654,GOBP_MYOBLAST_FUSION_INVOLVED_IN_SKELETAL_MUSCLE_REGENERATION,1
GOBP_POSITIVE_REGULATION_OF_...842,SET,6,-0.0195,-0.00035227,0.2925,0.52658,GOBP_POSITIVE_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
HP_ERYTHEMA_NODOSUM,SET,7,-0.023922,-0.00046678,0.35848,0.5266,HP_ERYTHEMA_NODOSUM,1
REACTOME_SLBP_DEPENDENT_PROC...,SET,11,-0.01445,-0.00035341,0.21612,0.52665,REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS,1
GOBP_RESPONSE_TO_IMMOBILIZAT...,SET,25,-0.010876,-0.00040084,0.16242,0.52669,GOBP_RESPONSE_TO_IMMOBILIZATION_STRESS,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...9,SET,6,-0.020245,-0.00036573,0.30236,0.52669,HP_ABNORMAL_MORPHOLOGY_OF_THE_PROXIMAL_PHALANX_OF_THE_HALLUX,1
GSE46606_UNSTIM_VS_CD40L_IL2...6,SET,180,-0.0042584,-0.00041936,0.063586,0.5267,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4_KO_BCELL_UP,1
HP_EPIBLEPHARON,SET,6,-0.022357,-0.00040389,0.3335,0.52672,HP_EPIBLEPHARON,1
HP_LARGE_CENTRAL_VISUAL_FIEL...,SET,13,-0.01532,-0.00040729,0.22849,0.52673,HP_LARGE_CENTRAL_VISUAL_FIELD_DEFECT,1
GOMF_ER_RETENTION_SEQUENCE_B...,SET,5,-0.023852,-0.00039336,0.35503,0.52678,GOMF_ER_RETENTION_SEQUENCE_BINDING,1
HP_STRIAE_DISTENSAE,SET,33,-0.010048,-0.00042539,0.14939,0.52681,HP_STRIAE_DISTENSAE,1
chr7p12,SET,18,-0.02256,-0.00070568,0.3352,0.52683,chr7p12,1
MODULE_261,SET,89,-0.0060382,-0.00041917,0.089459,0.52691,MODULE_261,1
HP_GENERALIZED_ICHTHYOSIS,SET,4,-0.025289,-0.00037303,0.37394,0.52696,HP_GENERALIZED_ICHTHYOSIS,1
HP_MOTOR_REGRESSION,SET,19,-0.013004,-0.00041791,0.19229,0.52696,HP_MOTOR_REGRESSION,1
GOBP_ONCOGENE_INDUCED_CELL_S...,SET,6,-0.020152,-0.00036404,0.29775,0.52698,GOBP_ONCOGENE_INDUCED_CELL_SENESCENCE,1
HAY_BONE_MARROW_CD34_POS_ERP,SET,8,-0.02148,-0.00044805,0.3172,0.52699,HAY_BONE_MARROW_CD34_POS_ERP,1
SESTO_RESPONSE_TO_UV_C5,SET,46,-0.0085275,-0.00042608,0.12545,0.5271,SESTO_RESPONSE_TO_UV_C5,1
GOBP_NUCLEOTIDE_EXCISION_REP...2,SET,6,-0.01938,-0.0003501,0.28505,0.5271,GOBP_NUCLEOTIDE_EXCISION_REPAIR_DNA_GAP_FILLING,1
HP_ABNORMAL_NEURON_MORPHOLOGY,SET,79,-0.0063237,-0.0004137,0.092977,0.52711,HP_ABNORMAL_NEURON_MORPHOLOGY,1
GOBP_REGULATION_OF_PHOSPHOLI...4,SET,32,-0.011084,-0.00046208,0.16289,0.52713,GOBP_REGULATION_OF_PHOSPHOLIPASE_C_ACTIVITY,1
GOBP_CARBOHYDRATE_PHOSPHORYL...,SET,21,-0.010674,-0.00036059,0.15656,0.52718,GOBP_CARBOHYDRATE_PHOSPHORYLATION,1
GOBP_MUSCLE_CELL_PROLIFERATI...,SET,189,-0.0044389,-0.00044782,0.065076,0.52719,GOBP_MUSCLE_CELL_PROLIFERATION,1
GOBP_GLYCOLYTIC_PROCESS_THRO...1,SET,19,-0.011717,-0.00037653,0.17137,0.52725,GOBP_GLYCOLYTIC_PROCESS_THROUGH_FRUCTOSE_6_PHOSPHATE,1
HP_ADRENOCORTICOTROPIC_HORMO...1,SET,14,-0.015361,-0.00042379,0.22435,0.52729,HP_ADRENOCORTICOTROPIC_HORMONE_DEFICIENCY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...13,SET,75,-0.0060635,-0.00038655,0.088496,0.52731,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,1
GSE24634_TREG_VS_TCONV_POST_...8,SET,177,-0.0041235,-0.0004027,0.060108,0.52735,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_UP,1
GOBP_NEGATIVE_REGULATION_OF_...192,SET,22,-0.011981,-0.00041426,0.17377,0.52748,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
DAZARD_UV_RESPONSE_CLUSTER_G6,SET,135,-0.0050399,-0.00043036,0.073019,0.52751,DAZARD_UV_RESPONSE_CLUSTER_G6,1
WP_ESTROGEN_METABOLISM_WP697,SET,14,-0.017689,-0.00048803,0.25605,0.52754,WP_ESTROGEN_METABOLISM_WP697,1
HP_ABNORMAL_GASTRIC_MUCOSA_M...,SET,39,-0.009698,-0.00044627,0.14027,0.52756,HP_ABNORMAL_GASTRIC_MUCOSA_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...604,SET,497,-0.0026947,-0.00043709,0.038967,0.52757,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,1
GSE13738_RESTING_VS_TCR_ACTI...2,SET,155,-0.0046487,-0.0004251,0.067063,0.52763,GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP,1
RHODES_UNDIFFERENTIATED_CANC...,SET,64,-0.0067937,-0.0004002,0.097757,0.5277,RHODES_UNDIFFERENTIATED_CANCER,1
GSE12001_MIR223_KO_VS_WT_NEU...1,SET,179,-0.0042316,-0.00041557,0.060894,0.5277,GSE12001_MIR223_KO_VS_WT_NEUTROPHIL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...73,SET,52,-0.0080937,-0.00042991,0.1164,0.52772,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOBP_DETECTION_OF_LIPOPOLYSA...,SET,5,-0.027948,-0.00046092,0.40166,0.52774,GOBP_DETECTION_OF_LIPOPOLYSACCHARIDE,1
HP_INTRA_ORAL_HYPERPIGMENTAT...,SET,7,-0.022936,-0.00044754,0.3296,0.52774,HP_INTRA_ORAL_HYPERPIGMENTATION,1
GOBP_NEGATIVE_REGULATION_OF_...578,SET,7,-0.024275,-0.00047367,0.34875,0.52775,GOBP_NEGATIVE_REGULATION_OF_RUFFLE_ASSEMBLY,1
MODULE_267,SET,14,-0.015107,-0.00041678,0.21687,0.52777,MODULE_267,1
GSE27786_NKCELL_VS_MONO_MAC_...1,SET,177,-0.0045086,-0.00044032,0.06472,0.52777,GSE27786_NKCELL_VS_MONO_MAC_DN,1
GSE29164_DAY3_VS_DAY7_CD8_TC...1,SET,187,-0.0043919,-0.00044075,0.063053,0.52777,GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DN,1
GOCC_INTRACELLULAR_CYCLIC_NU...,SET,5,-0.025735,-0.00042441,0.36911,0.52779,GOCC_INTRACELLULAR_CYCLIC_NUCLEOTIDE_ACTIVATED_CATION_CHANNEL_COMPLEX,1
HP_INCREASED_CEREBRAL_LIPOFU...,SET,11,-0.017361,-0.0004246,0.2486,0.52784,HP_INCREASED_CEREBRAL_LIPOFUSCIN,1
MIR5590_3P,SET,318,-0.0033443,-0.00043609,0.047738,0.52793,MIR5590_3P,1
CAMPS_COLON_CANCER_COPY_NUMB...2,SET,81,-0.0074028,-0.00049037,0.10536,0.52801,CAMPS_COLON_CANCER_COPY_NUMBER_UP,1
NATSUME_RESPONSE_TO_INTERFER...1,SET,51,-0.0083642,-0.00043999,0.11865,0.5281,NATSUME_RESPONSE_TO_INTERFERON_BETA_DN,1
chr3p12,SET,7,-0.031853,-0.00062153,0.45109,0.52815,chr3p12,1
HP_RECURRENT_SINOPULMONARY_I...,SET,58,-0.0075874,-0.00042556,0.10738,0.52817,HP_RECURRENT_SINOPULMONARY_INFECTIONS,1
MIR134_5P,SET,68,-0.0073333,-0.00044524,0.10375,0.52818,MIR134_5P,1
HP_EVERTED_UPPER_LIP_VERMILI...,SET,19,-0.013485,-0.00043335,0.19047,0.52822,HP_EVERTED_UPPER_LIP_VERMILION,1
GSE13738_RESTING_VS_BYSTANDE...2,SET,152,-0.0047608,-0.00043116,0.067253,0.52822,GSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP,1
TAATGTG_MIR323,SET,148,-0.0048619,-0.00043453,0.068525,0.52828,TAATGTG_MIR323,1
PPARA_02,SET,124,-0.0052161,-0.00042699,0.073315,0.52836,PPARA_02,1
GSE21927_SPLEEN_VS_4T1_TUMOR...2,SET,162,-0.0048076,-0.00044937,0.067543,0.52837,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,1
SCHLINGEMANN_SKIN_CARCINOGEN...2,SET,36,-0.010591,-0.00046829,0.14874,0.52838,SCHLINGEMANN_SKIN_CARCINOGENESIS_TPA_UP,1
GOBP_RESPONSE_TO_VITAMIN_A,SET,15,-0.016565,-0.00047303,0.23269,0.52838,GOBP_RESPONSE_TO_VITAMIN_A,1
GOBP_POSITIVE_REGULATION_OF_...488,SET,87,-0.0066218,-0.00045451,0.092839,0.52843,GOBP_POSITIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
HP_ABNORMALITY_OF_THE_UPPER_...1,SET,65,-0.0078213,-0.00046431,0.10965,0.52843,HP_ABNORMALITY_OF_THE_UPPER_ARM,1
GSE40655_FOXO1_KO_VS_WT_NTRE...1,SET,170,-0.0043727,-0.00041859,0.061314,0.52843,GSE40655_FOXO1_KO_VS_WT_NTREG_DN,1
HP_LOW_INSERTION_OF_COLUMELLA,SET,7,-0.021346,-0.0004165,0.29888,0.52847,HP_LOW_INSERTION_OF_COLUMELLA,1
GSE40274_CTRL_VS_FOXP3_AND_X...1,SET,134,-0.0053729,-0.0004571,0.075212,0.52847,GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOCC_MATRIX_SIDE_OF_MITOCHON...,SET,5,-0.025351,-0.00041808,0.35477,0.52848,GOCC_MATRIX_SIDE_OF_MITOCHONDRIAL_INNER_MEMBRANE,1
WP_HIJACK_OF_UBIQUITINATION_...,SET,6,-0.023227,-0.00041961,0.3249,0.5285,WP_HIJACK_OF_UBIQUITINATION_BY_SARSCOV2,1
GOBP_VIRAL_GENOME_REPLICATION,SET,117,-0.005745,-0.00045692,0.08034,0.5285,GOBP_VIRAL_GENOME_REPLICATION,1
GSE23321_EFFECTOR_MEMORY_VS_...1,SET,174,-0.0041912,-0.00040587,0.058417,0.5286,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
GOBP_STORE_OPERATED_CALCIUM_...,SET,20,-0.014041,-0.00046293,0.19551,0.52863,GOBP_STORE_OPERATED_CALCIUM_ENTRY,1
GSE29164_UNTREATED_VS_CD8_TC...3,SET,181,-0.0045716,-0.00045144,0.063529,0.52868,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,1
REACTOME_VIRAL_INFECTION_PAT...,SET,708,-0.0021982,-0.00042304,0.030539,0.52869,REACTOME_VIRAL_INFECTION_PATHWAYS,1
BLANCO_MELO_RESPIRATORY_SYNC...1,SET,104,-0.0059611,-0.00044715,0.082682,0.52874,BLANCO_MELO_RESPIRATORY_SYNCYTIAL_VIRUS_INFECTION_A594_CELLS_DN,1
MIR3064_3P,SET,154,-0.0050183,-0.00045743,0.069443,0.5288,MIR3064_3P,1
MIR3609,SET,324,-0.0034694,-0.00045656,0.047961,0.52883,MIR3609,1
GSE13411_SWITCHED_MEMORY_BCE...2,SET,178,-0.0045862,-0.00044915,0.063407,0.52883,GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP,1
MORF_LTK,SET,137,-0.0053545,-0.00046057,0.073987,0.52885,MORF_LTK,1
GOBP_CARBOHYDRATE_IMPORT_ACR...,SET,5,-0.031852,-0.00052529,0.43986,0.52886,GOBP_CARBOHYDRATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...457,SET,7,-0.022774,-0.00044438,0.31399,0.52891,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_NONSENSE_MEDIATED_DECAY,1
GSE22886_NAIVE_CD8_TCELL_VS_...5,SET,186,-0.0047101,-0.00047143,0.064939,0.52891,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_DN,1
VANGURP_PANCREATIC_DELTA_CELL,SET,73,-0.0079934,-0.00050277,0.11012,0.52893,VANGURP_PANCREATIC_DELTA_CELL,1
GSE3039_CD4_TCELL_VS_B1_BCEL...2,SET,184,-0.0044723,-0.00044524,0.061595,0.52894,GSE3039_CD4_TCELL_VS_B1_BCELL_UP,1
GSE37301_HEMATOPOIETIC_STEM_...12,SET,176,-0.0046224,-0.00045017,0.063597,0.52897,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_UP,1
GOCC_GTPASE_ACTIVATOR_COMPLEX,SET,11,-0.015853,-0.00038772,0.21797,0.52899,GOCC_GTPASE_ACTIVATOR_COMPLEX,1
GNF2_HDAC1,SET,99,-0.0056348,-0.00041244,0.077414,0.52901,GNF2_HDAC1,1
REACTOME_ACYL_CHAIN_REMODELI...2,SET,5,-0.029305,-0.00048329,0.40213,0.52905,REACTOME_ACYL_CHAIN_REMODELING_OF_DAG_AND_TAG,1
MODULE_495,SET,13,-0.019414,-0.00051613,0.26595,0.5291,MODULE_495,1
GSE5679_CTRL_VS_PPARG_LIGAND...3,SET,181,-0.004463,-0.00044072,0.061083,0.52912,GSE5679_CTRL_VS_PPARG_LIGAND_ROSIGLITAZONE_TREATED_DC_DN,1
KEGG_PROTEIN_EXPORT,SET,22,-0.012531,-0.00043327,0.17139,0.52914,KEGG_PROTEIN_EXPORT,1
GOBP_DISTAL_TUBULE_DEVELOPME...,SET,11,-0.020935,-0.00051201,0.28606,0.52917,GOBP_DISTAL_TUBULE_DEVELOPMENT,1
HP_RECURRENT_PNEUMONIA,SET,114,-0.0058349,-0.00045811,0.079592,0.52922,HP_RECURRENT_PNEUMONIA,1
HNF1_C,SET,225,-0.0043858,-0.00048228,0.059754,0.52925,HNF1_C,1
WP_MULTIPLE_EPIPHYSEAL_DYSPL...,SET,6,-0.026908,-0.00048611,0.36623,0.52929,WP_MULTIPLE_EPIPHYSEAL_DYSPLASIA_AND_PSEUDOACHONDROPLASIA_GENES,1
GOBP_PARKIN_MEDIATED_STIMULA...,SET,4,-0.034198,-0.00050446,0.46507,0.52931,GOBP_PARKIN_MEDIATED_STIMULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
GSE21379_WT_VS_SAP_KO_CD4_TC...1,SET,183,-0.0047708,-0.00047368,0.064777,0.52935,GSE21379_WT_VS_SAP_KO_CD4_TCELL_DN,1
GSE19401_UNSTIM_VS_RETINOIC_...4,SET,183,-0.004588,-0.00045553,0.062287,0.52936,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_UP,1
GOCC_OTHER_ORGANISM_PART,SET,4,-0.035113,-0.00051795,0.47658,0.52937,GOCC_OTHER_ORGANISM_PART,1
MANNO_MIDBRAIN_NEUROTYPES_HP...2,SET,263,-0.0038503,-0.00045728,0.05223,0.52938,MANNO_MIDBRAIN_NEUROTYPES_HPROGBP,1
REACTOME_IRF3_MEDIATED_INDUC...,SET,11,-0.016289,-0.00039838,0.22084,0.5294,REACTOME_IRF3_MEDIATED_INDUCTION_OF_TYPE_I_IFN,1
HP_RECURRENT_LOWER_RESPIRATO...,SET,213,-0.0043974,-0.00047065,0.059625,0.5294,HP_RECURRENT_LOWER_RESPIRATORY_TRACT_INFECTIONS,1
GOBP_AMINO_ACID_TRANSMEMBRAN...,SET,94,-0.006786,-0.00048406,0.091905,0.52943,GOBP_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_P38MAPK_C...,SET,41,-0.01064,-0.000502,0.14359,0.52954,GOBP_REGULATION_OF_P38MAPK_CASCADE,1
GSE9509_10MIN_VS_30MIN_LPS_S...1,SET,171,-0.0049367,-0.00047396,0.066289,0.52968,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_DN,1
LI_ESTROGENE_NON_MCF7_T47D_E...2,SET,15,-0.016001,-0.00045693,0.2146,0.52972,LI_ESTROGENE_NON_MCF7_T47D_E2_RESPONSE_UP,1
GOMF_HYDRO_LYASE_ACTIVITY,SET,52,-0.0092196,-0.00048971,0.12365,0.52972,GOMF_HYDRO_LYASE_ACTIVITY,1
GSE3982_BASOPHIL_VS_NKCELL_DN,SET,182,-0.0047617,-0.00047149,0.063836,0.52973,GSE3982_BASOPHIL_VS_NKCELL_DN,1
YAMANAKA_GLIOBLASTOMA_SURVIV...1,SET,8,-0.020773,-0.00043331,0.27839,0.52974,YAMANAKA_GLIOBLASTOMA_SURVIVAL_DN,1
GSE17721_CTRL_VS_POLYIC_8H_B...1,SET,183,-0.0046328,-0.00045998,0.06205,0.52976,GSE17721_CTRL_VS_POLYIC_8H_BMDC_DN,1
REACTOME_SCF_BETA_TRCP_MEDIA...,SET,52,-0.0077878,-0.00041366,0.10372,0.52993,REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1,1
GOBP_TRAIL_ACTIVATED_APOPTOT...,SET,9,-0.020509,-0.00045374,0.27298,0.52994,GOBP_TRAIL_ACTIVATED_APOPTOTIC_SIGNALING_PATHWAY,1
HP_LIMITED_KNEE_FLEXION,SET,4,-0.031993,-0.00047192,0.42481,0.53002,HP_LIMITED_KNEE_FLEXION,1
GSE14415_INDUCED_TREG_VS_FAI...2,SET,169,-0.0044079,-0.00042073,0.058514,0.53002,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_UP,1
MIR5585_5P,SET,115,-0.0059611,-0.00047006,0.079112,0.53003,MIR5585_5P,1
COLDREN_GEFITINIB_RESISTANCE...2,SET,72,-0.0072264,-0.00045141,0.095782,0.53007,COLDREN_GEFITINIB_RESISTANCE_UP,1
WP_SELENIUM_METABOLISM_AND_S...,SET,34,-0.011135,-0.0004785,0.14759,0.53007,WP_SELENIUM_METABOLISM_AND_SELENOPROTEINS,1
REACTOME_VISUAL_PHOTOTRANSDU...,SET,90,-0.0068966,-0.00048143,0.091336,0.53009,REACTOME_VISUAL_PHOTOTRANSDUCTION,1
MIR550B_3P,SET,49,-0.0093055,-0.00047984,0.12327,0.53009,MIR550B_3P,1
GNF2_MSH2,SET,26,-0.011372,-0.0004274,0.15051,0.53011,GNF2_MSH2,1
REACTOME_PKA_MEDIATED_PHOSPH...1,SET,19,-0.015474,-0.00049727,0.20478,0.53012,REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB,1
GOBP_EPITHELIAL_CELL_FATE_CO...,SET,14,-0.018782,-0.00051818,0.24855,0.53012,GOBP_EPITHELIAL_CELL_FATE_COMMITMENT,1
GOBP_REGULATION_OF_T_CELL_PR...,SET,163,-0.0054449,-0.00051049,0.071857,0.5302,GOBP_REGULATION_OF_T_CELL_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...185,SET,3,-0.037702,-0.00048164,0.49675,0.53025,GOBP_NEGATIVE_REGULATION_OF_DNA_CATABOLIC_PROCESS,1
GOBP_ACTIVATION_OF_PHOSPHOLI...,SET,21,-0.015365,-0.00051909,0.20228,0.53027,GOBP_ACTIVATION_OF_PHOSPHOLIPASE_C_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_M...3,SET,5,-0.028752,-0.00047417,0.37842,0.53028,GOBP_REGULATION_OF_PROTEIN_MONOUBIQUITINATION,1
GOBP_LEUKOCYTE_MIGRATION,SET,369,-0.0036079,-0.00050606,0.047441,0.53031,GOBP_LEUKOCYTE_MIGRATION,1
MIR598_3P,SET,10,-0.021948,-0.00051181,0.28852,0.53032,MIR598_3P,1
HP_SHORTENING_OF_ALL_MIDDLE_...,SET,6,-0.027627,-0.00049909,0.36304,0.53033,HP_SHORTENING_OF_ALL_MIDDLE_PHALANGES_OF_THE_FINGERS,1
GSE22886_IL2_VS_IL15_STIM_NK...1,SET,166,-0.0047525,-0.00044962,0.062435,0.53034,GSE22886_IL2_VS_IL15_STIM_NKCELL_DN,1
HP_ATLANTOAXIAL_INSTABILITY,SET,5,-0.027445,-0.00045261,0.36021,0.53037,HP_ATLANTOAXIAL_INSTABILITY,1
GSE27670_CTRL_VS_LMP1_TRANSD...1,SET,184,-0.0047506,-0.00047294,0.062303,0.53039,GSE27670_CTRL_VS_LMP1_TRANSDUCED_GC_BCELL_DN,1
TRAVAGLINI_LUNG_PROXIMAL_BAS...,SET,557,-0.0027488,-0.00047122,0.036014,0.53042,TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL,1
GOBP_GALACTOSE_METABOLIC_PRO...,SET,9,-0.019702,-0.00043589,0.25802,0.53043,GOBP_GALACTOSE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...571,SET,26,-0.013466,-0.00050611,0.17625,0.53045,GOBP_POSITIVE_REGULATION_OF_P38MAPK_CASCADE,1
MIR8062,SET,97,-0.0064195,-0.00046513,0.084008,0.53046,MIR8062,1
GOBP_CEREBRAL_CORTEX_GABAERG...3,SET,4,-0.03593,-0.00053,0.46948,0.5305,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_MIGRATION,1
HP_ENTEROCOLITIS,SET,19,-0.013877,-0.00044594,0.18129,0.53051,HP_ENTEROCOLITIS,1
GSE36392_TYPE_2_MYELOID_VS_E...2,SET,177,-0.00469,-0.00045804,0.061236,0.53052,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_UP,1
GOCC_PROTEASOME_COMPLEX,SET,60,-0.0074237,-0.00042347,0.096869,0.53054,GOCC_PROTEASOME_COMPLEX,1
GOBP_ANTERIOR_COMMISSURE_MOR...,SET,7,-0.027812,-0.00054266,0.36283,0.53055,GOBP_ANTERIOR_COMMISSURE_MORPHOGENESIS,1
GOBP_REGULATION_OF_OVARIAN_F...,SET,6,-0.024036,-0.00043422,0.31314,0.53059,GOBP_REGULATION_OF_OVARIAN_FOLLICLE_DEVELOPMENT,1
HP_FIBROSARCOMA,SET,9,-0.023263,-0.00051467,0.30288,0.53061,HP_FIBROSARCOMA,1
GSE13762_CTRL_VS_125_VITAMIN...4,SET,122,-0.0063031,-0.00051183,0.081952,0.53065,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_UP,1
GOBP_PYRIDINE_CONTAINING_COM...1,SET,30,-0.012177,-0.00049157,0.15829,0.53066,GOBP_PYRIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
HP_HYPERNATRIURIA,SET,9,-0.024107,-0.00053334,0.31288,0.53071,HP_HYPERNATRIURIA,1
HP_JERKY_OCULAR_PURSUIT_MOVE...,SET,8,-0.020126,-0.00041981,0.26122,0.53071,HP_JERKY_OCULAR_PURSUIT_MOVEMENTS,1
GOBP_PLASMA_MEMBRANE_RAFT_AS...,SET,7,-0.02486,-0.00048507,0.32247,0.53072,GOBP_PLASMA_MEMBRANE_RAFT_ASSEMBLY,1
GOMF_PEPTIDE_ANTIGEN_BINDING,SET,32,-0.012904,-0.00053799,0.16731,0.53074,GOMF_PEPTIDE_ANTIGEN_BINDING,1
MIR6797_3P,SET,58,-0.0088131,-0.0004943,0.11424,0.53075,MIR6797_3P,1
GSE46143_CTRL_VS_LMP2A_TRANS...1,SET,181,-0.0047567,-0.00046971,0.061624,0.53076,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_DN,1
REACTOME_KEAP1_NFE2L2_PATHWAY,SET,119,-0.0057924,-0.00046458,0.074886,0.53083,REACTOME_KEAP1_NFE2L2_PATHWAY,1
ACTGAAA_MIR30A3P_MIR30E3P,SET,180,-0.0047773,-0.00047046,0.061707,0.53085,ACTGAAA_MIR30A3P_MIR30E3P,1
GOBP_EMBRYONIC_PLACENTA_MORP...,SET,24,-0.013785,-0.00049783,0.17792,0.53088,GOBP_EMBRYONIC_PLACENTA_MORPHOGENESIS,1
GOMF_SIGNALING_RECEPTOR_REGU...,SET,489,-0.0032725,-0.00052665,0.042186,0.53092,GOMF_SIGNALING_RECEPTOR_REGULATOR_ACTIVITY,1
WALLACE_PROSTATE_CANCER_RACE...2,SET,257,-0.0044486,-0.00052236,0.057308,0.53094,WALLACE_PROSTATE_CANCER_RACE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...553,SET,20,-0.012888,-0.0004249,0.16572,0.53099,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,1
GOMF_ACTIVIN_RECEPTOR_ACTIVI...2,SET,5,-0.036302,-0.00059868,0.46643,0.53102,GOMF_ACTIVIN_RECEPTOR_ACTIVITY_TYPE_I,1
PUJANA_BRCA1_PCC_NETWORK,SET,1458,-0.0017192,-0.00046461,0.022011,0.53113,PUJANA_BRCA1_PCC_NETWORK,1
GOBP_REGULATION_OF_INTESTINA...1,SET,11,-0.020917,-0.00051158,0.26762,0.53115,GOBP_REGULATION_OF_INTESTINAL_ABSORPTION,1
HP_MITOCHONDRIAL_RESPIRATORY...,SET,10,-0.020028,-0.00046704,0.25591,0.53119,HP_MITOCHONDRIAL_RESPIRATORY_CHAIN_DEFECTS,1
GOMF_MOLYBDOPTERIN_COFACTOR_...,SET,4,-0.033482,-0.0004939,0.42771,0.5312,GOMF_MOLYBDOPTERIN_COFACTOR_BINDING,1
GSE17974_IL4_AND_ANTI_IL12_V...8,SET,143,-0.0056565,-0.000497,0.07226,0.5312,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_UP,1
MIR550B_2_5P,SET,46,-0.0096042,-0.00047988,0.12262,0.53122,MIR550B_2_5P,1
GSE14308_NAIVE_CD4_TCELL_VS_...1,SET,182,-0.0047419,-0.00046954,0.060498,0.53124,GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_DN,1
HUMMERICH_MALIGNANT_SKIN_TUM...2,SET,16,-0.015907,-0.00046912,0.20249,0.53131,HUMMERICH_MALIGNANT_SKIN_TUMOR_UP,1
GOBP_NITRIC_OXIDE_SYNTHASE_B...,SET,18,-0.018349,-0.00057394,0.23252,0.53145,GOBP_NITRIC_OXIDE_SYNTHASE_BIOSYNTHETIC_PROCESS,1
GOBP_REGULATION_OF_PHOSPHOLI...5,SET,14,-0.018123,-0.00050001,0.22964,0.53145,GOBP_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
GSE43863_NAIVE_VS_LY6C_INT_C...2,SET,160,-0.0053262,-0.00049479,0.067494,0.53145,GSE43863_NAIVE_VS_LY6C_INT_CXCR5POS_CD4_EFF_TCELL_D6_LCMV_UP,1
GOBP_POSITIVE_REGULATION_OF_...702,SET,6,-0.028063,-0.00050697,0.35546,0.53146,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_PROTEIN_E...2,SET,34,-0.011114,-0.00047757,0.14079,0.53146,GOBP_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,1
HP_NUCHAL_RIGIDITY,SET,10,-0.020396,-0.00047564,0.25838,0.53146,HP_NUCHAL_RIGIDITY,1
GOBP_NEGATIVE_REGULATION_OF_...400,SET,166,-0.0050674,-0.00047941,0.064041,0.53153,GOBP_NEGATIVE_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
MIR2052,SET,220,-0.0044863,-0.00048789,0.056681,0.53154,MIR2052,1
GOBP_FC_GAMMA_RECEPTOR_SIGNA...,SET,31,-0.013426,-0.00055095,0.16895,0.53167,GOBP_FC_GAMMA_RECEPTOR_SIGNALING_PATHWAY,1
HALLMARK_HYPOXIA,SET,178,-0.0052653,-0.00051565,0.066232,0.53168,HALLMARK_HYPOXIA,1
NELSON_RESPONSE_TO_ANDROGEN_...1,SET,17,-0.019001,-0.00057761,0.23874,0.53172,NELSON_RESPONSE_TO_ANDROGEN_DN,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...4,SET,11,-0.019756,-0.00048317,0.24793,0.53175,GOBP_NUCLEOSIDE_MONOPHOSPHATE_PHOSPHORYLATION,1
GOCC_TRANS_GOLGI_NETWORK_TRA...2,SET,18,-0.015423,-0.00048243,0.19356,0.53175,GOCC_TRANS_GOLGI_NETWORK_TRANSPORT_VESICLE_MEMBRANE,1
GOBP_REGULATION_OF_CARDIAC_M...7,SET,35,-0.012777,-0.00055706,0.16034,0.53176,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,1
GSE17721_PAM3CSK4_VS_GADIQUI...5,SET,180,-0.0048772,-0.0004803,0.061123,0.5318,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN,1
HP_UPPER_LIMB_AMYOTROPHY,SET,70,-0.0080632,-0.00049667,0.10081,0.53188,HP_UPPER_LIMB_AMYOTROPHY,1
GSE15750_WT_VS_TRAF6KO_DAY10...2,SET,175,-0.0050839,-0.00049372,0.063539,0.53189,GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP,1
GSE28237_FOLLICULAR_VS_EARLY...1,SET,181,-0.0049604,-0.00048983,0.061851,0.53196,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_DN,1
GOBP_REGULATION_OF_FAT_CELL_...2,SET,10,-0.023628,-0.000551,0.29446,0.53198,GOBP_REGULATION_OF_FAT_CELL_PROLIFERATION,1
HP_RAPIDLY_PROGRESSIVE,SET,35,-0.010774,-0.00046973,0.13425,0.53198,HP_RAPIDLY_PROGRESSIVE,1
HP_COLON_CANCER,SET,40,-0.010614,-0.00049462,0.1318,0.53209,HP_COLON_CANCER,1
RAMJAUN_APOPTOSIS_BY_TGFB1_V...4,SET,10,-0.02376,-0.00055406,0.29492,0.5321,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_UP,1
HP_WIDE_NOSE,SET,108,-0.0065028,-0.00049702,0.080721,0.5321,HP_WIDE_NOSE,1
HALLMARK_WNT_BETA_CATENIN_SI...,SET,41,-0.010638,-0.00050188,0.13195,0.53213,HALLMARK_WNT_BETA_CATENIN_SIGNALING,1
GOBP_NEGATIVE_CHEMOTAXIS,SET,46,-0.011013,-0.00055029,0.13633,0.53219,GOBP_NEGATIVE_CHEMOTAXIS,1
GOBP_ERBB3_SIGNALING_PATHWAY,SET,10,-0.0227,-0.00052936,0.2806,0.53224,GOBP_ERBB3_SIGNALING_PATHWAY,1
GOMF_GROWTH_FACTOR_BINDING,SET,126,-0.0065604,-0.00054133,0.081013,0.53227,GOMF_GROWTH_FACTOR_BINDING,1
GOBP_PRIMITIVE_STREAK_FORMAT...,SET,8,-0.02581,-0.00053836,0.31848,0.53229,GOBP_PRIMITIVE_STREAK_FORMATION,1
GSE34156_NOD2_LIGAND_VS_NOD2...2,SET,155,-0.005568,-0.00050917,0.068686,0.5323,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP,1
GOBP_RENAL_WATER_TRANSPORT,SET,9,-0.025537,-0.00056496,0.31491,0.53232,GOBP_RENAL_WATER_TRANSPORT,1
HP_PERMANENT_ATRIAL_FIBRILLA...,SET,9,-0.024979,-0.00055262,0.30776,0.53234,HP_PERMANENT_ATRIAL_FIBRILLATION,1
GOMF_FATZ_BINDING,SET,5,-0.030696,-0.00050623,0.37718,0.53243,GOMF_FATZ_BINDING,1
KEGG_MEDICUS_ENV_FACTOR_E2_T...2,SET,15,-0.01813,-0.00051772,0.22245,0.53248,KEGG_MEDICUS_ENV_FACTOR_E2_TO_RAS_ERK_SIGNALING_PATHWAY,1
DOANE_RESPONSE_TO_ANDROGEN_DN,SET,220,-0.0046879,-0.00050981,0.05744,0.53252,DOANE_RESPONSE_TO_ANDROGEN_DN,1
MODULE_171,SET,122,-0.0064137,-0.00052081,0.078565,0.53253,MODULE_171,1
GOBP_POSITIVE_REGULATION_OF_...341,SET,14,-0.018664,-0.00051491,0.2285,0.53255,GOBP_POSITIVE_REGULATION_OF_HORMONE_METABOLIC_PROCESS,1
VALK_AML_CLUSTER_7,SET,25,-0.014701,-0.00054182,0.17967,0.5326,VALK_AML_CLUSTER_7,1
GOBP_POSTSYNAPSE_TO_NUCLEUS_...,SET,6,-0.02089,-0.00037738,0.25513,0.53263,GOBP_POSTSYNAPSE_TO_NUCLEUS_SIGNALING_PATHWAY,1
GOBP_POLYOL_TRANSMEMBRANE_TR...,SET,10,-0.025356,-0.00059129,0.30919,0.53268,GOBP_POLYOL_TRANSMEMBRANE_TRANSPORT,1
GSE27241_WT_CTRL_VS_DIGOXIN_...1,SET,162,-0.0051824,-0.0004844,0.063144,0.53271,GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,1
HP_INTEROSSEUS_MUSCLE_ATROPHY,SET,4,-0.028673,-0.00042295,0.34895,0.53274,HP_INTEROSSEUS_MUSCLE_ATROPHY,1
HP_COLITIS,SET,62,-0.0090504,-0.00052477,0.1098,0.53285,HP_COLITIS,1
GOMF_VOLUME_SENSITIVE_ANION_...,SET,9,-0.02639,-0.00058384,0.31991,0.53287,GOMF_VOLUME_SENSITIVE_ANION_CHANNEL_ACTIVITY,1
HP_NEURAL_TUBE_DEFECT,SET,271,-0.0041459,-0.00049971,0.050233,0.53289,HP_NEURAL_TUBE_DEFECT,1
MIR5579_3P,SET,140,-0.005976,-0.00051958,0.072301,0.53294,MIR5579_3P,1
GOBP_NEGATIVE_REGULATION_OF_...304,SET,7,-0.028836,-0.00056266,0.34864,0.53296,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_13_PRODUCTION,1
KEGG_MEDICUS_PATHOGEN_SARS_C...3,SET,3,-0.06163,-0.00078734,0.74381,0.53302,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_TO_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE,1
GSE40184_HEALTHY_VS_HCV_INFE...1,SET,188,-0.004971,-0.00050019,0.059952,0.53304,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_DN,1
GOBP_PROTEIN_STABILIZATION,SET,187,-0.0049032,-0.00049207,0.059092,0.53306,GOBP_PROTEIN_STABILIZATION,1
GOBP_RESCUE_OF_STALLED_RIBOS...,SET,25,-0.012719,-0.00046879,0.15316,0.53309,GOBP_RESCUE_OF_STALLED_RIBOSOME,1
GSE20500_RETINOIC_ACID_VS_RA...1,SET,175,-0.0054059,-0.00052498,0.065071,0.5331,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...187,SET,26,-0.014567,-0.00054752,0.1753,0.53311,GOBP_POSITIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GSE17721_CTRL_VS_POLYIC_2H_B...1,SET,189,-0.0050782,-0.00051231,0.060926,0.53321,GSE17721_CTRL_VS_POLYIC_2H_BMDC_DN,1
WP_HEDGEHOG_SIGNALING_WP4249,SET,41,-0.011146,-0.00052587,0.13363,0.53324,WP_HEDGEHOG_SIGNALING_WP4249,1
GOBP_POSITIVE_REGULATION_OF_...453,SET,25,-0.016397,-0.00060435,0.1965,0.53325,GOBP_POSITIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,1
GOBP_CARDIAC_SEPTUM_CELL_DIF...,SET,5,-0.033869,-0.00055856,0.40562,0.53327,GOBP_CARDIAC_SEPTUM_CELL_DIFFERENTIATION,1
REACTOME_INTRINSIC_PATHWAY_O...,SET,20,-0.015771,-0.00051998,0.1886,0.53332,REACTOME_INTRINSIC_PATHWAY_OF_FIBRIN_CLOT_FORMATION,1
DORN_ADENOVIRUS_INFECTION_48...1,SET,37,-0.010785,-0.00048343,0.12887,0.53335,DORN_ADENOVIRUS_INFECTION_48HR_DN,1
HP_ABSENT_FOREARM_BONE,SET,24,-0.014753,-0.00053276,0.17629,0.53335,HP_ABSENT_FOREARM_BONE,1
GOCC_CELL_DIVISION_SITE,SET,58,-0.0091886,-0.00051536,0.10974,0.53336,GOCC_CELL_DIVISION_SITE,1
GOBP_NEGATIVE_REGULATION_OF_...351,SET,26,-0.013149,-0.00049421,0.15697,0.53338,GOBP_NEGATIVE_REGULATION_OF_LIPID_TRANSPORT,1
NABA_MATRISOME_POORLY_METAST...3,SET,35,-0.011917,-0.00051953,0.14191,0.53346,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA,1
GSE24972_WT_VS_IRF8_KO_MARGI...2,SET,174,-0.0054241,-0.00052526,0.064576,0.53347,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_UP,1
GOBP_MYELOID_CELL_DEVELOPMENT,SET,80,-0.0081716,-0.00053795,0.097155,0.53351,GOBP_MYELOID_CELL_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...423,SET,17,-0.016908,-0.00051399,0.20098,0.53352,GOBP_NEGATIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,1
WP_TRYPTOPHAN_METABOLISM,SET,29,-0.01412,-0.00056043,0.16763,0.53356,WP_TRYPTOPHAN_METABOLISM,1
KEGG_MEDICUS_PATHOGEN_HIV_GP...1,SET,12,-0.020361,-0.0005201,0.24132,0.53362,KEGG_MEDICUS_PATHOGEN_HIV_GP120_TO_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
GSE16385_MONOCYTE_VS_MACROPH...2,SET,178,-0.0051935,-0.00050863,0.061437,0.53368,GSE16385_MONOCYTE_VS_MACROPHAGE_UP,1
BLANCO_MELO_COVID19_SARS_COV...2,SET,68,-0.0092642,-0.00056247,0.1094,0.53374,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN,1
GOMF_PATCHED_BINDING,SET,8,-0.025349,-0.00052875,0.29938,0.53374,GOMF_PATCHED_BINDING,1
GOBP_REGULATION_OF_CELL_DIVI...,SET,171,-0.0055615,-0.00053395,0.065549,0.53381,GOBP_REGULATION_OF_CELL_DIVISION,1
GOBP_POSITIVE_REGULATION_OF_...612,SET,179,-0.0052931,-0.00051982,0.062335,0.53383,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS,1
EBNA1BP2_TARGET_GENES,SET,291,-0.0042199,-0.00052677,0.049685,0.53384,EBNA1BP2_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C2_CXC...,SET,118,-0.0070259,-0.00056115,0.082686,0.53386,HE_LIM_SUN_FETAL_LUNG_C2_CXCL9_POS_MACROPHAGE_CELL,1
ACEVEDO_LIVER_CANCER_DN,SET,490,-0.003269,-0.00052661,0.038424,0.5339,ACEVEDO_LIVER_CANCER_DN,1
MORF_KDR,SET,82,-0.0082494,-0.00054979,0.096864,0.53393,MORF_KDR,1
HP_DECREASED_TESTICULAR_SIZE,SET,148,-0.005817,-0.0005199,0.068101,0.53404,HP_DECREASED_TESTICULAR_SIZE,1
GOMF_CALCIUM_ION_BINDING,SET,661,-0.0030797,-0.00057345,0.035938,0.53415,GOMF_CALCIUM_ION_BINDING,1
GOCC_PERICHROMATIN_FIBRILS,SET,6,-0.031384,-0.00056696,0.36607,0.53416,GOCC_PERICHROMATIN_FIBRILS,1
CHEN_PDGF_TARGETS,SET,18,-0.019722,-0.0006169,0.23001,0.53417,CHEN_PDGF_TARGETS,1
GSE17322_CD103_POS_VS_CD11B_...2,SET,176,-0.0053173,-0.00051784,0.062001,0.53417,GSE17322_CD103_POS_VS_CD11B_HIGH_LUNG_DC_UP,1
FRANCO_BLOOD_SANOFI_PASTEUR_...4,SET,20,-0.015128,-0.00049877,0.17617,0.53422,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_14DY_POSITIVE,1
MIR4297,SET,161,-0.005805,-0.00054093,0.067544,0.53424,MIR4297,1
GSE15324_NAIVE_VS_ACTIVATED_...1,SET,184,-0.0052029,-0.00051798,0.060534,0.53425,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,1
GOBP_REGULATION_OF_HEART_RATE,SET,96,-0.0080549,-0.00058063,0.093679,0.53426,GOBP_REGULATION_OF_HEART_RATE,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...8,SET,17,-0.019793,-0.0006017,0.23011,0.53427,SHIN_B_CELL_LYMPHOMA_CLUSTER_9,1
MIR6733_3P,SET,128,-0.0066548,-0.00055343,0.077381,0.53427,MIR6733_3P,1
GSE33425_CD8_ALPHAALPHA_VS_A...1,SET,182,-0.0052924,-0.00052404,0.061516,0.53428,GSE33425_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,1
HP_DEVIATION_OF_THE_5TH_TOE,SET,16,-0.018204,-0.00053688,0.21154,0.53429,HP_DEVIATION_OF_THE_5TH_TOE,1
REACTOME_NOREPINEPHRINE_NEUR...,SET,16,-0.01961,-0.00057836,0.22776,0.53431,REACTOME_NOREPINEPHRINE_NEUROTRANSMITTER_RELEASE_CYCLE,1
GOCC_PROTEIN_PHOSPHATASE_TYP...2,SET,16,-0.0178,-0.00052496,0.20674,0.53431,GOCC_PROTEIN_PHOSPHATASE_TYPE_2A_COMPLEX,1
MORF_CASP2,SET,89,-0.0073702,-0.00051163,0.085564,0.53432,MORF_CASP2,1
MIR4701_3P,SET,46,-0.01007,-0.00050315,0.11687,0.53433,MIR4701_3P,1
GOBP_NUCLEAR_CHROMOSOME_SEGR...,SET,293,-0.0040776,-0.00051073,0.047259,0.53438,GOBP_NUCLEAR_CHROMOSOME_SEGREGATION,1
GSE12845_IGD_POS_VS_NEG_BLOO...1,SET,171,-0.0055214,-0.0005301,0.063995,0.53438,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN,1
MIR1227_5P,SET,97,-0.0071161,-0.00051561,0.082346,0.53443,MIR1227_5P,1
GSE3691_IFN_PRODUCING_KILLER...1,SET,177,-0.0054674,-0.00053396,0.063261,0.53444,GSE3691_IFN_PRODUCING_KILLER_DC_VS_CONVENTIONAL_DC_SPLEEN_DN,1
SIG_REGULATION_OF_THE_ACTIN_...,SET,30,-0.013012,-0.00052527,0.15015,0.53453,SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES,1
HP_UNILATERAL_RENAL_AGENESIS,SET,83,-0.0081344,-0.00054541,0.093757,0.53457,HP_UNILATERAL_RENAL_AGENESIS,1
AACATTC_MIR4093P,SET,137,-0.0064709,-0.0005566,0.074551,0.53458,AACATTC_MIR4093P,1
GSE2128_CTRL_VS_MIMETOPE_NEG...2,SET,158,-0.0058892,-0.00054369,0.067769,0.53462,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_UP,1
HOXD11_TARGET_GENES,SET,117,-0.0067768,-0.00053898,0.077803,0.5347,HOXD11_TARGET_GENES,1
GSE45365_HEALTHY_VS_MCMV_INF...8,SET,184,-0.0055004,-0.00054759,0.06303,0.53477,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN,1
CCCAGAG_MIR326,SET,137,-0.006282,-0.00054035,0.071939,0.53479,CCCAGAG_MIR326,1
SIPA1_TARGET_GENES,SET,102,-0.0070528,-0.00052395,0.080769,0.53479,SIPA1_TARGET_GENES,1
GSE18804_SPLEEN_MACROPHAGE_V...6,SET,170,-0.0056429,-0.00054019,0.06462,0.53479,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_UP,1
WP_IL6_SIGNALING,SET,42,-0.012156,-0.00058044,0.139,0.53484,WP_IL6_SIGNALING,1
GOBP_SYMPATHETIC_GANGLION_DE...,SET,9,-0.028094,-0.00062154,0.32107,0.53486,GOBP_SYMPATHETIC_GANGLION_DEVELOPMENT,1
GSE17974_0H_VS_1H_IN_VITRO_A...1,SET,183,-0.0052577,-0.00052202,0.059926,0.53496,GSE17974_0H_VS_1H_IN_VITRO_ACT_CD4_TCELL_DN,1
MIR3074_3P,SET,79,-0.0085715,-0.00056076,0.097629,0.53498,MIR3074_3P,1
KEGG_INSULIN_SIGNALING_PATHW...,SET,130,-0.0065566,-0.00054948,0.07464,0.535,KEGG_INSULIN_SIGNALING_PATHWAY,1
HP_SOFT_TISSUE_NEOPLASM,SET,5,-0.036279,-0.0005983,0.41299,0.535,HP_SOFT_TISSUE_NEOPLASM,1
GOMF_DOUBLE_STRANDED_METHYLA...,SET,4,-0.035049,-0.00051701,0.39886,0.53501,GOMF_DOUBLE_STRANDED_METHYLATED_DNA_BINDING,1
MODULE_322,SET,51,-0.0099305,-0.00052239,0.11295,0.53503,MODULE_322,1
GSE21927_EL4_VS_MCA203_TUMOR...2,SET,149,-0.0063922,-0.00057321,0.072596,0.53508,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_UP,1
GSE26928_CENTR_MEMORY_VS_CXC...1,SET,158,-0.0056818,-0.00052454,0.064488,0.5351,GSE26928_CENTR_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,1
MIR4298,SET,50,-0.0099983,-0.00052079,0.11328,0.53516,MIR4298,1
GOBP_REGULATION_OF_CARDIAC_M...1,SET,10,-0.026069,-0.00060792,0.29539,0.53516,GOBP_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,1
GOMF_SUPEROXIDE_GENERATING_N...2,SET,7,-0.029769,-0.00058086,0.33732,0.53516,GOMF_SUPEROXIDE_GENERATING_NAD_P_H_OXIDASE_ACTIVITY,1
GSE3039_ALPHAALPHA_CD8_TCELL...2,SET,189,-0.0051922,-0.00052382,0.058834,0.53516,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_UP,1
GOCC_SMAD_PROTEIN_COMPLEX,SET,9,-0.027171,-0.00060112,0.30757,0.5352,GOCC_SMAD_PROTEIN_COMPLEX,1
GOBP_URETERIC_BUD_ELONGATION,SET,7,-0.02565,-0.00050049,0.2902,0.53521,GOBP_URETERIC_BUD_ELONGATION,1
chr3q29,SET,43,-0.022302,-0.0010775,0.25231,0.53522,chr3q29,1
MIR4648,SET,37,-0.011477,-0.00051442,0.12976,0.53524,MIR4648,1
KEGG_PENTOSE_PHOSPHATE_PATHW...,SET,22,-0.014889,-0.00051483,0.1683,0.53525,KEGG_PENTOSE_PHOSPHATE_PATHWAY,1
GOMF_BETA_2_ADRENERGIC_RECEP...,SET,5,-0.032922,-0.00054293,0.37182,0.53528,GOMF_BETA_2_ADRENERGIC_RECEPTOR_BINDING,1
MODULE_328,SET,13,-0.020382,-0.00054188,0.2301,0.53529,MODULE_328,1
HP_ABNORMAL_PSYCHOTIC_PATTERN,SET,171,-0.0059656,-0.00057274,0.067341,0.53529,HP_ABNORMAL_PSYCHOTIC_PATTERN,1
GSE12366_PLASMA_CELL_VS_NAIV...2,SET,166,-0.0058724,-0.00055557,0.066145,0.53537,GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_UP,1
GOCC_VACUOLAR_PROTON_TRANSPO...,SET,8,-0.022964,-0.00047899,0.2586,0.53538,GOCC_VACUOLAR_PROTON_TRANSPORTING_V_TYPE_ATPASE_V0_DOMAIN,1
WANG_CLIM2_TARGETS_UP,SET,214,-0.0050331,-0.00053993,0.056649,0.5354,WANG_CLIM2_TARGETS_UP,1
DASU_IL6_SIGNALING_DN,SET,6,-0.034025,-0.00061467,0.38227,0.53546,DASU_IL6_SIGNALING_DN,1
LEF1_UP.V1_UP,SET,173,-0.0061057,-0.00058958,0.068601,0.53546,LEF1_UP.V1_UP,1
REACTOME_FORMATION_OF_SENESC...,SET,11,-0.022256,-0.00054433,0.24983,0.53549,REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF,1
HP_SHOCK,SET,12,-0.022202,-0.00056713,0.24909,0.53551,HP_SHOCK,1
GSE9006_TYPE_1_DIABETES_AT_D...1,SET,163,-0.0056514,-0.00052985,0.063416,0.53551,GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_DN,1
SESTO_RESPONSE_TO_UV_C2,SET,50,-0.010011,-0.00052147,0.11229,0.53552,SESTO_RESPONSE_TO_UV_C2,1
GSE2770_TGFB_AND_IL4_ACT_VS_...5,SET,175,-0.0054633,-0.00053056,0.061236,0.53554,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_6H_DN,1
MIR6845_3P,SET,124,-0.0069113,-0.00056577,0.077419,0.53557,MIR6845_3P,1
GOCC_DENSE_BODY,SET,5,-0.035236,-0.0005811,0.39455,0.53558,GOCC_DENSE_BODY,1
GSE2770_IL12_AND_TGFB_VS_IL4...2,SET,179,-0.005512,-0.00054131,0.061416,0.53576,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
PID_HIF1_TFPATHWAY,SET,64,-0.01004,-0.00059144,0.11175,0.53579,PID_HIF1_TFPATHWAY,1
GOBP_XENOBIOTIC_CATABOLIC_PR...,SET,23,-0.015302,-0.00054098,0.17035,0.53579,GOBP_XENOBIOTIC_CATABOLIC_PROCESS,1
HP_NEOPLASM_OF_THE_AUTONOMIC...,SET,10,-0.02835,-0.00066112,0.31556,0.53579,HP_NEOPLASM_OF_THE_AUTONOMIC_NERVOUS_SYSTEM,1
MIR4487,SET,73,-0.0090848,-0.00057141,0.10103,0.53583,MIR4487,1
ZHOU_CELL_CYCLE_GENES_IN_IR_...2,SET,8,-0.025241,-0.0005265,0.28059,0.53584,ZHOU_CELL_CYCLE_GENES_IN_IR_RESPONSE_2HR,1
GOBP_RESPONSE_TO_MISFOLDED_P...,SET,17,-0.017175,-0.00052211,0.19092,0.53584,GOBP_RESPONSE_TO_MISFOLDED_PROTEIN,1
HP_EYE_MOVEMENT_INDUCED_PAIN,SET,5,-0.036141,-0.00059602,0.40165,0.53585,HP_EYE_MOVEMENT_INDUCED_PAIN,1
COLINA_TARGETS_OF_4EBP1_AND_...,SET,320,-0.0043024,-0.00056274,0.047781,0.53587,COLINA_TARGETS_OF_4EBP1_AND_4EBP2,1
GRE_C,SET,112,-0.0073452,-0.00057164,0.081548,0.53588,GRE_C,1
ZNF223_TARGET_GENES,SET,257,-0.0046688,-0.00054822,0.051689,0.53599,ZNF223_TARGET_GENES,1
MOREAUX_MULTIPLE_MYELOMA_BY_...2,SET,326,-0.0044092,-0.000582,0.048756,0.53603,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP,1
KEGG_MEDICUS_REFERENCE_MAGI_...,SET,6,-0.030221,-0.00054596,0.33406,0.53604,KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY,1
REACTOME_SENSORY_PERCEPTION_...2,SET,45,-0.012775,-0.00063137,0.14113,0.53606,REACTOME_SENSORY_PERCEPTION_OF_TASTE,1
HP_ABDOMINAL_WALL_MUSCLE_WEA...,SET,14,-0.019154,-0.00052845,0.21163,0.53606,HP_ABDOMINAL_WALL_MUSCLE_WEAKNESS,1
MIR142_5P,SET,315,-0.0043492,-0.00056448,0.048016,0.53609,MIR142_5P,1
BIOCARTA_BTG2_PATHWAY,SET,11,-0.023013,-0.00056283,0.25395,0.5361,BIOCARTA_BTG2_PATHWAY,1
ULE_SPLICING_VIA_NOVA2,SET,42,-0.012026,-0.00057424,0.13247,0.53617,ULE_SPLICING_VIA_NOVA2,1
HP_TAPERED_DISTAL_PHALANGES_...,SET,6,-0.037315,-0.0006741,0.41063,0.5362,HP_TAPERED_DISTAL_PHALANGES_OF_FINGER,1
GOBP_C21_STEROID_HORMONE_BIO...,SET,19,-0.019036,-0.00061173,0.2094,0.53622,GOBP_C21_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,1
HP_NARROW_FORAMEN_OBTURATORI...,SET,4,-0.035317,-0.00052096,0.38843,0.53622,HP_NARROW_FORAMEN_OBTURATORIUM,1
HP_PULMONARY_ARTERY_DILATATI...,SET,12,-0.021859,-0.00055837,0.24045,0.53622,HP_PULMONARY_ARTERY_DILATATION,1
GOBP_GLYCOSYLATION,SET,223,-0.0052367,-0.00057332,0.057584,0.53623,GOBP_GLYCOSYLATION,1
GSE42021_CD24HI_VS_CD24INT_T...4,SET,180,-0.0057167,-0.00056297,0.062827,0.53625,GSE42021_CD24HI_VS_CD24INT_TREG_THYMUS_UP,1
HP_SMALL_EARLOBE,SET,23,-0.016501,-0.00058337,0.18122,0.53628,HP_SMALL_EARLOBE,1
GOBP_HORMONE_CATABOLIC_PROCE...,SET,12,-0.023994,-0.0006129,0.26322,0.53632,GOBP_HORMONE_CATABOLIC_PROCESS,1
GOBP_HISTONE_MRNA_METABOLIC_...,SET,20,-0.014427,-0.00047566,0.15822,0.53633,GOBP_HISTONE_MRNA_METABOLIC_PROCESS,1
HP_GLOBAL_BRAIN_ATROPHY,SET,58,-0.0098777,-0.00055402,0.10827,0.53635,HP_GLOBAL_BRAIN_ATROPHY,1
GSE36888_STAT5_AB_KNOCKIN_VS...6,SET,175,-0.0056417,-0.00054789,0.061812,0.53636,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_6H_UP,1
AREB6_04,SET,226,-0.0054464,-0.00060022,0.059607,0.5364,AREB6_04,1
RB_P107_DN.V1_UP,SET,121,-0.0067331,-0.00054452,0.073676,0.53641,RB_P107_DN.V1_UP,1
GOMF_LOW_DENSITY_LIPOPROTEIN...3,SET,23,-0.015707,-0.00055531,0.17167,0.53645,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,1
CHEOK_RESPONSE_TO_MERCAPTOPU...4,SET,8,-0.031382,-0.00065459,0.34233,0.53652,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_UP,1
GOBP_NEGATIVE_REGULATION_OF_...176,SET,11,-0.025337,-0.00061966,0.27619,0.53655,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
HP_ABDOMINAL_OBESITY,SET,24,-0.015996,-0.00057765,0.17428,0.53656,HP_ABDOMINAL_OBESITY,1
GSE6259_FLT3L_INDUCED_DEC205...3,SET,111,-0.0075991,-0.00058877,0.082678,0.53662,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_DN,1
GOMF_PROTEIN_TYROSINE_SERINE...,SET,22,-0.017204,-0.00059488,0.1868,0.53669,GOMF_PROTEIN_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,1
FLETCHER_PBMC_BCG_10W_INFANT...3,SET,165,-0.0063059,-0.0005948,0.068461,0.53669,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_DN,1
HP_EXERCISE_INDUCED_RHABDOMY...,SET,6,-0.026197,-0.00047326,0.28364,0.53679,HP_EXERCISE_INDUCED_RHABDOMYOLYSIS,1
KEGG_MEDICUS_REFERENCE_LPA_G...2,SET,8,-0.028174,-0.00058768,0.30503,0.5368,KEGG_MEDICUS_REFERENCE_LPA_GNAQ_11_RHOA_SIGNALING_PATHWAY,1
HP_RESPIRATORY_ARREST,SET,27,-0.015735,-0.00060267,0.17032,0.53681,HP_RESPIRATORY_ARREST,1
GOBP_ACROSOME_ASSEMBLY,SET,25,-0.014862,-0.00054775,0.16075,0.53683,GOBP_ACROSOME_ASSEMBLY,1
HP_ABNORMAL_METATARSAL_MORPH...,SET,139,-0.0068224,-0.00059106,0.073798,0.53683,HP_ABNORMAL_METATARSAL_MORPHOLOGY,1
MINGUEZ_LIVER_CANCER_VASCULA...1,SET,21,-0.018062,-0.0006102,0.19525,0.53685,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN,1
WP_APOPTOSIS_MODULATION_AND_...,SET,84,-0.0088271,-0.00059539,0.095188,0.53694,WP_APOPTOSIS_MODULATION_AND_SIGNALING,1
LEE_EARLY_T_LYMPHOCYTE_DN,SET,54,-0.011445,-0.00061948,0.12333,0.53697,LEE_EARLY_T_LYMPHOCYTE_DN,1
HP_INTRAHEPATIC_BILE_DUCT_DI...,SET,3,-0.046656,-0.00059604,0.50159,0.53705,HP_INTRAHEPATIC_BILE_DUCT_DILATATION,1
GSE22886_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.0055339,-0.00054796,0.059372,0.53713,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH2_DN,1
MIR766_3P,SET,142,-0.0066377,-0.00058119,0.07111,0.53718,MIR766_3P,1
GOBP_REGULATION_OF_ATTACHMEN...1,SET,9,-0.025542,-0.00056509,0.27366,0.53718,GOBP_REGULATION_OF_ATTACHMENT_OF_MITOTIC_SPINDLE_MICROTUBULES_TO_KINETOCHORE,1
GOBP_TOXIN_METABOLIC_PROCESS,SET,15,-0.020066,-0.00057302,0.21501,0.53718,GOBP_TOXIN_METABOLIC_PROCESS,1
HP_ABNORMAL_ATRIAL_ARRANGEME...,SET,41,-0.011642,-0.00054924,0.12471,0.53719,HP_ABNORMAL_ATRIAL_ARRANGEMENT,1
GOBP_AMINO_ACID_ACTIVATION,SET,26,-0.013752,-0.00051687,0.14716,0.53723,GOBP_AMINO_ACID_ACTIVATION,1
GOBP_PLATELET_MORPHOGENESIS,SET,23,-0.015021,-0.00053106,0.16058,0.53726,GOBP_PLATELET_MORPHOGENESIS,1
BOYAULT_LIVER_CANCER_SUBCLAS...6,SET,106,-0.0076335,-0.00057804,0.081546,0.53729,BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP,1
GOBP_REGULATION_OF_CYTOPLASM...2,SET,101,-0.0076259,-0.00056376,0.08147,0.53729,GOBP_REGULATION_OF_CYTOPLASMIC_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
GSE45382_UNTREATED_VS_TGFB_T...2,SET,179,-0.0059961,-0.00058886,0.064015,0.53731,GSE45382_UNTREATED_VS_TGFB_TREATED_MACROPHAGES_UP,1
GSE37416_CTRL_VS_0H_F_TULARE...2,SET,149,-0.0062051,-0.00055644,0.066201,0.53734,GSE37416_CTRL_VS_0H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
KEGG_MEDICUS_REFERENCE_MANNO...1,SET,3,-0.047414,-0.00060572,0.50568,0.53735,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_FKTN_TO_LARGE,1
REACTOME_REGULATION_OF_INSUL...2,SET,77,-0.0095506,-0.00061689,0.10168,0.53742,REACTOME_REGULATION_OF_INSULIN_SECRETION,1
MIR6073,SET,96,-0.0080449,-0.00057991,0.085652,0.53742,MIR6073,1
GOBP_CEREBELLAR_CORTEX_FORMA...,SET,22,-0.01735,-0.00059993,0.18445,0.53747,GOBP_CEREBELLAR_CORTEX_FORMATION,1
MIR454_3P,SET,386,-0.0041029,-0.00058831,0.043576,0.53751,MIR454_3P,1
DAVICIONI_TARGETS_OF_PAX_FOX...1,SET,62,-0.010951,-0.00063495,0.11626,0.53752,DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_DN,1
MIR499B_3P,SET,153,-0.0068862,-0.00062567,0.073096,0.53753,MIR499B_3P,1
HP_EEG_WITH_BURST_SUPPRESSION,SET,56,-0.010142,-0.00055899,0.10763,0.53754,HP_EEG_WITH_BURST_SUPPRESSION,1
MORI_MATURE_B_LYMPHOCYTE_DN,SET,69,-0.0093462,-0.00057158,0.09909,0.53757,MORI_MATURE_B_LYMPHOCYTE_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_CYC...,SET,1243,-0.0022179,-0.00055695,0.023476,0.53763,HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...448,SET,11,-0.027688,-0.00067718,0.29301,0.53764,GOBP_NEGATIVE_REGULATION_OF_NITRIC_OXIDE_METABOLIC_PROCESS,1
HP_ABNORMAL_SEPTUM_PELLUCIDU...,SET,92,-0.0081366,-0.00057423,0.086114,0.53764,HP_ABNORMAL_SEPTUM_PELLUCIDUM_MORPHOLOGY,1
GSE33424_CD161_HIGH_VS_INT_C...1,SET,184,-0.00582,-0.00057941,0.061542,0.53767,GSE33424_CD161_HIGH_VS_INT_CD8_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_NLRP1...,SET,4,-0.034299,-0.00050594,0.36258,0.53768,KEGG_MEDICUS_REFERENCE_NLRP1_INFLAMMASOME_SIGNALING_PATHWAY,1
RICKMAN_METASTASIS_DN,SET,243,-0.0051859,-0.00059234,0.054747,0.53773,RICKMAN_METASTASIS_DN,1
GSE21546_WT_VS_SAP1A_KO_AND_...1,SET,182,-0.0060531,-0.00059937,0.063912,0.53773,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
GSE32986_GMCSF_VS_GMCSF_AND_...3,SET,161,-0.0063841,-0.0005949,0.067276,0.5378,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,1
GSE29614_DAY3_VS_DAY7_TIV_FL...1,SET,158,-0.0062526,-0.00057724,0.065705,0.53791,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,1
MIR6851_5P,SET,95,-0.0081037,-0.00058111,0.085115,0.53793,MIR6851_5P,1
HP_IMPAIRED_DISTAL_PROPRIOCE...,SET,16,-0.018556,-0.00054726,0.19476,0.53795,HP_IMPAIRED_DISTAL_PROPRIOCEPTION,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...3,SET,12,-0.023716,-0.0006058,0.24873,0.53798,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
HP_SPINAL_CORD_TUMOR,SET,9,-0.027892,-0.00061706,0.29166,0.53809,HP_SPINAL_CORD_TUMOR,1
SVIL_TARGET_GENES,SET,10,-0.028247,-0.0006587,0.29513,0.53812,SVIL_TARGET_GENES,1
MIR6892_3P,SET,92,-0.0086192,-0.00060829,0.089965,0.53816,MIR6892_3P,1
HP_ELEVATED_SYSTOLIC_BLOOD_P...,SET,13,-0.022378,-0.00059493,0.2334,0.53819,HP_ELEVATED_SYSTOLIC_BLOOD_PRESSURE,1
GSE7831_1H_VS_4H_CPG_STIM_PD...1,SET,181,-0.0058,-0.00057274,0.06048,0.5382,GSE7831_1H_VS_4H_CPG_STIM_PDC_DN,1
HP_ADENOCARCINOMA_OF_THE_INT...,SET,38,-0.011822,-0.00053702,0.1232,0.53822,HP_ADENOCARCINOMA_OF_THE_INTESTINES,1
HP_BILATERAL_CAMPTODACTYLY,SET,5,-0.033618,-0.00055441,0.35017,0.53824,HP_BILATERAL_CAMPTODACTYLY,1
BIOCARTA_PCAF_PATHWAY,SET,13,-0.020708,-0.00055056,0.21565,0.53825,BIOCARTA_PCAF_PATHWAY,1
MIR4778_5P,SET,161,-0.0063896,-0.00059541,0.06652,0.53826,MIR4778_5P,1
MIR154_5P,SET,61,-0.010851,-0.00062412,0.11283,0.53831,MIR154_5P,1
GOBP_NEURON_PROJECTION_ORGAN...,SET,86,-0.0088207,-0.00060197,0.0917,0.53831,GOBP_NEURON_PROJECTION_ORGANIZATION,1
REACTOME_G_PROTEIN_MEDIATED_...,SET,52,-0.011908,-0.00063249,0.12373,0.53833,REACTOME_G_PROTEIN_MEDIATED_EVENTS,1
HP_PERIPHERAL_AXONAL_DEGENER...,SET,179,-0.0059137,-0.00058076,0.061441,0.53834,HP_PERIPHERAL_AXONAL_DEGENERATION,1
GOBP_BONE_TRABECULA_FORMATION,SET,11,-0.025154,-0.00061518,0.26121,0.53836,GOBP_BONE_TRABECULA_FORMATION,1
HP_EEG_WITH_GENERALIZED_SLOW...1,SET,32,-0.013882,-0.00057873,0.14414,0.53836,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY,1
GAVISH_3CA_MALIGNANT_METAPRO...26,SET,43,-0.012846,-0.00062064,0.1333,0.53839,GAVISH_3CA_MALIGNANT_METAPROGRAM_34_PLATELET_ACTIVATION,1
HP_SMALL_HAND,SET,94,-0.0086796,-0.00061914,0.089949,0.53844,HP_SMALL_HAND,1
TRAYNOR_RETT_SYNDROM_UP,SET,36,-0.016079,-0.00071094,0.16655,0.53845,TRAYNOR_RETT_SYNDROM_UP,1
GSE411_100MIN_VS_400MIN_IL6_...1,SET,182,-0.0055979,-0.00055429,0.057978,0.53846,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_DN,1
GSE42021_TCONV_PLN_VS_CD24IN...1,SET,184,-0.0058705,-0.00058443,0.060795,0.53846,GSE42021_TCONV_PLN_VS_CD24INT_TCONV_THYMUS_DN,1
FOXF1_TARGET_GENES,SET,5,-0.035746,-0.00058952,0.36992,0.53849,FOXF1_TARGET_GENES,1
WP_G1_TO_S_CELL_CYCLE_CONTROL,SET,64,-0.0096813,-0.0005703,0.10012,0.53852,WP_G1_TO_S_CELL_CYCLE_CONTROL,1
GSE360_L_MAJOR_VS_B_MALAYI_H...3,SET,183,-0.0056838,-0.00056433,0.058752,0.53853,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
HP_THORACOLUMBAR_KYPHOSIS,SET,18,-0.020403,-0.0006382,0.21058,0.53859,HP_THORACOLUMBAR_KYPHOSIS,1
MOOTHA_ROS,SET,7,-0.034493,-0.00067304,0.35597,0.5386,MOOTHA_ROS,1
MIR5192,SET,45,-0.011394,-0.00056309,0.11754,0.53861,MIR5192,1
GOBP_RNA_CAPPING,SET,13,-0.018889,-0.0005022,0.19449,0.53868,GOBP_RNA_CAPPING,1
GOBP_TYPE_B_PANCREATIC_CELL_...3,SET,27,-0.017061,-0.00065343,0.1756,0.5387,GOBP_TYPE_B_PANCREATIC_CELL_DIFFERENTIATION,1
GOCC_COATED_VESICLE_MEMBRANE,SET,185,-0.0060228,-0.00060121,0.061927,0.53874,GOCC_COATED_VESICLE_MEMBRANE,1
HP_HOFFMANN_SIGN,SET,9,-0.026208,-0.00057981,0.26948,0.53874,HP_HOFFMANN_SIGN,1
GOCC_GOLGI_TRANS_CISTERNA,SET,9,-0.030599,-0.00067696,0.31383,0.53884,GOCC_GOLGI_TRANS_CISTERNA,1
GOBP_RETINAL_BIPOLAR_NEURON_...,SET,7,-0.032346,-0.00063113,0.33152,0.53886,GOBP_RETINAL_BIPOLAR_NEURON_DIFFERENTIATION,1
SASSON_RESPONSE_TO_FORSKOLIN...2,SET,78,-0.0092078,-0.00059857,0.094153,0.53895,SASSON_RESPONSE_TO_FORSKOLIN_UP,1
GOBP_SYNAPSE_MATURATION,SET,33,-0.015031,-0.00063634,0.1536,0.53898,GOBP_SYNAPSE_MATURATION,1
MOROSETTI_FACIOSCAPULOHUMERA...2,SET,19,-0.018904,-0.00060751,0.19296,0.53902,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_UP,1
GOBP_ORGANIC_ACID_TRANSMEMBR...,SET,139,-0.0071683,-0.00062103,0.073067,0.53908,GOBP_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORT,1
GSE37532_VISCERAL_ADIPOSE_TI...5,SET,85,-0.0093644,-0.00063536,0.095442,0.53908,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_DN,1
GSE44732_UNSTIM_VS_IL27_STIM...2,SET,175,-0.0062567,-0.00060761,0.063772,0.53908,GSE44732_UNSTIM_VS_IL27_STIM_IMATURE_DC_UP,1
HP_RENAL_TUBULAR_ACIDOSIS,SET,39,-0.013261,-0.00061024,0.13503,0.53912,HP_RENAL_TUBULAR_ACIDOSIS,1
GSE9601_NFKB_INHIBITOR_VS_PI...2,SET,177,-0.0060012,-0.00058609,0.061101,0.53912,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
HP_HEPATIC_VEIN_THROMBOSIS,SET,9,-0.025665,-0.00056779,0.2612,0.53913,HP_HEPATIC_VEIN_THROMBOSIS,1
GOMF_MHC_CLASS_II_PROTEIN_BI...,SET,7,-0.032194,-0.00062818,0.32736,0.53917,GOMF_MHC_CLASS_II_PROTEIN_BINDING,1
WANG_BARRETTS_ESOPHAGUS_AND_...2,SET,24,-0.01822,-0.00065797,0.18523,0.53918,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_UP,1
GOCC_NUCLEAR_OUTER_MEMBRANE_...,SET,1100,-0.00259,-0.00061438,0.026304,0.53922,GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK,1
GSE2585_THYMIC_DC_VS_THYMIC_...2,SET,158,-0.0067995,-0.00062773,0.068988,0.53926,GSE2585_THYMIC_DC_VS_THYMIC_MACROPHAGE_UP,1
HOUSTIS_ROS,SET,34,-0.015536,-0.00066759,0.15756,0.53927,HOUSTIS_ROS,1
HP_CHOKING_EPISODES,SET,16,-0.022232,-0.00065567,0.22544,0.53928,HP_CHOKING_EPISODES,1
REACTOME_SYNTHESIS_OF_5_EICO...,SET,9,-0.029969,-0.00066303,0.30334,0.53935,REACTOME_SYNTHESIS_OF_5_EICOSATETRAENOIC_ACIDS,1
GOBP_SPINDLE_ORGANIZATION,SET,184,-0.0057193,-0.00056939,0.057868,0.53936,GOBP_SPINDLE_ORGANIZATION,1
WP_SPLICING_FACTOR_NOVA_REGU...,SET,41,-0.013007,-0.00061367,0.13151,0.53939,WP_SPLICING_FACTOR_NOVA_REGULATED_SYNAPTIC_PROTEINS,1
GOBP_DETECTION_OF_BIOTIC_STI...,SET,33,-0.014869,-0.00062949,0.1501,0.53945,GOBP_DETECTION_OF_BIOTIC_STIMULUS,1
REACTOME_TCR_SIGNALING,SET,108,-0.0078094,-0.00059688,0.078779,0.53948,REACTOME_TCR_SIGNALING,1
GOBP_REGULATION_OF_NUCLEOTID...6,SET,80,-0.0091343,-0.00060133,0.092088,0.53951,GOBP_REGULATION_OF_NUCLEOTIDE_METABOLIC_PROCESS,1
ZERBINI_RESPONSE_TO_SULINDAC...2,SET,9,-0.03271,-0.00072365,0.3291,0.53959,ZERBINI_RESPONSE_TO_SULINDAC_UP,1
GOBP_REGULATION_OF_GLYCOPROT...,SET,44,-0.01278,-0.00062458,0.12849,0.53961,GOBP_REGULATION_OF_GLYCOPROTEIN_METABOLIC_PROCESS,1
HP_MOTOR_SEIZURE,SET,367,-0.004349,-0.00060838,0.043727,0.53961,HP_MOTOR_SEIZURE,1
HP_RECURRENT_THROMBOPHLEBITIS,SET,6,-0.028948,-0.00052296,0.29086,0.53964,HP_RECURRENT_THROMBOPHLEBITIS,1
HP_ABNORMALITY_OF_THE_MIDDLE...2,SET,19,-0.020597,-0.00066192,0.20691,0.53965,HP_ABNORMALITY_OF_THE_MIDDLE_EAR_OSSICLES,1
HP_HAMARTOMATOUS_POLYPOSIS,SET,14,-0.021208,-0.00058511,0.21302,0.53965,HP_HAMARTOMATOUS_POLYPOSIS,1
WP_GLUCOSE_METABOLISM_IN_TRI...,SET,8,-0.029839,-0.00062241,0.29936,0.5397,WP_GLUCOSE_METABOLISM_IN_TRIPLENEGATIVE_BREAST_CANCER_CELLS,1
ZNF136_TARGET_GENES,SET,5,-0.037317,-0.00061541,0.37427,0.53971,ZNF136_TARGET_GENES,1
HP_PARIETAL_FORAMINA,SET,12,-0.025256,-0.00064513,0.25328,0.53971,HP_PARIETAL_FORAMINA,1
MIR5004_3P,SET,124,-0.0075758,-0.00062017,0.075962,0.53972,MIR5004_3P,1
KEGG_MEDICUS_ENV_FACTOR_ARSE...,SET,16,-0.01855,-0.00054708,0.18573,0.53978,KEGG_MEDICUS_ENV_FACTOR_ARSENIC_TO_ELECTRON_TRANSFER_IN_COMPLEX_IV,1
GAVISH_3CA_METAPROGRAM_CD4_T...3,SET,43,-0.012726,-0.00061483,0.1274,0.53978,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_DYSFUNCTION,1
REACTOME_NRIF_SIGNALS_CELL_D...,SET,14,-0.024675,-0.00068075,0.247,0.53979,REACTOME_NRIF_SIGNALS_CELL_DEATH_FROM_THE_NUCLEUS,1
REACTOME_NOTCH3_ACTIVATION_A...,SET,23,-0.017145,-0.00060612,0.17157,0.5398,REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS,1
GOBP_FOREBRAIN_NEURON_DIFFER...,SET,40,-0.015218,-0.00070915,0.15197,0.53988,GOBP_FOREBRAIN_NEURON_DIFFERENTIATION,1
VDR_Q6,SET,237,-0.0056293,-0.00063511,0.056187,0.5399,VDR_Q6,1
GOMF_AMIDE_BINDING,SET,231,-0.0057702,-0.00064282,0.057541,0.53994,GOMF_AMIDE_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...488,SET,5,-0.041336,-0.0006817,0.41187,0.53997,GOBP_NEGATIVE_REGULATION_OF_PHOSPHOLIPASE_ACTIVITY,1
HP_TAPERED_FINGER,SET,111,-0.0076472,-0.0005925,0.076185,0.53998,HP_TAPERED_FINGER,1
REACTOME_LTC4_CYSLTR_MEDIATE...,SET,6,-0.035494,-0.00064122,0.35348,0.53999,REACTOME_LTC4_CYSLTR_MEDIATED_IL4_PRODUCTION,1
ASTON_MAJOR_DEPRESSIVE_DISOR...2,SET,42,-0.013449,-0.00064218,0.13388,0.54001,ASTON_MAJOR_DEPRESSIVE_DISORDER_UP,1
MIR3975,SET,46,-0.012878,-0.00064346,0.12814,0.54003,MIR3975,1
HP_ABNORMALITY_OF_PREMOLAR,SET,12,-0.02664,-0.00068049,0.26506,0.54003,HP_ABNORMALITY_OF_PREMOLAR,1
GOBP_NEGATIVE_REGULATION_OF_...441,SET,9,-0.031447,-0.00069572,0.3127,0.54005,GOBP_NEGATIVE_REGULATION_OF_NEURON_MIGRATION,1
HP_PARKINSONISM,SET,125,-0.0074993,-0.00061636,0.074417,0.54013,HP_PARKINSONISM,1
GTTRYCATRR_UNKNOWN,SET,156,-0.0067327,-0.00061764,0.066678,0.54021,GTTRYCATRR_UNKNOWN,1
HP_HOARSE_CRY,SET,14,-0.024524,-0.00067659,0.2429,0.54021,HP_HOARSE_CRY,1
KEGG_MEDICUS_REFERENCE_MGLUR...1,SET,13,-0.02396,-0.00063701,0.23723,0.54022,KEGG_MEDICUS_REFERENCE_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
MODULE_15,SET,320,-0.0048801,-0.0006383,0.048234,0.54029,MODULE_15,1
LIU_VMYB_TARGETS_UP,SET,110,-0.0083215,-0.00064185,0.082135,0.54035,LIU_VMYB_TARGETS_UP,1
MEIS1AHOXA9_01,SET,107,-0.0090943,-0.00069189,0.089736,0.54036,MEIS1AHOXA9_01,1
HP_ALVEOLAR_RHABDOMYOSARCOMA,SET,5,-0.043685,-0.00072043,0.43059,0.5404,HP_ALVEOLAR_RHABDOMYOSARCOMA,1
HE_LIM_SUN_FETAL_LUNG_C0_AIR...,SET,20,-0.021279,-0.00070157,0.2097,0.54041,HE_LIM_SUN_FETAL_LUNG_C0_AIRWAY_FIBROBLAST,1
WP_OCTADECANOID_FORMATION_FR...,SET,12,-0.026997,-0.00068962,0.26589,0.54044,WP_OCTADECANOID_FORMATION_FROM_LINOLEIC_ACID,1
NIKOLSKY_BREAST_CANCER_12Q24...,SET,14,-0.044671,-0.0012324,0.43927,0.5405,NIKOLSKY_BREAST_CANCER_12Q24_AMPLICON,1
HP_UNILATERAL_CLEFT_PALATE,SET,18,-0.02152,-0.00067314,0.21164,0.5405,HP_UNILATERAL_CLEFT_PALATE,1
RUIZ_TNC_TARGETS_UP,SET,138,-0.0080332,-0.00069347,0.078961,0.54052,RUIZ_TNC_TARGETS_UP,1
WP_COMPLEMENT_SYSTEM_IN_NEUR...,SET,95,-0.0093086,-0.00066751,0.091363,0.54058,WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY,1
HP_NOCTURIA,SET,14,-0.023865,-0.00065841,0.23417,0.54059,HP_NOCTURIA,1
GOMF_PHOSPHOLIPID_SCRAMBLASE...,SET,15,-0.024284,-0.00069347,0.23818,0.5406,GOMF_PHOSPHOLIPID_SCRAMBLASE_ACTIVITY,1
MIR4518,SET,81,-0.0092001,-0.00060942,0.089986,0.54072,MIR4518,1
GOBP_PINOCYTOSIS,SET,20,-0.018124,-0.00059755,0.17715,0.54074,GOBP_PINOCYTOSIS,1
OHGUCHI_LIVER_HNF4A_TARGETS_...2,SET,45,-0.013504,-0.00066737,0.13198,0.54075,OHGUCHI_LIVER_HNF4A_TARGETS_UP,1
HP_BACK_PAIN,SET,68,-0.010621,-0.00064487,0.10375,0.54077,HP_BACK_PAIN,1
MIR3651,SET,18,-0.019879,-0.0006218,0.19415,0.54078,MIR3651,1
GATA2_01,SET,99,-0.0088595,-0.00064848,0.086339,0.54086,GATA2_01,1
REACTOME_SIGNALING_BY_MAPK_M...,SET,6,-0.040438,-0.00073052,0.39371,0.5409,REACTOME_SIGNALING_BY_MAPK_MUTANTS,1
GOBP_CELLULAR_KETONE_METABOL...,SET,198,-0.0062103,-0.00064111,0.060395,0.54095,GOBP_CELLULAR_KETONE_METABOLIC_PROCESS,1
HP_YELLOW_WHITE_LESIONS_OF_T...1,SET,17,-0.02214,-0.00067304,0.21484,0.54104,HP_YELLOW_WHITE_LESIONS_OF_THE_MACULA,1
GSE24574_BCL6_LOW_TFH_VS_NAI...2,SET,178,-0.006379,-0.00062472,0.061877,0.54105,GSE24574_BCL6_LOW_TFH_VS_NAIVE_CD4_TCELL_UP,1
HP_ABNORMAL_MUSCULOSKELETAL_...,SET,1455,-0.0023438,-0.00063284,0.022724,0.54107,HP_ABNORMAL_MUSCULOSKELETAL_PHYSIOLOGY,1
GOCC_CENTRIOLAR_SUBDISTAL_AP...,SET,9,-0.03015,-0.00066703,0.29196,0.54112,GOCC_CENTRIOLAR_SUBDISTAL_APPENDAGE,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...3,SET,273,-0.0057888,-0.00070026,0.056003,0.54116,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_2_CELL,1
GOBP_CELL_FATE_COMMITMENT_IN...1,SET,31,-0.016986,-0.00069701,0.1642,0.5412,GOBP_CELL_FATE_COMMITMENT_INVOLVED_IN_FORMATION_OF_PRIMARY_GERM_LAYER,1
GOBP_PROTEIN_K48_LINKED_DEUB...,SET,22,-0.016334,-0.00056478,0.15782,0.54121,GOBP_PROTEIN_K48_LINKED_DEUBIQUITINATION,1
GOCC_RECEPTOR_COMPLEX,SET,382,-0.0047782,-0.00068167,0.046169,0.54121,GOCC_RECEPTOR_COMPLEX,1
GOMF_MICROTUBULE_PLUS_END_BI...,SET,21,-0.017058,-0.00057626,0.16468,0.54125,GOMF_MICROTUBULE_PLUS_END_BINDING,1
GSE34217_MIR17_92_OVEREXPRES...1,SET,127,-0.00755,-0.00062543,0.07276,0.54132,GSE34217_MIR17_92_OVEREXPRESS_VS_WT_ACT_CD8_TCELL_DN,1
GSE15659_NAIVE_VS_PTPRC_NEG_...2,SET,156,-0.0068192,-0.00062559,0.065684,0.54134,GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_UP,1
HP_ROUND_EAR,SET,7,-0.03775,-0.00073658,0.36357,0.54135,HP_ROUND_EAR,1
GOBP_REGULATION_OF_CHONDROCY...2,SET,47,-0.014042,-0.00070917,0.13521,0.54136,GOBP_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
MUELLER_COMMON_TARGETS_OF_AM...1,SET,28,-0.017629,-0.00068757,0.16899,0.54154,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_DN,1
HOFT_CD4_POSITIVE_ALPHA_BETA...1,SET,43,-0.013382,-0.00064654,0.12816,0.54158,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,1
LANDIS_ERBB2_BREAST_PRENEOPL...1,SET,56,-0.012073,-0.0006654,0.11558,0.54159,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_DN,1
GOBP_DEPYRIMIDINATION,SET,8,-0.029762,-0.00062081,0.28418,0.5417,GOBP_DEPYRIMIDINATION,1
GOMF_MICROTUBULE_BINDING,SET,255,-0.005419,-0.00063386,0.051749,0.5417,GOMF_MICROTUBULE_BINDING,1
HOFFMAN_CLOCK_TARGETS_UP,SET,9,-0.035174,-0.00077817,0.33558,0.54174,HOFFMAN_CLOCK_TARGETS_UP,1
KEGG_ADIPOCYTOKINE_SIGNALING...,SET,63,-0.011324,-0.00066185,0.10793,0.54178,KEGG_ADIPOCYTOKINE_SIGNALING_PATHWAY,1
GOCC_X_CHROMOSOME,SET,6,-0.04003,-0.00072316,0.3814,0.54179,GOCC_X_CHROMOSOME,1
REACTOME_SUMOYLATION_OF_SUMO...,SET,33,-0.014508,-0.00061421,0.13815,0.54182,REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS,1
HP_FOCAL_MYOCLONIC_SEIZURE,SET,18,-0.020321,-0.00063564,0.19339,0.54184,HP_FOCAL_MYOCLONIC_SEIZURE,1
LEE_METASTASIS_AND_ALTERNATI...2,SET,65,-0.010995,-0.00065269,0.10455,0.54188,LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP,1
NAKAYA_MONOCYTE_FLUMIST_AGE_...2,SET,436,-0.0041769,-0.00063566,0.039697,0.5419,NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP,1
GOBP_REGULATION_OF_DOPAMINE_...2,SET,24,-0.020073,-0.00072491,0.19075,0.54191,GOBP_REGULATION_OF_DOPAMINE_SECRETION,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...9,SET,18,-0.021138,-0.00066118,0.20064,0.54195,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_RESPONDERS_VS_NONRESPONDERS_7DY_UP,1
WP_PI3KAKT_SIGNALING,SET,322,-0.0052947,-0.00069465,0.050186,0.54201,WP_PI3KAKT_SIGNALING,1
GNF2_TTK,SET,39,-0.013643,-0.00062779,0.12907,0.54209,GNF2_TTK,1
WP_MIR5093P_ALTERATION_OF_YA...,SET,17,-0.024795,-0.00075375,0.23415,0.54217,WP_MIR5093P_ALTERATION_OF_YAP1ECM_AXIS,1
HP_ERRATIC_MYOCLONUS,SET,4,-0.037672,-0.00055569,0.35572,0.54217,HP_ERRATIC_MYOCLONUS,1
GSE5542_IFNG_VS_IFNA_TREATED...3,SET,172,-0.0070172,-0.00067565,0.066247,0.54218,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_DN,1
KEGG_MEDICUS_REFERENCE_NAD_B...,SET,12,-0.027594,-0.00070485,0.26045,0.54219,KEGG_MEDICUS_REFERENCE_NAD_BIOSYNTHESIS,1
DYRK1A_TARGET_GENES,SET,600,-0.0036566,-0.00064982,0.03449,0.54222,DYRK1A_TARGET_GENES,1
GOBP_LIPID_HYDROXYLATION,SET,7,-0.035399,-0.00069071,0.3338,0.54223,GOBP_LIPID_HYDROXYLATION,1
MIR7156_5P,SET,126,-0.0080334,-0.00066287,0.075666,0.54228,MIR7156_5P,1
GNF2_CYP2B6,SET,49,-0.012828,-0.0006615,0.12073,0.54231,GNF2_CYP2B6,1
VERHAAK_GLIOBLASTOMA_NEURAL,SET,112,-0.0084328,-0.00065629,0.079329,0.54233,VERHAAK_GLIOBLASTOMA_NEURAL,1
WP_MITOCHONDRIAL_BETAOXIDATI...,SET,8,-0.032305,-0.00067385,0.30391,0.54233,WP_MITOCHONDRIAL_BETAOXIDATION,1
GSE360_CTRL_VS_B_MALAYI_LOW_...4,SET,181,-0.0065826,-0.00065002,0.061917,0.54233,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_UP,1
ZNF784_TARGET_GENES,SET,433,-0.0043,-0.00065219,0.040284,0.5425,ZNF784_TARGET_GENES,1
HP_ETHYLMALONIC_ACIDURIA,SET,9,-0.026718,-0.0005911,0.2499,0.54257,HP_ETHYLMALONIC_ACIDURIA,1
HP_POSTERIOR_HELIX_PIT,SET,4,-0.051224,-0.0007556,0.4788,0.5426,HP_POSTERIOR_HELIX_PIT,1
REACTOME_PD_1_SIGNALING,SET,18,-0.023623,-0.00073893,0.22072,0.54262,REACTOME_PD_1_SIGNALING,1
CAHOY_OLIGODENDROCUTIC,SET,88,-0.0097551,-0.0006734,0.091146,0.54262,CAHOY_OLIGODENDROCUTIC,1
MTOR_UP.V1_DN,SET,171,-0.0069522,-0.00066747,0.064955,0.54262,MTOR_UP.V1_DN,1
GOBP_NEGATIVE_REGULATION_OF_...4,SET,8,-0.029277,-0.00061068,0.27331,0.54265,GOBP_NEGATIVE_REGULATION_OF_ACTIN_NUCLEATION,1
HALLMARK_MYC_TARGETS_V2,SET,56,-0.011291,-0.00062228,0.10541,0.54265,HALLMARK_MYC_TARGETS_V2,1
HP_UPPER_LIMB_ASYMMETRY,SET,10,-0.031222,-0.00072808,0.29141,0.54266,HP_UPPER_LIMB_ASYMMETRY,1
NOJIMA_SFRP2_TARGETS_DN,SET,23,-0.021263,-0.0007517,0.19836,0.54268,NOJIMA_SFRP2_TARGETS_DN,1
CCATCCA_MIR432,SET,50,-0.012469,-0.00064948,0.11628,0.5427,CCATCCA_MIR432,1
GSE22886_NAIVE_BCELL_VS_NEUT...2,SET,171,-0.0070829,-0.00068001,0.06594,0.54277,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_UP,1
REACTOME_ALPHA_DEFENSINS,SET,6,-0.043592,-0.0007875,0.40573,0.54278,REACTOME_ALPHA_DEFENSINS,1
HP_ULNAR_DEVIATION_OF_THE_2N...,SET,7,-0.031396,-0.0006126,0.2922,0.54278,HP_ULNAR_DEVIATION_OF_THE_2ND_FINGER,1
HP_RENAL_MAGNESIUM_WASTING,SET,7,-0.034702,-0.00067712,0.32264,0.54283,HP_RENAL_MAGNESIUM_WASTING,1
BIOCARTA_PEPI_PATHWAY,SET,8,-0.034597,-0.00072165,0.32123,0.54288,BIOCARTA_PEPI_PATHWAY,1
GOBP_TRNA_METHYLATION,SET,36,-0.013445,-0.00059445,0.12482,0.54289,GOBP_TRNA_METHYLATION,1
HP_SUBCORTICAL_WHITE_MATTER_...,SET,3,-0.049244,-0.0006291,0.45614,0.54299,HP_SUBCORTICAL_WHITE_MATTER_CALCIFICATIONS,1
HP_ORAL_MUCOSAL_BLISTERS,SET,13,-0.025734,-0.00068418,0.23814,0.54303,HP_ORAL_MUCOSAL_BLISTERS,1
GSE46606_UNSTIM_VS_CD40L_IL2...9,SET,189,-0.0067746,-0.00068345,0.062665,0.54304,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,1
PAX8_TARGET_GENES,SET,65,-0.010615,-0.00063015,0.098166,0.54305,PAX8_TARGET_GENES,1
GOBP_CELLULAR_RESPONSE_TO_OS...,SET,52,-0.012621,-0.00067039,0.11662,0.54309,GOBP_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,1
GOMF_HISTONE_H3K27_METHYLTRA...,SET,5,-0.039728,-0.00065518,0.36706,0.54309,GOMF_HISTONE_H3K27_METHYLTRANSFERASE_ACTIVITY,1
GOBP_RESPONSE_TO_PROSTAGLAND...3,SET,23,-0.020841,-0.00073679,0.19243,0.54312,GOBP_RESPONSE_TO_PROSTAGLANDIN_E,1
GSE5455_HEALTHY_VS_TUMOR_BEA...4,SET,178,-0.0068695,-0.00067276,0.063415,0.54313,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_UP,1
GSE2770_UNTREATED_VS_IL4_TRE...6,SET,187,-0.0064165,-0.00064392,0.059186,0.54316,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_6H_UP,1
GOBP_MITOCHONDRIAL_RNA_PROCE...,SET,20,-0.018757,-0.00061843,0.17274,0.54323,GOBP_MITOCHONDRIAL_RNA_PROCESSING,1
GSE7219_UNSTIM_VS_LPS_AND_AN...2,SET,159,-0.0076659,-0.00070992,0.070587,0.54324,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_UP,1
REACTOME_RHOBTB_GTPASE_CYCLE,SET,34,-0.014208,-0.00061054,0.13049,0.54335,REACTOME_RHOBTB_GTPASE_CYCLE,1
GOBP_CARBOHYDRATE_METABOLIC_...,SET,516,-0.0040523,-0.0006694,0.037217,0.54335,GOBP_CARBOHYDRATE_METABOLIC_PROCESS,1
GOBP_DE_NOVO_PROTEIN_FOLDING,SET,39,-0.013851,-0.00063736,0.12715,0.54337,GOBP_DE_NOVO_PROTEIN_FOLDING,1
BOYAULT_LIVER_CANCER_SUBCLAS...2,SET,43,-0.01347,-0.0006508,0.12336,0.54347,BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP,1
MIKKELSEN_IPS_LCP_WITH_H3K4M...1,SET,157,-0.0074205,-0.0006829,0.067934,0.54349,MIKKELSEN_IPS_LCP_WITH_H3K4ME3,1
WP_GENES_ASSOCIATED_WITH_THE...,SET,17,-0.024651,-0.00074936,0.22559,0.54351,WP_GENES_ASSOCIATED_WITH_THE_DEVELOPMENT_OF_RHEUMATOID_ARTHRITIS,1
GOBP_BRANCHIOMOTOR_NEURON_AX...,SET,6,-0.039737,-0.00071785,0.36364,0.54351,GOBP_BRANCHIOMOTOR_NEURON_AXON_GUIDANCE,1
GOCC_LIPOPOLYSACCHARIDE_RECE...,SET,5,-0.047041,-0.00077578,0.43049,0.54351,GOCC_LIPOPOLYSACCHARIDE_RECEPTOR_COMPLEX,1
ZHONG_PFC_C2_ASCL1_POS_ASTRO...,SET,4,-0.054951,-0.00081059,0.50238,0.54355,ZHONG_PFC_C2_ASCL1_POS_ASTROCYTE,1
GOBP_DEHYDROASCORBIC_ACID_TR...,SET,7,-0.032449,-0.00063316,0.29658,0.54356,GOBP_DEHYDROASCORBIC_ACID_TRANSPORT,1
HP_AGENESIS_OF_MAXILLARY_INC...,SET,15,-0.024812,-0.00070855,0.22668,0.54358,HP_AGENESIS_OF_MAXILLARY_INCISOR,1
GSE38681_WT_VS_LYL1_KO_LYMPH...2,SET,179,-0.0066002,-0.00064818,0.060241,0.54362,GSE38681_WT_VS_LYL1_KO_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_UP,1
GSE23568_ID3_TRANSDUCED_VS_I...1,SET,182,-0.0069344,-0.00068663,0.063271,0.54364,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_DN,1
GOBP_L_AMINO_ACID_BIOSYNTHET...,SET,55,-0.012395,-0.00067703,0.11306,0.54365,GOBP_L_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_PURINE_NUCLEOSIDE_MONOP...2,SET,10,-0.031324,-0.00073046,0.28557,0.54367,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
TEF1_Q6,SET,209,-0.0067146,-0.00071195,0.061162,0.54371,TEF1_Q6,1
GSE2770_TGFB_AND_IL4_ACT_VS_...4,SET,184,-0.0067551,-0.00067251,0.061521,0.54372,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_UP,1
GOBP_REGULATION_OF_VIRAL_GEN...,SET,80,-0.010809,-0.00071157,0.098358,0.54375,GOBP_REGULATION_OF_VIRAL_GENOME_REPLICATION,1
GOCC_ASYMMETRIC_GLUTAMATERGI...,SET,13,-0.02745,-0.00072981,0.24968,0.54377,GOCC_ASYMMETRIC_GLUTAMATERGIC_EXCITATORY_SYNAPSE,1
GRADE_COLON_VS_RECTAL_CANCER...2,SET,34,-0.015783,-0.00067821,0.1435,0.54379,GRADE_COLON_VS_RECTAL_CANCER_UP,1
ZHANG_RESPONSE_TO_IKK_INHIBI...2,SET,215,-0.0067335,-0.00072401,0.061206,0.5438,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP,1
GOMF_MYOSIN_BINDING,SET,69,-0.011452,-0.0007004,0.10405,0.54382,GOMF_MYOSIN_BINDING,1
RICKMAN_TUMOR_DIFFERENTIATED...2,SET,111,-0.0087758,-0.00067994,0.079582,0.5439,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_UP,1
MIR4460,SET,78,-0.010436,-0.00067839,0.094465,0.54398,MIR4460,1
GAO_SMALL_INTESTINE_24W_C3_E...,SET,41,-0.013921,-0.00065679,0.12592,0.54401,GAO_SMALL_INTESTINE_24W_C3_ENTEROCYTE_PROGENITOR_SUBTYPE_1,1
MORF_RAB3A,SET,77,-0.01082,-0.00069888,0.097821,0.54404,MORF_RAB3A,1
REACTOME_N_GLYCAN_TRIMMING_A...,SET,5,-0.0519,-0.00085591,0.46875,0.54408,REACTOME_N_GLYCAN_TRIMMING_AND_ELONGATION_IN_THE_CIS_GOLGI,1
chr18q23,SET,15,-0.035876,-0.0010245,0.32368,0.54413,chr18q23,1
GSE40274_FOXP3_VS_FOXP3_AND_...7,SET,174,-0.0070546,-0.00068316,0.063514,0.54422,GSE40274_FOXP3_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
WANG_TARGETS_OF_MLL_CBP_FUSI...1,SET,38,-0.014741,-0.00066958,0.13256,0.54427,WANG_TARGETS_OF_MLL_CBP_FUSION_DN,1
GOBP_DNA_TEMPLATED_TRANSCRIP...2,SET,175,-0.0068109,-0.00066143,0.061233,0.54428,GOBP_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
HP_CEREBRAL_HAMARTOMA,SET,18,-0.018938,-0.00059239,0.17027,0.54428,HP_CEREBRAL_HAMARTOMA,1
GOBP_MYCOTOXIN_METABOLIC_PRO...,SET,7,-0.033809,-0.00065969,0.3038,0.54431,GOBP_MYCOTOXIN_METABOLIC_PROCESS,1
GOBP_CHONDROCYTE_DIFFERENTIA...1,SET,107,-0.0096605,-0.00073496,0.086718,0.54435,GOBP_CHONDROCYTE_DIFFERENTIATION,1
GOBP_MEMBRANE_RAFT_ASSEMBLY,SET,11,-0.027714,-0.00067781,0.2487,0.54436,GOBP_MEMBRANE_RAFT_ASSEMBLY,1
GOBP_IMMUNE_RESPONSE_INHIBIT...2,SET,10,-0.032912,-0.00076751,0.29519,0.54439,GOBP_IMMUNE_RESPONSE_INHIBITING_SIGNAL_TRANSDUCTION,1
GOBP_POSITIVE_REGULATION_OF_...200,SET,36,-0.015509,-0.00068572,0.13897,0.54443,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
MIR512_3P,SET,94,-0.0097163,-0.00069309,0.086936,0.54449,MIR512_3P,1
GOBP_OLIGODENDROCYTE_DIFFERE...,SET,104,-0.0098005,-0.00073514,0.087705,0.54449,GOBP_OLIGODENDROCYTE_DIFFERENTIATION,1
GSE22886_NEUTROPHIL_VS_MONOC...2,SET,169,-0.0074884,-0.00071477,0.06699,0.5445,GSE22886_NEUTROPHIL_VS_MONOCYTE_UP,1
GSE2770_UNTREATED_VS_IL12_TR...5,SET,178,-0.0069036,-0.0006761,0.061669,0.54457,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
GSE4748_LPS_VS_LPS_AND_CYANO...2,SET,170,-0.0072493,-0.00069398,0.064723,0.54459,GSE4748_LPS_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP,1
HAHTOLA_MYCOSIS_FUNGOIDES_CD...1,SET,101,-0.0090815,-0.00067137,0.081023,0.54462,HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN,1
HP_RENAL_SODIUM_WASTING,SET,7,-0.033987,-0.00066316,0.30207,0.54479,HP_RENAL_SODIUM_WASTING,1
GSE17721_PAM3CSK4_VS_CPG_1H_...2,SET,180,-0.0067776,-0.00066744,0.060209,0.54481,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_UP,1
GSE43957_UNTREATED_VS_NACL_T...1,SET,181,-0.0069839,-0.00068965,0.062004,0.54484,GSE43957_UNTREATED_VS_NACL_TREATED_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,1
GSE3982_MAC_VS_NEUTROPHIL_LP...2,SET,173,-0.007051,-0.00068087,0.062534,0.54489,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_UP,1
GOMF_BETA_TUBULIN_BINDING,SET,35,-0.015657,-0.00068261,0.13866,0.54495,GOMF_BETA_TUBULIN_BINDING,1
REACTOME_PROTEIN_HYDROXYLATI...,SET,17,-0.021604,-0.00065675,0.1913,0.54496,REACTOME_PROTEIN_HYDROXYLATION,1
NRF2_01,SET,250,-0.005524,-0.00063986,0.048866,0.545,NRF2_01,1
GOBP_REGULATION_OF_PROTEIN_L...3,SET,128,-0.0082717,-0.0006879,0.073122,0.54503,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
KEGG_MEDICUS_VARIANT_AMPLIFI...5,SET,14,-0.026355,-0.00072711,0.23276,0.54507,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,1
HP_ABNORMAL_JOINT_MORPHOLOGY,SET,1068,-0.002984,-0.00069811,0.026335,0.54511,HP_ABNORMAL_JOINT_MORPHOLOGY,1
GSE27859_CD11C_INT_F480_HI_M...1,SET,179,-0.0070946,-0.00069674,0.062561,0.54514,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_DN,1
HP_NARROW_PALATE,SET,164,-0.007241,-0.00068094,0.063843,0.54515,HP_NARROW_PALATE,1
GSE36078_UNTREATED_VS_AD5_T4...4,SET,179,-0.0071874,-0.00070585,0.063372,0.54515,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_MOUSE_LUNG_DC_UP,1
MIR6814_3P_MIR6872_5P,SET,7,-0.03529,-0.00068858,0.31092,0.54518,MIR6814_3P_MIR6872_5P,1
KEGG_MEDICUS_VARIANT_EML4_AL...1,SET,5,-0.056594,-0.00093333,0.49824,0.54522,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_JAK_STAT_SIGNALING_PATHWAY,1
ZHANG_ADIPOGENESIS_BY_BMP7,SET,14,-0.025742,-0.00071019,0.22646,0.54525,ZHANG_ADIPOGENESIS_BY_BMP7,1
GOBP_CELLULAR_ALDEHYDE_METAB...,SET,74,-0.011371,-0.00072008,0.099992,0.54527,GOBP_CELLULAR_ALDEHYDE_METABOLIC_PROCESS,1
MIR4501,SET,73,-0.010967,-0.00068979,0.096408,0.54528,MIR4501,1
GSE1112_HY_CD8AB_VS_HY_CD8AA...1,SET,163,-0.0077559,-0.00072716,0.068069,0.54536,GSE1112_HY_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
GOCC_NATA_COMPLEX,SET,4,-0.037521,-0.00055348,0.32878,0.54543,GOCC_NATA_COMPLEX,1
MIR499A_3P,SET,152,-0.0083833,-0.00075923,0.073311,0.54552,MIR499A_3P,1
MORF_UBE2I,SET,216,-0.0060253,-0.00064934,0.05268,0.54553,MORF_UBE2I,1
GOBP_PROTEIN_LOCALIZATION_TO...29,SET,9,-0.03419,-0.00075641,0.29874,0.54556,GOBP_PROTEIN_LOCALIZATION_TO_MEMBRANE_RAFT,1
HP_ABSENT_CIRCULATING_B_CELLS,SET,6,-0.043206,-0.00078052,0.37657,0.54567,HP_ABSENT_CIRCULATING_B_CELLS,1
HP_GAZE_EVOKED_NYSTAGMUS,SET,53,-0.012341,-0.00066174,0.10751,0.54569,HP_GAZE_EVOKED_NYSTAGMUS,1
RELA_DN.V1_UP,SET,136,-0.0084323,-0.00072267,0.073374,0.54575,RELA_DN.V1_UP,1
GOBP_REGULATION_OF_PROTEIN_T...3,SET,401,-0.0048879,-0.00071408,0.042515,0.54576,GOBP_REGULATION_OF_PROTEIN_TRANSPORT,1
GOMF_CYTOCHROME_B5_REDUCTASE...,SET,6,-0.035624,-0.00064355,0.30957,0.54581,GOMF_CYTOCHROME_B5_REDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H,1
MIR4671_5P,SET,7,-0.036507,-0.00071232,0.31701,0.54584,MIR4671_5P,1
GOBP_NOSE_DEVELOPMENT,SET,15,-0.026958,-0.00076983,0.2339,0.54588,GOBP_NOSE_DEVELOPMENT,1
DARWICHE_PAPILLOMA_RISK_LOW_...2,SET,148,-0.0081593,-0.00072923,0.070763,0.5459,DARWICHE_PAPILLOMA_RISK_LOW_UP,1
REACTOME_FLT3_SIGNALING_BY_C...,SET,6,-0.037577,-0.00067883,0.32563,0.54593,REACTOME_FLT3_SIGNALING_BY_CBL_MUTANTS,1
MIR6876_3P,SET,49,-0.014598,-0.00075277,0.12644,0.54596,MIR6876_3P,1
KIM_GASTRIC_CANCER_CHEMOSENS...,SET,86,-0.01049,-0.00071587,0.090839,0.54597,KIM_GASTRIC_CANCER_CHEMOSENSITIVITY,1
REACTOME_SIGNALING_BY_KIT_IN...,SET,20,-0.023492,-0.00077452,0.20343,0.54597,REACTOME_SIGNALING_BY_KIT_IN_DISEASE,1
SCHMIDT_POR_TARGETS_IN_LIMB_...2,SET,26,-0.017183,-0.00064584,0.14875,0.54598,SCHMIDT_POR_TARGETS_IN_LIMB_BUD_UP,1
GTGCCTT_MIR506,SET,664,-0.0038202,-0.00071289,0.03303,0.54604,GTGCCTT_MIR506,1
WP_DNA_REPAIR_PATHWAYS_FULL_...,SET,109,-0.0079083,-0.00060721,0.06836,0.54605,WP_DNA_REPAIR_PATHWAYS_FULL_NETWORK,1
GSE17974_CTRL_VS_ACT_IL4_AND...8,SET,167,-0.007753,-0.00073567,0.066999,0.54606,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_24H_CD4_TCELL_UP,1
MODULE_486,SET,85,-0.010178,-0.00069058,0.087939,0.54607,MODULE_486,1
GOBP_REGULATION_OF_MITOCHOND...8,SET,48,-0.013547,-0.00069141,0.11698,0.5461,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY,1
CTGAGCC_MIR24,SET,201,-0.0068435,-0.00071175,0.058988,0.54618,CTGAGCC_MIR24,1
GOBP_NEGATIVE_REGULATION_OF_...187,SET,107,-0.0090391,-0.00068768,0.077812,0.54624,GOBP_NEGATIVE_REGULATION_OF_DNA_METABOLIC_PROCESS,1
GOBP_POTASSIUM_ION_HOMEOSTAS...,SET,34,-0.017942,-0.00077101,0.15438,0.54626,GOBP_POTASSIUM_ION_HOMEOSTASIS,1
GSE28737_WT_VS_BCL6_KO_FOLLI...1,SET,183,-0.0072397,-0.0007188,0.062273,0.54627,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_DN,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...3,SET,5,-0.045463,-0.00074976,0.39072,0.54631,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_SIGNIFICANT_VARIATION_UP,1
HP_ANTERIOR_PITUITARY_HYPOPL...,SET,32,-0.017644,-0.0007356,0.15156,0.54634,HP_ANTERIOR_PITUITARY_HYPOPLASIA,1
GOCC_NUCLEAR_CHROMOSOME,SET,211,-0.0063658,-0.00067815,0.05465,0.54636,GOCC_NUCLEAR_CHROMOSOME,1
MIR499B_5P,SET,86,-0.010688,-0.00072941,0.091744,0.54637,MIR499B_5P,1
HP_PREMATURE_LOSS_OF_PERMANE...,SET,7,-0.03552,-0.00069306,0.3047,0.5464,HP_PREMATURE_LOSS_OF_PERMANENT_TEETH,1
GOBP_PROTEIN_LOCALIZATION_TO...5,SET,21,-0.023643,-0.00079874,0.20277,0.54641,GOBP_PROTEIN_LOCALIZATION_TO_CELL_CELL_JUNCTION,1
GSE8515_IL1_VS_IL6_4H_STIM_M...1,SET,172,-0.0075309,-0.00072511,0.064594,0.54641,GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN,1
WP_4HYDROXYTAMOXIFEN_DEXAMET...,SET,25,-0.021151,-0.00077955,0.18107,0.54649,WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION,1
IGLV5_37_TARGET_GENES,SET,473,-0.0047166,-0.00074685,0.04037,0.5465,IGLV5_37_TARGET_GENES,1
HP_CEREBRAL_HYPOMYELINATION,SET,25,-0.017534,-0.00064626,0.15,0.54653,HP_CEREBRAL_HYPOMYELINATION,1
MONNIER_POSTRADIATION_TUMOR_...2,SET,374,-0.0048048,-0.0006784,0.041095,0.54654,MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP,1
GOCC_NASCENT_POLYPEPTIDE_ASS...,SET,4,-0.044439,-0.00065553,0.38007,0.54654,GOCC_NASCENT_POLYPEPTIDE_ASSOCIATED_COMPLEX,1
chr14q12,SET,52,-0.027057,-0.0014372,0.23134,0.54655,chr14q12,1
GSE8621_LPS_STIM_VS_LPS_PRIM...1,SET,183,-0.0073266,-0.00072744,0.062646,0.54655,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,1
GOBP_MICROVILLUS_ASSEMBLY,SET,19,-0.024932,-0.00080123,0.2128,0.54663,GOBP_MICROVILLUS_ASSEMBLY,1
HP_ANGIOID_STREAKS_OF_THE_FU...,SET,10,-0.030114,-0.00070225,0.25705,0.54663,HP_ANGIOID_STREAKS_OF_THE_FUNDUS,1
GSE21670_TGFB_VS_TGFB_AND_IL...2,SET,181,-0.0074601,-0.00073667,0.063573,0.54671,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_CD4_TCELL_UP,1
ZHONG_SECRETOME_OF_LUNG_CANC...2,SET,122,-0.0087057,-0.00070693,0.074144,0.54673,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST,1
HP_ESOPHAGEAL_VARIX,SET,39,-0.017528,-0.00080657,0.14929,0.54673,HP_ESOPHAGEAL_VARIX,1
GOBP_REGULATION_OF_CELL_CYCL...3,SET,103,-0.009416,-0.00070292,0.080057,0.54681,GOBP_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
GOMF_CYTOKINE_ACTIVITY,SET,217,-0.0078548,-0.00084844,0.066765,0.54683,GOMF_CYTOKINE_ACTIVITY,1
HP_HANDGRIP_MYOTONIA,SET,6,-0.045212,-0.00081677,0.38368,0.5469,HP_HANDGRIP_MYOTONIA,1
KEGG_MEDICUS_REFERENCE_HEDGE...2,SET,6,-0.044205,-0.00079857,0.37509,0.54691,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_HH_LIGAND_SECRETION,1
HP_FOCAL_CORTICAL_DYSPLASIA_...,SET,5,-0.046218,-0.00076221,0.39189,0.54694,HP_FOCAL_CORTICAL_DYSPLASIA_TYPE_II,1
GOMF_L_ARGININE_TRANSMEMBRAN...,SET,11,-0.03463,-0.00084694,0.29322,0.54701,GOMF_L_ARGININE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_FIBRINOLY...,SET,18,-0.023837,-0.00074562,0.20176,0.54702,GOBP_REGULATION_OF_FIBRINOLYSIS,1
GOBP_LOBAR_BRONCHUS_EPITHELI...,SET,5,-0.050249,-0.0008287,0.4253,0.54703,GOBP_LOBAR_BRONCHUS_EPITHELIUM_DEVELOPMENT,1
GSE40666_UNTREATED_VS_IFNA_S...8,SET,188,-0.0074514,-0.00074976,0.063056,0.54703,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_UP,1
GOBP_PROTEIN_EXIT_FROM_ENDOP...,SET,45,-0.013276,-0.00065613,0.11223,0.54708,GOBP_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
GSE339_CD4POS_VS_CD4CD8DN_DC...3,SET,185,-0.0072917,-0.00072787,0.061643,0.54708,GSE339_CD4POS_VS_CD4CD8DN_DC_IN_CULTURE_UP,1
GSE22886_NAIVE_BCELL_VS_MONO...2,SET,161,-0.0081052,-0.00075528,0.068502,0.54709,GSE22886_NAIVE_BCELL_VS_MONOCYTE_UP,1
GOMF_PROTEIN_SERINE_KINASE_A...,SET,334,-0.0054283,-0.00072509,0.045824,0.54715,GOMF_PROTEIN_SERINE_KINASE_ACTIVITY,1
HARALAMBIEVA_PBMC_FLUARIX_AG...7,SET,1114,-0.0031799,-0.00075878,0.026821,0.54719,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE,1
WP_REGULATION_OF_WNT_BCATENI...,SET,16,-0.026572,-0.00078366,0.22403,0.54721,WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS,1
GOBP_ENDOTHELIAL_CELL_APOPTO...,SET,55,-0.014469,-0.00079032,0.12187,0.54725,GOBP_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,1
HP_ABNORMAL_FEMORAL_TORSION,SET,9,-0.030669,-0.0006785,0.25834,0.54725,HP_ABNORMAL_FEMORAL_TORSION,1
GAVISH_3CA_METAPROGRAM_EPITH...22,SET,50,-0.015465,-0.00080554,0.13004,0.54733,GAVISH_3CA_METAPROGRAM_EPITHELIAL_SECRETED,1
HP_APLASIA_HYPOPLASIA_OF_THE...40,SET,142,-0.0084635,-0.00074105,0.071169,0.54733,HP_APLASIA_HYPOPLASIA_OF_THE_LUNGS,1
REACTOME_SUMO_IS_PROTEOLYTIC...,SET,6,-0.034875,-0.00063003,0.29311,0.54735,REACTOME_SUMO_IS_PROTEOLYTICALLY_PROCESSED,1
HP_DECREASED_CERVICAL_SPINE_...1,SET,5,-0.046838,-0.00077244,0.39372,0.54735,HP_DECREASED_CERVICAL_SPINE_FLEXION_DUE_TO_CONTRACTURES_OF_POSTERIOR_CERVICAL_MUSCLES,1
HP_REDUCED_MUSCLE_FIBER_ALPH...,SET,8,-0.034073,-0.00071073,0.28599,0.54742,HP_REDUCED_MUSCLE_FIBER_ALPHA_DYSTROGLYCAN,1
KOHOUTEK_CCNT1_TARGETS,SET,47,-0.015377,-0.0007766,0.12899,0.54745,KOHOUTEK_CCNT1_TARGETS,1
GSE17721_CPG_VS_GARDIQUIMOD_...3,SET,181,-0.0072239,-0.00071335,0.060578,0.54746,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_DN,1
WP_OVERLAP_BETWEEN_SIGNAL_TR...,SET,51,-0.014467,-0.00076105,0.12131,0.54747,WP_OVERLAP_BETWEEN_SIGNAL_TRANSDUCTION_PATHWAYS_CONTRIBUTING_TO_LMNA_LAMINOPATHIES,1
HP_DISTAL_PERIPHERAL_SENSORY...,SET,6,-0.040536,-0.0007323,0.33989,0.54747,HP_DISTAL_PERIPHERAL_SENSORY_NEUROPATHY,1
GOBP_CENTRIOLE_ASSEMBLY,SET,45,-0.014386,-0.00071096,0.12047,0.54752,GOBP_CENTRIOLE_ASSEMBLY,1
REACTOME_PI3K_AKT_SIGNALING_...,SET,108,-0.010085,-0.00077082,0.084416,0.54755,REACTOME_PI3K_AKT_SIGNALING_IN_CANCER,1
HP_ANISOCORIA,SET,15,-0.026965,-0.00077004,0.22547,0.5476,HP_ANISOCORIA,1
HUMMERICH_SKIN_CANCER_PROGRE...1,SET,90,-0.010626,-0.00074179,0.088665,0.5477,HUMMERICH_SKIN_CANCER_PROGRESSION_DN,1
MIR127_5P,SET,80,-0.011877,-0.00078191,0.099105,0.5477,MIR127_5P,1
PPARG_01,SET,45,-0.014903,-0.00073654,0.12433,0.5477,PPARG_01,1
HP_ABNORMAL_TARSAL_OSSIFICAT...,SET,8,-0.034648,-0.00072272,0.28877,0.54775,HP_ABNORMAL_TARSAL_OSSIFICATION,1
HP_WEAKNESS_OF_LONG_FINGER_E...,SET,20,-0.020262,-0.00066804,0.16882,0.54777,HP_WEAKNESS_OF_LONG_FINGER_EXTENSOR_MUSCLES,1
GSE32986_UNSTIM_VS_GMCSF_STI...2,SET,166,-0.0076193,-0.00072084,0.063432,0.5478,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_UP,1
OUYANG_PROSTATE_CANCER_MARKE...,SET,20,-0.023476,-0.00077401,0.19543,0.54781,OUYANG_PROSTATE_CANCER_MARKERS,1
GOMF_MICROTUBULE_SEVERING_AT...,SET,9,-0.034471,-0.00076263,0.28685,0.54783,GOMF_MICROTUBULE_SEVERING_ATPASE_ACTIVITY,1
MASSARWEH_RESPONSE_TO_ESTRAD...,SET,59,-0.014218,-0.0008043,0.11824,0.54785,MASSARWEH_RESPONSE_TO_ESTRADIOL,1
GCNF_01,SET,67,-0.012889,-0.00077678,0.1072,0.54785,GCNF_01,1
GNF2_G22P1,SET,31,-0.016686,-0.0006847,0.13875,0.54786,GNF2_G22P1,1
KEGG_MEDICUS_PATHOGEN_HSV_GD...,SET,11,-0.029973,-0.00073306,0.2491,0.54789,KEGG_MEDICUS_PATHOGEN_HSV_GD_TO_HVEM_NFKB_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_IFN_R...,SET,28,-0.022472,-0.00087647,0.18675,0.54789,KEGG_MEDICUS_REFERENCE_IFN_RIPK1_3_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_EXOSOMAL_...,SET,18,-0.02277,-0.00071223,0.18917,0.5479,GOBP_REGULATION_OF_EXOSOMAL_SECRETION,1
GOBP_SPHINGOLIPID_BIOSYNTHET...,SET,107,-0.010369,-0.00078887,0.086099,0.54793,GOBP_SPHINGOLIPID_BIOSYNTHETIC_PROCESS,1
CEBP_Q3,SET,218,-0.0073035,-0.0007907,0.060634,0.54794,CEBP_Q3,1
GSE42724_MEMORY_BCELL_VS_PLA...2,SET,189,-0.0073956,-0.00074611,0.061394,0.54794,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_UP,1
HP_ABNORMAL_CIRCULATING_FOLL...,SET,77,-0.0114,-0.00073632,0.094606,0.54795,HP_ABNORMAL_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,1
CDC5L_TARGET_GENES,SET,225,-0.0067859,-0.00074621,0.056314,0.54796,CDC5L_TARGET_GENES,1
MODULE_104,SET,314,-0.0057532,-0.00074554,0.047705,0.54799,MODULE_104,1
GOCC_EXCITATORY_SYNAPSE,SET,57,-0.013919,-0.00077395,0.11532,0.54803,GOCC_EXCITATORY_SYNAPSE,1
GOBP_CARDIAC_MUSCLE_CELL_ACT...1,SET,77,-0.012668,-0.00081825,0.10488,0.54807,GOBP_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
WP_MICRORNA_NETWORK_ASSOCIAT...,SET,4,-0.056122,-0.00082785,0.46439,0.54809,WP_MICRORNA_NETWORK_ASSOCIATED_WITH_CHRONIC_LYMPHOCYTIC_LEUKEMIA,1
GSE6092_IFNG_VS_IFNG_AND_B_B...2,SET,166,-0.008135,-0.00076963,0.067288,0.54811,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,1
GOBP_REGULATION_OF_GERM_CELL...,SET,7,-0.033706,-0.00065768,0.27862,0.54814,GOBP_REGULATION_OF_GERM_CELL_PROLIFERATION,1
GOBP_HINDLIMB_MORPHOGENESIS,SET,34,-0.020031,-0.00086074,0.16556,0.54815,GOBP_HINDLIMB_MORPHOGENESIS,1
GSE5589_LPS_VS_LPS_AND_IL6_S...5,SET,173,-0.0075399,-0.00072808,0.062316,0.54815,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN,1
GOBP_LIPID_DIGESTION,SET,20,-0.025906,-0.0008541,0.21367,0.54825,GOBP_LIPID_DIGESTION,1
GAVISH_3CA_METAPROGRAM_ENDOT...3,SET,47,-0.016733,-0.00084512,0.13784,0.54831,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_1,1
GOBP_DNA_TEMPLATED_TRANSCRIP...1,SET,123,-0.0086724,-0.00070709,0.071403,0.54833,GOBP_DNA_TEMPLATED_TRANSCRIPTION_ELONGATION,1
DESCARTES_FETAL_HEART_ENDOCA...,SET,29,-0.020644,-0.00081939,0.16996,0.54834,DESCARTES_FETAL_HEART_ENDOCARDIAL_CELLS,1
GSE20727_ROS_INH_VS_ROS_INH_...1,SET,149,-0.0087736,-0.00078676,0.072209,0.54835,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_DN,1
MIR3142,SET,49,-0.014277,-0.00073618,0.11729,0.54844,MIR3142,1
GOCC_CYTOSKELETON_OF_PRESYNA...,SET,8,-0.039429,-0.00082243,0.32388,0.54845,GOCC_CYTOSKELETON_OF_PRESYNAPTIC_ACTIVE_ZONE,1
GSE6674_UNSTIM_VS_CPG_STIM_B...1,SET,145,-0.0083264,-0.00073665,0.068357,0.54847,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_DN,1
HP_DIFFUSE_WHITE_MATTER_ABNO...,SET,29,-0.018075,-0.00071741,0.14837,0.54848,HP_DIFFUSE_WHITE_MATTER_ABNORMALITIES,1
GOBP_POSITIVE_REGULATION_OF_...532,SET,145,-0.0086972,-0.00076946,0.07137,0.54849,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,1
GOMF_RECEPTOR_SIGNALING_PROT...,SET,3,-0.050524,-0.00064545,0.41455,0.5485,GOMF_RECEPTOR_SIGNALING_PROTEIN_TYROSINE_KINASE_ACTIVATOR_ACTIVITY,1
REACTOME_RUNX1_REGULATES_GEN...,SET,35,-0.017932,-0.0007818,0.14709,0.54852,REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION,1
GOBP_NEGATIVE_REGULATION_OF_...235,SET,5,-0.051289,-0.00084585,0.42065,0.54852,GOBP_NEGATIVE_REGULATION_OF_FAT_CELL_PROLIFERATION,1
OHM_METHYLATED_IN_ADULT_CANC...,SET,26,-0.020757,-0.00078016,0.17021,0.54853,OHM_METHYLATED_IN_ADULT_CANCERS,1
MODULE_126,SET,166,-0.0080673,-0.00076322,0.066131,0.54855,MODULE_126,1
GOBP_NEGATIVE_REGULATION_OF_...682,SET,5,-0.053413,-0.00088087,0.43782,0.54855,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_2_CELL_DIFFERENTIATION,1
GSE2405_0H_VS_3H_A_PHAGOCYTO...1,SET,163,-0.008558,-0.00080236,0.069975,0.54867,GSE2405_0H_VS_3H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
HP_DIFFUSE_CEREBRAL_ATROPHY,SET,45,-0.014976,-0.00074012,0.12227,0.54874,HP_DIFFUSE_CEREBRAL_ATROPHY,1
GSE22886_NAIVE_CD4_TCELL_VS_...1,SET,184,-0.0070174,-0.00069862,0.057226,0.5488,GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_DN,1
CAR_MYST2,SET,25,-0.019772,-0.00072872,0.16115,0.54882,CAR_MYST2,1
GOMF_OXIDOREDUCTASE_ACTIVITY...17,SET,10,-0.03345,-0.00078003,0.2726,0.54883,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_OTHER_NITROGENOUS_COMPOUNDS_AS_DONORS,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...2,SET,32,-0.020345,-0.00084819,0.16567,0.54887,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_7DY_DN,1
HP_ABNORMAL_CSF_METABOLITE_C...,SET,128,-0.0084617,-0.00070369,0.068867,0.54889,HP_ABNORMAL_CSF_METABOLITE_CONCENTRATION,1
MODULE_412,SET,13,-0.032109,-0.00085365,0.2609,0.54897,MODULE_412,1
TRAYNOR_RETT_SYNDROM_DN,SET,14,-0.029244,-0.00080682,0.23729,0.54904,TRAYNOR_RETT_SYNDROM_DN,1
GOBP_ESTABLISHMENT_OF_CELL_P...,SET,145,-0.0087118,-0.00077074,0.070695,0.54904,GOBP_ESTABLISHMENT_OF_CELL_POLARITY,1
HP_ABNORMAL_MIDDLE_EAR_MORPH...,SET,323,-0.0060362,-0.00079315,0.048983,0.54904,HP_ABNORMAL_MIDDLE_EAR_MORPHOLOGY,1
HOWLIN_PUBERTAL_MAMMARY_GLAND,SET,62,-0.014746,-0.00085499,0.11957,0.54907,HOWLIN_PUBERTAL_MAMMARY_GLAND,1
GOBP_REGULATION_OF_THE_FORCE...2,SET,5,-0.055889,-0.00092171,0.45285,0.54911,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION_BY_CHEMICAL_SIGNAL,1
KONDO_COLON_CANCER_HCP_WITH_...1,SET,22,-0.023304,-0.0008058,0.18872,0.54914,KONDO_COLON_CANCER_HCP_WITH_H3K27ME1,1
GOBP_REGULATION_OF_INTERLEUK...2,SET,4,-0.056179,-0.0008287,0.4548,0.54915,GOBP_REGULATION_OF_INTERLEUKIN_6_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_THE_TESTIS...,SET,177,-0.0076309,-0.00074524,0.061774,0.54915,HP_ABNORMALITY_OF_THE_TESTIS_SIZE,1
GSE20366_TREG_VS_NAIVE_CD4_T...4,SET,184,-0.0079628,-0.00079274,0.064453,0.54916,GSE20366_TREG_VS_NAIVE_CD4_TCELL_HOMEOSTATIC_CONVERSION_DN,1
GNF2_MLF1,SET,77,-0.012,-0.00077508,0.097028,0.54921,GNF2_MLF1,1
LEE_METASTASIS_AND_RNA_PROCE...,SET,16,-0.02311,-0.00068158,0.18678,0.54924,LEE_METASTASIS_AND_RNA_PROCESSING_UP,1
HP_VAGINAL_ATRESIA,SET,18,-0.027865,-0.00087159,0.22503,0.54927,HP_VAGINAL_ATRESIA,1
GSE33374_CD8_ALPHAALPHA_VS_A...1,SET,189,-0.0073917,-0.00074571,0.059689,0.54928,GSE33374_CD8_ALPHAALPHA_VS_ALPHABETA_CD161_HIGH_TCELL_DN,1
HP_CEREBRAL_INFARCT,SET,35,-0.01791,-0.00078084,0.14459,0.54929,HP_CEREBRAL_INFARCT,1
GOBP_SKELETAL_MUSCLE_TISSUE_...2,SET,36,-0.018438,-0.00081524,0.14881,0.5493,GOBP_SKELETAL_MUSCLE_TISSUE_REGENERATION,1
REACTOME_REGULATION_OF_IFNA_...,SET,22,-0.026311,-0.00090976,0.21231,0.54931,REACTOME_REGULATION_OF_IFNA_IFNB_SIGNALING,1
GOMF_POLYUBIQUITIN_MODIFICAT...,SET,45,-0.013944,-0.00068915,0.11239,0.54937,GOMF_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
WP_ESTRADIOL_REGULATION_IN_P...,SET,5,-0.048723,-0.00080353,0.39216,0.54944,WP_ESTRADIOL_REGULATION_IN_PORTOSINUSOIDAL_VASCULAR_DISEASE,1
GOCC_U6_SNRNP,SET,8,-0.032879,-0.00068581,0.26461,0.54944,GOCC_U6_SNRNP,1
GOBP_TRACHEA_DEVELOPMENT,SET,18,-0.027403,-0.00085715,0.22049,0.54945,GOBP_TRACHEA_DEVELOPMENT,1
GOBP_BONE_GROWTH,SET,31,-0.01948,-0.00079935,0.1567,0.54947,GOBP_BONE_GROWTH,1
RHEIN_ALL_GLUCOCORTICOID_THE...1,SET,324,-0.0057729,-0.0007597,0.046427,0.54948,RHEIN_ALL_GLUCOCORTICOID_THERAPY_DN,1
XU_HGF_TARGETS_REPRESSED_BY_...2,SET,9,-0.036138,-0.00079949,0.29063,0.54948,XU_HGF_TARGETS_REPRESSED_BY_AKT1_UP,1
HP_HYPOPLASIA_OF_THE_UTERUS,SET,47,-0.015905,-0.00080327,0.12788,0.54949,HP_HYPOPLASIA_OF_THE_UTERUS,1
GLINSKY_CANCER_DEATH_UP,SET,5,-0.040252,-0.00066383,0.32354,0.5495,GLINSKY_CANCER_DEATH_UP,1
WP_GLYCEROLIPIDS_AND_GLYCERO...,SET,21,-0.022579,-0.00076279,0.18136,0.54954,WP_GLYCEROLIPIDS_AND_GLYCEROPHOSPHOLIPIDS,1
REACTOME_ADIPOGENESIS,SET,104,-0.0098694,-0.00074031,0.079192,0.54959,REACTOME_ADIPOGENESIS,1
ZNF350_TARGET_GENES,SET,1153,-0.0031929,-0.00077424,0.025618,0.54959,ZNF350_TARGET_GENES,1
GOBP_REGULATION_OF_FAT_CELL_...1,SET,121,-0.01027,-0.00083055,0.082327,0.54964,GOBP_REGULATION_OF_FAT_CELL_DIFFERENTIATION,1
GOBP_MODULATION_BY_HOST_OF_V...1,SET,21,-0.022065,-0.00074542,0.1765,0.54974,GOBP_MODULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
HP_CONGENITAL_HEPATIC_FIBROS...,SET,42,-0.015364,-0.00073361,0.12288,0.54975,HP_CONGENITAL_HEPATIC_FIBROSIS,1
DAZARD_UV_RESPONSE_CLUSTER_G1,SET,53,-0.014349,-0.00076943,0.11469,0.54978,DAZARD_UV_RESPONSE_CLUSTER_G1,1
WP_FRAGILE_X_SYNDROME,SET,117,-0.0095164,-0.00075686,0.076046,0.54979,WP_FRAGILE_X_SYNDROME,1
GOCC_TRANSFERASE_COMPLEX_TRA...,SET,263,-0.0061101,-0.00072566,0.048825,0.54979,GOCC_TRANSFERASE_COMPLEX_TRANSFERRING_PHOSPHORUS_CONTAINING_GROUPS,1
GOBP_REGULATION_OF_CYTOKINET...,SET,7,-0.039196,-0.0007648,0.31304,0.54982,GOBP_REGULATION_OF_CYTOKINETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...303,SET,17,-0.024782,-0.00075335,0.19785,0.54984,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_12_PRODUCTION,1
BROWNE_HCMV_INFECTION_16HR_UP,SET,199,-0.0072279,-0.00074803,0.05768,0.54986,BROWNE_HCMV_INFECTION_16HR_UP,1
GOCC_SYNAPSE,SET,1367,-0.0030284,-0.00079462,0.024161,0.54987,GOCC_SYNAPSE,1
HP_PULMONARY_FIBROSIS,SET,68,-0.012855,-0.00078048,0.10247,0.54992,HP_PULMONARY_FIBROSIS,1
GOBP_REGULATION_OF_ENDOCRINE...,SET,39,-0.018829,-0.00086646,0.14994,0.54997,GOBP_REGULATION_OF_ENDOCRINE_PROCESS,1
TGAGATT_MIR216,SET,101,-0.010752,-0.00079483,0.085586,0.54998,TGAGATT_MIR216,1
GSE37301_PRO_BCELL_VS_RAG2_K...2,SET,164,-0.0083111,-0.00078158,0.066166,0.54998,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_UP,1
ZNF777_TARGET_GENES,SET,53,-0.014897,-0.00079881,0.11848,0.55003,ZNF777_TARGET_GENES,1
MIR4703_3P,SET,37,-0.01697,-0.00076065,0.13488,0.55006,MIR4703_3P,1
GOBP_REGULATION_OF_GLUTAMATE...1,SET,6,-0.046679,-0.00084327,0.37074,0.5501,GOBP_REGULATION_OF_GLUTAMATE_RECEPTOR_CLUSTERING,1
GSE35825_UNTREATED_VS_IFNA_S...1,SET,159,-0.0086756,-0.00080344,0.068871,0.55012,GSE35825_UNTREATED_VS_IFNA_STIM_MACROPHAGE_DN,1
GOMF_CYTIDINE_DEAMINASE_ACTI...,SET,10,-0.047124,-0.0010989,0.37389,0.55015,GOMF_CYTIDINE_DEAMINASE_ACTIVITY,1
GOMF_RNA_POLYMERASE_III_GENE...,SET,12,-0.024033,-0.0006139,0.19063,0.55016,GOMF_RNA_POLYMERASE_III_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
VERRECCHIA_RESPONSE_TO_TGFB1...3,SET,14,-0.029008,-0.00080031,0.22991,0.5502,VERRECCHIA_RESPONSE_TO_TGFB1_C3,1
GOBP_REGULATION_OF_NEUROTRAN...3,SET,72,-0.012556,-0.00078431,0.099423,0.55025,GOBP_REGULATION_OF_NEUROTRANSMITTER_SECRETION,1
GSE29949_CD8_NEG_DC_SPLEEN_V...5,SET,176,-0.0080205,-0.0007811,0.063348,0.55037,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_DN,1
GOBP_TENDON_DEVELOPMENT,SET,5,-0.056008,-0.00092366,0.44223,0.55039,GOBP_TENDON_DEVELOPMENT,1
RASHI_RESPONSE_TO_IONIZING_R...2,SET,117,-0.010186,-0.00081012,0.080371,0.55042,RASHI_RESPONSE_TO_IONIZING_RADIATION_2,1
GSE17721_0.5H_VS_8H_GARDIQUI...1,SET,184,-0.0078186,-0.00077838,0.061697,0.55042,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN,1
KRIEG_KDM3A_TARGETS_NOT_HYPO...,SET,176,-0.007706,-0.00075047,0.060769,0.55045,KRIEG_KDM3A_TARGETS_NOT_HYPOXIA,1
HP_BASAL_GANGLIA_CALCIFICATI...,SET,36,-0.018905,-0.00083586,0.1491,0.55045,HP_BASAL_GANGLIA_CALCIFICATION,1
BIOCARTA_BAD_PATHWAY,SET,24,-0.024059,-0.00086882,0.18968,0.55047,BIOCARTA_BAD_PATHWAY,1
MIR3611,SET,135,-0.0091719,-0.00078319,0.07231,0.55047,MIR3611,1
GSE22886_CTRL_VS_LPS_24H_DC_...1,SET,176,-0.0082696,-0.00080536,0.065179,0.55048,GSE22886_CTRL_VS_LPS_24H_DC_DN,1
GOMF_OXYSTEROL_BINDING,SET,16,-0.029999,-0.00088474,0.23602,0.55057,GOMF_OXYSTEROL_BINDING,1
HP_DUODENAL_ULCER,SET,12,-0.030947,-0.00079051,0.24329,0.55061,HP_DUODENAL_ULCER,1
GOMF_IGE_BINDING,SET,5,-0.044295,-0.0007305,0.34803,0.55064,GOMF_IGE_BINDING,1
HP_ABNORMAL_DIAPHYSIS_MORPHO...,SET,296,-0.0062365,-0.00078506,0.049002,0.55064,HP_ABNORMAL_DIAPHYSIS_MORPHOLOGY,1
MIR1226_3P,SET,99,-0.01068,-0.00078176,0.0839,0.55065,MIR1226_3P,1
GOBP_INTERNEURON_MIGRATION,SET,13,-0.035406,-0.0009413,0.27809,0.55065,GOBP_INTERNEURON_MIGRATION,1
NIKOLSKY_BREAST_CANCER_1Q32_...,SET,13,-0.043959,-0.0011687,0.34493,0.5507,NIKOLSKY_BREAST_CANCER_1Q32_AMPLICON,1
AZARE_NEOPLASTIC_TRANSFORMAT...1,SET,17,-0.0281,-0.00085421,0.22042,0.55072,AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN,1
HP_ARTERIOSCLEROSIS,SET,86,-0.012288,-0.0008386,0.096394,0.55072,HP_ARTERIOSCLEROSIS,1
REACTOME_RNA_POLYMERASE_II_T...2,SET,1235,-0.0032039,-0.00080214,0.025122,0.55074,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION,1
HP_DECREASED_CIRCULATING_IRO...,SET,5,-0.040699,-0.00067119,0.31905,0.55075,HP_DECREASED_CIRCULATING_IRON_CONCENTRATION,1
HP_RETINAL_PIGMENT_EPITHELIA...1,SET,36,-0.017716,-0.00078331,0.13887,0.55075,HP_RETINAL_PIGMENT_EPITHELIAL_ATROPHY,1
GOBP_CELLULAR_RESPONSE_TO_IN...1,SET,10,-0.029637,-0.00069112,0.23215,0.55079,GOBP_CELLULAR_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,1
GOBP_NEGATIVE_REGULATION_OF_...487,SET,53,-0.014318,-0.00076776,0.11212,0.5508,GOBP_NEGATIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
HP_ORTHOSTATIC_HYPOTENSION,SET,38,-0.018514,-0.00084096,0.14489,0.55084,HP_ORTHOSTATIC_HYPOTENSION,1
GSE24634_NAIVE_CD4_TCELL_VS_...4,SET,172,-0.00799,-0.00076932,0.062503,0.55086,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_UP,1
HP_PROGRESSIVE_SPASTICITY,SET,26,-0.020848,-0.00078359,0.16304,0.55087,HP_PROGRESSIVE_SPASTICITY,1
REACTOME_NUCLEAR_ENVELOPE_BR...,SET,50,-0.014263,-0.00074291,0.1115,0.55089,REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN,1
MEISSNER_ES_ICP_WITH_H3K4ME3,SET,29,-0.018978,-0.00075325,0.14832,0.5509,MEISSNER_ES_ICP_WITH_H3K4ME3,1
THAKAR_PBMC_INACTIVATED_INFL...2,SET,158,-0.0086906,-0.00080231,0.067932,0.5509,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_UP,1
GOBP_MYOTUBE_CELL_DEVELOPMENT,SET,37,-0.018205,-0.00081602,0.14221,0.55093,GOBP_MYOTUBE_CELL_DEVELOPMENT,1
GOCC_TRICARBOXYLIC_ACID_CYCL...,SET,18,-0.022093,-0.00069105,0.17255,0.55094,GOCC_TRICARBOXYLIC_ACID_CYCLE_HETEROMERIC_ENZYME_COMPLEX,1
REACTOME_POLO_LIKE_KINASE_ME...,SET,16,-0.023085,-0.00068082,0.18026,0.55095,REACTOME_POLO_LIKE_KINASE_MEDIATED_EVENTS,1
HP_MULTIPLE_SUTURE_CRANIOSYN...,SET,11,-0.035472,-0.00086754,0.277,0.55095,HP_MULTIPLE_SUTURE_CRANIOSYNOSTOSIS,1
GSE5542_UNTREATED_VS_IFNG_TR...4,SET,171,-0.0083726,-0.00080383,0.065349,0.55097,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
MIR3194_3P,SET,90,-0.011194,-0.00078143,0.087363,0.55098,MIR3194_3P,1
MIR323B_5P,SET,38,-0.016969,-0.00077078,0.13241,0.55098,MIR323B_5P,1
SCHAEFFER_PROSTATE_DEVELOPME...3,SET,375,-0.0061273,-0.00086627,0.047798,0.551,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN,1
GSE27786_CD4_TCELL_VS_ERYTHT...2,SET,182,-0.0074236,-0.00073507,0.057899,0.55101,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_UP,1
ZHANG_GATA6_TARGETS_UP,SET,12,-0.033253,-0.00084942,0.25917,0.55105,ZHANG_GATA6_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...567,SET,11,-0.033883,-0.00082867,0.26388,0.55108,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,1
HP_THORACIC_HYPOPLASIA,SET,130,-0.009668,-0.00081023,0.075305,0.55108,HP_THORACIC_HYPOPLASIA,1
HP_LONG_FOOT,SET,22,-0.021061,-0.00072823,0.16396,0.5511,HP_LONG_FOOT,1
GOBP_REGULATION_OF_CALCIUM_I...7,SET,57,-0.014915,-0.00082935,0.11611,0.55111,GOBP_REGULATION_OF_CALCIUM_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_SYNTHESIS_OF_IP3_AN...,SET,25,-0.020099,-0.00074077,0.15636,0.55114,REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL,1
MIR224_3P,SET,160,-0.0086024,-0.00079914,0.066856,0.55119,MIR224_3P,1
WP_S1P_RECEPTOR_SIGNAL_TRANS...,SET,25,-0.021619,-0.00079682,0.16792,0.55122,WP_S1P_RECEPTOR_SIGNAL_TRANSDUCTION,1
REACTOME_PROCESSING_OF_CAPPE...1,SET,28,-0.017761,-0.00069272,0.13788,0.55125,REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA,1
GSE30971_CTRL_VS_LPS_STIM_MA...2,SET,167,-0.0093132,-0.00088372,0.07229,0.55125,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_UP,1
REACTOME_RSV_HOST_INTERACTIO...,SET,84,-0.011958,-0.00080658,0.092811,0.55126,REACTOME_RSV_HOST_INTERACTIONS,1
GOBP_CELL_CHEMOTAXIS,SET,290,-0.0069337,-0.00086407,0.053809,0.55126,GOBP_CELL_CHEMOTAXIS,1
NKX6_1_TARGET_GENES,SET,23,-0.022466,-0.00079423,0.17429,0.55128,NKX6_1_TARGET_GENES,1
UNTERMAN_IPF_VS_CTRL_DC_UP,SET,4,-0.076246,-0.0011247,0.59132,0.5513,UNTERMAN_IPF_VS_CTRL_DC_UP,1
MORI_SMALL_PRE_BII_LYMPHOCYT...2,SET,73,-0.013115,-0.00082491,0.1016,0.55136,MORI_SMALL_PRE_BII_LYMPHOCYTE_UP,1
MIR545_3P,SET,349,-0.0061143,-0.00083452,0.047362,0.55136,MIR545_3P,1
HP_SHAWL_SCROTUM,SET,18,-0.025786,-0.00080658,0.19957,0.5514,HP_SHAWL_SCROTUM,1
DOANE_RESPONSE_TO_ANDROGEN_UP,SET,163,-0.0084687,-0.00079399,0.065518,0.55142,DOANE_RESPONSE_TO_ANDROGEN_UP,1
GSE11057_PBMC_VS_MEM_CD4_TCE...2,SET,178,-0.0086671,-0.0008488,0.066984,0.55147,GSE11057_PBMC_VS_MEM_CD4_TCELL_UP,1
GOBP_HEART_MORPHOGENESIS,SET,251,-0.0073837,-0.00085697,0.057055,0.55148,GOBP_HEART_MORPHOGENESIS,1
MIR6734_5P,SET,64,-0.013121,-0.00077293,0.10137,0.55149,MIR6734_5P,1
HP_GLIOBLASTOMA_MULTIFORME,SET,26,-0.019506,-0.00073314,0.1507,0.55149,HP_GLIOBLASTOMA_MULTIFORME,1
SMIRNOV_CIRCULATING_ENDOTHEL...1,SET,5,-0.049736,-0.00082022,0.3842,0.5515,SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_DN,1
MIR4482_5P,SET,32,-0.019237,-0.00080201,0.14854,0.55152,MIR4482_5P,1
HP_HYPERGRANULOSIS,SET,20,-0.023899,-0.00078795,0.18452,0.55153,HP_HYPERGRANULOSIS,1
GSE11057_NAIVE_VS_EFF_MEMORY...2,SET,165,-0.0085713,-0.00080849,0.066028,0.55164,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP,1
MIR4718,SET,97,-0.012312,-0.0008921,0.094803,0.55167,MIR4718,1
GOBP_RESPONSE_TO_ORGANIC_CYC...,SET,826,-0.0040045,-0.00082966,0.030813,0.5517,GOBP_RESPONSE_TO_ORGANIC_CYCLIC_COMPOUND,1
TRAVAGLINI_LUNG_PROXIMAL_CIL...,SET,1477,-0.0028881,-0.00078515,0.022198,0.55176,TRAVAGLINI_LUNG_PROXIMAL_CILIATED_CELL,1
WP_RESOLVIN_E1_AND_RESOLVIN_...,SET,11,-0.034868,-0.00085278,0.26786,0.55179,WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION,1
HP_ABNORMAL_METACARPOPHALANG...,SET,19,-0.027521,-0.00088442,0.21141,0.55179,HP_ABNORMAL_METACARPOPHALANGEAL_JOINT_MORPHOLOGY,1
GAGCTGG_MIR337,SET,144,-0.0088963,-0.00078437,0.068276,0.55183,GAGCTGG_MIR337,1
MIKKELSEN_ES_LCP_WITH_H3K4ME3,SET,132,-0.0096545,-0.00081525,0.074061,0.55186,MIKKELSEN_ES_LCP_WITH_H3K4ME3,1
HP_EDEMA_OF_THE_DORSUM_OF_HA...,SET,14,-0.028993,-0.00079989,0.22238,0.55187,HP_EDEMA_OF_THE_DORSUM_OF_HANDS,1
GOBP_CELLULAR_RESPONSE_TO_PE...3,SET,5,-0.048474,-0.00079942,0.37111,0.55196,GOBP_CELLULAR_RESPONSE_TO_PEPTIDOGLYCAN,1
HP_SEPTIC_ARTHRITIS,SET,7,-0.037728,-0.00073615,0.28882,0.55196,HP_SEPTIC_ARTHRITIS,1
HUMMEL_BURKITTS_LYMPHOMA_UP,SET,38,-0.018469,-0.00083891,0.14136,0.55197,HUMMEL_BURKITTS_LYMPHOMA_UP,1
GOMF_TRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.035053,-0.00073116,0.26831,0.55197,GOMF_TRNA_PSEUDOURIDINE_SYNTHASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...306,SET,33,-0.020954,-0.00088712,0.16031,0.552,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_IMPORT,1
ISHIKAWA_STING_SIGNALING,SET,10,-0.032549,-0.00075902,0.24895,0.55201,ISHIKAWA_STING_SIGNALING,1
KANNAN_TP53_TARGETS_DN,SET,21,-0.02612,-0.00088242,0.19977,0.55201,KANNAN_TP53_TARGETS_DN,1
HP_SUBVALVULAR_AORTIC_STENOS...,SET,21,-0.024764,-0.00083662,0.18943,0.55201,HP_SUBVALVULAR_AORTIC_STENOSIS,1
HP_OXYCEPHALY,SET,7,-0.040938,-0.00079879,0.31308,0.55202,HP_OXYCEPHALY,1
PID_AR_TF_PATHWAY,SET,49,-0.015621,-0.00080548,0.11931,0.55208,PID_AR_TF_PATHWAY,1
GSE34006_WT_VS_A2AR_KO_TREG_...2,SET,183,-0.008394,-0.00083341,0.064099,0.55209,GSE34006_WT_VS_A2AR_KO_TREG_UP,1
GUTIERREZ_WALDENSTROEMS_MACR...3,SET,10,-0.038034,-0.00088693,0.29019,0.55214,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_2,1
HP_VASCULITIS_IN_THE_SKIN,SET,7,-0.038105,-0.00074351,0.29047,0.55219,HP_VASCULITIS_IN_THE_SKIN,1
GSE369_PRE_VS_POST_IL6_INJEC...1,SET,177,-0.0082204,-0.00080282,0.062619,0.55222,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_DN,1
GOMF_RNA_POLYMERASE_II_CORE_...,SET,15,-0.028832,-0.00082333,0.21927,0.55231,GOMF_RNA_POLYMERASE_II_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,1
GAUSSMANN_MLL_AF4_FUSION_TAR...11,SET,31,-0.021944,-0.00090045,0.16681,0.55233,GAUSSMANN_MLL_AF4_FUSION_TARGETS_F_DN,1
GOMF_HISTONE_H3K36_METHYLTRA...,SET,11,-0.030474,-0.00074531,0.23155,0.55235,GOMF_HISTONE_H3K36_METHYLTRANSFERASE_ACTIVITY,1
GOMF_PEROXISOME_PROLIFERATOR...,SET,10,-0.04224,-0.00098501,0.32095,0.55235,GOMF_PEROXISOME_PROLIFERATOR_ACTIVATED_RECEPTOR_BINDING,1
HP_OPTIC_NERVE_COMPRESSION,SET,14,-0.030531,-0.00084232,0.23199,0.55235,HP_OPTIC_NERVE_COMPRESSION,1
GSE21546_SAP1A_KO_VS_SAP1A_K...4,SET,175,-0.0080754,-0.00078423,0.061354,0.55236,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
WP_AXON_GUIDANCE,SET,69,-0.014378,-0.0008793,0.10916,0.55239,WP_AXON_GUIDANCE,1
GOBP_3_UTR_MEDIATED_MRNA_STA...,SET,19,-0.02565,-0.0008243,0.19429,0.55252,GOBP_3_UTR_MEDIATED_MRNA_STABILIZATION,1
GOMF_PHOSPHATIDIC_ACID_BINDI...,SET,23,-0.024265,-0.00085785,0.18357,0.55258,GOMF_PHOSPHATIDIC_ACID_BINDING,1
GOBP_REGULATION_OF_LOW_DENSI...,SET,15,-0.028889,-0.00082497,0.21822,0.55266,GOBP_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
SIMBULAN_UV_RESPONSE_NORMAL_...1,SET,33,-0.020712,-0.00087687,0.15642,0.55267,SIMBULAN_UV_RESPONSE_NORMAL_DN,1
GOBP_PEPTIDYL_LYSINE_OXIDATI...,SET,5,-0.056535,-0.00093235,0.42672,0.5527,GOBP_PEPTIDYL_LYSINE_OXIDATION,1
GOMF_PROTEIN_LYSINE_6_OXIDAS...,SET,5,-0.056535,-0.00093235,0.42672,0.5527,GOMF_PROTEIN_LYSINE_6_OXIDASE_ACTIVITY,1
GSE20715_WT_VS_TLR4_KO_LUNG_...1,SET,177,-0.0082199,-0.00080277,0.062031,0.55271,GSE20715_WT_VS_TLR4_KO_LUNG_DN,1
HP_FATIGABLE_WEAKNESS_OF_BUL...,SET,52,-0.015034,-0.00079852,0.11333,0.55276,HP_FATIGABLE_WEAKNESS_OF_BULBAR_MUSCLES,1
AIZARANI_LIVER_C29_MVECS_2,SET,287,-0.0071716,-0.00088915,0.054056,0.55277,AIZARANI_LIVER_C29_MVECS_2,1
MIR3154,SET,107,-0.010523,-0.00080057,0.079308,0.55278,MIR3154,1
FUJII_YBX1_TARGETS_UP,SET,36,-0.018847,-0.0008333,0.142,0.55279,FUJII_YBX1_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...597,SET,10,-0.035861,-0.00083626,0.26991,0.55285,GOBP_POSITIVE_REGULATION_OF_PODOSOME_ASSEMBLY,1
GOCC_ENDOPLASMIC_RETICULUM_T...1,SET,24,-0.021221,-0.00076635,0.15963,0.55288,GOCC_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK,1
HP_ABNORMAL_MAXILLA_MORPHOLO...,SET,133,-0.0096861,-0.00082099,0.072839,0.55289,HP_ABNORMAL_MAXILLA_MORPHOLOGY,1
GOBP_PIECEMEAL_MICROAUTOPHAG...,SET,17,-0.026542,-0.00080684,0.19946,0.55293,GOBP_PIECEMEAL_MICROAUTOPHAGY_OF_THE_NUCLEUS,1
ZFP3_TARGET_GENES,SET,287,-0.0067172,-0.00083281,0.050458,0.55295,ZFP3_TARGET_GENES,1
ELK1_01,SET,253,-0.0069461,-0.00080934,0.052167,0.55296,ELK1_01,1
HP_RADIOULNAR_SYNOSTOSIS,SET,68,-0.013811,-0.00083852,0.10363,0.55301,HP_RADIOULNAR_SYNOSTOSIS,1
MODULE_525,SET,58,-0.01438,-0.00080655,0.10784,0.55304,MODULE_525,1
BYSTROEM_CORRELATED_WITH_IL5...2,SET,38,-0.017356,-0.00078835,0.13011,0.55306,BYSTROEM_CORRELATED_WITH_IL5_UP,1
MIR6736_5P,SET,42,-0.016128,-0.00077008,0.12081,0.5531,MIR6736_5P,1
GSE29949_CD8_POS_DC_SPLEEN_V...1,SET,173,-0.0086259,-0.00083294,0.064611,0.5531,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_DN,1
GOBP_REGULATION_OF_LYMPHOCYT...1,SET,468,-0.0055264,-0.00087056,0.04138,0.55312,GOBP_REGULATION_OF_LYMPHOCYTE_ACTIVATION,1
MIR3117_3P,SET,30,-0.020908,-0.00084401,0.15648,0.55314,MIR3117_3P,1
GOMF_RNA_POLYMERASE_I_ACTIVI...,SET,9,-0.030572,-0.00067637,0.22885,0.55314,GOMF_RNA_POLYMERASE_I_ACTIVITY,1
MIR501_5P,SET,126,-0.010255,-0.00084619,0.076749,0.55315,MIR501_5P,1
BIOCARTA_TOLL_PATHWAY,SET,22,-0.025381,-0.00087762,0.18981,0.55319,BIOCARTA_TOLL_PATHWAY,1
HP_OCCIPITAL_MENINGOCELE,SET,7,-0.045106,-0.00088011,0.33724,0.5532,HP_OCCIPITAL_MENINGOCELE,1
GOBP_FOCAL_ADHESION_ASSEMBLY,SET,82,-0.01207,-0.00080444,0.090211,0.55322,GOBP_FOCAL_ADHESION_ASSEMBLY,1
STAT5A_03,SET,233,-0.0076907,-0.00086042,0.057463,0.55323,STAT5A_03,1
GOBP_POSITIVE_REGULATION_OF_...84,SET,193,-0.008244,-0.00084036,0.061573,0.55325,GOBP_POSITIVE_REGULATION_OF_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
GOBP_CANONICAL_NF_KAPPAB_SIG...,SET,281,-0.0067998,-0.00083434,0.050772,0.55327,GOBP_CANONICAL_NF_KAPPAB_SIGNAL_TRANSDUCTION,1
SCHAEFFER_PROSTATE_DEVELOPME...17,SET,7,-0.050782,-0.00099087,0.37907,0.55328,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_UP,1
HOELZEL_NF1_TARGETS_DN,SET,99,-0.012962,-0.00094878,0.096694,0.55332,HOELZEL_NF1_TARGETS_DN,1
GSE23321_CD8_STEM_CELL_MEMOR...2,SET,174,-0.0088574,-0.00085774,0.066064,0.55333,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_UP,1
GSE1432_CTRL_VS_IFNG_6H_MICR...2,SET,183,-0.00813,-0.0008072,0.060585,0.55337,GSE1432_CTRL_VS_IFNG_6H_MICROGLIA_UP,1
HOEK_PBMC_INACTIVATED_INFLUE...5,SET,16,-0.028508,-0.00084077,0.21239,0.55339,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_7DY_DN,1
GOBP_REGULATION_OF_SKELETAL_...11,SET,6,-0.049643,-0.00089682,0.36969,0.55341,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,1
GOBP_CENP_A_CONTAINING_CHROM...,SET,9,-0.039809,-0.00088072,0.29624,0.55345,GOBP_CENP_A_CONTAINING_CHROMATIN_ASSEMBLY,1
GOBP_POSITIVE_REGULATION_OF_...695,SET,297,-0.006819,-0.0008598,0.05074,0.55345,GOBP_POSITIVE_REGULATION_OF_SECRETION,1
GOBP_REGULATION_OF_NEUROINFL...,SET,33,-0.021756,-0.00092105,0.16187,0.55346,GOBP_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,1
HP_ABNORMAL_URINE_SODIUM_CON...,SET,16,-0.029223,-0.00086185,0.21733,0.55348,HP_ABNORMAL_URINE_SODIUM_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...71,SET,8,-0.037927,-0.0007911,0.28199,0.55349,GOBP_NEGATIVE_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
GSE4984_GALECTIN1_VS_VEHICLE...1,SET,177,-0.0080673,-0.00078787,0.059962,0.55351,GSE4984_GALECTIN1_VS_VEHICLE_CTRL_TREATED_DC_DN,1
GOBP_T_CELL_ACTIVATION_VIA_T...,SET,10,-0.035796,-0.00083475,0.26597,0.55353,GOBP_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,1
GOBP_HYPOTHALAMUS_GONADOTROP...,SET,6,-0.05477,-0.00098944,0.40688,0.55354,GOBP_HYPOTHALAMUS_GONADOTROPHIN_RELEASING_HORMONE_NEURON_DIFFERENTIATION,1
WP_ALZHEIMERS_DISEASE,SET,248,-0.007085,-0.00081744,0.052611,0.55356,WP_ALZHEIMERS_DISEASE,1
WP_ALZHEIMERS_DISEASE_AND_MI...,SET,248,-0.007085,-0.00081744,0.052611,0.55356,WP_ALZHEIMERS_DISEASE_AND_MIRNA_EFFECTS,1
HOEK_NEUTROPHIL_2011_2012_TI...3,SET,7,-0.052058,-0.0010158,0.38642,0.55358,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_3DY_DN,1
ZWANG_DOWN_BY_2ND_EGF_PULSE,SET,210,-0.0076246,-0.00081034,0.056573,0.5536,ZWANG_DOWN_BY_2ND_EGF_PULSE,1
HP_APLASIA_HYPOPLASIA_OF_THE...16,SET,9,-0.039358,-0.00087074,0.29206,0.5536,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBRAL_WHITE_MATTER,1
HP_CEREBRAL_WHITE_MATTER_HYP...,SET,9,-0.039358,-0.00087074,0.29206,0.5536,HP_CEREBRAL_WHITE_MATTER_HYPOPLASIA,1
WP_PILOCYTIC_ASTROCYTOMA,SET,6,-0.03823,-0.00069063,0.28354,0.55363,WP_PILOCYTIC_ASTROCYTOMA,1
GSE3982_EFF_MEMORY_CD4_TCELL...6,SET,174,-0.0085464,-0.00082762,0.063284,0.55371,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH2_UP,1
GSE9509_LPS_VS_LPS_AND_IL10_...6,SET,168,-0.0087575,-0.00083345,0.064848,0.55371,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_30MIN_UP,1
GOBP_PROTEIN_N_LINKED_GLYCOS...1,SET,69,-0.013324,-0.00081487,0.098651,0.55372,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION,1
GOCC_AXON,SET,601,-0.0049415,-0.00087885,0.036572,0.55374,GOCC_AXON,1
LIU_IL13_MEMORY_MODEL_DN,SET,4,-0.049061,-0.0007237,0.36267,0.5538,LIU_IL13_MEMORY_MODEL_DN,1
WEBER_METHYLATED_LCP_IN_SPER...2,SET,14,-0.031366,-0.00086536,0.23165,0.55385,WEBER_METHYLATED_LCP_IN_SPERM_UP,1
GSE21063_WT_VS_NFATC1_KO_8H_...2,SET,179,-0.0080071,-0.00078635,0.059126,0.55386,GSE21063_WT_VS_NFATC1_KO_8H_ANTI_IGM_STIM_BCELL_UP,1
HP_APHASIA,SET,71,-0.014112,-0.00087543,0.10417,0.55388,HP_APHASIA,1
EPPERT_HSC_R,SET,107,-0.011502,-0.00087503,0.084816,0.55393,EPPERT_HSC_R,1
VANASSE_BCL2_TARGETS_DN,SET,53,-0.015075,-0.00080837,0.11116,0.55394,VANASSE_BCL2_TARGETS_DN,1
MIR5582_5P,SET,357,-0.0061159,-0.00084406,0.04508,0.55396,MIR5582_5P,1
GSE13493_DP_VS_CD4INTCD8POS_...1,SET,183,-0.0083709,-0.00083112,0.061655,0.554,GSE13493_DP_VS_CD4INTCD8POS_THYMOCYTE_DN,1
MIKKELSEN_NPC_ICP_WITH_H3K27...,SET,11,-0.039827,-0.00097405,0.29324,0.55402,MIKKELSEN_NPC_ICP_WITH_H3K27ME3,1
GOBP_SISTER_CHROMATID_SEGREG...,SET,218,-0.0074273,-0.00080409,0.054683,0.55402,GOBP_SISTER_CHROMATID_SEGREGATION,1
BIOCARTA_PTDINS_PATHWAY,SET,22,-0.021834,-0.00075496,0.16066,0.55405,BIOCARTA_PTDINS_PATHWAY,1
MORF_BCL2,SET,208,-0.0080242,-0.00084879,0.059021,0.55407,MORF_BCL2,1
GOBP_LIMB_BUD_FORMATION,SET,9,-0.041236,-0.00091228,0.30324,0.55408,GOBP_LIMB_BUD_FORMATION,1
BIOCARTA_CHEMICAL_PATHWAY,SET,18,-0.027167,-0.00084976,0.19956,0.55414,BIOCARTA_CHEMICAL_PATHWAY,1
GOMF_CHROMATIN_INSULATOR_SEQ...,SET,4,-0.048736,-0.0007189,0.35772,0.55418,GOMF_CHROMATIN_INSULATOR_SEQUENCE_BINDING,1
BIOCARTA_MALATEX_PATHWAY,SET,7,-0.04593,-0.0008962,0.33684,0.55423,BIOCARTA_MALATEX_PATHWAY,1
HP_ABNORMAL_STOOL_COMPOSITION,SET,18,-0.027936,-0.00087383,0.20461,0.5543,HP_ABNORMAL_STOOL_COMPOSITION,1
AMIT_SERUM_RESPONSE_120_MCF1...,SET,63,-0.014924,-0.00087226,0.10927,0.55432,AMIT_SERUM_RESPONSE_120_MCF10A,1
GOBP_REGULATION_OF_INWARD_RE...,SET,4,-0.064342,-0.00094911,0.47085,0.55435,GOBP_REGULATION_OF_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
GSE7568_IL4_VS_IL4_AND_TGFB_...2,SET,151,-0.0092508,-0.00083506,0.067673,0.55436,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_UP,1
GOBP_RESPONSE_TO_INTERLEUKIN...5,SET,17,-0.031976,-0.00097206,0.23366,0.55442,GOBP_RESPONSE_TO_INTERLEUKIN_17,1
HP_APLASTIC_ANEMIA,SET,24,-0.02342,-0.00084577,0.17074,0.55455,HP_APLASTIC_ANEMIA,1
GOMF_METALLOPEPTIDASE_ACTIVI...,SET,173,-0.0094757,-0.000915,0.069055,0.55457,GOMF_METALLOPEPTIDASE_ACTIVITY,1
GSE4142_NAIVE_VS_GC_BCELL_UP,SET,181,-0.0085191,-0.00084125,0.062063,0.55459,GSE4142_NAIVE_VS_GC_BCELL_UP,1
GOBP_TRACHEA_CARTILAGE_DEVEL...,SET,7,-0.045236,-0.00088265,0.32876,0.55472,GOBP_TRACHEA_CARTILAGE_DEVELOPMENT,1
SS18_SSX1_FUSION_UNIPROT_Q8I...,SET,311,-0.0070428,-0.00090836,0.051093,0.55482,SS18_SSX1_FUSION_UNIPROT_Q8IZH1_UNREVIEWED_TARGET_GENES,1
HP_ENCEPHALOPATHY,SET,276,-0.0067516,-0.00082113,0.048976,0.55482,HP_ENCEPHALOPATHY,1
GCACTTT_MIR175P_MIR20A_MIR10...,SET,545,-0.0050786,-0.00086147,0.036833,0.55483,GCACTTT_MIR175P_MIR20A_MIR106A_MIR106B_MIR20B_MIR519D,1
GOMF_PDZ_DOMAIN_BINDING,SET,80,-0.013419,-0.00088343,0.097287,0.55485,GOMF_PDZ_DOMAIN_BINDING,1
GOCC_CYTOPLASMIC_SIDE_OF_LYS...,SET,9,-0.03735,-0.0008263,0.27075,0.55486,GOCC_CYTOPLASMIC_SIDE_OF_LYSOSOMAL_MEMBRANE,1
ZNF816_TARGET_GENES,SET,419,-0.0057624,-0.00086008,0.041715,0.55493,ZNF816_TARGET_GENES,1
GAUCHER_PBMC_YF_VAX_STAMARIL...4,SET,53,-0.01593,-0.00085422,0.11524,0.55497,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_14DY_UP,1
GOBP_NEGATIVE_REGULATION_OF_...428,SET,2,-0.096384,-0.0010054,0.69685,0.555,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_PROLIFERATION,1
GOBP_GLYCEROLIPID_BIOSYNTHET...,SET,226,-0.0076167,-0.00083941,0.055059,0.55501,GOBP_GLYCEROLIPID_BIOSYNTHETIC_PROCESS,1
MIR6802_5P,SET,22,-0.02452,-0.00084782,0.17719,0.55503,MIR6802_5P,1
HP_X_LINKED_INHERITANCE,SET,11,-0.033175,-0.00081136,0.23968,0.55504,HP_X_LINKED_INHERITANCE,1
GOBP_HEXOSE_PHOSPHATE_TRANSP...,SET,6,-0.048858,-0.00088263,0.35239,0.55513,GOBP_HEXOSE_PHOSPHATE_TRANSPORT,1
MIR1281,SET,9,-0.041597,-0.00092027,0.30001,0.55514,MIR1281,1
GOBP_REGULATION_OF_TRANSPORT...,SET,194,-0.0088868,-0.0009082,0.063956,0.55525,GOBP_REGULATION_OF_TRANSPORTER_ACTIVITY,1
MIR21_3P,SET,122,-0.010996,-0.00089295,0.079083,0.55529,MIR21_3P,1
HP_ABSENT_PHALANGEAL_CREASE,SET,15,-0.032301,-0.00092241,0.23231,0.55529,HP_ABSENT_PHALANGEAL_CREASE,1
GOBP_HIGH_DENSITY_LIPOPROTEI...2,SET,11,-0.034595,-0.00084609,0.24856,0.55534,GOBP_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
DESCARTES_FETAL_EYE_GANGLION...,SET,33,-0.021644,-0.0009163,0.15553,0.55534,DESCARTES_FETAL_EYE_GANGLION_CELLS,1
MIR4732_3P,SET,81,-0.01339,-0.00088697,0.096144,0.55538,MIR4732_3P,1
MIR30C_1_3P,SET,119,-0.011365,-0.00091153,0.081563,0.55541,MIR30C_1_3P,1
HP_LIPOMA,SET,22,-0.02485,-0.00085923,0.17818,0.55546,HP_LIPOMA,1
GOBP_TRANSFORMING_GROWTH_FAC...1,SET,11,-0.040403,-0.00098813,0.28962,0.55547,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,1
HP_MICRONODULAR_CIRRHOSIS,SET,21,-0.0249,-0.00084119,0.17843,0.55549,HP_MICRONODULAR_CIRRHOSIS,1
BIOCARTA_LYM_PATHWAY,SET,13,-0.035855,-0.00095326,0.25691,0.5555,BIOCARTA_LYM_PATHWAY,1
CEBP_Q2_01,SET,239,-0.0080004,-0.00090637,0.057249,0.55557,CEBP_Q2_01,1
HP_NEOPLASM_OF_THE_LUNG,SET,60,-0.015415,-0.00087931,0.11031,0.55557,HP_NEOPLASM_OF_THE_LUNG,1
KRAS.AMP.LUNG_UP.V1_DN,SET,121,-0.011051,-0.00089371,0.079034,0.5556,KRAS.AMP.LUNG_UP.V1_DN,1
CREBP1_01,SET,156,-0.0097923,-0.00089832,0.069889,0.55571,CREBP1_01,1
KEGG_MEDICUS_REFERENCE_CXCR4...2,SET,12,-0.034431,-0.0008795,0.24555,0.55576,KEGG_MEDICUS_REFERENCE_CXCR4_GNAI_PI3K_BAD_SIGNALING_PATHWAY,1
MIR196A_1_3P,SET,358,-0.006466,-0.0008936,0.046097,0.55578,MIR196A_1_3P,1
GOMF_INTERLEUKIN_6_RECEPTOR_...,SET,6,-0.04532,-0.00081871,0.32305,0.55578,GOMF_INTERLEUKIN_6_RECEPTOR_BINDING,1
DORN_ADENOVIRUS_INFECTION_24...1,SET,38,-0.018439,-0.00083758,0.13125,0.55586,DORN_ADENOVIRUS_INFECTION_24HR_DN,1
HP_FOOD_ALLERGY,SET,15,-0.031773,-0.00090733,0.22619,0.55586,HP_FOOD_ALLERGY,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...2,SET,27,-0.025268,-0.00096777,0.17952,0.55597,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_3DY_UP,1
REACTOME_REGULATION_OF_PYRUV...1,SET,12,-0.036863,-0.00094163,0.26173,0.556,REACTOME_REGULATION_OF_PYRUVATE_DEHYDROGENASE_PDH_COMPLEX,1
GOBP_REGULATION_OF_FATTY_ACI...3,SET,82,-0.01307,-0.00087108,0.09277,0.55602,GOBP_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,1
HP_TRIANGULAR_FACE,SET,145,-0.0097361,-0.00086137,0.069097,0.55603,HP_TRIANGULAR_FACE,1
HP_TYPE_1_MUSCLE_FIBER_PREDO...,SET,60,-0.014284,-0.00081478,0.10137,0.55603,HP_TYPE_1_MUSCLE_FIBER_PREDOMINANCE,1
GSE27786_LIN_NEG_VS_ERYTHROB...1,SET,181,-0.0087009,-0.0008592,0.06175,0.55603,GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN,1
MORF_RAC1,SET,186,-0.0082136,-0.0008221,0.058271,0.55605,MORF_RAC1,1
HP_INTESTINAL_BLEEDING,SET,6,-0.047647,-0.00086075,0.33799,0.55605,HP_INTESTINAL_BLEEDING,1
LIAN_NEUTROPHIL_GRANULE_CONS...,SET,23,-0.027547,-0.00097389,0.19535,0.55607,LIAN_NEUTROPHIL_GRANULE_CONSTITUENTS,1
GSE17186_NAIVE_VS_CD21HIGH_T...1,SET,178,-0.0089288,-0.00087444,0.063258,0.55612,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,1
GOBP_PENILE_ERECTION,SET,7,-0.04507,-0.00087941,0.31926,0.55613,GOBP_PENILE_ERECTION,1
GOBP_REGULATION_OF_HUMORAL_I...1,SET,40,-0.020891,-0.00097355,0.14792,0.55615,GOBP_REGULATION_OF_HUMORAL_IMMUNE_RESPONSE,1
FRIDMAN_IMMORTALIZATION_DN,SET,31,-0.023105,-0.00094811,0.16351,0.55618,FRIDMAN_IMMORTALIZATION_DN,1
MIR3192_5P,SET,142,-0.010069,-0.00088166,0.071195,0.55624,MIR3192_5P,1
GOBP_RESPONSE_TO_TYPE_I_INTE...,SET,79,-0.014237,-0.00093138,0.10064,0.55624,GOBP_RESPONSE_TO_TYPE_I_INTERFERON,1
GOMF_KINASE_INHIBITOR_ACTIVI...,SET,73,-0.014273,-0.00089775,0.10085,0.55627,GOMF_KINASE_INHIBITOR_ACTIVITY,1
NFE2_01,SET,238,-0.0078807,-0.00089097,0.055638,0.55632,NFE2_01,1
MATSUMIYA_PBMC_MODIFIED_VACC...7,SET,9,-0.03801,-0.00084092,0.26802,0.55639,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_4_6MO_VACCINATED_VS_CANDIN_PLACEBO_BCG_PRIMED_28DY_UP,1
GOBP_BONE_TRABECULA_MORPHOGE...,SET,14,-0.033029,-0.00091123,0.23282,0.55641,GOBP_BONE_TRABECULA_MORPHOGENESIS,1
REACTOME_VASOPRESSIN_REGULAT...,SET,42,-0.019461,-0.00092923,0.13714,0.55642,REACTOME_VASOPRESSIN_REGULATES_RENAL_WATER_HOMEOSTASIS_VIA_AQUAPORINS,1
HP_ABNORMAL_CORTICAL_GYRATION,SET,347,-0.0063305,-0.00086159,0.044602,0.55643,HP_ABNORMAL_CORTICAL_GYRATION,1
HP_TACTILE_HYPERSENSITIVITY,SET,5,-0.047916,-0.00079022,0.3375,0.55645,HP_TACTILE_HYPERSENSITIVITY,1
GOBP_CARBOHYDRATE_MEDIATED_S...,SET,11,-0.038329,-0.00093741,0.26977,0.55649,GOBP_CARBOHYDRATE_MEDIATED_SIGNALING,1
RICKMAN_TUMOR_DIFFERENTIATED...6,SET,213,-0.007926,-0.00084831,0.055713,0.55656,RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP,1
WP_CANONICAL_AND_NONCANONICA...1,SET,27,-0.023298,-0.00089231,0.16378,0.55656,WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING,1
DACOSTA_LOW_DOSE_UV_RESPONSE...1,SET,8,-0.04178,-0.00087148,0.29332,0.55663,DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_DN,1
WP_HEART_DEVELOPMENT,SET,42,-0.020821,-0.00099418,0.14616,0.55664,WP_HEART_DEVELOPMENT,1
WP_ROBO4_AND_VEGF_SIGNALING_...,SET,6,-0.052042,-0.00094015,0.3652,0.55666,WP_ROBO4_AND_VEGF_SIGNALING_CROSSTALK,1
GSE35825_UNTREATED_VS_IFNG_S...1,SET,167,-0.0090027,-0.00085426,0.063145,0.55669,GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...9,SET,7,-0.041289,-0.00080563,0.28931,0.55674,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RASGAP,1
GSE18281_CORTICAL_VS_MEDULLA...1,SET,169,-0.0094604,-0.000903,0.066236,0.55679,GSE18281_CORTICAL_VS_MEDULLARY_THYMOCYTE_DN,1
GOBP_REGULATION_OF_MODIFICAT...1,SET,4,-0.062809,-0.00092649,0.43931,0.55684,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
GOBP_SPINDLE_LOCALIZATION,SET,61,-0.015414,-0.00088653,0.10774,0.55688,GOBP_SPINDLE_LOCALIZATION,1
HP_ABNORMAL_BLOOD_ZINC_CONCE...,SET,6,-0.046437,-0.00083889,0.32454,0.55689,HP_ABNORMAL_BLOOD_ZINC_CONCENTRATION,1
DNMT3A_TARGET_GENES,SET,489,-0.0055204,-0.00088841,0.038563,0.55691,DNMT3A_TARGET_GENES,1
BURTON_ADIPOGENESIS_8,SET,70,-0.014835,-0.00091376,0.10359,0.55693,BURTON_ADIPOGENESIS_8,1
GOBP_RETROGRADE_TRANS_SYNAPT...1,SET,9,-0.045521,-0.0010071,0.31783,0.55694,GOBP_RETROGRADE_TRANS_SYNAPTIC_SIGNALING,1
AACTGAC_MIR223,SET,90,-0.01257,-0.00087746,0.087682,0.557,AACTGAC_MIR223,1
GRAHAM_CML_QUIESCENT_VS_NORM...4,SET,82,-0.013453,-0.00089659,0.093795,0.55702,GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_UP,1
HP_INCISOR_MACRODONTIA,SET,15,-0.03471,-0.0009912,0.24188,0.55705,HP_INCISOR_MACRODONTIA,1
GOBP_CARDIAC_VENTRICLE_FORMA...,SET,7,-0.054105,-0.0010557,0.37684,0.55708,GOBP_CARDIAC_VENTRICLE_FORMATION,1
HP_HYPOPIGMENTED_SKIN_PATCHES,SET,105,-0.011264,-0.00084892,0.078446,0.55709,HP_HYPOPIGMENTED_SKIN_PATCHES,1
BIOCARTA_RNA_PATHWAY,SET,10,-0.03799,-0.00088591,0.26447,0.55711,BIOCARTA_RNA_PATHWAY,1
MODULE_86,SET,42,-0.018035,-0.00086117,0.12554,0.55711,MODULE_86,1
MIR2276_5P,SET,63,-0.015685,-0.00091676,0.10918,0.55712,MIR2276_5P,1
GSE36476_CTRL_VS_TSST_ACT_72...1,SET,181,-0.0084649,-0.00083589,0.058891,0.55715,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_DN,1
HP_RENAL_FANCONI_SYNDROME,SET,10,-0.037784,-0.00088111,0.26278,0.55716,HP_RENAL_FANCONI_SYNDROME,1
GOBP_REGULATION_OF_CELLULAR_...15,SET,13,-0.034345,-0.0009131,0.23858,0.55723,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OSMOTIC_STRESS,1
MIR1199_5P,SET,72,-0.014123,-0.00088221,0.098086,0.55724,MIR1199_5P,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_...2,SET,30,-0.023928,-0.00096595,0.16617,0.55725,GROSS_HYPOXIA_VIA_ELK3_ONLY_UP,1
HP_REDUCED_NATURAL_KILLER_CE...1,SET,11,-0.038922,-0.00095191,0.27023,0.55726,HP_REDUCED_NATURAL_KILLER_CELL_ACTIVITY,1
GOBP_MRNA_METHYLGUANOSINE_CA...,SET,14,-0.032264,-0.00089014,0.22396,0.55727,GOBP_MRNA_METHYLGUANOSINE_CAP_DECAPPING,1
GSE3982_DC_VS_TH1_UP,SET,186,-0.0090687,-0.00090767,0.062949,0.55727,GSE3982_DC_VS_TH1_UP,1
GOBP_RHOMBOMERE_DEVELOPMENT,SET,7,-0.057364,-0.0011193,0.39804,0.55729,GOBP_RHOMBOMERE_DEVELOPMENT,1
WANG_RESPONSE_TO_BEXAROTENE_...2,SET,31,-0.020718,-0.00085015,0.14372,0.55731,WANG_RESPONSE_TO_BEXAROTENE_UP,1
GSE3982_MAST_CELL_VS_CENT_ME...1,SET,163,-0.0091227,-0.00085531,0.063268,0.55732,GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_DN,1
NIKOLSKY_BREAST_CANCER_11Q12...,SET,144,-0.016833,-0.0014841,0.11673,0.55733,NIKOLSKY_BREAST_CANCER_11Q12_Q14_AMPLICON,1
GSE10273_HIGH_IL7_VS_HIGH_IL...1,SET,175,-0.0090486,-0.00087874,0.062708,0.55737,GSE10273_HIGH_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,1
GSE19888_ADENOSINE_A3R_INH_P...3,SET,173,-0.0085668,-0.00082723,0.059363,0.55737,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...46,SET,24,-0.026218,-0.0009468,0.18161,0.55739,GOBP_NEGATIVE_REGULATION_OF_BIOMINERAL_TISSUE_DEVELOPMENT,1
chr4q12,SET,33,-0.038875,-0.0016458,0.26909,0.55743,chr4q12,1
GSE9509_LPS_VS_LPS_AND_IL10_...1,SET,178,-0.0086548,-0.00084761,0.059778,0.55756,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_DN,1
REACTOME_DOWNSTREAM_SIGNALIN...4,SET,24,-0.023732,-0.00085704,0.16385,0.55758,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR3,1
KHETCHOUMIAN_TRIM24_TARGETS_...2,SET,44,-0.019337,-0.000945,0.13345,0.5576,KHETCHOUMIAN_TRIM24_TARGETS_UP,1
GOBP_VITAMIN_TRANSMEMBRANE_T...,SET,20,-0.026754,-0.00088209,0.18456,0.55763,GOBP_VITAMIN_TRANSMEMBRANE_TRANSPORT,1
GOBP_INCLUSION_BODY_ASSEMBLY,SET,22,-0.02657,-0.00091871,0.18318,0.55766,GOBP_INCLUSION_BODY_ASSEMBLY,1
GOBP_PRESYNAPTIC_MODULATION_...,SET,33,-0.022361,-0.00094668,0.15418,0.55766,GOBP_PRESYNAPTIC_MODULATION_OF_CHEMICAL_SYNAPTIC_TRANSMISSION,1
GSE5589_IL6_KO_VS_IL10_KO_LP...3,SET,179,-0.0091141,-0.00089507,0.062821,0.55768,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
HP_ABNORMALITY_OF_THE_FOOT_M...,SET,11,-0.039722,-0.00097148,0.27373,0.55769,HP_ABNORMALITY_OF_THE_FOOT_MUSCULATURE,1
HP_UNCOMBABLE_HAIR,SET,4,-0.070536,-0.0010405,0.48603,0.55769,HP_UNCOMBABLE_HAIR,1
GOBP_NEGATIVE_REGULATION_OF_...676,SET,30,-0.024024,-0.0009698,0.16552,0.5577,GOBP_NEGATIVE_REGULATION_OF_T_CELL_MEDIATED_IMMUNITY,1
REACTOME_PHOSPHORYLATION_OF_...1,SET,6,-0.039483,-0.00071327,0.27185,0.55774,REACTOME_PHOSPHORYLATION_OF_EMI1,1
GOBP_NUCLEOTIDE_SUGAR_METABO...,SET,34,-0.01885,-0.00081003,0.12975,0.55776,GOBP_NUCLEOTIDE_SUGAR_METABOLIC_PROCESS,1
CHX10_01,SET,203,-0.0091447,-0.00095576,0.062926,0.55777,CHX10_01,1
TGCTGAY_UNKNOWN,SET,483,-0.005733,-0.00091709,0.039417,0.55782,TGCTGAY_UNKNOWN,1
MIR5704,SET,47,-0.017841,-0.00090108,0.12245,0.55792,MIR5704,1
GOBP_POSITIVE_REGULATION_OF_...572,SET,61,-0.015337,-0.0008821,0.10527,0.55792,GOBP_POSITIVE_REGULATION_OF_PATTERN_RECOGNITION_RECEPTOR_SIGNALING_PATHWAY,1
SHETH_LIVER_CANCER_VS_TXNIP_...1,SET,236,-0.0081911,-0.00092221,0.0562,0.55794,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1,1
GSE20366_TREG_VS_NAIVE_CD4_T...6,SET,181,-0.0093339,-0.00092171,0.064005,0.55797,GSE20366_TREG_VS_NAIVE_CD4_TCELL_UP,1
HMGIY_Q6,SET,237,-0.0084529,-0.00095367,0.057945,0.55799,HMGIY_Q6,1
GOBP_RNA_SURVEILLANCE,SET,17,-0.026637,-0.00080973,0.18261,0.55799,GOBP_RNA_SURVEILLANCE,1
HP_PONTOCEREBELLAR_ATROPHY,SET,8,-0.037257,-0.00077713,0.25519,0.55804,HP_PONTOCEREBELLAR_ATROPHY,1
HP_CERVICAL_CORD_COMPRESSION,SET,6,-0.052234,-0.00094362,0.35731,0.55811,HP_CERVICAL_CORD_COMPRESSION,1
VANHARANTA_UTERINE_FIBROID_W...2,SET,57,-0.015818,-0.00087952,0.10817,0.55813,VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP,1
GOBP_REGULATION_OF_ICOSANOID...,SET,21,-0.029313,-0.0009903,0.20032,0.55817,GOBP_REGULATION_OF_ICOSANOID_SECRETION,1
GSE12845_PRE_GC_VS_DARKZONE_...1,SET,176,-0.0089546,-0.00087208,0.061177,0.55819,GSE12845_PRE_GC_VS_DARKZONE_GC_TONSIL_BCELL_DN,1
GSE21033_1H_VS_24H_POLYIC_ST...1,SET,152,-0.0098787,-0.00089466,0.067481,0.55819,GSE21033_1H_VS_24H_POLYIC_STIM_DC_DN,1
BACOLOD_RESISTANCE_TO_ALKYLA...2,SET,22,-0.028992,-0.0010025,0.19785,0.55825,BACOLOD_RESISTANCE_TO_ALKYLATING_AGENTS_UP,1
GSE17301_IFNA2_VS_IFNA2_AND_...1,SET,182,-0.0094999,-0.00094067,0.064749,0.55832,GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_DN,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...7,SET,423,-0.0059193,-0.00088761,0.040337,0.55833,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE,1
GOMF_ARRESTIN_FAMILY_PROTEIN...,SET,9,-0.03515,-0.00077763,0.23949,0.55834,GOMF_ARRESTIN_FAMILY_PROTEIN_BINDING,1
GOBP_GLUTAMATERGIC_NEURON_DI...,SET,15,-0.036512,-0.0010427,0.24871,0.55836,GOBP_GLUTAMATERGIC_NEURON_DIFFERENTIATION,1
DESCARTES_FETAL_KIDNEY_MESAN...,SET,42,-0.021021,-0.0010037,0.14314,0.55837,DESCARTES_FETAL_KIDNEY_MESANGIAL_CELLS,1
GOCC_INTERSTITIAL_MATRIX,SET,11,-0.043112,-0.0010544,0.2935,0.55839,GOCC_INTERSTITIAL_MATRIX,1
PROVENZANI_METASTASIS_UP,SET,169,-0.0098402,-0.00093925,0.066893,0.55847,PROVENZANI_METASTASIS_UP,1
GOBP_POSITIVE_REGULATION_OF_...692,SET,9,-0.047401,-0.0010487,0.32221,0.55848,GOBP_POSITIVE_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
GOMF_LIGAND_GATED_MONOATOMIC...3,SET,15,-0.034675,-0.00099019,0.23567,0.55849,GOMF_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY_INVOLVED_IN_REGULATION_OF_PRESYNAPTIC_MEMBRANE_POTENTIAL,1
ZNF830_TARGET_GENES,SET,235,-0.0080053,-0.00089941,0.054328,0.55857,ZNF830_TARGET_GENES,1
WP_MITOCHONDRIAL_LONG_CHAIN_...,SET,16,-0.031373,-0.00092526,0.21279,0.55861,WP_MITOCHONDRIAL_LONG_CHAIN_FATTY_ACID_BETAOXIDATION,1
HP_ACUTE_INFECTIOUS_PNEUMONIA,SET,5,-0.059281,-0.00097764,0.4018,0.55865,HP_ACUTE_INFECTIOUS_PNEUMONIA,1
SRPK1_TARGET_GENES,SET,304,-0.0069882,-0.00089129,0.047353,0.55866,SRPK1_TARGET_GENES,1
HP_BROAD_RIBS,SET,24,-0.027035,-0.0009763,0.18288,0.55876,HP_BROAD_RIBS,1
GSE10325_MYELOID_VS_LUPUS_MY...2,SET,170,-0.0096501,-0.00092379,0.065226,0.55881,GSE10325_MYELOID_VS_LUPUS_MYELOID_UP,1
GUTIERREZ_MULTIPLE_MYELOMA_UP,SET,30,-0.023046,-0.00093034,0.15574,0.55882,GUTIERREZ_MULTIPLE_MYELOMA_UP,1
MORF_XRCC5,SET,210,-0.0078481,-0.0008341,0.053015,0.55884,MORF_XRCC5,1
GOBP_CELLULAR_RESPONSE_TO_AC...2,SET,79,-0.014246,-0.00093196,0.096237,0.55884,GOBP_CELLULAR_RESPONSE_TO_ACID_CHEMICAL,1
chr9q32,SET,31,-0.03787,-0.001554,0.25579,0.55885,chr9q32,1
WP_MACROPHAGE_MARKERS,SET,8,-0.04717,-0.00098391,0.31862,0.55885,WP_MACROPHAGE_MARKERS,1
HOXA1_TARGET_GENES,SET,955,-0.0040939,-0.00090863,0.027633,0.55889,HOXA1_TARGET_GENES,1
GSE17721_PAM3CSK4_VS_GADIQUI...14,SET,184,-0.0090051,-0.0008965,0.060678,0.55899,GSE17721_PAM3CSK4_VS_GADIQUIMOD_4H_BMDC_UP,1
DELPUECH_FOXO3_TARGETS_UP,SET,61,-0.017033,-0.00097964,0.11468,0.55903,DELPUECH_FOXO3_TARGETS_UP,1
REACTOME_SENSORY_PERCEPTION,SET,515,-0.0069613,-0.0011488,0.046865,0.55904,REACTOME_SENSORY_PERCEPTION,1
GOBP_SUBSTANTIA_NIGRA_DEVELO...,SET,37,-0.019355,-0.00086753,0.12982,0.55926,GOBP_SUBSTANTIA_NIGRA_DEVELOPMENT,1
GSE27786_NKCELL_VS_NKTCELL_UP,SET,187,-0.0090822,-0.00091145,0.060901,0.55927,GSE27786_NKCELL_VS_NKTCELL_UP,1
HOEGERKORP_CD44_TARGETS_TEMP...1,SET,23,-0.025822,-0.00091288,0.17282,0.55939,HOEGERKORP_CD44_TARGETS_TEMPORAL_DN,1
ZNF274_TARGET_GENES,SET,743,-0.0046305,-0.00091201,0.030986,0.5594,ZNF274_TARGET_GENES,1
GSE46143_CTRL_VS_LMP2A_TRANS...2,SET,182,-0.0093827,-0.00092906,0.062754,0.55943,GSE46143_CTRL_VS_LMP2A_TRANSDUCED_CD10_POS_GC_BCELL_UP,1
GSE21927_SPLEEN_MONOCYTE_VS_...1,SET,166,-0.009841,-0.00093103,0.06577,0.55947,GSE21927_SPLEEN_MONOCYTE_VS_GMCSF_GCSF_BONE_MARROW_DN,1
MIR4653_3P,SET,47,-0.018683,-0.00094358,0.12471,0.55954,MIR4653_3P,1
HP_ABNORMAL_CONUS_TERMINALIS...,SET,29,-0.022835,-0.00090634,0.1523,0.55959,HP_ABNORMAL_CONUS_TERMINALIS_MORPHOLOGY,1
GOBP_ENDOCRINE_PANCREAS_DEVE...,SET,42,-0.02124,-0.0010142,0.14165,0.5596,GOBP_ENDOCRINE_PANCREAS_DEVELOPMENT,1
GOBP_L_ARGININE_IMPORT_ACROS...,SET,4,-0.07798,-0.0011503,0.51996,0.55961,GOBP_L_ARGININE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HE_LIM_SUN_FETAL_LUNG_C2_DC3...,SET,6,-0.051175,-0.00092449,0.34108,0.55963,HE_LIM_SUN_FETAL_LUNG_C2_DC3_CELL,1
HP_HYPOPLASTIC_ILIA,SET,47,-0.018716,-0.00094522,0.12473,0.55964,HP_HYPOPLASTIC_ILIA,1
MODULE_61,SET,47,-0.018244,-0.0009214,0.12157,0.55965,MODULE_61,1
GOBP_EXOCYST_LOCALIZATION,SET,5,-0.056674,-0.00093465,0.3775,0.55967,GOBP_EXOCYST_LOCALIZATION,1
DESCARTES_FETAL_HEART_LYMPHO...,SET,86,-0.014687,-0.0010023,0.097794,0.55969,DESCARTES_FETAL_HEART_LYMPHOID_CELLS,1
GCM_PPM1D,SET,23,-0.024273,-0.00085814,0.1614,0.55977,GCM_PPM1D,1
HP_NONCOMMUNICATING_HYDROCEP...,SET,6,-0.055774,-0.0010076,0.37072,0.55979,HP_NONCOMMUNICATING_HYDROCEPHALUS,1
GSE5542_UNTREATED_VS_IFNA_AN...2,SET,179,-0.0091179,-0.00089544,0.060606,0.55979,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,1
GOMF_AROMATASE_ACTIVITY,SET,25,-0.029753,-0.0010966,0.19727,0.55994,GOMF_AROMATASE_ACTIVITY,1
GSE14000_UNSTIM_VS_16H_LPS_D...3,SET,180,-0.009492,-0.00093475,0.062831,0.56004,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_UP,1
HP_TRANSIENT_HYPERPHENYLALAN...,SET,5,-0.062199,-0.0010258,0.41138,0.56009,HP_TRANSIENT_HYPERPHENYLALANINEMIA,1
GOBP_ADULT_LOCOMOTORY_BEHAVI...,SET,79,-0.014982,-0.00098016,0.099001,0.56014,GOBP_ADULT_LOCOMOTORY_BEHAVIOR,1
HP_SCHISTOCYTOSIS,SET,10,-0.03984,-0.00092906,0.26326,0.56014,HP_SCHISTOCYTOSIS,1
GOBP_POSITIVE_REGULATION_OF_...239,SET,6,-0.052293,-0.00094468,0.34505,0.56023,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DEVELOPMENT,1
HP_LUMBAR_HYPERLORDOSIS,SET,82,-0.01375,-0.00091637,0.090721,0.56023,HP_LUMBAR_HYPERLORDOSIS,1
MIR4671_3P,SET,191,-0.0094558,-0.00095893,0.062366,0.56025,MIR4671_3P,1
HP_ABNORMALITY_OF_THE_GLENOI...,SET,6,-0.054707,-0.0009883,0.36076,0.56027,HP_ABNORMALITY_OF_THE_GLENOID_FOSSA,1
GOMF_LARGE_RIBOSOMAL_SUBUNIT...,SET,5,-0.0531,-0.00087571,0.35002,0.56029,GOMF_LARGE_RIBOSOMAL_SUBUNIT_RRNA_BINDING,1
ZNF22_TARGET_GENES,SET,820,-0.004395,-0.00090739,0.028941,0.56035,ZNF22_TARGET_GENES,1
MIR2114_5P,SET,31,-0.022998,-0.0009437,0.15142,0.56036,MIR2114_5P,1
HP_DECREASED_SPECIFIC_ANTIBO...2,SET,3,-0.088958,-0.0011364,0.58507,0.56042,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_PROTEIN_CONJUGATED_POLYSACCHARIDE_VACCINE,1
PDGF_UP.V1_DN,SET,109,-0.0129,-0.00099053,0.084822,0.56044,PDGF_UP.V1_DN,1
GSE14350_IL2RB_KO_VS_WT_TEFF...2,SET,181,-0.0093808,-0.00092633,0.061676,0.56044,GSE14350_IL2RB_KO_VS_WT_TEFF_UP,1
GOBP_NEURON_INTRINSIC_APOPTO...,SET,18,-0.031941,-0.00099912,0.20997,0.56045,GOBP_NEURON_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,1
REACTOME_SIGNALING_BY_LEPTIN,SET,11,-0.047256,-0.0011557,0.31037,0.56051,REACTOME_SIGNALING_BY_LEPTIN,1
GSE23114_PERITONEAL_CAVITY_B...3,SET,178,-0.0097085,-0.0009508,0.063762,0.56051,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_UP,1
JONES_OVARY_GRANULOSA,SET,69,-0.016559,-0.0010127,0.10867,0.56055,JONES_OVARY_GRANULOSA,1
YAO_TEMPORAL_RESPONSE_TO_PRO...3,SET,63,-0.015699,-0.00091757,0.10301,0.56056,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_10,1
HP_DYSGENESIS_OF_THE_CEREBEL...,SET,7,-0.039142,-0.00076374,0.25684,0.56056,HP_DYSGENESIS_OF_THE_CEREBELLAR_VERMIS,1
GSE24142_ADULT_VS_FETAL_DN2_...2,SET,186,-0.0098256,-0.00098343,0.06445,0.56058,GSE24142_ADULT_VS_FETAL_DN2_THYMOCYTE_UP,1
MIR4736,SET,100,-0.012659,-0.00093125,0.083017,0.5606,MIR4736,1
BIOCARTA_EPHA4_PATHWAY,SET,8,-0.048866,-0.0010193,0.32039,0.56061,BIOCARTA_EPHA4_PATHWAY,1
BIOCARTA_EOSINOPHILS_PATHWAY,SET,7,-0.045222,-0.00088238,0.29645,0.56062,BIOCARTA_EOSINOPHILS_PATHWAY,1
GOBP_MACROPHAGE_ACTIVATION_I...,SET,19,-0.030975,-0.00099541,0.20299,0.56064,GOBP_MACROPHAGE_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_CONE_SHAPED_EPIPHYSIS,SET,72,-0.014769,-0.00092261,0.096735,0.56067,HP_CONE_SHAPED_EPIPHYSIS,1
HE_LIM_SUN_FETAL_LUNG_C3_EAR...,SET,593,-0.0051479,-0.00090965,0.033698,0.56071,HE_LIM_SUN_FETAL_LUNG_C3_EARLY_CAP_CELL,1
GOBP_CARDIOLIPIN_ACYL_CHAIN_...,SET,5,-0.072823,-0.001201,0.47645,0.56074,GOBP_CARDIOLIPIN_ACYL_CHAIN_REMODELING,1
MIR130A_3P,SET,356,-0.0069852,-0.00096271,0.045694,0.56075,MIR130A_3P,1
GOBP_POLY_A_PLUS_MRNA_EXPORT...,SET,18,-0.026576,-0.0008313,0.17384,0.56075,GOBP_POLY_A_PLUS_MRNA_EXPORT_FROM_NUCLEUS,1
HP_DEVIATED_NASAL_SEPTUM,SET,6,-0.054026,-0.000976,0.35337,0.56076,HP_DEVIATED_NASAL_SEPTUM,1
MIR4442,SET,4,-0.064305,-0.00094857,0.42004,0.56084,MIR4442,1
GOCC_U7_SNRNP,SET,7,-0.047825,-0.00093317,0.31237,0.56084,GOCC_U7_SNRNP,1
MIR6842_3P,SET,112,-0.012689,-0.00098751,0.08287,0.56085,MIR6842_3P,1
WP_ACUTE_VIRAL_MYOCARDITIS,SET,82,-0.014711,-0.00098043,0.095986,0.5609,WP_ACUTE_VIRAL_MYOCARDITIS,1
GSE39110_DAY3_VS_DAY6_POST_I...3,SET,178,-0.0094775,-0.00092818,0.061843,0.5609,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_DN,1
MIR1249_5P,SET,177,-0.0098866,-0.00096554,0.064439,0.56097,MIR1249_5P,1
GSE43955_TGFB_IL6_VS_TGFB_IL...2,SET,185,-0.0091135,-0.00090973,0.05938,0.56099,GSE43955_TGFB_IL6_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,1
GSE19888_ADENOSINE_A3R_INH_V...3,SET,179,-0.0098039,-0.00096281,0.063826,0.56104,GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN,1
HP_INCREASED_MEGAKARYOCYTE_C...,SET,7,-0.043984,-0.00085823,0.28538,0.56124,HP_INCREASED_MEGAKARYOCYTE_COUNT,1
HP_ABNORMAL_TEMPORAL_LOBE_MO...,SET,125,-0.011792,-0.00096913,0.076499,0.56125,HP_ABNORMAL_TEMPORAL_LOBE_MORPHOLOGY,1
GOBP_OLIGOSACCHARIDE_BIOSYNT...,SET,29,-0.026011,-0.0010324,0.16851,0.56133,GOBP_OLIGOSACCHARIDE_BIOSYNTHETIC_PROCESS,1
HP_INCREASED_URINARY_POTASSI...,SET,9,-0.046479,-0.0010283,0.30116,0.56133,HP_INCREASED_URINARY_POTASSIUM,1
GOMF_PROTEIN_PHOSPHORYLATED_...,SET,58,-0.017624,-0.00098851,0.11413,0.56136,GOMF_PROTEIN_PHOSPHORYLATED_AMINO_ACID_BINDING,1
HP_CHRONIC_HEPATIC_FAILURE,SET,14,-0.032682,-0.00090166,0.21162,0.56137,HP_CHRONIC_HEPATIC_FAILURE,1
GSE6269_FLU_VS_E_COLI_INF_PB...2,SET,147,-0.010127,-0.00090203,0.065536,0.5614,GSE6269_FLU_VS_E_COLI_INF_PBMC_UP,1
GOBP_SYNAPTIC_VESICLE_TRANSP...,SET,40,-0.020414,-0.00095129,0.13207,0.56142,GOBP_SYNAPTIC_VESICLE_TRANSPORT,1
GSE36888_UNTREATED_VS_IL2_TR...7,SET,179,-0.010248,-0.0010064,0.066281,0.56144,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_17H_DN,1
LY_AGING_MIDDLE_UP,SET,14,-0.040458,-0.0011162,0.26162,0.56145,LY_AGING_MIDDLE_UP,1
DI_MARTINO_MATRISOME_HIGHLY_...1,SET,26,-0.026076,-0.00098008,0.16844,0.56151,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC,1
REACTOME_RECYCLING_OF_BILE_A...,SET,18,-0.031841,-0.00099598,0.20568,0.56151,REACTOME_RECYCLING_OF_BILE_ACIDS_AND_SALTS,1
GOBP_MUSCLE_ORGAN_DEVELOPMENT,SET,328,-0.0075952,-0.0010056,0.049032,0.56155,GOBP_MUSCLE_ORGAN_DEVELOPMENT,1
GSE13522_WT_VS_IFNG_KO_SKING...2,SET,107,-0.01287,-0.00097917,0.083062,0.56157,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,1
HP_FOCAL_AWARE_SEIZURE,SET,26,-0.026462,-0.00099459,0.17063,0.56162,HP_FOCAL_AWARE_SEIZURE,1
GTTGNYNNRGNAAC_UNKNOWN,SET,94,-0.013622,-0.00097173,0.087806,0.56164,GTTGNYNNRGNAAC_UNKNOWN,1
HP_ABNORMAL_LYMPHOCYTE_MORPH...,SET,222,-0.0089513,-0.00097783,0.057702,0.56164,HP_ABNORMAL_LYMPHOCYTE_MORPHOLOGY,1
GOMF_INOSITOL_1_3_4_5_6_PENT...,SET,5,-0.045596,-0.00075196,0.29386,0.56165,GOMF_INOSITOL_1_3_4_5_6_PENTAKISPHOSPHATE_KINASE_ACTIVITY,1
WP_DISORDERS_IN_KETOLYSIS,SET,5,-0.052764,-0.00087017,0.34001,0.56166,WP_DISORDERS_IN_KETOLYSIS,1
MIR605_3P,SET,233,-0.008497,-0.00095063,0.054754,0.56166,MIR605_3P,1
GSE17721_CPG_VS_GARDIQUIMOD_...11,SET,183,-0.0094537,-0.00093862,0.06086,0.56172,GSE17721_CPG_VS_GARDIQUIMOD_2H_BMDC_DN,1
GSE21063_CTRL_VS_ANTI_IGM_ST...4,SET,162,-0.010513,-0.00098269,0.067597,0.5618,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_UP,1
HP_ABNORMAL_ILEUM_MORPHOLOGY,SET,33,-0.021592,-0.00091411,0.13879,0.56181,HP_ABNORMAL_ILEUM_MORPHOLOGY,1
HP_CLONIC_SEIZURE,SET,72,-0.01551,-0.00096885,0.099683,0.56182,HP_CLONIC_SEIZURE,1
MIR6082,SET,15,-0.033527,-0.00095741,0.21546,0.56183,MIR6082,1
GOBP_FOREBRAIN_VENTRICULAR_Z...,SET,5,-0.063653,-0.0010497,0.40875,0.56187,GOBP_FOREBRAIN_VENTRICULAR_ZONE_PROGENITOR_CELL_DIVISION,1
HP_DYSTROPHIC_TOENAIL,SET,19,-0.030725,-0.00098737,0.19704,0.56196,HP_DYSTROPHIC_TOENAIL,1
GOBP_POSITIVE_REGULATION_OF_...112,SET,11,-0.039545,-0.00096716,0.25352,0.56198,GOBP_POSITIVE_REGULATION_OF_CELLULAR_SENESCENCE,1
GOBP_SPHINGOSINE_1_PHOSPHATE...,SET,15,-0.035305,-0.0010082,0.22631,0.56198,GOBP_SPHINGOSINE_1_PHOSPHATE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_TRIGEMINAL_NERVE_DEVELO...,SET,12,-0.044451,-0.0011355,0.2846,0.56206,GOBP_TRIGEMINAL_NERVE_DEVELOPMENT,1
MIR4528,SET,203,-0.0096531,-0.0010089,0.061721,0.56214,MIR4528,1
GOBP_TERPENOID_CATABOLIC_PRO...,SET,7,-0.053701,-0.0010478,0.34338,0.56214,GOBP_TERPENOID_CATABOLIC_PROCESS,1
TIAN_TNF_SIGNALING_NOT_VIA_N...,SET,21,-0.031654,-0.0010694,0.20229,0.56217,TIAN_TNF_SIGNALING_NOT_VIA_NFKB,1
GOCC_PROTON_TRANSPORTING_V_T...3,SET,12,-0.039552,-0.0010103,0.25256,0.56222,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_V1_DOMAIN,1
GOBP_REGULATION_OF_GASTRULAT...,SET,15,-0.030227,-0.00086317,0.19298,0.56223,GOBP_REGULATION_OF_GASTRULATION,1
GAUCHER_PBMC_YF_VAX_STAMARIL...2,SET,183,-0.0099435,-0.00098726,0.063483,0.56223,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_10DY_UP,1
GOBP_DEVELOPMENTAL_PIGMENTAT...,SET,45,-0.021078,-0.0010417,0.13452,0.56225,GOBP_DEVELOPMENTAL_PIGMENTATION,1
GSE360_DC_VS_MAC_L_MAJOR_DN,SET,177,-0.009759,-0.00095308,0.062289,0.56225,GSE360_DC_VS_MAC_L_MAJOR_DN,1
GOBP_INSULIN_SECRETION,SET,187,-0.0098781,-0.00099132,0.062962,0.56233,GOBP_INSULIN_SECRETION,1
GOBP_SPINDLE_ELONGATION,SET,13,-0.038752,-0.0010303,0.2469,0.56236,GOBP_SPINDLE_ELONGATION,1
GOBP_FOREBRAIN_GENERATION_OF...,SET,50,-0.020959,-0.0010917,0.13345,0.5624,GOBP_FOREBRAIN_GENERATION_OF_NEURONS,1
GOBP_REGULATION_OF_PROTEIN_S...3,SET,286,-0.0076306,-0.00094444,0.04854,0.56246,GOBP_REGULATION_OF_PROTEIN_STABILITY,1
REACTOME_COPI_DEPENDENT_GOLG...,SET,95,-0.012713,-0.00091163,0.080856,0.56247,REACTOME_COPI_DEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1
GOBP_IRE1_MEDIATED_UNFOLDED_...,SET,20,-0.031417,-0.0010358,0.19968,0.56251,GOBP_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
GSE11961_FOLLICULAR_BCELL_VS...11,SET,185,-0.00942,-0.00094033,0.059876,0.56251,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_DN,1
HP_GLOMERULAR_SUBEPITHELIAL_...,SET,11,-0.038201,-0.00093429,0.2427,0.56254,HP_GLOMERULAR_SUBEPITHELIAL_DEPOSITS,1
WANG_TUMOR_INVASIVENESS_DN,SET,192,-0.009413,-0.00095706,0.059786,0.56255,WANG_TUMOR_INVASIVENESS_DN,1
BOSCO_INTERFERON_INDUCED_ANT...,SET,72,-0.015222,-0.0009509,0.096674,0.56256,BOSCO_INTERFERON_INDUCED_ANTIVIRAL_MODULE,1
UNTERMAN_IPF_VS_CTRL_B_CELL_...,SET,27,-0.03028,-0.0011598,0.19218,0.5626,UNTERMAN_IPF_VS_CTRL_B_CELL_DN,1
MODULE_2,SET,348,-0.0077296,-0.0010535,0.049052,0.56261,MODULE_2,1
HP_FACIAL_ASYMMETRY,SET,128,-0.011658,-0.00096951,0.073934,0.56265,HP_FACIAL_ASYMMETRY,1
FAN_OVARY_CL0_XBP1_SELK_HIGH...,SET,123,-0.011688,-0.00095297,0.074114,0.56265,FAN_OVARY_CL0_XBP1_SELK_HIGH_STROMAL_CELL,1
REACTOME_RRNA_MODIFICATION_I...2,SET,51,-0.017313,-0.00091074,0.10976,0.56267,REACTOME_RRNA_MODIFICATION_IN_THE_NUCLEUS_AND_CYTOSOL,1
HP_REDUCED_NUMBER_OF_CORNEAL...,SET,8,-0.051996,-0.0010846,0.32911,0.56277,HP_REDUCED_NUMBER_OF_CORNEAL_ENDOTHELIAL_CELLS,1
GSE36891_POLYIC_TLR3_VS_PAM_...2,SET,140,-0.012005,-0.0010438,0.075983,0.56277,GSE36891_POLYIC_TLR3_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_UP,1
HP_ABNORMALITY_OF_RENAL_EXCR...,SET,62,-0.017757,-0.0010296,0.11236,0.56278,HP_ABNORMALITY_OF_RENAL_EXCRETION,1
HP_DEPRESSION,SET,380,-0.0068704,-0.00097763,0.043469,0.56279,HP_DEPRESSION,1
GOCC_RNA_POLYMERASE_III_TRAN...,SET,9,-0.03702,-0.00081901,0.23415,0.56281,GOCC_RNA_POLYMERASE_III_TRANSCRIPTION_REGULATOR_COMPLEX,1
MIR6508_5P,SET,300,-0.0076646,-0.00097122,0.048441,0.56286,MIR6508_5P,1
GSE25123_IL4_VS_IL4_AND_ROSI...2,SET,190,-0.010168,-0.0010285,0.064258,0.56286,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
HP_NARROW_FOREHEAD,SET,150,-0.010595,-0.00095328,0.066902,0.56292,HP_NARROW_FOREHEAD,1
HP_HEPATIC_NECROSIS,SET,13,-0.034188,-0.00090892,0.21561,0.56299,HP_HEPATIC_NECROSIS,1
GOBP_AMINOPHOSPHOLIPID_TRANS...1,SET,6,-0.049087,-0.00088676,0.30952,0.563,GOBP_AMINOPHOSPHOLIPID_TRANSLOCATION,1
GOMF_AMINOPHOSPHOLIPID_FLIPP...,SET,6,-0.049087,-0.00088676,0.30952,0.563,GOMF_AMINOPHOSPHOLIPID_FLIPPASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...139,SET,42,-0.021391,-0.0010214,0.13478,0.56305,GOBP_NEGATIVE_REGULATION_OF_CHEMOTAXIS,1
GOMF_TELETHONIN_BINDING,SET,7,-0.057489,-0.0011217,0.36209,0.56307,GOMF_TELETHONIN_BINDING,1
MIR4521,SET,67,-0.016705,-0.0010068,0.10517,0.5631,MIR4521,1
GOBP_PYRIDINE_CONTAINING_COM...2,SET,91,-0.013126,-0.00092131,0.082639,0.5631,GOBP_PYRIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
MIR6829_3P,SET,77,-0.015586,-0.0010067,0.098055,0.56314,MIR6829_3P,1
REACTOME_RUNX3_REGULATES_YAP...,SET,7,-0.056458,-0.0011016,0.35498,0.56318,REACTOME_RUNX3_REGULATES_YAP1_MEDIATED_TRANSCRIPTION,1
PAPASPYRIDONOS_UNSTABLE_ATER...2,SET,51,-0.019389,-0.0010199,0.12189,0.56319,PAPASPYRIDONOS_UNSTABLE_ATEROSCLEROTIC_PLAQUE_UP,1
GOBP_LAMELLIPODIUM_MORPHOGEN...,SET,18,-0.029722,-0.0009297,0.18673,0.56323,GOBP_LAMELLIPODIUM_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...40,SET,44,-0.019804,-0.00096783,0.12434,0.56327,GOBP_NEGATIVE_REGULATION_OF_AXONOGENESIS,1
MIR4676_3P,SET,189,-0.0096107,-0.00096957,0.06029,0.56333,MIR4676_3P,1
GOBP_PEPTIDYL_AMINO_ACID_MOD...,SET,763,-0.0049216,-0.00098175,0.030872,0.56333,GOBP_PEPTIDYL_AMINO_ACID_MODIFICATION,1
REACTOME_SIGNALING_BY_TGFB_F...,SET,149,-0.010958,-0.00098266,0.068708,0.56336,REACTOME_SIGNALING_BY_TGFB_FAMILY_MEMBERS,1
GSE24574_BCL6_HIGH_TFH_VS_NA...2,SET,179,-0.01003,-0.00098503,0.062884,0.56336,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_UP,1
GOBP_ER_OVERLOAD_RESPONSE,SET,10,-0.049486,-0.001154,0.31018,0.56338,GOBP_ER_OVERLOAD_RESPONSE,1
GOBP_SKELETAL_SYSTEM_MORPHOG...,SET,218,-0.0098683,-0.0010684,0.061813,0.56342,GOBP_SKELETAL_SYSTEM_MORPHOGENESIS,1
GOBP_T_CELL_APOPTOTIC_PROCESS,SET,57,-0.01821,-0.0010125,0.11397,0.56347,GOBP_T_CELL_APOPTOTIC_PROCESS,1
REACTOME_CARNITINE_METABOLISM,SET,13,-0.036339,-0.00096611,0.22731,0.56351,REACTOME_CARNITINE_METABOLISM,1
GSE44649_WT_VS_MIR155_KO_ACT...2,SET,190,-0.0097821,-0.00098945,0.061183,0.56351,GSE44649_WT_VS_MIR155_KO_ACTIVATED_CD8_TCELL_UP,1
HP_ABNORMAL_BLOOD_VESSEL_MOR...,SET,855,-0.0047372,-0.00099769,0.029626,0.56352,HP_ABNORMAL_BLOOD_VESSEL_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_BLOOD...2,SET,7,-0.055749,-0.0010878,0.34828,0.56359,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_2_BIOSYNTHESIS,1
ANDERSON_BLOOD_CN54GP140_ADJ...5,SET,53,-0.017527,-0.00093985,0.10948,0.56359,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_6HR_DN,1
HP_JUVENILE_MYELOMONOCYTIC_L...,SET,18,-0.029208,-0.00091361,0.18241,0.56361,HP_JUVENILE_MYELOMONOCYTIC_LEUKEMIA,1
GSE39110_UNTREATED_VS_IL2_TR...2,SET,182,-0.010169,-0.0010069,0.063438,0.56368,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_UP,1
GSE17721_PAM3CSK4_VS_CPG_6H_...2,SET,177,-0.0094001,-0.00091803,0.058615,0.5637,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_UP,1
GOBP_REGULATION_OF_INTRINSIC...1,SET,160,-0.010448,-0.00097056,0.06512,0.56373,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
MIR4664_5P,SET,76,-0.015165,-0.00097319,0.0944,0.56381,MIR4664_5P,1
GSE16697_CD4_TCELL_VS_TFH_CD...2,SET,181,-0.010195,-0.0010067,0.063415,0.56386,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_UP,1
GOBP_CARDIAC_CHAMBER_DEVELOP...,SET,162,-0.011479,-0.001073,0.071234,0.56401,GOBP_CARDIAC_CHAMBER_DEVELOPMENT,1
REACTOME_ASYMMETRIC_LOCALIZA...,SET,61,-0.016101,-0.00092606,0.0999,0.56402,REACTOME_ASYMMETRIC_LOCALIZATION_OF_PCP_PROTEINS,1
HP_ABNORMAL_FOVEAL_MORPHOLOGY,SET,46,-0.021694,-0.001084,0.13434,0.56415,HP_ABNORMAL_FOVEAL_MORPHOLOGY,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...2,SET,5,-0.072889,-0.0012021,0.45128,0.56416,GOBP_GAMMA_AMINOBUTYRIC_ACID_IMPORT,1
chr6q25,SET,67,-0.036166,-0.0021796,0.22356,0.56426,chr6q25,1
GOBP_ATP_SYNTHESIS_COUPLED_E...,SET,81,-0.013067,-0.00086556,0.080762,0.56427,GOBP_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,1
SCHUHMACHER_MYC_TARGETS_DN,SET,7,-0.049579,-0.0009674,0.30634,0.56428,SCHUHMACHER_MYC_TARGETS_DN,1
GOBP_HYPEROSMOTIC_SALINITY_R...,SET,10,-0.046573,-0.0010861,0.2878,0.56428,GOBP_HYPEROSMOTIC_SALINITY_RESPONSE,1
GOMF_CADHERIN_BINDING_INVOLV...,SET,18,-0.03641,-0.0011389,0.225,0.56428,GOMF_CADHERIN_BINDING_INVOLVED_IN_CELL_CELL_ADHESION,1
GSE29617_CTRL_VS_TIV_FLU_VAC...1,SET,171,-0.010018,-0.0009618,0.061887,0.5643,GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_DN,1
GSE2706_UNSTIM_VS_2H_LPS_AND...2,SET,162,-0.010221,-0.00095539,0.063123,0.56432,GSE2706_UNSTIM_VS_2H_LPS_AND_R848_DC_UP,1
CHOW_RASSF1_TARGETS_DN,SET,29,-0.023039,-0.00091445,0.14226,0.56433,CHOW_RASSF1_TARGETS_DN,1
WP_FATTY_ACID_OMEGAOXIDATION,SET,15,-0.03968,-0.0011331,0.24477,0.56439,WP_FATTY_ACID_OMEGAOXIDATION,1
DESCARTES_FETAL_HEART_VASCUL...,SET,16,-0.037175,-0.0010964,0.22929,0.5644,DESCARTES_FETAL_HEART_VASCULAR_ENDOTHELIAL_CELLS,1
EVI1_03,SET,54,-0.018866,-0.0010211,0.11612,0.56453,EVI1_03,1
GOBP_DETECTION_OF_LIGHT_STIM...1,SET,58,-0.01854,-0.0010398,0.11412,0.56453,GOBP_DETECTION_OF_LIGHT_STIMULUS,1
GSE20152_SPHK1_KO_VS_WT_HTNF...1,SET,180,-0.0094288,-0.00092853,0.057972,0.5646,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_DN,1
GOBP_RESPONSE_TO_ISOQUINOLIN...,SET,13,-0.040434,-0.001075,0.24847,0.56463,GOBP_RESPONSE_TO_ISOQUINOLINE_ALKALOID,1
RAPA_EARLY_UP.V1_DN,SET,168,-0.010132,-0.00096422,0.062258,0.56464,RAPA_EARLY_UP.V1_DN,1
GOBP_INNER_DYNEIN_ARM_ASSEMB...,SET,11,-0.035803,-0.00087564,0.21985,0.56468,GOBP_INNER_DYNEIN_ARM_ASSEMBLY,1
TATA_01,SET,222,-0.0096001,-0.0010487,0.058844,0.5648,TATA_01,1
GOCC_TRANSCRIPTION_ELONGATIO...,SET,45,-0.019304,-0.00095402,0.11831,0.5648,GOCC_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,1
GOBP_REGULATION_OF_PROTEIN_L...5,SET,12,-0.042275,-0.0010799,0.25907,0.56481,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CENTROSOME,1
GOMF_TUBULIN_BINDING,SET,346,-0.0072158,-0.00098069,0.044207,0.56483,GOMF_TUBULIN_BINDING,1
WP_DNA_REPLICATION,SET,40,-0.019806,-0.00092299,0.12128,0.56486,WP_DNA_REPLICATION,1
GOCC_ANKYRIN_1_COMPLEX,SET,8,-0.053082,-0.0011072,0.32505,0.56486,GOCC_ANKYRIN_1_COMPLEX,1
GOCC_GOLGI_MEDIAL_CISTERNA,SET,11,-0.044808,-0.0010959,0.27432,0.56487,GOCC_GOLGI_MEDIAL_CISTERNA,1
ACCAATC_MIR509,SET,45,-0.023227,-0.0011479,0.14215,0.56489,ACCAATC_MIR509,1
DESCARTES_MAIN_FETAL_CILIATE...,SET,450,-0.0062941,-0.00097274,0.038496,0.56494,DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS,1
HP_RESPIRATORY_INSUFFICIENCY,SET,561,-0.005795,-0.00099687,0.035437,0.56495,HP_RESPIRATORY_INSUFFICIENCY,1
REACTOME_EVASION_BY_RSV_OF_H...,SET,28,-0.029025,-0.001132,0.17743,0.56497,REACTOME_EVASION_BY_RSV_OF_HOST_INTERFERON_RESPONSES,1
KRAS.DF.V1_DN,SET,169,-0.010887,-0.0010391,0.066518,0.565,KRAS.DF.V1_DN,1
GSE6259_33D1_POS_DC_VS_BCELL...2,SET,136,-0.01189,-0.001019,0.07265,0.565,GSE6259_33D1_POS_DC_VS_BCELL_UP,1
HP_HYPERGLYCEMIA,SET,77,-0.015818,-0.0010217,0.096619,0.56502,HP_HYPERGLYCEMIA,1
IIZUKA_LIVER_CANCER_PROGRESS...6,SET,13,-0.038468,-0.0010227,0.23473,0.56509,IIZUKA_LIVER_CANCER_PROGRESSION_L0_L1_UP,1
GSE27786_LSK_VS_NEUTROPHIL_UP,SET,172,-0.0098026,-0.00094385,0.059816,0.56509,GSE27786_LSK_VS_NEUTROPHIL_UP,1
PID_INSULIN_PATHWAY,SET,44,-0.02055,-0.0010043,0.12531,0.56513,PID_INSULIN_PATHWAY,1
REACTOME_DEGRADATION_OF_BETA...,SET,80,-0.01482,-0.00097563,0.090193,0.56526,REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX,1
GSE24634_IL4_VS_CTRL_TREATED...8,SET,177,-0.010042,-0.0009807,0.061115,0.56526,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY7_UP,1
GSE12845_IGD_NEG_BLOOD_VS_PR...1,SET,182,-0.0098534,-0.00097567,0.059914,0.56531,GSE12845_IGD_NEG_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,1
GSE25123_WT_VS_PPARG_KO_MACR...2,SET,164,-0.010697,-0.0010059,0.065024,0.56533,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN,1
HP_DYSTONIA,SET,462,-0.0063507,-0.00099416,0.03859,0.56536,HP_DYSTONIA,1
GOMF_PLUS_END_DIRECTED_MICRO...,SET,17,-0.033711,-0.0010248,0.20455,0.56545,GOMF_PLUS_END_DIRECTED_MICROTUBULE_MOTOR_ACTIVITY,1
GSE12003_4D_VS_8D_CULTURE_BM...1,SET,127,-0.011478,-0.00095086,0.06965,0.56545,GSE12003_4D_VS_8D_CULTURE_BM_PROGENITOR_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...2,SET,9,-0.049788,-0.0011015,0.3018,0.56552,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_15,1
HP_MELANOCYTIC_NEVUS,SET,64,-0.01576,-0.00092837,0.095488,0.56554,HP_MELANOCYTIC_NEVUS,1
GSE8835_HEALTHY_VS_CLL_CD4_T...1,SET,174,-0.010334,-0.0010007,0.062607,0.56555,GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...61,SET,8,-0.047581,-0.00099248,0.28823,0.56556,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
WANG_ESOPHAGUS_CANCER_VS_NOR...1,SET,95,-0.013856,-0.00099357,0.083897,0.56559,WANG_ESOPHAGUS_CANCER_VS_NORMAL_DN,1
HP_SEVERE_GLOBAL_DEVELOPMENT...,SET,197,-0.0098531,-0.0010146,0.059629,0.56562,HP_SEVERE_GLOBAL_DEVELOPMENTAL_DELAY,1
GOBP_VENTRICULAR_SEPTUM_DEVE...,SET,70,-0.017552,-0.0010811,0.10616,0.56566,GOBP_VENTRICULAR_SEPTUM_DEVELOPMENT,1
OKUMURA_INFLAMMATORY_RESPONS...,SET,157,-0.011112,-0.0010226,0.067165,0.5657,OKUMURA_INFLAMMATORY_RESPONSE_LPS,1
REACTOME_HEDGEHOG_ON_STATE,SET,82,-0.014154,-0.00094331,0.085545,0.56571,REACTOME_HEDGEHOG_ON_STATE,1
HP_SENSORY_NEUROPATHY,SET,88,-0.014248,-0.00098353,0.086106,0.56571,HP_SENSORY_NEUROPATHY,1
GROSS_HIF1A_TARGETS_DN,SET,21,-0.029955,-0.001012,0.18086,0.56577,GROSS_HIF1A_TARGETS_DN,1
WP_IL7_SIGNALING,SET,24,-0.031481,-0.0011369,0.19004,0.56579,WP_IL7_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...475,SET,14,-0.040707,-0.0011231,0.24569,0.5658,GOBP_NEGATIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
GSE41867_DAY8_VS_DAY15_LCMV_...2,SET,148,-0.011523,-0.0010299,0.06952,0.56582,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
HP_RENAL_DYSPLASIA,SET,62,-0.018013,-0.0010444,0.10858,0.56588,HP_RENAL_DYSPLASIA,1
WP_GLYCOLYSIS_IN_SENESCENCE,SET,9,-0.046184,-0.0010218,0.27809,0.56595,WP_GLYCOLYSIS_IN_SENESCENCE,1
MIR6819_5P,SET,75,-0.015623,-0.00099598,0.093985,0.56601,MIR6819_5P,1
BREDEMEYER_RAG_SIGNALING_NOT...1,SET,57,-0.018855,-0.0010484,0.11338,0.56604,BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN,1
MIR4742_3P,SET,201,-0.010092,-0.0010496,0.060639,0.56609,MIR4742_3P,1
HP_ABNORMAL_INTRAOCULAR_PRES...,SET,36,-0.024778,-0.0010956,0.14889,0.56609,HP_ABNORMAL_INTRAOCULAR_PRESSURE,1
GSE18791_CTRL_VS_NEWCASTLE_V...16,SET,182,-0.0098871,-0.000979,0.059382,0.56612,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_4H_UP,1
GSE13547_CTRL_VS_ANTI_IGM_ST...4,SET,169,-0.011019,-0.0010517,0.066103,0.56619,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP,1
MIR10A_5P_MIR10B_5P,SET,99,-0.014657,-0.0010728,0.087912,0.5662,MIR10A_5P_MIR10B_5P,1
HP_RETINAL_FLECKS,SET,8,-0.054358,-0.0011338,0.32599,0.56621,HP_RETINAL_FLECKS,1
ONGUSAHA_TP53_TARGETS,SET,33,-0.024169,-0.0010232,0.1448,0.56628,ONGUSAHA_TP53_TARGETS,1
GOMF_ACETYLGALACTOSAMINYLTRA...,SET,32,-0.027335,-0.0011396,0.16367,0.56632,GOMF_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
HP_EUNUCHOID_HABITUS,SET,21,-0.033009,-0.0011152,0.19764,0.56632,HP_EUNUCHOID_HABITUS,1
CHIARETTI_T_ALL_REFRACTORY_T...,SET,25,-0.028721,-0.0010585,0.17194,0.56633,CHIARETTI_T_ALL_REFRACTORY_TO_THERAPY,1
GSE2405_HEAT_KILLED_LYSATE_V...4,SET,186,-0.010774,-0.0010784,0.06446,0.56637,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP,1
GOCC_CLATHRIN_VESICLE_COAT,SET,32,-0.025457,-0.0010613,0.15225,0.56639,GOCC_CLATHRIN_VESICLE_COAT,1
GOBP_CARNITINE_TRANSPORT,SET,7,-0.067237,-0.0013119,0.40209,0.5664,GOBP_CARNITINE_TRANSPORT,1
DITTMER_PTHLH_TARGETS_UP,SET,104,-0.014322,-0.0010743,0.085618,0.56642,DITTMER_PTHLH_TARGETS_UP,1
KEGG_MEDICUS_REFERENCE_DERMA...,SET,7,-0.056032,-0.0010933,0.33499,0.56642,KEGG_MEDICUS_REFERENCE_DERMATAN_SULFATE_DEGRADATION,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...2,SET,7,-0.050471,-0.0009848,0.30172,0.56642,CAO_BLOOD_FLUMIST_AGE_05_14YO_1DY_UP,1
GOMF_QUATERNARY_AMMONIUM_GRO...1,SET,36,-0.02454,-0.001085,0.1467,0.56643,GOMF_QUATERNARY_AMMONIUM_GROUP_BINDING,1
chr9q22,SET,72,-0.029858,-0.0018652,0.17843,0.56645,chr9q22,1
GOBP_NEGATIVE_REGULATION_OF_...658,SET,5,-0.060198,-0.00099277,0.35958,0.56648,GOBP_NEGATIVE_REGULATION_OF_TRIGLYCERIDE_CATABOLIC_PROCESS,1
BILANGES_SERUM_RESPONSE_TRAN...,SET,29,-0.025508,-0.0010124,0.15201,0.56663,BILANGES_SERUM_RESPONSE_TRANSLATION,1
GOMF_UBIQUINOL_CYTOCHROME_C_...,SET,5,-0.049514,-0.00081657,0.29506,0.56663,GOMF_UBIQUINOL_CYTOCHROME_C_REDUCTASE_ACTIVITY,1
MIR4724_5P,SET,116,-0.013414,-0.0010623,0.079928,0.56664,MIR4724_5P,1
GOMF_PHOSPHATIDYLINOSITOL_PH...1,SET,6,-0.051516,-0.00093065,0.3068,0.56667,GOMF_PHOSPHATIDYLINOSITOL_PHOSPHATE_4_PHOSPHATASE_ACTIVITY,1
GSE9878_CTRL_VS_EBF_TRANSDUC...1,SET,180,-0.0099445,-0.00097931,0.059195,0.56671,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_DN,1
GOCC_AP_3_ADAPTOR_COMPLEX,SET,11,-0.04034,-0.0009866,0.24,0.56674,GOCC_AP_3_ADAPTOR_COMPLEX,1
GOBP_PROTEIN_LOCALIZATION_TO...28,SET,53,-0.018461,-0.00098991,0.10978,0.56677,GOBP_PROTEIN_LOCALIZATION_TO_LYSOSOME,1
ODONNELL_METASTASIS_UP,SET,70,-0.017692,-0.0010898,0.10518,0.56679,ODONNELL_METASTASIS_UP,1
MIR6760_3P,SET,96,-0.014848,-0.0010703,0.088237,0.56681,MIR6760_3P,1
PID_WNT_SIGNALING_PATHWAY,SET,25,-0.031694,-0.0011681,0.18813,0.56689,PID_WNT_SIGNALING_PATHWAY,1
MIR4506,SET,42,-0.021013,-0.0010034,0.12465,0.56694,MIR4506,1
HP_PERIPHERAL_RETINAL_DEGENE...,SET,6,-0.064854,-0.0011716,0.3843,0.56701,HP_PERIPHERAL_RETINAL_DEGENERATION,1
MIR3688_3P,SET,368,-0.0075586,-0.0010588,0.04477,0.56703,MIR3688_3P,1
GSE17721_LPS_VS_PAM3CSK4_6H_...1,SET,182,-0.010012,-0.00099138,0.059281,0.56706,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_DN,1
GSE6092_B_BURGDOFERI_VS_B_BU...2,SET,160,-0.011275,-0.0010474,0.066704,0.56711,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_UP,1
GSE21360_NAIVE_VS_PRIMARY_ME...1,SET,170,-0.011477,-0.0010987,0.067887,0.56712,GSE21360_NAIVE_VS_PRIMARY_MEMORY_CD8_TCELL_DN,1
HASLINGER_B_CLL_WITH_CHROMOS...,SET,20,-0.030413,-0.0010027,0.17973,0.56718,HASLINGER_B_CLL_WITH_CHROMOSOME_12_TRISOMY,1
HP_RICKETS,SET,37,-0.02514,-0.0011269,0.14853,0.5672,HP_RICKETS,1
MIR25_5P,SET,6,-0.063988,-0.001156,0.3776,0.56728,MIR25_5P,1
GOBP_MONOCYTE_EXTRAVASATION,SET,9,-0.049909,-0.0011042,0.29447,0.56729,GOBP_MONOCYTE_EXTRAVASATION,1
GSE17721_PAM3CSK4_VS_GADIQUI...16,SET,179,-0.010015,-0.00098353,0.059036,0.56735,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_UP,1
HP_OCULAR_ANTERIOR_SEGMENT_D...,SET,273,-0.0085965,-0.0010399,0.050654,0.56738,HP_OCULAR_ANTERIOR_SEGMENT_DYSGENESIS,1
PEART_HDAC_PROLIFERATION_CLU...1,SET,68,-0.016829,-0.0010217,0.099149,0.56739,PEART_HDAC_PROLIFERATION_CLUSTER_DN,1
IKEDA_MIR30_TARGETS_DN,SET,22,-0.031786,-0.0010991,0.18699,0.56749,IKEDA_MIR30_TARGETS_DN,1
HUMMERICH_BENIGN_SKIN_TUMOR_...2,SET,15,-0.036613,-0.0010455,0.21534,0.5675,HUMMERICH_BENIGN_SKIN_TUMOR_UP,1
KEGG_MEDICUS_REFERENCE_CXCR4...1,SET,9,-0.052539,-0.0011624,0.30888,0.56753,KEGG_MEDICUS_REFERENCE_CXCR4_GNA12_13_RHO_SIGNALING_PATHWAY,1
MIR4527,SET,64,-0.018013,-0.0010611,0.10582,0.56758,MIR4527,1
HP_DEPRESSED_NASAL_RIDGE,SET,112,-0.013409,-0.0010436,0.078776,0.56758,HP_DEPRESSED_NASAL_RIDGE,1
GOMF_NADPH_OXIDASE_H202_FORM...,SET,5,-0.057864,-0.00095428,0.33972,0.56762,GOMF_NADPH_OXIDASE_H202_FORMING_ACTIVITY,1
WP_ACTIVATION_OF_NLRP3_INFLA...,SET,6,-0.05425,-0.00098003,0.31835,0.56765,WP_ACTIVATION_OF_NLRP3_INFLAMMASOME_BY_SARSCOV2,1
GOMF_HISTONE_H4K20_METHYLTRA...,SET,6,-0.058925,-0.0010645,0.34578,0.56765,GOMF_HISTONE_H4K20_METHYLTRANSFERASE_ACTIVITY,1
chr1q21,SET,161,-0.025735,-0.0023981,0.15101,0.56766,chr1q21,1
GOBP_HEMATOPOIETIC_STEM_CELL...4,SET,5,-0.054937,-0.000906,0.32221,0.56769,GOBP_HEMATOPOIETIC_STEM_CELL_MIGRATION_TO_BONE_MARROW,1
HP_DEXAMETHASONE_SUPPRESSIBL...,SET,5,-0.077711,-0.0012816,0.45576,0.56769,HP_DEXAMETHASONE_SUPPRESSIBLE_PRIMARY_HYPERALDOSTERONISM,1
KEGG_MEDICUS_REFERENCE_ANGII...,SET,7,-0.060863,-0.0011876,0.35685,0.56771,KEGG_MEDICUS_REFERENCE_ANGII_AT1R_NOX2_SIGNALING_PATHWAY,1
SMID_BREAST_CANCER_RELAPSE_I...4,SET,34,-0.026927,-0.0011571,0.15783,0.56774,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_UP,1
GOBP_OOCYTE_ANTERIOR_POSTERI...,SET,6,-0.048678,-0.00087937,0.28521,0.56776,GOBP_OOCYTE_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,1
GSE37301_MULTIPOTENT_PROGENI...6,SET,181,-0.010543,-0.0010411,0.061772,0.56776,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,1
MIR345_3P,SET,199,-0.01031,-0.001067,0.060293,0.56788,MIR345_3P,1
GOBP_LIPID_PHOSPHORYLATION,SET,10,-0.043893,-0.0010236,0.2567,0.56788,GOBP_LIPID_PHOSPHORYLATION,1
GOBP_REGULATION_OF_INTRACELL...5,SET,61,-0.017933,-0.0010314,0.10488,0.56788,GOBP_REGULATION_OF_INTRACELLULAR_STEROID_HORMONE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_ATP_DEPENDENT_DIACYLGLY...,SET,10,-0.043893,-0.0010236,0.2567,0.56788,GOMF_ATP_DEPENDENT_DIACYLGLYCEROL_KINASE_ACTIVITY,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...3,SET,71,-0.018866,-0.0011703,0.11031,0.56789,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_DN,1
GOBP_POSITIVE_REGULATION_OF_...836,SET,30,-0.029476,-0.0011899,0.17233,0.5679,GOBP_POSITIVE_REGULATION_OF_VASOCONSTRICTION,1
GOBP_BEHAVIORAL_RESPONSE_TO_...1,SET,16,-0.037285,-0.0010996,0.2179,0.56793,GOBP_BEHAVIORAL_RESPONSE_TO_COCAINE,1
MIR12133,SET,352,-0.0080113,-0.001098,0.046786,0.56798,MIR12133,1
MIR6077,SET,220,-0.0098621,-0.0010725,0.057596,0.56798,MIR6077,1
RICKMAN_HEAD_AND_NECK_CANCER...6,SET,50,-0.022141,-0.0011533,0.12921,0.56803,RICKMAN_HEAD_AND_NECK_CANCER_F,1
GSE44649_NAIVE_VS_ACTIVATED_...1,SET,176,-0.010395,-0.0010123,0.060632,0.56806,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_DN,1
MANNO_MIDBRAIN_NEUROTYPES_HO...1,SET,339,-0.0083155,-0.0011189,0.048479,0.5681,MANNO_MIDBRAIN_NEUROTYPES_HOMTN,1
GSE17721_PAM3CSK4_VS_CPG_6H_...1,SET,187,-0.010451,-0.0010489,0.060905,0.56812,GSE17721_PAM3CSK4_VS_CPG_6H_BMDC_DN,1
HP_THORACIC_DYSPLASIA,SET,4,-0.061614,-0.00090887,0.35885,0.56816,HP_THORACIC_DYSPLASIA,1
KEGG_LYSINE_DEGRADATION,SET,37,-0.02227,-0.0009982,0.12967,0.56818,KEGG_LYSINE_DEGRADATION,1
MODULE_324,SET,126,-0.014332,-0.0011826,0.083412,0.56821,MODULE_324,1
HP_HYPOKALEMIC_ALKALOSIS,SET,12,-0.04469,-0.0011416,0.25987,0.56827,HP_HYPOKALEMIC_ALKALOSIS,1
ATGTTTC_MIR494,SET,142,-0.012371,-0.0010831,0.071922,0.56828,ATGTTTC_MIR494,1
BIOCARTA_PTC1_PATHWAY,SET,11,-0.038748,-0.00094767,0.2252,0.5683,BIOCARTA_PTC1_PATHWAY,1
GSE42021_CD24INT_VS_CD24LOW_...4,SET,172,-0.01101,-0.0010602,0.063964,0.56833,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_UP,1
GSE36476_CTRL_VS_TSST_ACT_40...4,SET,177,-0.011056,-0.0010798,0.064184,0.56838,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_YOUNG_UP,1
GOBP_REGULATION_OF_LONG_TERM...2,SET,12,-0.050394,-0.0012873,0.29242,0.56841,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_DEPRESSION,1
GSE16385_MONOCYTE_VS_12H_IFN...2,SET,183,-0.010589,-0.0010514,0.061437,0.56842,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_UP,1
GSE3982_CENT_MEMORY_CD4_TCEL...3,SET,182,-0.010078,-0.00099791,0.058451,0.56844,GSE3982_CENT_MEMORY_CD4_TCELL_VS_TH1_DN,1
GOBP_GANGLIOSIDE_CATABOLIC_P...,SET,7,-0.059607,-0.0011631,0.34532,0.56852,GOBP_GANGLIOSIDE_CATABOLIC_PROCESS,1
GNF2_TNFRSF1B,SET,58,-0.019507,-0.0010941,0.11298,0.56854,GNF2_TNFRSF1B,1
SHARMA_PILOCYTIC_ASTROCYTOMA...1,SET,6,-0.069552,-0.0012565,0.40277,0.56855,SHARMA_PILOCYTIC_ASTROCYTOMA_LOCATION_DN,1
WP_PLATELETMEDIATED_INTERACT...,SET,15,-0.0396,-0.0011309,0.22925,0.56857,WP_PLATELETMEDIATED_INTERACTIONS_WITH_VASCULAR_AND_CIRCULATING_CELLS,1
HP_FUSION_OF_THE_CEREBELLAR_...,SET,5,-0.055061,-0.00090806,0.31869,0.56858,HP_FUSION_OF_THE_CEREBELLAR_HEMISPHERES,1
GOBP_INTRACELLULAR_TRANSPORT...,SET,10,-0.048191,-0.0011238,0.27887,0.5686,GOBP_INTRACELLULAR_TRANSPORT_OF_VIRUS,1
GOBP_POSITIVE_REGULATION_OF_...102,SET,8,-0.054411,-0.001135,0.31485,0.5686,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_ACTIVATION,1
GOBP_VITAMIN_BIOSYNTHETIC_PR...,SET,24,-0.030729,-0.0011097,0.17781,0.5686,GOBP_VITAMIN_BIOSYNTHETIC_PROCESS,1
GSE15930_STIM_VS_STIM_AND_TR...2,SET,177,-0.010928,-0.0010673,0.063236,0.5686,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_24H_CD8_T_CELL_UP,1
GOBP_PROTEIN_POLY_ADP_RIBOSY...,SET,10,-0.042533,-0.00099185,0.24601,0.56863,GOBP_PROTEIN_POLY_ADP_RIBOSYLATION,1
MIR6839_5P,SET,88,-0.016449,-0.0011355,0.095131,0.56864,MIR6839_5P,1
HP_BRUSHFIELD_SPOTS,SET,12,-0.040055,-0.0010232,0.23158,0.56866,HP_BRUSHFIELD_SPOTS,1
GSE13306_TREG_VS_TCONV_LAMIN...1,SET,181,-0.010578,-0.0010445,0.061134,0.56868,GSE13306_TREG_VS_TCONV_LAMINA_PROPRIA_DN,1
WENDT_COHESIN_TARGETS_UP,SET,31,-0.026934,-0.0011052,0.15563,0.5687,WENDT_COHESIN_TARGETS_UP,1
CIC_TARGET_GENES,SET,376,-0.0075632,-0.0010707,0.043688,0.56872,CIC_TARGET_GENES,1
HP_ABNORMAL_GALLBLADDER_MORP...,SET,84,-0.016228,-0.0010946,0.093714,0.56874,HP_ABNORMAL_GALLBLADDER_MORPHOLOGY,1
MIR451A,SET,6,-0.065199,-0.0011778,0.37644,0.56875,MIR451A,1
GOBP_MACROPHAGE_FUSION,SET,6,-0.063793,-0.0011524,0.36792,0.56883,GOBP_MACROPHAGE_FUSION,1
MODULE_155,SET,24,-0.028855,-0.001042,0.16636,0.56885,MODULE_155,1
GOMF_SECONDARY_ACTIVE_MONOCA...,SET,17,-0.036899,-0.0011217,0.21259,0.5689,GOMF_SECONDARY_ACTIVE_MONOCARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_HORMONE_B...,SET,23,-0.032805,-0.0011598,0.1889,0.56893,GOBP_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
LAKE_ADULT_KIDNEY_C5_PROXIMA...,SET,359,-0.0079312,-0.0010976,0.045674,0.56893,LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM,1
GOBP_HEART_FORMATION,SET,31,-0.029453,-0.0012086,0.16953,0.56896,GOBP_HEART_FORMATION,1
GOBP_CORTISOL_METABOLIC_PROC...,SET,12,-0.046264,-0.0011818,0.26613,0.569,GOBP_CORTISOL_METABOLIC_PROCESS,1
HP_ABNORMAL_TOENAIL_MORPHOLO...,SET,152,-0.011781,-0.0010669,0.067722,0.56905,HP_ABNORMAL_TOENAIL_MORPHOLOGY,1
HP_ABNORMAL_THALAMIC_MRI_SIG...,SET,32,-0.023901,-0.00099642,0.13736,0.56907,HP_ABNORMAL_THALAMIC_MRI_SIGNAL_INTENSITY,1
GOBP_EPHRIN_RECEPTOR_SIGNALI...,SET,48,-0.021904,-0.0011179,0.12577,0.56913,GOBP_EPHRIN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_DIACYLGLYCEROL_METABOLI...,SET,25,-0.029642,-0.0010925,0.17018,0.56914,GOBP_DIACYLGLYCEROL_METABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_AL...1,SET,96,-0.015813,-0.0011399,0.090729,0.56918,GOBP_CELLULAR_RESPONSE_TO_ALCOHOL,1
GSE11884_WT_VS_FURIN_KO_NAIV...1,SET,116,-0.013725,-0.0010869,0.078663,0.56925,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_DN,1
MIR1236_5P,SET,73,-0.016704,-0.0010507,0.09572,0.56927,MIR1236_5P,1
GSE26488_WT_VS_HDAC7_KO_DOUB...2,SET,159,-0.011929,-0.0011047,0.068355,0.56927,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,1
WP_SREBF_AND_MIR33_IN_CHOLES...,SET,16,-0.034797,-0.0010263,0.19929,0.56931,WP_SREBF_AND_MIR33_IN_CHOLESTEROL_AND_LIPID_HOMEOSTASIS,1
GOBP_REGULATION_OF_SKELETAL_...7,SET,4,-0.077365,-0.0011412,0.44274,0.56936,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION,1
HASLINGER_B_CLL_WITH_13Q14_D...,SET,23,-0.032231,-0.0011395,0.18442,0.56937,HASLINGER_B_CLL_WITH_13Q14_DELETION,1
HP_OLIGURIA,SET,13,-0.042308,-0.0011248,0.24206,0.56937,HP_OLIGURIA,1
WP_RELATIONSHIP_BETWEEN_INFL...,SET,25,-0.030466,-0.0011229,0.17424,0.5694,WP_RELATIONSHIP_BETWEEN_INFLAMMATION_COX2_AND_EGFR,1
WP_TRANSLATION_FACTORS,SET,44,-0.01985,-0.00097008,0.11348,0.56943,WP_TRANSLATION_FACTORS,1
HP_NARROW_MOUTH,SET,208,-0.010361,-0.001096,0.059225,0.56944,HP_NARROW_MOUTH,1
WP_CELL_DIFFERENTIATION_EXPA...,SET,18,-0.038808,-0.0012139,0.22174,0.56946,WP_CELL_DIFFERENTIATION_EXPANDED_INDEX,1
FIGUEROA_AML_METHYLATION_CLU...13,SET,4,-0.088635,-0.0013075,0.50617,0.5695,FIGUEROA_AML_METHYLATION_CLUSTER_7_DN,1
BIOCARTA_PLK3_PATHWAY,SET,8,-0.045134,-0.00094144,0.25769,0.56952,BIOCARTA_PLK3_PATHWAY,1
GOCC_PHOSPHORYLASE_KINASE_CO...,SET,3,-0.070391,-0.00089926,0.40122,0.56963,GOCC_PHOSPHORYLASE_KINASE_COMPLEX,1
BIOCARTA_PML_PATHWAY,SET,17,-0.035539,-0.0010804,0.20256,0.56964,BIOCARTA_PML_PATHWAY,1
GSE29164_CD8_TCELL_VS_CD8_TC...2,SET,175,-0.01064,-0.0010333,0.060642,0.56964,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,1
REACTOME_FANCONI_ANEMIA_PATH...,SET,30,-0.02362,-0.00095349,0.1346,0.56965,REACTOME_FANCONI_ANEMIA_PATHWAY,1
GSE23502_WT_VS_HDC_KO_MYELOI...4,SET,185,-0.011022,-0.0011002,0.062752,0.56971,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_UP,1
ALKBH3_TARGET_GENES,SET,353,-0.0077903,-0.0010692,0.04435,0.56972,ALKBH3_TARGET_GENES,1
BUSSLINGER_GASTRIC_TUFT_CELLS,SET,11,-0.051466,-0.0012587,0.29292,0.56973,BUSSLINGER_GASTRIC_TUFT_CELLS,1
HP_ABNORMAL_BLOOD_SODIUM_CON...,SET,63,-0.020058,-0.0011723,0.11415,0.56974,HP_ABNORMAL_BLOOD_SODIUM_CONCENTRATION,1
HP_ABNORMAL_FEMORAL_NECK_HEA...,SET,180,-0.011028,-0.001086,0.062761,0.56974,HP_ABNORMAL_FEMORAL_NECK_HEAD_MORPHOLOGY,1
GSE35435_RESTING_VS_IL4_TREA...2,SET,175,-0.010734,-0.0010424,0.061079,0.56975,GSE35435_RESTING_VS_IL4_TREATED_MACROPHAGE_UP,1
GOCC_SECRETORY_GRANULE,SET,826,-0.0053995,-0.0011187,0.030699,0.56981,GOCC_SECRETORY_GRANULE,1
GOBP_VACUOLE_ORGANIZATION,SET,212,-0.0097996,-0.0010464,0.055699,0.56983,GOBP_VACUOLE_ORGANIZATION,1
MIR629_5P,SET,102,-0.015084,-0.0011206,0.08569,0.56986,MIR629_5P,1
GSE34156_UNTREATED_VS_6H_TLR...1,SET,163,-0.011268,-0.0010564,0.064004,0.56987,GSE34156_UNTREATED_VS_6H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
GSE369_PRE_VS_POST_IL6_INJEC...2,SET,176,-0.011141,-0.001085,0.063261,0.5699,GSE369_PRE_VS_POST_IL6_INJECTION_IFNG_KO_LIVER_UP,1
TTGGGAG_MIR150,SET,82,-0.015881,-0.0010584,0.090159,0.56991,TTGGGAG_MIR150,1
GSE17721_CTRL_VS_GARDIQUIMOD...8,SET,177,-0.011223,-0.001096,0.063614,0.57001,GSE17721_CTRL_VS_GARDIQUIMOD_24H_BMDC_UP,1
HP_SECONDARY_MICROCEPHALY,SET,174,-0.011049,-0.00107,0.062573,0.57008,HP_SECONDARY_MICROCEPHALY,1
GOBP_NEGATIVE_REGULATION_OF_...661,SET,5,-0.069282,-0.0011426,0.39192,0.57016,GOBP_NEGATIVE_REGULATION_OF_TUBULIN_DEACETYLATION,1
WP_OXIDATIVE_STRESS_RESPONSE,SET,29,-0.029776,-0.0011819,0.16821,0.57025,WP_OXIDATIVE_STRESS_RESPONSE,1
HP_RHABDOMYOMA,SET,5,-0.073135,-0.0012061,0.41318,0.57025,HP_RHABDOMYOMA,1
GOBP_CHROMATIN_LOOPING,SET,10,-0.039657,-0.00092478,0.224,0.57026,GOBP_CHROMATIN_LOOPING,1
MIR1289,SET,52,-0.022368,-0.0011881,0.1263,0.57029,MIR1289,1
MIR4652_5P,SET,32,-0.02483,-0.0010352,0.13999,0.57039,MIR4652_5P,1
KEGG_MEDICUS_REFERENCE_GPCR_...1,SET,31,-0.027976,-0.001148,0.1576,0.57045,KEGG_MEDICUS_REFERENCE_GPCR_PI3K_SIGNALING_PATHWAY,1
YAO_TEMPORAL_RESPONSE_TO_PRO...16,SET,69,-0.016996,-0.0010394,0.095718,0.57046,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7,1
GSE21063_CTRL_VS_ANTI_IGM_ST...11,SET,174,-0.010665,-0.0010328,0.060029,0.57051,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_DN,1
MIR5186,SET,31,-0.026101,-0.001071,0.14689,0.57052,MIR5186,1
BIOCARTA_ERYTH_PATHWAY,SET,15,-0.042802,-0.0012223,0.24079,0.57054,BIOCARTA_ERYTH_PATHWAY,1
GOMF_MUSCLE_ALPHA_ACTININ_BI...,SET,15,-0.041293,-0.0011792,0.23216,0.57059,GOMF_MUSCLE_ALPHA_ACTININ_BINDING,1
GOMF_I_SMAD_BINDING,SET,16,-0.042702,-0.0012594,0.23999,0.57061,GOMF_I_SMAD_BINDING,1
GOBP_NEURONAL_STEM_CELL_POPU...,SET,25,-0.029353,-0.0010818,0.16495,0.57062,GOBP_NEURONAL_STEM_CELL_POPULATION_MAINTENANCE,1
REACTOME_INTERCONVERSION_OF_...,SET,28,-0.029718,-0.0011591,0.16696,0.57064,REACTOME_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES,1
GOCC_P_BODY,SET,93,-0.015483,-0.0010986,0.086946,0.57067,GOCC_P_BODY,1
MIYAGAWA_TARGETS_OF_EWSR1_ET...2,SET,239,-0.010784,-0.0012217,0.060523,0.57071,MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_UP,1
GSE2706_UNSTIM_VS_2H_LPS_DC_...2,SET,155,-0.011239,-0.0010277,0.06306,0.57072,GSE2706_UNSTIM_VS_2H_LPS_DC_UP,1
GSE13485_DAY3_VS_DAY21_YF17D...1,SET,139,-0.013273,-0.0011499,0.074459,0.57074,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
GOBP_REGULATION_OF_INTRINSIC...6,SET,8,-0.052433,-0.0010937,0.29408,0.57075,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
ATCMNTCCGY_UNKNOWN,SET,47,-0.021339,-0.0010777,0.11965,0.57077,ATCMNTCCGY_UNKNOWN,1
GSE39152_CD103_NEG_VS_POS_ME...1,SET,186,-0.010923,-0.0010932,0.061226,0.57079,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN,1
MORF_RAN,SET,232,-0.0091628,-0.0010229,0.051358,0.5708,MORF_RAN,1
GOCC_VOLTAGE_GATED_CALCIUM_C...,SET,41,-0.024298,-0.0011463,0.1361,0.57085,GOCC_VOLTAGE_GATED_CALCIUM_CHANNEL_COMPLEX,1
BROWNE_HCMV_INFECTION_24HR_DN,SET,131,-0.013278,-0.001117,0.074334,0.57088,BROWNE_HCMV_INFECTION_24HR_DN,1
HP_IRREGULAR_ILIAC_CREST,SET,6,-0.064564,-0.0011664,0.36118,0.57093,HP_IRREGULAR_ILIAC_CREST,1
GSE3720_UNSTIM_VS_PMA_STIM_V...3,SET,173,-0.011126,-0.0010743,0.062223,0.57095,GSE3720_UNSTIM_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_DN,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...1,SET,7,-0.052624,-0.0010268,0.29429,0.57096,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
GSE7460_WT_VS_FOXP3_HET_ACT_...3,SET,176,-0.011349,-0.0011053,0.063394,0.57104,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_DN,1
MIKKELSEN_NPC_HCP_WITH_H3K4M...,SET,203,-0.011599,-0.0012122,0.064755,0.57108,MIKKELSEN_NPC_HCP_WITH_H3K4ME3_AND_H3K27ME3,1
GSE17721_CPG_VS_GARDIQUIMOD_...1,SET,186,-0.010962,-0.0010972,0.061184,0.57109,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
GSE37605_C57BL6_VS_NOD_FOXP3...7,SET,177,-0.011294,-0.001103,0.062991,0.57115,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_DN,1
MIR4649_5P,SET,8,-0.05115,-0.0010669,0.2852,0.57117,MIR4649_5P,1
GSE17721_CTRL_VS_GARDIQUIMOD...16,SET,179,-0.011222,-0.001102,0.06256,0.57118,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_UP,1
MIR4268,SET,54,-0.021783,-0.001179,0.1214,0.5712,MIR4268,1
GOCC_ENDOSOME,SET,963,-0.0049838,-0.0011105,0.027763,0.57123,GOCC_ENDOSOME,1
BURTON_ADIPOGENESIS_5,SET,101,-0.014012,-0.0010358,0.077976,0.5713,BURTON_ADIPOGENESIS_5,1
ZMYM2_TARGET_GENES,SET,109,-0.014654,-0.0011252,0.081536,0.57131,ZMYM2_TARGET_GENES,1
GSE20715_WT_VS_TLR4_KO_24H_O...2,SET,179,-0.01147,-0.0011265,0.063828,0.57131,GSE20715_WT_VS_TLR4_KO_24H_OZONE_LUNG_UP,1
MODULE_272,SET,12,-0.038162,-0.0009748,0.21231,0.57132,MODULE_272,1
GOCC_U2AF_COMPLEX,SET,3,-0.0806,-0.0010297,0.44822,0.57135,GOCC_U2AF_COMPLEX,1
GSE14908_RESTING_VS_HDM_STIM...1,SET,185,-0.010918,-0.0010898,0.060698,0.57137,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...11,SET,52,-0.020143,-0.0010699,0.11194,0.5714,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2,1
GOMF_LBD_DOMAIN_BINDING,SET,6,-0.073075,-0.0013201,0.40613,0.5714,GOMF_LBD_DOMAIN_BINDING,1
HP_ABNORMAL_SPERM_HEAD_MORPH...,SET,26,-0.031445,-0.0011819,0.1747,0.57142,HP_ABNORMAL_SPERM_HEAD_MORPHOLOGY,1
HP_INTESTINAL_PSEUDO_OBSTRUC...,SET,18,-0.033284,-0.0010411,0.18488,0.57144,HP_INTESTINAL_PSEUDO_OBSTRUCTION,1
WP_MICROGLIA_PATHOGEN_PHAGOC...,SET,37,-0.026254,-0.0011768,0.1458,0.57145,WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY,1
HP_ABNORMAL_SHAPE_OF_THE_PAL...,SET,51,-0.020668,-0.0010872,0.11474,0.57147,HP_ABNORMAL_SHAPE_OF_THE_PALPEBRAL_FISSURE,1
MIR4662A_3P,SET,63,-0.019469,-0.0011379,0.10801,0.57152,MIR4662A_3P,1
PID_MYC_PATHWAY,SET,25,-0.030354,-0.0011187,0.16839,0.57153,PID_MYC_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...704,SET,7,-0.061939,-0.0012086,0.34351,0.57154,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_METABOLIC_PROCESS,1
GOBP_RELAXATION_OF_CARDIAC_M...,SET,17,-0.038988,-0.0011852,0.2162,0.57156,GOBP_RELAXATION_OF_CARDIAC_MUSCLE,1
GOMF_G_PROTEIN_COUPLED_ADENO...,SET,5,-0.070064,-0.0011555,0.38815,0.57162,GOMF_G_PROTEIN_COUPLED_ADENOSINE_RECEPTOR_ACTIVITY,1
GOBP_CELL_PROLIFERATION_INVO...3,SET,9,-0.061438,-0.0013592,0.34033,0.57163,GOBP_CELL_PROLIFERATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,1
MIR1910_5P,SET,76,-0.017549,-0.0011262,0.0972,0.57164,MIR1910_5P,1
GATA_Q6,SET,177,-0.01199,-0.001171,0.066372,0.57168,GATA_Q6,1
NCOA2_TARGET_GENES,SET,380,-0.0080722,-0.0011486,0.044609,0.5718,NCOA2_TARGET_GENES,1
HP_LOW_PLASMA_CITRULLINE,SET,5,-0.067828,-0.0011186,0.37434,0.57189,HP_LOW_PLASMA_CITRULLINE,1
HP_EEG_WITH_POLYSPIKE_WAVE_C...,SET,46,-0.023745,-0.0011864,0.13103,0.5719,HP_EEG_WITH_POLYSPIKE_WAVE_COMPLEXES,1
GSE22886_IGG_IGA_MEMORY_BCEL...4,SET,179,-0.011463,-0.0011257,0.063222,0.57194,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_UP,1
REACTOME_PURINERGIC_SIGNALIN...,SET,23,-0.031233,-0.0011042,0.17212,0.57199,REACTOME_PURINERGIC_SIGNALING_IN_LEISHMANIASIS_INFECTION,1
HP_SHOULDER_GIRDLE_MUSCLE_AT...,SET,13,-0.039737,-0.0010565,0.21899,0.57199,HP_SHOULDER_GIRDLE_MUSCLE_ATROPHY,1
GOBP_NEUTRAL_AMINO_ACID_TRAN...,SET,54,-0.021394,-0.001158,0.1179,0.572,GOBP_NEUTRAL_AMINO_ACID_TRANSPORT,1
HP_HYDROMETROCOLPOS,SET,28,-0.0289,-0.0011271,0.15922,0.57202,HP_HYDROMETROCOLPOS,1
GSE17721_POLYIC_VS_GARDIQUIM...16,SET,186,-0.011565,-0.0011575,0.063684,0.57205,GSE17721_POLYIC_VS_GARDIQUIMOD_6H_BMDC_UP,1
GOBP_ANDROGEN_RECEPTOR_SIGNA...,SET,43,-0.022331,-0.0010789,0.12289,0.57209,GOBP_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_B_1_B_CELL_DIFFERENTIAT...,SET,5,-0.07552,-0.0012455,0.41532,0.57214,GOBP_B_1_B_CELL_DIFFERENTIATION,1
HP_PATENT_FORAMEN_OVALE,SET,112,-0.013791,-0.0010733,0.07585,0.57214,HP_PATENT_FORAMEN_OVALE,1
GOBP_REGULATION_OF_INTERLEUK...1,SET,9,-0.04947,-0.0010944,0.27187,0.57219,GOBP_REGULATION_OF_INTERLEUKIN_1_MEDIATED_SIGNALING_PATHWAY,1
REACTOME_REGULATION_OF_TBK1_...2,SET,10,-0.055547,-0.0012953,0.30516,0.57222,REACTOME_REGULATION_OF_TBK1_IKK_MEDIATED_ACTIVATION_OF_IRF3_IRF7_UPON_TLR3_LIGATION,1
GOBP_VESICLE_COATING,SET,37,-0.022556,-0.001011,0.12387,0.57224,GOBP_VESICLE_COATING,1
GOBP_NEGATIVE_REGULATION_OF_...35,SET,16,-0.038249,-0.0011281,0.21004,0.57225,GOBP_NEGATIVE_REGULATION_OF_ATP_DEPENDENT_ACTIVITY,1
GOCC_ATAC_COMPLEX,SET,12,-0.039302,-0.0010039,0.21581,0.57225,GOCC_ATAC_COMPLEX,1
BILANGES_SERUM_SENSITIVE_VIA...1,SET,20,-0.03569,-0.0011767,0.19591,0.57228,BILANGES_SERUM_SENSITIVE_VIA_TSC1,1
GOBP_NEGATIVE_REGULATION_OF_...700,SET,26,-0.033793,-0.0012701,0.18549,0.57228,GOBP_NEGATIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,1
GOCC_MIGRASOME,SET,5,-0.068098,-0.0011231,0.37376,0.57229,GOCC_MIGRASOME,1
HP_PERINUCLEAR_ANTINEUTROPHI...,SET,6,-0.054795,-0.00098988,0.30074,0.57229,HP_PERINUCLEAR_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,1
GSE29618_PRE_VS_DAY7_FLU_VAC...4,SET,174,-0.012027,-0.0011647,0.066008,0.57229,GSE29618_PRE_VS_DAY7_FLU_VACCINE_MDC_UP,1
MIR1179,SET,108,-0.014579,-0.0011143,0.079992,0.57231,MIR1179,1
REACTOME_ANTI_INFLAMMATORY_R...,SET,74,-0.017952,-0.0011368,0.098474,0.57232,REACTOME_ANTI_INFLAMMATORY_RESPONSE_FAVOURING_LEISHMANIA_PARASITE_INFECTION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...37,SET,25,-0.030986,-0.001142,0.16994,0.57234,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS,1
REACTOME_POLYMERASE_SWITCHIN...,SET,24,-0.028441,-0.0010271,0.15594,0.57236,REACTOME_POLYMERASE_SWITCHING_ON_THE_C_STRAND_OF_THE_TELOMERE,1
MIR6745,SET,85,-0.016618,-0.0011275,0.09111,0.57236,MIR6745,1
GSE17721_CTRL_VS_LPS_24H_BMD...1,SET,185,-0.010894,-0.0010875,0.059714,0.57238,GSE17721_CTRL_VS_LPS_24H_BMDC_DN,1
NEWMAN_ERCC6_TARGETS_UP,SET,23,-0.039118,-0.001383,0.21429,0.57242,NEWMAN_ERCC6_TARGETS_UP,1
GSE6674_CPG_VS_PL2_3_STIM_BC...1,SET,175,-0.011282,-0.0010956,0.061796,0.57243,GSE6674_CPG_VS_PL2_3_STIM_BCELL_DN,1
GOBP_GOLGI_VESICLE_TRANSPORT,SET,281,-0.0088338,-0.0010839,0.048383,0.57244,GOBP_GOLGI_VESICLE_TRANSPORT,1
HE_LIM_SUN_FETAL_LUNG_C1_EAR...1,SET,32,-0.031788,-0.0013253,0.17379,0.57257,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_AIRWAY_PROGENITOR_CELL,1
GOCC_GROWTH_FACTOR_COMPLEX,SET,8,-0.065543,-0.0013671,0.35787,0.57266,GOCC_GROWTH_FACTOR_COMPLEX,1
GSE18281_PERIMEDULLARY_CORTI...3,SET,157,-0.01225,-0.0011274,0.066833,0.57272,GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_DN,1
GSE3982_MAC_VS_TH1_DN,SET,180,-0.011095,-0.0010926,0.060492,0.57276,GSE3982_MAC_VS_TH1_DN,1
GSE22935_UNSTIM_VS_12H_MBOVI...4,SET,187,-0.011732,-0.0011773,0.063955,0.57277,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
GOMF_CXCR3_CHEMOKINE_RECEPTO...,SET,5,-0.087139,-0.0014371,0.4746,0.57284,GOMF_CXCR3_CHEMOKINE_RECEPTOR_BINDING,1
GOMF_ODORANT_BINDING,SET,95,-0.021462,-0.001539,0.11685,0.57286,GOMF_ODORANT_BINDING,1
GAVISH_3CA_METAPROGRAM_FIBRO...19,SET,49,-0.023629,-0.0012184,0.12864,0.57287,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MYOFIBROBLASTS,1
GOCC_CUL5_RING_UBIQUITIN_LIG...,SET,8,-0.056568,-0.00118,0.30796,0.57287,GOCC_CUL5_RING_UBIQUITIN_LIGASE_COMPLEX,1
GOMF_FIBROBLAST_GROWTH_FACTO...2,SET,5,-0.076721,-0.0012653,0.41764,0.57287,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_ACTIVITY,1
GOMF_ADENYLYLTRANSFERASE_ACT...,SET,21,-0.034336,-0.00116,0.18679,0.57292,GOMF_ADENYLYLTRANSFERASE_ACTIVITY,1
REACTOME_VESICLE_MEDIATED_TR...,SET,632,-0.0061128,-0.0011139,0.03322,0.573,REACTOME_VESICLE_MEDIATED_TRANSPORT,1
MIR583,SET,156,-0.012431,-0.0011404,0.067534,0.57302,MIR583,1
GOMF_POLY_A_SPECIFIC_RIBONUC...,SET,12,-0.044256,-0.0011305,0.24044,0.57302,GOMF_POLY_A_SPECIFIC_RIBONUCLEASE_ACTIVITY,1
GOBP_ESTABLISHMENT_OF_PROTEI...5,SET,241,-0.0097723,-0.0011117,0.053053,0.57307,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
FULLER_PBMC_F_TULARENSIS_VAC...3,SET,37,-0.025101,-0.0011251,0.13628,0.57307,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_DN,1
WP_NUCLEOTIDE_EXCISION_REPAI...,SET,55,-0.017579,-0.0009602,0.095394,0.5731,WP_NUCLEOTIDE_EXCISION_REPAIR_IN_XERODERMA_PIGMENTOSUM,1
MIR4732_5P,SET,18,-0.033916,-0.0010609,0.18405,0.5731,MIR4732_5P,1
GOMF_PHOSPHOLIPASE_INHIBITOR...,SET,12,-0.049098,-0.0012542,0.26634,0.57313,GOMF_PHOSPHOLIPASE_INHIBITOR_ACTIVITY,1
MODULE_245,SET,25,-0.031014,-0.0011431,0.16811,0.57318,MODULE_245,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...3,SET,96,-0.016447,-0.0011856,0.089124,0.5732,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGE_3DY_UP,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...2,SET,11,-0.045381,-0.0011099,0.24569,0.57327,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_MICROTUBULE_BASED_PROCE...,SET,831,-0.0053251,-0.0011064,0.028814,0.57331,GOBP_MICROTUBULE_BASED_PROCESS,1
HP_MUSCULAR_VENTRICULAR_SEPT...,SET,22,-0.033607,-0.001162,0.18183,0.57332,HP_MUSCULAR_VENTRICULAR_SEPTAL_DEFECT,1
GSE17721_LPS_VS_CPG_6H_BMDC_...2,SET,175,-0.011591,-0.0011257,0.062698,0.57334,GSE17721_LPS_VS_CPG_6H_BMDC_UP,1
WONG_PROTEASOME_GENE_MODULE,SET,47,-0.021537,-0.0010877,0.11647,0.57335,WONG_PROTEASOME_GENE_MODULE,1
NGUYEN_NOTCH1_TARGETS_DN,SET,78,-0.018014,-0.001171,0.097389,0.57337,NGUYEN_NOTCH1_TARGETS_DN,1
MIR543,SET,295,-0.0092455,-0.0011619,0.049978,0.57338,MIR543,1
HALLMARK_HEDGEHOG_SIGNALING,SET,33,-0.02914,-0.0012337,0.15748,0.5734,HALLMARK_HEDGEHOG_SIGNALING,1
NAGY_PCAF_COMPONENTS_HUMAN,SET,9,-0.047233,-0.001045,0.2551,0.57344,NAGY_PCAF_COMPONENTS_HUMAN,1
GOBP_NOREPINEPHRINE_UPTAKE,SET,8,-0.066078,-0.0013783,0.35685,0.57345,GOBP_NOREPINEPHRINE_UPTAKE,1
GSE17721_LPS_VS_GARDIQUIMOD_...11,SET,190,-0.010998,-0.0011125,0.059358,0.5735,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...770,SET,17,-0.035804,-0.0010884,0.19318,0.57352,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_III,1
GOCC_WNT_SIGNALOSOME,SET,13,-0.042737,-0.0011362,0.23054,0.57353,GOCC_WNT_SIGNALOSOME,1
GOBP_REGULATION_OF_T_CELL_AC...1,SET,358,-0.0089095,-0.0012313,0.048034,0.57357,GOBP_REGULATION_OF_T_CELL_ACTIVATION,1
GSE41867_DAY6_VS_DAY8_LCMV_C...2,SET,179,-0.011686,-0.0011477,0.062988,0.57359,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
FAN_EMBRYONIC_CTX_BRAIN_ENDO...1,SET,402,-0.0083346,-0.0012191,0.044917,0.5736,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_1,1
REACTOME_DISASSEMBLY_OF_THE_...,SET,29,-0.028596,-0.001135,0.15407,0.57362,REACTOME_DISASSEMBLY_OF_THE_DESTRUCTION_COMPLEX_AND_RECRUITMENT_OF_AXIN_TO_THE_MEMBRANE,1
WP_RESISTIN_AS_A_REGULATOR_O...,SET,32,-0.026863,-0.0011199,0.14472,0.57363,WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION,1
GOMF_INOSITOL_TETRAKISPHOSPH...1,SET,5,-0.077526,-0.0012785,0.4174,0.57367,GOMF_INOSITOL_TETRAKISPHOSPHATE_KINASE_ACTIVITY,1
REACTOME_SEROTONIN_NEUROTRAN...,SET,16,-0.040388,-0.0011911,0.21736,0.5737,REACTOME_SEROTONIN_NEUROTRANSMITTER_RELEASE_CYCLE,1
MIR3929,SET,73,-0.018293,-0.0011506,0.098387,0.57375,MIR3929,1
MIR4758_3P,SET,50,-0.020458,-0.0010656,0.11001,0.57376,MIR4758_3P,1
GOBP_NEGATIVE_REGULATION_OF_...171,SET,7,-0.065027,-0.0012688,0.34967,0.57376,GOBP_NEGATIVE_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
GOBP_DEVELOPMENTAL_INDUCTION,SET,30,-0.030879,-0.0012466,0.16601,0.57378,GOBP_DEVELOPMENTAL_INDUCTION,1
GOBP_REGULATION_OF_PROTEIN_C...4,SET,375,-0.0079937,-0.0011301,0.042976,0.57378,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
REACTOME_SWITCHING_OF_ORIGIN...,SET,88,-0.015161,-0.0010466,0.081427,0.57385,REACTOME_SWITCHING_OF_ORIGINS_TO_A_POST_REPLICATIVE_STATE,1
GSE5589_IL6_KO_VS_IL10_KO_LP...1,SET,179,-0.011908,-0.0011694,0.063884,0.57393,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,1
GOBP_REGULATION_OF_GLUCOSYLC...,SET,2,-0.12657,-0.0013202,0.67892,0.57394,GOBP_REGULATION_OF_GLUCOSYLCERAMIDE_CATABOLIC_PROCESS,1
GOBP_PERICENTRIC_HETEROCHROM...,SET,3,-0.10612,-0.0013557,0.56902,0.57397,GOBP_PERICENTRIC_HETEROCHROMATIN_FORMATION,1
GOMF_AMINOACYLASE_ACTIVITY,SET,4,-0.081583,-0.0012034,0.43714,0.57402,GOMF_AMINOACYLASE_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C3_INT...,SET,354,-0.0089693,-0.0012327,0.04806,0.57402,HE_LIM_SUN_FETAL_LUNG_C3_INTERMEDIATE_LYMPHATIC_ENDO_CELL,1
GSE17721_LPS_VS_GARDIQUIMOD_...12,SET,184,-0.012496,-0.001244,0.066932,0.57405,GSE17721_LPS_VS_GARDIQUIMOD_2H_BMDC_UP,1
WP_BMP_SIGNALING_IN_EYELID_D...,SET,19,-0.042514,-0.0013662,0.22765,0.57407,WP_BMP_SIGNALING_IN_EYELID_DEVELOPMENT,1
GSE13522_CTRL_VS_T_CRUZI_BRA...2,SET,131,-0.01428,-0.0012013,0.076269,0.57426,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_UP,1
GSE11961_FOLLICULAR_BCELL_VS...1,SET,180,-0.01169,-0.0011512,0.062427,0.57427,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GOBP_POSITIVE_REGULATION_OF_...375,SET,88,-0.017405,-0.0012015,0.092934,0.57428,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_6_PRODUCTION,1
MIR6895_5P,SET,38,-0.026206,-0.0011904,0.13988,0.5743,MIR6895_5P,1
GSE20500_CTRL_VS_RARA_ANTAGO...1,SET,180,-0.011221,-0.0011051,0.05989,0.57431,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_DN,1
YNTTTNNNANGCARM_UNKNOWN,SET,63,-0.021969,-0.001284,0.11719,0.57435,YNTTTNNNANGCARM_UNKNOWN,1
GSE21033_CTRL_VS_POLYIC_STIM...3,SET,175,-0.011834,-0.0011492,0.063105,0.57437,GSE21033_CTRL_VS_POLYIC_STIM_DC_1H_DN,1
GOBP_OLIGOPEPTIDE_TRANSPORT,SET,18,-0.037646,-0.0011776,0.20068,0.5744,GOBP_OLIGOPEPTIDE_TRANSPORT,1
REACTOME_LOSS_OF_FUNCTION_OF...1,SET,11,-0.046711,-0.0011424,0.24897,0.57441,REACTOME_LOSS_OF_FUNCTION_OF_MECP2_IN_RETT_SYNDROME,1
REACTOME_NEDDYLATION,SET,227,-0.010243,-0.0011313,0.054592,0.57442,REACTOME_NEDDYLATION,1
REACTOME_NFE2L2_REGULATING_M...,SET,8,-0.058686,-0.0012241,0.31276,0.57442,REACTOME_NFE2L2_REGULATING_MDR_ASSOCIATED_ENZYMES,1
GOMF_SULFURIC_ESTER_HYDROLAS...,SET,11,-0.050201,-0.0012278,0.26746,0.57444,GOMF_SULFURIC_ESTER_HYDROLASE_ACTIVITY,1
HP_MULTIFOCAL_EPILEPTIFORM_D...,SET,66,-0.020258,-0.0012118,0.10787,0.57448,HP_MULTIFOCAL_EPILEPTIFORM_DISCHARGES,1
REACTOME_FORMATION_OF_RNA_PO...,SET,52,-0.018618,-0.00098891,0.099041,0.57455,REACTOME_FORMATION_OF_RNA_POL_II_ELONGATION_COMPLEX,1
GOMF_PROTEIN_BINDING_INVOLVE...,SET,12,-0.051622,-0.0013186,0.27454,0.57457,GOMF_PROTEIN_BINDING_INVOLVED_IN_HETEROTYPIC_CELL_CELL_ADHESION,1
MIR6817_5P,SET,98,-0.016109,-0.0011732,0.085593,0.57464,MIR6817_5P,1
GOBP_VESICLE_CARGO_LOADING,SET,31,-0.02606,-0.0010694,0.13843,0.57466,GOBP_VESICLE_CARGO_LOADING,1
GOBP_RESPONSE_TO_COBALT_ION,SET,9,-0.050356,-0.0011141,0.26741,0.57468,GOBP_RESPONSE_TO_COBALT_ION,1
MATTHEWS_SKIN_CARCINOGENESIS...,SET,17,-0.04008,-0.0012184,0.21272,0.57472,MATTHEWS_SKIN_CARCINOGENESIS_VIA_JUN,1
REACTOME_INFLAMMASOMES,SET,19,-0.035318,-0.001135,0.18739,0.57475,REACTOME_INFLAMMASOMES,1
GOBP_REGULATION_OF_ORGAN_GRO...,SET,80,-0.019181,-0.0012627,0.10177,0.57475,GOBP_REGULATION_OF_ORGAN_GROWTH,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...6,SET,113,-0.015191,-0.0011875,0.080593,0.57475,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_AD5_NAB_TITERS_GTE_200_VS_LTE_200_1DY_UP,1
WP_AEROBIC_GLYCOLYSIS,SET,10,-0.039311,-0.0009167,0.20846,0.57478,WP_AEROBIC_GLYCOLYSIS,1
GOBP_DNA_CYTOSINE_DEAMINATION,SET,8,-0.080432,-0.0016777,0.4263,0.57483,GOBP_DNA_CYTOSINE_DEAMINATION,1
HP_ABNORMALITY_OF_PERIPHERAL...,SET,129,-0.013433,-0.0011215,0.071163,0.57486,HP_ABNORMALITY_OF_PERIPHERAL_NERVE_CONDUCTION,1
HP_PALMAR_HYPERLINEARITY,SET,6,-0.066676,-0.0012045,0.35322,0.57486,HP_PALMAR_HYPERLINEARITY,1
HP_EXPRESSIVE_APHASIA,SET,11,-0.048716,-0.0011915,0.2577,0.57497,HP_EXPRESSIVE_APHASIA,1
BIOCARTA_CFTR_PATHWAY,SET,10,-0.053964,-0.0012584,0.2854,0.57499,BIOCARTA_CFTR_PATHWAY,1
REACTOME_APC_C_CDH1_MEDIATED...,SET,70,-0.017132,-0.0010553,0.090579,0.57501,REACTOME_APC_C_CDH1_MEDIATED_DEGRADATION_OF_CDC20_AND_OTHER_APC_C_CDH1_TARGETED_PROTEINS_IN_LATE_MITOSIS_EARLY_G1,1
HP_AUTOAMPUTATION_OF_DIGITS,SET,13,-0.043005,-0.0011433,0.22736,0.57501,HP_AUTOAMPUTATION_OF_DIGITS,1
HP_VARICOSE_VEINS,SET,29,-0.03169,-0.0012578,0.16744,0.57506,HP_VARICOSE_VEINS,1
HP_GAIT_ATAXIA,SET,217,-0.010664,-0.0011518,0.056331,0.57507,HP_GAIT_ATAXIA,1
GOBP_POSITIVE_REGULATION_OF_...792,SET,12,-0.041977,-0.0010723,0.2217,0.57509,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
WP_ANGIOTENSIN_II_RECEPTOR_T...,SET,25,-0.03286,-0.0012111,0.17327,0.57521,WP_ANGIOTENSIN_II_RECEPTOR_TYPE_1_PATHWAY,1
GOBP_SENSORY_PERCEPTION,SET,813,-0.0067417,-0.0013862,0.035513,0.57528,GOBP_SENSORY_PERCEPTION,1
HP_3_4_FINGER_CUTANEOUS_SYND...,SET,6,-0.07689,-0.001389,0.4048,0.57532,HP_3_4_FINGER_CUTANEOUS_SYNDACTYLY,1
GSE24671_CTRL_VS_BAKIMULC_IN...2,SET,181,-0.01179,-0.0011642,0.062042,0.57536,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_UP,1
GSE42021_CD24LO_TREG_VS_CD24...2,SET,186,-0.012106,-0.0012117,0.063619,0.57546,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_UP,1
GOBP_INTERLEUKIN_23_PRODUCTI...,SET,10,-0.054259,-0.0012653,0.28498,0.5755,GOBP_INTERLEUKIN_23_PRODUCTION,1
GOCC_LSM2_8_COMPLEX,SET,7,-0.058109,-0.0011338,0.30516,0.57551,GOCC_LSM2_8_COMPLEX,1
TESAR_ALK_AND_JAK_TARGETS_MO...1,SET,4,-0.074912,-0.001105,0.393,0.57559,TESAR_ALK_AND_JAK_TARGETS_MOUSE_ES_D4_DN,1
ZHENG_IL22_SIGNALING_DN,SET,34,-0.0283,-0.0012161,0.14842,0.57561,ZHENG_IL22_SIGNALING_DN,1
HP_ABNORMAL_OPTIC_CHIASM_MOR...,SET,6,-0.076647,-0.0013846,0.40162,0.57567,HP_ABNORMAL_OPTIC_CHIASM_MORPHOLOGY,1
MIR6832_5P,SET,74,-0.018978,-0.0012018,0.099436,0.57568,MIR6832_5P,1
HSF2_TARGET_GENES,SET,196,-0.011032,-0.0011331,0.057765,0.57573,HSF2_TARGET_GENES,1
GOBP_REGULATION_OF_RNA_POLYM...2,SET,6,-0.063916,-0.0011546,0.33451,0.57576,GOBP_REGULATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,1
GOBP_UBIQUITIN_INDEPENDENT_P...,SET,5,-0.073613,-0.001214,0.38513,0.57579,GOBP_UBIQUITIN_INDEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,1
REACTOME_SIGNALING_BY_PDGFRA...,SET,12,-0.046035,-0.0011759,0.24081,0.5758,REACTOME_SIGNALING_BY_PDGFRA_TRANSMEMBRANE_JUXTAMEMBRANE_AND_KINASE_DOMAIN_MUTANTS,1
GOBP_EMBRYONIC_HEMOPOIESIS,SET,23,-0.034125,-0.0012064,0.17849,0.57581,GOBP_EMBRYONIC_HEMOPOIESIS,1
BUSSLINGER_ESOPHAGEAL_EARLY_...,SET,74,-0.018648,-0.0011809,0.097482,0.57585,BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS,1
REACTOME_NUCLEAR_EVENTS_STIM...,SET,32,-0.030081,-0.0012541,0.15712,0.57591,REACTOME_NUCLEAR_EVENTS_STIMULATED_BY_ALK_SIGNALING_IN_CANCER,1
GNF2_XRCC5,SET,65,-0.018355,-0.0010896,0.095871,0.57591,GNF2_XRCC5,1
GSE360_L_DONOVANI_VS_T_GONDI...4,SET,175,-0.012151,-0.00118,0.063442,0.57594,GSE360_L_DONOVANI_VS_T_GONDII_MAC_UP,1
GOMF_PROTEIN_TYROSINE_KINASE...3,SET,118,-0.014467,-0.0011555,0.075498,0.57598,GOMF_PROTEIN_TYROSINE_KINASE_BINDING,1
HP_LIMB_ATAXIA,SET,82,-0.017234,-0.0011486,0.089929,0.57599,HP_LIMB_ATAXIA,1
ZNF596_TARGET_GENES,SET,486,-0.0076061,-0.0012204,0.03968,0.576,ZNF596_TARGET_GENES,1
DEURIG_T_CELL_PROLYMPHOCYTIC...2,SET,310,-0.0091847,-0.0011827,0.047912,0.57601,DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP,1
NIKOLSKY_BREAST_CANCER_8Q23_...,SET,144,-0.025825,-0.0022769,0.13471,0.57601,NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON,1
GOBP_POSITIVE_REGULATION_OF_...324,SET,12,-0.050142,-0.0012808,0.26137,0.57607,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,1
MIR5694,SET,49,-0.023737,-0.001224,0.12369,0.57609,MIR5694,1
GOMF_LIPOPOLYSACCHARIDE_IMMU...,SET,6,-0.064089,-0.0011578,0.3339,0.57611,GOMF_LIPOPOLYSACCHARIDE_IMMUNE_RECEPTOR_ACTIVITY,1
BYSTRYKH_HEMATOPOIESIS_STEM_...4,SET,8,-0.050937,-0.0010625,0.26498,0.57622,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FLI1,1
GOBP_CELLULAR_RESPONSE_TO_PR...1,SET,6,-0.059922,-0.0010825,0.3116,0.57625,GOBP_CELLULAR_RESPONSE_TO_PROGESTERONE_STIMULUS,1
GSE1432_1H_VS_6H_IFNG_MICROG...1,SET,180,-0.012232,-0.0012046,0.063573,0.57629,GSE1432_1H_VS_6H_IFNG_MICROGLIA_DN,1
GOLUB_ALL_VS_AML_DN,SET,22,-0.036704,-0.0012691,0.1906,0.57635,GOLUB_ALL_VS_AML_DN,1
MIKKELSEN_IPS_LCP_WITH_H3K27...,SET,10,-0.048225,-0.0011246,0.25044,0.57635,MIKKELSEN_IPS_LCP_WITH_H3K27ME3,1
GOBP_EXTRACELLULAR_MATRIX_CO...,SET,13,-0.051953,-0.0013812,0.26975,0.57636,GOBP_EXTRACELLULAR_MATRIX_CONSTITUENT_SECRETION,1
GSE20198_IL12_VS_IL12_IL18_T...1,SET,191,-0.011548,-0.0011711,0.05996,0.57636,GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN,1
GSE40274_CTRL_VS_FOXP3_AND_G...1,SET,135,-0.013696,-0.0011695,0.071095,0.57638,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOCC_LOW_DENSITY_LIPOPROTEIN...,SET,13,-0.043863,-0.0011662,0.22753,0.57643,GOCC_LOW_DENSITY_LIPOPROTEIN_PARTICLE,1
HP_IMPAIRMENT_IN_PERSONALITY...,SET,200,-0.011372,-0.0011798,0.058982,0.57644,HP_IMPAIRMENT_IN_PERSONALITY_FUNCTIONING,1
MIR4727_3P,SET,31,-0.029786,-0.0012223,0.15449,0.57645,MIR4727_3P,1
HP_BLUE_NEVUS,SET,11,-0.048071,-0.0011757,0.24927,0.57646,HP_BLUE_NEVUS,1
REACTOME_SIGNALLING_TO_RAS,SET,20,-0.036,-0.0011869,0.18659,0.5765,REACTOME_SIGNALLING_TO_RAS,1
GOMF_OLFACTORY_RECEPTOR_ACTI...,SET,305,-0.013697,-0.0017498,0.07097,0.57652,GOMF_OLFACTORY_RECEPTOR_ACTIVITY,1
TERAMOTO_OPN_TARGETS_CLUSTER...1,SET,13,-0.043834,-0.0011654,0.22703,0.57655,TERAMOTO_OPN_TARGETS_CLUSTER_1,1
GOCC_GERM_CELL_NUCLEUS,SET,62,-0.019746,-0.0011449,0.1022,0.5766,GOCC_GERM_CELL_NUCLEUS,1
GSE27786_CD8_TCELL_VS_NEUTRO...1,SET,179,-0.01173,-0.0011519,0.060677,0.57664,GSE27786_CD8_TCELL_VS_NEUTROPHIL_DN,1
GSE5589_LPS_VS_LPS_AND_IL10_...2,SET,181,-0.012159,-0.0012007,0.062854,0.57669,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_UP,1
HP_ABNORMAL_BLADDER_MORPHOLO...,SET,66,-0.021119,-0.0012633,0.10915,0.57671,HP_ABNORMAL_BLADDER_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...462,SET,33,-0.026659,-0.0011286,0.1376,0.57681,GOBP_POSITIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
HP_POSTNATAL_GROWTH_RETARDAT...,SET,219,-0.011027,-0.0011965,0.056905,0.57682,HP_POSTNATAL_GROWTH_RETARDATION,1
VANTVEER_BREAST_CANCER_ESR1_...1,SET,207,-0.011592,-0.0012232,0.059795,0.57685,VANTVEER_BREAST_CANCER_ESR1_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_AT1...,SET,37,-0.028661,-0.0012847,0.14784,0.57686,HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL,1
GOMF_VERY_LONG_CHAIN_FATTY_A...,SET,9,-0.051767,-0.0011453,0.26693,0.57688,GOMF_VERY_LONG_CHAIN_FATTY_ACID_COA_LIGASE_ACTIVITY,1
GOBP_PARAXIAL_MESODERM_FORMA...,SET,6,-0.075834,-0.00137,0.39101,0.57689,GOBP_PARAXIAL_MESODERM_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...95,SET,771,-0.0061773,-0.0012384,0.031816,0.57697,GOBP_POSITIVE_REGULATION_OF_CATALYTIC_ACTIVITY,1
GSE19825_NAIVE_VS_DAY3_EFF_C...2,SET,177,-0.012826,-0.0012526,0.066067,0.57697,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_UP,1
MIR522_3P,SET,159,-0.013002,-0.0012041,0.066931,0.57701,MIR522_3P,1
HP_CONGENITAL_SENSORINEURAL_...,SET,54,-0.023365,-0.0012646,0.12025,0.57703,HP_CONGENITAL_SENSORINEURAL_HEARING_IMPAIRMENT,1
MIR3622B_5P,SET,47,-0.023543,-0.001189,0.12107,0.57709,MIR3622B_5P,1
GOBP_POSITIVE_REGULATION_OF_...687,SET,5,-0.081821,-0.0013494,0.42078,0.57709,GOBP_POSITIVE_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,1
CCCACAT_MIR2993P,SET,48,-0.022418,-0.0011442,0.11527,0.5771,CCCACAT_MIR2993P,1
GOBP_NUCLEAR_RNA_SURVEILLANCE,SET,14,-0.037589,-0.001037,0.19323,0.57712,GOBP_NUCLEAR_RNA_SURVEILLANCE,1
HP_OCULOMOTOR_APRAXIA,SET,103,-0.014903,-0.0011125,0.076611,0.57712,HP_OCULOMOTOR_APRAXIA,1
BIOCARTA_PLCE_PATHWAY,SET,11,-0.054155,-0.0013245,0.27811,0.57719,BIOCARTA_PLCE_PATHWAY,1
HP_CENTRAL_SLEEP_APNEA,SET,37,-0.029077,-0.0013033,0.14934,0.57719,HP_CENTRAL_SLEEP_APNEA,1
HOEK_NEUTROPHIL_2011_2012_TI...5,SET,37,-0.028981,-0.001299,0.14871,0.57726,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_DN,1
GOBP_ASPARAGINE_METABOLIC_PR...,SET,5,-0.067934,-0.0011203,0.34826,0.57733,GOBP_ASPARAGINE_METABOLIC_PROCESS,1
MODULE_568,SET,62,-0.020316,-0.001178,0.10412,0.57735,MODULE_568,1
KEGG_MEDICUS_REFERENCE_MICRO...4,SET,20,-0.037535,-0.0012375,0.19232,0.57737,KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY,1
HP_FOAM_CELLS,SET,12,-0.054023,-0.00138,0.2767,0.5774,HP_FOAM_CELLS,1
GSE23505_IL6_IL1_IL23_VS_IL6...1,SET,179,-0.011623,-0.0011414,0.059531,0.5774,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,1
GSE5589_LPS_VS_LPS_AND_IL6_S...1,SET,180,-0.0118,-0.001162,0.060396,0.57745,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
GAVISH_3CA_METAPROGRAM_FIBRO...17,SET,44,-0.028485,-0.0013921,0.1457,0.5775,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_MHC_II,1
GOBP_REGULATION_OF_SYSTEMIC_...2,SET,15,-0.048815,-0.001394,0.2495,0.57756,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_CIRCULATORY_RENIN_ANGIOTENSIN,1
GSE29618_LAIV_VS_TIV_FLU_VAC...4,SET,180,-0.012579,-0.0012387,0.064251,0.57761,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_MDC_UP,1
GSE2770_TGFB_AND_IL4_VS_TGFB...2,SET,139,-0.014425,-0.0012497,0.073628,0.57766,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
BIOCARTA_TID_PATHWAY,SET,19,-0.040011,-0.0012858,0.2041,0.57771,BIOCARTA_TID_PATHWAY,1
GOCC_PRERIBOSOME_LARGE_SUBUN...,SET,18,-0.034339,-0.0010741,0.17494,0.57781,GOCC_PRERIBOSOME_LARGE_SUBUNIT_PRECURSOR,1
GSE13306_RA_VS_UNTREATED_TRE...2,SET,173,-0.012295,-0.0011873,0.062597,0.57786,GSE13306_RA_VS_UNTREATED_TREG_UP,1
HORIUCHI_WTAP_TARGETS_UP,SET,269,-0.01056,-0.0012682,0.053736,0.5779,HORIUCHI_WTAP_TARGETS_UP,1
REACTOME_HDMS_DEMETHYLATE_HI...,SET,17,-0.035784,-0.0010878,0.18186,0.57799,REACTOME_HDMS_DEMETHYLATE_HISTONES,1
REACTOME_ACYL_CHAIN_REMODELI...1,SET,5,-0.079296,-0.0013077,0.40283,0.57802,REACTOME_ACYL_CHAIN_REMODELING_OF_CL,1
CACCAGC_MIR138,SET,208,-0.011955,-0.0012646,0.060737,0.57802,CACCAGC_MIR138,1
KEGG_MEDICUS_REFERENCE_GPCR_...2,SET,47,-0.026518,-0.0013393,0.13467,0.57805,KEGG_MEDICUS_REFERENCE_GPCR_PLCB_ITPR_SIGNALING_PATHWAY,1
REACTOME_STIMULI_SENSING_CHA...,SET,99,-0.017433,-0.001276,0.088497,0.57808,REACTOME_STIMULI_SENSING_CHANNELS,1
GSE2706_2H_VS_8H_R848_STIM_D...2,SET,172,-0.012889,-0.0012411,0.065352,0.57818,GSE2706_2H_VS_8H_R848_STIM_DC_UP,1
KUMAMOTO_RESPONSE_TO_NUTLIN_...1,SET,9,-0.047204,-0.0010443,0.23919,0.57822,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN,1
GOMF_TRNA_CYTIDINE_5_METHYLT...,SET,5,-0.064286,-0.0010602,0.32575,0.57822,GOMF_TRNA_CYTIDINE_5_METHYLTRANSFERASE_ACTIVITY,1
chr1q25,SET,73,-0.041415,-0.0026049,0.2095,0.57835,chr1q25,1
KEGG_MEDICUS_REFERENCE_ANGIO...,SET,28,-0.031657,-0.0012347,0.16012,0.57836,KEGG_MEDICUS_REFERENCE_ANGIOTENSIN_ALDOSTERONE_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_DENDRITIC...1,SET,11,-0.050625,-0.0012381,0.25603,0.57837,GOBP_REGULATION_OF_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
HP_SLEEP_WAKE_CYCLE_DISTURBA...,SET,36,-0.028885,-0.0012771,0.14608,0.57837,HP_SLEEP_WAKE_CYCLE_DISTURBANCE,1
GOBP_NEGATIVE_REGULATION_OF_...458,SET,7,-0.059105,-0.0011533,0.29871,0.57842,GOBP_NEGATIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
HP_CONTRACTURE_OF_THE_DISTAL...,SET,6,-0.07651,-0.0013822,0.3865,0.57846,HP_CONTRACTURE_OF_THE_DISTAL_INTERPHALANGEAL_JOINT_OF_THE_FINGERS,1
P53_02,SET,229,-0.011173,-0.0012394,0.056403,0.57851,P53_02,1
PID_LYMPH_ANGIOGENESIS_PATHW...,SET,24,-0.036384,-0.0013139,0.18359,0.57855,PID_LYMPH_ANGIOGENESIS_PATHWAY,1
WP_CODEINE_AND_MORPHINE_META...,SET,14,-0.046682,-0.0012879,0.23552,0.57856,WP_CODEINE_AND_MORPHINE_METABOLISM,1
REACTOME_REGULATION_OF_COMMI...,SET,10,-0.060851,-0.001419,0.30692,0.57858,REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO,1
HP_SLOPING_FOREHEAD,SET,165,-0.0122,-0.0011508,0.0615,0.57862,HP_SLOPING_FOREHEAD,1
GSE26928_EFF_MEMORY_VS_CXCR5...1,SET,164,-0.01293,-0.0012159,0.065165,0.57864,GSE26928_EFF_MEMORY_VS_CXCR5_POS_CD4_TCELL_DN,1
GSE22886_NAIVE_CD8_TCELL_VS_...4,SET,181,-0.012124,-0.0011972,0.061077,0.57867,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...225,SET,4,-0.084693,-0.0012493,0.42662,0.57868,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_DISASSEMBLY,1
GSE8685_IL2_STARVED_VS_IL15_...1,SET,178,-0.012372,-0.0012116,0.062275,0.57874,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN,1
GOBP_NATURAL_KILLER_CELL_ACT...1,SET,89,-0.019194,-0.0013324,0.096557,0.57878,GOBP_NATURAL_KILLER_CELL_ACTIVATION,1
GSE7768_OVA_ALONE_VS_OVA_WIT...4,SET,164,-0.012759,-0.0011999,0.064187,0.57878,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
GOBP_G2_MI_TRANSITION_OF_MEI...,SET,6,-0.061601,-0.0011128,0.30979,0.57881,GOBP_G2_MI_TRANSITION_OF_MEIOTIC_CELL_CYCLE,1
GSE22886_NAIVE_CD4_TCELL_VS_...7,SET,188,-0.011619,-0.0011691,0.058427,0.57882,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_DN,1
GOCC_NADH_DEHYDROGENASE_COMP...,SET,40,-0.022507,-0.0010489,0.11313,0.57885,GOCC_NADH_DEHYDROGENASE_COMPLEX,1
HP_INTRAALVEOLAR_PHOSPHOLIPI...,SET,7,-0.074914,-0.0014617,0.37652,0.57885,HP_INTRAALVEOLAR_PHOSPHOLIPID_ACCUMULATION,1
GOBP_GROWTH_HORMONE_RECEPTOR...,SET,10,-0.066231,-0.0015445,0.33285,0.57886,GOBP_GROWTH_HORMONE_RECEPTOR_SIGNALING_PATHWAY_VIA_JAK_STAT,1
GOBP_REGULATION_OF_REACTIVE_...2,SET,130,-0.014923,-0.0012506,0.074968,0.57889,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
REACTOME_RAC2_GTPASE_CYCLE,SET,78,-0.019972,-0.0012983,0.10032,0.5789,REACTOME_RAC2_GTPASE_CYCLE,1
HP_ABNORMAL_TRACHEAL_MORPHOL...,SET,150,-0.013673,-0.0012302,0.068646,0.57894,HP_ABNORMAL_TRACHEAL_MORPHOLOGY,1
REACTOME_THE_NLRP3_INFLAMMAS...,SET,14,-0.043492,-0.0011999,0.21828,0.57897,REACTOME_THE_NLRP3_INFLAMMASOME,1
HP_ABNORMALITY_OF_THE_PHALAN...1,SET,16,-0.04297,-0.0012673,0.21559,0.57899,HP_ABNORMALITY_OF_THE_PHALANGES_OF_THE_2ND_FINGER,1
GSE39820_IL1B_IL6_VS_IL1B_IL...1,SET,180,-0.012708,-0.0012515,0.063688,0.57908,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_DN,1
WP_DNA_IRDOUBLE_STRAND_BREAK...,SET,52,-0.021459,-0.0011398,0.10743,0.57916,WP_DNA_IRDOUBLE_STRAND_BREAKS_AND_CELLULAR_RESPONSE_VIA_ATM,1
GOCC_CLATHRIN_ADAPTOR_COMPLEX,SET,25,-0.032791,-0.0012086,0.16414,0.57917,GOCC_CLATHRIN_ADAPTOR_COMPLEX,1
WP_TRANSLATION_INHIBITORS_IN...,SET,45,-0.025199,-0.0012454,0.12612,0.57918,WP_TRANSLATION_INHIBITORS_IN_CHRONICALLY_ACTIVATED_PDGFRA_CELLS,1
GOBP_CELL_CELL_ADHESION,SET,898,-0.0063414,-0.0013671,0.031739,0.57918,GOBP_CELL_CELL_ADHESION,1
GSE17721_CPG_VS_GARDIQUIMOD_...15,SET,172,-0.012415,-0.0011954,0.062124,0.5792,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_DN,1
GOBP_REGULATORY_NCRNA_MEDIAT...1,SET,112,-0.015103,-0.0011754,0.075504,0.57927,GOBP_REGULATORY_NCRNA_MEDIATED_GENE_SILENCING,1
GAVISH_3CA_METAPROGRAM_CD8_T...3,SET,43,-0.029007,-0.0014014,0.14499,0.57928,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CYTOTOXIC,1
CHIANG_LIVER_CANCER_SUBCLASS...1,SET,155,-0.014507,-0.0013266,0.072463,0.57933,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN,1
GSE45365_CTRL_VS_MCMV_INFECT...2,SET,180,-0.012594,-0.0012402,0.062881,0.57937,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_UP,1
HP_ABNORMAL_3RD_FINGER_PHALA...,SET,6,-0.075883,-0.0013708,0.37884,0.57938,HP_ABNORMAL_3RD_FINGER_PHALANX_MORPHOLOGY,1
REACTOME_BETA_OXIDATION_OF_H...,SET,5,-0.074112,-0.0012222,0.36958,0.57946,REACTOME_BETA_OXIDATION_OF_HEXANOYL_COA_TO_BUTANOYL_COA,1
GOBP_SINGLE_STRANDED_VIRAL_R...,SET,17,-0.048015,-0.0014596,0.23943,0.57947,GOBP_SINGLE_STRANDED_VIRAL_RNA_REPLICATION_VIA_DOUBLE_STRANDED_DNA_INTERMEDIATE,1
GSE10856_CTRL_VS_TNFRSF6B_IN...2,SET,157,-0.013812,-0.0012711,0.068785,0.57957,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_UP,1
GOBP_ESTABLISHMENT_OF_PROTEI...11,SET,61,-0.020914,-0.0012029,0.10413,0.57959,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_VACUOLE,1
HP_SEBORRHEIC_DERMATITIS,SET,22,-0.036302,-0.0012552,0.1807,0.57961,HP_SEBORRHEIC_DERMATITIS,1
NIKOLSKY_BREAST_CANCER_7Q21_...,SET,72,-0.036275,-0.002266,0.18053,0.57962,NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON,1
DR1_Q3,SET,230,-0.01118,-0.0012428,0.055595,0.57969,DR1_Q3,1
REACTOME_G_ALPHA_Z_SIGNALLIN...,SET,48,-0.025633,-0.0013083,0.12742,0.57972,REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS,1
WAESCH_ANAPHASE_PROMOTING_CO...,SET,12,-0.046667,-0.0011921,0.23185,0.57976,WAESCH_ANAPHASE_PROMOTING_COMPLEX,1
REACTOME_TBC_RABGAPS,SET,40,-0.024169,-0.0011263,0.12007,0.57976,REACTOME_TBC_RABGAPS,1
MIR4728_5P,SET,517,-0.0074581,-0.0012332,0.037037,0.57979,MIR4728_5P,1
GAVISH_3CA_METAPROGRAM_B_CEL...10,SET,44,-0.027663,-0.0013519,0.13734,0.57981,GAVISH_3CA_METAPROGRAM_B_CELLS_PROGENITOR,1
HP_APLASIA_HYPOPLASIA_AFFECT...4,SET,140,-0.014102,-0.0012261,0.07002,0.57981,HP_APLASIA_HYPOPLASIA_AFFECTING_THE_FUNDUS,1
MIR92B_5P,SET,8,-0.055433,-0.0011563,0.27506,0.57986,MIR92B_5P,1
GOCC_POSTSYNAPTIC_DENSITY_ME...,SET,94,-0.018037,-0.0012867,0.089485,0.57987,GOCC_POSTSYNAPTIC_DENSITY_MEMBRANE,1
TURASHVILI_BREAST_LOBULAR_CA...4,SET,90,-0.018451,-0.001288,0.091527,0.57988,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_UP,1
WIERENGA_STAT5A_TARGETS_UP,SET,186,-0.013255,-0.0013267,0.065755,0.57988,WIERENGA_STAT5A_TARGETS_UP,1
GOBP_REGULATION_OF_CYTOPLASM...1,SET,7,-0.063774,-0.0012444,0.31635,0.57988,GOBP_REGULATION_OF_CYTOPLASMIC_MRNA_PROCESSING_BODY_ASSEMBLY,1
REACTOME_PURINE_SALVAGE,SET,12,-0.05014,-0.0012808,0.24849,0.57996,REACTOME_PURINE_SALVAGE,1
GOMF_URIDYLYLTRANSFERASE_ACT...,SET,5,-0.063297,-0.0010439,0.31364,0.57997,GOMF_URIDYLYLTRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...149,SET,6,-0.078311,-0.0014147,0.38788,0.58,GOBP_POSITIVE_REGULATION_OF_CEREBELLAR_GRANULE_CELL_PRECURSOR_PROLIFERATION,1
GOBP_ORGANELLE_LOCALIZATION,SET,556,-0.00708,-0.0012127,0.035058,0.58002,GOBP_ORGANELLE_LOCALIZATION,1
HP_INCREASED_CIRCULATING_IRO...,SET,11,-0.049245,-0.0012044,0.24386,0.58002,HP_INCREASED_CIRCULATING_IRON_CONCENTRATION,1
GOBP_CLUSTERING_OF_VOLTAGE_G...,SET,6,-0.070417,-0.0012721,0.34864,0.58003,GOBP_CLUSTERING_OF_VOLTAGE_GATED_SODIUM_CHANNELS,1
HP_ABNORMAL_MIDBRAIN_MORPHOL...,SET,72,-0.018105,-0.001131,0.089626,0.58004,HP_ABNORMAL_MIDBRAIN_MORPHOLOGY,1
WAMUNYOKOLI_OVARIAN_CANCER_G...1,SET,63,-0.022497,-0.0013149,0.11136,0.58005,WAMUNYOKOLI_OVARIAN_CANCER_GRADES_1_2_DN,1
GOMF_CYSTEINE_TYPE_PEPTIDASE...,SET,145,-0.013459,-0.0011907,0.066575,0.5801,GOMF_CYSTEINE_TYPE_PEPTIDASE_ACTIVITY,1
HP_DUPLICATION_OF_THUMB_PHAL...,SET,53,-0.022247,-0.0011929,0.11005,0.5801,HP_DUPLICATION_OF_THUMB_PHALANX,1
MIR208B_3P,SET,39,-0.027353,-0.0012587,0.13528,0.58012,MIR208B_3P,1
GOBP_NEGATIVE_REGULATION_OF_...244,SET,33,-0.028535,-0.001208,0.14107,0.58015,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_PROLIFERATION,1
GOBP_REGULATION_OF_AMINO_ACI...1,SET,14,-0.047934,-0.0013224,0.23693,0.58016,GOBP_REGULATION_OF_AMINO_ACID_TRANSMEMBRANE_TRANSPORT,1
GSE16755_CTRL_VS_IFNA_TREATE...2,SET,180,-0.012016,-0.0011833,0.059388,0.58017,GSE16755_CTRL_VS_IFNA_TREATED_MAC_UP,1
GSE1566_WT_VS_EZH2_KO_LN_TCE...2,SET,165,-0.013683,-0.0012907,0.067615,0.58019,GSE1566_WT_VS_EZH2_KO_LN_TCELL_UP,1
NOUSHMEHR_GBM_SOMATIC_MUTATED,SET,9,-0.064879,-0.0014354,0.32045,0.58022,NOUSHMEHR_GBM_SOMATIC_MUTATED,1
HP_SUBGLOTTIC_STENOSIS,SET,14,-0.046514,-0.0012833,0.22972,0.58023,HP_SUBGLOTTIC_STENOSIS,1
GSE2770_IL12_AND_TGFB_ACT_VS...6,SET,171,-0.013417,-0.0012881,0.066241,0.58025,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_UP,1
CTCTAGA_MIR526C_MIR518F_MIR5...,SET,48,-0.024761,-0.0012637,0.12223,0.58026,CTCTAGA_MIR526C_MIR518F_MIR526A,1
HP_FATIGABLE_WEAKNESS_OF_SWA...,SET,37,-0.026999,-0.0012102,0.13326,0.58027,HP_FATIGABLE_WEAKNESS_OF_SWALLOWING_MUSCLES,1
GSE7831_CPG_VS_INFLUENZA_STI...1,SET,186,-0.012861,-0.0012873,0.06344,0.58033,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_1H_DN,1
LI_PBMC_MENACTRA_AGE_18_45YO...6,SET,27,-0.036613,-0.0014023,0.1806,0.58033,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_NEGATIVE,1
MORF_IKBKG,SET,121,-0.014615,-0.0011819,0.072052,0.58037,MORF_IKBKG,1
GOBP_REGULATION_OF_PHOSPHOPR...,SET,38,-0.027233,-0.001237,0.13421,0.5804,GOBP_REGULATION_OF_PHOSPHOPROTEIN_PHOSPHATASE_ACTIVITY,1
GSE2770_TGFB_AND_IL4_VS_TGFB...4,SET,171,-0.011942,-0.0011465,0.058847,0.5804,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
GOBP_T_HELPER_2_CELL_CYTOKIN...,SET,13,-0.052984,-0.0014086,0.26102,0.58043,GOBP_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,1
GOBP_POSITIVE_REGULATION_OF_...796,SET,18,-0.039402,-0.0012325,0.19406,0.58045,GOBP_POSITIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
NIKOLSKY_BREAST_CANCER_21Q22...,SET,15,-0.072293,-0.0020644,0.3557,0.58053,NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON,1
HP_GANGLIONEUROBLASTOMA,SET,7,-0.079865,-0.0015583,0.39284,0.58055,HP_GANGLIONEUROBLASTOMA,1
GOBP_NEGATIVE_REGULATION_OF_...551,SET,30,-0.029452,-0.001189,0.14481,0.58058,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
WANG_PROSTATE_CANCER_ANDROGE...,SET,58,-0.023298,-0.0013067,0.11451,0.58061,WANG_PROSTATE_CANCER_ANDROGEN_INDEPENDENT,1
GOBP_MITOTIC_SISTER_CHROMATI...1,SET,21,-0.034972,-0.0011815,0.17189,0.58061,GOBP_MITOTIC_SISTER_CHROMATID_COHESION,1
GOMF_NUCLEAR_ESTROGEN_RECEPT...,SET,35,-0.028963,-0.0012627,0.14233,0.58062,GOMF_NUCLEAR_ESTROGEN_RECEPTOR_BINDING,1
MIR6740_3P,SET,146,-0.014109,-0.0012525,0.069305,0.58066,MIR6740_3P,1
GOBP_POSTSYNAPTIC_DENSITY_AS...,SET,24,-0.03707,-0.0013387,0.18205,0.58068,GOBP_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
chr6p11,SET,2,-0.12498,-0.0013037,0.61366,0.58069,chr6p11,1
GSE18893_CTRL_VS_TNF_TREATED...3,SET,178,-0.012135,-0.0011884,0.059583,0.58069,GSE18893_CTRL_VS_TNF_TREATED_TCONV_2H_DN,1
GOBP_GOLGI_TO_VACUOLE_TRANSP...,SET,20,-0.03594,-0.0011849,0.17646,0.5807,GOBP_GOLGI_TO_VACUOLE_TRANSPORT,1
GOMF_LIPOPROTEIN_PARTICLE_RE...2,SET,28,-0.03266,-0.0012738,0.16018,0.58078,GOMF_LIPOPROTEIN_PARTICLE_RECEPTOR_BINDING,1
HP_ABNORMAL_FEMUR_MORPHOLOGY,SET,270,-0.010433,-0.0012552,0.051167,0.58078,HP_ABNORMAL_FEMUR_MORPHOLOGY,1
GOBP_SKELETAL_MUSCLE_ATROPHY,SET,5,-0.079163,-0.0013055,0.38814,0.5808,GOBP_SKELETAL_MUSCLE_ATROPHY,1
GSE36476_CTRL_VS_TSST_ACT_72...3,SET,179,-0.012286,-0.0012065,0.060242,0.5808,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_DN,1
KRAS.KIDNEY_UP.V1_UP,SET,127,-0.016993,-0.0014077,0.083288,0.58083,KRAS.KIDNEY_UP.V1_UP,1
GSE17721_CTRL_VS_GARDIQUIMOD...15,SET,184,-0.012384,-0.0012329,0.06065,0.5809,GSE17721_CTRL_VS_GARDIQUIMOD_8H_BMDC_DN,1
HP_ABNORMAL_RENAL_MEDULLA_MO...,SET,57,-0.022133,-0.0012307,0.10834,0.58094,HP_ABNORMAL_RENAL_MEDULLA_MORPHOLOGY,1
WP_TGFBETA_RECEPTOR_SIGNALIN...,SET,55,-0.025544,-0.0013953,0.12497,0.58098,WP_TGFBETA_RECEPTOR_SIGNALING_IN_SKELETAL_DYSPLASIAS,1
GOCC_RNA_POLYMERASE_II_TRANS...1,SET,233,-0.010912,-0.0012208,0.053365,0.58101,GOCC_RNA_POLYMERASE_II_TRANSCRIPTION_REGULATOR_COMPLEX,1
REACTOME_DEPOSITION_OF_NEW_C...,SET,23,-0.040159,-0.0014197,0.19634,0.58103,REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE,1
MIKKELSEN_MEF_LCP_WITH_H3K27...,SET,61,-0.023403,-0.001346,0.11436,0.58107,MIKKELSEN_MEF_LCP_WITH_H3K27ME3,1
REACTOME_CGMP_EFFECTS,SET,15,-0.047252,-0.0013493,0.23084,0.58109,REACTOME_CGMP_EFFECTS,1
SMID_BREAST_CANCER_RELAPSE_I...10,SET,6,-0.067166,-0.0012134,0.32786,0.58116,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_UP,1
GSE24142_DN2_VS_DN3_THYMOCYT...2,SET,173,-0.013132,-0.001268,0.064088,0.58117,GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_UP,1
GSE24210_RESTING_TREG_VS_TCO...2,SET,179,-0.012864,-0.0012633,0.062763,0.5812,GSE24210_RESTING_TREG_VS_TCONV_UP,1
HP_MYDRIASIS,SET,16,-0.042777,-0.0012616,0.20839,0.58132,HP_MYDRIASIS,1
REACTOME_LAGGING_STRAND_SYNT...,SET,19,-0.035183,-0.0011306,0.17138,0.58133,REACTOME_LAGGING_STRAND_SYNTHESIS,1
HP_FOCAL_HEAD_NODDING_AUTOMA...,SET,5,-0.076825,-0.001267,0.37405,0.58136,HP_FOCAL_HEAD_NODDING_AUTOMATISM_SEIZURE,1
GOMF_ICOSANOID_BINDING,SET,7,-0.068718,-0.0013408,0.33453,0.58137,GOMF_ICOSANOID_BINDING,1
GSE29614_CTRL_VS_DAY7_TIV_FL...1,SET,159,-0.013636,-0.0012628,0.06638,0.58138,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_DN,1
USF_C,SET,262,-0.010722,-0.001271,0.052157,0.58144,USF_C,1
GOBP_REGULATION_OF_PROTEIN_L...2,SET,9,-0.057567,-0.0012736,0.27978,0.58151,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
MIR4322,SET,35,-0.032047,-0.0013971,0.15571,0.58153,MIR4322,1
HP_LARGE_POSTERIOR_FONTANELLE,SET,17,-0.04337,-0.0013184,0.21069,0.58154,HP_LARGE_POSTERIOR_FONTANELLE,1
GSE21670_STAT3_KO_VS_WT_CD4_...3,SET,178,-0.013153,-0.0012882,0.063877,0.58157,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_UP,1
GSE39820_TGFBETA1_VS_TGFBETA...4,SET,184,-0.012026,-0.0011973,0.058374,0.58161,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_TREATED_CD4_TCELL_UP,1
HP_INSULIN_RESISTANT_DIABETE...,SET,38,-0.03012,-0.0013682,0.14608,0.58168,HP_INSULIN_RESISTANT_DIABETES_MELLITUS,1
REACTOME_REGULATION_OF_TP53_...5,SET,87,-0.017919,-0.00123,0.086887,0.5817,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION,1
MORF_BRCA1,SET,242,-0.01081,-0.0012322,0.05241,0.5817,MORF_BRCA1,1
GOCC_BASEMENT_MEMBRANE,SET,85,-0.019542,-0.0013259,0.094681,0.58176,GOCC_BASEMENT_MEMBRANE,1
IL2_UP.V1_UP,SET,159,-0.01432,-0.0013262,0.069357,0.58179,IL2_UP.V1_UP,1
GOBP_REGULATION_OF_SPINDLE_O...,SET,46,-0.023275,-0.001163,0.11265,0.58184,GOBP_REGULATION_OF_SPINDLE_ORGANIZATION,1
GOBP_LOCALIZATION_WITHIN_MEM...,SET,619,-0.0070186,-0.0012662,0.033964,0.58186,GOBP_LOCALIZATION_WITHIN_MEMBRANE,1
REACTOME_ALPHA_OXIDATION_OF_...,SET,6,-0.06599,-0.0011921,0.31928,0.58187,REACTOME_ALPHA_OXIDATION_OF_PHYTANATE,1
KEGG_MEDICUS_REFERENCE_REGUL...11,SET,6,-0.064236,-0.0011604,0.31077,0.58188,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_SPRED_AND_NF1,1
GOBP_CELL_REDOX_HOMEOSTASIS,SET,34,-0.029805,-0.0012808,0.14413,0.58191,GOBP_CELL_REDOX_HOMEOSTASIS,1
REACTOME_SEROTONIN_RECEPTORS,SET,11,-0.05604,-0.0013706,0.27089,0.58194,REACTOME_SEROTONIN_RECEPTORS,1
GOBP_SENSORY_ORGAN_DEVELOPME...,SET,554,-0.0080402,-0.0013747,0.038859,0.58196,GOBP_SENSORY_ORGAN_DEVELOPMENT,1
GTF2E2_TARGET_GENES,SET,264,-0.010638,-0.0012658,0.051403,0.58198,GTF2E2_TARGET_GENES,1
GOMF_L_SERINE_TRANSMEMBRANE_...,SET,8,-0.060858,-0.0012694,0.29393,0.58201,GOMF_L_SERINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE37533_PPARG1_FOXP3_VS_FOX...4,SET,184,-0.012459,-0.0012403,0.060145,0.58205,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
GSE42724_MEMORY_BCELL_VS_PLA...1,SET,175,-0.01268,-0.0012314,0.06115,0.58214,GSE42724_MEMORY_BCELL_VS_PLASMABLAST_DN,1
MIR5580_5P,SET,109,-0.01695,-0.0013014,0.081715,0.58216,MIR5580_5P,1
GOBP_OMEGA_HYDROXYLASE_P450_...,SET,11,-0.057759,-0.0014126,0.27838,0.58218,GOBP_OMEGA_HYDROXYLASE_P450_PATHWAY,1
HP_IMPAIRED_PROPRIOCEPTION,SET,136,-0.014431,-0.0012368,0.069549,0.58218,HP_IMPAIRED_PROPRIOCEPTION,1
HP_DECREASED_CD4_CD8_RATIO,SET,8,-0.0616,-0.0012849,0.2968,0.58221,HP_DECREASED_CD4_CD8_RATIO,1
GOBP_EPITHELIAL_STRUCTURE_MA...,SET,32,-0.033966,-0.001416,0.16352,0.58227,GOBP_EPITHELIAL_STRUCTURE_MAINTENANCE,1
REACTOME_METHYLATION,SET,14,-0.047442,-0.0013089,0.22836,0.58229,REACTOME_METHYLATION,1
GSE39820_TGFBETA1_IL6_VS_TGF...1,SET,181,-0.012805,-0.0012645,0.061606,0.58233,GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_DN,1
TSHZ1_TARGET_GENES,SET,180,-0.012719,-0.0012526,0.061172,0.58235,TSHZ1_TARGET_GENES,1
GOBP_HEMOGLOBIN_BIOSYNTHETIC...,SET,13,-0.049486,-0.0013156,0.23802,0.58235,GOBP_HEMOGLOBIN_BIOSYNTHETIC_PROCESS,1
WP_MIRNA_REGULATION_OF_PROST...,SET,29,-0.032749,-0.0012998,0.15747,0.58237,WP_MIRNA_REGULATION_OF_PROSTATE_CANCER_SIGNALING,1
GOCC_PERICENTRIOLAR_MATERIAL,SET,21,-0.035936,-0.001214,0.17277,0.58238,GOCC_PERICENTRIOLAR_MATERIAL,1
REACTOME_SYNTHESIS_OF_LEUKOT...,SET,21,-0.043079,-0.0014553,0.20709,0.58239,REACTOME_SYNTHESIS_OF_LEUKOTRIENES_LT_AND_EOXINS_EX,1
HP_DECREASED_CIRCULATING_IGE,SET,5,-0.078424,-0.0012933,0.37701,0.58239,HP_DECREASED_CIRCULATING_IGE,1
HP_SINGLE_NARIS,SET,19,-0.040745,-0.0013094,0.19578,0.58243,HP_SINGLE_NARIS,1
LET_7D_3P,SET,8,-0.066999,-0.0013975,0.32176,0.58247,LET_7D_3P,1
GOBP_RECEPTOR_MEDIATED_ENDOC...2,SET,5,-0.08619,-0.0014214,0.41393,0.58247,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_INVOLVED_IN_CHOLESTEROL_TRANSPORT,1
HP_STEPPAGE_GAIT,SET,49,-0.024311,-0.0012536,0.11675,0.58247,HP_STEPPAGE_GAIT,1
GSE2770_UNTREATED_VS_TGFB_AN...1,SET,177,-0.013207,-0.0012898,0.063396,0.58251,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
HP_FACIAL_HYPEROSTOSIS,SET,4,-0.093516,-0.0013795,0.4488,0.58253,HP_FACIAL_HYPEROSTOSIS,1
PID_BETA_CATENIN_NUC_PATHWAY,SET,70,-0.02316,-0.0014266,0.11112,0.58255,PID_BETA_CATENIN_NUC_PATHWAY,1
chr11q14,SET,48,-0.049413,-0.0025219,0.23701,0.58257,chr11q14,1
HP_UPLIFTED_EARLOBE,SET,20,-0.039575,-0.0013048,0.18976,0.5826,HP_UPLIFTED_EARLOBE,1
HP_DERMATOCHALASIS,SET,8,-0.066646,-0.0013901,0.31868,0.58283,HP_DERMATOCHALASIS,1
FALVELLA_SMOKERS_WITH_LUNG_C...,SET,72,-0.021565,-0.0013471,0.10306,0.58287,FALVELLA_SMOKERS_WITH_LUNG_CANCER,1
GOBP_POSITIVE_REGULATION_OF_...715,SET,30,-0.034335,-0.001386,0.16406,0.58289,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
WP_VITAMIN_K_METABOLISM_AND_...,SET,12,-0.047212,-0.001206,0.2255,0.58292,WP_VITAMIN_K_METABOLISM_AND_ACTIVATION_OF_DEPENDENT_PROTEINS,1
TURASHVILI_BREAST_LOBULAR_CA...1,SET,81,-0.020751,-0.0013746,0.099069,0.58295,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_DN,1
HP_PUSTULE,SET,25,-0.036347,-0.0013396,0.17343,0.583,HP_PUSTULE,1
YAUCH_HEDGEHOG_SIGNALING_PAR...1,SET,237,-0.011751,-0.0013257,0.056028,0.58306,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN,1
BIOCARTA_GSK3_PATHWAY,SET,19,-0.040171,-0.0012909,0.19151,0.58307,BIOCARTA_GSK3_PATHWAY,1
SCGGAAGY_ELK1_02,SET,1127,-0.0052233,-0.0012532,0.024896,0.58309,SCGGAAGY_ELK1_02,1
GOBP_G_PROTEIN_COUPLED_RECEP...3,SET,54,-0.025963,-0.0014053,0.1237,0.58312,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY_COUPLED_TO_CYCLIC_NUCLEOTIDE_SECOND_MESSENGER,1
KIM_GLIS2_TARGETS_DN,SET,6,-0.067906,-0.0012267,0.32351,0.58313,KIM_GLIS2_TARGETS_DN,1
GOCC_ASTER,SET,10,-0.056916,-0.0013272,0.27115,0.58313,GOCC_ASTER,1
LEE_TARGETS_OF_PTCH1_AND_SUF...2,SET,51,-0.024509,-0.0012893,0.11675,0.58314,LEE_TARGETS_OF_PTCH1_AND_SUFU_UP,1
GSE29164_CD8_TCELL_VS_CD8_TC...3,SET,162,-0.014096,-0.0013175,0.06714,0.58314,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_DN,1
GSE21546_WT_VS_SAP1A_KO_AND_...4,SET,185,-0.013185,-0.0013161,0.062791,0.58315,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP,1
GOBP_REGULATION_OF_LONG_TERM...3,SET,46,-0.026776,-0.0013379,0.12745,0.5832,GOBP_REGULATION_OF_LONG_TERM_SYNAPTIC_POTENTIATION,1
GOBP_HEAD_MORPHOGENESIS,SET,35,-0.030772,-0.0013416,0.14636,0.58326,GOBP_HEAD_MORPHOGENESIS,1
TCTGGAC_MIR198,SET,78,-0.0203,-0.0013196,0.096516,0.58329,TCTGGAC_MIR198,1
GOBP_DNA_INTEGRATION,SET,7,-0.061762,-0.0012051,0.29356,0.58332,GOBP_DNA_INTEGRATION,1
GNF2_FOS,SET,34,-0.033182,-0.0014259,0.15768,0.58333,GNF2_FOS,1
GNF2_CARD15,SET,62,-0.024073,-0.0013958,0.11439,0.58334,GNF2_CARD15,1
CUI_TCF21_TARGETS_2_DN,SET,762,-0.0068011,-0.0013558,0.032315,0.58335,CUI_TCF21_TARGETS_2_DN,1
GSE28726_NAIVE_VS_ACTIVATED_...1,SET,186,-0.012827,-0.0012838,0.060898,0.58341,GSE28726_NAIVE_VS_ACTIVATED_CD4_TCELL_DN,1
GSE37301_HEMATOPOIETIC_STEM_...13,SET,159,-0.014767,-0.0013676,0.070106,0.58341,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_DN,1
GSE21033_3H_VS_12H_POLYIC_ST...2,SET,149,-0.014138,-0.0012678,0.067075,0.58347,GSE21033_3H_VS_12H_POLYIC_STIM_DC_UP,1
GOBP_REGULATION_OF_LIPOPOLYS...,SET,27,-0.035031,-0.0013417,0.16617,0.58348,GOBP_REGULATION_OF_LIPOPOLYSACCHARIDE_MEDIATED_SIGNALING_PATHWAY,1
WEST_ADRENOCORTICAL_TUMOR_MA...1,SET,18,-0.046273,-0.0014474,0.21948,0.58349,WEST_ADRENOCORTICAL_TUMOR_MARKERS_DN,1
REACTOME_MATURATION_OF_SPIKE...,SET,35,-0.029997,-0.0013078,0.14226,0.5835,REACTOME_MATURATION_OF_SPIKE_PROTEIN,1
GOBP_BIOLOGICAL_PROCESS_INVO...4,SET,47,-0.025701,-0.001298,0.12184,0.58353,GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTRASPECIES_INTERACTION_BETWEEN_ORGANISMS,1
GOBP_REGULATION_OF_EOSINOPHI...,SET,5,-0.085964,-0.0014177,0.40729,0.58358,GOBP_REGULATION_OF_EOSINOPHIL_MIGRATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...12,SET,66,-0.022028,-0.0013176,0.10432,0.58362,HP_APLASIA_HYPOPLASIA_OF_THE_BREASTS,1
HP_ABNORMAL_CELLULAR_COMPOSI...,SET,8,-0.072566,-0.0015136,0.34354,0.58364,HP_ABNORMAL_CELLULAR_COMPOSITION_OF_BRONCHOALVEOLAR_FLUID,1
HP_HALLUX_VARUS,SET,5,-0.085738,-0.001414,0.40551,0.58372,HP_HALLUX_VARUS,1
GOBP_REGULATION_OF_CILIUM_MO...,SET,36,-0.0304,-0.0013441,0.14377,0.58373,GOBP_REGULATION_OF_CILIUM_MOVEMENT,1
GSE24142_EARLY_THYMIC_PROGEN...5,SET,186,-0.013736,-0.0013748,0.064928,0.58377,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_FETAL_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...3,SET,5,-0.088857,-0.0014654,0.41993,0.58379,HP_APLASIA_HYPOPLASIA_OF_THE_2ND_METACARPAL,1
HP_ABNORMALITY_OF_CARTILAGE_...,SET,14,-0.049217,-0.0013579,0.23245,0.58384,HP_ABNORMALITY_OF_CARTILAGE_OF_EXTERNAL_EAR,1
GOCC_SPERM_CONNECTING_PIECE,SET,11,-0.055335,-0.0013533,0.26129,0.58386,GOCC_SPERM_CONNECTING_PIECE,1
GSE17721_0.5H_VS_12H_CPG_BMD...2,SET,181,-0.013261,-0.0013095,0.062593,0.58389,GSE17721_0.5H_VS_12H_CPG_BMDC_UP,1
GOBP_CEREBRAL_CORTEX_NEURON_...,SET,22,-0.042676,-0.0014756,0.20141,0.5839,GOBP_CEREBRAL_CORTEX_NEURON_DIFFERENTIATION,1
WP_CAMKK2_PATHWAY,SET,32,-0.032127,-0.0013394,0.1515,0.58397,WP_CAMKK2_PATHWAY,1
GOMF_SUPERCOILED_DNA_BINDING,SET,6,-0.068623,-0.0012397,0.32361,0.58397,GOMF_SUPERCOILED_DNA_BINDING,1
GOBP_CORTICOTROPIN_SECRETION,SET,6,-0.079957,-0.0014444,0.37694,0.58399,GOBP_CORTICOTROPIN_SECRETION,1
GOCC_NPBAF_COMPLEX,SET,14,-0.048456,-0.0013368,0.22817,0.58409,GOCC_NPBAF_COMPLEX,1
CCGNMNNTNACG_UNKNOWN,SET,74,-0.019567,-0.0012391,0.0921,0.58412,CCGNMNNTNACG_UNKNOWN,1
GOBP_MITOCHONDRIAL_GENE_EXPR...,SET,154,-0.013178,-0.0012012,0.062031,0.58412,GOBP_MITOCHONDRIAL_GENE_EXPRESSION,1
GOBP_IMP_CATABOLIC_PROCESS,SET,5,-0.084917,-0.0014004,0.39956,0.58415,GOBP_IMP_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_TRANSPORT,SET,1450,-0.0049949,-0.0013465,0.023502,0.58415,GOBP_REGULATION_OF_TRANSPORT,1
MIR1250_3P,SET,457,-0.0086022,-0.0013395,0.040461,0.58418,MIR1250_3P,1
HP_SANDWICH_APPEARANCE_OF_VE...,SET,5,-0.081518,-0.0013444,0.38333,0.5842,HP_SANDWICH_APPEARANCE_OF_VERTEBRAL_BODIES,1
JAZAERI_BREAST_CANCER_BRCA1_...1,SET,40,-0.030567,-0.0014245,0.14373,0.58421,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN,1
HMGB2_TARGET_GENES,SET,412,-0.0091219,-0.0013504,0.042876,0.58424,HMGB2_TARGET_GENES,1
BLALOCK_ALZHEIMERS_DISEASE_I...1,SET,149,-0.013984,-0.001254,0.065714,0.58426,BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_DN,1
GOMF_PHOSPHATIDYLETHANOLAMIN...1,SET,16,-0.043411,-0.0012803,0.20396,0.58427,GOMF_PHOSPHATIDYLETHANOLAMINE_BINDING,1
HP_PATHOLOGIC_FRACTURE,SET,57,-0.024678,-0.0013722,0.11592,0.58429,HP_PATHOLOGIC_FRACTURE,1
HP_DISTAL_RENAL_TUBULAR_ACID...,SET,6,-0.076158,-0.0013758,0.35767,0.58431,HP_DISTAL_RENAL_TUBULAR_ACIDOSIS,1
HP_CARPAL_BONE_HYPOPLASIA,SET,11,-0.050798,-0.0012424,0.23849,0.58433,HP_CARPAL_BONE_HYPOPLASIA,1
MIR6867_5P,SET,773,-0.0068659,-0.0013782,0.032176,0.58449,MIR6867_5P,1
PID_PLK1_PATHWAY,SET,42,-0.02597,-0.0012401,0.12163,0.58453,PID_PLK1_PATHWAY,1
DESCARTES_FETAL_LUNG_CILIATE...,SET,360,-0.0093742,-0.0012991,0.043878,0.58459,DESCARTES_FETAL_LUNG_CILIATED_EPITHELIAL_CELLS,1
GOBP_MITOCHONDRIAL_ATP_TRANS...,SET,6,-0.080935,-0.0014621,0.37876,0.5846,GOBP_MITOCHONDRIAL_ATP_TRANSMEMBRANE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...86,SET,28,-0.036321,-0.0014166,0.16999,0.5846,GOBP_NEGATIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
MIR6747_5P,SET,40,-0.027455,-0.0012794,0.12845,0.58462,MIR6747_5P,1
PID_EPHRINB_REV_PATHWAY,SET,29,-0.036605,-0.0014529,0.17122,0.58464,PID_EPHRINB_REV_PATHWAY,1
HP_RENAL_HYPOPLASIA_APLASIA,SET,298,-0.010275,-0.0012977,0.048063,0.58464,HP_RENAL_HYPOPLASIA_APLASIA,1
HP_ANTINEUTROPHIL_ANTIBODY_P...,SET,42,-0.027455,-0.0013109,0.12829,0.58473,HP_ANTINEUTROPHIL_ANTIBODY_POSITIVITY,1
GOCC_DENDRITE_TERMINUS,SET,11,-0.052358,-0.0012805,0.24434,0.58484,GOCC_DENDRITE_TERMINUS,1
HP_INTRACTABLE_DIARRHEA,SET,6,-0.078225,-0.0014132,0.36503,0.58484,HP_INTRACTABLE_DIARRHEA,1
chr12p12,SET,49,-0.04516,-0.0023287,0.21064,0.58488,chr12p12,1
GOCC_CORE_MEDIATOR_COMPLEX,SET,25,-0.032925,-0.0012135,0.15357,0.58488,GOCC_CORE_MEDIATOR_COMPLEX,1
GOMF_CHEMOKINE_ACTIVITY,SET,45,-0.032864,-0.0016242,0.15322,0.58492,GOMF_CHEMOKINE_ACTIVITY,1
MORF_RAD23B,SET,158,-0.013024,-0.0012024,0.060626,0.58505,MORF_RAD23B,1
GOBP_CERAMIDE_CATABOLIC_PROC...,SET,20,-0.043565,-0.0014364,0.20269,0.58509,GOBP_CERAMIDE_CATABOLIC_PROCESS,1
HP_ABNORMAL_CORNEAL_ENDOTHEL...,SET,18,-0.047364,-0.0014815,0.22031,0.58511,HP_ABNORMAL_CORNEAL_ENDOTHELIUM_MORPHOLOGY,1
GYORFFY_MITOXANTRONE_RESISTA...,SET,32,-0.034811,-0.0014513,0.16188,0.58513,GYORFFY_MITOXANTRONE_RESISTANCE,1
MIR6734_3P,SET,134,-0.015756,-0.0013404,0.073268,0.58513,MIR6734_3P,1
LI_ESTROGENE_EARLY_E2_RESPON...2,SET,82,-0.021293,-0.0014191,0.09895,0.58519,LI_ESTROGENE_EARLY_E2_RESPONSE_UP,1
KEGG_MEDICUS_REFERENCE_CCR2_...,SET,30,-0.033458,-0.0013506,0.15527,0.5853,KEGG_MEDICUS_REFERENCE_CCR2_GNB_G_PI3K_NFKB_SIGNALING_PATHWAY,1
HP_ABNORMAL_RIGHT_VENTRICLE_...,SET,61,-0.023763,-0.0013667,0.11023,0.58534,HP_ABNORMAL_RIGHT_VENTRICLE_MORPHOLOGY,1
HALLMARK_COMPLEMENT,SET,192,-0.013689,-0.0013918,0.063449,0.58541,HALLMARK_COMPLEMENT,1
DACOSTA_UV_RESPONSE_VIA_ERCC...3,SET,808,-0.0065438,-0.0013416,0.030312,0.58546,DACOSTA_UV_RESPONSE_VIA_ERCC3_DN,1
KEGG_MEDICUS_VARIANT_MLL_AF4...,SET,25,-0.038283,-0.001411,0.17726,0.58549,KEGG_MEDICUS_VARIANT_MLL_AF4_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
WP_CLEAR_CELL_RENAL_CELL_CAR...,SET,80,-0.019976,-0.0013151,0.092499,0.58549,WP_CLEAR_CELL_RENAL_CELL_CARCINOMA_PATHWAYS,1
KEGG_GLUTATHIONE_METABOLISM,SET,45,-0.029234,-0.0014448,0.13532,0.58552,KEGG_GLUTATHIONE_METABOLISM,1
HP_ABNORMAL_CIRCULATING_IRON...,SET,17,-0.041003,-0.0012465,0.18967,0.58558,HP_ABNORMAL_CIRCULATING_IRON_CONCENTRATION,1
MIR7113_3P,SET,84,-0.018966,-0.0012793,0.087697,0.58561,MIR7113_3P,1
REACTOME_HEME_BIOSYNTHESIS,SET,13,-0.049083,-0.0013049,0.22688,0.58564,REACTOME_HEME_BIOSYNTHESIS,1
MORF_RBBP8,SET,200,-0.012878,-0.0013361,0.059523,0.58564,MORF_RBBP8,1
GOBP_REGULATION_OF_ACYL_COA_...,SET,4,-0.10034,-0.0014801,0.46376,0.58564,GOBP_REGULATION_OF_ACYL_COA_BIOSYNTHETIC_PROCESS,1
ERWIN_COHEN_BLOOD_VACCINE_TC...2,SET,26,-0.038601,-0.0014508,0.17819,0.58575,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_DN,1
HP_ABNORMAL_TONGUE_PHYSIOLOGY,SET,57,-0.023695,-0.0013175,0.10933,0.58579,HP_ABNORMAL_TONGUE_PHYSIOLOGY,1
HAY_BONE_MARROW_STROMAL,SET,670,-0.0078386,-0.0014691,0.036157,0.58581,HAY_BONE_MARROW_STROMAL,1
LANDIS_ERBB2_BREAST_TUMORS_6...2,SET,22,-0.040415,-0.0013975,0.1861,0.58596,LANDIS_ERBB2_BREAST_TUMORS_65_UP,1
GOBP_MITOCHONDRION_ORGANIZAT...,SET,442,-0.0084039,-0.0012875,0.038684,0.58599,GOBP_MITOCHONDRION_ORGANIZATION,1
GOBP_REGULATION_OF_BLOOD_VES...,SET,7,-0.064095,-0.0012506,0.29505,0.58599,GOBP_REGULATION_OF_BLOOD_VESSEL_REMODELING,1
GOBP_NEGATIVE_REGULATION_OF_...213,SET,6,-0.076608,-0.001384,0.35253,0.58602,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,1
HP_ELEVATED_URINARY_MONOCARB...,SET,11,-0.054695,-0.0013377,0.25167,0.58602,HP_ELEVATED_URINARY_MONOCARBOXYLIC_ACID_LEVEL,1
GOBP_REGULATION_OF_FC_RECEPT...,SET,10,-0.061173,-0.0014265,0.28082,0.58622,GOBP_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,1
GOBP_SYNAPTIC_VESICLE_RECYCL...2,SET,4,-0.081758,-0.001206,0.37522,0.58624,GOBP_SYNAPTIC_VESICLE_RECYCLING_VIA_ENDOSOME,1
HP_SHORT_FIRST_METATARSAL,SET,4,-0.094362,-0.0013919,0.43281,0.58629,HP_SHORT_FIRST_METATARSAL,1
WP_ERBB_SIGNALING,SET,86,-0.020435,-0.0013946,0.093715,0.58631,WP_ERBB_SIGNALING,1
KOBAYASHI_RESPONSE_TO_ROMIDE...,SET,19,-0.046209,-0.001485,0.21187,0.58632,KOBAYASHI_RESPONSE_TO_ROMIDEPSIN,1
GSE32901_NAIVE_VS_TH17_ENRIC...2,SET,137,-0.015791,-0.0013583,0.072359,0.58637,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_UP,1
MATSUMIYA_PBMC_MODIFIED_VACC...5,SET,26,-0.037509,-0.0014098,0.17186,0.58638,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_VACCINATED_VS_CONTROL_TREATED_IN_VITRO_WITH_WILD_TYPE_MVA_6HR_UP,1
MIR3152_5P,SET,55,-0.02371,-0.0012951,0.1086,0.58641,MIR3152_5P,1
MODULE_382,SET,25,-0.040899,-0.0015074,0.1873,0.58642,MODULE_382,1
GSE39110_UNTREATED_VS_IL2_TR...4,SET,182,-0.013922,-0.0013785,0.06375,0.58644,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY6_POST_IMMUNIZATION_UP,1
GOBP_HOST_MEDIATED_REGULATIO...,SET,9,-0.063445,-0.0014036,0.29046,0.58645,GOBP_HOST_MEDIATED_REGULATION_OF_INTESTINAL_MICROBIOTA_COMPOSITION,1
YAO_TEMPORAL_RESPONSE_TO_PRO...9,SET,71,-0.022559,-0.0013994,0.10327,0.58646,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16,1
WU_CELL_MIGRATION,SET,167,-0.015473,-0.0014682,0.0708,0.58649,WU_CELL_MIGRATION,1
GOCC_OXOGLUTARATE_DEHYDROGEN...,SET,11,-0.047022,-0.00115,0.215,0.58656,GOCC_OXOGLUTARATE_DEHYDROGENASE_COMPLEX,1
GOBP_REGULATION_OF_GROWTH_RA...,SET,5,-0.086696,-0.0014298,0.39612,0.58662,GOBP_REGULATION_OF_GROWTH_RATE,1
GOBP_PHOSPHATIDYLINOSITOL_AC...,SET,6,-0.086797,-0.001568,0.39635,0.58667,GOBP_PHOSPHATIDYLINOSITOL_ACYL_CHAIN_REMODELING,1
GSE14769_UNSTIM_VS_60MIN_LPS...2,SET,180,-0.013222,-0.001302,0.060359,0.58669,GSE14769_UNSTIM_VS_60MIN_LPS_BMDM_UP,1
GOCC_SODIUM_POTASSIUM_EXCHAN...,SET,11,-0.06398,-0.0015648,0.29203,0.58671,GOCC_SODIUM_POTASSIUM_EXCHANGING_ATPASE_COMPLEX,1
MIR5000_3P,SET,89,-0.020014,-0.0013894,0.091229,0.58682,MIR5000_3P,1
GOBP_STRIATED_MUSCLE_ATROPHY,SET,7,-0.073768,-0.0014394,0.33628,0.58682,GOBP_STRIATED_MUSCLE_ATROPHY,1
BIOCARTA_THELPER_PATHWAY,SET,12,-0.059511,-0.0015201,0.27125,0.58683,BIOCARTA_THELPER_PATHWAY,1
HP_LIMITED_NECK_RANGE_OF_MOT...,SET,8,-0.075045,-0.0015653,0.34191,0.58686,HP_LIMITED_NECK_RANGE_OF_MOTION,1
BIOCARTA_IL1R_PATHWAY,SET,30,-0.037038,-0.0014952,0.16874,0.58687,BIOCARTA_IL1R_PATHWAY,1
DESCARTES_MAIN_FETAL_SATELLI...,SET,44,-0.027391,-0.0013386,0.12477,0.58688,DESCARTES_MAIN_FETAL_SATELLITE_CELLS,1
GSE26669_CD4_VS_CD8_TCELL_IN...1,SET,189,-0.013675,-0.0013796,0.062271,0.58691,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_DN,1
GOBP_REGULATION_OF_ATRIAL_CA...1,SET,9,-0.074362,-0.0016452,0.33856,0.58692,GOBP_REGULATION_OF_ATRIAL_CARDIAC_MUSCLE_CELL_MEMBRANE_DEPOLARIZATION,1
WP_THIAMINE_METABOLIC_PATHWA...,SET,8,-0.063409,-0.0013226,0.28857,0.58696,WP_THIAMINE_METABOLIC_PATHWAYS,1
GOBP_CELLULAR_PIGMENTATION,SET,60,-0.024823,-0.001416,0.11284,0.58706,GOBP_CELLULAR_PIGMENTATION,1
GOMF_GALACTOSIDASE_ACTIVITY,SET,6,-0.073022,-0.0013192,0.3319,0.58707,GOMF_GALACTOSIDASE_ACTIVITY,1
REACTOME_CYTOSOLIC_TRNA_AMIN...,SET,6,-0.062582,-0.0011306,0.28437,0.58709,REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION,1
MIR589_3P,SET,229,-0.012424,-0.0013782,0.056448,0.5871,MIR589_3P,1
BPTF_TARGET_GENES,SET,885,-0.0064558,-0.0013821,0.029321,0.58713,BPTF_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C0_MYO...1,SET,46,-0.031479,-0.0015729,0.14291,0.58717,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL,1
MIR511_3P,SET,154,-0.015008,-0.001368,0.068116,0.58719,MIR511_3P,1
GIAROLA_SILVA_BLOOD_INFLUENZ...,SET,4,-0.10183,-0.0015021,0.46221,0.58719,GIAROLA_SILVA_BLOOD_INFLUENZA_A_AGE_21_51YO_3DY_UP,1
GOBP_TRNA_PSEUDOURIDINE_SYNT...,SET,6,-0.068412,-0.0012359,0.3103,0.58725,GOBP_TRNA_PSEUDOURIDINE_SYNTHESIS,1
GSE40274_GATA1_VS_FOXP3_AND_...2,SET,180,-0.013708,-0.0013499,0.062158,0.58727,GSE40274_GATA1_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
HP_ANOSMIA,SET,47,-0.029174,-0.0014734,0.13226,0.58729,HP_ANOSMIA,1
GAUCHER_PBMC_YF_VAX_STAMARIL...12,SET,274,-0.011695,-0.0014173,0.053018,0.58729,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_7DY_UP,1
GOMF_ADP_PHOSPHATASE_ACTIVITY,SET,6,-0.07351,-0.001328,0.33314,0.58732,GOMF_ADP_PHOSPHATASE_ACTIVITY,1
GSE40274_CTRL_VS_FOXP3_AND_G...2,SET,125,-0.017,-0.0013972,0.077029,0.58733,GSE40274_CTRL_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
ALONSO_METASTASIS_EMT_UP,SET,32,-0.034814,-0.0014514,0.15765,0.58739,ALONSO_METASTASIS_EMT_UP,1
GOMF_DNA_DIRECTED_DNA_POLYME...,SET,22,-0.03136,-0.0010843,0.14185,0.58748,GOMF_DNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
GSE9650_EXHAUSTED_VS_MEMORY_...2,SET,183,-0.014294,-0.0014192,0.064663,0.58748,GSE9650_EXHAUSTED_VS_MEMORY_CD8_TCELL_UP,1
GSE17721_12H_VS_24H_LPS_BMDC...1,SET,181,-0.012953,-0.0012791,0.058512,0.5876,GSE17721_12H_VS_24H_LPS_BMDC_DN,1
GOMF_TRANSFERASE_ACTIVITY_TR...1,SET,54,-0.026729,-0.0014467,0.12071,0.58762,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_ALKYL_OR_ARYL_OTHER_THAN_METHYL_GROUPS,1
GCM_AQP4,SET,41,-0.029505,-0.001392,0.13321,0.58765,GCM_AQP4,1
GOBP_CELL_CELL_ADHESION_MEDI...1,SET,48,-0.028472,-0.0014532,0.12853,0.58766,GOBP_CELL_CELL_ADHESION_MEDIATED_BY_CADHERIN,1
GSE23321_CENTRAL_MEMORY_VS_N...2,SET,182,-0.013968,-0.0013831,0.063044,0.58767,GSE23321_CENTRAL_MEMORY_VS_NAIVE_CD8_TCELL_UP,1
HP_EXTRAMEDULLARY_HEMATOPOIE...,SET,19,-0.042525,-0.0013666,0.1919,0.58768,HP_EXTRAMEDULLARY_HEMATOPOIESIS,1
GOBP_MIGRACYTOSIS,SET,5,-0.093959,-0.0015495,0.42383,0.58772,GOBP_MIGRACYTOSIS,1
MIR582_5P,SET,326,-0.010535,-0.0013906,0.047515,0.58774,MIR582_5P,1
MIR4698,SET,572,-0.0081349,-0.0014126,0.036657,0.58781,MIR4698,1
MYOGNF1_01,SET,41,-0.029957,-0.0014133,0.13499,0.58781,MYOGNF1_01,1
TAKEDA_TARGETS_OF_NUP98_HOXA...4,SET,160,-0.016083,-0.0014941,0.072364,0.58794,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_UP,1
HP_HYPERTRIGLYCERIDEMIA,SET,112,-0.018331,-0.0014266,0.082478,0.58794,HP_HYPERTRIGLYCERIDEMIA,1
HP_ABNORMAL_BOWEL_SOUNDS,SET,8,-0.056083,-0.0011698,0.25214,0.58801,HP_ABNORMAL_BOWEL_SOUNDS,1
ELVIDGE_HYPOXIA_DN,SET,137,-0.014929,-0.0012841,0.067073,0.58807,ELVIDGE_HYPOXIA_DN,1
GSE17721_CPG_VS_GARDIQUIMOD_...16,SET,180,-0.014101,-0.0013887,0.0633,0.58814,GSE17721_CPG_VS_GARDIQUIMOD_6H_BMDC_UP,1
GOMF_PHOSPHOTYROSINE_RESIDUE...,SET,46,-0.028341,-0.0014161,0.1272,0.58816,GOMF_PHOSPHOTYROSINE_RESIDUE_BINDING,1
GSE39110_DAY3_VS_DAY6_POST_I...1,SET,181,-0.013943,-0.0013768,0.062561,0.58818,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_DN,1
REACTOME_NEF_AND_SIGNAL_TRAN...,SET,8,-0.067005,-0.0013976,0.3006,0.58819,REACTOME_NEF_AND_SIGNAL_TRANSDUCTION,1
GOBP_VITAMIN_TRANSPORT,SET,48,-0.027741,-0.0014158,0.12442,0.58821,GOBP_VITAMIN_TRANSPORT,1
GOMF_C_ACYLTRANSFERASE_ACTIV...,SET,19,-0.043334,-0.0013926,0.19436,0.58821,GOMF_C_ACYLTRANSFERASE_ACTIVITY,1
GOBP_EPIBOLY,SET,39,-0.027848,-0.0012815,0.12485,0.58825,GOBP_EPIBOLY,1
MIR3151_3P,SET,39,-0.026811,-0.0012337,0.12013,0.5883,MIR3151_3P,1
GOBP_NEGATIVE_REGULATION_OF_...599,SET,12,-0.05315,-0.0013577,0.23804,0.58834,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOBP_TRANSLATIONAL_ELONGATION,SET,59,-0.022402,-0.0012672,0.10032,0.58835,GOBP_TRANSLATIONAL_ELONGATION,1
GSE30962_PRIMARY_VS_SECONDAR...2,SET,183,-0.01332,-0.0013225,0.059565,0.58847,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_UP,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...4,SET,3,-0.10522,-0.0013442,0.47058,0.58847,CAO_BLOOD_FLUMIST_AGE_05_14YO_30DY_UP,1
GOBP_DETECTION_OF_TEMPERATUR...2,SET,19,-0.044734,-0.0014376,0.20004,0.58848,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_PAIN,1
GOBP_POSITIVE_REGULATION_OF_...576,SET,79,-0.023074,-0.0015095,0.10317,0.58848,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_SERINE_PHOSPHORYLATION,1
KEGG_MEDICUS_REFERENCE_TYPE_...3,SET,20,-0.052004,-0.0017146,0.23242,0.58852,KEGG_MEDICUS_REFERENCE_TYPE_I_INTERFERON_TO_JAK_STAT_SIGNALING_PATHWAY,1
GSE20366_CD103_KLRG1_DP_VS_D...1,SET,173,-0.014175,-0.0013688,0.063317,0.58857,GSE20366_CD103_KLRG1_DP_VS_DN_TREG_DN,1
HP_GRANULOMA,SET,6,-0.080565,-0.0014554,0.35984,0.58858,HP_GRANULOMA,1
HP_ABNORMALITY_OF_THE_ENDOCR...,SET,1249,-0.0054804,-0.0013793,0.024472,0.5886,HP_ABNORMALITY_OF_THE_ENDOCRINE_SYSTEM,1
GOBP_NEURAL_TUBE_DEVELOPMENT,SET,151,-0.015375,-0.0013879,0.068596,0.58867,GOBP_NEURAL_TUBE_DEVELOPMENT,1
GOBP_PLASMA_MEMBRANE_TUBULAT...,SET,18,-0.040831,-0.0012772,0.18203,0.58874,GOBP_PLASMA_MEMBRANE_TUBULATION,1
CEBPE_TARGET_GENES,SET,25,-0.044735,-0.0016488,0.19929,0.5888,CEBPE_TARGET_GENES,1
MODULE_91,SET,35,-0.027773,-0.0012108,0.12372,0.58881,MODULE_91,1
HP_THICK_CEREBRAL_CORTEX,SET,9,-0.057807,-0.0012789,0.25751,0.58881,HP_THICK_CEREBRAL_CORTEX,1
GSE11961_FOLLICULAR_BCELL_VS...5,SET,184,-0.014238,-0.0014174,0.063402,0.58884,GSE11961_FOLLICULAR_BCELL_VS_MARGINAL_ZONE_BCELL_DN,1
GSE21927_SPLEEN_C57BL6_VS_EL...2,SET,178,-0.013778,-0.0013494,0.061353,0.58884,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP,1
GOBP_REGULATION_OF_MACROPHAG...6,SET,5,-0.088622,-0.0014615,0.39461,0.58885,GOBP_REGULATION_OF_MACROPHAGE_FUSION,1
GOBP_SECRETORY_GRANULE_LOCAL...,SET,22,-0.042129,-0.0014567,0.18759,0.58885,GOBP_SECRETORY_GRANULE_LOCALIZATION,1
GSE4142_PLASMA_CELL_VS_MEMOR...1,SET,183,-0.013759,-0.0013661,0.061251,0.58886,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_DN,1
MIR6851_3P,SET,53,-0.025072,-0.0013444,0.11154,0.58893,MIR6851_3P,1
HP_MALAR_PROMINENCE,SET,5,-0.079834,-0.0013166,0.35515,0.58893,HP_MALAR_PROMINENCE,1
GSE9601_UNTREATED_VS_PI3K_IN...2,SET,157,-0.014731,-0.0013557,0.065505,0.58897,GSE9601_UNTREATED_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_UP,1
JIANG_HYPOXIA_VIA_VHL,SET,17,-0.045427,-0.0013809,0.20186,0.58903,JIANG_HYPOXIA_VIA_VHL,1
BOYERINAS_ONCOFETAL_TARGETS_...,SET,10,-0.063838,-0.0014887,0.2836,0.58905,BOYERINAS_ONCOFETAL_TARGETS_OF_LET7A1,1
GOCC_TRANSFERASE_COMPLEX,SET,758,-0.0066742,-0.0013272,0.029641,0.58907,GOCC_TRANSFERASE_COMPLEX,1
GSE16522_MEMORY_VS_NAIVE_CD8...1,SET,181,-0.014204,-0.0014026,0.063077,0.58908,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
GOBP_PHOSPHATIDYLINOSITOL_BI...,SET,117,-0.016781,-0.0013346,0.074513,0.58909,GOBP_PHOSPHATIDYLINOSITOL_BIOSYNTHETIC_PROCESS,1
GNF2_PTX3,SET,34,-0.037113,-0.0015948,0.16475,0.58912,GNF2_PTX3,1
GSE30962_ACUTE_VS_CHRONIC_LC...1,SET,186,-0.01422,-0.0014233,0.063106,0.58914,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_DN,1
GOBP_AGGRESSIVE_BEHAVIOR,SET,8,-0.079875,-0.0016661,0.3543,0.58918,GOBP_AGGRESSIVE_BEHAVIOR,1
SCHAEFFER_PROSTATE_DEVELOPME...16,SET,5,-0.094118,-0.0015522,0.4173,0.58922,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX6_DN,1
HP_CLITORAL_HYPERTROPHY,SET,60,-0.024449,-0.0013947,0.10829,0.58931,HP_CLITORAL_HYPERTROPHY,1
GOBP_EXOCYTOSIS,SET,322,-0.010542,-0.0013831,0.046688,0.58932,GOBP_EXOCYTOSIS,1
GOCC_MRNA_EDITING_COMPLEX,SET,5,-0.087198,-0.001438,0.386,0.58936,GOCC_MRNA_EDITING_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...531,SET,8,-0.063242,-0.0013191,0.27965,0.58945,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_ARBORIZATION,1
WP_NRXN1_DELETION_SYNDROME,SET,14,-0.054063,-0.0014915,0.23897,0.58949,WP_NRXN1_DELETION_SYNDROME,1
GSE7459_UNTREATED_VS_IL6_TRE...2,SET,117,-0.017771,-0.0014134,0.078507,0.58954,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_UP,1
SASSON_FSH_RESPONSE,SET,7,-0.079889,-0.0015588,0.35249,0.58965,SASSON_FSH_RESPONSE,1
GOBP_REGULATION_OF_INOSITOL_...1,SET,4,-0.10323,-0.0015228,0.45546,0.58965,GOBP_REGULATION_OF_INOSITOL_1_4_5_TRISPHOSPHATE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
MIR6841_3P,SET,49,-0.026554,-0.0013693,0.11713,0.58968,MIR6841_3P,1
GOCC_RNA_POLYMERASE_I_COMPLEX,SET,10,-0.050454,-0.0011766,0.22249,0.5897,GOCC_RNA_POLYMERASE_I_COMPLEX,1
HP_HYPOMETRIC_SACCADES,SET,13,-0.054116,-0.0014388,0.23851,0.58975,HP_HYPOMETRIC_SACCADES,1
GOBP_RIBONUCLEOSIDE_CATABOLI...,SET,18,-0.057752,-0.0018065,0.25448,0.58976,GOBP_RIBONUCLEOSIDE_CATABOLIC_PROCESS,1
GOBP_LUNG_CELL_DIFFERENTIATI...,SET,29,-0.037287,-0.0014799,0.16427,0.58978,GOBP_LUNG_CELL_DIFFERENTIATION,1
KEGG_COLORECTAL_CANCER,SET,61,-0.024781,-0.0014253,0.10913,0.58982,KEGG_COLORECTAL_CANCER,1
HP_DIFFUSE_OPTIC_DISC_PALLOR,SET,14,-0.051638,-0.0014247,0.22736,0.58983,HP_DIFFUSE_OPTIC_DISC_PALLOR,1
GOBP_PROTEIN_LOCALIZATION_TO...41,SET,6,-0.071795,-0.001297,0.3161,0.58984,GOBP_PROTEIN_LOCALIZATION_TO_PERINUCLEAR_REGION_OF_CYTOPLASM,1
HP_ABSENT_EYEBROW,SET,31,-0.037206,-0.0015268,0.1636,0.58995,HP_ABSENT_EYEBROW,1
REACTOME_AMINO_ACIDS_REGULAT...,SET,49,-0.026354,-0.001359,0.11582,0.59,REACTOME_AMINO_ACIDS_REGULATE_MTORC1,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...3,SET,17,-0.051622,-0.0015693,0.22683,0.59001,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_PROTEIN_COMPLEX,1
KEGG_MEDICUS_PATHOGEN_SALMON...9,SET,5,-0.069454,-0.0011454,0.30496,0.59008,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SPVD_TO_TNF_NFKB_SIGNALING_PATHWAY,1
HP_DECREASED_CIRCULATING_COP...,SET,6,-0.084467,-0.0015259,0.37089,0.59008,HP_DECREASED_CIRCULATING_COPPER_CONCENTRATION,1
HP_APLASIA_CUTIS_CONGENITA_O...3,SET,7,-0.064852,-0.0012654,0.28462,0.59012,HP_APLASIA_CUTIS_CONGENITA_OVER_THE_SCALP_VERTEX,1
GSE15324_ELF4_KO_VS_WT_ACTIV...1,SET,180,-0.013829,-0.0013618,0.060682,0.59013,GSE15324_ELF4_KO_VS_WT_ACTIVATED_CD8_TCELL_DN,1
GOBP_ANIMAL_ORGAN_MATURATION,SET,28,-0.038179,-0.001489,0.16748,0.59016,GOBP_ANIMAL_ORGAN_MATURATION,1
HP_INTELLECTUAL_DISABILITY_M...2,SET,132,-0.015753,-0.0013302,0.069094,0.59017,HP_INTELLECTUAL_DISABILITY_MODERATE,1
GOBP_REGULATION_OF_SYNAPSE_P...,SET,6,-0.086495,-0.0015625,0.37924,0.5902,GOBP_REGULATION_OF_SYNAPSE_PRUNING,1
AMIT_SERUM_RESPONSE_480_MCF1...,SET,32,-0.032762,-0.0013659,0.14356,0.59026,AMIT_SERUM_RESPONSE_480_MCF10A,1
HP_PRIMARY_HYPERCORTISOLISM,SET,9,-0.058809,-0.0013011,0.25745,0.59034,HP_PRIMARY_HYPERCORTISOLISM,1
PID_P38_MK2_PATHWAY,SET,21,-0.046525,-0.0015718,0.20357,0.59039,PID_P38_MK2_PATHWAY,1
MIR518A_5P_MIR527,SET,237,-0.012868,-0.0014518,0.056284,0.59042,MIR518A_5P_MIR527,1
TCANNTGAY_SREBP1_01,SET,421,-0.0092914,-0.00139,0.040635,0.59043,TCANNTGAY_SREBP1_01,1
GSE24574_BCL6_HIGH_TFH_VS_TF...2,SET,176,-0.014771,-0.0014386,0.064597,0.59044,GSE24574_BCL6_HIGH_TFH_VS_TFH_CD4_TCELL_UP,1
MIR4729,SET,642,-0.0077503,-0.001423,0.033888,0.59045,MIR4729,1
GOBP_AMINO_ACID_BETAINE_TRAN...,SET,12,-0.064292,-0.0016423,0.28089,0.59052,GOBP_AMINO_ACID_BETAINE_TRANSPORT,1
MODULE_72,SET,285,-0.011277,-0.0013933,0.049264,0.59053,MODULE_72,1
REACTOME_RHOBTB2_GTPASE_CYCLE,SET,22,-0.038052,-0.0013157,0.16618,0.59056,REACTOME_RHOBTB2_GTPASE_CYCLE,1
GSE21927_HEALTHY_VS_TUMOROUS...1,SET,139,-0.016606,-0.0014387,0.072507,0.59057,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_DN,1
TANG_SENESCENCE_TP53_TARGETS...2,SET,31,-0.035198,-0.0014443,0.1536,0.59062,TANG_SENESCENCE_TP53_TARGETS_UP,1
GOBP_SMOOTH_MUSCLE_ADAPTATION,SET,4,-0.11681,-0.001723,0.50937,0.59069,GOBP_SMOOTH_MUSCLE_ADAPTATION,1
GOBP_ESTABLISHMENT_OF_CENTRO...,SET,10,-0.068047,-0.0015868,0.29668,0.5907,GOBP_ESTABLISHMENT_OF_CENTROSOME_LOCALIZATION,1
KEGG_MEDICUS_REFERENCE_PYRIN...,SET,4,-0.083154,-0.0012266,0.36246,0.59073,KEGG_MEDICUS_REFERENCE_PYRIN_INFLAMMASOME_SIGNALING_PATHWAY,1
HP_ABNORMALITY_OF_THE_FEMALE...,SET,504,-0.0087097,-0.0014224,0.037945,0.59077,HP_ABNORMALITY_OF_THE_FEMALE_GENITALIA,1
REACTOME_TRANSMISSION_ACROSS...,SET,252,-0.013066,-0.0015194,0.056869,0.59086,REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES,1
GSE339_EX_VIVO_VS_IN_CULTURE...2,SET,180,-0.014141,-0.0013925,0.061543,0.59086,GSE339_EX_VIVO_VS_IN_CULTURE_CD4CD8DN_DC_UP,1
GOBP_RESPONSE_TO_CORTICOTROP...,SET,5,-0.098394,-0.0016227,0.42775,0.59096,GOBP_RESPONSE_TO_CORTICOTROPIN_RELEASING_HORMONE,1
MIR6789_5P,SET,20,-0.037803,-0.0012464,0.16433,0.59097,MIR6789_5P,1
GOBP_REGULATION_OF_PROTEIN_A...3,SET,34,-0.033995,-0.0014608,0.14778,0.59097,GOBP_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,1
GOMF_ZINC_ION_BINDING,SET,758,-0.0071722,-0.0014262,0.031177,0.59097,GOMF_ZINC_ION_BINDING,1
SIG_PIP3_SIGNALING_IN_CARDIA...,SET,62,-0.026549,-0.0015394,0.11532,0.59104,SIG_PIP3_SIGNALING_IN_CARDIAC_MYOCTES,1
GSE13306_LAMINA_PROPRIA_VS_S...2,SET,182,-0.014324,-0.0014184,0.062218,0.59104,GSE13306_LAMINA_PROPRIA_VS_SPLEEN_TREG_UP,1
DARWICHE_SKIN_TUMOR_PROMOTER...1,SET,175,-0.014544,-0.0014125,0.063152,0.59107,DARWICHE_SKIN_TUMOR_PROMOTER_DN,1
HP_OSTEOLYSIS,SET,72,-0.022955,-0.0014339,0.099662,0.59108,HP_OSTEOLYSIS,1
GOBP_PROTON_MOTIVE_FORCE_DRI...,SET,43,-0.02441,-0.0011793,0.10596,0.59109,GOBP_PROTON_MOTIVE_FORCE_DRIVEN_ATP_SYNTHESIS,1
GSE7852_TREG_VS_TCONV_UP,SET,183,-0.014734,-0.0014629,0.063929,0.59114,GSE7852_TREG_VS_TCONV_UP,1
HP_HYPERORALITY,SET,15,-0.051096,-0.0014591,0.22159,0.59118,HP_HYPERORALITY,1
MIR33A_3P,SET,393,-0.0098648,-0.001427,0.042776,0.59119,MIR33A_3P,1
GOCC_EXTERNAL_SIDE_OF_PLASMA...,SET,362,-0.011679,-0.0016229,0.050648,0.59119,GOCC_EXTERNAL_SIDE_OF_PLASMA_MEMBRANE,1
GOMF_BETA_GALACTOSIDASE_ACTI...,SET,5,-0.094127,-0.0015523,0.40817,0.59119,GOMF_BETA_GALACTOSIDASE_ACTIVITY,1
BLANCO_MELO_COVID19_SARS_COV...6,SET,70,-0.024932,-0.0015358,0.10804,0.59125,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_UP,1
GSE23925_DARK_ZONE_VS_NAIVE_...2,SET,182,-0.013762,-0.0013627,0.059626,0.59126,GSE23925_DARK_ZONE_VS_NAIVE_BCELL_UP,1
HP_TACHYPNEA,SET,88,-0.019372,-0.0013373,0.083927,0.59127,HP_TACHYPNEA,1
HP_PERSISTENT_HEAD_LAG,SET,25,-0.036548,-0.001347,0.15823,0.59134,HP_PERSISTENT_HEAD_LAG,1
WILLERT_WNT_SIGNALING,SET,21,-0.04483,-0.0015145,0.19405,0.59135,WILLERT_WNT_SIGNALING,1
GSE17721_LPS_VS_PAM3CSK4_1H_...2,SET,175,-0.013768,-0.0013371,0.059588,0.59136,GSE17721_LPS_VS_PAM3CSK4_1H_BMDC_UP,1
GOCC_MEIOTIC_SPINDLE,SET,12,-0.055761,-0.0014244,0.24129,0.59138,GOCC_MEIOTIC_SPINDLE,1
GOCC_OUTER_KINETOCHORE,SET,19,-0.043858,-0.0014094,0.18978,0.59138,GOCC_OUTER_KINETOCHORE,1
HP_SHAGREEN_PATCH,SET,5,-0.094063,-0.0015512,0.40695,0.59139,HP_SHAGREEN_PATCH,1
GOCC_LATE_ENDOSOME_MEMBRANE,SET,153,-0.015382,-0.0013976,0.066528,0.59142,GOCC_LATE_ENDOSOME_MEMBRANE,1
REACTOME_ATTACHMENT_AND_ENTRY,SET,16,-0.053279,-0.0015713,0.23025,0.59149,REACTOME_ATTACHMENT_AND_ENTRY,1
GSE27786_CD4_TCELL_VS_ERYTHT...1,SET,180,-0.013971,-0.0013758,0.060373,0.5915,GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN,1
HP_ABNORMAL_CEREBRAL_CORTEX_...,SET,678,-0.0075028,-0.0014142,0.032418,0.59151,HP_ABNORMAL_CEREBRAL_CORTEX_MORPHOLOGY,1
HP_PERIPHERAL_NEUROPATHY,SET,407,-0.0095121,-0.0013998,0.041097,0.59152,HP_PERIPHERAL_NEUROPATHY,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...5,SET,55,-0.023808,-0.0013005,0.10277,0.5916,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN,1
HP_ABSENT_OR_MINIMALLY_OSSIF...,SET,11,-0.056412,-0.0013797,0.2435,0.5916,HP_ABSENT_OR_MINIMALLY_OSSIFIED_VERTEBRAL_BODIES,1
HP_CONTRACTURE_OF_THE_PROXIM...3,SET,5,-0.082615,-0.0013625,0.35647,0.59164,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_5TH_FINGER,1
GSE27786_LSK_VS_NEUTROPHIL_DN,SET,181,-0.014268,-0.0014089,0.061556,0.59165,GSE27786_LSK_VS_NEUTROPHIL_DN,1
HP_UNUSUAL_INFECTION_BY_ANAT...,SET,95,-0.020584,-0.0014761,0.088776,0.59168,HP_UNUSUAL_INFECTION_BY_ANATOMICAL_SITE,1
GOMF_NEUROTRANSMITTER_RECEPT...3,SET,12,-0.061621,-0.001574,0.26572,0.59169,GOMF_NEUROTRANSMITTER_RECEPTOR_REGULATOR_ACTIVITY,1
HOLLERN_SOLID_NODULAR_BREAST...1,SET,29,-0.040357,-0.0016018,0.17401,0.5917,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_DN,1
KONG_E2F3_TARGETS,SET,90,-0.01982,-0.0013835,0.085435,0.59172,KONG_E2F3_TARGETS,1
REACTOME_REGULATION_OF_GLUCO...,SET,30,-0.033524,-0.0013533,0.14449,0.59173,REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN,1
CREB3L4_TARGET_GENES,SET,1160,-0.0057865,-0.0014071,0.024935,0.59175,CREB3L4_TARGET_GENES,1
GOBP_SENSORY_PERCEPTION_OF_U...,SET,7,-0.067576,-0.0013185,0.29112,0.59178,GOBP_SENSORY_PERCEPTION_OF_UMAMI_TASTE,1
MIR4539,SET,67,-0.023881,-0.0014392,0.10285,0.5918,MIR4539,1
MIR12123,SET,429,-0.0095797,-0.0014464,0.041234,0.59185,MIR12123,1
HP_GASTROSTOMY_TUBE_FEEDING_...,SET,93,-0.019113,-0.0013562,0.082167,0.59197,HP_GASTROSTOMY_TUBE_FEEDING_IN_INFANCY,1
GOBP_LIMBIC_SYSTEM_DEVELOPME...,SET,118,-0.019128,-0.0015277,0.082175,0.59203,GOBP_LIMBIC_SYSTEM_DEVELOPMENT,1
UNTERMAN_IPF_VS_CTRL_NK_CELL...2,SET,2,-0.11473,-0.0011967,0.49272,0.59206,UNTERMAN_IPF_VS_CTRL_NK_CELL_UP,1
HP_SYSTOLIC_HEART_MURMUR,SET,13,-0.06264,-0.0016654,0.2689,0.5921,HP_SYSTOLIC_HEART_MURMUR,1
GOBP_SIALYLATION,SET,10,-0.064886,-0.0015131,0.2784,0.59214,GOBP_SIALYLATION,1
WP_FOXP3_IN_COVID19,SET,13,-0.065698,-0.0017467,0.28177,0.59218,WP_FOXP3_IN_COVID19,1
MYOGENIN_Q6,SET,245,-0.01262,-0.0014473,0.054125,0.59218,MYOGENIN_Q6,1
WP_CYSTEINE_AND_METHIONINE_C...,SET,13,-0.05724,-0.0015218,0.24545,0.5922,WP_CYSTEINE_AND_METHIONINE_CATABOLISM,1
WIEMANN_TELOMERE_SHORTENING_...2,SET,9,-0.068008,-0.0015046,0.29152,0.59223,WIEMANN_TELOMERE_SHORTENING_AND_CHRONIC_LIVER_DAMAGE_UP,1
WANG_IMMORTALIZED_BY_HOXA9_A...2,SET,30,-0.039223,-0.0015834,0.1681,0.59225,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_UP,1
MIR4764_3P,SET,62,-0.025277,-0.0014656,0.10832,0.59226,MIR4764_3P,1
MIR545_5P,SET,286,-0.011823,-0.0014633,0.050657,0.59227,MIR545_5P,1
HP_ABNORMALITY_OF_ADRENAL_PH...,SET,131,-0.017449,-0.0014679,0.074766,0.59227,HP_ABNORMALITY_OF_ADRENAL_PHYSIOLOGY,1
GSE12198_CTRL_VS_HIGH_IL2_ST...2,SET,181,-0.014491,-0.001431,0.062049,0.59233,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_UP,1
MORF_PRKACA,SET,109,-0.018672,-0.0014337,0.079916,0.59237,MORF_PRKACA,1
GOBP_REGULATION_OF_LIPOPROTE...1,SET,12,-0.056861,-0.0014525,0.24337,0.59237,GOBP_REGULATION_OF_LIPOPROTEIN_LIPASE_ACTIVITY,1
GGCNRNWCTTYS_UNKNOWN,SET,77,-0.02202,-0.0014223,0.094226,0.59239,GGCNRNWCTTYS_UNKNOWN,1
RUBENSTEIN_SKELETAL_MUSCLE_E...,SET,123,-0.019257,-0.0015701,0.082387,0.5924,RUBENSTEIN_SKELETAL_MUSCLE_ENDOTHELIAL_CELLS,1
HP_LOW_MOLECULAR_WEIGHT_PROT...,SET,5,-0.088054,-0.0014522,0.3766,0.59243,HP_LOW_MOLECULAR_WEIGHT_PROTEINURIA,1
GSE6259_DEC205_POS_DC_VS_CD8...2,SET,168,-0.01472,-0.0014009,0.062959,0.59243,GSE6259_DEC205_POS_DC_VS_CD8_TCELL_UP,1
GOCC_SEMAPHORIN_RECEPTOR_COM...,SET,11,-0.065747,-0.001608,0.28112,0.59246,GOCC_SEMAPHORIN_RECEPTOR_COMPLEX,1
DESCARTES_MAIN_FETAL_HEPATOB...,SET,88,-0.021341,-0.0014732,0.091241,0.59247,DESCARTES_MAIN_FETAL_HEPATOBLASTS,1
GOBP_REGULATION_OF_LYMPHOID_...,SET,12,-0.054118,-0.0013824,0.23133,0.59248,GOBP_REGULATION_OF_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
HP_RECURRENT_SINUSITIS,SET,58,-0.025951,-0.0014556,0.11086,0.59254,HP_RECURRENT_SINUSITIS,1
GOMF_POLY_PURINE_TRACT_BINDI...,SET,26,-0.039007,-0.0014661,0.16657,0.59257,GOMF_POLY_PURINE_TRACT_BINDING,1
MIR4804_5P,SET,8,-0.066618,-0.0013896,0.28442,0.59259,MIR4804_5P,1
GOMF_GROWTH_FACTOR_RECEPTOR_...,SET,133,-0.017839,-0.001512,0.076151,0.59261,GOMF_GROWTH_FACTOR_RECEPTOR_BINDING,1
MIR6778_5P,SET,97,-0.018746,-0.0013582,0.079954,0.59268,MIR6778_5P,1
GSE5503_LIVER_DC_VS_MLN_DC_A...1,SET,176,-0.014114,-0.0013745,0.060199,0.59268,GSE5503_LIVER_DC_VS_MLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
NABA_CORE_MATRISOME,SET,252,-0.013555,-0.0015763,0.057797,0.59271,NABA_CORE_MATRISOME,1
MIR4683,SET,47,-0.030444,-0.0015376,0.12965,0.59283,MIR4683,1
MIKKELSEN_MCV6_ICP_WITH_H3K4...,SET,30,-0.038333,-0.0015474,0.1632,0.59285,MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
HP_WHITE_EYEBROW,SET,11,-0.064283,-0.0015722,0.27359,0.59288,HP_WHITE_EYEBROW,1
MANNE_COVID19_NONICU_VS_HEAL...1,SET,179,-0.016148,-0.0015859,0.068706,0.59291,MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN,1
HP_ABNORMAL_ANTITRAGUS_MORPH...,SET,10,-0.062763,-0.0014636,0.26697,0.59293,HP_ABNORMAL_ANTITRAGUS_MORPHOLOGY,1
HP_ABNORMAL_AMPLITUDE_OF_PAT...,SET,6,-0.085544,-0.0015454,0.36365,0.59298,HP_ABNORMAL_AMPLITUDE_OF_PATTERN_ELECTRORETINOGRAM,1
DESCARTES_FETAL_HEART_VISCER...,SET,73,-0.024423,-0.0015362,0.10383,0.59298,DESCARTES_FETAL_HEART_VISCERAL_NEURONS,1
HP_TUBE_FEEDING,SET,186,-0.014066,-0.0014079,0.059787,0.593,HP_TUBE_FEEDING,1
GOUYER_TATI_TARGETS_UP,SET,10,-0.071686,-0.0016717,0.30452,0.59305,GOUYER_TATI_TARGETS_UP,1
GSE3982_BCELL_VS_CENT_MEMORY...1,SET,175,-0.015417,-0.0014972,0.065485,0.59306,GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN,1
chr15q15,SET,86,-0.046142,-0.0031489,0.19594,0.59308,chr15q15,1
GSE37605_C57BL6_VS_NOD_FOXP3...2,SET,148,-0.017039,-0.0015228,0.072358,0.59308,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_UP,1
REACTOME_MITOCHONDRIAL_TRNA_...,SET,18,-0.045694,-0.0014293,0.19391,0.59314,REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION,1
GOBP_REGULATION_OF_CHLORIDE_...,SET,6,-0.074627,-0.0013481,0.31671,0.59314,GOBP_REGULATION_OF_CHLORIDE_TRANSPORT,1
GOMF_PEROXISOME_TARGETING_SE...,SET,3,-0.11458,-0.0014638,0.48608,0.59317,GOMF_PEROXISOME_TARGETING_SEQUENCE_BINDING,1
GOMF_GTPASE_ACTIVITY,SET,287,-0.012071,-0.0014966,0.051204,0.59318,GOMF_GTPASE_ACTIVITY,1
HP_INCREASED_CORNEAL_THICKNE...,SET,5,-0.10338,-0.001705,0.43842,0.59321,HP_INCREASED_CORNEAL_THICKNESS,1
GSE22229_UNTREATED_VS_IMMUNO...1,SET,180,-0.01561,-0.0015372,0.065992,0.59349,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_DN,1
GOBP_SERINE_PHOSPHORYLATION_...,SET,19,-0.05346,-0.001718,0.22586,0.59355,GOBP_SERINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
chr12q14,SET,32,-0.059218,-0.0024688,0.25009,0.59359,chr12q14,1
GOBP_NEGATIVE_REGULATION_OF_...372,SET,7,-0.08963,-0.0017489,0.37838,0.59362,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_DIFFERENTIATION,1
MORF_CTSB,SET,156,-0.016671,-0.0015294,0.070347,0.59366,MORF_CTSB,1
GOMF_INTERLEUKIN_2_RECEPTOR_...,SET,5,-0.081289,-0.0013406,0.34292,0.59369,GOMF_INTERLEUKIN_2_RECEPTOR_BINDING,1
MIR3189_5P,SET,47,-0.028002,-0.0014142,0.11809,0.59372,MIR3189_5P,1
GSE15750_DAY6_VS_DAY10_EFF_C...1,SET,180,-0.014378,-0.001416,0.060616,0.59375,GSE15750_DAY6_VS_DAY10_EFF_CD8_TCELL_DN,1
HOEK_MYELOID_DENDRITIC_CELL_...1,SET,5,-0.089681,-0.001479,0.37806,0.59375,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_1DY_DN,1
GSE11961_MARGINAL_ZONE_BCELL...8,SET,186,-0.014947,-0.001496,0.06295,0.59384,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_UP,1
KEGG_MEDICUS_PATHOGEN_EBV_LM...2,SET,5,-0.09373,-0.0015458,0.39471,0.59385,KEGG_MEDICUS_PATHOGEN_EBV_LMP1_TO_PI3K_SIGNALING_PATHWAY,1
GSE46242_CTRL_VS_EGR2_DELETE...2,SET,169,-0.015217,-0.0014524,0.064076,0.59386,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_UP,1
chr3p24,SET,30,-0.064729,-0.002613,0.27245,0.5939,chr3p24,1
GSE15215_CD2_POS_VS_NEG_PDC_...2,SET,182,-0.01466,-0.0014516,0.061686,0.59392,GSE15215_CD2_POS_VS_NEG_PDC_UP,1
WEST_ADRENOCORTICAL_CARCINOM...1,SET,23,-0.046521,-0.0016447,0.19566,0.59397,WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN,1
HP_EPISODIC_ATAXIA,SET,24,-0.042157,-0.0015224,0.17728,0.59398,HP_EPISODIC_ATAXIA,1
HP_ABNORMAL_POSTERIOR_PITUIT...,SET,33,-0.034062,-0.001442,0.14319,0.59401,HP_ABNORMAL_POSTERIOR_PITUITARY_MORPHOGENESIS,1
GNF2_SPTA1,SET,69,-0.024159,-0.0014775,0.10154,0.59403,GNF2_SPTA1,1
GOBP_ACTIVATION_OF_TRANSMEMB...,SET,6,-0.073654,-0.0013306,0.30952,0.59404,GOBP_ACTIVATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
DESCARTES_FETAL_LIVER_MYELOI...,SET,170,-0.016927,-0.0016205,0.071137,0.59404,DESCARTES_FETAL_LIVER_MYELOID_CELLS,1
REACTOME_FOXO_MEDIATED_TRANS...4,SET,28,-0.040426,-0.0015767,0.16988,0.59405,REACTOME_FOXO_MEDIATED_TRANSCRIPTION_OF_OXIDATIVE_STRESS_METABOLIC_AND_NEURONAL_GENES,1
HP_INCREASED_BODY_WEIGHT,SET,425,-0.0099825,-0.0015004,0.04194,0.59407,HP_INCREASED_BODY_WEIGHT,1
GOBP_ALPHA_LINOLENIC_ACID_ME...,SET,9,-0.066137,-0.0014632,0.2778,0.59409,GOBP_ALPHA_LINOLENIC_ACID_METABOLIC_PROCESS,1
GOBP_ESTABLISHMENT_OF_PROTEI...7,SET,416,-0.0096094,-0.0014293,0.040355,0.5941,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE,1
HP_CELLULITIS,SET,44,-0.030632,-0.001497,0.12861,0.59413,HP_CELLULITIS,1
GOCC_DENDRITIC_SHAFT,SET,39,-0.032858,-0.001512,0.1379,0.59416,GOCC_DENDRITIC_SHAFT,1
MIR6757_5P,SET,53,-0.026395,-0.0014154,0.11076,0.59418,MIR6757_5P,1
GOBP_NEGATIVE_REGULATION_OF_...117,SET,9,-0.065683,-0.0014531,0.27559,0.59419,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
MIR1305,SET,460,-0.0096234,-0.0015033,0.040365,0.59422,MIR1305,1
MIR571,SET,61,-0.026018,-0.0014965,0.10911,0.59424,MIR571,1
GSE24634_NAIVE_CD4_TCELL_VS_...3,SET,182,-0.014199,-0.0014059,0.05952,0.59427,GSE24634_NAIVE_CD4_TCELL_VS_DAY3_IL4_CONV_TREG_DN,1
LY_AGING_OLD_UP,SET,7,-0.088318,-0.0017233,0.37017,0.59429,LY_AGING_OLD_UP,1
GSE40274_IRF4_VS_FOXP3_AND_I...2,SET,157,-0.015045,-0.0013846,0.063058,0.59429,GSE40274_IRF4_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
MODULE_421,SET,15,-0.051883,-0.0014816,0.21743,0.5943,MODULE_421,1
GSE24972_MARGINAL_ZONE_BCELL...4,SET,171,-0.015475,-0.0014858,0.064848,0.59431,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_UP,1
GGGGCCC_MIR296,SET,66,-0.023596,-0.0014115,0.098852,0.59433,GGGGCCC_MIR296,1
GOMF_ENDOPEPTIDASE_ACTIVATOR...,SET,17,-0.05028,-0.0015285,0.21057,0.59436,GOMF_ENDOPEPTIDASE_ACTIVATOR_ACTIVITY,1
MIR4278,SET,31,-0.03598,-0.0014764,0.15066,0.59437,MIR4278,1
GOBP_POSITIVE_REGULATION_OF_...416,SET,6,-0.082918,-0.0014979,0.34697,0.59444,GOBP_POSITIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,1
HP_ABNORMAL_NECK_PHYSIOLOGY,SET,29,-0.039412,-0.0015643,0.16488,0.59446,HP_ABNORMAL_NECK_PHYSIOLOGY,1
MIR6878_5P,SET,197,-0.014825,-0.0015266,0.061998,0.59449,MIR6878_5P,1
HE_LIM_SUN_FETAL_LUNG_C0_MYO...2,SET,78,-0.024962,-0.0016227,0.10439,0.59449,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL,1
HP_ABNORMALITY_OF_THE_INTERN...,SET,19,-0.049996,-0.0016067,0.20902,0.59452,HP_ABNORMALITY_OF_THE_INTERNAL_AUDITORY_CANAL,1
HP_DECREASED_BODY_WEIGHT,SET,1375,-0.0055572,-0.001462,0.023223,0.59456,HP_DECREASED_BODY_WEIGHT,1
GOBP_POSITIVE_REGULATION_OF_...814,SET,9,-0.074516,-0.0016486,0.31122,0.59461,GOBP_POSITIVE_REGULATION_OF_T_HELPER_2_CELL_CYTOKINE_PRODUCTION,1
GOBP_REGULATION_OF_ATP_METAB...,SET,63,-0.024379,-0.0014249,0.10181,0.59462,GOBP_REGULATION_OF_ATP_METABOLIC_PROCESS,1
GNF2_IL2RB,SET,41,-0.033948,-0.0016016,0.14175,0.59464,GNF2_IL2RB,1
GSE3982_NEUTROPHIL_VS_NKCELL...2,SET,179,-0.015139,-0.0014868,0.063191,0.59467,GSE3982_NEUTROPHIL_VS_NKCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...108,SET,351,-0.010738,-0.0014698,0.044816,0.59468,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE,1
NIKOLSKY_BREAST_CANCER_16P13...,SET,101,-0.035412,-0.0026179,0.14778,0.59469,NIKOLSKY_BREAST_CANCER_16P13_AMPLICON,1
GOMF_XMP_5_NUCLEOSIDASE_ACTI...,SET,5,-0.11108,-0.001832,0.46348,0.59471,GOMF_XMP_5_NUCLEOSIDASE_ACTIVITY,1
MIR4427,SET,211,-0.014275,-0.0015207,0.059495,0.59481,MIR4427,1
MODULE_481,SET,81,-0.022584,-0.001496,0.094075,0.59486,MODULE_481,1
MODULE_544,SET,81,-0.022584,-0.001496,0.094075,0.59486,MODULE_544,1
HP_JUVENILE_ASEPTIC_NECROSIS,SET,41,-0.031442,-0.0014834,0.13095,0.59488,HP_JUVENILE_ASEPTIC_NECROSIS,1
GSE411_100MIN_VS_400MIN_IL6_...2,SET,179,-0.014741,-0.0014476,0.061391,0.59488,GSE411_100MIN_VS_400MIN_IL6_STIM_MACROPHAGE_UP,1
HOWLIN_CITED1_TARGETS_1_UP,SET,31,-0.038013,-0.0015599,0.15824,0.59492,HOWLIN_CITED1_TARGETS_1_UP,1
HP_NEONATAL_HYPOGLYCEMIA,SET,42,-0.031879,-0.0015222,0.13269,0.59493,HP_NEONATAL_HYPOGLYCEMIA,1
GOBP_PROCESS_UTILIZING_AUTOP...,SET,541,-0.0085003,-0.0014368,0.035376,0.59494,GOBP_PROCESS_UTILIZING_AUTOPHAGIC_MECHANISM,1
HP_IMMUNE_DYSREGULATION,SET,10,-0.062536,-0.0014583,0.26027,0.59494,HP_IMMUNE_DYSREGULATION,1
MIR4680_3P,SET,228,-0.013426,-0.0014861,0.055867,0.59496,MIR4680_3P,1
REACTOME_SIGNALING_BY_PDGFR_...,SET,20,-0.044859,-0.001479,0.18659,0.595,REACTOME_SIGNALING_BY_PDGFR_IN_DISEASE,1
GOCC_POSTSYNAPTIC_SPECIALIZA...2,SET,19,-0.04568,-0.001468,0.18992,0.59504,GOCC_POSTSYNAPTIC_SPECIALIZATION_INTRACELLULAR_COMPONENT,1
KEGG_P53_SIGNALING_PATHWAY,SET,66,-0.024361,-0.0014572,0.10125,0.59507,KEGG_P53_SIGNALING_PATHWAY,1
GOBP_CERAMIDE_TRANSPORT,SET,15,-0.053005,-0.0015136,0.22021,0.5951,GOBP_CERAMIDE_TRANSPORT,1
MODULE_295,SET,19,-0.047307,-0.0015202,0.19651,0.59512,MODULE_295,1
GOBP_PROTEIN_HETEROOLIGOMERI...,SET,29,-0.036053,-0.001431,0.14974,0.59513,GOBP_PROTEIN_HETEROOLIGOMERIZATION,1
GSE1112_OT1_VS_HY_CD8AB_THYM...1,SET,177,-0.014534,-0.0014194,0.060281,0.59526,GSE1112_OT1_VS_HY_CD8AB_THYMOCYTE_RTOC_CULTURE_DN,1
ERWIN_COHEN_BLOOD_TC_83_AGE_...,SET,108,-0.02048,-0.0015653,0.084945,0.59526,ERWIN_COHEN_BLOOD_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_2DY_UP,1
ZHAN_MULTIPLE_MYELOMA_CD1_UP,SET,40,-0.0339,-0.0015798,0.14059,0.59527,ZHAN_MULTIPLE_MYELOMA_CD1_UP,1
MODULE_235,SET,79,-0.023429,-0.0015327,0.097108,0.59532,MODULE_235,1
MIR4646_5P,SET,133,-0.017455,-0.0014795,0.072331,0.59534,MIR4646_5P,1
BANDRES_RESPONSE_TO_CARMUSTI...4,SET,18,-0.04797,-0.0015005,0.19869,0.59539,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_UP,1
GOBP_ORGANIC_CYCLIC_COMPOUND...,SET,559,-0.0086884,-0.001492,0.035983,0.5954,GOBP_ORGANIC_CYCLIC_COMPOUND_CATABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_PROT...1,SET,101,-0.019786,-0.0014627,0.081942,0.5954,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,1
LU_EZH2_TARGETS_DN,SET,343,-0.010922,-0.0014781,0.045229,0.59541,LU_EZH2_TARGETS_DN,1
MIR519A_3P_MIR519B_3P,SET,374,-0.010352,-0.0014616,0.042859,0.59542,MIR519A_3P_MIR519B_3P,1
FORTSCHEGGER_PHF8_TARGETS_UP,SET,230,-0.013519,-0.0015028,0.055859,0.59561,FORTSCHEGGER_PHF8_TARGETS_UP,1
SCHUETZ_BREAST_CANCER_DUCTAL...1,SET,78,-0.025002,-0.0016253,0.10329,0.59564,SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN,1
GOBP_REGULATION_OF_HYPERSENS...,SET,9,-0.068886,-0.001524,0.28432,0.59572,GOBP_REGULATION_OF_HYPERSENSITIVITY,1
HP_PARAPLEGIA,SET,126,-0.018392,-0.0015176,0.075892,0.59574,HP_PARAPLEGIA,1
GOMF_DNA_ENDONUCLEASE_ACTIVI...1,SET,38,-0.031487,-0.0014303,0.12991,0.59576,GOMF_DNA_ENDONUCLEASE_ACTIVITY,1
SANA_TNF_SIGNALING_DN,SET,74,-0.025047,-0.0015861,0.10328,0.5958,SANA_TNF_SIGNALING_DN,1
GOBP_FATTY_ACID_BIOSYNTHETIC...,SET,147,-0.016961,-0.0015108,0.069942,0.5958,GOBP_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
HP_INAPPROPRIATE_ANTIDIURETI...,SET,8,-0.070136,-0.0014629,0.28921,0.5958,HP_INAPPROPRIATE_ANTIDIURETIC_HORMONE_SECRETION,1
ZHANG_ANTIVIRAL_RESPONSE_TO_...1,SET,43,-0.033579,-0.0016223,0.1384,0.59585,ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN,1
STAT6_02,SET,239,-0.013765,-0.0015594,0.056725,0.59586,STAT6_02,1
HOSHIDA_LIVER_CANCER_SUBCLAS...2,SET,109,-0.019076,-0.0014647,0.078572,0.59591,HOSHIDA_LIVER_CANCER_SUBCLASS_S2,1
MEL18_DN.V1_UP,SET,133,-0.019246,-0.0016313,0.079264,0.59592,MEL18_DN.V1_UP,1
GOBP_EMBRYONIC_HINDLIMB_MORP...,SET,27,-0.045495,-0.0017425,0.1873,0.59596,GOBP_EMBRYONIC_HINDLIMB_MORPHOGENESIS,1
HP_INCREASED_CIRCULATING_COR...,SET,29,-0.039825,-0.0015807,0.16395,0.59596,HP_INCREASED_CIRCULATING_CORTISOL_LEVEL,1
GSE17721_LPS_VS_POLYIC_2H_BM...1,SET,190,-0.014092,-0.0014254,0.058,0.59598,GSE17721_LPS_VS_POLYIC_2H_BMDC_DN,1
GOBP_FATTY_ACID_BETA_OXIDATI...1,SET,70,-0.023125,-0.0014244,0.095112,0.59605,GOBP_FATTY_ACID_BETA_OXIDATION,1
GOBP_FERTILIZATION,SET,183,-0.015471,-0.001536,0.063563,0.59615,GOBP_FERTILIZATION,1
GOBP_MYOTUBE_DIFFERENTIATION,SET,117,-0.019694,-0.0015663,0.080857,0.59621,GOBP_MYOTUBE_DIFFERENTIATION,1
GOBP_CEREBRAL_CORTEX_TANGENT...,SET,5,-0.10252,-0.0016907,0.42089,0.59622,GOBP_CEREBRAL_CORTEX_TANGENTIAL_MIGRATION,1
BIOCARTA_ARAP_PATHWAY,SET,17,-0.045331,-0.001378,0.18606,0.59624,BIOCARTA_ARAP_PATHWAY,1
GOBP_T_CELL_LINEAGE_COMMITME...,SET,35,-0.036452,-0.0015892,0.14957,0.59627,GOBP_T_CELL_LINEAGE_COMMITMENT,1
GOBP_REGULATION_OF_PENTOSE_P...,SET,6,-0.081119,-0.0014654,0.33281,0.59628,GOBP_REGULATION_OF_PENTOSE_PHOSPHATE_SHUNT,1
CARRILLOREIXACH_HEPATOBLASTO...1,SET,973,-0.0071181,-0.0015939,0.029194,0.59631,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_DN,1
HP_ABNORMALITY_OF_THE_LOWER_...,SET,739,-0.0076267,-0.0014982,0.031241,0.59643,HP_ABNORMALITY_OF_THE_LOWER_URINARY_TRACT,1
HP_APLASIA_HYPOPLASIA_OF_MET...,SET,59,-0.027428,-0.0015515,0.11232,0.59646,HP_APLASIA_HYPOPLASIA_OF_METATARSAL_BONES,1
WP_GPR143_IN_MELANOCYTES_AND...,SET,29,-0.040431,-0.0016048,0.16554,0.59647,WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS,1
CROONQUIST_IL6_DEPRIVATION_DN,SET,91,-0.02043,-0.001434,0.083603,0.59653,CROONQUIST_IL6_DEPRIVATION_DN,1
GOBP_BONE_MORPHOGENESIS,SET,96,-0.022541,-0.0016248,0.09224,0.59653,GOBP_BONE_MORPHOGENESIS,1
GOBP_COMPARTMENT_PATTERN_SPE...,SET,5,-0.09624,-0.0015872,0.39367,0.59656,GOBP_COMPARTMENT_PATTERN_SPECIFICATION,1
KEGG_MEDICUS_REFERENCE_ADRB3...,SET,35,-0.035851,-0.001563,0.14664,0.59657,KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY,1
REACTOME_REGULATION_OF_TP53_...6,SET,36,-0.034214,-0.0015128,0.13994,0.59658,REACTOME_REGULATION_OF_TP53_EXPRESSION_AND_DEGRADATION,1
MIR1185_1_3P_MIR1185_2_3P,SET,376,-0.010688,-0.001513,0.043704,0.5966,MIR1185_1_3P_MIR1185_2_3P,1
GOBP_APOPTOTIC_CHROMOSOME_CO...,SET,6,-0.084505,-0.0015266,0.34554,0.5966,GOBP_APOPTOTIC_CHROMOSOME_CONDENSATION,1
GOCC_GAMMA_SECRETASE_COMPLEX,SET,6,-0.069208,-0.0012503,0.28293,0.59662,GOCC_GAMMA_SECRETASE_COMPLEX,1
HP_PROGRESSIVE_EXTRAPYRAMIDA...,SET,8,-0.073142,-0.0015256,0.2989,0.59666,HP_PROGRESSIVE_EXTRAPYRAMIDAL_MOVEMENT_DISORDER,1
HP_INCREASED_SUSCEPTIBILITY_...,SET,212,-0.01436,-0.0015334,0.058648,0.59672,HP_INCREASED_SUSCEPTIBILITY_TO_FRACTURES,1
GOBP_VERY_LONG_CHAIN_FATTY_A...2,SET,6,-0.07039,-0.0012716,0.2873,0.59677,GOBP_VERY_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,1
HP_SPARSE_SCALP_HAIR,SET,127,-0.018038,-0.0014942,0.073605,0.59679,HP_SPARSE_SCALP_HAIR,1
TIAN_TNF_SIGNALING_VIA_NFKB,SET,25,-0.046009,-0.0016957,0.18768,0.59683,TIAN_TNF_SIGNALING_VIA_NFKB,1
GSE37301_CD4_TCELL_VS_RAG2_K...2,SET,146,-0.017842,-0.0015839,0.072777,0.59683,GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_UP,1
GOCC_CLUSTER_OF_ACTIN_BASED_...,SET,155,-0.016739,-0.0015307,0.068271,0.59684,GOCC_CLUSTER_OF_ACTIN_BASED_CELL_PROJECTIONS,1
MIR4804_3P,SET,79,-0.023208,-0.0015183,0.094602,0.5969,MIR4804_3P,1
GOBP_POSITIVE_REGULATION_OF_...98,SET,41,-0.035378,-0.0016691,0.1442,0.5969,GOBP_POSITIVE_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
HP_FETAL_ULTRASOUND_SOFT_MAR...,SET,104,-0.019766,-0.0014827,0.080502,0.59698,HP_FETAL_ULTRASOUND_SOFT_MARKER,1
BIOCARTA_RHODOPSIN_PATHWAY,SET,8,-0.069133,-0.001442,0.28142,0.59702,BIOCARTA_RHODOPSIN_PATHWAY,1
REACTOME_MATURATION_OF_SARS_...3,SET,5,-0.082121,-0.0013543,0.33416,0.59706,REACTOME_MATURATION_OF_SARS_COV_2_SPIKE_PROTEIN,1
HARALAMBIEVA_PBMC_FLUARIX_AG...2,SET,405,-0.0099346,-0.0014584,0.040427,0.59706,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_0DY_POSITIVE,1
GSE40274_CTRL_VS_SATB1_TRANS...2,SET,150,-0.017554,-0.0015793,0.07142,0.59707,GSE40274_CTRL_VS_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
MIR4457,SET,112,-0.019421,-0.0015114,0.079012,0.59708,MIR4457,1
MIR376B_5P_MIR376C_5P,SET,44,-0.032105,-0.001569,0.13059,0.5971,MIR376B_5P_MIR376C_5P,1
GOMF_DOUBLE_STRANDED_DNA_3_5...,SET,4,-0.10144,-0.0014963,0.4126,0.5971,GOMF_DOUBLE_STRANDED_DNA_3_5_DNA_EXONUCLEASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...22,SET,9,-0.064028,-0.0014165,0.26036,0.59713,GOBP_NEGATIVE_REGULATION_OF_AMYLOID_BETA_CLEARANCE,1
MIR876_5P,SET,123,-0.019342,-0.001577,0.078609,0.59718,MIR876_5P,1
CHEOK_RESPONSE_TO_HD_MTX_UP,SET,19,-0.050416,-0.0016202,0.20471,0.59726,CHEOK_RESPONSE_TO_HD_MTX_UP,1
GOBP_POSITIVE_REGULATION_OF_...665,SET,9,-0.063894,-0.0014136,0.25932,0.59731,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_CLUSTERING,1
MORF_FDXR,SET,210,-0.013959,-0.0014836,0.056638,0.59734,MORF_FDXR,1
MIR6507_3P,SET,112,-0.019117,-0.0014878,0.077551,0.59735,MIR6507_3P,1
GOBP_POSITIVE_REGULATION_OF_...819,SET,18,-0.044983,-0.0014071,0.18249,0.59735,GOBP_POSITIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,1
SCHMAHL_PDGF_SIGNALING,SET,9,-0.078171,-0.0017294,0.31707,0.59737,SCHMAHL_PDGF_SIGNALING,1
HP_ABNORMAL_CIRCULATING_GLUT...2,SET,30,-0.035583,-0.0014364,0.14432,0.59737,HP_ABNORMAL_CIRCULATING_GLUTAMINE_FAMILY_AMINO_ACID_CONCENTRATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...26,SET,23,-0.047702,-0.0016864,0.19344,0.59739,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
REACTOME_ATTENUATION_PHASE,SET,26,-0.040508,-0.0015225,0.16426,0.59739,REACTOME_ATTENUATION_PHASE,1
MIR4433A_5P,SET,43,-0.031601,-0.0015267,0.12804,0.59746,MIR4433A_5P,1
HP_COILED_SPERM_FLAGELLA,SET,26,-0.03848,-0.0014463,0.15593,0.59746,HP_COILED_SPERM_FLAGELLA,1
HP_ABNORMAL_TRANSFERRIN_SATU...,SET,12,-0.057718,-0.0014743,0.23371,0.59753,HP_ABNORMAL_TRANSFERRIN_SATURATION,1
GSE26343_WT_VS_NFAT5_KO_MACR...2,SET,176,-0.015249,-0.0014851,0.061704,0.5976,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_LPS_STIM_DN,1
HP_ABNORMALITY_OF_VENOUS_PHY...,SET,11,-0.067339,-0.0016469,0.27245,0.59761,HP_ABNORMALITY_OF_VENOUS_PHYSIOLOGY,1
WP_TP53_NETWORK,SET,19,-0.052272,-0.0016798,0.21147,0.59762,WP_TP53_NETWORK,1
GOMF_PROTEIN_KINASE_A_CATALY...,SET,14,-0.055644,-0.0015352,0.22508,0.59763,GOMF_PROTEIN_KINASE_A_CATALYTIC_SUBUNIT_BINDING,1
WP_MARKERS_OF_KIDNEY_CELL_LI...,SET,57,-0.03032,-0.0016859,0.12263,0.59764,WP_MARKERS_OF_KIDNEY_CELL_LINEAGE,1
HP_HYPOCALCEMIA,SET,74,-0.025409,-0.0016091,0.10271,0.5977,HP_HYPOCALCEMIA,1
GSE16450_IMMATURE_VS_MATURE_...5,SET,184,-0.014771,-0.0014705,0.059695,0.59771,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_DN,1
REACTOME_CYCLIN_A_B1_B2_ASSO...,SET,24,-0.037925,-0.0013696,0.15326,0.59772,REACTOME_CYCLIN_A_B1_B2_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION,1
GOBP_MOTOR_NEURON_MIGRATION,SET,12,-0.072203,-0.0018443,0.2917,0.59775,GOBP_MOTOR_NEURON_MIGRATION,1
HP_TELECANTHUS,SET,148,-0.017326,-0.0015485,0.069914,0.59786,HP_TELECANTHUS,1
CHIANG_LIVER_CANCER_SUBCLASS...5,SET,24,-0.045973,-0.0016602,0.18548,0.59788,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_DN,1
MENSE_HYPOXIA_UP,SET,89,-0.021858,-0.0015173,0.088187,0.59788,MENSE_HYPOXIA_UP,1
SLEBOS_HEAD_AND_NECK_CANCER_...,SET,66,-0.024009,-0.0014361,0.096835,0.59791,SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP,1
WP_PROSTAGLANDIN_AND_LEUKOTR...2,SET,32,-0.03923,-0.0016355,0.15822,0.59791,WP_PROSTAGLANDIN_AND_LEUKOTRIENE_METABOLISM_IN_SENESCENCE_WP5321,1
REACTOME_RAC3_GTPASE_CYCLE,SET,82,-0.024312,-0.0016203,0.09804,0.59792,REACTOME_RAC3_GTPASE_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...632,SET,23,-0.044302,-0.0015662,0.17865,0.59792,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERE_LENGTHENING,1
GOBP_BODY_FLUID_SECRETION,SET,87,-0.023985,-0.0016463,0.096697,0.59795,GOBP_BODY_FLUID_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...464,SET,42,-0.030722,-0.001467,0.12382,0.59797,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,1
GOMF_CCR2_CHEMOKINE_RECEPTOR...,SET,5,-0.10599,-0.001748,0.42687,0.59805,GOMF_CCR2_CHEMOKINE_RECEPTOR_BINDING,1
EFC_Q6,SET,242,-0.013669,-0.0015581,0.054997,0.59814,EFC_Q6,1
MCM2_TARGET_GENES,SET,75,-0.023232,-0.0014811,0.093426,0.59819,MCM2_TARGET_GENES,1
GOBP_PROTEOGLYCAN_CATABOLIC_...,SET,9,-0.072558,-0.0016052,0.29179,0.59819,GOBP_PROTEOGLYCAN_CATABOLIC_PROCESS,1
GSE7831_CPG_VS_INFLUENZA_STI...4,SET,176,-0.015806,-0.0015393,0.063539,0.59822,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_UP,1
REACTOME_RUNX3_REGULATES_NOT...,SET,13,-0.054944,-0.0014608,0.22086,0.59823,REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING,1
GOBP_CUT_METABOLIC_PROCESS,SET,5,-0.081559,-0.001345,0.32773,0.59826,GOBP_CUT_METABOLIC_PROCESS,1
GOBP_BLOOD_VESSEL_ENDOTHELIA...3,SET,23,-0.048241,-0.0017055,0.19372,0.59833,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
GOBP_RESPONSE_TO_LEAD_ION,SET,19,-0.051183,-0.0016448,0.20545,0.59837,GOBP_RESPONSE_TO_LEAD_ION,1
ZNF680_TARGET_GENES,SET,614,-0.0083856,-0.0015069,0.033632,0.59845,ZNF680_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...229,SET,5,-0.10033,-0.0016546,0.40239,0.59845,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,1
GRASEMANN_RETINOBLASTOMA_WIT...,SET,14,-0.056538,-0.0015598,0.22672,0.59846,GRASEMANN_RETINOBLASTOMA_WITH_6P_AMPLIFICATION,1
HP_MOTOR_AXONAL_NEUROPATHY,SET,34,-0.032445,-0.0013942,0.1301,0.59847,HP_MOTOR_AXONAL_NEUROPATHY,1
GOMF_1_PHOSPHATIDYLINOSITOL_...5,SET,8,-0.073593,-0.0015351,0.29502,0.59849,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_5_KINASE_ACTIVITY,1
CDH4_TARGET_GENES,SET,56,-0.028895,-0.0015926,0.11575,0.59856,CDH4_TARGET_GENES,1
GOBP_VESICLE_MEDIATED_TRANSP...3,SET,209,-0.01456,-0.0015438,0.058318,0.59857,GOBP_VESICLE_MEDIATED_TRANSPORT_IN_SYNAPSE,1
GOBP_REGULATION_OF_VESICLE_M...,SET,467,-0.0098242,-0.001546,0.03934,0.5986,GOBP_REGULATION_OF_VESICLE_MEDIATED_TRANSPORT,1
REACTOME_TRP_CHANNELS,SET,27,-0.044365,-0.0016992,0.1776,0.59863,REACTOME_TRP_CHANNELS,1
AAGCACT_MIR520F,SET,219,-0.014215,-0.0015424,0.056882,0.59867,AAGCACT_MIR520F,1
GSE7568_IL4_VS_IL4_AND_DEXAM...2,SET,149,-0.016285,-0.0014603,0.065143,0.5987,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_UP,1
GOCC_TERTIARY_GRANULE,SET,147,-0.017721,-0.0015785,0.070884,0.59871,GOCC_TERTIARY_GRANULE,1
WHITE_NEUROBLASTOMA_WITH_1P3...,SET,19,-0.077312,-0.0024845,0.30918,0.59873,WHITE_NEUROBLASTOMA_WITH_1P36.3_DELETION,1
chr15q25,SET,58,-0.046401,-0.0026025,0.18546,0.59878,chr15q25,1
GSE36891_UNSTIM_VS_POLYIC_TL...2,SET,141,-0.019166,-0.0016723,0.076601,0.59878,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_UP,1
KEGG_MEDICUS_REFERENCE_RORA_...,SET,5,-0.08921,-0.0014712,0.35588,0.59897,KEGG_MEDICUS_REFERENCE_RORA_MEDIATED_TRANSCRIPTION,1
MIR4256,SET,68,-0.024972,-0.0015162,0.099592,0.59899,MIR4256,1
KEGG_NICOTINATE_AND_NICOTINA...,SET,24,-0.046258,-0.0016705,0.18445,0.59901,KEGG_NICOTINATE_AND_NICOTINAMIDE_METABOLISM,1
MIR28_3P,SET,46,-0.028295,-0.0014138,0.11282,0.59901,MIR28_3P,1
GOBP_VITAMIN_METABOLIC_PROCE...,SET,109,-0.019971,-0.0015334,0.079631,0.59901,GOBP_VITAMIN_METABOLIC_PROCESS,1
GOBP_PROTEIN_TARGETING_TO_VA...1,SET,44,-0.029827,-0.0014577,0.1189,0.59904,GOBP_PROTEIN_TARGETING_TO_VACUOLE,1
BIOCARTA_SALMONELLA_PATHWAY,SET,5,-0.073518,-0.0012124,0.2929,0.59909,BIOCARTA_SALMONELLA_PATHWAY,1
WP_PURINERGIC_SIGNALING,SET,29,-0.041367,-0.0016419,0.16478,0.59911,WP_PURINERGIC_SIGNALING,1
HP_CEREBRAL_CORTICAL_HEMIATR...,SET,5,-0.094353,-0.001556,0.37584,0.59911,HP_CEREBRAL_CORTICAL_HEMIATROPHY,1
GOBP_MITOCHONDRIAL_RESPIRATO...,SET,82,-0.020516,-0.0013673,0.081702,0.59913,GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY,1
MIR11181_5P,SET,65,-0.025719,-0.0015268,0.10236,0.59919,MIR11181_5P,1
WP_SARS_CORONAVIRUS_AND_INNA...,SET,26,-0.046409,-0.0017443,0.18459,0.59925,WP_SARS_CORONAVIRUS_AND_INNATE_IMMUNITY,1
DESCARTES_MAIN_FETAL_EXCITAT...,SET,5,-0.10471,-0.0017269,0.41633,0.59929,DESCARTES_MAIN_FETAL_EXCITATORY_NEURONS,1
GOBP_ADIPONECTIN_ACTIVATED_S...,SET,7,-0.083663,-0.0016324,0.33248,0.59934,GOBP_ADIPONECTIN_ACTIVATED_SIGNALING_PATHWAY,1
REACTOME_EICOSANOID_LIGAND_B...,SET,14,-0.058682,-0.001619,0.23303,0.59941,REACTOME_EICOSANOID_LIGAND_BINDING_RECEPTORS,1
GAO_SMALL_INTESTINE_24W_C1_T...,SET,8,-0.067903,-0.0014164,0.26962,0.59942,GAO_SMALL_INTESTINE_24W_C1_TUFT_PROGENITOR,1
GOBP_POSITIVE_REGULATION_OF_...322,SET,4,-0.12396,-0.0018285,0.4921,0.59943,GOBP_POSITIVE_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,1
HP_BROAD_DISTAL_PHALANX_OF_F...,SET,20,-0.04787,-0.0015783,0.18987,0.59952,HP_BROAD_DISTAL_PHALANX_OF_FINGER,1
HP_SHORT_MIDDLE_PHALANX_OF_T...2,SET,5,-0.10456,-0.0017243,0.41462,0.59954,HP_SHORT_MIDDLE_PHALANX_OF_TOE,1
KONDO_EZH2_TARGETS,SET,203,-0.015725,-0.0016435,0.062333,0.59959,KONDO_EZH2_TARGETS,1
MIR3615,SET,8,-0.081834,-0.001707,0.32435,0.59959,MIR3615,1
GOMF_MITOGEN_ACTIVATED_PROTE...3,SET,16,-0.049333,-0.001455,0.19548,0.59962,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_KINASE_BINDING,1
ACEVEDO_LIVER_CANCER_UP,SET,861,-0.0072767,-0.0015376,0.028815,0.59968,ACEVEDO_LIVER_CANCER_UP,1
GOBP_HISTAMINE_SECRETION,SET,12,-0.058308,-0.0014894,0.23089,0.59968,GOBP_HISTAMINE_SECRETION,1
HP_HYPERLYSINURIA,SET,5,-0.090251,-0.0014884,0.35735,0.59969,HP_HYPERLYSINURIA,1
REACTOME_CHK1_CHK2_CDS1_MEDI...,SET,13,-0.05656,-0.0015037,0.22393,0.5997,REACTOME_CHK1_CHK2_CDS1_MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX,1
GOBP_CELLULAR_MODIFIED_AMINO...3,SET,175,-0.016104,-0.0015639,0.063691,0.59981,GOBP_CELLULAR_MODIFIED_AMINO_ACID_METABOLIC_PROCESS,1
HP_CEREBRAL_VENOUS_THROMBOSIS,SET,8,-0.064968,-0.0013552,0.25692,0.59982,HP_CEREBRAL_VENOUS_THROMBOSIS,1
GSE15930_NAIVE_VS_72H_IN_VIT...2,SET,188,-0.015167,-0.0015261,0.059974,0.59982,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_CD8_TCELL_UP,1
REACTOME_APOPTOSIS,SET,163,-0.016303,-0.0015285,0.064466,0.59983,REACTOME_APOPTOSIS,1
GOMF_OLIGOSACCHARYL_TRANSFER...,SET,5,-0.099264,-0.001637,0.39246,0.59984,GOMF_OLIGOSACCHARYL_TRANSFERASE_ACTIVITY,1
HP_GLIOMA,SET,48,-0.029031,-0.0014817,0.11478,0.59984,HP_GLIOMA,1
GSE17580_TREG_VS_TEFF_S_MANS...1,SET,176,-0.016419,-0.001599,0.06491,0.59985,GSE17580_TREG_VS_TEFF_S_MANSONI_INF_DN,1
HP_LYMPHOPENIA,SET,163,-0.01713,-0.001606,0.067704,0.59987,HP_LYMPHOPENIA,1
GOBP_SENSORY_PERCEPTION_OF_S...3,SET,7,-0.076754,-0.0014976,0.30303,0.59997,GOBP_SENSORY_PERCEPTION_OF_SWEET_TASTE,1
HE_LIM_SUN_FETAL_LUNG_C6_DEU...,SET,190,-0.014644,-0.0014812,0.057806,0.59999,HE_LIM_SUN_FETAL_LUNG_C6_DEUTEROSOMAL_CELL,1
REACTOME_RHOV_GTPASE_CYCLE,SET,36,-0.033675,-0.0014889,0.13271,0.60015,REACTOME_RHOV_GTPASE_CYCLE,1
GOMF_NON_MEMBRANE_SPANNING_P...1,SET,43,-0.035073,-0.0016945,0.13822,0.60015,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_MU...,SET,8,-0.061891,-0.001291,0.24386,0.60017,GOBP_CELLULAR_RESPONSE_TO_MURAMYL_DIPEPTIDE,1
GOBP_MAST_CELL_PROLIFERATION,SET,7,-0.088966,-0.0017359,0.35012,0.60029,GOBP_MAST_CELL_PROLIFERATION,1
GOBP_RIBOSOMAL_LARGE_SUBUNIT...3,SET,7,-0.078277,-0.0015274,0.30802,0.6003,GOBP_RIBOSOMAL_LARGE_SUBUNIT_EXPORT_FROM_NUCLEUS,1
HP_EXERCISE_INTOLERANCE,SET,119,-0.019781,-0.0015866,0.077838,0.6003,HP_EXERCISE_INTOLERANCE,1
GSE8921_UNSTIM_VS_TLR1_2_STI...4,SET,178,-0.016525,-0.0016183,0.06502,0.60031,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_UP,1
HP_ABNORMALITY_OF_THE_AMNIOT...,SET,418,-0.010335,-0.0015408,0.04063,0.60039,HP_ABNORMALITY_OF_THE_AMNIOTIC_FLUID,1
HP_CRYPTOPHTHALMOS,SET,5,-0.11344,-0.0018708,0.44591,0.6004,HP_CRYPTOPHTHALMOS,1
GSE5589_UNSTIM_VS_45MIN_LPS_...4,SET,182,-0.015561,-0.0015408,0.061168,0.6004,GSE5589_UNSTIM_VS_45MIN_LPS_AND_IL6_STIM_MACROPHAGE_UP,1
REACTOME_DOWNREGULATION_OF_E...3,SET,8,-0.073059,-0.0015239,0.28717,0.60041,REACTOME_DOWNREGULATION_OF_ERBB4_SIGNALING,1
HP_DISTAL_ARTHROGRYPOSIS,SET,24,-0.046902,-0.0016938,0.18435,0.60041,HP_DISTAL_ARTHROGRYPOSIS,1
HP_MIDDLE_AGE_ONSET,SET,220,-0.014649,-0.0015931,0.057546,0.60047,HP_MIDDLE_AGE_ONSET,1
MIR7851_3P,SET,52,-0.03091,-0.0016418,0.1214,0.60049,MIR7851_3P,1
WP_REGUCALCIN_IN_PROXIMAL_TU...,SET,30,-0.037541,-0.0015155,0.14741,0.60051,WP_REGUCALCIN_IN_PROXIMAL_TUBULE_EPITHELIAL_KIDNEY_CELLS,1
ZHENG_FOXP3_TARGETS_IN_THYMU...2,SET,189,-0.01662,-0.0016767,0.065247,0.60053,ZHENG_FOXP3_TARGETS_IN_THYMUS_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...15,SET,36,-0.033493,-0.0014809,0.13144,0.60057,GAVISH_3CA_MALIGNANT_METAPROGRAM_24_CILIA,1
GOBP_RESPONSE_TO_NEMATODE,SET,7,-0.087633,-0.0017099,0.34391,0.60057,GOBP_RESPONSE_TO_NEMATODE,1
GSE37301_PRO_BCELL_VS_RAG2_K...1,SET,169,-0.017126,-0.0016346,0.067207,0.60057,GSE37301_PRO_BCELL_VS_RAG2_KO_NK_CELL_DN,1
GOMF_DOUBLE_STRANDED_DNA_EXO...,SET,6,-0.089779,-0.0016219,0.35226,0.60059,GOMF_DOUBLE_STRANDED_DNA_EXODEOXYRIBONUCLEASE_ACTIVITY,1
BLANCO_MELO_SARS_COV_1_INFEC...2,SET,11,-0.07064,-0.0017277,0.27697,0.60065,BLANCO_MELO_SARS_COV_1_INFECTION_MCR5_CELLS_UP,1
MIR98_3P,SET,667,-0.0085647,-0.0016017,0.033584,0.60065,MIR98_3P,1
GOCC_ANCHORING_JUNCTION,SET,837,-0.007734,-0.0016125,0.030314,0.60069,GOCC_ANCHORING_JUNCTION,1
MIR6783_5P,SET,144,-0.01891,-0.0016673,0.074018,0.60082,MIR6783_5P,1
MIR3692_3P,SET,261,-0.013696,-0.0016204,0.053593,0.60085,MIR3692_3P,1
HOLLERN_SQUAMOUS_BREAST_TUMOR,SET,169,-0.018107,-0.0017283,0.070808,0.60091,HOLLERN_SQUAMOUS_BREAST_TUMOR,1
GOCC_PROTON_TRANSPORTING_V_T...1,SET,24,-0.042669,-0.0015409,0.16686,0.60092,GOCC_PROTON_TRANSPORTING_V_TYPE_ATPASE_COMPLEX,1
GOMF_ACID_AMINO_ACID_LIGASE_...,SET,22,-0.045799,-0.0015836,0.17907,0.60093,GOMF_ACID_AMINO_ACID_LIGASE_ACTIVITY,1
LIU_OVARIAN_CANCER_TUMORS_AN...3,SET,74,-0.025144,-0.0015922,0.098213,0.60103,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP,1
GSE19825_NAIVE_VS_IL2RAHIGH_...2,SET,182,-0.016808,-0.0016643,0.065639,0.60105,GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP,1
GOBP_REGULATION_OF_PROTEIN_P...1,SET,179,-0.015782,-0.0015499,0.061617,0.60107,GOBP_REGULATION_OF_PROTEIN_POLYMERIZATION,1
GOBP_INORGANIC_ION_HOMEOSTAS...,SET,489,-0.010471,-0.0016851,0.040873,0.60109,GOBP_INORGANIC_ION_HOMEOSTASIS,1
GOBP_MAST_CELL_ACTIVATION,SET,64,-0.02786,-0.0016412,0.10873,0.60111,GOBP_MAST_CELL_ACTIVATION,1
AAGCCAT_MIR135A_MIR135B,SET,306,-0.012614,-0.001614,0.049213,0.60114,AAGCCAT_MIR135A_MIR135B,1
MODULE_214,SET,26,-0.045154,-0.0016971,0.17603,0.60122,MODULE_214,1
MIR1271_5P,SET,355,-0.011945,-0.0016441,0.046557,0.60125,MIR1271_5P,1
HP_ABNORMAL_PINEAL_MORPHOLOGY,SET,10,-0.066463,-0.0015499,0.25903,0.60125,HP_ABNORMAL_PINEAL_MORPHOLOGY,1
SANSOM_APC_TARGETS,SET,191,-0.015676,-0.0015897,0.060996,0.60141,SANSOM_APC_TARGETS,1
GOBP_NEURAL_TUBE_FORMATION,SET,99,-0.021021,-0.0015386,0.081792,0.60141,GOBP_NEURAL_TUBE_FORMATION,1
GOBP_CELL_FATE_COMMITMENT,SET,268,-0.014485,-0.0017363,0.056316,0.60149,GOBP_CELL_FATE_COMMITMENT,1
GOBP_REGULATION_OF_CAMP_DEPE...,SET,13,-0.058091,-0.0015444,0.22582,0.6015,GOBP_REGULATION_OF_CAMP_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
RAMALHO_STEMNESS_UP,SET,180,-0.015517,-0.0015281,0.060314,0.60151,RAMALHO_STEMNESS_UP,1
HP_INTESTINAL_LYMPHANGIECTAS...,SET,5,-0.1059,-0.0017464,0.41137,0.60157,HP_INTESTINAL_LYMPHANGIECTASIA,1
APRELIKOVA_BRCA1_TARGETS,SET,42,-0.031815,-0.0015191,0.12358,0.60158,APRELIKOVA_BRCA1_TARGETS,1
GSE22886_DAY0_VS_DAY1_MONOCY...2,SET,183,-0.016763,-0.0016644,0.065063,0.60166,GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP,1
GNF2_PA2G4,SET,75,-0.022542,-0.001437,0.087471,0.60168,GNF2_PA2G4,1
GOBP_REGULATION_OF_PHOSPHOLI...8,SET,6,-0.088866,-0.0016054,0.34481,0.60169,GOBP_REGULATION_OF_PHOSPHOLIPID_TRANSLOCATION,1
HP_FOCAL_ONSET_SEIZURE,SET,296,-0.012453,-0.0015676,0.048296,0.60174,HP_FOCAL_ONSET_SEIZURE,1
HP_CORNEAL_OPACITY,SET,247,-0.014037,-0.0016163,0.054394,0.60182,HP_CORNEAL_OPACITY,1
GOBP_SINGLE_FERTILIZATION,SET,150,-0.018239,-0.001641,0.070662,0.60184,GOBP_SINGLE_FERTILIZATION,1
REACTOME_COENZYME_A_BIOSYNTH...,SET,7,-0.068593,-0.0013384,0.2657,0.60185,REACTOME_COENZYME_A_BIOSYNTHESIS,1
REACTOME_LYSOSOME_VESICLE_BI...,SET,32,-0.036817,-0.0015349,0.1426,0.60186,REACTOME_LYSOSOME_VESICLE_BIOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...566,SET,62,-0.028688,-0.0016634,0.1111,0.60188,GOBP_POSITIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,1
GOBP_ENDOCRINE_PROCESS,SET,84,-0.025617,-0.0017279,0.099176,0.60191,GOBP_ENDOCRINE_PROCESS,1
MIR96_5P,SET,414,-0.011095,-0.0016463,0.042934,0.60196,MIR96_5P,1
MATZUK_OVULATION,SET,15,-0.059806,-0.0017079,0.23132,0.602,MATZUK_OVULATION,1
HUANG_FOXA2_TARGETS_DN,SET,35,-0.038202,-0.0016655,0.14772,0.60203,HUANG_FOXA2_TARGETS_DN,1
MIR218_1_3P,SET,84,-0.024565,-0.0016569,0.094993,0.60203,MIR218_1_3P,1
MIR4725_5P,SET,52,-0.030134,-0.0016006,0.11652,0.60203,MIR4725_5P,1
REACTOME_EXTRACELLULAR_MATRI...,SET,285,-0.0138,-0.0017051,0.053348,0.60206,REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION,1
HP_VISCERAL_ANGIOMATOSIS,SET,15,-0.057859,-0.0016523,0.22361,0.60208,HP_VISCERAL_ANGIOMATOSIS,1
GOCC_CYCLIN_CDK_POSITIVE_TRA...,SET,8,-0.063088,-0.0013159,0.24376,0.60211,GOCC_CYCLIN_CDK_POSITIVE_TRANSCRIPTION_ELONGATION_FACTOR_COMPLEX,1
GOBP_POINTED_END_ACTIN_FILAM...,SET,7,-0.072935,-0.0014231,0.28174,0.60213,GOBP_POINTED_END_ACTIN_FILAMENT_CAPPING,1
GSE22935_UNSTIM_VS_24H_MBOVI...1,SET,180,-0.016855,-0.0016598,0.065105,0.60214,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
ALCALAY_AML_BY_NPM1_LOCALIZA...2,SET,123,-0.020806,-0.0016964,0.080339,0.60217,ALCALAY_AML_BY_NPM1_LOCALIZATION_UP,1
ISHIDA_E2F_TARGETS,SET,50,-0.028376,-0.001478,0.10958,0.60217,ISHIDA_E2F_TARGETS,1
GOBP_MODULATION_OF_PROCESS_O...,SET,14,-0.063625,-0.0017554,0.24561,0.6022,GOBP_MODULATION_OF_PROCESS_OF_ANOTHER_ORGANISM,1
GSE360_DC_VS_MAC_B_MALAYI_LO...1,SET,176,-0.016236,-0.0015812,0.062646,0.60225,GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN,1
GSE21360_SECONDARY_VS_TERTIA...1,SET,149,-0.017699,-0.0015871,0.068278,0.60227,GSE21360_SECONDARY_VS_TERTIARY_MEMORY_CD8_TCELL_DN,1
GOMF_COA_LIGASE_ACTIVITY,SET,25,-0.044493,-0.0016399,0.17158,0.6023,GOMF_COA_LIGASE_ACTIVITY,1
GSE30083_SP2_VS_SP3_THYMOCYT...2,SET,185,-0.017303,-0.0017273,0.066712,0.60232,GSE30083_SP2_VS_SP3_THYMOCYTE_UP,1
DESCARTES_FETAL_ADRENAL_VASC...,SET,110,-0.021978,-0.0016952,0.084698,0.60237,DESCARTES_FETAL_ADRENAL_VASCULAR_ENDOTHELIAL_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...722,SET,22,-0.047484,-0.0016419,0.18295,0.60239,GOBP_POSITIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,1
HP_FETAL_ANOMALY,SET,490,-0.0099187,-0.0015978,0.038189,0.60246,HP_FETAL_ANOMALY,1
GSE7852_TREG_VS_TCONV_FAT_UP,SET,185,-0.016339,-0.001631,0.062872,0.60252,GSE7852_TREG_VS_TCONV_FAT_UP,1
BIOCARTA_PARKIN_PATHWAY,SET,7,-0.080059,-0.0015621,0.308,0.60254,BIOCARTA_PARKIN_PATHWAY,1
HP_ABNORMALITY_OF_THE_CALCAN...,SET,31,-0.043258,-0.0017751,0.16639,0.60256,HP_ABNORMALITY_OF_THE_CALCANEUS,1
BOYLAN_MULTIPLE_MYELOMA_PCA3...1,SET,63,-0.027758,-0.0016224,0.10667,0.60265,BOYLAN_MULTIPLE_MYELOMA_PCA3_DN,1
GOBP_AXIS_SPECIFICATION,SET,87,-0.024886,-0.0017081,0.095632,0.60265,GOBP_AXIS_SPECIFICATION,1
PID_RB_1PATHWAY,SET,60,-0.028807,-0.0016433,0.11064,0.60271,PID_RB_1PATHWAY,1
GOBP_REGULATION_OF_LYSOSOME_...2,SET,4,-0.11572,-0.001707,0.44439,0.60272,GOBP_REGULATION_OF_LYSOSOME_SIZE,1
GOCC_BORC_COMPLEX,SET,4,-0.11572,-0.001707,0.44439,0.60272,GOCC_BORC_COMPLEX,1
MIR760,SET,116,-0.019463,-0.0015414,0.07472,0.60275,MIR760,1
GOMF_CYTOSKELETAL_ANCHOR_ACT...,SET,23,-0.045429,-0.0016061,0.17437,0.60277,GOMF_CYTOSKELETAL_ANCHOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...556,SET,20,-0.050453,-0.0016634,0.19358,0.60281,GOBP_POSITIVE_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,1
HP_THORACOLUMBAR_SCOLIOSIS,SET,37,-0.03349,-0.0015011,0.12839,0.6029,HP_THORACOLUMBAR_SCOLIOSIS,1
STK33_NOMO_UP,SET,263,-0.014182,-0.0016843,0.054357,0.60291,STK33_NOMO_UP,1
GSE20366_EX_VIVO_VS_DEC205_C...2,SET,182,-0.01646,-0.0016299,0.063091,0.60291,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_NAIVE_CD4_TCELL_DN,1
MIR514A_5P,SET,61,-0.029689,-0.0017076,0.11373,0.60297,MIR514A_5P,1
HP_CRYPTORCHIDISM,SET,636,-0.0086935,-0.001589,0.033299,0.60298,HP_CRYPTORCHIDISM,1
GOBP_ACTIN_POLYMERIZATION_OR...,SET,171,-0.017164,-0.0016479,0.065717,0.60302,GOBP_ACTIN_POLYMERIZATION_OR_DEPOLYMERIZATION,1
GOBP_BLASTOCYST_GROWTH,SET,21,-0.045412,-0.0015342,0.17387,0.60302,GOBP_BLASTOCYST_GROWTH,1
GSE17721_POLYIC_VS_CPG_6H_BM...1,SET,184,-0.015711,-0.0015641,0.060127,0.60306,GSE17721_POLYIC_VS_CPG_6H_BMDC_DN,1
HP_INCREASED_LAXITY_OF_ANKLES,SET,5,-0.11097,-0.0018301,0.42464,0.60308,HP_INCREASED_LAXITY_OF_ANKLES,1
GSE6259_BCELL_VS_CD8_TCELL_DN,SET,168,-0.017387,-0.0016547,0.066499,0.60313,GSE6259_BCELL_VS_CD8_TCELL_DN,1
REACTOME_SIGNALING_BY_FGFR3,SET,38,-0.035457,-0.0016106,0.1356,0.60314,REACTOME_SIGNALING_BY_FGFR3,1
GSE3982_DC_VS_MAC_LPS_STIM_UP,SET,173,-0.016122,-0.0015568,0.061648,0.60315,GSE3982_DC_VS_MAC_LPS_STIM_UP,1
HP_RECURRENT_ENTEROVIRAL_INF...,SET,3,-0.12653,-0.0016165,0.48378,0.60317,HP_RECURRENT_ENTEROVIRAL_INFECTIONS,1
REACTOME_PROSTACYCLIN_SIGNAL...,SET,19,-0.053284,-0.0017123,0.2036,0.60323,REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR,1
GOBP_SPINAL_CORD_PATTERNING,SET,18,-0.053757,-0.0016815,0.20539,0.60323,GOBP_SPINAL_CORD_PATTERNING,1
GOBP_PERK_MEDIATED_UNFOLDED_...,SET,20,-0.050509,-0.0016653,0.19295,0.60325,GOBP_PERK_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
HP_LATERAL_CLAVICLE_HOOK,SET,11,-0.063712,-0.0015582,0.24337,0.60326,HP_LATERAL_CLAVICLE_HOOK,1
ZHONG_SECRETOME_OF_LUNG_CANC...3,SET,69,-0.026368,-0.0016126,0.1007,0.60328,ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE,1
HP_RECURRENT_SYSTEMIC_PYOGEN...,SET,5,-0.09925,-0.0016368,0.37893,0.60331,HP_RECURRENT_SYSTEMIC_PYOGENIC_INFECTIONS,1
GTCNYYATGR_UNKNOWN,SET,103,-0.021437,-0.0016003,0.081795,0.60337,GTCNYYATGR_UNKNOWN,1
HP_SHORTENING_OF_ALL_DISTAL_...,SET,12,-0.056061,-0.001432,0.21389,0.60338,HP_SHORTENING_OF_ALL_DISTAL_PHALANGES_OF_THE_FINGERS,1
GOBP_REGULATION_OF_RELAXATIO...2,SET,13,-0.068504,-0.0018213,0.26134,0.60339,GOBP_REGULATION_OF_RELAXATION_OF_MUSCLE,1
GOMF_HISTAMINE_RECEPTOR_ACTI...,SET,6,-0.092835,-0.0016771,0.35414,0.60339,GOMF_HISTAMINE_RECEPTOR_ACTIVITY,1
GOBP_REGULATION_OF_POSITIVE_...,SET,25,-0.048947,-0.001804,0.18669,0.60341,GOBP_REGULATION_OF_POSITIVE_CHEMOTAXIS,1
GSE5589_LPS_VS_LPS_AND_IL6_S...4,SET,172,-0.016981,-0.001635,0.064752,0.60343,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP,1
GSE19401_UNSTIM_VS_RETINOIC_...1,SET,184,-0.016636,-0.0016562,0.063397,0.60349,GSE19401_UNSTIM_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
HP_BRAIN_IMAGING_ABNORMALITY,SET,138,-0.01876,-0.0016195,0.071478,0.60351,HP_BRAIN_IMAGING_ABNORMALITY,1
HP_ABNORMALITY_OF_THE_ANKLE,SET,159,-0.017869,-0.0016549,0.06806,0.60355,HP_ABNORMALITY_OF_THE_ANKLE,1
HP_CLINODACTYLY,SET,492,-0.0098396,-0.0015882,0.03747,0.60357,HP_CLINODACTYLY,1
MEISSNER_BRAIN_ICP_WITH_H3K4...,SET,27,-0.039313,-0.0015057,0.14969,0.60358,MEISSNER_BRAIN_ICP_WITH_H3K4ME3,1
GOCC_ENZYME_ACTIVATOR_COMPLEX,SET,13,-0.053029,-0.0014098,0.20186,0.60361,GOCC_ENZYME_ACTIVATOR_COMPLEX,1
HP_FUNCTIONAL_ABNORMALITY_OF...3,SET,920,-0.0073734,-0.0016079,0.028067,0.60361,HP_FUNCTIONAL_ABNORMALITY_OF_THE_INNER_EAR,1
HP_AMAUROSIS_FUGAX,SET,40,-0.032797,-0.0015284,0.12483,0.60362,HP_AMAUROSIS_FUGAX,1
MIR3118,SET,70,-0.026956,-0.0016604,0.10256,0.60366,MIR3118,1
GOBP_GMP_METABOLIC_PROCESS,SET,25,-0.044664,-0.0016462,0.16992,0.60366,GOBP_GMP_METABOLIC_PROCESS,1
GOBP_ERROR_FREE_TRANSLESION_...,SET,5,-0.065779,-0.0010848,0.25016,0.6037,GOBP_ERROR_FREE_TRANSLESION_SYNTHESIS,1
HP_ABNORMAL_THIRD_VENTRICLE_...,SET,14,-0.064044,-0.0017669,0.24355,0.60371,HP_ABNORMAL_THIRD_VENTRICLE_MORPHOLOGY,1
HP_ABNORMAL_PROXIMAL_PHALANX...,SET,27,-0.043746,-0.0016755,0.16634,0.60372,HP_ABNORMAL_PROXIMAL_PHALANX_MORPHOLOGY_OF_THE_HAND,1
HP_HYPOCHROMIC_ANEMIA,SET,51,-0.030903,-0.0016256,0.1175,0.60372,HP_HYPOCHROMIC_ANEMIA,1
GOBP_GLYCINE_METABOLIC_PROCE...,SET,12,-0.05896,-0.0015061,0.22416,0.60373,GOBP_GLYCINE_METABOLIC_PROCESS,1
CREB3_TARGET_GENES,SET,389,-0.011125,-0.0016012,0.042293,0.60374,CREB3_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...669,SET,9,-0.061935,-0.0013702,0.23543,0.60375,GOBP_NEGATIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
HP_SLANTING_OF_THE_PALPEBRAL...,SET,622,-0.0087862,-0.0015888,0.033386,0.60379,HP_SLANTING_OF_THE_PALPEBRAL_FISSURE,1
BROWNE_HCMV_INFECTION_16HR_DN,SET,77,-0.026257,-0.001696,0.099761,0.6038,BROWNE_HCMV_INFECTION_16HR_DN,1
CALVET_IRINOTECAN_SENSITIVE_...2,SET,5,-0.10438,-0.0017214,0.39643,0.60384,CALVET_IRINOTECAN_SENSITIVE_VS_REVERTED_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...40,SET,868,-0.0074501,-0.0015804,0.028292,0.60385,GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE,1
KEGG_MEDICUS_REFERENCE_MDM2_...2,SET,11,-0.071323,-0.0017444,0.27079,0.60387,KEGG_MEDICUS_REFERENCE_MDM2_P21_CELL_CYCLE_G1_S_N00536,1
MIR4446_5P,SET,271,-0.013576,-0.0016363,0.051542,0.60388,MIR4446_5P,1
GOBP_SMOOTH_MUSCLE_CONTRACTI...,SET,104,-0.022916,-0.001719,0.086993,0.60389,GOBP_SMOOTH_MUSCLE_CONTRACTION,1
GSE32423_MEMORY_VS_NAIVE_CD8...5,SET,182,-0.016214,-0.0016055,0.061553,0.60389,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_UP,1
GOBP_POSITIVE_REGULATION_OF_...116,SET,2,-0.18476,-0.0019272,0.7007,0.60398,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,1
GOBP_RESPONSE_TO_PLATELET_DE...,SET,19,-0.054559,-0.0017533,0.2069,0.60399,GOBP_RESPONSE_TO_PLATELET_DERIVED_GROWTH_FACTOR,1
MODULE_118,SET,368,-0.011891,-0.0016656,0.045088,0.604,MODULE_118,1
WP_AEROBIC_GLYCOLYSIS_AUGMEN...,SET,11,-0.052728,-0.0012896,0.19988,0.60403,WP_AEROBIC_GLYCOLYSIS_AUGMENTED,1
GOCC_DYNACTIN_COMPLEX,SET,8,-0.070078,-0.0014617,0.2656,0.60405,GOCC_DYNACTIN_COMPLEX,1
GOBP_CDP_DIACYLGLYCEROL_BIOS...,SET,11,-0.073367,-0.0017943,0.27798,0.60408,GOBP_CDP_DIACYLGLYCEROL_BIOSYNTHETIC_PROCESS,1
CARM1_TARGET_GENES,SET,8,-0.081884,-0.001708,0.31005,0.60415,CARM1_TARGET_GENES,1
GOBP_BRANCHED_CHAIN_AMINO_AC...1,SET,5,-0.11276,-0.0018595,0.42679,0.60418,GOBP_BRANCHED_CHAIN_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_EYE_PHOTORECEPTOR_CELL_...1,SET,36,-0.039558,-0.0017491,0.14973,0.60418,GOBP_EYE_PHOTORECEPTOR_CELL_DEVELOPMENT,1
SRF_Q6,SET,228,-0.015465,-0.0017117,0.05852,0.60421,SRF_Q6,1
GOBP_POSITIVE_REGULATION_OF_...410,SET,25,-0.045813,-0.0016885,0.17335,0.60422,GOBP_POSITIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
NUYTTEN_NIPP1_TARGETS_DN,SET,766,-0.0081762,-0.001634,0.030929,0.60424,NUYTTEN_NIPP1_TARGETS_DN,1
HP_ARTHRALGIA_OF_THE_HIP,SET,8,-0.078578,-0.001639,0.29724,0.60425,HP_ARTHRALGIA_OF_THE_HIP,1
MIR7151_3P,SET,250,-0.01375,-0.0015927,0.052002,0.60427,MIR7151_3P,1
GOMF_NAD_P_H_DEHYDROGENASE_Q...,SET,5,-0.10324,-0.0017026,0.39042,0.60427,GOMF_NAD_P_H_DEHYDROGENASE_QUINONE_ACTIVITY,1
AIZARANI_LIVER_C13_LSECS_2,SET,255,-0.015257,-0.0017846,0.057695,0.60428,AIZARANI_LIVER_C13_LSECS_2,1
GOBP_BLOOD_VESSEL_MATURATION,SET,8,-0.084997,-0.0017729,0.32126,0.60433,GOBP_BLOOD_VESSEL_MATURATION,1
KEGG_MEDICUS_REFERENCE_NALP1...,SET,4,-0.09669,-0.0014263,0.3653,0.60437,KEGG_MEDICUS_REFERENCE_NALP12_INFLAMMASOME_SIGNALING_PATHWAY,1
GOCC_DEUTEROSOME,SET,5,-0.081164,-0.0013385,0.30623,0.60451,GOCC_DEUTEROSOME,1
GOBP_GLOMERULAR_ENDOTHELIUM_...,SET,4,-0.13708,-0.0020221,0.51718,0.60452,GOBP_GLOMERULAR_ENDOTHELIUM_DEVELOPMENT,1
WP_8P231_COPY_NUMBER_VARIATI...,SET,51,-0.041774,-0.0021975,0.15756,0.60454,WP_8P231_COPY_NUMBER_VARIATION_SYNDROME,1
GSE37416_CTRL_VS_24H_F_TULAR...1,SET,177,-0.015976,-0.0015602,0.060247,0.60456,GSE37416_CTRL_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOCC_MICROTUBULE_CYTOSKELETON,SET,1224,-0.0063967,-0.0015949,0.024121,0.60457,GOCC_MICROTUBULE_CYTOSKELETON,1
GSE3203_WT_VS_IFNAR1_KO_INFL...2,SET,179,-0.016933,-0.0016629,0.063843,0.60458,GSE3203_WT_VS_IFNAR1_KO_INFLUENZA_INFECTED_LN_BCELL_UP,1
BROWNE_HCMV_INFECTION_18HR_UP,SET,156,-0.017915,-0.0016435,0.067491,0.60466,BROWNE_HCMV_INFECTION_18HR_UP,1
GOBP_COPULATION,SET,19,-0.053849,-0.0017305,0.20285,0.60467,GOBP_COPULATION,1
MIR4778_3P,SET,230,-0.015274,-0.0016979,0.057528,0.60469,MIR4778_3P,1
HP_EXUDATIVE_RETINAL_DETACHM...,SET,5,-0.12034,-0.0019847,0.45323,0.6047,HP_EXUDATIVE_RETINAL_DETACHMENT,1
GAUTAM_EYE_IRIS_CILIARY_BODY...15,SET,83,-0.023795,-0.0015954,0.089609,0.6047,GAUTAM_EYE_IRIS_CILIARY_BODY_SCHWANN_CELLS,1
MODULE_84,SET,492,-0.010836,-0.001749,0.040792,0.60474,MODULE_84,1
GSE40274_LEF1_VS_FOXP3_AND_L...1,SET,173,-0.017304,-0.0016709,0.065058,0.60487,GSE40274_LEF1_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOCC_MALE_PRONUCLEUS,SET,6,-0.079574,-0.0014375,0.29914,0.60488,GOCC_MALE_PRONUCLEUS,1
GSE14908_ATOPIC_VS_NONATOPIC...2,SET,177,-0.016011,-0.0015637,0.060171,0.60492,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_UP,1
MIR186_3P,SET,131,-0.019399,-0.0016319,0.072882,0.60494,MIR186_3P,1
MODULE_55,SET,763,-0.0086793,-0.0017313,0.032595,0.60499,MODULE_55,1
SASAI_RESISTANCE_TO_NEOPLAST...,SET,45,-0.036419,-0.0017999,0.13672,0.60502,SASAI_RESISTANCE_TO_NEOPLASTIC_TRANSFROMATION,1
MIR6770_5P,SET,170,-0.017148,-0.0016416,0.064363,0.60504,MIR6770_5P,1
SIG_IL4RECEPTOR_IN_B_LYPHOCY...,SET,27,-0.043838,-0.001679,0.16447,0.60509,SIG_IL4RECEPTOR_IN_B_LYPHOCYTES,1
GOBP_FIBRINOLYSIS,SET,27,-0.045335,-0.0017364,0.17009,0.60509,GOBP_FIBRINOLYSIS,1
MIR3678_5P,SET,13,-0.059899,-0.0015925,0.22468,0.60511,MIR3678_5P,1
REACTOME_REGULATION_OF_MITF_...3,SET,15,-0.05736,-0.001638,0.21492,0.60522,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_LYSOSOME_BIOGENESIS_AND_AUTOPHAGY,1
GOBP_REGULATION_OF_PHOSPHATI...2,SET,10,-0.078401,-0.0018283,0.29374,0.60523,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,1
HP_BILATERAL_CHOANAL_ATRESIA,SET,9,-0.064381,-0.0014243,0.24111,0.60527,HP_BILATERAL_CHOANAL_ATRESIA,1
HP_MOTOR_TICS,SET,11,-0.064327,-0.0015732,0.24087,0.60529,HP_MOTOR_TICS,1
MIR892C_3P,SET,189,-0.016078,-0.001622,0.060172,0.60534,MIR892C_3P,1
HOWARD_NK_CELL_INACT_MONOV_I...1,SET,19,-0.05417,-0.0017408,0.20271,0.60535,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_UP,1
GOBP_MATERNAL_PLACENTA_DEVEL...,SET,33,-0.039121,-0.0016562,0.14634,0.60539,GOBP_MATERNAL_PLACENTA_DEVELOPMENT,1
SCHAEFFER_PROSTATE_DEVELOPME...12,SET,33,-0.035254,-0.0014925,0.1318,0.60545,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN,1
HP_ABNORMAL_HAND_MORPHOLOGY,SET,920,-0.0075258,-0.0016411,0.028131,0.60547,HP_ABNORMAL_HAND_MORPHOLOGY,1
HU_FETAL_RETINA_RPC,SET,97,-0.024246,-0.0017568,0.090603,0.6055,HU_FETAL_RETINA_RPC,1
GSE34156_UNTREATED_VS_6H_NOD...4,SET,160,-0.017525,-0.001628,0.065457,0.60555,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_UP,1
STEARMAN_LUNG_CANCER_EARLY_V...2,SET,118,-0.019592,-0.0015648,0.073162,0.60557,STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP,1
HP_OCULOGYRIC_CRISIS,SET,12,-0.068811,-0.0017577,0.25693,0.60558,HP_OCULOGYRIC_CRISIS,1
HP_CARDIAC_DIVERTICULUM,SET,20,-0.045041,-0.001485,0.16815,0.6056,HP_CARDIAC_DIVERTICULUM,1
GOMF_DNA_REPLICATION_ORIGIN_...,SET,15,-0.056222,-0.0016055,0.20981,0.60563,GOMF_DNA_REPLICATION_ORIGIN_BINDING,1
DESCARTES_MAIN_FETAL_MESOTHE...,SET,22,-0.052598,-0.0018187,0.19614,0.60571,DESCARTES_MAIN_FETAL_MESOTHELIAL_CELLS,1
HP_PALMOPLANTAR_BLISTERING,SET,11,-0.067741,-0.0016567,0.25256,0.60573,HP_PALMOPLANTAR_BLISTERING,1
GOCC_MITOCHONDRIAL_INTERMEMB...,SET,5,-0.087638,-0.0014453,0.3267,0.60575,GOCC_MITOCHONDRIAL_INTERMEMBRANE_SPACE_PROTEIN_TRANSPORTER_COMPLEX,1
PGM3_TARGET_GENES,SET,214,-0.015266,-0.0016376,0.056897,0.60576,PGM3_TARGET_GENES,1
GOMF_HYDROXYMETHYL_FORMYL_AN...,SET,8,-0.06925,-0.0014445,0.25796,0.60582,GOMF_HYDROXYMETHYL_FORMYL_AND_RELATED_TRANSFERASE_ACTIVITY,1
HP_CHRONIC_RHINITIS,SET,49,-0.031258,-0.0016118,0.11644,0.60582,HP_CHRONIC_RHINITIS,1
GSE21670_TGFB_VS_TGFB_AND_IL...4,SET,180,-0.016873,-0.0016616,0.062818,0.60588,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GSE34156_UNTREATED_VS_24H_NO...1,SET,144,-0.018323,-0.0016155,0.068219,0.60588,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
HANSON_HRAS_SIGNALING_VIA_NF...,SET,21,-0.049444,-0.0016704,0.18402,0.60591,HANSON_HRAS_SIGNALING_VIA_NFKB,1
GSE22432_CONVENTIONAL_CDC_VS...2,SET,181,-0.016219,-0.0016016,0.060368,0.60591,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_UP,1
KEGG_LYSOSOME,SET,113,-0.020858,-0.0016305,0.077599,0.60595,KEGG_LYSOSOME,1
GSE29618_PDC_VS_MDC_DAY7_FLU...2,SET,173,-0.017913,-0.0017298,0.066638,0.60596,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_UP,1
MATZUK_POSTIMPLANTATION_AND_...,SET,13,-0.065608,-0.0017443,0.24402,0.60598,MATZUK_POSTIMPLANTATION_AND_POSTPARTUM,1
HP_ABNORMAL_CIRCULATING_LYSI...,SET,5,-0.11993,-0.0019778,0.44603,0.60598,HP_ABNORMAL_CIRCULATING_LYSINE_CONCENTRATION,1
GOMF_OMEGA_PEPTIDASE_ACTIVITY,SET,12,-0.068359,-0.0017462,0.25423,0.60599,GOMF_OMEGA_PEPTIDASE_ACTIVITY,1
THAKAR_PBMC_INACTIVATED_INFL...11,SET,97,-0.022431,-0.0016253,0.083407,0.60601,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_NONRESPONDER_2DY_UP,1
GOBP_EPITHELIAL_TUBE_FORMATI...,SET,131,-0.019535,-0.0016434,0.072597,0.60607,GOBP_EPITHELIAL_TUBE_FORMATION,1
GSE14415_INDUCED_TREG_VS_FAI...1,SET,168,-0.018189,-0.001731,0.067581,0.60609,GSE14415_INDUCED_TREG_VS_FAILED_INDUCED_TREG_DN,1
chr10q26,SET,91,-0.046069,-0.0032336,0.17114,0.6061,chr10q26,1
GOBP_POSITIVE_REGULATION_OF_...269,SET,47,-0.035114,-0.0017734,0.13041,0.60613,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE7568_CTRL_VS_24H_TGFB_TRE...2,SET,180,-0.016443,-0.0016193,0.061049,0.60617,GSE7568_CTRL_VS_24H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_UP,1
GOCC_MEMBRANE_COAT,SET,93,-0.022418,-0.0015906,0.083209,0.60619,GOCC_MEMBRANE_COAT,1
REACTOME_FLT3_SIGNALING,SET,37,-0.034869,-0.0015629,0.12941,0.6062,REACTOME_FLT3_SIGNALING,1
GOBP_RESPONSE_TO_METHIONINE,SET,5,-0.11242,-0.0018541,0.41724,0.60621,GOBP_RESPONSE_TO_METHIONINE,1
REACTOME_SYNTHESIS_OF_PI,SET,5,-0.10242,-0.0016891,0.38,0.60624,REACTOME_SYNTHESIS_OF_PI,1
GSE33162_UNTREATED_VS_4H_LPS...4,SET,185,-0.015954,-0.0015926,0.05919,0.60624,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_UP,1
MIR106A_5P,SET,596,-0.0095184,-0.001686,0.035311,0.60625,MIR106A_5P,1
HP_SUBSTANTIA_NIGRA_GLIOSIS,SET,10,-0.067468,-0.0015733,0.25023,0.60627,HP_SUBSTANTIA_NIGRA_GLIOSIS,1
PTF1BETA_Q6,SET,214,-0.015848,-0.0017001,0.058757,0.60631,PTF1BETA_Q6,1
GSE411_UNSTIM_VS_100MIN_IL6_...1,SET,186,-0.016099,-0.0016113,0.059686,0.60631,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_DN,1
HP_ABNORMAL_URINARY_PURINE_L...,SET,7,-0.10401,-0.0020294,0.38543,0.60636,HP_ABNORMAL_URINARY_PURINE_LEVEL,1
HP_ABSENCE_OF_PUBERTAL_DEVEL...,SET,30,-0.044618,-0.0018012,0.16534,0.60636,HP_ABSENCE_OF_PUBERTAL_DEVELOPMENT,1
GSE36476_YOUNG_VS_OLD_DONOR_...6,SET,173,-0.017728,-0.0017119,0.065695,0.60636,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_72H_TSST_ACT_UP,1
OKAWA_NEUROBLASTOMA_1P36_31_...,SET,22,-0.089107,-0.0030811,0.33015,0.60638,OKAWA_NEUROBLASTOMA_1P36_31_DELETION,1
GSE28737_FOLLICULAR_VS_MARGI...3,SET,179,-0.017388,-0.0017076,0.064413,0.6064,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_DN,1
GSE21927_HEALTHY_VS_TUMOROUS...2,SET,167,-0.017458,-0.0016566,0.064663,0.60641,GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP,1
SENGUPTA_EBNA1_ANTICORRELATED,SET,126,-0.019743,-0.0016291,0.073097,0.60645,SENGUPTA_EBNA1_ANTICORRELATED,1
GOBP_REGULATION_OF_SALIVA_SE...,SET,7,-0.11107,-0.0021672,0.41116,0.60647,GOBP_REGULATION_OF_SALIVA_SECRETION,1
GOMF_U3_SNORNA_BINDING,SET,8,-0.080469,-0.0016785,0.29761,0.60657,GOMF_U3_SNORNA_BINDING,1
JU_AGING_TERC_TARGETS_UP,SET,6,-0.095887,-0.0017322,0.35455,0.60659,JU_AGING_TERC_TARGETS_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...10,SET,50,-0.035846,-0.0018671,0.13254,0.60659,GAVISH_3CA_MALIGNANT_METAPROGRAM_19_EPITHELIAL_SENESCENCE,1
GSE339_CD8POS_VS_CD4CD8DN_DC...4,SET,184,-0.016271,-0.0016199,0.060163,0.60659,GSE339_CD8POS_VS_CD4CD8DN_DC_UP,1
GOMF_NERVE_GROWTH_FACTOR_REC...,SET,4,-0.13668,-0.0020162,0.50516,0.60664,GOMF_NERVE_GROWTH_FACTOR_RECEPTOR_BINDING,1
BUSSLINGER_GASTRIC_ANTRAL_ECS,SET,10,-0.082052,-0.0019134,0.3032,0.60666,BUSSLINGER_GASTRIC_ANTRAL_ECS,1
GOBP_PHASIC_SMOOTH_MUSCLE_CO...,SET,24,-0.051799,-0.0018706,0.19118,0.60678,GOBP_PHASIC_SMOOTH_MUSCLE_CONTRACTION,1
BIOCARTA_BOTULIN_PATHWAY,SET,5,-0.1125,-0.0018553,0.41504,0.60682,BIOCARTA_BOTULIN_PATHWAY,1
HP_ABNORMAL_ATRIOVENTRICULAR...2,SET,14,-0.063373,-0.0017484,0.23369,0.60688,HP_ABNORMAL_ATRIOVENTRICULAR_CONNECTION,1
HP_VASCULITIS,SET,65,-0.030134,-0.0017889,0.11105,0.60694,HP_VASCULITIS,1
GOBP_REGULATION_OF_ENTRY_OF_...,SET,7,-0.083509,-0.0016294,0.30773,0.60695,GOBP_REGULATION_OF_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...631,SET,18,-0.053827,-0.0016837,0.1983,0.60697,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE_VIA_TELOMERASE,1
GOBP_NERVOUS_SYSTEM_PROCESS_...,SET,10,-0.075595,-0.0017628,0.27847,0.60698,GOBP_NERVOUS_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
HP_BICARBONATE_WASTING_RENAL...,SET,5,-0.10389,-0.0017133,0.38252,0.60703,HP_BICARBONATE_WASTING_RENAL_TUBULAR_ACIDOSIS,1
HP_RECURRENT_OPPORTUNISTIC_I...,SET,9,-0.077966,-0.0017249,0.28697,0.60707,HP_RECURRENT_OPPORTUNISTIC_INFECTIONS,1
GOMF_AP_2_ADAPTOR_COMPLEX_BI...,SET,10,-0.069553,-0.0016219,0.25598,0.60708,GOMF_AP_2_ADAPTOR_COMPLEX_BINDING,1
NUYTTEN_EZH2_TARGETS_UP,SET,942,-0.0077798,-0.0017156,0.028604,0.60718,NUYTTEN_EZH2_TARGETS_UP,1
HP_GINGIVITIS,SET,29,-0.044355,-0.0017605,0.16308,0.60718,HP_GINGIVITIS,1
HP_ACCESSORY_SPLEEN,SET,33,-0.036311,-0.0015372,0.13343,0.60724,HP_ACCESSORY_SPLEEN,1
CADWELL_ATG16L1_TARGETS_DN,SET,61,-0.026887,-0.0015464,0.098775,0.60727,CADWELL_ATG16L1_TARGETS_DN,1
HP_HYPERINTENSITY_OF_CEREBRA...,SET,72,-0.027513,-0.0017187,0.10107,0.60727,HP_HYPERINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,1
GSE17974_IL4_AND_ANTI_IL12_V...14,SET,164,-0.017002,-0.0015989,0.062455,0.60727,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP,1
GSE11367_CTRL_VS_IL17_TREATE...1,SET,101,-0.024019,-0.0017757,0.088218,0.60729,GSE11367_CTRL_VS_IL17_TREATED_SMOOTH_MUSCLE_CELL_DN,1
HP_LIMB_DYSMETRIA,SET,14,-0.06048,-0.0016686,0.22208,0.60732,HP_LIMB_DYSMETRIA,1
LET_7F_2_3P,SET,371,-0.011979,-0.0016847,0.043928,0.60745,LET_7F_2_3P,1
GOMF_MAP_KINASE_ACTIVITY,SET,16,-0.064189,-0.0018931,0.2354,0.60745,GOMF_MAP_KINASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_INVOLV...10,SET,4,-0.13583,-0.0020036,0.49804,0.60747,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_MUSCULATURE_OF_THE_EXTREMITIES,1
MIR1296_5P,SET,26,-0.045692,-0.0017173,0.1675,0.60749,MIR1296_5P,1
GCM_TPR,SET,29,-0.039854,-0.0015818,0.14594,0.6076,GCM_TPR,1
MIR4790_3P,SET,77,-0.025839,-0.001669,0.094616,0.60761,MIR4790_3P,1
MIR504_5P,SET,53,-0.031492,-0.0016887,0.11531,0.60761,MIR504_5P,1
GOBP_REGULATION_OF_RELEASE_O...1,SET,41,-0.036985,-0.0017449,0.1354,0.60763,GOBP_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,1
GRAESSMANN_RESPONSE_TO_MC_AN...2,SET,567,-0.0097877,-0.0016924,0.03583,0.60764,GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP,1
MIR4639_3P,SET,66,-0.028562,-0.0017085,0.10453,0.60766,MIR4639_3P,1
DESCARTES_FETAL_KIDNEY_MEGAK...,SET,103,-0.024669,-0.0018415,0.090289,0.60766,DESCARTES_FETAL_KIDNEY_MEGAKARYOCYTES,1
REACTOME_PROTEIN_REPAIR,SET,6,-0.093305,-0.0016856,0.34143,0.60768,REACTOME_PROTEIN_REPAIR,1
MIR519C_3P,SET,375,-0.011702,-0.0016544,0.04282,0.60768,MIR519C_3P,1
MIR548T_5P,SET,389,-0.012197,-0.0017556,0.044625,0.60769,MIR548T_5P,1
GOMF_RISC_COMPLEX_BINDING,SET,4,-0.11872,-0.0017512,0.43436,0.60769,GOMF_RISC_COMPLEX_BINDING,1
SARTIPY_NORMAL_AT_INSULIN_RE...1,SET,17,-0.055225,-0.0016788,0.20201,0.60771,SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN,1
GSE22886_IGG_IGA_MEMORY_BCEL...3,SET,177,-0.017191,-0.0016789,0.062879,0.60772,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BM_PLASMA_CELL_DN,1
WP_ELECTRON_TRANSPORT_CHAIN_...,SET,69,-0.023808,-0.001456,0.087068,0.60774,WP_ELECTRON_TRANSPORT_CHAIN_OXPHOS_SYSTEM_IN_MITOCHONDRIA,1
HP_CHOREOATHETOSIS,SET,101,-0.02328,-0.001721,0.085127,0.60775,HP_CHOREOATHETOSIS,1
MIR6792_3P,SET,117,-0.021755,-0.0017302,0.07954,0.60777,MIR6792_3P,1
GOBP_NEGATIVE_REGULATION_OF_...395,SET,27,-0.045453,-0.0017409,0.16617,0.60778,GOBP_NEGATIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,1
GOBP_SKELETAL_SYSTEM_DEVELOP...,SET,484,-0.011457,-0.0018346,0.041865,0.60783,GOBP_SKELETAL_SYSTEM_DEVELOPMENT,1
MCMURRAY_TP53_HRAS_COOPERATI...2,SET,26,-0.049598,-0.0018642,0.1812,0.60785,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_UP,1
MIR6791_3P,SET,76,-0.026994,-0.0017323,0.098581,0.60789,MIR6791_3P,1
GOBP_POSITIVE_REGULATION_OF_...845,SET,129,-0.022035,-0.0018395,0.080435,0.60793,GOBP_POSITIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,1
MIR26A_2_3P,SET,66,-0.028078,-0.0016795,0.10247,0.60796,MIR26A_2_3P,1
GOBP_CRANIAL_NERVE_MORPHOGEN...,SET,29,-0.047371,-0.0018802,0.17287,0.60797,GOBP_CRANIAL_NERVE_MORPHOGENESIS,1
MIR5571_5P,SET,149,-0.019446,-0.0017438,0.070956,0.60798,MIR5571_5P,1
GSE21063_CTRL_VS_ANTI_IGM_ST...1,SET,183,-0.016947,-0.0016826,0.061814,0.60802,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_DN,1
MIR4309,SET,40,-0.035085,-0.001635,0.12795,0.60803,MIR4309,1
GOMF_NEUREXIN_FAMILY_PROTEIN...,SET,8,-0.084685,-0.0017664,0.30877,0.60806,GOMF_NEUREXIN_FAMILY_PROTEIN_BINDING,1
GOBP_MICROTUBULE_BUNDLE_FORM...,SET,99,-0.021741,-0.0015913,0.07923,0.60811,GOBP_MICROTUBULE_BUNDLE_FORMATION,1
GOBP_BRAIN_DERIVED_NEUROTROP...,SET,6,-0.10596,-0.0019142,0.38611,0.60812,GOBP_BRAIN_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_STEM_CELL...4,SET,79,-0.027413,-0.0017934,0.099894,0.60812,GOBP_REGULATION_OF_STEM_CELL_PROLIFERATION,1
GOMF_HEPARAN_SULFATE_PROTEOG...,SET,18,-0.061659,-0.0019287,0.22459,0.60816,GOMF_HEPARAN_SULFATE_PROTEOGLYCAN_BINDING,1
DESCARTES_FETAL_HEART_MEGAKA...,SET,80,-0.027852,-0.0018336,0.1014,0.60822,DESCARTES_FETAL_HEART_MEGAKARYOCYTES,1
WP_INTERACTIONS_BETWEEN_LOXL...,SET,17,-0.053302,-0.0016203,0.19398,0.60825,WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY,1
GSE25123_CTRL_VS_ROSIGLITAZO...4,SET,176,-0.018438,-0.0017957,0.067108,0.60825,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,1
HP_PSEUDOEPIPHYSES_OF_HAND_B...,SET,14,-0.063761,-0.0017591,0.23185,0.60835,HP_PSEUDOEPIPHYSES_OF_HAND_BONES,1
GSE25088_WT_VS_STAT6_KO_MACR...6,SET,180,-0.017154,-0.0016893,0.062362,0.60837,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_ROSIGLITAZONE_STIM_DN,1
HP_MENINGIOMA,SET,42,-0.033963,-0.0016217,0.12336,0.60846,HP_MENINGIOMA,1
HP_SHORT_THUMB,SET,104,-0.022654,-0.0016993,0.082273,0.60847,HP_SHORT_THUMB,1
GOBP_TRNA_DECAY,SET,16,-0.058963,-0.001739,0.2141,0.60849,GOBP_TRNA_DECAY,1
ACTWSNACTNY_UNKNOWN,SET,96,-0.021606,-0.0015575,0.078436,0.60852,ACTWSNACTNY_UNKNOWN,1
MIR5007_3P,SET,109,-0.022837,-0.0017535,0.082885,0.60854,MIR5007_3P,1
GOBP_EXPLORATION_BEHAVIOR,SET,29,-0.045606,-0.0018101,0.16539,0.60863,GOBP_EXPLORATION_BEHAVIOR,1
MIR6080,SET,42,-0.037253,-0.0017788,0.13506,0.60866,MIR6080,1
GOBP_CARBON_DIOXIDE_TRANSPORT,SET,12,-0.080709,-0.0020616,0.29252,0.60869,GOBP_CARBON_DIOXIDE_TRANSPORT,1
GOBP_VASCULATURE_DEVELOPMENT,SET,691,-0.0093891,-0.001786,0.034005,0.60876,GOBP_VASCULATURE_DEVELOPMENT,1
GOBP_REGULATION_OF_MICROTUBU...3,SET,7,-0.078647,-0.0015346,0.28469,0.60882,GOBP_REGULATION_OF_MICROTUBULE_BINDING,1
GOBP_REGULATION_OF_SENSORY_P...,SET,13,-0.066735,-0.0017742,0.24155,0.60883,GOBP_REGULATION_OF_SENSORY_PERCEPTION,1
REACTOME_PROPIONYL_COA_CATAB...,SET,4,-0.13651,-0.0020137,0.49402,0.60885,REACTOME_PROPIONYL_COA_CATABOLISM,1
GOBP_XENOBIOTIC_METABOLIC_PR...,SET,120,-0.02348,-0.0018911,0.084962,0.60886,GOBP_XENOBIOTIC_METABOLIC_PROCESS,1
chr3q22,SET,54,-0.064055,-0.003467,0.2316,0.60895,chr3q22,1
GOCC_APICOLATERAL_PLASMA_MEM...,SET,23,-0.053065,-0.001876,0.19182,0.60897,GOCC_APICOLATERAL_PLASMA_MEMBRANE,1
WP_TGFBETA_RECEPTOR_SIGNALING,SET,51,-0.036143,-0.0019013,0.13059,0.60902,WP_TGFBETA_RECEPTOR_SIGNALING,1
GOBP_GLUCOCORTICOID_METABOLI...,SET,24,-0.049021,-0.0017703,0.17712,0.60902,GOBP_GLUCOCORTICOID_METABOLIC_PROCESS,1
HP_FOCAL_SENSORY_SEIZURE_WIT...,SET,6,-0.082873,-0.0014971,0.29936,0.60905,HP_FOCAL_SENSORY_SEIZURE_WITH_VISUAL_FEATURES,1
GOBP_REGULATION_OF_LIPOPROTE...3,SET,21,-0.049508,-0.0016725,0.17882,0.60906,GOBP_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GOBP_RECEPTOR_MEDIATED_ENDOC...3,SET,10,-0.080322,-0.0018731,0.28996,0.60911,GOBP_RECEPTOR_MEDIATED_ENDOCYTOSIS_OF_VIRUS_BY_HOST_CELL,1
GOBP_CELLULAR_EXTRAVASATION,SET,69,-0.030358,-0.0018566,0.10959,0.60912,GOBP_CELLULAR_EXTRAVASATION,1
YIH_RESPONSE_TO_ARSENITE_C1,SET,21,-0.050799,-0.0017161,0.18323,0.6092,YIH_RESPONSE_TO_ARSENITE_C1,1
ER_Q6_02,SET,235,-0.015566,-0.0017488,0.056146,0.6092,ER_Q6_02,1
HP_PATENT_DUCTUS_ARTERIOSUS,SET,334,-0.01282,-0.0017124,0.04622,0.60925,HP_PATENT_DUCTUS_ARTERIOSUS,1
GOBP_INDOLALKYLAMINE_METABOL...,SET,11,-0.078493,-0.0019197,0.28274,0.60934,GOBP_INDOLALKYLAMINE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...252,SET,56,-0.034885,-0.0019227,0.12565,0.60935,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
HP_INCREASED_C_PEPTIDE_LEVEL,SET,13,-0.075076,-0.001996,0.27041,0.60935,HP_INCREASED_C_PEPTIDE_LEVEL,1
GOBP_RESPONSE_TO_LEPTIN,SET,21,-0.054263,-0.0018332,0.1954,0.60938,GOBP_RESPONSE_TO_LEPTIN,1
MORF_CDC10,SET,140,-0.018496,-0.0016082,0.066587,0.60941,MORF_CDC10,1
ATM_DN.V1_UP,SET,138,-0.020235,-0.0017468,0.072825,0.60944,ATM_DN.V1_UP,1
GSE16385_UNTREATED_VS_12H_RO...5,SET,165,-0.018121,-0.0017092,0.065171,0.60951,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_DN,1
WP_COPPER_HOMEOSTASIS,SET,49,-0.033853,-0.0017456,0.12172,0.60954,WP_COPPER_HOMEOSTASIS,1
MIR764,SET,46,-0.032314,-0.0016146,0.11612,0.6096,MIR764,1
GOBP_VESICLE_TARGETING_TO_FR...,SET,31,-0.037265,-0.0015292,0.13391,0.6096,GOBP_VESICLE_TARGETING_TO_FROM_OR_WITHIN_GOLGI,1
GOCC_POSTSYNAPTIC_RECYCLING_...,SET,7,-0.079466,-0.0015505,0.28542,0.60965,GOCC_POSTSYNAPTIC_RECYCLING_ENDOSOME,1
GOBP_REGULATION_OF_TELOMERE_...2,SET,94,-0.022866,-0.0016311,0.082055,0.60975,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE,1
GOBP_LABYRINTHINE_LAYER_MORP...,SET,20,-0.056964,-0.0018781,0.20439,0.60976,GOBP_LABYRINTHINE_LAYER_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...231,SET,33,-0.040461,-0.0017129,0.14514,0.60979,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_METABOLIC_PROCESS,1
REACTOME_METHIONINE_SALVAGE_...,SET,6,-0.11054,-0.001997,0.39635,0.60984,REACTOME_METHIONINE_SALVAGE_PATHWAY,1
MIR6859_3P,SET,33,-0.043298,-0.0018331,0.15522,0.60985,MIR6859_3P,1
TTTTGAG_MIR373,SET,213,-0.016082,-0.0017212,0.057656,0.60985,TTTTGAG_MIR373,1
LET_7F_1_3P,SET,663,-0.009393,-0.0017516,0.03367,0.60987,LET_7F_1_3P,1
BROWNE_HCMV_INFECTION_20HR_UP,SET,214,-0.016001,-0.0017165,0.057343,0.60989,BROWNE_HCMV_INFECTION_20HR_UP,1
WP_REGULATION_OF_ACTIN_CYTOS...,SET,140,-0.020904,-0.0018175,0.074886,0.60993,WP_REGULATION_OF_ACTIN_CYTOSKELETON,1
MIR5688,SET,715,-0.0091275,-0.0017649,0.032684,0.60998,MIR5688,1
BLANCO_MELO_COVID19_SARS_COV...7,SET,16,-0.059034,-0.001741,0.21134,0.61,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_DN,1
GSE33292_WT_VS_TCF1_KO_DN3_T...1,SET,189,-0.016293,-0.0016437,0.05833,0.61,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN,1
GOBP_EPITHELIAL_CELL_PROLIFE...4,SET,5,-0.11916,-0.0019651,0.42648,0.61003,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
HP_ABNORMAL_CIRCULATING_BILI...,SET,114,-0.022441,-0.0017619,0.080311,0.61004,HP_ABNORMAL_CIRCULATING_BILIRUBIN_CONCENTRATION,1
GSE16385_MONOCYTE_VS_12H_IL4...1,SET,188,-0.015916,-0.0016014,0.056916,0.61012,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN,1
HP_HIGH_NARROW_PALATE,SET,128,-0.019936,-0.0016579,0.071271,0.61015,HP_HIGH_NARROW_PALATE,1
MIR3663_3P,SET,134,-0.019807,-0.001685,0.070722,0.61028,MIR3663_3P,1
GSE25088_CTRL_VS_IL4_AND_ROS...1,SET,170,-0.0177,-0.0016944,0.063199,0.61029,GSE25088_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
GOBP_REGULATION_OF_STRIATED_...3,SET,18,-0.06397,-0.002001,0.22825,0.61036,GOBP_REGULATION_OF_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,1
REACTOME_INITIAL_TRIGGERING_...,SET,17,-0.06867,-0.0020875,0.24484,0.61044,REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT,1
SESTO_RESPONSE_TO_UV_C7,SET,64,-0.030971,-0.0018244,0.11041,0.61046,SESTO_RESPONSE_TO_UV_C7,1
GOMF_1_PHOSPHATIDYLINOSITOL_...6,SET,15,-0.062412,-0.0017823,0.22248,0.61046,GOMF_1_PHOSPHATIDYLINOSITOL_BINDING,1
STEIN_ESR1_TARGETS,SET,77,-0.028611,-0.001848,0.10194,0.61051,STEIN_ESR1_TARGETS,1
GOMF_CYTOKINE_BINDING,SET,130,-0.022062,-0.0018489,0.078608,0.61051,GOMF_CYTOKINE_BINDING,1
HP_UNILATERAL_RENAL_HYPOPLAS...,SET,4,-0.11831,-0.0017452,0.42139,0.61055,HP_UNILATERAL_RENAL_HYPOPLASIA,1
MIR5584_3P,SET,124,-0.022216,-0.0018187,0.079119,0.61056,MIR5584_3P,1
BRUINS_UVC_RESPONSE_VIA_TP53...3,SET,85,-0.025808,-0.0017511,0.091885,0.6106,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_C,1
REACTOME_FGFRL1_MODULATION_O...,SET,13,-0.073777,-0.0019614,0.26266,0.6106,REACTOME_FGFRL1_MODULATION_OF_FGFR1_SIGNALING,1
GOBP_P38MAPK_CASCADE,SET,53,-0.035032,-0.0018785,0.12469,0.61062,GOBP_P38MAPK_CASCADE,1
CUI_DEVELOPING_HEART_ENDOCAR...,SET,50,-0.036453,-0.0018988,0.12968,0.61068,CUI_DEVELOPING_HEART_ENDOCARDIAL_CELL,1
ABRAHAM_ALPC_VS_MULTIPLE_MYE...1,SET,20,-0.052243,-0.0017225,0.18585,0.61069,ABRAHAM_ALPC_VS_MULTIPLE_MYELOMA_DN,1
GOMF_RNA_POLYMERASE_II_C_TER...,SET,10,-0.065813,-0.0015347,0.23411,0.61069,GOMF_RNA_POLYMERASE_II_C_TERMINAL_DOMAIN_BINDING,1
GSE19923_E2A_KO_VS_HEB_AND_E...2,SET,180,-0.018208,-0.0017931,0.064744,0.61073,GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP,1
CRX_Q4,SET,247,-0.015775,-0.0018164,0.056056,0.6108,CRX_Q4,1
GSE9878_CTRL_VS_EBF_TRANSDUC...2,SET,190,-0.017301,-0.0017499,0.06148,0.6108,GSE9878_CTRL_VS_EBF_TRANSDUCED_PAX5_KO_PRO_BCELL_UP,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...5,SET,4,-0.11567,-0.0017062,0.41091,0.61083,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAH7.8_TO_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...1,SET,180,-0.018088,-0.0017813,0.064253,0.61084,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_129_MOUSE_DN,1
GOBP_REGULATION_OF_VENTRICUL...1,SET,12,-0.078547,-0.0020064,0.27862,0.61099,GOBP_REGULATION_OF_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
WP_METABOLIC_REPROGRAMMING_I...2,SET,41,-0.036651,-0.0017292,0.12994,0.61105,WP_METABOLIC_REPROGRAMMING_IN_PANCREATIC_CANCER,1
GOMF_ELECTRON_TRANSFER_ACTIV...,SET,96,-0.022047,-0.0015892,0.078142,0.61108,GOMF_ELECTRON_TRANSFER_ACTIVITY,1
GOMF_SUGAR_TRANSMEMBRANE_TRA...,SET,25,-0.048971,-0.0018049,0.17357,0.61108,GOMF_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_NEUROPATHIC_SPINAL_ARTHRO...,SET,20,-0.05234,-0.0017257,0.18549,0.61109,HP_NEUROPATHIC_SPINAL_ARTHROPATHY,1
GOBP_REGULATION_OF_SMALL_MOL...,SET,289,-0.014314,-0.0017808,0.050698,0.61116,GOBP_REGULATION_OF_SMALL_MOLECULE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...821,SET,12,-0.073757,-0.001884,0.26117,0.61118,GOBP_POSITIVE_REGULATION_OF_URINE_VOLUME,1
GOMF_N_ACYLTRANSFERASE_ACTIV...,SET,79,-0.025306,-0.0016556,0.089577,0.61122,GOMF_N_ACYLTRANSFERASE_ACTIVITY,1
STAT5B_01,SET,223,-0.016519,-0.0018086,0.058467,0.61123,STAT5B_01,1
GOBP_GLYCOSYL_COMPOUND_BIOSY...,SET,21,-0.050683,-0.0017122,0.17939,0.61123,GOBP_GLYCOSYL_COMPOUND_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_METH...,SET,15,-0.063435,-0.0018115,0.22448,0.61125,HP_ABNORMAL_CIRCULATING_METHIONINE_CONCENTRATION,1
HP_INCREASED_TOTAL_BILIRUBIN,SET,14,-0.059044,-0.001629,0.20883,0.61131,HP_INCREASED_TOTAL_BILIRUBIN,1
GSE14769_20MIN_VS_360MIN_LPS...2,SET,177,-0.01678,-0.0016388,0.059347,0.61131,GSE14769_20MIN_VS_360MIN_LPS_BMDM_UP,1
KEGG_BASAL_CELL_CARCINOMA,SET,53,-0.033407,-0.0017914,0.11811,0.61135,KEGG_BASAL_CELL_CARCINOMA,1
HP_INFLEXIBLE_ADHERENCE_TO_R...,SET,2,-0.18158,-0.0018941,0.64174,0.61139,HP_INFLEXIBLE_ADHERENCE_TO_ROUTINES,1
KEGG_MEDICUS_REFERENCE_IGF_I...1,SET,13,-0.069385,-0.0018447,0.24514,0.61143,KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_IL2_F...,SET,20,-0.059936,-0.0019761,0.21163,0.61149,KEGG_MEDICUS_REFERENCE_IL2_FAMILY_TO_JAK_STAT_SIGNALING_PATHWAY,1
WP_POLYCYSTIC_KIDNEY_DISEASE...,SET,82,-0.027396,-0.0018258,0.096708,0.61152,WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY,1
GOMF_PHOSPHOLIPASE_BINDING,SET,18,-0.057857,-0.0018098,0.20422,0.61153,GOMF_PHOSPHOLIPASE_BINDING,1
MIR6780B_3P,SET,56,-0.031901,-0.0017582,0.11255,0.61158,MIR6780B_3P,1
GOBP_PHOSPHATIDYLINOSITOL_ME...2,SET,147,-0.0189,-0.0016835,0.066666,0.6116,GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS,1
GSE7460_TREG_VS_TCONV_ACT_WI...1,SET,179,-0.01752,-0.0017206,0.061803,0.6116,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_DN,1
WP_INTRACELLULAR_TRAFFICKING...,SET,27,-0.04709,-0.0018036,0.16607,0.61162,WP_INTRACELLULAR_TRAFFICKING_PROTEINS_INVOLVED_IN_CMT_NEUROPATHY,1
MODULE_400,SET,18,-0.060451,-0.0018909,0.21312,0.61166,MODULE_400,1
BANDRES_RESPONSE_TO_CARMUSTI...2,SET,8,-0.077994,-0.0016269,0.27492,0.61168,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_UP,1
GOBP_AORTA_SMOOTH_MUSCLE_TIS...,SET,4,-0.12105,-0.0017857,0.4266,0.6117,GOBP_AORTA_SMOOTH_MUSCLE_TISSUE_MORPHOGENESIS,1
GOMF_ACTIN_BINDING,SET,400,-0.012314,-0.0017968,0.043397,0.6117,GOMF_ACTIN_BINDING,1
GOCC_TIGHT_JUNCTION,SET,116,-0.022606,-0.0017902,0.079623,0.61176,GOCC_TIGHT_JUNCTION,1
IRF2_01,SET,118,-0.022986,-0.0018359,0.080948,0.61178,IRF2_01,1
GOBP_MORPHOGENESIS_OF_AN_EPI...3,SET,60,-0.029233,-0.0016675,0.10293,0.61179,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_SHEET,1
WP_REGULATORY_CIRCUITS_OF_ST...,SET,72,-0.031098,-0.0019426,0.10948,0.61181,WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING,1
SA_G2_AND_M_PHASES,SET,8,-0.072584,-0.001514,0.25551,0.61182,SA_G2_AND_M_PHASES,1
REACTOME_RESPONSE_OF_EIF2AK1...,SET,14,-0.065205,-0.0017989,0.2295,0.61184,REACTOME_RESPONSE_OF_EIF2AK1_HRI_TO_HEME_DEFICIENCY,1
GSE17721_CTRL_VS_GARDIQUIMOD...10,SET,171,-0.017937,-0.0017221,0.063129,0.61184,GSE17721_CTRL_VS_GARDIQUIMOD_2H_BMDC_UP,1
GSE5589_LPS_VS_LPS_AND_IL6_S...6,SET,176,-0.017884,-0.0017417,0.062945,0.61184,GSE5589_LPS_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOCC_CHECKPOINT_CLAMP_COMPLEX,SET,5,-0.10674,-0.0017604,0.37552,0.61189,GOCC_CHECKPOINT_CLAMP_COMPLEX,1
REACTOME_DIFFERENTIATION_OF_...,SET,37,-0.041964,-0.001881,0.14751,0.61198,REACTOME_DIFFERENTIATION_OF_KERATINOCYTES_IN_INTERFOLLICULAR_EPIDERMIS_IN_MAMMALIAN_SKIN,1
IL15_UP.V1_UP,SET,164,-0.019034,-0.00179,0.066898,0.61199,IL15_UP.V1_UP,1
MIR539_5P,SET,341,-0.013253,-0.0017884,0.046578,0.612,MIR539_5P,1
GOMF_DEHYDROASCORBIC_ACID_TR...,SET,6,-0.090776,-0.0016399,0.31903,0.612,GOMF_DEHYDROASCORBIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE9988_LPS_VS_LPS_AND_ANTI_...2,SET,177,-0.018158,-0.0017733,0.063806,0.61201,GSE9988_LPS_VS_LPS_AND_ANTI_TREM1_MONOCYTE_UP,1
GSE20500_RETINOIC_ACID_VS_RA...2,SET,182,-0.018372,-0.0018192,0.064491,0.61213,GSE20500_RETINOIC_ACID_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,1
GOBP_REGULATION_OF_RESPIRATO...3,SET,22,-0.053357,-0.0018449,0.18728,0.61214,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE,1
HP_APLASIA_HYPOPLASIA_OF_THE...63,SET,116,-0.021606,-0.0017111,0.075835,0.61214,HP_APLASIA_HYPOPLASIA_OF_THE_RIBS,1
HP_TOENAIL_DYSPLASIA,SET,15,-0.068493,-0.0019559,0.24024,0.61222,HP_TOENAIL_DYSPLASIA,1
BOYLAN_MULTIPLE_MYELOMA_C_UP,SET,44,-0.037195,-0.0018178,0.13043,0.61224,BOYLAN_MULTIPLE_MYELOMA_C_UP,1
GOBP_NEGATIVE_REGULATION_OF_...124,SET,159,-0.019176,-0.0017758,0.06724,0.61225,GOBP_NEGATIVE_REGULATION_OF_CELL_PROJECTION_ORGANIZATION,1
KEGG_MEDICUS_PATHOGEN_ESCHER...7,SET,4,-0.12215,-0.0018018,0.4282,0.61227,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_LPA_GNA12_13_RHOA_SIGNALING_PATHWAY,1
GOCC_ACROSOMAL_VESICLE,SET,132,-0.021698,-0.0018322,0.076032,0.61232,GOCC_ACROSOMAL_VESICLE,1
GSE3982_EOSINOPHIL_VS_MAST_C...2,SET,178,-0.018123,-0.0017748,0.063505,0.61232,GSE3982_EOSINOPHIL_VS_MAST_CELL_UP,1
GSE23321_CENTRAL_VS_EFFECTOR...2,SET,182,-0.017997,-0.001782,0.063055,0.61233,GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,1
GAUTAM_EYE_IRIS_CILIARY_BODY...11,SET,112,-0.024039,-0.0018709,0.084227,0.61233,GAUTAM_EYE_IRIS_CILIARY_BODY_MONOCYTES,1
REACTOME_ACTIVATION_OF_NIMA_...,SET,7,-0.073941,-0.0014427,0.25898,0.61237,REACTOME_ACTIVATION_OF_NIMA_KINASES_NEK9_NEK6_NEK7,1
WP_TGFB_SMAD_SIGNALING,SET,11,-0.08564,-0.0020945,0.2999,0.61239,WP_TGFB_SMAD_SIGNALING,1
LEE_AGING_MUSCLE_DN,SET,38,-0.037972,-0.0017248,0.13292,0.61243,LEE_AGING_MUSCLE_DN,1
GSE20727_CTRL_VS_ROS_INHIBIT...2,SET,176,-0.017428,-0.0016973,0.061005,0.61244,GSE20727_CTRL_VS_ROS_INHIBITOR_TREATED_DC_UP,1
GOCC_U1_SNRNP,SET,18,-0.052081,-0.0016291,0.18227,0.61246,GOCC_U1_SNRNP,1
GOBP_PHOSPHATIDYLCHOLINE_BIO...,SET,26,-0.046055,-0.001731,0.16111,0.61251,GOBP_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,1
GSE18804_SPLEEN_MACROPHAGE_V...5,SET,174,-0.018537,-0.0017951,0.064776,0.61263,GSE18804_SPLEEN_MACROPHAGE_VS_TUMORAL_MACROPHAGE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...526,SET,11,-0.084249,-0.0020605,0.29429,0.61267,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
GOMF_CALCIUM_INDEPENDENT_PHO...,SET,9,-0.077928,-0.0017241,0.27216,0.61269,GOMF_CALCIUM_INDEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,1
WANG_SMARCE1_TARGETS_DN,SET,322,-0.013836,-0.0018153,0.048302,0.61273,WANG_SMARCE1_TARGETS_DN,1
GOBP_CELLULAR_RESPONSE_TO_CA...5,SET,137,-0.021059,-0.0018114,0.073485,0.61278,GOBP_CELLULAR_RESPONSE_TO_CARBOHYDRATE_STIMULUS,1
GSE3039_CD4_TCELL_VS_B2_BCEL...2,SET,183,-0.018299,-0.0018168,0.063844,0.6128,GSE3039_CD4_TCELL_VS_B2_BCELL_UP,1
GOCC_CYTOSOLIC_REGION,SET,19,-0.055068,-0.0017697,0.19209,0.61282,GOCC_CYTOSOLIC_REGION,1
REACTOME_COLLAGEN_BIOSYNTHES...,SET,65,-0.031807,-0.0018882,0.11093,0.61284,REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES,1
HP_POOR_FINE_MOTOR_COORDINAT...,SET,64,-0.030342,-0.0017874,0.10581,0.61285,HP_POOR_FINE_MOTOR_COORDINATION,1
HP_ELEVATED_CIRCULATING_GLUT...,SET,6,-0.096586,-0.0017449,0.33674,0.61288,HP_ELEVATED_CIRCULATING_GLUTARIC_ACID_CONCENTRATION,1
GOMF_LYSINE_N_METHYLTRANSFER...,SET,49,-0.034189,-0.001763,0.11916,0.61291,GOMF_LYSINE_N_METHYLTRANSFERASE_ACTIVITY,1
HP_INCREASED_JITTER_AT_SINGL...,SET,7,-0.10168,-0.001984,0.35436,0.61292,HP_INCREASED_JITTER_AT_SINGLE_FIBER_EMG,1
GOBP_NEGATIVE_REGULATION_OF_...151,SET,44,-0.035494,-0.0017346,0.12364,0.61297,GOBP_NEGATIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,1
HP_PROMINENT_NASAL_BRIDGE,SET,202,-0.016275,-0.0016968,0.056683,0.61299,HP_PROMINENT_NASAL_BRIDGE,1
GOBP_PROTEIN_LOCALIZATION_TO...34,SET,11,-0.064694,-0.0015822,0.22527,0.61301,GOBP_PROTEIN_LOCALIZATION_TO_NON_MOTILE_CILIUM,1
GSE41176_WT_VS_TAK1_KO_ANTI_...4,SET,183,-0.018214,-0.0018084,0.063402,0.61305,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP,1
HP_PROXIMAL_AMYOTROPHY,SET,48,-0.034218,-0.0017464,0.11909,0.61307,HP_PROXIMAL_AMYOTROPHY,1
HP_HAND_MUSCLE_ATROPHY,SET,48,-0.034579,-0.0017648,0.1203,0.61311,HP_HAND_MUSCLE_ATROPHY,1
HAY_BONE_MARROW_CD34_POS_LMPP,SET,6,-0.11184,-0.0020204,0.38909,0.61311,HAY_BONE_MARROW_CD34_POS_LMPP,1
HP_ABNORMAL_HEMOGLOBIN,SET,65,-0.0298,-0.0017691,0.10365,0.61313,HP_ABNORMAL_HEMOGLOBIN,1
REACTOME_NUCLEAR_PORE_COMPLE...,SET,34,-0.038482,-0.0016536,0.13362,0.61332,REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY,1
GOBP_LEPTIN_MEDIATED_SIGNALI...,SET,10,-0.076841,-0.0017919,0.26683,0.61332,GOBP_LEPTIN_MEDIATED_SIGNALING_PATHWAY,1
HP_ABNORMAL_TESTIS_MORPHOLOGY,SET,832,-0.0084515,-0.001757,0.029336,0.61336,HP_ABNORMAL_TESTIS_MORPHOLOGY,1
GSE25123_WT_VS_PPARG_KO_MACR...5,SET,178,-0.018459,-0.0018078,0.064074,0.61336,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_UP,1
GOBP_RESPONSE_TO_HEPARIN,SET,6,-0.12027,-0.0021727,0.41737,0.61339,GOBP_RESPONSE_TO_HEPARIN,1
HP_ABNORMAL_TEMPER_TANTRUMS,SET,29,-0.044216,-0.001755,0.15344,0.61339,HP_ABNORMAL_TEMPER_TANTRUMS,1
MIR1301_5P,SET,50,-0.03396,-0.0017689,0.11783,0.6134,MIR1301_5P,1
HP_ABNORMAL_PATTERN_ELECTROR...,SET,7,-0.096644,-0.0018857,0.33502,0.61351,HP_ABNORMAL_PATTERN_ELECTRORETINOGRAM,1
GOBP_POSITIVE_REGULATION_OF_...759,SET,6,-0.095147,-0.0017189,0.32979,0.61352,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_2_SIGNALING_PATHWAY,1
GOMF_LONG_CHAIN_FATTY_ACID_T...,SET,15,-0.061097,-0.0017447,0.21168,0.61357,GOMF_LONG_CHAIN_FATTY_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
TCCATTKW_UNKNOWN,SET,217,-0.016498,-0.001782,0.057124,0.61363,TCCATTKW_UNKNOWN,1
HP_SKEWFOOT,SET,6,-0.10719,-0.0019364,0.37087,0.61371,HP_SKEWFOOT,1
HP_SYNKINESIS,SET,28,-0.048831,-0.0019045,0.16889,0.61375,HP_SYNKINESIS,1
GSE3982_NEUTROPHIL_VS_CENT_M...2,SET,188,-0.017859,-0.001797,0.061757,0.61378,GSE3982_NEUTROPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,1
GOCC_PRESYNAPTIC_ACTIVE_ZONE...1,SET,16,-0.064195,-0.0018933,0.22191,0.61381,GOCC_PRESYNAPTIC_ACTIVE_ZONE_CYTOPLASMIC_COMPONENT,1
GOBP_VENTRICULAR_CARDIAC_MUS...3,SET,14,-0.075022,-0.0020698,0.25933,0.61382,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
HE_LIM_SUN_FETAL_LUNG_C4_ILC...3,SET,166,-0.02009,-0.0019007,0.069412,0.61387,HE_LIM_SUN_FETAL_LUNG_C4_ILCP_CELL,1
GSE17974_0H_VS_72H_IN_VITRO_...1,SET,170,-0.017912,-0.0017147,0.061881,0.61388,GSE17974_0H_VS_72H_IN_VITRO_ACT_CD4_TCELL_DN,1
ACTGTAG_MIR139,SET,109,-0.023824,-0.0018292,0.082277,0.61392,ACTGTAG_MIR139,1
GSE22601_DOUBLE_POSITIVE_VS_...2,SET,167,-0.018778,-0.0017818,0.06485,0.61392,GSE22601_DOUBLE_POSITIVE_VS_CD4_SINGLE_POSITIVE_THYMOCYTE_UP,1
GOBP_POSITIVE_REGULATION_OF_...16,SET,6,-0.10559,-0.0019076,0.36462,0.61394,GOBP_POSITIVE_REGULATION_OF_AGGREPHAGY,1
GSE25677_MPL_VS_MPL_AND_R848...1,SET,118,-0.022424,-0.001791,0.077417,0.61395,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_DN,1
WEST_ADRENOCORTICAL_TUMOR_UP,SET,280,-0.014446,-0.0017694,0.049865,0.61397,WEST_ADRENOCORTICAL_TUMOR_UP,1
GOBP_REGULATION_OF_NUCLEAR_T...3,SET,13,-0.065248,-0.0017347,0.22523,0.61397,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
MIR6809_5P,SET,125,-0.021816,-0.0017931,0.075297,0.61399,MIR6809_5P,1
HP_PATCHY_HYPOPIGMENTATION_O...,SET,21,-0.058126,-0.0019637,0.2006,0.614,HP_PATCHY_HYPOPIGMENTATION_OF_HAIR,1
MARTINEZ_TP53_TARGETS_UP,SET,570,-0.010317,-0.0017886,0.035603,0.61401,MARTINEZ_TP53_TARGETS_UP,1
GOBP_REGULATION_OF_HEART_CON...,SET,190,-0.018962,-0.001918,0.065426,0.61402,GOBP_REGULATION_OF_HEART_CONTRACTION,1
DODD_NASOPHARYNGEAL_CARCINOM...2,SET,1247,-0.0070552,-0.0017743,0.024335,0.61406,DODD_NASOPHARYNGEAL_CARCINOMA_UP,1
REACTOME_ESTROGEN_DEPENDENT_...1,SET,87,-0.025473,-0.0017484,0.08786,0.61406,REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION,1
HP_SPARSE_MEDIAL_EYEBROW,SET,5,-0.10971,-0.0018094,0.37844,0.61406,HP_SPARSE_MEDIAL_EYEBROW,1
HP_BASAL_GANGLIA_CYSTS,SET,6,-0.089287,-0.001613,0.30792,0.61408,HP_BASAL_GANGLIA_CYSTS,1
GOMF_MDM2_MDM4_FAMILY_PROTEI...,SET,10,-0.082575,-0.0019256,0.28475,0.61409,GOMF_MDM2_MDM4_FAMILY_PROTEIN_BINDING,1
HP_TRICHORRHEXIS_NODOSA,SET,9,-0.072074,-0.0015945,0.2485,0.6141,HP_TRICHORRHEXIS_NODOSA,1
CASTELLANO_HRAS_TARGETS_DN,SET,4,-0.11771,-0.0017363,0.40548,0.6142,CASTELLANO_HRAS_TARGETS_DN,1
DELACROIX_RAR_TARGETS_DN,SET,25,-0.051636,-0.0019031,0.17787,0.6142,DELACROIX_RAR_TARGETS_DN,1
GSE18281_SUBCAPSULAR_VS_CENT...1,SET,188,-0.017849,-0.001796,0.061482,0.61421,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_DN,1
GOCC_LUMENAL_SIDE_OF_MEMBRANE,SET,38,-0.039326,-0.0017863,0.13545,0.61422,GOCC_LUMENAL_SIDE_OF_MEMBRANE,1
HP_INCREASED_CIRCULATING_ACT...,SET,14,-0.065321,-0.0018021,0.22498,0.61422,HP_INCREASED_CIRCULATING_ACTH_LEVEL,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...2,SET,178,-0.017685,-0.0017319,0.06089,0.61426,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
REACTOME_GLYCOSPHINGOLIPID_M...,SET,50,-0.035875,-0.0018686,0.12351,0.61427,REACTOME_GLYCOSPHINGOLIPID_METABOLISM,1
GSE17186_BLOOD_VS_CORD_BLOOD...6,SET,186,-0.018022,-0.0018038,0.062043,0.61427,GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP,1
LINSLEY_MIR16_TARGETS,SET,193,-0.016795,-0.001712,0.057807,0.61429,LINSLEY_MIR16_TARGETS,1
GOMF_IGG_BINDING,SET,10,-0.089528,-0.0020878,0.30814,0.6143,GOMF_IGG_BINDING,1
GOBP_PROTEIN_LOCALIZATION_TO...49,SET,71,-0.029555,-0.0018334,0.10166,0.61436,GOBP_PROTEIN_LOCALIZATION_TO_SYNAPSE,1
chr6p12,SET,59,-0.058566,-0.0033129,0.20144,0.61437,chr6p12,1
GOBP_SEMAPHORIN_PLEXIN_SIGNA...,SET,42,-0.040335,-0.0019259,0.13868,0.61441,GOBP_SEMAPHORIN_PLEXIN_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...283,SET,6,-0.099809,-0.0018031,0.343,0.61447,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,1
REACTOME_NEUROTRANSMITTER_RE...2,SET,47,-0.039942,-0.0020172,0.13724,0.61448,REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE,1
GOBP_MICROTUBULE_ORGANIZING_...1,SET,30,-0.042338,-0.0017091,0.14539,0.61455,GOBP_MICROTUBULE_ORGANIZING_CENTER_LOCALIZATION,1
WP_MIRNA_TARGETS_IN_ECM_AND_...,SET,22,-0.057774,-0.0019977,0.19834,0.61458,WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS,1
TDRD3_TARGET_GENES,SET,3,-0.12952,-0.0016547,0.44421,0.61469,TDRD3_TARGET_GENES,1
HP_PITUITARY_GROWTH_HORMONE_...,SET,16,-0.057417,-0.0016933,0.19691,0.6147,HP_PITUITARY_GROWTH_HORMONE_CELL_ADENOMA,1
HP_PERIPHERAL_EDEMA,SET,12,-0.074065,-0.0018919,0.25395,0.61472,HP_PERIPHERAL_EDEMA,1
WP_MITOCHONDRIAL_FATTY_ACID_...2,SET,12,-0.075201,-0.0019209,0.25782,0.61473,WP_MITOCHONDRIAL_FATTY_ACID_SYNTHESIS_AND_RESPIRATION,1
GOBP_CHROMOSOME_SEGREGATION,SET,383,-0.012026,-0.0017178,0.041224,0.61475,GOBP_CHROMOSOME_SEGREGATION,1
GOBP_PROTEIN_LOCALIZATION_TO...33,SET,4,-0.11991,-0.0017688,0.41101,0.61476,GOBP_PROTEIN_LOCALIZATION_TO_MOTILE_CILIUM,1
DESCARTES_FETAL_HEART_CARDIO...,SET,6,-0.10789,-0.001949,0.3698,0.61476,DESCARTES_FETAL_HEART_CARDIOMYOCYTES,1
GSE34156_NOD2_LIGAND_VS_NOD2...3,SET,182,-0.018428,-0.0018247,0.063154,0.61477,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
HP_HEPATIC_FAILURE,SET,133,-0.020928,-0.0017738,0.071719,0.61478,HP_HEPATIC_FAILURE,1
HOEK_NEUTROPHIL_2011_2012_TI...1,SET,50,-0.034585,-0.0018014,0.1185,0.6148,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_DN,1
WP_PURINE_METABOLISM_AND_REL...,SET,20,-0.056286,-0.0018557,0.19279,0.61484,WP_PURINE_METABOLISM_AND_RELATED_DISORDERS,1
GSE1460_INTRATHYMIC_T_PROGEN...9,SET,174,-0.020041,-0.0019408,0.068643,0.61484,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN,1
GAO_STOMACH_24W_C5_PUTATIVE_...,SET,51,-0.035685,-0.0018772,0.12216,0.6149,GAO_STOMACH_24W_C5_PUTATIVE_PIT_CELL_PROGENITOR,1
MIR150_3P,SET,119,-0.022407,-0.0017972,0.076702,0.61491,MIR150_3P,1
MASRI_RESISTANCE_TO_TAMOXIFE...1,SET,16,-0.067521,-0.0019913,0.23094,0.615,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_DN,1
GOCC_B_WICH_COMPLEX,SET,7,-0.086739,-0.0016925,0.2966,0.61502,GOCC_B_WICH_COMPLEX,1
AP1_Q6_01,SET,239,-0.016256,-0.0018416,0.055576,0.61504,AP1_Q6_01,1
GOMF_DENEDDYLASE_ACTIVITY,SET,6,-0.091424,-0.0016516,0.31232,0.61513,GOMF_DENEDDYLASE_ACTIVITY,1
KRIEG_HYPOXIA_VIA_KDM3A,SET,46,-0.039073,-0.0019523,0.13347,0.61514,KRIEG_HYPOXIA_VIA_KDM3A,1
REACTOME_SIGNALING_BY_WNT,SET,260,-0.015259,-0.001802,0.052099,0.61519,REACTOME_SIGNALING_BY_WNT,1
GSE2405_S_AUREUS_VS_UNTREATE...2,SET,173,-0.01738,-0.0016783,0.059337,0.6152,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_UP,1
AFP1_Q6,SET,237,-0.017249,-0.0019461,0.058886,0.61521,AFP1_Q6,1
GOMF_PROTEIN_DEMETHYLASE_ACT...,SET,24,-0.047537,-0.0017167,0.16219,0.61527,GOMF_PROTEIN_DEMETHYLASE_ACTIVITY,1
REACTOME_SODIUM_CALCIUM_EXCH...,SET,11,-0.088022,-0.0021528,0.3003,0.61528,REACTOME_SODIUM_CALCIUM_EXCHANGERS,1
TONKS_TARGETS_OF_RUNX1_RUNX1...11,SET,14,-0.071214,-0.0019647,0.24293,0.61529,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_UP,1
GSE7460_TREG_VS_TCONV_ACT_UP,SET,175,-0.019368,-0.0018809,0.066048,0.61533,GSE7460_TREG_VS_TCONV_ACT_UP,1
HP_PLATYSPONDYLY,SET,108,-0.023752,-0.0018154,0.080995,0.61534,HP_PLATYSPONDYLY,1
GSE40666_STAT1_KO_VS_STAT4_K...2,SET,172,-0.017215,-0.0016576,0.058689,0.61536,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_UP,1
HP_ABNORMAL_SPINAL_MENINGEAL...,SET,22,-0.055133,-0.0019064,0.18791,0.61539,HP_ABNORMAL_SPINAL_MENINGEAL_MORPHOLOGY,1
MIR889_5P,SET,110,-0.02358,-0.0018187,0.0803,0.61548,MIR889_5P,1
GSE29614_CTRL_VS_TIV_FLU_VAC...1,SET,152,-0.020113,-0.0018215,0.068498,0.61548,GSE29614_CTRL_VS_TIV_FLU_VACCINE_PBMC_2007_DN,1
GSE23114_WT_VS_SLE2C1_MOUSE_...4,SET,191,-0.017278,-0.0017522,0.058828,0.61551,GSE23114_WT_VS_SLE2C1_MOUSE_SPLEEN_B1A_BCELL_UP,1
BHATI_G2M_ARREST_BY_2METHOXY...2,SET,107,-0.02343,-0.0017825,0.079726,0.61557,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP,1
GSE3039_ALPHAALPHA_CD8_TCELL...4,SET,181,-0.018549,-0.0018317,0.06312,0.61557,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP,1
GOBP_PROTEIN_K63_LINKED_UBIQ...,SET,64,-0.029564,-0.0017415,0.10057,0.6156,GOBP_PROTEIN_K63_LINKED_UBIQUITINATION,1
GSE6674_ANTI_IGM_VS_ANTI_IGM...1,SET,177,-0.018169,-0.0017744,0.06181,0.6156,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
GOBP_REGULATION_OF_ALDOSTERO...,SET,8,-0.096374,-0.0020102,0.32776,0.61563,GOBP_REGULATION_OF_ALDOSTERONE_METABOLIC_PROCESS,1
GSE14308_TH17_VS_NAIVE_CD4_T...1,SET,182,-0.018273,-0.0018094,0.062107,0.6157,GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN,1
GOBP_RESPONSE_TO_ALDOSTERONE,SET,17,-0.062582,-0.0019024,0.21266,0.61572,GOBP_RESPONSE_TO_ALDOSTERONE,1
GOCC_RNA_POLYMERASE_I_TRANSC...,SET,5,-0.10028,-0.0016538,0.34065,0.61576,GOCC_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATOR_COMPLEX,1
GOCC_RNA_POLYMERASE_TRANSCRI...,SET,5,-0.10028,-0.0016538,0.34065,0.61576,GOCC_RNA_POLYMERASE_TRANSCRIPTION_FACTOR_SL1_COMPLEX,1
ATF6_01,SET,118,-0.022134,-0.0017678,0.075169,0.61579,ATF6_01,1
GOMF_NADPLUS_PROTEIN_CYSTEIN...,SET,6,-0.10148,-0.0018332,0.34459,0.6158,GOMF_NADPLUS_PROTEIN_CYSTEINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
MIR1263,SET,50,-0.036695,-0.0019114,0.12456,0.61585,MIR1263,1
WP_TCELL_ANTIGEN_RECEPTOR_TC...,SET,59,-0.032527,-0.00184,0.11037,0.61589,WP_TCELL_ANTIGEN_RECEPTOR_TCR_PATHWAY_DURING_STAPHYLOCOCCUS_AUREUS_INFECTION,1
YAUCH_HEDGEHOG_SIGNALING_PAR...2,SET,132,-0.022975,-0.0019401,0.077922,0.61594,YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP,1
MIR216B_5P,SET,85,-0.027,-0.0018319,0.091549,0.61597,MIR216B_5P,1
NATSUME_RESPONSE_TO_INTERFER...2,SET,69,-0.03143,-0.0019222,0.10651,0.61604,NATSUME_RESPONSE_TO_INTERFERON_BETA_UP,1
HP_IMPAIRED_EXECUTIVE_FUNCTI...,SET,9,-0.0829,-0.001834,0.28075,0.61611,HP_IMPAIRED_EXECUTIVE_FUNCTIONING,1
GSE7568_IL4_TGFB_DEXAMETHASO...2,SET,154,-0.018467,-0.0016833,0.062537,0.61611,GSE7568_IL4_TGFB_DEXAMETHASONE_VS_IL4_TGFB_TREATED_MACROPHAGE_UP,1
HP_DECREASED_DLCO,SET,22,-0.05216,-0.0018035,0.17655,0.61617,HP_DECREASED_DLCO,1
GOBP_AGGREPHAGY,SET,16,-0.057146,-0.0016854,0.19339,0.61619,GOBP_AGGREPHAGY,1
GOBP_RESPONSE_TO_GROWTH_FACT...,SET,663,-0.010258,-0.0019129,0.03471,0.61621,GOBP_RESPONSE_TO_GROWTH_FACTOR,1
REACTOME_HIV_TRANSCRIPTION_E...,SET,38,-0.033461,-0.0015199,0.11319,0.61624,REACTOME_HIV_TRANSCRIPTION_ELONGATION,1
GOBP_REGULATION_OF_URINE_VOL...,SET,19,-0.061871,-0.0019883,0.20916,0.61631,GOBP_REGULATION_OF_URINE_VOLUME,1
GOMF_CARNITINE_TRANSMEMBRANE...,SET,5,-0.14741,-0.0024311,0.49834,0.61631,GOMF_CARNITINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_BRONCHOALVEOLAR_...,SET,14,-0.077848,-0.0021477,0.263,0.61638,HP_ABNORMAL_BRONCHOALVEOLAR_LAVAGE_FLUID_MORPHOLOGY,1
GOBP_FACIAL_NERVE_STRUCTURAL...,SET,8,-0.098889,-0.0020627,0.33407,0.61639,GOBP_FACIAL_NERVE_STRUCTURAL_ORGANIZATION,1
GSE29618_BCELL_VS_PDC_DAY7_F...1,SET,181,-0.019253,-0.0019012,0.065025,0.61642,GSE29618_BCELL_VS_PDC_DAY7_FLU_VACCINE_DN,1
GOMF_ATPASE_COUPLED_ION_TRAN...,SET,22,-0.052523,-0.0018161,0.17728,0.61649,GOMF_ATPASE_COUPLED_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR2276_3P,SET,109,-0.02406,-0.0018474,0.081184,0.61652,MIR2276_3P,1
GSE13493_CD4INTCD8POS_VS_CD8...1,SET,182,-0.017836,-0.0017661,0.060183,0.61652,GSE13493_CD4INTCD8POS_VS_CD8POS_THYMOCYTE_DN,1
DESCARTES_FETAL_STOMACH_PDE1...,SET,20,-0.05769,-0.001902,0.19445,0.61664,DESCARTES_FETAL_STOMACH_PDE1C_ACSM3_POSITIVE_CELLS,1
HP_PARTIAL_DUPLICATION_OF_TH...2,SET,38,-0.037321,-0.0016952,0.12578,0.61665,HP_PARTIAL_DUPLICATION_OF_THE_PHALANX_OF_HAND,1
GOBP_ESTABLISHMENT_OF_SPINDL...,SET,42,-0.037947,-0.0018119,0.12782,0.61672,GOBP_ESTABLISHMENT_OF_SPINDLE_ORIENTATION,1
SMID_BREAST_CANCER_RELAPSE_I...5,SET,10,-0.077699,-0.0018119,0.26157,0.61678,SMID_BREAST_CANCER_RELAPSE_IN_LIVER_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...3,SET,8,-0.090572,-0.0018892,0.30472,0.61685,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
GOMF_GALACTOSYLTRANSFERASE_A...,SET,32,-0.047763,-0.0019913,0.16067,0.61687,GOMF_GALACTOSYLTRANSFERASE_ACTIVITY,1
MIR6893_5P,SET,163,-0.019816,-0.0018579,0.066647,0.61689,MIR6893_5P,1
HP_JOINT_SWELLING,SET,46,-0.040996,-0.0020484,0.13786,0.61691,HP_JOINT_SWELLING,1
MIR642A_3P_MIR642B_3P,SET,126,-0.02232,-0.0018417,0.07505,0.61692,MIR642A_3P_MIR642B_3P,1
HP_CONNECTIVE_TISSUE_NEVI,SET,6,-0.11164,-0.0020168,0.37533,0.61693,HP_CONNECTIVE_TISSUE_NEVI,1
GSE13306_TREG_VS_TCONV_UP,SET,187,-0.018415,-0.001848,0.061885,0.61698,GSE13306_TREG_VS_TCONV_UP,1
MIR6881_3P,SET,160,-0.019942,-0.0018526,0.067006,0.617,MIR6881_3P,1
MODULE_571,SET,14,-0.070492,-0.0019448,0.23685,0.617,MODULE_571,1
WP_VALPROIC_ACID_PATHWAY,SET,11,-0.074937,-0.0018327,0.25171,0.61704,WP_VALPROIC_ACID_PATHWAY,1
BUSSLINGER_DUODENAL_TUFT_CEL...,SET,71,-0.033148,-0.0020563,0.1113,0.61708,BUSSLINGER_DUODENAL_TUFT_CELLS,1
WP_CANCER_IMMUNOTHERAPY_BY_P...,SET,22,-0.056129,-0.0019408,0.18843,0.6171,WP_CANCER_IMMUNOTHERAPY_BY_PD1_BLOCKADE,1
SAFFORD_T_LYMPHOCYTE_ANERGY,SET,85,-0.0279,-0.001893,0.093652,0.61711,SAFFORD_T_LYMPHOCYTE_ANERGY,1
HP_INCREASED_CIRCULATING_LAC...2,SET,73,-0.030605,-0.001925,0.10274,0.61711,HP_INCREASED_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,1
MIR4529_3P,SET,43,-0.038658,-0.0018677,0.12974,0.61713,MIR4529_3P,1
GOBP_NEGATIVE_REGULATION_OF_...224,SET,3,-0.15858,-0.0020259,0.5317,0.61724,GOBP_NEGATIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
LI_PBMC_MENACTRA_AGE_18_45YO...7,SET,34,-0.049046,-0.0021075,0.16442,0.61726,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE,1
HP_DECREASED_MUSCLE_MASS,SET,53,-0.033857,-0.0018155,0.1135,0.61727,HP_DECREASED_MUSCLE_MASS,1
MIR4699_3P,SET,440,-0.012395,-0.0018947,0.041544,0.61728,MIR4699_3P,1
KEGG_NEUROTROPHIN_SIGNALING_...,SET,120,-0.023127,-0.0018626,0.077508,0.61729,KEGG_NEUROTROPHIN_SIGNALING_PATHWAY,1
GSE17721_PAM3CSK4_VS_CPG_24H...1,SET,182,-0.018035,-0.0017858,0.060443,0.61729,GSE17721_PAM3CSK4_VS_CPG_24H_BMDC_DN,1
HP_CSF_PLEOCYTOSIS,SET,23,-0.051629,-0.0018253,0.173,0.61731,HP_CSF_PLEOCYTOSIS,1
HP_ABNORMAL_TRICUSPID_VALVE_...1,SET,35,-0.046789,-0.0020399,0.15674,0.61734,HP_ABNORMAL_TRICUSPID_VALVE_MORPHOLOGY,1
GOBP_EPITHELIAL_TUBE_MORPHOG...,SET,315,-0.014579,-0.0018922,0.04878,0.61748,GOBP_EPITHELIAL_TUBE_MORPHOGENESIS,1
GOBP_RESPONSE_TO_MOLECULE_OF...1,SET,326,-0.01485,-0.0019602,0.049677,0.6175,GOBP_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,1
GOBP_SPERM_FLAGELLUM_ASSEMBLY,SET,42,-0.036113,-0.0017244,0.12074,0.61756,GOBP_SPERM_FLAGELLUM_ASSEMBLY,1
GOBP_INTRINSIC_APOPTOTIC_SIG...8,SET,10,-0.078404,-0.0018283,0.26193,0.61766,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
GOMF_CAMP_DEPENDENT_PROTEIN_...3,SET,12,-0.071969,-0.0018384,0.24041,0.61767,GOMF_CAMP_DEPENDENT_PROTEIN_KINASE_REGULATOR_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_FIBRO...13,SET,48,-0.040264,-0.002055,0.13448,0.61768,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_HYPOXIA,1
GOBP_CELL_FATE_SPECIFICATION...,SET,7,-0.093499,-0.0018244,0.31227,0.61769,GOBP_CELL_FATE_SPECIFICATION_INVOLVED_IN_PATTERN_SPECIFICATION,1
GOBP_NEGATIVE_REGULATION_OF_...577,SET,23,-0.04675,-0.0016528,0.15613,0.61769,GOBP_NEGATIVE_REGULATION_OF_RNA_SPLICING,1
GOBP_REGULATION_OF_IRE1_MEDI...,SET,14,-0.073558,-0.0020294,0.24562,0.61771,GOBP_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
GSE3039_ALPHABETA_CD8_TCELL_...1,SET,179,-0.018684,-0.0018349,0.062361,0.61776,GSE3039_ALPHABETA_CD8_TCELL_VS_B1_BCELL_DN,1
GOBP_LUNG_LOBE_DEVELOPMENT,SET,7,-0.11325,-0.0022097,0.37796,0.61777,GOBP_LUNG_LOBE_DEVELOPMENT,1
HP_MACULAR_COLOBOMA,SET,10,-0.081729,-0.0019059,0.27277,0.61777,HP_MACULAR_COLOBOMA,1
GSE2770_IL12_ACT_VS_ACT_CD4_...2,SET,167,-0.01974,-0.0018731,0.065866,0.61779,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_UP,1
MIR216B_3P,SET,115,-0.023046,-0.0018172,0.076896,0.6178,MIR216B_3P,1
GOBP_HORMONE_TRANSPORT,SET,304,-0.015144,-0.0019315,0.05053,0.6178,GOBP_HORMONE_TRANSPORT,1
GOBP_REGULATION_OF_SKELETAL_...1,SET,5,-0.09238,-0.0015235,0.30811,0.61784,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ACETYLCHOLINE_GATED_CHANNEL_CLUSTERING,1
TARTE_PLASMA_CELL_VS_PLASMAB...2,SET,354,-0.014218,-0.0019541,0.047406,0.61788,TARTE_PLASMA_CELL_VS_PLASMABLAST_UP,1
GOBP_REGULATION_OF_CILIUM_BE...1,SET,15,-0.063587,-0.0018158,0.21191,0.61793,GOBP_REGULATION_OF_CILIUM_BEAT_FREQUENCY,1
POU3F2_02,SET,228,-0.017087,-0.0018913,0.056925,0.61797,POU3F2_02,1
MIR4999_5P,SET,81,-0.02785,-0.0018448,0.092719,0.61805,MIR4999_5P,1
GOBP_THELARCHE,SET,4,-0.14828,-0.0021873,0.49364,0.61805,GOBP_THELARCHE,1
GOMF_LIPASE_BINDING,SET,6,-0.11085,-0.0020025,0.36896,0.61807,GOMF_LIPASE_BINDING,1
GOBP_VASODILATION,SET,45,-0.042558,-0.0021033,0.14165,0.61808,GOBP_VASODILATION,1
HP_ABNORMAL_CIRCULATING_ATRI...,SET,8,-0.072047,-0.0015028,0.23972,0.61812,HP_ABNORMAL_CIRCULATING_ATRIAL_NATRIURETIC_PEPTIDE_PRO_HORMONE_CONCENTRATION,1
GOBP_TRANSCRIPTION_DEPENDENT...,SET,7,-0.092098,-0.001797,0.30628,0.61817,GOBP_TRANSCRIPTION_DEPENDENT_TETHERING_OF_RNA_POLYMERASE_II_GENE_DNA_AT_NUCLEAR_PERIPHERY,1
HP_ENURESIS,SET,29,-0.049344,-0.0019585,0.16407,0.61819,HP_ENURESIS,1
HP_SCHIZOPHRENIA,SET,61,-0.036134,-0.0020783,0.12016,0.61819,HP_SCHIZOPHRENIA,1
REACTOME_APOPTOTIC_CLEAVAGE_...2,SET,11,-0.085534,-0.0020919,0.2843,0.61823,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELL_ADHESION_PROTEINS,1
GOMF_BIS_5_ADENOSYL_PENTAPHO...,SET,3,-0.18695,-0.0023883,0.62095,0.61832,GOMF_BIS_5_ADENOSYL_PENTAPHOSPHATASE_ACTIVITY,1
GSE14000_UNSTIM_VS_4H_LPS_DC...4,SET,173,-0.01803,-0.001741,0.059877,0.61834,GSE14000_UNSTIM_VS_4H_LPS_DC_UP,1
WESTON_VEGFA_TARGETS_3HR,SET,59,-0.035628,-0.0020154,0.1183,0.61835,WESTON_VEGFA_TARGETS_3HR,1
GOBP_OTIC_VESICLE_MORPHOGENE...,SET,10,-0.076574,-0.0017857,0.25425,0.61836,GOBP_OTIC_VESICLE_MORPHOGENESIS,1
GOCC_AMPHISOME,SET,13,-0.067433,-0.0017928,0.22377,0.61842,GOCC_AMPHISOME,1
REACTOME_MICRORNA_MIRNA_BIOG...,SET,24,-0.047544,-0.001717,0.15775,0.61844,REACTOME_MICRORNA_MIRNA_BIOGENESIS,1
REACTOME_APOPTOTIC_CLEAVAGE_...1,SET,35,-0.042931,-0.0018717,0.14241,0.61847,REACTOME_APOPTOTIC_CLEAVAGE_OF_CELLULAR_PROTEINS,1
GOBP_CARDIAC_VASCULAR_SMOOTH...,SET,8,-0.10342,-0.0021571,0.34303,0.61847,GOBP_CARDIAC_VASCULAR_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GOCC_IRON_SULFUR_CLUSTER_ASS...,SET,8,-0.090455,-0.0018868,0.29987,0.61854,GOCC_IRON_SULFUR_CLUSTER_ASSEMBLY_COMPLEX,1
SA_TRKA_RECEPTOR,SET,16,-0.060059,-0.0017713,0.19907,0.61856,SA_TRKA_RECEPTOR,1
REACTOME_INTRINSIC_PATHWAY_F...,SET,52,-0.035999,-0.0019121,0.11932,0.61856,REACTOME_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1
KAAB_FAILED_HEART_ATRIUM_DN,SET,133,-0.021586,-0.0018296,0.071503,0.61863,KAAB_FAILED_HEART_ATRIUM_DN,1
GOBP_PLATELET_DERIVED_GROWTH...2,SET,14,-0.072131,-0.00199,0.23893,0.61863,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,1
MIR4422,SET,416,-0.013029,-0.0019378,0.043131,0.6187,MIR4422,1
GAUTSCHI_SRC_SIGNALING,SET,8,-0.096715,-0.0020174,0.32003,0.61875,GAUTSCHI_SRC_SIGNALING,1
MIR421,SET,160,-0.020078,-0.0018652,0.066438,0.61875,MIR421,1
GOBP_GALACTOSE_CATABOLIC_PRO...2,SET,5,-0.10638,-0.0017544,0.35202,0.61875,GOBP_GALACTOSE_CATABOLIC_PROCESS_VIA_UDP_GALACTOSE,1
WP_DEGRADATION_PATHWAY_OF_SP...,SET,15,-0.073396,-0.0020959,0.24284,0.61876,WP_DEGRADATION_PATHWAY_OF_SPHINGOLIPIDS_INCLUDING_DISEASES,1
MODULE_154,SET,67,-0.032606,-0.0019651,0.10788,0.61876,MODULE_154,1
GOBP_SELF_PROTEOLYSIS,SET,12,-0.078217,-0.001998,0.25874,0.61879,GOBP_SELF_PROTEOLYSIS,1
GOBP_PLACENTA_BLOOD_VESSEL_D...,SET,29,-0.049556,-0.0019669,0.16391,0.6188,GOBP_PLACENTA_BLOOD_VESSEL_DEVELOPMENT,1
HP_PATENT_DUCTUS_ARTERIOSUS_...,SET,5,-0.10686,-0.0017624,0.35336,0.61883,HP_PATENT_DUCTUS_ARTERIOSUS_AFTER_BIRTH_AT_TERM,1
TTTGTAG_MIR520D,SET,311,-0.014994,-0.0019339,0.049569,0.61886,TTTGTAG_MIR520D,1
GOBP_CORPUS_CALLOSUM_MORPHOG...,SET,5,-0.10903,-0.001798,0.3604,0.61887,GOBP_CORPUS_CALLOSUM_MORPHOGENESIS,1
MIR196A_5P_MIR196B_5P,SET,85,-0.026719,-0.0018129,0.088314,0.61888,MIR196A_5P_MIR196B_5P,1
GOBP_OVARIAN_FOLLICLE_DEVELO...,SET,55,-0.036024,-0.0019677,0.11907,0.61888,GOBP_OVARIAN_FOLLICLE_DEVELOPMENT,1
GOCC_COLLAGEN_TYPE_IV_TRIMER,SET,4,-0.14415,-0.0021264,0.47644,0.61888,GOCC_COLLAGEN_TYPE_IV_TRIMER,1
HP_SPONTANEOUS_PNEUMOTHORAX,SET,14,-0.075467,-0.0020821,0.24943,0.61888,HP_SPONTANEOUS_PNEUMOTHORAX,1
GOMF_HYDROLASE_ACTIVITY_ACTI...4,SET,32,-0.050116,-0.0020894,0.16559,0.61892,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDINES,1
REACTOME_RECEPTOR_MEDIATED_M...,SET,10,-0.076917,-0.0017937,0.25413,0.61893,REACTOME_RECEPTOR_MEDIATED_MITOPHAGY,1
KEGG_MEDICUS_REFERENCE_N_GLY...1,SET,16,-0.065723,-0.0019383,0.21709,0.61895,KEGG_MEDICUS_REFERENCE_N_GLYCAN_BIOSYNTHESIS,1
GOBP_PYRIMIDINE_NUCLEOSIDE_M...2,SET,14,-0.064259,-0.0017728,0.21223,0.61897,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_PLATELET_ACTIVATING_FAC...,SET,8,-0.088856,-0.0018534,0.29342,0.61899,GOBP_PLATELET_ACTIVATING_FACTOR_METABOLIC_PROCESS,1
GOMF_LYSINE_N_ACETYLTRANSFER...,SET,6,-0.10604,-0.0019157,0.34976,0.61912,GOMF_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY_ACTING_ON_ACETYL_PHOSPHATE_AS_DONOR,1
GOCC_GBAF_COMPLEX,SET,12,-0.073847,-0.0018863,0.24338,0.61922,GOCC_GBAF_COMPLEX,1
OCT_Q6,SET,217,-0.018189,-0.0019647,0.059926,0.61925,OCT_Q6,1
GOMF_ACID_THIOL_LIGASE_ACTIV...,SET,29,-0.047914,-0.0019018,0.15781,0.61929,GOMF_ACID_THIOL_LIGASE_ACTIVITY,1
FARMER_BREAST_CANCER_APOCRIN...1,SET,297,-0.015423,-0.0019447,0.050775,0.61934,FARMER_BREAST_CANCER_APOCRINE_VS_BASAL,1
GOCC_CYTOLYTIC_GRANULE,SET,14,-0.079189,-0.0021847,0.26059,0.61939,GOCC_CYTOLYTIC_GRANULE,1
GSE19198_CTRL_VS_IL21_TREATE...4,SET,183,-0.019832,-0.0019691,0.065262,0.61939,GSE19198_CTRL_VS_IL21_TREATED_TCELL_24H_UP,1
GOMF_G_PROTEIN_ACTIVITY,SET,46,-0.036286,-0.0018131,0.11928,0.61951,GOMF_G_PROTEIN_ACTIVITY,1
GOMF_C_X3_C_CHEMOKINE_BINDING,SET,5,-0.12289,-0.0020267,0.40361,0.61962,GOMF_C_X3_C_CHEMOKINE_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...726,SET,11,-0.086769,-0.0021221,0.28483,0.61968,GOBP_POSITIVE_REGULATION_OF_STEROID_HORMONE_SECRETION,1
GOMF_CARBOHYDRATE_BINDING,SET,248,-0.017424,-0.0020104,0.057195,0.61968,GOMF_CARBOHYDRATE_BINDING,1
GSE14415_NATURAL_TREG_VS_TCO...2,SET,146,-0.022045,-0.001957,0.072364,0.61968,GSE14415_NATURAL_TREG_VS_TCONV_UP,1
GSE3039_NKT_CELL_VS_ALPHABET...2,SET,183,-0.018179,-0.0018049,0.059667,0.61969,GSE3039_NKT_CELL_VS_ALPHABETA_CD8_TCELL_UP,1
REACTOME_LDL_CLEARANCE,SET,19,-0.060441,-0.0019423,0.19835,0.6197,REACTOME_LDL_CLEARANCE,1
HP_COMPLEX_FEBRILE_SEIZURE,SET,15,-0.063526,-0.0018141,0.20833,0.61979,HP_COMPLEX_FEBRILE_SEIZURE,1
GSE1460_CORD_VS_ADULT_BLOOD_...1,SET,176,-0.018887,-0.0018394,0.061921,0.61982,GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_DN,1
GOBP_RESPONSE_TO_INTERLEUKIN...4,SET,11,-0.089524,-0.0021895,0.29322,0.61994,GOBP_RESPONSE_TO_INTERLEUKIN_15,1
GOBP_CARDIOLIPIN_BIOSYNTHETI...,SET,7,-0.10087,-0.0019682,0.33032,0.61996,GOBP_CARDIOLIPIN_BIOSYNTHETIC_PROCESS,1
GSE3982_CTRL_VS_IGE_STIM_MAS...1,SET,180,-0.018517,-0.0018235,0.060621,0.61999,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...476,SET,7,-0.11279,-0.0022008,0.36918,0.62001,GOBP_NEGATIVE_REGULATION_OF_P38MAPK_CASCADE,1
GSE27786_LIN_NEG_VS_CD4_TCEL...2,SET,180,-0.018317,-0.0018038,0.059951,0.62002,GSE27786_LIN_NEG_VS_CD4_TCELL_UP,1
FRASOR_TAMOXIFEN_RESPONSE_UP,SET,44,-0.039887,-0.0019493,0.13053,0.62003,FRASOR_TAMOXIFEN_RESPONSE_UP,1
GSE32986_UNSTIM_VS_CURDLAN_H...1,SET,174,-0.01934,-0.0018728,0.063292,0.62003,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,1
MORF_GMPS,SET,40,-0.036091,-0.0016819,0.11808,0.62006,MORF_GMPS,1
HP_IRREGULARLY_SHAPED_SPERM_...,SET,11,-0.068406,-0.001673,0.22382,0.62006,HP_IRREGULARLY_SHAPED_SPERM_TAIL,1
MIR6858_3P,SET,41,-0.041799,-0.001972,0.13673,0.62009,MIR6858_3P,1
GSE40274_CTRL_VS_XBP1_TRANSD...1,SET,148,-0.019994,-0.0017869,0.065395,0.6201,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GCM_DDX11,SET,44,-0.035022,-0.0017116,0.1145,0.62015,GCM_DDX11,1
BONCI_TARGETS_OF_MIR15A_AND_...,SET,90,-0.026711,-0.0018646,0.0873,0.62018,BONCI_TARGETS_OF_MIR15A_AND_MIR16_1,1
THAKAR_PBMC_INACTIVATED_INFL...3,SET,66,-0.031034,-0.0018564,0.10143,0.62019,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_7DY_DN,1
GSE369_SOCS3_KO_VS_IFNG_KO_L...2,SET,170,-0.020657,-0.0019775,0.067499,0.62021,GSE369_SOCS3_KO_VS_IFNG_KO_LIVER_UP,1
HP_ABNORMAL_GLOBUS_PALLIDUS_...,SET,21,-0.054196,-0.0018309,0.17707,0.62022,HP_ABNORMAL_GLOBUS_PALLIDUS_MORPHOLOGY,1
MIR4478,SET,162,-0.020138,-0.0018823,0.065779,0.62025,MIR4478,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...3,SET,35,-0.042677,-0.0018606,0.13936,0.62029,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6_UP,1
PARK_HSC_VS_MULTIPOTENT_PROG...1,SET,14,-0.067948,-0.0018746,0.22182,0.62032,PARK_HSC_VS_MULTIPOTENT_PROGENITORS_DN,1
chr7q31,SET,58,-0.063333,-0.0035522,0.20662,0.62039,chr7q31,1
HP_MODERATELY_SHORT_STATURE,SET,4,-0.11835,-0.0017457,0.38606,0.62041,HP_MODERATELY_SHORT_STATURE,1
HP_ABNORMAL_EYEBROW_MORPHOLO...,SET,580,-0.010672,-0.0018657,0.034795,0.62047,HP_ABNORMAL_EYEBROW_MORPHOLOGY,1
HP_COMPLETE_OR_NEAR_COMPLETE...2,SET,5,-0.10444,-0.0017223,0.34046,0.62048,HP_COMPLETE_OR_NEAR_COMPLETE_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,1
GOBP_REGULATION_OF_NUCLEOTID...3,SET,22,-0.056635,-0.0019583,0.18456,0.62052,GOBP_REGULATION_OF_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOMF_TORC2_COMPLEX_BINDING,SET,4,-0.1414,-0.0020858,0.46064,0.62056,GOMF_TORC2_COMPLEX_BINDING,1
WP_METHIONINE_METABOLISM_LEA...,SET,10,-0.09297,-0.002168,0.30281,0.62058,WP_METHIONINE_METABOLISM_LEADING_TO_SULFUR_AMINO_ACIDS_AND_RELATED_DISORDERS,1
GOBP_ADENYLATE_CYCLASE_INHIB...5,SET,7,-0.11567,-0.0022571,0.37666,0.62062,GOBP_ADENYLATE_CYCLASE_INHIBITING_SEROTONIN_RECEPTOR_SIGNALING_PATHWAY,1
HP_ATROPHY_DEGENERATION_INVO...1,SET,14,-0.075646,-0.002087,0.2463,0.62062,HP_ATROPHY_DEGENERATION_INVOLVING_THE_CAUDATE_NUCLEUS,1
GOCC_MICROTUBULE_BUNDLE,SET,6,-0.091858,-0.0016594,0.29906,0.62064,GOCC_MICROTUBULE_BUNDLE,1
GOCC_SITE_OF_POLARIZED_GROWTH,SET,153,-0.021173,-0.0019238,0.068928,0.62064,GOCC_SITE_OF_POLARIZED_GROWTH,1
GOBP_POSITIVE_REGULATION_OF_...782,SET,95,-0.027837,-0.0019962,0.090568,0.62071,GOBP_POSITIVE_REGULATION_OF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_SIGNALING_PATHWAY,1
GSE17721_POLYIC_VS_GARDIQUIM...7,SET,182,-0.018955,-0.0018769,0.061647,0.62076,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_DN,1
YY1_02,SET,228,-0.016598,-0.0018371,0.053959,0.6208,YY1_02,1
GOBP_ION_CHANNEL_MODULATING_...,SET,8,-0.10056,-0.0020975,0.3269,0.62081,GOBP_ION_CHANNEL_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
WP_NUCLEOTIDE_EXCISION_REPAIR,SET,41,-0.034146,-0.001611,0.11099,0.62082,WP_NUCLEOTIDE_EXCISION_REPAIR,1
GSE45739_UNSTIM_VS_ACD3_ACD2...3,SET,178,-0.019966,-0.0019554,0.064879,0.62086,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_WT_CD4_TCELL_DN,1
GOBP_REGULATION_OF_VESICLE_S...,SET,15,-0.069103,-0.0019733,0.22448,0.62089,GOBP_REGULATION_OF_VESICLE_SIZE,1
HP_ABNORMAL_THYROID_STIMULAT...,SET,39,-0.040513,-0.0018642,0.1316,0.6209,HP_ABNORMAL_THYROID_STIMULATING_HORMONE_LEVEL,1
MODULE_403,SET,43,-0.037957,-0.0018338,0.12312,0.62107,MODULE_403,1
GSE20715_0H_VS_6H_OZONE_TLR4...2,SET,179,-0.019288,-0.0018942,0.062538,0.62112,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_UP,1
HP_ABNORMAL_SPERM_TAIL_MORPH...,SET,36,-0.040579,-0.0017942,0.13155,0.62114,HP_ABNORMAL_SPERM_TAIL_MORPHOLOGY,1
HP_NARROW_FOOT,SET,4,-0.13305,-0.0019626,0.43128,0.62115,HP_NARROW_FOOT,1
GOBP_HOMOLOGOUS_CHROMOSOME_P...,SET,44,-0.035767,-0.0017479,0.11588,0.62121,GOBP_HOMOLOGOUS_CHROMOSOME_PAIRING_AT_MEIOSIS,1
SASSON_RESPONSE_TO_GONADOTRO...1,SET,85,-0.027811,-0.001887,0.090097,0.62122,SASSON_RESPONSE_TO_GONADOTROPHINS_DN,1
REACTOME_MITOCHONDRIAL_FATTY...2,SET,11,-0.071426,-0.0017469,0.23138,0.62122,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_SATURATED_FATTY_ACIDS,1
MIR4768_5P,SET,302,-0.015214,-0.0019342,0.049286,0.62122,MIR4768_5P,1
WP_INTERFERONMEDIATED_SIGNAL...,SET,33,-0.054818,-0.0023207,0.17754,0.62125,WP_INTERFERONMEDIATED_SIGNALING,1
GOCC_BRUSH_BORDER_MEMBRANE,SET,55,-0.03351,-0.0018304,0.10852,0.62125,GOCC_BRUSH_BORDER_MEMBRANE,1
HP_ABNORMAL_QT_INTERVAL,SET,55,-0.03697,-0.0020194,0.11967,0.62131,HP_ABNORMAL_QT_INTERVAL,1
MIR1587,SET,55,-0.03275,-0.0017889,0.10598,0.62134,MIR1587,1
GOBP_EMBRYONIC_ORGAN_MORPHOG...,SET,281,-0.01665,-0.002043,0.053878,0.62135,GOBP_EMBRYONIC_ORGAN_MORPHOGENESIS,1
GOBP_INTERLEUKIN_5_MEDIATED_...,SET,6,-0.11356,-0.0020515,0.36727,0.62141,GOBP_INTERLEUKIN_5_MEDIATED_SIGNALING_PATHWAY,1
HP_PRIMARY_MICROCEPHALY,SET,67,-0.029856,-0.0017994,0.096559,0.62142,HP_PRIMARY_MICROCEPHALY,1
HP_ABNORMAL_ANKLE_MORPHOLOGY,SET,87,-0.028729,-0.0019719,0.0929,0.62143,HP_ABNORMAL_ANKLE_MORPHOLOGY,1
HP_CHRONIC_MYELOGENOUS_LEUKE...,SET,9,-0.083792,-0.0018538,0.27095,0.62143,HP_CHRONIC_MYELOGENOUS_LEUKEMIA,1
GOBP_NEGATIVE_REGULATION_OF_...480,SET,5,-0.11888,-0.0019605,0.38433,0.62146,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,1
HP_ABNORMAL_RENAL_MORPHOLOGY,SET,984,-0.0085532,-0.0019254,0.027641,0.6215,HP_ABNORMAL_RENAL_MORPHOLOGY,1
HP_WEAKNESS_OF_THE_INTRINSIC...,SET,24,-0.047721,-0.0017233,0.15417,0.62155,HP_WEAKNESS_OF_THE_INTRINSIC_HAND_MUSCLES,1
HP_ABNORMALITY_OF_THE_CERVIC...,SET,375,-0.013405,-0.0018952,0.043299,0.62156,HP_ABNORMALITY_OF_THE_CERVICAL_SPINE,1
HP_ARTERIAL_RUPTURE,SET,8,-0.098454,-0.0020536,0.31799,0.62157,HP_ARTERIAL_RUPTURE,1
PID_IL5_PATHWAY,SET,14,-0.073375,-0.0020243,0.23697,0.62158,PID_IL5_PATHWAY,1
HP_HIGH_HYPERMETROPIA,SET,70,-0.032543,-0.0020046,0.1051,0.62158,HP_HIGH_HYPERMETROPIA,1
GOBP_GLUTAMINE_FAMILY_AMINO_...1,SET,14,-0.068937,-0.0019019,0.2226,0.6216,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
GOBP_TELOMERE_LOCALIZATION,SET,8,-0.081996,-0.0017103,0.26476,0.6216,GOBP_TELOMERE_LOCALIZATION,1
GOMF_PHOSPHATIDYLINOSITOL_3_...12,SET,11,-0.083862,-0.002051,0.27077,0.62161,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATORY_SUBUNIT_BINDING,1
GOCC_CLATHRIN_COAT,SET,48,-0.037302,-0.0019038,0.1204,0.62165,GOCC_CLATHRIN_COAT,1
GSE37301_CD4_TCELL_VS_GRANUL...1,SET,170,-0.020926,-0.0020033,0.067511,0.62171,GSE37301_CD4_TCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
HP_IMPAIRED_HORIZONTAL_SMOOT...,SET,7,-0.08518,-0.0016621,0.27475,0.62173,HP_IMPAIRED_HORIZONTAL_SMOOTH_PURSUIT,1
chr17q12,SET,86,-0.057677,-0.0039362,0.18597,0.62177,chr17q12,1
GOMF_SUMO_LIGASE_ACTIVITY,SET,12,-0.080164,-0.0020477,0.25848,0.62177,GOMF_SUMO_LIGASE_ACTIVITY,1
RUTELLA_RESPONSE_TO_HGF_UP,SET,379,-0.014117,-0.0020063,0.045515,0.62178,RUTELLA_RESPONSE_TO_HGF_UP,1
ZNF418_TARGET_GENES,SET,26,-0.053826,-0.0020231,0.17345,0.62184,ZNF418_TARGET_GENES,1
HP_ABNORMAL_FOREARM_MORPHOLO...,SET,211,-0.018152,-0.0019337,0.05849,0.62185,HP_ABNORMAL_FOREARM_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...707,SET,38,-0.045941,-0.0020868,0.14802,0.62186,GOBP_POSITIVE_REGULATION_OF_SMAD_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_HIPPOCAMPUS_DEVELOPMENT,SET,90,-0.028635,-0.0019989,0.092254,0.62187,GOBP_HIPPOCAMPUS_DEVELOPMENT,1
GSE28130_ACTIVATED_VS_INDUCE...1,SET,171,-0.020679,-0.0019854,0.06662,0.62187,GSE28130_ACTIVATED_VS_INDUCEED_TREG_DN,1
REACTOME_NCAM1_INTERACTIONS,SET,41,-0.044063,-0.0020788,0.14189,0.62192,REACTOME_NCAM1_INTERACTIONS,1
GOBP_LUNG_ASSOCIATED_MESENCH...,SET,9,-0.094906,-0.0020996,0.30561,0.62193,GOBP_LUNG_ASSOCIATED_MESENCHYME_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...278,SET,10,-0.088468,-0.002063,0.28484,0.62194,GOBP_NEGATIVE_REGULATION_OF_HORMONE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMALITY_OF_THE_THORAC...,SET,47,-0.039848,-0.0020125,0.12829,0.62195,HP_ABNORMALITY_OF_THE_THORACIC_CAVITY,1
GOBP_TRNA_TRANSPORT,SET,6,-0.082466,-0.0014898,0.2654,0.62199,GOBP_TRNA_TRANSPORT,1
CHICAS_RB1_TARGETS_GROWING,SET,221,-0.018102,-0.0019731,0.058238,0.62203,CHICAS_RB1_TARGETS_GROWING,1
GSE37416_0H_VS_24H_F_TULAREN...2,SET,166,-0.019883,-0.001881,0.063955,0.62205,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOBP_BRANCHING_MORPHOGENESIS...1,SET,144,-0.023566,-0.0020777,0.075772,0.6221,GOBP_BRANCHING_MORPHOGENESIS_OF_AN_EPITHELIAL_TUBE,1
HP_APNEIC_EPISODES_IN_INFANCY,SET,9,-0.087453,-0.0019348,0.28114,0.62212,HP_APNEIC_EPISODES_IN_INFANCY,1
GOMF_T_CELL_RECEPTOR_BINDING,SET,10,-0.086,-0.0020055,0.27645,0.62213,GOMF_T_CELL_RECEPTOR_BINDING,1
HP_LAMBDOIDAL_CRANIOSYNOSTOS...,SET,15,-0.060064,-0.0017152,0.19305,0.62215,HP_LAMBDOIDAL_CRANIOSYNOSTOSIS,1
GSE13522_CTRL_VS_T_CRUZI_BRA...1,SET,181,-0.02009,-0.0019839,0.064566,0.62216,GSE13522_CTRL_VS_T_CRUZI_BRAZIL_STRAIN_INF_SKIN_DN,1
NCX_01,SET,160,-0.021548,-0.0020017,0.069241,0.62217,NCX_01,1
MIR8055,SET,64,-0.032758,-0.0019297,0.10525,0.62219,MIR8055,1
GOBP_REGULATION_OF_EXIT_FROM...,SET,16,-0.064212,-0.0018938,0.20631,0.62219,GOBP_REGULATION_OF_EXIT_FROM_MITOSIS,1
MYLLYKANGAS_AMPLIFICATION_HO...18,SET,12,-0.075008,-0.001916,0.24095,0.62221,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_8,1
GOBP_VENTRICULAR_CARDIAC_MUS...2,SET,10,-0.098892,-0.0023061,0.31764,0.62222,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
GOBP_VOCALIZATION_BEHAVIOR,SET,15,-0.07261,-0.0020735,0.23323,0.62222,GOBP_VOCALIZATION_BEHAVIOR,1
GOBP_NEURON_PROJECTION_GUIDA...,SET,217,-0.019424,-0.0020981,0.062379,0.62224,GOBP_NEURON_PROJECTION_GUIDANCE,1
GCM_PPP1CC,SET,51,-0.031551,-0.0016597,0.10132,0.62226,GCM_PPP1CC,1
GOBP_NEGATIVE_REGULATION_OF_...2,SET,40,-0.039053,-0.0018199,0.12539,0.62227,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_DEPOLYMERIZATION,1
CHEN_ETV5_TARGETS_SERTOLI,SET,24,-0.062284,-0.0022492,0.19993,0.6223,CHEN_ETV5_TARGETS_SERTOLI,1
MIR5004_5P,SET,114,-0.024179,-0.0018983,0.077591,0.62233,MIR5004_5P,1
CCAWYNNGAAR_UNKNOWN,SET,123,-0.024038,-0.0019599,0.077131,0.62234,CCAWYNNGAAR_UNKNOWN,1
REACTOME_ION_TRANSPORT_BY_P_...,SET,51,-0.037784,-0.0019876,0.12117,0.62241,REACTOME_ION_TRANSPORT_BY_P_TYPE_ATPASES,1
MIR501_3P_MIR502_3P,SET,65,-0.03438,-0.002041,0.11024,0.62242,MIR501_3P_MIR502_3P,1
GOBP_POSITIVE_REGULATION_OF_...476,SET,116,-0.02398,-0.0018991,0.076896,0.62242,GOBP_POSITIVE_REGULATION_OF_MITOTIC_CELL_CYCLE,1
GSE22886_NAIVE_CD8_TCELL_VS_...2,SET,172,-0.019514,-0.0018789,0.062565,0.62244,GSE22886_NAIVE_CD8_TCELL_VS_DC_UP,1
HP_SEGMENTAL_PERIPHERAL_DEMY...,SET,10,-0.085502,-0.0019939,0.27404,0.62248,HP_SEGMENTAL_PERIPHERAL_DEMYELINATION_REMYELINATION,1
HP_ENLARGED_JOINTS,SET,12,-0.070454,-0.0017997,0.22579,0.62249,HP_ENLARGED_JOINTS,1
GOMF_RNA_EXONUCLEASE_ACTIVITY,SET,43,-0.035959,-0.0017373,0.11519,0.62254,GOMF_RNA_EXONUCLEASE_ACTIVITY,1
KENNY_CTNNB1_TARGETS_UP,SET,47,-0.0378,-0.0019091,0.12107,0.62255,KENNY_CTNNB1_TARGETS_UP,1
GOBP_MINERALOCORTICOID_BIOSY...,SET,12,-0.088375,-0.0022575,0.28303,0.62257,GOBP_MINERALOCORTICOID_BIOSYNTHETIC_PROCESS,1
HP_LIMB_MYOCLONUS,SET,25,-0.054104,-0.0019941,0.17328,0.62257,HP_LIMB_MYOCLONUS,1
LEE_SP4_THYMOCYTE,SET,15,-0.074756,-0.0021348,0.23937,0.62259,LEE_SP4_THYMOCYTE,1
GOMF_CYTOSKELETAL_PROTEIN_BI...,SET,910,-0.0089443,-0.0019404,0.028623,0.62266,GOMF_CYTOSKELETAL_PROTEIN_BINDING,1
HP_NARROW_INTERNAL_AUDITORY_...,SET,15,-0.071051,-0.002029,0.22738,0.62266,HP_NARROW_INTERNAL_AUDITORY_CANAL,1
DESCARTES_MAIN_FETAL_TROPHOB...,SET,125,-0.024493,-0.0020131,0.078374,0.62268,DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS,1
KAMMINGA_SENESCENCE,SET,38,-0.041123,-0.001868,0.13157,0.62269,KAMMINGA_SENESCENCE,1
GSE6674_UNSTIM_VS_CPG_STIM_B...2,SET,131,-0.023063,-0.0019402,0.073791,0.62269,GSE6674_UNSTIM_VS_CPG_STIM_BCELL_UP,1
RAMASWAMY_METASTASIS_DN,SET,51,-0.036114,-0.0018998,0.11551,0.62272,RAMASWAMY_METASTASIS_DN,1
LIU_OVARIAN_CANCER_TUMORS_AN...2,SET,1383,-0.0081561,-0.0021515,0.026081,0.62275,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_DN,1
GSE37301_MULTIPOTENT_PROGENI...11,SET,184,-0.018635,-0.0018552,0.059537,0.62286,GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,1
KEGG_MEDICUS_REFERENCE_BLOOD...1,SET,6,-0.11525,-0.0020821,0.36816,0.62288,KEGG_MEDICUS_REFERENCE_BLOOD_GROUP_H_O_ANTIGEN_TYPE_1_BIOSYNTHESIS,1
GOBP_REGULATION_OF_CARDIAC_M...11,SET,5,-0.14777,-0.0024369,0.47187,0.62291,GOBP_REGULATION_OF_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,1
HP_SQUAMOUS_CELL_CARCINOMA_O...,SET,22,-0.049185,-0.0017007,0.15707,0.62291,HP_SQUAMOUS_CELL_CARCINOMA_OF_THE_SKIN,1
GOBP_PYRIMIDINE_NUCLEOSIDE_C...,SET,15,-0.089382,-0.0025524,0.2854,0.62293,GOBP_PYRIMIDINE_NUCLEOSIDE_CATABOLIC_PROCESS,1
HP_INCREASED_FEMALE_LIBIDO,SET,18,-0.066769,-0.0020885,0.21312,0.62297,HP_INCREASED_FEMALE_LIBIDO,1
GEORGES_TARGETS_OF_MIR192_AN...,SET,796,-0.0094813,-0.00193,0.030249,0.62303,GEORGES_TARGETS_OF_MIR192_AND_MIR215,1
GOMF_PROTEIN_SERINE_THREONIN...3,SET,10,-0.089762,-0.0020932,0.28638,0.62303,GOMF_PROTEIN_SERINE_THREONINE_KINASE_BINDING,1
HP_PULMONARY_EDEMA,SET,25,-0.05491,-0.0020238,0.17512,0.62307,HP_PULMONARY_EDEMA,1
GSE25088_WT_VS_STAT6_KO_MACR...1,SET,181,-0.019362,-0.0019119,0.061743,0.62308,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_DN,1
GOCC_INTERCALATED_DISC,SET,50,-0.039808,-0.0020735,0.12692,0.6231,GOCC_INTERCALATED_DISC,1
HP_NEONATAL_BREATHING_DYSREG...,SET,5,-0.091671,-0.0015118,0.29227,0.62311,HP_NEONATAL_BREATHING_DYSREGULATION,1
REACTOME_TELOMERE_C_STRAND_L...,SET,32,-0.04241,-0.0017681,0.13514,0.62317,REACTOME_TELOMERE_C_STRAND_LAGGING_STRAND_SYNTHESIS,1
TCTGATA_MIR361,SET,79,-0.02941,-0.001924,0.09371,0.62318,TCTGATA_MIR361,1
MIR7848_3P,SET,26,-0.052624,-0.0019779,0.16766,0.62319,MIR7848_3P,1
KAUFFMANN_MELANOMA_RELAPSE_DN,SET,6,-0.10402,-0.0018792,0.33131,0.62323,KAUFFMANN_MELANOMA_RELAPSE_DN,1
GSE17186_CD21LOW_VS_CD21HIGH...1,SET,176,-0.019167,-0.0018667,0.061037,0.62325,GSE17186_CD21LOW_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_DN,1
ZHENG_CORD_BLOOD_C1_PUTATIVE...,SET,92,-0.029221,-0.0020622,0.093026,0.62328,ZHENG_CORD_BLOOD_C1_PUTATIVE_MEGAKARYOCYTE_PROGENITOR,1
JAK2_DN.V1_UP,SET,158,-0.022907,-0.0021147,0.072914,0.6233,JAK2_DN.V1_UP,1
REACTOME_COBALAMIN_CBL_METAB...,SET,6,-0.10012,-0.0018086,0.31851,0.62336,REACTOME_COBALAMIN_CBL_METABOLISM,1
REACTOME_ERYTHROPOIETIN_ACTI...4,SET,7,-0.12717,-0.0024813,0.40441,0.62341,REACTOME_ERYTHROPOIETIN_ACTIVATES_STAT5,1
KEGG_RIBOFLAVIN_METABOLISM,SET,13,-0.070755,-0.0018811,0.22499,0.62342,KEGG_RIBOFLAVIN_METABOLISM,1
GOBP_NEUROMUSCULAR_PROCESS_C...1,SET,50,-0.040337,-0.0021011,0.12821,0.62347,GOBP_NEUROMUSCULAR_PROCESS_CONTROLLING_BALANCE,1
BLANCO_MELO_COVID19_SARS_COV...4,SET,428,-0.013134,-0.0019807,0.041734,0.6235,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP,1
MIKKELSEN_PLURIPOTENT_STATE_...1,SET,8,-0.11231,-0.0023426,0.35685,0.62351,MIKKELSEN_PLURIPOTENT_STATE_DN,1
GOBP_REGULATION_OF_AUTOPHAGY,SET,333,-0.014357,-0.001915,0.045614,0.62352,GOBP_REGULATION_OF_AUTOPHAGY,1
GOMF_PHOSPHOLIPASE_ACTIVATOR...,SET,15,-0.06209,-0.0017731,0.19728,0.62352,GOMF_PHOSPHOLIPASE_ACTIVATOR_ACTIVITY,1
GSE43863_LY6C_INT_CXCR5POS_V...1,SET,181,-0.020177,-0.0019924,0.064101,0.62353,GSE43863_LY6C_INT_CXCR5POS_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,1
GSE21380_NON_TFH_VS_GERMINAL...2,SET,176,-0.020245,-0.0019716,0.064306,0.62355,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_UP,1
GSE17721_CTRL_VS_POLYIC_0.5H...2,SET,180,-0.019593,-0.0019294,0.062224,0.62357,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_UP,1
MORF_PTPN9,SET,51,-0.03499,-0.0018406,0.1111,0.6236,MORF_PTPN9,1
KEGG_MEDICUS_REFERENCE_TSH_D...,SET,12,-0.075805,-0.0019364,0.24064,0.62362,KEGG_MEDICUS_REFERENCE_TSH_DUOX2_TG_SIGNALING_PATHWAY,1
GOBP_LABYRINTHINE_LAYER_BLOO...,SET,18,-0.063132,-0.0019748,0.20036,0.62366,GOBP_LABYRINTHINE_LAYER_BLOOD_VESSEL_DEVELOPMENT,1
GOBP_CLATHRIN_DEPENDENT_ENDO...,SET,47,-0.037964,-0.0019174,0.12047,0.62367,GOBP_CLATHRIN_DEPENDENT_ENDOCYTOSIS,1
GOCC_INO80_TYPE_COMPLEX,SET,27,-0.046614,-0.0017853,0.14792,0.62367,GOCC_INO80_TYPE_COMPLEX,1
HP_RETINOPATHY_OF_PREMATURITY,SET,4,-0.12617,-0.0018612,0.40029,0.6237,HP_RETINOPATHY_OF_PREMATURITY,1
GOMF_PHOSPHATIDYLINOSITOL_3_...11,SET,4,-0.1024,-0.0015106,0.32459,0.6238,GOMF_PHOSPHATIDYLINOSITOL_3_KINASE_INHIBITOR_ACTIVITY,1
KUUSELO_PANCREATIC_CANCER_19...,SET,31,-0.07186,-0.0029488,0.22777,0.62381,KUUSELO_PANCREATIC_CANCER_19Q13_AMPLIFICATION,1
MIR6751_3P,SET,73,-0.030787,-0.0019364,0.097558,0.62384,MIR6751_3P,1
GOCC_PALMITOYLTRANSFERASE_CO...,SET,10,-0.080761,-0.0018833,0.25591,0.62384,GOCC_PALMITOYLTRANSFERASE_COMPLEX,1
KEGG_MEDICUS_VARIANT_MUTATIO...59,SET,11,-0.080642,-0.0019723,0.2555,0.62385,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...664,SET,15,-0.074114,-0.0021164,0.2348,0.62386,GOBP_NEGATIVE_REGULATION_OF_TYPE_2_IMMUNE_RESPONSE,1
GSE17812_WT_VS_THPOK_KO_MEMO...1,SET,181,-0.020441,-0.0020185,0.064735,0.6239,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_DN,1
IVANOVA_HEMATOPOIESIS_STEM_C...4,SET,18,-0.059296,-0.0018548,0.18775,0.62393,IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM,1
SEMENZA_HIF1_TARGETS,SET,32,-0.049978,-0.0020836,0.15823,0.62394,SEMENZA_HIF1_TARGETS,1
HP_HYPERTROPHIC_NERVE_CHANGES,SET,6,-0.12649,-0.0022851,0.40049,0.62394,HP_HYPERTROPHIC_NERVE_CHANGES,1
HP_ABNORMAL_UVULA_MORPHOLOGY,SET,168,-0.019832,-0.0018874,0.062786,0.62395,HP_ABNORMAL_UVULA_MORPHOLOGY,1
GOMF_ORGANIC_ACID_TRANSMEMBR...,SET,174,-0.020904,-0.0020243,0.066127,0.62404,GOMF_ORGANIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR6715A_3P,SET,148,-0.02239,-0.0020011,0.070817,0.62406,MIR6715A_3P,1
GOBP_REGULATION_OF_HEPATOCYT...2,SET,16,-0.065086,-0.0019196,0.20587,0.62406,GOBP_REGULATION_OF_HEPATOCYTE_PROLIFERATION,1
GOBP_POSITIVE_REGULATION_OF_...307,SET,39,-0.042737,-0.0019666,0.13513,0.6241,GOBP_POSITIVE_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
WP_FATTY_ACID_TRANSPORTERS,SET,17,-0.066607,-0.0020248,0.21059,0.62411,WP_FATTY_ACID_TRANSPORTERS,1
REACTOME_ACTIVATED_NTRK2_SIG...2,SET,11,-0.072123,-0.0017639,0.22799,0.62413,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_FRS2_AND_FRS3,1
HP_HYPERTYROSINEMIA,SET,6,-0.10687,-0.0019307,0.33779,0.62414,HP_HYPERTYROSINEMIA,1
HP_COXA_VARA,SET,58,-0.034698,-0.0019461,0.10966,0.62416,HP_COXA_VARA,1
BLANCO_MELO_COVID19_SARS_COV...8,SET,302,-0.016836,-0.0021403,0.0532,0.62417,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_CALU3_CELLS_UP,1
HP_VAGINAL_FISTULA,SET,25,-0.051835,-0.0019105,0.16377,0.62419,HP_VAGINAL_FISTULA,1
MIR889_3P,SET,214,-0.018714,-0.0020076,0.05911,0.62422,MIR889_3P,1
BIOCARTA_IL2_PATHWAY,SET,20,-0.063183,-0.0020831,0.19948,0.62428,BIOCARTA_IL2_PATHWAY,1
GOCC_PRESYNAPTIC_ACTIVE_ZONE...2,SET,30,-0.051896,-0.002095,0.16383,0.62429,GOCC_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,1
GOBP_POSITIVE_REGULATION_OF_...475,SET,7,-0.10972,-0.0021408,0.34557,0.62457,GOBP_POSITIVE_REGULATION_OF_MITOPHAGY_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
HP_EYELID_MYOCLONIA_SEIZURE,SET,7,-0.090382,-0.0017636,0.28463,0.62458,HP_EYELID_MYOCLONIA_SEIZURE,1
HP_PALMAR_HYPERHIDROSIS,SET,15,-0.073115,-0.0020879,0.2301,0.62466,HP_PALMAR_HYPERHIDROSIS,1
REACTOME_ROLE_OF_LAT2_NTAL_L...,SET,16,-0.063028,-0.0018588,0.19834,0.62467,REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION,1
GSE11961_PLASMA_CELL_DAY7_VS...1,SET,187,-0.019191,-0.001926,0.060351,0.62475,GSE11961_PLASMA_CELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
GOBP_NEGATIVE_REGULATION_OF_...435,SET,14,-0.071834,-0.0019818,0.22587,0.62477,GOBP_NEGATIVE_REGULATION_OF_NERVOUS_SYSTEM_PROCESS,1
GSE37416_12H_VS_24H_F_TULARE...1,SET,166,-0.020376,-0.0019277,0.064065,0.62478,GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_HIPPOCAMPAL_NEURON_APOP...,SET,6,-0.12355,-0.002232,0.38826,0.62484,GOBP_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,1
GOCC_CLATHRIN_COATED_VESICLE,SET,201,-0.019554,-0.0020337,0.061422,0.62489,GOCC_CLATHRIN_COATED_VESICLE,1
REACTOME_TRNA_AMINOACYLATION,SET,24,-0.050984,-0.0018412,0.1601,0.62493,REACTOME_TRNA_AMINOACYLATION,1
REACTOME_TGF_BETA_RECEPTOR_S...1,SET,46,-0.038773,-0.0019373,0.12167,0.62501,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_ACTIVATES_SMADS,1
GAVISH_3CA_MALIGNANT_METAPRO...28,SET,19,-0.070852,-0.0022769,0.22233,0.62501,GAVISH_3CA_MALIGNANT_METAPROGRAM_36_IG,1
KEGG_MEDICUS_REFERENCE_ELECT...1,SET,36,-0.037748,-0.001669,0.11836,0.6251,KEGG_MEDICUS_REFERENCE_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_NEGATIVE_REGULATION_OF_...581,SET,8,-0.081007,-0.0016897,0.25398,0.62511,GOBP_NEGATIVE_REGULATION_OF_SCHWANN_CELL_PROLIFERATION,1
GSE7852_LN_VS_THYMUS_TCONV_DN,SET,187,-0.019215,-0.0019283,0.060239,0.62513,GSE7852_LN_VS_THYMUS_TCONV_DN,1
MARCINIAK_ER_STRESS_RESPONSE...,SET,20,-0.060701,-0.0020013,0.19013,0.62523,MARCINIAK_ER_STRESS_RESPONSE_VIA_CHOP,1
MEBARKI_HCC_PROGENITOR_WNT_UP,SET,168,-0.022391,-0.002131,0.070136,0.62523,MEBARKI_HCC_PROGENITOR_WNT_UP,1
GOBP_NEGATIVE_REGULATION_OF_...673,SET,9,-0.090665,-0.0020058,0.28375,0.62533,GOBP_NEGATIVE_REGULATION_OF_T_CELL_DIFFERENTIATION_IN_THYMUS,1
MIR2053,SET,159,-0.021462,-0.0019876,0.067168,0.62534,MIR2053,1
GSE42088_UNINF_VS_LEISHMANIA...1,SET,184,-0.01977,-0.0019682,0.061867,0.62534,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_24H_DN,1
GOCC_ER_UBIQUITIN_LIGASE_COM...,SET,4,-0.13689,-0.0020192,0.42833,0.62536,GOCC_ER_UBIQUITIN_LIGASE_COMPLEX,1
WEBER_METHYLATED_HCP_IN_FIBR...2,SET,6,-0.11323,-0.0020455,0.35423,0.62538,WEBER_METHYLATED_HCP_IN_FIBROBLAST_UP,1
GOCC_ALPHA_KETOACID_DEHYDROG...,SET,15,-0.062965,-0.0017981,0.19698,0.62538,GOCC_ALPHA_KETOACID_DEHYDROGENASE_COMPLEX,1
GARGALOVIC_RESPONSE_TO_OXIDI...14,SET,25,-0.052164,-0.0019226,0.16317,0.62539,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_UP,1
HP_PAROXYSMAL_SUPRAVENTRICUL...,SET,5,-0.13334,-0.002199,0.41704,0.62541,HP_PAROXYSMAL_SUPRAVENTRICULAR_TACHYCARDIA,1
GOBP_REGULATION_OF_AUTOPHAGO...2,SET,15,-0.065562,-0.0018722,0.20502,0.62543,GOBP_REGULATION_OF_AUTOPHAGOSOME_MATURATION,1
GOBP_EXPORT_ACROSS_PLASMA_ME...,SET,65,-0.036287,-0.0021542,0.11346,0.62545,GOBP_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_REGULATION_OF_POTASSIUM...1,SET,7,-0.10663,-0.0020806,0.33338,0.62546,GOBP_REGULATION_OF_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
GSE6259_FLT3L_INDUCED_DEC205...2,SET,139,-0.022879,-0.0019821,0.07153,0.62546,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_UP,1
HP_PSYCHOMOTOR_DETERIORATION,SET,19,-0.060063,-0.0019302,0.18766,0.62554,HP_PSYCHOMOTOR_DETERIORATION,1
GSE15659_NAIVE_CD4_TCELL_VS_...4,SET,160,-0.02055,-0.0019091,0.064162,0.62562,GSE15659_NAIVE_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,1
HP_DEVIATION_OF_THE_HAND_OR_...,SET,478,-0.012338,-0.0019637,0.038514,0.62565,HP_DEVIATION_OF_THE_HAND_OR_OF_FINGERS_OF_THE_HAND,1
HP_DECREASED_LIGHT_AND_DARK_...,SET,14,-0.073965,-0.0020406,0.23081,0.62569,HP_DECREASED_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM_AMPLITUDE,1
MEF2_04,SET,23,-0.056351,-0.0019922,0.1758,0.62571,MEF2_04,1
GOBP_REGULATION_OF_HYDROGEN_...2,SET,9,-0.092553,-0.0020476,0.28869,0.62574,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_MEDIATED_PROGRAMMED_CELL_DEATH,1
WP_EXRNA_MECHANISM_OF_ACTION...,SET,6,-0.10128,-0.0018297,0.31582,0.62578,WP_EXRNA_MECHANISM_OF_ACTION_AND_BIOGENESIS,1
GOMF_COBALAMIN_BINDING,SET,8,-0.090001,-0.0018773,0.28065,0.62578,GOMF_COBALAMIN_BINDING,1
REACTOME_ETHANOL_OXIDATION,SET,12,-0.094729,-0.0024198,0.29536,0.62579,REACTOME_ETHANOL_OXIDATION,1
GOBP_POSITIVE_REGULATION_OF_...295,SET,5,-0.14737,-0.0024303,0.45919,0.62586,GOBP_POSITIVE_REGULATION_OF_GASTRULATION,1
GSE27291_0H_VS_6H_STIM_GAMMA...1,SET,157,-0.021305,-0.0019607,0.066391,0.62586,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_DN,1
GOMF_LAMIN_BINDING,SET,16,-0.06917,-0.00204,0.2155,0.62588,GOMF_LAMIN_BINDING,1
GOBP_ANTIGEN_PROCESSING_AND_...12,SET,17,-0.079865,-0.0024278,0.24866,0.62596,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_IB,1
MIR195_3P,SET,206,-0.019103,-0.0020111,0.059436,0.62605,MIR195_3P,1
GSE14308_TH1_VS_INDUCED_TREG...2,SET,180,-0.01925,-0.0018957,0.059881,0.62607,GSE14308_TH1_VS_INDUCED_TREG_UP,1
GNF2_BNIP3L,SET,61,-0.033836,-0.0019461,0.10521,0.62612,GNF2_BNIP3L,1
KEGG_MEDICUS_REFERENCE_DNA_R...1,SET,24,-0.049892,-0.0018017,0.15505,0.62619,KEGG_MEDICUS_REFERENCE_DNA_REPLICATION_LICENSING,1
GAVISH_3CA_METAPROGRAM_CD8_T...1,SET,44,-0.042749,-0.0020892,0.13281,0.62623,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CELL_CYCLE,1
GSE20715_0H_VS_24H_OZONE_TLR...1,SET,193,-0.020013,-0.00204,0.062164,0.62625,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_DN,1
GSE34156_UNTREATED_VS_6H_NOD...2,SET,149,-0.022176,-0.0019886,0.068885,0.62625,GSE34156_UNTREATED_VS_6H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
GSE23308_CTRL_VS_CORTICOSTER...1,SET,186,-0.019718,-0.0019736,0.061236,0.62627,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_DN,1
MIR106B_5P,SET,632,-0.011021,-0.0020082,0.034224,0.62628,MIR106B_5P,1
GOMF_LIPID_TRANSMEMBRANE_TRA...,SET,54,-0.038536,-0.0020858,0.11965,0.6263,GOMF_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...262,SET,8,-0.11681,-0.0024366,0.36258,0.62634,GOBP_NEGATIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...4,SET,266,-0.017081,-0.00204,0.053004,0.62637,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DY_AT_1DYPOSITIVE,1
HP_CEREBRAL_ARTERIOVENOUS_MA...,SET,7,-0.097489,-0.0019022,0.30234,0.62644,HP_CEREBRAL_ARTERIOVENOUS_MALFORMATION,1
MIR6754_3P,SET,88,-0.029459,-0.0020336,0.091317,0.6265,MIR6754_3P,1
GOBP_PH_REDUCTION,SET,6,-0.12453,-0.0022496,0.3856,0.62663,GOBP_PH_REDUCTION,1
GSE22601_IMMATURE_CD4_SINGLE...6,SET,163,-0.022432,-0.0021031,0.069462,0.62663,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_UP,1
GSE43955_TH0_VS_TGFB_IL6_TH1...7,SET,177,-0.020135,-0.0019665,0.062349,0.62663,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_30H_DN,1
KEGG_ARRHYTHMOGENIC_RIGHT_VE...,SET,70,-0.034135,-0.0021026,0.10565,0.62668,KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC,1
WP_ARRHYTHMOGENIC_RIGHT_VENT...,SET,70,-0.034135,-0.0021026,0.10565,0.62668,WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1
MIR4791,SET,58,-0.034849,-0.0019546,0.10786,0.62669,MIR4791,1
CHESLER_BRAIN_HIGHEST_EXPRES...,SET,34,-0.045751,-0.001966,0.14155,0.62673,CHESLER_BRAIN_HIGHEST_EXPRESSION,1
VRTN_TARGET_GENES,SET,9,-0.09097,-0.0020126,0.28132,0.62679,VRTN_TARGET_GENES,1
GOBP_REGULATION_OF_BRANCHING...2,SET,5,-0.14568,-0.0024025,0.45047,0.6268,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,1
HP_ABNORMALITY_OF_THE_UPPER_...2,SET,1520,-0.0072445,-0.0019954,0.022394,0.62684,HP_ABNORMALITY_OF_THE_UPPER_LIMB,1
GOBP_REGULATION_OF_SYNAPTIC_...11,SET,12,-0.08356,-0.0021345,0.25828,0.62685,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_MEMBRANE_ORGANIZATION,1
HP_RETICULOCYTOSIS,SET,41,-0.042888,-0.0020234,0.13256,0.62685,HP_RETICULOCYTOSIS,1
RTTTNNNYTGGM_UNKNOWN,SET,141,-0.024178,-0.0021096,0.074711,0.62689,RTTTNNNYTGGM_UNKNOWN,1
GSE27786_NKTCELL_VS_NEUTROPH...1,SET,181,-0.020617,-0.0020359,0.063676,0.62695,GSE27786_NKTCELL_VS_NEUTROPHIL_DN,1
GOBP_OLFACTORY_LOBE_DEVELOPM...,SET,36,-0.051723,-0.0022869,0.15973,0.62696,GOBP_OLFACTORY_LOBE_DEVELOPMENT,1
GSE2405_HEAT_KILLED_LYSATE_V...2,SET,189,-0.020975,-0.0021161,0.064771,0.62697,GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...1,SET,8,-0.15593,-0.0032524,0.48132,0.62701,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_0W_14W_METALLOTHIONEIN_SUBSET_UP,1
WP_METABOLIC_REPROGRAMMING_I...1,SET,39,-0.041019,-0.0018875,0.1266,0.62703,WP_METABOLIC_REPROGRAMMING_IN_COLON_CANCER,1
GOBP_GLUTAMATE_CATABOLIC_PRO...,SET,7,-0.10642,-0.0020766,0.32832,0.62708,GOBP_GLUTAMATE_CATABOLIC_PROCESS,1
GSE14699_DELETIONAL_TOLERANC...2,SET,169,-0.021268,-0.0020301,0.065611,0.62709,GSE14699_DELETIONAL_TOLERANCE_VS_ACTIVATED_CD8_TCELL_UP,1
REACTOME_INTERACTION_BETWEEN...,SET,30,-0.055181,-0.0022276,0.1702,0.62711,REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS,1
chr22q13,SET,177,-0.041386,-0.0040418,0.12764,0.62712,chr22q13,1
REACTOME_TCF_DEPENDENT_SIGNA...,SET,165,-0.020817,-0.0019635,0.064191,0.62714,REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT,1
GOMF_POTASSIUM_ION_LEAK_CHAN...,SET,16,-0.071014,-0.0020944,0.21885,0.62721,GOMF_POTASSIUM_ION_LEAK_CHANNEL_ACTIVITY,1
GNF2_SPINK1,SET,24,-0.064341,-0.0023235,0.19826,0.62723,GNF2_SPINK1,1
GOBP_AIM2_INFLAMMASOME_COMPL...,SET,5,-0.1042,-0.0017185,0.32102,0.62726,GOBP_AIM2_INFLAMMASOME_COMPLEX_ASSEMBLY,1
GOCC_SPECTRIN,SET,9,-0.088413,-0.001956,0.27237,0.62726,GOCC_SPECTRIN,1
HP_RECURRENT_APHTHOUS_STOMAT...,SET,44,-0.043204,-0.0021114,0.13307,0.62728,HP_RECURRENT_APHTHOUS_STOMATITIS,1
HP_ANEMIC_PALLOR,SET,14,-0.073066,-0.0020158,0.22494,0.62734,HP_ANEMIC_PALLOR,1
DESCARTES_FETAL_PANCREAS_LYM...1,SET,41,-0.046091,-0.0021745,0.14184,0.62739,DESCARTES_FETAL_PANCREAS_LYMPHATIC_ENDOTHELIAL_CELLS,1
CHAF1B_TARGET_GENES,SET,719,-0.010639,-0.0020627,0.032736,0.6274,CHAF1B_TARGET_GENES,1
KEGG_MEDICUS_REFERENCE_TGFA_...1,SET,9,-0.09446,-0.0020898,0.29063,0.62742,KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY,1
MIR4318,SET,100,-0.026794,-0.001971,0.082436,0.62742,MIR4318,1
GOBP_VESICLE_CYTOSKELETAL_TR...,SET,55,-0.036142,-0.0019742,0.11118,0.62744,GOBP_VESICLE_CYTOSKELETAL_TRAFFICKING,1
MIR6088,SET,152,-0.02195,-0.0019879,0.067501,0.62748,MIR6088,1
HP_IMPAIRED_DISTAL_TACTILE_S...,SET,18,-0.058846,-0.0018407,0.18094,0.62749,HP_IMPAIRED_DISTAL_TACTILE_SENSATION,1
MIR4662A_5P,SET,81,-0.030354,-0.0020107,0.093304,0.62753,MIR4662A_5P,1
GOBP_NEGATIVE_REGULATION_OF_...616,SET,34,-0.047067,-0.0020225,0.14466,0.62754,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,1
WP_MECHANOREGULATION_AND_PAT...,SET,44,-0.042827,-0.002093,0.13154,0.62763,WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS,1
HP_HEPATOCELLULAR_CARCINOMA,SET,75,-0.031914,-0.0020345,0.098014,0.62764,HP_HEPATOCELLULAR_CARCINOMA,1
REACTOME_NCAM_SIGNALING_FOR_...,SET,62,-0.03585,-0.0020787,0.11006,0.62768,REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH,1
KEGG_MEDICUS_REFERENCE_TRH_T...,SET,12,-0.085351,-0.0021802,0.26197,0.62771,KEGG_MEDICUS_REFERENCE_TRH_TRHR_PLCB_PKC_SIGNALING_PATHWAY,1
CUI_TCF21_TARGETS_DN,SET,30,-0.057491,-0.0023208,0.17645,0.62772,CUI_TCF21_TARGETS_DN,1
GOBP_PROTEIN_FOLDING_IN_ENDO...,SET,10,-0.080126,-0.0018685,0.24592,0.62772,GOBP_PROTEIN_FOLDING_IN_ENDOPLASMIC_RETICULUM,1
NGUYEN_NOTCH1_TARGETS_UP,SET,25,-0.057441,-0.0021171,0.17618,0.6278,NGUYEN_NOTCH1_TARGETS_UP,1
BIOCARTA_PROTEASOME_PATHWAY,SET,17,-0.058149,-0.0017677,0.17824,0.62788,BIOCARTA_PROTEASOME_PATHWAY,1
WP_PRIMARY_FOCAL_SEGMENTAL_G...,SET,70,-0.033708,-0.0020763,0.1033,0.6279,WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS,1
SNAPC4_TARGET_GENES,SET,61,-0.033901,-0.0019498,0.10389,0.6279,SNAPC4_TARGET_GENES,1
GSE44649_WT_VS_MIR155_KO_NAI...2,SET,184,-0.020575,-0.0020483,0.063029,0.62795,GSE44649_WT_VS_MIR155_KO_NAIVE_CD8_TCELL_UP,1
GOBP_PROTEASOME_ASSEMBLY,SET,11,-0.078881,-0.0019292,0.24162,0.62796,GOBP_PROTEASOME_ASSEMBLY,1
GAVISH_3CA_METAPROGRAM_EPITH...3,SET,44,-0.041534,-0.0020298,0.12719,0.62799,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CELL_CYCLE,1
FINETTI_BREAST_CANCER_KINOME...1,SET,14,-0.079205,-0.0021852,0.24251,0.62802,FINETTI_BREAST_CANCER_KINOME_GREEN,1
HP_VENOUS_INSUFFICIENCY,SET,35,-0.04926,-0.0021476,0.15075,0.62808,HP_VENOUS_INSUFFICIENCY,1
GSE37416_0H_VS_24H_F_TULAREN...1,SET,177,-0.020063,-0.0019594,0.061396,0.62808,GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
HP_POSTERIOR_UVEITIS,SET,5,-0.13119,-0.0021636,0.40114,0.62818,HP_POSTERIOR_UVEITIS,1
TBK1.DN.48HRS_DN,SET,46,-0.04052,-0.0020246,0.12386,0.62822,TBK1.DN.48HRS_DN,1
IWANAGA_CARCINOGENESIS_BY_KR...4,SET,158,-0.022404,-0.0020684,0.068475,0.62824,IWANAGA_CARCINOGENESIS_BY_KRAS_UP,1
PID_NOTCH_PATHWAY,SET,56,-0.035368,-0.0019493,0.10807,0.62827,PID_NOTCH_PATHWAY,1
GOBP_PURINERGIC_NUCLEOTIDE_R...,SET,27,-0.060242,-0.0023073,0.18396,0.62834,GOBP_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_LEFT_RIGHT_AXIS_SPECIFI...,SET,12,-0.087828,-0.0022435,0.26815,0.62837,GOBP_LEFT_RIGHT_AXIS_SPECIFICATION,1
REACTOME_TRANSCRIPTIONAL_REG...6,SET,91,-0.027133,-0.0019045,0.082809,0.62841,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX3,1
MIR302B_5P,SET,187,-0.020301,-0.0020373,0.061958,0.62841,MIR302B_5P,1
GOMF_ATPASE_COUPLED_LIPID_TR...,SET,8,-0.1027,-0.0021422,0.31341,0.62843,GOMF_ATPASE_COUPLED_LIPID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...184,SET,30,-0.050668,-0.0020454,0.15457,0.62847,GOBP_NEGATIVE_REGULATION_OF_DNA_BIOSYNTHETIC_PROCESS,1
GOBP_PROSTATE_GLANDULAR_ACIN...2,SET,6,-0.12042,-0.0021754,0.36719,0.62852,GOBP_PROSTATE_GLANDULAR_ACINUS_MORPHOGENESIS,1
GSE33292_WT_VS_TCF1_KO_DN3_T...2,SET,176,-0.021571,-0.0021008,0.065779,0.62852,GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP,1
HOEK_NEUTROPHIL_2011_2012_TI...6,SET,17,-0.065876,-0.0020026,0.20079,0.62857,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_7DY_UP,1
GSE43955_TH0_VS_TGFB_IL6_TH1...6,SET,173,-0.021052,-0.0020328,0.064163,0.62858,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_UP,1
GSE44955_MCSF_VS_MCSF_AND_IL...1,SET,180,-0.020554,-0.0020241,0.062638,0.6286,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_DN,1
REACTOME_INLB_MEDIATED_ENTRY...,SET,13,-0.076328,-0.0020293,0.23258,0.62861,REACTOME_INLB_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELL,1
GSE22611_UNSTIM_VS_6H_MDP_ST...3,SET,180,-0.020167,-0.0019861,0.06143,0.62865,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
TTF1_Q6,SET,239,-0.018263,-0.0020691,0.055611,0.6287,TTF1_Q6,1
OCT1_01,SET,227,-0.019649,-0.0021702,0.059788,0.62879,OCT1_01,1
PID_ERBB1_INTERNALIZATION_PA...,SET,40,-0.042042,-0.0019592,0.12788,0.62883,PID_ERBB1_INTERNALIZATION_PATHWAY,1
REACTOME_BIOLOGICAL_OXIDATIO...,SET,204,-0.022207,-0.0023266,0.067542,0.62884,REACTOME_BIOLOGICAL_OXIDATIONS,1
KEGG_MEDICUS_VARIANT_MUTATIO...77,SET,37,-0.038534,-0.0017272,0.11718,0.62886,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
MIR3935,SET,70,-0.032607,-0.0020085,0.099136,0.62889,MIR3935,1
chr20p11,SET,52,-0.071525,-0.0037991,0.21738,0.62893,chr20p11,1
GOBP_INHIBITORY_POSTSYNAPTIC...,SET,13,-0.084195,-0.0022384,0.25575,0.629,GOBP_INHIBITORY_POSTSYNAPTIC_POTENTIAL,1
ZNF30_TARGET_GENES,SET,1186,-0.0081616,-0.0020053,0.02478,0.62906,ZNF30_TARGET_GENES,1
MIR2682_5P,SET,106,-0.028047,-0.0021238,0.085137,0.62908,MIR2682_5P,1
GSE22886_NAIVE_CD4_TCELL_VS_...5,SET,182,-0.019644,-0.0019452,0.059632,0.62908,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH1_DN,1
MIR656_5P,SET,32,-0.048298,-0.0020136,0.1466,0.62909,MIR656_5P,1
GSE45365_NK_CELL_VS_CD8_TCEL...2,SET,171,-0.021746,-0.0020878,0.065967,0.62916,GSE45365_NK_CELL_VS_CD8_TCELL_MCMV_INFECTION_DN,1
PACHER_TARGETS_OF_IGF1_AND_I...,SET,35,-0.051475,-0.0022442,0.15611,0.6292,PACHER_TARGETS_OF_IGF1_AND_IGF2_UP,1
WP_CATALYTIC_CYCLE_OF_MAMMAL...,SET,5,-0.15567,-0.0025672,0.47209,0.6292,WP_CATALYTIC_CYCLE_OF_MAMMALIAN_FLAVINCONTAINING_MONOOXYGENASES_FMOS,1
GOBP_PUTRESCINE_BIOSYNTHETIC...,SET,5,-0.1066,-0.001758,0.32327,0.6292,GOBP_PUTRESCINE_BIOSYNTHETIC_PROCESS,1
GOMF_N_N_DIMETHYLANILINE_MON...,SET,5,-0.15567,-0.0025672,0.47209,0.6292,GOMF_N_N_DIMETHYLANILINE_MONOOXYGENASE_ACTIVITY,1
HP_CENTRAL_DIABETES_INSIPIDUS,SET,20,-0.063869,-0.0021058,0.19365,0.62923,HP_CENTRAL_DIABETES_INSIPIDUS,1
ZHAN_V1_LATE_DIFFERENTIATION...1,SET,11,-0.076176,-0.001863,0.23094,0.62924,ZHAN_V1_LATE_DIFFERENTIATION_GENES_DN,1
GOBP_NEGATIVE_REGULATION_OF_...373,SET,12,-0.075459,-0.0019275,0.22875,0.62925,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_MIGRATION,1
GOBP_PROTEIN_LINEAR_POLYUBIQ...,SET,3,-0.1441,-0.0018409,0.43685,0.62925,GOBP_PROTEIN_LINEAR_POLYUBIQUITINATION,1
GOBP_FORMATION_OF_PRIMARY_GE...,SET,118,-0.027167,-0.0021699,0.082311,0.62932,GOBP_FORMATION_OF_PRIMARY_GERM_LAYER,1
GOMF_PROTEASE_BINDING,SET,126,-0.024875,-0.0020525,0.07535,0.62935,GOMF_PROTEASE_BINDING,1
GOBP_REGULATION_OF_POSTSYNAP...1,SET,6,-0.11469,-0.0020719,0.34725,0.62941,GOBP_REGULATION_OF_POSTSYNAPSE_ASSEMBLY,1
WP_SEBALEIC_ACID_FORMATION_A...,SET,5,-0.13839,-0.0022822,0.41889,0.62944,WP_SEBALEIC_ACID_FORMATION_AND_METABOLISM,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...7,SET,129,-0.023525,-0.001964,0.071208,0.62944,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_IFNG_KO_DN,1
GOBP_NEURAL_CREST_CELL_FATE_...,SET,6,-0.1349,-0.002437,0.40811,0.6295,GOBP_NEURAL_CREST_CELL_FATE_COMMITMENT,1
CORONEL_RFX7_DIRECT_TARGETS_...,SET,39,-0.044593,-0.002052,0.1349,0.62951,CORONEL_RFX7_DIRECT_TARGETS_UP,1
GOMF_PH_DOMAIN_BINDING,SET,8,-0.098195,-0.0020482,0.297,0.62954,GOMF_PH_DOMAIN_BINDING,1
MCCABE_HOXC6_TARGETS_CANCER_...1,SET,19,-0.063142,-0.0020291,0.19085,0.62962,MCCABE_HOXC6_TARGETS_CANCER_DN,1
GOBP_REGULATION_OF_STEROID_M...,SET,91,-0.030863,-0.0021663,0.093248,0.62967,GOBP_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
HP_ABNORMAL_MOTOR_NERVE_COND...,SET,60,-0.034545,-0.0019706,0.10437,0.62967,HP_ABNORMAL_MOTOR_NERVE_CONDUCTION_VELOCITY,1
GOBP_CALCIUM_ION_REGULATED_E...2,SET,21,-0.061556,-0.0020795,0.18596,0.62968,GOBP_CALCIUM_ION_REGULATED_EXOCYTOSIS_OF_NEUROTRANSMITTER,1
JONES_OVARY_THECA,SET,44,-0.047886,-0.0023402,0.14462,0.62972,JONES_OVARY_THECA,1
GOBP_PHOSPHATE_ION_TRANSMEMB...,SET,14,-0.076048,-0.0020981,0.22964,0.62974,GOBP_PHOSPHATE_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_GOLGI_DISASSEMBLY,SET,6,-0.10788,-0.0019489,0.32567,0.62977,GOBP_GOLGI_DISASSEMBLY,1
MORF_PTEN,SET,77,-0.029786,-0.0019239,0.089884,0.62982,MORF_PTEN,1
BOYAULT_LIVER_CANCER_SUBCLAS...16,SET,58,-0.035639,-0.0019989,0.10751,0.62986,BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP,1
LUI_THYROID_CANCER_CLUSTER_3,SET,26,-0.052839,-0.001986,0.15941,0.62986,LUI_THYROID_CANCER_CLUSTER_3,1
LET_7B_3P,SET,662,-0.011164,-0.0020803,0.03368,0.62986,LET_7B_3P,1
MATTIOLI_MULTIPLE_MYELOMA_SU...,SET,10,-0.10005,-0.0023332,0.30177,0.62989,MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS,1
HSF2_01,SET,230,-0.018851,-0.0020956,0.056849,0.6299,HSF2_01,1
GOCC_HOPS_COMPLEX,SET,14,-0.06893,-0.0019017,0.20788,0.6299,GOCC_HOPS_COMPLEX,1
GSE18893_TCONV_VS_TREG_2H_CU...2,SET,174,-0.020306,-0.0019664,0.061235,0.62991,GSE18893_TCONV_VS_TREG_2H_CULTURE_UP,1
GSE2405_S_AUREUS_VS_A_PHAGOC...2,SET,183,-0.021733,-0.0021578,0.065498,0.62998,GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP,1
GSE22935_UNSTIM_VS_48H_MBOVI...2,SET,178,-0.021132,-0.0020695,0.063679,0.62999,GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
GOBP_IMMATURE_T_CELL_PROLIFE...,SET,11,-0.090548,-0.0022145,0.27279,0.63003,GOBP_IMMATURE_T_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_MESENCHYM...1,SET,32,-0.056845,-0.0023699,0.17123,0.63005,GOBP_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,1
HP_DYSPNEA,SET,432,-0.013765,-0.0020854,0.04145,0.63008,HP_DYSPNEA,1
DESCARTES_FETAL_EYE_SMOOTH_M...,SET,53,-0.038922,-0.0020871,0.1172,0.63009,DESCARTES_FETAL_EYE_SMOOTH_MUSCLE_CELLS,1
GOBP_REGULATION_OF_ACTIN_FIL...2,SET,341,-0.015434,-0.0020828,0.046463,0.63013,GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS,1
LET_7A_3P,SET,665,-0.011177,-0.0020872,0.033632,0.63018,LET_7A_3P,1
HP_ABNORMAL_CIRCULATING_PROG...,SET,6,-0.11237,-0.00203,0.33803,0.63021,HP_ABNORMAL_CIRCULATING_PROGESTERONE_LEVEL,1
GOCC_SECRETORY_VESICLE,SET,986,-0.0094056,-0.0021193,0.028279,0.63028,GOCC_SECRETORY_VESICLE,1
GSE14386_UNTREATED_VS_IFNA_T...1,SET,149,-0.024415,-0.0021894,0.073408,0.63028,GSE14386_UNTREATED_VS_IFNA_TREATED_ACT_PBMC_MS_PATIENT_DN,1
GOBP_NUCLEAR_TRANSPORT,SET,307,-0.015322,-0.0019636,0.046038,0.63036,GOBP_NUCLEAR_TRANSPORT,1
HP_ABNORMALITY_OF_MULTIPLE_C...,SET,165,-0.02136,-0.0020148,0.06417,0.63038,HP_ABNORMALITY_OF_MULTIPLE_CELL_LINEAGES_IN_THE_BONE_MARROW,1
REACTOME_MITOCHONDRIAL_FATTY...3,SET,6,-0.11281,-0.0020379,0.33886,0.63039,REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION_OF_UNSATURATED_FATTY_ACIDS,1
HP_INCREASED_CIRCULATING_GON...,SET,75,-0.031303,-0.0019956,0.094032,0.63039,HP_INCREASED_CIRCULATING_GONADOTROPIN_LEVEL,1
GOBP_SPLEEN_DEVELOPMENT,SET,38,-0.046922,-0.0021314,0.14094,0.6304,GOBP_SPLEEN_DEVELOPMENT,1
HP_IVORY_EPIPHYSES,SET,9,-0.096508,-0.0021351,0.28983,0.63042,HP_IVORY_EPIPHYSES,1
ZHONG_PFC_MAJOR_TYPES_INTERN...,SET,13,-0.087724,-0.0023323,0.2634,0.63045,ZHONG_PFC_MAJOR_TYPES_INTERNEURON,1
GOBP_POSITIVE_REGULATION_OF_...29,SET,33,-0.053283,-0.0022558,0.15997,0.63046,GOBP_POSITIVE_REGULATION_OF_ANIMAL_ORGAN_MORPHOGENESIS,1
HP_DECREASED_SERUM_ZINC,SET,4,-0.12105,-0.0017856,0.3634,0.63047,HP_DECREASED_SERUM_ZINC,1
HP_PROMINENT_CRUS_OF_HELIX,SET,5,-0.13693,-0.0022582,0.4108,0.63055,HP_PROMINENT_CRUS_OF_HELIX,1
HOFT_CD4_POSITIVE_ALPHA_BETA...4,SET,37,-0.047066,-0.0021096,0.14121,0.63055,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_7DY_UP,1
GOBP_POSITIVE_REGULATION_OF_...314,SET,7,-0.12214,-0.0023831,0.36591,0.63073,GOBP_POSITIVE_REGULATION_OF_GONADOTROPIN_SECRETION,1
HP_MORTALITY_AGING,SET,399,-0.013737,-0.0020019,0.041128,0.63081,HP_MORTALITY_AGING,1
GSE10463_CD40L_AND_VA347_VS_...1,SET,147,-0.023074,-0.0020553,0.069082,0.63081,GSE10463_CD40L_AND_VA347_VS_CD40L_IN_DC_DN,1
SRY_01,SET,210,-0.019925,-0.0021176,0.05964,0.63084,SRY_01,1
HP_VENTRICULAR_SEPTAL_HYPERT...,SET,12,-0.075253,-0.0019223,0.22521,0.63086,HP_VENTRICULAR_SEPTAL_HYPERTROPHY,1
YAP1_DN,SET,37,-0.049558,-0.0022214,0.14828,0.63089,YAP1_DN,1
GOBP_REGULATION_OF_SKELETAL_...6,SET,7,-0.10296,-0.002009,0.30797,0.63093,GOBP_REGULATION_OF_SKELETAL_MUSCLE_CONTRACTION_BY_CALCIUM_ION_SIGNALING,1
FIRESTEIN_CTNNB1_PATHWAY_AND...,SET,6,-0.12599,-0.0022761,0.37665,0.631,FIRESTEIN_CTNNB1_PATHWAY_AND_PROLIFERATION,1
SATO_SILENCED_BY_DEACETYLATI...,SET,36,-0.050183,-0.0022188,0.15002,0.631,SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER,1
SCIAN_INVERSED_TARGETS_OF_TP...1,SET,26,-0.055666,-0.0020922,0.16635,0.63105,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_DN,1
MIR3130_5P,SET,49,-0.040104,-0.002068,0.11983,0.63106,MIR3130_5P,1
HP_ABNORMAL_TEMPORAL_BONE_MO...,SET,4,-0.18439,-0.0027199,0.55052,0.63116,HP_ABNORMAL_TEMPORAL_BONE_MORPHOLOGY,1
HP_UNDETECTABLE_VISUAL_EVOKE...,SET,8,-0.092916,-0.0019381,0.27738,0.63118,HP_UNDETECTABLE_VISUAL_EVOKED_POTENTIALS,1
GSE21546_SAP1A_KO_VS_SAP1A_K...3,SET,185,-0.019651,-0.0019616,0.058662,0.63118,GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
SNRNP70_TARGET_GENES,SET,685,-0.010657,-0.0020187,0.031804,0.63122,SNRNP70_TARGET_GENES,1
DESCARTES_FETAL_LIVER_MEGAKA...,SET,113,-0.027685,-0.0021641,0.08258,0.63128,DESCARTES_FETAL_LIVER_MEGAKARYOCYTES,1
HP_ABNORMAL_LEUKOCYTE_PHYSIO...,SET,263,-0.017599,-0.0020901,0.052455,0.63137,HP_ABNORMAL_LEUKOCYTE_PHYSIOLOGY,1
MIR3155A_MIR3155B,SET,71,-0.033068,-0.0020514,0.098559,0.63138,MIR3155A_MIR3155B,1
GOBP_REGULATION_OF_CONNECTIV...,SET,5,-0.12518,-0.0020644,0.37293,0.63143,GOBP_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,1
TEF_Q6,SET,235,-0.019518,-0.0021929,0.058137,0.63146,TEF_Q6,1
GOBP_REGULATION_OF_NUCLEASE_...,SET,21,-0.063137,-0.002133,0.18804,0.63147,GOBP_REGULATION_OF_NUCLEASE_ACTIVITY,1
MIR4434,SET,148,-0.022985,-0.0020543,0.068425,0.63153,MIR4434,1
STAMBOLSKY_RESPONSE_TO_VITAM...1,SET,22,-0.062361,-0.0021563,0.18552,0.63162,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN,1
COMP1_01,SET,103,-0.031386,-0.002343,0.093309,0.6317,COMP1_01,1
HP_ABNORMALITY_OF_NEURONAL_M...,SET,424,-0.013359,-0.0020056,0.039717,0.6317,HP_ABNORMALITY_OF_NEURONAL_MIGRATION,1
GOBP_CELLULAR_RESPONSE_TO_FL...,SET,19,-0.069712,-0.0022403,0.20719,0.63174,GOBP_CELLULAR_RESPONSE_TO_FLUID_SHEAR_STRESS,1
GOBP_RESPONSE_TO_ESTRADIOL,SET,113,-0.027914,-0.002182,0.082963,0.63174,GOBP_RESPONSE_TO_ESTRADIOL,1
GSE14699_NAIVE_VS_DELETIONAL...2,SET,133,-0.024872,-0.0021081,0.073907,0.63176,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_UP,1
GSE17721_CTRL_VS_LPS_0.5H_BM...2,SET,179,-0.021493,-0.0021108,0.063858,0.63178,GSE17721_CTRL_VS_LPS_0.5H_BMDC_UP,1
REACTOME_NPAS4_REGULATES_EXP...,SET,20,-0.069551,-0.0022931,0.20663,0.63179,REACTOME_NPAS4_REGULATES_EXPRESSION_OF_TARGET_GENES,1
GOBP_REGULATION_OF_ENDOTHELI...3,SET,34,-0.050736,-0.0021802,0.15072,0.6318,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GOBP_CAMP_PKA_SIGNAL_TRANSDU...,SET,5,-0.13122,-0.0021641,0.38969,0.63184,GOBP_CAMP_PKA_SIGNAL_TRANSDUCTION,1
GOBP_PYRIDINE_CONTAINING_COM...3,SET,158,-0.021899,-0.0020217,0.065034,0.63184,GOBP_PYRIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...742,SET,6,-0.13236,-0.0023911,0.393,0.63186,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
MIR1233_3P,SET,71,-0.038107,-0.0023639,0.11312,0.63189,MIR1233_3P,1
MIR548AJ_5P_MIR548G_5P_MIR54...,SET,446,-0.013893,-0.0021377,0.04123,0.63192,MIR548AJ_5P_MIR548G_5P_MIR548X_5P,1
WP_OXIDATIVE_PHOSPHORYLATION,SET,35,-0.040673,-0.0017732,0.12068,0.63196,WP_OXIDATIVE_PHOSPHORYLATION,1
HP_CARDIORESPIRATORY_ARREST,SET,10,-0.096123,-0.0022415,0.28517,0.63197,HP_CARDIORESPIRATORY_ARREST,1
GOBP_ICOSANOID_METABOLIC_PRO...,SET,110,-0.02803,-0.002162,0.083147,0.63198,GOBP_ICOSANOID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_RESPONSE_...14,SET,161,-0.023531,-0.0021927,0.06979,0.632,GOBP_REGULATION_OF_RESPONSE_TO_WOUNDING,1
GOBP_MAMMARY_GLAND_EPITHELIA...1,SET,17,-0.074773,-0.002273,0.22165,0.63207,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_DIFFERENTIATION,1
GSE6092_CTRL_VS_BORRELIA_BIR...2,SET,143,-0.022595,-0.0019853,0.066978,0.63207,GSE6092_CTRL_VS_BORRELIA_BIRGDOFERI_INF_ENDOTHELIAL_CELL_UP,1
GOCC_RECYCLING_ENDOSOME_MEMB...,SET,97,-0.028374,-0.0020559,0.084103,0.63208,GOCC_RECYCLING_ENDOSOME_MEMBRANE,1
HP_ANTECUBITAL_PTERYGIUM,SET,7,-0.12087,-0.0023584,0.35822,0.6321,HP_ANTECUBITAL_PTERYGIUM,1
GENTILE_UV_RESPONSE_CLUSTER_...1,SET,17,-0.069597,-0.0021157,0.20622,0.63212,GENTILE_UV_RESPONSE_CLUSTER_D1,1
LOPES_METHYLATED_IN_COLON_CA...2,SET,27,-0.06246,-0.0023922,0.18505,0.63214,LOPES_METHYLATED_IN_COLON_CANCER_UP,1
HP_ABNORMALITY_OF_JOINT_MOBI...,SET,1163,-0.0084488,-0.002057,0.025027,0.63216,HP_ABNORMALITY_OF_JOINT_MOBILITY,1
GOBP_STEROL_HOMEOSTASIS,SET,84,-0.031417,-0.0021191,0.093018,0.63222,GOBP_STEROL_HOMEOSTASIS,1
GOCC_PROTON_TRANSPORTING_TWO...1,SET,26,-0.054686,-0.0020554,0.16188,0.63225,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX,1
MIR16_2_3P,SET,205,-0.020121,-0.0021132,0.059545,0.63228,MIR16_2_3P,1
FIGUEROA_AML_METHYLATION_CLU...1,SET,41,-0.045832,-0.0021623,0.1356,0.63232,FIGUEROA_AML_METHYLATION_CLUSTER_1_DN,1
GOMF_RNA_DIRECTED_DNA_POLYME...,SET,6,-0.10612,-0.0019171,0.31385,0.63237,GOMF_RNA_DIRECTED_DNA_POLYMERASE_ACTIVITY,1
DURANTE_ADULT_OLFACTORY_NEUR...1,SET,32,-0.051142,-0.0021321,0.15122,0.63239,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_BOWMANS_GLAND,1
HP_KETOTIC_HYPOGLYCEMIA,SET,12,-0.084542,-0.0021595,0.24993,0.63242,HP_KETOTIC_HYPOGLYCEMIA,1
MIR153_5P,SET,950,-0.0097517,-0.002159,0.028826,0.63243,MIR153_5P,1
GSE27786_LIN_NEG_VS_MONO_MAC...1,SET,182,-0.02027,-0.0020071,0.059887,0.63249,GSE27786_LIN_NEG_VS_MONO_MAC_DN,1
GSE2706_R848_VS_R848_AND_LPS...2,SET,148,-0.022256,-0.0019891,0.065754,0.6325,GSE2706_R848_VS_R848_AND_LPS_2H_STIM_DC_UP,1
GAVISH_3CA_METAPROGRAM_EPITH...11,SET,48,-0.044003,-0.0022458,0.12994,0.63256,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI_1,1
REACTOME_VOLTAGE_GATED_POTAS...,SET,42,-0.050794,-0.0024254,0.14986,0.63267,REACTOME_VOLTAGE_GATED_POTASSIUM_CHANNELS,1
HP_ABNORMAL_BASAL_GANGLIA_MR...,SET,35,-0.046452,-0.0020252,0.13704,0.63268,HP_ABNORMAL_BASAL_GANGLIA_MRI_SIGNAL_INTENSITY,1
GSE17721_CPG_VS_GARDIQUIMOD_...10,SET,186,-0.020809,-0.0020827,0.061379,0.6327,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_UP,1
GOCC_MHC_CLASS_I_PROTEIN_COM...,SET,9,-0.10346,-0.0022889,0.30509,0.63273,GOCC_MHC_CLASS_I_PROTEIN_COMPLEX,1
KEGG_MEDICUS_REFERENCE_CCR_C...,SET,31,-0.055587,-0.002281,0.16391,0.63274,KEGG_MEDICUS_REFERENCE_CCR_CXCR_GNB_G_PI3K_RAC_SIGNALING_PATHWAY,1
GROSS_HYPOXIA_VIA_ELK3_ONLY_...1,SET,44,-0.043677,-0.0021345,0.12877,0.63277,GROSS_HYPOXIA_VIA_ELK3_ONLY_DN,1
HP_SLEEP_RELATED_BREATHING_D...,SET,148,-0.023985,-0.0021437,0.070713,0.63277,HP_SLEEP_RELATED_BREATHING_DISORDERS,1
GOBP_POSITIVE_REGULATION_OF_...265,SET,15,-0.067857,-0.0019378,0.20001,0.63279,GOBP_POSITIVE_REGULATION_OF_EXOSOMAL_SECRETION,1
chr6p24,SET,31,-0.092289,-0.0037871,0.27183,0.63289,chr6p24,1
REACTOME_MISCELLANEOUS_TRANS...,SET,21,-0.064383,-0.0021751,0.18963,0.63289,REACTOME_MISCELLANEOUS_TRANSPORT_AND_BINDING_EVENTS,1
GOBP_REGULATION_OF_INSULIN_L...,SET,20,-0.073531,-0.0024243,0.21657,0.63289,GOBP_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_CHROMATIN_BINDING,SET,522,-0.0126,-0.002093,0.037107,0.6329,GOMF_CHROMATIN_BINDING,1
GSE42724_NAIVE_VS_MEMORY_BCE...2,SET,184,-0.020295,-0.0020205,0.059771,0.6329,GSE42724_NAIVE_VS_MEMORY_BCELL_UP,1
PID_VEGFR1_2_PATHWAY,SET,68,-0.033982,-0.0020632,0.10002,0.63297,PID_VEGFR1_2_PATHWAY,1
GOBP_CHROMATIN_REMODELING,SET,516,-0.012257,-0.0020247,0.036076,0.63298,GOBP_CHROMATIN_REMODELING,1
GOBP_PYRIMIDINE_DIMER_REPAIR,SET,9,-0.071047,-0.0015718,0.20909,0.63299,GOBP_PYRIMIDINE_DIMER_REPAIR,1
WP_VITAMIN_D_METABOLISM,SET,10,-0.089545,-0.0020881,0.26352,0.633,WP_VITAMIN_D_METABOLISM,1
KEGG_ASCORBATE_AND_ALDARATE_...,SET,23,-0.078421,-0.0027725,0.23075,0.63301,KEGG_ASCORBATE_AND_ALDARATE_METABOLISM,1
GOBP_APOPTOTIC_PROCESS_IN_BO...,SET,5,-0.13988,-0.0023069,0.41152,0.63304,GOBP_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,1
GOBP_POSITIVE_REGULATION_OF_...703,SET,8,-0.11861,-0.0024741,0.34884,0.63308,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,1
HP_APLASIA_HYPOPLASIA_OF_THE...38,SET,10,-0.08817,-0.0020561,0.25927,0.63309,HP_APLASIA_HYPOPLASIA_OF_THE_INNER_EAR,1
GSE6674_UNSTIM_VS_ANTI_IGM_A...1,SET,178,-0.020411,-0.0019989,0.059995,0.63315,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
HP_PIERRE_ROBIN_SEQUENCE,SET,25,-0.056686,-0.0020892,0.16657,0.63319,HP_PIERRE_ROBIN_SEQUENCE,1
GOBP_CRANIOFACIAL_SUTURE_MOR...,SET,19,-0.07272,-0.0023369,0.21364,0.63321,GOBP_CRANIOFACIAL_SUTURE_MORPHOGENESIS,1
GSE27786_LIN_NEG_VS_NKTCELL_...1,SET,184,-0.01991,-0.0019821,0.058493,0.63321,GSE27786_LIN_NEG_VS_NKTCELL_DN,1
GSE22886_NAIVE_BCELL_VS_DC_DN,SET,188,-0.020546,-0.0020674,0.060306,0.63333,GSE22886_NAIVE_BCELL_VS_DC_DN,1
HALLMARK_PANCREAS_BETA_CELLS,SET,38,-0.053086,-0.0024114,0.15581,0.63334,HALLMARK_PANCREAS_BETA_CELLS,1
REACTOME_TP53_REGULATES_TRAN...9,SET,18,-0.064138,-0.0020062,0.18817,0.63339,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_G2_CELL_CYCLE_ARREST,1
GOMF_TRNA_URIDINE_METHYLTRAN...,SET,3,-0.1363,-0.0017412,0.39946,0.63352,GOMF_TRNA_URIDINE_METHYLTRANSFERASE_ACTIVITY,1
MIR548A_5P,SET,444,-0.013688,-0.0021016,0.040108,0.63355,MIR548A_5P,1
HP_PERSISTENT_OPEN_ANTERIOR_...,SET,7,-0.094757,-0.0018489,0.27761,0.63357,HP_PERSISTENT_OPEN_ANTERIOR_FONTANELLE,1
HP_CONGENITAL_FIBROSIS_OF_EX...,SET,6,-0.11816,-0.0021346,0.34606,0.63361,HP_CONGENITAL_FIBROSIS_OF_EXTRAOCULAR_MUSCLES,1
ZNF558_TARGET_GENES,SET,225,-0.018963,-0.0020852,0.055534,0.63362,ZNF558_TARGET_GENES,1
GOCC_RNAI_EFFECTOR_COMPLEX,SET,15,-0.080122,-0.002288,0.23465,0.63362,GOCC_RNAI_EFFECTOR_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...72,SET,43,-0.0448,-0.0021644,0.13111,0.63371,GOBP_POSITIVE_REGULATION_OF_B_CELL_PROLIFERATION,1
GCM_HMGA2,SET,107,-0.026757,-0.0020356,0.078282,0.63375,GCM_HMGA2,1
GOBP_RESPONSE_TO_DIETARY_EXC...,SET,33,-0.053149,-0.0022501,0.1555,0.63375,GOBP_RESPONSE_TO_DIETARY_EXCESS,1
GSE17721_4_VS_24H_GARDIQUIMO...1,SET,177,-0.021214,-0.0020718,0.062043,0.63379,GSE17721_4_VS_24H_GARDIQUIMOD_BMDC_DN,1
TAXCREB_01,SET,121,-0.026313,-0.0021279,0.076939,0.63382,TAXCREB_01,1
HP_FUNCTIONAL_INTESTINAL_OBS...,SET,10,-0.098787,-0.0023037,0.2888,0.63385,HP_FUNCTIONAL_INTESTINAL_OBSTRUCTION,1
GOBP_SPERM_DNA_CONDENSATION,SET,14,-0.073265,-0.0020213,0.21416,0.63386,GOBP_SPERM_DNA_CONDENSATION,1
GOBP_REGULATION_OF_STORE_OPE...2,SET,14,-0.08096,-0.0022336,0.23653,0.63393,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_ENTRY,1
GOBP_DITERPENOID_METABOLIC_P...,SET,86,-0.034668,-0.0023659,0.10126,0.63396,GOBP_DITERPENOID_METABOLIC_PROCESS,1
GOBP_2FE_2S_CLUSTER_ASSEMBLY,SET,8,-0.10337,-0.0021561,0.30191,0.63397,GOBP_2FE_2S_CLUSTER_ASSEMBLY,1
DESCARTES_MAIN_FETAL_MEGAKAR...,SET,155,-0.023545,-0.0021531,0.068765,0.63397,DESCARTES_MAIN_FETAL_MEGAKARYOCYTES,1
REACTOME_SIGNALING_BY_NOTCH,SET,168,-0.021003,-0.0019989,0.061338,0.63398,REACTOME_SIGNALING_BY_NOTCH,1
GOBP_COCHLEA_DEVELOPMENT,SET,48,-0.044428,-0.0022675,0.12968,0.63405,GOBP_COCHLEA_DEVELOPMENT,1
BIOCARTA_P38MAPK_PATHWAY,SET,35,-0.048505,-0.0021147,0.14156,0.63406,BIOCARTA_P38MAPK_PATHWAY,1
GOBP_MITOCHONDRIAL_PROTON_TR...,SET,5,-0.13445,-0.0022173,0.39236,0.63407,GOBP_MITOCHONDRIAL_PROTON_TRANSPORTING_ATP_SYNTHASE_COMPLEX_ASSEMBLY,1
REACTOME_TRAF6_MEDIATED_IRF7...1,SET,26,-0.062416,-0.0023459,0.18213,0.63408,REACTOME_TRAF6_MEDIATED_IRF7_ACTIVATION,1
MIR93_5P,SET,570,-0.012397,-0.0021491,0.036171,0.6341,MIR93_5P,1
GSE10239_MEMORY_VS_DAY4.5_EF...1,SET,181,-0.020894,-0.0020633,0.06096,0.6341,GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_MO...,SET,209,-0.021081,-0.0022352,0.061479,0.63416,GOBP_CELLULAR_RESPONSE_TO_MOLECULE_OF_BACTERIAL_ORIGIN,1
GSE7460_CTRL_VS_TGFB_TREATED...6,SET,177,-0.021795,-0.0021285,0.063503,0.63428,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_UP,1
PID_CXCR3_PATHWAY,SET,42,-0.04612,-0.0022022,0.13436,0.6343,PID_CXCR3_PATHWAY,1
HP_ABNORMAL_NASAL_DORSUM_MOR...,SET,228,-0.018616,-0.0020605,0.054231,0.6343,HP_ABNORMAL_NASAL_DORSUM_MORPHOLOGY,1
UNTERMAN_IPF_VS_CTRL_MONOCYT...2,SET,11,-0.088886,-0.0021739,0.25889,0.63433,UNTERMAN_IPF_VS_CTRL_MONOCYTE_UP,1
GSE17974_0H_VS_6H_IN_VITRO_A...1,SET,178,-0.020269,-0.001985,0.05903,0.63433,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_DN,1
GOBP_METANEPHRIC_RENAL_VESIC...,SET,14,-0.091927,-0.0025362,0.26767,0.63436,GOBP_METANEPHRIC_RENAL_VESICLE_MORPHOGENESIS,1
REACTOME_HS_GAG_DEGRADATION,SET,21,-0.067516,-0.0022809,0.19649,0.63443,REACTOME_HS_GAG_DEGRADATION,1
GOBP_DNA_REPAIR,SET,530,-0.011799,-0.0019746,0.034338,0.63443,GOBP_DNA_REPAIR,1
GSE15659_TREG_VS_TCONV_UP,SET,150,-0.023597,-0.0021231,0.068651,0.63447,GSE15659_TREG_VS_TCONV_UP,1
MORF_FLT1,SET,116,-0.027623,-0.0021876,0.080337,0.63451,MORF_FLT1,1
MANN_RESPONSE_TO_AMIFOSTINE_...2,SET,19,-0.059862,-0.0019237,0.17405,0.63455,MANN_RESPONSE_TO_AMIFOSTINE_UP,1
GOBP_VASCULAR_ENDOTHELIAL_GR...2,SET,6,-0.14439,-0.0026084,0.41981,0.63455,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_2_SIGNALING_PATHWAY,1
AMIT_EGF_RESPONSE_480_HELA,SET,154,-0.023977,-0.0021856,0.069686,0.6346,AMIT_EGF_RESPONSE_480_HELA,1
GSE29618_MONOCYTE_VS_MDC_UP,SET,186,-0.022464,-0.0022484,0.065254,0.63467,GSE29618_MONOCYTE_VS_MDC_UP,1
VERHAAK_GLIOBLASTOMA_MESENCH...,SET,204,-0.021435,-0.0022457,0.062261,0.63468,VERHAAK_GLIOBLASTOMA_MESENCHYMAL,1
WILLIAMS_ESR2_TARGETS_DN,SET,10,-0.099419,-0.0023184,0.28872,0.6347,WILLIAMS_ESR2_TARGETS_DN,1
REACTOME_TRISTETRAPROLIN_TTP...,SET,16,-0.06548,-0.0019312,0.19017,0.6347,REACTOME_TRISTETRAPROLIN_TTP_ZFP36_BINDS_AND_DESTABILIZES_MRNA,1
MIR3925_3P,SET,161,-0.022857,-0.0021299,0.066368,0.63472,MIR3925_3P,1
GSE40273_XBP1_KO_VS_WT_TREG_...2,SET,185,-0.021341,-0.0021303,0.061935,0.63479,GSE40273_XBP1_KO_VS_WT_TREG_UP,1
EGFR_UP.V1_DN,SET,162,-0.023064,-0.0021558,0.066925,0.63481,EGFR_UP.V1_DN,1
HP_BRISK_REFLEXES,SET,99,-0.027097,-0.0019833,0.078606,0.63484,HP_BRISK_REFLEXES,1
BLANCO_MELO_COVID19_SARS_COV...1,SET,90,-0.032112,-0.0022416,0.093148,0.63485,BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1
HP_BUPHTHALMOS,SET,24,-0.065119,-0.0023516,0.18883,0.6349,HP_BUPHTHALMOS,1
HP_ABNORMALITY_OF_THE_PLANTA...,SET,159,-0.023656,-0.0021908,0.068591,0.63491,HP_ABNORMALITY_OF_THE_PLANTAR_SKIN_OF_FOOT,1
CTACTAG_MIR325,SET,13,-0.076905,-0.0020446,0.22293,0.63494,CTACTAG_MIR325,1
MANNO_MIDBRAIN_NEUROTYPES_HS...,SET,389,-0.015893,-0.0022876,0.046068,0.63495,MANNO_MIDBRAIN_NEUROTYPES_HSERT,1
HP_ABNORMAL_TUBULAR_BASEMENT...,SET,5,-0.11821,-0.0019494,0.34257,0.63497,HP_ABNORMAL_TUBULAR_BASEMENT_MEMBRANE_MORPHOLOGY,1
HP_OSTEOARTHRITIS,SET,57,-0.04051,-0.0022525,0.11741,0.63497,HP_OSTEOARTHRITIS,1
MODULE_539,SET,15,-0.079912,-0.002282,0.23152,0.63501,MODULE_539,1
GOBP_DGMP_METABOLIC_PROCESS,SET,6,-0.12034,-0.0021739,0.34848,0.63507,GOBP_DGMP_METABOLIC_PROCESS,1
HIRSCH_CELLULAR_TRANSFORMATI...1,SET,91,-0.030657,-0.0021519,0.088747,0.63512,HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_DN,1
MIR452_3P,SET,118,-0.028303,-0.0022606,0.081932,0.63512,MIR452_3P,1
GOBP_POSITIVE_REGULATION_OF_...103,SET,5,-0.1356,-0.0022363,0.39235,0.63518,GOBP_POSITIVE_REGULATION_OF_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
GOMF_L_GLUTAMINE_TRANSMEMBRA...,SET,8,-0.11164,-0.0023287,0.32286,0.63525,GOMF_L_GLUTAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE17974_0H_VS_6H_IN_VITRO_A...2,SET,162,-0.023313,-0.002179,0.067418,0.63525,GSE17974_0H_VS_6H_IN_VITRO_ACT_CD4_TCELL_UP,1
GOBP_REGULATION_OF_SYNAPTIC_...12,SET,8,-0.096875,-0.0020207,0.28009,0.63528,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_PRIMING,1
REACTOME_MET_ACTIVATES_PTPN11,SET,5,-0.1253,-0.0020665,0.36212,0.63534,REACTOME_MET_ACTIVATES_PTPN11,1
GUENTHER_GROWTH_SPHERICAL_VS...2,SET,20,-0.07368,-0.0024292,0.21283,0.6354,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP,1
HP_ABNORMAL_INCISOR_MORPHOLO...,SET,55,-0.041013,-0.0022402,0.1184,0.63547,HP_ABNORMAL_INCISOR_MORPHOLOGY,1
ATF4_Q2,SET,227,-0.019258,-0.002127,0.055594,0.63548,ATF4_Q2,1
HP_SYRINGOMYELIA,SET,30,-0.049443,-0.001996,0.14271,0.6355,HP_SYRINGOMYELIA,1
TURJANSKI_MAPK14_TARGETS,SET,9,-0.10292,-0.0022771,0.29694,0.63556,TURJANSKI_MAPK14_TARGETS,1
MIR3186_5P,SET,2,-0.18293,-0.0019081,0.52775,0.63556,MIR3186_5P,1
GOBP_NUCLEOSIDE_SALVAGE,SET,10,-0.097204,-0.0022668,0.28044,0.63556,GOBP_NUCLEOSIDE_SALVAGE,1
ZNF507_TARGET_GENES,SET,511,-0.012696,-0.0020873,0.03661,0.63562,ZNF507_TARGET_GENES,1
GSE17721_12H_VS_24H_PAM3CSK4...2,SET,182,-0.021024,-0.0020817,0.060614,0.63564,GSE17721_12H_VS_24H_PAM3CSK4_BMDC_UP,1
GOBP_REGULATION_OF_HORMONE_L...,SET,511,-0.013824,-0.0022729,0.039844,0.63569,GOBP_REGULATION_OF_HORMONE_LEVELS,1
MIR20B_5P,SET,571,-0.012527,-0.0021734,0.036099,0.6357,MIR20B_5P,1
GOBP_DETECTION_OF_ABIOTIC_ST...,SET,130,-0.026679,-0.0022358,0.076888,0.6357,GOBP_DETECTION_OF_ABIOTIC_STIMULUS,1
GSE12392_CD8A_POS_VS_NEG_SPL...3,SET,188,-0.020861,-0.002099,0.060104,0.63573,GSE12392_CD8A_POS_VS_NEG_SPLEEN_IFNB_KO_DC_DN,1
JIANG_MELANOMA_TRM_HIGH_SURV...,SET,19,-0.069151,-0.0022222,0.19919,0.63576,JIANG_MELANOMA_TRM_HIGH_SURVIVAL_22_GENE_SIGNATURE,1
GOBP_NEGATIVE_REGULATION_OF_...257,SET,12,-0.086737,-0.0022156,0.24964,0.63587,GOBP_NEGATIVE_REGULATION_OF_GLUCOSE_IMPORT,1
GSE26488_HDAC7_KO_VS_VP16_TR...2,SET,157,-0.023663,-0.0021777,0.068087,0.6359,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,1
TAL1ALPHAE47_01,SET,228,-0.020255,-0.002242,0.05826,0.63595,TAL1ALPHAE47_01,1
GOMF_CAMP_RESPONSE_ELEMENT_B...1,SET,12,-0.087132,-0.0022257,0.25046,0.63603,GOMF_CAMP_RESPONSE_ELEMENT_BINDING,1
GSE12198_CTRL_VS_LOW_IL2_STI...2,SET,181,-0.020896,-0.0020634,0.060069,0.63603,GSE12198_CTRL_VS_LOW_IL2_STIM_NK_CELL_UP,1
GOMF_PROTEOGLYCAN_BINDING,SET,35,-0.054292,-0.002367,0.15605,0.63604,GOMF_PROTEOGLYCAN_BINDING,1
GOCC_EARLY_ENDOSOME_LUMEN,SET,5,-0.13444,-0.0022171,0.3863,0.63608,GOCC_EARLY_ENDOSOME_LUMEN,1
MIR5100,SET,84,-0.032836,-0.0022148,0.094321,0.63612,MIR5100,1
GOBP_POSITIVE_REGULATION_OF_...580,SET,64,-0.040554,-0.0023889,0.11648,0.63614,GOBP_POSITIVE_REGULATION_OF_PHAGOCYTOSIS,1
GOBP_RESPONSE_TO_RETINOIC_AC...,SET,101,-0.031794,-0.0023504,0.091316,0.63614,GOBP_RESPONSE_TO_RETINOIC_ACID,1
GOBP_REGULATION_OF_CELLULAR_...1,SET,12,-0.083141,-0.0021238,0.23877,0.63616,GOBP_REGULATION_OF_CELLULAR_AMINO_ACID_METABOLIC_PROCESS,1
PECE_MAMMARY_STEM_CELL_UP,SET,121,-0.025234,-0.0020407,0.072459,0.63617,PECE_MAMMARY_STEM_CELL_UP,1
REACTOME_SHC_MEDIATED_CASCAD...3,SET,19,-0.068237,-0.0021928,0.19594,0.63618,REACTOME_SHC_MEDIATED_CASCADE_FGFR4,1
WP_RETINOL_METABOLISM,SET,15,-0.078581,-0.002244,0.22559,0.6362,WP_RETINOL_METABOLISM,1
MODULE_45,SET,528,-0.013453,-0.0022471,0.03862,0.6362,MODULE_45,1
GOMF_ATPASE_INHIBITOR_ACTIVI...,SET,4,-0.14513,-0.0021408,0.41655,0.63623,GOMF_ATPASE_INHIBITOR_ACTIVITY,1
GOBP_PUTRESCINE_METABOLIC_PR...,SET,7,-0.1013,-0.0019767,0.29074,0.63624,GOBP_PUTRESCINE_METABOLIC_PROCESS,1
GSE15330_HSC_VS_LYMPHOID_PRI...2,SET,177,-0.021334,-0.0020835,0.061219,0.63626,GSE15330_HSC_VS_LYMPHOID_PRIMED_MULTIPOTENT_PROGENITOR_IKAROS_KO_DN,1
REACTOME_SULFIDE_OXIDATION_T...,SET,5,-0.11744,-0.0019368,0.33696,0.63628,REACTOME_SULFIDE_OXIDATION_TO_SULFATE,1
GOMF_PROTEIN_DOMAIN_SPECIFIC...,SET,600,-0.012024,-0.0021367,0.034483,0.63633,GOMF_PROTEIN_DOMAIN_SPECIFIC_BINDING,1
GSE32901_NAIVE_VS_TH17_ENRIC...1,SET,154,-0.024036,-0.002191,0.068929,0.63634,GSE32901_NAIVE_VS_TH17_ENRICHED_CD4_TCELL_DN,1
MIR4448,SET,61,-0.038247,-0.0021998,0.10968,0.63635,MIR4448,1
GOBP_POSITIVE_REGULATION_OF_...668,SET,14,-0.076942,-0.0021228,0.22052,0.63642,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_RECYCLING,1
TSENG_ADIPOGENIC_POTENTIAL_UP,SET,25,-0.059522,-0.0021938,0.17055,0.63645,TSENG_ADIPOGENIC_POTENTIAL_UP,1
GSE10325_CD4_TCELL_VS_BCELL_...1,SET,166,-0.024142,-0.002284,0.069178,0.63645,GSE10325_CD4_TCELL_VS_BCELL_DN,1
HP_ABNORMAL_LIVER_PARENCHYMA...,SET,10,-0.087349,-0.0020369,0.25027,0.63646,HP_ABNORMAL_LIVER_PARENCHYMA_MORPHOLOGY,1
HP_HYPOREFLEXIA,SET,349,-0.015281,-0.0020857,0.043781,0.63647,HP_HYPOREFLEXIA,1
REACTOME_DNA_REPLICATION_PRE...,SET,94,-0.026999,-0.0019259,0.077314,0.63653,REACTOME_DNA_REPLICATION_PRE_INITIATION,1
HP_HELICOBACTER_PYLORI_INFEC...,SET,4,-0.14989,-0.0022111,0.42915,0.63656,HP_HELICOBACTER_PYLORI_INFECTION,1
CAGCTTT_MIR320,SET,220,-0.020362,-0.0022144,0.058289,0.63658,CAGCTTT_MIR320,1
HP_LEFT_VENTRICULAR_OUTFLOW_...,SET,8,-0.11945,-0.0024916,0.34193,0.63658,HP_LEFT_VENTRICULAR_OUTFLOW_TRACT_OBSTRUCTION,1
GOBP_GASTRIC_ACID_SECRETION,SET,13,-0.079664,-0.002118,0.22799,0.63661,GOBP_GASTRIC_ACID_SECRETION,1
P53_DN.V1_UP,SET,178,-0.024081,-0.0023584,0.068891,0.63666,P53_DN.V1_UP,1
MIDORIKAWA_AMPLIFIED_IN_LIVE...,SET,51,-0.059839,-0.0031478,0.17115,0.63669,MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER,1
HP_AXILLARY_PTERYGIUM,SET,9,-0.10153,-0.0022463,0.29038,0.6367,HP_AXILLARY_PTERYGIUM,1
GAVISH_3CA_METAPROGRAM_B_CEL...2,SET,40,-0.047376,-0.0022078,0.13544,0.63675,GAVISH_3CA_METAPROGRAM_B_CELLS_CELL_CYCLE,1
GSE13522_CTRL_VS_T_CRUZI_Y_S...4,SET,122,-0.02506,-0.002035,0.071642,0.63675,GSE13522_CTRL_VS_T_CRUZI_Y_STRAIN_INF_SKIN_BALBC_MOUSE_UP,1
HP_ABNORMAL_EXTERNAL_NOSE_MO...,SET,789,-0.010265,-0.0020807,0.029339,0.63678,HP_ABNORMAL_EXTERNAL_NOSE_MORPHOLOGY,1
GSE37533_PPARG2_FOXP3_VS_FOX...2,SET,172,-0.021225,-0.0020437,0.060663,0.63679,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,1
REACTOME_CREB1_PHOSPHORYLATI...1,SET,25,-0.063001,-0.002322,0.18004,0.6368,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_NMDA_RECEPTOR_MEDIATED_ACTIVATION_OF_RAS_SIGNALING,1
GOMF_DEATH_DOMAIN_BINDING,SET,10,-0.10202,-0.002379,0.29143,0.63685,GOMF_DEATH_DOMAIN_BINDING,1
GOBP_LEUKOTRIENE_CATABOLIC_P...,SET,6,-0.11957,-0.0021601,0.34154,0.63686,GOBP_LEUKOTRIENE_CATABOLIC_PROCESS,1
GSE7460_TCONV_VS_TREG_THYMUS...2,SET,182,-0.022169,-0.0021951,0.063322,0.63686,GSE7460_TCONV_VS_TREG_THYMUS_UP,1
HP_TRICUSPID_ATRESIA,SET,11,-0.10584,-0.0025885,0.30222,0.63691,HP_TRICUSPID_ATRESIA,1
HP_ABNORMAL_HEART_MORPHOLOGY,SET,1338,-0.0082485,-0.002143,0.023523,0.63707,HP_ABNORMAL_HEART_MORPHOLOGY,1
LI_CYTIDINE_ANALOG_PATHWAY,SET,17,-0.074359,-0.0022605,0.21196,0.63714,LI_CYTIDINE_ANALOG_PATHWAY,1
GSE9006_HEALTHY_VS_TYPE_2_DI...2,SET,176,-0.020637,-0.0020098,0.058801,0.63719,GSE9006_HEALTHY_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...6,SET,29,-0.058292,-0.0023137,0.16602,0.63725,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_JNK_SIGNALING_PATHWAY,1
MIR4715_3P,SET,67,-0.03752,-0.0022613,0.10684,0.63728,MIR4715_3P,1
DESCARTES_FETAL_LUNG_BRONCHI...,SET,48,-0.048193,-0.0024597,0.13719,0.63731,DESCARTES_FETAL_LUNG_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,1
GOBP_NUCLEOSIDE_MONOPHOSPHAT...3,SET,69,-0.035913,-0.0021963,0.10222,0.63733,GOBP_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
REACTOME_MISCELLANEOUS_SUBST...,SET,12,-0.093957,-0.0024,0.26732,0.63738,REACTOME_MISCELLANEOUS_SUBSTRATES,1
GNF2_PPP6C,SET,35,-0.044877,-0.0019565,0.12767,0.6374,GNF2_PPP6C,1
GSE41867_LCMV_ARMSTRONG_VS_C...2,SET,176,-0.021633,-0.0021068,0.061525,0.63743,GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_UP,1
CAMP_UP.V1_UP,SET,180,-0.020875,-0.0020558,0.059368,0.63744,CAMP_UP.V1_UP,1
MOOTHA_FFA_OXYDATION,SET,22,-0.061186,-0.0021157,0.17397,0.63747,MOOTHA_FFA_OXYDATION,1
SCHLOSSER_MYC_TARGETS_AND_SE...1,SET,42,-0.042115,-0.002011,0.11974,0.63747,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN,1
GOCC_CYTOPLASMIC_SIDE_OF_MEM...,SET,186,-0.021886,-0.0021905,0.062225,0.63747,GOCC_CYTOPLASMIC_SIDE_OF_MEMBRANE,1
MODULE_492,SET,16,-0.075103,-0.002215,0.21351,0.63748,MODULE_492,1
MOOTHA_PYR,SET,5,-0.17239,-0.002843,0.49005,0.63749,MOOTHA_PYR,1
GOBP_RESPONSE_TO_UV_C,SET,13,-0.080547,-0.0021414,0.22895,0.63751,GOBP_RESPONSE_TO_UV_C,1
HP_ABNORMAL_VENTRICULAR_AXIS,SET,5,-0.14781,-0.0024377,0.42009,0.63753,HP_ABNORMAL_VENTRICULAR_AXIS,1
REACTOME_REGULATION_OF_INSUL...1,SET,116,-0.029845,-0.0023635,0.084796,0.63756,REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS,1
EVI1_01,SET,14,-0.076464,-0.0021096,0.21726,0.63756,EVI1_01,1
HP_SHORT_RIBS,SET,58,-0.037796,-0.0021199,0.10737,0.63758,HP_SHORT_RIBS,1
GOBP_POLY_A_DEPENDENT_SNORNA...,SET,6,-0.10213,-0.001845,0.28987,0.6377,GOBP_POLY_A_DEPENDENT_SNORNA_3_END_PROCESSING,1
HP_EEG_WITH_GENERALIZED_POLY...,SET,6,-0.12407,-0.0022413,0.35212,0.63771,HP_EEG_WITH_GENERALIZED_POLYSPIKES,1
GOBP_DETERMINATION_OF_LEFT_R...,SET,10,-0.10241,-0.0023882,0.29064,0.63772,GOBP_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY_IN_LATERAL_MESODERM,1
GOBP_AUTOPHAGOSOME_ORGANIZAT...,SET,112,-0.026912,-0.0020944,0.076359,0.63774,GOBP_AUTOPHAGOSOME_ORGANIZATION,1
HP_TOE_CLINODACTYLY,SET,24,-0.059791,-0.0021592,0.16958,0.6378,HP_TOE_CLINODACTYLY,1
HP_EPIDIDYMITIS,SET,3,-0.18946,-0.0024204,0.53723,0.63783,HP_EPIDIDYMITIS,1
GOMF_MONOATOMIC_CATION_BICAR...,SET,13,-0.075496,-0.0020071,0.21403,0.63785,GOMF_MONOATOMIC_CATION_BICARBONATE_SYMPORTER_ACTIVITY,1
HP_GENU_VARUM,SET,54,-0.040937,-0.0022157,0.11605,0.63786,HP_GENU_VARUM,1
HOWARD_PBMC_INACT_MONOV_INFL...1,SET,27,-0.063103,-0.0024169,0.17874,0.63797,HOWARD_PBMC_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_19_39YO_AS03_ADJUVANT_VS_BUFFER_1DY_DN,1
GOBP_REGULATION_OF_CHRONIC_I...,SET,8,-0.10244,-0.0021367,0.29011,0.63799,GOBP_REGULATION_OF_CHRONIC_INFLAMMATORY_RESPONSE,1
GSE37534_GW1929_VS_ROSIGLITA...1,SET,147,-0.023379,-0.0020825,0.066213,0.63799,GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
MODULE_385,SET,28,-0.061539,-0.0024001,0.17415,0.63809,MODULE_385,1
HP_NEOPLASM_OF_THE_ADRENAL_C...,SET,26,-0.063476,-0.0023858,0.17943,0.63824,HP_NEOPLASM_OF_THE_ADRENAL_CORTEX,1
HP_ABSENT_INNER_DYNEIN_ARMS,SET,7,-0.10054,-0.0019617,0.28399,0.63834,HP_ABSENT_INNER_DYNEIN_ARMS,1
GOBP_RESPONSE_TO_BACTERIUM,SET,612,-0.01318,-0.0023647,0.037219,0.63837,GOBP_RESPONSE_TO_BACTERIUM,1
GCM_PRKCG,SET,55,-0.037128,-0.002028,0.10483,0.63839,GCM_PRKCG,1
GOMF_ADENOSINE_DEAMINASE_ACT...,SET,12,-0.087197,-0.0022274,0.24619,0.6384,GOMF_ADENOSINE_DEAMINASE_ACTIVITY,1
GOBP_NEUROBLAST_MIGRATION,SET,6,-0.13514,-0.0024414,0.38147,0.63843,GOBP_NEUROBLAST_MIGRATION,1
GOBP_POSITIVE_REGULATION_OF_...649,SET,11,-0.075347,-0.0018428,0.21266,0.63844,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SUMOYLATION,1
GOMF_1_PHOSPHATIDYLINOSITOL_...3,SET,7,-0.12632,-0.0024647,0.35649,0.63845,GOMF_1_PHOSPHATIDYLINOSITOL_4_5_BISPHOSPHATE_3_KINASE_ACTIVITY,1
HP_INFANTILE_AXIAL_HYPOTONIA,SET,42,-0.046362,-0.0022138,0.13085,0.63845,HP_INFANTILE_AXIAL_HYPOTONIA,1
REACTOME_SIGNALING_BY_FGFR4_...,SET,11,-0.080558,-0.0019702,0.22731,0.63848,REACTOME_SIGNALING_BY_FGFR4_IN_DISEASE,1
DESCARTES_FETAL_ADRENAL_STRO...,SET,122,-0.029962,-0.002433,0.084523,0.63851,DESCARTES_FETAL_ADRENAL_STROMAL_CELLS,1
GOMF_PURINE_NUCLEOTIDE_TRANS...,SET,25,-0.064936,-0.0023933,0.18317,0.63852,GOMF_PURINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
REACTOME_E3_UBIQUITIN_LIGASE...,SET,39,-0.045839,-0.0021093,0.12927,0.63855,REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS,1
HP_ABNORMAL_NUMBER_OF_ERYTHR...,SET,42,-0.043228,-0.0020641,0.12185,0.63862,HP_ABNORMAL_NUMBER_OF_ERYTHROID_PRECURSORS,1
BIOCARTA_41BB_PATHWAY,SET,18,-0.06821,-0.0021336,0.19216,0.63869,BIOCARTA_41BB_PATHWAY,1
GSE46606_IRF4MID_VS_WT_CD40L...4,SET,190,-0.021639,-0.0021887,0.06096,0.63869,GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
HP_DECREASED_THYROID_STIMULA...,SET,11,-0.090801,-0.0022207,0.25578,0.6387,HP_DECREASED_THYROID_STIMULATING_HORMONE_LEVEL,1
MODULE_352,SET,17,-0.064806,-0.0019701,0.18252,0.63872,MODULE_352,1
HP_OPTIC_DISC_COLOBOMA,SET,24,-0.05798,-0.0020938,0.16327,0.63874,HP_OPTIC_DISC_COLOBOMA,1
SCHERER_PBMC_YF_VAX_AGE_18_4...1,SET,222,-0.019701,-0.0021521,0.055471,0.63876,SCHERER_PBMC_YF_VAX_AGE_18_40YO_4_TO_7DY_DN,1
GSE17721_CTRL_VS_LPS_24H_BMD...2,SET,187,-0.021353,-0.0021429,0.060121,0.63877,GSE17721_CTRL_VS_LPS_24H_BMDC_UP,1
GOMF_MHC_CLASS_I_PROTEIN_COM...,SET,5,-0.11963,-0.0019729,0.33668,0.63882,GOMF_MHC_CLASS_I_PROTEIN_COMPLEX_BINDING,1
GSE16451_CTRL_VS_WEST_EQUINE...1,SET,177,-0.021642,-0.0021136,0.060895,0.63885,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_DN,1
HP_METAPHYSEAL_STRIATIONS,SET,11,-0.10015,-0.0024495,0.28177,0.63887,HP_METAPHYSEAL_STRIATIONS,1
HP_FRONTAL_LOBE_DEMENTIA,SET,18,-0.067124,-0.0020996,0.18883,0.63888,HP_FRONTAL_LOBE_DEMENTIA,1
GOMF_INSULIN_LIKE_GROWTH_FAC...1,SET,18,-0.081092,-0.0025365,0.22793,0.63899,GOMF_INSULIN_LIKE_GROWTH_FACTOR_BINDING,1
MODULE_358,SET,71,-0.035534,-0.0022043,0.099869,0.639,MODULE_358,1
TAKEDA_TARGETS_OF_NUP98_HOXA...1,SET,131,-0.028394,-0.0023886,0.079782,0.63904,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_10D_DN,1
WP_MODULATORS_OF_TCR_SIGNALI...,SET,57,-0.039548,-0.002199,0.11106,0.63911,WP_MODULATORS_OF_TCR_SIGNALING_AND_T_CELL_ACTIVATION,1
HP_INCREASED_LEFT_VENTRICULA...,SET,21,-0.068101,-0.0023007,0.19111,0.63921,HP_INCREASED_LEFT_VENTRICULAR_END_DIASTOLIC_VOLUME,1
BIOCARTA_RANKL_PATHWAY,SET,14,-0.08866,-0.0024461,0.24867,0.63928,BIOCARTA_RANKL_PATHWAY,1
REACTOME_REGULATION_OF_RUNX2...,SET,69,-0.033138,-0.0020266,0.092941,0.63928,REACTOME_REGULATION_OF_RUNX2_EXPRESSION_AND_ACTIVITY,1
MIR12136,SET,903,-0.01033,-0.0022329,0.028959,0.63935,MIR12136,1
GSE17721_0.5H_VS_8H_POLYIC_B...2,SET,183,-0.020706,-0.0020559,0.058043,0.63935,GSE17721_0.5H_VS_8H_POLYIC_BMDC_UP,1
GOBP_EPITHELIAL_TUBE_BRANCHI...,SET,30,-0.058139,-0.002347,0.16295,0.63937,GOBP_EPITHELIAL_TUBE_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,1
GOCC_NBAF_COMPLEX,SET,16,-0.079587,-0.0023472,0.22307,0.63937,GOCC_NBAF_COMPLEX,1
GOMF_NADPLUS_PROTEIN_LYSINE_...,SET,5,-0.13726,-0.0022637,0.38473,0.63937,GOMF_NADPLUS_PROTEIN_LYSINE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
GSE17721_0.5H_VS_4H_PAM3CSK4...1,SET,191,-0.021419,-0.0021721,0.060027,0.63938,GSE17721_0.5H_VS_4H_PAM3CSK4_BMDC_DN,1
GSE6259_FLT3L_INDUCED_DEC205...1,SET,149,-0.02383,-0.002137,0.066761,0.63943,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_BCELL_DN,1
GOBP_FACIAL_NERVE_MORPHOGENE...,SET,9,-0.11332,-0.0025071,0.31746,0.63944,GOBP_FACIAL_NERVE_MORPHOGENESIS,1
GOBP_DEADENYLATION_DEPENDENT...,SET,10,-0.098971,-0.002308,0.27716,0.63949,GOBP_DEADENYLATION_DEPENDENT_DECAPPING_OF_NUCLEAR_TRANSCRIBED_MRNA,1
GOBP_REGULATION_OF_CHAPERONE...,SET,8,-0.094796,-0.0019773,0.26547,0.63949,GOBP_REGULATION_OF_CHAPERONE_MEDIATED_AUTOPHAGY,1
HP_ABNORMAL_B_CELL_SUBSET_DI...,SET,26,-0.063344,-0.0023808,0.17739,0.63949,HP_ABNORMAL_B_CELL_SUBSET_DISTRIBUTION,1
GOBP_SURFACTANT_HOMEOSTASIS,SET,20,-0.069513,-0.0022918,0.19456,0.63956,GOBP_SURFACTANT_HOMEOSTASIS,1
GOBP_MICROTUBULE_CYTOSKELETO...2,SET,157,-0.022808,-0.002099,0.063803,0.63963,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION_INVOLVED_IN_MITOSIS,1
KEGG_MEDICUS_REFERENCE_CXCR4...4,SET,31,-0.056707,-0.002327,0.15862,0.63964,KEGG_MEDICUS_REFERENCE_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY,1
GOCC_CATALYTIC_COMPLEX,SET,1516,-0.0076842,-0.002114,0.021494,0.63964,GOCC_CATALYTIC_COMPLEX,1
GOMF_CAMP_BINDING,SET,23,-0.064736,-0.0022886,0.18105,0.63966,GOMF_CAMP_BINDING,1
KEGG_OTHER_GLYCAN_DEGRADATION,SET,15,-0.081717,-0.0023336,0.2285,0.63968,KEGG_OTHER_GLYCAN_DEGRADATION,1
REACTOME_CHL1_INTERACTIONS,SET,8,-0.12771,-0.002664,0.35712,0.63968,REACTOME_CHL1_INTERACTIONS,1
HP_AREFLEXIA_OF_LOWER_LIMBS,SET,76,-0.033324,-0.0021385,0.093179,0.63969,HP_AREFLEXIA_OF_LOWER_LIMBS,1
GSE11057_NAIVE_VS_CENT_MEMOR...2,SET,153,-0.024538,-0.0022295,0.068581,0.63975,GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,1
HP_ABNORMAL_FEMORAL_NECK_MOR...,SET,139,-0.025479,-0.0022074,0.071206,0.63976,HP_ABNORMAL_FEMORAL_NECK_MORPHOLOGY,1
GOBP_INFLAMMATORY_RESPONSE_T...2,SET,24,-0.065989,-0.002383,0.18438,0.63979,GOBP_INFLAMMATORY_RESPONSE_TO_WOUNDING,1
GOMF_MRNA_3_UTR_AU_RICH_REGI...,SET,28,-0.053856,-0.0021005,0.15026,0.63998,GOMF_MRNA_3_UTR_AU_RICH_REGION_BINDING,1
GOBP_REGULATION_OF_INTESTINA...2,SET,9,-0.1036,-0.0022921,0.28896,0.64003,GOBP_REGULATION_OF_INTESTINAL_LIPID_ABSORPTION,1
GOMF_PRE_MRNA_INTRONIC_BINDI...,SET,13,-0.075325,-0.0020026,0.21007,0.64004,GOMF_PRE_MRNA_INTRONIC_BINDING,1
GOBP_REGULATION_OF_APOPTOTIC...5,SET,347,-0.016412,-0.0022337,0.045751,0.6401,GOBP_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_MACROPHAGE_DIFFERENTIAT...,SET,57,-0.043963,-0.0024445,0.12249,0.64017,GOBP_MACROPHAGE_DIFFERENTIATION,1
HP_CHILLS,SET,18,-0.071549,-0.002238,0.19934,0.64017,HP_CHILLS,1
GSE6674_ANTI_IGM_VS_ANTI_IGM...2,SET,183,-0.022004,-0.0021847,0.061308,0.64017,GSE6674_ANTI_IGM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
CHIANG_LIVER_CANCER_SUBCLASS...9,SET,163,-0.022725,-0.0021306,0.063305,0.64019,CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN,1
HP_CHROMOSOMAL_BREAKAGE_INDU...2,SET,13,-0.079724,-0.0021195,0.2221,0.64019,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_IONIZING_RADIATION,1
MIR548AV_3P,SET,162,-0.023614,-0.0022072,0.065758,0.64024,MIR548AV_3P,1
GOBP_VENTRICULAR_TRABECULA_M...,SET,14,-0.09404,-0.0025945,0.26187,0.64024,GOBP_VENTRICULAR_TRABECULA_MYOCARDIUM_MORPHOGENESIS,1
NIKOLSKY_BREAST_CANCER_12Q13...,SET,42,-0.082243,-0.0039271,0.229,0.64025,NIKOLSKY_BREAST_CANCER_12Q13_Q21_AMPLICON,1
MIR371A_3P,SET,9,-0.10779,-0.0023846,0.30009,0.64027,MIR371A_3P,1
KEGG_MEDICUS_PATHOGEN_ESCHER...2,SET,17,-0.066513,-0.002022,0.18516,0.64028,KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY,1
KEGG_MEDICUS_PATHOGEN_HCMV_G...2,SET,7,-0.11435,-0.0022311,0.31833,0.64028,KEGG_MEDICUS_PATHOGEN_HCMV_GH_TO_ITGA_B_RHOA_SIGNALING_PATHWAY,1
GSE42021_TCONV_PLN_VS_TREG_P...1,SET,183,-0.023396,-0.0023229,0.065132,0.64028,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_DN,1
GOBP_REGULATION_OF_LEUKOCYTE...8,SET,213,-0.021669,-0.0023192,0.060318,0.64029,GOBP_REGULATION_OF_LEUKOCYTE_MIGRATION,1
GSE11386_NAIVE_VS_MEMORY_BCE...1,SET,144,-0.026092,-0.0023005,0.072631,0.64029,GSE11386_NAIVE_VS_MEMORY_BCELL_DN,1
GOMF_STEROID_HYDROXYLASE_ACT...,SET,26,-0.065194,-0.0024503,0.18143,0.64032,GOMF_STEROID_HYDROXYLASE_ACTIVITY,1
GSE24634_TEFF_VS_TCONV_DAY3_...2,SET,183,-0.021374,-0.0021222,0.059486,0.64032,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_UP,1
GOBP_INTRINSIC_APOPTOTIC_SIG...1,SET,283,-0.017527,-0.0021581,0.048771,0.64034,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE2770_IL12_AND_TGFB_VS_IL4...1,SET,173,-0.022544,-0.0021769,0.062694,0.64042,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN,1
GOBP_BRANCHING_INVOLVED_IN_M...,SET,21,-0.072531,-0.0024503,0.2017,0.64043,GOBP_BRANCHING_INVOLVED_IN_MAMMARY_GLAND_DUCT_MORPHOGENESIS,1
HOFFMANN_IMMATURE_TO_MATURE_...1,SET,43,-0.048922,-0.0023636,0.13596,0.64051,HOFFMANN_IMMATURE_TO_MATURE_B_LYMPHOCYTE_DN,1
GOBP_ELECTRON_TRANSPORT_CHAIN,SET,107,-0.02608,-0.0019841,0.072461,0.64054,GOBP_ELECTRON_TRANSPORT_CHAIN,1
WP_EFFECTS_OF_MFN2_MUTATION,SET,22,-0.067922,-0.0023486,0.18865,0.64059,WP_EFFECTS_OF_MFN2_MUTATION,1
GOCC_FACIT_COLLAGEN_TRIMER,SET,6,-0.13968,-0.0025233,0.38784,0.64063,GOCC_FACIT_COLLAGEN_TRIMER,1
GSE11864_UNTREATED_VS_CSF1_I...4,SET,169,-0.02259,-0.0021562,0.062722,0.64063,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_UP,1
GSE27786_BCELL_VS_CD8_TCELL_...1,SET,180,-0.022306,-0.0021967,0.061925,0.64065,GSE27786_BCELL_VS_CD8_TCELL_DN,1
MIR371A_5P,SET,159,-0.02366,-0.0021912,0.065681,0.64066,MIR371A_5P,1
HP_ABNORMALITY_OF_THE_SPINOC...,SET,10,-0.089946,-0.0020975,0.24968,0.64067,HP_ABNORMALITY_OF_THE_SPINOCEREBELLAR_TRACTS,1
GOBP_MOTOR_BEHAVIOR,SET,20,-0.065376,-0.0021554,0.18145,0.64068,GOBP_MOTOR_BEHAVIOR,1
MIR4640_3P,SET,14,-0.076652,-0.0021148,0.2127,0.64072,MIR4640_3P,1
KEGG_T_CELL_RECEPTOR_SIGNALI...,SET,103,-0.030132,-0.0022494,0.083599,0.64074,KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_ESTABLISHMENT_OF_PROTEI...1,SET,1554,-0.007911,-0.002201,0.021948,0.64074,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
GOCC_SPERM_MIDPIECE,SET,50,-0.045601,-0.0023752,0.12651,0.64075,GOCC_SPERM_MIDPIECE,1
GOBP_REGULATION_OF_MORPHOGEN...2,SET,46,-0.048674,-0.0024321,0.13501,0.64077,GOBP_REGULATION_OF_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,1
GOMF_SERINE_HYDROLASE_ACTIVI...,SET,182,-0.024568,-0.0024327,0.068124,0.64081,GOMF_SERINE_HYDROLASE_ACTIVITY,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...3,SET,179,-0.022244,-0.0021845,0.06167,0.64084,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_DN,1
GSE17974_0H_VS_4H_IN_VITRO_A...1,SET,179,-0.021261,-0.002088,0.058939,0.64085,GSE17974_0H_VS_4H_IN_VITRO_ACT_CD4_TCELL_DN,1
KIM_WT1_TARGETS_DN,SET,426,-0.014533,-0.0021868,0.040277,0.64088,KIM_WT1_TARGETS_DN,1
REACTOME_RECEPTOR_TYPE_TYROS...,SET,16,-0.082039,-0.0024195,0.22729,0.64093,REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES,1
GSE24102_GRANULOCYSTIC_MDSC_...2,SET,183,-0.022343,-0.0022184,0.061901,0.64093,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_UP,1
WP_METASTATIC_BRAIN_TUMOR,SET,6,-0.13818,-0.0024963,0.38278,0.64094,WP_METASTATIC_BRAIN_TUMOR,1
MIR6788_5P,SET,115,-0.029941,-0.002361,0.082931,0.64096,MIR6788_5P,1
GSE36527_CD69_NEG_VS_POS_TRE...1,SET,185,-0.021367,-0.0021329,0.059169,0.64099,GSE36527_CD69_NEG_VS_POS_TREG_CD62L_LOS_KLRG1_NEG_DN,1
GSE3920_IFNB_VS_IFNG_TREATED...2,SET,144,-0.025969,-0.0022897,0.071907,0.641,GSE3920_IFNB_VS_IFNG_TREATED_ENDOTHELIAL_CELL_UP,1
GOMF_PSEUDOURIDINE_SYNTHASE_...,SET,12,-0.078559,-0.0020067,0.21743,0.64106,GOMF_PSEUDOURIDINE_SYNTHASE_ACTIVITY,1
GSE17721_0.5H_VS_24H_LPS_BMD...2,SET,183,-0.022765,-0.0022603,0.062997,0.64108,GSE17721_0.5H_VS_24H_LPS_BMDC_UP,1
GOMF_NUCLEAR_RETINOID_X_RECE...,SET,17,-0.074499,-0.0022647,0.20612,0.64111,GOMF_NUCLEAR_RETINOID_X_RECEPTOR_BINDING,1
GSE44955_MCSF_VS_MCSF_AND_IL...2,SET,175,-0.022903,-0.0022242,0.063361,0.64112,GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP,1
DUTERTRE_ESTRADIOL_RESPONSE_...3,SET,86,-0.035637,-0.002432,0.098524,0.64121,DUTERTRE_ESTRADIOL_RESPONSE_6HR_DN,1
REACTOME_TRANSLATION_OF_SARS...1,SET,28,-0.055344,-0.0021585,0.15299,0.64123,REACTOME_TRANSLATION_OF_SARS_COV_1_STRUCTURAL_PROTEINS,1
KIM_WT1_TARGETS_12HR_DN,SET,202,-0.021125,-0.0022024,0.058392,0.64124,KIM_WT1_TARGETS_12HR_DN,1
HUMMERICH_SKIN_CANCER_PROGRE...2,SET,84,-0.035057,-0.0023646,0.096888,0.64126,HUMMERICH_SKIN_CANCER_PROGRESSION_UP,1
HP_ABNORMAL_CIRCULATING_NON_...,SET,21,-0.067019,-0.0022641,0.18515,0.64131,HP_ABNORMAL_CIRCULATING_NON_PROTEINOGENIC_AMINO_ACID_CONCENTRATION,1
GOBP_LIPID_MODIFICATION,SET,168,-0.023006,-0.0021895,0.063548,0.64133,GOBP_LIPID_MODIFICATION,1
GOBP_TRANSCRIPTION_INITIATIO...2,SET,142,-0.024571,-0.0021514,0.067849,0.64137,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_II_PROMOTER,1
GSE25088_ROSIGLITAZONE_VS_IL...2,SET,180,-0.022329,-0.0021989,0.061651,0.64139,GSE25088_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
HP_METAMORPHOPSIA,SET,17,-0.07727,-0.002349,0.21333,0.6414,HP_METAMORPHOPSIA,1
GSE13229_IMM_VS_INTMATURE_NK...2,SET,180,-0.023271,-0.0022916,0.064232,0.64143,GSE13229_IMM_VS_INTMATURE_NKCELL_UP,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...3,SET,150,-0.023433,-0.0021083,0.064676,0.64144,GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN,1
DASU_IL6_SIGNALING_UP,SET,56,-0.042892,-0.002364,0.1183,0.64153,DASU_IL6_SIGNALING_UP,1
GSE12845_IGD_POS_BLOOD_VS_PR...1,SET,186,-0.021569,-0.0021588,0.059489,0.64153,GSE12845_IGD_POS_BLOOD_VS_PRE_GC_TONSIL_BCELL_DN,1
XU_RESPONSE_TO_TRETINOIN_DN,SET,10,-0.10392,-0.0024234,0.2866,0.64155,XU_RESPONSE_TO_TRETINOIN_DN,1
HP_FLATTENED_EPIPHYSIS,SET,22,-0.063079,-0.0021811,0.17392,0.64158,HP_FLATTENED_EPIPHYSIS,1
GOBP_REGULATION_OF_MEMBRANE_...1,SET,41,-0.052985,-0.0024998,0.14599,0.64167,GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION,1
SMIRNOV_RESPONSE_TO_IR_2HR_DN,SET,51,-0.044726,-0.0023528,0.1232,0.64171,SMIRNOV_RESPONSE_TO_IR_2HR_DN,1
GOMF_PROTEIN_MEMBRANE_ADAPTO...,SET,32,-0.050993,-0.0021259,0.14043,0.64174,GOMF_PROTEIN_MEMBRANE_ADAPTOR_ACTIVITY,1
JOHANSSON_BRAIN_CANCER_EARLY...2,SET,6,-0.11718,-0.002117,0.32255,0.64181,JOHANSSON_BRAIN_CANCER_EARLY_VS_LATE_UP,1
MORF_EI24,SET,118,-0.026394,-0.0021081,0.072618,0.64187,MORF_EI24,1
GSE33425_CD161_HIGH_VS_NEG_C...1,SET,178,-0.024041,-0.0023544,0.066137,0.64188,GSE33425_CD161_HIGH_VS_NEG_CD8_TCELL_DN,1
GOMF_ENDODEOXYRIBONUCLEASE_A...,SET,11,-0.088205,-0.0021572,0.24252,0.64196,GOMF_ENDODEOXYRIBONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
GSE6269_E_COLI_VS_STREP_PNEU...1,SET,153,-0.025282,-0.0022971,0.069504,0.64197,GSE6269_E_COLI_VS_STREP_PNEUMO_INF_PBMC_DN,1
GSE7219_WT_VS_NIK_NFKB2_KO_L...1,SET,184,-0.023074,-0.0022972,0.063429,0.64199,GSE7219_WT_VS_NIK_NFKB2_KO_LPS_AND_ANTI_CD40_STIM_DC_DN,1
SOTIRIOU_BREAST_CANCER_GRADE...1,SET,48,-0.042823,-0.0021856,0.1177,0.642,SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN,1
GOBP_REGULATION_OF_RNA_EXPOR...,SET,14,-0.073861,-0.0020378,0.203,0.64201,GOBP_REGULATION_OF_RNA_EXPORT_FROM_NUCLEUS,1
GSE21670_STAT3_KO_VS_WT_CD4_...1,SET,187,-0.023281,-0.0023364,0.063989,0.64201,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_DN,1
RYTGCNNRGNAAC_MIF1_01,SET,78,-0.035003,-0.0022754,0.096195,0.64202,RYTGCNNRGNAAC_MIF1_01,1
ZNF660_TARGET_GENES,SET,599,-0.012796,-0.0022722,0.035164,0.64203,ZNF660_TARGET_GENES,1
GOBP_MEIOTIC_SPINDLE_ORGANIZ...,SET,16,-0.077852,-0.002296,0.21392,0.64204,GOBP_MEIOTIC_SPINDLE_ORGANIZATION,1
REACTOME_ACTIVATION_OF_THE_A...,SET,10,-0.10471,-0.0024418,0.28771,0.64205,REACTOME_ACTIVATION_OF_THE_AP_1_FAMILY_OF_TRANSCRIPTION_FACTORS,1
REACTOME_TRAFFICKING_AND_PRO...,SET,11,-0.093678,-0.0022911,0.25729,0.64211,REACTOME_TRAFFICKING_AND_PROCESSING_OF_ENDOSOMAL_TLR,1
HP_ABNORMAL_SOFT_PALATE_MORP...,SET,224,-0.019836,-0.0021765,0.054461,0.64215,HP_ABNORMAL_SOFT_PALATE_MORPHOLOGY,1
WP_MAP3K1_ROLE_IN_PROMOTING_...,SET,16,-0.082485,-0.0024327,0.22645,0.64217,WP_MAP3K1_ROLE_IN_PROMOTING_AND_BLOCKING_GONADAL_DETERMINATION,1
GSE40274_CTRL_VS_XBP1_TRANSD...2,SET,156,-0.025501,-0.0023394,0.07,0.64218,GSE40274_CTRL_VS_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GSE27291_0H_VS_7D_STIM_GAMMA...1,SET,159,-0.023918,-0.002215,0.065632,0.64223,GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN,1
ZNF416_TARGET_GENES,SET,4,-0.14461,-0.0021332,0.39672,0.64226,ZNF416_TARGET_GENES,1
GOMF_MAP_KINASE_KINASE_ACTIV...,SET,15,-0.078043,-0.0022286,0.21398,0.64234,GOMF_MAP_KINASE_KINASE_ACTIVITY,1
HOEK_B_CELL_2011_2012_TIV_AD...5,SET,33,-0.056738,-0.0024021,0.15552,0.64238,HOEK_B_CELL_2011_2012_TIV_ADULT_7DY_UP,1
MIR564,SET,14,-0.085734,-0.0023653,0.23498,0.64239,MIR564,1
GSE27241_WT_VS_RORGT_KO_TH17...4,SET,138,-0.025137,-0.0021699,0.068887,0.6424,GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_UP,1
REACTOME_ROS_AND_RNS_PRODUCT...,SET,33,-0.055073,-0.0023316,0.15085,0.64247,REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES,1
MORF_EIF3S6,SET,113,-0.02691,-0.0021036,0.0737,0.64249,MORF_EIF3S6,1
GOMF_SNORNA_BINDING,SET,28,-0.053918,-0.0021029,0.14765,0.64251,GOMF_SNORNA_BINDING,1
GOMF_BETA_GALACTOSIDE_CMP_AL...,SET,7,-0.10373,-0.002024,0.28401,0.64253,GOMF_BETA_GALACTOSIDE_CMP_ALPHA_2_3_SIALYLTRANSFERASE_ACTIVITY,1
GSE2770_TGFB_AND_IL4_VS_IL12...6,SET,184,-0.022069,-0.0021971,0.060411,0.64256,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
MIR940,SET,164,-0.024376,-0.0022924,0.06672,0.64257,MIR940,1
GSE40666_UNTREATED_VS_IFNA_S...7,SET,176,-0.023427,-0.0022815,0.064114,0.64259,GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN,1
GOBP_VENTRAL_SPINAL_CORD_INT...,SET,13,-0.092176,-0.0024506,0.25225,0.6426,GOBP_VENTRAL_SPINAL_CORD_INTERNEURON_DIFFERENTIATION,1
GOBP_LEUKOCYTE_DEGRANULATION,SET,75,-0.035312,-0.0022511,0.096609,0.64263,GOBP_LEUKOCYTE_DEGRANULATION,1
TRAVAGLINI_LUNG_IGSF21_DENDR...,SET,43,-0.051963,-0.0025105,0.14206,0.64274,TRAVAGLINI_LUNG_IGSF21_DENDRITIC_CELL,1
GOMF_MONOCARBOXYLATE_SODIUM_...,SET,13,-0.086512,-0.0023,0.2364,0.6428,GOMF_MONOCARBOXYLATE_SODIUM_SYMPORTER_ACTIVITY,1
SA_PROGRAMMED_CELL_DEATH,SET,12,-0.090551,-0.002313,0.24737,0.64284,SA_PROGRAMMED_CELL_DEATH,1
GOBP_POSITIVE_REGULATION_OF_...660,SET,18,-0.075518,-0.0023622,0.20629,0.64284,GOBP_POSITIVE_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_ACTIVATION_OF_MEIOSIS,SET,5,-0.14348,-0.0023663,0.3918,0.64289,GOBP_ACTIVATION_OF_MEIOSIS,1
GOMF_CALCIUM_ACTIVATED_POTAS...,SET,13,-0.096108,-0.0025551,0.26231,0.64296,GOMF_CALCIUM_ACTIVATED_POTASSIUM_CHANNEL_ACTIVITY,1
HP_IMPAIRED_VIBRATORY_SENSAT...,SET,113,-0.028088,-0.0021956,0.076664,0.64296,HP_IMPAIRED_VIBRATORY_SENSATION,1
DESCARTES_FETAL_MUSCLE_MYELO...,SET,106,-0.031869,-0.0024133,0.086967,0.64298,DESCARTES_FETAL_MUSCLE_MYELOID_CELLS,1
GOMF_MODIFICATION_DEPENDENT_...,SET,156,-0.022935,-0.002104,0.062533,0.6431,GOMF_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
HP_GASTROINTESTINAL_INFLAMMA...,SET,150,-0.026406,-0.0023758,0.071948,0.64319,HP_GASTROINTESTINAL_INFLAMMATION,1
GOCC_PRESPLICEOSOME,SET,17,-0.074931,-0.0022778,0.20412,0.64322,GOCC_PRESPLICEOSOME,1
IRF_Q6,SET,219,-0.021345,-0.002316,0.058108,0.64331,IRF_Q6,1
MIR448,SET,327,-0.017611,-0.0023281,0.047933,0.64334,MIR448,1
HP_COMPENSATORY_HEAD_POSTURE,SET,21,-0.069859,-0.0023601,0.19014,0.64334,HP_COMPENSATORY_HEAD_POSTURE,1
GOBP_TRACHEA_MORPHOGENESIS,SET,11,-0.1069,-0.0026145,0.29092,0.64336,GOBP_TRACHEA_MORPHOGENESIS,1
GAVISH_3CA_METAPROGRAM_EPITH...19,SET,46,-0.048781,-0.0024374,0.13275,0.64337,GAVISH_3CA_METAPROGRAM_EPITHELIAL_PDAC_RELATED_2,1
GOMF_SPLICING_FACTOR_BINDING,SET,5,-0.12805,-0.0021118,0.34843,0.64338,GOMF_SPLICING_FACTOR_BINDING,1
XU_CREBBP_TARGETS_DN,SET,36,-0.048871,-0.0021608,0.13293,0.64342,XU_CREBBP_TARGETS_DN,1
GSE31082_DN_VS_DP_THYMOCYTE_...2,SET,174,-0.021997,-0.0021301,0.059803,0.64349,GSE31082_DN_VS_DP_THYMOCYTE_UP,1
HP_NEURONAL_LOSS_IN_CENTRAL_...,SET,34,-0.049475,-0.002126,0.13447,0.64353,HP_NEURONAL_LOSS_IN_CENTRAL_NERVOUS_SYSTEM,1
WP_NOTCH_SIGNALING_WP61,SET,58,-0.040074,-0.0022477,0.10889,0.64357,WP_NOTCH_SIGNALING_WP61,1
HP_DEEPLY_SET_EYE,SET,216,-0.020956,-0.0022584,0.056941,0.64357,HP_DEEPLY_SET_EYE,1
GSE34156_TLR1_TLR2_LIGAND_VS...3,SET,147,-0.025265,-0.0022505,0.068646,0.64358,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
ELVIDGE_HIF2A_TARGETS_UP,SET,6,-0.13194,-0.0023835,0.35827,0.64366,ELVIDGE_HIF2A_TARGETS_UP,1
PID_ARF6_PATHWAY,SET,35,-0.053484,-0.0023317,0.14524,0.64366,PID_ARF6_PATHWAY,1
GSE25088_CTRL_VS_ROSIGLITAZO...4,SET,159,-0.024652,-0.002283,0.066908,0.64373,GSE25088_CTRL_VS_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_UP,1
GOMF_ORGANIC_ACID_SODIUM_SYM...,SET,32,-0.057603,-0.0024015,0.1563,0.64377,GOMF_ORGANIC_ACID_SODIUM_SYMPORTER_ACTIVITY,1
chr9p21,SET,42,-0.080217,-0.0038303,0.21748,0.64388,chr9p21,1
CARRILLOREIXACH_HEPATOBLASTO...2,SET,18,-0.074146,-0.0023193,0.20101,0.64388,CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPERMETHYLATED_AND_DN,1
REACTOME_SYNTHESIS_OF_PA,SET,35,-0.058119,-0.0025338,0.15753,0.64391,REACTOME_SYNTHESIS_OF_PA,1
JONES_OVARY_PERICYTE,SET,152,-0.026426,-0.0023933,0.071622,0.64392,JONES_OVARY_PERICYTE,1
MATSUDA_NATURAL_KILLER_DIFFE...,SET,437,-0.015051,-0.002293,0.04078,0.64396,MATSUDA_NATURAL_KILLER_DIFFERENTIATION,1
KEGG_ENDOCYTOSIS,SET,175,-0.023777,-0.0023091,0.064406,0.644,KEGG_ENDOCYTOSIS,1
MIR6833_5P,SET,119,-0.0293,-0.00235,0.079363,0.644,MIR6833_5P,1
KRAS.LUNG.BREAST_UP.V1_DN,SET,129,-0.028716,-0.0023973,0.077775,0.64401,KRAS.LUNG.BREAST_UP.V1_DN,1
chr12q15,SET,23,-0.11281,-0.0039882,0.30536,0.64409,chr12q15,1
GAVISH_3CA_METAPROGRAM_EPITH...4,SET,35,-0.052593,-0.0022929,0.14237,0.64409,GAVISH_3CA_METAPROGRAM_EPITHELIAL_CILIA,1
GOBP_DOLICHYL_DIPHOSPHATE_ME...,SET,4,-0.15975,-0.0023565,0.43222,0.64416,GOBP_DOLICHYL_DIPHOSPHATE_METABOLIC_PROCESS,1
GSE37533_UNTREATED_VS_PIOGLI...3,SET,180,-0.023254,-0.00229,0.062899,0.64419,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN,1
HP_AUTOIMMUNITY,SET,264,-0.020214,-0.0024052,0.05466,0.64424,HP_AUTOIMMUNITY,1
GOBP_ANTERIOR_POSTERIOR_AXIS...,SET,51,-0.045045,-0.0023696,0.1218,0.64425,GOBP_ANTERIOR_POSTERIOR_AXIS_SPECIFICATION,1
MIR183_3P,SET,186,-0.022824,-0.0022845,0.061691,0.6443,MIR183_3P,1
GOBP_PANCREAS_DEVELOPMENT,SET,74,-0.038637,-0.0024467,0.10443,0.6443,GOBP_PANCREAS_DEVELOPMENT,1
REACTOME_ARYL_HYDROCARBON_RE...,SET,6,-0.10131,-0.0018302,0.27375,0.64434,REACTOME_ARYL_HYDROCARBON_RECEPTOR_SIGNALLING,1
GOBP_SYNAPTIC_VESICLE_MATURA...,SET,21,-0.066771,-0.0022557,0.18036,0.64438,GOBP_SYNAPTIC_VESICLE_MATURATION,1
GOBP_MRNA_PSEUDOURIDINE_SYNT...,SET,8,-0.092918,-0.0019382,0.25091,0.64443,GOBP_MRNA_PSEUDOURIDINE_SYNTHESIS,1
GOBP_REGULATION_OF_WNT_SIGNA...1,SET,302,-0.01899,-0.0024142,0.051277,0.64443,GOBP_REGULATION_OF_WNT_SIGNALING_PATHWAY,1
HP_ABNORMAL_ILIUM_MORPHOLOGY,SET,85,-0.034098,-0.0023135,0.092077,0.64443,HP_ABNORMAL_ILIUM_MORPHOLOGY,1
SMAD_Q6,SET,232,-0.021471,-0.0023971,0.057965,0.64446,SMAD_Q6,1
GOBP_POSITIVE_REGULATION_OF_...123,SET,31,-0.05688,-0.0023341,0.15355,0.64447,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
KEGG_MEDICUS_REFERENCE_TLR3_...1,SET,9,-0.10197,-0.0022558,0.27521,0.64449,KEGG_MEDICUS_REFERENCE_TLR3_IRF3_SIGNALING_PATHWAY,1
HP_SUBEPIDERMAL_BLISTERING,SET,11,-0.093456,-0.0022857,0.25219,0.64452,HP_SUBEPIDERMAL_BLISTERING,1
PEREZ_TP53_TARGETS,SET,1026,-0.010139,-0.0023278,0.027331,0.64467,PEREZ_TP53_TARGETS,1
HP_DYSGENESIS_OF_THE_BASAL_G...,SET,5,-0.13888,-0.0022903,0.37433,0.64468,HP_DYSGENESIS_OF_THE_BASAL_GANGLIA,1
HP_ABNORMALITY_OF_THE_DISTAL...6,SET,29,-0.056163,-0.0022292,0.15136,0.6447,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,1
HP_CURLY_EYELASHES,SET,12,-0.093922,-0.0023991,0.25311,0.6447,HP_CURLY_EYELASHES,1
HP_PROMINENT_SUPRAORBITAL_RI...,SET,33,-0.05609,-0.0023746,0.15114,0.64472,HP_PROMINENT_SUPRAORBITAL_RIDGES,1
GOMF_GLYCOSAMINOGLYCAN_BINDI...,SET,226,-0.022837,-0.0025167,0.061525,0.64475,GOMF_GLYCOSAMINOGLYCAN_BINDING,1
MIR212_3P,SET,170,-0.023608,-0.00226,0.063579,0.6448,MIR212_3P,1
GAUSSMANN_MLL_AF4_FUSION_TAR...7,SET,10,-0.10109,-0.0023574,0.2721,0.64487,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_DN,1
HP_REDUCED_DELAYED_HYPERSENS...,SET,4,-0.15121,-0.0022304,0.40695,0.64489,HP_REDUCED_DELAYED_HYPERSENSITIVITY,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...4,SET,13,-0.08725,-0.0023197,0.2348,0.6449,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_TYROSINE_PHOSPHORYLATIO...,SET,74,-0.037156,-0.0023529,0.099901,0.64503,GOBP_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
GOCC_PYRUVATE_DEHYDROGENASE_...,SET,5,-0.16215,-0.0026742,0.43584,0.64507,GOCC_PYRUVATE_DEHYDROGENASE_COMPLEX,1
HP_LONG_CLAVICLES,SET,13,-0.095727,-0.002545,0.25722,0.64511,HP_LONG_CLAVICLES,1
HP_INCREASED_CIRCULATING_AND...,SET,17,-0.07459,-0.0022675,0.20041,0.64512,HP_INCREASED_CIRCULATING_ANDROGEN_CONCENTRATION,1
MODULE_308,SET,63,-0.037852,-0.0022123,0.10164,0.64521,MODULE_308,1
GOBP_REGULATION_OF_RECEPTOR_...6,SET,107,-0.029726,-0.0022615,0.0798,0.64524,GOBP_REGULATION_OF_RECEPTOR_MEDIATED_ENDOCYTOSIS,1
RORIE_TARGETS_OF_EWSR1_FLI1_...1,SET,25,-0.06991,-0.0025766,0.18763,0.64527,RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN,1
GCNP_SHH_UP_EARLY.V1_UP,SET,156,-0.02409,-0.0022099,0.064652,0.64528,GCNP_SHH_UP_EARLY.V1_UP,1
PID_LIS1_PATHWAY,SET,27,-0.058426,-0.0022377,0.15678,0.64529,PID_LIS1_PATHWAY,1
GSE21927_UNTREATED_VS_GMCSF_...2,SET,166,-0.024888,-0.0023546,0.066785,0.6453,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_UP,1
GSE14350_TREG_VS_TEFF_IN_IL2...1,SET,184,-0.022963,-0.0022861,0.061612,0.64531,GSE14350_TREG_VS_TEFF_IN_IL2RB_KO_DN,1
GOBP_PURINE_RIBONUCLEOSIDE_S...,SET,6,-0.14128,-0.0025522,0.37868,0.64545,GOBP_PURINE_RIBONUCLEOSIDE_SALVAGE,1
HP_ABNORMAL_ANKLE_PHYSIOLOGY,SET,54,-0.042201,-0.0022841,0.11306,0.64552,HP_ABNORMAL_ANKLE_PHYSIOLOGY,1
GSE360_L_MAJOR_VS_T_GONDII_M...1,SET,178,-0.022238,-0.0021779,0.059576,0.64552,GSE360_L_MAJOR_VS_T_GONDII_MAC_DN,1
HP_PREMATURE_ARTERIOSCLEROSIS,SET,8,-0.1308,-0.0027284,0.35038,0.64554,HP_PREMATURE_ARTERIOSCLEROSIS,1
GOBP_REGULATION_OF_PROTEIN_G...,SET,11,-0.094032,-0.0022997,0.25187,0.64555,GOBP_REGULATION_OF_PROTEIN_GLYCOSYLATION,1
DESCARTES_FETAL_CEREBRUM_OLI...,SET,48,-0.051617,-0.0026344,0.13825,0.64555,DESCARTES_FETAL_CEREBRUM_OLIGODENDROCYTES,1
KEGG_MEDICUS_VARIANT_MUTATIO...32,SET,20,-0.071238,-0.0023487,0.19076,0.64558,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
HP_ABNORMAL_VAGINA_MORPHOLOGY,SET,111,-0.030703,-0.0023788,0.0822,0.64562,HP_ABNORMAL_VAGINA_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_CXCR_...1,SET,27,-0.062035,-0.002376,0.16606,0.64564,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_ERK_SIGNALING_PATHWAY,1
ZNF740_TARGET_GENES,SET,1190,-0.0094014,-0.0023135,0.025156,0.64569,ZNF740_TARGET_GENES,1
ISSAEVA_MLL2_TARGETS,SET,52,-0.048541,-0.0025783,0.12988,0.6457,ISSAEVA_MLL2_TARGETS,1
KEGG_MEDICUS_VARIANT_AMPLIFI...15,SET,14,-0.087177,-0.0024051,0.23317,0.64575,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PLCG_CAMK_SIGNALING_PATHWAY,1
MIR3665,SET,73,-0.036633,-0.0023042,0.097966,0.64577,MIR3665,1
MIR147A,SET,57,-0.042974,-0.0023895,0.11491,0.64579,MIR147A,1
GOBP_TELENCEPHALON_REGIONALI...,SET,13,-0.10887,-0.0028943,0.29107,0.6458,GOBP_TELENCEPHALON_REGIONALIZATION,1
HP_PERIPHERAL_RETINAL_AVASCU...,SET,7,-0.13048,-0.0025459,0.3488,0.64582,HP_PERIPHERAL_RETINAL_AVASCULARIZATION,1
CAIRO_HEPATOBLASTOMA_POOR_SU...,SET,13,-0.079502,-0.0021137,0.2125,0.64585,CAIRO_HEPATOBLASTOMA_POOR_SURVIVAL,1
HP_INTRINSIC_HAND_MUSCLE_ATR...,SET,24,-0.067777,-0.0024476,0.18105,0.64593,HP_INTRINSIC_HAND_MUSCLE_ATROPHY,1
REACTOME_FORMATION_OF_THE_BE...,SET,31,-0.058475,-0.0023995,0.15616,0.64596,REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX,1
REACTOME_DEUBIQUITINATION,SET,217,-0.02056,-0.0022209,0.054876,0.64604,REACTOME_DEUBIQUITINATION,1
GSE41867_DAY8_EFFECTOR_VS_DA...4,SET,186,-0.021863,-0.0021882,0.058331,0.6461,GSE41867_DAY8_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,1
WP_INVOLVEMENT_OF_SECRETASE_...,SET,16,-0.083448,-0.0024611,0.22259,0.64613,WP_INVOLVEMENT_OF_SECRETASE_IN_NEURODEGENERATIVE_DISEASES,1
GOMF_RIBOSOME_BINDING,SET,87,-0.032346,-0.0022202,0.08625,0.64618,GOMF_RIBOSOME_BINDING,1
GSE36078_WT_VS_IL1R_KO_LUNG_...4,SET,181,-0.023298,-0.0023006,0.062118,0.64619,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_T425A_HEXON_INF_UP,1
GOBP_MEIOTIC_SPINDLE_ASSEMBLY,SET,10,-0.10502,-0.0024491,0.27991,0.64625,GOBP_MEIOTIC_SPINDLE_ASSEMBLY,1
GOCC_PROTON_TRANSPORTING_TWO...2,SET,13,-0.090962,-0.0024183,0.24232,0.64631,GOCC_PROTON_TRANSPORTING_TWO_SECTOR_ATPASE_COMPLEX_CATALYTIC_DOMAIN,1
LOPES_METHYLATED_IN_COLON_CA...1,SET,28,-0.061391,-0.0023944,0.16351,0.64634,LOPES_METHYLATED_IN_COLON_CANCER_DN,1
GOCC_DISTAL_AXON,SET,249,-0.020906,-0.0024168,0.055644,0.64643,GOCC_DISTAL_AXON,1
GOBP_REGULATION_OF_CELLULAR_...4,SET,311,-0.018194,-0.0023466,0.048421,0.64645,GOBP_REGULATION_OF_CELLULAR_COMPONENT_SIZE,1
WP_NCRNAS_INVOLVED_IN_STAT3_...,SET,13,-0.094568,-0.0025142,0.25154,0.64652,WP_NCRNAS_INVOLVED_IN_STAT3_SIGNALING_IN_HEPATOCELLULAR_CARCINOMA,1
GSE24634_IL4_VS_CTRL_TREATED...6,SET,180,-0.024573,-0.0024199,0.065348,0.64655,GSE24634_IL4_VS_CTRL_TREATED_NAIVE_CD4_TCELL_DAY5_UP,1
GOBP_NEGATIVE_REGULATION_OF_...292,SET,12,-0.10002,-0.002555,0.26567,0.64672,GOBP_NEGATIVE_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,1
FLORIO_NEOCORTEX_BASAL_RADIA...1,SET,170,-0.024132,-0.0023101,0.064086,0.64675,FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_DN,1
HP_ABNORMAL_URINE_POTASSIUM_...,SET,16,-0.086767,-0.002559,0.23038,0.64677,HP_ABNORMAL_URINE_POTASSIUM_CONCENTRATION,1
GSE10240_CTRL_VS_IL17_STIM_P...1,SET,182,-0.023073,-0.0022846,0.061244,0.64681,GSE10240_CTRL_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
REACTOME_FGFR2_MUTANT_RECEPT...,SET,32,-0.055855,-0.0023286,0.14825,0.64682,REACTOME_FGFR2_MUTANT_RECEPTOR_ACTIVATION,1
HALLMARK_IL6_JAK_STAT3_SIGNA...,SET,80,-0.038035,-0.0025039,0.10095,0.64683,HALLMARK_IL6_JAK_STAT3_SIGNALING,1
MIR4685_5P,SET,113,-0.029235,-0.0022853,0.077572,0.64686,MIR4685_5P,1
GOBP_POSITIVE_REGULATION_OF_...191,SET,167,-0.024529,-0.0023276,0.065042,0.64696,GOBP_POSITIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,1
GOCC_POSTSYNAPTIC_CYTOSOL,SET,13,-0.090163,-0.0023971,0.23907,0.64696,GOCC_POSTSYNAPTIC_CYTOSOL,1
MIR208A_3P,SET,38,-0.051421,-0.0023357,0.13633,0.64698,MIR208A_3P,1
GSE37301_LYMPHOID_PRIMED_MPP...2,SET,167,-0.02443,-0.0023181,0.064764,0.64699,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_UP,1
SCIBETTA_KDM5B_TARGETS_UP,SET,18,-0.074874,-0.002342,0.19845,0.64702,SCIBETTA_KDM5B_TARGETS_UP,1
GOMF_POLY_ADP_D_RIBOSE_MODIF...,SET,2,-0.23137,-0.0024135,0.6132,0.64703,GOMF_POLY_ADP_D_RIBOSE_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
HP_CHRONIC_GASTRITIS,SET,2,-0.22996,-0.0023987,0.60945,0.64703,HP_CHRONIC_GASTRITIS,1
YAGI_AML_RELAPSE_PROGNOSIS,SET,33,-0.057822,-0.0024479,0.15323,0.64704,YAGI_AML_RELAPSE_PROGNOSIS,1
AGTGCGT_MIR521,SET,6,-0.11451,-0.0020687,0.3034,0.64707,AGTGCGT_MIR521,1
GOBP_NEGATIVE_REGULATION_OF_...545,SET,4,-0.15965,-0.0023551,0.42297,0.64708,GOBP_NEGATIVE_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_ISOPENTENYL_DIPHOSPHATE...,SET,5,-0.12567,-0.0020725,0.33292,0.64709,GOBP_ISOPENTENYL_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
MIR489_3P,SET,69,-0.039606,-0.0024222,0.10484,0.64719,MIR489_3P,1
HOEK_NEUTROPHIL_2011_2012_TI...2,SET,28,-0.069728,-0.0027195,0.18453,0.64723,HOEK_NEUTROPHIL_2011_2012_TIV_ADULT_1DY_UP,1
HP_OCULAR_PAIN,SET,20,-0.07442,-0.0024536,0.19694,0.64724,HP_OCULAR_PAIN,1
HP_SUBRETINAL_FLUID,SET,9,-0.11583,-0.0025626,0.3065,0.64725,HP_SUBRETINAL_FLUID,1
HP_BLADDER_NEOPLASM,SET,33,-0.055858,-0.0023648,0.14778,0.64727,HP_BLADDER_NEOPLASM,1
MYLLYKANGAS_AMPLIFICATION_HO...9,SET,19,-0.074639,-0.0023986,0.19746,0.64728,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23,1
HP_CAROTID_ARTERY_TORTUOSITY,SET,4,-0.17372,-0.0025626,0.45948,0.64732,HP_CAROTID_ARTERY_TORTUOSITY,1
HP_RECURRENT_STREPTOCOCCAL_I...,SET,3,-0.168,-0.0021462,0.44429,0.64733,HP_RECURRENT_STREPTOCOCCAL_INFECTIONS,1
WP_MRNA_PROTEIN_AND_METABOLI...,SET,7,-0.11992,-0.0023399,0.31687,0.64745,WP_MRNA_PROTEIN_AND_METABOLITE_INDUCATION_PATHWAY_BY_CYCLOSPORIN_A,1
chr15q14,SET,23,-0.11701,-0.0041369,0.30914,0.64747,chr15q14,1
GSE17721_CTRL_VS_CPG_1H_BMDC...2,SET,186,-0.02195,-0.002197,0.057971,0.64752,GSE17721_CTRL_VS_CPG_1H_BMDC_UP,1
GOBP_PIGMENTATION,SET,105,-0.032449,-0.0024457,0.085633,0.64763,GOBP_PIGMENTATION,1
JAERVINEN_AMPLIFIED_IN_LARYN...,SET,39,-0.051055,-0.0023493,0.13472,0.64764,JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER,1
REACTOME_MRNA_DECAY_BY_5_TO_...,SET,15,-0.079173,-0.0022609,0.20888,0.64766,REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE,1
GAO_ESOPHAGUS_25W_C4_FGFR1HI...,SET,178,-0.023489,-0.0023004,0.061948,0.64772,GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS,1
GSE29618_PRE_VS_DAY7_POST_LA...4,SET,169,-0.024967,-0.0023831,0.065836,0.64774,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_UP,1
SATO_SILENCED_BY_METHYLATION...1,SET,369,-0.017472,-0.0024507,0.046069,0.64775,SATO_SILENCED_BY_METHYLATION_IN_PANCREATIC_CANCER_1,1
GOBP_NEGATIVE_REGULATION_OF_...532,SET,725,-0.012095,-0.0023543,0.031891,0.64775,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,1
RECHTIEN_PBMC_RVSV_ZEBOV_AGE...,SET,10,-0.10991,-0.0025631,0.28978,0.64776,RECHTIEN_PBMC_RVSV_ZEBOV_AGE_18_55YO_1DY_UP,1
GSE11961_FOLLICULAR_BCELL_VS...2,SET,186,-0.022516,-0.0022536,0.059346,0.6478,GSE11961_FOLLICULAR_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
HP_SMALL_BASAL_GANGLIA,SET,13,-0.086271,-0.0022936,0.22737,0.64781,HP_SMALL_BASAL_GANGLIA,1
GOBP_NEGATIVE_REGULATION_OF_...536,SET,64,-0.041026,-0.0024168,0.10808,0.64787,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SECRETION,1
TAVOR_CEBPA_TARGETS_UP,SET,47,-0.05151,-0.0026015,0.13569,0.64789,TAVOR_CEBPA_TARGETS_UP,1
GOBP_TIGHT_JUNCTION_ORGANIZA...,SET,75,-0.038181,-0.0024341,0.10057,0.64789,GOBP_TIGHT_JUNCTION_ORGANIZATION,1
PASTURAL_RIZ1_TARGETS_DN,SET,5,-0.16564,-0.0027317,0.43603,0.64798,PASTURAL_RIZ1_TARGETS_DN,1
MODULE_120,SET,67,-0.039291,-0.002368,0.10343,0.64798,MODULE_120,1
MODULE_234,SET,53,-0.050142,-0.0026887,0.13198,0.648,MODULE_234,1
MALTA_CURATED_STEMNESS_MARKE...,SET,20,-0.081758,-0.0026955,0.21514,0.64803,MALTA_CURATED_STEMNESS_MARKERS,1
MIR8067,SET,250,-0.019998,-0.0023164,0.052626,0.64803,MIR8067,1
GSE5463_CTRL_VS_DEXAMETHASON...2,SET,187,-0.023786,-0.0023871,0.06254,0.64815,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_UP,1
GCM_HBP1,SET,63,-0.03801,-0.0022216,0.099921,0.64817,GCM_HBP1,1
GOBP_FLAVIN_CONTAINING_COMPO...,SET,6,-0.12672,-0.0022893,0.33313,0.64817,GOBP_FLAVIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GSE34515_CD16_NEG_MONOCYTE_V...2,SET,180,-0.024423,-0.0024051,0.064165,0.64826,GSE34515_CD16_NEG_MONOCYTE_VS_DC_UP,1
GSE1925_3H_VS_24H_IFNG_STIM_...4,SET,170,-0.024469,-0.0023424,0.064273,0.64829,GSE1925_3H_VS_24H_IFNG_STIM_MACROPHAGE_UP,1
GOCC_ATPASE_DEPENDENT_TRANSM...,SET,24,-0.07265,-0.0026236,0.19081,0.6483,GOCC_ATPASE_DEPENDENT_TRANSMEMBRANE_TRANSPORT_COMPLEX,1
GOBP_DENDRITE_EXTENSION,SET,32,-0.056515,-0.0023561,0.14842,0.64831,GOBP_DENDRITE_EXTENSION,1
GOBP_VESICLE_MEDIATED_TRANSP...2,SET,44,-0.048333,-0.0023621,0.12691,0.64834,GOBP_VESICLE_MEDIATED_TRANSPORT_BETWEEN_ENDOSOMAL_COMPARTMENTS,1
GOMF_LIPOTEICHOIC_ACID_BINDI...,SET,5,-0.14951,-0.0024657,0.39249,0.64837,GOMF_LIPOTEICHOIC_ACID_BINDING,1
GOBP_MORPHOGENESIS_OF_EMBRYO...,SET,144,-0.026923,-0.0023737,0.070667,0.64839,GOBP_MORPHOGENESIS_OF_EMBRYONIC_EPITHELIUM,1
GOBP_SPINDLE_MIDZONE_ASSEMBLY,SET,13,-0.082271,-0.0021873,0.21593,0.6484,GOBP_SPINDLE_MIDZONE_ASSEMBLY,1
DESCARTES_FETAL_SPLEEN_MYELO...,SET,110,-0.034255,-0.0026421,0.089858,0.64847,DESCARTES_FETAL_SPLEEN_MYELOID_CELLS,1
GOBP_NEURAL_CREST_CELL_MIGRA...,SET,6,-0.14126,-0.0025519,0.3705,0.64849,GOBP_NEURAL_CREST_CELL_MIGRATION_INVOLVED_IN_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,1
GOBP_POSITIVE_THYMIC_T_CELL_...,SET,15,-0.0888,-0.0025358,0.23291,0.64849,GOBP_POSITIVE_THYMIC_T_CELL_SELECTION,1
GOBP_HISTAMINE_TRANSPORT,SET,15,-0.082057,-0.0023433,0.2151,0.64858,GOBP_HISTAMINE_TRANSPORT,1
GOCC_ER_MEMBRANE_INSERTION_C...,SET,12,-0.090958,-0.0023234,0.23843,0.64858,GOCC_ER_MEMBRANE_INSERTION_COMPLEX,1
GOBP_CYSTEINE_CATABOLIC_PROC...,SET,3,-0.20354,-0.0026003,0.53347,0.6486,GOBP_CYSTEINE_CATABOLIC_PROCESS,1
GOBP_PERICARDIUM_DEVELOPMENT,SET,18,-0.081301,-0.0025431,0.21291,0.64871,GOBP_PERICARDIUM_DEVELOPMENT,1
GNF2_TPT1,SET,34,-0.054139,-0.0023264,0.14175,0.64874,GNF2_TPT1,1
AP2ALPHA_01,SET,223,-0.020996,-0.0022986,0.054964,0.64876,AP2ALPHA_01,1
GOBP_POSITIVE_REGULATION_OF_...337,SET,3,-0.16418,-0.0020974,0.42975,0.64878,GOBP_POSITIVE_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GSE5542_IFNA_VS_IFNA_AND_IFN...1,SET,182,-0.022926,-0.00227,0.059999,0.6488,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
REACTOME_ASPARAGINE_N_LINKED...,SET,291,-0.018303,-0.0022848,0.047898,0.64881,REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION,1
GOMF_GLUTATHIONE_TRANSFERASE...,SET,23,-0.080948,-0.0028618,0.2118,0.64884,GOMF_GLUTATHIONE_TRANSFERASE_ACTIVITY,1
GOBP_RESPONSE_TO_ZINC_ION,SET,44,-0.051466,-0.0025152,0.13465,0.64885,GOBP_RESPONSE_TO_ZINC_ION,1
VERRECCHIA_RESPONSE_TO_TGFB1...4,SET,11,-0.1027,-0.0025118,0.26856,0.64892,VERRECCHIA_RESPONSE_TO_TGFB1_C4,1
DESCARTES_MAIN_FETAL_BRONCHI...,SET,34,-0.061929,-0.0026612,0.1619,0.64896,DESCARTES_MAIN_FETAL_BRONCHIOLAR_AND_ALVEOLAR_EPITHELIAL_CELLS,1
GOBP_REGULATION_OF_INTRACELL...6,SET,242,-0.020121,-0.0022936,0.052593,0.64898,GOBP_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
GSE15733_BM_VS_SPLEEN_MEMORY...1,SET,176,-0.023714,-0.0023094,0.061978,0.64899,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_DN,1
REACTOME_NEGATIVE_REGULATION...5,SET,29,-0.062602,-0.0024848,0.16361,0.649,REACTOME_NEGATIVE_REGULATION_OF_FGFR4_SIGNALING,1
GSE21360_PRIMARY_VS_SECONDAR...1,SET,179,-0.02358,-0.0023157,0.061619,0.64901,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...2,SET,9,-0.1045,-0.0023118,0.27306,0.64902,GOBP_PROTEIN_LOCALIZATION_TO_AXON,1
HP_ABNORMAL_CARDIAC_VENTRICL...,SET,599,-0.013109,-0.0023277,0.034252,0.64904,HP_ABNORMAL_CARDIAC_VENTRICLE_MORPHOLOGY,1
GROSS_HYPOXIA_VIA_HIF1A_ONLY,SET,8,-0.12946,-0.0027003,0.33816,0.64907,GROSS_HYPOXIA_VIA_HIF1A_ONLY,1
SCHAEFFER_SOX9_TARGETS_IN_PR...2,SET,19,-0.082571,-0.0026535,0.21565,0.64909,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_UP,1
GOBP_SPLICEOSOMAL_TRI_SNRNP_...,SET,15,-0.067826,-0.0019369,0.17714,0.6491,GOBP_SPLICEOSOMAL_TRI_SNRNP_COMPLEX_ASSEMBLY,1
GOBP_INTESTINAL_EPITHELIAL_C...3,SET,6,-0.12922,-0.0023344,0.33733,0.64916,GOBP_INTESTINAL_EPITHELIAL_CELL_MATURATION,1
GSE360_L_DONOVANI_VS_B_MALAY...3,SET,187,-0.022796,-0.0022877,0.059484,0.64922,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
SCIAN_CELL_CYCLE_TARGETS_OF_...1,SET,22,-0.068152,-0.0023565,0.17771,0.64933,SCIAN_CELL_CYCLE_TARGETS_OF_TP53_AND_TP73_DN,1
GOMF_ARYL_HYDROCARBON_RECEPT...,SET,7,-0.094165,-0.0018374,0.24552,0.64934,GOMF_ARYL_HYDROCARBON_RECEPTOR_BINDING,1
MIR26A_1_3P,SET,66,-0.039097,-0.0023387,0.10191,0.64938,MIR26A_1_3P,1
GOBP_REGULATION_OF_HIPPOCAMP...,SET,5,-0.16965,-0.0027979,0.44221,0.64938,GOBP_REGULATION_OF_HIPPOCAMPAL_NEURON_APOPTOTIC_PROCESS,1
GOBP_OLEFINIC_COMPOUND_METAB...,SET,154,-0.028064,-0.0025581,0.073139,0.6494,GOBP_OLEFINIC_COMPOUND_METABOLIC_PROCESS,1
GSE3039_NKT_CELL_VS_ALPHAALP...2,SET,185,-0.024651,-0.0024608,0.064247,0.6494,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_UP,1
REACTOME_BETA_OXIDATION_OF_O...,SET,5,-0.1439,-0.0023731,0.37492,0.64944,REACTOME_BETA_OXIDATION_OF_OCTANOYL_COA_TO_HEXANOYL_COA,1
GOBP_NUCLEAR_MIGRATION,SET,24,-0.064547,-0.002331,0.16817,0.64944,GOBP_NUCLEAR_MIGRATION,1
ENGELMANN_CANCER_PROGENITORS...1,SET,59,-0.043843,-0.0024801,0.11418,0.64949,ENGELMANN_CANCER_PROGENITORS_DN,1
GSE18791_CTRL_VS_NEWCASTLE_V...12,SET,138,-0.027719,-0.0023929,0.072173,0.64953,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_UP,1
HP_ERYTHEMA,SET,106,-0.0313,-0.0023702,0.081471,0.64958,HP_ERYTHEMA,1
GOBP_REGULATION_OF_FEAR_RESP...,SET,9,-0.12283,-0.0027174,0.31967,0.6496,GOBP_REGULATION_OF_FEAR_RESPONSE,1
AGGAAGC_MIR5163P,SET,113,-0.031553,-0.0024665,0.082097,0.64963,AGGAAGC_MIR5163P,1
HP_NON_MOTOR_SEIZURE,SET,174,-0.024373,-0.0023603,0.063412,0.64964,HP_NON_MOTOR_SEIZURE,1
KEGG_MEDICUS_REFERENCE_CA2_C...1,SET,19,-0.072706,-0.0023365,0.18905,0.64972,KEGG_MEDICUS_REFERENCE_CA2_CAM_CAMK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_MIRNA_MET...,SET,81,-0.036441,-0.0024139,0.094759,0.64972,GOBP_REGULATION_OF_MIRNA_METABOLIC_PROCESS,1
HP_SWAN_NECK_LIKE_DEFORMITIE...,SET,8,-0.12646,-0.0026377,0.3288,0.64973,HP_SWAN_NECK_LIKE_DEFORMITIES_OF_THE_FINGERS,1
BURTON_ADIPOGENESIS_10,SET,26,-0.063735,-0.0023955,0.16569,0.64976,BURTON_ADIPOGENESIS_10,1
MIR410_5P,SET,38,-0.049374,-0.0022427,0.12834,0.64978,MIR410_5P,1
GOCC_NUCLEAR_PERIPHERY,SET,139,-0.027605,-0.0023916,0.071698,0.64988,GOCC_NUCLEAR_PERIPHERY,1
REACTOME_RUNX1_INTERACTS_WIT...,SET,36,-0.056765,-0.0025098,0.14742,0.6499,REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN,1
RAPA_EARLY_UP.V1_UP,SET,142,-0.028413,-0.0024878,0.073787,0.64991,RAPA_EARLY_UP.V1_UP,1
HP_PELVIC_GIRDLE_AMYOTROPHY,SET,3,-0.14253,-0.0018209,0.37007,0.64993,HP_PELVIC_GIRDLE_AMYOTROPHY,1
GOMF_LEUKOTRIENE_C4_SYNTHASE...,SET,5,-0.15968,-0.0026333,0.41456,0.64994,GOMF_LEUKOTRIENE_C4_SYNTHASE_ACTIVITY,1
MIR520F_3P,SET,184,-0.023534,-0.0023429,0.061089,0.64997,MIR520F_3P,1
WP_INTERACTIONS_OF_NATURAL_K...,SET,28,-0.065676,-0.0025615,0.17046,0.64998,WP_INTERACTIONS_OF_NATURAL_KILLER_CELLS_IN_PANCREATIC_CANCER,1
GOCC_PICLN_SM_PROTEIN_COMPLEX,SET,6,-0.11539,-0.0020846,0.29951,0.64998,GOCC_PICLN_SM_PROTEIN_COMPLEX,1
BIOCARTA_REELIN_PATHWAY,SET,7,-0.12983,-0.0025332,0.33694,0.64999,BIOCARTA_REELIN_PATHWAY,1
GSE3337_4H_VS_16H_IFNG_IN_CD...2,SET,187,-0.023166,-0.0023248,0.060113,0.65002,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_UP,1
PURWIN_MEWO_SOX10_TARGETS,SET,82,-0.03668,-0.0024446,0.095171,0.65003,PURWIN_MEWO_SOX10_TARGETS,1
SCHAEFFER_PROSTATE_DEVELOPME...8,SET,14,-0.07565,-0.0020871,0.19626,0.65005,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX1_UP,1
MORF_TERF1,SET,61,-0.037499,-0.0021568,0.097286,0.65005,MORF_TERF1,1
HP_ANGIOFIBROMAS,SET,31,-0.05266,-0.0021609,0.13659,0.65007,HP_ANGIOFIBROMAS,1
GOCC_APICAL_PART_OF_CELL,SET,434,-0.016456,-0.0024988,0.042683,0.65008,GOCC_APICAL_PART_OF_CELL,1
WP_COMPLEMENTMEDIATED_INFLAM...,SET,10,-0.10366,-0.0024172,0.26867,0.65018,WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY,1
GOBP_FLAVONE_METABOLIC_PROCE...,SET,6,-0.13409,-0.0024223,0.34751,0.65019,GOBP_FLAVONE_METABOLIC_PROCESS,1
MORF_PAPSS1,SET,97,-0.031847,-0.0023075,0.082515,0.65023,MORF_PAPSS1,1
GOBP_NEGATIVE_REGULATION_OF_...469,SET,43,-0.055162,-0.002665,0.1429,0.65026,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,1
DITTMER_PTHLH_TARGETS_DN,SET,69,-0.040439,-0.0024731,0.10475,0.65027,DITTMER_PTHLH_TARGETS_DN,1
DESCARTES_FETAL_HEART_MYELOI...,SET,104,-0.033709,-0.0025285,0.087278,0.65033,DESCARTES_FETAL_HEART_MYELOID_CELLS,1
GOCC_CILIARY_PLASM,SET,135,-0.026652,-0.0022758,0.069004,0.65034,GOCC_CILIARY_PLASM,1
GOBP_ATP_METABOLIC_PROCESS,SET,176,-0.022678,-0.0022085,0.058703,0.65037,GOBP_ATP_METABOLIC_PROCESS,1
HP_OLIGOARTHRITIS,SET,12,-0.1029,-0.0026284,0.26635,0.65037,HP_OLIGOARTHRITIS,1
GOBP_BRAIN_MORPHOGENESIS,SET,37,-0.054077,-0.0024239,0.13997,0.65038,GOBP_BRAIN_MORPHOGENESIS,1
KEGG_MEDICUS_VARIANT_MUTATIO...65,SET,37,-0.045246,-0.0020281,0.11708,0.65041,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_TDP43_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
REACTOME_TETRAHYDROBIOPTERIN...,SET,10,-0.092875,-0.0021658,0.24031,0.65042,REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION,1
HP_STROKE_LIKE_EPISODE,SET,12,-0.092285,-0.0023573,0.23877,0.65043,HP_STROKE_LIKE_EPISODE,1
GOMF_14_3_3_PROTEIN_BINDING,SET,29,-0.060907,-0.0024175,0.1575,0.65051,GOMF_14_3_3_PROTEIN_BINDING,1
GOMF_CARBOHYDRATE_PHOSPHATAS...,SET,8,-0.10779,-0.0022483,0.27865,0.65055,GOMF_CARBOHYDRATE_PHOSPHATASE_ACTIVITY,1
GSE2770_TGFB_AND_IL4_VS_TGFB...1,SET,166,-0.024572,-0.0023247,0.063527,0.65055,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
HP_ABNORMALITY_OF_THE_STAPES,SET,13,-0.10078,-0.0026794,0.26039,0.65064,HP_ABNORMALITY_OF_THE_STAPES,1
MIR138_5P,SET,189,-0.023954,-0.0024166,0.061876,0.65067,MIR138_5P,1
HOWARD_NK_CELL_INACT_MONOV_I...2,SET,56,-0.046006,-0.0025356,0.11883,0.65068,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_28DY_DN,1
BUSSLINGER_DUODENAL_K_CELLS,SET,17,-0.083386,-0.0025349,0.21537,0.65068,BUSSLINGER_DUODENAL_K_CELLS,1
GOBP_GRANULOCYTE_MIGRATION,SET,140,-0.030597,-0.0026602,0.079013,0.65071,GOBP_GRANULOCYTE_MIGRATION,1
REACTOME_FORMATION_OF_WDR5_C...,SET,37,-0.04908,-0.0021999,0.12673,0.65073,REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES,1
GOBP_ANTRAL_OVARIAN_FOLLICLE...,SET,12,-0.0924,-0.0023603,0.23858,0.65073,GOBP_ANTRAL_OVARIAN_FOLLICLE_GROWTH,1
MIR3133,SET,447,-0.01601,-0.0024662,0.041313,0.65081,MIR3133,1
REACTOME_GLYCOSPHINGOLIPID_T...,SET,8,-0.10385,-0.0021662,0.2679,0.65086,REACTOME_GLYCOSPHINGOLIPID_TRANSPORT,1
GOBP_ACINAR_CELL_DIFFERENTIA...,SET,5,-0.16751,-0.0027625,0.43203,0.65089,GOBP_ACINAR_CELL_DIFFERENTIATION,1
SHIPP_DLBCL_VS_FOLLICULAR_LY...1,SET,36,-0.055752,-0.002465,0.14377,0.65091,SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN,1
RFX1_01,SET,224,-0.021875,-0.0024002,0.056401,0.65093,RFX1_01,1
PID_AVB3_INTEGRIN_PATHWAY,SET,72,-0.039841,-0.0024887,0.10269,0.65097,PID_AVB3_INTEGRIN_PATHWAY,1
HP_NEUROGENIC_BLADDER,SET,65,-0.038514,-0.0022864,0.099263,0.65099,HP_NEUROGENIC_BLADDER,1
HP_POOR_COORDINATION,SET,32,-0.058669,-0.002446,0.15118,0.65102,HP_POOR_COORDINATION,1
GSE10422_WT_VS_BAFF_TRANSGEN...2,SET,157,-0.025843,-0.0023783,0.066592,0.65102,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_UP,1
WP_ADHD_AND_AUTISM_ASD_PATHW...,SET,342,-0.018717,-0.0025294,0.048208,0.65109,WP_ADHD_AND_AUTISM_ASD_PATHWAYS,1
HP_ABNORMAL_CEREBRAL_VEIN_MO...,SET,8,-0.11498,-0.0023984,0.29613,0.6511,HP_ABNORMAL_CEREBRAL_VEIN_MORPHOLOGY,1
SOGA_COLORECTAL_CANCER_MYC_UP,SET,76,-0.036404,-0.0023361,0.093743,0.65111,SOGA_COLORECTAL_CANCER_MYC_UP,1
HP_ABNORMAL_PULMONARY_THORAC...,SET,132,-0.029789,-0.0025155,0.076703,0.65112,HP_ABNORMAL_PULMONARY_THORACIC_IMAGING_FINDING,1
GOMF_PROSTANOID_RECEPTOR_ACT...,SET,11,-0.11088,-0.0027119,0.28546,0.65115,GOMF_PROSTANOID_RECEPTOR_ACTIVITY,1
GOBP_PRENYLATION,SET,10,-0.10113,-0.0023583,0.26034,0.65116,GOBP_PRENYLATION,1
GOBP_BLOOD_VESSEL_ENDOTHELIA...1,SET,11,-0.10567,-0.0025843,0.27166,0.65135,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_DIFFERENTIATION,1
MIR548AQ_5P,SET,445,-0.015602,-0.0023982,0.04011,0.65136,MIR548AQ_5P,1
GOBP_MESENCHYMAL_CELL_APOPTO...,SET,15,-0.099637,-0.0028453,0.25608,0.65139,GOBP_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,1
GSE26030_UNSTIM_VS_RESTIM_TH...5,SET,192,-0.022863,-0.0023245,0.058731,0.65146,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_DN,1
REACTOME_NEF_MEDIATES_DOWN_M...,SET,20,-0.070984,-0.0023403,0.18232,0.65148,REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS,1
GSE16385_MONOCYTE_VS_12H_ROS...4,SET,173,-0.02397,-0.0023146,0.061555,0.65151,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_UP,1
GOBP_RESPONSE_TO_PROTOZOAN,SET,28,-0.069158,-0.0026973,0.17759,0.65152,GOBP_RESPONSE_TO_PROTOZOAN,1
JIANG_MELANOMA_TRM11_CD8,SET,43,-0.053396,-0.0025797,0.1371,0.65153,JIANG_MELANOMA_TRM11_CD8,1
GSE41087_WT_VS_FOXP3_MUT_ANT...2,SET,168,-0.025383,-0.0024157,0.065103,0.65169,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_UP,1
GSE339_CD4POS_VS_CD4CD8DN_DC...1,SET,179,-0.02432,-0.0023884,0.062352,0.65175,GSE339_CD4POS_VS_CD4CD8DN_DC_DN,1
HP_RETINAL_EXUDATE,SET,8,-0.11452,-0.0023888,0.29353,0.65178,HP_RETINAL_EXUDATE,1
FAN_OVARY_CL12_T_LYMPHOCYTE_...,SET,138,-0.028111,-0.0024267,0.072042,0.65181,FAN_OVARY_CL12_T_LYMPHOCYTE_NK_CELL_2,1
GOBP_REGULATION_OF_UBIQUITIN...1,SET,149,-0.026519,-0.0023781,0.067956,0.65182,GOBP_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GOBP_SPINAL_CORD_OLIGODENDRO...,SET,5,-0.18041,-0.0029752,0.4623,0.65182,GOBP_SPINAL_CORD_OLIGODENDROCYTE_CELL_DIFFERENTIATION,1
REACTOME_SIGNALING_BY_FGFR2_...2,SET,42,-0.048749,-0.0023277,0.12489,0.65185,REACTOME_SIGNALING_BY_FGFR2_IN_DISEASE,1
HP_HYPOPLASIA_OF_THE_OLFACTO...,SET,6,-0.14759,-0.0026663,0.37812,0.65185,HP_HYPOPLASIA_OF_THE_OLFACTORY_BULB,1
GSE13411_NAIVE_VS_MEMORY_BCE...1,SET,181,-0.023986,-0.0023686,0.061439,0.65188,GSE13411_NAIVE_VS_MEMORY_BCELL_DN,1
SAMOLS_TARGETS_OF_KHSV_MIRNA...2,SET,8,-0.13194,-0.0027522,0.33788,0.65192,SAMOLS_TARGETS_OF_KHSV_MIRNAS_UP,1
GOBP_LENS_FIBER_CELL_MORPHOG...,SET,6,-0.14311,-0.0025853,0.36632,0.65197,GOBP_LENS_FIBER_CELL_MORPHOGENESIS,1
LEE_LIVER_CANCER_ACOX1_UP,SET,62,-0.046692,-0.0027073,0.1195,0.652,LEE_LIVER_CANCER_ACOX1_UP,1
REACTOME_RUNX1_REGULATES_TRA...1,SET,6,-0.12915,-0.0023331,0.33052,0.652,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_BCR_SIGNALING,1
GOBP_INTESTINAL_CHOLESTEROL_...,SET,17,-0.089793,-0.0027296,0.22971,0.65206,GOBP_INTESTINAL_CHOLESTEROL_ABSORPTION,1
GSE29949_CD8_NEG_DC_SPLEEN_V...6,SET,184,-0.02435,-0.0024242,0.062286,0.65208,GSE29949_CD8_NEG_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,1
GAVISH_3CA_METAPROGRAM_CD8_T...6,SET,47,-0.04687,-0.0023672,0.11988,0.65209,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_HEAT_SHOCK,1
MIR6083,SET,236,-0.022251,-0.0025051,0.056891,0.65214,MIR6083,1
GOBP_POSITIVE_REGULATION_OF_...189,SET,15,-0.081836,-0.002337,0.20923,0.65215,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
HP_DEVIATION_OF_THE_THUMB,SET,41,-0.049709,-0.0023452,0.12705,0.65219,HP_DEVIATION_OF_THE_THUMB,1
HP_SLENDER_LONG_BONES_WITH_N...,SET,5,-0.12953,-0.0021362,0.33108,0.65219,HP_SLENDER_LONG_BONES_WITH_NARROW_DIAPHYSES,1
HP_ABNORMAL_EKG,SET,120,-0.031358,-0.0025256,0.080141,0.65221,HP_ABNORMAL_EKG,1
HP_PARKINSONISM_WITH_FAVORAB...,SET,22,-0.069306,-0.0023964,0.17712,0.65221,HP_PARKINSONISM_WITH_FAVORABLE_RESPONSE_TO_DOPAMINERGIC_MEDICATION,1
GACAGGG_MIR339,SET,63,-0.039589,-0.0023139,0.10116,0.65223,GACAGGG_MIR339,1
WP_NSP1_FROM_SARSCOV2_INHIBI...,SET,12,-0.090063,-0.0023006,0.2301,0.65225,WP_NSP1_FROM_SARSCOV2_INHIBITS_TRANSLATION_INITIATION_IN_THE_HOST_CELL,1
GOMF_TRANSFORMING_GROWTH_FAC...2,SET,13,-0.098691,-0.0026238,0.25212,0.65226,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY,1
GOBP_ATP_BIOSYNTHETIC_PROCESS,SET,62,-0.03616,-0.0020966,0.092353,0.6523,GOBP_ATP_BIOSYNTHETIC_PROCESS,1
GSE23984_CTRL_VS_HYPOCALEMIC...2,SET,176,-0.024412,-0.0023775,0.06235,0.6523,GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_UP,1
REACTOME_METABOLISM_OF_NUCLE...,SET,92,-0.035468,-0.0025031,0.090579,0.65231,REACTOME_METABOLISM_OF_NUCLEOTIDES,1
HATADA_METHYLATED_IN_LUNG_CA...2,SET,350,-0.018159,-0.0024819,0.046371,0.65232,HATADA_METHYLATED_IN_LUNG_CANCER_UP,1
WP_MET_IN_TYPE_1_PAPILLARY_R...,SET,53,-0.045509,-0.0024403,0.11618,0.65236,WP_MET_IN_TYPE_1_PAPILLARY_RENAL_CELL_CARCINOMA,1
HP_PROXIMAL_HYPERREFLEXIA,SET,36,-0.053156,-0.0023503,0.13567,0.65239,HP_PROXIMAL_HYPERREFLEXIA,1
MORF_SP3,SET,75,-0.035757,-0.0022795,0.091245,0.65243,MORF_SP3,1
QIU_PBMC_HEPTATITIS_B_SURFAC...7,SET,28,-0.068445,-0.0026695,0.17449,0.65256,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_7DY_UP,1
MIR7157_3P,SET,174,-0.025141,-0.0024346,0.06409,0.65257,MIR7157_3P,1
KIM_WT1_TARGETS_12HR_UP,SET,154,-0.027619,-0.0025176,0.070401,0.65258,KIM_WT1_TARGETS_12HR_UP,1
MIR12113,SET,83,-0.036816,-0.0024685,0.093827,0.65261,MIR12113,1
GROSS_ELK3_TARGETS_DN,SET,32,-0.062169,-0.0025918,0.15834,0.6527,GROSS_ELK3_TARGETS_DN,1
MIR6837_3P,SET,101,-0.032688,-0.0024165,0.083251,0.65271,MIR6837_3P,1
HP_SMALL_EPIPHYSES,SET,20,-0.077779,-0.0025644,0.19794,0.65282,HP_SMALL_EPIPHYSES,1
LINDGREN_BLADDER_CANCER_CLUS...6,SET,205,-0.022593,-0.0023727,0.057475,0.65287,LINDGREN_BLADDER_CANCER_CLUSTER_3_DN,1
GSE24634_TEFF_VS_TCONV_DAY10...2,SET,183,-0.024414,-0.002424,0.062104,0.65288,GSE24634_TEFF_VS_TCONV_DAY10_IN_CULTURE_UP,1
HOEBEKE_LYMPHOID_STEM_CELL_DN,SET,82,-0.038089,-0.0025385,0.096886,0.65289,HOEBEKE_LYMPHOID_STEM_CELL_DN,1
KORKOLA_CHORIOCARCINOMA,SET,5,-0.16164,-0.0026657,0.41115,0.65289,KORKOLA_CHORIOCARCINOMA,1
GSE32901_TH1_VS_TH17_ENRICHE...1,SET,142,-0.027766,-0.0024312,0.070572,0.653,GSE32901_TH1_VS_TH17_ENRICHED_CD4_TCELL_DN,1
GOBP_REGULATION_OF_MITOCHOND...12,SET,18,-0.077385,-0.0024206,0.19667,0.65301,GOBP_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
HP_ERYTHROMELALGIA,SET,7,-0.11875,-0.0023171,0.30175,0.65304,HP_ERYTHROMELALGIA,1
GOBP_REGULATION_OF_CELL_FATE...2,SET,23,-0.067452,-0.0023847,0.17136,0.65307,GOBP_REGULATION_OF_CELL_FATE_SPECIFICATION,1
HP_HEMIPLEGIA,SET,33,-0.061536,-0.0026052,0.15622,0.65317,HP_HEMIPLEGIA,1
GOBP_INTERNEURON_MIGRATION_F...,SET,6,-0.1646,-0.0029735,0.41776,0.65321,GOBP_INTERNEURON_MIGRATION_FROM_THE_SUBPALLIUM_TO_THE_CORTEX,1
GOBP_PROGRAMMED_CELL_DEATH_I...2,SET,12,-0.097772,-0.0024975,0.24813,0.65322,GOBP_PROGRAMMED_CELL_DEATH_IN_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
GSE6674_UNSTIM_VS_ANTI_IGM_A...2,SET,185,-0.024177,-0.0024134,0.061356,0.65322,GSE6674_UNSTIM_VS_ANTI_IGM_AND_CPG_STIM_BCELL_UP,1
IBRAHIM_NRF1_DOWN,SET,127,-0.029843,-0.0024721,0.075724,0.65324,IBRAHIM_NRF1_DOWN,1
GSE19941_IL10_KO_VS_IL10_KO_...2,SET,177,-0.025119,-0.0024532,0.063732,0.65326,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_UP,1
HP_SEVERE_PLATYSPONDYLY,SET,8,-0.11418,-0.0023817,0.28968,0.65327,HP_SEVERE_PLATYSPONDYLY,1
GCTTGAA_MIR498,SET,98,-0.03408,-0.0024819,0.08645,0.65329,GCTTGAA_MIR498,1
PID_HDAC_CLASSI_PATHWAY,SET,60,-0.041321,-0.0023571,0.1047,0.65346,PID_HDAC_CLASSI_PATHWAY,1
GOMF_NUCLEAR_RETINOIC_ACID_R...,SET,24,-0.066218,-0.0023913,0.16777,0.65346,GOMF_NUCLEAR_RETINOIC_ACID_RECEPTOR_BINDING,1
MIR3171,SET,73,-0.03548,-0.0022316,0.089888,0.65347,MIR3171,1
GOBP_NEGATIVE_REGULATION_OF_...39,SET,7,-0.1276,-0.0024898,0.32328,0.65347,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,1
GSE5589_LPS_VS_LPS_AND_IL6_S...3,SET,188,-0.024068,-0.0024217,0.060957,0.65351,GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,1
HNF4_DR1_Q3,SET,243,-0.02144,-0.002449,0.054289,0.65355,HNF4_DR1_Q3,1
GSE30083_SP1_VS_SP4_THYMOCYT...2,SET,181,-0.024641,-0.0024332,0.062367,0.65361,GSE30083_SP1_VS_SP4_THYMOCYTE_UP,1
GOMF_MODIFIED_AMINO_ACID_TRA...,SET,30,-0.060825,-0.0024554,0.15394,0.65362,GOMF_MODIFIED_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE23505_UNTREATED_VS_4DAY_I...1,SET,178,-0.026137,-0.0025597,0.066152,0.65362,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_IL23_TREATED_CD4_TCELL_DN,1
GOMF_CHONDROITIN_SULFATE_BIN...,SET,9,-0.11828,-0.0026167,0.2993,0.65364,GOMF_CHONDROITIN_SULFATE_BINDING,1
MIR6796_3P,SET,55,-0.044896,-0.0024523,0.1136,0.65365,MIR6796_3P,1
IVANOVA_HEMATOPOIESIS_STEM_C...2,SET,515,-0.01497,-0.0024705,0.037868,0.65369,IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR,1
REACTOME_METABOLISM_OF_POLYA...,SET,55,-0.039092,-0.0021353,0.098801,0.65382,REACTOME_METABOLISM_OF_POLYAMINES,1
MIR7108_5P,SET,43,-0.052928,-0.0025571,0.13377,0.65382,MIR7108_5P,1
GOBP_PLASMA_MEMBRANE_RAFT_OR...,SET,11,-0.10423,-0.0025491,0.26342,0.65382,GOBP_PLASMA_MEMBRANE_RAFT_ORGANIZATION,1
HP_HYPOPLASTIC_IRIS_STROMA,SET,8,-0.14149,-0.0029514,0.35752,0.65386,HP_HYPOPLASTIC_IRIS_STROMA,1
GSE17721_LPS_VS_PAM3CSK4_0.5...1,SET,174,-0.02529,-0.0024491,0.063875,0.65392,GSE17721_LPS_VS_PAM3CSK4_0.5H_BMDC_DN,1
WP_SIGNAL_TRANSDUCTION_THROU...,SET,32,-0.063206,-0.0026351,0.15963,0.65393,WP_SIGNAL_TRANSDUCTION_THROUGH_IL1R,1
MORF_DAP,SET,69,-0.03694,-0.0022591,0.093292,0.65393,MORF_DAP,1
GOCC_PLASMA_MEMBRANE_SIGNALI...,SET,180,-0.026597,-0.0026192,0.067167,0.65394,GOCC_PLASMA_MEMBRANE_SIGNALING_RECEPTOR_COMPLEX,1
REACTOME_TRANSCRIPTION_COUPL...,SET,73,-0.033554,-0.0021105,0.084698,0.654,REACTOME_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR_TC_NER,1
GOBP_SCHWANN_CELL_DIFFERENTI...,SET,47,-0.04935,-0.0024924,0.12454,0.65404,GOBP_SCHWANN_CELL_DIFFERENTIATION,1
GOBP_SYNAPTONEMAL_COMPLEX_OR...,SET,23,-0.061886,-0.0021879,0.15616,0.65406,GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION,1
GOCC_NUCLEAR_SPECK,SET,374,-0.016486,-0.0023277,0.041598,0.65406,GOCC_NUCLEAR_SPECK,1
HP_BILATERAL_CONDUCTIVE_HEAR...,SET,6,-0.11501,-0.0020778,0.29021,0.65406,HP_BILATERAL_CONDUCTIVE_HEARING_IMPAIRMENT,1
BIOCARTA_BLYMPHOCYTE_PATHWAY,SET,10,-0.12374,-0.0028856,0.31221,0.65407,BIOCARTA_BLYMPHOCYTE_PATHWAY,1
GOCC_STEREOCILIUM_MEMBRANE,SET,5,-0.17876,-0.0029481,0.45099,0.65408,GOCC_STEREOCILIUM_MEMBRANE,1
SWEET_KRAS_ONCOGENIC_SIGNATU...,SET,82,-0.036896,-0.002459,0.09306,0.65412,SWEET_KRAS_ONCOGENIC_SIGNATURE,1
GOMF_CARBOHYDRATE_KINASE_ACT...,SET,20,-0.064401,-0.0021233,0.16235,0.6542,GOMF_CARBOHYDRATE_KINASE_ACTIVITY,1
IBRAHIM_NRF2_DOWN,SET,129,-0.029435,-0.0024573,0.074191,0.65422,IBRAHIM_NRF2_DOWN,1
KEGG_MEDICUS_VARIANT_MUTATIO...24,SET,35,-0.048652,-0.0021211,0.12261,0.65424,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_GALACTOLIPID_METABOLIC_...,SET,9,-0.11803,-0.0026111,0.29742,0.65425,GOBP_GALACTOLIPID_METABOLIC_PROCESS,1
ERWIN_COHEN_PBMC_TC_83_AGE_1...4,SET,31,-0.067733,-0.0027794,0.17068,0.65426,ERWIN_COHEN_PBMC_TC_83_AGE_18_45YO_RESPONDERS_PREVIOUSLY_IMMUNIZED_24HR_DEG_CANONICAL_PATHWAY_MEMBERS_UP,1
MIR6718_5P,SET,63,-0.0419,-0.0024489,0.10556,0.65429,MIR6718_5P,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...1,SET,6,-0.13072,-0.0023615,0.32928,0.65431,CAO_BLOOD_FLUZONE_AGE_05_14YO_1DY_DN,1
REACTOME_NEGATIVE_REGULATION...10,SET,51,-0.041639,-0.0021904,0.10481,0.65442,REACTOME_NEGATIVE_REGULATION_OF_NOTCH4_SIGNALING,1
HP_VESTIBULAR_HYPOFUNCTION,SET,15,-0.09197,-0.0026263,0.23149,0.65442,HP_VESTIBULAR_HYPOFUNCTION,1
REACTOME_SIGNALING_BY_VEGF,SET,101,-0.033352,-0.0024656,0.083943,0.65443,REACTOME_SIGNALING_BY_VEGF,1
MODULE_291,SET,61,-0.045938,-0.0026421,0.11558,0.65448,MODULE_291,1
GOBP_MEMBRANOUS_SEPTUM_MORPH...,SET,6,-0.16499,-0.0029806,0.41505,0.65451,GOBP_MEMBRANOUS_SEPTUM_MORPHOGENESIS,1
KEGG_MEDICUS_REFERENCE_BMP_H...2,SET,6,-0.12483,-0.0022551,0.31397,0.65453,KEGG_MEDICUS_REFERENCE_BMP_HAMP_SIGNALING_PATHWAY_AUXILIARY_FACTOR,1
GSE26669_CD4_VS_CD8_TCELL_IN...2,SET,181,-0.024769,-0.0024459,0.062285,0.65456,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_COSTIM_BLOCK_UP,1
HP_THICKENED_GLOMERULAR_BASE...,SET,9,-0.10829,-0.0023958,0.27226,0.65459,HP_THICKENED_GLOMERULAR_BASEMENT_MEMBRANE,1
WP_RETINOBLASTOMA_GENE_IN_CA...,SET,81,-0.035774,-0.0023697,0.089932,0.6546,WP_RETINOBLASTOMA_GENE_IN_CANCER,1
HP_ONYCHOGRYPOSIS_OF_TOENAILS,SET,7,-0.11909,-0.0023236,0.29935,0.65462,HP_ONYCHOGRYPOSIS_OF_TOENAILS,1
MORF_CUL1,SET,68,-0.037,-0.0022464,0.092966,0.65468,MORF_CUL1,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...1,SET,22,-0.082406,-0.0028494,0.20701,0.65471,HE_LIM_SUN_FETAL_LUNG_C1_LATE_AIRWAY_PROGENITOR_CELL,1
MARTINELLI_IMMATURE_NEUTROPH...1,SET,13,-0.10925,-0.0029046,0.27437,0.65476,MARTINELLI_IMMATURE_NEUTROPHIL_DN,1
GSE34156_NOD2_LIGAND_VS_TLR1...3,SET,169,-0.026845,-0.0025624,0.067415,0.65476,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN,1
REACTOME_SIGNAL_REGULATORY_P...,SET,14,-0.096968,-0.0026753,0.24346,0.65479,REACTOME_SIGNAL_REGULATORY_PROTEIN_FAMILY_INTERACTIONS,1
GOBP_REGULATION_OF_CELL_MATR...,SET,115,-0.03141,-0.0024768,0.078864,0.65479,GOBP_REGULATION_OF_CELL_MATRIX_ADHESION,1
GRUETZMANN_PANCREATIC_CANCER...1,SET,182,-0.024929,-0.0024685,0.062579,0.65482,GRUETZMANN_PANCREATIC_CANCER_DN,1
HP_MULTIPLE_GASTRIC_POLYPS,SET,7,-0.11741,-0.002291,0.29473,0.65482,HP_MULTIPLE_GASTRIC_POLYPS,1
TESAR_ALK_TARGETS_HUMAN_ES_5...1,SET,5,-0.14727,-0.0024287,0.36966,0.65483,TESAR_ALK_TARGETS_HUMAN_ES_5D_DN,1
BROWNE_HCMV_INFECTION_30MIN_...1,SET,126,-0.029492,-0.0024336,0.074022,0.65484,BROWNE_HCMV_INFECTION_30MIN_DN,1
HP_GENERALIZED_LIMB_MUSCLE_A...,SET,18,-0.075465,-0.0023605,0.18941,0.65484,HP_GENERALIZED_LIMB_MUSCLE_ATROPHY,1
REACTOME_ACYL_CHAIN_REMODELL...4,SET,16,-0.088554,-0.0026117,0.22216,0.65491,REACTOME_ACYL_CHAIN_REMODELLING_OF_PI,1
GOMF_SPHINGOLIPID_BINDING,SET,25,-0.065807,-0.0024254,0.16507,0.65493,GOMF_SPHINGOLIPID_BINDING,1
HP_COGNITIVE_DISTORTION,SET,29,-0.062184,-0.0024682,0.15598,0.65493,HP_COGNITIVE_DISTORTION,1
GOBP_DTTP_METABOLIC_PROCESS,SET,5,-0.15613,-0.0025749,0.39161,0.65494,GOBP_DTTP_METABOLIC_PROCESS,1
HP_PAST_MEDICAL_HISTORY,SET,156,-0.027532,-0.0025258,0.069053,0.65494,HP_PAST_MEDICAL_HISTORY,1
GSE26030_TH1_VS_TH17_DAY5_PO...2,SET,183,-0.02459,-0.0024414,0.061671,0.65495,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_UP,1
HP_TRUNCAL_OBESITY,SET,71,-0.039826,-0.0024705,0.09984,0.65501,HP_TRUNCAL_OBESITY,1
GOBP_DUMP_METABOLIC_PROCESS,SET,7,-0.1348,-0.0026303,0.3379,0.65503,GOBP_DUMP_METABOLIC_PROCESS,1
HP_CUTANEOUS_AMYLOIDOSIS,SET,5,-0.14792,-0.0024395,0.37076,0.65504,HP_CUTANEOUS_AMYLOIDOSIS,1
GOBP_PROTEIN_LOCALIZATION_TO...43,SET,6,-0.11276,-0.0020371,0.28248,0.65512,GOBP_PROTEIN_LOCALIZATION_TO_PHOTORECEPTOR_OUTER_SEGMENT,1
GOBP_SUPEROXIDE_METABOLIC_PR...,SET,62,-0.044776,-0.0025963,0.11217,0.65512,GOBP_SUPEROXIDE_METABOLIC_PROCESS,1
HP_COMMON_ATRIUM,SET,8,-0.11486,-0.0023958,0.28773,0.65512,HP_COMMON_ATRIUM,1
REACTOME_COPI_MEDIATED_ANTER...,SET,99,-0.031896,-0.0023347,0.079884,0.65516,REACTOME_COPI_MEDIATED_ANTEROGRADE_TRANSPORT,1
WP_ENERGY_METABOLISM,SET,47,-0.047351,-0.0023915,0.11857,0.65518,WP_ENERGY_METABOLISM,1
REACTOME_INTEGRATION_OF_ENER...,SET,106,-0.034007,-0.0025752,0.085138,0.65521,REACTOME_INTEGRATION_OF_ENERGY_METABOLISM,1
GOBP_SPHINGOID_METABOLIC_PRO...,SET,18,-0.083732,-0.0026191,0.20958,0.65524,GOBP_SPHINGOID_METABOLIC_PROCESS,1
GOBP_MACROAUTOPHAGY,SET,325,-0.017936,-0.0023639,0.044885,0.65528,GOBP_MACROAUTOPHAGY,1
HP_ALOBAR_HOLOPROSENCEPHALY,SET,6,-0.15794,-0.0028533,0.39523,0.65528,HP_ALOBAR_HOLOPROSENCEPHALY,1
WP_GPCRS_CLASS_B_SECRETINLIKE,SET,22,-0.079415,-0.002746,0.19871,0.65529,WP_GPCRS_CLASS_B_SECRETINLIKE,1
GOMF_SECONDARY_ACTIVE_SULFAT...,SET,11,-0.10193,-0.0024928,0.25504,0.65529,GOMF_SECONDARY_ACTIVE_SULFATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_CHEMOKINE_RECEPTOR_BIND...,SET,60,-0.051174,-0.0029192,0.12802,0.65532,GOMF_CHEMOKINE_RECEPTOR_BINDING,1
HP_CAMPTODACTYLY_OF_TOE,SET,11,-0.10495,-0.0025667,0.26244,0.65537,HP_CAMPTODACTYLY_OF_TOE,1
CUI_DEVELOPING_HEART_CORONAR...,SET,37,-0.062712,-0.0028109,0.15682,0.65538,CUI_DEVELOPING_HEART_CORONARY_VASCULAR_ENDOTHELIAL_CELL,1
COLLER_MYC_TARGETS_DN,SET,4,-0.17572,-0.0025921,0.43934,0.65541,COLLER_MYC_TARGETS_DN,1
HP_CONGENITAL_ADRENAL_HYPERP...,SET,5,-0.16202,-0.002672,0.40496,0.65545,HP_CONGENITAL_ADRENAL_HYPERPLASIA,1
MORF_STK17A,SET,158,-0.026973,-0.0024902,0.067414,0.65546,MORF_STK17A,1
GOBP_HYPOTHALAMUS_CELL_MIGRA...,SET,6,-0.16302,-0.002945,0.40726,0.65552,GOBP_HYPOTHALAMUS_CELL_MIGRATION,1
HP_GENERALIZED_MYOCLONIC_SEI...,SET,114,-0.0315,-0.0024731,0.078696,0.65552,HP_GENERALIZED_MYOCLONIC_SEIZURE,1
GOBP_RECEPTOR_RECYCLING,SET,43,-0.05016,-0.0024234,0.1253,0.65553,GOBP_RECEPTOR_RECYCLING,1
HP_ABNORMALITY_OF_THE_TONGUE...,SET,3,-0.15799,-0.0020183,0.39454,0.65558,HP_ABNORMALITY_OF_THE_TONGUE_MUSCLE,1
GSE20366_CD103_POS_VS_NEG_TR...1,SET,177,-0.025371,-0.0024778,0.063341,0.65562,GSE20366_CD103_POS_VS_NEG_TREG_KLRG1NEG_DN,1
GOBP_REACTIVE_OXYGEN_SPECIES...1,SET,45,-0.049455,-0.0024441,0.12341,0.65569,GOBP_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
HP_ANGLE_CLOSURE_GLAUCOMA,SET,5,-0.17459,-0.0028793,0.43552,0.65575,HP_ANGLE_CLOSURE_GLAUCOMA,1
YOKOE_CANCER_TESTIS_ANTIGENS,SET,33,-0.055616,-0.0023545,0.1387,0.65578,YOKOE_CANCER_TESTIS_ANTIGENS,1
GOBP_MODIFICATION_OF_POSTSYN...2,SET,21,-0.070045,-0.0023663,0.17467,0.65579,GOBP_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,1
HP_IMPAIRED_MYOCARDIAL_CONTR...,SET,8,-0.13231,-0.0027598,0.32994,0.65579,HP_IMPAIRED_MYOCARDIAL_CONTRACTILITY,1
GSE6875_TCONV_VS_FOXP3_KO_TR...2,SET,180,-0.025426,-0.0025039,0.063386,0.65583,GSE6875_TCONV_VS_FOXP3_KO_TREG_UP,1
REACTOME_METABOLISM_OF_LIPIDS,SET,701,-0.013033,-0.0024963,0.03249,0.65584,REACTOME_METABOLISM_OF_LIPIDS,1
WP_NEURODEGENERATION_WITH_BR...,SET,41,-0.050001,-0.002359,0.12464,0.65585,WP_NEURODEGENERATION_WITH_BRAIN_IRON_ACCUMULATION_NBIA_SUBTYPES_PATHWAY,1
HE_LIM_SUN_FETAL_LUNG_C1_SQU...,SET,230,-0.023644,-0.0026284,0.058923,0.65589,HE_LIM_SUN_FETAL_LUNG_C1_SQUAMOUS_CELL,1
MODULE_92,SET,143,-0.032163,-0.002826,0.080138,0.65591,MODULE_92,1
GOBP_RENAL_RESPONSE_TO_BLOOD...,SET,7,-0.15701,-0.0030635,0.39097,0.656,GOBP_RENAL_RESPONSE_TO_BLOOD_FLOW_INVOLVED_IN_CIRCULATORY_RENIN_ANGIOTENSIN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GSE2706_2H_VS_8H_R848_STIM_D...1,SET,166,-0.026165,-0.0024754,0.065128,0.65606,GSE2706_2H_VS_8H_R848_STIM_DC_DN,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...5,SET,29,-0.061475,-0.00244,0.15301,0.65607,GOBP_NUCLEAR_TRANSCRIBED_MRNA_POLY_A_TAIL_SHORTENING,1
TCOF1_TARGET_GENES,SET,12,-0.096499,-0.002465,0.23997,0.65621,TCOF1_TARGET_GENES,1
MIR4684_3P,SET,114,-0.033375,-0.0026203,0.082959,0.65627,MIR4684_3P,1
ANDERSON_BLOOD_CN54GP140_ADJ...3,SET,30,-0.055528,-0.0022416,0.13802,0.65627,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_3DY_DN,1
HP_GASTROPARESIS,SET,30,-0.057163,-0.0023076,0.14203,0.65633,HP_GASTROPARESIS,1
HP_PROXIMAL_RENAL_TUBULAR_AC...,SET,10,-0.097962,-0.0022844,0.2434,0.65633,HP_PROXIMAL_RENAL_TUBULAR_ACIDOSIS,1
GOBP_RIBOSOMAL_LARGE_SUBUNIT...2,SET,60,-0.040513,-0.002311,0.10064,0.65636,GOBP_RIBOSOMAL_LARGE_SUBUNIT_BIOGENESIS,1
GSE5589_LPS_AND_IL10_VS_LPS_...3,SET,179,-0.025535,-0.0025077,0.06343,0.65637,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN,1
HP_PREMATURE_LOSS_OF_TEETH,SET,53,-0.046739,-0.0025063,0.11605,0.65643,HP_PREMATURE_LOSS_OF_TEETH,1
GSE37301_PRO_BCELL_VS_CD4_TC...2,SET,155,-0.027372,-0.0025031,0.067917,0.65653,GSE37301_PRO_BCELL_VS_CD4_TCELL_UP,1
GOCC_NSL_COMPLEX,SET,9,-0.099664,-0.0022049,0.24728,0.65654,GOCC_NSL_COMPLEX,1
RIGGI_EWING_SARCOMA_PROGENIT...2,SET,389,-0.019342,-0.002784,0.047978,0.65657,RIGGI_EWING_SARCOMA_PROGENITOR_UP,1
GOMF_OXIDOREDUCTASE_ACTIVITY...26,SET,9,-0.12977,-0.0028709,0.32181,0.65661,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_OXIDATION_OF_A_PAIR_OF_DONORS_RESULTING_IN_THE_REDUCTION_OF_MOLECULAR_OXYGEN_TO_TWO_MOLECULES_OF_WATER,1
GOBP_EPIDERMAL_CELL_DIFFEREN...,SET,225,-0.025588,-0.0028138,0.063447,0.65663,GOBP_EPIDERMAL_CELL_DIFFERENTIATION,1
GNF2_CD14,SET,32,-0.065047,-0.0027118,0.16125,0.65666,GNF2_CD14,1
HP_WHEEZING,SET,52,-0.046017,-0.0024443,0.11405,0.65671,HP_WHEEZING,1
GSE35543_IN_VITRO_ITREG_VS_C...2,SET,183,-0.024893,-0.0024716,0.061686,0.65672,GSE35543_IN_VITRO_ITREG_VS_CONVERTED_EX_ITREG_UP,1
MATHEW_FANCONI_ANEMIA_GENES,SET,10,-0.094978,-0.0022149,0.23535,0.65673,MATHEW_FANCONI_ANEMIA_GENES,1
ENK_UV_RESPONSE_EPIDERMIS_DN,SET,483,-0.016089,-0.0025736,0.039859,0.65676,ENK_UV_RESPONSE_EPIDERMIS_DN,1
BIOCARTA_RAC1_PATHWAY,SET,21,-0.076548,-0.002586,0.18959,0.6568,BIOCARTA_RAC1_PATHWAY,1
ERCC8_TARGET_GENES,SET,7,-0.13445,-0.0026235,0.33299,0.65681,ERCC8_TARGET_GENES,1
GOBP_SECONDARY_METABOLIC_PRO...,SET,55,-0.049689,-0.0027141,0.12305,0.65682,GOBP_SECONDARY_METABOLIC_PROCESS,1
GOCC_CUL3_RING_UBIQUITIN_LIG...,SET,37,-0.058007,-0.0026001,0.14358,0.65689,GOCC_CUL3_RING_UBIQUITIN_LIGASE_COMPLEX,1
ZHOU_INFLAMMATORY_RESPONSE_L...1,SET,323,-0.018693,-0.0024563,0.046254,0.65695,ZHOU_INFLAMMATORY_RESPONSE_LIVE_DN,1
GOBP_RESPONSE_TO_DIACYL_BACT...,SET,4,-0.1798,-0.0026523,0.4448,0.65698,GOBP_RESPONSE_TO_DIACYL_BACTERIAL_LIPOPEPTIDE,1
CYCLIN_D1_KE_.V1_DN,SET,179,-0.025591,-0.0025132,0.06329,0.65702,CYCLIN_D1_KE_.V1_DN,1
KEGG_MEDICUS_REFERENCE_FLT3L...2,SET,15,-0.08192,-0.0023394,0.20248,0.6571,KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY,1
GSE3982_EOSINOPHIL_VS_DC_DN,SET,184,-0.025165,-0.0025053,0.062189,0.65713,GSE3982_EOSINOPHIL_VS_DC_DN,1
GSE17721_LPS_VS_CPG_4H_BMDC_...1,SET,172,-0.024944,-0.0024017,0.061637,0.65714,GSE17721_LPS_VS_CPG_4H_BMDC_DN,1
REACTOME_INTERLEUKIN_6_FAMIL...,SET,24,-0.068589,-0.0024769,0.16947,0.65716,REACTOME_INTERLEUKIN_6_FAMILY_SIGNALING,1
GATA3_01,SET,220,-0.023728,-0.0025805,0.058607,0.65721,GATA3_01,1
HP_TETRAPLEGIA,SET,31,-0.059034,-0.0024225,0.14579,0.65723,HP_TETRAPLEGIA,1
GOBP_OLIGOSACCHARIDE_METABOL...,SET,63,-0.044304,-0.0025894,0.10939,0.65727,GOBP_OLIGOSACCHARIDE_METABOLIC_PROCESS,1
AMIT_EGF_RESPONSE_20_HELA,SET,10,-0.11045,-0.0025757,0.27265,0.6573,AMIT_EGF_RESPONSE_20_HELA,1
GSE22611_MUTANT_NOD2_TRANSDU...2,SET,172,-0.025317,-0.0024377,0.062479,0.65734,GSE22611_MUTANT_NOD2_TRANSDUCED_VS_CTRL_HEK293T_STIMULATED_WITH_MDP_6H_UP,1
GOBP_REGULATION_OF_MITOTIC_C...3,SET,9,-0.10477,-0.0023179,0.25853,0.65736,GOBP_REGULATION_OF_MITOTIC_CENTROSOME_SEPARATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...78,SET,7,-0.12253,-0.0023909,0.30227,0.6574,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01048,1
REACTOME_NEGATIVE_REGULATION...8,SET,19,-0.078981,-0.0025381,0.19481,0.65741,REACTOME_NEGATIVE_REGULATION_OF_MET_ACTIVITY,1
GSE25677_MPL_VS_R848_STIM_BC...1,SET,166,-0.027122,-0.0025659,0.06686,0.6575,GSE25677_MPL_VS_R848_STIM_BCELL_DN,1
GOBP_CHEMOREPULSION_OF_AXON,SET,6,-0.14866,-0.0026856,0.36641,0.65752,GOBP_CHEMOREPULSION_OF_AXON,1
GCTCTTG_MIR335,SET,80,-0.036298,-0.0023896,0.089461,0.65753,GCTCTTG_MIR335,1
chr5q21,SET,14,-0.14059,-0.0038788,0.34648,0.65754,chr5q21,1
BYSTRYKH_SCP2_QTL,SET,6,-0.11749,-0.0021224,0.28952,0.65755,BYSTRYKH_SCP2_QTL,1
GOCC_STEREOCILIUM_BASE,SET,7,-0.13251,-0.0025856,0.32652,0.65757,GOCC_STEREOCILIUM_BASE,1
MIR6737_5P,SET,72,-0.038812,-0.0024245,0.095626,0.65758,MIR6737_5P,1
GOBP_REGULATION_OF_PHENOTYPI...,SET,3,-0.23361,-0.0029844,0.57545,0.65761,GOBP_REGULATION_OF_PHENOTYPIC_SWITCHING,1
REACTOME_INSULIN_PROCESSING,SET,23,-0.072115,-0.0025495,0.17762,0.65763,REACTOME_INSULIN_PROCESSING,1
REACTOME_INSULIN_RECEPTOR_RE...,SET,28,-0.064736,-0.0025248,0.15944,0.65764,REACTOME_INSULIN_RECEPTOR_RECYCLING,1
DESCARTES_MAIN_FETAL_CLC_IL5...,SET,151,-0.026586,-0.0023999,0.065476,0.65764,DESCARTES_MAIN_FETAL_CLC_IL5RA_POSITIVE_CELLS,1
GNF2_CCNA1,SET,56,-0.047408,-0.0026129,0.11671,0.6577,GNF2_CCNA1,1
GSE21927_SPLENIC_VS_TUMOR_MO...2,SET,164,-0.026176,-0.0024616,0.064442,0.6577,GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_UP,1
GOBP_ANTIBACTERIAL_PEPTIDE_P...,SET,10,-0.12206,-0.0028464,0.30033,0.65778,GOBP_ANTIBACTERIAL_PEPTIDE_PRODUCTION,1
HP_MUSCLE_FLACCIDITY,SET,13,-0.10412,-0.0027682,0.25615,0.6578,HP_MUSCLE_FLACCIDITY,1
MAX_01,SET,240,-0.022193,-0.0025194,0.054587,0.65783,MAX_01,1
GSE2770_IL12_VS_IL4_TREATED_...5,SET,184,-0.023863,-0.0023756,0.05869,0.65784,GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN,1
ZNF791_TARGET_GENES,SET,41,-0.050719,-0.0023928,0.12472,0.65787,ZNF791_TARGET_GENES,1
GSE3039_ALPHAALPHA_CD8_TCELL...1,SET,184,-0.025688,-0.0025574,0.063155,0.6579,GSE3039_ALPHAALPHA_CD8_TCELL_VS_B1_BCELL_DN,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...3,SET,119,-0.029825,-0.0023922,0.073314,0.65793,GOBP_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
GSE18804_SPLEEN_MACROPHAGE_V...3,SET,174,-0.026627,-0.0025785,0.065434,0.65797,GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN,1
GOBP_REGULATION_OF_CELLULAR_...14,SET,6,-0.16116,-0.0029114,0.39593,0.65801,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_MACROPHAGE_COLONY_STIMULATING_FACTOR_STIMULUS,1
GOBP_MACROPHAGE_INFLAMMATORY...,SET,6,-0.14611,-0.0026395,0.35873,0.6581,GOBP_MACROPHAGE_INFLAMMATORY_PROTEIN_1_ALPHA_PRODUCTION,1
REACTOME_TRANSCRIPTIONAL_REG...5,SET,112,-0.030949,-0.0024086,0.075976,0.65812,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX2,1
GOBP_POSITIVE_REGULATION_OF_...8,SET,22,-0.081774,-0.0028275,0.20063,0.65821,GOBP_POSITIVE_REGULATION_OF_ACTIVATED_T_CELL_PROLIFERATION,1
GSE43955_1H_VS_10H_ACT_CD4_T...4,SET,173,-0.026616,-0.0025701,0.065295,0.65822,GSE43955_1H_VS_10H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
REACTOME_ACTIVATION_OF_RAC1_...,SET,7,-0.12058,-0.0023528,0.29566,0.6583,REACTOME_ACTIVATION_OF_RAC1_DOWNSTREAM_OF_NMDARS,1
GSE411_UNSTIM_VS_400MIN_IL6_...2,SET,183,-0.024921,-0.0024743,0.061066,0.6584,GSE411_UNSTIM_VS_400MIN_IL6_STIM_MACROPHAGE_UP,1
HP_GALACTOSURIA,SET,4,-0.15484,-0.0022841,0.37935,0.65842,HP_GALACTOSURIA,1
KEGG_MEDICUS_REFERENCE_EGF_E...8,SET,13,-0.096472,-0.0025648,0.23633,0.65844,KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_JNK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_AMACRINE_...,SET,6,-0.15677,-0.002832,0.38397,0.65846,GOBP_REGULATION_OF_AMACRINE_CELL_DIFFERENTIATION,1
GOCC_MKS_COMPLEX,SET,13,-0.080937,-0.0021518,0.19824,0.65846,GOCC_MKS_COMPLEX,1
HP_UNILATERAL_PTOSIS,SET,8,-0.11833,-0.0024682,0.28979,0.65848,HP_UNILATERAL_PTOSIS,1
REACTOME_BETA_OXIDATION_OF_B...,SET,5,-0.15664,-0.0025833,0.38346,0.65855,REACTOME_BETA_OXIDATION_OF_BUTANOYL_COA_TO_ACETYL_COA,1
MIR7843_3P,SET,80,-0.039309,-0.0025878,0.096098,0.65874,MIR7843_3P,1
GOMF_ACYLGLYCEROL_O_ACYLTRAN...,SET,24,-0.073808,-0.0026654,0.18041,0.65877,GOMF_ACYLGLYCEROL_O_ACYLTRANSFERASE_ACTIVITY,1
HP_DECREASED_SPECIFIC_PNEUMO...,SET,7,-0.14365,-0.0028029,0.35112,0.65877,HP_DECREASED_SPECIFIC_PNEUMOCOCCAL_ANTIBODY_LEVEL,1
GARGALOVIC_RESPONSE_TO_OXIDI...1,SET,10,-0.10505,-0.0024497,0.25663,0.65885,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_DN,1
GSE1460_INTRATHYMIC_T_PROGEN...7,SET,178,-0.025718,-0.0025187,0.062817,0.65888,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,1
WP_INSULIN_SIGNALING,SET,156,-0.027648,-0.0025364,0.067519,0.65891,WP_INSULIN_SIGNALING,1
WP_ALLOGRAFT_REJECTION,SET,82,-0.042456,-0.0028295,0.10367,0.65892,WP_ALLOGRAFT_REJECTION,1
REACTOME_RUNX1_REGULATES_TRA...6,SET,5,-0.1656,-0.002731,0.40434,0.65893,REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_WNT_SIGNALING,1
GSE18893_CTRL_VS_TNF_TREATED...2,SET,179,-0.025599,-0.0025139,0.062502,0.65893,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_UP,1
HP_NEOPLASIA_OF_THE_NASOPHAR...,SET,5,-0.14642,-0.0024148,0.35734,0.65901,HP_NEOPLASIA_OF_THE_NASOPHARYNX,1
YIH_RESPONSE_TO_ARSENITE_C2,SET,14,-0.087061,-0.0024019,0.21243,0.65904,YIH_RESPONSE_TO_ARSENITE_C2,1
GOMF_EXONUCLEASE_ACTIVITY,SET,82,-0.034443,-0.0022955,0.084032,0.65905,GOMF_EXONUCLEASE_ACTIVITY,1
MODULE_534,SET,9,-0.12456,-0.0027557,0.30378,0.65911,MODULE_534,1
HFH1_01,SET,217,-0.02468,-0.0026658,0.060158,0.65919,HFH1_01,1
GSE13306_RA_VS_UNTREATED_MEM...2,SET,189,-0.025226,-0.0025449,0.061482,0.65921,GSE13306_RA_VS_UNTREATED_MEM_CD4_TCELL_UP,1
KEGG_MEDICUS_VARIANT_DUPLICA...1,SET,4,-0.22034,-0.0032503,0.53694,0.65923,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_JAK_STAT_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...263,SET,4,-0.15122,-0.0022307,0.36846,0.65925,GOBP_POSITIVE_REGULATION_OF_EXIT_FROM_MITOSIS,1
HP_CERVICAL_C2_C3_VERTEBRAL_...,SET,11,-0.10424,-0.0025494,0.25398,0.65925,HP_CERVICAL_C2_C3_VERTEBRAL_FUSION,1
HP_RHIZOMELIC_ARM_SHORTENING,SET,9,-0.12902,-0.0028544,0.31434,0.65926,HP_RHIZOMELIC_ARM_SHORTENING,1
GOCC_RSC_TYPE_COMPLEX,SET,15,-0.090377,-0.0025809,0.22016,0.65928,GOCC_RSC_TYPE_COMPLEX,1
REACTOME_SIGNALING_BY_NOTCH1...2,SET,52,-0.046598,-0.0024751,0.11347,0.65934,REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER,1
ZHOU_PANCREATIC_EXOCRINE_PRO...,SET,11,-0.12121,-0.0029644,0.29509,0.65937,ZHOU_PANCREATIC_EXOCRINE_PROGENITOR,1
GOBP_PRIMARY_ALCOHOL_BIOSYNT...,SET,14,-0.10068,-0.0027778,0.24512,0.65937,GOBP_PRIMARY_ALCOHOL_BIOSYNTHETIC_PROCESS,1
HP_ACUTE_PHASE_RESPONSE,SET,168,-0.027645,-0.002631,0.067301,0.65938,HP_ACUTE_PHASE_RESPONSE,1
GOBP_PROTEIN_TARGETING_TO_ME...,SET,107,-0.032481,-0.0024711,0.079067,0.65939,GOBP_PROTEIN_TARGETING_TO_MEMBRANE,1
AGTCTAG_MIR151,SET,20,-0.07863,-0.0025924,0.19139,0.6594,AGTCTAG_MIR151,1
GOBP_POLYSACCHARIDE_METABOLI...,SET,97,-0.035278,-0.0025561,0.085858,0.65942,GOBP_POLYSACCHARIDE_METABOLIC_PROCESS,1
MIR4269,SET,190,-0.025586,-0.002588,0.062268,0.65943,MIR4269,1
GOBP_NEGATIVE_T_CELL_SELECTI...,SET,13,-0.11022,-0.0029303,0.26822,0.65943,GOBP_NEGATIVE_T_CELL_SELECTION,1
GSE13493_DP_VS_CD8POS_THYMOC...1,SET,181,-0.024688,-0.0024379,0.060078,0.65943,GSE13493_DP_VS_CD8POS_THYMOCYTE_DN,1
GSE37301_MULTIPOTENT_PROGENI...7,SET,169,-0.027829,-0.0026563,0.067713,0.65946,GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_DN,1
GOBP_POSITIVE_REGULATION_OF_...457,SET,14,-0.082053,-0.0022638,0.19956,0.65952,GOBP_POSITIVE_REGULATION_OF_METAPHASE_ANAPHASE_TRANSITION_OF_CELL_CYCLE,1
HP_ABNORMAL_CIRCULATING_APOL...,SET,9,-0.10088,-0.0022317,0.24526,0.65957,HP_ABNORMAL_CIRCULATING_APOLIPOPROTEIN_CONCENTRATION,1
PID_A6B1_A6B4_INTEGRIN_PATHW...,SET,46,-0.052292,-0.0026128,0.12701,0.65972,PID_A6B1_A6B4_INTEGRIN_PATHWAY,1
ZNF410_TARGET_GENES,SET,488,-0.015644,-0.0025151,0.037985,0.65977,ZNF410_TARGET_GENES,1
GOBP_LATERAL_SPROUTING_FROM_...,SET,9,-0.13184,-0.0029167,0.32011,0.65978,GOBP_LATERAL_SPROUTING_FROM_AN_EPITHELIUM,1
AIYAR_COBRA1_TARGETS_UP,SET,36,-0.060895,-0.0026925,0.14784,0.6598,AIYAR_COBRA1_TARGETS_UP,1
ZHOU_INFLAMMATORY_RESPONSE_L...2,SET,389,-0.018469,-0.0026584,0.044809,0.65989,ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...249,SET,14,-0.096793,-0.0026704,0.23479,0.65992,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION_VIA_CHROMOSOMAL_CPG_ISLAND_METHYLATION,1
MIR488_5P,SET,71,-0.041257,-0.0025593,0.10004,0.65997,MIR488_5P,1
MIR124_3P,SET,691,-0.013556,-0.0025787,0.032866,0.66,MIR124_3P,1
GOBP_MACROPINOCYTOSIS,SET,8,-0.12936,-0.0026983,0.31363,0.66,GOBP_MACROPINOCYTOSIS,1
MIR744_3P,SET,55,-0.045245,-0.0024714,0.10969,0.66001,MIR744_3P,1
chr1p12,SET,16,-0.14938,-0.0044054,0.36205,0.66004,chr1p12,1
HE_LIM_SUN_FETAL_LUNG_C0_INT...1,SET,62,-0.048663,-0.0028217,0.11795,0.66004,HE_LIM_SUN_FETAL_LUNG_C0_INTERM_CHONDROCYTE,1
DESCARTES_FETAL_INTESTINE_IN...,SET,208,-0.025222,-0.002668,0.061125,0.66006,DESCARTES_FETAL_INTESTINE_INTESTINAL_EPITHELIAL_CELLS,1
PRC2_EED_DN.V1_UP,SET,172,-0.027303,-0.0026289,0.066148,0.6601,PRC2_EED_DN.V1_UP,1
HP_HYPERACTIVE_DEEP_TENDON_R...,SET,22,-0.070395,-0.0024341,0.17054,0.66012,HP_HYPERACTIVE_DEEP_TENDON_REFLEXES,1
WP_MYOMETRIAL_RELAXATION_AND...,SET,153,-0.029231,-0.0026559,0.070797,0.66015,WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS,1
REACTOME_FCERI_MEDIATED_MAPK...,SET,32,-0.060381,-0.0025173,0.14621,0.66019,REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION,1
HP_COLLECTIONISM,SET,10,-0.1035,-0.0024136,0.25056,0.66022,HP_COLLECTIONISM,1
JI_CARCINOGENESIS_BY_KRAS_AN...2,SET,12,-0.099797,-0.0025492,0.24156,0.66024,JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP,1
GNF2_MAPT,SET,39,-0.062613,-0.0028812,0.15151,0.66029,GNF2_MAPT,1
GSE7568_IL4_VS_IL4_AND_DEXAM...1,SET,138,-0.028759,-0.0024826,0.069586,0.6603,GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN,1
MODULE_123,SET,233,-0.023987,-0.0026837,0.058004,0.66039,MODULE_123,1
MIR6835_5P,SET,30,-0.060828,-0.0024555,0.14697,0.66052,MIR6835_5P,1
GSE17974_CTRL_VS_ACT_IL4_AND...5,SET,176,-0.025113,-0.0024458,0.060677,0.66052,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_1H_CD4_TCELL_DN,1
HP_THIN_SKIN,SET,83,-0.037071,-0.0024856,0.089556,0.66054,HP_THIN_SKIN,1
GOBP_REGULATION_OF_NUCLEOTID...5,SET,28,-0.067232,-0.0026222,0.16235,0.6606,GOBP_REGULATION_OF_NUCLEOTIDE_EXCISION_REPAIR,1
GOBP_NEGATIVE_REGULATION_OF_...539,SET,4,-0.18396,-0.0027136,0.44403,0.66067,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TARGETING_TO_MEMBRANE,1
HP_HEMIPLEGIA_HEMIPARESIS,SET,192,-0.025532,-0.0025959,0.061609,0.66071,HP_HEMIPLEGIA_HEMIPARESIS,1
JAEGER_METASTASIS_UP,SET,38,-0.057527,-0.0026131,0.13879,0.66074,JAEGER_METASTASIS_UP,1
HP_BRONCHIAL_WALL_THICKENING,SET,6,-0.17177,-0.0031031,0.41442,0.66074,HP_BRONCHIAL_WALL_THICKENING,1
GOBP_MAINTENANCE_OF_ANIMAL_O...,SET,5,-0.16718,-0.0027571,0.40331,0.66075,GOBP_MAINTENANCE_OF_ANIMAL_ORGAN_IDENTITY,1
GSE24634_NAIVE_CD4_TCELL_VS_...8,SET,181,-0.024699,-0.002439,0.059583,0.66075,GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP,1
DESCARTES_FETAL_LUNG_SQUAMOU...,SET,176,-0.028461,-0.0027718,0.068657,0.66076,DESCARTES_FETAL_LUNG_SQUAMOUS_EPITHELIAL_CELLS,1
GSE43955_TH0_VS_TGFB_IL6_TH1...4,SET,188,-0.026037,-0.0026199,0.062801,0.66078,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_UP,1
MODULE_455,SET,36,-0.056536,-0.0024997,0.13635,0.6608,MODULE_455,1
HP_UROGENITAL_FISTULA,SET,46,-0.050133,-0.002505,0.12088,0.66083,HP_UROGENITAL_FISTULA,1
KEGG_MEDICUS_VARIANT_MUTATIO...10,SET,8,-0.12641,-0.0026368,0.30474,0.66086,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KIT_TO_PI3K_SIGNALING_PATHWAY,1
MIR632,SET,56,-0.048476,-0.0026717,0.11684,0.66088,MIR632,1
GOMF_SULFATIDE_BINDING,SET,6,-0.12986,-0.002346,0.31297,0.6609,GOMF_SULFATIDE_BINDING,1
GARCIA_PINERES_PBMC_HPV_16_L...3,SET,259,-0.022102,-0.0026051,0.053258,0.66092,GARCIA_PINERES_PBMC_HPV_16_L1_VLP_AGE_18_25YO_2MO_DN,1
MODULE_36,SET,146,-0.027537,-0.0024446,0.066355,0.66093,MODULE_36,1
HP_DECREASED_CIRCULATING_COM...4,SET,3,-0.23509,-0.0030033,0.56648,0.66093,HP_DECREASED_CIRCULATING_COMPLEMENT_FACTOR_I_CONCENTRATION,1
HP_2_3_FINGER_SYNDACTYLY,SET,9,-0.11216,-0.0024813,0.27023,0.66094,HP_2_3_FINGER_SYNDACTYLY,1
GOBP_POSITIVE_REGULATION_OF_...42,SET,12,-0.11322,-0.002892,0.27256,0.66107,GOBP_POSITIVE_REGULATION_OF_ASTROCYTE_DIFFERENTIATION,1
TURASHVILI_BREAST_CARCINOMA_...1,SET,3,-0.20255,-0.0025876,0.48701,0.66126,TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1
MIR575,SET,49,-0.046973,-0.0024222,0.11293,0.66128,MIR575,1
HP_MALIGNANT_GASTROINTESTINA...,SET,70,-0.040177,-0.0024748,0.096581,0.66129,HP_MALIGNANT_GASTROINTESTINAL_TRACT_TUMORS,1
HP_ABNORMAL_HAIRSHAFT_MORPHO...,SET,25,-0.064249,-0.002368,0.15437,0.66137,HP_ABNORMAL_HAIRSHAFT_MORPHOLOGY,1
GOBP_GLYCEROPHOSPHOLIPID_BIO...,SET,190,-0.025087,-0.0025375,0.060255,0.66142,GOBP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
MODULE_241,SET,69,-0.044978,-0.0027507,0.10803,0.66143,MODULE_241,1
MIR514A_3P_MIR514B_3P,SET,101,-0.034757,-0.0025695,0.083461,0.66146,MIR514A_3P_MIR514B_3P,1
MORF_RFC1,SET,100,-0.033438,-0.0024598,0.08027,0.6615,MORF_RFC1,1
MODULE_178,SET,15,-0.10316,-0.0029459,0.24761,0.66152,MODULE_178,1
GTGCCAT_MIR183,SET,159,-0.028687,-0.0026566,0.068851,0.66153,GTGCCAT_MIR183,1
GOBP_REGULATION_OF_POSTSYNAP...3,SET,9,-0.11935,-0.0026405,0.28642,0.66155,GOBP_REGULATION_OF_POSTSYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
MORF_EIF3S2,SET,220,-0.021755,-0.0023659,0.052205,0.66156,MORF_EIF3S2,1
HP_SECONDARY_AMENORRHEA,SET,62,-0.042872,-0.0024859,0.10282,0.66164,HP_SECONDARY_AMENORRHEA,1
REACTOME_PROSTANOID_LIGAND_R...,SET,9,-0.13035,-0.0028837,0.31254,0.66168,REACTOME_PROSTANOID_LIGAND_RECEPTORS,1
HP_FLARED_ILIAC_WING,SET,16,-0.086712,-0.0025574,0.20792,0.66168,HP_FLARED_ILIAC_WING,1
REACTOME_FORMATION_OF_TC_NER...,SET,48,-0.044154,-0.0022535,0.10586,0.66169,REACTOME_FORMATION_OF_TC_NER_PRE_INCISION_COMPLEX,1
CDPCR3HD_01,SET,213,-0.025322,-0.0027102,0.060689,0.66175,CDPCR3HD_01,1
GOCC_POSTSYNAPTIC_SPECIALIZA...3,SET,121,-0.033649,-0.0027213,0.080646,0.66175,GOCC_POSTSYNAPTIC_SPECIALIZATION_MEMBRANE,1
GOBP_MODULATION_BY_HOST_OF_V...3,SET,3,-0.2167,-0.0027684,0.51918,0.6618,GOBP_MODULATION_BY_HOST_OF_VIRAL_RNA_GENOME_REPLICATION,1
HP_EOSINOPHILIC_INFILTRATION...,SET,10,-0.12675,-0.0029557,0.30358,0.66184,HP_EOSINOPHILIC_INFILTRATION_OF_THE_ESOPHAGUS,1
GOBP_POSITIVE_REGULATION_OF_...293,SET,6,-0.16946,-0.0030614,0.40562,0.66195,GOBP_POSITIVE_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,1
GSE37416_12H_VS_48H_F_TULARE...1,SET,148,-0.029198,-0.0026096,0.069866,0.66199,GSE37416_12H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_DN,1
GOBP_TRABECULA_FORMATION,SET,27,-0.072576,-0.0027797,0.17366,0.662,GOBP_TRABECULA_FORMATION,1
GOMF_MICROFIBRIL_BINDING,SET,6,-0.16733,-0.0030229,0.40037,0.662,GOMF_MICROFIBRIL_BINDING,1
GOMF_LIPASE_ACTIVATOR_ACTIVI...,SET,19,-0.076306,-0.0024522,0.18253,0.66204,GOMF_LIPASE_ACTIVATOR_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_PINK_...,SET,15,-0.091257,-0.002606,0.21827,0.66206,KEGG_MEDICUS_REFERENCE_PINK_PARKIN_MEDIATED_AUTOPHAGOSOME_FORMATION,1
GOBP_REGULATION_OF_DNA_BINDI...1,SET,67,-0.046278,-0.002789,0.11067,0.66208,GOBP_REGULATION_OF_DNA_BINDING,1
MIR1910_3P,SET,165,-0.027805,-0.0026227,0.066483,0.66211,MIR1910_3P,1
WP_THYROXINE_THYROID_HORMONE...,SET,23,-0.075699,-0.0026762,0.18091,0.66219,WP_THYROXINE_THYROID_HORMONE_PRODUCTION,1
GSE3982_NKCELL_VS_TH1_DN,SET,180,-0.025957,-0.0025562,0.062028,0.6622,GSE3982_NKCELL_VS_TH1_DN,1
GSE12505_WT_VS_E2_2_HET_PDC_...1,SET,143,-0.029616,-0.0026022,0.070758,0.66223,GSE12505_WT_VS_E2_2_HET_PDC_DN,1
HP_MULTIPLE_JOINT_CONTRACTUR...,SET,57,-0.043351,-0.0024105,0.10355,0.66226,HP_MULTIPLE_JOINT_CONTRACTURES,1
GOBP_REGULATION_OF_DENDRITE_...3,SET,57,-0.046937,-0.0026099,0.11207,0.66232,GOBP_REGULATION_OF_DENDRITE_MORPHOGENESIS,1
ENK_UV_RESPONSE_KERATINOCYTE...2,SET,470,-0.016275,-0.0025691,0.038854,0.66234,ENK_UV_RESPONSE_KERATINOCYTE_UP,1
HP_EPIDERMAL_NEVUS,SET,11,-0.096764,-0.0023666,0.23098,0.66237,HP_EPIDERMAL_NEVUS,1
HNF6_Q6,SET,217,-0.025726,-0.0027789,0.061402,0.66238,HNF6_Q6,1
GOBP_AMINOGLYCAN_CATABOLIC_P...,SET,32,-0.063944,-0.0026659,0.15259,0.66241,GOBP_AMINOGLYCAN_CATABOLIC_PROCESS,1
ZHAN_MULTIPLE_MYELOMA_MF_UP,SET,40,-0.055103,-0.0025679,0.13148,0.66242,ZHAN_MULTIPLE_MYELOMA_MF_UP,1
WP_1Q211_COPY_NUMBER_VARIATI...,SET,23,-0.085023,-0.0030059,0.20287,0.66243,WP_1Q211_COPY_NUMBER_VARIATION_SYNDROME,1
REACTOME_SYNTHESIS_OF_SUBSTR...,SET,58,-0.044659,-0.0025048,0.10644,0.6626,REACTOME_SYNTHESIS_OF_SUBSTRATES_IN_N_GLYCAN_BIOSYTHESIS,1
MORF_HDAC2,SET,248,-0.020912,-0.0024128,0.049826,0.66265,MORF_HDAC2,1
HP_EXTERNAL_GENITAL_HYPOPLAS...,SET,436,-0.0168,-0.0025567,0.040022,0.66267,HP_EXTERNAL_GENITAL_HYPOPLASIA,1
ZNF354C_TARGET_GENES,SET,10,-0.10632,-0.0024794,0.25314,0.66276,ZNF354C_TARGET_GENES,1
QIU_PBMC_HEPTATITIS_B_SURFAC...2,SET,7,-0.1537,-0.002999,0.36594,0.66276,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_0_TO_35DY_JOINTLY_UP,1
ZBTB49_TARGET_GENES,SET,7,-0.11215,-0.0021883,0.26682,0.66287,ZBTB49_TARGET_GENES,1
HP_MILD_SHORT_STATURE,SET,18,-0.088042,-0.0027539,0.20947,0.66287,HP_MILD_SHORT_STATURE,1
GOLDRATH_ANTIGEN_RESPONSE,SET,322,-0.019746,-0.0025906,0.046973,0.66289,GOLDRATH_ANTIGEN_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...629,SET,6,-0.17157,-0.0030995,0.40813,0.66289,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_CORTEX,1
GSE9960_GRAM_NEG_VS_GRAM_POS...2,SET,175,-0.026406,-0.0025644,0.062811,0.6629,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_UP,1
HP_CORTICAL_THICKENING_OF_LO...,SET,5,-0.15441,-0.0025465,0.36714,0.66297,HP_CORTICAL_THICKENING_OF_LONG_BONE_DIAPHYSES,1
GOCC_PLASMA_MEMBRANE_PROTEIN...,SET,566,-0.016089,-0.0027796,0.038246,0.663,GOCC_PLASMA_MEMBRANE_PROTEIN_COMPLEX,1
HP_INVERTED_NIPPLES,SET,44,-0.049001,-0.0023947,0.11643,0.66306,HP_INVERTED_NIPPLES,1
BIOCARTA_EPONFKB_PATHWAY,SET,11,-0.10996,-0.0026892,0.26122,0.66309,BIOCARTA_EPONFKB_PATHWAY,1
GOBP_RIG_I_SIGNALING_PATHWAY,SET,22,-0.073192,-0.0025308,0.17388,0.6631,GOBP_RIG_I_SIGNALING_PATHWAY,1
HP_ABNORMAL_EPIPHYSIS_MORPHO...2,SET,36,-0.059324,-0.002623,0.14091,0.66312,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY_OF_THE_PHALANGES_OF_THE_HAND,1
HP_CSF_LYMPHOCYTIC_PLEIOCYTO...,SET,18,-0.080583,-0.0025206,0.1914,0.66313,HP_CSF_LYMPHOCYTIC_PLEIOCYTOSIS,1
GSE360_T_GONDII_VS_B_MALAYI_...8,SET,174,-0.026473,-0.0025636,0.062831,0.66324,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_MAC_UP,1
GOBP_RESPONSE_TO_MINERALOCOR...,SET,36,-0.063078,-0.002789,0.14969,0.66327,GOBP_RESPONSE_TO_MINERALOCORTICOID,1
MIR4265,SET,36,-0.064788,-0.0028646,0.15372,0.66329,MIR4265,1
LIU_CDX2_TARGETS_DN,SET,8,-0.14423,-0.0030085,0.34217,0.66331,LIU_CDX2_TARGETS_DN,1
GSE6259_FLT3L_INDUCED_VS_WT_...2,SET,165,-0.028882,-0.0027243,0.068512,0.66332,GSE6259_FLT3L_INDUCED_VS_WT_SPLENIC_DC_33D1_POS_UP,1
GOBP_LIPID_BIOSYNTHETIC_PROC...,SET,671,-0.014004,-0.0026265,0.033219,0.66333,GOBP_LIPID_BIOSYNTHETIC_PROCESS,1
REACTOME_COLLAGEN_FORMATION,SET,88,-0.040522,-0.0027973,0.096117,0.66334,REACTOME_COLLAGEN_FORMATION,1
KEGG_MEDICUS_REFERENCE_BLOCK...,SET,12,-0.099617,-0.0025446,0.23627,0.66335,KEGG_MEDICUS_REFERENCE_BLOCKING_UBIQUITINATION_OF_H2AK119_BY_CK2,1
BLANCO_MELO_COVID19_SARS_COV...11,SET,159,-0.026297,-0.0024353,0.062364,0.66336,BLANCO_MELO_COVID19_SARS_COV_2_POS_PATIENT_LUNG_TISSUE_DN,1
GOBP_AMINOPHOSPHOLIPID_TRANS...2,SET,8,-0.11911,-0.0024845,0.28247,0.66337,GOBP_AMINOPHOSPHOLIPID_TRANSPORT,1
WP_CLOCKCONTROLLED_AUTOPHAGY...,SET,77,-0.042618,-0.0027527,0.10106,0.66338,WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM,1
MIKKELSEN_MCV6_LCP_WITH_H3K2...,SET,24,-0.074587,-0.0026935,0.17684,0.6634,MIKKELSEN_MCV6_LCP_WITH_H3K27ME3,1
WANG_ADIPOGENIC_GENES_REPRES...,SET,24,-0.072883,-0.002632,0.1728,0.6634,WANG_ADIPOGENIC_GENES_REPRESSED_BY_SIRT1,1
MIR377_3P,SET,216,-0.024024,-0.0025891,0.056962,0.6634,MIR377_3P,1
ZNF555_TARGET_GENES,SET,91,-0.0354,-0.0024848,0.08392,0.66342,ZNF555_TARGET_GENES,1
HAHTOLA_CTCL_CUTANEOUS,SET,21,-0.074668,-0.0025225,0.17696,0.66347,HAHTOLA_CTCL_CUTANEOUS,1
GOCC_PLATELET_ALPHA_GRANULE_...2,SET,16,-0.098101,-0.0028932,0.2325,0.66347,GOCC_PLATELET_ALPHA_GRANULE_MEMBRANE,1
HP_NONSPHEROCYTIC_HEMOLYTIC_...,SET,7,-0.1165,-0.0022731,0.27606,0.66348,HP_NONSPHEROCYTIC_HEMOLYTIC_ANEMIA,1
GCM_DENR,SET,49,-0.045663,-0.0023546,0.10817,0.66353,GCM_DENR,1
GOBP_GROWTH_PLATE_CARTILAGE_...3,SET,19,-0.082752,-0.0026593,0.19604,0.66353,GOBP_GROWTH_PLATE_CARTILAGE_DEVELOPMENT,1
HP_SENSORY_BEHAVIORAL_ABNORM...,SET,295,-0.02094,-0.0026316,0.0496,0.66355,HP_SENSORY_BEHAVIORAL_ABNORMALITY,1
GOMF_DNA_TOPOISOMERASE_ACTIV...,SET,7,-0.11559,-0.0022553,0.27355,0.66368,GOMF_DNA_TOPOISOMERASE_ACTIVITY,1
HP_ABSENCE_OF_LYMPH_NODE_GER...,SET,5,-0.18113,-0.0029871,0.42862,0.6637,HP_ABSENCE_OF_LYMPH_NODE_GERMINAL_CENTER,1
ZNF514_TARGET_GENES,SET,7,-0.14086,-0.0027484,0.33322,0.66374,ZNF514_TARGET_GENES,1
chr16p13,SET,209,-0.050577,-0.0053627,0.11962,0.66378,chr16p13,1
PETROVA_PROX1_TARGETS_UP,SET,25,-0.073313,-0.0027021,0.17335,0.66382,PETROVA_PROX1_TARGETS_UP,1
WP_FEMALE_STEROID_HORMONES_I...,SET,14,-0.089169,-0.0024601,0.21072,0.66391,WP_FEMALE_STEROID_HORMONES_IN_CARDIOMYOCYTE_ENERGY_METABOLISM,1
HP_ELEVATED_CIRCULATING_CREA...,SET,265,-0.021199,-0.0025271,0.050096,0.66391,HP_ELEVATED_CIRCULATING_CREATINE_KINASE_CONCENTRATION,1
TAGHAVI_NEOPLASTIC_TRANSFORM...,SET,11,-0.093578,-0.0022887,0.22108,0.66395,TAGHAVI_NEOPLASTIC_TRANSFORMATION,1
GOBP_POSITIVE_REGULATION_OF_...400,SET,27,-0.073242,-0.0028052,0.17298,0.664,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_APOPTOTIC_PROCESS,1
HP_ABNORMAL_URETER_PHYSIOLOGY,SET,213,-0.024592,-0.002632,0.058051,0.66408,HP_ABNORMAL_URETER_PHYSIOLOGY,1
GOBP_LABYRINTHINE_LAYER_DEVE...,SET,42,-0.056766,-0.0027106,0.13389,0.66421,GOBP_LABYRINTHINE_LAYER_DEVELOPMENT,1
HE_LIM_SUN_FETAL_LUNG_C0_EAR...1,SET,71,-0.042007,-0.0026058,0.099028,0.66428,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_FIBROBLAST,1
HP_ABNORMAL_CONSUMPTION_BEHA...,SET,253,-0.023865,-0.0027806,0.056257,0.66429,HP_ABNORMAL_CONSUMPTION_BEHAVIOR,1
BORCZUK_MALIGNANT_MESOTHELIO...2,SET,266,-0.020617,-0.0024623,0.048588,0.66434,BORCZUK_MALIGNANT_MESOTHELIOMA_UP,1
GSE33162_HDAC3_KO_VS_HDAC3_K...3,SET,176,-0.026949,-0.0026245,0.063509,0.66434,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_DN,1
GOCC_MRNA_CLEAVAGE_FACTOR_CO...,SET,22,-0.069899,-0.0024169,0.16469,0.66437,GOCC_MRNA_CLEAVAGE_FACTOR_COMPLEX,1
HP_ABNORMAL_ILIAC_WING_MORPH...,SET,53,-0.049809,-0.0026709,0.11735,0.66437,HP_ABNORMAL_ILIAC_WING_MORPHOLOGY,1
HP_ABNORMAL_SERUM_INSULIN_LI...,SET,26,-0.068653,-0.0025804,0.16169,0.66443,HP_ABNORMAL_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1_LEVEL,1
GOBP_VENTRICULAR_SYSTEM_DEVE...,SET,30,-0.062322,-0.0025158,0.14675,0.66446,GOBP_VENTRICULAR_SYSTEM_DEVELOPMENT,1
HP_ABNORMAL_HEMATOCRIT,SET,11,-0.1051,-0.0025705,0.24746,0.66448,HP_ABNORMAL_HEMATOCRIT,1
GOCC_TORC1_COMPLEX,SET,6,-0.12388,-0.002238,0.29163,0.66451,GOCC_TORC1_COMPLEX,1
GSE42021_TREG_PLN_VS_TREG_PR...2,SET,175,-0.02698,-0.0026202,0.063511,0.66451,GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...3,SET,6,-0.15536,-0.0028065,0.3655,0.6646,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
HP_ABNORMAL_REFLEX,SET,1089,-0.010859,-0.0025638,0.025541,0.66463,HP_ABNORMAL_REFLEX,1
TRAVAGLINI_LUNG_CLASSICAL_MO...,SET,248,-0.023835,-0.0027499,0.05604,0.66469,TRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL,1
GOMF_PHOSPHATIDYLCHOLINE_BIN...,SET,28,-0.070735,-0.0027588,0.16628,0.66472,GOMF_PHOSPHATIDYLCHOLINE_BINDING,1
GOBP_REGULATION_OF_DNA_METAB...,SET,447,-0.016507,-0.0025428,0.038793,0.66477,GOBP_REGULATION_OF_DNA_METABOLIC_PROCESS,1
WP_CELL_CYCLE,SET,116,-0.032416,-0.0025671,0.07616,0.66481,WP_CELL_CYCLE,1
GOBP_REGULATION_OF_MICROGLIA...,SET,17,-0.092793,-0.0028208,0.218,0.66482,GOBP_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,1
MIKKELSEN_MEF_HCP_WITH_H3K27...,SET,558,-0.0169,-0.0028997,0.039699,0.66484,MIKKELSEN_MEF_HCP_WITH_H3K27ME3,1
FISCHER_DIRECT_P53_TARGETS_M...,SET,290,-0.020644,-0.0025726,0.048484,0.66486,FISCHER_DIRECT_P53_TARGETS_META_ANALYSIS,1
GOBP_AMP_SALVAGE,SET,4,-0.18747,-0.0027653,0.44025,0.66488,GOBP_AMP_SALVAGE,1
GOBP_REGULATION_OF_LOCOMOTIO...,SET,5,-0.21818,-0.0035982,0.51218,0.66494,GOBP_REGULATION_OF_LOCOMOTION_INVOLVED_IN_LOCOMOTORY_BEHAVIOR,1
WP_GLIOBLASTOMA_SIGNALING,SET,80,-0.041196,-0.002712,0.096702,0.66495,WP_GLIOBLASTOMA_SIGNALING,1
THAKAR_PBMC_INACTIVATED_INFL...8,SET,582,-0.014465,-0.0025331,0.033956,0.66495,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_UP,1
CIZ_01,SET,216,-0.025507,-0.0027489,0.059861,0.66498,CIZ_01,1
GOBP_7_METHYLGUANOSINE_CAP_H...,SET,8,-0.10877,-0.0022689,0.25522,0.66501,GOBP_7_METHYLGUANOSINE_CAP_HYPERMETHYLATION,1
HP_HYPOPLASIA_OF_THE_BLADDER,SET,5,-0.15616,-0.0025753,0.36641,0.66501,HP_HYPOPLASIA_OF_THE_BLADDER,1
chr1p33,SET,28,-0.11039,-0.0043054,0.25899,0.66503,chr1p33,1
HP_NARROW_ILIAC_WING,SET,8,-0.11583,-0.0024161,0.27174,0.66503,HP_NARROW_ILIAC_WING,1
THUM_SYSTOLIC_HEART_FAILURE_...2,SET,366,-0.019246,-0.0026887,0.045134,0.66509,THUM_SYSTOLIC_HEART_FAILURE_UP,1
HP_INCREASED_HEPATIC_ECHOGEN...,SET,5,-0.16517,-0.0027239,0.38732,0.6651,HP_INCREASED_HEPATIC_ECHOGENICITY,1
MORF_PPP2R5B,SET,156,-0.028917,-0.0026528,0.067809,0.66511,MORF_PPP2R5B,1
BLANCO_MELO_HUMAN_PARAINFLUE...2,SET,188,-0.02835,-0.0028526,0.066472,0.66513,BLANCO_MELO_HUMAN_PARAINFLUENZA_VIRUS_3_INFECTION_A594_CELLS_UP,1
GOBP_POSITIVE_REGULATION_OF_...465,SET,52,-0.052636,-0.0027958,0.12339,0.66516,GOBP_POSITIVE_REGULATION_OF_MIRNA_TRANSCRIPTION,1
GOBP_HYPOTHALAMUS_CELL_DIFFE...,SET,11,-0.12907,-0.0031566,0.30244,0.66522,GOBP_HYPOTHALAMUS_CELL_DIFFERENTIATION,1
HP_GONADAL_DYSGENESIS,SET,28,-0.062726,-0.0024464,0.14695,0.66526,HP_GONADAL_DYSGENESIS,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...2,SET,96,-0.034195,-0.0024649,0.080104,0.66527,GOBP_NUCLEOSIDE_DIPHOSPHATE_CATABOLIC_PROCESS,1
HP_INCREASED_LEVEL_OF_L_FUCO...,SET,16,-0.089171,-0.0026299,0.20887,0.66527,HP_INCREASED_LEVEL_OF_L_FUCOSE_IN_URINE,1
HP_PRELINGUAL_SENSORINEURAL_...,SET,11,-0.11794,-0.0028845,0.27623,0.6653,HP_PRELINGUAL_SENSORINEURAL_HEARING_IMPAIRMENT,1
MODULE_489,SET,26,-0.070602,-0.0026536,0.16528,0.66537,MODULE_489,1
GOBP_REGULATION_OF_CALCIDIOL...,SET,7,-0.14014,-0.0027344,0.32807,0.66537,GOBP_REGULATION_OF_CALCIDIOL_1_MONOOXYGENASE_ACTIVITY,1
GOBP_HEART_FIELD_SPECIFICATI...,SET,17,-0.10611,-0.0032257,0.24838,0.66538,GOBP_HEART_FIELD_SPECIFICATION,1
GOBP_NEGATIVE_REGULATION_OF_...203,SET,7,-0.1476,-0.0028801,0.34536,0.66545,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
REACTOME_TNF_SIGNALING,SET,51,-0.047526,-0.0025001,0.11113,0.66555,REACTOME_TNF_SIGNALING,1
MODULE_221,SET,29,-0.063157,-0.0025068,0.14766,0.66557,MODULE_221,1
HP_ABNORMAL_HAIR_PATTERN,SET,308,-0.020415,-0.0026205,0.047719,0.6656,HP_ABNORMAL_HAIR_PATTERN,1
GOBP_TUBE_FORMATION,SET,144,-0.029922,-0.0026382,0.069939,0.66561,GOBP_TUBE_FORMATION,1
GOBP_SKELETAL_MUSCLE_TISSUE_...1,SET,10,-0.11956,-0.0027881,0.27939,0.66565,GOBP_SKELETAL_MUSCLE_TISSUE_GROWTH,1
HAY_BONE_MARROW_PLASMA_CELL,SET,85,-0.040117,-0.0027219,0.09373,0.66567,HAY_BONE_MARROW_PLASMA_CELL,1
GOMF_HISTONE_H3_ACETYLTRANSF...,SET,15,-0.088347,-0.0025229,0.20639,0.66569,GOMF_HISTONE_H3_ACETYLTRANSFERASE_ACTIVITY,1
HP_HYPOINTENSITY_OF_CEREBRAL...,SET,12,-0.10379,-0.0026513,0.24246,0.6657,HP_HYPOINTENSITY_OF_CEREBRAL_WHITE_MATTER_ON_MRI,1
GOBP_SECONDARY_PALATE_DEVELO...,SET,26,-0.080287,-0.0030176,0.18754,0.66571,GOBP_SECONDARY_PALATE_DEVELOPMENT,1
HP_CLONUS,SET,98,-0.035697,-0.0025997,0.083381,0.66571,HP_CLONUS,1
MIR4656,SET,98,-0.036706,-0.0026732,0.085727,0.66573,MIR4656,1
HP_TAPERED_SPERM_HEAD,SET,7,-0.14838,-0.0028952,0.34654,0.66574,HP_TAPERED_SPERM_HEAD,1
CEBALLOS_TARGETS_OF_TP53_AND...2,SET,18,-0.09301,-0.0029093,0.21721,0.66575,CEBALLOS_TARGETS_OF_TP53_AND_MYC_UP,1
MIR3152_3P,SET,76,-0.042628,-0.0027355,0.099528,0.66578,MIR3152_3P,1
GOBP_AMINOACYL_TRNA_METABOLI...,SET,8,-0.10656,-0.0022227,0.24878,0.66579,GOBP_AMINOACYL_TRNA_METABOLISM_INVOLVED_IN_TRANSLATIONAL_FIDELITY,1
GOMF_AMINOACYL_TRNA_EDITING_...,SET,8,-0.10656,-0.0022227,0.24878,0.66579,GOMF_AMINOACYL_TRNA_EDITING_ACTIVITY,1
GSE17721_0.5H_VS_4H_CPG_BMDC...2,SET,185,-0.025372,-0.0025327,0.059234,0.6658,GSE17721_0.5H_VS_4H_CPG_BMDC_UP,1
REACTOME_DCC_MEDIATED_ATTRAC...,SET,14,-0.087486,-0.0024137,0.20421,0.66582,REACTOME_DCC_MEDIATED_ATTRACTIVE_SIGNALING,1
GSE27859_DC_VS_CD11C_INT_F48...2,SET,182,-0.025166,-0.0024919,0.05874,0.66583,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
CHIN_BREAST_CANCER_COPY_NUMB...2,SET,27,-0.073255,-0.0028057,0.17097,0.66584,CHIN_BREAST_CANCER_COPY_NUMBER_UP,1
HP_ABNORMAL_MALE_REPRODUCTIV...,SET,283,-0.021267,-0.0026187,0.049612,0.66592,HP_ABNORMAL_MALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,1
MIR3120_3P,SET,320,-0.020591,-0.0026933,0.04803,0.66593,MIR3120_3P,1
GSE17721_POLYIC_VS_CPG_2H_BM...1,SET,182,-0.026668,-0.0026407,0.062205,0.66593,GSE17721_POLYIC_VS_CPG_2H_BMDC_DN,1
MIR761,SET,209,-0.023858,-0.0025296,0.055621,0.66601,MIR761,1
WP_OSTEOCLAST_SIGNALING,SET,16,-0.094443,-0.0027854,0.22014,0.66604,WP_OSTEOCLAST_SIGNALING,1
VERRECCHIA_DELAYED_RESPONSE_...,SET,36,-0.062649,-0.00277,0.14595,0.66612,VERRECCHIA_DELAYED_RESPONSE_TO_TGFB1,1
GSE37301_LYMPHOID_PRIMED_MPP...5,SET,178,-0.025584,-0.0025055,0.059598,0.66613,GSE37301_LYMPHOID_PRIMED_MPP_VS_GRAN_MONO_PROGENITOR_DN,1
HALLMARK_ADIPOGENESIS,SET,187,-0.025749,-0.0025841,0.05998,0.66615,HALLMARK_ADIPOGENESIS,1
GNF2_MCM4,SET,52,-0.047504,-0.0025232,0.11061,0.66621,GNF2_MCM4,1
GOBP_RESPONSE_TO_STEROL,SET,32,-0.066818,-0.0027857,0.15555,0.66624,GOBP_RESPONSE_TO_STEROL,1
HE_LIM_SUN_FETAL_LUNG_C1_GHR...1,SET,140,-0.033011,-0.0028701,0.076826,0.66629,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NEUROENDOCRINE_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...427,SET,23,-0.079735,-0.0028189,0.18554,0.6663,GOBP_NEGATIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
GSE16450_CTRL_VS_IFNA_6H_STI...4,SET,187,-0.02711,-0.0027207,0.063088,0.6663,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP,1
QUEREC_MODEL_PBMC_YF_17D_VAC...2,SET,35,-0.059705,-0.002603,0.13889,0.66635,QUEREC_MODEL_PBMC_YF_17D_VACCINE_AGE_18_45_7DY_PREDICTIVE,1
GOBP_PROTEIN_MONOUBIQUITINAT...,SET,42,-0.051319,-0.0024504,0.11936,0.66638,GOBP_PROTEIN_MONOUBIQUITINATION,1
GNF2_SERPINI2,SET,21,-0.090997,-0.0030742,0.21153,0.66646,GNF2_SERPINI2,1
MIR5189_3P,SET,51,-0.05021,-0.0026412,0.11671,0.66647,MIR5189_3P,1
HP_DUPLICATION_INVOLVING_BON...,SET,122,-0.031795,-0.0025819,0.073895,0.6665,HP_DUPLICATION_INVOLVING_BONES_OF_THE_FEET,1
WP_METHYLATION_PATHWAYS,SET,9,-0.13054,-0.002888,0.30336,0.66651,WP_METHYLATION_PATHWAYS,1
GOBP_GLYCOSAMINOGLYCAN_CATAB...,SET,26,-0.072009,-0.0027065,0.16727,0.66658,GOBP_GLYCOSAMINOGLYCAN_CATABOLIC_PROCESS,1
HP_ABNORMALITY_OF_THE_PERIUN...,SET,20,-0.083833,-0.002764,0.19471,0.6666,HP_ABNORMALITY_OF_THE_PERIUNGUAL_REGION,1
GOBP_NUCLEOBASE_CONTAINING_S...3,SET,8,-0.13453,-0.0028062,0.31224,0.66671,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_INTERCONVERSION,1
OSMAN_BLOOD_CHAD63_KH_AGE_18...2,SET,1577,-0.0098642,-0.0027627,0.022893,0.66672,OSMAN_BLOOD_CHAD63_KH_AGE_18_50YO_HIGH_DOSE_SUBJECTS_24HR_UP,1
GOMF_5_DEOXYRIBOSE_5_PHOSPHA...,SET,7,-0.11623,-0.002268,0.26969,0.66676,GOMF_5_DEOXYRIBOSE_5_PHOSPHATE_LYASE_ACTIVITY,1
GSE17721_POLYIC_VS_GARDIQUIM...8,SET,181,-0.026086,-0.0025759,0.060523,0.66677,GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP,1
GOMF_SPHINGOLIPID_TRANSFER_A...,SET,7,-0.12519,-0.0024428,0.2904,0.66681,GOMF_SPHINGOLIPID_TRANSFER_ACTIVITY,1
MIR6792_5P,SET,113,-0.036366,-0.0028427,0.084292,0.66692,MIR6792_5P,1
MODULE_256,SET,54,-0.046678,-0.0025264,0.10814,0.667,MODULE_256,1
HP_TICS,SET,22,-0.073584,-0.0025443,0.17046,0.66701,HP_TICS,1
GOMF_ACYLGLYCEROL_LIPASE_ACT...,SET,15,-0.088561,-0.002529,0.20513,0.66702,GOMF_ACYLGLYCEROL_LIPASE_ACTIVITY,1
HP_IRIS_ATROPHY,SET,8,-0.155,-0.003233,0.35892,0.66707,HP_IRIS_ATROPHY,1
HP_ABNORMAL_LUMBAR_SPINE_MOR...,SET,26,-0.07488,-0.0028144,0.17336,0.6671,HP_ABNORMAL_LUMBAR_SPINE_MORPHOLOGY,1
HP_RECURRENT_MENINGITIS,SET,3,-0.23935,-0.0030577,0.55413,0.6671,HP_RECURRENT_MENINGITIS,1
chr20q11,SET,118,-0.088646,-0.0070801,0.20507,0.66722,chr20q11,1
GOBP_ADP_TRANSPORT,SET,10,-0.12079,-0.0028167,0.27941,0.66723,GOBP_ADP_TRANSPORT,1
WP_CCL18_SIGNALING,SET,33,-0.069457,-0.0029405,0.16058,0.66732,WP_CCL18_SIGNALING,1
RFX7_TARGET_GENES,SET,403,-0.017882,-0.0026188,0.041339,0.66734,RFX7_TARGET_GENES,1
HP_ACANTHOLYSIS,SET,10,-0.11682,-0.0027242,0.27003,0.66735,HP_ACANTHOLYSIS,1
CAFFAREL_RESPONSE_TO_THC_DN,SET,29,-0.063027,-0.0025016,0.14561,0.66743,CAFFAREL_RESPONSE_TO_THC_DN,1
HP_ADDICTIVE_BEHAVIOR,SET,29,-0.070714,-0.0028067,0.16336,0.66745,HP_ADDICTIVE_BEHAVIOR,1
GOBP_HEART_TRABECULA_FORMATI...,SET,15,-0.10324,-0.0029481,0.23844,0.66748,GOBP_HEART_TRABECULA_FORMATION,1
HP_PUBERTY_AND_GONADAL_DISOR...,SET,561,-0.015507,-0.0026676,0.035812,0.66749,HP_PUBERTY_AND_GONADAL_DISORDERS,1
GOCC_PERINUCLEAR_THECA,SET,4,-0.23189,-0.0034206,0.53545,0.66752,GOCC_PERINUCLEAR_THECA,1
GOBP_ODONTOBLAST_DIFFERENTIA...,SET,16,-0.10217,-0.0030133,0.23579,0.6676,GOBP_ODONTOBLAST_DIFFERENTIATION,1
HP_ABNORMAL_MALE_GERM_CELL_M...,SET,57,-0.047079,-0.0026177,0.10865,0.6676,HP_ABNORMAL_MALE_GERM_CELL_MORPHOLOGY,1
REACTOME_BETA_OXIDATION_OF_L...,SET,5,-0.16328,-0.0026928,0.37678,0.66762,REACTOME_BETA_OXIDATION_OF_LAUROYL_COA_TO_DECANOYL_COA_COA,1
SRF_Q4,SET,202,-0.026483,-0.0027611,0.06111,0.66763,SRF_Q4,1
HP_SUTURAL_CATARACT,SET,7,-0.12982,-0.0025331,0.29956,0.66763,HP_SUTURAL_CATARACT,1
GSE7852_LN_VS_THYMUS_TREG_UP,SET,182,-0.027796,-0.0027523,0.064127,0.66765,GSE7852_LN_VS_THYMUS_TREG_UP,1
REACTOME_ION_CHANNEL_TRANSPO...,SET,170,-0.028829,-0.0027598,0.066468,0.66775,REACTOME_ION_CHANNEL_TRANSPORT,1
GOBP_ASPARTATE_TRANSMEMBRANE...,SET,20,-0.082468,-0.002719,0.19013,0.66776,GOBP_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
HP_TIBIAL_TORSION,SET,20,-0.080885,-0.0026668,0.18639,0.66784,HP_TIBIAL_TORSION,1
MIR519D_3P,SET,567,-0.015732,-0.0027203,0.036249,0.66785,MIR519D_3P,1
GSE14415_ACT_VS_CTRL_NATURAL...2,SET,157,-0.027926,-0.00257,0.064335,0.66788,GSE14415_ACT_VS_CTRL_NATURAL_TREG_UP,1
REACTOME_FORMATION_OF_LATERA...,SET,5,-0.17417,-0.0028724,0.40119,0.66791,REACTOME_FORMATION_OF_LATERAL_PLATE_MESODERM,1
HP_ABNORMAL_PANCREAS_SIZE,SET,33,-0.068221,-0.0028882,0.15714,0.66791,HP_ABNORMAL_PANCREAS_SIZE,1
DESCARTES_FETAL_CEREBRUM_EXC...,SET,13,-0.11218,-0.0029826,0.25834,0.66794,DESCARTES_FETAL_CEREBRUM_EXCITATORY_NEURONS,1
KEGG_AMINO_SUGAR_AND_NUCLEOT...,SET,40,-0.053279,-0.0024829,0.12262,0.66804,KEGG_AMINO_SUGAR_AND_NUCLEOTIDE_SUGAR_METABOLISM,1
RPS14_DN.V1_DN,SET,167,-0.027473,-0.0026069,0.063222,0.66805,RPS14_DN.V1_DN,1
GSE29949_CD8_POS_DC_SPLEEN_V...4,SET,171,-0.028038,-0.0026919,0.064523,0.66805,GSE29949_CD8_POS_DC_SPLEEN_VS_MONOCYTE_BONE_MARROW_UP,1
GSE19198_1H_VS_6H_IL21_TREAT...1,SET,186,-0.027339,-0.0027363,0.062911,0.66806,GSE19198_1H_VS_6H_IL21_TREATED_TCELL_DN,1
MIR10397_5P,SET,67,-0.043236,-0.0026057,0.099456,0.66812,MIR10397_5P,1
GOBP_DETECTION_OF_CHEMICAL_S...,SET,45,-0.063471,-0.0031368,0.14597,0.66815,GOBP_DETECTION_OF_CHEMICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_TASTE,1
GOMF_METHYL_CPG_BINDING,SET,25,-0.070758,-0.0026079,0.16273,0.66815,GOMF_METHYL_CPG_BINDING,1
HP_ALOPECIA,SET,218,-0.025371,-0.0027467,0.058338,0.66818,HP_ALOPECIA,1
GOBP_AORTA_DEVELOPMENT,SET,60,-0.049546,-0.0028263,0.1139,0.66821,GOBP_AORTA_DEVELOPMENT,1
REACTOME_RUNX3_REGULATES_BCL...,SET,5,-0.18617,-0.0030703,0.42787,0.66826,REACTOME_RUNX3_REGULATES_BCL2L11_BIM_TRANSCRIPTION,1
GOBP_NATURAL_KILLER_CELL_ACT...2,SET,29,-0.079507,-0.0031557,0.18268,0.6683,GOBP_NATURAL_KILLER_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_ABNORMAL_LOWER_MOTOR_NEUR...,SET,26,-0.067204,-0.0025259,0.15436,0.66835,HP_ABNORMAL_LOWER_MOTOR_NEURON_MORPHOLOGY,1
KAECH_NAIVE_VS_DAY8_EFF_CD8_...1,SET,184,-0.026973,-0.0026853,0.061956,0.66835,KAECH_NAIVE_VS_DAY8_EFF_CD8_TCELL_DN,1
GOMF_CHEMOATTRACTANT_ACTIVITY,SET,32,-0.0667,-0.0027808,0.15315,0.6684,GOMF_CHEMOATTRACTANT_ACTIVITY,1
HP_ENTROPION,SET,20,-0.068075,-0.0022444,0.1563,0.66841,HP_ENTROPION,1
GOBP_REGULATION_OF_CARBOHYDR...1,SET,88,-0.039887,-0.0027534,0.091568,0.66843,GOBP_REGULATION_OF_CARBOHYDRATE_BIOSYNTHETIC_PROCESS,1
WP_LEUCINE_ISOLEUCINE_AND_VA...,SET,22,-0.080396,-0.0027799,0.18456,0.66844,WP_LEUCINE_ISOLEUCINE_AND_VALINE_METABOLISM,1
WP_10Q1121Q1123_COPY_NUMBER_...,SET,55,-0.051151,-0.002794,0.11738,0.6685,WP_10Q1121Q1123_COPY_NUMBER_VARIATION_SYNDROME,1
HP_NAIL_DYSPLASIA,SET,140,-0.031255,-0.0027175,0.071702,0.66854,HP_NAIL_DYSPLASIA,1
GOBP_DNA_STRAND_ELONGATION_I...,SET,14,-0.08189,-0.0022593,0.18771,0.66867,GOBP_DNA_STRAND_ELONGATION_INVOLVED_IN_DNA_REPLICATION,1
GSE23505_IL6_IL1_VS_IL6_IL1_...3,SET,169,-0.026042,-0.0024858,0.059654,0.66878,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN,1
KEGG_JAK_STAT_SIGNALING_PATH...,SET,140,-0.034623,-0.0030103,0.079265,0.66887,KEGG_JAK_STAT_SIGNALING_PATHWAY,1
GSE27786_BCELL_VS_NKTCELL_UP,SET,180,-0.025954,-0.0025559,0.059416,0.66888,GSE27786_BCELL_VS_NKTCELL_UP,1
MIR493_5P,SET,431,-0.018369,-0.0027798,0.042043,0.66891,MIR493_5P,1
HP_HYPOLIPOPROTEINEMIA,SET,58,-0.049405,-0.002771,0.11308,0.66891,HP_HYPOLIPOPROTEINEMIA,1
REACTOME_FREE_FATTY_ACID_REC...,SET,4,-0.2209,-0.0032584,0.50535,0.66898,REACTOME_FREE_FATTY_ACID_RECEPTORS,1
GOBP_SKELETAL_MUSCLE_CELL_DI...,SET,72,-0.044683,-0.0027912,0.10222,0.66899,GOBP_SKELETAL_MUSCLE_CELL_DIFFERENTIATION,1
GSE19941_UNSTIM_VS_LPS_AND_I...4,SET,158,-0.029446,-0.0027184,0.067349,0.66902,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP,1
GOBP_SOMATIC_STEM_CELL_POPUL...,SET,61,-0.049167,-0.0028279,0.11244,0.66904,GOBP_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,1
MIR4476,SET,203,-0.026283,-0.0027469,0.060095,0.66907,MIR4476,1
REACTOME_ACTIVATION_OF_AMPK_...,SET,26,-0.076881,-0.0028896,0.17575,0.6691,REACTOME_ACTIVATION_OF_AMPK_DOWNSTREAM_OF_NMDARS,1
REACTOME_INACTIVATION_OF_CDC...,SET,8,-0.13337,-0.0027819,0.30481,0.66914,REACTOME_INACTIVATION_OF_CDC42_AND_RAC1,1
GOMF_NUCLEOSOMAL_DNA_BINDING,SET,24,-0.078321,-0.0028284,0.17899,0.66915,GOMF_NUCLEOSOMAL_DNA_BINDING,1
GSE17974_CTRL_VS_ACT_IL4_AND...11,SET,177,-0.026273,-0.0025658,0.060037,0.66916,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_48H_CD4_TCELL_DN,1
GOBP_POST_TRANSLATIONAL_PROT...3,SET,8,-0.139,-0.0028994,0.31762,0.66917,GOBP_POST_TRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,1
GSE43700_UNTREATED_VS_IL10_T...1,SET,187,-0.027062,-0.0027158,0.061837,0.66917,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_DN,1
GOBP_RESPONSE_TO_XENOBIOTIC_...,SET,417,-0.01908,-0.0028412,0.043595,0.66918,GOBP_RESPONSE_TO_XENOBIOTIC_STIMULUS,1
GOMF_LIPID_TRANSPORTER_ACTIV...,SET,158,-0.030659,-0.0028304,0.07005,0.66919,GOMF_LIPID_TRANSPORTER_ACTIVITY,1
GSE36888_STAT5_AB_KNOCKIN_VS...3,SET,186,-0.027859,-0.0027884,0.06365,0.66919,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN,1
NAKAYA_MYELOID_DENDRITIC_CEL...4,SET,337,-0.019634,-0.0026342,0.044814,0.66935,NAKAYA_MYELOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP,1
BERTUCCI_INVASIVE_CARCINOMA_...2,SET,20,-0.078603,-0.0025915,0.17938,0.66937,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_UP,1
GOMF_TRANSLATION_FACTOR_ACTI...,SET,71,-0.039867,-0.0024731,0.090975,0.66939,GOMF_TRANSLATION_FACTOR_ACTIVITY_RNA_BINDING,1
MATZUK_FERTILIZATION,SET,7,-0.13702,-0.0026735,0.31262,0.66941,MATZUK_FERTILIZATION,1
GOCC_TRANSCRIPTION_EXPORT_CO...2,SET,4,-0.16803,-0.0024786,0.38337,0.66941,GOCC_TRANSCRIPTION_EXPORT_COMPLEX_2,1
REACTOME_RND3_GTPASE_CYCLE,SET,41,-0.059271,-0.0027963,0.13521,0.66943,REACTOME_RND3_GTPASE_CYCLE,1
DESCARTES_FETAL_THYMUS_THYMI...,SET,197,-0.0286,-0.0029451,0.065246,0.66943,DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS,1
GOCC_EXTRINSIC_COMPONENT_OF_...6,SET,7,-0.10887,-0.0021243,0.24835,0.66944,GOCC_EXTRINSIC_COMPONENT_OF_POSTSYNAPTIC_MEMBRANE,1
REACTOME_NUCLEOTIDE_LIKE_PUR...,SET,13,-0.11426,-0.0030378,0.26063,0.66945,REACTOME_NUCLEOTIDE_LIKE_PURINERGIC_RECEPTORS,1
GOMF_GTPASE_BINDING,SET,283,-0.021378,-0.0026322,0.048755,0.66948,GOMF_GTPASE_BINDING,1
QUEREC_PBMC_YF_17D_VACCINE_A...1,SET,42,-0.06098,-0.0029117,0.13907,0.66948,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_3DY_UP,1
QUEREC_PBMC_YF_17D_VACCINE_A...2,SET,42,-0.06098,-0.0029117,0.13907,0.66948,QUEREC_PBMC_YF_17D_VACCINE_AGE_18_45YO_7DY_UP,1
GCM_RAB10,SET,162,-0.027181,-0.0025406,0.061984,0.66949,GCM_RAB10,1
HP_IMMOTILE_CILIA,SET,9,-0.12517,-0.0027692,0.2854,0.66951,HP_IMMOTILE_CILIA,1
RB_P130_DN.V1_DN,SET,119,-0.033874,-0.0027168,0.077224,0.66954,RB_P130_DN.V1_DN,1
GOBP_PHENOL_CONTAINING_COMPO...2,SET,7,-0.16407,-0.0032013,0.3737,0.66968,GOBP_PHENOL_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_PROTEIN_TRANSPORT_INTO_...,SET,4,-0.19364,-0.0028564,0.44106,0.66968,GOBP_PROTEIN_TRANSPORT_INTO_MEMBRANE_RAFT,1
LHX2_TARGET_GENES,SET,1130,-0.011305,-0.0027157,0.025746,0.66971,LHX2_TARGET_GENES,1
GOMF_QUINONE_BINDING,SET,14,-0.086369,-0.0023828,0.19667,0.66973,GOMF_QUINONE_BINDING,1
GOBP_LACTATION,SET,37,-0.064196,-0.0028775,0.14616,0.66974,GOBP_LACTATION,1
GOMF_CARGO_ADAPTOR_ACTIVITY,SET,20,-0.083112,-0.0027402,0.18923,0.66975,GOMF_CARGO_ADAPTOR_ACTIVITY,1
GAVISH_3CA_METAPROGRAM_ENDOT...10,SET,46,-0.059965,-0.0029962,0.13652,0.66976,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_1,1
MIR7978,SET,78,-0.041112,-0.0026726,0.093589,0.66977,MIR7978,1
ZHOU_TNF_SIGNALING_30MIN,SET,42,-0.054797,-0.0026165,0.12471,0.66981,ZHOU_TNF_SIGNALING_30MIN,1
RB_P130_DN.V1_UP,SET,117,-0.033987,-0.0027031,0.077344,0.66982,RB_P130_DN.V1_UP,1
BANDRES_RESPONSE_TO_CARMUSTI...1,SET,31,-0.067402,-0.0027658,0.15333,0.66988,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_24HR_DN,1
MIR4768_3P,SET,174,-0.027071,-0.0026215,0.061575,0.6699,MIR4768_3P,1
HP_ABNORMALITY_OF_IRON_HOMEO...,SET,23,-0.072728,-0.0025712,0.16539,0.66993,HP_ABNORMALITY_OF_IRON_HOMEOSTASIS,1
GOBP_APOPTOTIC_SIGNALING_PAT...,SET,559,-0.015829,-0.0027183,0.035994,0.66995,GOBP_APOPTOTIC_SIGNALING_PATHWAY,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...1,SET,85,-0.041308,-0.0028027,0.093926,0.66995,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_ADDNL_EXON_LVL_UP,1
GSE20366_TREG_VS_TCONV_UP,SET,179,-0.028207,-0.0027701,0.064125,0.66998,GSE20366_TREG_VS_TCONV_UP,1
GOBP_PHOSPHOLIPID_BIOSYNTHET...,SET,230,-0.024004,-0.0026684,0.054567,0.66999,GOBP_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
GOBP_TOLERANCE_INDUCTION,SET,27,-0.078263,-0.0029975,0.17791,0.67,GOBP_TOLERANCE_INDUCTION,1
GOBP_REGULATION_OF_LEUKOCYTE...5,SET,41,-0.056696,-0.0026749,0.12887,0.67001,GOBP_REGULATION_OF_LEUKOCYTE_DEGRANULATION,1
GOBP_CEREBRAL_CORTEX_GABAERG...1,SET,5,-0.1813,-0.0029899,0.412,0.67004,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DEVELOPMENT,1
MIR3529_3P,SET,493,-0.017115,-0.0027652,0.038885,0.67008,MIR3529_3P,1
GSE40273_EOS_KO_VS_WT_TREG_UP,SET,181,-0.026744,-0.0026409,0.060723,0.67019,GSE40273_EOS_KO_VS_WT_TREG_UP,1
MIR652_5P,SET,34,-0.062285,-0.0026765,0.14134,0.67028,MIR652_5P,1
HP_CONJUNCTIVAL_HYPEREMIA,SET,5,-0.17908,-0.0029534,0.40636,0.67028,HP_CONJUNCTIVAL_HYPEREMIA,1
GOBP_NEGATIVE_REGULATION_OF_...446,SET,5,-0.1883,-0.0031054,0.42725,0.67029,GOBP_NEGATIVE_REGULATION_OF_NEUTROPHIL_MIGRATION,1
HP_PROTUBERANT_ABDOMEN,SET,39,-0.06025,-0.0027724,0.13666,0.67035,HP_PROTUBERANT_ABDOMEN,1
IVANOV_MUTATED_IN_COLON_CANC...,SET,13,-0.084418,-0.0022444,0.19145,0.67037,IVANOV_MUTATED_IN_COLON_CANCER,1
HP_DARK_URINE,SET,9,-0.12418,-0.0027474,0.28161,0.67038,HP_DARK_URINE,1
GOBP_REGULATION_OF_DNA_STRAN...,SET,17,-0.092938,-0.0028252,0.21073,0.6704,GOBP_REGULATION_OF_DNA_STRAND_ELONGATION,1
HAHTOLA_SEZARY_SYNDROM_DN,SET,38,-0.061794,-0.0028069,0.14009,0.67043,HAHTOLA_SEZARY_SYNDROM_DN,1
GOBP_CELLULAR_MODIFIED_AMINO...2,SET,29,-0.068513,-0.0027194,0.1553,0.67045,GOBP_CELLULAR_MODIFIED_AMINO_ACID_CATABOLIC_PROCESS,1
MIR1306_5P,SET,45,-0.053546,-0.0026463,0.12133,0.67051,MIR1306_5P,1
MIR1266_5P,SET,83,-0.039263,-0.0026326,0.088961,0.67052,MIR1266_5P,1
HP_BROAD_JAW,SET,5,-0.15248,-0.0025147,0.34547,0.67053,HP_BROAD_JAW,1
JAK2_DN.V1_DN,SET,116,-0.032744,-0.0025931,0.074162,0.67058,JAK2_DN.V1_DN,1
GSE26030_TH1_VS_TH17_DAY15_P...1,SET,176,-0.028853,-0.0028099,0.065283,0.67074,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_DN,1
GOBP_NEGATIVE_REGULATION_OF_...274,SET,7,-0.14882,-0.0029039,0.33663,0.67079,GOBP_NEGATIVE_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
SMID_BREAST_CANCER_ERBB2_DN,SET,5,-0.16902,-0.0027874,0.38229,0.6708,SMID_BREAST_CANCER_ERBB2_DN,1
REACTOME_PHOSPHOLIPASE_C_MED...3,SET,14,-0.10716,-0.0029565,0.24227,0.67087,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR4,1
LIN_MELANOMA_COPY_NUMBER_DN,SET,38,-0.060563,-0.002751,0.1369,0.67089,LIN_MELANOMA_COPY_NUMBER_DN,1
GOBP_MECHANORECEPTOR_DIFFERE...,SET,65,-0.049379,-0.0029313,0.11162,0.67089,GOBP_MECHANORECEPTOR_DIFFERENTIATION,1
MCBRYAN_PUBERTAL_BREAST_3_4W...1,SET,32,-0.064508,-0.0026894,0.14577,0.67095,MCBRYAN_PUBERTAL_BREAST_3_4WK_DN,1
REACTOME_HATS_ACETYLATE_HIST...,SET,71,-0.041367,-0.0025662,0.093457,0.67098,REACTOME_HATS_ACETYLATE_HISTONES,1
DAZARD_UV_RESPONSE_CLUSTER_G...1,SET,21,-0.087204,-0.002946,0.197,0.67099,DAZARD_UV_RESPONSE_CLUSTER_G24,1
GOBP_PANCREATIC_A_CELL_DIFFE...,SET,10,-0.14591,-0.0034026,0.32956,0.67103,GOBP_PANCREATIC_A_CELL_DIFFERENTIATION,1
GOCC_PROXIMAL_DENDRITE,SET,6,-0.15814,-0.0028568,0.35712,0.67105,GOCC_PROXIMAL_DENDRITE,1
REACTOME_AMPK_INHIBITS_CHREB...,SET,8,-0.14167,-0.002955,0.31974,0.67114,REACTOME_AMPK_INHIBITS_CHREBP_TRANSCRIPTIONAL_ACTIVATION_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C1_SMG...2,SET,653,-0.015229,-0.0028192,0.034372,0.67114,HE_LIM_SUN_FETAL_LUNG_C1_SMG_CELL,1
TST1_01,SET,221,-0.026737,-0.0029142,0.060343,0.67115,TST1_01,1
GSE15659_RESTING_VS_ACTIVATE...1,SET,167,-0.028404,-0.0026952,0.064087,0.67119,GSE15659_RESTING_VS_ACTIVATED_TREG_DN,1
GOBP_G_PROTEIN_COUPLED_PURIN...1,SET,10,-0.15366,-0.0035834,0.34664,0.67122,GOBP_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_G_PROTEIN_COUPLED_PURIN...,SET,10,-0.15366,-0.0035834,0.34664,0.67122,GOMF_G_PROTEIN_COUPLED_PURINERGIC_NUCLEOTIDE_RECEPTOR_ACTIVITY,1
GOMF_G_PROTEIN_BETA_GAMMA_SU...,SET,21,-0.087165,-0.0029447,0.19659,0.67126,GOMF_G_PROTEIN_BETA_GAMMA_SUBUNIT_COMPLEX_BINDING,1
REACTOME_SIGNALING_BY_HEDGEH...,SET,144,-0.029131,-0.0025684,0.065687,0.67129,REACTOME_SIGNALING_BY_HEDGEHOG,1
GOBP_NEGATIVE_REGULATION_OF_...316,SET,13,-0.11051,-0.0029381,0.24915,0.67132,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_ESTROGEN_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_HDR_THROUGH_MMEJ_AL...,SET,11,-0.10264,-0.0025104,0.23136,0.67135,REACTOME_HDR_THROUGH_MMEJ_ALT_NHEJ,1
MIR6125,SET,8,-0.1294,-0.0026991,0.2916,0.67138,MIR6125,1
EPPERT_CE_HSC_LSC,SET,36,-0.068116,-0.0030117,0.15349,0.67139,EPPERT_CE_HSC_LSC,1
SERVITJA_ISLET_HNF1A_TARGETS...2,SET,155,-0.032665,-0.0029871,0.073597,0.67141,SERVITJA_ISLET_HNF1A_TARGETS_UP,1
THILLAINADESAN_ZNF217_TARGET...1,SET,6,-0.17174,-0.0031026,0.38684,0.67146,THILLAINADESAN_ZNF217_TARGETS_DN,1
WP_CYTOKINECYTOKINE_RECEPTOR...,SET,241,-0.027492,-0.0031275,0.061922,0.67147,WP_CYTOKINECYTOKINE_RECEPTOR_INTERACTION,1
BILBAN_B_CLL_LPL_UP,SET,55,-0.050746,-0.0027718,0.11427,0.67151,BILBAN_B_CLL_LPL_UP,1
REACTOME_REGULATION_OF_GENE_...5,SET,15,-0.09404,-0.0026855,0.21174,0.67153,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_LATE_STAGE_BRANCHING_MORPHOGENESIS_PANCREATIC_BUD_PRECURSOR_CELLS,1
GSE37301_MULTIPOTENT_PROGENI...5,SET,188,-0.027223,-0.0027392,0.061279,0.67156,GSE37301_MULTIPOTENT_PROGENITOR_VS_GRAN_MONO_PROGENITOR_DN,1
GOBP_PROTEIN_DEUBIQUITINATION,SET,71,-0.041042,-0.002546,0.092378,0.67158,GOBP_PROTEIN_DEUBIQUITINATION,1
GOMF_TYPE_1_ANGIOTENSIN_RECE...,SET,6,-0.18375,-0.0033195,0.41353,0.6716,GOMF_TYPE_1_ANGIOTENSIN_RECEPTOR_BINDING,1
LMO2COM_01,SET,241,-0.025274,-0.0028751,0.056876,0.67161,LMO2COM_01,1
HP_PANCYTOPENIA,SET,116,-0.034318,-0.0027178,0.07721,0.67165,HP_PANCYTOPENIA,1
GOCC_LEADING_EDGE_MEMBRANE,SET,170,-0.029051,-0.002781,0.065353,0.67166,GOCC_LEADING_EDGE_MEMBRANE,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...4,SET,12,-0.10598,-0.0027072,0.2384,0.67168,LOPEZ_MESOTHELIOMA_SURVIVAL_UP,1
MIR5703,SET,150,-0.030222,-0.0027191,0.067967,0.67171,MIR5703,1
GOBP_L_GLUTAMINE_IMPORT_ACRO...,SET,4,-0.19451,-0.0028692,0.43745,0.67171,GOBP_L_GLUTAMINE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_HOLOPROSENCEPHALY,SET,69,-0.04335,-0.0026512,0.097492,0.67171,HP_HOLOPROSENCEPHALY,1
HP_SHORT_SPERM_FLAGELLA,SET,27,-0.06768,-0.0025922,0.15219,0.67173,HP_SHORT_SPERM_FLAGELLA,1
HP_ENCEPHALOCELE,SET,110,-0.034715,-0.0026777,0.078061,0.67174,HP_ENCEPHALOCELE,1
GSE4984_UNTREATED_VS_LPS_TRE...2,SET,144,-0.030542,-0.0026928,0.068639,0.67183,GSE4984_UNTREATED_VS_LPS_TREATED_DC_UP,1
MIR6741_5P,SET,22,-0.071799,-0.0024826,0.16134,0.67185,MIR6741_5P,1
GOBP_NEGATIVE_REGULATION_OF_...317,SET,2,-0.26958,-0.002812,0.60577,0.67185,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
REACTOME_RHO_GTPASES_ACTIVAT...4,SET,11,-0.098008,-0.002397,0.22021,0.67186,REACTOME_RHO_GTPASES_ACTIVATE_KTN1,1
HALLMARK_MITOTIC_SPINDLE,SET,187,-0.025927,-0.0026019,0.058248,0.67188,HALLMARK_MITOTIC_SPINDLE,1
KEGG_PYRIMIDINE_METABOLISM,SET,90,-0.037546,-0.0026209,0.084341,0.6719,KEGG_PYRIMIDINE_METABOLISM,1
HP_OVERGROWTH_OF_EXTERNAL_GE...,SET,9,-0.1515,-0.0033517,0.34032,0.6719,HP_OVERGROWTH_OF_EXTERNAL_GENITALIA,1
KRAS.PROSTATE_UP.V1_UP,SET,122,-0.03536,-0.0028713,0.079397,0.67196,KRAS.PROSTATE_UP.V1_UP,1
GOMF_5_N_7_METHYLGUANOSINE_5...,SET,9,-0.14377,-0.0031806,0.32279,0.67198,GOMF_5_N_7_METHYLGUANOSINE_5_TRIPHOSPHO_MRNA_HYDROLASE_ACTIVITY,1
HP_OPTIC_NERVE_MISROUTING,SET,5,-0.1865,-0.0030757,0.41866,0.67201,HP_OPTIC_NERVE_MISROUTING,1
GOBP_MITOCHONDRIAL_FUSION,SET,30,-0.066807,-0.0026969,0.14995,0.67202,GOBP_MITOCHONDRIAL_FUSION,1
RYAN_MANTLE_CELL_LYMPHOMA_NO...,SET,143,-0.034547,-0.0030354,0.077525,0.67206,RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP,1
GOMF_C_METHYLTRANSFERASE_ACT...,SET,6,-0.13916,-0.002514,0.31229,0.67206,GOMF_C_METHYLTRANSFERASE_ACTIVITY,1
KEGG_MEDICUS_PATHOGEN_EBV_LM...3,SET,5,-0.18317,-0.0030208,0.41093,0.67211,KEGG_MEDICUS_PATHOGEN_EBV_LMP2A_TO_PI3K_SIGNALING_PATHWAY,1
REACTOME_TRANSPORT_OF_NUCLEO...1,SET,10,-0.12551,-0.0029267,0.28155,0.67211,REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE,1
GAVIN_FOXP3_TARGETS_CLUSTER_...7,SET,91,-0.038257,-0.0026853,0.085803,0.67215,GAVIN_FOXP3_TARGETS_CLUSTER_T7,1
GOBP_PROTEIN_NITROSYLATION,SET,13,-0.11327,-0.0030115,0.25401,0.67218,GOBP_PROTEIN_NITROSYLATION,1
MIR6511A_5P,SET,175,-0.028804,-0.0027972,0.064587,0.67219,MIR6511A_5P,1
HP_SUBMUCOUS_CLEFT_PALATE,SET,70,-0.043272,-0.0026654,0.097021,0.6722,HP_SUBMUCOUS_CLEFT_PALATE,1
HP_SACCADIC_OSCILLATION,SET,20,-0.095295,-0.0031419,0.21364,0.67222,HP_SACCADIC_OSCILLATION,1
KEGG_MEDICUS_REFERENCE_NRG_E...,SET,11,-0.11055,-0.0027038,0.24782,0.67224,KEGG_MEDICUS_REFERENCE_NRG_ERBB4_PI3K_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...677,SET,61,-0.047242,-0.0027172,0.10586,0.6723,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
GOMF_STEROID_HORMONE_BINDING,SET,6,-0.17226,-0.0031119,0.38597,0.67231,GOMF_STEROID_HORMONE_BINDING,1
MODULE_210,SET,26,-0.079612,-0.0029923,0.17836,0.67233,MODULE_210,1
GSE39110_DAY3_VS_DAY6_POST_I...4,SET,183,-0.026963,-0.0026771,0.060407,0.67233,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_WITH_IL2_TREATMENT_UP,1
TIAN_BHLHA15_TARGETS,SET,15,-0.093296,-0.0026642,0.209,0.67234,TIAN_BHLHA15_TARGETS,1
GSE21546_ELK1_KO_VS_SAP1A_KO...1,SET,187,-0.027574,-0.0027672,0.061769,0.67235,GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
GOBP_AXON_EXTENSION,SET,94,-0.038664,-0.002758,0.086576,0.67241,GOBP_AXON_EXTENSION,1
MODULE_299,SET,34,-0.059426,-0.0025536,0.13304,0.67244,MODULE_299,1
HP_HIP_SUBLUXATION,SET,19,-0.087438,-0.0028099,0.19567,0.67251,HP_HIP_SUBLUXATION,1
GSE17721_CTRL_VS_CPG_6H_BMDC...1,SET,178,-0.027596,-0.0027026,0.061757,0.67251,GSE17721_CTRL_VS_CPG_6H_BMDC_DN,1
GOBP_PROTEIN_REPAIR,SET,7,-0.13081,-0.0025523,0.29267,0.67254,GOBP_PROTEIN_REPAIR,1
HP_CLOVERLEAF_SKULL,SET,8,-0.12074,-0.0025185,0.27006,0.67259,HP_CLOVERLEAF_SKULL,1
GOCC_MULTIVESICULAR_BODY_LUM...,SET,5,-0.17167,-0.0028311,0.38392,0.67261,GOCC_MULTIVESICULAR_BODY_LUMEN,1
MIR9500,SET,145,-0.030134,-0.002666,0.06737,0.67266,MIR9500,1
GOCC_RNA_POLYMERASE_COMPLEX,SET,90,-0.036056,-0.0025169,0.080604,0.67268,GOCC_RNA_POLYMERASE_COMPLEX,1
KEGG_MEDICUS_PATHOGEN_EBV_EB...2,SET,7,-0.1413,-0.0027571,0.31582,0.67271,KEGG_MEDICUS_PATHOGEN_EBV_EBNA2_TO_RBP_JK_MEDIATED_TRANSCRIPTION,1
GOBP_PROTEIN_DNA_COMPLEX_DIS...,SET,21,-0.087233,-0.002947,0.19496,0.67272,GOBP_PROTEIN_DNA_COMPLEX_DISASSEMBLY,1
ZNF544_TARGET_GENES,SET,3,-0.18805,-0.0024024,0.42025,0.67273,ZNF544_TARGET_GENES,1
MONTERO_THYROID_CANCER_POOR_...1,SET,9,-0.11612,-0.0025689,0.25948,0.67274,MONTERO_THYROID_CANCER_POOR_SURVIVAL_DN,1
DESCARTES_FETAL_CEREBRUM_INH...,SET,32,-0.077711,-0.0032398,0.17364,0.67276,DESCARTES_FETAL_CEREBRUM_INHIBITORY_NEURONS,1
GOBP_EMBRYONIC_SKELETAL_SYST...2,SET,89,-0.044494,-0.0030887,0.099406,0.67278,GOBP_EMBRYONIC_SKELETAL_SYSTEM_MORPHOGENESIS,1
MIR1184,SET,151,-0.030032,-0.002711,0.067082,0.67281,MIR1184,1
GOMF_PEROXIREDOXIN_ACTIVITY,SET,6,-0.13716,-0.0024778,0.30636,0.67281,GOMF_PEROXIREDOXIN_ACTIVITY,1
GSE40273_GATA1_KO_VS_WT_TREG...1,SET,185,-0.027529,-0.002748,0.061492,0.67281,GSE40273_GATA1_KO_VS_WT_TREG_DN,1
TACAATC_MIR508,SET,58,-0.049505,-0.0027766,0.11053,0.67287,TACAATC_MIR508,1
GOBP_ODONTOGENESIS,SET,122,-0.037079,-0.0030109,0.082789,0.67288,GOBP_ODONTOGENESIS,1
BILBAN_B_CLL_LPL_DN,SET,37,-0.064379,-0.0028857,0.14367,0.67295,BILBAN_B_CLL_LPL_DN,1
REACTOME_TRAIL_SIGNALING,SET,8,-0.16077,-0.0033534,0.35871,0.67298,REACTOME_TRAIL_SIGNALING,1
GOBP_MUSCLE_TISSUE_DEVELOPME...,SET,398,-0.019803,-0.0028824,0.044188,0.67298,GOBP_MUSCLE_TISSUE_DEVELOPMENT,1
HP_MUCOSAL_TELANGIECTASIAE,SET,36,-0.055982,-0.0024752,0.12489,0.67302,HP_MUCOSAL_TELANGIECTASIAE,1
MIKKELSEN_IPS_HCP_WITH_H3_UN...,SET,77,-0.045835,-0.0029606,0.10223,0.67304,MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED,1
GSE8685_IL2_STARVED_VS_IL21_...1,SET,186,-0.026448,-0.0026471,0.058981,0.67307,GSE8685_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
HP_HEPATIC_FIBROSIS,SET,134,-0.031489,-0.002679,0.070178,0.67318,HP_HEPATIC_FIBROSIS,1
HP_APLASIA_OF_THE_PROXIMAL_P...,SET,9,-0.12281,-0.0027171,0.27345,0.67333,HP_APLASIA_OF_THE_PROXIMAL_PHALANGES_OF_THE_HAND,1
HP_IMPAIRED_GLUCOSE_TOLERANCE,SET,36,-0.068924,-0.0030475,0.15343,0.67336,HP_IMPAIRED_GLUCOSE_TOLERANCE,1
REACTOME_ACTIVATION_OF_PUMA_...,SET,9,-0.13777,-0.003048,0.30663,0.67339,REACTOME_ACTIVATION_OF_PUMA_AND_TRANSLOCATION_TO_MITOCHONDRIA,1
REACTOME_TP53_REGULATES_TRAN...7,SET,19,-0.08736,-0.0028074,0.19441,0.67341,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_CYTOCHROME_C_RELEASE,1
GOCC_RADIAL_SPOKE,SET,12,-0.087921,-0.0022459,0.19557,0.67349,GOCC_RADIAL_SPOKE,1
AAGTCCA_MIR422B_MIR422A,SET,63,-0.046934,-0.0027431,0.10436,0.67355,AAGTCCA_MIR422B_MIR422A,1
MATSUMIYA_PBMC_MODIFIED_VACC...1,SET,60,-0.051472,-0.0029361,0.11445,0.67355,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_2DY_UP,1
HP_ABNORMALITY_OF_THE_FRONTA...,SET,184,-0.027422,-0.00273,0.060962,0.67358,HP_ABNORMALITY_OF_THE_FRONTAL_HAIRLINE,1
REACTOME_PKMTS_METHYLATE_HIS...,SET,36,-0.059105,-0.0026133,0.13137,0.67361,REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES,1
GOBP_POSITIVE_REGULATION_OF_...167,SET,28,-0.064633,-0.0025208,0.14364,0.67362,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEPARATION,1
GSE15330_WT_VS_IKAROS_KO_GRA...1,SET,185,-0.027768,-0.0027719,0.061647,0.6738,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_DN,1
REACTOME_INTERLEUKIN_7_SIGNA...,SET,21,-0.087664,-0.0029616,0.1946,0.67382,REACTOME_INTERLEUKIN_7_SIGNALING,1
GSE30971_CTRL_VS_LPS_STIM_MA...4,SET,178,-0.028438,-0.0027851,0.063121,0.67383,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_4H_UP,1
GOBP_REGULATION_OF_CALCIUM_I...9,SET,18,-0.094907,-0.0029687,0.21062,0.67386,GOBP_REGULATION_OF_CALCIUM_ION_TRANSPORT_INTO_CYTOSOL,1
GSE17721_LPS_VS_CPG_0.5H_BMD...1,SET,179,-0.028025,-0.0027522,0.062179,0.6739,GSE17721_LPS_VS_CPG_0.5H_BMDC_DN,1
GOBP_REGULATION_OF_PRESYNAPT...1,SET,12,-0.1232,-0.0031469,0.27328,0.67394,GOBP_REGULATION_OF_PRESYNAPTIC_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
KEGG_MEDICUS_REFERENCE_26S_P...,SET,37,-0.054636,-0.0024489,0.12116,0.67398,KEGG_MEDICUS_REFERENCE_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...90,SET,37,-0.054636,-0.0024489,0.12116,0.67398,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_UBQLN2_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
MIR4733_5P,SET,83,-0.04241,-0.0028436,0.094015,0.67404,MIR4733_5P,1
WP_OVERVIEW_OF_PROINFLAMMATO...,SET,121,-0.041521,-0.0033579,0.092033,0.67406,WP_OVERVIEW_OF_PROINFLAMMATORY_AND_PROFIBROTIC_MEDIATORS,1
REACTOME_TRAFFICKING_OF_AMPA...,SET,29,-0.073375,-0.0029124,0.16254,0.67416,REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS,1
HP_HYPOTENSION,SET,103,-0.039398,-0.0029411,0.087268,0.67417,HP_HYPOTENSION,1
GOCC_CD40_RECEPTOR_COMPLEX,SET,11,-0.10645,-0.0026035,0.23571,0.67422,GOCC_CD40_RECEPTOR_COMPLEX,1
KEGG_MEDICUS_VARIANT_AMPLIFI...4,SET,8,-0.13712,-0.0028601,0.3036,0.67423,KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY,1
HP_APLASIA_HYPOPLASIA_OF_THE...65,SET,28,-0.071739,-0.002798,0.1588,0.67427,HP_APLASIA_HYPOPLASIA_OF_THE_SCAPULAE,1
GSE41087_WT_VS_FOXP3_MUT_ANT...1,SET,173,-0.027602,-0.0026653,0.061086,0.67431,GSE41087_WT_VS_FOXP3_MUT_ANTI_CD3_CD28_STIM_CD4_TCELL_DN,1
GOBP_REGULATION_OF_GROWTH,SET,527,-0.017372,-0.0028992,0.038443,0.67433,GOBP_REGULATION_OF_GROWTH,1
MENON_FETAL_KIDNEY_3_STROMAL...,SET,68,-0.051148,-0.0031054,0.11317,0.67434,MENON_FETAL_KIDNEY_3_STROMAL_CELLS,1
GAVISH_3CA_METAPROGRAM_FIBRO...8,SET,45,-0.067334,-0.0033277,0.14895,0.67438,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_7,1
GSE2770_IL12_AND_TGFB_VS_IL4...3,SET,162,-0.030532,-0.0028538,0.067535,0.67439,GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...2,SET,96,-0.04355,-0.0031392,0.096332,0.67439,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_1_CELL,1
GSE1791_CTRL_VS_NEUROMEDINU_...3,SET,141,-0.033068,-0.0028853,0.073134,0.67442,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_12H_DN,1
MIR548E_5P,SET,659,-0.015441,-0.002871,0.034149,0.67443,MIR548E_5P,1
MIR3120_5P,SET,77,-0.042631,-0.0027536,0.094254,0.67447,MIR3120_5P,1
GOMF_DIACYLGLYCEROL_BINDING,SET,13,-0.10497,-0.0027908,0.23209,0.67447,GOMF_DIACYLGLYCEROL_BINDING,1
BARRIER_CANCER_RELAPSE_NORMA...1,SET,27,-0.069439,-0.0026595,0.15343,0.67457,BARRIER_CANCER_RELAPSE_NORMAL_SAMPLE_DN,1
KEGG_MEDICUS_REFERENCE_REGUL...4,SET,4,-0.22532,-0.0033237,0.49766,0.67464,KEGG_MEDICUS_REFERENCE_REGULATION_OF_FIBRINOLYTIC_SYSTEM_C1INH,1
PRAMOONJAGO_SOX4_TARGETS_UP,SET,48,-0.059743,-0.0030491,0.13194,0.67465,PRAMOONJAGO_SOX4_TARGETS_UP,1
GOBP_POST_ANAL_TAIL_MORPHOGE...,SET,18,-0.089614,-0.0028031,0.19792,0.67465,GOBP_POST_ANAL_TAIL_MORPHOGENESIS,1
GOBP_INNER_EAR_RECEPTOR_CELL...1,SET,44,-0.061564,-0.0030087,0.13593,0.67469,GOBP_INNER_EAR_RECEPTOR_CELL_DEVELOPMENT,1
GOBP_REGULATION_OF_VESICLE_F...,SET,22,-0.087477,-0.0030247,0.19308,0.67475,GOBP_REGULATION_OF_VESICLE_FUSION,1
GOBP_PHOTORECEPTOR_CELL_DEVE...,SET,49,-0.057291,-0.0029542,0.12644,0.67476,GOBP_PHOTORECEPTOR_CELL_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...630,SET,31,-0.064364,-0.0026412,0.14203,0.67479,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_MAINTENANCE,1
HP_PORENCEPHALIC_CYST,SET,30,-0.068685,-0.0027727,0.1515,0.67486,HP_PORENCEPHALIC_CYST,1
SANA_RESPONSE_TO_IFNG_DN,SET,79,-0.044448,-0.0029078,0.098029,0.67487,SANA_RESPONSE_TO_IFNG_DN,1
JIANG_MELANOMA_TRM10_LAMINA_...,SET,79,-0.048406,-0.0031668,0.10673,0.67491,JIANG_MELANOMA_TRM10_LAMINA_PROPRIA,1
GOBP_REGULATION_OF_UBIQUITIN...2,SET,18,-0.084337,-0.002638,0.18593,0.67494,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,1
MODULE_389,SET,196,-0.027147,-0.0027884,0.059817,0.67502,MODULE_389,1
HP_ABNORMAL_DURA_MATER_MORPH...,SET,23,-0.076404,-0.0027011,0.1683,0.67508,HP_ABNORMAL_DURA_MATER_MORPHOLOGY,1
HP_PAROTITIS,SET,4,-0.21171,-0.003123,0.46627,0.6751,HP_PAROTITIS,1
HOEK_MYELOID_DENDRITIC_CELL_...5,SET,6,-0.16248,-0.0029353,0.35785,0.6751,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_DN,1
chr18q11,SET,27,-0.15982,-0.0061211,0.35194,0.67512,chr18q11,1
MEISSNER_NPC_HCP_WITH_H3K4ME2,SET,447,-0.019136,-0.0029478,0.042095,0.6753,MEISSNER_NPC_HCP_WITH_H3K4ME2,1
GOBP_REGULATION_OF_DENDRITIC...3,SET,14,-0.10726,-0.0029591,0.23587,0.67534,GOBP_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,1
GOBP_INTESTINE_SMOOTH_MUSCLE...,SET,8,-0.13675,-0.0028523,0.30071,0.67535,GOBP_INTESTINE_SMOOTH_MUSCLE_CONTRACTION,1
GHO_ATF5_TARGETS_UP,SET,12,-0.12161,-0.0031065,0.26741,0.67536,GHO_ATF5_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...480,SET,17,-0.084685,-0.0025743,0.18619,0.67538,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEPARATION,1
HP_LONG_NOSE,SET,32,-0.065701,-0.0027391,0.14445,0.67538,HP_LONG_NOSE,1
HP_RECURRENT_UPPER_AND_LOWER...,SET,14,-0.11179,-0.0030842,0.24573,0.67542,HP_RECURRENT_UPPER_AND_LOWER_RESPIRATORY_TRACT_INFECTIONS,1
DESCARTES_FETAL_STOMACH_STRO...,SET,42,-0.064311,-0.0030708,0.14136,0.67542,DESCARTES_FETAL_STOMACH_STROMAL_CELLS,1
MIR1273H_3P,SET,88,-0.041769,-0.0028833,0.091807,0.67543,MIR1273H_3P,1
HP_ACIDEMIA,SET,22,-0.078884,-0.0027276,0.17334,0.67547,HP_ACIDEMIA,1
GOBP_MICROVILLUS_ORGANIZATION,SET,27,-0.073251,-0.0028055,0.16095,0.67548,GOBP_MICROVILLUS_ORGANIZATION,1
WP_KENNEDY_PATHWAY_FROM_SPHI...,SET,13,-0.10438,-0.0027751,0.22932,0.67551,WP_KENNEDY_PATHWAY_FROM_SPHINGOLIPIDS,1
NUFIP1_TARGET_GENES,SET,39,-0.061346,-0.0028229,0.13471,0.67558,NUFIP1_TARGET_GENES,1
GSE46242_CTRL_VS_EGR2_DELETE...4,SET,168,-0.029025,-0.0027623,0.063728,0.6756,GSE46242_CTRL_VS_EGR2_DELETED_TH1_CD4_TCELL_UP,1
GOMF_PROTEIN_KINASE_C_BINDING,SET,48,-0.058722,-0.002997,0.12892,0.67561,GOMF_PROTEIN_KINASE_C_BINDING,1
SEKI_INFLAMMATORY_RESPONSE_L...1,SET,20,-0.096867,-0.0031937,0.21264,0.67563,SEKI_INFLAMMATORY_RESPONSE_LPS_DN,1
WP_PLURIPOTENT_STEM_CELL_DIF...,SET,46,-0.061629,-0.0030793,0.13529,0.67563,WP_PLURIPOTENT_STEM_CELL_DIFFERENTIATION_PATHWAY,1
GSE45365_WT_VS_IFNAR_KO_BCEL...2,SET,153,-0.030697,-0.0027891,0.067387,0.67564,GSE45365_WT_VS_IFNAR_KO_BCELL_MCMV_INFECTION_DN,1
GOBP_POSITIVE_REGULATION_OF_...325,SET,5,-0.17523,-0.0028898,0.38455,0.67568,GOBP_POSITIVE_REGULATION_OF_HAIR_FOLLICLE_MATURATION,1
GOBP_PEPTIDYL_SERINE_AUTOPHO...,SET,8,-0.13504,-0.0028167,0.29628,0.67572,GOBP_PEPTIDYL_SERINE_AUTOPHOSPHORYLATION,1
GOBP_REGULATION_OF_CELL_POPU...,SET,1516,-0.010719,-0.0029488,0.023495,0.67588,GOBP_REGULATION_OF_CELL_POPULATION_PROLIFERATION,1
GOCC_U4_SNRNP,SET,10,-0.10656,-0.0024848,0.23356,0.67588,GOCC_U4_SNRNP,1
GSE17721_LPS_VS_GARDIQUIMOD_...2,SET,185,-0.027452,-0.0027403,0.060173,0.67588,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
HE_LIM_SUN_FETAL_LUNG_C4_ACT...,SET,46,-0.058133,-0.0029047,0.12735,0.67597,HE_LIM_SUN_FETAL_LUNG_C4_ACTIVATED_NK_CELL,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...1,SET,8,-0.14642,-0.0030541,0.3207,0.676,HE_LIM_SUN_FETAL_LUNG_C4_NKT1_CELL,1
BIOCARTA_TNFR2_PATHWAY,SET,15,-0.097229,-0.0027765,0.21293,0.67602,BIOCARTA_TNFR2_PATHWAY,1
GSE43863_TFH_VS_LY6C_INT_CXC...3,SET,178,-0.029185,-0.0028582,0.063908,0.67604,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_DN,1
MODULE_242,SET,187,-0.028291,-0.0028391,0.061946,0.67606,MODULE_242,1
HP_PALMOPLANTAR_ERYTHEMA,SET,5,-0.20807,-0.0034314,0.45555,0.67607,HP_PALMOPLANTAR_ERYTHEMA,1
GOBP_PROTEIN_CONTAINING_COMP...2,SET,231,-0.023932,-0.0026662,0.052374,0.67614,GOBP_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
MIR142_3P,SET,163,-0.030943,-0.0029011,0.067711,0.67616,MIR142_3P,1
MIR192_3P,SET,95,-0.040365,-0.0028945,0.088308,0.67619,MIR192_3P,1
GSE10325_CD4_TCELL_VS_LUPUS_...1,SET,178,-0.030082,-0.002946,0.065803,0.67621,GSE10325_CD4_TCELL_VS_LUPUS_CD4_TCELL_DN,1
GOBP_EPITHELIAL_MESENCHYMAL_...,SET,5,-0.20797,-0.0034298,0.4548,0.67626,GOBP_EPITHELIAL_MESENCHYMAL_CELL_SIGNALING,1
DESCARTES_MAIN_FETAL_SYMPATH...,SET,40,-0.065696,-0.0030615,0.14367,0.67626,DESCARTES_MAIN_FETAL_SYMPATHOBLASTS,1
GOBP_REGULATION_OF_PROTEIN_K...3,SET,18,-0.096752,-0.0030264,0.21156,0.67628,GOBP_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,1
HP_ABNORMAL_LIGHT_AND_DARK_A...,SET,35,-0.069654,-0.0030367,0.15229,0.6763,HP_ABNORMAL_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,1
GUO_TARGETS_OF_IRS1_AND_IRS2,SET,91,-0.038912,-0.0027313,0.085018,0.67641,GUO_TARGETS_OF_IRS1_AND_IRS2,1
GSE17721_CTRL_VS_LPS_0.5H_BM...1,SET,182,-0.029073,-0.0028787,0.063511,0.67643,GSE17721_CTRL_VS_LPS_0.5H_BMDC_DN,1
HP_ANTERIOR_POLAR_CATARACT,SET,7,-0.16504,-0.0032202,0.36048,0.67646,HP_ANTERIOR_POLAR_CATARACT,1
MIR3064_5P,SET,133,-0.033297,-0.0028222,0.072706,0.67651,MIR3064_5P,1
ZHONG_PFC_C9_ORG_OTHER,SET,71,-0.050853,-0.0031546,0.11104,0.67651,ZHONG_PFC_C9_ORG_OTHER,1
GOMF_BMP_BINDING,SET,18,-0.091808,-0.0028717,0.20042,0.67655,GOMF_BMP_BINDING,1
HP_INCREASED_SENSITIVITY_TO_...,SET,12,-0.10863,-0.0027748,0.23703,0.67662,HP_INCREASED_SENSITIVITY_TO_IONIZING_RADIATION,1
GOMF_CYTOKINE_RECEPTOR_BINDI...,SET,247,-0.026479,-0.003049,0.057776,0.67663,GOMF_CYTOKINE_RECEPTOR_BINDING,1
MIR506_3P,SET,693,-0.015043,-0.0028654,0.032819,0.67665,MIR506_3P,1
HP_INCREASED_ADIPOSE_TISSUE,SET,9,-0.12873,-0.0028479,0.28084,0.67665,HP_INCREASED_ADIPOSE_TISSUE,1
SETD7_TARGET_GENES,SET,718,-0.014168,-0.0027452,0.03091,0.67666,SETD7_TARGET_GENES,1
GOBP_REGULATION_OF_GLYCOGEN_...3,SET,31,-0.070214,-0.0028812,0.15317,0.67666,GOBP_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...388,SET,7,-0.168,-0.003278,0.36639,0.67671,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_PROLIFERATION,1
SMID_BREAST_CANCER_RELAPSE_I...3,SET,76,-0.046728,-0.0029986,0.1019,0.67672,SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN,1
REACTOME_GLUCAGON_TYPE_LIGAN...,SET,33,-0.07044,-0.0029821,0.15361,0.67672,REACTOME_GLUCAGON_TYPE_LIGAND_RECEPTORS,1
HALLMARK_XENOBIOTIC_METABOLI...,SET,193,-0.028426,-0.0028976,0.061982,0.67674,HALLMARK_XENOBIOTIC_METABOLISM,1
GOBP_SMALL_MOLECULE_BIOSYNTH...,SET,539,-0.016851,-0.0028431,0.03674,0.67676,GOBP_SMALL_MOLECULE_BIOSYNTHETIC_PROCESS,1
GSE13762_CTRL_VS_125_VITAMIN...3,SET,119,-0.035717,-0.0028647,0.077861,0.67678,GSE13762_CTRL_VS_125_VITAMIND_DAY5_DC_DN,1
GSE22611_NOD2_VS_MUTANT_NOD2...1,SET,159,-0.029953,-0.0027739,0.065281,0.67682,GSE22611_NOD2_VS_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
MORF_ANP32B,SET,178,-0.026938,-0.0026381,0.058693,0.67687,MORF_ANP32B,1
WP_COHESIN_COMPLEX_CORNELIA_...,SET,27,-0.067244,-0.0025755,0.14647,0.67692,WP_COHESIN_COMPLEX_CORNELIA_DE_LANGE_SYNDROME,1
GSE3982_EFF_MEMORY_VS_CENT_M...1,SET,172,-0.029163,-0.0028079,0.063493,0.67699,GSE3982_EFF_MEMORY_VS_CENT_MEMORY_CD4_TCELL_DN,1
GOBP_DE_NOVO_CENTRIOLE_ASSEM...1,SET,5,-0.15858,-0.0026153,0.3452,0.67702,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY,1
GOMF_P_TYPE_POTASSIUM_TRANSM...,SET,8,-0.15777,-0.003291,0.34339,0.67704,GOMF_P_TYPE_POTASSIUM_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_SYSTEM_PR...,SET,510,-0.018327,-0.0030102,0.03988,0.67707,GOBP_REGULATION_OF_SYSTEM_PROCESS,1
GOBP_VESICLE_LOCALIZATION,SET,202,-0.025953,-0.0027058,0.056465,0.67711,GOBP_VESICLE_LOCALIZATION,1
MIR4704_3P,SET,124,-0.035361,-0.0028947,0.076924,0.67713,MIR4704_3P,1
KYNG_DNA_DAMAGE_BY_UV,SET,51,-0.054027,-0.0028421,0.11751,0.67716,KYNG_DNA_DAMAGE_BY_UV,1
GOCC_SPECTRIN_ASSOCIATED_CYT...,SET,9,-0.13704,-0.0030318,0.29798,0.6772,GOCC_SPECTRIN_ASSOCIATED_CYTOSKELETON,1
GOBP_POSITIVE_REGULATION_OF_...839,SET,30,-0.065793,-0.002656,0.14299,0.67729,GOBP_POSITIVE_REGULATION_OF_VIRAL_GENOME_REPLICATION,1
REACTOME_SCAVENGING_BY_CLASS...2,SET,6,-0.18047,-0.0032602,0.39217,0.6773,REACTOME_SCAVENGING_BY_CLASS_B_RECEPTORS,1
HP_INCREASED_CIRCULATING_PRO...,SET,26,-0.072027,-0.0027072,0.15644,0.67738,HP_INCREASED_CIRCULATING_PROLACTIN_CONCENTRATION,1
GOCC_SPINDLE_POLE,SET,162,-0.029543,-0.0027614,0.064144,0.67745,GOCC_SPINDLE_POLE,1
GSE23505_IL6_IL1_IL23_VS_IL6...2,SET,180,-0.028746,-0.0028308,0.062412,0.67745,GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
GOBP_CARBOHYDRATE_DERIVATIVE...3,SET,965,-0.012874,-0.0028715,0.027948,0.67747,GOBP_CARBOHYDRATE_DERIVATIVE_METABOLIC_PROCESS,1
HOXD1_TARGET_GENES,SET,56,-0.049581,-0.0027327,0.1076,0.67752,HOXD1_TARGET_GENES,1
HP_KELOIDS,SET,9,-0.1237,-0.0027367,0.26843,0.67754,HP_KELOIDS,1
GSE40068_CXCR5POS_BCL6POS_TF...2,SET,177,-0.027845,-0.0027194,0.060423,0.67754,GSE40068_CXCR5POS_BCL6POS_TFH_VS_CXCR5NEG_BCL6NEG_CD4_TCELL_UP,1
HP_AGENESIS_OF_INCISOR,SET,31,-0.074331,-0.0030502,0.16122,0.67762,HP_AGENESIS_OF_INCISOR,1
HP_METATARSUS_VALGUS,SET,19,-0.091224,-0.0029316,0.19778,0.67769,HP_METATARSUS_VALGUS,1
MIR1282,SET,10,-0.12285,-0.0028649,0.26633,0.6777,MIR1282,1
GOBP_REGULATION_OF_ESTABLISH...3,SET,11,-0.096999,-0.0023723,0.21024,0.67773,GOBP_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
GAVISH_3CA_METAPROGRAM_EPITH...7,SET,47,-0.061719,-0.0031171,0.13377,0.67774,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_2,1
REACTOME_SCAVENGING_BY_CLASS...1,SET,19,-0.098454,-0.0031639,0.21323,0.67786,REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS,1
REACTOME_DISORDERS_OF_TRANSM...,SET,166,-0.029438,-0.0027851,0.063733,0.67792,REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS,1
HP_BRACHYDACTYLY,SET,337,-0.021163,-0.0028393,0.045788,0.67803,HP_BRACHYDACTYLY,1
GOBP_MOTILE_CILIUM_ASSEMBLY,SET,64,-0.045405,-0.0026747,0.098229,0.67804,GOBP_MOTILE_CILIUM_ASSEMBLY,1
MIR6802_3P,SET,36,-0.063807,-0.0028212,0.13803,0.67805,MIR6802_3P,1
HP_ABNORMAL_THORAX_MORPHOLOGY,SET,783,-0.014009,-0.0028293,0.030306,0.67805,HP_ABNORMAL_THORAX_MORPHOLOGY,1
GOBP_CARDIAC_RIGHT_VENTRICLE...,SET,19,-0.10035,-0.0032247,0.21703,0.67808,GOBP_CARDIAC_RIGHT_VENTRICLE_MORPHOGENESIS,1
GSE26669_CD4_VS_CD8_TCELL_IN...4,SET,184,-0.028739,-0.0028611,0.062158,0.67808,GSE26669_CD4_VS_CD8_TCELL_IN_MLR_UP,1
MIR4290,SET,62,-0.044963,-0.0026071,0.097236,0.6781,MIR4290,1
HP_THICKENED_RIBS,SET,7,-0.15097,-0.0029457,0.32647,0.67811,HP_THICKENED_RIBS,1
KIM_LIVER_CANCER_POOR_SURVIV...1,SET,41,-0.061378,-0.0028957,0.13272,0.67812,KIM_LIVER_CANCER_POOR_SURVIVAL_DN,1
MIR301A_3P,SET,352,-0.021251,-0.0029126,0.045952,0.67812,MIR301A_3P,1
HP_HYPOPLASTIC_NASAL_BRIDGE,SET,5,-0.15866,-0.0026165,0.34307,0.67812,HP_HYPOPLASTIC_NASAL_BRIDGE,1
HE_LIM_SUN_FETAL_LUNG_C3_OMD...,SET,323,-0.023234,-0.0030529,0.05023,0.67815,HE_LIM_SUN_FETAL_LUNG_C3_OMD_POS_ENDOTHELIAL_CELL,1
GSE17721_CTRL_VS_POLYIC_4H_B...1,SET,184,-0.02888,-0.0028752,0.062435,0.67816,GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN,1
HP_PROGRESSIVE_LANGUAGE_DETE...,SET,11,-0.1125,-0.0027515,0.24309,0.67825,HP_PROGRESSIVE_LANGUAGE_DETERIORATION,1
GSE18791_CTRL_VS_NEWCASTLE_V...1,SET,170,-0.03096,-0.0029638,0.066883,0.67828,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_10H_DN,1
KRAS.PROSTATE_UP.V1_DN,SET,124,-0.036513,-0.002989,0.078866,0.6783,KRAS.PROSTATE_UP.V1_DN,1
HP_PARTIAL_ANOMALOUS_PULMONA...,SET,6,-0.16242,-0.0029341,0.35079,0.67832,HP_PARTIAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,1
GSE11961_MEMORY_BCELL_DAY7_V...5,SET,181,-0.027966,-0.0027616,0.060384,0.67836,GSE11961_MEMORY_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,1
HP_POSTURAL_TREMOR,SET,53,-0.052172,-0.0027976,0.11264,0.67837,HP_POSTURAL_TREMOR,1
SWEET_KRAS_TARGETS_UP,SET,74,-0.049694,-0.0031469,0.10727,0.67841,SWEET_KRAS_TARGETS_UP,1
HP_ABNORMAL_PROPORTION_OF_CD...1,SET,26,-0.077267,-0.0029041,0.16675,0.67845,HP_ABNORMAL_PROPORTION_OF_CD4_POSITIVE_HELPER_T_CELLS,1
REACTOME_VEGFR2_MEDIATED_VAS...,SET,26,-0.077888,-0.0029274,0.16805,0.67849,REACTOME_VEGFR2_MEDIATED_VASCULAR_PERMEABILITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...38,SET,15,-0.094917,-0.0027105,0.20477,0.67851,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH_GROUP_OF_DONORS_NAD_OR_NADP_AS_ACCEPTOR,1
GOBP_RETINAL_ROD_CELL_DEVELO...,SET,10,-0.12843,-0.0029949,0.27701,0.67854,GOBP_RETINAL_ROD_CELL_DEVELOPMENT,1
REACTOME_P75NTR_REGULATES_AX...,SET,9,-0.14467,-0.0032007,0.31197,0.67858,REACTOME_P75NTR_REGULATES_AXONOGENESIS,1
HJURP_TARGET_GENES,SET,27,-0.072204,-0.0027654,0.15568,0.6786,HJURP_TARGET_GENES,1
MIR6737_3P,SET,173,-0.029801,-0.0028776,0.06425,0.67861,MIR6737_3P,1
GOBP_RESPONSE_TO_PEPTIDE,SET,20,-0.092746,-0.0030578,0.19988,0.67867,GOBP_RESPONSE_TO_PEPTIDE,1
HP_PREMATURE_OSTEOARTHRITIS,SET,9,-0.13475,-0.0029812,0.29042,0.67867,HP_PREMATURE_OSTEOARTHRITIS,1
DACOSTA_UV_RESPONSE_VIA_ERCC...2,SET,65,-0.047237,-0.0028042,0.10178,0.67871,DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_UP,1
HP_MOTOR_STEREOTYPY,SET,224,-0.025819,-0.002833,0.055581,0.67887,HP_MOTOR_STEREOTYPY,1
ETS2_B,SET,257,-0.024552,-0.002883,0.052846,0.67889,ETS2_B,1
GOBP_REGULATION_OF_THE_FORCE...1,SET,24,-0.085474,-0.0030867,0.18389,0.67896,GOBP_REGULATION_OF_THE_FORCE_OF_HEART_CONTRACTION,1
GSE20715_0H_VS_24H_OZONE_TLR...2,SET,175,-0.030625,-0.0029741,0.065885,0.67897,GSE20715_0H_VS_24H_OZONE_TLR4_KO_LUNG_UP,1
NAKAYAMA_FRA2_TARGETS,SET,43,-0.06481,-0.0031312,0.1394,0.679,NAKAYAMA_FRA2_TARGETS,1
WP_HIPPOCAMPAL_SYNAPTOGENESI...,SET,27,-0.085935,-0.0032913,0.18484,0.679,WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS,1
HP_SHORT_4TH_TOE,SET,5,-0.14806,-0.0024418,0.31839,0.67904,HP_SHORT_4TH_TOE,1
HP_ABNORMAL_POSTURING,SET,5,-0.16008,-0.00264,0.3442,0.67906,HP_ABNORMAL_POSTURING,1
GCM_NUMA1,SET,51,-0.049189,-0.0025876,0.10574,0.6791,GCM_NUMA1,1
HP_MACRODONTIA_OF_PERMANENT_...,SET,12,-0.12315,-0.0031459,0.26473,0.67911,HP_MACRODONTIA_OF_PERMANENT_MAXILLARY_CENTRAL_INCISOR,1
GOBP_INTERLEUKIN_17_MEDIATED...,SET,11,-0.13079,-0.0031986,0.28108,0.67914,GOBP_INTERLEUKIN_17_MEDIATED_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CELLULAR_...8,SET,7,-0.15041,-0.0029348,0.32319,0.67917,GOBP_REGULATION_OF_CELLULAR_PH_REDUCTION,1
GSE43955_TH0_VS_TGFB_IL6_TH1...10,SET,181,-0.028427,-0.0028072,0.06107,0.6792,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_UP,1
GSE37301_COMMON_LYMPHOID_PRO...6,SET,177,-0.029747,-0.0029051,0.063897,0.67923,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_PRO_BCELL_UP,1
BIOCARTA_SUMO_PATHWAY,SET,6,-0.13222,-0.0023887,0.284,0.67924,BIOCARTA_SUMO_PATHWAY,1
WP_FAMILIAL_PARTIAL_LIPODYST...,SET,30,-0.075671,-0.0030547,0.16251,0.67926,WP_FAMILIAL_PARTIAL_LIPODYSTROPHY,1
MIR4446_3P,SET,56,-0.051976,-0.0028647,0.11161,0.67928,MIR4446_3P,1
MIR8078,SET,28,-0.073812,-0.0028788,0.15847,0.67931,MIR8078,1
GAO_STOMACH_24W_C6_PIT_CELL,SET,12,-0.11095,-0.0028341,0.23809,0.67939,GAO_STOMACH_24W_C6_PIT_CELL,1
HP_NEOPLASM_OF_THE_GASTROINT...,SET,285,-0.02375,-0.0029345,0.050958,0.67941,HP_NEOPLASM_OF_THE_GASTROINTESTINAL_TRACT,1
GSE10325_LUPUS_BCELL_VS_LUPU...1,SET,188,-0.030569,-0.0030758,0.065579,0.67944,GSE10325_LUPUS_BCELL_VS_LUPUS_MYELOID_DN,1
GOBP_REGULATION_OF_BICELLULA...,SET,21,-0.08601,-0.0029057,0.18451,0.67945,GOBP_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
UNTERMAN_PROGRESSIVE_VS_STAB...1,SET,4,-0.23578,-0.003478,0.50572,0.67947,UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN,1
REACTOME_GAMMA_CARBOXYLATION...2,SET,9,-0.12899,-0.0028537,0.27667,0.67947,REACTOME_GAMMA_CARBOXYLATION_TRANSPORT_AND_AMINO_TERMINAL_CLEAVAGE_OF_PROTEINS,1
HP_ABNORMALITY_OF_THE_MENSTR...,SET,290,-0.023277,-0.0029008,0.049924,0.67948,HP_ABNORMALITY_OF_THE_MENSTRUAL_CYCLE,1
HP_LONG_PALM,SET,3,-0.27339,-0.0034926,0.58625,0.67951,HP_LONG_PALM,1
GOBP_PEPTIDE_METABOLIC_PROCE...,SET,72,-0.047958,-0.0029958,0.10283,0.67953,GOBP_PEPTIDE_METABOLIC_PROCESS,1
GOBP_GLIOGENESIS,SET,325,-0.023062,-0.0030395,0.049444,0.67954,GOBP_GLIOGENESIS,1
NAKAYA_PBMC_FLUMIST_AGE_18_5...5,SET,10,-0.14505,-0.0033824,0.3108,0.67964,NAKAYA_PBMC_FLUMIST_AGE_18_50YO_7DY_IFN_SUBSET_DN,1
NR1D1_TARGET_GENES,SET,88,-0.040841,-0.0028192,0.087475,0.67971,NR1D1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...202,SET,4,-0.2204,-0.0032511,0.47201,0.67972,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,1
GSE17721_CTRL_VS_PAM3CSK4_4H...2,SET,183,-0.028214,-0.0028013,0.060423,0.67973,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_UP,1
FEV_TARGET_GENES,SET,1339,-0.010991,-0.0028565,0.023534,0.67976,FEV_TARGET_GENES,1
HARALAMBIEVA_PBMC_FLUARIX_AG...3,SET,8,-0.13999,-0.0029199,0.29966,0.6798,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE,1
REACTOME_TRANSPORT_OF_NUCLEO...2,SET,8,-0.12873,-0.0026852,0.27556,0.67981,REACTOME_TRANSPORT_OF_NUCLEOTIDE_SUGARS,1
BIOCARTA_CK1_PATHWAY,SET,16,-0.10343,-0.0030503,0.22131,0.67987,BIOCARTA_CK1_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...289,SET,181,-0.030195,-0.0029817,0.064612,0.67987,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_RESPONSE,1
MODULE_28,SET,31,-0.060195,-0.0024701,0.12877,0.67991,MODULE_28,1
GOBP_LOCOMOTORY_BEHAVIOR,SET,194,-0.029222,-0.0029864,0.0625,0.67994,GOBP_LOCOMOTORY_BEHAVIOR,1
REACTOME_REGULATION_OF_ENDOG...3,SET,37,-0.06552,-0.0029368,0.14012,0.67997,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS,1
FARMER_BREAST_CANCER_CLUSTER...6,SET,14,-0.11269,-0.003109,0.24086,0.68005,FARMER_BREAST_CANCER_CLUSTER_6,1
GOBP_ANDROGEN_BIOSYNTHETIC_P...,SET,10,-0.12513,-0.0029179,0.26726,0.68017,GOBP_ANDROGEN_BIOSYNTHETIC_PROCESS,1
MIR197_3P,SET,90,-0.039875,-0.0027835,0.085167,0.68018,MIR197_3P,1
GOBP_POSITIVE_REGULATION_OF_...635,SET,98,-0.039191,-0.0028541,0.083694,0.6802,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_MEMBRANE,1
GOBP_REGULATION_OF_ANATOMICA...1,SET,750,-0.015226,-0.0030124,0.032515,0.68021,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_MORPHOGENESIS,1
GOBP_SUBPALLIUM_DEVELOPMENT,SET,26,-0.085181,-0.0032016,0.18188,0.68022,GOBP_SUBPALLIUM_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...666,SET,38,-0.071537,-0.0032495,0.15273,0.68025,GOBP_NEGATIVE_REGULATION_OF_TYPE_II_INTERFERON_PRODUCTION,1
KIM_RESPONSE_TO_TSA_AND_DECI...2,SET,108,-0.037219,-0.0028447,0.079453,0.68026,KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP,1
TATTATA_MIR374,SET,265,-0.025924,-0.0030903,0.055343,0.68026,TATTATA_MIR374,1
HP_OSTEOARTHRITIS_OF_THE_SMA...,SET,4,-0.20861,-0.0030772,0.44525,0.68029,HP_OSTEOARTHRITIS_OF_THE_SMALL_JOINTS_OF_THE_HAND,1
MEISSNER_BRAIN_HCP_WITH_H3K4...1,SET,16,-0.099512,-0.0029349,0.21226,0.6804,MEISSNER_BRAIN_HCP_WITH_H3K4ME2,1
GOBP_POSITIVE_REGULATION_OF_...5,SET,45,-0.060059,-0.0029682,0.12808,0.68043,GOBP_POSITIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,1
PAX3_TARGET_GENES,SET,1195,-0.012126,-0.0029899,0.025858,0.68045,PAX3_TARGET_GENES,1
GOBP_TISSUE_MORPHOGENESIS,SET,576,-0.017398,-0.0030314,0.037094,0.68047,GOBP_TISSUE_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...562,SET,472,-0.018105,-0.0028639,0.038582,0.68055,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,1
KONDO_PROSTATE_CANCER_HCP_WI...,SET,87,-0.045819,-0.003145,0.097628,0.68058,KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3,1
GSE21063_3H_VS_16H_ANTI_IGM_...2,SET,179,-0.030204,-0.0029662,0.064347,0.6806,GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP,1
GAUTAM_EYE_CORNEA_CONJUNCTIV...,SET,92,-0.04244,-0.0029951,0.090402,0.68062,GAUTAM_EYE_CORNEA_CONJUNCTIVAL_CELLS,1
GSE26351_UNSTIM_VS_BMP_PATHW...2,SET,173,-0.029637,-0.0028618,0.063119,0.68065,GSE26351_UNSTIM_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP,1
GSE1460_INTRATHYMIC_T_PROGEN...8,SET,184,-0.028402,-0.0028275,0.060483,0.68067,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,1
GOBP_REGULATION_OF_RESPIRATO...4,SET,11,-0.12918,-0.0031594,0.27503,0.68071,GOBP_REGULATION_OF_RESPIRATORY_GASEOUS_EXCHANGE_BY_NERVOUS_SYSTEM_PROCESS,1
GOCC_PEPTIDASE_COMPLEX,SET,115,-0.033742,-0.0026607,0.071836,0.68072,GOCC_PEPTIDASE_COMPLEX,1
GSE6259_33D1_POS_VS_DEC205_P...4,SET,174,-0.030946,-0.0029967,0.065859,0.68077,GSE6259_33D1_POS_VS_DEC205_POS_SPLENIC_DC_UP,1
MIR4425,SET,84,-0.041456,-0.0027962,0.088212,0.6808,MIR4425,1
GOBP_REGULATION_OF_NATURAL_K...1,SET,38,-0.068142,-0.0030953,0.14497,0.68083,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
MIR4773,SET,171,-0.030416,-0.0029202,0.064704,0.68085,MIR4773,1
GSE21360_TERTIARY_VS_QUATERN...1,SET,162,-0.033224,-0.0031055,0.070661,0.68089,GSE21360_TERTIARY_VS_QUATERNARY_MEMORY_CD8_TCELL_DN,1
HP_ABNORMALITY_OF_PULMONARY_...,SET,168,-0.030707,-0.0029224,0.065297,0.68091,HP_ABNORMALITY_OF_PULMONARY_CIRCULATION,1
GSE5589_LPS_VS_LPS_AND_IL10_...5,SET,181,-0.0287,-0.0028341,0.061031,0.68091,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_DN,1
GOBP_MYELOID_LEUKOCYTE_MIGRA...,SET,217,-0.029253,-0.0031598,0.062201,0.68092,GOBP_MYELOID_LEUKOCYTE_MIGRATION,1
DESCARTES_FETAL_EYE_AMACRINE...,SET,7,-0.15204,-0.0029667,0.32331,0.68092,DESCARTES_FETAL_EYE_AMACRINE_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...327,SET,5,-0.18163,-0.0029955,0.38594,0.68104,GOBP_NEGATIVE_REGULATION_OF_IRE1_MEDIATED_UNFOLDED_PROTEIN_RESPONSE,1
HP_INTESTINAL_PERFORATION,SET,5,-0.15954,-0.0026311,0.33893,0.68108,HP_INTESTINAL_PERFORATION,1
DESCARTES_FETAL_PLACENTA_AFP...,SET,156,-0.033371,-0.0030614,0.070883,0.6811,DESCARTES_FETAL_PLACENTA_AFP_ALB_POSITIVE_CELLS,1
KIM_PTEN_TARGETS_UP,SET,17,-0.096467,-0.0029325,0.20479,0.6812,KIM_PTEN_TARGETS_UP,1
GSE40277_EOS_AND_LEF1_TRANSD...1,SET,188,-0.028528,-0.0028704,0.060545,0.68124,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_DN,1
GOBP_ESTABLISHMENT_OF_PROTEI...10,SET,17,-0.084199,-0.0025596,0.17865,0.68128,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_TELOMERE,1
MIR204_3P,SET,128,-0.034905,-0.0029028,0.074053,0.6813,MIR204_3P,1
GOBP_REGULATION_OF_MOLECULAR...,SET,1746,-0.010189,-0.0029877,0.021618,0.6813,GOBP_REGULATION_OF_MOLECULAR_FUNCTION,1
HP_HYPERKETONEMIA,SET,4,-0.20581,-0.0030358,0.4365,0.68135,HP_HYPERKETONEMIA,1
GOBP_PERISTALSIS,SET,12,-0.13373,-0.0034159,0.28351,0.68142,GOBP_PERISTALSIS,1
GOCC_GUANYL_NUCLEOTIDE_EXCHA...,SET,22,-0.082248,-0.0028439,0.17437,0.68142,GOCC_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_COMPLEX,1
GSE360_L_MAJOR_VS_T_GONDII_D...2,SET,178,-0.031444,-0.0030794,0.066656,0.68144,GSE360_L_MAJOR_VS_T_GONDII_DC_UP,1
AMIT_SERUM_RESPONSE_40_MCF10A,SET,29,-0.084223,-0.0033429,0.17851,0.68147,AMIT_SERUM_RESPONSE_40_MCF10A,1
PID_MET_PATHWAY,SET,77,-0.043394,-0.0028029,0.091966,0.68148,PID_MET_PATHWAY,1
MODY_HIPPOCAMPUS_NEONATAL,SET,30,-0.075227,-0.0030368,0.15941,0.6815,MODY_HIPPOCAMPUS_NEONATAL,1
KEGG_NUCLEOTIDE_EXCISION_REP...,SET,40,-0.052624,-0.0024523,0.11149,0.68154,KEGG_NUCLEOTIDE_EXCISION_REPAIR,1
GOBP_ATP_EXPORT,SET,6,-0.19189,-0.0034666,0.40652,0.68154,GOBP_ATP_EXPORT,1
GOMF_SOLUTE_INORGANIC_ANION_...,SET,31,-0.071703,-0.0029423,0.1519,0.68155,GOMF_SOLUTE_INORGANIC_ANION_ANTIPORTER_ACTIVITY,1
GOBP_REGULATION_OF_OSTEOBLAS...1,SET,116,-0.038851,-0.0030768,0.082278,0.6816,GOBP_REGULATION_OF_OSTEOBLAST_DIFFERENTIATION,1
KEGG_MEDICUS_VARIANT_TGFA_OV...,SET,8,-0.14289,-0.0029805,0.3025,0.68166,KEGG_MEDICUS_VARIANT_TGFA_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_ESTABLISHMENT_OF_ENDOTH...2,SET,13,-0.11523,-0.0030635,0.24386,0.68172,GOBP_ESTABLISHMENT_OF_ENDOTHELIAL_INTESTINAL_BARRIER,1
MIR214_3P,SET,222,-0.025469,-0.0027822,0.053899,0.68173,MIR214_3P,1
HP_ABNORMAL_ENCHONDRAL_OSSIF...,SET,126,-0.035772,-0.0029517,0.075692,0.68175,HP_ABNORMAL_ENCHONDRAL_OSSIFICATION,1
GOBP_VACUOLAR_ACIDIFICATION,SET,32,-0.069737,-0.0029074,0.14753,0.68178,GOBP_VACUOLAR_ACIDIFICATION,1
ACACTCC_MIR122A,SET,68,-0.045986,-0.002792,0.097282,0.68179,ACACTCC_MIR122A,1
HP_AUTOAMPUTATION,SET,15,-0.10103,-0.002885,0.2137,0.6818,HP_AUTOAMPUTATION,1
GSE360_T_GONDII_VS_M_TUBERCU...3,SET,176,-0.029925,-0.0029143,0.063295,0.68181,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_DN,1
REACTOME_ACTIVATION_OF_KAINA...,SET,29,-0.075853,-0.0030107,0.1603,0.68196,REACTOME_ACTIVATION_OF_KAINATE_RECEPTORS_UPON_GLUTAMATE_BINDING,1
PU1_Q6,SET,221,-0.027823,-0.0030326,0.058796,0.68197,PU1_Q6,1
GOBP_REGULATION_OF_NUCLEOTID...4,SET,49,-0.053912,-0.00278,0.11392,0.68197,GOBP_REGULATION_OF_NUCLEOTIDE_CATABOLIC_PROCESS,1
MIR9718,SET,95,-0.042967,-0.0030811,0.090791,0.68198,MIR9718,1
GSE6259_CD4_TCELL_VS_CD8_TCE...1,SET,165,-0.029944,-0.0028244,0.06327,0.68198,GSE6259_CD4_TCELL_VS_CD8_TCELL_DN,1
GOBP_RESPONSE_TO_TYPE_II_INT...,SET,112,-0.039151,-0.003047,0.082723,0.68199,GOBP_RESPONSE_TO_TYPE_II_INTERFERON,1
MIR2277_3P,SET,15,-0.10444,-0.0029824,0.2205,0.68212,MIR2277_3P,1
GSE22611_UNSTIM_VS_6H_MDP_ST...2,SET,178,-0.029878,-0.0029261,0.063081,0.68212,GSE22611_UNSTIM_VS_6H_MDP_STIM_MUTANT_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
chr4p11,SET,8,-0.22128,-0.0046157,0.46716,0.68213,chr4p11,1
HP_PRIMITIVE_NEUROECTODERMAL...,SET,68,-0.048034,-0.0029163,0.1014,0.68214,HP_PRIMITIVE_NEUROECTODERMAL_TUMOR,1
GOBP_ASPARTATE_FAMILY_AMINO_...2,SET,12,-0.11477,-0.0029318,0.24228,0.68215,GOBP_ASPARTATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...147,SET,8,-0.12999,-0.0027115,0.2744,0.68215,GOBP_POSITIVE_REGULATION_OF_CENTRIOLE_REPLICATION,1
GCM_SMO,SET,58,-0.050151,-0.0028129,0.10586,0.68216,GCM_SMO,1
MURAKAMI_UV_RESPONSE_24HR,SET,20,-0.086032,-0.0028365,0.18153,0.68222,MURAKAMI_UV_RESPONSE_24HR,1
GSE46606_UNSTIM_VS_CD40L_IL2...4,SET,178,-0.029347,-0.0028741,0.061919,0.68223,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_UP,1
GSE5679_PPARG_LIGAND_ROSIGLI...1,SET,185,-0.028519,-0.0028468,0.060168,0.68224,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_DN,1
GSE21670_IL6_VS_TGFB_AND_IL6...3,SET,179,-0.02933,-0.0028804,0.061865,0.68228,GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
MIR10401_5P,SET,73,-0.048229,-0.0030335,0.1017,0.68233,MIR10401_5P,1
GSE12366_GC_VS_MEMORY_BCELL_...2,SET,174,-0.029434,-0.0028504,0.062049,0.68238,GSE12366_GC_VS_MEMORY_BCELL_UP,1
HP_INFANTILE_SPASMS,SET,119,-0.036583,-0.0029341,0.077097,0.68243,HP_INFANTILE_SPASMS,1
CHICAS_RB1_TARGETS_LOW_SERUM,SET,74,-0.046094,-0.0029189,0.097133,0.68244,CHICAS_RB1_TARGETS_LOW_SERUM,1
GSE3982_MAC_VS_NEUTROPHIL_LP...1,SET,167,-0.031372,-0.0029768,0.066111,0.68244,GSE3982_MAC_VS_NEUTROPHIL_LPS_STIM_DN,1
GSE5589_WT_VS_IL6_KO_LPS_AND...4,SET,175,-0.029305,-0.0028459,0.061736,0.68249,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
GSE32986_UNSTIM_VS_GMCSF_AND...3,SET,174,-0.029511,-0.0028578,0.062149,0.68255,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_LOWDOSE_STIM_DC_DN,1
NOUZOVA_METHYLATED_IN_APL,SET,57,-0.058209,-0.0032366,0.12254,0.68261,NOUZOVA_METHYLATED_IN_APL,1
GOBP_GABAERGIC_NEURON_DIFFER...,SET,18,-0.11215,-0.0035082,0.23609,0.68262,GOBP_GABAERGIC_NEURON_DIFFERENTIATION,1
GOMF_BETA_N_ACETYLHEXOSAMINI...,SET,3,-0.23946,-0.0030591,0.50403,0.68264,GOMF_BETA_N_ACETYLHEXOSAMINIDASE_ACTIVITY,1
HP_ABNORMAL_THYMUS_MORPHOLOGY,SET,51,-0.058422,-0.0030732,0.12297,0.68264,HP_ABNORMAL_THYMUS_MORPHOLOGY,1
GSE18893_TCONV_VS_TREG_2H_TN...1,SET,174,-0.030277,-0.002932,0.063711,0.68268,GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN,1
GSE3039_CD4_TCELL_VS_ALPHAAL...2,SET,182,-0.029903,-0.0029609,0.062922,0.68269,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_UP,1
GSE36826_NORMAL_VS_STAPH_AUR...1,SET,183,-0.028582,-0.0028378,0.060125,0.68273,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN,1
REACTOME_SIGNALING_BY_TGF_BE...1,SET,91,-0.040256,-0.0028256,0.08467,0.68276,REACTOME_SIGNALING_BY_TGF_BETA_RECEPTOR_COMPLEX,1
TGTYNNNNNRGCARM_UNKNOWN,SET,79,-0.045044,-0.0029468,0.094699,0.68284,TGTYNNNNNRGCARM_UNKNOWN,1
PGF_UP.V1_DN,SET,174,-0.030548,-0.0029582,0.064211,0.68287,PGF_UP.V1_DN,1
WP_HOSTPATHOGEN_INTERACTION_...1,SET,21,-0.09288,-0.0031378,0.19518,0.68291,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_APOPTOSIS,1
GOMF_LAMININ_1_BINDING,SET,7,-0.18078,-0.0035275,0.37979,0.68296,GOMF_LAMININ_1_BINDING,1
MIR9986,SET,148,-0.033624,-0.0030052,0.070629,0.68299,MIR9986,1
ZNF257_TARGET_GENES,SET,447,-0.018881,-0.0029085,0.039642,0.68307,ZNF257_TARGET_GENES,1
GOBP_REGULATION_OF_MYELOID_D...,SET,4,-0.23258,-0.0034308,0.48823,0.68309,GOBP_REGULATION_OF_MYELOID_DENDRITIC_CELL_ACTIVATION,1
REACTOME_DEGRADATION_OF_AXIN,SET,52,-0.05014,-0.0026632,0.10525,0.6831,REACTOME_DEGRADATION_OF_AXIN,1
GSE20715_0H_VS_6H_OZONE_TLR4...1,SET,189,-0.029366,-0.0029626,0.061628,0.68314,GSE20715_0H_VS_6H_OZONE_TLR4_KO_LUNG_DN,1
NGFIC_01,SET,224,-0.026326,-0.0028886,0.055245,0.68315,NGFIC_01,1
GOMF_HISTONE_H3K9_DEMETHYLAS...,SET,12,-0.11288,-0.0028834,0.23686,0.68316,GOMF_HISTONE_H3K9_DEMETHYLASE_ACTIVITY,1
REACTOME_SHC_MEDIATED_CASCAD...2,SET,17,-0.097286,-0.0029574,0.20413,0.68317,REACTOME_SHC_MEDIATED_CASCADE_FGFR3,1
ZNF746_TARGET_GENES,SET,55,-0.053793,-0.0029383,0.11286,0.68319,ZNF746_TARGET_GENES,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...3,SET,220,-0.025553,-0.0027789,0.053602,0.68321,GOBP_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
REACTOME_TRANSCRIPTIONAL_ACT...1,SET,50,-0.056166,-0.0029255,0.11779,0.68326,REACTOME_TRANSCRIPTIONAL_ACTIVATION_OF_MITOCHONDRIAL_BIOGENESIS,1
HP_MISSING_RIBS,SET,60,-0.050562,-0.0028842,0.10603,0.68326,HP_MISSING_RIBS,1
KEGG_MEDICUS_REFERENCE_HEME_...,SET,8,-0.13855,-0.0028901,0.29054,0.68327,KEGG_MEDICUS_REFERENCE_HEME_BIOSYNTHESIS,1
WP_HEMESYNTHESIS_DEFECTS_AND...,SET,8,-0.13855,-0.0028901,0.29054,0.68327,WP_HEMESYNTHESIS_DEFECTS_AND_PORPHYRIAS,1
WP_HEME_BIOSYNTHESIS,SET,8,-0.13855,-0.0028901,0.29054,0.68327,WP_HEME_BIOSYNTHESIS,1
GSE28737_FOLLICULAR_VS_MARGI...4,SET,185,-0.027877,-0.0027827,0.058454,0.68328,GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_UP,1
MIR485_3P,SET,207,-0.029524,-0.0031156,0.061877,0.68336,MIR485_3P,1
GOMF_PROTEIN_PHOSPHATASE_2A_...,SET,26,-0.084416,-0.0031728,0.17689,0.6834,GOMF_PROTEIN_PHOSPHATASE_2A_BINDING,1
HAY_BONE_MARROW_DENDRITIC_CE...,SET,167,-0.03216,-0.0030516,0.067384,0.68341,HAY_BONE_MARROW_DENDRITIC_CELL,1
IWANAGA_E2F1_TARGETS_NOT_IND...,SET,6,-0.15128,-0.0027329,0.31694,0.68343,IWANAGA_E2F1_TARGETS_NOT_INDUCED_BY_SERUM,1
GOBP_POSITIVE_REGULATION_OF_...525,SET,8,-0.15155,-0.0031611,0.31741,0.68348,GOBP_POSITIVE_REGULATION_OF_NEUROEPITHELIAL_CELL_DIFFERENTIATION,1
EWSR1_TARGET_GENES,SET,771,-0.014543,-0.0029154,0.030452,0.68351,EWSR1_TARGET_GENES,1
GOBP_REGULATION_OF_DNA_REPLI...,SET,117,-0.03713,-0.0029531,0.077708,0.68361,GOBP_REGULATION_OF_DNA_REPLICATION,1
PDGF_ERK_DN.V1_DN,SET,135,-0.034514,-0.0029471,0.072233,0.68361,PDGF_ERK_DN.V1_DN,1
HP_FINGER_CLINODACTYLY,SET,387,-0.020339,-0.0029201,0.042563,0.68362,HP_FINGER_CLINODACTYLY,1
MIR4436B_5P,SET,121,-0.038013,-0.0030741,0.079546,0.68363,MIR4436B_5P,1
GSE15930_STIM_VS_STIM_AND_TR...3,SET,190,-0.028257,-0.0028582,0.059124,0.68365,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_DN,1
BIOCARTA_RAN_PATHWAY,SET,5,-0.15904,-0.0026229,0.33266,0.68371,BIOCARTA_RAN_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...22,SET,6,-0.17429,-0.0031486,0.36444,0.68376,GOBP_POSITIVE_REGULATION_OF_AMINE_METABOLIC_PROCESS,1
GSE20715_WT_VS_TLR4_KO_6H_OZ...2,SET,183,-0.028952,-0.0028745,0.060538,0.68376,GSE20715_WT_VS_TLR4_KO_6H_OZONE_LUNG_UP,1
GSE45837_WT_VS_GFI1_KO_PDC_UP,SET,164,-0.030448,-0.0028633,0.063638,0.68384,GSE45837_WT_VS_GFI1_KO_PDC_UP,1
GOMF_NUCLEOBASE_CONTAINING_C...2,SET,52,-0.057961,-0.0030787,0.12113,0.68385,GOMF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_TRICUSPID_VALVE_PROLAPSE,SET,10,-0.13224,-0.0030839,0.27636,0.68386,HP_TRICUSPID_VALVE_PROLAPSE,1
GOBP_REGULATION_OF_T_CELL_AC...2,SET,6,-0.15305,-0.002765,0.31981,0.68388,GOBP_REGULATION_OF_T_CELL_ACTIVATION_VIA_T_CELL_RECEPTOR_CONTACT_WITH_ANTIGEN_BOUND_TO_MHC_MOLECULE_ON_ANTIGEN_PRESENTING_CELL,1
ANDERSON_BLOOD_CN54GP140_ADJ...7,SET,6,-0.16084,-0.0029055,0.33603,0.6839,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_7DY_DN,1
HP_NEOPLASM_OF_THE_PITUITARY...,SET,64,-0.047667,-0.0028079,0.09958,0.68391,HP_NEOPLASM_OF_THE_PITUITARY_GLAND,1
GOBP_SEROTONIN_TRANSPORT,SET,20,-0.10008,-0.0032996,0.20903,0.68395,GOBP_SEROTONIN_TRANSPORT,1
HP_HYPOCALCEMIC_TETANY,SET,7,-0.16351,-0.0031905,0.34146,0.68398,HP_HYPOCALCEMIC_TETANY,1
HP_INHERITANCE_QUALIFIER,SET,302,-0.024037,-0.0030558,0.050196,0.68398,HP_INHERITANCE_QUALIFIER,1
MIR184,SET,7,-0.14095,-0.0027503,0.29432,0.68399,MIR184,1
HP_URETEROCELE,SET,25,-0.084933,-0.0031303,0.17733,0.68401,HP_URETEROCELE,1
GSE22229_RENAL_TRANSPLANT_VS...1,SET,179,-0.030763,-0.0030211,0.064226,0.68402,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_DN,1
GSE2770_UNTREATED_VS_TGFB_AN...4,SET,175,-0.02963,-0.0028775,0.06185,0.68405,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
GOBP_SEQUESTERING_OF_IRON_ION,SET,5,-0.19799,-0.0032653,0.41315,0.68411,GOBP_SEQUESTERING_OF_IRON_ION,1
GSE24634_NAIVE_CD4_TCELL_VS_...5,SET,187,-0.027473,-0.0027571,0.057328,0.68411,GSE24634_NAIVE_CD4_TCELL_VS_DAY5_IL4_CONV_TREG_DN,1
HP_BLISTERING_BY_HISTOLOGICA...,SET,13,-0.10611,-0.0028211,0.22136,0.68415,HP_BLISTERING_BY_HISTOLOGICAL_LOCATION,1
HP_FLATTENED_FEMORAL_HEAD,SET,6,-0.14335,-0.0025897,0.29907,0.68415,HP_FLATTENED_FEMORAL_HEAD,1
REACTOME_ER_TO_GOLGI_ANTEROG...,SET,150,-0.03141,-0.002826,0.065525,0.68416,REACTOME_ER_TO_GOLGI_ANTEROGRADE_TRANSPORT,1
REACTOME_PRE_NOTCH_PROCESSIN...1,SET,18,-0.090377,-0.002827,0.18853,0.68416,REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI,1
MIR4708_3P,SET,91,-0.041714,-0.0029279,0.087005,0.68418,MIR4708_3P,1
GOBP_STARTLE_RESPONSE,SET,25,-0.081426,-0.0030011,0.16982,0.6842,GOBP_STARTLE_RESPONSE,1
DALESSIO_TSA_RESPONSE,SET,19,-0.10679,-0.0034319,0.22272,0.68421,DALESSIO_TSA_RESPONSE,1
HP_CLINODACTYLY_OF_THE_3RD_F...,SET,6,-0.18516,-0.0033449,0.38614,0.68421,HP_CLINODACTYLY_OF_THE_3RD_FINGER,1
GOBP_PROTEIN_K6_LINKED_UBIQU...,SET,15,-0.10119,-0.0028897,0.21096,0.68427,GOBP_PROTEIN_K6_LINKED_UBIQUITINATION,1
GOBP_SEQUESTERING_OF_BMP_IN_...,SET,4,-0.21119,-0.0031152,0.44019,0.6843,GOBP_SEQUESTERING_OF_BMP_IN_EXTRACELLULAR_MATRIX,1
REACTOME_REGULATION_OF_TP53_...2,SET,28,-0.073612,-0.002871,0.1534,0.68434,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ACETYLATION,1
GSE18791_CTRL_VS_NEWCASTLE_V...9,SET,162,-0.031834,-0.0029756,0.066325,0.68437,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_18H_DN,1
REACTOME_PLATELET_ADHESION_T...,SET,15,-0.11226,-0.0032057,0.23386,0.68439,REACTOME_PLATELET_ADHESION_TO_EXPOSED_COLLAGEN,1
KANG_CISPLATIN_RESISTANCE_DN,SET,8,-0.13744,-0.0028669,0.28629,0.68441,KANG_CISPLATIN_RESISTANCE_DN,1
BIOCARTA_MSP_PATHWAY,SET,6,-0.1663,-0.0030042,0.34638,0.68442,BIOCARTA_MSP_PATHWAY,1
MARTORIATI_MDM4_TARGETS_NEUR...2,SET,150,-0.033723,-0.0030341,0.070214,0.68448,MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP,1
MIR500B_5P,SET,51,-0.055315,-0.0029098,0.11515,0.68452,MIR500B_5P,1
REACTOME_P75_NTR_RECEPTOR_ME...,SET,87,-0.044092,-0.0030264,0.091779,0.68453,REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING,1
GOCC_APICAL_JUNCTION_COMPLEX,SET,130,-0.036024,-0.003019,0.074987,0.68453,GOCC_APICAL_JUNCTION_COMPLEX,1
GOMF_FIBRONECTIN_BINDING,SET,30,-0.082906,-0.0033468,0.17255,0.68455,GOMF_FIBRONECTIN_BINDING,1
KEGG_MEDICUS_REFERENCE_CCR5_...,SET,26,-0.079636,-0.0029932,0.16573,0.68457,KEGG_MEDICUS_REFERENCE_CCR5_GNB_G_PLCB_G_PKC_SIGNALING_PATHWAY,1
HP_ABNORMAL_BREATH_SOUND,SET,112,-0.038265,-0.002978,0.079619,0.68459,HP_ABNORMAL_BREATH_SOUND,1
GOBP_NEGATIVE_REGULATION_OF_...291,SET,10,-0.12645,-0.0029488,0.2631,0.6846,GOBP_NEGATIVE_REGULATION_OF_IMMUNOGLOBULIN_PRODUCTION,1
HOFMANN_CELL_LYMPHOMA_DN,SET,37,-0.063383,-0.002841,0.1318,0.6847,HOFMANN_CELL_LYMPHOMA_DN,1
HP_PARESTHESIA,SET,119,-0.036727,-0.0029457,0.076373,0.6847,HP_PARESTHESIA,1
WHITFIELD_CELL_CYCLE_S,SET,128,-0.034838,-0.0028972,0.072426,0.68474,WHITFIELD_CELL_CYCLE_S,1
MODULE_88,SET,765,-0.015569,-0.0031096,0.032366,0.68475,MODULE_88,1
MATZUK_EMBRYONIC_GERM_CELL,SET,18,-0.1062,-0.0033219,0.22075,0.68477,MATZUK_EMBRYONIC_GERM_CELL,1
GOBP_PEPTIDE_CATABOLIC_PROCE...,SET,19,-0.098761,-0.0031738,0.20524,0.68481,GOBP_PEPTIDE_CATABOLIC_PROCESS,1
GOCC_NEURONAL_RIBONUCLEOPROT...,SET,3,-0.2186,-0.0027927,0.45421,0.68484,GOCC_NEURONAL_RIBONUCLEOPROTEIN_GRANULE,1
GOBP_ACETATE_ESTER_METABOLIC...,SET,6,-0.17204,-0.0031079,0.35739,0.68487,GOBP_ACETATE_ESTER_METABOLIC_PROCESS,1
MODULE_501,SET,15,-0.10766,-0.0030745,0.22362,0.6849,MODULE_501,1
GOBP_LONG_CHAIN_FATTY_ACID_M...,SET,102,-0.041816,-0.0031065,0.086852,0.6849,GOBP_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
HP_ACROPARESTHESIA,SET,9,-0.14554,-0.0032199,0.30228,0.68491,HP_ACROPARESTHESIA,1
GOBP_GMP_BIOSYNTHETIC_PROCESS,SET,13,-0.11114,-0.0029549,0.23077,0.68495,GOBP_GMP_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_NUMBER_OF_VERTEB...,SET,3,-0.21656,-0.0027665,0.44963,0.68496,HP_ABNORMAL_NUMBER_OF_VERTEBRAE,1
HP_POLYMICROGYRIA,SET,179,-0.029503,-0.0028974,0.061242,0.685,HP_POLYMICROGYRIA,1
GSE6092_B_BURGDOFERI_VS_B_BU...1,SET,171,-0.031109,-0.0029867,0.064569,0.68502,GSE6092_B_BURGDOFERI_VS_B_BURGDORFERI_AND_IFNG_STIM_ENDOTHELIAL_CELL_DN,1
REACTOME_RAS_ACTIVATION_UPON...,SET,19,-0.096741,-0.0031089,0.20076,0.68505,REACTOME_RAS_ACTIVATION_UPON_CA2_INFLUX_THROUGH_NMDA_RECEPTOR,1
HP_OCULAR_ALBINISM,SET,27,-0.07958,-0.0030479,0.16514,0.68506,HP_OCULAR_ALBINISM,1
GOMF_TRANSCRIPTION_COREPRESS...1,SET,174,-0.030278,-0.0029321,0.062821,0.68508,GOMF_TRANSCRIPTION_COREPRESSOR_ACTIVITY,1
GCM_RAD21,SET,32,-0.064674,-0.0026963,0.13417,0.6851,GCM_RAD21,1
GAVISH_3CA_METAPROGRAM_CD8_T...10,SET,47,-0.064648,-0.003265,0.1341,0.68513,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_NAIVE_3,1
GSE36392_TYPE_2_MYELOID_VS_N...2,SET,182,-0.029527,-0.0029237,0.061246,0.68513,GSE36392_TYPE_2_MYELOID_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,1
MIR4517,SET,189,-0.030954,-0.0031228,0.064201,0.68514,MIR4517,1
MIR3681_3P,SET,357,-0.022112,-0.0030517,0.045856,0.68516,MIR3681_3P,1
GOBP_MAINTENANCE_OF_SISTER_C...,SET,8,-0.13383,-0.0027915,0.27753,0.68517,GOBP_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
MIR202_5P,SET,103,-0.039874,-0.0029766,0.082666,0.68522,MIR202_5P,1
GSE22033_UNTREATED_VS_ROSIGL...2,SET,182,-0.028407,-0.0028128,0.058885,0.68524,GSE22033_UNTREATED_VS_ROSIGLITAZONE_TREATED_MEF_UP,1
OZANNE_AP1_TARGETS_UP,SET,14,-0.10167,-0.0028051,0.21075,0.68525,OZANNE_AP1_TARGETS_UP,1
GSE39556_UNTREATED_VS_3H_POL...1,SET,184,-0.03084,-0.0030703,0.063924,0.68525,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN,1
GSE3982_MAST_CELL_VS_BASOPHI...2,SET,174,-0.031145,-0.003016,0.064555,0.68525,GSE3982_MAST_CELL_VS_BASOPHIL_UP,1
ANDERSEN_CHOLANGIOCARCINOMA_...2,SET,172,-0.03297,-0.0031745,0.068334,0.68526,ANDERSEN_CHOLANGIOCARCINOMA_CLASS2,1
GOMF_PHOSPHATASE_INHIBITOR_A...,SET,41,-0.060306,-0.0028451,0.12497,0.6853,GOMF_PHOSPHATASE_INHIBITOR_ACTIVITY,1
WCAANNNYCAG_UNKNOWN,SET,228,-0.027752,-0.0030718,0.0575,0.68532,WCAANNNYCAG_UNKNOWN,1
GSE41867_DAY6_EFFECTOR_VS_DA...3,SET,186,-0.029068,-0.0029094,0.060212,0.68536,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,1
REACTOME_BIOSYNTHESIS_OF_THE...,SET,72,-0.045365,-0.0028338,0.093968,0.68537,REACTOME_BIOSYNTHESIS_OF_THE_N_GLYCAN_PRECURSOR_DOLICHOL_LIPID_LINKED_OLIGOSACCHARIDE_LLO_AND_TRANSFER_TO_A_NASCENT_PROTEIN,1
HP_ABNORMAL_PATTERN_OF_RESPI...,SET,677,-0.015878,-0.0029907,0.03288,0.68541,HP_ABNORMAL_PATTERN_OF_RESPIRATION,1
HP_HYPERPIGMENTATION_IN_SUN_...,SET,7,-0.1237,-0.0024137,0.25611,0.68546,HP_HYPERPIGMENTATION_IN_SUN_EXPOSED_AREAS,1
HP_MIGRAINE_WITH_AURA,SET,12,-0.12989,-0.0033178,0.2689,0.68546,HP_MIGRAINE_WITH_AURA,1
GOBP_PYRIMIDINE_NUCLEOTIDE_B...,SET,28,-0.075472,-0.0029436,0.15621,0.6855,GOBP_PYRIMIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
ACEVEDO_LIVER_CANCER_WITH_H3...3,SET,82,-0.044454,-0.0029627,0.091942,0.68562,ACEVEDO_LIVER_CANCER_WITH_H3K9ME3_DN,1
MORF_TTN,SET,45,-0.061746,-0.0030516,0.12769,0.68565,MORF_TTN,1
GOBP_NEGATIVE_REGULATION_OF_...655,SET,377,-0.021438,-0.0030388,0.044331,0.68566,GOBP_NEGATIVE_REGULATION_OF_TRANSPORT,1
GOBP_REGULATION_OF_MORPHOGEN...1,SET,59,-0.056646,-0.0032043,0.11713,0.68567,GOBP_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GOBP_MESENCHYME_MORPHOGENESIS,SET,58,-0.060941,-0.003418,0.12601,0.68568,GOBP_MESENCHYME_MORPHOGENESIS,1
GSE41867_DAY6_VS_DAY8_LCMV_C...1,SET,183,-0.028441,-0.0028239,0.058795,0.68571,GSE41867_DAY6_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
REACTOME_DISEASES_OF_GLYCOSY...,SET,130,-0.036239,-0.003037,0.074899,0.68574,REACTOME_DISEASES_OF_GLYCOSYLATION,1
GOCC_CLOCK_BMAL_TRANSCRIPTIO...,SET,2,-0.39182,-0.0040872,0.80986,0.68574,GOCC_CLOCK_BMAL_TRANSCRIPTION_COMPLEX,1
GSE41176_UNSTIM_VS_ANTI_IGM_...11,SET,174,-0.031947,-0.0030937,0.066026,0.68575,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_DN,1
GOBP_REGULATION_OF_PHOSPHATE...,SET,7,-0.1626,-0.0031727,0.336,0.68578,GOBP_REGULATION_OF_PHOSPHATE_TRANSPORT,1
GSE46025_WT_VS_FOXO1_KO_KLRG...1,SET,161,-0.030982,-0.0028871,0.064013,0.68581,GSE46025_WT_VS_FOXO1_KO_KLRG1_LOW_CD8_EFFECTOR_TCELL_DN,1
HP_CONVEX_NASAL_RIDGE,SET,82,-0.04201,-0.0027998,0.086792,0.68582,HP_CONVEX_NASAL_RIDGE,1
GSE21927_BALBC_VS_C57BL6_MON...2,SET,153,-0.03333,-0.0030283,0.068851,0.68583,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_UP,1
GSE21678_WT_VS_FOXO1_FOXO3_K...2,SET,161,-0.033042,-0.003079,0.068253,0.68584,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_UP,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...5,SET,6,-0.17701,-0.0031978,0.36566,0.68584,CAO_BLOOD_FLUZONE_AGE_05_14YO_7DY_DN,1
CHIARADONNA_NEOPLASTIC_TRANS...2,SET,102,-0.042569,-0.0031624,0.087913,0.68588,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP,1
GOBP_PHAGOCYTOSIS,SET,221,-0.029126,-0.0031746,0.060148,0.68589,GOBP_PHAGOCYTOSIS,1
STEIN_ESTROGEN_RESPONSE_NOT_...,SET,17,-0.11208,-0.0034071,0.23144,0.6859,STEIN_ESTROGEN_RESPONSE_NOT_VIA_ESRRA,1
REACTOME_DEACTIVATION_OF_THE...,SET,38,-0.067469,-0.0030647,0.13927,0.68596,REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX,1
GOBP_CONVERGENT_EXTENSION_IN...2,SET,9,-0.12929,-0.0028604,0.26688,0.68597,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_GASTRULATION,1
HP_EPISODIC_HYPOKALEMIA,SET,4,-0.2328,-0.0034341,0.48036,0.68603,HP_EPISODIC_HYPOKALEMIA,1
HP_UPPER_LIMB_SPASTICITY,SET,22,-0.088035,-0.003044,0.1816,0.68607,HP_UPPER_LIMB_SPASTICITY,1
MIR4735_5P,SET,170,-0.031534,-0.0030188,0.065042,0.6861,MIR4735_5P,1
MORF_DCC,SET,99,-0.042633,-0.0031206,0.087929,0.68611,MORF_DCC,1
HP_KETOSIS,SET,60,-0.053927,-0.0030762,0.11122,0.68611,HP_KETOSIS,1
FOXN3_TARGET_GENES,SET,1155,-0.01279,-0.003104,0.026378,0.68612,FOXN3_TARGET_GENES,1
GSE15324_NAIVE_VS_ACTIVATED_...2,SET,171,-0.030042,-0.0028843,0.061958,0.68612,GSE15324_NAIVE_VS_ACTIVATED_CD8_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...451,SET,15,-0.10248,-0.0029265,0.21134,0.68613,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_PROTEIN_ECTODOMAIN_PROTEOLYSIS,1
GOUYER_TUMOR_INVASIVENESS,SET,8,-0.16846,-0.003514,0.34736,0.68616,GOUYER_TUMOR_INVASIVENESS,1
HP_INTRACEREBRAL_PERIVENTRIC...,SET,6,-0.1613,-0.002914,0.33242,0.68624,HP_INTRACEREBRAL_PERIVENTRICULAR_CALCIFICATIONS,1
REACTOME_CHROMATIN_MODIFYING...,SET,183,-0.028392,-0.0028189,0.058506,0.68626,REACTOME_CHROMATIN_MODIFYING_ENZYMES,1
HP_ABNORMAL_INTONATION,SET,59,-0.054962,-0.0031091,0.11324,0.68628,HP_ABNORMAL_INTONATION,1
GSE29618_PRE_VS_DAY7_POST_LA...5,SET,185,-0.029473,-0.0029421,0.060727,0.68628,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MONOCYTE_DN,1
GOBP_MATURATION_OF_5_8S_RRNA,SET,33,-0.061461,-0.002602,0.12661,0.68632,GOBP_MATURATION_OF_5_8S_RRNA,1
KIM_GERMINAL_CENTER_T_HELPER...1,SET,12,-0.13995,-0.0035749,0.28808,0.68645,KIM_GERMINAL_CENTER_T_HELPER_DN,1
REACTOME_COPI_INDEPENDENT_GO...,SET,50,-0.05857,-0.0030508,0.12055,0.68646,REACTOME_COPI_INDEPENDENT_GOLGI_TO_ER_RETROGRADE_TRAFFIC,1
HP_ABNORMAL_LIMB_EPIPHYSIS_M...,SET,120,-0.038113,-0.0030696,0.07837,0.68663,HP_ABNORMAL_LIMB_EPIPHYSIS_MORPHOLOGY,1
MIR8060,SET,91,-0.042509,-0.0029837,0.087375,0.6867,MIR8060,1
REACTOME_DEFECTIVE_CHST3_CAU...,SET,7,-0.17047,-0.0033262,0.35032,0.68673,REACTOME_DEFECTIVE_CHST3_CAUSES_SEDCJD,1
GOCC_TERMINAL_BOUTON,SET,43,-0.065878,-0.0031828,0.13536,0.68675,GOCC_TERMINAL_BOUTON,1
GSE37301_HEMATOPOIETIC_STEM_...10,SET,185,-0.03018,-0.0030127,0.062013,0.68675,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_MULTIPOTENT_PROGENITOR_UP,1
MANNO_MIDBRAIN_NEUROTYPES_HR...3,SET,385,-0.022458,-0.0032162,0.04614,0.68677,MANNO_MIDBRAIN_NEUROTYPES_HRGL2B,1
KEGG_ONE_CARBON_POOL_BY_FOLA...,SET,17,-0.085982,-0.0026138,0.17661,0.68681,KEGG_ONE_CARBON_POOL_BY_FOLATE,1
GSE29164_UNTREATED_VS_CD8_TC...5,SET,184,-0.03051,-0.0030374,0.062667,0.68682,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_DN,1
REACTOME_REGULATION_OF_SIGNA...1,SET,21,-0.096578,-0.0032627,0.19832,0.68686,REACTOME_REGULATION_OF_SIGNALING_BY_CBL,1
MODULE_350,SET,55,-0.053693,-0.0029328,0.11024,0.68688,MODULE_350,1
GOCC_INTRACELLULAR_PROTEIN_C...,SET,807,-0.014049,-0.0028786,0.028845,0.68689,GOCC_INTRACELLULAR_PROTEIN_CONTAINING_COMPLEX,1
HP_AMBLYOPIA,SET,99,-0.040276,-0.002948,0.082678,0.68692,HP_AMBLYOPIA,1
GOBP_LONG_CHAIN_FATTY_ACID_C...,SET,8,-0.14805,-0.0030882,0.30391,0.68693,GOBP_LONG_CHAIN_FATTY_ACID_CATABOLIC_PROCESS,1
GOBP_PERIPHERAL_NERVOUS_SYST...1,SET,28,-0.078754,-0.0030716,0.16163,0.68695,GOBP_PERIPHERAL_NERVOUS_SYSTEM_AXON_ENSHEATHMENT,1
GOBP_DOPAMINE_BIOSYNTHETIC_P...,SET,12,-0.12521,-0.0031984,0.25696,0.68697,GOBP_DOPAMINE_BIOSYNTHETIC_PROCESS,1
REACTOME_NEGATIVE_REGULATION...4,SET,27,-0.082013,-0.0031411,0.16828,0.687,REACTOME_NEGATIVE_REGULATION_OF_FGFR3_SIGNALING,1
GOMF_5_3_DNA_HELICASE_ACTIVI...,SET,8,-0.13609,-0.0028388,0.27924,0.687,GOMF_5_3_DNA_HELICASE_ACTIVITY,1
MODULE_357,SET,72,-0.051076,-0.0031906,0.10478,0.68702,MODULE_357,1
GOMF_CCR6_CHEMOKINE_RECEPTOR...,SET,5,-0.21593,-0.003561,0.44287,0.68707,GOMF_CCR6_CHEMOKINE_RECEPTOR_BINDING,1
MIR135A_3P,SET,33,-0.07325,-0.0031011,0.15022,0.68708,MIR135A_3P,1
GOBP_PEPTIDYL_CYSTEINE_MODIF...,SET,39,-0.066114,-0.0030423,0.13554,0.68715,GOBP_PEPTIDYL_CYSTEINE_MODIFICATION,1
GOBP_CARDIOCYTE_DIFFERENTIAT...,SET,142,-0.035787,-0.0031335,0.073355,0.68717,GOBP_CARDIOCYTE_DIFFERENTIATION,1
AIZARANI_LIVER_C12_NK_NKT_CE...,SET,43,-0.067102,-0.0032419,0.13754,0.68717,AIZARANI_LIVER_C12_NK_NKT_CELLS_4,1
HP_ABNORMAL_URINE_CHLORIDE_C...,SET,5,-0.21353,-0.0035215,0.43761,0.6872,HP_ABNORMAL_URINE_CHLORIDE_CONCENTRATION,1
HP_AORTIC_VALVE_STENOSIS,SET,51,-0.059273,-0.003118,0.12145,0.68724,HP_AORTIC_VALVE_STENOSIS,1
HP_REDUCED_CIRCULATING_CH50_...,SET,4,-0.19769,-0.0029162,0.40506,0.68724,HP_REDUCED_CIRCULATING_CH50_ACTIVITY,1
GOBP_PYRIMIDINE_CONTAINING_C...1,SET,37,-0.067064,-0.003006,0.13737,0.6873,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...694,SET,16,-0.10865,-0.0032043,0.22246,0.68736,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_PERMEABILITY,1
GSE22611_NOD2_VS_CTRL_TRANSD...1,SET,185,-0.029668,-0.0029615,0.060746,0.68736,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_DN,1
CRX_NRL_DN.V1_UP,SET,131,-0.036594,-0.0030784,0.074922,0.68737,CRX_NRL_DN.V1_UP,1
HP_INTERMITTENT_JAUNDICE,SET,9,-0.14185,-0.0031383,0.29041,0.68738,HP_INTERMITTENT_JAUNDICE,1
GOBP_MAINTENANCE_OF_PROTEIN_...7,SET,24,-0.080311,-0.0029002,0.16432,0.68749,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_NUCLEUS,1
GSE19401_RETINOIC_ACID_VS_RE...1,SET,187,-0.02819,-0.002829,0.057674,0.6875,GSE19401_RETINOIC_ACID_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
GSE13547_CTRL_VS_ANTI_IGM_ST...1,SET,151,-0.03335,-0.0030104,0.068219,0.68753,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_12H_DN,1
HP_LARGE_FORAMEN_MAGNUM,SET,5,-0.17749,-0.0029271,0.36294,0.68758,HP_LARGE_FORAMEN_MAGNUM,1
REACTOME_REGULATION_OF_TP53_...3,SET,14,-0.10842,-0.0029911,0.22161,0.68766,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_ASSOCIATION_WITH_CO_FACTORS,1
GOMF_QUATERNARY_AMMONIUM_GRO...2,SET,13,-0.13177,-0.0035032,0.26926,0.6877,GOMF_QUATERNARY_AMMONIUM_GROUP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE3982_EOSINOPHIL_VS_TH1_DN,SET,179,-0.029359,-0.0028832,0.059997,0.6877,GSE3982_EOSINOPHIL_VS_TH1_DN,1
GOCC_NUCLEAR_INCLUSION_BODY,SET,11,-0.10044,-0.0024565,0.20523,0.68772,GOCC_NUCLEAR_INCLUSION_BODY,1
GOBP_REGULATION_OF_RIG_I_SIG...,SET,17,-0.09401,-0.0028578,0.19196,0.68783,GOBP_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,1
GUTIERREZ_WALDENSTROEMS_MACR...2,SET,10,-0.14318,-0.0033389,0.29226,0.68789,GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_UP,1
HP_EEG_WITH_PHOTOPAROXYSMAL_...,SET,15,-0.10948,-0.0031264,0.22341,0.68795,HP_EEG_WITH_PHOTOPAROXYSMAL_RESPONSE,1
GSE4590_PRE_BCELL_VS_VPREB_P...2,SET,140,-0.035377,-0.0030759,0.072184,0.68796,GSE4590_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP,1
MIR6829_5P,SET,89,-0.043694,-0.0030332,0.089074,0.68812,MIR6829_5P,1
HP_CRUMPLED_LONG_BONES,SET,6,-0.15477,-0.002796,0.31553,0.68812,HP_CRUMPLED_LONG_BONES,1
GOBP_REGULATION_OF_PHAGOCYTO...,SET,90,-0.047867,-0.0033414,0.097575,0.68813,GOBP_REGULATION_OF_PHAGOCYTOSIS,1
GOBP_TRIPARTITE_REGIONAL_SUB...,SET,17,-0.10053,-0.003056,0.2049,0.68815,GOBP_TRIPARTITE_REGIONAL_SUBDIVISION,1
TRAVAGLINI_LUNG_AIRWAY_SMOOT...,SET,157,-0.033965,-0.0031258,0.069198,0.68823,TRAVAGLINI_LUNG_AIRWAY_SMOOTH_MUSCLE_CELL,1
WP_TNFALPHA_SIGNALING,SET,89,-0.041711,-0.0028955,0.084973,0.68824,WP_TNFALPHA_SIGNALING,1
GSE7218_UNSTIM_VS_ANTIGEN_ST...1,SET,156,-0.035246,-0.0032334,0.071785,0.68828,GSE7218_UNSTIM_VS_ANTIGEN_STIM_THROUGH_IGG_BCELL_DN,1
REACTOME_RIPK1_MEDIATED_REGU...,SET,28,-0.074043,-0.0028878,0.15074,0.68835,REACTOME_RIPK1_MEDIATED_REGULATED_NECROSIS,1
GSE15330_MEGAKARYOCYTE_ERYTH...5,SET,178,-0.028986,-0.0028388,0.059006,0.68837,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_UP,1
GATA1_01,SET,216,-0.028579,-0.0030799,0.058173,0.68838,GATA1_01,1
HP_SOMNAMBULISM,SET,7,-0.16218,-0.0031645,0.32994,0.68848,HP_SOMNAMBULISM,1
GOMF_CARBOHYDRATE_DERIVATIVE...,SET,54,-0.05949,-0.0032199,0.12101,0.6885,GOMF_CARBOHYDRATE_DERIVATIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR4752,SET,74,-0.048181,-0.0030511,0.097973,0.68856,MIR4752,1
GOCC_CYTOPLASMIC_EXOSOME_RNA...,SET,15,-0.085897,-0.0024529,0.17464,0.68858,GOCC_CYTOPLASMIC_EXOSOME_RNASE_COMPLEX,1
MARSHALL_VIRAL_INFECTION_RES...2,SET,9,-0.15409,-0.0034089,0.31312,0.68868,MARSHALL_VIRAL_INFECTION_RESPONSE_UP,1
GOBP_SCHWANN_CELL_PROLIFERAT...,SET,9,-0.11633,-0.0025736,0.23635,0.6887,GOBP_SCHWANN_CELL_PROLIFERATION,1
HP_SHORT_FOURTH_METATARSAL,SET,15,-0.10457,-0.0029862,0.21245,0.68871,HP_SHORT_FOURTH_METATARSAL,1
BERENJENO_TRANSFORMED_BY_RHO...1,SET,354,-0.022198,-0.003051,0.045093,0.68874,BERENJENO_TRANSFORMED_BY_RHOA_DN,1
MIR302D_5P,SET,183,-0.030816,-0.0030596,0.062591,0.68876,MIR302D_5P,1
MIR125A_3P,SET,68,-0.049743,-0.0030201,0.10102,0.68879,MIR125A_3P,1
CROONQUIST_NRAS_SIGNALING_UP,SET,32,-0.079325,-0.0033071,0.16108,0.6888,CROONQUIST_NRAS_SIGNALING_UP,1
REACTOME_ASSOCIATION_OF_TRIC...,SET,36,-0.06253,-0.0027647,0.12695,0.68883,REACTOME_ASSOCIATION_OF_TRIC_CCT_WITH_TARGET_PROTEINS_DURING_BIOSYNTHESIS,1
GOBP_EXIT_FROM_MITOSIS,SET,29,-0.071205,-0.0028262,0.14449,0.68892,GOBP_EXIT_FROM_MITOSIS,1
GOBP_FC_RECEPTOR_MEDIATED_ST...,SET,30,-0.081065,-0.0032725,0.1645,0.68892,GOBP_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,1
MODULE_375,SET,85,-0.049101,-0.0033314,0.099631,0.68893,MODULE_375,1
GOBP_RETINAL_CELL_APOPTOTIC_...,SET,6,-0.17355,-0.0031352,0.35205,0.68898,GOBP_RETINAL_CELL_APOPTOTIC_PROCESS,1
GSE16522_ANTI_CD3CD28_STIM_V...4,SET,174,-0.03085,-0.0029875,0.062575,0.689,GSE16522_ANTI_CD3CD28_STIM_VS_UNSTIM_NAIVE_CD8_TCELL_UP,1
RYTTCCTG_ETS2_B,SET,1009,-0.013728,-0.003127,0.027836,0.68905,RYTTCCTG_ETS2_B,1
WP_PROTEASOME_DEGRADATION,SET,56,-0.050949,-0.0028081,0.10326,0.68914,WP_PROTEASOME_DEGRADATION,1
HP_ABNORMAL_CELLULAR_PHENOTY...,SET,573,-0.016835,-0.0029259,0.034111,0.68918,HP_ABNORMAL_CELLULAR_PHENOTYPE,1
HP_AXONAL_DEGENERATION,SET,20,-0.088758,-0.0029263,0.17978,0.68924,HP_AXONAL_DEGENERATION,1
GOBP_GLYCEROL_3_PHOSPHATE_ME...,SET,7,-0.17856,-0.003484,0.36153,0.6893,GOBP_GLYCEROL_3_PHOSPHATE_METABOLIC_PROCESS,1
GTATGAT_MIR154_MIR487,SET,64,-0.053748,-0.0031662,0.1088,0.68934,GTATGAT_MIR154_MIR487,1
GOBP_ACTION_POTENTIAL,SET,158,-0.036416,-0.0033619,0.073701,0.68938,GOBP_ACTION_POTENTIAL,1
KEGG_MEDICUS_VARIANT_OLIGOME...,SET,13,-0.10607,-0.0028199,0.21463,0.68941,KEGG_MEDICUS_VARIANT_OLIGOMERIC_CONFORMATION_PRPC_TO_ANTEROGRADE_AXONAL_TRANSPORT,1
GOBP_DNA_REPLICATION_INITIAT...,SET,35,-0.065216,-0.0028432,0.13195,0.68943,GOBP_DNA_REPLICATION_INITIATION,1
HP_CARDIAC_SHUNT,SET,14,-0.12238,-0.0033764,0.24757,0.68946,HP_CARDIAC_SHUNT,1
GOBP_CELLULAR_RESPONSE_TO_PR...3,SET,20,-0.10551,-0.0034787,0.21342,0.68948,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_STIMULUS,1
GSE360_T_GONDII_VS_M_TUBERCU...2,SET,178,-0.031717,-0.0031062,0.064146,0.6895,GSE360_T_GONDII_VS_M_TUBERCULOSIS_DC_UP,1
HP_ONYCHOLYSIS,SET,20,-0.092441,-0.0030478,0.18692,0.68953,HP_ONYCHOLYSIS,1
HP_BLOCK_VERTEBRAE,SET,5,-0.19625,-0.0032364,0.3968,0.68954,HP_BLOCK_VERTEBRAE,1
ACACTAC_MIR1423P,SET,118,-0.038835,-0.0031017,0.078515,0.68956,ACACTAC_MIR1423P,1
AP1_Q2,SET,242,-0.02723,-0.003104,0.055045,0.68959,AP1_Q2,1
HP_BRONCHOMALACIA,SET,23,-0.078537,-0.0027765,0.15871,0.68964,HP_BRONCHOMALACIA,1
HP_ABNORMAL_CIRCULATING_PORP...,SET,8,-0.14478,-0.0030199,0.29245,0.68972,HP_ABNORMAL_CIRCULATING_PORPHYRIN_CONCENTRATION,1
MIR17_5P,SET,580,-0.017711,-0.0030963,0.035755,0.68982,MIR17_5P,1
BENPORATH_PRC2_TARGETS,SET,575,-0.020129,-0.0035042,0.040632,0.68983,BENPORATH_PRC2_TARGETS,1
KARLSSON_TGFB1_TARGETS_DN,SET,175,-0.031617,-0.0030705,0.063824,0.68983,KARLSSON_TGFB1_TARGETS_DN,1
GSE2405_0H_VS_6H_A_PHAGOCYTO...1,SET,170,-0.032995,-0.0031586,0.066593,0.68986,GSE2405_0H_VS_6H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
HP_HYPOCALCIURIA,SET,9,-0.1596,-0.003531,0.32211,0.68987,HP_HYPOCALCIURIA,1
SUZUKI_CTCFL_TARGETS_UP,SET,11,-0.12592,-0.0030796,0.2541,0.68989,SUZUKI_CTCFL_TARGETS_UP,1
GOBP_CARBOHYDRATE_DERIVATIVE...2,SET,249,-0.026926,-0.0031127,0.054336,0.68989,GOBP_CARBOHYDRATE_DERIVATIVE_CATABOLIC_PROCESS,1
GSE17721_CPG_VS_GARDIQUIMOD_...5,SET,181,-0.030659,-0.0030275,0.061849,0.68995,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_DN,1
WP_HOSTPATHOGEN_INTERACTION_...2,SET,18,-0.10023,-0.0031353,0.20217,0.68998,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_AUTOPHAGY,1
MIR4749_3P,SET,49,-0.057772,-0.002979,0.1165,0.69001,MIR4749_3P,1
HP_AVASCULAR_NECROSIS_OF_THE...,SET,29,-0.07626,-0.0030269,0.15367,0.69014,HP_AVASCULAR_NECROSIS_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,1
ZNF436_TARGET_GENES,SET,409,-0.020979,-0.0030946,0.04226,0.6902,ZNF436_TARGET_GENES,1
GSE41176_WT_VS_TAK1_KO_ANTI_...3,SET,170,-0.032518,-0.0031129,0.065469,0.69029,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN,1
GOBP_NEGATIVE_REGULATION_OF_...463,SET,14,-0.13373,-0.0036896,0.26923,0.6903,GOBP_NEGATIVE_REGULATION_OF_OLIGODENDROCYTE_DIFFERENTIATION,1
FIGUEROA_AML_METHYLATION_CLU...10,SET,12,-0.11728,-0.0029957,0.23606,0.69033,FIGUEROA_AML_METHYLATION_CLUSTER_5_UP,1
GOBP_POSITIVE_REGULATION_OF_...776,SET,4,-0.24164,-0.0035645,0.48638,0.69034,GOBP_POSITIVE_REGULATION_OF_TRANSFORMING_GROWTH_FACTOR_BETA1_PRODUCTION,1
GSE27786_CD4_TCELL_VS_NEUTRO...2,SET,178,-0.030489,-0.0029859,0.061367,0.69034,GSE27786_CD4_TCELL_VS_NEUTROPHIL_UP,1
WANG_SMARCE1_TARGETS_UP,SET,259,-0.02855,-0.0033652,0.057449,0.69039,WANG_SMARCE1_TARGETS_UP,1
RICKMAN_TUMOR_DIFFERENTIATED...1,SET,15,-0.11234,-0.0032079,0.22599,0.69043,RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN,1
HP_ABNORMAL_ENDOMETRIUM_MORP...,SET,28,-0.069736,-0.0027198,0.14028,0.69045,HP_ABNORMAL_ENDOMETRIUM_MORPHOLOGY,1
GOBP_REGULATION_OF_INCLUSION...,SET,17,-0.10368,-0.0031517,0.20853,0.69047,GOBP_REGULATION_OF_INCLUSION_BODY_ASSEMBLY,1
MZF1_TARGET_GENES,SET,1377,-0.011724,-0.0030864,0.023578,0.69048,MZF1_TARGET_GENES,1
KEGG_MEDICUS_VARIANT_MUTATIO...27,SET,11,-0.12465,-0.0030485,0.25056,0.69057,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
HP_ABNORMAL_RESPIRATORY_MOTI...,SET,29,-0.073756,-0.0029275,0.14826,0.69058,HP_ABNORMAL_RESPIRATORY_MOTILE_CILIUM_PHYSIOLOGY,1
HP_DYSPHAGIA,SET,466,-0.019571,-0.0030766,0.039338,0.69058,HP_DYSPHAGIA,1
MIR4669,SET,10,-0.12085,-0.0028183,0.2429,0.6906,MIR4669,1
GOBP_ACTIVIN_RECEPTOR_SIGNAL...,SET,44,-0.067903,-0.0033184,0.13645,0.69063,GOBP_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,1
HEBERT_MATRISOME_TNBC_BONE_M...2,SET,4,-0.22627,-0.0033378,0.4546,0.69067,HEBERT_MATRISOME_TNBC_BONE_METASTASIS_TUMOR_CELL_DERIVED,1
WANG_LSD1_TARGETS_DN,SET,34,-0.076733,-0.0032973,0.15416,0.69067,WANG_LSD1_TARGETS_DN,1
GOBP_MITOCHONDRION_ENDOPLASM...,SET,7,-0.15084,-0.0029432,0.30303,0.69067,GOBP_MITOCHONDRION_ENDOPLASMIC_RETICULUM_MEMBRANE_TETHERING,1
MIR504_3P,SET,130,-0.034547,-0.0028952,0.069396,0.69069,MIR504_3P,1
HP_SEVERE_INTRAUTERINE_GROWT...,SET,13,-0.12894,-0.0034281,0.25901,0.69069,HP_SEVERE_INTRAUTERINE_GROWTH_RETARDATION,1
REACTOME_TGFBR3_EXPRESSION,SET,25,-0.090268,-0.003327,0.18129,0.69072,REACTOME_TGFBR3_EXPRESSION,1
TTCCGTT_MIR191,SET,28,-0.074657,-0.0029118,0.14995,0.69072,TTCCGTT_MIR191,1
GOBP_RESPONSE_TO_GONADOTROPIN,SET,27,-0.090108,-0.0034512,0.18089,0.6908,GOBP_RESPONSE_TO_GONADOTROPIN,1
GOBP_CELL_DIFFERENTIATION_IN...2,SET,53,-0.06524,-0.0034984,0.13096,0.69081,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GSE42088_UNINF_VS_LEISHMANIA...7,SET,169,-0.032937,-0.0031438,0.066111,0.69083,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_DN,1
GSE27859_CD11C_INT_F480_HI_M...2,SET,159,-0.032417,-0.0030021,0.065049,0.69088,GSE27859_CD11C_INT_F480_HI_MACROPHAGE_VS_CD11C_ING_F480_INT_DC_UP,1
MIR8080,SET,127,-0.037291,-0.0030891,0.074822,0.69089,MIR8080,1
HP_ABNORMALITY_OF_THE_NAIL,SET,449,-0.020169,-0.0031138,0.040458,0.69094,HP_ABNORMALITY_OF_THE_NAIL,1
REACTOME_TGF_BETA_RECEPTOR_S...2,SET,15,-0.11984,-0.0034222,0.24037,0.69095,REACTOME_TGF_BETA_RECEPTOR_SIGNALING_IN_EMT_EPITHELIAL_TO_MESENCHYMAL_TRANSITION,1
HP_ABNORMAL_LOWER_LIMB_METAP...,SET,20,-0.093702,-0.0030893,0.18795,0.69095,HP_ABNORMAL_LOWER_LIMB_METAPHYSIS_MORPHOLOGY,1
GOBP_PYRIDINE_NUCLEOTIDE_BIO...,SET,27,-0.082704,-0.0031676,0.16586,0.69098,GOBP_PYRIDINE_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...299,SET,9,-0.15774,-0.0034897,0.31623,0.69104,GOBP_NEGATIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
HP_BROAD_ALVEOLAR_RIDGES,SET,12,-0.12772,-0.0032625,0.256,0.69107,HP_BROAD_ALVEOLAR_RIDGES,1
HP_RENAL_ATROPHY,SET,7,-0.1566,-0.0030557,0.31386,0.69109,HP_RENAL_ATROPHY,1
MIR4330,SET,82,-0.045899,-0.003059,0.091945,0.69118,MIR4330,1
GOBP_CORTISOL_SECRETION,SET,5,-0.17744,-0.0029263,0.35531,0.69125,GOBP_CORTISOL_SECRETION,1
GARGALOVIC_RESPONSE_TO_OXIDI...13,SET,10,-0.14381,-0.0033537,0.28789,0.6913,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_MAGENTA_DN,1
GSE37533_PPARG1_FOXP3_VS_FOX...2,SET,188,-0.029427,-0.002961,0.058889,0.69136,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN,1
GOCC_STEREOCILIA_COUPLING_LI...,SET,7,-0.19497,-0.0038044,0.38998,0.69144,GOCC_STEREOCILIA_COUPLING_LINK,1
GSE39556_CD8A_DC_VS_NK_CELL_...3,SET,179,-0.029246,-0.0028721,0.058498,0.69144,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_UP,1
GOBP_QUATERNARY_AMMONIUM_GRO...,SET,16,-0.11911,-0.003513,0.23824,0.69145,GOBP_QUATERNARY_AMMONIUM_GROUP_TRANSPORT,1
HP_TYPE_E_BRACHYDACTYLY,SET,5,-0.20475,-0.0033767,0.40952,0.69145,HP_TYPE_E_BRACHYDACTYLY,1
GOBP_POSITIVE_REGULATION_OF_...440,SET,76,-0.050103,-0.0032152,0.1002,0.69147,GOBP_POSITIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,1
HP_MALE_HYPOGONADISM,SET,38,-0.069442,-0.0031543,0.13887,0.69147,HP_MALE_HYPOGONADISM,1
GOBP_REGULATION_OF_LUNG_BLOO...,SET,3,-0.25998,-0.0033213,0.51987,0.69149,GOBP_REGULATION_OF_LUNG_BLOOD_PRESSURE,1
GOMF_TITIN_BINDING,SET,13,-0.11108,-0.0029532,0.22207,0.69153,GOMF_TITIN_BINDING,1
MIR519A_2_5P_MIR520B_5P,SET,190,-0.029902,-0.0030245,0.059764,0.69158,MIR519A_2_5P_MIR520B_5P,1
KEGG_MEDICUS_REFERENCE_BASE_...3,SET,9,-0.12487,-0.0027626,0.2495,0.69162,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_NEIL_GLYCOSYLASE,1
GSE22033_WT_VS_PPARG_KO_MEF_...1,SET,180,-0.031939,-0.0031453,0.06382,0.69162,GSE22033_WT_VS_PPARG_KO_MEF_DN,1
GOBP_GROWTH,SET,819,-0.015475,-0.0031931,0.030919,0.69163,GOBP_GROWTH,1
GSE12839_CTRL_VS_IL12_TREATE...1,SET,111,-0.040119,-0.0031084,0.080148,0.69165,GSE12839_CTRL_VS_IL12_TREATED_PBMC_DN,1
GOBP_OTIC_VESICLE_FORMATION,SET,8,-0.14014,-0.0029231,0.27994,0.69167,GOBP_OTIC_VESICLE_FORMATION,1
MIR3187_3P,SET,63,-0.05177,-0.0030258,0.1034,0.6917,MIR3187_3P,1
HP_OPTIC_DISC_HYPOPLASIA,SET,16,-0.10351,-0.0030527,0.2067,0.69173,HP_OPTIC_DISC_HYPOPLASIA,1
GOBP_GRANULOCYTE_ACTIVATION,SET,45,-0.062826,-0.0031049,0.12544,0.69175,GOBP_GRANULOCYTE_ACTIVATION,1
GSE41176_UNSTIM_VS_ANTI_IGM_...13,SET,182,-0.031723,-0.0031412,0.063331,0.69178,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN,1
LOPEZ_EPITHELIOID_MESOTHELIO...,SET,15,-0.10577,-0.0030203,0.21108,0.69183,LOPEZ_EPITHELIOID_MESOTHELIOMA,1
GOBP_MESENCHYMAL_CELL_DEVELO...,SET,6,-0.2044,-0.0036926,0.40795,0.69183,GOBP_MESENCHYMAL_CELL_DEVELOPMENT,1
HP_NO_SOCIAL_INTERACTION,SET,5,-0.24239,-0.0039975,0.48334,0.69198,HP_NO_SOCIAL_INTERACTION,1
GOBP_DNA_REPLICATION,SET,260,-0.025181,-0.0029737,0.050204,0.69201,GOBP_DNA_REPLICATION,1
GOBP_PERICARDIUM_MORPHOGENES...,SET,8,-0.16878,-0.0035206,0.33648,0.69202,GOBP_PERICARDIUM_MORPHOGENESIS,1
MIR541_3P,SET,94,-0.043516,-0.0031041,0.086747,0.69204,MIR541_3P,1
REACTOME_POST_CHAPERONIN_TUB...,SET,21,-0.091257,-0.003083,0.1819,0.69205,REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,1
BRACHAT_RESPONSE_TO_CAMPTOTH...2,SET,19,-0.091697,-0.0029468,0.18273,0.6921,BRACHAT_RESPONSE_TO_CAMPTOTHECIN_UP,1
GOBP_CEREBRAL_CORTEX_GABAERG...2,SET,9,-0.16582,-0.0036686,0.33034,0.69216,GOBP_CEREBRAL_CORTEX_GABAERGIC_INTERNEURON_DIFFERENTIATION,1
GOBP_REGULATION_OF_MICROTUBU...8,SET,85,-0.043074,-0.0029225,0.085803,0.69217,GOBP_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
GOBP_L_LYSINE_TRANSMEMBRANE_...,SET,6,-0.19221,-0.0034723,0.38284,0.69219,GOBP_L_LYSINE_TRANSMEMBRANE_TRANSPORT,1
GOBP_ORNITHINE_TRANSPORT,SET,6,-0.19221,-0.0034723,0.38284,0.69219,GOBP_ORNITHINE_TRANSPORT,1
GOMF_L_LYSINE_TRANSMEMBRANE_...,SET,6,-0.19221,-0.0034723,0.38284,0.69219,GOMF_L_LYSINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...785,SET,773,-0.01586,-0.0031836,0.031588,0.6922,GOBP_POSITIVE_REGULATION_OF_TRANSPORT,1
GOBP_SMALL_NUCLEOLAR_RIBONUC...,SET,10,-0.12799,-0.0029846,0.25486,0.69223,GOBP_SMALL_NUCLEOLAR_RIBONUCLEOPROTEIN_COMPLEX_ASSEMBLY,1
HP_HYPOPLASTIC_HEART,SET,43,-0.067506,-0.0032614,0.13438,0.69228,HP_HYPOPLASTIC_HEART,1
GSE14699_NAIVE_VS_ACT_CD8_TC...2,SET,174,-0.03309,-0.0032044,0.065864,0.6923,GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP,1
GOBP_REGULATION_OF_CELL_MIGR...,SET,36,-0.073047,-0.0032297,0.14538,0.69232,GOBP_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
MIR6825_5P,SET,380,-0.022566,-0.003211,0.044909,0.69233,MIR6825_5P,1
GINESTIER_BREAST_CANCER_20Q1...2,SET,95,-0.043085,-0.0030896,0.085741,0.69234,GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_UP,1
MIR548AN,SET,438,-0.020691,-0.0031558,0.041169,0.69237,MIR548AN,1
MIR133A_5P,SET,122,-0.037475,-0.0030431,0.074546,0.69241,MIR133A_5P,1
MIR202_3P,SET,229,-0.028365,-0.0031464,0.056424,0.69241,MIR202_3P,1
HOEK_MYELOID_DENDRITIC_CELL_...6,SET,20,-0.10968,-0.0036161,0.21814,0.69244,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_7DY_UP,1
HP_DECREASED_DISTAL_SENSORY_...,SET,9,-0.15093,-0.003339,0.30016,0.69245,HP_DECREASED_DISTAL_SENSORY_NERVE_ACTION_POTENTIAL,1
ZSCAN26_TARGET_GENES,SET,4,-0.22316,-0.0032919,0.44345,0.6926,ZSCAN26_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...192,SET,155,-0.03826,-0.0034987,0.075996,0.69267,GOBP_POSITIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
GOBP_MICROTUBULE_BASED_TRANS...,SET,187,-0.030361,-0.0030469,0.060277,0.69276,GOBP_MICROTUBULE_BASED_TRANSPORT,1
HP_THYROTOXICOSIS_WITH_DIFFU...,SET,4,-0.24083,-0.0035524,0.47813,0.69276,HP_THYROTOXICOSIS_WITH_DIFFUSE_GOITER,1
VALK_AML_WITH_CEBPA,SET,31,-0.084833,-0.0034811,0.16841,0.69277,VALK_AML_WITH_CEBPA,1
HP_GENU_VALGUM,SET,139,-0.036453,-0.0031582,0.072362,0.69278,HP_GENU_VALGUM,1
GOCC_ARYL_HYDROCARBON_RECEPT...,SET,6,-0.14915,-0.0026944,0.29606,0.69279,GOCC_ARYL_HYDROCARBON_RECEPTOR_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...310,SET,35,-0.073927,-0.003223,0.14672,0.69282,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_PRODUCTION,1
GOMF_CYCLIN_DEPENDENT_PROTEI...3,SET,12,-0.13166,-0.0033632,0.26129,0.69283,GOMF_CYCLIN_DEPENDENT_PROTEIN_SERINE_THREONINE_KINASE_INHIBITOR_ACTIVITY,1
MODULE_189,SET,10,-0.11803,-0.0027525,0.23423,0.69284,MODULE_189,1
GSE7459_UNTREATED_VS_IL6_TRE...1,SET,125,-0.039338,-0.0032332,0.078053,0.69286,GSE7459_UNTREATED_VS_IL6_TREATED_ACT_CD4_TCELL_DN,1
HP_ABNORMAL_PULMONARY_VEIN_M...,SET,66,-0.050522,-0.0030221,0.10023,0.69288,HP_ABNORMAL_PULMONARY_VEIN_MORPHOLOGY,1
GOBP_PEPTIDYL_HISTIDINE_MODI...,SET,9,-0.11761,-0.002602,0.23329,0.69292,GOBP_PEPTIDYL_HISTIDINE_MODIFICATION,1
HP_MILIA,SET,16,-0.11052,-0.0032596,0.21922,0.69292,HP_MILIA,1
GOBP_VASCULOGENESIS,SET,79,-0.050076,-0.003276,0.099316,0.69294,GOBP_VASCULOGENESIS,1
GSE17301_ACD3_ACD28_VS_ACD3_...3,SET,183,-0.032826,-0.0032592,0.065078,0.69301,GSE17301_ACD3_ACD28_VS_ACD3_ACD28_AND_IFNA5_STIM_CD8_TCELL_DN,1
REACTOME_MEIOSIS,SET,56,-0.052572,-0.0028975,0.10422,0.69302,REACTOME_MEIOSIS,1
GOCC_COATED_VESICLE,SET,292,-0.025113,-0.0031402,0.049777,0.69305,GOCC_COATED_VESICLE,1
POU6F1_01,SET,211,-0.031443,-0.0033496,0.062319,0.69306,POU6F1_01,1
GSE3982_NKCELL_VS_TH2_UP,SET,171,-0.033101,-0.0031779,0.065572,0.69315,GSE3982_NKCELL_VS_TH2_UP,1
GSE5503_LIVER_DC_VS_PLN_DC_A...2,SET,184,-0.031098,-0.003096,0.061594,0.69318,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOMF_ORGANOPHOSPHATE_ESTER_T...,SET,35,-0.077657,-0.0033856,0.15379,0.6932,GOMF_ORGANOPHOSPHATE_ESTER_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_FLAVIN_ADENINE_DINUCLEO...,SET,81,-0.045981,-0.0030458,0.091054,0.69321,GOMF_FLAVIN_ADENINE_DINUCLEOTIDE_BINDING,1
HP_PARTIAL_ABSENCE_OF_THUMB,SET,9,-0.13712,-0.0030335,0.27148,0.69324,HP_PARTIAL_ABSENCE_OF_THUMB,1
GOBP_REGULATION_OF_GLOMERULA...,SET,9,-0.16581,-0.0036682,0.32825,0.69326,GOBP_REGULATION_OF_GLOMERULAR_FILTRATION,1
GOBP_INDOLE_CONTAINING_COMPO...2,SET,9,-0.16594,-0.0036711,0.3285,0.69327,GOBP_INDOLE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_PROTEIN_L...9,SET,12,-0.12542,-0.0032036,0.24816,0.69335,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
GOBP_REGULATION_OF_CELL_GROW...2,SET,14,-0.11598,-0.0031997,0.22946,0.69337,GOBP_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
GSE37605_TREG_VS_TCONV_C57BL...1,SET,158,-0.034613,-0.0031955,0.068484,0.69337,GSE37605_TREG_VS_TCONV_C57BL6_FOXP3_FUSION_GFP_DN,1
GOBP_NEGATIVE_REGULATION_OF_...288,SET,117,-0.04218,-0.0033547,0.083436,0.69341,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_EFFECTOR_PROCESS,1
HP_APLASIA_HYPOPLASIA_OF_THE...70,SET,127,-0.037776,-0.0031294,0.074696,0.69347,HP_APLASIA_HYPOPLASIA_OF_THE_THUMB,1
MIR7112_5P,SET,7,-0.14962,-0.0029194,0.29568,0.69357,MIR7112_5P,1
GSE12003_MIR223_KO_VS_WT_BM_...3,SET,125,-0.036415,-0.0029929,0.071962,0.69358,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_8D_CULTURE_DN,1
REACTOME_THE_ROLE_OF_NEF_IN_...,SET,27,-0.080176,-0.0030708,0.15843,0.69359,REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...202,SET,17,-0.10807,-0.0032852,0.21355,0.69359,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
GOBP_AUTONOMIC_NERVOUS_SYSTE...,SET,40,-0.072921,-0.0033982,0.14409,0.6936,GOBP_AUTONOMIC_NERVOUS_SYSTEM_DEVELOPMENT,1
HP_MYOCLONIC_SEIZURE,SET,210,-0.028786,-0.0030594,0.05687,0.69363,HP_MYOCLONIC_SEIZURE,1
WEST_ADRENOCORTICAL_TUMOR_MA...2,SET,22,-0.10114,-0.003497,0.1998,0.69364,WEST_ADRENOCORTICAL_TUMOR_MARKERS_UP,1
PLASARI_TGFB1_TARGETS_10HR_DN,SET,235,-0.03006,-0.0033773,0.059369,0.69368,PLASARI_TGFB1_TARGETS_10HR_DN,1
HP_LYMPHOCYTOSIS,SET,22,-0.090642,-0.0031341,0.17902,0.69368,HP_LYMPHOCYTOSIS,1
GOBP_POSITIVE_REGULATION_OF_...213,SET,4,-0.198,-0.0029207,0.39095,0.69373,GOBP_POSITIVE_REGULATION_OF_DNA_DAMAGE_CHECKPOINT,1
LINDGREN_BLADDER_CANCER_CLUS...4,SET,8,-0.1468,-0.0030622,0.28977,0.69379,LINDGREN_BLADDER_CANCER_CLUSTER_2A_UP,1
HP_ABNORMALITY_OF_THE_VESTIB...,SET,9,-0.15423,-0.0034121,0.30435,0.69383,HP_ABNORMALITY_OF_THE_VESTIBULOCOCHLEAR_NERVE,1
MIR5682,SET,205,-0.030686,-0.0032227,0.060542,0.69387,MIR5682,1
GOBP_ENDOMEMBRANE_SYSTEM_ORG...,SET,531,-0.018298,-0.0030649,0.0361,0.69387,GOBP_ENDOMEMBRANE_SYSTEM_ORGANIZATION,1
HP_PREGNANCY_EXPOSURE,SET,5,-0.19092,-0.0031487,0.37666,0.69388,HP_PREGNANCY_EXPOSURE,1
GNF2_MKI67,SET,27,-0.084538,-0.0032378,0.16673,0.69393,GNF2_MKI67,1
GOMF_PHOSPHATIDYLCHOLINE_FLI...,SET,5,-0.20187,-0.0033292,0.39761,0.69417,GOMF_PHOSPHATIDYLCHOLINE_FLIPPASE_ACTIVITY,1
HP_ABNORMAL_LUNG_DEVELOPMENT,SET,208,-0.029632,-0.0031345,0.058363,0.69417,HP_ABNORMAL_LUNG_DEVELOPMENT,1
HP_GENERALIZED_EDEMA,SET,24,-0.08195,-0.0029594,0.1614,0.69418,HP_GENERALIZED_EDEMA,1
REACTOME_FORMATION_OF_XYLULO...,SET,5,-0.19931,-0.003287,0.39243,0.69423,REACTOME_FORMATION_OF_XYLULOSE_5_PHOSPHATE,1
GOBP_GLUCURONATE_CATABOLIC_P...,SET,5,-0.19931,-0.003287,0.39243,0.69423,GOBP_GLUCURONATE_CATABOLIC_PROCESS_TO_XYLULOSE_5_PHOSPHATE,1
KEGG_MEDICUS_VARIANT_SCRAPIE...1,SET,35,-0.062301,-0.0027162,0.12265,0.69425,KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GSE10240_IL22_VS_IL17_STIM_P...2,SET,171,-0.031507,-0.0030249,0.062024,0.69427,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
HP_ANTERIOR_BEAKING_OF_LUMBA...,SET,5,-0.2011,-0.0033165,0.39575,0.69432,HP_ANTERIOR_BEAKING_OF_LUMBAR_VERTEBRAE,1
MIR6505_5P,SET,187,-0.031816,-0.0031929,0.062611,0.69433,MIR6505_5P,1
GOBP_AMYLOID_PRECURSOR_PROTE...1,SET,13,-0.11791,-0.0031348,0.23203,0.69433,GOBP_AMYLOID_PRECURSOR_PROTEIN_BIOSYNTHETIC_PROCESS,1
chr17q25,SET,176,-0.063643,-0.0061981,0.12522,0.69436,chr17q25,1
GOBP_REGULATION_OF_MICROTUBU...1,SET,47,-0.063537,-0.0032089,0.12501,0.69436,GOBP_REGULATION_OF_MICROTUBULE_BASED_MOVEMENT,1
HP_ABNORMALITY_OF_THE_KNEE,SET,371,-0.022795,-0.0032058,0.044846,0.69437,HP_ABNORMALITY_OF_THE_KNEE,1
HP_HYPOPIGMENTED_MACULE,SET,24,-0.082039,-0.0029627,0.16135,0.69443,HP_HYPOPIGMENTED_MACULE,1
GOMF_ALCOHOL_DEHYDROGENASE_N...1,SET,7,-0.27436,-0.0053533,0.53955,0.69444,GOMF_ALCOHOL_DEHYDROGENASE_NADPLUS_ACTIVITY_ZINC_DEPENDENT,1
WP_ARSENIC_METABOLISM_AND_RE...,SET,9,-0.14919,-0.0033007,0.29335,0.69447,WP_ARSENIC_METABOLISM_AND_REACTIVE_OXYGEN_SPECIES_GENERATION,1
GOBP_OSTEOBLAST_PROLIFERATION,SET,32,-0.079458,-0.0033126,0.15619,0.69453,GOBP_OSTEOBLAST_PROLIFERATION,1
TERAMOTO_OPN_TARGETS_CLUSTER...5,SET,25,-0.085425,-0.0031485,0.16791,0.69454,TERAMOTO_OPN_TARGETS_CLUSTER_6,1
HP_ABNORMAL_CIRCULATING_CALC...,SET,46,-0.062101,-0.0031029,0.12202,0.6946,HP_ABNORMAL_CIRCULATING_CALCIUM_PHOSPHATE_REGULATING_HORMONE_CONCENTRATION,1
GOCC_INNER_DYNEIN_ARM,SET,4,-0.15462,-0.0022808,0.30375,0.69463,GOCC_INNER_DYNEIN_ARM,1
GOBP_CD8_POSITIVE_ALPHA_BETA...2,SET,15,-0.11785,-0.0033654,0.23149,0.69466,GOBP_CD8_POSITIVE_ALPHA_BETA_T_CELL_DIFFERENTIATION,1
HP_URETHRAL_FISTULA,SET,4,-0.16668,-0.0024587,0.32731,0.6947,HP_URETHRAL_FISTULA,1
HP_URETHROVAGINAL_FISTULA,SET,4,-0.16668,-0.0024587,0.32731,0.6947,HP_URETHROVAGINAL_FISTULA,1
HP_IRIDODONESIS,SET,4,-0.24354,-0.0035925,0.47825,0.69471,HP_IRIDODONESIS,1
GOBP_POSITIVE_REGULATION_OF_...551,SET,6,-0.17682,-0.0031942,0.34719,0.69472,GOBP_POSITIVE_REGULATION_OF_NUCLEASE_ACTIVITY,1
MACAEVA_PBMC_RESPONSE_TO_IR,SET,90,-0.0441,-0.0030785,0.086555,0.6948,MACAEVA_PBMC_RESPONSE_TO_IR,1
GSE24634_TREG_VS_TCONV_POST_...5,SET,177,-0.033033,-0.003226,0.064814,0.69485,GSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN,1
GOBP_INTERLEUKIN_21_PRODUCTI...,SET,2,-0.33436,-0.0034877,0.65586,0.6949,GOBP_INTERLEUKIN_21_PRODUCTION,1
GOBP_POSITIVE_REGULATION_OF_...469,SET,4,-0.178,-0.0026257,0.34915,0.6949,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,1
GSE27786_BCELL_VS_NEUTROPHIL...2,SET,184,-0.029101,-0.0028971,0.057077,0.69492,GSE27786_BCELL_VS_NEUTROPHIL_UP,1
WP_SEROTONIN_AND_ANXIETY,SET,15,-0.11498,-0.0032834,0.2255,0.69493,WP_SEROTONIN_AND_ANXIETY,1
MIR3943,SET,39,-0.070565,-0.0032471,0.13839,0.69493,MIR3943,1
GOBP_POSITIVE_REGULATION_OF_...115,SET,20,-0.1012,-0.0033364,0.19839,0.695,GOBP_POSITIVE_REGULATION_OF_CELL_ADHESION_MEDIATED_BY_INTEGRIN,1
GOBP_REGULATION_OF_GAMMA_DEL...1,SET,11,-0.13307,-0.0032545,0.26084,0.69503,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,1
GOBP_NEGATIVE_REGULATION_OF_...232,SET,13,-0.12686,-0.0033727,0.2485,0.69514,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_OXIDATION,1
REACTOME_CA_DEPENDENT_EVENTS,SET,35,-0.07878,-0.0034346,0.15426,0.69522,REACTOME_CA_DEPENDENT_EVENTS,1
GOBP_PROTEIN_LOCALIZATION_TO...11,SET,36,-0.066356,-0.0029339,0.1299,0.69526,GOBP_PROTEIN_LOCALIZATION_TO_CHROMATIN,1
HP_RETINAL_TELANGIECTASIA,SET,14,-0.10621,-0.0029303,0.20784,0.69533,HP_RETINAL_TELANGIECTASIA,1
GSE7852_THYMUS_VS_FAT_TREG_DN,SET,178,-0.032281,-0.0031614,0.063161,0.69535,GSE7852_THYMUS_VS_FAT_TREG_DN,1
HP_HYPERNASAL_SPEECH,SET,88,-0.047379,-0.0032706,0.092688,0.69538,HP_HYPERNASAL_SPEECH,1
JINESH_BLEBBISHIELD_TRANSFOR...1,SET,248,-0.027112,-0.0031281,0.053035,0.6954,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_DN,1
HP_BRADYPHRENIA,SET,5,-0.17418,-0.0028725,0.3406,0.69545,HP_BRADYPHRENIA,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...6,SET,93,-0.040709,-0.0028885,0.079598,0.69547,GOMF_UBIQUITIN_LIKE_PROTEIN_PEPTIDASE_ACTIVITY,1
GOBP_MORPHOGENESIS_OF_AN_EPI...4,SET,472,-0.020677,-0.0032708,0.040428,0.69549,GOBP_MORPHOGENESIS_OF_AN_EPITHELIUM,1
GOCC_MHC_PROTEIN_COMPLEX,SET,21,-0.11121,-0.0037569,0.21733,0.69557,GOCC_MHC_PROTEIN_COMPLEX,1
GOBP_ORGAN_GROWTH,SET,151,-0.037219,-0.0033597,0.072725,0.69559,GOBP_ORGAN_GROWTH,1
chr16q23,SET,51,-0.098564,-0.0051849,0.19258,0.6956,chr16q23,1
GOMF_VASCULAR_ENDOTHELIAL_GR...3,SET,7,-0.18775,-0.0036634,0.36682,0.69561,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_ACTIVITY,1
GOBP_GASTRULATION,SET,177,-0.03273,-0.0031965,0.063944,0.69562,GOBP_GASTRULATION,1
GOBP_LIVER_MORPHOGENESIS,SET,25,-0.088042,-0.0032449,0.17201,0.69562,GOBP_LIVER_MORPHOGENESIS,1
GSE9960_HEALTHY_VS_GRAM_NEG_...1,SET,163,-0.032571,-0.0030537,0.063631,0.69562,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,1
HP_CONSPICUOUSLY_HAPPY_DISPO...,SET,5,-0.24708,-0.0040747,0.4827,0.69563,HP_CONSPICUOUSLY_HAPPY_DISPOSITION,1
MOTAMED_RESPONSE_TO_ANDROGEN...2,SET,4,-0.25619,-0.0037791,0.50041,0.69566,MOTAMED_RESPONSE_TO_ANDROGEN_UP,1
GSE26488_CTRL_VS_PEPTIDE_INJ...4,SET,148,-0.035467,-0.0031698,0.069273,0.69567,GSE26488_CTRL_VS_PEPTIDE_INJECTION_OT2_THYMOCYTE_UP,1
GSE12003_4D_VS_8D_CULTURE_MI...1,SET,153,-0.035347,-0.0032116,0.069031,0.69569,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_DN,1
GSE39820_CTRL_VS_TGFBETA1_IL...2,SET,181,-0.033017,-0.0032603,0.064479,0.69569,GSE39820_CTRL_VS_TGFBETA1_IL6_CD4_TCELL_UP,1
GSE46242_CTRL_VS_EGR2_DELETE...1,SET,168,-0.034529,-0.0032861,0.067428,0.6957,GSE46242_CTRL_VS_EGR2_DELETED_ANERGIC_TH1_CD4_TCELL_DN,1
GOBP_REGULATION_OF_TELOMERE_...1,SET,26,-0.078614,-0.0029548,0.1535,0.69573,GOBP_REGULATION_OF_TELOMERE_CAPPING,1
HP_ABNORMALITY_OF_THE_PROXIM...2,SET,7,-0.15546,-0.0030334,0.30346,0.69577,HP_ABNORMALITY_OF_THE_PROXIMAL_PHALANX_OF_THE_THUMB,1
GSE43863_NAIVE_VS_MEMORY_LY6...1,SET,184,-0.030351,-0.0030216,0.059221,0.69585,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_DN,1
KEGG_MEDICUS_REFERENCE_TRANS...4,SET,5,-0.20099,-0.0033147,0.39215,0.69586,KEGG_MEDICUS_REFERENCE_TRANSPORT_OF_CALCIUM,1
HP_JERKY_HEAD_MOVEMENTS,SET,11,-0.14497,-0.0035455,0.28271,0.69594,HP_JERKY_HEAD_MOVEMENTS,1
CHARAFE_BREAST_CANCER_LUMINA...2,SET,341,-0.023743,-0.003204,0.046293,0.69598,CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_UP,1
GOMF_METHYLATION_DEPENDENT_P...,SET,66,-0.04901,-0.0029317,0.095501,0.69609,GOMF_METHYLATION_DEPENDENT_PROTEIN_BINDING,1
KEGG_MEDICUS_VARIANT_MUTATIO...54,SET,14,-0.11565,-0.0031906,0.22526,0.69616,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GOBP_LEUKOTRIENE_B4_METABOLI...,SET,5,-0.19416,-0.0032021,0.37814,0.69618,GOBP_LEUKOTRIENE_B4_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...613,SET,11,-0.13081,-0.0031992,0.25475,0.69619,GOBP_NEGATIVE_REGULATION_OF_STEROL_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...793,SET,104,-0.044275,-0.0033211,0.086218,0.69621,GOBP_POSITIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_SUPERFAMILY_CYTOKINE_PRODUCTION,1
REACTOME_CLASS_I_MHC_MEDIATE...,SET,353,-0.022509,-0.0030894,0.043801,0.69633,REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION,1
REACTOME_SUMOYLATION_OF_UBIQ...,SET,37,-0.067966,-0.0030465,0.13226,0.69633,REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS,1
GSE20366_EX_VIVO_VS_HOMEOSTA...2,SET,180,-0.030729,-0.0030261,0.059796,0.69634,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...692,SET,5,-0.22265,-0.0036718,0.43322,0.69635,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_CELL_PROLIFERATION,1
GOMF_PHOSPHOTRANSFERASE_ACTI...2,SET,7,-0.15153,-0.0029567,0.2948,0.69638,GOMF_PHOSPHOTRANSFERASE_ACTIVITY_NITROGENOUS_GROUP_AS_ACCEPTOR,1
KEGG_MEDICUS_VARIANT_MUTATIO...46,SET,7,-0.19535,-0.0038117,0.3799,0.69645,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_REST_MEDIATED_TRANSCRIPTIONAL_REPRESSION,1
KEGG_MEDICUS_REFERENCE_TELOM...1,SET,3,-0.18928,-0.002418,0.36805,0.69646,KEGG_MEDICUS_REFERENCE_TELOMERASE_RNA_MATURATION,1
WP_SARSCOV2_INNATE_IMMUNITY_...,SET,62,-0.056327,-0.003266,0.10952,0.69648,WP_SARSCOV2_INNATE_IMMUNITY_EVASION_AND_CELLSPECIFIC_IMMUNE_RESPONSE,1
HP_ABNORMALLY_LOW_T_CELL_REC...,SET,6,-0.1982,-0.0035806,0.38531,0.69651,HP_ABNORMALLY_LOW_T_CELL_RECEPTOR_EXCISION_CIRCLE_LEVEL,1
HP_VISUALLY_INDUCED_SEIZURE,SET,15,-0.11995,-0.0034253,0.23311,0.69656,HP_VISUALLY_INDUCED_SEIZURE,1
GSE21927_SPLEEN_C57BL6_VS_EL...1,SET,184,-0.029694,-0.0029562,0.057712,0.69656,GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_DN,1
GOBP_NEGATIVE_REGULATION_OF_...522,SET,4,-0.22322,-0.0032927,0.4338,0.69657,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_K63_LINKED_UBIQUITINATION,1
HP_COMMUNICATING_HYDROCEPHAL...,SET,21,-0.090375,-0.0030532,0.17564,0.69657,HP_COMMUNICATING_HYDROCEPHALUS,1
MODULE_281,SET,28,-0.076732,-0.0029927,0.14911,0.69658,MODULE_281,1
MIR3649,SET,18,-0.1072,-0.0033532,0.2083,0.6966,MIR3649,1
GSE16450_IMMATURE_VS_MATURE_...1,SET,180,-0.031553,-0.0031073,0.061286,0.69667,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_DN,1
GOBP_REGULATION_OF_GLUCOCORT...1,SET,9,-0.16054,-0.0035518,0.3118,0.69668,GOBP_REGULATION_OF_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,1
GSE360_CTRL_VS_T_GONDII_DC_UP,SET,179,-0.033038,-0.0032446,0.064142,0.69675,GSE360_CTRL_VS_T_GONDII_DC_UP,1
MIR4713_3P,SET,37,-0.073436,-0.0032916,0.14255,0.69678,MIR4713_3P,1
GOBP_PURINE_RIBONUCLEOSIDE_M...,SET,19,-0.11571,-0.0037185,0.2246,0.69679,GOBP_PURINE_RIBONUCLEOSIDE_METABOLIC_PROCESS,1
HP_CURLY_HAIR,SET,30,-0.07473,-0.0030168,0.14503,0.69682,HP_CURLY_HAIR,1
JOHANSSON_GLIOMAGENESIS_BY_P...1,SET,21,-0.097097,-0.0032802,0.18839,0.69686,JOHANSSON_GLIOMAGENESIS_BY_PDGFB_DN,1
ELLWOOD_MYC_TARGETS_UP,SET,13,-0.12547,-0.0033358,0.24333,0.69695,ELLWOOD_MYC_TARGETS_UP,1
ZNF577_TARGET_GENES,SET,381,-0.022436,-0.0031967,0.043497,0.697,ZNF577_TARGET_GENES,1
MIR6504_5P,SET,128,-0.03803,-0.0031627,0.073699,0.69707,MIR6504_5P,1
MIR30C_2_3P,SET,117,-0.042455,-0.0033766,0.08225,0.69713,MIR30C_2_3P,1
MODULE_146,SET,96,-0.04777,-0.0034435,0.092549,0.69713,MODULE_146,1
MODULE_164,SET,58,-0.059389,-0.003331,0.11505,0.69714,MODULE_164,1
HP_HYPOCHOLESTEROLEMIA,SET,17,-0.10277,-0.0031241,0.19909,0.69714,HP_HYPOCHOLESTEROLEMIA,1
GSE23114_WT_VS_SLE2C1_MOUSE_...2,SET,169,-0.032667,-0.0031181,0.063269,0.69718,GSE23114_WT_VS_SLE2C1_MOUSE_PERITONEAL_CAVITY_B1A_BCELL_UP,1
HAHTOLA_SEZARY_SYNDROM_UP,SET,83,-0.048558,-0.0032558,0.094038,0.6972,HAHTOLA_SEZARY_SYNDROM_UP,1
MIKKELSEN_NPC_LCP_WITH_H3K4M...,SET,55,-0.057649,-0.0031489,0.11162,0.69723,MIKKELSEN_NPC_LCP_WITH_H3K4ME3,1
GSE17974_2.5H_VS_72H_IL4_AND...1,SET,177,-0.031734,-0.0030992,0.06136,0.69748,GSE17974_2.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,1
MAYBURD_RESPONSE_TO_L663536_...2,SET,22,-0.092173,-0.0031871,0.17821,0.69749,MAYBURD_RESPONSE_TO_L663536_UP,1
PARK_TRETINOIN_RESPONSE,SET,11,-0.14691,-0.0035931,0.28405,0.69749,PARK_TRETINOIN_RESPONSE,1
GOBP_POSTSYNAPTIC_CYTOSKELET...,SET,17,-0.11517,-0.0035012,0.22267,0.6975,GOBP_POSTSYNAPTIC_CYTOSKELETON_ORGANIZATION,1
GSE27859_MACROPHAGE_VS_CD11C...2,SET,159,-0.03321,-0.0030756,0.064202,0.69752,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_UP,1
GSE22886_NAIVE_VS_IGG_IGA_ME...1,SET,173,-0.034086,-0.0032914,0.065876,0.69757,GSE22886_NAIVE_VS_IGG_IGA_MEMORY_BCELL_DN,1
BIOCARTA_G1_PATHWAY,SET,28,-0.085205,-0.0033232,0.16464,0.6976,BIOCARTA_G1_PATHWAY,1
GOCC_MHC_CLASS_II_PROTEIN_CO...,SET,13,-0.14989,-0.003985,0.28955,0.69765,GOCC_MHC_CLASS_II_PROTEIN_COMPLEX,1
MIR29B_1_5P,SET,155,-0.035205,-0.0032194,0.068002,0.69767,MIR29B_1_5P,1
GSE17721_POLYIC_VS_CPG_2H_BM...2,SET,182,-0.031355,-0.0031047,0.060557,0.69769,GSE17721_POLYIC_VS_CPG_2H_BMDC_UP,1
REACTOME_COMPLEX_IV_ASSEMBLY,SET,41,-0.057921,-0.0027326,0.11186,0.6977,REACTOME_COMPLEX_IV_ASSEMBLY,1
GOBP_REGULATION_OF_HYDROLASE...,SET,643,-0.018463,-0.0033924,0.035656,0.6977,GOBP_REGULATION_OF_HYDROLASE_ACTIVITY,1
MIR4324,SET,238,-0.028812,-0.0032574,0.055634,0.69772,MIR4324,1
GOCC_POSTSYNAPTIC_ENDOSOME,SET,13,-0.1138,-0.0030255,0.21968,0.69777,GOCC_POSTSYNAPTIC_ENDOSOME,1
GOBP_POSITIVE_REGULATION_OF_...491,SET,98,-0.043836,-0.0031924,0.084612,0.6978,GOBP_POSITIVE_REGULATION_OF_MRNA_CATABOLIC_PROCESS,1
HP_FEBRILE_SEIZURE_WITHIN_TH...,SET,123,-0.039733,-0.0032396,0.076692,0.6978,HP_FEBRILE_SEIZURE_WITHIN_THE_AGE_RANGE_OF_3_MONTHS_TO_6_YEARS,1
SUBTIL_PROGESTIN_TARGETS,SET,31,-0.078328,-0.0032142,0.15117,0.69782,SUBTIL_PROGESTIN_TARGETS,1
DESCARTES_FETAL_KIDNEY_METAN...,SET,110,-0.045677,-0.0035232,0.088152,0.69783,DESCARTES_FETAL_KIDNEY_METANEPHRIC_CELLS,1
GOBP_REGULATION_OF_DELAYED_R...,SET,15,-0.12309,-0.0035152,0.23753,0.69784,GOBP_REGULATION_OF_DELAYED_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...662,SET,66,-0.057212,-0.0034223,0.1104,0.69785,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
GOCC_U2_SNRNP,SET,22,-0.082254,-0.0028441,0.15872,0.69785,GOCC_U2_SNRNP,1
GOBP_NON_PROTEINOGENIC_AMINO...2,SET,14,-0.12617,-0.0034808,0.24343,0.69786,GOBP_NON_PROTEINOGENIC_AMINO_ACID_CATABOLIC_PROCESS,1
REACTOME_TP53_REGULATES_TRAN...5,SET,12,-0.13128,-0.0033535,0.25328,0.69788,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_DEATH_RECEPTORS_AND_LIGANDS,1
GOBP_FOREBRAIN_REGIONALIZATI...,SET,23,-0.1068,-0.0037759,0.20606,0.69788,GOBP_FOREBRAIN_REGIONALIZATION,1
HP_NAIL_DYSTROPHY,SET,125,-0.039932,-0.003282,0.077038,0.69789,HP_NAIL_DYSTROPHY,1
MODULE_402,SET,12,-0.13712,-0.0035027,0.26451,0.69791,MODULE_402,1
GOBP_UNSATURATED_FATTY_ACID_...1,SET,45,-0.06619,-0.0032712,0.12767,0.69792,GOBP_UNSATURATED_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
GSE9037_CTRL_VS_LPS_4H_STIM_...1,SET,183,-0.030749,-0.0030529,0.059299,0.69795,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN,1
HP_LOWER_LIMB_SPASTICITY,SET,189,-0.030653,-0.0030925,0.059108,0.69798,HP_LOWER_LIMB_SPASTICITY,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...7,SET,15,-0.10993,-0.0031391,0.21193,0.69801,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
GOMF_COENZYME_A_DIPHOSPHATAS...,SET,5,-0.19425,-0.0032036,0.37438,0.69807,GOMF_COENZYME_A_DIPHOSPHATASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...44,SET,5,-0.16021,-0.0026422,0.30871,0.69811,HP_APLASIA_HYPOPLASIA_OF_THE_MUSCULATURE_OF_THE_PELVIS,1
MIR4295,SET,353,-0.023639,-0.0032445,0.045547,0.69812,MIR4295,1
KEGG_DRUG_METABOLISM_CYTOCHR...,SET,65,-0.071087,-0.00422,0.13696,0.69813,KEGG_DRUG_METABOLISM_CYTOCHROME_P450,1
MIR6808_5P,SET,164,-0.034514,-0.0032457,0.066492,0.69814,MIR6808_5P,1
MIR3680_3P,SET,491,-0.021312,-0.0034365,0.041055,0.69815,MIR3680_3P,1
NABA_BASEMENT_MEMBRANES,SET,37,-0.078166,-0.0035036,0.15055,0.69818,NABA_BASEMENT_MEMBRANES,1
WP_MODULATION_OF_PI3KAKTMTOR...,SET,14,-0.12823,-0.0035377,0.24692,0.69822,WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS,1
GSE37533_UNTREATED_VS_PIOGLI...5,SET,144,-0.034882,-0.0030755,0.06717,0.69823,GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG2_AND_FOXP3_TRASDUCED_DN,1
HP_ABNORMAL_CIRCULATING_FREE...1,SET,9,-0.13746,-0.0030411,0.26449,0.69837,HP_ABNORMAL_CIRCULATING_FREE_FATTY_ACID_CONCENTRATION,1
GSE11961_FOLLICULAR_BCELL_VS...8,SET,180,-0.032697,-0.0032199,0.062899,0.69841,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY40_UP,1
chr4q21,SET,60,-0.10501,-0.00599,0.20198,0.69843,chr4q21,1
KEGG_MEDICUS_REFERENCE_COHES...4,SET,6,-0.19587,-0.0035384,0.37671,0.69845,KEGG_MEDICUS_REFERENCE_COHESIN_LOADING,1
BIOCARTA_HSWI_SNF_PATHWAY,SET,12,-0.12443,-0.0031785,0.23923,0.69851,BIOCARTA_HSWI_SNF_PATHWAY,1
GAVISH_3CA_METAPROGRAM_ENDOT...1,SET,45,-0.067114,-0.0033169,0.12898,0.69858,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_CELL_CYCLE,1
WP_SECRETION_OF_HYDROCHLORIC...,SET,5,-0.21572,-0.0035575,0.41447,0.69862,WP_SECRETION_OF_HYDROCHLORIC_ACID_IN_PARIETAL_CELLS,1
HP_ABNORMAL_MACROSCOPIC_URIN...,SET,47,-0.063457,-0.0032049,0.12188,0.6987,HP_ABNORMAL_MACROSCOPIC_URINE_APPEARANCE,1
GOBP_REGULATION_OF_SMOOTH_MU...2,SET,34,-0.0745,-0.0032014,0.14307,0.69871,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
GOCC_DNA_REPLICATION_FACTOR_...1,SET,12,-0.11728,-0.0029959,0.22525,0.69871,GOCC_DNA_REPLICATION_FACTOR_A_COMPLEX,1
HP_ABNORMAL_CIRCULATING_INTE...1,SET,23,-0.095612,-0.0033802,0.18361,0.69872,HP_ABNORMAL_CIRCULATING_INTERFERON_CONCENTRATION,1
HP_ABNORMAL_DENTAL_PULP_MORP...,SET,50,-0.061676,-0.0032125,0.11842,0.69875,HP_ABNORMAL_DENTAL_PULP_MORPHOLOGY,1
MIR4291,SET,351,-0.023275,-0.0031856,0.044682,0.69878,MIR4291,1
HP_INCREASED_MUSCLE_GLYCOGEN...,SET,8,-0.13776,-0.0028735,0.26444,0.6988,HP_INCREASED_MUSCLE_GLYCOGEN_CONTENT,1
GSE11864_UNTREATED_VS_CSF1_I...5,SET,164,-0.033226,-0.0031246,0.063762,0.69885,GSE11864_UNTREATED_VS_CSF1_IN_MAC_DN,1
MIR2114_3P,SET,40,-0.068797,-0.003206,0.13202,0.69886,MIR2114_3P,1
WP_INSULIN_SIGNALING_IN_ADIP...1,SET,8,-0.16411,-0.0034232,0.31486,0.69889,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_DIABETIC_CONDITION,1
WP_INSULIN_SIGNALING_IN_ADIP...2,SET,8,-0.16411,-0.0034232,0.31486,0.69889,WP_INSULIN_SIGNALING_IN_ADIPOCYTES_NORMAL_CONDITION,1
GARGALOVIC_RESPONSE_TO_OXIDI...9,SET,71,-0.055644,-0.0034518,0.10669,0.69901,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_DN,1
HP_CONGENITAL_GIANT_MELANOCY...,SET,5,-0.18035,-0.0029742,0.34579,0.69901,HP_CONGENITAL_GIANT_MELANOCYTIC_NEVUS,1
GOMF_TRANSCRIPTION_REGULATOR...3,SET,26,-0.091965,-0.0034565,0.17629,0.69905,GOMF_TRANSCRIPTION_REGULATOR_INHIBITOR_ACTIVITY,1
GOMF_ATPASE_COUPLED_MONOATOM...,SET,49,-0.063189,-0.0032583,0.12111,0.69907,GOMF_ATPASE_COUPLED_MONOATOMIC_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_MITOCHONDRIAL_RESPIRASO...,SET,7,-0.14132,-0.0027574,0.27082,0.6991,GOBP_MITOCHONDRIAL_RESPIRASOME_ASSEMBLY,1
DESCARTES_FETAL_INTESTINE_ST...,SET,33,-0.084314,-0.0035695,0.16152,0.69916,DESCARTES_FETAL_INTESTINE_STROMAL_CELLS,1
GSE11057_NAIVE_CD4_VS_PBMC_C...1,SET,186,-0.031993,-0.0032021,0.061285,0.69917,GSE11057_NAIVE_CD4_VS_PBMC_CD4_TCELL_DN,1
DESCARTES_FETAL_LUNG_CSH1_CS...,SET,180,-0.03248,-0.0031986,0.062213,0.69919,DESCARTES_FETAL_LUNG_CSH1_CSH2_POSITIVE_CELLS,1
HP_HORIZONTAL_EYEBROW,SET,32,-0.078347,-0.0032663,0.15,0.69927,HP_HORIZONTAL_EYEBROW,1
DESERT_PERIVENOUS_HEPATOCELL...,SET,144,-0.037204,-0.0032803,0.07122,0.6993,DESERT_PERIVENOUS_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
GSE22432_CONVENTIONAL_CDC_VS...1,SET,185,-0.03142,-0.0031364,0.060144,0.6993,GSE22432_CONVENTIONAL_CDC_VS_PLASMACYTOID_PDC_DN,1
HP_BILATERAL_TONIC_CLONIC_SE...3,SET,41,-0.074087,-0.0034953,0.14181,0.69932,HP_BILATERAL_TONIC_CLONIC_SEIZURE_WITH_GENERALIZED_ONSET,1
SENESE_HDAC2_TARGETS_UP,SET,106,-0.041491,-0.0031419,0.079387,0.69939,SENESE_HDAC2_TARGETS_UP,1
GOBP_ARTERY_DEVELOPMENT,SET,100,-0.046914,-0.0034511,0.089755,0.6994,GOBP_ARTERY_DEVELOPMENT,1
GOBP_PARAXIAL_MESODERM_MORPH...,SET,9,-0.16586,-0.0036694,0.31729,0.69942,GOBP_PARAXIAL_MESODERM_MORPHOGENESIS,1
MIR132_5P,SET,8,-0.15708,-0.0032764,0.30046,0.69944,MIR132_5P,1
AP4_Q5,SET,235,-0.028657,-0.0032196,0.054803,0.69948,AP4_Q5,1
PID_PI3KCI_AKT_PATHWAY,SET,34,-0.071257,-0.003062,0.13625,0.69951,PID_PI3KCI_AKT_PATHWAY,1
MIR365A_5P,SET,30,-0.083095,-0.0033544,0.15885,0.69954,MIR365A_5P,1
GOBP_RESPONSE_TO_FRUCTOSE,SET,10,-0.12247,-0.0028558,0.23406,0.69958,GOBP_RESPONSE_TO_FRUCTOSE,1
BENPORATH_CYCLING_GENES,SET,589,-0.017705,-0.0031182,0.033838,0.69959,BENPORATH_CYCLING_GENES,1
TRAVAGLINI_LUNG_VEIN_CELL,SET,37,-0.07812,-0.0035016,0.14929,0.6996,TRAVAGLINI_LUNG_VEIN_CELL,1
GOBP_HIPPO_SIGNALING,SET,53,-0.066222,-0.003551,0.12649,0.6997,GOBP_HIPPO_SIGNALING,1
GOBP_U4_SNRNA_3_END_PROCESSI...,SET,7,-0.13763,-0.0026855,0.26287,0.69971,GOBP_U4_SNRNA_3_END_PROCESSING,1
MORF_MYST2,SET,60,-0.051412,-0.0029327,0.098162,0.69977,MORF_MYST2,1
REACTOME_SIGNALING_BY_WNT_IN...,SET,32,-0.079756,-0.0033251,0.15227,0.69978,REACTOME_SIGNALING_BY_WNT_IN_CANCER,1
GOMF_DNA_POLYMERASE_ACTIVITY,SET,27,-0.0683,-0.0026159,0.13036,0.69983,GOMF_DNA_POLYMERASE_ACTIVITY,1
MIR6515_5P,SET,79,-0.04862,-0.0031808,0.09279,0.69985,MIR6515_5P,1
GOCC_CYTOCHROME_COMPLEX,SET,34,-0.068907,-0.002961,0.1315,0.69986,GOCC_CYTOCHROME_COMPLEX,1
JONES_TCOF1_TARGETS,SET,5,-0.19454,-0.0032083,0.37117,0.6999,JONES_TCOF1_TARGETS,1
KEGG_MEDICUS_REFERENCE_BASE_...2,SET,8,-0.14528,-0.0030303,0.27718,0.6999,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_MONOFUNCTIONAL_GLYCOSYLASE,1
GOBP_POSITIVE_REGULATION_OF_...641,SET,1112,-0.013708,-0.0032683,0.02615,0.69993,GOBP_POSITIVE_REGULATION_OF_PROTEIN_METABOLIC_PROCESS,1
GSE36888_UNTREATED_VS_IL2_TR...10,SET,177,-0.032613,-0.003185,0.062208,0.69994,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_2H_UP,1
RODRIGUES_THYROID_CARCINOMA_...2,SET,636,-0.017755,-0.0032451,0.03385,0.70003,RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_EAR...2,SET,498,-0.019643,-0.0031893,0.037449,0.70004,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_STALK_CELL,1
HP_ORTHOKERATOSIS,SET,18,-0.10469,-0.0032748,0.19957,0.70007,HP_ORTHOKERATOSIS,1
GOMF_TOLL_LIKE_RECEPTOR_4_BI...,SET,5,-0.17539,-0.0028925,0.33422,0.70013,GOMF_TOLL_LIKE_RECEPTOR_4_BINDING,1
HP_ABNORMAL_INFERIOR_VENA_CA...,SET,42,-0.063422,-0.0030284,0.12085,0.70014,HP_ABNORMAL_INFERIOR_VENA_CAVA_MORPHOLOGY,1
HEBERT_MATRISOME_TNBC_BONE_M...1,SET,10,-0.15252,-0.0035568,0.2906,0.70015,HEBERT_MATRISOME_TNBC_BONE_METASTASIS,1
GOBP_POSITIVE_REGULATION_OF_...2,SET,11,-0.13406,-0.0032788,0.25543,0.70015,GOBP_POSITIVE_REGULATION_OF_ACROSOME_REACTION,1
GOBP_THROMBIN_ACTIVATED_RECE...,SET,13,-0.13752,-0.0036561,0.26202,0.70015,GOBP_THROMBIN_ACTIVATED_RECEPTOR_SIGNALING_PATHWAY,1
GSE19825_IL2RALOW_VS_IL2RAHI...1,SET,182,-0.031746,-0.0031434,0.06046,0.70023,GSE19825_IL2RALOW_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN,1
GINESTIER_BREAST_CANCER_ZNF2...1,SET,304,-0.02372,-0.0030253,0.045172,0.70024,GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN,1
REACTOME_HCMV_EARLY_EVENTS,SET,68,-0.05406,-0.0032822,0.10295,0.70025,REACTOME_HCMV_EARLY_EVENTS,1
GSE20727_ROS_INH_VS_ROS_INH_...2,SET,177,-0.033207,-0.0032431,0.063216,0.70031,GSE20727_ROS_INH_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,1
HP_THICKENED_SKIN,SET,381,-0.023074,-0.0032876,0.04392,0.70033,HP_THICKENED_SKIN,1
GOBP_CENTRIOLE_CENTRIOLE_COH...,SET,14,-0.1233,-0.0034017,0.23467,0.70034,GOBP_CENTRIOLE_CENTRIOLE_COHESION,1
HE_LIM_SUN_FETAL_LUNG_C0_MES...1,SET,264,-0.028767,-0.0034229,0.054735,0.7004,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_1_CELL,1
ELVIDGE_HIF1A_AND_HIF2A_TARG...2,SET,37,-0.06887,-0.003087,0.131,0.70046,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_UP,1
HP_DISTAL_SYMPHALANGISM,SET,6,-0.18218,-0.0032911,0.34651,0.70047,HP_DISTAL_SYMPHALANGISM,1
FOXR2_TARGET_GENES,SET,168,-0.034013,-0.003237,0.064685,0.70049,FOXR2_TARGET_GENES,1
WP_MITOCHONDRIAL_FATTY_ACID_...1,SET,18,-0.10117,-0.0031647,0.19241,0.7005,WP_MITOCHONDRIAL_FATTY_ACID_OXIDATION_DISORDERS,1
HP_ABNORMAL_CLITORIS_MORPHOL...,SET,81,-0.049825,-0.0033004,0.09475,0.7005,HP_ABNORMAL_CLITORIS_MORPHOLOGY,1
TOMIDA_METASTASIS_UP,SET,23,-0.092348,-0.0032648,0.17558,0.70054,TOMIDA_METASTASIS_UP,1
ODONNELL_TFRC_TARGETS_DN,SET,116,-0.038282,-0.0030317,0.072774,0.70057,ODONNELL_TFRC_TARGETS_DN,1
MIR4766_3P,SET,151,-0.038855,-0.0035073,0.073861,0.70057,MIR4766_3P,1
HP_PHALANGEAL_DISLOCATION,SET,7,-0.18929,-0.0036934,0.35972,0.70062,HP_PHALANGEAL_DISLOCATION,1
WOO_LIVER_CANCER_RECURRENCE_...2,SET,97,-0.046275,-0.0033529,0.08794,0.70063,WOO_LIVER_CANCER_RECURRENCE_UP,1
GSE2770_UNTREATED_VS_ACT_CD4...3,SET,164,-0.035302,-0.0033198,0.066997,0.70087,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_48H_DN,1
REACTOME_PLATELET_SENSITIZAT...,SET,16,-0.1095,-0.0032295,0.20774,0.70094,REACTOME_PLATELET_SENSITIZATION_BY_LDL,1
GOBP_PROTEIN_MODIFICATION_BY...2,SET,91,-0.043174,-0.0030304,0.081907,0.70094,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_REMOVAL,1
MIR1257,SET,88,-0.0479,-0.0033066,0.090861,0.70096,MIR1257,1
GOMF_OXIDOREDUCTASE_ACTIVITY...8,SET,5,-0.17741,-0.0029257,0.33648,0.70098,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_CH_OR_CH2_GROUPS_DISULFIDE_AS_ACCEPTOR,1
HP_LONG_THORAX,SET,6,-0.17868,-0.0032278,0.33886,0.701,HP_LONG_THORAX,1
GOMF_TOLL_LIKE_RECEPTOR_BIND...,SET,14,-0.12457,-0.0034368,0.23621,0.70103,GOMF_TOLL_LIKE_RECEPTOR_BINDING,1
FRANCO_BLOOD_SANOFI_PASTEUR_...2,SET,19,-0.10397,-0.0033411,0.19711,0.70106,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_0DY_POSITIVE,1
GSE40274_EOS_VS_FOXP3_AND_EO...1,SET,108,-0.044684,-0.0034152,0.084698,0.7011,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...631,SET,18,-0.10001,-0.0031283,0.18951,0.70115,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
MIR7849_3P,SET,105,-0.045136,-0.0034018,0.085522,0.70117,MIR7849_3P,1
BENPORATH_SOX2_TARGETS,SET,663,-0.017754,-0.0033106,0.033616,0.70129,BENPORATH_SOX2_TARGETS,1
GOBP_REGULATION_OF_SYNAPSE_S...1,SET,7,-0.16576,-0.0032343,0.31382,0.70131,GOBP_REGULATION_OF_SYNAPSE_STRUCTURAL_PLASTICITY,1
GOCC_INTEGRIN_COMPLEX,SET,29,-0.088859,-0.0035269,0.1682,0.70135,GOCC_INTEGRIN_COMPLEX,1
GOBP_CONVERGENT_EXTENSION_IN...1,SET,5,-0.2312,-0.0038129,0.43758,0.70137,GOBP_CONVERGENT_EXTENSION_INVOLVED_IN_AXIS_ELONGATION,1
HP_DECREASED_ACTIVITY_OF_MIT...4,SET,41,-0.06235,-0.0029416,0.11798,0.70141,HP_DECREASED_ACTIVITY_OF_MITOCHONDRIAL_COMPLEX_III,1
GTTATAT_MIR410,SET,80,-0.050602,-0.0033312,0.09573,0.70145,GTTATAT_MIR410,1
REACTOME_MISMATCH_REPAIR,SET,15,-0.096569,-0.0027577,0.18266,0.70149,REACTOME_MISMATCH_REPAIR,1
HP_DIABETIC_KETOACIDOSIS,SET,19,-0.11346,-0.0036461,0.21459,0.7015,HP_DIABETIC_KETOACIDOSIS,1
MIR198,SET,76,-0.054746,-0.0035132,0.10353,0.70151,MIR198,1
chr2q31,SET,73,-0.10046,-0.0063187,0.18995,0.70155,chr2q31,1
GOBP_RENAL_FILTRATION,SET,27,-0.094726,-0.003628,0.17911,0.70155,GOBP_RENAL_FILTRATION,1
GOBP_POSITIVE_REGULATION_OF_...220,SET,118,-0.041681,-0.003329,0.078793,0.70159,GOBP_POSITIVE_REGULATION_OF_DNA_REPAIR,1
GOMF_COMPLEMENT_RECEPTOR_ACT...,SET,10,-0.18263,-0.0042588,0.34519,0.70161,GOMF_COMPLEMENT_RECEPTOR_ACTIVITY,1
GSE40274_CTRL_VS_FOXP3_AND_I...2,SET,146,-0.037403,-0.0033204,0.070696,0.70162,GSE40274_CTRL_VS_FOXP3_AND_IRF4_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_MONOCYTE_AGGREGATION,SET,5,-0.24104,-0.0039751,0.45548,0.70166,GOBP_MONOCYTE_AGGREGATION,1
HP_SHORT_PHALANX_OF_THE_THUMB,SET,29,-0.088997,-0.0035324,0.16816,0.70167,HP_SHORT_PHALANX_OF_THE_THUMB,1
HP_WIDELY_SPACED_MAXILLARY_C...,SET,9,-0.13702,-0.0030314,0.25887,0.70171,HP_WIDELY_SPACED_MAXILLARY_CENTRAL_INCISORS,1
MIR3085_3P,SET,132,-0.038355,-0.0032388,0.07244,0.70176,MIR3085_3P,1
P53_DN.V2_UP,SET,133,-0.041602,-0.0035262,0.078573,0.70176,P53_DN.V2_UP,1
MIR320A_5P,SET,98,-0.046069,-0.0033551,0.086999,0.70178,MIR320A_5P,1
GOCC_FEMALE_PRONUCLEUS,SET,8,-0.14393,-0.0030022,0.27177,0.7018,GOCC_FEMALE_PRONUCLEUS,1
GAVISH_3CA_METAPROGRAM_FIBRO...1,SET,47,-0.073069,-0.0036903,0.13793,0.70185,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1,1
GSE42724_MEMORY_VS_B1_BCELL_...1,SET,169,-0.034962,-0.0033372,0.065998,0.70185,GSE42724_MEMORY_VS_B1_BCELL_DN,1
KEGG_MEDICUS_ENV_FACTOR_TCDD...,SET,19,-0.12318,-0.0039584,0.2325,0.70187,KEGG_MEDICUS_ENV_FACTOR_TCDD_TO_AHR_SIGNALING_PATHWAY,1
HP_HYPERPIGMENTED_HYPOPIGMEN...,SET,5,-0.20925,-0.0034509,0.39485,0.70192,HP_HYPERPIGMENTED_HYPOPIGMENTED_MACULES,1
JACKSON_DNMT1_TARGETS_DN,SET,20,-0.11037,-0.003639,0.20826,0.70193,JACKSON_DNMT1_TARGETS_DN,1
GOBP_DEFINITIVE_HEMOPOIESIS,SET,18,-0.12293,-0.0038451,0.23194,0.70194,GOBP_DEFINITIVE_HEMOPOIESIS,1
HP_SMALL_INTESTINAL_STENOSIS,SET,27,-0.077929,-0.0029847,0.14703,0.70194,HP_SMALL_INTESTINAL_STENOSIS,1
HE_LIM_SUN_FETAL_LUNG_C7_FGF...,SET,45,-0.065866,-0.0032552,0.12425,0.70197,HE_LIM_SUN_FETAL_LUNG_C7_FGFBP2_POS_NEURAL_PROGENITOR_CELL,1
GOBP_DIPEPTIDE_TRANSMEMBRANE...,SET,8,-0.15601,-0.0032541,0.29428,0.70199,GOBP_DIPEPTIDE_TRANSMEMBRANE_TRANSPORT,1
MIR7107_3P,SET,49,-0.06577,-0.0033914,0.12401,0.70206,MIR7107_3P,1
REACTOME_MEMBRANE_TRAFFICKING,SET,596,-0.018042,-0.0031958,0.034017,0.70207,REACTOME_MEMBRANE_TRAFFICKING,1
GSE29617_CTRL_VS_DAY3_TIV_FL...1,SET,178,-0.032042,-0.0031381,0.060411,0.70208,GSE29617_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_2008_DN,1
MORF_CNTN1,SET,91,-0.045339,-0.0031824,0.085467,0.70211,MORF_CNTN1,1
MIR4317,SET,88,-0.047283,-0.003264,0.089116,0.70214,MIR4317,1
MIR4520_3P,SET,81,-0.050325,-0.0033336,0.094836,0.70217,MIR4520_3P,1
GOBP_AZOLE_TRANSMEMBRANE_TRA...,SET,13,-0.13074,-0.0034759,0.24606,0.7024,GOBP_AZOLE_TRANSMEMBRANE_TRANSPORT,1
PID_TNF_PATHWAY,SET,43,-0.06417,-0.0031003,0.12077,0.70241,PID_TNF_PATHWAY,1
GSE2826_WT_VS_XID_BCELL_UP,SET,183,-0.033197,-0.0032961,0.062474,0.70242,GSE2826_WT_VS_XID_BCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...271,SET,5,-0.20406,-0.0033652,0.38395,0.70245,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...37,SET,4,-0.19742,-0.0029122,0.37144,0.70246,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_MATURATION,1
GSE17721_LPS_VS_PAM3CSK4_6H_...2,SET,186,-0.032508,-0.0032537,0.06116,0.70247,GSE17721_LPS_VS_PAM3CSK4_6H_BMDC_UP,1
GOMF_TELOMERASE_INHIBITOR_AC...,SET,5,-0.20213,-0.0033335,0.38016,0.70253,GOMF_TELOMERASE_INHIBITOR_ACTIVITY,1
MIR3912_3P,SET,5,-0.19007,-0.0031345,0.35732,0.70261,MIR3912_3P,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...8,SET,13,-0.12195,-0.0032422,0.22927,0.70261,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_EXPANSION_AND_CONTRACTION_1D_NOT_INFORMATIVE_OF_LONG_TERM_RESPONSES_POSITIVE,1
BOYLAN_MULTIPLE_MYELOMA_PCA3...2,SET,75,-0.058085,-0.0037029,0.10919,0.70262,BOYLAN_MULTIPLE_MYELOMA_PCA3_UP,1
REACTOME_ELECTRIC_TRANSMISSI...,SET,4,-0.24324,-0.0035881,0.45726,0.70262,REACTOME_ELECTRIC_TRANSMISSION_ACROSS_GAP_JUNCTIONS,1
GOCC_AXON_HILLOCK,SET,7,-0.17378,-0.0033909,0.32668,0.70262,GOCC_AXON_HILLOCK,1
GOBP_CD4_POSITIVE_CD25_POSIT...,SET,7,-0.19418,-0.0037888,0.36499,0.70264,GOBP_CD4_POSITIVE_CD25_POSITIVE_ALPHA_BETA_REGULATORY_T_CELL_DIFFERENTIATION,1
GOBP_RNA_PROCESSING,SET,833,-0.014644,-0.0030462,0.027522,0.70267,GOBP_RNA_PROCESSING,1
GOBP_PYRIMIDINE_NUCLEOSIDE_D...2,SET,9,-0.14038,-0.0031056,0.26378,0.70269,GOBP_PYRIMIDINE_NUCLEOSIDE_DIPHOSPHATE_METABOLIC_PROCESS,1
HP_PARTIAL_ABSENCE_OF_CEREBE...,SET,4,-0.19111,-0.002819,0.3591,0.7027,HP_PARTIAL_ABSENCE_OF_CEREBELLAR_VERMIS,1
GOMF_G_PROTEIN_COUPLED_OPIOI...,SET,7,-0.17152,-0.0033466,0.32226,0.70271,GOMF_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_ACTIVITY,1
GSE17974_2H_VS_72H_UNTREATED...1,SET,164,-0.033108,-0.0031134,0.062208,0.70271,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_DN,1
HSF_Q6,SET,183,-0.033287,-0.003305,0.062513,0.7028,HSF_Q6,1
HP_DECREASED_ACHILLES_REFLEX,SET,8,-0.16148,-0.0033683,0.30317,0.70286,HP_DECREASED_ACHILLES_REFLEX,1
GSE24726_WT_VS_E2_2_KO_PDC_DN,SET,181,-0.032333,-0.0031929,0.060699,0.70287,GSE24726_WT_VS_E2_2_KO_PDC_DN,1
GOBP_VALINE_METABOLIC_PROCESS,SET,7,-0.16937,-0.0033048,0.31754,0.70311,GOBP_VALINE_METABOLIC_PROCESS,1
HP_CONGENITAL_THROMBOCYTOPEN...,SET,4,-0.19311,-0.0028486,0.36204,0.70311,HP_CONGENITAL_THROMBOCYTOPENIA,1
GOBP_RESPONSE_TO_GONADOTROPI...,SET,5,-0.18775,-0.0030963,0.35194,0.70314,GOBP_RESPONSE_TO_GONADOTROPIN_RELEASING_HORMONE,1
GOBP_NEGATIVE_REGULATION_OF_...460,SET,23,-0.088664,-0.0031346,0.16617,0.70318,GOBP_NEGATIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,1
MORF_PPP2CA,SET,117,-0.03769,-0.0029976,0.070626,0.70321,MORF_PPP2CA,1
GSE3720_UNSTIM_VS_LPS_STIM_V...2,SET,176,-0.033877,-0.0032992,0.063477,0.70322,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP,1
LAU_APOPTOSIS_CDKN2A_UP,SET,55,-0.058663,-0.0032043,0.10986,0.70331,LAU_APOPTOSIS_CDKN2A_UP,1
HP_CONE_SHAPED_EPIPHYSES_OF_...,SET,27,-0.08383,-0.0032107,0.15699,0.70332,HP_CONE_SHAPED_EPIPHYSES_OF_THE_PHALANGES_OF_THE_HAND,1
HOWLIN_CITED1_TARGETS_1_DN,SET,36,-0.083086,-0.0036736,0.15548,0.70346,HOWLIN_CITED1_TARGETS_1_DN,1
HP_ELEVATED_BRONCHOALVEOLAR_...,SET,6,-0.22201,-0.0040106,0.41545,0.70346,HP_ELEVATED_BRONCHOALVEOLAR_LAVAGE_FLUID_NEUTROPHIL_PROPORTION,1
GOBP_REGULATION_OF_MYELOID_C...1,SET,29,-0.082782,-0.0032857,0.15483,0.70355,GOBP_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,1
MIR301B_3P,SET,351,-0.024594,-0.0033661,0.045997,0.70356,MIR301B_3P,1
HP_MICROPENIS,SET,226,-0.029801,-0.0032842,0.055731,0.70358,HP_MICROPENIS,1
KEGG_MEDICUS_REFERENCE_N_GLY...2,SET,11,-0.13369,-0.0032697,0.24999,0.7036,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_ALG6_TO_OST,1
GOMF_LYSOPHOSPHOLIPID_ACYLTR...,SET,18,-0.11502,-0.0035977,0.21506,0.70361,GOMF_LYSOPHOSPHOLIPID_ACYLTRANSFERASE_ACTIVITY,1
MIR4474_3P,SET,79,-0.052943,-0.0034636,0.098982,0.70363,MIR4474_3P,1
TGANTCA_AP1_C,SET,1018,-0.014985,-0.0034278,0.028017,0.70363,TGANTCA_AP1_C,1
GOMF_UBIQUITIN_LIGASE_COMPLE...,SET,6,-0.17199,-0.0031071,0.32154,0.70364,GOMF_UBIQUITIN_LIGASE_COMPLEX_SCAFFOLD_ACTIVITY,1
ZHONG_PFC_C3_ASTROCYTE,SET,338,-0.024782,-0.0033296,0.046326,0.70365,ZHONG_PFC_C3_ASTROCYTE,1
GOMF_HEXOSE_TRANSMEMBRANE_TR...,SET,21,-0.10721,-0.0036219,0.20036,0.7037,GOMF_HEXOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMALITY_OF_VITAMIN_K_...,SET,13,-0.13625,-0.0036223,0.25456,0.70375,HP_ABNORMALITY_OF_VITAMIN_K_METABOLISM,1
ELF5_TARGET_GENES,SET,379,-0.023614,-0.0033558,0.044114,0.70377,ELF5_TARGET_GENES,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...1,SET,378,-0.022487,-0.0031915,0.042009,0.70377,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...307,SET,2,-0.39295,-0.0040989,0.73404,0.70378,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_1_ALPHA_PRODUCTION,1
GOCC_PHOSPHATIDYLINOSITOL_3_...3,SET,8,-0.15393,-0.0032107,0.28751,0.7038,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_III,1
MIR4745_5P,SET,79,-0.051101,-0.0033431,0.095448,0.70381,MIR4745_5P,1
GOBP_PERIPHERAL_NERVOUS_SYST...4,SET,8,-0.16039,-0.0033456,0.29945,0.70389,GOBP_PERIPHERAL_NERVOUS_SYSTEM_MYELIN_MAINTENANCE,1
GOMF_DEUBIQUITINASE_ACTIVITY,SET,81,-0.045711,-0.0030279,0.085335,0.7039,GOMF_DEUBIQUITINASE_ACTIVITY,1
HP_ABNORMAL_LABIA_MORPHOLOGY,SET,72,-0.054647,-0.0034136,0.10202,0.7039,HP_ABNORMAL_LABIA_MORPHOLOGY,1
GSE36476_CTRL_VS_TSST_ACT_16...1,SET,181,-0.031587,-0.0031192,0.058945,0.70397,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_DN,1
GENTLES_LEUKEMIC_STEM_CELL_DN,SET,16,-0.11355,-0.0033487,0.21188,0.70398,GENTLES_LEUKEMIC_STEM_CELL_DN,1
MORF_BUB1,SET,43,-0.06364,-0.0030747,0.11875,0.70399,MORF_BUB1,1
KEGG_PROGESTERONE_MEDIATED_O...,SET,79,-0.049323,-0.0032268,0.092016,0.70403,KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION,1
GOBP_REGULATION_OF_RESPONSE_...5,SET,984,-0.015166,-0.0034139,0.028288,0.70405,GOBP_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
GOBP_POSITIVE_REGULATION_OF_...96,SET,4,-0.2305,-0.0034001,0.42993,0.70407,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_METABOLIC_PROCESS,1
GOBP_MEGAKARYOCYTE_DEVELOPME...,SET,20,-0.10535,-0.0034733,0.19646,0.70409,GOBP_MEGAKARYOCYTE_DEVELOPMENT,1
GSE24814_STAT5_KO_VS_WT_PRE_...2,SET,176,-0.035943,-0.0035005,0.06703,0.7041,GSE24814_STAT5_KO_VS_WT_PRE_BCELL_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...3,SET,42,-0.076343,-0.0036453,0.14234,0.70414,GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1,1
GOBP_POSITIVE_REGULATION_BY_...1,SET,10,-0.14701,-0.0034282,0.27407,0.70415,GOBP_POSITIVE_REGULATION_BY_HOST_OF_VIRAL_GENOME_REPLICATION,1
MIR548AW,SET,539,-0.019806,-0.0033416,0.036915,0.7042,MIR548AW,1
GSE3039_NKT_CELL_VS_B2_BCELL...1,SET,185,-0.03369,-0.003363,0.062722,0.70441,GSE3039_NKT_CELL_VS_B2_BCELL_DN,1
CHARAFE_BREAST_CANCER_BASAL_...2,SET,108,-0.044393,-0.003393,0.08264,0.70443,CHARAFE_BREAST_CANCER_BASAL_VS_MESENCHYMAL_UP,1
GOBP_POSITIVE_REGULATION_OF_...548,SET,6,-0.15731,-0.0028418,0.29281,0.70444,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_CELL_CYCLE_DNA_REPLICATION,1
MIR6812_5P,SET,62,-0.05601,-0.0032477,0.10419,0.70457,MIR6812_5P,1
HNF4_Q6,SET,244,-0.028787,-0.0032948,0.053535,0.70461,HNF4_Q6,1
GOERING_BLOOD_HDL_CHOLESTERO...1,SET,8,-0.18593,-0.0038782,0.34574,0.70463,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_CIS,1
GSE45881_CXCR6HI_VS_CXCR1LO_...2,SET,168,-0.033364,-0.0031753,0.062025,0.70468,GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...10,SET,62,-0.057021,-0.0033062,0.10598,0.70471,GOBP_PROTEIN_LOCALIZATION_TO_CELL_SURFACE,1
ZNF597_TARGET_GENES,SET,607,-0.018614,-0.0033264,0.034595,0.70472,ZNF597_TARGET_GENES,1
HP_MESOAXIAL_HAND_POLYDACTYLY,SET,10,-0.14708,-0.0034298,0.27329,0.70477,HP_MESOAXIAL_HAND_POLYDACTYLY,1
GSE10147_IL3_VS_IL3_AND_CPG_...2,SET,132,-0.03913,-0.0033042,0.072709,0.70477,GSE10147_IL3_VS_IL3_AND_CPG_STIM_PDC_UP,1
HP_UVEAL_ECTROPION,SET,7,-0.18015,-0.0035151,0.33473,0.70478,HP_UVEAL_ECTROPION,1
MIR1178_3P,SET,83,-0.052094,-0.0034929,0.096788,0.70479,MIR1178_3P,1
HP_DECREASED_SERUM_INSULIN_L...,SET,21,-0.098654,-0.0033328,0.18328,0.7048,HP_DECREASED_SERUM_INSULIN_LIKE_GROWTH_FACTOR_1,1
HP_HYPOSMIA,SET,49,-0.065437,-0.0033743,0.12157,0.7048,HP_HYPOSMIA,1
BUSSLINGER_DUODENAL_EC_CELLS,SET,27,-0.098893,-0.0037876,0.18372,0.70481,BUSSLINGER_DUODENAL_EC_CELLS,1
GOBP_CRD_MEDIATED_MRNA_STABI...,SET,11,-0.13779,-0.0033699,0.2559,0.70486,GOBP_CRD_MEDIATED_MRNA_STABILIZATION,1
GSE11961_MEMORY_BCELL_DAY7_V...1,SET,174,-0.03367,-0.0032606,0.06253,0.70487,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
MIR1294,SET,150,-0.03781,-0.0034018,0.070203,0.70491,MIR1294,1
GOBP_ANTERIOR_HEAD_DEVELOPME...,SET,7,-0.18893,-0.0036865,0.35078,0.70492,GOBP_ANTERIOR_HEAD_DEVELOPMENT,1
MIR3140_5P,SET,121,-0.040452,-0.0032714,0.0751,0.70493,MIR3140_5P,1
MODULE_458,SET,31,-0.084817,-0.0034805,0.15746,0.70494,MODULE_458,1
GOBP_REGULATION_OF_CYSTEINE_...4,SET,5,-0.18408,-0.0030358,0.34169,0.70496,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,1
GOBP_DCMP_CATABOLIC_PROCESS,SET,6,-0.19185,-0.0034658,0.35605,0.70499,GOBP_DCMP_CATABOLIC_PROCESS,1
KEGG_CELL_CYCLE,SET,120,-0.040558,-0.0032665,0.075251,0.70504,KEGG_CELL_CYCLE,1
HP_PARIETAL_CORTICAL_ATROPHY,SET,8,-0.15739,-0.003283,0.29203,0.70504,HP_PARIETAL_CORTICAL_ATROPHY,1
DORN_ADENOVIRUS_INFECTION_12...2,SET,23,-0.089526,-0.003165,0.16609,0.70506,DORN_ADENOVIRUS_INFECTION_12HR_UP,1
HP_MYOSITIS,SET,34,-0.08333,-0.0035808,0.1546,0.70506,HP_MYOSITIS,1
MORF_MAP3K14,SET,106,-0.045521,-0.003447,0.084421,0.70513,MORF_MAP3K14,1
WP_INTEGRINMEDIATED_CELL_ADH...,SET,95,-0.048193,-0.0034559,0.089337,0.70521,WP_INTEGRINMEDIATED_CELL_ADHESION,1
GOBP_ASCENDING_AORTA_DEVELOP...,SET,5,-0.23128,-0.0038143,0.42873,0.70521,GOBP_ASCENDING_AORTA_DEVELOPMENT,1
FAN_OVARY_CL16_LYMPHATIC_END...,SET,206,-0.03322,-0.0034972,0.061576,0.70522,FAN_OVARY_CL16_LYMPHATIC_ENDOTHELIAL_CELL,1
HP_ABNORMALITY_OF_THE_PERIPH...,SET,405,-0.022334,-0.0032787,0.041398,0.70523,HP_ABNORMALITY_OF_THE_PERIPHERAL_NERVOUS_SYSTEM,1
GSE16385_MONOCYTE_VS_12H_IFN...1,SET,174,-0.035266,-0.0034151,0.065348,0.70528,GSE16385_MONOCYTE_VS_12H_IFNG_TNF_TREATED_MACROPHAGE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...639,SET,43,-0.068408,-0.003305,0.12675,0.7053,GOBP_NEGATIVE_REGULATION_OF_TORC1_SIGNALING,1
MARTINEZ_RB1_AND_TP53_TARGET...2,SET,569,-0.019299,-0.0033428,0.03575,0.70534,MARTINEZ_RB1_AND_TP53_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...621,SET,19,-0.09757,-0.0031355,0.18074,0.70534,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXPORT_FROM_NUCLEUS,1
GOBP_REGULATION_OF_AUTOPHAGY...2,SET,10,-0.16014,-0.0037345,0.29664,0.70535,GOBP_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION_IN_RESPONSE_TO_MITOCHONDRIAL_DEPOLARIZATION,1
GSE14000_UNSTIM_VS_4H_LPS_DC...1,SET,179,-0.03551,-0.0034873,0.065777,0.70535,GSE14000_UNSTIM_VS_4H_LPS_DC_DN,1
GOBP_ARF_PROTEIN_SIGNAL_TRAN...,SET,21,-0.098092,-0.0033139,0.18164,0.70541,GOBP_ARF_PROTEIN_SIGNAL_TRANSDUCTION,1
GOMF_ORGANIC_ANION_TRANSMEMB...,SET,253,-0.02959,-0.0034477,0.054784,0.70544,GOMF_ORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_TNFRELATED_WEAK_INDUCER_O...,SET,42,-0.069935,-0.0033393,0.12947,0.70545,WP_TNFRELATED_WEAK_INDUCER_OF_APOPTOSIS_TWEAK_SIGNALING,1
MIR211_5P,SET,346,-0.02495,-0.0033909,0.046163,0.70556,MIR211_5P,1
PID_BMP_PATHWAY,SET,38,-0.080847,-0.0036724,0.14956,0.70559,PID_BMP_PATHWAY,1
GSE22025_TGFB1_VS_TGFB1_AND_...2,SET,179,-0.034604,-0.0033984,0.064007,0.70561,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP,1
GOBP_UDP_GLUCOSE_METABOLIC_P...,SET,6,-0.1458,-0.002634,0.26964,0.70565,GOBP_UDP_GLUCOSE_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_RESPONSE_...2,SET,158,-0.035754,-0.0033008,0.066117,0.70566,GOBP_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
WORSCHECH_TUMOR_REJECTION_UP,SET,58,-0.062252,-0.0034915,0.11511,0.70567,WORSCHECH_TUMOR_REJECTION_UP,1
HP_MOTOR_DELAY,SET,852,-0.015619,-0.0032841,0.028882,0.70567,HP_MOTOR_DELAY,1
GOBP_NEGATIVE_REGULATION_OF_...204,SET,36,-0.08158,-0.003607,0.15085,0.70568,GOBP_NEGATIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,1
GRADE_COLON_AND_RECTAL_CANCE...1,SET,94,-0.04817,-0.0034361,0.089064,0.70569,GRADE_COLON_AND_RECTAL_CANCER_DN,1
LUI_THYROID_CANCER_CLUSTER_4,SET,10,-0.16741,-0.0039039,0.30953,0.70569,LUI_THYROID_CANCER_CLUSTER_4,1
DEN_INTERACT_WITH_LCA5,SET,24,-0.10041,-0.003626,0.18561,0.70573,DEN_INTERACT_WITH_LCA5,1
GOBP_OLIGODENDROCYTE_APOPTOT...,SET,5,-0.22255,-0.0036703,0.41129,0.70578,GOBP_OLIGODENDROCYTE_APOPTOTIC_PROCESS,1
MIR3135A,SET,30,-0.075278,-0.0030389,0.13911,0.70579,MIR3135A,1
REACTOME_TRANSCRIPTIONAL_ACT...2,SET,48,-0.062523,-0.003191,0.11553,0.70581,REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER,1
GOBP_L_SERINE_CATABOLIC_PROC...,SET,3,-0.24789,-0.0031669,0.45806,0.70581,GOBP_L_SERINE_CATABOLIC_PROCESS,1
HP_CEREBRAL_WHITE_MATTER_ATR...,SET,56,-0.057801,-0.0031857,0.10681,0.70581,HP_CEREBRAL_WHITE_MATTER_ATROPHY,1
WP_NANOPARTICLE_TRIGGERED_RE...,SET,12,-0.14215,-0.0036309,0.26259,0.70585,WP_NANOPARTICLE_TRIGGERED_REGULATED_NECROSIS,1
HP_PSEUDOEPIPHYSES_OF_THE_ME...,SET,8,-0.16214,-0.003382,0.29946,0.70589,HP_PSEUDOEPIPHYSES_OF_THE_METACARPALS,1
GOBP_RESPONSE_TO_ALCOHOL,SET,244,-0.03082,-0.0035275,0.056916,0.70592,GOBP_RESPONSE_TO_ALCOHOL,1
GOBP_REGULATION_OF_MITOCHOND...7,SET,29,-0.076728,-0.0030454,0.14167,0.70595,GOBP_REGULATION_OF_MITOCHONDRIAL_GENE_EXPRESSION,1
GOBP_NEGATIVE_REGULATION_OF_...695,SET,4,-0.25198,-0.0037169,0.4652,0.70597,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_WOUND_HEALING,1
GOBP_RESPONSE_TO_OSMOTIC_STR...,SET,79,-0.051372,-0.0033608,0.094806,0.70604,GOBP_RESPONSE_TO_OSMOTIC_STRESS,1
MORF_PML,SET,133,-0.039831,-0.0033761,0.073426,0.70625,MORF_PML,1
GOCC_NMDA_SELECTIVE_GLUTAMAT...,SET,9,-0.1582,-0.0035,0.29163,0.70625,GOCC_NMDA_SELECTIVE_GLUTAMATE_RECEPTOR_COMPLEX,1
MODULE_4,SET,19,-0.09199,-0.0029562,0.16952,0.70631,MODULE_4,1
GOMF_TRANSLATION_REGULATOR_A...2,SET,91,-0.043485,-0.0030523,0.080086,0.70642,GOMF_TRANSLATION_REGULATOR_ACTIVITY_NUCLEIC_ACID_BINDING,1
GOBP_REGULATION_OF_HYDROGEN_...1,SET,7,-0.18132,-0.003538,0.33393,0.70643,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_BIOSYNTHETIC_PROCESS,1
DESCARTES_FETAL_ADRENAL_CSH1...,SET,146,-0.040204,-0.003569,0.074033,0.70645,DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS,1
HP_ABNORMAL_HARD_PALATE_MORP...,SET,71,-0.052023,-0.0032272,0.095764,0.70652,HP_ABNORMAL_HARD_PALATE_MORPHOLOGY,1
WP_IL1_SIGNALING,SET,52,-0.064394,-0.0034204,0.11853,0.70653,WP_IL1_SIGNALING,1
SOX10_TARGET_GENES,SET,205,-0.031996,-0.0033603,0.058893,0.70653,SOX10_TARGET_GENES,1
GOBP_STRIATUM_DEVELOPMENT,SET,20,-0.10918,-0.0035996,0.20096,0.70653,GOBP_STRIATUM_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...746,SET,6,-0.20718,-0.0037427,0.38131,0.70654,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_VESICLE_FUSION_TO_PRESYNAPTIC_ACTIVE_ZONE_MEMBRANE,1
HP_ABSENT_PALMAR_CREASE,SET,13,-0.12727,-0.0033837,0.23424,0.70655,HP_ABSENT_PALMAR_CREASE,1
GSE8621_UNSTIM_VS_LPS_STIM_M...2,SET,183,-0.03382,-0.0033579,0.062236,0.70657,GSE8621_UNSTIM_VS_LPS_STIM_MACROPHAGE_UP,1
KINSEY_TARGETS_OF_EWSR1_FLII...1,SET,299,-0.027158,-0.0034356,0.049936,0.70672,KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN,1
AIZARANI_LIVER_C3_NK_NKT_CEL...,SET,139,-0.039961,-0.003462,0.073481,0.70672,AIZARANI_LIVER_C3_NK_NKT_CELLS_2,1
GSE45365_NK_CELL_VS_CD8_TCEL...1,SET,144,-0.040455,-0.0035668,0.074383,0.70673,GSE45365_NK_CELL_VS_CD8_TCELL_DN,1
REACTOME_DISEASES_ASSOCIATED...4,SET,61,-0.064421,-0.0037052,0.11844,0.70675,REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS,1
GOMF_ALPHA_N_ACETYLNEURAMINA...,SET,6,-0.23282,-0.004206,0.42803,0.70676,GOMF_ALPHA_N_ACETYLNEURAMINATE_ALPHA_2_8_SIALYLTRANSFERASE_ACTIVITY,1
MIR4790_5P,SET,13,-0.12301,-0.0032703,0.22606,0.70682,MIR4790_5P,1
GOBP_LOOP_OF_HENLE_DEVELOPME...,SET,11,-0.15216,-0.0037215,0.27961,0.70685,GOBP_LOOP_OF_HENLE_DEVELOPMENT,1
REACTOME_AMINE_LIGAND_BINDIN...,SET,40,-0.082088,-0.0038254,0.15078,0.70692,REACTOME_AMINE_LIGAND_BINDING_RECEPTORS,1
HP_ABNORMALITY_OF_RENIN_ANGI...,SET,35,-0.083497,-0.0036403,0.15334,0.70696,HP_ABNORMALITY_OF_RENIN_ANGIOTENSIN_SYSTEM,1
HP_REDUNDANT_NECK_SKIN,SET,28,-0.08064,-0.0031451,0.14809,0.70696,HP_REDUNDANT_NECK_SKIN,1
WP_ENDOTHELIN_PATHWAYS,SET,31,-0.089553,-0.0036748,0.16444,0.70698,WP_ENDOTHELIN_PATHWAYS,1
MIR361_3P,SET,81,-0.050432,-0.0033406,0.092606,0.70698,MIR361_3P,1
REACTOME_PROCESSING_AND_ACTI...,SET,10,-0.12296,-0.0028675,0.22569,0.70706,REACTOME_PROCESSING_AND_ACTIVATION_OF_SUMO,1
GILDEA_METASTASIS,SET,28,-0.089843,-0.0035041,0.16489,0.70707,GILDEA_METASTASIS,1
HP_PILI_CANALICULI,SET,5,-0.24079,-0.003971,0.4419,0.70709,HP_PILI_CANALICULI,1
HSF1_01,SET,246,-0.029353,-0.0033731,0.053857,0.70713,HSF1_01,1
HP_ABNORMAL_MYELINATION,SET,539,-0.018961,-0.0031991,0.034786,0.70715,HP_ABNORMAL_MYELINATION,1
HP_AXIAL_HYPOTONIA,SET,288,-0.026828,-0.003332,0.0492,0.70722,HP_AXIAL_HYPOTONIA,1
KEGG_MEDICUS_VARIANT_MUTATIO...57,SET,37,-0.064026,-0.0028699,0.1174,0.70724,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
WP_CARDIAC_PROGENITOR_DIFFER...,SET,50,-0.073441,-0.0038254,0.13465,0.70726,WP_CARDIAC_PROGENITOR_DIFFERENTIATION,1
GOBP_PHOSPHATIDYLCHOLINE_ACY...,SET,13,-0.1272,-0.0033817,0.23304,0.7074,GOBP_PHOSPHATIDYLCHOLINE_ACYL_CHAIN_REMODELING,1
GAVISH_3CA_MALIGNANT_METAPRO...23,SET,48,-0.073436,-0.003748,0.13452,0.70743,GAVISH_3CA_MALIGNANT_METAPROGRAM_31_ALVEOLAR,1
WP_WARBURG_EFFECT_MODULATED_...,SET,24,-0.095247,-0.0034396,0.17446,0.70744,WP_WARBURG_EFFECT_MODULATED_BY_DEUBIQUITINATING_ENZYMES_AND_THEIR_SUBSTRATES,1
GOMF_PROTEINASE_ACTIVATED_RE...,SET,5,-0.24459,-0.0040337,0.4478,0.70753,GOMF_PROTEINASE_ACTIVATED_RECEPTOR_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_CA2_E...2,SET,5,-0.20045,-0.0033057,0.36696,0.70754,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_STORE_OPERATED_CA2_CHANNEL,1
GSE3565_DUSP1_VS_WT_SPLENOCY...3,SET,141,-0.037371,-0.0032607,0.068412,0.70756,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_UP,1
GOBP_REGULATION_OF_PROTEIN_L...8,SET,10,-0.13602,-0.003172,0.24896,0.70759,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,1
LIN_NPAS4_TARGETS_DN,SET,65,-0.060379,-0.0035844,0.11047,0.70765,LIN_NPAS4_TARGETS_DN,1
GOBP_REGULATION_OF_NUCLEOBAS...,SET,17,-0.10324,-0.0031383,0.18889,0.70765,GOBP_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,1
REACTOME_SIGNALING_BY_SCF_KIT,SET,42,-0.070637,-0.0033728,0.12923,0.70767,REACTOME_SIGNALING_BY_SCF_KIT,1
HP_LOWER_LIMB_UNDERGROWTH,SET,14,-0.12426,-0.0034282,0.22722,0.70776,HP_LOWER_LIMB_UNDERGROWTH,1
chr8q12,SET,27,-0.16571,-0.0063466,0.30297,0.70778,chr8q12,1
CUI_TCF21_TARGETS_UP,SET,35,-0.088827,-0.0038726,0.16241,0.70779,CUI_TCF21_TARGETS_UP,1
GROSS_HYPOXIA_VIA_ELK3_AND_H...1,SET,98,-0.046427,-0.0033811,0.084884,0.70779,GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_DN,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...5,SET,107,-0.04154,-0.0031603,0.075938,0.70782,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_NEGATIVE,1
GOBP_REGULATION_OF_LEUKOCYTE...10,SET,18,-0.1165,-0.0036442,0.21296,0.70783,GOBP_REGULATION_OF_LEUKOCYTE_TETHERING_OR_ROLLING,1
HP_CHRONIC_CSF_LYMPHOCYTOSIS,SET,8,-0.15802,-0.003296,0.28883,0.70784,HP_CHRONIC_CSF_LYMPHOCYTOSIS,1
GOBP_NEGATIVE_REGULATION_OF_...332,SET,5,-0.24986,-0.0041206,0.45659,0.70788,GOBP_NEGATIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,1
GSE10422_WT_VS_BAFF_TRANSGEN...1,SET,120,-0.04353,-0.0035059,0.079541,0.7079,GSE10422_WT_VS_BAFF_TRANSGENIC_LN_BCELL_DN,1
GSE11057_NAIVE_VS_MEMORY_CD4...1,SET,174,-0.03532,-0.0034203,0.064534,0.70791,GSE11057_NAIVE_VS_MEMORY_CD4_TCELL_DN,1
GSE5455_EX_VIVO_VS_POST_24H_...2,SET,183,-0.032975,-0.0032739,0.060237,0.70795,GSE5455_EX_VIVO_VS_POST_24H_INCUBATION_MONOCYTES_FROM_TUMOR_BEARING_MOUSE_UP,1
GOBP_PROTEIN_DEPOLYMERIZATION,SET,108,-0.041929,-0.0032047,0.076588,0.70796,GOBP_PROTEIN_DEPOLYMERIZATION,1
MIR101_2_5P,SET,6,-0.17438,-0.0031502,0.31848,0.70799,MIR101_2_5P,1
GOBP_ETHANOL_METABOLIC_PROCE...,SET,11,-0.15533,-0.003799,0.2837,0.70799,GOBP_ETHANOL_METABOLIC_PROCESS,1
GOBP_EYE_MORPHOGENESIS,SET,155,-0.039754,-0.0036353,0.072553,0.70813,GOBP_EYE_MORPHOGENESIS,1
GSE15930_NAIVE_VS_72H_IN_VIT...4,SET,187,-0.032999,-0.0033116,0.060195,0.70822,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,1
GOBP_NONRIBOSOMAL_PEPTIDE_BI...,SET,17,-0.11469,-0.0034864,0.20919,0.70823,GOBP_NONRIBOSOMAL_PEPTIDE_BIOSYNTHETIC_PROCESS,1
HP_MICROCYTIC_ANEMIA,SET,37,-0.078793,-0.0035317,0.14371,0.70825,HP_MICROCYTIC_ANEMIA,1
GOBP_NEGATIVE_REGULATION_OF_...330,SET,8,-0.19037,-0.0039709,0.34714,0.70828,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
PID_CDC42_REG_PATHWAY,SET,25,-0.092733,-0.0034178,0.16907,0.70831,PID_CDC42_REG_PATHWAY,1
GOBP_REGULATION_OF_CELL_CYCL...2,SET,172,-0.036389,-0.0035038,0.066341,0.70833,GOBP_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOBP_INTERLEUKIN_2_MEDIATED_...,SET,8,-0.18796,-0.0039206,0.34264,0.70834,GOBP_INTERLEUKIN_2_MEDIATED_SIGNALING_PATHWAY,1
GSE21360_SECONDARY_VS_QUATER...2,SET,174,-0.038262,-0.0037052,0.069752,0.70834,GSE21360_SECONDARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,1
HP_THIN_RIBS,SET,46,-0.068411,-0.0034182,0.12467,0.7084,HP_THIN_RIBS,1
BIOCARTA_LDL_PATHWAY,SET,6,-0.22259,-0.0040211,0.40552,0.70846,BIOCARTA_LDL_PATHWAY,1
GOCC_UBIQUITIN_LIGASE_COMPLEX,SET,282,-0.027164,-0.0033389,0.049485,0.70847,GOCC_UBIQUITIN_LIGASE_COMPLEX,1
GOBP_GOLGI_LOCALIZATION,SET,12,-0.12354,-0.0031556,0.22498,0.70853,GOBP_GOLGI_LOCALIZATION,1
GOBP_REGULATION_OF_GLUTAMINE...,SET,6,-0.19791,-0.0035753,0.36037,0.70855,GOBP_REGULATION_OF_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
MIR6504_3P,SET,342,-0.025924,-0.0035033,0.047196,0.70859,MIR6504_3P,1
GSE14769_UNSTIM_VS_40MIN_LPS...2,SET,178,-0.035883,-0.0035142,0.065327,0.70859,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_UP,1
GSE18791_UNSTIM_VS_NEWCATSLE...6,SET,143,-0.04123,-0.0036226,0.075045,0.70863,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_1H_UP,1
MIR7161_3P,SET,77,-0.05241,-0.0033852,0.095387,0.70865,MIR7161_3P,1
GOBP_NEGATIVE_REGULATION_OF_...247,SET,954,-0.015233,-0.0033792,0.027718,0.70869,GOBP_NEGATIVE_REGULATION_OF_GENE_EXPRESSION,1
GOBP_POSITIVE_REGULATION_OF_...156,SET,8,-0.15837,-0.0033034,0.28812,0.70872,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_BIOSYNTHETIC_PROCESS,1
HP_PAIN_IN_HEAD_AND_NECK_REG...,SET,40,-0.075477,-0.0035173,0.13732,0.70872,HP_PAIN_IN_HEAD_AND_NECK_REGION,1
HP_RECURRENT_PHARYNGITIS,SET,7,-0.21201,-0.0041369,0.3857,0.70873,HP_RECURRENT_PHARYNGITIS,1
GOMF_ALCOHOL_BINDING,SET,85,-0.051856,-0.0035184,0.094324,0.70876,GOMF_ALCOHOL_BINDING,1
GSE27786_LIN_NEG_VS_BCELL_DN,SET,182,-0.032521,-0.0032201,0.059145,0.70878,GSE27786_LIN_NEG_VS_BCELL_DN,1
GSE20366_TREG_VS_NAIVE_CD4_T...1,SET,182,-0.034808,-0.0034466,0.063305,0.70879,GSE20366_TREG_VS_NAIVE_CD4_TCELL_DEC205_CONVERSION_DN,1
WP_AMPLIFICATION_AND_EXPANSI...,SET,17,-0.1247,-0.0037908,0.22676,0.70881,WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS,1
GOCC_SWI_SNF_COMPLEX,SET,28,-0.089205,-0.0034792,0.16221,0.70881,GOCC_SWI_SNF_COMPLEX,1
GSE21927_SPLEEN_VS_4T1_TUMOR...1,SET,173,-0.034653,-0.0033462,0.062992,0.70888,GSE21927_SPLEEN_VS_4T1_TUMOR_MONOCYTE_BALBC_DN,1
GOMF_TBP_CLASS_PROTEIN_BINDI...,SET,23,-0.098715,-0.0034899,0.17944,0.70889,GOMF_TBP_CLASS_PROTEIN_BINDING,1
HP_ABNORMAL_RIB_OSSIFICATION,SET,8,-0.17408,-0.0036311,0.31642,0.70889,HP_ABNORMAL_RIB_OSSIFICATION,1
GSE18281_SUBCAPSULAR_CORTICA...1,SET,167,-0.035554,-0.0033736,0.064626,0.70889,GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_DN,1
PID_ILK_PATHWAY,SET,44,-0.066437,-0.0032468,0.12076,0.7089,PID_ILK_PATHWAY,1
HP_SHORT_PALM,SET,93,-0.046718,-0.0033148,0.084904,0.70892,HP_SHORT_PALM,1
MIR550A_3P,SET,70,-0.057908,-0.0035669,0.10522,0.70895,MIR550A_3P,1
HP_SUPERNUMERARY_MAXILLARY_I...,SET,3,-0.30763,-0.00393,0.55898,0.70895,HP_SUPERNUMERARY_MAXILLARY_INCISOR,1
GOMF_AMINO_ACID_MONOATOMIC_C...1,SET,4,-0.19762,-0.0029151,0.35896,0.70902,GOMF_AMINO_ACID_MONOATOMIC_CATION_ANTIPORTER_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...271,SET,12,-0.14343,-0.0036636,0.26045,0.70907,GOBP_POSITIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
WP_22Q112_COPY_NUMBER_VARIAT...,SET,105,-0.049576,-0.0037365,0.090017,0.70909,WP_22Q112_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_POSITIVE_REGULATION_OF_...763,SET,6,-0.20397,-0.0036847,0.37032,0.7091,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,1
GSE17721_LPS_VS_CPG_0.5H_BMD...2,SET,177,-0.033295,-0.0032517,0.060442,0.70913,GSE17721_LPS_VS_CPG_0.5H_BMDC_UP,1
HP_ANISOCYTOSIS,SET,17,-0.11976,-0.0036405,0.21732,0.7092,HP_ANISOCYTOSIS,1
HP_RENAL_ANGIOMYOLIPOMA,SET,5,-0.1899,-0.0031317,0.34456,0.70922,HP_RENAL_ANGIOMYOLIPOMA,1
WP_BIOSYNTHESIS_AND_TURNOVER...,SET,8,-0.16484,-0.0034383,0.29908,0.70923,WP_BIOSYNTHESIS_AND_TURNOVER_OF_1DEOXYSPHINGOID_BASES,1
ZHONG_PFC_MAJOR_TYPES_NPCS,SET,126,-0.041547,-0.0034282,0.075383,0.70923,ZHONG_PFC_MAJOR_TYPES_NPCS,1
GSE26928_NAIVE_VS_CENT_MEMOR...1,SET,170,-0.034344,-0.0032877,0.062293,0.70929,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN,1
HP_ABNORMAL_OSSIFICATION_OF_...,SET,10,-0.15122,-0.0035264,0.27427,0.7093,HP_ABNORMAL_OSSIFICATION_OF_THE_PUBIC_BONE,1
HP_NREM_PARASOMNIA,SET,16,-0.12292,-0.0036253,0.22289,0.70935,HP_NREM_PARASOMNIA,1
HP_ABNORMALITY_OF_RADIAL_EPI...,SET,5,-0.21742,-0.0035857,0.3942,0.70937,HP_ABNORMALITY_OF_RADIAL_EPIPHYSES,1
GSE43955_10H_VS_60H_ACT_CD4_...1,SET,182,-0.035666,-0.0035316,0.064644,0.70943,GSE43955_10H_VS_60H_ACT_CD4_TCELL_DN,1
HP_ACETABULAR_DYSPLASIA,SET,23,-0.090733,-0.0032077,0.16444,0.70944,HP_ACETABULAR_DYSPLASIA,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...4,SET,11,-0.16055,-0.0039266,0.29091,0.70949,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_NFY_MEDIATED_TRANSCRIPTION,1
KEGG_MEDICUS_REFERENCE_PDGF_...1,SET,13,-0.13564,-0.003606,0.24572,0.70952,KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY,1
GSE3337_CTRL_VS_4H_IFNG_IN_C...1,SET,187,-0.033834,-0.0033954,0.061284,0.70955,GSE3337_CTRL_VS_4H_IFNG_IN_CD8POS_DC_DN,1
GOBP_CELL_DIFFERENTIATION_IN...3,SET,21,-0.11799,-0.0039862,0.21371,0.70956,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_METANEPHROS_DEVELOPMENT,1
REACTOME_MRNA_EDITING,SET,9,-0.18323,-0.0040537,0.33182,0.70959,REACTOME_MRNA_EDITING,1
chr11q24,SET,81,-0.10159,-0.0067294,0.18395,0.70962,chr11q24,1
RORA2_01,SET,134,-0.040924,-0.0034816,0.074099,0.70962,RORA2_01,1
HP_INCREASED_WAIST_TO_HIP_RA...,SET,36,-0.085573,-0.0037836,0.15494,0.70963,HP_INCREASED_WAIST_TO_HIP_RATIO,1
GOBP_MRNA_METABOLIC_PROCESS,SET,643,-0.01731,-0.0031806,0.03134,0.70964,GOBP_MRNA_METABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_CREA...1,SET,10,-0.13806,-0.0032195,0.24984,0.70972,HP_ABNORMAL_CIRCULATING_CREATINE_CONCENTRATION,1
GSE29164_CD8_TCELL_VS_CD8_TC...1,SET,184,-0.035011,-0.0034856,0.06336,0.70972,GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,1
HP_CONGENITAL_HEMOLYTIC_ANEM...,SET,8,-0.18016,-0.0037579,0.32599,0.70974,HP_CONGENITAL_HEMOLYTIC_ANEMIA,1
MIR340_3P,SET,44,-0.06879,-0.0033618,0.12447,0.70975,MIR340_3P,1
GSE17721_0.5H_VS_12H_PAM3CSK...1,SET,184,-0.032695,-0.0032549,0.059149,0.70978,GSE17721_0.5H_VS_12H_PAM3CSK4_BMDC_DN,1
GOBP_PROTEIN_MODIFICATION_BY...1,SET,746,-0.016877,-0.0033305,0.030525,0.70983,GOBP_PROTEIN_MODIFICATION_BY_SMALL_PROTEIN_CONJUGATION,1
GSE46606_UNSTIM_VS_CD40L_IL2...11,SET,162,-0.035861,-0.0033519,0.064841,0.70988,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_DN,1
REACTOME_REPLACEMENT_OF_PROT...,SET,6,-0.20001,-0.0036132,0.36162,0.70989,REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS,1
HP_APLASIA_HYPOPLASIA_OF_THE...57,SET,38,-0.077658,-0.0035275,0.14041,0.70989,HP_APLASIA_HYPOPLASIA_OF_THE_PHALANGES_OF_THE_THUMB,1
WP_15Q11Q13_COPY_NUMBER_VARI...,SET,48,-0.067996,-0.0034704,0.12294,0.7099,WP_15Q11Q13_COPY_NUMBER_VARIATION,1
GOBP_POSITIVE_REGULATION_OF_...739,SET,8,-0.17023,-0.0035507,0.30777,0.7099,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_MATURATION,1
GOBP_REGULATION_OF_THYROID_H...,SET,7,-0.18438,-0.0035976,0.33335,0.7099,GOBP_REGULATION_OF_THYROID_HORMONE_GENERATION,1
KASLER_HDAC7_TARGETS_1_UP,SET,181,-0.034491,-0.0034059,0.06234,0.70996,KASLER_HDAC7_TARGETS_1_UP,1
MODULE_222,SET,10,-0.15479,-0.0036096,0.27975,0.70997,MODULE_222,1
GOBP_PROTEIN_LOCALIZATION_TO...17,SET,67,-0.054589,-0.0032899,0.09865,0.70999,GOBP_PROTEIN_LOCALIZATION_TO_CILIUM,1
GSE43863_TFH_VS_LY6C_INT_CXC...4,SET,184,-0.035556,-0.0035398,0.064249,0.71001,GSE43863_TFH_VS_LY6C_INT_CXCR5POS_MEMORY_CD4_TCELL_UP,1
CLASPER_LYMPHATIC_VESSELS_DU...2,SET,18,-0.11839,-0.0037033,0.21392,0.71002,CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_UP,1
MIR656_3P,SET,358,-0.025266,-0.0034918,0.04565,0.71003,MIR656_3P,1
WP_LIPID_METABOLISM_IN_SENES...,SET,20,-0.10587,-0.0034906,0.19123,0.71008,WP_LIPID_METABOLISM_IN_SENESCENT_CELLS,1
MIR196A_3P,SET,115,-0.043614,-0.0034392,0.07878,0.71008,MIR196A_3P,1
PTEN_DN.V2_UP,SET,126,-0.044647,-0.003684,0.080641,0.71009,PTEN_DN.V2_UP,1
GSE22432_MULTIPOTENT_VS_COMM...4,SET,178,-0.03356,-0.0032867,0.060606,0.71012,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UP,1
GOBP_INTRACILIARY_TRANSPORT,SET,40,-0.074768,-0.0034843,0.13499,0.71017,GOBP_INTRACILIARY_TRANSPORT,1
REACTOME_RNA_POLYMERASE_II_T...1,SET,71,-0.049137,-0.0030481,0.088697,0.7102,REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES,1
GOBP_INTRACILIARY_ANTEROGRAD...,SET,15,-0.12197,-0.003483,0.22014,0.71023,GOBP_INTRACILIARY_ANTEROGRADE_TRANSPORT,1
KEGG_MEDICUS_REFERENCE_NLRP3...,SET,5,-0.19079,-0.0031464,0.34427,0.71027,KEGG_MEDICUS_REFERENCE_NLRP3_INFLAMMASOME_SIGNALING_PATHWAY,1
THUM_MIR21_TARGETS_HEART_DIS...2,SET,16,-0.13347,-0.0039365,0.24083,0.71028,THUM_MIR21_TARGETS_HEART_DISEASE_UP,1
GOCC_IKAPPAB_KINASE_COMPLEX,SET,6,-0.16649,-0.0030077,0.30039,0.7103,GOCC_IKAPPAB_KINASE_COMPLEX,1
KEGG_OXIDATIVE_PHOSPHORYLATI...,SET,96,-0.042901,-0.0030924,0.077395,0.71031,KEGG_OXIDATIVE_PHOSPHORYLATION,1
GOMF_MONOCARBOXYLIC_ACID_TRA...,SET,67,-0.059609,-0.0035925,0.10754,0.71031,GOMF_MONOCARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE25088_IL4_VS_IL4_AND_ROSI...3,SET,178,-0.034596,-0.0033882,0.062409,0.71033,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_STAT6_KO_MACROPHAGE_DAY10_DN,1
JIANG_CORE_DUPLICON_GENES,SET,4,-0.20508,-0.0030252,0.36981,0.7104,JIANG_CORE_DUPLICON_GENES,1
GSE14415_ACT_TCONV_VS_ACT_NA...2,SET,158,-0.038194,-0.0035261,0.068865,0.71042,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP,1
BIOCARTA_MITR_PATHWAY,SET,5,-0.21923,-0.0036154,0.39523,0.71044,BIOCARTA_MITR_PATHWAY,1
GOCC_FILAMENTOUS_ACTIN,SET,30,-0.083029,-0.0033518,0.14967,0.71047,GOCC_FILAMENTOUS_ACTIN,1
GOBP_HETEROCHROMATIN_ORGANIZ...,SET,13,-0.11944,-0.0031754,0.21523,0.71052,GOBP_HETEROCHROMATIN_ORGANIZATION,1
HP_ABNORMAL_SALIVARY_GLAND_M...,SET,27,-0.085489,-0.0032742,0.15393,0.71067,HP_ABNORMAL_SALIVARY_GLAND_MORPHOLOGY,1
REACTOME_TRANSCRIPTIONAL_REG...13,SET,28,-0.10131,-0.0039511,0.18241,0.71068,REACTOME_TRANSCRIPTIONAL_REGULATION_OF_PLURIPOTENT_STEM_CELLS,1
WP_G13_SIGNALING,SET,35,-0.080314,-0.0035015,0.14455,0.71076,WP_G13_SIGNALING,1
REACTOME_SENSORY_PROCESSING_...1,SET,69,-0.059213,-0.0036213,0.10656,0.71078,REACTOME_SENSORY_PROCESSING_OF_SOUND,1
GOBP_ESTABLISHMENT_OF_PROTEI...4,SET,38,-0.072203,-0.0032797,0.12994,0.71078,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,1
GOBP_AMYLOID_BETA_CLEARANCE_...2,SET,7,-0.16166,-0.0031544,0.29091,0.7108,GOBP_AMYLOID_BETA_CLEARANCE_BY_TRANSCYTOSIS,1
GSE25123_CTRL_VS_IL4_STIM_PP...2,SET,179,-0.033741,-0.0033136,0.060701,0.71084,GSE25123_CTRL_VS_IL4_STIM_PPARG_KO_MACROPHAGE_UP,1
WP_HFE_EFFECT_ON_HEPCIDIN_PR...,SET,6,-0.18697,-0.0033776,0.33634,0.71085,WP_HFE_EFFECT_ON_HEPCIDIN_PRODUCTION,1
GSE9509_10MIN_VS_30MIN_LPS_S...2,SET,174,-0.034835,-0.0033733,0.062667,0.71085,GSE9509_10MIN_VS_30MIN_LPS_STIM_IL10_KO_MACROPHAGE_UP,1
GSE23568_CTRL_TRANSDUCED_VS_...1,SET,187,-0.033374,-0.0033493,0.060033,0.71087,GSE23568_CTRL_TRANSDUCED_VS_WT_CD8_TCELL_DN,1
GOCC_ENDOLYSOSOME_LUMEN,SET,5,-0.21605,-0.003563,0.38848,0.71094,GOCC_ENDOLYSOSOME_LUMEN,1
GSE37534_PIOGLITAZONE_VS_ROS...2,SET,174,-0.032831,-0.0031793,0.059034,0.71094,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP,1
HP_CUTANEOUS_SYNDACTYLY_OF_T...,SET,25,-0.099932,-0.0036831,0.17964,0.71099,HP_CUTANEOUS_SYNDACTYLY_OF_TOES,1
DARWICHE_PAPILLOMA_PROGRESSI...,SET,72,-0.055823,-0.0034871,0.10032,0.71104,DARWICHE_PAPILLOMA_PROGRESSION_RISK,1
KEGG_MEDICUS_REFERENCE_REGUL...10,SET,6,-0.16388,-0.0029605,0.29447,0.71107,KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_RAS_UBIQUITINATION_BY_CUL3_COMPLEX,1
MIR362_5P,SET,50,-0.064535,-0.0033615,0.11595,0.71108,MIR362_5P,1
HP_MIGRAINE,SET,120,-0.043771,-0.0035253,0.078618,0.71115,HP_MIGRAINE,1
GOBP_AXONAL_TRANSPORT_OF_MIT...,SET,16,-0.1212,-0.0035744,0.21767,0.71116,GOBP_AXONAL_TRANSPORT_OF_MITOCHONDRION,1
GOBP_MYOBLAST_FATE_COMMITMENT,SET,6,-0.216,-0.0039021,0.38792,0.71117,GOBP_MYOBLAST_FATE_COMMITMENT,1
HP_SKIN_PLAQUE,SET,41,-0.072626,-0.0034264,0.13043,0.71117,HP_SKIN_PLAQUE,1
GSE19772_HCMV_INFL_VS_HCMV_I...2,SET,187,-0.034666,-0.0034789,0.062243,0.71121,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,1
GAUSSMANN_MLL_AF4_FUSION_TAR...13,SET,26,-0.092252,-0.0034673,0.16562,0.71124,GAUSSMANN_MLL_AF4_FUSION_TARGETS_G_DN,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...5,SET,15,-0.1244,-0.0035524,0.22326,0.7113,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_5,1
REACTOME_GLI_PROTEINS_BIND_P...,SET,7,-0.18657,-0.0036405,0.33473,0.71137,REACTOME_GLI_PROTEINS_BIND_PROMOTERS_OF_HH_RESPONSIVE_GENES_TO_PROMOTE_TRANSCRIPTION,1
MIR1909_3P,SET,120,-0.042837,-0.00345,0.076839,0.7114,MIR1909_3P,1
HP_ABNORMAL_DRINKING_BEHAVIOR,SET,50,-0.070554,-0.003675,0.12656,0.7114,HP_ABNORMAL_DRINKING_BEHAVIOR,1
ACEVEDO_NORMAL_TISSUE_ADJACE...1,SET,321,-0.025752,-0.0033735,0.046188,0.71142,ACEVEDO_NORMAL_TISSUE_ADJACENT_TO_LIVER_TUMOR_DN,1
GOBP_MYOBLAST_DIFFERENTIATION,SET,108,-0.046438,-0.0035493,0.08329,0.71142,GOBP_MYOBLAST_DIFFERENTIATION,1
WP_INTRAFLAGELLAR_TRANSPORT_...,SET,22,-0.098112,-0.0033925,0.17596,0.71143,WP_INTRAFLAGELLAR_TRANSPORT_PROTEINS_BINDING_TO_DYNEIN,1
TUBG1_TARGET_GENES,SET,2,-0.24013,-0.0025049,0.43065,0.71144,TUBG1_TARGET_GENES,1
HNF4_01_B,SET,233,-0.030063,-0.0033634,0.053892,0.71152,HNF4_01_B,1
ZNF618_TARGET_GENES,SET,1051,-0.01509,-0.0035039,0.027051,0.71153,ZNF618_TARGET_GENES,1
HP_FLATTENED_FEMORAL_EPIPHYS...,SET,12,-0.1327,-0.0033898,0.23787,0.71154,HP_FLATTENED_FEMORAL_EPIPHYSIS,1
ROAZ_01,SET,8,-0.14736,-0.0030738,0.2641,0.71157,ROAZ_01,1
HEDVAT_ELF4_TARGETS_UP,SET,12,-0.15978,-0.0040815,0.28625,0.71164,HEDVAT_ELF4_TARGETS_UP,1
GSE4142_PLASMA_CELL_VS_MEMOR...2,SET,176,-0.037029,-0.0036062,0.066338,0.71164,GSE4142_PLASMA_CELL_VS_MEMORY_BCELL_UP,1
WP_GENES_RELATED_TO_PRIMARY_...,SET,88,-0.047239,-0.0032609,0.084608,0.71168,WP_GENES_RELATED_TO_PRIMARY_CILIUM_DEVELOPMENT_BASED_ON_CRISPR,1
HP_BOWING_OF_THE_ARM,SET,38,-0.080269,-0.0036461,0.14374,0.71172,HP_BOWING_OF_THE_ARM,1
MIR4441,SET,271,-0.028549,-0.003441,0.0511,0.71181,MIR4441,1
GOBP_REGULATION_OF_CARDIAC_M...2,SET,27,-0.095384,-0.0036532,0.17071,0.71183,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
MIR548B_3P,SET,91,-0.048633,-0.0034136,0.087021,0.71187,MIR548B_3P,1
GCM_DFFA,SET,116,-0.03975,-0.003148,0.071125,0.71187,GCM_DFFA,1
GOMF_ESTROGEN_16_ALPHA_HYDRO...,SET,8,-0.17474,-0.0036448,0.31256,0.71193,GOMF_ESTROGEN_16_ALPHA_HYDROXYLASE_ACTIVITY,1
GOMF_TRANSFERASE_ACTIVITY_TR...2,SET,25,-0.10019,-0.0036928,0.17915,0.71201,GOMF_TRANSFERASE_ACTIVITY_TRANSFERRING_NITROGENOUS_GROUPS,1
REACTOME_DIGESTION_AND_ABSOR...,SET,22,-0.11451,-0.0039594,0.20474,0.71202,REACTOME_DIGESTION_AND_ABSORPTION,1
GOBP_REGULATION_OF_RYANODINE...,SET,20,-0.1224,-0.0040355,0.21882,0.71204,GOBP_REGULATION_OF_RYANODINE_SENSITIVE_CALCIUM_RELEASE_CHANNEL_ACTIVITY,1
GOBP_REGULATION_OF_DIGESTIVE...,SET,38,-0.079546,-0.0036132,0.1422,0.71205,GOBP_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
GOMF_IODIDE_TRANSMEMBRANE_TR...,SET,5,-0.16458,-0.0027142,0.29419,0.71206,GOMF_IODIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_DECREASED_ACTIVITY_OF_THE...,SET,10,-0.16947,-0.0039519,0.30289,0.71209,HP_DECREASED_ACTIVITY_OF_THE_PYRUVATE_DEHYDROGENASE_COMPLEX,1
HP_ABNORMALITIES_OF_PLACENTA...,SET,103,-0.049042,-0.003661,0.087645,0.7121,HP_ABNORMALITIES_OF_PLACENTA_OR_UMBILICAL_CORD,1
GOBP_POSITIVE_REGULATION_OF_...367,SET,8,-0.14834,-0.0030943,0.26511,0.71211,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,1
HP_ENTRAPMENT_NEUROPATHY,SET,10,-0.15143,-0.0035314,0.27058,0.71214,HP_ENTRAPMENT_NEUROPATHY,1
REACTOME_REACTIONS_SPECIFIC_...,SET,10,-0.15954,-0.0037204,0.28502,0.71217,REACTOME_REACTIONS_SPECIFIC_TO_THE_COMPLEX_N_GLYCAN_SYNTHESIS_PATHWAY,1
CEBALLOS_TARGETS_OF_TP53_AND...1,SET,29,-0.080816,-0.0032077,0.14435,0.71221,CEBALLOS_TARGETS_OF_TP53_AND_MYC_DN,1
JIANG_HYPOXIA_NORMAL,SET,189,-0.033239,-0.0033533,0.059367,0.71222,JIANG_HYPOXIA_NORMAL,1
REACTOME_IRS_ACTIVATION,SET,5,-0.24946,-0.004114,0.44547,0.71226,REACTOME_IRS_ACTIVATION,1
GOMF_GLUTAMATE_RECEPTOR_BIND...,SET,42,-0.072021,-0.0034389,0.1286,0.71227,GOMF_GLUTAMATE_RECEPTOR_BINDING,1
REACTOME_ASSEMBLY_OF_ACTIVE_...,SET,17,-0.12194,-0.0037069,0.21772,0.71228,REACTOME_ASSEMBLY_OF_ACTIVE_LPL_AND_LIPC_LIPASE_COMPLEXES,1
GOBP_RESPONSE_TO_ARSENIC_CON...,SET,30,-0.084421,-0.003408,0.15073,0.71228,GOBP_RESPONSE_TO_ARSENIC_CONTAINING_SUBSTANCE,1
GOBP_EOSINOPHIL_MEDIATED_IMM...,SET,8,-0.1566,-0.0032664,0.2796,0.71229,GOBP_EOSINOPHIL_MEDIATED_IMMUNITY,1
HP_SPASTIC_PARAPARETIC_GAIT,SET,9,-0.17086,-0.00378,0.30504,0.7123,HP_SPASTIC_PARAPARETIC_GAIT,1
HP_HYPOTHALAMIC_GONADOTROPIN...,SET,20,-0.11634,-0.0038356,0.20767,0.71232,HP_HYPOTHALAMIC_GONADOTROPIN_RELEASING_HORMONE_DEFICIENCY,1
GSE29615_DAY3_VS_DAY7_LAIV_F...1,SET,162,-0.037742,-0.0035278,0.067362,0.71236,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,1
GOBP_POSITIVE_REGULATION_OF_...435,SET,25,-0.096957,-0.0035735,0.17303,0.71237,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_MIGRATION,1
FIGUEROA_AML_METHYLATION_CLU...14,SET,104,-0.047956,-0.0035972,0.085548,0.71245,FIGUEROA_AML_METHYLATION_CLUSTER_7_UP,1
REACTOME_SYNTHESIS_OF_VERY_L...,SET,23,-0.11066,-0.0039121,0.19737,0.71248,REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS,1
chr20p13,SET,78,-0.11106,-0.0072197,0.19808,0.71249,chr20p13,1
LIANG_HEMATOPOIESIS_STEM_CEL...4,SET,33,-0.080092,-0.0033908,0.14284,0.71249,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_DN,1
GRAESSMANN_APOPTOSIS_BY_SERU...1,SET,215,-0.032555,-0.0035004,0.058057,0.71251,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN,1
MYLLYKANGAS_AMPLIFICATION_HO...6,SET,5,-0.21883,-0.0036089,0.39015,0.71256,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_2,1
MODULE_137,SET,495,-0.02276,-0.0036845,0.040576,0.71257,MODULE_137,1
HP_ABNORMAL_EUSTACHIAN_TUBE_...,SET,4,-0.30061,-0.0044343,0.53593,0.71257,HP_ABNORMAL_EUSTACHIAN_TUBE_MORPHOLOGY,1
GOMF_GLYCOLIPID_BINDING,SET,28,-0.08638,-0.003369,0.15397,0.71261,GOMF_GLYCOLIPID_BINDING,1
GOCC_BBAF_COMPLEX,SET,10,-0.17031,-0.0039715,0.30348,0.71266,GOCC_BBAF_COMPLEX,1
GOMF_SNRNP_BINDING,SET,9,-0.14193,-0.0031399,0.2529,0.71266,GOMF_SNRNP_BINDING,1
GOBP_EMBRYONIC_PLACENTA_DEVE...,SET,83,-0.053838,-0.0036098,0.095907,0.71272,GOBP_EMBRYONIC_PLACENTA_DEVELOPMENT,1
MIR1343_5P,SET,114,-0.043864,-0.0034439,0.078134,0.71273,MIR1343_5P,1
GSE32986_UNSTIM_VS_CURDLAN_H...2,SET,179,-0.034441,-0.0033823,0.061346,0.71274,GSE32986_UNSTIM_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,1
GOMF_U1_SNRNP_BINDING,SET,6,-0.16262,-0.0029378,0.28958,0.7128,GOMF_U1_SNRNP_BINDING,1
GSE23505_UNTREATED_VS_4DAY_I...5,SET,184,-0.035729,-0.003557,0.063593,0.71288,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TREATED_CD4_TCELL_DN,1
GOBP_AMINO_ACID_TRANSPORT,SET,147,-0.041202,-0.0036701,0.073332,0.71289,GOBP_AMINO_ACID_TRANSPORT,1
HP_ABNORMAL_PALMAR_DERMATOGL...,SET,226,-0.030635,-0.0033762,0.054511,0.71294,HP_ABNORMAL_PALMAR_DERMATOGLYPHICS,1
BUFFA_HYPOXIA_METAGENE,SET,44,-0.071617,-0.0034999,0.12737,0.71303,BUFFA_HYPOXIA_METAGENE,1
MIR4428,SET,114,-0.043662,-0.0034281,0.077647,0.71305,MIR4428,1
GOBP_MAINTENANCE_OF_PROTEIN_...5,SET,7,-0.19561,-0.0038167,0.34779,0.71309,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_EXTRACELLULAR_REGION,1
GOBP_REGULATION_OF_INTRINSIC...5,SET,3,-0.239,-0.0030532,0.42492,0.71309,GOBP_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,1
HP_GENERALIZED_CEREBRAL_ATRO...,SET,11,-0.13804,-0.0033761,0.24543,0.71309,HP_GENERALIZED_CEREBRAL_ATROPHY_HYPOPLASIA,1
GOBP_TRICUSPID_VALVE_DEVELOP...,SET,7,-0.20194,-0.0039402,0.35892,0.71315,GOBP_TRICUSPID_VALVE_DEVELOPMENT,1
HP_ABNORMAL_HEAD_BLOOD_VESSE...,SET,64,-0.063188,-0.0037222,0.1123,0.71317,HP_ABNORMAL_HEAD_BLOOD_VESSEL_MORPHOLOGY,1
ESC_J1_UP_EARLY.V1_UP,SET,155,-0.038815,-0.0035495,0.068982,0.71317,ESC_J1_UP_EARLY.V1_UP,1
GOBP_REGULATION_OF_CATION_CH...,SET,86,-0.055258,-0.0037711,0.098188,0.7132,GOBP_REGULATION_OF_CATION_CHANNEL_ACTIVITY,1
MIR5197_3P,SET,178,-0.036009,-0.0035265,0.063982,0.71321,MIR5197_3P,1
MIR635,SET,40,-0.078066,-0.0036379,0.13866,0.71327,MIR635,1
GOMF_HEXOSYLTRANSFERASE_ACTI...,SET,184,-0.037526,-0.0037359,0.066658,0.71327,GOMF_HEXOSYLTRANSFERASE_ACTIVITY,1
GOBP_ACUTE_INFLAMMATORY_RESP...1,SET,99,-0.052093,-0.003813,0.092523,0.71329,GOBP_ACUTE_INFLAMMATORY_RESPONSE,1
GSE7460_TREG_VS_TCONV_ACT_WI...2,SET,175,-0.037115,-0.0036044,0.065904,0.71334,GSE7460_TREG_VS_TCONV_ACT_WITH_TGFB_UP,1
HP_INCREASED_URINARY_PORPHOB...,SET,5,-0.22611,-0.0037289,0.4014,0.71338,HP_INCREASED_URINARY_PORPHOBILINOGEN,1
GSE19198_6H_VS_24H_IL21_TREA...2,SET,179,-0.036371,-0.0035718,0.064569,0.71338,GSE19198_6H_VS_24H_IL21_TREATED_TCELL_UP,1
GOBP_REGULATION_OF_TRANSLATI...11,SET,8,-0.15035,-0.0031362,0.26687,0.71341,GOBP_REGULATION_OF_TRANSLATION_INITIATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
HP_ABNORMAL_ISOHEMAGGLUTININ...,SET,7,-0.20094,-0.0039208,0.35654,0.71348,HP_ABNORMAL_ISOHEMAGGLUTININ_LEVEL,1
WP_LUNG_PATHOLOGY_OF_COVID19,SET,15,-0.12547,-0.003583,0.22261,0.7135,WP_LUNG_PATHOLOGY_OF_COVID19,1
GOCC_TRANSCRIPTION_FACTOR_TF...1,SET,5,-0.18444,-0.0030417,0.32718,0.71353,GOCC_TRANSCRIPTION_FACTOR_TFIIA_COMPLEX,1
GSE3982_MAC_VS_BCELL_DN,SET,163,-0.035298,-0.0033094,0.062614,0.71353,GSE3982_MAC_VS_BCELL_DN,1
GOBP_PROTON_TRANSMEMBRANE_TR...,SET,118,-0.043069,-0.0034399,0.076372,0.7136,GOBP_PROTON_TRANSMEMBRANE_TRANSPORT,1
HP_ABNORMAL_PROSODY,SET,61,-0.063286,-0.0036399,0.1122,0.71363,HP_ABNORMAL_PROSODY,1
REACTOME_CLASS_C_3_METABOTRO...,SET,37,-0.092464,-0.0041445,0.16385,0.71373,REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS,1
GOBP_MICTURITION,SET,8,-0.17529,-0.0036564,0.31061,0.71374,GOBP_MICTURITION,1
KEGG_FRUCTOSE_AND_MANNOSE_ME...,SET,28,-0.076622,-0.0029884,0.13573,0.7138,KEGG_FRUCTOSE_AND_MANNOSE_METABOLISM,1
GOBERT_OLIGODENDROCYTE_DIFFE...1,SET,979,-0.015829,-0.0035547,0.028034,0.71384,GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN,1
GCM_BNIP1,SET,67,-0.054497,-0.0032844,0.096498,0.71387,GCM_BNIP1,1
GOBP_NEGATIVE_REGULATION_OF_...328,SET,34,-0.078354,-0.003367,0.13874,0.71387,GOBP_NEGATIVE_REGULATION_OF_JNK_CASCADE,1
OLSSON_E2F3_TARGETS_DN,SET,33,-0.087734,-0.0037143,0.15533,0.7139,OLSSON_E2F3_TARGETS_DN,1
MIR3156_3P,SET,86,-0.048019,-0.003277,0.085,0.71393,MIR3156_3P,1
GOMF_GPI_LINKED_EPHRIN_RECEP...,SET,6,-0.22198,-0.00401,0.39294,0.71393,GOMF_GPI_LINKED_EPHRIN_RECEPTOR_ACTIVITY,1
MIR3923,SET,45,-0.068451,-0.0033829,0.12117,0.71394,MIR3923,1
HP_ALTERNATING_ESOTROPIA,SET,10,-0.14693,-0.0034263,0.26007,0.71394,HP_ALTERNATING_ESOTROPIA,1
USF_02,SET,237,-0.03098,-0.0034952,0.054832,0.71396,USF_02,1
REACTOME_REGULATION_OF_MITF_...4,SET,41,-0.076051,-0.003588,0.13459,0.71398,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION,1
MIR9985,SET,570,-0.020727,-0.0035931,0.036678,0.71399,MIR9985,1
AGCYRWTTC_UNKNOWN,SET,107,-0.046388,-0.0035291,0.08209,0.71399,AGCYRWTTC_UNKNOWN,1
OCT1_05,SET,222,-0.033921,-0.0037055,0.060022,0.71401,OCT1_05,1
MORI_PRE_BI_LYMPHOCYTE_DN,SET,71,-0.055974,-0.0034723,0.099024,0.71405,MORI_PRE_BI_LYMPHOCYTE_DN,1
REACTOME_MRNA_SPLICING,SET,191,-0.03073,-0.0031164,0.054335,0.71415,REACTOME_MRNA_SPLICING,1
GOBP_REGULATION_OF_CELLULAR_...10,SET,285,-0.029553,-0.0036515,0.05224,0.7142,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,1
HP_PIGMENTARY_RETINOPATHY,SET,163,-0.03677,-0.0034474,0.065,0.7142,HP_PIGMENTARY_RETINOPATHY,1
GOBP_INSULIN_SECRETION_INVOL...,SET,59,-0.060935,-0.0034469,0.10771,0.71421,GOBP_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
GOBP_ERYTHROCYTE_MATURATION,SET,18,-0.11212,-0.0035069,0.19816,0.71422,GOBP_ERYTHROCYTE_MATURATION,1
GOBP_REGULATION_OF_TUBE_SIZE,SET,140,-0.043847,-0.0038123,0.077494,0.71424,GOBP_REGULATION_OF_TUBE_SIZE,1
GOMF_NARROW_PORE_CHANNEL_ACT...,SET,19,-0.11596,-0.0037266,0.20494,0.71424,GOMF_NARROW_PORE_CHANNEL_ACTIVITY,1
MYLLYKANGAS_AMPLIFICATION_HO...5,SET,5,-0.22162,-0.0036549,0.39161,0.71427,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_18,1
REACTOME_SIGNALING_BY_LTK,SET,10,-0.14956,-0.0034877,0.26429,0.71427,REACTOME_SIGNALING_BY_LTK,1
SCHRAETS_MLL_TARGETS_DN,SET,32,-0.09461,-0.0039443,0.16714,0.71432,SCHRAETS_MLL_TARGETS_DN,1
CACGTTT_MIR302A,SET,29,-0.087963,-0.0034914,0.15539,0.71432,CACGTTT_MIR302A,1
GSE17186_BLOOD_VS_CORD_BLOOD...2,SET,187,-0.034264,-0.0034386,0.060518,0.71436,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_UP,1
BIOCARTA_AHSP_PATHWAY,SET,9,-0.1575,-0.0034845,0.27817,0.71437,BIOCARTA_AHSP_PATHWAY,1
GSE3039_NKT_CELL_VS_B2_BCELL...2,SET,190,-0.036466,-0.0036884,0.064404,0.71437,GSE3039_NKT_CELL_VS_B2_BCELL_UP,1
GSE26030_UNSTIM_VS_RESTIM_TH...4,SET,166,-0.038422,-0.003635,0.067837,0.71443,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_UP,1
MIR4714_3P,SET,53,-0.065719,-0.003524,0.116,0.71448,MIR4714_3P,1
MIR3606_3P,SET,331,-0.026388,-0.0035093,0.046573,0.7145,MIR3606_3P,1
MIR487A_5P,SET,94,-0.047893,-0.0034164,0.084512,0.71454,MIR487A_5P,1
MIR487B_5P,SET,94,-0.047893,-0.0034164,0.084512,0.71454,MIR487B_5P,1
GOBP_REGULATION_OF_AXON_GUID...,SET,11,-0.16731,-0.004092,0.29522,0.71455,GOBP_REGULATION_OF_AXON_GUIDANCE,1
HP_UNILATERAL_CLEFT_LIP,SET,8,-0.14242,-0.0029707,0.25125,0.71458,HP_UNILATERAL_CLEFT_LIP,1
HP_SYNOSTOSIS_INVOLVING_THE_...,SET,10,-0.15885,-0.0037044,0.28021,0.71461,HP_SYNOSTOSIS_INVOLVING_THE_ELBOW,1
GOMF_NEUTRAL_L_AMINO_ACID_TR...,SET,40,-0.07926,-0.0036936,0.13979,0.71463,GOMF_NEUTRAL_L_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_MRNA_MODIFICATION,SET,17,-0.10123,-0.0030773,0.17854,0.71464,GOBP_MRNA_MODIFICATION,1
GOBP_REGULATION_OF_STORE_OPE...1,SET,5,-0.19523,-0.0032196,0.34426,0.71467,GOBP_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,1
REACTOME_SYNTHESIS_OF_PE,SET,12,-0.14556,-0.0037181,0.2566,0.71472,REACTOME_SYNTHESIS_OF_PE,1
HP_RENAL_CORTICOMEDULLARY_CY...,SET,8,-0.16278,-0.0033953,0.28696,0.71472,HP_RENAL_CORTICOMEDULLARY_CYSTS,1
REACTOME_ROLE_OF_ABL_IN_ROBO...,SET,8,-0.16186,-0.0033763,0.28533,0.71474,REACTOME_ROLE_OF_ABL_IN_ROBO_SLIT_SIGNALING,1
GOBP_REGULATION_OF_BONE_MINE...2,SET,5,-0.22649,-0.0037352,0.39919,0.71477,GOBP_REGULATION_OF_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,1
HP_SHORT_LONG_BONE,SET,238,-0.030881,-0.0034913,0.054412,0.71482,HP_SHORT_LONG_BONE,1
WDHD1_TARGET_GENES,SET,148,-0.039269,-0.0035097,0.069181,0.71485,WDHD1_TARGET_GENES,1
HP_ABNORMAL_GASTROINTESTINAL...2,SET,6,-0.21102,-0.0038122,0.37171,0.71488,HP_ABNORMAL_GASTROINTESTINAL_VASCULAR_MORPHOLOGY,1
GOBP_CADMIUM_ION_TRANSMEMBRA...,SET,6,-0.20283,-0.0036642,0.35714,0.71495,GOBP_CADMIUM_ION_TRANSMEMBRANE_TRANSPORT,1
TATA_C,SET,259,-0.031277,-0.0036867,0.055067,0.71497,TATA_C,1
GOCC_ZONA_PELLUCIDA_RECEPTOR...,SET,8,-0.13848,-0.0028886,0.24382,0.71497,GOCC_ZONA_PELLUCIDA_RECEPTOR_COMPLEX,1
GAVIN_PDE3B_TARGETS,SET,20,-0.11372,-0.0037495,0.2002,0.715,GAVIN_PDE3B_TARGETS,1
GROSS_ELK3_TARGETS_UP,SET,25,-0.10534,-0.0038824,0.18542,0.71501,GROSS_ELK3_TARGETS_UP,1
HP_FEMORAL_HERNIA,SET,17,-0.11868,-0.0036077,0.20886,0.71506,HP_FEMORAL_HERNIA,1
GOBP_PURINE_CONTAINING_COMPO...1,SET,138,-0.039866,-0.0034415,0.070146,0.71509,GOBP_PURINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_RESPONSE_TO_SELENIUM_ION,SET,5,-0.19011,-0.0031352,0.33445,0.71512,GOBP_RESPONSE_TO_SELENIUM_ION,1
GAUTAM_EYE_IRIS_CILIARY_BODY...12,SET,104,-0.048107,-0.0036085,0.084633,0.71512,GAUTAM_EYE_IRIS_CILIARY_BODY_PIGMENTED_CILIARY_BODY_CELLS,1
HP_ABNORMALITY_OF_LIMB_BONE,SET,1523,-0.012711,-0.0035043,0.022357,0.71517,HP_ABNORMALITY_OF_LIMB_BONE,1
TRAVAGLINI_LUNG_MUCOUS_CELL,SET,116,-0.049522,-0.0039219,0.087083,0.71521,TRAVAGLINI_LUNG_MUCOUS_CELL,1
GOMF_NUCLEOTIDE_TRANSMEMBRAN...,SET,29,-0.096444,-0.003828,0.16957,0.71524,GOMF_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_NEUROTRANSMITTER_REUPTA...,SET,33,-0.090893,-0.003848,0.1598,0.71525,GOBP_NEUROTRANSMITTER_REUPTAKE,1
ZBTB12_TARGET_GENES,SET,1036,-0.015207,-0.0035071,0.026732,0.71527,ZBTB12_TARGET_GENES,1
GNF2_CENPE,SET,38,-0.077369,-0.0035144,0.136,0.71528,GNF2_CENPE,1
GOMF_P_TYPE_TRANSMEMBRANE_TR...,SET,22,-0.1003,-0.003468,0.1763,0.71528,GOMF_P_TYPE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...23,SET,6,-0.15537,-0.0028068,0.27306,0.71532,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM_EXIT_SITE,1
MIR654_5P,SET,95,-0.049119,-0.0035223,0.08632,0.71533,MIR654_5P,1
GOBP_NEGATIVE_REGULATION_OF_...197,SET,65,-0.055846,-0.0033152,0.098142,0.71533,GOBP_NEGATIVE_REGULATION_OF_ENDOCYTOSIS,1
GSE21380_NON_TFH_VS_GERMINAL...1,SET,184,-0.034396,-0.0034243,0.060445,0.71533,GSE21380_NON_TFH_VS_GERMINAL_CENTER_TFH_CD4_TCELL_DN,1
GAO_LARGE_INTESTINE_24W_C1_D...,SET,93,-0.055333,-0.0039261,0.097212,0.71539,GAO_LARGE_INTESTINE_24W_C1_DCLK1POS_PROGENITOR,1
REACTOME_GLUTAMATE_NEUROTRAN...,SET,23,-0.11076,-0.0039156,0.19456,0.71541,REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE,1
GOBP_PSEUDOPODIUM_ORGANIZATI...,SET,15,-0.12152,-0.0034702,0.21343,0.71545,GOBP_PSEUDOPODIUM_ORGANIZATION,1
HP_PHOTOSENSITIVE_TONIC_CLON...,SET,12,-0.15141,-0.0038675,0.2659,0.71546,HP_PHOTOSENSITIVE_TONIC_CLONIC_SEIZURE,1
GOBP_NORADRENERGIC_NEURON_DI...,SET,9,-0.20158,-0.0044596,0.35396,0.71549,GOBP_NORADRENERGIC_NEURON_DIFFERENTIATION,1
GSE27786_NKTCELL_VS_NEUTROPH...2,SET,175,-0.035249,-0.0034232,0.061887,0.71551,GSE27786_NKTCELL_VS_NEUTROPHIL_UP,1
MIR3157_3P,SET,35,-0.080923,-0.003528,0.142,0.71561,MIR3157_3P,1
HP_FEEDING_DIFFICULTIES_IN_I...,SET,509,-0.021119,-0.0034655,0.037057,0.71562,HP_FEEDING_DIFFICULTIES_IN_INFANCY,1
GSE37532_VISCERAL_ADIPOSE_TI...4,SET,156,-0.036097,-0.0033115,0.06334,0.71562,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_UP,1
MORF_HEAB,SET,79,-0.051091,-0.0033425,0.089635,0.71566,MORF_HEAB,1
GOBP_CELLULAR_RESPONSE_TO_IR...,SET,7,-0.18039,-0.0035198,0.31639,0.71571,GOBP_CELLULAR_RESPONSE_TO_IRON_ION,1
GOBP_ACYLGLYCEROL_HOMEOSTASIS,SET,38,-0.078449,-0.0035634,0.13758,0.71572,GOBP_ACYLGLYCEROL_HOMEOSTASIS,1
HP_VESTIBULAR_SCHWANNOMA,SET,6,-0.20084,-0.0036281,0.3522,0.71574,HP_VESTIBULAR_SCHWANNOMA,1
REACTOME_SYNTHESIS_OF_16_20_...,SET,9,-0.169,-0.0037389,0.2963,0.71578,REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE,1
MORF_DAP3,SET,175,-0.033298,-0.0032337,0.058381,0.71578,MORF_DAP3,1
GOBP_MIRNA_METABOLIC_PROCESS,SET,92,-0.050489,-0.0035632,0.088494,0.71584,GOBP_MIRNA_METABOLIC_PROCESS,1
CHIARETTI_ACUTE_LYMPHOBLASTI...,SET,63,-0.05689,-0.0033251,0.099703,0.71586,CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70,1
WP_AUTOPHAGY_IN_PANCREATIC_D...,SET,18,-0.11278,-0.0035276,0.19761,0.7159,WP_AUTOPHAGY_IN_PANCREATIC_DUCTAL_ADENOCARCINOMA,1
BOCHKIS_FOXA2_TARGETS,SET,394,-0.024439,-0.0035397,0.042813,0.71594,BOCHKIS_FOXA2_TARGETS,1
GOBP_NEGATIVE_REGULATION_OF_...168,SET,235,-0.032372,-0.003637,0.056704,0.71596,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE,1
GSE32986_UNSTIM_VS_CURDLAN_L...1,SET,176,-0.036217,-0.0035271,0.063414,0.71604,GSE32986_UNSTIM_VS_CURDLAN_LOWDOSE_STIM_DC_DN,1
REACTOME_MHC_CLASS_II_ANTIGE...,SET,117,-0.044357,-0.0035278,0.077632,0.71612,REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION,1
chr2q34,SET,15,-0.22067,-0.0063017,0.38618,0.71614,chr2q34,1
GSE29164_UNTREATED_VS_CD8_TC...8,SET,188,-0.035764,-0.0035986,0.062577,0.71618,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY7_UP,1
GAO_SMALL_INTESTINE_24W_C2_P...,SET,17,-0.12042,-0.0036606,0.21068,0.71619,GAO_SMALL_INTESTINE_24W_C2_PROCRPOS_PROGENITOR,1
GOBP_REGULATION_OF_PROTEIN_A...4,SET,4,-0.25048,-0.0036948,0.43821,0.7162,GOBP_REGULATION_OF_PROTEIN_AUTOUBIQUITINATION,1
HP_CHILBLAINS,SET,10,-0.14584,-0.0034009,0.25502,0.71629,HP_CHILBLAINS,1
GSE360_HIGH_DOSE_B_MALAYI_VS...3,SET,179,-0.03823,-0.0037544,0.066852,0.71629,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_DN,1
MIR6131,SET,89,-0.050236,-0.0034873,0.08784,0.7163,MIR6131,1
GSE5589_LPS_VS_LPS_AND_IL10_...7,SET,185,-0.035483,-0.003542,0.062038,0.71632,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_DN,1
GOCC_TERTIARY_GRANULE_LUMEN,SET,50,-0.07149,-0.0037237,0.12498,0.71635,GOCC_TERTIARY_GRANULE_LUMEN,1
WP_PARKINSONS_DISEASE_PATHWAY,SET,33,-0.08025,-0.0033974,0.14028,0.71636,WP_PARKINSONS_DISEASE_PATHWAY,1
DESCARTES_MAIN_FETAL_NEUROEN...,SET,27,-0.098644,-0.0037781,0.17242,0.71637,DESCARTES_MAIN_FETAL_NEUROENDOCRINE_CELLS,1
GOBP_TELOMERE_MAINTENANCE_IN...,SET,30,-0.082819,-0.0033433,0.14475,0.71638,GOBP_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,1
MIR6862_3P,SET,26,-0.084927,-0.003192,0.14842,0.71641,MIR6862_3P,1
GOBP_MODULATION_BY_HOST_OF_V...2,SET,43,-0.072904,-0.0035222,0.12738,0.71644,GOBP_MODULATION_BY_HOST_OF_VIRAL_PROCESS,1
GAUTAM_EYE_CHOROID_SCLERA_CH...,SET,128,-0.041829,-0.0034786,0.073086,0.71644,GAUTAM_EYE_CHOROID_SCLERA_CHOROID_ENDOTHELIAL_CELLS,1
P53_DECAMER_Q2,SET,233,-0.031508,-0.0035251,0.055049,0.71646,P53_DECAMER_Q2,1
BIOCARTA_IL7_PATHWAY,SET,16,-0.12401,-0.0036573,0.21663,0.71648,BIOCARTA_IL7_PATHWAY,1
GOMF_PHOSPHOLIPASE_C_ACTIVITY,SET,29,-0.085004,-0.0033739,0.14845,0.71654,GOMF_PHOSPHOLIPASE_C_ACTIVITY,1
HP_CONGENITAL_ABNORMAL_HAIR_...,SET,272,-0.028662,-0.003461,0.050056,0.71654,HP_CONGENITAL_ABNORMAL_HAIR_PATTERN,1
GOBP_POSITIVE_REGULATION_OF_...310,SET,15,-0.1354,-0.0038664,0.23645,0.71655,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_PATHOGEN_SALMON...5,SET,9,-0.16301,-0.0036064,0.28465,0.71656,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_RHOA_SIGNALING_PATHWAY,1
GSE7852_THYMUS_VS_FAT_TCONV_...1,SET,178,-0.037992,-0.0037207,0.066329,0.7166,GSE7852_THYMUS_VS_FAT_TCONV_DN,1
GSE21546_WT_VS_SAP1A_KO_AND_...2,SET,164,-0.038576,-0.0036277,0.067342,0.71662,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
GSE2770_TGFB_AND_IL4_ACT_VS_...3,SET,179,-0.036203,-0.0035553,0.063191,0.71664,GSE2770_TGFB_AND_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,1
GSE3982_BCELL_VS_TH2_DN,SET,173,-0.035887,-0.0034653,0.06264,0.71664,GSE3982_BCELL_VS_TH2_DN,1
GSE17974_1.5H_VS_72H_IL4_AND...1,SET,165,-0.034879,-0.0032899,0.060869,0.71668,GSE17974_1.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,1
HP_ABNORMAL_PLACENTA_MORPHOL...,SET,33,-0.092375,-0.0039108,0.16119,0.7167,HP_ABNORMAL_PLACENTA_MORPHOLOGY,1
MIR4305,SET,50,-0.067428,-0.0035121,0.11763,0.71675,MIR4305,1
MODULE_274,SET,76,-0.059834,-0.0038396,0.10437,0.71676,MODULE_274,1
GOBP_POSITIVE_REGULATION_OF_...844,SET,9,-0.16663,-0.0036864,0.29062,0.7168,GOBP_POSITIVE_REGULATION_OF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,1
HP_KINKED_BRAINSTEM,SET,4,-0.22044,-0.0032517,0.38438,0.71684,HP_KINKED_BRAINSTEM,1
HP_MENINGOENCEPHALOCELE,SET,4,-0.22044,-0.0032517,0.38438,0.71684,HP_MENINGOENCEPHALOCELE,1
DING_LUNG_CANCER_MUTATED_SIG...,SET,25,-0.10001,-0.0036859,0.1743,0.71693,DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY,1
HP_ATRIOVENTRICULAR_CANAL_DE...,SET,52,-0.062726,-0.0033317,0.10929,0.71699,HP_ATRIOVENTRICULAR_CANAL_DEFECT,1
HP_OSTEOMALACIA,SET,22,-0.10913,-0.0037735,0.19014,0.717,HP_OSTEOMALACIA,1
LUI_THYROID_CANCER_PAX8_PPAR...1,SET,44,-0.070616,-0.003451,0.12302,0.71701,LUI_THYROID_CANCER_PAX8_PPARG_DN,1
HP_MITRAL_ATRESIA,SET,11,-0.16608,-0.0040618,0.28934,0.71701,HP_MITRAL_ATRESIA,1
GOBP_PROTOPORPHYRINOGEN_IX_M...,SET,10,-0.14609,-0.0034067,0.2545,0.71702,GOBP_PROTOPORPHYRINOGEN_IX_METABOLIC_PROCESS,1
HP_CALVARIAL_SKULL_DEFECT,SET,27,-0.094013,-0.0036007,0.16376,0.71704,HP_CALVARIAL_SKULL_DEFECT,1
GOMF_VIRION_BINDING,SET,9,-0.16764,-0.0037089,0.292,0.71706,GOMF_VIRION_BINDING,1
GOBP_REGULATION_OF_MUSCLE_OR...,SET,23,-0.11952,-0.0042255,0.20811,0.71712,GOBP_REGULATION_OF_MUSCLE_ORGAN_DEVELOPMENT,1
HP_CHORIORETINAL_DEGENERATION,SET,48,-0.074497,-0.0038021,0.12969,0.71716,HP_CHORIORETINAL_DEGENERATION,1
REACTOME_PYRIMIDINE_CATABOLI...,SET,12,-0.147,-0.0037549,0.25582,0.71722,REACTOME_PYRIMIDINE_CATABOLISM,1
GOBP_VACUOLAR_TRANSPORT,SET,161,-0.037083,-0.0034555,0.064528,0.71724,GOBP_VACUOLAR_TRANSPORT,1
GOBP_REGULATION_OF_RECEPTOR_...5,SET,16,-0.1187,-0.0035007,0.2065,0.71729,GOBP_REGULATION_OF_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
DESCARTES_FETAL_EYE_RETINAL_...2,SET,10,-0.16951,-0.003953,0.2949,0.71729,DESCARTES_FETAL_EYE_RETINAL_PROGENITORS_AND_MULLER_GLIA,1
DESERT_PERIPORTAL_HEPATOCELL...,SET,147,-0.040783,-0.0036327,0.070935,0.71733,DESERT_PERIPORTAL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
HP_SELF_BITING,SET,8,-0.17688,-0.0036894,0.30762,0.71734,HP_SELF_BITING,1
REACTOME_BUTYRATE_RESPONSE_F...,SET,16,-0.10803,-0.0031861,0.18783,0.71741,REACTOME_BUTYRATE_RESPONSE_FACTOR_1_BRF1_BINDS_AND_DESTABILIZES_MRNA,1
GSE41978_ID2_KO_AND_BIM_KO_V...1,SET,177,-0.037375,-0.0036501,0.064982,0.71741,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
HP_ABNORMALITY_OF_THE_SPLEEN,SET,557,-0.020995,-0.0035992,0.03649,0.71748,HP_ABNORMALITY_OF_THE_SPLEEN,1
HP_INTRACELLULAR_ACCUMULATIO...,SET,13,-0.12497,-0.0033226,0.21714,0.71753,HP_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,1
chr15q23,SET,33,-0.14369,-0.006083,0.24965,0.71754,chr15q23,1
HP_CACHEXIA,SET,89,-0.048504,-0.0033671,0.084267,0.71755,HP_CACHEXIA,1
HP_ABNORMALITY_OF_HAIR_TEXTU...,SET,157,-0.037939,-0.0034915,0.065907,0.71757,HP_ABNORMALITY_OF_HAIR_TEXTURE,1
GSE37534_UNTREATED_VS_PIOGLI...2,SET,176,-0.035514,-0.0034587,0.061691,0.71758,GSE37534_UNTREATED_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,1
HP_THYROID_AGENESIS,SET,7,-0.20417,-0.0039839,0.35462,0.7176,HP_THYROID_AGENESIS,1
ABDELMOHSEN_ELAVL4_TARGETS,SET,15,-0.13104,-0.003742,0.22758,0.71762,ABDELMOHSEN_ELAVL4_TARGETS,1
GOBP_INTRINSIC_APOPTOTIC_SIG...6,SET,6,-0.18412,-0.0033262,0.31972,0.71765,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYDROGEN_PEROXIDE,1
WP_CILIARY_LANDSCAPE,SET,197,-0.033165,-0.0034151,0.057571,0.71771,WP_CILIARY_LANDSCAPE,1
REACTOME_CYTOCHROME_P450_ARR...,SET,63,-0.067837,-0.0039649,0.11773,0.71775,REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE,1
GOBP_L_AMINO_ACID_METABOLIC_...,SET,161,-0.038079,-0.0035484,0.066072,0.7178,GOBP_L_AMINO_ACID_METABOLIC_PROCESS,1
GSE5589_WT_VS_IL10_KO_LPS_AN...1,SET,103,-0.050023,-0.0037343,0.086787,0.71782,GSE5589_WT_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_DN,1
HINATA_NFKB_TARGETS_FIBROBLA...,SET,80,-0.055565,-0.003658,0.096392,0.71784,HINATA_NFKB_TARGETS_FIBROBLAST_UP,1
GOBP_VESICLE_MEDIATED_TRANSP...1,SET,1412,-0.013369,-0.0035605,0.023191,0.71785,GOBP_VESICLE_MEDIATED_TRANSPORT,1
HP_MELANOMA,SET,74,-0.052132,-0.0033013,0.090431,0.71785,HP_MELANOMA,1
HP_ABNORMAL_CIRCULATING_DICA...,SET,139,-0.041468,-0.0035926,0.071914,0.7179,HP_ABNORMAL_CIRCULATING_DICARBOXYLIC_ACID_CONCENTRATION,1
GAVISH_3CA_MALIGNANT_METAPRO...30,SET,45,-0.071048,-0.0035113,0.12321,0.71791,GAVISH_3CA_MALIGNANT_METAPROGRAM_38_GLUTATHIONE,1
GOBP_POST_EMBRYONIC_HEMOPOIE...,SET,5,-0.19777,-0.0032616,0.34258,0.71813,GOBP_POST_EMBRYONIC_HEMOPOIESIS,1
GOBP_GLUTAMATE_METABOLIC_PRO...,SET,32,-0.087922,-0.0036655,0.15228,0.71815,GOBP_GLUTAMATE_METABOLIC_PROCESS,1
GSE360_LOW_DOSE_B_MALAYI_VS_...4,SET,184,-0.034661,-0.0034506,0.060008,0.71823,GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_MAC_UP,1
GOBP_MITOCHONDRIAL_OUTER_MEM...,SET,26,-0.091072,-0.003423,0.15765,0.71826,GOBP_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION,1
MIR302C_5P,SET,524,-0.02194,-0.0036514,0.037975,0.71828,MIR302C_5P,1
HP_DUPLICATION_OF_THE_DISTAL...1,SET,12,-0.1322,-0.003377,0.22883,0.71828,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_HAND,1
GOBP_CEREBRAL_CORTEX_REGIONA...,SET,7,-0.22759,-0.0044407,0.39383,0.71832,GOBP_CEREBRAL_CORTEX_REGIONALIZATION,1
BASAKI_YBX1_TARGETS_UP,SET,261,-0.029136,-0.0034473,0.050373,0.7185,BASAKI_YBX1_TARGETS_UP,1
WP_PENTOSE_PHOSPHATE_PATHWAY...,SET,7,-0.19204,-0.0037471,0.33202,0.7185,WP_PENTOSE_PHOSPHATE_PATHWAY_IN_SENESCENT_CELLS,1
GOBP_SODIUM_ION_HOMEOSTASIS,SET,46,-0.080209,-0.0040077,0.13866,0.71851,GOBP_SODIUM_ION_HOMEOSTASIS,1
MORF_NOS2A,SET,263,-0.030655,-0.0036408,0.052981,0.71857,MORF_NOS2A,1
MIR5589_3P,SET,149,-0.04148,-0.0037196,0.071681,0.71859,MIR5589_3P,1
GSE5542_UNTREATED_VS_IFNG_TR...1,SET,167,-0.036664,-0.003479,0.063348,0.71863,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_DN,1
WP_CELL_LINEAGE_MAP_FOR_NEUR...,SET,122,-0.047716,-0.0038747,0.082429,0.71866,WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION,1
GOBP_POSITIVE_REGULATION_OF_...775,SET,340,-0.02697,-0.0036342,0.046588,0.71867,GOBP_POSITIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,1
REACTOME_CHROMATIN_MODIFICAT...,SET,7,-0.1837,-0.0035845,0.31718,0.71876,REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT,1
GOMF_ENZYME_INHIBITOR_ACTIVI...,SET,355,-0.027323,-0.0037605,0.047172,0.71878,GOMF_ENZYME_INHIBITOR_ACTIVITY,1
MIR130B_3P,SET,358,-0.026455,-0.0036561,0.045668,0.7188,MIR130B_3P,1
HP_MIOSIS,SET,25,-0.10632,-0.0039187,0.18354,0.71881,HP_MIOSIS,1
HE_LIM_SUN_FETAL_LUNG_C7_SST...,SET,333,-0.027786,-0.0037061,0.047956,0.71884,HE_LIM_SUN_FETAL_LUNG_C7_SST_POS_NEURON_CELL,1
GSE24671_BAKIMULC_VS_SENDAI_...1,SET,173,-0.034461,-0.0033276,0.059466,0.71887,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN,1
GOBP_MITOCHONDRIAL_RNA_MODIF...,SET,8,-0.15516,-0.0032365,0.26774,0.71888,GOBP_MITOCHONDRIAL_RNA_MODIFICATION,1
GOBP_ETHER_METABOLIC_PROCESS,SET,24,-0.10464,-0.0037787,0.18054,0.71889,GOBP_ETHER_METABOLIC_PROCESS,1
GSE2770_UNTREATED_VS_IL4_TRE...2,SET,188,-0.035512,-0.0035732,0.061272,0.7189,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_2H_UP,1
GSE32164_RESTING_DIFFERENTIA...3,SET,188,-0.035459,-0.0035679,0.061179,0.7189,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_DN,1
STARK_HYPPOCAMPUS_22Q11_DELE...1,SET,19,-0.14288,-0.0045916,0.24634,0.71904,STARK_HYPPOCAMPUS_22Q11_DELETION_DN,1
GSE3982_EOSINOPHIL_VS_TH2_DN,SET,180,-0.036086,-0.0035536,0.062167,0.71919,GSE3982_EOSINOPHIL_VS_TH2_DN,1
HP_ASPIRATION_PNEUMONIA,SET,88,-0.050648,-0.0034962,0.087238,0.71923,HP_ASPIRATION_PNEUMONIA,1
HP_PULMONARY_ARTERY_HYPOPLAS...,SET,8,-0.1898,-0.003959,0.32691,0.71924,HP_PULMONARY_ARTERY_HYPOPLASIA,1
GOCC_9PLUS0_NON_MOTILE_CILIUM,SET,114,-0.046058,-0.0036162,0.079324,0.71925,GOCC_9PLUS0_NON_MOTILE_CILIUM,1
GOCC_ENDOCYTIC_VESICLE_MEMBR...,SET,178,-0.038717,-0.0037918,0.066677,0.71927,GOCC_ENDOCYTIC_VESICLE_MEMBRANE,1
DING_LUNG_CANCER_MUTATED_REC...,SET,6,-0.19769,-0.0035713,0.34035,0.71933,DING_LUNG_CANCER_MUTATED_RECURRENTLY,1
MIR6868_3P,SET,241,-0.032864,-0.0037385,0.056574,0.71934,MIR6868_3P,1
GOBP_POSITIVE_REGULATION_OF_...138,SET,852,-0.018036,-0.0037922,0.031045,0.71936,GOBP_POSITIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,1
GOBP_MITOCHONDRIAL_DEPOLARIZ...,SET,21,-0.11346,-0.0038331,0.19526,0.71941,GOBP_MITOCHONDRIAL_DEPOLARIZATION,1
MODULE_560,SET,10,-0.14468,-0.0033739,0.24887,0.7195,MODULE_560,1
HP_DEATH_IN_INFANCY,SET,221,-0.031878,-0.0034745,0.054829,0.71951,HP_DEATH_IN_INFANCY,1
WP_HIPPOMERLIN_SIGNALING_DYS...,SET,113,-0.049156,-0.0038425,0.08453,0.71955,WP_HIPPOMERLIN_SIGNALING_DYSREGULATION,1
GSE26030_UNSTIM_VS_RESTIM_TH...8,SET,180,-0.036715,-0.0036156,0.063125,0.71959,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_UP,1
HP_HYPOGONADOTROPIC_HYPOGONA...,SET,146,-0.041147,-0.0036528,0.070739,0.7196,HP_HYPOGONADOTROPIC_HYPOGONADISM,1
HP_FOCAL_DYSTONIA,SET,122,-0.043119,-0.0035014,0.074114,0.71964,HP_FOCAL_DYSTONIA,1
PID_PTP1B_PATHWAY,SET,52,-0.072468,-0.0038492,0.12451,0.71972,PID_PTP1B_PATHWAY,1
HP_EXTRAHEPATIC_CHOLESTASIS,SET,10,-0.16978,-0.0039591,0.29165,0.71976,HP_EXTRAHEPATIC_CHOLESTASIS,1
LI_ESTROGENE_MCF7_E2_RESPONS...2,SET,46,-0.077356,-0.0038651,0.13287,0.71978,LI_ESTROGENE_MCF7_E2_RESPONSE_UP,1
GSE32986_GMCSF_AND_CURDLAN_L...1,SET,165,-0.039043,-0.0036827,0.067058,0.71979,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN,1
MIR205_5P,SET,201,-0.035196,-0.0036605,0.060437,0.71983,MIR205_5P,1
HE_LIM_SUN_FETAL_LUNG_C4_CYC...1,SET,594,-0.019216,-0.0033983,0.032997,0.71983,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL,1
WP_CELLULAR_PROTEOSTASIS,SET,5,-0.17403,-0.00287,0.29882,0.71984,WP_CELLULAR_PROTEOSTASIS,1
GOBP_SPERM_CAPACITATION,SET,29,-0.09079,-0.0036036,0.15589,0.71984,GOBP_SPERM_CAPACITATION,1
GOBP_OPSONIZATION,SET,15,-0.15039,-0.0042947,0.25821,0.71986,GOBP_OPSONIZATION,1
GSE6259_FLT3L_INDUCED_33D1_P...5,SET,130,-0.042863,-0.0035921,0.073592,0.71986,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_DN,1
GOMF_CCR_CHEMOKINE_RECEPTOR_...,SET,38,-0.096951,-0.0044039,0.16645,0.71987,GOMF_CCR_CHEMOKINE_RECEPTOR_BINDING,1
HP_ABNORMAL_ERYTHROCYTE_ENZY...,SET,37,-0.073929,-0.0033137,0.12691,0.71989,HP_ABNORMAL_ERYTHROCYTE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
MIR454_5P,SET,21,-0.10773,-0.0036394,0.18488,0.71994,MIR454_5P,1
HP_MULTIPLE_GLOMERULAR_CYSTS,SET,3,-0.30042,-0.0038379,0.51558,0.71994,HP_MULTIPLE_GLOMERULAR_CYSTS,1
WARTERS_IR_RESPONSE_5GY,SET,44,-0.069221,-0.0033829,0.11879,0.71995,WARTERS_IR_RESPONSE_5GY,1
GSE11864_UNTREATED_VS_CSF1_P...1,SET,176,-0.034816,-0.0033906,0.059748,0.71995,GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN,1
GSE17721_PAM3CSK4_VS_CPG_0.5...2,SET,179,-0.035459,-0.0034823,0.060831,0.72002,GSE17721_PAM3CSK4_VS_CPG_0.5H_BMDC_UP,1
GOMF_PHEROMONE_RECEPTOR_ACTI...,SET,3,-0.31523,-0.0040271,0.54022,0.72023,GOMF_PHEROMONE_RECEPTOR_ACTIVITY,1
BARRIER_COLON_CANCER_RECURRE...2,SET,37,-0.082954,-0.0037182,0.14215,0.72024,BARRIER_COLON_CANCER_RECURRENCE_UP,1
GOMF_THIOREDOXIN_DEPENDENT_P...,SET,4,-0.22435,-0.0033094,0.38444,0.72025,GOMF_THIOREDOXIN_DEPENDENT_PEROXIREDOXIN_ACTIVITY,1
HP_TETANY,SET,21,-0.11907,-0.0040226,0.20397,0.72031,HP_TETANY,1
GSE7768_OVA_ALONE_VS_OVA_WIT...3,SET,148,-0.039624,-0.0035414,0.067869,0.72033,GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,1
HP_ABNORMAL_LEFT_VENTRICLE_M...,SET,111,-0.044513,-0.0034488,0.076236,0.72035,HP_ABNORMAL_LEFT_VENTRICLE_MORPHOLOGY,1
MIR4633_5P,SET,38,-0.081944,-0.0037222,0.14033,0.72036,MIR4633_5P,1
MIR513B_5P,SET,254,-0.031247,-0.0036478,0.053505,0.72038,MIR513B_5P,1
WALLACE_PROSTATE_CANCER_RACE...1,SET,74,-0.056242,-0.0035616,0.096291,0.72041,WALLACE_PROSTATE_CANCER_RACE_DN,1
MIR6753_3P,SET,50,-0.071917,-0.003746,0.12313,0.72041,MIR6753_3P,1
GOBP_POSITIVE_REGULATION_OF_...634,SET,8,-0.18954,-0.0039536,0.32452,0.72041,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
REACTOME_O_GLYCOSYLATION_OF_...,SET,36,-0.090794,-0.0040144,0.15541,0.72046,REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS,1
GOBP_REGULATION_OF_EARLY_END...,SET,16,-0.13278,-0.0039159,0.22717,0.72054,GOBP_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,1
PID_PI3KCI_PATHWAY,SET,47,-0.071457,-0.0036089,0.12224,0.72057,PID_PI3KCI_PATHWAY,1
MAHADEVAN_IMATINIB_RESISTANC...2,SET,17,-0.13804,-0.0041962,0.23612,0.72058,MAHADEVAN_IMATINIB_RESISTANCE_UP,1
KEGG_PROPANOATE_METABOLISM,SET,31,-0.088059,-0.0036135,0.15062,0.7206,KEGG_PROPANOATE_METABOLISM,1
GAO_LARGE_INTESTINE_ADULT_CF...,SET,22,-0.10978,-0.0037959,0.18776,0.72061,GAO_LARGE_INTESTINE_ADULT_CF_GOBLET_CELL_SUBTYPE_1,1
TGASTMAGC_NFE2_01,SET,172,-0.037459,-0.0036067,0.06406,0.72064,TGASTMAGC_NFE2_01,1
MODULE_366,SET,29,-0.087071,-0.0034559,0.1489,0.72064,MODULE_366,1
GOMF_FRUCTOSE_6_PHOSPHATE_BI...,SET,4,-0.19515,-0.0028786,0.33373,0.72064,GOMF_FRUCTOSE_6_PHOSPHATE_BINDING,1
GSE30971_CTRL_VS_LPS_STIM_MA...1,SET,173,-0.037562,-0.0036271,0.064203,0.72074,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_HET_2H_DN,1
HP_BARRETT_ESOPHAGUS,SET,6,-0.20289,-0.0036653,0.34674,0.72077,HP_BARRETT_ESOPHAGUS,1
HP_VITRITIS,SET,2,-0.51717,-0.0053947,0.88375,0.72079,HP_VITRITIS,1
MORF_IFNA1,SET,175,-0.03859,-0.0037476,0.065929,0.72083,MORF_IFNA1,1
HP_WIDELY_SPACED_PRIMARY_TEE...,SET,5,-0.22404,-0.0036947,0.38268,0.72087,HP_WIDELY_SPACED_PRIMARY_TEETH,1
GOBP_FAT_CELL_DIFFERENTIATION,SET,218,-0.03544,-0.0038368,0.060532,0.72088,GOBP_FAT_CELL_DIFFERENTIATION,1
GOMF_INSULIN_LIKE_GROWTH_FAC...2,SET,8,-0.20841,-0.0043472,0.35592,0.72091,GOMF_INSULIN_LIKE_GROWTH_FACTOR_II_BINDING,1
GOBP_MORPHOGENESIS_OF_A_BRAN...,SET,189,-0.038629,-0.0038971,0.065958,0.72094,GOBP_MORPHOGENESIS_OF_A_BRANCHING_STRUCTURE,1
GSE22033_UNTREATED_VS_MRL24_...1,SET,176,-0.037494,-0.0036515,0.063989,0.72104,GSE22033_UNTREATED_VS_MRL24_TREATED_MEF_DN,1
HP_DEMYELINATING_PERIPHERAL_...,SET,49,-0.068964,-0.0035561,0.11768,0.72107,HP_DEMYELINATING_PERIPHERAL_NEUROPATHY,1
LEE_LIVER_CANCER_MYC_E2F1_UP,SET,55,-0.072654,-0.0039685,0.12396,0.72109,LEE_LIVER_CANCER_MYC_E2F1_UP,1
GOBP_CELLULAR_RESPONSE_TO_TH...,SET,12,-0.1571,-0.004013,0.26798,0.72114,GOBP_CELLULAR_RESPONSE_TO_THYROID_HORMONE_STIMULUS,1
HP_ABNORMAL_CIRCULATING_SEX_...,SET,108,-0.047748,-0.0036495,0.08142,0.72121,HP_ABNORMAL_CIRCULATING_SEX_HORMONE_CONCENTRATION,1
GOBP_REGULATION_OF_MITOTIC_C...2,SET,311,-0.02786,-0.0035933,0.047499,0.72124,GOBP_REGULATION_OF_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
GSE4748_CYANOBACTERIUM_LPSLI...1,SET,159,-0.040523,-0.0037527,0.069073,0.72128,GSE4748_CYANOBACTERIUM_LPSLIKE_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
GSE22935_UNSTIM_VS_24H_MBOVI...2,SET,189,-0.036276,-0.0036597,0.061833,0.72129,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MACROPHAGE_UP,1
GSE32423_MEMORY_VS_NAIVE_CD8...1,SET,176,-0.037723,-0.0036738,0.064299,0.72129,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_DN,1
REACTOME_ADAPTIVE_IMMUNE_SYS...,SET,707,-0.018908,-0.0036364,0.032226,0.72131,REACTOME_ADAPTIVE_IMMUNE_SYSTEM,1
REACTOME_DNA_DAMAGE_REVERSAL,SET,8,-0.17378,-0.0036248,0.29608,0.72137,REACTOME_DNA_DAMAGE_REVERSAL,1
GOBP_POSITIVE_REGULATION_OF_...194,SET,13,-0.14695,-0.003907,0.25027,0.72146,GOBP_POSITIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
WIEDERSCHAIN_TARGETS_OF_BMI1...,SET,55,-0.072613,-0.0039663,0.12365,0.72147,WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2,1
GOBP_EMBRYONIC_BRAIN_DEVELOP...,SET,15,-0.13565,-0.0038738,0.23096,0.72151,GOBP_EMBRYONIC_BRAIN_DEVELOPMENT,1
RORA1_01,SET,219,-0.033796,-0.0036671,0.057533,0.72153,RORA1_01,1
GOBP_POSITIVE_REGULATION_OF_...626,SET,10,-0.18398,-0.0042904,0.31318,0.72155,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_A_SIGNALING,1
GOCC_HISTONE_DEACETYLASE_COM...,SET,73,-0.05354,-0.0033675,0.091131,0.72156,GOCC_HISTONE_DEACETYLASE_COMPLEX,1
GSE17721_POLYIC_VS_PAM3CSK4_...11,SET,186,-0.036809,-0.0036842,0.06263,0.72164,GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_DN,1
HP_MACULAR_THICKENING,SET,38,-0.081916,-0.0037209,0.13935,0.72167,HP_MACULAR_THICKENING,1
GSE15624_CTRL_VS_3H_HALOFUGI...1,SET,144,-0.039229,-0.0034588,0.066713,0.72174,GSE15624_CTRL_VS_3H_HALOFUGINONE_TREATED_CD4_TCELL_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...2,SET,62,-0.068875,-0.0039936,0.11707,0.72184,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1,1
HP_ABNORMAL_CALVARIA_MORPHOL...,SET,859,-0.016835,-0.0035534,0.028607,0.72189,HP_ABNORMAL_CALVARIA_MORPHOLOGY,1
HP_ABNORMAL_MYOCARDIUM_MORPH...,SET,511,-0.021526,-0.0035391,0.036578,0.72189,HP_ABNORMAL_MYOCARDIUM_MORPHOLOGY,1
MIR491_5P,SET,97,-0.049381,-0.0035779,0.0839,0.72192,MIR491_5P,1
GOBP_L_CYSTINE_TRANSPORT,SET,6,-0.19895,-0.003594,0.33801,0.72193,GOBP_L_CYSTINE_TRANSPORT,1
GSE360_L_DONOVANI_VS_M_TUBER...2,SET,177,-0.037296,-0.0036424,0.06336,0.72194,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_DC_UP,1
chr8q24,SET,152,-0.085332,-0.0077281,0.14489,0.72205,chr8q24,1
GOBP_CARDIAC_MUSCLE_CELL_PRO...,SET,45,-0.081147,-0.0040104,0.13777,0.72206,GOBP_CARDIAC_MUSCLE_CELL_PROLIFERATION,1
GAO_LARGE_INTESTINE_24W_C11_...,SET,293,-0.031777,-0.0039801,0.053952,0.72206,GAO_LARGE_INTESTINE_24W_C11_PANETH_LIKE_CELL,1
HAY_BONE_MARROW_CD34_POS_PRE...2,SET,96,-0.053672,-0.0038688,0.091119,0.72207,HAY_BONE_MARROW_CD34_POS_PRE_PC,1
WU_HBX_TARGETS_3_DN,SET,13,-0.14656,-0.0038965,0.24878,0.7221,WU_HBX_TARGETS_3_DN,1
MIR3945,SET,34,-0.083078,-0.00357,0.14102,0.72211,MIR3945,1
GOBP_EPITHELIAL_TO_MESENCHYM...2,SET,18,-0.13504,-0.0042241,0.22923,0.72211,GOBP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_INVOLVED_IN_ENDOCARDIAL_CUSHION_FORMATION,1
GOBP_AUTOPHAGOSOME_MATURATION,SET,60,-0.056957,-0.003249,0.096668,0.72213,GOBP_AUTOPHAGOSOME_MATURATION,1
HP_SUDDEN_LOSS_OF_VISUAL_ACU...,SET,5,-0.20275,-0.0033436,0.34408,0.72215,HP_SUDDEN_LOSS_OF_VISUAL_ACUITY,1
GOCC_AXONEMAL_MICROTUBULE,SET,26,-0.096148,-0.0036138,0.16314,0.72218,GOCC_AXONEMAL_MICROTUBULE,1
MIR204_5P,SET,347,-0.027171,-0.0036981,0.046089,0.72225,MIR204_5P,1
GOBP_RESPONSE_TO_CYTOKINE,SET,858,-0.018245,-0.0038489,0.030931,0.72235,GOBP_RESPONSE_TO_CYTOKINE,1
GOCC_CATALYTIC_STEP_2_SPLICE...,SET,83,-0.049127,-0.0032939,0.083271,0.72239,GOCC_CATALYTIC_STEP_2_SPLICEOSOME,1
HENDRICKS_SMARCA4_TARGETS_DN,SET,41,-0.085001,-0.0040102,0.14403,0.72245,HENDRICKS_SMARCA4_TARGETS_DN,1
GSE17186_NAIVE_VS_CD21LOW_TR...3,SET,180,-0.037,-0.0036437,0.062678,0.72251,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_DN,1
KEGG_O_GLYCAN_BIOSYNTHESIS,SET,27,-0.10972,-0.0042023,0.18584,0.72254,KEGG_O_GLYCAN_BIOSYNTHESIS,1
GOBP_ENDOTHELIAL_CELL_ACTIVA...,SET,9,-0.18964,-0.0041955,0.32119,0.72254,GOBP_ENDOTHELIAL_CELL_ACTIVATION,1
MIR4797_5P,SET,105,-0.046387,-0.0034961,0.078553,0.72257,MIR4797_5P,1
GSE25123_IL4_VS_IL4_AND_ROSI...4,SET,125,-0.042948,-0.0035298,0.072723,0.72259,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_DAY10_UP,1
GSE27786_CD8_TCELL_VS_NKTCEL...1,SET,180,-0.037241,-0.0036674,0.063059,0.72259,GSE27786_CD8_TCELL_VS_NKTCELL_DN,1
HP_LUMBAR_SCOLIOSIS,SET,15,-0.11756,-0.003357,0.19894,0.7227,HP_LUMBAR_SCOLIOSIS,1
MIR539_3P,SET,207,-0.036511,-0.0038529,0.061776,0.72274,MIR539_3P,1
GOBP_CELLULAR_RESPONSE_TO_IO...,SET,66,-0.059403,-0.0035534,0.10048,0.72281,GOBP_CELLULAR_RESPONSE_TO_IONIZING_RADIATION,1
HP_ERYTHEMATOUS_PLAQUE,SET,13,-0.12247,-0.0032559,0.20714,0.72281,HP_ERYTHEMATOUS_PLAQUE,1
HP_FAILURE_TO_THRIVE_SECONDA...,SET,6,-0.21399,-0.0038658,0.36193,0.72282,HP_FAILURE_TO_THRIVE_SECONDARY_TO_RECURRENT_INFECTIONS,1
HP_FUNCTIONAL_ABNORMALITY_OF...2,SET,1080,-0.015627,-0.0036752,0.026431,0.72282,HP_FUNCTIONAL_ABNORMALITY_OF_THE_GASTROINTESTINAL_TRACT,1
RODRIGUES_THYROID_CARCINOMA_...5,SET,586,-0.020415,-0.0035867,0.034516,0.72289,RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP,1
MIR6853_3P,SET,186,-0.036415,-0.0036447,0.061563,0.72291,MIR6853_3P,1
BIOCARTA_PPARG_PATHWAY,SET,8,-0.19646,-0.0040979,0.33204,0.72296,BIOCARTA_PPARG_PATHWAY,1
NFY_01,SET,230,-0.03456,-0.0038419,0.05841,0.72296,NFY_01,1
GSE32901_TH1_VS_TH17_NEG_CD4...2,SET,114,-0.047274,-0.0037116,0.079893,0.72297,GSE32901_TH1_VS_TH17_NEG_CD4_TCELL_UP,1
MORF_REV3L,SET,55,-0.061416,-0.0033547,0.10373,0.7231,MORF_REV3L,1
HP_ABNORMAL_CORONARY_ARTERY_...2,SET,6,-0.19773,-0.0035721,0.33387,0.72315,HP_ABNORMAL_CORONARY_ARTERY_ORIGIN,1
GOBP_REGULATION_OF_MYOBLAST_...1,SET,70,-0.061348,-0.0037789,0.10355,0.72321,GOBP_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
GOBP_ADENOSINE_TO_INOSINE_ED...,SET,6,-0.22559,-0.0040753,0.38078,0.72322,GOBP_ADENOSINE_TO_INOSINE_EDITING,1
FIGUEROA_AML_METHYLATION_CLU...6,SET,151,-0.041775,-0.003771,0.070499,0.72326,FIGUEROA_AML_METHYLATION_CLUSTER_3_UP,1
CAFFAREL_RESPONSE_TO_THC_24H...3,SET,44,-0.071548,-0.0034966,0.12074,0.72327,CAFFAREL_RESPONSE_TO_THC_24HR_5_DN,1
HP_ABSENT_SEPTUM_PELLUCIDUM,SET,54,-0.067308,-0.003643,0.11358,0.72327,HP_ABSENT_SEPTUM_PELLUCIDUM,1
GOMF_GLUCOSE_SODIUM_SYMPORTE...,SET,7,-0.19584,-0.0038212,0.33043,0.72329,GOMF_GLUCOSE_SODIUM_SYMPORTER_ACTIVITY,1
GSE19941_IL10_KO_VS_IL10_KO_...3,SET,179,-0.036125,-0.0035477,0.060949,0.7233,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_DN,1
GOBP_CELL_CYCLE_G1_S_PHASE_T...,SET,222,-0.034686,-0.0037891,0.05852,0.72332,GOBP_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
GOBP_NEGATIVE_REGULATION_OF_...445,SET,7,-0.16604,-0.0032398,0.28009,0.72334,GOBP_NEGATIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,1
GSE5589_LPS_VS_LPS_AND_IL10_...11,SET,186,-0.035825,-0.0035857,0.06043,0.72335,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN,1
HP_PLATYBASIA,SET,16,-0.144,-0.004247,0.2429,0.72336,HP_PLATYBASIA,1
GSE16450_CTRL_VS_IFNA_6H_STI...2,SET,180,-0.038111,-0.0037531,0.064261,0.72343,GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP,1
BUSSLINGER_DUODENAL_PANETH_C...,SET,15,-0.15152,-0.004327,0.25539,0.7235,BUSSLINGER_DUODENAL_PANETH_CELLS,1
MIR1299,SET,300,-0.029582,-0.0037485,0.049854,0.72353,MIR1299,1
MIR12116,SET,48,-0.067075,-0.0034233,0.11301,0.72358,MIR12116,1
chr6q21,SET,46,-0.12748,-0.0063696,0.21473,0.72363,chr6q21,1
KEGG_LONG_TERM_DEPRESSION,SET,66,-0.064295,-0.003846,0.10829,0.72366,KEGG_LONG_TERM_DEPRESSION,1
VALK_AML_WITH_11Q23_REARRANG...,SET,17,-0.12305,-0.0037406,0.20721,0.72368,VALK_AML_WITH_11Q23_REARRANGED,1
MODULE_445,SET,11,-0.15348,-0.0037537,0.25842,0.72371,MODULE_445,1
GOCC_ORGANELLE_MEMBRANE_CONT...,SET,40,-0.076072,-0.0035451,0.12809,0.72371,GOCC_ORGANELLE_MEMBRANE_CONTACT_SITE,1
MIR939_5P,SET,114,-0.046562,-0.0036557,0.078396,0.72372,MIR939_5P,1
HP_SCALING_SKIN,SET,42,-0.078049,-0.0037268,0.13138,0.72376,HP_SCALING_SKIN,1
GOBP_ENUCLEATE_ERYTHROCYTE_D...1,SET,5,-0.2575,-0.0042466,0.43341,0.72378,GOBP_ENUCLEATE_ERYTHROCYTE_DEVELOPMENT,1
GOBP_CDC42_PROTEIN_SIGNAL_TR...,SET,15,-0.14607,-0.0041713,0.24581,0.72382,GOBP_CDC42_PROTEIN_SIGNAL_TRANSDUCTION,1
AIZARANI_LIVER_C31_KUPFFER_C...,SET,107,-0.049776,-0.0037869,0.083752,0.72385,AIZARANI_LIVER_C31_KUPFFER_CELLS_5,1
GOBP_REGULATION_OF_RESPONSE_...8,SET,16,-0.12874,-0.0037969,0.2166,0.72387,GOBP_REGULATION_OF_RESPONSE_TO_OSMOTIC_STRESS,1
NIKOLSKY_BREAST_CANCER_7P15_...,SET,11,-0.2424,-0.0059285,0.4078,0.72388,NIKOLSKY_BREAST_CANCER_7P15_AMPLICON,1
GOBP_VESICLE_TARGETING,SET,62,-0.056124,-0.0032543,0.094417,0.72388,GOBP_VESICLE_TARGETING,1
GSE9006_TYPE_1_VS_TYPE_2_DIA...2,SET,181,-0.034197,-0.0033769,0.057513,0.72394,GSE9006_TYPE_1_VS_TYPE_2_DIABETES_PBMC_AT_DX_UP,1
GSE37605_C57BL6_VS_NOD_FOXP3...1,SET,169,-0.038007,-0.0036277,0.063917,0.72395,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TCONV_DN,1
HP_THYROID_CARCINOMA,SET,57,-0.06798,-0.0037799,0.11431,0.72398,HP_THYROID_CARCINOMA,1
HP_PREMATURE_ADRENARCHE,SET,10,-0.17978,-0.0041925,0.30214,0.72409,HP_PREMATURE_ADRENARCHE,1
REACTOME_TNFR2_NON_CANONICAL...,SET,95,-0.050285,-0.0036059,0.084483,0.72414,REACTOME_TNFR2_NON_CANONICAL_NF_KB_PATHWAY,1
GOBP_REGULATION_OF_CARTILAGE...,SET,62,-0.068649,-0.0039805,0.11534,0.72414,GOBP_REGULATION_OF_CARTILAGE_DEVELOPMENT,1
XU_HGF_SIGNALING_NOT_VIA_AKT...1,SET,18,-0.11201,-0.0035037,0.18818,0.72415,XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_DN,1
MIR6875_3P,SET,361,-0.02686,-0.0037272,0.04512,0.72418,MIR6875_3P,1
GOMF_TRANSMEMBRANE_EPHRIN_RE...,SET,15,-0.14886,-0.004251,0.25001,0.72422,GOMF_TRANSMEMBRANE_EPHRIN_RECEPTOR_ACTIVITY,1
chr7q34,SET,50,-0.12809,-0.006672,0.21511,0.72423,chr7q34,1
GOBP_INTEGRATED_STRESS_RESPO...,SET,44,-0.076741,-0.0037504,0.12888,0.72423,GOBP_INTEGRATED_STRESS_RESPONSE_SIGNALING,1
GARGALOVIC_RESPONSE_TO_OXIDI...10,SET,16,-0.12616,-0.0037207,0.21185,0.72424,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP,1
GOBP_BLASTOCYST_DEVELOPMENT,SET,110,-0.04717,-0.0036383,0.079208,0.72425,GOBP_BLASTOCYST_DEVELOPMENT,1
GOCC_CIS_GOLGI_NETWORK,SET,56,-0.060771,-0.0033494,0.10204,0.72426,GOCC_CIS_GOLGI_NETWORK,1
GSE35825_IFNA_VS_IFNG_STIM_M...1,SET,178,-0.035728,-0.003499,0.059989,0.72427,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...35,SET,7,-0.17493,-0.0034133,0.29366,0.7243,HP_APLASIA_HYPOPLASIA_OF_THE_GALLBLADDER,1
GOBP_INTERLEUKIN_18_PRODUCTI...,SET,12,-0.13777,-0.0035192,0.23124,0.72434,GOBP_INTERLEUKIN_18_PRODUCTION,1
GOBP_PRIMITIVE_HEMOPOIESIS,SET,8,-0.19409,-0.0040486,0.32573,0.72436,GOBP_PRIMITIVE_HEMOPOIESIS,1
HP_SHORT_LOWER_LIMBS,SET,12,-0.14326,-0.0036595,0.24043,0.72436,HP_SHORT_LOWER_LIMBS,1
GOBP_ANTIGEN_PROCESSING_AND_...6,SET,36,-0.089692,-0.0039657,0.15051,0.72438,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN,1
GAO_ESOPHAGUS_25W_C3_FGFR1LO...,SET,43,-0.07472,-0.00361,0.12539,0.72438,GAO_ESOPHAGUS_25W_C3_FGFR1LOW_EPITHELIAL_CELLS,1
GSE11057_EFF_MEM_VS_CENT_MEM...2,SET,169,-0.03992,-0.0038104,0.066975,0.72442,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_UP,1
GOBP_DEVELOPMENTAL_GROWTH,SET,587,-0.021811,-0.0038352,0.036593,0.72443,GOBP_DEVELOPMENTAL_GROWTH,1
HP_ABNORMAL_CIRCULATING_ADRE...,SET,42,-0.077877,-0.0037186,0.13063,0.72446,HP_ABNORMAL_CIRCULATING_ADRENOCORTICOTROPIN_CONCENTRATION,1
GOBP_FAT_CELL_PROLIFERATION,SET,15,-0.14086,-0.0040226,0.23626,0.72448,GOBP_FAT_CELL_PROLIFERATION,1
HP_DYSPLASIA_OF_THE_FEMORAL_...,SET,5,-0.21582,-0.0035593,0.36194,0.72451,HP_DYSPLASIA_OF_THE_FEMORAL_HEAD,1
GOMF_POSTSYNAPTIC_NEUROTRANS...,SET,67,-0.067881,-0.004091,0.11381,0.72455,GOMF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
TBK1.DN.48HRS_UP,SET,48,-0.069377,-0.0035409,0.11631,0.72457,TBK1.DN.48HRS_UP,1
ZNF581_TARGET_GENES,SET,266,-0.030387,-0.0036291,0.050939,0.72458,ZNF581_TARGET_GENES,1
GOCC_SCF_UBIQUITIN_LIGASE_CO...,SET,59,-0.067657,-0.0038272,0.11336,0.72469,GOCC_SCF_UBIQUITIN_LIGASE_COMPLEX,1
GOMF_INTEGRIN_BINDING_INVOLV...,SET,5,-0.24434,-0.0040296,0.40932,0.72472,GOMF_INTEGRIN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,1
HP_ABNORMAL_CIRCULATING_LIPI...,SET,290,-0.030274,-0.0037727,0.050716,0.72472,HP_ABNORMAL_CIRCULATING_LIPID_CONCENTRATION,1
GOBP_PROTEIN_OXIDATION,SET,12,-0.16023,-0.004093,0.26836,0.72477,GOBP_PROTEIN_OXIDATION,1
WP_PRADERWILLI_AND_ANGELMAN_...,SET,93,-0.056738,-0.0040258,0.095007,0.72481,WP_PRADERWILLI_AND_ANGELMAN_SYNDROME,1
MIR6764_5P,SET,213,-0.034921,-0.0037375,0.058473,0.72481,MIR6764_5P,1
WP_TAR_SYNDROME,SET,49,-0.073,-0.0037643,0.12221,0.72485,WP_TAR_SYNDROME,1
NABA_MATRISOME_MULTIPLE_MYEL...,SET,9,-0.18889,-0.0041789,0.31621,0.72486,NABA_MATRISOME_MULTIPLE_MYELOMA,1
HP_ANGIOSARCOMA,SET,5,-0.22782,-0.0037571,0.38123,0.72494,HP_ANGIOSARCOMA,1
HP_HYPOPLASIA_OF_THE_IRIS,SET,30,-0.099271,-0.0040074,0.16611,0.72495,HP_HYPOPLASIA_OF_THE_IRIS,1
GOBP_FORMATION_OF_ANATOMICAL...,SET,6,-0.20581,-0.003718,0.34437,0.72496,GOBP_FORMATION_OF_ANATOMICAL_BOUNDARY,1
HP_REDUCED_C_PEPTIDE_LEVEL,SET,7,-0.21624,-0.0042193,0.36179,0.72497,HP_REDUCED_C_PEPTIDE_LEVEL,1
AKT_UP.V1_UP,SET,149,-0.041811,-0.0037493,0.069935,0.72503,AKT_UP.V1_UP,1
HP_SYNOVIAL_LINING_HYPERPLAS...,SET,8,-0.1928,-0.0040216,0.32232,0.72513,HP_SYNOVIAL_LINING_HYPERPLASIA,1
GSE22886_NAIVE_BCELL_VS_MONO...1,SET,189,-0.036905,-0.0037232,0.061693,0.72515,GSE22886_NAIVE_BCELL_VS_MONOCYTE_DN,1
DESCARTES_FETAL_PANCREAS_VAS...,SET,54,-0.074717,-0.0040441,0.12487,0.7252,DESCARTES_FETAL_PANCREAS_VASCULAR_ENDOTHELIAL_CELLS,1
HP_DRY_SKIN,SET,163,-0.038457,-0.0036056,0.064266,0.72521,HP_DRY_SKIN,1
GOMF_CYSTEINE_TYPE_EXOPEPTID...,SET,4,-0.25057,-0.0036962,0.41869,0.72523,GOMF_CYSTEINE_TYPE_EXOPEPTIDASE_ACTIVITY,1
GOMF_NUCLEOTIDASE_ACTIVITY,SET,13,-0.13267,-0.0035271,0.22155,0.72535,GOMF_NUCLEOTIDASE_ACTIVITY,1
HP_ABNORMAL_VENA_CAVA_MORPHO...,SET,68,-0.05972,-0.0036258,0.099713,0.72538,HP_ABNORMAL_VENA_CAVA_MORPHOLOGY,1
GSE3982_EOSINOPHIL_VS_MAC_DN,SET,178,-0.037903,-0.003712,0.063285,0.72538,GSE3982_EOSINOPHIL_VS_MAC_DN,1
HP_SENSORY_ATAXIA,SET,14,-0.12797,-0.0035307,0.21366,0.72539,HP_SENSORY_ATAXIA,1
GOCC_N_TERMINAL_PROTEIN_ACET...,SET,9,-0.14335,-0.0031715,0.23933,0.7254,GOCC_N_TERMINAL_PROTEIN_ACETYLTRANSFERASE_COMPLEX,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...3,SET,15,-0.12636,-0.0036085,0.21094,0.72542,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
HP_DECREASED_LDL_CHOLESTEROL...,SET,13,-0.13884,-0.0036914,0.23176,0.72544,HP_DECREASED_LDL_CHOLESTEROL_CONCENTRATION,1
HP_APLASIA_HYPOPLASIA_INVOLV...15,SET,42,-0.083644,-0.003994,0.13961,0.72545,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETAL_MUSCULATURE,1
RAY_TUMORIGENESIS_BY_ERBB2_C...2,SET,176,-0.037989,-0.0036997,0.063404,0.72546,RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_UP,1
GOMF_ACYL_COA_BINDING,SET,18,-0.11941,-0.003735,0.19926,0.72549,GOMF_ACYL_COA_BINDING,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...4,SET,78,-0.057041,-0.0037081,0.095179,0.72551,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA2_UP,1
HP_BILE_DUCT_PROLIFERATION,SET,18,-0.10732,-0.0033571,0.17907,0.72553,HP_BILE_DUCT_PROLIFERATION,1
GSE4748_CTRL_VS_LPS_AND_CYAN...1,SET,189,-0.037715,-0.0038048,0.062923,0.72553,GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_DN,1
GOBP_GLUCOSE_CATABOLIC_PROCE...,SET,21,-0.10041,-0.0033923,0.16751,0.72556,GOBP_GLUCOSE_CATABOLIC_PROCESS,1
GSE24142_DN2_VS_DN3_THYMOCYT...5,SET,180,-0.038381,-0.0037797,0.064005,0.72563,GSE24142_DN2_VS_DN3_THYMOCYTE_FETAL_UP,1
REACTOME_CONDENSATION_OF_PRO...2,SET,11,-0.13807,-0.0033767,0.23023,0.72564,REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES,1
GOBP_REGULATION_OF_MOTOR_NEU...,SET,15,-0.12562,-0.0035874,0.20941,0.72571,GOBP_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GOMF_TELOMERIC_DNA_BINDING,SET,37,-0.08025,-0.0035971,0.13376,0.72573,GOMF_TELOMERIC_DNA_BINDING,1
REACTOME_CELLULAR_RESPONSE_T...4,SET,6,-0.17113,-0.0030914,0.28516,0.72578,REACTOME_CELLULAR_RESPONSE_TO_MITOCHONDRIAL_STRESS,1
GOBP_INTRACELLULAR_SODIUM_IO...,SET,22,-0.12427,-0.004297,0.20708,0.72578,GOBP_INTRACELLULAR_SODIUM_ION_HOMEOSTASIS,1
GOBP_REGULATION_OF_FATTY_ACI...1,SET,17,-0.12257,-0.003726,0.20423,0.7258,GOBP_REGULATION_OF_FATTY_ACID_BETA_OXIDATION,1
HP_RESPIRATORY_FAILURE_REQUI...,SET,29,-0.093003,-0.0036914,0.15494,0.72582,HP_RESPIRATORY_FAILURE_REQUIRING_ASSISTED_VENTILATION,1
MODULE_491,SET,68,-0.060316,-0.003662,0.10047,0.72586,MODULE_491,1
HP_SECRETORY_DIARRHEA,SET,12,-0.13711,-0.0035024,0.22837,0.72588,HP_SECRETORY_DIARRHEA,1
TURJANSKI_MAPK8_AND_MAPK9_TA...,SET,7,-0.17485,-0.0034117,0.29113,0.72594,TURJANSKI_MAPK8_AND_MAPK9_TARGETS,1
GOBP_POST_EMBRYONIC_EYE_MORP...,SET,7,-0.21006,-0.0040987,0.34975,0.72594,GOBP_POST_EMBRYONIC_EYE_MORPHOGENESIS,1
GOBP_REGULATION_OF_DEOXYRIBO...,SET,10,-0.16189,-0.0037753,0.26955,0.72595,GOBP_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,1
GOBP_MITOTIC_SPINDLE_ELONGAT...,SET,11,-0.16311,-0.0039892,0.27148,0.72602,GOBP_MITOTIC_SPINDLE_ELONGATION,1
GSE8685_IL15_ACT_IL2_STARVED...1,SET,141,-0.042005,-0.003665,0.069911,0.72602,GSE8685_IL15_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_DN,1
MIR548AR_5P,SET,450,-0.024002,-0.0037095,0.039945,0.72604,MIR548AR_5P,1
GOBP_SENSORY_ORGAN_MORPHOGEN...,SET,261,-0.033755,-0.0039939,0.05617,0.72606,GOBP_SENSORY_ORGAN_MORPHOGENESIS,1
GSE24634_TEFF_VS_TCONV_DAY5_...2,SET,188,-0.035345,-0.0035564,0.058816,0.72606,GSE24634_TEFF_VS_TCONV_DAY5_IN_CULTURE_UP,1
HP_ABNORMAL_UPPER_LIP_MORPHO...,SET,814,-0.017838,-0.00367,0.029672,0.72614,HP_ABNORMAL_UPPER_LIP_MORPHOLOGY,1
CREB_Q4,SET,237,-0.03347,-0.0037762,0.055661,0.72619,CREB_Q4,1
MIR6739_5P,SET,243,-0.032263,-0.0036852,0.053627,0.72628,MIR6739_5P,1
GSE39152_CD103_NEG_VS_POS_ME...2,SET,185,-0.037723,-0.0037656,0.062693,0.72631,GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_UP,1
GOBP_CYTIDINE_TO_URIDINE_EDI...,SET,10,-0.22332,-0.0052076,0.37112,0.72632,GOBP_CYTIDINE_TO_URIDINE_EDITING,1
HP_ABNORMAL_ADIPOSE_TISSUE_M...,SET,214,-0.034909,-0.0037449,0.058003,0.72636,HP_ABNORMAL_ADIPOSE_TISSUE_MORPHOLOGY,1
GSE15330_LYMPHOID_MULTIPOTEN...5,SET,190,-0.036711,-0.0037132,0.06099,0.72638,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN,1
GOMF_GUANYL_RIBONUCLEOTIDE_B...,SET,342,-0.027951,-0.0037772,0.046435,0.72639,GOMF_GUANYL_RIBONUCLEOTIDE_BINDING,1
HP_ENLARGED_TONSILS,SET,5,-0.22197,-0.0036606,0.36867,0.72643,HP_ENLARGED_TONSILS,1
MURARO_PANCREAS_DELTA_CELL,SET,222,-0.037632,-0.0041108,0.062503,0.72643,MURARO_PANCREAS_DELTA_CELL,1
HP_VASCULAR_GRANULAR_OSMIOPH...,SET,12,-0.13868,-0.0035425,0.23033,0.72644,HP_VASCULAR_GRANULAR_OSMIOPHILIC_MATERIAL_DEPOSITION,1
GOCC_CELL_PROJECTION_MEMBRANE,SET,330,-0.027633,-0.0036694,0.045892,0.72645,GOCC_CELL_PROJECTION_MEMBRANE,1
chr2p22,SET,40,-0.15989,-0.007451,0.26552,0.72647,chr2p22,1
DESCARTES_MAIN_FETAL_ENS_NEU...,SET,27,-0.10269,-0.0039332,0.17051,0.7265,DESCARTES_MAIN_FETAL_ENS_NEURONS,1
GOBP_UMP_CATABOLIC_PROCESS,SET,5,-0.23039,-0.0037995,0.3825,0.72651,GOBP_UMP_CATABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_ENDOT...8,SET,46,-0.081225,-0.0040585,0.13485,0.72653,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_6,1
GOCC_CD95_DEATH_INDUCING_SIG...,SET,6,-0.22436,-0.0040532,0.37238,0.72658,GOCC_CD95_DEATH_INDUCING_SIGNALING_COMPLEX,1
GSE7460_TCONV_VS_TREG_LN_UP,SET,184,-0.039255,-0.003908,0.065149,0.72659,GSE7460_TCONV_VS_TREG_LN_UP,1
HP_METABOLIC_ALKALOSIS,SET,18,-0.12936,-0.0040463,0.21467,0.7266,HP_METABOLIC_ALKALOSIS,1
GSE17721_0.5H_VS_8H_PAM3CSK4...1,SET,186,-0.03626,-0.0036292,0.060175,0.7266,GSE17721_0.5H_VS_8H_PAM3CSK4_BMDC_DN,1
GOMF_STRUCTURAL_CONSTITUENT_...11,SET,23,-0.10983,-0.003883,0.18227,0.72661,GOMF_STRUCTURAL_CONSTITUENT_OF_SYNAPSE,1
GOBP_AXONOGENESIS_INVOLVED_I...,SET,9,-0.17745,-0.0039257,0.29442,0.72664,GOBP_AXONOGENESIS_INVOLVED_IN_INNERVATION,1
GOCC_MITOTIC_COHESIN_COMPLEX,SET,4,-0.32823,-0.0048417,0.54458,0.72665,GOCC_MITOTIC_COHESIN_COMPLEX,1
BENPORATH_SUZ12_TARGETS,SET,874,-0.019606,-0.0041726,0.032525,0.72668,BENPORATH_SUZ12_TARGETS,1
GOBP_RESPONSE_TO_BMP,SET,147,-0.043703,-0.0038928,0.072489,0.7267,GOBP_RESPONSE_TO_BMP,1
chr4q33,SET,5,-0.31815,-0.0052468,0.52757,0.72676,chr4q33,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...6,SET,34,-0.10447,-0.0044891,0.17323,0.72676,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY,1
GOCC_FASCIA_ADHERENS,SET,9,-0.19218,-0.0042517,0.31863,0.72679,GOCC_FASCIA_ADHERENS,1
GOBP_EMBRYONIC_PATTERN_SPECI...,SET,63,-0.065036,-0.0038012,0.10779,0.72685,GOBP_EMBRYONIC_PATTERN_SPECIFICATION,1
MIR3606_5P,SET,141,-0.044061,-0.0038444,0.073025,0.72687,MIR3606_5P,1
GOMF_3_5_EXONUCLEASE_ACTIVITY,SET,56,-0.060768,-0.0033493,0.1007,0.72689,GOMF_3_5_EXONUCLEASE_ACTIVITY,1
GSE29618_PDC_VS_MDC_DAY7_FLU...1,SET,179,-0.039747,-0.0039034,0.065819,0.72704,GSE29618_PDC_VS_MDC_DAY7_FLU_VACCINE_DN,1
GOBP_DEOXYRIBONUCLEOTIDE_BIO...,SET,14,-0.13239,-0.0036527,0.2192,0.72707,GOBP_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
VAN_DEN_BIGGELAAR_PBMC_PREVN...1,SET,62,-0.063765,-0.0036973,0.10557,0.72708,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_8MO_UP,1
HP_ELEVATED_CIRCULATING_ALDO...,SET,6,-0.18123,-0.0032739,0.30002,0.72709,HP_ELEVATED_CIRCULATING_ALDOLASE_CONCENTRATION,1
MIR2116_3P,SET,68,-0.063238,-0.0038394,0.10468,0.7271,MIR2116_3P,1
GOBP_RETINOL_METABOLIC_PROCE...,SET,50,-0.07881,-0.004105,0.13046,0.72711,GOBP_RETINOL_METABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_PROT...3,SET,607,-0.020899,-0.0037348,0.034593,0.72712,HP_ABNORMAL_CIRCULATING_PROTEIN_CONCENTRATION,1
MIR548BB_5P,SET,447,-0.024165,-0.0037225,0.039993,0.72716,MIR548BB_5P,1
HALLMARK_EPITHELIAL_MESENCHY...,SET,187,-0.041031,-0.0041177,0.067903,0.72716,HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION,1
TRAVAGLINI_LUNG_PLATELET_MEG...,SET,513,-0.022651,-0.0037311,0.037483,0.72717,TRAVAGLINI_LUNG_PLATELET_MEGAKARYOCYTE_CELL,1
GOMF_GUANINE_NUCLEOTIDE_TRAN...,SET,5,-0.27852,-0.0045933,0.46083,0.72721,GOMF_GUANINE_NUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
VANOEVELEN_MYOGENESIS_SIN3A_...,SET,207,-0.03281,-0.0034624,0.054282,0.72722,VANOEVELEN_MYOGENESIS_SIN3A_TARGETS,1
GOBP_G_PROTEIN_COUPLED_PURIN...2,SET,10,-0.167,-0.0038944,0.27624,0.72726,GOBP_G_PROTEIN_COUPLED_PURINERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GSE14000_4H_VS_16H_LPS_DC_TR...1,SET,172,-0.037102,-0.0035724,0.061363,0.72728,GSE14000_4H_VS_16H_LPS_DC_TRANSLATED_RNA_DN,1
AR_Q6,SET,234,-0.033933,-0.0038044,0.056117,0.7273,AR_Q6,1
HP_ALEXIA,SET,7,-0.18402,-0.0035907,0.3043,0.72732,HP_ALEXIA,1
chr10q25,SET,51,-0.12757,-0.0067108,0.21092,0.72735,chr10q25,1
GOBP_CORNIFIED_ENVELOPE_ASSE...,SET,6,-0.19965,-0.0036067,0.33007,0.72736,GOBP_CORNIFIED_ENVELOPE_ASSEMBLY,1
YAATNANRNNNCAG_UNKNOWN,SET,61,-0.065517,-0.0037682,0.10831,0.72738,YAATNANRNNNCAG_UNKNOWN,1
GOBP_MULTI_PASS_TRANSMEMBRAN...,SET,8,-0.21049,-0.0043906,0.34791,0.72741,GOBP_MULTI_PASS_TRANSMEMBRANE_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
GOCC_MULTI_PASS_TRANSLOCON_C...,SET,8,-0.21049,-0.0043906,0.34791,0.72741,GOCC_MULTI_PASS_TRANSLOCON_COMPLEX,1
GOBP_GDP_MANNOSE_METABOLIC_P...,SET,6,-0.15425,-0.0027866,0.25494,0.72743,GOBP_GDP_MANNOSE_METABOLIC_PROCESS,1
HP_ASTROCYTOSIS,SET,21,-0.11454,-0.0038697,0.18929,0.72745,HP_ASTROCYTOSIS,1
GNF2_PTPN4,SET,45,-0.077755,-0.0038427,0.12849,0.72746,GNF2_PTPN4,1
HP_APLASIA_HYPOPLASIA_OF_THE...62,SET,44,-0.084247,-0.0041172,0.13921,0.72747,HP_APLASIA_HYPOPLASIA_OF_THE_RETINA,1
MIR3666,SET,353,-0.027754,-0.0038092,0.045852,0.7275,MIR3666,1
HP_GENERALIZED_ONSET_MOTOR_S...,SET,158,-0.040524,-0.0037412,0.066952,0.7275,HP_GENERALIZED_ONSET_MOTOR_SEIZURE,1
LE_EGR2_TARGETS_DN,SET,103,-0.050976,-0.0038054,0.084216,0.72751,LE_EGR2_TARGETS_DN,1
DESCARTES_MAIN_FETAL_INHIBIT...2,SET,4,-0.30426,-0.0044881,0.50259,0.72753,DESCARTES_MAIN_FETAL_INHIBITORY_NEURONS,1
GOCC_CYTOPLASMIC_REGION,SET,251,-0.031268,-0.003629,0.051647,0.72755,GOCC_CYTOPLASMIC_REGION,1
GSE43955_10H_VS_30H_ACT_CD4_...2,SET,183,-0.038417,-0.0038143,0.06345,0.72756,GSE43955_10H_VS_30H_ACT_CD4_TCELL_UP,1
GSE27859_DC_VS_CD11C_INT_F48...4,SET,184,-0.037173,-0.0037008,0.061378,0.72762,GSE27859_DC_VS_CD11C_INT_F480_INT_DC_UP,1
HP_BLEPHARITIS,SET,43,-0.071199,-0.0034399,0.11754,0.72766,HP_BLEPHARITIS,1
KEGG_MEDICUS_REFERENCE_CD80_...2,SET,21,-0.10638,-0.0035937,0.17558,0.7277,KEGG_MEDICUS_REFERENCE_CD80_CD86_CTLA4_PP2A_SIGNALING_PATHWAY,1
MIR3620_5P,SET,49,-0.067278,-0.0034692,0.11102,0.72774,MIR3620_5P,1
HP_GYNECOMASTIA,SET,91,-0.053676,-0.0037676,0.088546,0.7278,HP_GYNECOMASTIA,1
GOBP_PROTEIN_LOCALIZATION_TO...14,SET,27,-0.086664,-0.0033193,0.14294,0.72784,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME_TELOMERIC_REGION,1
HP_HYPERLIPOPROTEINEMIA,SET,38,-0.087192,-0.0039606,0.14377,0.72789,HP_HYPERLIPOPROTEINEMIA,1
HP_ABDOMINAL_MASS,SET,9,-0.21379,-0.0047299,0.35251,0.7279,HP_ABDOMINAL_MASS,1
HP_SPONTANEOUS_HEMATOMAS,SET,18,-0.13801,-0.0043169,0.22755,0.72791,HP_SPONTANEOUS_HEMATOMAS,1
WP_CIRCADIAN_RHYTHM_GENES,SET,191,-0.038883,-0.0039432,0.064094,0.72796,WP_CIRCADIAN_RHYTHM_GENES,1
MYC_UP.V1_UP,SET,159,-0.038873,-0.0036,0.064058,0.72802,MYC_UP.V1_UP,1
REACTOME_FORMATION_OF_THE_EA...,SET,32,-0.075576,-0.0031508,0.12449,0.7281,REACTOME_FORMATION_OF_THE_EARLY_ELONGATION_COMPLEX,1
REACTOME_HIGHLY_CALCIUM_PERM...1,SET,9,-0.21238,-0.0046986,0.34981,0.72812,REACTOME_HIGHLY_CALCIUM_PERMEABLE_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1
MATTIOLI_MULTIPLE_MYELOMA_WI...,SET,31,-0.10177,-0.004176,0.16757,0.72817,MATTIOLI_MULTIPLE_MYELOMA_WITH_14Q32_TRANSLOCATIONS,1
DHIMAN_PBMC_ATTENUVAX_AGE_15...2,SET,44,-0.076727,-0.0037497,0.12634,0.72817,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_UP,1
GOBP_REGULATION_OF_CENTROSOM...,SET,52,-0.069605,-0.0036972,0.11461,0.72818,GOBP_REGULATION_OF_CENTROSOME_CYCLE,1
WP_VITAMIN_B6DEPENDENT_AND_R...,SET,6,-0.20727,-0.0037443,0.34124,0.7282,WP_VITAMIN_B6DEPENDENT_AND_RESPONSIVE_DISORDERS,1
GSE6259_FLT3L_INDUCED_33D1_P...6,SET,134,-0.044607,-0.003795,0.073419,0.72826,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD8_TCELL_UP,1
TONKS_TARGETS_OF_RUNX1_RUNX1...3,SET,16,-0.12811,-0.0037782,0.21081,0.7283,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_GRANULOCYTE_DN,1
HP_PRECOCIOUS_ATHEROSCLEROSIS,SET,12,-0.16386,-0.0041857,0.26958,0.72835,HP_PRECOCIOUS_ATHEROSCLEROSIS,1
HP_CONJUNCTIVAL_HAMARTOMA,SET,10,-0.14459,-0.0033717,0.23781,0.7284,HP_CONJUNCTIVAL_HAMARTOMA,1
MORF_MAP2K7,SET,157,-0.042355,-0.0038979,0.069655,0.72842,MORF_MAP2K7,1
ATF2_S_UP.V1_DN,SET,168,-0.041,-0.0039019,0.067424,0.72843,ATF2_S_UP.V1_DN,1
MIR182_3P,SET,61,-0.068468,-0.0039379,0.11258,0.72846,MIR182_3P,1
GOBP_DNA_STRAND_ELONGATION,SET,35,-0.080325,-0.0035019,0.13207,0.72847,GOBP_DNA_STRAND_ELONGATION,1
HP_ABNORMAL_MUSCLE_TISSUE_ME...,SET,45,-0.072516,-0.0035838,0.11913,0.72864,HP_ABNORMAL_MUSCLE_TISSUE_METABOLITE_CONCENTRATION,1
HP_DECREASED_CIRCULATING_ALD...,SET,18,-0.12945,-0.0040492,0.21267,0.72864,HP_DECREASED_CIRCULATING_ALDOSTERONE_LEVEL,1
MIR4753_5P,SET,156,-0.042085,-0.0038608,0.069116,0.7287,MIR4753_5P,1
GAVISH_3CA_METAPROGRAM_B_CEL...11,SET,41,-0.080968,-0.00382,0.13297,0.72871,GAVISH_3CA_METAPROGRAM_B_CELLS_RESPIRATION,1
GOBP_NEUROTROPHIN_TRK_RECEPT...,SET,24,-0.096623,-0.0034893,0.15867,0.72871,GOBP_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_CGMP_CATABOLIC_PROCESS,SET,5,-0.22818,-0.003763,0.37468,0.72873,GOBP_CGMP_CATABOLIC_PROCESS,1
WP_AUTOPHAGY,SET,30,-0.089202,-0.003601,0.14646,0.72875,WP_AUTOPHAGY,1
GOBP_TRANSFERRIN_TRANSPORT,SET,10,-0.15891,-0.0037058,0.26092,0.72876,GOBP_TRANSFERRIN_TRANSPORT,1
ZHAN_VARIABLE_EARLY_DIFFEREN...1,SET,27,-0.087331,-0.0033448,0.14336,0.72879,ZHAN_VARIABLE_EARLY_DIFFERENTIATION_GENES_DN,1
GSE27786_LSK_VS_BCELL_UP,SET,175,-0.038137,-0.0037036,0.062601,0.7288,GSE27786_LSK_VS_BCELL_UP,1
GOBP_TROPHOBLAST_GIANT_CELL_...,SET,12,-0.16494,-0.0042133,0.27074,0.72881,GOBP_TROPHOBLAST_GIANT_CELL_DIFFERENTIATION,1
REACTOME_MAPK6_MAPK4_SIGNALI...,SET,86,-0.052518,-0.0035841,0.086181,0.72886,REACTOME_MAPK6_MAPK4_SIGNALING,1
KEGG_MEDICUS_REFERENCE_BMP15...,SET,6,-0.23359,-0.0042199,0.38329,0.72888,KEGG_MEDICUS_REFERENCE_BMP15_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_WNT_PROTE...,SET,5,-0.2357,-0.0038871,0.38671,0.7289,GOBP_REGULATION_OF_WNT_PROTEIN_SECRETION,1
GOBP_WNT_PROTEIN_SECRETION,SET,5,-0.2357,-0.0038871,0.38671,0.7289,GOBP_WNT_PROTEIN_SECRETION,1
HP_PHOTORECEPTOR_LAYER_LOSS_...,SET,5,-0.21543,-0.0035527,0.35328,0.729,HP_PHOTORECEPTOR_LAYER_LOSS_ON_MACULAR_OCT,1
HE_LIM_SUN_FETAL_LUNG_C2_PRO...1,SET,258,-0.031108,-0.0036597,0.051011,0.72901,HE_LIM_SUN_FETAL_LUNG_C2_PROMONOCYTE_LIKE_CELL,1
MARSON_FOXP3_CORE_DIRECT_TAR...,SET,17,-0.1438,-0.0043713,0.23576,0.72904,MARSON_FOXP3_CORE_DIRECT_TARGETS,1
MIR5695,SET,87,-0.055135,-0.0037844,0.090379,0.72908,MIR5695,1
GOBP_IN_UTERO_EMBRYONIC_DEVE...,SET,378,-0.026227,-0.0037224,0.042987,0.7291,GOBP_IN_UTERO_EMBRYONIC_DEVELOPMENT,1
GSE40666_NAIVE_VS_EFFECTOR_C...1,SET,185,-0.039017,-0.0038947,0.063952,0.7291,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,1
MIR10399_5P,SET,332,-0.029465,-0.0039242,0.048291,0.72912,MIR10399_5P,1
GOBP_THORAX_AND_ANTERIOR_ABD...,SET,5,-0.31633,-0.0052169,0.51834,0.72916,GOBP_THORAX_AND_ANTERIOR_ABDOMEN_DETERMINATION,1
YAMAZAKI_TCEB3_TARGETS_UP,SET,155,-0.043533,-0.0039809,0.071329,0.72917,YAMAZAKI_TCEB3_TARGETS_UP,1
GSE13306_TREG_RA_VS_TCONV_RA...2,SET,192,-0.036356,-0.0036965,0.059567,0.72918,GSE13306_TREG_RA_VS_TCONV_RA_UP,1
GOMF_MITOGEN_ACTIVATED_PROTE...2,SET,10,-0.16242,-0.0037876,0.26608,0.7292,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_KINASE_BINDING,1
TRAVAGLINI_LUNG_PERICYTE_CELL,SET,110,-0.054569,-0.004209,0.089368,0.72927,TRAVAGLINI_LUNG_PERICYTE_CELL,1
GSE8515_CTRL_VS_IL6_4H_STIM_...1,SET,170,-0.041288,-0.0039525,0.067607,0.7293,GSE8515_CTRL_VS_IL6_4H_STIM_MAC_DN,1
GOCC_ALVEOLAR_LAMELLAR_BODY,SET,8,-0.186,-0.0038797,0.30455,0.72931,GOCC_ALVEOLAR_LAMELLAR_BODY,1
HP_ABNORMAL_PATELLA_MORPHOLO...,SET,91,-0.056605,-0.0039731,0.092661,0.72936,HP_ABNORMAL_PATELLA_MORPHOLOGY,1
GSE7768_OVA_ALONE_VS_OVA_WIT...2,SET,155,-0.04021,-0.003677,0.065804,0.72941,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP,1
GOBP_PARANODAL_JUNCTION_ASSE...,SET,6,-0.22815,-0.0041216,0.37315,0.72953,GOBP_PARANODAL_JUNCTION_ASSEMBLY,1
GOBP_GONADOTROPIN_SECRETION,SET,17,-0.13888,-0.0042218,0.22714,0.72954,GOBP_GONADOTROPIN_SECRETION,1
HP_PERIODIC_HYPOKALEMIC_PARE...,SET,7,-0.21057,-0.0041086,0.34436,0.72955,HP_PERIODIC_HYPOKALEMIC_PARESIS,1
GSE1925_3H_VS_24H_IFNG_STIM_...2,SET,187,-0.037604,-0.0037738,0.061498,0.72955,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
GOBP_ENDOLYSOSOMAL_TOLL_LIKE...,SET,45,-0.075158,-0.0037144,0.12291,0.72956,GOBP_ENDOLYSOSOMAL_TOLL_LIKE_RECEPTOR_SIGNALING_PATHWAY,1
WANG_THOC1_TARGETS_UP,SET,5,-0.24809,-0.0040915,0.40566,0.72959,WANG_THOC1_TARGETS_UP,1
GOCC_KINESIN_COMPLEX,SET,47,-0.0697,-0.0035202,0.11395,0.72962,GOCC_KINESIN_COMPLEX,1
GSE2706_R848_VS_LPS_8H_STIM_...1,SET,158,-0.04328,-0.0039956,0.070741,0.72966,GSE2706_R848_VS_LPS_8H_STIM_DC_DN,1
GOERING_BLOOD_HDL_CHOLESTERO...2,SET,12,-0.1583,-0.0040437,0.2587,0.7297,GOERING_BLOOD_HDL_CHOLESTEROL_QTL_TRANS,1
RICHERT_PBMC_HIV_LIPO_5_AGE_...4,SET,25,-0.11621,-0.004283,0.18985,0.72976,RICHERT_PBMC_HIV_LIPO_5_AGE_37_48YO_STIMULATED_VS_UNSTIMULATED_14W_TOP_FUNCTIONAL_NETWORK_UP,1
GSE29164_DAY3_VS_DAY7_UNTREA...1,SET,175,-0.039234,-0.0038102,0.064048,0.72992,GSE29164_DAY3_VS_DAY7_UNTREATED_MELANOMA_DN,1
RASHI_RESPONSE_TO_IONIZING_R...6,SET,72,-0.058794,-0.0036727,0.095939,0.73,RASHI_RESPONSE_TO_IONIZING_RADIATION_6,1
MIR15A_3P,SET,32,-0.092442,-0.0038539,0.15083,0.73002,MIR15A_3P,1
HP_BIFID_UVULA,SET,139,-0.042838,-0.0037113,0.069891,0.73003,HP_BIFID_UVULA,1
SU_TESTIS,SET,68,-0.059331,-0.0036022,0.096792,0.73005,SU_TESTIS,1
GOBP_POSITIVE_REGULATION_OF_...447,SET,5,-0.27405,-0.0045195,0.44708,0.73005,GOBP_POSITIVE_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,1
GCM_BMPR2,SET,78,-0.055457,-0.0036051,0.090462,0.73007,GCM_BMPR2,1
MORF_IL13,SET,216,-0.035025,-0.0037747,0.057128,0.73009,MORF_IL13,1
GOBP_POSITIVE_REGULATION_OF_...619,SET,4,-0.26773,-0.0039492,0.43658,0.73014,GOBP_POSITIVE_REGULATION_OF_PROTEIN_DEUBIQUITINATION,1
HP_PULMONARY_ARTERY_ANEURYSM,SET,7,-0.19371,-0.0037796,0.31582,0.73017,HP_PULMONARY_ARTERY_ANEURYSM,1
DESCARTES_FETAL_EYE_LENS_FIB...,SET,58,-0.074353,-0.0041703,0.12123,0.73017,DESCARTES_FETAL_EYE_LENS_FIBRE_CELLS,1
GOBP_PROTEIN_TO_MEMBRANE_DOC...,SET,5,-0.23543,-0.0038826,0.38378,0.73021,GOBP_PROTEIN_TO_MEMBRANE_DOCKING,1
GOBP_NEGATIVE_REGULATION_OF_...537,SET,82,-0.057023,-0.0038003,0.092917,0.73029,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
ZNF549_TARGET_GENES,SET,1015,-0.016374,-0.0037403,0.026681,0.7303,ZNF549_TARGET_GENES,1
REACTOME_FERTILIZATION,SET,26,-0.098937,-0.0037186,0.16119,0.73032,REACTOME_FERTILIZATION,1
REACTOME_FORMATION_OF_APOPTO...,SET,10,-0.14988,-0.0034952,0.24414,0.73036,REACTOME_FORMATION_OF_APOPTOSOME,1
GSE9946_MATURE_STIMULATORY_V...4,SET,120,-0.046451,-0.0037411,0.075655,0.73038,GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,1
HP_MACULAR_EDEMA,SET,32,-0.093169,-0.0038843,0.15172,0.73041,HP_MACULAR_EDEMA,1
HE_LIM_SUN_FETAL_LUNG_C2_PRO...2,SET,44,-0.078783,-0.0038502,0.12826,0.73047,HE_LIM_SUN_FETAL_LUNG_C2_PROMYELOCYTE_LIKE_CELL,1
GOBP_GENITALIA_DEVELOPMENT,SET,46,-0.083038,-0.0041491,0.13518,0.73048,GOBP_GENITALIA_DEVELOPMENT,1
GOBP_OVULATION_FROM_OVARIAN_...,SET,9,-0.18083,-0.0040005,0.29436,0.73049,GOBP_OVULATION_FROM_OVARIAN_FOLLICLE,1
HP_LOW_FRUSTRATION_TOLERANCE,SET,22,-0.10913,-0.0037735,0.17761,0.73054,HP_LOW_FRUSTRATION_TOLERANCE,1
HP_2_4_FINGER_SYNDACTYLY,SET,4,-0.24494,-0.0036131,0.39856,0.73057,HP_2_4_FINGER_SYNDACTYLY,1
GSE40666_WT_VS_STAT1_KO_CD8_...1,SET,181,-0.037883,-0.0037409,0.061629,0.73062,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_DN,1
HP_MULTINODULAR_GOITER,SET,5,-0.24368,-0.0040186,0.39632,0.73067,HP_MULTINODULAR_GOITER,1
GSE9601_NFKB_INHIBITOR_VS_PI...1,SET,185,-0.04079,-0.0040718,0.066333,0.73069,GSE9601_NFKB_INHIBITOR_VS_PI3K_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN,1
ZNF320_TARGET_GENES,SET,1229,-0.015364,-0.0038378,0.024984,0.7307,ZNF320_TARGET_GENES,1
MIR885_5P,SET,102,-0.049482,-0.003676,0.080463,0.73071,MIR885_5P,1
GOBP_POSITIVE_REGULATION_OF_...756,SET,5,-0.23327,-0.003847,0.3793,0.73072,GOBP_POSITIVE_REGULATION_OF_THYROID_HORMONE_GENERATION,1
GOBP_CEREBELLAR_CORTEX_DEVEL...,SET,46,-0.07651,-0.0038229,0.12438,0.73076,GOBP_CEREBELLAR_CORTEX_DEVELOPMENT,1
GSE13485_CTRL_VS_DAY7_YF17D_...1,SET,187,-0.039312,-0.0039452,0.063907,0.73077,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_DN,1
GSE43955_1H_VS_10H_ACT_CD4_T...2,SET,185,-0.037068,-0.0037002,0.060247,0.73081,GSE43955_1H_VS_10H_ACT_CD4_TCELL_UP,1
MIR4676_5P,SET,51,-0.068543,-0.0036056,0.11139,0.73084,MIR4676_5P,1
BIOCARTA_G2_PATHWAY,SET,24,-0.097958,-0.0035375,0.15918,0.73085,BIOCARTA_G2_PATHWAY,1
MIR9983_3P,SET,424,-0.025914,-0.0038903,0.042103,0.73088,MIR9983_3P,1
GOBP_POSITIVE_REGULATION_OF_...207,SET,1216,-0.01608,-0.0039969,0.026123,0.7309,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS,1
GOBP_DENDRITIC_SPINE_MORPHOG...,SET,54,-0.07288,-0.0039446,0.11839,0.73091,GOBP_DENDRITIC_SPINE_MORPHOGENESIS,1
MORF_ORC1L,SET,62,-0.062038,-0.0035972,0.10077,0.73092,MORF_ORC1L,1
GOMF_TRANSMEMBRANE_TRANSPORT...,SET,125,-0.049162,-0.0040406,0.079861,0.73092,GOMF_TRANSMEMBRANE_TRANSPORTER_BINDING,1
HP_DECREASED_CIRCULATING_IGG...1,SET,7,-0.18558,-0.0036212,0.30146,0.73092,HP_DECREASED_CIRCULATING_IGG2_LEVEL,1
HP_ABNORMAL_LOWER_LIMB_BONE_...,SET,671,-0.020314,-0.00381,0.032997,0.73093,HP_ABNORMAL_LOWER_LIMB_BONE_MORPHOLOGY,1
SMIRNOV_RESPONSE_TO_IR_6HR_UP,SET,157,-0.040433,-0.003721,0.065668,0.73096,SMIRNOV_RESPONSE_TO_IR_6HR_UP,1
QI_PLASMACYTOMA_DN,SET,92,-0.052284,-0.0036899,0.084893,0.73101,QI_PLASMACYTOMA_DN,1
GOCC_CATION_TRANSPORTING_ATP...,SET,18,-0.13709,-0.0042881,0.22259,0.73101,GOCC_CATION_TRANSPORTING_ATPASE_COMPLEX,1
ATGCTGG_MIR338,SET,108,-0.048343,-0.0036949,0.07848,0.73105,ATGCTGG_MIR338,1
GOBP_REGULATION_OF_GLIAL_CEL...4,SET,36,-0.089055,-0.0039375,0.14456,0.73106,GOBP_REGULATION_OF_GLIAL_CELL_PROLIFERATION,1
chr5q35,SET,116,-0.098362,-0.0077897,0.15964,0.7311,chr5q35,1
GSE17974_CTRL_VS_ACT_IL4_AND...14,SET,172,-0.041229,-0.0039698,0.066914,0.7311,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_4H_CD4_TCELL_UP,1
RUVBL1_TARGET_GENES,SET,126,-0.046657,-0.0038499,0.075704,0.73115,RUVBL1_TARGET_GENES,1
GOBP_MICROTUBULE_ANCHORING_A...,SET,13,-0.14139,-0.0037589,0.22937,0.73118,GOBP_MICROTUBULE_ANCHORING_AT_MICROTUBULE_ORGANIZING_CENTER,1
GIAROLA_SILVA_BLOOD_PANDEMRI...1,SET,5,-0.19821,-0.0032688,0.32145,0.73125,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_30DY_UP,1
PHESSE_TARGETS_OF_APC_AND_MB...2,SET,15,-0.14244,-0.0040676,0.23098,0.73127,PHESSE_TARGETS_OF_APC_AND_MBD2_UP,1
GOBP_NEGATIVE_REGULATION_OF_...3,SET,54,-0.069749,-0.0037752,0.11308,0.73131,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_POLYMERIZATION,1
GSE22886_NAIVE_CD4_TCELL_VS_...8,SET,181,-0.03901,-0.0038522,0.063222,0.73139,GSE22886_NAIVE_CD4_TCELL_VS_48H_ACT_TH2_UP,1
GOBP_NEGATIVE_REGULATION_OF_...377,SET,5,-0.2634,-0.004344,0.42686,0.7314,GOBP_NEGATIVE_REGULATION_OF_MAST_CELL_DEGRANULATION,1
GOBP_REGULATION_OF_T_CELL_EX...,SET,5,-0.23326,-0.0038469,0.378,0.73141,GOBP_REGULATION_OF_T_CELL_EXTRAVASATION,1
GOBP_MAMMARY_GLAND_EPITHELIA...2,SET,25,-0.11599,-0.0042749,0.1879,0.73147,GOBP_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
GOCC_CHROMOSOME_PASSENGER_CO...,SET,6,-0.21905,-0.0039571,0.35485,0.73148,GOCC_CHROMOSOME_PASSENGER_COMPLEX,1
CEBPB_01,SET,240,-0.034154,-0.0038773,0.055308,0.73155,CEBPB_01,1
GSE32423_CTRL_VS_IL7_IL4_MEM...1,SET,190,-0.035493,-0.00359,0.057477,0.73155,GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_DN,1
GOBP_DOPAMINE_METABOLIC_PROC...,SET,33,-0.096654,-0.0040919,0.15651,0.73157,GOBP_DOPAMINE_METABOLIC_PROCESS,1
HP_NON_OBSTRUCTIVE_AZOOSPERM...,SET,48,-0.07237,-0.0036936,0.11718,0.73157,HP_NON_OBSTRUCTIVE_AZOOSPERMIA,1
REACTOME_GP1B_IX_V_ACTIVATIO...,SET,11,-0.17348,-0.0042428,0.28073,0.73169,REACTOME_GP1B_IX_V_ACTIVATION_SIGNALLING,1
HP_DIMINISHED_ABILITY_TO_CON...,SET,9,-0.15874,-0.0035118,0.25688,0.73169,HP_DIMINISHED_ABILITY_TO_CONCENTRATE,1
HP_HYPOKALEMIC_METABOLIC_ALK...,SET,9,-0.18557,-0.0041054,0.30025,0.73172,HP_HYPOKALEMIC_METABOLIC_ALKALOSIS,1
GSE22886_DC_VS_MONOCYTE_UP,SET,186,-0.0384,-0.0038434,0.062132,0.73172,GSE22886_DC_VS_MONOCYTE_UP,1
HOFT_CD4_POSITIVE_ALPHA_BETA...7,SET,12,-0.14604,-0.0037304,0.2363,0.73172,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_DN,1
KEGG_HYPERTROPHIC_CARDIOMYOP...,SET,79,-0.061022,-0.0039921,0.098732,0.73173,KEGG_HYPERTROPHIC_CARDIOMYOPATHY_HCM,1
MIR6505_3P,SET,87,-0.055128,-0.0037839,0.089173,0.73178,MIR6505_3P,1
HP_PHOTOPHOBIA,SET,246,-0.033501,-0.0038498,0.054188,0.73179,HP_PHOTOPHOBIA,1
GSE2770_UNTREATED_VS_IL4_TRE...4,SET,188,-0.036882,-0.0037111,0.059647,0.73182,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_UP,1
GSE7460_FOXP3_MUT_VS_HET_ACT...1,SET,182,-0.038308,-0.0037932,0.06194,0.73187,GSE7460_FOXP3_MUT_VS_HET_ACT_TCONV_DN,1
REACTOME_MEIOTIC_SYNAPSIS,SET,31,-0.087915,-0.0036076,0.14207,0.73197,REACTOME_MEIOTIC_SYNAPSIS,1
GSE5589_WT_VS_IL6_KO_LPS_STI...4,SET,172,-0.038003,-0.0036592,0.061408,0.73199,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
DORN_ADENOVIRUS_INFECTION_32...1,SET,36,-0.08171,-0.0036127,0.13203,0.732,DORN_ADENOVIRUS_INFECTION_32HR_DN,1
GOBP_RNA_SECONDARY_STRUCTURE...,SET,8,-0.18438,-0.003846,0.29791,0.73201,GOBP_RNA_SECONDARY_STRUCTURE_UNWINDING,1
SU_THYMUS,SET,19,-0.13951,-0.0044833,0.2254,0.73202,SU_THYMUS,1
KEGG_MEDICUS_VARIANT_MUTATIO...21,SET,28,-0.099156,-0.0038673,0.16019,0.73203,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_SMO_TO_HEDGEHOG_SIGNALING_PATHWAY,1
KEGG_MEDICUS_VARIANT_MUTATIO...85,SET,28,-0.099156,-0.0038673,0.16019,0.73203,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PTCH1_TO_HEDGEHOG_SIGNALING_PATHWAY,1
GSE9650_GP33_VS_GP276_LCMV_S...2,SET,180,-0.039979,-0.003937,0.06455,0.73215,GSE9650_GP33_VS_GP276_LCMV_SPECIFIC_EXHAUSTED_CD8_TCELL_UP,1
PID_FANCONI_PATHWAY,SET,40,-0.07519,-0.0035039,0.12139,0.73217,PID_FANCONI_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...511,SET,6,-0.20321,-0.0036711,0.32803,0.7322,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_ACETYLATION,1
HP_HYPERCOAGULABILITY,SET,15,-0.13974,-0.0039906,0.22556,0.73222,HP_HYPERCOAGULABILITY,1
KEGG_MEDICUS_REFERENCE_ANTIG...1,SET,11,-0.19079,-0.0046661,0.30788,0.73226,KEGG_MEDICUS_REFERENCE_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_II_MOLECULES,1
HP_ABNORMALITY_OF_THE_DISTAL...4,SET,34,-0.091065,-0.0039132,0.14694,0.73228,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
GOMF_SINGLE_STRANDED_DNA_END...,SET,10,-0.14848,-0.0034624,0.23955,0.7323,GOMF_SINGLE_STRANDED_DNA_ENDODEOXYRIBONUCLEASE_ACTIVITY,1
HP_OSTEOCHONDROMA,SET,7,-0.21584,-0.0042115,0.34825,0.7323,HP_OSTEOCHONDROMA,1
MANNO_MIDBRAIN_NEUROTYPES_HP...4,SET,298,-0.030586,-0.0038629,0.049335,0.73236,MANNO_MIDBRAIN_NEUROTYPES_HPROGFPM,1
YTAATTAA_LHX3_01,SET,179,-0.043095,-0.0042322,0.069504,0.73238,YTAATTAA_LHX3_01,1
MANNE_COVID19_ICU_VS_HEALTHY...1,SET,134,-0.04957,-0.0042172,0.079924,0.73244,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN,1
GOMF_BILE_ACID_BINDING,SET,10,-0.18841,-0.0043937,0.30379,0.73244,GOMF_BILE_ACID_BINDING,1
HP_LACTIC_ACIDOSIS,SET,149,-0.040177,-0.0036028,0.064777,0.73244,HP_LACTIC_ACIDOSIS,1
REACTOME_RAF_ACTIVATION,SET,32,-0.088097,-0.0036728,0.14202,0.73247,REACTOME_RAF_ACTIVATION,1
GOCC_CORTICAL_ENDOPLASMIC_RE...,SET,5,-0.21625,-0.0035663,0.34859,0.73248,GOCC_CORTICAL_ENDOPLASMIC_RETICULUM,1
GOMF_LIPOPROTEIN_LIPASE_ACTI...,SET,9,-0.21178,-0.0046854,0.3413,0.73254,GOMF_LIPOPROTEIN_LIPASE_ACTIVITY,1
GOCC_SIGNAL_RECOGNITION_PART...,SET,6,-0.1696,-0.0030639,0.2732,0.73263,GOCC_SIGNAL_RECOGNITION_PARTICLE,1
IVANOVA_HEMATOPOIESIS_INTERM...,SET,123,-0.044539,-0.0036314,0.071719,0.7327,IVANOVA_HEMATOPOIESIS_INTERMEDIATE_PROGENITOR,1
GOBP_MALE_MATING_BEHAVIOR,SET,7,-0.23361,-0.0045583,0.37618,0.7327,GOBP_MALE_MATING_BEHAVIOR,1
GOMF_LIGASE_ACTIVITY_FORMING...1,SET,7,-0.19347,-0.003775,0.31149,0.73273,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_CARBON_BONDS,1
GOBP_CAMP_BIOSYNTHETIC_PROCE...,SET,10,-0.1759,-0.0041019,0.28315,0.73277,GOBP_CAMP_BIOSYNTHETIC_PROCESS,1
GOBP_BICARBONATE_TRANSPORT,SET,36,-0.0846,-0.0037405,0.13617,0.73278,GOBP_BICARBONATE_TRANSPORT,1
GOBP_EOSINOPHIL_MIGRATION,SET,28,-0.11609,-0.0045278,0.18683,0.73282,GOBP_EOSINOPHIL_MIGRATION,1
KEGG_FATTY_ACID_METABOLISM,SET,41,-0.080791,-0.0038116,0.13001,0.73283,KEGG_FATTY_ACID_METABOLISM,1
REACTOME_FATTY_ACYL_COA_BIOS...,SET,35,-0.093824,-0.0040905,0.15098,0.73284,REACTOME_FATTY_ACYL_COA_BIOSYNTHESIS,1
MIR548AP_5P_MIR548J_5P,SET,442,-0.024967,-0.003825,0.040177,0.73284,MIR548AP_5P_MIR548J_5P,1
HP_RESPIRATORY_FAILURE,SET,228,-0.033811,-0.0037424,0.054391,0.7329,HP_RESPIRATORY_FAILURE,1
GOBP_RESPONSE_TO_MITOCHONDRI...,SET,16,-0.12503,-0.0036874,0.20109,0.73294,GOBP_RESPONSE_TO_MITOCHONDRIAL_DEPOLARISATION,1
GOBP_LIPOXIN_METABOLIC_PROCE...,SET,5,-0.25482,-0.0042025,0.40979,0.73297,GOBP_LIPOXIN_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_DENDRITIC...2,SET,10,-0.17352,-0.0040463,0.27903,0.73298,GOBP_REGULATION_OF_DENDRITIC_CELL_CHEMOTAXIS,1
GSE19888_ADENOSINE_A3R_ACT_V...3,SET,182,-0.037742,-0.0037371,0.060691,0.73298,GSE19888_ADENOSINE_A3R_ACT_VS_TCELL_MEMBRANES_ACT_AND_A3R_INH_PRETREAT_IN_MAST_CELL_DN,1
GSE21546_WT_VS_SAP1A_KO_AND_...3,SET,183,-0.039604,-0.0039322,0.063686,0.73298,GSE21546_WT_VS_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
JIANG_AGING_CEREBRAL_CORTEX_...2,SET,31,-0.096316,-0.0039523,0.15486,0.73301,JIANG_AGING_CEREBRAL_CORTEX_UP,1
WP_OLIGODENDROCYTE_SPECIFICA...,SET,29,-0.10536,-0.0041818,0.1694,0.73301,WP_OLIGODENDROCYTE_SPECIFICATION_AND_DIFFERENTIATION_LEADING_TO_MYELIN_COMPONENTS_FOR_CNS,1
HP_ILEAL_ATRESIA,SET,4,-0.26923,-0.0039714,0.4328,0.73305,HP_ILEAL_ATRESIA,1
HP_HYPOCHLOREMIA,SET,6,-0.25093,-0.0045331,0.40336,0.73306,HP_HYPOCHLOREMIA,1
GOBP_ENDOCARDIAL_CUSHION_MOR...,SET,42,-0.093712,-0.0044747,0.15057,0.73315,GOBP_ENDOCARDIAL_CUSHION_MORPHOGENESIS,1
GSE26928_EFF_MEM_VS_CENTR_ME...1,SET,146,-0.042764,-0.0037963,0.068692,0.73321,GSE26928_EFF_MEM_VS_CENTR_MEM_CD4_TCELL_DN,1
GOBP_CXCL12_ACTIVATED_CXCR4_...,SET,4,-0.28651,-0.0042263,0.46007,0.73327,GOBP_CXCL12_ACTIVATED_CXCR4_SIGNALING_PATHWAY,1
GSE17721_POLYIC_VS_PAM3CSK4_...9,SET,179,-0.037514,-0.0036841,0.060241,0.73327,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...38,SET,35,-0.076082,-0.003317,0.12215,0.7333,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
MIR11401,SET,7,-0.21641,-0.0042226,0.34741,0.73333,MIR11401,1
CAFFAREL_RESPONSE_TO_THC_UP,SET,29,-0.093638,-0.0037166,0.1503,0.73335,CAFFAREL_RESPONSE_TO_THC_UP,1
MIR887_3P,SET,5,-0.24227,-0.0039954,0.38879,0.73339,MIR887_3P,1
GSE21360_NAIVE_VS_TERTIARY_M...2,SET,169,-0.040237,-0.0038407,0.064575,0.73339,GSE21360_NAIVE_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
GOCC_NUCLEAR_REPLICATION_FORK,SET,39,-0.080174,-0.0036893,0.12866,0.7334,GOCC_NUCLEAR_REPLICATION_FORK,1
HP_EMOTIONAL_LABILITY,SET,154,-0.04173,-0.0038038,0.066949,0.73346,HP_EMOTIONAL_LABILITY,1
KORKOLA_EMBRYONAL_CARCINOMA_...2,SET,28,-0.11271,-0.0043961,0.18082,0.73347,KORKOLA_EMBRYONAL_CARCINOMA_UP,1
GOBP_REGULATION_OF_MIRNA_TRA...,SET,72,-0.064492,-0.0040287,0.10344,0.7335,GOBP_REGULATION_OF_MIRNA_TRANSCRIPTION,1
GOMF_NADPLUS_PROTEIN_ARGININ...,SET,6,-0.22789,-0.004117,0.36554,0.7335,GOMF_NADPLUS_PROTEIN_ARGININE_ADP_RIBOSYLTRANSFERASE_ACTIVITY,1
BIOCARTA_TCYTOTOXIC_PATHWAY,SET,12,-0.16897,-0.0043163,0.27092,0.73359,BIOCARTA_TCYTOTOXIC_PATHWAY,1
MIR4495,SET,435,-0.026195,-0.003982,0.041992,0.73362,MIR4495,1
GOBP_RESOLUTION_OF_DNA_RECOM...,SET,6,-0.18678,-0.0033743,0.29942,0.73362,GOBP_RESOLUTION_OF_DNA_RECOMBINATION_INTERMEDIATES,1
GOBP_RESPONSE_TO_HYDROGEN_PE...,SET,89,-0.057211,-0.0039715,0.091702,0.73364,GOBP_RESPONSE_TO_HYDROGEN_PEROXIDE,1
KEGG_PHOSPHATIDYLINOSITOL_SI...,SET,75,-0.059223,-0.0037755,0.094907,0.73368,KEGG_PHOSPHATIDYLINOSITOL_SIGNALING_SYSTEM,1
GSE40068_BCL6_POS_VS_NEG_CXC...1,SET,178,-0.039808,-0.0038986,0.06378,0.73373,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_DN,1
GSE16450_CTRL_VS_IFNA_12H_ST...3,SET,189,-0.036788,-0.0037113,0.058914,0.73382,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_DN,1
MIR3188,SET,72,-0.060297,-0.0037666,0.096508,0.73394,MIR3188,1
GSE32255_UNSTIM_VS_4H_LPS_ST...1,SET,140,-0.044357,-0.0038566,0.070997,0.73394,GSE32255_UNSTIM_VS_4H_LPS_STIM_DC_DN,1
chr2p25,SET,45,-0.13679,-0.0067603,0.21886,0.73401,chr2p25,1
GOMF_STRUCTURAL_CONSTITUENT_...3,SET,20,-0.1361,-0.0044871,0.21774,0.73402,GOMF_STRUCTURAL_CONSTITUENT_OF_EYE_LENS,1
GOBP_REGULATION_OF_GLUCONEOG...,SET,43,-0.080867,-0.0039069,0.12933,0.7341,GOBP_REGULATION_OF_GLUCONEOGENESIS,1
GOBP_RECEPTOR_LOCALIZATION_T...2,SET,56,-0.073842,-0.0040698,0.11809,0.73411,GOBP_RECEPTOR_LOCALIZATION_TO_SYNAPSE,1
HP_RETINAL_FOLD,SET,10,-0.17443,-0.0040677,0.27894,0.73412,HP_RETINAL_FOLD,1
MIR6798_3P,SET,35,-0.08692,-0.0037895,0.13893,0.73421,MIR6798_3P,1
LIN_SILENCED_BY_TUMOR_MICROE...,SET,96,-0.058195,-0.0041949,0.092971,0.73432,LIN_SILENCED_BY_TUMOR_MICROENVIRONMENT,1
MIR223_5P,SET,138,-0.04479,-0.0038665,0.071537,0.73437,MIR223_5P,1
GOMF_KINESIN_BINDING,SET,39,-0.079217,-0.0036452,0.12651,0.73439,GOMF_KINESIN_BINDING,1
HP_CIRRHOSIS,SET,147,-0.043842,-0.0039052,0.070012,0.7344,HP_CIRRHOSIS,1
GOBP_CARDIOLIPIN_METABOLIC_P...,SET,13,-0.16052,-0.0042676,0.25629,0.73445,GOBP_CARDIOLIPIN_METABOLIC_PROCESS,1
GSE3920_UNTREATED_VS_IFNA_TR...2,SET,164,-0.041898,-0.0039401,0.066879,0.73449,GSE3920_UNTREATED_VS_IFNA_TREATED_ENDOTHELIAL_CELL_UP,1
WP_DRUG_INDUCTION_OF_BILE_AC...,SET,17,-0.13234,-0.0040229,0.21123,0.7345,WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY,1
ROESSLER_LIVER_CANCER_METAST...1,SET,46,-0.07984,-0.0039893,0.12743,0.73451,ROESSLER_LIVER_CANCER_METASTASIS_DN,1
HP_CUTIS_MARMORATA,SET,60,-0.070596,-0.0040271,0.11266,0.73455,HP_CUTIS_MARMORATA,1
MODULE_157,SET,100,-0.051738,-0.0038059,0.082555,0.73457,MODULE_157,1
GSE360_DC_VS_MAC_B_MALAYI_HI...1,SET,181,-0.039363,-0.003887,0.062797,0.73461,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_DN,1
GOBP_NEURON_FATE_COMMITMENT,SET,67,-0.072362,-0.0043611,0.11544,0.73462,GOBP_NEURON_FATE_COMMITMENT,1
GAO_SMALL_INTESTINE_24W_C6_G...,SET,40,-0.080561,-0.0037542,0.1285,0.73465,GAO_SMALL_INTESTINE_24W_C6_GOBLET_CELLS,1
GOBP_MESENCHYMAL_EPITHELIAL_...,SET,9,-0.19864,-0.0043947,0.31679,0.73468,GOBP_MESENCHYMAL_EPITHELIAL_CELL_SIGNALING,1
REACTOME_SYNTHESIS_OF_GDP_MA...,SET,5,-0.18109,-0.0029866,0.28878,0.7347,REACTOME_SYNTHESIS_OF_GDP_MANNOSE,1
GOBP_RESPONSE_TO_ABIOTIC_STI...,SET,1026,-0.017174,-0.0039429,0.027383,0.73473,GOBP_RESPONSE_TO_ABIOTIC_STIMULUS,1
DAVIES_MULTIPLE_MYELOMA_VS_M...1,SET,23,-0.11998,-0.0042416,0.19127,0.73475,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_DN,1
HP_FLAT_OCCIPUT,SET,52,-0.070673,-0.0037539,0.11267,0.73475,HP_FLAT_OCCIPUT,1
KEGG_MEDICUS_VARIANT_MUTATIO...79,SET,6,-0.2022,-0.0036528,0.32232,0.73477,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PINK1_TO_INTRINSIC_APOPTOTIC_PATHWAY_N01050,1
GOBP_NEGATIVE_REGULATION_OF_...111,SET,272,-0.031376,-0.0037886,0.050013,0.73478,GOBP_NEGATIVE_REGULATION_OF_CELL_CYCLE_PROCESS,1
GOBP_PROSTATE_GLANDULAR_ACIN...1,SET,10,-0.17729,-0.0041342,0.2826,0.73478,GOBP_PROSTATE_GLANDULAR_ACINUS_DEVELOPMENT,1
GOCC_AP_1_ADAPTOR_COMPLEX,SET,10,-0.16284,-0.0037974,0.25954,0.73481,GOCC_AP_1_ADAPTOR_COMPLEX,1
GCM_TEC,SET,29,-0.092834,-0.0036847,0.1479,0.73489,GCM_TEC,1
HP_ABNORMAL_CIRCULATING_ANDR...1,SET,89,-0.05741,-0.0039853,0.091464,0.73489,HP_ABNORMAL_CIRCULATING_ANDROGEN_LEVEL,1
HP_HYPOURICEMIA,SET,16,-0.1354,-0.0039933,0.21571,0.7349,HP_HYPOURICEMIA,1
GATAAGR_GATA_C,SET,277,-0.032522,-0.0039625,0.051809,0.73491,GATAAGR_GATA_C,1
RNCTGNYNRNCTGNY_UNKNOWN,SET,65,-0.065156,-0.003868,0.10376,0.73498,RNCTGNYNRNCTGNY_UNKNOWN,1
GOMF_NUCLEOSIDE_TRIPHOSPHATA...,SET,445,-0.025037,-0.0038484,0.039863,0.73502,GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY,1
GSE5589_WT_VS_IL6_KO_LPS_AND...2,SET,91,-0.056849,-0.0039903,0.090483,0.73508,GSE5589_WT_VS_IL6_KO_LPS_AND_IL10_STIM_MACROPHAGE_180MIN_UP,1
LI_ESTROGENE_LATE_E2_RESPONS...2,SET,52,-0.078965,-0.0041943,0.12567,0.73512,LI_ESTROGENE_LATE_E2_RESPONSE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...175,SET,6,-0.24405,-0.0044089,0.38831,0.73516,GOBP_NEGATIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,1
GOBP_SNRNA_3_END_PROCESSING,SET,18,-0.10743,-0.0033604,0.17093,0.73516,GOBP_SNRNA_3_END_PROCESSING,1
GOBP_NEGATIVE_REGULATION_OF_...339,SET,129,-0.050223,-0.0041928,0.079889,0.73521,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CELL_CELL_ADHESION,1
GOBP_NEGATIVE_REGULATION_OF_...535,SET,6,-0.22521,-0.0040684,0.35822,0.73522,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYUBIQUITINATION,1
GOBP_L_ARGININE_TRANSMEMBRAN...,SET,13,-0.16836,-0.004476,0.26772,0.73527,GOBP_L_ARGININE_TRANSMEMBRANE_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...798,SET,61,-0.069456,-0.0039948,0.11042,0.73534,GOBP_POSITIVE_REGULATION_OF_TYROSINE_PHOSPHORYLATION_OF_STAT_PROTEIN,1
HP_ABNORMAL_HAIR_QUANTITY,SET,758,-0.01939,-0.0038556,0.03082,0.73536,HP_ABNORMAL_HAIR_QUANTITY,1
GOBP_PROTEIN_LOCALIZATION_TO...50,SET,81,-0.056316,-0.0037304,0.089511,0.73537,GOBP_PROTEIN_LOCALIZATION_TO_VACUOLE,1
GOMF_MONOSACCHARIDE_BINDING,SET,69,-0.062051,-0.0037949,0.098621,0.73538,GOMF_MONOSACCHARIDE_BINDING,1
HP_EAR_PAIN,SET,15,-0.13421,-0.0038327,0.21331,0.73539,HP_EAR_PAIN,1
GSE17721_LPS_VS_POLYIC_8H_BM...2,SET,180,-0.038377,-0.0037793,0.060991,0.7354,GSE17721_LPS_VS_POLYIC_8H_BMDC_UP,1
MIR4251,SET,353,-0.029332,-0.0040259,0.046608,0.73543,MIR4251,1
GENTILE_UV_RESPONSE_CLUSTER_...3,SET,52,-0.072984,-0.0038766,0.11595,0.73546,GENTILE_UV_RESPONSE_CLUSTER_D4,1
FOURATI_BLOOD_TWINRIX_AGE_25...1,SET,598,-0.022292,-0.003955,0.035407,0.73551,FOURATI_BLOOD_TWINRIX_AGE_25_83YO_RESPONDERS_VS_POOR_RESPONDERS_0DY_DN,1
GOCC_STEREOCILIA_ANKLE_LINK_...,SET,5,-0.29081,-0.0047959,0.46186,0.73553,GOCC_STEREOCILIA_ANKLE_LINK_COMPLEX,1
GOBP_MITOCHONDRION_LOCALIZAT...,SET,45,-0.07949,-0.0039285,0.12624,0.73554,GOBP_MITOCHONDRION_LOCALIZATION,1
PID_INSULIN_GLUCOSE_PATHWAY,SET,26,-0.10381,-0.0039018,0.16483,0.73559,PID_INSULIN_GLUCOSE_PATHWAY,1
SNACANNNYSYAGA_UNKNOWN,SET,79,-0.057896,-0.0037876,0.091911,0.73562,SNACANNNYSYAGA_UNKNOWN,1
WP_LEUKOTRIENE_METABOLIC_PAT...,SET,13,-0.14878,-0.0039556,0.23618,0.73563,WP_LEUKOTRIENE_METABOLIC_PATHWAY,1
MIR6893_3P,SET,86,-0.056764,-0.0038738,0.09011,0.73563,MIR6893_3P,1
MODULE_212,SET,302,-0.031127,-0.0039571,0.0494,0.73568,MODULE_212,1
GOMF_TYPE_5_METABOTROPIC_GLU...,SET,6,-0.23167,-0.0041852,0.36762,0.73571,GOMF_TYPE_5_METABOTROPIC_GLUTAMATE_RECEPTOR_BINDING,1
HP_METAPHYSEAL_SCLEROSIS,SET,12,-0.16753,-0.0042793,0.26581,0.73573,HP_METAPHYSEAL_SCLEROSIS,1
DESCARTES_FETAL_STOMACH_ERYT...,SET,86,-0.056241,-0.0038382,0.089232,0.73574,DESCARTES_FETAL_STOMACH_ERYTHROBLASTS,1
REACTOME_HEDGEHOG_OFF_STATE,SET,108,-0.047855,-0.0036576,0.07592,0.73576,REACTOME_HEDGEHOG_OFF_STATE,1
GSE37416_0H_VS_48H_F_TULAREN...2,SET,177,-0.039544,-0.0038619,0.062724,0.73579,GSE37416_0H_VS_48H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOBP_POSITIVE_REGULATION_OF_...509,SET,42,-0.08527,-0.0040716,0.13524,0.73582,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_DIFFERENTIATION,1
MIR664B_3P,SET,442,-0.026227,-0.004018,0.041567,0.73596,MIR664B_3P,1
KEGG_MEDICUS_PATHOGEN_HIV_TA...1,SET,8,-0.18106,-0.0037768,0.28691,0.736,KEGG_MEDICUS_PATHOGEN_HIV_TAT_NEF_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
GSE37605_C57BL6_VS_NOD_FOXP3...4,SET,109,-0.053235,-0.0040875,0.084316,0.7361,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_UP,1
GOCC_SAGA_COMPLEX,SET,21,-0.098467,-0.0033265,0.15592,0.73614,GOCC_SAGA_COMPLEX,1
GOMF_HYDROLASE_ACTIVITY_ACTI...3,SET,15,-0.13657,-0.0038999,0.21625,0.73615,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_CARBON_NITROGEN_BUT_NOT_PEPTIDE_BONDS_IN_CYCLIC_AMIDES,1
GROSS_HYPOXIA_VIA_HIF1A_UP,SET,75,-0.060693,-0.0038692,0.096088,0.73619,GROSS_HYPOXIA_VIA_HIF1A_UP,1
MIR642A_5P,SET,82,-0.059524,-0.0039671,0.094229,0.7362,MIR642A_5P,1
GOBP_HEPATICOBILIARY_SYSTEM_...,SET,141,-0.046694,-0.0040741,0.073917,0.73621,GOBP_HEPATICOBILIARY_SYSTEM_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...98,SET,3,-0.36173,-0.0046212,0.57245,0.73627,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
GOBP_REGULATION_OF_MONONUCLE...,SET,130,-0.04772,-0.0039992,0.07552,0.73627,GOBP_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
RADMACHER_AML_PROGNOSIS,SET,73,-0.065855,-0.0041421,0.10421,0.73628,RADMACHER_AML_PROGNOSIS,1
GOBP_REGULATION_OF_DENDRITE_...2,SET,24,-0.12005,-0.0043353,0.18997,0.73629,GOBP_REGULATION_OF_DENDRITE_EXTENSION,1
GOCC_PHOTORECEPTOR_CONNECTIN...,SET,37,-0.085652,-0.0038392,0.13553,0.7363,GOCC_PHOTORECEPTOR_CONNECTING_CILIUM,1
WESTON_VEGFA_TARGETS_12HR,SET,21,-0.12861,-0.004345,0.20349,0.73631,WESTON_VEGFA_TARGETS_12HR,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...2,SET,31,-0.099152,-0.0040687,0.15688,0.73632,SHIN_B_CELL_LYMPHOMA_CLUSTER_2,1
GOBP_SNORNA_LOCALIZATION,SET,6,-0.19428,-0.0035097,0.3073,0.73637,GOBP_SNORNA_LOCALIZATION,1
TTTNNANAGCYR_UNKNOWN,SET,79,-0.062181,-0.0040679,0.098336,0.73641,TTTNNANAGCYR_UNKNOWN,1
GOBP_MITOCHONDRIAL_ELECTRON_...2,SET,42,-0.06915,-0.0033019,0.10936,0.73641,GOBP_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,1
TACTTGA_MIR26A_MIR26B,SET,273,-0.032758,-0.0039627,0.051794,0.73646,TACTTGA_MIR26A_MIR26B,1
GOMF_OXIDOREDUCTION_DRIVEN_A...,SET,52,-0.061547,-0.0032691,0.097302,0.73648,GOMF_OXIDOREDUCTION_DRIVEN_ACTIVE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GTCAGGA_MIR378,SET,50,-0.075105,-0.003912,0.11871,0.73652,GTCAGGA_MIR378,1
YTTCCNNNGGAMR_UNKNOWN,SET,46,-0.082697,-0.004132,0.13069,0.73656,YTTCCNNNGGAMR_UNKNOWN,1
HP_ABNORMALITY_OF_EXTRAPYRAM...,SET,270,-0.032181,-0.0038718,0.050844,0.73661,HP_ABNORMALITY_OF_EXTRAPYRAMIDAL_MOTOR_FUNCTION,1
HP_CERVICAL_NEOPLASM,SET,6,-0.2571,-0.0046446,0.40618,0.73662,HP_CERVICAL_NEOPLASM,1
HP_LEFT_VENTRICULAR_HYPERTRO...,SET,87,-0.053416,-0.0036664,0.08439,0.73662,HP_LEFT_VENTRICULAR_HYPERTROPHY,1
GARGALOVIC_RESPONSE_TO_OXIDI...4,SET,126,-0.048184,-0.0039759,0.076117,0.73664,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP,1
MIR6721_5P,SET,316,-0.030372,-0.0039481,0.047974,0.73666,MIR6721_5P,1
GAUTAM_EYE_CHOROID_SCLERA_AC...,SET,104,-0.049834,-0.0037381,0.078701,0.7367,GAUTAM_EYE_CHOROID_SCLERA_ACTIVATED_T_CELLS,1
GSE6875_TCONV_VS_TREG_DN,SET,186,-0.040542,-0.0040578,0.064017,0.73673,GSE6875_TCONV_VS_TREG_DN,1
GOBP_GLUCOSE_IMPORT_ACROSS_P...,SET,4,-0.30726,-0.0045324,0.48503,0.73678,GOBP_GLUCOSE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...145,SET,4,-0.26106,-0.0038509,0.41202,0.73683,GOBP_NEGATIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...275,SET,4,-0.26106,-0.0038509,0.41202,0.73683,GOBP_NEGATIVE_REGULATION_OF_HETEROCHROMATIN_FORMATION,1
REACTOME_REGULATION_OF_TP53_...4,SET,17,-0.1388,-0.0042195,0.21906,0.73684,REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_METHYLATION,1
HP_CONGENITAL_PTOSIS,SET,4,-0.25686,-0.003789,0.4053,0.73688,HP_CONGENITAL_PTOSIS,1
GOBP_SPINDLE_ASSEMBLY_INVOLV...,SET,8,-0.18915,-0.0039454,0.29844,0.73689,GOBP_SPINDLE_ASSEMBLY_INVOLVED_IN_FEMALE_MEIOSIS,1
HP_T_WAVE_INVERSION,SET,5,-0.22502,-0.0037109,0.35499,0.73691,HP_T_WAVE_INVERSION,1
GOBP_INTRACELLULAR_GLUCOSE_H...,SET,142,-0.046163,-0.004042,0.07282,0.73693,GOBP_INTRACELLULAR_GLUCOSE_HOMEOSTASIS,1
REACTOME_INTERLEUKIN_1_PROCE...,SET,9,-0.17021,-0.0037656,0.26841,0.737,REACTOME_INTERLEUKIN_1_PROCESSING,1
GSE2770_TGFB_AND_IL4_VS_IL12...5,SET,181,-0.03782,-0.0037346,0.05964,0.737,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
AMIT_SERUM_RESPONSE_240_MCF1...,SET,53,-0.080564,-0.0043201,0.12703,0.73703,AMIT_SERUM_RESPONSE_240_MCF10A,1
RFX1_02,SET,252,-0.032784,-0.0038124,0.051681,0.73707,RFX1_02,1
GSE6259_FLT3L_INDUCED_33D1_P...1,SET,176,-0.038677,-0.0037667,0.060966,0.73708,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_BCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_GL...3,SET,43,-0.079164,-0.0038247,0.12478,0.7371,GOBP_CELLULAR_RESPONSE_TO_GLUCOSE_STARVATION,1
HP_GONADOTROPIN_DEFICIENCY,SET,8,-0.20814,-0.0043415,0.32805,0.73711,HP_GONADOTROPIN_DEFICIENCY,1
GOBP_REGULATION_OF_PROTEIN_C...5,SET,110,-0.04916,-0.0037918,0.077474,0.73713,GOBP_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
GOBP_AEROBIC_RESPIRATION,SET,147,-0.04035,-0.0035941,0.06358,0.73716,GOBP_AEROBIC_RESPIRATION,1
HP_EXERCISE_INDUCED_MYOGLOBI...,SET,7,-0.15739,-0.003071,0.24797,0.73719,HP_EXERCISE_INDUCED_MYOGLOBINURIA,1
GSE22611_MUTANT_NOD2_VS_CTRL...2,SET,176,-0.03978,-0.0038741,0.062665,0.73722,GSE22611_MUTANT_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,1
GOMF_CARBONATE_DEHYDRATASE_A...,SET,14,-0.1551,-0.004279,0.24424,0.73729,GOMF_CARBONATE_DEHYDRATASE_ACTIVITY,1
MIR5587_5P,SET,101,-0.052104,-0.0038519,0.082021,0.73736,MIR5587_5P,1
MIR6865_3P,SET,41,-0.079671,-0.0037588,0.12542,0.73736,MIR6865_3P,1
FRASOR_RESPONSE_TO_ESTRADIOL...1,SET,69,-0.06914,-0.0042284,0.10884,0.73737,FRASOR_RESPONSE_TO_ESTRADIOL_DN,1
HP_ADENOCARCINOMA_OF_THE_SMA...,SET,9,-0.15279,-0.0033803,0.24049,0.73739,HP_ADENOCARCINOMA_OF_THE_SMALL_INTESTINE,1
TORCHIA_TARGETS_OF_EWSR1_FLI...2,SET,19,-0.13447,-0.0043214,0.2116,0.73744,TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_TOP20_DN,1
HP_EPISODIC_VOMITING,SET,37,-0.078078,-0.0034997,0.12286,0.73744,HP_EPISODIC_VOMITING,1
WU_ALZHEIMER_DISEASE_UP,SET,9,-0.19523,-0.0043192,0.30719,0.73745,WU_ALZHEIMER_DISEASE_UP,1
GOBP_MOTOR_NEURON_AXON_GUIDA...,SET,23,-0.11976,-0.004234,0.18843,0.73747,GOBP_MOTOR_NEURON_AXON_GUIDANCE,1
KOKKINAKIS_METHIONINE_DEPRIV...4,SET,113,-0.053621,-0.0041915,0.084355,0.73749,KOKKINAKIS_METHIONINE_DEPRIVATION_96HR_UP,1
GOBP_POSITIVE_REGULATION_OF_...221,SET,40,-0.083661,-0.0038987,0.13162,0.73749,GOBP_POSITIVE_REGULATION_OF_DNA_REPLICATION,1
HP_HYPOPLASIA_OF_THE_CORPUS_...,SET,391,-0.026509,-0.0038252,0.041699,0.73752,HP_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
LE_NEURONAL_DIFFERENTIATION_...1,SET,18,-0.11078,-0.0034651,0.17422,0.73755,LE_NEURONAL_DIFFERENTIATION_DN,1
REACTOME_CROSS_PRESENTATION_...1,SET,6,-0.23636,-0.0042699,0.37175,0.73755,REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES,1
GOBP_REGULATION_OF_HYDROGEN_...3,SET,17,-0.13187,-0.0040087,0.2074,0.73755,GOBP_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
SPIRA_SMOKERS_LUNG_CANCER_DN,SET,14,-0.13973,-0.003855,0.21975,0.73756,SPIRA_SMOKERS_LUNG_CANCER_DN,1
GOBP_NEGATIVE_REGULATION_OF_...523,SET,6,-0.21774,-0.0039335,0.34243,0.73756,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY_BY_REGULATION_OF_PROTEIN_PHOSPHORYLATION,1
GCM_CSNK1A1,SET,35,-0.077924,-0.0033973,0.12254,0.73758,GCM_CSNK1A1,1
BROWNE_HCMV_INFECTION_24HR_UP,SET,136,-0.045654,-0.0039127,0.07178,0.73761,BROWNE_HCMV_INFECTION_24HR_UP,1
GOBP_GALACTOSE_CATABOLIC_PRO...1,SET,6,-0.20967,-0.0037878,0.32946,0.73774,GOBP_GALACTOSE_CATABOLIC_PROCESS,1
HP_ABNORMAL_BLOOD_GAS_LEVEL,SET,44,-0.084335,-0.0041215,0.13251,0.73775,HP_ABNORMAL_BLOOD_GAS_LEVEL,1
KRISHNAN_FURIN_TARGETS_DN,SET,9,-0.14624,-0.0032354,0.22978,0.73776,KRISHNAN_FURIN_TARGETS_DN,1
WP_COVID19_ADVERSE_OUTCOME_P...,SET,14,-0.15254,-0.0042084,0.23964,0.73778,WP_COVID19_ADVERSE_OUTCOME_PATHWAY,1
KEGG_MEDICUS_REFERENCE_TAC3_...,SET,10,-0.17443,-0.0040677,0.27399,0.73781,KEGG_MEDICUS_REFERENCE_TAC3_TACR3_PLC_PKC_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...311,SET,17,-0.14182,-0.0043111,0.22276,0.73781,GOBP_POSITIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
HP_HYPERPLASIA_OF_THE_MAXILLA,SET,9,-0.21119,-0.0046722,0.33167,0.73785,HP_HYPERPLASIA_OF_THE_MAXILLA,1
MIR4798_3P,SET,10,-0.14448,-0.0033693,0.22688,0.73788,MIR4798_3P,1
SARRIO_EPITHELIAL_MESENCHYMA...1,SET,133,-0.049304,-0.004179,0.077414,0.7379,SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN,1
MODULE_285,SET,41,-0.078207,-0.0036897,0.12279,0.7379,MODULE_285,1
GOBP_REGULATION_OF_ENDOTHELI...1,SET,19,-0.13618,-0.0043763,0.21375,0.73797,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_CHEMOTAXIS,1
REACTOME_NEUROTRANSMITTER_RE...1,SET,191,-0.041244,-0.0041826,0.064734,0.73798,REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION,1
HP_DECREASED_CIRCULATING_ADE...,SET,7,-0.21569,-0.0042086,0.33849,0.738,HP_DECREASED_CIRCULATING_ADENOSYLCOBALAMIN_CONCENTRATION,1
chr3p11,SET,7,-0.29313,-0.0057195,0.45998,0.73802,chr3p11,1
GSE40685_NAIVE_CD4_TCELL_VS_...2,SET,186,-0.039112,-0.0039146,0.061373,0.73802,GSE40685_NAIVE_CD4_TCELL_VS_FOXP3_KO_TREG_PRECURSOR_UP,1
GOMF_BMP_RECEPTOR_BINDING,SET,10,-0.17191,-0.0040088,0.26974,0.73803,GOMF_BMP_RECEPTOR_BINDING,1
MIR4667_3P,SET,118,-0.049171,-0.0039272,0.077141,0.73807,MIR4667_3P,1
HP_ABNORMAL_CIRCULATING_LACT...,SET,90,-0.058778,-0.0041031,0.092202,0.73809,HP_ABNORMAL_CIRCULATING_LACTATE_DEHYDROGENASE_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...661,SET,17,-0.13733,-0.0041749,0.21542,0.7381,GOBP_POSITIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_ODONTOID_TISSUE_...,SET,207,-0.037265,-0.0039325,0.058454,0.7381,HP_ABNORMAL_ODONTOID_TISSUE_MORPHOLOGY,1
FLECHNER_PBL_KIDNEY_TRANSPLA...1,SET,37,-0.089258,-0.0040008,0.13995,0.73819,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1
HP_DISTAL_JOINT_HYPERMOBILITY,SET,7,-0.22164,-0.0043247,0.34751,0.7382,HP_DISTAL_JOINT_HYPERMOBILITY,1
GOBP_PLASMA_LIPOPROTEIN_PART...,SET,40,-0.088421,-0.0041205,0.13862,0.73821,GOBP_PLASMA_LIPOPROTEIN_PARTICLE_CLEARANCE,1
HP_DECREASED_CIRCULATING_AND...,SET,62,-0.071577,-0.0041503,0.1122,0.73824,HP_DECREASED_CIRCULATING_ANDROGEN_CONCENTRATION,1
GOBP_CEREBELLAR_PURKINJE_CEL...1,SET,23,-0.10759,-0.0038036,0.16862,0.73828,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...276,SET,23,-0.12035,-0.0042547,0.18859,0.73831,GOBP_POSITIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,1
HP_ABNORMAL_CEREBROSPINAL_FL...,SET,531,-0.022711,-0.0038041,0.035575,0.73839,HP_ABNORMAL_CEREBROSPINAL_FLUID_MORPHOLOGY,1
GOBP_REGULATION_OF_ANTIBACTE...,SET,7,-0.22345,-0.0043599,0.35,0.7384,GOBP_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,1
GSE46242_TH1_VS_ANERGIC_TH1_...4,SET,166,-0.042048,-0.0039781,0.065863,0.7384,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_UP,1
GSE3039_CD4_TCELL_VS_NKT_CEL...2,SET,183,-0.037082,-0.0036818,0.058081,0.73841,GSE3039_CD4_TCELL_VS_NKT_CELL_UP,1
GOBP_RENAL_SYSTEM_VASCULATUR...2,SET,8,-0.22019,-0.0045929,0.34481,0.73845,GOBP_RENAL_SYSTEM_VASCULATURE_MORPHOGENESIS,1
HP_INCREASED_RED_BLOOD_CELL_...,SET,5,-0.20973,-0.0034587,0.32838,0.73848,HP_INCREASED_RED_BLOOD_CELL_MASS,1
GOBP_POSITIVE_REGULATION_OF_...371,SET,7,-0.23417,-0.0045691,0.36663,0.73849,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_23_PRODUCTION,1
GOBP_REGULATION_OF_DEVELOPME...1,SET,272,-0.034857,-0.0042089,0.054561,0.73854,GOBP_REGULATION_OF_DEVELOPMENTAL_GROWTH,1
GOBP_REGULATION_OF_ENDOSOME_...3,SET,3,-0.27009,-0.0034504,0.42272,0.73856,GOBP_REGULATION_OF_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
GOBP_REGULATION_OF_RESPIRATO...5,SET,14,-0.15669,-0.004323,0.24521,0.73859,GOBP_REGULATION_OF_RESPIRATORY_SYSTEM_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...623,SET,6,-0.24804,-0.0044809,0.38805,0.73865,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
GSE22589_HIV_VS_HIV_AND_SIV_...2,SET,181,-0.039988,-0.0039488,0.062554,0.73867,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_UP,1
MIR5003_5P,SET,177,-0.04122,-0.0040256,0.064455,0.73875,MIR5003_5P,1
GOBP_POSITIVE_REGULATION_OF_...761,SET,13,-0.13867,-0.0036868,0.21679,0.7388,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
HP_INCREASED_ERYTHROCYTE_PRO...,SET,4,-0.26775,-0.0039496,0.41847,0.73886,HP_INCREASED_ERYTHROCYTE_PROTOPORPHYRIN_CONCENTRATION,1
GSE7548_NAIVE_VS_DAY28_PCC_I...2,SET,186,-0.037418,-0.0037451,0.058481,0.73886,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP,1
GOBP_LUTEINIZING_HORMONE_SEC...,SET,11,-0.18101,-0.004427,0.28286,0.73888,GOBP_LUTEINIZING_HORMONE_SECRETION,1
HP_CHROMOSOME_BREAKAGE,SET,36,-0.082864,-0.0036638,0.12949,0.73888,HP_CHROMOSOME_BREAKAGE,1
NAKAYA_MONOCYTE_FLUARIX_FLUV...1,SET,86,-0.058601,-0.0039992,0.091543,0.73896,NAKAYA_MONOCYTE_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
GOCC_OLIGOSACCHARYLTRANSFERA...,SET,13,-0.15151,-0.004028,0.23659,0.73903,GOCC_OLIGOSACCHARYLTRANSFERASE_COMPLEX,1
GSE29614_CTRL_VS_DAY7_TIV_FL...2,SET,145,-0.047053,-0.0041629,0.073473,0.73904,GSE29614_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,1
HP_HEMORRHAGE_OF_THE_EYE,SET,46,-0.07896,-0.0039453,0.12329,0.73905,HP_HEMORRHAGE_OF_THE_EYE,1
BCAT_BILD_ET_AL_UP,SET,42,-0.084402,-0.0040301,0.13179,0.73905,BCAT_BILD_ET_AL_UP,1
LEE_NEURAL_CREST_STEM_CELL_UP,SET,139,-0.050068,-0.0043377,0.078162,0.73909,LEE_NEURAL_CREST_STEM_CELL_UP,1
GOBP_REGULATION_OF_REMOVAL_O...,SET,6,-0.21071,-0.0038065,0.32891,0.73911,GOBP_REGULATION_OF_REMOVAL_OF_SUPEROXIDE_RADICALS,1
GOMF_CALCIUM_POTASSIUM_SODIU...,SET,5,-0.29937,-0.0049371,0.467,0.73925,GOMF_CALCIUM_POTASSIUM_SODIUM_ANTIPORTER_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_GNRH_...,SET,20,-0.12475,-0.004113,0.19457,0.73929,KEGG_MEDICUS_REFERENCE_GNRH_GNRHR_PLCB_PKC_SIGNALING_PATHWAY,1
GOBP_SA_NODE_CELL_TO_ATRIAL_...2,SET,9,-0.197,-0.0043584,0.30724,0.7393,GOBP_SA_NODE_CELL_TO_ATRIAL_CARDIAC_MUSCLE_CELL_SIGNALING,1
GSE39820_IL1B_IL6_VS_IL1B_IL...2,SET,181,-0.040651,-0.0040142,0.063391,0.73932,GSE39820_IL1B_IL6_VS_IL1B_IL6_IL23A_TREATED_CD4_TCELL_UP,1
MODY_HIPPOCAMPUS_POSTNATAL,SET,52,-0.071797,-0.0038135,0.11196,0.73933,MODY_HIPPOCAMPUS_POSTNATAL,1
WUNDER_INFLAMMATORY_RESPONSE...1,SET,11,-0.16134,-0.0039459,0.25158,0.73933,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_DN,1
KEGG_MEDICUS_REFERENCE_MEMBR...,SET,9,-0.17508,-0.0038733,0.27288,0.73943,KEGG_MEDICUS_REFERENCE_MEMBRANE_INITIATED_PROGESTERONE_SIGNALING_PATHWAY,1
GSE27786_LSK_VS_NKCELL_DN,SET,182,-0.040202,-0.0039807,0.062658,0.73943,GSE27786_LSK_VS_NKCELL_DN,1
HP_APLASIA_HYPOPLASIA_OF_THE...34,SET,26,-0.10434,-0.0039215,0.16261,0.73944,HP_APLASIA_HYPOPLASIA_OF_THE_FIBULA,1
KEGG_MEDICUS_VARIANT_MUTATIO...81,SET,5,-0.22466,-0.0037051,0.34999,0.73953,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_PRKN_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
HP_SUPERNUMERARY_SPLEENS,SET,81,-0.055343,-0.0036659,0.086192,0.73959,HP_SUPERNUMERARY_SPLEENS,1
HP_LARYNGEAL_EDEMA,SET,4,-0.30437,-0.0044898,0.47393,0.73963,HP_LARYNGEAL_EDEMA,1
HP_ABNORMAL_SEVENTH_CRANIAL_...,SET,167,-0.041068,-0.0038969,0.063943,0.73964,HP_ABNORMAL_SEVENTH_CRANIAL_PHYSIOLOGY,1
REACTOME_TELOMERE_EXTENSION_...,SET,22,-0.10841,-0.0037486,0.16876,0.73969,REACTOME_TELOMERE_EXTENSION_BY_TELOMERASE,1
GSE29614_CTRL_VS_DAY3_TIV_FL...2,SET,151,-0.044541,-0.0040207,0.069319,0.73974,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...297,SET,83,-0.05876,-0.0039398,0.091424,0.73979,GOBP_NEGATIVE_REGULATION_OF_INNATE_IMMUNE_RESPONSE,1
GOBP_VITAMIN_E_METABOLIC_PRO...,SET,6,-0.21233,-0.0038358,0.33032,0.73982,GOBP_VITAMIN_E_METABOLIC_PROCESS,1
GSE17721_POLYIC_VS_PAM3CSK4_...13,SET,182,-0.038614,-0.0038235,0.060061,0.73985,GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN,1
GOBP_REACTIVE_GLIOSIS,SET,5,-0.27729,-0.004573,0.43129,0.73986,GOBP_REACTIVE_GLIOSIS,1
HE_LIM_SUN_FETAL_LUNG_C0_ADV...,SET,62,-0.075003,-0.0043489,0.11663,0.73991,HE_LIM_SUN_FETAL_LUNG_C0_ADVENTITIAL_FIBROBLAST,1
GOBP_REGULATION_OF_METAPHASE...,SET,14,-0.14936,-0.0041208,0.23225,0.73992,GOBP_REGULATION_OF_METAPHASE_PLATE_CONGRESSION,1
GOBP_ACTIN_MODIFICATION,SET,4,-0.26897,-0.0039676,0.41802,0.74003,GOBP_ACTIN_MODIFICATION,1
GOMF_AP_1_ADAPTOR_COMPLEX_BI...,SET,5,-0.2281,-0.0037618,0.35445,0.74006,GOMF_AP_1_ADAPTOR_COMPLEX_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...162,SET,33,-0.10267,-0.0043467,0.15953,0.74007,GOBP_NEGATIVE_REGULATION_OF_CYTOKINE_PRODUCTION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_CHRONIC_NEUTROPENIA,SET,9,-0.16123,-0.003567,0.25047,0.74011,HP_CHRONIC_NEUTROPENIA,1
GOBP_REGULATION_OF_PROTEASOM...2,SET,113,-0.049349,-0.0038576,0.076661,0.74012,GOBP_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
MULLIGHAN_MLL_SIGNATURE_2_UP,SET,389,-0.026995,-0.0038856,0.041924,0.74018,MULLIGHAN_MLL_SIGNATURE_2_UP,1
GOBP_REGULATION_OF_INTEGRIN_...3,SET,18,-0.13088,-0.0040939,0.20321,0.74023,GOBP_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,1
GOBP_EXOCYTIC_PROCESS,SET,75,-0.060631,-0.0038653,0.094123,0.74026,GOBP_EXOCYTIC_PROCESS,1
GOBP_DOPAMINE_TRANSPORT,SET,43,-0.086207,-0.0041649,0.13382,0.74027,GOBP_DOPAMINE_TRANSPORT,1
GOBP_CLATHRIN_COAT_ASSEMBLY,SET,18,-0.12556,-0.0039275,0.1949,0.74029,GOBP_CLATHRIN_COAT_ASSEMBLY,1
ZHONG_PFC_C8_UNKNOWN_NEUROD2...,SET,80,-0.064168,-0.0042243,0.099587,0.74032,ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON,1
GOBP_POSITIVE_REGULATION_OF_...436,SET,3,-0.26055,-0.0033286,0.40436,0.74033,GOBP_POSITIVE_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
GOMF_PHOSPHOLIPID_TRANSPORTE...,SET,58,-0.071432,-0.0040065,0.11085,0.74033,GOMF_PHOSPHOLIPID_TRANSPORTER_ACTIVITY,1
BYSTRYKH_HEMATOPOIESIS_STEM_...3,SET,7,-0.21559,-0.0042066,0.33453,0.74036,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3,1
GSE1791_CTRL_VS_NEUROMEDINU_...6,SET,160,-0.043565,-0.004047,0.067593,0.74038,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_3H_UP,1
GOMF_MAP_KINASE_PHOSPHATASE_...,SET,13,-0.15864,-0.0042177,0.24613,0.74039,GOMF_MAP_KINASE_PHOSPHATASE_ACTIVITY,1
MIR888_3P,SET,105,-0.052215,-0.0039353,0.080996,0.74042,MIR888_3P,1
HE_LIM_SUN_FETAL_LUNG_C2_DC1...,SET,292,-0.032718,-0.004091,0.050752,0.74042,HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL,1
GSE3982_EOSINOPHIL_VS_NEUTRO...2,SET,179,-0.037431,-0.003676,0.058046,0.74049,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_UP,1
HOFMANN_MYELODYSPLASTIC_SYND...5,SET,20,-0.11356,-0.0037441,0.17607,0.74053,HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN,1
GOBP_CELLULAR_RESPONSE_TO_LE...2,SET,17,-0.13828,-0.0042035,0.21438,0.74053,GOBP_CELLULAR_RESPONSE_TO_LEPTIN_STIMULUS,1
GSE5589_LPS_VS_LPS_AND_IL10_...3,SET,185,-0.041422,-0.0041349,0.064217,0.74054,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_45MIN_DN,1
TUOMISTO_TUMOR_SUPPRESSION_B...1,SET,19,-0.12934,-0.0041565,0.2005,0.74057,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_DN,1
GOCC_INTRACILIARY_TRANSPORT_...3,SET,15,-0.1625,-0.0046406,0.25186,0.7406,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_B,1
GOBP_PYRIMIDINE_NUCLEOTIDE_C...,SET,21,-0.11892,-0.0040174,0.18429,0.74062,GOBP_PYRIMIDINE_NUCLEOTIDE_CATABOLIC_PROCESS,1
GOBP_DETECTION_OF_STIMULUS_I...1,SET,418,-0.03571,-0.0053237,0.055339,0.74063,GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,1
GSE14413_UNSTIM_VS_IFNB_STIM...5,SET,105,-0.053059,-0.0039989,0.082225,0.74063,GSE14413_UNSTIM_VS_IFNB_STIM_RAW264_CELLS_DN,1
HP_ABNORMAL_PULMONARY_INTERS...,SET,135,-0.046712,-0.0039887,0.072373,0.74067,HP_ABNORMAL_PULMONARY_INTERSTITIAL_MORPHOLOGY,1
REACTOME_DOWNSTREAM_SIGNALIN...3,SET,29,-0.099886,-0.0039646,0.15472,0.74072,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR2,1
GOBP_POSITIVE_REGULATION_OF_...550,SET,12,-0.15354,-0.0039221,0.23784,0.74072,GOBP_POSITIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
GSE19923_WT_VS_E2A_KO_DP_THY...1,SET,176,-0.04026,-0.0039208,0.062362,0.74072,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_DN,1
WP_EDA_SIGNALING_IN_HAIR_FOL...,SET,12,-0.16762,-0.0042816,0.2596,0.74075,WP_EDA_SIGNALING_IN_HAIR_FOLLICLE_DEVELOPMENT,1
GSE37605_C57BL6_VS_NOD_FOXP3...3,SET,179,-0.040841,-0.0040108,0.063249,0.74076,GSE37605_C57BL6_VS_NOD_FOXP3_FUSION_GFP_TREG_DN,1
GOBP_REGULATION_OF_SPINDLE_A...,SET,32,-0.084411,-0.0035191,0.13072,0.74077,GOBP_REGULATION_OF_SPINDLE_ASSEMBLY,1
GSE14908_ATOPIC_VS_NONATOPIC...3,SET,180,-0.037375,-0.0036806,0.057873,0.74079,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_DN,1
GSE22886_NAIVE_BCELL_VS_NEUT...1,SET,179,-0.042653,-0.0041888,0.066046,0.7408,GSE22886_NAIVE_BCELL_VS_NEUTROPHIL_DN,1
GSE2706_R848_VS_R848_AND_LPS...3,SET,158,-0.045712,-0.0042201,0.070779,0.7408,GSE2706_R848_VS_R848_AND_LPS_8H_STIM_DC_DN,1
HP_FLEXION_CONTRACTURE_OF_TH...,SET,4,-0.31743,-0.0046824,0.49131,0.74089,HP_FLEXION_CONTRACTURE_OF_THE_2ND_FINGER,1
GOBP_POSITIVE_REGULATION_OF_...757,SET,11,-0.16487,-0.0040321,0.25507,0.74097,GOBP_POSITIVE_REGULATION_OF_TISSUE_REMODELING,1
GSE22611_UNSTIM_VS_6H_MDP_ST...4,SET,177,-0.040864,-0.0039909,0.06322,0.74098,GSE22611_UNSTIM_VS_6H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
chr1q43,SET,21,-0.19748,-0.0066715,0.30551,0.74099,chr1q43,1
GOBP_URETERIC_BUD_FORMATION,SET,5,-0.28033,-0.0046232,0.4334,0.74112,GOBP_URETERIC_BUD_FORMATION,1
PID_IL1_PATHWAY,SET,32,-0.096459,-0.0040214,0.14912,0.74114,PID_IL1_PATHWAY,1
MORF_UBE2N,SET,82,-0.053746,-0.003582,0.083078,0.74116,MORF_UBE2N,1
REACTOME_REGULATION_OF_ENDOG...1,SET,80,-0.058991,-0.0038835,0.091165,0.7412,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS,1
GOCC_GOLGI_TRANSPORT_COMPLEX,SET,10,-0.16485,-0.0038442,0.25475,0.74121,GOCC_GOLGI_TRANSPORT_COMPLEX,1
GSE10211_UV_INACT_SENDAI_VS_...1,SET,141,-0.046591,-0.0040651,0.071988,0.74125,GSE10211_UV_INACT_SENDAI_VS_LIVE_SENDAI_VIRUS_TRACHEAL_EPITHELIAL_CELLS_DN,1
HP_PROMINENT_NASAL_TIP,SET,25,-0.11245,-0.0041445,0.17369,0.74131,HP_PROMINENT_NASAL_TIP,1
HP_AXILLARY_FRECKLING,SET,5,-0.22194,-0.0036602,0.34279,0.74133,HP_AXILLARY_FRECKLING,1
REACTOME_RUNX2_REGULATES_GEN...,SET,8,-0.19843,-0.0041389,0.30645,0.74134,REACTOME_RUNX2_REGULATES_GENES_INVOLVED_IN_CELL_MIGRATION,1
HP_CONFUSIONAL_AROUSAL,SET,9,-0.19569,-0.0043293,0.30222,0.74135,HP_CONFUSIONAL_AROUSAL,1
PASINI_SUZ12_TARGETS_DN,SET,289,-0.034122,-0.004245,0.05268,0.74141,PASINI_SUZ12_TARGETS_DN,1
chr13q22,SET,14,-0.24304,-0.0067052,0.37521,0.74142,chr13q22,1
GOBP_INTERLEUKIN_33_MEDIATED...,SET,7,-0.21371,-0.00417,0.32992,0.74143,GOBP_INTERLEUKIN_33_MEDIATED_SIGNALING_PATHWAY,1
GOMF_TAT_PROTEIN_BINDING,SET,10,-0.1652,-0.0038524,0.25502,0.74144,GOMF_TAT_PROTEIN_BINDING,1
MIR767_3P,SET,115,-0.055489,-0.0043755,0.085638,0.74149,MIR767_3P,1
HP_HEMIATROPHY,SET,4,-0.25874,-0.0038166,0.39929,0.7415,HP_HEMIATROPHY,1
chr11p12,SET,6,-0.28591,-0.005165,0.4412,0.74151,chr11p12,1
MIR7151_5P,SET,42,-0.085585,-0.0040866,0.13205,0.74155,MIR7151_5P,1
ZHENG_CORD_BLOOD_C5_SIMILAR_...,SET,53,-0.085142,-0.0045656,0.1313,0.74164,ZHENG_CORD_BLOOD_C5_SIMILAR_TO_HSC_C6_PUTATIVE_ALTERED_METABOLIC_STATE,1
GOCC_PROTEIN_COMPLEX_INVOLVE...2,SET,5,-0.23187,-0.0038238,0.35754,0.74166,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_CELL_ADHESION,1
GSE15930_STIM_VS_STIM_AND_IL...2,SET,179,-0.038818,-0.0038122,0.059854,0.74168,GSE15930_STIM_VS_STIM_AND_IL12_24H_CD8_T_CELL_UP,1
GOBP_CELL_FATE_SPECIFICATION,SET,101,-0.057344,-0.0042393,0.088414,0.74169,GOBP_CELL_FATE_SPECIFICATION,1
HP_NON_MIDLINE_CLEFT_OF_THE_...,SET,34,-0.09188,-0.0039482,0.14166,0.7417,HP_NON_MIDLINE_CLEFT_OF_THE_UPPER_LIP,1
GSE18791_UNSTIM_VS_NEWCATSLE...7,SET,140,-0.04549,-0.0039551,0.070125,0.74173,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN,1
GSE1740_MCSF_VS_MCSF_AND_IFN...4,SET,184,-0.039032,-0.0038858,0.060165,0.74174,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_WITH_IFNA_STIM_UP,1
MOROSETTI_FACIOSCAPULOHUMERA...1,SET,12,-0.16036,-0.0040963,0.247,0.74191,MOROSETTI_FACIOSCAPULOHUMERAL_MUSCULAR_DISTROPHY_DN,1
REACTOME_TRANSPORT_OF_RCBL_W...,SET,8,-0.19433,-0.0040535,0.29922,0.74198,REACTOME_TRANSPORT_OF_RCBL_WITHIN_THE_BODY,1
GOCC_CHITOSOME,SET,20,-0.13206,-0.0043542,0.20332,0.742,GOCC_CHITOSOME,1
REACTOME_CARDIOGENESIS,SET,24,-0.12128,-0.0043796,0.18666,0.74205,REACTOME_CARDIOGENESIS,1
REACTOME_INTEGRIN_CELL_SURFA...,SET,81,-0.066007,-0.0043723,0.10155,0.74216,REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS,1
MIR526B_5P,SET,94,-0.05719,-0.0040795,0.087965,0.7422,MIR526B_5P,1
GOBP_CELL_DIFFERENTIATION_IN...1,SET,24,-0.12147,-0.0043865,0.18681,0.74222,GOBP_CELL_DIFFERENTIATION_INVOLVED_IN_EMBRYONIC_PLACENTA_DEVELOPMENT,1
GOMF_PHOSPHORYLATION_DEPENDE...,SET,8,-0.21264,-0.0044354,0.32702,0.74222,GOMF_PHOSPHORYLATION_DEPENDENT_PROTEIN_BINDING,1
GOBP_MALE_GAMETE_GENERATION,SET,530,-0.02324,-0.0038893,0.035741,0.74223,GOBP_MALE_GAMETE_GENERATION,1
JINESH_BLEBBISHIELD_TRANSFOR...2,SET,154,-0.047411,-0.0043216,0.072893,0.74228,JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP,1
GOBP_PROTEASOMAL_PROTEIN_CAT...,SET,482,-0.024423,-0.003903,0.037536,0.74236,GOBP_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,1
HP_HYPOTELORISM,SET,114,-0.04876,-0.0038283,0.074939,0.74237,HP_HYPOTELORISM,1
HP_MYOGLOBINURIA,SET,23,-0.095891,-0.0033901,0.14736,0.74238,HP_MYOGLOBINURIA,1
ZWANG_EGF_PERSISTENTLY_DN,SET,56,-0.066707,-0.0036766,0.10251,0.74239,ZWANG_EGF_PERSISTENTLY_DN,1
HP_OLIGOHYDRAMNIOS,SET,166,-0.041581,-0.0039339,0.063897,0.74239,HP_OLIGOHYDRAMNIOS,1
WP_KISSPEPTINKISSPEPTIN_RECE...,SET,38,-0.091844,-0.0041719,0.14109,0.74247,WP_KISSPEPTINKISSPEPTIN_RECEPTOR_SYSTEM_IN_THE_OVARY,1
GOBP_NEUTROPHIL_HOMEOSTASIS,SET,19,-0.12863,-0.0041336,0.19758,0.74248,GOBP_NEUTROPHIL_HOMEOSTASIS,1
GSE21927_C26GM_VS_4T1_TUMOR_...2,SET,175,-0.041179,-0.003999,0.063249,0.74249,GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_UP,1
GOBP_AUDITORY_RECEPTOR_CELL_...1,SET,24,-0.11827,-0.0042711,0.18166,0.7425,GOBP_AUDITORY_RECEPTOR_CELL_DEVELOPMENT,1
GOBP_SINOATRIAL_NODE_DEVELOP...,SET,12,-0.18153,-0.0046371,0.2788,0.74251,GOBP_SINOATRIAL_NODE_DEVELOPMENT,1
HP_ABNORMALITY_OF_THE_DISTAL...5,SET,9,-0.185,-0.0040928,0.28406,0.74256,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_HALLUX,1
HP_TYPIFIED_BY_INCOMPLETE_PE...,SET,132,-0.049122,-0.004148,0.075426,0.74256,HP_TYPIFIED_BY_INCOMPLETE_PENETRANCE,1
HP_VOLVULUS,SET,13,-0.14656,-0.0038964,0.22501,0.74258,HP_VOLVULUS,1
MIR1200,SET,301,-0.032476,-0.004122,0.049847,0.74264,MIR1200,1
BIOCARTA_ACTINY_PATHWAY,SET,11,-0.1358,-0.0033214,0.20842,0.74266,BIOCARTA_ACTINY_PATHWAY,1
GOBP_AMMONIUM_ION_METABOLIC_...,SET,22,-0.1302,-0.0045021,0.19981,0.74268,GOBP_AMMONIUM_ION_METABOLIC_PROCESS,1
PID_MYC_ACTIV_PATHWAY,SET,77,-0.064425,-0.0041613,0.098859,0.74269,PID_MYC_ACTIV_PATHWAY,1
HP_TRIGONOCEPHALY,SET,40,-0.087741,-0.0040888,0.13464,0.74269,HP_TRIGONOCEPHALY,1
GCM_FANCL,SET,21,-0.10628,-0.0035906,0.16309,0.7427,GCM_FANCL,1
HP_ABNORMAL_CELL_MORPHOLOGY,SET,42,-0.077558,-0.0037034,0.11899,0.74273,HP_ABNORMAL_CELL_MORPHOLOGY,1
GOCC_CLATHRIN_SCULPTED_MONOA...,SET,5,-0.25696,-0.0042377,0.39421,0.74274,GOCC_CLATHRIN_SCULPTED_MONOAMINE_TRANSPORT_VESICLE,1
GSE6259_FLT3L_INDUCED_33D1_P...4,SET,159,-0.043444,-0.0040233,0.066642,0.74276,GSE6259_FLT3L_INDUCED_33D1_POS_DC_VS_CD4_TCELL_UP,1
HP_BLISTERING_BY_ANATOMICAL_...,SET,25,-0.1106,-0.0040764,0.16965,0.74277,HP_BLISTERING_BY_ANATOMICAL_LOCATION,1
GSE6090_UNSTIM_VS_DC_SIGN_ST...2,SET,153,-0.041046,-0.0037294,0.062951,0.7428,GSE6090_UNSTIM_VS_DC_SIGN_STIM_DC_UP,1
GSE25890_CTRL_VS_IL33_IL7_TR...2,SET,179,-0.040869,-0.0040136,0.062678,0.74281,GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_UP,1
GOBP_LOCOMOTOR_RHYTHM,SET,16,-0.14323,-0.0042243,0.21966,0.74282,GOBP_LOCOMOTOR_RHYTHM,1
GOBP_CELLULAR_RESPONSE_TO_CH...2,SET,17,-0.13596,-0.0041331,0.20847,0.74286,GOBP_CELLULAR_RESPONSE_TO_CHOLESTEROL,1
HP_IMMUNOLOGIC_HYPERSENSITIV...,SET,210,-0.038954,-0.00414,0.059718,0.74289,HP_IMMUNOLOGIC_HYPERSENSITIVITY,1
WP_BONE_MORPHOGENIC_PROTEIN_...,SET,11,-0.17199,-0.0042063,0.2635,0.74302,WP_BONE_MORPHOGENIC_PROTEIN_SIGNALING_AND_REGULATION,1
REACTOME_MINERALOCORTICOID_B...,SET,6,-0.24493,-0.0044247,0.37504,0.74314,REACTOME_MINERALOCORTICOID_BIOSYNTHESIS,1
HE_LIM_SUN_FETAL_LUNG_C2_MEG...,SET,615,-0.023041,-0.0041436,0.035265,0.74323,HE_LIM_SUN_FETAL_LUNG_C2_MEGAKARYOCYTE,1
MIR625_3P,SET,45,-0.086247,-0.0042624,0.13196,0.74331,MIR625_3P,1
GOBP_POSITIVE_REGULATION_OF_...750,SET,29,-0.09722,-0.0038588,0.14871,0.74337,GOBP_POSITIVE_REGULATION_OF_TELOMERASE_ACTIVITY,1
GOMF_MITOGEN_ACTIVATED_PROTE...4,SET,7,-0.22845,-0.0044575,0.34943,0.74337,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_P38_BINDING,1
MIR143_3P_MIR4770,SET,187,-0.040395,-0.0040538,0.061782,0.74338,MIR143_3P_MIR4770,1
LET_7D_5P,SET,316,-0.031913,-0.0041484,0.048805,0.7434,LET_7D_5P,1
IPF1_Q4,SET,216,-0.039629,-0.0042708,0.060603,0.74341,IPF1_Q4,1
MIR205_3P,SET,359,-0.029535,-0.0040874,0.045166,0.74342,MIR205_3P,1
HP_ABNORMAL_RAPID_EYE_MOVEME...,SET,13,-0.16612,-0.0044165,0.25398,0.74346,HP_ABNORMAL_RAPID_EYE_MOVEMENT_SLEEP,1
HP_CONGENITAL_BILATERAL_HIP_...,SET,6,-0.26863,-0.0048528,0.41061,0.74351,HP_CONGENITAL_BILATERAL_HIP_DISLOCATION,1
GSE339_EX_VIVO_VS_IN_CULTURE...5,SET,188,-0.041018,-0.0041273,0.062696,0.74352,GSE339_EX_VIVO_VS_IN_CULTURE_CD8POS_DC_DN,1
GNF2_DEK,SET,51,-0.07244,-0.0038106,0.11071,0.74354,GNF2_DEK,1
TRAVAGLINI_LUNG_CAPILLARY_CE...,SET,14,-0.16336,-0.0045068,0.24963,0.74357,TRAVAGLINI_LUNG_CAPILLARY_CELL,1
GOBP_MODIFICATION_DEPENDENT_...,SET,566,-0.022602,-0.0039049,0.034532,0.74361,GOBP_MODIFICATION_DEPENDENT_MACROMOLECULE_CATABOLIC_PROCESS,1
GOBP_SYNAPTIC_VESICLE_LUMEN_...,SET,15,-0.13859,-0.0039576,0.21174,0.74361,GOBP_SYNAPTIC_VESICLE_LUMEN_ACIDIFICATION,1
KEGG_MEDICUS_REFERENCE_INACT...,SET,6,-0.18637,-0.0033668,0.28471,0.74363,KEGG_MEDICUS_REFERENCE_INACTIVATION_OF_CONDENSIN_I,1
HP_MYOPIC_ASTIGMATISM,SET,6,-0.22076,-0.003988,0.33722,0.74365,HP_MYOPIC_ASTIGMATISM,1
HP_ABNORMALITY_OF_PROTHROMBIN,SET,47,-0.085396,-0.0043129,0.13044,0.74366,HP_ABNORMALITY_OF_PROTHROMBIN,1
HP_ABNORMAL_DERMATOGLYPHICS,SET,270,-0.032918,-0.0039604,0.050276,0.74368,HP_ABNORMAL_DERMATOGLYPHICS,1
MYCMAX_01,SET,235,-0.037113,-0.0041697,0.056678,0.7437,MYCMAX_01,1
GOBP_G1_TO_G0_TRANSITION,SET,18,-0.11901,-0.0037225,0.18173,0.74371,GOBP_G1_TO_G0_TRANSITION,1
MIR6722_3P,SET,161,-0.043444,-0.0040483,0.066334,0.74374,MIR6722_3P,1
GOMF_HISTONE_READER_ACTIVITY,SET,16,-0.12364,-0.0036463,0.18877,0.74374,GOMF_HISTONE_READER_ACTIVITY,1
GOBP_CELL_SURFACE_RECEPTOR_P...2,SET,582,-0.023891,-0.0041836,0.036472,0.74378,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_KINASE_SIGNALING_PATHWAY,1
GSE21546_WT_VS_SAP1A_KO_ANTI...1,SET,183,-0.039598,-0.0039315,0.060441,0.74381,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN,1
ZNF579_TARGET_GENES,SET,613,-0.022486,-0.0040376,0.034321,0.74382,ZNF579_TARGET_GENES,1
GOBP_G_PROTEIN_COUPLED_RECEP...1,SET,9,-0.1812,-0.0040087,0.27656,0.74382,GOBP_G_PROTEIN_COUPLED_RECEPTOR_INTERNALIZATION,1
HP_ADVANCED_OSSIFICATION_OF_...,SET,10,-0.16517,-0.0038516,0.25209,0.74382,HP_ADVANCED_OSSIFICATION_OF_CARPAL_BONES,1
KEGG_REGULATION_OF_AUTOPHAGY,SET,31,-0.11409,-0.0046819,0.17408,0.74389,KEGG_REGULATION_OF_AUTOPHAGY,1
CYCLIN_D1_KE_.V1_UP,SET,178,-0.040991,-0.0040144,0.062542,0.74389,CYCLIN_D1_KE_.V1_UP,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...6,SET,82,-0.05922,-0.0039468,0.090348,0.74391,HP_ABNORMAL_MORPHOLOGY_OF_THE_MUSCULATURE_OF_THE_NECK,1
GSE13411_NAIVE_VS_IGM_MEMORY...2,SET,171,-0.042256,-0.0040569,0.064436,0.74401,GSE13411_NAIVE_VS_IGM_MEMORY_BCELL_UP,1
GOBP_REGULATION_OF_VASCULAR_...4,SET,29,-0.10424,-0.0041373,0.15894,0.74403,GOBP_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_HIGHLY_ARCHED_EYEBROW,SET,177,-0.038836,-0.0037928,0.059203,0.74408,HP_HIGHLY_ARCHED_EYEBROW,1
GOBP_CARBOHYDRATE_CATABOLIC_...,SET,157,-0.042523,-0.0039134,0.064821,0.74409,GOBP_CARBOHYDRATE_CATABOLIC_PROCESS,1
GOCC_CILIARY_TRANSITION_ZONE,SET,65,-0.064658,-0.0038384,0.098523,0.74417,GOCC_CILIARY_TRANSITION_ZONE,1
GOBP_LIPID_OXIDATION,SET,107,-0.053028,-0.0040343,0.080782,0.74422,GOBP_LIPID_OXIDATION,1
AUNG_GASTRIC_CANCER,SET,47,-0.076845,-0.003881,0.117,0.74434,AUNG_GASTRIC_CANCER,1
GOCC_INTEGRATOR_COMPLEX,SET,13,-0.14484,-0.0038507,0.22052,0.74434,GOCC_INTEGRATOR_COMPLEX,1
GOBP_CELLULAR_RESPONSE_TO_OX...3,SET,1069,-0.017992,-0.0042111,0.027387,0.74439,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,1
GOCC_MICROTUBULE,SET,416,-0.026494,-0.0039406,0.040322,0.74443,GOCC_MICROTUBULE,1
GOBP_THROMBOPOIETIN_MEDIATED...,SET,5,-0.22017,-0.003631,0.33501,0.74447,GOBP_THROMBOPOIETIN_MEDIATED_SIGNALING_PATHWAY,1
GOMF_MECHANOSENSITIVE_MONOAT...1,SET,5,-0.22818,-0.0037631,0.34714,0.74451,GOMF_MECHANOSENSITIVE_MONOATOMIC_CATION_CHANNEL_ACTIVITY,1
ZNF532_TARGET_GENES,SET,53,-0.078652,-0.0042175,0.11964,0.74453,ZNF532_TARGET_GENES,1
HP_HYPERCHOLESTEROLEMIA,SET,71,-0.070569,-0.0043777,0.10735,0.74453,HP_HYPERCHOLESTEROLEMIA,1
GOCC_GATOR1_COMPLEX,SET,5,-0.23231,-0.0038313,0.35317,0.74466,GOCC_GATOR1_COMPLEX,1
HP_SHORT_DIGIT,SET,523,-0.024191,-0.0040223,0.036775,0.74466,HP_SHORT_DIGIT,1
GSE29617_CTRL_VS_DAY7_TIV_FL...1,SET,160,-0.042207,-0.0039209,0.06416,0.74467,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_DN,1
GSE20152_SPHK1_KO_VS_WT_HTNF...2,SET,179,-0.041291,-0.0040551,0.06276,0.7447,GSE20152_SPHK1_KO_VS_WT_HTNFA_OVERXPRESS_ANKLE_UP,1
HP_ABNORMAL_ODONTOID_PROCESS...,SET,28,-0.10355,-0.0040386,0.15728,0.74484,HP_ABNORMAL_ODONTOID_PROCESS_MORPHOLOGY,1
CAR_IGFBP1,SET,55,-0.081595,-0.0044569,0.1239,0.7449,CAR_IGFBP1,1
GOBP_HORMONE_METABOLIC_PROCE...,SET,228,-0.040249,-0.004455,0.061111,0.74493,GOBP_HORMONE_METABOLIC_PROCESS,1
HP_GINGIVAL_RECESSION,SET,5,-0.24023,-0.0039618,0.36474,0.74493,HP_GINGIVAL_RECESSION,1
PUJANA_BREAST_CANCER_WITH_BR...1,SET,8,-0.1699,-0.0035439,0.25795,0.74494,PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_DN,1
BIOCARTA_INFLAM_PATHWAY,SET,25,-0.12021,-0.0044304,0.1825,0.74494,BIOCARTA_INFLAM_PATHWAY,1
GUILLAUMOND_KLF10_TARGETS_UP,SET,48,-0.082421,-0.0042066,0.12512,0.74497,GUILLAUMOND_KLF10_TARGETS_UP,1
GOBP_AMACRINE_CELL_DIFFERENT...,SET,12,-0.1843,-0.0047077,0.27975,0.74498,GOBP_AMACRINE_CELL_DIFFERENTIATION,1
GSE1448_ANTI_VALPHA2_VS_VBET...2,SET,184,-0.041444,-0.004126,0.062892,0.74504,GSE1448_ANTI_VALPHA2_VS_VBETA5_DP_THYMOCYTE_UP,1
MIR6771_3P,SET,89,-0.058276,-0.0040455,0.088422,0.74507,MIR6771_3P,1
GOBP_DNA_LIGATION_INVOLVED_I...,SET,5,-0.19169,-0.0031613,0.29083,0.74509,GOBP_DNA_LIGATION_INVOLVED_IN_DNA_REPAIR,1
REACTOME_SYNTHESIS_OF_PIPS_A...1,SET,15,-0.12073,-0.0034476,0.18312,0.74514,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_EARLY_ENDOSOME_MEMBRANE,1
GOBP_POSITIVE_REGULATION_OF_...463,SET,58,-0.075125,-0.0042136,0.11393,0.74518,GOBP_POSITIVE_REGULATION_OF_MIRNA_METABOLIC_PROCESS,1
GSE17186_NAIVE_VS_CD21HIGH_T...4,SET,178,-0.041682,-0.0040822,0.063203,0.74521,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_UP,1
GSE36392_EOSINOPHIL_VS_NEUTR...2,SET,183,-0.041242,-0.0040947,0.062506,0.7453,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_UP,1
MIKKELSEN_DEDIFFERENTIATED_S...1,SET,7,-0.24056,-0.0046938,0.36459,0.74531,MIKKELSEN_DEDIFFERENTIATED_STATE_DN,1
GOBP_CELLULAR_RESPONSE_TO_PE...1,SET,13,-0.16703,-0.0044407,0.25314,0.74532,GOBP_CELLULAR_RESPONSE_TO_PEPTIDE,1
REACTOME_DEFECTS_IN_VITAMIN_...,SET,20,-0.11991,-0.0039535,0.18169,0.74537,REACTOME_DEFECTS_IN_VITAMIN_AND_COFACTOR_METABOLISM,1
KEGG_ASTHMA,SET,25,-0.12579,-0.0046361,0.19057,0.74539,KEGG_ASTHMA,1
GOBP_PARALLEL_ACTIN_FILAMENT...,SET,7,-0.2185,-0.0042635,0.33092,0.74546,GOBP_PARALLEL_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
REACTOME_EPIGENETIC_REGULATI...,SET,182,-0.038662,-0.0038282,0.058547,0.74548,REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION,1
HP_PROMINENT_CALCANEUS,SET,9,-0.19056,-0.0042158,0.2885,0.74553,HP_PROMINENT_CALCANEUS,1
HP_ABNORMAL_SIZE_OF_PITUITAR...,SET,27,-0.1074,-0.0041136,0.16257,0.74558,HP_ABNORMAL_SIZE_OF_PITUITARY_GLAND,1
HP_CENTRAL_PRIMITIVE_NEUROEC...,SET,6,-0.2601,-0.0046988,0.39369,0.74558,HP_CENTRAL_PRIMITIVE_NEUROECTODERMAL_TUMOR,1
GOBP_RIBOSOME_ASSOCIATED_UBI...,SET,7,-0.15381,-0.0030011,0.23275,0.74563,GOBP_RIBOSOME_ASSOCIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GSE17721_CTRL_VS_CPG_12H_BMD...2,SET,183,-0.0407,-0.004041,0.061592,0.74563,GSE17721_CTRL_VS_CPG_12H_BMDC_UP,1
GSE21927_SPLEEN_VS_TUMOR_MON...1,SET,168,-0.04338,-0.0041284,0.065632,0.74568,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_DN,1
GSE22935_UNSTIM_VS_12H_MBOVI...1,SET,183,-0.040087,-0.0039802,0.06064,0.74571,GSE22935_UNSTIM_VS_12H_MBOVIS_BCG_STIM_MACROPHAGE_DN,1
CAO_BLOOD_FLUMIST_AGE_05_14Y...6,SET,7,-0.20749,-0.0040485,0.31382,0.74575,CAO_BLOOD_FLUMIST_AGE_05_14YO_7DY_UP,1
MIR6715B_5P,SET,200,-0.039787,-0.0041278,0.060169,0.74577,MIR6715B_5P,1
BUSSLINGER_GASTRIC_D_CELLS,SET,24,-0.12665,-0.0045735,0.19152,0.74578,BUSSLINGER_GASTRIC_D_CELLS,1
MIR520A_5P,SET,146,-0.046172,-0.0040988,0.06979,0.74588,MIR520A_5P,1
GSE36009_WT_VS_NLRP10_KO_DC_...2,SET,180,-0.038436,-0.0037851,0.058097,0.74588,GSE36009_WT_VS_NLRP10_KO_DC_LPS_STIM_DN,1
WP_OSTEOBLAST_DIFFERENTIATIO...,SET,116,-0.057467,-0.004551,0.086852,0.7459,WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES,1
HP_ABNORMALITY_OF_KREBS_CYCL...,SET,8,-0.2112,-0.0044053,0.3192,0.7459,HP_ABNORMALITY_OF_KREBS_CYCLE_METABOLISM,1
GOBP_RESPONSE_TO_INACTIVITY,SET,12,-0.17923,-0.0045783,0.27085,0.74593,GOBP_RESPONSE_TO_INACTIVITY,1
WP_NEUROTRANSMITTER_DISORDERS,SET,9,-0.1936,-0.0042831,0.29254,0.74594,WP_NEUROTRANSMITTER_DISORDERS,1
MORF_BNIP1,SET,174,-0.041145,-0.0039845,0.062171,0.74595,MORF_BNIP1,1
GSE23114_PERITONEAL_CAVITY_B...2,SET,175,-0.041729,-0.0040524,0.063049,0.74596,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_IN_SLE2C1_MOUSE_DN,1
GSE16385_UNTREATED_VS_12H_RO...3,SET,176,-0.04245,-0.0041341,0.064108,0.74606,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_IL4_TREATED_MACROPHAGE_DN,1
MIR4799_5P,SET,364,-0.02986,-0.0041605,0.045094,0.74607,MIR4799_5P,1
GSE20715_0H_VS_24H_OZONE_LUN...1,SET,189,-0.041458,-0.0041825,0.062608,0.74607,GSE20715_0H_VS_24H_OZONE_LUNG_DN,1
GOBP_MANNOSE_METABOLIC_PROCE...,SET,9,-0.16136,-0.0035698,0.24362,0.74612,GOBP_MANNOSE_METABOLIC_PROCESS,1
GOBP_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,-0.1507,-0.0038495,0.22753,0.74612,GOBP_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORT,1
HP_DUPLICATION_OF_PHALANX_OF...,SET,12,-0.13953,-0.0035641,0.21065,0.74613,HP_DUPLICATION_OF_PHALANX_OF_TOE,1
GSE37301_GRANULOCYTE_MONOCYT...1,SET,184,-0.03978,-0.0039603,0.060055,0.74613,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_DN,1
GSE18148_CBFB_KO_VS_WT_TREG_...1,SET,174,-0.044394,-0.004299,0.067019,0.74614,GSE18148_CBFB_KO_VS_WT_TREG_DN,1
MIR628_5P,SET,75,-0.067892,-0.0043281,0.10249,0.74615,MIR628_5P,1
MIR4536_3P,SET,19,-0.13107,-0.0042121,0.19783,0.74619,MIR4536_3P,1
HP_ERYTHROID_DYSPLASIA,SET,4,-0.2903,-0.0042821,0.43805,0.74623,HP_ERYTHROID_DYSPLASIA,1
HP_ARTERIOVENOUS_MALFORMATION,SET,53,-0.075056,-0.0040247,0.11326,0.74624,HP_ARTERIOVENOUS_MALFORMATION,1
HP_ABNORMALITY_OF_THE_DISTAL...2,SET,5,-0.24014,-0.0039604,0.36235,0.74625,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_2ND_FINGER,1
KEGG_MEDICUS_REFERENCE_HEDGE...3,SET,9,-0.19763,-0.0043722,0.29807,0.74634,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY_PTCH_CORECEPTOR,1
MIR6715B_3P,SET,116,-0.051828,-0.0041044,0.078156,0.74637,MIR6715B_3P,1
GOBP_DENDRITIC_CELL_ANTIGEN_...,SET,13,-0.15025,-0.0039947,0.22658,0.74637,GOBP_DENDRITIC_CELL_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOBP_MEMBRANE_FUSION_INVOLVE...,SET,4,-0.31815,-0.004693,0.47972,0.74639,GOBP_MEMBRANE_FUSION_INVOLVED_IN_VIRAL_ENTRY_INTO_HOST_CELL,1
GSE9037_WT_VS_IRAK4_KO_LPS_4...2,SET,184,-0.040573,-0.0040392,0.061164,0.74644,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_UP,1
GOCC_CULLIN_RING_UBIQUITIN_L...,SET,164,-0.04411,-0.0041481,0.066485,0.74648,GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX,1
MIR532_3P,SET,74,-0.062224,-0.0039404,0.093779,0.7465,MIR532_3P,1
GOBP_ATRIAL_CARDIAC_MUSCLE_T...1,SET,20,-0.14342,-0.0047285,0.21611,0.74653,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,1
HP_ELEVATED_URINARY_3_HYDROX...,SET,5,-0.25842,-0.0042618,0.38931,0.74658,HP_ELEVATED_URINARY_3_HYDROXYBUTYRIC_ACID,1
HP_PETERS_ANOMALY,SET,18,-0.13537,-0.0042343,0.20394,0.74658,HP_PETERS_ANOMALY,1
HP_REDUCED_BLOOD_FOLATE_CONC...,SET,4,-0.31048,-0.0045798,0.46773,0.74658,HP_REDUCED_BLOOD_FOLATE_CONCENTRATION,1
GNF2_CDC20,SET,52,-0.074895,-0.0039781,0.11281,0.74662,GNF2_CDC20,1
MIR6794_3P,SET,77,-0.067863,-0.0043834,0.10221,0.74663,MIR6794_3P,1
LOPEZ_MESOTHELIOMA_SURVIVAL_...1,SET,10,-0.21691,-0.0050583,0.32645,0.7468,LOPEZ_MESOTHELIOMA_SURVIVAL_DN,1
KAAB_FAILED_HEART_ATRIUM_UP,SET,32,-0.097287,-0.0040559,0.14639,0.74684,KAAB_FAILED_HEART_ATRIUM_UP,1
HP_CHORDEE,SET,13,-0.15935,-0.0042364,0.23975,0.74685,HP_CHORDEE,1
GOBP_POSITIVE_REGULATION_OF_...789,SET,8,-0.18595,-0.0038786,0.27975,0.74687,GOBP_POSITIVE_REGULATION_OF_TRIGLYCERIDE_LIPASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...492,SET,274,-0.034331,-0.0041604,0.051641,0.74691,GOBP_NEGATIVE_REGULATION_OF_PHOSPHORYLATION,1
MIR660_3P,SET,91,-0.057987,-0.0040702,0.087187,0.747,MIR660_3P,1
GOBP_PATTERN_SPECIFICATION_I...,SET,8,-0.24588,-0.0051287,0.36968,0.74701,GOBP_PATTERN_SPECIFICATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GSE37301_PRO_BCELL_VS_GRANUL...2,SET,132,-0.05016,-0.0042357,0.075406,0.74704,GSE37301_PRO_BCELL_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
HP_ANOMALOUS_TRICHROMACY,SET,9,-0.23984,-0.0053061,0.36049,0.74707,HP_ANOMALOUS_TRICHROMACY,1
HP_TRITANOMALY,SET,9,-0.23984,-0.0053061,0.36049,0.74707,HP_TRITANOMALY,1
GOBP_LYSOSOMAL_TRANSPORT,SET,126,-0.049421,-0.0040779,0.074279,0.74708,GOBP_LYSOSOMAL_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...612,SET,27,-0.11621,-0.0044509,0.17466,0.74708,GOBP_NEGATIVE_REGULATION_OF_STEROID_METABOLIC_PROCESS,1
HP_JOINT_DISLOCATION,SET,330,-0.030862,-0.0040981,0.046385,0.74708,HP_JOINT_DISLOCATION,1
GOBP_VITAMIN_K_METABOLIC_PRO...,SET,11,-0.16347,-0.0039979,0.24562,0.74714,GOBP_VITAMIN_K_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_MICROVILL...3,SET,13,-0.14827,-0.003942,0.22271,0.74721,GOBP_REGULATION_OF_MICROVILLUS_ORGANIZATION,1
MIR125B_2_3P,SET,121,-0.049583,-0.0040098,0.074465,0.74724,MIR125B_2_3P,1
GOBP_OLIGODENDROCYTE_PROGENI...,SET,8,-0.21844,-0.0045564,0.32801,0.74727,GOBP_OLIGODENDROCYTE_PROGENITOR_PROLIFERATION,1
GSE27434_WT_VS_DNMT1_KO_TREG...2,SET,182,-0.039382,-0.0038996,0.059137,0.74728,GSE27434_WT_VS_DNMT1_KO_TREG_UP,1
GOBP_EMBRYONIC_PROCESS_INVOL...,SET,6,-0.23259,-0.0042018,0.34916,0.74733,GOBP_EMBRYONIC_PROCESS_INVOLVED_IN_FEMALE_PREGNANCY,1
VANTVEER_BREAST_CANCER_ESR1_...2,SET,136,-0.049326,-0.0042274,0.074037,0.74737,VANTVEER_BREAST_CANCER_ESR1_UP,1
GSE41176_WT_VS_TAK1_KO_ANTI_...1,SET,174,-0.043381,-0.0042009,0.065101,0.7474,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_1H_DN,1
REACTOME_RECOGNITION_AND_ASS...,SET,10,-0.16878,-0.0039359,0.25328,0.74741,REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE,1
GOMF_5_3_DNA_EXONUCLEASE_ACT...,SET,9,-0.16287,-0.0036032,0.24441,0.74741,GOMF_5_3_DNA_EXONUCLEASE_ACTIVITY,1
GOBP_HINDBRAIN_DEVELOPMENT,SET,142,-0.049242,-0.0043115,0.073885,0.74744,GOBP_HINDBRAIN_DEVELOPMENT,1
GSE14769_UNSTIM_VS_80MIN_LPS...2,SET,182,-0.039228,-0.0038842,0.058856,0.74745,GSE14769_UNSTIM_VS_80MIN_LPS_BMDM_UP,1
HP_SPERMATOGENESIS_MATURATIO...,SET,11,-0.14525,-0.0035524,0.21792,0.74746,HP_SPERMATOGENESIS_MATURATION_ARREST,1
BRF1_TARGET_GENES,SET,37,-0.098325,-0.0044073,0.14751,0.74748,BRF1_TARGET_GENES,1
GOMF_LIPID_KINASE_ACTIVITY,SET,39,-0.090959,-0.0041856,0.13644,0.7475,GOMF_LIPID_KINASE_ACTIVITY,1
WP_LIPID_METABOLISM_PATHWAY,SET,28,-0.10068,-0.0039268,0.15101,0.74753,WP_LIPID_METABOLISM_PATHWAY,1
HP_YOUNG_ADULT_ONSET,SET,512,-0.024675,-0.0040606,0.037002,0.74756,HP_YOUNG_ADULT_ONSET,1
GSE39022_LN_VS_SPLEEN_DC_DN,SET,175,-0.041817,-0.004061,0.062699,0.74759,GSE39022_LN_VS_SPLEEN_DC_DN,1
GSE37301_MULTIPOTENT_PROGENI...1,SET,177,-0.04017,-0.0039231,0.060228,0.7476,GSE37301_MULTIPOTENT_PROGENITOR_VS_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...166,SET,27,-0.092071,-0.0035263,0.13802,0.74764,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,1
GOMF_GLUTAMATE_GATED_RECEPTO...,SET,15,-0.15524,-0.0044332,0.23272,0.74764,GOMF_GLUTAMATE_GATED_RECEPTOR_ACTIVITY,1
HP_ELEVATED_CIRCULATING_THYR...,SET,27,-0.10519,-0.004029,0.15769,0.74764,HP_ELEVATED_CIRCULATING_THYROID_STIMULATING_HORMONE_CONCENTRATION,1
ZNF134_TARGET_GENES,SET,843,-0.019335,-0.0040449,0.028977,0.74769,ZNF134_TARGET_GENES,1
WP_HUNGER_AND_SATIETY,SET,8,-0.2012,-0.0041967,0.30145,0.74774,WP_HUNGER_AND_SATIETY,1
GOBP_FATTY_ACYL_COA_METABOLI...,SET,37,-0.098779,-0.0044276,0.14796,0.74781,GOBP_FATTY_ACYL_COA_METABOLIC_PROCESS,1
GOMF_1_PHOSPHATIDYLINOSITOL_...2,SET,15,-0.16298,-0.0046541,0.2441,0.74783,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_REGULATOR_ACTIVITY,1
HP_PHTHISIS_BULBI,SET,13,-0.16655,-0.004428,0.24944,0.74783,HP_PHTHISIS_BULBI,1
HP_CHORIOCARCINOMA,SET,8,-0.21962,-0.0045811,0.32889,0.74785,HP_CHORIOCARCINOMA,1
MIR219A_2_3P,SET,65,-0.067514,-0.0040079,0.1011,0.74787,MIR219A_2_3P,1
GOBP_MEMBRANE_DOCKING,SET,83,-0.059681,-0.0040016,0.089365,0.74788,GOBP_MEMBRANE_DOCKING,1
GOBP_REGULATION_OF_CELL_CYCL...1,SET,41,-0.081155,-0.0038288,0.12151,0.74789,GOBP_REGULATION_OF_CELL_CYCLE_CHECKPOINT,1
GSE16697_CD4_TCELL_VS_TFH_CD...1,SET,183,-0.042136,-0.0041835,0.063088,0.74789,GSE16697_CD4_TCELL_VS_TFH_CD4_TCELL_DN,1
GSE15659_CD45RA_NEG_CD4_TCEL...4,SET,155,-0.045726,-0.0041815,0.068453,0.74792,GSE15659_CD45RA_NEG_CD4_TCELL_VS_NONSUPPRESSIVE_TCELL_UP,1
MIR548AS_5P,SET,442,-0.026834,-0.004111,0.040166,0.74795,MIR548AS_5P,1
GOBP_CMP_METABOLIC_PROCESS,SET,8,-0.20876,-0.0043545,0.31246,0.74796,GOBP_CMP_METABOLIC_PROCESS,1
HP_INCREASED_CIRCULATING_FRE...,SET,5,-0.21423,-0.003533,0.32065,0.74796,HP_INCREASED_CIRCULATING_FREE_FATTY_ACID_LEVEL,1
GSE42021_TREG_PLN_VS_CD24HI_...2,SET,185,-0.043023,-0.0042947,0.064396,0.74796,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP,1
GSE16522_MEMORY_VS_NAIVE_ANT...2,SET,172,-0.043357,-0.0041747,0.064882,0.74801,GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP,1
GOBP_REGULATION_OF_PINOCYTOS...,SET,12,-0.14592,-0.0037273,0.2183,0.74806,GOBP_REGULATION_OF_PINOCYTOSIS,1
GOMF_TUMOR_NECROSIS_FACTOR_R...1,SET,9,-0.20871,-0.0046174,0.31223,0.74807,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_ACTIVITY,1
LIANG_HEMATOPOIESIS_STEM_CEL...1,SET,37,-0.095441,-0.004278,0.14274,0.74813,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_DN,1
GOMF_EPHRIN_RECEPTOR_ACTIVITY,SET,18,-0.14939,-0.0046729,0.22338,0.74817,GOMF_EPHRIN_RECEPTOR_ACTIVITY,1
HP_ABSENT_BRAINSTEM_AUDITORY...,SET,9,-0.18662,-0.0041288,0.27906,0.74817,HP_ABSENT_BRAINSTEM_AUDITORY_RESPONSES,1
GSE3982_MAC_VS_TH1_UP,SET,181,-0.042643,-0.0042109,0.063766,0.74817,GSE3982_MAC_VS_TH1_UP,1
BUSSLINGER_GASTRIC_X_CELLS,SET,172,-0.045351,-0.0043667,0.067811,0.74818,BUSSLINGER_GASTRIC_X_CELLS,1
GSE11057_NAIVE_VS_EFF_MEMORY...1,SET,173,-0.042671,-0.0041205,0.063785,0.74824,GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_DN,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...4,SET,7,-0.20784,-0.0040554,0.31058,0.74831,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_UP,1
GOBP_SENSORY_SYSTEM_DEVELOPM...,SET,383,-0.031014,-0.0044302,0.046341,0.74833,GOBP_SENSORY_SYSTEM_DEVELOPMENT,1
GOBP_FRUCTOSE_METABOLIC_PROC...,SET,13,-0.12913,-0.0034331,0.19294,0.74834,GOBP_FRUCTOSE_METABOLIC_PROCESS,1
GOBP_FACE_MORPHOGENESIS,SET,30,-0.10729,-0.0043312,0.1603,0.74835,GOBP_FACE_MORPHOGENESIS,1
GOBP_PYRIMIDINE_NUCLEOSIDE_M...3,SET,8,-0.20513,-0.0042789,0.30647,0.74836,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_CATABOLIC_PROCESS,1
GSE21360_PRIMARY_VS_TERTIARY...2,SET,186,-0.039639,-0.0039675,0.05922,0.74836,GSE21360_PRIMARY_VS_TERTIARY_MEMORY_CD8_TCELL_UP,1
MIR12127,SET,74,-0.064395,-0.0040778,0.0962,0.74837,MIR12127,1
GOBP_PENTOSE_PHOSPHATE_SHUNT...,SET,6,-0.22938,-0.0041437,0.34262,0.7484,GOBP_PENTOSE_PHOSPHATE_SHUNT_NON_OXIDATIVE_BRANCH,1
GSE360_DC_VS_MAC_B_MALAYI_HI...2,SET,181,-0.041743,-0.0041221,0.062344,0.74843,GSE360_DC_VS_MAC_B_MALAYI_HIGH_DOSE_UP,1
GSE17721_PAM3CSK4_VS_GADIQUI...11,SET,182,-0.040016,-0.0039623,0.059745,0.74849,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_DN,1
GOMF_EXTRACELLULAR_LIGAND_GA...,SET,67,-0.075949,-0.0045772,0.11337,0.74853,GOMF_EXTRACELLULAR_LIGAND_GATED_MONOATOMIC_ION_CHANNEL_ACTIVITY,1
HP_POSTERIOR_BLEPHARITIS,SET,5,-0.23391,-0.0038576,0.34914,0.74855,HP_POSTERIOR_BLEPHARITIS,1
MIR4642,SET,90,-0.061601,-0.0043001,0.091946,0.74856,MIR4642,1
TGANNYRGCA_TCF11MAFG_01,SET,271,-0.03483,-0.0041981,0.051977,0.7486,TGANNYRGCA_TCF11MAFG_01,1
GSE29615_CTRL_VS_DAY3_LAIV_I...2,SET,175,-0.042938,-0.0041699,0.064074,0.74861,GSE29615_CTRL_VS_DAY3_LAIV_IFLU_VACCINE_PBMC_UP,1
GU_PDEF_TARGETS_UP,SET,68,-0.075247,-0.0045686,0.11228,0.74862,GU_PDEF_TARGETS_UP,1
GOBP_REGULATION_OF_FOREBRAIN...,SET,5,-0.28794,-0.0047486,0.42964,0.74863,GOBP_REGULATION_OF_FOREBRAIN_NEURON_DIFFERENTIATION,1
KEGG_MEDICUS_VARIANT_MUTATIO...36,SET,6,-0.22295,-0.0040276,0.33264,0.74865,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ATXN1_TO_RORA_MEDIATED_TRANSCRIPTION,1
GOBP_AUTOPHAGOSOME_LYSOSOME_...,SET,11,-0.16701,-0.0040846,0.24916,0.74866,GOBP_AUTOPHAGOSOME_LYSOSOME_FUSION,1
GSE14908_ATOPIC_VS_NONATOPIC...1,SET,174,-0.041298,-0.0039993,0.061609,0.74867,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_HDM_STIM_CD4_TCELL_DN,1
WP_RALA_DOWNSTREAM_REGULATED...,SET,12,-0.15456,-0.0039481,0.23056,0.74869,WP_RALA_DOWNSTREAM_REGULATED_GENES,1
WP_OSX_AND_MIRNAS_IN_TOOTH_D...,SET,15,-0.15794,-0.0045102,0.23551,0.74877,WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT,1
GOBP_TOLERANCE_INDUCTION_TO_...,SET,5,-0.27987,-0.0046155,0.41726,0.7488,GOBP_TOLERANCE_INDUCTION_TO_SELF_ANTIGEN,1
REACTOME_ACTIVATION_OF_TRKA_...,SET,6,-0.25143,-0.0045422,0.37478,0.74885,REACTOME_ACTIVATION_OF_TRKA_RECEPTORS,1
GSE13887_HEALTHY_VS_LUPUS_RE...1,SET,114,-0.053478,-0.0041987,0.079705,0.74887,GSE13887_HEALTHY_VS_LUPUS_RESTING_CD4_TCELL_DN,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...7,SET,12,-0.17454,-0.0044584,0.26014,0.74887,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_T_CELL_RESPONSES_1D_INFORMATIVE_OF_LONG_TERM_RESPONSES_NEGATIVE,1
HP_ABNORMAL_ENZYME_ACTIVITY_...2,SET,7,-0.17871,-0.003487,0.26631,0.74891,HP_ABNORMAL_ENZYME_ACTIVITY_IN_MUSCLE_TISSUE,1
GOBP_5S_CLASS_RRNA_TRANSCRIP...,SET,6,-0.18914,-0.0034168,0.28177,0.74897,GOBP_5S_CLASS_RRNA_TRANSCRIPTION_BY_RNA_POLYMERASE_III,1
GOCC_TRANSCRIPTION_FACTOR_TF...4,SET,6,-0.18914,-0.0034168,0.28177,0.74897,GOCC_TRANSCRIPTION_FACTOR_TFIIIC_COMPLEX,1
ZNF445_TARGET_GENES,SET,7,-0.22086,-0.0043094,0.329,0.74898,ZNF445_TARGET_GENES,1
GAVIN_FOXP3_TARGETS_CLUSTER_...1,SET,72,-0.067954,-0.0042449,0.10122,0.74899,GAVIN_FOXP3_TARGETS_CLUSTER_P2,1
GOBP_POLYPRENOL_METABOLIC_PR...,SET,23,-0.10588,-0.0037434,0.15769,0.74903,GOBP_POLYPRENOL_METABOLIC_PROCESS,1
NR2E3_TARGET_GENES,SET,8,-0.2276,-0.0047474,0.33892,0.74905,NR2E3_TARGET_GENES,1
HP_MALIGNANT_NEOPLASM_OF_THE...,SET,95,-0.05755,-0.0041269,0.085697,0.74906,HP_MALIGNANT_NEOPLASM_OF_THE_CENTRAL_NERVOUS_SYSTEM,1
MODULE_227,SET,14,-0.15427,-0.0042561,0.2297,0.74908,MODULE_227,1
HP_OSTEOPATHIA_STRIATA,SET,3,-0.46213,-0.0059037,0.68805,0.74909,HP_OSTEOPATHIA_STRIATA,1
HP_PERSONALITY_DISORDER,SET,16,-0.13887,-0.0040955,0.2067,0.74915,HP_PERSONALITY_DISORDER,1
HP_SYMPTOMATIC_SEIZURES,SET,35,-0.10156,-0.0044276,0.15115,0.74917,HP_SYMPTOMATIC_SEIZURES,1
GOBP_REGULATION_OF_OPSIN_MED...,SET,8,-0.18403,-0.0038387,0.27389,0.74918,GOBP_REGULATION_OF_OPSIN_MEDIATED_SIGNALING_PATHWAY,1
FIGUEROA_AML_METHYLATION_CLU...12,SET,127,-0.051788,-0.0042901,0.077047,0.74925,FIGUEROA_AML_METHYLATION_CLUSTER_6_UP,1
GOBP_ANTIMICROBIAL_PEPTIDE_P...,SET,12,-0.18768,-0.0047941,0.27919,0.74928,GOBP_ANTIMICROBIAL_PEPTIDE_PRODUCTION,1
MIR6830_3P,SET,191,-0.043682,-0.0044299,0.064978,0.74929,MIR6830_3P,1
GSE3982_EOSINOPHIL_VS_BCELL_...2,SET,182,-0.044699,-0.004426,0.06647,0.74935,GSE3982_EOSINOPHIL_VS_BCELL_UP,1
GOBP_REGULATION_OF_PLATELET_...2,SET,29,-0.11461,-0.0045489,0.17041,0.74938,GOBP_REGULATION_OF_PLATELET_AGGREGATION,1
MIR363_5P,SET,65,-0.070498,-0.0041851,0.10481,0.74941,MIR363_5P,1
MIR6876_5P,SET,205,-0.040059,-0.0042071,0.059534,0.74948,MIR6876_5P,1
GOBP_REGULATION_OF_EPIDERMIS...,SET,58,-0.08038,-0.0045083,0.11946,0.74948,GOBP_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
HP_CIGARETTE_PAPER_SCARS,SET,10,-0.19711,-0.0045966,0.29292,0.7495,HP_CIGARETTE_PAPER_SCARS,1
HP_ABNORMALITY_OF_VISUAL_EVO...,SET,63,-0.070352,-0.0041119,0.10453,0.74953,HP_ABNORMALITY_OF_VISUAL_EVOKED_POTENTIALS,1
GSE14308_INDUCED_VS_NATURAL_...1,SET,182,-0.041569,-0.0041161,0.061765,0.74953,GSE14308_INDUCED_VS_NATURAL_TREG_DN,1
GOBP_PROXIMAL_DISTAL_PATTERN...1,SET,34,-0.10724,-0.0046083,0.1593,0.74959,GOBP_PROXIMAL_DISTAL_PATTERN_FORMATION,1
GOBP_UROGENITAL_SYSTEM_DEVEL...,SET,64,-0.081367,-0.0047931,0.12084,0.74963,GOBP_UROGENITAL_SYSTEM_DEVELOPMENT,1
HP_SACCADIC_SMOOTH_PURSUIT,SET,21,-0.11377,-0.0038434,0.16896,0.74963,HP_SACCADIC_SMOOTH_PURSUIT,1
SIG_CHEMOTAXIS,SET,39,-0.087558,-0.0040291,0.13001,0.74967,SIG_CHEMOTAXIS,1
HP_PARAKERATOSIS,SET,30,-0.10676,-0.0043099,0.15852,0.74968,HP_PARAKERATOSIS,1
MIR365B_5P,SET,31,-0.1055,-0.0043291,0.15664,0.74969,MIR365B_5P,1
GOBP_CELL_CYCLE_G2_M_PHASE_T...,SET,139,-0.047437,-0.0041098,0.070423,0.74971,GOBP_CELL_CYCLE_G2_M_PHASE_TRANSITION,1
MIR4647_MIR4662B,SET,77,-0.064002,-0.004134,0.094974,0.74981,MIR4647_MIR4662B,1
GOMF_PHOSPHATASE_ACTIVITY,SET,231,-0.036369,-0.0040516,0.053962,0.74983,GOMF_PHOSPHATASE_ACTIVITY,1
DESCARTES_FETAL_PANCREAS_CCL...,SET,44,-0.093857,-0.0045868,0.13926,0.74983,DESCARTES_FETAL_PANCREAS_CCL19_CCL21_POSITIVE_CELLS,1
HP_WIDENED_CEREBRAL_SUBARACH...,SET,3,-0.41196,-0.0052628,0.61121,0.74984,HP_WIDENED_CEREBRAL_SUBARACHNOID_SPACE,1
GOBP_STRIATED_MUSCLE_TISSUE_...,SET,239,-0.038729,-0.0043877,0.057439,0.74993,GOBP_STRIATED_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_EMBRYONIC_SKELETAL_JOIN...1,SET,14,-0.16623,-0.0045862,0.24646,0.74999,GOBP_EMBRYONIC_SKELETAL_JOINT_DEVELOPMENT,1
TTCYNRGAA_STAT5B_01,SET,300,-0.033473,-0.0042415,0.049626,0.75,TTCYNRGAA_STAT5B_01,1
HP_RETINAL_NEOVASCULARIZATION,SET,9,-0.20561,-0.0045489,0.30478,0.75004,HP_RETINAL_NEOVASCULARIZATION,1
POS_RESPONSE_TO_HISTAMINE_DN,SET,11,-0.14878,-0.0036386,0.22051,0.75006,POS_RESPONSE_TO_HISTAMINE_DN,1
GOMF_TRANSITION_METAL_ION_BI...,SET,1009,-0.018699,-0.0042593,0.027706,0.75013,GOMF_TRANSITION_METAL_ION_BINDING,1
REACTOME_DISEASES_OF_MITOTIC...,SET,36,-0.092147,-0.0040742,0.1365,0.75018,REACTOME_DISEASES_OF_MITOTIC_CELL_CYCLE,1
GOCC_PWP2P_CONTAINING_SUBCOM...,SET,4,-0.24327,-0.0035885,0.36021,0.75027,GOCC_PWP2P_CONTAINING_SUBCOMPLEX_OF_90S_PRERIBOSOME,1
GSE16385_ROSIGLITAZONE_IL4_V...3,SET,188,-0.040635,-0.0040887,0.060151,0.75033,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_DN,1
GOBP_SYNAPTIC_TRANSMISSION_G...3,SET,5,-0.26929,-0.004441,0.39846,0.75042,GOBP_SYNAPTIC_TRANSMISSION_GLYCINERGIC,1
HP_IRIS_HYPOPIGMENTATION,SET,58,-0.079224,-0.0044435,0.11718,0.7505,HP_IRIS_HYPOPIGMENTATION,1
GOBP_CANNABINOID_SIGNALING_P...,SET,7,-0.23873,-0.0046582,0.35309,0.75052,GOBP_CANNABINOID_SIGNALING_PATHWAY,1
GSE21927_UNTREATED_VS_GMCSF_...1,SET,163,-0.045233,-0.0042408,0.066898,0.75052,GSE21927_UNTREATED_VS_GMCSF_GCSF_TREATED_BONE_MARROW_DN,1
HE_LIM_SUN_FETAL_LUNG_C3_CYC...,SET,388,-0.028003,-0.0040256,0.041405,0.75058,HE_LIM_SUN_FETAL_LUNG_C3_CYCLING_DEFINITIVE_ERYTHROBLAST,1
GSE3982_DC_VS_BASOPHIL_UP,SET,182,-0.042597,-0.0042179,0.062972,0.75062,GSE3982_DC_VS_BASOPHIL_UP,1
GSE6875_TCONV_VS_TREG_UP,SET,180,-0.041774,-0.0041138,0.061744,0.75066,GSE6875_TCONV_VS_TREG_UP,1
HP_LOW_ANTERIOR_HAIRLINE,SET,130,-0.049242,-0.0041267,0.072763,0.75071,HP_LOW_ANTERIOR_HAIRLINE,1
GSE12845_NAIVE_VS_DARKZONE_G...2,SET,170,-0.044571,-0.0042668,0.065858,0.75072,GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP,1
HP_POLYSPLENIA,SET,49,-0.075951,-0.0039164,0.11221,0.75074,HP_POLYSPLENIA,1
LANDIS_ERBB2_BREAST_PRENEOPL...2,SET,17,-0.13668,-0.0041549,0.20192,0.75075,LANDIS_ERBB2_BREAST_PRENEOPLASTIC_UP,1
MIR8064,SET,73,-0.068621,-0.0043161,0.10137,0.75077,MIR8064,1
TSAI_DNAJB4_TARGETS_DN,SET,6,-0.22796,-0.0041181,0.33671,0.7508,TSAI_DNAJB4_TARGETS_DN,1
GOBP_OVULATION,SET,16,-0.15777,-0.0046529,0.23299,0.75083,GOBP_OVULATION,1
GOBP_METANEPHROS_DEVELOPMENT,SET,86,-0.069365,-0.0047338,0.10241,0.7509,GOBP_METANEPHROS_DEVELOPMENT,1
GOMF_ORGANOPHOSPHATE_PHOSPHA...,SET,7,-0.21276,-0.0041515,0.31403,0.75096,GOMF_ORGANOPHOSPHATE_PHOSPHATE_ANTIPORTER_ACTIVITY,1
HP_PROGRESSIVE_ENCEPHALOPATHY,SET,10,-0.17203,-0.0040117,0.25389,0.75097,HP_PROGRESSIVE_ENCEPHALOPATHY,1
ZNF214_TARGET_GENES,SET,12,-0.17598,-0.0044953,0.25967,0.75102,ZNF214_TARGET_GENES,1
MODULE_23,SET,521,-0.026124,-0.0043356,0.038535,0.75108,MODULE_23,1
GSE41867_NAIVE_VS_DAY6_LCMV_...1,SET,187,-0.042257,-0.0042407,0.062328,0.7511,GSE41867_NAIVE_VS_DAY6_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...2,SET,6,-0.22792,-0.0041175,0.33615,0.75112,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...516,SET,129,-0.050229,-0.0041933,0.074069,0.75115,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_ASSEMBLY,1
GOCC_CYTOPLASMIC_SIDE_OF_PLA...,SET,152,-0.047564,-0.0043076,0.070129,0.75118,GOCC_CYTOPLASMIC_SIDE_OF_PLASMA_MEMBRANE,1
GOCC_R2TP_COMPLEX,SET,5,-0.22344,-0.0036849,0.32936,0.75124,GOCC_R2TP_COMPLEX,1
SHETH_LIVER_CANCER_VS_TXNIP_...6,SET,51,-0.081791,-0.0043025,0.12054,0.75127,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM6,1
RICKMAN_HEAD_AND_NECK_CANCER...3,SET,101,-0.061494,-0.0045461,0.090621,0.7513,RICKMAN_HEAD_AND_NECK_CANCER_C,1
GOBP_POSITIVE_REGULATION_OF_...331,SET,8,-0.18348,-0.0038271,0.27025,0.7514,GOBP_POSITIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
CEBP_01,SET,238,-0.038975,-0.0044064,0.057401,0.75143,CEBP_01,1
GOBP_REPRODUCTIVE_PROCESS,SET,1329,-0.016405,-0.0042489,0.024159,0.75144,GOBP_REPRODUCTIVE_PROCESS,1
GSE34156_UNTREATED_VS_6H_NOD...3,SET,166,-0.043845,-0.004148,0.064567,0.75145,GSE34156_UNTREATED_VS_6H_NOD2_LIGAND_TREATED_MONOCYTE_DN,1
BUSSLINGER_DUODENAL_I_CELLS,SET,14,-0.15402,-0.0042492,0.2267,0.75155,BUSSLINGER_DUODENAL_I_CELLS,1
HP_LOWER_LIMB_ASYMMETRY,SET,41,-0.094796,-0.0044723,0.13951,0.75158,HP_LOWER_LIMB_ASYMMETRY,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...1,SET,341,-0.033927,-0.0045781,0.049921,0.75162,FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL,1
GSE2770_TGFB_AND_IL4_VS_IL12...2,SET,172,-0.041997,-0.0040438,0.061786,0.75166,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
GSE27786_CD8_TCELL_VS_NKCELL...1,SET,182,-0.042068,-0.0041655,0.061883,0.75168,GSE27786_CD8_TCELL_VS_NKCELL_DN,1
GOMF_ALPHA_1_4_GLUCOSIDASE_A...,SET,5,-0.26539,-0.0043767,0.39035,0.7517,GOMF_ALPHA_1_4_GLUCOSIDASE_ACTIVITY,1
ZNF213_TARGET_GENES,SET,474,-0.026362,-0.0041786,0.038771,0.75172,ZNF213_TARGET_GENES,1
GOBP_BENZENE_CONTAINING_COMP...,SET,23,-0.12944,-0.004576,0.19036,0.75173,GOBP_BENZENE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_NODULAR_REGENERATIVE_HYPE...,SET,5,-0.28638,-0.0047229,0.42116,0.75174,HP_NODULAR_REGENERATIVE_HYPERPLASIA_OF_LIVER,1
GOMF_POLY_A_RNA_POLYMERASE_A...,SET,5,-0.2761,-0.0045533,0.40589,0.75181,GOMF_POLY_A_RNA_POLYMERASE_ACTIVITY,1
HP_ABNORMAL_AORTIC_ARCH_MORP...,SET,58,-0.076401,-0.0042852,0.11232,0.75181,HP_ABNORMAL_AORTIC_ARCH_MORPHOLOGY,1
HP_INCREASED_BODY_MASS_INDEX,SET,4,-0.28495,-0.0042033,0.41892,0.75181,HP_INCREASED_BODY_MASS_INDEX,1
GSE23568_ID3_TRANSDUCED_VS_I...2,SET,187,-0.041363,-0.004151,0.06081,0.75181,GSE23568_ID3_TRANSDUCED_VS_ID3_KO_CD8_TCELL_UP,1
GOCC_ENDOPLASMIC_RETICULUM_P...1,SET,8,-0.18598,-0.0038793,0.27337,0.75184,GOCC_ENDOPLASMIC_RETICULUM_PALMITOYLTRANSFERASE_COMPLEX,1
DICER1_TARGET_GENES,SET,52,-0.079661,-0.0042313,0.11707,0.75189,DICER1_TARGET_GENES,1
RICKMAN_HEAD_AND_NECK_CANCER...1,SET,88,-0.066631,-0.0045996,0.097914,0.7519,RICKMAN_HEAD_AND_NECK_CANCER_A,1
GOBP_CELLULAR_RESPONSE_TO_L_...2,SET,11,-0.16977,-0.004152,0.24947,0.7519,GOBP_CELLULAR_RESPONSE_TO_L_LEUCINE,1
DI_MARTINO_MATRISOME_HIGHLY_...2,SET,17,-0.14385,-0.0043729,0.21134,0.75195,DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED,1
GSE14413_UNSTIM_VS_IFNB_STIM...4,SET,129,-0.049248,-0.0041114,0.072352,0.75195,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_UP,1
GOCC_PHAGOCYTIC_VESICLE_MEMB...,SET,67,-0.069444,-0.0041852,0.10201,0.75199,GOCC_PHAGOCYTIC_VESICLE_MEMBRANE,1
DESCARTES_FETAL_LIVER_MESOTH...,SET,266,-0.038003,-0.0045387,0.055809,0.75204,DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS,1
HP_FLAT_NASAL_ALAE,SET,8,-0.15301,-0.0031916,0.22467,0.75207,HP_FLAT_NASAL_ALAE,1
HP_ABNORMAL_RENAL_CORTICOMED...,SET,21,-0.12978,-0.0043845,0.1905,0.75215,HP_ABNORMAL_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
GOBP_CELLULAR_RESPONSE_TO_X_...,SET,11,-0.15308,-0.003744,0.22469,0.75216,GOBP_CELLULAR_RESPONSE_TO_X_RAY,1
PID_TCR_JNK_PATHWAY,SET,14,-0.15714,-0.0043353,0.23063,0.75217,PID_TCR_JNK_PATHWAY,1
GOMF_PROMOTER_SPECIFIC_CHROM...,SET,62,-0.071348,-0.004137,0.10469,0.75223,GOMF_PROMOTER_SPECIFIC_CHROMATIN_BINDING,1
SMCHD1_TARGET_GENES,SET,30,-0.10884,-0.0043939,0.15968,0.75227,SMCHD1_TARGET_GENES,1
GOCC_TRANSCRIPTION_FACTOR_AP...,SET,5,-0.29951,-0.0049394,0.43934,0.75229,GOCC_TRANSCRIPTION_FACTOR_AP_1_COMPLEX,1
BOYAULT_LIVER_CANCER_SUBCLAS...5,SET,37,-0.09719,-0.0043564,0.14256,0.7523,BOYAULT_LIVER_CANCER_SUBCLASS_G1_DN,1
WIERENGA_STAT5A_TARGETS_GROU...1,SET,117,-0.054523,-0.0043363,0.079973,0.7523,WIERENGA_STAT5A_TARGETS_GROUP1,1
GOBP_REGULATION_OF_PODOSOME_...,SET,13,-0.16078,-0.0042746,0.23582,0.75232,GOBP_REGULATION_OF_PODOSOME_ASSEMBLY,1
PID_LYSOPHOSPHOLIPID_PATHWAY,SET,63,-0.074624,-0.0043616,0.10944,0.75233,PID_LYSOPHOSPHOLIPID_PATHWAY,1
GOBP_MEMBRANE_FISSION,SET,44,-0.080816,-0.0039495,0.11852,0.75233,GOBP_MEMBRANE_FISSION,1
GOBP_REGULATION_OF_HEMATOPOI...2,SET,17,-0.13117,-0.0039874,0.19237,0.75233,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
GOBP_TYPE_B_PANCREATIC_CELL_...4,SET,23,-0.12703,-0.0044908,0.1863,0.75233,GOBP_TYPE_B_PANCREATIC_CELL_PROLIFERATION,1
GOBP_OPTIC_NERVE_MORPHOGENES...,SET,6,-0.26637,-0.004812,0.39052,0.7524,GOBP_OPTIC_NERVE_MORPHOGENESIS,1
HP_NUMEROUS_NEVI,SET,11,-0.17435,-0.0042642,0.25559,0.75243,HP_NUMEROUS_NEVI,1
HP_TURRICEPHALY,SET,42,-0.088105,-0.004207,0.12915,0.75244,HP_TURRICEPHALY,1
GOBP_MUSCLE_SYSTEM_PROCESS,SET,411,-0.029641,-0.0043826,0.043442,0.75247,GOBP_MUSCLE_SYSTEM_PROCESS,1
GSE5542_IFNA_VS_IFNA_AND_IFN...3,SET,173,-0.041523,-0.0040095,0.060858,0.75247,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
GOBP_REGULATION_OF_GLUCOSE_M...,SET,88,-0.063303,-0.0043698,0.092756,0.75253,GOBP_REGULATION_OF_GLUCOSE_METABOLIC_PROCESS,1
ODONNELL_TARGETS_OF_MYC_AND_...1,SET,42,-0.082233,-0.0039266,0.12047,0.75257,ODONNELL_TARGETS_OF_MYC_AND_TFRC_DN,1
GOBP_REGULATION_OF_TUMOR_NEC...,SET,57,-0.075687,-0.0042084,0.11085,0.75262,GOBP_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_TELOMERIC_D_LOOP_DISASS...,SET,7,-0.22923,-0.0044728,0.33569,0.75265,GOBP_TELOMERIC_D_LOOP_DISASSEMBLY,1
KEGG_HEDGEHOG_SIGNALING_PATH...,SET,54,-0.081055,-0.0043871,0.11869,0.75266,KEGG_HEDGEHOG_SIGNALING_PATHWAY,1
GOBP_PROTEIN_METHYLATION,SET,40,-0.084537,-0.0039395,0.12378,0.75268,GOBP_PROTEIN_METHYLATION,1
HP_INCREASED_SKULL_OSSIFICAT...,SET,8,-0.20592,-0.0042952,0.30139,0.75276,HP_INCREASED_SKULL_OSSIFICATION,1
GOMF_NEUROLIGIN_FAMILY_PROTE...,SET,5,-0.24432,-0.0040292,0.3575,0.75282,GOMF_NEUROLIGIN_FAMILY_PROTEIN_BINDING,1
HP_METATARSUS_ADDUCTUS,SET,44,-0.088983,-0.0043486,0.1302,0.75282,HP_METATARSUS_ADDUCTUS,1
MODULE_399,SET,49,-0.08553,-0.0044104,0.12514,0.75285,MODULE_399,1
MIR329_3P,SET,106,-0.05966,-0.0045177,0.087276,0.75287,MIR329_3P,1
GOBP_NEUROMUSCULAR_JUNCTION_...,SET,47,-0.080513,-0.0040663,0.11774,0.75296,GOBP_NEUROMUSCULAR_JUNCTION_DEVELOPMENT,1
GOBP_REGULATION_OF_RAC_PROTE...,SET,23,-0.11686,-0.0041313,0.17088,0.75297,GOBP_REGULATION_OF_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_SUCCINATE_TRANSMEMBRANE...,SET,6,-0.2391,-0.0043194,0.34961,0.75298,GOBP_SUCCINATE_TRANSMEMBRANE_TRANSPORT,1
GOMF_SUCCINATE_TRANSMEMBRANE...,SET,6,-0.2391,-0.0043194,0.34961,0.75298,GOMF_SUCCINATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
ONDER_CDH1_TARGETS_2_UP,SET,225,-0.041413,-0.004554,0.060546,0.75301,ONDER_CDH1_TARGETS_2_UP,1
GOBP_PROTEIN_TARGETING_TO_VA...2,SET,5,-0.25486,-0.0042031,0.3725,0.75307,GOBP_PROTEIN_TARGETING_TO_VACUOLE_INVOLVED_IN_AUTOPHAGY,1
MIR6881_5P,SET,48,-0.084161,-0.0042954,0.123,0.75309,MIR6881_5P,1
GOCC_NUCLEOTIDE_EXCISION_REP...,SET,11,-0.13604,-0.0033271,0.19876,0.75314,GOCC_NUCLEOTIDE_EXCISION_REPAIR_COMPLEX,1
MIR6730_3P,SET,74,-0.067059,-0.0042465,0.097968,0.75316,MIR6730_3P,1
GOBP_POLYSACCHARIDE_CATABOLI...,SET,26,-0.11307,-0.0042499,0.16518,0.75318,GOBP_POLYSACCHARIDE_CATABOLIC_PROCESS,1
FRASOR_TAMOXIFEN_RESPONSE_DN,SET,10,-0.18272,-0.0042609,0.26691,0.75319,FRASOR_TAMOXIFEN_RESPONSE_DN,1
MATZUK_SPERMATID_DIFFERENTIA...,SET,35,-0.096702,-0.0042159,0.14125,0.7532,MATZUK_SPERMATID_DIFFERENTIATION,1
MURAKAMI_UV_RESPONSE_6HR_DN,SET,21,-0.12921,-0.0043651,0.18874,0.7532,MURAKAMI_UV_RESPONSE_6HR_DN,1
GSE7831_UNSTIM_VS_INFLUENZA_...2,SET,179,-0.042156,-0.00414,0.061577,0.7532,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_1H_UP,1
MIR548AH_3P_MIR548AM_3P,SET,715,-0.021926,-0.0042397,0.032014,0.75329,MIR548AH_3P_MIR548AM_3P,1
GOBP_REGULATION_OF_LEUKOCYTE...4,SET,115,-0.056264,-0.0044366,0.08215,0.75329,GOBP_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
FARMER_BREAST_CANCER_CLUSTER...8,SET,7,-0.24382,-0.0047574,0.35589,0.75335,FARMER_BREAST_CANCER_CLUSTER_8,1
GOBP_OUTFLOW_TRACT_SEPTUM_MO...,SET,26,-0.13062,-0.0049095,0.19059,0.75343,GOBP_OUTFLOW_TRACT_SEPTUM_MORPHOGENESIS,1
BIOCARTA_EIF2_PATHWAY,SET,9,-0.18608,-0.0041167,0.27149,0.75345,BIOCARTA_EIF2_PATHWAY,1
GOBP_TRNA_THREONYLCARBAMOYLA...1,SET,13,-0.13984,-0.0037177,0.20393,0.75354,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_METABOLIC_PROCESS,1
MIR27A_3P_MIR27B_3P,SET,570,-0.025147,-0.0043594,0.036662,0.75361,MIR27A_3P_MIR27B_3P,1
HP_AORTIC_TORTUOSITY,SET,6,-0.27471,-0.0049628,0.40036,0.75369,HP_AORTIC_TORTUOSITY,1
HUTTMANN_B_CLL_POOR_SURVIVAL...2,SET,241,-0.038307,-0.0043578,0.055826,0.7537,HUTTMANN_B_CLL_POOR_SURVIVAL_UP,1
GOBP_SEROTONIN_UPTAKE,SET,12,-0.18055,-0.0046119,0.26311,0.7537,GOBP_SEROTONIN_UPTAKE,1
HP_OBSESSIVE_COMPULSIVE_TRAIT,SET,36,-0.095282,-0.0042129,0.13883,0.75374,HP_OBSESSIVE_COMPULSIVE_TRAIT,1
REACTOME_ERYTHROCYTES_TAKE_U...1,SET,11,-0.18059,-0.0044168,0.26309,0.75377,REACTOME_ERYTHROCYTES_TAKE_UP_CARBON_DIOXIDE_AND_RELEASE_OXYGEN,1
GSE13547_CTRL_VS_ANTI_IGM_ST...5,SET,141,-0.050163,-0.0043768,0.073044,0.75387,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_DN,1
GOBP_ENDOPLASMIC_RETICULUM_M...,SET,11,-0.14907,-0.0036459,0.21703,0.75392,GOBP_ENDOPLASMIC_RETICULUM_MEMBRANE_ORGANIZATION,1
HP_APLASIA_OF_THE_MUSCULATURE,SET,9,-0.21254,-0.004702,0.30939,0.75394,HP_APLASIA_OF_THE_MUSCULATURE,1
REACTOME_REGULATION_OF_NPAS4...2,SET,5,-0.27358,-0.0045117,0.39818,0.75398,REACTOME_REGULATION_OF_NPAS4_GENE_TRANSCRIPTION,1
KOKKINAKIS_METHIONINE_DEPRIV...2,SET,125,-0.054109,-0.0044472,0.078749,0.75399,KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP,1
GOCC_CYTOPLASMIC_DYNEIN_COMP...,SET,16,-0.14071,-0.0041499,0.20477,0.754,GOCC_CYTOPLASMIC_DYNEIN_COMPLEX,1
GOMF_KINASE_BINDING,SET,732,-0.021646,-0.0042329,0.0315,0.754,GOMF_KINASE_BINDING,1
REACTOME_EFFECTS_OF_PIP2_HYD...,SET,26,-0.1118,-0.0042019,0.16268,0.75403,REACTOME_EFFECTS_OF_PIP2_HYDROLYSIS,1
GOCC_SEX_CHROMATIN,SET,4,-0.25809,-0.0038071,0.37552,0.75405,GOCC_SEX_CHROMATIN,1
LTE2_UP.V1_UP,SET,178,-0.046263,-0.0045308,0.067293,0.75411,LTE2_UP.V1_UP,1
GSE339_EX_VIVO_VS_IN_CULTURE...4,SET,187,-0.041267,-0.0041413,0.060021,0.75412,GSE339_EX_VIVO_VS_IN_CULTURE_CD4POS_DC_UP,1
GSE4811_CLASSSICALY_ACTIVATE...2,SET,174,-0.042244,-0.0040908,0.061436,0.75415,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...613,SET,5,-0.2673,-0.0044082,0.38872,0.75416,GOBP_POSITIVE_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
GOBP_AUTOPHAGY_OF_PEROXISOME,SET,13,-0.16622,-0.0044191,0.24171,0.75417,GOBP_AUTOPHAGY_OF_PEROXISOME,1
GOMF_NEDD8_TRANSFERASE_ACTIV...,SET,7,-0.19832,-0.0038697,0.28839,0.75417,GOMF_NEDD8_TRANSFERASE_ACTIVITY,1
HP_TYPE_II_LISSENCEPHALY,SET,12,-0.15992,-0.0040851,0.23253,0.7542,HP_TYPE_II_LISSENCEPHALY,1
MIR4311,SET,325,-0.032017,-0.0042198,0.046527,0.75431,MIR4311,1
GOBP_PROTEIN_TRANSPORT,SET,1301,-0.016426,-0.0042129,0.023871,0.75431,GOBP_PROTEIN_TRANSPORT,1
GOBP_TRIGLYCERIDE_RICH_LIPOP...2,SET,12,-0.17989,-0.0045951,0.26141,0.75431,GOBP_TRIGLYCERIDE_RICH_LIPOPROTEIN_PARTICLE_REMODELING,1
GCM_MAX,SET,29,-0.10266,-0.0040746,0.14917,0.75432,GCM_MAX,1
GOBP_ANTIFUNGAL_HUMORAL_RESP...,SET,4,-0.3248,-0.0047912,0.47199,0.75432,GOBP_ANTIFUNGAL_HUMORAL_RESPONSE,1
RGTTAMWNATT_HNF1_01,SET,65,-0.076279,-0.0045283,0.11084,0.75433,RGTTAMWNATT_HNF1_01,1
WP_GENETIC_CAUSES_OF_PORTOSI...,SET,30,-0.10758,-0.004343,0.1563,0.75437,WP_GENETIC_CAUSES_OF_PORTOSINUSOIDAL_VASCULAR_DISEASE,1
GSE5589_UNSTIM_VS_45MIN_LPS_...6,SET,183,-0.04354,-0.0043229,0.063246,0.7544,GSE5589_UNSTIM_VS_45MIN_LPS_STIM_MACROPHAGE_UP,1
GSE15659_NONSUPPRESSIVE_TCEL...2,SET,162,-0.045325,-0.0042366,0.065831,0.75443,GSE15659_NONSUPPRESSIVE_TCELL_VS_ACTIVATED_TREG_UP,1
NKX2_5_TARGET_GENES,SET,1230,-0.017187,-0.0042949,0.024956,0.75448,NKX2_5_TARGET_GENES,1
DESCARTES_FETAL_MUSCLE_SCHWA...,SET,101,-0.063442,-0.0046901,0.092103,0.75453,DESCARTES_FETAL_MUSCLE_SCHWANN_CELLS,1
LIAO_METASTASIS,SET,476,-0.026239,-0.0041677,0.03809,0.75455,LIAO_METASTASIS,1
GOCC_CILIUM,SET,635,-0.022986,-0.0041981,0.033362,0.75458,GOCC_CILIUM,1
GOCC_PERINUCLEAR_ENDOPLASMIC...,SET,19,-0.13305,-0.0042758,0.19309,0.7546,GOCC_PERINUCLEAR_ENDOPLASMIC_RETICULUM,1
REACTOME_SIGNALING_BY_HIPPO,SET,19,-0.14759,-0.0047429,0.21415,0.75464,REACTOME_SIGNALING_BY_HIPPO,1
GOBP_CARDIAC_MUSCLE_MYOBLAST...,SET,3,-0.32371,-0.0041355,0.46971,0.75464,GOBP_CARDIAC_MUSCLE_MYOBLAST_PROLIFERATION,1
GOBP_MESONEPHROS_DEVELOPMENT,SET,97,-0.065076,-0.0047151,0.094384,0.75473,GOBP_MESONEPHROS_DEVELOPMENT,1
BAFNA_MUC4_TARGETS_UP,SET,3,-0.35138,-0.0044889,0.50956,0.75476,BAFNA_MUC4_TARGETS_UP,1
KEGG_LIMONENE_AND_PINENE_DEG...,SET,9,-0.17512,-0.0038742,0.25395,0.75476,KEGG_LIMONENE_AND_PINENE_DEGRADATION,1
HP_UNICORONAL_SYNOSTOSIS,SET,7,-0.25219,-0.0049207,0.36572,0.75476,HP_UNICORONAL_SYNOSTOSIS,1
GSE25147_UNSTIM_VS_HELIOBACT...1,SET,148,-0.050865,-0.004546,0.073762,0.75477,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_DN,1
GOCC_CELL_BODY,SET,508,-0.026834,-0.0043992,0.038902,0.75483,GOCC_CELL_BODY,1
GSE17974_IL4_AND_ANTI_IL12_V...16,SET,151,-0.048734,-0.0043992,0.070629,0.7549,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_6H_ACT_CD4_TCELL_UP,1
GOBP_SPHINGOLIPID_MEDIATED_S...,SET,17,-0.14751,-0.0044843,0.2136,0.75508,GOBP_SPHINGOLIPID_MEDIATED_SIGNALING_PATHWAY,1
GOBP_MRNA_3_END_PROCESSING_B...,SET,6,-0.20193,-0.003648,0.2923,0.75516,GOBP_MRNA_3_END_PROCESSING_BY_STEM_LOOP_BINDING_AND_CLEAVAGE,1
GSE17721_LPS_VS_GARDIQUIMOD_...18,SET,182,-0.043733,-0.0043304,0.063305,0.75516,GSE17721_LPS_VS_GARDIQUIMOD_8H_BMDC_UP,1
NFMUE1_Q6,SET,217,-0.038956,-0.0042079,0.056373,0.75523,NFMUE1_Q6,1
GOBP_HEMATOPOIETIC_PROGENITO...,SET,128,-0.052307,-0.00435,0.075672,0.75529,GOBP_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GSE17974_0H_VS_2H_IN_VITRO_A...1,SET,177,-0.041828,-0.004085,0.060498,0.75534,GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN,1
GOBP_REGULATION_OF_DEFENSE_R...1,SET,728,-0.022489,-0.0043863,0.032515,0.75541,GOBP_REGULATION_OF_DEFENSE_RESPONSE,1
GSE3982_MAST_CELL_VS_BCELL_DN,SET,161,-0.045709,-0.0042593,0.066086,0.75542,GSE3982_MAST_CELL_VS_BCELL_DN,1
CREL_01,SET,242,-0.038181,-0.0043523,0.055197,0.75544,CREL_01,1
HP_DYSARTHRIA,SET,538,-0.02466,-0.0041569,0.03565,0.75544,HP_DYSARTHRIA,1
KEGG_MEDICUS_REFERENCE_ISOLE...,SET,9,-0.19202,-0.0042481,0.27758,0.75545,KEGG_MEDICUS_REFERENCE_ISOLEUCINE_DEGRADATION,1
MIR4499,SET,103,-0.059782,-0.0044628,0.086331,0.75568,MIR4499,1
MORF_FANCG,SET,156,-0.044776,-0.0041077,0.064658,0.75569,MORF_FANCG,1
CUI_DEVELOPING_HEART_RIGHT_V...,SET,20,-0.12869,-0.004243,0.18578,0.75575,CUI_DEVELOPING_HEART_RIGHT_VENTRICULAR_CARDIOMYOCYTE,1
REACTOME_OXIDATIVE_STRESS_IN...,SET,61,-0.079109,-0.00455,0.11419,0.75577,REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE,1
HP_ABNORMAL_NASAL_CAVITY_MOR...,SET,16,-0.14728,-0.0043436,0.21247,0.7559,HP_ABNORMAL_NASAL_CAVITY_MORPHOLOGY,1
REACTOME_REGULATION_OF_CDH11...3,SET,9,-0.20471,-0.004529,0.29531,0.75591,REACTOME_REGULATION_OF_CDH11_MRNA_TRANSLATION_BY_MICRORNAS,1
GSE34515_CD16_NEG_VS_POS_MON...1,SET,163,-0.044919,-0.0042114,0.064794,0.75592,GSE34515_CD16_NEG_VS_POS_MONOCYTE_DN,1
HP_ECTOPIC_CALCIFICATION,SET,209,-0.04215,-0.0044692,0.060776,0.75601,HP_ECTOPIC_CALCIFICATION,1
HP_BONE_FRACTURE,SET,21,-0.11401,-0.0038518,0.16438,0.75603,HP_BONE_FRACTURE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...29,SET,47,-0.086377,-0.0043624,0.12451,0.75607,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_ALDEHYDE_OR_OXO_GROUP_OF_DONORS,1
GSE10094_LCMV_VS_LISTERIA_IN...1,SET,178,-0.043683,-0.0042781,0.062968,0.75607,GSE10094_LCMV_VS_LISTERIA_IND_EFF_CD4_TCELL_DN,1
HALLMARK_KRAS_SIGNALING_DN,SET,175,-0.045413,-0.0044102,0.065459,0.75608,HALLMARK_KRAS_SIGNALING_DN,1
GSE17721_CTRL_VS_POLYIC_4H_B...2,SET,183,-0.04118,-0.0040887,0.059352,0.7561,GSE17721_CTRL_VS_POLYIC_4H_BMDC_UP,1
GOBP_INNER_EAR_MORPHOGENESIS,SET,98,-0.062471,-0.0045496,0.090007,0.75617,GOBP_INNER_EAR_MORPHOGENESIS,1
MIR6832_3P,SET,233,-0.03914,-0.0043789,0.05639,0.75618,MIR6832_3P,1
GOBP_CELLULAR_HYPEROSMOTIC_R...,SET,19,-0.13342,-0.0042876,0.19222,0.75619,GOBP_CELLULAR_HYPEROSMOTIC_RESPONSE,1
ZNF302_TARGET_GENES,SET,4,-0.24254,-0.0035776,0.34941,0.7562,ZNF302_TARGET_GENES,1
HP_HYPOPLASTIC_VERTEBRAL_BOD...,SET,17,-0.14291,-0.0043444,0.20585,0.75623,HP_HYPOPLASTIC_VERTEBRAL_BODIES,1
LI_ESTROGENE_LATE_E2_RESPONS...1,SET,71,-0.075092,-0.0046582,0.10815,0.75626,LI_ESTROGENE_LATE_E2_RESPONSE_DN,1
GOBP_SMOOTH_MUSCLE_CELL_PROL...,SET,131,-0.054583,-0.0045918,0.078603,0.75628,GOBP_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
GOMF_ENZYME_REGULATOR_ACTIVI...,SET,1191,-0.017669,-0.0043498,0.025445,0.75628,GOMF_ENZYME_REGULATOR_ACTIVITY,1
chr16q13,SET,25,-0.18918,-0.0069724,0.27235,0.75634,chr16q13,1
GOBP_MESENCHYMAL_TO_EPITHELI...1,SET,18,-0.16223,-0.0050745,0.23356,0.75635,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION,1
MODULE_297,SET,72,-0.07153,-0.0044683,0.10296,0.75639,MODULE_297,1
HP_ABNORMAL_ESOPHAGUS_PHYSIO...,SET,774,-0.021275,-0.004273,0.030621,0.7564,HP_ABNORMAL_ESOPHAGUS_PHYSIOLOGY,1
GOMF_NEUROPEPTIDE_BINDING,SET,28,-0.12365,-0.0048227,0.17795,0.75643,GOMF_NEUROPEPTIDE_BINDING,1
GOBP_MUSCLE_CELL_FATE_COMMIT...,SET,16,-0.17555,-0.0051774,0.25263,0.75644,GOBP_MUSCLE_CELL_FATE_COMMITMENT,1
HP_EROSION_OF_ORAL_MUCOSA,SET,89,-0.06499,-0.0045116,0.093517,0.75645,HP_EROSION_OF_ORAL_MUCOSA,1
MIR218_2_3P,SET,46,-0.085291,-0.0042617,0.12271,0.75649,MIR218_2_3P,1
SCIAN_INVERSED_TARGETS_OF_TP...2,SET,9,-0.20738,-0.0045879,0.29833,0.7565,SCIAN_INVERSED_TARGETS_OF_TP53_AND_TP73_UP,1
GSE26030_UNSTIM_VS_RESTIM_TH...7,SET,180,-0.043485,-0.0042823,0.062557,0.75651,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN,1
GSE37532_VISCERAL_ADIPOSE_TI...6,SET,112,-0.058002,-0.004514,0.08343,0.75653,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TCONV_CD4_TCELL_UP,1
DURANTE_ADULT_OLFACTORY_NEUR...12,SET,35,-0.11484,-0.0050069,0.16516,0.75658,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_MONOCYTES,1
HP_TYPE_II_DIABETES_MELLITUS,SET,191,-0.043885,-0.0044505,0.063101,0.75662,HP_TYPE_II_DIABETES_MELLITUS,1
HP_SUPERNUMERARY_NIPPLE,SET,46,-0.081269,-0.0040607,0.11679,0.75674,HP_SUPERNUMERARY_NIPPLE,1
MIR103A_2_5P,SET,140,-0.049916,-0.0043399,0.071726,0.75676,MIR103A_2_5P,1
GOMF_PROTEIN_TYROSINE_PHOSPH...,SET,89,-0.06367,-0.0044199,0.091479,0.75678,GOMF_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_PHARYNX,SET,198,-0.042452,-0.0043824,0.060987,0.75681,HP_ABNORMALITY_OF_THE_PHARYNX,1
REACTOME_SPHINGOLIPID_METABO...,SET,95,-0.061458,-0.0044071,0.088285,0.75682,REACTOME_SPHINGOLIPID_METABOLISM,1
GOBP_GLIAL_CELL_PROLIFERATION,SET,52,-0.085058,-0.0045179,0.12218,0.75684,GOBP_GLIAL_CELL_PROLIFERATION,1
GOBP_SECONDARY_METABOLITE_BI...,SET,24,-0.12893,-0.0046561,0.18519,0.75685,GOBP_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
GSE3982_EOSINOPHIL_VS_NEUTRO...1,SET,170,-0.04429,-0.0042399,0.063617,0.75685,GSE3982_EOSINOPHIL_VS_NEUTROPHIL_DN,1
GSE1460_CD4_THYMOCYTE_VS_NAI...3,SET,176,-0.044125,-0.0042973,0.063373,0.75687,GSE1460_CD4_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN,1
ALCALA_APOPTOSIS,SET,80,-0.062863,-0.0041384,0.090278,0.75688,ALCALA_APOPTOSIS,1
HP_MOTOR_POLYNEUROPATHY,SET,33,-0.10515,-0.0044517,0.15102,0.75688,HP_MOTOR_POLYNEUROPATHY,1
HOFMANN_MYELODYSPLASTIC_SYND...2,SET,8,-0.21122,-0.0044058,0.30332,0.75689,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_UP,1
GNF2_RAD23A,SET,60,-0.074087,-0.0042262,0.10633,0.75701,GNF2_RAD23A,1
chr8q21,SET,67,-0.13734,-0.0082771,0.19711,0.75702,chr8q21,1
GOBP_RESPONSE_TO_ACID_CHEMIC...,SET,119,-0.055008,-0.0044119,0.078949,0.75702,GOBP_RESPONSE_TO_ACID_CHEMICAL,1
MIR5194,SET,33,-0.10587,-0.0044822,0.15193,0.75705,MIR5194,1
GOBP_CELL_DIFFERENTIATION_IN...5,SET,20,-0.14414,-0.0047524,0.20682,0.75708,GOBP_CELL_DIFFERENTIATION_IN_HINDBRAIN,1
HP_ABNORMAL_EYELID_PHYSIOLOGY,SET,36,-0.095222,-0.0042102,0.13661,0.75711,HP_ABNORMAL_EYELID_PHYSIOLOGY,1
MEF2_03,SET,204,-0.04234,-0.0044359,0.060737,0.75713,MEF2_03,1
GSE14350_TREG_VS_TEFF_UP,SET,181,-0.04322,-0.0042679,0.061989,0.75716,GSE14350_TREG_VS_TEFF_UP,1
GSE29618_LAIV_VS_TIV_FLU_VAC...8,SET,171,-0.042112,-0.0040431,0.060383,0.75722,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP,1
GOBP_ACTIN_FILAMENT_BUNDLE_O...,SET,152,-0.048481,-0.0043907,0.069513,0.75723,GOBP_ACTIN_FILAMENT_BUNDLE_ORGANIZATION,1
HP_CYSTOID_MACULAR_EDEMA,SET,19,-0.13628,-0.0043795,0.19539,0.75724,HP_CYSTOID_MACULAR_EDEMA,1
GSE21360_PRIMARY_VS_QUATERNA...2,SET,157,-0.050355,-0.0046342,0.072183,0.75728,GSE21360_PRIMARY_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,1
REACTOME_IRF3_MEDIATED_ACTIV...,SET,5,-0.22108,-0.003646,0.31691,0.75729,REACTOME_IRF3_MEDIATED_ACTIVATION_OF_TYPE_1_IFN,1
GOBP_RETINAL_CONE_CELL_DIFFE...,SET,13,-0.17802,-0.0047328,0.25509,0.75736,GOBP_RETINAL_CONE_CELL_DIFFERENTIATION,1
HP_GENERALIZED_TONIC_SEIZURE,SET,50,-0.082484,-0.0042963,0.1182,0.75736,HP_GENERALIZED_TONIC_SEIZURE,1
HP_HYPOPLASIA_OF_PENIS,SET,340,-0.032145,-0.0043315,0.046049,0.75743,HP_HYPOPLASIA_OF_PENIS,1
KRAS.600.LUNG.BREAST_UP.V1_DN,SET,253,-0.038343,-0.0044676,0.054922,0.75745,KRAS.600.LUNG.BREAST_UP.V1_DN,1
SOGA_COLORECTAL_CANCER_MYC_DN,SET,69,-0.073082,-0.0044695,0.10466,0.7575,SOGA_COLORECTAL_CANCER_MYC_DN,1
GOBP_RESPONSE_TO_CATECHOLAMI...,SET,55,-0.084844,-0.0046344,0.12147,0.75756,GOBP_RESPONSE_TO_CATECHOLAMINE,1
REACTOME_TRANSPORT_TO_THE_GO...,SET,181,-0.042679,-0.0042145,0.061089,0.75761,REACTOME_TRANSPORT_TO_THE_GOLGI_AND_SUBSEQUENT_MODIFICATION,1
MIR548AK_MIR548AM_5P_MIR548C...,SET,444,-0.028027,-0.0043033,0.040111,0.75764,MIR548AK_MIR548AM_5P_MIR548C_5P_MIR548H_5P_MIR548O_5P_MIR548AU_5P,1
MIR548O_5P_MIR548W,SET,444,-0.028027,-0.0043033,0.040111,0.75764,MIR548O_5P_MIR548W,1
GOBP_BEHAVIOR,SET,612,-0.025105,-0.0045042,0.035917,0.75771,GOBP_BEHAVIOR,1
GSE17721_CTRL_VS_PAM3CSK4_12...2,SET,181,-0.043097,-0.0042557,0.061651,0.75773,GSE17721_CTRL_VS_PAM3CSK4_12H_BMDC_UP,1
GOMF_C2H2_ZINC_FINGER_DOMAIN...,SET,12,-0.17415,-0.0044484,0.24904,0.7578,GOMF_C2H2_ZINC_FINGER_DOMAIN_BINDING,1
GOBP_REGULATION_OF_LEUKOCYTE...9,SET,246,-0.040338,-0.0046355,0.057675,0.75784,GOBP_REGULATION_OF_LEUKOCYTE_PROLIFERATION,1
HP_ABNORMAL_BRAIN_EVOKED_POT...,SET,91,-0.060532,-0.0042488,0.086542,0.75786,HP_ABNORMAL_BRAIN_EVOKED_POTENTIALS,1
GOBP_POSITIVE_REGULATION_OF_...86,SET,72,-0.071251,-0.0044509,0.10186,0.75787,GOBP_POSITIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
chr2q12,SET,24,-0.19993,-0.00722,0.28573,0.75794,chr2q12,1
HP_HODGKIN_LYMPHOMA,SET,25,-0.11076,-0.0040823,0.15829,0.75795,HP_HODGKIN_LYMPHOMA,1
GOBP_MYELOID_CELL_APOPTOTIC_...,SET,36,-0.09628,-0.004257,0.13755,0.75802,GOBP_MYELOID_CELL_APOPTOTIC_PROCESS,1
GSE360_L_MAJOR_VS_B_MALAYI_H...1,SET,180,-0.043702,-0.0043037,0.062432,0.75803,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN,1
GOBP_RESPONSE_TO_OXYGEN_CONT...,SET,1510,-0.016249,-0.0044622,0.02321,0.75806,GOBP_RESPONSE_TO_OXYGEN_CONTAINING_COMPOUND,1
HP_ABNORMAL_LENGTH_OF_CORPUS...,SET,6,-0.26221,-0.004737,0.37452,0.75807,HP_ABNORMAL_LENGTH_OF_CORPUS_CALLOSUM,1
WP_LACTATE_SHUTTLE_IN_GLIAL_...,SET,12,-0.18404,-0.0047012,0.26286,0.75808,WP_LACTATE_SHUTTLE_IN_GLIAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...378,SET,5,-0.27351,-0.0045106,0.39054,0.75814,GOBP_NEGATIVE_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
BROWNE_HCMV_INFECTION_14HR_DN,SET,257,-0.036892,-0.004332,0.052674,0.75815,BROWNE_HCMV_INFECTION_14HR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...417,SET,57,-0.078606,-0.0043708,0.11223,0.75816,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,1
chr4q28,SET,19,-0.19874,-0.0063868,0.28366,0.75823,chr4q28,1
BIOCARTA_CTLA4_PATHWAY,SET,17,-0.14811,-0.0045024,0.21139,0.75823,BIOCARTA_CTLA4_PATHWAY,1
GOMF_CUPROUS_ION_BINDING,SET,8,-0.19447,-0.0040565,0.27753,0.75826,GOMF_CUPROUS_ION_BINDING,1
HP_ABNORMAL_HEPATIC_ECHOGENI...,SET,7,-0.24293,-0.0047401,0.34668,0.75826,HP_ABNORMAL_HEPATIC_ECHOGENICITY,1
GOBP_POSITIVE_REGULATION_OF_...277,SET,61,-0.079948,-0.0045982,0.11408,0.75828,GOBP_POSITIVE_REGULATION_OF_FAT_CELL_DIFFERENTIATION,1
WEIGEL_OXIDATIVE_STRESS_RESP...,SET,32,-0.10275,-0.0042836,0.14658,0.75834,WEIGEL_OXIDATIVE_STRESS_RESPONSE,1
ZNF101_TARGET_GENES,SET,360,-0.031147,-0.0043163,0.044425,0.75838,ZNF101_TARGET_GENES,1
HE_LIM_SUN_FETAL_LUNG_C3_SCG...,SET,523,-0.026606,-0.0044239,0.037949,0.75838,HE_LIM_SUN_FETAL_LUNG_C3_SCG3_POS_LYMPHATIC_ENDOTHELIAL_CELL,1
HP_LONG_PENIS,SET,11,-0.18401,-0.0045004,0.26245,0.75839,HP_LONG_PENIS,1
GSE5679_PPARG_LIGAND_ROSIGLI...2,SET,181,-0.042312,-0.0041782,0.060333,0.75844,GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_RARA_AGONIST_AM580_TREATED_DC_UP,1
GOBP_WYBUTOSINE_METABOLIC_PR...,SET,6,-0.20805,-0.0037584,0.29663,0.75846,GOBP_WYBUTOSINE_METABOLIC_PROCESS,1
GOBP_ENERGY_HOMEOSTASIS,SET,76,-0.070488,-0.0045233,0.10046,0.75854,GOBP_ENERGY_HOMEOSTASIS,1
FOURNIER_ACINAR_DEVELOPMENT_...4,SET,22,-0.12646,-0.0043728,0.18023,0.75856,FOURNIER_ACINAR_DEVELOPMENT_LATE_DN,1
GOMF_ANDROGEN_BINDING,SET,4,-0.24759,-0.0036522,0.35285,0.75856,GOMF_ANDROGEN_BINDING,1
HP_ABNORMAL_CIRCULATING_GLUT...1,SET,11,-0.15482,-0.0037863,0.2206,0.75859,HP_ABNORMAL_CIRCULATING_GLUTAMINE_CONCENTRATION,1
GSE3203_INFLUENZA_INF_VS_IFN...2,SET,185,-0.044521,-0.0044442,0.063438,0.7586,GSE3203_INFLUENZA_INF_VS_IFNB_TREATED_LN_BCELL_UP,1
MIR6726_5P,SET,45,-0.08218,-0.0040614,0.11708,0.75863,MIR6726_5P,1
GOMF_EXTRACELLULAR_MATRIX_ST...1,SET,152,-0.052197,-0.0047272,0.074359,0.75864,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT,1
GOBP_TRABECULA_MORPHOGENESIS,SET,46,-0.095036,-0.0047486,0.13538,0.75865,GOBP_TRABECULA_MORPHOGENESIS,1
GSE26351_WNT_VS_BMP_PATHWAY_...1,SET,176,-0.043015,-0.0041892,0.061271,0.75867,GSE26351_WNT_VS_BMP_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_DN,1
GSE40274_EOS_VS_FOXP3_AND_EO...2,SET,135,-0.047633,-0.0040674,0.067848,0.75867,GSE40274_EOS_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
REACTOME_N_GLYCAN_ANTENNAE_E...2,SET,26,-0.12695,-0.0047715,0.18079,0.75872,REACTOME_N_GLYCAN_ANTENNAE_ELONGATION_IN_THE_MEDIAL_TRANS_GOLGI,1
MEL18_DN.V1_DN,SET,135,-0.056441,-0.0048195,0.08036,0.75877,MEL18_DN.V1_DN,1
MEBARKI_HCC_PROGENITOR_FZD8C...1,SET,373,-0.031527,-0.0044456,0.044882,0.75879,MEBARKI_HCC_PROGENITOR_FZD8CRD_DN,1
HP_LACRIMAL_DUCT_ATRESIA,SET,5,-0.30331,-0.0050021,0.43177,0.7588,HP_LACRIMAL_DUCT_ATRESIA,1
HP_LENTICONUS,SET,8,-0.21974,-0.0045836,0.31277,0.75883,HP_LENTICONUS,1
MIR95_3P,SET,5,-0.2964,-0.0048881,0.42181,0.75887,MIR95_3P,1
GSE7460_TCONV_VS_TREG_LN_DN,SET,181,-0.045737,-0.0045164,0.065081,0.7589,GSE7460_TCONV_VS_TREG_LN_DN,1
GOBP_REGULATION_OF_VITAMIN_D...1,SET,7,-0.23227,-0.0045321,0.33042,0.75896,GOBP_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
HP_PERIPAPILLARY_CHORIORETIN...,SET,5,-0.28906,-0.0047671,0.41117,0.75898,HP_PERIPAPILLARY_CHORIORETINAL_ATROPHY,1
ACATATC_MIR190,SET,54,-0.088693,-0.0048005,0.12615,0.759,ACATATC_MIR190,1
MIR8085,SET,208,-0.042123,-0.0044557,0.059905,0.75901,MIR8085,1
HP_CONICAL_TOOTH,SET,49,-0.089775,-0.0046293,0.12768,0.75901,HP_CONICAL_TOOTH,1
GOBP_ER_NUCLEUS_SIGNALING_PA...,SET,44,-0.089415,-0.0043697,0.12714,0.75905,GOBP_ER_NUCLEUS_SIGNALING_PATHWAY,1
GSE7831_UNSTIM_VS_INFLUENZA_...4,SET,186,-0.044227,-0.0044267,0.06289,0.75905,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_UP,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...5,SET,23,-0.12137,-0.0042908,0.17256,0.75907,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_METABOLIC_PROCESS,1
GSE27786_BCELL_VS_CD4_TCELL_...2,SET,180,-0.043112,-0.0042456,0.061294,0.75908,GSE27786_BCELL_VS_CD4_TCELL_UP,1
GSE18791_CTRL_VS_NEWCASTLE_V...11,SET,150,-0.049132,-0.0044205,0.06984,0.75912,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_1H_DN,1
chr8p22,SET,20,-0.23778,-0.0078396,0.33792,0.75917,chr8p22,1
GSE36476_CTRL_VS_TSST_ACT_72...4,SET,175,-0.046029,-0.0044701,0.065391,0.75925,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_YOUNG_UP,1
MODULE_340,SET,24,-0.11834,-0.0042735,0.1681,0.75927,MODULE_340,1
GSE11924_TH2_VS_TH17_CD4_TCE...2,SET,178,-0.044439,-0.0043521,0.063113,0.75931,GSE11924_TH2_VS_TH17_CD4_TCELL_UP,1
HP_ABNORMAL_HYPNAGOGIA,SET,8,-0.2249,-0.0046911,0.31937,0.75933,HP_ABNORMAL_HYPNAGOGIA,1
REACTOME_TRANSCRIPTIONAL_REG...2,SET,57,-0.081851,-0.0045512,0.11621,0.75938,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_MECP2,1
PID_RHODOPSIN_PATHWAY,SET,21,-0.12158,-0.0041073,0.17259,0.75941,PID_RHODOPSIN_PATHWAY,1
GOMF_ACETYLCHOLINE_BINDING,SET,10,-0.18425,-0.0042966,0.26155,0.75942,GOMF_ACETYLCHOLINE_BINDING,1
MODULE_127,SET,12,-0.15701,-0.0040107,0.22282,0.75948,MODULE_127,1
GOBP_REGULATION_OF_CELLULAR_...3,SET,898,-0.020239,-0.0043631,0.028714,0.75954,GOBP_REGULATION_OF_CELLULAR_COMPONENT_BIOGENESIS,1
HP_HIGH_ANTERIOR_HAIRLINE,SET,59,-0.073882,-0.0041793,0.1048,0.75959,HP_HIGH_ANTERIOR_HAIRLINE,1
GOBP_MULTICELLULAR_ORGANISMA...6,SET,820,-0.020948,-0.0043249,0.029711,0.7596,GOBP_MULTICELLULAR_ORGANISMAL_REPRODUCTIVE_PROCESS,1
GSE29949_CD8_NEG_DC_SPLEEN_V...4,SET,168,-0.046946,-0.0044679,0.066588,0.7596,GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_UP,1
LHX9_TARGET_GENES,SET,1165,-0.018249,-0.0044465,0.025882,0.75962,LHX9_TARGET_GENES,1
MIR8073,SET,76,-0.067769,-0.0043489,0.096108,0.75963,MIR8073,1
GSE3920_UNTREATED_VS_IFNB_TR...2,SET,183,-0.04414,-0.0043825,0.062598,0.75963,GSE3920_UNTREATED_VS_IFNB_TREATED_ENDOTHELIAL_CELL_UP,1
GOBP_BLOOD_VESSEL_ENDOTHELIA...2,SET,109,-0.058882,-0.0045211,0.083498,0.75965,GOBP_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,1
GOBP_ONE_CARBON_METABOLIC_PR...,SET,36,-0.09877,-0.004367,0.14005,0.75967,GOBP_ONE_CARBON_METABOLIC_PROCESS,1
GSE27786_LSK_VS_MONO_MAC_UP,SET,174,-0.042915,-0.0041558,0.060843,0.75969,GSE27786_LSK_VS_MONO_MAC_UP,1
MIR802,SET,121,-0.055145,-0.0044596,0.078175,0.75971,MIR802,1
HP_NEONATAL_INSULIN_DEPENDEN...,SET,20,-0.14232,-0.0046921,0.20171,0.75976,HP_NEONATAL_INSULIN_DEPENDENT_DIABETES_MELLITUS,1
GSE27291_6H_VS_7D_STIM_GAMMA...2,SET,176,-0.042486,-0.0041376,0.060186,0.75987,GSE27291_6H_VS_7D_STIM_GAMMADELTA_TCELL_UP,1
KOINUMA_COLON_CANCER_MSI_UP,SET,16,-0.13964,-0.0041184,0.19781,0.75988,KOINUMA_COLON_CANCER_MSI_UP,1
HP_SUBSARCOLEMMAL_ACCUMULATI...,SET,5,-0.19735,-0.0032546,0.27953,0.7599,HP_SUBSARCOLEMMAL_ACCUMULATIONS_OF_ABNORMALLY_SHAPED_MITOCHONDRIA,1
HP_RHOMBENCEPHALOSYNAPSIS,SET,15,-0.15183,-0.0043358,0.21504,0.75992,HP_RHOMBENCEPHALOSYNAPSIS,1
HP_EARLY_YOUNG_ADULT_ONSET,SET,57,-0.077948,-0.0043342,0.11039,0.75993,HP_EARLY_YOUNG_ADULT_ONSET,1
GOBP_EMBRYONIC_SKELETAL_JOIN...2,SET,10,-0.20771,-0.0048437,0.29412,0.75997,GOBP_EMBRYONIC_SKELETAL_JOINT_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_BY_...4,SET,13,-0.16575,-0.0044067,0.23466,0.76001,GOBP_POSITIVE_REGULATION_BY_SYMBIONT_OF_ENTRY_INTO_HOST,1
GOBP_REPLACEMENT_OSSIFICATION,SET,28,-0.12246,-0.0047761,0.17337,0.76001,GOBP_REPLACEMENT_OSSIFICATION,1
MIR370_5P,SET,67,-0.072354,-0.0043606,0.10241,0.76006,MIR370_5P,1
WANG_CLIM2_TARGETS_DN,SET,162,-0.042979,-0.0040172,0.060829,0.76007,WANG_CLIM2_TARGETS_DN,1
GOBP_MONOSACCHARIDE_BIOSYNTH...,SET,79,-0.065523,-0.0042866,0.092738,0.76007,GOBP_MONOSACCHARIDE_BIOSYNTHETIC_PROCESS,1
GSE12505_WT_VS_E2_2_HET_PDC_...2,SET,119,-0.055189,-0.0044264,0.078112,0.76007,GSE12505_WT_VS_E2_2_HET_PDC_UP,1
GOBP_CATECHOL_CONTAINING_COM...3,SET,46,-0.096311,-0.0048123,0.13631,0.76008,GOBP_CATECHOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
REACTOME_REGULATION_OF_MITF_...1,SET,18,-0.15366,-0.0048064,0.21741,0.76014,REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_APOPTOSIS,1
GOCC_GID_COMPLEX,SET,5,-0.26144,-0.0043116,0.36992,0.76014,GOCC_GID_COMPLEX,1
REACTOME_DEGRADATION_OF_THE_...,SET,132,-0.056195,-0.0047453,0.079498,0.76017,REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX,1
MIR498_3P,SET,196,-0.042709,-0.0043869,0.060417,0.76018,MIR498_3P,1
GOBP_MAINTENANCE_OF_LENS_TRA...,SET,7,-0.26242,-0.0051205,0.37121,0.76019,GOBP_MAINTENANCE_OF_LENS_TRANSPARENCY,1
GOBP_NEGATIVE_REGULATION_OF_...219,SET,118,-0.054585,-0.0043597,0.077213,0.76019,GOBP_NEGATIVE_REGULATION_OF_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION,1
GOBP_ENDOTHELIN_RECEPTOR_SIG...,SET,10,-0.2036,-0.0047478,0.28792,0.76025,GOBP_ENDOTHELIN_RECEPTOR_SIGNALING_PATHWAY,1
GSE1112_OT1_CD8AB_VS_HY_CD8A...2,SET,132,-0.052495,-0.0044328,0.074225,0.76028,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_UP,1
MIR548AD_5P_MIR548AE_5P_MIR5...,SET,445,-0.028332,-0.0043548,0.040053,0.76032,MIR548AD_5P_MIR548AE_5P_MIR548AY_5P_MIR548B_5P_MIR548D_5P,1
GOBP_BRANCH_ELONGATION_INVOL...,SET,5,-0.31499,-0.0051946,0.44526,0.76034,GOBP_BRANCH_ELONGATION_INVOLVED_IN_MAMMARY_GLAND_DUCT_BRANCHING,1
GSE21927_SPLEEN_VS_TUMOR_MON...2,SET,142,-0.048529,-0.0042491,0.068575,0.76042,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_BALBC_UP,1
GOBP_SCHWANN_CELL_MIGRATION,SET,5,-0.27784,-0.004582,0.39255,0.76045,GOBP_SCHWANN_CELL_MIGRATION,1
HP_SPINOCEREBELLAR_TRACT_DEG...,SET,8,-0.19114,-0.0039869,0.27004,0.76046,HP_SPINOCEREBELLAR_TRACT_DEGENERATION,1
HOLLEMAN_DAUNORUBICIN_B_ALL_...2,SET,10,-0.19019,-0.0044351,0.26869,0.76047,HOLLEMAN_DAUNORUBICIN_B_ALL_UP,1
HP_BONE_CYST,SET,27,-0.11346,-0.0043456,0.1603,0.76047,HP_BONE_CYST,1
chr4q22,SET,31,-0.20001,-0.0082074,0.28255,0.76049,chr4q22,1
HP_FRACTURES_OF_THE_LONG_BON...,SET,12,-0.14949,-0.0038186,0.2111,0.76056,HP_FRACTURES_OF_THE_LONG_BONES,1
GOCC_SYNAPSE_ASSOCIATED_EXTR...,SET,12,-0.19861,-0.0050732,0.28038,0.76063,GOCC_SYNAPSE_ASSOCIATED_EXTRACELLULAR_MATRIX,1
GOBP_ERBB_SIGNALING_PATHWAY,SET,122,-0.053518,-0.0043458,0.075548,0.76065,GOBP_ERBB_SIGNALING_PATHWAY,1
MIR610,SET,77,-0.071399,-0.0046117,0.10074,0.76076,MIR610,1
REACTOME_ASSEMBLY_OF_COLLAGE...,SET,59,-0.085174,-0.0048181,0.12017,0.76077,REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES,1
GOMF_MANNOSE_BINDING,SET,22,-0.13182,-0.0045581,0.18597,0.76078,GOMF_MANNOSE_BINDING,1
AMIT_EGF_RESPONSE_240_HELA,SET,56,-0.081008,-0.0044648,0.11428,0.7608,AMIT_EGF_RESPONSE_240_HELA,1
GOBP_CELLULAR_RESPONSE_TO_MA...2,SET,7,-0.24104,-0.0047033,0.34003,0.7608,GOBP_CELLULAR_RESPONSE_TO_MAGNESIUM_ION,1
REACTOME_TRANSCRIPTIONAL_REG...9,SET,337,-0.030736,-0.0041236,0.043351,0.76083,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53,1
GSE26727_WT_VS_KLF2_KO_LPS_S...1,SET,189,-0.042158,-0.0042531,0.059461,0.76083,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...604,SET,12,-0.19545,-0.0049925,0.27562,0.76087,GOBP_NEGATIVE_REGULATION_OF_SODIUM_ION_TRANSMEMBRANE_TRANSPORT,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...2,SET,11,-0.17589,-0.0043017,0.24804,0.76087,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GOBP_OLIGOSACCHARIDE_LIPID_I...,SET,20,-0.11791,-0.0038875,0.16627,0.76088,GOBP_OLIGOSACCHARIDE_LIPID_INTERMEDIATE_BIOSYNTHETIC_PROCESS,1
GTGCAAT_MIR25_MIR32_MIR92_MI...,SET,281,-0.036333,-0.0044581,0.051228,0.76091,GTGCAAT_MIR25_MIR32_MIR92_MIR363_MIR367,1
GSE22886_NAIVE_CD8_TCELL_VS_...6,SET,172,-0.046465,-0.004474,0.065492,0.76098,GSE22886_NAIVE_CD8_TCELL_VS_MONOCYTE_UP,1
TRAVAGLINI_LUNG_CD8_NAIVE_T_...,SET,131,-0.055746,-0.0046896,0.078569,0.76099,TRAVAGLINI_LUNG_CD8_NAIVE_T_CELL,1
GSE30962_PRIMARY_VS_SECONDAR...1,SET,180,-0.045388,-0.0044697,0.063961,0.76103,GSE30962_PRIMARY_VS_SECONDARY_ACUTE_LCMV_INF_CD8_TCELL_DN,1
REACTOME_MITOCHONDRIAL_BIOGE...,SET,68,-0.071361,-0.0043326,0.1005,0.76117,REACTOME_MITOCHONDRIAL_BIOGENESIS,1
WP_ALPHA_6_BETA_4_SIGNALING,SET,33,-0.10502,-0.0044461,0.14789,0.76118,WP_ALPHA_6_BETA_4_SIGNALING,1
GSE7548_NAIVE_VS_DAY28_PCC_I...1,SET,173,-0.046687,-0.0045082,0.065742,0.76119,GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_DN,1
GSE3982_DC_VS_BASOPHIL_DN,SET,172,-0.044286,-0.0042641,0.062357,0.7612,GSE3982_DC_VS_BASOPHIL_DN,1
MIR671_5P,SET,117,-0.054475,-0.0043325,0.076704,0.76121,MIR671_5P,1
GOBP_WOUND_HEALING_SPREADING...,SET,26,-0.11051,-0.0041537,0.15561,0.76121,GOBP_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
HP_CORONAL_CLEFT_VERTEBRAE,SET,17,-0.14433,-0.0043874,0.2032,0.76123,HP_CORONAL_CLEFT_VERTEBRAE,1
HP_OPSOCLONUS,SET,14,-0.18283,-0.0050443,0.25739,0.76125,HP_OPSOCLONUS,1
GSE34392_ST2_KO_VS_WT_DAY8_L...1,SET,189,-0.046655,-0.0047068,0.065671,0.76128,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...694,SET,9,-0.21687,-0.004798,0.30521,0.76132,GOBP_POSITIVE_REGULATION_OF_SECONDARY_METABOLITE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...673,SET,42,-0.10141,-0.0048423,0.14269,0.76135,GOBP_POSITIVE_REGULATION_OF_RELEASE_OF_SEQUESTERED_CALCIUM_ION_INTO_CYTOSOL,1
HERNANDEZ_MITOTIC_ARREST_BY_...1,SET,35,-0.10962,-0.0047793,0.15425,0.76136,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_DN,1
HP_SECOND_DEGREE_ATRIOVENTRI...,SET,12,-0.17256,-0.0044078,0.24277,0.76138,HP_SECOND_DEGREE_ATRIOVENTRICULAR_BLOCK,1
GOBP_POSITIVE_REGULATION_OF_...49,SET,147,-0.049086,-0.0043724,0.069057,0.76139,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY,1
ROY_WOUND_BLOOD_VESSEL_DN,SET,19,-0.14171,-0.0045541,0.19936,0.76141,ROY_WOUND_BLOOD_VESSEL_DN,1
HP_INCREASED_HEPATOCELLULAR_...,SET,3,-0.30739,-0.0039269,0.43236,0.76144,HP_INCREASED_HEPATOCELLULAR_LIPID_DROPLETS,1
REACTOME_CTLA4_INHIBITORY_SI...,SET,21,-0.12809,-0.0043275,0.18015,0.76147,REACTOME_CTLA4_INHIBITORY_SIGNALING,1
HP_ABNORMAL_NUMBER_OF_PERMAN...,SET,30,-0.10782,-0.0043525,0.15162,0.76149,HP_ABNORMAL_NUMBER_OF_PERMANENT_TEETH,1
GOBP_REGULATION_OF_MEMBRANE_...14,SET,5,-0.23934,-0.0039471,0.3365,0.76153,GOBP_REGULATION_OF_MEMBRANE_TUBULATION,1
HP_DERMATAN_SULFATE_EXCRETIO...,SET,4,-0.28364,-0.004184,0.39879,0.76154,HP_DERMATAN_SULFATE_EXCRETION_IN_URINE,1
GOMF_OSMOSENSOR_ACTIVITY,SET,5,-0.2898,-0.0047792,0.40733,0.76159,GOMF_OSMOSENSOR_ACTIVITY,1
IRX2_TARGET_GENES,SET,187,-0.042047,-0.0042196,0.059099,0.7616,IRX2_TARGET_GENES,1
GSE41867_DAY8_VS_DAY15_LCMV_...1,SET,133,-0.053961,-0.0045737,0.075772,0.76181,GSE41867_DAY8_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN,1
MIR636,SET,204,-0.044148,-0.0046253,0.06199,0.76182,MIR636,1
GSE42021_CD24HI_VS_CD24LOW_T...3,SET,183,-0.045698,-0.0045372,0.064147,0.76188,GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_DN,1
GOBP_RESPONSE_TO_HYDROPEROXI...,SET,19,-0.14562,-0.0046795,0.20431,0.76199,GOBP_RESPONSE_TO_HYDROPEROXIDE,1
GSE40666_WT_VS_STAT4_KO_CD8_...4,SET,174,-0.044989,-0.0043567,0.06312,0.76199,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
HP_APLASIA_HYPOPLASIA_INVOLV...16,SET,1045,-0.019151,-0.0044348,0.026869,0.762,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_SKELETON,1
REACTOME_UB_SPECIFIC_PROCESS...,SET,148,-0.046429,-0.0041496,0.065138,0.76201,REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES,1
GSE17721_PAM3CSK4_VS_GADIQUI...10,SET,184,-0.044634,-0.0044436,0.062592,0.7621,GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP,1
WORSCHECH_TUMOR_EVASION_AND_...1,SET,14,-0.16905,-0.0046641,0.23705,0.76212,WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_DN,1
REACTOME_CS_DS_DEGRADATION,SET,12,-0.18053,-0.0046114,0.25312,0.76214,REACTOME_CS_DS_DEGRADATION,1
GOBP_CARDIAC_VENTRICLE_DEVEL...,SET,121,-0.058569,-0.0047366,0.08212,0.76214,GOBP_CARDIAC_VENTRICLE_DEVELOPMENT,1
WP_NEUROINFLAMMATION_AND_GLU...,SET,135,-0.055462,-0.0047359,0.077748,0.76218,WP_NEUROINFLAMMATION_AND_GLUTAMATERGIC_SIGNALING,1
MIR4287,SET,115,-0.055376,-0.0043667,0.077589,0.76229,MIR4287,1
HP_STIFF_NECK,SET,5,-0.2777,-0.0045797,0.38908,0.76229,HP_STIFF_NECK,1
MANNO_MIDBRAIN_NEUROTYPES_HN...1,SET,619,-0.026199,-0.0047264,0.036707,0.7623,MANNO_MIDBRAIN_NEUROTYPES_HNBGABA,1
GSE25088_WT_VS_STAT6_KO_MACR...2,SET,178,-0.042366,-0.0041491,0.059354,0.76231,GSE25088_WT_VS_STAT6_KO_MACROPHAGE_IL4_STIM_DN,1
REACTOME_GOLGI_TO_ER_RETROGR...,SET,129,-0.050056,-0.0041789,0.070125,0.76232,REACTOME_GOLGI_TO_ER_RETROGRADE_TRANSPORT,1
REACTOME_PCNA_DEPENDENT_LONG...,SET,21,-0.1203,-0.004064,0.1685,0.76236,REACTOME_PCNA_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,1
LI_WILMS_TUMOR,SET,23,-0.14413,-0.0050956,0.20187,0.76238,LI_WILMS_TUMOR,1
GOBP_REGULATION_OF_APOPTOTIC...4,SET,4,-0.32861,-0.0048474,0.4602,0.7624,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_IN_BONE_MARROW_CELL,1
HP_ABNORMAL_INTESTINE_MORPHO...,SET,675,-0.023499,-0.0044199,0.032901,0.76245,HP_ABNORMAL_INTESTINE_MORPHOLOGY,1
HP_ORTHOSTATIC_HYPOTENSION_D...,SET,15,-0.17186,-0.0049076,0.24062,0.76245,HP_ORTHOSTATIC_HYPOTENSION_DUE_TO_AUTONOMIC_DYSFUNCTION,1
HP_SPONDYLOMETAPHYSEAL_DYSPL...,SET,8,-0.20731,-0.0043242,0.29024,0.76247,HP_SPONDYLOMETAPHYSEAL_DYSPLASIA,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...3,SET,25,-0.10505,-0.0038718,0.14707,0.76248,HP_ABNORMAL_MORPHOLOGY_OF_THE_CONJUNCTIVAL_VASCULATURE,1
HP_EXAGGERATED_STARTLE_RESPO...,SET,29,-0.11823,-0.0046928,0.1655,0.7625,HP_EXAGGERATED_STARTLE_RESPONSE,1
GOBP_NEGATIVE_REGULATION_OF_...527,SET,6,-0.23315,-0.0042119,0.32636,0.76251,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,1
PID_RAC1_REG_PATHWAY,SET,36,-0.10038,-0.004438,0.14048,0.76254,PID_RAC1_REG_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...582,SET,172,-0.049421,-0.0047585,0.069167,0.76254,GOBP_POSITIVE_REGULATION_OF_PHOSPHATIDYLINOSITOL_3_KINASE_PROTEIN_KINASE_B_SIGNAL_TRANSDUCTION,1
GOBP_ALDITOL_BIOSYNTHETIC_PR...,SET,5,-0.33341,-0.0054984,0.46657,0.76257,GOBP_ALDITOL_BIOSYNTHETIC_PROCESS,1
MIR548Y,SET,451,-0.028535,-0.0044147,0.039926,0.76259,MIR548Y,1
MIR4764_5P,SET,68,-0.072698,-0.0044138,0.10169,0.76266,MIR4764_5P,1
GOBP_CIRCADIAN_RHYTHM,SET,193,-0.045115,-0.0045988,0.063103,0.76267,GOBP_CIRCADIAN_RHYTHM,1
GOMF_DOUBLE_STRANDED_TELOMER...,SET,9,-0.20041,-0.0044337,0.28026,0.76271,GOMF_DOUBLE_STRANDED_TELOMERIC_DNA_BINDING,1
GOBP_REGULATORY_T_CELL_DIFFE...,SET,35,-0.10448,-0.0045551,0.14611,0.76272,GOBP_REGULATORY_T_CELL_DIFFERENTIATION,1
HP_PERIPORTAL_FIBROSIS,SET,10,-0.17685,-0.0041241,0.2473,0.76274,HP_PERIPORTAL_FIBROSIS,1
GOBP_MONOATOMIC_ION_HOMEOSTA...,SET,561,-0.026878,-0.0046236,0.037578,0.76277,GOBP_MONOATOMIC_ION_HOMEOSTASIS,1
GOBP_NEUROTRANSMITTER_RECEPT...1,SET,33,-0.10606,-0.00449,0.14828,0.76277,GOBP_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,1
GSE33425_CD161_INT_VS_NEG_CD...1,SET,190,-0.044655,-0.0045168,0.062427,0.76279,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_DN,1
GOBP_SUBSTRATE_INDEPENDENT_T...,SET,9,-0.2393,-0.0052942,0.33436,0.76291,GOBP_SUBSTRATE_INDEPENDENT_TELENCEPHALIC_TANGENTIAL_MIGRATION,1
SMID_BREAST_CANCER_NORMAL_LI...2,SET,422,-0.031853,-0.0047709,0.044493,0.76297,SMID_BREAST_CANCER_NORMAL_LIKE_UP,1
GOBP_REDUCTION_OF_FOOD_INTAK...,SET,6,-0.24735,-0.0044685,0.34542,0.76303,GOBP_REDUCTION_OF_FOOD_INTAKE_IN_RESPONSE_TO_DIETARY_EXCESS,1
GOBP_MACROPHAGE_MIGRATION,SET,57,-0.079976,-0.004447,0.11168,0.76305,GOBP_MACROPHAGE_MIGRATION,1
GSE13522_WT_VS_IFNAR_KO_SKIN...3,SET,152,-0.051563,-0.0046698,0.071988,0.76308,GSE13522_WT_VS_IFNAR_KO_SKIN_DN,1
HP_CAESARIAN_SECTION,SET,13,-0.17739,-0.0047162,0.24762,0.76312,HP_CAESARIAN_SECTION,1
TGFB_UP.V1_UP,SET,176,-0.048941,-0.0047663,0.068315,0.76312,TGFB_UP.V1_UP,1
HARRIS_BRAIN_CANCER_PROGENIT...,SET,37,-0.10298,-0.0046161,0.14375,0.76313,HARRIS_BRAIN_CANCER_PROGENITORS,1
GOBP_PROTEIN_CONTAINING_COMP...4,SET,37,-0.10811,-0.0048458,0.15089,0.76315,GOBP_PROTEIN_CONTAINING_COMPLEX_REMODELING,1
GOCC_LATE_ENDOSOME,SET,279,-0.036492,-0.0044619,0.050922,0.76319,GOCC_LATE_ENDOSOME,1
GOBP_DE_NOVO_CENTRIOLE_ASSEM...2,SET,4,-0.28956,-0.0042713,0.40402,0.76321,GOBP_DE_NOVO_CENTRIOLE_ASSEMBLY_INVOLVED_IN_MULTI_CILIATED_EPITHELIAL_CELL_DIFFERENTIATION,1
GSE2826_WT_VS_XID_BCELL_DN,SET,183,-0.046991,-0.0046656,0.06553,0.76334,GSE2826_WT_VS_XID_BCELL_DN,1
HP_PALMOPLANTAR_HYPERKERATOS...,SET,120,-0.057428,-0.0046252,0.080078,0.76336,HP_PALMOPLANTAR_HYPERKERATOSIS,1
REACTOME_ACTIVATED_NTRK2_SIG...4,SET,7,-0.2516,-0.0049093,0.35077,0.7634,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_PI3K,1
GOBP_REGULATION_OF_TOLL_LIKE...2,SET,14,-0.1468,-0.0040501,0.20463,0.76342,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,1
GOBP_MORPHOGENESIS_OF_AN_EPI...1,SET,13,-0.19323,-0.0051372,0.26935,0.76343,GOBP_MORPHOGENESIS_OF_AN_EPITHELIAL_BUD,1
HP_FEMALE_HYPOGONADISM,SET,28,-0.11936,-0.0046552,0.16638,0.76343,HP_FEMALE_HYPOGONADISM,1
LIU_CDX2_TARGETS_UP,SET,32,-0.11362,-0.0047368,0.15834,0.76348,LIU_CDX2_TARGETS_UP,1
GSE22601_IMMATURE_CD4_SINGLE...4,SET,184,-0.045389,-0.0045187,0.06325,0.7635,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
CCAGGGG_MIR331,SET,83,-0.064275,-0.0043096,0.089557,0.76352,CCAGGGG_MIR331,1
GOCC_GLYCOPROTEIN_COMPLEX,SET,21,-0.12872,-0.0043487,0.17936,0.76352,GOCC_GLYCOPROTEIN_COMPLEX,1
HP_ANENCEPHALY,SET,37,-0.091556,-0.0041038,0.12757,0.76352,HP_ANENCEPHALY,1
GOBP_FLOOR_PLATE_DEVELOPMENT,SET,10,-0.17466,-0.0040729,0.24334,0.76354,GOBP_FLOOR_PLATE_DEVELOPMENT,1
GSE13485_DAY3_VS_DAY21_YF17D...2,SET,176,-0.043861,-0.0042716,0.061109,0.76354,GSE13485_DAY3_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
GOBP_EAR_MORPHOGENESIS,SET,117,-0.059566,-0.0047375,0.082986,0.76355,GOBP_EAR_MORPHOGENESIS,1
GSE15330_WT_VS_IKAROS_KO_MEG...2,SET,180,-0.043352,-0.0042692,0.060398,0.76355,GSE15330_WT_VS_IKAROS_KO_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,1
HP_PERIFOVEAL_RING_OF_HYPERA...,SET,15,-0.15865,-0.0045306,0.22101,0.76357,HP_PERIFOVEAL_RING_OF_HYPERAUTOFLUORESCENCE,1
HP_FEMALE_SEXUAL_DYSFUNCTION,SET,61,-0.080145,-0.0046095,0.11164,0.76358,HP_FEMALE_SEXUAL_DYSFUNCTION,1
GOBP_POSITIVE_REGULATION_OF_...249,SET,189,-0.046774,-0.0047187,0.06515,0.7636,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
REACTOME_SIALIC_ACID_METABOL...,SET,33,-0.10984,-0.0046502,0.15297,0.76363,REACTOME_SIALIC_ACID_METABOLISM,1
GSE12003_4D_VS_8D_CULTURE_MI...2,SET,134,-0.05485,-0.0046664,0.076386,0.76364,GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP,1
MODULE_194,SET,15,-0.1483,-0.0042349,0.20648,0.76368,MODULE_194,1
GSE2706_2H_VS_8H_R848_AND_LP...1,SET,177,-0.046571,-0.0045482,0.064832,0.76372,GSE2706_2H_VS_8H_R848_AND_LPS_STIM_DC_DN,1
KAYO_AGING_MUSCLE_DN,SET,106,-0.05452,-0.0041285,0.075895,0.76373,KAYO_AGING_MUSCLE_DN,1
HP_OBSTRUCTIVE_AZOOSPERMIA,SET,27,-0.10774,-0.0041265,0.14998,0.76373,HP_OBSTRUCTIVE_AZOOSPERMIA,1
TGCAAAC_MIR452,SET,86,-0.068979,-0.0047074,0.096009,0.76376,TGCAAAC_MIR452,1
HP_ABNORMAL_CIRCULATING_CITR...,SET,10,-0.20578,-0.0047988,0.28642,0.76376,HP_ABNORMAL_CIRCULATING_CITRULLINE_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...199,SET,6,-0.23195,-0.0041902,0.32281,0.76378,GOBP_POSITIVE_REGULATION_OF_DENDRITIC_CELL_DIFFERENTIATION,1
FLOTHO_PEDIATRIC_ALL_THERAPY...1,SET,28,-0.11837,-0.0046169,0.16474,0.76379,FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_DN,1
FLECHNER_PBL_KIDNEY_TRANSPLA...2,SET,137,-0.049605,-0.0042668,0.06903,0.7638,FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP,1
CHEOK_RESPONSE_TO_MERCAPTOPU...6,SET,11,-0.17019,-0.0041624,0.23678,0.76385,CHEOK_RESPONSE_TO_MERCAPTOPURINE_UP,1
ACCGAGC_MIR423,SET,5,-0.29879,-0.0049276,0.41563,0.76389,ACCGAGC_MIR423,1
MIR4659B_5P,SET,91,-0.063529,-0.0044591,0.088332,0.76399,MIR4659B_5P,1
HP_POLYURIA,SET,35,-0.1068,-0.0046564,0.14847,0.76404,HP_POLYURIA,1
MIR4458,SET,318,-0.035018,-0.0045661,0.048666,0.7641,MIR4458,1
REACTOME_PHASE_I_FUNCTIONALI...,SET,99,-0.067076,-0.0049097,0.0932,0.76414,REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS,1
ZNF711_TARGET_GENES,SET,1383,-0.0167,-0.0044054,0.023205,0.76414,ZNF711_TARGET_GENES,1
GOBP_GAMMA_DELTA_T_CELL_ACTI...,SET,23,-0.12799,-0.0045247,0.1778,0.76418,GOBP_GAMMA_DELTA_T_CELL_ACTIVATION,1
HP_HEREDITARY_NONPOLYPOSIS_C...,SET,32,-0.10806,-0.0045052,0.15009,0.76424,HP_HEREDITARY_NONPOLYPOSIS_COLORECTAL_CARCINOMA,1
GSE40666_UNTREATED_VS_IFNA_S...3,SET,177,-0.043404,-0.0042389,0.060276,0.76426,GSE40666_UNTREATED_VS_IFNA_STIM_EFFECTOR_CD8_TCELL_90MIN_DN,1
HP_NEURODEGENERATION,SET,76,-0.066795,-0.0042864,0.092748,0.76429,HP_NEURODEGENERATION,1
GSE14769_UNSTIM_VS_120MIN_LP...1,SET,194,-0.045054,-0.0046044,0.062557,0.7643,GSE14769_UNSTIM_VS_120MIN_LPS_BMDM_DN,1
HP_NARROW_PALPEBRAL_FISSURE,SET,59,-0.076823,-0.0043457,0.10666,0.76431,HP_NARROW_PALPEBRAL_FISSURE,1
GSE40274_FOXP3_VS_FOXP3_AND_...9,SET,179,-0.044547,-0.0043748,0.061845,0.76432,GSE40274_FOXP3_VS_FOXP3_AND_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
REACTOME_RRNA_PROCESSING_IN_...,SET,6,-0.20549,-0.0037122,0.28523,0.76437,REACTOME_RRNA_PROCESSING_IN_THE_MITOCHONDRION,1
KEGG_MEDICUS_REFERENCE_ICOSL...,SET,8,-0.22415,-0.0046754,0.31109,0.76439,KEGG_MEDICUS_REFERENCE_ICOSLG_ICOS_PI3K_SIGNALING_PATHWAY,1
MIR452_5P,SET,197,-0.042509,-0.0043774,0.058995,0.7644,MIR452_5P,1
GSE40666_NAIVE_VS_EFFECTOR_C...2,SET,177,-0.046451,-0.0045365,0.06446,0.76442,GSE40666_NAIVE_VS_EFFECTOR_CD8_TCELL_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...32,SET,40,-0.086134,-0.0040139,0.11952,0.76443,GAVISH_3CA_MALIGNANT_METAPROGRAM_3_CELL_CYLCE_HMG_RICH,1
GSE21360_NAIVE_VS_SECONDARY_...1,SET,156,-0.049939,-0.0045813,0.069297,0.76443,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_DN,1
MODULE_41,SET,510,-0.027388,-0.0044985,0.037999,0.76447,MODULE_41,1
BECKER_TAMOXIFEN_RESISTANCE_...2,SET,51,-0.088539,-0.0046575,0.12283,0.76448,BECKER_TAMOXIFEN_RESISTANCE_UP,1
GAUCHER_PBMC_YF_VAX_STAMARIL...8,SET,206,-0.043636,-0.0045938,0.060538,0.76448,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_UP,1
HP_WIDENED_SUBARACHNOID_SPACE,SET,28,-0.10967,-0.0042774,0.15215,0.76449,HP_WIDENED_SUBARACHNOID_SPACE,1
GOBP_FUCOSE_CATABOLIC_PROCESS,SET,9,-0.2273,-0.0050286,0.31531,0.7645,GOBP_FUCOSE_CATABOLIC_PROCESS,1
HP_INCREASED_HEMATOCRIT,SET,9,-0.19613,-0.004339,0.27207,0.7645,HP_INCREASED_HEMATOCRIT,1
GOBP_REGULATION_OF_POTASSIUM...2,SET,4,-0.34178,-0.0050416,0.4739,0.76461,GOBP_REGULATION_OF_POTASSIUM_ION_IMPORT,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...5,SET,5,-0.27217,-0.0044886,0.37738,0.76461,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_EXECUTION_PHASE_OF_APOPTOSIS,1
HP_PAROXYSMAL_DYSTONIA,SET,20,-0.13862,-0.0045704,0.19217,0.76465,HP_PAROXYSMAL_DYSTONIA,1
KEGG_RENAL_CELL_CARCINOMA,SET,64,-0.07733,-0.0045553,0.10718,0.7647,KEGG_RENAL_CELL_CARCINOMA,1
GOBP_RESPONSE_TO_INSECTICIDE,SET,6,-0.28247,-0.0051028,0.39137,0.76477,GOBP_RESPONSE_TO_INSECTICIDE,1
GOMF_PHOSPHOLIPASE_A2_ACTIVI...,SET,28,-0.11509,-0.0044888,0.15945,0.76478,GOMF_PHOSPHOLIPASE_A2_ACTIVITY,1
GSE11961_MEMORY_BCELL_DAY40_...1,SET,178,-0.045836,-0.0044889,0.0635,0.76479,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
KENNEDY_PBMC_DRYVAX_AGE_18_5...,SET,11,-0.19182,-0.0046913,0.26572,0.76481,KENNEDY_PBMC_DRYVAX_AGE_18_50YO_STIMULATED_VS_UNSTIMULATED_1_TO_48MO_TOP_DEG_UP,1
HP_NON_PERIODIC_RECURRENT_FE...,SET,11,-0.1756,-0.0042948,0.24316,0.76491,HP_NON_PERIODIC_RECURRENT_FEVER,1
REACTOME_TNFS_BIND_THEIR_PHY...,SET,27,-0.13259,-0.0050783,0.18357,0.76494,REACTOME_TNFS_BIND_THEIR_PHYSIOLOGICAL_RECEPTORS,1
GOBP_POSITIVE_REGULATION_OF_...437,SET,6,-0.27563,-0.0049793,0.38154,0.76498,GOBP_POSITIVE_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
GOMF_L_ASPARTATE_TRANSMEMBRA...,SET,9,-0.19567,-0.004329,0.27083,0.765,GOMF_L_ASPARTATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_DIOL_BIOSYNTHETIC_PROCE...,SET,20,-0.13545,-0.0044657,0.18747,0.76501,GOBP_DIOL_BIOSYNTHETIC_PROCESS,1
GSE22033_WT_VS_PPARG_KO_MEF_...2,SET,174,-0.044197,-0.0042799,0.061162,0.76504,GSE22033_WT_VS_PPARG_KO_MEF_UP,1
SCHAVOLT_TARGETS_OF_TP53_AND...,SET,15,-0.14709,-0.0042004,0.20354,0.76505,SCHAVOLT_TARGETS_OF_TP53_AND_TP63,1
HP_TONGUE_FASCICULATIONS,SET,36,-0.10017,-0.0044288,0.13861,0.76505,HP_TONGUE_FASCICULATIONS,1
GSE5589_LPS_VS_LPS_AND_IL10_...12,SET,183,-0.045677,-0.0045351,0.063202,0.76507,GSE5589_LPS_VS_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
HP_ABNORMALITY_OF_UPPER_LIP_...,SET,387,-0.030594,-0.0043925,0.04233,0.76508,HP_ABNORMALITY_OF_UPPER_LIP_VERMILLION,1
GSE8921_UNSTIM_VS_TLR1_2_STI...3,SET,187,-0.044401,-0.0044558,0.061413,0.76515,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_24H_DN,1
GOBP_NUCLEOSIDE_BISPHOSPHATE...3,SET,111,-0.059625,-0.0046197,0.082459,0.76518,GOBP_NUCLEOSIDE_BISPHOSPHATE_METABOLIC_PROCESS,1
PID_SYNDECAN_1_PATHWAY,SET,43,-0.096596,-0.0046668,0.13358,0.76519,PID_SYNDECAN_1_PATHWAY,1
GOCC_COP9_SIGNALOSOME,SET,31,-0.10475,-0.0042984,0.14486,0.76519,GOCC_COP9_SIGNALOSOME,1
REACTOME_SYNTHESIS_OF_12_EIC...,SET,7,-0.24114,-0.0047052,0.33345,0.76521,REACTOME_SYNTHESIS_OF_12_EICOSATETRAENOIC_ACID_DERIVATIVES,1
GOMF_STRUCTURAL_CONSTITUENT_...8,SET,7,-0.24733,-0.004826,0.34194,0.76525,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
GOMF_NODAL_BINDING,SET,2,-0.50365,-0.0052536,0.69622,0.76528,GOMF_NODAL_BINDING,1
HP_REGIONAL_ABNORMALITY_OF_S...,SET,469,-0.028208,-0.0044482,0.038988,0.76531,HP_REGIONAL_ABNORMALITY_OF_SKIN,1
GSE2770_UNTREATED_VS_IL12_TR...3,SET,180,-0.042944,-0.004229,0.059356,0.76531,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
GOBP_MIRNA_MEDIATED_GENE_SIL...2,SET,8,-0.21252,-0.0044329,0.29364,0.76538,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_MRNA_DESTABILIZATION,1
GATA1_03,SET,218,-0.042045,-0.0045519,0.058077,0.76545,GATA1_03,1
GOBP_VENTRICULAR_SEPTUM_MORP...,SET,40,-0.11197,-0.0052178,0.15466,0.76545,GOBP_VENTRICULAR_SEPTUM_MORPHOGENESIS,1
MIR6749_3P,SET,100,-0.062267,-0.0045805,0.085999,0.76548,MIR6749_3P,1
MIR95_5P,SET,606,-0.025013,-0.0044665,0.034545,0.76549,MIR95_5P,1
GOBP_REGULATION_OF_VASCULATU...,SET,265,-0.039609,-0.0047217,0.054698,0.76551,GOBP_REGULATION_OF_VASCULATURE_DEVELOPMENT,1
GSE20366_EX_VIVO_VS_DEC205_C...1,SET,182,-0.045395,-0.0044949,0.06268,0.76554,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_DN,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...2,SET,69,-0.078688,-0.0048123,0.10862,0.7656,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_UP,1
GOBP_REGULATION_OF_HOMOPHILI...,SET,5,-0.28157,-0.0046436,0.38866,0.76561,GOBP_REGULATION_OF_HOMOPHILIC_CELL_ADHESION,1
MIR3201,SET,74,-0.068826,-0.0043585,0.09497,0.76568,MIR3201,1
GOBP_CEREBELLAR_GRANULAR_LAY...1,SET,12,-0.19368,-0.0049474,0.26723,0.7657,GOBP_CEREBELLAR_GRANULAR_LAYER_DEVELOPMENT,1
MIR769_3P,SET,27,-0.11838,-0.0045341,0.16331,0.76573,MIR769_3P,1
GOBP_NEGATIVE_REGULATION_OF_...410,SET,11,-0.17507,-0.0042818,0.24152,0.76573,GOBP_NEGATIVE_REGULATION_OF_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GSE16451_CTRL_VS_WEST_EQUINE...2,SET,178,-0.046695,-0.0045731,0.064409,0.76576,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_IMMATURE_NEURON_CELL_LINE_UP,1
HP_ABNORMALITY_OF_THE_VERTEB...2,SET,35,-0.10944,-0.0047712,0.15093,0.7658,HP_ABNORMALITY_OF_THE_VERTEBRAL_ENDPLATES,1
GOBP_EMBRYONIC_ORGAN_DEVELOP...,SET,430,-0.03127,-0.0047267,0.04312,0.76583,GOBP_EMBRYONIC_ORGAN_DEVELOPMENT,1
REACTOME_REGULATION_OF_CDH19...,SET,7,-0.23083,-0.004504,0.31816,0.76593,REACTOME_REGULATION_OF_CDH19_EXPRESSION_AND_FUNCTION,1
GOBP_POSITIVE_REGULATION_OF_...708,SET,69,-0.076141,-0.0046566,0.10494,0.76593,GOBP_POSITIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
MODULE_184,SET,28,-0.10905,-0.0042532,0.1503,0.76594,MODULE_184,1
GOBP_NEURON_CELLULAR_HOMEOST...,SET,58,-0.078746,-0.0044167,0.10853,0.76594,GOBP_NEURON_CELLULAR_HOMEOSTASIS,1
GSE14000_UNSTIM_VS_4H_LPS_DC...3,SET,180,-0.043803,-0.0043136,0.06037,0.76594,GSE14000_UNSTIM_VS_4H_LPS_DC_TRANSLATED_RNA_UP,1
GSE3982_EOSINOPHIL_VS_MAST_C...1,SET,174,-0.045978,-0.0044525,0.063361,0.76597,GSE3982_EOSINOPHIL_VS_MAST_CELL_DN,1
HP_THICK_HAIR,SET,19,-0.12685,-0.0040765,0.17478,0.76602,HP_THICK_HAIR,1
GSE29618_PRE_VS_DAY7_POST_TI...3,SET,177,-0.0436,-0.0042581,0.060068,0.76603,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_MDC_DN,1
MODULE_158,SET,41,-0.09313,-0.0043938,0.12828,0.76607,MODULE_158,1
GOMF_JUN_KINASE_BINDING,SET,11,-0.18783,-0.0045938,0.25872,0.76607,GOMF_JUN_KINASE_BINDING,1
HP_U_SHAPED_UPPER_LIP_VERMIL...,SET,6,-0.2034,-0.0036744,0.28014,0.76609,HP_U_SHAPED_UPPER_LIP_VERMILION,1
GSE45365_WT_VS_IFNAR_KO_BCEL...1,SET,149,-0.050235,-0.0045047,0.069186,0.7661,GSE45365_WT_VS_IFNAR_KO_BCELL_DN,1
GSE41867_DAY6_EFFECTOR_VS_DA...2,SET,185,-0.04484,-0.004476,0.061752,0.76612,GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...29,SET,607,-0.025467,-0.0045511,0.03507,0.76613,HP_APLASIA_HYPOPLASIA_OF_THE_EXTREMITIES,1
MIKKELSEN_PARTIALLY_REPROGRA...,SET,9,-0.20875,-0.0046183,0.28744,0.76615,MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY,1
GSE23505_UNTREATED_VS_4DAY_I...4,SET,182,-0.045223,-0.0044778,0.06225,0.76622,GSE23505_UNTREATED_VS_4DAY_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
KEGG_MEDICUS_REFERENCE_DNA_D...,SET,6,-0.26242,-0.0047407,0.36119,0.76624,KEGG_MEDICUS_REFERENCE_DNA_DEGRADATION_BY_EXTRACELLULAR_ENDOLYSOSOMAL_DNASE,1
HP_PANCREATITIS,SET,73,-0.075383,-0.0047414,0.10376,0.76624,HP_PANCREATITIS,1
AACGGTT_MIR451,SET,9,-0.23956,-0.0052999,0.3297,0.76626,AACGGTT_MIR451,1
GOMF_CILIARY_NEUROTROPHIC_FA...,SET,6,-0.24144,-0.0043617,0.33227,0.76627,GOMF_CILIARY_NEUROTROPHIC_FACTOR_RECEPTOR_BINDING,1
GSE17721_CTRL_VS_PAM3CSK4_24...1,SET,180,-0.045208,-0.004452,0.062211,0.76628,GSE17721_CTRL_VS_PAM3CSK4_24H_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...206,SET,9,-0.22715,-0.0050253,0.31252,0.76633,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PIGMENTATION,1
PHESSE_TARGETS_OF_APC_AND_MB...1,SET,9,-0.23286,-0.0051517,0.32032,0.76637,PHESSE_TARGETS_OF_APC_AND_MBD2_DN,1
GOBP_PROTEIN_DNA_COMPLEX_ASS...,SET,147,-0.047887,-0.0042655,0.06587,0.76638,GOBP_PROTEIN_DNA_COMPLEX_ASSEMBLY,1
MIR10527_5P,SET,531,-0.028114,-0.0047091,0.038665,0.76641,MIR10527_5P,1
HP_HEMIHYPERTROPHY,SET,14,-0.16064,-0.0044318,0.22091,0.76643,HP_HEMIHYPERTROPHY,1
FONTAINE_FOLLICULAR_THYROID_...2,SET,71,-0.070724,-0.0043873,0.097256,0.76644,FONTAINE_FOLLICULAR_THYROID_ADENOMA_UP,1
HP_INFANTILE_ONSET,SET,1172,-0.018262,-0.0044621,0.025113,0.76644,HP_INFANTILE_ONSET,1
GOBP_PROTEIN_LOCALIZATION_TO...12,SET,95,-0.058814,-0.0042175,0.080871,0.76646,GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
chr2p15,SET,15,-0.20835,-0.0059499,0.28647,0.76647,chr2p15,1
PID_NEPHRIN_NEPH1_PATHWAY,SET,30,-0.10952,-0.0044213,0.15059,0.76647,PID_NEPHRIN_NEPH1_PATHWAY,1
DESCARTES_FETAL_LIVER_LYMPHO...,SET,90,-0.070065,-0.004891,0.096297,0.76656,DESCARTES_FETAL_LIVER_LYMPHOID_CELLS,1
GOBP_REGULATION_OF_HEART_GRO...,SET,55,-0.090577,-0.0049475,0.12447,0.76659,GOBP_REGULATION_OF_HEART_GROWTH,1
GOMF_GAP_JUNCTION_HEMI_CHANN...,SET,6,-0.29729,-0.0053706,0.40852,0.76661,GOMF_GAP_JUNCTION_HEMI_CHANNEL_ACTIVITY,1
GOBP_EMBRYONIC_DIGESTIVE_TRA...1,SET,33,-0.12191,-0.0051611,0.16751,0.76662,GOBP_EMBRYONIC_DIGESTIVE_TRACT_DEVELOPMENT,1
KEGG_MEDICUS_VARIANT_MUTATIO...91,SET,38,-0.08687,-0.003946,0.11935,0.76665,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_VCP_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
GOBP_REGULATION_OF_PROTEIN_C...2,SET,11,-0.17991,-0.0044,0.2471,0.76671,GOBP_REGULATION_OF_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
HOEK_B_CELL_2011_2012_TIV_AD...2,SET,3,-0.35936,-0.0045909,0.49353,0.76673,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_DN,1
GOBP_REGULATION_OF_TOLL_LIKE...3,SET,28,-0.11404,-0.0044479,0.1566,0.76676,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
HE_LIM_SUN_FETAL_LUNG_C7_COL...,SET,65,-0.083757,-0.0049722,0.11501,0.76676,HE_LIM_SUN_FETAL_LUNG_C7_COL20A1_POS_SCHWANN_CELL,1
MIR6731_5P,SET,207,-0.04344,-0.0045841,0.05962,0.76688,MIR6731_5P,1
GSE1432_6H_VS_24H_IFNG_MICRO...2,SET,178,-0.04592,-0.0044971,0.063008,0.76693,GSE1432_6H_VS_24H_IFNG_MICROGLIA_UP,1
GOBP_REGULATION_OF_PROTEIN_B...,SET,112,-0.05743,-0.0044695,0.078796,0.76695,GOBP_REGULATION_OF_PROTEIN_BINDING,1
HP_HYPOPLASTIC_DERMOEPIDERMA...,SET,7,-0.25336,-0.0049436,0.34757,0.76698,HP_HYPOPLASTIC_DERMOEPIDERMAL_HEMIDESMOSOMES,1
GOBP_CARNITINE_TRANSMEMBRANE...,SET,6,-0.32196,-0.0058164,0.4416,0.76702,GOBP_CARNITINE_TRANSMEMBRANE_TRANSPORT,1
VALK_AML_CLUSTER_16,SET,22,-0.13446,-0.0046491,0.18436,0.76709,VALK_AML_CLUSTER_16,1
GOBP_NEGATIVE_REGULATION_OF_...207,SET,12,-0.19928,-0.0050903,0.27316,0.76715,GOBP_NEGATIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
GOBP_REGULATION_OF_PROTEIN_T...4,SET,40,-0.099085,-0.0046175,0.13581,0.76718,GOBP_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
MIR6865_5P,SET,55,-0.080634,-0.0044044,0.1105,0.76721,MIR6865_5P,1
GOBP_RESPONSE_TO_LIGHT_INTEN...,SET,15,-0.16206,-0.004628,0.22207,0.76724,GOBP_RESPONSE_TO_LIGHT_INTENSITY,1
REACTOME_VXPX_CARGO_TARGETIN...,SET,20,-0.13194,-0.0043499,0.18076,0.76727,REACTOME_VXPX_CARGO_TARGETING_TO_CILIUM,1
BIOCARTA_VDR_PATHWAY,SET,24,-0.11857,-0.0042819,0.16243,0.76729,BIOCARTA_VDR_PATHWAY,1
REACTOME_CD28_DEPENDENT_PI3K...,SET,22,-0.1401,-0.0048443,0.19193,0.76729,REACTOME_CD28_DEPENDENT_PI3K_AKT_SIGNALING,1
HP_THIN_VERMILION_BORDER,SET,346,-0.032943,-0.0044773,0.045127,0.7673,HP_THIN_VERMILION_BORDER,1
KEGG_MEDICUS_REFERENCE_COHES...1,SET,4,-0.27037,-0.0039883,0.37035,0.76731,KEGG_MEDICUS_REFERENCE_COHESIN_ACETYLATION,1
GOBP_NEGATIVE_REGULATION_OF_...569,SET,8,-0.24077,-0.0050222,0.32974,0.76736,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TUMOR_CELL,1
GOMF_METAL_DEPENDENT_DEUBIQU...,SET,11,-0.19867,-0.0048589,0.27206,0.76737,GOMF_METAL_DEPENDENT_DEUBIQUITINASE_ACTIVITY,1
TRAVAGLINI_LUNG_NATURAL_KILL...2,SET,30,-0.12776,-0.0051574,0.17494,0.76738,TRAVAGLINI_LUNG_NATURAL_KILLER_T_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...75,SET,47,-0.085404,-0.0043133,0.11694,0.7674,GOBP_NEGATIVE_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
GSE29949_MICROGLIA_BRAIN_VS_...2,SET,180,-0.046812,-0.00461,0.064097,0.7674,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_UP,1
BIOCARTA_TOB1_PATHWAY,SET,19,-0.15105,-0.0048541,0.20674,0.76749,BIOCARTA_TOB1_PATHWAY,1
HP_CLOSED_NEURAL_TUBE_DEFECT,SET,67,-0.077445,-0.0046674,0.10599,0.7675,HP_CLOSED_NEURAL_TUBE_DEFECT,1
HP_ABNORMALITY_OF_RETINAL_PI...,SET,283,-0.036486,-0.0044926,0.049935,0.76751,HP_ABNORMALITY_OF_RETINAL_PIGMENTATION,1
HES2_TARGET_GENES,SET,1002,-0.02028,-0.0046044,0.027748,0.76757,HES2_TARGET_GENES,1
GOBP_GLOMERULUS_VASCULATURE_...,SET,6,-0.28905,-0.0052217,0.39542,0.7676,GOBP_GLOMERULUS_VASCULATURE_MORPHOGENESIS,1
HP_PANCREATIC_HYPOPLASIA,SET,24,-0.13754,-0.0049671,0.18816,0.7676,HP_PANCREATIC_HYPOPLASIA,1
BENPORATH_EED_TARGETS,SET,903,-0.023433,-0.0050649,0.032056,0.76761,BENPORATH_EED_TARGETS,1
GSE17721_0.5H_VS_12H_GARDIQU...1,SET,189,-0.044061,-0.0044451,0.060268,0.76763,GSE17721_0.5H_VS_12H_GARDIQUIMOD_BMDC_DN,1
chr8p12,SET,22,-0.25444,-0.0087978,0.34799,0.76766,chr8p12,1
HP_REDUCED_FACTOR_VII_ACTIVI...,SET,5,-0.26756,-0.0044125,0.36593,0.76766,HP_REDUCED_FACTOR_VII_ACTIVITY,1
WP_NICOTINE_METABOLISM_IN_LI...,SET,6,-0.30922,-0.0055861,0.42285,0.76769,WP_NICOTINE_METABOLISM_IN_LIVER_CELLS,1
CHIARADONNA_NEOPLASTIC_TRANS...1,SET,135,-0.054007,-0.0046116,0.073841,0.76772,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN,1
MIR3074_5P,SET,136,-0.05459,-0.0046785,0.074609,0.76781,MIR3074_5P,1
GOBP_OTOLITH_DEVELOPMENT,SET,10,-0.2096,-0.0048877,0.28643,0.76783,GOBP_OTOLITH_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...533,SET,9,-0.21583,-0.0047749,0.29494,0.76784,GOBP_POSITIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,1
PID_HES_HEY_PATHWAY,SET,45,-0.097576,-0.0048223,0.13332,0.76787,PID_HES_HEY_PATHWAY,1
GSE22432_MULTIPOTENT_PROGENI...4,SET,187,-0.044511,-0.0044669,0.06082,0.76787,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_UP,1
GOCC_FC_RECEPTOR_COMPLEX,SET,5,-0.31032,-0.0051177,0.42383,0.76797,GOCC_FC_RECEPTOR_COMPLEX,1
GR_01,SET,183,-0.046917,-0.0046582,0.064062,0.76802,GR_01,1
GOMF_RNA_DNA_HYBRID_RIBONUCL...,SET,6,-0.28614,-0.0051692,0.3906,0.76808,GOMF_RNA_DNA_HYBRID_RIBONUCLEASE_ACTIVITY,1
GOCC_CLATHRIN_COMPLEX,SET,8,-0.20594,-0.0042956,0.28102,0.76816,GOCC_CLATHRIN_COMPLEX,1
CHIANG_LIVER_CANCER_SUBCLASS...2,SET,154,-0.052937,-0.0048254,0.072236,0.76817,CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_UP,1
GOBP_ANGIOGENESIS_INVOLVED_I...2,SET,27,-0.12769,-0.0048905,0.17423,0.76817,GOBP_ANGIOGENESIS_INVOLVED_IN_WOUND_HEALING,1
HP_MIXED_DEMYELINATING_AND_A...,SET,3,-0.35445,-0.0045281,0.48365,0.76817,HP_MIXED_DEMYELINATING_AND_AXONAL_POLYNEUROPATHY,1
GSE40441_NRP1_POS_INDUCED_TR...1,SET,181,-0.043814,-0.0043266,0.059778,0.7682,GSE40441_NRP1_POS_INDUCED_TREG_VS_NRP1_NEG_NATURAL_TREG_DN,1
GOBP_HEART_TRABECULA_MORPHOG...,SET,31,-0.1237,-0.0050759,0.16856,0.76848,GOBP_HEART_TRABECULA_MORPHOGENESIS,1
BIOCARTA_FBW7_PATHWAY,SET,9,-0.22028,-0.0048734,0.30015,0.76849,BIOCARTA_FBW7_PATHWAY,1
HP_ACRAL_BLISTERING,SET,9,-0.19764,-0.0043725,0.26924,0.76854,HP_ACRAL_BLISTERING,1
MIR6827_5P,SET,75,-0.067967,-0.0043329,0.092584,0.76855,MIR6827_5P,1
MIR6798_5P,SET,42,-0.093602,-0.0044694,0.12748,0.76859,MIR6798_5P,1
GSE360_L_DONOVANI_VS_B_MALAY...8,SET,186,-0.046093,-0.0046134,0.062775,0.7686,GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_UP,1
GOBP_DOPAMINE_RECEPTOR_SIGNA...,SET,37,-0.10559,-0.0047328,0.14375,0.76867,GOBP_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_RAB_GERANYLGERANYLA...,SET,57,-0.08238,-0.0045806,0.11213,0.76872,REACTOME_RAB_GERANYLGERANYLATION,1
MIR5197_5P,SET,164,-0.048329,-0.0045448,0.065762,0.7688,MIR5197_5P,1
AGCGCTT_MIR518F_MIR518E_MIR5...,SET,16,-0.15102,-0.004454,0.20549,0.76881,AGCGCTT_MIR518F_MIR518E_MIR518A,1
MODULE_21,SET,9,-0.19398,-0.0042915,0.26383,0.7689,MODULE_21,1
MODULE_56,SET,9,-0.19398,-0.0042915,0.26383,0.7689,MODULE_56,1
GOBP_CHOLESTEROL_IMPORT,SET,9,-0.23057,-0.005101,0.31359,0.7689,GOBP_CHOLESTEROL_IMPORT,1
WP_MAMMARY_GLAND_DEVELOPMENT...1,SET,15,-0.17229,-0.00492,0.23432,0.76891,WP_MAMMARY_GLAND_DEVELOPMENT_EMBRYONIC_DEVELOPMENT_STAGE_1_OF_4,1
MIR5187_5P,SET,98,-0.06304,-0.004591,0.085729,0.76893,MIR5187_5P,1
GOBP_NEGATIVE_REGULATION_OF_...306,SET,3,-0.39977,-0.0051071,0.54356,0.76897,GOBP_NEGATIVE_REGULATION_OF_INTERLEUKIN_18_PRODUCTION,1
GOBP_REGULATION_OF_PROSTAGLA...,SET,14,-0.19578,-0.0054013,0.26619,0.76897,GOBP_REGULATION_OF_PROSTAGLANDIN_SECRETION,1
GSE3920_IFNA_VS_IFNB_TREATED...1,SET,151,-0.051293,-0.0046301,0.069729,0.76901,GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN,1
GOBP_RENAL_SODIUM_EXCRETION,SET,11,-0.19827,-0.004849,0.26949,0.76904,GOBP_RENAL_SODIUM_EXCRETION,1
MORF_TERF2IP,SET,109,-0.052715,-0.0040476,0.07165,0.76905,MORF_TERF2IP,1
TRAVAGLINI_LUNG_SIGNALING_AL...,SET,67,-0.082819,-0.0049913,0.11254,0.7691,TRAVAGLINI_LUNG_SIGNALING_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,1
GSE5542_IFNG_VS_IFNA_TREATED...2,SET,178,-0.043491,-0.0042592,0.059097,0.76911,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,1
GCNP_SHH_UP_EARLY.V1_DN,SET,150,-0.051008,-0.0045893,0.069291,0.76917,GCNP_SHH_UP_EARLY.V1_DN,1
MIR6811_5P,SET,66,-0.079456,-0.0047529,0.10792,0.7692,MIR6811_5P,1
GSE36392_TYPE_2_MYELOID_VS_E...1,SET,176,-0.04807,-0.0046815,0.06529,0.76921,GSE36392_TYPE_2_MYELOID_VS_EOSINOPHIL_IL25_TREATED_LUNG_DN,1
MIR136_5P,SET,102,-0.062046,-0.0046094,0.084264,0.76923,MIR136_5P,1
STAMBOLSKY_RESPONSE_TO_VITAM...2,SET,75,-0.073193,-0.0046661,0.099387,0.76927,STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_UP,1
HP_VENTRICULAR_HYPERTROPHY,SET,138,-0.050035,-0.0043193,0.067932,0.7693,HP_VENTRICULAR_HYPERTROPHY,1
TAAYNRNNTCC_UNKNOWN,SET,159,-0.049925,-0.0046235,0.06778,0.76931,TAAYNRNNTCC_UNKNOWN,1
YATTNATC_UNKNOWN,SET,340,-0.035635,-0.0048017,0.048358,0.7694,YATTNATC_UNKNOWN,1
chr1p13,SET,106,-0.13082,-0.0099061,0.17749,0.76944,chr1p13,1
HP_ABNORMAL_NERVE_CONDUCTION...,SET,104,-0.058519,-0.0043896,0.0794,0.76944,HP_ABNORMAL_NERVE_CONDUCTION_VELOCITY,1
MIR5681A,SET,135,-0.051922,-0.0044336,0.070445,0.76945,MIR5681A,1
VAN_DEN_BIGGELAAR_PBMC_PREVN...3,SET,102,-0.057755,-0.0042906,0.078361,0.76945,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_UP,1
GOBP_SEQUESTERING_OF_EXTRACE...,SET,10,-0.21616,-0.0050407,0.29324,0.76948,GOBP_SEQUESTERING_OF_EXTRACELLULAR_LIGAND_FROM_RECEPTOR,1
HP_ABNORMAL_EMOTION,SET,598,-0.025646,-0.0045502,0.03479,0.76948,HP_ABNORMAL_EMOTION,1
CTAWWWATA_RSRFC4_Q2,SET,324,-0.03544,-0.0046639,0.048075,0.76949,CTAWWWATA_RSRFC4_Q2,1
WANG_MLL_TARGETS,SET,273,-0.040455,-0.0048938,0.054872,0.76951,WANG_MLL_TARGETS,1
GOBP_RRNA_CATABOLIC_PROCESS,SET,12,-0.15072,-0.0038499,0.20442,0.76951,GOBP_RRNA_CATABOLIC_PROCESS,1
GSE2706_UNSTIM_VS_8H_R848_DC...2,SET,172,-0.047268,-0.0045512,0.064115,0.76951,GSE2706_UNSTIM_VS_8H_R848_DC_UP,1
HP_ABSENT_LACRIMAL_PUNCTUM,SET,6,-0.26499,-0.0047871,0.3593,0.76959,HP_ABSENT_LACRIMAL_PUNCTUM,1
GOBP_POSITIVE_REGULATION_OF_...132,SET,99,-0.066388,-0.0048593,0.090005,0.76962,GOBP_POSITIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,1
MIR513A_3P_MIR513C_3P,SET,409,-0.030982,-0.0045701,0.042001,0.76963,MIR513A_3P_MIR513C_3P,1
GOBP_MITOCHONDRIAL_FISSION,SET,37,-0.10749,-0.0048182,0.1457,0.76967,GOBP_MITOCHONDRIAL_FISSION,1
GOBP_REGULATION_OF_FATTY_ACI...4,SET,31,-0.11391,-0.0046742,0.15436,0.76972,GOBP_REGULATION_OF_FATTY_ACID_OXIDATION,1
HP_MOTOR_NEURON_ATROPHY,SET,61,-0.076537,-0.004402,0.10372,0.76972,HP_MOTOR_NEURON_ATROPHY,1
GOBP_EYE_PHOTORECEPTOR_CELL_...2,SET,49,-0.093271,-0.0048095,0.12637,0.76975,GOBP_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,1
WP_RIOK1_AND_RIOK2_IN_EGFR_A...,SET,15,-0.16526,-0.0047193,0.2239,0.76977,WP_RIOK1_AND_RIOK2_IN_EGFR_AND_PI3KMEDIATED_TUMORIGENESIS,1
GSE41867_NAIVE_VS_DAY15_LCMV...4,SET,145,-0.052621,-0.0046555,0.071285,0.76979,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_UP,1
GSE17721_LPS_VS_PAM3CSK4_8H_...2,SET,182,-0.045403,-0.0044957,0.061504,0.7698,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_UP,1
KEGG_MEDICUS_VARIANT_DUPLICA...3,SET,14,-0.16211,-0.0044724,0.21956,0.76984,KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY,1
GOBP_BRONCHUS_DEVELOPMENT,SET,11,-0.21289,-0.0052068,0.2883,0.76987,GOBP_BRONCHUS_DEVELOPMENT,1
FOSTER_TOLERANT_MACROPHAGE_DN,SET,383,-0.033983,-0.0048543,0.046012,0.76991,FOSTER_TOLERANT_MACROPHAGE_DN,1
HP_PROTRUSIO_ACETABULI,SET,12,-0.19715,-0.0050359,0.26688,0.76995,HP_PROTRUSIO_ACETABULI,1
HOFMANN_MYELODYSPLASTIC_SYND...4,SET,20,-0.13986,-0.0046112,0.1893,0.76999,HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP,1
GOBP_POSITIVE_REGULATION_OF_...748,SET,22,-0.13268,-0.0045876,0.17957,0.77,GOBP_POSITIVE_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
chr12q12,SET,24,-0.2251,-0.0081289,0.30462,0.77003,chr12q12,1
BASAKI_YBX1_TARGETS_DN,SET,350,-0.034659,-0.0047372,0.046902,0.77003,BASAKI_YBX1_TARGETS_DN,1
GSE36888_UNTREATED_VS_IL2_TR...3,SET,173,-0.04681,-0.0045201,0.063318,0.77013,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_2H_DN,1
HP_DECREASED_CIRCULATING_ACT...,SET,28,-0.11612,-0.004529,0.15705,0.77017,HP_DECREASED_CIRCULATING_ACTH_CONCENTRATION,1
GOBP_SYNAPTIC_MEMBRANE_ADHES...,SET,26,-0.13988,-0.0052574,0.18917,0.77018,GOBP_SYNAPTIC_MEMBRANE_ADHESION,1
HP_HERPES_SIMPLEX_ENCEPHALIT...,SET,9,-0.20532,-0.0045424,0.27764,0.7702,HP_HERPES_SIMPLEX_ENCEPHALITIS,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...2,SET,16,-0.15948,-0.0047034,0.21564,0.77021,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_2,1
FOURATI_BLOOD_TWINRIX_AGE_65...2,SET,5,-0.28102,-0.0046345,0.3799,0.77026,FOURATI_BLOOD_TWINRIX_AGE_65_81YO_RESPONDERS_VS_POOR_RESPONDERS_TRAINING_SET_0DY_NETWORK_INFERENCE_DN,1
GOBP_ARGININE_BIOSYNTHETIC_P...,SET,4,-0.27729,-0.0040904,0.37478,0.77031,GOBP_ARGININE_BIOSYNTHETIC_PROCESS,1
MIR4685_3P,SET,117,-0.057405,-0.0045656,0.077583,0.77032,MIR4685_3P,1
TAATAAT_MIR126,SET,201,-0.047665,-0.0049573,0.064414,0.77034,TAATAAT_MIR126,1
HP_THORACIC_PLATYSPONDYLY,SET,6,-0.2279,-0.0041171,0.30791,0.77039,HP_THORACIC_PLATYSPONDYLY,1
GOBP_L_AMINO_ACID_TRANSPORT,SET,88,-0.06936,-0.0047879,0.093688,0.77044,GOBP_L_AMINO_ACID_TRANSPORT,1
GSE17974_CTRL_VS_ACT_IL4_AND...17,SET,169,-0.04638,-0.004427,0.062644,0.77046,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_72H_CD4_TCELL_DN,1
KRAS.300_UP.V1_DN,SET,125,-0.057652,-0.0047383,0.077864,0.77047,KRAS.300_UP.V1_DN,1
GOBP_NEGATIVE_REGULATION_OF_...193,SET,8,-0.23898,-0.0049849,0.32276,0.77048,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_TRANSCRIPTION_INITIATION,1
GSE29164_DAY3_VS_DAY7_CD8_TC...3,SET,184,-0.0457,-0.0045496,0.061709,0.77052,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_DN,1
GOBP_THYROID_HORMONE_GENERAT...,SET,22,-0.13862,-0.0047931,0.18717,0.77054,GOBP_THYROID_HORMONE_GENERATION,1
DAIRKEE_CANCER_PRONE_RESPONS...2,SET,107,-0.058826,-0.0044754,0.079422,0.77055,DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2,1
REACTOME_CARGO_CONCENTRATION...,SET,31,-0.10641,-0.0043664,0.14366,0.77055,REACTOME_CARGO_CONCENTRATION_IN_THE_ER,1
GENTILE_UV_RESPONSE_CLUSTER_...6,SET,30,-0.10988,-0.0044356,0.14832,0.77059,GENTILE_UV_RESPONSE_CLUSTER_D7,1
VILLANUEVA_LIVER_CANCER_KRT1...1,SET,55,-0.082391,-0.0045004,0.11119,0.77064,VILLANUEVA_LIVER_CANCER_KRT19_DN,1
GOBP_KIDNEY_EPITHELIUM_DEVEL...,SET,143,-0.058505,-0.0051405,0.078943,0.77068,GOBP_KIDNEY_EPITHELIUM_DEVELOPMENT,1
GSE360_DC_VS_MAC_L_DONOVANI_...2,SET,189,-0.046294,-0.0046703,0.062466,0.77068,GSE360_DC_VS_MAC_L_DONOVANI_UP,1
GOBP_MITOTIC_NUCLEAR_MEMBRAN...2,SET,10,-0.17995,-0.0041964,0.24278,0.77072,GOBP_MITOTIC_NUCLEAR_MEMBRANE_ORGANIZATION,1
HP_ABNORMAL_CIRCULATING_ALDO...1,SET,21,-0.12387,-0.0041848,0.16705,0.7708,HP_ABNORMAL_CIRCULATING_ALDOLASE_CONCENTRATION,1
BIOCARTA_RANBP2_PATHWAY,SET,10,-0.20054,-0.0046766,0.27042,0.77083,BIOCARTA_RANBP2_PATHWAY,1
GOBP_RIBONUCLEOSIDE_METABOLI...,SET,32,-0.13566,-0.0056557,0.18279,0.77099,GOBP_RIBONUCLEOSIDE_METABOLIC_PROCESS,1
HP_ABNORMAL_EPIPHYSIS_MORPHO...1,SET,246,-0.039895,-0.0045846,0.053755,0.771,HP_ABNORMAL_EPIPHYSIS_MORPHOLOGY,1
GOBP_ORGANISM_EMERGENCE_FROM...,SET,22,-0.13018,-0.0045014,0.1754,0.77101,GOBP_ORGANISM_EMERGENCE_FROM_PROTECTIVE_STRUCTURE,1
GSE34205_HEALTHY_VS_RSV_INF_...1,SET,170,-0.048458,-0.0046389,0.065286,0.77103,GSE34205_HEALTHY_VS_RSV_INF_INFANT_PBMC_DN,1
GSE36392_EOSINOPHIL_VS_MAC_I...2,SET,176,-0.048349,-0.0047086,0.065121,0.77109,GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP,1
REACTOME_BASE_EXCISION_REPAI...,SET,17,-0.1422,-0.0043227,0.1915,0.77111,REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION,1
GSE17721_LPS_VS_PAM3CSK4_16H...1,SET,182,-0.047091,-0.0046628,0.063399,0.77118,GSE17721_LPS_VS_PAM3CSK4_16H_BMDC_DN,1
GOBP_REACTIVE_OXYGEN_SPECIES...2,SET,201,-0.045949,-0.0047788,0.061855,0.77121,GOBP_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
MIR6828_5P,SET,159,-0.04912,-0.0045489,0.066118,0.77123,MIR6828_5P,1
GOMF_HISTONE_METHYLTRANSFERA...2,SET,13,-0.15294,-0.0040662,0.20585,0.77125,GOMF_HISTONE_METHYLTRANSFERASE_BINDING,1
HP_UNCONTROLLED_EYE_MOVEMENTS,SET,8,-0.26414,-0.0055097,0.3554,0.77133,HP_UNCONTROLLED_EYE_MOVEMENTS,1
GOBP_METANEPHRIC_MESENCHYMAL...,SET,5,-0.32249,-0.0053184,0.43374,0.77141,GOBP_METANEPHRIC_MESENCHYMAL_CELL_DIFFERENTIATION,1
GSE3982_MAST_CELL_VS_DC_UP,SET,161,-0.048185,-0.00449,0.064792,0.77146,GSE3982_MAST_CELL_VS_DC_UP,1
GOBP_POSITIVE_REGULATION_OF_...510,SET,14,-0.16934,-0.0046718,0.22767,0.77149,GOBP_POSITIVE_REGULATION_OF_MYOBLAST_FUSION,1
HU_FETAL_RETINA_AMACRINE,SET,57,-0.093227,-0.0051838,0.12531,0.77155,HU_FETAL_RETINA_AMACRINE,1
GSE3720_VD1_VS_VD2_GAMMADELT...2,SET,171,-0.04725,-0.0045364,0.063505,0.77157,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_UP,1
HP_CHOROID_PLEXUS_CYST,SET,10,-0.2189,-0.0051048,0.29419,0.77159,HP_CHOROID_PLEXUS_CYST,1
GREGORY_SYNTHETIC_LETHAL_WIT...,SET,128,-0.054411,-0.004525,0.073121,0.7716,GREGORY_SYNTHETIC_LETHAL_WITH_IMATINIB,1
GOMF_CLATHRIN_LIGHT_CHAIN_BI...,SET,6,-0.22731,-0.0041064,0.30547,0.7716,GOMF_CLATHRIN_LIGHT_CHAIN_BINDING,1
GOCC_GLIAL_CELL_PROJECTION,SET,38,-0.11102,-0.0050431,0.14912,0.77171,GOCC_GLIAL_CELL_PROJECTION,1
LINDGREN_BLADDER_CANCER_CLUS...2,SET,104,-0.062607,-0.0046962,0.084061,0.77179,LINDGREN_BLADDER_CANCER_CLUSTER_1_UP,1
GOBP_NEGATIVE_REGULATION_OF_...106,SET,181,-0.04937,-0.0048752,0.066278,0.77183,GOBP_NEGATIVE_REGULATION_OF_CELL_CELL_ADHESION,1
GOCC_COSTAMERE,SET,16,-0.1586,-0.0046776,0.21287,0.77188,GOCC_COSTAMERE,1
GOBP_POSITIVE_REGULATION_OF_...125,SET,239,-0.040773,-0.0046192,0.05472,0.77189,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...636,SET,11,-0.19902,-0.0048674,0.26707,0.77192,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_4_SIGNALING_PATHWAY,1
GSE17721_LPS_VS_POLYIC_1H_BM...1,SET,180,-0.04477,-0.0044088,0.06006,0.77198,GSE17721_LPS_VS_POLYIC_1H_BMDC_DN,1
HP_ABNORMAL_SKIN_MORPHOLOGY_...,SET,361,-0.032881,-0.0045628,0.044109,0.77199,HP_ABNORMAL_SKIN_MORPHOLOGY_OF_THE_PALM,1
GOBP_MITOCHONDRIAL_PROTEIN_P...,SET,12,-0.16997,-0.0043418,0.22801,0.772,GOBP_MITOCHONDRIAL_PROTEIN_PROCESSING,1
GRABARCZYK_BCL11B_TARGETS_DN,SET,56,-0.082885,-0.0045682,0.11118,0.77201,GRABARCZYK_BCL11B_TARGETS_DN,1
PID_RHOA_PATHWAY,SET,42,-0.1004,-0.0047938,0.13462,0.77209,PID_RHOA_PATHWAY,1
GSE21927_SPLENIC_C26GM_TUMOR...4,SET,135,-0.053911,-0.0046034,0.07228,0.77212,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_BONE_MARROW_MONOCYTES_UP,1
GOBP_NEGATIVE_REGULATION_OF_...276,SET,21,-0.13965,-0.0047179,0.18718,0.77219,GOBP_NEGATIVE_REGULATION_OF_HIPPO_SIGNALING,1
GSE37301_PRO_BCELL_VS_CD4_TC...1,SET,150,-0.052208,-0.0046972,0.069975,0.77219,GSE37301_PRO_BCELL_VS_CD4_TCELL_DN,1
KEGG_MEDICUS_REFERENCE_BMP_S...2,SET,14,-0.18049,-0.0049796,0.24186,0.77224,KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST,1
MIR10524_5P,SET,79,-0.073245,-0.0047917,0.098138,0.77226,MIR10524_5P,1
GCM_ING1,SET,61,-0.0698,-0.0040146,0.093518,0.77228,GCM_ING1,1
WP_MONOAMINE_GPCRS,SET,32,-0.12069,-0.0050315,0.16164,0.77236,WP_MONOAMINE_GPCRS,1
GCAAGGA_MIR502,SET,65,-0.074571,-0.0044268,0.099864,0.77238,GCAAGGA_MIR502,1
GOBP_POSITIVE_REGULATION_OF_...140,SET,5,-0.33019,-0.0054454,0.44212,0.77241,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_HEART_MORPHOGENESIS,1
GSE11961_GERMINAL_CENTER_BCE...3,SET,184,-0.047862,-0.0047649,0.064074,0.77246,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_MEMORY_BCELL_DAY40_DN,1
HP_ABNORMAL_ERYTHROCYTE_PHYS...,SET,15,-0.17604,-0.0050272,0.23563,0.7725,HP_ABNORMAL_ERYTHROCYTE_PHYSIOLOGY,1
GOBP_TRANSLATIONAL_READTHROU...,SET,8,-0.2381,-0.0049664,0.31867,0.77251,GOBP_TRANSLATIONAL_READTHROUGH,1
GOCC_MEMBRANE_MICRODOMAIN,SET,270,-0.039644,-0.0047697,0.05305,0.77255,GOCC_MEMBRANE_MICRODOMAIN,1
GOBP_NEGATIVE_REGULATION_OF_...361,SET,151,-0.055048,-0.0049691,0.073647,0.7726,GOBP_NEGATIVE_REGULATION_OF_LYMPHOCYTE_ACTIVATION,1
KYNG_DNA_DAMAGE_UP,SET,188,-0.046275,-0.0046562,0.061908,0.77261,KYNG_DNA_DAMAGE_UP,1
HP_ABNORMAL_FUNDUS_MORPHOLOGY,SET,1215,-0.018376,-0.004566,0.024569,0.77275,HP_ABNORMAL_FUNDUS_MORPHOLOGY,1
GSE17186_NAIVE_VS_CD21LOW_TR...2,SET,175,-0.045276,-0.0043969,0.060528,0.77277,GSE17186_NAIVE_VS_CD21LOW_TRANSITIONAL_BCELL_CORD_BLOOD_UP,1
HP_HEMOGLOBINURIA,SET,8,-0.21426,-0.0044691,0.28641,0.77279,HP_HEMOGLOBINURIA,1
GOBP_CARDIAC_CELL_FATE_COMMI...,SET,12,-0.21181,-0.0054105,0.28305,0.77286,GOBP_CARDIAC_CELL_FATE_COMMITMENT,1
LAKE_ADULT_KIDNEY_C11_THIN_A...,SET,158,-0.052034,-0.0048037,0.069522,0.7729,LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB,1
HP_DECREASED_PROPORTION_OF_C...2,SET,8,-0.21755,-0.0045379,0.29065,0.77291,HP_DECREASED_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...473,SET,14,-0.14586,-0.0040242,0.19486,0.77294,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_TRANSLATION,1
HP_APNEA,SET,213,-0.042853,-0.0045864,0.057245,0.77294,HP_APNEA,1
GTF3A_TARGET_GENES,SET,12,-0.18199,-0.0046488,0.24304,0.77301,GTF3A_TARGET_GENES,1
WP_INTERLEUKIN1_INDUCED_ACTI...,SET,9,-0.2116,-0.0046812,0.28255,0.77303,WP_INTERLEUKIN1_INDUCED_ACTIVATION_OF_NFKB,1
GOBP_FRUCTOSE_TRANSMEMBRANE_...,SET,9,-0.20935,-0.0046316,0.27956,0.77303,GOBP_FRUCTOSE_TRANSMEMBRANE_TRANSPORT,1
MIR4659A_5P,SET,73,-0.074288,-0.0046726,0.099194,0.77304,MIR4659A_5P,1
GSE18791_UNSTIM_VS_NEWCATSLE...8,SET,135,-0.055787,-0.0047637,0.074479,0.77308,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_UP,1
HMG20B_TARGET_GENES,SET,1493,-0.017206,-0.0047005,0.022967,0.77311,HMG20B_TARGET_GENES,1
GSE2770_UNTREATED_VS_TGFB_AN...2,SET,184,-0.046631,-0.0046423,0.062244,0.77311,GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
CHARAFE_BREAST_CANCER_LUMINA...4,SET,401,-0.032346,-0.0047255,0.043172,0.77314,CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP,1
GOBP_PYRIMIDINE_NUCLEOSIDE_T...1,SET,17,-0.15477,-0.0047048,0.20657,0.77314,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...104,SET,207,-0.043831,-0.0046254,0.058498,0.77315,GOBP_POSITIVE_REGULATION_OF_CELLULAR_CATABOLIC_PROCESS,1
GSE19941_UNSTIM_VS_LPS_AND_I...1,SET,184,-0.045198,-0.0044997,0.060323,0.77315,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,1
GSE39916_B_CELL_SPLEEN_VS_PL...2,SET,181,-0.048597,-0.0047989,0.064856,0.77316,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_UP,1
HP_CONGENITAL_MALFORMATION_O...1,SET,454,-0.029778,-0.004622,0.039738,0.77317,HP_CONGENITAL_MALFORMATION_OF_THE_GREAT_ARTERIES,1
GOCC_FEMALE_GERM_CELL_NUCLEUS,SET,14,-0.17078,-0.0047117,0.22789,0.77318,GOCC_FEMALE_GERM_CELL_NUCLEUS,1
HP_PROBOSCIS,SET,16,-0.15852,-0.0046751,0.21151,0.7732,HP_PROBOSCIS,1
GOBP_SOFT_PALATE_DEVELOPMENT,SET,5,-0.33155,-0.0054678,0.44234,0.77323,GOBP_SOFT_PALATE_DEVELOPMENT,1
GOBP_REGULATION_OF_CARBOHYDR...3,SET,163,-0.049813,-0.0046703,0.066454,0.77324,GOBP_REGULATION_OF_CARBOHYDRATE_METABOLIC_PROCESS,1
GOCC_COLLAGEN_TRIMER,SET,83,-0.077997,-0.0052297,0.10405,0.77324,GOCC_COLLAGEN_TRIMER,1
KEGG_ALPHA_LINOLENIC_ACID_ME...,SET,19,-0.15258,-0.0049032,0.20353,0.77326,KEGG_ALPHA_LINOLENIC_ACID_METABOLISM,1
MIR8485,SET,922,-0.021425,-0.0046769,0.028579,0.77328,MIR8485,1
GOBP_VASOCONSTRICTION,SET,83,-0.074567,-0.0049997,0.099461,0.77328,GOBP_VASOCONSTRICTION,1
GOBP_REGULATION_OF_MODIFICAT...2,SET,9,-0.1876,-0.0041504,0.25021,0.7733,GOBP_REGULATION_OF_MODIFICATION_OF_POSTSYNAPTIC_STRUCTURE,1
GOBP_NEGATIVE_REGULATION_OF_...393,SET,13,-0.17516,-0.0046567,0.23358,0.77333,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION,1
ATGCTGC_MIR103_MIR107,SET,198,-0.043516,-0.0044923,0.058027,0.77335,ATGCTGC_MIR103_MIR107,1
GSE9988_ANTI_TREM1_VS_ANTI_T...2,SET,181,-0.044837,-0.0044275,0.059787,0.77335,GSE9988_ANTI_TREM1_VS_ANTI_TREM1_AND_LPS_MONOCYTE_UP,1
GOBP_ADENYLATE_CYCLASE_MODUL...,SET,249,-0.04347,-0.0050254,0.05796,0.77337,GOBP_ADENYLATE_CYCLASE_MODULATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
ZNF664_TARGET_GENES,SET,766,-0.023148,-0.0046262,0.03086,0.77339,ZNF664_TARGET_GENES,1
GOBP_INSEMINATION,SET,13,-0.17619,-0.0046843,0.23489,0.7734,GOBP_INSEMINATION,1
GSE37301_HEMATOPOIETIC_STEM_...7,SET,154,-0.049409,-0.0045038,0.065861,0.77343,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_LYMPHOID_PRIMED_MPP_DN,1
GAO_ESOPHAGUS_25W_C2_KRT6BPO...,SET,66,-0.084807,-0.005073,0.11302,0.77348,GAO_ESOPHAGUS_25W_C2_KRT6BPOS_SECRETORY_PROGENITOR_CELLS,1
REACTOME_CHYLOMICRON_REMODEL...,SET,10,-0.2289,-0.0053378,0.30503,0.77349,REACTOME_CHYLOMICRON_REMODELING,1
WP_ID_SIGNALING,SET,15,-0.17047,-0.0048681,0.22715,0.77351,WP_ID_SIGNALING,1
GOBP_NEGATIVE_REGULATION_OF_...470,SET,12,-0.20322,-0.0051911,0.27079,0.77352,GOBP_NEGATIVE_REGULATION_OF_OSTEOBLAST_PROLIFERATION,1
GOBP_SKIN_MORPHOGENESIS,SET,13,-0.16928,-0.0045007,0.22556,0.77352,GOBP_SKIN_MORPHOGENESIS,1
GOMF_MANGANESE_ION_BINDING,SET,61,-0.08199,-0.0047157,0.10924,0.77354,GOMF_MANGANESE_ION_BINDING,1
WP_ANDROGEN_RECEPTOR_SIGNALI...,SET,83,-0.068428,-0.0045881,0.091125,0.77365,WP_ANDROGEN_RECEPTOR_SIGNALING,1
GOBP_RESPONSE_TO_X_RAY,SET,26,-0.11238,-0.0042237,0.14964,0.77366,GOBP_RESPONSE_TO_X_RAY,1
GOBP_PURINE_NUCLEOSIDE_MONOP...1,SET,18,-0.14953,-0.0046772,0.19909,0.77369,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_NUCLEOTIDE_EXCISION_REP...1,SET,80,-0.064041,-0.004216,0.085264,0.7737,GOBP_NUCLEOTIDE_EXCISION_REPAIR,1
GSE26030_UNSTIM_VS_RESTIM_TH...3,SET,174,-0.049548,-0.0047982,0.065954,0.77375,GSE26030_UNSTIM_VS_RESTIM_TH17_DAY5_POST_POLARIZATION_DN,1
MIR6772_5P,SET,31,-0.10888,-0.0044678,0.14492,0.77376,MIR6772_5P,1
CREBL2_TARGET_GENES,SET,7,-0.26814,-0.005232,0.35688,0.77377,CREBL2_TARGET_GENES,1
GOBP_ESTABLISHMENT_OF_EPITHE...1,SET,16,-0.1647,-0.0048575,0.2192,0.77378,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_APICAL_BASAL_POLARITY,1
GOMF_METAL_ION_SENSOR_ACTIVI...,SET,8,-0.26667,-0.0055625,0.35491,0.77379,GOMF_METAL_ION_SENSOR_ACTIVITY,1
GSE46606_IRF4_KO_VS_WT_UNSTI...1,SET,182,-0.050038,-0.0049546,0.066586,0.77381,GSE46606_IRF4_KO_VS_WT_UNSTIM_BCELL_DN,1
GOBP_RESPONSE_TO_ERYTHROPOIE...,SET,6,-0.30883,-0.0055791,0.41094,0.77383,GOBP_RESPONSE_TO_ERYTHROPOIETIN,1
WP_NEOVASCULARIZATION_PROCES...,SET,37,-0.11745,-0.0052643,0.15626,0.77384,WP_NEOVASCULARIZATION_PROCESSES,1
GOBP_REGULATION_OF_T_CIRCLE_...,SET,5,-0.2303,-0.003798,0.30638,0.77387,GOBP_REGULATION_OF_T_CIRCLE_FORMATION,1
GOBP_LATERAL_MESODERM_DEVELO...,SET,18,-0.16681,-0.0052178,0.22191,0.77388,GOBP_LATERAL_MESODERM_DEVELOPMENT,1
PID_INTEGRIN_A9B1_PATHWAY,SET,22,-0.14525,-0.0050224,0.19321,0.77391,PID_INTEGRIN_A9B1_PATHWAY,1
GOBP_REGULATION_OF_FIBROBLAS...1,SET,18,-0.14368,-0.0044943,0.19109,0.77394,GOBP_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
HP_BICORONAL_SYNOSTOSIS,SET,9,-0.18906,-0.0041827,0.25139,0.77399,HP_BICORONAL_SYNOSTOSIS,1
DESCARTES_MAIN_FETAL_HEMATOP...,SET,38,-0.098337,-0.0044668,0.13076,0.77399,DESCARTES_MAIN_FETAL_HEMATOPOIETIC_STEM_CELLS,1
GOMF_BENZODIAZEPINE_RECEPTOR...,SET,9,-0.26149,-0.0057852,0.34768,0.774,GOMF_BENZODIAZEPINE_RECEPTOR_ACTIVITY,1
GOBP_MESENCHYMAL_TO_EPITHELI...2,SET,11,-0.23079,-0.0056445,0.30679,0.77405,GOBP_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,1
GOBP_NUCLEOSOME_ORGANIZATION,SET,64,-0.074807,-0.0044067,0.09943,0.77408,GOBP_NUCLEOSOME_ORGANIZATION,1
HARALAMBIEVA_PBMC_M_M_R_II_A...1,SET,642,-0.026925,-0.0049435,0.035782,0.77411,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN,1
ANDERSON_BLOOD_CN54GP140_ADJ...1,SET,77,-0.065963,-0.0042606,0.087651,0.77414,ANDERSON_BLOOD_CN54GP140_ADJUVANTED_WITH_GLA_AF_AGE_18_45YO_1DY_DN,1
HIPC_SIGNATURES_PROJECT_PBMC...1,SET,6,-0.23818,-0.0043029,0.31645,0.77417,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_DOWN,1
KEGG_MEDICUS_REFERENCE_CA2_E...1,SET,12,-0.19189,-0.0049018,0.25494,0.77418,KEGG_MEDICUS_REFERENCE_CA2_ENTRY_LIGAND_GATED_CA2_CHANNEL,1
GOBP_COMMON_MYELOID_PROGENIT...,SET,9,-0.21087,-0.0046652,0.28009,0.77423,GOBP_COMMON_MYELOID_PROGENITOR_CELL_PROLIFERATION,1
GOBP_REGULATION_OF_MITOCHOND...9,SET,36,-0.10034,-0.0044364,0.13327,0.77423,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_PERMEABILITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
HP_MACULAR_HYPOPIGMENTATION,SET,5,-0.31793,-0.0052432,0.42229,0.77423,HP_MACULAR_HYPOPIGMENTATION,1
GOMF_RECEPTOR_ANTAGONIST_ACT...,SET,16,-0.1541,-0.0045447,0.20465,0.77427,GOMF_RECEPTOR_ANTAGONIST_ACTIVITY,1
HP_CHRONIC_NONINFECTIOUS_LYM...,SET,11,-0.18432,-0.0045079,0.24477,0.77428,HP_CHRONIC_NONINFECTIOUS_LYMPHADENOPATHY,1
BIOCARTA_IL2RB_PATHWAY,SET,35,-0.11304,-0.0049284,0.15011,0.7743,BIOCARTA_IL2RB_PATHWAY,1
GOBP_PROTEIN_LOCALIZATION_TO...1,SET,6,-0.28222,-0.0050984,0.37464,0.77436,GOBP_PROTEIN_LOCALIZATION_TO_ADHERENS_JUNCTION,1
MIR32_3P,SET,306,-0.037153,-0.0047539,0.049307,0.77442,MIR32_3P,1
GOBP_PYRIMIDINE_NUCLEOSIDE_M...4,SET,20,-0.13572,-0.0044746,0.18007,0.77447,GOBP_PYRIMIDINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
REACTOME_DNA_DAMAGE_TELOMERE...,SET,27,-0.11584,-0.0044369,0.15369,0.77449,REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE,1
HP_CLINODACTYLY_OF_THE_5TH_T...,SET,13,-0.17655,-0.0046937,0.23423,0.77449,HP_CLINODACTYLY_OF_THE_5TH_TOE,1
GOBP_G_PROTEIN_COUPLED_OPIOI...,SET,11,-0.20262,-0.0049555,0.26873,0.77456,GOBP_G_PROTEIN_COUPLED_OPIOID_RECEPTOR_SIGNALING_PATHWAY,1
HP_LEFT_TO_RIGHT_SHUNT,SET,10,-0.22475,-0.0052411,0.2981,0.77456,HP_LEFT_TO_RIGHT_SHUNT,1
PID_AURORA_A_PATHWAY,SET,31,-0.10445,-0.0042861,0.13853,0.77457,PID_AURORA_A_PATHWAY,1
GSE17721_POLYIC_VS_GARDIQUIM...5,SET,177,-0.045736,-0.0044667,0.060641,0.77464,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_DN,1
WP_1P36_COPY_NUMBER_VARIATIO...,SET,89,-0.080995,-0.0056226,0.10737,0.77468,WP_1P36_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_NEGATIVE_REGULATION_OF_...544,SET,57,-0.080119,-0.0044549,0.1062,0.7747,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS_INVOLVED_IN_PROTEIN_CATABOLIC_PROCESS,1
GOMF_ACYLTRANSFERASE_ACTIVITY,SET,651,-0.024886,-0.0045999,0.03297,0.77481,GOMF_ACYLTRANSFERASE_ACTIVITY,1
GSE46606_UNSTIM_VS_CD40L_IL2...12,SET,143,-0.053411,-0.0046929,0.070729,0.77491,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4_KO_BCELL_UP,1
GSE19923_WT_VS_HEB_KO_DP_THY...2,SET,184,-0.04782,-0.0047607,0.063316,0.77495,GSE19923_WT_VS_HEB_KO_DP_THYMOCYTE_UP,1
GOMF_RNA_POLYMERASE_II_CTD_H...2,SET,17,-0.1439,-0.0043746,0.19053,0.77496,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_MODIFYING_ACTIVITY,1
GOMF_DEOXYRIBONUCLEASE_I_ACT...,SET,4,-0.32953,-0.0048608,0.43626,0.77497,GOMF_DEOXYRIBONUCLEASE_I_ACTIVITY,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...4,SET,18,-0.15192,-0.0047519,0.20108,0.77502,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_RAS_ERK_SIGNALING_PATHWAY,1
ZNF282_TARGET_GENES,SET,852,-0.02216,-0.0046592,0.029331,0.77502,ZNF282_TARGET_GENES,1
GOCC_DNA_RECOMBINASE_MEDIATO...,SET,7,-0.22488,-0.004388,0.29765,0.77503,GOCC_DNA_RECOMBINASE_MEDIATOR_COMPLEX,1
HP_OBSTRUCTIVE_SLEEP_APNEA,SET,72,-0.077813,-0.0048608,0.10299,0.77504,HP_OBSTRUCTIVE_SLEEP_APNEA,1
GSE3982_MAC_VS_NEUTROPHIL_DN,SET,174,-0.048907,-0.004736,0.064728,0.77504,GSE3982_MAC_VS_NEUTROPHIL_DN,1
ZHONG_PFC_C2_UNKNOWN_NPC,SET,72,-0.06898,-0.004309,0.091291,0.77505,ZHONG_PFC_C2_UNKNOWN_NPC,1
REACTOME_FORMATION_OF_THE_AN...,SET,9,-0.25857,-0.0057206,0.34219,0.77506,REACTOME_FORMATION_OF_THE_ANTERIOR_NEURAL_PLATE,1
MORF_ETV3,SET,60,-0.08255,-0.0047089,0.10924,0.77508,MORF_ETV3,1
GSE40277_EOS_AND_LEF1_TRANSD...2,SET,177,-0.048189,-0.0047062,0.063756,0.77512,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,1
DESCARTES_FETAL_HEART_ERYTHR...,SET,242,-0.038287,-0.0043643,0.050632,0.77523,DESCARTES_FETAL_HEART_ERYTHROBLASTS,1
GSE32901_TH17_EMRICHED_VS_TH...2,SET,102,-0.065966,-0.0049006,0.087219,0.77527,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_UP,1
GOCC_CUTICULAR_PLATE,SET,8,-0.2353,-0.0049081,0.3111,0.77528,GOCC_CUTICULAR_PLATE,1
WANG_LMO4_TARGETS_UP,SET,311,-0.035628,-0.0045952,0.047086,0.77537,WANG_LMO4_TARGETS_UP,1
GOMF_LIPASE_INHIBITOR_ACTIVI...,SET,16,-0.17015,-0.0050182,0.22482,0.77543,GOMF_LIPASE_INHIBITOR_ACTIVITY,1
GSE5503_LIVER_DC_VS_SPLEEN_D...1,SET,173,-0.046123,-0.0044537,0.060931,0.77546,GSE5503_LIVER_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
MODULE_205,SET,276,-0.039539,-0.0048088,0.052223,0.77551,MODULE_205,1
MIR579_3P,SET,449,-0.031212,-0.0048185,0.041212,0.77558,MIR579_3P,1
MIR6742_5P,SET,40,-0.097932,-0.0045637,0.12929,0.77561,MIR6742_5P,1
THAKAR_PBMC_INACTIVATED_INFL...7,SET,547,-0.026456,-0.0044956,0.034925,0.77562,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...442,SET,115,-0.059696,-0.0047073,0.078786,0.77568,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_DEVELOPMENT,1
PID_KIT_PATHWAY,SET,51,-0.095119,-0.0050037,0.12552,0.7757,PID_KIT_PATHWAY,1
MIR1914_3P,SET,23,-0.13988,-0.0049451,0.18459,0.7757,MIR1914_3P,1
DURANTE_ADULT_OLFACTORY_NEUR...26,SET,80,-0.07778,-0.0051204,0.10262,0.77575,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_VASCULAR_SMOOTH_MUSCLE_CELLS,1
GOBP_GLYCINE_TRANSPORT,SET,14,-0.18613,-0.005135,0.24556,0.77576,GOBP_GLYCINE_TRANSPORT,1
HP_HYPOPLASTIC_NIPPLES,SET,31,-0.10724,-0.0044005,0.14144,0.77583,HP_HYPOPLASTIC_NIPPLES,1
GSE5589_WT_VS_IL10_KO_LPS_AN...6,SET,177,-0.047625,-0.0046512,0.062809,0.77585,GSE5589_WT_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
PGBD5_TARGET_GENES,SET,14,-0.16695,-0.004606,0.22016,0.77586,PGBD5_TARGET_GENES,1
HP_GUSTATORY_LACRIMATION,SET,4,-0.36945,-0.0054498,0.48705,0.77594,HP_GUSTATORY_LACRIMATION,1
HP_OPTIC_NERVE_DYSPLASIA,SET,6,-0.28469,-0.0051431,0.3753,0.77594,HP_OPTIC_NERVE_DYSPLASIA,1
GSE6681_DELETED_FOXP3_VS_WT_...1,SET,176,-0.047547,-0.0046306,0.062681,0.77594,GSE6681_DELETED_FOXP3_VS_WT_TREG_DN,1
WP_KYNURENINE_PATHWAY_AND_LI...,SET,24,-0.1382,-0.0049909,0.18218,0.77595,WP_KYNURENINE_PATHWAY_AND_LINKS_TO_CELL_SENESCENCE,1
HP_CHRONIC_PAIN,SET,6,-0.22137,-0.003999,0.29176,0.77599,HP_CHRONIC_PAIN,1
REACTOME_TP53_REGULATES_TRAN...10,SET,13,-0.18342,-0.0048765,0.24173,0.77601,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_SEVERAL_ADDITIONAL_CELL_DEATH_GENES_WHOSE_SPECIFIC_ROLES_IN_P53_DEPENDENT_APOPTOSIS_REMAIN_UNCERTAIN,1
GSE45365_CD8A_DC_VS_CD11B_DC...5,SET,149,-0.053417,-0.0047901,0.070394,0.77602,GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP,1
GOMF_NON_MEMBRANE_SPANNING_P...2,SET,10,-0.1959,-0.0045684,0.25814,0.77604,GOMF_NON_MEMBRANE_SPANNING_PROTEIN_TYROSINE_PHOSPHATASE_ACTIVITY,1
GSE13485_DAY1_VS_DAY21_YF17D...2,SET,160,-0.048923,-0.0045448,0.064463,0.77605,GSE13485_DAY1_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
PR_02,SET,123,-0.058881,-0.0048007,0.077579,0.77606,PR_02,1
GOCC_MITOCHONDRIAL_MATRIX,SET,448,-0.029082,-0.0044849,0.038319,0.77606,GOCC_MITOCHONDRIAL_MATRIX,1
GOBP_INTERLEUKIN_4_PRODUCTION,SET,29,-0.13096,-0.0051982,0.17251,0.77611,GOBP_INTERLEUKIN_4_PRODUCTION,1
GOMF_N_FORMYL_PEPTIDE_RECEPT...,SET,4,-0.4028,-0.0059417,0.53057,0.77612,GOMF_N_FORMYL_PEPTIDE_RECEPTOR_ACTIVITY,1
REACTOME_SPECIFICATION_OF_TH...,SET,16,-0.17896,-0.0052779,0.23572,0.77613,REACTOME_SPECIFICATION_OF_THE_NEURAL_PLATE_BORDER,1
GCM_PSME1,SET,75,-0.069851,-0.004453,0.091964,0.77623,GCM_PSME1,1
GCM_SMARCD1,SET,90,-0.064082,-0.0044733,0.08435,0.77628,GCM_SMARCD1,1
HP_ABNORMAL_SMALL_INTESTINE_...,SET,244,-0.041332,-0.0047306,0.054399,0.7763,HP_ABNORMAL_SMALL_INTESTINE_MORPHOLOGY,1
HP_CEREBELLAR_ATROPHY,SET,393,-0.030634,-0.0044315,0.040314,0.77634,HP_CEREBELLAR_ATROPHY,1
KEGG_MEDICUS_REFERENCE_AUTOP...2,SET,5,-0.24563,-0.0040509,0.32323,0.77635,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR_GRASP55,1
ALFANO_MYC_TARGETS,SET,224,-0.042905,-0.0047077,0.056455,0.77636,ALFANO_MYC_TARGETS,1
REACTOME_SIGNALING_BY_INSULI...,SET,79,-0.072733,-0.0047583,0.095706,0.77636,REACTOME_SIGNALING_BY_INSULIN_RECEPTOR,1
GNF2_DDX5,SET,58,-0.077601,-0.0043525,0.10211,0.77636,GNF2_DDX5,1
GSE1740_MCSF_VS_MCSF_AND_IFN...1,SET,172,-0.047117,-0.0045367,0.061993,0.77638,GSE1740_MCSF_VS_MCSF_AND_IFNG_DAY2_DERIVED_MACROPHAGE_DN,1
GSE41867_NAIVE_VS_DAY15_LCMV...3,SET,164,-0.048517,-0.0045626,0.06382,0.77643,GSE41867_NAIVE_VS_DAY15_LCMV_CONE13_EFFECTOR_CD8_TCELL_DN,1
chr4q32,SET,38,-0.17669,-0.0080258,0.2324,0.77645,chr4q32,1
GSE9960_GRAM_POS_VS_GRAM_NEG...2,SET,178,-0.046813,-0.0045846,0.061574,0.77645,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,1
GOCC_FIBRILLAR_CENTER,SET,134,-0.052665,-0.0044805,0.069269,0.77646,GOCC_FIBRILLAR_CENTER,1
MIKHAYLOVA_OXIDATIVE_STRESS_...1,SET,6,-0.31421,-0.0056763,0.41321,0.77649,MIKHAYLOVA_OXIDATIVE_STRESS_RESPONSE_VIA_VHL_DN,1
GOBP_POSITIVE_REGULATION_OF_...94,SET,485,-0.029306,-0.0046974,0.038532,0.77654,GOBP_POSITIVE_REGULATION_OF_CATABOLIC_PROCESS,1
REACTOME_MYOGENESIS,SET,28,-0.13339,-0.0052026,0.17535,0.77658,REACTOME_MYOGENESIS,1
GOBP_TRANSCRIPTION_ELONGATIO...2,SET,8,-0.19272,-0.0040199,0.25329,0.77662,GOBP_TRANSCRIPTION_ELONGATION_COUPLED_CHROMATIN_REMODELING,1
GSE30083_SP1_VS_SP2_THYMOCYT...1,SET,184,-0.049327,-0.0049108,0.064826,0.77664,GSE30083_SP1_VS_SP2_THYMOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...708,SET,70,-0.079347,-0.0048875,0.10424,0.77673,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING,1
GSE18791_CTRL_VS_NEWCASTLE_V...8,SET,181,-0.045353,-0.0044785,0.059576,0.77674,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_UP,1
OCT1_02,SET,187,-0.051125,-0.0051307,0.067153,0.77676,OCT1_02,1
GOBP_RNA_POLYMERASE_I_PREINI...,SET,9,-0.20352,-0.0045026,0.26733,0.77676,GOBP_RNA_POLYMERASE_I_PREINITIATION_COMPLEX_ASSEMBLY,1
GOBP_TRANSCRIPTION_INITIATIO...3,SET,9,-0.20352,-0.0045026,0.26733,0.77676,GOBP_TRANSCRIPTION_INITIATION_AT_RNA_POLYMERASE_I_PROMOTER,1
HP_SYMPHALANGISM_OF_MIDDLE_P...2,SET,5,-0.28965,-0.0047769,0.38039,0.77681,HP_SYMPHALANGISM_OF_MIDDLE_PHALANX_OF_FINGER,1
HP_INCREASED_PROTEINOGENIC_A...,SET,42,-0.10111,-0.0048279,0.13277,0.77682,HP_INCREASED_PROTEINOGENIC_AMINO_ACID_LEVEL_IN_URINE,1
HP_CHORIORETINAL_COLOBOMA,SET,40,-0.10384,-0.004839,0.13635,0.77683,HP_CHORIORETINAL_COLOBOMA,1
GOBP_MUSCLE_ORGAN_MORPHOGENE...,SET,76,-0.081867,-0.0052536,0.10749,0.77685,GOBP_MUSCLE_ORGAN_MORPHOGENESIS,1
GOBP_REGULATION_OF_INTRACELL...2,SET,9,-0.20839,-0.0046102,0.2736,0.77686,GOBP_REGULATION_OF_INTRACELLULAR_LIPID_TRANSPORT,1
HP_DECREASED_SKULL_OSSIFICAT...,SET,38,-0.1056,-0.0047968,0.13861,0.77693,HP_DECREASED_SKULL_OSSIFICATION,1
ROY_WOUND_BLOOD_VESSEL_UP,SET,45,-0.10025,-0.0049546,0.13157,0.77696,ROY_WOUND_BLOOD_VESSEL_UP,1
GSE19772_CTRL_VS_HCMV_INF_MO...1,SET,184,-0.047244,-0.0047034,0.062,0.77696,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,1
HP_HEINZ_BODIES,SET,2,-0.43052,-0.0044908,0.56488,0.77701,HP_HEINZ_BODIES,1
GSE22432_MULTIPOTENT_PROGENI...3,SET,177,-0.045582,-0.0044516,0.059805,0.77701,GSE22432_MULTIPOTENT_PROGENITOR_VS_PDC_DN,1
GOBP_PLATELET_DERIVED_GROWTH...3,SET,53,-0.093287,-0.0050023,0.12239,0.77703,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GSE42021_TCONV_PLN_VS_CD24LO...2,SET,182,-0.045937,-0.0045486,0.060267,0.77703,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_UP,1
GOBP_ENDODERMAL_CELL_FATE_SP...,SET,7,-0.28708,-0.0056016,0.37652,0.7771,GOBP_ENDODERMAL_CELL_FATE_SPECIFICATION,1
LIANG_HEMATOPOIESIS_STEM_CEL...3,SET,15,-0.15549,-0.0044403,0.20392,0.77712,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_QTL,1
MIR4740_3P,SET,7,-0.24356,-0.0047524,0.31939,0.77714,MIR4740_3P,1
WP_MECP2_AND_ASSOCIATED_RETT...,SET,68,-0.08261,-0.0050156,0.10831,0.77717,WP_MECP2_AND_ASSOCIATED_RETT_SYNDROME,1
PAL_PRMT5_TARGETS_UP,SET,186,-0.046003,-0.0046044,0.060299,0.77724,PAL_PRMT5_TARGETS_UP,1
MIR219B_5P,SET,41,-0.096942,-0.0045736,0.12707,0.77724,MIR219B_5P,1
BUSSLINGER_GASTRIC_REG3A_POS...,SET,40,-0.1153,-0.0053732,0.15113,0.77724,BUSSLINGER_GASTRIC_REG3A_POSITIVE_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...651,SET,236,-0.041356,-0.0046561,0.05419,0.77731,GOBP_POSITIVE_REGULATION_OF_PROTEIN_TRANSPORT,1
chr4q31,SET,62,-0.15054,-0.008729,0.19725,0.77732,chr4q31,1
MARIADASON_RESPONSE_TO_BUTYR...1,SET,6,-0.29836,-0.00539,0.39092,0.77733,MARIADASON_RESPONSE_TO_BUTYRATE_CURCUMIN_SULINDAC_TSA_1,1
GOBP_POSITIVE_REGULATION_OF_...633,SET,6,-0.25796,-0.0046602,0.33797,0.77734,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CILIUM,1
GCAAGAC_MIR431,SET,43,-0.10346,-0.0049982,0.13554,0.77735,GCAAGAC_MIR431,1
GOBP_EMBRYONIC_MORPHOGENESIS,SET,573,-0.028439,-0.0049427,0.03726,0.77735,GOBP_EMBRYONIC_MORPHOGENESIS,1
GOBP_REGULATION_OF_CELLULAR_...17,SET,460,-0.029439,-0.0045987,0.038563,0.77738,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_STRESS,1
GOBP_MICROTUBULE_ORGANIZING_...2,SET,143,-0.051164,-0.0044955,0.067013,0.77741,GOBP_MICROTUBULE_ORGANIZING_CENTER_ORGANIZATION,1
WP_PATHOPHYSIOLOGICAL_ROLES_...,SET,15,-0.17602,-0.0050267,0.23051,0.77745,WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1,1
GOBP_OTIC_VESICLE_DEVELOPMENT,SET,14,-0.16823,-0.0046413,0.22026,0.7775,GOBP_OTIC_VESICLE_DEVELOPMENT,1
GSE27786_BCELL_VS_MONO_MAC_UP,SET,170,-0.048933,-0.0046844,0.064065,0.7775,GSE27786_BCELL_VS_MONO_MAC_UP,1
GOBP_DOUBLE_STRAND_BREAK_REP...7,SET,6,-0.24438,-0.0044148,0.31993,0.77752,GOBP_DOUBLE_STRAND_BREAK_REPAIR_VIA_SINGLE_STRAND_ANNEALING,1
HP_AMBIGUOUS_GENITALIA_FEMALE,SET,8,-0.24139,-0.0050352,0.316,0.77753,HP_AMBIGUOUS_GENITALIA_FEMALE,1
HP_ENDOCARDIAL_FIBROSIS,SET,6,-0.28121,-0.0050801,0.36812,0.77753,HP_ENDOCARDIAL_FIBROSIS,1
HP_NOCTURNAL_SEIZURES,SET,18,-0.16356,-0.0051162,0.21412,0.77753,HP_NOCTURNAL_SEIZURES,1
HP_ABNORMAL_BLOOD_FOLATE_CON...,SET,10,-0.20529,-0.0047873,0.26873,0.77754,HP_ABNORMAL_BLOOD_FOLATE_CONCENTRATION,1
GSE25123_WT_VS_PPARG_KO_MACR...1,SET,177,-0.048112,-0.0046987,0.062979,0.77754,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_DN,1
HP_NONPROGRESSIVE_CEREBELLAR...,SET,8,-0.23588,-0.0049202,0.3087,0.7776,HP_NONPROGRESSIVE_CEREBELLAR_ATAXIA,1
MODULE_379,SET,178,-0.048589,-0.0047585,0.06358,0.77763,MODULE_379,1
HP_LIPOMATOUS_TUMOR,SET,42,-0.099984,-0.0047742,0.13083,0.77763,HP_LIPOMATOUS_TUMOR,1
GOBP_FATTY_ACID_CATABOLIC_PR...,SET,101,-0.061091,-0.0045163,0.079922,0.77768,GOBP_FATTY_ACID_CATABOLIC_PROCESS,1
SESTO_RESPONSE_TO_UV_C1,SET,68,-0.07543,-0.0045797,0.098671,0.7777,SESTO_RESPONSE_TO_UV_C1,1
GOMF_REGULATORY_RNA_BINDING,SET,38,-0.10099,-0.0045875,0.13207,0.77776,GOMF_REGULATORY_RNA_BINDING,1
HP_ABNORMAL_EATING_BEHAVIOR,SET,114,-0.063927,-0.0050191,0.083593,0.77778,HP_ABNORMAL_EATING_BEHAVIOR,1
GOBP_STRESS_GRANULE_ASSEMBLY,SET,32,-0.11076,-0.0046175,0.14479,0.77784,GOBP_STRESS_GRANULE_ASSEMBLY,1
MIR6748_3P,SET,79,-0.071332,-0.0046666,0.093231,0.77789,MIR6748_3P,1
GOMF_GLYCEROPHOSPHODIESTER_P...,SET,4,-0.30174,-0.004451,0.39437,0.77789,GOMF_GLYCEROPHOSPHODIESTER_PHOSPHODIESTERASE_ACTIVITY,1
HP_OPTIC_ATROPHY,SET,512,-0.027864,-0.0045855,0.036418,0.77789,HP_OPTIC_ATROPHY,1
BIOCARTA_RAS_PATHWAY,SET,20,-0.14645,-0.0048286,0.19141,0.7779,BIOCARTA_RAS_PATHWAY,1
GOBP_NEUROTRANSMITTER_SECRET...,SET,135,-0.055347,-0.004726,0.07231,0.77798,GOBP_NEUROTRANSMITTER_SECRETION,1
WP_PATHOGENESIS_OF_SARSCOV2_...,SET,18,-0.17219,-0.005386,0.22494,0.778,WP_PATHOGENESIS_OF_SARSCOV2_MEDIATED_BY_NSP9NSP10_COMPLEX,1
FONTAINE_THYROID_TUMOR_UNCER...2,SET,33,-0.11814,-0.0050013,0.15432,0.77801,FONTAINE_THYROID_TUMOR_UNCERTAIN_MALIGNANCY_UP,1
MIR4536_5P,SET,41,-0.098575,-0.0046507,0.12877,0.77801,MIR4536_5P,1
HP_RENAL_HAMARTOMA,SET,7,-0.24426,-0.004766,0.31908,0.77801,HP_RENAL_HAMARTOMA,1
GOBP_REGULATION_OF_SYNAPTIC_...2,SET,194,-0.047058,-0.0048092,0.061468,0.77803,GOBP_REGULATION_OF_SYNAPTIC_PLASTICITY,1
GOBP_DETECTION_OF_TEMPERATUR...3,SET,5,-0.31885,-0.0052584,0.41647,0.77804,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS_INVOLVED_IN_THERMOCEPTION,1
GSE41978_WT_VS_BIM_KO_KLRG1_...2,SET,185,-0.045689,-0.0045608,0.059675,0.77805,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
GOBP_ESTABLISHMENT_OR_MAINTE...5,SET,11,-0.22491,-0.0055007,0.29372,0.77808,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_TRANSMEMBRANE_ELECTROCHEMICAL_GRADIENT,1
KEGG_MEDICUS_REFERENCE_AREG_...1,SET,11,-0.19963,-0.0048824,0.26069,0.77809,KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY,1
GOBP_MESONEPHRIC_TUBULE_FORM...,SET,8,-0.26439,-0.0055149,0.34526,0.77809,GOBP_MESONEPHRIC_TUBULE_FORMATION,1
MODULE_485,SET,49,-0.088219,-0.004549,0.11518,0.77813,MODULE_485,1
MIR103A_1_5P,SET,136,-0.055708,-0.0047743,0.072727,0.77815,MIR103A_1_5P,1
GOCC_SPINDLE_POLE_CENTROSOME,SET,11,-0.18009,-0.0044045,0.235,0.77826,GOCC_SPINDLE_POLE_CENTROSOME,1
GNF2_AF1Q,SET,25,-0.13606,-0.0050147,0.17753,0.77827,GNF2_AF1Q,1
REACTOME_AKT_PHOSPHORYLATES_...2,SET,9,-0.20514,-0.0045384,0.26764,0.77829,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_NUCLEUS,1
GOBP_REFLEX,SET,22,-0.14209,-0.004913,0.18538,0.7783,GOBP_REFLEX,1
REACTOME_REGULATION_OF_GENE_...2,SET,21,-0.15492,-0.0052336,0.20208,0.77834,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS,1
GOBP_EPITHELIAL_CELL_PROLIFE...3,SET,10,-0.22313,-0.0052033,0.29105,0.77835,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_PROSTATE_GLAND_DEVELOPMENT,1
chr11q22,SET,51,-0.17386,-0.0091455,0.22676,0.77836,chr11q22,1
GOBP_FATTY_ACID_TRANSMEMBRAN...,SET,19,-0.14127,-0.0045397,0.18423,0.7784,GOBP_FATTY_ACID_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_ANATOMICA...2,SET,445,-0.031852,-0.004896,0.041538,0.7784,GOBP_REGULATION_OF_ANATOMICAL_STRUCTURE_SIZE,1
HP_PTOSIS,SET,652,-0.025,-0.0046244,0.032594,0.77846,HP_PTOSIS,1
MIR4694_3P,SET,281,-0.039453,-0.0048409,0.05142,0.77853,MIR4694_3P,1
AIZARANI_LIVER_C5_NK_NKT_CEL...,SET,110,-0.064944,-0.0050092,0.084636,0.77855,AIZARANI_LIVER_C5_NK_NKT_CELLS_3,1
GOBP_POSITIVE_REGULATION_OF_...698,SET,1622,-0.017204,-0.00488,0.022418,0.77857,GOBP_POSITIVE_REGULATION_OF_SIGNALING,1
GOBP_LYSOSOMAL_LUMEN_ACIDIFI...,SET,20,-0.14104,-0.0046501,0.18374,0.77863,GOBP_LYSOSOMAL_LUMEN_ACIDIFICATION,1
GOBP_NATURAL_KILLER_CELL_DIF...,SET,24,-0.14591,-0.0052693,0.19007,0.77865,GOBP_NATURAL_KILLER_CELL_DIFFERENTIATION,1
GNF2_S100A4,SET,44,-0.099343,-0.0048549,0.12934,0.77878,GNF2_S100A4,1
GOCC_AUTOPHAGOSOME,SET,105,-0.060416,-0.0045535,0.078645,0.77882,GOCC_AUTOPHAGOSOME,1
GOBP_BLOOD_VESSEL_MORPHOGENE...,SET,579,-0.028734,-0.0050192,0.037402,0.77883,GOBP_BLOOD_VESSEL_MORPHOGENESIS,1
HP_FOCAL_CORTICAL_DYSPLASIA,SET,15,-0.16416,-0.0046879,0.21362,0.7789,HP_FOCAL_CORTICAL_DYSPLASIA,1
HAND1E47_01,SET,245,-0.043019,-0.0049336,0.05596,0.77897,HAND1E47_01,1
HP_SLOWLY_PROGRESSIVE,SET,141,-0.054465,-0.0047522,0.070846,0.77898,HP_SLOWLY_PROGRESSIVE,1
LUND_SILENCED_BY_METHYLATION,SET,14,-0.1634,-0.0045081,0.21253,0.77899,LUND_SILENCED_BY_METHYLATION,1
GOBP_POSITIVE_REGULATION_OF_...765,SET,47,-0.089282,-0.0045092,0.11612,0.779,GOBP_POSITIVE_REGULATION_OF_TORC1_SIGNALING,1
GOBP_RIBONUCLEOSIDE_MONOPHOS...3,SET,52,-0.091424,-0.0048561,0.1189,0.77903,GOBP_RIBONUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
HP_ABNORMAL_FEMALE_REPRODUCT...,SET,354,-0.03487,-0.0047926,0.045348,0.77903,HP_ABNORMAL_FEMALE_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,1
PID_IFNG_PATHWAY,SET,40,-0.10513,-0.0048993,0.13672,0.77904,PID_IFNG_PATHWAY,1
WP_NONALCOHOLIC_FATTY_LIVER_...,SET,146,-0.05,-0.0044387,0.065014,0.77907,WP_NONALCOHOLIC_FATTY_LIVER_DISEASE,1
GSE5589_IL6_KO_VS_IL10_KO_LP...8,SET,176,-0.049919,-0.0048615,0.064908,0.77907,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_UP,1
REACTOME_CHYLOMICRON_ASSEMBLY,SET,10,-0.1958,-0.004566,0.25456,0.7791,REACTOME_CHYLOMICRON_ASSEMBLY,1
chr6q13,SET,19,-0.22624,-0.0072705,0.29412,0.77911,chr6q13,1
REACTOME_METABOLISM_OF_AMINO...,SET,330,-0.035084,-0.0046588,0.045608,0.77912,REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES,1
HP_ANAL_FISTULA,SET,7,-0.22824,-0.0044535,0.2967,0.77913,HP_ANAL_FISTULA,1
HP_LIMB_DYSTONIA,SET,74,-0.071243,-0.0045115,0.092576,0.77922,HP_LIMB_DYSTONIA,1
GSE3982_BASOPHIL_VS_EFF_MEMO...2,SET,184,-0.047589,-0.0047377,0.061832,0.77924,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
HP_EMG_NEUROPATHIC_CHANGES,SET,48,-0.089541,-0.00457,0.11633,0.77926,HP_EMG_NEUROPATHIC_CHANGES,1
HP_ATELECTASIS,SET,67,-0.0804,-0.0048455,0.10445,0.77927,HP_ATELECTASIS,1
GOBP_REGULATION_OF_B_CELL_PR...,SET,62,-0.085914,-0.0049816,0.11161,0.77928,GOBP_REGULATION_OF_B_CELL_PROLIFERATION,1
GSE5589_IL6_KO_VS_IL10_KO_LP...10,SET,175,-0.04774,-0.0046362,0.061997,0.77935,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP,1
GOBP_WHITE_FAT_CELL_DIFFEREN...,SET,16,-0.16431,-0.0048459,0.21338,0.77936,GOBP_WHITE_FAT_CELL_DIFFERENTIATION,1
ACCAAAG_MIR9,SET,467,-0.030049,-0.0047286,0.039021,0.77937,ACCAAAG_MIR9,1
GOBP_REGULATION_OF_CGMP_MEDI...,SET,10,-0.21534,-0.0050218,0.27962,0.77938,GOBP_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
GOBP_PIGMENT_GRANULE_ORGANIZ...,SET,37,-0.11115,-0.0049821,0.1443,0.77942,GOBP_PIGMENT_GRANULE_ORGANIZATION,1
LIANG_HEMATOPOIESIS_STEM_CEL...5,SET,36,-0.11114,-0.004914,0.14426,0.77947,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_SMALL_VS_HUGE_UP,1
GOBP_REGULATION_OF_HAIR_CYCLE,SET,28,-0.13193,-0.0051457,0.17124,0.77949,GOBP_REGULATION_OF_HAIR_CYCLE,1
GOBP_REGULATORY_NCRNA_PROCES...,SET,65,-0.075063,-0.0044561,0.097406,0.77953,GOBP_REGULATORY_NCRNA_PROCESSING,1
GSE37319_WT_VS_RC3H1_KO_CD44...2,SET,130,-0.058212,-0.0048785,0.075526,0.77957,GSE37319_WT_VS_RC3H1_KO_CD44LOW_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...374,SET,141,-0.055181,-0.0048147,0.071587,0.77959,GOBP_NEGATIVE_REGULATION_OF_MAPK_CASCADE,1
GLI3_TARGET_GENES,SET,588,-0.026881,-0.0047306,0.034868,0.77962,GLI3_TARGET_GENES,1
HP_ADRENOCORTICAL_ABNORMALITY,SET,9,-0.2175,-0.0048118,0.28208,0.77966,HP_ADRENOCORTICAL_ABNORMALITY,1
MIR559,SET,497,-0.029328,-0.0047572,0.038031,0.77969,MIR559,1
GOBP_POSITIVE_REGULATION_OF_...441,SET,5,-0.27799,-0.0045845,0.36041,0.77974,GOBP_POSITIVE_REGULATION_OF_MAST_CELL_ACTIVATION,1
GSE21360_PRIMARY_VS_SECONDAR...2,SET,176,-0.047857,-0.0046607,0.062035,0.77977,GSE21360_PRIMARY_VS_SECONDARY_MEMORY_CD8_TCELL_UP,1
MIR484,SET,81,-0.071856,-0.0047598,0.093126,0.77982,MIR484,1
GOBP_XENOBIOTIC_EXPORT_FROM_...,SET,13,-0.17068,-0.0045378,0.22118,0.77984,GOBP_XENOBIOTIC_EXPORT_FROM_CELL,1
GOBP_TYPE_III_INTERFERON_PRO...,SET,3,-0.34365,-0.0043901,0.44528,0.77987,GOBP_TYPE_III_INTERFERON_PRODUCTION,1
GSE2770_IL12_VS_TGFB_AND_IL1...2,SET,116,-0.060834,-0.0048177,0.078806,0.77992,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
GOBP_NEGATIVE_REGULATION_OF_...300,SET,6,-0.2593,-0.0046844,0.33589,0.77993,GOBP_NEGATIVE_REGULATION_OF_INTERFERON_ALPHA_PRODUCTION,1
HP_HYPERACTIVE_RENIN_ANGIOTE...,SET,8,-0.26624,-0.0055535,0.34488,0.77994,HP_HYPERACTIVE_RENIN_ANGIOTENSIN_SYSTEM,1
HP_ABNORMALITY_OF_LIPOPROTEI...,SET,82,-0.073776,-0.0049169,0.095554,0.77997,HP_ABNORMALITY_OF_LIPOPROTEIN_CHOLESTEROL_CONCENTRATION,1
MIR6793_5P,SET,56,-0.091173,-0.005025,0.11807,0.78,MIR6793_5P,1
DESCARTES_FETAL_LUNG_LYMPHAT...,SET,48,-0.098699,-0.0050374,0.12775,0.78012,DESCARTES_FETAL_LUNG_LYMPHATIC_ENDOTHELIAL_CELLS,1
GOBP_CELL_JUNCTION_DISASSEMB...,SET,27,-0.14749,-0.0056488,0.19088,0.78013,GOBP_CELL_JUNCTION_DISASSEMBLY,1
HP_HETEROCHROMIA_IRIDIS,SET,23,-0.14309,-0.0050587,0.18518,0.78014,HP_HETEROCHROMIA_IRIDIS,1
MARIADASON_RESPONSE_TO_BUTYR...4,SET,16,-0.15811,-0.004663,0.20458,0.78018,MARIADASON_RESPONSE_TO_BUTYRATE_SULINDAC_4,1
GOBP_HEMOGLOBIN_METABOLIC_PR...,SET,17,-0.15948,-0.004848,0.20634,0.7802,GOBP_HEMOGLOBIN_METABOLIC_PROCESS,1
SAFB2_TARGET_GENES,SET,614,-0.026686,-0.0047954,0.034526,0.78021,SAFB2_TARGET_GENES,1
MULLIGHAN_NPM1_MUTATED_SIGNA...3,SET,65,-0.074465,-0.0044205,0.09632,0.78026,MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_DN,1
KEGG_GLYCOSPHINGOLIPID_BIOSY...2,SET,13,-0.1849,-0.0049159,0.23918,0.78026,KEGG_GLYCOSPHINGOLIPID_BIOSYNTHESIS_GLOBO_SERIES,1
HP_TOE_JOINT_CONTRACTURE,SET,27,-0.12782,-0.0048957,0.16534,0.78027,HP_TOE_JOINT_CONTRACTURE,1
GOBP_ARGININE_METABOLIC_PROC...,SET,17,-0.1569,-0.0047697,0.20294,0.78028,GOBP_ARGININE_METABOLIC_PROCESS,1
HP_UNDETECTABLE_LIGHT_AND_DA...,SET,13,-0.19888,-0.0052874,0.25722,0.78029,HP_UNDETECTABLE_LIGHT_AND_DARK_ADAPTED_ELECTRORETINOGRAM,1
GSE1112_OT1_CD8AB_VS_HY_CD8A...1,SET,153,-0.051342,-0.0046649,0.066379,0.78037,GSE1112_OT1_CD8AB_VS_HY_CD8AA_THYMOCYTE_RTOC_CULTURE_DN,1
HP_IRREGULAR_EPIPHYSES,SET,21,-0.14069,-0.0047528,0.18185,0.78043,HP_IRREGULAR_EPIPHYSES,1
GOBP_EAR_DEVELOPMENT,SET,209,-0.048123,-0.0051024,0.062182,0.7805,GOBP_EAR_DEVELOPMENT,1
GSE14308_TH2_VS_NAIVE_CD4_TC...2,SET,175,-0.047173,-0.0045811,0.060955,0.7805,GSE14308_TH2_VS_NAIVE_CD4_TCELL_UP,1
PECE_MAMMARY_STEM_CELL_DN,SET,122,-0.058917,-0.0047843,0.076127,0.78051,PECE_MAMMARY_STEM_CELL_DN,1
REACTOME_FRS_MEDIATED_FGFR4_...,SET,21,-0.14078,-0.0047561,0.18188,0.78054,REACTOME_FRS_MEDIATED_FGFR4_SIGNALING,1
HNF3ALPHA_Q6,SET,184,-0.049328,-0.0049108,0.063726,0.78055,HNF3ALPHA_Q6,1
HP_FAILURE_TO_THRIVE,SET,957,-0.021369,-0.0047476,0.027605,0.78056,HP_FAILURE_TO_THRIVE,1
GSE14000_UNSTIM_VS_16H_LPS_D...4,SET,169,-0.04771,-0.0045539,0.061625,0.78059,GSE14000_UNSTIM_VS_16H_LPS_DC_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...15,SET,30,-0.13368,-0.0053966,0.17267,0.7806,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_PINK_DN,1
GOBP_POSITIVE_REGULATION_OF_...250,SET,5,-0.32971,-0.0054375,0.4258,0.78063,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
REACTOME_CELL_JUNCTION_ORGAN...,SET,105,-0.068303,-0.0051479,0.088189,0.78068,REACTOME_CELL_JUNCTION_ORGANIZATION,1
MIR3619_5P,SET,255,-0.03914,-0.0045782,0.050526,0.78072,MIR3619_5P,1
CTCNANGTGNY_UNKNOWN,SET,74,-0.07362,-0.004662,0.09503,0.78074,CTCNANGTGNY_UNKNOWN,1
HP_ABSENT_FOVEAL_REFLEX,SET,14,-0.18086,-0.0049898,0.23341,0.78078,HP_ABSENT_FOVEAL_REFLEX,1
WIKMAN_ASBESTOS_LUNG_CANCER_...2,SET,15,-0.16382,-0.0046782,0.21141,0.7808,WIKMAN_ASBESTOS_LUNG_CANCER_UP,1
GOCC_PAM_COMPLEX_TIM23_ASSOC...,SET,5,-0.26648,-0.0043947,0.34383,0.78084,GOCC_PAM_COMPLEX_TIM23_ASSOCIATED_IMPORT_MOTOR,1
PRC1_BMI_UP.V1_UP,SET,162,-0.052755,-0.0049311,0.068063,0.78085,PRC1_BMI_UP.V1_UP,1
GOMF_NMDA_GLUTAMATE_RECEPTOR...,SET,7,-0.25929,-0.0050593,0.3345,0.78087,GOMF_NMDA_GLUTAMATE_RECEPTOR_ACTIVITY,1
DESCARTES_FETAL_CEREBRUM_VAS...,SET,437,-0.033858,-0.0051584,0.043675,0.78089,DESCARTES_FETAL_CEREBRUM_VASCULAR_ENDOTHELIAL_CELLS,1
GOBP_HEME_B_METABOLIC_PROCESS,SET,9,-0.21281,-0.0047081,0.27447,0.78093,GOBP_HEME_B_METABOLIC_PROCESS,1
GOMF_KINASE_REGULATOR_ACTIVI...,SET,253,-0.041173,-0.0047974,0.053102,0.78093,GOMF_KINASE_REGULATOR_ACTIVITY,1
DESCARTES_FETAL_CEREBELLUM_A...,SET,112,-0.06817,-0.0053054,0.08792,0.78093,DESCARTES_FETAL_CEREBELLUM_ASTROCYTES,1
KEGG_MEDICUS_VARIANT_LOSS_OF...3,SET,6,-0.22799,-0.0041187,0.29402,0.78095,KEGG_MEDICUS_VARIANT_LOSS_OF_RASSF1_TO_RAS_RASSF1_SIGNALING_PATHWAY,1
HERNANDEZ_ABERRANT_MITOSIS_B...2,SET,65,-0.086154,-0.0051145,0.1111,0.78096,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_2NM_UP,1
OISHI_CHOLANGIOMA_STEM_CELL_...1,SET,253,-0.043209,-0.0050346,0.055707,0.78102,OISHI_CHOLANGIOMA_STEM_CELL_LIKE_DN,1
GOCC_ACETYLTRANSFERASE_COMPL...,SET,89,-0.063031,-0.0043755,0.081257,0.78103,GOCC_ACETYLTRANSFERASE_COMPLEX,1
GSE17721_CTRL_VS_PAM3CSK4_6H...1,SET,181,-0.047705,-0.0047108,0.061492,0.78106,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_DN,1
GOBP_AMINE_CATABOLIC_PROCESS,SET,14,-0.19883,-0.0054855,0.25628,0.78107,GOBP_AMINE_CATABOLIC_PROCESS,1
MIR503_3P,SET,36,-0.11329,-0.0050092,0.14597,0.78116,MIR503_3P,1
GOBP_REGULATION_OF_INTRACELL...3,SET,139,-0.052808,-0.0045751,0.068037,0.78117,GOBP_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
GSE11057_EFF_MEM_VS_CENT_MEM...1,SET,158,-0.052275,-0.004826,0.06735,0.78117,GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN,1
GOBP_CARDIAC_CHAMBER_MORPHOG...,SET,121,-0.066995,-0.005418,0.086306,0.78119,GOBP_CARDIAC_CHAMBER_MORPHOGENESIS,1
GOCC_NUCLEAR_INNER_MEMBRANE,SET,48,-0.089978,-0.0045923,0.11591,0.7812,GOCC_NUCLEAR_INNER_MEMBRANE,1
GOBP_FIBROBLAST_PROLIFERATION,SET,105,-0.064573,-0.0048667,0.08317,0.78124,GOBP_FIBROBLAST_PROLIFERATION,1
DESERT_STEM_CELL_HEPATOCELLU...,SET,229,-0.044313,-0.0049155,0.057063,0.78129,DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP,1
SUNG_METASTASIS_STROMA_UP,SET,102,-0.067548,-0.0050182,0.086984,0.78129,SUNG_METASTASIS_STROMA_UP,1
MODULE_38,SET,424,-0.033396,-0.0050136,0.042999,0.78132,MODULE_38,1
GSE5099_DAY3_VS_DAY7_MCSF_TR...2,SET,169,-0.049456,-0.0047206,0.063673,0.78134,GSE5099_DAY3_VS_DAY7_MCSF_TREATED_MACROPHAGE_UP,1
CEBPGAMMA_Q6,SET,233,-0.044696,-0.0050005,0.05754,0.78135,CEBPGAMMA_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...21,SET,15,-0.18645,-0.0053243,0.24002,0.78135,GOBP_NEGATIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
CAAGGAT_MIR362,SET,59,-0.080465,-0.0045517,0.10357,0.78138,CAAGGAT_MIR362,1
HP_DECREASED_METHYLMALONYL_C...,SET,5,-0.31284,-0.0051592,0.40268,0.78138,HP_DECREASED_METHYLMALONYL_COA_MUTASE_ACTIVITY,1
GSE32164_ALTERNATIVELY_ACT_M...1,SET,179,-0.046982,-0.004614,0.06047,0.7814,GSE32164_ALTERNATIVELY_ACT_M2_VS_CMYC_INHIBITED_MACROPHAGE_DN,1
GOCC_NUCLEAR_PORE_NUCLEAR_BA...,SET,11,-0.18426,-0.0045065,0.23713,0.78142,GOCC_NUCLEAR_PORE_NUCLEAR_BASKET,1
GOMF_SUMO_BINDING,SET,16,-0.1485,-0.0043797,0.19103,0.78152,GOMF_SUMO_BINDING,1
HP_ABNORMAL_URINE_PH,SET,129,-0.05823,-0.0048613,0.074885,0.78159,HP_ABNORMAL_URINE_PH,1
GOMF_OLIGOSACCHARIDE_BINDING,SET,17,-0.17631,-0.0053595,0.22671,0.78162,GOMF_OLIGOSACCHARIDE_BINDING,1
GOBP_CYTOSKELETON_DEPENDENT_...2,SET,180,-0.048456,-0.0047718,0.062301,0.78164,GOBP_CYTOSKELETON_DEPENDENT_INTRACELLULAR_TRANSPORT,1
GOBP_PHENOTYPIC_SWITCHING,SET,7,-0.27037,-0.0052755,0.34762,0.78164,GOBP_PHENOTYPIC_SWITCHING,1
MIR548AA_MIR548AP_3P_MIR548T...,SET,505,-0.02961,-0.0048403,0.038068,0.78166,MIR548AA_MIR548AP_3P_MIR548T_3P,1
REACTOME_INSULIN_RECEPTOR_SI...,SET,53,-0.091416,-0.004902,0.11752,0.78167,REACTOME_INSULIN_RECEPTOR_SIGNALLING_CASCADE,1
HP_BREAST_HYPOPLASIA,SET,42,-0.10479,-0.0050039,0.13472,0.78167,HP_BREAST_HYPOPLASIA,1
MORF_G22P1,SET,152,-0.048673,-0.0044081,0.062557,0.78173,MORF_G22P1,1
GOBP_MICROGLIAL_CELL_MIGRATI...,SET,8,-0.25664,-0.0053531,0.32977,0.78177,GOBP_MICROGLIAL_CELL_MIGRATION,1
GOBP_MELANOSOME_ASSEMBLY,SET,18,-0.15484,-0.0048435,0.1989,0.78185,GOBP_MELANOSOME_ASSEMBLY,1
GOBP_RENAL_VESICLE_DEVELOPME...,SET,18,-0.17699,-0.0055361,0.22736,0.78185,GOBP_RENAL_VESICLE_DEVELOPMENT,1
GOBP_PHOSPHATIDIC_ACID_METAB...,SET,35,-0.11689,-0.0050962,0.15013,0.78189,GOBP_PHOSPHATIDIC_ACID_METABOLIC_PROCESS,1
GOBP_GLYCINE_BIOSYNTHETIC_PR...,SET,5,-0.28379,-0.0046802,0.36444,0.78192,GOBP_GLYCINE_BIOSYNTHETIC_PROCESS,1
HP_SHORTENED_QT_INTERVAL,SET,13,-0.20238,-0.0053806,0.25984,0.78197,HP_SHORTENED_QT_INTERVAL,1
REACTOME_EPHRIN_SIGNALING,SET,17,-0.16442,-0.0049982,0.21108,0.78198,REACTOME_EPHRIN_SIGNALING,1
CHEN_HOXA5_TARGETS_6HR_UP,SET,9,-0.23314,-0.0051579,0.29922,0.78205,CHEN_HOXA5_TARGETS_6HR_UP,1
GOBP_POSITIVE_REGULATION_OF_...57,SET,98,-0.06998,-0.0050964,0.089812,0.78206,GOBP_POSITIVE_REGULATION_OF_BINDING,1
TAAWWATAG_RSRFC4_Q2,SET,148,-0.054487,-0.0048697,0.069924,0.78207,TAAWWATAG_RSRFC4_Q2,1
GOMF_MOLECULAR_FUNCTION_INHI...,SET,457,-0.032557,-0.0050696,0.041776,0.7821,GOMF_MOLECULAR_FUNCTION_INHIBITOR_ACTIVITY,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...3,SET,8,-0.25427,-0.0053038,0.32618,0.78217,GOBP_CENTRAL_NERVOUS_SYSTEM_MYELIN_FORMATION,1
GSE42021_CD24INT_VS_CD24LOW_...3,SET,179,-0.049331,-0.0048446,0.063249,0.78228,GSE42021_CD24INT_VS_CD24LOW_TREG_THYMUS_DN,1
HASLINGER_B_CLL_WITH_MUTATED...,SET,16,-0.17346,-0.0051158,0.22239,0.78229,HASLINGER_B_CLL_WITH_MUTATED_VH_GENES,1
GOCC_APICAL_CORTEX,SET,8,-0.2198,-0.0045849,0.28179,0.78231,GOCC_APICAL_CORTEX,1
HP_PYODERMA,SET,4,-0.39036,-0.0057581,0.50039,0.78233,HP_PYODERMA,1
GOMF_FRUCTOSE_TRANSMEMBRANE_...,SET,8,-0.23152,-0.0048293,0.29674,0.78237,GOMF_FRUCTOSE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_PROTEIN_M...2,SET,1100,-0.020501,-0.0048632,0.026268,0.78244,GOBP_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,1
MORI_PLASMA_CELL_UP,SET,45,-0.098302,-0.0048582,0.12595,0.78245,MORI_PLASMA_CELL_UP,1
WP_SYNAPTIC_VESICLE_PATHWAY,SET,49,-0.096032,-0.0049519,0.12304,0.78245,WP_SYNAPTIC_VESICLE_PATHWAY,1
MEF2_02,SET,201,-0.047541,-0.0049445,0.060912,0.78245,MEF2_02,1
HP_DYSPLASTIC_CORPUS_CALLOSUM,SET,40,-0.10276,-0.0047889,0.13164,0.78248,HP_DYSPLASTIC_CORPUS_CALLOSUM,1
MODULE_125,SET,42,-0.099033,-0.0047287,0.12684,0.78252,MODULE_125,1
GOBP_NEGATIVE_REGULATION_OF_...558,SET,18,-0.1554,-0.0048609,0.19904,0.78252,GOBP_NEGATIVE_REGULATION_OF_RELEASE_OF_CYTOCHROME_C_FROM_MITOCHONDRIA,1
GOMF_L_GLUTAMATE_TRANSMEMBRA...,SET,14,-0.1817,-0.0050131,0.23259,0.78266,GOMF_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE19888_NO_PRETREAT_VS_ADEN...2,SET,177,-0.048549,-0.0047414,0.062139,0.78268,GSE19888_NO_PRETREAT_VS_ADENOSINE_A3R_INHIBITOR_PRETREATED_MAST_CELL_TCELL_MEMBRANES_ACT_UP,1
ZNF561_TARGET_GENES,SET,690,-0.025352,-0.004819,0.032435,0.78277,ZNF561_TARGET_GENES,1
GOBP_REGULATION_OF_ELECTRON_...,SET,3,-0.36188,-0.0046231,0.463,0.78277,GOBP_REGULATION_OF_ELECTRON_TRANSFER_ACTIVITY,1
REACTOME_HIGHLY_CALCIUM_PERM...2,SET,11,-0.24089,-0.0058916,0.3082,0.78278,REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS,1
GSE25123_ROSIGLITAZONE_VS_IL...2,SET,177,-0.049044,-0.0047897,0.062737,0.78281,GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
GOBP_POSITIVE_REGULATION_OF_...838,SET,3,-0.35226,-0.0045002,0.45041,0.78291,GOBP_POSITIVE_REGULATION_OF_VESICLE_TRANSPORT_ALONG_MICROTUBULE,1
MIR548I,SET,442,-0.03136,-0.0048044,0.040094,0.78294,MIR548I,1
GOBP_IRON_COORDINATION_ENTIT...,SET,11,-0.20706,-0.005064,0.26462,0.78302,GOBP_IRON_COORDINATION_ENTITY_TRANSPORT,1
GOMF_NEUROTRANSMITTER_RECEPT...1,SET,90,-0.076957,-0.0053721,0.098352,0.78302,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_CHOL...,SET,140,-0.057631,-0.0050107,0.073649,0.78304,HP_ABNORMAL_CIRCULATING_CHOLESTEROL_CONCENTRATION,1
HP_ABNORMAL_RENAL_PELVIS_MOR...,SET,244,-0.041682,-0.0047707,0.053245,0.78313,HP_ABNORMAL_RENAL_PELVIS_MORPHOLOGY,1
GSE6674_UNSTIM_VS_PL2_3_STIM...2,SET,133,-0.059451,-0.005039,0.075941,0.78314,GSE6674_UNSTIM_VS_PL2_3_STIM_BCELL_UP,1
GOMF_PROTEIN_GLUTAMINE_GAMMA...,SET,9,-0.23169,-0.0051258,0.29588,0.78319,GOMF_PROTEIN_GLUTAMINE_GAMMA_GLUTAMYLTRANSFERASE_ACTIVITY,1
VALK_AML_CLUSTER_9,SET,32,-0.12529,-0.0052234,0.15998,0.78322,VALK_AML_CLUSTER_9,1
GOBP_MEGAKARYOCYTE_DIFFERENT...,SET,47,-0.099904,-0.0050456,0.12754,0.78327,GOBP_MEGAKARYOCYTE_DIFFERENTIATION,1
GOMF_VOLTAGE_GATED_POTASSIUM...1,SET,96,-0.076239,-0.0054956,0.097327,0.78328,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY,1
MIR3670,SET,50,-0.091073,-0.0047437,0.11625,0.78331,MIR3670,1
GSE18791_CTRL_VS_NEWCASTLE_V...5,SET,166,-0.052033,-0.0049227,0.066398,0.78337,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_14H_DN,1
GOBP_REGULATION_OF_SISTER_CH...1,SET,11,-0.19144,-0.004682,0.24419,0.78347,GOBP_REGULATION_OF_SISTER_CHROMATID_COHESION,1
HP_ABDOMINAL_DISTENTION,SET,139,-0.057515,-0.0049829,0.073337,0.78355,HP_ABDOMINAL_DISTENTION,1
GOBP_RESPONSE_TO_VASOPRESSIN,SET,8,-0.24615,-0.0051343,0.31383,0.78357,GOBP_RESPONSE_TO_VASOPRESSIN,1
GSE16385_MONOCYTE_VS_12H_IL4...2,SET,175,-0.052189,-0.0050683,0.06654,0.78357,GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_UP,1
LI_ESTROGENE_EARLY_E2_RESPON...1,SET,73,-0.084946,-0.0053429,0.10829,0.78359,LI_ESTROGENE_EARLY_E2_RESPONSE_DN,1
HP_VITREORETINOPATHY,SET,21,-0.1526,-0.0051554,0.1945,0.78364,HP_VITREORETINOPATHY,1
HP_ABNORMALITY_OF_CORNEAL_TH...,SET,115,-0.062224,-0.0049066,0.079304,0.78366,HP_ABNORMALITY_OF_CORNEAL_THICKNESS,1
PID_IL4_2PATHWAY,SET,55,-0.092812,-0.0050696,0.11828,0.78368,PID_IL4_2PATHWAY,1
MUELLER_COMMON_TARGETS_OF_AM...2,SET,12,-0.20373,-0.0052042,0.25963,0.78369,MUELLER_COMMON_TARGETS_OF_AML_FUSIONS_UP,1
HP_GENERALIZED_LYMPHADENOPAT...,SET,9,-0.24152,-0.0053434,0.30774,0.78372,HP_GENERALIZED_LYMPHADENOPATHY,1
GOBP_INTRACELLULAR_PH_ELEVAT...,SET,7,-0.24449,-0.0047705,0.31148,0.78375,GOBP_INTRACELLULAR_PH_ELEVATION,1
GOBP_UNSATURATED_FATTY_ACID_...2,SET,104,-0.067659,-0.0050752,0.086193,0.78376,GOBP_UNSATURATED_FATTY_ACID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_TELOMERE_...3,SET,19,-0.14538,-0.004672,0.1852,0.78377,GOBP_REGULATION_OF_TELOMERE_MAINTENANCE_IN_RESPONSE_TO_DNA_DAMAGE,1
GOBP_L_ASPARTATE_TRANSMEMBRA...,SET,11,-0.19811,-0.0048453,0.25234,0.7838,GOBP_L_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
GOBP_INTEGRIN_BIOSYNTHETIC_P...,SET,4,-0.37607,-0.0055474,0.47895,0.78383,GOBP_INTEGRIN_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...428,SET,4,-0.33027,-0.0048718,0.42061,0.78384,GOBP_POSITIVE_REGULATION_OF_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...648,SET,114,-0.063408,-0.0049783,0.080749,0.78384,GOBP_POSITIVE_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
GOCC_AXONEMAL_OUTER_DOUBLET,SET,14,-0.19472,-0.0053722,0.24793,0.78389,GOCC_AXONEMAL_OUTER_DOUBLET,1
GSE27786_LSK_VS_ERYTHROBLAST...2,SET,178,-0.048071,-0.0047078,0.061205,0.78389,GSE27786_LSK_VS_ERYTHROBLAST_UP,1
REACTOME_SYNTHESIS_OF_EPOXY_...,SET,8,-0.23496,-0.004901,0.29909,0.78394,REACTOME_SYNTHESIS_OF_EPOXY_EET_AND_DIHYDROXYEICOSATRIENOIC_ACIDS_DHET,1
REACTOME_NITRIC_OXIDE_STIMUL...,SET,19,-0.16545,-0.005317,0.21059,0.78396,REACTOME_NITRIC_OXIDE_STIMULATES_GUANYLATE_CYCLASE,1
GOBP_ACTOMYOSIN_STRUCTURE_OR...,SET,205,-0.046644,-0.0048987,0.059369,0.78396,GOBP_ACTOMYOSIN_STRUCTURE_ORGANIZATION,1
HP_PULMONARY_ARTERIAL_HYPERT...,SET,130,-0.057568,-0.0048245,0.073271,0.78397,HP_PULMONARY_ARTERIAL_HYPERTENSION,1
PID_ATF2_PATHWAY,SET,58,-0.096598,-0.0054179,0.12294,0.78398,PID_ATF2_PATHWAY,1
HP_ASTHMA,SET,150,-0.054523,-0.0049055,0.069391,0.78398,HP_ASTHMA,1
GSE3920_IFNA_VS_IFNG_TREATED...1,SET,153,-0.054293,-0.004933,0.069099,0.78398,GSE3920_IFNA_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN,1
GOBP_PLATELET_AGGREGATION,SET,73,-0.084362,-0.0053062,0.10733,0.78406,GOBP_PLATELET_AGGREGATION,1
HP_EYELID_MYOCLONUS,SET,9,-0.22635,-0.0050078,0.28797,0.78407,HP_EYELID_MYOCLONUS,1
GSE17721_POLYIC_VS_GARDIQUIM...2,SET,184,-0.048819,-0.0048602,0.062104,0.78409,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
GOBP_REGULATION_OF_EXTENT_OF...,SET,84,-0.07364,-0.004967,0.093672,0.7841,GOBP_REGULATION_OF_EXTENT_OF_CELL_GROWTH,1
HP_ABNORMALITY_OF_THE_SUBUNG...,SET,11,-0.1823,-0.0044584,0.23187,0.78412,HP_ABNORMALITY_OF_THE_SUBUNGUAL_REGION,1
GOBP_POSITIVE_REGULATION_OF_...720,SET,8,-0.20879,-0.0043551,0.26551,0.78417,GOBP_POSITIVE_REGULATION_OF_SPINDLE_ASSEMBLY,1
KEGG_MEDICUS_REFERENCE_CGAS_...,SET,13,-0.23281,-0.0061894,0.29601,0.7842,KEGG_MEDICUS_REFERENCE_CGAS_STING_SIGNALING_PATHWAY,1
HP_ABNORMAL_GROWTH_HORMONE_L...,SET,25,-0.13311,-0.0049059,0.16923,0.78422,HP_ABNORMAL_GROWTH_HORMONE_LEVEL,1
GOBP_NUCLEAR_TRANSCRIBED_MRN...2,SET,57,-0.086383,-0.0048032,0.10982,0.78423,GOBP_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
GOBP_PHOSPHORYLATION,SET,1257,-0.019547,-0.0049341,0.024851,0.78423,GOBP_PHOSPHORYLATION,1
BUSSLINGER_DUODENAL_GOBLET_C...,SET,15,-0.19707,-0.0056275,0.25054,0.78423,BUSSLINGER_DUODENAL_GOBLET_CELLS,1
REACTOME_DIGESTION_OF_DIETAR...2,SET,6,-0.3558,-0.0064277,0.45222,0.78429,REACTOME_DIGESTION_OF_DIETARY_LIPID,1
MIR3960_MIR8072,SET,17,-0.31238,-0.009496,0.39701,0.7843,MIR3960_MIR8072,1
GOBP_BRADYKININ_CATABOLIC_PR...,SET,7,-0.27949,-0.0054535,0.35506,0.7844,GOBP_BRADYKININ_CATABOLIC_PROCESS,1
chr14q31,SET,15,-0.27739,-0.0079212,0.35237,0.78441,chr14q31,1
GSE23398_WT_VS_IL2_KO_CD4_TC...1,SET,180,-0.048093,-0.0047361,0.061087,0.78444,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_DN,1
MIR320A_3P_MIR320B_MIR320C_M...,SET,276,-0.041803,-0.0050842,0.053092,0.78446,MIR320A_3P_MIR320B_MIR320C_MIR320D,1
FOXM1_01,SET,226,-0.045573,-0.0050224,0.057873,0.78449,FOXM1_01,1
HP_GLYCOSURIA,SET,40,-0.10561,-0.0049216,0.13411,0.78449,HP_GLYCOSURIA,1
HP_IMPAIRED_TACTILE_SENSATION,SET,32,-0.11125,-0.0046382,0.14126,0.78452,HP_IMPAIRED_TACTILE_SENSATION,1
GOBP_BUNDLE_OF_HIS_CELL_TO_P...1,SET,15,-0.20443,-0.0058377,0.25956,0.78453,GOBP_BUNDLE_OF_HIS_CELL_TO_PURKINJE_MYOCYTE_COMMUNICATION,1
GNF2_NS,SET,37,-0.099813,-0.0044739,0.12669,0.7846,GNF2_NS,1
KEGG_MEDICUS_VARIANT_EML4_AL...2,SET,8,-0.23793,-0.0049629,0.30197,0.78462,KEGG_MEDICUS_VARIANT_EML4_ALK_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_INTRI...,SET,13,-0.19553,-0.0051983,0.24808,0.7847,KEGG_MEDICUS_REFERENCE_INTRINSIC_APOPTOTIC_PATHWAY,1
GSE29615_DAY3_VS_DAY7_LAIV_F...2,SET,145,-0.055949,-0.0049499,0.070982,0.78471,GSE29615_DAY3_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,1
GOBP_REGULATION_OF_INNER_EAR...,SET,8,-0.24133,-0.0050339,0.30616,0.78472,GOBP_REGULATION_OF_INNER_EAR_AUDITORY_RECEPTOR_CELL_DIFFERENTIATION,1
ASH1L_TARGET_GENES,SET,1138,-0.020592,-0.0049629,0.026121,0.78475,ASH1L_TARGET_GENES,1
GSE26343_WT_VS_NFAT5_KO_MACR...4,SET,181,-0.047572,-0.0046976,0.060339,0.78477,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_UP,1
GOBP_MRNA_EXPORT_FROM_NUCLEUS,SET,60,-0.076946,-0.0043893,0.097577,0.78481,GOBP_MRNA_EXPORT_FROM_NUCLEUS,1
KEGG_GRAFT_VERSUS_HOST_DISEA...,SET,33,-0.13196,-0.0055864,0.16732,0.78484,KEGG_GRAFT_VERSUS_HOST_DISEASE,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...9,SET,65,-0.074719,-0.0044356,0.094706,0.78492,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_POSITIVE,1
GOBP_CELLULAR_RESPONSE_TO_MI...,SET,12,-0.21269,-0.0054329,0.26956,0.78495,GOBP_CELLULAR_RESPONSE_TO_MINERALOCORTICOID_STIMULUS,1
MIR7_1_3P,SET,593,-0.028731,-0.0050768,0.036409,0.78497,MIR7_1_3P,1
HP_ABNORMAL_PELVIS_BONE_OSSI...,SET,15,-0.16807,-0.0047996,0.21297,0.78499,HP_ABNORMAL_PELVIS_BONE_OSSIFICATION,1
HP_PERISYLVIAN_POLYMICROGYRIA,SET,32,-0.12473,-0.0052001,0.15795,0.78513,HP_PERISYLVIAN_POLYMICROGYRIA,1
MIR664A_3P,SET,359,-0.036174,-0.0050061,0.0458,0.78518,MIR664A_3P,1
REACTOME_OVARIAN_TUMOR_DOMAI...,SET,34,-0.11084,-0.0047627,0.14029,0.78524,REACTOME_OVARIAN_TUMOR_DOMAIN_PROTEASES,1
GOBP_POSITIVE_REGULATION_OF_...553,SET,61,-0.084501,-0.0048601,0.10696,0.78525,GOBP_POSITIVE_REGULATION_OF_NUCLEOCYTOPLASMIC_TRANSPORT,1
MIR4275,SET,139,-0.056545,-0.0048989,0.071568,0.78526,MIR4275,1
MORF_PSMF1,SET,159,-0.050571,-0.0046833,0.064007,0.78526,MORF_PSMF1,1
WP_DISORDERS_OF_FRUCTOSE_MET...,SET,12,-0.1706,-0.0043578,0.2159,0.78528,WP_DISORDERS_OF_FRUCTOSE_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...570,SET,7,-0.21224,-0.0041413,0.26858,0.7853,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
DESCARTES_FETAL_HEART_STROMA...,SET,25,-0.14441,-0.0053224,0.18274,0.7853,DESCARTES_FETAL_HEART_STROMAL_CELLS,1
PID_IL8_CXCR2_PATHWAY,SET,34,-0.11515,-0.0049482,0.14566,0.78539,PID_IL8_CXCR2_PATHWAY,1
WP_GLYCOLYSIS_AND_GLUCONEOGE...,SET,38,-0.10215,-0.0046398,0.12919,0.78542,WP_GLYCOLYSIS_AND_GLUCONEOGENESIS,1
GSE9988_LPS_VS_LOW_LPS_MONOC...1,SET,147,-0.05497,-0.0048965,0.069523,0.78543,GSE9988_LPS_VS_LOW_LPS_MONOCYTE_DN,1
GSE46606_IRF4_KO_VS_WT_CD40L...3,SET,169,-0.049583,-0.0047327,0.062698,0.78547,GSE46606_IRF4_KO_VS_WT_CD40L_IL2_IL5_3DAY_STIMULATED_BCELL_DN,1
GNF2_BUB1,SET,26,-0.11812,-0.0044396,0.14933,0.78553,GNF2_BUB1,1
JAATINEN_HEMATOPOIETIC_STEM_...1,SET,208,-0.050515,-0.0053434,0.063829,0.78564,JAATINEN_HEMATOPOIETIC_STEM_CELL_DN,1
HP_ABNORMALITY_OF_PRENATAL_D...,SET,881,-0.022656,-0.0048401,0.028628,0.78564,HP_ABNORMALITY_OF_PRENATAL_DEVELOPMENT_OR_BIRTH,1
GOBP_GLOMERULAR_BASEMENT_MEM...,SET,11,-0.21005,-0.0051372,0.26535,0.78569,GOBP_GLOMERULAR_BASEMENT_MEMBRANE_DEVELOPMENT,1
HP_INSPIRATORY_STRIDOR,SET,14,-0.18036,-0.0049761,0.22784,0.7857,HP_INSPIRATORY_STRIDOR,1
GOBP_ENDODERM_DEVELOPMENT,SET,80,-0.080011,-0.0052673,0.10107,0.78572,GOBP_ENDODERM_DEVELOPMENT,1
GOBP_INTRACILIARY_RETROGRADE...,SET,10,-0.19838,-0.0046261,0.25055,0.78575,GOBP_INTRACILIARY_RETROGRADE_TRANSPORT,1
BUCKANOVICH_T_LYMPHOCYTE_HOM...2,SET,18,-0.16364,-0.0051187,0.20663,0.7858,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_UP,1
MIR5093,SET,221,-0.045251,-0.0049322,0.057139,0.7858,MIR5093,1
GOBP_POSITIVE_REGULATION_OF_...701,SET,6,-0.2569,-0.004641,0.32439,0.7858,GOBP_POSITIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,1
GSE37534_PIOGLITAZONE_VS_ROS...1,SET,145,-0.058286,-0.0051566,0.073593,0.78582,GSE37534_PIOGLITAZONE_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
VARELA_ZMPSTE24_TARGETS_DN,SET,35,-0.11555,-0.0050376,0.14586,0.78588,VARELA_ZMPSTE24_TARGETS_DN,1
HP_MEGALENCEPHALY,SET,40,-0.10775,-0.0050211,0.13601,0.78588,HP_MEGALENCEPHALY,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...3,SET,913,-0.023259,-0.0050536,0.029351,0.78594,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_UP,1
LEE_BMP2_TARGETS_UP,SET,699,-0.026748,-0.0051163,0.033746,0.786,LEE_BMP2_TARGETS_UP,1
LIM_MAMMARY_LUMINAL_MATURE_DN,SET,90,-0.075772,-0.0052894,0.095595,0.786,LIM_MAMMARY_LUMINAL_MATURE_DN,1
HP_PROXIMAL_RADIO_ULNAR_SYNO...,SET,6,-0.32176,-0.0058127,0.40593,0.78601,HP_PROXIMAL_RADIO_ULNAR_SYNOSTOSIS,1
GOBP_REGULATION_OF_APPETITE,SET,20,-0.16066,-0.005297,0.20265,0.78604,GOBP_REGULATION_OF_APPETITE,1
MAINA_VHL_TARGETS_UP,SET,10,-0.23416,-0.0054605,0.29532,0.78608,MAINA_VHL_TARGETS_UP,1
MIR518C_5P,SET,175,-0.050971,-0.00495,0.064284,0.78608,MIR518C_5P,1
GOMF_2_ACYLGLYCEROL_3_PHOSPH...,SET,8,-0.26017,-0.0054269,0.32803,0.78615,GOMF_2_ACYLGLYCEROL_3_PHOSPHATE_O_ACYLTRANSFERASE_ACTIVITY,1
GOBP_XYLULOSE_5_PHOSPHATE_ME...,SET,6,-0.28613,-0.0051691,0.36074,0.78616,GOBP_XYLULOSE_5_PHOSPHATE_METABOLIC_PROCESS,1
MORF_PPP6C,SET,95,-0.060193,-0.0043164,0.075878,0.78619,MORF_PPP6C,1
GOCC_INTERPHOTORECEPTOR_MATR...,SET,5,-0.35981,-0.0059338,0.45357,0.78619,GOCC_INTERPHOTORECEPTOR_MATRIX,1
GOMF_INORGANIC_DIPHOSPHATE_P...,SET,4,-0.38655,-0.005702,0.48721,0.78622,GOMF_INORGANIC_DIPHOSPHATE_PHOSPHATASE_ACTIVITY,1
KEGG_MEDICUS_VARIANT_AMPLIFI...14,SET,8,-0.24171,-0.0050419,0.30463,0.78624,KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...1,SET,7,-0.27287,-0.0053243,0.34388,0.78626,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_0DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_DN,1
HP_ABNORMAL_CIRCULATING_PROT...2,SET,58,-0.083135,-0.0046628,0.10476,0.78628,HP_ABNORMAL_CIRCULATING_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_CONCENTRATION,1
GSE11961_MARGINAL_ZONE_BCELL...6,SET,181,-0.049385,-0.0048767,0.062228,0.78628,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY40_UP,1
HP_EXTRA_AXIAL_CEREBROSPINAL...,SET,14,-0.16996,-0.0046891,0.21414,0.78631,HP_EXTRA_AXIAL_CEREBROSPINAL_FLUID_ACCUMULATION,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...1,SET,17,-0.16804,-0.0051082,0.21163,0.7864,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_1,1
GOBP_NEUROTRANSMITTER_TRANSP...,SET,194,-0.049062,-0.005014,0.061777,0.78645,GOBP_NEUROTRANSMITTER_TRANSPORT,1
GOBP_FERMENTATION,SET,3,-0.3876,-0.0049517,0.48804,0.78646,GOBP_FERMENTATION,1
GSE41867_DAY6_EFFECTOR_VS_DA...4,SET,183,-0.049518,-0.0049164,0.062348,0.78646,GSE41867_DAY6_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,1
GSE7568_IL4_VS_IL4_AND_TGFB_...1,SET,176,-0.047311,-0.0046075,0.059563,0.78648,GSE7568_IL4_VS_IL4_AND_TGFB_TREATED_MACROPHAGE_24H_DN,1
GSE360_CTRL_VS_B_MALAYI_HIGH...3,SET,189,-0.047475,-0.0047896,0.059763,0.78651,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_MAC_DN,1
GSE22886_NAIVE_CD4_TCELL_VS_...11,SET,179,-0.048024,-0.0047163,0.060439,0.78657,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_DN,1
REACTOME_GLYCEROPHOSPHOLIPID...1,SET,113,-0.065733,-0.0051383,0.082717,0.78659,REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS,1
MIR600,SET,129,-0.062474,-0.0052156,0.078616,0.78659,MIR600,1
GOCC_SARCOPLASM,SET,92,-0.069022,-0.0048712,0.086839,0.78664,GOCC_SARCOPLASM,1
GOBP_NEGATIVE_REGULATION_OF_...565,SET,364,-0.036228,-0.0050476,0.045577,0.78665,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_EXTERNAL_STIMULUS,1
GOBP_NEGATIVE_REGULATION_OF_...707,SET,157,-0.055717,-0.0051276,0.070093,0.78666,GOBP_NEGATIVE_REGULATION_OF_WNT_SIGNALING_PATHWAY,1
GSE40277_EOS_AND_LEF1_TRANSD...4,SET,179,-0.050099,-0.0049201,0.063009,0.78672,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_UP,1
MIR10393_5P,SET,135,-0.057985,-0.0049513,0.072922,0.78673,MIR10393_5P,1
WP_GNAQ_PATHWAYS_IN_PORTWINE...,SET,20,-0.15121,-0.0049855,0.19017,0.78674,WP_GNAQ_PATHWAYS_IN_PORTWINE_STAIN,1
GOBP_REGULATION_OF_MRNA_EXPO...,SET,8,-0.19084,-0.0039806,0.23999,0.78675,GOBP_REGULATION_OF_MRNA_EXPORT_FROM_NUCLEUS,1
GOBP_RESPONSE_TO_INTERLEUKIN...11,SET,14,-0.16947,-0.0046754,0.21311,0.78675,GOBP_RESPONSE_TO_INTERLEUKIN_7,1
GOBP_UDP_N_ACETYLGLUCOSAMINE...3,SET,5,-0.26432,-0.0043591,0.33228,0.78682,GOBP_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORT,1
GOMF_UDP_N_ACETYLGLUCOSAMINE...,SET,5,-0.26432,-0.0043591,0.33228,0.78682,GOMF_UDP_N_ACETYLGLUCOSAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_B_CELL_PROLIFERATION,SET,96,-0.075146,-0.0054168,0.09446,0.78684,GOBP_B_CELL_PROLIFERATION,1
GOBP_NEGATIVE_REGULATION_OF_...349,SET,94,-0.070547,-0.0050323,0.088667,0.78687,GOBP_NEGATIVE_REGULATION_OF_LIPID_METABOLIC_PROCESS,1
MIR650,SET,108,-0.06521,-0.0049841,0.081957,0.78688,MIR650,1
GOMF_HYDROLASE_ACTIVITY_ACTI...7,SET,677,-0.025669,-0.0048349,0.032257,0.78691,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ESTER_BONDS,1
GSE3982_MAST_CELL_VS_NEUTROP...1,SET,176,-0.050347,-0.0049032,0.06327,0.78691,GSE3982_MAST_CELL_VS_NEUTROPHIL_DN,1
SESTO_RESPONSE_TO_UV_C0,SET,98,-0.064965,-0.0047312,0.081632,0.78693,SESTO_RESPONSE_TO_UV_C0,1
MIR12124,SET,289,-0.038466,-0.0047854,0.048325,0.78697,MIR12124,1
HP_TEMPERATURE_INSTABILITY,SET,34,-0.11583,-0.0049775,0.14551,0.787,HP_TEMPERATURE_INSTABILITY,1
GSE17721_CPG_VS_GARDIQUIMOD_...4,SET,184,-0.051064,-0.0050837,0.064143,0.78701,GSE17721_CPG_VS_GARDIQUIMOD_12H_BMDC_UP,1
GSE29614_CTRL_VS_DAY3_TIV_FL...1,SET,139,-0.059633,-0.0051664,0.074904,0.78702,GSE29614_CTRL_VS_DAY3_TIV_FLU_VACCINE_PBMC_DN,1
HP_EEG_WITH_FOCAL_SHARP_WAVES,SET,10,-0.20935,-0.0048819,0.26294,0.78703,HP_EEG_WITH_FOCAL_SHARP_WAVES,1
ZHONG_PFC_C4_PTGDS_POS_OPC,SET,132,-0.061464,-0.0051902,0.077179,0.78709,ZHONG_PFC_C4_PTGDS_POS_OPC,1
REACTOME_DOWNSTREAM_SIGNALIN...2,SET,31,-0.11967,-0.0049108,0.15024,0.78713,REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR1,1
TRIP13_TARGET_GENES,SET,69,-0.080366,-0.004915,0.1009,0.78713,TRIP13_TARGET_GENES,1
WP_GASTRIC_CANCER_NETWORK_2,SET,30,-0.12507,-0.0050488,0.15699,0.78717,WP_GASTRIC_CANCER_NETWORK_2,1
KEGG_LINOLEIC_ACID_METABOLISM,SET,29,-0.13965,-0.0055428,0.17522,0.78726,KEGG_LINOLEIC_ACID_METABOLISM,1
NAM_FXYD5_TARGETS_DN,SET,17,-0.15487,-0.0047079,0.1943,0.78729,NAM_FXYD5_TARGETS_DN,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...8,SET,5,-0.26727,-0.0044078,0.33525,0.78734,GOMF_UBIQUITIN_LIKE_PROTEIN_SPECIFIC_ENDOPEPTIDASE_ACTIVITY,1
SP1_Q6_01,SET,231,-0.04297,-0.004787,0.053895,0.78735,SP1_Q6_01,1
FERRANDO_T_ALL_WITH_MLL_ENL_...1,SET,78,-0.073547,-0.0047811,0.092235,0.78738,FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_DN,1
GOBP_MAMMARY_GLAND_EPITHELIU...,SET,67,-0.089692,-0.0054055,0.11246,0.78743,GOBP_MAMMARY_GLAND_EPITHELIUM_DEVELOPMENT,1
MIR548AB,SET,444,-0.031971,-0.0049089,0.040085,0.78744,MIR548AB,1
GSE2770_IL12_ACT_VS_ACT_CD4_...1,SET,181,-0.048266,-0.0047662,0.060501,0.78749,GSE2770_IL12_ACT_VS_ACT_CD4_TCELL_2H_DN,1
GSE360_L_MAJOR_VS_B_MALAYI_H...2,SET,177,-0.051888,-0.0050675,0.065004,0.78763,GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
SIMBULAN_PARP1_TARGETS_DN,SET,16,-0.15602,-0.0046014,0.19544,0.78765,SIMBULAN_PARP1_TARGETS_DN,1
NAKAJIMA_MAST_CELL,SET,40,-0.11253,-0.0052442,0.14093,0.78772,NAKAJIMA_MAST_CELL,1
GOBP_MULTICELLULAR_ORGANISMA...1,SET,75,-0.080309,-0.0051197,0.10057,0.78772,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_CHEMICAL_HOMEOSTASIS,1
GOBP_POSITIVE_REGULATION_OF_...62,SET,50,-0.098016,-0.0051054,0.1227,0.7878,GOBP_POSITIVE_REGULATION_OF_BLOOD_VESSEL_ENDOTHELIAL_CELL_MIGRATION,1
GOBP_SALIVA_SECRETION,SET,13,-0.20658,-0.0054923,0.25855,0.78785,GOBP_SALIVA_SECRETION,1
HP_LIP_TELANGIECTASIA,SET,5,-0.28636,-0.0047226,0.3584,0.78785,HP_LIP_TELANGIECTASIA,1
GSE22229_UNTREATED_VS_IMMUNO...2,SET,171,-0.052452,-0.0050358,0.065636,0.78789,GSE22229_UNTREATED_VS_IMMUNOSUPP_THERAPY_RENAL_TRANSPLANT_PATIENT_PBMC_UP,1
KLEIN_TARGETS_OF_BCR_ABL1_FU...,SET,40,-0.11565,-0.0053896,0.1447,0.78792,KLEIN_TARGETS_OF_BCR_ABL1_FUSION,1
GOBP_DNA_DAMAGE_RESPONSE_SIG...2,SET,19,-0.14545,-0.0046742,0.18192,0.788,GOBP_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR_RESULTING_IN_CELL_CYCLE_ARREST,1
WU_APOPTOSIS_BY_CDKN1A_VIA_T...,SET,50,-0.090527,-0.0047153,0.11322,0.78801,WU_APOPTOSIS_BY_CDKN1A_VIA_TP53,1
KEGG_ALANINE_ASPARTATE_AND_G...,SET,29,-0.13034,-0.0051732,0.16298,0.78806,KEGG_ALANINE_ASPARTATE_AND_GLUTAMATE_METABOLISM,1
HP_ABNORMAL_QRS_COMPLEX,SET,9,-0.25379,-0.0056147,0.31732,0.78808,HP_ABNORMAL_QRS_COMPLEX,1
MATZUK_STEROIDOGENESIS,SET,6,-0.31004,-0.0056009,0.38763,0.78809,MATZUK_STEROIDOGENESIS,1
GSE24574_BCL6_HIGH_TFH_VS_TC...1,SET,188,-0.050895,-0.0051211,0.063628,0.7881,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_DN,1
GOBP_NEUROPEPTIDE_SIGNALING_...,SET,92,-0.075932,-0.0053588,0.094905,0.78816,GOBP_NEUROPEPTIDE_SIGNALING_PATHWAY,1
REACTOME_PLASMA_LIPOPROTEIN_...4,SET,32,-0.1216,-0.0050697,0.15197,0.78819,REACTOME_PLASMA_LIPOPROTEIN_REMODELING,1
REACTOME_SYNTHESIS_OF_WYBUTO...,SET,6,-0.23327,-0.004214,0.29152,0.78819,REACTOME_SYNTHESIS_OF_WYBUTOSINE_AT_G37_OF_TRNA_PHE,1
GOMF_LIGASE_ACTIVITY_FORMING...2,SET,45,-0.098364,-0.0048613,0.12292,0.7882,GOMF_LIGASE_ACTIVITY_FORMING_CARBON_NITROGEN_BONDS,1
HP_GENERALIZED_HYPOTONIA,SET,580,-0.027489,-0.0048056,0.034352,0.7882,HP_GENERALIZED_HYPOTONIA,1
HP_MULTICYSTIC_KIDNEY_DYSPLA...,SET,82,-0.07225,-0.0048152,0.090288,0.7882,HP_MULTICYSTIC_KIDNEY_DYSPLASIA,1
GOMF_DYSTROGLYCAN_BINDING,SET,10,-0.20462,-0.0047716,0.25564,0.78826,GOMF_DYSTROGLYCAN_BINDING,1
GOMF_PYRIMIDINE_NUCLEOTIDE_S...,SET,10,-0.20466,-0.0047725,0.25567,0.78828,GOMF_PYRIMIDINE_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMALITY_OF_LOWER_LIMB...,SET,639,-0.02701,-0.0049481,0.033742,0.78828,HP_ABNORMALITY_OF_LOWER_LIMB_JOINT,1
TGIF_01,SET,229,-0.045081,-0.0050007,0.056301,0.78835,TGIF_01,1
GOBP_REGULATION_OF_OSTEOCLAS...3,SET,6,-0.258,-0.0046609,0.32218,0.78837,GOBP_REGULATION_OF_OSTEOCLAST_PROLIFERATION,1
BOQUEST_STEM_CELL_DN,SET,205,-0.052456,-0.005509,0.065499,0.78839,BOQUEST_STEM_CELL_DN,1
GOBP_REGULATION_OF_POSTSYNAP...5,SET,17,-0.17261,-0.0052472,0.21553,0.78839,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ORGANIZATION,1
GOBP_PYRIMIDINE_RIBONUCLEOTI...3,SET,29,-0.12409,-0.0049253,0.15492,0.78843,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_METABOLIC_PROCESS,1
HP_RHEGMATOGENOUS_RETINAL_DE...,SET,11,-0.21113,-0.0051637,0.26359,0.78843,HP_RHEGMATOGENOUS_RETINAL_DETACHMENT,1
REACTOME_APC_C_CDC20_MEDIATE...,SET,22,-0.13404,-0.0046346,0.16732,0.78845,REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B,1
FRANCO_BLOOD_SANOFI_PASTEUR_...7,SET,17,-0.16424,-0.0049928,0.20499,0.78849,FRANCO_BLOOD_SANOFI_PASTEUR_SA_INACTIVATED_INFLUENZA_VACCINE_CORRELATED_WITH_ANTIBODY_RESPONSE_AGE_18_40YO_3DY_POSITIVE,1
GSE2197_CPG_DNA_VS_UNTREATED...2,SET,177,-0.05086,-0.0049671,0.063473,0.78851,GSE2197_CPG_DNA_VS_UNTREATED_IN_DC_UP,1
GSE37534_UNTREATED_VS_GW1929...2,SET,183,-0.051161,-0.0050796,0.063844,0.78853,GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_UP,1
GOMF_HORMONE_ACTIVITY,SET,111,-0.069767,-0.0054055,0.087054,0.78855,GOMF_HORMONE_ACTIVITY,1
STN1_TARGET_GENES,SET,8,-0.25186,-0.0052534,0.31423,0.78857,STN1_TARGET_GENES,1
GOMF_MONOOXYGENASE_ACTIVITY,SET,100,-0.074761,-0.0054995,0.093277,0.78857,GOMF_MONOOXYGENASE_ACTIVITY,1
ZNF623_TARGET_GENES,SET,335,-0.03662,-0.0048988,0.04567,0.78867,ZNF623_TARGET_GENES,1
CREIGHTON_ENDOCRINE_THERAPY_...3,SET,650,-0.028269,-0.0052214,0.035253,0.78869,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_3,1
GSE22886_IGG_IGA_MEMORY_BCEL...1,SET,170,-0.050056,-0.0047919,0.062421,0.78869,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
WP_REGULATION_OF_APOPTOSIS_B...,SET,24,-0.13741,-0.0049622,0.17131,0.78875,WP_REGULATION_OF_APOPTOSIS_BY_PARATHYROID_HORMONERELATED_PROTEIN,1
GOBP_INTESTINAL_EPITHELIAL_C...1,SET,16,-0.18216,-0.0053722,0.22695,0.7889,GOBP_INTESTINAL_EPITHELIAL_CELL_DEVELOPMENT,1
REACTOME_COHESIN_LOADING_ONT...,SET,7,-0.27813,-0.0054268,0.3465,0.78891,REACTOME_COHESIN_LOADING_ONTO_CHROMATIN,1
ZNF547_TARGET_GENES,SET,263,-0.042688,-0.0050698,0.053182,0.78891,ZNF547_TARGET_GENES,1
GOBP_ESTABLISHMENT_OF_ORGANE...,SET,436,-0.03192,-0.0048577,0.039759,0.78896,GOBP_ESTABLISHMENT_OF_ORGANELLE_LOCALIZATION,1
GNF2_ESPL1,SET,35,-0.10573,-0.0046096,0.13168,0.78899,GNF2_ESPL1,1
GOBP_MODIFICATION_OF_SYNAPTI...,SET,26,-0.12863,-0.0048345,0.16019,0.789,GOBP_MODIFICATION_OF_SYNAPTIC_STRUCTURE,1
HP_TONGUE_ATROPHY,SET,49,-0.094318,-0.0048635,0.11744,0.78904,HP_TONGUE_ATROPHY,1
MIR410_3P,SET,297,-0.040078,-0.0050534,0.049901,0.78905,MIR410_3P,1
HP_HYPOPLASTIC_FEMALE_EXTERN...,SET,55,-0.092136,-0.0050327,0.11471,0.78906,HP_HYPOPLASTIC_FEMALE_EXTERNAL_GENITALIA,1
MIR4743_3P,SET,185,-0.050391,-0.0050302,0.062734,0.78908,MIR4743_3P,1
GSE26030_TH1_VS_TH17_DAY5_PO...1,SET,183,-0.050464,-0.0050104,0.062824,0.78908,GSE26030_TH1_VS_TH17_DAY5_POST_POLARIZATION_DN,1
GOBP_SMOOTH_MUSCLE_CELL_DIFF...,SET,59,-0.090543,-0.0051218,0.11272,0.78909,GOBP_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
SMITH_LIVER_CANCER,SET,45,-0.10467,-0.005173,0.13029,0.78911,SMITH_LIVER_CANCER,1
GOBP_REGULATION_OF_MIRNA_CAT...,SET,4,-0.27613,-0.0040733,0.34372,0.78912,GOBP_REGULATION_OF_MIRNA_CATABOLIC_PROCESS,1
GOBP_APICAL_JUNCTION_ASSEMBLY,SET,71,-0.082143,-0.0050957,0.10224,0.78914,GOBP_APICAL_JUNCTION_ASSEMBLY,1
MIR4761_5P,SET,62,-0.084303,-0.0048882,0.10492,0.78915,MIR4761_5P,1
GSE22886_NAIVE_CD4_TCELL_VS_...15,SET,174,-0.055476,-0.0053722,0.069042,0.78915,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_DN,1
GSE10240_CTRL_VS_IL17_AND_IL...2,SET,182,-0.046692,-0.0046234,0.058105,0.78918,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
GSE14308_NAIVE_CD4_TCELL_VS_...4,SET,177,-0.048738,-0.0047598,0.06065,0.78918,GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_UP,1
MIR150_5P,SET,160,-0.051997,-0.0048303,0.064697,0.78921,MIR150_5P,1
WP_THERMOGENESIS,SET,105,-0.066784,-0.0050334,0.083084,0.78924,WP_THERMOGENESIS,1
MIR15B_3P,SET,73,-0.081654,-0.0051358,0.10158,0.78924,MIR15B_3P,1
FOX_Q2,SET,191,-0.051145,-0.0051867,0.063628,0.78925,FOX_Q2,1
GOBP_CYTOPLASMIC_SEQUESTERIN...1,SET,4,-0.32094,-0.0047342,0.39922,0.78927,GOBP_CYTOPLASMIC_SEQUESTERING_OF_NF_KAPPAB,1
GOBP_POSITIVE_REGULATION_OF_...781,SET,5,-0.27135,-0.0044749,0.33753,0.78927,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,1
HP_ROTARY_NYSTAGMUS,SET,21,-0.14613,-0.0049369,0.18177,0.78928,HP_ROTARY_NYSTAGMUS,1
REACTOME_INOSITOL_PHOSPHATE_...,SET,45,-0.091342,-0.0045142,0.11357,0.78937,REACTOME_INOSITOL_PHOSPHATE_METABOLISM,1
HE_LIM_SUN_FETAL_LUNG_C2_APO...2,SET,436,-0.032466,-0.0049409,0.040364,0.7894,HE_LIM_SUN_FETAL_LUNG_C2_APOE_POS_M2_MACROPHAGE_CELL,1
GSE22886_CD8_TCELL_VS_BCELL_...1,SET,170,-0.052632,-0.0050384,0.065399,0.78952,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_DN,1
MIR140_3P,SET,129,-0.059407,-0.0049596,0.073806,0.78956,MIR140_3P,1
REACTOME_PHOSPHATE_BOND_HYDR...1,SET,8,-0.22766,-0.0047487,0.28281,0.78958,REACTOME_PHOSPHATE_BOND_HYDROLYSIS_BY_NTPDASE_PROTEINS,1
GOBP_NEGATIVE_REGULATION_OF_...179,SET,82,-0.078894,-0.005258,0.098006,0.78958,GOBP_NEGATIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,1
GOBP_GAMMA_DELTA_T_CELL_DIFF...,SET,13,-0.18791,-0.0049957,0.2334,0.78961,GOBP_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
HP_BULBAR_PALSY,SET,39,-0.10502,-0.0048328,0.13045,0.78961,HP_BULBAR_PALSY,1
GSE17721_CTRL_VS_POLYIC_8H_B...2,SET,178,-0.047832,-0.0046844,0.059403,0.78964,GSE17721_CTRL_VS_POLYIC_8H_BMDC_UP,1
GOMF_POLY_ADP_D_RIBOSE_BINDI...,SET,4,-0.27682,-0.0040833,0.34376,0.78966,GOMF_POLY_ADP_D_RIBOSE_BINDING,1
GOBP_REGULATION_OF_BMP_SIGNA...,SET,93,-0.075737,-0.0053739,0.094033,0.78971,GOBP_REGULATION_OF_BMP_SIGNALING_PATHWAY,1
GOMF_AMIDINE_LYASE_ACTIVITY,SET,7,-0.25391,-0.0049544,0.31525,0.78971,GOMF_AMIDINE_LYASE_ACTIVITY,1
GOBP_REGULATION_OF_MITOCHOND...2,SET,17,-0.17224,-0.005236,0.21383,0.78973,GOBP_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,1
GSE19888_CTRL_VS_A3R_INHIBIT...1,SET,168,-0.053606,-0.0051017,0.066516,0.78985,GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN,1
BIOCARTA_AKAPCENTROSOME_PATH...,SET,14,-0.1763,-0.0048641,0.21874,0.78987,BIOCARTA_AKAPCENTROSOME_PATHWAY,1
DESCARTES_MAIN_FETAL_SQUAMOU...,SET,94,-0.076466,-0.0054546,0.094862,0.7899,DESCARTES_MAIN_FETAL_SQUAMOUS_EPITHELIAL_CELLS,1
HP_ABNORMALITY_OF_OCULAR_SMO...,SET,64,-0.076172,-0.0044871,0.094467,0.78997,HP_ABNORMALITY_OF_OCULAR_SMOOTH_PURSUIT,1
HP_ABNORMAL_SPACED_INCISORS,SET,12,-0.18374,-0.0046936,0.22787,0.78997,HP_ABNORMAL_SPACED_INCISORS,1
MIR5001_3P,SET,139,-0.056953,-0.0049341,0.070613,0.79003,MIR5001_3P,1
GOMF_DYNEIN_LIGHT_CHAIN_BIND...,SET,5,-0.27775,-0.0045806,0.34435,0.79005,GOMF_DYNEIN_LIGHT_CHAIN_BINDING,1
GOBP_DETECTION_OF_STIMULUS,SET,532,-0.037177,-0.0062329,0.046087,0.79007,GOBP_DETECTION_OF_STIMULUS,1
HP_DELAYED_PUBIC_BONE_OSSIFI...,SET,7,-0.28111,-0.0054851,0.34835,0.79016,HP_DELAYED_PUBIC_BONE_OSSIFICATION,1
BURTON_ADIPOGENESIS_12,SET,28,-0.12367,-0.0048234,0.15323,0.79019,BURTON_ADIPOGENESIS_12,1
KYNG_DNA_DAMAGE_BY_4NQO,SET,33,-0.10871,-0.0046022,0.13464,0.79028,KYNG_DNA_DAMAGE_BY_4NQO,1
GOBP_ENZYME_LINKED_RECEPTOR_...,SET,891,-0.024145,-0.0051859,0.029901,0.79031,GOBP_ENZYME_LINKED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY,1
MIR3657,SET,49,-0.099859,-0.0051493,0.12365,0.79034,MIR3657,1
GOBP_PYRIMIDINE_NUCLEOBASE_M...,SET,20,-0.14945,-0.0049274,0.18504,0.79036,GOBP_PYRIMIDINE_NUCLEOBASE_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...498,SET,26,-0.1264,-0.0047506,0.15643,0.79044,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOBP_ARGININE_CATABOLIC_PROC...,SET,9,-0.25213,-0.005578,0.31196,0.79051,GOBP_ARGININE_CATABOLIC_PROCESS,1
GOMF_HEPARIN_BINDING,SET,160,-0.059158,-0.0054956,0.073171,0.79059,GOMF_HEPARIN_BINDING,1
GOBP_UBIQUITIN_RECYCLING,SET,12,-0.20114,-0.0051378,0.24872,0.79065,GOBP_UBIQUITIN_RECYCLING,1
GOBP_IMPORT_INTO_NUCLEUS,SET,160,-0.052474,-0.0048747,0.064883,0.79067,GOBP_IMPORT_INTO_NUCLEUS,1
REACTOME_SUMOYLATION_OF_TRAN...2,SET,19,-0.15575,-0.0050052,0.19257,0.79069,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_FACTORS,1
GOBP_FOAM_CELL_DIFFERENTIATI...,SET,37,-0.12074,-0.0054121,0.14926,0.79071,GOBP_FOAM_CELL_DIFFERENTIATION,1
SIGMAR1_TARGET_GENES,SET,9,-0.22285,-0.0049302,0.27547,0.79073,SIGMAR1_TARGET_GENES,1
HUPER_BREAST_BASAL_VS_LUMINA...2,SET,51,-0.10327,-0.0054323,0.12764,0.79076,HUPER_BREAST_BASAL_VS_LUMINAL_UP,1
MIR12130,SET,29,-0.12571,-0.0049897,0.15537,0.79076,MIR12130,1
GOBP_MESENCHYMAL_CELL_DIFFER...2,SET,6,-0.32542,-0.0058788,0.40221,0.79076,GOBP_MESENCHYMAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
HP_FRAGILE_SKIN,SET,34,-0.12025,-0.0051672,0.14863,0.79076,HP_FRAGILE_SKIN,1
WP_LEUKOCYTEINTRINSIC_HIPPO_...,SET,30,-0.12776,-0.0051573,0.15789,0.79078,WP_LEUKOCYTEINTRINSIC_HIPPO_PATHWAY_FUNCTIONS,1
GOBP_PODOSOME_ASSEMBLY,SET,21,-0.15017,-0.0050733,0.18554,0.79085,GOBP_PODOSOME_ASSEMBLY,1
KEGG_PRIMARY_IMMUNODEFICIENCY,SET,30,-0.13675,-0.0055205,0.16889,0.79094,KEGG_PRIMARY_IMMUNODEFICIENCY,1
GSE9037_CTRL_VS_LPS_1H_STIM_...2,SET,173,-0.051492,-0.0049722,0.063582,0.79098,GSE9037_CTRL_VS_LPS_1H_STIM_BMDM_UP,1
GSE360_L_MAJOR_VS_M_TUBERCUL...3,SET,166,-0.052348,-0.0049525,0.064636,0.79099,GSE360_L_MAJOR_VS_M_TUBERCULOSIS_MAC_DN,1
GOBP_REGULATION_OF_MICROTUBU...2,SET,235,-0.042403,-0.0047641,0.052351,0.79102,GOBP_REGULATION_OF_MICROTUBULE_BASED_PROCESS,1
GSE3982_MAST_CELL_VS_TH2_DN,SET,182,-0.048255,-0.0047782,0.059576,0.79102,GSE3982_MAST_CELL_VS_TH2_DN,1
REACTOME_METABOLIC_DISORDERS...,SET,32,-0.12445,-0.0051884,0.15363,0.79104,REACTOME_METABOLIC_DISORDERS_OF_BIOLOGICAL_OXIDATION_ENZYMES,1
HP_ABNORMAL_GLIAL_CELL_MORPH...,SET,143,-0.054437,-0.004783,0.067194,0.79106,HP_ABNORMAL_GLIAL_CELL_MORPHOLOGY,1
GOBP_REGULATION_OF_HIGH_DENS...,SET,4,-0.3088,-0.0045552,0.38116,0.79107,GOBP_REGULATION_OF_HIGH_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
HUANG_DASATINIB_SENSITIVITY_...,SET,75,-0.087759,-0.0055946,0.1083,0.79112,HUANG_DASATINIB_SENSITIVITY_UP,1
HP_ABNORMAL_5TH_FINGER_MORPH...,SET,435,-0.032305,-0.0049107,0.039864,0.79113,HP_ABNORMAL_5TH_FINGER_MORPHOLOGY,1
GSE21670_UNTREATED_VS_TGFB_I...3,SET,177,-0.050013,-0.0048844,0.061718,0.79113,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
GSE23398_WT_VS_IL2_KO_CD4_TC...2,SET,180,-0.050589,-0.0049819,0.062427,0.79113,GSE23398_WT_VS_IL2_KO_CD4_TCELL_SCURFY_MOUSE_UP,1
MODULE_54,SET,237,-0.043147,-0.004868,0.053234,0.79117,MODULE_54,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...3,SET,107,-0.072486,-0.0055146,0.089407,0.79124,GOBP_PHOSPHOLIPASE_C_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
HP_LIMBAL_DERMOID,SET,8,-0.23152,-0.0048293,0.28555,0.79125,HP_LIMBAL_DERMOID,1
HP_DECREASED_CIRCULATING_PRE...,SET,4,-0.39263,-0.0057917,0.48421,0.79127,HP_DECREASED_CIRCULATING_PREALBUMIN_CONCENTRATION,1
GSE25146_UNSTIM_VS_HELIOBACT...2,SET,165,-0.049176,-0.0046385,0.060648,0.79127,GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_UP,1
HP_CENTRAL_OPACIFICATION_OF_...,SET,21,-0.1729,-0.005841,0.2132,0.7913,HP_CENTRAL_OPACIFICATION_OF_THE_CORNEA,1
HP_CHROMOSOMAL_BREAKAGE_INDU...1,SET,16,-0.15026,-0.0044317,0.18528,0.79132,HP_CHROMOSOMAL_BREAKAGE_INDUCED_BY_CROSSLINKING_AGENTS,1
GSE13484_12H_UNSTIM_VS_YF17D...2,SET,177,-0.050496,-0.0049315,0.062237,0.79141,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
SCHLOSSER_SERUM_RESPONSE_AUG...,SET,100,-0.062421,-0.0045918,0.076921,0.79145,SCHLOSSER_SERUM_RESPONSE_AUGMENTED_BY_MYC,1
GOMF_SODIUM_CHANNEL_REGULATO...,SET,38,-0.11901,-0.0054058,0.14663,0.79149,GOMF_SODIUM_CHANNEL_REGULATOR_ACTIVITY,1
WP_NUCLEOTIDE_GPCRS,SET,9,-0.2355,-0.00521,0.29015,0.7915,WP_NUCLEOTIDE_GPCRS,1
HP_ABNORMAL_LONG_BONE_MORPHO...,SET,686,-0.026207,-0.0049678,0.032287,0.79151,HP_ABNORMAL_LONG_BONE_MORPHOLOGY,1
GOMF_NADPLUS_NUCLEOTIDASE_CY...,SET,14,-0.24259,-0.0066929,0.29884,0.79154,GOMF_NADPLUS_NUCLEOTIDASE_CYCLIC_ADP_RIBOSE_GENERATING,1
KEGG_MEDICUS_REFERENCE_SPIND...,SET,20,-0.15474,-0.0051017,0.19059,0.79156,KEGG_MEDICUS_REFERENCE_SPINDLE_ASSEMBLY_CHECKPOINT_SIGNALING,1
HP_ACROMICRIA,SET,8,-0.29622,-0.0061788,0.36486,0.79156,HP_ACROMICRIA,1
GOBP_FOLATE_TRANSMEMBRANE_TR...,SET,5,-0.35969,-0.0059319,0.44295,0.79161,GOBP_FOLATE_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_MAMMARY_G...,SET,14,-0.19392,-0.0053501,0.2388,0.79161,GOBP_REGULATION_OF_MAMMARY_GLAND_EPITHELIAL_CELL_PROLIFERATION,1
GOCC_SCHAFFER_COLLATERAL_CA1...,SET,88,-0.074663,-0.005154,0.091939,0.79163,GOCC_SCHAFFER_COLLATERAL_CA1_SYNAPSE,1
HP_INCREASED_NEURONAL_AUTOFL...,SET,9,-0.23096,-0.0051098,0.2844,0.79163,HP_INCREASED_NEURONAL_AUTOFLUORESCENT_LIPOPIGMENT,1
MIR8075,SET,90,-0.075785,-0.0052903,0.093314,0.79164,MIR8075,1
GOMF_PHOSPHATE_TRANSMEMBRANE...,SET,16,-0.17499,-0.005161,0.21547,0.79164,GOMF_PHOSPHATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_GONA...,SET,110,-0.06467,-0.0049881,0.07963,0.79164,HP_ABNORMAL_CIRCULATING_GONADOTROPIN_CONCENTRATION,1
REACTOME_NGF_INDEPENDANT_TRK...,SET,5,-0.32917,-0.0054285,0.40529,0.79165,REACTOME_NGF_INDEPENDANT_TRKA_ACTIVATION,1
GOBP_SENSORY_PERCEPTION_OF_B...,SET,43,-0.12409,-0.005995,0.15278,0.79165,GOBP_SENSORY_PERCEPTION_OF_BITTER_TASTE,1
HP_ABNORMALITY_OF_SKIN_PHYSI...,SET,505,-0.031426,-0.0051372,0.038693,0.79165,HP_ABNORMALITY_OF_SKIN_PHYSIOLOGY,1
HP_ENLARGED_METAPHYSES,SET,5,-0.29093,-0.0047979,0.35821,0.79165,HP_ENLARGED_METAPHYSES,1
GOBP_ESTABLISHMENT_OF_SISTER...,SET,7,-0.23143,-0.0045157,0.28491,0.79169,GOBP_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,1
GOBP_METANEPHRIC_NEPHRON_DEV...,SET,40,-0.12557,-0.0058515,0.15457,0.79169,GOBP_METANEPHRIC_NEPHRON_DEVELOPMENT,1
REACTOME_G_PROTEIN_ACTIVATION,SET,24,-0.14755,-0.0053283,0.18162,0.79171,REACTOME_G_PROTEIN_ACTIVATION,1
GOBP_POSITIVE_REGULATION_OF_...740,SET,10,-0.2154,-0.0050231,0.26506,0.79179,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_PLASTICITY,1
GOLDRATH_NAIVE_VS_EFF_CD8_TC...1,SET,180,-0.050731,-0.0049959,0.062408,0.79185,GOLDRATH_NAIVE_VS_EFF_CD8_TCELL_DN,1
MIR3197,SET,5,-0.25796,-0.0042542,0.31734,0.79186,MIR3197,1
REACTOME_NONCANONICAL_ACTIVA...,SET,7,-0.2431,-0.0047434,0.29899,0.79191,REACTOME_NONCANONICAL_ACTIVATION_OF_NOTCH3,1
GOBP_TUBULIN_COMPLEX_ASSEMBLY,SET,8,-0.19644,-0.0040975,0.24157,0.79194,GOBP_TUBULIN_COMPLEX_ASSEMBLY,1
MIR3162_5P,SET,67,-0.082022,-0.0049433,0.10086,0.79195,MIR3162_5P,1
MODULE_100,SET,495,-0.032999,-0.0053422,0.040578,0.79195,MODULE_100,1
GOBP_REGULATION_OF_ANTIGEN_P...1,SET,18,-0.16347,-0.0051133,0.20099,0.79198,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
KEGG_SPLICEOSOME,SET,117,-0.056281,-0.0044762,0.069191,0.792,KEGG_SPLICEOSOME,1
HP_RESPONSE_TO_DRUGS_ACTING_...,SET,6,-0.28491,-0.005147,0.35027,0.79201,HP_RESPONSE_TO_DRUGS_ACTING_ON_NEUROMUSCULAR_TRANSMISSION,1
GOMF_TUMOR_NECROSIS_FACTOR_R...3,SET,46,-0.10149,-0.0050712,0.12476,0.79203,GOMF_TUMOR_NECROSIS_FACTOR_RECEPTOR_SUPERFAMILY_BINDING,1
GOMF_TELOMERASE_ACTIVITY,SET,5,-0.26901,-0.0044364,0.33066,0.79205,GOMF_TELOMERASE_ACTIVITY,1
MODULE_169,SET,89,-0.077574,-0.0053851,0.095334,0.79209,MODULE_169,1
HP_MULTIFOCAL_SEIZURES,SET,16,-0.16852,-0.0049701,0.20709,0.7921,HP_MULTIFOCAL_SEIZURES,1
MODULE_418,SET,56,-0.091921,-0.0050663,0.11294,0.79214,MODULE_418,1
GNF2_CD1D,SET,38,-0.11521,-0.0052334,0.14154,0.79217,GNF2_CD1D,1
REACTOME_BRANCHED_CHAIN_AMIN...,SET,20,-0.14795,-0.004878,0.18175,0.79218,REACTOME_BRANCHED_CHAIN_AMINO_ACID_CATABOLISM,1
MARSON_BOUND_BY_FOXP3_UNSTIM...,SET,1068,-0.022365,-0.0052323,0.027467,0.79224,MARSON_BOUND_BY_FOXP3_UNSTIMULATED,1
HP_EEG_WITH_GENERALIZED_SLOW...2,SET,9,-0.21447,-0.0047448,0.26338,0.79226,HP_EEG_WITH_GENERALIZED_SLOW_ACTIVITY_GRADE_4,1
HP_METHYLMALONIC_ACIDEMIA,SET,13,-0.18047,-0.0047979,0.22162,0.79226,HP_METHYLMALONIC_ACIDEMIA,1
GOBP_BRANCHING_INVOLVED_IN_P...,SET,12,-0.22379,-0.0057164,0.27481,0.79227,GOBP_BRANCHING_INVOLVED_IN_PROSTATE_GLAND_MORPHOGENESIS,1
GSE17721_CPG_VS_GARDIQUIMOD_...9,SET,178,-0.0513,-0.005024,0.06299,0.79229,GSE17721_CPG_VS_GARDIQUIMOD_24H_BMDC_DN,1
GOCC_SMC5_SMC6_COMPLEX,SET,6,-0.24221,-0.0043756,0.2974,0.7923,GOCC_SMC5_SMC6_COMPLEX,1
HP_ABNORMALITY_OF_DENTAL_STR...,SET,315,-0.038085,-0.004943,0.046742,0.7924,HP_ABNORMALITY_OF_DENTAL_STRUCTURE,1
GOBP_EXCRETION,SET,28,-0.13665,-0.0053297,0.16771,0.79241,GOBP_EXCRETION,1
HP_LACUNAR_STROKE,SET,6,-0.26046,-0.0047053,0.31946,0.79255,HP_LACUNAR_STROKE,1
KRAS.BREAST_UP.V1_UP,SET,118,-0.070344,-0.0056184,0.086262,0.79259,KRAS.BREAST_UP.V1_UP,1
HP_PROGRESSIVE_EXTERNAL_OPHT...,SET,20,-0.1372,-0.0045234,0.16819,0.79266,HP_PROGRESSIVE_EXTERNAL_OPHTHALMOPLEGIA,1
GOMF_INTRAMOLECULAR_PHOSPHOT...,SET,10,-0.19108,-0.0044559,0.23425,0.79267,GOMF_INTRAMOLECULAR_PHOSPHOTRANSFERASE_ACTIVITY,1
GOMF_NEUROTROPHIN_BINDING,SET,9,-0.25228,-0.0055814,0.30925,0.79268,GOMF_NEUROTROPHIN_BINDING,1
MORF_RPA1,SET,59,-0.079889,-0.0045191,0.097909,0.79273,MORF_RPA1,1
GOBP_POSITIVE_REGULATION_OF_...710,SET,33,-0.11917,-0.0050451,0.14602,0.79278,GOBP_POSITIVE_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_TY...,SET,91,-0.073534,-0.0051614,0.090095,0.7928,GOBP_CELLULAR_RESPONSE_TO_TYPE_II_INTERFERON,1
GOMF_CXCR_CHEMOKINE_RECEPTOR...,SET,17,-0.20114,-0.0061144,0.24639,0.79284,GOMF_CXCR_CHEMOKINE_RECEPTOR_BINDING,1
ZNF184_TARGET_GENES,SET,1078,-0.021172,-0.004975,0.025934,0.79285,ZNF184_TARGET_GENES,1
GOBP_INHIBITORY_SYNAPSE_ASSE...,SET,23,-0.16993,-0.0060074,0.20813,0.79287,GOBP_INHIBITORY_SYNAPSE_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...296,SET,8,-0.25088,-0.005233,0.3072,0.79294,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,1
MIR548BA,SET,159,-0.054745,-0.0050698,0.067012,0.79301,MIR548BA,1
GSE32986_UNSTIM_VS_GMCSF_STI...1,SET,180,-0.049535,-0.0048781,0.060633,0.79302,GSE32986_UNSTIM_VS_GMCSF_STIM_DC_DN,1
GSE5503_MLN_DC_VS_SPLEEN_DC_...2,SET,178,-0.051937,-0.0050865,0.063575,0.79302,GSE5503_MLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP,1
GOBP_RESPONSE_TO_IRON_ION,SET,27,-0.13872,-0.005313,0.16979,0.79303,GOBP_RESPONSE_TO_IRON_ION,1
chr10q23,SET,81,-0.14738,-0.0097623,0.18025,0.79321,chr10q23,1
GOCC_BETA_CATENIN_TCF_COMPLEX,SET,13,-0.20226,-0.0053774,0.24737,0.79321,GOCC_BETA_CATENIN_TCF_COMPLEX,1
HP_INAPPROPRIATE_BEHAVIOR,SET,14,-0.17893,-0.0049366,0.21885,0.79321,HP_INAPPROPRIATE_BEHAVIOR,1
GOBP_PROTEIN_MATURATION_BY_4...,SET,4,-0.42276,-0.0062361,0.51702,0.79323,GOBP_PROTEIN_MATURATION_BY_4FE_4S_CLUSTER_TRANSFER,1
GOBP_REGULATION_OF_FEEDING_B...,SET,25,-0.15852,-0.0058424,0.19386,0.79323,GOBP_REGULATION_OF_FEEDING_BEHAVIOR,1
GOMF_GABA_RECEPTOR_ACTIVITY,SET,19,-0.19655,-0.0063163,0.24035,0.79325,GOMF_GABA_RECEPTOR_ACTIVITY,1
GOBP_DEVELOPMENTAL_CELL_GROW...,SET,199,-0.049954,-0.0051698,0.061075,0.79329,GOBP_DEVELOPMENTAL_CELL_GROWTH,1
MIR6509_5P,SET,88,-0.072687,-0.0050176,0.088865,0.7933,MIR6509_5P,1
MIR4761_3P,SET,46,-0.10419,-0.0052057,0.12737,0.79331,MIR4761_3P,1
GOCC_BRAHMA_COMPLEX,SET,14,-0.20413,-0.0056318,0.24954,0.79332,GOCC_BRAHMA_COMPLEX,1
MIR6784_3P,SET,35,-0.10654,-0.0046447,0.13022,0.79335,MIR6784_3P,1
GOBP_POSITIVE_REGULATION_OF_...266,SET,14,-0.17528,-0.0048359,0.21415,0.79346,GOBP_POSITIVE_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
HP_ABNORMAL_URINARY_ORGANIC_...,SET,57,-0.094466,-0.0052526,0.11541,0.79347,HP_ABNORMAL_URINARY_ORGANIC_COMPOUND_LEVEL,1
GSE4590_SMALL_VS_LARGE_PRE_B...2,SET,164,-0.05478,-0.0051515,0.066922,0.79348,GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP,1
BUSSLINGER_DUODENAL_LATE_IMM...,SET,164,-0.054962,-0.0051687,0.067144,0.79348,BUSSLINGER_DUODENAL_LATE_IMMATURE_ENTEROCYTES,1
PID_RHOA_REG_PATHWAY,SET,42,-0.10718,-0.0051176,0.13092,0.7935,PID_RHOA_REG_PATHWAY,1
HP_LOW_GRADE_FEVER,SET,11,-0.23268,-0.0056907,0.2842,0.79352,HP_LOW_GRADE_FEVER,1
HP_DELAYED_CRANIAL_SUTURE_CL...,SET,87,-0.073664,-0.0050562,0.089944,0.7936,HP_DELAYED_CRANIAL_SUTURE_CLOSURE,1
SMID_BREAST_CANCER_RELAPSE_I...9,SET,22,-0.14882,-0.0051459,0.18169,0.79364,SMID_BREAST_CANCER_RELAPSE_IN_PLEURA_DN,1
NCOA4_TARGET_GENES,SET,845,-0.023575,-0.0049374,0.028779,0.79365,NCOA4_TARGET_GENES,1
YAO_TEMPORAL_RESPONSE_TO_PRO...13,SET,15,-0.16889,-0.004823,0.20614,0.79369,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_4,1
GSE23321_CD8_STEM_CELL_MEMOR...1,SET,159,-0.050249,-0.0046535,0.061331,0.79369,GSE23321_CD8_STEM_CELL_MEMORY_VS_CENTRAL_MEMORY_CD8_TCELL_DN,1
DESCARTES_FETAL_LIVER_STELLA...,SET,122,-0.070386,-0.0057156,0.085902,0.79371,DESCARTES_FETAL_LIVER_STELLATE_CELLS,1
MIR3941,SET,303,-0.039621,-0.0050452,0.048342,0.79377,MIR3941,1
PID_VEGF_VEGFR_PATHWAY,SET,9,-0.25711,-0.0056882,0.3137,0.79378,PID_VEGF_VEGFR_PATHWAY,1
LI_WILMS_TUMOR_VS_FETAL_KIDN...1,SET,153,-0.055847,-0.0050743,0.06813,0.79381,LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN,1
MIR499A_5P,SET,160,-0.054876,-0.0050978,0.066936,0.79384,MIR499A_5P,1
HP_DIMINISHED_MOTIVATION,SET,563,-0.029205,-0.0050326,0.035617,0.79387,HP_DIMINISHED_MOTIVATION,1
BIOCARTA_CHREBP_PATHWAY,SET,19,-0.15677,-0.005038,0.19114,0.79394,BIOCARTA_CHREBP_PATHWAY,1
KEGG_MEDICUS_REFERENCE_BMP9_...,SET,8,-0.24322,-0.0050733,0.29653,0.79395,KEGG_MEDICUS_REFERENCE_BMP9_10_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CYCLIC_NU...,SET,6,-0.2571,-0.0046445,0.31344,0.79395,GOBP_REGULATION_OF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_ITGA_...5,SET,27,-0.13187,-0.0050506,0.16073,0.79401,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOG_RAC_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...178,SET,7,-0.28476,-0.0055563,0.34701,0.79406,GOBP_POSITIVE_REGULATION_OF_CORTICOSTEROID_HORMONE_SECRETION,1
GSE22886_NAIVE_CD8_TCELL_VS_...3,SET,181,-0.050611,-0.0049977,0.061675,0.79406,GSE22886_NAIVE_CD8_TCELL_VS_MEMORY_TCELL_DN,1
GOBP_PROTEIN_DESUMOYLATION,SET,9,-0.21026,-0.0046518,0.2562,0.79409,GOBP_PROTEIN_DESUMOYLATION,1
HP_ABNORMAL_PALM_MORPHOLOGY,SET,445,-0.032654,-0.0050192,0.039787,0.79409,HP_ABNORMAL_PALM_MORPHOLOGY,1
MIR6776_5P,SET,83,-0.073071,-0.0048994,0.089028,0.79411,MIR6776_5P,1
GSE27786_BCELL_VS_NKCELL_DN,SET,183,-0.050111,-0.0049754,0.061045,0.79414,GSE27786_BCELL_VS_NKCELL_DN,1
NABA_MATRISOME_POORLY_METAST...4,SET,23,-0.14482,-0.0051199,0.17638,0.79419,NABA_MATRISOME_POORLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,1
MIR1915_3P,SET,156,-0.056163,-0.0051523,0.068399,0.79421,MIR1915_3P,1
GSE3039_NKT_CELL_VS_ALPHAALP...1,SET,188,-0.05211,-0.0052433,0.063457,0.79422,GSE3039_NKT_CELL_VS_ALPHAALPHA_CD8_TCELL_DN,1
MYCMAX_03,SET,231,-0.044748,-0.0049851,0.05449,0.79423,MYCMAX_03,1
MASRI_RESISTANCE_TO_TAMOXIFE...2,SET,15,-0.19221,-0.0054888,0.23404,0.79424,MASRI_RESISTANCE_TO_TAMOXIFEN_AND_AROMATASE_INHIBITORS_UP,1
GOMF_DOUBLE_STRANDED_RNA_ADE...,SET,6,-0.31364,-0.0056659,0.38191,0.79424,GOMF_DOUBLE_STRANDED_RNA_ADENOSINE_DEAMINASE_ACTIVITY,1
GSE7460_WT_VS_FOXP3_HET_ACT_...2,SET,186,-0.051164,-0.005121,0.062268,0.79436,GSE7460_WT_VS_FOXP3_HET_ACT_TCONV_UP,1
GOBP_PROTEIN_CONTAINING_COMP...3,SET,177,-0.052544,-0.0051315,0.063946,0.79437,GOBP_PROTEIN_CONTAINING_COMPLEX_LOCALIZATION,1
GSE16266_CTRL_VS_HEATSHOCK_A...2,SET,173,-0.050445,-0.0048711,0.061383,0.7944,GSE16266_CTRL_VS_HEATSHOCK_AND_LPS_STIM_MEF_UP,1
GOBP_L_AMINO_ACID_CATABOLIC_...,SET,60,-0.090459,-0.0051601,0.11005,0.79444,GOBP_L_AMINO_ACID_CATABOLIC_PROCESS,1
HP_MULTIPLE_RIB_FRACTURES,SET,10,-0.24265,-0.0056584,0.29521,0.79444,HP_MULTIPLE_RIB_FRACTURES,1
GOBP_POSITIVE_REGULATION_OF_...684,SET,33,-0.12896,-0.0054594,0.15688,0.79445,GOBP_POSITIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE9509_LPS_VS_LPS_AND_IL10_...2,SET,187,-0.054224,-0.0054417,0.065964,0.79447,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_10MIN_UP,1
GOMF_ALPHA_GLUCOSIDASE_ACTIV...,SET,7,-0.26573,-0.005185,0.3232,0.79451,GOMF_ALPHA_GLUCOSIDASE_ACTIVITY,1
GOCC_CIA_COMPLEX,SET,2,-0.41021,-0.0042789,0.49889,0.79453,GOCC_CIA_COMPLEX,1
HP_ABNORMAL_PLACENTAL_MEMBRA...,SET,13,-0.22262,-0.0059187,0.27075,0.79453,HP_ABNORMAL_PLACENTAL_MEMBRANE_MORPHOLOGY,1
REACTOME_TRIGLYCERIDE_BIOSYN...,SET,12,-0.21612,-0.0055206,0.26279,0.79457,REACTOME_TRIGLYCERIDE_BIOSYNTHESIS,1
ZHAN_MULTIPLE_MYELOMA_MS_DN,SET,38,-0.11031,-0.0050109,0.13411,0.79461,ZHAN_MULTIPLE_MYELOMA_MS_DN,1
GOBP_GLYCOSIDE_TRANSPORT,SET,5,-0.33034,-0.0054478,0.4016,0.79461,GOBP_GLYCOSIDE_TRANSPORT,1
VISALA_AGING_LYMPHOCYTE_DN,SET,16,-0.1623,-0.0047866,0.19731,0.79462,VISALA_AGING_LYMPHOCYTE_DN,1
GOBP_CELLULAR_RESPONSE_TO_HY...1,SET,63,-0.088157,-0.0051526,0.10717,0.79462,GOBP_CELLULAR_RESPONSE_TO_HYDROGEN_PEROXIDE,1
REACTOME_REGULATION_OF_TP53_...1,SET,152,-0.05476,-0.0049593,0.066567,0.79464,REACTOME_REGULATION_OF_TP53_ACTIVITY,1
GOBP_INOSITOL_TRISPHOSPHATE_...2,SET,10,-0.24606,-0.0057381,0.29911,0.79465,GOBP_INOSITOL_TRISPHOSPHATE_METABOLIC_PROCESS,1
GSE3337_4H_VS_16H_IFNG_IN_CD...1,SET,184,-0.052073,-0.0051842,0.063285,0.79469,GSE3337_4H_VS_16H_IFNG_IN_CD8POS_DC_DN,1
GSE21380_NON_TFH_VS_TFH_CD4_...2,SET,183,-0.052177,-0.0051805,0.0634,0.79474,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_UP,1
GOBP_ORGAN_INDUCTION,SET,20,-0.17356,-0.0057222,0.21084,0.79479,GOBP_ORGAN_INDUCTION,1
MIR3136_3P,SET,60,-0.084271,-0.0048071,0.10237,0.79481,MIR3136_3P,1
PUJANA_CHEK2_PCC_NETWORK,SET,695,-0.025123,-0.0047921,0.030515,0.79482,PUJANA_CHEK2_PCC_NETWORK,1
GOMF_KINASE_ACTIVATOR_ACTIVI...,SET,130,-0.060481,-0.0050686,0.073457,0.79484,GOMF_KINASE_ACTIVATOR_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...5,SET,120,-0.07006,-0.0056426,0.085057,0.79494,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_SECRETORY_PROGENITORS_CELL,1
GOBP_REGULATION_OF_MITOCHOND...5,SET,27,-0.13924,-0.0053329,0.169,0.79499,GOBP_REGULATION_OF_MITOCHONDRIAL_FISSION,1
GOMF_TYPE_I_INTERFERON_RECEP...,SET,13,-0.29696,-0.007895,0.36038,0.79503,GOMF_TYPE_I_INTERFERON_RECEPTOR_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...228,SET,28,-0.12804,-0.0049939,0.15537,0.79505,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
KEGG_MEDICUS_REFERENCE_N_GLY...4,SET,7,-0.18209,-0.003553,0.22096,0.79506,KEGG_MEDICUS_REFERENCE_N_GLYCAN_PRECURSOR_BIOSYNTHESIS_GLC_6P_TO_MAN_P_DOL,1
GOMF_ACTIVIN_RECEPTOR_BINDING,SET,8,-0.25204,-0.0052573,0.30582,0.79506,GOMF_ACTIVIN_RECEPTOR_BINDING,1
KEGG_MEDICUS_REFERENCE_REGUL...15,SET,5,-0.30335,-0.0050027,0.36807,0.79507,KEGG_MEDICUS_REFERENCE_REGULATION_OF_TNF_NFKB_SIGNALING_PATHWAY_LUBAC_MEDIATED_LINEAR_UBIQUITINATION,1
GSE17721_CTRL_VS_PAM3CSK4_8H...2,SET,178,-0.05009,-0.0049056,0.06076,0.79514,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_UP,1
GOMF_INTERLEUKIN_1_RECEPTOR_...1,SET,6,-0.33037,-0.0059683,0.40069,0.79517,GOMF_INTERLEUKIN_1_RECEPTOR_ACTIVITY,1
REACTOME_ASSEMBLY_OF_THE_HIV...,SET,15,-0.17318,-0.0049455,0.21003,0.79518,REACTOME_ASSEMBLY_OF_THE_HIV_VIRION,1
MIR6774_5P,SET,43,-0.10697,-0.005168,0.12973,0.79518,MIR6774_5P,1
GOCC_CONDENSED_NUCLEAR_CHROM...,SET,70,-0.076196,-0.0046934,0.092411,0.79518,GOCC_CONDENSED_NUCLEAR_CHROMOSOME,1
GSE8678_IL7R_LOW_VS_HIGH_EFF...2,SET,183,-0.05164,-0.0051272,0.062627,0.79518,GSE8678_IL7R_LOW_VS_HIGH_EFF_CD8_TCELL_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...8,SET,25,-0.15911,-0.0058641,0.19295,0.79519,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_UP,1
GOBP_POSITIVE_REGULATION_OF_...681,SET,6,-0.28233,-0.0051004,0.34238,0.7952,GOBP_POSITIVE_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
VEGF_A_UP.V1_DN,SET,181,-0.050356,-0.0049726,0.061056,0.79524,VEGF_A_UP.V1_DN,1
HP_PUNCTATE_PALMOPLANTAR_HYP...,SET,6,-0.25745,-0.0046509,0.31213,0.79525,HP_PUNCTATE_PALMOPLANTAR_HYPERKERATOSIS,1
HP_FREQUENT_FALLS,SET,117,-0.064175,-0.005104,0.077803,0.79526,HP_FREQUENT_FALLS,1
GSE8685_IL2_ACT_IL2_STARVED_...4,SET,161,-0.056155,-0.0052327,0.068077,0.79527,GSE8685_IL2_ACT_IL2_STARVED_VS_IL21_ACT_IL2_STARVED_CD4_TCELL_UP,1
GOMF_VASCULAR_ENDOTHELIAL_GR...4,SET,12,-0.21378,-0.0054608,0.25914,0.79529,GOMF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_BINDING,1
HE_LIM_SUN_FETAL_LUNG_C3_HMO...,SET,22,-0.15854,-0.0054819,0.19217,0.7953,HE_LIM_SUN_FETAL_LUNG_C3_HMOX1_POS_PRIMITIVE_ERYTHROBLAST,1
HP_TRUNCAL_ATAXIA,SET,66,-0.084588,-0.0050598,0.10252,0.79533,HP_TRUNCAL_ATAXIA,1
GSE43955_1H_VS_20H_ACT_CD4_T...4,SET,185,-0.050956,-0.0050865,0.061757,0.79534,GSE43955_1H_VS_20H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
MIR6888_5P,SET,45,-0.11247,-0.0055584,0.13629,0.79538,MIR6888_5P,1
FULLER_PBMC_F_TULARENSIS_VAC...2,SET,7,-0.2504,-0.0048858,0.3034,0.7954,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_336HR_SUSTAINED_UP,1
MATZUK_LUTEAL_GENES,SET,8,-0.24857,-0.0051849,0.30117,0.79541,MATZUK_LUTEAL_GENES,1
GSE33162_HDAC3_KO_VS_HDAC3_K...4,SET,182,-0.049269,-0.0048786,0.059693,0.79541,GSE33162_HDAC3_KO_VS_HDAC3_KO_MACROPHAGE_UP,1
HP_MONOTONIC_SPEECH,SET,8,-0.28139,-0.0058695,0.3408,0.7955,HP_MONOTONIC_SPEECH,1
GOBP_REGULATION_OF_NEUROBLAS...,SET,51,-0.10676,-0.005616,0.12929,0.79551,GOBP_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
HP_UNEXPLAINED_FEVERS,SET,18,-0.16648,-0.0052075,0.20162,0.79551,HP_UNEXPLAINED_FEVERS,1
GSE13887_RESTING_VS_ACT_CD4_...2,SET,94,-0.069485,-0.0049566,0.084146,0.79553,GSE13887_RESTING_VS_ACT_CD4_TCELL_UP,1
GOMF_SEMAPHORIN_RECEPTOR_BIN...,SET,23,-0.15241,-0.0053883,0.18456,0.79554,GOMF_SEMAPHORIN_RECEPTOR_BINDING,1
GOBP_NEURON_MIGRATION,SET,166,-0.057824,-0.0054705,0.069996,0.79562,GOBP_NEURON_MIGRATION,1
MANNE_COVID19_COMBINED_COHOR...1,SET,196,-0.054604,-0.0056087,0.066096,0.79563,MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...216,SET,29,-0.13149,-0.005219,0.15916,0.79563,GOBP_NEGATIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_BCR_B...,SET,14,-0.20037,-0.0055279,0.24251,0.79565,KEGG_MEDICUS_REFERENCE_BCR_BCAP_CD19_PI3K_SIGNALING_PATHWAY,1
LINDSTEDT_DENDRITIC_CELL_MAT...2,SET,45,-0.11726,-0.0057953,0.14191,0.79568,LINDSTEDT_DENDRITIC_CELL_MATURATION_B,1
GCM_CDH5,SET,31,-0.12036,-0.0049388,0.14562,0.79574,GCM_CDH5,1
GAUTAM_EYE_CORNEA_CYTOTOXIC_...,SET,124,-0.060807,-0.0049777,0.073564,0.79576,GAUTAM_EYE_CORNEA_CYTOTOXIC_T_CELLS,1
FAN_EMBRYONIC_CTX_MICROGLIA_3,SET,19,-0.1808,-0.0058101,0.21867,0.79582,FAN_EMBRYONIC_CTX_MICROGLIA_3,1
WP_TRIACYLGLYCERIDE_SYNTHESIS,SET,20,-0.16906,-0.005574,0.20445,0.79585,WP_TRIACYLGLYCERIDE_SYNTHESIS,1
GOBP_RENAL_SYSTEM_PROCESS_IN...2,SET,24,-0.15193,-0.0054865,0.1837,0.79589,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
TTCYRGAA_UNKNOWN,SET,300,-0.0408,-0.0051699,0.04933,0.7959,TTCYRGAA_UNKNOWN,1
DESCARTES_FETAL_HEART_SATB2_...,SET,84,-0.087308,-0.005889,0.10556,0.7959,DESCARTES_FETAL_HEART_SATB2_LRRC7_POSITIVE_CELLS,1
GOBP_CYTIDINE_METABOLIC_PROC...,SET,11,-0.29227,-0.0071482,0.35337,0.79591,GOBP_CYTIDINE_METABOLIC_PROCESS,1
HP_ELEVATED_CIRCULATING_ACYL...,SET,17,-0.16409,-0.0049881,0.19826,0.79605,HP_ELEVATED_CIRCULATING_ACYLCARNITINE_CONCENTRATION,1
MIR8077,SET,62,-0.093806,-0.0054392,0.11334,0.79607,MIR8077,1
MIR935,SET,106,-0.069844,-0.0052889,0.084373,0.7961,MIR935,1
GOBP_CEREBELLAR_PURKINJE_CEL...3,SET,15,-0.17318,-0.0049454,0.2092,0.7961,GOBP_CEREBELLAR_PURKINJE_CELL_LAYER_MORPHOGENESIS,1
GSE8685_IL2_STARVED_VS_IL2_A...2,SET,183,-0.051024,-0.005066,0.061628,0.79614,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_UP,1
TONKS_TARGETS_OF_RUNX1_RUNX1...10,SET,7,-0.28407,-0.0055427,0.34303,0.79619,TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_SUSTAINED_IN_GRANULOCYTE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...255,SET,5,-0.36428,-0.0060076,0.43987,0.7962,GOBP_NEGATIVE_REGULATION_OF_GLUCOCORTICOID_METABOLIC_PROCESS,1
TSAI_RESPONSE_TO_IONIZING_RA...,SET,142,-0.05747,-0.005032,0.069369,0.79629,TSAI_RESPONSE_TO_IONIZING_RADIATION,1
HP_MIGRAINE_WITHOUT_AURA,SET,7,-0.28995,-0.0056575,0.34992,0.79633,HP_MIGRAINE_WITHOUT_AURA,1
GRAESSMANN_RESPONSE_TO_MC_AN...4,SET,200,-0.051012,-0.0052923,0.061559,0.79635,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_UP,1
GSE21379_WT_VS_SAP_KO_TFH_CD...2,SET,175,-0.05329,-0.0051752,0.064301,0.79637,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_UP,1
GSE33425_CD161_INT_VS_NEG_CD...2,SET,187,-0.051539,-0.0051722,0.062188,0.79637,GSE33425_CD161_INT_VS_NEG_CD8_TCELL_UP,1
CHICAS_RB1_TARGETS_CONFLUENT,SET,500,-0.033325,-0.0054213,0.040207,0.79639,CHICAS_RB1_TARGETS_CONFLUENT,1
HP_ABNORMALITY_OF_FOLATE_MET...,SET,13,-0.19985,-0.0053134,0.24112,0.7964,HP_ABNORMALITY_OF_FOLATE_METABOLISM,1
KEGG_MEDICUS_REFERENCE_ITGA_...6,SET,29,-0.13547,-0.005377,0.16339,0.79647,KEGG_MEDICUS_REFERENCE_ITGA_B_TALIN_VINCULIN_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...389,SET,89,-0.074742,-0.0051885,0.090131,0.79651,GOBP_POSITIVE_REGULATION_OF_JNK_CASCADE,1
HP_OPEN_NEURAL_TUBE_DEFECT,SET,134,-0.058874,-0.0050087,0.070971,0.7966,HP_OPEN_NEURAL_TUBE_DEFECT,1
GSE24972_MARGINAL_ZONE_BCELL...2,SET,181,-0.052098,-0.0051446,0.062799,0.79661,GSE24972_MARGINAL_ZONE_BCELL_VS_FOLLICULAR_BCELL_IRF8_KO_DN,1
GSE46242_TH1_VS_ANERGIC_TH1_...3,SET,169,-0.053697,-0.0051254,0.064717,0.79665,GSE46242_TH1_VS_ANERGIC_TH1_CD4_TCELL_WITH_EGR2_DELETED_DN,1
HP_ABNORMAL_CSF_CARBOXYLIC_A...,SET,24,-0.13424,-0.0048478,0.16178,0.79666,HP_ABNORMAL_CSF_CARBOXYLIC_ACID_CONCENTRATION,1
GATA1_02,SET,218,-0.049257,-0.0053326,0.059344,0.79673,GATA1_02,1
HP_PANCREATIC_ISLET_CELL_ADE...,SET,9,-0.25431,-0.0056263,0.30628,0.79682,HP_PANCREATIC_ISLET_CELL_ADENOMA,1
GOCC_SERINE_TYPE_PEPTIDASE_C...,SET,13,-0.23793,-0.0063258,0.28649,0.79687,GOCC_SERINE_TYPE_PEPTIDASE_COMPLEX,1
GOBP_VITAMIN_D_BIOSYNTHETIC_...,SET,10,-0.22797,-0.0053161,0.27444,0.79691,GOBP_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
REACTOME_REGULATION_OF_RUNX3...,SET,52,-0.08846,-0.0046987,0.10648,0.79694,REACTOME_REGULATION_OF_RUNX3_EXPRESSION_AND_ACTIVITY,1
GOBP_PHAGOSOME_MATURATION,SET,28,-0.14263,-0.0055629,0.17168,0.79694,GOBP_PHAGOSOME_MATURATION,1
HP_SHORT_4TH_METACARPAL,SET,10,-0.24292,-0.0056647,0.29238,0.79696,HP_SHORT_4TH_METACARPAL,1
GOBP_NEGATIVE_REGULATION_OF_...233,SET,7,-0.2578,-0.0050303,0.31027,0.79698,GOBP_NEGATIVE_REGULATION_OF_FATTY_ACID_TRANSPORT,1
GOBP_INTRACELLULAR_PROTEIN_T...1,SET,29,-0.13213,-0.0052442,0.15901,0.79699,GOBP_INTRACELLULAR_PROTEIN_TRANSMEMBRANE_TRANSPORT,1
GSE43955_TH0_VS_TGFB_IL6_TH1...3,SET,182,-0.052517,-0.0052001,0.063202,0.79699,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN,1
GOMF_PHOSPHOPROTEIN_BINDING,SET,87,-0.076572,-0.0052558,0.092134,0.79703,GOMF_PHOSPHOPROTEIN_BINDING,1
GSE16451_IMMATURE_VS_MATURE_...1,SET,181,-0.049978,-0.0049353,0.060133,0.79704,GSE16451_IMMATURE_VS_MATURE_NEURON_CELL_LINE_WEST_EQUINE_ENC_VIRUS_DN,1
GSE21670_UNTREATED_VS_IL6_TR...4,SET,167,-0.055458,-0.0052624,0.066717,0.79708,GSE21670_UNTREATED_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GSE18893_CTRL_VS_TNF_TREATED...1,SET,178,-0.053435,-0.0052331,0.064268,0.79713,GSE18893_CTRL_VS_TNF_TREATED_TCONV_24H_DN,1
GOBP_POSITIVE_REGULATION_OF_...585,SET,9,-0.22607,-0.0050014,0.27187,0.79716,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_BIOSYNTHETIC_PROCESS,1
GOCC_PRONUCLEUS,SET,12,-0.19402,-0.0049559,0.23332,0.79716,GOCC_PRONUCLEUS,1
GOMF_ADENYLATE_CYCLASE_ACTIV...,SET,14,-0.1923,-0.0053054,0.23122,0.79719,GOMF_ADENYLATE_CYCLASE_ACTIVITY,1
MIR548F_5P,SET,446,-0.034138,-0.0052531,0.041046,0.79721,MIR548F_5P,1
WP_17Q12_COPY_NUMBER_VARIATI...,SET,84,-0.14584,-0.0098368,0.17533,0.79724,WP_17Q12_COPY_NUMBER_VARIATION_SYNDROME,1
HP_PINEAL_CYST,SET,8,-0.23697,-0.0049429,0.28484,0.79727,HP_PINEAL_CYST,1
HP_X_LINKED_RECESSIVE_INHERI...,SET,10,-0.20943,-0.0048838,0.25166,0.79734,HP_X_LINKED_RECESSIVE_INHERITANCE,1
GOBP_CHEMICAL_SYNAPTIC_TRANS...,SET,104,-0.071235,-0.0053434,0.085595,0.79736,GOBP_CHEMICAL_SYNAPTIC_TRANSMISSION_POSTSYNAPTIC,1
GSE17721_CTRL_VS_CPG_4H_BMDC...1,SET,179,-0.05238,-0.005144,0.062922,0.79742,GSE17721_CTRL_VS_CPG_4H_BMDC_DN,1
MIR6126,SET,106,-0.066064,-0.0050026,0.079328,0.79751,MIR6126,1
GSE17721_LPS_VS_PAM3CSK4_8H_...1,SET,180,-0.049608,-0.0048853,0.059564,0.79753,GSE17721_LPS_VS_PAM3CSK4_8H_BMDC_DN,1
GOBP_LYMPHOID_PROGENITOR_CEL...,SET,24,-0.1436,-0.0051857,0.17239,0.79756,GOBP_LYMPHOID_PROGENITOR_CELL_DIFFERENTIATION,1
GOBP_PYRIMIDINE_DEOXYRIBONUC...4,SET,6,-0.27226,-0.0049185,0.32679,0.79761,GOBP_PYRIMIDINE_DEOXYRIBONUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GSE29618_LAIV_VS_TIV_FLU_VAC...2,SET,166,-0.053964,-0.0051053,0.064772,0.79761,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_UP,1
GOMF_OPSIN_BINDING,SET,4,-0.38667,-0.0057037,0.46407,0.79763,GOMF_OPSIN_BINDING,1
SCHAEFFER_PROSTATE_DEVELOPME...4,SET,404,-0.037399,-0.0054835,0.044881,0.79765,SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP,1
AFFAR_YY1_TARGETS_UP,SET,178,-0.053529,-0.0052424,0.06423,0.79769,AFFAR_YY1_TARGETS_UP,1
GOBP_REGULATION_OF_ACTIN_FIL...4,SET,135,-0.060851,-0.005196,0.073001,0.79773,GOBP_REGULATION_OF_ACTIN_FILAMENT_LENGTH,1
GOBP_MESODERMAL_CELL_FATE_CO...,SET,17,-0.17434,-0.0052998,0.20909,0.7978,GOBP_MESODERMAL_CELL_FATE_COMMITMENT,1
WP_PI3KAKTMTOR_SIGNALING_AND...,SET,31,-0.13503,-0.0055411,0.16194,0.79781,WP_PI3KAKTMTOR_SIGNALING_AND_THERAPEUTIC_OPPORTUNITIES_IN_PROSTATE_CANCER,1
GOBP_INTERFERON_MEDIATED_SIG...,SET,98,-0.074703,-0.0054404,0.089587,0.79781,GOBP_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
chr2q14,SET,65,-0.14655,-0.0087,0.17575,0.79782,chr2q14,1
HP_UVEAL_MELANOMA,SET,8,-0.22402,-0.0046728,0.26861,0.79786,HP_UVEAL_MELANOMA,1
HP_COMPULSIVE_BEHAVIORS,SET,137,-0.059807,-0.0051443,0.071699,0.79789,HP_COMPULSIVE_BEHAVIORS,1
HP_IMPAIRED_OCULAR_ABDUCTION,SET,4,-0.40476,-0.0059706,0.4852,0.79791,HP_IMPAIRED_OCULAR_ABDUCTION,1
GSE2128_CTRL_VS_MIMETOPE_NEG...1,SET,182,-0.050102,-0.004961,0.060052,0.79794,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_C57BL6_DN,1
GSE29949_MICROGLIA_BRAIN_VS_...4,SET,180,-0.053141,-0.0052332,0.063688,0.79797,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP,1
MODULE_381,SET,11,-0.21751,-0.0053198,0.26062,0.79803,MODULE_381,1
MIR1193,SET,32,-0.11779,-0.0049108,0.14112,0.79806,MIR1193,1
CREB_02,SET,232,-0.046176,-0.0051551,0.055317,0.79806,CREB_02,1
MIR1238_3P,SET,30,-0.12477,-0.0050368,0.14945,0.7981,MIR1238_3P,1
GSE3982_MAST_CELL_VS_TH1_DN,SET,173,-0.053061,-0.0051237,0.063548,0.79813,GSE3982_MAST_CELL_VS_TH1_DN,1
KYNG_ENVIRONMENTAL_STRESS_RE...3,SET,33,-0.11725,-0.0049638,0.14038,0.7982,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_4NQO_IN_WS,1
GSE17974_0H_VS_12H_IN_VITRO_...2,SET,167,-0.054259,-0.0051486,0.064958,0.79822,GSE17974_0H_VS_12H_IN_VITRO_ACT_CD4_TCELL_UP,1
GOBP_REGULATION_OF_TRANS_SYN...,SET,447,-0.03453,-0.0053192,0.041327,0.79829,GOBP_REGULATION_OF_TRANS_SYNAPTIC_SIGNALING,1
GSE41176_WT_VS_TAK1_KO_ANTI_...8,SET,180,-0.051581,-0.0050796,0.061722,0.79833,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_6H_UP,1
SU_PLACENTA,SET,23,-0.1524,-0.0053877,0.18235,0.79834,SU_PLACENTA,1
GOMF_FATTY_ACYL_COA_SYNTHASE...,SET,6,-0.3591,-0.0064873,0.42965,0.79836,GOMF_FATTY_ACYL_COA_SYNTHASE_ACTIVITY,1
CAR_HPX,SET,70,-0.090274,-0.0055606,0.10798,0.79843,CAR_HPX,1
GOBP_MELANOCYTE_DIFFERENTIAT...,SET,23,-0.16123,-0.0057001,0.19285,0.79843,GOBP_MELANOCYTE_DIFFERENTIATION,1
MIR93_3P,SET,106,-0.065461,-0.004957,0.078272,0.79851,MIR93_3P,1
GOBP_RESPONSE_TO_BACTERIAL_L...,SET,8,-0.25123,-0.0052403,0.30032,0.79857,GOBP_RESPONSE_TO_BACTERIAL_LIPOPROTEIN,1
GOBP_REGULATION_OF_WOUND_HEA...2,SET,10,-0.19278,-0.0044956,0.23041,0.79861,GOBP_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...194,SET,5,-0.31327,-0.0051663,0.37438,0.79863,GOBP_NEGATIVE_REGULATION_OF_DOPAMINE_SECRETION,1
HP_ADULT_ONSET,SET,777,-0.025616,-0.0051544,0.030613,0.79863,HP_ADULT_ONSET,1
BENPORATH_NOS_TARGETS,SET,160,-0.058777,-0.0054602,0.07024,0.79864,BENPORATH_NOS_TARGETS,1
MIR10399_3P,SET,8,-0.24052,-0.005017,0.28743,0.79864,MIR10399_3P,1
HP_CORTICAL_DYSPLASIA,SET,51,-0.099715,-0.0052454,0.11916,0.79864,HP_CORTICAL_DYSPLASIA,1
EN1_01,SET,98,-0.076071,-0.00554,0.090894,0.79868,EN1_01,1
RASHI_RESPONSE_TO_IONIZING_R...4,SET,45,-0.10745,-0.0053102,0.12835,0.79874,RASHI_RESPONSE_TO_IONIZING_RADIATION_4,1
MIR4637,SET,51,-0.098376,-0.005175,0.11751,0.79875,MIR4637,1
GOBP_REGULATION_OF_KERATINOC...1,SET,35,-0.13399,-0.0058414,0.16,0.79881,GOBP_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
GSE37301_COMMON_LYMPHOID_PRO...4,SET,178,-0.051726,-0.0050657,0.061766,0.79882,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_GRAN_MONO_PROGENITOR_UP,1
GOBP_DNA_DEAMINATION,SET,11,-0.23335,-0.005707,0.2786,0.79886,GOBP_DNA_DEAMINATION,1
HP_PERSEVERATIVE_THOUGHT,SET,19,-0.15792,-0.0050749,0.1885,0.79892,HP_PERSEVERATIVE_THOUGHT,1
GSE3982_BCELL_VS_EFF_MEMORY_...1,SET,177,-0.054275,-0.0053005,0.064771,0.79896,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_DN,1
NAKAYA_MYELOID_DENDRITIC_CEL...1,SET,238,-0.043773,-0.0049489,0.052239,0.79896,NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
HP_POSTERIOR_PLAGIOCEPHALY,SET,7,-0.27658,-0.0053967,0.33003,0.79899,HP_POSTERIOR_PLAGIOCEPHALY,1
HP_MICROTIA_THIRD_DEGREE,SET,10,-0.19753,-0.0046064,0.2357,0.799,HP_MICROTIA_THIRD_DEGREE,1
HP_PORTAL_INFLAMMATION,SET,4,-0.41049,-0.0060551,0.48979,0.799,HP_PORTAL_INFLAMMATION,1
HP_PERIPHERAL_ARTERIOVENOUS_...,SET,7,-0.2704,-0.0052762,0.32262,0.79902,HP_PERIPHERAL_ARTERIOVENOUS_FISTULA,1
GUENTHER_GROWTH_SPHERICAL_VS...1,SET,24,-0.15371,-0.0055509,0.18333,0.79911,GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_DN,1
WP_SYNTHESIS_OF_CERAMIDES_AN...,SET,22,-0.15863,-0.005485,0.18916,0.79914,WP_SYNTHESIS_OF_CERAMIDES_AND_1DEOXYCERAMIDES,1
GOBP_DIGESTIVE_SYSTEM_DEVELO...,SET,140,-0.063879,-0.0055539,0.076175,0.79914,GOBP_DIGESTIVE_SYSTEM_DEVELOPMENT,1
HP_DUPLICATION_OF_THE_DISTAL...2,SET,6,-0.26797,-0.0048409,0.31952,0.79916,HP_DUPLICATION_OF_THE_DISTAL_PHALANX_OF_THE_THUMB,1
GSE18791_UNSTIM_VS_NEWCATSLE...10,SET,179,-0.04952,-0.0048632,0.05904,0.79919,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_6H_UP,1
HP_BROAD_NECK,SET,21,-0.14379,-0.0048578,0.1714,0.79924,HP_BROAD_NECK,1
GOBP_AMIDE_CATABOLIC_PROCESS,SET,16,-0.17119,-0.0050489,0.20398,0.79934,GOBP_AMIDE_CATABOLIC_PROCESS,1
MIR19A_3P,SET,592,-0.030485,-0.0053824,0.036311,0.79942,MIR19A_3P,1
HP_GENERALIZED_OSTEOPOROSIS,SET,17,-0.17306,-0.0052608,0.20613,0.79942,HP_GENERALIZED_OSTEOPOROSIS,1
GSE37563_WT_VS_CTLA4_KO_CD4_...1,SET,168,-0.051948,-0.0049439,0.061852,0.79951,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_DN,1
REACTOME_CELL_DEATH_SIGNALLI...,SET,67,-0.089673,-0.0054044,0.10676,0.79952,REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE,1
GOBP_GLYCOSYLCERAMIDE_CATABO...,SET,6,-0.28589,-0.0051646,0.34033,0.79955,GOBP_GLYCOSYLCERAMIDE_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_SYNAPTIC_...5,SET,34,-0.12469,-0.0053579,0.14843,0.79955,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GABAERGIC,1
GSE7831_1H_VS_4H_INFLUENZA_S...2,SET,182,-0.052472,-0.0051956,0.062465,0.79955,GSE7831_1H_VS_4H_INFLUENZA_STIM_PDC_UP,1
HP_TOTAL_ANOMALOUS_PULMONARY...,SET,11,-0.19151,-0.0046838,0.22797,0.79956,HP_TOTAL_ANOMALOUS_PULMONARY_VENOUS_RETURN,1
MIR495_3P,SET,639,-0.028964,-0.005306,0.034468,0.79963,MIR495_3P,1
HOEK_PBMC_INACTIVATED_INFLUE...1,SET,8,-0.21675,-0.0045211,0.25792,0.79965,HOEK_PBMC_INACTIVATED_INFLUENZA_ADULT_1DY_DN,1
BMI1_DN.V1_UP,SET,137,-0.064964,-0.0055879,0.077282,0.79971,BMI1_DN.V1_UP,1
GSE18281_MEDULLARY_THYMOCYTE...1,SET,167,-0.053152,-0.0050435,0.063228,0.79972,GSE18281_MEDULLARY_THYMOCYTE_VS_WHOLE_MEDULLA_THYMUS_DN,1
CAIRO_HEPATOBLASTOMA_UP,SET,190,-0.052328,-0.0052929,0.062245,0.79973,CAIRO_HEPATOBLASTOMA_UP,1
MIR4436A,SET,77,-0.084911,-0.0054845,0.10099,0.79976,MIR4436A,1
GSE19374_UNINF_VS_LISTERIA_I...2,SET,177,-0.053841,-0.0052582,0.06403,0.79978,GSE19374_UNINF_VS_LISTERIA_INFECTED_MACROPHAGE_UP,1
GOBP_FEEDING_BEHAVIOR,SET,97,-0.080361,-0.0058227,0.095553,0.79982,GOBP_FEEDING_BEHAVIOR,1
GOBP_CGMP_MEDIATED_SIGNALING,SET,26,-0.14559,-0.0054719,0.17309,0.79985,GOBP_CGMP_MEDIATED_SIGNALING,1
GNF2_MAP2K3,SET,66,-0.087318,-0.0052231,0.1038,0.79987,GNF2_MAP2K3,1
GSE5503_PLN_DC_VS_SPLEEN_DC_...1,SET,181,-0.050848,-0.0050211,0.060448,0.79987,GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
GOMF_UBIQUITIN_LIGASE_INHIBI...,SET,9,-0.26058,-0.0057649,0.3096,0.8,GOMF_UBIQUITIN_LIGASE_INHIBITOR_ACTIVITY,1
MYB_Q3,SET,233,-0.046422,-0.0051936,0.055152,0.80002,MYB_Q3,1
GOBP_REGULATION_OF_BRANCHING...1,SET,6,-0.3251,-0.005873,0.38621,0.80003,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_LUNG_MORPHOGENESIS,1
GSE41176_UNSTIM_VS_ANTI_IGM_...5,SET,170,-0.052371,-0.0050135,0.062209,0.80006,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_DN,1
HP_REDUCED_RENAL_CORTICOMEDU...,SET,14,-0.18978,-0.0052358,0.22539,0.8001,HP_REDUCED_RENAL_CORTICOMEDULLARY_DIFFERENTIATION,1
GOBP_STABILIZATION_OF_MEMBRA...,SET,17,-0.17894,-0.0054398,0.21249,0.80013,GOBP_STABILIZATION_OF_MEMBRANE_POTENTIAL,1
GOBP_REGULATION_OF_MUSCLE_SY...,SET,215,-0.050617,-0.0054425,0.060095,0.80018,GOBP_REGULATION_OF_MUSCLE_SYSTEM_PROCESS,1
GSE1432_CTRL_VS_IFNG_1H_MICR...2,SET,173,-0.052324,-0.0050525,0.062098,0.80027,GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_UP,1
WANG_RECURRENT_LIVER_CANCER_...2,SET,16,-0.18452,-0.0054418,0.21897,0.80028,WANG_RECURRENT_LIVER_CANCER_UP,1
GOBP_BILE_ACID_AND_BILE_SALT...,SET,29,-0.13965,-0.005543,0.1657,0.80033,GOBP_BILE_ACID_AND_BILE_SALT_TRANSPORT,1
GOMF_PHOSPHATIDYLCHOLINE_TRA...2,SET,18,-0.17149,-0.0053643,0.20346,0.80035,GOMF_PHOSPHATIDYLCHOLINE_TRANSPORTER_ACTIVITY,1
GOBP_MONOCARBOXYLIC_ACID_CAT...,SET,125,-0.062015,-0.005097,0.073565,0.80038,GOBP_MONOCARBOXYLIC_ACID_CATABOLIC_PROCESS,1
REACTOME_PI_METABOLISM,SET,77,-0.078737,-0.0050857,0.093394,0.8004,REACTOME_PI_METABOLISM,1
GOBP_CENTROSOME_SEPARATION,SET,16,-0.16744,-0.0049381,0.1986,0.8004,GOBP_CENTROSOME_SEPARATION,1
KANG_FLUOROURACIL_RESISTANCE...1,SET,16,-0.17725,-0.0052274,0.21022,0.80042,KANG_FLUOROURACIL_RESISTANCE_DN,1
GOBP_REGULATION_OF_DNA_REPAIR,SET,194,-0.048034,-0.004909,0.056969,0.80043,GOBP_REGULATION_OF_DNA_REPAIR,1
HP_NEOPLASM_OF_THE_TONGUE,SET,42,-0.1021,-0.0048752,0.12108,0.80044,HP_NEOPLASM_OF_THE_TONGUE,1
REACTOME_APC_C_MEDIATED_DEGR...,SET,84,-0.071,-0.0047889,0.084186,0.80048,REACTOME_APC_C_MEDIATED_DEGRADATION_OF_CELL_CYCLE_PROTEINS,1
GSE17721_PAM3CSK4_VS_CPG_12H...1,SET,187,-0.051264,-0.0051446,0.060784,0.80049,GSE17721_PAM3CSK4_VS_CPG_12H_BMDC_DN,1
GOMF_1_ALKYL_2_ACETYLGLYCERO...,SET,8,-0.21978,-0.0045843,0.26057,0.80051,GOMF_1_ALKYL_2_ACETYLGLYCEROPHOSPHOCHOLINE_ESTERASE_ACTIVITY,1
GOMF_WW_DOMAIN_BINDING,SET,21,-0.15192,-0.0051324,0.18007,0.80057,GOMF_WW_DOMAIN_BINDING,1
GSE21033_CTRL_VS_POLYIC_STIM...10,SET,183,-0.052155,-0.0051783,0.061809,0.8006,GSE21033_CTRL_VS_POLYIC_STIM_DC_6H_UP,1
HP_HYPOPHOSPHATEMIC_RICKETS,SET,18,-0.17825,-0.0055757,0.21108,0.80079,HP_HYPOPHOSPHATEMIC_RICKETS,1
GOBP_BASE_CONVERSION_OR_SUBS...,SET,16,-0.22447,-0.0066202,0.2658,0.8008,GOBP_BASE_CONVERSION_OR_SUBSTITUTION_EDITING,1
GOCC_RESPIRATORY_CHAIN_COMPL...,SET,21,-0.14983,-0.0050618,0.17742,0.8008,GOCC_RESPIRATORY_CHAIN_COMPLEX_IV,1
MIR26B_3P,SET,95,-0.070576,-0.005061,0.08356,0.80083,MIR26B_3P,1
GCM_ERCC4,SET,25,-0.13775,-0.0050769,0.16307,0.80086,GCM_ERCC4,1
HP_ABNORMALITY_OF_MACULAR_PI...,SET,36,-0.12581,-0.0055628,0.14891,0.8009,HP_ABNORMALITY_OF_MACULAR_PIGMENTATION,1
POU3F2_01,SET,96,-0.076315,-0.0055011,0.090306,0.80096,POU3F2_01,1
MIR1251_5P,SET,23,-0.13785,-0.0048734,0.16311,0.80097,MIR1251_5P,1
HP_ABNORMALLY_LARGE_GLOBE,SET,39,-0.1169,-0.0053793,0.13832,0.80098,HP_ABNORMALLY_LARGE_GLOBE,1
HP_ABNORMALITY_OF_ACID_BASE_...,SET,378,-0.034861,-0.0049478,0.041238,0.80104,HP_ABNORMALITY_OF_ACID_BASE_HOMEOSTASIS,1
GOBP_GLUTAMINE_TRANSPORT,SET,9,-0.26069,-0.0057674,0.30821,0.80117,GOBP_GLUTAMINE_TRANSPORT,1
GSE23505_IL6_IL1_VS_IL6_IL1_...2,SET,178,-0.052321,-0.0051241,0.061855,0.80118,GSE23505_IL6_IL1_VS_IL6_IL1_IL23_TREATED_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...552,SET,6,-0.3203,-0.0057863,0.37863,0.8012,GOBP_POSITIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_TRANSPORT,1
HP_HEMIFACIAL_SPASM,SET,12,-0.19222,-0.0049101,0.2272,0.80123,HP_HEMIFACIAL_SPASM,1
GOBP_REGULATION_OF_MACROPHAG...4,SET,31,-0.13872,-0.0056924,0.1639,0.80132,GOBP_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
GOMF_LYSOZYME_ACTIVITY,SET,9,-0.25276,-0.0055919,0.29862,0.80133,GOMF_LYSOZYME_ACTIVITY,1
HP_INFANTILE_ENCEPHALOPATHY,SET,8,-0.25469,-0.0053126,0.30083,0.8014,HP_INFANTILE_ENCEPHALOPATHY,1
GOBP_REGULATION_OF_ACROSOME_...,SET,18,-0.17933,-0.0056095,0.21179,0.80143,GOBP_REGULATION_OF_ACROSOME_REACTION,1
GOBP_REGULATION_OF_MACROAUTO...,SET,166,-0.053969,-0.0051058,0.063735,0.80143,GOBP_REGULATION_OF_MACROAUTOPHAGY,1
MODULE_150,SET,12,-0.17234,-0.0044022,0.20351,0.80144,MODULE_150,1
GOBP_NEGATIVE_REGULATION_OF_...509,SET,44,-0.10325,-0.0050457,0.12192,0.80144,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_PROTEIN_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...430,SET,25,-0.15844,-0.0058394,0.18706,0.8015,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_ACTIVATION,1
GOBP_LIGAND_GATED_ION_CHANNE...,SET,30,-0.14254,-0.0057542,0.16828,0.80151,GOBP_LIGAND_GATED_ION_CHANNEL_SIGNALING_PATHWAY,1
GOBP_MICROGLIAL_CELL_ACTIVAT...,SET,5,-0.3485,-0.0057474,0.41141,0.80152,GOBP_MICROGLIAL_CELL_ACTIVATION_INVOLVED_IN_IMMUNE_RESPONSE,1
MIR561_5P,SET,131,-0.060741,-0.0051098,0.071698,0.80155,MIR561_5P,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...8,SET,72,-0.087239,-0.0054496,0.10296,0.80158,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_CORRELATED_WITH_CD8_T_CELL_RESPONSE_3DY_NEGATIVE,1
LEE_CALORIE_RESTRICTION_MUSC...2,SET,36,-0.11983,-0.0052983,0.14141,0.80161,LEE_CALORIE_RESTRICTION_MUSCLE_UP,1
SA_MMP_CYTOKINE_CONNECTION,SET,15,-0.20486,-0.0058501,0.24173,0.80163,SA_MMP_CYTOKINE_CONNECTION,1
GOBP_POSITIVE_REGULATION_OF_...738,SET,56,-0.10591,-0.0058374,0.12496,0.80165,GOBP_POSITIVE_REGULATION_OF_SYNAPSE_ASSEMBLY,1
WP_UREA_CYCLE_AND_ASSOCIATED...,SET,23,-0.14522,-0.0051341,0.17131,0.8017,WP_UREA_CYCLE_AND_ASSOCIATED_PATHWAYS,1
MIR4293,SET,99,-0.071837,-0.0052582,0.084721,0.80176,MIR4293,1
GOBP_EPIDERMAL_GROWTH_FACTOR...,SET,102,-0.070006,-0.0052007,0.082558,0.80176,GOBP_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
CREB_Q4_01,SET,192,-0.052217,-0.0053091,0.06157,0.8018,CREB_Q4_01,1
GOBP_TRANSCRIPTION_ELONGATIO...1,SET,6,-0.31228,-0.0056415,0.36819,0.80182,GOBP_TRANSCRIPTION_ELONGATION_BY_RNA_POLYMERASE_I,1
GSE30962_PRIMARY_VS_SECONDAR...3,SET,176,-0.056158,-0.0054692,0.06621,0.80183,GSE30962_PRIMARY_VS_SECONDARY_CHRONIC_LCMV_INF_CD8_TCELL_DN,1
MIR6770_3P,SET,4,-0.3157,-0.0046569,0.37217,0.80185,MIR6770_3P,1
GOBP_REGULATION_OF_SYSTEMIC_...4,SET,33,-0.13527,-0.0057269,0.15947,0.80185,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_HORMONE,1
RODWELL_AGING_KIDNEY_DN,SET,124,-0.066665,-0.0054573,0.078588,0.80186,RODWELL_AGING_KIDNEY_DN,1
SABATES_COLORECTAL_ADENOMA_DN,SET,260,-0.047582,-0.0056193,0.05609,0.80186,SABATES_COLORECTAL_ADENOMA_DN,1
GSE40666_WT_VS_STAT1_KO_CD8_...2,SET,182,-0.054818,-0.005428,0.064615,0.80188,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_UP,1
GOBP_MEIOTIC_SISTER_CHROMATI...,SET,12,-0.20846,-0.0053248,0.24563,0.80195,GOBP_MEIOTIC_SISTER_CHROMATID_COHESION,1
GSE22589_SIV_VS_HIV_AND_SIV_...2,SET,179,-0.05457,-0.0053591,0.06429,0.802,GSE22589_SIV_VS_HIV_AND_SIV_INFECTED_DC_UP,1
GOBP_KETONE_CATABOLIC_PROCESS,SET,12,-0.19922,-0.005089,0.23469,0.80202,GOBP_KETONE_CATABOLIC_PROCESS,1
HP_ANTERIOR_PLAGIOCEPHALY,SET,5,-0.35821,-0.0059074,0.42196,0.80203,HP_ANTERIOR_PLAGIOCEPHALY,1
chr16q11,SET,7,-0.57336,-0.011188,0.67536,0.80204,chr16q11,1
GOBP_EYE_PIGMENTATION,SET,4,-0.34953,-0.0051559,0.41159,0.80211,GOBP_EYE_PIGMENTATION,1
GOBP_FOLIC_ACID_CONTAINING_C...3,SET,27,-0.12596,-0.0048242,0.1483,0.80214,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_ACYL...,SET,21,-0.15307,-0.0051713,0.18022,0.80215,HP_ABNORMAL_CIRCULATING_ACYLCARNITINE_CONCENTRATION,1
HP_THROMBOPHLEBITIS,SET,10,-0.20153,-0.0046995,0.23722,0.8022,HP_THROMBOPHLEBITIS,1
GSE45365_BCELL_VS_CD8_TCELL_...1,SET,137,-0.062154,-0.0053462,0.073156,0.80222,GSE45365_BCELL_VS_CD8_TCELL_DN,1
GSE5679_CTRL_VS_RARA_AGONIST...1,SET,180,-0.051628,-0.0050842,0.060762,0.80224,GSE5679_CTRL_VS_RARA_AGONIST_AM580_TREATED_DC_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_BAS...,SET,100,-0.076097,-0.0055979,0.089562,0.80224,HE_LIM_SUN_FETAL_LUNG_C2_BASOPHIL_CELL,1
GOBP_RENAL_SYSTEM_PROCESS_IN...1,SET,14,-0.20375,-0.0056212,0.23976,0.80228,GOBP_RENAL_SYSTEM_PROCESS_INVOLVED_IN_REGULATION_OF_BLOOD_VOLUME,1
MIR647,SET,75,-0.081335,-0.0051851,0.095706,0.80229,MIR647,1
DURANTE_ADULT_OLFACTORY_NEUR...13,SET,72,-0.092017,-0.0057481,0.10828,0.80229,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_NK_CELLS,1
GOBP_REGULATION_OF_TYPE_I_IN...,SET,40,-0.11126,-0.005185,0.1309,0.80232,GOBP_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
KYNG_RESPONSE_TO_H2O2_VIA_ER...1,SET,17,-0.18168,-0.005523,0.21363,0.80246,KYNG_RESPONSE_TO_H2O2_VIA_ERCC6,1
WP_T_CELL_RECEPTOR_AND_COSTI...,SET,27,-0.14268,-0.0054646,0.16775,0.80249,WP_T_CELL_RECEPTOR_AND_COSTIMULATORY_SIGNALING,1
GOBP_HEPARAN_SULFATE_PROTEOG...4,SET,8,-0.2595,-0.0054128,0.30507,0.80251,GOBP_HEPARAN_SULFATE_PROTEOGLYCAN_CATABOLIC_PROCESS,1
IL2_UP.V1_DN,SET,159,-0.05889,-0.0054537,0.069218,0.80255,IL2_UP.V1_DN,1
GSE13485_PRE_VS_POST_YF17D_V...2,SET,167,-0.055391,-0.005256,0.0651,0.80257,GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_UP,1
GSE360_CTRL_VS_B_MALAYI_LOW_...3,SET,179,-0.052576,-0.0051633,0.061793,0.80257,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
GOBP_GAMMA_AMINOBUTYRIC_ACID...5,SET,26,-0.15915,-0.0059817,0.18702,0.80261,GOBP_GAMMA_AMINOBUTYRIC_ACID_SIGNALING_PATHWAY,1
GOBP_IODIDE_TRANSPORT,SET,9,-0.1983,-0.0043871,0.233,0.80264,GOBP_IODIDE_TRANSPORT,1
KEGG_ERBB_SIGNALING_PATHWAY,SET,83,-0.080846,-0.0054207,0.094979,0.80266,KEGG_ERBB_SIGNALING_PATHWAY,1
GSE43863_TH1_VS_LY6C_LOW_CXC...1,SET,184,-0.052601,-0.0052367,0.061788,0.8027,GSE43863_TH1_VS_LY6C_LOW_CXCR5NEG_EFFECTOR_CD4_TCELL_DN,1
PAX6_TARGET_GENES,SET,695,-0.027991,-0.0053393,0.032878,0.80271,PAX6_TARGET_GENES,1
GOMF_CHLORIDE_ION_BINDING,SET,9,-0.27221,-0.0060223,0.31973,0.80272,GOMF_CHLORIDE_ION_BINDING,1
HP_ABNORMAL_RETINAL_MORPHOLO...,SET,847,-0.025074,-0.0052572,0.029445,0.80276,HP_ABNORMAL_RETINAL_MORPHOLOGY,1
HP_INCREASED_HEPATIC_GLYCOGE...,SET,11,-0.23164,-0.0056654,0.27202,0.80277,HP_INCREASED_HEPATIC_GLYCOGEN_CONTENT,1
PURBEY_TARGETS_OF_CTBP1_AND_...1,SET,150,-0.056774,-0.0051081,0.066658,0.80281,PURBEY_TARGETS_OF_CTBP1_AND_SATB1_DN,1
GOCC_PROTEASOME_REGULATORY_P...1,SET,11,-0.17471,-0.0042729,0.2051,0.80284,GOCC_PROTEASOME_REGULATORY_PARTICLE_BASE_SUBCOMPLEX,1
GSE2585_CTEC_VS_THYMIC_DC_UP,SET,178,-0.05439,-0.0053266,0.063847,0.80285,GSE2585_CTEC_VS_THYMIC_DC_UP,1
REACTOME_E2F_ENABLED_INHIBIT...,SET,9,-0.20002,-0.0044252,0.23475,0.80291,REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION,1
MIR6889_5P,SET,11,-0.23073,-0.005643,0.27076,0.80293,MIR6889_5P,1
BMI1_DN_MEL18_DN.V1_UP,SET,135,-0.066483,-0.005677,0.078016,0.80293,BMI1_DN_MEL18_DN.V1_UP,1
GSE26495_NAIVE_VS_PD1LOW_CD8...1,SET,185,-0.054736,-0.0054639,0.064229,0.80294,GSE26495_NAIVE_VS_PD1LOW_CD8_TCELL_DN,1
HP_NEPHROCALCINOSIS,SET,86,-0.083291,-0.0056842,0.097731,0.80296,HP_NEPHROCALCINOSIS,1
MIR4641,SET,60,-0.09136,-0.0052115,0.10718,0.803,MIR4641,1
GSE21033_CTRL_VS_POLYIC_STIM...7,SET,178,-0.050916,-0.0049865,0.059729,0.80301,GSE21033_CTRL_VS_POLYIC_STIM_DC_3H_DN,1
YAMASHITA_LIVER_CANCER_STEM_...1,SET,70,-0.092057,-0.0056705,0.10798,0.80304,YAMASHITA_LIVER_CANCER_STEM_CELL_DN,1
SCHLOSSER_MYC_TARGETS_AND_SE...2,SET,45,-0.10328,-0.005104,0.12111,0.80309,SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_UP,1
GAL_LEUKEMIC_STEM_CELL_DN,SET,212,-0.04925,-0.0052589,0.057743,0.80314,GAL_LEUKEMIC_STEM_CELL_DN,1
KEGG_MEDICUS_PATHOGEN_KSHV_V...5,SET,24,-0.15247,-0.0055063,0.17876,0.80315,KEGG_MEDICUS_PATHOGEN_KSHV_VGPCR_TO_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,1
GOBP_CANONICAL_WNT_SIGNALING...,SET,288,-0.045016,-0.0055908,0.052773,0.80317,GOBP_CANONICAL_WNT_SIGNALING_PATHWAY,1
GOBP_LUNG_EPITHELIUM_DEVELOP...,SET,45,-0.11338,-0.0056033,0.1329,0.8032,GOBP_LUNG_EPITHELIUM_DEVELOPMENT,1
GOBP_GAP_JUNCTION_ASSEMBLY,SET,16,-0.21145,-0.0062361,0.24783,0.80322,GOBP_GAP_JUNCTION_ASSEMBLY,1
PID_THROMBIN_PAR1_PATHWAY,SET,42,-0.11228,-0.0053615,0.13155,0.80332,PID_THROMBIN_PAR1_PATHWAY,1
BAKKER_FOXO3_TARGETS_UP,SET,51,-0.10181,-0.0053554,0.11925,0.80336,BAKKER_FOXO3_TARGETS_UP,1
GOBP_ARACHIDONIC_ACID_METABO...,SET,55,-0.1029,-0.0056206,0.12051,0.80341,GOBP_ARACHIDONIC_ACID_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_BRANCHING...5,SET,5,-0.36069,-0.0059484,0.42233,0.80346,GOBP_REGULATION_OF_BRANCHING_MORPHOGENESIS_OF_A_NERVE,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...5,SET,13,-0.2133,-0.0056707,0.2497,0.8035,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_DN,1
REACTOME_BIOTIN_TRANSPORT_AN...,SET,10,-0.20517,-0.0047845,0.24018,0.80351,REACTOME_BIOTIN_TRANSPORT_AND_METABOLISM,1
GOBP_ESTABLISHMENT_OF_PROTEI...9,SET,58,-0.093236,-0.0052294,0.10913,0.80353,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
GSE25088_IL4_VS_IL4_AND_ROSI...2,SET,183,-0.053091,-0.0052712,0.062132,0.80358,GSE25088_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP,1
HP_DECREASED_SPECIFIC_ANTIBO...1,SET,12,-0.20507,-0.0052384,0.23999,0.80359,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_POLYSACCHARIDE_VACCINE,1
ZNF626_TARGET_GENES,SET,12,-0.20061,-0.0051245,0.23474,0.80361,ZNF626_TARGET_GENES,1
HP_SUBACUTE_PROGRESSIVE_VIRA...,SET,9,-0.23894,-0.0052861,0.27956,0.80363,HP_SUBACUTE_PROGRESSIVE_VIRAL_HEPATITIS,1
CTCTATG_MIR368,SET,38,-0.11951,-0.0054285,0.13981,0.80365,CTCTATG_MIR368,1
GOBP_REGULATION_OF_BLOOD_CIR...,SET,240,-0.050199,-0.0056988,0.058729,0.80365,GOBP_REGULATION_OF_BLOOD_CIRCULATION,1
GOCC_CAVEOLA,SET,75,-0.087942,-0.0056063,0.10288,0.80366,GOCC_CAVEOLA,1
chr2q32,SET,41,-0.2121,-0.010007,0.24812,0.80367,chr2q32,1
WP_CALORIC_RESTRICTION_AND_A...,SET,8,-0.25799,-0.0053813,0.30174,0.80372,WP_CALORIC_RESTRICTION_AND_AGING,1
GOMF_7S_RNA_BINDING,SET,7,-0.224,-0.0043707,0.26189,0.8038,GOMF_7S_RNA_BINDING,1
MEIS1_01,SET,225,-0.048579,-0.005342,0.056796,0.80381,MEIS1_01,1
GOBP_MIDDLE_EAR_MORPHOGENESIS,SET,19,-0.18341,-0.0058942,0.21441,0.80384,GOBP_MIDDLE_EAR_MORPHOGENESIS,1
GOBP_POSITIVE_REGULATION_OF_...713,SET,36,-0.13388,-0.0059192,0.15649,0.80385,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,1
GOBP_STEROID_HORMONE_BIOSYNT...,SET,43,-0.11439,-0.0055268,0.13367,0.80393,GOBP_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,1
HP_DUODENAL_ADENOCARCINOMA,SET,7,-0.23187,-0.0045243,0.27094,0.80394,HP_DUODENAL_ADENOCARCINOMA,1
MIR4326,SET,78,-0.086332,-0.0056122,0.10087,0.80396,MIR4326,1
GOBP_NOTOCHORD_DEVELOPMENT,SET,16,-0.19046,-0.005617,0.22248,0.80401,GOBP_NOTOCHORD_DEVELOPMENT,1
GOMF_RNA_EXONUCLEASE_ACTIVIT...,SET,39,-0.10356,-0.0047656,0.12096,0.80405,GOMF_RNA_EXONUCLEASE_ACTIVITY_PRODUCING_5_PHOSPHOMONOESTERS,1
GAVISH_3CA_METAPROGRAM_CD4_T...8,SET,49,-0.10318,-0.0053205,0.1205,0.80407,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_STRESS_HSP,1
GSE2770_UNTREATED_VS_ACT_CD4...2,SET,180,-0.055951,-0.0055099,0.065332,0.80411,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_UP,1
HP_ADRENAL_INSUFFICIENCY,SET,93,-0.075287,-0.0053419,0.087906,0.80412,HP_ADRENAL_INSUFFICIENCY,1
GOCC_NUCLEOID,SET,41,-0.10253,-0.0048371,0.11967,0.8042,GOCC_NUCLEOID,1
CHANG_IMMORTALIZED_BY_HPV31_...2,SET,65,-0.087211,-0.0051772,0.10179,0.80422,CHANG_IMMORTALIZED_BY_HPV31_UP,1
KEGG_MEDICUS_ENV_FACTOR_PARA...,SET,5,-0.36525,-0.0060235,0.42629,0.80422,KEGG_MEDICUS_ENV_FACTOR_PARAQUAT_TO_FAS_JNK_SIGNALING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_FGF_F...2,SET,33,-0.13557,-0.0057395,0.15821,0.80425,KEGG_MEDICUS_REFERENCE_FGF_FGFR_RAS_ERK_SIGNALING_PATHWAY,1
GSE4142_GC_BCELL_VS_MEMORY_B...2,SET,182,-0.053282,-0.0052759,0.062178,0.80425,GSE4142_GC_BCELL_VS_MEMORY_BCELL_UP,1
GOBP_ORGANELLE_TRANSPORT_ALO...,SET,79,-0.080412,-0.0052606,0.09381,0.80432,GOBP_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
GOBP_C4_DICARBOXYLATE_TRANSP...,SET,28,-0.13871,-0.0054099,0.16178,0.80438,GOBP_C4_DICARBOXYLATE_TRANSPORT,1
MIR7705,SET,45,-0.10789,-0.0053322,0.12582,0.80441,MIR7705,1
HP_CHORIORETINAL_ATROPHY,SET,40,-0.12091,-0.0056345,0.141,0.80441,HP_CHORIORETINAL_ATROPHY,1
GOMF_TRANSFORMING_GROWTH_FAC...3,SET,5,-0.37,-0.006102,0.43148,0.80442,GOMF_TRANSFORMING_GROWTH_FACTOR_BETA_RECEPTOR_ACTIVITY_TYPE_I,1
GSE10325_CD4_TCELL_VS_MYELOI...2,SET,179,-0.0547,-0.0053719,0.063786,0.80443,GSE10325_CD4_TCELL_VS_MYELOID_UP,1
HP_INCREASED_ASPARTATE_FAMIL...,SET,7,-0.27186,-0.0053045,0.31699,0.80444,HP_INCREASED_ASPARTATE_FAMILY_AMINO_ACID_LEVEL_IN_URINE,1
MODULE_354,SET,17,-0.19993,-0.0060776,0.2331,0.80446,MODULE_354,1
KEGG_MEDICUS_REFERENCE_CD40_...,SET,7,-0.28048,-0.0054728,0.327,0.80448,KEGG_MEDICUS_REFERENCE_CD40_NFKB_SIGNALING_PATHWAY,1
GOBP_BEHAVIORAL_RESPONSE_TO_...3,SET,8,-0.29191,-0.0060889,0.34029,0.8045,GOBP_BEHAVIORAL_RESPONSE_TO_NICOTINE,1
HFH3_01,SET,176,-0.055758,-0.0054302,0.064993,0.80452,HFH3_01,1
GOBP_MEMBRANE_LIPID_METABOLI...,SET,203,-0.051393,-0.0053713,0.05989,0.80458,GOBP_MEMBRANE_LIPID_METABOLIC_PROCESS,1
GSE24142_ADULT_VS_FETAL_EARL...2,SET,183,-0.054857,-0.0054465,0.06392,0.80461,GSE24142_ADULT_VS_FETAL_EARLY_THYMIC_PROGENITOR_UP,1
RACTNNRTTTNC_UNKNOWN,SET,111,-0.069551,-0.0053888,0.081018,0.80468,RACTNNRTTTNC_UNKNOWN,1
GSE29618_MONOCYTE_VS_PDC_UP,SET,185,-0.056281,-0.0056181,0.065555,0.80469,GSE29618_MONOCYTE_VS_PDC_UP,1
HP_ABNORMAL_DENTATE_NUCLEUS_...,SET,12,-0.1902,-0.0048584,0.22153,0.8047,HP_ABNORMAL_DENTATE_NUCLEUS_MORPHOLOGY,1
MIR936,SET,127,-0.063767,-0.0052824,0.074268,0.80471,MIR936,1
GOBP_POSITIVE_REGULATION_OF_...360,SET,11,-0.21186,-0.0051816,0.24675,0.80471,GOBP_POSITIVE_REGULATION_OF_INTEGRIN_MEDIATED_SIGNALING_PATHWAY,1
HP_IMPAIRED_OCULAR_ADDUCTION,SET,9,-0.25384,-0.0056159,0.29551,0.80482,HP_IMPAIRED_OCULAR_ADDUCTION,1
HP_HIGH_MYOPIA,SET,76,-0.084485,-0.0054216,0.098345,0.80484,HP_HIGH_MYOPIA,1
GOBP_DNA_REPLICATION_CHECKPO...,SET,20,-0.13923,-0.0045904,0.16207,0.80485,GOBP_DNA_REPLICATION_CHECKPOINT_SIGNALING,1
GSE29164_DAY3_VS_DAY7_CD8_TC...4,SET,183,-0.052346,-0.0051972,0.060926,0.80487,GSE29164_DAY3_VS_DAY7_CD8_TCELL_TREATED_MELANOMA_UP,1
GSE4142_NAIVE_BCELL_VS_PLASM...2,SET,175,-0.053564,-0.0052018,0.062332,0.80492,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_UP,1
GOMF_MECHANOSENSITIVE_MONOAT...2,SET,16,-0.18713,-0.005519,0.21775,0.80493,GOMF_MECHANOSENSITIVE_MONOATOMIC_ION_CHANNEL_ACTIVITY,1
HP_INCREASED_CIRCULATING_IGE...,SET,39,-0.11678,-0.0053736,0.13588,0.80494,HP_INCREASED_CIRCULATING_IGE_LEVEL,1
GOBP_TRYPTOPHAN_CATABOLIC_PR...,SET,5,-0.389,-0.0064152,0.45254,0.80498,GOBP_TRYPTOPHAN_CATABOLIC_PROCESS_TO_KYNURENINE,1
DESCARTES_FETAL_INTESTINE_ER...,SET,132,-0.064164,-0.0054182,0.074645,0.80499,DESCARTES_FETAL_INTESTINE_ERYTHROBLASTS,1
GOBP_POSITIVE_REGULATION_OF_...190,SET,4,-0.28992,-0.0042766,0.33724,0.80501,GOBP_POSITIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATIONAL_INITIATION,1
GSE9037_WT_VS_IRAK4_KO_LPS_4...1,SET,187,-0.054175,-0.0054367,0.063008,0.80505,GSE9037_WT_VS_IRAK4_KO_LPS_4H_STIM_BMDM_DN,1
GSE40493_BCL6_KO_VS_WT_TREG_...1,SET,95,-0.076369,-0.0054764,0.088816,0.80506,GSE40493_BCL6_KO_VS_WT_TREG_DN,1
BURTON_ADIPOGENESIS_PEAK_AT_...3,SET,42,-0.10858,-0.0051848,0.12626,0.8051,BURTON_ADIPOGENESIS_PEAK_AT_24HR,1
HP_GASTROESOPHAGEAL_REFLUX,SET,434,-0.034953,-0.0053074,0.040639,0.80513,HP_GASTROESOPHAGEAL_REFLUX,1
GOBP_VERY_LOW_DENSITY_LIPOPR...1,SET,11,-0.22862,-0.0055914,0.26575,0.80518,GOBP_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_ASSEMBLY,1
HP_PULMONARY_INSUFFICIENCY,SET,24,-0.14873,-0.0053711,0.17289,0.80518,HP_PULMONARY_INSUFFICIENCY,1
GOMF_POTASSIUM_CHANNEL_ACTIV...1,SET,5,-0.36021,-0.0059404,0.41855,0.80526,GOMF_POTASSIUM_CHANNEL_ACTIVATOR_ACTIVITY,1
REACTOME_ANTIGEN_PROCESSING_...2,SET,287,-0.041464,-0.0051409,0.048179,0.80527,REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION,1
HP_LEUKOENCEPHALOPATHY,SET,190,-0.049597,-0.0050166,0.057618,0.80531,HP_LEUKOENCEPHALOPATHY,1
GOMF_ALCOHOL_DEHYDROGENASE_N...3,SET,24,-0.17572,-0.0063457,0.20412,0.80533,GOMF_ALCOHOL_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,1
GOBP_LONG_TERM_MEMORY,SET,37,-0.12129,-0.0054367,0.14089,0.80534,GOBP_LONG_TERM_MEMORY,1
GAUTAM_EYE_IRIS_CILIARY_BODY...9,SET,202,-0.049891,-0.0052016,0.057948,0.80536,GAUTAM_EYE_IRIS_CILIARY_BODY_MELANOCYTES,1
COATES_MACROPHAGE_M1_VS_M2_DN,SET,75,-0.087662,-0.0055885,0.10181,0.80538,COATES_MACROPHAGE_M1_VS_M2_DN,1
GOBP_RNA_IMPORT_INTO_MITOCHO...,SET,5,-0.24036,-0.003964,0.27915,0.80539,GOBP_RNA_IMPORT_INTO_MITOCHONDRION,1
HP_SARCOMA,SET,167,-0.056758,-0.0053857,0.065912,0.80541,HP_SARCOMA,1
MODULE_277,SET,47,-0.096601,-0.0048788,0.11214,0.8055,MODULE_277,1
GOBP_REGULATION_OF_PIGMENTAT...,SET,17,-0.18311,-0.0055664,0.21248,0.80559,GOBP_REGULATION_OF_PIGMENTATION,1
HOFMANN_MYELODYSPLASTIC_SYND...1,SET,20,-0.15646,-0.0051586,0.18154,0.80562,HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN,1
MIR548AE_3P_MIR548AQ_3P,SET,720,-0.027512,-0.0053376,0.031921,0.80562,MIR548AE_3P_MIR548AQ_3P,1
HP_DEFICIT_IN_GRAMMAR,SET,9,-0.21745,-0.0048107,0.25228,0.80563,HP_DEFICIT_IN_GRAMMAR,1
GOMF_GLYCINE_TRANSMEMBRANE_T...,SET,9,-0.25281,-0.005593,0.29329,0.80565,GOMF_GLYCINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_HIF1A_AND_PPARG_REGULATIO...,SET,6,-0.32887,-0.0059411,0.38128,0.8058,WP_HIF1A_AND_PPARG_REGULATION_OF_GLYCOLYSIS,1
GOBP_ALDITOL_METABOLIC_PROCE...,SET,21,-0.175,-0.005912,0.20289,0.8058,GOBP_ALDITOL_METABOLIC_PROCESS,1
MIR513A_5P,SET,346,-0.040321,-0.00548,0.046742,0.80582,MIR513A_5P,1
GOBP_REGULATION_OF_SYNCYTIUM...,SET,27,-0.14307,-0.0054794,0.16584,0.80584,GOBP_REGULATION_OF_SYNCYTIUM_FORMATION_BY_PLASMA_MEMBRANE_FUSION,1
GOMF_GALACTOSYLCERAMIDASE_AC...,SET,4,-0.33934,-0.0050056,0.39331,0.80587,GOMF_GALACTOSYLCERAMIDASE_ACTIVITY,1
GSE40277_EOS_AND_LEF1_TRANSD...3,SET,181,-0.055214,-0.0054523,0.063994,0.80587,GSE40277_EOS_AND_LEF1_TRANSDUCED_VS_GATA1_AND_SATB1_TRANSDUCED_CD4_TCELL_DN,1
GSE21546_UNSTIM_VS_ANTI_CD3_...8,SET,175,-0.057311,-0.0055656,0.066404,0.80594,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_DP_THYMOCYTES_UP,1
KMCATNNWGGA_UNKNOWN,SET,87,-0.074107,-0.0050866,0.085853,0.80597,KMCATNNWGGA_UNKNOWN,1
GOMF_AZOLE_TRANSMEMBRANE_TRA...,SET,12,-0.21957,-0.0056087,0.25433,0.80602,GOMF_AZOLE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
CAFFAREL_RESPONSE_TO_THC_8HR...3,SET,11,-0.21212,-0.0051878,0.24565,0.80606,CAFFAREL_RESPONSE_TO_THC_8HR_5_DN,1
GOBP_RETINA_LAYER_FORMATION,SET,22,-0.17079,-0.0059054,0.19779,0.80606,GOBP_RETINA_LAYER_FORMATION,1
GOMF_SPHINGOSINE_N_ACYLTRANS...,SET,6,-0.29546,-0.0053375,0.34204,0.80615,GOMF_SPHINGOSINE_N_ACYLTRANSFERASE_ACTIVITY,1
MIR3149,SET,130,-0.064263,-0.0053855,0.07438,0.8062,MIR3149,1
GOBP_POSITIVE_REGULATION_OF_...128,SET,91,-0.081956,-0.0057526,0.094851,0.80621,GOBP_POSITIVE_REGULATION_OF_CELL_DIVISION,1
HP_HYPOPLASTIC_CERVICAL_VERT...,SET,6,-0.34106,-0.0061613,0.39469,0.80623,HP_HYPOPLASTIC_CERVICAL_VERTEBRAE,1
GOBP_REGULATION_OF_GTPASE_AC...,SET,245,-0.050024,-0.005737,0.05789,0.80624,GOBP_REGULATION_OF_GTPASE_ACTIVITY,1
HP_MILD_MICROCEPHALY,SET,17,-0.1763,-0.0053595,0.20402,0.80624,HP_MILD_MICROCEPHALY,1
GOBP_REGULATION_OF_CELL_CYCL...4,SET,398,-0.036116,-0.0052569,0.041783,0.80631,GOBP_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
GOMF_TUMOR_NECROSIS_FACTOR_B...,SET,6,-0.27086,-0.0048932,0.31335,0.80631,GOMF_TUMOR_NECROSIS_FACTOR_BINDING,1
MIR4327,SET,74,-0.09531,-0.0060355,0.11025,0.80633,MIR4327,1
REACTOME_SIGNALING_BY_CTNNB1...,SET,14,-0.19081,-0.0052643,0.22071,0.80635,REACTOME_SIGNALING_BY_CTNNB1_PHOSPHO_SITE_MUTANTS,1
MIR135A_5P,SET,283,-0.045006,-0.0055416,0.052049,0.80639,MIR135A_5P,1
WP_UDPDERIVED_SUGARS_SYNTHES...,SET,11,-0.22057,-0.0053946,0.25507,0.8064,WP_UDPDERIVED_SUGARS_SYNTHESIS_IN_FIBROBLASTS,1
GSE1460_INTRATHYMIC_T_PROGEN...10,SET,176,-0.052345,-0.0050978,0.060528,0.80642,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_UP,1
PRKDC_TARGET_GENES,SET,697,-0.027934,-0.0053358,0.0323,0.80643,PRKDC_TARGET_GENES,1
MIR135B_5P,SET,282,-0.045098,-0.0055432,0.052144,0.80644,MIR135B_5P,1
GOBP_MORPHOGENESIS_OF_A_POLA...,SET,58,-0.1001,-0.0056144,0.11574,0.80644,GOBP_MORPHOGENESIS_OF_A_POLARIZED_EPITHELIUM,1
HP_FASTING_HYPERINSULINEMIA,SET,9,-0.25128,-0.0055593,0.29054,0.80644,HP_FASTING_HYPERINSULINEMIA,1
GSE42021_TREG_PLN_VS_CD24LO_...2,SET,171,-0.053932,-0.0051779,0.062351,0.80646,GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP,1
E2F1_UP.V1_UP,SET,172,-0.052351,-0.0050407,0.060523,0.80647,E2F1_UP.V1_UP,1
GSE21033_3H_VS_24H_POLYIC_ST...1,SET,108,-0.0673,-0.0051438,0.0778,0.80649,GSE21033_3H_VS_24H_POLYIC_STIM_DC_DN,1
GSE18281_CORTEX_VS_MEDULLA_T...2,SET,163,-0.054982,-0.0051549,0.063547,0.80654,GSE18281_CORTEX_VS_MEDULLA_THYMUS_UP,1
GSE41867_DAY8_EFFECTOR_VS_DA...1,SET,178,-0.053882,-0.0052769,0.06227,0.80656,GSE41867_DAY8_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...9,SET,5,-0.39376,-0.0064937,0.45503,0.80657,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_TNF_JNK_SIGNALING_PATHWAY,1
ZNF501_TARGET_GENES,SET,13,-0.21026,-0.0055899,0.24297,0.80657,ZNF501_TARGET_GENES,1
HP_GENETIC_ANTICIPATION,SET,8,-0.21331,-0.0044495,0.2465,0.80658,HP_GENETIC_ANTICIPATION,1
GSE14908_RESTING_VS_HDM_STIM...3,SET,177,-0.05372,-0.0052464,0.06207,0.8066,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_DN,1
GOMF_MOLECULAR_FUNCTION_ACTI...,SET,1021,-0.024454,-0.0056013,0.028252,0.80663,GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY,1
GSE27786_LSK_VS_NKTCELL_DN,SET,173,-0.053634,-0.0051791,0.061961,0.80664,GSE27786_LSK_VS_NKTCELL_DN,1
MIR3658,SET,734,-0.027682,-0.0054204,0.031974,0.80669,MIR3658,1
MODULE_57,SET,55,-0.092969,-0.0050782,0.10738,0.80669,MODULE_57,1
CHEOK_RESPONSE_TO_MERCAPTOPU...1,SET,23,-0.15735,-0.0055627,0.18168,0.80676,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...55,SET,35,-0.106,-0.0046215,0.1224,0.80677,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_26S_PROTEASOME_MEDIATED_PROTEIN_DEGRADATION,1
REACTOME_ACTIVATION_OF_RAS_I...,SET,5,-0.29927,-0.0049354,0.34553,0.80678,REACTOME_ACTIVATION_OF_RAS_IN_B_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...841,SET,60,-0.092524,-0.0052779,0.10682,0.80679,GOBP_POSITIVE_REGULATION_OF_VIRAL_PROCESS,1
GSE17721_POLYIC_VS_CPG_24H_B...2,SET,188,-0.052797,-0.0053124,0.060956,0.80679,GSE17721_POLYIC_VS_CPG_24H_BMDC_UP,1
BUSSLINGER_GASTRIC_CHIEF_CEL...,SET,51,-0.10689,-0.0056229,0.12338,0.80685,BUSSLINGER_GASTRIC_CHIEF_CELLS,1
KEGG_MEDICUS_REFERENCE_VALIN...,SET,8,-0.2626,-0.0054775,0.30307,0.80688,KEGG_MEDICUS_REFERENCE_VALINE_DEGRADATION,1
DAVICIONI_MOLECULAR_ARMS_VS_...1,SET,166,-0.0609,-0.0057616,0.070281,0.80689,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_DN,1
HP_MARCUS_GUNN_JAW_WINKING_S...,SET,10,-0.25306,-0.0059013,0.29196,0.80696,HP_MARCUS_GUNN_JAW_WINKING_SYNKINESIS,1
HP_HYPERPHOSPHATEMIA,SET,17,-0.18566,-0.0056439,0.21417,0.80699,HP_HYPERPHOSPHATEMIA,1
HAY_BONE_MARROW_NK_CELLS,SET,323,-0.041589,-0.0054647,0.047969,0.80702,HAY_BONE_MARROW_NK_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...348,SET,5,-0.39579,-0.0065273,0.45649,0.80703,GOBP_POSITIVE_REGULATION_OF_IMMATURE_T_CELL_PROLIFERATION,1
HP_ABNORMAL_PUPIL_MORPHOLOGY,SET,66,-0.096637,-0.0057806,0.11146,0.80703,HP_ABNORMAL_PUPIL_MORPHOLOGY,1
ONO_AML1_TARGETS_UP,SET,23,-0.16866,-0.0059627,0.19451,0.80704,ONO_AML1_TARGETS_UP,1
CONRAD_STEM_CELL,SET,35,-0.13401,-0.0058423,0.15455,0.80705,CONRAD_STEM_CELL,1
GSE17721_0.5H_VS_24H_GARDIQU...2,SET,172,-0.053621,-0.0051629,0.061838,0.80705,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_UP,1
HP_RADIAL_DEVIATION_OF_THE_H...1,SET,8,-0.30288,-0.0063176,0.34927,0.80707,HP_RADIAL_DEVIATION_OF_THE_HAND,1
GOBP_T_CELL_PROLIFERATION_IN...,SET,5,-0.3429,-0.005655,0.39541,0.80708,GOBP_T_CELL_PROLIFERATION_INVOLVED_IN_IMMUNE_RESPONSE,1
HP_PARTIAL_ABSENCE_OF_SPECIF...1,SET,6,-0.31846,-0.0057531,0.36719,0.8071,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_TETANUS_VACCINE,1
GSE13229_MATURE_VS_INTMATURE...1,SET,176,-0.054363,-0.0052943,0.062682,0.8071,GSE13229_MATURE_VS_INTMATURE_NKCELL_DN,1
GSE13485_CTRL_VS_DAY7_YF17D_...2,SET,163,-0.056374,-0.0052854,0.065001,0.8071,GSE13485_CTRL_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
GOBP_SCF_DEPENDENT_PROTEASOM...,SET,43,-0.11468,-0.0055405,0.13218,0.80719,GOBP_SCF_DEPENDENT_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
REACTOME_CD28_CO_STIMULATION,SET,32,-0.13505,-0.0056301,0.15563,0.80722,REACTOME_CD28_CO_STIMULATION,1
GOBP_CYTOPLASM_ORGANIZATION,SET,15,-0.17507,-0.0049994,0.20176,0.80722,GOBP_CYTOPLASM_ORGANIZATION,1
GOMF_DEATH_RECEPTOR_ACTIVITY,SET,12,-0.23647,-0.0060404,0.2725,0.80724,GOMF_DEATH_RECEPTOR_ACTIVITY,1
BIOCARTA_MAPK_PATHWAY,SET,79,-0.082183,-0.0053765,0.09469,0.80728,BIOCARTA_MAPK_PATHWAY,1
HP_BREAST_APLASIA,SET,16,-0.17785,-0.0052451,0.20491,0.80728,HP_BREAST_APLASIA,1
MIR3127_5P,SET,49,-0.10368,-0.0053465,0.11945,0.80729,MIR3127_5P,1
GOBP_SOMATIC_MOTOR_NEURON_DI...,SET,5,-0.34085,-0.0056212,0.39268,0.8073,GOBP_SOMATIC_MOTOR_NEURON_DIFFERENTIATION,1
GSE41867_NAIVE_VS_DAY15_LCMV...5,SET,177,-0.052096,-0.0050878,0.060002,0.80736,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_DN,1
MORF_PTPRR,SET,83,-0.083777,-0.0056172,0.096458,0.80744,MORF_PTPRR,1
GSE31082_DN_VS_CD4_SP_THYMOC...2,SET,172,-0.051294,-0.0049389,0.059057,0.80745,GSE31082_DN_VS_CD4_SP_THYMOCYTE_UP,1
GOBP_CELL_PROJECTION_ORGANIZ...,SET,1457,-0.020246,-0.0054699,0.023304,0.80751,GOBP_CELL_PROJECTION_ORGANIZATION,1
HOEK_NK_CELL_2011_2012_TIV_3...,SET,208,-0.054507,-0.0057657,0.06274,0.80751,HOEK_NK_CELL_2011_2012_TIV_3D_VS_0DY_ADULT_3D_DN,1
GSE25147_UNSTIM_VS_HELIOBACT...2,SET,151,-0.057062,-0.0051509,0.065677,0.80752,GSE25147_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_MKN45_CELL_UP,1
GOBP_PROSTATE_GLAND_DEVELOPM...,SET,47,-0.12258,-0.0061906,0.14106,0.80755,GOBP_PROSTATE_GLAND_DEVELOPMENT,1
HP_KNEE_PAIN,SET,15,-0.21174,-0.0060465,0.24363,0.80759,HP_KNEE_PAIN,1
DURANTE_ADULT_OLFACTORY_NEUR...20,SET,27,-0.15453,-0.0059186,0.17779,0.80762,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_COLUMNAR_CELLS,1
MODULE_497,SET,29,-0.14856,-0.0058966,0.17091,0.80763,MODULE_497,1
GNF2_TNFSF10,SET,30,-0.13318,-0.0053763,0.1532,0.80766,GNF2_TNFSF10,1
KEGG_MEDICUS_REFERENCE_CA2_P...1,SET,6,-0.25909,-0.0046805,0.29801,0.80767,KEGG_MEDICUS_REFERENCE_CA2_PLCD_ITPR_SIGNALING_PATHWAY,1
GOBP_RHODOPSIN_MEDIATED_SIGN...,SET,10,-0.21602,-0.0050375,0.24847,0.80768,GOBP_RHODOPSIN_MEDIATED_SIGNALING_PATHWAY,1
HP_INCREASED_FECAL_PORPHYRIN,SET,4,-0.33337,-0.0049175,0.38345,0.80768,HP_INCREASED_FECAL_PORPHYRIN,1
DESCARTES_FETAL_MUSCLE_SATEL...,SET,41,-0.1214,-0.0057275,0.13958,0.80777,DESCARTES_FETAL_MUSCLE_SATELLITE_CELLS,1
HP_POPLITEAL_PTERYGIUM,SET,8,-0.27954,-0.0058309,0.32132,0.80783,HP_POPLITEAL_PTERYGIUM,1
GSE27786_BCELL_VS_NEUTROPHIL...1,SET,184,-0.053669,-0.005343,0.061692,0.80783,GSE27786_BCELL_VS_NEUTROPHIL_DN,1
GSE411_UNSTIM_VS_100MIN_IL6_...3,SET,186,-0.055029,-0.0055078,0.063237,0.8079,GSE411_UNSTIM_VS_100MIN_IL6_STIM_SOCS3_KO_MACROPHAGE_DN,1
GOBP_REGULATION_OF_LIPID_TRA...2,SET,4,-0.43286,-0.0063851,0.4973,0.80796,GOBP_REGULATION_OF_LIPID_TRANSPORTER_ACTIVITY,1
GSE29618_PDC_VS_MDC_UP,SET,173,-0.057066,-0.0055104,0.065538,0.80804,GSE29618_PDC_VS_MDC_UP,1
SMID_BREAST_CANCER_LUMINAL_B...2,SET,155,-0.062035,-0.0056728,0.071239,0.80806,SMID_BREAST_CANCER_LUMINAL_B_UP,1
GOBP_SYNAPTIC_SIGNALING,SET,717,-0.028706,-0.0055581,0.032963,0.80807,GOBP_SYNAPTIC_SIGNALING,1
HP_HIP_PAIN,SET,11,-0.21297,-0.0052087,0.24455,0.80808,HP_HIP_PAIN,1
GOBP_PHOSPHATIDYLINOSITOL_PH...,SET,59,-0.092314,-0.005222,0.10599,0.8081,GOBP_PHOSPHATIDYLINOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GEISS_RESPONSE_TO_DSRNA_DN,SET,15,-0.18403,-0.0052554,0.2113,0.80811,GEISS_RESPONSE_TO_DSRNA_DN,1
HP_HYPOPLASIA_OF_THE_FEMORAL...,SET,5,-0.3663,-0.0060409,0.42052,0.80813,HP_HYPOPLASIA_OF_THE_FEMORAL_HEAD,1
ARP1_01,SET,142,-0.060388,-0.0052875,0.069325,0.80814,ARP1_01,1
ZNF586_TARGET_GENES,SET,35,-0.12117,-0.0052826,0.13907,0.80819,ZNF586_TARGET_GENES,1
REACTOME_POTENTIAL_THERAPEUT...,SET,92,-0.074168,-0.0052343,0.085118,0.80821,REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS,1
WP_ENTEROHEPATIC_CIRCULATION...,SET,12,-0.22154,-0.005659,0.25426,0.80821,WP_ENTEROHEPATIC_CIRCULATION_OF_BILE_ACIDS,1
MIR5684,SET,35,-0.126,-0.0054931,0.14459,0.80823,MIR5684,1
HP_ABNORMAL_SACCADIC_EYE_MOV...,SET,84,-0.07739,-0.00522,0.088793,0.80828,HP_ABNORMAL_SACCADIC_EYE_MOVEMENTS,1
GOBP_NEGATIVE_REGULATION_OF_...629,SET,8,-0.21543,-0.0044935,0.24711,0.80833,GOBP_NEGATIVE_REGULATION_OF_TELOMERE_CAPPING,1
BROWNE_HCMV_INFECTION_12HR_DN,SET,88,-0.084653,-0.0058436,0.09709,0.80836,BROWNE_HCMV_INFECTION_12HR_DN,1
ERBB2_UP.V1_DN,SET,180,-0.053597,-0.0052781,0.061473,0.80836,ERBB2_UP.V1_DN,1
GENTILE_UV_RESPONSE_CLUSTER_...4,SET,35,-0.11847,-0.0051651,0.13587,0.80838,GENTILE_UV_RESPONSE_CLUSTER_D5,1
chr15q22,SET,65,-0.1795,-0.010656,0.2058,0.80844,chr15q22,1
GOBP_EPIDIDYMIS_DEVELOPMENT,SET,3,-0.50059,-0.0063951,0.57379,0.80851,GOBP_EPIDIDYMIS_DEVELOPMENT,1
HP_INTELLECTUAL_DISABILITY_S...,SET,312,-0.041149,-0.0053156,0.047162,0.80852,HP_INTELLECTUAL_DISABILITY_SEVERE,1
MIR6872_3P,SET,61,-0.0964,-0.0055445,0.11048,0.80855,MIR6872_3P,1
HP_APLASIA_OF_THE_OVARY,SET,4,-0.30117,-0.0044426,0.34516,0.80855,HP_APLASIA_OF_THE_OVARY,1
GOBP_NEGATIVE_REGULATION_OF_...32,SET,6,-0.28282,-0.0051091,0.32409,0.80856,GOBP_NEGATIVE_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
CHIANG_LIVER_CANCER_SUBCLASS...8,SET,161,-0.059041,-0.0055017,0.067654,0.80858,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_UP,1
MIR6516_3P,SET,126,-0.066221,-0.0054642,0.075853,0.80867,MIR6516_3P,1
WP_PGK1_PKM2_KHKCKHKA_ACTING...,SET,10,-0.19226,-0.0044835,0.22021,0.80868,WP_PGK1_PKM2_KHKCKHKA_ACTING_AS_PROTEIN_KINASES,1
GSE24671_CTRL_VS_BAKIMULC_IN...1,SET,151,-0.064028,-0.0057797,0.073333,0.80869,GSE24671_CTRL_VS_BAKIMULC_INFECTED_MOUSE_SPLENOCYTES_DN,1
GOCC_ENDOPEPTIDASE_COMPLEX,SET,84,-0.074305,-0.0050119,0.085087,0.80874,GOCC_ENDOPEPTIDASE_COMPLEX,1
GSE15930_STIM_VS_STIM_AND_IL...5,SET,174,-0.055828,-0.0054063,0.063915,0.80879,GSE15930_STIM_VS_STIM_AND_IL12_72H_CD8_T_CELL_DN,1
GCM_RBM8A,SET,70,-0.08254,-0.0050842,0.094464,0.80887,GCM_RBM8A,1
HP_ABNORMAL_PROPORTION_OF_CD...3,SET,17,-0.17411,-0.0052929,0.19927,0.80887,HP_ABNORMAL_PROPORTION_OF_CD8_POSITIVE_T_CELLS,1
HP_ADIPOSE_TISSUE_LOSS,SET,27,-0.14153,-0.0054205,0.16197,0.80888,HP_ADIPOSE_TISSUE_LOSS,1
GOMF_MORPHOGEN_ACTIVITY,SET,6,-0.29266,-0.005287,0.33488,0.80891,GOMF_MORPHOGEN_ACTIVITY,1
HP_SUICIDAL_IDEATION,SET,21,-0.15401,-0.0052029,0.17623,0.80891,HP_SUICIDAL_IDEATION,1
MYLLYKANGAS_AMPLIFICATION_HO...16,SET,6,-0.28212,-0.0050965,0.3228,0.80892,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_6,1
HP_ABLEPHARON,SET,5,-0.33419,-0.0055114,0.3824,0.80892,HP_ABLEPHARON,1
GSE22886_NAIVE_CD4_TCELL_VS_...9,SET,188,-0.053834,-0.0054168,0.061594,0.80894,GSE22886_NAIVE_CD4_TCELL_VS_DC_DN,1
GSE32986_UNSTIM_VS_GMCSF_AND...2,SET,181,-0.053525,-0.0052855,0.061241,0.80894,GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,1
GSE8921_UNSTIM_VS_TLR1_2_STI...2,SET,183,-0.054953,-0.0054561,0.062873,0.80895,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_12H_UP,1
REACTOME_JOSEPHIN_DOMAIN_DUBS,SET,9,-0.23232,-0.0051398,0.26575,0.80899,REACTOME_JOSEPHIN_DOMAIN_DUBS,1
HP_ABNORMALITY_OF_OCULAR_ABD...,SET,11,-0.22903,-0.0056014,0.26197,0.809,HP_ABNORMALITY_OF_OCULAR_ABDUCTION,1
REACTOME_MITF_M_DEPENDENT_GE...,SET,91,-0.076847,-0.005394,0.087896,0.80901,REACTOME_MITF_M_DEPENDENT_GENE_EXPRESSION,1
GSE7460_CTRL_VS_TGFB_TREATED...2,SET,184,-0.053551,-0.0053313,0.061248,0.80903,GSE7460_CTRL_VS_TGFB_TREATED_ACT_CD8_TCELL_UP,1
GOBP_RESPONSE_TO_HYDROSTATIC...,SET,7,-0.29802,-0.0058151,0.34076,0.80909,GOBP_RESPONSE_TO_HYDROSTATIC_PRESSURE,1
YGTCCTTGR_UNKNOWN,SET,85,-0.07708,-0.0052298,0.088132,0.8091,YGTCCTTGR_UNKNOWN,1
HP_ABNORMAL_LARGE_INTESTINE_...2,SET,52,-0.10494,-0.005574,0.11998,0.80911,HP_ABNORMAL_LARGE_INTESTINE_PHYSIOLOGY,1
HP_IRON_DEFICIENCY_ANEMIA,SET,27,-0.14081,-0.0053929,0.16094,0.80918,HP_IRON_DEFICIENCY_ANEMIA,1
GSE17721_POLYIC_VS_PAM3CSK4_...5,SET,172,-0.053864,-0.0051863,0.06156,0.8092,GSE17721_POLYIC_VS_PAM3CSK4_16H_BMDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...685,SET,9,-0.26054,-0.005764,0.29772,0.80924,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_LIGASE_ACTIVITY,1
GOBP_NEUTRAL_LIPID_METABOLIC...,SET,122,-0.067684,-0.0054962,0.077337,0.80926,GOBP_NEUTRAL_LIPID_METABOLIC_PROCESS,1
GOMF_GDP_DISSOCIATION_INHIBI...,SET,15,-0.1844,-0.0052657,0.2107,0.80926,GOMF_GDP_DISSOCIATION_INHIBITOR_ACTIVITY,1
PYEON_CANCER_HEAD_AND_NECK_V...2,SET,157,-0.059667,-0.0054911,0.068172,0.80927,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP,1
GSE19198_1H_VS_24H_IL21_TREA...2,SET,179,-0.056403,-0.0055391,0.064436,0.8093,GSE19198_1H_VS_24H_IL21_TREATED_TCELL_UP,1
ERR1_Q2,SET,231,-0.048986,-0.0054572,0.055959,0.80931,ERR1_Q2,1
GSE29618_PDC_VS_MDC_DN,SET,183,-0.056474,-0.0056071,0.06451,0.80932,GSE29618_PDC_VS_MDC_DN,1
GOBP_CRANIAL_NERVE_FORMATION,SET,10,-0.28084,-0.0065491,0.3208,0.80933,GOBP_CRANIAL_NERVE_FORMATION,1
HP_POIKILOCYTOSIS,SET,49,-0.10652,-0.0054928,0.12167,0.80933,HP_POIKILOCYTOSIS,1
MIR5193,SET,158,-0.05875,-0.0054238,0.067076,0.80944,MIR5193,1
GSE14413_UNSTIM_VS_IFNB_STIM...3,SET,124,-0.064782,-0.0053031,0.073965,0.80944,GSE14413_UNSTIM_VS_IFNB_STIM_NIH3T3_CELLS_DN,1
GSE11961_GERMINAL_CENTER_BCE...2,SET,179,-0.055652,-0.0054654,0.063532,0.80947,GSE11961_GERMINAL_CENTER_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
REACTOME_EARLY_PHASE_OF_HIV_...,SET,14,-0.18525,-0.0051109,0.21145,0.8095,REACTOME_EARLY_PHASE_OF_HIV_LIFE_CYCLE,1
HP_ABNORMAL_CENTRAL_SENSORY_...,SET,12,-0.20877,-0.0053328,0.23827,0.80953,HP_ABNORMAL_CENTRAL_SENSORY_FUNCTION,1
MIR1238_5P_MIR4758_5P,SET,43,-0.11241,-0.0054307,0.12827,0.80957,MIR1238_5P_MIR4758_5P,1
MIR6817_3P,SET,203,-0.053483,-0.0055897,0.060993,0.80971,MIR6817_3P,1
ZNF454_TARGET_GENES,SET,11,-0.2301,-0.0056275,0.26242,0.80971,ZNF454_TARGET_GENES,1
GOCC_APOLIPOPROTEIN_B_MRNA_E...,SET,4,-0.39914,-0.0058877,0.45513,0.80974,GOCC_APOLIPOPROTEIN_B_MRNA_EDITING_ENZYME_COMPLEX,1
GOBP_OXIDATIVE_PHOSPHORYLATI...,SET,105,-0.063237,-0.0047661,0.072107,0.80975,GOBP_OXIDATIVE_PHOSPHORYLATION,1
GOBP_REGULATION_OF_MYOBLAST_...2,SET,19,-0.17671,-0.0056787,0.20145,0.8098,GOBP_REGULATION_OF_MYOBLAST_FUSION,1
MIR4672,SET,335,-0.040825,-0.0054612,0.046531,0.80985,MIR4672,1
GSE21063_CTRL_VS_ANTI_IGM_ST...3,SET,149,-0.058175,-0.0052167,0.066302,0.80987,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_3H_DN,1
GSE36078_UNTREATED_VS_AD5_T4...1,SET,181,-0.055333,-0.005464,0.06306,0.80988,GSE36078_UNTREATED_VS_AD5_T425A_HEXON_INF_IL1R_KO_MOUSE_LUNG_DC_DN,1
GOBP_ANGIOGENESIS_INVOLVED_I...1,SET,5,-0.36793,-0.0060678,0.41927,0.8099,GOBP_ANGIOGENESIS_INVOLVED_IN_CORONARY_VASCULAR_MORPHOGENESIS,1
REACTOME_SYNTHESIS_OF_PIPS_A...3,SET,16,-0.17086,-0.005039,0.19469,0.80992,REACTOME_SYNTHESIS_OF_PIPS_AT_THE_GOLGI_MEMBRANE,1
HP_RETINOPATHY,SET,128,-0.067677,-0.0056282,0.077114,0.80992,HP_RETINOPATHY,1
BENPORATH_ES_CORE_NINE_CORRE...,SET,95,-0.077103,-0.005529,0.087836,0.80997,BENPORATH_ES_CORE_NINE_CORRELATED,1
BIOCARTA_ARF_PATHWAY,SET,17,-0.18653,-0.0056704,0.21249,0.80997,BIOCARTA_ARF_PATHWAY,1
GSE17974_CTRL_VS_ACT_IL4_AND...15,SET,178,-0.054657,-0.0053528,0.062259,0.81,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_6H_CD4_TCELL_DN,1
GSE42021_TCONV_PLN_VS_CD24LO...1,SET,180,-0.054925,-0.0054089,0.062545,0.81006,GSE42021_TCONV_PLN_VS_CD24LO_TCONV_THYMUS_DN,1
HP_INCREASED_CONNECTIVE_TISS...,SET,24,-0.14693,-0.0053061,0.16732,0.81007,HP_INCREASED_CONNECTIVE_TISSUE,1
GSE7348_UNSTIM_VS_TOLERIZED_...1,SET,145,-0.060964,-0.0053936,0.069418,0.81008,GSE7348_UNSTIM_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,1
GOBP_REGULATION_OF_DENDRITIC...4,SET,53,-0.10325,-0.0055368,0.11756,0.81011,GOBP_REGULATION_OF_DENDRITIC_SPINE_DEVELOPMENT,1
HP_ABNORMAL_CIRCULATING_IGM_...,SET,94,-0.077793,-0.0055492,0.088564,0.81013,HP_ABNORMAL_CIRCULATING_IGM_LEVEL,1
GSE32164_RESTING_DIFFERENTIA...4,SET,181,-0.056674,-0.0055964,0.064504,0.81019,GSE32164_RESTING_DIFFERENTIATED_VS_CMYC_INHIBITED_MACROPHAGE_UP,1
MIR3622A_3P_MIR3622B_3P,SET,90,-0.082877,-0.0057853,0.094312,0.81023,MIR3622A_3P_MIR3622B_3P,1
WP_OMEGA9_FATTY_ACID_SYNTHES...,SET,13,-0.23355,-0.0062092,0.26575,0.81024,WP_OMEGA9_FATTY_ACID_SYNTHESIS,1
KEGG_MEDICUS_REFERENCE_DISAS...,SET,16,-0.17769,-0.0052406,0.20218,0.81026,KEGG_MEDICUS_REFERENCE_DISASSEMBLY_OF_MCC,1
HP_HYPOVOLEMIC_SHOCK,SET,5,-0.37534,-0.00619,0.42704,0.81028,HP_HYPOVOLEMIC_SHOCK,1
HP_ABNORMAL_CIRCULATING_IGE_...,SET,44,-0.11235,-0.0054907,0.12782,0.81029,HP_ABNORMAL_CIRCULATING_IGE_LEVEL,1
GOBP_REGULATION_OF_POLYAMINE...,SET,5,-0.28156,-0.0046434,0.32024,0.81035,GOBP_REGULATION_OF_POLYAMINE_TRANSMEMBRANE_TRANSPORT,1
GOMF_ORNITHINE_DECARBOXYLASE...,SET,5,-0.28156,-0.0046434,0.32024,0.81035,GOMF_ORNITHINE_DECARBOXYLASE_REGULATOR_ACTIVITY,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...6,SET,171,-0.05664,-0.0054379,0.064415,0.81037,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_6H_UP,1
GOBP_REGULATION_OF_VASCULOGE...,SET,15,-0.19955,-0.0056986,0.22694,0.81038,GOBP_REGULATION_OF_VASCULOGENESIS,1
chr11p14,SET,21,-0.27865,-0.0094135,0.31677,0.81047,chr11p14,1
HOLLERN_ADENOMYOEPITHELIAL_B...,SET,17,-0.17042,-0.0051808,0.19367,0.81056,HOLLERN_ADENOMYOEPITHELIAL_BREAST_TUMOR,1
REACTOME_SIGNAL_AMPLIFICATION,SET,33,-0.13643,-0.0057759,0.15502,0.81058,REACTOME_SIGNAL_AMPLIFICATION,1
NEMETH_INFLAMMATORY_RESPONSE...1,SET,28,-0.14436,-0.0056303,0.16403,0.81059,NEMETH_INFLAMMATORY_RESPONSE_LPS_DN,1
PID_P38_MKK3_6PATHWAY,SET,26,-0.14132,-0.0053116,0.16049,0.81071,PID_P38_MKK3_6PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...72,SET,9,-0.24831,-0.0054934,0.28199,0.81071,GOBP_NEGATIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,1
HP_ABNORMAL_METAPHYSEAL_TRAB...,SET,21,-0.15675,-0.0052955,0.178,0.81073,HP_ABNORMAL_METAPHYSEAL_TRABECULATION,1
GOBP_PROTEIN_TRANSPORT_TO_VA...,SET,15,-0.17459,-0.0049857,0.19823,0.81076,GOBP_PROTEIN_TRANSPORT_TO_VACUOLE_INVOLVED_IN_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS_VIA_THE_MULTIVESICULAR_BODY_SORTING_PATHWAY,1
KEGG_MEDICUS_REFERENCE_MODIF...2,SET,5,-0.25317,-0.0041752,0.28742,0.81079,KEGG_MEDICUS_REFERENCE_MODIFYING_OF_CONDENSIN_I_SUBUNITS,1
GOMF_PROTEIN_PRENYLTRANSFERA...,SET,6,-0.28341,-0.0051199,0.3217,0.81083,GOMF_PROTEIN_PRENYLTRANSFERASE_ACTIVITY,1
HP_RHEUMATOID_FACTOR_POSITIVE,SET,18,-0.18187,-0.0056888,0.20643,0.81084,HP_RHEUMATOID_FACTOR_POSITIVE,1
GSE15330_LYMPHOID_MULTIPOTEN...8,SET,181,-0.053804,-0.005313,0.061067,0.81085,GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP,1
HP_PROGRESSIVE_NIGHT_BLINDNE...,SET,85,-0.080151,-0.0054381,0.090965,0.81087,HP_PROGRESSIVE_NIGHT_BLINDNESS,1
HP_ATTENUATION_OF_RETINAL_BL...,SET,118,-0.068623,-0.0054809,0.077869,0.8109,HP_ATTENUATION_OF_RETINAL_BLOOD_VESSELS,1
GOBP_DENDRITIC_SPINE_DEVELOP...,SET,88,-0.08039,-0.0055494,0.091221,0.81091,GOBP_DENDRITIC_SPINE_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...560,SET,8,-0.31299,-0.0065287,0.35511,0.81094,GOBP_POSITIVE_REGULATION_OF_OPSONIZATION,1
WP_STEROL_REGULATORY_ELEMENT...,SET,67,-0.085877,-0.0051756,0.097426,0.81096,WP_STEROL_REGULATORY_ELEMENTBINDING_PROTEINS_SREBP_SIGNALING,1
HP_ABNORMAL_URINE_MAGNESIUM_...,SET,9,-0.25883,-0.0057263,0.29364,0.81096,HP_ABNORMAL_URINE_MAGNESIUM_CONCENTRATION,1
HP_RENAL_AGENESIS,SET,178,-0.054368,-0.0053245,0.06168,0.81096,HP_RENAL_AGENESIS,1
HP_ABNORMAL_PROLACTIN_LEVEL,SET,26,-0.15002,-0.0056386,0.17019,0.81097,HP_ABNORMAL_PROLACTIN_LEVEL,1
GSE17721_LPS_VS_GARDIQUIMOD_...1,SET,185,-0.0527,-0.0052606,0.059786,0.81097,GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
GOCC_LATERAL_PLASMA_MEMBRANE,SET,65,-0.093825,-0.0055699,0.10642,0.811,GOCC_LATERAL_PLASMA_MEMBRANE,1
MIR548J_3P,SET,717,-0.028206,-0.0054613,0.03199,0.81102,MIR548J_3P,1
HP_CENTRAL_ADRENAL_INSUFFICI...,SET,18,-0.17166,-0.0053694,0.19466,0.81107,HP_CENTRAL_ADRENAL_INSUFFICIENCY,1
WP_CHOLESTEROL_METABOLISM,SET,69,-0.089954,-0.0055013,0.10199,0.81111,WP_CHOLESTEROL_METABOLISM,1
HP_HYPOVOLEMIA,SET,30,-0.14897,-0.0060138,0.1689,0.81111,HP_HYPOVOLEMIA,1
HP_BILATERAL_TALIPES_EQUINOV...,SET,43,-0.1175,-0.0056769,0.13316,0.81122,HP_BILATERAL_TALIPES_EQUINOVARUS,1
REACTOME_REGULATION_OF_PTEN_...3,SET,9,-0.25878,-0.0057252,0.29319,0.81128,REACTOME_REGULATION_OF_PTEN_MRNA_TRANSLATION,1
GOBP_NEGATIVE_REGULATION_OF_...618,SET,13,-0.21495,-0.0057146,0.24348,0.81132,GOBP_NEGATIVE_REGULATION_OF_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING,1
HP_SHORT_TELOMERE_LENGTH,SET,14,-0.19356,-0.0053401,0.21921,0.81137,HP_SHORT_TELOMERE_LENGTH,1
GSE34515_CD16_POS_MONOCYTE_V...2,SET,188,-0.054711,-0.005505,0.061955,0.8114,GSE34515_CD16_POS_MONOCYTE_VS_DC_UP,1
GOBP_NAD_METABOLIC_PROCESS,SET,57,-0.094688,-0.005265,0.10722,0.81141,GOBP_NAD_METABOLIC_PROCESS,1
ISHIDA_TARGETS_OF_SYT_SSX_FU...,SET,6,-0.34494,-0.0062315,0.39046,0.81149,ISHIDA_TARGETS_OF_SYT_SSX_FUSIONS,1
TAKEDA_TARGETS_OF_NUP98_HOXA...3,SET,112,-0.074591,-0.0058051,0.084421,0.81153,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN,1
GSE22140_GERMFREE_VS_SPF_ART...2,SET,186,-0.054405,-0.0054454,0.061569,0.81155,GSE22140_GERMFREE_VS_SPF_ARTHRITIC_MOUSE_CD4_TCELL_UP,1
GOMF_GUANYLYLTRANSFERASE_ACT...,SET,4,-0.34784,-0.005131,0.39344,0.81167,GOMF_GUANYLYLTRANSFERASE_ACTIVITY,1
HE_LIM_SUN_FETAL_LUNG_C3_LYM...,SET,345,-0.042986,-0.0058339,0.048622,0.81167,HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL,1
WU_HBX_TARGETS_2_DN,SET,14,-0.20697,-0.0057101,0.23406,0.81172,WU_HBX_TARGETS_2_DN,1
BECKER_TAMOXIFEN_RESISTANCE_...1,SET,49,-0.11141,-0.005745,0.12599,0.81173,BECKER_TAMOXIFEN_RESISTANCE_DN,1
GOBP_HETEROPHILIC_CELL_CELL_...,SET,46,-0.12522,-0.0062565,0.14157,0.81178,GOBP_HETEROPHILIC_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,1
GOBP_POSITIVE_REGULATION_OF_...429,SET,79,-0.08181,-0.0053521,0.092485,0.8118,GOBP_POSITIVE_REGULATION_OF_MACROAUTOPHAGY,1
GGCACAT_MIR455,SET,54,-0.099571,-0.0053893,0.11252,0.81188,GGCACAT_MIR455,1
GGTGTGT_MIR329,SET,103,-0.080212,-0.005988,0.090616,0.81197,GGTGTGT_MIR329,1
HP_PROMINENT_SUPERFICIAL_BLO...,SET,33,-0.12511,-0.0052965,0.1413,0.81202,HP_PROMINENT_SUPERFICIAL_BLOOD_VESSELS,1
HP_IMPAIRED_MASTICATION,SET,41,-0.12068,-0.0056936,0.13629,0.81205,HP_IMPAIRED_MASTICATION,1
WHITFIELD_CELL_CYCLE_G2,SET,152,-0.058481,-0.0052963,0.066037,0.81207,WHITFIELD_CELL_CYCLE_G2,1
GOBP_POSITIVE_REGULATION_OF_...131,SET,4,-0.4121,-0.0060788,0.46531,0.81209,GOBP_POSITIVE_REGULATION_OF_CELL_GROWTH_INVOLVED_IN_CARDIAC_MUSCLE_CELL_DEVELOPMENT,1
GOBP_INTRA_GOLGI_VESICLE_MED...,SET,32,-0.12241,-0.0051033,0.13819,0.81213,GOBP_INTRA_GOLGI_VESICLE_MEDIATED_TRANSPORT,1
GSE21033_CTRL_VS_POLYIC_STIM...5,SET,137,-0.063686,-0.0054779,0.071892,0.81215,GSE21033_CTRL_VS_POLYIC_STIM_DC_24H_DN,1
RAGHAVACHARI_PLATELET_SPECIF...,SET,60,-0.099642,-0.0056839,0.11247,0.81216,RAGHAVACHARI_PLATELET_SPECIFIC_GENES,1
WP_LUNG_FIBROSIS,SET,59,-0.10613,-0.0060035,0.11977,0.81222,WP_LUNG_FIBROSIS,1
LASTOWSKA_COAMPLIFIED_WITH_M...,SET,35,-0.15986,-0.0069696,0.18036,0.81228,LASTOWSKA_COAMPLIFIED_WITH_MYCN,1
GOBP_POSITIVE_REGULATION_OF_...840,SET,22,-0.15543,-0.0053742,0.17535,0.81228,GOBP_POSITIVE_REGULATION_OF_VIRAL_LIFE_CYCLE,1
GSE17721_0.5H_VS_24H_CPG_BMD...1,SET,188,-0.057427,-0.0057783,0.06478,0.81232,GSE17721_0.5H_VS_24H_CPG_BMDC_DN,1
GSE24142_ADULT_VS_FETAL_DN3_...2,SET,180,-0.056678,-0.0055815,0.063925,0.81235,GSE24142_ADULT_VS_FETAL_DN3_THYMOCYTE_UP,1
KEGG_MEDICUS_REFERENCE_REGUL...3,SET,4,-0.40091,-0.0059138,0.45214,0.81237,KEGG_MEDICUS_REFERENCE_REGULATION_OF_EXTRINSIC_APOPTOTIC_PATHWAY_XIAP,1
MIR517A_3P_MIR517B_3P_MIR517...,SET,19,-0.16394,-0.0052685,0.18489,0.81237,MIR517A_3P_MIR517B_3P_MIR517C_3P,1
GOMF_MITOCHONDRIAL_RIBOSOME_...,SET,8,-0.25698,-0.0053603,0.2898,0.81239,GOMF_MITOCHONDRIAL_RIBOSOME_BINDING,1
SARTIPY_BLUNTED_BY_INSULIN_R...2,SET,18,-0.18526,-0.005795,0.20891,0.8124,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_UP,1
HP_MISALIGNMENT_OF_INCISORS,SET,14,-0.18003,-0.0049668,0.20299,0.81243,HP_MISALIGNMENT_OF_INCISORS,1
HP_GENERALIZED_NEONATAL_HYPO...,SET,18,-0.15805,-0.0049438,0.17817,0.81247,HP_GENERALIZED_NEONATAL_HYPOTONIA,1
GOMF_OXIDOREDUCTASE_ACTIVITY...31,SET,59,-0.08922,-0.0050469,0.10057,0.8125,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS,1
CUI_DEVELOPING_HEART_5TH_WEE...1,SET,36,-0.13276,-0.0058697,0.14964,0.81251,CUI_DEVELOPING_HEART_5TH_WEEK_ATRIAL_CARDIOMYOCYTE,1
REACTOME_NEGATIVE_REGULATION...6,SET,14,-0.1783,-0.0049192,0.2009,0.81259,REACTOME_NEGATIVE_REGULATION_OF_FLT3,1
GOBP_CHORIO_ALLANTOIC_FUSION,SET,6,-0.33775,-0.0061015,0.38054,0.81261,GOBP_CHORIO_ALLANTOIC_FUSION,1
REACTOME_CREATINE_METABOLISM,SET,10,-0.2386,-0.0055641,0.26881,0.81262,REACTOME_CREATINE_METABOLISM,1
GOCC_TRAPPII_PROTEIN_COMPLEX,SET,9,-0.23175,-0.0051272,0.26109,0.81262,GOCC_TRAPPII_PROTEIN_COMPLEX,1
DESCARTES_FETAL_CEREBRUM_AST...,SET,141,-0.065926,-0.0057522,0.074266,0.81265,DESCARTES_FETAL_CEREBRUM_ASTROCYTES,1
GOBP_MONOSACCHARIDE_METABOLI...,SET,226,-0.048777,-0.0053755,0.05494,0.81267,GOBP_MONOSACCHARIDE_METABOLIC_PROCESS,1
HP_ABNORMAL_CIRCULATING_META...,SET,1251,-0.021767,-0.0054824,0.024518,0.81268,HP_ABNORMAL_CIRCULATING_METABOLITE_CONCENTRATION,1
GSE17721_PAM3CSK4_VS_CPG_1H_...1,SET,176,-0.054611,-0.0053184,0.061504,0.8127,GSE17721_PAM3CSK4_VS_CPG_1H_BMDC_DN,1
HP_ELEVATED_CIRCULATING_ALAN...,SET,70,-0.084158,-0.0051839,0.094778,0.81271,HP_ELEVATED_CIRCULATING_ALANINE_AMINOTRANSFERASE_CONCENTRATION,1
GOBP_GUANINE_METABOLIC_PROCE...,SET,4,-0.36447,-0.0053763,0.41035,0.81278,GOBP_GUANINE_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...253,SET,16,-0.18795,-0.005543,0.21158,0.8128,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_PROLIFERATION,1
PARK_HSC_MARKERS,SET,41,-0.11633,-0.0054884,0.13095,0.81283,PARK_HSC_MARKERS,1
GOMF_ATP_TRANSMEMBRANE_TRANS...,SET,12,-0.23055,-0.0058891,0.25951,0.81283,GOMF_ATP_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
KEGG_APOPTOSIS,SET,81,-0.083451,-0.0055279,0.093911,0.81289,KEGG_APOPTOSIS,1
HP_ABNORMAL_CIRCULATING_HOMO...,SET,15,-0.19061,-0.0054433,0.21449,0.81291,HP_ABNORMAL_CIRCULATING_HOMOCYSTEINE_CONCENTRATION,1
GOMF_GDP_PHOSPHATASE_ACTIVITY,SET,10,-0.23123,-0.0053922,0.26017,0.81293,GOMF_GDP_PHOSPHATASE_ACTIVITY,1
GOBP_REGULATION_OF_PEPTIDASE...,SET,268,-0.048565,-0.0058216,0.054633,0.81297,GOBP_REGULATION_OF_PEPTIDASE_ACTIVITY,1
HP_INTUSSUSCEPTION,SET,10,-0.24688,-0.0057571,0.27772,0.81298,HP_INTUSSUSCEPTION,1
GOBP_REGULATION_OF_HEART_RAT...1,SET,39,-0.13313,-0.006126,0.14969,0.81309,GOBP_REGULATION_OF_HEART_RATE_BY_CARDIAC_CONDUCTION,1
GOBP_BILE_ACID_SIGNALING_PAT...,SET,11,-0.2411,-0.0058966,0.27104,0.81314,GOBP_BILE_ACID_SIGNALING_PATHWAY,1
EIF4E_UP,SET,88,-0.075238,-0.0051937,0.084569,0.81317,EIF4E_UP,1
GSE15750_WT_VS_TRAF6KO_DAY6_...2,SET,176,-0.054627,-0.00532,0.0614,0.81318,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_UP,1
REACTOME_GLYCEROPHOSPHOLIPID...2,SET,7,-0.29272,-0.0057115,0.32896,0.81321,REACTOME_GLYCEROPHOSPHOLIPID_CATABOLISM,1
HOLLMANN_APOPTOSIS_VIA_CD40_...1,SET,234,-0.049943,-0.0055994,0.056111,0.81328,HOLLMANN_APOPTOSIS_VIA_CD40_DN,1
MIR4779,SET,133,-0.064778,-0.0054906,0.072778,0.81328,MIR4779,1
GOMF_NEUROPEPTIDE_Y_RECEPTOR...,SET,8,-0.32433,-0.0067652,0.36434,0.81331,GOMF_NEUROPEPTIDE_Y_RECEPTOR_ACTIVITY,1
REACTOME_GAP_JUNCTION_DEGRAD...,SET,12,-0.22362,-0.0057123,0.25119,0.81333,REACTOME_GAP_JUNCTION_DEGRADATION,1
GOCC_INTRACILIARY_TRANSPORT_...1,SET,22,-0.16672,-0.0057648,0.18726,0.81335,GOCC_INTRACILIARY_TRANSPORT_PARTICLE,1
REACTOME_RHO_GTPASE_CYCLE,SET,412,-0.036983,-0.0054748,0.041522,0.81345,REACTOME_RHO_GTPASE_CYCLE,1
MIR4540,SET,47,-0.1058,-0.0053434,0.11878,0.81345,MIR4540,1
WP_BIOSYNTHESIS_AND_REGENERA...,SET,12,-0.20544,-0.0052478,0.23063,0.81347,WP_BIOSYNTHESIS_AND_REGENERATION_OF_TETRAHYDROBIOPTERIN_AND_CATABOLISM_OF_PHENYLALANINE,1
GOBP_NEGATIVE_REGULATION_OF_...600,SET,15,-0.18885,-0.0053929,0.21198,0.8135,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_DIFFERENTIATION,1
HP_SPLENOMEGALY,SET,431,-0.037486,-0.0056728,0.042077,0.8135,HP_SPLENOMEGALY,1
GSE26290_WT_VS_PDK1_KO_ANTI_...2,SET,169,-0.058925,-0.0056244,0.066136,0.81352,GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_UP,1
WP_MALE_INFERTILITY,SET,132,-0.064966,-0.0054859,0.07291,0.81354,WP_MALE_INFERTILITY,1
GOBP_SYNCYTIUM_FORMATION,SET,60,-0.09879,-0.0056353,0.11087,0.81355,GOBP_SYNCYTIUM_FORMATION,1
HP_ABNORMAL_SHAPE_OF_THE_RAD...,SET,24,-0.16476,-0.0059501,0.18488,0.81358,HP_ABNORMAL_SHAPE_OF_THE_RADIUS,1
REACTOME_TRIF_MEDIATED_PROGR...,SET,9,-0.26428,-0.0058468,0.29653,0.81359,REACTOME_TRIF_MEDIATED_PROGRAMMED_CELL_DEATH,1
MIR516A_5P,SET,6,-0.30431,-0.0054975,0.34145,0.81359,MIR516A_5P,1
ZHONG_PFC_C1_DLX5_POS_INTERN...,SET,6,-0.36228,-0.0065447,0.40646,0.81361,ZHONG_PFC_C1_DLX5_POS_INTERNEURON,1
HP_MATERNAL_DIABETES,SET,39,-0.12435,-0.005722,0.13951,0.81362,HP_MATERNAL_DIABETES,1
CARRILLOREIXACH_14Q32OVEREXP...,SET,2,-0.67729,-0.0070649,0.75984,0.81363,CARRILLOREIXACH_14Q32OVEREXPRESSION_IN_HEPATOBLASTOMA,1
YAGI_AML_SURVIVAL,SET,108,-0.07244,-0.0055367,0.081269,0.81363,YAGI_AML_SURVIVAL,1
GSE41867_DAY15_EFFECTOR_VS_D...4,SET,178,-0.056814,-0.0055641,0.063737,0.81363,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP,1
INGA_TP53_TARGETS,SET,16,-0.18673,-0.005507,0.20947,0.81364,INGA_TP53_TARGETS,1
LIU_LIVER_CANCER,SET,29,-0.1326,-0.0052632,0.14876,0.81364,LIU_LIVER_CANCER,1
GSE17721_CTRL_VS_GARDIQUIMOD...12,SET,184,-0.052357,-0.0052124,0.058726,0.81368,GSE17721_CTRL_VS_GARDIQUIMOD_4H_BMDC_UP,1
MIR1322,SET,68,-0.10691,-0.0064909,0.1199,0.81371,MIR1322,1
HP_ESOPHAGEAL_ATRESIA,SET,25,-0.14169,-0.0052222,0.15888,0.81374,HP_ESOPHAGEAL_ATRESIA,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...1,SET,183,-0.055619,-0.0055223,0.062348,0.81382,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_DN,1
MIR6758_3P,SET,99,-0.076017,-0.0055641,0.085192,0.81388,MIR6758_3P,1
GOBP_ESTABLISHMENT_OF_MITOCH...1,SET,27,-0.15105,-0.0057854,0.16927,0.8139,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION,1
HP_FEMALE_REPRODUCTIVE_SYSTE...,SET,70,-0.088116,-0.0054277,0.098722,0.81395,HP_FEMALE_REPRODUCTIVE_SYSTEM_NEOPLASM,1
SMITH_TERT_TARGETS_DN,SET,83,-0.087452,-0.0058636,0.097964,0.81398,SMITH_TERT_TARGETS_DN,1
HP_ANAL_STENOSIS,SET,30,-0.14806,-0.0059772,0.16585,0.814,HP_ANAL_STENOSIS,1
GSE14415_INDUCED_TREG_VS_FOX...3,SET,161,-0.061782,-0.0057571,0.069203,0.814,GSE14415_INDUCED_TREG_VS_FOXP3_KO_INDUCED_TREG_IL2_CULTURE_UP,1
MIR3529_5P,SET,32,-0.13623,-0.0056797,0.15258,0.81404,MIR3529_5P,1
GOBP_REGULATION_OF_EXTRINSIC...2,SET,43,-0.11692,-0.0056486,0.13093,0.81406,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_ABSENCE_OF_LIGAND,1
REACTOME_SMAC_XIAP_REGULATED...,SET,6,-0.27005,-0.0048786,0.30239,0.81408,REACTOME_SMAC_XIAP_REGULATED_APOPTOTIC_RESPONSE,1
GSE15330_WT_VS_IKAROS_KO_LYM...1,SET,180,-0.053468,-0.0052654,0.059866,0.8141,GSE15330_WT_VS_IKAROS_KO_LYMPHOID_MULTIPOTENT_PROGENITOR_DN,1
HP_ABNORMALITY_OF_PANCREAS_P...,SET,149,-0.064357,-0.0057711,0.072024,0.81421,HP_ABNORMALITY_OF_PANCREAS_PHYSIOLOGY,1
GSE9650_NAIVE_VS_MEMORY_CD8_...1,SET,181,-0.057908,-0.0057183,0.064809,0.81421,GSE9650_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
GNF2_CEBPA,SET,63,-0.096125,-0.0056182,0.10757,0.81423,GNF2_CEBPA,1
GOBP_MELANOCYTE_PROLIFERATION,SET,5,-0.35727,-0.0058921,0.39973,0.81427,GOBP_MELANOCYTE_PROLIFERATION,1
HP_PERITONEAL_ABSCESS,SET,11,-0.25508,-0.0062385,0.28534,0.81432,HP_PERITONEAL_ABSCESS,1
LI_DCP2_BOUND_MRNA,SET,78,-0.077894,-0.0050637,0.087126,0.81434,LI_DCP2_BOUND_MRNA,1
CTCCAAG_MIR432,SET,74,-0.085188,-0.0053945,0.095282,0.81435,CTCCAAG_MIR432,1
GOBP_LIPID_IMPORT_INTO_CELL,SET,19,-0.17121,-0.0055019,0.19147,0.81438,GOBP_LIPID_IMPORT_INTO_CELL,1
GOMF_UBIQUITIN_PROTEIN_TRANS...2,SET,12,-0.23772,-0.0060722,0.26585,0.81438,GOMF_UBIQUITIN_PROTEIN_TRANSFERASE_INHIBITOR_ACTIVITY,1
MIR18A_5P_MIR18B_5P,SET,117,-0.069748,-0.0055473,0.077996,0.8144,MIR18A_5P_MIR18B_5P,1
GOBP_NEGATIVE_REGULATION_OF_...498,SET,11,-0.23225,-0.0056803,0.25972,0.8144,GOBP_NEGATIVE_REGULATION_OF_PLATELET_AGGREGATION,1
GOBP_NEGATIVE_REGULATION_OF_...703,SET,5,-0.35694,-0.0058866,0.39891,0.81454,GOBP_NEGATIVE_REGULATION_OF_VITAMIN_D_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_TENDON_MORPHOLOGY,SET,752,-0.028018,-0.0055502,0.031309,0.81456,HP_ABNORMAL_TENDON_MORPHOLOGY,1
REACTOME_NFE2L2_REGULATING_E...,SET,5,-0.32534,-0.0053654,0.3635,0.81461,REACTOME_NFE2L2_REGULATING_ER_STRESS_ASSOCIATED_GENES,1
GSE28726_NAIVE_VS_ACTIVATED_...3,SET,187,-0.054315,-0.0054508,0.060685,0.81461,GSE28726_NAIVE_VS_ACTIVATED_NKTCELL_DN,1
GOMF_CAMP_RESPONSE_ELEMENT_B...2,SET,8,-0.27005,-0.0056329,0.3017,0.81462,GOMF_CAMP_RESPONSE_ELEMENT_BINDING_PROTEIN_BINDING,1
HP_ABNORMAL_LACRIMAL_PUNCTUM...,SET,8,-0.26535,-0.0055348,0.29646,0.81462,HP_ABNORMAL_LACRIMAL_PUNCTUM_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C0_MID...3,SET,850,-0.027163,-0.005705,0.030346,0.81463,HE_LIM_SUN_FETAL_LUNG_C0_MID_MESOTHELIAL_CELL,1
GOBP_CELLULAR_RESPONSE_TO_ZI...,SET,20,-0.19955,-0.0065792,0.22292,0.81464,GOBP_CELLULAR_RESPONSE_TO_ZINC_ION,1
GOMF_SIGNALING_RECEPTOR_INHI...,SET,27,-0.14976,-0.005736,0.16724,0.81474,GOMF_SIGNALING_RECEPTOR_INHIBITOR_ACTIVITY,1
HP_HYPOPLASIA_OF_THE_PRIMARY...,SET,7,-0.27547,-0.005375,0.30754,0.81479,HP_HYPOPLASIA_OF_THE_PRIMARY_TEETH,1
REACTOME_SUMOYLATION_OF_IMMU...,SET,10,-0.23838,-0.005559,0.26612,0.8148,REACTOME_SUMOYLATION_OF_IMMUNE_RESPONSE_PROTEINS,1
HP_ABNORMAL_P_WAVE,SET,5,-0.3891,-0.006417,0.43438,0.81481,HP_ABNORMAL_P_WAVE,1
MIR3614_5P,SET,64,-0.096973,-0.0057124,0.10823,0.81486,MIR3614_5P,1
FURUKAWA_DUSP6_TARGETS_PCI35...1,SET,71,-0.088639,-0.0054986,0.098926,0.81487,FURUKAWA_DUSP6_TARGETS_PCI35_DN,1
GOMF_ALKALINE_PHOSPHATASE_AC...,SET,5,-0.38624,-0.0063698,0.43106,0.81487,GOMF_ALKALINE_PHOSPHATASE_ACTIVITY,1
HP_CUTANEOUS_SYNDACTYLY,SET,64,-0.092349,-0.00544,0.10302,0.81499,HP_CUTANEOUS_SYNDACTYLY,1
HP_EPIDERMAL_ACANTHOSIS,SET,49,-0.10947,-0.0056447,0.12209,0.81503,HP_EPIDERMAL_ACANTHOSIS,1
TOOKER_GEMCITABINE_RESISTANC...2,SET,73,-0.088005,-0.0055353,0.09815,0.81504,TOOKER_GEMCITABINE_RESISTANCE_UP,1
PID_TAP63_PATHWAY,SET,53,-0.10202,-0.0054705,0.11375,0.81511,PID_TAP63_PATHWAY,1
GOBP_LOW_DENSITY_LIPOPROTEIN...1,SET,27,-0.15294,-0.0058575,0.17051,0.81512,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
HP_ABNORMAL_4TH_FINGER_MORPH...,SET,20,-0.18276,-0.0060255,0.20371,0.81517,HP_ABNORMAL_4TH_FINGER_MORPHOLOGY,1
GSE23308_CTRL_VS_CORTICOSTER...2,SET,173,-0.055878,-0.0053957,0.062275,0.81521,GSE23308_CTRL_VS_CORTICOSTERONE_TREATED_MACROPHAGE_MINERALCORTICOID_REC_KO_DN,1
MIR3938,SET,68,-0.087734,-0.0053267,0.097764,0.81524,MIR3938,1
GSE24142_EARLY_THYMIC_PROGEN...6,SET,188,-0.059599,-0.0059969,0.06641,0.81525,GSE24142_EARLY_THYMIC_PROGENITOR_VS_DN2_THYMOCYTE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...333,SET,157,-0.06148,-0.0056579,0.068492,0.8153,GOBP_NEGATIVE_REGULATION_OF_KINASE_ACTIVITY,1
MIR424_5P,SET,476,-0.034339,-0.0054542,0.038255,0.81531,MIR424_5P,1
MIR552_5P,SET,175,-0.057983,-0.005631,0.06458,0.81536,MIR552_5P,1
GOBP_CEMENTUM_MINERALIZATION,SET,5,-0.3624,-0.0059766,0.40363,0.81536,GOBP_CEMENTUM_MINERALIZATION,1
GSE11884_WT_VS_FURIN_KO_NAIV...2,SET,121,-0.07054,-0.0057047,0.078564,0.81536,GSE11884_WT_VS_FURIN_KO_NAIVE_CD4_TCELL_UP,1
GSE14769_UNSTIM_VS_360MIN_LP...1,SET,192,-0.053487,-0.0054383,0.05956,0.81541,GSE14769_UNSTIM_VS_360MIN_LPS_BMDM_DN,1
chr10p11,SET,23,-0.27376,-0.0096783,0.30483,0.81542,chr10p11,1
HP_VENTRICULAR_FIBRILLATION,SET,52,-0.108,-0.0057364,0.12023,0.81547,HP_VENTRICULAR_FIBRILLATION,1
GOBP_GLUTAMINE_FAMILY_AMINO_...2,SET,24,-0.16735,-0.0060434,0.18628,0.8155,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...30,SET,6,-0.34268,-0.0061906,0.38141,0.81552,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_IRE1A_JNK_SIGNALING_PATHWAY,1
HP_SEPSIS,SET,106,-0.076151,-0.0057665,0.08476,0.81552,HP_SEPSIS,1
HP_GRANULAR_MACULAR_APPEARAN...,SET,8,-0.29567,-0.0061673,0.32901,0.81558,HP_GRANULAR_MACULAR_APPEARANCE,1
GOMF_PROTEASOME_ACTIVATING_A...,SET,6,-0.2535,-0.0045795,0.28205,0.8156,GOMF_PROTEASOME_ACTIVATING_ACTIVITY,1
ROSS_LEUKEMIA_WITH_MLL_FUSIO...,SET,76,-0.088495,-0.0056789,0.098455,0.81562,ROSS_LEUKEMIA_WITH_MLL_FUSIONS,1
MIR6816_3P,SET,31,-0.12736,-0.0052263,0.14169,0.81564,MIR6816_3P,1
GCM_USP6,SET,67,-0.084818,-0.0051118,0.094328,0.81572,GCM_USP6,1
HP_MACROVESICULAR_HEPATIC_ST...,SET,15,-0.17309,-0.0049428,0.19247,0.81575,HP_MACROVESICULAR_HEPATIC_STEATOSIS,1
GSE22611_NOD2_TRANSD_VS_CTRL...3,SET,178,-0.058489,-0.0057281,0.065036,0.81576,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_DN,1
REACTOME_CLASS_I_PEROXISOMAL...,SET,18,-0.16299,-0.0050982,0.18115,0.81586,REACTOME_CLASS_I_PEROXISOMAL_MEMBRANE_PROTEIN_IMPORT,1
GSE29618_PRE_VS_DAY7_POST_TI...7,SET,175,-0.054118,-0.0052556,0.060139,0.81591,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_DN,1
MIR509_5P,SET,141,-0.063041,-0.0055005,0.070048,0.81593,MIR509_5P,1
MORF_FOSL1,SET,371,-0.040298,-0.0056674,0.044771,0.81596,MORF_FOSL1,1
GOBP_HAIR_CELL_DIFFERENTIATI...,SET,50,-0.11333,-0.0059033,0.12591,0.81597,GOBP_HAIR_CELL_DIFFERENTIATION,1
HP_RETINOSCHISIS,SET,7,-0.35238,-0.0068757,0.39148,0.81597,HP_RETINOSCHISIS,1
HP_CLAW_HAND_DEFORMITY,SET,8,-0.27871,-0.0058136,0.30961,0.81599,HP_CLAW_HAND_DEFORMITY,1
GSE22611_NOD2_VS_CTRL_TRANSD...2,SET,174,-0.056391,-0.0054608,0.062638,0.81601,GSE22611_NOD2_VS_CTRL_TRANSDUCED_HEK293T_CELL_UP,1
GOBP_FOLIC_ACID_CONTAINING_C...2,SET,5,-0.2929,-0.0048303,0.32529,0.81604,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_SECONDARY...2,SET,15,-0.21358,-0.0060992,0.23721,0.81604,GOBP_REGULATION_OF_SECONDARY_METABOLIC_PROCESS,1
GSE2770_TGFB_AND_IL4_VS_TGFB...5,SET,174,-0.058491,-0.0056641,0.064955,0.81606,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
GOBP_ZYGOTIC_DETERMINATION_O...,SET,6,-0.41229,-0.0074482,0.45783,0.81608,GOBP_ZYGOTIC_DETERMINATION_OF_ANTERIOR_POSTERIOR_AXIS_EMBRYO,1
WP_GLYCEROPHOSPHOLIPID_BIOSY...,SET,27,-0.15055,-0.0057661,0.16712,0.81616,WP_GLYCEROPHOSPHOLIPID_BIOSYNTHETIC_PATHWAY,1
REACTOME_REVERSIBLE_HYDRATIO...,SET,11,-0.25004,-0.0061152,0.27753,0.81618,REACTOME_REVERSIBLE_HYDRATION_OF_CARBON_DIOXIDE,1
MIR6815_5P,SET,54,-0.10037,-0.0054325,0.1114,0.81619,MIR6815_5P,1
GSE21670_TGFB_VS_TGFB_AND_IL...3,SET,184,-0.053002,-0.0052767,0.058825,0.8162,GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
GOBP_HOMEOSTASIS_OF_NUMBER_O...1,SET,295,-0.045023,-0.0056581,0.049963,0.81623,GOBP_HOMEOSTASIS_OF_NUMBER_OF_CELLS,1
GOMF_CALCIUM_DEPENDENT_PROTE...1,SET,74,-0.10022,-0.0063465,0.11122,0.81623,GOMF_CALCIUM_DEPENDENT_PROTEIN_BINDING,1
HP_ABNORMAL_EPIPHYSEAL_OSSIF...,SET,70,-0.092789,-0.0057155,0.10297,0.81624,HP_ABNORMAL_EPIPHYSEAL_OSSIFICATION,1
GSE35543_IN_VIVO_NTREG_VS_IN...2,SET,170,-0.063707,-0.0060986,0.070691,0.81625,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_UP,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...7,SET,19,-0.15826,-0.0050858,0.17561,0.81626,GOMF_UBIQUITIN_LIKE_PROTEIN_READER_ACTIVITY,1
ZSCAN23_TARGET_GENES,SET,63,-0.097674,-0.0057088,0.10837,0.81627,ZSCAN23_TARGET_GENES,1
GSE17721_POLYIC_VS_GARDIQUIM...12,SET,177,-0.055642,-0.0054341,0.061732,0.81629,GSE17721_POLYIC_VS_GARDIQUIMOD_2H_BMDC_UP,1
MCCABE_HOXC6_TARGETS_CANCER_...2,SET,23,-0.16608,-0.0058715,0.18423,0.81633,MCCABE_HOXC6_TARGETS_CANCER_UP,1
PAL_PRMT5_TARGETS_DN,SET,27,-0.15939,-0.0061049,0.1768,0.81635,PAL_PRMT5_TARGETS_DN,1
SRC_UP.V1_UP,SET,149,-0.063707,-0.0057129,0.070659,0.81636,SRC_UP.V1_UP,1
GOBP_CELLULAR_HOMEOSTASIS,SET,747,-0.029082,-0.0057426,0.032228,0.81656,GOBP_CELLULAR_HOMEOSTASIS,1
GOBP_G1_TO_G0_TRANSITION_INV...,SET,6,-0.28141,-0.0050838,0.31185,0.81658,GOBP_G1_TO_G0_TRANSITION_INVOLVED_IN_CELL_DIFFERENTIATION,1
GSE13887_ACT_CD4_VS_NO_TREAT...2,SET,116,-0.071814,-0.0056873,0.079576,0.81659,GSE13887_ACT_CD4_VS_NO_TREATED_CD4_TCELL_UP,1
GOBP_SMOOTHENED_SIGNALING_PA...1,SET,129,-0.066091,-0.0055176,0.0732,0.8167,GOBP_SMOOTHENED_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...280,SET,9,-0.27692,-0.0061265,0.30669,0.81671,GOBP_POSITIVE_REGULATION_OF_FEEDING_BEHAVIOR,1
GSE360_CTRL_VS_B_MALAYI_LOW_...2,SET,180,-0.0579,-0.0057019,0.064126,0.81671,GSE360_CTRL_VS_B_MALAYI_LOW_DOSE_DC_UP,1
GSE3982_EOSINOPHIL_VS_EFF_ME...2,SET,174,-0.055953,-0.0054184,0.061963,0.81673,GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
SOBOLEV_PBMC_PANDEMRIX_AGE_1...7,SET,4,-0.36467,-0.0053792,0.40382,0.81674,SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN,1
MIR379_5P,SET,41,-0.12256,-0.0057823,0.13572,0.81675,MIR379_5P,1
GOBP_COPPER_ION_HOMEOSTASIS,SET,18,-0.17817,-0.0055732,0.19729,0.81675,GOBP_COPPER_ION_HOMEOSTASIS,1
HP_ABNORMALITY_OF_THE_TEMPOR...,SET,18,-0.19312,-0.0060406,0.21373,0.81688,HP_ABNORMALITY_OF_THE_TEMPOROMANDIBULAR_JOINT,1
GALIE_TUMOR_STEMNESS_GENES,SET,6,-0.35695,-0.0064483,0.39503,0.81689,GALIE_TUMOR_STEMNESS_GENES,1
KAYO_AGING_MUSCLE_UP,SET,208,-0.05176,-0.0054751,0.057278,0.81691,KAYO_AGING_MUSCLE_UP,1
MIR98_5P,SET,361,-0.041194,-0.0057164,0.045583,0.81692,MIR98_5P,1
GIAROLA_SILVA_BLOOD_PANDEMRI...2,SET,4,-0.32391,-0.004778,0.35841,0.81693,GIAROLA_SILVA_BLOOD_PANDEMRIX_AGE_21_51YO_3DY_UP,1
GAO_SMALL_INTESTINE_24W_C7_S...,SET,39,-0.12374,-0.005694,0.13691,0.81695,GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR,1
GOBP_EMBRYO_DEVELOPMENT,SET,1049,-0.024537,-0.0056923,0.027147,0.81696,GOBP_EMBRYO_DEVELOPMENT,1
GOBP_MICROTUBULE_ANCHORING,SET,21,-0.15698,-0.0053034,0.17367,0.81697,GOBP_MICROTUBULE_ANCHORING,1
GLI1_UP.V1_UP,SET,21,-0.16637,-0.0056207,0.18406,0.81698,GLI1_UP.V1_UP,1
GOMF_BIOTIN_BINDING,SET,5,-0.35343,-0.0058287,0.39096,0.817,GOMF_BIOTIN_BINDING,1
MIR7855_5P,SET,70,-0.094611,-0.0058277,0.10464,0.81704,MIR7855_5P,1
GOCC_INTRACILIARY_TRANSPORT_...2,SET,8,-0.23685,-0.0049404,0.26191,0.81708,GOCC_INTRACILIARY_TRANSPORT_PARTICLE_A,1
MIR340_5P,SET,707,-0.029679,-0.0057079,0.032813,0.81712,MIR340_5P,1
MARSON_FOXP3_TARGETS_STIMULA...1,SET,10,-0.23125,-0.0053927,0.25564,0.81715,MARSON_FOXP3_TARGETS_STIMULATED_DN,1
GOMF_INSULIN_LIKE_GROWTH_FAC...3,SET,13,-0.24117,-0.0064118,0.26661,0.81715,GOMF_INSULIN_LIKE_GROWTH_FACTOR_I_BINDING,1
REACTOME_SLC_TRANSPORTER_DIS...,SET,92,-0.080709,-0.005696,0.089215,0.81717,REACTOME_SLC_TRANSPORTER_DISORDERS,1
LINDSTEDT_DENDRITIC_CELL_MAT...3,SET,60,-0.10312,-0.0058823,0.11398,0.81718,LINDSTEDT_DENDRITIC_CELL_MATURATION_C,1
MIR1244,SET,86,-0.081704,-0.0055759,0.090275,0.81727,MIR1244,1
GOBP_NEGATIVE_REGULATION_OF_...557,SET,6,-0.37549,-0.0067833,0.41488,0.81727,GOBP_NEGATIVE_REGULATION_OF_RELAXATION_OF_MUSCLE,1
HP_ABNORMAL_HEART_RATE_VARIA...,SET,22,-0.15909,-0.0055008,0.17575,0.81731,HP_ABNORMAL_HEART_RATE_VARIABILITY,1
REACTOME_SIGNALING_BY_TYPE_1...,SET,52,-0.10802,-0.0057377,0.11931,0.81737,REACTOME_SIGNALING_BY_TYPE_1_INSULIN_LIKE_GROWTH_FACTOR_1_RECEPTOR_IGF1R,1
HP_BOWING_OF_THE_LEGS,SET,217,-0.052787,-0.0057019,0.058287,0.81743,HP_BOWING_OF_THE_LEGS,1
HP_INCREASED_CIRCULATING_HEM...,SET,12,-0.21722,-0.0055486,0.23985,0.81743,HP_INCREASED_CIRCULATING_HEMOGLOBIN_CONCENTRATION,1
MIR129_5P,SET,336,-0.042918,-0.0057496,0.047343,0.81767,MIR129_5P,1
HP_EURYBLEPHARON,SET,9,-0.2384,-0.0052741,0.26298,0.81767,HP_EURYBLEPHARON,1
GSE14415_FOXP3_KO_NATURAL_TR...1,SET,158,-0.060966,-0.0056284,0.067243,0.8177,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_DN,1
REACTOME_FRS_MEDIATED_FGFR3_...,SET,19,-0.1708,-0.0054887,0.18837,0.81771,REACTOME_FRS_MEDIATED_FGFR3_SIGNALING,1
MIR548AR_3P,SET,512,-0.03412,-0.005615,0.037611,0.81784,MIR548AR_3P,1
GOBP_TETRAHYDROFOLATE_METABO...,SET,17,-0.16487,-0.005012,0.18174,0.81784,GOBP_TETRAHYDROFOLATE_METABOLIC_PROCESS,1
TOP2B_TARGET_GENES,SET,483,-0.035592,-0.0056935,0.039231,0.81785,TOP2B_TARGET_GENES,1
MIR12122,SET,193,-0.055569,-0.0056645,0.061249,0.81786,MIR12122,1
HP_EPIGASTRIC_PAIN,SET,11,-0.24337,-0.0059522,0.26823,0.81788,HP_EPIGASTRIC_PAIN,1
INGRAM_SHH_TARGETS_DN,SET,57,-0.10657,-0.0059255,0.11744,0.8179,INGRAM_SHH_TARGETS_DN,1
chr6q22,SET,54,-0.19861,-0.01075,0.21887,0.81791,chr6q22,1
REACTOME_COOPERATION_OF_PDCL...,SET,38,-0.12203,-0.005543,0.13447,0.81792,REACTOME_COOPERATION_OF_PDCL_PHLP1_AND_TRIC_CCT_IN_G_PROTEIN_BETA_FOLDING,1
GSE44649_NAIVE_VS_ACTIVATED_...2,SET,175,-0.052918,-0.005139,0.058307,0.81794,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_DN,1
LIU_TARGETS_OF_VMYB_VS_CMYB_...1,SET,38,-0.13564,-0.0061613,0.14944,0.81796,LIU_TARGETS_OF_VMYB_VS_CMYB_DN,1
HP_4_5_FINGER_SYNDACTYLY,SET,5,-0.37452,-0.0061765,0.41261,0.81797,HP_4_5_FINGER_SYNDACTYLY,1
HP_MACRODACTYLY,SET,4,-0.34557,-0.0050976,0.38069,0.81799,HP_MACRODACTYLY,1
HP_RENAL_NECROSIS,SET,5,-0.33442,-0.0055151,0.3684,0.81799,HP_RENAL_NECROSIS,1
MIR4693_3P,SET,56,-0.10026,-0.005526,0.11042,0.81805,MIR4693_3P,1
GCM_CHUK,SET,69,-0.088643,-0.0054212,0.097612,0.81808,GCM_CHUK,1
TBP_01,SET,223,-0.05351,-0.0058584,0.058918,0.81811,TBP_01,1
GOBP_POSITIVE_REGULATION_OF_...611,SET,47,-0.11642,-0.0058796,0.12819,0.81811,GOBP_POSITIVE_REGULATION_OF_PROTEIN_BINDING,1
GOBP_REGULATION_OF_PROTEIN_S...2,SET,239,-0.049575,-0.0056164,0.054584,0.81812,GOBP_REGULATION_OF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_EREG_...1,SET,11,-0.23653,-0.0057848,0.26039,0.81815,KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY,1
HARALAMBIEVA_PBMC_FLUARIX_AG...8,SET,555,-0.030284,-0.0051826,0.033339,0.81815,HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE,1
HE_LIM_SUN_FETAL_LUNG_C2_DC2...,SET,49,-0.11619,-0.0059911,0.1279,0.81816,HE_LIM_SUN_FETAL_LUNG_C2_DC2_CELL,1
MIR4429,SET,275,-0.048299,-0.0058637,0.053165,0.81818,MIR4429,1
GOBP_C_X_C_CHEMOKINE_RECEPTO...,SET,5,-0.37451,-0.0061762,0.41222,0.81819,GOBP_C_X_C_CHEMOKINE_RECEPTOR_CXCR4_SIGNALING_PATHWAY,1
PAX4_03,SET,234,-0.050798,-0.0056952,0.055905,0.81823,PAX4_03,1
GOBP_NEURAL_NUCLEUS_DEVELOPM...,SET,57,-0.10003,-0.0055623,0.11008,0.81824,GOBP_NEURAL_NUCLEUS_DEVELOPMENT,1
GOBP_NEURON_PROJECTION_REGEN...,SET,55,-0.10819,-0.0059093,0.11903,0.81829,GOBP_NEURON_PROJECTION_REGENERATION,1
BERENJENO_TRANSFORMED_BY_RHO...6,SET,497,-0.033423,-0.0054213,0.036765,0.81834,BERENJENO_TRANSFORMED_BY_RHOA_UP,1
WP_ETHANOL_EFFECTS_ON_HISTON...,SET,29,-0.13908,-0.0055202,0.15297,0.81837,WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS,1
GOBP_CELLULAR_RESPONSE_TO_OR...2,SET,1775,-0.019771,-0.0058401,0.021746,0.81837,GOBP_CELLULAR_RESPONSE_TO_ORGANIC_SUBSTANCE,1
HP_ANTIPHOSPHOLIPID_ANTIBODY...,SET,16,-0.18904,-0.0055752,0.2079,0.81839,HP_ANTIPHOSPHOLIPID_ANTIBODY_POSITIVITY,1
GSE17721_LPS_VS_CPG_4H_BMDC_...2,SET,188,-0.056077,-0.0056425,0.06167,0.8184,GSE17721_LPS_VS_CPG_4H_BMDC_UP,1
VANTVEER_BREAST_CANCER_BRCA1...2,SET,31,-0.13077,-0.005366,0.14379,0.81843,VANTVEER_BREAST_CANCER_BRCA1_UP,1
HP_PROMINENT_INTERPHALANGEAL...,SET,6,-0.30859,-0.0055747,0.3392,0.81852,HP_PROMINENT_INTERPHALANGEAL_JOINTS,1
GOBP_REGULATION_OF_MESONEPHR...,SET,4,-0.39848,-0.005878,0.43786,0.8186,GOBP_REGULATION_OF_MESONEPHROS_DEVELOPMENT,1
GOBP_ENDOTHELIAL_CELL_CHEMOT...,SET,26,-0.16097,-0.00605,0.17687,0.81861,GOBP_ENDOTHELIAL_CELL_CHEMOTAXIS,1
KEGG_MEDICUS_REFERENCE_UREA_...,SET,5,-0.30727,-0.0050674,0.33761,0.81862,KEGG_MEDICUS_REFERENCE_UREA_CYCLE,1
GSE30971_2H_VS_4H_LPS_STIM_M...1,SET,152,-0.064552,-0.0058462,0.070926,0.81862,GSE30971_2H_VS_4H_LPS_STIM_MACROPHAGE_WBP7_HET_DN,1
GOMF_DESUMOYLASE_ACTIVITY,SET,7,-0.25944,-0.0050622,0.285,0.81866,GOMF_DESUMOYLASE_ACTIVITY,1
RYTGCNWTGGNR_UNKNOWN,SET,100,-0.076209,-0.0056061,0.083699,0.81872,RYTGCNWTGGNR_UNKNOWN,1
HP_ABNORMAL_VISUAL_FIELD_TEST,SET,20,-0.16807,-0.0055413,0.18453,0.8188,HP_ABNORMAL_VISUAL_FIELD_TEST,1
HP_NASAL_CONGESTION,SET,47,-0.10796,-0.0054523,0.11852,0.81881,HP_NASAL_CONGESTION,1
HP_SUPERNUMERARY_BONES_OF_TH...,SET,23,-0.15463,-0.0054667,0.16976,0.81881,HP_SUPERNUMERARY_BONES_OF_THE_AXIAL_SKELETON,1
GOBP_POSITIVE_REGULATION_OF_...561,SET,83,-0.08293,-0.0055604,0.091039,0.81883,GOBP_POSITIVE_REGULATION_OF_ORGANELLE_ASSEMBLY,1
GSE16266_LPS_VS_HEATSHOCK_AN...1,SET,176,-0.056491,-0.0055016,0.062012,0.81884,GSE16266_LPS_VS_HEATSHOCK_AND_LPS_STIM_MEF_DN,1
BIOCARTA_CDC25_PATHWAY,SET,9,-0.2398,-0.0053052,0.2632,0.81887,BIOCARTA_CDC25_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_AL...2,SET,16,-0.20171,-0.0059489,0.22135,0.81892,GOBP_CELLULAR_RESPONSE_TO_ALDEHYDE,1
HP_OVERTUBULATED_LONG_BONES,SET,7,-0.2792,-0.0054478,0.30638,0.81893,HP_OVERTUBULATED_LONG_BONES,1
GOBP_ESTABLISHMENT_OF_LOCALI...,SET,1770,-0.018731,-0.0055259,0.020553,0.81895,GOBP_ESTABLISHMENT_OF_LOCALIZATION_IN_CELL,1
GOBP_RESPONSE_TO_L_LEUCINE,SET,14,-0.2109,-0.0058185,0.23135,0.819,GOBP_RESPONSE_TO_L_LEUCINE,1
GOBP_RETINAL_ROD_CELL_DIFFER...,SET,16,-0.19531,-0.0057601,0.21425,0.819,GOBP_RETINAL_ROD_CELL_DIFFERENTIATION,1
ZIRN_TRETINOIN_RESPONSE_DN,SET,5,-0.32714,-0.005395,0.35884,0.81902,ZIRN_TRETINOIN_RESPONSE_DN,1
REACTOME_TRNA_PROCESSING_IN_...1,SET,3,-0.41245,-0.0052691,0.45242,0.81902,REACTOME_TRNA_PROCESSING_IN_THE_MITOCHONDRION,1
GOBP_PHOSPHATE_ION_TRANSPORT,SET,27,-0.16253,-0.0062248,0.17827,0.81902,GOBP_PHOSPHATE_ION_TRANSPORT,1
GSE27786_CD4_TCELL_VS_NKTCEL...2,SET,180,-0.054778,-0.0053944,0.060084,0.81903,GSE27786_CD4_TCELL_VS_NKTCELL_UP,1
GOCC_TELOMERASE_HOLOENZYME_C...,SET,19,-0.16162,-0.0051939,0.17724,0.81908,GOCC_TELOMERASE_HOLOENZYME_COMPLEX,1
GOCC_MICROFIBRIL,SET,11,-0.22525,-0.0055091,0.24697,0.81913,GOCC_MICROFIBRIL,1
HP_VISUAL_AGNOSIA,SET,7,-0.26503,-0.0051713,0.29056,0.81914,HP_VISUAL_AGNOSIA,1
GOBP_POSITIVE_REGULATION_OF_...468,SET,19,-0.18678,-0.0060022,0.20476,0.81916,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_FISSION,1
GOBP_RETINAL_PIGMENT_EPITHEL...,SET,6,-0.35855,-0.0064773,0.393,0.8192,GOBP_RETINAL_PIGMENT_EPITHELIUM_DEVELOPMENT,1
MIR6886_3P,SET,84,-0.079693,-0.0053753,0.087347,0.81921,MIR6886_3P,1
GOBP_NEGATIVE_REGULATION_OF_...607,SET,12,-0.23553,-0.0060164,0.25814,0.81922,GOBP_NEGATIVE_REGULATION_OF_SPROUTING_ANGIOGENESIS,1
GOMF_PHOSPHATIDYLINOSITOL_KI...,SET,25,-0.16133,-0.005946,0.17682,0.81922,GOMF_PHOSPHATIDYLINOSITOL_KINASE_ACTIVITY,1
ZNF530_TARGET_GENES,SET,23,-0.16605,-0.0058705,0.18193,0.8193,ZNF530_TARGET_GENES,1
GSE36009_WT_VS_NLRP10_KO_DC_...4,SET,184,-0.056318,-0.0056067,0.061678,0.8194,GSE36009_WT_VS_NLRP10_KO_DC_UP,1
HP_MITTEN_DEFORMITY,SET,9,-0.25986,-0.0057489,0.28457,0.81942,HP_MITTEN_DEFORMITY,1
GOCC_TRANSLOCON_COMPLEX,SET,5,-0.33059,-0.0054521,0.36199,0.81944,GOCC_TRANSLOCON_COMPLEX,1
DE_YY1_TARGETS_UP,SET,17,-0.20734,-0.0063031,0.22697,0.81951,DE_YY1_TARGETS_UP,1
HP_UTERUS_DIDELPHYS,SET,10,-0.23768,-0.0055425,0.26013,0.81955,HP_UTERUS_DIDELPHYS,1
GSE27786_NKTCELL_VS_MONO_MAC...1,SET,179,-0.058557,-0.0057507,0.064076,0.8196,GSE27786_NKTCELL_VS_MONO_MAC_DN,1
KRAS.LUNG.BREAST_UP.V1_UP,SET,126,-0.075039,-0.0061918,0.0821,0.81963,KRAS.LUNG.BREAST_UP.V1_UP,1
GOBP_NEGATIVE_REGULATION_OF_...693,SET,10,-0.22647,-0.0052811,0.24773,0.81968,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GNF2_BUB1B,SET,49,-0.099555,-0.0051336,0.10889,0.81971,GNF2_BUB1B,1
GOBP_REGULATION_OF_MYOBLAST_...3,SET,15,-0.19834,-0.0056639,0.21693,0.81971,GOBP_REGULATION_OF_MYOBLAST_PROLIFERATION,1
GSE30083_SP2_VS_SP3_THYMOCYT...1,SET,183,-0.058701,-0.0058282,0.064203,0.81971,GSE30083_SP2_VS_SP3_THYMOCYTE_DN,1
GOBP_POSITIVE_REGULATION_OF_...406,SET,151,-0.066965,-0.0060449,0.073237,0.81973,GOBP_POSITIVE_REGULATION_OF_LEUKOCYTE_PROLIFERATION,1
GSE3982_BCELL_VS_EFF_MEMORY_...2,SET,171,-0.058516,-0.005618,0.063991,0.81975,GSE3982_BCELL_VS_EFF_MEMORY_CD4_TCELL_UP,1
HP_CLEFT_LIP,SET,175,-0.057116,-0.0055467,0.062457,0.81976,HP_CLEFT_LIP,1
MIR34B_3P,SET,98,-0.073465,-0.0053502,0.08033,0.81978,MIR34B_3P,1
WP_TUMOR_SUPPRESSOR_ACTIVITY...,SET,29,-0.14936,-0.0059282,0.1633,0.8198,WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1,1
GOBP_REGULATION_OF_ANTIMICRO...2,SET,9,-0.2906,-0.006429,0.31773,0.8198,GOBP_REGULATION_OF_ANTIMICROBIAL_PEPTIDE_PRODUCTION,1
GOBP_POSITIVE_REGULATION_OF_...278,SET,5,-0.3688,-0.0060821,0.40318,0.81983,GOBP_POSITIVE_REGULATION_OF_FC_RECEPTOR_MEDIATED_STIMULATORY_SIGNALING_PATHWAY,1
MIR653_5P,SET,116,-0.07186,-0.0056909,0.078545,0.81987,MIR653_5P,1
GOBP_PROTEIN_MATURATION_BY_I...,SET,11,-0.23606,-0.0057734,0.25795,0.81994,GOBP_PROTEIN_MATURATION_BY_IRON_SULFUR_CLUSTER_TRANSFER,1
HP_ABNORMAL_BLOOD_TRANSITION...,SET,37,-0.12232,-0.0054826,0.13364,0.81996,HP_ABNORMAL_BLOOD_TRANSITION_ELEMENT_CATION_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...206,SET,25,-0.15404,-0.0056773,0.1683,0.81997,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
MARTENS_TRETINOIN_RESPONSE_DN,SET,683,-0.029359,-0.0055535,0.032072,0.82,MARTENS_TRETINOIN_RESPONSE_DN,1
GOBP_TRANSITION_BETWEEN_FAST...,SET,7,-0.28083,-0.0054797,0.30679,0.82,GOBP_TRANSITION_BETWEEN_FAST_AND_SLOW_FIBER,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...3,SET,158,-0.057358,-0.0052952,0.062642,0.82007,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_CONTRACTION_OF_VZV_SPECIFIC_T_CELLS_PEAK_TO_28DYAT_1DY_NEGATIVE,1
ZEILSTRA_CD44_TARGETS_DN,SET,9,-0.2487,-0.0055022,0.27155,0.82012,ZEILSTRA_CD44_TARGETS_DN,1
GSE8921_UNSTIM_VS_TLR1_2_STI...6,SET,186,-0.054385,-0.0054434,0.059382,0.82012,GSE8921_UNSTIM_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
REACTOME_KSRP_KHSRP_BINDS_AN...,SET,16,-0.17368,-0.0051223,0.18961,0.82016,REACTOME_KSRP_KHSRP_BINDS_AND_DESTABILIZES_MRNA,1
GOBP_COMMA_SHAPED_BODY_MORPH...,SET,5,-0.43107,-0.0071091,0.47047,0.82023,GOBP_COMMA_SHAPED_BODY_MORPHOGENESIS,1
GOMF_PROTEIN_SERINE_THREONIN...1,SET,63,-0.096482,-0.0056391,0.1053,0.82023,GOMF_PROTEIN_SERINE_THREONINE_KINASE_ACTIVATOR_ACTIVITY,1
GSE17721_CTRL_VS_CPG_8H_BMDC...2,SET,178,-0.05623,-0.0055069,0.061367,0.82024,GSE17721_CTRL_VS_CPG_8H_BMDC_UP,1
WP_DISORDERS_OF_FOLATE_METAB...,SET,19,-0.16232,-0.0052164,0.1771,0.8203,WP_DISORDERS_OF_FOLATE_METABOLISM_AND_TRANSPORT,1
ATACCTC_MIR202,SET,168,-0.059823,-0.0056933,0.06527,0.8203,ATACCTC_MIR202,1
HP_TYPE_2_MUSCLE_FIBER_ATROP...,SET,16,-0.17965,-0.0052985,0.19601,0.8203,HP_TYPE_2_MUSCLE_FIBER_ATROPHY,1
GOBP_POSITIVE_REGULATION_OF_...431,SET,18,-0.18315,-0.0057289,0.19977,0.82038,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,1
GOBP_LYSINE_METABOLIC_PROCESS,SET,8,-0.25271,-0.0052712,0.27553,0.82047,GOBP_LYSINE_METABOLIC_PROCESS,1
GSE5099_UNSTIM_VS_MCSF_TREAT...3,SET,174,-0.058366,-0.005652,0.06363,0.82049,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY7_DN,1
GOBP_RIBONUCLEOSIDE_DIPHOSPH...,SET,10,-0.24038,-0.0056055,0.26205,0.8205,GOBP_RIBONUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_PHENOL_CONTAINING_COMPO...1,SET,44,-0.1258,-0.0061481,0.13714,0.82051,GOBP_PHENOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_BASE_...1,SET,8,-0.25438,-0.0053061,0.27728,0.82053,KEGG_MEDICUS_REFERENCE_BASE_EXCISION_AND_STRAND_CLEAVAGE_BY_BIFUNCTIONAL_GLYCOSYLASE,1
KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,SET,55,-0.10708,-0.0058488,0.11668,0.8206,KYNG_DNA_DAMAGE_BY_4NQO_OR_UV,1
HAY_BONE_MARROW_CD34_POS_MUL...,SET,17,-0.19669,-0.0059793,0.21429,0.82065,HAY_BONE_MARROW_CD34_POS_MULTILIN,1
KEGG_MEDICUS_REFERENCE_HYDRO...,SET,8,-0.28195,-0.0058812,0.30717,0.82066,KEGG_MEDICUS_REFERENCE_HYDROLYSIS_OF_SPHINGOMYELIN,1
GOBP_MDA_5_SIGNALING_PATHWAY,SET,10,-0.19867,-0.004633,0.2164,0.82071,GOBP_MDA_5_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CORTICOTR...,SET,4,-0.41122,-0.0060658,0.44784,0.82074,GOBP_REGULATION_OF_CORTICOTROPIN_SECRETION,1
GSE40274_CTRL_VS_LEF1_TRANSD...2,SET,156,-0.06232,-0.0057171,0.067865,0.82076,GSE40274_CTRL_VS_LEF1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
GOBP_ATRIAL_CARDIAC_MUSCLE_T...2,SET,5,-0.3908,-0.006445,0.42556,0.82077,GOBP_ATRIAL_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,1
GOBP_PROTEIN_INSERTION_INTO_...1,SET,25,-0.14979,-0.0055206,0.1631,0.82077,GOBP_PROTEIN_INSERTION_INTO_ER_MEMBRANE,1
ATTCTTT_MIR186,SET,241,-0.051226,-0.0058274,0.055763,0.82085,ATTCTTT_MIR186,1
MCDOWELL_ACUTE_LUNG_INJURY_UP,SET,43,-0.12546,-0.0060613,0.13653,0.82092,MCDOWELL_ACUTE_LUNG_INJURY_UP,1
chr21q22,SET,149,-0.13131,-0.011775,0.14289,0.82093,chr21q22,1
HP_PROTRUDING_TONGUE,SET,38,-0.12666,-0.0057533,0.13782,0.82094,HP_PROTRUDING_TONGUE,1
GSE9960_GRAM_NEG_VS_GRAM_NEG...1,SET,167,-0.055263,-0.0052438,0.060136,0.82094,GSE9960_GRAM_NEG_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,1
GSE41978_WT_VS_ID2_KO_KLRG1_...1,SET,190,-0.05844,-0.0059112,0.063589,0.82095,GSE41978_WT_VS_ID2_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
PIAS4_TARGET_GENES,SET,49,-0.11413,-0.0058853,0.12413,0.82106,PIAS4_TARGET_GENES,1
GSE17721_LPS_VS_POLYIC_6H_BM...2,SET,182,-0.058,-0.005743,0.063079,0.82107,GSE17721_LPS_VS_POLYIC_6H_BMDC_UP,1
GOBP_REGULATION_OF_MITOTIC_N...,SET,116,-0.071045,-0.0056264,0.077246,0.82114,GOBP_REGULATION_OF_MITOTIC_NUCLEAR_DIVISION,1
GSE8685_IL2_STARVED_VS_IL2_A...1,SET,177,-0.056611,-0.0055287,0.061543,0.82117,GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN,1
GOBP_CILIARY_NEUROTROPHIC_FA...,SET,5,-0.37828,-0.0062384,0.41109,0.82126,GOBP_CILIARY_NEUROTROPHIC_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_FATTY_ACID_HOMEOSTASIS,SET,15,-0.19449,-0.0055539,0.21132,0.82129,GOBP_FATTY_ACID_HOMEOSTASIS,1
HP_MENINGOCELE,SET,53,-0.10945,-0.0058693,0.11891,0.82133,HP_MENINGOCELE,1
KEGG_MEDICUS_REFERENCE_PP2A_...,SET,18,-0.17047,-0.0053324,0.18519,0.82134,KEGG_MEDICUS_REFERENCE_PP2A_AKT_SIGNALING_PATHWAY,1
GSE3982_BASOPHIL_VS_EFF_MEMO...1,SET,172,-0.057586,-0.0055447,0.062559,0.82134,GSE3982_BASOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...4,SET,6,-0.33178,-0.0059937,0.3604,0.82136,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
GOMF_DINUCLEOTIDE_PHOSPHATAS...,SET,7,-0.31968,-0.0062377,0.34715,0.82143,GOMF_DINUCLEOTIDE_PHOSPHATASE_ACTIVITY,1
MIR383_5P,SET,70,-0.09155,-0.0056392,0.099413,0.82144,MIR383_5P,1
RIZ_ERYTHROID_DIFFERENTIATIO...3,SET,24,-0.16846,-0.0060837,0.18292,0.82146,RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2,1
KEGG_MEDICUS_REFERENCE_ARNO_...,SET,24,-0.14792,-0.0053416,0.1606,0.82147,KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
NFE2L2.V2,SET,396,-0.041587,-0.0060383,0.045153,0.82148,NFE2L2.V2,1
GCM_FANCC,SET,111,-0.070974,-0.005499,0.077056,0.82149,GCM_FANCC,1
EVI1_06,SET,19,-0.1714,-0.0055082,0.18608,0.8215,EVI1_06,1
GOMF_CYTOKINE_RECEPTOR_ACTIV...,SET,87,-0.094606,-0.0064936,0.10269,0.82153,GOMF_CYTOKINE_RECEPTOR_ACTIVITY,1
GSE14908_RESTING_VS_HDM_STIM...4,SET,186,-0.056423,-0.0056474,0.061241,0.82155,GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP,1
AATGGAG_MIR136,SET,68,-0.095383,-0.0057911,0.10352,0.82157,AATGGAG_MIR136,1
HP_BIFID_NOSE,SET,11,-0.22974,-0.0056188,0.24933,0.82158,HP_BIFID_NOSE,1
GSE29949_MICROGLIA_BRAIN_VS_...3,SET,184,-0.059758,-0.0059492,0.064837,0.82164,GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_DN,1
HP_MACULAR_SCAR,SET,5,-0.37756,-0.0062265,0.40956,0.82169,HP_MACULAR_SCAR,1
GOMF_MIRNA_BINDING,SET,28,-0.13684,-0.0053372,0.14844,0.8217,GOMF_MIRNA_BINDING,1
WP_ENVELOPE_PROTEINS_AND_THE...,SET,43,-0.12427,-0.0060037,0.13479,0.82171,WP_ENVELOPE_PROTEINS_AND_THEIR_POTENTIAL_ROLES_IN_EDMD_PHYSIOPATHOLOGY,1
GOBP_CARDIAC_MUSCLE_TISSUE_M...,SET,58,-0.11231,-0.006299,0.1218,0.82175,GOBP_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,1
GSE11864_CSF1_VS_CSF1_IFNG_P...1,SET,173,-0.057374,-0.0055402,0.062216,0.82178,GSE11864_CSF1_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
MIR532_5P,SET,68,-0.094009,-0.0057077,0.10191,0.82186,MIR532_5P,1
REACTOME_IMMUNOREGULATORY_IN...,SET,114,-0.081133,-0.00637,0.08794,0.82188,REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL,1
WP_IMMUNE_INFILTRATION_IN_PA...,SET,38,-0.13244,-0.0060157,0.14352,0.82193,WP_IMMUNE_INFILTRATION_IN_PANCREATIC_CANCER,1
HP_ABNORMAL_VESTIBULO_OCULAR...,SET,7,-0.28714,-0.0056027,0.31115,0.82194,HP_ABNORMAL_VESTIBULO_OCULAR_REFLEX,1
GOBP_REGULATION_OF_MESODERMA...2,SET,6,-0.33358,-0.0060261,0.36147,0.82195,GOBP_REGULATION_OF_MESODERMAL_CELL_FATE_SPECIFICATION,1
GOBP_REGULATION_OF_CELL_PROJ...3,SET,11,-0.21674,-0.0053008,0.23481,0.822,GOBP_REGULATION_OF_CELL_PROJECTION_SIZE,1
GSE15139_GMCSF_TREATED_VS_UN...1,SET,187,-0.0542,-0.0054393,0.05872,0.822,GSE15139_GMCSF_TREATED_VS_UNTREATED_NEUTROPHILS_DN,1
GOBP_POSITIVE_REGULATION_OF_...379,SET,953,-0.026563,-0.0058899,0.028774,0.82203,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
REACTOME_MELANIN_BIOSYNTHESIS,SET,5,-0.41285,-0.0068086,0.44713,0.82207,REACTOME_MELANIN_BIOSYNTHESIS,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...3,SET,12,-0.23481,-0.0059979,0.25426,0.82212,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01350,1
HP_METAPHYSEAL_DYSPLASIA,SET,31,-0.13916,-0.0057102,0.15066,0.82216,HP_METAPHYSEAL_DYSPLASIA,1
MENON_FETAL_KIDNEY_9_ENDOTHE...,SET,91,-0.092189,-0.0064709,0.099809,0.82216,MENON_FETAL_KIDNEY_9_ENDOTHELIAL_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...520,SET,5,-0.36076,-0.0059495,0.39057,0.82217,GOBP_POSITIVE_REGULATION_OF_NECROPTOTIC_PROCESS,1
GOCC_RESPIRASOME,SET,82,-0.074302,-0.0049519,0.080428,0.82221,GOCC_RESPIRASOME,1
GSE37533_PPARG1_FOXP3_VS_FOX...3,SET,189,-0.05723,-0.0057737,0.061943,0.82223,GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,1
WP_DNA_DAMAGE_RESPONSE_ONLY_...,SET,108,-0.077226,-0.0059025,0.083583,0.82224,WP_DNA_DAMAGE_RESPONSE_ONLY_ATM_DEPENDENT,1
GSE37301_HEMATOPOIETIC_STEM_...11,SET,149,-0.060755,-0.0054481,0.065746,0.82228,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_PRO_BCELL_DN,1
GOBP_REGULATION_OF_MEGAKARYO...,SET,22,-0.17529,-0.0060611,0.18957,0.82243,GOBP_REGULATION_OF_MEGAKARYOCYTE_DIFFERENTIATION,1
MIR4735_3P,SET,107,-0.075385,-0.0057352,0.08152,0.82244,MIR4735_3P,1
HP_ANKLE_CLONUS,SET,44,-0.11277,-0.0055111,0.12195,0.82245,HP_ANKLE_CLONUS,1
GOBP_INTESTINAL_STEM_CELL_HO...,SET,5,-0.33781,-0.005571,0.36528,0.82246,GOBP_INTESTINAL_STEM_CELL_HOMEOSTASIS,1
MIR3153,SET,190,-0.056768,-0.005742,0.061372,0.82251,MIR3153,1
SOX3_TARGET_GENES,SET,414,-0.039123,-0.0058053,0.042296,0.82251,SOX3_TARGET_GENES,1
GOCC_INO80_COMPLEX,SET,16,-0.19843,-0.0058523,0.21453,0.82251,GOCC_INO80_COMPLEX,1
HP_ABNORMAL_CHORIORETINAL_MO...,SET,135,-0.068716,-0.0058676,0.074275,0.82255,HP_ABNORMAL_CHORIORETINAL_MORPHOLOGY,1
GOBP_REGULATION_OF_JNK_CASCA...,SET,131,-0.068512,-0.0057635,0.074046,0.82258,GOBP_REGULATION_OF_JNK_CASCADE,1
GOBP_CATECHOLAMINE_UPTAKE,SET,17,-0.19925,-0.006057,0.21534,0.82259,GOBP_CATECHOLAMINE_UPTAKE,1
NOUZOVA_TRETINOIN_AND_H4_ACE...,SET,123,-0.065148,-0.0053117,0.070398,0.82262,NOUZOVA_TRETINOIN_AND_H4_ACETYLATION,1
GOMF_UNIPORTER_ACTIVITY,SET,9,-0.30474,-0.0067419,0.32923,0.82267,GOMF_UNIPORTER_ACTIVITY,1
BLANCO_MELO_MERS_COV_INFECTI...2,SET,230,-0.051335,-0.0057066,0.055447,0.82273,BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP,1
HP_FRONTAL_HIRSUTISM,SET,8,-0.2342,-0.0048851,0.25283,0.82285,HP_FRONTAL_HIRSUTISM,1
GOBP_LENS_MORPHOGENESIS_IN_C...,SET,19,-0.19792,-0.0063604,0.21359,0.82294,GOBP_LENS_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
GOCC_SIDE_OF_MEMBRANE,SET,661,-0.033632,-0.0062623,0.03628,0.82303,GOCC_SIDE_OF_MEMBRANE,1
GSE27670_BLIMP1_VS_LMP1_TRAN...2,SET,180,-0.058455,-0.0057565,0.063048,0.82307,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_UP,1
JIANG_AGING_HYPOTHALAMUS_DN,SET,31,-0.1388,-0.0056955,0.14969,0.82308,JIANG_AGING_HYPOTHALAMUS_DN,1
REACTOME_SPERM_MOTILITY_AND_...,SET,9,-0.23938,-0.005296,0.25815,0.82311,REACTOME_SPERM_MOTILITY_AND_TAXES,1
MIR12135,SET,185,-0.056599,-0.0056499,0.06103,0.82313,MIR12135,1
MURARO_PANCREAS_ENDOTHELIAL_...,SET,337,-0.046181,-0.0061958,0.049787,0.82318,MURARO_PANCREAS_ENDOTHELIAL_CELL,1
HOEK_NK_CELL_2011_2012_TIV_1...,SET,42,-0.12846,-0.0061336,0.13847,0.82321,HOEK_NK_CELL_2011_2012_TIV_1D_VS_0DY_ADULT_1D_DN,1
GOBP_NADH_METABOLIC_PROCESS,SET,28,-0.13507,-0.0052681,0.14559,0.82323,GOBP_NADH_METABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_AFFECT...1,SET,814,-0.027754,-0.00571,0.029906,0.8233,HP_APLASIA_HYPOPLASIA_AFFECTING_BONES_OF_THE_AXIAL_SKELETON,1
FOXG1_TARGET_GENES,SET,476,-0.035543,-0.0056455,0.038291,0.82335,FOXG1_TARGET_GENES,1
OUELLET_CULTURED_OVARIAN_CAN...1,SET,30,-0.14711,-0.0059387,0.15847,0.82337,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_DN,1
GOBP_TYPE_II_INTERFERON_MEDI...,SET,26,-0.14973,-0.0056277,0.16128,0.82338,GOBP_TYPE_II_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOMF_GLUCOSIDASE_ACTIVITY,SET,13,-0.21335,-0.0056721,0.22979,0.82341,GOMF_GLUCOSIDASE_ACTIVITY,1
HP_EXTRAPYRAMIDAL_DYSKINESIA,SET,6,-0.34806,-0.0062877,0.37487,0.82341,HP_EXTRAPYRAMIDAL_DYSKINESIA,1
GSE17721_CPG_VS_GARDIQUIMOD_...2,SET,185,-0.055097,-0.0054999,0.059342,0.82341,GSE17721_CPG_VS_GARDIQUIMOD_0.5H_BMDC_UP,1
DURAND_STROMA_S_UP,SET,261,-0.052273,-0.0061849,0.056297,0.82343,DURAND_STROMA_S_UP,1
LI_PBMC_MENACTRA_AGE_18_45YO...9,SET,54,-0.12073,-0.0065344,0.13,0.82347,LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_POLYSACCHARIDE_ANTIBODY_3DY_POSITIVE,1
GOBP_REGULATION_OF_MEMBRANE_...4,SET,15,-0.23241,-0.0066369,0.25025,0.82348,GOBP_REGULATION_OF_MEMBRANE_INVAGINATION,1
ERBB2_UP.V1_UP,SET,170,-0.063026,-0.0060335,0.06786,0.82349,ERBB2_UP.V1_UP,1
GOBP_DETECTION_OF_VISIBLE_LI...,SET,43,-0.12022,-0.0058084,0.1294,0.82358,GOBP_DETECTION_OF_VISIBLE_LIGHT,1
GOBP_CELL_SUBSTRATE_JUNCTION...1,SET,8,-0.30728,-0.0064096,0.33067,0.82362,GOBP_CELL_SUBSTRATE_JUNCTION_DISASSEMBLY,1
GUCY1B1_TARGET_GENES,SET,518,-0.034718,-0.0057458,0.037359,0.82363,GUCY1B1_TARGET_GENES,1
GOBP_NONASSOCIATIVE_LEARNING,SET,6,-0.32864,-0.005937,0.35361,0.82365,GOBP_NONASSOCIATIVE_LEARNING,1
HP_ABNORMALITY_OF_THE_CRUS_O...,SET,10,-0.25077,-0.0058478,0.26977,0.82369,HP_ABNORMALITY_OF_THE_CRUS_OF_THE_HELIX,1
GOBP_NEGATIVE_REGULATION_OF_...7,SET,16,-0.22448,-0.0066204,0.24147,0.82371,GOBP_NEGATIVE_REGULATION_OF_ACTIVIN_RECEPTOR_SIGNALING_PATHWAY,1
HP_RECURRENT_MYOGLOBINURIA,SET,5,-0.28363,-0.0046775,0.30509,0.82372,HP_RECURRENT_MYOGLOBINURIA,1
GSE37301_HEMATOPOIETIC_STEM_...1,SET,118,-0.075403,-0.0060224,0.081104,0.82373,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_DN,1
AAGGGAT_MIR188,SET,67,-0.095229,-0.0057392,0.10242,0.82374,AAGGGAT_MIR188,1
GOBP_VESICLE_TARGETING_ROUGH...,SET,24,-0.14469,-0.0052251,0.15562,0.82374,GOBP_VESICLE_TARGETING_ROUGH_ER_TO_CIS_GOLGI,1
TGTTTGY_HNF3_Q6,SET,650,-0.032132,-0.005935,0.034555,0.82378,TGTTTGY_HNF3_Q6,1
GOBP_REGULATION_OF_RECEPTOR_...4,SET,61,-0.099379,-0.0057158,0.10682,0.8239,GOBP_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
CAGCACT_MIR5123P,SET,141,-0.070546,-0.0061553,0.075821,0.82392,CAGCACT_MIR5123P,1
HP_FIBROUS_TISSUE_NEOPLASM,SET,78,-0.087832,-0.0057097,0.094391,0.82394,HP_FIBROUS_TISSUE_NEOPLASM,1
HP_PRIMARY_AMENORRHEA,SET,108,-0.076317,-0.005833,0.082015,0.82394,HP_PRIMARY_AMENORRHEA,1
GOBP_PROTEIN_ACYLATION,SET,83,-0.082045,-0.0055011,0.088143,0.82402,GOBP_PROTEIN_ACYLATION,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...4,SET,333,-0.042654,-0.0056892,0.045817,0.82406,GOMF_UBIQUITIN_LIKE_PROTEIN_LIGASE_ACTIVITY,1
NADELLA_PRKAR1A_TARGETS_UP,SET,9,-0.30165,-0.0066735,0.324,0.82407,NADELLA_PRKAR1A_TARGETS_UP,1
GOBP_MEIOTIC_CYTOKINESIS,SET,7,-0.27147,-0.005297,0.29159,0.82407,GOBP_MEIOTIC_CYTOKINESIS,1
DAZARD_RESPONSE_TO_UV_NHEK_DN,SET,283,-0.046705,-0.0057508,0.050152,0.82414,DAZARD_RESPONSE_TO_UV_NHEK_DN,1
GAUCHER_PBMC_YF_VAX_STAMARIL...6,SET,26,-0.16192,-0.0060857,0.17386,0.82415,GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_28DY_UP,1
PRC2_SUZ12_UP.V1_UP,SET,165,-0.061559,-0.0058065,0.06608,0.82422,PRC2_SUZ12_UP.V1_UP,1
DORSAM_HOXA9_TARGETS_DN,SET,30,-0.14832,-0.0059874,0.15919,0.82425,DORSAM_HOXA9_TARGETS_DN,1
GOBP_VASCULAR_ENDOTHELIAL_GR...3,SET,53,-0.11234,-0.0060241,0.12057,0.82426,GOBP_VASCULAR_ENDOTHELIAL_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_INORGANIC_S...,SET,469,-0.037642,-0.0059358,0.040391,0.82431,GOBP_RESPONSE_TO_INORGANIC_SUBSTANCE,1
DESCARTES_FETAL_CEREBRUM_LIM...,SET,22,-0.18364,-0.0063497,0.19704,0.82432,DESCARTES_FETAL_CEREBRUM_LIMBIC_SYSTEM_NEURONS,1
MATSUMIYA_PBMC_MODIFIED_VACC...3,SET,10,-0.27358,-0.0063798,0.29354,0.82433,MATSUMIYA_PBMC_MODIFIED_VACCINIA_ANKARA_VACCINE_AGE_18_55YO_LOW_VS_HIGH_RESPONDERS_2DY_GO_T_CELL_ACTIV_AND_CO_STIM_UP,1
GOBP_MIRNA_MEDIATED_GENE_SIL...1,SET,18,-0.18274,-0.0057161,0.19606,0.82434,GOBP_MIRNA_MEDIATED_GENE_SILENCING_BY_INHIBITION_OF_TRANSLATION,1
GGCAGCT_MIR22,SET,209,-0.053889,-0.0057138,0.057807,0.82438,GGCAGCT_MIR22,1
GOCC_SORTING_ENDOSOME,SET,6,-0.35968,-0.0064977,0.38569,0.82447,GOCC_SORTING_ENDOSOME,1
HP_KNEE_OSTEOARTHRITIS,SET,14,-0.23294,-0.0064267,0.24977,0.82449,HP_KNEE_OSTEOARTHRITIS,1
GAO_LARGE_INTESTINE_24W_C5_L...,SET,50,-0.1159,-0.0060368,0.12427,0.82449,GAO_LARGE_INTESTINE_24W_C5_LGR5POS_STEM_CELL,1
GOMF_MANNOSYLTRANSFERASE_ACT...,SET,24,-0.14891,-0.0053775,0.15966,0.8245,GOMF_MANNOSYLTRANSFERASE_ACTIVITY,1
GOMF_GALACTOSIDE_BINDING,SET,5,-0.40743,-0.0067192,0.43675,0.82455,GOMF_GALACTOSIDE_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...574,SET,7,-0.25829,-0.0050397,0.27679,0.82462,GOBP_NEGATIVE_REGULATION_OF_RIG_I_SIGNALING_PATHWAY,1
GSE37532_WT_VS_PPARG_KO_LN_T...4,SET,156,-0.06065,-0.005564,0.06499,0.82464,GSE37532_WT_VS_PPARG_KO_LN_TREG_UP,1
HP_ABNORMAL_SUBCUTANEOUS_FAT...,SET,8,-0.23914,-0.0049881,0.25618,0.82471,HP_ABNORMAL_SUBCUTANEOUS_FAT_TISSUE_DISTRIBUTION,1
LI_AMPLIFIED_IN_LUNG_CANCER,SET,165,-0.06239,-0.0058849,0.066828,0.82474,LI_AMPLIFIED_IN_LUNG_CANCER,1
HP_APLASIA_HYPOPLASIA_INVOLV...3,SET,164,-0.060034,-0.0056456,0.064302,0.82474,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_THORAX,1
GSE43863_DAY6_EFF_VS_DAY150_...2,SET,177,-0.060644,-0.0059226,0.064945,0.82478,GSE43863_DAY6_EFF_VS_DAY150_MEM_LY6C_INT_CXCR5POS_CD4_TCELL_UP,1
GEORGES_CELL_CYCLE_MIR192_TA...,SET,58,-0.1009,-0.0056593,0.10804,0.82482,GEORGES_CELL_CYCLE_MIR192_TARGETS,1
GSE25123_CTRL_VS_IL4_AND_ROS...4,SET,177,-0.060333,-0.0058922,0.064599,0.82483,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_PPARG_KO_MACROPHAGE_UP,1
GOZGIT_ESR1_TARGETS_DN,SET,656,-0.033435,-0.006203,0.035794,0.82487,GOZGIT_ESR1_TARGETS_DN,1
REACTOME_PROCESSIVE_SYNTHESI...2,SET,14,-0.18166,-0.005012,0.19446,0.82489,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_LAGGING_STRAND,1
GOMF_CALCIUM_DEPENDENT_PHOSP...1,SET,17,-0.21134,-0.0064247,0.2262,0.82493,GOMF_CALCIUM_DEPENDENT_PHOSPHOLIPASE_A2_ACTIVITY,1
GOMF_HISTONE_H4K20_MONOMETHY...,SET,3,-0.53846,-0.0068788,0.57628,0.82494,GOMF_HISTONE_H4K20_MONOMETHYLTRANSFERASE_ACTIVITY,1
MIR128_2_5P,SET,11,-0.26148,-0.006395,0.27976,0.82501,MIR128_2_5P,1
GOBP_TUMOR_NECROSIS_FACTOR_M...,SET,104,-0.07817,-0.0058636,0.083635,0.82501,GOBP_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
DESCARTES_FETAL_EYE_PHOTOREC...,SET,29,-0.16523,-0.0065583,0.17676,0.82505,DESCARTES_FETAL_EYE_PHOTORECEPTOR_CELLS,1
GSE19888_CTRL_VS_T_CELL_MEMB...1,SET,187,-0.056756,-0.0056957,0.060707,0.82508,GSE19888_CTRL_VS_T_CELL_MEMBRANES_ACT_MAST_CELL_DN,1
GOMF_METALLOCHAPERONE_ACTIVI...,SET,12,-0.20421,-0.0052163,0.21841,0.8251,GOMF_METALLOCHAPERONE_ACTIVITY,1
GOCC_MITOTIC_SPINDLE,SET,167,-0.057292,-0.0054364,0.061266,0.82513,GOCC_MITOTIC_SPINDLE,1
QIU_PBMC_HEPTATITIS_B_SURFAC...4,SET,14,-0.22478,-0.0062015,0.24037,0.82513,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_UP,1
LI_ESTROGENE_MID_E2_RESPONSE...2,SET,14,-0.22319,-0.0061576,0.23864,0.82517,LI_ESTROGENE_MID_E2_RESPONSE_UP,1
AIZARANI_LIVER_C1_NK_NKT_CEL...,SET,136,-0.0715,-0.0061278,0.076437,0.82521,AIZARANI_LIVER_C1_NK_NKT_CELLS_1,1
MULLIGHAN_NPM1_SIGNATURE_3_DN,SET,143,-0.064925,-0.0057045,0.069398,0.82524,MULLIGHAN_NPM1_SIGNATURE_3_DN,1
GSE14000_4H_VS_16H_LPS_DC_UP,SET,165,-0.061119,-0.005765,0.065328,0.82525,GSE14000_4H_VS_16H_LPS_DC_UP,1
GOCC_SCAR_COMPLEX,SET,11,-0.21759,-0.0053217,0.23256,0.82526,GOCC_SCAR_COMPLEX,1
MIR4294,SET,69,-0.096892,-0.0059256,0.10353,0.82532,MIR4294,1
GOBP_METANEPHRIC_PROXIMAL_TU...,SET,5,-0.38658,-0.0063754,0.41307,0.82532,GOBP_METANEPHRIC_PROXIMAL_TUBULE_DEVELOPMENT,1
HP_WIDELY_PATENT_FONTANELLES...,SET,15,-0.21588,-0.0061649,0.23062,0.82538,HP_WIDELY_PATENT_FONTANELLES_AND_SUTURES,1
GOBP_MAINTENANCE_OF_APICAL_B...,SET,9,-0.30904,-0.006837,0.33006,0.82544,GOBP_MAINTENANCE_OF_APICAL_BASAL_CELL_POLARITY,1
GOBP_REGULATION_OF_MAINTENAN...,SET,4,-0.35257,-0.0052007,0.37652,0.82545,GOBP_REGULATION_OF_MAINTENANCE_OF_SISTER_CHROMATID_COHESION,1
REACTOME_TRANSLATION_OF_SARS...2,SET,54,-0.10519,-0.0056935,0.11233,0.82548,REACTOME_TRANSLATION_OF_SARS_COV_2_STRUCTURAL_PROTEINS,1
HP_CRACKLES,SET,21,-0.18296,-0.006181,0.19535,0.8255,HP_CRACKLES,1
MIR4793_3P,SET,68,-0.09611,-0.0058352,0.10261,0.82554,MIR4793_3P,1
HP_HYPOPHOSPHATEMIA,SET,41,-0.13125,-0.006192,0.1401,0.82557,HP_HYPOPHOSPHATEMIA,1
GOBP_IMP_METABOLIC_PROCESS,SET,15,-0.20916,-0.0059729,0.22326,0.82558,GOBP_IMP_METABOLIC_PROCESS,1
GSE30962_ACUTE_VS_CHRONIC_LC...2,SET,176,-0.05915,-0.0057605,0.063131,0.8256,GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP,1
GSE1566_WT_VS_EZH2_KO_LN_TCE...1,SET,178,-0.059213,-0.005799,0.063197,0.82561,GSE1566_WT_VS_EZH2_KO_LN_TCELL_DN,1
GOBP_REGULATION_OF_TRANSFERA...,SET,565,-0.033891,-0.0058502,0.036167,0.82564,GOBP_REGULATION_OF_TRANSFERASE_ACTIVITY,1
REACTOME_REGULATION_OF_HSF1_...,SET,77,-0.086024,-0.0055564,0.091782,0.82568,REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE,1
HP_WIDELY_SPACED_TEETH,SET,103,-0.076169,-0.0056861,0.08126,0.8257,HP_WIDELY_SPACED_TEETH,1
GOBP_REGULATION_OF_SREBP_SIG...,SET,6,-0.31922,-0.0057669,0.34049,0.82575,GOBP_REGULATION_OF_SREBP_SIGNALING_PATHWAY,1
HP_CORONAL_CRANIOSYNOSTOSIS,SET,26,-0.1414,-0.0053145,0.15079,0.82579,HP_CORONAL_CRANIOSYNOSTOSIS,1
GSE3982_EOSINOPHIL_VS_DC_UP,SET,174,-0.060808,-0.0058886,0.064841,0.82582,GSE3982_EOSINOPHIL_VS_DC_UP,1
GSE29618_BCELL_VS_MONOCYTE_D...1,SET,185,-0.062095,-0.0061984,0.066205,0.82585,GSE29618_BCELL_VS_MONOCYTE_DAY7_FLU_VACCINE_DN,1
HP_TELANGIECTASIA_OF_THE_SKIN,SET,70,-0.086334,-0.0053179,0.092044,0.82586,HP_TELANGIECTASIA_OF_THE_SKIN,1
GGCKCATGS_UNKNOWN,SET,68,-0.099465,-0.0060389,0.10604,0.82588,GGCKCATGS_UNKNOWN,1
HP_NAUSEA_AND_VOMITING,SET,487,-0.035642,-0.0057244,0.037986,0.82595,HP_NAUSEA_AND_VOMITING,1
HP_TESSIER_CLEFT,SET,17,-0.18612,-0.005658,0.19836,0.82595,HP_TESSIER_CLEFT,1
HP_ULNAR_DEVIATION_OF_THE_HA...1,SET,27,-0.16142,-0.0061825,0.17203,0.82595,HP_ULNAR_DEVIATION_OF_THE_HAND,1
GOBP_REGULATION_OF_CYTOPLASM...3,SET,32,-0.13033,-0.0054336,0.1389,0.82596,GOBP_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
MODULE_284,SET,40,-0.12451,-0.0058021,0.13267,0.82598,MODULE_284,1
SOX9_B1,SET,213,-0.056139,-0.0060084,0.05982,0.82599,SOX9_B1,1
MODULE_371,SET,26,-0.14976,-0.0056287,0.15957,0.826,MODULE_371,1
GOMF_FATTY_ACID_DERIVATIVE_B...,SET,18,-0.187,-0.0058492,0.19924,0.82601,GOMF_FATTY_ACID_DERIVATIVE_BINDING,1
MALONEY_RESPONSE_TO_17AAG_UP,SET,37,-0.13686,-0.0061346,0.14582,0.82602,MALONEY_RESPONSE_TO_17AAG_UP,1
MIR516A_3P_MIR516B_3P,SET,160,-0.062522,-0.0058081,0.066615,0.82602,MIR516A_3P_MIR516B_3P,1
HP_WIDENED_CEREBELLAR_SUBARA...,SET,6,-0.33228,-0.0060027,0.35402,0.82602,HP_WIDENED_CEREBELLAR_SUBARACHNOID_SPACE,1
WP_MIR517_RELATIONSHIP_WITH_...,SET,5,-0.32598,-0.005376,0.3473,0.82603,WP_MIR517_RELATIONSHIP_WITH_ARCN1_AND_USP1,1
GOBP_ENDOCARDIUM_DEVELOPMENT,SET,12,-0.263,-0.006718,0.28018,0.82604,GOBP_ENDOCARDIUM_DEVELOPMENT,1
GAUSSMANN_MLL_AF4_FUSION_TAR...4,SET,23,-0.17735,-0.0062698,0.18891,0.82607,GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP,1
URS_ADIPOCYTE_DIFFERENTIATIO...2,SET,64,-0.10203,-0.0060106,0.10869,0.82607,URS_ADIPOCYTE_DIFFERENTIATION_UP,1
GOBP_REGULATION_OF_CELLULAR_...11,SET,16,-0.20531,-0.006055,0.2187,0.82607,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HEAT,1
GOCC_DNA_REPAIR_COMPLEX,SET,20,-0.15561,-0.0051305,0.16575,0.82608,GOCC_DNA_REPAIR_COMPLEX,1
GOBP_NEGATIVE_REGULATION_OF_...259,SET,5,-0.39434,-0.0065033,0.41999,0.82611,GOBP_NEGATIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
TRAVAGLINI_LUNG_LYMPHATIC_CE...,SET,191,-0.061608,-0.0062477,0.065608,0.82613,TRAVAGLINI_LUNG_LYMPHATIC_CELL,1
BIOCARTA_RB_PATHWAY,SET,13,-0.21185,-0.0056324,0.22561,0.82614,BIOCARTA_RB_PATHWAY,1
REACTOME_INHIBITION_OF_DNA_R...,SET,19,-0.15988,-0.0051379,0.17023,0.82617,REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE,1
GOBP_SPHINGOMYELIN_METABOLIC...,SET,20,-0.17356,-0.0057224,0.18481,0.82617,GOBP_SPHINGOMYELIN_METABOLIC_PROCESS,1
GOBP_RESPONSE_TO_IONIZING_RA...,SET,129,-0.067661,-0.0056486,0.072041,0.82618,GOBP_RESPONSE_TO_IONIZING_RADIATION,1
REACTOME_RA_BIOSYNTHESIS_PAT...,SET,22,-0.18688,-0.0064617,0.19896,0.8262,REACTOME_RA_BIOSYNTHESIS_PATHWAY,1
GOCC_CUL2_RING_UBIQUITIN_LIG...,SET,20,-0.17678,-0.0058284,0.18808,0.82637,GOCC_CUL2_RING_UBIQUITIN_LIGASE_COMPLEX,1
GOBP_REGULATION_OF_CATALYTIC...,SET,1230,-0.023963,-0.0059882,0.025488,0.82643,GOBP_REGULATION_OF_CATALYTIC_ACTIVITY,1
GSE14415_INDUCED_VS_NATURAL_...2,SET,130,-0.06907,-0.0057884,0.073457,0.82646,GSE14415_INDUCED_VS_NATURAL_TREG_UP,1
REACTOME_NEGATIVE_REGULATION...2,SET,31,-0.14976,-0.0061454,0.15924,0.82651,REACTOME_NEGATIVE_REGULATION_OF_FGFR1_SIGNALING,1
MIR7_2_3P,SET,591,-0.034297,-0.0060506,0.036458,0.82657,MIR7_2_3P,1
GOMF_COPPER_ION_BINDING,SET,57,-0.10599,-0.0058937,0.11265,0.82663,GOMF_COPPER_ION_BINDING,1
CEBPZ_TARGET_GENES,SET,1239,-0.023125,-0.0057984,0.024572,0.82667,CEBPZ_TARGET_GENES,1
GOBP_HEPOXILIN_METABOLIC_PRO...,SET,7,-0.35832,-0.0069915,0.38072,0.82668,GOBP_HEPOXILIN_METABOLIC_PROCESS,1
MIR10226,SET,69,-0.098516,-0.006025,0.10467,0.82669,MIR10226,1
GNF2_CCNB2,SET,53,-0.10693,-0.0057338,0.11361,0.82669,GNF2_CCNB2,1
GOBP_REGULATION_OF_PROSTATIC...,SET,5,-0.42264,-0.0069701,0.44905,0.82669,GOBP_REGULATION_OF_PROSTATIC_BUD_FORMATION,1
WP_3Q29_COPY_NUMBER_VARIATIO...,SET,57,-0.11817,-0.0065705,0.12553,0.82672,WP_3Q29_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_WOUND_HEALING,SET,399,-0.041647,-0.0060693,0.044222,0.82684,GOBP_WOUND_HEALING,1
GSE43955_10H_VS_30H_ACT_CD4_...1,SET,185,-0.058042,-0.0057939,0.06163,0.82684,GSE43955_10H_VS_30H_ACT_CD4_TCELL_DN,1
GSE16385_IFNG_TNF_VS_ROSIGLI...1,SET,143,-0.067025,-0.0058891,0.071165,0.82685,GSE16385_IFNG_TNF_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
REACTOME_REGULATION_OF_BETA_...,SET,41,-0.12965,-0.0061167,0.13765,0.82686,REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT,1
HP_PANHYPOPITUITARISM,SET,25,-0.14936,-0.0055048,0.15853,0.82693,HP_PANHYPOPITUITARISM,1
REACTOME_CONVERSION_FROM_APC...,SET,19,-0.16767,-0.0053882,0.17794,0.82697,REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE,1
HE_LIM_SUN_FETAL_LUNG_C1_INT...,SET,243,-0.054302,-0.0062025,0.057623,0.82699,HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL,1
TRAVAGLINI_LUNG_ALVEOLAR_EPI...2,SET,126,-0.076505,-0.0063128,0.08117,0.82703,TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_2_CELL,1
GOBP_XMP_METABOLIC_PROCESS,SET,7,-0.29888,-0.0058318,0.31707,0.82706,GOBP_XMP_METABOLIC_PROCESS,1
MIR6874_5P,SET,35,-0.13992,-0.0061,0.14843,0.82707,MIR6874_5P,1
GAVISH_3CA_METAPROGRAM_EPITH...5,SET,47,-0.12583,-0.0063551,0.13344,0.82715,GAVISH_3CA_METAPROGRAM_EPITHELIAL_COLON_RELATED,1
MIR3191_5P,SET,147,-0.066687,-0.0059401,0.070712,0.82717,MIR3191_5P,1
GOBP_TETRAPYRROLE_METABOLIC_...,SET,57,-0.10269,-0.0057097,0.10885,0.82725,GOBP_TETRAPYRROLE_METABOLIC_PROCESS,1
GSE4535_BM_DERIVED_DC_VS_FOL...2,SET,179,-0.061289,-0.006019,0.064942,0.82734,GSE4535_BM_DERIVED_DC_VS_FOLLICULAR_DC_UP,1
GSE37532_TREG_VS_TCONV_PPARG...3,SET,172,-0.0596,-0.0057386,0.063144,0.82737,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_DN,1
MIR122_3P,SET,8,-0.26993,-0.0056304,0.28598,0.82738,MIR122_3P,1
GOBP_REGULATION_OF_ANIMAL_OR...1,SET,26,-0.17703,-0.0066539,0.18756,0.82738,GOBP_REGULATION_OF_ANIMAL_ORGAN_FORMATION,1
HP_SMALL_INTESTINAL_DYSMOTIL...,SET,6,-0.28226,-0.005099,0.29896,0.82744,HP_SMALL_INTESTINAL_DYSMOTILITY,1
MIR5581_5P,SET,67,-0.096633,-0.0058238,0.10235,0.82745,MIR5581_5P,1
HP_ABNORMAL_VENOUS_MORPHOLOGY,SET,136,-0.067697,-0.0058019,0.071679,0.82753,HP_ABNORMAL_VENOUS_MORPHOLOGY,1
GOBP_NUCLEOSIDE_PHOSPHATE_CA...,SET,165,-0.060562,-0.0057125,0.064114,0.82756,GOBP_NUCLEOSIDE_PHOSPHATE_CATABOLIC_PROCESS,1
HP_NEPHRONOPHTHISIS,SET,35,-0.12737,-0.0055528,0.13477,0.82768,HP_NEPHRONOPHTHISIS,1
REACTOME_VEGF_LIGAND_RECEPTO...,SET,7,-0.33277,-0.006493,0.3521,0.82769,REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS,1
GOBP_REGULATION_OF_VITAMIN_D...2,SET,10,-0.24108,-0.0056218,0.25507,0.8277,GOBP_REGULATION_OF_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
STAMBOLSKY_BOUND_BY_MUTATED_...,SET,13,-0.22149,-0.0058885,0.23433,0.82772,STAMBOLSKY_BOUND_BY_MUTATED_TP53,1
GNF2_MATK,SET,23,-0.16059,-0.0056774,0.16989,0.82773,GNF2_MATK,1
REACTOME_PURINE_RIBONUCLEOSI...,SET,9,-0.26815,-0.0059325,0.28364,0.82777,REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS,1
GOBP_CAMKK_AMPK_SIGNALING_CA...,SET,9,-0.27337,-0.0060478,0.28914,0.82778,GOBP_CAMKK_AMPK_SIGNALING_CASCADE,1
AACTTT_UNKNOWN,SET,1694,-0.021295,-0.0061599,0.022521,0.8278,AACTTT_UNKNOWN,1
MIR3925_5P,SET,141,-0.067609,-0.005899,0.0715,0.82781,MIR3925_5P,1
GSE45365_NK_CELL_VS_CD8A_DC_...2,SET,161,-0.062322,-0.0058074,0.065892,0.82787,GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN,1
GOBP_REGULATION_OF_NEUROTRAN...4,SET,88,-0.084824,-0.0058554,0.089682,0.82788,GOBP_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,1
GOBP_GLUCOSE_METABOLIC_PROCE...,SET,168,-0.061409,-0.0058443,0.0649,0.82797,GOBP_GLUCOSE_METABOLIC_PROCESS,1
HE_LIM_SUN_FETAL_LUNG_C4_CD4...,SET,30,-0.15881,-0.0064111,0.16778,0.82806,HE_LIM_SUN_FETAL_LUNG_C4_CD4_T_CELL,1
LEE_AGING_MUSCLE_UP,SET,34,-0.14536,-0.0062463,0.1535,0.82817,LEE_AGING_MUSCLE_UP,1
GOBP_TRYPTOPHAN_METABOLIC_PR...,SET,10,-0.29376,-0.0068503,0.3102,0.82817,GOBP_TRYPTOPHAN_METABOLIC_PROCESS,1
REACTOME_TRANSPORT_OF_MATURE...2,SET,74,-0.082612,-0.0052315,0.087219,0.82822,REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM,1
GSE22886_NAIVE_TCELL_VS_NEUT...2,SET,175,-0.057517,-0.0055857,0.060725,0.82822,GSE22886_NAIVE_TCELL_VS_NEUTROPHIL_UP,1
TCTAGAG_MIR517,SET,41,-0.12412,-0.0058559,0.13102,0.82826,TCTAGAG_MIR517,1
GATA1_05,SET,260,-0.052197,-0.0061642,0.05509,0.8283,GATA1_05,1
GOBP_CELL_CELL_SIGNALING,SET,1198,-0.024973,-0.0061645,0.026349,0.82837,GOBP_CELL_CELL_SIGNALING,1
HP_STEREOTYPICAL_BODY_ROCKING,SET,6,-0.29061,-0.0052499,0.3066,0.82839,HP_STEREOTYPICAL_BODY_ROCKING,1
HP_REDUCED_FACTOR_XI_ACTIVITY,SET,13,-0.19854,-0.0052783,0.20942,0.82843,HP_REDUCED_FACTOR_XI_ACTIVITY,1
GSE6674_PL2_3_VS_ANTI_IGM_AN...1,SET,179,-0.061208,-0.006011,0.064565,0.82843,GSE6674_PL2_3_VS_ANTI_IGM_AND_CPG_STIM_BCELL_DN,1
CHOI_ATL_ACUTE_STAGE,SET,4,-0.42503,-0.0062696,0.4483,0.82845,CHOI_ATL_ACUTE_STAGE,1
WP_PERTURBATIONS_TO_HOSTCELL...,SET,42,-0.11987,-0.0057235,0.12643,0.82845,WP_PERTURBATIONS_TO_HOSTCELL_AUTOPHAGY_INDUCED_BY_SARSCOV2_PROTEINS,1
HP_ABNORMALITY_OF_THE_HYPOTH...1,SET,360,-0.041417,-0.0057395,0.043667,0.82855,HP_ABNORMALITY_OF_THE_HYPOTHALAMUS_PITUITARY_AXIS,1
GOBP_NEGATIVE_REGULATION_OF_...505,SET,43,-0.13013,-0.0062871,0.13718,0.82859,GOBP_NEGATIVE_REGULATION_OF_PRODUCTION_OF_MOLECULAR_MEDIATOR_OF_IMMUNE_RESPONSE,1
HP_PALMAR_TELANGIECTASIA,SET,7,-0.32174,-0.0062779,0.33914,0.82861,HP_PALMAR_TELANGIECTASIA,1
DESCARTES_MAIN_FETAL_DUCTAL_...,SET,50,-0.12322,-0.0064182,0.12988,0.82862,DESCARTES_MAIN_FETAL_DUCTAL_CELLS,1
DELASERNA_MYOD_TARGETS_UP,SET,81,-0.09134,-0.0060504,0.096265,0.82864,DELASERNA_MYOD_TARGETS_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...28,SET,43,-0.10665,-0.0051527,0.1124,0.82864,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_ELECTRON_TRANSFER_IN_COMPLEX_I,1
GOBP_POSITIVE_REGULATION_OF_...484,SET,13,-0.25867,-0.006877,0.2726,0.82866,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
REACTOME_GPCR_LIGAND_BINDING,SET,426,-0.04379,-0.0065891,0.046143,0.82868,REACTOME_GPCR_LIGAND_BINDING,1
HP_CUPPED_EAR,SET,57,-0.10239,-0.0056932,0.10788,0.82872,HP_CUPPED_EAR,1
HP_TONIC_SEIZURE,SET,121,-0.071553,-0.0057866,0.075386,0.82872,HP_TONIC_SEIZURE,1
VANLOO_SP3_TARGETS_UP,SET,9,-0.29022,-0.0064206,0.30564,0.82882,VANLOO_SP3_TARGETS_UP,1
GOBP_PROTEIN_IMPORT_INTO_PER...3,SET,4,-0.38925,-0.0057418,0.40989,0.82884,GOBP_PROTEIN_IMPORT_INTO_PEROXISOME_MATRIX_SUBSTRATE_RELEASE,1
ZNF582_TARGET_GENES,SET,51,-0.10993,-0.005783,0.11573,0.82892,ZNF582_TARGET_GENES,1
GOCC_PROCENTRIOLE_REPLICATIO...,SET,6,-0.26901,-0.0048598,0.28313,0.82897,GOCC_PROCENTRIOLE_REPLICATION_COMPLEX,1
HP_PULMONARY_ARTERIOVENOUS_M...,SET,4,-0.43149,-0.006365,0.45413,0.82898,HP_PULMONARY_ARTERIOVENOUS_MALFORMATION,1
PID_HNF3A_PATHWAY,SET,42,-0.13206,-0.0063057,0.13897,0.829,PID_HNF3A_PATHWAY,1
MIR3942_3P,SET,299,-0.046956,-0.0059403,0.049411,0.82902,MIR3942_3P,1
GGCAGAC_MIR346,SET,40,-0.12932,-0.0060265,0.13607,0.82903,GGCAGAC_MIR346,1
HP_MICROCORNEA,SET,111,-0.075713,-0.0058662,0.079664,0.82904,HP_MICROCORNEA,1
KEGG_CELL_ADHESION_MOLECULES...,SET,119,-0.08138,-0.0065271,0.085601,0.82911,KEGG_CELL_ADHESION_MOLECULES_CAMS,1
MIR34A_5P,SET,283,-0.047013,-0.0057887,0.049444,0.82915,MIR34A_5P,1
GOBP_REGULATION_OF_PROTEIN_L...6,SET,9,-0.23717,-0.0052471,0.2494,0.82919,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,1
GAO_LARGE_INTESTINE_24W_C2_M...,SET,104,-0.082891,-0.0062177,0.087164,0.82919,GAO_LARGE_INTESTINE_24W_C2_MKI67POS_PROGENITOR,1
GOBP_LONG_CHAIN_FATTY_ACYL_C...1,SET,18,-0.20783,-0.0065008,0.21847,0.82926,GOBP_LONG_CHAIN_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,1
MEINHOLD_OVARIAN_CANCER_LOW_...1,SET,19,-0.18421,-0.0059198,0.19363,0.82928,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_DN,1
ZHONG_PFC_C3_MICROGLIA,SET,431,-0.039868,-0.0060332,0.041899,0.82932,ZHONG_PFC_C3_MICROGLIA,1
HP_LEWY_BODIES,SET,25,-0.15716,-0.0057924,0.16515,0.82935,HP_LEWY_BODIES,1
GOBP_RESPONSE_TO_L_GLUTAMATE,SET,15,-0.20723,-0.0059178,0.21769,0.82944,GOBP_RESPONSE_TO_L_GLUTAMATE,1
GALLUZZI_PERMEABILIZE_MITOCH...,SET,39,-0.13989,-0.0064373,0.14694,0.82945,GALLUZZI_PERMEABILIZE_MITOCHONDRIA,1
GOBP_REGULATION_OF_NUCLEAR_D...,SET,142,-0.067,-0.0058664,0.070376,0.82945,GOBP_REGULATION_OF_NUCLEAR_DIVISION,1
KEGG_MEDICUS_VARIANT_MLL_ENL...,SET,11,-0.27825,-0.0068053,0.29226,0.82946,KEGG_MEDICUS_VARIANT_MLL_ENL_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
GSE22589_HEALTHY_VS_HIV_INFE...1,SET,183,-0.059496,-0.0059072,0.062492,0.82946,GSE22589_HEALTHY_VS_HIV_INFECTED_DC_DN,1
GOBP_ALPHA_AMINO_ACID_METABO...,SET,194,-0.057527,-0.005879,0.060419,0.82948,GOBP_ALPHA_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_PONS_DEVELOPMENT,SET,11,-0.24718,-0.0060452,0.25958,0.8295,GOBP_PONS_DEVELOPMENT,1
HP_GLIOSIS,SET,89,-0.080979,-0.0056215,0.085043,0.8295,HP_GLIOSIS,1
GOMF_HYDROLASE_ACTIVITY_ACTI...9,SET,121,-0.076454,-0.006183,0.080287,0.82951,GOMF_HYDROLASE_ACTIVITY_ACTING_ON_GLYCOSYL_BONDS,1
GSE22601_CD4_SINGLE_POSITIVE...2,SET,181,-0.056309,-0.0055604,0.05913,0.82952,GSE22601_CD4_SINGLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
GOBP_ADULT_BEHAVIOR,SET,141,-0.071126,-0.0062059,0.074687,0.82953,GOBP_ADULT_BEHAVIOR,1
HNF1_Q6,SET,233,-0.056717,-0.0063454,0.059547,0.82956,HNF1_Q6,1
HP_PATCHY_PALMOPLANTAR_HYPER...,SET,6,-0.38203,-0.0069015,0.40108,0.82957,HP_PATCHY_PALMOPLANTAR_HYPERKERATOSIS,1
GOBP_NEUROTRANSMITTER_UPTAKE,SET,43,-0.12967,-0.0062645,0.13613,0.82958,GOBP_NEUROTRANSMITTER_UPTAKE,1
GOBP_GLYCOLYTIC_PROCESS_THRO...2,SET,16,-0.17942,-0.0052915,0.18833,0.82962,GOBP_GLYCOLYTIC_PROCESS_THROUGH_GLUCOSE_6_PHOSPHATE,1
GOBP_NEGATIVE_REGULATION_OF_...321,SET,46,-0.11431,-0.0057118,0.11999,0.82962,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
BRCA1_DN.V1_UP,SET,112,-0.079622,-0.0061966,0.083576,0.82962,BRCA1_DN.V1_UP,1
GOBP_VESICLE_TRANSPORT_ALONG...1,SET,8,-0.27164,-0.0056661,0.28509,0.82966,GOBP_VESICLE_TRANSPORT_ALONG_ACTIN_FILAMENT,1
GSE22601_DOUBLE_NEGATIVE_VS_...4,SET,163,-0.066237,-0.0062101,0.069513,0.82966,GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
GSE25677_R848_VS_MPL_AND_R84...1,SET,146,-0.064759,-0.0057489,0.067949,0.82971,GSE25677_R848_VS_MPL_AND_R848_STIM_BCELL_DN,1
DAZARD_RESPONSE_TO_UV_SCC_UP,SET,88,-0.083138,-0.005739,0.087213,0.82977,DAZARD_RESPONSE_TO_UV_SCC_UP,1
MIR221_5P,SET,74,-0.093434,-0.0059167,0.098005,0.82979,MIR221_5P,1
GAVISH_3CA_METAPROGRAM_B_CEL...3,SET,48,-0.1183,-0.0060375,0.12408,0.8298,GAVISH_3CA_METAPROGRAM_B_CELLS_GERMINAL_CENTER,1
BOGNI_TREATMENT_RELATED_MYEL...2,SET,25,-0.16684,-0.0061491,0.17495,0.82985,BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_UP,1
KATSANOU_ELAVL1_TARGETS_UP,SET,155,-0.06891,-0.0063016,0.072252,0.82989,KATSANOU_ELAVL1_TARGETS_UP,1
GOBP_NEUROBLAST_DIFFERENTIAT...,SET,6,-0.418,-0.0075513,0.43826,0.82989,GOBP_NEUROBLAST_DIFFERENTIATION,1
HP_ALOPECIA_TOTALIS,SET,13,-0.25188,-0.0066965,0.26408,0.8299,HP_ALOPECIA_TOTALIS,1
HP_WEAKNESS_DUE_TO_UPPER_MOT...,SET,427,-0.038707,-0.0058309,0.04058,0.82991,HP_WEAKNESS_DUE_TO_UPPER_MOTOR_NEURON_DYSFUNCTION,1
HP_HYPERPROSTAGLANDINURIA,SET,6,-0.38274,-0.0069142,0.40121,0.82994,HP_HYPERPROSTAGLANDINURIA,1
GOBP_EXOCRINE_SYSTEM_DEVELOP...,SET,48,-0.12213,-0.0062334,0.12801,0.82997,GOBP_EXOCRINE_SYSTEM_DEVELOPMENT,1
GOCC_CELL_POLE,SET,9,-0.26844,-0.0059389,0.28137,0.82997,GOCC_CELL_POLE,1
GSE25123_CTRL_VS_IL4_AND_ROS...1,SET,172,-0.059444,-0.0057236,0.062303,0.82998,GSE25123_CTRL_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
HE_LIM_SUN_FETAL_LUNG_C2_S10...,SET,32,-0.15439,-0.0064367,0.16182,0.82998,HE_LIM_SUN_FETAL_LUNG_C2_S100A12_HI_CLASSICAL_MONOCYTE,1
HP_OROFACIAL_DYSKINESIA,SET,24,-0.1585,-0.0057239,0.1661,0.83001,HP_OROFACIAL_DYSKINESIA,1
GSE14415_NATURAL_TREG_VS_FOX...1,SET,144,-0.066788,-0.0058886,0.069993,0.83001,GSE14415_NATURAL_TREG_VS_FOXP3_KO_NATURAL_TREG_DN,1
GSE26727_WT_VS_KLF2_KO_LPS_S...2,SET,179,-0.060852,-0.005976,0.063772,0.83001,GSE26727_WT_VS_KLF2_KO_LPS_STIM_MACROPHAGE_UP,1
WP_CELL_INTERACTIONS_OF_THE_...,SET,23,-0.1875,-0.0066288,0.19649,0.83002,WP_CELL_INTERACTIONS_OF_THE_PANCREATIC_CANCER_MICROENVIRONMENT,1
GOBP_POSITIVE_REGULATION_OF_...602,SET,39,-0.13798,-0.0063494,0.1446,0.83002,GOBP_POSITIVE_REGULATION_OF_POTASSIUM_ION_TRANSPORT,1
HP_DISTURBANCE_DURING_TRANSI...,SET,17,-0.20949,-0.0063683,0.21951,0.83004,HP_DISTURBANCE_DURING_TRANSITIONS_BETWEEN_SLEEP_AND_WAKE_STATES,1
MIR4443,SET,155,-0.066042,-0.0060393,0.069199,0.83005,MIR4443,1
MIR4772_3P,SET,82,-0.092454,-0.0061617,0.096873,0.83005,MIR4772_3P,1
GAO_LARGE_INTESTINE_24W_C7_G...,SET,16,-0.20613,-0.0060792,0.21598,0.83005,GAO_LARGE_INTESTINE_24W_C7_GOBLET_PROGENITOR,1
GOBP_GLUCOCORTICOID_BIOSYNTH...,SET,16,-0.22786,-0.0067202,0.23873,0.83007,GOBP_GLUCOCORTICOID_BIOSYNTHETIC_PROCESS,1
HP_HYDROPS_FETALIS,SET,115,-0.073194,-0.0057716,0.076678,0.83009,HP_HYDROPS_FETALIS,1
MIR362_3P,SET,107,-0.083583,-0.0063589,0.087549,0.83013,MIR362_3P,1
GOBP_REGULATION_OF_KINASE_AC...,SET,468,-0.038051,-0.0059941,0.039856,0.83013,GOBP_REGULATION_OF_KINASE_ACTIVITY,1
MIR497_5P,SET,476,-0.036437,-0.0057875,0.038164,0.83014,MIR497_5P,1
GSE41978_WT_VS_ID2_KO_AND_BI...2,SET,179,-0.057088,-0.0056064,0.059795,0.83014,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
WP_MITOCHONDRIAL_GENE_EXPRES...,SET,18,-0.18838,-0.0058925,0.1973,0.83015,WP_MITOCHONDRIAL_GENE_EXPRESSION,1
HP_ABSENT_SKIN_PIGMENTATION,SET,5,-0.40602,-0.0066959,0.4252,0.83017,HP_ABSENT_SKIN_PIGMENTATION,1
RUAN_RESPONSE_TO_TROGLITAZON...1,SET,16,-0.22454,-0.0066222,0.23513,0.8302,RUAN_RESPONSE_TO_TROGLITAZONE_DN,1
HP_FACIAL_GRIMACING,SET,10,-0.23611,-0.005506,0.24724,0.8302,HP_FACIAL_GRIMACING,1
MCCLUNG_DELTA_FOSB_TARGETS_2...,SET,43,-0.13343,-0.0064465,0.13964,0.83034,MCCLUNG_DELTA_FOSB_TARGETS_2WK,1
SNAPC2_TARGET_GENES,SET,4,-0.27289,-0.0040255,0.28558,0.83035,SNAPC2_TARGET_GENES,1
HP_ABNORMAL_URINE_ALPHA_KETO...,SET,14,-0.22091,-0.0060946,0.23115,0.83037,HP_ABNORMAL_URINE_ALPHA_KETOGLUTARATE_CONCENTRATION,1
GSE360_L_DONOVANI_VS_L_MAJOR...4,SET,180,-0.059698,-0.0058789,0.062456,0.83042,GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP,1
HP_PTERYGIUM,SET,45,-0.11403,-0.0056357,0.11929,0.83045,HP_PTERYGIUM,1
GOBP_NEGATIVE_REGULATION_OF_...384,SET,18,-0.17926,-0.0056071,0.18746,0.83052,GOBP_NEGATIVE_REGULATION_OF_MEMBRANE_PERMEABILITY,1
KEGG_MEDICUS_VARIANT_MUTATIO...23,SET,16,-0.19503,-0.0057519,0.20392,0.83056,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
REACTOME_G_ALPHA_I_SIGNALLIN...,SET,296,-0.051573,-0.0064921,0.053916,0.8306,REACTOME_G_ALPHA_I_SIGNALLING_EVENTS,1
GOBP_PROTEIN_DNA_COMPLEX_ORG...,SET,726,-0.029026,-0.0056539,0.030342,0.83062,GOBP_PROTEIN_DNA_COMPLEX_ORGANIZATION,1
GOBP_REGULATION_OF_OSTEOBLAS...2,SET,26,-0.17031,-0.006401,0.17803,0.83062,GOBP_REGULATION_OF_OSTEOBLAST_PROLIFERATION,1
HP_ANOPHTHALMIA,SET,59,-0.10178,-0.0057572,0.10638,0.83063,HP_ANOPHTHALMIA,1
HP_SELF_INJURIOUS_BEHAVIOR,SET,166,-0.064046,-0.0060592,0.066938,0.83066,HP_SELF_INJURIOUS_BEHAVIOR,1
KEGG_MEDICUS_PATHOGEN_HIV_TA...2,SET,14,-0.29522,-0.0081449,0.30849,0.83071,KEGG_MEDICUS_PATHOGEN_HIV_TAT_TO_TLR2_4_NFKB_SIGNALING_PATHWAY,1
SUPT20H_TARGET_GENES,SET,1113,-0.024434,-0.005828,0.025532,0.83071,SUPT20H_TARGET_GENES,1
HP_ANTERIORLY_PLACED_ANUS,SET,56,-0.10862,-0.0059866,0.1135,0.83071,HP_ANTERIORLY_PLACED_ANUS,1
CTTTGCA_MIR527,SET,215,-0.055388,-0.0059555,0.05787,0.83074,CTTTGCA_MIR527,1
TRAVAGLINI_LUNG_BASAL_CELL,SET,174,-0.06377,-0.0061754,0.066628,0.83074,TRAVAGLINI_LUNG_BASAL_CELL,1
HP_PROMINENT_STERNUM,SET,12,-0.26516,-0.0067733,0.27703,0.83075,HP_PROMINENT_STERNUM,1
GOBP_CARDIAC_FIBROBLAST_CELL...,SET,4,-0.39848,-0.005878,0.41628,0.83077,GOBP_CARDIAC_FIBROBLAST_CELL_DIFFERENTIATION,1
MIR4481,SET,121,-0.074038,-0.0059876,0.077344,0.83078,MIR4481,1
MODULE_464,SET,14,-0.20623,-0.0056898,0.21539,0.83083,MODULE_464,1
HP_ABNORMAL_RIB_CAGE_MORPHOL...,SET,339,-0.044003,-0.0059208,0.045956,0.83083,HP_ABNORMAL_RIB_CAGE_MORPHOLOGY,1
HP_BRONCHITIS,SET,62,-0.10342,-0.0059968,0.10802,0.83083,HP_BRONCHITIS,1
GCM_GSTA4,SET,57,-0.10475,-0.0058245,0.10933,0.83099,GCM_GSTA4,1
MARIADASON_RESPONSE_TO_CURCU...2,SET,12,-0.21301,-0.0054412,0.2223,0.83102,MARIADASON_RESPONSE_TO_CURCUMIN_SULINDAC_7,1
GSE15330_WT_VS_IKAROS_KO_GRA...2,SET,187,-0.058715,-0.0058924,0.061262,0.83107,GSE15330_WT_VS_IKAROS_KO_GRANULOCYTE_MONOCYTE_PROGENITOR_UP,1
MELLMAN_TUT1_TARGETS_DN,SET,46,-0.11621,-0.0058066,0.12123,0.83112,MELLMAN_TUT1_TARGETS_DN,1
GOMF_VOLTAGE_GATED_MONOATOMI...1,SET,14,-0.21721,-0.0059926,0.22655,0.83115,GOMF_VOLTAGE_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...448,SET,10,-0.28217,-0.0065801,0.29426,0.8312,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_DEPOLARIZATION,1
MIR4733_3P,SET,66,-0.096854,-0.0057936,0.101,0.83121,MIR4733_3P,1
GOBP_GENERAL_ADAPTATION_SYND...1,SET,6,-0.35173,-0.0063541,0.36678,0.83121,GOBP_GENERAL_ADAPTATION_SYNDROME,1
GOBP_REGULATION_OF_PHOSPHORU...,SET,1031,-0.026315,-0.0060552,0.027439,0.83122,GOBP_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,1
GSE29618_MONOCYTE_VS_PDC_DN,SET,170,-0.062215,-0.0059558,0.064864,0.83125,GSE29618_MONOCYTE_VS_PDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...638,SET,58,-0.10557,-0.0059214,0.11006,0.83128,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
GSE36888_STAT5_AB_KNOCKIN_VS...2,SET,182,-0.058764,-0.0058187,0.061246,0.83133,GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_17H_UP,1
HP_RECURRENT_GASTROENTERITIS,SET,12,-0.22531,-0.0057552,0.23481,0.83135,HP_RECURRENT_GASTROENTERITIS,1
HP_UTERINE_RUPTURE,SET,8,-0.34003,-0.0070927,0.35434,0.83137,HP_UTERINE_RUPTURE,1
GOBP_NEGATIVE_REGULATION_OF_...186,SET,12,-0.24837,-0.0063444,0.2588,0.83139,GOBP_NEGATIVE_REGULATION_OF_DNA_DAMAGE_RESPONSE_SIGNAL_TRANSDUCTION_BY_P53_CLASS_MEDIATOR,1
GOCC_ENDOPLASMIC_RETICULUM_E...,SET,28,-0.1453,-0.0056669,0.15137,0.83144,GOCC_ENDOPLASMIC_RETICULUM_EXIT_SITE,1
HP_RECURRENT_MALADAPTIVE_BEH...,SET,961,-0.026928,-0.0059943,0.028048,0.83148,HP_RECURRENT_MALADAPTIVE_BEHAVIOR,1
GOBP_PHOTOTRANSDUCTION_VISIB...,SET,16,-0.20091,-0.0059254,0.20926,0.83149,GOBP_PHOTOTRANSDUCTION_VISIBLE_LIGHT,1
GOMF_PROTEIN_ARGININE_OMEGA_...1,SET,7,-0.3103,-0.0060546,0.32319,0.83149,GOMF_PROTEIN_ARGININE_OMEGA_N_ASYMMETRIC_METHYLTRANSFERASE_ACTIVITY,1
chr5q14,SET,46,-0.20658,-0.010322,0.21516,0.8315,chr5q14,1
GOBP_GLYCEROPHOSPHOLIPID_MET...,SET,277,-0.048422,-0.0058997,0.050424,0.83154,GOBP_GLYCEROPHOSPHOLIPID_METABOLIC_PROCESS,1
GOMF_FIBROBLAST_GROWTH_FACTO...1,SET,23,-0.17049,-0.0060274,0.17753,0.83155,GOMF_FIBROBLAST_GROWTH_FACTOR_BINDING,1
GOMF_HORMONE_RECEPTOR_BINDING,SET,29,-0.16351,-0.00649,0.17024,0.83158,GOMF_HORMONE_RECEPTOR_BINDING,1
REACTOME_RND2_GTPASE_CYCLE,SET,40,-0.12635,-0.0058881,0.13153,0.83163,REACTOME_RND2_GTPASE_CYCLE,1
WP_BIOTIN_METABOLISM_INCLUDI...,SET,9,-0.26873,-0.0059452,0.27971,0.83165,WP_BIOTIN_METABOLISM_INCLUDING_IMDS,1
GRAESSMANN_APOPTOSIS_BY_SERU...2,SET,509,-0.03602,-0.0059107,0.037491,0.83166,GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_UP,1
BANG_VERTEPORFIN_ENDOMETRIAL...1,SET,13,-0.21868,-0.0058138,0.22759,0.83167,BANG_VERTEPORFIN_ENDOMETRIAL_CANCER_CELLS_DN,1
GOMF_LIGASE_ACTIVITY,SET,123,-0.069666,-0.0056801,0.072498,0.8317,GOMF_LIGASE_ACTIVITY,1
GOBP_NUCLEOSIDE_DIPHOSPHATE_...1,SET,13,-0.22254,-0.0059166,0.23158,0.83171,GOBP_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
HP_HYPOPLASIA_OF_THE_ODONTOI...,SET,22,-0.16788,-0.0058047,0.17468,0.83173,HP_HYPOPLASIA_OF_THE_ODONTOID_PROCESS,1
KEGG_MEDICUS_VARIANT_EWSR1_W...,SET,5,-0.39489,-0.0065124,0.41087,0.83174,KEGG_MEDICUS_VARIANT_EWSR1_WT1_FUSION_TO_TRANSCRIPTIONAL_ACTIVATION,1
HP_ABNORMAL_METENCEPHALON_MO...,SET,887,-0.026905,-0.0057663,0.027993,0.83176,HP_ABNORMAL_METENCEPHALON_MORPHOLOGY,1
GOBP_MODIFICATION_OF_POSTSYN...1,SET,10,-0.25464,-0.0059381,0.26492,0.83177,GOBP_MODIFICATION_OF_POSTSYNAPTIC_ACTIN_CYTOSKELETON,1
ZNF239_TARGET_GENES,SET,32,-0.14469,-0.0060321,0.15052,0.83179,ZNF239_TARGET_GENES,1
GOBP_PEPTIDE_ANTIGEN_ASSEMBL...1,SET,12,-0.29138,-0.007443,0.30308,0.83181,GOBP_PEPTIDE_ANTIGEN_ASSEMBLY_WITH_MHC_CLASS_II_PROTEIN_COMPLEX,1
MIR6506_3P,SET,5,-0.30313,-0.0049992,0.31525,0.83186,MIR6506_3P,1
MIR7155_3P,SET,61,-0.097801,-0.005625,0.10169,0.8319,MIR7155_3P,1
HP_ABNORMALITY_OF_THE_INTRIN...,SET,35,-0.12228,-0.0053312,0.12714,0.83192,HP_ABNORMALITY_OF_THE_INTRINSIC_PATHWAY,1
REACTOME_SIGNALING_BY_NOTCH1,SET,68,-0.095785,-0.0058155,0.099565,0.83198,REACTOME_SIGNALING_BY_NOTCH1,1
GOBP_GOLGI_TO_LYSOSOME_TRANS...,SET,12,-0.2167,-0.0055353,0.22525,0.83198,GOBP_GOLGI_TO_LYSOSOME_TRANSPORT,1
GOBP_DISTAL_CONVOLUTED_TUBUL...,SET,4,-0.47338,-0.0069829,0.49187,0.83207,GOBP_DISTAL_CONVOLUTED_TUBULE_DEVELOPMENT,1
GOBP_PROTEIN_AUTOPHOSPHORYLA...,SET,175,-0.063429,-0.0061598,0.065882,0.83216,GOBP_PROTEIN_AUTOPHOSPHORYLATION,1
MORI_EMU_MYC_LYMPHOMA_BY_ONS...1,SET,16,-0.20198,-0.0059569,0.20972,0.83225,MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN,1
REACTOME_HIV_INFECTION,SET,215,-0.050026,-0.005379,0.051941,0.83225,REACTOME_HIV_INFECTION,1
HP_ABNORMAL_PULMONARY_VALVE_...1,SET,3,-0.49903,-0.0063752,0.51812,0.83226,HP_ABNORMAL_PULMONARY_VALVE_CUSP_MORPHOLOGY,1
HERNANDEZ_MITOTIC_ARREST_BY_...3,SET,14,-0.22403,-0.0061809,0.23256,0.8323,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_DN,1
GSE14308_TH2_VS_TH1_DN,SET,181,-0.058577,-0.0057844,0.060802,0.83232,GSE14308_TH2_VS_TH1_DN,1
REACTOME_HDACS_DEACETYLATE_H...,SET,29,-0.13668,-0.005425,0.14185,0.83235,REACTOME_HDACS_DEACETYLATE_HISTONES,1
MIR1243,SET,56,-0.10605,-0.0058448,0.11006,0.83235,MIR1243,1
CACCCBINDINGFACTOR_Q6,SET,244,-0.052185,-0.0059728,0.054161,0.83235,CACCCBINDINGFACTOR_Q6,1
GOMF_SH3_DOMAIN_BINDING,SET,112,-0.074662,-0.0058106,0.07749,0.83235,GOMF_SH3_DOMAIN_BINDING,1
HP_EEG_WITH_GENERALIZED_SHAR...,SET,8,-0.2942,-0.0061368,0.30533,0.83236,HP_EEG_WITH_GENERALIZED_SHARP_SLOW_WAVES,1
HP_TYPICALLY_DE_NOVO,SET,11,-0.23643,-0.0057825,0.24534,0.8324,HP_TYPICALLY_DE_NOVO,1
BRUNO_HEMATOPOIESIS,SET,61,-0.10981,-0.0063157,0.11391,0.83247,BRUNO_HEMATOPOIESIS,1
KYNG_ENVIRONMENTAL_STRESS_RE...6,SET,23,-0.16135,-0.0057042,0.16737,0.83247,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_UV_IN_OLD,1
GOMF_AMMONIA_LYASE_ACTIVITY,SET,5,-0.41078,-0.0067744,0.42611,0.83247,GOMF_AMMONIA_LYASE_ACTIVITY,1
HP_UNDETECTABLE_ELECTRORETIN...,SET,33,-0.15221,-0.006444,0.15789,0.83249,HP_UNDETECTABLE_ELECTRORETINOGRAM,1
GOBP_MICROTUBULE_CYTOSKELETO...1,SET,577,-0.032871,-0.005732,0.034094,0.8325,GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
SHIPP_DLBCL_CURED_VS_FATAL_DN,SET,38,-0.13273,-0.0060293,0.13767,0.83251,SHIPP_DLBCL_CURED_VS_FATAL_DN,1
CERVERA_SDHB_TARGETS_1_UP,SET,111,-0.082856,-0.0064197,0.085923,0.83255,CERVERA_SDHB_TARGETS_1_UP,1
TONG_INTERACT_WITH_PTTG1,SET,51,-0.1038,-0.0054605,0.10765,0.83255,TONG_INTERACT_WITH_PTTG1,1
GAVISH_3CA_METAPROGRAM_FIBRO...10,SET,48,-0.12777,-0.0065209,0.13249,0.83256,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_9,1
HP_SPONDYLOEPIPHYSEAL_DYSPLA...,SET,9,-0.27567,-0.0060987,0.28585,0.83256,HP_SPONDYLOEPIPHYSEAL_DYSPLASIA,1
GOBP_REGULATION_OF_TRANSLATI...3,SET,13,-0.18502,-0.0049189,0.19175,0.83269,GOBP_REGULATION_OF_TRANSLATIONAL_FIDELITY,1
KEGG_MEDICUS_VARIANT_MUTATIO...13,SET,9,-0.25819,-0.005712,0.26756,0.83271,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_KRAS_NRAS_TO_PI3K_SIGNALING_PATHWAY,1
REACTOME_CLASS_A_1_RHODOPSIN...,SET,299,-0.053169,-0.0067263,0.0551,0.83271,REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS,1
YANG_BREAST_CANCER_ESR1_LASE...1,SET,42,-0.12561,-0.0059976,0.13012,0.8328,YANG_BREAST_CANCER_ESR1_LASER_DN,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...2,SET,79,-0.089838,-0.0058773,0.093066,0.8328,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
HP_PROMINENT_COCCYX,SET,5,-0.42387,-0.0069904,0.43911,0.8328,HP_PROMINENT_COCCYX,1
MODULE_66,SET,503,-0.038722,-0.0063176,0.040112,0.83281,MODULE_66,1
HP_INTERCOSTAL_MUSCLE_WEAKNE...,SET,9,-0.29458,-0.0065172,0.30516,0.83281,HP_INTERCOSTAL_MUSCLE_WEAKNESS,1
GOBP_VESTIBULOCOCHLEAR_NERVE...3,SET,7,-0.36982,-0.0072159,0.38307,0.83282,GOBP_VESTIBULOCOCHLEAR_NERVE_MORPHOGENESIS,1
MIR875_3P,SET,283,-0.049048,-0.0060393,0.050803,0.83283,MIR875_3P,1
GOBP_IONOTROPIC_GLUTAMATE_RE...,SET,21,-0.19382,-0.0065479,0.20076,0.83283,GOBP_IONOTROPIC_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_ORGANIC_ACID_CATABOLIC_...,SET,234,-0.052708,-0.0059094,0.054591,0.83285,GOBP_ORGANIC_ACID_CATABOLIC_PROCESS,1
GSE360_L_DONOVANI_VS_B_MALAY...4,SET,176,-0.063463,-0.0061805,0.065709,0.83292,GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP,1
chr18q21,SET,76,-0.17934,-0.011508,0.18566,0.83296,chr18q21,1
HP_CRANIOFACIAL_HYPEROSTOSIS,SET,24,-0.14547,-0.0052534,0.15057,0.83301,HP_CRANIOFACIAL_HYPEROSTOSIS,1
GOBP_RESPONSE_TO_WATER,SET,13,-0.22521,-0.0059875,0.23308,0.83303,GOBP_RESPONSE_TO_WATER,1
HP_MESOAXIAL_FOOT_POLYDACTYLY,SET,4,-0.4917,-0.007253,0.50888,0.83303,HP_MESOAXIAL_FOOT_POLYDACTYLY,1
GSE40274_XBP1_VS_FOXP3_AND_X...2,SET,177,-0.060725,-0.0059305,0.062822,0.83313,GSE40274_XBP1_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
BILD_SRC_ONCOGENIC_SIGNATURE,SET,55,-0.10425,-0.0056941,0.10783,0.83315,BILD_SRC_ONCOGENIC_SIGNATURE,1
HSIAO_LIVER_SPECIFIC_GENES,SET,229,-0.057364,-0.0063632,0.05934,0.83315,HSIAO_LIVER_SPECIFIC_GENES,1
GOBP_REGULATION_OF_GLYCOGEN_...4,SET,4,-0.38066,-0.0056151,0.39369,0.8332,GOBP_REGULATION_OF_GLYCOGEN_STARCH_SYNTHASE_ACTIVITY,1
GOBP_PROTEIN_LOCALIZATION_TO...31,SET,37,-0.12541,-0.0056211,0.12969,0.83322,GOBP_PROTEIN_LOCALIZATION_TO_MICROTUBULE_ORGANIZING_CENTER,1
NIKOLSKY_BREAST_CANCER_6P24_...,SET,21,-0.27626,-0.0093328,0.28557,0.83331,NIKOLSKY_BREAST_CANCER_6P24_P22_AMPLICON,1
GOBP_SPROUTING_ANGIOGENESIS,SET,126,-0.075379,-0.0062199,0.077925,0.83331,GOBP_SPROUTING_ANGIOGENESIS,1
REACTOME_XENOBIOTICS,SET,23,-0.18628,-0.0065855,0.19253,0.83334,REACTOME_XENOBIOTICS,1
USF_01,SET,229,-0.053721,-0.0059591,0.055525,0.83335,USF_01,1
GOBP_REGULATION_OF_TELOMERAS...,SET,43,-0.12052,-0.0058226,0.12455,0.83338,GOBP_REGULATION_OF_TELOMERASE_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_AMIN...,SET,150,-0.065362,-0.0058807,0.067539,0.83341,HP_ABNORMAL_CIRCULATING_AMINO_ACID_CONCENTRATION,1
HP_ABNORMAL_PUPILLARY_FUNCTI...,SET,70,-0.10218,-0.0062939,0.10558,0.83342,HP_ABNORMAL_PUPILLARY_FUNCTION,1
GGARNTKYCCA_UNKNOWN,SET,70,-0.10445,-0.0064341,0.10793,0.83343,GGARNTKYCCA_UNKNOWN,1
GOBP_OSTEOBLAST_DEVELOPMENT,SET,16,-0.21458,-0.0063285,0.2217,0.83344,GOBP_OSTEOBLAST_DEVELOPMENT,1
HP_ABNORMAL_URINARY_ELECTROL...,SET,104,-0.082908,-0.006219,0.085646,0.83348,HP_ABNORMAL_URINARY_ELECTROLYTE_CONCENTRATION,1
ERWIN_COHEN_BLOOD_LIVE_VACCI...,SET,618,-0.03333,-0.0060081,0.034429,0.83349,ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP,1
GOBP_POLAR_BODY_EXTRUSION_AF...,SET,4,-0.35935,-0.0053008,0.3711,0.83355,GOBP_POLAR_BODY_EXTRUSION_AFTER_MEIOTIC_DIVISIONS,1
GOBP_ANOIKIS,SET,31,-0.15077,-0.0061869,0.15565,0.83363,GOBP_ANOIKIS,1
REACTOME_SIGNALING_BY_MET,SET,76,-0.095024,-0.0060979,0.098065,0.83372,REACTOME_SIGNALING_BY_MET,1
GOBP_POSITIVE_REGULATION_OF_...60,SET,33,-0.15253,-0.0064574,0.15741,0.83372,GOBP_POSITIVE_REGULATION_OF_BLOOD_CIRCULATION,1
PID_CASPASE_PATHWAY,SET,50,-0.1147,-0.0059745,0.11832,0.83382,PID_CASPASE_PATHWAY,1
GOCC_FILOPODIUM_MEMBRANE,SET,16,-0.21285,-0.0062775,0.21955,0.83384,GOCC_FILOPODIUM_MEMBRANE,1
GTAAACC_MIR2995P,SET,42,-0.13042,-0.0062274,0.13449,0.8339,GTAAACC_MIR2995P,1
GOMF_SERINE_TYPE_CARBOXYPEPT...,SET,5,-0.319,-0.0052609,0.32895,0.83391,GOMF_SERINE_TYPE_CARBOXYPEPTIDASE_ACTIVITY,1
MIR604,SET,13,-0.21716,-0.0057735,0.22393,0.83392,MIR604,1
GOBP_OSTEOCLAST_PROLIFERATION,SET,11,-0.25098,-0.0061382,0.25878,0.83393,GOBP_OSTEOCLAST_PROLIFERATION,1
GSE28726_ACT_CD4_TCELL_VS_AC...3,SET,185,-0.060445,-0.0060338,0.062325,0.83393,GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN,1
GSE25087_FETAL_VS_ADULT_TCON...1,SET,156,-0.062468,-0.0057307,0.064398,0.83398,GSE25087_FETAL_VS_ADULT_TCONV_DN,1
WRNIP1_TARGET_GENES,SET,967,-0.026305,-0.005873,0.027116,0.83399,WRNIP1_TARGET_GENES,1
BIOCARTA_TSP1_PATHWAY,SET,7,-0.34166,-0.0066665,0.35218,0.83401,BIOCARTA_TSP1_PATHWAY,1
GOBP_ACTIVATION_OF_PROTEIN_K...3,SET,3,-0.51541,-0.0065845,0.53102,0.83412,GOBP_ACTIVATION_OF_PROTEIN_KINASE_C_ACTIVITY,1
REACTOME_G_BETA_GAMMA_SIGNAL...2,SET,25,-0.16934,-0.0062414,0.17445,0.83415,REACTOME_G_BETA_GAMMA_SIGNALLING_THROUGH_PI3KGAMMA,1
MIR509_3_5P,SET,140,-0.068262,-0.005935,0.070306,0.8342,MIR509_3_5P,1
GOCC_KINOCILIUM,SET,10,-0.27215,-0.0063465,0.2803,0.8342,GOCC_KINOCILIUM,1
DESCARTES_MAIN_FETAL_MYELOID...,SET,78,-0.097531,-0.0063403,0.10044,0.83423,DESCARTES_MAIN_FETAL_MYELOID_CELLS,1
WUNDER_INFLAMMATORY_RESPONSE...2,SET,59,-0.1117,-0.0063184,0.11502,0.83424,WUNDER_INFLAMMATORY_RESPONSE_AND_CHOLESTEROL_UP,1
WP_MIR124_PREDICTED_INTERACT...,SET,6,-0.3037,-0.0054864,0.31265,0.83431,WP_MIR124_PREDICTED_INTERACTIONS_WITH_CELL_CYCLE_AND_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...534,SET,68,-0.098235,-0.0059642,0.10113,0.83431,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_POLYMERIZATION,1
GSE26488_WT_VS_VP16_TRANSGEN...1,SET,150,-0.069743,-0.0062748,0.071781,0.83437,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,1
GSE15330_MEGAKARYOCYTE_ERYTH...4,SET,175,-0.061476,-0.0059701,0.063264,0.8344,GSE15330_MEGAKARYOCYTE_ERYTHROID_VS_GRANULOCYTE_MONOCYTE_PROGENITOR_IKAROS_KO_DN,1
GOCC_MANCHETTE,SET,20,-0.18714,-0.0061698,0.19256,0.83443,GOCC_MANCHETTE,1
GOBP_SENSORY_PERCEPTION_OF_M...,SET,171,-0.066428,-0.0063777,0.068349,0.83444,GOBP_SENSORY_PERCEPTION_OF_MECHANICAL_STIMULUS,1
MIR331_5P,SET,66,-0.097701,-0.0058442,0.10048,0.83455,MIR331_5P,1
HP_HYDRANENCEPHALY,SET,8,-0.28681,-0.0059826,0.29497,0.83455,HP_HYDRANENCEPHALY,1
HP_PICA,SET,8,-0.25361,-0.0052901,0.26079,0.83459,HP_PICA,1
GOMF_U4_SNRNA_BINDING,SET,5,-0.25999,-0.0042877,0.26734,0.8346,GOMF_U4_SNRNA_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...94,SET,8,-0.28852,-0.0060181,0.29658,0.83467,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPIRATION,1
HP_ULNAR_BOWING,SET,16,-0.23861,-0.0070373,0.24527,0.83468,HP_ULNAR_BOWING,1
REACTOME_PTK6_REGULATES_PROT...,SET,5,-0.39675,-0.0065431,0.40775,0.83472,REACTOME_PTK6_REGULATES_PROTEINS_INVOLVED_IN_RNA_PROCESSING,1
GOBP_AXIS_ELONGATION,SET,28,-0.17405,-0.0067883,0.17888,0.83472,GOBP_AXIS_ELONGATION,1
DURANTE_ADULT_OLFACTORY_NEUR...3,SET,21,-0.19455,-0.0065727,0.19994,0.83474,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD4_T_CELLS,1
MIR659_5P,SET,25,-0.1776,-0.0065458,0.18251,0.83475,MIR659_5P,1
KEGG_GLYCEROPHOSPHOLIPID_MET...,SET,69,-0.10195,-0.0062349,0.10476,0.83476,KEGG_GLYCEROPHOSPHOLIPID_METABOLISM,1
GOBP_PROTEIN_CATABOLIC_PROCE...2,SET,21,-0.18215,-0.0061535,0.18716,0.83477,GOBP_PROTEIN_CATABOLIC_PROCESS_IN_THE_VACUOLE,1
HP_MYOCLONUS,SET,323,-0.045383,-0.0059632,0.046626,0.8348,HP_MYOCLONUS,1
GSE7831_CPG_VS_INFLUENZA_STI...3,SET,177,-0.059399,-0.005801,0.061026,0.8348,GSE7831_CPG_VS_INFLUENZA_STIM_PDC_4H_DN,1
MIR4789_5P,SET,350,-0.043789,-0.0059849,0.044986,0.83481,MIR4789_5P,1
GOBP_POSITIVE_CHEMOTAXIS,SET,60,-0.11122,-0.0063443,0.11425,0.83482,GOBP_POSITIVE_CHEMOTAXIS,1
GOBP_ESTABLISHMENT_OR_MAINTE...4,SET,22,-0.17689,-0.0061164,0.1817,0.83485,GOBP_ESTABLISHMENT_OR_MAINTENANCE_OF_MONOPOLAR_CELL_POLARITY,1
REACTOME_DEPOLYMERIZATION_OF...,SET,14,-0.21146,-0.0058339,0.21715,0.83491,REACTOME_DEPOLYMERIZATION_OF_THE_NUCLEAR_LAMINA,1
GOBP_SNRNA_PROCESSING,SET,22,-0.1566,-0.0054149,0.16078,0.83496,GOBP_SNRNA_PROCESSING,1
GOCC_PRESYNAPTIC_ACTIVE_ZONE,SET,73,-0.10165,-0.0063935,0.10436,0.83498,GOCC_PRESYNAPTIC_ACTIVE_ZONE,1
YCATTAA_UNKNOWN,SET,499,-0.03896,-0.0063318,0.039991,0.83502,YCATTAA_UNKNOWN,1
HP_HYPERURICEMIA,SET,23,-0.15902,-0.0056218,0.16322,0.83503,HP_HYPERURICEMIA,1
GOBP_RECEPTOR_INTERNALIZATION,SET,120,-0.075148,-0.0060524,0.077129,0.83504,GOBP_RECEPTOR_INTERNALIZATION,1
GOBP_RESPONSE_TO_BILE_ACID,SET,7,-0.33641,-0.0065641,0.34521,0.83509,GOBP_RESPONSE_TO_BILE_ACID,1
REACTOME_CD163_MEDIATING_AN_...,SET,8,-0.29287,-0.0061088,0.30048,0.83513,REACTOME_CD163_MEDIATING_AN_ANTI_INFLAMMATORY_RESPONSE,1
GOBP_PHYSIOLOGICAL_CARDIAC_M...,SET,21,-0.18605,-0.0062852,0.19088,0.83513,GOBP_PHYSIOLOGICAL_CARDIAC_MUSCLE_HYPERTROPHY,1
HOFFMAN_CLOCK_TARGETS_DN,SET,10,-0.23734,-0.0055346,0.24343,0.8352,HOFFMAN_CLOCK_TARGETS_DN,1
HP_ABNORMALITY_OF_VITAMIN_B1...,SET,30,-0.15351,-0.0061968,0.15743,0.83523,HP_ABNORMALITY_OF_VITAMIN_B12_METABOLISM,1
GSE17721_POLYIC_VS_GARDIQUIM...13,SET,191,-0.056392,-0.0057188,0.057829,0.83525,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_DN,1
GSE28237_FOLLICULAR_VS_LATE_...2,SET,180,-0.064335,-0.0063356,0.065966,0.83528,GSE28237_FOLLICULAR_VS_LATE_GC_BCELL_UP,1
LIANG_HEMATOPOIESIS_STEM_CEL...2,SET,39,-0.13133,-0.0060435,0.13466,0.83529,LIANG_HEMATOPOIESIS_STEM_CELL_NUMBER_LARGE_VS_TINY_UP,1
MYLLYKANGAS_AMPLIFICATION_HO...11,SET,9,-0.27003,-0.0059741,0.27682,0.83533,MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_25,1
GOCC_IGM_IMMUNOGLOBULIN_COMP...,SET,3,-0.53302,-0.0068094,0.54638,0.83535,GOCC_IGM_IMMUNOGLOBULIN_COMPLEX,1
HP_INTERRUPTED_AORTIC_ARCH,SET,18,-0.19815,-0.0061981,0.20311,0.83536,HP_INTERRUPTED_AORTIC_ARCH,1
GCM_CSNK1D,SET,29,-0.14506,-0.0057576,0.14867,0.83538,GCM_CSNK1D,1
HP_APLASIA_OF_THE_BLADDER,SET,5,-0.37791,-0.0062324,0.38717,0.83548,HP_APLASIA_OF_THE_BLADDER,1
ZHAN_EARLY_DIFFERENTIATION_G...2,SET,7,-0.31822,-0.0062091,0.326,0.83549,ZHAN_EARLY_DIFFERENTIATION_GENES_UP,1
GNF2_RRM2,SET,38,-0.12873,-0.0058475,0.13187,0.83552,GNF2_RRM2,1
HP_ABNORMAL_URINE_PHOSPHATE_...,SET,26,-0.16053,-0.0060334,0.16443,0.83552,HP_ABNORMAL_URINE_PHOSPHATE_CONCENTRATION,1
GSE13522_CTRL_VS_T_CRUZI_G_S...1,SET,121,-0.073876,-0.0059745,0.075674,0.83552,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN,1
GOCC_VARICOSITY,SET,8,-0.34881,-0.0072757,0.35728,0.83553,GOCC_VARICOSITY,1
GOBP_SMOOTH_MUSCLE_TISSUE_DE...,SET,24,-0.18055,-0.0065202,0.18492,0.83555,GOBP_SMOOTH_MUSCLE_TISSUE_DEVELOPMENT,1
MATZUK_SPERMATOGONIA,SET,25,-0.17123,-0.006311,0.17534,0.8356,MATZUK_SPERMATOGONIA,1
GSE22589_HIV_VS_HIV_AND_SIV_...1,SET,182,-0.058835,-0.0058257,0.060244,0.83561,GSE22589_HIV_VS_HIV_AND_SIV_INFECTED_DC_DN,1
chr5q15,SET,19,-0.28628,-0.0091999,0.29312,0.83563,chr5q15,1
GSE15750_DAY6_VS_DAY10_TRAF6...2,SET,180,-0.058816,-0.0057921,0.060217,0.83564,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_UP,1
GSE40068_BCL6_POS_VS_NEG_CXC...2,SET,186,-0.059973,-0.0060026,0.061402,0.83564,GSE40068_BCL6_POS_VS_NEG_CXCR5_POS_TFH_UP,1
WP_EBOLA_VIRUS_INFECTION_IN_...,SET,123,-0.077101,-0.0062863,0.078917,0.83571,WP_EBOLA_VIRUS_INFECTION_IN_HOST,1
GCCNNNWTAAR_UNKNOWN,SET,132,-0.073024,-0.0061663,0.074738,0.83573,GCCNNNWTAAR_UNKNOWN,1
GOBP_DEVELOPMENT_OF_SECONDAR...1,SET,6,-0.38347,-0.0069275,0.39238,0.83579,GOBP_DEVELOPMENT_OF_SECONDARY_FEMALE_SEXUAL_CHARACTERISTICS,1
GOBP_L_GLUTAMATE_TRANSMEMBRA...,SET,29,-0.15537,-0.0061669,0.15897,0.83579,GOBP_L_GLUTAMATE_TRANSMEMBRANE_TRANSPORT,1
HP_ABNORMALITY_OF_SKULL_OSSI...,SET,46,-0.1231,-0.0061509,0.12592,0.83586,HP_ABNORMALITY_OF_SKULL_OSSIFICATION,1
REACTOME_CASPASE_ACTIVATION_...3,SET,25,-0.16832,-0.0062038,0.17215,0.83589,REACTOME_CASPASE_ACTIVATION_VIA_EXTRINSIC_APOPTOTIC_SIGNALLING_PATHWAY,1
HP_ABNORMAL_CSF_GLUCOSE_CONC...,SET,6,-0.3559,-0.0064294,0.36384,0.836,HP_ABNORMAL_CSF_GLUCOSE_CONCENTRATION,1
HP_SPINAL_CORD_COMPRESSION,SET,34,-0.14731,-0.0063301,0.15056,0.83607,HP_SPINAL_CORD_COMPRESSION,1
GOBP_NITROGEN_COMPOUND_TRANS...,SET,1731,-0.020646,-0.0060305,0.021098,0.8361,GOBP_NITROGEN_COMPOUND_TRANSPORT,1
ASTIER_INTEGRIN_SIGNALING,SET,54,-0.12034,-0.0065135,0.12294,0.83616,ASTIER_INTEGRIN_SIGNALING,1
SIG_PIP3_SIGNALING_IN_B_LYMP...,SET,34,-0.14629,-0.0062862,0.14945,0.83617,SIG_PIP3_SIGNALING_IN_B_LYMPHOCYTES,1
MISHRA_CARCINOMA_ASSOCIATED_...1,SET,20,-0.19581,-0.0064559,0.19999,0.83622,MISHRA_CARCINOMA_ASSOCIATED_FIBROBLAST_DN,1
SHETH_LIVER_CANCER_VS_TXNIP_...4,SET,258,-0.052428,-0.006168,0.053545,0.83624,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM4,1
MIR3612,SET,110,-0.078861,-0.0060827,0.08052,0.8363,MIR3612,1
GOBP_RESPONSE_TO_EPIDERMAL_G...,SET,42,-0.12606,-0.0060191,0.12871,0.8363,GOBP_RESPONSE_TO_EPIDERMAL_GROWTH_FACTOR,1
GSE14769_UNSTIM_VS_40MIN_LPS...1,SET,190,-0.062602,-0.0063321,0.063905,0.83635,GSE14769_UNSTIM_VS_40MIN_LPS_BMDM_DN,1
REACTOME_TNFR1_MEDIATED_CERA...,SET,5,-0.35944,-0.0059278,0.36692,0.83636,REACTOME_TNFR1_MEDIATED_CERAMIDE_PRODUCTION,1
CARRILLOREIXACH_MRS3_VS_LOWE...1,SET,144,-0.07427,-0.0065482,0.075809,0.83638,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_DN,1
MIR11181_3P,SET,183,-0.060886,-0.0060452,0.062145,0.83638,MIR11181_3P,1
MIR627_5P,SET,36,-0.13125,-0.0058033,0.13397,0.83638,MIR627_5P,1
HP_CYSTINURIA,SET,6,-0.44157,-0.0079771,0.45067,0.8364,HP_CYSTINURIA,1
GAVISH_3CA_METAPROGRAM_FIBRO...3,SET,48,-0.13468,-0.0068739,0.13745,0.83641,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_2,1
GSE17721_CTRL_VS_POLYIC_6H_B...2,SET,174,-0.059177,-0.0057306,0.060389,0.83643,GSE17721_CTRL_VS_POLYIC_6H_BMDC_UP,1
REACTOME_NEGATIVE_REGULATION...3,SET,32,-0.15526,-0.0064729,0.15844,0.83644,REACTOME_NEGATIVE_REGULATION_OF_FGFR2_SIGNALING,1
GSE2770_TGFB_AND_IL4_VS_IL12...3,SET,183,-0.060388,-0.0059957,0.061624,0.83644,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
MIR648,SET,47,-0.12367,-0.0062457,0.12619,0.83645,MIR648,1
DESCARTES_FETAL_INTESTINE_LY...2,SET,129,-0.078419,-0.0065467,0.08002,0.83645,DESCARTES_FETAL_INTESTINE_LYMPHOID_CELLS,1
GOBP_REGULATION_OF_MODIFICAT...3,SET,12,-0.2205,-0.0056325,0.22499,0.83646,GOBP_REGULATION_OF_MODIFICATION_OF_SYNAPTIC_STRUCTURE,1
WP_MEVALONATE_ARM_OF_CHOLEST...,SET,13,-0.19253,-0.0051186,0.19644,0.83647,WP_MEVALONATE_ARM_OF_CHOLESTEROL_BIOSYNTHESIS_PATHWAY,1
HP_ABNORMAL_VISUAL_FIXATION,SET,24,-0.17073,-0.0061654,0.1742,0.83647,HP_ABNORMAL_VISUAL_FIXATION,1
GOBP_HAIR_FOLLICLE_MATURATION,SET,15,-0.22115,-0.0063153,0.22562,0.83649,GOBP_HAIR_FOLLICLE_MATURATION,1
PRC2_EED_DN.V1_DN,SET,177,-0.057897,-0.0056543,0.059065,0.83651,PRC2_EED_DN.V1_DN,1
HP_UVEITIS,SET,47,-0.12763,-0.0064461,0.1302,0.83652,HP_UVEITIS,1
GOBP_RESPONSE_TO_OZONE,SET,5,-0.42961,-0.007085,0.43821,0.83654,GOBP_RESPONSE_TO_OZONE,1
GOBP_NEGATIVE_REGULATION_OF_...513,SET,62,-0.10264,-0.0059512,0.10468,0.83656,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_BINDING,1
BIOCARTA_UCALPAIN_PATHWAY,SET,14,-0.22643,-0.0062469,0.23088,0.83663,BIOCARTA_UCALPAIN_PATHWAY,1
HP_HYPOPLASTIC_HELICES,SET,10,-0.28358,-0.006613,0.28914,0.83664,HP_HYPOPLASTIC_HELICES,1
HE_LIM_SUN_FETAL_LUNG_C4_TH1...,SET,15,-0.23307,-0.0066556,0.23764,0.83664,HE_LIM_SUN_FETAL_LUNG_C4_TH17_CELL,1
REACTOME_RHOBTB1_GTPASE_CYCLE,SET,22,-0.15595,-0.0053923,0.15897,0.8367,REACTOME_RHOBTB1_GTPASE_CYCLE,1
PID_DELTA_NP63_PATHWAY,SET,43,-0.13094,-0.0063262,0.13347,0.83671,PID_DELTA_NP63_PATHWAY,1
GOMF_L_ORNITHINE_TRANSMEMBRA...,SET,4,-0.50162,-0.0073994,0.51132,0.83671,GOMF_L_ORNITHINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...25,SET,7,-0.33287,-0.0064951,0.33926,0.83674,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_PTERIDINE_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
HP_ABNORMALITY_OF_URINE_HOME...,SET,658,-0.032874,-0.0061078,0.033504,0.83674,HP_ABNORMALITY_OF_URINE_HOMEOSTASIS,1
GOBP_REGULATION_OF_CRISTAE_F...,SET,5,-0.39312,-0.0064832,0.40045,0.83687,GOBP_REGULATION_OF_CRISTAE_FORMATION,1
MODULE_63,SET,197,-0.064517,-0.0066436,0.0657,0.83694,MODULE_63,1
MODULE_239,SET,109,-0.078508,-0.006028,0.079939,0.83697,MODULE_239,1
GOBP_RENAL_TUBULAR_SECRETION,SET,18,-0.20572,-0.0064349,0.20945,0.837,GOBP_RENAL_TUBULAR_SECRETION,1
GOBP_RESPONSE_TO_ETHANOL,SET,118,-0.080254,-0.0064098,0.081703,0.83701,GOBP_RESPONSE_TO_ETHANOL,1
REACTOME_NEURONAL_SYSTEM,SET,384,-0.045645,-0.0065285,0.046463,0.83704,REACTOME_NEURONAL_SYSTEM,1
REACTOME_ACTIVATION_OF_NOXA_...,SET,5,-0.41938,-0.0069163,0.42688,0.83705,REACTOME_ACTIVATION_OF_NOXA_AND_TRANSLOCATION_TO_MITOCHONDRIA,1
REACTOME_PI3K_AKT_ACTIVATION,SET,9,-0.29922,-0.0066198,0.30451,0.8371,REACTOME_PI3K_AKT_ACTIVATION,1
GOBP_REGULATION_OF_MICROVILL...2,SET,7,-0.26889,-0.0052466,0.27363,0.83711,GOBP_REGULATION_OF_MICROVILLUS_LENGTH,1
HP_HYPOPLASIA_OF_THE_PONS,SET,82,-0.085598,-0.0057048,0.087108,0.83711,HP_HYPOPLASIA_OF_THE_PONS,1
GOBP_CELLULAR_RESPONSE_TO_PR...2,SET,15,-0.23418,-0.0066874,0.2383,0.83712,GOBP_CELLULAR_RESPONSE_TO_PROSTAGLANDIN_E_STIMULUS,1
GOBP_ADHERENS_JUNCTION_ASSEM...,SET,13,-0.22741,-0.0060461,0.23135,0.83719,GOBP_ADHERENS_JUNCTION_ASSEMBLY,1
ROZANOV_MMP14_TARGETS_DN,SET,30,-0.16248,-0.0065591,0.16522,0.83729,ROZANOV_MMP14_TARGETS_DN,1
GSE5589_UNSTIM_VS_180MIN_LPS...2,SET,183,-0.059364,-0.0058941,0.060366,0.83729,GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP,1
HP_POSTEXERTIONAL_SYMPTOM_EX...,SET,14,-0.21929,-0.0060499,0.22298,0.8373,HP_POSTEXERTIONAL_SYMPTOM_EXACERBATION,1
HALLMARK_IL2_STAT5_SIGNALING,SET,187,-0.064549,-0.0064778,0.065634,0.8373,HALLMARK_IL2_STAT5_SIGNALING,1
MORF_NF1,SET,160,-0.064812,-0.0060208,0.065864,0.83744,MORF_NF1,1
GSE39820_CTRL_VS_TGFBETA1_IL...3,SET,180,-0.059534,-0.0058628,0.060493,0.83747,GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_DN,1
GOBP_BRANCHING_MORPHOGENESIS...2,SET,10,-0.29469,-0.006872,0.29938,0.83751,GOBP_BRANCHING_MORPHOGENESIS_OF_A_NERVE,1
GOCC_POST_MRNA_RELEASE_SPLIC...,SET,10,-0.24829,-0.00579,0.25219,0.83757,GOCC_POST_MRNA_RELEASE_SPLICEOSOMAL_COMPLEX,1
HP_HYPOGLYCEMIC_COMA,SET,20,-0.18539,-0.0061122,0.18829,0.83758,HP_HYPOGLYCEMIC_COMA,1
HP_DECREASED_SPECIFIC_ANTIBO...4,SET,29,-0.16514,-0.0065548,0.16772,0.83759,HP_DECREASED_SPECIFIC_ANTIBODY_RESPONSE_TO_VACCINATION,1
GOBP_EXTRACELLULAR_REGULATIO...,SET,12,-0.25205,-0.0064385,0.25593,0.83764,GOBP_EXTRACELLULAR_REGULATION_OF_SIGNAL_TRANSDUCTION,1
GOBP_RESPONSE_TO_FLUID_SHEAR...,SET,33,-0.15724,-0.0066568,0.15966,0.83765,GOBP_RESPONSE_TO_FLUID_SHEAR_STRESS,1
GSE17721_LPS_VS_PAM3CSK4_2H_...1,SET,179,-0.060266,-0.0059186,0.061182,0.83769,GSE17721_LPS_VS_PAM3CSK4_2H_BMDC_DN,1
GOBP_PRONEPHROS_DEVELOPMENT,SET,9,-0.27356,-0.006052,0.27765,0.83774,GOBP_PRONEPHROS_DEVELOPMENT,1
ZHANG_RESPONSE_TO_IKK_INHIBI...1,SET,96,-0.08912,-0.0064241,0.090445,0.83777,ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN,1
GOBP_INTRACELLULAR_PHOSPHATE...,SET,9,-0.32789,-0.0072541,0.33274,0.83778,GOBP_INTRACELLULAR_PHOSPHATE_ION_HOMEOSTASIS,1
MIR11400,SET,8,-0.25645,-0.0053492,0.26022,0.8378,MIR11400,1
HP_IRIDOCYCLITIS,SET,10,-0.26447,-0.0061673,0.26833,0.83783,HP_IRIDOCYCLITIS,1
GSE15659_TREG_VS_TCONV_DN,SET,150,-0.069677,-0.0062689,0.070683,0.83787,GSE15659_TREG_VS_TCONV_DN,1
GSE17721_CTRL_VS_CPG_24H_BMD...2,SET,180,-0.060365,-0.0059446,0.061225,0.83792,GSE17721_CTRL_VS_CPG_24H_BMDC_UP,1
GOBP_POSITIVE_REGULATION_OF_...127,SET,807,-0.031384,-0.0064303,0.031829,0.83793,GOBP_POSITIVE_REGULATION_OF_CELL_DIFFERENTIATION,1
HP_OLIGOMENORRHEA,SET,37,-0.12871,-0.0057694,0.1305,0.838,HP_OLIGOMENORRHEA,1
GOBP_IMP_BIOSYNTHETIC_PROCESS,SET,10,-0.26553,-0.006192,0.26919,0.83803,GOBP_IMP_BIOSYNTHETIC_PROCESS,1
HP_NEOPLASM_OF_THE_LIVER,SET,132,-0.075698,-0.0063922,0.076741,0.83803,HP_NEOPLASM_OF_THE_LIVER,1
WP_EFFECT_OF_OMEGA3_PUFA_ON_...,SET,115,-0.081286,-0.0064098,0.082396,0.83806,WP_EFFECT_OF_OMEGA3_PUFA_ON_HUNTINGTONS_DISEASE_PATHWAYS,1
GSE27786_NKTCELL_VS_MONO_MAC...2,SET,175,-0.059728,-0.0058004,0.060532,0.8381,GSE27786_NKTCELL_VS_MONO_MAC_UP,1
HP_APPENDICULAR_SPASTICITY,SET,335,-0.044667,-0.0059752,0.045266,0.83811,HP_APPENDICULAR_SPASTICITY,1
CARRILLOREIXACH_MRS3_VS_LOWE...2,SET,38,-0.12943,-0.005879,0.13115,0.83813,CARRILLOREIXACH_MRS3_VS_LOWER_RISK_HEPATOBLASTOMA_UP,1
SEMBA_FHIT_TARGETS_DN,SET,9,-0.27705,-0.0061293,0.28073,0.83814,SEMBA_FHIT_TARGETS_DN,1
MODULE_65,SET,7,-0.30118,-0.0058767,0.30517,0.83815,MODULE_65,1
GOBP_NORADRENERGIC_NEURON_DE...,SET,4,-0.49036,-0.0072333,0.49682,0.83817,GOBP_NORADRENERGIC_NEURON_DEVELOPMENT,1
REACTOME_INDUCTION_OF_CELL_C...,SET,12,-0.2543,-0.0064957,0.25764,0.83818,REACTOME_INDUCTION_OF_CELL_CELL_FUSION,1
GOBP_TUBE_MORPHOGENESIS,SET,812,-0.030841,-0.0063377,0.031246,0.83818,GOBP_TUBE_MORPHOGENESIS,1
HP_GLOBOZOOSPERMIA,SET,6,-0.3766,-0.0068034,0.38153,0.83819,HP_GLOBOZOOSPERMIA,1
GOMF_HISTONE_H3K9ME2_METHYLT...,SET,7,-0.28764,-0.0056126,0.2914,0.8382,GOMF_HISTONE_H3K9ME2_METHYLTRANSFERASE_ACTIVITY,1
GSE27786_CD8_TCELL_VS_ERYTHR...1,SET,183,-0.062838,-0.006239,0.063658,0.8382,GSE27786_CD8_TCELL_VS_ERYTHROBLAST_DN,1
GOBP_SULFUR_AMINO_ACID_TRANS...,SET,12,-0.23923,-0.0061108,0.24234,0.83821,GOBP_SULFUR_AMINO_ACID_TRANSPORT,1
GOBP_FREE_UBIQUITIN_CHAIN_PO...,SET,8,-0.3106,-0.0064788,0.31459,0.83825,GOBP_FREE_UBIQUITIN_CHAIN_POLYMERIZATION,1
GSE27786_ERYTHROBLAST_VS_NEU...1,SET,176,-0.058212,-0.0056691,0.058938,0.83834,GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN,1
REACTOME_PDH_COMPLEX_SYNTHES...,SET,4,-0.50029,-0.0073798,0.50642,0.83839,REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR,1
GOBP_MAINTENANCE_OF_PROTEIN_...6,SET,5,-0.39178,-0.0064611,0.39658,0.83839,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_MITOCHONDRION,1
GOMF_PYRUVATE_DEHYDROGENASE_...3,SET,4,-0.50029,-0.0073798,0.50642,0.83839,GOMF_PYRUVATE_DEHYDROGENASE_ACTIVITY,1
HP_CURVILINEAR_INTRACELLULAR...,SET,11,-0.2415,-0.0059063,0.24445,0.83839,HP_CURVILINEAR_INTRACELLULAR_ACCUMULATION_OF_AUTOFLUORESCENT_LIPOPIGMENT_STORAGE_MATERIAL,1
GOBP_EPITHELIAL_CILIUM_MOVEM...,SET,9,-0.25049,-0.0055416,0.25339,0.83854,GOBP_EPITHELIAL_CILIUM_MOVEMENT_INVOLVED_IN_DETERMINATION_OF_LEFT_RIGHT_ASYMMETRY,1
GOBP_TRICARBOXYLIC_ACID_TRAN...,SET,5,-0.38939,-0.0064217,0.39382,0.8386,GOBP_TRICARBOXYLIC_ACID_TRANSPORT,1
HP_ASYMMETRIC_GROWTH,SET,58,-0.11459,-0.0064273,0.1159,0.8386,HP_ASYMMETRIC_GROWTH,1
GOBP_NEGATIVE_REGULATION_OF_...656,SET,57,-0.11844,-0.0065854,0.11975,0.83868,GOBP_NEGATIVE_REGULATION_OF_TRANSPORTER_ACTIVITY,1
GOBP_MUCOSA_ASSOCIATED_LYMPH...,SET,8,-0.31999,-0.0066746,0.32342,0.83875,GOBP_MUCOSA_ASSOCIATED_LYMPHOID_TISSUE_DEVELOPMENT,1
MIR19B_3P,SET,594,-0.035863,-0.0063422,0.036245,0.83877,MIR19B_3P,1
HP_ABNORMAL_FETAL_SKIN_MORPH...,SET,14,-0.212,-0.0058488,0.21426,0.83877,HP_ABNORMAL_FETAL_SKIN_MORPHOLOGY,1
GSE37301_HEMATOPOIETIC_STEM_...14,SET,155,-0.067647,-0.0061861,0.068369,0.83877,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_RAG2_KO_NK_CELL_UP,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...8,SET,182,-0.060711,-0.0060114,0.061349,0.83881,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_6H_UP,1
GSE557_WT_VS_CIITA_KO_DC_UP,SET,182,-0.057204,-0.0056643,0.057803,0.83882,GSE557_WT_VS_CIITA_KO_DC_UP,1
ERWIN_COHEN_BLOOD_VACCINE_TC...4,SET,71,-0.1028,-0.0063768,0.10386,0.83884,ERWIN_COHEN_BLOOD_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_7DY_UP,1
GSE32901_TH17_EMRICHED_VS_TH...1,SET,158,-0.064525,-0.0059569,0.06519,0.83886,GSE32901_TH17_EMRICHED_VS_TH17_NEG_CD4_TCELL_DN,1
BIOCARTA_ALK_PATHWAY,SET,34,-0.14888,-0.0063976,0.1504,0.83888,BIOCARTA_ALK_PATHWAY,1
GOMF_C4_DICARBOXYLATE_TRANSM...,SET,15,-0.21196,-0.006053,0.2141,0.83891,GOMF_C4_DICARBOXYLATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ASPIRATION,SET,26,-0.16207,-0.0060913,0.16364,0.839,HP_ASPIRATION,1
ADA2_TARGET_GENES,SET,755,-0.030973,-0.0061473,0.031272,0.83901,ADA2_TARGET_GENES,1
MORF_RAB11A,SET,51,-0.10179,-0.0053544,0.10277,0.83901,MORF_RAB11A,1
MIR16_5P,SET,532,-0.035966,-0.0060298,0.036306,0.83906,MIR16_5P,1
GOBP_NADP_METABOLIC_PROCESS,SET,40,-0.13452,-0.0062689,0.13578,0.83908,GOBP_NADP_METABOLIC_PROCESS,1
GOBP_REGULATION_OF_CHONDROCY...1,SET,4,-0.51651,-0.0076191,0.52134,0.83909,GOBP_REGULATION_OF_CHONDROCYTE_DEVELOPMENT,1
HP_REMNANTS_OF_THE_HYALOID_V...,SET,9,-0.26288,-0.0058158,0.2653,0.83912,HP_REMNANTS_OF_THE_HYALOID_VASCULAR_SYSTEM,1
HP_EEG_WITH_PARIETAL_EPILEPT...,SET,4,-0.52927,-0.0078073,0.53408,0.83915,HP_EEG_WITH_PARIETAL_EPILEPTIFORM_DISCHARGES,1
GSE360_T_GONDII_VS_B_MALAYI_...2,SET,176,-0.065014,-0.0063316,0.065603,0.83916,GSE360_T_GONDII_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
HP_ABNORMALITY_OF_THE_EXTRAO...,SET,11,-0.21744,-0.005318,0.21938,0.83919,HP_ABNORMALITY_OF_THE_EXTRAOCULAR_MUSCLES,1
MIR5579_5P,SET,71,-0.098294,-0.0060975,0.099167,0.8392,MIR5579_5P,1
IVANOVA_HEMATOPOIESIS_MATURE...,SET,259,-0.051881,-0.0061153,0.052339,0.83921,IVANOVA_HEMATOPOIESIS_MATURE_CELL,1
REACTOME_NFE2L2_REGULATING_I...,SET,5,-0.39491,-0.0065127,0.3984,0.83921,REACTOME_NFE2L2_REGULATING_INFLAMMATION_ASSOCIATED_GENES,1
TERF2_TARGET_GENES,SET,97,-0.084053,-0.0060902,0.084791,0.83922,TERF2_TARGET_GENES,1
DESCARTES_MAIN_FETAL_ENS_GLIA,SET,11,-0.25314,-0.0061912,0.25536,0.83923,DESCARTES_MAIN_FETAL_ENS_GLIA,1
HE_LIM_SUN_FETAL_LUNG_C3_MID...,SET,50,-0.12977,-0.0067594,0.1309,0.83924,HE_LIM_SUN_FETAL_LUNG_C3_MID_CAP_CELL,1
MIR7162_5P,SET,162,-0.065787,-0.0061492,0.066357,0.83925,MIR7162_5P,1
MORF_PPP2R5E,SET,72,-0.087787,-0.0054838,0.088547,0.83925,MORF_PPP2R5E,1
HP_ECTOPIC_THYROID,SET,5,-0.43307,-0.007142,0.43673,0.8393,HP_ECTOPIC_THYROID,1
GOMF_ALPHA_KETOGLUTARATE_TRA...,SET,6,-0.32962,-0.0059546,0.33236,0.83933,GOMF_ALPHA_KETOGLUTARATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GATTGGY_NFY_Q6_01,SET,1023,-0.02711,-0.0062153,0.027331,0.83937,GATTGGY_NFY_Q6_01,1
GSE360_CTRL_VS_B_MALAYI_HIGH...2,SET,173,-0.061451,-0.0059339,0.061952,0.83937,GSE360_CTRL_VS_B_MALAYI_HIGH_DOSE_DC_UP,1
GOBP_KIDNEY_MORPHOGENESIS,SET,92,-0.09645,-0.0068069,0.097233,0.83938,GOBP_KIDNEY_MORPHOGENESIS,1
HP_SPASTICITY,SET,777,-0.029437,-0.0059232,0.029673,0.8394,HP_SPASTICITY,1
HP_ABNORMAL_INTERNAL_CAROTID...,SET,10,-0.29018,-0.0067668,0.29248,0.83942,HP_ABNORMAL_INTERNAL_CAROTID_ARTERY_MORPHOLOGY,1
GSE21670_STAT3_KO_VS_WT_CD4_...2,SET,175,-0.066561,-0.006464,0.067085,0.83944,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_IL6_TREATED_DN,1
GSE22611_NOD2_TRANSD_VS_CTRL...4,SET,173,-0.061023,-0.0058925,0.061502,0.83944,GSE22611_NOD2_TRANSD_VS_CTRL_TRANSD_HEK293_MDP_STIM_6H_UP,1
LI_PBMC_MENOMUNE_A_C_Y_W_135...3,SET,19,-0.20914,-0.006721,0.21077,0.83946,LI_PBMC_MENOMUNE_A_C_Y_W_135_AGE_18_45YO_CORRELATED_WITH_ANTIBODY_RESPONSE_3DY_NEGATIVE,1
GAVISH_3CA_METAPROGRAM_FIBRO...11,SET,44,-0.12742,-0.0062271,0.1284,0.83949,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CELL_CYCLE,1
GSE36078_UNTREATED_VS_AD5_IN...3,SET,175,-0.06227,-0.0060473,0.062744,0.8395,GSE36078_UNTREATED_VS_AD5_INF_MOUSE_LUNG_DC_DN,1
GOMF_TRNA_SPECIFIC_ADENOSINE...,SET,8,-0.30294,-0.0063191,0.30522,0.83953,GOMF_TRNA_SPECIFIC_ADENOSINE_DEAMINASE_ACTIVITY,1
HP_EPENDYMOMA,SET,19,-0.19053,-0.0061229,0.19189,0.83962,HP_EPENDYMOMA,1
REACTOME_PHOSPHORYLATION_OF_...2,SET,19,-0.16586,-0.0053301,0.16703,0.83964,REACTOME_PHOSPHORYLATION_OF_THE_APC_C,1
TAXCREB_02,SET,25,-0.16921,-0.0062363,0.17038,0.83967,TAXCREB_02,1
TOMLINS_PROSTATE_CANCER_UP,SET,36,-0.13599,-0.0060128,0.1369,0.83972,TOMLINS_PROSTATE_CANCER_UP,1
HP_11_PAIRS_OF_RIBS,SET,44,-0.12369,-0.0060447,0.1245,0.83975,HP_11_PAIRS_OF_RIBS,1
GOBP_CORTICOSTERONE_SECRETION,SET,5,-0.40692,-0.0067108,0.40955,0.83978,GOBP_CORTICOSTERONE_SECRETION,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...1,SET,5,-0.45013,-0.0074234,0.45301,0.83979,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TAT_TO_TNF_JNK_SIGNALING_PATHWAY,1
HP_ABNORMAL_GALLBLADDER_PHYS...,SET,18,-0.19324,-0.0060444,0.19447,0.8398,HP_ABNORMAL_GALLBLADDER_PHYSIOLOGY,1
GOMF_PROTEIN_SERINE_THREONIN...7,SET,42,-0.13018,-0.0062161,0.131,0.83982,GOMF_PROTEIN_SERINE_THREONINE_TYROSINE_KINASE_ACTIVITY,1
GSE13485_DAY1_VS_DAY3_YF17D_...2,SET,141,-0.074489,-0.0064993,0.074952,0.83984,GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_UP,1
GSE22886_NAIVE_CD4_TCELL_VS_...12,SET,171,-0.064273,-0.0061708,0.064672,0.83984,GSE22886_NAIVE_CD4_TCELL_VS_MEMORY_TCELL_UP,1
GSE25087_TREG_VS_TCONV_ADULT...2,SET,174,-0.065993,-0.0063906,0.066403,0.83984,GSE25087_TREG_VS_TCONV_ADULT_UP,1
GOBP_RHYTHMIC_BEHAVIOR,SET,46,-0.13315,-0.006653,0.13397,0.83985,GOBP_RHYTHMIC_BEHAVIOR,1
KEGG_MEDICUS_REFERENCE_STERO...,SET,5,-0.39672,-0.0065425,0.39914,0.83986,KEGG_MEDICUS_REFERENCE_STEROID_HORMONE_BIOSYNTHESIS_PROGESTERONE_TO_CORTISOL_CORTISONE,1
LE_SKI_TARGETS_DN,SET,6,-0.42491,-0.0076761,0.42743,0.83991,LE_SKI_TARGETS_DN,1
MIR10395_3P,SET,130,-0.071969,-0.0060313,0.072388,0.83993,MIR10395_3P,1
WANG_BARRETTS_ESOPHAGUS_UP,SET,50,-0.12808,-0.0066716,0.12882,0.83995,WANG_BARRETTS_ESOPHAGUS_UP,1
REACTOME_REGULATION_OF_MECP2...,SET,29,-0.16039,-0.0063662,0.16131,0.83996,REACTOME_REGULATION_OF_MECP2_EXPRESSION_AND_ACTIVITY,1
GOCC_FICOLIN_1_RICH_GRANULE_...2,SET,52,-0.11861,-0.0063001,0.11929,0.83996,GOCC_FICOLIN_1_RICH_GRANULE_MEMBRANE,1
MIR6855_5P,SET,61,-0.10588,-0.0060896,0.10647,0.83999,MIR6855_5P,1
SUMO1_TARGET_GENES,SET,804,-0.030058,-0.0061477,0.030223,0.84002,SUMO1_TARGET_GENES,1
GSE18281_SUBCAPSULAR_VS_PERI...2,SET,182,-0.061766,-0.006116,0.062104,0.84002,GSE18281_SUBCAPSULAR_VS_PERIMEDULLARY_CORTICAL_REGION_OF_THYMUS_UP,1
REACTOME_PI_3K_CASCADE_FGFR4,SET,19,-0.20089,-0.0064557,0.20195,0.84006,REACTOME_PI_3K_CASCADE_FGFR4,1
HP_ABNORMAL_FETAL_MORPHOLOGY,SET,265,-0.051346,-0.0061209,0.051613,0.84008,HP_ABNORMAL_FETAL_MORPHOLOGY,1
HP_INCREASED_B_CELL_COUNT,SET,11,-0.2762,-0.006755,0.27761,0.8401,HP_INCREASED_B_CELL_COUNT,1
chr3q11,SET,20,-0.32249,-0.010633,0.32402,0.8402,chr3q11,1
GOBP_REGULATION_OF_NEURON_MI...,SET,43,-0.13721,-0.0066292,0.13786,0.84021,GOBP_REGULATION_OF_NEURON_MIGRATION,1
MIR6811_3P,SET,55,-0.11762,-0.0064244,0.11814,0.84025,MIR6811_3P,1
GOBP_SYNAPTIC_SIGNALING_VIA_...,SET,6,-0.4148,-0.0074934,0.41661,0.84029,GOBP_SYNAPTIC_SIGNALING_VIA_NEUROPEPTIDE,1
HP_ABNORMAL_BRAINSTEM_MORPHO...,SET,249,-0.051007,-0.0058966,0.051208,0.84038,HP_ABNORMAL_BRAINSTEM_MORPHOLOGY,1
GSE24574_BCL6_HIGH_TFH_VS_NA...1,SET,187,-0.05938,-0.0059591,0.059611,0.8404,GSE24574_BCL6_HIGH_TFH_VS_NAIVE_CD4_TCELL_DN,1
GSE17186_MEMORY_VS_NAIVE_BCE...1,SET,183,-0.061952,-0.0061511,0.062191,0.84041,GSE17186_MEMORY_VS_NAIVE_BCELL_DN,1
GSE15930_NAIVE_VS_72H_IN_VIT...6,SET,185,-0.058688,-0.0058584,0.058911,0.84042,GSE15930_NAIVE_VS_72H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
GSE17721_4_VS_24H_CPG_BMDC_DN,SET,176,-0.060437,-0.0058858,0.060665,0.84042,GSE17721_4_VS_24H_CPG_BMDC_DN,1
REACTOME_ECM_PROTEOGLYCANS,SET,73,-0.10587,-0.0066593,0.10627,0.84043,REACTOME_ECM_PROTEOGLYCANS,1
HP_DECREASED_CIRCULATING_GON...,SET,37,-0.1419,-0.0063606,0.14241,0.84047,HP_DECREASED_CIRCULATING_GONADOTROPIN_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...415,SET,9,-0.28603,-0.006328,0.28699,0.84053,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_ADAPTATION,1
GOBP_POSITIVE_REGULATION_OF_...237,SET,16,-0.21432,-0.0063209,0.21503,0.84054,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_APOPTOTIC_PROCESS,1
GUO_HEX_TARGETS_DN,SET,60,-0.1046,-0.0059669,0.10491,0.84062,GUO_HEX_TARGETS_DN,1
KENNY_CTNNB1_TARGETS_DN,SET,49,-0.11736,-0.0060517,0.1177,0.84063,KENNY_CTNNB1_TARGETS_DN,1
GOBP_CELL_CELL_JUNCTION_ORGA...,SET,199,-0.063482,-0.0065698,0.063662,0.84065,GOBP_CELL_CELL_JUNCTION_ORGANIZATION,1
TCATCTC_MIR143,SET,131,-0.071911,-0.0060495,0.072107,0.84068,TCATCTC_MIR143,1
GOBP_TELOMERE_CAPPING,SET,37,-0.12781,-0.0057287,0.12816,0.84068,GOBP_TELOMERE_CAPPING,1
GSE25677_MPL_VS_MPL_AND_R848...2,SET,141,-0.069359,-0.0060517,0.069545,0.84069,GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP,1
REACTOME_CYTOSOLIC_IRON_SULF...,SET,10,-0.24006,-0.005598,0.24069,0.8407,REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY,1
MIR548P,SET,541,-0.036897,-0.0062365,0.036992,0.84072,MIR548P,1
GOBP_REGULATION_OF_LIPID_CAT...,SET,59,-0.11471,-0.0064888,0.11498,0.84076,GOBP_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
HP_POIKILODERMA,SET,23,-0.1515,-0.005356,0.15186,0.84077,HP_POIKILODERMA,1
GSE3039_ALPHAALPHA_VS_ALPHAB...2,SET,179,-0.062647,-0.0061523,0.062792,0.84078,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_UP,1
HP_BIRTH_LENGTH_LESS_THAN_3R...,SET,13,-0.20389,-0.0054207,0.20432,0.84083,HP_BIRTH_LENGTH_LESS_THAN_3RD_PERCENTILE,1
WP_ARYL_HYDROCARBON_RECEPTOR...1,SET,46,-0.12506,-0.0062489,0.12528,0.84092,WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2586,1
GAVISH_3CA_METAPROGRAM_FIBRO...9,SET,48,-0.13213,-0.0067437,0.13234,0.84096,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_8,1
GAVIN_FOXP3_TARGETS_CLUSTER_...3,SET,92,-0.093771,-0.0066178,0.093912,0.84098,GAVIN_FOXP3_TARGETS_CLUSTER_P4,1
KEGG_MEDICUS_VARIANT_MUTATIO...20,SET,8,-0.2975,-0.0062056,0.29791,0.841,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_MITOCHONDRIAL_TRNA_PROC...,SET,12,-0.20695,-0.0052863,0.20723,0.841,GOBP_MITOCHONDRIAL_TRNA_PROCESSING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...14,SET,10,-0.2377,-0.0055431,0.23803,0.841,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_HEME_PROTEIN_AS_ACCEPTOR,1
GOCC_PROTEIN_COMPLEX_INVOLVE...3,SET,17,-0.21001,-0.0063842,0.21029,0.84102,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_MATRIX_ADHESION,1
GSE22886_NAIVE_TCELL_VS_MONO...1,SET,189,-0.064411,-0.0064981,0.064472,0.84111,GSE22886_NAIVE_TCELL_VS_MONOCYTE_DN,1
GSE32986_CURDLAN_LOWDOSE_VS_...2,SET,175,-0.062952,-0.0061135,0.063,0.84115,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_UP,1
HP_MACROTIA,SET,219,-0.05598,-0.0060742,0.056019,0.84117,HP_MACROTIA,1
MIR222_5P,SET,174,-0.063306,-0.0061305,0.063344,0.84119,MIR222_5P,1
HP_PERSISTENT_PUPILLARY_MEMB...,SET,9,-0.30932,-0.0068433,0.30948,0.84121,HP_PERSISTENT_PUPILLARY_MEMBRANE,1
GOBP_FEMALE_GENITALIA_DEVELO...,SET,19,-0.20907,-0.0067188,0.20917,0.84123,GOBP_FEMALE_GENITALIA_DEVELOPMENT,1
KEGG_MEDICUS_REFERENCE_TLR7_...1,SET,16,-0.26265,-0.0077463,0.26276,0.84124,KEGG_MEDICUS_REFERENCE_TLR7_8_9_IRF5_SIGNALING_PATHWAY,1
GOCC_PROTEIN_COMPLEX_INVOLVE...1,SET,55,-0.11825,-0.0064589,0.11829,0.84126,GOCC_PROTEIN_COMPLEX_INVOLVED_IN_CELL_ADHESION,1
REACTOME_ADP_SIGNALLING_THRO...1,SET,25,-0.18067,-0.0066587,0.1807,0.8413,REACTOME_ADP_SIGNALLING_THROUGH_P2Y_PURINOCEPTOR_1,1
HP_LACK_OF_INSIGHT,SET,10,-0.23549,-0.0054915,0.23552,0.8413,HP_LACK_OF_INSIGHT,1
HAY_BONE_MARROW_CD34_POS_EO_...,SET,15,-0.23485,-0.0067066,0.23487,0.84132,HAY_BONE_MARROW_CD34_POS_EO_B_MAST,1
GSE36009_UNSTIM_VS_LPS_STIM_...1,SET,181,-0.060167,-0.0059414,0.060168,0.84134,GSE36009_UNSTIM_VS_LPS_STIM_DC_DN,1
GSE5589_LPS_VS_LPS_AND_IL10_...1,SET,176,-0.063666,-0.0062003,0.063663,0.84135,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_180MIN_DN,1
GOBP_NEGATIVE_REGULATION_OF_...549,SET,9,-0.27258,-0.0060304,0.27256,0.84136,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_BINDING,1
SANSOM_APC_TARGETS_DN,SET,333,-0.047192,-0.0062945,0.047184,0.84138,SANSOM_APC_TARGETS_DN,1
GOCC_SPINDLE,SET,386,-0.041258,-0.005916,0.041248,0.84139,GOCC_SPINDLE,1
VERNOCHET_ADIPOGENESIS,SET,18,-0.23052,-0.0072104,0.23042,0.84143,VERNOCHET_ADIPOGENESIS,1
GOMF_CARBOXYLIC_ESTER_HYDROL...,SET,138,-0.073059,-0.0063069,0.073016,0.84148,GOMF_CARBOXYLIC_ESTER_HYDROLASE_ACTIVITY,1
chr4q34,SET,19,-0.32953,-0.01059,0.32927,0.84153,chr4q34,1
DURANTE_ADULT_OLFACTORY_NEUR...6,SET,71,-0.10832,-0.0067194,0.10822,0.84155,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_FIBROBLASTS_STROMAL_CELLS,1
REACTOME_RESPONSE_TO_METAL_I...,SET,14,-0.2888,-0.0079676,0.28853,0.84156,REACTOME_RESPONSE_TO_METAL_IONS,1
chr6p22,SET,103,-0.13619,-0.010167,0.13605,0.84159,chr6p22,1
LUI_TARGETS_OF_PAX8_PPARG_FU...,SET,32,-0.14395,-0.0060015,0.14379,0.84161,LUI_TARGETS_OF_PAX8_PPARG_FUSION,1
HP_LANGUAGE_IMPAIRMENT,SET,988,-0.027143,-0.0061219,0.02711,0.84163,HP_LANGUAGE_IMPAIRMENT,1
MIR5585_3P,SET,77,-0.097171,-0.0062764,0.09705,0.84164,MIR5585_3P,1
IIZUKA_LIVER_CANCER_PROGRESS...1,SET,23,-0.15831,-0.0055966,0.1581,0.84165,IIZUKA_LIVER_CANCER_PROGRESSION_G1_G2_DN,1
GOMF_VINCULIN_BINDING,SET,11,-0.26391,-0.0064544,0.26354,0.84167,GOMF_VINCULIN_BINDING,1
HP_PANCREATIC_ENDOCRINE_TUMOR,SET,13,-0.25318,-0.0067311,0.25281,0.8417,HP_PANCREATIC_ENDOCRINE_TUMOR,1
GOBP_HEMOSTASIS,SET,221,-0.061168,-0.0066671,0.061075,0.84171,GOBP_HEMOSTASIS,1
GOBP_POSITIVE_REGULATION_OF_...291,SET,9,-0.30668,-0.0067848,0.30618,0.84173,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_ACTIVATION,1
REACTOME_ACETYLCHOLINE_REGUL...,SET,10,-0.2943,-0.006863,0.29378,0.84176,REACTOME_ACETYLCHOLINE_REGULATES_INSULIN_SECRETION,1
GOCC_INCLUSION_BODY,SET,66,-0.097807,-0.0058506,0.097637,0.84176,GOCC_INCLUSION_BODY,1
REACTOME_ACYL_CHAIN_REMODELL...3,SET,18,-0.213,-0.0066627,0.21259,0.84181,REACTOME_ACYL_CHAIN_REMODELLING_OF_PG,1
MIR4645_3P,SET,102,-0.081825,-0.0060788,0.081643,0.84188,MIR4645_3P,1
GSE11961_MEMORY_BCELL_DAY7_V...4,SET,179,-0.062819,-0.0061693,0.062675,0.84189,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_UP,1
GSE5142_CTRL_VS_HTERT_TRANSD...2,SET,188,-0.06185,-0.0062233,0.061707,0.84189,GSE5142_CTRL_VS_HTERT_TRANSDUCED_CD8_TCELL_EARLY_PASSAGE_CLONE_UP,1
BOSCO_ALLERGEN_INDUCED_TH2_A...,SET,133,-0.078763,-0.0066759,0.078553,0.84198,BOSCO_ALLERGEN_INDUCED_TH2_ASSOCIATED_MODULE,1
GOMF_RETINYL_PALMITATE_ESTER...,SET,6,-0.39178,-0.0070775,0.3907,0.842,GOMF_RETINYL_PALMITATE_ESTERASE_ACTIVITY,1
GOBP_NADPH_REGENERATION,SET,21,-0.18825,-0.0063596,0.18771,0.84202,GOBP_NADPH_REGENERATION,1
GOBP_POSITIVE_REGULATION_OF_...345,SET,6,-0.37299,-0.0067381,0.37192,0.84203,GOBP_POSITIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
GAVISH_3CA_METAPROGRAM_EPITH...10,SET,48,-0.13921,-0.0071051,0.13881,0.84204,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN,1
GOBP_REGULATION_OF_OXIDATIVE...2,SET,37,-0.12955,-0.005807,0.12914,0.84212,GOBP_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_ENDOSOMAL_LUMEN_ACIDIFI...,SET,11,-0.24448,-0.0059792,0.24362,0.84218,GOBP_ENDOSOMAL_LUMEN_ACIDIFICATION,1
GOBP_INTESTINAL_EPITHELIAL_C...2,SET,26,-0.17783,-0.0066836,0.17717,0.84223,GOBP_INTESTINAL_EPITHELIAL_CELL_DIFFERENTIATION,1
REACTOME_UPTAKE_AND_FUNCTION...1,SET,11,-0.28459,-0.0069602,0.28341,0.84234,REACTOME_UPTAKE_AND_FUNCTION_OF_ANTHRAX_TOXINS,1
MIR6768_3P,SET,127,-0.076136,-0.0063071,0.075816,0.84236,MIR6768_3P,1
HP_ANNULAR_PANCREAS,SET,25,-0.18129,-0.0066817,0.18044,0.84247,HP_ANNULAR_PANCREAS,1
GOBP_ORGANIC_HYDROXY_COMPOUN...1,SET,225,-0.058016,-0.0063797,0.05774,0.84249,GOBP_ORGANIC_HYDROXY_COMPOUND_BIOSYNTHETIC_PROCESS,1
MODULE_170,SET,89,-0.093939,-0.0065212,0.093476,0.84253,MODULE_170,1
GOBP_HAIR_FOLLICLE_PLACODE_F...,SET,4,-0.46279,-0.0068267,0.46045,0.84257,GOBP_HAIR_FOLLICLE_PLACODE_FORMATION,1
MURARO_PANCREAS_EPSILON_CELL,SET,42,-0.14106,-0.0067354,0.1403,0.84265,MURARO_PANCREAS_EPSILON_CELL,1
GOBP_ISOLEUCINE_METABOLIC_PR...,SET,6,-0.36005,-0.0065043,0.35807,0.84267,GOBP_ISOLEUCINE_METABOLIC_PROCESS,1
DPPA3_TARGET_GENES,SET,16,-0.1942,-0.0057273,0.19312,0.84268,DPPA3_TARGET_GENES,1
GOMF_OXIDOREDUCTASE_ACTIVITY...23,SET,42,-0.147,-0.0070191,0.14616,0.84272,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_REDUCED_FLAVIN_OR_FLAVOPROTEIN_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
GOBP_INTESTINAL_LIPID_ABSORP...,SET,21,-0.19499,-0.0065874,0.19387,0.84274,GOBP_INTESTINAL_LIPID_ABSORPTION,1
MODULE_330,SET,27,-0.17246,-0.0066054,0.17146,0.84275,MODULE_330,1
HP_MOTOR_DETERIORATION,SET,27,-0.15539,-0.0059514,0.15449,0.84275,HP_MOTOR_DETERIORATION,1
GOBP_METANEPHRIC_TUBULE_DEVE...,SET,23,-0.19879,-0.0070278,0.19759,0.8428,GOBP_METANEPHRIC_TUBULE_DEVELOPMENT,1
OHGUCHI_LIVER_HNF4A_TARGETS_...1,SET,154,-0.071808,-0.0065455,0.071364,0.84284,OHGUCHI_LIVER_HNF4A_TARGETS_DN,1
GOBP_INNERVATION,SET,26,-0.18525,-0.0069626,0.1841,0.84284,GOBP_INNERVATION,1
GOBP_REGULATION_OF_DNA_METHY...,SET,14,-0.21354,-0.0058914,0.2122,0.84286,GOBP_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
GSE2706_LPS_VS_R848_AND_LPS_...1,SET,128,-0.076943,-0.0063987,0.076457,0.84287,GSE2706_LPS_VS_R848_AND_LPS_2H_STIM_DC_DN,1
GOBP_ASYMMETRIC_CELL_DIVISION,SET,18,-0.22134,-0.0069235,0.21993,0.84289,GOBP_ASYMMETRIC_CELL_DIVISION,1
GSE21033_CTRL_VS_POLYIC_STIM...2,SET,144,-0.070956,-0.0062561,0.070501,0.84289,GSE21033_CTRL_VS_POLYIC_STIM_DC_12H_UP,1
HP_IRREGULAR_CAPITAL_FEMORAL...,SET,4,-0.38251,-0.0056424,0.38,0.84293,HP_IRREGULAR_CAPITAL_FEMORAL_EPIPHYSIS,1
GOCC_MICROVILLUS,SET,94,-0.086768,-0.0061894,0.086177,0.84299,GOCC_MICROVILLUS,1
HP_HYPOTHALAMIC_HYPOTHYROIDI...,SET,12,-0.23993,-0.0061288,0.23822,0.84307,HP_HYPOTHALAMIC_HYPOTHYROIDISM,1
HP_CHIN_WITH_H_SHAPED_CREASE,SET,4,-0.52248,-0.007707,0.51871,0.84309,HP_CHIN_WITH_H_SHAPED_CREASE,1
SHETH_LIVER_CANCER_VS_TXNIP_...3,SET,69,-0.10351,-0.0063302,0.10275,0.84312,SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM3,1
GSE26488_HDAC7_KO_VS_VP16_TR...1,SET,187,-0.062604,-0.0062826,0.062146,0.84312,GSE26488_HDAC7_KO_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,1
HP_NEONATAL_HYPERBILIRUBINEM...,SET,22,-0.18808,-0.0065034,0.18667,0.84316,HP_NEONATAL_HYPERBILIRUBINEMIA,1
ESC_J1_UP_LATE.V1_UP,SET,163,-0.070029,-0.0065656,0.069497,0.84318,ESC_J1_UP_LATE.V1_UP,1
REACTOME_SHC_MEDIATED_CASCAD...1,SET,21,-0.18999,-0.0064184,0.18853,0.8432,REACTOME_SHC_MEDIATED_CASCADE_FGFR1,1
GOBP_MATURATION_OF_LSU_RRNA,SET,23,-0.15205,-0.0053755,0.15088,0.84322,GOBP_MATURATION_OF_LSU_RRNA,1
REACTOME_CREB1_PHOSPHORYLATI...3,SET,8,-0.33732,-0.0070362,0.33466,0.84325,REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_CAMKII_CAMKK_CAMKIV_CASCASDE,1
REACTOME_ABERRANT_REGULATION...1,SET,19,-0.18155,-0.0058342,0.1801,0.84327,REACTOME_ABERRANT_REGULATION_OF_MITOTIC_EXIT_IN_CANCER_DUE_TO_RB1_DEFECTS,1
GOBP_METENCEPHALON_DEVELOPME...,SET,101,-0.08641,-0.006388,0.085721,0.84327,GOBP_METENCEPHALON_DEVELOPMENT,1
PARENT_MTOR_SIGNALING_UP,SET,504,-0.036502,-0.0059611,0.036205,0.84331,PARENT_MTOR_SIGNALING_UP,1
GOBP_SYMPATHETIC_NERVOUS_SYS...,SET,21,-0.20794,-0.0070249,0.20625,0.84332,GOBP_SYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,1
GOMF_PROTEIN_LIPID_COMPLEX_B...,SET,28,-0.17723,-0.0069123,0.17575,0.84336,GOMF_PROTEIN_LIPID_COMPLEX_BINDING,1
GAUTAM_EYE_CHOROID_SCLERA_ME...,SET,136,-0.070162,-0.0060131,0.069577,0.84336,GAUTAM_EYE_CHOROID_SCLERA_MELANOCYTES,1
GOBP_REGULATION_OF_LIPOPHAGY,SET,5,-0.40051,-0.0066052,0.39714,0.84338,GOBP_REGULATION_OF_LIPOPHAGY,1
GSE411_WT_VS_SOCS3_KO_MACROP...2,SET,183,-0.058421,-0.0058004,0.057928,0.84339,GSE411_WT_VS_SOCS3_KO_MACROPHAGE_IL6_STIM_100MIN_DN,1
KEGG_MEDICUS_REFERENCE_HEDGE...1,SET,14,-0.21425,-0.005911,0.21239,0.84345,KEGG_MEDICUS_REFERENCE_HEDGEHOG_SIGNALING_PATHWAY,1
GSE9988_ANTI_TREM1_AND_LPS_V...3,SET,187,-0.061382,-0.00616,0.060845,0.84346,GSE9988_ANTI_TREM1_AND_LPS_VS_VEHICLE_TREATED_MONOCYTES_DN,1
GOBP_ENDODERM_FORMATION,SET,56,-0.12086,-0.0066612,0.11978,0.84352,GOBP_ENDODERM_FORMATION,1
REACTOME_POST_TRANSLATIONAL_...1,SET,87,-0.092892,-0.006376,0.092052,0.84354,REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS,1
LI_LUNG_CANCER,SET,40,-0.12869,-0.0059973,0.12752,0.84356,LI_LUNG_CANCER,1
GOMF_RNA_POLYMERASE_I_TRANSC...,SET,9,-0.2611,-0.0057764,0.25871,0.84356,GOMF_RNA_POLYMERASE_I_TRANSCRIPTION_REGULATORY_REGION_SEQUENCE_SPECIFIC_DNA_BINDING,1
GOBP_REGULATION_OF_SKELETAL_...8,SET,10,-0.32014,-0.0074655,0.3172,0.84357,GOBP_REGULATION_OF_SKELETAL_MUSCLE_FIBER_DEVELOPMENT,1
GOBP_SPHINGOLIPID_METABOLIC_...,SET,158,-0.071542,-0.0066047,0.070872,0.84362,GOBP_SPHINGOLIPID_METABOLIC_PROCESS,1
GSE7460_CTRL_VS_FOXP3_OVEREX...1,SET,184,-0.063171,-0.006289,0.062573,0.84364,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_1_DN,1
GOBP_DNA_TOPOLOGICAL_CHANGE,SET,9,-0.23396,-0.005176,0.23168,0.84371,GOBP_DNA_TOPOLOGICAL_CHANGE,1
HP_BICORNUATE_UTERUS,SET,48,-0.11955,-0.0061017,0.11832,0.84384,HP_BICORNUATE_UTERUS,1
GSE16385_ROSIGLITAZONE_IL4_V...5,SET,182,-0.061948,-0.006134,0.06131,0.84384,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_DN,1
MIR1226_5P,SET,40,-0.13645,-0.0063587,0.13503,0.84386,MIR1226_5P,1
REACTOME_NEGATIVE_REGULATION...12,SET,15,-0.24059,-0.0068704,0.238,0.84395,REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_WNT_LIGAND_ANTAGONISTS,1
GSE17721_PAM3CSK4_VS_CPG_2H_...1,SET,181,-0.06157,-0.00608,0.060895,0.84401,GSE17721_PAM3CSK4_VS_CPG_2H_BMDC_DN,1
YBX3_TARGET_GENES,SET,52,-0.1162,-0.0061719,0.11491,0.84404,YBX3_TARGET_GENES,1
HP_GASTROINTESTINAL_ARTERIOV...,SET,4,-0.51516,-0.0075992,0.50944,0.84404,HP_GASTROINTESTINAL_ARTERIOVENOUS_MALFORMATION,1
HP_APLASIA_HYPOPLASIA_INVOLV...17,SET,62,-0.10737,-0.0062257,0.10617,0.84406,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_VERTEBRAL_COLUMN,1
GSE41867_NAIVE_VS_DAY8_LCMV_...5,SET,179,-0.061231,-0.0060132,0.060544,0.84406,GSE41867_NAIVE_VS_DAY8_LCMV_EFFECTOR_CD8_TCELL_DN,1
GOBP_CATECHOLAMINE_UPTAKE_IN...,SET,11,-0.2634,-0.0064419,0.26038,0.84413,GOBP_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
EVI1_04,SET,198,-0.065545,-0.0067664,0.064787,0.84415,EVI1_04,1
HE_LIM_SUN_FETAL_LUNG_C4_CD8...,SET,46,-0.13321,-0.0066558,0.13165,0.84418,HE_LIM_SUN_FETAL_LUNG_C4_CD8_T_CELL,1
GOBP_TRNA_THREONYLCARBAMOYLA...2,SET,4,-0.33435,-0.004932,0.33042,0.8442,GOBP_TRNA_THREONYLCARBAMOYLADENOSINE_MODIFICATION,1
GTATTAT_MIR3693P,SET,192,-0.065425,-0.006652,0.064645,0.84424,GTATTAT_MIR3693P,1
GOBP_REGULATION_OF_BLOOD_VOL...,SET,5,-0.44791,-0.0073868,0.44255,0.84425,GOBP_REGULATION_OF_BLOOD_VOLUME_BY_RENIN_ANGIOTENSIN,1
GSE10325_BCELL_VS_MYELOID_DN,SET,182,-0.063955,-0.0063327,0.063182,0.84428,GSE10325_BCELL_VS_MYELOID_DN,1
GOMF_OXO_ACID_LYASE_ACTIVITY,SET,7,-0.32971,-0.0064334,0.32568,0.84432,GOMF_OXO_ACID_LYASE_ACTIVITY,1
GOBP_PRIMARY_ALCOHOL_CATABOL...,SET,13,-0.26856,-0.0071401,0.26524,0.84435,GOBP_PRIMARY_ALCOHOL_CATABOLIC_PROCESS,1
GOBP_NITRIC_OXIDE_CGMP_MEDIA...,SET,7,-0.37084,-0.0072359,0.36617,0.8444,GOBP_NITRIC_OXIDE_CGMP_MEDIATED_SIGNALING,1
GOBP_CYTOKINE_MEDIATED_SIGNA...,SET,472,-0.042397,-0.0067065,0.041862,0.84441,GOBP_CYTOKINE_MEDIATED_SIGNALING_PATHWAY,1
MIR5582_3P,SET,601,-0.03565,-0.0063405,0.035193,0.84446,MIR5582_3P,1
GOBP_POSITIVE_REGULATION_OF_...159,SET,7,-0.36018,-0.0070278,0.35553,0.84448,GOBP_POSITIVE_REGULATION_OF_CHOLESTEROL_STORAGE,1
GSE37605_FOXP3_FUSION_GFP_VS...3,SET,151,-0.071565,-0.0064601,0.07064,0.84448,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_NOD_DN,1
GOBP_HEME_TRANSPORT,SET,8,-0.31279,-0.0065243,0.30873,0.84449,GOBP_HEME_TRANSPORT,1
GOMF_HEME_TRANSMEMBRANE_TRAN...,SET,8,-0.31279,-0.0065243,0.30873,0.84449,GOMF_HEME_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_ARP2_3_CO...,SET,18,-0.18325,-0.005732,0.18086,0.84451,GOBP_REGULATION_OF_ARP2_3_COMPLEX_MEDIATED_ACTIN_NUCLEATION,1
MIR4750_3P,SET,36,-0.13407,-0.0059276,0.1323,0.84455,MIR4750_3P,1
MODULE_128,SET,87,-0.095657,-0.0065657,0.09437,0.84461,MODULE_128,1
KANG_AR_TARGETS_UP,SET,16,-0.24513,-0.0072295,0.24176,0.84469,KANG_AR_TARGETS_UP,1
HP_TETRAPLEGIA_TETRAPARESIS,SET,125,-0.075263,-0.0061858,0.074224,0.8447,HP_TETRAPLEGIA_TETRAPARESIS,1
MIR195_5P,SET,534,-0.036694,-0.0061632,0.036186,0.84471,MIR195_5P,1
HARALAMBIEVA_PBMC_M_M_R_II_A...2,SET,843,-0.031895,-0.0066725,0.031453,0.84472,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP,1
GOMF_STRUCTURAL_CONSTITUENT_...7,SET,18,-0.20636,-0.006455,0.20345,0.84478,GOMF_STRUCTURAL_CONSTITUENT_OF_POSTSYNAPSE,1
GOBP_POLYAMINE_BIOSYNTHETIC_...,SET,12,-0.21655,-0.0055315,0.21348,0.84479,GOBP_POLYAMINE_BIOSYNTHETIC_PROCESS,1
GOBP_TORC2_SIGNALING,SET,10,-0.28398,-0.0066222,0.27994,0.8448,GOBP_TORC2_SIGNALING,1
GOMF_PROTEIN_HETERODIMERIZAT...,SET,232,-0.058301,-0.0065088,0.05747,0.84481,GOMF_PROTEIN_HETERODIMERIZATION_ACTIVITY,1
HP_ABNORMALITY_OF_CIRCULATIN...2,SET,62,-0.10951,-0.0063498,0.10795,0.84481,HP_ABNORMALITY_OF_CIRCULATING_GLUCOCORTICOID_LEVEL,1
GOCC_ORGANELLE_ENVELOPE_LUMEN,SET,83,-0.093977,-0.0063011,0.092634,0.84482,GOCC_ORGANELLE_ENVELOPE_LUMEN,1
GSE7460_CD8_TCELL_VS_TREG_AC...1,SET,179,-0.060385,-0.0059302,0.059518,0.84484,GSE7460_CD8_TCELL_VS_TREG_ACT_DN,1
PAX4_04,SET,195,-0.064039,-0.0065612,0.063117,0.84485,PAX4_04,1
GOBP_POSITIVE_REGULATION_OF_...50,SET,15,-0.20679,-0.0059053,0.20381,0.84485,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGY_OF_MITOCHONDRION,1
HP_DECREASED_CIRCULATING_IGG...2,SET,9,-0.27376,-0.0060565,0.2697,0.84495,HP_DECREASED_CIRCULATING_IGG_SUBCLASS_LEVEL,1
GOBP_ENDOTHELIAL_CELL_FATE_C...,SET,8,-0.3343,-0.0069731,0.32928,0.845,GOBP_ENDOTHELIAL_CELL_FATE_COMMITMENT,1
GSE21927_SPLENIC_C26GM_TUMOR...2,SET,151,-0.067372,-0.0060815,0.06635,0.84503,GSE21927_SPLENIC_C26GM_TUMOROUS_VS_4T1_TUMOR_MONOCYTES_UP,1
GOBP_INTERNAL_PROTEIN_AMINO_...,SET,10,-0.2293,-0.0053471,0.22581,0.84505,GOBP_INTERNAL_PROTEIN_AMINO_ACID_ACETYLATION,1
KEGG_MEDICUS_REFERENCE_LONG_...,SET,17,-0.18866,-0.005735,0.18576,0.84509,KEGG_MEDICUS_REFERENCE_LONG_PATCH_BER,1
WP_PROXIMAL_TUBULE_TRANSPORT,SET,55,-0.11837,-0.0064657,0.11653,0.84513,WP_PROXIMAL_TUBULE_TRANSPORT,1
GOBP_SENSORY_PERCEPTION_OF_T...2,SET,29,-0.16842,-0.0066848,0.16578,0.84516,GOBP_SENSORY_PERCEPTION_OF_TEMPERATURE_STIMULUS,1
GOBP_DENDRITE_ARBORIZATION,SET,11,-0.26689,-0.0065273,0.26266,0.84521,GOBP_DENDRITE_ARBORIZATION,1
GOBP_SODIUM_DEPENDENT_PHOSPH...,SET,12,-0.27658,-0.007065,0.27218,0.84522,GOBP_SODIUM_DEPENDENT_PHOSPHATE_TRANSPORT,1
GOBP_REGULATION_OF_DENDRITIC...6,SET,41,-0.1433,-0.0067605,0.14101,0.84523,GOBP_REGULATION_OF_DENDRITIC_SPINE_MORPHOGENESIS,1
GOBP_HEME_A_METABOLIC_PROCESS,SET,10,-0.26392,-0.0061544,0.25968,0.84526,GOBP_HEME_A_METABOLIC_PROCESS,1
HP_LIPEMIA_RETINALIS,SET,4,-0.42393,-0.0062533,0.4171,0.84526,HP_LIPEMIA_RETINALIS,1
GOBP_REGULATION_OF_JUN_KINAS...,SET,39,-0.13498,-0.0062113,0.13277,0.84533,GOBP_REGULATION_OF_JUN_KINASE_ACTIVITY,1
GOBP_FOREBRAIN_RADIAL_GLIAL_...,SET,7,-0.33765,-0.0065882,0.33203,0.8454,GOBP_FOREBRAIN_RADIAL_GLIAL_CELL_DIFFERENTIATION,1
GOBP_RETROGRADE_TRANSPORT_VE...,SET,9,-0.29563,-0.0065404,0.2907,0.84541,GOBP_RETROGRADE_TRANSPORT_VESICLE_RECYCLING_WITHIN_GOLGI,1
MIR888_5P,SET,220,-0.057827,-0.0062888,0.056857,0.84543,MIR888_5P,1
chr1p21,SET,29,-0.26544,-0.010536,0.26094,0.84548,chr1p21,1
CLIMENT_BREAST_CANCER_COPY_N...1,SET,8,-0.308,-0.0064246,0.30277,0.84548,CLIMENT_BREAST_CANCER_COPY_NUMBER_DN,1
HP_HYPOESTHESIA,SET,16,-0.20798,-0.0061337,0.20445,0.84548,HP_HYPOESTHESIA,1
GTGCAAA_MIR507,SET,117,-0.083541,-0.0066442,0.082113,0.84551,GTGCAAA_MIR507,1
BENPORATH_OCT4_TARGETS,SET,258,-0.055603,-0.0065415,0.054648,0.84553,BENPORATH_OCT4_TARGETS,1
CURSONS_NATURAL_KILLER_CELLS,SET,17,-0.22344,-0.0067925,0.21958,0.84555,CURSONS_NATURAL_KILLER_CELLS,1
GOCC_CYTOPLASMIC_UBIQUITIN_L...,SET,6,-0.36074,-0.0065169,0.35445,0.84559,GOCC_CYTOPLASMIC_UBIQUITIN_LIGASE_COMPLEX,1
GTTAAAG_MIR302B,SET,63,-0.10576,-0.0061814,0.10391,0.84561,GTTAAAG_MIR302B,1
HP_CLITORAL_HYPOPLASIA,SET,26,-0.16553,-0.0062214,0.16259,0.84567,HP_CLITORAL_HYPOPLASIA,1
GOBP_MESODERMAL_CELL_FATE_SP...,SET,13,-0.23957,-0.0063692,0.23528,0.8457,GOBP_MESODERMAL_CELL_FATE_SPECIFICATION,1
GOBP_DETECTION_OF_LIGHT_STIM...2,SET,19,-0.19801,-0.0063631,0.19442,0.84575,GOBP_DETECTION_OF_LIGHT_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION,1
GSE41176_WT_VS_TAK1_KO_ANTI_...5,SET,177,-0.065331,-0.0063803,0.064147,0.84576,GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN,1
HP_BROAD_CHIN,SET,8,-0.34199,-0.0071335,0.33573,0.84581,HP_BROAD_CHIN,1
GSE3720_VD1_VS_VD2_GAMMADELT...3,SET,183,-0.060933,-0.0060498,0.059815,0.84582,GSE3720_VD1_VS_VD2_GAMMADELTA_TCELL_WITH_LPS_STIM_DN,1
REACTOME_SYNTHESIS_OF_KETONE...,SET,8,-0.32638,-0.0068079,0.32029,0.8459,REACTOME_SYNTHESIS_OF_KETONE_BODIES,1
KEGG_TYROSINE_METABOLISM,SET,38,-0.15187,-0.0068987,0.14903,0.84591,KEGG_TYROSINE_METABOLISM,1
HP_ABNORMALITY_OF_THE_MUSCUL...4,SET,12,-0.25692,-0.0065628,0.25209,0.84594,HP_ABNORMALITY_OF_THE_MUSCULATURE_OF_THE_UPPER_ARM,1
GSE22601_DOUBLE_POSITIVE_VS_...4,SET,186,-0.064949,-0.0065006,0.063715,0.84598,GSE22601_DOUBLE_POSITIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP,1
REACTOME_ANCHORING_FIBRIL_FO...,SET,13,-0.2518,-0.0066945,0.247,0.846,REACTOME_ANCHORING_FIBRIL_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...534,SET,17,-0.22065,-0.0067077,0.21644,0.846,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_SECRETION,1
GOCC_GABA_RECEPTOR_COMPLEX,SET,18,-0.25302,-0.0079143,0.24809,0.8461,GOCC_GABA_RECEPTOR_COMPLEX,1
HAEGERSTRAND_RESPONSE_TO_IMA...,SET,9,-0.34717,-0.0076807,0.34036,0.84613,HAEGERSTRAND_RESPONSE_TO_IMATINIB,1
GOBP_FATTY_ACID_METABOLIC_PR...,SET,367,-0.046011,-0.0064366,0.045108,0.84614,GOBP_FATTY_ACID_METABOLIC_PROCESS,1
HP_ABSENCE_OF_THE_SACRUM,SET,8,-0.30276,-0.0063152,0.29675,0.84619,HP_ABSENCE_OF_THE_SACRUM,1
WP_10Q22Q23_COPY_NUMBER_VARI...,SET,55,-0.12957,-0.0070776,0.12698,0.84622,WP_10Q22Q23_COPY_NUMBER_VARIATION,1
GOBP_SIGNAL_COMPLEX_ASSEMBLY,SET,8,-0.2833,-0.0059093,0.27762,0.84624,GOBP_SIGNAL_COMPLEX_ASSEMBLY,1
MODULE_215,SET,14,-0.27039,-0.0074597,0.26484,0.84635,MODULE_215,1
GTACTGT_MIR101,SET,233,-0.057287,-0.0064091,0.0561,0.8464,GTACTGT_MIR101,1
HP_PREMATURE_LOSS_OF_PRIMARY...,SET,19,-0.20915,-0.0067211,0.20479,0.84643,HP_PREMATURE_LOSS_OF_PRIMARY_TEETH,1
GSE25123_WT_VS_PPARG_KO_MACR...7,SET,181,-0.063794,-0.0062996,0.062456,0.84647,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP,1
REACTOME_MET_ACTIVATES_PI3K_...,SET,6,-0.38628,-0.0069783,0.37815,0.84648,REACTOME_MET_ACTIVATES_PI3K_AKT_SIGNALING,1
GSE23308_WT_VS_MINERALCORTIC...1,SET,174,-0.066002,-0.0063916,0.064612,0.84649,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_DN,1
HP_B_LYMPHOCYTOPENIA,SET,53,-0.12226,-0.0065559,0.11968,0.8465,HP_B_LYMPHOCYTOPENIA,1
MIR3934_3P,SET,90,-0.088219,-0.0061582,0.086346,0.84653,MIR3934_3P,1
WP_FLUOROPYRIMIDINE_ACTIVITY,SET,33,-0.14409,-0.0061001,0.14101,0.84656,WP_FLUOROPYRIMIDINE_ACTIVITY,1
BIOCARTA_STATHMIN_PATHWAY,SET,20,-0.19186,-0.0063255,0.18773,0.8466,BIOCARTA_STATHMIN_PATHWAY,1
RPA1_TARGET_GENES,SET,39,-0.13835,-0.0063664,0.13536,0.84663,RPA1_TARGET_GENES,1
LEF1_UP.V1_DN,SET,166,-0.070357,-0.0066562,0.068826,0.84666,LEF1_UP.V1_DN,1
THAKAR_PBMC_INACTIVATED_INFL...5,SET,787,-0.030157,-0.0061054,0.029498,0.84668,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN,1
BIOCARTA_BCELLSURVIVAL_PATHW...,SET,14,-0.2555,-0.007049,0.24987,0.84673,BIOCARTA_BCELLSURVIVAL_PATHWAY,1
GOMF_TRANSMEMBRANE_RECEPTOR_...4,SET,18,-0.20681,-0.0064688,0.20221,0.84677,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_SERINE_THREONINE_KINASE_BINDING,1
MIR8087,SET,125,-0.077878,-0.0064007,0.076147,0.84678,MIR8087,1
HP_HYPERPHENYLALANINEMIA,SET,6,-0.37505,-0.0067754,0.3667,0.84678,HP_HYPERPHENYLALANINEMIA,1
GOBP_LIPID_LOCALIZATION,SET,453,-0.042358,-0.0065676,0.041409,0.84682,GOBP_LIPID_LOCALIZATION,1
REACTOME_ASPARTATE_AND_ASPAR...,SET,11,-0.25484,-0.0062327,0.24908,0.84687,REACTOME_ASPARTATE_AND_ASPARAGINE_METABOLISM,1
REACTOME_TELOMERE_C_STRAND_S...,SET,11,-0.23066,-0.0056412,0.22541,0.8469,REACTOME_TELOMERE_C_STRAND_SYNTHESIS_INITIATION,1
GOBP_PYRIMIDINE_RIBONUCLEOTI...2,SET,8,-0.3078,-0.0064203,0.30066,0.84702,GOBP_PYRIMIDINE_RIBONUCLEOTIDE_CATABOLIC_PROCESS,1
ATOH8_TARGET_GENES,SET,38,-0.1391,-0.0063184,0.13578,0.84718,ATOH8_TARGET_GENES,1
MIR584_3P,SET,96,-0.087015,-0.0062724,0.084934,0.84719,MIR584_3P,1
GOMF_GLUTAMATE_GATED_CALCIUM...,SET,7,-0.34715,-0.0067737,0.33885,0.84719,GOMF_GLUTAMATE_GATED_CALCIUM_ION_CHANNEL_ACTIVITY,1
BANDRES_RESPONSE_TO_CARMUSTI...8,SET,18,-0.20484,-0.0064072,0.19993,0.84721,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_48HR_UP,1
MIR544A,SET,202,-0.06118,-0.0063786,0.059712,0.84721,MIR544A,1
GSE10325_LUPUS_CD4_TCELL_VS_...2,SET,175,-0.068135,-0.0066168,0.066495,0.84723,GSE10325_LUPUS_CD4_TCELL_VS_LUPUS_BCELL_UP,1
GOBP_REGULATION_OF_POSTSYNAP...2,SET,100,-0.088395,-0.0065025,0.086263,0.84724,GOBP_REGULATION_OF_POSTSYNAPSE_ORGANIZATION,1
HP_ELEVATED_URINARY_VANILLYL...,SET,9,-0.35209,-0.0077894,0.34359,0.84725,HP_ELEVATED_URINARY_VANILLYLMANDELIC_ACID,1
HP_ODONTOGENIC_NEOPLASM,SET,6,-0.30196,-0.005455,0.29467,0.84725,HP_ODONTOGENIC_NEOPLASM,1
MIR4325,SET,245,-0.055993,-0.0064216,0.054634,0.84728,MIR4325,1
GOBP_ACUTE_INFLAMMATORY_RESP...2,SET,23,-0.1983,-0.0070107,0.19347,0.8473,GOBP_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
HP_PEG_SHAPED_MAXILLARY_LATE...,SET,24,-0.19095,-0.0068958,0.18631,0.8473,HP_PEG_SHAPED_MAXILLARY_LATERAL_INCISORS,1
WP_CARDIAC_HYPERTROPHIC_RESP...,SET,53,-0.12099,-0.0064877,0.11804,0.84731,WP_CARDIAC_HYPERTROPHIC_RESPONSE,1
SU_PANCREAS,SET,39,-0.13524,-0.0062231,0.13192,0.84734,SU_PANCREAS,1
REACTOME_VITAMIN_B1_THIAMIN_...,SET,5,-0.36557,-0.0060288,0.35658,0.84736,REACTOME_VITAMIN_B1_THIAMIN_METABOLISM,1
GOBP_THIAMINE_CONTAINING_COM...,SET,5,-0.36557,-0.0060288,0.35658,0.84736,GOBP_THIAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_THIAMINE_DIPHOSPHATE_ME...,SET,5,-0.36557,-0.0060288,0.35658,0.84736,GOBP_THIAMINE_DIPHOSPHATE_METABOLIC_PROCESS,1
GSE1925_CTRL_VS_3H_IFNG_STIM...4,SET,186,-0.062295,-0.0062351,0.060753,0.8474,GSE1925_CTRL_VS_3H_IFNG_STIM_MACROPHAGE_UP,1
UEDA_CENTRAL_CLOCK,SET,79,-0.098656,-0.0064542,0.096191,0.84746,UEDA_CENTRAL_CLOCK,1
MIR3691_3P,SET,59,-0.10329,-0.0058427,0.10069,0.84749,MIR3691_3P,1
REACTOME_P38MAPK_EVENTS,SET,13,-0.24695,-0.0065656,0.24073,0.84751,REACTOME_P38MAPK_EVENTS,1
HP_CHRONIC_BRONCHITIS,SET,21,-0.17524,-0.0059202,0.17083,0.84751,HP_CHRONIC_BRONCHITIS,1
TARTE_PLASMA_CELL_VS_PLASMAB...1,SET,277,-0.048949,-0.0059639,0.04771,0.84754,TARTE_PLASMA_CELL_VS_PLASMABLAST_DN,1
GSE39820_CTRL_VS_IL1B_IL6_CD...1,SET,182,-0.065114,-0.0064475,0.063433,0.84767,GSE39820_CTRL_VS_IL1B_IL6_CD4_TCELL_DN,1
GSE13485_DAY3_VS_DAY7_YF17D_...1,SET,175,-0.067258,-0.0065317,0.065518,0.84768,GSE13485_DAY3_VS_DAY7_YF17D_VACCINE_PBMC_DN,1
GOBP_POSITIVE_REGULATION_OF_...327,SET,23,-0.19913,-0.00704,0.19393,0.84774,GOBP_POSITIVE_REGULATION_OF_HEART_RATE,1
GOBP_POSITIVE_REGULATION_OF_...108,SET,5,-0.3884,-0.0064054,0.37817,0.8478,GOBP_POSITIVE_REGULATION_OF_CELLULAR_PH_REDUCTION,1
CROONQUIST_NRAS_VS_STROMAL_S...2,SET,36,-0.13974,-0.0061784,0.13604,0.84782,CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...22,SET,75,-0.10259,-0.0065401,0.099879,0.84782,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_TURQUOISE_UP,1
HP_ABNORMALITY_OF_THE_FIFTH_...,SET,8,-0.34432,-0.0071821,0.33515,0.84787,HP_ABNORMALITY_OF_THE_FIFTH_METATARSAL_BONE,1
HP_POOR_APPETITE,SET,47,-0.12486,-0.0063059,0.12151,0.84791,HP_POOR_APPETITE,1
GSE41978_WT_VS_ID2_KO_AND_BI...1,SET,179,-0.063067,-0.0061936,0.061376,0.84791,GSE41978_WT_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
HNF3_Q6,SET,165,-0.070446,-0.0066447,0.068555,0.84792,HNF3_Q6,1
GOBP_POSITIVE_REGULATION_OF_...806,SET,93,-0.09866,-0.0070003,0.095995,0.84796,GOBP_POSITIVE_REGULATION_OF_T_CELL_PROLIFERATION,1
GSE29618_PRE_VS_DAY7_FLU_VAC...7,SET,177,-0.060703,-0.0059283,0.059063,0.84796,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_DN,1
MIR1296_3P,SET,34,-0.14025,-0.0060268,0.13645,0.84798,MIR1296_3P,1
GOBP_GROWTH_HORMONE_SECRETION,SET,12,-0.2637,-0.006736,0.25655,0.84799,GOBP_GROWTH_HORMONE_SECRETION,1
HP_ABNORMALITY_OF_THE_PINEAL...,SET,14,-0.23089,-0.00637,0.22462,0.84799,HP_ABNORMALITY_OF_THE_PINEAL_GLAND,1
MIR6071,SET,155,-0.068032,-0.0062213,0.066173,0.84804,MIR6071,1
PID_RANBP2_PATHWAY,SET,11,-0.27045,-0.0066144,0.26299,0.84811,PID_RANBP2_PATHWAY,1
REACTOME_FRUCTOSE_CATABOLISM,SET,5,-0.30893,-0.0050948,0.3004,0.84811,REACTOME_FRUCTOSE_CATABOLISM,1
GOBP_DTMP_METABOLIC_PROCESS,SET,6,-0.31095,-0.0056174,0.30237,0.84811,GOBP_DTMP_METABOLIC_PROCESS,1
GOCC_ZONULA_ADHERENS,SET,7,-0.33735,-0.0065825,0.32797,0.84816,GOCC_ZONULA_ADHERENS,1
KEGG_MEDICUS_PATHOGEN_YERSIN...2,SET,6,-0.39802,-0.0071903,0.38693,0.84817,KEGG_MEDICUS_PATHOGEN_YERSINIA_YOPP_J_TO_TLR2_4_MAPK_SIGNALING_PATHWAY,1
GOBP_ANDROGEN_METABOLIC_PROC...,SET,28,-0.17414,-0.0067917,0.16929,0.84817,GOBP_ANDROGEN_METABOLIC_PROCESS,1
REACTOME_METABOLISM_OF_FOLAT...,SET,16,-0.19643,-0.0057931,0.19093,0.84821,REACTOME_METABOLISM_OF_FOLATE_AND_PTERINES,1
QIU_PBMC_HEPTATITIS_B_SURFAC...6,SET,13,-0.27413,-0.0072881,0.26644,0.84822,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_3DY_UP,1
HP_ABNORMALITY_OF_THE_HUMERO...,SET,51,-0.11992,-0.006308,0.11654,0.84824,HP_ABNORMALITY_OF_THE_HUMERORADIAL_JOINT,1
MEISSNER_NPC_HCP_WITH_H3K27M...,SET,76,-0.11314,-0.0072607,0.10995,0.84827,MEISSNER_NPC_HCP_WITH_H3K27ME3,1
GOMF_DISACCHARIDE_BINDING,SET,5,-0.35339,-0.005828,0.34334,0.84831,GOMF_DISACCHARIDE_BINDING,1
KEGG_MEDICUS_VARIANT_AMPLIFI...6,SET,9,-0.28959,-0.0064067,0.28133,0.84834,KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY,1
HP_ABNORMAL_CEREBELLAR_CORTE...,SET,4,-0.34694,-0.0051177,0.33698,0.84838,HP_ABNORMAL_CEREBELLAR_CORTEX_MORPHOLOGY,1
HOFT_PBMC_TICE_BCG_RBCG_AG85...,SET,35,-0.15474,-0.0067464,0.1503,0.84838,HOFT_PBMC_TICE_BCG_RBCG_AG85A_AG85B_AGE_18_40YO_CORRELATED_WITH_WHOLE_BLOOD_BACTERICIDAL_ACTIVITY_NEGATIVE,1
GOBP_SIGNALING_RECEPTOR_LIGA...,SET,36,-0.14833,-0.0065582,0.14406,0.8484,GOBP_SIGNALING_RECEPTOR_LIGAND_PRECURSOR_PROCESSING,1
WP_NANOPARTICLE_TRIGGERED_AU...,SET,22,-0.17922,-0.006197,0.17406,0.84841,WP_NANOPARTICLE_TRIGGERED_AUTOPHAGIC_CELL_DEATH,1
GOBP_PROTEIN_LOCALIZATION_TO...16,SET,8,-0.27529,-0.0057422,0.26736,0.84841,GOBP_PROTEIN_LOCALIZATION_TO_CILIARY_TRANSITION_ZONE,1
LET_7F_5P,SET,362,-0.04679,-0.0065018,0.045432,0.84847,LET_7F_5P,1
RUAN_RESPONSE_TO_TNF_TROGLIT...1,SET,36,-0.15523,-0.0068633,0.1507,0.8485,RUAN_RESPONSE_TO_TNF_TROGLITAZONE_DN,1
HP_METAPHYSEAL_CUPPING,SET,14,-0.23571,-0.0065029,0.22883,0.8485,HP_METAPHYSEAL_CUPPING,1
GSE11961_MEMORY_BCELL_DAY7_V...8,SET,186,-0.062896,-0.0062952,0.061062,0.8485,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_UP,1
GOCC_DESMOSOME,SET,26,-0.18631,-0.0070023,0.18082,0.84856,GOCC_DESMOSOME,1
GOBP_NEGATIVE_REGULATION_OF_...325,SET,5,-0.35997,-0.0059365,0.34929,0.84862,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OSMOTIC_STRESS,1
HP_PUNDING,SET,6,-0.41441,-0.0074865,0.40212,0.84863,HP_PUNDING,1
GOBP_VESTIBULOCOCHLEAR_NERVE...1,SET,11,-0.29716,-0.0072677,0.2883,0.84866,GOBP_VESTIBULOCOCHLEAR_NERVE_DEVELOPMENT,1
MODULE_257,SET,153,-0.06469,-0.0058777,0.062756,0.84868,MODULE_257,1
MIR891B,SET,115,-0.078102,-0.0061586,0.075731,0.84879,MIR891B,1
GSE37533_PPARG2_FOXP3_VS_FOX...3,SET,175,-0.065815,-0.0063915,0.063802,0.84885,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,1
MIR6733_5P,SET,240,-0.055586,-0.0063104,0.053881,0.84887,MIR6733_5P,1
GOBP_RESPONSE_TO_PAIN,SET,35,-0.15428,-0.0067264,0.14953,0.84891,GOBP_RESPONSE_TO_PAIN,1
GOMF_C_C_CHEMOKINE_BINDING,SET,22,-0.21651,-0.0074864,0.20984,0.84891,GOMF_C_C_CHEMOKINE_BINDING,1
GOBP_MIRNA_PROCESSING,SET,40,-0.13211,-0.0061566,0.12802,0.84895,GOBP_MIRNA_PROCESSING,1
GOBP_ESTABLISHMENT_OF_LEFT_R...,SET,5,-0.3878,-0.0063955,0.37574,0.84898,GOBP_ESTABLISHMENT_OF_LEFT_RIGHT_ASYMMETRY,1
SRF_Q5_01,SET,203,-0.063378,-0.0066239,0.061385,0.84907,SRF_Q5_01,1
GSE41867_DAY6_VS_DAY8_LCMV_A...2,SET,175,-0.06458,-0.0062716,0.06254,0.8491,GSE41867_DAY6_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
GSE27786_LSK_VS_BCELL_DN,SET,182,-0.064086,-0.0063456,0.062055,0.84913,GSE27786_LSK_VS_BCELL_DN,1
GOBP_REGULATION_OF_CYTOSKELE...,SET,463,-0.040448,-0.0063385,0.039164,0.84914,GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION,1
GSE14308_TH17_VS_INDUCED_TRE...1,SET,186,-0.060497,-0.0060551,0.058574,0.84915,GSE14308_TH17_VS_INDUCED_TREG_DN,1
GSE3982_DC_VS_MAC_DN,SET,178,-0.066884,-0.0065502,0.064758,0.84915,GSE3982_DC_VS_MAC_DN,1
GOMF_G_PROTEIN_COUPLED_RECEP...2,SET,254,-0.058364,-0.0068137,0.056507,0.84916,GOMF_G_PROTEIN_COUPLED_RECEPTOR_BINDING,1
GSE5589_UNSTIM_VS_180MIN_LPS...4,SET,180,-0.064236,-0.0063258,0.062192,0.84916,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP,1
chr2q24,SET,48,-0.2534,-0.012933,0.24524,0.84925,chr2q24,1
HP_THYROIDITIS,SET,45,-0.13051,-0.0064498,0.12629,0.84927,HP_THYROIDITIS,1
CGGTGTG_MIR220,SET,5,-0.41169,-0.0067895,0.39839,0.84928,CGGTGTG_MIR220,1
GSE20198_UNTREATED_VS_IL12_T...1,SET,182,-0.063429,-0.0062806,0.061371,0.84931,GSE20198_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...1,SET,3,-0.55979,-0.0071514,0.5416,0.84933,GOBP_POSITIVE_REGULATION_OF_3_UTR_MEDIATED_MRNA_STABILIZATION,1
GOBP_REGULATION_OF_ACTIN_FIL...3,SET,94,-0.090857,-0.0064811,0.087901,0.84934,GOBP_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
GOCC_SWI_SNF_SUPERFAMILY_TYP...,SET,88,-0.087807,-0.0060613,0.084949,0.84934,GOCC_SWI_SNF_SUPERFAMILY_TYPE_COMPLEX,1
GOBP_CEREBELLAR_GRANULAR_LAY...2,SET,6,-0.45019,-0.0081329,0.43553,0.84935,GOBP_CEREBELLAR_GRANULAR_LAYER_FORMATION,1
GOBP_PROTEIN_LOCALIZATION_TO...46,SET,39,-0.14365,-0.0066104,0.13898,0.84935,GOBP_PROTEIN_LOCALIZATION_TO_POSTSYNAPSE,1
MIR6511B_5P,SET,66,-0.11137,-0.0066618,0.10774,0.84936,MIR6511B_5P,1
GOBP_POSITIVE_REGULATION_OF_...153,SET,11,-0.26479,-0.0064759,0.25608,0.84942,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GSE27786_CD8_TCELL_VS_NEUTRO...2,SET,175,-0.062361,-0.0060561,0.060308,0.84943,GSE27786_CD8_TCELL_VS_NEUTROPHIL_UP,1
GOBP_POSITIVE_REGULATION_OF_...490,SET,32,-0.16191,-0.0067499,0.15654,0.8495,GOBP_POSITIVE_REGULATION_OF_MORPHOGENESIS_OF_AN_EPITHELIUM,1
HP_RETINAL_VEIN_OCCLUSION,SET,6,-0.3581,-0.0064692,0.34619,0.84952,HP_RETINAL_VEIN_OCCLUSION,1
WP_EPITHELIAL_TO_MESENCHYMAL...,SET,153,-0.075561,-0.0068654,0.073011,0.84964,WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER,1
GOBP_THYROID_HORMONE_METABOL...,SET,28,-0.1761,-0.0068682,0.17014,0.84967,GOBP_THYROID_HORMONE_METABOLIC_PROCESS,1
HP_ABNORMAL_LIVER_PHYSIOLOGY,SET,24,-0.18523,-0.0066891,0.17894,0.84969,HP_ABNORMAL_LIVER_PHYSIOLOGY,1
HP_CRUMPLED_EAR,SET,5,-0.37461,-0.006178,0.36188,0.8497,HP_CRUMPLED_EAR,1
GSE5589_UNSTIM_VS_180MIN_LPS...3,SET,182,-0.061435,-0.0060832,0.059331,0.84977,GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_DN,1
HP_ABNORMAL_CORNEAL_EPITHELI...,SET,95,-0.087968,-0.0063081,0.08495,0.84978,HP_ABNORMAL_CORNEAL_EPITHELIUM_MORPHOLOGY,1
AGUIRRE_PANCREATIC_CANCER_CO...1,SET,221,-0.062641,-0.0068276,0.060474,0.84985,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_DN,1
GOCC_DEATH_INDUCING_SIGNALIN...,SET,9,-0.30896,-0.0068354,0.29827,0.84986,GOCC_DEATH_INDUCING_SIGNALING_COMPLEX,1
HP_PROMINENT_ANTITRAGUS,SET,6,-0.3443,-0.0062199,0.33235,0.84988,HP_PROMINENT_ANTITRAGUS,1
BOYAULT_LIVER_CANCER_SUBCLAS...10,SET,51,-0.13342,-0.0070183,0.12876,0.84994,BOYAULT_LIVER_CANCER_SUBCLASS_G3_DN,1
ENK_UV_RESPONSE_KERATINOCYTE...1,SET,438,-0.041136,-0.0062743,0.039697,0.84995,ENK_UV_RESPONSE_KERATINOCYTE_DN,1
GOBP_REGULATION_OF_FATTY_ACI...5,SET,31,-0.16537,-0.0067861,0.15955,0.85001,GOBP_REGULATION_OF_FATTY_ACID_TRANSPORT,1
GOBP_MAMMARY_GLAND_DUCT_MORP...,SET,30,-0.17572,-0.0070935,0.16952,0.85002,GOBP_MAMMARY_GLAND_DUCT_MORPHOGENESIS,1
GSE20727_CTRL_VS_H2O2_TREATE...1,SET,174,-0.064191,-0.0062162,0.061918,0.85006,GSE20727_CTRL_VS_H2O2_TREATED_DC_DN,1
GSE4984_UNTREATED_VS_VEHICLE...2,SET,136,-0.074317,-0.0063692,0.071664,0.85013,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP,1
GOBP_REGULATION_OF_ENDOPLASM...2,SET,5,-0.36495,-0.0060186,0.35191,0.85014,GOBP_REGULATION_OF_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,1
GOMF_NUCLEOTIDE_SUGAR_TRANSM...,SET,12,-0.24371,-0.0062253,0.23495,0.85019,GOMF_NUCLEOTIDE_SUGAR_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ABNORMALITY_OF_REFRACTION,SET,600,-0.035942,-0.0063872,0.034646,0.85022,HP_ABNORMALITY_OF_REFRACTION,1
GSE20152_HTNFA_OVERXPRESS_AN...1,SET,173,-0.063449,-0.0061268,0.061157,0.85024,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_DN,1
GOBP_AMINO_ACID_METABOLIC_PR...,SET,255,-0.054394,-0.0063624,0.052424,0.85026,GOBP_AMINO_ACID_METABOLIC_PROCESS,1
ZNF329_TARGET_GENES,SET,439,-0.041756,-0.0063759,0.040238,0.85029,ZNF329_TARGET_GENES,1
GOBP_MITOCHONDRIAL_FRAGMENTA...,SET,10,-0.30607,-0.0071375,0.29495,0.85029,GOBP_MITOCHONDRIAL_FRAGMENTATION_INVOLVED_IN_APOPTOTIC_PROCESS,1
DURANTE_ADULT_OLFACTORY_NEUR...4,SET,58,-0.12202,-0.0068438,0.11757,0.85032,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_CD8_T_CELLS,1
GOCC_PLATELET_DENSE_GRANULE_...1,SET,13,-0.23345,-0.0062065,0.22492,0.85033,GOCC_PLATELET_DENSE_GRANULE_LUMEN,1
GSE27786_CD4_TCELL_VS_NKTCEL...1,SET,184,-0.062833,-0.0062554,0.060529,0.85037,GSE27786_CD4_TCELL_VS_NKTCELL_DN,1
MIR6746_5P,SET,5,-0.41783,-0.0068908,0.40247,0.8504,MIR6746_5P,1
GOBP_MYOBLAST_FUSION,SET,44,-0.13787,-0.0067378,0.13277,0.85045,GOBP_MYOBLAST_FUSION,1
BROWNE_HCMV_INFECTION_2HR_DN,SET,47,-0.13308,-0.0067212,0.12815,0.85047,BROWNE_HCMV_INFECTION_2HR_DN,1
GOBP_BRONCHIOLE_DEVELOPMENT,SET,6,-0.39653,-0.0071634,0.38173,0.85054,GOBP_BRONCHIOLE_DEVELOPMENT,1
KAZMIN_PBMC_P_FALCIPARUM_RTS...1,SET,39,-0.15387,-0.0070804,0.14812,0.85054,KAZMIN_PBMC_P_FALCIPARUM_RTSS_AS01_AGE_UNKNOWN_CORRELATED_WITH_PROTECTION_56DY_NEGATIVE,1
HP_ABNORMAL_HAIR_WHORL,SET,27,-0.17772,-0.0068066,0.17106,0.85058,HP_ABNORMAL_HAIR_WHORL,1
HP_APLASIA_HYPOPLASIA_OF_THE...80,SET,33,-0.15436,-0.0065348,0.14857,0.85058,HP_APLASIA_HYPOPLASIA_OF_THE_VERTEBRAE,1
SENGUPTA_NASOPHARYNGEAL_CARC...3,SET,146,-0.076995,-0.0068351,0.074107,0.85059,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_DN,1
NADERI_BREAST_CANCER_PROGNOS...1,SET,14,-0.26777,-0.0073877,0.25769,0.85062,NADERI_BREAST_CANCER_PROGNOSIS_DN,1
CSR_EARLY_UP.V1_DN,SET,113,-0.079769,-0.0062356,0.076766,0.85062,CSR_EARLY_UP.V1_DN,1
GOBP_BRANCH_ELONGATION_OF_AN...,SET,19,-0.22965,-0.0073801,0.221,0.85063,GOBP_BRANCH_ELONGATION_OF_AN_EPITHELIUM,1
GSE27859_MACROPHAGE_VS_CD11C...1,SET,168,-0.065562,-0.0062395,0.063077,0.85069,GSE27859_MACROPHAGE_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,1
GSE39556_CD8A_DC_VS_NK_CELL_...1,SET,178,-0.068183,-0.0066775,0.065593,0.8507,GSE39556_CD8A_DC_VS_NK_CELL_DN,1
GOBP_MEMBRANE_TUBULATION,SET,4,-0.46617,-0.0068765,0.44843,0.85072,GOBP_MEMBRANE_TUBULATION,1
HP_ALKALOSIS,SET,29,-0.16465,-0.006535,0.15838,0.85072,HP_ALKALOSIS,1
GSE13306_TREG_VS_TCONV_DN,SET,186,-0.061101,-0.0061156,0.058777,0.85072,GSE13306_TREG_VS_TCONV_DN,1
HP_BEAKING_OF_VERTEBRAL_BODI...,SET,25,-0.16884,-0.0062227,0.16238,0.85076,HP_BEAKING_OF_VERTEBRAL_BODIES,1
GOBP_GLUTAMINE_FAMILY_AMINO_...3,SET,66,-0.11396,-0.0068166,0.10959,0.85077,GOBP_GLUTAMINE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
SENGUPTA_NASOPHARYNGEAL_CARC...1,SET,293,-0.051717,-0.0064776,0.049722,0.85085,SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN,1
KRAS.KIDNEY_UP.V1_DN,SET,121,-0.085698,-0.0069306,0.082386,0.85087,KRAS.KIDNEY_UP.V1_DN,1
YU_BAP1_TARGETS,SET,29,-0.16194,-0.0064276,0.15566,0.8509,YU_BAP1_TARGETS,1
GSE7852_THYMUS_VS_FAT_TREG_UP,SET,188,-0.060678,-0.0061055,0.058319,0.85093,GSE7852_THYMUS_VS_FAT_TREG_UP,1
HP_WRITER_S_CRAMP,SET,18,-0.19843,-0.006207,0.19069,0.85096,HP_WRITER_S_CRAMP,1
GOBP_NEGATIVE_REGULATION_OF_...241,SET,3,-0.56912,-0.0072705,0.54671,0.85105,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,1
REACTOME_COLLAGEN_DEGRADATION,SET,61,-0.12171,-0.0070003,0.11691,0.85106,REACTOME_COLLAGEN_DEGRADATION,1
GOBP_POSTSYNAPSE_ORGANIZATION,SET,181,-0.066284,-0.0065454,0.063672,0.85106,GOBP_POSTSYNAPSE_ORGANIZATION,1
GOBP_REGULATION_OF_VACUOLE_O...,SET,54,-0.11761,-0.0063657,0.11297,0.85107,GOBP_REGULATION_OF_VACUOLE_ORGANIZATION,1
HP_ABNORMAL_URINE_CARBOHYDRA...,SET,37,-0.13868,-0.0062161,0.13321,0.85107,HP_ABNORMAL_URINE_CARBOHYDRATE_LEVEL,1
MODULE_97,SET,88,-0.089595,-0.0061848,0.086059,0.85108,MODULE_97,1
REACTOME_RESOLUTION_OF_ABASI...,SET,37,-0.12755,-0.0057174,0.12251,0.85109,REACTOME_RESOLUTION_OF_ABASIC_SITES_AP_SITES,1
WANG_RECURRENT_LIVER_CANCER_...1,SET,16,-0.23486,-0.0069267,0.22557,0.85111,WANG_RECURRENT_LIVER_CANCER_DN,1
HP_ABNORMAL_CIRCULATING_C_PE...,SET,26,-0.19177,-0.0072077,0.18416,0.85112,HP_ABNORMAL_CIRCULATING_C_PEPTIDE_CONCENTRATION,1
MIR670_5P,SET,230,-0.058157,-0.006465,0.05585,0.85113,MIR670_5P,1
GSE12392_WT_VS_IFNAR_KO_CD8A...1,SET,168,-0.064939,-0.0061803,0.062357,0.85115,GSE12392_WT_VS_IFNAR_KO_CD8A_NEG_SPLEEN_DC_DN,1
GSE37532_TREG_VS_TCONV_CD4_T...4,SET,119,-0.086217,-0.006915,0.082778,0.85118,GSE37532_TREG_VS_TCONV_CD4_TCELL_FROM_VISCERAL_ADIPOSE_TISSUE_UP,1
GOBP_POSITIVE_REGULATION_OF_...358,SET,28,-0.15931,-0.0062136,0.15292,0.85125,GOBP_POSITIVE_REGULATION_OF_INSULIN_SECRETION_INVOLVED_IN_CELLULAR_RESPONSE_TO_GLUCOSE_STIMULUS,1
GSE5503_LIVER_DC_VS_PLN_DC_A...1,SET,176,-0.062482,-0.006085,0.059963,0.85129,GSE5503_LIVER_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN,1
HP_POOR_MOTOR_COORDINATION,SET,77,-0.10027,-0.0064764,0.096215,0.85132,HP_POOR_MOTOR_COORDINATION,1
GOBP_CHROMOSOME_CONDENSATION,SET,31,-0.14187,-0.0058215,0.13609,0.85138,GOBP_CHROMOSOME_CONDENSATION,1
GOBP_SULFUR_COMPOUND_CATABOL...,SET,40,-0.14099,-0.0065702,0.13524,0.8514,GOBP_SULFUR_COMPOUND_CATABOLIC_PROCESS,1
HP_ABNORMAL_DERMOEPIDERMAL_J...,SET,12,-0.2757,-0.0070426,0.26444,0.85142,HP_ABNORMAL_DERMOEPIDERMAL_JUNCTION_MORPHOLOGY,1
GOBP_REGULATION_OF_TYPE_B_PA...2,SET,11,-0.28243,-0.0069074,0.27082,0.85148,GOBP_REGULATION_OF_TYPE_B_PANCREATIC_CELL_PROLIFERATION,1
GSE6269_E_COLI_VS_STAPH_AURE...1,SET,162,-0.068913,-0.0064414,0.066058,0.85157,GSE6269_E_COLI_VS_STAPH_AUREUS_INF_PBMC_DN,1
REACTOME_ARACHIDONATE_PRODUC...,SET,5,-0.37872,-0.0062457,0.36298,0.8516,REACTOME_ARACHIDONATE_PRODUCTION_FROM_DAG,1
GSE24726_WT_VS_E2_2_KO_PDC_UP,SET,177,-0.065885,-0.0064345,0.063148,0.8516,GSE24726_WT_VS_E2_2_KO_PDC_UP,1
KEGG_GLYCOLYSIS_GLUCONEOGENE...,SET,54,-0.1197,-0.0064787,0.11472,0.85161,KEGG_GLYCOLYSIS_GLUCONEOGENESIS,1
NIKOLSKY_BREAST_CANCER_20Q12...,SET,136,-0.14628,-0.012537,0.14019,0.85162,NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON,1
GOBP_CELL_DIFFERENTIATION_IN...6,SET,47,-0.14026,-0.0070836,0.13439,0.85167,GOBP_CELL_DIFFERENTIATION_IN_SPINAL_CORD,1
CATTTCA_MIR203,SET,259,-0.054029,-0.0063684,0.051768,0.85168,CATTTCA_MIR203,1
HP_INTESTINAL_ATRESIA,SET,56,-0.11708,-0.006453,0.11218,0.85169,HP_INTESTINAL_ATRESIA,1
GOBP_HINDBRAIN_MATURATION,SET,5,-0.41287,-0.0068089,0.39548,0.85174,GOBP_HINDBRAIN_MATURATION,1
GSE15930_NAIVE_VS_24H_IN_VIT...4,SET,188,-0.063929,-0.0064326,0.061214,0.85183,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
GOBP_SYNAPTIC_VESICLE_DOCKING,SET,9,-0.28766,-0.0063641,0.27539,0.85188,GOBP_SYNAPTIC_VESICLE_DOCKING,1
GOMF_DIPEPTIDASE_ACTIVITY,SET,17,-0.21415,-0.0065101,0.20502,0.85188,GOMF_DIPEPTIDASE_ACTIVITY,1
GCM_RAP2A,SET,33,-0.15245,-0.0064542,0.14592,0.85193,GCM_RAP2A,1
PID_LKB1_PATHWAY,SET,45,-0.13197,-0.0065223,0.1263,0.85196,PID_LKB1_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_EL...,SET,10,-0.27427,-0.0063958,0.26248,0.85196,GOBP_CELLULAR_RESPONSE_TO_ELECTRICAL_STIMULUS,1
MIR548AG,SET,158,-0.070168,-0.0064779,0.067147,0.85198,MIR548AG,1
HP_DELAYED_BRAINSTEM_AUDITOR...,SET,3,-0.53405,-0.0068226,0.51098,0.85202,HP_DELAYED_BRAINSTEM_AUDITORY_EVOKED_RESPONSE_CONDUCTION_TIME,1
GOBP_FACULTATIVE_HETEROCHROM...,SET,37,-0.14005,-0.0062773,0.13399,0.85203,GOBP_FACULTATIVE_HETEROCHROMATIN_FORMATION,1
GSE17721_PAM3CSK4_VS_GADIQUI...12,SET,184,-0.067163,-0.0066864,0.06425,0.85206,GSE17721_PAM3CSK4_VS_GADIQUIMOD_2H_BMDC_UP,1
MIR4435,SET,79,-0.099758,-0.0065263,0.095378,0.8522,MIR4435,1
HP_HYPOPROTEINEMIA,SET,18,-0.20146,-0.0063017,0.19259,0.85223,HP_HYPOPROTEINEMIA,1
IBRAHIM_NRF3_UP,SET,5,-0.41079,-0.0067746,0.39268,0.85224,IBRAHIM_NRF3_UP,1
GSE15930_STIM_VS_STIM_AND_IL...3,SET,190,-0.068356,-0.0069141,0.065342,0.85224,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_DN,1
GOBP_REGULATION_OF_TRANSLATI...12,SET,11,-0.24573,-0.0060098,0.23488,0.85225,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
GOBP_NUCLEAR_MIGRATION_ALONG...,SET,5,-0.37306,-0.0061524,0.35657,0.85227,GOBP_NUCLEAR_MIGRATION_ALONG_MICROTUBULE,1
GOBP_CEREBRAL_CORTEX_CELL_MI...,SET,42,-0.14284,-0.0068205,0.13647,0.85237,GOBP_CEREBRAL_CORTEX_CELL_MIGRATION,1
CRGAARNNNNCGA_UNKNOWN,SET,39,-0.14101,-0.0064888,0.13471,0.85239,CRGAARNNNNCGA_UNKNOWN,1
GOMF_CARBON_NITROGEN_LIGASE_...,SET,10,-0.25648,-0.005981,0.24494,0.85247,GOMF_CARBON_NITROGEN_LIGASE_ACTIVITY_WITH_GLUTAMINE_AS_AMIDO_N_DONOR,1
VEGF_A_UP.V1_UP,SET,177,-0.065731,-0.0064194,0.062771,0.85248,VEGF_A_UP.V1_UP,1
MIR3616_3P,SET,54,-0.11462,-0.0062037,0.10944,0.85251,MIR3616_3P,1
GOBP_AMINO_ACID_CATABOLIC_PR...,SET,94,-0.091079,-0.0064969,0.086955,0.85254,GOBP_AMINO_ACID_CATABOLIC_PROCESS,1
WANG_IMMORTALIZED_BY_HOXA9_A...1,SET,24,-0.19673,-0.0071044,0.18779,0.85258,WANG_IMMORTALIZED_BY_HOXA9_AND_MEIS1_DN,1
BENPORATH_ES_WITH_H3K27ME3,SET,1000,-0.03191,-0.0072379,0.03045,0.85266,BENPORATH_ES_WITH_H3K27ME3,1
GOBP_AXON_DEVELOPMENT,SET,470,-0.043264,-0.0068296,0.041286,0.85266,GOBP_AXON_DEVELOPMENT,1
KEGG_MEDICUS_VARIANT_EGFR_OV...,SET,10,-0.28165,-0.0065681,0.26873,0.85269,KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY,1
BANDRES_RESPONSE_TO_CARMUSTI...3,SET,148,-0.073187,-0.0065411,0.069827,0.8527,BANDRES_RESPONSE_TO_CARMUSTIN_MGMT_48HR_DN,1
chr5q12,SET,26,-0.28261,-0.010622,0.26959,0.85275,chr5q12,1
GOBP_PHOTORECEPTOR_CELL_DIFF...,SET,63,-0.11825,-0.0069112,0.11274,0.85287,GOBP_PHOTORECEPTOR_CELL_DIFFERENTIATION,1
KEGG_PORPHYRIN_AND_CHLOROPHY...,SET,35,-0.17645,-0.0076926,0.1682,0.85291,KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM,1
HP_HIP_OSTEOARTHRITIS,SET,17,-0.24419,-0.0074233,0.23269,0.853,HP_HIP_OSTEOARTHRITIS,1
HP_NARROW_NASAL_BRIDGE,SET,41,-0.14371,-0.0067799,0.13688,0.8531,HP_NARROW_NASAL_BRIDGE,1
GSE16385_UNTREATED_VS_12H_RO...6,SET,142,-0.078569,-0.0068794,0.07483,0.85313,GSE16385_UNTREATED_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...780,SET,4,-0.38067,-0.0056152,0.36249,0.85317,GOBP_POSITIVE_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_ENDOPLASMIC_RETICULUM_STRESS,1
HP_SUPRANUCLEAR_OPHTHALMOPLE...,SET,4,-0.33228,-0.0049014,0.31639,0.85318,HP_SUPRANUCLEAR_OPHTHALMOPLEGIA,1
HP_TETRAPARESIS,SET,101,-0.087305,-0.0064542,0.083126,0.8532,HP_TETRAPARESIS,1
KEGG_MEDICUS_PATHOGEN_EBV_BA...,SET,7,-0.32614,-0.0063636,0.31047,0.85324,KEGG_MEDICUS_PATHOGEN_EBV_BARF1_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
HP_ASTIGMATISM,SET,196,-0.061224,-0.0062887,0.058278,0.85326,HP_ASTIGMATISM,1
HP_POSITIVE_BLOOD_INFECTIOUS...,SET,17,-0.2079,-0.0063199,0.19789,0.85326,HP_POSITIVE_BLOOD_INFECTIOUS_AGENT_TEST,1
GOBP_NEGATIVE_REGULATION_OF_...566,SET,11,-0.28153,-0.0068854,0.26795,0.85329,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,1
GOCC_PEPTIDASE_INHIBITOR_COM...,SET,11,-0.29233,-0.0071496,0.2782,0.85332,GOCC_PEPTIDASE_INHIBITOR_COMPLEX,1
GOBP_SRP_DEPENDENT_COTRANSLA...2,SET,3,-0.43518,-0.0055595,0.4141,0.85334,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_SIGNAL_SEQUENCE_RECOGNITION,1
GOCC_SAGA_TYPE_COMPLEX,SET,33,-0.13187,-0.0055829,0.12549,0.85334,GOCC_SAGA_TYPE_COMPLEX,1
WP_PROLINE_AND_HYDROXYPROLIN...,SET,5,-0.47407,-0.0078183,0.45096,0.85342,WP_PROLINE_AND_HYDROXYPROLINE_PATHWAYS,1
GSE30153_LUPUS_VS_HEALTHY_DO...2,SET,184,-0.064178,-0.0063892,0.061048,0.85342,GSE30153_LUPUS_VS_HEALTHY_DONOR_BCELL_UP,1
GSE18791_CTRL_VS_NEWCASTLE_V...7,SET,168,-0.069297,-0.006595,0.065917,0.85343,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_16H_DN,1
NAKAMURA_LUNG_CANCER_DIFFERE...,SET,12,-0.2646,-0.0067588,0.25167,0.85344,NAKAMURA_LUNG_CANCER_DIFFERENTIATION_MARKERS,1
HP_AGENESIS_OF_CORPUS_CALLOS...,SET,301,-0.050353,-0.0063908,0.04789,0.85346,HP_AGENESIS_OF_CORPUS_CALLOSUM,1
REACTOME_GASTRULATION,SET,118,-0.079622,-0.0063594,0.075715,0.8535,REACTOME_GASTRULATION,1
GOBP_NEGATIVE_REGULATION_OF_...270,SET,14,-0.25115,-0.0069289,0.23883,0.8535,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_PROGENITOR_CELL_DIFFERENTIATION,1
GSE21927_BALBC_VS_C57BL6_MON...1,SET,148,-0.071477,-0.0063882,0.067971,0.8535,GSE21927_BALBC_VS_C57BL6_MONOCYTE_SPLEEN_DN,1
BROWNE_HCMV_INFECTION_12HR_UP,SET,100,-0.088959,-0.006544,0.08459,0.85351,BROWNE_HCMV_INFECTION_12HR_UP,1
HP_PULMONARY_HYPOPLASIA,SET,121,-0.080722,-0.0065282,0.076747,0.85355,HP_PULMONARY_HYPOPLASIA,1
USF2_Q6,SET,246,-0.058892,-0.0067677,0.055983,0.85359,USF2_Q6,1
GOMF_G_PROTEIN_BETA_SUBUNIT_...,SET,21,-0.21561,-0.0072838,0.20495,0.85359,GOMF_G_PROTEIN_BETA_SUBUNIT_BINDING,1
HP_FLARED_NOSTRILS,SET,6,-0.35166,-0.0063529,0.33429,0.85359,HP_FLARED_NOSTRILS,1
HOWARD_MONOCYTE_INACT_MONOV_...1,SET,35,-0.16261,-0.0070894,0.15455,0.85362,HOWARD_MONOCYTE_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_1DY_DN,1
HP_SCARRING_ALOPECIA_OF_SCALP,SET,13,-0.25038,-0.0066566,0.23793,0.85366,HP_SCARRING_ALOPECIA_OF_SCALP,1
GSE41978_KLRG1_HIGH_VS_LOW_E...2,SET,183,-0.067967,-0.0067483,0.064587,0.85367,GSE41978_KLRG1_HIGH_VS_LOW_EFFECTOR_CD8_TCELL_UP,1
REACTOME_RESOLUTION_OF_AP_SI...,SET,24,-0.16426,-0.0059321,0.15609,0.85369,REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_RE...3,SET,63,-0.12089,-0.0070655,0.11486,0.85371,GOBP_CELLULAR_RESPONSE_TO_RETINOIC_ACID,1
GOBP_POSITIVE_REGULATION_OF_...504,SET,9,-0.30919,-0.0068403,0.29376,0.85371,GOBP_POSITIVE_REGULATION_OF_MYELOID_CELL_APOPTOTIC_PROCESS,1
GSE20727_DNFB_ALLERGEN_VS_RO...2,SET,163,-0.070504,-0.0066102,0.066982,0.85373,GSE20727_DNFB_ALLERGEN_VS_ROS_INH_AND_DNFB_ALLERGEN_TREATED_DC_UP,1
MCM3_TARGET_GENES,SET,184,-0.065574,-0.0065282,0.062296,0.85374,MCM3_TARGET_GENES,1
MODULE_333,SET,27,-0.15217,-0.0058283,0.14457,0.85374,MODULE_333,1
HP_BIFID_EPIGLOTTIS,SET,5,-0.35058,-0.0057817,0.33305,0.85374,HP_BIFID_EPIGLOTTIS,1
GSE41867_NAIVE_VS_EFFECTOR_C...1,SET,182,-0.060027,-0.0059438,0.057023,0.85375,GSE41867_NAIVE_VS_EFFECTOR_CD8_TCELL_DN,1
HP_BILATERAL_SINGLE_TRANSVER...,SET,55,-0.12207,-0.0066676,0.11595,0.85377,HP_BILATERAL_SINGLE_TRANSVERSE_PALMAR_CREASES,1
GSE12366_GC_BCELL_VS_PLASMA_...1,SET,162,-0.068233,-0.0063778,0.064799,0.85382,GSE12366_GC_BCELL_VS_PLASMA_CELL_DN,1
GOBP_NITROGEN_CYCLE_METABOLI...,SET,12,-0.23617,-0.0060328,0.22424,0.85388,GOBP_NITROGEN_CYCLE_METABOLIC_PROCESS,1
GATA6_01,SET,236,-0.061614,-0.006937,0.05849,0.85392,GATA6_01,1
AIZARANI_LIVER_C6_KUPFFER_CE...,SET,203,-0.065646,-0.0068609,0.062284,0.85404,AIZARANI_LIVER_C6_KUPFFER_CELLS_2,1
MURAKAMI_UV_RESPONSE_1HR_UP,SET,14,-0.24051,-0.0066355,0.22817,0.85408,MURAKAMI_UV_RESPONSE_1HR_UP,1
HE_LIM_SUN_FETAL_LUNG_C2_PLA...,SET,316,-0.050858,-0.0066111,0.048246,0.85408,HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL,1
GGGNNTTTCC_NFKB_Q6_01,SET,126,-0.08062,-0.0066524,0.076471,0.85411,GGGNNTTTCC_NFKB_Q6_01,1
KEGG_ALLOGRAFT_REJECTION,SET,32,-0.17656,-0.007361,0.16743,0.85418,KEGG_ALLOGRAFT_REJECTION,1
BIOCARTA_PRION_PATHWAY,SET,12,-0.24514,-0.0062618,0.23244,0.8542,BIOCARTA_PRION_PATHWAY,1
GOMF_K48_LINKED_POLYUBIQUITI...,SET,7,-0.34072,-0.0066482,0.32305,0.85421,GOMF_K48_LINKED_POLYUBIQUITIN_MODIFICATION_DEPENDENT_PROTEIN_BINDING,1
GOCC_CARBOXY_TERMINAL_DOMAIN...,SET,19,-0.16552,-0.005319,0.15689,0.85427,GOCC_CARBOXY_TERMINAL_DOMAIN_PROTEIN_KINASE_COMPLEX,1
GSE41867_NAIVE_VS_DAY8_LCMV_...4,SET,185,-0.062552,-0.0062441,0.059286,0.8543,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
GOCC_PRP19_COMPLEX,SET,14,-0.24244,-0.0066887,0.22977,0.85431,GOCC_PRP19_COMPLEX,1
KEGG_MEDICUS_REFERENCE_IGF2_...,SET,11,-0.27792,-0.0067972,0.26338,0.85433,KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY,1
GOBP_INTESTINAL_ABSORPTION,SET,40,-0.1481,-0.0069016,0.14035,0.85433,GOBP_INTESTINAL_ABSORPTION,1
GOBP_LATERAL_MESODERM_MORPHO...,SET,5,-0.43117,-0.0071107,0.40855,0.85436,GOBP_LATERAL_MESODERM_MORPHOGENESIS,1
GOBP_MONOATOMIC_ANION_TRANSP...,SET,159,-0.075542,-0.0069959,0.071562,0.85442,GOBP_MONOATOMIC_ANION_TRANSPORT,1
MIR6767_3P,SET,24,-0.18145,-0.0065525,0.17187,0.85445,MIR6767_3P,1
GOBP_NEGATIVE_REGULATION_OF_...555,SET,21,-0.20148,-0.0068067,0.19084,0.85446,GOBP_NEGATIVE_REGULATION_OF_REGULATED_SECRETORY_PATHWAY,1
GOMF_ADENYLATE_CYCLASE_BINDI...,SET,12,-0.27346,-0.0069852,0.25899,0.85448,GOMF_ADENYLATE_CYCLASE_BINDING,1
KANNAN_BLOOD_2012_2013_TIV_A...2,SET,190,-0.063274,-0.0064001,0.059926,0.85448,KANNAN_BLOOD_2012_2013_TIV_AGE_65PLS_REVACCINATED_IN_6_9_MO_VS_REVACCINATED_IN_12_13_MO_UP,1
GSE22935_WT_VS_MYD88_KO_MACR...6,SET,184,-0.065747,-0.0065454,0.062258,0.85452,GSE22935_WT_VS_MYD88_KO_MACROPHAGE_48H_MBOVIS_BCG_STIM_UP,1
GOBP_PLUS_END_DIRECTED_ORGAN...,SET,7,-0.34043,-0.0066425,0.32231,0.85456,GOBP_PLUS_END_DIRECTED_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
ER_Q6_01,SET,240,-0.058029,-0.0065878,0.054935,0.85458,ER_Q6_01,1
LEE_LIVER_CANCER_CIPROFIBRAT...2,SET,57,-0.12322,-0.0068516,0.1166,0.85468,LEE_LIVER_CANCER_CIPROFIBRATE_UP,1
LIN_NPAS4_TARGETS_UP,SET,156,-0.069593,-0.0063843,0.065856,0.85468,LIN_NPAS4_TARGETS_UP,1
ONO_FOXP3_TARGETS_DN,SET,40,-0.1468,-0.0068411,0.13892,0.85468,ONO_FOXP3_TARGETS_DN,1
MIR4700_3P,SET,86,-0.098495,-0.0067218,0.093204,0.85469,MIR4700_3P,1
GOBP_REGULATION_OF_ENDOCYTOS...,SET,269,-0.054513,-0.0065465,0.051567,0.85477,GOBP_REGULATION_OF_ENDOCYTOSIS,1
GOBP_POSITIVE_REGULATION_OF_...390,SET,27,-0.17313,-0.0066311,0.16374,0.85483,GOBP_POSITIVE_REGULATION_OF_JUN_KINASE_ACTIVITY,1
GSE2124_CTRL_VS_LYMPHOTOXIN_...1,SET,178,-0.064721,-0.0063385,0.061207,0.85483,GSE2124_CTRL_VS_LYMPHOTOXIN_BETA_TREATED_MLN_DN,1
NADLER_HYPERGLYCEMIA_AT_OBES...,SET,53,-0.12878,-0.0069056,0.12178,0.85485,NADLER_HYPERGLYCEMIA_AT_OBESITY,1
HE_LIM_SUN_FETAL_LUNG_C0_ACT...,SET,522,-0.040516,-0.0067305,0.038312,0.85486,HE_LIM_SUN_FETAL_LUNG_C0_ACTC_POS_SMC_CELL,1
SHEN_SMARCA2_TARGETS_DN,SET,265,-0.056963,-0.0067905,0.053859,0.85488,SHEN_SMARCA2_TARGETS_DN,1
ATF_B,SET,174,-0.068795,-0.006662,0.065029,0.85495,ATF_B,1
HP_RECURRENT_INFECTION_OF_TH...,SET,35,-0.14833,-0.0064668,0.1402,0.85496,HP_RECURRENT_INFECTION_OF_THE_GASTROINTESTINAL_TRACT,1
GSE24634_NAIVE_CD4_TCELL_VS_...2,SET,168,-0.069132,-0.0065793,0.065324,0.85503,GSE24634_NAIVE_CD4_TCELL_VS_DAY10_IL4_CONV_TREG_UP,1
RAMJAUN_APOPTOSIS_BY_TGFB1_V...3,SET,10,-0.30549,-0.0071239,0.28865,0.85505,RAMJAUN_APOPTOSIS_BY_TGFB1_VIA_SMAD4_DN,1
GCM_CALM1,SET,98,-0.086623,-0.0063085,0.081838,0.85507,GCM_CALM1,1
MIR3146,SET,44,-0.13893,-0.0067894,0.13125,0.85508,MIR3146,1
GOBP_METANEPHRIC_LOOP_OF_HEN...,SET,5,-0.43823,-0.0072272,0.41384,0.85518,GOBP_METANEPHRIC_LOOP_OF_HENLE_DEVELOPMENT,1
SINGH_KRAS_DEPENDENCY_SIGNAT...,SET,19,-0.21427,-0.0068857,0.20228,0.85525,SINGH_KRAS_DEPENDENCY_SIGNATURE,1
GSE360_T_GONDII_VS_M_TUBERCU...4,SET,181,-0.065713,-0.006489,0.062034,0.85526,GSE360_T_GONDII_VS_M_TUBERCULOSIS_MAC_UP,1
HP_CEREBRAL_DYSMYELINATION,SET,12,-0.22673,-0.0057916,0.21403,0.85527,HP_CEREBRAL_DYSMYELINATION,1
GOBP_U2_TYPE_PRESPLICEOSOME_...,SET,22,-0.1695,-0.0058608,0.15998,0.85531,GOBP_U2_TYPE_PRESPLICEOSOME_ASSEMBLY,1
GOMF_ATP_ACTIVATED_INWARD_RE...,SET,6,-0.47103,-0.0085093,0.44451,0.85534,GOMF_ATP_ACTIVATED_INWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
GATA_C,SET,237,-0.059898,-0.0067578,0.056516,0.85538,GATA_C,1
SYED_ESTRADIOL_RESPONSE,SET,15,-0.22991,-0.0065653,0.21692,0.8554,SYED_ESTRADIOL_RESPONSE,1
GOBP_POSITIVE_REGULATION_OF_...823,SET,23,-0.1812,-0.0064059,0.17094,0.85543,GOBP_POSITIVE_REGULATION_OF_VACUOLE_ORGANIZATION,1
HP_MUTISM,SET,46,-0.12705,-0.0063483,0.11983,0.85548,HP_MUTISM,1
GOBP_MODULATION_OF_MICROTUBU...,SET,4,-0.42776,-0.0063098,0.40341,0.8555,GOBP_MODULATION_OF_MICROTUBULE_CYTOSKELETON_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,1
HP_SPINAL_CANAL_STENOSIS,SET,35,-0.155,-0.0067574,0.14618,0.8555,HP_SPINAL_CANAL_STENOSIS,1
HU_FETAL_RETINA_BLOOD,SET,244,-0.059467,-0.0068063,0.056074,0.85554,HU_FETAL_RETINA_BLOOD,1
GSE17721_CTRL_VS_GARDIQUIMOD...3,SET,184,-0.065738,-0.0065445,0.061984,0.85555,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_DN,1
GOCC_ZYMOGEN_GRANULE,SET,18,-0.19834,-0.006204,0.18699,0.85558,GOCC_ZYMOGEN_GRANULE,1
GOBP_DEVELOPMENTAL_GROWTH_IN...,SET,212,-0.063605,-0.0067917,0.059956,0.85561,GOBP_DEVELOPMENTAL_GROWTH_INVOLVED_IN_MORPHOGENESIS,1
GOMF_MHC_CLASS_II_RECEPTOR_A...,SET,8,-0.37854,-0.0078958,0.35681,0.85562,GOMF_MHC_CLASS_II_RECEPTOR_ACTIVITY,1
PID_ARF6_DOWNSTREAM_PATHWAY,SET,15,-0.24652,-0.0070398,0.23234,0.85565,PID_ARF6_DOWNSTREAM_PATHWAY,1
HP_ABNORMAL_FEMORAL_HEAD_MOR...,SET,87,-0.096759,-0.0066414,0.091187,0.85567,HP_ABNORMAL_FEMORAL_HEAD_MORPHOLOGY,1
GSE23321_EFFECTOR_MEMORY_VS_...2,SET,172,-0.069994,-0.0067394,0.065943,0.85575,GSE23321_EFFECTOR_MEMORY_VS_NAIVE_CD8_TCELL_UP,1
TURASHVILI_BREAST_DUCTAL_CAR...4,SET,71,-0.11062,-0.0068624,0.10422,0.85576,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_LOBULAR_NORMAL_UP,1
HP_ABNORMAL_FEMALE_EXTERNAL_...,SET,137,-0.078052,-0.0067136,0.073524,0.85578,HP_ABNORMAL_FEMALE_EXTERNAL_GENITALIA_MORPHOLOGY,1
GOBP_REGULATION_OF_RESPONSE_...9,SET,27,-0.17799,-0.006817,0.16762,0.85584,GOBP_REGULATION_OF_RESPONSE_TO_OXIDATIVE_STRESS,1
HP_DIFFUSE_DEMYELINATION_OF_...,SET,8,-0.33868,-0.0070645,0.31896,0.85584,HP_DIFFUSE_DEMYELINATION_OF_THE_CEREBRAL_WHITE_MATTER,1
GOBP_CELLULAR_RESPONSE_TO_OX...1,SET,225,-0.060399,-0.0066418,0.056879,0.85585,GOBP_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
GSE9650_EFFECTOR_VS_EXHAUSTE...1,SET,177,-0.069989,-0.0068352,0.065888,0.85593,GSE9650_EFFECTOR_VS_EXHAUSTED_CD8_TCELL_DN,1
GOBP_SPERM_MOTILITY,SET,122,-0.07746,-0.00629,0.072914,0.85595,GOBP_SPERM_MOTILITY,1
BHATI_G2M_ARREST_BY_2METHOXY...1,SET,107,-0.086205,-0.0065584,0.081115,0.85605,BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_DN,1
GSE36392_TYPE_2_MYELOID_VS_M...1,SET,181,-0.062079,-0.0061302,0.058411,0.85606,GSE36392_TYPE_2_MYELOID_VS_MAC_IL25_TREATED_LUNG_DN,1
GOMF_PEPTIDE_LYSINE_N_ACETYL...,SET,43,-0.12265,-0.0059256,0.1154,0.85607,GOMF_PEPTIDE_LYSINE_N_ACETYLTRANSFERASE_ACTIVITY,1
XU_GH1_EXOGENOUS_TARGETS_UP,SET,48,-0.13091,-0.0066816,0.12317,0.85608,XU_GH1_EXOGENOUS_TARGETS_UP,1
GOBP_CELLULAR_RESPONSE_TO_ST...4,SET,14,-0.24332,-0.0067129,0.22886,0.85614,GOBP_CELLULAR_RESPONSE_TO_STEROL_DEPLETION,1
REACTOME_CDC6_ASSOCIATION_WI...,SET,8,-0.27292,-0.0056928,0.25669,0.85615,REACTOME_CDC6_ASSOCIATION_WITH_THE_ORC_ORIGIN_COMPLEX,1
GSE41867_NAIVE_VS_DAY8_LCMV_...3,SET,159,-0.069385,-0.0064256,0.06526,0.85615,GSE41867_NAIVE_VS_DAY8_LCMV_CLONE13_EFFECTOR_CD8_TCELL_DN,1
HP_SIRENOMELIA,SET,11,-0.28573,-0.0069882,0.26871,0.85618,HP_SIRENOMELIA,1
HP_DEGENERATION_OF_THE_STRIA...,SET,11,-0.26337,-0.0064413,0.24754,0.85631,HP_DEGENERATION_OF_THE_STRIATUM,1
GSE43863_TH1_VS_TFH_MEMORY_C...1,SET,181,-0.066703,-0.0065868,0.062689,0.85633,GSE43863_TH1_VS_TFH_MEMORY_CD4_TCELL_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_ASP...,SET,105,-0.093926,-0.0070791,0.088276,0.85633,HE_LIM_SUN_FETAL_LUNG_C0_ASPN_POS_CHONDROCYTE,1
GSE4748_CTRL_VS_LPS_STIM_DC_...2,SET,183,-0.069049,-0.0068556,0.064893,0.85634,GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP,1
MIR140_5P,SET,82,-0.096919,-0.0064593,0.091049,0.85643,MIR140_5P,1
HP_RETROCEREBELLAR_CYST,SET,7,-0.29792,-0.0058132,0.27982,0.85648,HP_RETROCEREBELLAR_CYST,1
DESCARTES_FETAL_PLACENTA_LYM...,SET,114,-0.090187,-0.0070808,0.084709,0.85648,DESCARTES_FETAL_PLACENTA_LYMPHOID_CELLS,1
GOMF_PROTEIN_HORMONE_RECEPTO...,SET,18,-0.22929,-0.007172,0.21531,0.85653,GOMF_PROTEIN_HORMONE_RECEPTOR_ACTIVITY,1
REACTOME_DISEASES_OF_PROGRAM...,SET,42,-0.13958,-0.0066648,0.13107,0.85654,REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH,1
HP_ABNORMAL_T_CELL_SUBSET_DI...,SET,69,-0.11013,-0.006735,0.10341,0.85654,HP_ABNORMAL_T_CELL_SUBSET_DISTRIBUTION,1
MIR5680,SET,425,-0.045137,-0.006784,0.042381,0.85656,MIR5680,1
GOMF_ARGININE_BINDING,SET,6,-0.40412,-0.0073006,0.37942,0.85658,GOMF_ARGININE_BINDING,1
HP_ESODEVIATION,SET,200,-0.061595,-0.0063904,0.057828,0.85659,HP_ESODEVIATION,1
GOBP_RESPIRATORY_SYSTEM_DEVE...,SET,209,-0.065758,-0.0069723,0.061712,0.85668,GOBP_RESPIRATORY_SYSTEM_DEVELOPMENT,1
GOBP_REGULATION_OF_EXCITATOR...,SET,17,-0.22948,-0.0069761,0.21536,0.85669,GOBP_REGULATION_OF_EXCITATORY_SYNAPSE_ASSEMBLY,1
GOBP_NEPHRON_TUBULE_FORMATION,SET,18,-0.24456,-0.0076497,0.22949,0.8567,GOBP_NEPHRON_TUBULE_FORMATION,1
HP_DECREASED_PROPORTION_OF_C...1,SET,9,-0.30428,-0.0067318,0.28546,0.85676,HP_DECREASED_PROPORTION_OF_CD3_POSITIVE_T_CELLS,1
NFKAPPAB65_01,SET,230,-0.059904,-0.0066593,0.056191,0.8568,NFKAPPAB65_01,1
GSE35685_CD34POS_CD10NEG_CD6...2,SET,184,-0.064741,-0.0064453,0.060722,0.85683,GSE35685_CD34POS_CD10NEG_CD62LPOS_VS_CD34POS_CD10POS_BONE_MARROW_UP,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...2,SET,179,-0.066973,-0.0065772,0.06281,0.85684,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_UP,1
BANDRES_RESPONSE_TO_CARMUSTI...6,SET,12,-0.22866,-0.0058409,0.21443,0.85687,BANDRES_RESPONSE_TO_CARMUSTIN_WITHOUT_MGMT_24HR_UP,1
MIR4262,SET,704,-0.034772,-0.0066738,0.032606,0.85687,MIR4262,1
FIGUEROA_AML_METHYLATION_CLU...4,SET,47,-0.13243,-0.0066883,0.12418,0.85689,FIGUEROA_AML_METHYLATION_CLUSTER_2_UP,1
HP_MYOCLONIC_SPASMS,SET,29,-0.1639,-0.0065055,0.15367,0.85692,HP_MYOCLONIC_SPASMS,1
MIKKELSEN_ES_ICP_WITH_H3K27M...,SET,41,-0.14492,-0.0068371,0.13586,0.85694,MIKKELSEN_ES_ICP_WITH_H3K27ME3,1
GOBP_GLUTAMATE_REUPTAKE,SET,6,-0.42967,-0.0077622,0.4028,0.85694,GOBP_GLUTAMATE_REUPTAKE,1
MIR3124_3P,SET,204,-0.063042,-0.0066048,0.059079,0.85702,MIR3124_3P,1
ROZANOV_MMP14_CORRELATED,SET,10,-0.30951,-0.0072176,0.29002,0.85705,ROZANOV_MMP14_CORRELATED,1
GOBP_ORNITHINE_METABOLIC_PRO...,SET,9,-0.27096,-0.0059947,0.2539,0.85706,GOBP_ORNITHINE_METABOLIC_PROCESS,1
GOBP_METANEPHRIC_GLOMERULUS_...1,SET,16,-0.2613,-0.0077063,0.24479,0.8571,GOBP_METANEPHRIC_GLOMERULUS_DEVELOPMENT,1
HP_UPPER_EYELID_COLOBOMA,SET,9,-0.30488,-0.0067449,0.28562,0.8571,HP_UPPER_EYELID_COLOBOMA,1
HP_REDUCED_CIRCULATING_PROLA...,SET,20,-0.19966,-0.0065827,0.18704,0.85711,HP_REDUCED_CIRCULATING_PROLACTIN_CONCENTRATION,1
HP_COGNITIVE_IMPAIRMENT,SET,878,-0.030634,-0.0065338,0.028697,0.85713,HP_COGNITIVE_IMPAIRMENT,1
GAGCCAG_MIR149,SET,130,-0.075973,-0.0063669,0.071157,0.85716,GAGCCAG_MIR149,1
SMID_BREAST_CANCER_NORMAL_LI...1,SET,6,-0.40332,-0.007286,0.37772,0.85718,SMID_BREAST_CANCER_NORMAL_LIKE_DN,1
REACTOME_FORMATION_OF_DEFINI...,SET,14,-0.26297,-0.007255,0.24622,0.85723,REACTOME_FORMATION_OF_DEFINITIVE_ENDODERM,1
HP_UPPER_EXTREMITY_JOINT_DIS...,SET,81,-0.096294,-0.0063785,0.090162,0.85723,HP_UPPER_EXTREMITY_JOINT_DISLOCATION,1
GOBP_DICARBOXYLIC_ACID_CATAB...,SET,17,-0.20715,-0.0062971,0.19386,0.85735,GOBP_DICARBOXYLIC_ACID_CATABOLIC_PROCESS,1
MA_MYELOID_DIFFERENTIATION_UP,SET,37,-0.15297,-0.0068565,0.14313,0.85739,MA_MYELOID_DIFFERENTIATION_UP,1
GOBP_NEGATIVE_REGULATION_OF_...290,SET,472,-0.043207,-0.0068346,0.040424,0.85742,GOBP_NEGATIVE_REGULATION_OF_IMMUNE_SYSTEM_PROCESS,1
REACTOME_PHOSPHOLIPID_METABO...,SET,189,-0.06647,-0.0067059,0.062186,0.85743,REACTOME_PHOSPHOLIPID_METABOLISM,1
GSE17721_CPG_VS_GARDIQUIMOD_...14,SET,189,-0.06509,-0.0065666,0.060892,0.85744,GSE17721_CPG_VS_GARDIQUIMOD_4H_BMDC_UP,1
MODULE_108,SET,52,-0.14822,-0.0078727,0.13865,0.85745,MODULE_108,1
WP_MAPK_CASCADE,SET,31,-0.1567,-0.00643,0.14657,0.85748,WP_MAPK_CASCADE,1
GOBP_PROTEIN_LIPID_COMPLEX_O...,SET,52,-0.12907,-0.0068558,0.12073,0.85749,GOBP_PROTEIN_LIPID_COMPLEX_ORGANIZATION,1
GOBP_DISACCHARIDE_METABOLIC_...,SET,11,-0.2795,-0.0068359,0.26141,0.85751,GOBP_DISACCHARIDE_METABOLIC_PROCESS,1
GOBP_TELENCEPHALON_GLIAL_CEL...,SET,25,-0.19529,-0.0071979,0.18263,0.85754,GOBP_TELENCEPHALON_GLIAL_CELL_MIGRATION,1
HP_EPISODIC_METABOLIC_ACIDOS...,SET,4,-0.50926,-0.007512,0.47618,0.85756,HP_EPISODIC_METABOLIC_ACIDOSIS,1
HP_AMINOACIDURIA,SET,123,-0.078237,-0.0063789,0.073154,0.85757,HP_AMINOACIDURIA,1
REACTOME_NOSTRIN_MEDIATED_EN...,SET,5,-0.3637,-0.005998,0.34003,0.8576,REACTOME_NOSTRIN_MEDIATED_ENOS_TRAFFICKING,1
YANG_BREAST_CANCER_ESR1_LASE...2,SET,27,-0.16724,-0.0064055,0.15635,0.85761,YANG_BREAST_CANCER_ESR1_LASER_UP,1
GOBP_REGULATION_OF_MYOFIBROB...,SET,6,-0.37315,-0.0067411,0.34878,0.85766,GOBP_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...337,SET,5,-0.47673,-0.007862,0.44539,0.85776,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_ADHESION_TO_VASCULAR_ENDOTHELIAL_CELL,1
GSE7460_WT_VS_FOXP3_HET_ACT_...4,SET,183,-0.066668,-0.0066193,0.062267,0.85784,GSE7460_WT_VS_FOXP3_HET_ACT_WITH_TGFB_TCONV_UP,1
HP_PLACENTAL_ABRUPTION,SET,4,-0.53182,-0.0078449,0.49668,0.85785,HP_PLACENTAL_ABRUPTION,1
MIR3662,SET,850,-0.032132,-0.0067485,0.030006,0.85788,MIR3662,1
LMNB2_TARGET_GENES,SET,31,-0.15367,-0.0063059,0.14346,0.85795,LMNB2_TARGET_GENES,1
GOCC_PHOSPHATIDYLINOSITOL_3_...2,SET,9,-0.34979,-0.0077386,0.32652,0.85797,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX_CLASS_I,1
HP_ADRENOCORTICAL_ADENOMA,SET,9,-0.33195,-0.0073439,0.30984,0.85799,HP_ADRENOCORTICAL_ADENOMA,1
HP_INSOMNIA,SET,62,-0.11643,-0.0067507,0.10867,0.858,HP_INSOMNIA,1
GOCC_CILIARY_MEMBRANE,SET,72,-0.10111,-0.0063162,0.094365,0.85802,GOCC_CILIARY_MEMBRANE,1
chr21q21,SET,25,-0.30144,-0.01111,0.28132,0.85803,chr21q21,1
USF_Q6,SET,227,-0.0582,-0.006428,0.054307,0.85806,USF_Q6,1
MODULE_303,SET,27,-0.17198,-0.0065868,0.16047,0.85806,MODULE_303,1
HP_ABNORMALITY_OF_THE_INCISOR,SET,93,-0.093141,-0.0066088,0.086912,0.85806,HP_ABNORMALITY_OF_THE_INCISOR,1
GSE24726_WT_VS_E2_22_KO_PDC_...,SET,178,-0.066281,-0.0064912,0.061844,0.85808,GSE24726_WT_VS_E2_22_KO_PDC_DAY4_POST_DELETION_DN,1
WP_IL5_SIGNALING,SET,38,-0.15386,-0.0069887,0.14353,0.85812,WP_IL5_SIGNALING,1
GSE35685_CD34POS_CD38NEG_VS_...3,SET,188,-0.065667,-0.0066075,0.061247,0.85817,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_DN,1
HP_HYPERTONIA,SET,977,-0.028762,-0.0064527,0.026821,0.85821,HP_HYPERTONIA,1
GSE19888_ADENOSINE_A3R_INH_V...5,SET,177,-0.070912,-0.0069254,0.066122,0.85823,GSE19888_ADENOSINE_A3R_INH_VS_INH_PRETREAT_AND_ACT_WITH_TCELL_MEMBRANES_MAST_CELL_DN,1
HOEGERKORP_CD44_TARGETS_DIRE...2,SET,24,-0.18746,-0.0067699,0.17475,0.8583,HOEGERKORP_CD44_TARGETS_DIRECT_UP,1
GOBP_NEGATIVE_REGULATION_OF_...173,SET,6,-0.36265,-0.0065514,0.33803,0.85832,GOBP_NEGATIVE_REGULATION_OF_DENDRITE_MORPHOGENESIS,1
MIR3147,SET,35,-0.1689,-0.0073634,0.1574,0.85837,MIR3147,1
BIOCARTA_CTL_PATHWAY,SET,13,-0.26346,-0.0070045,0.24551,0.85839,BIOCARTA_CTL_PATHWAY,1
HP_ABNORMAL_ACETABULUM_MORPH...,SET,84,-0.096373,-0.0065004,0.089803,0.85839,HP_ABNORMAL_ACETABULUM_MORPHOLOGY,1
GOBP_PROSTATE_GLAND_MORPHOGE...,SET,26,-0.20624,-0.0077514,0.19216,0.85842,GOBP_PROSTATE_GLAND_MORPHOGENESIS,1
GOBP_REGULATION_OF_NITRIC_OX...1,SET,6,-0.39114,-0.007066,0.36441,0.85844,GOBP_REGULATION_OF_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,1
GOBP_RESPONSE_TO_VITAMIN_D,SET,35,-0.16773,-0.0073127,0.15627,0.85844,GOBP_RESPONSE_TO_VITAMIN_D,1
GSE21670_TGFB_VS_IL6_TREATED...3,SET,185,-0.067612,-0.0067492,0.062987,0.85845,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_DN,1
GOBP_CELLULAR_RESPONSE_TO_EX...1,SET,13,-0.24633,-0.006549,0.2294,0.85854,GOBP_CELLULAR_RESPONSE_TO_EXOGENOUS_DSRNA,1
HOEK_MONOCYTE_2011_2012_TIV_...4,SET,2,-0.78851,-0.008225,0.73428,0.85855,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_UP,1
HP_HYPOKETOTIC_HYPOGLYCEMIA,SET,14,-0.23978,-0.0066154,0.22319,0.85865,HP_HYPOKETOTIC_HYPOGLYCEMIA,1
GSE40666_STAT1_KO_VS_STAT4_K...1,SET,139,-0.080535,-0.0069772,0.074949,0.8587,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_DN,1
TFIIA_Q6,SET,231,-0.06207,-0.0069148,0.057761,0.85871,TFIIA_Q6,1
GOBP_CELLULAR_HYPOTONIC_RESP...,SET,11,-0.28794,-0.0070423,0.26791,0.85875,GOBP_CELLULAR_HYPOTONIC_RESPONSE,1
GOBP_ISOPRENOID_CATABOLIC_PR...,SET,9,-0.32888,-0.0072761,0.30601,0.85875,GOBP_ISOPRENOID_CATABOLIC_PROCESS,1
GOBP_BLASTODERM_SEGMENTATION,SET,22,-0.19493,-0.0067402,0.18136,0.85877,GOBP_BLASTODERM_SEGMENTATION,1
GOBP_PROTEIN_LOCALIZATION_TO...9,SET,318,-0.050903,-0.0066375,0.047357,0.85878,GOBP_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
GOBP_LUNG_ALVEOLUS_DEVELOPME...,SET,51,-0.13568,-0.0071374,0.12622,0.8588,GOBP_LUNG_ALVEOLUS_DEVELOPMENT,1
HERNANDEZ_ABERRANT_MITOSIS_B...4,SET,18,-0.22145,-0.0069269,0.206,0.85881,HERNANDEZ_ABERRANT_MITOSIS_BY_DOCETACEL_4NM_UP,1
ISRE_01,SET,227,-0.061945,-0.0068416,0.05762,0.85882,ISRE_01,1
MIR4300,SET,57,-0.11582,-0.0064402,0.10773,0.85883,MIR4300,1
ZNF41_TARGET_GENES,SET,171,-0.068863,-0.0066114,0.064029,0.85891,ZNF41_TARGET_GENES,1
KYNG_WERNER_SYNDROM_AND_NORM...2,SET,74,-0.099264,-0.0062859,0.092283,0.85895,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_UP,1
GOBP_REGULATION_OF_PLASMA_LI...,SET,75,-0.107,-0.0068214,0.099474,0.85896,GOBP_REGULATION_OF_PLASMA_LIPOPROTEIN_PARTICLE_LEVELS,1
GOBP_REGULATION_OF_MICROTUBU...4,SET,148,-0.068684,-0.0061386,0.063835,0.85902,GOBP_REGULATION_OF_MICROTUBULE_CYTOSKELETON_ORGANIZATION,1
GOBP_GROWTH_PLATE_CARTILAGE_...1,SET,5,-0.48674,-0.0080271,0.45229,0.85906,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DEVELOPMENT,1
GOBP_REGULATION_OF_BODY_FLUI...,SET,352,-0.052272,-0.0071644,0.048571,0.85907,GOBP_REGULATION_OF_BODY_FLUID_LEVELS,1
FAN_EMBRYONIC_CTX_ASTROCYTE_1,SET,73,-0.10831,-0.0068122,0.10063,0.85909,FAN_EMBRYONIC_CTX_ASTROCYTE_1,1
chr10q24,SET,109,-0.16848,-0.012936,0.15651,0.85914,chr10q24,1
HP_BRACHYTURRICEPHALY,SET,8,-0.33505,-0.0069888,0.31121,0.85917,HP_BRACHYTURRICEPHALY,1
HP_PULMONARY_INTERSTITIAL_TH...,SET,7,-0.38279,-0.007469,0.35552,0.85919,HP_PULMONARY_INTERSTITIAL_THICKENING,1
REACTOME_CELL_CELL_JUNCTION_...,SET,80,-0.11133,-0.007329,0.10339,0.85921,REACTOME_CELL_CELL_JUNCTION_ORGANIZATION,1
GSE14415_ACT_TCONV_VS_ACT_NA...1,SET,164,-0.071862,-0.006758,0.066732,0.85923,GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_DN,1
GSE42021_TREG_PLN_VS_CD24HI_...1,SET,183,-0.062935,-0.0062486,0.058442,0.85923,GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_DN,1
MANNE_COVID19_ICU_VS_HEALTHY...2,SET,117,-0.082473,-0.0065593,0.076569,0.85928,MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_UP,1
HP_CRANIOSYNOSTOSIS,SET,162,-0.069132,-0.0064618,0.064172,0.85932,HP_CRANIOSYNOSTOSIS,1
MODULE_263,SET,44,-0.17184,-0.0083978,0.1595,0.85933,MODULE_263,1
GOBP_DETECTION_OF_MECHANICAL...4,SET,13,-0.27947,-0.00743,0.2594,0.85934,GOBP_DETECTION_OF_MECHANICAL_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION_OF_SOUND,1
GSE42088_UNINF_VS_LEISHMANIA...8,SET,183,-0.069473,-0.0068977,0.064474,0.85937,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_8H_UP,1
MORF_MYL3,SET,63,-0.11801,-0.0068972,0.1095,0.85941,MORF_MYL3,1
GOBP_POSITIVE_REGULATION_OF_...472,SET,7,-0.31252,-0.006098,0.28998,0.85941,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_OUTER_MEMBRANE_PERMEABILIZATION_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
NAKAMURA_ADIPOGENESIS_EARLY_...1,SET,33,-0.16645,-0.0070467,0.15444,0.85942,NAKAMURA_ADIPOGENESIS_EARLY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...355,SET,11,-0.27477,-0.0067201,0.25493,0.85943,GOBP_NEGATIVE_REGULATION_OF_LIPOPROTEIN_PARTICLE_CLEARANCE,1
GOBP_POSITIVE_REGULATION_OF_...31,SET,5,-0.44594,-0.0073543,0.41375,0.85943,GOBP_POSITIVE_REGULATION_OF_ANTIBACTERIAL_PEPTIDE_PRODUCTION,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...1,SET,185,-0.066985,-0.0066866,0.062142,0.85946,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_12H_DN,1
GOBP_SPERMIDINE_TRANSPORT,SET,5,-0.48897,-0.008064,0.4536,0.85947,GOBP_SPERMIDINE_TRANSPORT,1
MIR3151_5P,SET,48,-0.12185,-0.0062189,0.11302,0.8595,MIR3151_5P,1
FOXO1_01,SET,220,-0.063533,-0.0069093,0.058912,0.85957,FOXO1_01,1
GSE12845_IGD_POS_VS_NEG_BLOO...2,SET,170,-0.067666,-0.0064777,0.062742,0.85958,GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_UP,1
LU_TUMOR_VASCULATURE_UP,SET,27,-0.19309,-0.0073953,0.17903,0.8596,LU_TUMOR_VASCULATURE_UP,1
GSE36826_NORMAL_VS_STAPH_AUR...2,SET,187,-0.066741,-0.0066978,0.061876,0.85961,GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_UP,1
GSE11924_TH1_VS_TH17_CD4_TCE...2,SET,182,-0.067252,-0.0066592,0.062348,0.85962,GSE11924_TH1_VS_TH17_CD4_TCELL_UP,1
GSE360_L_MAJOR_VS_B_MALAYI_L...1,SET,178,-0.066807,-0.0065427,0.061933,0.85963,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_DC_DN,1
HP_HYPOGONADISM,SET,377,-0.046474,-0.0065875,0.043077,0.85966,HP_HYPOGONADISM,1
MIR4433B_3P,SET,28,-0.16906,-0.0065937,0.15666,0.85974,MIR4433B_3P,1
GNF2_RPA1,SET,25,-0.16906,-0.0062309,0.15666,0.85974,GNF2_RPA1,1
MIR4777_3P,SET,61,-0.11179,-0.0064296,0.10358,0.85975,MIR4777_3P,1
GOBP_MATERNAL_PROCESS_INVOLV...2,SET,5,-0.35085,-0.005786,0.32506,0.85977,GOBP_MATERNAL_PROCESS_INVOLVED_IN_PARTURITION,1
BYSTRYKH_HEMATOPOIESIS_STEM_...7,SET,720,-0.034414,-0.0066767,0.031883,0.85978,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS,1
GOBP_PROTEIN_O_LINKED_GLYCOS...2,SET,8,-0.31225,-0.0065132,0.28925,0.85982,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_SERINE,1
HP_INFERIOR_CEREBELLAR_VERMI...,SET,13,-0.24169,-0.0064256,0.22385,0.85985,HP_INFERIOR_CEREBELLAR_VERMIS_HYPOPLASIA,1
GSE45365_WT_VS_IFNAR_KO_CD11...4,SET,161,-0.069464,-0.0064729,0.064337,0.85985,GSE45365_WT_VS_IFNAR_KO_CD11B_DC_UP,1
HP_EXTERNAL_OPHTHALMOPLEGIA,SET,51,-0.12114,-0.0063727,0.11218,0.85989,HP_EXTERNAL_OPHTHALMOPLEGIA,1
REACTOME_LONG_TERM_POTENTIAT...,SET,22,-0.21121,-0.0073032,0.19557,0.85992,REACTOME_LONG_TERM_POTENTIATION,1
WP_SPHINGOLIPID_METABOLISM_O...,SET,23,-0.2061,-0.0072864,0.19082,0.85994,WP_SPHINGOLIPID_METABOLISM_OVERVIEW,1
HP_ICHTHYOSIS,SET,123,-0.082227,-0.0067042,0.076125,0.85996,HP_ICHTHYOSIS,1
REACTOME_SYNTHESIS_OF_DOLICH...,SET,5,-0.42773,-0.007054,0.39594,0.85999,REACTOME_SYNTHESIS_OF_DOLICHYL_PHOSPHATE,1
GOBP_PEXOPHAGY,SET,5,-0.40532,-0.0066843,0.37517,0.86,GOBP_PEXOPHAGY,1
GOBP_NEGATIVE_ADAPTATION_OF_...,SET,12,-0.26535,-0.006778,0.24543,0.86018,GOBP_NEGATIVE_ADAPTATION_OF_SIGNALING_PATHWAY,1
GOBP_VERY_LONG_CHAIN_FATTY_A...3,SET,33,-0.16636,-0.007043,0.15387,0.86018,GOBP_VERY_LONG_CHAIN_FATTY_ACID_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...51,SET,52,-0.13433,-0.0071349,0.12424,0.86019,GOBP_NEGATIVE_REGULATION_OF_BMP_SIGNALING_PATHWAY,1
GOBP_NEPHRON_MORPHOGENESIS,SET,75,-0.11583,-0.0073841,0.10713,0.8602,GOBP_NEPHRON_MORPHOGENESIS,1
GOBP_REGULATION_OF_EPIDERMAL...,SET,16,-0.21754,-0.0064157,0.20119,0.8602,GOBP_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,1
MIR4654,SET,51,-0.12897,-0.0067842,0.11927,0.86021,MIR4654,1
MIR548AI_MIR570_5P,SET,161,-0.071966,-0.0067061,0.06654,0.86027,MIR548AI_MIR570_5P,1
GOBP_POSITIVE_REGULATION_OF_...605,SET,7,-0.36113,-0.0070465,0.33382,0.86033,GOBP_POSITIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,1
GOBP_REGULATION_OF_ANTIGEN_P...2,SET,5,-0.39804,-0.0065643,0.3679,0.86035,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_ANTIGEN,1
PHONG_TNF_RESPONSE_VIA_P38_P...,SET,155,-0.080409,-0.0073531,0.074302,0.86041,PHONG_TNF_RESPONSE_VIA_P38_PARTIAL,1
GSE43955_TH0_VS_TGFB_IL6_TH1...16,SET,184,-0.068478,-0.0068173,0.063272,0.86043,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP,1
HP_REDUCED_CEREBRAL_WHITE_MA...,SET,31,-0.16566,-0.0067977,0.15306,0.86044,HP_REDUCED_CEREBRAL_WHITE_MATTER_VOLUME,1
DEMAGALHAES_AGING_UP,SET,48,-0.12744,-0.0065045,0.11772,0.86051,DEMAGALHAES_AGING_UP,1
WP_SYNAPTIC_SIGNALING_ASSOCI...,SET,50,-0.13255,-0.006904,0.12242,0.86052,WP_SYNAPTIC_SIGNALING_ASSOCIATED_WITH_AUTISM_SPECTRUM_DISORDER,1
DESCARTES_FETAL_THYMUS_THYMO...,SET,19,-0.22913,-0.0073632,0.21163,0.86052,DESCARTES_FETAL_THYMUS_THYMOCYTES,1
MIR1914_5P,SET,55,-0.13002,-0.007102,0.12008,0.86055,MIR1914_5P,1
E4BP4_01,SET,194,-0.069822,-0.0071355,0.064478,0.86056,E4BP4_01,1
HP_ENTHESITIS,SET,10,-0.34108,-0.0079538,0.31498,0.86056,HP_ENTHESITIS,1
GOBP_NEGATIVE_REGULATION_OF_...705,SET,8,-0.35474,-0.0073995,0.32754,0.8606,GOBP_NEGATIVE_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
KEGG_RENIN_ANGIOTENSIN_SYSTEM,SET,15,-0.25893,-0.0073942,0.23905,0.86062,KEGG_RENIN_ANGIOTENSIN_SYSTEM,1
GSE6674_CPG_VS_CPG_AND_ANTI_...2,SET,176,-0.065459,-0.0063749,0.060433,0.86062,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_UP,1
KEGG_NITROGEN_METABOLISM,SET,21,-0.20496,-0.006924,0.18921,0.86064,KEGG_NITROGEN_METABOLISM,1
NFKB_C,SET,244,-0.059373,-0.0067955,0.054809,0.86065,NFKB_C,1
HP_CYCLOPIA,SET,19,-0.20402,-0.0065563,0.18832,0.86067,HP_CYCLOPIA,1
HP_RHINORRHEA,SET,7,-0.30147,-0.0058823,0.27822,0.86071,HP_RHINORRHEA,1
GSE20198_IL12_VS_IFNA_TREATE...1,SET,180,-0.068037,-0.0067001,0.062785,0.86073,GSE20198_IL12_VS_IFNA_TREATED_ACT_CD4_TCELL_DN,1
AGGAGTG_MIR483,SET,54,-0.12233,-0.0066212,0.11288,0.86074,AGGAGTG_MIR483,1
GOBP_NUCLEOBASE_BIOSYNTHETIC...,SET,15,-0.22135,-0.006321,0.20422,0.86079,GOBP_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
MIR3680_5P,SET,31,-0.14891,-0.0061107,0.13736,0.86083,MIR3680_5P,1
CHIANG_LIVER_CANCER_SUBCLASS...4,SET,22,-0.21206,-0.0073325,0.19555,0.86091,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_UP,1
REACTOME_SENSORY_PROCESSING_...2,SET,49,-0.13979,-0.0072084,0.12889,0.86094,REACTOME_SENSORY_PROCESSING_OF_SOUND_BY_OUTER_HAIR_CELLS_OF_THE_COCHLEA,1
REACTOME_KETONE_BODY_METABOL...,SET,10,-0.3168,-0.0073877,0.29208,0.86095,REACTOME_KETONE_BODY_METABOLISM,1
HP_MILD_GLOBAL_DEVELOPMENTAL...,SET,70,-0.10877,-0.0067001,0.10029,0.86095,HP_MILD_GLOBAL_DEVELOPMENTAL_DELAY,1
GSE7768_OVA_WITH_LPS_VS_OVA_...1,SET,154,-0.072341,-0.0065941,0.066698,0.86095,GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,1
SRPK2_TARGET_GENES,SET,47,-0.13275,-0.0067047,0.12239,0.86097,SRPK2_TARGET_GENES,1
GENTILE_UV_HIGH_DOSE_DN,SET,269,-0.05568,-0.0066867,0.051328,0.86098,GENTILE_UV_HIGH_DOSE_DN,1
CHIARADONNA_NEOPLASTIC_TRANS...3,SET,49,-0.13962,-0.0071997,0.12871,0.86099,CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN,1
LASTOWSKA_NEUROBLASTOMA_COPY...1,SET,731,-0.03984,-0.0077857,0.036718,0.86104,LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN,1
GOBP_POSITIVE_REGULATION_OF_...203,SET,5,-0.40724,-0.006716,0.37531,0.86104,GOBP_POSITIVE_REGULATION_OF_DEOXYRIBONUCLEASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...610,SET,21,-0.2044,-0.0069052,0.18828,0.86116,GOBP_POSITIVE_REGULATION_OF_PROTEIN_AUTOPHOSPHORYLATION,1
GOBP_FAT_SOLUBLE_VITAMIN_BIO...,SET,13,-0.26629,-0.0070797,0.24525,0.8612,GOBP_FAT_SOLUBLE_VITAMIN_BIOSYNTHETIC_PROCESS,1
MODULE_503,SET,103,-0.090737,-0.0067736,0.083553,0.86125,MODULE_503,1
HP_OPTIC_NERVE_GLIOMA,SET,5,-0.41761,-0.0068872,0.38453,0.86126,HP_OPTIC_NERVE_GLIOMA,1
GOBP_REGULATION_OF_VOLTAGE_G...1,SET,21,-0.21097,-0.0071274,0.19423,0.8613,GOBP_REGULATION_OF_VOLTAGE_GATED_CALCIUM_CHANNEL_ACTIVITY,1
GOCC_PRESYNAPTIC_ENDOCYTIC_Z...,SET,9,-0.32295,-0.0071447,0.29731,0.8613,GOCC_PRESYNAPTIC_ENDOCYTIC_ZONE,1
GOBP_POSITIVE_REGULATION_OF_...537,SET,4,-0.34263,-0.0050542,0.31539,0.86133,GOBP_POSITIVE_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_VESICLE_TETHERING_INVOL...,SET,9,-0.2867,-0.0063429,0.2639,0.86134,GOBP_VESICLE_TETHERING_INVOLVED_IN_EXOCYTOSIS,1
REACTOME_G_ALPHA_S_SIGNALLIN...,SET,152,-0.079956,-0.0072412,0.073596,0.86135,REACTOME_G_ALPHA_S_SIGNALLING_EVENTS,1
GSE16266_CTRL_VS_LPS_STIM_ME...2,SET,182,-0.071493,-0.0070791,0.065805,0.86135,GSE16266_CTRL_VS_LPS_STIM_MEF_UP,1
GSE28737_WT_VS_BCL6_KO_MARGI...2,SET,178,-0.067279,-0.0065889,0.061926,0.86135,GSE28737_WT_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP,1
GOBP_REGULATION_OF_CHROMOSOM...3,SET,125,-0.078007,-0.0064113,0.071792,0.86138,GOBP_REGULATION_OF_CHROMOSOME_SEGREGATION,1
GOCC_U12_TYPE_SPLICEOSOMAL_C...,SET,24,-0.16079,-0.0058066,0.14792,0.86148,GOCC_U12_TYPE_SPLICEOSOMAL_COMPLEX,1
GOBP_REGULATION_OF_RESPONSE_...11,SET,1249,-0.026849,-0.0067572,0.024697,0.8615,GOBP_REGULATION_OF_RESPONSE_TO_STRESS,1
GOBP_TORC1_SIGNALING,SET,92,-0.092203,-0.0065071,0.084812,0.86151,GOBP_TORC1_SIGNALING,1
REACTOME_RNA_POLYMERASE_I_PR...,SET,27,-0.14685,-0.0056244,0.13507,0.86152,REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE,1
GSE32986_GMCSF_VS_GMCSF_AND_...2,SET,182,-0.067713,-0.0067048,0.062281,0.86152,GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,1
GOBP_VENTRAL_SPINAL_CORD_DEV...,SET,44,-0.14602,-0.0071361,0.13431,0.86153,GOBP_VENTRAL_SPINAL_CORD_DEVELOPMENT,1
MIR449C_3P,SET,50,-0.12636,-0.0065816,0.11621,0.86154,MIR449C_3P,1
GSE21774_CD62L_POS_CD56_BRIG...2,SET,173,-0.073482,-0.0070956,0.067583,0.86154,GSE21774_CD62L_POS_CD56_BRIGHT_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP,1
HP_ABNORMALITY_OF_SPINAL_FAC...,SET,5,-0.4424,-0.007296,0.40687,0.86155,HP_ABNORMALITY_OF_SPINAL_FACET_JOINT,1
GARGALOVIC_RESPONSE_TO_OXIDI...2,SET,32,-0.16966,-0.0070733,0.15603,0.86156,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLACK_UP,1
GOMF_STEROL_ESTERASE_ACTIVITY,SET,7,-0.36437,-0.0071097,0.33508,0.86157,GOMF_STEROL_ESTERASE_ACTIVITY,1
GOBP_RESPONSE_TO_NUTRIENT,SET,156,-0.077939,-0.00715,0.071626,0.86173,GOBP_RESPONSE_TO_NUTRIENT,1
WP_KININKALLIKREIN_PATHWAY,SET,7,-0.42219,-0.0082379,0.38795,0.86175,WP_KININKALLIKREIN_PATHWAY,1
GAUTAM_EYE_IRIS_CILIARY_BODY...8,SET,99,-0.098203,-0.007188,0.090232,0.86177,GAUTAM_EYE_IRIS_CILIARY_BODY_MEG3_HIGH_FIBROBLASTS,1
chr19q13,SET,730,-0.085567,-0.016711,0.078612,0.8618,chr19q13,1
KEGG_VALINE_LEUCINE_AND_ISOL...1,SET,6,-0.37274,-0.0067337,0.34245,0.8618,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_BIOSYNTHESIS,1
CDC73_TARGET_GENES,SET,480,-0.040606,-0.006476,0.0373,0.86184,CDC73_TARGET_GENES,1
GSE32986_GMCSF_AND_CURDLAN_L...2,SET,178,-0.066753,-0.0065374,0.061316,0.86184,GSE32986_GMCSF_AND_CURDLAN_LOWDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP,1
GSE36476_YOUNG_VS_OLD_DONOR_...3,SET,179,-0.065319,-0.0064148,0.060001,0.86184,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_DN,1
GSE41176_UNSTIM_VS_ANTI_IGM_...12,SET,182,-0.064493,-0.006386,0.059242,0.86184,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_24H_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...44,SET,5,-0.43859,-0.007233,0.40284,0.86186,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_EXTRINSIC_APOPTOTIC_PATHWAY,1
REACTOME_RUNX2_REGULATES_OST...,SET,21,-0.22559,-0.0076211,0.2072,0.86186,REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION,1
MIR330_5P,SET,169,-0.071831,-0.0068563,0.065955,0.86193,MIR330_5P,1
HP_ABNORMALITY_OF_THE_VASCUL...,SET,337,-0.049893,-0.0066939,0.045807,0.86196,HP_ABNORMALITY_OF_THE_VASCULATURE_OF_THE_EYE,1
HP_PSORIASIFORM_LESION,SET,3,-0.59814,-0.0076413,0.54898,0.86204,HP_PSORIASIFORM_LESION,1
GSE45365_CTRL_VS_MCMV_INFECT...1,SET,172,-0.068551,-0.0066005,0.062917,0.86204,GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN,1
GOBP_PROTEIN_K27_LINKED_UBIQ...,SET,11,-0.26088,-0.0063803,0.2394,0.86208,GOBP_PROTEIN_K27_LINKED_UBIQUITINATION,1
BILD_MYC_ONCOGENIC_SIGNATURE,SET,181,-0.065303,-0.0064486,0.05992,0.8621,BILD_MYC_ONCOGENIC_SIGNATURE,1
GOBP_POSITIVE_REGULATION_OF_...85,SET,95,-0.10155,-0.0072822,0.093172,0.86212,GOBP_POSITIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
CAFFAREL_RESPONSE_TO_THC_8HR...4,SET,13,-0.24692,-0.0065647,0.22651,0.86216,CAFFAREL_RESPONSE_TO_THC_8HR_5_UP,1
GOMF_PHOSPHATASE_ACTIVATOR_A...,SET,16,-0.23,-0.0067832,0.21098,0.86216,GOMF_PHOSPHATASE_ACTIVATOR_ACTIVITY,1
GOBP_MIRNA_CATABOLIC_PROCESS,SET,8,-0.29549,-0.0061635,0.27105,0.86217,GOBP_MIRNA_CATABOLIC_PROCESS,1
GSE3982_DC_VS_TH1_DN,SET,177,-0.065835,-0.0064295,0.060388,0.86218,GSE3982_DC_VS_TH1_DN,1
MIR6769A_5P,SET,43,-0.14065,-0.0067955,0.129,0.86221,MIR6769A_5P,1
MIR151A_3P,SET,30,-0.17582,-0.0070977,0.16124,0.86223,MIR151A_3P,1
GSE43955_TH0_VS_TGFB_IL6_TH1...9,SET,184,-0.069253,-0.0068945,0.063502,0.86226,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_42H_DN,1
GOBP_B_CELL_LINEAGE_COMMITME...,SET,6,-0.35341,-0.0063844,0.32404,0.86228,GOBP_B_CELL_LINEAGE_COMMITMENT,1
GOBP_CAVEOLIN_MEDIATED_ENDOC...,SET,11,-0.27575,-0.006744,0.25281,0.86229,GOBP_CAVEOLIN_MEDIATED_ENDOCYTOSIS,1
GSE15330_LYMPHOID_MULTIPOTEN...9,SET,177,-0.068424,-0.0066824,0.062732,0.8623,GSE15330_LYMPHOID_MULTIPOTENT_VS_PRO_BCELL_DN,1
ZFP36L1_TARGET_GENES,SET,47,-0.13348,-0.0067415,0.12237,0.86232,ZFP36L1_TARGET_GENES,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...3,SET,259,-0.060612,-0.0071444,0.055565,0.86232,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
GOBP_REGULATION_OF_CARDIOBLA...,SET,5,-0.46989,-0.0077493,0.43069,0.86236,GOBP_REGULATION_OF_CARDIOBLAST_DIFFERENTIATION,1
GSE17721_CTRL_VS_CPG_1H_BMDC...1,SET,187,-0.067918,-0.0068159,0.062245,0.86239,GSE17721_CTRL_VS_CPG_1H_BMDC_DN,1
JAEGER_METASTASIS_DN,SET,236,-0.063244,-0.0071204,0.057946,0.86245,JAEGER_METASTASIS_DN,1
MOHANKUMAR_HOXA1_TARGETS_DN,SET,151,-0.080676,-0.0072825,0.073915,0.86246,MOHANKUMAR_HOXA1_TARGETS_DN,1
GSE37563_WT_VS_CTLA4_KO_CD4_...2,SET,149,-0.075766,-0.0067942,0.069416,0.86246,GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP,1
KRAS.AMP.LUNG_UP.V1_UP,SET,117,-0.088791,-0.0070618,0.081335,0.86251,KRAS.AMP.LUNG_UP.V1_UP,1
MIR6883_3P,SET,50,-0.13763,-0.0071686,0.12606,0.86252,MIR6883_3P,1
MIR34B_5P,SET,120,-0.087616,-0.0070565,0.080245,0.86254,MIR34B_5P,1
MIR3650,SET,49,-0.12782,-0.0065912,0.11704,0.86261,MIR3650,1
MIR3085_5P,SET,33,-0.15867,-0.0067173,0.14523,0.8627,MIR3085_5P,1
HP_DILATED_CARDIOMYOPATHY,SET,139,-0.075781,-0.0065654,0.069342,0.86277,HP_DILATED_CARDIOMYOPATHY,1
HP_PERIORBITAL_ECCHYMOSIS_WI...,SET,7,-0.42436,-0.0082803,0.38824,0.8628,HP_PERIORBITAL_ECCHYMOSIS_WITH_TARSAL_PLATE_SPARING,1
GSE24726_WT_VS_E2_2_KO_PDC_D...2,SET,177,-0.067318,-0.0065744,0.061589,0.8628,GSE24726_WT_VS_E2_2_KO_PDC_DAY6_POST_DELETION_DN,1
FLETCHER_PBMC_BCG_10W_INFANT...4,SET,89,-0.11115,-0.0077161,0.10168,0.86284,FLETCHER_PBMC_BCG_10W_INFANT_PPD_STIMULATED_VS_UNSTIMULATED_10W_UP,1
HP_SLURRED_SPEECH,SET,45,-0.1358,-0.0067113,0.12421,0.86286,HP_SLURRED_SPEECH,1
ZHONG_PFC_C1_MICROGLIA,SET,233,-0.057178,-0.006397,0.052299,0.86286,ZHONG_PFC_C1_MICROGLIA,1
HP_VISUAL_FIXATION_INSTABILI...,SET,12,-0.26481,-0.0067644,0.24221,0.86287,HP_VISUAL_FIXATION_INSTABILITY,1
HP_ABNORMAL_RENAL_ECHOGENICI...,SET,31,-0.17666,-0.0072492,0.16151,0.86297,HP_ABNORMAL_RENAL_ECHOGENICITY,1
HP_CORTICAL_MYOCLONUS,SET,14,-0.23974,-0.0066142,0.21918,0.86297,HP_CORTICAL_MYOCLONUS,1
GOBP_CELLULAR_RESPONSE_TO_CH...1,SET,287,-0.055445,-0.0068742,0.050688,0.86298,GOBP_CELLULAR_RESPONSE_TO_CHEMICAL_STRESS,1
GOBP_TRIGLYCERIDE_METABOLIC_...,SET,96,-0.096015,-0.0069211,0.087778,0.86298,GOBP_TRIGLYCERIDE_METABOLIC_PROCESS,1
HP_OCCIPITAL_ENCEPHALOCELE,SET,36,-0.15186,-0.0067142,0.13883,0.86298,HP_OCCIPITAL_ENCEPHALOCELE,1
HP_ADRENOCORTICAL_CARCINOMA,SET,17,-0.23143,-0.0070354,0.21155,0.86301,HP_ADRENOCORTICAL_CARCINOMA,1
GOBP_CRANIAL_NERVE_STRUCTURA...,SET,10,-0.33169,-0.0077348,0.30318,0.86302,GOBP_CRANIAL_NERVE_STRUCTURAL_ORGANIZATION,1
GSE360_CTRL_VS_L_DONOVANI_MA...2,SET,183,-0.066941,-0.0066464,0.061183,0.86304,GSE360_CTRL_VS_L_DONOVANI_MAC_UP,1
GOCC_VESICLE_COAT,SET,59,-0.11431,-0.0064663,0.10447,0.86306,GOCC_VESICLE_COAT,1
MAEKAWA_ATF2_TARGETS,SET,22,-0.19842,-0.0068607,0.18131,0.86309,MAEKAWA_ATF2_TARGETS,1
GOBP_EXTRACELLULAR_MATRIX_AS...,SET,43,-0.14233,-0.0068763,0.13005,0.86311,GOBP_EXTRACELLULAR_MATRIX_ASSEMBLY,1
REACTOME_CYTOCHROME_C_MEDIAT...,SET,12,-0.25122,-0.0064172,0.22949,0.86317,REACTOME_CYTOCHROME_C_MEDIATED_APOPTOTIC_RESPONSE,1
HP_ABNORMAL_IMMUNE_SERUM_PRO...,SET,42,-0.14962,-0.0071441,0.13666,0.86319,HP_ABNORMAL_IMMUNE_SERUM_PROTEIN_PHYSIOLOGY,1
GOMF_NADPLUS_NUCLEOSIDASE_AC...,SET,9,-0.41887,-0.0092669,0.38258,0.86321,GOMF_NADPLUS_NUCLEOSIDASE_ACTIVITY,1
GOBP_REGULATION_OF_OPSONIZAT...,SET,10,-0.35328,-0.0082382,0.32256,0.86329,GOBP_REGULATION_OF_OPSONIZATION,1
HP_ABNORMAL_ABDOMEN_MORPHOLO...,SET,723,-0.035189,-0.0068407,0.032128,0.86329,HP_ABNORMAL_ABDOMEN_MORPHOLOGY,1
GOBP_DETECTION_OF_TEMPERATUR...1,SET,26,-0.19226,-0.0072263,0.17551,0.86334,GOBP_DETECTION_OF_TEMPERATURE_STIMULUS,1
DIRMEIER_LMP1_RESPONSE_LATE_...2,SET,53,-0.13036,-0.0069903,0.11897,0.8634,DIRMEIER_LMP1_RESPONSE_LATE_UP,1
SCHAEFFER_PROSTATE_DEVELOPME...5,SET,428,-0.043069,-0.0064955,0.039301,0.86343,SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN,1
GOBP_EXCITATORY_CHEMICAL_SYN...,SET,10,-0.31705,-0.0073936,0.28928,0.86346,GOBP_EXCITATORY_CHEMICAL_SYNAPTIC_TRANSMISSION,1
HP_ACUTE_RHABDOMYOLYSIS,SET,5,-0.39133,-0.0064537,0.35701,0.86348,HP_ACUTE_RHABDOMYOLYSIS,1
GOMF_PATTERN_RECOGNITION_REC...,SET,28,-0.17933,-0.0069942,0.16359,0.8635,GOMF_PATTERN_RECOGNITION_RECEPTOR_ACTIVITY,1
WP_NANOMATERIALINDUCED_INFLA...,SET,5,-0.38327,-0.0063208,0.34958,0.86354,WP_NANOMATERIALINDUCED_INFLAMMASOME_ACTIVATION,1
HP_BIPOLAR_AFFECTIVE_DISORDER,SET,24,-0.18889,-0.0068215,0.17229,0.86354,HP_BIPOLAR_AFFECTIVE_DISORDER,1
REACTOME_APC_CDC20_MEDIATED_...,SET,24,-0.18569,-0.0067057,0.16933,0.86358,REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A,1
GOBP_REGULATION_OF_EPITHELIA...6,SET,7,-0.39266,-0.0076617,0.35789,0.86371,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
GOBP_PLATELET_ACTIVATION,SET,131,-0.087617,-0.0073707,0.07984,0.86376,GOBP_PLATELET_ACTIVATION,1
GOBP_NEGATIVE_REGULATION_OF_...11,SET,5,-0.45038,-0.0074276,0.41035,0.86379,GOBP_NEGATIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_LIPOPHAGY,SET,9,-0.31493,-0.0069673,0.28693,0.8638,REACTOME_LIPOPHAGY,1
MIR3973,SET,233,-0.060945,-0.0068184,0.055519,0.86383,MIR3973,1
HP_MILD_PROTEINURIA,SET,4,-0.41705,-0.0061519,0.37987,0.86386,HP_MILD_PROTEINURIA,1
GSE5589_WT_VS_IL6_KO_LPS_STI...3,SET,182,-0.069946,-0.006926,0.063703,0.86389,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_45MIN_DN,1
HP_ABNORMAL_OPTIC_NERVE_MORP...,SET,753,-0.033529,-0.0066462,0.030533,0.86392,HP_ABNORMAL_OPTIC_NERVE_MORPHOLOGY,1
GOBP_MATURATION_OF_5_8S_RRNA...,SET,24,-0.16202,-0.005851,0.14742,0.86411,GOBP_MATURATION_OF_5_8S_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
HP_ABNORMALITY_OF_SKIN_PIGME...,SET,435,-0.04387,-0.0066688,0.039907,0.86418,HP_ABNORMALITY_OF_SKIN_PIGMENTATION,1
PRDM4_TARGET_GENES,SET,467,-0.04409,-0.0069383,0.040105,0.86419,PRDM4_TARGET_GENES,1
HP_EEG_WITH_SERIES_OF_FOCAL_...,SET,10,-0.2802,-0.0065342,0.25488,0.86419,HP_EEG_WITH_SERIES_OF_FOCAL_SPIKES,1
GOBP_REGULATION_OF_STEROID_H...1,SET,15,-0.26606,-0.0075977,0.24199,0.86421,GOBP_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,1
LEE_AGING_CEREBELLUM_UP,SET,78,-0.1031,-0.0067026,0.093764,0.86424,LEE_AGING_CEREBELLUM_UP,1
YWATTWNNRGCT_UNKNOWN,SET,63,-0.12153,-0.0071033,0.11051,0.86427,YWATTWNNRGCT_UNKNOWN,1
VERRECCHIA_RESPONSE_TO_TGFB1...6,SET,5,-0.41817,-0.0068963,0.38022,0.86429,VERRECCHIA_RESPONSE_TO_TGFB1_C6,1
REACTOME_METABOLISM_OF_ANGIO...,SET,15,-0.28639,-0.0081782,0.26032,0.86436,REACTOME_METABOLISM_OF_ANGIOTENSINOGEN_TO_ANGIOTENSINS,1
MIR934,SET,73,-0.11003,-0.0069205,0.099993,0.8644,MIR934,1
GOBP_REGULATION_OF_SMOOTH_MU...3,SET,56,-0.12931,-0.0071271,0.11749,0.86447,GOBP_REGULATION_OF_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_MITOCHONDRIAL_DNA_REPAIR,SET,6,-0.33073,-0.0059747,0.30048,0.86448,GOBP_MITOCHONDRIAL_DNA_REPAIR,1
HP_UPSLANTED_PALPEBRAL_FISSU...,SET,270,-0.054522,-0.0065597,0.049531,0.8645,HP_UPSLANTED_PALPEBRAL_FISSURE,1
WP_EUKARYOTIC_TRANSCRIPTION_...,SET,41,-0.12539,-0.005916,0.11387,0.86459,WP_EUKARYOTIC_TRANSCRIPTION_INITIATION,1
HP_DOWNBEAT_NYSTAGMUS,SET,7,-0.3437,-0.0067063,0.31207,0.86462,HP_DOWNBEAT_NYSTAGMUS,1
MIR380_3P,SET,210,-0.063623,-0.0067618,0.057755,0.86468,MIR380_3P,1
GOBP_CELL_FATE_DETERMINATION,SET,40,-0.16472,-0.0076763,0.14953,0.86468,GOBP_CELL_FATE_DETERMINATION,1
GSE6875_WT_VS_FOXP3_KO_TREG_...2,SET,177,-0.070086,-0.0068447,0.063612,0.86471,GSE6875_WT_VS_FOXP3_KO_TREG_UP,1
REACTOME_RHO_GTPASES_ACTIVAT...8,SET,9,-0.30962,-0.00685,0.281,0.86473,REACTOME_RHO_GTPASES_ACTIVATE_RHOTEKIN_AND_RHOPHILINS,1
HP_SELECTIVE_TOOTH_AGENESIS,SET,40,-0.163,-0.0075958,0.14792,0.86474,HP_SELECTIVE_TOOTH_AGENESIS,1
MIR3944_5P,SET,103,-0.08815,-0.0065805,0.079993,0.86475,MIR3944_5P,1
REACTOME_ESTABLISHMENT_OF_SI...,SET,8,-0.33093,-0.0069028,0.3003,0.86476,REACTOME_ESTABLISHMENT_OF_SISTER_CHROMATID_COHESION,1
MIR4438,SET,61,-0.11847,-0.006814,0.10751,0.86477,MIR4438,1
GOBP_INTERNAL_PEPTIDYL_LYSIN...,SET,8,-0.26662,-0.0055613,0.24189,0.86481,GOBP_INTERNAL_PEPTIDYL_LYSINE_ACETYLATION,1
HP_ELEVATED_CIRCULATING_ASPA...,SET,68,-0.10979,-0.006666,0.099589,0.86486,HP_ELEVATED_CIRCULATING_ASPARTATE_AMINOTRANSFERASE_CONCENTRATION,1
GSE13411_IGM_VS_SWITCHED_MEM...2,SET,174,-0.071906,-0.0069633,0.065221,0.86487,GSE13411_IGM_VS_SWITCHED_MEMORY_BCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...479,SET,44,-0.14976,-0.0073186,0.13583,0.86488,GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION,1
GSE43955_TH0_VS_TGFB_IL6_IL2...3,SET,187,-0.068219,-0.0068461,0.061853,0.86496,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_DN,1
BIOCARTA_CSK_PATHWAY,SET,18,-0.22883,-0.0071576,0.20747,0.86497,BIOCARTA_CSK_PATHWAY,1
MIR214_5P,SET,49,-0.13536,-0.00698,0.12271,0.865,MIR214_5P,1
GOBP_NEGATIVE_REGULATION_OF_...31,SET,213,-0.06455,-0.0069086,0.058515,0.86501,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...55,SET,22,-0.22663,-0.0078362,0.20544,0.86501,GOBP_POSITIVE_REGULATION_OF_BEHAVIOR,1
SMID_BREAST_CANCER_LUMINAL_A...2,SET,78,-0.11204,-0.0072834,0.10156,0.86503,SMID_BREAST_CANCER_LUMINAL_A_UP,1
WP_NEURAL_CREST_DIFFERENTIAT...,SET,94,-0.1019,-0.0072685,0.092351,0.86505,WP_NEURAL_CREST_DIFFERENTIATION,1
GOCC_RUFFLE_MEMBRANE,SET,95,-0.094236,-0.0067576,0.085405,0.86507,GOCC_RUFFLE_MEMBRANE,1
GOBP_PHENOL_CONTAINING_COMPO...3,SET,103,-0.099436,-0.0074231,0.090114,0.86508,GOBP_PHENOL_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
HP_HAPPY_DEMEANOR,SET,23,-0.23122,-0.0081744,0.20953,0.86509,HP_HAPPY_DEMEANOR,1
GSE21678_WT_VS_FOXO1_FOXO3_K...1,SET,163,-0.069049,-0.0064738,0.06257,0.8651,GSE21678_WT_VS_FOXO1_FOXO3_KO_TREG_DN,1
LIU_TOPBP1_TARGETS,SET,12,-0.28026,-0.007159,0.25388,0.86518,LIU_TOPBP1_TARGETS,1
HOLLMANN_APOPTOSIS_VIA_CD40_...2,SET,184,-0.069786,-0.0069475,0.063206,0.86522,HOLLMANN_APOPTOSIS_VIA_CD40_UP,1
GSE27786_LSK_VS_LIN_NEG_CELL...2,SET,179,-0.068146,-0.0066924,0.061721,0.86522,GSE27786_LSK_VS_LIN_NEG_CELL_UP,1
GSE17721_CTRL_VS_CPG_4H_BMDC...2,SET,188,-0.066036,-0.0066445,0.059803,0.86524,GSE17721_CTRL_VS_CPG_4H_BMDC_UP,1
GOBP_RESPONSE_TO_GRANULOCYTE...,SET,9,-0.32898,-0.0072782,0.29787,0.86529,GOBP_RESPONSE_TO_GRANULOCYTE_MACROPHAGE_COLONY_STIMULATING_FACTOR,1
GOBP_RESPONSE_TO_THYROID_HOR...,SET,22,-0.21275,-0.0073564,0.19263,0.86529,GOBP_RESPONSE_TO_THYROID_HORMONE,1
HP_DECREASED_CALVARIAL_OSSIF...,SET,17,-0.2347,-0.0071348,0.21251,0.86529,HP_DECREASED_CALVARIAL_OSSIFICATION,1
NUMATA_CSF3_SIGNALING_VIA_ST...,SET,21,-0.22394,-0.0075654,0.20274,0.86531,NUMATA_CSF3_SIGNALING_VIA_STAT3,1
MIR1247_5P,SET,4,-0.49196,-0.0072569,0.44538,0.86532,MIR1247_5P,1
GOBP_POSTSYNAPTIC_NEUROTRANS...,SET,26,-0.17727,-0.0066629,0.16046,0.86537,GOBP_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,1
DESCARTES_FETAL_STOMACH_CILI...,SET,225,-0.059801,-0.0065761,0.054123,0.86539,DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...561,SET,5,-0.42537,-0.007015,0.38495,0.86541,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST_INVOLVED_IN_INFLAMMATORY_RESPONSE,1
GOBP_REGULATION_OF_INFLAMMAT...3,SET,10,-0.3074,-0.0071683,0.27818,0.86542,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_WOUNDING,1
GOBP_REGULATION_OF_PROTEIN_I...,SET,56,-0.12304,-0.0067811,0.11133,0.86545,GOBP_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
GOBP_STRIATED_MUSCLE_CELL_DI...,SET,281,-0.057224,-0.0070214,0.051776,0.86546,GOBP_STRIATED_MUSCLE_CELL_DIFFERENTIATION,1
HP_EXODEVIATION,SET,104,-0.087678,-0.0065768,0.079331,0.86546,HP_EXODEVIATION,1
GSE360_HIGH_DOSE_B_MALAYI_VS...1,SET,186,-0.069489,-0.0069551,0.062874,0.86546,GSE360_HIGH_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_DN,1
MIR6769B_3P,SET,76,-0.10727,-0.006884,0.097056,0.86547,MIR6769B_3P,1
GOBP_CELL_GROWTH,SET,428,-0.046043,-0.006944,0.041647,0.86553,GOBP_CELL_GROWTH,1
MIR3667_3P,SET,136,-0.082487,-0.0070694,0.074609,0.86554,MIR3667_3P,1
GSE17974_0H_VS_48H_IN_VITRO_...1,SET,173,-0.067365,-0.0065049,0.060921,0.86558,GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_DN,1
GOBP_RIBONUCLEOPROTEIN_COMPL...2,SET,10,-0.24869,-0.0057994,0.22485,0.86564,GOBP_RIBONUCLEOPROTEIN_COMPLEX_LOCALIZATION,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...1,SET,6,-0.43377,-0.0078361,0.39201,0.86574,KEGG_MEDICUS_PATHOGEN_SHIGELLA_FIMA_TO_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
FAN_EMBRYONIC_CTX_BIG_GROUPS...5,SET,123,-0.088657,-0.0072285,0.080114,0.86576,FAN_EMBRYONIC_CTX_BIG_GROUPS_GLIAL,1
REACTOME_METALLOTHIONEINS_BI...,SET,11,-0.44469,-0.010876,0.40184,0.86577,REACTOME_METALLOTHIONEINS_BIND_METALS,1
KEGG_MEDICUS_REFERENCE_COHES...2,SET,15,-0.23256,-0.006641,0.21013,0.86579,KEGG_MEDICUS_REFERENCE_COHESIN_DISSOCIATION_IN_ANAPHASE,1
PID_INTEGRIN_CS_PATHWAY,SET,25,-0.20166,-0.0074326,0.18221,0.8658,PID_INTEGRIN_CS_PATHWAY,1
MIR3977,SET,139,-0.077386,-0.0067044,0.069913,0.86582,MIR3977,1
GSE26030_TH1_VS_TH17_DAY15_P...2,SET,181,-0.068084,-0.0067231,0.061509,0.86582,GSE26030_TH1_VS_TH17_DAY15_POST_POLARIZATION_UP,1
WHITEFORD_PEDIATRIC_CANCER_M...,SET,111,-0.087673,-0.0067929,0.079187,0.86588,WHITEFORD_PEDIATRIC_CANCER_MARKERS,1
HP_APLASIA_OF_METACARPAL_BON...,SET,12,-0.27624,-0.0070562,0.24949,0.86589,HP_APLASIA_OF_METACARPAL_BONES,1
REACTOME_ACTIVATED_NTRK2_SIG...1,SET,6,-0.39441,-0.0071252,0.35619,0.86591,REACTOME_ACTIVATED_NTRK2_SIGNALS_THROUGH_CDK5,1
GOMF_ACID_PHOSPHATASE_ACTIVI...,SET,6,-0.34796,-0.006286,0.31423,0.86592,GOMF_ACID_PHOSPHATASE_ACTIVITY,1
GSE37301_LYMPHOID_PRIMED_MPP...1,SET,176,-0.067307,-0.0065549,0.06078,0.86593,GSE37301_LYMPHOID_PRIMED_MPP_VS_CD4_TCELL_DN,1
GCM_MSN,SET,23,-0.19427,-0.006868,0.17534,0.86605,GCM_MSN,1
RGAANNTTC_HSF1_01,SET,407,-0.046937,-0.006907,0.042354,0.8661,RGAANNTTC_HSF1_01,1
FAN_EMBRYONIC_CTX_MICROGLIA_1,SET,137,-0.077015,-0.0066244,0.069498,0.8661,FAN_EMBRYONIC_CTX_MICROGLIA_1,1
GSE5542_UNTREATED_VS_IFNG_TR...3,SET,180,-0.070959,-0.0069879,0.064026,0.86612,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
GSE27786_LIN_NEG_VS_NEUTROPH...2,SET,172,-0.067882,-0.0065361,0.061232,0.86619,GSE27786_LIN_NEG_VS_NEUTROPHIL_UP,1
HP_CENTRAL_HYPOTHYROIDISM,SET,63,-0.1219,-0.0071249,0.10994,0.86624,HP_CENTRAL_HYPOTHYROIDISM,1
MARTINEZ_RESPONSE_TO_TRABECT...1,SET,45,-0.14054,-0.0069454,0.12672,0.86628,MARTINEZ_RESPONSE_TO_TRABECTEDIN,1
GOBP_GLOMERULUS_MORPHOGENESIS,SET,9,-0.35687,-0.0078952,0.32179,0.86628,GOBP_GLOMERULUS_MORPHOGENESIS,1
chr7p15,SET,40,-0.25894,-0.012067,0.23345,0.86631,chr7p15,1
GSE23502_BM_VS_COLON_TUMOR_M...1,SET,181,-0.069002,-0.0068138,0.062203,0.86634,GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN,1
GOBP_ENDOPLASMIC_RETICULUM_P...,SET,5,-0.42756,-0.0070512,0.38542,0.86635,GOBP_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_TETHERING,1
GOBP_POSITIVE_REGULATION_OF_...464,SET,5,-0.39971,-0.0065919,0.36021,0.86642,GOBP_POSITIVE_REGULATION_OF_MIRNA_PROCESSING,1
GSE25087_FETAL_VS_ADULT_TREG...2,SET,176,-0.067767,-0.0065997,0.061067,0.86643,GSE25087_FETAL_VS_ADULT_TREG_UP,1
GOCC_OUTER_DENSE_FIBER,SET,4,-0.50326,-0.0074236,0.45348,0.86644,GOCC_OUTER_DENSE_FIBER,1
GOBP_REGULATION_OF_MITOCHOND...3,SET,6,-0.35258,-0.0063695,0.31768,0.86646,GOBP_REGULATION_OF_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,1
WHITFIELD_CELL_CYCLE_G2_M,SET,183,-0.067446,-0.0066965,0.060764,0.86649,WHITFIELD_CELL_CYCLE_G2_M,1
GOBP_POSITIVE_REGULATION_OF_...205,SET,145,-0.081807,-0.0072376,0.073702,0.86649,GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_GROWTH,1
GSE45365_NK_CELL_VS_CD8_TCEL...4,SET,143,-0.075165,-0.0066043,0.067709,0.86652,GSE45365_NK_CELL_VS_CD8_TCELL_UP,1
HP_ABNORMAL_SCALP_MORPHOLOGY,SET,385,-0.047226,-0.0067633,0.042539,0.86653,HP_ABNORMAL_SCALP_MORPHOLOGY,1
GOMF_RIBOSOMAL_LARGE_SUBUNIT...,SET,12,-0.25824,-0.0065964,0.23257,0.86658,GOMF_RIBOSOMAL_LARGE_SUBUNIT_BINDING,1
HP_INCOORDINATION,SET,251,-0.05834,-0.006771,0.052535,0.8666,HP_INCOORDINATION,1
GOBP_POSITIVE_REGULATION_OF_...246,SET,57,-0.13919,-0.0077396,0.12533,0.86661,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION,1
GSE22886_NAIVE_CD4_TCELL_VS_...13,SET,189,-0.071007,-0.0071636,0.06394,0.86661,GSE22886_NAIVE_CD4_TCELL_VS_MONOCYTE_DN,1
MIR15A_5P,SET,535,-0.040108,-0.0067427,0.036114,0.86662,MIR15A_5P,1
GSE37534_GW1929_VS_PIOGLITAZ...1,SET,180,-0.069571,-0.0068512,0.062634,0.86665,GSE37534_GW1929_VS_PIOGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN,1
HP_CONGENITAL_LARYNGEAL_STRI...,SET,7,-0.34232,-0.0066794,0.30811,0.86671,HP_CONGENITAL_LARYNGEAL_STRIDOR,1
KUMAMOTO_RESPONSE_TO_NUTLIN_...2,SET,9,-0.28321,-0.0062656,0.25487,0.86675,KUMAMOTO_RESPONSE_TO_NUTLIN_3A_UP,1
KEGG_ECM_RECEPTOR_INTERACTION,SET,82,-0.10887,-0.0072557,0.097969,0.86676,KEGG_ECM_RECEPTOR_INTERACTION,1
MIR15B_5P,SET,532,-0.040277,-0.0067527,0.036242,0.86678,MIR15B_5P,1
HP_ABNORMAL_CIRCULATING_CERU...,SET,10,-0.302,-0.0070425,0.27175,0.86678,HP_ABNORMAL_CIRCULATING_CERULOPLASMIN_CONCENTRATION,1
GOBP_ALCOHOL_BIOSYNTHETIC_PR...,SET,126,-0.082535,-0.0068103,0.074252,0.86683,GOBP_ALCOHOL_BIOSYNTHETIC_PROCESS,1
GSE3691_IFN_PRODUCING_KILLER...4,SET,177,-0.070157,-0.0068516,0.063112,0.86684,GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_UP,1
HP_LATE_ONSET,SET,123,-0.084928,-0.0069244,0.076398,0.86685,HP_LATE_ONSET,1
GGCNNMSMYNTTG_UNKNOWN,SET,69,-0.11067,-0.0067682,0.099527,0.86691,GGCNNMSMYNTTG_UNKNOWN,1
WP_LEPTININSULIN_SIGNALING_O...,SET,16,-0.26345,-0.0077697,0.23687,0.86697,WP_LEPTININSULIN_SIGNALING_OVERLAP,1
XIE_ST_HSC_S1PR3_OE_DN,SET,23,-0.21312,-0.0075345,0.19158,0.86702,XIE_ST_HSC_S1PR3_OE_DN,1
GOBP_PEPTIDYL_TYROSINE_DEPHO...1,SET,27,-0.18444,-0.0070642,0.16576,0.86707,GOBP_PEPTIDYL_TYROSINE_DEPHOSPHORYLATION,1
HP_HYPOPARATHYROIDISM,SET,28,-0.18452,-0.0071967,0.16583,0.86708,HP_HYPOPARATHYROIDISM,1
MYOD_Q6_01,SET,237,-0.061205,-0.0069052,0.054989,0.86714,MYOD_Q6_01,1
GOBP_I_KAPPAB_PHOSPHORYLATION,SET,13,-0.29129,-0.0077444,0.26172,0.86714,GOBP_I_KAPPAB_PHOSPHORYLATION,1
HP_NON_HODGKIN_LYMPHOMA,SET,38,-0.15654,-0.0071104,0.14063,0.86717,HP_NON_HODGKIN_LYMPHOMA,1
GOBP_FATTY_ACID_TRANSPORT,SET,115,-0.092033,-0.0072572,0.082663,0.86721,GOBP_FATTY_ACID_TRANSPORT,1
LET_7I_5P,SET,362,-0.050624,-0.0070345,0.045458,0.86728,LET_7I_5P,1
HP_ORTHOKERATOTIC_HYPERKERAT...,SET,7,-0.35612,-0.0069486,0.31977,0.86728,HP_ORTHOKERATOTIC_HYPERKERATOSIS,1
MODULE_82,SET,22,-0.17024,-0.0058864,0.15282,0.86736,MODULE_82,1
GOBP_REGULATION_OF_MITOCHOND...14,SET,6,-0.34555,-0.0062424,0.31012,0.86741,GOBP_REGULATION_OF_MITOCHONDRIAL_TRANSCRIPTION,1
GOBP_PROTEIN_LOCALIZATION_TO...44,SET,260,-0.05826,-0.0068802,0.052269,0.86748,GOBP_PROTEIN_LOCALIZATION_TO_PLASMA_MEMBRANE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...35,SET,17,-0.25843,-0.0078562,0.23187,0.86748,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS,1
GOMF_PROTON_CHANNEL_ACTIVITY,SET,9,-0.29539,-0.0065351,0.26503,0.86748,GOMF_PROTON_CHANNEL_ACTIVITY,1
HP_BONE_SPICULE_PIGMENTATION...,SET,101,-0.093848,-0.0069379,0.084199,0.86748,HP_BONE_SPICULE_PIGMENTATION_OF_THE_RETINA,1
GSE7460_CD8_TCELL_VS_TREG_AC...2,SET,179,-0.067715,-0.00665,0.060748,0.8675,GSE7460_CD8_TCELL_VS_TREG_ACT_UP,1
GOBP_HEPATOCYTE_DIFFERENTIAT...,SET,13,-0.29665,-0.0078869,0.26611,0.86752,GOBP_HEPATOCYTE_DIFFERENTIATION,1
HP_GENERALIZED_ONSET_SEIZURE,SET,277,-0.056358,-0.0068666,0.050556,0.86752,HP_GENERALIZED_ONSET_SEIZURE,1
HP_RETINAL_DETACHMENT,SET,97,-0.099986,-0.0072446,0.08969,0.86752,HP_RETINAL_DETACHMENT,1
GOBP_RESPONSE_TO_FUNGICIDE,SET,7,-0.31871,-0.0062186,0.28585,0.86755,GOBP_RESPONSE_TO_FUNGICIDE,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...1,SET,22,-0.22002,-0.0076078,0.19729,0.86761,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE,1
GOBP_NEGATIVE_REGULATION_OF_...596,SET,50,-0.13633,-0.0071013,0.12222,0.86768,GOBP_NEGATIVE_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
GOBP_REGULATION_OF_KIDNEY_SI...,SET,5,-0.45952,-0.0075783,0.41193,0.86768,GOBP_REGULATION_OF_KIDNEY_SIZE,1
GTGTTGA_MIR505,SET,89,-0.10039,-0.0069688,0.089958,0.86777,GTGTTGA_MIR505,1
GOBP_NEGATIVE_REGULATION_OF_...236,SET,5,-0.4955,-0.0081717,0.444,0.86778,GOBP_NEGATIVE_REGULATION_OF_FEEDING_BEHAVIOR,1
GSE2770_UNTREATED_VS_IL12_TR...1,SET,172,-0.068766,-0.0066212,0.061615,0.86779,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_DN,1
REACTOME_DEFECTS_IN_BIOTIN_B...,SET,8,-0.33181,-0.0069211,0.2973,0.8678,REACTOME_DEFECTS_IN_BIOTIN_BTN_METABOLISM,1
GOBP_NEGATIVE_REGULATION_OF_...494,SET,5,-0.33023,-0.005446,0.29582,0.86785,GOBP_NEGATIVE_REGULATION_OF_PINOCYTOSIS,1
GOMF_C_X_C_CHEMOKINE_RECEPTO...,SET,7,-0.36759,-0.0071724,0.32929,0.86785,GOMF_C_X_C_CHEMOKINE_RECEPTOR_ACTIVITY,1
GSE26488_WT_VS_HDAC7_KO_DOUB...1,SET,157,-0.075885,-0.0069836,0.067975,0.86786,GSE26488_WT_VS_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_DN,1
KEGG_GNRH_SIGNALING_PATHWAY,SET,98,-0.098966,-0.0072073,0.088639,0.86789,KEGG_GNRH_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_NEUTROPHI...5,SET,5,-0.43228,-0.0071291,0.38718,0.86789,GOBP_REGULATION_OF_NEUTROPHIL_MEDIATED_CYTOTOXICITY,1
GSE12845_IGD_POS_BLOOD_VS_NA...2,SET,160,-0.070588,-0.0065574,0.063222,0.86789,GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_UP,1
CAGCCTC_MIR4855P,SET,135,-0.078769,-0.0067261,0.070544,0.86791,CAGCCTC_MIR4855P,1
MIR6759_3P,SET,93,-0.10217,-0.0072497,0.091502,0.86792,MIR6759_3P,1
GOMF_PHOSPHATIDYLSERINE_1_AC...,SET,6,-0.34458,-0.0062249,0.30856,0.86794,GOMF_PHOSPHATIDYLSERINE_1_ACYLHYDROLASE_ACTIVITY,1
HP_OROTICACIDURIA,SET,7,-0.35526,-0.0069319,0.3181,0.86795,HP_OROTICACIDURIA,1
KEGG_MEDICUS_REFERENCE_MANNO...2,SET,5,-0.36179,-0.0059665,0.32393,0.86796,KEGG_MEDICUS_REFERENCE_MANNOSE_TYPE_O_GLYCAN_BIOSYNTHESIS_POMT_TO_POMK,1
GOBP_INTRACELLULAR_OXYGEN_HO...,SET,6,-0.38626,-0.006978,0.34586,0.86796,GOBP_INTRACELLULAR_OXYGEN_HOMEOSTASIS,1
GOBP_NEGATIVE_REGULATION_OF_...167,SET,13,-0.28518,-0.007582,0.25529,0.86802,GOBP_NEGATIVE_REGULATION_OF_CYTOSOLIC_CALCIUM_ION_CONCENTRATION,1
REACTOME_GLYCOGEN_METABOLISM,SET,21,-0.19743,-0.0066699,0.17669,0.86808,REACTOME_GLYCOGEN_METABOLISM,1
HNF4_01,SET,244,-0.059499,-0.0068099,0.053247,0.86808,HNF4_01,1
HE_LIM_SUN_FETAL_LUNG_C4_CYC...2,SET,809,-0.032269,-0.0066195,0.02887,0.86815,HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_T_CELL,1
MIR498_5P,SET,216,-0.066359,-0.0071515,0.059356,0.8682,MIR498_5P,1
MEF2C_TARGET_GENES,SET,1333,-0.026549,-0.0068859,0.023745,0.86823,MEF2C_TARGET_GENES,1
GOBP_CELLULAR_DEFENSE_RESPON...,SET,47,-0.14395,-0.0072702,0.12873,0.86826,GOBP_CELLULAR_DEFENSE_RESPONSE,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...2,SET,23,-0.18892,-0.006679,0.16892,0.86829,GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_UP,1
GOBP_RESPONSE_TO_MUSCLE_ACTI...,SET,24,-0.21365,-0.0077157,0.19101,0.86833,GOBP_RESPONSE_TO_MUSCLE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...244,SET,26,-0.19977,-0.0075085,0.17858,0.86834,GOBP_POSITIVE_REGULATION_OF_EPIDERMIS_DEVELOPMENT,1
HP_BLIND_VAGINA,SET,2,-0.66913,-0.0069798,0.59818,0.86834,HP_BLIND_VAGINA,1
HP_DEXTROTRANSPOSITION_OF_TH...,SET,5,-0.36047,-0.0059448,0.32223,0.86835,HP_DEXTROTRANSPOSITION_OF_THE_GREAT_ARTERIES,1
STEIN_ESRRA_TARGETS_DN,SET,94,-0.093875,-0.0066964,0.083908,0.86838,STEIN_ESRRA_TARGETS_DN,1
KEGG_MEDICUS_PATHOGEN_HPV_E5...1,SET,6,-0.44334,-0.0080091,0.39626,0.86838,KEGG_MEDICUS_PATHOGEN_HPV_E5_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,1
KEGG_MEDICUS_PATHOGEN_KSHV_M...1,SET,6,-0.44334,-0.0080091,0.39626,0.86838,KEGG_MEDICUS_PATHOGEN_KSHV_MIR1_2_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,1
HP_IRON_ACCUMULATION_IN_BRAIN,SET,14,-0.23165,-0.006391,0.207,0.86844,HP_IRON_ACCUMULATION_IN_BRAIN,1
GOMF_DIPEPTIDYL_PEPTIDASE_AC...,SET,12,-0.26919,-0.0068763,0.24054,0.86845,GOMF_DIPEPTIDYL_PEPTIDASE_ACTIVITY,1
SMID_BREAST_CANCER_BASAL_DN,SET,632,-0.039819,-0.0072559,0.035574,0.86849,SMID_BREAST_CANCER_BASAL_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...45,SET,21,-0.20739,-0.0070063,0.18528,0.86849,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
GSE26343_WT_VS_NFAT5_KO_MACR...1,SET,186,-0.071171,-0.0071235,0.063582,0.8685,GSE26343_WT_VS_NFAT5_KO_MACROPHAGE_DN,1
BIOCARTA_DNAFRAGMENT_PATHWAY,SET,10,-0.3574,-0.0083345,0.31926,0.86852,BIOCARTA_DNAFRAGMENT_PATHWAY,1
REACTOME_BICARBONATE_TRANSPO...,SET,10,-0.29383,-0.0068521,0.26245,0.86855,REACTOME_BICARBONATE_TRANSPORTERS,1
GOBP_RETINAL_CELL_PROGRAMMED...,SET,6,-0.4104,-0.0074141,0.36654,0.86856,GOBP_RETINAL_CELL_PROGRAMMED_CELL_DEATH,1
GSE24634_TREG_VS_TCONV_POST_...4,SET,181,-0.066767,-0.0065931,0.059631,0.86857,GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP,1
GOCC_LATERAL_PART_OF_CELL,SET,5,-0.46713,-0.0077038,0.41716,0.86859,GOCC_LATERAL_PART_OF_CELL,1
HP_SQUAMOUS_CELL_CARCINOMA,SET,62,-0.11076,-0.006422,0.098891,0.86863,HP_SQUAMOUS_CELL_CARCINOMA,1
TAKAO_RESPONSE_TO_UVB_RADIAT...1,SET,87,-0.098116,-0.0067346,0.087594,0.86866,TAKAO_RESPONSE_TO_UVB_RADIATION_DN,1
TGAYRTCA_ATF3_Q6,SET,497,-0.043843,-0.0071115,0.039135,0.8687,TGAYRTCA_ATF3_Q6,1
GOBP_POSITIVE_REGULATION_OF_...479,SET,6,-0.33285,-0.006013,0.2969,0.86886,GOBP_POSITIVE_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,1
REACTOME_DIGESTION_OF_DIETAR...1,SET,7,-0.36295,-0.007082,0.32375,0.86887,REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE,1
MAF_Q6,SET,233,-0.06407,-0.007168,0.057146,0.86888,MAF_Q6,1
GOBP_PHOSPHATIDYLINOSITOL_3_...2,SET,21,-0.18845,-0.0063665,0.16808,0.86889,GOBP_PHOSPHATIDYLINOSITOL_3_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_LYSOSOMAL_PROTEIN_CATAB...,SET,18,-0.22324,-0.0069829,0.19896,0.86906,GOBP_LYSOSOMAL_PROTEIN_CATABOLIC_PROCESS,1
RAHMAN_TP53_TARGETS_PHOSPHOR...,SET,19,-0.21377,-0.0068696,0.19051,0.86908,RAHMAN_TP53_TARGETS_PHOSPHORYLATED,1
GGGNRMNNYCAT_UNKNOWN,SET,74,-0.10724,-0.0067913,0.095575,0.86908,GGGNRMNNYCAT_UNKNOWN,1
MORF_BECN1,SET,96,-0.086604,-0.0062428,0.077182,0.86908,MORF_BECN1,1
GOMF_GAMMA_CATENIN_BINDING,SET,12,-0.27575,-0.0070438,0.24573,0.86909,GOMF_GAMMA_CATENIN_BINDING,1
KEGG_TRYPTOPHAN_METABOLISM,SET,36,-0.15799,-0.0069854,0.14077,0.86914,KEGG_TRYPTOPHAN_METABOLISM,1
GOBP_REGULATION_OF_MACROPHAG...7,SET,42,-0.14813,-0.007073,0.13195,0.86918,GOBP_REGULATION_OF_MACROPHAGE_MIGRATION,1
GOBP_LAYER_FORMATION_IN_CERE...,SET,13,-0.29187,-0.0077597,0.25995,0.86923,GOBP_LAYER_FORMATION_IN_CEREBRAL_CORTEX,1
GOBP_FOLIC_ACID_METABOLIC_PR...,SET,13,-0.22709,-0.0060374,0.20224,0.86924,GOBP_FOLIC_ACID_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_MUTATIO...58,SET,6,-0.41274,-0.0074562,0.36755,0.86926,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_PERK_ATF4_SIGNALING_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...466,SET,22,-0.2132,-0.0073717,0.18986,0.86926,GOBP_NEGATIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...583,SET,153,-0.080167,-0.0072839,0.071384,0.86928,GOBP_NEGATIVE_REGULATION_OF_SECRETION,1
WP_AMINO_ACID_METABOLISM,SET,80,-0.10859,-0.0071484,0.096676,0.86932,WP_AMINO_ACID_METABOLISM,1
MIR602,SET,7,-0.29971,-0.005848,0.26683,0.86932,MIR602,1
HP_FACIAL_TICS,SET,14,-0.25969,-0.0071646,0.2312,0.86932,HP_FACIAL_TICS,1
MARZEC_IL2_SIGNALING_DN,SET,36,-0.15867,-0.0070157,0.14124,0.86937,MARZEC_IL2_SIGNALING_DN,1
REACTOME_PRESYNAPTIC_FUNCTIO...,SET,21,-0.21034,-0.0071058,0.18722,0.86937,REACTOME_PRESYNAPTIC_FUNCTION_OF_KAINATE_RECEPTORS,1
GOCC_U2_TYPE_CATALYTIC_STEP_...,SET,30,-0.15387,-0.0062114,0.13694,0.8694,GOCC_U2_TYPE_CATALYTIC_STEP_2_SPLICEOSOME,1
KEGG_MEDICUS_VARIANT_MUTATIO...19,SET,11,-0.28386,-0.0069425,0.25263,0.86941,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PRKCG_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
REACTOME_SIGNALING_BY_GPCR,SET,652,-0.040836,-0.0075537,0.036342,0.86941,REACTOME_SIGNALING_BY_GPCR,1
MORF_ERH,SET,97,-0.089288,-0.0064695,0.079449,0.86945,MORF_ERH,1
HP_SCAPULOPERONEAL_AMYOTROPHY,SET,5,-0.42069,-0.0069379,0.37429,0.86948,HP_SCAPULOPERONEAL_AMYOTROPHY,1
GSE3982_BCELL_VS_BASOPHIL_DN,SET,176,-0.073224,-0.0071311,0.065139,0.86951,GSE3982_BCELL_VS_BASOPHIL_DN,1
HP_PROLONGED_PARTIAL_THROMBO...,SET,30,-0.18244,-0.0073649,0.16225,0.86958,HP_PROLONGED_PARTIAL_THROMBOPLASTIN_TIME,1
HP_ACANTHOSIS_NIGRICANS,SET,57,-0.13464,-0.0074863,0.11973,0.86959,HP_ACANTHOSIS_NIGRICANS,1
BYSTRYKH_HEMATOPOIESIS_STEM_...9,SET,26,-0.18687,-0.0070236,0.16616,0.86963,BYSTRYKH_HEMATOPOIESIS_STEM_CELL_SCP2_QTL_TRANS,1
GOBP_ESTABLISHMENT_OF_MITOTI...1,SET,5,-0.38814,-0.006401,0.34501,0.8697,GOBP_ESTABLISHMENT_OF_MITOTIC_SISTER_CHROMATID_COHESION,1
GOBP_PRIMARY_ALCOHOL_METABOL...,SET,95,-0.10421,-0.007473,0.092626,0.86972,GOBP_PRIMARY_ALCOHOL_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...196,SET,14,-0.28273,-0.0078003,0.25115,0.86986,GOBP_POSITIVE_REGULATION_OF_DENDRITE_DEVELOPMENT,1
HP_APLASIA_HYPOPLASIA_OF_THE...73,SET,27,-0.18829,-0.0072116,0.16723,0.8699,HP_APLASIA_HYPOPLASIA_OF_THE_TIBIA,1
GOBP_ERYTHROCYTE_DEVELOPMENT,SET,38,-0.15024,-0.0068246,0.13343,0.86991,GOBP_ERYTHROCYTE_DEVELOPMENT,1
HP_ABNORMAL_URINARY_NUCLEOBA...,SET,11,-0.33826,-0.0082729,0.30041,0.86991,HP_ABNORMAL_URINARY_NUCLEOBASE_CONCENTRATION,1
REACTOME_DEFECTIVE_INTRINSIC...,SET,25,-0.1994,-0.0073491,0.17707,0.86993,REACTOME_DEFECTIVE_INTRINSIC_PATHWAY_FOR_APOPTOSIS,1
MORF_MSH3,SET,225,-0.061568,-0.0067704,0.054674,0.86993,MORF_MSH3,1
GOMF_NUCLEOTIDYLTRANSFERASE_...,SET,120,-0.079355,-0.0063912,0.070467,0.86994,GOMF_NUCLEOTIDYLTRANSFERASE_ACTIVITY,1
GOBP_MITOCHONDRIAL_RNA_METAB...,SET,50,-0.12141,-0.0063238,0.10779,0.86999,GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS,1
HALLMARK_GLYCOLYSIS,SET,182,-0.069945,-0.0069258,0.062097,0.86999,HALLMARK_GLYCOLYSIS,1
HP_ABNORMAL_PUPILLARY_LIGHT_...,SET,28,-0.18406,-0.0071787,0.16338,0.87003,HP_ABNORMAL_PUPILLARY_LIGHT_REFLEX,1
GSE17721_0.5H_VS_4H_LPS_BMDC...2,SET,183,-0.067168,-0.0066689,0.059614,0.87006,GSE17721_0.5H_VS_4H_LPS_BMDC_UP,1
GOCC_PREFOLDIN_COMPLEX,SET,6,-0.31338,-0.0056612,0.27811,0.87008,GOCC_PREFOLDIN_COMPLEX,1
MIR4286,SET,79,-0.10067,-0.0065856,0.089329,0.8701,MIR4286,1
GOBP_REGULATION_OF_CELLULAR_...20,SET,41,-0.14045,-0.0066264,0.12463,0.87011,GOBP_REGULATION_OF_CELLULAR_SENESCENCE,1
GOBP_REGULATION_OF_CELL_JUNC...,SET,198,-0.070523,-0.0072804,0.062558,0.87019,GOBP_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,1
MIR520E_5P,SET,147,-0.080344,-0.0071566,0.071266,0.8702,MIR520E_5P,1
HP_PERSISTENT_EBV_VIREMIA,SET,12,-0.25509,-0.0065161,0.22624,0.87024,HP_PERSISTENT_EBV_VIREMIA,1
GOBP_SUCCINYL_COA_CATABOLIC_...,SET,6,-0.39322,-0.0071036,0.34868,0.87028,GOBP_SUCCINYL_COA_CATABOLIC_PROCESS,1
GOBP_PROTEIN_LOCALIZATION_TO...21,SET,12,-0.29506,-0.0075369,0.26163,0.87029,GOBP_PROTEIN_LOCALIZATION_TO_EARLY_ENDOSOME,1
GOBP_MULTICELLULAR_ORGANISMA...3,SET,24,-0.18832,-0.0068007,0.16697,0.8703,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_IRON_ION_HOMEOSTASIS,1
HP_T_LYMPHOCYTOPENIA,SET,60,-0.12326,-0.0070314,0.10928,0.87032,HP_T_LYMPHOCYTOPENIA,1
GOBP_GLYCEROPHOSPHOLIPID_CAT...,SET,34,-0.16801,-0.0072196,0.14894,0.87034,GOBP_GLYCEROPHOSPHOLIPID_CATABOLIC_PROCESS,1
GOBP_CELL_CELL_JUNCTION_DISA...,SET,5,-0.52593,-0.0086735,0.46612,0.8704,GOBP_CELL_CELL_JUNCTION_DISASSEMBLY,1
MIR490_3P,SET,40,-0.15192,-0.0070798,0.13464,0.87042,MIR490_3P,1
GOBP_REGULATION_OF_NUCLEAR_T...1,SET,21,-0.20152,-0.0068082,0.17855,0.87047,GOBP_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
GNF2_PTPRC,SET,59,-0.12387,-0.007007,0.10969,0.87059,GNF2_PTPRC,1
KEGG_MEDICUS_VARIANT_BCR_ABL...1,SET,11,-0.28355,-0.0069347,0.25107,0.87062,KEGG_MEDICUS_VARIANT_BCR_ABL_FUSION_KINASE_TO_PI3K_SIGNALING_PATHWAY,1
HP_TRUNCAL_TITUBATION,SET,7,-0.37745,-0.0073648,0.33421,0.87062,HP_TRUNCAL_TITUBATION,1
WP_NRP1TRIGGERED_SIGNALING_I...,SET,52,-0.14397,-0.0076472,0.12744,0.87069,WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER,1
MIR605_5P,SET,125,-0.087806,-0.0072167,0.077726,0.87069,MIR605_5P,1
GOBP_NUCLEOSIDE_TRIPHOSPHATE...1,SET,85,-0.09272,-0.0062909,0.082053,0.87075,GOBP_NUCLEOSIDE_TRIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOBP_DENDRITIC_CELL_MIGRATION,SET,31,-0.18564,-0.0076178,0.16428,0.87076,GOBP_DENDRITIC_CELL_MIGRATION,1
GOBP_REGULATION_OF_TRANSMISS...,SET,13,-0.28193,-0.0074955,0.24949,0.87076,GOBP_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,1
HP_GENERALIZED_HIRSUTISM,SET,86,-0.1045,-0.0071313,0.092473,0.87076,HP_GENERALIZED_HIRSUTISM,1
REACTOME_IL_6_TYPE_CYTOKINE_...,SET,17,-0.22873,-0.0069533,0.20241,0.87077,REACTOME_IL_6_TYPE_CYTOKINE_RECEPTOR_LIGAND_INTERACTIONS,1
HP_CONGENITAL_LOCALIZED_ABSE...,SET,9,-0.28766,-0.006364,0.25454,0.87077,HP_CONGENITAL_LOCALIZED_ABSENCE_OF_SKIN,1
MIR629_3P,SET,165,-0.076563,-0.0072217,0.067747,0.87078,MIR629_3P,1
GOMF_NAD_P_H_OXIDASE_H2O2_FO...,SET,8,-0.30988,-0.0064637,0.27413,0.87084,GOMF_NAD_P_H_OXIDASE_H2O2_FORMING_ACTIVITY,1
GOMF_CALCIUM_DEPENDENT_CYSTE...,SET,15,-0.26958,-0.0076982,0.23846,0.87086,GOMF_CALCIUM_DEPENDENT_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
HP_THUMB_CONTRACTURE,SET,4,-0.57316,-0.0084547,0.50697,0.87087,HP_THUMB_CONTRACTURE,1
GOBP_POSITIVE_REGULATION_OF_...729,SET,4,-0.51124,-0.0075413,0.45217,0.87089,GOBP_POSITIVE_REGULATION_OF_STORE_OPERATED_CALCIUM_CHANNEL_ACTIVITY,1
GOBP_REGULATION_OF_DEFENSE_R...2,SET,18,-0.22279,-0.0069689,0.19704,0.87091,GOBP_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
HP_MACROORCHIDISM,SET,10,-0.30344,-0.0070761,0.26836,0.87091,HP_MACROORCHIDISM,1
GSE14415_FOXP3_KO_NATURAL_TR...2,SET,153,-0.076359,-0.006938,0.067521,0.87094,GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP,1
ZHAN_MULTIPLE_MYELOMA_CD2_UP,SET,42,-0.15742,-0.0075165,0.13918,0.87096,ZHAN_MULTIPLE_MYELOMA_CD2_UP,1
LAKE_ADULT_KIDNEY_C25_ENDOTH...,SET,37,-0.17501,-0.0078443,0.15473,0.87097,LAKE_ADULT_KIDNEY_C25_ENDOTHELIAL_CELLS_UNASSIGNED,1
GOBP_REGULATION_OF_ADHERENS_...,SET,5,-0.43648,-0.0071984,0.38583,0.87103,GOBP_REGULATION_OF_ADHERENS_JUNCTION_ORGANIZATION,1
HP_INCREASED_CIRCULATING_INT...1,SET,20,-0.2255,-0.0074347,0.19933,0.87103,HP_INCREASED_CIRCULATING_INTERFERON_GAMMA_CONCENTRATION,1
BIOCARTA_ASBCELL_PATHWAY,SET,10,-0.33098,-0.0077183,0.29255,0.87104,BIOCARTA_ASBCELL_PATHWAY,1
GOMF_OXIDOREDUCTASE_ACTIVITY...15,SET,12,-0.26598,-0.0067942,0.23507,0.87107,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_NAD_P_H_OXYGEN_AS_ACCEPTOR,1
HARALAMBIEVA_PBMC_TIV_AGE_50...1,SET,19,-0.22454,-0.0072158,0.19844,0.87108,HARALAMBIEVA_PBMC_TIV_AGE_50_74YO_CORRELATED_WITH_MEMORY_B_CELL_RESPONSE_28DY_NEGATIVE,1
GOMF_ACIDIC_AMINO_ACID_TRANS...,SET,18,-0.23421,-0.0073261,0.20695,0.87113,GOMF_ACIDIC_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
AMIT_EGF_RESPONSE_480_MCF10A,SET,42,-0.14995,-0.0071598,0.13246,0.87117,AMIT_EGF_RESPONSE_480_MCF10A,1
HP_VIRAL_ENCEPHALITIS,SET,11,-0.28592,-0.0069927,0.25255,0.8712,HP_VIRAL_ENCEPHALITIS,1
GOBP_REGULATION_OF_RESPONSE_...10,SET,10,-0.29471,-0.0068726,0.26031,0.87121,GOBP_REGULATION_OF_RESPONSE_TO_REACTIVE_OXYGEN_SPECIES,1
STONER_ESOPHAGEAL_CARCINOGEN...1,SET,6,-0.37491,-0.0067728,0.33111,0.87123,STONER_ESOPHAGEAL_CARCINOGENESIS_DN,1
AP2REP_01,SET,157,-0.077577,-0.0071394,0.068514,0.87124,AP2REP_01,1
GOMF_TFIID_CLASS_TRANSCRIPTI...,SET,10,-0.29504,-0.0068802,0.26054,0.87126,GOMF_TFIID_CLASS_TRANSCRIPTION_FACTOR_COMPLEX_BINDING,1
NKX3A_01,SET,205,-0.071652,-0.0075251,0.063271,0.87127,NKX3A_01,1
WP_FOCAL_ADHESION_PI3KAKTMTO...,SET,288,-0.059173,-0.0073491,0.052251,0.87128,WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING,1
GOMF_ANGIOTENSIN_RECEPTOR_AC...,SET,4,-0.54774,-0.0080797,0.48366,0.87128,GOMF_ANGIOTENSIN_RECEPTOR_ACTIVITY,1
HP_CORONARY_ARTERY_ANEURYSM,SET,7,-0.43054,-0.0084008,0.38018,0.87128,HP_CORONARY_ARTERY_ANEURYSM,1
SOUCEK_MYC_TARGETS,SET,10,-0.3238,-0.0075508,0.28589,0.8713,SOUCEK_MYC_TARGETS,1
HP_PROXIMAL_PLACEMENT_OF_THU...,SET,34,-0.16144,-0.0069372,0.14247,0.87141,HP_PROXIMAL_PLACEMENT_OF_THUMB,1
GREB1_TARGET_GENES,SET,683,-0.037659,-0.0071235,0.033233,0.87142,GREB1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...153,SET,9,-0.35562,-0.0078676,0.31383,0.87142,GOBP_NEGATIVE_REGULATION_OF_COLLATERAL_SPROUTING,1
GOBP_REGULATION_OF_ADENYLATE...2,SET,42,-0.15693,-0.0074934,0.13846,0.87147,GOBP_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,1
HP_DILATION_OF_VIRCHOW_ROBIN...,SET,13,-0.28831,-0.007665,0.25432,0.87152,HP_DILATION_OF_VIRCHOW_ROBIN_SPACES,1
ZWANG_TRANSIENTLY_UP_BY_2ND_...,SET,1330,-0.027999,-0.0072544,0.024695,0.87156,ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY,1
GOBP_POSITIVE_REGULATION_OF_...663,SET,5,-0.45498,-0.0075034,0.40128,0.87156,GOBP_POSITIVE_REGULATION_OF_RECEPTOR_BINDING,1
KEGG_MEDICUS_REFERENCE_CHRNA...,SET,6,-0.43411,-0.0078423,0.38284,0.87158,KEGG_MEDICUS_REFERENCE_CHRNA7_E2F_SIGNALING_PATHWAY,1
LEE_LIVER_CANCER_MYC_UP,SET,49,-0.13992,-0.0072151,0.12339,0.87159,LEE_LIVER_CANCER_MYC_UP,1
YANG_BREAST_CANCER_ESR1_UP,SET,35,-0.16666,-0.0072658,0.14693,0.87165,YANG_BREAST_CANCER_ESR1_UP,1
CREIGHTON_ENDOCRINE_THERAPY_...5,SET,430,-0.047647,-0.0072023,0.041992,0.87174,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5,1
GOBP_POSITIVE_REGULATION_OF_...623,SET,39,-0.15108,-0.0069521,0.13315,0.87174,GOBP_POSITIVE_REGULATION_OF_PROTEIN_IMPORT_INTO_NUCLEUS,1
GOBP_CLEAVAGE_FURROW_FORMATI...,SET,7,-0.4007,-0.0078185,0.35298,0.87184,GOBP_CLEAVAGE_FURROW_FORMATION,1
HP_AMNIOTIC_CONSTRICTION_RING,SET,10,-0.3488,-0.0081339,0.30727,0.87184,HP_AMNIOTIC_CONSTRICTION_RING,1
WINTER_HYPOXIA_UP,SET,87,-0.098027,-0.0067284,0.086346,0.87186,WINTER_HYPOXIA_UP,1
PURBEY_TARGETS_OF_CTBP1_NOT_...1,SET,352,-0.051383,-0.0070425,0.045254,0.87189,PURBEY_TARGETS_OF_CTBP1_NOT_SATB1_DN,1
MIR6738_5P,SET,25,-0.20106,-0.0074103,0.17708,0.87189,MIR6738_5P,1
GSE3982_MAC_VS_EFF_MEMORY_CD...1,SET,173,-0.072343,-0.0069856,0.063708,0.87192,GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN,1
MIR2355_5P,SET,118,-0.083985,-0.0067078,0.073957,0.87193,MIR2355_5P,1
MIR548AU_3P,SET,157,-0.076606,-0.00705,0.067456,0.87194,MIR548AU_3P,1
NOUSHMEHR_GBM_GERMLINE_MUTAT...,SET,7,-0.38178,-0.0074494,0.33613,0.87197,NOUSHMEHR_GBM_GERMLINE_MUTATED,1
GOBP_CELLULAR_SENESCENCE,SET,93,-0.098033,-0.0069559,0.086297,0.87201,GOBP_CELLULAR_SENESCENCE,1
WP_BARDETBIEDL_SYNDROME,SET,76,-0.10436,-0.0066972,0.091849,0.87207,WP_BARDETBIEDL_SYNDROME,1
GOBP_NEGATIVE_REGULATION_OF_...26,SET,14,-0.24483,-0.0067547,0.2154,0.87215,GOBP_NEGATIVE_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1
RIZ_ERYTHROID_DIFFERENTIATIO...1,SET,32,-0.18668,-0.007783,0.16423,0.87216,RIZ_ERYTHROID_DIFFERENTIATION_12HR,1
REACTOME_TRANSCRIPTIONAL_REG...10,SET,38,-0.15253,-0.0069283,0.13416,0.87219,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_VENTX,1
MIR187_5P,SET,163,-0.077952,-0.0073085,0.068562,0.87221,MIR187_5P,1
KEGG_MEDICUS_REFERENCE_ITGA_...4,SET,22,-0.21547,-0.0074503,0.18948,0.87226,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGEF_RHOA_SIGNALING_PATHWAY,1
GOBP_CARDIAC_MUSCLE_CELL_DIF...,SET,112,-0.092199,-0.0071754,0.081071,0.87228,GOBP_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
GOMF_ESTROGEN_2_HYDROXYLASE_...,SET,5,-0.48139,-0.007939,0.42321,0.87232,GOMF_ESTROGEN_2_HYDROXYLASE_ACTIVITY,1
HP_BONE_MARROW_FOAM_CELLS,SET,5,-0.5499,-0.0090688,0.48325,0.87242,HP_BONE_MARROW_FOAM_CELLS,1
MIR10526_3P,SET,105,-0.094538,-0.0071252,0.083058,0.87248,MIR10526_3P,1
MODULE_576,SET,102,-0.095638,-0.0071049,0.084015,0.8725,MODULE_576,1
GOBP_MACROPHAGE_COLONY_STIMU...2,SET,7,-0.4102,-0.0080039,0.36034,0.87251,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_SIGNALING_PATHWAY,1
GOBP_METANEPHRIC_DISTAL_TUBU...,SET,6,-0.43612,-0.0078786,0.38306,0.87254,GOBP_METANEPHRIC_DISTAL_TUBULE_DEVELOPMENT,1
KEGG_MEDICUS_REFERENCE_ITGA_...2,SET,29,-0.18678,-0.0074136,0.16401,0.8726,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY,1
MIR5701,SET,179,-0.071149,-0.0069873,0.062475,0.87261,MIR5701,1
GOBP_NEGATIVE_REGULATION_OF_...138,SET,21,-0.22915,-0.0077415,0.20119,0.87263,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,1
HP_HYPOPLASTIC_LABIA_MAJORA,SET,34,-0.1578,-0.0067807,0.13854,0.87264,HP_HYPOPLASTIC_LABIA_MAJORA,1
GSE1925_CTRL_VS_3H_IFNG_STIM...1,SET,181,-0.073369,-0.007245,0.064417,0.87264,GSE1925_CTRL_VS_3H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,1
GOBP_REGULATION_OF_PROTEIN_D...3,SET,77,-0.10416,-0.0067277,0.091445,0.87265,GOBP_REGULATION_OF_PROTEIN_DEPOLYMERIZATION,1
HU_FETAL_RETINA_PHOTORECEPTOR,SET,65,-0.12849,-0.0076279,0.11277,0.87274,HU_FETAL_RETINA_PHOTORECEPTOR,1
HP_EPICANTHUS_INVERSUS,SET,13,-0.28508,-0.0075791,0.25017,0.87275,HP_EPICANTHUS_INVERSUS,1
MIR5696,SET,621,-0.039671,-0.0071679,0.034812,0.87276,MIR5696,1
GOBP_REGULATION_OF_PROTEIN_L...12,SET,9,-0.29413,-0.0065071,0.25808,0.87278,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,1
GSE3565_DUSP1_VS_WT_SPLENOCY...4,SET,148,-0.084914,-0.0075891,0.074505,0.87279,GSE3565_DUSP1_VS_WT_SPLENOCYTES_UP,1
GOBP_GTP_METABOLIC_PROCESS,SET,22,-0.20912,-0.0072307,0.18347,0.8728,GOBP_GTP_METABOLIC_PROCESS,1
GSE7852_LN_VS_THYMUS_TREG_DN,SET,179,-0.071538,-0.0070255,0.062767,0.8728,GSE7852_LN_VS_THYMUS_TREG_DN,1
HP_RENAL_TUBULAR_DYSFUNCTION,SET,90,-0.097234,-0.0067876,0.085308,0.87281,HP_RENAL_TUBULAR_DYSFUNCTION,1
GOBP_REGULATION_OF_SYNAPTIC_...3,SET,8,-0.33792,-0.0070485,0.29644,0.87283,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_CHOLINERGIC,1
TRAVAGLINI_LUNG_DIFFERENTIAT...,SET,148,-0.083643,-0.0074756,0.073349,0.87292,TRAVAGLINI_LUNG_DIFFERENTIATING_BASAL_CELL,1
HNF3B_01,SET,196,-0.071821,-0.0073771,0.062961,0.873,HNF3B_01,1
GOMF_ALKALI_METAL_ION_BINDING,SET,19,-0.21469,-0.0068994,0.1882,0.87301,GOMF_ALKALI_METAL_ION_BINDING,1
CORRE_MULTIPLE_MYELOMA_DN,SET,52,-0.13903,-0.0073848,0.12185,0.87305,CORRE_MULTIPLE_MYELOMA_DN,1
MIR4524B_3P,SET,65,-0.12526,-0.0074362,0.10975,0.87314,MIR4524B_3P,1
GOBP_PARASYMPATHETIC_NERVOUS...,SET,17,-0.2548,-0.0077456,0.22323,0.87314,GOBP_PARASYMPATHETIC_NERVOUS_SYSTEM_DEVELOPMENT,1
GOBP_HEART_GROWTH,SET,76,-0.12004,-0.0077032,0.10516,0.87317,GOBP_HEART_GROWTH,1
MANNO_MIDBRAIN_NEUROTYPES_HN...5,SET,197,-0.071182,-0.00733,0.062348,0.8732,MANNO_MIDBRAIN_NEUROTYPES_HNPROG,1
GOBP_EPIDERMIS_MORPHOGENESIS,SET,36,-0.18597,-0.0082226,0.16284,0.87327,GOBP_EPIDERMIS_MORPHOGENESIS,1
HP_ABNORMALITY_OF_REPRODUCTI...,SET,755,-0.035456,-0.0070372,0.031045,0.87328,HP_ABNORMALITY_OF_REPRODUCTIVE_SYSTEM_PHYSIOLOGY,1
chr1q42,SET,83,-0.2118,-0.014201,0.18544,0.8733,chr1q42,1
GOBP_FATTY_ACID_DERIVATIVE_M...,SET,68,-0.12079,-0.0073339,0.10576,0.8733,GOBP_FATTY_ACID_DERIVATIVE_METABOLIC_PROCESS,1
HP_STEREOTYPIC_WHOLE_BODY_MO...,SET,8,-0.30449,-0.0063513,0.26658,0.87331,HP_STEREOTYPIC_WHOLE_BODY_MOVEMENTS,1
ONDER_CDH1_TARGETS_3_UP,SET,15,-0.26259,-0.0074987,0.22987,0.87333,ONDER_CDH1_TARGETS_3_UP,1
GSE17186_NAIVE_VS_CD21HIGH_T...2,SET,176,-0.069042,-0.0067238,0.060441,0.87333,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_CORD_BLOOD_UP,1
ONKEN_UVEAL_MELANOMA_UP,SET,718,-0.036988,-0.0071664,0.032374,0.87337,ONKEN_UVEAL_MELANOMA_UP,1
GSE17721_CTRL_VS_POLYIC_1H_B...2,SET,176,-0.069113,-0.0067308,0.06049,0.87338,GSE17721_CTRL_VS_POLYIC_1H_BMDC_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_CLU...,SET,64,-0.13266,-0.0078149,0.1161,0.8734,HE_LIM_SUN_FETAL_LUNG_C1_CLUB_CELL,1
GOBP_POSITIVE_REGULATION_OF_...231,SET,17,-0.24931,-0.0075788,0.21817,0.87342,GOBP_POSITIVE_REGULATION_OF_EMBRYONIC_DEVELOPMENT,1
GSE360_DC_VS_MAC_L_MAJOR_UP,SET,172,-0.072865,-0.0070158,0.063763,0.87342,GSE360_DC_VS_MAC_L_MAJOR_UP,1
GOBP_REGULATION_OF_ANOIKIS,SET,22,-0.20583,-0.007117,0.1801,0.87344,GOBP_REGULATION_OF_ANOIKIS,1
GAVISH_3CA_METAPROGRAM_ENDOT...9,SET,45,-0.1571,-0.007764,0.13746,0.87345,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_7,1
HP_WIDE_CRANIAL_SUTURES,SET,27,-0.18919,-0.0072462,0.16545,0.87358,HP_WIDE_CRANIAL_SUTURES,1
GOBP_NEPHRON_TUBULE_EPITHELI...,SET,13,-0.31655,-0.0084158,0.2768,0.8736,GOBP_NEPHRON_TUBULE_EPITHELIAL_CELL_DIFFERENTIATION,1
REACTOME_NEPHRIN_FAMILY_INTE...,SET,21,-0.20395,-0.0068901,0.17833,0.87361,REACTOME_NEPHRIN_FAMILY_INTERACTIONS,1
GOMF_INORGANIC_ANION_TRANSME...,SET,146,-0.083905,-0.0074486,0.073349,0.87366,GOMF_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE11057_CD4_CENT_MEM_VS_PBM...1,SET,175,-0.075199,-0.0073029,0.065734,0.87368,GSE11057_CD4_CENT_MEM_VS_PBMC_DN,1
GOBP_REGULATION_OF_EXTRINSIC...3,SET,45,-0.13912,-0.0068755,0.12158,0.87374,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_VIA_DEATH_DOMAIN_RECEPTORS,1
GOCC_FIBRILLAR_COLLAGEN_TRIM...,SET,12,-0.30716,-0.007846,0.26843,0.87374,GOCC_FIBRILLAR_COLLAGEN_TRIMER,1
HP_ENDOCARDIAL_FIBROELASTOSIS,SET,7,-0.37844,-0.0073842,0.33073,0.87374,HP_ENDOCARDIAL_FIBROELASTOSIS,1
MODULE_73,SET,20,-0.24345,-0.0080266,0.21274,0.87376,MODULE_73,1
HP_DECREASED_ADIPOSE_TISSUE,SET,43,-0.14533,-0.0070211,0.12695,0.87384,HP_DECREASED_ADIPOSE_TISSUE,1
GOBP_UTP_METABOLIC_PROCESS,SET,11,-0.31349,-0.0076671,0.27384,0.87385,GOBP_UTP_METABOLIC_PROCESS,1
TCCAGAT_MIR5165P,SET,96,-0.098726,-0.0071165,0.086233,0.87386,TCCAGAT_MIR5165P,1
HP_CUTANEOUS_MELANOMA,SET,19,-0.18907,-0.006076,0.16514,0.87388,HP_CUTANEOUS_MELANOMA,1
GSE22886_TCELL_VS_BCELL_NAIV...1,SET,167,-0.078362,-0.0074357,0.068434,0.8739,GSE22886_TCELL_VS_BCELL_NAIVE_DN,1
HP_ABNORMAL_CNS_MYELINATION,SET,360,-0.048222,-0.0066826,0.042108,0.87393,HP_ABNORMAL_CNS_MYELINATION,1
GOCC_CELL_CELL_JUNCTION,SET,471,-0.046669,-0.0073747,0.040746,0.87396,GOCC_CELL_CELL_JUNCTION,1
SYNCRIP_TARGET_GENES,SET,16,-0.2368,-0.0069837,0.20672,0.87399,SYNCRIP_TARGET_GENES,1
GOBP_ENDOSOMAL_TRANSPORT,SET,255,-0.057938,-0.006777,0.050579,0.87399,GOBP_ENDOSOMAL_TRANSPORT,1
HP_COMBINED_IMMUNODEFICIENCY,SET,35,-0.17181,-0.0074905,0.14997,0.87402,HP_COMBINED_IMMUNODEFICIENCY,1
LAKE_ADULT_KIDNEY_C28_INTERS...,SET,79,-0.11928,-0.0078032,0.1041,0.87406,LAKE_ADULT_KIDNEY_C28_INTERSTITIUM,1
GOBP_FORMATION_OF_EXTRACHROM...,SET,13,-0.23699,-0.0063006,0.2068,0.87409,GOBP_FORMATION_OF_EXTRACHROMOSOMAL_CIRCULAR_DNA,1
GOBP_DOPAMINE_SECRETION,SET,29,-0.19213,-0.0076258,0.16765,0.8741,GOBP_DOPAMINE_SECRETION,1
HP_PROTEIN_AVOIDANCE,SET,5,-0.42835,-0.0070642,0.37372,0.87413,HP_PROTEIN_AVOIDANCE,1
GOBP_REGULATION_OF_SPROUTING...,SET,40,-0.1564,-0.0072882,0.13642,0.87418,GOBP_REGULATION_OF_SPROUTING_ANGIOGENESIS,1
GSE18791_CTRL_VS_NEWCASTLE_V...4,SET,177,-0.068336,-0.0066738,0.059609,0.87418,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_UP,1
REACTOME_RECYCLING_OF_EIF2_G...,SET,7,-0.31669,-0.0061793,0.27621,0.8742,REACTOME_RECYCLING_OF_EIF2_GDP,1
SIRT3_TARGET_GENES,SET,38,-0.15199,-0.0069039,0.13256,0.87421,SIRT3_TARGET_GENES,1
GOBP_REGULATION_OF_PEPTIDYL_...1,SET,8,-0.36437,-0.0076004,0.31778,0.87422,GOBP_REGULATION_OF_PEPTIDYL_CYSTEINE_S_NITROSYLATION,1
HP_ABNORMAL_COLUMELLA_MORPHO...,SET,78,-0.10636,-0.0069145,0.09276,0.87423,HP_ABNORMAL_COLUMELLA_MORPHOLOGY,1
REACTOME_GERM_LAYER_FORMATIO...,SET,15,-0.26585,-0.0075917,0.23184,0.87424,REACTOME_GERM_LAYER_FORMATION_AT_GASTRULATION,1
HP_EEG_WITH_FOCAL_SPIKES,SET,30,-0.17681,-0.0071375,0.15418,0.87425,HP_EEG_WITH_FOCAL_SPIKES,1
HP_DECREASED_CIRCULATING_CER...,SET,8,-0.3405,-0.0071024,0.29686,0.8743,HP_DECREASED_CIRCULATING_CERULOPLASMIN_CONCENTRATION,1
ELVIDGE_HYPOXIA_BY_DMOG_UP,SET,122,-0.093244,-0.0075717,0.081284,0.87433,ELVIDGE_HYPOXIA_BY_DMOG_UP,1
LET_7G_5P,SET,361,-0.052216,-0.0072458,0.045515,0.87435,LET_7G_5P,1
HP_NYCTALOPIA,SET,200,-0.069588,-0.0072196,0.060656,0.87436,HP_NYCTALOPIA,1
MIR6838_5P,SET,489,-0.043245,-0.0069595,0.037682,0.87443,MIR6838_5P,1
RAAGNYNNCTTY_UNKNOWN,SET,135,-0.088731,-0.0075767,0.077304,0.87447,RAAGNYNNCTTY_UNKNOWN,1
REACTOME_POST_TRANSLATIONAL_...2,SET,1290,-0.02749,-0.0070228,0.023946,0.8745,REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION,1
HP_DEEP_VENOUS_THROMBOSIS,SET,17,-0.19881,-0.0060437,0.17318,0.8745,HP_DEEP_VENOUS_THROMBOSIS,1
KIM_ALL_DISORDERS_CALB1_CORR...1,SET,35,-0.1691,-0.0073723,0.14729,0.87453,KIM_ALL_DISORDERS_CALB1_CORR_DN,1
DAZARD_UV_RESPONSE_CLUSTER_G5,SET,8,-0.26511,-0.0055298,0.23074,0.87471,DAZARD_UV_RESPONSE_CLUSTER_G5,1
GOBP_CELL_MIGRATION_INVOLVED...5,SET,51,-0.14055,-0.0073934,0.12232,0.87472,GOBP_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
KEGG_MEDICUS_REFERENCE_LECTI...1,SET,10,-0.3896,-0.0090854,0.33894,0.87481,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_FIBRINOGEN_TO_FIBRIN,1
REACTOME_RUNX2_REGULATES_BON...,SET,28,-0.20386,-0.0079509,0.17728,0.87491,REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT,1
HECKER_IFNB1_TARGETS,SET,88,-0.11478,-0.007923,0.099804,0.87492,HECKER_IFNB1_TARGETS,1
HP_ABNORMAL_CIRCULATING_HAPT...,SET,11,-0.28181,-0.0068923,0.24502,0.87495,HP_ABNORMAL_CIRCULATING_HAPTOGLOBIN_CONCENTRATION,1
HP_ALLERGIC_RHINITIS,SET,10,-0.28083,-0.006549,0.2441,0.87502,HP_ALLERGIC_RHINITIS,1
KAAB_HEART_ATRIUM_VS_VENTRIC...1,SET,240,-0.061493,-0.006981,0.053445,0.87504,KAAB_HEART_ATRIUM_VS_VENTRICLE_DN,1
GOMF_S100_PROTEIN_BINDING,SET,14,-0.26706,-0.007368,0.2321,0.87505,GOMF_S100_PROTEIN_BINDING,1
WEI_MIR34A_TARGETS,SET,136,-0.083367,-0.0071448,0.072442,0.87508,WEI_MIR34A_TARGETS,1
GSE39110_DAY3_VS_DAY6_POST_I...2,SET,180,-0.074183,-0.0073054,0.064456,0.87511,GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP,1
GSE6566_STRONG_VS_WEAK_DC_ST...2,SET,156,-0.080779,-0.0074105,0.070185,0.87511,GSE6566_STRONG_VS_WEAK_DC_STIMULATED_CD4_TCELL_UP,1
GOCC_REPLICATION_FORK,SET,69,-0.1071,-0.0065497,0.093031,0.87516,GOCC_REPLICATION_FORK,1
MIR9_5P,SET,436,-0.047488,-0.0072269,0.04125,0.87517,MIR9_5P,1
HP_FATIGABLE_WEAKNESS_OF_DIS...,SET,8,-0.32137,-0.0067034,0.27911,0.87521,HP_FATIGABLE_WEAKNESS_OF_DISTAL_LIMB_MUSCLES,1
HDGF_TARGET_GENES,SET,718,-0.036365,-0.0070459,0.031579,0.87524,HDGF_TARGET_GENES,1
GCM_PRKAG1,SET,44,-0.1312,-0.0064118,0.11392,0.87526,GCM_PRKAG1,1
PELLICCIOTTA_HDAC_IN_ANTIGEN...2,SET,60,-0.1143,-0.0065201,0.099232,0.8753,PELLICCIOTTA_HDAC_IN_ANTIGEN_PRESENTATION_UP,1
VANTVEER_BREAST_CANCER_BRCA1...1,SET,37,-0.15804,-0.007084,0.13716,0.87538,VANTVEER_BREAST_CANCER_BRCA1_DN,1
GSE29614_DAY3_VS_DAY7_TIV_FL...2,SET,144,-0.084555,-0.007455,0.073376,0.8754,GSE29614_DAY3_VS_DAY7_TIV_FLU_VACCINE_PBMC_UP,1
LIU_OVARIAN_CANCER_TUMORS_AN...1,SET,33,-0.19175,-0.008118,0.1664,0.87541,LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN,1
GOBP_REGULATION_OF_PHOSPHORY...,SET,890,-0.03398,-0.0072942,0.029484,0.87543,GOBP_REGULATION_OF_PHOSPHORYLATION,1
GSE17721_0.5H_VS_24H_POLYIC_...2,SET,183,-0.070831,-0.0070325,0.061447,0.87548,GSE17721_0.5H_VS_24H_POLYIC_BMDC_UP,1
WP_AMINO_ACID_TRANSPORT_DEFE...,SET,8,-0.33916,-0.0070744,0.29415,0.87554,WP_AMINO_ACID_TRANSPORT_DEFECTS_IEMS,1
MODULE_355,SET,29,-0.16811,-0.0066724,0.1458,0.87554,MODULE_355,1
KEGG_MEDICUS_REFERENCE_MGLUR...2,SET,20,-0.21915,-0.0072255,0.19006,0.87556,KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY,1
SCHUHMACHER_MYC_TARGETS_UP,SET,74,-0.10951,-0.0069347,0.094965,0.87557,SCHUHMACHER_MYC_TARGETS_UP,1
HP_ABNORMAL_FINGERTIP_MORPHO...,SET,76,-0.11203,-0.007189,0.097147,0.87557,HP_ABNORMAL_FINGERTIP_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...645,SET,187,-0.072135,-0.0072392,0.062549,0.87559,GOBP_NEGATIVE_REGULATION_OF_TRANSFERASE_ACTIVITY,1
GOCC_NETWORK_FORMING_COLLAGE...,SET,6,-0.43372,-0.0078353,0.37606,0.87561,GOCC_NETWORK_FORMING_COLLAGEN_TRIMER,1
REACTOME_INTRA_GOLGI_AND_RET...,SET,194,-0.0662,-0.0067654,0.057391,0.87564,REACTOME_INTRA_GOLGI_AND_RETROGRADE_GOLGI_TO_ER_TRAFFIC,1
GTGTCAA_MIR514,SET,55,-0.12206,-0.006667,0.10581,0.87565,GTGTCAA_MIR514,1
MIR6837_5P,SET,116,-0.088891,-0.0070396,0.077043,0.8757,MIR6837_5P,1
HP_IMPAIRED_RENAL_CONCENTRAT...,SET,6,-0.38273,-0.006914,0.33169,0.87571,HP_IMPAIRED_RENAL_CONCENTRATING_ABILITY,1
GOBP_NEGATIVE_REGULATION_OF_...120,SET,32,-0.18133,-0.0075599,0.15713,0.87575,GOBP_NEGATIVE_REGULATION_OF_CELL_MATRIX_ADHESION,1
GOCC_CHROMOSOME_TELOMERIC_RE...2,SET,12,-0.26438,-0.0067533,0.22908,0.87576,GOCC_CHROMOSOME_TELOMERIC_REPEAT_REGION,1
MIR449C_5P,SET,121,-0.092343,-0.007468,0.080009,0.87578,MIR449C_5P,1
HP_ABNORMAL_LIVER_MORPHOLOGY,SET,792,-0.035329,-0.0071741,0.030608,0.87579,HP_ABNORMAL_LIVER_MORPHOLOGY,1
chr2q23,SET,21,-0.35579,-0.01202,0.30822,0.87582,chr2q23,1
MIR6869_5P,SET,37,-0.15404,-0.0069047,0.13344,0.87582,MIR6869_5P,1
GOBP_POSITIVE_REGULATION_OF_...515,SET,8,-0.34947,-0.0072894,0.3027,0.87584,GOBP_POSITIVE_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
PID_INTEGRIN5_PATHWAY,SET,16,-0.26303,-0.0077573,0.22779,0.87589,PID_INTEGRIN5_PATHWAY,1
GOMF_PURINE_RIBONUCLEOTIDE_T...,SET,20,-0.23872,-0.0078706,0.20673,0.87589,GOMF_PURINE_RIBONUCLEOTIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_BOWED_FOREARM_BONES,SET,31,-0.19053,-0.0078185,0.165,0.87589,HP_BOWED_FOREARM_BONES,1
HP_ABNORMAL_BLOOD_PHOSPHATE_...,SET,58,-0.13525,-0.0075857,0.11711,0.87591,HP_ABNORMAL_BLOOD_PHOSPHATE_CONCENTRATION,1
GOBP_RESPONSE_TO_ACTIVITY,SET,72,-0.12099,-0.0075578,0.10473,0.876,GOBP_RESPONSE_TO_ACTIVITY,1
CAIRO_HEPATOBLASTOMA_CLASSES...1,SET,195,-0.072129,-0.0073901,0.062427,0.87603,CAIRO_HEPATOBLASTOMA_CLASSES_DN,1
HP_ABNORMAL_ULNAR_METAPHYSIS...,SET,10,-0.36677,-0.0085529,0.31736,0.87609,HP_ABNORMAL_ULNAR_METAPHYSIS_MORPHOLOGY,1
GOCC_TRAPPIII_PROTEIN_COMPLEX,SET,10,-0.2871,-0.006695,0.24841,0.8761,GOCC_TRAPPIII_PROTEIN_COMPLEX,1
GOMF_HYDROLASE_ACTIVITY_HYDR...2,SET,83,-0.1093,-0.0073286,0.094558,0.87613,GOMF_HYDROLASE_ACTIVITY_HYDROLYZING_O_GLYCOSYL_COMPOUNDS,1
MIR4314,SET,121,-0.086617,-0.0070049,0.074933,0.87614,MIR4314,1
GOBP_ESTABLISHMENT_OF_MEIOTI...,SET,6,-0.44065,-0.0079605,0.38118,0.87616,GOBP_ESTABLISHMENT_OF_MEIOTIC_SPINDLE_LOCALIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...27,SET,18,-0.25138,-0.0078631,0.21744,0.87617,GOBP_NEGATIVE_REGULATION_OF_ANOIKIS,1
HP_PROGRESSIVE_MACROCEPHALY,SET,7,-0.37002,-0.0072198,0.32005,0.87618,HP_PROGRESSIVE_MACROCEPHALY,1
MIR3183,SET,75,-0.11281,-0.0071918,0.097563,0.87621,MIR3183,1
GOBP_POSITIVE_REGULATION_OF_...530,SET,15,-0.24313,-0.0069431,0.21027,0.87621,GOBP_POSITIVE_REGULATION_OF_NEURON_MIGRATION,1
GSE15930_STIM_VS_STIM_AND_IF...5,SET,181,-0.069674,-0.0068802,0.060258,0.87621,GSE15930_STIM_VS_STIM_AND_IFNAB_72H_CD8_T_CELL_DN,1
CASP8AP2_TARGET_GENES,SET,262,-0.059516,-0.0070552,0.051464,0.87625,CASP8AP2_TARGET_GENES,1
GSE12392_WT_VS_IFNB_KO_CD8A_...1,SET,185,-0.073712,-0.0073581,0.063732,0.87627,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN,1
REACTOME_PI_3K_CASCADE_FGFR3,SET,17,-0.24399,-0.007417,0.21095,0.87628,REACTOME_PI_3K_CASCADE_FGFR3,1
MIR3617_3P,SET,79,-0.10907,-0.0071358,0.094296,0.8763,MIR3617_3P,1
GOCC_MICROVILLUS_MEMBRANE,SET,29,-0.18529,-0.0073544,0.16018,0.87631,GOCC_MICROVILLUS_MEMBRANE,1
HP_ENLARGEMENT_OF_THE_COSTOC...,SET,8,-0.36614,-0.0076373,0.31653,0.87631,HP_ENLARGEMENT_OF_THE_COSTOCHONDRAL_JUNCTION,1
GOBP_REGULATION_OF_SMOOTHENE...,SET,79,-0.106,-0.0069345,0.091603,0.87639,GOBP_REGULATION_OF_SMOOTHENED_SIGNALING_PATHWAY,1
GSE7460_CTRL_VS_FOXP3_OVEREX...4,SET,181,-0.071904,-0.0071004,0.062126,0.87643,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_UP,1
CUI_DEVELOPING_HEART_SMOOTH_...,SET,41,-0.15654,-0.0073855,0.13526,0.87643,CUI_DEVELOPING_HEART_SMOOTH_MUSCLE_CELL,1
GOBP_PEPTIDE_BIOSYNTHETIC_PR...,SET,25,-0.20675,-0.0076201,0.17864,0.87644,GOBP_PEPTIDE_BIOSYNTHETIC_PROCESS,1
WILLIAMS_ESR2_TARGETS_UP,SET,25,-0.18876,-0.0069571,0.16308,0.87646,WILLIAMS_ESR2_TARGETS_UP,1
GCM_BECN1,SET,62,-0.11532,-0.0066865,0.09961,0.8765,GCM_BECN1,1
GOBP_NEGATIVE_REGULATION_OF_...129,SET,5,-0.48114,-0.0079349,0.41556,0.87652,GOBP_NEGATIVE_REGULATION_OF_CELL_VOLUME,1
MODULE_343,SET,24,-0.18929,-0.0068359,0.16348,0.87654,MODULE_343,1
HP_ABNORMAL_SKULL_BASE_MORPH...,SET,205,-0.067018,-0.0070384,0.057874,0.87656,HP_ABNORMAL_SKULL_BASE_MORPHOLOGY,1
GCM_GSPT1,SET,154,-0.071295,-0.0064988,0.061564,0.87657,GCM_GSPT1,1
HP_ENLARGED_POSTERIOR_FOSSA,SET,163,-0.072693,-0.0068154,0.062772,0.87657,HP_ENLARGED_POSTERIOR_FOSSA,1
GOCC_NON_MOTILE_CILIUM,SET,146,-0.081349,-0.0072216,0.070244,0.87658,GOCC_NON_MOTILE_CILIUM,1
HP_INCREASED_CIRCULATING_VER...,SET,8,-0.37343,-0.0077893,0.32242,0.8766,HP_INCREASED_CIRCULATING_VERY_LONG_CHAIN_FATTY_ACID_CONCENTRATION,1
KINNEY_DNMT1_METHYLATION_TAR...,SET,14,-0.28018,-0.00773,0.2419,0.87661,KINNEY_DNMT1_METHYLATION_TARGETS,1
CATRRAGC_UNKNOWN,SET,122,-0.087278,-0.0070873,0.075352,0.87662,CATRRAGC_UNKNOWN,1
WP_APOPTOSIS,SET,82,-0.10984,-0.0073201,0.094811,0.87666,WP_APOPTOSIS,1
GOMF_ACETYLGLUCOSAMINYLTRANS...,SET,40,-0.17269,-0.0080475,0.14905,0.87668,GOMF_ACETYLGLUCOSAMINYLTRANSFERASE_ACTIVITY,1
CHANG_IMMORTALIZED_BY_HPV31_...1,SET,58,-0.13067,-0.0073288,0.11276,0.87672,CHANG_IMMORTALIZED_BY_HPV31_DN,1
GSE37336_LY6C_POS_VS_NEG_NAI...2,SET,132,-0.087831,-0.0074167,0.075791,0.87673,GSE37336_LY6C_POS_VS_NEG_NAIVE_CD4_TCELL_UP,1
HP_VISUAL_ACUITY_TEST_ABNORM...,SET,21,-0.21251,-0.0071793,0.18338,0.87674,HP_VISUAL_ACUITY_TEST_ABNORMALITY,1
HP_MULTIPLE_JOINT_DISLOCATION,SET,7,-0.36284,-0.0070798,0.31305,0.87677,HP_MULTIPLE_JOINT_DISLOCATION,1
MIR6867_3P,SET,105,-0.093542,-0.0070501,0.080676,0.87686,MIR6867_3P,1
GSE41867_NAIVE_VS_DAY6_LCMV_...3,SET,179,-0.071638,-0.0070353,0.061786,0.87686,GSE41867_NAIVE_VS_DAY6_LCMV_EFFECTOR_CD8_TCELL_DN,1
GOBP_RESPONSE_TO_NICOTINE,SET,51,-0.15449,-0.0081266,0.13322,0.87689,GOBP_RESPONSE_TO_NICOTINE,1
DESCARTES_FETAL_MUSCLE_STROM...,SET,65,-0.13602,-0.008075,0.11728,0.87693,DESCARTES_FETAL_MUSCLE_STROMAL_CELLS,1
MIR4661_5P,SET,36,-0.15258,-0.0067461,0.1315,0.87702,MIR4661_5P,1
GOBP_HYPOTONIC_RESPONSE,SET,13,-0.28655,-0.0076182,0.24694,0.87704,GOBP_HYPOTONIC_RESPONSE,1
GOBP_NITRIC_OXIDE_MEDIATED_S...,SET,19,-0.25054,-0.0080513,0.2159,0.87706,GOBP_NITRIC_OXIDE_MEDIATED_SIGNAL_TRANSDUCTION,1
GOBP_CATECHOL_CONTAINING_COM...1,SET,20,-0.23636,-0.0077926,0.20365,0.87709,GOBP_CATECHOL_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOMF_EXONUCLEASE_ACTIVITY_AC...,SET,58,-0.11547,-0.0064767,0.099489,0.8771,GOMF_EXONUCLEASE_ACTIVITY_ACTIVE_WITH_EITHER_RIBO_OR_DEOXYRIBONUCLEIC_ACIDS_AND_PRODUCING_5_PHOSPHOMONOESTERS,1
GOBP_POSITIVE_REGULATION_OF_...395,SET,273,-0.061195,-0.0074026,0.052719,0.87713,GOBP_POSITIVE_REGULATION_OF_KINASE_ACTIVITY,1
WP_METHIONINE_DE_NOVO_AND_SA...,SET,21,-0.23474,-0.0079304,0.20222,0.87714,WP_METHIONINE_DE_NOVO_AND_SALVAGE_PATHWAY,1
HP_ABNORMAL_CIRCULATING_FERR...,SET,47,-0.14613,-0.0073803,0.12588,0.87715,HP_ABNORMAL_CIRCULATING_FERRITIN_CONCENTRATION,1
GSE14308_TH2_VS_NATURAL_TREG...1,SET,181,-0.073183,-0.0072267,0.063018,0.87723,GSE14308_TH2_VS_NATURAL_TREG_DN,1
GOCC_TRANSCRIPTION_FACTOR_TF...3,SET,11,-0.23824,-0.0058267,0.20512,0.87727,GOCC_TRANSCRIPTION_FACTOR_TFIIH_HOLO_COMPLEX,1
HP_SHORT_1ST_METACARPAL,SET,21,-0.23012,-0.007774,0.19809,0.87731,HP_SHORT_1ST_METACARPAL,1
MIR138_2_3P,SET,154,-0.08335,-0.0075976,0.071739,0.87734,MIR138_2_3P,1
HP_LEIOMYOSARCOMA,SET,28,-0.18949,-0.0073906,0.16308,0.87737,HP_LEIOMYOSARCOMA,1
HP_NEUROFIBROMA,SET,19,-0.21434,-0.0068879,0.18446,0.87737,HP_NEUROFIBROMA,1
GSE9509_LPS_VS_LPS_AND_IL10_...3,SET,173,-0.072291,-0.0069806,0.062214,0.87737,GSE9509_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_20MIN_DN,1
WP_INFLAMMATORY_RESPONSE_PAT...,SET,28,-0.19874,-0.0077512,0.17095,0.87749,WP_INFLAMMATORY_RESPONSE_PATHWAY,1
MIR3924,SET,306,-0.05759,-0.0073688,0.049525,0.87754,MIR3924,1
KEGG_MEDICUS_REFERENCE_AUTOP...9,SET,13,-0.29377,-0.0078103,0.25256,0.87761,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_SEQUESTOSOME_1_LIKE_RECEPTOR,1
GOBP_AMEBOIDAL_TYPE_CELL_MIG...,SET,402,-0.051462,-0.0075273,0.044237,0.87764,GOBP_AMEBOIDAL_TYPE_CELL_MIGRATION,1
chr17p13,SET,218,-0.15713,-0.017011,0.13505,0.87767,chr17p13,1
HP_SKELETAL_DYSPLASIA,SET,169,-0.074881,-0.0071474,0.064355,0.87769,HP_SKELETAL_DYSPLASIA,1
HP_ABNORMAL_GLUCOSE_HOMEOSTA...,SET,623,-0.039878,-0.0072166,0.034269,0.87772,HP_ABNORMAL_GLUCOSE_HOMEOSTASIS,1
GOBP_MRNA_PROCESSING,SET,425,-0.04374,-0.0065741,0.03758,0.87776,GOBP_MRNA_PROCESSING,1
GOMF_CALCIUM_DEPENDENT_PROTE...2,SET,10,-0.31657,-0.0073823,0.27191,0.87783,GOMF_CALCIUM_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
MODULE_43,SET,92,-0.098387,-0.0069435,0.084496,0.87786,MODULE_43,1
HP_ANTI_THYROGLOBULIN_ANTIBO...,SET,6,-0.44035,-0.007955,0.37816,0.87787,HP_ANTI_THYROGLOBULIN_ANTIBODY_POSITIVITY,1
GOBP_DIACYLGLYCEROL_CATABOLI...,SET,5,-0.44214,-0.0072916,0.37963,0.87791,GOBP_DIACYLGLYCEROL_CATABOLIC_PROCESS,1
MIR3913_5P,SET,79,-0.1081,-0.0070719,0.092795,0.87797,MIR3913_5P,1
KEGG_UBIQUITIN_MEDIATED_PROT...,SET,120,-0.083951,-0.0067614,0.072056,0.878,KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS,1
MORF_ATRX,SET,204,-0.065561,-0.0068687,0.056265,0.87802,MORF_ATRX,1
GSE36476_YOUNG_VS_OLD_DONOR_...1,SET,166,-0.076282,-0.0072168,0.065462,0.87804,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_16H_TSST_ACT_DN,1
GOCC_EXTRINSIC_COMPONENT_OF_...9,SET,13,-0.24102,-0.0064078,0.2068,0.87808,GOCC_EXTRINSIC_COMPONENT_OF_SYNAPTIC_MEMBRANE,1
GCM_RAF1,SET,37,-0.14878,-0.0066687,0.12764,0.8781,GCM_RAF1,1
HP_TORSION_DYSTONIA,SET,7,-0.34838,-0.0067977,0.29884,0.87814,HP_TORSION_DYSTONIA,1
GOBP_PROTEIN_K48_LINKED_UBIQ...,SET,94,-0.099961,-0.0071305,0.085738,0.87816,GOBP_PROTEIN_K48_LINKED_UBIQUITINATION,1
GOBP_REGULATION_OF_CHROMOSOM...1,SET,11,-0.25456,-0.0062259,0.21834,0.87816,GOBP_REGULATION_OF_CHROMOSOME_CONDENSATION,1
GSE9960_GRAM_NEG_VS_GRAM_POS...1,SET,179,-0.071403,-0.0070123,0.061237,0.87819,GSE9960_GRAM_NEG_VS_GRAM_POS_SEPSIS_PBMC_DN,1
GSE17721_0.5H_VS_4H_LPS_BMDC...1,SET,184,-0.073978,-0.0073649,0.063443,0.8782,GSE17721_0.5H_VS_4H_LPS_BMDC_DN,1
GOBP_POSITIVE_REGULATION_OF_...485,SET,19,-0.22612,-0.0072667,0.19391,0.87821,GOBP_POSITIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,1
GOBP_POSITIVE_REGULATION_OF_...467,SET,8,-0.37869,-0.007899,0.3247,0.87824,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_DEPOLARIZATION,1
HP_ABNORMAL_URINE_METABOLITE...,SET,522,-0.042918,-0.0071294,0.036797,0.87825,HP_ABNORMAL_URINE_METABOLITE_LEVEL,1
MIR7854_3P,SET,99,-0.096919,-0.007094,0.083094,0.87826,MIR7854_3P,1
HP_ABNORMAL_ELECTRORETINOGRAM,SET,188,-0.073533,-0.0073989,0.063043,0.87826,HP_ABNORMAL_ELECTRORETINOGRAM,1
GOBP_MOLTING_CYCLE,SET,114,-0.10084,-0.0079169,0.086424,0.87834,GOBP_MOLTING_CYCLE,1
MIR12128,SET,129,-0.087489,-0.007304,0.074967,0.8784,MIR12128,1
DESCARTES_MAIN_FETAL_THYMIC_...,SET,139,-0.082371,-0.0071363,0.070578,0.8784,DESCARTES_MAIN_FETAL_THYMIC_EPITHELIAL_CELLS,1
GOBP_MITOCHONDRIAL_RNA_CATAB...,SET,6,-0.35469,-0.0064075,0.30386,0.87844,GOBP_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,1
SOBOLEV_T_CELL_PANDEMRIX_AGE...2,SET,21,-0.21121,-0.0071352,0.18094,0.87844,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_7DY_DN,1
HP_ECTOPIC_ANUS,SET,72,-0.11714,-0.0073176,0.10034,0.87848,HP_ECTOPIC_ANUS,1
TRAVAGLINI_LUNG_NATURAL_KILL...1,SET,121,-0.096513,-0.0078052,0.082666,0.87849,TRAVAGLINI_LUNG_NATURAL_KILLER_CELL,1
HP_ABNORMALITY_OF_DENTAL_COL...,SET,31,-0.17603,-0.0072234,0.15077,0.8785,HP_ABNORMALITY_OF_DENTAL_COLOR,1
HE_LIM_SUN_FETAL_LUNG_C4_CD5...,SET,5,-0.44047,-0.0072641,0.37721,0.87853,HE_LIM_SUN_FETAL_LUNG_C4_CD56BRIGHT_NK_CELL,1
GSE13484_UNSTIM_VS_YF17D_VAC...2,SET,179,-0.068988,-0.0067751,0.059067,0.87858,GSE13484_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP,1
BOYLAN_MULTIPLE_MYELOMA_D_CL...2,SET,25,-0.19911,-0.0073387,0.17041,0.87868,BOYLAN_MULTIPLE_MYELOMA_D_CLUSTER_UP,1
GOBP_RESPONSE_TO_MERCURY_ION,SET,10,-0.31404,-0.0073233,0.26877,0.87868,GOBP_RESPONSE_TO_MERCURY_ION,1
GAUSSMANN_MLL_AF4_FUSION_TAR...8,SET,36,-0.16714,-0.0073902,0.14304,0.87869,GAUSSMANN_MLL_AF4_FUSION_TARGETS_D_UP,1
REACTOME_ENDOSOMAL_VACUOLAR_...,SET,11,-0.31914,-0.0078053,0.27306,0.87874,REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY,1
HP_SLOW_PUPILLARY_LIGHT_RESP...,SET,17,-0.23473,-0.0071357,0.20082,0.87876,HP_SLOW_PUPILLARY_LIGHT_RESPONSE,1
GSE6674_CPG_VS_PL2_3_STIM_BC...2,SET,171,-0.070272,-0.0067467,0.060114,0.87879,GSE6674_CPG_VS_PL2_3_STIM_BCELL_UP,1
GOBP_REGULATION_OF_CELL_CHEM...,SET,5,-0.47916,-0.0079022,0.40982,0.87883,GOBP_REGULATION_OF_CELL_CHEMOTAXIS_TO_FIBROBLAST_GROWTH_FACTOR,1
AAAYRNCTG_UNKNOWN,SET,324,-0.056884,-0.0074859,0.04865,0.87884,AAAYRNCTG_UNKNOWN,1
GOBP_REGULATION_OF_SYSTEMIC_...8,SET,40,-0.17225,-0.008027,0.14731,0.87885,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_MEDIATED_BY_A_CHEMICAL_SIGNAL,1
GSE21546_WT_VS_ELK1_KO_ANTI_...2,SET,183,-0.073124,-0.0072602,0.06252,0.87891,GSE21546_WT_VS_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
GOBP_PROXIMAL_TUBULE_DEVELOP...,SET,10,-0.32712,-0.0076284,0.27961,0.87897,GOBP_PROXIMAL_TUBULE_DEVELOPMENT,1
GOBP_OSTEOBLAST_DIFFERENTIAT...,SET,209,-0.071037,-0.0075321,0.060707,0.87902,GOBP_OSTEOBLAST_DIFFERENTIATION,1
GOBP_NEGATIVE_REGULATION_OF_...568,SET,1523,-0.026666,-0.0073514,0.022788,0.87903,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_STIMULUS,1
GOBP_REGULATION_OF_MESENCHYM...3,SET,7,-0.4482,-0.0087454,0.38302,0.87903,GOBP_REGULATION_OF_MESENCHYMAL_TO_EPITHELIAL_TRANSITION_INVOLVED_IN_METANEPHROS_MORPHOGENESIS,1
GOBP_REGULATION_OF_ENDODEOXY...,SET,8,-0.35722,-0.0074512,0.30525,0.87904,GOBP_REGULATION_OF_ENDODEOXYRIBONUCLEASE_ACTIVITY,1
MOREAUX_B_LYMPHOCYTE_MATURAT...1,SET,69,-0.10651,-0.0065141,0.09101,0.87906,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN,1
WP_HOSTPATHOGEN_INTERACTION_...4,SET,35,-0.18585,-0.0081024,0.15876,0.87912,WP_HOSTPATHOGEN_INTERACTION_OF_HUMAN_CORONAVIRUSES_MAPK_SIGNALING,1
GOBP_ACTIN_FILAMENT_ORGANIZA...,SET,412,-0.050089,-0.007415,0.042785,0.87914,GOBP_ACTIN_FILAMENT_ORGANIZATION,1
PILON_KLF1_TARGETS_UP,SET,439,-0.048217,-0.0073624,0.041178,0.87918,PILON_KLF1_TARGETS_UP,1
WILENSKY_RESPONSE_TO_DARAPLA...,SET,25,-0.18962,-0.0069885,0.16193,0.87918,WILENSKY_RESPONSE_TO_DARAPLADIB,1
HE_LIM_SUN_FETAL_LUNG_C2_NEU...,SET,58,-0.1371,-0.0076898,0.11709,0.87918,HE_LIM_SUN_FETAL_LUNG_C2_NEUTROPHIL_CELL,1
SUH_COEXPRESSED_WITH_ID1_AND...,SET,18,-0.26053,-0.0081494,0.22239,0.8793,SUH_COEXPRESSED_WITH_ID1_AND_ID2_UP,1
MIR30A_3P,SET,347,-0.053129,-0.007231,0.045351,0.8793,MIR30A_3P,1
MIR517_5P,SET,78,-0.11097,-0.0072138,0.09469,0.87938,MIR517_5P,1
GOBP_NEGATIVE_REGULATION_OF_...550,SET,15,-0.22872,-0.0065315,0.19516,0.87939,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_INTERNALIZATION,1
GSE1925_CTRL_VS_IFNG_PRIMED_...5,SET,186,-0.07168,-0.0071743,0.061162,0.87939,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_DN,1
GSE9988_LOW_LPS_VS_VEHICLE_T...1,SET,183,-0.071604,-0.0071093,0.061084,0.87944,GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,1
REACTOME_ACTIVATION_OF_PPARG...,SET,10,-0.32983,-0.0076914,0.28133,0.87947,REACTOME_ACTIVATION_OF_PPARGC1A_PGC_1ALPHA_BY_PHOSPHORYLATION,1
GOBP_BEHAVIORAL_RESPONSE_TO_...4,SET,19,-0.23107,-0.0074257,0.19706,0.87952,GOBP_BEHAVIORAL_RESPONSE_TO_PAIN,1
GSE37533_PPARG2_FOXP3_VS_FOX...4,SET,175,-0.07394,-0.0071806,0.063033,0.8796,GSE37533_PPARG2_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
WP_LIPID_PARTICLES_COMPOSITI...,SET,10,-0.32729,-0.0076322,0.27898,0.87963,WP_LIPID_PARTICLES_COMPOSITION,1
MIR335_3P,SET,786,-0.037016,-0.0074894,0.031552,0.87963,MIR335_3P,1
GOBP_RETROGRADE_TRANSPORT_EN...,SET,88,-0.096966,-0.0066936,0.082643,0.87966,GOBP_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,1
GSE17721_LPS_VS_PAM3CSK4_24H...1,SET,178,-0.072755,-0.0071252,0.062001,0.87968,GSE17721_LPS_VS_PAM3CSK4_24H_BMDC_DN,1
GOBP_REGULATION_OF_EPITHELIA...5,SET,335,-0.057551,-0.0076988,0.049042,0.8797,GOBP_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
GOBP_WALKING_BEHAVIOR,SET,34,-0.17703,-0.0076073,0.15083,0.87974,GOBP_WALKING_BEHAVIOR,1
GOBP_POSITIVE_REGULATION_OF_...630,SET,70,-0.1189,-0.0073239,0.10129,0.87977,GOBP_POSITIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_CELL_PERIPHERY,1
GAUSSMANN_MLL_AF4_FUSION_TAR...1,SET,90,-0.11015,-0.0076892,0.093831,0.87978,GAUSSMANN_MLL_AF4_FUSION_TARGETS_A_DN,1
HP_LONG_UPPER_LIP,SET,6,-0.49049,-0.0088608,0.41778,0.8798,HP_LONG_UPPER_LIP,1
MODULE_397,SET,110,-0.090961,-0.007016,0.077457,0.87986,MODULE_397,1
GOBP_POSITIVE_REGULATION_OF_...142,SET,5,-0.38267,-0.0063109,0.32571,0.87997,GOBP_POSITIVE_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,1
GOBP_NEGATIVE_REGULATION_OF_...560,SET,6,-0.41543,-0.0075048,0.35358,0.87998,GOBP_NEGATIVE_REGULATION_OF_RESPIRATORY_BURST,1
MIR103A_3P_MIR107,SET,234,-0.065115,-0.0073004,0.055419,0.87999,MIR103A_3P_MIR107,1
GOBP_SPONTANEOUS_NEUROTRANSM...,SET,7,-0.41105,-0.0080204,0.34983,0.87999,GOBP_SPONTANEOUS_NEUROTRANSMITTER_SECRETION,1
GOMF_SODIUM_PHOSPHATE_SYMPOR...,SET,13,-0.32599,-0.0086668,0.27744,0.87999,GOMF_SODIUM_PHOSPHATE_SYMPORTER_ACTIVITY,1
GOBP_ECTODERMAL_PLACODE_DEVE...,SET,12,-0.30348,-0.007752,0.25825,0.88002,GOBP_ECTODERMAL_PLACODE_DEVELOPMENT,1
GSE14000_UNSTIM_VS_16H_LPS_D...2,SET,176,-0.078809,-0.007675,0.06705,0.88007,GSE14000_UNSTIM_VS_16H_LPS_DC_TRANSLATED_RNA_DN,1
GOBP_CEREBELLAR_CORTEX_MORPH...,SET,32,-0.17896,-0.0074609,0.15225,0.88009,GOBP_CEREBELLAR_CORTEX_MORPHOGENESIS,1
HP_IMPULSIVITY,SET,128,-0.087901,-0.0073101,0.074779,0.88009,HP_IMPULSIVITY,1
HP_ABNORMAL_NASOPHARYNX_MORP...,SET,160,-0.080169,-0.0074474,0.0682,0.8801,HP_ABNORMAL_NASOPHARYNX_MORPHOLOGY,1
GOCC_PRC1_COMPLEX,SET,17,-0.23913,-0.0072693,0.20338,0.88015,GOCC_PRC1_COMPLEX,1
GSE22432_CDC_VS_COMMON_DC_PR...1,SET,184,-0.071746,-0.0071427,0.061011,0.88019,GSE22432_CDC_VS_COMMON_DC_PROGENITOR_DN,1
LUCAS_HNF4A_TARGETS_UP,SET,53,-0.1321,-0.0070834,0.11232,0.88022,LUCAS_HNF4A_TARGETS_UP,1
WP_PHOSPHOINOSITIDES_METABOL...,SET,43,-0.14426,-0.0069698,0.12265,0.88023,WP_PHOSPHOINOSITIDES_METABOLISM,1
MIR4789_3P,SET,305,-0.058434,-0.0074648,0.049674,0.88027,MIR4789_3P,1
GOBP_INTRACELLULAR_PROTEIN_T...2,SET,630,-0.038755,-0.0070512,0.03294,0.8803,GOBP_INTRACELLULAR_PROTEIN_TRANSPORT,1
RANKIN_ANGIOGENIC_TARGETS_OF...2,SET,5,-0.50634,-0.0083505,0.43028,0.88035,RANKIN_ANGIOGENIC_TARGETS_OF_VHL_HIF2A_UP,1
GOMF_AMP_BINDING,SET,15,-0.22776,-0.0065042,0.19348,0.88044,GOMF_AMP_BINDING,1
GSE21670_UNTREATED_VS_TGFB_I...2,SET,170,-0.074732,-0.007154,0.06348,0.88044,GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP,1
GSE39916_B_CELL_SPLEEN_VS_PL...1,SET,179,-0.078275,-0.0076871,0.06649,0.88044,GSE39916_B_CELL_SPLEEN_VS_PLASMA_CELL_BONE_MARROW_DN,1
HP_PROLONGED_QRS_COMPLEX,SET,6,-0.47296,-0.0085441,0.40174,0.88045,HP_PROLONGED_QRS_COMPLEX,1
HP_ABNORMAL_UPPER_LIMB_METAP...,SET,15,-0.29819,-0.0085152,0.25324,0.88049,HP_ABNORMAL_UPPER_LIMB_METAPHYSIS_MORPHOLOGY,1
GSE21774_CD62L_POS_CD56_DIM_...1,SET,180,-0.073116,-0.0072003,0.062095,0.88049,GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_DN,1
GSE27241_CTRL_VS_DIGOXIN_TRE...3,SET,164,-0.077672,-0.0073043,0.065964,0.88049,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN,1
DESCARTES_FETAL_INTESTINE_VA...,SET,38,-0.17215,-0.0078197,0.14618,0.88052,DESCARTES_FETAL_INTESTINE_VASCULAR_ENDOTHELIAL_CELLS,1
AHRR_TARGET_GENES,SET,1029,-0.031981,-0.0073524,0.027149,0.88059,AHRR_TARGET_GENES,1
GOBP_AXONEME_ASSEMBLY,SET,70,-0.11241,-0.006924,0.095416,0.88061,GOBP_AXONEME_ASSEMBLY,1
MIR6841_5P,SET,32,-0.1782,-0.0074291,0.15125,0.88063,MIR6841_5P,1
SHANK_TAL1_TARGETS_DN,SET,10,-0.3283,-0.0076557,0.27856,0.8807,SHANK_TAL1_TARGETS_DN,1
KEGG_MEDICUS_REFERENCE_KISS1...,SET,11,-0.32788,-0.0080191,0.2782,0.88071,KEGG_MEDICUS_REFERENCE_KISS1_KISS1R_PLCB_PKC_SIGNALING_PATHWAY,1
HE_LIM_SUN_FETAL_LUNG_C7_SCH...,SET,214,-0.066248,-0.0071069,0.056192,0.88079,HE_LIM_SUN_FETAL_LUNG_C7_SCHWANN_PRECURSOR_CELL,1
REACTOME_TRANSLOCATION_OF_SL...,SET,69,-0.11943,-0.0073039,0.10128,0.88083,REACTOME_TRANSLOCATION_OF_SLC2A4_GLUT4_TO_THE_PLASMA_MEMBRANE,1
WP_SRF_AND_MIRS_IN_SMOOTH_MU...,SET,10,-0.36095,-0.0084171,0.30594,0.88095,WP_SRF_AND_MIRS_IN_SMOOTH_MUSCLE_DIFFERENTIATION_AND_PROLIFERATION,1
SEMBA_FHIT_TARGETS_UP,SET,11,-0.30011,-0.0073399,0.25434,0.88098,SEMBA_FHIT_TARGETS_UP,1
GSE27786_LSK_VS_NKCELL_UP,SET,177,-0.07223,-0.0070541,0.061213,0.88099,GSE27786_LSK_VS_NKCELL_UP,1
REACTOME_UNBLOCKING_OF_NMDA_...,SET,19,-0.24721,-0.0079442,0.20948,0.88101,REACTOME_UNBLOCKING_OF_NMDA_RECEPTORS_GLUTAMATE_BINDING_AND_ACTIVATION,1
HP_URINARY_INCONTINENCE,SET,134,-0.085847,-0.0073034,0.072723,0.88108,HP_URINARY_INCONTINENCE,1
GOMF_SOLUTE_SODIUM_SYMPORTER...,SET,77,-0.12064,-0.0077923,0.10217,0.88114,GOMF_SOLUTE_SODIUM_SYMPORTER_ACTIVITY,1
GOMF_PROTEIN_SEQUESTERING_AC...,SET,25,-0.20293,-0.0074794,0.17186,0.88116,GOMF_PROTEIN_SEQUESTERING_ACTIVITY,1
HP_ABNORMAL_LABIA_MAJORA_MOR...,SET,40,-0.1503,-0.0070041,0.12727,0.88117,HP_ABNORMAL_LABIA_MAJORA_MORPHOLOGY,1
GOMF_NUCLEASE_INHIBITOR_ACTI...,SET,6,-0.37085,-0.0066995,0.31402,0.88119,GOMF_NUCLEASE_INHIBITOR_ACTIVITY,1
REACTOME_ERYTHROPOIETIN_ACTI...1,SET,12,-0.33497,-0.0085564,0.28356,0.88125,REACTOME_ERYTHROPOIETIN_ACTIVATES_PHOSPHOINOSITIDE_3_KINASE_PI3K,1
HDAC8_TARGET_GENES,SET,126,-0.088974,-0.0073417,0.075319,0.88125,HDAC8_TARGET_GENES,1
GSE29618_PRE_VS_DAY7_POST_LA...8,SET,178,-0.075641,-0.0074078,0.064032,0.88125,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_UP,1
GOBP_RESPONSE_TO_CADMIUM_ION,SET,55,-0.14543,-0.0079437,0.12306,0.88135,GOBP_RESPONSE_TO_CADMIUM_ION,1
GOBP_ACETYL_COA_BIOSYNTHETIC...1,SET,15,-0.2562,-0.0073161,0.21677,0.88136,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...3,SET,184,-0.071879,-0.0071559,0.060816,0.88137,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_DN,1
HP_ABNORMAL_SENSORY_NERVE_CO...,SET,24,-0.19212,-0.0069378,0.16253,0.8814,HP_ABNORMAL_SENSORY_NERVE_CONDUCTION_VELOCITY,1
MIR30D_3P,SET,350,-0.053398,-0.0072983,0.045172,0.88141,MIR30D_3P,1
KANG_AR_TARGETS_DN,SET,18,-0.25425,-0.007953,0.21504,0.88146,KANG_AR_TARGETS_DN,1
GSE3203_HEALTHY_VS_INFLUENZA...1,SET,179,-0.074702,-0.0073363,0.063182,0.88146,GSE3203_HEALTHY_VS_INFLUENZA_INFECTED_LN_BCELL_DN,1
PYEON_CANCER_HEAD_AND_NECK_V...1,SET,19,-0.24487,-0.0078693,0.20707,0.8815,PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_DN,1
WP_SEROTONIN_AND_ANXIETYRELA...,SET,12,-0.29656,-0.0075752,0.25078,0.8815,WP_SEROTONIN_AND_ANXIETYRELATED_EVENTS,1
GSE12845_NAIVE_VS_PRE_GC_TON...2,SET,180,-0.074618,-0.0073483,0.063096,0.88151,GSE12845_NAIVE_VS_PRE_GC_TONSIL_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_LECTI...2,SET,8,-0.39767,-0.0082949,0.33625,0.88152,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COAGULATION_CASCADE_PROTHROMBIN_TO_THROMBIN,1
VOIGT_PBMC_FLUARIX_AGE_50_74...,SET,18,-0.25016,-0.0078248,0.2115,0.88154,VOIGT_PBMC_FLUARIX_AGE_50_74YO_FEMALES_VS_MALES_0DY_TO_28D_UP,1
GOBP_ENDOCHONDRAL_BONE_MORPH...,SET,56,-0.14399,-0.0079358,0.12173,0.88156,GOBP_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
WESTON_VEGFA_TARGETS,SET,85,-0.117,-0.0079382,0.098906,0.88157,WESTON_VEGFA_TARGETS,1
MIR6507_5P,SET,306,-0.059694,-0.0076381,0.05046,0.88158,MIR6507_5P,1
GOMF_TETRAPYRROLE_BINDING,SET,135,-0.091768,-0.0078361,0.077575,0.88158,GOMF_TETRAPYRROLE_BINDING,1
DAVIES_MULTIPLE_MYELOMA_VS_M...2,SET,12,-0.25429,-0.0064955,0.21495,0.88159,DAVIES_MULTIPLE_MYELOMA_VS_MGUS_UP,1
GOMF_EXOPEPTIDASE_ACTIVITY,SET,95,-0.10738,-0.0077001,0.090756,0.88162,GOMF_EXOPEPTIDASE_ACTIVITY,1
BRCA2_TARGET_GENES,SET,1258,-0.029058,-0.0073375,0.024558,0.88164,BRCA2_TARGET_GENES,1
TURASHVILI_BREAST_DUCTAL_CAR...2,SET,42,-0.16746,-0.0079961,0.14151,0.88166,TURASHVILI_BREAST_DUCTAL_CARCINOMA_VS_DUCTAL_NORMAL_UP,1
KOHOUTEK_CCNT2_TARGETS,SET,54,-0.13701,-0.0074156,0.11576,0.8817,KOHOUTEK_CCNT2_TARGETS,1
HP_ABNORMAL_TRABECULAR_BONE_...,SET,28,-0.18871,-0.0073602,0.15944,0.88171,HP_ABNORMAL_TRABECULAR_BONE_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...225,SET,5,-0.5635,-0.0092931,0.476,0.88175,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...83,SET,7,-0.37063,-0.0072318,0.31307,0.88176,GOBP_POSITIVE_REGULATION_OF_CAMP_MEDIATED_SIGNALING,1
ELVIDGE_HIF1A_TARGETS_UP,SET,62,-0.11863,-0.0068785,0.1002,0.88177,ELVIDGE_HIF1A_TARGETS_UP,1
GOBP_NEGATIVE_REGULATION_OF_...524,SET,193,-0.070544,-0.007191,0.05958,0.88179,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION,1
MIR4307,SET,389,-0.052725,-0.0075891,0.044527,0.88181,MIR4307,1
GSE36888_UNTREATED_VS_IL2_TR...6,SET,171,-0.078794,-0.0075649,0.066533,0.88184,GSE36888_UNTREATED_VS_IL2_TREATED_STAT5_AB_KNOCKIN_TCELL_6H_UP,1
MIR31_3P,SET,51,-0.14305,-0.0075249,0.12078,0.88185,MIR31_3P,1
GOBP_ORGANONITROGEN_COMPOUND...2,SET,1308,-0.028324,-0.0072823,0.023905,0.88195,GOBP_ORGANONITROGEN_COMPOUND_CATABOLIC_PROCESS,1
HP_OTOSCLEROSIS,SET,6,-0.4602,-0.0083137,0.38841,0.88195,HP_OTOSCLEROSIS,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...1,SET,7,-0.41695,-0.0081356,0.35183,0.882,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_ANTIGEN_PROCESSING_AND_PRESENTATION_BY_MHC_CLASS_I_MOLECULES,1
HP_ABNORMAL_LOWER_LIMB_EPIPH...,SET,84,-0.11145,-0.0075171,0.094014,0.88207,HP_ABNORMAL_LOWER_LIMB_EPIPHYSIS_MORPHOLOGY,1
GSE19198_CTRL_VS_IL21_TREATE...1,SET,183,-0.075517,-0.0074979,0.063698,0.88209,GSE19198_CTRL_VS_IL21_TREATED_TCELL_1H_DN,1
GSE34392_ST2_KO_VS_WT_DAY8_L...2,SET,182,-0.070688,-0.0069994,0.059612,0.88214,GSE34392_ST2_KO_VS_WT_DAY8_LCMV_EFFECTOR_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...562,SET,114,-0.093004,-0.007302,0.078426,0.88216,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_BIOTIC_STIMULUS,1
TERAMOTO_OPN_TARGETS_CLUSTER...3,SET,13,-0.23832,-0.006336,0.20096,0.88217,TERAMOTO_OPN_TARGETS_CLUSTER_4,1
HP_FIBROADENOMA_OF_THE_BREAST,SET,11,-0.29221,-0.0071467,0.2464,0.88217,HP_FIBROADENOMA_OF_THE_BREAST,1
DAVICIONI_PAX_FOXO1_SIGNATUR...1,SET,19,-0.24996,-0.0080326,0.21076,0.88218,DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_EAR...2,SET,518,-0.046631,-0.0077175,0.039312,0.88222,HE_LIM_SUN_FETAL_LUNG_C0_EARLY_MESOTHELIAL_CELL,1
AUJLA_IL22_AND_IL17A_SIGNALI...,SET,10,-0.31442,-0.007332,0.26505,0.88223,AUJLA_IL22_AND_IL17A_SIGNALING,1
GOBP_POSITIVE_REGULATION_OF_...154,SET,67,-0.1289,-0.0077688,0.10866,0.88225,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_PRODUCTION,1
GOBP_ORGANIC_CATION_TRANSPORT,SET,108,-0.10326,-0.0078924,0.086989,0.88239,GOBP_ORGANIC_CATION_TRANSPORT,1
GOBP_SIRNA_PROCESSING,SET,8,-0.36869,-0.0076904,0.31054,0.88243,GOBP_SIRNA_PROCESSING,1
GSE3982_NEUTROPHIL_VS_EFF_ME...2,SET,183,-0.073245,-0.0072723,0.061692,0.88243,GSE3982_NEUTROPHIL_VS_EFF_MEMORY_CD4_TCELL_UP,1
HP_ABNORMALITY_OF_THE_POSTER...,SET,99,-0.096504,-0.0070636,0.08128,0.88244,HP_ABNORMALITY_OF_THE_POSTERIOR_HAIRLINE,1
HP_ABNORMAL_PERIPHERAL_NERVO...2,SET,151,-0.078449,-0.0070815,0.066059,0.88249,HP_ABNORMAL_PERIPHERAL_NERVOUS_SYSTEM_PHYSIOLOGY,1
chr11q21,SET,28,-0.32816,-0.012799,0.27627,0.88254,chr11q21,1
GOBP_POSITIVE_REGULATION_OF_...622,SET,7,-0.35125,-0.0068537,0.29568,0.88256,GOBP_POSITIVE_REGULATION_OF_PROTEIN_GLYCOSYLATION,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...3,SET,18,-0.24221,-0.0075763,0.20389,0.88257,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_2_PRODUCTION,1
GOBP_ENDOSOMAL_VESICLE_FUSION,SET,15,-0.23181,-0.0066197,0.19512,0.88258,GOBP_ENDOSOMAL_VESICLE_FUSION,1
GOBP_MONOSACCHARIDE_CATABOLI...,SET,44,-0.14084,-0.0068827,0.11851,0.88264,GOBP_MONOSACCHARIDE_CATABOLIC_PROCESS,1
GSE17721_POLYIC_VS_CPG_4H_BM...2,SET,180,-0.073522,-0.0072403,0.061864,0.88266,GSE17721_POLYIC_VS_CPG_4H_BMDC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...144,SET,3,-0.67073,-0.0085686,0.56423,0.88272,GOBP_NEGATIVE_REGULATION_OF_CHONDROCYTE_PROLIFERATION,1
HP_HYPERMETHIONINEMIA,SET,7,-0.44082,-0.0086013,0.3708,0.88274,HP_HYPERMETHIONINEMIA,1
KEGG_MEDICUS_VARIANT_MUTATIO...50,SET,6,-0.43156,-0.0077963,0.36287,0.88283,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PDYN_TO_TRANSPORT_OF_CALCIUM,1
MODULE_117,SET,652,-0.043024,-0.0079586,0.036177,0.88283,MODULE_117,1
GOCC_DYSTROPHIN_ASSOCIATED_G...,SET,17,-0.22868,-0.0069515,0.19225,0.88286,GOCC_DYSTROPHIN_ASSOCIATED_GLYCOPROTEIN_COMPLEX,1
GSE27786_LIN_NEG_VS_BCELL_UP,SET,185,-0.073887,-0.0073756,0.06212,0.88286,GSE27786_LIN_NEG_VS_BCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...416,SET,41,-0.15918,-0.00751,0.13382,0.88288,GOBP_NEGATIVE_REGULATION_OF_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GSE16385_IFNG_TNF_VS_UNSTIM_...1,SET,179,-0.075495,-0.0074141,0.063465,0.88288,GSE16385_IFNG_TNF_VS_UNSTIM_MACROPHAGE_ROSIGLITAZONE_TREATED_DN,1
PEPPER_CHRONIC_LYMPHOCYTIC_L...1,SET,21,-0.23874,-0.0080654,0.20068,0.8829,PEPPER_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN,1
MIR2115_5P,SET,123,-0.088488,-0.0072147,0.074361,0.88296,MIR2115_5P,1
chr2q11,SET,69,-0.27075,-0.016558,0.22746,0.88303,chr2q11,1
GOMF_CELL_MATRIX_ADHESION_ME...,SET,8,-0.39831,-0.0083082,0.33459,0.88305,GOMF_CELL_MATRIX_ADHESION_MEDIATOR_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...54,SET,5,-0.35682,-0.0058846,0.29974,0.88306,GOBP_POSITIVE_REGULATION_OF_BASEMENT_MEMBRANE_ASSEMBLY_INVOLVED_IN_EMBRYONIC_BODY_MORPHOGENESIS,1
HP_STUTTERING,SET,9,-0.32567,-0.007205,0.27355,0.88307,HP_STUTTERING,1
GOBP_REGULATION_OF_EXTRACELL...1,SET,20,-0.22206,-0.0073212,0.1865,0.8831,GOBP_REGULATION_OF_EXTRACELLULAR_MATRIX_ASSEMBLY,1
HP_ABNORMALITY_OF_DNA_REPAIR,SET,14,-0.20647,-0.0056962,0.17338,0.88313,HP_ABNORMALITY_OF_DNA_REPAIR,1
GOBP_CELL_CELL_ADHESION_VIA_...,SET,260,-0.075704,-0.0089403,0.06357,0.88314,GOBP_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,1
BEIER_GLIOMA_STEM_CELL_DN,SET,60,-0.12906,-0.0073618,0.10835,0.88318,BEIER_GLIOMA_STEM_CELL_DN,1
REACTOME_TRANSCRIPTIONAL_REG...3,SET,32,-0.19061,-0.0079465,0.16,0.88322,REACTOME_TRANSCRIPTIONAL_REGULATION_BY_NPAS4,1
GSE22025_TGFB1_VS_TGFB1_AND_...1,SET,180,-0.078724,-0.0077525,0.06608,0.88323,GSE22025_TGFB1_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
ELVIDGE_HYPOXIA_UP,SET,155,-0.08397,-0.0076787,0.070462,0.8833,ELVIDGE_HYPOXIA_UP,1
MIR433_5P,SET,7,-0.37782,-0.0073721,0.31704,0.88331,MIR433_5P,1
GOBP_RESPONSE_TO_TUMOR_NECRO...,SET,213,-0.070834,-0.0075812,0.059435,0.88332,GOBP_RESPONSE_TO_TUMOR_NECROSIS_FACTOR,1
GOMF_PROFILIN_BINDING,SET,10,-0.32444,-0.0075659,0.27222,0.88333,GOMF_PROFILIN_BINDING,1
GOBP_FATTY_ACID_ELONGATION,SET,13,-0.32333,-0.0085961,0.27123,0.88338,GOBP_FATTY_ACID_ELONGATION,1
HP_REDUCED_PANCREATIC_BETA_C...,SET,7,-0.4629,-0.0090321,0.38831,0.88338,HP_REDUCED_PANCREATIC_BETA_CELLS,1
KEGG_MEDICUS_REFERENCE_TGF_B...,SET,8,-0.40326,-0.0084116,0.33824,0.88341,KEGG_MEDICUS_REFERENCE_TGF_BETA_SIGNALING_PATHWAY,1
GOBP_VESICLE_MEDIATED_TRANSP...4,SET,138,-0.0839,-0.0072428,0.070372,0.88341,GOBP_VESICLE_MEDIATED_TRANSPORT_TO_THE_PLASMA_MEMBRANE,1
FARMER_BREAST_CANCER_CLUSTER...1,SET,38,-0.18636,-0.0084651,0.1563,0.88342,FARMER_BREAST_CANCER_CLUSTER_1,1
MIR4723_3P,SET,76,-0.11574,-0.0074275,0.097042,0.8835,MIR4723_3P,1
MIR4712_3P,SET,57,-0.1375,-0.0076452,0.11527,0.88351,MIR4712_3P,1
SERVITJA_LIVER_HNF1A_TARGETS...2,SET,132,-0.090923,-0.0076777,0.076216,0.88355,SERVITJA_LIVER_HNF1A_TARGETS_UP,1
WP_GASTRIC_CANCER_NETWORK_1,SET,24,-0.20743,-0.007491,0.17388,0.88356,WP_GASTRIC_CANCER_NETWORK_1,1
GOBP_VESTIBULOCOCHLEAR_NERVE...2,SET,5,-0.5492,-0.0090573,0.46034,0.88357,GOBP_VESTIBULOCOCHLEAR_NERVE_FORMATION,1
KEGG_MEDICUS_REFERENCE_TELOM...2,SET,16,-0.23333,-0.0068813,0.19556,0.88358,KEGG_MEDICUS_REFERENCE_TELOMERE_ELONGATION,1
GOBP_DENDRITIC_CELL_CHEMOTAX...,SET,24,-0.22144,-0.0079968,0.1856,0.88358,GOBP_DENDRITIC_CELL_CHEMOTAXIS,1
SUPT16H_TARGET_GENES,SET,1360,-0.027749,-0.0072639,0.023256,0.8836,SUPT16H_TARGET_GENES,1
LEE_AGING_CEREBELLUM_DN,SET,66,-0.1299,-0.0077701,0.10884,0.88364,LEE_AGING_CEREBELLUM_DN,1
HP_THICKENED_EARS,SET,11,-0.32107,-0.0078524,0.26903,0.88364,HP_THICKENED_EARS,1
MIR449A,SET,280,-0.059591,-0.0072991,0.049922,0.88369,MIR449A,1
HP_OLIGODACTYLY,SET,24,-0.20149,-0.0072765,0.16879,0.8837,HP_OLIGODACTYLY,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...8,SET,8,-0.324,-0.0067583,0.27142,0.8837,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_28DY_UP,1
PID_RAC1_PATHWAY,SET,51,-0.13826,-0.0072729,0.11581,0.88371,PID_RAC1_PATHWAY,1
GOBP_CHONDROCYTE_HYPERTROPHY,SET,6,-0.51182,-0.0092462,0.42868,0.88374,GOBP_CHONDROCYTE_HYPERTROPHY,1
GSE29618_MONOCYTE_VS_PDC_DAY...1,SET,174,-0.075812,-0.0073415,0.063494,0.88375,GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_DN,1
GOCC_PHOTORECEPTOR_RIBBON_SY...,SET,9,-0.37124,-0.0082131,0.31092,0.88376,GOCC_PHOTORECEPTOR_RIBBON_SYNAPSE,1
GOBP_ACETYL_COA_METABOLIC_PR...,SET,30,-0.1795,-0.0072463,0.15032,0.88377,GOBP_ACETYL_COA_METABOLIC_PROCESS,1
BIOCARTA_CPSF_PATHWAY,SET,9,-0.31145,-0.0068903,0.26079,0.8838,BIOCARTA_CPSF_PATHWAY,1
MIR5699_3P,SET,60,-0.13433,-0.0076624,0.11248,0.88381,MIR5699_3P,1
GCM_SMARCC1,SET,32,-0.16812,-0.007009,0.14076,0.88382,GCM_SMARCC1,1
PAX2_02,SET,241,-0.068935,-0.0078419,0.057715,0.88383,PAX2_02,1
RYTAAWNNNTGAY_UNKNOWN,SET,55,-0.14083,-0.0076924,0.11791,0.88383,RYTAAWNNNTGAY_UNKNOWN,1
HP_IRREGULAR_DENTITION,SET,7,-0.39401,-0.007688,0.32985,0.88385,HP_IRREGULAR_DENTITION,1
HP_DESQUAMATION_OF_SKIN_SOON...,SET,11,-0.28913,-0.0070713,0.24205,0.88386,HP_DESQUAMATION_OF_SKIN_SOON_AFTER_BIRTH,1
GOBP_REGULATION_OF_REACTIVE_...1,SET,35,-0.16569,-0.0072235,0.13863,0.88398,GOBP_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...548,SET,36,-0.17216,-0.0076119,0.14403,0.88401,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_METABOLIC_PROCESS,1
GOBP_NEPHRON_EPITHELIUM_DEVE...,SET,113,-0.10566,-0.0082591,0.088374,0.88405,GOBP_NEPHRON_EPITHELIUM_DEVELOPMENT,1
GSE29949_DC_BRAIN_VS_MONOCYT...2,SET,176,-0.073765,-0.0071838,0.061699,0.88406,GSE29949_DC_BRAIN_VS_MONOCYTE_BONE_MARROW_UP,1
GOBP_RESPONSE_TO_LUTEINIZING...,SET,7,-0.3883,-0.0075766,0.32472,0.88411,GOBP_RESPONSE_TO_LUTEINIZING_HORMONE,1
HP_B_CELL_LYMPHOMA,SET,21,-0.2325,-0.0078547,0.19442,0.88412,HP_B_CELL_LYMPHOMA,1
GSE3982_DC_VS_NEUTROPHIL_LPS...1,SET,176,-0.077281,-0.0075263,0.064618,0.88414,GSE3982_DC_VS_NEUTROPHIL_LPS_STIM_DN,1
REACTOME_CASPASE_MEDIATED_CL...,SET,12,-0.28025,-0.0071588,0.23432,0.88415,REACTOME_CASPASE_MEDIATED_CLEAVAGE_OF_CYTOSKELETAL_PROTEINS,1
DESCARTES_FETAL_EYE_ASTROCYT...,SET,28,-0.21462,-0.0083707,0.17944,0.88416,DESCARTES_FETAL_EYE_ASTROCYTES,1
ZHOU_INFLAMMATORY_RESPONSE_F...1,SET,250,-0.065504,-0.0075876,0.054762,0.88418,ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN,1
HP_ABNORMAL_BLISTERING_OF_TH...,SET,103,-0.10319,-0.0077035,0.086267,0.88418,HP_ABNORMAL_BLISTERING_OF_THE_SKIN,1
GOBP_DOPAMINERGIC_NEURON_AXO...,SET,6,-0.4084,-0.0073779,0.34139,0.8842,GOBP_DOPAMINERGIC_NEURON_AXON_GUIDANCE,1
GOBP_PROTEIN_N_LINKED_GLYCOS...2,SET,23,-0.21699,-0.0076713,0.18139,0.8842,GOBP_PROTEIN_N_LINKED_GLYCOSYLATION_VIA_ASPARAGINE,1
GOBP_REGULATION_OF_HOMOTYPIC...,SET,36,-0.18139,-0.0080201,0.15161,0.88423,GOBP_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
MIR1208,SET,119,-0.0915,-0.0073388,0.076475,0.88424,MIR1208,1
TURASHVILI_BREAST_LOBULAR_CA...2,SET,62,-0.1407,-0.0081583,0.11759,0.88426,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP,1
HE_LIM_SUN_FETAL_LUNG_C2_ADC...1,SET,152,-0.085584,-0.0077509,0.071524,0.88426,HE_LIM_SUN_FETAL_LUNG_C2_ADC_1_CELL,1
MODULE_440,SET,18,-0.23964,-0.0074958,0.20026,0.88427,MODULE_440,1
ELVIDGE_HIF1A_AND_HIF2A_TARG...1,SET,94,-0.10553,-0.0075277,0.088184,0.88428,ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN,1
GOBP_CELL_CELL_JUNCTION_ASSE...,SET,146,-0.088807,-0.0078837,0.074208,0.88428,GOBP_CELL_CELL_JUNCTION_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...169,SET,4,-0.45556,-0.00672,0.38069,0.88428,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_BACTERIUM,1
GOMF_TRANSMEMBRANE_RECEPTOR_...2,SET,16,-0.26061,-0.0076861,0.21778,0.88428,GOMF_TRANSMEMBRANE_RECEPTOR_PROTEIN_PHOSPHATASE_ACTIVITY,1
GOMF_NEUROTRANSMITTER_RECEPT...2,SET,52,-0.15731,-0.0083558,0.13143,0.88432,GOMF_NEUROTRANSMITTER_RECEPTOR_ACTIVITY_INVOLVED_IN_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,1
GOBP_POSITIVE_REGULATION_OF_...170,SET,16,-0.26734,-0.0078846,0.22331,0.88437,GOBP_POSITIVE_REGULATION_OF_CIRCADIAN_RHYTHM,1
GOBP_POSITIVE_REGULATION_OF_...321,SET,183,-0.079961,-0.0079391,0.066781,0.88441,GOBP_POSITIVE_REGULATION_OF_GTPASE_ACTIVITY,1
GOBP_REGULATION_OF_AXON_EXTE...1,SET,69,-0.12097,-0.0073981,0.10103,0.88441,GOBP_REGULATION_OF_AXON_EXTENSION,1
GSE27670_BLIMP1_VS_LMP1_TRAN...1,SET,184,-0.072589,-0.0072266,0.060612,0.88446,GSE27670_BLIMP1_VS_LMP1_TRANSDUCED_GC_BCELL_DN,1
GOBP_EPITHELIAL_CELL_PROLIFE...1,SET,408,-0.053079,-0.0078202,0.044309,0.88452,GOBP_EPITHELIAL_CELL_PROLIFERATION,1
TAATTA_CHX10_01,SET,730,-0.040378,-0.0078858,0.033705,0.88453,TAATTA_CHX10_01,1
KEGG_STARCH_AND_SUCROSE_META...,SET,45,-0.17409,-0.0086038,0.14531,0.88455,KEGG_STARCH_AND_SUCROSE_METABOLISM,1
REACTOME_CDC42_GTPASE_CYCLE,SET,142,-0.086808,-0.0076008,0.072455,0.88455,REACTOME_CDC42_GTPASE_CYCLE,1
GOBP_GLIAL_CELL_DERIVED_NEUR...,SET,15,-0.26001,-0.007425,0.21703,0.88455,GOBP_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_DOPAMINE_...1,SET,11,-0.36604,-0.0089523,0.30552,0.88455,GOBP_REGULATION_OF_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
HP_REDUCED_NUMBER_OF_INTRAHE...,SET,5,-0.4923,-0.0081188,0.41091,0.88455,HP_REDUCED_NUMBER_OF_INTRAHEPATIC_BILE_DUCTS,1
GSE22443_IL2_VS_IL12_TREATED...1,SET,188,-0.072265,-0.0072713,0.060315,0.88456,GSE22443_IL2_VS_IL12_TREATED_ACT_CD8_TCELL_DN,1
GOMF_HMG_BOX_DOMAIN_BINDING,SET,12,-0.28366,-0.0072457,0.23664,0.88467,GOMF_HMG_BOX_DOMAIN_BINDING,1
REACTOME_FRUCTOSE_METABOLISM,SET,7,-0.32768,-0.0063938,0.27335,0.88469,REACTOME_FRUCTOSE_METABOLISM,1
HP_ANTERIOR_CHAMBER_SYNECHIAE,SET,27,-0.21915,-0.0083933,0.18278,0.88473,HP_ANTERIOR_CHAMBER_SYNECHIAE,1
GSE39556_UNTREATED_VS_3H_POL...4,SET,178,-0.074175,-0.0072643,0.061862,0.88473,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP,1
GSE21670_UNTREATED_VS_TGFB_T...4,SET,181,-0.072138,-0.0071235,0.060158,0.88476,GSE21670_UNTREATED_VS_TGFB_TREATED_STAT3_KO_CD4_TCELL_UP,1
HP_DELAYED_EPIPHYSEAL_OSSIFI...,SET,37,-0.16952,-0.0075983,0.14135,0.88478,HP_DELAYED_EPIPHYSEAL_OSSIFICATION,1
HP_HYPERPITUITARISM,SET,110,-0.093445,-0.0072075,0.077911,0.8848,HP_HYPERPITUITARISM,1
REACTOME_LDL_REMODELING,SET,6,-0.36249,-0.0065484,0.30218,0.88484,REACTOME_LDL_REMODELING,1
GOBP_REGULATION_OF_NITRIC_OX...3,SET,20,-0.23258,-0.0076681,0.19388,0.88485,GOBP_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
GSE411_UNSTIM_VS_100MIN_IL6_...2,SET,185,-0.075323,-0.0075189,0.062789,0.88485,GSE411_UNSTIM_VS_100MIN_IL6_STIM_MACROPHAGE_UP,1
HP_GAZE_EVOKED_HORIZONTAL_NY...,SET,17,-0.25184,-0.0076558,0.20992,0.88487,HP_GAZE_EVOKED_HORIZONTAL_NYSTAGMUS,1
GSE7509_UNSTIM_VS_TNFA_IL1B_...2,SET,175,-0.073163,-0.0071051,0.060968,0.88493,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_UP,1
MIR877_5P,SET,75,-0.11547,-0.0073614,0.096172,0.88506,MIR877_5P,1
HP_METHYLMALONIC_ACIDURIA,SET,18,-0.23713,-0.0074172,0.19745,0.8851,HP_METHYLMALONIC_ACIDURIA,1
GSE22886_UNSTIM_VS_STIM_MEMO...1,SET,182,-0.06954,-0.0068857,0.057897,0.88513,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_DN,1
GSE33162_UNTREATED_VS_4H_LPS...1,SET,182,-0.074621,-0.0073889,0.062126,0.88514,GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_HET_MACROPHAGE_DN,1
GOBP_NUCLEOBASE_CATABOLIC_PR...,SET,10,-0.33657,-0.0078488,0.28017,0.88518,GOBP_NUCLEOBASE_CATABOLIC_PROCESS,1
GOMF_CARBON_NITROGEN_LYASE_A...,SET,13,-0.30131,-0.0080106,0.25079,0.8852,GOMF_CARBON_NITROGEN_LYASE_ACTIVITY,1
GOBP_INTRACELLULAR_POTASSIUM...,SET,15,-0.29638,-0.0084637,0.24661,0.88527,GOBP_INTRACELLULAR_POTASSIUM_ION_HOMEOSTASIS,1
GSE19941_IL10_KO_VS_IL10_KO_...4,SET,181,-0.074693,-0.0073758,0.062115,0.88541,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_STIM_MACROPHAGE_UP,1
REACTOME_FCGR_ACTIVATION,SET,12,-0.3007,-0.0076811,0.25,0.88547,REACTOME_FCGR_ACTIVATION,1
GOBP_RESPONSE_TO_GAMMA_RADIA...,SET,47,-0.14731,-0.0074399,0.12247,0.88548,GOBP_RESPONSE_TO_GAMMA_RADIATION,1
GSE29615_CTRL_VS_DAY7_LAIV_F...2,SET,153,-0.08424,-0.007654,0.070031,0.88548,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_UP,1
GOCC_ATPASE_COMPLEX,SET,117,-0.090354,-0.0071861,0.075109,0.8855,GOCC_ATPASE_COMPLEX,1
GSE7509_UNSTIM_VS_TNFA_IL1B_...1,SET,80,-0.11099,-0.0073064,0.09226,0.8855,GSE7509_UNSTIM_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
HP_ABNORMAL_AUDITORY_EVOKED_...,SET,22,-0.21255,-0.0073493,0.17668,0.88551,HP_ABNORMAL_AUDITORY_EVOKED_POTENTIALS,1
KEGG_MEDICUS_REFERENCE_P4_PR...1,SET,8,-0.36101,-0.0075303,0.30002,0.88556,KEGG_MEDICUS_REFERENCE_P4_PR_PI3K_SIGNALING_PATHWAY,1
GOMF_BICARBONATE_MONOATOMIC_...,SET,12,-0.28499,-0.0072797,0.2368,0.8856,GOMF_BICARBONATE_MONOATOMIC_ANION_ANTIPORTER_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_NLRC4...,SET,4,-0.39536,-0.005832,0.32846,0.88564,KEGG_MEDICUS_REFERENCE_NLRC4_INFLAMMASOME_SIGNALING_PATHWAY,1
HP_ABNORMAL_CIRCULATING_VITA...3,SET,19,-0.23737,-0.007628,0.1972,0.88564,HP_ABNORMAL_CIRCULATING_VITAMIN_E_CONCENTRATION,1
MACLACHLAN_BRCA1_TARGETS_UP,SET,19,-0.22578,-0.0072558,0.18756,0.88565,MACLACHLAN_BRCA1_TARGETS_UP,1
MIR1304_3P,SET,100,-0.10309,-0.0075836,0.085632,0.88568,MIR1304_3P,1
HP_DEPLETION_OF_MITOCHONDRIA...,SET,16,-0.22704,-0.0066959,0.18858,0.88568,HP_DEPLETION_OF_MITOCHONDRIAL_DNA_IN_MUSCLE_TISSUE,1
GSE42021_CD24LO_TREG_VS_CD24...1,SET,184,-0.070693,-0.0070379,0.058718,0.88569,GSE42021_CD24LO_TREG_VS_CD24LO_TCONV_THYMUS_DN,1
MIR4264,SET,97,-0.1047,-0.0075865,0.086939,0.88576,MIR4264,1
GSE36891_UNSTIM_VS_PAM_TLR2_...1,SET,143,-0.081822,-0.0071892,0.067941,0.88576,GSE36891_UNSTIM_VS_PAM_TLR2_STIM_PERITONEAL_MACROPHAGE_DN,1
GOBP_REGULATION_OF_HEPATOCYT...1,SET,8,-0.38391,-0.0080078,0.31865,0.88585,GOBP_REGULATION_OF_HEPATOCYTE_APOPTOTIC_PROCESS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...28,SET,23,-0.23888,-0.0084451,0.19825,0.88588,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_SINGLE_DONORS_WITH_INCORPORATION_OF_MOLECULAR_OXYGEN,1
GOBP_ADENYLATE_CYCLASE_INHIB...1,SET,5,-0.53043,-0.0087477,0.4401,0.88594,GOBP_ADENYLATE_CYCLASE_INHIBITING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
MIR6752_3P,SET,131,-0.085368,-0.0071815,0.070797,0.88605,MIR6752_3P,1
HP_LARYNGOTRACHEAL_STENOSIS,SET,5,-0.49127,-0.0081019,0.40739,0.88607,HP_LARYNGOTRACHEAL_STENOSIS,1
PID_THROMBIN_PAR4_PATHWAY,SET,15,-0.27115,-0.0077432,0.22483,0.88609,PID_THROMBIN_PAR4_PATHWAY,1
GSE22935_UNSTIM_VS_24H_MBOVI...4,SET,192,-0.070775,-0.007196,0.058678,0.88612,GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_UP,1
GSE21063_WT_VS_NFATC1_KO_BCE...2,SET,186,-0.073836,-0.0073902,0.061192,0.88621,GSE21063_WT_VS_NFATC1_KO_BCELL_UP,1
KIM_ALL_DISORDERS_OLIGODENDR...1,SET,30,-0.17259,-0.0069674,0.14301,0.88624,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN,1
GOBP_NEGATIVE_REGULATION_OF_...426,SET,10,-0.34543,-0.0080553,0.28622,0.88625,GOBP_NEGATIVE_REGULATION_OF_MYELOID_LEUKOCYTE_MEDIATED_IMMUNITY,1
VALK_AML_CLUSTER_13,SET,29,-0.20562,-0.0081615,0.17036,0.88627,VALK_AML_CLUSTER_13,1
GOBP_PYRUVATE_FAMILY_AMINO_A...1,SET,10,-0.30829,-0.0071892,0.25541,0.88628,GOBP_PYRUVATE_FAMILY_AMINO_ACID_CATABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_AUTOP...1,SET,15,-0.24384,-0.0069634,0.20201,0.88629,KEGG_MEDICUS_REFERENCE_AUTOPHAGOSOME_AND_LYSOSOME_FUSION_TETHERING_FACTOR,1
GOBP_PROTEIN_POLYUBIQUITINAT...,SET,251,-0.062738,-0.0072815,0.051976,0.88629,GOBP_PROTEIN_POLYUBIQUITINATION,1
BIOCARTA_AKAP13_PATHWAY,SET,11,-0.31888,-0.0077988,0.26416,0.88631,BIOCARTA_AKAP13_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...650,SET,4,-0.50945,-0.0075149,0.42202,0.88631,GOBP_NEGATIVE_REGULATION_OF_TRANSLATIONAL_ELONGATION,1
WNT_UP.V1_DN,SET,160,-0.085608,-0.0079527,0.070916,0.88631,WNT_UP.V1_DN,1
REACTOME_GLYCOSPHINGOLIPID_C...,SET,31,-0.18396,-0.0075487,0.15237,0.88633,REACTOME_GLYCOSPHINGOLIPID_CATABOLISM,1
GSE13547_CTRL_VS_ANTI_IGM_ST...3,SET,149,-0.08384,-0.0075182,0.069436,0.88636,GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN,1
REACTOME_LINOLEIC_ACID_LA_ME...,SET,7,-0.43309,-0.0084506,0.35861,0.88641,REACTOME_LINOLEIC_ACID_LA_METABOLISM,1
MIR4728_3P,SET,99,-0.10488,-0.0076764,0.086831,0.88643,MIR4728_3P,1
GOBP_POSITIVE_REGULATION_OF_...373,SET,23,-0.22783,-0.0080545,0.18862,0.88644,GOBP_POSITIVE_REGULATION_OF_INTERLEUKIN_4_PRODUCTION,1
GOBP_PYRIMIDINE_CONTAINING_C...2,SET,41,-0.17626,-0.0083158,0.14593,0.88644,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_CATABOLIC_PROCESS,1
GSE29949_CD8_POS_DC_SPLEEN_V...2,SET,184,-0.074204,-0.0073874,0.061433,0.88645,GSE29949_CD8_POS_DC_SPLEEN_VS_DC_BRAIN_UP,1
REACTOME_SENESCENCE_ASSOCIAT...,SET,49,-0.14725,-0.0075928,0.12186,0.88652,REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
WP_SENESCENCEASSOCIATED_SECR...,SET,49,-0.14725,-0.0075928,0.12186,0.88652,WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP,1
MIR548AJ_3P_MIR548X_3P,SET,835,-0.035997,-0.0074964,0.029793,0.88652,MIR548AJ_3P_MIR548X_3P,1
MIR6823_3P,SET,56,-0.13402,-0.0073867,0.11092,0.88652,MIR6823_3P,1
GOBP_HORMONE_MEDIATED_APOPTO...,SET,5,-0.49644,-0.0081871,0.41086,0.88652,GOBP_HORMONE_MEDIATED_APOPTOTIC_SIGNALING_PATHWAY,1
HP_INCREASED_CIRCULATING_IGG...,SET,23,-0.22415,-0.0079245,0.18549,0.88655,HP_INCREASED_CIRCULATING_IGG_LEVEL,1
GSE360_CTRL_VS_L_MAJOR_DC_UP,SET,180,-0.074462,-0.0073329,0.061611,0.88658,GSE360_CTRL_VS_L_MAJOR_DC_UP,1
WP_P53_TRANSCRIPTIONAL_GENE_...,SET,89,-0.10252,-0.0071167,0.084795,0.88666,WP_P53_TRANSCRIPTIONAL_GENE_NETWORK,1
FRASOR_RESPONSE_TO_ESTRADIOL...2,SET,33,-0.18444,-0.0078084,0.15255,0.88667,FRASOR_RESPONSE_TO_ESTRADIOL_UP,1
HP_EXCESSIVE_DAYTIME_SOMNOLE...,SET,64,-0.12765,-0.0075195,0.10557,0.88669,HP_EXCESSIVE_DAYTIME_SOMNOLENCE,1
HP_EEG_WITH_CONTINUOUS_SLOW_...,SET,8,-0.34146,-0.0071225,0.28239,0.8867,HP_EEG_WITH_CONTINUOUS_SLOW_ACTIVITY,1
MIR30E_3P,SET,348,-0.054803,-0.0074693,0.045319,0.88671,MIR30E_3P,1
GOBP_CELL_ADHESION_MOLECULE_...,SET,11,-0.34965,-0.0085515,0.28912,0.88673,GOBP_CELL_ADHESION_MOLECULE_PRODUCTION,1
HP_EYE_OF_THE_TIGER_ANOMALY_...,SET,9,-0.32114,-0.0071047,0.26551,0.88676,HP_EYE_OF_THE_TIGER_ANOMALY_OF_GLOBUS_PALLIDUS,1
GOBP_AUTOPHAGIC_CELL_DEATH,SET,9,-0.33545,-0.0074213,0.2773,0.8868,GOBP_AUTOPHAGIC_CELL_DEATH,1
GOBP_STRIATED_MUSCLE_ADAPTAT...,SET,45,-0.16021,-0.007918,0.13243,0.88681,GOBP_STRIATED_MUSCLE_ADAPTATION,1
KYNG_DNA_DAMAGE_BY_GAMMA_RAD...,SET,69,-0.12634,-0.0077265,0.10441,0.88685,KYNG_DNA_DAMAGE_BY_GAMMA_RADIATION,1
GSE15330_HSC_VS_MEGAKARYOCYT...2,SET,176,-0.078023,-0.0075985,0.064483,0.88685,GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_DN,1
HOEBEKE_LYMPHOID_STEM_CELL_UP,SET,86,-0.10862,-0.007413,0.08974,0.88693,HOEBEKE_LYMPHOID_STEM_CELL_UP,1
PAX4_02,SET,217,-0.072248,-0.0078039,0.059688,0.88693,PAX4_02,1
HP_IMPAIRED_VIBRATION_SENSAT...1,SET,10,-0.31208,-0.0072775,0.25781,0.88695,HP_IMPAIRED_VIBRATION_SENSATION_AT_ANKLES,1
GSE22611_UNSTIM_VS_2H_MDP_ST...3,SET,176,-0.077339,-0.0075319,0.063889,0.88695,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_DN,1
GSE22886_IGA_VS_IGM_MEMORY_B...2,SET,172,-0.079337,-0.007639,0.06553,0.88699,GSE22886_IGA_VS_IGM_MEMORY_BCELL_UP,1
HP_EEG_WITH_CENTROTEMPORAL_E...,SET,3,-0.65454,-0.0083617,0.54057,0.88701,HP_EEG_WITH_CENTROTEMPORAL_EPILEPTIFORM_DISCHARGES,1
GSE13411_NAIVE_VS_SWITCHED_M...2,SET,175,-0.077713,-0.007547,0.06418,0.88701,GSE13411_NAIVE_VS_SWITCHED_MEMORY_BCELL_UP,1
PID_CERAMIDE_PATHWAY,SET,43,-0.15778,-0.0076228,0.13029,0.88703,PID_CERAMIDE_PATHWAY,1
KEGG_MEDICUS_REFERENCE_CXCR_...2,SET,26,-0.20975,-0.0078835,0.1732,0.88705,KEGG_MEDICUS_REFERENCE_CXCR_GNB_G_PI3K_AKT_SIGNALING_PATHWAY,1
GOCC_G_PROTEIN_COUPLED_RECEP...1,SET,11,-0.33479,-0.0081879,0.27643,0.88706,GOCC_G_PROTEIN_COUPLED_RECEPTOR_COMPLEX,1
MIR1470,SET,14,-0.26092,-0.0071985,0.21541,0.8871,MIR1470,1
REACTOME_REGULATION_OF_PTEN_...1,SET,57,-0.13,-0.0072286,0.10732,0.88711,REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION,1
GOBP_REGULATION_OF_GONADOTRO...,SET,12,-0.34616,-0.0088424,0.28576,0.88711,GOBP_REGULATION_OF_GONADOTROPIN_SECRETION,1
MIR576_3P,SET,58,-0.13414,-0.0075237,0.11072,0.88714,MIR576_3P,1
HP_ALLERGY,SET,35,-0.18014,-0.0078536,0.14868,0.88716,HP_ALLERGY,1
GOBP_POSITIVE_REGULATION_OF_...243,SET,87,-0.11438,-0.007851,0.094402,0.88717,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_PROLIFERATION,1
GOBP_BRANCHED_CHAIN_AMINO_AC...3,SET,27,-0.19486,-0.0074632,0.16081,0.88718,GOBP_BRANCHED_CHAIN_AMINO_ACID_METABOLIC_PROCESS,1
REACTOME_ACYL_CHAIN_REMODELL...2,SET,23,-0.23183,-0.0081958,0.19131,0.8872,REACTOME_ACYL_CHAIN_REMODELLING_OF_PE,1
REACTOME_DOPAMINE_NEUROTRANS...,SET,20,-0.24418,-0.0080505,0.20148,0.88722,REACTOME_DOPAMINE_NEUROTRANSMITTER_RELEASE_CYCLE,1
REACTOME_PHASE_4_RESTING_MEM...,SET,19,-0.24733,-0.0079481,0.20406,0.88724,REACTOME_PHASE_4_RESTING_MEMBRANE_POTENTIAL,1
MORF_BAG5,SET,52,-0.12866,-0.0068338,0.10615,0.88725,MORF_BAG5,1
WAGSCHAL_EHMT2_TARGETS_UP,SET,10,-0.33903,-0.0079061,0.27969,0.88727,WAGSCHAL_EHMT2_TARGETS_UP,1
GSE40666_WT_VS_STAT1_KO_CD8_...3,SET,186,-0.072803,-0.0072868,0.060057,0.88728,GSE40666_WT_VS_STAT1_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_DN,1
HP_DECREASED_NUMBER_OF_PERIP...,SET,45,-0.15185,-0.0075045,0.12523,0.88733,HP_DECREASED_NUMBER_OF_PERIPHERAL_MYELINATED_NERVE_FIBERS,1
MIR555,SET,39,-0.16212,-0.0074602,0.13369,0.88736,MIR555,1
GOBP_MONOCYTE_CHEMOTAXIS,SET,47,-0.15547,-0.0078521,0.12819,0.88739,GOBP_MONOCYTE_CHEMOTAXIS,1
GOMF_HISTONE_H4_DEMETHYLASE_...,SET,4,-0.49118,-0.0072455,0.40498,0.8874,GOMF_HISTONE_H4_DEMETHYLASE_ACTIVITY,1
GOBP_VESICLE_TETHERING,SET,30,-0.17989,-0.0072618,0.1483,0.88743,GOBP_VESICLE_TETHERING,1
REACTOME_REGULATION_OF_PTEN_...4,SET,65,-0.11465,-0.0068059,0.094481,0.88751,REACTOME_REGULATION_OF_PTEN_STABILITY_AND_ACTIVITY,1
HP_SHORT_GREATER_SCIATIC_NOT...,SET,3,-0.64634,-0.008257,0.53251,0.88757,HP_SHORT_GREATER_SCIATIC_NOTCH,1
GOMF_VITAMIN_D_BINDING,SET,6,-0.48215,-0.0087102,0.39718,0.88761,GOMF_VITAMIN_D_BINDING,1
LET_7B_5P,SET,362,-0.055129,-0.0076605,0.045411,0.88762,LET_7B_5P,1
GOBP_TUBE_DEVELOPMENT,SET,1010,-0.034314,-0.0078198,0.028265,0.88762,GOBP_TUBE_DEVELOPMENT,1
GOBP_MAMMARY_GLAND_FORMATION,SET,7,-0.44933,-0.0087674,0.37009,0.88764,GOBP_MAMMARY_GLAND_FORMATION,1
GSE18791_UNSTIM_VS_NEWCATSLE...4,SET,175,-0.073366,-0.0071249,0.060413,0.8877,GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_18H_UP,1
MODULE_265,SET,25,-0.22408,-0.0082587,0.18447,0.88775,MODULE_265,1
GSE29164_UNTREATED_VS_CD8_TC...2,SET,174,-0.075815,-0.0073418,0.062406,0.88778,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_UP,1
REACTOME_SYNTHESIS_OF_IP2_IP...,SET,13,-0.23765,-0.0063182,0.19558,0.88783,REACTOME_SYNTHESIS_OF_IP2_IP_AND_INS_IN_THE_CYTOSOL,1
GENTILE_UV_RESPONSE_CLUSTER_...2,SET,37,-0.18744,-0.0084016,0.15425,0.88784,GENTILE_UV_RESPONSE_CLUSTER_D2,1
GOBP_TELOMERIC_LOOP_DISASSEM...,SET,9,-0.32059,-0.0070926,0.26382,0.88785,GOBP_TELOMERIC_LOOP_DISASSEMBLY,1
GOMF_MAP_KINASE_TYROSINE_SER...,SET,11,-0.33755,-0.0082555,0.27776,0.88786,GOMF_MAP_KINASE_TYROSINE_SERINE_THREONINE_PHOSPHATASE_ACTIVITY,1
HP_CALVARIAL_HYPEROSTOSIS,SET,10,-0.28877,-0.0067341,0.23762,0.88786,HP_CALVARIAL_HYPEROSTOSIS,1
GOBP_POST_CHAPERONIN_TUBULIN...,SET,6,-0.34363,-0.0062078,0.28274,0.88788,GOBP_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY,1
SCHAEFFER_PROSTATE_DEVELOPME...14,SET,8,-0.36916,-0.0077002,0.30366,0.88794,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX5_DN,1
KEGG_MEDICUS_REFERENCE_RELN_...,SET,15,-0.27382,-0.0078194,0.22522,0.88796,KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY,1
HP_CEREBELLAR_DYSPLASIA,SET,18,-0.24864,-0.0077773,0.20449,0.88798,HP_CEREBELLAR_DYSPLASIA,1
HP_REDUCED_VISUAL_ACUITY,SET,518,-0.045169,-0.0074754,0.037142,0.88802,HP_REDUCED_VISUAL_ACUITY,1
MIR128_1_5P,SET,12,-0.32813,-0.0083818,0.26978,0.88805,MIR128_1_5P,1
GSE20484_MCSG_VS_CXCL4_MONOC...2,SET,159,-0.081761,-0.0075718,0.067222,0.88805,GSE20484_MCSG_VS_CXCL4_MONOCYTE_DERIVED_MACROPHAGE_UP,1
GSE43955_TH0_VS_TGFB_IL6_TH1...5,SET,180,-0.075563,-0.0074413,0.062116,0.88809,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN,1
MORF_MDM2,SET,248,-0.066464,-0.0076683,0.05463,0.88812,MORF_MDM2,1
HP_DECREASED_ABSENT_ANKLE_RE...,SET,37,-0.16097,-0.0072153,0.13229,0.88815,HP_DECREASED_ABSENT_ANKLE_REFLEXES,1
HP_WEAK_EXTRAOCULAR_MUSCLES,SET,12,-0.28901,-0.0073825,0.23751,0.88816,HP_WEAK_EXTRAOCULAR_MUSCLES,1
GAO_LARGE_INTESTINE_ADULT_CJ...,SET,439,-0.053829,-0.0082194,0.044232,0.88818,GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS,1
GOBP_INTRACELLULAR_DISTRIBUT...,SET,7,-0.41233,-0.0080455,0.33878,0.88821,GOBP_INTRACELLULAR_DISTRIBUTION_OF_MITOCHONDRIA,1
MIR3909,SET,68,-0.12713,-0.0077184,0.10445,0.88822,MIR3909,1
MIR6848_3P,SET,81,-0.1206,-0.0079889,0.099071,0.88826,MIR6848_3P,1
GSE15659_RESTING_TREG_VS_NON...2,SET,161,-0.080681,-0.0075181,0.066273,0.88827,GSE15659_RESTING_TREG_VS_NONSUPPRESSIVE_TCELL_UP,1
BOYLAN_MULTIPLE_MYELOMA_D_UP,SET,82,-0.11508,-0.0076699,0.094529,0.88828,BOYLAN_MULTIPLE_MYELOMA_D_UP,1
GAO_STOMACH_24W_C1_PROCRPOS_...,SET,37,-0.15123,-0.0067785,0.1242,0.88831,GAO_STOMACH_24W_C1_PROCRPOS_MULTIPOTENT_PROGENITOR,1
HP_LIMB_FASCICULATIONS,SET,6,-0.40731,-0.0073582,0.33446,0.88835,HP_LIMB_FASCICULATIONS,1
GOBP_MANNOSYLATION,SET,20,-0.2267,-0.0074744,0.18612,0.88839,GOBP_MANNOSYLATION,1
MARTINEZ_RB1_TARGETS_UP,SET,644,-0.040861,-0.0075136,0.033542,0.88842,MARTINEZ_RB1_TARGETS_UP,1
GOBP_PYRUVATE_FAMILY_AMINO_A...2,SET,12,-0.28975,-0.0074013,0.23783,0.88843,GOBP_PYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GOCC_SERINE_TYPE_ENDOPEPTIDA...,SET,11,-0.38388,-0.0093887,0.31508,0.88845,GOCC_SERINE_TYPE_ENDOPEPTIDASE_COMPLEX,1
GSE19401_UNSTIM_VS_RETINOIC_...3,SET,169,-0.078289,-0.0074727,0.064251,0.88847,GSE19401_UNSTIM_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,1
TRAVAGLINI_LUNG_MACROPHAGE_C...,SET,191,-0.081199,-0.0082345,0.066611,0.88857,TRAVAGLINI_LUNG_MACROPHAGE_CELL,1
GSE5679_RARA_AGONIST_AM580_V...1,SET,181,-0.078417,-0.0077436,0.064323,0.88859,GSE5679_RARA_AGONIST_AM580_VS_AM580_AND_ROSIGLITAZONE_TREATED_DC_DN,1
CHOW_RASSF1_TARGETS_UP,SET,22,-0.1974,-0.0068255,0.16191,0.8886,CHOW_RASSF1_TARGETS_UP,1
GOBP_POSITIVE_REGULATION_OF_...165,SET,99,-0.094082,-0.0068863,0.077169,0.8886,GOBP_POSITIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
GOBP_PYRIMIDINE_RIBONUCLEOSI...5,SET,16,-0.26884,-0.0079288,0.22051,0.8886,GOBP_PYRIMIDINE_RIBONUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
YAMAZAKI_TCEB3_TARGETS_DN,SET,180,-0.075846,-0.0074691,0.062204,0.88863,YAMAZAKI_TCEB3_TARGETS_DN,1
GSE2128_C57BL6_VS_NOD_THYMOC...1,SET,176,-0.074568,-0.007262,0.061153,0.88864,GSE2128_C57BL6_VS_NOD_THYMOCYTE_DN,1
MIR525_5P,SET,143,-0.085789,-0.0075378,0.070353,0.88865,MIR525_5P,1
MIR622,SET,74,-0.11955,-0.0075706,0.098039,0.88865,MIR622,1
GOBP_REGULATION_OF_MUSCLE_TI...,SET,42,-0.17134,-0.0081812,0.1405,0.88867,GOBP_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
HOEK_MYELOID_DENDRITIC_CELL_...3,SET,16,-0.24362,-0.0071849,0.19977,0.88867,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_DN,1
CDP_02,SET,97,-0.10775,-0.0078075,0.08833,0.88874,CDP_02,1
MIR500A_5P,SET,140,-0.086521,-0.0075226,0.070908,0.8888,MIR500A_5P,1
OUELLET_OVARIAN_CANCER_INVAS...2,SET,104,-0.092056,-0.0069052,0.075431,0.88883,OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1
GOBP_NEGATIVE_REGULATION_OF_...170,SET,15,-0.26522,-0.0075739,0.21732,0.88884,GOBP_NEGATIVE_REGULATION_OF_DEFENSE_RESPONSE_TO_VIRUS,1
SHIPP_DLBCL_CURED_VS_FATAL_UP,SET,36,-0.17726,-0.0078377,0.14522,0.88889,SHIPP_DLBCL_CURED_VS_FATAL_UP,1
HP_ABNORMALITY_OF_NAIL_COLOR,SET,17,-0.26143,-0.0079474,0.21416,0.8889,HP_ABNORMALITY_OF_NAIL_COLOR,1
REACTOME_BETA_CATENIN_PHOSPH...,SET,16,-0.25693,-0.0075773,0.21044,0.88893,REACTOME_BETA_CATENIN_PHOSPHORYLATION_CASCADE,1
HAHTOLA_MYCOSIS_FUNGOIDES_UP,SET,14,-0.28285,-0.0078035,0.23166,0.88894,HAHTOLA_MYCOSIS_FUNGOIDES_UP,1
GOBP_MAMMARY_GLAND_DEVELOPME...,SET,128,-0.098476,-0.0081895,0.08065,0.88895,GOBP_MAMMARY_GLAND_DEVELOPMENT,1
WP_SPHINGOLIPID_METABOLISM_I...1,SET,23,-0.22478,-0.0079467,0.18406,0.88899,WP_SPHINGOLIPID_METABOLISM_INTEGRATED_PATHWAY,1
GOBP_RESPONSE_TO_STEROL_DEPL...,SET,15,-0.27136,-0.0077491,0.2222,0.88899,GOBP_RESPONSE_TO_STEROL_DEPLETION,1
HINATA_NFKB_TARGETS_KERATINO...1,SET,22,-0.24246,-0.0083834,0.19853,0.889,HINATA_NFKB_TARGETS_KERATINOCYTE_DN,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...4,SET,27,-0.19213,-0.0073585,0.15731,0.88902,GAZDA_DIAMOND_BLACKFAN_ANEMIA_MYELOID_UP,1
GAVISH_3CA_MALIGNANT_METAPRO...6,SET,44,-0.17375,-0.0084911,0.14226,0.88902,GAVISH_3CA_MALIGNANT_METAPROGRAM_15_EMT_4,1
BIOCARTA_GLEEVEC_PATHWAY,SET,23,-0.23454,-0.0082919,0.19198,0.88909,BIOCARTA_GLEEVEC_PATHWAY,1
CAGGTCC_MIR492,SET,54,-0.12938,-0.0070025,0.10582,0.88925,CAGGTCC_MIR492,1
GOCC_REPLISOME,SET,22,-0.19992,-0.0069126,0.1635,0.88927,GOCC_REPLISOME,1
GU_PDEF_TARGETS_DN,SET,37,-0.18546,-0.0083129,0.15162,0.88936,GU_PDEF_TARGETS_DN,1
TRAVAGLINI_LUNG_PROLIFERATIN...3,SET,121,-0.091912,-0.0074331,0.075138,0.88937,TRAVAGLINI_LUNG_PROLIFERATING_NK_T_CELL,1
PIT1_Q6,SET,202,-0.077285,-0.0080577,0.063167,0.88942,PIT1_Q6,1
MIR1227_3P,SET,67,-0.12608,-0.0075984,0.10304,0.88944,MIR1227_3P,1
MIR4423_3P,SET,116,-0.095671,-0.0075766,0.078171,0.88949,MIR4423_3P,1
GOBP_PURINE_NUCLEOBASE_METAB...,SET,17,-0.2418,-0.0073505,0.19756,0.8895,GOBP_PURINE_NUCLEOBASE_METABOLIC_PROCESS,1
RAMALHO_STEMNESS_DN,SET,65,-0.12802,-0.0076001,0.1046,0.88951,RAMALHO_STEMNESS_DN,1
YAO_TEMPORAL_RESPONSE_TO_PRO...1,SET,68,-0.12466,-0.0075684,0.10184,0.88953,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0,1
HP_ABNORMALITY_OF_GLYCOLIPID...,SET,9,-0.33494,-0.0074101,0.27363,0.88953,HP_ABNORMALITY_OF_GLYCOLIPID_METABOLISM,1
HARALAMBIEVA_PBMC_M_M_R_II_A...5,SET,13,-0.33099,-0.0087999,0.2704,0.88953,HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_LOW_ANTIBODY_RESPONDERS_TO_TREATMENT_7YR_UP,1
GOBP_REGULATION_OF_RENAL_SOD...,SET,7,-0.39802,-0.0077663,0.32513,0.88955,GOBP_REGULATION_OF_RENAL_SODIUM_EXCRETION,1
GSE2770_UNTREATED_VS_ACT_CD4...6,SET,180,-0.076578,-0.0075412,0.062555,0.88955,GSE2770_UNTREATED_VS_ACT_CD4_TCELL_6H_UP,1
DESCARTES_MAIN_FETAL_CCL19_C...,SET,159,-0.081992,-0.0075931,0.066967,0.88958,DESCARTES_MAIN_FETAL_CCL19_CCL21_POSITIVE_CELLS,1
MIR548AO_3P,SET,17,-0.25233,-0.0076707,0.20608,0.8896,MIR548AO_3P,1
TGCGCANK_UNKNOWN,SET,491,-0.046028,-0.0074221,0.037592,0.8896,TGCGCANK_UNKNOWN,1
WILSON_PROTEASES_AT_TUMOR_BO...1,SET,5,-0.52328,-0.0086297,0.42732,0.88962,WILSON_PROTEASES_AT_TUMOR_BONE_INTERFACE_DN,1
HP_ABNORMAL_CIRCULATING_ORGA...,SET,657,-0.040633,-0.0075439,0.033178,0.88965,HP_ABNORMAL_CIRCULATING_ORGANIC_COMPOUND_CONCENTRATION,1
chr20q13,SET,207,-0.16694,-0.017617,0.13629,0.88968,chr20q13,1
SHEDDEN_LUNG_CANCER_GOOD_SUR...1,SET,252,-0.067078,-0.0078005,0.054762,0.88969,SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A12,1
HE_LIM_SUN_FETAL_LUNG_C1_PRO...1,SET,176,-0.085423,-0.0083192,0.069719,0.88975,HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL,1
GOBP_MITOTIC_DNA_REPLICATION...,SET,11,-0.27024,-0.0066092,0.22054,0.88977,GOBP_MITOTIC_DNA_REPLICATION_CHECKPOINT_SIGNALING,1
WP_OXIDATION_BY_CYTOCHROME_P...,SET,61,-0.14522,-0.0083525,0.11848,0.88984,WP_OXIDATION_BY_CYTOCHROME_P450,1
GOBP_GLUCAN_METABOLIC_PROCESS,SET,74,-0.11861,-0.0075112,0.096764,0.88985,GOBP_GLUCAN_METABOLIC_PROCESS,1
KEGG_MEDICUS_PATHOGEN_SHIGEL...7,SET,28,-0.18549,-0.0072345,0.15131,0.88987,KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
HP_ELEVATED_CIRCULATING_PARA...,SET,18,-0.26272,-0.0082177,0.21431,0.88987,HP_ELEVATED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,1
GOBP_REGULATION_OF_RAS_PROTE...,SET,46,-0.15978,-0.0079833,0.13032,0.88989,GOBP_REGULATION_OF_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
KEGG_GALACTOSE_METABOLISM,SET,24,-0.19557,-0.0070624,0.15949,0.88993,KEGG_GALACTOSE_METABOLISM,1
NADLER_OBESITY_UP,SET,58,-0.1428,-0.008009,0.11641,0.89001,NADLER_OBESITY_UP,1
WATANABE_RECTAL_CANCER_RADIO...2,SET,96,-0.098696,-0.0071144,0.080453,0.89004,WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP,1
REACTOME_PROCESSING_OF_CAPPE...2,SET,255,-0.058037,-0.0067886,0.047302,0.89007,REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA,1
GSE22886_UNSTIM_VS_IL2_STIM_...2,SET,169,-0.077387,-0.0073866,0.063074,0.89007,GSE22886_UNSTIM_VS_IL2_STIM_NKCELL_UP,1
MIR5583_3P,SET,76,-0.12447,-0.0079875,0.10144,0.89009,MIR5583_3P,1
WP_NOCGMPPKG_MEDIATED_NEUROP...,SET,41,-0.16572,-0.0078185,0.13503,0.89013,WP_NOCGMPPKG_MEDIATED_NEUROPROTECTION,1
GOMF_GUANYLATE_CYCLASE_ACTIV...,SET,5,-0.45698,-0.0075364,0.37228,0.89018,GOMF_GUANYLATE_CYCLASE_ACTIVITY,1
GCM_FCGR2B,SET,35,-0.16772,-0.0073123,0.13661,0.89023,GCM_FCGR2B,1
GOBP_GRANULOCYTE_COLONY_STIM...1,SET,5,-0.47141,-0.0077744,0.38392,0.89025,GOBP_GRANULOCYTE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
GSE27786_LSK_VS_ERYTHROBLAST...1,SET,178,-0.075326,-0.007377,0.06134,0.89027,GSE27786_LSK_VS_ERYTHROBLAST_DN,1
MIR3667_5P,SET,53,-0.14439,-0.0077427,0.11758,0.89028,MIR3667_5P,1
BIDUS_METASTASIS_UP,SET,186,-0.070855,-0.0070918,0.057694,0.89029,BIDUS_METASTASIS_UP,1
GOBP_SODIUM_ION_EXPORT_ACROS...,SET,15,-0.3069,-0.0087641,0.24989,0.89029,GOBP_SODIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
HP_IMPAIRMENT_OF_ACTIVITIES_...,SET,170,-0.079715,-0.007631,0.064892,0.89035,HP_IMPAIRMENT_OF_ACTIVITIES_OF_DAILY_LIVING,1
GSE3982_CTRL_VS_LPS_4H_MAC_UP,SET,177,-0.07231,-0.0070619,0.058858,0.89037,GSE3982_CTRL_VS_LPS_4H_MAC_UP,1
GOBP_RESPONSE_TO_INTERLEUKIN...7,SET,9,-0.42753,-0.0094584,0.34796,0.8904,GOBP_RESPONSE_TO_INTERLEUKIN_2,1
OCT1_Q6,SET,229,-0.07098,-0.0078735,0.057756,0.89045,OCT1_Q6,1
HP_ELEVATED_URINARY_HOMOVANI...,SET,9,-0.41117,-0.0090966,0.33453,0.89047,HP_ELEVATED_URINARY_HOMOVANILLIC_ACID,1
MIR5591_5P,SET,59,-0.13087,-0.0074031,0.10646,0.89051,MIR5591_5P,1
GOMF_CYCLIC_NUCLEOTIDE_BINDI...,SET,36,-0.17542,-0.0077562,0.1427,0.89051,GOMF_CYCLIC_NUCLEOTIDE_BINDING,1
REACTOME_APOPTOTIC_FACTOR_ME...,SET,17,-0.2421,-0.0073595,0.19693,0.89052,REACTOME_APOPTOTIC_FACTOR_MEDIATED_RESPONSE,1
TERAMOTO_OPN_TARGETS_CLUSTER...2,SET,7,-0.31623,-0.0061703,0.2572,0.89055,TERAMOTO_OPN_TARGETS_CLUSTER_3,1
GSE43700_UNTREATED_VS_IL10_T...2,SET,184,-0.078433,-0.0078084,0.063793,0.89055,GSE43700_UNTREATED_VS_IL10_TREATED_PBMC_UP,1
MIR4666A_3P,SET,502,-0.048333,-0.0078781,0.039291,0.89067,MIR4666A_3P,1
HP_ANTALGIC_GAIT,SET,9,-0.40309,-0.0089177,0.32763,0.8907,HP_ANTALGIC_GAIT,1
HP_PRIMARY_ADRENAL_INSUFFICI...,SET,55,-0.13987,-0.00764,0.11368,0.89071,HP_PRIMARY_ADRENAL_INSUFFICIENCY,1
GOCC_NUCLEOTIDE_ACTIVATED_PR...,SET,10,-0.30735,-0.0071672,0.24977,0.89074,GOCC_NUCLEOTIDE_ACTIVATED_PROTEIN_KINASE_COMPLEX,1
MORI_LARGE_PRE_BII_LYMPHOCYT...2,SET,81,-0.11488,-0.0076096,0.093347,0.89077,MORI_LARGE_PRE_BII_LYMPHOCYTE_UP,1
GOBP_RESPONSE_TO_PHEROMONE,SET,6,-0.41188,-0.0074407,0.33466,0.89079,GOBP_RESPONSE_TO_PHEROMONE,1
KEGG_MEDICUS_REFERENCE_KITLG...1,SET,11,-0.31999,-0.0078259,0.25992,0.89085,KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY,1
MCCLUNG_CREB1_TARGETS_DN,SET,51,-0.15156,-0.0079727,0.12309,0.89088,MCCLUNG_CREB1_TARGETS_DN,1
VALK_AML_CLUSTER_3,SET,27,-0.21701,-0.0083116,0.17623,0.89091,VALK_AML_CLUSTER_3,1
HP_CLEFT_UPPER_LIP,SET,126,-0.091806,-0.0075754,0.074551,0.89092,HP_CLEFT_UPPER_LIP,1
AMIT_SERUM_RESPONSE_20_MCF10A,SET,15,-0.28902,-0.0082534,0.23466,0.89095,AMIT_SERUM_RESPONSE_20_MCF10A,1
HP_LETHARGY,SET,191,-0.072985,-0.0074015,0.059257,0.89095,HP_LETHARGY,1
GOBP_PHOSPHATIDYLGLYCEROL_ME...,SET,32,-0.19646,-0.0081905,0.15948,0.89099,GOBP_PHOSPHATIDYLGLYCEROL_METABOLIC_PROCESS,1
FEVR_CTNNB1_TARGETS_UP,SET,636,-0.042877,-0.0078368,0.034798,0.89104,FEVR_CTNNB1_TARGETS_UP,1
GOBP_TELENCEPHALON_DEVELOPME...,SET,257,-0.068237,-0.0080125,0.055357,0.89114,GOBP_TELENCEPHALON_DEVELOPMENT,1
HP_ABNORMAL_MORPHOLOGY_OF_TH...8,SET,31,-0.19267,-0.0079063,0.15631,0.89114,HP_ABNORMAL_MORPHOLOGY_OF_THE_OLFACTORY_BULB,1
GOBP_POSITIVE_REGULATION_OF_...528,SET,62,-0.13735,-0.0079641,0.11142,0.89115,GOBP_POSITIVE_REGULATION_OF_NEURON_APOPTOTIC_PROCESS,1
GOBP_ALCOHOL_CATABOLIC_PROCE...,SET,32,-0.20409,-0.0085085,0.16555,0.89116,GOBP_ALCOHOL_CATABOLIC_PROCESS,1
MORI_SMALL_PRE_BII_LYMPHOCYT...1,SET,73,-0.11617,-0.0073071,0.094233,0.89117,MORI_SMALL_PRE_BII_LYMPHOCYTE_DN,1
GOBP_TETRAHYDROFOLATE_BIOSYN...,SET,6,-0.3756,-0.0067854,0.30464,0.89119,GOBP_TETRAHYDROFOLATE_BIOSYNTHETIC_PROCESS,1
GAVISH_3CA_MALIGNANT_METAPRO...21,SET,48,-0.14059,-0.0071754,0.11403,0.8912,GAVISH_3CA_MALIGNANT_METAPROGRAM_2_CELL_CYCLE_G1_S,1
HP_DERMOID_CYST,SET,6,-0.44956,-0.0081214,0.36461,0.8912,HP_DERMOID_CYST,1
GAUSSMANN_MLL_AF4_FUSION_TAR...5,SET,20,-0.24684,-0.0081384,0.20018,0.89123,GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN,1
GOBP_CAMP_MEDIATED_SIGNALING,SET,53,-0.15117,-0.0081063,0.12258,0.89126,GOBP_CAMP_MEDIATED_SIGNALING,1
GSE13547_WT_VS_ZFX_KO_BCELL_...1,SET,142,-0.085642,-0.0074987,0.069441,0.89126,GSE13547_WT_VS_ZFX_KO_BCELL_ANTI_IGM_STIM_12H_DN,1
REACTOME_PHOSPHOLIPASE_C_MED...1,SET,16,-0.28204,-0.0083179,0.22867,0.89127,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR1,1
GOBP_REGULATION_OF_INFLAMMAT...1,SET,358,-0.058492,-0.0080836,0.047425,0.89127,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE,1
GOBP_CYTOPLASMIC_SEQUESTERIN...2,SET,13,-0.2695,-0.0071651,0.2185,0.89128,GOBP_CYTOPLASMIC_SEQUESTERING_OF_PROTEIN,1
GSE9006_1MONTH_VS_4MONTH_POS...2,SET,177,-0.080087,-0.0078214,0.064925,0.8913,GSE9006_1MONTH_VS_4MONTH_POST_TYPE_1_DIABETES_DX_PBMC_UP,1
GOBP_REGULATION_OF_EPITHELIA...3,SET,14,-0.32725,-0.0090284,0.26527,0.89132,GOBP_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOBP_SEGMENT_SPECIFICATION,SET,15,-0.29266,-0.0083574,0.23722,0.89134,GOBP_SEGMENT_SPECIFICATION,1
HP_ANTERIOR_SUBCAPSULAR_CATA...,SET,6,-0.44012,-0.0079508,0.35671,0.89135,HP_ANTERIOR_SUBCAPSULAR_CATARACT,1
GSE16450_IMMATURE_VS_MATURE_...2,SET,180,-0.077529,-0.0076349,0.062836,0.89136,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP,1
DESCARTES_MAIN_FETAL_ENDOCAR...,SET,66,-0.12991,-0.007771,0.10529,0.89137,DESCARTES_MAIN_FETAL_ENDOCARDIAL_CELLS,1
MIR4321,SET,4,-0.4968,-0.0073283,0.40262,0.89138,MIR4321,1
HP_ABNORMAL_RESPONSE_TO_ACTH...,SET,6,-0.45356,-0.0081937,0.36748,0.89143,HP_ABNORMAL_RESPONSE_TO_ACTH_STIMULATION_TEST,1
HE_LIM_SUN_FETAL_LUNG_C1_MID...1,SET,14,-0.31138,-0.0085907,0.25223,0.89149,HE_LIM_SUN_FETAL_LUNG_C1_MID_AIRWAY_PROGENITOR_CELL,1
GSE7348_LPS_VS_TOLERIZED_AND...1,SET,157,-0.081185,-0.0074714,0.065744,0.89155,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_DN,1
SCHERER_PBMC_APSV_WETVAX_AGE...4,SET,156,-0.086775,-0.0079606,0.07027,0.89155,SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_50_TO_60DY_UP,1
HP_HYPERGLYCINURIA,SET,14,-0.30377,-0.0083808,0.24599,0.89156,HP_HYPERGLYCINURIA,1
GOMF_JUN_KINASE_KINASE_KINAS...,SET,9,-0.36427,-0.0080588,0.2949,0.89161,GOMF_JUN_KINASE_KINASE_KINASE_ACTIVITY,1
DESCARTES_FETAL_CEREBRUM_SKO...,SET,48,-0.16295,-0.0083167,0.13192,0.89162,DESCARTES_FETAL_CEREBRUM_SKOR2_NPSR1_POSITIVE_CELLS,1
HP_PERIODIC_PARALYSIS,SET,9,-0.37655,-0.0083307,0.30471,0.89172,HP_PERIODIC_PARALYSIS,1
MODULE_356,SET,140,-0.085768,-0.0074571,0.069402,0.89173,MODULE_356,1
GOBP_ACETYL_COA_BIOSYNTHETIC...2,SET,8,-0.39919,-0.0083266,0.32298,0.89175,GOBP_ACETYL_COA_BIOSYNTHETIC_PROCESS_FROM_PYRUVATE,1
GOBP_POSITIVE_REGULATION_OF_...378,SET,89,-0.10315,-0.0071609,0.083459,0.89176,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_PROTEIN_TRANSPORT,1
HP_ABNORMALITY_OF_THE_SENSE_...,SET,119,-0.095111,-0.0076284,0.076952,0.89176,HP_ABNORMALITY_OF_THE_SENSE_OF_SMELL,1
MIR4795_3P,SET,629,-0.042994,-0.0078165,0.034779,0.8918,MIR4795_3P,1
HP_SPERMATOCYTE_MATURATION_A...,SET,3,-0.4896,-0.0062547,0.39604,0.89181,HP_SPERMATOCYTE_MATURATION_ARREST,1
GOBP_MULTICELLULAR_ORGANISMA...2,SET,758,-0.040007,-0.0079555,0.032355,0.89186,GOBP_MULTICELLULAR_ORGANISMAL_LEVEL_HOMEOSTASIS,1
CTTTGTA_MIR524,SET,397,-0.053632,-0.0077968,0.043372,0.89187,CTTTGTA_MIR524,1
GOBP_REGULATION_OF_INFLAMMAT...2,SET,39,-0.17087,-0.0078629,0.13813,0.89196,GOBP_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GSE22025_PROGESTERONE_VS_TGF...1,SET,181,-0.08009,-0.0079088,0.064736,0.89198,GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN,1
GOBP_MODIFIED_AMINO_ACID_TRA...,SET,38,-0.17927,-0.0081431,0.14485,0.89207,GOBP_MODIFIED_AMINO_ACID_TRANSPORT,1
HP_THIN_BONY_CORTEX,SET,18,-0.25243,-0.007896,0.2039,0.89213,HP_THIN_BONY_CORTEX,1
GSE17721_CTRL_VS_LPS_12H_BMD...2,SET,173,-0.076195,-0.0073575,0.061542,0.89215,GSE17721_CTRL_VS_LPS_12H_BMDC_UP,1
GSE38697_LIGHT_ZONE_VS_DARK_...2,SET,154,-0.080807,-0.0073658,0.065244,0.89223,GSE38697_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP,1
GOBP_REGULATION_OF_RESPONSE_...13,SET,14,-0.25452,-0.0070221,0.20548,0.89225,GOBP_REGULATION_OF_RESPONSE_TO_TYPE_II_INTERFERON,1
MCCLUNG_COCAINE_REWARD_5D,SET,68,-0.12779,-0.0077587,0.10316,0.89227,MCCLUNG_COCAINE_REWARD_5D,1
HP_ABNORMAL_CIRCULATING_NUCL...,SET,42,-0.15346,-0.0073276,0.12388,0.89227,HP_ABNORMAL_CIRCULATING_NUCLEOBASE_CONCENTRATION,1
GOBP_POSITIVE_REGULATION_OF_...471,SET,6,-0.41803,-0.0075518,0.33739,0.89232,GOBP_POSITIVE_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,1
MIR1537_3P,SET,9,-0.40711,-0.0090067,0.32857,0.89233,MIR1537_3P,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...2,SET,6,-0.47132,-0.0085145,0.38037,0.89234,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,1
WINNEPENNINCKX_MELANOMA_META...2,SET,151,-0.079024,-0.0071334,0.063768,0.89236,WINNEPENNINCKX_MELANOMA_METASTASIS_UP,1
GOBP_AMINE_BIOSYNTHETIC_PROC...,SET,35,-0.17463,-0.0076133,0.14091,0.89237,GOBP_AMINE_BIOSYNTHETIC_PROCESS,1
HP_SINGLE_TRANSVERSE_PALMAR_...,SET,179,-0.075722,-0.0074364,0.061098,0.89238,HP_SINGLE_TRANSVERSE_PALMAR_CREASE,1
GOBP_MITOTIC_CELL_CYCLE_PHAS...,SET,403,-0.051629,-0.0075609,0.041658,0.89239,GOBP_MITOTIC_CELL_CYCLE_PHASE_TRANSITION,1
GOBP_NEGATIVE_REGULATION_OF_...407,SET,30,-0.18732,-0.007562,0.15113,0.89241,GOBP_NEGATIVE_REGULATION_OF_MONONUCLEAR_CELL_MIGRATION,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...3,SET,5,-0.50086,-0.00826,0.40407,0.89242,KEGG_MEDICUS_PATHOGEN_HTLV_1_TAX_TO_E47_MEDIATED_TRANSCRIPTION,1
REACTOME_RNA_POLYMERASE_I_TR...3,SET,26,-0.17188,-0.0064603,0.13866,0.89243,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_TERMINATION,1
HP_ABNORMAL_UTERINE_CERVIX_M...,SET,11,-0.37385,-0.0091432,0.3014,0.89257,HP_ABNORMAL_UTERINE_CERVIX_MORPHOLOGY,1
REACTOME_DISEASES_ASSOCIATED...5,SET,9,-0.41925,-0.0092753,0.33793,0.89262,REACTOME_DISEASES_ASSOCIATED_WITH_SURFACTANT_METABOLISM,1
GOBP_PYRIMIDINE_CONTAINING_C...3,SET,80,-0.12137,-0.0079899,0.097827,0.89262,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GSE40443_INDUCED_VS_TOTAL_TR...2,SET,181,-0.078006,-0.0077029,0.062869,0.89265,GSE40443_INDUCED_VS_TOTAL_TREG_UP,1
GSE3982_EFF_MEMORY_CD4_TCELL...1,SET,172,-0.079765,-0.0076802,0.064276,0.89269,GSE3982_EFF_MEMORY_CD4_TCELL_VS_NKCELL_DN,1
GOBP_REGULATION_OF_GUANYL_NU...,SET,6,-0.46271,-0.0083589,0.37283,0.8927,GOBP_REGULATION_OF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
HP_INTRAHEPATIC_BILIARY_ATRE...,SET,7,-0.36444,-0.0071111,0.29357,0.89277,HP_INTRAHEPATIC_BILIARY_ATRESIA,1
HP_DYSOSTOSIS_MULTIPLEX,SET,21,-0.2183,-0.0073747,0.1758,0.89283,HP_DYSOSTOSIS_MULTIPLEX,1
GOMF_POLYPEPTIDE_N_ACETYLGAL...,SET,17,-0.28889,-0.0087822,0.23262,0.89286,GOMF_POLYPEPTIDE_N_ACETYLGALACTOSAMINYLTRANSFERASE_ACTIVITY,1
HP_INCREASED_THETA_FREQUENCY...,SET,10,-0.35253,-0.0082208,0.28385,0.89287,HP_INCREASED_THETA_FREQUENCY_ACTIVITY_IN_EEG,1
GSE9650_NAIVE_VS_EXHAUSTED_C...1,SET,176,-0.082557,-0.0080401,0.066466,0.89289,GSE9650_NAIVE_VS_EXHAUSTED_CD8_TCELL_DN,1
REACTOME_IRS_MEDIATED_SIGNAL...,SET,47,-0.15527,-0.0078419,0.12499,0.89293,REACTOME_IRS_MEDIATED_SIGNALLING,1
GOBP_NEGATIVE_REGULATION_OF_...93,SET,8,-0.40452,-0.0084378,0.32562,0.89293,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_EXTRAVASATION,1
GOBP_NEGATIVE_REGULATION_OF_...697,SET,11,-0.34241,-0.0083743,0.27561,0.89294,GOBP_NEGATIVE_REGULATION_OF_VASOCONSTRICTION,1
TMTCGCGANR_UNKNOWN,SET,148,-0.08409,-0.0075155,0.067684,0.89295,TMTCGCGANR_UNKNOWN,1
HP_ABNORMAL_BASAL_GANGLIA_MO...,SET,158,-0.081744,-0.0075466,0.065786,0.89298,HP_ABNORMAL_BASAL_GANGLIA_MORPHOLOGY,1
GSE21379_TFH_VS_NON_TFH_CD4_...2,SET,178,-0.079612,-0.0077968,0.064068,0.89299,GSE21379_TFH_VS_NON_TFH_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...92,SET,13,-0.28849,-0.00767,0.23212,0.89304,GOBP_POSITIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...2,SET,11,-0.31785,-0.0077736,0.25571,0.89306,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339,1
REACTOME_CELL_CELL_COMMUNICA...,SET,139,-0.094295,-0.0081694,0.075841,0.89312,REACTOME_CELL_CELL_COMMUNICATION,1
KEGG_MEDICUS_REFERENCE_CDC25...,SET,9,-0.28769,-0.0063647,0.2313,0.8932,KEGG_MEDICUS_REFERENCE_CDC25_CELL_CYCLE_G2_M,1
HP_MYOPIA,SET,364,-0.055294,-0.0077042,0.044447,0.89325,HP_MYOPIA,1
REACTOME_TRANSCRIPTIONAL_AND...,SET,42,-0.16744,-0.0079949,0.13458,0.89326,REACTOME_TRANSCRIPTIONAL_AND_POST_TRANSLATIONAL_REGULATION_OF_MITF_M_EXPRESSION_AND_ACTIVITY,1
HELLER_SILENCED_BY_METHYLATI...1,SET,100,-0.11313,-0.0083223,0.090911,0.89332,HELLER_SILENCED_BY_METHYLATION_DN,1
MODULE_401,SET,16,-0.28618,-0.0084401,0.22996,0.89333,MODULE_401,1
GSE6259_33D1_POS_DC_VS_BCELL...1,SET,133,-0.088703,-0.0075184,0.071274,0.89334,GSE6259_33D1_POS_DC_VS_BCELL_DN,1
GOBP_SUBSTRATE_DEPENDENT_CEL...1,SET,23,-0.22467,-0.0079429,0.18052,0.89335,GOBP_SUBSTRATE_DEPENDENT_CELL_MIGRATION,1
MIR558,SET,106,-0.10277,-0.0077821,0.08257,0.89336,MIR558,1
LET_7A_5P_LET_7C_5P_LET_7E_5P,SET,360,-0.056765,-0.0078664,0.045594,0.89343,LET_7A_5P_LET_7C_5P_LET_7E_5P,1
HP_POOR_GROSS_MOTOR_COORDINA...,SET,12,-0.32668,-0.0083448,0.26237,0.89345,HP_POOR_GROSS_MOTOR_COORDINATION,1
HP_APLASTIC_CLAVICLE,SET,16,-0.22856,-0.0067409,0.18356,0.89346,HP_APLASTIC_CLAVICLE,1
HP_ABNORMALITY_OF_THE_CURVAT...,SET,305,-0.059264,-0.0075709,0.047591,0.89348,HP_ABNORMALITY_OF_THE_CURVATURE_OF_THE_CORNEA,1
MIR3180_5P,SET,289,-0.062046,-0.007719,0.049817,0.89351,MIR3180_5P,1
GOBP_REGULATION_OF_CELL_GROW...1,SET,354,-0.057019,-0.0078368,0.045782,0.89351,GOBP_REGULATION_OF_CELL_GROWTH,1
GOBP_WNT_SIGNALING_PATHWAY_C...,SET,5,-0.58011,-0.009567,0.46551,0.89364,GOBP_WNT_SIGNALING_PATHWAY_CALCIUM_MODULATING_PATHWAY,1
FERRARI_RESPONSE_TO_FENRETIN...1,SET,5,-0.55867,-0.0092135,0.44825,0.89367,FERRARI_RESPONSE_TO_FENRETINIDE_DN,1
GOMF_BILE_ACID_TRANSMEMBRANE...,SET,20,-0.25506,-0.0084092,0.20461,0.89371,GOMF_BILE_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GSE7509_UNSTIM_VS_IFNA_STIM_...2,SET,169,-0.077437,-0.0073914,0.062121,0.89371,GSE7509_UNSTIM_VS_IFNA_STIM_IMMATURE_DC_UP,1
GSE41867_DAY15_EFFECTOR_VS_D...3,SET,154,-0.08246,-0.0075165,0.066133,0.89377,GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_DN,1
REACTOME_COSTIMULATION_BY_TH...,SET,62,-0.14173,-0.008218,0.11366,0.89379,REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY,1
GSE28449_WT_VS_LRF_KO_GERMIN...2,SET,174,-0.082679,-0.0080065,0.06628,0.89387,GSE28449_WT_VS_LRF_KO_GERMINAL_CENTER_BCELL_UP,1
HP_PREMATURE_OVARIAN_INSUFFI...,SET,61,-0.12672,-0.0072884,0.10156,0.89392,HP_PREMATURE_OVARIAN_INSUFFICIENCY,1
GOBP_PYRIMIDINE_NUCLEOTIDE_M...,SET,49,-0.14884,-0.0076748,0.11922,0.89405,GOBP_PYRIMIDINE_NUCLEOTIDE_METABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_CO...1,SET,10,-0.35578,-0.0082968,0.28494,0.89409,GOBP_CELLULAR_RESPONSE_TO_COCAINE,1
GSE21670_STAT3_KO_VS_WT_CD4_...5,SET,173,-0.076117,-0.00735,0.06096,0.89409,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_TGFB_IL6_TREATED_UP,1
LEE_LIVER_CANCER_DENA_UP,SET,56,-0.15089,-0.0083162,0.12084,0.8941,LEE_LIVER_CANCER_DENA_UP,1
GSE16451_CTRL_VS_WEST_EQUINE...3,SET,182,-0.077312,-0.0076553,0.061914,0.8941,GSE16451_CTRL_VS_WEST_EQUINE_ENC_VIRUS_MATURE_NEURON_CELL_LINE_DN,1
MODULE_175,SET,52,-0.14933,-0.007932,0.11958,0.89412,MODULE_175,1
BERGER_MBD2_TARGETS,SET,4,-0.62916,-0.0092808,0.50344,0.89429,BERGER_MBD2_TARGETS,1
HP_HORNER_SYNDROME,SET,9,-0.42775,-0.0094633,0.34222,0.89433,HP_HORNER_SYNDROME,1
GSE46606_UNSTIM_VS_CD40L_IL2...14,SET,174,-0.080741,-0.0078189,0.064592,0.89435,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP,1
GCM_DPF2,SET,27,-0.18191,-0.0069674,0.14551,0.89438,GCM_DPF2,1
GOBP_NEGATIVE_REGULATION_OF_...134,SET,5,-0.53092,-0.0087557,0.42455,0.89444,GOBP_NEGATIVE_REGULATION_OF_CGMP_MEDIATED_SIGNALING,1
GSE40274_FOXP3_VS_FOXP3_AND_...2,SET,184,-0.078112,-0.0077765,0.062464,0.89444,GSE40274_FOXP3_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
MIR6855_3P,SET,45,-0.15418,-0.0076196,0.12328,0.89445,MIR6855_3P,1
GOBP_LENS_DEVELOPMENT_IN_CAM...,SET,79,-0.13053,-0.0085396,0.10435,0.89451,GOBP_LENS_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
GSE11961_UNSTIM_VS_ANTI_IGM_...2,SET,182,-0.07839,-0.007762,0.062658,0.89454,GSE11961_UNSTIM_VS_ANTI_IGM_AND_CD40_STIM_6H_FOLLICULAR_BCELL_UP,1
GOBP_RESPONSE_TO_METAL_ION,SET,322,-0.06116,-0.0080242,0.048875,0.89459,GOBP_RESPONSE_TO_METAL_ION,1
GOMF_MONOATOMIC_ANION_TRANSM...,SET,131,-0.098286,-0.0082682,0.078534,0.89462,GOMF_MONOATOMIC_ANION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_PHOTOPSIA,SET,90,-0.11044,-0.0077094,0.088243,0.89462,HP_PHOTOPSIA,1
HP_VAGINAL_NEOPLASM,SET,8,-0.47591,-0.0099269,0.38024,0.89463,HP_VAGINAL_NEOPLASM,1
RRCCGTTA_UNKNOWN,SET,79,-0.11864,-0.0077613,0.094769,0.89468,RRCCGTTA_UNKNOWN,1
GSE45365_WT_VS_IFNAR_KO_CD8A...3,SET,186,-0.074922,-0.0074989,0.059849,0.89468,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_UP,1
HAY_BONE_MARROW_CD8_T_CELL,SET,61,-0.13869,-0.0079766,0.11077,0.89471,HAY_BONE_MARROW_CD8_T_CELL,1
GOBP_CENTROSOME_DUPLICATION,SET,71,-0.11914,-0.0073906,0.095145,0.89474,GOBP_CENTROSOME_DUPLICATION,1
HP_OVAL_FACE,SET,15,-0.27113,-0.0077426,0.21651,0.89475,HP_OVAL_FACE,1
REACTOME_ACTIVATION_OF_RAC1,SET,11,-0.30824,-0.0075387,0.24614,0.89476,REACTOME_ACTIVATION_OF_RAC1,1
REACTOME_LATE_SARS_COV_2_INF...,SET,66,-0.12888,-0.0077096,0.10292,0.89477,REACTOME_LATE_SARS_COV_2_INFECTION_EVENTS,1
GOBP_ESTABLISHMENT_OF_MITOCH...2,SET,22,-0.23064,-0.0079749,0.18416,0.89478,GOBP_ESTABLISHMENT_OF_MITOCHONDRION_LOCALIZATION_MICROTUBULE_MEDIATED,1
HP_ABNORMAL_LIBIDO,SET,37,-0.17697,-0.0079325,0.14131,0.89478,HP_ABNORMAL_LIBIDO,1
GRAHAM_CML_DIVIDING_VS_NORMA...2,SET,9,-0.33915,-0.0075031,0.27073,0.89483,GRAHAM_CML_DIVIDING_VS_NORMAL_DIVIDING_UP,1
HP_CERVICAL_SPINE_INSTABILITY,SET,8,-0.4288,-0.0089442,0.34222,0.89489,HP_CERVICAL_SPINE_INSTABILITY,1
GSE26928_NAIVE_VS_CENT_MEMOR...2,SET,163,-0.080128,-0.0075125,0.063947,0.8949,GSE26928_NAIVE_VS_CENT_MEMORY_CD4_TCELL_UP,1
GSE37416_0H_VS_6H_F_TULARENS...2,SET,166,-0.081296,-0.0076912,0.064876,0.89491,GSE37416_0H_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
HP_PERIPHERAL_VISUAL_FIELD_L...,SET,92,-0.11062,-0.007807,0.088273,0.89492,HP_PERIPHERAL_VISUAL_FIELD_LOSS,1
HE_LIM_SUN_FETAL_LUNG_C2_NON...,SET,16,-0.25438,-0.0075022,0.20295,0.89496,HE_LIM_SUN_FETAL_LUNG_C2_NON_CLASSICAL_MONOCYTE,1
GOCC_MANNOSYLTRANSFERASE_COM...,SET,4,-0.40244,-0.0059364,0.32106,0.89498,GOCC_MANNOSYLTRANSFERASE_COMPLEX,1
GOCC_RIBBON_SYNAPSE,SET,15,-0.29075,-0.0083028,0.23193,0.895,GOCC_RIBBON_SYNAPSE,1
HP_HYDROXYPROLINEMIA,SET,5,-0.58859,-0.0097068,0.46951,0.895,HP_HYDROXYPROLINEMIA,1
REACTOME_SEMA4D_MEDIATED_INH...,SET,8,-0.40272,-0.0084003,0.32123,0.89501,REACTOME_SEMA4D_MEDIATED_INHIBITION_OF_CELL_ATTACHMENT_AND_MIGRATION,1
MIR4445_5P,SET,85,-0.11283,-0.0076552,0.08999,0.89503,MIR4445_5P,1
OCT1_Q5_01,SET,224,-0.07437,-0.0081601,0.059316,0.89503,OCT1_Q5_01,1
GSE12392_WT_VS_IFNB_KO_CD8A_...4,SET,176,-0.076968,-0.0074958,0.061387,0.89504,GSE12392_WT_VS_IFNB_KO_CD8A_POS_SPLEEN_DC_UP,1
HE_LIM_SUN_FETAL_LUNG_C1_LAT...2,SET,98,-0.11571,-0.0084268,0.092286,0.89504,HE_LIM_SUN_FETAL_LUNG_C1_LATE_BASAL_CELL,1
GOBP_REGULATION_OF_ORGANELLE...3,SET,8,-0.38546,-0.0080403,0.30738,0.89507,GOBP_REGULATION_OF_ORGANELLE_TRANSPORT_ALONG_MICROTUBULE,1
HP_ECTROPION,SET,58,-0.12209,-0.0068476,0.097352,0.89509,HP_ECTROPION,1
ATAGGAA_MIR202,SET,95,-0.11163,-0.0080046,0.089001,0.89511,ATAGGAA_MIR202,1
GOBP_POSITIVE_REGULATION_OF_...391,SET,4,-0.53904,-0.0079514,0.42978,0.89511,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_APOPTOTIC_PROCESS,1
REACTOME_DOPAMINE_RECEPTORS,SET,5,-0.55153,-0.0090957,0.43967,0.89515,REACTOME_DOPAMINE_RECEPTORS,1
GOMF_DOPAMINE_NEUROTRANSMITT...,SET,5,-0.55153,-0.0090957,0.43967,0.89515,GOMF_DOPAMINE_NEUROTRANSMITTER_RECEPTOR_ACTIVITY,1
MIR4289,SET,63,-0.13394,-0.0078283,0.10676,0.89518,MIR4289,1
GSE22886_NEUTROPHIL_VS_DC_DN,SET,177,-0.075543,-0.0073776,0.060212,0.89518,GSE22886_NEUTROPHIL_VS_DC_DN,1
HP_AGENESIS_OF_LATERAL_INCIS...,SET,23,-0.23108,-0.0081695,0.18417,0.8952,HP_AGENESIS_OF_LATERAL_INCISOR,1
HP_PARATHYROID_ADENOMA,SET,15,-0.29425,-0.0084029,0.2345,0.89522,HP_PARATHYROID_ADENOMA,1
GOBP_T_CELL_HOMEOSTASIS,SET,44,-0.15942,-0.0077908,0.12704,0.89523,GOBP_T_CELL_HOMEOSTASIS,1
HP_HYPOPLASIA_OF_THE_VENTRAL...,SET,6,-0.46721,-0.0084403,0.3722,0.8953,HP_HYPOPLASIA_OF_THE_VENTRAL_PONS,1
SENESE_HDAC1_TARGETS_DN,SET,221,-0.073638,-0.0080263,0.058654,0.89534,SENESE_HDAC1_TARGETS_DN,1
HP_MICROPHTHALMIA,SET,239,-0.067915,-0.0076942,0.054096,0.89534,HP_MICROPHTHALMIA,1
chr3p21,SET,185,-0.17669,-0.017638,0.14071,0.89537,chr3p21,1
GOBP_HRI_MEDIATED_SIGNALING,SET,5,-0.42707,-0.0070431,0.34011,0.89538,GOBP_HRI_MEDIATED_SIGNALING,1
HALLMARK_APICAL_JUNCTION,SET,183,-0.080389,-0.0079816,0.064,0.89545,HALLMARK_APICAL_JUNCTION,1
GOBP_NEGATIVE_REGULATION_OF_...284,SET,5,-0.49894,-0.0082284,0.39721,0.89546,GOBP_NEGATIVE_REGULATION_OF_HYDROGEN_PEROXIDE_METABOLIC_PROCESS,1
GOCC_NEURON_PROJECTION,SET,1215,-0.03251,-0.0080777,0.025876,0.8955,GOCC_NEURON_PROJECTION,1
GOMF_GABA_A_RECEPTOR_ACTIVITY,SET,16,-0.33365,-0.0098402,0.26552,0.89554,GOMF_GABA_A_RECEPTOR_ACTIVITY,1
GSE15624_CTRL_VS_6H_HALOFUGI...1,SET,142,-0.082505,-0.007224,0.065652,0.89556,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_DN,1
MODULE_426,SET,81,-0.11809,-0.0078224,0.093956,0.89559,MODULE_426,1
HP_FACIAL_MYOKYMIA,SET,7,-0.34507,-0.0067331,0.27455,0.89559,HP_FACIAL_MYOKYMIA,1
GOBP_SPERMATID_DIFFERENTIATI...,SET,190,-0.074615,-0.0075472,0.05936,0.89561,GOBP_SPERMATID_DIFFERENTIATION,1
HE_LIM_SUN_FETAL_LUNG_C7_TM4...1,SET,51,-0.15885,-0.0083564,0.12637,0.89563,HE_LIM_SUN_FETAL_LUNG_C7_TM4SF4_POS_CHODL_POS_NEURON_CELL,1
chr3p23,SET,3,-0.73783,-0.0094259,0.58667,0.89574,chr3p23,1
HP_SUBCORTICAL_HETEROTOPIA,SET,11,-0.29323,-0.0071717,0.23315,0.89574,HP_SUBCORTICAL_HETEROTOPIA,1
REACTOME_ERCC6_CSB_AND_EHMT2...,SET,15,-0.24872,-0.0071025,0.19774,0.89576,REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION,1
GOMF_PEPTIDE_HORMONE_RECEPTO...,SET,19,-0.26082,-0.0083817,0.20736,0.89576,GOMF_PEPTIDE_HORMONE_RECEPTOR_BINDING,1
HP_ABNORMAL_NIPPLE_MORPHOLOGY,SET,209,-0.070394,-0.0074639,0.055964,0.89577,HP_ABNORMAL_NIPPLE_MORPHOLOGY,1
HP_ABDUCENS_PALSY,SET,9,-0.37745,-0.0083505,0.30004,0.8958,HP_ABDUCENS_PALSY,1
GOBP_MUSCLE_STRUCTURE_DEVELO...,SET,639,-0.043746,-0.0080139,0.034771,0.89582,GOBP_MUSCLE_STRUCTURE_DEVELOPMENT,1
DESCARTES_FETAL_PANCREAS_DUC...,SET,96,-0.11751,-0.0084708,0.093374,0.89589,DESCARTES_FETAL_PANCREAS_DUCTAL_CELLS,1
MORF_RAB1A,SET,173,-0.074388,-0.0071831,0.059102,0.89591,MORF_RAB1A,1
REACTOME_P75NTR_NEGATIVELY_R...,SET,6,-0.42499,-0.0076775,0.33765,0.89592,REACTOME_P75NTR_NEGATIVELY_REGULATES_CELL_CYCLE_VIA_SC1,1
MIR1264,SET,109,-0.098877,-0.007592,0.078548,0.89594,MIR1264,1
MIR6820_5P,SET,11,-0.31532,-0.0077118,0.25047,0.89596,MIR6820_5P,1
chr9q34,SET,182,-0.15377,-0.015226,0.12213,0.89599,chr9q34,1
GOBP_NAD_BIOSYNTHESIS_VIA_NI...,SET,9,-0.36516,-0.0080786,0.29002,0.89599,GOBP_NAD_BIOSYNTHESIS_VIA_NICOTINAMIDE_RIBOSIDE_SALVAGE_PATHWAY,1
GOMF_HISTONE_H3K4ME_H3K4ME2_...,SET,2,-0.83032,-0.0086612,0.65941,0.89601,GOMF_HISTONE_H3K4ME_H3K4ME2_H3K4ME3_DEMETHYLASE_ACTIVITY,1
GSE2770_UNTREATED_VS_IL4_TRE...3,SET,174,-0.076233,-0.0073823,0.060536,0.89603,GSE2770_UNTREATED_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN,1
MIR1303,SET,189,-0.076404,-0.007708,0.060665,0.89606,MIR1303,1
GOBP_POSITIVE_REGULATION_OF_...705,SET,4,-0.56229,-0.0082943,0.44643,0.89607,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_GROWTH,1
GSE35685_CD34POS_CD38NEG_VS_...2,SET,172,-0.07909,-0.0076153,0.062777,0.89613,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10NEG_CD62LPOS_BONE_MARROW_UP,1
GSE32423_IL7_VS_IL4_MEMORY_C...1,SET,181,-0.075044,-0.0074105,0.059565,0.89614,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_DN,1
CAIRO_PML_TARGETS_BOUND_BY_M...2,SET,22,-0.22787,-0.0078792,0.18083,0.89618,CAIRO_PML_TARGETS_BOUND_BY_MYC_UP,1
GSE6259_33D1_POS_DC_VS_CD8_T...1,SET,112,-0.10112,-0.0078693,0.080233,0.8962,GSE6259_33D1_POS_DC_VS_CD8_TCELL_DN,1
GSE7460_CTRL_VS_TGFB_TREATED...8,SET,181,-0.08175,-0.0080726,0.064868,0.8962,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_UP,1
GSE7596_AKT_TRANSD_VS_CTRL_C...1,SET,109,-0.10556,-0.0081048,0.083734,0.89627,GSE7596_AKT_TRANSD_VS_CTRL_CD4_TCONV_WITH_TGFB_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_PUL...1,SET,202,-0.081127,-0.0084582,0.064342,0.89631,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL,1
GOBP_GLAND_DEVELOPMENT,SET,427,-0.055699,-0.0083906,0.044163,0.89637,GOBP_GLAND_DEVELOPMENT,1
PID_CXCR4_PATHWAY,SET,95,-0.10973,-0.0078688,0.086993,0.89641,PID_CXCR4_PATHWAY,1
GSE37416_0H_VS_3H_F_TULARENS...2,SET,179,-0.077667,-0.0076274,0.061572,0.89641,GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GSE37301_HEMATOPOIETIC_STEM_...5,SET,162,-0.086101,-0.0080479,0.06825,0.89644,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_DN,1
GOBP_MEMBRANE_REPOLARIZATION...1,SET,26,-0.23339,-0.008772,0.18499,0.89645,GOBP_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,1
ONO_AML1_TARGETS_DN,SET,37,-0.19805,-0.0088772,0.15697,0.89646,ONO_AML1_TARGETS_DN,1
HP_URETHRAL_STRICTURE,SET,16,-0.27191,-0.0080193,0.21548,0.89649,HP_URETHRAL_STRICTURE,1
GOBP_NEGATIVE_REGULATION_OF_...432,SET,10,-0.32214,-0.0075122,0.25529,0.8965,GOBP_NEGATIVE_REGULATION_OF_NATURAL_KILLER_CELL_ACTIVATION,1
GOMF_SERINE_TYPE_EXOPEPTIDAS...,SET,12,-0.29186,-0.0074553,0.23129,0.8965,GOMF_SERINE_TYPE_EXOPEPTIDASE_ACTIVITY,1
MIR552_3P,SET,53,-0.14504,-0.0077772,0.11486,0.89665,MIR552_3P,1
CCTGTGA_MIR513,SET,116,-0.098532,-0.0078032,0.078021,0.89668,CCTGTGA_MIR513,1
HP_BRAIN_STEM_COMPRESSION,SET,14,-0.28402,-0.0078359,0.22488,0.89669,HP_BRAIN_STEM_COMPRESSION,1
BIOCARTA_CASPASE_PATHWAY,SET,21,-0.23152,-0.0078216,0.1833,0.89672,BIOCARTA_CASPASE_PATHWAY,1
GOBP_METANEPHROS_MORPHOGENES...,SET,30,-0.22455,-0.0090648,0.17774,0.89677,GOBP_METANEPHROS_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...370,SET,12,-0.32271,-0.0082434,0.25543,0.89677,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CYTOKINE_PRODUCTION,1
GOBP_PYRIMIDINE_NUCLEOSIDE_T...2,SET,22,-0.23857,-0.0082491,0.18881,0.89679,GOBP_PYRIMIDINE_NUCLEOSIDE_TRIPHOSPHATE_METABOLIC_PROCESS,1
GSE27241_CTRL_VS_DIGOXIN_TRE...4,SET,175,-0.077527,-0.0075289,0.061356,0.8968,GSE27241_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP,1
MCMURRAY_TP53_HRAS_COOPERATI...1,SET,64,-0.14808,-0.0087232,0.11719,0.89681,MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...2,SET,6,-0.46876,-0.0084682,0.37094,0.89682,GOBP_CENTRAL_NERVOUS_SYSTEM_MATURATION,1
GOBP_NEGATIVE_REGULATION_OF_...681,SET,8,-0.43353,-0.0090428,0.34304,0.89683,GOBP_NEGATIVE_REGULATION_OF_T_HELPER_1_TYPE_IMMUNE_RESPONSE,1
HP_ABNORMAL_CIRCULATING_VITA...1,SET,17,-0.25884,-0.0078684,0.20474,0.89691,HP_ABNORMAL_CIRCULATING_VITAMIN_A_CONCENTRATION,1
HP_ABNORMAL_CONJUGATE_EYE_MO...,SET,1020,-0.033322,-0.007629,0.026358,0.89691,HP_ABNORMAL_CONJUGATE_EYE_MOVEMENT,1
GOBP_NUCLEOSIDE_BISPHOSPHATE...1,SET,51,-0.15107,-0.0079468,0.11948,0.89694,GOBP_NUCLEOSIDE_BISPHOSPHATE_BIOSYNTHETIC_PROCESS,1
WP_GPCRS_OTHER,SET,86,-0.12443,-0.0084915,0.098408,0.89695,WP_GPCRS_OTHER,1
MIR3180_MIR3180_3P,SET,20,-0.24852,-0.0081938,0.19652,0.89699,MIR3180_MIR3180_3P,1
HP_APLASIA_OF_THE_OLFACTORY_...,SET,13,-0.30938,-0.0082253,0.24455,0.89708,HP_APLASIA_OF_THE_OLFACTORY_BULB,1
HP_ABNORMALITY_OF_THE_RADIAL...,SET,46,-0.15519,-0.0077543,0.12266,0.89709,HP_ABNORMALITY_OF_THE_RADIAL_HEAD,1
GOBP_REGULATION_OF_CELL_PROL...2,SET,6,-0.39059,-0.0070561,0.3087,0.8971,GOBP_REGULATION_OF_CELL_PROLIFERATION_IN_BONE_MARROW,1
GOMF_EXTRACELLULAR_MATRIX_PR...,SET,6,-0.50605,-0.009142,0.39987,0.89715,GOMF_EXTRACELLULAR_MATRIX_PROTEIN_BINDING,1
HP_LEUKONYCHIA,SET,14,-0.29784,-0.0082172,0.23535,0.89715,HP_LEUKONYCHIA,1
HP_PARTIAL_ATRIOVENTRICULAR_...,SET,5,-0.4371,-0.0072086,0.34538,0.89716,HP_PARTIAL_ATRIOVENTRICULAR_CANAL_DEFECT,1
GSE339_CD4POS_VS_CD8POS_DC_UP,SET,186,-0.078901,-0.0078971,0.062324,0.89723,GSE339_CD4POS_VS_CD8POS_DC_UP,1
GSE2770_UNTREATED_VS_IL12_TR...2,SET,178,-0.079505,-0.0077863,0.062799,0.89724,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_2H_UP,1
GOBP_GLYCOLIPID_CATABOLIC_PR...,SET,20,-0.24524,-0.0080855,0.1937,0.89725,GOBP_GLYCOLIPID_CATABOLIC_PROCESS,1
HP_HEPATOSPLENOMEGALY,SET,152,-0.08804,-0.0079732,0.06951,0.89734,HP_HEPATOSPLENOMEGALY,1
MIR548F_3P,SET,434,-0.051681,-0.0078474,0.040801,0.89736,MIR548F_3P,1
GOBP_NEGATIVE_REGULATION_OF_...571,SET,92,-0.11515,-0.0081264,0.090894,0.89738,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_WOUNDING,1
WEBER_METHYLATED_HCP_IN_SPER...1,SET,28,-0.19652,-0.0076648,0.15512,0.89739,WEBER_METHYLATED_HCP_IN_SPERM_DN,1
HP_OPEN_OPERCULUM,SET,6,-0.48614,-0.0087823,0.38374,0.89739,HP_OPEN_OPERCULUM,1
HP_ABNORMAL_THORACIC_SPINE_M...,SET,94,-0.10379,-0.0074037,0.081918,0.89742,HP_ABNORMAL_THORACIC_SPINE_MORPHOLOGY,1
GOBP_NEGATIVE_REGULATION_OF_...103,SET,272,-0.067829,-0.0081903,0.053531,0.89743,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION,1
VALK_AML_CLUSTER_5,SET,28,-0.2036,-0.007941,0.16066,0.89747,VALK_AML_CLUSTER_5,1
STREICHER_LSM1_TARGETS_DN,SET,18,-0.25783,-0.0080649,0.20342,0.8975,STREICHER_LSM1_TARGETS_DN,1
MAHADEVAN_IMATINIB_RESISTANC...1,SET,19,-0.29176,-0.009376,0.23018,0.89751,MAHADEVAN_IMATINIB_RESISTANCE_DN,1
HP_SHORT_TIBIA,SET,23,-0.2254,-0.0079685,0.1777,0.89766,HP_SHORT_TIBIA,1
REACTOME_TP53_REGULATES_META...,SET,77,-0.1177,-0.0076023,0.092769,0.89772,REACTOME_TP53_REGULATES_METABOLIC_GENES,1
GOMF_MYOSIN_LIGHT_CHAIN_BIND...,SET,8,-0.40684,-0.0084862,0.32063,0.89775,GOMF_MYOSIN_LIGHT_CHAIN_BINDING,1
GSE16385_MONOCYTE_VS_MACROPH...1,SET,171,-0.081445,-0.0078194,0.06418,0.89777,GSE16385_MONOCYTE_VS_MACROPHAGE_DN,1
HP_EXOPHORIA,SET,6,-0.41835,-0.0075575,0.32961,0.89781,HP_EXOPHORIA,1
GSE2706_2H_VS_8H_LPS_STIM_DC...1,SET,162,-0.085159,-0.0079598,0.067089,0.89783,GSE2706_2H_VS_8H_LPS_STIM_DC_DN,1
GSE7852_LN_VS_FAT_TCONV_DN,SET,176,-0.084379,-0.0082175,0.066476,0.89783,GSE7852_LN_VS_FAT_TCONV_DN,1
GOBP_CELLULAR_CATABOLIC_PROC...,SET,1035,-0.033704,-0.0077698,0.026549,0.89786,GOBP_CELLULAR_CATABOLIC_PROCESS,1
DUNNE_TARGETS_OF_AML1_MTG8_F...1,SET,17,-0.26102,-0.0079347,0.2056,0.89787,DUNNE_TARGETS_OF_AML1_MTG8_FUSION_DN,1
MIR6890_3P,SET,82,-0.12121,-0.0080783,0.095477,0.89787,MIR6890_3P,1
REACTOME_RNA_POLYMERASE_II_P...,SET,72,-0.10806,-0.0067502,0.085114,0.89788,REACTOME_RNA_POLYMERASE_II_PRE_TRANSCRIPTION_EVENTS,1
GSE6259_BCELL_VS_CD4_TCELL_DN,SET,167,-0.080985,-0.0076846,0.063764,0.89796,GSE6259_BCELL_VS_CD4_TCELL_DN,1
GOBP_HYPEROSMOTIC_RESPONSE,SET,25,-0.22056,-0.0081291,0.17365,0.89797,GOBP_HYPEROSMOTIC_RESPONSE,1
GSE17721_0.5H_VS_24H_LPS_BMD...1,SET,183,-0.077042,-0.0076492,0.060647,0.89801,GSE17721_0.5H_VS_24H_LPS_BMDC_DN,1
DER_IFN_BETA_RESPONSE_DN,SET,6,-0.46037,-0.0083167,0.36235,0.89804,DER_IFN_BETA_RESPONSE_DN,1
REACTOME_REPRODUCTION,SET,93,-0.10649,-0.0075557,0.083801,0.89807,REACTOME_REPRODUCTION,1
HP_BITEMPORAL_HEMIANOPIA,SET,16,-0.25337,-0.0074726,0.19938,0.89809,HP_BITEMPORAL_HEMIANOPIA,1
CUI_DEVELOPING_HEART_C4_ENDO...,SET,135,-0.101,-0.0086242,0.079476,0.89809,CUI_DEVELOPING_HEART_C4_ENDOTHELIAL_CELL,1
GSE11961_FOLLICULAR_BCELL_VS...10,SET,182,-0.077045,-0.0076289,0.060623,0.89811,GSE11961_FOLLICULAR_BCELL_VS_MEMORY_BCELL_DAY7_UP,1
GSE22432_MULTIPOTENT_VS_COMM...3,SET,175,-0.076456,-0.0074249,0.060144,0.89816,GSE22432_MULTIPOTENT_VS_COMMON_DC_PROGENITOR_UNTREATED_UP,1
VANDESLUIS_COMMD1_TARGETS_GR...4,SET,17,-0.27712,-0.0084242,0.21798,0.89818,VANDESLUIS_COMMD1_TARGETS_GROUP_4_DN,1
CHEMNITZ_RESPONSE_TO_PROSTAG...2,SET,126,-0.090741,-0.0074874,0.071374,0.89819,CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_UP,1
TTTGCAC_MIR19A_MIR19B,SET,467,-0.051168,-0.0080521,0.040227,0.8983,TTTGCAC_MIR19A_MIR19B,1
HP_KERATOCONJUNCTIVITIS,SET,43,-0.16515,-0.0079787,0.12983,0.89831,HP_KERATOCONJUNCTIVITIS,1
HP_COMA,SET,91,-0.11014,-0.0077309,0.086582,0.89832,HP_COMA,1
WP_CANONICAL_AND_NONCANONICA...2,SET,17,-0.28452,-0.0086492,0.22365,0.89833,WP_CANONICAL_AND_NONCANONICAL_TGFB_SIGNALING,1
GNF2_HPN,SET,130,-0.095933,-0.0080396,0.075411,0.89833,GNF2_HPN,1
REACTOME_PHASE_1_INACTIVATIO...,SET,6,-0.43639,-0.0078835,0.34298,0.89837,REACTOME_PHASE_1_INACTIVATION_OF_FAST_NA_CHANNELS,1
MIR6824_5P,SET,73,-0.13696,-0.0086143,0.10763,0.89839,MIR6824_5P,1
SILIGAN_BOUND_BY_EWS_FLT1_FU...,SET,43,-0.1728,-0.0083486,0.13579,0.89841,SILIGAN_BOUND_BY_EWS_FLT1_FUSION,1
REACTOME_FATTY_ACIDS,SET,15,-0.31457,-0.0089832,0.24705,0.89854,REACTOME_FATTY_ACIDS,1
MIR372_5P,SET,226,-0.07071,-0.0077927,0.055524,0.89857,MIR372_5P,1
GSE35543_IN_VIVO_NTREG_VS_CO...2,SET,157,-0.08314,-0.0076513,0.06528,0.89859,GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_UP,1
GOBP_PLANAR_CELL_POLARITY_PA...1,SET,6,-0.52491,-0.0094826,0.41201,0.89866,GOBP_PLANAR_CELL_POLARITY_PATHWAY_INVOLVED_IN_AXIS_ELONGATION,1
GOBP_PROTEIN_TRANSPORT_WITHI...,SET,6,-0.43459,-0.0078509,0.34104,0.89872,GOBP_PROTEIN_TRANSPORT_WITHIN_LIPID_BILAYER,1
GSE45365_HEALTHY_VS_MCMV_INF...12,SET,153,-0.084988,-0.007722,0.066685,0.89874,GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8_TCELL_IFNAR_KO_UP,1
MIR765,SET,257,-0.069562,-0.0081681,0.054576,0.89876,MIR765,1
GOCC_CORVET_COMPLEX,SET,7,-0.35905,-0.0070058,0.28167,0.89879,GOCC_CORVET_COMPLEX,1
GGGATGC_MIR3245P,SET,42,-0.16035,-0.0076568,0.12578,0.89881,GGGATGC_MIR3245P,1
WP_PHOSPHATIDYL_INOSITOL_PHO...,SET,40,-0.16128,-0.0075158,0.12645,0.89891,WP_PHOSPHATIDYL_INOSITOL_PHOSPHATE_PATHWAY,1
REACTOME_MET_INTERACTS_WITH_...,SET,5,-0.56286,-0.0092826,0.44124,0.89895,REACTOME_MET_INTERACTS_WITH_TNS_PROTEINS,1
GSE17974_IL4_AND_ANTI_IL12_V...9,SET,144,-0.094599,-0.0083406,0.074147,0.89898,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_2H_ACT_CD4_TCELL_DN,1
HP_SUBCAPSULAR_CATARACT,SET,104,-0.10512,-0.007885,0.082342,0.89912,HP_SUBCAPSULAR_CATARACT,1
GNF2_RAB7L1,SET,31,-0.18725,-0.0076839,0.14666,0.89915,GNF2_RAB7L1,1
HE_LIM_SUN_FETAL_LUNG_C2_PRE...,SET,509,-0.047367,-0.0077728,0.037084,0.89924,HE_LIM_SUN_FETAL_LUNG_C2_PRE_PDC_DC5_CELL,1
KIM_ALL_DISORDERS_OLIGODENDR...2,SET,679,-0.04009,-0.0075621,0.031378,0.89931,KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_UP,1
GOCC_PHOTORECEPTOR_OUTER_SEG...2,SET,16,-0.23971,-0.0070695,0.18761,0.89931,GOCC_PHOTORECEPTOR_OUTER_SEGMENT_MEMBRANE,1
GOMF_AMYLASE_ACTIVITY,SET,2,-0.81425,-0.0084935,0.63726,0.89932,GOMF_AMYLASE_ACTIVITY,1
GSE3982_BCELL_VS_TH2_UP,SET,173,-0.080053,-0.0077301,0.062651,0.89933,GSE3982_BCELL_VS_TH2_UP,1
WP_ALANINE_AND_ASPARTATE_MET...,SET,11,-0.31499,-0.0077038,0.24645,0.89939,WP_ALANINE_AND_ASPARTATE_METABOLISM,1
GSE17721_0.5H_VS_8H_POLYIC_B...1,SET,184,-0.080059,-0.0079702,0.06263,0.89942,GSE17721_0.5H_VS_8H_POLYIC_BMDC_DN,1
HP_SHALLOW_ANTERIOR_CHAMBER,SET,17,-0.26502,-0.0080564,0.20732,0.89943,HP_SHALLOW_ANTERIOR_CHAMBER,1
REACTOME_PROTEIN_METHYLATION,SET,14,-0.30223,-0.0083382,0.2364,0.89944,REACTOME_PROTEIN_METHYLATION,1
REACTOME_NEGATIVE_REGULATION...9,SET,20,-0.23883,-0.0078741,0.18679,0.89947,REACTOME_NEGATIVE_REGULATION_OF_NMDA_RECEPTOR_MEDIATED_NEURONAL_TRANSMISSION,1
GOBP_RENAL_SYSTEM_DEVELOPMENT,SET,315,-0.065822,-0.0085431,0.05148,0.89947,GOBP_RENAL_SYSTEM_DEVELOPMENT,1
KEGG_BUTANOATE_METABOLISM,SET,31,-0.1935,-0.0079401,0.15131,0.8995,KEGG_BUTANOATE_METABOLISM,1
GOBP_MUSCLE_CELL_APOPTOTIC_P...,SET,76,-0.1221,-0.0078356,0.095486,0.8995,GOBP_MUSCLE_CELL_APOPTOTIC_PROCESS,1
MIR6836_3P,SET,53,-0.14957,-0.0080203,0.11695,0.89953,MIR6836_3P,1
MIR7856_5P,SET,363,-0.057067,-0.0079405,0.044621,0.89953,MIR7856_5P,1
REACTOME_REGULATION_OF_KIT_S...,SET,15,-0.27717,-0.0079151,0.21671,0.89954,REACTOME_REGULATION_OF_KIT_SIGNALING,1
GAVISH_3CA_MALIGNANT_METAPRO...20,SET,47,-0.16928,-0.0085496,0.13235,0.89955,GAVISH_3CA_MALIGNANT_METAPROGRAM_29_NPC_OPC,1
HP_APLASIA_HYPOPLASIA_OF_THE...20,SET,5,-0.41955,-0.0069192,0.32795,0.8996,HP_APLASIA_HYPOPLASIA_OF_THE_DIAPHRAGM,1
REACTOME_REGULATION_BY_C_FLIP,SET,11,-0.3249,-0.007946,0.25393,0.89962,REACTOME_REGULATION_BY_C_FLIP,1
GOBP_FATTY_ACID_ALPHA_OXIDAT...,SET,8,-0.40989,-0.0085497,0.32037,0.89962,GOBP_FATTY_ACID_ALPHA_OXIDATION,1
GOCC_LSM1_7_PAT1_COMPLEX,SET,5,-0.40948,-0.0067529,0.31999,0.89966,GOCC_LSM1_7_PAT1_COMPLEX,1
GOBP_MALONYL_COA_METABOLIC_P...,SET,6,-0.44801,-0.0080935,0.35001,0.89972,GOBP_MALONYL_COA_METABOLIC_PROCESS,1
CTGYNNCTYTAA_UNKNOWN,SET,81,-0.12294,-0.0081438,0.096046,0.89973,CTGYNNCTYTAA_UNKNOWN,1
GSE4984_UNTREATED_VS_VEHICLE...1,SET,153,-0.085437,-0.0077627,0.066736,0.89976,GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_DN,1
FAN_EMBRYONIC_CTX_BRAIN_MYEL...,SET,121,-0.10477,-0.0084728,0.081832,0.89977,FAN_EMBRYONIC_CTX_BRAIN_MYELOID,1
AAANWWTGC_UNKNOWN,SET,183,-0.082248,-0.0081662,0.064238,0.89979,AAANWWTGC_UNKNOWN,1
GGGYGTGNY_UNKNOWN,SET,598,-0.044898,-0.0079658,0.035053,0.89987,GGGYGTGNY_UNKNOWN,1
GOBP_NEGATIVE_REGULATION_OF_...696,SET,88,-0.12194,-0.0084174,0.095203,0.89987,GOBP_NEGATIVE_REGULATION_OF_VASCULATURE_DEVELOPMENT,1
GOBP_BONE_MINERALIZATION_INV...,SET,11,-0.34179,-0.0083593,0.26683,0.89989,GOBP_BONE_MINERALIZATION_INVOLVED_IN_BONE_MATURATION,1
BARRIER_CANCER_RELAPSE_TUMOR...1,SET,10,-0.29249,-0.0068208,0.22829,0.89994,BARRIER_CANCER_RELAPSE_TUMOR_SAMPLE_DN,1
GOBP_CELLULAR_RESPONSE_TO_LU...,SET,5,-0.52161,-0.0086022,0.40706,0.89997,GOBP_CELLULAR_RESPONSE_TO_LUTEINIZING_HORMONE_STIMULUS,1
GSE7509_FCGRIIB_VS_TNFA_IL1B...1,SET,131,-0.091361,-0.0076857,0.071292,0.89998,GSE7509_FCGRIIB_VS_TNFA_IL1B_IL6_PGE_STIM_DC_DN,1
GOCC_RNA_POLYMERASE_II_HOLOE...,SET,67,-0.11812,-0.0071189,0.092173,0.89999,GOCC_RNA_POLYMERASE_II_HOLOENZYME,1
HP_INTERSTITIAL_PNEUMONITIS,SET,15,-0.29233,-0.0083481,0.22808,0.90002,HP_INTERSTITIAL_PNEUMONITIS,1
GOBP_REGULATION_OF_MEMBRANE_...12,SET,4,-0.58758,-0.0086673,0.45841,0.90003,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GOBP_REGULATION_OF_MEMBRANE_...13,SET,4,-0.58758,-0.0086673,0.45841,0.90003,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
HP_FIBULAR_HYPOPLASIA,SET,22,-0.2226,-0.0076967,0.17366,0.90003,HP_FIBULAR_HYPOPLASIA,1
HP_PROGRESSIVE_MICROCEPHALY,SET,82,-0.11498,-0.007663,0.089699,0.90004,HP_PROGRESSIVE_MICROCEPHALY,1
REACTOME_DEATH_RECEPTOR_SIGN...,SET,139,-0.091947,-0.0079659,0.071718,0.90008,REACTOME_DEATH_RECEPTOR_SIGNALING,1
TGACAGNY_MEIS1_01,SET,766,-0.040673,-0.0081286,0.031723,0.90009,TGACAGNY_MEIS1_01,1
GOBP_REGULATION_OF_SKELETAL_...10,SET,24,-0.22742,-0.0082128,0.17737,0.9001,GOBP_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_LYMPHOCYTE_HOMEOSTASIS,SET,71,-0.13094,-0.0081228,0.10209,0.90018,GOBP_LYMPHOCYTE_HOMEOSTASIS,1
HP_STILLBIRTH,SET,28,-0.20761,-0.0080971,0.16185,0.9002,HP_STILLBIRTH,1
GOBP_VENTRICULAR_COMPACT_MYO...,SET,7,-0.45985,-0.0089726,0.35845,0.90023,GOBP_VENTRICULAR_COMPACT_MYOCARDIUM_MORPHOGENESIS,1
HP_ABNORMAL_ANTERIOR_CHAMBER...,SET,54,-0.15638,-0.008464,0.12189,0.90024,HP_ABNORMAL_ANTERIOR_CHAMBER_MORPHOLOGY,1
LANDIS_BREAST_CANCER_PROGRES...2,SET,40,-0.16911,-0.0078808,0.13178,0.9003,LANDIS_BREAST_CANCER_PROGRESSION_UP,1
BIOCARTA_GCR_PATHWAY,SET,17,-0.27487,-0.0083557,0.21418,0.9003,BIOCARTA_GCR_PATHWAY,1
MIR6890_5P,SET,18,-0.23758,-0.0074314,0.18513,0.9003,MIR6890_5P,1
GOBP_KETONE_BODY_BIOSYNTHETI...,SET,6,-0.44767,-0.0080873,0.34885,0.9003,GOBP_KETONE_BODY_BIOSYNTHETIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...835,SET,11,-0.32668,-0.0079896,0.25456,0.9003,GOBP_POSITIVE_REGULATION_OF_VASCULOGENESIS,1
GSE25123_CTRL_VS_ROSIGLITAZO...1,SET,178,-0.081287,-0.0079608,0.06333,0.90034,GSE25123_CTRL_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
REACTOME_CELLULAR_HEXOSE_TRA...,SET,18,-0.26103,-0.0081648,0.20333,0.90038,REACTOME_CELLULAR_HEXOSE_TRANSPORT,1
MIR1245B_3P,SET,129,-0.093781,-0.0078293,0.073049,0.90039,MIR1245B_3P,1
GSE43863_DAY6_EFF_VS_DAY150_...4,SET,184,-0.079508,-0.0079154,0.061924,0.90041,GSE43863_DAY6_EFF_VS_DAY150_MEM_TFH_CD4_TCELL_UP,1
REACTOME_PHOSPHOLIPASE_C_MED...2,SET,17,-0.29066,-0.008836,0.22637,0.90042,REACTOME_PHOSPHOLIPASE_C_MEDIATED_CASCADE_FGFR2,1
GOBP_CEREBRAL_CORTEX_RADIALL...,SET,33,-0.2002,-0.0084756,0.1559,0.90045,GOBP_CEREBRAL_CORTEX_RADIALLY_ORIENTED_CELL_MIGRATION,1
GOBP_CELLULAR_RESPONSE_TO_ST...1,SET,157,-0.087416,-0.0080449,0.068065,0.90047,GOBP_CELLULAR_RESPONSE_TO_STARVATION,1
HP_ABNORMAL_DUODENUM_MORPHOL...,SET,81,-0.11678,-0.0077358,0.0909,0.90055,HP_ABNORMAL_DUODENUM_MORPHOLOGY,1
GOBP_REGULATION_OF_GAMMA_DEL...2,SET,9,-0.3754,-0.0083051,0.29209,0.90063,GOBP_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
HP_SELF_MUTILATION,SET,39,-0.17262,-0.0079431,0.13429,0.90067,HP_SELF_MUTILATION,1
GOBP_NEGATIVE_REGULATION_OF_...547,SET,12,-0.28934,-0.0073908,0.22508,0.90068,GOBP_NEGATIVE_REGULATION_OF_REACTIVE_OXYGEN_SPECIES_BIOSYNTHETIC_PROCESS,1
MODULE_414,SET,8,-0.44057,-0.0091897,0.34252,0.90081,MODULE_414,1
GSE10147_IL3_AND_HIVP17_VS_I...1,SET,134,-0.091464,-0.0077813,0.07109,0.90087,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN,1
BRCA1_DN.V1_DN,SET,115,-0.10389,-0.008192,0.080727,0.90093,BRCA1_DN.V1_DN,1
GOBP_LIPID_HOMEOSTASIS,SET,150,-0.088914,-0.0079997,0.069088,0.90094,GOBP_LIPID_HOMEOSTASIS,1
GOCC_SEPTIN_CYTOSKELETON,SET,2,-0.69097,-0.0072076,0.53689,0.90094,GOCC_SEPTIN_CYTOSKELETON,1
GOBP_VENTRICULAR_CARDIAC_MUS...1,SET,33,-0.21198,-0.0089745,0.16468,0.90099,GOBP_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GSE22886_NAIVE_BCELL_VS_BM_P...1,SET,182,-0.08037,-0.0079581,0.062434,0.90099,GSE22886_NAIVE_BCELL_VS_BM_PLASMA_CELL_DN,1
GOBP_DETECTION_OF_CELL_DENSI...,SET,8,-0.36019,-0.0075132,0.27964,0.90113,GOBP_DETECTION_OF_CELL_DENSITY,1
GOBP_NEGATIVE_REGULATION_OF_...123,SET,641,-0.046011,-0.0084415,0.035719,0.90114,GOBP_NEGATIVE_REGULATION_OF_CELL_POPULATION_PROLIFERATION,1
GOCC_CELL_CORTEX_REGION,SET,34,-0.18015,-0.0077413,0.13985,0.90116,GOCC_CELL_CORTEX_REGION,1
EGR3_01,SET,72,-0.12784,-0.0079861,0.099216,0.90121,EGR3_01,1
HP_ABNORMAL_NUMBER_OF_INCISO...,SET,51,-0.15173,-0.0079817,0.11768,0.90136,HP_ABNORMAL_NUMBER_OF_INCISORS,1
HP_OCULOMOTOR_NERVE_PALSY,SET,27,-0.20848,-0.0079849,0.16169,0.90136,HP_OCULOMOTOR_NERVE_PALSY,1
WP_INDUCTION_OF_AUTOPHAGY_AN...,SET,11,-0.3165,-0.0077408,0.24546,0.90137,WP_INDUCTION_OF_AUTOPHAGY_AND_TOLLLIKE_RECEPTOR_SIGNALING_BY_GRAPHENE_OXIDE,1
GOBP_SUCCINYL_COA_METABOLIC_...,SET,9,-0.33291,-0.007365,0.25818,0.90137,GOBP_SUCCINYL_COA_METABOLIC_PROCESS,1
GSE27291_0H_VS_6H_STIM_GAMMA...2,SET,152,-0.086634,-0.007846,0.067186,0.90137,GSE27291_0H_VS_6H_STIM_GAMMADELTA_TCELL_UP,1
GSE21927_SPLEEN_VS_TUMOR_MON...4,SET,157,-0.086577,-0.0079676,0.067138,0.90139,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_UP,1
HP_NONIMMUNE_HYDROPS_FETALIS,SET,58,-0.13318,-0.00747,0.10326,0.90142,HP_NONIMMUNE_HYDROPS_FETALIS,1
GOBP_REGULATION_OF_ACUTE_INF...2,SET,13,-0.30737,-0.0081719,0.23831,0.90143,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GSE30083_SP1_VS_SP3_THYMOCYT...1,SET,181,-0.081904,-0.0080879,0.063503,0.90143,GSE30083_SP1_VS_SP3_THYMOCYTE_DN,1
GOBP_REGULATION_OF_MITOCHOND...13,SET,5,-0.39474,-0.00651,0.30604,0.90144,GOBP_REGULATION_OF_MITOCHONDRIAL_RNA_CATABOLIC_PROCESS,1
GSE37416_CTRL_VS_3H_F_TULARE...2,SET,168,-0.079053,-0.0075235,0.061278,0.90148,GSE37416_CTRL_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_UP,1
GOBP_POSITIVE_REGULATION_OF_...827,SET,35,-0.2043,-0.008907,0.15836,0.90149,GOBP_POSITIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
SESTO_RESPONSE_TO_UV_C8,SET,66,-0.1381,-0.0082609,0.10704,0.9015,SESTO_RESPONSE_TO_UV_C8,1
MIR483_5P,SET,7,-0.44802,-0.0087419,0.34723,0.90152,MIR483_5P,1
HP_DEVELOPMENTAL_CATARACT,SET,109,-0.10026,-0.0076979,0.077692,0.90154,HP_DEVELOPMENTAL_CATARACT,1
KEGG_MEDICUS_ENV_FACTOR_NNK_...1,SET,9,-0.37863,-0.0083766,0.29338,0.90156,KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_CHRNA7_E2F_SIGNALING_PATHWAY,1
GOBP_EOSINOPHIL_ACTIVATION,SET,8,-0.36294,-0.0075705,0.28123,0.90156,GOBP_EOSINOPHIL_ACTIVATION,1
MIR3156_5P,SET,61,-0.15206,-0.0087458,0.11781,0.9016,MIR3156_5P,1
GSE13485_DAY7_VS_DAY21_YF17D...2,SET,183,-0.08233,-0.0081743,0.063778,0.90162,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_UP,1
GSE28237_FOLLICULAR_VS_EARLY...2,SET,167,-0.079958,-0.0075871,0.061933,0.90165,GSE28237_FOLLICULAR_VS_EARLY_GC_BCELL_UP,1
JAZAERI_BREAST_CANCER_BRCA1_...2,SET,45,-0.14918,-0.0073726,0.11554,0.90166,JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_UP,1
GOBP_INTERMEMBRANE_LIPID_TRA...,SET,28,-0.19587,-0.0076395,0.15168,0.90171,GOBP_INTERMEMBRANE_LIPID_TRANSFER,1
GSE1460_NAIVE_CD4_TCELL_ADUL...2,SET,170,-0.078089,-0.0074754,0.060446,0.90179,GSE1460_NAIVE_CD4_TCELL_ADULT_BLOOD_VS_THYMIC_STROMAL_CELL_UP,1
REACTOME_TNFR1_INDUCED_PROAP...,SET,23,-0.22581,-0.0079833,0.17478,0.90181,REACTOME_TNFR1_INDUCED_PROAPOPTOTIC_SIGNALING,1
GSE17721_0.5H_VS_24H_PAM3CSK...1,SET,186,-0.076788,-0.0076856,0.059414,0.90188,GSE17721_0.5H_VS_24H_PAM3CSK4_BMDC_DN,1
REACTOME_NUCLEOTIDE_BIOSYNTH...,SET,12,-0.31671,-0.0080901,0.24498,0.90195,REACTOME_NUCLEOTIDE_BIOSYNTHESIS,1
MIR548BC,SET,433,-0.052688,-0.0079913,0.040755,0.90195,MIR548BC,1
WP_MTHFR_DEFICIENCY,SET,22,-0.22621,-0.0078217,0.17497,0.90197,WP_MTHFR_DEFICIENCY,1
GOBP_NEGATIVE_REGULATION_OF_...223,SET,30,-0.20959,-0.0084608,0.16211,0.90197,GOBP_NEGATIVE_REGULATION_OF_EXOCYTOSIS,1
DUTTA_APOPTOSIS_VIA_NFKB,SET,32,-0.19859,-0.0082793,0.15356,0.90202,DUTTA_APOPTOSIS_VIA_NFKB,1
MIR6750_3P,SET,62,-0.14505,-0.0084102,0.11216,0.90202,MIR6750_3P,1
GSE12392_IFNAR_KO_VS_IFNB_KO...1,SET,185,-0.083581,-0.0083433,0.06461,0.90209,GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_DN,1
GSE360_T_GONDII_VS_B_MALAYI_...5,SET,183,-0.080343,-0.007977,0.062107,0.90209,GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN,1
GOBP_PHENYLPROPANOID_METABOL...,SET,7,-0.45359,-0.0088506,0.35062,0.90211,GOBP_PHENYLPROPANOID_METABOLIC_PROCESS,1
HP_CONGENITAL_NYSTAGMUS,SET,19,-0.25949,-0.0083391,0.20057,0.90212,HP_CONGENITAL_NYSTAGMUS,1
GOBP_RESPONSE_TO_IRON_II_ION,SET,6,-0.46092,-0.0083266,0.35603,0.90226,GOBP_RESPONSE_TO_IRON_II_ION,1
VAN_DEN_BIGGELAAR_PBMC_PREVN...2,SET,4,-0.57849,-0.0085334,0.44686,0.90226,VAN_DEN_BIGGELAAR_PBMC_PREVNAR_9MO_INFANT_STIMULATED_VS_UNSTIMULATED_9MO_DN,1
MIR337_3P,SET,110,-0.1031,-0.0079522,0.079634,0.90227,MIR337_3P,1
TTGGAGA_MIR5155P_MIR519E,SET,123,-0.096378,-0.007858,0.074444,0.90227,TTGGAGA_MIR5155P_MIR519E,1
GOBP_NEGATIVE_REGULATION_OF_...375,SET,43,-0.16697,-0.0080667,0.12897,0.90227,GOBP_NEGATIVE_REGULATION_OF_MAP_KINASE_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_VITA...2,SET,24,-0.23607,-0.0085251,0.18235,0.90227,HP_ABNORMAL_CIRCULATING_VITAMIN_B12_CONCENTRATION,1
NABA_MATRISOME_HIGHLY_METAST...3,SET,18,-0.2716,-0.0084956,0.20977,0.90229,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA,1
MIR5003_3P,SET,293,-0.065019,-0.0081437,0.050212,0.90231,MIR5003_3P,1
HP_RECURRENT_FRACTURES,SET,124,-0.099377,-0.0081351,0.07674,0.90233,HP_RECURRENT_FRACTURES,1
MIR920,SET,47,-0.15053,-0.0076023,0.11622,0.90237,MIR920,1
GSE37605_FOXP3_FUSION_GFP_VS...2,SET,174,-0.087796,-0.0085021,0.067775,0.9024,GSE37605_FOXP3_FUSION_GFP_VS_IRES_GFP_TREG_C57BL6_UP,1
MODULE_253,SET,20,-0.24879,-0.0082027,0.19203,0.90244,MODULE_253,1
REACTOME_B_WICH_COMPLEX_POSI...,SET,28,-0.18375,-0.0071667,0.14182,0.90245,REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION,1
HE_PTEN_TARGETS_UP,SET,18,-0.26985,-0.0084407,0.20826,0.90246,HE_PTEN_TARGETS_UP,1
HP_OLIVOPONTOCEREBELLAR_ATRO...,SET,6,-0.35671,-0.006444,0.27526,0.90249,HP_OLIVOPONTOCEREBELLAR_ATROPHY,1
GOBP_CELLULAR_RESPONSE_TO_HE...,SET,59,-0.1406,-0.0079532,0.10845,0.90258,GOBP_CELLULAR_RESPONSE_TO_HEAT,1
SCHAEFFER_PROSTATE_DEVELOPME...9,SET,7,-0.43061,-0.0084021,0.3321,0.90261,SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX2_DN,1
HP_ABNORMALITY_OF_THE_BLADDER,SET,465,-0.051588,-0.0081012,0.039785,0.90262,HP_ABNORMALITY_OF_THE_BLADDER,1
HP_CHONDROCALCINOSIS,SET,21,-0.26797,-0.009053,0.20664,0.90265,HP_CHONDROCALCINOSIS,1
HE_LIM_SUN_FETAL_LUNG_C1_EAR...3,SET,124,-0.094379,-0.007726,0.072767,0.90268,HE_LIM_SUN_FETAL_LUNG_C1_EARLY_TIP_CELL,1
GOCC_RECYCLING_ENDOSOME,SET,187,-0.07808,-0.0078358,0.060196,0.90269,GOCC_RECYCLING_ENDOSOME,1
HP_TOXEMIA_OF_PREGNANCY,SET,24,-0.24034,-0.0086794,0.18529,0.90269,HP_TOXEMIA_OF_PREGNANCY,1
GOBP_REGULATION_OF_MITOCHOND...4,SET,5,-0.43389,-0.0071555,0.33448,0.90271,GOBP_REGULATION_OF_MITOCHONDRIAL_ELECTRON_TRANSPORT_NADH_TO_UBIQUINONE,1
GOBP_REGULATION_OF_MEMBRANE_...11,SET,7,-0.45557,-0.0088892,0.35117,0.90272,GOBP_REGULATION_OF_MEMBRANE_REPOLARIZATION_DURING_ACTION_POTENTIAL,1
HP_ABNORMAL_THOUGHT_PATTERN,SET,63,-0.13478,-0.0078778,0.10388,0.90275,HP_ABNORMAL_THOUGHT_PATTERN,1
REACTOME_CASPASE_ACTIVATION_...1,SET,16,-0.27675,-0.0081621,0.2133,0.90276,REACTOME_CASPASE_ACTIVATION_VIA_DEATH_RECEPTORS_IN_THE_PRESENCE_OF_LIGAND,1
HP_PATCHY_CHANGES_OF_BONE_MI...,SET,5,-0.51472,-0.0084887,0.39656,0.90284,HP_PATCHY_CHANGES_OF_BONE_MINERAL_DENSITY,1
GOMF_AMINOACYLTRANSFERASE_AC...,SET,444,-0.051518,-0.00791,0.03969,0.90285,GOMF_AMINOACYLTRANSFERASE_ACTIVITY,1
HP_UPPER_EYELID_EDEMA,SET,6,-0.48371,-0.0087383,0.37263,0.90286,HP_UPPER_EYELID_EDEMA,1
GOBP_POSITIVE_REGULATION_OF_...124,SET,103,-0.10643,-0.0079451,0.081989,0.90287,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_PHASE_TRANSITION,1
GSE7348_UNSTIM_VS_LPS_STIM_M...1,SET,158,-0.093068,-0.0085919,0.071692,0.90288,GSE7348_UNSTIM_VS_LPS_STIM_MACROPHAGE_DN,1
GOBP_REGULATION_OF_NEUROTROP...,SET,9,-0.32159,-0.0071146,0.2477,0.9029,GOBP_REGULATION_OF_NEUROTROPHIN_TRK_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_ALPHA_TUBULIN_BINDING,SET,35,-0.17287,-0.0075366,0.13314,0.90292,GOMF_ALPHA_TUBULIN_BINDING,1
GOBP_REGULATION_OF_RECEPTOR_...7,SET,25,-0.20953,-0.0077226,0.16135,0.90295,GOBP_REGULATION_OF_RECEPTOR_RECYCLING,1
GSE13485_DAY1_VS_DAY7_YF17D_...2,SET,140,-0.09577,-0.0083266,0.07375,0.90295,GSE13485_DAY1_VS_DAY7_YF17D_VACCINE_PBMC_UP,1
GOBP_ANIMAL_ORGAN_MORPHOGENE...,SET,953,-0.038714,-0.0085841,0.02981,0.90297,GOBP_ANIMAL_ORGAN_MORPHOGENESIS,1
BAKKER_FOXO3_TARGETS_DN,SET,157,-0.08495,-0.0078179,0.065404,0.903,BAKKER_FOXO3_TARGETS_DN,1
HP_ATROPHIC_GASTRITIS,SET,7,-0.38062,-0.0074268,0.29304,0.903,HP_ATROPHIC_GASTRITIS,1
MIR4279,SET,198,-0.079555,-0.0082128,0.061243,0.90302,MIR4279,1
GOBP_REGULATION_OF_UBIQUITIN...3,SET,35,-0.1776,-0.0077431,0.13672,0.90303,GOBP_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,1
BOYAULT_LIVER_CANCER_SUBCLAS...13,SET,11,-0.37376,-0.009141,0.28769,0.90305,BOYAULT_LIVER_CANCER_SUBCLASS_G56_UP,1
GSE37301_MULTIPOTENT_PROGENI...9,SET,163,-0.089389,-0.0083808,0.068804,0.90305,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_DN,1
GOBP_MAMMARY_GLAND_BRANCHING...,SET,6,-0.51463,-0.009297,0.3961,0.90306,GOBP_MAMMARY_GLAND_BRANCHING_INVOLVED_IN_PREGNANCY,1
GSE17721_12H_VS_24H_CPG_BMDC...1,SET,178,-0.078273,-0.0076656,0.060242,0.90307,GSE17721_12H_VS_24H_CPG_BMDC_DN,1
chr11q25,SET,13,-0.54906,-0.014597,0.4225,0.90311,chr11q25,1
GOBP_INTRACELLULAR_AMINO_ACI...,SET,8,-0.39922,-0.0083272,0.30719,0.90312,GOBP_INTRACELLULAR_AMINO_ACID_HOMEOSTASIS,1
GOBP_SNARE_COMPLEX_ASSEMBLY,SET,21,-0.22308,-0.0075365,0.17165,0.90313,GOBP_SNARE_COMPLEX_ASSEMBLY,1
MODULE_522,SET,31,-0.20112,-0.0082528,0.15468,0.90323,MODULE_522,1
GOBP_ORGANIC_ANION_TRANSPORT,SET,425,-0.055786,-0.0083846,0.042903,0.90324,GOBP_ORGANIC_ANION_TRANSPORT,1
HP_SCANNING_SPEECH,SET,14,-0.3224,-0.0088946,0.24793,0.90326,HP_SCANNING_SPEECH,1
GSE17721_12H_VS_24H_CPG_BMDC...2,SET,186,-0.080262,-0.0080334,0.061716,0.90328,GSE17721_12H_VS_24H_CPG_BMDC_UP,1
GOBP_FAT_SOLUBLE_VITAMIN_MET...,SET,47,-0.16421,-0.0082932,0.12625,0.9033,GOBP_FAT_SOLUBLE_VITAMIN_METABOLIC_PROCESS,1
HEIDENBLAD_AMPLICON_12P11_12...1,SET,20,-0.25001,-0.0082427,0.19217,0.90335,HEIDENBLAD_AMPLICON_12P11_12_DN,1
BIOCARTA_AKAP95_PATHWAY,SET,11,-0.2941,-0.0071929,0.22608,0.90335,BIOCARTA_AKAP95_PATHWAY,1
DESCARTES_FETAL_PANCREAS_LYM...2,SET,112,-0.1123,-0.0087396,0.08632,0.90335,DESCARTES_FETAL_PANCREAS_LYMPHOID_CELLS,1
GOMF_OXIDOREDUCTASE_ACTIVITY...36,SET,14,-0.34796,-0.0096,0.26746,0.90336,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_NH2_GROUP_OF_DONORS_OXYGEN_AS_ACCEPTOR,1
GOBP_MITOCHONDRIAL_TRANSLATI...2,SET,5,-0.42933,-0.0070804,0.32999,0.90337,GOBP_MITOCHONDRIAL_TRANSLATIONAL_ELONGATION,1
DESCARTES_MAIN_FETAL_SCHWANN...,SET,37,-0.18325,-0.0082141,0.14083,0.9034,DESCARTES_MAIN_FETAL_SCHWANN_CELLS,1
WP_NANOMATERIAL_INDUCED_APOP...,SET,19,-0.24959,-0.0080209,0.1918,0.90342,WP_NANOMATERIAL_INDUCED_APOPTOSIS,1
GSE17721_CTRL_VS_LPS_4H_BMDC...2,SET,185,-0.076713,-0.0076577,0.058948,0.90342,GSE17721_CTRL_VS_LPS_4H_BMDC_UP,1
GOBP_NEGATIVE_REGULATION_OF_...517,SET,70,-0.12272,-0.0075592,0.0943,0.90343,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_CONTAINING_COMPLEX_DISASSEMBLY,1
GOBP_TROPHOBLAST_CELL_MIGRAT...,SET,15,-0.28616,-0.0081718,0.21989,0.90343,GOBP_TROPHOBLAST_CELL_MIGRATION,1
HP_ABNORMAL_STOMACH_MORPHOLO...,SET,244,-0.071421,-0.0081745,0.054874,0.90346,HP_ABNORMAL_STOMACH_MORPHOLOGY,1
GOMF_C_PALMITOYLTRANSFERASE_...,SET,5,-0.5351,-0.0088247,0.41104,0.9035,GOMF_C_PALMITOYLTRANSFERASE_ACTIVITY,1
WOO_LIVER_CANCER_RECURRENCE_...1,SET,75,-0.12884,-0.0082139,0.098967,0.90352,WOO_LIVER_CANCER_RECURRENCE_DN,1
GOBP_NEGATIVE_REGULATION_OF_...95,SET,92,-0.12112,-0.0085482,0.093036,0.90352,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_GROWTH_FACTOR_STIMULUS,1
YAO_TEMPORAL_RESPONSE_TO_PRO...18,SET,69,-0.12932,-0.0079089,0.099323,0.90354,YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9,1
GOBP_NEGATIVE_REGULATION_OF_...118,SET,28,-0.2175,-0.0084829,0.16705,0.90354,GOBP_NEGATIVE_REGULATION_OF_CELL_JUNCTION_ASSEMBLY,1
GSE39110_UNTREATED_VS_IL2_TR...1,SET,183,-0.079525,-0.0078958,0.061062,0.9036,GSE39110_UNTREATED_VS_IL2_TREATED_CD8_TCELL_DAY3_POST_IMMUNIZATION_DN,1
HP_KNUCKLE_PAD,SET,7,-0.41611,-0.0081191,0.31947,0.90362,HP_KNUCKLE_PAD,1
GSE7764_IL15_TREATED_VS_CTRL...2,SET,175,-0.077619,-0.0075379,0.059576,0.90368,GSE7764_IL15_TREATED_VS_CTRL_NK_CELL_24H_UP,1
CTATGCA_MIR153,SET,203,-0.077355,-0.0080847,0.059368,0.9037,CTATGCA_MIR153,1
KEGG_MEDICUS_REFERENCE_HEPAR...2,SET,6,-0.44384,-0.0080181,0.3406,0.90373,KEGG_MEDICUS_REFERENCE_HEPARAN_SULFATE_DEGRADATION,1
chr3q28,SET,12,-0.56338,-0.014391,0.43228,0.90375,chr3q28,1
GCM_HDAC1,SET,35,-0.17032,-0.0074255,0.13068,0.90377,GCM_HDAC1,1
GOBP_NEGATIVE_REGULATION_OF_...640,SET,61,-0.13581,-0.0078113,0.10419,0.90379,GOBP_NEGATIVE_REGULATION_OF_TOR_SIGNALING,1
HP_ABNORMALITY_OF_VITAMIN_B_...,SET,41,-0.17359,-0.0081896,0.13316,0.9038,HP_ABNORMALITY_OF_VITAMIN_B_METABOLISM,1
DESCARTES_MAIN_FETAL_PHOTORE...,SET,67,-0.14806,-0.0089235,0.11358,0.9038,DESCARTES_MAIN_FETAL_PHOTORECEPTOR_CELLS,1
MODULE_195,SET,138,-0.091408,-0.0078909,0.070114,0.90382,MODULE_195,1
HP_ABNORMALITY_OF_HEPATOBILI...,SET,181,-0.07874,-0.0077754,0.060374,0.90391,HP_ABNORMALITY_OF_HEPATOBILIARY_SYSTEM_PHYSIOLOGY,1
GOBP_KIDNEY_MESENCHYME_DEVEL...,SET,15,-0.32573,-0.0093017,0.24972,0.90394,GOBP_KIDNEY_MESENCHYME_DEVELOPMENT,1
HP_OROMOTOR_APRAXIA,SET,24,-0.22659,-0.0081829,0.17371,0.90395,HP_OROMOTOR_APRAXIA,1
HP_RENAL_PHOSPHATE_WASTING,SET,11,-0.35509,-0.0086845,0.27221,0.90395,HP_RENAL_PHOSPHATE_WASTING,1
GAVISH_3CA_METAPROGRAM_CD4_T...1,SET,45,-0.17267,-0.0085338,0.13237,0.90396,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CELL_CYCLE,1
GOBP_ANTEROGRADE_NEURONAL_DE...,SET,6,-0.43502,-0.0078587,0.33343,0.90399,GOBP_ANTEROGRADE_NEURONAL_DENSE_CORE_VESICLE_TRANSPORT,1
GSE32255_WT_VS_JMJD2D_KNOCKD...1,SET,129,-0.093797,-0.0078306,0.07189,0.904,GSE32255_WT_VS_JMJD2D_KNOCKDOWN_4H_LPS_STIM_DC_DN,1
GOMF_G_PROTEIN_COUPLED_GLUTA...2,SET,8,-0.40609,-0.0084705,0.31123,0.90401,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_BINDING,1
HP_ABNORMALITY_OF_THE_DISTAL...3,SET,4,-0.59573,-0.0087876,0.45656,0.90401,HP_ABNORMALITY_OF_THE_DISTAL_PHALANX_OF_THE_3RD_FINGER,1
HP_DECREASED_VIGILANCE,SET,9,-0.36884,-0.00816,0.28268,0.90401,HP_DECREASED_VIGILANCE,1
GOMF_DOLICHYL_PHOSPHATE_MANN...,SET,8,-0.33915,-0.0070743,0.25992,0.90402,GOMF_DOLICHYL_PHOSPHATE_MANNOSE_PROTEIN_MANNOSYLTRANSFERASE_ACTIVITY,1
MIR6831_3P,SET,55,-0.14344,-0.0078348,0.10991,0.90405,MIR6831_3P,1
GSE22025_UNTREATED_VS_PROGES...1,SET,184,-0.084531,-0.0084155,0.06477,0.90406,GSE22025_UNTREATED_VS_PROGESTERONE_TREATED_CD4_TCELL_DN,1
KUMAR_AUTOPHAGY_NETWORK,SET,59,-0.14305,-0.0080923,0.10958,0.90413,KUMAR_AUTOPHAGY_NETWORK,1
GOBP_CHONDROCYTE_DEVELOPMENT,SET,29,-0.23105,-0.0091706,0.17691,0.90422,GOBP_CHONDROCYTE_DEVELOPMENT,1
GSE22886_NAIVE_CD8_TCELL_VS_...8,SET,173,-0.080888,-0.0078107,0.061931,0.90423,GSE22886_NAIVE_CD8_TCELL_VS_NEUTROPHIL_UP,1
NAKAMURA_ADIPOGENESIS_LATE_DN,SET,33,-0.19972,-0.0084555,0.1529,0.90426,NAKAMURA_ADIPOGENESIS_LATE_DN,1
REACTOME_DIGESTION,SET,17,-0.30767,-0.0093531,0.23546,0.90433,REACTOME_DIGESTION,1
GOBP_REGULATION_OF_PROTEIN_S...4,SET,20,-0.2168,-0.007148,0.16591,0.90434,GOBP_REGULATION_OF_PROTEIN_SUMOYLATION,1
ZHONG_PFC_C8_ORG_PROLIFERATI...,SET,57,-0.14107,-0.0078441,0.10795,0.90436,ZHONG_PFC_C8_ORG_PROLIFERATING,1
ZERBINI_RESPONSE_TO_SULINDAC...1,SET,6,-0.35452,-0.0064046,0.27125,0.90438,ZERBINI_RESPONSE_TO_SULINDAC_DN,1
GSE24492_LYVE_NEG_VS_POS_MAC...2,SET,168,-0.081223,-0.00773,0.062143,0.90439,GSE24492_LYVE_NEG_VS_POS_MACROPHAGE_UP,1
GSE28737_WT_VS_BCL6_KO_FOLLI...2,SET,180,-0.082012,-0.0080764,0.06274,0.90441,GSE28737_WT_VS_BCL6_KO_FOLLICULAR_BCELL_UP,1
GOBP_EMBRYONIC_CLEAVAGE,SET,8,-0.3687,-0.0076906,0.28205,0.90442,GOBP_EMBRYONIC_CLEAVAGE,1
HP_ASYMMETRIC_SEPTAL_HYPERTR...,SET,13,-0.32996,-0.0087724,0.25242,0.90442,HP_ASYMMETRIC_SEPTAL_HYPERTROPHY,1
GSE14308_TH1_VS_NAIVE_CD4_TC...2,SET,178,-0.080071,-0.0078417,0.061253,0.90442,GSE14308_TH1_VS_NAIVE_CD4_TCELL_UP,1
GSE28237_EARLY_VS_LATE_GC_BC...2,SET,183,-0.08502,-0.0084413,0.065032,0.90445,GSE28237_EARLY_VS_LATE_GC_BCELL_UP,1
HP_ABNORMALITY_OF_THE_BREAST,SET,393,-0.053611,-0.0077552,0.041001,0.90448,HP_ABNORMALITY_OF_THE_BREAST,1
GOMF_DICARBOXYLIC_ACID_TRANS...,SET,30,-0.1972,-0.0079608,0.15079,0.90452,GOMF_DICARBOXYLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_OTOLITH_MORPHOGENESIS,SET,5,-0.5313,-0.008762,0.4061,0.9046,GOBP_OTOLITH_MORPHOGENESIS,1
GOBP_NEGATIVE_REGULATION_OF_...506,SET,815,-0.039906,-0.0082149,0.030498,0.90464,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_CELL_DEATH,1
GOBP_MUSCLE_CELL_DIFFERENTIA...,SET,376,-0.058063,-0.0082195,0.044367,0.90468,GOBP_MUSCLE_CELL_DIFFERENTIATION,1
GOBP_REGULATION_OF_SOMATIC_S...,SET,11,-0.33645,-0.0082286,0.25706,0.9047,GOBP_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,1
GOBP_POSITIVE_REGULATION_OF_...111,SET,29,-0.20736,-0.0082304,0.1584,0.90473,GOBP_POSITIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_TRANSFORMING_GROWTH_FACTOR_BETA_STIMULUS,1
NFY_Q6,SET,223,-0.075853,-0.0083045,0.057944,0.90474,NFY_Q6,1
GOBP_POSITIVE_REGULATION_OF_...732,SET,7,-0.35283,-0.0068844,0.26951,0.90475,GOBP_POSITIVE_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,1
PPARA_TARGET_GENES,SET,55,-0.14102,-0.0077026,0.1077,0.90479,PPARA_TARGET_GENES,1
GOMF_RNA_POLYMERASE_I_GENERA...,SET,3,-0.6228,-0.0079564,0.47565,0.90479,GOMF_RNA_POLYMERASE_I_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
RODRIGUES_NTN1_TARGETS_UP,SET,14,-0.33147,-0.009145,0.25311,0.90483,RODRIGUES_NTN1_TARGETS_UP,1
MODULE_456,SET,102,-0.1106,-0.0082166,0.084452,0.90483,MODULE_456,1
GSE19401_PAM2CSK4_VS_RETINOI...3,SET,175,-0.081785,-0.0079425,0.06244,0.90486,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_STIM_FOLLICULAR_DC_DN,1
IL21_UP.V1_UP,SET,166,-0.087113,-0.0082415,0.066505,0.90487,IL21_UP.V1_UP,1
GSE22103_LPS_VS_GMCSF_AND_IF...2,SET,173,-0.078715,-0.0076009,0.060083,0.90491,GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_UP,1
HP_ABNORMAL_CIRCULATING_IGA_...,SET,95,-0.11569,-0.0082958,0.088293,0.90494,HP_ABNORMAL_CIRCULATING_IGA_LEVEL,1
ZNF510_TARGET_GENES,SET,36,-0.18194,-0.0080445,0.13884,0.90497,ZNF510_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...381,SET,127,-0.093786,-0.0077691,0.071563,0.90498,GOBP_POSITIVE_REGULATION_OF_INTRACELLULAR_TRANSPORT,1
GOBP_NEURON_PROJECTION_EXTEN...1,SET,149,-0.090996,-0.0081599,0.069433,0.90499,GOBP_NEURON_PROJECTION_EXTENSION,1
GOBP_NEGATIVE_REGULATION_OF_...499,SET,12,-0.32281,-0.0082457,0.24625,0.90504,GOBP_NEGATIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GAVISH_3CA_METAPROGRAM_EPITH...6,SET,45,-0.17289,-0.0085445,0.13185,0.9051,GAVISH_3CA_METAPROGRAM_EPITHELIAL_EMT_LIKE_1,1
GSE2770_IL12_VS_TGFB_AND_IL1...6,SET,169,-0.087131,-0.0083167,0.06645,0.9051,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
GSE2826_XID_VS_BTK_KO_BCELL_...1,SET,185,-0.081579,-0.0081434,0.062214,0.90511,GSE2826_XID_VS_BTK_KO_BCELL_DN,1
MIR1203,SET,4,-0.54209,-0.0079963,0.41308,0.90528,MIR1203,1
GSE3982_DC_VS_NKCELL_DN,SET,166,-0.0855,-0.0080889,0.065152,0.90529,GSE3982_DC_VS_NKCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...443,SET,16,-0.2871,-0.0084672,0.21865,0.90541,GOBP_NEGATIVE_REGULATION_OF_NEURON_PROJECTION_REGENERATION,1
GOBP_REGULATION_OF_SMALL_GTP...,SET,280,-0.068124,-0.0083442,0.051874,0.90545,GOBP_REGULATION_OF_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
HP_SPOKEN_WORD_RECOGNITION_D...,SET,8,-0.38237,-0.0079759,0.29109,0.9055,HP_SPOKEN_WORD_RECOGNITION_DEFICIT,1
REACTOME_HIV_LIFE_CYCLE,SET,138,-0.084524,-0.0072966,0.064342,0.90551,REACTOME_HIV_LIFE_CYCLE,1
GSE17721_LPS_VS_GARDIQUIMOD_...14,SET,179,-0.081842,-0.0080375,0.062297,0.90553,GSE17721_LPS_VS_GARDIQUIMOD_4H_BMDC_UP,1
chr5p14,SET,5,-0.73163,-0.012066,0.55682,0.90556,chr5p14,1
GOMF_PEPTIDE_N_ACETYLTRANSFE...,SET,46,-0.14835,-0.0074122,0.11287,0.90561,GOMF_PEPTIDE_N_ACETYLTRANSFERASE_ACTIVITY,1
HP_ABNORMAL_GREATER_SCIATIC_...,SET,19,-0.26128,-0.0083965,0.1988,0.90562,HP_ABNORMAL_GREATER_SCIATIC_NOTCH_MORPHOLOGY,1
CATGTAA_MIR496,SET,161,-0.087003,-0.0081073,0.066193,0.90563,CATGTAA_MIR496,1
HP_ABNORMAL_T_CELL_PROLIFERA...,SET,14,-0.27836,-0.0076796,0.21176,0.90565,HP_ABNORMAL_T_CELL_PROLIFERATION,1
GSE22229_RENAL_TRANSPLANT_VS...2,SET,183,-0.081271,-0.0080691,0.061826,0.90565,GSE22229_RENAL_TRANSPLANT_VS_HEALTHY_PBMC_UP,1
DER_IFN_ALPHA_RESPONSE_DN,SET,4,-0.58365,-0.0086095,0.444,0.90566,DER_IFN_ALPHA_RESPONSE_DN,1
GOMF_GUANYL_NUCLEOTIDE_EXCHA...,SET,215,-0.074643,-0.0080259,0.056778,0.90568,GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
GSE5589_IL6_KO_VS_IL10_KO_LP...7,SET,184,-0.081189,-0.0080827,0.061754,0.90569,GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
GOMF_CGMP_BINDING,SET,15,-0.2832,-0.0080873,0.2154,0.9057,GOMF_CGMP_BINDING,1
GOBP_LOW_DENSITY_LIPOPROTEIN...2,SET,16,-0.30021,-0.008854,0.22832,0.90572,GOBP_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,1
GOBP_REGULATION_OF_NEURON_PR...3,SET,30,-0.21344,-0.0086163,0.16232,0.90573,GOBP_REGULATION_OF_NEURON_PROJECTION_REGENERATION,1
GSE20152_HTNFA_OVERXPRESS_AN...2,SET,174,-0.085784,-0.0083072,0.065234,0.90574,GSE20152_HTNFA_OVERXPRESS_ANKLE_VS_CTRL_SPHK1_KO_ANKLE_UP,1
GOBP_PYRIMIDINE_NUCLEOBASE_C...,SET,8,-0.40304,-0.008407,0.30647,0.90575,GOBP_PYRIMIDINE_NUCLEOBASE_CATABOLIC_PROCESS,1
GSE13485_DAY7_VS_DAY21_YF17D...1,SET,141,-0.098242,-0.0085719,0.074692,0.90579,GSE13485_DAY7_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
GSE20366_EX_VIVO_VS_HOMEOSTA...1,SET,182,-0.082192,-0.0081384,0.062489,0.90579,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_NAIVE_CD4_TCELL_DN,1
JI_METASTASIS_REPRESSED_BY_S...,SET,24,-0.25593,-0.0092423,0.19457,0.9058,JI_METASTASIS_REPRESSED_BY_STK11,1
LAKE_ADULT_KIDNEY_C8_DECENDI...,SET,253,-0.070195,-0.0081789,0.053359,0.90582,LAKE_ADULT_KIDNEY_C8_DECENDING_THIN_LIMB,1
GOBP_CELL_MIGRATION_IN_HINDB...,SET,16,-0.29512,-0.0087038,0.22431,0.90585,GOBP_CELL_MIGRATION_IN_HINDBRAIN,1
DANG_REGULATED_BY_MYC_UP,SET,65,-0.13419,-0.0079662,0.10197,0.90591,DANG_REGULATED_BY_MYC_UP,1
GOBP_CELLULAR_RESPONSE_TO_GO...,SET,17,-0.3108,-0.009448,0.23615,0.90592,GOBP_CELLULAR_RESPONSE_TO_GONADOTROPIN_STIMULUS,1
GOBP_ALPHA_KETOGLUTARATE_TRA...,SET,7,-0.41426,-0.0080831,0.31473,0.90594,GOBP_ALPHA_KETOGLUTARATE_TRANSPORT,1
HP_LENS_LUXATION,SET,6,-0.5041,-0.0091066,0.383,0.90594,HP_LENS_LUXATION,1
GOMF_OXIDOREDUCTASE_ACTIVITY...3,SET,9,-0.39037,-0.0086364,0.29655,0.90597,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_SULFUR_GROUP_OF_DONORS_DISULFIDE_AS_ACCEPTOR,1
GSE21379_WT_VS_SAP_KO_TFH_CD...1,SET,179,-0.083287,-0.0081793,0.063262,0.906,GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...191,SET,10,-0.33665,-0.0078506,0.2556,0.90609,GOBP_NEGATIVE_REGULATION_OF_DNA_TEMPLATED_DNA_REPLICATION,1
BIOCARTA_ACE2_PATHWAY,SET,9,-0.43003,-0.0095137,0.32648,0.9061,BIOCARTA_ACE2_PATHWAY,1
GOBP_MESODERMAL_CELL_DIFFERE...,SET,31,-0.20664,-0.0084793,0.15685,0.90614,GOBP_MESODERMAL_CELL_DIFFERENTIATION,1
MODULE_417,SET,21,-0.25731,-0.0086928,0.19529,0.90617,MODULE_417,1
HP_INCREASED_URINE_PROTEINOG...,SET,10,-0.32376,-0.00755,0.24569,0.9062,HP_INCREASED_URINE_PROTEINOGENIC_AMINO_ACID_DERIVATIVE_LEVEL,1
MIR6843_3P,SET,82,-0.12979,-0.0086498,0.098476,0.90623,MIR6843_3P,1
GOBP_NEGATIVE_REGULATION_OF_...245,SET,4,-0.62572,-0.0092299,0.47452,0.90634,GOBP_NEGATIVE_REGULATION_OF_FILOPODIUM_ASSEMBLY,1
DESCARTES_MAIN_FETAL_BIPOLAR...,SET,48,-0.17989,-0.009181,0.13642,0.90634,DESCARTES_MAIN_FETAL_BIPOLAR_CELLS,1
JEON_SMAD6_TARGETS_DN,SET,19,-0.24924,-0.0080095,0.18901,0.90635,JEON_SMAD6_TARGETS_DN,1
GOBP_ADENYLATE_CYCLASE_ACTIV...3,SET,162,-0.093588,-0.0087477,0.070958,0.90639,GOBP_ADENYLATE_CYCLASE_ACTIVATING_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
ZNF354A_TARGET_GENES,SET,15,-0.30906,-0.0088257,0.23426,0.90646,ZNF354A_TARGET_GENES,1
GOCC_G_PROTEIN_COUPLED_RECEP...2,SET,7,-0.44085,-0.008602,0.33416,0.90646,GOCC_G_PROTEIN_COUPLED_RECEPTOR_DIMERIC_COMPLEX,1
MODULE_40,SET,82,-0.12615,-0.0084072,0.095593,0.90651,MODULE_40,1
DURANTE_ADULT_OLFACTORY_NEUR...22,SET,32,-0.20638,-0.008604,0.15638,0.90654,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_HORIZONTAL_BASAL_CELLS,1
MODULE_300,SET,33,-0.19602,-0.0082988,0.14852,0.90655,MODULE_300,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...1,SET,6,-0.49034,-0.0088581,0.37147,0.90658,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_12_SIGNALING_PATHWAY,1
COUP_DR1_Q6,SET,218,-0.074166,-0.0080294,0.056181,0.9066,COUP_DR1_Q6,1
GOMF_VOLTAGE_GATED_POTASSIUM...2,SET,14,-0.33266,-0.0091777,0.25198,0.90661,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,1
GOBP_RESPONSE_TO_CARBOHYDRATE,SET,212,-0.076721,-0.0081923,0.058103,0.90665,GOBP_RESPONSE_TO_CARBOHYDRATE,1
HP_IRREGULAR_VERTEBRAL_ENDPL...,SET,27,-0.22095,-0.0084624,0.16733,0.90665,HP_IRREGULAR_VERTEBRAL_ENDPLATES,1
PID_HEDGEHOG_2PATHWAY,SET,21,-0.24592,-0.0083079,0.18621,0.90668,PID_HEDGEHOG_2PATHWAY,1
WP_FACTORS_AND_PATHWAYS_AFFE...,SET,36,-0.1876,-0.0082945,0.14205,0.90668,WP_FACTORS_AND_PATHWAYS_AFFECTING_INSULINLIKE_GROWTH_FACTOR_IGF1AKT_SIGNALING,1
PANGAS_TUMOR_SUPPRESSION_BY_...1,SET,128,-0.098453,-0.0081876,0.074542,0.9067,PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_DN,1
GOBP_CEREBELLAR_GRANULAR_LAY...3,SET,8,-0.48953,-0.010211,0.37064,0.9067,GOBP_CEREBELLAR_GRANULAR_LAYER_MORPHOGENESIS,1
IYENGAR_RESPONSE_TO_ADIPOCYT...,SET,10,-0.39253,-0.0091536,0.29719,0.90671,IYENGAR_RESPONSE_TO_ADIPOCYTE_FACTORS,1
RIZKI_TUMOR_INVASIVENESS_3D_...2,SET,186,-0.080497,-0.0080569,0.060941,0.90672,RIZKI_TUMOR_INVASIVENESS_3D_UP,1
VANTVEER_BREAST_CANCER_POOR_...,SET,44,-0.17642,-0.0086217,0.13354,0.90676,VANTVEER_BREAST_CANCER_POOR_PROGNOSIS,1
GOCC_HIPPOCAMPAL_MOSSY_FIBER,SET,6,-0.42128,-0.0076106,0.31883,0.90679,GOCC_HIPPOCAMPAL_MOSSY_FIBER,1
GSE3982_MAST_CELL_VS_EFF_MEM...1,SET,171,-0.085777,-0.0082353,0.064919,0.90679,GSE3982_MAST_CELL_VS_EFF_MEMORY_CD4_TCELL_DN,1
GSE23502_WT_VS_HDC_KO_MYELOI...3,SET,173,-0.089938,-0.0086846,0.068051,0.90684,GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_COLON_TUMOR_DN,1
KEGG_ADHERENS_JUNCTION,SET,66,-0.13969,-0.0083561,0.10569,0.90685,KEGG_ADHERENS_JUNCTION,1
GOBP_N_ACYLETHANOLAMINE_META...,SET,5,-0.45379,-0.0074837,0.34329,0.90689,GOBP_N_ACYLETHANOLAMINE_METABOLIC_PROCESS,1
GOBP_LIPID_GLYCOSYLATION,SET,11,-0.34489,-0.0084351,0.26086,0.90693,GOBP_LIPID_GLYCOSYLATION,1
GOMF_PEPTIDOGLYCAN_MURALYTIC...,SET,13,-0.34395,-0.0091444,0.26015,0.90693,GOMF_PEPTIDOGLYCAN_MURALYTIC_ACTIVITY,1
HP_HYPERGONADOTROPIC_HYPOGON...,SET,54,-0.14067,-0.0076139,0.10638,0.90696,HP_HYPERGONADOTROPIC_HYPOGONADISM,1
REACTOME_THROMBOXANE_SIGNALL...,SET,24,-0.24178,-0.0087314,0.18278,0.90705,REACTOME_THROMBOXANE_SIGNALLING_THROUGH_TP_RECEPTOR,1
GOBP_REGULATION_OF_MUSCLE_CE...,SET,132,-0.097901,-0.008267,0.074005,0.90706,GOBP_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,1
GSE27786_BCELL_VS_CD4_TCELL_...1,SET,177,-0.083712,-0.0081755,0.063268,0.9071,GSE27786_BCELL_VS_CD4_TCELL_DN,1
GOBP_PROTEIN_LOCALIZATION_TO...22,SET,65,-0.1303,-0.0077351,0.098428,0.90721,GOBP_PROTEIN_LOCALIZATION_TO_ENDOPLASMIC_RETICULUM,1
GOBP_NEGATIVE_REGULATION_OF_...530,SET,35,-0.18241,-0.0079524,0.13778,0.90723,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_LOCALIZATION_TO_NUCLEUS,1
HP_ABNORMAL_AUDITORY_CANAL_M...,SET,76,-0.12525,-0.0080374,0.094586,0.90727,HP_ABNORMAL_AUDITORY_CANAL_MORPHOLOGY,1
GOMF_RIBOSOMAL_PROTEIN_S6_KI...,SET,5,-0.47794,-0.0078821,0.3608,0.90735,GOMF_RIBOSOMAL_PROTEIN_S6_KINASE_ACTIVITY,1
REACTOME_HSF1_DEPENDENT_TRAN...,SET,36,-0.18712,-0.0082733,0.14125,0.90736,REACTOME_HSF1_DEPENDENT_TRANSACTIVATION,1
MODULE_334,SET,147,-0.090679,-0.0080772,0.068452,0.90736,MODULE_334,1
HOSHIDA_LIVER_CANCER_LATE_RE...1,SET,63,-0.14055,-0.008215,0.10609,0.90739,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_DN,1
GOCC_SEC61_TRANSLOCON_COMPLEX,SET,4,-0.5085,-0.0075009,0.38379,0.9074,GOCC_SEC61_TRANSLOCON_COMPLEX,1
GSE18804_BRAIN_VS_COLON_TUMO...1,SET,174,-0.08834,-0.0085547,0.066674,0.9074,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_DN,1
MIR3978,SET,228,-0.07365,-0.008152,0.055583,0.90741,MIR3978,1
GSE17721_CTRL_VS_LPS_8H_BMDC...2,SET,180,-0.08294,-0.0081678,0.062589,0.90743,GSE17721_CTRL_VS_LPS_8H_BMDC_UP,1
KEGG_SPHINGOLIPID_METABOLISM,SET,34,-0.20435,-0.0087809,0.15418,0.90746,KEGG_SPHINGOLIPID_METABOLISM,1
MIR7112_3P,SET,87,-0.12405,-0.0085146,0.093599,0.90746,MIR7112_3P,1
CERIBELLI_PROMOTERS_INACTIVE...,SET,30,-0.20841,-0.0084131,0.15723,0.90748,CERIBELLI_PROMOTERS_INACTIVE_AND_BOUND_BY_NFY,1
KRAS.BREAST_UP.V1_DN,SET,124,-0.10569,-0.008652,0.079725,0.90752,KRAS.BREAST_UP.V1_DN,1
GOBP_NEGATIVE_REGULATION_OF_...611,SET,6,-0.52592,-0.0095008,0.39664,0.90756,GOBP_NEGATIVE_REGULATION_OF_STEROID_HORMONE_BIOSYNTHETIC_PROCESS,1
MORF_SMC1L1,SET,54,-0.13362,-0.0072323,0.10077,0.90758,MORF_SMC1L1,1
KUROKAWA_LIVER_CANCER_EARLY_...2,SET,12,-0.2861,-0.0073082,0.21575,0.90759,KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_UP,1
GOBP_REGULATION_OF_SUPRAMOLE...,SET,336,-0.060538,-0.0081102,0.045647,0.90761,GOBP_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,1
GOBP_CAMERA_TYPE_EYE_PHOTORE...,SET,31,-0.20491,-0.0084086,0.1545,0.90762,GOBP_CAMERA_TYPE_EYE_PHOTORECEPTOR_CELL_DIFFERENTIATION,1
HP_OPISTHOTONUS,SET,47,-0.15946,-0.0080535,0.12023,0.90763,HP_OPISTHOTONUS,1
GSE10240_IL22_VS_IL22_AND_IL...2,SET,185,-0.080091,-0.0079949,0.060376,0.90766,GSE10240_IL22_VS_IL22_AND_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP,1
SMTTTTGT_UNKNOWN,SET,359,-0.060941,-0.0084336,0.045935,0.90768,SMTTTTGT_UNKNOWN,1
GOBP_NEGATIVE_REGULATION_OF_...628,SET,9,-0.40206,-0.008895,0.30301,0.90772,GOBP_NEGATIVE_REGULATION_OF_TELOMERASE_ACTIVITY,1
GOBP_TERMINATION_OF_RNA_POLY...,SET,10,-0.37806,-0.0088163,0.28492,0.90772,GOBP_TERMINATION_OF_RNA_POLYMERASE_II_TRANSCRIPTION,1
GSE339_CD4POS_VS_CD4CD8DN_DC...4,SET,187,-0.078898,-0.0079178,0.05945,0.90776,GSE339_CD4POS_VS_CD4CD8DN_DC_UP,1
GSE6681_DELETED_FOXP3_VS_WT_...2,SET,175,-0.086435,-0.008394,0.065125,0.90777,GSE6681_DELETED_FOXP3_VS_WT_TREG_UP,1
REACTOME_CELLULAR_SENESCENCE,SET,123,-0.10142,-0.0082688,0.07641,0.90778,REACTOME_CELLULAR_SENESCENCE,1
GSE22886_UNSTIM_VS_STIM_MEMO...2,SET,178,-0.086668,-0.0084878,0.065294,0.9078,GSE22886_UNSTIM_VS_STIM_MEMORY_TCELL_UP,1
MODULE_480,SET,83,-0.11732,-0.0078664,0.088372,0.90784,MODULE_480,1
HP_HOODED_EYELID,SET,6,-0.42458,-0.0076701,0.3198,0.90784,HP_HOODED_EYELID,1
SOBOLEV_T_CELL_PANDEMRIX_AGE...1,SET,23,-0.23252,-0.0082204,0.17514,0.90784,SOBOLEV_T_CELL_PANDEMRIX_AGE_18_64YO_1DY_UP,1
MIR651_3P,SET,728,-0.042577,-0.0083043,0.032066,0.90787,MIR651_3P,1
POU1F1_Q6,SET,218,-0.080482,-0.0087132,0.060611,0.90788,POU1F1_Q6,1
JAZAG_TGFB1_SIGNALING_DN,SET,32,-0.18766,-0.0078235,0.14131,0.90789,JAZAG_TGFB1_SIGNALING_DN,1
HP_HYPOINSULINEMIA,SET,21,-0.26973,-0.0091122,0.20311,0.90789,HP_HYPOINSULINEMIA,1
chr14q22,SET,43,-0.35869,-0.017329,0.27005,0.90794,chr14q22,1
MIR4777_5P,SET,101,-0.11432,-0.0084512,0.086066,0.90795,MIR4777_5P,1
GOBP_REGULATION_OF_LYSOSOMAL...,SET,27,-0.20393,-0.0078104,0.15351,0.90797,GOBP_REGULATION_OF_LYSOSOMAL_LUMEN_PH,1
FOXO4_TARGET_GENES,SET,293,-0.06294,-0.0078833,0.047377,0.90798,FOXO4_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...34,SET,7,-0.48252,-0.0094151,0.36312,0.90804,GOBP_POSITIVE_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,1
GSE16522_MEMORY_VS_NAIVE_CD8...2,SET,170,-0.081741,-0.0078251,0.061513,0.90804,GSE16522_MEMORY_VS_NAIVE_CD8_TCELL_UP,1
MIR3130_3P,SET,45,-0.15708,-0.007763,0.11819,0.90807,MIR3130_3P,1
HP_BRAIN_NEOPLASM,SET,16,-0.25587,-0.0075461,0.19251,0.90808,HP_BRAIN_NEOPLASM,1
GSE45365_NK_CELL_VS_CD11B_DC...4,SET,176,-0.084416,-0.0082211,0.063508,0.9081,GSE45365_NK_CELL_VS_CD11B_DC_UP,1
HP_HYPOHIDROSIS,SET,64,-0.14478,-0.0085287,0.10888,0.90818,HP_HYPOHIDROSIS,1
GSE41978_ID2_KO_AND_BIM_KO_V...2,SET,175,-0.085385,-0.0082921,0.064211,0.90819,GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
GOBP_REGULATION_OF_RESPONSE_...3,SET,4,-0.49421,-0.0072901,0.37163,0.90821,GOBP_REGULATION_OF_RESPONSE_TO_DRUG,1
HP_FACIAL_SHAPE_DEFORMATION,SET,14,-0.33205,-0.0091609,0.24966,0.90823,HP_FACIAL_SHAPE_DEFORMATION,1
GOBP_CELLULAR_RESPONSE_TO_DS...,SET,19,-0.26673,-0.0085717,0.20055,0.90824,GOBP_CELLULAR_RESPONSE_TO_DSRNA,1
GOBP_METANEPHRIC_NEPHRON_MOR...,SET,24,-0.26378,-0.0095259,0.19832,0.90824,GOBP_METANEPHRIC_NEPHRON_MORPHOGENESIS,1
DESCARTES_FETAL_HEART_CLC_IL...,SET,17,-0.28164,-0.0085615,0.21175,0.90824,DESCARTES_FETAL_HEART_CLC_IL5RA_POSITIVE_CELLS,1
WP_METABOLIC_PATHWAY_OF_LDL_...,SET,17,-0.28147,-0.0085566,0.2116,0.90827,WP_METABOLIC_PATHWAY_OF_LDL_HDL_AND_TG_INCLUDING_DISEASES,1
FINETTI_BREAST_CANCER_KINOME...2,SET,16,-0.27442,-0.0080932,0.20623,0.90833,FINETTI_BREAST_CANCER_KINOME_RED,1
GOMF_CELL_ADHESION_MOLECULE_...,SET,502,-0.05119,-0.0083437,0.038462,0.90838,GOMF_CELL_ADHESION_MOLECULE_BINDING,1
GOCC_EXOCYST,SET,16,-0.27713,-0.0081733,0.20822,0.90839,GOCC_EXOCYST,1
HP_CAPILLARY_HEMANGIOMA,SET,37,-0.18999,-0.0085159,0.14272,0.90843,HP_CAPILLARY_HEMANGIOMA,1
HP_GENERALIZED_HYPERREFLEXIA,SET,10,-0.28944,-0.0067497,0.21743,0.90843,HP_GENERALIZED_HYPERREFLEXIA,1
GOBP_RRNA_5_END_PROCESSING,SET,5,-0.45624,-0.0075242,0.34271,0.90844,GOBP_RRNA_5_END_PROCESSING,1
PEDERSEN_METASTASIS_BY_ERBB2...6,SET,346,-0.062522,-0.0084974,0.046955,0.90849,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_7,1
HP_ECZEMATOID_DERMATITIS,SET,145,-0.092585,-0.0081912,0.069528,0.9085,HP_ECZEMATOID_DERMATITIS,1
GSE3720_UNSTIM_VS_LPS_STIM_V...1,SET,130,-0.1025,-0.0085899,0.076963,0.90853,GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_DN,1
MIR574_5P,SET,77,-0.12647,-0.008169,0.094942,0.90858,MIR574_5P,1
GOBP_POSITIVE_REGULATION_OF_...245,SET,32,-0.2062,-0.0085966,0.15476,0.90863,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_APOPTOTIC_PROCESS,1
GSE22886_IGG_IGA_MEMORY_BCEL...2,SET,180,-0.085958,-0.0084649,0.064492,0.9087,GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...347,SET,26,-0.23391,-0.0087917,0.17549,0.90871,GOBP_NEGATIVE_REGULATION_OF_LIPID_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_ACTIN_FIL...5,SET,233,-0.074529,-0.0083382,0.055905,0.90875,GOBP_REGULATION_OF_ACTIN_FILAMENT_ORGANIZATION,1
HP_DECREASED_HEAD_CIRCUMFERE...,SET,1163,-0.032794,-0.0079841,0.024599,0.90875,HP_DECREASED_HEAD_CIRCUMFERENCE,1
GSE5589_IL6_KO_VS_IL10_KO_LP...4,SET,182,-0.085407,-0.0084568,0.064042,0.90882,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP,1
GOCC_INTERCELLULAR_CANALICUL...,SET,6,-0.52585,-0.0094996,0.39426,0.90885,GOCC_INTERCELLULAR_CANALICULUS,1
USF_Q6_01,SET,221,-0.07339,-0.0079992,0.055005,0.90893,USF_Q6_01,1
HP_JOINT_STIFFNESS,SET,177,-0.085248,-0.0083254,0.063884,0.90896,HP_JOINT_STIFFNESS,1
HP_VIRAL_INFECTION_INDUCED_R...,SET,9,-0.36033,-0.0079718,0.27003,0.90896,HP_VIRAL_INFECTION_INDUCED_RHABDOMYOLYSIS,1
GSE15930_STIM_VS_STIM_AND_IL...4,SET,186,-0.079093,-0.0079164,0.059271,0.90896,GSE15930_STIM_VS_STIM_AND_IL12_48H_CD8_T_CELL_UP,1
GOBP_EXTRINSIC_APOPTOTIC_SIG...1,SET,216,-0.078782,-0.0084903,0.059033,0.90898,GOBP_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
HP_ABNORMAL_FLASH_VISUAL_EVO...,SET,13,-0.28987,-0.0077067,0.21721,0.90898,HP_ABNORMAL_FLASH_VISUAL_EVOKED_POTENTIALS,1
HP_ABNORMAL_VISUAL_ACCOMMODA...,SET,5,-0.48438,-0.0079882,0.36283,0.90905,HP_ABNORMAL_VISUAL_ACCOMMODATION,1
GSE8384_CTRL_VS_B_ABORTUS_4H...1,SET,179,-0.086707,-0.0085152,0.064929,0.90912,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_DN,1
GOBP_MAMMALIAN_OOGENESIS_STA...,SET,12,-0.34877,-0.008909,0.26115,0.90914,GOBP_MAMMALIAN_OOGENESIS_STAGE,1
WP_FATTY_ACID_BETAOXIDATION,SET,31,-0.20351,-0.0083509,0.15234,0.90919,WP_FATTY_ACID_BETAOXIDATION,1
GSE15324_ELF4_KO_VS_WT_NAIVE...2,SET,181,-0.081704,-0.0080681,0.061163,0.90919,GSE15324_ELF4_KO_VS_WT_NAIVE_CD8_TCELL_UP,1
GOBP_EPITHELIAL_CELL_PROLIFE...2,SET,10,-0.41104,-0.0095852,0.30762,0.90925,GOBP_EPITHELIAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_MORPHOGENESIS,1
GOMF_HEPARAN_SULFATE_BINDING,SET,7,-0.44623,-0.0087068,0.33393,0.90927,GOMF_HEPARAN_SULFATE_BINDING,1
GOBP_MUSCLE_HYPERTROPHY_IN_R...,SET,24,-0.23433,-0.0084622,0.17533,0.9093,GOBP_MUSCLE_HYPERTROPHY_IN_RESPONSE_TO_STRESS,1
GOBP_POSITIVE_REGULATION_OF_...439,SET,429,-0.057358,-0.0086602,0.042911,0.90933,GOBP_POSITIVE_REGULATION_OF_MAPK_CASCADE,1
HP_SEVERE_PHOTOSENSITIVITY,SET,5,-0.39949,-0.0065882,0.29879,0.90938,HP_SEVERE_PHOTOSENSITIVITY,1
MODULE_182,SET,89,-0.11514,-0.0079929,0.086108,0.9094,MODULE_182,1
HP_ABNORMAL_ERYTHROID_LINEAG...,SET,6,-0.4789,-0.0086514,0.35815,0.90941,HP_ABNORMAL_ERYTHROID_LINEAGE_CELL_MORPHOLOGY,1
HP_RECURRENT_BRONCHITIS,SET,33,-0.20176,-0.0085417,0.15089,0.90941,HP_RECURRENT_BRONCHITIS,1
GOBP_ICOSANOID_TRANSPORT,SET,64,-0.1516,-0.0089303,0.11334,0.90948,GOBP_ICOSANOID_TRANSPORT,1
SMID_BREAST_CANCER_RELAPSE_I...2,SET,87,-0.12688,-0.0087088,0.094841,0.90951,SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP,1
GSE12392_CD8A_POS_VS_NEG_SPL...1,SET,185,-0.080597,-0.0080454,0.060242,0.90952,GSE12392_CD8A_POS_VS_NEG_SPLEEN_DC_DN,1
BUSSLINGER_GASTRIC_PARIETAL_...,SET,220,-0.072721,-0.0079085,0.054354,0.90953,BUSSLINGER_GASTRIC_PARIETAL_CELLS,1
GOBP_PRE_MIRNA_PROCESSING,SET,14,-0.30723,-0.0084761,0.22961,0.90955,GOBP_PRE_MIRNA_PROCESSING,1
KEGG_MEDICUS_REFERENCE_FANCO...,SET,12,-0.27439,-0.007009,0.20504,0.90958,KEGG_MEDICUS_REFERENCE_FANCONI_ANEMIA_PATHWAY,1
MIR137_3P,SET,482,-0.053706,-0.0085826,0.040102,0.90974,MIR137_3P,1
GOBP_SKIN_DEVELOPMENT,SET,301,-0.072958,-0.00926,0.054474,0.90976,GOBP_SKIN_DEVELOPMENT,1
WP_GLP1_FROM_INTESTINE_AND_P...,SET,6,-0.54342,-0.0098169,0.40566,0.9098,WP_GLP1_FROM_INTESTINE_AND_PANCREAS_AND_ROLE_IN_GLUCOSE_HOMEOSTASIS,1
GOBP_POSITIVE_REGULATION_OF_...90,SET,23,-0.26506,-0.0093707,0.19787,0.9098,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_PROLIFERATION,1
GOCC_JUNCTIONAL_MEMBRANE_COM...,SET,6,-0.46744,-0.0084444,0.34893,0.90981,GOCC_JUNCTIONAL_MEMBRANE_COMPLEX,1
MIR1182,SET,28,-0.22601,-0.0088149,0.1687,0.90982,MIR1182,1
HP_PROGRESSIVE_PULMONARY_FUN...,SET,13,-0.31084,-0.0082642,0.23203,0.90982,HP_PROGRESSIVE_PULMONARY_FUNCTION_IMPAIRMENT,1
LANG_MYB_FAMILY_TARGETS,SET,28,-0.20678,-0.008065,0.15434,0.90984,LANG_MYB_FAMILY_TARGETS,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...1,SET,178,-0.082652,-0.0080945,0.06169,0.90984,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN,1
HP_EEG_WITH_SPIKE_WAVE_COMPL...2,SET,8,-0.46712,-0.0097436,0.34853,0.90991,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES_2_5_3_5_HZ,1
GOBP_LEUKOCYTE_TETHERING_OR_...,SET,34,-0.21034,-0.0090387,0.15692,0.90994,GOBP_LEUKOCYTE_TETHERING_OR_ROLLING,1
HP_MILD_MYOPIA,SET,4,-0.66042,-0.0097418,0.49261,0.90997,HP_MILD_MYOPIA,1
HP_VILLOUS_ATROPHY,SET,24,-0.20844,-0.0075272,0.15547,0.90997,HP_VILLOUS_ATROPHY,1
GSE32034_LY6C_HIGH_VS_LOW_MO...2,SET,181,-0.086618,-0.0085534,0.06461,0.90997,GSE32034_LY6C_HIGH_VS_LOW_MONOCYTE_UP,1
GARGALOVIC_RESPONSE_TO_OXIDI...17,SET,24,-0.24286,-0.0087702,0.18111,0.91002,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_RED_DN,1
HP_IRRITABILITY,SET,243,-0.072459,-0.0082765,0.054034,0.91003,HP_IRRITABILITY,1
MIR513B_3P,SET,144,-0.096977,-0.0085503,0.072293,0.9101,MIR513B_3P,1
GOBP_POSITIVE_REGULATION_OF_...438,SET,5,-0.55656,-0.0091786,0.4149,0.9101,GOBP_POSITIVE_REGULATION_OF_MAPKKK_CASCADE_BY_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
WP_PEPTIDE_GPCRS,SET,66,-0.15705,-0.0093941,0.11707,0.91011,WP_PEPTIDE_GPCRS,1
GOBP_REGULATION_OF_MAP_KINAS...,SET,124,-0.10274,-0.0084107,0.076577,0.91015,GOBP_REGULATION_OF_MAP_KINASE_ACTIVITY,1
GOBP_PHOSPHATIDYLGLYCEROL_AC...,SET,9,-0.4201,-0.0092941,0.31301,0.91021,GOBP_PHOSPHATIDYLGLYCEROL_ACYL_CHAIN_REMODELING,1
GSE24102_GRANULOCYSTIC_MDSC_...1,SET,181,-0.082397,-0.0081366,0.06139,0.91022,GSE24102_GRANULOCYSTIC_MDSC_VS_NEUTROPHIL_DN,1
FAN_EMBRYONIC_CTX_BRAIN_ENDO...2,SET,277,-0.073577,-0.0089645,0.054819,0.91022,FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2,1
MIR1268A_MIR1268B,SET,7,-0.46055,-0.0089864,0.34312,0.91024,MIR1268A_MIR1268B,1
WP_TGFBETA_SIGNALING_IN_THYR...,SET,19,-0.26263,-0.0084399,0.19564,0.91026,WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION,1
ODONNELL_METASTASIS_DN,SET,23,-0.26082,-0.009221,0.19426,0.9103,ODONNELL_METASTASIS_DN,1
GOBP_LOBAR_BRONCHUS_DEVELOPM...,SET,6,-0.51783,-0.0093547,0.38562,0.91033,GOBP_LOBAR_BRONCHUS_DEVELOPMENT,1
HP_DEATH_IN_CHILDHOOD,SET,111,-0.10302,-0.0079819,0.076707,0.91036,HP_DEATH_IN_CHILDHOOD,1
ATM_DN.V1_DN,SET,124,-0.10731,-0.0087848,0.079904,0.91036,ATM_DN.V1_DN,1
HP_UTERINE_PROLAPSE,SET,6,-0.55054,-0.0099457,0.4099,0.91037,HP_UTERINE_PROLAPSE,1
GOBP_REGULATION_OF_MITOCHOND...6,SET,12,-0.29964,-0.0076541,0.22308,0.91039,GOBP_REGULATION_OF_MITOCHONDRIAL_FUSION,1
GOBP_POLARIZED_EPITHELIAL_CE...,SET,24,-0.24458,-0.0088324,0.182,0.91049,GOBP_POLARIZED_EPITHELIAL_CELL_DIFFERENTIATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...1,SET,28,-0.22115,-0.0086253,0.16457,0.91049,HP_APLASIA_HYPOPLASIA_OF_THE_1ST_METACARPAL,1
GSE20366_EX_VIVO_VS_HOMEOSTA...3,SET,179,-0.085614,-0.0084079,0.063708,0.91049,GSE20366_EX_VIVO_VS_HOMEOSTATIC_CONVERSION_TREG_DN,1
QI_PBMC_ZOSTAVAX_AGE_50_75YO...6,SET,224,-0.077694,-0.0085249,0.057812,0.9105,QI_PBMC_ZOSTAVAX_AGE_50_75YO_CORRELATED_WITH_EXPANSION_OF_VZV_SPECIFIC_T_CELLS_TO_PEAK_AT_1DY_POSITIVE,1
GOBP_VASCULAR_ASSOCIATED_SMO...4,SET,26,-0.26447,-0.00994,0.19678,0.91051,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,1
GOMF_MELANOCORTIN_RECEPTOR_A...,SET,6,-0.5242,-0.0094698,0.39005,0.91051,GOMF_MELANOCORTIN_RECEPTOR_ACTIVITY,1
GSE21927_SPLEEN_VS_TUMOR_MON...3,SET,149,-0.094888,-0.008509,0.070567,0.91062,GSE21927_SPLEEN_VS_TUMOR_MONOCYTE_C57BL6_DN,1
BIOCARTA_TCRA_PATHWAY,SET,10,-0.37794,-0.0088135,0.28103,0.91065,BIOCARTA_TCRA_PATHWAY,1
REACTOME_G_PROTEIN_BETA_GAMM...,SET,30,-0.20969,-0.0084648,0.15592,0.91065,REACTOME_G_PROTEIN_BETA_GAMMA_SIGNALLING,1
HUTTMANN_B_CLL_POOR_SURVIVAL...1,SET,57,-0.14965,-0.0083209,0.11127,0.91067,HUTTMANN_B_CLL_POOR_SURVIVAL_DN,1
TSENG_ADIPOGENIC_POTENTIAL_DN,SET,38,-0.20283,-0.009213,0.15081,0.91067,TSENG_ADIPOGENIC_POTENTIAL_DN,1
GSE17721_0.5H_VS_8H_CPG_BMDC...1,SET,183,-0.081145,-0.0080566,0.060334,0.91067,GSE17721_0.5H_VS_8H_CPG_BMDC_DN,1
MIR541_5P,SET,113,-0.1044,-0.0081611,0.077605,0.91073,MIR541_5P,1
GOBP_ANTEROGRADE_DENDRITIC_T...2,SET,5,-0.57692,-0.0095144,0.42882,0.91074,GOBP_ANTEROGRADE_DENDRITIC_TRANSPORT_OF_NEUROTRANSMITTER_RECEPTOR_COMPLEX,1
ZAK_PBMC_MRKAD5_HIV_1_GAG_PO...5,SET,125,-0.10695,-0.0087901,0.079477,0.91079,ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_3DY_UP,1
LAKE_ADULT_KIDNEY_C26_MESANG...,SET,164,-0.092732,-0.0087205,0.068904,0.91081,LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS,1
KAECH_DAY8_EFF_VS_DAY15_EFF_...2,SET,176,-0.078875,-0.0076815,0.058601,0.91084,KAECH_DAY8_EFF_VS_DAY15_EFF_CD8_TCELL_UP,1
REACTOME_REGULATION_OF_NPAS4...3,SET,9,-0.39171,-0.0086661,0.29097,0.91088,REACTOME_REGULATION_OF_NPAS4_MRNA_TRANSLATION,1
KEGG_BASE_EXCISION_REPAIR,SET,32,-0.18249,-0.0076079,0.13554,0.9109,KEGG_BASE_EXCISION_REPAIR,1
BIOCARTA_CTCF_PATHWAY,SET,24,-0.26028,-0.0093996,0.19331,0.91092,BIOCARTA_CTCF_PATHWAY,1
REACTOME_REGULATION_OF_NFE2L...,SET,8,-0.4228,-0.008819,0.31399,0.91092,REACTOME_REGULATION_OF_NFE2L2_GENE_EXPRESSION,1
MIR9902,SET,259,-0.071348,-0.0084099,0.052988,0.91092,MIR9902,1
LI_PROSTATE_CANCER_EPIGENETIC,SET,30,-0.21504,-0.008681,0.15969,0.91095,LI_PROSTATE_CANCER_EPIGENETIC,1
GOBP_UTERUS_DEVELOPMENT,SET,25,-0.23771,-0.0087612,0.17651,0.91095,GOBP_UTERUS_DEVELOPMENT,1
GOBP_RESPONSE_TO_STARVATION,SET,191,-0.083196,-0.008437,0.061769,0.91098,GOBP_RESPONSE_TO_STARVATION,1
HP_IRREGULAR_ACETABULAR_ROOF,SET,6,-0.41089,-0.0074228,0.30506,0.91099,HP_IRREGULAR_ACETABULAR_ROOF,1
GOMF_TRIGLYCERIDE_LIPASE_ACT...,SET,24,-0.27757,-0.010024,0.20605,0.91102,GOMF_TRIGLYCERIDE_LIPASE_ACTIVITY,1
MIR4502,SET,68,-0.13453,-0.0081679,0.099862,0.91103,MIR4502,1
OHM_EMBRYONIC_CARCINOMA_UP,SET,6,-0.49914,-0.0090171,0.37044,0.91107,OHM_EMBRYONIC_CARCINOMA_UP,1
HP_HYPERACTIVE_PATELLAR_REFL...,SET,16,-0.26502,-0.0078161,0.19666,0.91109,HP_HYPERACTIVE_PATELLAR_REFLEX,1
WP_CILIOPATHIES,SET,162,-0.085538,-0.0079953,0.063473,0.9111,WP_CILIOPATHIES,1
HP_CEREBELLAR_MALFORMATION,SET,219,-0.075705,-0.0082145,0.056177,0.9111,HP_CEREBELLAR_MALFORMATION,1
GOBP_MESENCHYMAL_CELL_PROLIF...2,SET,6,-0.52105,-0.0094128,0.38657,0.91114,GOBP_MESENCHYMAL_CELL_PROLIFERATION_INVOLVED_IN_LUNG_DEVELOPMENT,1
GOMF_INTRACILIARY_TRANSPORT_...,SET,2,-0.74387,-0.0077594,0.55187,0.91115,GOMF_INTRACILIARY_TRANSPORT_PARTICLE_B_BINDING,1
KEGG_MEDICUS_VARIANT_MUTATIO...40,SET,6,-0.43614,-0.007879,0.32348,0.91121,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_AUTOPHAGY_VESICLE_NUCLEATION,1
MIR6748_5P,SET,59,-0.15196,-0.0085961,0.11271,0.91121,MIR6748_5P,1
HP_SOFT_TISSUE_SARCOMA,SET,124,-0.10298,-0.00843,0.07636,0.91126,HP_SOFT_TISSUE_SARCOMA,1
GSE36826_WT_VS_IL1R_KO_SKIN_...3,SET,179,-0.078908,-0.0077493,0.058503,0.91129,GSE36826_WT_VS_IL1R_KO_SKIN_STAPH_AUREUS_INF_UP,1
COLIN_PILOCYTIC_ASTROCYTOMA_...2,SET,33,-0.20933,-0.008862,0.15513,0.91139,COLIN_PILOCYTIC_ASTROCYTOMA_VS_GLIOBLASTOMA_UP,1
HP_VISUAL_FIELD_DEFECT,SET,256,-0.0717,-0.008403,0.053134,0.91139,HP_VISUAL_FIELD_DEFECT,1
MIR3121_5P,SET,95,-0.12156,-0.0087171,0.09008,0.9114,MIR3121_5P,1
HP_ABNORMALITY_OF_THE_UTERUS,SET,225,-0.07625,-0.0083848,0.056498,0.91142,HP_ABNORMALITY_OF_THE_UTERUS,1
GSE3982_CTRL_VS_PMA_STIM_EOS...1,SET,175,-0.088331,-0.0085781,0.065446,0.91143,GSE3982_CTRL_VS_PMA_STIM_EOSINOPHIL_DN,1
NAKAMURA_CANCER_MICROENVIRON...2,SET,24,-0.24776,-0.0089474,0.18356,0.91144,NAKAMURA_CANCER_MICROENVIRONMENT_UP,1
BLANCO_MELO_COVID19_SARS_COV...9,SET,14,-0.34587,-0.0095421,0.2562,0.91148,BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_DN,1
HP_CLUBBING_OF_FINGERS,SET,37,-0.19262,-0.008634,0.14267,0.9115,HP_CLUBBING_OF_FINGERS,1
GOBP_NITROGEN_UTILIZATION,SET,5,-0.50367,-0.0083063,0.37304,0.91151,GOBP_NITROGEN_UTILIZATION,1
GOBP_L_KYNURENINE_METABOLIC_...,SET,5,-0.55357,-0.0091292,0.40987,0.91158,GOBP_L_KYNURENINE_METABOLIC_PROCESS,1
LEE_TARGETS_OF_PTCH1_AND_SUF...1,SET,80,-0.13172,-0.0086713,0.097506,0.91162,LEE_TARGETS_OF_PTCH1_AND_SUFU_DN,1
GOBP_DETOXIFICATION_OF_COPPE...,SET,13,-0.43277,-0.011506,0.32037,0.91162,GOBP_DETOXIFICATION_OF_COPPER_ION,1
MTF1_Q4,SET,222,-0.078777,-0.0086055,0.058294,0.9117,MTF1_Q4,1
TAKADA_GASTRIC_CANCER_COPY_N...2,SET,7,-0.42983,-0.008387,0.318,0.91175,TAKADA_GASTRIC_CANCER_COPY_NUMBER_UP,1
GOMF_LIPID_PHOSPHATASE_ACTIV...,SET,7,-0.43534,-0.0084945,0.32205,0.91177,GOMF_LIPID_PHOSPHATASE_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_OF_THE...10,SET,13,-0.32595,-0.0086657,0.24113,0.91177,HP_APLASIA_HYPOPLASIA_OF_THE_BLADDER,1
GOBP_STEROL_TRANSPORT,SET,106,-0.11149,-0.0084426,0.08247,0.91179,GOBP_STEROL_TRANSPORT,1
MODULE_168,SET,10,-0.39719,-0.0092623,0.29379,0.9118,MODULE_168,1
GSE29618_PRE_VS_DAY7_POST_LA...3,SET,172,-0.086966,-0.0083736,0.064323,0.91181,GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_MDC_DN,1
REACTOME_FICOLINS_BIND_TO_RE...,SET,5,-0.57957,-0.0095582,0.42861,0.91184,REACTOME_FICOLINS_BIND_TO_REPETITIVE_CARBOHYDRATE_STRUCTURES_ON_THE_TARGET_CELL_SURFACE,1
GOBP_REGULATION_OF_GLUTAMATE...4,SET,5,-0.54104,-0.0089227,0.4001,0.91184,GOBP_REGULATION_OF_GLUTAMATE_SECRETION_NEUROTRANSMISSION,1
GOBP_REGULATION_OF_L_GLUTAMA...,SET,8,-0.40088,-0.0083618,0.29639,0.91189,GOBP_REGULATION_OF_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOMF_COLLAGEN_BINDING_INVOLV...,SET,4,-0.66912,-0.0098702,0.4947,0.9119,GOMF_COLLAGEN_BINDING_INVOLVED_IN_CELL_MATRIX_ADHESION,1
GSE22886_NAIVE_CD4_TCELL_VS_...16,SET,176,-0.083064,-0.0080894,0.061411,0.9119,GSE22886_NAIVE_CD4_TCELL_VS_NEUTROPHIL_UP,1
GSE22886_TH1_VS_TH2_12H_ACT_...2,SET,180,-0.082658,-0.00814,0.061111,0.9119,GSE22886_TH1_VS_TH2_12H_ACT_UP,1
PID_P53_DOWNSTREAM_PATHWAY,SET,134,-0.096502,-0.0082099,0.071318,0.91198,PID_P53_DOWNSTREAM_PATHWAY,1
GOBP_AMP_BIOSYNTHETIC_PROCESS,SET,10,-0.34975,-0.008156,0.25847,0.91198,GOBP_AMP_BIOSYNTHETIC_PROCESS,1
MEIS1BHOXA9_01,SET,127,-0.11038,-0.0091435,0.081555,0.91203,MEIS1BHOXA9_01,1
REACTOME_TRANSCRIPTION_OF_TH...,SET,62,-0.12252,-0.0071042,0.090513,0.91207,REACTOME_TRANSCRIPTION_OF_THE_HIV_GENOME,1
GSE21927_UNTREATED_VS_GMCSF_...3,SET,153,-0.093684,-0.0085121,0.069207,0.91207,GSE21927_UNTREATED_VS_GMCSF_IL6_TREATED_BONE_MARROW_DN,1
GOBP_REGULATION_OF_ORGANELLE...2,SET,1094,-0.03535,-0.008364,0.026111,0.9121,GOBP_REGULATION_OF_ORGANELLE_ORGANIZATION,1
MASSARWEH_TAMOXIFEN_RESISTAN...1,SET,212,-0.082536,-0.0088131,0.060961,0.91211,MASSARWEH_TAMOXIFEN_RESISTANCE_DN,1
ONGUSAHA_BRCA1_TARGETS_DN,SET,11,-0.34282,-0.0083844,0.25319,0.91212,ONGUSAHA_BRCA1_TARGETS_DN,1
MIR4748,SET,61,-0.14261,-0.0082023,0.10531,0.91216,MIR4748,1
HP_SMALL_CEREBRAL_CORTEX,SET,8,-0.41572,-0.0086714,0.30698,0.91216,HP_SMALL_CEREBRAL_CORTEX,1
GSE3982_DC_VS_NKCELL_UP,SET,181,-0.088532,-0.0087424,0.065363,0.9122,GSE3982_DC_VS_NKCELL_UP,1
GOBP_EPITHELIAL_CELL_CELL_AD...,SET,16,-0.29321,-0.0086476,0.21647,0.91221,GOBP_EPITHELIAL_CELL_CELL_ADHESION,1
HP_METAPHYSEAL_CHONDRODYSPLA...,SET,10,-0.38738,-0.0090336,0.28597,0.91222,HP_METAPHYSEAL_CHONDRODYSPLASIA,1
GOBP_POSITIVE_REGULATION_OF_...837,SET,10,-0.40823,-0.0095199,0.30135,0.91223,GOBP_POSITIVE_REGULATION_OF_VESICLE_FUSION,1
HP_PARAPLEGIA_PARAPARESIS,SET,181,-0.082573,-0.0081539,0.060954,0.91223,HP_PARAPLEGIA_PARAPARESIS,1
HP_LUMBAR_KYPHOSIS,SET,6,-0.45466,-0.0082136,0.33559,0.91225,HP_LUMBAR_KYPHOSIS,1
HP_ABNORMAL_CIRCULATING_NITR...,SET,154,-0.089338,-0.0081434,0.065932,0.91228,HP_ABNORMAL_CIRCULATING_NITROGEN_COMPOUND_CONCENTRATION,1
CCCNNGGGAR_OLF1_01,SET,293,-0.068357,-0.0085618,0.050447,0.91229,CCCNNGGGAR_OLF1_01,1
WEBER_METHYLATED_LCP_IN_SPER...1,SET,6,-0.4674,-0.0084437,0.34484,0.91234,WEBER_METHYLATED_LCP_IN_SPERM_DN,1
GSE15659_RESTING_VS_ACTIVATE...2,SET,154,-0.092962,-0.0084738,0.068586,0.91235,GSE15659_RESTING_VS_ACTIVATED_TREG_UP,1
REACTOME_TLR3_MEDIATED_TICAM...,SET,6,-0.51886,-0.0093734,0.38279,0.91236,REACTOME_TLR3_MEDIATED_TICAM1_DEPENDENT_PROGRAMMED_CELL_DEATH,1
GOMF_VASOPRESSIN_RECEPTOR_AC...,SET,6,-0.51675,-0.0093351,0.38123,0.91236,GOMF_VASOPRESSIN_RECEPTOR_ACTIVITY,1
ACAGGGT_MIR10A_MIR10B,SET,111,-0.10554,-0.0081768,0.077853,0.91237,ACAGGGT_MIR10A_MIR10B,1
GOBP_POSITIVE_REGULATION_OF_...760,SET,8,-0.37606,-0.0078442,0.2774,0.91239,GOBP_POSITIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_3_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_MITOTIC_R...,SET,6,-0.37919,-0.0068501,0.27968,0.91241,GOBP_REGULATION_OF_MITOTIC_RECOMBINATION,1
HP_DECREASED_CIRCULATING_ANT...,SET,175,-0.086227,-0.0083738,0.063578,0.91248,HP_DECREASED_CIRCULATING_ANTIBODY_LEVEL,1
HP_PITUITARY_CORTICOTROPIC_C...,SET,11,-0.34445,-0.0084243,0.25397,0.91248,HP_PITUITARY_CORTICOTROPIC_CELL_ADENOMA,1
MIR548AZ_3P,SET,437,-0.054991,-0.0083781,0.04054,0.91252,MIR548AZ_3P,1
HP_HYPERVENTILATION,SET,26,-0.24783,-0.0093149,0.1827,0.91252,HP_HYPERVENTILATION,1
GOBP_REGULATION_OF_MESODERMA...1,SET,8,-0.44235,-0.0092268,0.32595,0.91261,GOBP_REGULATION_OF_MESODERMAL_CELL_DIFFERENTIATION,1
GSE37301_COMMON_LYMPHOID_PRO...2,SET,168,-0.085485,-0.0081356,0.062986,0.91263,GSE37301_COMMON_LYMPHOID_PROGENITOR_VS_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...592,SET,2,-0.81889,-0.0085419,0.60327,0.91267,GOBP_NEGATIVE_REGULATION_OF_SISTER_CHROMATID_COHESION,1
YKACATTT_UNKNOWN,SET,257,-0.073606,-0.008643,0.054209,0.91273,YKACATTT_UNKNOWN,1
PAX5_01,SET,138,-0.098425,-0.0084966,0.072476,0.91276,PAX5_01,1
GOBP_ETHANOLAMINE_CONTAINING...,SET,7,-0.41728,-0.0081421,0.30724,0.91279,GOBP_ETHANOLAMINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GOBP_MAINTENANCE_OF_GASTROIN...,SET,21,-0.28503,-0.0096291,0.20984,0.9128,GOBP_MAINTENANCE_OF_GASTROINTESTINAL_EPITHELIUM,1
GOCC_LEWY_BODY,SET,7,-0.40246,-0.0078529,0.29626,0.91283,GOCC_LEWY_BODY,1
GOBP_PROTEIN_O_LINKED_MANNOS...,SET,14,-0.2893,-0.0079816,0.21293,0.91287,GOBP_PROTEIN_O_LINKED_MANNOSYLATION,1
GSE17974_0H_VS_0.5H_IN_VITRO...1,SET,160,-0.087538,-0.008132,0.064428,0.91287,GSE17974_0H_VS_0.5H_IN_VITRO_ACT_CD4_TCELL_DN,1
BCL6B_TARGET_GENES,SET,129,-0.1031,-0.0086076,0.075882,0.91288,BCL6B_TARGET_GENES,1
KHETCHOUMIAN_TRIM24_TARGETS_...1,SET,7,-0.47653,-0.0092982,0.35067,0.9129,KHETCHOUMIAN_TRIM24_TARGETS_DN,1
ONO_FOXP3_TARGETS_UP,SET,21,-0.28706,-0.0096978,0.21112,0.91303,ONO_FOXP3_TARGETS_UP,1
ADCYAP1_TARGET_GENES,SET,7,-0.40762,-0.0079535,0.29977,0.91304,ADCYAP1_TARGET_GENES,1
GSE22886_CD4_TCELL_VS_BCELL_...1,SET,170,-0.088865,-0.008507,0.065348,0.91306,GSE22886_CD4_TCELL_VS_BCELL_NAIVE_DN,1
MIR7150,SET,121,-0.10173,-0.0082274,0.074782,0.91314,MIR7150,1
HP_ABNORMAL_PROXIMAL_FEMORAL...,SET,8,-0.39062,-0.0081478,0.28714,0.91314,HP_ABNORMAL_PROXIMAL_FEMORAL_METAPHYSIS_MORPHOLOGY,1
GSE35825_IFNA_VS_IFNG_STIM_M...2,SET,154,-0.093219,-0.0084972,0.068511,0.91318,GSE35825_IFNA_VS_IFNG_STIM_MACROPHAGE_UP,1
GSE37532_WT_VS_PPARG_KO_VISC...4,SET,167,-0.085773,-0.0081389,0.063037,0.91318,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TREG_UP,1
HP_DELAYED_CLOSURE_OF_THE_AN...,SET,29,-0.19809,-0.0078625,0.14558,0.91319,HP_DELAYED_CLOSURE_OF_THE_ANTERIOR_FONTANELLE,1
GOBP_DE_NOVO_AMP_BIOSYNTHETI...,SET,6,-0.46167,-0.0083401,0.33925,0.91321,GOBP_DE_NOVO_AMP_BIOSYNTHETIC_PROCESS,1
GOBP_BODY_MORPHOGENESIS,SET,45,-0.16767,-0.0082864,0.12321,0.91322,GOBP_BODY_MORPHOGENESIS,1
MIR4769_5P,SET,39,-0.18611,-0.0085639,0.13673,0.91325,MIR4769_5P,1
GOCC_BASAL_CORTEX,SET,5,-0.4003,-0.0066016,0.29403,0.9133,GOCC_BASAL_CORTEX,1
GOBP_VASCULAR_ASSOCIATED_SMO...5,SET,57,-0.16369,-0.0091016,0.12022,0.91333,GOBP_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
GSE29615_CTRL_VS_LAIV_FLU_VA...1,SET,136,-0.096723,-0.0082894,0.071021,0.91337,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_DN,1
BOYLAN_MULTIPLE_MYELOMA_PCA1...2,SET,98,-0.12344,-0.0089895,0.090636,0.91338,BOYLAN_MULTIPLE_MYELOMA_PCA1_UP,1
HP_TYPICAL_ABSENCE_SEIZURE,SET,37,-0.19081,-0.0085526,0.1401,0.91338,HP_TYPICAL_ABSENCE_SEIZURE,1
GOBP_NEGATIVE_REGULATION_OF_...624,SET,8,-0.46175,-0.0096315,0.339,0.91341,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GOBP_POSITIVE_REGULATION_OF_...160,SET,20,-0.28093,-0.0092622,0.20624,0.91342,GOBP_POSITIVE_REGULATION_OF_CHONDROCYTE_DIFFERENTIATION,1
MIR548A_3P,SET,431,-0.055773,-0.0084401,0.040942,0.91343,MIR548A_3P,1
HP_CONGENITAL_CONTRACTURE,SET,156,-0.092718,-0.0085058,0.068058,0.91345,HP_CONGENITAL_CONTRACTURE,1
HE_LIM_SUN_FETAL_LUNG_C4_NKT...2,SET,8,-0.42869,-0.008942,0.31467,0.91345,HE_LIM_SUN_FETAL_LUNG_C4_NKT2_CELL,1
GSE3982_MAC_VS_TH2_DN,SET,187,-0.079303,-0.0079585,0.058207,0.91346,GSE3982_MAC_VS_TH2_DN,1
GOBP_ROOF_OF_MOUTH_DEVELOPME...,SET,89,-0.1373,-0.0095313,0.10072,0.91357,GOBP_ROOF_OF_MOUTH_DEVELOPMENT,1
GOBP_BRANCHED_CHAIN_AMINO_AC...2,SET,21,-0.23884,-0.0080687,0.1752,0.91358,GOBP_BRANCHED_CHAIN_AMINO_ACID_CATABOLIC_PROCESS,1
GSE4811_CLASSSICALY_ACTIVATE...1,SET,177,-0.088498,-0.0086429,0.064915,0.9136,GSE4811_CLASSSICALY_ACTIVATED_VS_TYPE_2_ACTIVATED_MACROPHAGE_DN,1
ARNT_02,SET,217,-0.075707,-0.0081776,0.055514,0.91367,ARNT_02,1
HP_BLINDNESS,SET,266,-0.069225,-0.0082676,0.05076,0.91367,HP_BLINDNESS,1
HP_CERVICAL_RIBS,SET,10,-0.33309,-0.0077676,0.24425,0.91367,HP_CERVICAL_RIBS,1
MA_RAT_AGING_DN,SET,144,-0.10036,-0.0088487,0.07357,0.91373,MA_RAT_AGING_DN,1
GSE9650_NAIVE_VS_EFF_CD8_TCE...1,SET,188,-0.086919,-0.0087458,0.063704,0.91377,GSE9650_NAIVE_VS_EFF_CD8_TCELL_DN,1
GSE2770_UNTREATED_VS_TGFB_AN...12,SET,183,-0.082906,-0.0082314,0.060755,0.9138,GSE2770_UNTREATED_VS_TGFB_AND_IL4_TREATED_ACT_CD4_TCELL_4H_UP,1
GOCC_ALPHA_BETA_T_CELL_RECEP...,SET,4,-0.57865,-0.0085357,0.424,0.91383,GOCC_ALPHA_BETA_T_CELL_RECEPTOR_COMPLEX,1
MIR4513,SET,46,-0.16724,-0.0083561,0.12253,0.91384,MIR4513,1
GOBP_PROTEIN_LOCALIZATION_TO...26,SET,29,-0.18448,-0.0073223,0.13517,0.91384,GOBP_PROTEIN_LOCALIZATION_TO_GOLGI_APPARATUS,1
GSE41867_NAIVE_VS_DAY15_LCMV...6,SET,183,-0.082365,-0.0081778,0.060343,0.91385,GSE41867_NAIVE_VS_DAY15_LCMV_EFFECTOR_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...667,SET,22,-0.24966,-0.0086325,0.1829,0.91386,GOBP_NEGATIVE_REGULATION_OF_TYPE_I_INTERFERON_MEDIATED_SIGNALING_PATHWAY,1
GOCC_CLATHRIN_COATED_PIT,SET,73,-0.13429,-0.0084469,0.098357,0.91392,GOCC_CLATHRIN_COATED_PIT,1
DESCARTES_MAIN_FETAL_RETINAL...2,SET,43,-0.18225,-0.0088051,0.13347,0.91394,DESCARTES_MAIN_FETAL_RETINAL_PROGENITORS_AND_MULLER_GLIA,1
GSE17721_CPG_VS_GARDIQUIMOD_...6,SET,185,-0.085908,-0.0085755,0.062894,0.91401,GSE17721_CPG_VS_GARDIQUIMOD_16H_BMDC_UP,1
HP_ABNORMAL_NERVOUS_SYSTEM_E...,SET,610,-0.046065,-0.0082517,0.033722,0.91402,HP_ABNORMAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
GSE2770_TGFB_AND_IL4_VS_IL12...4,SET,173,-0.08573,-0.0082783,0.062756,0.91404,GSE2770_TGFB_AND_IL4_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
WP_SARSCOV2_AND_COVID19_PATH...,SET,8,-0.46812,-0.0097645,0.34261,0.91407,WP_SARSCOV2_AND_COVID19_PATHWAY,1
GOMF_GLYCINE_N_ACYLTRANSFERA...,SET,4,-0.77532,-0.011437,0.56742,0.91409,GOMF_GLYCINE_N_ACYLTRANSFERASE_ACTIVITY,1
GSE13547_2H_VS_12_H_ANTI_IGM...4,SET,154,-0.093603,-0.0085322,0.068495,0.91411,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_ZFX_KO_BCELL_UP,1
MIR302F,SET,167,-0.090953,-0.0086304,0.06654,0.91416,MIR302F,1
GOBP_ESTABLISHMENT_OF_EPITHE...2,SET,32,-0.21219,-0.0088462,0.15522,0.91418,GOBP_ESTABLISHMENT_OF_EPITHELIAL_CELL_POLARITY,1
HP_MACULAR_HYPERPIGMENTATION,SET,6,-0.54796,-0.009899,0.40077,0.91422,HP_MACULAR_HYPERPIGMENTATION,1
GSE36476_YOUNG_VS_OLD_DONOR_...4,SET,176,-0.089402,-0.0087067,0.065389,0.91422,GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_40H_TSST_ACT_UP,1
REACTOME_LYSINE_CATABOLISM,SET,12,-0.3198,-0.0081689,0.23388,0.91424,REACTOME_LYSINE_CATABOLISM,1
GSE39820_TGFBETA3_IL6_VS_TGF...2,SET,181,-0.084655,-0.0083595,0.061907,0.91425,GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP,1
REACTOME_REGULATION_OF_HOMOT...,SET,30,-0.2218,-0.008954,0.16215,0.91432,REACTOME_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
GOBP_REGULATION_OF_POSTSYNAP...10,SET,15,-0.29335,-0.0083771,0.21443,0.91434,GOBP_REGULATION_OF_POSTSYNAPTIC_SPECIALIZATION_ASSEMBLY,1
HP_CRANIAL_HYPEROSTOSIS,SET,40,-0.16338,-0.0076135,0.11942,0.91435,HP_CRANIAL_HYPEROSTOSIS,1
GSE23505_IL6_IL1_VS_IL6_IL1_...4,SET,186,-0.083272,-0.0083346,0.060855,0.91439,GSE23505_IL6_IL1_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_UP,1
HP_RESTLESS_LEGS,SET,22,-0.24219,-0.0083743,0.17694,0.91446,HP_RESTLESS_LEGS,1
HP_ARTHROGRYPOSIS_MULTIPLEX_...,SET,122,-0.10455,-0.0084899,0.076378,0.91447,HP_ARTHROGRYPOSIS_MULTIPLEX_CONGENITA,1
HP_INCREASED_FEMORAL_ANTEVER...,SET,4,-0.47019,-0.0069358,0.34347,0.91448,HP_INCREASED_FEMORAL_ANTEVERSION,1
HP_VELOPHARYNGEAL_INSUFFICIE...,SET,26,-0.22973,-0.0086344,0.1678,0.9145,HP_VELOPHARYNGEAL_INSUFFICIENCY,1
GOBP_POSITIVE_REGULATION_OF_...218,SET,9,-0.35168,-0.0077804,0.25686,0.91452,GOBP_POSITIVE_REGULATION_OF_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
HP_SKULL_ASYMMETRY,SET,7,-0.44476,-0.0086781,0.32477,0.91456,HP_SKULL_ASYMMETRY,1
MIR4500,SET,465,-0.05534,-0.0086904,0.040409,0.91457,MIR4500,1
REACTOME_NRAGE_SIGNALS_DEATH...,SET,53,-0.16194,-0.0086837,0.11819,0.91467,REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK,1
REACTOME_RUNX2_REGULATES_CHO...,SET,5,-0.53948,-0.008897,0.3937,0.91469,REACTOME_RUNX2_REGULATES_CHONDROCYTE_MATURATION,1
MYF6_TARGET_GENES,SET,13,-0.31558,-0.0083901,0.2303,0.9147,MYF6_TARGET_GENES,1
HP_EEG_WITH_SPIKE_WAVE_COMPL...1,SET,88,-0.1279,-0.0088287,0.093334,0.9147,HP_EEG_WITH_SPIKE_WAVE_COMPLEXES,1
HP_CHRONIC_CONSTIPATION,SET,90,-0.12326,-0.0086046,0.089947,0.91471,HP_CHRONIC_CONSTIPATION,1
REACTOME_REGULATION_OF_GENE_...4,SET,5,-0.59092,-0.0097452,0.43109,0.91476,REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_ENDOCRINE_COMMITTED_NEUROG3_PROGENITOR_CELLS,1
MIR4643,SET,197,-0.083309,-0.0085788,0.060767,0.9148,MIR4643,1
MIR6814_5P,SET,100,-0.1147,-0.0084374,0.08366,0.9148,MIR6814_5P,1
HP_ABNORMAL_METAPHYSIS_MORPH...,SET,204,-0.080868,-0.0084725,0.058969,0.91486,HP_ABNORMAL_METAPHYSIS_MORPHOLOGY,1
PID_SMAD2_3NUCLEAR_PATHWAY,SET,75,-0.13645,-0.0086987,0.099494,0.91487,PID_SMAD2_3NUCLEAR_PATHWAY,1
GSE17812_WT_VS_THPOK_KO_MEMO...2,SET,182,-0.083746,-0.0082924,0.061051,0.91492,GSE17812_WT_VS_THPOK_KO_MEMORY_CD8_TCELL_UP,1
GSE15930_NAIVE_VS_24H_IN_VIT...2,SET,187,-0.084714,-0.0085015,0.061752,0.91494,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_CD8_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...366,SET,31,-0.20029,-0.0082188,0.14599,0.91495,GOBP_NEGATIVE_REGULATION_OF_MACROAUTOPHAGY,1
GSE7852_LN_VS_FAT_TREG_UP,SET,181,-0.083764,-0.0082715,0.061054,0.91495,GSE7852_LN_VS_FAT_TREG_UP,1
REACTOME_RHOF_GTPASE_CYCLE,SET,39,-0.18847,-0.0086726,0.13735,0.91498,REACTOME_RHOF_GTPASE_CYCLE,1
CCTGAGT_MIR510,SET,35,-0.18992,-0.0082801,0.13839,0.91502,CCTGAGT_MIR510,1
GOMF_HYDROPEROXY_ICOSATETRAE...,SET,7,-0.47594,-0.0092865,0.3468,0.91502,GOMF_HYDROPEROXY_ICOSATETRAENOATE_DEHYDRATASE_ACTIVITY,1
HP_ABNORMAL_PARATHYROID_MORP...,SET,22,-0.26295,-0.009092,0.19154,0.91508,HP_ABNORMAL_PARATHYROID_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...356,SET,10,-0.4325,-0.010086,0.31503,0.9151,GOBP_POSITIVE_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOCC_CASPASE_COMPLEX,SET,10,-0.32611,-0.0076049,0.23754,0.9151,GOCC_CASPASE_COMPLEX,1
HP_FEEDING_DIFFICULTIES,SET,1009,-0.035895,-0.0081762,0.026146,0.9151,HP_FEEDING_DIFFICULTIES,1
GSE3982_EOSINOPHIL_VS_NKCELL...1,SET,171,-0.087926,-0.0084416,0.064035,0.91513,GSE3982_EOSINOPHIL_VS_NKCELL_DN,1
GOMF_INTRAMOLECULAR_OXIDORED...2,SET,5,-0.39638,-0.006537,0.28863,0.91516,GOMF_INTRAMOLECULAR_OXIDOREDUCTASE_ACTIVITY_INTERCONVERTING_ALDOSES_AND_KETOSES,1
GOCC_TOR_COMPLEX,SET,12,-0.31917,-0.0081529,0.23237,0.9152,GOCC_TOR_COMPLEX,1
HP_INCREASED_LEVEL_OF_HIPPUR...,SET,5,-0.53671,-0.0088512,0.3907,0.91523,HP_INCREASED_LEVEL_OF_HIPPURIC_ACID_IN_URINE,1
GOBP_RAC_PROTEIN_SIGNAL_TRAN...,SET,44,-0.16715,-0.0081688,0.12166,0.91525,GOBP_RAC_PROTEIN_SIGNAL_TRANSDUCTION,1
GOBP_ESTABLISHMENT_OF_SKIN_B...,SET,33,-0.21782,-0.0092217,0.15845,0.91538,GOBP_ESTABLISHMENT_OF_SKIN_BARRIER,1
HP_LOW_ALKALINE_PHOSPHATASE,SET,10,-0.39436,-0.0091963,0.28688,0.91538,HP_LOW_ALKALINE_PHOSPHATASE,1
HP_BASILAR_IMPRESSION,SET,5,-0.57862,-0.0095424,0.42087,0.9154,HP_BASILAR_IMPRESSION,1
HP_TYPE_I_TRANSFERRIN_ISOFOR...,SET,17,-0.22795,-0.0069295,0.1658,0.9154,HP_TYPE_I_TRANSFERRIN_ISOFORM_PROFILE,1
GSE17721_CTRL_VS_LPS_12H_BMD...1,SET,182,-0.084114,-0.0083288,0.061179,0.91541,GSE17721_CTRL_VS_LPS_12H_BMDC_DN,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...4,SET,23,-0.25364,-0.0089671,0.18443,0.91547,OVSYANNIKOVA_PBMC_FLUARIX_AGE_50_74YO_COMMON_WITH_BOTH_HAI_AND_VNA_28DY_VS_3DY_USED_IN_HAI_AND_VNA_RESPONSE_MODELS_UP,1
GOBP_TRUNK_SEGMENTATION,SET,5,-0.53559,-0.0088329,0.3894,0.91549,GOBP_TRUNK_SEGMENTATION,1
MURAKAMI_UV_RESPONSE_6HR_UP,SET,31,-0.20578,-0.0084441,0.14959,0.91552,MURAKAMI_UV_RESPONSE_6HR_UP,1
HP_TRACHEOBRONCHOMALACIA,SET,7,-0.36674,-0.0071559,0.26658,0.91554,HP_TRACHEOBRONCHOMALACIA,1
MIR4418,SET,118,-0.10655,-0.0085102,0.077447,0.91555,MIR4418,1
GOBP_REGULATION_OF_ANDROGEN_...,SET,25,-0.21717,-0.0080041,0.15781,0.9156,GOBP_REGULATION_OF_ANDROGEN_RECEPTOR_SIGNALING_PATHWAY,1
GSE26023_PHD3_KO_VS_WT_NEUTR...1,SET,179,-0.084282,-0.008277,0.061242,0.91561,GSE26023_PHD3_KO_VS_WT_NEUTROPHIL_HYPOXIA_DN,1
REACTOME_FRS_MEDIATED_FGFR1_...,SET,23,-0.2421,-0.0085592,0.17591,0.91562,REACTOME_FRS_MEDIATED_FGFR1_SIGNALING,1
GOBP_PORPHYRIN_CONTAINING_CO...,SET,48,-0.16225,-0.008281,0.11784,0.91571,GOBP_PORPHYRIN_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GSE6092_IFNG_VS_IFNG_AND_B_B...1,SET,160,-0.095928,-0.0089114,0.069658,0.91576,GSE6092_IFNG_VS_IFNG_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,1
GOCC_SECONDARY_LYSOSOME,SET,19,-0.26332,-0.0084619,0.19119,0.91577,GOCC_SECONDARY_LYSOSOME,1
GSE7568_CTRL_VS_3H_TGFB_TREA...1,SET,150,-0.091708,-0.0082511,0.066575,0.91581,GSE7568_CTRL_VS_3H_TGFB_TREATED_MACROPHAGES_WITH_IL4_AND_DEXAMETHASONE_DN,1
GOMF_RETROMER_COMPLEX_BINDING,SET,6,-0.53152,-0.009602,0.38582,0.91583,GOMF_RETROMER_COMPLEX_BINDING,1
GOBP_CARBOHYDRATE_HOMEOSTASIS,SET,229,-0.07831,-0.0086867,0.056814,0.91594,GOBP_CARBOHYDRATE_HOMEOSTASIS,1
KEGG_MEDICUS_REFERENCE_ITGA_...3,SET,22,-0.26189,-0.0090553,0.18999,0.91596,KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY,1
RACCACAR_AML_Q6,SET,240,-0.076613,-0.0086974,0.05557,0.91599,RACCACAR_AML_Q6,1
MIR6754_5P,SET,111,-0.10919,-0.00846,0.079192,0.91602,MIR6754_5P,1
GOCC_ISWI_TYPE_COMPLEX,SET,12,-0.32329,-0.0082581,0.23445,0.91603,GOCC_ISWI_TYPE_COMPLEX,1
HP_GLAUCOMA,SET,316,-0.067602,-0.0087877,0.049027,0.91603,HP_GLAUCOMA,1
GOBP_PEPTIDYL_THREONINE_MODI...,SET,100,-0.1189,-0.0087467,0.08621,0.91608,GOBP_PEPTIDYL_THREONINE_MODIFICATION,1
MIR607,SET,872,-0.040875,-0.0086895,0.02963,0.91612,MIR607,1
BCAT.100_UP.V1_DN,SET,24,-0.24213,-0.008744,0.1755,0.91614,BCAT.100_UP.V1_DN,1
REACTOME_RUNX3_REGULATES_CDK...,SET,7,-0.43361,-0.0084606,0.31427,0.91615,REACTOME_RUNX3_REGULATES_CDKN1A_TRANSCRIPTION,1
SREBP1_01,SET,140,-0.09602,-0.0083484,0.069592,0.91616,SREBP1_01,1
HP_CERVICAL_MYELOPATHY,SET,7,-0.46134,-0.0090016,0.33435,0.91617,HP_CERVICAL_MYELOPATHY,1
HP_FASTING_HYPOGLYCEMIA,SET,20,-0.27566,-0.0090885,0.19975,0.9162,HP_FASTING_HYPOGLYCEMIA,1
HARALAMBIEVA_PBMC_DRYVAX_AGE...,SET,14,-0.33213,-0.0091632,0.24066,0.91621,HARALAMBIEVA_PBMC_DRYVAX_AGE_18_40YO_STIMULATED_VS_UNSTIMULATED_9_TO_34MO_UP,1
GCM_RING1,SET,98,-0.11095,-0.0080799,0.080388,0.91622,GCM_RING1,1
GOBP_REGULATION_OF_BRANCHING...4,SET,17,-0.30691,-0.0093297,0.22237,0.91622,GOBP_REGULATION_OF_BRANCHING_INVOLVED_IN_URETERIC_BUD_MORPHOGENESIS,1
GSE3039_B2_VS_B1_BCELL_DN,SET,180,-0.081308,-0.008007,0.0589,0.91626,GSE3039_B2_VS_B1_BCELL_DN,1
HP_PREMATURE_BIRTH,SET,151,-0.091804,-0.008287,0.066501,0.91627,HP_PREMATURE_BIRTH,1
GOCC_ACTIN_BASED_CELL_PROJEC...,SET,208,-0.082162,-0.008691,0.059515,0.91628,GOCC_ACTIN_BASED_CELL_PROJECTION,1
GHANDHI_DIRECT_IRRADIATION_UP,SET,98,-0.12576,-0.0091586,0.091072,0.91633,GHANDHI_DIRECT_IRRADIATION_UP,1
TSUDA_ALVEOLAR_SOFT_PART_SAR...,SET,10,-0.39158,-0.0091314,0.28356,0.91634,TSUDA_ALVEOLAR_SOFT_PART_SARCOMA,1
GSE2128_CTRL_VS_MIMETOPE_NEG...3,SET,164,-0.089694,-0.0084348,0.064935,0.91639,GSE2128_CTRL_VS_MIMETOPE_NEGATIVE_SELECTION_DP_THYMOCYTE_NOD_DN,1
KYNG_DNA_DAMAGE_DN,SET,171,-0.086589,-0.0083132,0.062684,0.91641,KYNG_DNA_DAMAGE_DN,1
GOBP_BOX_C_D_SNORNP_ASSEMBLY,SET,8,-0.37783,-0.0078811,0.27341,0.91649,GOBP_BOX_C_D_SNORNP_ASSEMBLY,1
GOCC_SOMATODENDRITIC_COMPART...,SET,771,-0.044204,-0.0088617,0.031983,0.91652,GOCC_SOMATODENDRITIC_COMPARTMENT,1
HP_ADRENOCORTICOTROPIC_HORMO...2,SET,4,-0.53547,-0.0078987,0.38742,0.91653,HP_ADRENOCORTICOTROPIC_HORMONE_EXCESS,1
BOYAULT_LIVER_CANCER_SUBCLAS...3,SET,14,-0.35992,-0.0099298,0.26036,0.91656,BOYAULT_LIVER_CANCER_SUBCLASS_G12_DN,1
MEBARKI_HCC_PROGENITOR_WNT_D...4,SET,13,-0.33267,-0.0088445,0.24064,0.91657,MEBARKI_HCC_PROGENITOR_WNT_DN_CTNNB1_INDEPENDENT,1
HP_ARTERIAL_DISSECTION,SET,12,-0.39648,-0.010128,0.28676,0.91659,HP_ARTERIAL_DISSECTION,1
GOBP_GENITALIA_MORPHOGENESIS,SET,11,-0.39969,-0.0097753,0.28884,0.91678,GOBP_GENITALIA_MORPHOGENESIS,1
HP_ABSENCE_OF_SUBCUTANEOUS_F...,SET,13,-0.29398,-0.0078157,0.21228,0.91695,HP_ABSENCE_OF_SUBCUTANEOUS_FAT,1
HP_CONSTRICTION_OF_PERIPHERA...,SET,126,-0.10522,-0.0086822,0.075943,0.91704,HP_CONSTRICTION_OF_PERIPHERAL_VISUAL_FIELD,1
HP_MYELOMENINGOCELE,SET,20,-0.2768,-0.0091261,0.19977,0.91705,HP_MYELOMENINGOCELE,1
ZIM3_TARGET_GENES,SET,800,-0.040718,-0.0083082,0.029386,0.91706,ZIM3_TARGET_GENES,1
CROONQUIST_STROMAL_STIMULATI...1,SET,11,-0.38018,-0.0092981,0.27433,0.9171,CROONQUIST_STROMAL_STIMULATION_DN,1
HP_ABNORMAL_LUNG_LOBATION,SET,37,-0.20091,-0.0090055,0.14493,0.91716,HP_ABNORMAL_LUNG_LOBATION,1
HP_AUTOIMMUNE_HEMOLYTIC_ANEM...,SET,39,-0.2006,-0.0092308,0.1447,0.91717,HP_AUTOIMMUNE_HEMOLYTIC_ANEMIA,1
HP_LOSS_OF_CONSCIOUSNESS,SET,23,-0.25524,-0.0090235,0.1841,0.91718,HP_LOSS_OF_CONSCIOUSNESS,1
CAGTGTT_MIR141_MIR200A,SET,288,-0.068706,-0.008533,0.049554,0.91719,CAGTGTT_MIR141_MIR200A,1
AR_Q2,SET,115,-0.11212,-0.0088411,0.080859,0.91721,AR_Q2,1
GOMF_ARACHIDONIC_ACID_MONOOX...,SET,18,-0.32046,-0.010024,0.23111,0.91721,GOMF_ARACHIDONIC_ACID_MONOOXYGENASE_ACTIVITY,1
GSE37532_VISCERAL_ADIPOSE_TI...8,SET,155,-0.091319,-0.0083508,0.065852,0.91723,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP,1
HP_HYPOTHERMIA,SET,40,-0.17967,-0.0083729,0.12956,0.91724,HP_HYPOTHERMIA,1
GOMF_CTPASE_ACTIVITY,SET,5,-0.55535,-0.0091586,0.40042,0.91726,GOMF_CTPASE_ACTIVITY,1
GOMF_OUTWARD_RECTIFIER_POTAS...,SET,26,-0.24306,-0.0091355,0.17523,0.91728,GOMF_OUTWARD_RECTIFIER_POTASSIUM_CHANNEL_ACTIVITY,1
HP_GERMINOMA,SET,12,-0.34913,-0.0089181,0.2517,0.91728,HP_GERMINOMA,1
HP_LARGE_FLESHY_EARS,SET,13,-0.35785,-0.0095138,0.25799,0.91728,HP_LARGE_FLESHY_EARS,1
NCOA6_TARGET_GENES,SET,275,-0.072153,-0.0087596,0.052009,0.91732,NCOA6_TARGET_GENES,1
WP_PYRIMIDINE_METABOLISM_AND...,SET,19,-0.26833,-0.008623,0.19338,0.91736,WP_PYRIMIDINE_METABOLISM_AND_RELATED_DISEASES,1
GOBP_S_SHAPED_BODY_MORPHOGEN...,SET,7,-0.54185,-0.010573,0.3905,0.91736,GOBP_S_SHAPED_BODY_MORPHOGENESIS,1
GOMF_BASAL_TRANSCRIPTION_MAC...,SET,56,-0.15421,-0.0084991,0.11113,0.91736,GOMF_BASAL_TRANSCRIPTION_MACHINERY_BINDING,1
HP_TRACHEOMALACIA,SET,43,-0.16833,-0.0081326,0.1213,0.91737,HP_TRACHEOMALACIA,1
HE_LIM_SUN_FETAL_LUNG_C1_MID...2,SET,136,-0.11123,-0.0095329,0.080143,0.91741,HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...538,SET,7,-0.39939,-0.0077929,0.28765,0.91749,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_SUMOYLATION,1
REACTOME_CELLULAR_RESPONSE_T...2,SET,95,-0.11444,-0.0082061,0.0824,0.91754,REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS,1
GSE3720_LPS_VS_PMA_STIM_VD2_...2,SET,118,-0.10705,-0.0085502,0.077085,0.91754,GSE3720_LPS_VS_PMA_STIM_VD2_GAMMADELTA_TCELL_UP,1
MIR649,SET,62,-0.14426,-0.0083648,0.10384,0.91761,MIR649,1
HP_CHERRY_RED_SPOT_OF_THE_MA...,SET,13,-0.31212,-0.0082981,0.22465,0.91763,HP_CHERRY_RED_SPOT_OF_THE_MACULA,1
GOCC_CRD_MEDIATED_MRNA_STABI...,SET,6,-0.442,-0.0079849,0.31811,0.91764,GOCC_CRD_MEDIATED_MRNA_STABILITY_COMPLEX,1
GAVISH_3CA_MALIGNANT_METAPRO...22,SET,47,-0.19295,-0.009745,0.13884,0.91769,GAVISH_3CA_MALIGNANT_METAPROGRAM_30_PDAC_CLASSICAL,1
HP_ANTERIOR_RIB_CUPPING,SET,15,-0.29299,-0.0083668,0.21082,0.91769,HP_ANTERIOR_RIB_CUPPING,1
HP_ABNORMALLY_LOW_PITCHED_VO...,SET,10,-0.37466,-0.0087369,0.26958,0.9177,HP_ABNORMALLY_LOW_PITCHED_VOICE,1
AMIT_EGF_RESPONSE_120_HELA,SET,63,-0.14693,-0.0085875,0.10571,0.91772,AMIT_EGF_RESPONSE_120_HELA,1
HP_ABNORMAL_LIVER_METABOLITE...,SET,182,-0.084399,-0.008357,0.060714,0.91774,HP_ABNORMAL_LIVER_METABOLITE_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...48,SET,45,-0.18301,-0.0090446,0.13164,0.91776,GOBP_NEGATIVE_REGULATION_OF_BLOOD_PRESSURE,1
CDX1_TARGET_GENES,SET,35,-0.20686,-0.0090187,0.14879,0.91778,CDX1_TARGET_GENES,1
GOBP_REGULATION_OF_SIGNALING...,SET,89,-0.13169,-0.0091417,0.094712,0.91779,GOBP_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,1
CREIGHTON_AKT1_SIGNALING_VIA...1,SET,20,-0.24298,-0.0080109,0.1747,0.91785,CREIGHTON_AKT1_SIGNALING_VIA_MTOR_DN,1
GOBP_LATE_ENDOSOME_TO_GOLGI_...,SET,3,-0.53991,-0.0068974,0.38817,0.91787,GOBP_LATE_ENDOSOME_TO_GOLGI_TRANSPORT,1
GOCC_SUMO_LIGASE_COMPLEX,SET,10,-0.33772,-0.0078756,0.24279,0.91788,GOCC_SUMO_LIGASE_COMPLEX,1
HP_GASTROINTESTINAL_STROMA_T...,SET,19,-0.27761,-0.0089212,0.19957,0.91788,HP_GASTROINTESTINAL_STROMA_TUMOR,1
GOBP_AMIDE_METABOLIC_PROCESS,SET,399,-0.060422,-0.0088055,0.043435,0.91789,GOBP_AMIDE_METABOLIC_PROCESS,1
BMI1_DN.V1_DN,SET,122,-0.11651,-0.0094608,0.08375,0.9179,BMI1_DN.V1_DN,1
DHIMAN_PBMC_ATTENUVAX_AGE_15...1,SET,17,-0.29238,-0.008888,0.21015,0.91792,DHIMAN_PBMC_ATTENUVAX_AGE_15_25YO_SUBQ_7_OR_14DY_DN,1
HP_ATRIAL_FLUTTER,SET,17,-0.30942,-0.009406,0.22238,0.91794,HP_ATRIAL_FLUTTER,1
GOBP_EQUILIBRIOCEPTION,SET,8,-0.47749,-0.00996,0.34316,0.91795,GOBP_EQUILIBRIOCEPTION,1
GOCC_CATSPER_COMPLEX,SET,11,-0.31981,-0.0078217,0.22981,0.91797,GOCC_CATSPER_COMPLEX,1
WESTON_VEGFA_TARGETS_6HR,SET,43,-0.20061,-0.0096921,0.14414,0.918,WESTON_VEGFA_TARGETS_6HR,1
HP_DECREASED_CIRCULATING_COR...,SET,32,-0.20641,-0.0086054,0.1483,0.91801,HP_DECREASED_CIRCULATING_CORTISOL_LEVEL,1
GSE22886_IGM_MEMORY_BCELL_VS...2,SET,175,-0.088612,-0.0086054,0.063647,0.91807,GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP,1
HP_SUBCORTICAL_BAND_HETEROTO...,SET,10,-0.33403,-0.0077894,0.2399,0.91809,HP_SUBCORTICAL_BAND_HETEROTOPIA,1
HP_INTERICTAL_EEG_ABNORMALITY,SET,289,-0.068702,-0.0085471,0.049338,0.9181,HP_INTERICTAL_EEG_ABNORMALITY,1
GOBP_PHOSPHATIDYLCHOLINE_MET...,SET,68,-0.1439,-0.0087365,0.1033,0.91818,GOBP_PHOSPHATIDYLCHOLINE_METABOLIC_PROCESS,1
HP_ANKLE_SWELLING,SET,12,-0.37708,-0.0096322,0.27063,0.91824,HP_ANKLE_SWELLING,1
GOMF_DEUBIQUITINASE_ACTIVATO...,SET,7,-0.37372,-0.007292,0.26819,0.91825,GOMF_DEUBIQUITINASE_ACTIVATOR_ACTIVITY,1
MIR6750_5P,SET,63,-0.13805,-0.0080687,0.099055,0.91828,MIR6750_5P,1
GOBP_ENDOPLASMIC_RETICULUM_L...,SET,9,-0.4326,-0.0095707,0.31041,0.91828,GOBP_ENDOPLASMIC_RETICULUM_LOCALIZATION,1
HP_ESOPHAGITIS,SET,33,-0.2188,-0.0092631,0.15699,0.91829,HP_ESOPHAGITIS,1
RIGGINS_TAMOXIFEN_RESISTANCE...2,SET,53,-0.16931,-0.0090788,0.12147,0.91831,RIGGINS_TAMOXIFEN_RESISTANCE_UP,1
GOBP_POSITIVE_REGULATION_OF_...24,SET,22,-0.26794,-0.0092645,0.19221,0.91833,GOBP_POSITIVE_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GOBP_POSITIVE_REGULATION_OF_...433,SET,18,-0.31688,-0.0099119,0.2273,0.91835,GOBP_POSITIVE_REGULATION_OF_MACROPHAGE_DERIVED_FOAM_CELL_DIFFERENTIATION,1
GOBP_LIPID_METABOLIC_PROCESS,SET,1267,-0.034823,-0.0088224,0.024977,0.91836,GOBP_LIPID_METABOLIC_PROCESS,1
THAKAR_PBMC_INACTIVATED_INFL...1,SET,56,-0.15512,-0.0085495,0.11121,0.91845,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_NONRESPONDER_28DY_DN,1
HP_ABNORMALITY_OF_T_CELL_PHY...,SET,50,-0.16961,-0.0088345,0.12159,0.91848,HP_ABNORMALITY_OF_T_CELL_PHYSIOLOGY,1
NF1_Q6_01,SET,249,-0.076302,-0.0088209,0.054696,0.91849,NF1_Q6_01,1
GOBP_ACTIVATION_OF_NF_KAPPAB...,SET,10,-0.39917,-0.0093085,0.28611,0.91851,GOBP_ACTIVATION_OF_NF_KAPPAB_INDUCING_KINASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...394,SET,33,-0.1914,-0.0081028,0.13711,0.91862,GOBP_NEGATIVE_REGULATION_OF_MICROTUBULE_POLYMERIZATION_OR_DEPOLYMERIZATION,1
HP_DECREASED_CIRCULATING_FOL...,SET,30,-0.21747,-0.0087788,0.15578,0.91863,HP_DECREASED_CIRCULATING_FOLLICLE_STIMULATING_HORMONE_CONCENTRATION,1
DELYS_THYROID_CANCER_UP,SET,415,-0.060947,-0.0090543,0.043646,0.91869,DELYS_THYROID_CANCER_UP,1
DESCARTES_FETAL_SPLEEN_STC2_...,SET,10,-0.39395,-0.0091869,0.28211,0.91871,DESCARTES_FETAL_SPLEEN_STC2_TLX1_POSITIVE_CELLS,1
VANTVEER_BREAST_CANCER_METAS...1,SET,96,-0.12682,-0.0091418,0.090779,0.91879,VANTVEER_BREAST_CANCER_METASTASIS_DN,1
REACTOME_TP53_REGULATES_TRAN...4,SET,42,-0.1769,-0.0084468,0.1266,0.91882,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CELL_DEATH_GENES,1
HP_LEUKOCORIA,SET,6,-0.52628,-0.0095074,0.37666,0.91882,HP_LEUKOCORIA,1
chr5q31,SET,179,-0.20612,-0.020243,0.14752,0.91883,chr5q31,1
MODULE_7,SET,214,-0.079922,-0.0085737,0.057186,0.91887,MODULE_7,1
GOBP_CELLULAR_DETOXIFICATION...,SET,9,-0.40199,-0.0088935,0.28764,0.91887,GOBP_CELLULAR_DETOXIFICATION_OF_ALDEHYDE,1
HP_ABNORMAL_BRONCHUS_PHYSIOL...,SET,20,-0.24938,-0.0082222,0.17843,0.91888,HP_ABNORMAL_BRONCHUS_PHYSIOLOGY,1
HP_LOW_SELF_ESTEEM,SET,10,-0.43563,-0.010159,0.31165,0.91891,HP_LOW_SELF_ESTEEM,1
GOBP_REGULATION_OF_CELLULAR_...16,SET,17,-0.29847,-0.0090733,0.21349,0.91894,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_OXIDATIVE_STRESS,1
GOMF_RECEPTOR_SERINE_THREONI...,SET,24,-0.2526,-0.0091219,0.18068,0.91894,GOMF_RECEPTOR_SERINE_THREONINE_KINASE_BINDING,1
GSE3039_CD4_TCELL_VS_NKT_CEL...1,SET,180,-0.083724,-0.0082449,0.059876,0.91898,GSE3039_CD4_TCELL_VS_NKT_CELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...226,SET,6,-0.56145,-0.010143,0.4015,0.91899,GOBP_POSITIVE_REGULATION_OF_DOPAMINE_SECRETION,1
ONDER_CDH1_TARGETS_3_DN,SET,55,-0.17294,-0.0094462,0.12366,0.91901,ONDER_CDH1_TARGETS_3_DN,1
HP_ABNORMALITY_OF_URINE_CALC...,SET,63,-0.15987,-0.0093438,0.11428,0.91907,HP_ABNORMALITY_OF_URINE_CALCIUM_CONCENTRATION,1
HP_ARTERIOVENOUS_FISTULA,SET,10,-0.39272,-0.0091581,0.28074,0.91907,HP_ARTERIOVENOUS_FISTULA,1
GOBP_PEPTIDE_CROSS_LINKING,SET,26,-0.2336,-0.0087798,0.16696,0.9191,GOBP_PEPTIDE_CROSS_LINKING,1
GOMF_VOLTAGE_GATED_POTASSIUM...3,SET,11,-0.41343,-0.010111,0.29549,0.91911,GOMF_VOLTAGE_GATED_POTASSIUM_CHANNEL_ACTIVITY_INVOLVED_IN_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL_REPOLARIZATION,1
GOBP_NEGATIVE_REGULATION_OF_...541,SET,19,-0.27143,-0.0087227,0.19398,0.91913,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_TYROSINE_KINASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...93,SET,29,-0.24493,-0.0097216,0.17502,0.91916,GOBP_POSITIVE_REGULATION_OF_CARTILAGE_DEVELOPMENT,1
HP_GASTROINTESTINAL_ATRESIA,SET,75,-0.13274,-0.0084619,0.094845,0.91916,HP_GASTROINTESTINAL_ATRESIA,1
WP_GPR40_PATHWAY,SET,15,-0.28679,-0.0081897,0.20491,0.91917,WP_GPR40_PATHWAY,1
MANNO_MIDBRAIN_NEUROTYPES_HR...4,SET,296,-0.073615,-0.0092667,0.052598,0.91917,MANNO_MIDBRAIN_NEUROTYPES_HRGL2C,1
HP_FETAL_POLYURIA,SET,11,-0.38044,-0.0093046,0.27172,0.91925,HP_FETAL_POLYURIA,1
GSE32423_MEMORY_VS_NAIVE_CD8...2,SET,177,-0.086983,-0.0084949,0.062122,0.91926,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_DN,1
GOBP_REGULATION_OF_VASOCONST...,SET,63,-0.16449,-0.0096139,0.11747,0.91927,GOBP_REGULATION_OF_VASOCONSTRICTION,1
GOBP_CELLULAR_RESPONSE_TO_HY...2,SET,9,-0.44321,-0.0098055,0.31649,0.9193,GOBP_CELLULAR_RESPONSE_TO_HYDROPEROXIDE,1
GSE24574_BCL6_HIGH_TFH_VS_TC...2,SET,175,-0.092896,-0.0090215,0.066319,0.91935,GSE24574_BCL6_HIGH_TFH_VS_TCONV_CD4_TCELL_UP,1
GOBP_EXTERNAL_ENCAPSULATING_...,SET,307,-0.071479,-0.0091607,0.051019,0.91939,GOBP_EXTERNAL_ENCAPSULATING_STRUCTURE_ORGANIZATION,1
REACTOME_THE_PHOTOTRANSDUCTI...,SET,31,-0.20025,-0.0082173,0.14292,0.91941,REACTOME_THE_PHOTOTRANSDUCTION_CASCADE,1
MIR3065_5P,SET,414,-0.057928,-0.0085957,0.041339,0.91943,MIR3065_5P,1
MIR3119,SET,341,-0.064907,-0.0087588,0.046311,0.91947,MIR3119,1
GOBP_PURINE_NUCLEOSIDE_MONOP...3,SET,38,-0.19539,-0.0088752,0.13939,0.9195,GOBP_PURINE_NUCLEOSIDE_MONOPHOSPHATE_METABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_LI...3,SET,33,-0.21535,-0.0091168,0.15361,0.91952,GOBP_CELLULAR_RESPONSE_TO_LIPOPROTEIN_PARTICLE_STIMULUS,1
KRASNOSELSKAYA_ILF3_TARGETS_...1,SET,43,-0.17637,-0.0085209,0.12579,0.91954,KRASNOSELSKAYA_ILF3_TARGETS_DN,1
GOBP_NEGATIVE_REGULATION_OF_...149,SET,11,-0.38396,-0.0093904,0.27386,0.91954,GOBP_NEGATIVE_REGULATION_OF_CIRCADIAN_RHYTHM,1
GOBP_SKELETAL_MUSCLE_ADAPTAT...,SET,22,-0.26663,-0.0092193,0.19017,0.91954,GOBP_SKELETAL_MUSCLE_ADAPTATION,1
HP_LYMPH_NODE_HYPOPLASIA,SET,3,-0.74194,-0.0094783,0.52916,0.91955,HP_LYMPH_NODE_HYPOPLASIA,1
MODULE_196,SET,22,-0.25996,-0.0089886,0.1854,0.91956,MODULE_196,1
HOFT_CD4_POSITIVE_ALPHA_BETA...2,SET,17,-0.26917,-0.0081826,0.19195,0.91958,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_UP,1
GSE34156_UNTREATED_VS_24H_TL...1,SET,160,-0.091148,-0.0084674,0.064987,0.91962,GSE34156_UNTREATED_VS_24H_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_DN,1
GSE16385_IFNG_TNF_VS_IL4_STI...3,SET,161,-0.09171,-0.0085459,0.065381,0.91964,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_ROSIGLITAZONE_TREATED_UP,1
GOMF_HISTONE_H3K4_DEMETHYLAS...,SET,4,-0.55864,-0.0082405,0.39815,0.91969,GOMF_HISTONE_H3K4_DEMETHYLASE_ACTIVITY,1
GOBP_NEGATIVE_REGULATION_OF_...456,SET,10,-0.37893,-0.0088365,0.27005,0.91971,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_TRANSCRIBED_MRNA_CATABOLIC_PROCESS_DEADENYLATION_DEPENDENT_DECAY,1
GOMF_PHOSPHOLIPASE_A1_ACTIVI...,SET,13,-0.32907,-0.0087488,0.23452,0.91971,GOMF_PHOSPHOLIPASE_A1_ACTIVITY,1
ROESSLER_LIVER_CANCER_METAST...2,SET,100,-0.11519,-0.0084735,0.082077,0.91974,ROESSLER_LIVER_CANCER_METASTASIS_UP,1
KEGG_MEDICUS_PATHOGEN_SALMON...4,SET,29,-0.21022,-0.0083438,0.14979,0.91974,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY,1
GOBP_NEURAL_RETINA_DEVELOPME...,SET,79,-0.14308,-0.0093601,0.10195,0.91974,GOBP_NEURAL_RETINA_DEVELOPMENT,1
HP_PERSISTENT_CMV_VIREMIA,SET,5,-0.54945,-0.0090614,0.39144,0.91978,HP_PERSISTENT_CMV_VIREMIA,1
GOBP_POSITIVE_REGULATION_OF_...240,SET,10,-0.42053,-0.0098066,0.29959,0.91979,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_DIFFERENTIATION,1
HE_LIM_SUN_FETAL_LUNG_C1_PUL...2,SET,270,-0.07614,-0.0091605,0.054242,0.91979,HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL,1
GOBP_ENUCLEATE_ERYTHROCYTE_D...2,SET,12,-0.39297,-0.010038,0.2799,0.91983,GOBP_ENUCLEATE_ERYTHROCYTE_DIFFERENTIATION,1
GSE10500_ARTHRITIC_SYNOVIAL_...2,SET,136,-0.099552,-0.0085319,0.070905,0.91984,GSE10500_ARTHRITIC_SYNOVIAL_FLUID_VS_HEALTHY_MACROPHAGE_UP,1
HP_THYROID_DYSGENESIS,SET,7,-0.52071,-0.01016,0.37084,0.91985,HP_THYROID_DYSGENESIS,1
MIR3144_5P,SET,46,-0.17828,-0.0089081,0.12694,0.9199,MIR3144_5P,1
GOBP_AMINO_ACID_BETAINE_BIOS...,SET,5,-0.59132,-0.0097519,0.42099,0.91992,GOBP_AMINO_ACID_BETAINE_BIOSYNTHETIC_PROCESS,1
TOMIDA_LUNG_CANCER_POOR_SURV...,SET,5,-0.60417,-0.0099637,0.43011,0.91993,TOMIDA_LUNG_CANCER_POOR_SURVIVAL,1
chr7p21,SET,35,-0.33631,-0.014662,0.23942,0.91994,chr7p21,1
MIR5586_3P,SET,48,-0.17536,-0.0089498,0.12483,0.91994,MIR5586_3P,1
HP_BIVENTRICULAR_HYPERTROPHY,SET,13,-0.31118,-0.0082732,0.22153,0.91994,HP_BIVENTRICULAR_HYPERTROPHY,1
GOCC_9PLUS0_MOTILE_CILIUM,SET,4,-0.64618,-0.0095318,0.45981,0.92003,GOCC_9PLUS0_MOTILE_CILIUM,1
GOMF_DIHYDROPYRIMIDINASE_ACT...,SET,6,-0.50462,-0.0091161,0.35903,0.92006,GOMF_DIHYDROPYRIMIDINASE_ACTIVITY,1
TARTE_PLASMA_CELL_VS_B_LYMPH...2,SET,75,-0.13701,-0.0087343,0.097454,0.92011,TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_UP,1
GOBP_DENDRITE_DEVELOPMENT,SET,220,-0.081127,-0.0088227,0.057701,0.92013,GOBP_DENDRITE_DEVELOPMENT,1
GOCC_PRE_SNORNP_COMPLEX,SET,7,-0.41217,-0.0080422,0.29313,0.92014,GOCC_PRE_SNORNP_COMPLEX,1
HP_APRAXIA,SET,192,-0.080953,-0.0082308,0.057567,0.92016,HP_APRAXIA,1
HP_OVOID_VERTEBRAL_BODIES,SET,34,-0.2068,-0.0088866,0.14704,0.9202,HP_OVOID_VERTEBRAL_BODIES,1
GSE15659_CD45RA_NEG_CD4_TCEL...6,SET,159,-0.095437,-0.0088383,0.067843,0.92024,GSE15659_CD45RA_NEG_CD4_TCELL_VS_RESTING_TREG_UP,1
ZIRN_TRETINOIN_RESPONSE_WT1_...2,SET,23,-0.27199,-0.0096157,0.19329,0.9203,ZIRN_TRETINOIN_RESPONSE_WT1_UP,1
WP_2Q13_COPY_NUMBER_VARIATIO...,SET,57,-0.18674,-0.010384,0.1327,0.92032,WP_2Q13_COPY_NUMBER_VARIATION_SYNDROME,1
GOBP_CHONDROCYTE_DIFFERENTIA...2,SET,14,-0.32908,-0.0090789,0.23381,0.92035,GOBP_CHONDROCYTE_DIFFERENTIATION_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GOBP_INOSITOL_PHOSPHATE_META...,SET,38,-0.18649,-0.0084709,0.13246,0.92041,GOBP_INOSITOL_PHOSPHATE_METABOLIC_PROCESS,1
MIR3175,SET,158,-0.092152,-0.0085074,0.065452,0.92042,MIR3175,1
HP_HORIZONTAL_PENDULAR_NYSTA...,SET,7,-0.45156,-0.0088109,0.32067,0.92045,HP_HORIZONTAL_PENDULAR_NYSTAGMUS,1
MODULE_275,SET,15,-0.32161,-0.0091842,0.22835,0.92049,MODULE_275,1
HP_AUTOIMMUNE_THROMBOCYTOPEN...,SET,43,-0.18837,-0.0091007,0.13374,0.92049,HP_AUTOIMMUNE_THROMBOCYTOPENIA,1
HP_MULTIPLE_LIPOMAS,SET,31,-0.21633,-0.008877,0.15357,0.92052,HP_MULTIPLE_LIPOMAS,1
GOBP_REGULATION_OF_HAIR_FOLL...,SET,20,-0.27976,-0.0092238,0.19858,0.92055,GOBP_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,1
GOBP_REGULATION_OF_CYSTEINE_...3,SET,11,-0.33617,-0.0082219,0.23853,0.92063,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
HU_ANGIOGENESIS_UP,SET,20,-0.26297,-0.0086701,0.18654,0.92067,HU_ANGIOGENESIS_UP,1
WP_SARSCOV2_MITOCHONDRIAL_CH...,SET,22,-0.2492,-0.0086165,0.17676,0.9207,WP_SARSCOV2_MITOCHONDRIAL_CHRONIC_OXIDATIVE_STRESS_AND_ENDOTHELIAL_DYSFUNCTION,1
GSE17721_CTRL_VS_LPS_2H_BMDC...2,SET,184,-0.08247,-0.0082103,0.058467,0.9208,GSE17721_CTRL_VS_LPS_2H_BMDC_UP,1
WP_BIOMARKERS_FOR_UREA_CYCLE...,SET,11,-0.3653,-0.0089343,0.25895,0.92083,WP_BIOMARKERS_FOR_UREA_CYCLE_DISORDERS,1
GOCC_PHOTORECEPTOR_OUTER_SEG...1,SET,82,-0.13138,-0.0087559,0.093115,0.92086,GOCC_PHOTORECEPTOR_OUTER_SEGMENT,1
ICSBP_Q6,SET,231,-0.08012,-0.0089257,0.056778,0.92089,ICSBP_Q6,1
WHITFIELD_CELL_CYCLE_LITERAT...,SET,44,-0.16009,-0.0078235,0.11342,0.92093,WHITFIELD_CELL_CYCLE_LITERATURE,1
BAKER_HEMATOPOESIS_STAT1_TAR...,SET,10,-0.3616,-0.0084324,0.25619,0.92094,BAKER_HEMATOPOESIS_STAT1_TARGETS,1
GOMF_NEUROPEPTIDE_RECEPTOR_B...,SET,29,-0.22979,-0.0091208,0.16277,0.92098,GOMF_NEUROPEPTIDE_RECEPTOR_BINDING,1
GSE7509_UNSTIM_VS_FCGRIIB_ST...2,SET,167,-0.091318,-0.008665,0.064683,0.92098,GSE7509_UNSTIM_VS_FCGRIIB_STIM_DC_UP,1
GOCC_INSULIN_RESPONSIVE_COMP...,SET,7,-0.41542,-0.0081057,0.29422,0.92101,GOCC_INSULIN_RESPONSIVE_COMPARTMENT,1
HP_SYSTEMIC_LUPUS_ERYTHEMATO...,SET,29,-0.23668,-0.009394,0.16762,0.92101,HP_SYSTEMIC_LUPUS_ERYTHEMATOSUS,1
REACTOME_PEPTIDE_LIGAND_BIND...,SET,180,-0.10151,-0.0099963,0.071887,0.92102,REACTOME_PEPTIDE_LIGAND_BINDING_RECEPTORS,1
HOXC11_TARGET_GENES,SET,48,-0.1631,-0.008324,0.11549,0.92105,HOXC11_TARGET_GENES,1
BIOCARTA_EFP_PATHWAY,SET,16,-0.27225,-0.0080294,0.19273,0.9211,BIOCARTA_EFP_PATHWAY,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...6,SET,27,-0.22479,-0.0086094,0.1591,0.92114,SHIN_B_CELL_LYMPHOMA_CLUSTER_7,1
GOBP_NEUROBLAST_PROLIFERATION,SET,78,-0.14215,-0.0092411,0.10061,0.92115,GOBP_NEUROBLAST_PROLIFERATION,1
GOBP_INFLAMMATORY_RESPONSE_T...1,SET,70,-0.15513,-0.0095554,0.10978,0.92117,GOBP_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GOBP_PURINE_CONTAINING_COMPO...2,SET,484,-0.053924,-0.0086348,0.038159,0.92118,GOBP_PURINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GSE30962_ACUTE_VS_CHRONIC_LC...4,SET,180,-0.087709,-0.0086374,0.062069,0.92118,GSE30962_ACUTE_VS_CHRONIC_LCMV_SECONDARY_INF_CD8_TCELL_UP,1
HP_NEOPLASM_OF_THE_STOMACH,SET,85,-0.12658,-0.008588,0.089561,0.92121,HP_NEOPLASM_OF_THE_STOMACH,1
GOBP_RESPONSE_TO_CORTICOSTER...1,SET,146,-0.10527,-0.0093451,0.07448,0.92122,GOBP_RESPONSE_TO_CORTICOSTEROID,1
GOMF_CHROMATIN_PROTEIN_ADAPT...,SET,24,-0.22476,-0.0081167,0.15902,0.92123,GOMF_CHROMATIN_PROTEIN_ADAPTOR_ACTIVITY,1
WP_MAMMARY_GLAND_DEVELOPMENT...2,SET,10,-0.40995,-0.0095599,0.28998,0.92127,WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4,1
GOBP_MITOTIC_SISTER_CHROMATI...4,SET,60,-0.14535,-0.0082914,0.10279,0.92132,GOBP_MITOTIC_SISTER_CHROMATID_SEPARATION,1
GOBP_INOSITOL_PHOSPHATE_BIOS...,SET,26,-0.22679,-0.008524,0.1603,0.92143,GOBP_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GOMF_5_3_EXONUCLEASE_ACTIVITY,SET,17,-0.25741,-0.0078251,0.18187,0.92151,GOMF_5_3_EXONUCLEASE_ACTIVITY,1
KEGG_FOLATE_BIOSYNTHESIS,SET,10,-0.37459,-0.0087354,0.26466,0.92152,KEGG_FOLATE_BIOSYNTHESIS,1
GSE3039_CD4_TCELL_VS_ALPHABE...2,SET,175,-0.091091,-0.0088462,0.064357,0.92152,GSE3039_CD4_TCELL_VS_ALPHABETA_CD8_TCELL_UP,1
MORF_ARL3,SET,280,-0.07271,-0.0089059,0.051362,0.92155,MORF_ARL3,1
HP_NEPHROLITHIASIS,SET,131,-0.1104,-0.0092874,0.077983,0.92156,HP_NEPHROLITHIASIS,1
MYBL1_TARGET_GENES,SET,354,-0.06175,-0.0084871,0.043611,0.9216,MYBL1_TARGET_GENES,1
GSE3720_UNSTIM_VS_LPS_STIM_V...3,SET,129,-0.10744,-0.0089698,0.075881,0.9216,GSE3720_UNSTIM_VS_LPS_STIM_VD2_GAMMADELTA_TCELL_DN,1
HP_SHOULDER_DISLOCATION,SET,16,-0.28802,-0.0084944,0.20339,0.92161,HP_SHOULDER_DISLOCATION,1
REACTOME_FRS_MEDIATED_FGFR2_...,SET,24,-0.24773,-0.0089462,0.17486,0.92171,REACTOME_FRS_MEDIATED_FGFR2_SIGNALING,1
GOBP_REGULATION_OF_EXTRINSIC...1,SET,145,-0.10077,-0.0089151,0.071105,0.92177,GOBP_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE2585_THYMIC_MACROPHAGE_VS...1,SET,165,-0.094492,-0.0089129,0.066656,0.92184,GSE2585_THYMIC_MACROPHAGE_VS_MTEC_DN,1
HP_PRURITIS_ON_HAND,SET,5,-0.55149,-0.009095,0.38897,0.92187,HP_PRURITIS_ON_HAND,1
GOBP_NEGATIVE_REGULATION_OF_...277,SET,13,-0.34807,-0.0092539,0.24549,0.92188,GOBP_NEGATIVE_REGULATION_OF_HOMOTYPIC_CELL_CELL_ADHESION,1
HP_COARSE_HAIR,SET,48,-0.15891,-0.0081105,0.11207,0.92189,HP_COARSE_HAIR,1
GOMF_CHEMOKINE_BINDING,SET,29,-0.25151,-0.0099826,0.17736,0.9219,GOMF_CHEMOKINE_BINDING,1
HP_ABNORMALITY_OF_SOMATOSENS...,SET,14,-0.32412,-0.0089423,0.22852,0.92195,HP_ABNORMALITY_OF_SOMATOSENSORY_EVOKED_POTENTIALS,1
REACTOME_HEME_SIGNALING,SET,45,-0.18351,-0.0090692,0.12936,0.92199,REACTOME_HEME_SIGNALING,1
GOBP_ALCOHOL_METABOLIC_PROCE...,SET,334,-0.066845,-0.0089289,0.047119,0.92199,GOBP_ALCOHOL_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...36,SET,5,-0.631,-0.010406,0.44456,0.9221,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...37,SET,5,-0.631,-0.010406,0.44456,0.9221,GOBP_POSITIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,1
MIR4751,SET,31,-0.20711,-0.0084987,0.14585,0.92219,MIR4751,1
MIR4666A_5P,SET,226,-0.080012,-0.0088178,0.056339,0.92221,MIR4666A_5P,1
GSE42088_UNINF_VS_LEISHMANIA...4,SET,184,-0.091235,-0.0090829,0.06424,0.92222,GSE42088_UNINF_VS_LEISHMANIA_INF_DC_2H_UP,1
GSE21063_3H_VS_16H_ANTI_IGM_...4,SET,181,-0.086444,-0.0085362,0.060861,0.92224,GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP,1
GOBP_CELLULAR_RESPONSE_TO_OX...2,SET,11,-0.37863,-0.0092602,0.26654,0.92226,GOBP_CELLULAR_RESPONSE_TO_OXIDISED_LOW_DENSITY_LIPOPROTEIN_PARTICLE_STIMULUS,1
HEBERT_MATRISOME_TNBC_LUNG_M...1,SET,20,-0.27698,-0.009132,0.19497,0.92228,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS,1
GOBP_EXPORT_FROM_CELL,SET,834,-0.043336,-0.0090197,0.030502,0.9223,GOBP_EXPORT_FROM_CELL,1
GOBP_CELL_MORPHOGENESIS_INVO...,SET,535,-0.055237,-0.009286,0.038868,0.92236,GOBP_CELL_MORPHOGENESIS_INVOLVED_IN_NEURON_DIFFERENTIATION,1
CAIRO_HEPATOBLASTOMA_DN,SET,243,-0.081398,-0.0092975,0.05727,0.92238,CAIRO_HEPATOBLASTOMA_DN,1
GOBP_DIADENOSINE_POLYPHOSPHA...1,SET,3,-0.75021,-0.009584,0.52782,0.92238,GOBP_DIADENOSINE_POLYPHOSPHATE_CATABOLIC_PROCESS,1
GOBP_DIADENOSINE_POLYPHOSPHA...2,SET,3,-0.75021,-0.009584,0.52782,0.92238,GOBP_DIADENOSINE_POLYPHOSPHATE_METABOLIC_PROCESS,1
MORF_ARAF1,SET,70,-0.13344,-0.0082192,0.093875,0.92239,MORF_ARAF1,1
GOBP_SECONDARY_HEART_FIELD_S...,SET,11,-0.42793,-0.010466,0.30106,0.92239,GOBP_SECONDARY_HEART_FIELD_SPECIFICATION,1
KEGG_ETHER_LIPID_METABOLISM,SET,30,-0.229,-0.0092443,0.1611,0.9224,KEGG_ETHER_LIPID_METABOLISM,1
GSE6259_FLT3L_INDUCED_DEC205...4,SET,147,-0.092078,-0.0082018,0.064774,0.92241,GSE6259_FLT3L_INDUCED_DEC205_POS_DC_VS_CD4_TCELL_UP,1
LIU_IL13_MEMORY_MODEL_UP,SET,17,-0.28173,-0.0085645,0.19818,0.92242,LIU_IL13_MEMORY_MODEL_UP,1
GCM_SUPT4H1,SET,52,-0.15724,-0.0083519,0.1106,0.92243,GCM_SUPT4H1,1
GNF2_SERPINB5,SET,27,-0.24222,-0.0092769,0.17037,0.92244,GNF2_SERPINB5,1
REACTOME_NEUREXINS_AND_NEURO...,SET,51,-0.17308,-0.0091045,0.12171,0.92248,REACTOME_NEUREXINS_AND_NEUROLIGINS,1
chr2p16,SET,35,-0.31644,-0.013796,0.22246,0.92254,chr2p16,1
GCM_SUFU,SET,70,-0.12986,-0.0079989,0.091276,0.92258,GCM_SUFU,1
DESCARTES_FETAL_CEREBELLUM_O...,SET,68,-0.16229,-0.0098533,0.11406,0.92259,DESCARTES_FETAL_CEREBELLUM_OLIGODENDROCYTES,1
SHIRAISHI_PLZF_TARGETS_UP,SET,9,-0.37345,-0.0082621,0.26245,0.92261,SHIRAISHI_PLZF_TARGETS_UP,1
GOBP_ANIMAL_ORGAN_REGENERATI...,SET,61,-0.15896,-0.0091424,0.11171,0.92261,GOBP_ANIMAL_ORGAN_REGENERATION,1
GOBP_RIBOSE_PHOSPHATE_BIOSYN...,SET,176,-0.085938,-0.0083693,0.060387,0.92264,GOBP_RIBOSE_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
FOURNIER_ACINAR_DEVELOPMENT_...5,SET,11,-0.40487,-0.009902,0.28442,0.92269,FOURNIER_ACINAR_DEVELOPMENT_LATE_UP,1
GOBP_INTRACELLULAR_SIGNALING...,SET,1731,-0.031029,-0.0090631,0.021799,0.92269,GOBP_INTRACELLULAR_SIGNALING_CASSETTE,1
HP_SEVERE_B_LYMPHOCYTOPENIA,SET,6,-0.4568,-0.0082522,0.32091,0.92269,HP_SEVERE_B_LYMPHOCYTOPENIA,1
GOBP_POSITIVE_REGULATION_OF_...625,SET,230,-0.080908,-0.0089942,0.056813,0.92278,GOBP_POSITIVE_REGULATION_OF_PROTEIN_KINASE_ACTIVITY,1
HP_ANHYDRAMNIOS,SET,6,-0.48037,-0.008678,0.33731,0.92278,HP_ANHYDRAMNIOS,1
HP_HAND_TREMOR,SET,37,-0.19718,-0.0088381,0.13842,0.92283,HP_HAND_TREMOR,1
GOBP_AROMATIC_AMINO_ACID_FAM...,SET,16,-0.33579,-0.0099033,0.23573,0.92284,GOBP_AROMATIC_AMINO_ACID_FAMILY_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_CATECHOLA...2,SET,8,-0.44271,-0.0092345,0.31074,0.92287,GOBP_REGULATION_OF_CATECHOLAMINE_UPTAKE_INVOLVED_IN_SYNAPTIC_TRANSMISSION,1
GOBP_CALCIUM_DEPENDENT_CELL_...,SET,47,-0.2012,-0.010162,0.14119,0.92291,GOBP_CALCIUM_DEPENDENT_CELL_CELL_ADHESION_VIA_PLASMA_MEMBRANE_CELL_ADHESION_MOLECULES,1
GSE21380_NON_TFH_VS_TFH_CD4_...1,SET,180,-0.090298,-0.0088924,0.063365,0.92292,GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN,1
REACTOME_APEX1_INDEPENDENT_R...,SET,7,-0.37513,-0.0073196,0.26322,0.92294,REACTOME_APEX1_INDEPENDENT_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY,1
BROWNE_HCMV_INFECTION_6HR_DN,SET,147,-0.098849,-0.0088049,0.069343,0.92298,BROWNE_HCMV_INFECTION_6HR_DN,1
KEGG_MEDICUS_VARIANT_BCL2_OV...,SET,7,-0.44098,-0.0086046,0.30931,0.92302,KEGG_MEDICUS_VARIANT_BCL2_OVEREXPRESSION_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
FRIDMAN_SENESCENCE_DN,SET,11,-0.3311,-0.0080977,0.2322,0.92304,FRIDMAN_SENESCENCE_DN,1
WP_METABOLIC_EPILEPTIC_DISOR...,SET,80,-0.13085,-0.0086139,0.091764,0.92304,WP_METABOLIC_EPILEPTIC_DISORDERS,1
HP_PROGRESSIVE_VISUAL_LOSS,SET,93,-0.12366,-0.0087743,0.086728,0.92304,HP_PROGRESSIVE_VISUAL_LOSS,1
HP_ABNORMAL_PORTAL_VENOUS_SY...,SET,13,-0.35762,-0.0095079,0.25062,0.92319,HP_ABNORMAL_PORTAL_VENOUS_SYSTEM_MORPHOLOGY,1
WP_REGULATION_OF_SISTER_CHRO...,SET,13,-0.36923,-0.0098164,0.25873,0.92321,WP_REGULATION_OF_SISTER_CHROMATID_SEPARATION_AT_THE_METAPHASEANAPHASE_TRANSITION,1
GOMF_CALMODULIN_DEPENDENT_PR...1,SET,24,-0.2329,-0.0084105,0.16309,0.92334,GOMF_CALMODULIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY,1
GSE3982_MAC_VS_CENT_MEMORY_C...1,SET,167,-0.090745,-0.0086107,0.063533,0.92339,GSE3982_MAC_VS_CENT_MEMORY_CD4_TCELL_DN,1
GOBP_ACETYLCHOLINE_SECRETION,SET,5,-0.52403,-0.0086422,0.36687,0.9234,GOBP_ACETYLCHOLINE_SECRETION,1
KEGG_MEDICUS_REFERENCE_LECTI...3,SET,9,-0.44194,-0.0097773,0.30934,0.92344,KEGG_MEDICUS_REFERENCE_LECTIN_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION,1
GOBP_ORGANIC_ACID_TRANSPORT,SET,331,-0.06988,-0.0092931,0.048912,0.92344,GOBP_ORGANIC_ACID_TRANSPORT,1
GSE14308_TH2_VS_INDUCED_TREG...2,SET,181,-0.090504,-0.0089371,0.06334,0.92347,GSE14308_TH2_VS_INDUCED_TREG_UP,1
MORF_ITGA2,SET,47,-0.18248,-0.009216,0.1277,0.92348,MORF_ITGA2,1
GOBP_REGULATION_OF_ORGANELLE...1,SET,231,-0.077189,-0.0085992,0.054014,0.9235,GOBP_REGULATION_OF_ORGANELLE_ASSEMBLY,1
REACTOME_SIGNALING_BY_MEMBRA...,SET,5,-0.5438,-0.0089682,0.38041,0.92356,REACTOME_SIGNALING_BY_MEMBRANE_TETHERED_FUSIONS_OF_PDGFRA_OR_PDGFRB,1
GOBP_TEMPERATURE_HOMEOSTASIS,SET,177,-0.094689,-0.0092475,0.066238,0.92356,GOBP_TEMPERATURE_HOMEOSTASIS,1
DESCARTES_FETAL_INTESTINE_EN...2,SET,131,-0.11559,-0.0097242,0.080837,0.92362,DESCARTES_FETAL_INTESTINE_ENS_NEURONS,1
HP_MULTIFOCAL_CEREBRAL_WHITE...,SET,15,-0.30841,-0.0088072,0.21565,0.92365,HP_MULTIFOCAL_CEREBRAL_WHITE_MATTER_ABNORMALITIES,1
GOBP_PROTEIN_TRIMERIZATION,SET,17,-0.29182,-0.008871,0.20404,0.92366,GOBP_PROTEIN_TRIMERIZATION,1
PSIP1_TARGET_GENES,SET,547,-0.051119,-0.0086867,0.035739,0.92368,PSIP1_TARGET_GENES,1
GOBP_ASPARTATE_METABOLIC_PRO...,SET,6,-0.5473,-0.0098872,0.38257,0.92372,GOBP_ASPARTATE_METABOLIC_PROCESS,1
GOBP_NEURON_FATE_SPECIFICATI...,SET,32,-0.22878,-0.0095381,0.15992,0.92372,GOBP_NEURON_FATE_SPECIFICATION,1
HOOI_ST7_TARGETS_UP,SET,84,-0.13461,-0.0090792,0.094079,0.92374,HOOI_ST7_TARGETS_UP,1
GOBP_LONG_CHAIN_FATTY_ACID_I...,SET,10,-0.38228,-0.0089146,0.26717,0.92375,GOBP_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
HP_LONG_NASAL_BRIDGE,SET,4,-0.58908,-0.0086895,0.41132,0.92394,HP_LONG_NASAL_BRIDGE,1
HP_BASAL_GANGLIA_GLIOSIS,SET,8,-0.46018,-0.0095988,0.32131,0.92395,HP_BASAL_GANGLIA_GLIOSIS,1
HP_INVOLUNTARY_MOVEMENTS,SET,910,-0.040235,-0.0087284,0.028093,0.92395,HP_INVOLUNTARY_MOVEMENTS,1
SRC_UP.V1_DN,SET,147,-0.099566,-0.0088688,0.069476,0.92407,SRC_UP.V1_DN,1
GOBP_NUCLEOBASE_METABOLIC_PR...,SET,36,-0.19529,-0.0086348,0.13626,0.9241,GOBP_NUCLEOBASE_METABOLIC_PROCESS,1
KUMAR_PATHOGEN_LOAD_BY_MACRO...,SET,228,-0.080324,-0.0088908,0.05604,0.92411,KUMAR_PATHOGEN_LOAD_BY_MACROPHAGES,1
HP_ABNORMAL_T_CELL_MORPHOLOGY,SET,105,-0.11992,-0.0090384,0.083668,0.92411,HP_ABNORMAL_T_CELL_MORPHOLOGY,1
GSE32423_IL7_VS_IL4_MEMORY_C...2,SET,182,-0.086097,-0.0085252,0.060066,0.92411,GSE32423_IL7_VS_IL4_MEMORY_CD8_TCELL_UP,1
HP_RESPIRATORY_DISTRESS,SET,192,-0.087381,-0.0088844,0.060961,0.92412,HP_RESPIRATORY_DISTRESS,1
GOBP_BASEMENT_MEMBRANE_ASSEM...,SET,9,-0.36167,-0.0080013,0.25225,0.92417,GOBP_BASEMENT_MEMBRANE_ASSEMBLY,1
GOBP_NEGATIVE_REGULATION_OF_...81,SET,11,-0.37612,-0.0091989,0.26224,0.92424,GOBP_NEGATIVE_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,1
GOBP_VERY_LONG_CHAIN_FATTY_A...1,SET,13,-0.38925,-0.010349,0.2714,0.92424,GOBP_VERY_LONG_CHAIN_FATTY_ACID_BIOSYNTHETIC_PROCESS,1
LEE_LIVER_CANCER_ACOX1_DN,SET,62,-0.15955,-0.0092512,0.11123,0.92426,LEE_LIVER_CANCER_ACOX1_DN,1
GOBP_ACETATE_ESTER_TRANSPORT,SET,9,-0.40544,-0.0089697,0.28264,0.92427,GOBP_ACETATE_ESTER_TRANSPORT,1
GOBP_REGULATION_OF_EXCRETION,SET,9,-0.4254,-0.0094113,0.29655,0.92427,GOBP_REGULATION_OF_EXCRETION,1
HP_CEREBRAL_EDEMA,SET,28,-0.22188,-0.0086537,0.15467,0.92427,HP_CEREBRAL_EDEMA,1
GSE2826_XID_VS_BTK_KO_BCELL_...2,SET,187,-0.089515,-0.0089832,0.062394,0.9243,GSE2826_XID_VS_BTK_KO_BCELL_UP,1
GOBP_CELLULAR_RESPIRATION,SET,189,-0.08173,-0.0082453,0.056966,0.92431,GOBP_CELLULAR_RESPIRATION,1
GOBP_KYNURENINE_METABOLIC_PR...,SET,9,-0.45587,-0.010085,0.31759,0.9244,GOBP_KYNURENINE_METABOLIC_PROCESS,1
GOBP_VESICLE_DOCKING,SET,57,-0.16091,-0.008947,0.11209,0.92442,GOBP_VESICLE_DOCKING,1
TFEB_TARGET_GENES,SET,1069,-0.038292,-0.0089623,0.026672,0.92444,TFEB_TARGET_GENES,1
GOBP_PTERIDINE_CONTAINING_CO...2,SET,33,-0.19668,-0.0083264,0.137,0.92444,GOBP_PTERIDINE_CONTAINING_COMPOUND_METABOLIC_PROCESS,1
GSE13887_RESTING_VS_NO_TREAT...2,SET,113,-0.11901,-0.0093027,0.082885,0.92446,GSE13887_RESTING_VS_NO_TREATED_CD4_TCELL_UP,1
HP_TREMOR_BY_ANATOMICAL_SITE,SET,86,-0.13358,-0.0091161,0.093024,0.92448,HP_TREMOR_BY_ANATOMICAL_SITE,1
YOSHIMURA_MAPK8_TARGETS_DN,SET,350,-0.065152,-0.0089049,0.045368,0.9245,YOSHIMURA_MAPK8_TARGETS_DN,1
GOBP_REGULATION_OF_CAVEOLIN_...,SET,6,-0.51221,-0.0092531,0.35665,0.92451,GOBP_REGULATION_OF_CAVEOLIN_MEDIATED_ENDOCYTOSIS,1
PAX6_01,SET,86,-0.13584,-0.0092704,0.094582,0.92452,PAX6_01,1
HP_HYPERMETRIC_SACCADES,SET,11,-0.34384,-0.0084093,0.23941,0.92452,HP_HYPERMETRIC_SACCADES,1
GAVISH_3CA_METAPROGRAM_CD8_T...12,SET,47,-0.17342,-0.0087587,0.12071,0.92459,GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_UNASSIGNED_2,1
GSE13522_WT_VS_IFNAR_KO_SKIN...2,SET,187,-0.092843,-0.0093173,0.064617,0.92461,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP,1
GOMF_LIGAND_GATED_MONOATOMIC...1,SET,42,-0.21316,-0.010178,0.14835,0.92462,GOMF_LIGAND_GATED_MONOATOMIC_ANION_CHANNEL_ACTIVITY,1
MORF_TNFRSF6,SET,146,-0.10295,-0.0091395,0.071642,0.92464,MORF_TNFRSF6,1
GOMF_ADENYLATE_KINASE_ACTIVI...,SET,9,-0.42617,-0.0094284,0.29656,0.92464,GOMF_ADENYLATE_KINASE_ACTIVITY,1
AP3_Q6,SET,228,-0.085752,-0.0094916,0.05967,0.92465,AP3_Q6,1
HP_THIN_UPPER_LIP_VERMILION,SET,263,-0.074064,-0.0087962,0.051525,0.9247,HP_THIN_UPPER_LIP_VERMILION,1
GSE27786_CD8_TCELL_VS_NKCELL...2,SET,187,-0.085441,-0.0085745,0.059439,0.9247,GSE27786_CD8_TCELL_VS_NKCELL_UP,1
GOBP_ENDOTHELIAL_CELL_PROLIF...,SET,147,-0.1053,-0.0093798,0.073251,0.92471,GOBP_ENDOTHELIAL_CELL_PROLIFERATION,1
GSE25677_MPL_VS_R848_STIM_BC...2,SET,161,-0.10144,-0.0094527,0.070541,0.92478,GSE25677_MPL_VS_R848_STIM_BCELL_UP,1
GOBP_INTRACELLULAR_GLUTAMATE...,SET,6,-0.52176,-0.0094257,0.36279,0.9248,GOBP_INTRACELLULAR_GLUTAMATE_HOMEOSTASIS,1
GSE10147_IL3_AND_HIVP17_VS_I...2,SET,132,-0.10993,-0.0092831,0.076428,0.92483,GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_UP,1
MOREAUX_MULTIPLE_MYELOMA_BY_...1,SET,153,-0.089461,-0.0081283,0.062191,0.92484,MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN,1
GSE4142_NAIVE_BCELL_VS_PLASM...1,SET,187,-0.086663,-0.0086971,0.060236,0.92488,GSE4142_NAIVE_BCELL_VS_PLASMA_CELL_DN,1
GOCC_T_CELL_RECEPTOR_COMPLEX,SET,15,-0.33918,-0.0096858,0.23573,0.92489,GOCC_T_CELL_RECEPTOR_COMPLEX,1
LEE_LIVER_CANCER_E2F1_UP,SET,60,-0.17925,-0.010225,0.12458,0.9249,LEE_LIVER_CANCER_E2F1_UP,1
GOBP_EXTRACELLULAR_EXOSOME_A...,SET,7,-0.48189,-0.0094027,0.33484,0.92494,GOBP_EXTRACELLULAR_EXOSOME_ASSEMBLY,1
GOCC_CILIARY_TIP,SET,40,-0.18847,-0.008783,0.13096,0.92494,GOCC_CILIARY_TIP,1
GOBP_METANEPHRIC_TUBULE_MORP...,SET,10,-0.41794,-0.0097461,0.29038,0.92495,GOBP_METANEPHRIC_TUBULE_MORPHOGENESIS,1
GAVISH_3CA_METAPROGRAM_CD4_T...2,SET,44,-0.20695,-0.010114,0.14376,0.92499,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_CYTOTOXIC,1
GOBP_NEGATIVE_REGULATION_OF_...654,SET,5,-0.59021,-0.0097336,0.40998,0.925,GOBP_NEGATIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,1
GSE17186_BLOOD_VS_CORD_BLOOD...4,SET,189,-0.085635,-0.0086392,0.059485,0.925,GSE17186_BLOOD_VS_CORD_BLOOD_CD21LOW_TRANSITIONAL_BCELL_UP,1
ZNF224_TARGET_GENES,SET,1078,-0.037515,-0.0088151,0.026058,0.92501,ZNF224_TARGET_GENES,1
GOMF_GLYCOSPHINGOLIPID_BINDI...,SET,10,-0.38586,-0.008998,0.26794,0.92507,GOMF_GLYCOSPHINGOLIPID_BINDING,1
WIKMAN_ASBESTOS_LUNG_CANCER_...1,SET,28,-0.22454,-0.0087575,0.1559,0.92509,WIKMAN_ASBESTOS_LUNG_CANCER_DN,1
MIR183_5P,SET,210,-0.085383,-0.0090745,0.059281,0.9251,MIR183_5P,1
GCM_DEAF1,SET,24,-0.22556,-0.0081457,0.1566,0.92511,GCM_DEAF1,1
MIR4799_3P,SET,78,-0.13833,-0.0089924,0.09603,0.92512,MIR4799_3P,1
HP_HYPOCALCEMIC_SEIZURES,SET,12,-0.36603,-0.0093497,0.2541,0.92512,HP_HYPOCALCEMIC_SEIZURES,1
HP_INCREASED_INTERVERTEBRAL_...,SET,6,-0.49153,-0.0088797,0.3412,0.92514,HP_INCREASED_INTERVERTEBRAL_SPACE,1
HP_CUTANEOUS_PHOTOSENSITIVITY,SET,94,-0.11891,-0.008482,0.082531,0.92516,HP_CUTANEOUS_PHOTOSENSITIVITY,1
HP_LARGE_ILIAC_WING,SET,3,-0.70759,-0.0090395,0.49107,0.92519,HP_LARGE_ILIAC_WING,1
HP_CENTRAL_HETEROCHROMIA,SET,6,-0.54565,-0.0098574,0.37861,0.92523,HP_CENTRAL_HETEROCHROMIA,1
GOCC_PHOTORECEPTOR_DISC_MEMB...,SET,18,-0.27078,-0.0084699,0.18787,0.92524,GOCC_PHOTORECEPTOR_DISC_MEMBRANE,1
HP_ANISOMETROPIA,SET,4,-0.49815,-0.0073482,0.34542,0.92536,HP_ANISOMETROPIA,1
KEGG_MEDICUS_REFERENCE_AUTOP...4,SET,7,-0.40682,-0.0079379,0.28208,0.92537,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_E3_UBIQUITIN_LIGASE_MALIN,1
HOEK_B_CELL_2011_2012_TIV_AD...1,SET,5,-0.46011,-0.007588,0.31901,0.92539,HOEK_B_CELL_2011_2012_TIV_ADULT_1DY_UP,1
CHIANG_LIVER_CANCER_SUBCLASS...7,SET,166,-0.098897,-0.0093563,0.068555,0.92542,CHIANG_LIVER_CANCER_SUBCLASS_PROLIFERATION_DN,1
GOMF_VOLTAGE_GATED_CHLORIDE_...,SET,9,-0.39057,-0.0086408,0.27075,0.92542,GOMF_VOLTAGE_GATED_CHLORIDE_CHANNEL_ACTIVITY,1
HP_APLASIA_HYPOPLASIA_INVOLV...8,SET,40,-0.19412,-0.009046,0.13454,0.92545,HP_APLASIA_HYPOPLASIA_INVOLVING_THE_FEMORAL_HEAD_AND_NECK,1
GCM_MAPK10,SET,73,-0.14594,-0.0091793,0.10113,0.92548,GCM_MAPK10,1
HP_DECREASED_CIRCULATING_VIT...2,SET,31,-0.21033,-0.008631,0.14575,0.92549,HP_DECREASED_CIRCULATING_VITAMIN_D_CONCENTRATION,1
GOBP_MOTOR_NEURON_APOPTOTIC_...,SET,21,-0.25766,-0.0087046,0.17854,0.9255,GOBP_MOTOR_NEURON_APOPTOTIC_PROCESS,1
GOBP_ENDOTHELIAL_CELL_MORPHO...,SET,9,-0.47802,-0.010575,0.33105,0.92561,GOBP_ENDOTHELIAL_CELL_MORPHOGENESIS,1
HP_AMENORRHEA,SET,171,-0.093669,-0.008993,0.064865,0.92563,HP_AMENORRHEA,1
HP_HYPERINSULINEMIC_HYPOGLYC...,SET,25,-0.25188,-0.0092835,0.17442,0.92563,HP_HYPERINSULINEMIC_HYPOGLYCEMIA,1
GSE25123_WT_VS_PPARG_KO_MACR...4,SET,182,-0.093875,-0.0092953,0.065004,0.92564,GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN,1
GOBP_DIGESTION,SET,127,-0.11647,-0.0096479,0.080642,0.92565,GOBP_DIGESTION,1
GAVISH_3CA_METAPROGRAM_ENDOT...7,SET,48,-0.19161,-0.0097793,0.13267,0.92566,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_5,1
GOBP_SYNAPTIC_VESICLE_BUDDING,SET,12,-0.34101,-0.0087107,0.23605,0.92571,GOBP_SYNAPTIC_VESICLE_BUDDING,1
GOBP_REGULATION_OF_CLATHRIN_...,SET,16,-0.28471,-0.0083967,0.19703,0.92576,GOBP_REGULATION_OF_CLATHRIN_DEPENDENT_ENDOCYTOSIS,1
HP_BILATERAL_SENSORINEURAL_H...,SET,60,-0.15771,-0.0089965,0.10914,0.92577,HP_BILATERAL_SENSORINEURAL_HEARING_IMPAIRMENT,1
PETROVA_ENDOTHELIUM_LYMPHATI...2,SET,125,-0.11198,-0.0092038,0.077491,0.92578,PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_UP,1
CBX5_TARGET_GENES,SET,592,-0.050806,-0.0089703,0.035153,0.9258,CBX5_TARGET_GENES,1
REACTOME_ACTIVATION_OF_CASPA...,SET,5,-0.50518,-0.0083312,0.34951,0.92582,REACTOME_ACTIVATION_OF_CASPASES_THROUGH_APOPTOSOME_MEDIATED_CLEAVAGE,1
HP_CLASS_III_OBESITY,SET,5,-0.7179,-0.011839,0.49665,0.92583,HP_CLASS_III_OBESITY,1
DESCARTES_MAIN_FETAL_EXTRAVI...,SET,97,-0.12893,-0.0093418,0.089185,0.92586,DESCARTES_MAIN_FETAL_EXTRAVILLOUS_TROPHOBLASTS,1
GOCC_EXTRINSIC_COMPONENT_OF_...8,SET,6,-0.54001,-0.0097553,0.37351,0.92587,GOCC_EXTRINSIC_COMPONENT_OF_PRESYNAPTIC_MEMBRANE,1
BIOCARTA_DSP_PATHWAY,SET,8,-0.50163,-0.010463,0.34688,0.92592,BIOCARTA_DSP_PATHWAY,1
GOBP_MESENCHYMAL_STEM_CELL_M...,SET,6,-0.5856,-0.010579,0.40494,0.92592,GOBP_MESENCHYMAL_STEM_CELL_MAINTENANCE_INVOLVED_IN_NEPHRON_MORPHOGENESIS,1
HP_LOW_HANGING_COLUMELLA,SET,43,-0.17866,-0.0086318,0.12351,0.92598,HP_LOW_HANGING_COLUMELLA,1
chr7p13,SET,30,-0.41133,-0.016605,0.28431,0.92601,chr7p13,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...2,SET,8,-0.335,-0.0069878,0.23152,0.92604,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_CDC25_CELL_CYCLE_G2M,1
GOBP_MACROPHAGE_CHEMOTAXIS,SET,39,-0.1888,-0.0086878,0.13048,0.92604,GOBP_MACROPHAGE_CHEMOTAXIS,1
GOMF_ADENYL_NUCLEOTIDE_EXCHA...,SET,15,-0.27609,-0.0078842,0.1908,0.92604,GOMF_ADENYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY,1
VANDESLUIS_COMMD1_TARGETS_GR...2,SET,32,-0.24694,-0.010295,0.17065,0.92605,VANDESLUIS_COMMD1_TARGETS_GROUP_3_DN,1
GOBP_ACYL_COA_METABOLIC_PROC...,SET,85,-0.13725,-0.0093121,0.094825,0.9261,GOBP_ACYL_COA_METABOLIC_PROCESS,1
ZHAN_MULTIPLE_MYELOMA_CD2_DN,SET,44,-0.18348,-0.0089668,0.12676,0.92611,ZHAN_MULTIPLE_MYELOMA_CD2_DN,1
GOBP_DIOL_METABOLIC_PROCESS,SET,26,-0.24176,-0.0090867,0.16702,0.92611,GOBP_DIOL_METABOLIC_PROCESS,1
GOCC_NEURON_PROJECTION_TERMI...,SET,117,-0.12054,-0.0095866,0.083269,0.92612,GOCC_NEURON_PROJECTION_TERMINUS,1
HP_HYPERSOMNIA,SET,15,-0.32321,-0.0092298,0.22322,0.92617,HP_HYPERSOMNIA,1
BIOCARTA_MITOCHONDRIA_PATHWAY,SET,17,-0.29308,-0.0089094,0.20235,0.92624,BIOCARTA_MITOCHONDRIA_PATHWAY,1
GOBP_DIPHOSPHOINOSITOL_POLYP...,SET,2,-1.1594,-0.012094,0.80046,0.92624,GOBP_DIPHOSPHOINOSITOL_POLYPHOSPHATE_METABOLIC_PROCESS,1
GOMF_ENDOPOLYPHOSPHATASE_ACT...,SET,2,-1.1594,-0.012094,0.80046,0.92624,GOMF_ENDOPOLYPHOSPHATASE_ACTIVITY,1
GAVIN_FOXP3_TARGETS_CLUSTER_...6,SET,82,-0.13666,-0.0091077,0.094347,0.92625,GAVIN_FOXP3_TARGETS_CLUSTER_T4,1
KEGG_PURINE_METABOLISM,SET,144,-0.10005,-0.0088209,0.069068,0.92626,KEGG_PURINE_METABOLISM,1
GOMF_APOLIPOPROTEIN_RECEPTOR...,SET,7,-0.458,-0.0089366,0.31616,0.92627,GOMF_APOLIPOPROTEIN_RECEPTOR_BINDING,1
REACTOME_CYP2E1_REACTIONS,SET,11,-0.39884,-0.0097544,0.27529,0.92629,REACTOME_CYP2E1_REACTIONS,1
GOBP_CELLULAR_LIPID_METABOLI...,SET,924,-0.041749,-0.0091226,0.028817,0.92629,GOBP_CELLULAR_LIPID_METABOLIC_PROCESS,1
GOBP_CDP_CHOLINE_PATHWAY,SET,6,-0.4446,-0.0080318,0.30684,0.92631,GOBP_CDP_CHOLINE_PATHWAY,1
HP_HIGHLY_ELEVATED_CREATINE_...,SET,6,-0.4609,-0.0083263,0.31804,0.92635,HP_HIGHLY_ELEVATED_CREATINE_KINASE,1
HP_ABNORMAL_ANTERIOR_EYE_SEG...,SET,1153,-0.037046,-0.0089831,0.025559,0.92638,HP_ABNORMAL_ANTERIOR_EYE_SEGMENT_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...392,SET,15,-0.37859,-0.010811,0.26118,0.9264,GOBP_POSITIVE_REGULATION_OF_KERATINOCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_RENAL_SYS...,SET,20,-0.30173,-0.0099479,0.2081,0.92645,GOBP_REGULATION_OF_RENAL_SYSTEM_PROCESS,1
GOMF_SMALL_PROTEIN_ACTIVATIN...,SET,5,-0.43932,-0.0072451,0.30296,0.92647,GOMF_SMALL_PROTEIN_ACTIVATING_ENZYME_BINDING,1
MODULE_173,SET,16,-0.33543,-0.0098926,0.23129,0.92649,MODULE_173,1
HP_CARDIOMYOCYTE_HYPERTROPHY,SET,8,-0.42918,-0.0089522,0.29585,0.92655,HP_CARDIOMYOCYTE_HYPERTROPHY,1
GOBP_MONOAMINE_TRANSPORT,SET,72,-0.15184,-0.0094852,0.10466,0.92657,GOBP_MONOAMINE_TRANSPORT,1
HP_CERVICAL_SPINAL_CANAL_STE...,SET,9,-0.45104,-0.0099785,0.31069,0.9267,HP_CERVICAL_SPINAL_CANAL_STENOSIS,1
GOMF_PEPTIDOGLYCAN_IMMUNE_RE...,SET,5,-0.62484,-0.010305,0.43018,0.92681,GOMF_PEPTIDOGLYCAN_IMMUNE_RECEPTOR_ACTIVITY,1
GOBP_NAD_CATABOLIC_PROCESS,SET,16,-0.27928,-0.0082367,0.19226,0.92683,GOBP_NAD_CATABOLIC_PROCESS,1
GOBP_REGULATION_OF_LYASE_ACT...,SET,53,-0.17572,-0.0094226,0.12094,0.92687,GOBP_REGULATION_OF_LYASE_ACTIVITY,1
ZNF585B_TARGET_GENES,SET,96,-0.1263,-0.0091041,0.086896,0.92694,ZNF585B_TARGET_GENES,1
GOBP_RESPONSE_TO_COPPER_ION,SET,31,-0.24471,-0.010042,0.16836,0.92695,GOBP_RESPONSE_TO_COPPER_ION,1
DODD_NASOPHARYNGEAL_CARCINOM...1,SET,1481,-0.033661,-0.0091624,0.023153,0.927,DODD_NASOPHARYNGEAL_CARCINOMA_DN,1
HP_SOLITARY_MEDIAN_MAXILLARY...,SET,22,-0.24129,-0.0083432,0.16595,0.92702,HP_SOLITARY_MEDIAN_MAXILLARY_CENTRAL_INCISOR,1
MIR3170,SET,47,-0.17443,-0.0088098,0.11995,0.92705,MIR3170,1
REACTOME_NEPHRON_DEVELOPMENT,SET,12,-0.39273,-0.010032,0.27003,0.92707,REACTOME_NEPHRON_DEVELOPMENT,1
REACTOME_INHIBITION_OF_THE_P...,SET,20,-0.25888,-0.0085353,0.17795,0.92712,REACTOME_INHIBITION_OF_THE_PROTEOLYTIC_ACTIVITY_OF_APC_C_REQUIRED_FOR_THE_ONSET_OF_ANAPHASE_BY_MITOTIC_SPINDLE_CHECKPOINT_COMPONENTS,1
GOBP_RNA_POLYMERASE_II_PREIN...,SET,52,-0.15502,-0.0082339,0.10656,0.92713,GOBP_RNA_POLYMERASE_II_PREINITIATION_COMPLEX_ASSEMBLY,1
GSE13522_WT_VS_IFNG_KO_SKING...1,SET,110,-0.1134,-0.0087467,0.077948,0.92713,GSE13522_WT_VS_IFNG_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,1
GSE30971_CTRL_VS_LPS_STIM_MA...5,SET,173,-0.093282,-0.0090076,0.064116,0.92714,GSE30971_CTRL_VS_LPS_STIM_MACROPHAGE_WBP7_KO_2H_DN,1
JOSEPH_RESPONSE_TO_SODIUM_BU...1,SET,57,-0.16595,-0.0092273,0.11405,0.92716,JOSEPH_RESPONSE_TO_SODIUM_BUTYRATE_DN,1
GOCC_MCRD_MEDIATED_MRNA_STAB...,SET,5,-0.5462,-0.0090077,0.37538,0.92716,GOCC_MCRD_MEDIATED_MRNA_STABILITY_COMPLEX,1
HIPC_SIGNATURES_PROJECT_PBMC...2,SET,9,-0.42022,-0.0092968,0.28877,0.92718,HIPC_SIGNATURES_PROJECT_PBMC_TRIVALENT_INFLUENZA_VACCINE_HIGH_RESPONDERS_VS_LOW_RESPONDERS_YOUNGER_ADULTS_21_35_HIGH_RESPONDERS_0D_UP,1
GOBP_GLYCEROL_ETHER_METABOLI...,SET,19,-0.29188,-0.00938,0.20058,0.92719,GOBP_GLYCEROL_ETHER_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...260,SET,6,-0.46191,-0.0083446,0.31734,0.92723,GOBP_NEGATIVE_REGULATION_OF_GLYCOGEN_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...590,SET,34,-0.21869,-0.0093974,0.15025,0.92723,GOBP_NEGATIVE_REGULATION_OF_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
GSE10273_LOW_IL7_VS_HIGH_IL7...1,SET,178,-0.089782,-0.0087927,0.061666,0.92729,GSE10273_LOW_IL7_VS_HIGH_IL7_AND_IRF4_IN_IRF4_8_NULL_PRE_BCELL_DN,1
KEGG_MEDICUS_REFERENCE_HGF_M...1,SET,10,-0.40729,-0.0094979,0.27964,0.92736,KEGG_MEDICUS_REFERENCE_HGF_MET_PI3K_SIGNALING_PATHWAY,1
PRC2_EZH2_UP.V1_UP,SET,171,-0.10079,-0.0096764,0.069197,0.92737,PRC2_EZH2_UP.V1_UP,1
GOBP_DNA_METHYLATION_DEPENDE...,SET,30,-0.22381,-0.0090351,0.15365,0.92738,GOBP_DNA_METHYLATION_DEPENDENT_HETEROCHROMATIN_FORMATION,1
MIR6816_5P,SET,19,-0.29587,-0.009508,0.2031,0.92741,MIR6816_5P,1
GOCC_DENDRITE_CYTOPLASM,SET,26,-0.23208,-0.0087229,0.1593,0.92741,GOCC_DENDRITE_CYTOPLASM,1
HP_ATONIC_SEIZURE,SET,87,-0.12992,-0.0089178,0.089164,0.92745,HP_ATONIC_SEIZURE,1
HP_OVERHANGING_NASAL_TIP,SET,7,-0.37068,-0.0072328,0.25433,0.9275,HP_OVERHANGING_NASAL_TIP,1
BIOCARTA_IL17_PATHWAY,SET,15,-0.35776,-0.010216,0.24538,0.92757,BIOCARTA_IL17_PATHWAY,1
GSE42021_CD24INT_VS_CD24LOW_...1,SET,175,-0.096167,-0.0093391,0.065944,0.92761,GSE42021_CD24INT_VS_CD24LOW_TCONV_THYMUS_DN,1
GSE34156_NOD2_LIGAND_VS_TLR1...1,SET,155,-0.093697,-0.0085683,0.064239,0.92765,GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
FULLER_PBMC_F_TULARENSIS_VAC...4,SET,14,-0.33195,-0.0091583,0.22753,0.9277,FULLER_PBMC_F_TULARENSIS_VACCINE_LVS_AGE_22_54YO_18HR_TO_48HR_EARLY_UP,1
GSE10240_CTRL_VS_IL17_AND_IL...1,SET,191,-0.085269,-0.0086472,0.058444,0.92771,GSE10240_CTRL_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
GOCC_TRAPP_COMPLEX,SET,14,-0.32927,-0.0090842,0.22562,0.92776,GOCC_TRAPP_COMPLEX,1
MIR23C,SET,538,-0.054715,-0.0092232,0.037491,0.92777,MIR23C,1
LI_INDUCED_T_TO_NATURAL_KILL...2,SET,288,-0.074044,-0.009196,0.050728,0.9278,LI_INDUCED_T_TO_NATURAL_KILLER_UP,1
WEIGEL_OXIDATIVE_STRESS_BY_T...,SET,35,-0.21435,-0.0093449,0.14683,0.92782,WEIGEL_OXIDATIVE_STRESS_BY_TBH_AND_H2O2,1
DESCARTES_MAIN_FETAL_VISCERA...,SET,43,-0.19461,-0.0094023,0.13331,0.92782,DESCARTES_MAIN_FETAL_VISCERAL_NEURONS,1
GOBP_NUCLEOBASE_CONTAINING_S...4,SET,582,-0.050875,-0.0089087,0.034844,0.92786,GOBP_NUCLEOBASE_CONTAINING_SMALL_MOLECULE_METABOLIC_PROCESS,1
KEGG_MEDICUS_REFERENCE_GLYCO...3,SET,5,-0.55022,-0.0090741,0.37673,0.92792,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_,1
GOBP_PHOSPHAGEN_METABOLIC_PR...,SET,5,-0.48236,-0.0079549,0.33024,0.92794,GOBP_PHOSPHAGEN_METABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...74,SET,126,-0.11473,-0.0094672,0.078529,0.92799,GOBP_NEGATIVE_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
GSE36009_WT_VS_NLRP10_KO_DC_...1,SET,188,-0.086479,-0.0087015,0.059186,0.928,GSE36009_WT_VS_NLRP10_KO_DC_DN,1
MIR5009_3P,SET,155,-0.10317,-0.0094348,0.070595,0.92805,MIR5009_3P,1
REACTOME_SYNTHESIS_OF_PC,SET,27,-0.23164,-0.0088718,0.15848,0.92807,REACTOME_SYNTHESIS_OF_PC,1
GOBP_NEGATIVE_REGULATION_OF_...77,SET,8,-0.42815,-0.0089307,0.29286,0.92811,GOBP_NEGATIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
HP_MIDLINE_DEFECT_OF_THE_NOSE,SET,15,-0.31803,-0.0090819,0.21754,0.92811,HP_MIDLINE_DEFECT_OF_THE_NOSE,1
GSE34205_RSV_VS_FLU_INF_INFA...1,SET,175,-0.094959,-0.0092218,0.064937,0.92816,GSE34205_RSV_VS_FLU_INF_INFANT_PBMC_DN,1
MIR8083,SET,49,-0.17582,-0.0090664,0.12023,0.92817,MIR8083,1
GSE23308_WT_VS_MINERALCORTIC...2,SET,175,-0.091475,-0.0088835,0.062544,0.9282,GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_CORTICOSTERONE_TREATED_UP,1
GSE20366_EX_VIVO_VS_DEC205_C...4,SET,182,-0.088858,-0.0087985,0.060734,0.92827,GSE20366_EX_VIVO_VS_DEC205_CONVERSION_UP,1
WEINBERGER_BLOOD_TWINRIX_AGE...2,SET,7,-0.51397,-0.010029,0.35123,0.9283,WEINBERGER_BLOOD_TWINRIX_AGE_20_40_AND_60_84YO_CORRELATED_WITH_HIGH_ANTI_HBS_CONC_AT_WEEK_30_PRIMARY_VACC_1DY_POSITIVE,1
REACTOME_RETROGRADE_TRANSPOR...,SET,46,-0.17105,-0.0085466,0.11688,0.92831,REACTOME_RETROGRADE_TRANSPORT_AT_THE_TRANS_GOLGI_NETWORK,1
HP_KERATITIS,SET,70,-0.14463,-0.0089091,0.098812,0.92836,HP_KERATITIS,1
KEGG_MEDICUS_REFERENCE_ITGA_...1,SET,25,-0.26116,-0.0096255,0.1784,0.92838,KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY,1
GSE13484_12H_UNSTIM_VS_YF17D...1,SET,177,-0.09505,-0.0092827,0.064929,0.92838,GSE13484_12H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_DN,1
REACTOME_POU5F1_OCT4_SOX2_NA...2,SET,9,-0.50233,-0.011113,0.34312,0.9284,REACTOME_POU5F1_OCT4_SOX2_NANOG_REPRESS_GENES_RELATED_TO_DIFFERENTIATION,1
GSE22886_CD8_TCELL_VS_BCELL_...2,SET,183,-0.087717,-0.0087091,0.059915,0.9284,GSE22886_CD8_TCELL_VS_BCELL_NAIVE_UP,1
HP_DIASTEMA,SET,22,-0.22983,-0.0079467,0.15697,0.92841,HP_DIASTEMA,1
GOCC_GOLGI_ASSOCIATED_VESICL...,SET,52,-0.16102,-0.0085526,0.10997,0.92843,GOCC_GOLGI_ASSOCIATED_VESICLE_MEMBRANE,1
MIR505_5P,SET,50,-0.17353,-0.0090387,0.1185,0.92844,MIR505_5P,1
GOBP_LIPOPHAGY,SET,7,-0.47142,-0.0091984,0.32191,0.92845,GOBP_LIPOPHAGY,1
MODULE_147,SET,101,-0.11946,-0.0088315,0.081565,0.92848,MODULE_147,1
GSE11961_MARGINAL_ZONE_BCELL...7,SET,175,-0.096246,-0.0093468,0.065712,0.92848,GSE11961_MARGINAL_ZONE_BCELL_VS_MEMORY_BCELL_DAY7_DN,1
MIR432_3P,SET,57,-0.1658,-0.0092189,0.11319,0.92851,MIR432_3P,1
GOCC_AXONEMAL_B_TUBULE_INNER...,SET,5,-0.58836,-0.0097031,0.40156,0.92855,GOCC_AXONEMAL_B_TUBULE_INNER_SHEATH,1
GSE29949_MICROGLIA_BRAIN_VS_...1,SET,176,-0.094018,-0.0091562,0.064169,0.92855,GSE29949_MICROGLIA_BRAIN_VS_CD8_NEG_DC_SPLEEN_DN,1
GSE27434_WT_VS_DNMT1_KO_TREG...1,SET,183,-0.094843,-0.0094167,0.064724,0.92858,GSE27434_WT_VS_DNMT1_KO_TREG_DN,1
HP_BIRD_LIKE_FACIES,SET,13,-0.2935,-0.007803,0.20025,0.92862,HP_BIRD_LIKE_FACIES,1
GOBP_NEGATIVE_REGULATION_OF_...105,SET,5,-0.61405,-0.010127,0.41892,0.92864,GOBP_NEGATIVE_REGULATION_OF_CELL_ADHESION_MOLECULE_PRODUCTION,1
WP_7Q1123_COPY_NUMBER_VARIAT...,SET,86,-0.139,-0.009486,0.094817,0.92866,WP_7Q1123_COPY_NUMBER_VARIATION_SYNDROME,1
REACTOME_GLYCOGEN_BREAKDOWN_...,SET,11,-0.33956,-0.0083046,0.23159,0.9287,REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS,1
GSE20366_CD103_POS_VS_CD103_...2,SET,181,-0.092285,-0.009113,0.062907,0.9288,GSE20366_CD103_POS_VS_CD103_KLRG1_DP_TREG_UP,1
GSE13522_CTRL_VS_T_CRUZI_G_S...2,SET,186,-0.090264,-0.0090344,0.061527,0.92881,GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP,1
GSE28783_ANTI_MIR33_VS_UNTRE...1,SET,177,-0.098132,-0.0095837,0.066886,0.92882,GSE28783_ANTI_MIR33_VS_UNTREATED_ATHEROSCLEROSIS_MACROPHAGE_DN,1
GOBP_ANTIGEN_PROCESSING_AND_...13,SET,30,-0.25417,-0.010261,0.17324,0.92883,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,1
GSE19772_CTRL_VS_HCMV_INF_MO...2,SET,168,-0.092119,-0.0087669,0.06278,0.92885,GSE19772_CTRL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_UP,1
HP_ABNORMAL_T_CELL_ACTIVATION,SET,5,-0.54557,-0.0089974,0.37179,0.92886,HP_ABNORMAL_T_CELL_ACTIVATION,1
GSE21670_TGFB_VS_IL6_TREATED...1,SET,177,-0.087302,-0.0085261,0.059494,0.92886,GSE21670_TGFB_VS_IL6_TREATED_CD4_TCELL_DN,1
GSE19772_HCMV_INFL_VS_HCMV_I...1,SET,181,-0.088976,-0.0087862,0.060629,0.92888,GSE19772_HCMV_INFL_VS_HCMV_INF_MONOCYTES_AND_PI3K_INHIBITION_DN,1
GOBP_MOLTING_CYCLE_PROCESS,SET,95,-0.13908,-0.0099732,0.094729,0.92896,GOBP_MOLTING_CYCLE_PROCESS,1
HP_RECURRENT_OTITIS_MEDIA,SET,173,-0.096497,-0.009318,0.065728,0.92896,HP_RECURRENT_OTITIS_MEDIA,1
GOBP_MAINTENANCE_OF_PROTEIN_...4,SET,62,-0.15468,-0.0089687,0.10534,0.92899,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION_IN_CELL,1
JI_RESPONSE_TO_FSH_DN,SET,49,-0.18263,-0.0094176,0.12436,0.92903,JI_RESPONSE_TO_FSH_DN,1
KYNG_ENVIRONMENTAL_STRESS_RE...8,SET,48,-0.16798,-0.0085733,0.11436,0.92905,KYNG_ENVIRONMENTAL_STRESS_RESPONSE_UP,1
GOBP_REGULATION_OF_GLIAL_CEL...3,SET,18,-0.32045,-0.010024,0.21816,0.92906,GOBP_REGULATION_OF_GLIAL_CELL_MIGRATION,1
KIM_BIPOLAR_DISORDER_OLIGODE...2,SET,597,-0.048448,-0.0085887,0.032978,0.92908,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP,1
GOBP_CHEMOKINE_C_X_C_MOTIF_L...2,SET,6,-0.50043,-0.0090404,0.34053,0.92915,GOBP_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,1
WP_CONVERSION_OF_ANGIOTENSIN...,SET,5,-0.68572,-0.011309,0.46659,0.92916,WP_CONVERSION_OF_ANGIOTENSINOGEN_TO_ANGIOTENSIN_II,1
MIR5010_5P,SET,33,-0.21981,-0.009306,0.14956,0.92917,MIR5010_5P,1
PARK_OSTEOBLAST_DIFFERENTIAT...2,SET,12,-0.39875,-0.010186,0.2713,0.92918,PARK_OSTEOBLAST_DIFFERENTIATION_BY_PHENYLAMIL_UP,1
GOBP_RETINA_VASCULATURE_DEVE...,SET,18,-0.28736,-0.0089886,0.19552,0.92918,GOBP_RETINA_VASCULATURE_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
HP_ATROPHY_DEGENERATION_AFFE...1,SET,36,-0.21369,-0.0094483,0.14538,0.9292,HP_ATROPHY_DEGENERATION_AFFECTING_THE_BRAINSTEM,1
GOBP_MUSCLE_CELL_MIGRATION,SET,80,-0.15168,-0.0099852,0.10317,0.92924,GOBP_MUSCLE_CELL_MIGRATION,1
MIR3168,SET,122,-0.11007,-0.0089378,0.074838,0.92931,MIR3168,1
ZHAN_MULTIPLE_MYELOMA_UP,SET,47,-0.16203,-0.0081832,0.11016,0.92932,ZHAN_MULTIPLE_MYELOMA_UP,1
VALK_AML_CLUSTER_15,SET,28,-0.2524,-0.0098443,0.17156,0.92938,VALK_AML_CLUSTER_15,1
MODULE_79,SET,89,-0.13775,-0.0095624,0.093618,0.9294,MODULE_79,1
GOBP_BRANCHING_INVOLVED_IN_S...,SET,22,-0.27516,-0.0095144,0.18701,0.9294,GOBP_BRANCHING_INVOLVED_IN_SALIVARY_GLAND_MORPHOGENESIS,1
GSE27786_LIN_NEG_VS_NKCELL_DN,SET,180,-0.087467,-0.0086136,0.059438,0.92942,GSE27786_LIN_NEG_VS_NKCELL_DN,1
GSE45739_UNSTIM_VS_ACD3_ACD2...1,SET,176,-0.09692,-0.0094389,0.06586,0.92943,GSE45739_UNSTIM_VS_ACD3_ACD28_STIM_NRAS_KO_CD4_TCELL_DN,1
MORF_USP5,SET,46,-0.16252,-0.0081206,0.1104,0.92949,MORF_USP5,1
WP_IDO_METABOLIC_PATHWAY,SET,9,-0.46032,-0.010184,0.31269,0.9295,WP_IDO_METABOLIC_PATHWAY,1
GSE34156_UNTREATED_VS_24H_NO...2,SET,154,-0.10168,-0.0092688,0.069071,0.9295,GSE34156_UNTREATED_VS_24H_NOD2_AND_TLR1_TLR2_LIGAND_TREATED_MONOCYTE_UP,1
CHIANG_LIVER_CANCER_SUBCLASS...3,SET,46,-0.18209,-0.0090981,0.12368,0.92952,CHIANG_LIVER_CANCER_SUBCLASS_INTERFERON_DN,1
MEINHOLD_OVARIAN_CANCER_LOW_...2,SET,10,-0.44253,-0.01032,0.30051,0.92956,MEINHOLD_OVARIAN_CANCER_LOW_GRADE_UP,1
HP_LOWER_LIMB_METAPHYSEAL_IR...,SET,9,-0.41841,-0.0092566,0.28413,0.92956,HP_LOWER_LIMB_METAPHYSEAL_IRREGULARITY,1
HEN1_01,SET,182,-0.091935,-0.0091032,0.062424,0.92958,HEN1_01,1
WINZEN_DEGRADED_VIA_KHSRP,SET,96,-0.14589,-0.010516,0.09905,0.92961,WINZEN_DEGRADED_VIA_KHSRP,1
GOBP_GASTRIC_MOTILITY,SET,5,-0.54452,-0.0089801,0.36966,0.92962,GOBP_GASTRIC_MOTILITY,1
GGGACCA_MIR133A_MIR133B,SET,184,-0.096084,-0.0095656,0.065221,0.92964,GGGACCA_MIR133A_MIR133B,1
GSE42724_NAIVE_VS_MEMORY_BCE...1,SET,172,-0.096121,-0.009255,0.065236,0.92967,GSE42724_NAIVE_VS_MEMORY_BCELL_DN,1
GSE7852_LN_VS_FAT_TREG_DN,SET,181,-0.096144,-0.0094941,0.06525,0.92968,GSE7852_LN_VS_FAT_TREG_DN,1
HP_MUCOPOLYSACCHARIDURIA,SET,19,-0.27326,-0.0087816,0.18534,0.9298,HP_MUCOPOLYSACCHARIDURIA,1
GOMF_RETINOIC_ACID_4_HYDROXY...,SET,10,-0.40731,-0.0094982,0.27624,0.92981,GOMF_RETINOIC_ACID_4_HYDROXYLASE_ACTIVITY,1
GSE13306_TREG_VS_TCONV_SPLEE...2,SET,183,-0.098145,-0.0097445,0.066565,0.92981,GSE13306_TREG_VS_TCONV_SPLEEN_UP,1
MORF_IL16,SET,214,-0.085308,-0.0091515,0.05785,0.92984,MORF_IL16,1
MIR296_5P,SET,50,-0.1648,-0.0085839,0.11175,0.92985,MIR296_5P,1
GOBP_HINDBRAIN_MORPHOGENESIS,SET,40,-0.20113,-0.0093727,0.13638,0.92985,GOBP_HINDBRAIN_MORPHOGENESIS,1
GSE17974_IL4_AND_ANTI_IL12_V...18,SET,153,-0.10442,-0.0094873,0.070794,0.92988,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_72H_ACT_CD4_TCELL_UP,1
GSE19941_UNSTIM_VS_LPS_AND_I...3,SET,175,-0.091805,-0.0089155,0.062243,0.92988,GSE19941_UNSTIM_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_DN,1
GOBP_REGULATION_OF_COPII_VES...,SET,5,-0.44163,-0.0072833,0.29936,0.92992,GOBP_REGULATION_OF_COPII_VESICLE_COATING,1
GSE360_L_DONOVANI_VS_M_TUBER...4,SET,184,-0.093083,-0.0092669,0.063046,0.93007,GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP,1
MIR193B_5P,SET,55,-0.1633,-0.0089199,0.1106,0.93009,MIR193B_5P,1
GOMF_SEQUENCE_SPECIFIC_SINGL...,SET,12,-0.32503,-0.0083027,0.22009,0.93013,GOMF_SEQUENCE_SPECIFIC_SINGLE_STRANDED_DNA_BINDING,1
GSE7460_CTRL_VS_FOXP3_OVEREX...3,SET,174,-0.091582,-0.0088687,0.062014,0.93013,GSE7460_CTRL_VS_FOXP3_OVEREXPR_TCONV_DN,1
GSE20727_CTRL_VS_DNFB_ALLERG...2,SET,179,-0.092728,-0.0091065,0.062783,0.93015,GSE20727_CTRL_VS_DNFB_ALLERGEN_TREATED_DC_UP,1
MORF_CDC2L5,SET,134,-0.1033,-0.0087885,0.069932,0.93018,MORF_CDC2L5,1
SRF_C,SET,198,-0.089361,-0.009225,0.060457,0.9303,SRF_C,1
MIKKELSEN_IPS_ICP_WITH_H3K27...,SET,54,-0.17203,-0.0093111,0.11638,0.93032,MIKKELSEN_IPS_ICP_WITH_H3K27ME3,1
GOBP_NEGATIVE_REGULATION_OF_...41,SET,28,-0.23049,-0.0089895,0.15592,0.93032,GOBP_NEGATIVE_REGULATION_OF_AXON_EXTENSION,1
KEGG_MEDICUS_VARIANT_MUTATIO...14,SET,5,-0.51603,-0.0085103,0.34901,0.93036,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_LRRK2_TO_INTRINSIC_APOPTOTIC_PATHWAY,1
GOBP_PROTEIN_SUMOYLATION,SET,59,-0.1513,-0.0085586,0.1023,0.93042,GOBP_PROTEIN_SUMOYLATION,1
GOBP_REGULATION_OF_SNARE_COM...,SET,13,-0.32648,-0.0086798,0.22073,0.93043,GOBP_REGULATION_OF_SNARE_COMPLEX_ASSEMBLY,1
HP_APLASIA_HYPOPLASIA_OF_THE...68,SET,16,-0.30559,-0.0090126,0.20659,0.93045,HP_APLASIA_HYPOPLASIA_OF_THE_STERNUM,1
HP_BASAL_CELL_CARCINOMA,SET,61,-0.14326,-0.0082394,0.096847,0.93045,HP_BASAL_CELL_CARCINOMA,1
MIR1266_3P,SET,48,-0.17005,-0.008679,0.11495,0.93046,MIR1266_3P,1
GOBP_CARTILAGE_DEVELOPMENT_I...,SET,31,-0.23236,-0.009535,0.15705,0.9305,GOBP_CARTILAGE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GSE360_DC_VS_MAC_T_GONDII_DN,SET,182,-0.094879,-0.0093947,0.06412,0.93052,GSE360_DC_VS_MAC_T_GONDII_DN,1
GOBP_CELLULAR_RESPONSE_TO_IN...2,SET,5,-0.59852,-0.0098706,0.40441,0.93056,GOBP_CELLULAR_RESPONSE_TO_INDOLE_3_METHANOL,1
MIR4464,SET,62,-0.15233,-0.0088324,0.10291,0.93059,MIR4464,1
GLI1_TARGET_GENES,SET,421,-0.06142,-0.0091887,0.041492,0.93059,GLI1_TARGET_GENES,1
MIR23A_3P_MIR23B_3P,SET,536,-0.055638,-0.0093619,0.037568,0.93069,MIR23A_3P_MIR23B_3P,1
GOBP_ENDOSOME_TO_PLASMA_MEMB...,SET,14,-0.33934,-0.0093621,0.22911,0.9307,GOBP_ENDOSOME_TO_PLASMA_MEMBRANE_PROTEIN_TRANSPORT,1
HP_ABNORMAL_LENS_MORPHOLOGY,SET,720,-0.047126,-0.009143,0.031819,0.9307,HP_ABNORMAL_LENS_MORPHOLOGY,1
GSE9037_CTRL_VS_LPS_4H_STIM_...2,SET,177,-0.094047,-0.0091848,0.063488,0.93073,GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_UP,1
HP_ERYTHROID_HYPERPLASIA,SET,14,-0.30756,-0.0084853,0.20761,0.93075,HP_ERYTHROID_HYPERPLASIA,1
MIR4720_5P,SET,79,-0.14132,-0.009245,0.09538,0.93077,MIR4720_5P,1
HP_URTICARIA,SET,49,-0.17342,-0.0089425,0.11705,0.93077,HP_URTICARIA,1
GOBP_DETERMINATION_OF_DIGEST...,SET,6,-0.42826,-0.0077366,0.28902,0.93079,GOBP_DETERMINATION_OF_DIGESTIVE_TRACT_LEFT_RIGHT_ASYMMETRY,1
HOEK_MONOCYTE_2011_2012_TIV_...3,SET,4,-0.70913,-0.01046,0.47856,0.93079,HOEK_MONOCYTE_2011_2012_TIV_ADULT_3DY_DN,1
REACTOME_REGULATION_OF_NPAS4...1,SET,13,-0.36113,-0.0096012,0.24362,0.93087,REACTOME_REGULATION_OF_NPAS4_GENE_EXPRESSION,1
HP_KETONURIA,SET,32,-0.2102,-0.0087631,0.1418,0.93087,HP_KETONURIA,1
HP_ABNORMAL_RIB_MORPHOLOGY,SET,290,-0.073963,-0.0092172,0.049886,0.9309,HP_ABNORMAL_RIB_MORPHOLOGY,1
MIR7974,SET,80,-0.1419,-0.0093417,0.095699,0.93093,MIR7974,1
MODULE_288,SET,34,-0.25346,-0.010892,0.17094,0.93093,MODULE_288,1
GSE2770_IL12_AND_TGFB_ACT_VS...4,SET,178,-0.090767,-0.0088892,0.061203,0.93096,GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_48H_UP,1
REACTOME_AMINO_ACID_CONJUGAT...,SET,8,-0.61144,-0.012754,0.41222,0.93099,REACTOME_AMINO_ACID_CONJUGATION,1
WHITESIDE_CISPLATIN_RESISTAN...2,SET,11,-0.37495,-0.0091703,0.25274,0.93102,WHITESIDE_CISPLATIN_RESISTANCE_UP,1
GOBP_RESPONSE_TO_AMINO_ACID_...,SET,50,-0.17242,-0.0089811,0.11623,0.93102,GOBP_RESPONSE_TO_AMINO_ACID_STARVATION,1
BIOCARTA_TALL1_PATHWAY,SET,15,-0.3508,-0.010018,0.23645,0.93104,BIOCARTA_TALL1_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...387,SET,10,-0.46697,-0.010889,0.31474,0.93104,GOBP_NEGATIVE_REGULATION_OF_MESENCHYMAL_CELL_APOPTOTIC_PROCESS,1
ZNF785_TARGET_GENES,SET,55,-0.16593,-0.0090635,0.11183,0.93105,ZNF785_TARGET_GENES,1
GOBP_SIGNAL_TRANSDUCTION_IN_...1,SET,66,-0.15831,-0.0094696,0.10669,0.93106,GOBP_SIGNAL_TRANSDUCTION_IN_ABSENCE_OF_LIGAND,1
WP_BURN_WOUND_HEALING,SET,95,-0.13995,-0.010036,0.094307,0.93108,WP_BURN_WOUND_HEALING,1
PBXIP1_TARGET_GENES,SET,196,-0.089166,-0.0091588,0.060082,0.9311,PBXIP1_TARGET_GENES,1
MORF_BCL2L11,SET,161,-0.10103,-0.0094145,0.068055,0.93116,MORF_BCL2L11,1
HP_CONGENITAL_ONSET,SET,951,-0.041355,-0.0091605,0.027853,0.93118,HP_CONGENITAL_ONSET,1
REACTOME_MATURATION_OF_SARS_...1,SET,11,-0.33352,-0.0081569,0.22457,0.93124,REACTOME_MATURATION_OF_SARS_COV_1_NUCLEOPROTEIN,1
LEIN_CEREBELLUM_MARKERS,SET,76,-0.15123,-0.009705,0.1018,0.93131,LEIN_CEREBELLUM_MARKERS,1
GCM_ZNF198,SET,111,-0.11144,-0.008634,0.074998,0.93133,GCM_ZNF198,1
GOBP_INTRACELLULAR_TRANSPORT,SET,1228,-0.035639,-0.0088991,0.023986,0.93133,GOBP_INTRACELLULAR_TRANSPORT,1
ATF2_UP.V1_UP,SET,171,-0.096932,-0.0093062,0.065234,0.93134,ATF2_UP.V1_UP,1
GOBP_TRANSEPITHELIAL_CHLORID...,SET,8,-0.46433,-0.0096853,0.31246,0.93136,GOBP_TRANSEPITHELIAL_CHLORIDE_TRANSPORT,1
STARK_BRAIN_22Q11_DELETION,SET,10,-0.3959,-0.0092322,0.26639,0.93137,STARK_BRAIN_22Q11_DELETION,1
GOBP_ANTIGEN_PROCESSING_AND_...8,SET,27,-0.27395,-0.010492,0.18432,0.93139,GOBP_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_EXOGENOUS_PEPTIDE_ANTIGEN_VIA_MHC_CLASS_II,1
GOBP_VITAMIN_D_RECEPTOR_SIGN...,SET,12,-0.35843,-0.0091556,0.24112,0.93142,GOBP_VITAMIN_D_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_G_ALPHA_12_13_SIGNA...,SET,74,-0.15076,-0.0095471,0.10141,0.93144,REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS,1
GOBP_NEGATIVE_REGULATION_OF_...619,SET,137,-0.10431,-0.0089725,0.070131,0.93154,GOBP_NEGATIVE_REGULATION_OF_SUPRAMOLECULAR_FIBER_ORGANIZATION,1
GSE44649_NAIVE_VS_ACTIVATED_...3,SET,176,-0.09228,-0.008987,0.062036,0.93155,GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP,1
WP_MRNA_PROCESSING,SET,117,-0.10323,-0.0082101,0.069391,0.93157,WP_MRNA_PROCESSING,1
GOBP_TRANSCRIPTION_PREINITIA...,SET,64,-0.14529,-0.0085586,0.097652,0.93159,GOBP_TRANSCRIPTION_PREINITIATION_COMPLEX_ASSEMBLY,1
GCM_NCAM1,SET,115,-0.11402,-0.0089909,0.076612,0.93165,GCM_NCAM1,1
KEGG_MEDICUS_REFERENCE_CD80_...1,SET,10,-0.40872,-0.0095311,0.27452,0.93173,KEGG_MEDICUS_REFERENCE_CD80_CD86_CD28_PI3K_SIGNALING_PATHWAY,1
REACTOME_PHENYLALANINE_METAB...,SET,5,-0.66863,-0.011027,0.44909,0.93173,REACTOME_PHENYLALANINE_METABOLISM,1
GSE21033_1H_VS_24H_POLYIC_ST...2,SET,154,-0.10294,-0.009383,0.069138,0.93173,GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP,1
GSE13485_CTRL_VS_DAY3_YF17D_...2,SET,151,-0.10413,-0.0093999,0.069927,0.93177,GSE13485_CTRL_VS_DAY3_YF17D_VACCINE_PBMC_UP,1
GSE24671_BAKIMULC_VS_SENDAI_...2,SET,182,-0.088493,-0.0087624,0.05942,0.93178,GSE24671_BAKIMULC_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_UP,1
REACTOME_PROTEIN_FOLDING,SET,92,-0.12585,-0.0088819,0.084503,0.93179,REACTOME_PROTEIN_FOLDING,1
FREAC3_01,SET,232,-0.087168,-0.0097316,0.058516,0.93183,FREAC3_01,1
HP_CHRONIC_LUNG_DISEASE,SET,39,-0.19659,-0.0090465,0.13197,0.93184,HP_CHRONIC_LUNG_DISEASE,1
KEGG_MEDICUS_REFERENCE_TETHE...,SET,9,-0.39816,-0.0088088,0.26727,0.93185,KEGG_MEDICUS_REFERENCE_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,1
GOBP_FRUCTOSE_6_PHOSPHATE_ME...,SET,12,-0.35134,-0.0089746,0.23583,0.93185,GOBP_FRUCTOSE_6_PHOSPHATE_METABOLIC_PROCESS,1
GOBP_CYCLIC_NUCLEOTIDE_BIOSY...,SET,17,-0.31813,-0.0096709,0.21353,0.93186,GOBP_CYCLIC_NUCLEOTIDE_BIOSYNTHETIC_PROCESS,1
GOMF_POLY_G_BINDING,SET,7,-0.44438,-0.0086708,0.29823,0.93189,GOMF_POLY_G_BINDING,1
GSE23925_LIGHT_ZONE_VS_DARK_...1,SET,187,-0.091084,-0.0091407,0.061114,0.93193,GSE23925_LIGHT_ZONE_VS_DARK_ZONE_BCELL_DN,1
HP_BILATERAL_MICROPHTHALMOS,SET,19,-0.26472,-0.0085072,0.17757,0.93198,HP_BILATERAL_MICROPHTHALMOS,1
GOBP_TRANSCRIPTION_COUPLED_N...,SET,10,-0.36161,-0.0084326,0.24253,0.93201,GOBP_TRANSCRIPTION_COUPLED_NUCLEOTIDE_EXCISION_REPAIR,1
CHIBA_RESPONSE_TO_TSA,SET,37,-0.20621,-0.0092432,0.13829,0.93204,CHIBA_RESPONSE_TO_TSA,1
BERNARD_PPAPDC1B_TARGETS_DN,SET,53,-0.18204,-0.0097615,0.12203,0.93211,BERNARD_PPAPDC1B_TARGETS_DN,1
MODULE_110,SET,4,-0.52214,-0.0077021,0.35001,0.93211,MODULE_110,1
GOBP_L_PHENYLALANINE_METABOL...,SET,8,-0.48981,-0.010217,0.32835,0.93211,GOBP_L_PHENYLALANINE_METABOLIC_PROCESS,1
MODULE_76,SET,78,-0.15788,-0.010263,0.10583,0.93212,MODULE_76,1
REACTOME_DISEASES_ASSOCIATED...3,SET,19,-0.25364,-0.008151,0.17001,0.93213,REACTOME_DISEASES_ASSOCIATED_WITH_N_GLYCOSYLATION_OF_PROTEINS,1
GOBP_POSITIVE_REGULATION_OF_...596,SET,5,-0.57224,-0.0094372,0.38351,0.93216,GOBP_POSITIVE_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_DYSCALCULIA,SET,22,-0.24467,-0.00846,0.16396,0.93217,HP_DYSCALCULIA,1
GOBP_NEGATIVE_REGULATION_OF_...563,SET,79,-0.13776,-0.0090124,0.092306,0.9322,GOBP_NEGATIVE_REGULATION_OF_RESPONSE_TO_CYTOKINE_STIMULUS,1
HOSHIDA_LIVER_CANCER_LATE_RE...2,SET,56,-0.17197,-0.0094784,0.11521,0.93224,HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP,1
WEBER_METHYLATED_ICP_IN_SPER...2,SET,8,-0.39464,-0.0082317,0.26434,0.93226,WEBER_METHYLATED_ICP_IN_SPERM_UP,1
GOBP_NEGATIVE_REGULATION_OF_...627,SET,20,-0.28466,-0.0093852,0.19067,0.93227,GOBP_NEGATIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
GOBP_EPIDERMIS_DEVELOPMENT,SET,356,-0.073678,-0.010154,0.049341,0.9323,GOBP_EPIDERMIS_DEVELOPMENT,1
GOMF_LIPID_TRANSFER_ACTIVITY,SET,50,-0.1808,-0.0094175,0.12108,0.93231,GOMF_LIPID_TRANSFER_ACTIVITY,1
REACTOME_DISEASES_ASSOCIATED...2,SET,13,-0.3017,-0.0080211,0.20201,0.93233,REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSYLATION_PRECURSOR_BIOSYNTHESIS,1
MIF1_01,SET,163,-0.099459,-0.0093248,0.066581,0.93238,MIF1_01,1
GOBP_THERMOCEPTION,SET,8,-0.50134,-0.010457,0.33561,0.93238,GOBP_THERMOCEPTION,1
GSE8621_LPS_PRIMED_UNSTIM_VS...1,SET,177,-0.089627,-0.0087531,0.059968,0.93248,GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN,1
KEGG_MATURITY_ONSET_DIABETES...,SET,25,-0.28919,-0.010659,0.19342,0.93256,KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,1
GSE21670_TGFB_VS_IL6_TREATED...4,SET,188,-0.092363,-0.0092936,0.061772,0.93256,GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...766,SET,65,-0.15302,-0.009084,0.1023,0.93263,GOBP_POSITIVE_REGULATION_OF_TOR_SIGNALING,1
MIR2392,SET,68,-0.1566,-0.0095079,0.1047,0.93264,MIR2392,1
HP_LARGE_FOREHEAD,SET,21,-0.27777,-0.0093839,0.18568,0.93265,HP_LARGE_FOREHEAD,1
HP_PARTIAL_DUPLICATION_OF_TH...1,SET,6,-0.47968,-0.0086655,0.32058,0.9327,HP_PARTIAL_DUPLICATION_OF_THE_DISTAL_PHALANGES_OF_THE_HAND,1
HP_DUANE_ANOMALY,SET,22,-0.27153,-0.0093888,0.18145,0.93273,HP_DUANE_ANOMALY,1
GSE37301_GRANULOCYTE_MONOCYT...2,SET,166,-0.097412,-0.0092158,0.06509,0.93274,GSE37301_GRANULOCYTE_MONOCYTE_PROGENITOR_VS_RAG2_KO_NK_CELL_UP,1
VANDESLUIS_NORMAL_EMBRYOS_UP,SET,5,-0.60409,-0.0099625,0.40358,0.93277,VANDESLUIS_NORMAL_EMBRYOS_UP,1
GOBP_MESONEPHRIC_DUCT_DEVELO...,SET,8,-0.46572,-0.0097144,0.3111,0.9328,GOBP_MESONEPHRIC_DUCT_DEVELOPMENT,1
WNT_UP.V1_UP,SET,167,-0.10095,-0.009579,0.067423,0.93283,WNT_UP.V1_UP,1
GOMF_PYRUVATE_TRANSMEMBRANE_...,SET,5,-0.59753,-0.0098542,0.399,0.93287,GOMF_PYRUVATE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MAHAJAN_RESPONSE_TO_IL1A_DN,SET,63,-0.16031,-0.0093699,0.10704,0.93288,MAHAJAN_RESPONSE_TO_IL1A_DN,1
GOBP_ENTRY_OF_BACTERIUM_INTO...,SET,9,-0.40142,-0.0088809,0.26797,0.93293,GOBP_ENTRY_OF_BACTERIUM_INTO_HOST_CELL,1
GOBP_ENERGY_RESERVE_METABOLI...,SET,85,-0.13804,-0.0093659,0.092143,0.93294,GOBP_ENERGY_RESERVE_METABOLIC_PROCESS,1
KEGG_MEDICUS_VARIANT_AMPLIFI...17,SET,8,-0.47465,-0.0099006,0.31676,0.93298,KEGG_MEDICUS_VARIANT_AMPLIFIED_REL_TO_TRANSCRIPTION,1
BALDWIN_PRKCI_TARGETS_UP,SET,32,-0.24932,-0.010394,0.16638,0.93299,BALDWIN_PRKCI_TARGETS_UP,1
MIR6769B_5P,SET,71,-0.15171,-0.0094114,0.10124,0.93299,MIR6769B_5P,1
GOBP_RESPONSE_TO_ANGIOTENSIN,SET,38,-0.22799,-0.010356,0.15211,0.93303,GOBP_RESPONSE_TO_ANGIOTENSIN,1
HP_ABNORMAL_VISUAL_ELECTROPH...,SET,233,-0.083938,-0.0093909,0.056004,0.93303,HP_ABNORMAL_VISUAL_ELECTROPHYSIOLOGY,1
GSE41176_UNSTIM_VS_ANTI_IGM_...6,SET,180,-0.101,-0.0099463,0.067374,0.93307,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_3H_UP,1
SANA_TNF_SIGNALING_UP,SET,79,-0.15346,-0.01004,0.10232,0.93315,SANA_TNF_SIGNALING_UP,1
GOBP_LEUKOCYTE_HOMEOSTASIS,SET,101,-0.12834,-0.0094878,0.085573,0.93315,GOBP_LEUKOCYTE_HOMEOSTASIS,1
HP_INTESTINAL_CARCINOID,SET,6,-0.45856,-0.0082841,0.30575,0.93316,HP_INTESTINAL_CARCINOID,1
LTE2_UP.V1_DN,SET,172,-0.10372,-0.0099866,0.06913,0.93323,LTE2_UP.V1_DN,1
WP_KETOGENESIS_AND_KETOLYSIS,SET,8,-0.49026,-0.010226,0.32675,0.93324,WP_KETOGENESIS_AND_KETOLYSIS,1
REACTOME_RNA_POLYMERASE_II_T...3,SET,60,-0.14362,-0.0081927,0.095708,0.93327,REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION,1
GOBP_REGULATION_OF_NATURAL_K...3,SET,13,-0.36502,-0.0097044,0.24322,0.93328,GOBP_REGULATION_OF_NATURAL_KILLER_CELL_DIFFERENTIATION,1
HP_UPPER_MOTOR_NEURON_DYSFUN...,SET,1035,-0.039294,-0.0090585,0.026183,0.93328,HP_UPPER_MOTOR_NEURON_DYSFUNCTION,1
GSE20715_0H_VS_24H_OZONE_LUN...2,SET,183,-0.092853,-0.009219,0.061872,0.93328,GSE20715_0H_VS_24H_OZONE_LUNG_UP,1
HP_ABNORMAL_OVARIAN_PHYSIOLO...,SET,87,-0.13126,-0.0090096,0.08746,0.93329,HP_ABNORMAL_OVARIAN_PHYSIOLOGY,1
chr16p12,SET,78,-0.26622,-0.017307,0.1773,0.93338,chr16p12,1
GOBP_PROTEIN_RETENTION_IN_ER...,SET,8,-0.40807,-0.008512,0.27172,0.93342,GOBP_PROTEIN_RETENTION_IN_ER_LUMEN,1
GSE38304_MYC_NEG_VS_POS_GC_B...1,SET,182,-0.097462,-0.0096504,0.064877,0.93347,GSE38304_MYC_NEG_VS_POS_GC_BCELL_DN,1
GOBP_MONOCARBOXYLIC_ACID_TRA...,SET,173,-0.10179,-0.0098292,0.067756,0.93348,GOBP_MONOCARBOXYLIC_ACID_TRANSPORT,1
KAECH_NAIVE_VS_MEMORY_CD8_TC...1,SET,184,-0.096272,-0.0095844,0.064075,0.9335,KAECH_NAIVE_VS_MEMORY_CD8_TCELL_DN,1
CREBP1CJUN_01,SET,238,-0.083052,-0.0093896,0.055262,0.93355,CREBP1CJUN_01,1
MORF_DMPK,SET,153,-0.10412,-0.0094601,0.069272,0.93357,MORF_DMPK,1
GOBP_REGULATION_OF_GENERATIO...,SET,121,-0.10992,-0.008889,0.073113,0.93362,GOBP_REGULATION_OF_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
CDX2_Q5,SET,232,-0.091135,-0.010174,0.06059,0.93372,CDX2_Q5,1
MIR3682_5P,SET,88,-0.13213,-0.0091208,0.087827,0.93375,MIR3682_5P,1
GOBP_REGULATION_OF_VASCULAR_...3,SET,8,-0.45202,-0.0094285,0.30046,0.93375,GOBP_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_SIGNAL_RELEASE,SET,456,-0.061695,-0.0095966,0.041009,0.93375,GOBP_SIGNAL_RELEASE,1
KEGG_GLYCOSAMINOGLYCAN_DEGRA...,SET,20,-0.30027,-0.0098997,0.19955,0.93379,KEGG_GLYCOSAMINOGLYCAN_DEGRADATION,1
GOBP_LENS_FIBER_CELL_DEVELOP...,SET,14,-0.35563,-0.0098116,0.2363,0.93383,GOBP_LENS_FIBER_CELL_DEVELOPMENT,1
HP_ABNORMALITY_OF_COORDINATI...,SET,1042,-0.039289,-0.009086,0.026095,0.93391,HP_ABNORMALITY_OF_COORDINATION,1
GSE7831_1H_VS_4H_CPG_STIM_PD...2,SET,179,-0.091275,-0.0089638,0.060613,0.93394,GSE7831_1H_VS_4H_CPG_STIM_PDC_UP,1
GOBP_FIBROBLAST_GROWTH_FACTO...1,SET,7,-0.51543,-0.010057,0.34227,0.93395,GOBP_FIBROBLAST_GROWTH_FACTOR_PRODUCTION,1
GSE15930_NAIVE_VS_48H_IN_VIT...4,SET,184,-0.093704,-0.0093287,0.062205,0.93401,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IFNAB_CD8_TCELL_UP,1
GSE39556_CD8A_DC_VS_NK_CELL_...2,SET,181,-0.096186,-0.0094982,0.063851,0.93401,GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN,1
FONTAINE_PAPILLARY_THYROID_C...2,SET,61,-0.16983,-0.0097679,0.11271,0.93406,FONTAINE_PAPILLARY_THYROID_CARCINOMA_UP,1
GSE13485_CTRL_VS_DAY21_YF17D...1,SET,129,-0.1133,-0.0094587,0.07518,0.93409,GSE13485_CTRL_VS_DAY21_YF17D_VACCINE_PBMC_DN,1
MIR147B_3P,SET,5,-0.6267,-0.010335,0.41581,0.93411,MIR147B_3P,1
GOBP_DELAMINATION,SET,7,-0.43189,-0.0084271,0.28655,0.93411,GOBP_DELAMINATION,1
REACTOME_LISTERIA_MONOCYTOGE...,SET,18,-0.2932,-0.0091712,0.19453,0.93412,REACTOME_LISTERIA_MONOCYTOGENES_ENTRY_INTO_HOST_CELLS,1
GOBP_TOR_SIGNALING,SET,146,-0.10208,-0.0090622,0.06771,0.93417,GOBP_TOR_SIGNALING,1
HP_ANTI_SMOOTH_MUSCLE_ANTIBO...,SET,5,-0.51509,-0.0084947,0.34165,0.93417,HP_ANTI_SMOOTH_MUSCLE_ANTIBODY_POSITIVITY,1
CHANGOLKAR_H2AFY_TARGETS_UP,SET,43,-0.19937,-0.009632,0.13218,0.93425,CHANGOLKAR_H2AFY_TARGETS_UP,1
HP_LIMITED_PRONATION_SUPINAT...,SET,11,-0.44339,-0.010844,0.29385,0.93433,HP_LIMITED_PRONATION_SUPINATION_OF_FOREARM,1
MODULE_166,SET,48,-0.18152,-0.0092642,0.12029,0.93435,MODULE_166,1
GOBP_NEGATIVE_REGULATION_OF_...691,SET,20,-0.29967,-0.0098801,0.19855,0.93438,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
MIR548E_3P,SET,433,-0.061556,-0.0093363,0.040766,0.93447,MIR548E_3P,1
HP_CARCINOID_TUMOR,SET,12,-0.33471,-0.0085498,0.22164,0.93449,HP_CARCINOID_TUMOR,1
GOBP_MYOBLAST_PROLIFERATION,SET,24,-0.26607,-0.0096084,0.17618,0.9345,GOBP_MYOBLAST_PROLIFERATION,1
GSE32034_UNTREATED_VS_ROSIGL...1,SET,177,-0.093049,-0.0090873,0.061595,0.93455,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_HIGH_MONOCYTE_DN,1
CHEN_LIVER_METABOLISM_QTL_CIS,SET,88,-0.15354,-0.010599,0.10162,0.93459,CHEN_LIVER_METABOLISM_QTL_CIS,1
GSE27786_LIN_NEG_VS_CD4_TCEL...1,SET,181,-0.09266,-0.00915,0.061322,0.9346,GSE27786_LIN_NEG_VS_CD4_TCELL_DN,1
LET_7I_3P,SET,5,-0.57986,-0.0095628,0.38356,0.9347,LET_7I_3P,1
SP1_Q2_01,SET,239,-0.084083,-0.0095258,0.055617,0.9347,SP1_Q2_01,1
GSE19401_PAM2CSK4_VS_RETINOI...1,SET,180,-0.094296,-0.009286,0.062365,0.93472,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_DN,1
MIR4426,SET,133,-0.1119,-0.0094848,0.074001,0.93475,MIR4426,1
GOMF_SULFUR_COMPOUND_BINDING,SET,246,-0.086713,-0.0099647,0.057337,0.93477,GOMF_SULFUR_COMPOUND_BINDING,1
HP_DELAYED_ABILITY_TO_STAND,SET,14,-0.34761,-0.0095901,0.22984,0.93478,HP_DELAYED_ABILITY_TO_STAND,1
GOLDRATH_EFF_VS_MEMORY_CD8_T...2,SET,183,-0.09246,-0.00918,0.061125,0.9348,GOLDRATH_EFF_VS_MEMORY_CD8_TCELL_UP,1
GSE32986_CURDLAN_LOWDOSE_VS_...1,SET,190,-0.096075,-0.0097178,0.063517,0.9348,GSE32986_CURDLAN_LOWDOSE_VS_CURDLAN_HIGHDOSE_STIM_DC_DN,1
GOBP_RIGHTING_REFLEX,SET,8,-0.46933,-0.0097896,0.31022,0.93484,GOBP_RIGHTING_REFLEX,1
GOBP_VITAMIN_CATABOLIC_PROCE...,SET,15,-0.33463,-0.0095559,0.22119,0.93484,GOBP_VITAMIN_CATABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...422,SET,35,-0.22921,-0.0099931,0.1515,0.93485,GOBP_POSITIVE_REGULATION_OF_LYASE_ACTIVITY,1
GOBP_FATTY_ACYL_COA_BIOSYNTH...,SET,25,-0.27666,-0.010197,0.18284,0.93487,GOBP_FATTY_ACYL_COA_BIOSYNTHETIC_PROCESS,1
HP_CHOROID_PLEXUS_CARCINOMA,SET,5,-0.67994,-0.011213,0.44935,0.93487,HP_CHOROID_PLEXUS_CARCINOMA,1
HP_ABULIA,SET,10,-0.39746,-0.0092685,0.26259,0.93493,HP_ABULIA,1
DESCARTES_FETAL_LUNG_VISCERA...,SET,168,-0.1075,-0.010231,0.070996,0.935,DESCARTES_FETAL_LUNG_VISCERAL_NEURONS,1
HP_PORTAL_VEIN_THROMBOSIS,SET,11,-0.40597,-0.0099289,0.26801,0.93508,HP_PORTAL_VEIN_THROMBOSIS,1
GOBP_POSITIVE_REGULATION_OF_...89,SET,8,-0.42241,-0.008811,0.27883,0.9351,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
REACTOME_MECP2_REGULATES_TRA...2,SET,7,-0.56966,-0.011115,0.37596,0.93513,REACTOME_MECP2_REGULATES_TRANSCRIPTION_OF_NEURONAL_LIGANDS,1
GOBP_DENDRITE_MORPHOGENESIS,SET,131,-0.11327,-0.0095292,0.074749,0.93515,GOBP_DENDRITE_MORPHOGENESIS,1
GOBP_REGULATION_OF_CAMP_MEDI...,SET,19,-0.29922,-0.0096158,0.19746,0.93515,GOBP_REGULATION_OF_CAMP_MEDIATED_SIGNALING,1
GOBP_RESPONSE_TO_STILBENOID,SET,7,-0.61515,-0.012003,0.40579,0.93522,GOBP_RESPONSE_TO_STILBENOID,1
KEGG_TYPE_I_DIABETES_MELLITUS,SET,39,-0.23424,-0.010779,0.15451,0.93523,KEGG_TYPE_I_DIABETES_MELLITUS,1
MORF_ATF2,SET,288,-0.077077,-0.0095726,0.050837,0.93525,MORF_ATF2,1
GOBP_GLUTAMINE_METABOLIC_PRO...,SET,25,-0.25696,-0.0094705,0.16947,0.93526,GOBP_GLUTAMINE_METABOLIC_PROCESS,1
HP_PITUITARY_HYPOTHYROIDISM,SET,35,-0.21851,-0.0095263,0.14411,0.93526,HP_PITUITARY_HYPOTHYROIDISM,1
TGCCTTA_MIR124A,SET,511,-0.057261,-0.0094142,0.037763,0.93527,TGCCTTA_MIR124A,1
GSE11864_UNTREATED_VS_CSF1_I...1,SET,172,-0.093568,-0.0090093,0.061705,0.93528,GSE11864_UNTREATED_VS_CSF1_IFNG_IN_MAC_DN,1
GOBP_FATTY_ACID_ELONGATION_S...,SET,8,-0.51479,-0.010738,0.33947,0.93529,GOBP_FATTY_ACID_ELONGATION_SATURATED_FATTY_ACID,1
GOBP_REGULATION_OF_INTEGRIN_...2,SET,3,-0.84683,-0.010818,0.55842,0.93529,GOBP_REGULATION_OF_INTEGRIN_BIOSYNTHETIC_PROCESS,1
GOBP_ACTIVATION_OF_CYSTEINE_...1,SET,13,-0.33935,-0.009022,0.22371,0.93535,GOBP_ACTIVATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
HP_IMPAIRED_SMOOTH_PURSUIT,SET,38,-0.1888,-0.008576,0.12445,0.93537,HP_IMPAIRED_SMOOTH_PURSUIT,1
GOCC_SUPER_ELONGATION_COMPLEX,SET,5,-0.52303,-0.0086256,0.34468,0.93541,GOCC_SUPER_ELONGATION_COMPLEX,1
GSE17721_CTRL_VS_CPG_6H_BMDC...2,SET,181,-0.090753,-0.0089617,0.0598,0.93543,GSE17721_CTRL_VS_CPG_6H_BMDC_UP,1
NRL_DN.V1_UP,SET,131,-0.11323,-0.0095255,0.074608,0.93544,NRL_DN.V1_UP,1
FERREIRA_EWINGS_SARCOMA_UNST...2,SET,148,-0.096784,-0.0086501,0.063765,0.93546,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP,1
MIR449B_5P,SET,237,-0.082505,-0.0093084,0.054356,0.93547,MIR449B_5P,1
HP_ABNORMAL_1ST_METACARPAL_M...,SET,31,-0.23734,-0.0097391,0.15636,0.93547,HP_ABNORMAL_1ST_METACARPAL_MORPHOLOGY,1
HP_VERTEBRAL_WEDGING,SET,16,-0.30299,-0.0089358,0.19955,0.93553,HP_VERTEBRAL_WEDGING,1
HP_MACULAR_HYPOPLASIA,SET,13,-0.384,-0.010209,0.25289,0.93554,HP_MACULAR_HYPOPLASIA,1
GOBP_CALCITONIN_FAMILY_RECEP...,SET,7,-0.53102,-0.010361,0.34963,0.93558,GOBP_CALCITONIN_FAMILY_RECEPTOR_SIGNALING_PATHWAY,1
HP_SPASTIC_DIPLEGIA,SET,29,-0.24064,-0.0095513,0.15841,0.93562,HP_SPASTIC_DIPLEGIA,1
GSE27786_CD8_TCELL_VS_MONO_M...2,SET,171,-0.092903,-0.0089194,0.061147,0.93565,GSE27786_CD8_TCELL_VS_MONO_MAC_UP,1
BUSSLINGER_DUODENAL_MATURE_E...,SET,237,-0.083183,-0.0093849,0.054743,0.93568,BUSSLINGER_DUODENAL_MATURE_ENTEROCYTES,1
GOBP_GLYCEROLIPID_METABOLIC_...,SET,357,-0.068437,-0.0094451,0.045025,0.93573,GOBP_GLYCEROLIPID_METABOLIC_PROCESS,1
MODULE_96,SET,36,-0.2348,-0.010382,0.15447,0.93574,MODULE_96,1
GSE21063_WT_VS_NFATC1_KO_3H_...1,SET,190,-0.094877,-0.0095966,0.062412,0.93576,GSE21063_WT_VS_NFATC1_KO_3H_ANTI_IGM_STIM_BCELL_DN,1
GOBP_REGULATION_OF_GLUCAGON_...,SET,8,-0.4441,-0.0092634,0.2921,0.93578,GOBP_REGULATION_OF_GLUCAGON_SECRETION,1
GOCC_FLOTILLIN_COMPLEX,SET,9,-0.41197,-0.0091142,0.27094,0.9358,GOCC_FLOTILLIN_COMPLEX,1
ATATGCA_MIR448,SET,191,-0.10311,-0.010457,0.067804,0.93582,ATATGCA_MIR448,1
GOBP_ANIMAL_ORGAN_FORMATION,SET,64,-0.17625,-0.010382,0.1159,0.93582,GOBP_ANIMAL_ORGAN_FORMATION,1
GSE22886_NEUTROPHIL_VS_MONOC...1,SET,176,-0.092894,-0.0090468,0.061086,0.93582,GSE22886_NEUTROPHIL_VS_MONOCYTE_DN,1
GOCC_ASTROCYTE_PROJECTION,SET,21,-0.31065,-0.010495,0.20426,0.93584,GOCC_ASTROCYTE_PROJECTION,1
RASHI_RESPONSE_TO_IONIZING_R...3,SET,43,-0.1816,-0.0087738,0.1194,0.93585,RASHI_RESPONSE_TO_IONIZING_RADIATION_3,1
GSE2770_IL12_VS_TGFB_AND_IL1...3,SET,184,-0.093412,-0.0092996,0.061406,0.93589,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
GOMF_CHLORIDE_TRANSMEMBRANE_...,SET,107,-0.13221,-0.010058,0.086897,0.93592,GOMF_CHLORIDE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
MIR654_3P,SET,71,-0.15211,-0.0094358,0.099961,0.93595,MIR654_3P,1
GOBP_POSITIVE_REGULATION_OF_...749,SET,11,-0.37166,-0.0090898,0.24423,0.93596,GOBP_POSITIVE_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
chr1p31,SET,77,-0.28204,-0.018217,0.18532,0.93598,chr1p31,1
GOBP_CELL_CYCLE_PHASE_TRANSI...,SET,495,-0.057303,-0.0092766,0.037644,0.93602,GOBP_CELL_CYCLE_PHASE_TRANSITION,1
PID_TRAIL_PATHWAY,SET,27,-0.25409,-0.0097318,0.1669,0.93604,PID_TRAIL_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...586,SET,12,-0.36019,-0.0092006,0.23659,0.93604,GOBP_POSITIVE_REGULATION_OF_PHOSPHOLIPID_METABOLIC_PROCESS,1
MIR1321,SET,124,-0.12088,-0.0098955,0.079397,0.93605,MIR1321,1
GOBP_POSITIVE_REGULATION_OF_...499,SET,66,-0.16142,-0.0096556,0.10602,0.93606,GOBP_POSITIVE_REGULATION_OF_MUSCLE_CELL_DIFFERENTIATION,1
GSE21360_NAIVE_VS_QUATERNARY...2,SET,188,-0.091602,-0.009217,0.060146,0.93611,GSE21360_NAIVE_VS_QUATERNARY_MEMORY_CD8_TCELL_UP,1
MIR212_5P,SET,86,-0.1357,-0.0092606,0.089084,0.93614,MIR212_5P,1
GOBP_CORONARY_VASCULATURE_DE...,SET,45,-0.19287,-0.0095319,0.12662,0.93614,GOBP_CORONARY_VASCULATURE_DEVELOPMENT,1
GOCC_SPERM_PRINCIPAL_PIECE,SET,29,-0.24088,-0.0095609,0.15814,0.93614,GOCC_SPERM_PRINCIPAL_PIECE,1
HE_LIM_SUN_FETAL_LUNG_C0_MES...3,SET,156,-0.11144,-0.010223,0.073163,0.93614,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_3_CELL,1
HP_HEMATOCHEZIA,SET,20,-0.29923,-0.0098657,0.19642,0.93616,HP_HEMATOCHEZIA,1
HP_TELANGIECTASIA,SET,136,-0.10102,-0.0086581,0.0663,0.93621,HP_TELANGIECTASIA,1
GOBP_GLUCOSE_6_PHOSPHATE_MET...,SET,26,-0.25332,-0.0095212,0.16624,0.93622,GOBP_GLUCOSE_6_PHOSPHATE_METABOLIC_PROCESS,1
chr3p13,SET,10,-0.61013,-0.014228,0.40032,0.93625,chr3p13,1
GSE17721_PAM3CSK4_VS_GADIQUI...15,SET,182,-0.095757,-0.0094816,0.062827,0.93625,GSE17721_PAM3CSK4_VS_GADIQUIMOD_6H_BMDC_DN,1
GOBP_PROSTATIC_BUD_FORMATION,SET,7,-0.58415,-0.011398,0.38314,0.93632,GOBP_PROSTATIC_BUD_FORMATION,1
GOBP_POSITIVE_REGULATION_OF_...774,SET,17,-0.33936,-0.010316,0.22257,0.93633,GOBP_POSITIVE_REGULATION_OF_TRANSCRIPTION_REGULATORY_REGION_DNA_BINDING,1
GOBP_REGULATION_OF_GAP_JUNCT...,SET,9,-0.50513,-0.011175,0.33124,0.93636,GOBP_REGULATION_OF_GAP_JUNCTION_ASSEMBLY,1
GOMF_TRANSLATION_REPRESSOR_A...,SET,30,-0.21496,-0.0086775,0.14092,0.9364,GOMF_TRANSLATION_REPRESSOR_ACTIVITY,1
ROSS_AML_WITH_MLL_FUSIONS,SET,69,-0.15423,-0.009432,0.1011,0.93642,ROSS_AML_WITH_MLL_FUSIONS,1
HP_CLEFT_ALA_NASI,SET,4,-0.76018,-0.011213,0.49788,0.93659,HP_CLEFT_ALA_NASI,1
GOCC_PROTEASOME_CORE_COMPLEX...1,SET,8,-0.35505,-0.0074059,0.23252,0.93661,GOCC_PROTEASOME_CORE_COMPLEX_ALPHA_SUBUNIT_COMPLEX,1
GSE2770_IL12_VS_TGFB_AND_IL1...5,SET,184,-0.091608,-0.00912,0.059981,0.93664,GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN,1
KEGG_MEDICUS_REFERENCE_ACH_C...1,SET,7,-0.47222,-0.009214,0.30911,0.93669,KEGG_MEDICUS_REFERENCE_ACH_CHRN_PI3K_SIGNALING_PATHWAY,1
REACTOME_INLA_MEDIATED_ENTRY...,SET,8,-0.47296,-0.0098654,0.3096,0.93669,REACTOME_INLA_MEDIATED_ENTRY_OF_LISTERIA_MONOCYTOGENES_INTO_HOST_CELLS,1
MIR3136_5P,SET,69,-0.16347,-0.0099972,0.10699,0.93672,MIR3136_5P,1
ALCALAY_AML_BY_NPM1_LOCALIZA...1,SET,168,-0.099731,-0.0094914,0.065269,0.93674,ALCALAY_AML_BY_NPM1_LOCALIZATION_DN,1
LEE_LIVER_CANCER_SURVIVAL_UP,SET,166,-0.1015,-0.0096023,0.066418,0.93675,LEE_LIVER_CANCER_SURVIVAL_UP,1
GOBP_REGULATION_OF_INTRACELL...4,SET,1637,-0.033751,-0.0096138,0.022082,0.93679,GOBP_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
HP_ABNORMAL_PONS_MORPHOLOGY,SET,105,-0.11665,-0.0087919,0.076307,0.93682,HP_ABNORMAL_PONS_MORPHOLOGY,1
BIOCARTA_CARM_ER_PATHWAY,SET,22,-0.26821,-0.0092739,0.17544,0.93683,BIOCARTA_CARM_ER_PATHWAY,1
GOBP_CELL_MOTILITY_INVOLVED_...,SET,5,-0.56339,-0.0092913,0.36853,0.93683,GOBP_CELL_MOTILITY_INVOLVED_IN_CEREBRAL_CORTEX_RADIAL_GLIA_GUIDED_MIGRATION,1
RADAEVA_RESPONSE_TO_IFNA1_DN,SET,10,-0.47953,-0.011182,0.31365,0.93684,RADAEVA_RESPONSE_TO_IFNA1_DN,1
GSE17721_PAM3CSK4_VS_GADIQUI...17,SET,183,-0.093991,-0.0093321,0.06148,0.93684,GSE17721_PAM3CSK4_VS_GADIQUIMOD_8H_BMDC_DN,1
GARGALOVIC_RESPONSE_TO_OXIDI...7,SET,21,-0.27553,-0.0093084,0.18019,0.93688,GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN,1
GOBP_EXTRACELLULAR_TRANSPORT,SET,38,-0.18891,-0.0085812,0.12352,0.9369,GOBP_EXTRACELLULAR_TRANSPORT,1
GSE16385_IFNG_TNF_VS_IL4_STI...1,SET,150,-0.10363,-0.0093242,0.067765,0.9369,GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN,1
CHEMELLO_SOLEUS_VS_EDL_MYOFI...1,SET,5,-0.58497,-0.0096472,0.38249,0.93691,CHEMELLO_SOLEUS_VS_EDL_MYOFIBERS_DN,1
BIOCARTA_TNFR1_PATHWAY,SET,29,-0.24205,-0.0096072,0.15824,0.93693,BIOCARTA_TNFR1_PATHWAY,1
FIGUEROA_AML_METHYLATION_CLU...8,SET,99,-0.13428,-0.0098286,0.087777,0.93696,FIGUEROA_AML_METHYLATION_CLUSTER_4_UP,1
MIR6818_5P,SET,100,-0.13258,-0.0097532,0.086667,0.93696,MIR6818_5P,1
MIR5002_5P,SET,233,-0.086354,-0.0096611,0.056436,0.937,MIR5002_5P,1
HP_ABNORMAL_BLOOD_GLUCOSE_CO...,SET,285,-0.075921,-0.0093806,0.049616,0.937,HP_ABNORMAL_BLOOD_GLUCOSE_CONCENTRATION,1
MODULE_190,SET,8,-0.56323,-0.011748,0.36806,0.93702,MODULE_190,1
REACTOME_SYNDECAN_INTERACTIO...,SET,26,-0.26517,-0.0099665,0.1732,0.93711,REACTOME_SYNDECAN_INTERACTIONS,1
GOCC_RPAP3_R2TP_PREFOLDIN_LI...,SET,9,-0.39773,-0.0087993,0.25978,0.93711,GOCC_RPAP3_R2TP_PREFOLDIN_LIKE_COMPLEX,1
MORF_HAT1,SET,153,-0.09465,-0.0085998,0.061812,0.93714,MORF_HAT1,1
REACTOME_CONJUGATION_OF_BENZ...,SET,6,-0.68826,-0.012434,0.44935,0.93719,REACTOME_CONJUGATION_OF_BENZOATE_WITH_GLYCINE,1
GOBP_RESPONSE_TO_FIBROBLAST_...,SET,107,-0.13454,-0.010236,0.087839,0.93719,GOBP_RESPONSE_TO_FIBROBLAST_GROWTH_FACTOR,1
GOBP_REGULATION_OF_MITOCHOND...10,SET,62,-0.16783,-0.0097315,0.10955,0.93723,GOBP_REGULATION_OF_MITOCHONDRIAL_MEMBRANE_POTENTIAL,1
HP_GENERALIZED_NON_CONVULSIV...,SET,16,-0.32003,-0.0094386,0.20887,0.93725,HP_GENERALIZED_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,1
GOCC_GAMMA_DELTA_T_CELL_RECE...,SET,3,-0.74882,-0.0095662,0.48864,0.93728,GOCC_GAMMA_DELTA_T_CELL_RECEPTOR_COMPLEX,1
GOCC_RNA_N6_METHYLADENOSINE_...,SET,8,-0.4375,-0.0091258,0.2855,0.93728,GOCC_RNA_N6_METHYLADENOSINE_METHYLTRANSFERASE_COMPLEX,1
GSE21774_CD56_BRIGHT_VS_DIM_...2,SET,176,-0.10188,-0.0099221,0.066484,0.93728,GSE21774_CD56_BRIGHT_VS_DIM_CD62L_POSITIVE_NK_CELL_UP,1
HP_SHORT_FEMUR,SET,25,-0.26819,-0.0098845,0.175,0.93729,HP_SHORT_FEMUR,1
HP_DECREASED_CIRCULATING_TOT...3,SET,66,-0.16086,-0.0096221,0.10496,0.9373,HP_DECREASED_CIRCULATING_TOTAL_IGM,1
HP_HEAD_TITUBATION,SET,18,-0.31412,-0.0098256,0.20494,0.93733,HP_HEAD_TITUBATION,1
GOMF_C_X_C_CHEMOKINE_BINDING,SET,4,-0.64879,-0.0095703,0.42322,0.93735,GOMF_C_X_C_CHEMOKINE_BINDING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...20,SET,6,-0.53849,-0.0097279,0.35122,0.93737,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_PAIRED_DONORS_WITH_INCORPORATION_OR_REDUCTION_OF_MOLECULAR_OXYGEN_ANOTHER_COMPOUND_AS_ONE_DONOR_AND_INCORPORATION_OF_ONE_ATOM_OF_OXYGEN,1
GOMF_UBIQUITIN_SPECIFIC_PROT...,SET,14,-0.30085,-0.0083001,0.19623,0.93737,GOMF_UBIQUITIN_SPECIFIC_PROTEASE_BINDING,1
GSE17721_PAM3CSK4_VS_GADIQUI...6,SET,180,-0.096907,-0.0095432,0.063207,0.93737,GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_UP,1
NAKAYA_B_CELL_FLUMIST_AGE_18...1,SET,347,-0.069179,-0.0094154,0.045121,0.93737,NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN,1
TAKEDA_TARGETS_OF_NUP98_HOXA...5,SET,28,-0.26812,-0.010457,0.17482,0.93743,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_DN,1
REACTOME_MTOR_SIGNALLING,SET,40,-0.19745,-0.0092015,0.12874,0.93744,REACTOME_MTOR_SIGNALLING,1
WP_SLEEP_REGULATION,SET,38,-0.23776,-0.0108,0.15498,0.9375,WP_SLEEP_REGULATION,1
GOBP_PROTEIN_K29_LINKED_UBIQ...,SET,10,-0.39471,-0.0092045,0.25727,0.93751,GOBP_PROTEIN_K29_LINKED_UBIQUITINATION,1
GOMF_PHOSPHATIDYLCHOLINE_TRA...1,SET,5,-0.57093,-0.0094156,0.37207,0.93753,GOMF_PHOSPHATIDYLCHOLINE_TRANSFER_ACTIVITY,1
WAKABAYASHI_ADIPOGENESIS_PPA...2,SET,599,-0.053543,-0.0095074,0.03489,0.93755,WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D,1
MODULE_64,SET,491,-0.064066,-0.010331,0.041747,0.93755,MODULE_64,1
GOCC_LAMELLAR_BODY,SET,18,-0.33313,-0.01042,0.21708,0.93755,GOCC_LAMELLAR_BODY,1
GSE17721_0.5H_VS_24H_GARDIQU...1,SET,184,-0.089147,-0.0088751,0.058083,0.93758,GSE17721_0.5H_VS_24H_GARDIQUIMOD_BMDC_DN,1
OLF1_01,SET,242,-0.084379,-0.0096184,0.054973,0.93759,OLF1_01,1
GSE6674_ANTI_IGM_VS_CPG_STIM...2,SET,180,-0.096637,-0.0095166,0.062956,0.9376,GSE6674_ANTI_IGM_VS_CPG_STIM_BCELL_UP,1
AGTTCTC_MIR146A_MIR146B,SET,50,-0.1819,-0.0094746,0.11849,0.93762,AGTTCTC_MIR146A_MIR146B,1
GOBP_FEMALE_MEIOSIS_I,SET,9,-0.45522,-0.010071,0.29651,0.93763,GOBP_FEMALE_MEIOSIS_I,1
GOMF_INTRACELLULARLY_CALCIUM...,SET,20,-0.31967,-0.01054,0.20818,0.93767,GOMF_INTRACELLULARLY_CALCIUM_GATED_CHLORIDE_CHANNEL_ACTIVITY,1
MIR6744_5P,SET,42,-0.20268,-0.0096781,0.13198,0.93769,MIR6744_5P,1
ZHAN_MULTIPLE_MYELOMA_CD1_VS...2,SET,60,-0.1741,-0.0099313,0.11331,0.93779,ZHAN_MULTIPLE_MYELOMA_CD1_VS_CD2_UP,1
HP_APLASIA_HYPOPLASIA_OF_THE...45,SET,219,-0.086213,-0.0093547,0.056107,0.93779,HP_APLASIA_HYPOPLASIA_OF_THE_NAILS,1
GSE5463_CTRL_VS_DEXAMETHASON...1,SET,177,-0.10113,-0.009877,0.065798,0.93785,GSE5463_CTRL_VS_DEXAMETHASONE_TREATED_THYMOCYTE_DN,1
GSE3982_BASOPHIL_VS_TH1_UP,SET,179,-0.094842,-0.0093141,0.0617,0.93786,GSE3982_BASOPHIL_VS_TH1_UP,1
NABA_COLLAGENS,SET,42,-0.21759,-0.01039,0.14152,0.93791,NABA_COLLAGENS,1
REACTOME_COLLAGEN_CHAIN_TRIM...,SET,42,-0.21759,-0.01039,0.14152,0.93791,REACTOME_COLLAGEN_CHAIN_TRIMERIZATION,1
PAX2_01,SET,49,-0.18463,-0.0095203,0.12008,0.93791,PAX2_01,1
GOMF_PHOSPHOLIPID_TRANSFER_A...,SET,20,-0.26401,-0.0087043,0.1717,0.93792,GOMF_PHOSPHOLIPID_TRANSFER_ACTIVITY,1
MIR4420,SET,176,-0.09685,-0.009432,0.062974,0.93796,MIR4420,1
WP_ECTODERM_DIFFERENTIATION,SET,121,-0.12898,-0.010431,0.083843,0.93801,WP_ECTODERM_DIFFERENTIATION,1
GOCC_TRANSCRIPTION_FACTOR_TF...5,SET,17,-0.26355,-0.0080118,0.17127,0.93807,GOCC_TRANSCRIPTION_FACTOR_TFTC_COMPLEX,1
HP_PANCREATIC_ISLET_CELL_HYP...,SET,10,-0.48289,-0.011261,0.31375,0.9381,HP_PANCREATIC_ISLET_CELL_HYPERPLASIA,1
THAKAR_PBMC_INACTIVATED_INFL...6,SET,377,-0.065796,-0.0093262,0.042747,0.93811,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_UP,1
GCM_MYST2,SET,159,-0.095131,-0.00881,0.061791,0.93816,GCM_MYST2,1
GOBP_REGULATION_OF_POSTSYNAP...4,SET,13,-0.36647,-0.0097431,0.23804,0.93816,GOBP_REGULATION_OF_POSTSYNAPTIC_DENSITY_ASSEMBLY,1
GOBP_REGULATION_OF_SKELETAL_...2,SET,11,-0.39191,-0.0095849,0.25455,0.93817,GOBP_REGULATION_OF_SKELETAL_MUSCLE_ADAPTATION,1
GSE32423_IL7_VS_IL7_IL4_NAIV...2,SET,172,-0.10126,-0.0097498,0.065757,0.9382,GSE32423_IL7_VS_IL7_IL4_NAIVE_CD8_TCELL_UP,1
MIR181A_5P_MIR181B_5P,SET,555,-0.056241,-0.0096245,0.036521,0.93821,MIR181A_5P_MIR181B_5P,1
HP_FETAL_PYELECTASIS,SET,9,-0.46786,-0.010351,0.3038,0.93821,HP_FETAL_PYELECTASIS,1
chr14q13,SET,22,-0.37858,-0.01309,0.24579,0.93825,chr14q13,1
GOMF_TRANSKETOLASE_OR_TRANSA...,SET,3,-0.75315,-0.0096215,0.48891,0.93827,GOMF_TRANSKETOLASE_OR_TRANSALDOLASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...180,SET,35,-0.24093,-0.010504,0.15636,0.93832,GOBP_POSITIVE_REGULATION_OF_CYCLASE_ACTIVITY,1
BIOCARTA_WNT_LRP6_PATHWAY,SET,6,-0.58412,-0.010552,0.37907,0.93833,BIOCARTA_WNT_LRP6_PATHWAY,1
MIR6777_5P,SET,5,-0.63616,-0.010491,0.4128,0.93834,MIR6777_5P,1
ZHENG_RESPONSE_TO_ARSENITE_DN,SET,11,-0.36084,-0.0088251,0.23412,0.93837,ZHENG_RESPONSE_TO_ARSENITE_DN,1
FREDERICK_PRKCI_TARGETS,SET,9,-0.41937,-0.009278,0.27204,0.9384,FREDERICK_PRKCI_TARGETS,1
DING_LUNG_CANCER_MUTATED_FRE...,SET,12,-0.36911,-0.0094285,0.23939,0.93844,DING_LUNG_CANCER_MUTATED_FREQUENTLY,1
PID_GLYPICAN_1PATHWAY,SET,26,-0.26327,-0.0098951,0.17072,0.93847,PID_GLYPICAN_1PATHWAY,1
GOBP_REGULATION_OF_CELLULAR_...9,SET,42,-0.19177,-0.0091567,0.12435,0.93847,GOBP_REGULATION_OF_CELLULAR_RESPIRATION,1
HP_ABNORMAL_CIRCULATING_COPP...,SET,11,-0.39077,-0.0095572,0.2533,0.93854,HP_ABNORMAL_CIRCULATING_COPPER_CONCENTRATION,1
REACTOME_GPVI_MEDIATED_ACTIV...,SET,33,-0.23707,-0.010037,0.15364,0.93857,REACTOME_GPVI_MEDIATED_ACTIVATION_CASCADE,1
RLF_TARGET_GENES,SET,268,-0.080996,-0.0097091,0.052483,0.93861,RLF_TARGET_GENES,1
GOBP_POSITIVE_REGULATION_OF_...714,SET,79,-0.15487,-0.010132,0.10035,0.93862,GOBP_POSITIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_PROLIFERATION,1
GOMF_MAP_KINASE_KINASE_KINAS...1,SET,22,-0.27944,-0.0096622,0.18105,0.93863,GOMF_MAP_KINASE_KINASE_KINASE_ACTIVITY,1
GSE22589_HEALTHY_VS_HIV_AND_...2,SET,182,-0.091636,-0.0090736,0.059363,0.93866,GSE22589_HEALTHY_VS_HIV_AND_SIV_INFECTED_DC_UP,1
chr2q21,SET,33,-0.47574,-0.020141,0.30815,0.93868,chr2q21,1
GOMF_INTRAMOLECULAR_TRANSFER...,SET,26,-0.22915,-0.0086126,0.14843,0.93868,GOMF_INTRAMOLECULAR_TRANSFERASE_ACTIVITY,1
MODULE_35,SET,4,-0.6034,-0.0089008,0.39076,0.93872,MODULE_35,1
GOMF_3_5_RNA_HELICASE_ACTIVI...,SET,5,-0.79229,-0.013066,0.51307,0.93872,GOMF_3_5_RNA_HELICASE_ACTIVITY,1
GOMF_EUKARYOTIC_TRANSLATION_...,SET,6,-0.51646,-0.00933,0.33441,0.93874,GOMF_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2ALPHA_KINASE_ACTIVITY,1
chr3q24,SET,15,-0.52106,-0.01488,0.33731,0.93879,chr3q24,1
GOBP_CELL_JUNCTION_ASSEMBLY,SET,421,-0.067289,-0.010067,0.04356,0.93879,GOBP_CELL_JUNCTION_ASSEMBLY,1
GOBP_NEUROTRANSMITTER_LOADIN...,SET,7,-0.55249,-0.01078,0.35762,0.93881,GOBP_NEUROTRANSMITTER_LOADING_INTO_SYNAPTIC_VESICLE,1
GOBP_REGULATION_OF_POSTSYNAP...7,SET,134,-0.11985,-0.010196,0.077569,0.93883,GOBP_REGULATION_OF_POSTSYNAPTIC_MEMBRANE_POTENTIAL,1
GOBP_POSITIVE_REGULATION_OF_...536,SET,5,-0.63778,-0.010518,0.41256,0.93893,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,1
GOMF_SIALIC_ACID_BINDING,SET,20,-0.34255,-0.011294,0.22157,0.93894,GOMF_SIALIC_ACID_BINDING,1
HP_ABNORMAL_CEREBELLAR_VERMI...,SET,317,-0.070861,-0.0092256,0.045822,0.93899,HP_ABNORMAL_CEREBELLAR_VERMIS_MORPHOLOGY,1
MIR1285_5P,SET,60,-0.17384,-0.0099164,0.1124,0.93902,MIR1285_5P,1
GOBP_NEGATIVE_REGULATION_OF_...401,SET,620,-0.05456,-0.0098505,0.03527,0.93905,GOBP_NEGATIVE_REGULATION_OF_MOLECULAR_FUNCTION,1
HP_ALOPECIA_UNIVERSALIS,SET,11,-0.44102,-0.010786,0.2851,0.93905,HP_ALOPECIA_UNIVERSALIS,1
WP_ANGIOPOIETINLIKE_PROTEIN_...,SET,126,-0.11974,-0.0098801,0.07739,0.93908,WP_ANGIOPOIETINLIKE_PROTEIN_8_REGULATORY_PATHWAY,1
GCM_NF2,SET,266,-0.074851,-0.0089395,0.048374,0.9391,GCM_NF2,1
GOBP_REGULATION_OF_CIRCADIAN...2,SET,5,-0.67069,-0.011061,0.43342,0.93911,GOBP_REGULATION_OF_CIRCADIAN_SLEEP_WAKE_CYCLE_NON_REM_SLEEP,1
MIR1206,SET,105,-0.12222,-0.0092117,0.07895,0.93919,MIR1206,1
KORKOLA_CHORIOCARCINOMA_UP,SET,3,-0.86602,-0.011064,0.55929,0.93923,KORKOLA_CHORIOCARCINOMA_UP,1
MIR5588_5P,SET,80,-0.14752,-0.0097116,0.095274,0.93923,MIR5588_5P,1
GOBP_AROMATIC_AMINO_ACID_MET...,SET,29,-0.2629,-0.010435,0.16977,0.93925,GOBP_AROMATIC_AMINO_ACID_METABOLIC_PROCESS,1
MORF_RAF1,SET,108,-0.11203,-0.008563,0.072323,0.93931,MORF_RAF1,1
HP_TYPE_II_TRANSFERRIN_ISOFO...,SET,13,-0.3536,-0.0094008,0.22825,0.93932,HP_TYPE_II_TRANSFERRIN_ISOFORM_PROFILE,1
FAN_EMBRYONIC_CTX_IN_5_INTER...,SET,5,-0.69771,-0.011506,0.45035,0.93933,FAN_EMBRYONIC_CTX_IN_5_INTERNEURON,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...6,SET,174,-0.096988,-0.0093922,0.062601,0.93934,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_3H_UP,1
RICKMAN_HEAD_AND_NECK_CANCER...4,SET,30,-0.27357,-0.011044,0.1765,0.93941,RICKMAN_HEAD_AND_NECK_CANCER_D,1
MODULE_78,SET,20,-0.29915,-0.0098628,0.193,0.93941,MODULE_78,1
GSE19888_ADENOSINE_A3R_INH_V...7,SET,177,-0.097991,-0.00957,0.063217,0.93943,GSE19888_ADENOSINE_A3R_INH_VS_TCELL_MEMBRANES_ACT_MAST_CELL_DN,1
HOSHIDA_LIVER_CANCER_SURVIVA...2,SET,71,-0.16246,-0.010078,0.10479,0.93946,HOSHIDA_LIVER_CANCER_SURVIVAL_UP,1
HP_ABNORMALITY_OF_TIBIAL_EPI...,SET,4,-0.74282,-0.010957,0.47902,0.9395,HP_ABNORMALITY_OF_TIBIAL_EPIPHYSES,1
HP_HEPATOMEGALY,SET,574,-0.055466,-0.0096479,0.035766,0.93952,HP_HEPATOMEGALY,1
PHONG_TNF_TARGETS_DN,SET,8,-0.48492,-0.010115,0.31265,0.93954,PHONG_TNF_TARGETS_DN,1
GSE3982_CTRL_VS_IGE_STIM_MAS...2,SET,183,-0.094207,-0.0093535,0.060727,0.93958,GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP,1
TGATTTRY_GFI1_01,SET,263,-0.086968,-0.010329,0.056052,0.93961,TGATTTRY_GFI1_01,1
GOBP_REGULATION_OF_PH,SET,95,-0.13384,-0.0095974,0.086233,0.93967,GOBP_REGULATION_OF_PH,1
P53_DN.V2_DN,SET,134,-0.11401,-0.0096993,0.073455,0.93967,P53_DN.V2_DN,1
GOBP_POSITIVE_REGULATION_OF_...289,SET,5,-0.58899,-0.0097135,0.37945,0.93969,GOBP_POSITIVE_REGULATION_OF_G0_TO_G1_TRANSITION,1
GOBP_GROWTH_PLATE_CARTILAGE_...2,SET,9,-0.45774,-0.010127,0.29486,0.93971,GOBP_GROWTH_PLATE_CARTILAGE_CHONDROCYTE_DIFFERENTIATION,1
MIR1183,SET,112,-0.12487,-0.0097181,0.080434,0.93972,MIR1183,1
HP_NEUROMUSCULAR_DYSPHAGIA,SET,11,-0.38501,-0.0094163,0.24795,0.93976,HP_NEUROMUSCULAR_DYSPHAGIA,1
TUOMISTO_TUMOR_SUPPRESSION_B...2,SET,17,-0.36259,-0.011023,0.23349,0.93977,TUOMISTO_TUMOR_SUPPRESSION_BY_COL13A1_UP,1
MODULE_192,SET,100,-0.12895,-0.009486,0.08304,0.93977,MODULE_192,1
GOBP_CGMP_BIOSYNTHETIC_PROCE...,SET,7,-0.50425,-0.009839,0.32469,0.93978,GOBP_CGMP_BIOSYNTHETIC_PROCESS,1
GSE11864_CSF1_VS_CSF1_PAM3CY...2,SET,166,-0.098859,-0.0093528,0.06364,0.93983,GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP,1
GOBP_POSITIVE_REGULATION_OF_...152,SET,5,-0.5648,-0.0093145,0.36356,0.93984,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_X_C_MOTIF_LIGAND_1_PRODUCTION,1
P53_DN.V1_DN,SET,179,-0.10397,-0.01021,0.066917,0.93986,P53_DN.V1_DN,1
GOMF_NERVE_GROWTH_FACTOR_BIN...,SET,5,-0.64598,-0.010653,0.41571,0.93989,GOMF_NERVE_GROWTH_FACTOR_BINDING,1
MORF_ERCC2,SET,98,-0.1263,-0.0091977,0.081272,0.9399,MORF_ERCC2,1
CREIGHTON_ENDOCRINE_THERAPY_...2,SET,366,-0.066069,-0.0092301,0.04248,0.94005,CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2,1
HERNANDEZ_MITOTIC_ARREST_BY_...2,SET,23,-0.30999,-0.010959,0.19926,0.9401,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_1_UP,1
GSE27896_HDAC6_KO_VS_WT_TREG...1,SET,150,-0.10577,-0.009516,0.067983,0.94011,GSE27896_HDAC6_KO_VS_WT_TREG_DN,1
SILIGAN_TARGETS_OF_EWS_FLI1_...1,SET,17,-0.31429,-0.0095541,0.202,0.94012,SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN,1
GOMF_PROTEIN_TYROSINE_THREON...,SET,9,-0.51362,-0.011363,0.33012,0.94012,GOMF_PROTEIN_TYROSINE_THREONINE_PHOSPHATASE_ACTIVITY,1
GSE27786_LSK_VS_CD4_TCELL_DN,SET,177,-0.097576,-0.0095294,0.062715,0.94012,GSE27786_LSK_VS_CD4_TCELL_DN,1
WP_NONCLASSICAL_ROLE_OF_VITA...,SET,6,-0.59704,-0.010786,0.38369,0.94014,WP_NONCLASSICAL_ROLE_OF_VITAMIN_D,1
GOBP_REGULATION_OF_CHROMATIN...2,SET,28,-0.22894,-0.0089293,0.14708,0.94021,GOBP_REGULATION_OF_CHROMATIN_ORGANIZATION,1
REACTOME_SIGNALING_BY_BMP,SET,28,-0.24614,-0.0096,0.15812,0.94022,REACTOME_SIGNALING_BY_BMP,1
GOBP_NEGATIVE_REGULATION_OF_...414,SET,12,-0.4533,-0.011579,0.29119,0.94023,GOBP_NEGATIVE_REGULATION_OF_MULTICELLULAR_ORGANISM_GROWTH,1
MODULE_294,SET,18,-0.2849,-0.0089116,0.18293,0.94031,MODULE_294,1
GSE3982_EOSINOPHIL_VS_CENT_M...2,SET,180,-0.099269,-0.0097758,0.063735,0.94032,GSE3982_EOSINOPHIL_VS_CENT_MEMORY_CD4_TCELL_UP,1
GSE37301_HEMATOPOIETIC_STEM_...6,SET,149,-0.10833,-0.0097144,0.069518,0.94041,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_GRAN_MONO_PROGENITOR_UP,1
REACTOME_MATURATION_OF_SARS_...2,SET,15,-0.30276,-0.0086458,0.19427,0.94043,REACTOME_MATURATION_OF_SARS_COV_2_NUCLEOPROTEIN,1
GSE37301_LYMPHOID_PRIMED_MPP...8,SET,176,-0.093731,-0.0091283,0.060144,0.94043,GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_UP,1
GOBP_SMALL_MOLECULE_METABOLI...,SET,1631,-0.034152,-0.0097118,0.02191,0.94046,GOBP_SMALL_MOLECULE_METABOLIC_PROCESS,1
GSE22140_HEALTHY_VS_ARTHRITI...3,SET,183,-0.094935,-0.0094258,0.060907,0.94046,GSE22140_HEALTHY_VS_ARTHRITIC_MOUSE_CD4_TCELL_DN,1
GSE42724_NAIVE_BCELL_VS_PLAS...1,SET,179,-0.099779,-0.009799,0.064013,0.94046,GSE42724_NAIVE_BCELL_VS_PLASMABLAST_DN,1
GOBP_VENTRICULAR_CARDIAC_MUS...5,SET,60,-0.19151,-0.010925,0.12284,0.9405,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_PROTEIN_LOCALIZATION_TO...37,SET,15,-0.3206,-0.0091552,0.20561,0.94053,GOBP_PROTEIN_LOCALIZATION_TO_NUCLEOLUS,1
HP_DENTAL_ENAMEL_PITS,SET,8,-0.53088,-0.011073,0.34042,0.94055,HP_DENTAL_ENAMEL_PITS,1
LIM_MAMMARY_STEM_CELL_DN,SET,387,-0.066099,-0.00949,0.042382,0.94056,LIM_MAMMARY_STEM_CELL_DN,1
REACTOME_ENERGY_DEPENDENT_RE...,SET,28,-0.23843,-0.0092991,0.15285,0.9406,REACTOME_ENERGY_DEPENDENT_REGULATION_OF_MTOR_BY_LKB1_AMPK,1
MODULE_153,SET,31,-0.23335,-0.0095754,0.14958,0.94062,MODULE_153,1
HP_HYPOGLYCEMIA,SET,230,-0.085772,-0.0095349,0.054962,0.94068,HP_HYPOGLYCEMIA,1
GSE2706_R848_VS_LPS_2H_STIM_...2,SET,142,-0.11408,-0.0099887,0.073095,0.94069,GSE2706_R848_VS_LPS_2H_STIM_DC_UP,1
HP_ABNORMALITY_OF_TASTE_SENS...,SET,5,-0.5874,-0.0096873,0.3763,0.94073,HP_ABNORMALITY_OF_TASTE_SENSATION,1
GOBP_REGULATION_OF_CANONICAL...,SET,234,-0.090883,-0.010189,0.058216,0.94074,GOBP_REGULATION_OF_CANONICAL_WNT_SIGNALING_PATHWAY,1
MATTIOLI_MGUS_VS_MULTIPLE_MY...,SET,13,-0.39169,-0.010414,0.25082,0.94081,MATTIOLI_MGUS_VS_MULTIPLE_MYELOMA,1
GOBP_MICROTUBULE_DEPOLYMERIZ...,SET,41,-0.18705,-0.008825,0.11978,0.94081,GOBP_MICROTUBULE_DEPOLYMERIZATION,1
GOBP_CARDIOBLAST_DIFFERENTIA...,SET,16,-0.37794,-0.011146,0.242,0.94082,GOBP_CARDIOBLAST_DIFFERENTIATION,1
ASGHARZADEH_NEUROBLASTOMA_PO...,SET,37,-0.21562,-0.0096646,0.13804,0.94085,ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN,1
GOBP_REGULATION_OF_TRANSLATI...13,SET,20,-0.28092,-0.0092619,0.17981,0.94088,GOBP_REGULATION_OF_TRANSLATION_IN_RESPONSE_TO_STRESS,1
GOBP_ESTABLISHMENT_OF_PROTEI...3,SET,23,-0.24047,-0.0085016,0.15391,0.94089,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMOSOME,1
KEGG_MEDICUS_PATHOGEN_HTLV_1...2,SET,6,-0.63285,-0.011433,0.40496,0.94093,KEGG_MEDICUS_PATHOGEN_HTLV_1_P12_TO_JAK_STAT_SIGNALING_PATHWAY,1
MIR4670_3P,SET,137,-0.11352,-0.0097642,0.072641,0.94093,MIR4670_3P,1
HP_ABNORMAL_B_CELL_MORPHOLOGY,SET,90,-0.14202,-0.0099142,0.09085,0.941,HP_ABNORMAL_B_CELL_MORPHOLOGY,1
HP_PULMONARY_CARCINOID_TUMOR,SET,8,-0.41728,-0.008704,0.26683,0.94107,HP_PULMONARY_CARCINOID_TUMOR,1
GSE40666_STAT1_KO_VS_STAT4_K...4,SET,167,-0.093654,-0.0088867,0.059883,0.94108,GSE40666_STAT1_KO_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP,1
GOBP_REGULATION_OF_OXIDATIVE...1,SET,19,-0.28548,-0.009174,0.18252,0.94109,GOBP_REGULATION_OF_OXIDATIVE_PHOSPHORYLATION,1
NEBEN_AML_WITH_FLT3_OR_NRAS_...1,SET,12,-0.38181,-0.0097528,0.24409,0.94111,NEBEN_AML_WITH_FLT3_OR_NRAS_DN,1
MODULE_410,SET,35,-0.24455,-0.010662,0.15629,0.94117,MODULE_410,1
QI_HYPOXIA,SET,128,-0.11589,-0.0096377,0.074051,0.9412,QI_HYPOXIA,1
GOBP_REGULATION_OF_CYSTEINE_...2,SET,146,-0.11146,-0.0098948,0.071213,0.94122,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
HP_TRANSIENT_NEONATAL_DIABET...,SET,15,-0.37739,-0.010777,0.2411,0.94123,HP_TRANSIENT_NEONATAL_DIABETES_MELLITUS,1
MIR937_5P,SET,50,-0.19513,-0.010164,0.12466,0.94124,MIR937_5P,1
GSE3982_EOSINOPHIL_VS_BCELL_...1,SET,177,-0.095116,-0.0092892,0.060757,0.94126,GSE3982_EOSINOPHIL_VS_BCELL_DN,1
GOBP_V_D_J_RECOMBINATION,SET,17,-0.30031,-0.0091293,0.19182,0.94127,GOBP_V_D_J_RECOMBINATION,1
MORF_EIF4E,SET,79,-0.14094,-0.0092202,0.090017,0.94128,MORF_EIF4E,1
GOBP_REGULATION_OF_FIBROBLAS...2,SET,29,-0.26432,-0.010491,0.16881,0.94129,GOBP_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...609,SET,11,-0.38115,-0.0093217,0.24338,0.94132,GOBP_POSITIVE_REGULATION_OF_PROTEIN_ACETYLATION,1
MIR8063,SET,362,-0.069841,-0.0097047,0.044592,0.94134,MIR8063,1
KEGG_MEDICUS_REFERENCE_KERAT...,SET,5,-0.62391,-0.010289,0.39834,0.94135,KEGG_MEDICUS_REFERENCE_KERATAN_SULFATE_DEGRADATION,1
MIR181C_5P,SET,556,-0.057162,-0.0097907,0.036492,0.94137,MIR181C_5P,1
MIR6774_3P,SET,5,-0.70602,-0.011644,0.4507,0.94137,MIR6774_3P,1
GOBP_REGULATION_OF_SYNAPSE_A...,SET,105,-0.14213,-0.010712,0.090716,0.9414,GOBP_REGULATION_OF_SYNAPSE_ASSEMBLY,1
GSE15930_NAIVE_VS_48H_IN_VIT...6,SET,187,-0.09744,-0.0097786,0.062195,0.9414,GSE15930_NAIVE_VS_48H_IN_VITRO_STIM_IL12_CD8_TCELL_UP,1
BIOCARTA_P35ALZHEIMERS_PATHW...,SET,8,-0.51391,-0.01072,0.32794,0.94145,BIOCARTA_P35ALZHEIMERS_PATHWAY,1
GSE9946_LISTERIA_INF_MATURE_...2,SET,123,-0.1136,-0.0092626,0.072491,0.94145,GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP,1
PASINI_SUZ12_TARGETS_UP,SET,93,-0.14461,-0.01026,0.092258,0.94148,PASINI_SUZ12_TARGETS_UP,1
RPS14_DN.V1_UP,SET,180,-0.10338,-0.01018,0.06595,0.94149,RPS14_DN.V1_UP,1
GSE14308_TH2_VS_NAIVE_CD4_TC...1,SET,178,-0.092994,-0.0091073,0.059315,0.94152,GSE14308_TH2_VS_NAIVE_CD4_TCELL_DN,1
GSE15750_WT_VS_TRAF6KO_DAY6_...1,SET,185,-0.097528,-0.0097355,0.062205,0.94153,GSE15750_WT_VS_TRAF6KO_DAY6_EFF_CD8_TCELL_DN,1
HP_BAND_KERATOPATHY,SET,14,-0.41112,-0.011342,0.26217,0.94157,HP_BAND_KERATOPATHY,1
BIOCARTA_RACC_PATHWAY,SET,11,-0.46677,-0.011416,0.2975,0.94166,BIOCARTA_RACC_PATHWAY,1
GOBP_LIPOXYGENASE_PATHWAY,SET,11,-0.45508,-0.01113,0.28985,0.94179,GOBP_LIPOXYGENASE_PATHWAY,1
HP_ABNORMAL_CIRCULATING_INTE...3,SET,31,-0.25636,-0.01052,0.16325,0.94182,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_CONCENTRATION,1
GOBP_NEGATIVE_REGULATION_OF_...356,SET,294,-0.080687,-0.010123,0.051378,0.94184,GOBP_NEGATIVE_REGULATION_OF_LOCOMOTION,1
GOMF_ALPHA_2A_ADRENERGIC_REC...,SET,4,-0.75191,-0.011091,0.47878,0.94184,GOMF_ALPHA_2A_ADRENERGIC_RECEPTOR_BINDING,1
ZNF354B_TARGET_GENES,SET,161,-0.10379,-0.0096716,0.066078,0.94187,ZNF354B_TARGET_GENES,1
FOXO4_01,SET,229,-0.091263,-0.010123,0.058099,0.94188,FOXO4_01,1
GOBP_TANGENTIAL_MIGRATION_FR...,SET,7,-0.54042,-0.010545,0.34395,0.94193,GOBP_TANGENTIAL_MIGRATION_FROM_THE_SUBVENTRICULAR_ZONE_TO_THE_OLFACTORY_BULB,1
CREB_01,SET,242,-0.086056,-0.0098095,0.054755,0.94197,CREB_01,1
GOBP_ADULT_FEEDING_BEHAVIOR,SET,9,-0.50377,-0.011145,0.32051,0.94199,GOBP_ADULT_FEEDING_BEHAVIOR,1
GOBP_PIGMENT_METABOLIC_PROCE...,SET,72,-0.16094,-0.010054,0.10239,0.942,GOBP_PIGMENT_METABOLIC_PROCESS,1
GNF2_RTN1,SET,47,-0.21233,-0.010724,0.13508,0.94201,GNF2_RTN1,1
HP_DYSMETRIA,SET,158,-0.10117,-0.0093399,0.064357,0.94202,HP_DYSMETRIA,1
GOBP_SECRETION,SET,899,-0.046155,-0.0099552,0.029353,0.94206,GOBP_SECRETION,1
MIR6506_5P,SET,93,-0.13486,-0.0095689,0.085762,0.94207,MIR6506_5P,1
MIR4756_5P,SET,123,-0.12537,-0.010222,0.079719,0.94209,MIR4756_5P,1
WP_CORI_CYCLE,SET,13,-0.33699,-0.0089593,0.21427,0.9421,WP_CORI_CYCLE,1
GSE40274_SATB1_VS_FOXP3_AND_...1,SET,105,-0.13162,-0.00992,0.08366,0.94216,GSE40274_SATB1_VS_FOXP3_AND_SATB1_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
HP_FLARING_OF_RIB_CAGE,SET,7,-0.55582,-0.010845,0.35328,0.94217,HP_FLARING_OF_RIB_CAGE,1
HOWARD_NK_CELL_INACT_MONOV_I...3,SET,66,-0.15488,-0.0092646,0.098421,0.94221,HOWARD_NK_CELL_INACT_MONOV_INFLUENZA_A_INDONESIA_05_2005_H5N1_AGE_18_49YO_3DY_UP,1
KEGG_MEDICUS_VARIANT_MUTATIO...64,SET,10,-0.38726,-0.0090308,0.24602,0.94226,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SPTBN2_TO_MGLUR1_TRPC3_SIGNALING_PATHWAY,1
CAIRO_LIVER_DEVELOPMENT_UP,SET,145,-0.11238,-0.0099422,0.071371,0.94231,CAIRO_LIVER_DEVELOPMENT_UP,1
TRAVAGLINI_LUNG_PROLIFERATIN...1,SET,800,-0.046085,-0.0094033,0.029269,0.94231,TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL,1
GSE3982_DC_VS_BCELL_DN,SET,163,-0.10114,-0.009482,0.064229,0.94232,GSE3982_DC_VS_BCELL_DN,1
GOBP_DEVELOPMENT_OF_SECONDAR...2,SET,9,-0.51343,-0.011359,0.32603,0.94234,GOBP_DEVELOPMENT_OF_SECONDARY_SEXUAL_CHARACTERISTICS,1
NABA_MATRISOME_HIGHLY_METAST...4,SET,12,-0.40002,-0.010218,0.25399,0.94235,NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED,1
GOBP_REGULATION_OF_CYCLASE_A...,SET,51,-0.20037,-0.01054,0.12721,0.94239,GOBP_REGULATION_OF_CYCLASE_ACTIVITY,1
ALONSO_METASTASIS_DN,SET,23,-0.29326,-0.010368,0.18616,0.9424,ALONSO_METASTASIS_DN,1
GOBP_POSITIVE_REGULATION_OF_...122,SET,54,-0.18227,-0.0098656,0.11568,0.94243,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_G1_S_PHASE_TRANSITION,1
HP_ABNORMAL_HYPOTHALAMUS_PHY...,SET,49,-0.1978,-0.0102,0.12554,0.94244,HP_ABNORMAL_HYPOTHALAMUS_PHYSIOLOGY,1
CAFFAREL_RESPONSE_TO_THC_8HR...2,SET,5,-0.60764,-0.010021,0.3855,0.9425,CAFFAREL_RESPONSE_TO_THC_8HR_3_UP,1
GOBP_RESPONSE_TO_AMPHETAMINE,SET,34,-0.24899,-0.010699,0.15794,0.94254,GOBP_RESPONSE_TO_AMPHETAMINE,1
GOBP_REGULATION_OF_MELANOCYT...,SET,6,-0.64495,-0.011651,0.40899,0.94259,GOBP_REGULATION_OF_MELANOCYTE_DIFFERENTIATION,1
MIR181B_2_3P_MIR181B_3P,SET,188,-0.095732,-0.0096326,0.060695,0.94262,MIR181B_2_3P_MIR181B_3P,1
GOMF_EXTRACELLULAR_MATRIX_ST...3,SET,42,-0.22516,-0.010751,0.14276,0.94262,GOMF_EXTRACELLULAR_MATRIX_STRUCTURAL_CONSTITUENT_CONFERRING_TENSILE_STRENGTH,1
GOBP_LINOLEIC_ACID_METABOLIC...,SET,19,-0.31937,-0.010263,0.20243,0.94267,GOBP_LINOLEIC_ACID_METABOLIC_PROCESS,1
LI_WILMS_TUMOR_ANAPLASTIC_DN,SET,5,-0.64442,-0.010628,0.40845,0.94268,LI_WILMS_TUMOR_ANAPLASTIC_DN,1
REACTOME_FGFR2C_LIGAND_BINDI...,SET,12,-0.43852,-0.011201,0.27794,0.94268,REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION,1
MIR34C_5P,SET,240,-0.085419,-0.0096972,0.054106,0.94279,MIR34C_5P,1
ID2_TARGET_GENES,SET,873,-0.045709,-0.0097226,0.028952,0.9428,ID2_TARGET_GENES,1
WP_HAIR_FOLLICLE_DEVELOPMENT...2,SET,31,-0.26843,-0.011015,0.17,0.94282,WP_HAIR_FOLLICLE_DEVELOPMENT_ORGANOGENESIS_STAGE_2_OF_3,1
HP_ABNORMAL_CEREBRAL_SUBCORT...,SET,1030,-0.041762,-0.0096055,0.02645,0.94282,HP_ABNORMAL_CEREBRAL_SUBCORTEX_MORPHOLOGY,1
KEGG_MEDICUS_REFERENCE_FASLG...,SET,5,-0.63675,-0.010501,0.40319,0.94286,KEGG_MEDICUS_REFERENCE_FASLG_RIPK1_3_SIGNALING_PATHWAY,1
REACTOME_GENERATION_OF_SECON...,SET,27,-0.27034,-0.010354,0.17118,0.94286,REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES,1
GSE5589_IL6_KO_VS_IL10_KO_LP...6,SET,184,-0.093212,-0.0092797,0.059021,0.94286,GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOBP_PLATELET_DERIVED_GROWTH...1,SET,7,-0.55028,-0.010737,0.34839,0.94288,GOBP_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,1
GOCC_GOLGI_ASSOCIATED_VESICLE,SET,85,-0.13863,-0.0094059,0.087725,0.94297,GOCC_GOLGI_ASSOCIATED_VESICLE,1
FOXD3_01,SET,179,-0.10426,-0.010239,0.065969,0.94299,FOXD3_01,1
LET_7C_3P,SET,537,-0.058467,-0.0098469,0.036976,0.94307,LET_7C_3P,1
GOBP_POSITIVE_REGULATION_OF_...290,SET,43,-0.2007,-0.0096962,0.12692,0.94309,GOBP_POSITIVE_REGULATION_OF_G1_S_TRANSITION_OF_MITOTIC_CELL_CYCLE,1
GOBP_PROTEIN_ACETYLATION,SET,49,-0.17909,-0.0092347,0.11321,0.94315,GOBP_PROTEIN_ACETYLATION,1
GOBP_POSITIVE_REGULATION_OF_...14,SET,28,-0.27651,-0.010784,0.17474,0.94321,GOBP_POSITIVE_REGULATION_OF_ADENYLATE_CYCLASE_ACTIVITY,1
REACTOME_UREA_CYCLE,SET,9,-0.42905,-0.0094921,0.27113,0.94322,REACTOME_UREA_CYCLE,1
HP_ABNORMAL_PITUITARY_GLAND_...,SET,304,-0.076233,-0.0097229,0.048144,0.94333,HP_ABNORMAL_PITUITARY_GLAND_MORPHOLOGY,1
HP_PARTIAL_AGENESIS_OF_THE_C...,SET,46,-0.18527,-0.0092574,0.11701,0.94333,HP_PARTIAL_AGENESIS_OF_THE_CORPUS_CALLOSUM,1
MIKKELSEN_IPS_ICP_WITH_H3K4M...,SET,116,-0.13045,-0.010331,0.082377,0.94334,MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3,1
HP_MEDULLOBLASTOMA,SET,18,-0.31244,-0.009773,0.19731,0.94334,HP_MEDULLOBLASTOMA,1
GOBP_METANEPHRIC_TUBULE_FORM...,SET,6,-0.58229,-0.010519,0.36768,0.94336,GOBP_METANEPHRIC_TUBULE_FORMATION,1
HP_ABNORMAL_SUPERIOR_CEREBEL...,SET,12,-0.33223,-0.0084864,0.20974,0.9434,HP_ABNORMAL_SUPERIOR_CEREBELLAR_PEDUNCLE_MORPHOLOGY,1
GSE18203_CTRL_VS_INTRATUMORA...2,SET,187,-0.094319,-0.0094654,0.059542,0.9434,GSE18203_CTRL_VS_INTRATUMORAL_CPG_INJ_MC38_TUMOR_UP,1
REACTOME_EPITHELIAL_MESENCHY...,SET,6,-0.51236,-0.0092559,0.32341,0.94342,REACTOME_EPITHELIAL_MESENCHYMAL_TRANSITION_EMT_DURING_GASTRULATION,1
HP_HYPERTRICHOSIS,SET,234,-0.086013,-0.0096434,0.054293,0.94342,HP_HYPERTRICHOSIS,1
GOMF_FILAMIN_BINDING,SET,12,-0.40294,-0.010293,0.25421,0.94352,GOMF_FILAMIN_BINDING,1
VERHAAK_GLIOBLASTOMA_CLASSIC...,SET,152,-0.11274,-0.01021,0.071118,0.94354,VERHAAK_GLIOBLASTOMA_CLASSICAL,1
HP_ATYPICAL_ABSENCE_SEIZURE,SET,31,-0.2385,-0.0097866,0.15043,0.94356,HP_ATYPICAL_ABSENCE_SEIZURE,1
WP_ROLES_OF_CERAMIDES_IN_DEV...,SET,23,-0.29168,-0.010312,0.18394,0.94359,WP_ROLES_OF_CERAMIDES_IN_DEVELOPMENT_OF_INSULIN_RESISTANCE,1
GAVISH_3CA_METAPROGRAM_CD4_T...9,SET,43,-0.21916,-0.010589,0.13818,0.94363,GAVISH_3CA_METAPROGRAM_CD4_T_CELLS_T_REG,1
GOBP_NEGATIVE_REGULATION_OF_...686,SET,15,-0.3422,-0.0097722,0.21573,0.94365,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_PROTEIN_TRANSFERASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...721,SET,12,-0.35208,-0.0089934,0.22191,0.94369,GOBP_POSITIVE_REGULATION_OF_SPINDLE_CHECKPOINT,1
GSE16450_CTRL_VS_IFNA_6H_STI...3,SET,176,-0.096536,-0.0094015,0.060842,0.9437,GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_DN,1
GSE2935_UV_INACTIVATED_VS_LI...1,SET,162,-0.11119,-0.010393,0.070071,0.94371,GSE2935_UV_INACTIVATED_VS_LIVE_SENDAI_VIRUS_INF_MACROPHAGE_DN,1
WP_15Q133_COPY_NUMBER_VARIAT...,SET,16,-0.324,-0.0095556,0.20418,0.94372,WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME,1
WP_FAMILIAL_HYPERLIPIDEMIA_T...4,SET,22,-0.28452,-0.009838,0.17923,0.94379,WP_FAMILIAL_HYPERLIPIDEMIA_TYPE_4,1
ZNF707_TARGET_GENES,SET,35,-0.22506,-0.0098122,0.14168,0.94391,ZNF707_TARGET_GENES,1
GSE11961_MEMORY_BCELL_DAY7_V...7,SET,185,-0.099268,-0.0099092,0.06248,0.94394,GSE11961_MEMORY_BCELL_DAY7_VS_PLASMA_CELL_DAY7_DN,1
DESCARTES_MAIN_FETAL_ELF3_AG...,SET,127,-0.11093,-0.009189,0.069814,0.94395,DESCARTES_MAIN_FETAL_ELF3_AGBL2_POSITIVE_CELLS,1
GROSS_HYPOXIA_VIA_ELK3_UP,SET,192,-0.095584,-0.0097184,0.060151,0.94397,GROSS_HYPOXIA_VIA_ELK3_UP,1
HE_LIM_SUN_FETAL_LUNG_C3_GRI...,SET,113,-0.14008,-0.01095,0.088149,0.94397,HE_LIM_SUN_FETAL_LUNG_C3_GRIA2_POS_ARTERIAL_ENDO_CELL,1
LI_ESTROGENE_META_E2_RESPONS...2,SET,61,-0.18413,-0.01059,0.11585,0.944,LI_ESTROGENE_META_E2_RESPONSE_UP,1
MIR4525,SET,32,-0.24081,-0.01004,0.1515,0.94402,MIR4525,1
GOBP_HEPATOCYTE_APOPTOTIC_PR...,SET,19,-0.32473,-0.010435,0.20427,0.94404,GOBP_HEPATOCYTE_APOPTOTIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...208,SET,13,-0.35703,-0.0094921,0.22455,0.94407,GOBP_POSITIVE_REGULATION_OF_DIGESTIVE_SYSTEM_PROCESS,1
GSE16385_ROSIGLITAZONE_VS_UN...2,SET,178,-0.10555,-0.010337,0.066351,0.94416,GSE16385_ROSIGLITAZONE_VS_UNTREATED_IFNG_TNF_STIM_MACROPHAGE_UP,1
NAKAYA_PLASMACYTOID_DENDRITI...1,SET,168,-0.0967,-0.009203,0.060778,0.94419,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN,1
HP_DECEREBRATE_RIGIDITY,SET,5,-0.59025,-0.0097343,0.37089,0.94423,HP_DECEREBRATE_RIGIDITY,1
REACTOME_SUMOYLATION_OF_TRAN...1,SET,41,-0.20066,-0.0094667,0.12607,0.94426,REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS,1
GSE43955_10H_VS_60H_ACT_CD4_...4,SET,180,-0.098441,-0.0096943,0.061844,0.94427,GSE43955_10H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_UP,1
GOCC_CORNIFIED_ENVELOPE,SET,58,-0.21461,-0.012037,0.13478,0.94433,GOCC_CORNIFIED_ENVELOPE,1
GOBP_REGULATION_OF_PIGMENT_C...,SET,8,-0.55689,-0.011616,0.34973,0.94434,GOBP_REGULATION_OF_PIGMENT_CELL_DIFFERENTIATION,1
GOMF_PHOSPHORIC_ESTER_HYDROL...,SET,318,-0.073651,-0.0096038,0.046228,0.94444,GOMF_PHOSPHORIC_ESTER_HYDROLASE_ACTIVITY,1
HP_ABSENT_DISTAL_PHALANGES,SET,6,-0.60353,-0.010903,0.37881,0.94444,HP_ABSENT_DISTAL_PHALANGES,1
GOBP_NEGATIVE_REGULATION_OF_...237,SET,8,-0.50967,-0.010631,0.31987,0.94445,GOBP_NEGATIVE_REGULATION_OF_FERROPTOSIS,1
GOBP_DENSE_CORE_GRANULE_TRAN...,SET,10,-0.42604,-0.009935,0.26726,0.94453,GOBP_DENSE_CORE_GRANULE_TRANSPORT,1
MIR4496,SET,268,-0.085866,-0.010293,0.053864,0.94454,MIR4496,1
HP_ABNORMALITY_OF_THE_CALF,SET,272,-0.083523,-0.010085,0.052382,0.94458,HP_ABNORMALITY_OF_THE_CALF,1
GSE39820_CTRL_VS_TGFBETA3_IL...3,SET,176,-0.10178,-0.0099118,0.063827,0.94458,GSE39820_CTRL_VS_TGFBETA3_IL6_IL23A_CD4_TCELL_DN,1
REACTOME_POST_TRANSCRIPTIONA...,SET,7,-0.55445,-0.010819,0.34769,0.9446,REACTOME_POST_TRANSCRIPTIONAL_SILENCING_BY_SMALL_RNAS,1
KEGG_MEDICUS_VARIANT_MUTATIO...17,SET,7,-0.49131,-0.0095865,0.30802,0.94464,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_PI3K_TO_PI3K_SIGNALING_PATHWAY,1
SASAI_TARGETS_OF_CXCR6_AND_P...2,SET,12,-0.41999,-0.010728,0.26328,0.94466,SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP,1
TGACGTCA_ATF3_Q6,SET,211,-0.09441,-0.010058,0.059176,0.94468,TGACGTCA_ATF3_Q6,1
HP_BIFID_RIBS,SET,16,-0.3286,-0.0096911,0.20592,0.94472,HP_BIFID_RIBS,1
MIR4786_3P,SET,149,-0.11472,-0.010287,0.07187,0.94477,MIR4786_3P,1
GOBP_POSITIVE_REGULATION_OF_...741,SET,153,-0.11339,-0.010302,0.071028,0.94479,GOBP_POSITIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
PR_Q2,SET,239,-0.090191,-0.010218,0.05649,0.94481,PR_Q2,1
BUSSLINGER_GASTRIC_OXYNTIC_E...,SET,74,-0.17108,-0.010834,0.10715,0.94481,BUSSLINGER_GASTRIC_OXYNTIC_ENTEROCHROMAFFIN_LIKE_CELLS,1
HP_RECURRENT_HYPOGLYCEMIA,SET,21,-0.30034,-0.010147,0.1881,0.94483,HP_RECURRENT_HYPOGLYCEMIA,1
GOBP_PHOSPHATIDYLCHOLINE_CAT...,SET,16,-0.34575,-0.010197,0.21651,0.94485,GOBP_PHOSPHATIDYLCHOLINE_CATABOLIC_PROCESS,1
HP_APLASIA_HYPOPLASIA_INVOLV...2,SET,317,-0.077328,-0.010068,0.048403,0.94492,HP_APLASIA_HYPOPLASIA_INVOLVING_BONES_OF_THE_LOWER_LIMBS,1
GOBP_G0_TO_G1_TRANSITION,SET,36,-0.21998,-0.0097264,0.13769,0.94493,GOBP_G0_TO_G1_TRANSITION,1
IVANOVA_HEMATOPOIESIS_LATE_P...,SET,466,-0.060018,-0.0094349,0.037563,0.94495,IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR,1
MODULE_465,SET,13,-0.37827,-0.010057,0.23673,0.94495,MODULE_465,1
HP_HIRSUTISM,SET,195,-0.095571,-0.0097919,0.059811,0.94496,HP_HIRSUTISM,1
WP_CONGENITAL_GENERALIZED_LI...,SET,16,-0.34885,-0.010288,0.21828,0.94499,WP_CONGENITAL_GENERALIZED_LIPODYSTROPHY,1
HP_MELENA,SET,21,-0.29979,-0.010128,0.18754,0.94503,HP_MELENA,1
GSE24972_WT_VS_IRF8_KO_SPLEE...2,SET,180,-0.103,-0.010144,0.064423,0.94506,GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP,1
GOBP_PHOSPHOLIPASE_C_ACTIVAT...1,SET,8,-0.56542,-0.011794,0.3536,0.94509,GOBP_PHOSPHOLIPASE_C_ACTIVATING_DOPAMINE_RECEPTOR_SIGNALING_PATHWAY,1
MIR8081,SET,50,-0.18955,-0.0098732,0.11851,0.94513,MIR8081,1
GOBP_GRANZYME_MEDIATED_PROGR...,SET,8,-0.51327,-0.010706,0.32088,0.94514,GOBP_GRANZYME_MEDIATED_PROGRAMMED_CELL_DEATH_SIGNALING_PATHWAY,1
GSE2585_THYMIC_DC_VS_MTEC_UP,SET,172,-0.10253,-0.0098721,0.0641,0.94514,GSE2585_THYMIC_DC_VS_MTEC_UP,1
GOBP_JNK_CASCADE,SET,159,-0.10788,-0.0099904,0.067441,0.94515,GOBP_JNK_CASCADE,1
HP_PATELLAR_HYPOPLASIA,SET,14,-0.38492,-0.010619,0.24062,0.94516,HP_PATELLAR_HYPOPLASIA,1
HESS_TARGETS_OF_HOXA9_AND_ME...2,SET,67,-0.16509,-0.0099495,0.10318,0.9452,HESS_TARGETS_OF_HOXA9_AND_MEIS1_UP,1
GOMF_SULFUR_AMINO_ACID_TRANS...,SET,11,-0.38438,-0.0094009,0.24017,0.94524,GOMF_SULFUR_AMINO_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_ELEVATED_TRANSFERRIN_SATU...,SET,9,-0.44172,-0.0097725,0.27598,0.94525,HP_ELEVATED_TRANSFERRIN_SATURATION,1
GSE36476_CTRL_VS_TSST_ACT_40...2,SET,178,-0.10242,-0.01003,0.063919,0.94544,GSE36476_CTRL_VS_TSST_ACT_40H_MEMORY_CD4_TCELL_OLD_UP,1
GOBP_GENERAL_ADAPTATION_SYND...2,SET,5,-0.62851,-0.010365,0.39222,0.94546,GOBP_GENERAL_ADAPTATION_SYNDROME_BEHAVIORAL_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...127,SET,53,-0.19329,-0.010365,0.12061,0.94548,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_ADHESION,1
GOBP_BASE_EXCISION_REPAIR,SET,41,-0.18188,-0.008581,0.11348,0.9455,GOBP_BASE_EXCISION_REPAIR,1
GOBP_RESPONSE_TO_TEMPERATURE...,SET,160,-0.10718,-0.0099566,0.066864,0.94552,GOBP_RESPONSE_TO_TEMPERATURE_STIMULUS,1
FLECHNER_BIOPSY_KIDNEY_TRANS...1,SET,23,-0.25953,-0.0091752,0.16186,0.94557,FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_OK_VS_DONOR_DN,1
HP_ABNORMALITY_OF_FUNDUS_PIG...,SET,39,-0.21049,-0.0096859,0.1312,0.94567,HP_ABNORMALITY_OF_FUNDUS_PIGMENTATION,1
REACTOME_FGFR1B_LIGAND_BINDI...,SET,8,-0.51729,-0.01079,0.3224,0.94569,REACTOME_FGFR1B_LIGAND_BINDING_AND_ACTIVATION,1
NOTCH3_TARGET_GENES,SET,1079,-0.043108,-0.010134,0.026859,0.94575,NOTCH3_TARGET_GENES,1
GSE27786_LIN_NEG_VS_ERYTHROB...2,SET,183,-0.094755,-0.0094079,0.059032,0.94576,GSE27786_LIN_NEG_VS_ERYTHROBLAST_UP,1
GOBP_NEGATIVE_REGULATION_OF_...343,SET,49,-0.19675,-0.010146,0.12256,0.94578,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_MIGRATION,1
HP_HEAD_TREMOR,SET,39,-0.21916,-0.010085,0.13652,0.94579,HP_HEAD_TREMOR,1
GOBP_REGULATION_OF_BILE_ACID...3,SET,5,-0.58015,-0.0095677,0.36134,0.9458,GOBP_REGULATION_OF_BILE_ACID_SECRETION,1
MIR6513_3P,SET,133,-0.11811,-0.010011,0.073543,0.94585,MIR6513_3P,1
GSE3039_CD4_TCELL_VS_ALPHAAL...1,SET,178,-0.10003,-0.0097965,0.062286,0.94585,GSE3039_CD4_TCELL_VS_ALPHAALPHA_CD8_TCELL_DN,1
KEGG_INTESTINAL_IMMUNE_NETWO...,SET,40,-0.23311,-0.010863,0.14514,0.94586,KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION,1
REACTOME_HIV_TRANSCRIPTION_I...,SET,43,-0.17974,-0.008684,0.11189,0.9459,REACTOME_HIV_TRANSCRIPTION_INITIATION,1
HP_SHORT_NASAL_BRIDGE,SET,5,-0.71079,-0.011722,0.44247,0.9459,HP_SHORT_NASAL_BRIDGE,1
GOBP_PROTEIN_QUALITY_CONTROL...,SET,23,-0.24878,-0.0087952,0.15479,0.94599,GOBP_PROTEIN_QUALITY_CONTROL_FOR_MISFOLDED_OR_INCOMPLETELY_SYNTHESIZED_PROTEINS,1
HOLLERN_SOLID_NODULAR_BREAST...2,SET,9,-0.52693,-0.011657,0.32774,0.94605,HOLLERN_SOLID_NODULAR_BREAST_TUMOR_UP,1
PDGF_UP.V1_UP,SET,134,-0.11434,-0.0097275,0.071118,0.94605,PDGF_UP.V1_UP,1
KEGG_MTOR_SIGNALING_PATHWAY,SET,49,-0.20732,-0.010691,0.12889,0.94612,KEGG_MTOR_SIGNALING_PATHWAY,1
PIEPOLI_LGI1_TARGETS_DN,SET,12,-0.4087,-0.01044,0.25402,0.94617,PIEPOLI_LGI1_TARGETS_DN,1
MORF_MAGEA9,SET,376,-0.072131,-0.010211,0.044825,0.9462,MORF_MAGEA9,1
HP_EEG_WITH_GENERALIZED_EPIL...,SET,247,-0.085614,-0.0098582,0.053202,0.94621,HP_EEG_WITH_GENERALIZED_EPILEPTIFORM_DISCHARGES,1
GSE2405_S_AUREUS_VS_UNTREATE...1,SET,180,-0.10021,-0.0098682,0.062264,0.94623,GSE2405_S_AUREUS_VS_UNTREATED_NEUTROPHIL_DN,1
GSE5589_LPS_VS_LPS_AND_IL10_...8,SET,179,-0.10114,-0.0099325,0.062807,0.94633,GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_45MIN_UP,1
BRUINS_UVC_RESPONSE_VIA_TP53...4,SET,246,-0.087835,-0.010094,0.054531,0.94637,BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_D,1
MIR6765_5P,SET,7,-0.52429,-0.01023,0.3255,0.94637,MIR6765_5P,1
GSE46606_IRF4HIGH_VS_IRF4MID...1,SET,178,-0.10289,-0.010076,0.063877,0.94637,GSE46606_IRF4HIGH_VS_IRF4MID_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_DN,1
IWANAGA_CARCINOGENESIS_BY_KR...2,SET,333,-0.076673,-0.010227,0.047599,0.94638,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_DN,1
REACTOME_DEFECTIVE_CSF2RB_CA...,SET,7,-0.62413,-0.012178,0.38739,0.94641,REACTOME_DEFECTIVE_CSF2RB_CAUSES_SMDP5,1
GOBP_RESPONSE_TO_INCREASED_O...,SET,23,-0.27026,-0.0095545,0.16775,0.94641,GOBP_RESPONSE_TO_INCREASED_OXYGEN_LEVELS,1
MIR3664_5P,SET,69,-0.15873,-0.0097073,0.098512,0.94643,MIR3664_5P,1
GOBP_REGULATION_OF_PLATELET_...4,SET,8,-0.48422,-0.0101,0.3005,0.94644,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_BETA_SIGNALING_PATHWAY,1
GNF2_TIMP2,SET,39,-0.24487,-0.011268,0.15193,0.94648,GNF2_TIMP2,1
BIOCARTA_D4GDI_PATHWAY,SET,12,-0.38832,-0.0099192,0.24092,0.94649,BIOCARTA_D4GDI_PATHWAY,1
BIOCARTA_SODD_PATHWAY,SET,10,-0.41872,-0.0097644,0.25977,0.9465,BIOCARTA_SODD_PATHWAY,1
GOBP_REGENERATION,SET,180,-0.10578,-0.010417,0.065617,0.94652,GOBP_REGENERATION,1
HP_ABNORMAL_PROPORTION_OF_ME...,SET,5,-0.63971,-0.01055,0.3968,0.94653,HP_ABNORMAL_PROPORTION_OF_MEMORY_T_CELLS,1
GOBP_MEMBRANE_HYPERPOLARIZAT...,SET,11,-0.4067,-0.0099467,0.25223,0.94656,GOBP_MEMBRANE_HYPERPOLARIZATION,1
GOBP_PALLIUM_DEVELOPMENT,SET,174,-0.10773,-0.010432,0.066802,0.94658,GOBP_PALLIUM_DEVELOPMENT,1
GOCC_RIPOPTOSOME,SET,6,-0.66038,-0.01193,0.40942,0.94661,GOCC_RIPOPTOSOME,1
GOBP_FOREBRAIN_DEVELOPMENT,SET,380,-0.074107,-0.010545,0.045922,0.9467,GOBP_FOREBRAIN_DEVELOPMENT,1
GOBP_ORGANIC_HYDROXY_COMPOUN...4,SET,254,-0.088314,-0.01031,0.054724,0.94671,GOBP_ORGANIC_HYDROXY_COMPOUND_TRANSPORT,1
MIR510_3P,SET,337,-0.075614,-0.010145,0.046849,0.94673,MIR510_3P,1
MIR633,SET,128,-0.11646,-0.0096848,0.072148,0.94674,MIR633,1
GOBP_PARENTAL_BEHAVIOR,SET,13,-0.44341,-0.011789,0.2747,0.94674,GOBP_PARENTAL_BEHAVIOR,1
GSE37605_C57BL6_VS_NOD_FOXP3...8,SET,107,-0.13315,-0.01013,0.082491,0.94674,GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TREG_UP,1
GOBP_POSITIVE_REGULATION_OF_...460,SET,7,-0.55668,-0.010862,0.34485,0.94675,GOBP_POSITIVE_REGULATION_OF_MICROGLIAL_CELL_ACTIVATION,1
HP_VISUAL_IMPAIRMENT,SET,995,-0.044165,-0.0099941,0.02736,0.94675,HP_VISUAL_IMPAIRMENT,1
RAG1_TARGET_GENES,SET,852,-0.047549,-0.0099975,0.029455,0.94676,RAG1_TARGET_GENES,1
MODULE_337,SET,58,-0.16859,-0.0094558,0.10443,0.94677,MODULE_337,1
HFH8_01,SET,191,-0.10315,-0.01046,0.063891,0.94678,HFH8_01,1
GSE11961_FOLLICULAR_BCELL_VS...12,SET,184,-0.099969,-0.0099524,0.061913,0.9468,GSE11961_FOLLICULAR_BCELL_VS_PLASMA_CELL_DAY7_UP,1
HP_ABNORMAL_MAGNESIUM_CONCEN...,SET,31,-0.26596,-0.010913,0.16465,0.94686,HP_ABNORMAL_MAGNESIUM_CONCENTRATION,1
GAVISH_3CA_METAPROGRAM_ENDOT...5,SET,47,-0.22067,-0.011145,0.1366,0.94689,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_ENDO_3,1
GSE20500_CTRL_VS_RARA_ANTAGO...2,SET,182,-0.097247,-0.0096292,0.060197,0.94689,GSE20500_CTRL_VS_RARA_ANTAGONIST_TREATED_CD4_TCELL_UP,1
chr10p13,SET,28,-0.41643,-0.016242,0.25776,0.9469,chr10p13,1
MIR181D_5P,SET,554,-0.059039,-0.010095,0.036542,0.9469,MIR181D_5P,1
GOBP_POSITIVE_REGULATION_OF_...527,SET,14,-0.39246,-0.010828,0.24292,0.9469,GOBP_POSITIVE_REGULATION_OF_NEUROINFLAMMATORY_RESPONSE,1
DESCARTES_FETAL_STOMACH_MUC1...,SET,81,-0.1594,-0.010559,0.098651,0.94693,DESCARTES_FETAL_STOMACH_MUC13_DMBT1_POSITIVE_CELLS,1
DESCARTES_MAIN_FETAL_CHROMAF...,SET,15,-0.31981,-0.0091327,0.19791,0.94694,DESCARTES_MAIN_FETAL_CHROMAFFIN_CELLS,1
GOBP_REGULATION_OF_AUTOPHAGO...1,SET,43,-0.20418,-0.0098644,0.12633,0.94696,GOBP_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
GOBP_RNA_SPLICING,SET,398,-0.063741,-0.0092778,0.039437,0.94697,GOBP_RNA_SPLICING,1
GOCC_EUKARYOTIC_TRANSLATION_...1,SET,5,-0.52529,-0.0086629,0.32501,0.94697,GOCC_EUKARYOTIC_TRANSLATION_INITIATION_FACTOR_2B_COMPLEX,1
HP_METABOLIC_ACIDOSIS,SET,149,-0.10681,-0.0095783,0.066083,0.94698,HP_METABOLIC_ACIDOSIS,1
GOBP_RESPONSE_TO_AMINE,SET,50,-0.20716,-0.010791,0.12814,0.94702,GOBP_RESPONSE_TO_AMINE,1
REACTOME_DEFENSINS,SET,32,-0.32476,-0.013539,0.20082,0.94707,REACTOME_DEFENSINS,1
GOBP_CELLULAR_RESPONSE_TO_ST...3,SET,22,-0.30246,-0.010458,0.18703,0.94707,GOBP_CELLULAR_RESPONSE_TO_STEROL,1
MIR4509,SET,60,-0.17247,-0.0098383,0.10663,0.94711,MIR4509,1
DAVICIONI_RHABDOMYOSARCOMA_P...1,SET,13,-0.47018,-0.0125,0.29066,0.94712,DAVICIONI_RHABDOMYOSARCOMA_PAX_FOXO1_FUSION_DN,1
MIR6822_5P,SET,64,-0.15932,-0.0093849,0.098451,0.94718,MIR6822_5P,1
GOMF_CALCITONIN_FAMILY_RECEP...,SET,6,-0.58214,-0.010516,0.35974,0.94718,GOMF_CALCITONIN_FAMILY_RECEPTOR_ACTIVITY,1
YY1_01,SET,225,-0.090382,-0.0099388,0.055849,0.94719,YY1_01,1
BURTON_ADIPOGENESIS_4,SET,42,-0.20757,-0.0099114,0.12825,0.94722,BURTON_ADIPOGENESIS_4,1
MIR1248,SET,120,-0.13118,-0.010565,0.081023,0.94728,MIR1248,1
HP_MODERATE_GLOBAL_DEVELOPME...,SET,22,-0.27462,-0.0094955,0.16961,0.94728,HP_MODERATE_GLOBAL_DEVELOPMENTAL_DELAY,1
HP_ABNORMALITY_OF_AMINO_ACID...,SET,7,-0.49692,-0.009696,0.30684,0.94732,HP_ABNORMALITY_OF_AMINO_ACID_METABOLISM,1
GSE43863_NAIVE_VS_MEMORY_LY6...2,SET,174,-0.10484,-0.010152,0.064733,0.94732,GSE43863_NAIVE_VS_MEMORY_LY6C_INT_CXCR5POS_CD4_TCELL_D150_LCMV_UP,1
GOBP_MESONEPHRIC_TUBULE_MORP...,SET,62,-0.18936,-0.010979,0.11689,0.94737,GOBP_MESONEPHRIC_TUBULE_MORPHOGENESIS,1
GSE11961_MEMORY_BCELL_DAY40_...2,SET,182,-0.098224,-0.0097259,0.060634,0.94737,GSE11961_MEMORY_BCELL_DAY40_VS_GERMINAL_CENTER_BCELL_DAY40_UP,1
HP_MYOFIBER_DISARRAY,SET,10,-0.39862,-0.0092957,0.24602,0.9474,HP_MYOFIBER_DISARRAY,1
MIR6861_5P,SET,62,-0.16957,-0.0098323,0.10465,0.94742,MIR6861_5P,1
GOBP_POSITIVE_REGULATION_OF_...535,SET,22,-0.31046,-0.010735,0.19159,0.94742,GOBP_POSITIVE_REGULATION_OF_NEUROTRANSMITTER_TRANSPORT,1
TURASHVILI_BREAST_LOBULAR_CA...3,SET,67,-0.17972,-0.010832,0.1109,0.94743,TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN,1
GOBP_CHEMOKINE_PRODUCTION,SET,90,-0.15307,-0.010685,0.094451,0.94744,GOBP_CHEMOKINE_PRODUCTION,1
TTAYRTAA_E4BP4_01,SET,236,-0.094734,-0.010666,0.058453,0.94745,TTAYRTAA_E4BP4_01,1
GSE8685_IL2_STARVED_VS_IL15_...2,SET,182,-0.10069,-0.0099705,0.062124,0.94747,GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,1
YGACNNYACAR_UNKNOWN,SET,83,-0.15276,-0.010242,0.094233,0.94749,YGACNNYACAR_UNKNOWN,1
DESCARTES_FETAL_PLACENTA_TRO...,SET,66,-0.18776,-0.011231,0.11582,0.9475,DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS,1
GOMF_PHOSPHATIDYL_PHOSPHOLIP...,SET,11,-0.41943,-0.010258,0.25864,0.94755,GOMF_PHOSPHATIDYL_PHOSPHOLIPASE_B_ACTIVITY,1
HP_HEPARAN_SULFATE_EXCRETION...,SET,8,-0.45595,-0.0095106,0.28115,0.94756,HP_HEPARAN_SULFATE_EXCRETION_IN_URINE,1
GSE37532_VISCERAL_ADIPOSE_TI...3,SET,120,-0.11992,-0.0096582,0.073936,0.94758,GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN,1
MIR7160_3P,SET,27,-0.26579,-0.01018,0.16383,0.94763,MIR7160_3P,1
FOSTER_TOLERANT_MACROPHAGE_UP,SET,151,-0.11823,-0.010672,0.072869,0.94764,FOSTER_TOLERANT_MACROPHAGE_UP,1
BIOCARTA_CTBP1_PATHWAY,SET,8,-0.42362,-0.0088361,0.26104,0.94768,BIOCARTA_CTBP1_PATHWAY,1
WP_DIFFERENTIATION_OF_WHITE_...,SET,25,-0.30546,-0.011258,0.18821,0.94769,WP_DIFFERENTIATION_OF_WHITE_AND_BROWN_ADIPOCYTE,1
GOMF_SPHINGOSINE_1_PHOSPHATE...1,SET,2,-0.98768,-0.010303,0.60845,0.94772,GOMF_SPHINGOSINE_1_PHOSPHATE_PHOSPHATASE_ACTIVITY,1
GOMF_POTASSIUM_ION_BINDING,SET,13,-0.39452,-0.010489,0.24302,0.94774,GOMF_POTASSIUM_ION_BINDING,1
CC2D1A_TARGET_GENES,SET,1191,-0.040692,-0.010017,0.025061,0.94777,CC2D1A_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...101,SET,21,-0.27935,-0.0094375,0.172,0.94782,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_SENESCENCE,1
GOBP_UREA_CYCLE,SET,10,-0.39583,-0.0092306,0.24369,0.94784,GOBP_UREA_CYCLE,1
LIU_PROSTATE_CANCER_UP,SET,87,-0.15285,-0.010491,0.094096,0.94785,LIU_PROSTATE_CANCER_UP,1
MIR299_3P,SET,50,-0.18347,-0.0095567,0.11292,0.94789,MIR299_3P,1
GOBP_PHOSPHOLIPID_METABOLIC_...,SET,342,-0.073678,-0.0099565,0.045342,0.9479,GOBP_PHOSPHOLIPID_METABOLIC_PROCESS,1
GOCC_PHOSPHATIDYLINOSITOL_3_...1,SET,29,-0.26751,-0.010618,0.16462,0.9479,GOCC_PHOSPHATIDYLINOSITOL_3_KINASE_COMPLEX,1
HP_FACIAL_HEMANGIOMA,SET,19,-0.32992,-0.010602,0.20303,0.94791,HP_FACIAL_HEMANGIOMA,1
GOBP_POSITIVE_REGULATION_OF_...177,SET,3,-0.78114,-0.0099792,0.48068,0.94792,GOBP_POSITIVE_REGULATION_OF_CONNECTIVE_TISSUE_REPLACEMENT,1
MIR6826_3P,SET,93,-0.13661,-0.0096932,0.084022,0.94801,MIR6826_3P,1
FOXJ2_01,SET,168,-0.11168,-0.010629,0.068684,0.94802,FOXJ2_01,1
MIR466,SET,372,-0.070685,-0.009954,0.043469,0.94803,MIR466,1
GOBP_MAINTENANCE_OF_PROTEIN_...2,SET,42,-0.20094,-0.0095947,0.12357,0.94803,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ORGANELLE,1
HP_ABNORMAL_PROPORTION_OF_CL...,SET,17,-0.38529,-0.011713,0.2369,0.94806,HP_ABNORMAL_PROPORTION_OF_CLASS_SWITCHED_MEMORY_B_CELLS,1
GOBP_REGULATION_OF_PROTEIN_A...1,SET,17,-0.318,-0.0096669,0.19546,0.94811,GOBP_REGULATION_OF_PROTEIN_ACETYLATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...19,SET,646,-0.053439,-0.009841,0.032845,0.94812,HP_APLASIA_HYPOPLASIA_OF_THE_CORPUS_CALLOSUM,1
GOBP_PHARYNGEAL_ARCH_ARTERY_...,SET,9,-0.51793,-0.011458,0.31831,0.94814,GOBP_PHARYNGEAL_ARCH_ARTERY_MORPHOGENESIS,1
GOBP_REGULATION_OF_SYSTEMIC_...5,SET,6,-0.68712,-0.012413,0.42208,0.94822,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_NOREPINEPHRINE_EPINEPHRINE,1
HP_PROLINURIA,SET,7,-0.55411,-0.010812,0.34038,0.94822,HP_PROLINURIA,1
HP_ABNORMAL_TISSUE_METABOLIT...,SET,238,-0.086429,-0.0097714,0.053087,0.94823,HP_ABNORMAL_TISSUE_METABOLITE_CONCENTRATION,1
GOBP_POTASSIUM_ION_EXPORT_AC...,SET,18,-0.3633,-0.011364,0.22313,0.94825,GOBP_POTASSIUM_ION_EXPORT_ACROSS_PLASMA_MEMBRANE,1
LUI_THYROID_CANCER_CLUSTER_5,SET,14,-0.38067,-0.010502,0.23368,0.94833,LUI_THYROID_CANCER_CLUSTER_5,1
GSE23114_PERITONEAL_CAVITY_B...4,SET,164,-0.10676,-0.010039,0.065531,0.94834,GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_UP,1
GOBP_FIBROBLAST_APOPTOTIC_PR...,SET,24,-0.27435,-0.0099075,0.1684,0.94835,GOBP_FIBROBLAST_APOPTOTIC_PROCESS,1
HP_AGYRIA,SET,15,-0.31384,-0.0089622,0.19264,0.94835,HP_AGYRIA,1
JEON_SMAD6_TARGETS_UP,SET,23,-0.32531,-0.011501,0.19965,0.94837,JEON_SMAD6_TARGETS_UP,1
GOMF_ADRENERGIC_RECEPTOR_BIN...,SET,16,-0.35275,-0.010404,0.21649,0.94838,GOMF_ADRENERGIC_RECEPTOR_BINDING,1
JNK_DN.V1_DN,SET,167,-0.11219,-0.010646,0.06884,0.94841,JNK_DN.V1_DN,1
GOBP_RESPONSE_TO_LITHIUM_ION,SET,16,-0.3553,-0.010479,0.21796,0.94846,GOBP_RESPONSE_TO_LITHIUM_ION,1
HP_WIDE_PUBIC_SYMPHYSIS,SET,7,-0.58341,-0.011384,0.35787,0.94847,HP_WIDE_PUBIC_SYMPHYSIS,1
HP_METAPHYSEAL_IRREGULARITY,SET,44,-0.20931,-0.010229,0.12838,0.94848,HP_METAPHYSEAL_IRREGULARITY,1
GOBP_PROTEIN_O_LINKED_GLYCOS...3,SET,10,-0.49001,-0.011427,0.30045,0.94854,GOBP_PROTEIN_O_LINKED_GLYCOSYLATION_VIA_THREONINE,1
HOEK_MYELOID_DENDRITIC_CELL_...4,SET,3,-0.97149,-0.012411,0.59566,0.94854,HOEK_MYELOID_DENDRITIC_CELL_2011_2012_TIV_ADULT_3DY_UP,1
KEGG_MEDICUS_REFERENCE_IL1_I...1,SET,17,-0.36332,-0.011045,0.22273,0.94856,KEGG_MEDICUS_REFERENCE_IL1_IL1R_JNK_SIGNALING_PATHWAY,1
GSE40277_GATA1_AND_SATB1_TRA...2,SET,181,-0.10054,-0.0099277,0.061636,0.94856,GSE40277_GATA1_AND_SATB1_TRANSDUCED_VS_CTRL_CD4_TCELL_UP,1
MORF_FSHR,SET,244,-0.091034,-0.010419,0.055796,0.9486,MORF_FSHR,1
GSE19941_LPS_VS_LPS_AND_IL10...1,SET,137,-0.12465,-0.010721,0.076397,0.9486,GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_MACROPHAGE_DN,1
HP_PERIANAL_ABSCESS,SET,8,-0.52816,-0.011017,0.32371,0.94861,HP_PERIANAL_ABSCESS,1
GOBP_RESPONSE_TO_CHEMOKINE,SET,91,-0.1684,-0.01182,0.1032,0.94864,GOBP_RESPONSE_TO_CHEMOKINE,1
GOMF_3_5_CYCLIC_AMP_PHOSPHOD...,SET,22,-0.31288,-0.010819,0.19163,0.94873,GOMF_3_5_CYCLIC_AMP_PHOSPHODIESTERASE_ACTIVITY,1
HP_TREMOR,SET,540,-0.0591,-0.0099803,0.036196,0.94873,HP_TREMOR,1
GOBP_ORGANIC_HYDROXY_COMPOUN...3,SET,513,-0.063102,-0.010394,0.038644,0.94875,GOBP_ORGANIC_HYDROXY_COMPOUND_METABOLIC_PROCESS,1
GOBP_PEPTIDYL_LYSINE_TRIMETH...,SET,5,-0.5291,-0.0087257,0.32401,0.94876,GOBP_PEPTIDYL_LYSINE_TRIMETHYLATION,1
GOBP_VIRAL_PROTEIN_PROCESSING,SET,31,-0.24487,-0.010048,0.14993,0.94879,GOBP_VIRAL_PROTEIN_PROCESSING,1
GOBP_NEURON_CELL_CELL_ADHESI...,SET,13,-0.40998,-0.0109,0.25098,0.94881,GOBP_NEURON_CELL_CELL_ADHESION,1
GOBP_NEGATIVE_REGULATION_OF_...340,SET,20,-0.31369,-0.010342,0.19203,0.94882,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_CHEMOTAXIS,1
DOANE_BREAST_CANCER_CLASSES_...2,SET,66,-0.17347,-0.010376,0.10614,0.94889,DOANE_BREAST_CANCER_CLASSES_UP,1
FURUKAWA_DUSP6_TARGETS_PCI35...2,SET,61,-0.19318,-0.011111,0.11814,0.94898,FURUKAWA_DUSP6_TARGETS_PCI35_UP,1
GSE29618_PRE_VS_DAY7_FLU_VAC...1,SET,175,-0.10044,-0.0097543,0.061418,0.94901,GSE29618_PRE_VS_DAY7_FLU_VACCINE_BCELL_DN,1
GOBP_REGULATION_OF_ACUTE_INF...1,SET,44,-0.22121,-0.010811,0.13526,0.94902,GOBP_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
HP_INCREASED_URINARY_NON_PRO...,SET,31,-0.26838,-0.011013,0.16406,0.94906,HP_INCREASED_URINARY_NON_PROTEINOGENIC_AMINO_ACID_LEVEL,1
GSE36392_EOSINOPHIL_VS_NEUTR...1,SET,179,-0.099842,-0.0098051,0.06102,0.94909,GSE36392_EOSINOPHIL_VS_NEUTROPHIL_IL25_TREATED_LUNG_DN,1
HP_ABNORMAL_CHOROID_PLEXUS_M...,SET,18,-0.36651,-0.011464,0.22399,0.9491,HP_ABNORMAL_CHOROID_PLEXUS_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...136,SET,19,-0.33002,-0.010605,0.20161,0.94916,GOBP_POSITIVE_REGULATION_OF_CELL_MIGRATION_INVOLVED_IN_SPROUTING_ANGIOGENESIS,1
NAGASHIMA_NRG1_SIGNALING_DN,SET,50,-0.18951,-0.0098712,0.11574,0.94922,NAGASHIMA_NRG1_SIGNALING_DN,1
BERNARD_PPAPDC1B_TARGETS_UP,SET,34,-0.23239,-0.009986,0.14191,0.94924,BERNARD_PPAPDC1B_TARGETS_UP,1
ZNF133_TARGET_GENES,SET,175,-0.10312,-0.010015,0.062973,0.94924,ZNF133_TARGET_GENES,1
HP_FLARED_METAPHYSIS,SET,49,-0.19052,-0.0098241,0.11628,0.94933,HP_FLARED_METAPHYSIS,1
GSE3039_ALPHAALPHA_VS_ALPHAB...1,SET,189,-0.10491,-0.010584,0.064003,0.9494,GSE3039_ALPHAALPHA_VS_ALPHABETA_CD8_TCELL_DN,1
CTTTAAR_UNKNOWN,SET,878,-0.049233,-0.010501,0.030018,0.9495,CTTTAAR_UNKNOWN,1
GOMF_VOLTAGE_GATED_SODIUM_CH...2,SET,5,-0.71955,-0.011867,0.43872,0.9495,GOMF_VOLTAGE_GATED_SODIUM_CHANNEL_ACTIVITY_INVOLVED_IN_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GSE25085_FETAL_LIVER_VS_ADUL...1,SET,167,-0.10001,-0.0094897,0.060965,0.94953,GSE25085_FETAL_LIVER_VS_ADULT_BM_SP4_THYMIC_IMPLANT_DN,1
REACTOME_TP53_REGULATES_TRAN...2,SET,12,-0.35604,-0.0090946,0.21691,0.94963,REACTOME_TP53_REGULATES_TRANSCRIPTION_OF_CASPASE_ACTIVATORS_AND_CASPASES,1
HP_ABNORMAL_CORTICAL_BONE_MO...,SET,77,-0.16014,-0.010343,0.097541,0.94967,HP_ABNORMAL_CORTICAL_BONE_MORPHOLOGY,1
GSE29164_UNTREATED_VS_CD8_TC...4,SET,172,-0.10087,-0.0097122,0.061431,0.94969,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY7_UP,1
WP_TRANSCRIPTION_COFACTORS_S...,SET,17,-0.37652,-0.011446,0.22929,0.94971,WP_TRANSCRIPTION_COFACTORS_SKI_AND_SKIL_PROTEIN_PARTNERS,1
GOBP_REGULATION_OF_CIRCADIAN...1,SET,105,-0.13903,-0.010479,0.084654,0.94973,GOBP_REGULATION_OF_CIRCADIAN_RHYTHM,1
HFH4_01,SET,180,-0.10782,-0.010618,0.065646,0.94974,HFH4_01,1
GSE8921_3H_VS_24H_TLR1_2_STI...1,SET,184,-0.10491,-0.010444,0.063825,0.94987,GSE8921_3H_VS_24H_TLR1_2_STIM_MONOCYTE_DN,1
ATCTTGC_MIR31,SET,70,-0.15814,-0.0097407,0.096184,0.94991,ATCTTGC_MIR31,1
GOBP_REGULATION_OF_GUANYLATE...,SET,6,-0.69133,-0.012489,0.4205,0.94991,GOBP_REGULATION_OF_GUANYLATE_CYCLASE_ACTIVITY,1
GOMF_CYCLASE_ACTIVITY,SET,17,-0.34721,-0.010555,0.21117,0.94992,GOMF_CYCLASE_ACTIVITY,1
NOTCH_DN.V1_DN,SET,161,-0.11325,-0.010553,0.06888,0.94992,NOTCH_DN.V1_DN,1
GOCC_CELL_CELL_CONTACT_ZONE,SET,68,-0.17347,-0.010532,0.10548,0.94997,GOCC_CELL_CELL_CONTACT_ZONE,1
GSE12366_NAIVE_VS_MEMORY_BCE...2,SET,162,-0.10779,-0.010075,0.065534,0.94999,GSE12366_NAIVE_VS_MEMORY_BCELL_UP,1
CHANGOLKAR_H2AFY_TARGETS_DN,SET,35,-0.21997,-0.0095899,0.13372,0.95,CHANGOLKAR_H2AFY_TARGETS_DN,1
MIR3196,SET,19,-0.33597,-0.010797,0.20422,0.95002,MIR3196,1
KEGG_MEDICUS_REFERENCE_BETA_...1,SET,11,-0.39907,-0.0097601,0.24256,0.95003,KEGG_MEDICUS_REFERENCE_BETA_OXIDATION,1
HP_ABNORMAL_TIBIA_MORPHOLOGY,SET,90,-0.15528,-0.01084,0.094383,0.95003,HP_ABNORMAL_TIBIA_MORPHOLOGY,1
MIR20B_3P,SET,65,-0.16915,-0.010042,0.1028,0.95005,MIR20B_3P,1
MORF_BMPR2,SET,47,-0.22129,-0.011176,0.13446,0.95009,MORF_BMPR2,1
GSE39820_CTRL_VS_IL1B_IL6_IL...2,SET,180,-0.10278,-0.010122,0.062447,0.9501,GSE39820_CTRL_VS_IL1B_IL6_IL23A_CD4_TCELL_UP,1
FONTAINE_PAPILLARY_THYROID_C...1,SET,73,-0.16856,-0.010602,0.1024,0.95011,FONTAINE_PAPILLARY_THYROID_CARCINOMA_DN,1
GSE13738_TCR_VS_BYSTANDER_AC...1,SET,169,-0.1075,-0.010261,0.065285,0.95017,GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN,1
REACTOME_PI_3K_CASCADE_FGFR1,SET,21,-0.31925,-0.010785,0.19387,0.95018,REACTOME_PI_3K_CASCADE_FGFR1,1
GOBP_RIBOSOMAL_SUBUNIT_EXPOR...,SET,15,-0.36012,-0.010284,0.2187,0.95018,GOBP_RIBOSOMAL_SUBUNIT_EXPORT_FROM_NUCLEUS,1
WP_SULINDAC_METABOLIC_PATHWAY,SET,5,-0.68827,-0.011351,0.4178,0.95025,WP_SULINDAC_METABOLIC_PATHWAY,1
HP_DYSGERMINOMA,SET,9,-0.45013,-0.0099584,0.27324,0.95025,HP_DYSGERMINOMA,1
HP_3_METHYLGLUTARIC_ACIDURIA,SET,5,-0.55452,-0.0091449,0.33655,0.95028,HP_3_METHYLGLUTARIC_ACIDURIA,1
PID_SYNDECAN_4_PATHWAY,SET,31,-0.25484,-0.010457,0.15466,0.95029,PID_SYNDECAN_4_PATHWAY,1
KEGG_VALINE_LEUCINE_AND_ISOL...2,SET,42,-0.20838,-0.00995,0.12645,0.9503,KEGG_VALINE_LEUCINE_AND_ISOLEUCINE_DEGRADATION,1
MODULE_427,SET,100,-0.13279,-0.0097684,0.080578,0.95031,MODULE_427,1
REACTOME_MITF_M_REGULATED_ME...,SET,124,-0.12564,-0.010285,0.076231,0.95034,REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT,1
REACTOME_SODIUM_COUPLED_PHOS...,SET,5,-0.69395,-0.011444,0.42098,0.95036,REACTOME_SODIUM_COUPLED_PHOSPHATE_COTRANSPORTERS,1
GSE17721_LPS_VS_GARDIQUIMOD_...15,SET,180,-0.097986,-0.0096495,0.059441,0.95036,GSE17721_LPS_VS_GARDIQUIMOD_6H_BMDC_DN,1
KEGG_MEDICUS_VARIANT_MUTATIO...69,SET,6,-0.52641,-0.0095098,0.31928,0.95039,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_ATXN3_TO_AUTOPHAGY_VESICLE_NUCLEATION,1
GOBP_INTRINSIC_APOPTOTIC_SIG...9,SET,54,-0.18207,-0.0098543,0.11042,0.95039,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_OXIDATIVE_STRESS,1
MODULE_12,SET,324,-0.084933,-0.011177,0.051504,0.95042,MODULE_12,1
GOBP_POSITIVE_REGULATION_OF_...699,SET,21,-0.3135,-0.010591,0.19009,0.95044,GOBP_POSITIVE_REGULATION_OF_SIGNALING_RECEPTOR_ACTIVITY,1
GOBP_SMALL_MOLECULE_CATABOLI...,SET,350,-0.074867,-0.010233,0.045388,0.95047,GOBP_SMALL_MOLECULE_CATABOLIC_PROCESS,1
REACTOME_SPHINGOLIPID_CATABO...,SET,9,-0.43723,-0.0096731,0.26504,0.95048,REACTOME_SPHINGOLIPID_CATABOLISM,1
MORF_CAMK4,SET,253,-0.089859,-0.01047,0.054461,0.95052,MORF_CAMK4,1
GSE19888_ADENOSINE_A3R_INH_P...2,SET,170,-0.1079,-0.010329,0.065394,0.95052,GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP,1
GSE45365_WT_VS_IFNAR_KO_CD8A...2,SET,171,-0.10931,-0.010495,0.066239,0.95054,GSE45365_WT_VS_IFNAR_KO_CD8A_DC_MCMV_INFECTION_DN,1
GOBP_MAMMARY_GLAND_INVOLUTION,SET,8,-0.55851,-0.01165,0.33837,0.95058,GOBP_MAMMARY_GLAND_INVOLUTION,1
HP_ABNORMAL_ORAL_GLUCOSE_TOL...,SET,15,-0.39879,-0.011388,0.24159,0.95059,HP_ABNORMAL_ORAL_GLUCOSE_TOLERANCE,1
HP_FACIAL_CAPILLARY_HEMANGIO...,SET,10,-0.4808,-0.011212,0.2912,0.95064,HP_FACIAL_CAPILLARY_HEMANGIOMA,1
GTGACTT_MIR224,SET,139,-0.1144,-0.009911,0.069247,0.95073,GTGACTT_MIR224,1
MIR6720_5P,SET,123,-0.12468,-0.010165,0.075464,0.95074,MIR6720_5P,1
HP_POLYPHAGIA,SET,67,-0.18446,-0.011117,0.11165,0.95074,HP_POLYPHAGIA,1
HP_REDUCED_PROTEIN_C_ACTIVITY,SET,10,-0.38678,-0.0090195,0.23411,0.95074,HP_REDUCED_PROTEIN_C_ACTIVITY,1
GSE5542_IFNA_VS_IFNA_AND_IFN...4,SET,177,-0.099326,-0.0097004,0.060116,0.95075,GSE5542_IFNA_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_UP,1
HP_ABNORMALITY_OF_THE_METOPI...,SET,80,-0.14971,-0.0098559,0.090558,0.95085,HP_ABNORMALITY_OF_THE_METOPIC_SUTURE,1
GOBP_APOPTOTIC_PROCESS_INVOL...3,SET,23,-0.33004,-0.011668,0.19958,0.95089,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_MORPHOGENESIS,1
GSE26030_UNSTIM_VS_RESTIM_TH...6,SET,184,-0.10349,-0.010303,0.062585,0.95089,GSE26030_UNSTIM_VS_RESTIM_TH1_DAY15_POST_POLARIZATION_UP,1
KEGG_MEDICUS_PATHOGEN_SALMON...3,SET,8,-0.4599,-0.009593,0.2781,0.9509,KEGG_MEDICUS_PATHOGEN_SALMONELLA_SIFA_TO_TETHERING_OF_LATE_ENDOSOMES_AND_LYSOSOMES,1
REACTOME_ACTIVATION_OF_THE_P...1,SET,11,-0.37752,-0.009233,0.22821,0.95095,REACTOME_ACTIVATION_OF_THE_PHOTOTRANSDUCTION_CASCADE,1
KIM_TIAL1_TARGETS,SET,29,-0.26367,-0.010466,0.15939,0.95096,KIM_TIAL1_TARGETS,1
HP_ABNORMAL_SEXUAL_BEHAVIOR,SET,7,-0.51555,-0.01006,0.31162,0.95097,HP_ABNORMAL_SEXUAL_BEHAVIOR,1
GOCC_EXTRINSIC_COMPONENT_OF_...5,SET,97,-0.14559,-0.010549,0.087972,0.95102,GOCC_EXTRINSIC_COMPONENT_OF_PLASMA_MEMBRANE,1
GSE32423_MEMORY_VS_NAIVE_CD8...4,SET,178,-0.11143,-0.010913,0.067336,0.95102,GSE32423_MEMORY_VS_NAIVE_CD8_TCELL_IL7_IL4_UP,1
STAT_Q6,SET,234,-0.093262,-0.010456,0.05634,0.95106,STAT_Q6,1
WP_SARSCOV2_AND_ACE2_RECEPTO...,SET,6,-0.67444,-0.012184,0.40731,0.95111,WP_SARSCOV2_AND_ACE2_RECEPTOR_MOLECULAR_MECHANISMS,1
GOBP_RIBOSE_PHOSPHATE_METABO...,SET,405,-0.068088,-0.0099953,0.041117,0.95113,GOBP_RIBOSE_PHOSPHATE_METABOLIC_PROCESS,1
BUSSLINGER_DUODENAL_BCHE_CEL...,SET,39,-0.2388,-0.010989,0.14421,0.95113,BUSSLINGER_DUODENAL_BCHE_CELLS,1
MIR4421,SET,49,-0.20292,-0.010464,0.12252,0.95116,MIR4421,1
DOUGLAS_BMI1_TARGETS_DN,SET,293,-0.080746,-0.010114,0.048739,0.9512,DOUGLAS_BMI1_TARGETS_DN,1
HEIDENBLAD_AMPLICON_12P11_12...2,SET,33,-0.2507,-0.010614,0.15131,0.95122,HEIDENBLAD_AMPLICON_12P11_12_UP,1
GOCC_NURF_COMPLEX,SET,5,-0.5452,-0.0089913,0.32897,0.95126,GOCC_NURF_COMPLEX,1
GOCC_FICOLIN_1_RICH_GRANULE_...1,SET,120,-0.12592,-0.010142,0.075967,0.95129,GOCC_FICOLIN_1_RICH_GRANULE_LUMEN,1
PID_HDAC_CLASSII_PATHWAY,SET,30,-0.25771,-0.010404,0.15545,0.95131,PID_HDAC_CLASSII_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...662,SET,26,-0.27296,-0.010259,0.16461,0.95135,GOBP_NEGATIVE_REGULATION_OF_TUMOR_NECROSIS_FACTOR_MEDIATED_SIGNALING_PATHWAY,1
GOBP_SYNAPTIC_TRANSMISSION_G...1,SET,56,-0.19707,-0.010862,0.11884,0.95136,GOBP_SYNAPTIC_TRANSMISSION_GABAERGIC,1
HP_ATTENTION_DEFICIT_HYPERAC...,SET,349,-0.074232,-0.010132,0.044763,0.95137,HP_ATTENTION_DEFICIT_HYPERACTIVITY_DISORDER,1
GOBP_TUBE_LUMEN_CAVITATION,SET,4,-0.76704,-0.011315,0.46246,0.95139,GOBP_TUBE_LUMEN_CAVITATION,1
DURANTE_ADULT_OLFACTORY_NEUR...21,SET,15,-0.38072,-0.010872,0.22954,0.9514,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_EPITHELIAL_CELLS,1
REACTOME_LOSS_OF_MECP2_BINDI...,SET,5,-0.56656,-0.0093436,0.34157,0.95141,REACTOME_LOSS_OF_MECP2_BINDING_ABILITY_TO_THE_NCOR_SMRT_COMPLEX,1
GOBP_CARTILAGE_MORPHOGENESIS,SET,9,-0.54091,-0.011967,0.32608,0.95142,GOBP_CARTILAGE_MORPHOGENESIS,1
HP_THICK_EYEBROW,SET,134,-0.12335,-0.010494,0.074357,0.95143,HP_THICK_EYEBROW,1
REACTOME_CHEMOKINE_RECEPTORS...,SET,54,-0.22823,-0.012353,0.13757,0.95144,REACTOME_CHEMOKINE_RECEPTORS_BIND_CHEMOKINES,1
GSE17721_LPS_VS_POLYIC_0.5H_...1,SET,182,-0.10058,-0.0099593,0.06062,0.95145,GSE17721_LPS_VS_POLYIC_0.5H_BMDC_DN,1
HP_AQUEDUCTAL_STENOSIS,SET,21,-0.2706,-0.0091417,0.16306,0.95148,HP_AQUEDUCTAL_STENOSIS,1
GSE40068_CXCR5NEG_BCL6NEG_CD...1,SET,183,-0.10427,-0.010353,0.062833,0.95148,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_DN,1
GOBP_ACTIN_FILAMENT_BASED_TR...,SET,10,-0.4162,-0.0097056,0.25078,0.95149,GOBP_ACTIN_FILAMENT_BASED_TRANSPORT,1
MIR6782_3P,SET,79,-0.15527,-0.010158,0.093551,0.95151,MIR6782_3P,1
DURANTE_ADULT_OLFACTORY_NEUR...16,SET,47,-0.22239,-0.011232,0.13395,0.95156,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_MICROVILLAR_CELLS,1
GSE40666_UNTREATED_VS_IFNA_S...1,SET,174,-0.098765,-0.0095642,0.059478,0.95159,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_DN,1
GOMF_SODIUM_CHANNEL_INHIBITO...,SET,8,-0.56791,-0.011846,0.34197,0.9516,GOMF_SODIUM_CHANNEL_INHIBITOR_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_TBK1_...,SET,10,-0.43837,-0.010223,0.26396,0.95161,KEGG_MEDICUS_REFERENCE_TBK1_MEDIATED_AUTOPHAGOSOME_FORMATION,1
HP_ACANTHOCYTOSIS,SET,10,-0.43073,-0.010044,0.25932,0.95164,HP_ACANTHOCYTOSIS,1
KLEIN_PRIMARY_EFFUSION_LYMPH...2,SET,46,-0.19783,-0.009885,0.1191,0.95165,KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP,1
GOBP_REGULATION_OF_PLASMA_ME...1,SET,16,-0.34812,-0.010267,0.20954,0.95168,GOBP_REGULATION_OF_PLASMA_MEMBRANE_ORGANIZATION,1
GOMF_G_PROTEIN_COUPLED_CHEMO...,SET,24,-0.32879,-0.011874,0.1979,0.95168,GOMF_G_PROTEIN_COUPLED_CHEMOATTRACTANT_RECEPTOR_ACTIVITY,1
REACTOME_INTERLEUKIN_36_PATH...,SET,7,-0.82027,-0.016005,0.49361,0.95171,REACTOME_INTERLEUKIN_36_PATHWAY,1
HP_ABNORMAL_CIRCULATING_SULF...,SET,23,-0.29915,-0.010576,0.17998,0.95175,HP_ABNORMAL_CIRCULATING_SULFUR_AMINO_ACID_CONCENTRATION,1
GSE360_L_MAJOR_VS_B_MALAYI_L...3,SET,177,-0.1011,-0.0098738,0.060808,0.9518,GSE360_L_MAJOR_VS_B_MALAYI_LOW_DOSE_MAC_DN,1
MIR8056,SET,40,-0.22111,-0.010304,0.13295,0.95185,MIR8056,1
GTTNYYNNGGTNA_UNKNOWN,SET,80,-0.15271,-0.010053,0.091818,0.95186,GTTNYYNNGGTNA_UNKNOWN,1
GSE40184_HEALTHY_VS_HCV_INFE...2,SET,178,-0.10268,-0.010056,0.061732,0.95187,GSE40184_HEALTHY_VS_HCV_INFECTED_DONOR_PBMC_UP,1
GOMF_PHOSPHATIDATE_PHOSPHATA...,SET,3,-0.78959,-0.010087,0.4746,0.9519,GOMF_PHOSPHATIDATE_PHOSPHATASE_ACTIVITY,1
ZNF560_TARGET_GENES,SET,42,-0.21265,-0.010154,0.12782,0.95191,ZNF560_TARGET_GENES,1
GOBP_CELL_PROJECTION_MORPHOG...,SET,614,-0.059714,-0.010731,0.035888,0.95192,GOBP_CELL_PROJECTION_MORPHOGENESIS,1
GOBP_REGULATION_OF_LONG_CHAI...1,SET,6,-0.56483,-0.010204,0.33944,0.95194,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_BROWN_FAT_CELL_DIFFEREN...,SET,50,-0.20346,-0.010598,0.12225,0.95196,GOBP_BROWN_FAT_CELL_DIFFERENTIATION,1
HP_LARYNGEAL_STENOSIS,SET,14,-0.42474,-0.011718,0.25521,0.95196,HP_LARYNGEAL_STENOSIS,1
GSE34156_NOD2_LIGAND_VS_NOD2...1,SET,158,-0.10751,-0.0099253,0.064601,0.95196,GSE34156_NOD2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN,1
MIR2113,SET,234,-0.095052,-0.010657,0.05711,0.95197,MIR2113,1
GOBP_HEMATOPOIETIC_STEM_CELL...5,SET,31,-0.24091,-0.0098857,0.14475,0.95197,GOBP_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
GOBP_ORGANOPHOSPHATE_CATABOL...,SET,222,-0.09327,-0.010189,0.056009,0.95206,GOBP_ORGANOPHOSPHATE_CATABOLIC_PROCESS,1
HP_MEDIAN_CLEFT_UPPER_LIP,SET,32,-0.2395,-0.0099849,0.14382,0.95206,HP_MEDIAN_CLEFT_UPPER_LIP,1
GOMF_COPPER_CHAPERONE_ACTIVI...,SET,6,-0.44705,-0.008076,0.26843,0.95207,GOMF_COPPER_CHAPERONE_ACTIVITY,1
HP_ABNORMAL_CIRCULATING_ORNI...,SET,5,-0.67739,-0.011171,0.40676,0.95207,HP_ABNORMAL_CIRCULATING_ORNITHINE_CONCENTRATION,1
GOMF_SUMO_TRANSFERASE_ACTIVI...,SET,24,-0.30457,-0.010999,0.18283,0.95211,GOMF_SUMO_TRANSFERASE_ACTIVITY,1
HP_METAPHYSEAL_WIDENING,SET,89,-0.14662,-0.010178,0.08802,0.95211,HP_METAPHYSEAL_WIDENING,1
REACTOME_RHOU_GTPASE_CYCLE,SET,37,-0.21988,-0.0098559,0.13197,0.95215,REACTOME_RHOU_GTPASE_CYCLE,1
GOBP_POSITIVE_REGULATION_OF_...563,SET,44,-0.22709,-0.011098,0.13628,0.95217,GOBP_POSITIVE_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
GSE39556_UNTREATED_VS_3H_POL...2,SET,180,-0.11081,-0.010912,0.066497,0.95217,GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_UP,1
ZHONG_PFC_C1_OPC,SET,218,-0.092858,-0.010053,0.055723,0.95218,ZHONG_PFC_C1_OPC,1
GOBP_URETER_MORPHOGENESIS,SET,7,-0.49628,-0.0096834,0.29778,0.95219,GOBP_URETER_MORPHOGENESIS,1
GOBP_VESICLE_DOCKING_INVOLVE...,SET,35,-0.23177,-0.010105,0.13906,0.95221,GOBP_VESICLE_DOCKING_INVOLVED_IN_EXOCYTOSIS,1
HP_ABNORMAL_PAROTID_GLAND_MO...,SET,8,-0.51099,-0.010659,0.30648,0.95226,HP_ABNORMAL_PAROTID_GLAND_MORPHOLOGY,1
REACTOME_INTRAFLAGELLAR_TRAN...,SET,44,-0.21737,-0.010623,0.13033,0.95232,REACTOME_INTRAFLAGELLAR_TRANSPORT,1
GSE7768_OVA_ALONE_VS_OVA_WIT...1,SET,158,-0.11481,-0.010599,0.068834,0.95232,GSE7768_OVA_ALONE_VS_OVA_WITH_LPS_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_DN,1
GOBP_DNA_REPLICATION_DEPENDE...,SET,6,-0.44784,-0.0080904,0.26843,0.95237,GOBP_DNA_REPLICATION_DEPENDENT_CHROMATIN_ASSEMBLY,1
GOBP_PURINE_NUCLEOBASE_BIOSY...,SET,8,-0.47298,-0.0098658,0.28347,0.95239,GOBP_PURINE_NUCLEOBASE_BIOSYNTHETIC_PROCESS,1
BROWNE_HCMV_INFECTION_30MIN_...2,SET,47,-0.21381,-0.010798,0.12812,0.95241,BROWNE_HCMV_INFECTION_30MIN_UP,1
MIR3918,SET,83,-0.14622,-0.009804,0.087623,0.95241,MIR3918,1
HP_INCREASED_SERUM_SEROTONIN,SET,9,-0.43289,-0.0095769,0.25934,0.95245,HP_INCREASED_SERUM_SEROTONIN,1
IWANAGA_CARCINOGENESIS_BY_KR...3,SET,169,-0.10558,-0.010078,0.063246,0.95247,IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP,1
HP_PROFOUND_HEARING_IMPAIRME...,SET,10,-0.47923,-0.011175,0.28706,0.95248,HP_PROFOUND_HEARING_IMPAIRMENT,1
REACTOME_BASE_EXCISION_REPAIR,SET,44,-0.19006,-0.0092883,0.1138,0.95254,REACTOME_BASE_EXCISION_REPAIR,1
GSE19401_PLN_VS_PEYERS_PATCH...2,SET,171,-0.1076,-0.01033,0.064406,0.9526,GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_UP,1
HE_LIM_SUN_FETAL_LUNG_C0_MYO...3,SET,22,-0.33982,-0.01175,0.20334,0.95265,HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_3_CELL,1
GOBP_NEGATIVE_REGULATION_OF_...331,SET,21,-0.34153,-0.011538,0.20434,0.95266,GOBP_NEGATIVE_REGULATION_OF_KERATINOCYTE_PROLIFERATION,1
HP_OPHTHALMOPARESIS,SET,244,-0.08722,-0.0099827,0.052187,0.95266,HP_OPHTHALMOPARESIS,1
GSE5589_LPS_AND_IL10_VS_LPS_...6,SET,180,-0.099753,-0.0098235,0.059688,0.95266,GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_UP,1
GOBP_POSITIVE_REGULATION_OF_...734,SET,41,-0.2342,-0.011049,0.1401,0.9527,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,1
REACTOME_PTK6_REGULATES_RTKS...,SET,8,-0.53454,-0.01115,0.31973,0.95271,REACTOME_PTK6_REGULATES_RTKS_AND_THEIR_EFFECTORS_AKT1_AND_DOK1,1
WP_PANCREATIC_CANCER_SUBTYPES,SET,46,-0.22848,-0.011416,0.13667,0.95271,WP_PANCREATIC_CANCER_SUBTYPES,1
GSE7348_LPS_VS_TOLERIZED_AND...2,SET,170,-0.10393,-0.0099494,0.062166,0.95271,GSE7348_LPS_VS_TOLERIZED_AND_LPS_STIM_MACROPHAGE_UP,1
REACTOME_FGFR1C_LIGAND_BINDI...,SET,13,-0.43692,-0.011616,0.26131,0.95273,REACTOME_FGFR1C_LIGAND_BINDING_AND_ACTIVATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...52,SET,30,-0.25509,-0.010298,0.15257,0.95273,HP_APLASIA_HYPOPLASIA_OF_THE_PATELLA,1
GOBP_RESPONSE_TO_AXON_INJURY,SET,79,-0.16346,-0.010694,0.097753,0.95275,GOBP_RESPONSE_TO_AXON_INJURY,1
GOBP_EATING_BEHAVIOR,SET,37,-0.25314,-0.011347,0.15137,0.95276,GOBP_EATING_BEHAVIOR,1
MIR4258,SET,5,-0.64278,-0.010601,0.38426,0.95281,MIR4258,1
REACTOME_CHOLINE_CATABOLISM,SET,6,-0.63867,-0.011538,0.38175,0.95283,REACTOME_CHOLINE_CATABOLISM,1
GSE17721_LPS_VS_POLYIC_4H_BM...2,SET,184,-0.10009,-0.0099644,0.059822,0.95284,GSE17721_LPS_VS_POLYIC_4H_BMDC_UP,1
GOBP_CELLULAR_RESPONSE_TO_L_...1,SET,6,-0.5676,-0.010254,0.33922,0.95285,GOBP_CELLULAR_RESPONSE_TO_L_GLUTAMATE,1
HP_POSTERIOR_STAPHYLOMA,SET,7,-0.61032,-0.011909,0.36472,0.95287,HP_POSTERIOR_STAPHYLOMA,1
GOBP_NEGATIVE_REGULATION_OF_...242,SET,16,-0.38581,-0.011378,0.23048,0.95292,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...230,SET,8,-0.52881,-0.01103,0.31584,0.95296,GOBP_POSITIVE_REGULATION_OF_EARLY_ENDOSOME_TO_LATE_ENDOSOME_TRANSPORT,1
CHIBA_RESPONSE_TO_TSA_UP,SET,48,-0.21991,-0.011224,0.13133,0.95297,CHIBA_RESPONSE_TO_TSA_UP,1
MORF_PRKCA,SET,154,-0.11623,-0.010595,0.069413,0.95297,MORF_PRKCA,1
GOBP_REGULATION_OF_VERY_LOW_...2,SET,6,-0.61591,-0.011127,0.36781,0.95298,GOBP_REGULATION_OF_VERY_LOW_DENSITY_LIPOPROTEIN_PARTICLE_REMODELING,1
GSE19401_NAIVE_VS_IMMUNIZED_...1,SET,181,-0.10419,-0.010289,0.062217,0.95299,GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_DN,1
GAVISH_3CA_METAPROGRAM_EPITH...24,SET,44,-0.21888,-0.010697,0.1306,0.95312,GAVISH_3CA_METAPROGRAM_EPITHELIAL_V_ATPASE,1
GOBP_POSITIVE_REGULATION_OF_...784,SET,5,-0.69156,-0.011405,0.41252,0.95317,GOBP_POSITIVE_REGULATION_OF_TRANSMISSION_OF_NERVE_IMPULSE,1
HP_ECTROPION_OF_LOWER_EYELIDS,SET,7,-0.43072,-0.0084042,0.25688,0.95319,HP_ECTROPION_OF_LOWER_EYELIDS,1
CCAWWNAAGG_SRF_Q4,SET,77,-0.17171,-0.011091,0.10239,0.95322,CCAWWNAAGG_SRF_Q4,1
GOBP_NUCLEOSIDE_PHOSPHATE_BI...,SET,232,-0.090095,-0.010058,0.053724,0.95322,GOBP_NUCLEOSIDE_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
GSE15750_DAY6_VS_DAY10_TRAF6...1,SET,183,-0.099695,-0.0098984,0.059449,0.95322,GSE15750_DAY6_VS_DAY10_TRAF6KO_EFF_CD8_TCELL_DN,1
GOBP_CO_TRANSCRIPTIONAL_RNA_...,SET,10,-0.38315,-0.008935,0.22845,0.95324,GOBP_CO_TRANSCRIPTIONAL_RNA_3_END_PROCESSING_CLEAVAGE_AND_POLYADENYLATION_PATHWAY,1
GOBP_NEGATIVE_REGULATION_OF_...147,SET,49,-0.18909,-0.0097506,0.11271,0.95329,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_SEGREGATION,1
KEGG_MEDICUS_REFERENCE_OKAZA...,SET,11,-0.38212,-0.0093455,0.22775,0.9533,KEGG_MEDICUS_REFERENCE_OKAZAKI_FRAGMENT_MATURATION,1
GOBP_ACYLGLYCEROL_TRANSPORT,SET,6,-0.52911,-0.0095585,0.31529,0.95334,GOBP_ACYLGLYCEROL_TRANSPORT,1
REACTOME_SARS_COV_2_MODULATE...1,SET,11,-0.37335,-0.0091311,0.22244,0.95336,REACTOME_SARS_COV_2_MODULATES_AUTOPHAGY,1
HP_ABNORMAL_SHARPEY_FIBER_MO...,SET,31,-0.29005,-0.011902,0.17279,0.95338,HP_ABNORMAL_SHARPEY_FIBER_MORPHOLOGY,1
GOMF_MOLECULAR_TRANSDUCER_AC...,SET,1299,-0.046806,-0.011996,0.02788,0.9534,GOMF_MOLECULAR_TRANSDUCER_ACTIVITY,1
NFKB_Q6_01,SET,223,-0.094337,-0.010328,0.056179,0.95344,NFKB_Q6_01,1
HP_ASTERIXIS,SET,5,-0.69262,-0.011422,0.41234,0.95348,HP_ASTERIXIS,1
GSE17721_CPG_VS_GARDIQUIMOD_...18,SET,179,-0.10271,-0.010087,0.061146,0.95349,GSE17721_CPG_VS_GARDIQUIMOD_8H_BMDC_UP,1
MULLIGHAN_NPM1_MUTATED_SIGNA...1,SET,110,-0.12965,-0.01,0.077131,0.9536,MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_DN,1
HP_ARRHINENCEPHALY,SET,30,-0.24656,-0.0099533,0.14661,0.95368,HP_ARRHINENCEPHALY,1
XU_HGF_TARGETS_INDUCED_BY_AK...1,SET,21,-0.33573,-0.011342,0.19956,0.95374,XU_HGF_TARGETS_INDUCED_BY_AKT1_48HR_DN,1
HP_REDUCED_CONSCIOUSNESS,SET,206,-0.098323,-0.010351,0.058435,0.95377,HP_REDUCED_CONSCIOUSNESS,1
GOBP_ERYTHROSE_4_PHOSPHATE_P...,SET,17,-0.37848,-0.011506,0.22491,0.95379,GOBP_ERYTHROSE_4_PHOSPHATE_PHOSPHOENOLPYRUVATE_FAMILY_AMINO_ACID_METABOLIC_PROCESS,1
GOBP_TYROSINE_CATABOLIC_PROC...,SET,6,-0.62059,-0.011211,0.36876,0.95379,GOBP_TYROSINE_CATABOLIC_PROCESS,1
HP_JOINT_CONTRACTURE_OF_THE_...1,SET,7,-0.56107,-0.010948,0.33328,0.95385,HP_JOINT_CONTRACTURE_OF_THE_4TH_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...615,SET,25,-0.29122,-0.010733,0.17293,0.9539,GOBP_NEGATIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
MIR3654,SET,43,-0.20838,-0.010067,0.12373,0.95391,MIR3654,1
MCLACHLAN_DENTAL_CARIES_DN,SET,70,-0.17951,-0.011057,0.10658,0.95393,MCLACHLAN_DENTAL_CARIES_DN,1
NAGY_STAGA_COMPONENTS_HUMAN,SET,13,-0.34688,-0.0092222,0.2059,0.95396,NAGY_STAGA_COMPONENTS_HUMAN,1
REACTOME_ADHERENS_JUNCTIONS_...,SET,51,-0.2199,-0.011568,0.13051,0.95399,REACTOME_ADHERENS_JUNCTIONS_INTERACTIONS,1
HP_PULMONARY_INTERSTITIAL_HI...,SET,21,-0.3271,-0.01105,0.19412,0.954,HP_PULMONARY_INTERSTITIAL_HIGH_RESOLUTION_COMPUTED_TOMOGRAPHY_ABNORMALITY,1
GOBP_NEGATIVE_REGULATION_OF_...684,SET,46,-0.1932,-0.0096536,0.11464,0.95403,GOBP_NEGATIVE_REGULATION_OF_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
WP_NEUROGENESIS_REGULATION_I...,SET,55,-0.20439,-0.011164,0.12127,0.95404,WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM,1
GOBP_REGULATION_OF_AMINO_ACI...2,SET,40,-0.24493,-0.011414,0.1453,0.95407,GOBP_REGULATION_OF_AMINO_ACID_TRANSPORT,1
GOBP_TISSUE_MIGRATION,SET,295,-0.086696,-0.010895,0.051414,0.95411,GOBP_TISSUE_MIGRATION,1
chr15q12,SET,4,-0.87534,-0.012912,0.5191,0.95412,chr15q12,1
GOBP_NEGATIVE_REGULATION_OF_...266,SET,17,-0.36278,-0.011028,0.21511,0.95414,GOBP_NEGATIVE_REGULATION_OF_GTPASE_ACTIVITY,1
KEGG_MEDICUS_REFERENCE_CROSS...,SET,15,-0.38009,-0.010854,0.22527,0.95421,KEGG_MEDICUS_REFERENCE_CROSSTALK_BETWEEN_EXTRINSIC_AND_INTRINSIC_APOPTOTIC_PATHWAYS,1
HP_SMALL_NAIL,SET,157,-0.11298,-0.010398,0.066949,0.95425,HP_SMALL_NAIL,1
GOBP_NEGATIVE_REGULATION_OF_...268,SET,5,-0.63889,-0.010536,0.37855,0.95426,GOBP_NEGATIVE_REGULATION_OF_HAIR_FOLLICLE_DEVELOPMENT,1
GOCC_LIPID_DROPLET,SET,91,-0.15353,-0.010777,0.090972,0.95426,GOCC_LIPID_DROPLET,1
GOBP_VITAMIN_D_METABOLIC_PRO...,SET,21,-0.31431,-0.010618,0.18618,0.95431,GOBP_VITAMIN_D_METABOLIC_PROCESS,1
REACTOME_PI_3K_CASCADE_FGFR2,SET,22,-0.32494,-0.011236,0.19246,0.95432,REACTOME_PI_3K_CASCADE_FGFR2,1
HP_APLASIA_HYPOPLASIA_OF_THE...14,SET,269,-0.083366,-0.010012,0.049371,0.95434,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLAR_VERMIS,1
HP_PITUITARY_PROLACTIN_CELL_...,SET,7,-0.51235,-0.0099971,0.30338,0.95436,HP_PITUITARY_PROLACTIN_CELL_ADENOMA,1
MIR4469,SET,104,-0.14017,-0.010514,0.082946,0.95446,MIR4469,1
CHUANG_OXIDATIVE_STRESS_RESP...2,SET,26,-0.2916,-0.01096,0.17255,0.95447,CHUANG_OXIDATIVE_STRESS_RESPONSE_UP,1
GOMF_METALLOEXOPEPTIDASE_ACT...,SET,63,-0.20038,-0.011712,0.11857,0.95447,GOMF_METALLOEXOPEPTIDASE_ACTIVITY,1
GOBP_CELLULAR_RESPONSE_TO_UV...3,SET,4,-0.5858,-0.0086412,0.34655,0.95451,GOBP_CELLULAR_RESPONSE_TO_UV_C,1
GOBP_NEGATIVE_REGULATION_OF_...404,SET,5,-0.75287,-0.012416,0.44541,0.95451,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
YORDY_RECIPROCAL_REGULATION_...1,SET,63,-0.19528,-0.011414,0.1155,0.95454,YORDY_RECIPROCAL_REGULATION_BY_ETS1_AND_SP100_DN,1
GOBP_NEGATIVE_REGULATION_OF_...166,SET,135,-0.12089,-0.010323,0.071484,0.95459,GOBP_NEGATIVE_REGULATION_OF_CYTOSKELETON_ORGANIZATION,1
GSE27786_BCELL_VS_MONO_MAC_DN,SET,180,-0.10487,-0.010327,0.061992,0.95463,GSE27786_BCELL_VS_MONO_MAC_DN,1
LEE_CALORIE_RESTRICTION_MUSC...1,SET,41,-0.20295,-0.0095751,0.11992,0.95471,LEE_CALORIE_RESTRICTION_MUSCLE_DN,1
GOBP_HINDBRAIN_RADIAL_GLIA_G...,SET,8,-0.5843,-0.012188,0.34513,0.95476,GOBP_HINDBRAIN_RADIAL_GLIA_GUIDED_CELL_MIGRATION,1
KTGGYRSGAA_UNKNOWN,SET,68,-0.16729,-0.010157,0.098805,0.95477,KTGGYRSGAA_UNKNOWN,1
GOBP_MONOCYTE_CHEMOTACTIC_PR...,SET,18,-0.39393,-0.012322,0.23268,0.95477,GOBP_MONOCYTE_CHEMOTACTIC_PROTEIN_1_PRODUCTION,1
GSE27092_WT_VS_HDAC7_PHOSPHO...1,SET,186,-0.10065,-0.010074,0.059431,0.95482,GSE27092_WT_VS_HDAC7_PHOSPHO_DEFICIENT_CD8_TCELL_DN,1
GOMF_CORTICOTROPIN_RELEASING...,SET,5,-0.67375,-0.011111,0.39777,0.95484,GOMF_CORTICOTROPIN_RELEASING_HORMONE_RECEPTOR_BINDING,1
WP_PENTOSE_PHOSPHATE_METABOL...,SET,6,-0.61237,-0.011063,0.3615,0.95486,WP_PENTOSE_PHOSPHATE_METABOLISM,1
HP_CONTRACTURE_OF_THE_PROXIM...2,SET,5,-0.62365,-0.010285,0.36799,0.95493,HP_CONTRACTURE_OF_THE_PROXIMAL_INTERPHALANGEAL_JOINT_OF_THE_4TH_FINGER,1
GOBP_METANEPHRIC_EPITHELIUM_...,SET,27,-0.30912,-0.011839,0.18238,0.95495,GOBP_METANEPHRIC_EPITHELIUM_DEVELOPMENT,1
GOBP_TETRAHYDROBIOPTERIN_MET...,SET,8,-0.47382,-0.0098832,0.27948,0.95499,GOBP_TETRAHYDROBIOPTERIN_METABOLIC_PROCESS,1
GOMF_METALLOCARBOXYPEPTIDASE...,SET,29,-0.29979,-0.011899,0.17683,0.95499,GOMF_METALLOCARBOXYPEPTIDASE_ACTIVITY,1
HP_ABNORMAL_DIGESTIVE_SYSTEM...,SET,923,-0.048218,-0.010531,0.028439,0.955,HP_ABNORMAL_DIGESTIVE_SYSTEM_MORPHOLOGY,1
GSE43955_TH0_VS_TGFB_IL6_TH1...13,SET,184,-0.10941,-0.010892,0.064531,0.955,GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN,1
GOMF_S_ADENOSYL_L_METHIONINE...,SET,16,-0.32125,-0.0094746,0.18946,0.95502,GOMF_S_ADENOSYL_L_METHIONINE_BINDING,1
MIR3928_5P,SET,94,-0.14993,-0.010695,0.088397,0.95505,MIR3928_5P,1
HP_ADRENOCORTICOTROPIN_DEFIC...,SET,6,-0.5735,-0.01036,0.33815,0.95505,HP_ADRENOCORTICOTROPIN_DEFICIENT_ADRENAL_INSUFFICIENCY,1
GOBP_DIGESTIVE_SYSTEM_PROCESS,SET,102,-0.14916,-0.011081,0.08794,0.95506,GOBP_DIGESTIVE_SYSTEM_PROCESS,1
MIR4688,SET,44,-0.19911,-0.0097307,0.11738,0.95507,MIR4688,1
HEIDENBLAD_AMPLIFIED_IN_BONE...,SET,7,-0.60893,-0.011882,0.35895,0.95509,HEIDENBLAD_AMPLIFIED_IN_BONE_CANCER,1
GOBP_CYCLIC_NUCLEOTIDE_CATAB...,SET,14,-0.38297,-0.010566,0.22575,0.95509,GOBP_CYCLIC_NUCLEOTIDE_CATABOLIC_PROCESS,1
KEGG_N_GLYCAN_BIOSYNTHESIS,SET,44,-0.20595,-0.010065,0.12135,0.95516,KEGG_N_GLYCAN_BIOSYNTHESIS,1
HP_ABNORMAL_CORNEA_MORPHOLOGY,SET,640,-0.057326,-0.01051,0.033773,0.95518,HP_ABNORMAL_CORNEA_MORPHOLOGY,1
GOBP_ESTROUS_CYCLE,SET,16,-0.35226,-0.010389,0.20752,0.95519,GOBP_ESTROUS_CYCLE,1
ZNF37A_TARGET_GENES,SET,116,-0.13438,-0.010642,0.079126,0.95527,ZNF37A_TARGET_GENES,1
chr1p35,SET,77,-0.33855,-0.021868,0.19925,0.95534,chr1p35,1
MIR491_3P,SET,108,-0.13766,-0.010522,0.081022,0.95534,MIR491_3P,1
GSE15930_NAIVE_VS_24H_IN_VIT...6,SET,187,-0.10556,-0.010593,0.062118,0.95536,GSE15930_NAIVE_VS_24H_IN_VITRO_STIM_INFAB_CD8_TCELL_UP,1
GOMF_1_PHOSPHATIDYLINOSITOL_...1,SET,10,-0.48609,-0.011335,0.28598,0.9554,GOMF_1_PHOSPHATIDYLINOSITOL_3_KINASE_ACTIVITY,1
GOBP_FAT_SOLUBLE_VITAMIN_CAT...,SET,12,-0.46351,-0.01184,0.27261,0.95545,GOBP_FAT_SOLUBLE_VITAMIN_CATABOLIC_PROCESS,1
MIR1976,SET,79,-0.16025,-0.010484,0.094244,0.95546,MIR1976,1
REACTOME_NEF_MEDIATED_DOWNRE...,SET,9,-0.43326,-0.0095853,0.25474,0.9555,REACTOME_NEF_MEDIATED_DOWNREGULATION_OF_MHC_CLASS_I_COMPLEX_CELL_SURFACE_EXPRESSION,1
KEGG_MEDICUS_VARIANT_MUTATIO...48,SET,6,-0.62153,-0.011228,0.36537,0.95553,KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TNF_JNK_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_L_ASCORBIC_...,SET,5,-0.72256,-0.011916,0.42473,0.95554,GOBP_RESPONSE_TO_L_ASCORBIC_ACID,1
WANG_TNF_TARGETS,SET,24,-0.31285,-0.011298,0.18389,0.95555,WANG_TNF_TARGETS,1
E2F_Q2,SET,170,-0.11256,-0.010776,0.066134,0.95562,E2F_Q2,1
YANG_BCL3_TARGETS_DN,SET,8,-0.52717,-0.010996,0.30971,0.95563,YANG_BCL3_TARGETS_DN,1
BUSSLINGER_ESOPHAGEAL_LATE_S...,SET,130,-0.13753,-0.011526,0.08078,0.95567,BUSSLINGER_ESOPHAGEAL_LATE_SUPRABASAL_CELLS,1
GSE8515_CTRL_VS_IL1_4H_STIM_...2,SET,177,-0.10758,-0.010507,0.063175,0.9557,GSE8515_CTRL_VS_IL1_4H_STIM_MAC_UP,1
KEGG_GLYCEROLIPID_METABOLISM,SET,41,-0.22927,-0.010817,0.13454,0.95581,KEGG_GLYCEROLIPID_METABOLISM,1
HP_APLASIA_HYPOPLASIA_OF_THE...13,SET,18,-0.37266,-0.011657,0.21865,0.95584,HP_APLASIA_HYPOPLASIA_OF_THE_CAPITAL_FEMORAL_EPIPHYSIS,1
HP_SCLERAL_STAPHYLOMA,SET,9,-0.50613,-0.011197,0.29693,0.95585,HP_SCLERAL_STAPHYLOMA,1
MIR615_3P,SET,6,-0.58299,-0.010532,0.3419,0.95591,MIR615_3P,1
GAVISH_3CA_METAPROGRAM_FIBRO...2,SET,49,-0.23567,-0.012152,0.13816,0.95597,GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_10,1
GOMF_INTERLEUKIN_1_RECEPTOR_...2,SET,17,-0.41248,-0.012539,0.2417,0.95604,GOMF_INTERLEUKIN_1_RECEPTOR_BINDING,1
HP_APLASIA_HYPOPLASIA_OF_THE...15,SET,459,-0.064954,-0.010136,0.03806,0.95604,HP_APLASIA_HYPOPLASIA_OF_THE_CEREBELLUM,1
GOBP_CELL_MOTILITY,SET,1578,-0.039203,-0.010983,0.02297,0.95605,GOBP_CELL_MOTILITY,1
KEGG_MEDICUS_REFERENCE_STRAD...,SET,8,-0.4969,-0.010365,0.29106,0.9561,KEGG_MEDICUS_REFERENCE_STRAD_STK11_TSC_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_ANTIMICRO...1,SET,11,-0.47097,-0.011519,0.27575,0.95617,GOBP_REGULATION_OF_ANTIMICROBIAL_HUMORAL_RESPONSE,1
HP_FOOD_INTOLERANCE,SET,9,-0.43118,-0.0095392,0.25245,0.95617,HP_FOOD_INTOLERANCE,1
GOCC_MICROTUBULE_ORGANIZING_...2,SET,10,-0.44648,-0.010412,0.26138,0.95619,GOCC_MICROTUBULE_ORGANIZING_CENTER_ATTACHMENT_SITE,1
HP_PALATE_FISTULA,SET,12,-0.45495,-0.011621,0.26627,0.95623,HP_PALATE_FISTULA,1
GSE41867_NAIVE_VS_DAY8_LCMV_...2,SET,179,-0.10662,-0.010471,0.062404,0.95623,GSE41867_NAIVE_VS_DAY8_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP,1
GOBP_FATTY_ACID_DERIVATIVE_B...,SET,43,-0.23577,-0.011391,0.13798,0.95624,GOBP_FATTY_ACID_DERIVATIVE_BIOSYNTHETIC_PROCESS,1
GOBP_METANEPHRIC_MESENCHYME_...,SET,13,-0.4519,-0.012014,0.26447,0.95624,GOBP_METANEPHRIC_MESENCHYME_DEVELOPMENT,1
HP_ACUTE_PANCREATITIS,SET,7,-0.58741,-0.011462,0.34377,0.95624,HP_ACUTE_PANCREATITIS,1
GOMF_PHOSPHORUS_OXYGEN_LYASE...,SET,20,-0.34355,-0.011327,0.201,0.95628,GOMF_PHOSPHORUS_OXYGEN_LYASE_ACTIVITY,1
HP_ELEVATED_HEMOGLOBIN_A1C,SET,26,-0.30976,-0.011642,0.18124,0.95628,HP_ELEVATED_HEMOGLOBIN_A1C,1
GOCC_PERIKARYON,SET,131,-0.13165,-0.011075,0.077019,0.95629,GOCC_PERIKARYON,1
HP_CHOROIDEREMIA,SET,6,-0.67405,-0.012177,0.39432,0.9563,HP_CHOROIDEREMIA,1
WP_THYROID_HORMONES_PRODUCTI...,SET,90,-0.15284,-0.01067,0.089346,0.95642,WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS,1
GOBP_MYOFIBROBLAST_DIFFERENT...,SET,10,-0.46607,-0.010868,0.27243,0.95643,GOBP_MYOFIBROBLAST_DIFFERENTIATION,1
GSE13547_CTRL_VS_ANTI_IGM_ST...6,SET,126,-0.13134,-0.010838,0.076774,0.95643,GSE13547_CTRL_VS_ANTI_IGM_STIM_ZFX_KO_BCELL_12H_UP,1
MORF_MT4,SET,234,-0.093228,-0.010452,0.054482,0.95647,MORF_MT4,1
GOBP_RETROGRADE_VESICLE_MEDI...,SET,48,-0.18403,-0.0093926,0.10754,0.95648,GOBP_RETROGRADE_VESICLE_MEDIATED_TRANSPORT_GOLGI_TO_ENDOPLASMIC_RETICULUM,1
REACTOME_SYNTHESIS_OF_LIPOXI...,SET,6,-0.63577,-0.011485,0.37133,0.95656,REACTOME_SYNTHESIS_OF_LIPOXINS_LX,1
ALX4_01,SET,15,-0.40731,-0.011631,0.23782,0.9566,ALX4_01,1
BOYAULT_LIVER_CANCER_SUBCLAS...1,SET,45,-0.21847,-0.010797,0.12755,0.95661,BOYAULT_LIVER_CANCER_SUBCLASS_G123_DN,1
MISSIAGLIA_REGULATED_BY_METH...1,SET,107,-0.13038,-0.0099194,0.07612,0.95662,MISSIAGLIA_REGULATED_BY_METHYLATION_DN,1
MIR3190_3P,SET,109,-0.13496,-0.010363,0.078787,0.95663,MIR3190_3P,1
GSE14000_4H_VS_16H_LPS_DC_DN,SET,161,-0.10675,-0.0099478,0.062316,0.95665,GSE14000_4H_VS_16H_LPS_DC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...358,SET,8,-0.53635,-0.011188,0.31304,0.95667,GOBP_NEGATIVE_REGULATION_OF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_CLEARANCE,1
HP_LARGE_FONTANELLES,SET,151,-0.11988,-0.010821,0.069962,0.95668,HP_LARGE_FONTANELLES,1
GOBP_TOOTH_ERUPTION,SET,5,-0.69307,-0.01143,0.40442,0.9567,GOBP_TOOTH_ERUPTION,1
GOBP_MATURATION_OF_LSU_RRNA_...,SET,16,-0.31157,-0.009189,0.18179,0.95671,GOBP_MATURATION_OF_LSU_RRNA_FROM_TRICISTRONIC_RRNA_TRANSCRIPT_SSU_RRNA_5_8S_RRNA_LSU_RRNA,1
KEGG_MEDICUS_VARIANT_MUTATIO...71,SET,6,-0.56761,-0.010254,0.33117,0.95672,KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_DJ1_TO_FAS_JNK_SIGNALING_PATWHAY,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...1,SET,117,-0.14833,-0.011797,0.08648,0.95684,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL,1
HP_POSTERIOR_SYNECHIAE_OF_TH...,SET,10,-0.49489,-0.011541,0.2885,0.95685,HP_POSTERIOR_SYNECHIAE_OF_THE_ANTERIOR_CHAMBER,1
GOBP_NEGATIVE_REGULATION_OF_...280,SET,64,-0.19502,-0.011488,0.11366,0.95689,GOBP_NEGATIVE_REGULATION_OF_HORMONE_SECRETION,1
GSE16385_MONOCYTE_VS_12H_ROS...6,SET,171,-0.11233,-0.010784,0.065459,0.95691,GSE16385_MONOCYTE_VS_12H_ROSIGLITAZONE_TREATED_MACROPHAGE_UP,1
CYTAGCAAY_UNKNOWN,SET,135,-0.12332,-0.01053,0.071854,0.95694,CYTAGCAAY_UNKNOWN,1
GOBP_REGULATION_OF_I_KAPPAB_...,SET,7,-0.57735,-0.011265,0.33636,0.95695,GOBP_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
GSE17721_CPG_VS_GARDIQUIMOD_...8,SET,190,-0.10221,-0.010338,0.059546,0.95695,GSE17721_CPG_VS_GARDIQUIMOD_1H_BMDC_UP,1
GSE9988_ANTI_TREM1_VS_CTRL_T...1,SET,188,-0.10261,-0.010324,0.059779,0.95695,GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN,1
GOBP_REGULATION_OF_SYNAPSE_S...2,SET,231,-0.099673,-0.011104,0.058055,0.95699,GOBP_REGULATION_OF_SYNAPSE_STRUCTURE_OR_ACTIVITY,1
GOBP_FEAR_RESPONSE,SET,45,-0.24021,-0.011872,0.1399,0.957,GOBP_FEAR_RESPONSE,1
GOBP_REGULATION_OF_PROGRAMME...2,SET,27,-0.27658,-0.010593,0.16105,0.95704,GOBP_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,1
HP_FEMORAL_BOWING,SET,41,-0.23895,-0.011273,0.13911,0.95706,HP_FEMORAL_BOWING,1
HP_SPEECH_APRAXIA,SET,28,-0.26042,-0.010157,0.15159,0.95708,HP_SPEECH_APRAXIA,1
GOBP_NEGATIVE_REGULATION_OF_...205,SET,13,-0.39028,-0.010376,0.22715,0.95711,GOBP_NEGATIVE_REGULATION_OF_EPIDERMAL_GROWTH_FACTOR_ACTIVATED_RECEPTOR_ACTIVITY,1
BIOCARTA_FAS_PATHWAY,SET,30,-0.28263,-0.011409,0.16446,0.95714,BIOCARTA_FAS_PATHWAY,1
REACTOME_INTRACELLULAR_SIGNA...,SET,300,-0.082895,-0.010504,0.048235,0.95715,REACTOME_INTRACELLULAR_SIGNALING_BY_SECOND_MESSENGERS,1
GOBP_REGULATION_OF_AEROBIC_R...,SET,27,-0.2585,-0.0099006,0.15039,0.95717,GOBP_REGULATION_OF_AEROBIC_RESPIRATION,1
MIR431_5P,SET,49,-0.19618,-0.010116,0.11412,0.9572,MIR431_5P,1
ICHIBA_GRAFT_VERSUS_HOST_DIS...1,SET,51,-0.21504,-0.011312,0.12506,0.95722,ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_DN,1
GOBP_NEGATIVE_REGULATION_OF_...437,SET,11,-0.44938,-0.010991,0.26136,0.95722,GOBP_NEGATIVE_REGULATION_OF_NEUROBLAST_PROLIFERATION,1
HP_ANKYLOBLEPHARON,SET,13,-0.344,-0.0091456,0.20006,0.95723,HP_ANKYLOBLEPHARON,1
HP_HYDROCEPHALUS,SET,351,-0.075278,-0.010303,0.043774,0.95725,HP_HYDROCEPHALUS,1
GOBP_AMP_METABOLIC_PROCESS,SET,20,-0.32963,-0.010868,0.19163,0.95729,GOBP_AMP_METABOLIC_PROCESS,1
FAN_EMBRYONIC_CTX_OPC,SET,48,-0.23529,-0.012009,0.13679,0.95729,FAN_EMBRYONIC_CTX_OPC,1
GSE29164_UNTREATED_VS_CD8_TC...6,SET,175,-0.10502,-0.010199,0.061044,0.95731,GSE29164_UNTREATED_VS_CD8_TCELL_TREATED_MELANOMA_DAY3_UP,1
MIR1261,SET,76,-0.16387,-0.010516,0.095244,0.95732,MIR1261,1
MIR4692,SET,202,-0.10335,-0.010775,0.060051,0.95737,MIR4692,1
GOBP_MITOCHONDRIAL_TRANSCRIP...,SET,19,-0.29725,-0.0095523,0.17271,0.95737,GOBP_MITOCHONDRIAL_TRANSCRIPTION,1
HP_NEOPLASM_OF_THE_SKIN,SET,198,-0.099744,-0.010297,0.057956,0.95737,HP_NEOPLASM_OF_THE_SKIN,1
GOMF_CORE_PROMOTER_SEQUENCE_...,SET,35,-0.24687,-0.010763,0.14342,0.95739,GOMF_CORE_PROMOTER_SEQUENCE_SPECIFIC_DNA_BINDING,1
REACTOME_DEFECTIVE_LFNG_CAUS...,SET,5,-0.69647,-0.011486,0.40442,0.95747,REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3,1
HP_GINGIVAL_FIBROMATOSIS,SET,22,-0.31671,-0.010951,0.18388,0.95748,HP_GINGIVAL_FIBROMATOSIS,1
GOMF_HEXOKINASE_ACTIVITY,SET,5,-0.737,-0.012154,0.42791,0.95749,GOMF_HEXOKINASE_ACTIVITY,1
HP_TIBIAL_BOWING,SET,33,-0.27709,-0.011731,0.16083,0.95753,HP_TIBIAL_BOWING,1
TRAVAGLINI_LUNG_NEUROENDOCRI...,SET,114,-0.14595,-0.011459,0.084703,0.95756,TRAVAGLINI_LUNG_NEUROENDOCRINE_CELL,1
REACTOME_CAMK_IV_MEDIATED_PH...,SET,10,-0.52005,-0.012127,0.30174,0.95759,REACTOME_CAMK_IV_MEDIATED_PHOSPHORYLATION_OF_CREB,1
GOBP_CHROMOSOME_SEPARATION,SET,78,-0.15522,-0.010091,0.090055,0.9576,GOBP_CHROMOSOME_SEPARATION,1
MATZUK_EARLY_ANTRAL_FOLLICLE,SET,12,-0.46527,-0.011885,0.26991,0.95762,MATZUK_EARLY_ANTRAL_FOLLICLE,1
HP_INCREASED_CUP_TO_DISC_RAT...,SET,8,-0.59255,-0.01236,0.34369,0.95765,HP_INCREASED_CUP_TO_DISC_RATIO,1
GSE26495_NAIVE_VS_PD1HIGH_CD...1,SET,181,-0.11139,-0.011,0.064589,0.9577,GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_DN,1
GOBP_MACROPHAGE_COLONY_STIMU...1,SET,6,-0.6052,-0.010933,0.35088,0.95771,GOBP_MACROPHAGE_COLONY_STIMULATING_FACTOR_PRODUCTION,1
HP_MANDIBULAR_APLASIA,SET,10,-0.42251,-0.0098527,0.24495,0.95771,HP_MANDIBULAR_APLASIA,1
GSE14415_INDUCED_TREG_VS_TCO...1,SET,146,-0.12093,-0.010736,0.070109,0.95772,GSE14415_INDUCED_TREG_VS_TCONV_DN,1
MOREAUX_B_LYMPHOCYTE_MATURAT...2,SET,72,-0.18185,-0.01136,0.10541,0.95774,MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_UP,1
RTAAACA_FREAC2_01,SET,846,-0.053542,-0.01122,0.031036,0.95774,RTAAACA_FREAC2_01,1
GOCC_ASTROCYTE_END_FOOT,SET,11,-0.47245,-0.011555,0.27384,0.95775,GOCC_ASTROCYTE_END_FOOT,1
HP_HYDROXYPROLINURIA,SET,9,-0.59439,-0.01315,0.34453,0.95775,HP_HYDROXYPROLINURIA,1
HP_RETINAL_DEGENERATION,SET,261,-0.0886,-0.010483,0.051337,0.9578,HP_RETINAL_DEGENERATION,1
GSE17974_0.5H_VS_72H_IL4_AND...1,SET,175,-0.10324,-0.010026,0.059819,0.95781,GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...165,SET,9,-0.47453,-0.010498,0.2749,0.95783,GOBP_NEGATIVE_REGULATION_OF_CYTOPLASMIC_TRANSLATION,1
HP_PROFOUND_SENSORINEURAL_HE...,SET,9,-0.52561,-0.011628,0.30448,0.95784,HP_PROFOUND_SENSORINEURAL_HEARING_IMPAIRMENT,1
HP_HYPOCHROMIA,SET,13,-0.40445,-0.010753,0.23424,0.95787,HP_HYPOCHROMIA,1
GOBP_REGULATION_OF_SYSTEMIC_...7,SET,4,-0.84091,-0.012404,0.48696,0.9579,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE_BY_VASOPRESSIN,1
MODULE_367,SET,28,-0.29198,-0.011388,0.16903,0.95794,MODULE_367,1
HE_LIM_SUN_FETAL_LUNG_C2_SPP...,SET,44,-0.23073,-0.011276,0.13357,0.95795,HE_LIM_SUN_FETAL_LUNG_C2_SPP1_POS_MACROPHAGE_CELL,1
AP2GAMMA_01,SET,234,-0.093534,-0.010487,0.054133,0.95798,AP2GAMMA_01,1
HP_TRANSIENT_GLOBAL_AMNESIA,SET,20,-0.32661,-0.010768,0.18901,0.958,HP_TRANSIENT_GLOBAL_AMNESIA,1
HP_CARIOUS_TEETH,SET,147,-0.1215,-0.010823,0.070302,0.95803,HP_CARIOUS_TEETH,1
GOBP_POSITIVE_REGULATION_OF_...309,SET,11,-0.48731,-0.011918,0.28184,0.95809,GOBP_POSITIVE_REGULATION_OF_GLUTAMATE_SECRETION,1
GSE18791_CTRL_VS_NEWCASTLE_V...3,SET,169,-0.11351,-0.010835,0.065633,0.95813,GSE18791_CTRL_VS_NEWCASTLE_VIRUS_DC_12H_DN,1
GSE19923_WT_VS_E2A_KO_DP_THY...2,SET,181,-0.10885,-0.010749,0.062919,0.95818,GSE19923_WT_VS_E2A_KO_DP_THYMOCYTE_UP,1
BUSSLINGER_DUODENAL_MX_CELLS,SET,10,-0.46812,-0.010916,0.27055,0.9582,BUSSLINGER_DUODENAL_MX_CELLS,1
HP_MEDULLARY_NEPHROCALCINOSIS,SET,10,-0.51205,-0.011941,0.29589,0.95822,HP_MEDULLARY_NEPHROCALCINOSIS,1
HP_DYSMETRIC_SACCADES,SET,15,-0.33756,-0.0096395,0.19505,0.95823,HP_DYSMETRIC_SACCADES,1
KEGG_MEDICUS_VARIANT_MUTATIO...15,SET,9,-0.50122,-0.011089,0.28954,0.95827,KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_MET_TO_PI3K_SIGNALING_PATHWAY,1
GCM_AIP,SET,34,-0.22928,-0.0098523,0.13242,0.9583,GCM_AIP,1
MIR483_3P,SET,49,-0.21081,-0.01087,0.12175,0.95831,MIR483_3P,1
MIR6800_3P,SET,27,-0.27812,-0.010652,0.16063,0.95831,MIR6800_3P,1
KEGG_AUTOIMMUNE_THYROID_DISE...,SET,44,-0.25924,-0.012669,0.14964,0.9584,KEGG_AUTOIMMUNE_THYROID_DISEASE,1
GOBP_NEGATIVE_REGULATION_OF_...322,SET,96,-0.14654,-0.010563,0.084569,0.95843,GOBP_NEGATIVE_REGULATION_OF_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOCC_SPLICEOSOMAL_COMPLEX,SET,178,-0.099613,-0.0097555,0.057483,0.95843,GOCC_SPLICEOSOMAL_COMPLEX,1
MIR12121,SET,27,-0.30597,-0.011719,0.17656,0.95844,MIR12121,1
HE_LIM_SUN_FETAL_LUNG_C0_PER...,SET,186,-0.11626,-0.011636,0.067068,0.95848,HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE,1
MIR5007_5P,SET,53,-0.20511,-0.010998,0.11832,0.95849,MIR5007_5P,1
DURCHDEWALD_SKIN_CARCINOGENE...1,SET,242,-0.096696,-0.011022,0.055776,0.9585,DURCHDEWALD_SKIN_CARCINOGENESIS_DN,1
DOANE_BREAST_CANCER_CLASSES_...1,SET,32,-0.27205,-0.011342,0.15686,0.95856,DOANE_BREAST_CANCER_CLASSES_DN,1
MIR557,SET,204,-0.10287,-0.010778,0.059318,0.95856,MIR557,1
KEGG_MEDICUS_REFERENCE_TYROS...,SET,5,-0.66468,-0.010962,0.38323,0.95857,KEGG_MEDICUS_REFERENCE_TYROSINE_DEGRADATION,1
REACTOME_TYROSINE_CATABOLISM,SET,5,-0.66468,-0.010962,0.38323,0.95857,REACTOME_TYROSINE_CATABOLISM,1
WP_TYROSINE_METABOLISM_AND_R...,SET,5,-0.66468,-0.010962,0.38323,0.95857,WP_TYROSINE_METABOLISM_AND_RELATED_DISORDERS,1
MORF_AATF,SET,197,-0.096049,-0.0098907,0.055378,0.95857,MORF_AATF,1
HP_RENAL_TUBULAR_ATROPHY,SET,18,-0.3284,-0.010272,0.18934,0.95857,HP_RENAL_TUBULAR_ATROPHY,1
HP_INFLAMMATORY_ABNORMALITY_...,SET,189,-0.10717,-0.010812,0.061778,0.9586,HP_INFLAMMATORY_ABNORMALITY_OF_THE_EYE,1
HP_HEMIANOPIA,SET,37,-0.23907,-0.010716,0.13779,0.95863,HP_HEMIANOPIA,1
HP_NEOPLASM_OF_THE_PARATHYRO...,SET,18,-0.36311,-0.011358,0.20927,0.95863,HP_NEOPLASM_OF_THE_PARATHYROID_GLAND,1
HOFT_CD4_POSITIVE_ALPHA_BETA...5,SET,36,-0.23872,-0.010555,0.13758,0.95863,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_56D_TOP_100_DEG_AFTER_IN_VITRO_RE_STIMULATION_DN,1
GSE46606_DAY1_VS_DAY3_CD40L_...6,SET,176,-0.11287,-0.010992,0.065045,0.95865,GSE46606_DAY1_VS_DAY3_CD40L_IL2_IL5_STIMULATED_IRF4MID_BCELL_UP,1
GRAESSMANN_RESPONSE_TO_MC_AN...3,SET,76,-0.16852,-0.010814,0.097103,0.95867,GRAESSMANN_RESPONSE_TO_MC_AND_SERUM_DEPRIVATION_DN,1
AUTS2_TARGET_GENES,SET,487,-0.066768,-0.010724,0.038471,0.95867,AUTS2_TARGET_GENES,1
GOBP_ADAPTIVE_THERMOGENESIS,SET,160,-0.1203,-0.011176,0.069303,0.9587,GOBP_ADAPTIVE_THERMOGENESIS,1
HE_LIM_SUN_FETAL_LUNG_C4_TRE...,SET,36,-0.27698,-0.012246,0.15946,0.9588,HE_LIM_SUN_FETAL_LUNG_C4_TREG_CELL,1
MIR4520_2_3P,SET,111,-0.14101,-0.010925,0.081173,0.95881,MIR4520_2_3P,1
HP_ABNORMAL_UTERUS_MORPHOLOGY,SET,138,-0.12164,-0.010501,0.070012,0.95884,HP_ABNORMAL_UTERUS_MORPHOLOGY,1
SARTIPY_BLUNTED_BY_INSULIN_R...1,SET,17,-0.40001,-0.01216,0.2301,0.95892,SARTIPY_BLUNTED_BY_INSULIN_RESISTANCE_DN,1
MIR562,SET,59,-0.18896,-0.010689,0.1087,0.95892,MIR562,1
SMAD3_Q6,SET,214,-0.10383,-0.011138,0.059727,0.95892,SMAD3_Q6,1
MIR758_3P,SET,112,-0.13584,-0.010572,0.078134,0.95893,MIR758_3P,1
GOBP_PYRIMIDINE_CONTAINING_C...5,SET,16,-0.39516,-0.011654,0.2273,0.95893,GOBP_PYRIMIDINE_CONTAINING_COMPOUND_TRANSMEMBRANE_TRANSPORT,1
GOBP_EMBRYONIC_DIGESTIVE_TRA...2,SET,17,-0.40835,-0.012414,0.2348,0.95899,GOBP_EMBRYONIC_DIGESTIVE_TRACT_MORPHOGENESIS,1
IIZUKA_LIVER_CANCER_PROGRESS...7,SET,8,-0.49389,-0.010302,0.28395,0.95901,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_DN,1
HP_HYPSARRHYTHMIA,SET,159,-0.11483,-0.010634,0.06601,0.95903,HP_HYPSARRHYTHMIA,1
HP_PRIMARY_HYPERPARATHYROIDI...,SET,13,-0.44883,-0.011933,0.25801,0.95903,HP_PRIMARY_HYPERPARATHYROIDISM,1
MIR4424,SET,109,-0.14324,-0.010998,0.082335,0.95904,MIR4424,1
HP_BONE_MARROW_HYPOCELLULARI...,SET,64,-0.17519,-0.01032,0.10069,0.95905,HP_BONE_MARROW_HYPOCELLULARITY,1
HP_ABNORMAL_FETAL_GENITOURIN...,SET,11,-0.47598,-0.011641,0.27345,0.95912,HP_ABNORMAL_FETAL_GENITOURINARY_SYSTEM_MORPHOLOGY,1
GOBP_REGULATION_OF_INOSITOL_...2,SET,15,-0.41142,-0.011749,0.23634,0.95913,GOBP_REGULATION_OF_INOSITOL_PHOSPHATE_BIOSYNTHETIC_PROCESS,1
WP_APOPTOSIS_MODULATION_BY_H...,SET,18,-0.34637,-0.010834,0.19888,0.9592,WP_APOPTOSIS_MODULATION_BY_HSP70,1
GSE5542_UNTREATED_VS_IFNA_AN...3,SET,177,-0.10929,-0.010673,0.062729,0.95926,GSE5542_UNTREATED_VS_IFNA_AND_IFNG_TREATED_EPITHELIAL_CELLS_6H_DN,1
MIR2355_3P,SET,97,-0.15419,-0.011172,0.088479,0.9593,MIR2355_3P,1
SAKAI_TUMOR_INFILTRATING_MON...2,SET,26,-0.28192,-0.010596,0.16175,0.95932,SAKAI_TUMOR_INFILTRATING_MONOCYTES_UP,1
GSE15624_CTRL_VS_6H_HALOFUGI...2,SET,123,-0.13786,-0.01124,0.079089,0.95933,GSE15624_CTRL_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP,1
GOBP_DETOXIFICATION_OF_INORG...,SET,20,-0.41984,-0.013842,0.24081,0.95936,GOBP_DETOXIFICATION_OF_INORGANIC_COMPOUND,1
GOBP_NEGATIVE_REGULATION_OF_...30,SET,5,-0.77427,-0.012769,0.44407,0.95937,GOBP_NEGATIVE_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
GCM_DLG1,SET,69,-0.1669,-0.010207,0.095684,0.95944,GCM_DLG1,1
HP_ABNORMAL_ERYTHROCYTE_MORP...,SET,599,-0.060693,-0.010777,0.034793,0.95945,HP_ABNORMAL_ERYTHROCYTE_MORPHOLOGY,1
HP_COLPOCEPHALY,SET,28,-0.26936,-0.010506,0.15442,0.95945,HP_COLPOCEPHALY,1
GOCC_STEREOCILIUM_BUNDLE,SET,60,-0.19883,-0.011342,0.11397,0.95946,GOCC_STEREOCILIUM_BUNDLE,1
KEGG_BETA_ALANINE_METABOLISM,SET,21,-0.33466,-0.011306,0.19182,0.95947,KEGG_BETA_ALANINE_METABOLISM,1
HALLMARK_DNA_REPAIR,SET,137,-0.1138,-0.0097883,0.065218,0.95949,HALLMARK_DNA_REPAIR,1
GOBP_REGULATION_OF_CARDIOCYT...,SET,25,-0.29875,-0.011011,0.17118,0.95952,GOBP_REGULATION_OF_CARDIOCYTE_DIFFERENTIATION,1
GOBP_REGULATION_OF_RESPONSE_...6,SET,15,-0.41067,-0.011727,0.23531,0.95952,GOBP_REGULATION_OF_RESPONSE_TO_FOOD,1
HP_ABNORMALITY_OF_ALKALINE_P...,SET,120,-0.13575,-0.010933,0.07778,0.95953,HP_ABNORMALITY_OF_ALKALINE_PHOSPHATASE_LEVEL,1
HP_HETEROTROPIA,SET,234,-0.093734,-0.010509,0.053698,0.95955,HP_HETEROTROPIA,1
GSE15735_2H_VS_12H_HDAC_INHI...1,SET,189,-0.10926,-0.011023,0.062588,0.95956,GSE15735_2H_VS_12H_HDAC_INHIBITOR_TREATED_CD4_TCELL_DN,1
HP_ABNORMALITY_OF_THE_PYLORUS,SET,92,-0.16048,-0.011326,0.091919,0.95957,HP_ABNORMALITY_OF_THE_PYLORUS,1
GOBP_FATTY_ACID_BETA_OXIDATI...2,SET,11,-0.37455,-0.0091605,0.21452,0.95959,GOBP_FATTY_ACID_BETA_OXIDATION_USING_ACYL_COA_DEHYDROGENASE,1
GOMF_POLYAMINE_TRANSMEMBRANE...,SET,10,-0.53218,-0.01241,0.3048,0.95959,GOMF_POLYAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
GOBP_REGULATION_OF_PEPTIDYL_...2,SET,10,-0.45876,-0.010698,0.26273,0.9596,GOBP_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,1
WP_GLYCOGEN_SYNTHESIS_AND_DE...,SET,35,-0.23958,-0.010445,0.13719,0.95961,WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION,1
MIR1236_3P,SET,170,-0.11499,-0.011008,0.065848,0.95962,MIR1236_3P,1
REACTOME_FORMATION_OF_THE_UR...,SET,19,-0.39397,-0.012661,0.22557,0.95964,REACTOME_FORMATION_OF_THE_URETERIC_BUD,1
GSE1791_CTRL_VS_NEUROMEDINU_...8,SET,176,-0.11107,-0.010817,0.063568,0.95969,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_UP,1
WP_NGLYCAN_BIOSYNTHESIS,SET,53,-0.18847,-0.010106,0.10786,0.95971,WP_NGLYCAN_BIOSYNTHESIS,1
HAN_JNK_SINGALING_UP,SET,34,-0.26539,-0.011404,0.15184,0.95974,HAN_JNK_SINGALING_UP,1
GOBP_BASOLATERAL_PROTEIN_SEC...,SET,5,-0.60586,-0.0099916,0.34662,0.95975,GOBP_BASOLATERAL_PROTEIN_SECRETION,1
GOMF_SEMAPHORIN_RECEPTOR_ACT...,SET,10,-0.54229,-0.012646,0.31025,0.95975,GOMF_SEMAPHORIN_RECEPTOR_ACTIVITY,1
GSE17721_CTRL_VS_POLYIC_1H_B...1,SET,180,-0.11308,-0.011136,0.064682,0.95978,GSE17721_CTRL_VS_POLYIC_1H_BMDC_DN,1
GOBP_CELLULAR_RESPONSE_TO_IN...3,SET,196,-0.11118,-0.01142,0.063565,0.95985,GOBP_CELLULAR_RESPONSE_TO_INORGANIC_SUBSTANCE,1
HP_ABNORMAL_URINARY_COLOR,SET,18,-0.3301,-0.010325,0.18866,0.95991,HP_ABNORMAL_URINARY_COLOR,1
GOBP_POSITIVE_REGULATION_OF_...209,SET,33,-0.28304,-0.011983,0.16174,0.95993,GOBP_POSITIVE_REGULATION_OF_DNA_BINDING,1
GOBP_REGULATION_OF_PROTEIN_E...1,SET,24,-0.27463,-0.0099177,0.15688,0.95998,GOBP_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
GOBP_REGULATION_OF_LONG_CHAI...2,SET,7,-0.53662,-0.010471,0.3065,0.96,GOBP_REGULATION_OF_LONG_CHAIN_FATTY_ACID_IMPORT_INTO_CELL,1
DESCARTES_FETAL_STOMACH_ENS_...2,SET,64,-0.19456,-0.011461,0.11112,0.96,DESCARTES_FETAL_STOMACH_ENS_NEURONS,1
GOBP_INORGANIC_ANION_TRANSPO...,SET,159,-0.12465,-0.011544,0.07118,0.96004,GOBP_INORGANIC_ANION_TRANSPORT,1
GOBP_RESPONSE_TO_WOUNDING,SET,530,-0.067382,-0.011276,0.038476,0.96004,GOBP_RESPONSE_TO_WOUNDING,1
GOBP_HEAD_DEVELOPMENT,SET,702,-0.058856,-0.011281,0.033603,0.96006,GOBP_HEAD_DEVELOPMENT,1
KEGG_MEDICUS_REFERENCE_TNF_R...,SET,7,-0.53328,-0.010405,0.30444,0.96008,KEGG_MEDICUS_REFERENCE_TNF_RIPK1_3_SIGNALING_PATHWAY,1
WYAAANNRNNNGCG_UNKNOWN,SET,63,-0.18955,-0.011079,0.10818,0.96012,WYAAANNRNNNGCG_UNKNOWN,1
GOBP_NEGATIVE_REGULATION_OF_...429,SET,4,-0.69036,-0.010183,0.39398,0.96013,GOBP_NEGATIVE_REGULATION_OF_MYOFIBROBLAST_DIFFERENTIATION,1
GOBP_REGULATION_OF_RETROGRAD...2,SET,5,-0.65094,-0.010735,0.37146,0.96014,GOBP_REGULATION_OF_RETROGRADE_TRANSPORT_ENDOSOME_TO_GOLGI,1
HP_HYPOPLASTIC_ACETABULAE,SET,5,-0.72144,-0.011898,0.41162,0.96016,HP_HYPOPLASTIC_ACETABULAE,1
GOBP_PURINE_NUCLEOSIDE_DIPHO...,SET,6,-0.65035,-0.011749,0.37105,0.96017,GOBP_PURINE_NUCLEOSIDE_DIPHOSPHATE_BIOSYNTHETIC_PROCESS,1
KEGG_MEDICUS_PATHOGEN_SARS_C...1,SET,6,-0.72609,-0.013117,0.41416,0.9602,KEGG_MEDICUS_PATHOGEN_SARS_COV_2_S_N_TO_LECTIN_PATHWAY_OF_COAGULATION_CASCADE,1
GNF2_EGFR,SET,29,-0.30557,-0.012129,0.17428,0.96022,GNF2_EGFR,1
CHEOK_RESPONSE_TO_MERCAPTOPU...3,SET,17,-0.39112,-0.01189,0.22303,0.96025,CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_LD_MTX_DN,1
HP_IMPAIRED_ANTIGEN_SPECIFIC...,SET,47,-0.22719,-0.011474,0.12955,0.96025,HP_IMPAIRED_ANTIGEN_SPECIFIC_RESPONSE,1
HP_ANEMIA_DUE_TO_REDUCED_LIF...,SET,139,-0.12578,-0.010897,0.071719,0.96026,HP_ANEMIA_DUE_TO_REDUCED_LIFE_SPAN_OF_RED_CELLS,1
GOBP_INOSITOL_TRISPHOSPHATE_...1,SET,6,-0.61865,-0.011176,0.35268,0.96029,GOBP_INOSITOL_TRISPHOSPHATE_BIOSYNTHETIC_PROCESS,1
MIR4439,SET,66,-0.19395,-0.011601,0.11053,0.96034,MIR4439,1
HP_ABNORMAL_CIRCULATING_ALDO...2,SET,10,-0.49673,-0.011584,0.28305,0.96035,HP_ABNORMAL_CIRCULATING_ALDOSTERONE,1
GOBP_MITOCHONDRIAL_DNA_METAB...,SET,21,-0.29305,-0.0099002,0.16695,0.96039,GOBP_MITOCHONDRIAL_DNA_METABOLIC_PROCESS,1
DESCARTES_FETAL_KIDNEY_URETE...,SET,236,-0.10527,-0.011852,0.059966,0.9604,DESCARTES_FETAL_KIDNEY_URETERIC_BUD_CELLS,1
GOBP_MEMBRANE_REPOLARIZATION...3,SET,14,-0.44983,-0.01241,0.25624,0.96041,GOBP_MEMBRANE_REPOLARIZATION_DURING_VENTRICULAR_CARDIAC_MUSCLE_CELL_ACTION_POTENTIAL,1
GSE17721_POLYIC_VS_GARDIQUIM...14,SET,181,-0.10238,-0.01011,0.058311,0.96042,GSE17721_POLYIC_VS_GARDIQUIMOD_4H_BMDC_UP,1
chr9p23,SET,4,-0.93299,-0.013763,0.53139,0.96043,chr9p23,1
HP_THIN_CORPUS_CALLOSUM,SET,735,-0.054337,-0.010647,0.030943,0.96045,HP_THIN_CORPUS_CALLOSUM,1
LIU_COMMON_CANCER_GENES,SET,59,-0.18188,-0.010288,0.10356,0.96047,LIU_COMMON_CANCER_GENES,1
GOBP_PHOSPHATIDYLETHANOLAMIN...3,SET,23,-0.31761,-0.011229,0.18084,0.96048,GOBP_PHOSPHATIDYLETHANOLAMINE_METABOLIC_PROCESS,1
GOBP_CELLULAR_RESPONSE_TO_CO...3,SET,22,-0.37346,-0.012913,0.21255,0.96053,GOBP_CELLULAR_RESPONSE_TO_COPPER_ION,1
MIR6810_5P,SET,58,-0.18924,-0.010614,0.10771,0.96054,MIR6810_5P,1
GOBP_RIBOSOMAL_SMALL_SUBUNIT...3,SET,8,-0.6034,-0.012586,0.34331,0.96059,GOBP_RIBOSOMAL_SMALL_SUBUNIT_EXPORT_FROM_NUCLEUS,1
GSE41867_DAY6_VS_DAY15_LCMV_...4,SET,147,-0.126,-0.011224,0.071684,0.9606,GSE41867_DAY6_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP,1
HP_ABNORMAL_VITREOUS_HUMOR_M...,SET,42,-0.23402,-0.011174,0.13311,0.96063,HP_ABNORMAL_VITREOUS_HUMOR_MORPHOLOGY,1
HP_ELONGATED_SUPERIOR_CEREBE...,SET,10,-0.41347,-0.0096421,0.23513,0.96066,HP_ELONGATED_SUPERIOR_CEREBELLAR_PEDUNCLE,1
GOMF_ALPHA_CATENIN_BINDING,SET,10,-0.49744,-0.0116,0.28283,0.96069,GOMF_ALPHA_CATENIN_BINDING,1
DER_IFN_GAMMA_RESPONSE_DN,SET,10,-0.50366,-0.011745,0.28627,0.96074,DER_IFN_GAMMA_RESPONSE_DN,1
HP_CNS_HYPOMYELINATION,SET,79,-0.1571,-0.010278,0.089287,0.96075,HP_CNS_HYPOMYELINATION,1
GOBP_INTRACELLULAR_PH_REDUCT...,SET,51,-0.21278,-0.011193,0.12092,0.96077,GOBP_INTRACELLULAR_PH_REDUCTION,1
GOBP_PEPTIDOGLYCAN_METABOLIC...,SET,6,-0.64612,-0.011672,0.3671,0.96079,GOBP_PEPTIDOGLYCAN_METABOLIC_PROCESS,1
GOMF_BETA_CATENIN_BINDING,SET,98,-0.15622,-0.011377,0.088734,0.96083,GOMF_BETA_CATENIN_BINDING,1
MIR6529_5P,SET,42,-0.22925,-0.010947,0.13021,0.96084,MIR6529_5P,1
GOMF_FATTY_ACID_ELONGASE_ACT...,SET,7,-0.63077,-0.012308,0.35821,0.96087,GOMF_FATTY_ACID_ELONGASE_ACTIVITY,1
GOBP_CHLORIDE_TRANSPORT,SET,113,-0.14932,-0.011672,0.084788,0.96088,GOBP_CHLORIDE_TRANSPORT,1
GOBP_NEUTRAL_LIPID_CATABOLIC...,SET,37,-0.25369,-0.011371,0.14405,0.96088,GOBP_NEUTRAL_LIPID_CATABOLIC_PROCESS,1
GOBP_MAINTENANCE_OF_PROTEIN_...1,SET,12,-0.39824,-0.010173,0.22608,0.96092,GOBP_MAINTENANCE_OF_PROTEIN_LOCALIZATION_IN_ENDOPLASMIC_RETICULUM,1
REACTOME_DISEASES_OF_METABOL...,SET,227,-0.10011,-0.011057,0.056819,0.96095,REACTOME_DISEASES_OF_METABOLISM,1
HP_ABNORMAL_SPERM_AXONEME_MO...,SET,6,-0.64108,-0.011581,0.3638,0.96097,HP_ABNORMAL_SPERM_AXONEME_MORPHOLOGY,1
GOMF_CADMIUM_ION_BINDING,SET,5,-0.6878,-0.011343,0.39018,0.96102,GOMF_CADMIUM_ION_BINDING,1
KEGG_MEDICUS_VARIANT_DELETED...,SET,9,-0.50757,-0.011229,0.28789,0.96104,KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX,1
GSE37532_TREG_VS_TCONV_PPARG...2,SET,180,-0.10207,-0.010051,0.057896,0.96104,GSE37532_TREG_VS_TCONV_PPARG_KO_CD4_TCELL_FROM_LN_UP,1
WATANABE_ULCERATIVE_COLITIS_...2,SET,17,-0.36863,-0.011206,0.20906,0.96106,WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP,1
GOBP_CELLULAR_RESPONSE_TO_OX...4,SET,145,-0.12005,-0.010621,0.068086,0.96106,GOBP_CELLULAR_RESPONSE_TO_OXYGEN_LEVELS,1
GOBP_REGULATION_OF_RECEPTOR_...1,SET,13,-0.4169,-0.011084,0.23634,0.96112,GOBP_REGULATION_OF_RECEPTOR_BINDING,1
HP_ABNORMAL_FACTOR_IX_ACTIVI...,SET,5,-0.55286,-0.0091177,0.31329,0.96118,HP_ABNORMAL_FACTOR_IX_ACTIVITY,1
MEK_UP.V1_DN,SET,162,-0.11974,-0.011192,0.067849,0.96119,MEK_UP.V1_DN,1
REACTOME_ASSEMBLY_AND_CELL_S...,SET,39,-0.25784,-0.011865,0.14607,0.96122,REACTOME_ASSEMBLY_AND_CELL_SURFACE_PRESENTATION_OF_NMDA_RECEPTORS,1
HP_ABNORMALITY_OF_CENTRAL_NE...,SET,525,-0.064299,-0.010711,0.036428,0.96122,HP_ABNORMALITY_OF_CENTRAL_NERVOUS_SYSTEM_ELECTROPHYSIOLOGY,1
KEGG_BASAL_TRANSCRIPTION_FAC...,SET,31,-0.24149,-0.0099097,0.13678,0.96126,KEGG_BASAL_TRANSCRIPTION_FACTORS,1
MIR4707_5P,SET,9,-0.46848,-0.010364,0.26526,0.9613,MIR4707_5P,1
GSE3982_BCELL_VS_NKCELL_DN,SET,171,-0.11869,-0.011395,0.067205,0.9613,GSE3982_BCELL_VS_NKCELL_DN,1
HP_RETINAL_THINNING,SET,28,-0.28583,-0.011148,0.16182,0.96132,HP_RETINAL_THINNING,1
GSE43955_10H_VS_60H_ACT_CD4_...2,SET,177,-0.10954,-0.010698,0.062018,0.96132,GSE43955_10H_VS_60H_ACT_CD4_TCELL_UP,1
GOMF_MAP_KINASE_SCAFFOLD_ACT...,SET,12,-0.43554,-0.011125,0.24657,0.96133,GOMF_MAP_KINASE_SCAFFOLD_ACTIVITY,1
HAY_BONE_MARROW_CD34_POS_MKP,SET,54,-0.22225,-0.012029,0.12578,0.96137,HAY_BONE_MARROW_CD34_POS_MKP,1
HP_MADELUNG_DEFORMITY,SET,4,-0.69538,-0.010258,0.3935,0.96139,HP_MADELUNG_DEFORMITY,1
GSE43955_TH0_VS_TGFB_IL6_IL2...4,SET,186,-0.1083,-0.01084,0.061285,0.96139,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_60H_UP,1
THAKAR_PBMC_INACTIVATED_INFL...12,SET,5,-0.62091,-0.01024,0.35131,0.96141,THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_70PLS_VS_21_30YO_0DY_UP,1
LIU_BREAST_CANCER,SET,25,-0.28523,-0.010512,0.16138,0.96142,LIU_BREAST_CANCER,1
HP_ABNORMAL_RESPONSE_TO_ENDO...,SET,130,-0.13214,-0.011074,0.074753,0.96143,HP_ABNORMAL_RESPONSE_TO_ENDOCRINE_STIMULATION_TEST,1
HP_ANAL_ATRESIA,SET,111,-0.14027,-0.010868,0.079348,0.96144,HP_ANAL_ATRESIA,1
KEGG_MEDICUS_REFERENCE_AUTOP...7,SET,5,-0.72841,-0.012013,0.41202,0.96145,KEGG_MEDICUS_REFERENCE_AUTOPHAGY_VESICLE_NUCLEATION_ELONGATION_MATURATION_PACER_RUBCN_PI3KC3_C2,1
GSE29618_MONOCYTE_VS_MDC_DAY...2,SET,189,-0.11784,-0.011889,0.066659,0.96145,GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...146,SET,83,-0.15554,-0.010429,0.08798,0.96146,GOBP_NEGATIVE_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
GNF2_CDH3,SET,26,-0.30599,-0.011501,0.17306,0.96147,GNF2_CDH3,1
HP_DEFECTIVE_DNA_REPAIR_AFTE...,SET,10,-0.35489,-0.0082759,0.2007,0.96148,HP_DEFECTIVE_DNA_REPAIR_AFTER_ULTRAVIOLET_RADIATION_DAMAGE,1
GOCC_TORC2_COMPLEX,SET,9,-0.5056,-0.011186,0.2859,0.9615,GOCC_TORC2_COMPLEX,1
GSE17721_CTRL_VS_PAM3CSK4_4H...1,SET,187,-0.10893,-0.010932,0.061595,0.96151,GSE17721_CTRL_VS_PAM3CSK4_4H_BMDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...227,SET,92,-0.15797,-0.011148,0.089314,0.96152,GOBP_NEGATIVE_REGULATION_OF_EXTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
DING_LUNG_CANCER_EXPRESSION_...,SET,96,-0.15514,-0.011183,0.087698,0.96155,DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER,1
GSE24634_TREG_VS_TCONV_POST_...7,SET,186,-0.11326,-0.011336,0.063966,0.96167,GSE24634_TREG_VS_TCONV_POST_DAY7_IL4_CONVERSION_DN,1
MIR5191,SET,27,-0.29158,-0.011168,0.16466,0.96169,MIR5191,1
PIONTEK_PKD1_TARGETS_DN,SET,15,-0.36754,-0.010496,0.20737,0.96183,PIONTEK_PKD1_TARGETS_DN,1
CSR_LATE_UP.V1_DN,SET,130,-0.13791,-0.011557,0.077797,0.96185,CSR_LATE_UP.V1_DN,1
HE_LIM_SUN_FETAL_LUNG_C0_VAS...2,SET,156,-0.12812,-0.011754,0.072269,0.96187,HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_2_CELL,1
GSE22342_CD11C_HIGH_VS_LOW_D...2,SET,174,-0.11337,-0.010979,0.063942,0.96188,GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP,1
BIOCARTA_MTA3_PATHWAY,SET,17,-0.36203,-0.011005,0.20411,0.96193,BIOCARTA_MTA3_PATHWAY,1
SMITH_TERT_TARGETS_UP,SET,130,-0.1273,-0.010669,0.071771,0.96194,SMITH_TERT_TARGETS_UP,1
GOMF_CELL_ADHESIVE_PROTEIN_B...,SET,5,-0.80332,-0.013248,0.45283,0.96196,GOMF_CELL_ADHESIVE_PROTEIN_BINDING_INVOLVED_IN_BUNDLE_OF_HIS_CELL_PURKINJE_MYOCYTE_COMMUNICATION,1
HP_ABNORMAL_JEJUNUM_MORPHOLO...,SET,9,-0.50277,-0.011123,0.28332,0.96201,HP_ABNORMAL_JEJUNUM_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...17,SET,24,-0.31466,-0.011363,0.1773,0.96202,GOBP_POSITIVE_REGULATION_OF_ALCOHOL_BIOSYNTHETIC_PROCESS,1
HP_PLAGIOCEPHALY,SET,134,-0.12679,-0.010787,0.071414,0.96208,HP_PLAGIOCEPHALY,1
GSE18804_BRAIN_VS_COLON_TUMO...2,SET,144,-0.13272,-0.011702,0.074752,0.96208,GSE18804_BRAIN_VS_COLON_TUMORAL_MACROPHAGE_UP,1
HALLMARK_ESTROGEN_RESPONSE_L...,SET,185,-0.11581,-0.01156,0.065218,0.9621,HALLMARK_ESTROGEN_RESPONSE_LATE,1
GOBP_POSITIVE_REGULATION_OF_...590,SET,564,-0.065901,-0.011366,0.037094,0.96217,GOBP_POSITIVE_REGULATION_OF_PHOSPHORYLATION,1
GOBP_CELL_MORPHOGENESIS,SET,896,-0.053076,-0.01143,0.029874,0.96218,GOBP_CELL_MORPHOGENESIS,1
KRAS.LUNG_UP.V1_DN,SET,128,-0.13474,-0.011205,0.075837,0.96218,KRAS.LUNG_UP.V1_DN,1
MIR7157_5P,SET,194,-0.10865,-0.011103,0.061136,0.96222,MIR7157_5P,1
HP_ORAL_PHARYNGEAL_DYSPHAGIA,SET,39,-0.23975,-0.011032,0.1349,0.96223,HP_ORAL_PHARYNGEAL_DYSPHAGIA,1
GTAGGCA_MIR189,SET,25,-0.31222,-0.011507,0.17559,0.9623,GTAGGCA_MIR189,1
GOCC_CELL_TIP,SET,7,-0.57913,-0.0113,0.32566,0.96231,GOCC_CELL_TIP,1
WP_FGF23_SIGNALING_IN_HYPOPH...,SET,22,-0.34715,-0.012004,0.1952,0.96233,WP_FGF23_SIGNALING_IN_HYPOPHOSPHATEMIC_RICKETS_AND_RELATED_DISORDERS,1
GOBP_REGULATION_OF_STRIATED_...1,SET,78,-0.17571,-0.011423,0.098784,0.96235,GOBP_REGULATION_OF_STRIATED_MUSCLE_CELL_DIFFERENTIATION,1
MIR5001_5P,SET,160,-0.11216,-0.010419,0.063036,0.96239,MIR5001_5P,1
HP_ABNORMAL_BRAINSTEM_WHITE_...,SET,15,-0.34752,-0.009924,0.19531,0.96239,HP_ABNORMAL_BRAINSTEM_WHITE_MATTER_MORPHOLOGY,1
MIR1267,SET,70,-0.17693,-0.010898,0.099405,0.96245,MIR1267,1
WP_HYPOTHETICAL_CRANIOFACIAL...,SET,7,-0.55386,-0.010807,0.31111,0.96248,WP_HYPOTHETICAL_CRANIOFACIAL_DEVELOPMENT_PATHWAY,1
FREAC7_01,SET,173,-0.12046,-0.011631,0.067659,0.96248,FREAC7_01,1
GOMF_CALMODULIN_BINDING,SET,197,-0.10905,-0.011229,0.06124,0.9625,GOMF_CALMODULIN_BINDING,1
GSE22611_UNSTIM_VS_2H_MDP_ST...4,SET,170,-0.1151,-0.011018,0.064611,0.96257,GSE22611_UNSTIM_VS_2H_MDP_STIM_NOD2_TRANSDUCED_HEK293T_CELL_UP,1
GSE9988_ANTI_TREM1_VS_VEHICL...1,SET,184,-0.11045,-0.010996,0.061983,0.96262,GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN,1
HP_OVARIAN_PAPILLARY_ADENOCA...,SET,6,-0.57287,-0.010349,0.32139,0.96266,HP_OVARIAN_PAPILLARY_ADENOCARCINOMA,1
GOBP_CYTOSOLIC_TRANSPORT,SET,123,-0.12741,-0.010388,0.071469,0.96268,GOBP_CYTOSOLIC_TRANSPORT,1
GSE2405_0H_VS_12H_A_PHAGOCYT...1,SET,178,-0.11349,-0.011114,0.063631,0.96274,GSE2405_0H_VS_12H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_DN,1
GOBP_REGULATION_OF_PROTEIN_F...,SET,9,-0.51253,-0.011339,0.28735,0.96275,GOBP_REGULATION_OF_PROTEIN_FOLDING,1
MIR423_5P,SET,124,-0.12665,-0.010368,0.071005,0.96276,MIR423_5P,1
HP_ABNORMAL_CIRCULATING_HORM...,SET,434,-0.073164,-0.01111,0.041011,0.96278,HP_ABNORMAL_CIRCULATING_HORMONE_CONCENTRATION,1
GOBP_RAS_PROTEIN_SIGNAL_TRAN...,SET,116,-0.1389,-0.011,0.07785,0.96279,GOBP_RAS_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE13547_2H_VS_12_H_ANTI_IGM...2,SET,166,-0.12143,-0.011488,0.068027,0.96287,GSE13547_2H_VS_12_H_ANTI_IGM_STIM_BCELL_UP,1
GOBP_RESPONSE_TO_INTERLEUKIN...8,SET,6,-0.57143,-0.010323,0.32005,0.9629,GOBP_RESPONSE_TO_INTERLEUKIN_3,1
GSE17721_POLYIC_VS_PAM3CSK4_...10,SET,186,-0.10662,-0.010671,0.059709,0.96291,GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP,1
MODULE_279,SET,123,-0.13403,-0.010928,0.075039,0.96295,MODULE_279,1
BIOCARTA_GHRELIN_PATHWAY,SET,13,-0.50147,-0.013332,0.28071,0.96297,BIOCARTA_GHRELIN_PATHWAY,1
HP_ABNORMALITY_OF_THE_COSTOC...,SET,17,-0.39835,-0.01211,0.22295,0.963,HP_ABNORMALITY_OF_THE_COSTOCHONDRAL_JUNCTION,1
HP_CARDIAC_ARREST,SET,146,-0.13226,-0.011741,0.074019,0.96301,HP_CARDIAC_ARREST,1
CHEN_LUNG_CANCER_SURVIVAL,SET,24,-0.29222,-0.010553,0.16352,0.96302,CHEN_LUNG_CANCER_SURVIVAL,1
HP_DYSTROPHIC_FINGERNAILS,SET,25,-0.28503,-0.010505,0.1595,0.96302,HP_DYSTROPHIC_FINGERNAILS,1
GSE37605_TREG_VS_TCONV_NOD_F...1,SET,154,-0.12291,-0.011203,0.068756,0.96307,GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_DN,1
WP_BASE_EXCISION_REPAIR,SET,30,-0.24699,-0.0099707,0.13815,0.96309,WP_BASE_EXCISION_REPAIR,1
WP_PHOSPHODIESTERASES_IN_NEU...,SET,52,-0.21955,-0.011661,0.12279,0.9631,WP_PHOSPHODIESTERASES_IN_NEURONAL_FUNCTION,1
GOBP_SPERM_AXONEME_ASSEMBLY,SET,26,-0.28444,-0.010691,0.15905,0.96313,GOBP_SPERM_AXONEME_ASSEMBLY,1
BERENJENO_TRANSFORMED_BY_RHO...4,SET,25,-0.32222,-0.011876,0.18012,0.96318,BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN,1
GOBP_NEGATIVE_REGULATION_OF_...295,SET,26,-0.30665,-0.011525,0.17141,0.96318,GOBP_NEGATIVE_REGULATION_OF_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
SEIDEN_MET_SIGNALING,SET,18,-0.33107,-0.010356,0.18503,0.9632,SEIDEN_MET_SIGNALING,1
GOBP_ESTABLISHMENT_OF_PROTEI...2,SET,5,-0.60016,-0.0098976,0.33542,0.9632,GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_CHROMATIN,1
HP_ABNORMAL_CIRCULATING_FATT...2,SET,68,-0.17719,-0.010758,0.099026,0.96321,HP_ABNORMAL_CIRCULATING_FATTY_ACID_CONCENTRATION,1
REACTOME_NOTCH1_INTRACELLULA...,SET,43,-0.22973,-0.011099,0.12836,0.96324,REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION,1
GOBP_POSITIVE_REGULATION_OF_...502,SET,21,-0.36274,-0.012254,0.20267,0.96325,GOBP_POSITIVE_REGULATION_OF_MUSCLE_TISSUE_DEVELOPMENT,1
GSE26890_CXCR1_NEG_VS_POS_EF...2,SET,180,-0.11405,-0.011232,0.063714,0.96327,GSE26890_CXCR1_NEG_VS_POS_EFFECTOR_CD8_TCELL_UP,1
GSE41176_UNSTIM_VS_ANTI_IGM_...15,SET,174,-0.11545,-0.01118,0.064489,0.96328,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_6H_DN,1
REACTOME_SIGNALING_BY_ACTIVA...,SET,11,-0.50754,-0.012413,0.28337,0.96335,REACTOME_SIGNALING_BY_ACTIVATED_POINT_MUTANTS_OF_FGFR1,1
GOBP_PHOSPHOLIPID_HOMEOSTASIS,SET,17,-0.37595,-0.011429,0.20989,0.96336,GOBP_PHOSPHOLIPID_HOMEOSTASIS,1
GOBP_ADRENERGIC_RECEPTOR_SIG...,SET,30,-0.29808,-0.012033,0.16639,0.96338,GOBP_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
REACTOME_PROTEIN_UBIQUITINAT...,SET,57,-0.19329,-0.010747,0.10789,0.96339,REACTOME_PROTEIN_UBIQUITINATION,1
HP_DISINHIBITION,SET,540,-0.065578,-0.011074,0.036605,0.96339,HP_DISINHIBITION,1
GCM_MAP4K4,SET,161,-0.11221,-0.010456,0.062628,0.9634,GCM_MAP4K4,1
GSE1740_UNSTIM_VS_IFNA_STIMU...2,SET,154,-0.11847,-0.010799,0.066115,0.96341,GSE1740_UNSTIM_VS_IFNA_STIMULATED_MCSF_DERIVED_MACROPHAGE_UP,1
WALLACE_PROSTATE_CANCER_UP,SET,18,-0.37072,-0.011596,0.20686,0.96343,WALLACE_PROSTATE_CANCER_UP,1
REACTOME_FORMATION_OF_THE_NE...,SET,17,-0.41076,-0.012487,0.22919,0.96344,REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT,1
GSE17721_CTRL_VS_POLYIC_24H_...2,SET,177,-0.1091,-0.010655,0.060876,0.96344,GSE17721_CTRL_VS_POLYIC_24H_BMDC_UP,1
MIR3976,SET,104,-0.14916,-0.011189,0.083222,0.96345,MIR3976,1
GOBP_REGULATION_OF_MICROTUBU...5,SET,25,-0.26992,-0.0099485,0.1506,0.96345,GOBP_REGULATION_OF_MICROTUBULE_DEPOLYMERIZATION,1
HP_SPECIFIC_LEARNING_DISABIL...,SET,267,-0.092419,-0.011058,0.051561,0.96346,HP_SPECIFIC_LEARNING_DISABILITY,1
REACTOME_LECTIN_PATHWAY_OF_C...,SET,8,-0.61705,-0.012871,0.34417,0.96349,REACTOME_LECTIN_PATHWAY_OF_COMPLEMENT_ACTIVATION,1
GOBP_MAPK_CASCADE,SET,686,-0.060461,-0.011461,0.033724,0.96349,GOBP_MAPK_CASCADE,1
GSE3565_DUSP1_VS_WT_SPLENOCY...2,SET,146,-0.1325,-0.011763,0.073908,0.96349,GSE3565_DUSP1_VS_WT_SPLENOCYTES_POST_LPS_INJECTION_DN,1
GOBP_REGULATION_OF_NAD_P_H_O...,SET,5,-0.68477,-0.011293,0.38169,0.96359,GOBP_REGULATION_OF_NAD_P_H_OXIDASE_ACTIVITY,1
HP_EPISPADIAS,SET,25,-0.26964,-0.009938,0.15022,0.96366,HP_EPISPADIAS,1
GSE43955_TH0_VS_TGFB_IL6_IL2...2,SET,182,-0.11395,-0.011283,0.063484,0.96366,GSE43955_TH0_VS_TGFB_IL6_IL23_TH17_ACT_CD4_TCELL_52H_UP,1
HP_VITILIGO,SET,22,-0.34499,-0.011929,0.19217,0.96369,HP_VITILIGO,1
GOBP_POSITIVE_REGULATION_OF_...642,SET,682,-0.059454,-0.011238,0.033114,0.9637,GOBP_POSITIVE_REGULATION_OF_PROTEIN_MODIFICATION_PROCESS,1
MIKKELSEN_MCV6_ICP_WITH_H3K2...,SET,74,-0.1887,-0.011949,0.10507,0.96374,MIKKELSEN_MCV6_ICP_WITH_H3K27ME3,1
GOCC_CELL_BODY_MEMBRANE,SET,32,-0.30124,-0.012559,0.16772,0.96376,GOCC_CELL_BODY_MEMBRANE,1
HP_ABNORMAL_HEAD_MOVEMENTS,SET,33,-0.27782,-0.011762,0.15464,0.96379,HP_ABNORMAL_HEAD_MOVEMENTS,1
MIR147B_5P,SET,285,-0.091896,-0.011354,0.051147,0.9638,MIR147B_5P,1
GSE19941_IL10_KO_VS_IL10_KO_...6,SET,183,-0.1154,-0.011457,0.064209,0.96384,GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_UNSTIM_MACROPHAGE_UP,1
GOBP_CARDIAC_VENTRICLE_MORPH...,SET,68,-0.20679,-0.012555,0.11504,0.96387,GOBP_CARDIAC_VENTRICLE_MORPHOGENESIS,1
GOCC_CYTOPLASMIC_MICROTUBULE,SET,81,-0.16813,-0.011137,0.093533,0.96387,GOCC_CYTOPLASMIC_MICROTUBULE,1
GSE5589_WT_VS_IL6_KO_LPS_STI...1,SET,129,-0.13808,-0.011528,0.076804,0.96389,GSE5589_WT_VS_IL6_KO_LPS_STIM_MACROPHAGE_180MIN_DN,1
GSE3982_MAC_VS_BASOPHIL_DN,SET,167,-0.11752,-0.011152,0.065361,0.96391,GSE3982_MAC_VS_BASOPHIL_DN,1
MODULE_407,SET,13,-0.44955,-0.011952,0.24998,0.96393,MODULE_407,1
GOBP_CELLULAR_RESPONSE_TO_AN...1,SET,32,-0.29399,-0.012257,0.16348,0.96393,GOBP_CELLULAR_RESPONSE_TO_ANGIOTENSIN,1
HP_ABNORMALITY_OF_THE_PARATH...,SET,68,-0.19297,-0.011716,0.10729,0.96395,HP_ABNORMALITY_OF_THE_PARATHYROID_GLAND,1
MIR4739,SET,127,-0.14094,-0.011675,0.078357,0.96396,MIR4739,1
REACTOME_BETA_DEFENSINS,SET,26,-0.41547,-0.015616,0.23097,0.96397,REACTOME_BETA_DEFENSINS,1
FEKIR_HEPARG_SIDE_POP_VS_HEP...2,SET,77,-0.17359,-0.011212,0.096495,0.96398,FEKIR_HEPARG_SIDE_POP_VS_HEPARG_UP,1
GNF2_SNRK,SET,26,-0.29115,-0.010943,0.16184,0.96398,GNF2_SNRK,1
KAECH_DAY8_EFF_VS_MEMORY_CD8...1,SET,184,-0.11133,-0.011084,0.061886,0.96398,KAECH_DAY8_EFF_VS_MEMORY_CD8_TCELL_DN,1
GSE30083_SP3_VS_SP4_THYMOCYT...2,SET,180,-0.11856,-0.011676,0.065889,0.96402,GSE30083_SP3_VS_SP4_THYMOCYTE_UP,1
GSE3982_MAC_VS_NKCELL_DN,SET,177,-0.11563,-0.011292,0.064249,0.96404,GSE3982_MAC_VS_NKCELL_DN,1
REACTOME_RNA_POLYMERASE_I_TR...1,SET,45,-0.19546,-0.0096601,0.1086,0.96405,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION,1
HP_SENSORIMOTOR_NEUROPATHY,SET,73,-0.18103,-0.011387,0.10058,0.96405,HP_SENSORIMOTOR_NEUROPATHY,1
GSE9960_GRAM_POS_VS_GRAM_NEG...1,SET,174,-0.12028,-0.011648,0.066829,0.96405,GSE9960_GRAM_POS_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN,1
ZIRN_TRETINOIN_RESPONSE_UP,SET,16,-0.41354,-0.012196,0.22973,0.96407,ZIRN_TRETINOIN_RESPONSE_UP,1
MIR762,SET,164,-0.11192,-0.010525,0.062153,0.96411,MIR762,1
GOBP_REGULATION_OF_PROTEIN_L...10,SET,4,-0.6984,-0.010302,0.38788,0.96411,GOBP_REGULATION_OF_PROTEIN_LOCALIZATION_TO_LYSOSOME,1
GOBP_POSITIVE_REGULATION_OF_...388,SET,6,-0.64402,-0.011634,0.35763,0.96413,GOBP_POSITIVE_REGULATION_OF_I_KAPPAB_PHOSPHORYLATION,1
GOBP_POSITIVE_REGULATION_OF_...564,SET,41,-0.25859,-0.0122,0.14358,0.96415,GOBP_POSITIVE_REGULATION_OF_ORGAN_GROWTH,1
GSE17721_CTRL_VS_LPS_8H_BMDC...1,SET,185,-0.11106,-0.011086,0.061656,0.96416,GSE17721_CTRL_VS_LPS_8H_BMDC_DN,1
GSE17721_LPS_VS_POLYIC_2H_BM...2,SET,187,-0.11619,-0.01166,0.064494,0.96418,GSE17721_LPS_VS_POLYIC_2H_BMDC_UP,1
MIR412_5P,SET,5,-0.63508,-0.010474,0.35238,0.96424,MIR412_5P,1
MIR487A_3P,SET,92,-0.1606,-0.011334,0.089091,0.96427,MIR487A_3P,1
COLDREN_GEFITINIB_RESISTANCE...1,SET,205,-0.11149,-0.011709,0.061838,0.9643,COLDREN_GEFITINIB_RESISTANCE_DN,1
GOMF_OPIOID_RECEPTOR_BINDING,SET,7,-0.65575,-0.012795,0.36368,0.9643,GOMF_OPIOID_RECEPTOR_BINDING,1
HP_VENTRICULOMEGALY,SET,641,-0.059377,-0.010894,0.032925,0.96433,HP_VENTRICULOMEGALY,1
WP_UREA_CYCLE_AND_RELATED_DI...,SET,8,-0.52285,-0.010906,0.28989,0.96434,WP_UREA_CYCLE_AND_RELATED_DISEASES,1
METTL14_TARGET_GENES,SET,109,-0.14678,-0.01127,0.081349,0.9644,METTL14_TARGET_GENES,1
HP_DECREASED_LYMPHOCYTE_APOP...,SET,6,-0.59516,-0.010752,0.32985,0.9644,HP_DECREASED_LYMPHOCYTE_APOPTOSIS,1
XU_GH1_AUTOCRINE_TARGETS_UP,SET,158,-0.12073,-0.011146,0.066903,0.96442,XU_GH1_AUTOCRINE_TARGETS_UP,1
GOBP_REGULATION_OF_GTP_BINDI...,SET,8,-0.57036,-0.011897,0.31607,0.96442,GOBP_REGULATION_OF_GTP_BINDING,1
HP_DECREASED_CIRCULATING_IGA...,SET,70,-0.18228,-0.011228,0.10101,0.96443,HP_DECREASED_CIRCULATING_IGA_LEVEL,1
GOMF_STEROL_TRANSFER_ACTIVITY,SET,24,-0.33572,-0.012124,0.18602,0.96444,GOMF_STEROL_TRANSFER_ACTIVITY,1
GOMF_LYSOPHOSPHOLIPASE_ACTIV...,SET,26,-0.30043,-0.011292,0.16644,0.96445,GOMF_LYSOPHOSPHOLIPASE_ACTIVITY,1
HP_FACIAL_TELANGIECTASIA,SET,15,-0.35342,-0.010092,0.1958,0.96445,HP_FACIAL_TELANGIECTASIA,1
GOBP_BLOOD_VESSEL_REMODELING,SET,40,-0.24475,-0.011406,0.13559,0.96446,GOBP_BLOOD_VESSEL_REMODELING,1
GOMF_SIRNA_BINDING,SET,7,-0.61364,-0.011973,0.33996,0.96446,GOMF_SIRNA_BINDING,1
HP_REDUCED_PROTEIN_S_ACTIVITY,SET,8,-0.43309,-0.0090337,0.23991,0.96447,HP_REDUCED_PROTEIN_S_ACTIVITY,1
MIR2278,SET,95,-0.15101,-0.010829,0.083645,0.96448,MIR2278,1
MIR3646,SET,771,-0.056958,-0.011419,0.031536,0.96454,MIR3646,1
HP_HYPEROSTOSIS,SET,47,-0.20518,-0.010363,0.11361,0.96454,HP_HYPEROSTOSIS,1
CHENG_IMPRINTED_BY_ESTRADIOL,SET,98,-0.16238,-0.011826,0.089888,0.96457,CHENG_IMPRINTED_BY_ESTRADIOL,1
WP_UREA_CYCLE_AND_METABOLISM...,SET,18,-0.35012,-0.010952,0.19368,0.96466,WP_UREA_CYCLE_AND_METABOLISM_OF_AMINO_GROUPS,1
GOBP_REGULATION_OF_METANEPHR...,SET,5,-0.80382,-0.013256,0.44454,0.9647,GOBP_REGULATION_OF_METANEPHROS_DEVELOPMENT,1
GSE9988_LPS_VS_CTRL_TREATED_...1,SET,189,-0.10492,-0.010585,0.05802,0.96471,GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN,1
KEGG_NEUROACTIVE_LIGAND_RECE...,SET,252,-0.10686,-0.012427,0.059057,0.9648,KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION,1
HP_ABNORMALITY_OF_FONTANELLES,SET,180,-0.11346,-0.011173,0.062674,0.96487,HP_ABNORMALITY_OF_FONTANELLES,1
MODULE_293,SET,10,-0.52968,-0.012352,0.29254,0.96489,MODULE_293,1
GNF2_CD7,SET,34,-0.27923,-0.011999,0.15421,0.9649,GNF2_CD7,1
GOBP_PROTECTION_FROM_NON_HOM...,SET,9,-0.43374,-0.0095958,0.23954,0.9649,GOBP_PROTECTION_FROM_NON_HOMOLOGOUS_END_JOINING_AT_TELOMERE,1
GOBP_SMOOTH_MUSCLE_CELL_MIGR...,SET,67,-0.20845,-0.012563,0.11509,0.96493,GOBP_SMOOTH_MUSCLE_CELL_MIGRATION,1
GSE46606_UNSTIM_VS_CD40L_IL2...16,SET,168,-0.12364,-0.011767,0.068248,0.96497,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
KEGG_MEDICUS_REFERENCE_FAS_J...,SET,7,-0.58887,-0.01149,0.32499,0.965,KEGG_MEDICUS_REFERENCE_FAS_JNK_SIGNALING_PATHWAY,1
GOBP_TETRAPYRROLE_BIOSYNTHET...,SET,29,-0.26704,-0.010599,0.14737,0.965,GOBP_TETRAPYRROLE_BIOSYNTHETIC_PROCESS,1
YNGTTNNNATT_UNKNOWN,SET,339,-0.090055,-0.012117,0.049678,0.96506,YNGTTNNNATT_UNKNOWN,1
GOBP_CARDIAC_MUSCLE_CELL_CAR...,SET,7,-0.67768,-0.013223,0.37367,0.96512,GOBP_CARDIAC_MUSCLE_CELL_CARDIAC_MUSCLE_CELL_ADHESION,1
GOMF_MONOATOMIC_ANION_CHANNE...,SET,88,-0.17955,-0.012394,0.098963,0.96518,GOMF_MONOATOMIC_ANION_CHANNEL_ACTIVITY,1
HP_MALNUTRITION,SET,41,-0.24417,-0.011519,0.13453,0.96523,HP_MALNUTRITION,1
GOCC_U2_TYPE_SPLICEOSOMAL_CO...,SET,86,-0.14397,-0.009825,0.079277,0.96531,GOCC_U2_TYPE_SPLICEOSOMAL_COMPLEX,1
GOMF_1_PHOSPHATIDYLINOSITOL_...4,SET,7,-0.6057,-0.011818,0.33347,0.96533,GOMF_1_PHOSPHATIDYLINOSITOL_4_PHOSPHATE_3_KINASE_ACTIVITY,1
REACTOME_FGFR1_LIGAND_BINDIN...,SET,17,-0.42511,-0.012923,0.23403,0.96534,REACTOME_FGFR1_LIGAND_BINDING_AND_ACTIVATION,1
GRABARCZYK_BCL11B_TARGETS_UP,SET,68,-0.1848,-0.01122,0.10173,0.96535,GRABARCZYK_BCL11B_TARGETS_UP,1
LI_CISPLATIN_RESISTANCE_UP,SET,24,-0.35034,-0.012652,0.19286,0.96535,LI_CISPLATIN_RESISTANCE_UP,1
HP_CHRONIC_DIARRHEA,SET,93,-0.15796,-0.011208,0.086943,0.96537,HP_CHRONIC_DIARRHEA,1
GSE40274_CTRL_VS_FOXP3_AND_E...1,SET,148,-0.12509,-0.01118,0.068851,0.96537,GSE40274_CTRL_VS_FOXP3_AND_EOS_TRANSDUCED_ACTIVATED_CD4_TCELL_DN,1
AML1_01,SET,251,-0.10123,-0.011749,0.055695,0.96543,AML1_01,1
AML1_Q6,SET,251,-0.10123,-0.011749,0.055695,0.96543,AML1_Q6,1
MIR6735_3P,SET,33,-0.25601,-0.010838,0.14083,0.96544,MIR6735_3P,1
GOBP_RESPONSE_TO_VITAMIN_K,SET,4,-0.88528,-0.013059,0.48702,0.96544,GOBP_RESPONSE_TO_VITAMIN_K,1
MORF_MAGEA8,SET,226,-0.10522,-0.011596,0.05788,0.96546,MORF_MAGEA8,1
GOBP_RESPONSE_TO_SYMBIONT,SET,6,-0.5868,-0.010601,0.32276,0.96546,GOBP_RESPONSE_TO_SYMBIONT,1
GOCC_CALCITONIN_FAMILY_RECEP...,SET,5,-0.75462,-0.012445,0.41508,0.96546,GOCC_CALCITONIN_FAMILY_RECEPTOR_COMPLEX,1
FERREIRA_EWINGS_SARCOMA_UNST...1,SET,86,-0.16301,-0.011124,0.089658,0.96547,FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_DN,1
MIR6529_3P,SET,80,-0.18215,-0.011992,0.10013,0.96556,MIR6529_3P,1
HP_MECONIUM_STAINED_AMNIOTIC...,SET,8,-0.5712,-0.011915,0.31392,0.96558,HP_MECONIUM_STAINED_AMNIOTIC_FLUID,1
MIR154_3P,SET,91,-0.1628,-0.011427,0.089444,0.96562,MIR154_3P,1
GSE18281_SUBCAPSULAR_VS_CENT...2,SET,168,-0.11569,-0.01101,0.063562,0.96562,GSE18281_SUBCAPSULAR_VS_CENTRAL_CORTICAL_REGION_OF_THYMUS_UP,1
HP_INSULINOMA,SET,6,-0.64106,-0.011581,0.35215,0.96564,HP_INSULINOMA,1
GOBP_CENTRAL_NERVOUS_SYSTEM_...1,SET,931,-0.053374,-0.011705,0.029317,0.96566,GOBP_CENTRAL_NERVOUS_SYSTEM_DEVELOPMENT,1
GOMF_CASPASE_BINDING,SET,12,-0.40239,-0.010279,0.22095,0.9657,GOMF_CASPASE_BINDING,1
GOBP_ICOSANOID_SECRETION,SET,47,-0.24259,-0.012252,0.13314,0.96577,GOBP_ICOSANOID_SECRETION,1
HP_RIGHT_VENTRICULAR_CARDIOM...,SET,7,-0.67771,-0.013224,0.37162,0.96589,HP_RIGHT_VENTRICULAR_CARDIOMYOPATHY,1
LANDIS_ERBB2_BREAST_TUMORS_3...2,SET,140,-0.13078,-0.011371,0.071679,0.96596,LANDIS_ERBB2_BREAST_TUMORS_324_UP,1
PID_CDC42_PATHWAY,SET,68,-0.18978,-0.011522,0.10401,0.96596,PID_CDC42_PATHWAY,1
GOBP_SYNAPSE_ASSEMBLY,SET,190,-0.12176,-0.012315,0.066701,0.96602,GOBP_SYNAPSE_ASSEMBLY,1
GOBP_L_GLUTAMATE_IMPORT_ACRO...,SET,17,-0.39405,-0.011979,0.21584,0.96604,GOBP_L_GLUTAMATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
MIR3177_5P,SET,146,-0.12649,-0.011229,0.069229,0.96615,MIR3177_5P,1
HP_SUBCORTICAL_CEREBRAL_ATRO...,SET,25,-0.3179,-0.011717,0.17397,0.96616,HP_SUBCORTICAL_CEREBRAL_ATROPHY,1
GOBP_REGULATION_OF_G_PROTEIN...,SET,133,-0.13656,-0.011575,0.074731,0.96617,GOBP_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
WP_6Q16_COPY_NUMBER_VARIATION,SET,14,-0.43169,-0.01191,0.23621,0.96619,WP_6Q16_COPY_NUMBER_VARIATION,1
GOBP_CELLULAR_RESPONSE_TO_CA...1,SET,33,-0.31808,-0.013466,0.17396,0.96626,GOBP_CELLULAR_RESPONSE_TO_CADMIUM_ION,1
GSE3982_DC_VS_TH2_DN,SET,178,-0.11065,-0.010837,0.06051,0.96627,GSE3982_DC_VS_TH2_DN,1
GOBP_PROTEIN_AUTOUBIQUITINAT...,SET,67,-0.18079,-0.010896,0.098841,0.9663,GOBP_PROTEIN_AUTOUBIQUITINATION,1
ZWANG_EGF_INTERVAL_UP,SET,76,-0.17754,-0.011393,0.097041,0.96633,ZWANG_EGF_INTERVAL_UP,1
GOBP_VENTRICULAR_CARDIAC_MUS...6,SET,45,-0.25851,-0.012776,0.14129,0.96634,GOBP_VENTRICULAR_CARDIAC_MUSCLE_TISSUE_MORPHOGENESIS,1
FUJII_YBX1_TARGETS_DN,SET,183,-0.11349,-0.011268,0.062021,0.96635,FUJII_YBX1_TARGETS_DN,1
GOBP_REGULATION_OF_DOPAMINER...,SET,9,-0.588,-0.013009,0.32135,0.96635,GOBP_REGULATION_OF_DOPAMINERGIC_NEURON_DIFFERENTIATION,1
GOMF_UBIQUITIN_LIKE_PROTEIN_...2,SET,36,-0.24654,-0.0109,0.13474,0.96635,GOMF_UBIQUITIN_LIKE_PROTEIN_CONJUGATING_ENZYME_ACTIVITY,1
GOBP_SPINAL_CORD_DEVELOPMENT,SET,93,-0.17167,-0.012181,0.093782,0.96641,GOBP_SPINAL_CORD_DEVELOPMENT,1
MIR6806_3P,SET,94,-0.16164,-0.01153,0.088265,0.96646,MIR6806_3P,1
GOBP_NEGATIVE_REGULATION_OF_...54,SET,4,-0.80915,-0.011936,0.44179,0.96648,GOBP_NEGATIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,1
GSE15733_BM_VS_SPLEEN_MEMORY...2,SET,176,-0.11702,-0.011396,0.063887,0.96649,GSE15733_BM_VS_SPLEEN_MEMORY_CD4_TCELL_UP,1
HP_MULTIPLE_MITOCHONDRIAL_DN...,SET,9,-0.42948,-0.0095016,0.2344,0.96653,HP_MULTIPLE_MITOCHONDRIAL_DNA_DELETIONS,1
MIR18B_3P,SET,46,-0.22198,-0.011091,0.12115,0.96654,MIR18B_3P,1
GOBP_RESPONSE_TO_HYPEROXIA,SET,17,-0.38602,-0.011735,0.21064,0.96656,GOBP_RESPONSE_TO_HYPEROXIA,1
HP_HYPERAMMONEMIA,SET,66,-0.17982,-0.010756,0.098122,0.96656,HP_HYPERAMMONEMIA,1
GOBP_REGULATION_OF_TRANSLATI...5,SET,12,-0.41742,-0.010662,0.22774,0.96658,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_BY_EIF2_ALPHA_PHOSPHORYLATION,1
GOBP_TRANS_SYNAPTIC_SIGNALIN...3,SET,7,-0.66093,-0.012896,0.3602,0.96673,GOBP_TRANS_SYNAPTIC_SIGNALING_BY_TRANS_SYNAPTIC_COMPLEX,1
GSE3982_EFF_MEMORY_CD4_TCELL...4,SET,173,-0.11908,-0.011499,0.064885,0.96676,GSE3982_EFF_MEMORY_CD4_TCELL_VS_TH1_UP,1
MIR5581_3P,SET,117,-0.14069,-0.011189,0.076627,0.96681,MIR5581_3P,1
GOBP_SOMITE_SPECIFICATION,SET,4,-0.79931,-0.011791,0.43538,0.96681,GOBP_SOMITE_SPECIFICATION,1
GOBP_MITOCHONDRIAL_RNA_3_END...,SET,6,-0.58065,-0.01049,0.31623,0.96682,GOBP_MITOCHONDRIAL_RNA_3_END_PROCESSING,1
GNF2_TST,SET,102,-0.1535,-0.011404,0.083591,0.96684,GNF2_TST,1
GOBP_REGULATION_OF_NEURON_DI...,SET,176,-0.12745,-0.012412,0.069391,0.96686,GOBP_REGULATION_OF_NEURON_DIFFERENTIATION,1
REACTOME_MET_RECEPTOR_RECYCL...,SET,10,-0.49879,-0.011632,0.27147,0.96691,REACTOME_MET_RECEPTOR_RECYCLING,1
GOBP_POSITIVE_REGULATION_OF_...173,SET,98,-0.16775,-0.012217,0.091302,0.96691,GOBP_POSITIVE_REGULATION_OF_COLD_INDUCED_THERMOGENESIS,1
GTGGTGA_MIR197,SET,64,-0.18919,-0.011145,0.10289,0.96701,GTGGTGA_MIR197,1
HP_ABNORMAL_CONJUNCTIVA_MORP...,SET,150,-0.12469,-0.011219,0.067818,0.96701,HP_ABNORMAL_CONJUNCTIVA_MORPHOLOGY,1
GSE17721_0.5H_VS_24H_POLYIC_...1,SET,183,-0.10948,-0.01087,0.059536,0.96702,GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN,1
REACTOME_CDH11_HOMOTYPIC_AND...,SET,7,-0.62795,-0.012253,0.3414,0.96706,REACTOME_CDH11_HOMOTYPIC_AND_HETEROTYPIC_INTERACTIONS,1
HP_LOCALIZED_HIRSUTISM,SET,17,-0.35031,-0.010649,0.19035,0.96713,HP_LOCALIZED_HIRSUTISM,1
GOMF_ADENOSINE_RECEPTOR_BIND...,SET,7,-0.62876,-0.012269,0.34162,0.96715,GOMF_ADENOSINE_RECEPTOR_BINDING,1
HP_PRECOCIOUS_PUBERTY_IN_FEM...,SET,9,-0.55442,-0.012266,0.30116,0.96718,HP_PRECOCIOUS_PUBERTY_IN_FEMALES,1
HP_MACRODONTIA,SET,27,-0.30283,-0.011598,0.16445,0.96721,HP_MACRODONTIA,1
GSE7831_UNSTIM_VS_INFLUENZA_...3,SET,181,-0.11549,-0.011404,0.062718,0.96721,GSE7831_UNSTIM_VS_INFLUENZA_STIM_PDC_4H_DN,1
GSE9960_HEALTHY_VS_SEPSIS_PB...2,SET,166,-0.11937,-0.011293,0.064826,0.96721,GSE9960_HEALTHY_VS_SEPSIS_PBMC_UP,1
REACTOME_SMALL_INTERFERING_R...,SET,9,-0.54608,-0.012081,0.29649,0.96724,REACTOME_SMALL_INTERFERING_RNA_SIRNA_BIOGENESIS,1
BIOCARTA_DICER_PATHWAY,SET,5,-0.77502,-0.012781,0.42077,0.96725,BIOCARTA_DICER_PATHWAY,1
GSE45365_NK_CELL_VS_CD8A_DC_...1,SET,182,-0.12067,-0.011948,0.065504,0.96726,GSE45365_NK_CELL_VS_CD8A_DC_DN,1
HP_BRACHYCEPHALY,SET,216,-0.10745,-0.01158,0.058324,0.96727,HP_BRACHYCEPHALY,1
GOBP_MITOCHONDRIAL_DNA_REPLI...,SET,13,-0.38197,-0.010155,0.20732,0.96728,GOBP_MITOCHONDRIAL_DNA_REPLICATION,1
GOBP_ENDOCYTIC_RECYCLING,SET,74,-0.1805,-0.01143,0.09796,0.9673,GOBP_ENDOCYTIC_RECYCLING,1
GOMF_OXIDOREDUCTASE_ACTIVITY...1,SET,11,-0.40946,-0.010014,0.22222,0.9673,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_A_HEME_GROUP_OF_DONORS,1
GSE20715_0H_VS_48H_OZONE_TLR...2,SET,187,-0.11547,-0.011588,0.062636,0.96737,GSE20715_0H_VS_48H_OZONE_TLR4_KO_LUNG_UP,1
MIR1298_3P,SET,41,-0.24777,-0.01169,0.13438,0.96739,MIR1298_3P,1
REACTOME_PROTEIN_PROTEIN_INT...,SET,77,-0.18488,-0.011942,0.10026,0.9674,REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES,1
GOBP_NEUROBLAST_DIVISION,SET,14,-0.42524,-0.011732,0.23042,0.96751,GOBP_NEUROBLAST_DIVISION,1
KEGG_MEDICUS_REFERENCE_CREAT...,SET,7,-0.55932,-0.010913,0.30293,0.96757,KEGG_MEDICUS_REFERENCE_CREATINE_PATHWAY,1
NAGY_TFTC_COMPONENTS_HUMAN,SET,17,-0.31502,-0.0095763,0.17061,0.96758,NAGY_TFTC_COMPONENTS_HUMAN,1
RIZKI_TUMOR_INVASIVENESS_2D_...2,SET,60,-0.19851,-0.011324,0.10751,0.96758,RIZKI_TUMOR_INVASIVENESS_2D_UP,1
GOBP_NEGATIVE_REGULATION_OF_...267,SET,55,-0.21755,-0.011883,0.1178,0.9676,GOBP_NEGATIVE_REGULATION_OF_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
GAUTAM_EYE_IRIS_CILIARY_BODY...10,SET,77,-0.18601,-0.012014,0.10068,0.96766,GAUTAM_EYE_IRIS_CILIARY_BODY_MGP_HIGH_FIBROBLASTS,1
GOBP_NEGATIVE_REGULATION_OF_...531,SET,25,-0.30861,-0.011374,0.16702,0.96767,GOBP_NEGATIVE_REGULATION_OF_PROTEIN_MATURATION,1
HP_HYPERREFLEXIA,SET,707,-0.057706,-0.011098,0.031226,0.96769,HP_HYPERREFLEXIA,1
GOBP_NEGATIVE_REGULATION_OF_...341,SET,12,-0.46518,-0.011883,0.25169,0.96771,GOBP_NEGATIVE_REGULATION_OF_LEUKOCYTE_DEGRANULATION,1
ENK_UV_RESPONSE_EPIDERMIS_UP,SET,269,-0.09487,-0.011393,0.051322,0.96773,ENK_UV_RESPONSE_EPIDERMIS_UP,1
GOBP_SRP_DEPENDENT_COTRANSLA...1,SET,16,-0.35977,-0.01061,0.19463,0.96773,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1
GOMF_PROTEIN_FOLDING_CHAPERO...2,SET,125,-0.13589,-0.011169,0.073504,0.96775,GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING,1
GOBP_POSITIVE_REGULATION_OF_...151,SET,5,-0.71217,-0.011745,0.38513,0.96777,GOBP_POSITIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
GSE8685_IL2_ACT_IL2_STARVED_...2,SET,181,-0.11223,-0.011083,0.060665,0.96783,GSE8685_IL2_ACT_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_UP,1
HP_DROWSINESS,SET,52,-0.20481,-0.010879,0.11067,0.96788,HP_DROWSINESS,1
REACTOME_ACYL_CHAIN_REMODELL...1,SET,25,-0.34038,-0.012545,0.18391,0.96789,REACTOME_ACYL_CHAIN_REMODELLING_OF_PC,1
GOBP_POSITIVE_REGULATION_OF_...242,SET,96,-0.16594,-0.011961,0.089653,0.9679,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,1
HP_IMPAIRED_T_CELL_FUNCTION,SET,28,-0.30018,-0.011707,0.16218,0.9679,HP_IMPAIRED_T_CELL_FUNCTION,1
GOBP_REGULATION_OF_SYNAPTIC_...14,SET,3,-0.94459,-0.012067,0.51025,0.96792,GOBP_REGULATION_OF_SYNAPTIC_VESICLE_TRANSPORT,1
HAND1_TARGET_GENES,SET,362,-0.083233,-0.011566,0.044949,0.96796,HAND1_TARGET_GENES,1
GOBP_RESPONSE_TO_FOOD,SET,35,-0.28076,-0.012241,0.1516,0.96798,GOBP_RESPONSE_TO_FOOD,1
HP_HEPATOCELLULAR_ADENOMA,SET,17,-0.41825,-0.012714,0.22583,0.96798,HP_HEPATOCELLULAR_ADENOMA,1
VALK_AML_CLUSTER_6,SET,32,-0.28213,-0.011762,0.15231,0.96801,VALK_AML_CLUSTER_6,1
GOMF_RNA_POLYMERASE_II_CTD_H...3,SET,7,-0.5387,-0.010511,0.29079,0.96802,GOMF_RNA_POLYMERASE_II_CTD_HEPTAPEPTIDE_REPEAT_PHOSPHATASE_ACTIVITY,1
GOCC_MYELIN_SHEATH_ABAXONAL_...,SET,6,-0.61411,-0.011094,0.33145,0.96804,GOCC_MYELIN_SHEATH_ABAXONAL_REGION,1
GOBP_REGULATION_OF_CYSTEINE_...1,SET,176,-0.12019,-0.011705,0.064862,0.96805,GOBP_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
MIR6738_3P,SET,137,-0.12951,-0.01114,0.06986,0.96811,MIR6738_3P,1
GOMF_1_4_ALPHA_OLIGOGLUCAN_P...,SET,5,-0.66777,-0.011013,0.36019,0.96812,GOMF_1_4_ALPHA_OLIGOGLUCAN_PHOSPHORYLASE_ACTIVITY,1
GSE46606_IRF4HIGH_VS_WT_CD40...4,SET,180,-0.11834,-0.011654,0.063829,0.96812,GSE46606_IRF4HIGH_VS_WT_CD40L_IL2_IL5_DAY3_STIMULATED_BCELL_UP,1
GSE9037_WT_VS_IRAK4_KO_BMDM_...1,SET,179,-0.11484,-0.011278,0.061933,0.96814,GSE9037_WT_VS_IRAK4_KO_BMDM_DN,1
ELVIDGE_HIF1A_TARGETS_DN,SET,81,-0.17443,-0.011554,0.094047,0.96817,ELVIDGE_HIF1A_TARGETS_DN,1
GOBP_METANEPHRIC_NEPHRON_TUB...2,SET,8,-0.60849,-0.012692,0.32804,0.96819,GOBP_METANEPHRIC_NEPHRON_TUBULE_MORPHOGENESIS,1
GSE3982_MAST_CELL_VS_NKCELL_...1,SET,179,-0.1174,-0.011529,0.06329,0.96819,GSE3982_MAST_CELL_VS_NKCELL_DN,1
MIR203A_3P,SET,334,-0.088185,-0.011779,0.047528,0.96822,MIR203A_3P,1
CAO_BLOOD_FLUZONE_AGE_05_14Y...3,SET,7,-0.59721,-0.011653,0.3218,0.96825,CAO_BLOOD_FLUZONE_AGE_05_14YO_30DY_DN,1
GOBP_CIRCADIAN_SLEEP_WAKE_CY...3,SET,16,-0.42156,-0.012433,0.22708,0.9683,GOBP_CIRCADIAN_SLEEP_WAKE_CYCLE_SLEEP,1
WP_13Q1212_COPY_NUMBER_VARIA...,SET,31,-0.27709,-0.01137,0.14924,0.96831,WP_13Q1212_COPY_NUMBER_VARIATION,1
REACTOME_PROCESSIVE_SYNTHESI...1,SET,19,-0.32984,-0.0106,0.17762,0.96833,REACTOME_PROCESSIVE_SYNTHESIS_ON_THE_C_STRAND_OF_THE_TELOMERE,1
WP_EXTRACELLULAR_VESICLEMEDI...,SET,29,-0.30101,-0.011947,0.1621,0.96833,WP_EXTRACELLULAR_VESICLEMEDIATED_SIGNALING_IN_RECIPIENT_CELLS,1
HP_IMPAIRED_VISUOSPATIAL_CON...,SET,19,-0.36561,-0.011749,0.1969,0.96833,HP_IMPAIRED_VISUOSPATIAL_CONSTRUCTIVE_COGNITION,1
GSE13547_WT_VS_ZFX_KO_BCELL_...6,SET,156,-0.1334,-0.012238,0.071819,0.96837,GSE13547_WT_VS_ZFX_KO_BCELL_UP,1
GOBP_CATECHOLAMINE_TRANSPORT,SET,61,-0.21032,-0.012097,0.11317,0.96844,GOBP_CATECHOLAMINE_TRANSPORT,1
REACTOME_TFAP2_AP_2_FAMILY_R...1,SET,5,-0.7417,-0.012232,0.39881,0.96853,REACTOME_TFAP2_AP_2_FAMILY_REGULATES_TRANSCRIPTION_OF_CELL_CYCLE_FACTORS,1
BIOCARTA_CERAMIDE_PATHWAY,SET,20,-0.36077,-0.011894,0.19395,0.96856,BIOCARTA_CERAMIDE_PATHWAY,1
HP_CONGENITAL_ICHTHYOSIFORM_...,SET,27,-0.31976,-0.012247,0.17189,0.96857,HP_CONGENITAL_ICHTHYOSIFORM_ERYTHRODERMA,1
MORF_SS18,SET,56,-0.19462,-0.010726,0.10461,0.96858,MORF_SS18,1
REACTOME_FGFR2B_LIGAND_BINDI...,SET,10,-0.57882,-0.013498,0.31107,0.9686,REACTOME_FGFR2B_LIGAND_BINDING_AND_ACTIVATION,1
REACTOME_POSITIVE_EPIGENETIC...,SET,42,-0.2159,-0.010309,0.11603,0.9686,REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION,1
GOBP_GENERATION_OF_PRECURSOR...,SET,393,-0.076082,-0.011006,0.040887,0.96861,GOBP_GENERATION_OF_PRECURSOR_METABOLITES_AND_ENERGY,1
MIR4498,SET,232,-0.10406,-0.011618,0.055908,0.96864,MIR4498,1
GOBP_POSITIVE_REGULATION_OF_...704,SET,18,-0.39699,-0.012418,0.21329,0.96864,GOBP_POSITIVE_REGULATION_OF_SKELETAL_MUSCLE_TISSUE_DEVELOPMENT,1
GOBP_REGULATION_OF_MONOOXYGE...,SET,32,-0.28125,-0.011725,0.15106,0.96868,GOBP_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
HP_ABNORMALITY_OF_THE_ANTERI...2,SET,110,-0.14682,-0.011325,0.078854,0.96869,HP_ABNORMALITY_OF_THE_ANTERIOR_FONTANELLE,1
GSE24726_WT_VS_E2_2_KO_PDC_D...1,SET,186,-0.1149,-0.011501,0.061696,0.96872,GSE24726_WT_VS_E2_2_KO_PDC_DAY4_POST_DELETION_UP,1
GOBP_SMALL_GTPASE_MEDIATED_S...,SET,462,-0.074453,-0.011655,0.039961,0.96877,GOBP_SMALL_GTPASE_MEDIATED_SIGNAL_TRANSDUCTION,1
MIR3122,SET,59,-0.19864,-0.011237,0.10661,0.96878,MIR3122,1
HP_PULMONARY_OPACITY,SET,22,-0.35038,-0.012115,0.18804,0.96878,HP_PULMONARY_OPACITY,1
GOBP_REGULATION_OF_ANTIGEN_P...3,SET,4,-0.83872,-0.012372,0.45009,0.96879,GOBP_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION_OF_PEPTIDE_OR_POLYSACCHARIDE_ANTIGEN_VIA_MHC_CLASS_II,1
REACTOME_ACTIVATION_OF_NMDA_...,SET,85,-0.17641,-0.01197,0.094668,0.9688,REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS,1
HP_USUAL_INTERSTITIAL_PNEUMO...,SET,13,-0.45142,-0.012001,0.24224,0.9688,HP_USUAL_INTERSTITIAL_PNEUMONIA,1
KEGG_MEDICUS_REFERENCE_COPI_...,SET,23,-0.27556,-0.0097419,0.14782,0.96884,KEGG_MEDICUS_REFERENCE_COPI_VESICLE_FORMATION,1
HP_PAPILLOMA,SET,46,-0.21556,-0.010771,0.11563,0.96884,HP_PAPILLOMA,1
GOBP_D_AMINO_ACID_TRANSPORT,SET,6,-0.67415,-0.012179,0.36157,0.96886,GOBP_D_AMINO_ACID_TRANSPORT,1
HP_HEMATEMESIS,SET,17,-0.41455,-0.012602,0.22231,0.96888,HP_HEMATEMESIS,1
GOMF_G_PROTEIN_COUPLED_RECEP...1,SET,696,-0.074947,-0.014306,0.040185,0.96891,GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY,1
GSE40666_WT_VS_STAT4_KO_CD8_...1,SET,175,-0.11292,-0.010967,0.060543,0.96891,GSE40666_WT_VS_STAT4_KO_CD8_TCELL_DN,1
HP_HYPOLIPIDEMIA,SET,10,-0.49293,-0.011495,0.2642,0.96895,HP_HYPOLIPIDEMIA,1
MIR148A_5P,SET,102,-0.15605,-0.011593,0.083598,0.96902,MIR148A_5P,1
GOBP_NEGATIVE_REGULATION_OF_...246,SET,4,-0.63635,-0.0093868,0.34088,0.96903,GOBP_NEGATIVE_REGULATION_OF_G0_TO_G1_TRANSITION,1
GSE29164_UNTREATED_VS_CD8_TC...1,SET,183,-0.11076,-0.010997,0.05933,0.96903,GSE29164_UNTREATED_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN,1
GOBP_REGULATION_OF_KIDNEY_DE...,SET,31,-0.31483,-0.012919,0.16863,0.96904,GOBP_REGULATION_OF_KIDNEY_DEVELOPMENT,1
GOBP_MAINTENANCE_OF_PROTEIN_...3,SET,81,-0.17387,-0.011517,0.093118,0.96906,GOBP_MAINTENANCE_OF_PROTEIN_LOCATION,1
GOBP_PROTEIN_LOCALIZATION_TO...3,SET,7,-0.60084,-0.011724,0.32173,0.96908,GOBP_PROTEIN_LOCALIZATION_TO_BASOLATERAL_PLASMA_MEMBRANE,1
GOBP_NEGATIVE_REGULATION_OF_...606,SET,4,-0.91213,-0.013455,0.48828,0.96911,GOBP_NEGATIVE_REGULATION_OF_SOMATIC_STEM_CELL_POPULATION_MAINTENANCE,1
GSE21670_UNTREATED_VS_TGFB_T...1,SET,177,-0.11964,-0.011684,0.064029,0.96915,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_DN,1
MIR599,SET,81,-0.17399,-0.011525,0.0931,0.96917,MIR599,1
GOBP_RETINA_VASCULATURE_MORP...,SET,9,-0.54878,-0.012141,0.29362,0.96918,GOBP_RETINA_VASCULATURE_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
MIR6757_3P,SET,96,-0.15771,-0.011369,0.084343,0.96924,MIR6757_3P,1
GCGCTTT_MIR518B_MIR518C_MIR5...,SET,17,-0.35322,-0.010738,0.1889,0.96925,GCGCTTT_MIR518B_MIR518C_MIR518D,1
GOBP_CELL_PROLIFERATION_IN_B...,SET,8,-0.52943,-0.011043,0.28311,0.96925,GOBP_CELL_PROLIFERATION_IN_BONE_MARROW,1
GOBP_DENTINOGENESIS,SET,6,-0.72264,-0.013055,0.38637,0.96927,GOBP_DENTINOGENESIS,1
GOBP_REGULATION_OF_MDA_5_SIG...,SET,6,-0.54616,-0.0098665,0.29186,0.96934,GOBP_REGULATION_OF_MDA_5_SIGNALING_PATHWAY,1
GOMF_CARBOXYPEPTIDASE_ACTIVI...,SET,42,-0.25258,-0.01206,0.13497,0.96934,GOMF_CARBOXYPEPTIDASE_ACTIVITY,1
GSE12392_WT_VS_IFNB_KO_CD8A_...2,SET,185,-0.11338,-0.011318,0.060566,0.96939,GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_UP,1
GSE31082_CD4_VS_CD8_SP_THYMO...2,SET,178,-0.11831,-0.011587,0.063199,0.9694,GSE31082_CD4_VS_CD8_SP_THYMOCYTE_UP,1
ATCATGA_MIR433,SET,107,-0.14937,-0.011364,0.079772,0.96942,ATCATGA_MIR433,1
RNGTGGGC_UNKNOWN,SET,709,-0.061354,-0.011816,0.032761,0.96944,RNGTGGGC_UNKNOWN,1
GOCC_SHELTERIN_COMPLEX,SET,6,-0.5954,-0.010756,0.31788,0.96946,GOCC_SHELTERIN_COMPLEX,1
KEGG_MEDICUS_VARIANT_AMPLIFI...9,SET,9,-0.54055,-0.011959,0.28858,0.96947,KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_CENTROMER...1,SET,4,-0.95168,-0.014038,0.50807,0.96947,GOBP_REGULATION_OF_CENTROMERE_COMPLEX_ASSEMBLY,1
QIU_PBMC_HEPTATITIS_B_SURFAC...3,SET,7,-0.62789,-0.012251,0.33519,0.96947,QIU_PBMC_HEPTATITIS_B_SURFACE_ANTIGEN_AGE_UNDER50_NON_RESPONDERS_VS_RESPONDERS_28DY_DN,1
ZHAN_V1_LATE_DIFFERENTIATION...2,SET,31,-0.28996,-0.011898,0.15474,0.96952,ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP,1
GSE5542_IFNG_VS_IFNA_TREATED...1,SET,175,-0.1209,-0.011742,0.064512,0.96954,GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_DN,1
GSE5542_UNTREATED_VS_IFNA_TR...4,SET,172,-0.12589,-0.012122,0.067172,0.96954,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_6H_UP,1
NAKAYA_PBMC_FLUARIX_FLUVIRIN...6,SET,379,-0.081313,-0.011556,0.043381,0.96955,NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE,1
GOMF_MEMBRANE_POTENTIAL_DRIV...,SET,5,-0.82137,-0.013546,0.43814,0.96957,GOMF_MEMBRANE_POTENTIAL_DRIVEN_UNIPORTER_ACTIVITY,1
HP_INVOLUNTARY_VOCALIZATION,SET,42,-0.23299,-0.011125,0.12426,0.96959,HP_INVOLUNTARY_VOCALIZATION,1
GOCC_MMXD_COMPLEX,SET,3,-0.78713,-0.010056,0.4196,0.96966,GOCC_MMXD_COMPLEX,1
HP_RIDGED_NAIL,SET,20,-0.32627,-0.010757,0.17389,0.96968,HP_RIDGED_NAIL,1
MIR375_3P,SET,36,-0.26518,-0.011725,0.14124,0.96977,MIR375_3P,1
GSE5099_MONOCYTE_VS_CLASSICA...1,SET,177,-0.11368,-0.011102,0.060537,0.96979,GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN,1
GSE8921_UNSTIM_0H_VS_TLR1_2_...4,SET,171,-0.12414,-0.011919,0.066096,0.96982,GSE8921_UNSTIM_0H_VS_TLR1_2_STIM_MONOCYTE_24H_UP,1
GOBP_REGULATION_OF_TRANSLATI...6,SET,15,-0.39174,-0.011187,0.20842,0.96991,GOBP_REGULATION_OF_TRANSLATIONAL_INITIATION_IN_RESPONSE_TO_STRESS,1
HP_OPEN_ANGLE_GLAUCOMA,SET,12,-0.51007,-0.013029,0.27136,0.96992,HP_OPEN_ANGLE_GLAUCOMA,1
MIR505_3P,SET,98,-0.15624,-0.011378,0.083066,0.97,MIR505_3P,1
GOBP_POSITIVE_REGULATION_OF_...450,SET,11,-0.51108,-0.012499,0.27164,0.97004,GOBP_POSITIVE_REGULATION_OF_MEMBRANE_POTENTIAL,1
HP_ABNORMAL_BRAIN_FDG_POSITR...,SET,23,-0.32074,-0.011339,0.17046,0.97005,HP_ABNORMAL_BRAIN_FDG_POSITRON_EMISSION_TOMOGRAPHY,1
GOBP_APOPTOTIC_PROCESS_INVOL...2,SET,4,-0.97178,-0.014335,0.5164,0.97006,GOBP_APOPTOTIC_PROCESS_INVOLVED_IN_HEART_MORPHOGENESIS,1
TURJANSKI_MAPK11_TARGETS,SET,4,-0.82019,-0.012099,0.43575,0.97009,TURJANSKI_MAPK11_TARGETS,1
GSE13522_WT_VS_IFNG_KO_SKIN_...1,SET,109,-0.15608,-0.011984,0.082924,0.97009,GSE13522_WT_VS_IFNG_KO_SKIN_DN,1
GOBP_LONG_CHAIN_FATTY_ACID_T...,SET,65,-0.19921,-0.011826,0.10582,0.97011,GOBP_LONG_CHAIN_FATTY_ACID_TRANSPORT,1
GSE17721_0.5H_VS_4H_GARDIQUI...1,SET,185,-0.1149,-0.011469,0.061028,0.97012,GSE17721_0.5H_VS_4H_GARDIQUIMOD_BMDC_DN,1
HE_LIM_SUN_FETAL_LUNG_C1_GHR...2,SET,376,-0.08509,-0.012045,0.045193,0.97013,HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL,1
GSE19825_NAIVE_VS_DAY3_EFF_C...1,SET,181,-0.11009,-0.010871,0.05844,0.97019,GSE19825_NAIVE_VS_DAY3_EFF_CD8_TCELL_DN,1
GOMF_HETEROTRIMERIC_G_PROTEI...,SET,5,-0.81157,-0.013384,0.43075,0.97022,GOMF_HETEROTRIMERIC_G_PROTEIN_BINDING,1
GOBP_FIBROBLAST_GROWTH_FACTO...2,SET,74,-0.19985,-0.012655,0.10606,0.97023,GOBP_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_RENAL_TUBULE_DEVELOPMENT,SET,96,-0.17991,-0.012969,0.095473,0.97024,GOBP_RENAL_TUBULE_DEVELOPMENT,1
DURANTE_ADULT_OLFACTORY_NEUR...7,SET,31,-0.31199,-0.012802,0.16556,0.97024,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_GLOBOSE_BASAL_CELLS,1
GOBP_NEUROTRANSMITTER_RECEPT...3,SET,24,-0.34844,-0.012583,0.18489,0.97025,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT,1
HOLLEMAN_DAUNORUBICIN_ALL_UP,SET,6,-0.66235,-0.011966,0.35142,0.97026,HOLLEMAN_DAUNORUBICIN_ALL_UP,1
HP_ABNORMAL_RENAL_TUBULAR_RE...,SET,19,-0.37314,-0.011991,0.1979,0.97031,HP_ABNORMAL_RENAL_TUBULAR_RESORPTION,1
MIR7702,SET,50,-0.21384,-0.011139,0.11339,0.97034,MIR7702,1
MIR6512_3P,SET,122,-0.1428,-0.011596,0.075681,0.9704,MIR6512_3P,1
GOMF_PEPTIDE_HORMONE_BINDING,SET,48,-0.25283,-0.012904,0.13396,0.97044,GOMF_PEPTIDE_HORMONE_BINDING,1
HP_RETINAL_NONATTACHMENT,SET,7,-0.64624,-0.01261,0.34237,0.97045,HP_RETINAL_NONATTACHMENT,1
KOMMAGANI_TP63_GAMMA_TARGETS,SET,9,-0.51673,-0.011432,0.27363,0.97051,KOMMAGANI_TP63_GAMMA_TARGETS,1
GOBP_REGULATION_OF_MUSCLE_HY...,SET,53,-0.23737,-0.012728,0.12569,0.97051,GOBP_REGULATION_OF_MUSCLE_HYPERTROPHY,1
GOMF_GENERAL_TRANSCRIPTION_I...2,SET,50,-0.21715,-0.011311,0.11496,0.97054,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,1
PEDERSEN_METASTASIS_BY_ERBB2...5,SET,25,-0.36261,-0.013365,0.19192,0.97057,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6,1
HENDRICKS_SMARCA4_TARGETS_UP,SET,51,-0.24238,-0.01275,0.12828,0.97058,HENDRICKS_SMARCA4_TARGETS_UP,1
MIR1277_5P,SET,820,-0.058409,-0.012059,0.030892,0.97066,MIR1277_5P,1
GOBP_RESPONSE_TO_MAGNESIUM_I...,SET,20,-0.38735,-0.012771,0.2048,0.9707,GOBP_RESPONSE_TO_MAGNESIUM_ION,1
CHIARETTI_T_ALL_RELAPSE_PROG...,SET,17,-0.39909,-0.012132,0.21098,0.97072,CHIARETTI_T_ALL_RELAPSE_PROGNOSIS,1
GOBP_LONG_TERM_SYNAPTIC_POTE...,SET,89,-0.17278,-0.011995,0.091341,0.97072,GOBP_LONG_TERM_SYNAPTIC_POTENTIATION,1
MODULE_543,SET,14,-0.44048,-0.012152,0.23282,0.97074,MODULE_543,1
GOLDRATH_IMMUNE_MEMORY,SET,61,-0.21627,-0.012439,0.1143,0.97075,GOLDRATH_IMMUNE_MEMORY,1
MARTIN_INTERACT_WITH_HDAC,SET,37,-0.24984,-0.011199,0.13204,0.97076,MARTIN_INTERACT_WITH_HDAC,1
AKT_UP_MTOR_DN.V1_UP,SET,166,-0.12777,-0.012088,0.067524,0.97076,AKT_UP_MTOR_DN.V1_UP,1
GOBP_BIOGENIC_AMINE_METABOLI...,SET,83,-0.18338,-0.012295,0.096902,0.97077,GOBP_BIOGENIC_AMINE_METABOLIC_PROCESS,1
GNF2_ATM,SET,25,-0.30865,-0.011376,0.16309,0.97078,GNF2_ATM,1
WILLIAMS_ESR1_TARGETS_UP,SET,25,-0.34295,-0.01264,0.18118,0.9708,WILLIAMS_ESR1_TARGETS_UP,1
GAO_LARGE_INTESTINE_24W_C8_G...,SET,38,-0.28339,-0.012873,0.14971,0.97081,GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL,1
GOBP_CELLULAR_RESPONSE_TO_AM...1,SET,5,-0.80957,-0.013351,0.42764,0.97082,GOBP_CELLULAR_RESPONSE_TO_AMMONIUM_ION,1
GOBP_RESPONSE_TO_AMMONIUM_ION,SET,5,-0.80957,-0.013351,0.42764,0.97082,GOBP_RESPONSE_TO_AMMONIUM_ION,1
HP_LICHENIFICATION,SET,15,-0.40654,-0.01161,0.21471,0.97084,HP_LICHENIFICATION,1
CDC5_01,SET,228,-0.11148,-0.01234,0.058856,0.97089,CDC5_01,1
WP_GENES_CONTROLLING_NEPHROG...,SET,41,-0.27992,-0.013206,0.14775,0.97091,WP_GENES_CONTROLLING_NEPHROGENESIS,1
MIR12120,SET,164,-0.1252,-0.011774,0.066088,0.97091,MIR12120,1
BAHD1_TARGET_GENES,SET,18,-0.36355,-0.011372,0.19186,0.97094,BAHD1_TARGET_GENES,1
GOBP_REGULATION_OF_SISTER_CH...2,SET,101,-0.15227,-0.011257,0.080335,0.97098,GOBP_REGULATION_OF_SISTER_CHROMATID_SEGREGATION,1
GSE13411_NAIVE_VS_MEMORY_BCE...2,SET,163,-0.12633,-0.011844,0.066647,0.97098,GSE13411_NAIVE_VS_MEMORY_BCELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...68,SET,14,-0.43362,-0.011963,0.22869,0.97102,GOBP_POSITIVE_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,1
GOCC_CATENIN_COMPLEX,SET,31,-0.32074,-0.013162,0.16916,0.97102,GOCC_CATENIN_COMPLEX,1
GOBP_NEPHRIC_DUCT_FORMATION,SET,5,-0.8147,-0.013436,0.42959,0.97104,GOBP_NEPHRIC_DUCT_FORMATION,1
MORF_TFDP2,SET,211,-0.10936,-0.011651,0.057659,0.97106,MORF_TFDP2,1
HP_PSEUDOARTHROSIS,SET,8,-0.57195,-0.01193,0.30154,0.97106,HP_PSEUDOARTHROSIS,1
MIR3174,SET,38,-0.27247,-0.012376,0.14357,0.97113,MIR3174,1
GSE17721_PAM3CSK4_VS_GADIQUI...1,SET,180,-0.11799,-0.01162,0.062167,0.97114,GSE17721_PAM3CSK4_VS_GADIQUIMOD_0.5H_BMDC_DN,1
DESCARTES_FETAL_INTESTINE_SM...,SET,41,-0.25996,-0.012264,0.13693,0.97117,DESCARTES_FETAL_INTESTINE_SMOOTH_MUSCLE_CELLS,1
GOCC_INSULIN_LIKE_GROWTH_FAC...,SET,5,-0.84255,-0.013895,0.44373,0.9712,GOCC_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEIN_COMPLEX,1
GOMF_FIBROBLAST_GROWTH_FACTO...3,SET,24,-0.36623,-0.013226,0.19285,0.97121,GOMF_FIBROBLAST_GROWTH_FACTOR_RECEPTOR_BINDING,1
GSE29617_CTRL_VS_DAY7_TIV_FL...2,SET,171,-0.13439,-0.012902,0.070765,0.97121,GSE29617_CTRL_VS_DAY7_TIV_FLU_VACCINE_PBMC_2008_UP,1
GOBP_HEMATOPOIETIC_STEM_CELL...2,SET,19,-0.38661,-0.012424,0.20349,0.97127,GOBP_HEMATOPOIETIC_STEM_CELL_HOMEOSTASIS,1
GOBP_L_LEUCINE_METABOLIC_PRO...,SET,8,-0.55435,-0.011563,0.29174,0.97128,GOBP_L_LEUCINE_METABOLIC_PROCESS,1
MENON_FETAL_KIDNEY_0_CAP_MES...,SET,73,-0.18684,-0.011752,0.098336,0.97128,MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS,1
SIG_CD40PATHWAYMAP,SET,33,-0.28517,-0.012073,0.15007,0.97129,SIG_CD40PATHWAYMAP,1
WP_GDNFRET_SIGNALING_AXIS,SET,20,-0.42711,-0.014082,0.22477,0.97129,WP_GDNFRET_SIGNALING_AXIS,1
HP_BILATERAL_RENAL_AGENESIS,SET,10,-0.58229,-0.013579,0.30639,0.97131,HP_BILATERAL_RENAL_AGENESIS,1
GOBP_POLYAMINE_METABOLIC_PRO...,SET,15,-0.37335,-0.010662,0.19642,0.97133,GOBP_POLYAMINE_METABOLIC_PROCESS,1
E2F1_UP.V1_DN,SET,176,-0.12237,-0.011917,0.064292,0.97149,E2F1_UP.V1_DN,1
GOCC_COMPLEX_OF_COLLAGEN_TRI...,SET,19,-0.38438,-0.012353,0.20191,0.97152,GOCC_COMPLEX_OF_COLLAGEN_TRIMERS,1
MIR616_3P,SET,41,-0.26116,-0.012321,0.13714,0.97155,MIR616_3P,1
WP_GLYCOSAMINOGLYCAN_DEGRADA...,SET,16,-0.4177,-0.012319,0.21933,0.97156,WP_GLYCOSAMINOGLYCAN_DEGRADATION,1
HP_DICARBOXYLIC_ACIDURIA,SET,64,-0.20011,-0.011788,0.10507,0.97157,HP_DICARBOXYLIC_ACIDURIA,1
HP_DECREASED_NUMBER_OF_LARGE...,SET,18,-0.349,-0.010917,0.18322,0.97159,HP_DECREASED_NUMBER_OF_LARGE_PERIPHERAL_MYELINATED_NERVE_FIBERS,1
NUYTTEN_NIPP1_TARGETS_UP,SET,665,-0.062378,-0.011649,0.032745,0.9716,NUYTTEN_NIPP1_TARGETS_UP,1
chr4p13,SET,12,-0.68505,-0.017499,0.3596,0.97161,chr4p13,1
GOBP_CGMP_METABOLIC_PROCESS,SET,13,-0.4533,-0.012052,0.23781,0.97168,GOBP_CGMP_METABOLIC_PROCESS,1
GOBP_MODULATION_BY_VIRUS_OF_...,SET,3,-0.91679,-0.011712,0.48095,0.97168,GOBP_MODULATION_BY_VIRUS_OF_HOST_PROCESS,1
chr1p32,SET,63,-0.34767,-0.02032,0.18237,0.97169,chr1p32,1
GOBP_REGULATION_OF_STRESS_GR...,SET,11,-0.39793,-0.0097321,0.20873,0.97169,GOBP_REGULATION_OF_STRESS_GRANULE_ASSEMBLY,1
GOMF_SHORT_CHAIN_FATTY_ACYL_...,SET,5,-0.66181,-0.010914,0.34715,0.97169,GOMF_SHORT_CHAIN_FATTY_ACYL_COA_DEHYDROGENASE_ACTIVITY,1
GSE17580_TREG_VS_TEFF_DN,SET,189,-0.11692,-0.011796,0.06133,0.97169,GSE17580_TREG_VS_TEFF_DN,1
GSE16450_IMMATURE_VS_MATURE_...6,SET,164,-0.12541,-0.011794,0.065775,0.97171,GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_UP,1
GOBP_CYTOSOLIC_RIBOSOME_ASSE...,SET,7,-0.54774,-0.010688,0.28726,0.97172,GOBP_CYTOSOLIC_RIBOSOME_ASSEMBLY,1
GOBP_REGULATION_OF_PHOSPHATI...1,SET,5,-0.77295,-0.012747,0.40537,0.97172,GOBP_REGULATION_OF_PHOSPHATIDYLCHOLINE_BIOSYNTHETIC_PROCESS,1
HP_ABNORMAL_COCCYX_MORPHOLOGY,SET,8,-0.66587,-0.013889,0.34916,0.97174,HP_ABNORMAL_COCCYX_MORPHOLOGY,1
HP_HYPOPLASIA_OF_THE_FRONTAL...,SET,33,-0.26134,-0.011064,0.13699,0.97178,HP_HYPOPLASIA_OF_THE_FRONTAL_LOBES,1
GOMF_SIGNALING_ADAPTOR_ACTIV...,SET,109,-0.15412,-0.011834,0.080732,0.97186,GOMF_SIGNALING_ADAPTOR_ACTIVITY,1
NF1_Q6,SET,240,-0.10715,-0.012164,0.056121,0.97187,NF1_Q6,1
GOMF_GLUTAMATE_SODIUM_SYMPOR...,SET,5,-0.82979,-0.013685,0.43463,0.97187,GOMF_GLUTAMATE_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_PIGMENT_BIOSYNTHETIC_PR...,SET,49,-0.2295,-0.011834,0.12018,0.97191,GOBP_PIGMENT_BIOSYNTHETIC_PROCESS,1
REPIN1_TARGET_GENES,SET,5,-0.82436,-0.013595,0.43159,0.97193,REPIN1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...709,SET,5,-0.56007,-0.0092364,0.29321,0.97193,GOBP_NEGATIVE_REGULATION_OF_WOUND_HEALING_SPREADING_OF_EPIDERMAL_CELLS,1
IGLESIAS_E2F_TARGETS_DN,SET,11,-0.52334,-0.012799,0.27397,0.97194,IGLESIAS_E2F_TARGETS_DN,1
HP_TITUBATION,SET,29,-0.31236,-0.012398,0.16353,0.97194,HP_TITUBATION,1
FAN_EMBRYONIC_CTX_NSC_2,SET,215,-0.10605,-0.011403,0.055503,0.97197,FAN_EMBRYONIC_CTX_NSC_2,1
GOBP_OVULATION_CYCLE_PROCESS,SET,49,-0.24867,-0.012823,0.13012,0.97199,GOBP_OVULATION_CYCLE_PROCESS,1
GOBP_RESPONSE_TO_STIMULUS_IN...,SET,13,-0.46919,-0.012474,0.24547,0.97201,GOBP_RESPONSE_TO_STIMULUS_INVOLVED_IN_REGULATION_OF_MUSCLE_ADAPTATION,1
HP_ORGANIC_ACIDURIA,SET,112,-0.15563,-0.012112,0.081402,0.97204,HP_ORGANIC_ACIDURIA,1
HP_RESPIRATORY_ALKALOSIS,SET,5,-0.71003,-0.01171,0.37138,0.97205,HP_RESPIRATORY_ALKALOSIS,1
MIR379_3P_MIR411_3P,SET,173,-0.12895,-0.012452,0.067436,0.97207,MIR379_3P_MIR411_3P,1
HP_PARASOMNIA,SET,37,-0.26932,-0.012072,0.14078,0.97212,HP_PARASOMNIA,1
MIR186_5P,SET,507,-0.072815,-0.011926,0.038057,0.97214,MIR186_5P,1
GOBP_CARDIAC_MUSCLE_CELL_MYO...,SET,11,-0.55655,-0.013612,0.29079,0.97218,GOBP_CARDIAC_MUSCLE_CELL_MYOBLAST_DIFFERENTIATION,1
RB_P107_DN.V1_DN,SET,110,-0.14246,-0.010988,0.07443,0.97218,RB_P107_DN.V1_DN,1
GOMF_DEATH_RECEPTOR_BINDING,SET,19,-0.35292,-0.011342,0.18436,0.9722,GOMF_DEATH_RECEPTOR_BINDING,1
GSE17721_POLYIC_VS_GARDIQUIM...6,SET,186,-0.11697,-0.011707,0.061102,0.9722,GSE17721_POLYIC_VS_GARDIQUIMOD_16H_BMDC_UP,1
GSE22886_CD8_VS_CD4_NAIVE_TC...1,SET,176,-0.12364,-0.012041,0.064583,0.97221,GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...272,SET,3,-1.185,-0.015139,0.61886,0.97223,GOBP_NEGATIVE_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
HP_APLASIA_HYPOPLASIA_OF_THE...23,SET,6,-0.75968,-0.013724,0.39675,0.97223,HP_APLASIA_HYPOPLASIA_OF_THE_DISTAL_PHALANX_OF_THE_5TH_FINGER,1
GOBP_NEGATIVE_REGULATION_OF_...319,SET,511,-0.07208,-0.011851,0.037638,0.97225,GOBP_NEGATIVE_REGULATION_OF_INTRACELLULAR_SIGNAL_TRANSDUCTION,1
HP_SECONDARY_GROWTH_HORMONE_...,SET,15,-0.39623,-0.011315,0.20688,0.97226,HP_SECONDARY_GROWTH_HORMONE_DEFICIENCY,1
GOCC_POSTSYNAPSE,SET,608,-0.068139,-0.012187,0.035568,0.97229,GOCC_POSTSYNAPSE,1
HOLLEMAN_PREDNISOLONE_RESIST...3,SET,9,-0.60174,-0.013313,0.31407,0.9723,HOLLEMAN_PREDNISOLONE_RESISTANCE_B_ALL_DN,1
GOBP_KETONE_BODY_METABOLIC_P...,SET,10,-0.54742,-0.012766,0.28568,0.97232,GOBP_KETONE_BODY_METABOLIC_PROCESS,1
CROSBY_E2F4_TARGETS,SET,6,-0.611,-0.011038,0.31881,0.97234,CROSBY_E2F4_TARGETS,1
GOBP_HOMOTYPIC_CELL_CELL_ADH...,SET,94,-0.17881,-0.012755,0.093303,0.97234,GOBP_HOMOTYPIC_CELL_CELL_ADHESION,1
GOMF_PHOSPHOLIPASE_ACTIVITY,SET,101,-0.15929,-0.011776,0.083116,0.97234,GOMF_PHOSPHOLIPASE_ACTIVITY,1
GOCC_90S_PRERIBOSOME,SET,23,-0.31186,-0.011025,0.1627,0.97236,GOCC_90S_PRERIBOSOME,1
HP_ELEVATED_CIRCULATING_GROW...,SET,15,-0.40757,-0.011639,0.21259,0.97238,HP_ELEVATED_CIRCULATING_GROWTH_HORMONE_CONCENTRATION,1
GOBP_G_PROTEIN_COUPLED_RECEP...2,SET,1096,-0.058037,-0.013743,0.030271,0.97239,GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY,1
MIR3184_3P,SET,66,-0.18893,-0.011301,0.098525,0.97241,MIR3184_3P,1
GSE17721_CTRL_VS_CPG_12H_BMD...1,SET,184,-0.11802,-0.011749,0.061542,0.97241,GSE17721_CTRL_VS_CPG_12H_BMDC_DN,1
GNF2_MMP11,SET,36,-0.30165,-0.013337,0.15727,0.97244,GNF2_MMP11,1
GOBP_FOREBRAIN_CELL_MIGRATION,SET,59,-0.22729,-0.012857,0.11849,0.97245,GOBP_FOREBRAIN_CELL_MIGRATION,1
WELCSH_BRCA1_TARGETS_UP,SET,180,-0.11775,-0.011596,0.06138,0.97246,WELCSH_BRCA1_TARGETS_UP,1
GOBP_RESPONSE_TO_DISACCHARIDE,SET,8,-0.53554,-0.011171,0.27903,0.97252,GOBP_RESPONSE_TO_DISACCHARIDE,1
HP_PERIVENTRICULAR_HETEROTOP...,SET,37,-0.2458,-0.011018,0.12805,0.97254,HP_PERIVENTRICULAR_HETEROTOPIA,1
GOBP_REGULATION_OF_LUTEINIZI...,SET,7,-0.69434,-0.013548,0.36167,0.97255,GOBP_REGULATION_OF_LUTEINIZING_HORMONE_SECRETION,1
GNF2_KISS1,SET,43,-0.27661,-0.013364,0.144,0.97262,GNF2_KISS1,1
GSE9960_HEALTHY_VS_GRAM_NEG_...2,SET,148,-0.13146,-0.011749,0.068415,0.97266,GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_UP,1
HP_PROPORTIONATE_TALL_STATURE,SET,14,-0.42738,-0.011791,0.22231,0.97272,HP_PROPORTIONATE_TALL_STATURE,1
GOBP_L_GLUTAMATE_IMPORT,SET,39,-0.26444,-0.012168,0.13753,0.97274,GOBP_L_GLUTAMATE_IMPORT,1
MIR12117,SET,84,-0.16831,-0.011353,0.087512,0.97277,MIR12117,1
HP_FRONTAL_UPSWEEP_OF_HAIR,SET,20,-0.38353,-0.012645,0.19941,0.97278,HP_FRONTAL_UPSWEEP_OF_HAIR,1
WP_HEAD_AND_NECK_SQUAMOUS_CE...,SET,73,-0.19623,-0.012343,0.10199,0.97281,WP_HEAD_AND_NECK_SQUAMOUS_CELL_CARCINOMA,1
REACTOME_CRMPS_IN_SEMA3A_SIG...,SET,15,-0.44505,-0.012709,0.2313,0.97282,REACTOME_CRMPS_IN_SEMA3A_SIGNALING,1
GSE36888_UNTREATED_VS_IL2_TR...11,SET,174,-0.11728,-0.011357,0.060916,0.97289,GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN,1
WOTTON_RUNX_TARGETS_UP,SET,18,-0.38402,-0.012012,0.19938,0.97294,WOTTON_RUNX_TARGETS_UP,1
GOBP_MAINTENANCE_OF_CELL_POL...,SET,15,-0.48624,-0.013885,0.25244,0.97295,GOBP_MAINTENANCE_OF_CELL_POLARITY,1
WANG_BARRETTS_ESOPHAGUS_AND_...1,SET,33,-0.28802,-0.012194,0.14941,0.97305,WANG_BARRETTS_ESOPHAGUS_AND_ESOPHAGUS_CANCER_DN,1
HP_ABNORMAL_CILIARY_BODY_MOR...,SET,6,-0.63497,-0.011471,0.32931,0.97307,HP_ABNORMAL_CILIARY_BODY_MORPHOLOGY,1
chr12q22,SET,18,-0.65941,-0.020626,0.34193,0.9731,chr12q22,1
ZHOU_PANCREATIC_ENDOCRINE_PR...,SET,12,-0.53529,-0.013674,0.27757,0.9731,ZHOU_PANCREATIC_ENDOCRINE_PROGENITOR,1
REACTOME_FGFR2_LIGAND_BINDIN...,SET,19,-0.44307,-0.014238,0.22965,0.97315,REACTOME_FGFR2_LIGAND_BINDING_AND_ACTIVATION,1
HP_SPLIT_FOOT,SET,6,-0.59353,-0.010722,0.30763,0.97315,HP_SPLIT_FOOT,1
MIR3689A_5P_MIR3689B_5P_MIR3...,SET,110,-0.15883,-0.012251,0.0823,0.97318,MIR3689A_5P_MIR3689B_5P_MIR3689E_MIR3689F,1
BUCKANOVICH_T_LYMPHOCYTE_HOM...1,SET,19,-0.33772,-0.010853,0.17494,0.97322,BUCKANOVICH_T_LYMPHOCYTE_HOMING_ON_TUMOR_DN,1
WEBER_METHYLATED_LCP_IN_FIBR...1,SET,9,-0.56549,-0.012511,0.29284,0.97325,WEBER_METHYLATED_LCP_IN_FIBROBLAST_DN,1
WP_BIOMARKERS_FOR_PYRIMIDINE...,SET,15,-0.40788,-0.011648,0.21115,0.9733,WP_BIOMARKERS_FOR_PYRIMIDINE_METABOLISM_DISORDERS,1
HP_APLASIA_OF_THE_LEFT_HEMID...,SET,5,-0.80976,-0.013354,0.41901,0.97335,HP_APLASIA_OF_THE_LEFT_HEMIDIAPHRAGM,1
MIR4323,SET,37,-0.25989,-0.011649,0.13447,0.97336,MIR4323,1
GSE17186_MEMORY_VS_CD21LOW_T...2,SET,176,-0.11929,-0.011618,0.061723,0.97336,GSE17186_MEMORY_VS_CD21LOW_TRANSITIONAL_BCELL_UP,1
GOCC_FICOLIN_1_RICH_GRANULE,SET,172,-0.1239,-0.01193,0.064097,0.97338,GOCC_FICOLIN_1_RICH_GRANULE,1
GSE40068_CXCR5NEG_BCL6NEG_CD...2,SET,184,-0.11813,-0.011761,0.061073,0.97345,GSE40068_CXCR5NEG_BCL6NEG_CD4_TCELL_VS_CXCR5POS_BCL6NEG_TFH_UP,1
HP_ASYMMETRY_OF_SPINAL_FACET...,SET,4,-0.88683,-0.013082,0.45847,0.97346,HP_ASYMMETRY_OF_SPINAL_FACET_JOINTS,1
GOCC_PERICILIARY_MEMBRANE_CO...,SET,4,-0.78545,-0.011586,0.40601,0.97347,GOCC_PERICILIARY_MEMBRANE_COMPARTMENT,1
HP_MORNING_MYOCLONIC_JERKS,SET,10,-0.56679,-0.013217,0.29279,0.97355,HP_MORNING_MYOCLONIC_JERKS,1
HP_SCHIZENCEPHALY,SET,9,-0.63975,-0.014154,0.33045,0.97356,HP_SCHIZENCEPHALY,1
MIR6755_5P,SET,32,-0.28308,-0.011802,0.14619,0.97358,MIR6755_5P,1
MIKKELSEN_ES_ICP_WITH_H3K4ME3,SET,619,-0.066098,-0.011924,0.034125,0.97362,MIKKELSEN_ES_ICP_WITH_H3K4ME3,1
BREDEMEYER_RAG_SIGNALING_VIA...1,SET,38,-0.26778,-0.012163,0.13817,0.97368,BREDEMEYER_RAG_SIGNALING_VIA_ATM_NOT_VIA_NFKB_DN,1
MIR3184_5P,SET,120,-0.1395,-0.011235,0.071964,0.9737,MIR3184_5P,1
GOBP_THIAMINE_TRANSPORT,SET,8,-0.61748,-0.01288,0.31849,0.97373,GOBP_THIAMINE_TRANSPORT,1
MINGUEZ_LIVER_CANCER_VASCULA...2,SET,13,-0.40539,-0.010778,0.20898,0.97379,MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_UP,1
GOBP_DETERMINATION_OF_LIVER_...,SET,5,-0.72034,-0.01188,0.3713,0.9738,GOBP_DETERMINATION_OF_LIVER_LEFT_RIGHT_ASYMMETRY,1
HP_PANNICULITIS,SET,25,-0.34999,-0.0129,0.18034,0.97384,HP_PANNICULITIS,1
GSE2128_C57BL6_VS_NOD_CD4CD8...2,SET,175,-0.12402,-0.012044,0.06391,0.97384,GSE2128_C57BL6_VS_NOD_CD4CD8_DP_THYMOCYTE_UP,1
chr22q11,SET,98,-0.31321,-0.02281,0.16133,0.97389,chr22q11,1
HP_APLASIA_HYPOPLASIA_OF_THE...33,SET,62,-0.21318,-0.012361,0.10973,0.97398,HP_APLASIA_HYPOPLASIA_OF_THE_FEMUR,1
GSE21670_UNTREATED_VS_IL6_TR...2,SET,169,-0.1209,-0.01154,0.062217,0.97399,GSE21670_UNTREATED_VS_IL6_TREATED_CD4_TCELL_UP,1
JAIN_NFKB_SIGNALING,SET,68,-0.19067,-0.011576,0.09808,0.97404,JAIN_NFKB_SIGNALING,1
GOBP_PARTURITION,SET,14,-0.43421,-0.01198,0.22331,0.97407,GOBP_PARTURITION,1
GOBP_ALDITOL_CATABOLIC_PROCE...,SET,5,-0.82877,-0.013668,0.4262,0.97408,GOBP_ALDITOL_CATABOLIC_PROCESS,1
MIR4512,SET,17,-0.4103,-0.012473,0.21098,0.97409,MIR4512,1
HP_T_CELL_LYMPHOMA,SET,14,-0.42157,-0.011631,0.21674,0.9741,HP_T_CELL_LYMPHOMA,1
GOMF_CYSTEINE_TYPE_ENDOPEPTI...7,SET,18,-0.39156,-0.012248,0.20128,0.97413,GOMF_CYSTEINE_TYPE_ENDOPEPTIDASE_INHIBITOR_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
GSE41176_UNSTIM_VS_ANTI_IGM_...4,SET,183,-0.12601,-0.012511,0.064746,0.97418,GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_24H_UP,1
HP_SPEECH_ARTICULATION_DIFFI...,SET,29,-0.32684,-0.012973,0.16791,0.9742,HP_SPEECH_ARTICULATION_DIFFICULTIES,1
ZHENG_FOXP3_TARGETS_DN,SET,6,-0.78362,-0.014156,0.4024,0.97425,ZHENG_FOXP3_TARGETS_DN,1
AGCGCAG_MIR191,SET,12,-0.44622,-0.011398,0.22909,0.97427,AGCGCAG_MIR191,1
KIM_BIPOLAR_DISORDER_OLIGODE...1,SET,81,-0.18547,-0.012285,0.095163,0.97434,KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_DN,1
KIM_ALL_DISORDERS_DURATION_C...1,SET,131,-0.13375,-0.011252,0.068617,0.97436,KIM_ALL_DISORDERS_DURATION_CORR_DN,1
GSE12198_CTRL_VS_HIGH_IL2_ST...1,SET,186,-0.11851,-0.011862,0.060795,0.97436,GSE12198_CTRL_VS_HIGH_IL2_STIM_NK_CELL_DN,1
GOBP_REGULATION_OF_RHO_PROTE...,SET,80,-0.18745,-0.01234,0.096155,0.97437,GOBP_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
HP_GLUTARIC_ACIDURIA,SET,7,-0.59584,-0.011626,0.30559,0.97439,HP_GLUTARIC_ACIDURIA,1
GOBP_STRESS_FIBER_ASSEMBLY,SET,103,-0.16561,-0.012363,0.084909,0.97443,GOBP_STRESS_FIBER_ASSEMBLY,1
FAN_EMBRYONIC_CTX_EX_4_EXCIT...,SET,133,-0.14402,-0.012207,0.073834,0.97444,FAN_EMBRYONIC_CTX_EX_4_EXCITATORY_NEURON,1
GSE29618_LAIV_VS_TIV_FLU_VAC...1,SET,171,-0.1201,-0.01153,0.061541,0.9745,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_BCELL_DN,1
GALI_TP53_TARGETS_APOPTOTIC_...1,SET,6,-0.57202,-0.010334,0.29296,0.97456,GALI_TP53_TARGETS_APOPTOTIC_DN,1
HP_PROGRESSIVE_CEREBELLAR_AT...,SET,57,-0.20555,-0.01143,0.10526,0.97458,HP_PROGRESSIVE_CEREBELLAR_ATAXIA,1
GOBP_POSITIVE_REGULATION_OF_...121,SET,17,-0.36968,-0.011238,0.18926,0.9746,GOBP_POSITIVE_REGULATION_OF_CELL_CYCLE_CHECKPOINT,1
GOBP_NEGATIVE_REGULATION_OF_...483,SET,40,-0.25424,-0.011848,0.13015,0.97461,GOBP_NEGATIVE_REGULATION_OF_PEPTIDYL_TYROSINE_PHOSPHORYLATION,1
GOBP_COLLECTING_DUCT_DEVELOP...,SET,15,-0.49511,-0.014139,0.25342,0.97463,GOBP_COLLECTING_DUCT_DEVELOPMENT,1
GOCC_PSEUDOPODIUM,SET,16,-0.40219,-0.011862,0.20581,0.97465,GOCC_PSEUDOPODIUM,1
HP_GIANT_SOMATOSENSORY_EVOKE...,SET,5,-0.70875,-0.011688,0.3627,0.97465,HP_GIANT_SOMATOSENSORY_EVOKED_POTENTIALS,1
HP_HYPOPITUITARISM,SET,159,-0.13171,-0.012197,0.067398,0.97465,HP_HYPOPITUITARISM,1
GSE2585_CD80_HIGH_VS_LOW_AIR...2,SET,176,-0.12649,-0.012319,0.064718,0.97467,GSE2585_CD80_HIGH_VS_LOW_AIRE_KO_MTEC_UP,1
LYF1_01,SET,238,-0.10963,-0.012394,0.056086,0.97468,LYF1_01,1
HP_STOMACH_CANCER,SET,33,-0.2827,-0.011968,0.14457,0.97472,HP_STOMACH_CANCER,1
GOBP_REGULATION_OF_MEMBRANE_...8,SET,420,-0.087017,-0.013003,0.04449,0.97475,GOBP_REGULATION_OF_MEMBRANE_POTENTIAL,1
MORF_PPP5C,SET,87,-0.1642,-0.011271,0.083941,0.97477,MORF_PPP5C,1
GOMF_HISTONE_DEACETYLASE_REG...,SET,5,-0.83716,-0.013806,0.42789,0.97479,GOMF_HISTONE_DEACETYLASE_REGULATOR_ACTIVITY,1
REACTOME_SPECIFICATION_OF_PR...,SET,11,-0.58801,-0.014381,0.30042,0.97483,REACTOME_SPECIFICATION_OF_PRIMORDIAL_GERM_CELLS,1
GSE33425_CD161_HIGH_VS_INT_C...1,SET,178,-0.12396,-0.01214,0.063337,0.97483,GSE33425_CD161_HIGH_VS_INT_CD8_TCELL_DN,1
GSE10239_MEMORY_VS_KLRG1HIGH...1,SET,182,-0.11804,-0.011688,0.060277,0.97489,GSE10239_MEMORY_VS_KLRG1HIGH_EFF_CD8_TCELL_DN,1
GSE13306_TREG_RA_VS_TCONV_RA...1,SET,177,-0.12697,-0.0124,0.064826,0.97491,GSE13306_TREG_RA_VS_TCONV_RA_DN,1
GOBP_GLUTAMATE_RECEPTOR_SIGN...,SET,48,-0.25882,-0.01321,0.13207,0.97498,GOBP_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
MIR346,SET,61,-0.20936,-0.012041,0.10682,0.97499,MIR346,1
GOBP_REGULATION_OF_CHROMOSOM...2,SET,225,-0.10566,-0.011619,0.053903,0.97501,GOBP_REGULATION_OF_CHROMOSOME_ORGANIZATION,1
GSE13762_CTRL_VS_125_VITAMIN...1,SET,120,-0.14572,-0.011736,0.074335,0.97501,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN,1
GOBP_POSITIVE_REGULATION_OF_...394,SET,8,-0.62615,-0.013061,0.3194,0.97502,GOBP_POSITIVE_REGULATION_OF_KIDNEY_DEVELOPMENT,1
GAVISH_3CA_MALIGNANT_METAPRO...4,SET,48,-0.26349,-0.013448,0.13437,0.97505,GAVISH_3CA_MALIGNANT_METAPROGRAM_13_EMT_2,1
HP_ATRESIA_OF_THE_EXTERNAL_A...,SET,45,-0.23964,-0.011843,0.12221,0.97505,HP_ATRESIA_OF_THE_EXTERNAL_AUDITORY_CANAL,1
KIM_MYCL1_AMPLIFICATION_TARG...2,SET,12,-0.52874,-0.013506,0.26958,0.97507,KIM_MYCL1_AMPLIFICATION_TARGETS_UP,1
MORF_MLLT10,SET,268,-0.10281,-0.012324,0.052417,0.97507,MORF_MLLT10,1
BILANGES_SERUM_SENSITIVE_GEN...,SET,72,-0.19371,-0.0121,0.098728,0.97511,BILANGES_SERUM_SENSITIVE_GENES,1
GOBP_ORGANIC_HYDROXY_COMPOUN...2,SET,51,-0.25095,-0.013201,0.1279,0.97511,GOBP_ORGANIC_HYDROXY_COMPOUND_CATABOLIC_PROCESS,1
MIR4695_3P,SET,70,-0.20474,-0.012612,0.10434,0.97512,MIR4695_3P,1
GOBP_NEGATIVE_REGULATION_OF_...125,SET,5,-0.7678,-0.012662,0.39131,0.97512,GOBP_NEGATIVE_REGULATION_OF_CELL_PROLIFERATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GSE360_HIGH_VS_LOW_DOSE_B_MA...4,SET,177,-0.11739,-0.011465,0.059813,0.97515,GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_MAC_UP,1
TING_SILENCED_BY_DICER,SET,26,-0.3601,-0.013534,0.18344,0.97517,TING_SILENCED_BY_DICER,1
GOBP_NEGATIVE_REGULATION_OF_...493,SET,6,-0.7515,-0.013576,0.38266,0.97522,GOBP_NEGATIVE_REGULATION_OF_PHOTORECEPTOR_CELL_DIFFERENTIATION,1
PEDERSEN_TARGETS_OF_611CTF_I...,SET,68,-0.21946,-0.013324,0.11174,0.97523,PEDERSEN_TARGETS_OF_611CTF_ISOFORM_OF_ERBB2,1
GOBP_REGULATION_OF_BASEMENT_...,SET,11,-0.44277,-0.010829,0.22542,0.97524,GOBP_REGULATION_OF_BASEMENT_MEMBRANE_ORGANIZATION,1
HP_ABNORMALITY_OF_THE_PROTEI...,SET,13,-0.40567,-0.010785,0.20643,0.9753,HP_ABNORMALITY_OF_THE_PROTEIN_C_ANTICOAGULANT_PATHWAY,1
TFDP2_TARGET_GENES,SET,4,-0.68526,-0.010108,0.34843,0.97538,TFDP2_TARGET_GENES,1
GOBP_REGULATION_OF_MITOTIC_S...1,SET,53,-0.21616,-0.011591,0.1099,0.97539,GOBP_REGULATION_OF_MITOTIC_SISTER_CHROMATID_SEGREGATION,1
chr6q16,SET,24,-0.64918,-0.023444,0.32996,0.97543,chr6q16,1
GAVIN_IL2_RESPONSIVE_FOXP3_T...2,SET,15,-0.50886,-0.014531,0.25864,0.97543,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_UP,1
REACTOME_MET_PROMOTES_CELL_M...,SET,41,-0.28198,-0.013303,0.14332,0.97543,REACTOME_MET_PROMOTES_CELL_MOTILITY,1
HP_PROMINENT_METOPIC_RIDGE,SET,57,-0.21854,-0.012152,0.11108,0.97543,HP_PROMINENT_METOPIC_RIDGE,1
HP_NEOPLASM_OF_STRIATED_MUSC...,SET,29,-0.32441,-0.012876,0.16484,0.97546,HP_NEOPLASM_OF_STRIATED_MUSCLE,1
HP_INCOMPREHENSIBLE_SPEECH,SET,8,-0.54378,-0.011343,0.27624,0.97549,HP_INCOMPREHENSIBLE_SPEECH,1
GOBP_RETINA_MORPHOGENESIS_IN...,SET,62,-0.22211,-0.012879,0.11279,0.97553,GOBP_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
GSE3982_MEMORY_CD4_TCELL_VS_...2,SET,172,-0.13147,-0.012658,0.066742,0.97556,GSE3982_MEMORY_CD4_TCELL_VS_BCELL_UP,1
GSE16385_IL4_VS_ROSIGLITAZON...1,SET,157,-0.13025,-0.011987,0.0661,0.9756,GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_DN,1
MIKKELSEN_ES_ICP_WITH_H3K4ME...,SET,126,-0.15957,-0.013167,0.080978,0.97561,MIKKELSEN_ES_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
GOBP_REGULATION_OF_ACTOMYOSI...,SET,94,-0.17323,-0.012357,0.087895,0.97562,GOBP_REGULATION_OF_ACTOMYOSIN_STRUCTURE_ORGANIZATION,1
GOBP_MULTICELLULAR_ORGANISMA...7,SET,91,-0.18682,-0.013113,0.094771,0.97565,GOBP_MULTICELLULAR_ORGANISMAL_RESPONSE_TO_STRESS,1
GSE17721_CTRL_VS_POLYIC_0.5H...1,SET,187,-0.11817,-0.011859,0.05993,0.97568,GSE17721_CTRL_VS_POLYIC_0.5H_BMDC_DN,1
TSANG_PBMC_FLUVIRIN_PANDEMRI...,SET,65,-0.20996,-0.012464,0.10647,0.97568,TSANG_PBMC_FLUVIRIN_PANDEMRIX_ADULT_CORR_WITH_CELL_FREQ_CD27HI_CD38HI_CD20_NEG_PLASMABLASTS_AND_CD38PLUS_OF_IGD_CD27PLUS_MEM_B_CELLS_7DY_POSITIVE,1
OSWALD_HEMATOPOIETIC_STEM_CE...1,SET,241,-0.10595,-0.012052,0.053724,0.97569,OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN,1
GOCC_CALCIUM_AND_CALMODULIN_...,SET,5,-0.80336,-0.013249,0.40737,0.97569,GOCC_CALCIUM_AND_CALMODULIN_DEPENDENT_PROTEIN_KINASE_COMPLEX,1
HP_ABNORMAL_MACULAR_MORPHOLO...,SET,189,-0.12451,-0.012561,0.063121,0.97572,HP_ABNORMAL_MACULAR_MORPHOLOGY,1
DESCARTES_FETAL_CEREBELLUM_G...,SET,26,-0.35531,-0.013354,0.18004,0.97577,DESCARTES_FETAL_CEREBELLUM_GRANULE_NEURONS,1
MIKI_COEXPRESSED_WITH_CYP19A1,SET,7,-0.61151,-0.011932,0.30969,0.97583,MIKI_COEXPRESSED_WITH_CYP19A1,1
HP_DIPLOPIA,SET,85,-0.17611,-0.011949,0.089157,0.97587,HP_DIPLOPIA,1
HP_ABNORMAL_FETAL_CENTRAL_NE...,SET,5,-0.7496,-0.012362,0.37948,0.97588,HP_ABNORMAL_FETAL_CENTRAL_NERVOUS_SYSTEM_MORPHOLOGY,1
GOBP_THIOESTER_BIOSYNTHETIC_...,SET,41,-0.27216,-0.01284,0.13769,0.97595,GOBP_THIOESTER_BIOSYNTHETIC_PROCESS,1
NAKAYA_PLASMACYTOID_DENDRITI...2,SET,186,-0.12022,-0.012032,0.060815,0.97596,NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP,1
HOLLEMAN_PREDNISOLONE_RESIST...1,SET,11,-0.48789,-0.011932,0.24675,0.97599,HOLLEMAN_PREDNISOLONE_RESISTANCE_ALL_DN,1
GOMF_3_CHLOROALLYL_ALDEHYDE_...,SET,5,-0.6583,-0.010856,0.33291,0.97599,GOMF_3_CHLOROALLYL_ALDEHYDE_DEHYDROGENASE_ACTIVITY,1
GOBP_HOMOPHILIC_CELL_ADHESIO...,SET,157,-0.17512,-0.016116,0.088544,0.97602,GOBP_HOMOPHILIC_CELL_ADHESION_VIA_PLASMA_MEMBRANE_ADHESION_MOLECULES,1
GSE16266_CTRL_VS_LPS_STIM_ME...1,SET,179,-0.12876,-0.012645,0.065101,0.97602,GSE16266_CTRL_VS_LPS_STIM_MEF_DN,1
GOBP_ORGANOPHOSPHATE_BIOSYNT...,SET,508,-0.073194,-0.011999,0.037003,0.97603,GOBP_ORGANOPHOSPHATE_BIOSYNTHETIC_PROCESS,1
chr15q13,SET,18,-0.53493,-0.016732,0.27037,0.97606,chr15q13,1
chr2q35,SET,64,-0.40591,-0.023911,0.20513,0.97608,chr2q35,1
GSE6092_UNSTIM_VS_IFNG_STIM_...2,SET,180,-0.12216,-0.01203,0.0617,0.97613,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_UP,1
GOMF_METALLODIPEPTIDASE_ACTI...,SET,8,-0.63223,-0.013187,0.31924,0.97616,GOMF_METALLODIPEPTIDASE_ACTIVITY,1
AAGCACA_MIR218,SET,373,-0.090287,-0.012731,0.045586,0.97617,AAGCACA_MIR218,1
GOMF_BILE_ACID_SODIUM_SYMPOR...,SET,5,-0.75742,-0.012491,0.38242,0.97617,GOMF_BILE_ACID_SODIUM_SYMPORTER_ACTIVITY,1
GOBP_REGULATION_OF_ENDOTHELI...4,SET,154,-0.14004,-0.012765,0.070689,0.9762,GOBP_REGULATION_OF_ENDOTHELIAL_CELL_MIGRATION,1
chr1q32,SET,139,-0.30718,-0.026613,0.15499,0.97625,chr1q32,1
REACTOME_REGULATION_OF_ENDOG...4,SET,9,-0.45634,-0.010096,0.23006,0.97634,REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX,1
GSE11961_MEMORY_BCELL_DAY7_V...3,SET,179,-0.12456,-0.012232,0.062789,0.97635,GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY7_DN,1
MODULE_141,SET,14,-0.51203,-0.014126,0.25805,0.97638,MODULE_141,1
BIOCARTA_TCAPOPTOSIS_PATHWAY,SET,9,-0.57714,-0.012768,0.29071,0.97643,BIOCARTA_TCAPOPTOSIS_PATHWAY,1
GSE14699_NAIVE_VS_DELETIONAL...1,SET,185,-0.12596,-0.012573,0.06343,0.97646,GSE14699_NAIVE_VS_DELETIONAL_TOLERANCE_CD8_TCELL_DN,1
HERNANDEZ_MITOTIC_ARREST_BY_...4,SET,53,-0.22742,-0.012195,0.11451,0.97648,HERNANDEZ_MITOTIC_ARREST_BY_DOCETAXEL_2_UP,1
MIR1911_5P,SET,24,-0.3223,-0.011639,0.16227,0.97649,MIR1911_5P,1
HP_REDUCED_ATTENTION_REGULAT...,SET,439,-0.080465,-0.012287,0.040512,0.97649,HP_REDUCED_ATTENTION_REGULATION,1
HP_DISTICHIASIS,SET,8,-0.58913,-0.012289,0.29656,0.97651,HP_DISTICHIASIS,1
GOBP_PENTOSE_METABOLIC_PROCE...,SET,12,-0.48822,-0.012471,0.24572,0.97652,GOBP_PENTOSE_METABOLIC_PROCESS,1
MODULE_13,SET,470,-0.077503,-0.012234,0.039007,0.97653,MODULE_13,1
HP_PARATHYROID_HYPERPLASIA,SET,10,-0.54343,-0.012673,0.27348,0.97654,HP_PARATHYROID_HYPERPLASIA,1
GOBP_FOLIC_ACID_CONTAINING_C...1,SET,8,-0.53431,-0.011145,0.26886,0.97655,GOBP_FOLIC_ACID_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
GOCC_PRECATALYTIC_SPLICEOSOME,SET,48,-0.2085,-0.010641,0.1049,0.97657,GOCC_PRECATALYTIC_SPLICEOSOME,1
ZFP91_TARGET_GENES,SET,1121,-0.051308,-0.012279,0.025805,0.9766,ZFP91_TARGET_GENES,1
chr7q33,SET,24,-0.42542,-0.015363,0.21394,0.97662,chr7q33,1
GOBP_UBIQUITIN_DEPENDENT_END...,SET,7,-0.60054,-0.011718,0.30182,0.97668,GOBP_UBIQUITIN_DEPENDENT_ENDOCYTOSIS,1
GSE1925_CTRL_VS_24H_IFNG_STI...3,SET,174,-0.12111,-0.011728,0.060858,0.9767,GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN,1
MODULE_112,SET,237,-0.12011,-0.013551,0.060348,0.97671,MODULE_112,1
REACTOME_RNA_POLYMERASE_I_TR...2,SET,42,-0.22258,-0.010628,0.11183,0.97672,REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION_INITIATION,1
HP_DECREASED_SPECIFIC_ANTI_P...,SET,7,-0.68015,-0.013271,0.34167,0.97673,HP_DECREASED_SPECIFIC_ANTI_POLYSACCHARIDE_ANTIBODY_LEVEL,1
GSE17186_MEMORY_VS_CD21HIGH_...1,SET,187,-0.12733,-0.012778,0.063966,0.97673,GSE17186_MEMORY_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...97,SET,11,-0.57689,-0.014109,0.28973,0.97676,GOBP_POSITIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,1
GSE20198_UNTREATED_VS_IL12_I...2,SET,183,-0.12426,-0.012338,0.062408,0.97676,GSE20198_UNTREATED_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_UP,1
CUI_DEVELOPING_HEART_LEFT_VE...,SET,37,-0.30351,-0.013604,0.15242,0.97676,CUI_DEVELOPING_HEART_LEFT_VENTRICULAR_CARDIOMYOCYTE,1
GSE21360_NAIVE_VS_SECONDARY_...2,SET,173,-0.13365,-0.012906,0.067117,0.97677,GSE21360_NAIVE_VS_SECONDARY_MEMORY_CD8_TCELL_UP,1
HP_VITREOUS_HEMORRHAGE,SET,16,-0.41495,-0.012238,0.20835,0.97679,HP_VITREOUS_HEMORRHAGE,1
GOBP_NEGATIVE_REGULATION_OF_...637,SET,4,-0.871,-0.012848,0.43727,0.9768,GOBP_NEGATIVE_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,1
GOBP_CAMP_CATABOLIC_PROCESS,SET,9,-0.58881,-0.013027,0.29558,0.97681,GOBP_CAMP_CATABOLIC_PROCESS,1
OSF2_Q6,SET,245,-0.1116,-0.012799,0.055982,0.97689,OSF2_Q6,1
MIR544B,SET,191,-0.11946,-0.012115,0.059911,0.97692,MIR544B,1
GOBP_D_ASPARTATE_TRANSMEMBRA...,SET,5,-0.78162,-0.01289,0.39193,0.97693,GOBP_D_ASPARTATE_TRANSMEMBRANE_TRANSPORT,1
GSE17721_CTRL_VS_CPG_2H_BMDC...2,SET,176,-0.12584,-0.012255,0.063078,0.97697,GSE17721_CTRL_VS_CPG_2H_BMDC_UP,1
GOBP_L_LEUCINE_CATABOLIC_PRO...,SET,6,-0.65076,-0.011756,0.32618,0.97698,GOBP_L_LEUCINE_CATABOLIC_PROCESS,1
GSE37533_PPARG1_FOXP3_VS_PPA...4,SET,164,-0.12392,-0.011653,0.062071,0.97705,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP,1
GSE22432_MULTIPOTENT_PROGENI...1,SET,183,-0.12115,-0.012028,0.060668,0.97707,GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...397,SET,6,-0.65933,-0.011911,0.33015,0.97708,GOBP_NEGATIVE_REGULATION_OF_MITOCHONDRIAL_FUSION,1
GOBP_FOLIC_ACID_TRANSPORT,SET,10,-0.62919,-0.014673,0.31505,0.97709,GOBP_FOLIC_ACID_TRANSPORT,1
GSE13306_RA_VS_UNTREATED_TCO...1,SET,179,-0.12919,-0.012687,0.064666,0.97712,GSE13306_RA_VS_UNTREATED_TCONV_DN,1
MIR4310,SET,262,-0.1045,-0.012387,0.052301,0.97713,MIR4310,1
MIR519E_5P,SET,285,-0.10093,-0.01247,0.050512,0.97714,MIR519E_5P,1
BOYLAN_MULTIPLE_MYELOMA_C_D_...1,SET,247,-0.11532,-0.013279,0.057709,0.97715,BOYLAN_MULTIPLE_MYELOMA_C_D_DN,1
GCM_RAN,SET,178,-0.12082,-0.011832,0.060455,0.97716,GCM_RAN,1
CACTGCC_MIR34A_MIR34C_MIR449,SET,258,-0.10138,-0.011927,0.050708,0.9772,CACTGCC_MIR34A_MIR34C_MIR449,1
GOBP_POSITIVE_REGULATION_OF_...326,SET,31,-0.33975,-0.013942,0.16992,0.97721,GOBP_POSITIVE_REGULATION_OF_HEART_GROWTH,1
GOBP_POSITIVE_REGULATION_OF_...241,SET,4,-0.94767,-0.013979,0.47379,0.97725,GOBP_POSITIVE_REGULATION_OF_ENDOTHELIAL_CELL_MATRIX_ADHESION_VIA_FIBRONECTIN,1
HP_GALACTORRHEA,SET,9,-0.551,-0.01219,0.27549,0.97725,HP_GALACTORRHEA,1
GOBP_ACTIVATION_OF_ADENYLATE...,SET,23,-0.3986,-0.014092,0.19925,0.97727,GOBP_ACTIVATION_OF_ADENYLATE_CYCLASE_ACTIVITY,1
HOEK_B_CELL_2011_2012_TIV_AD...3,SET,30,-0.29724,-0.011999,0.14857,0.97728,HOEK_B_CELL_2011_2012_TIV_ADULT_3DY_UP,1
HP_FLUCTUATIONS_IN_CONSCIOUS...,SET,6,-0.7638,-0.013798,0.38166,0.97731,HP_FLUCTUATIONS_IN_CONSCIOUSNESS,1
MORF_RAP1A,SET,133,-0.13982,-0.011851,0.069856,0.97733,MORF_RAP1A,1
WP_FAS_LIGAND_PATHWAY_AND_ST...,SET,42,-0.26777,-0.012786,0.13375,0.97735,WP_FAS_LIGAND_PATHWAY_AND_STRESS_INDUCTION_OF_HEAT_SHOCK_PROTEINS,1
GOBP_NEGATIVE_REGULATION_OF_...128,SET,14,-0.4659,-0.012854,0.23272,0.97735,GOBP_NEGATIVE_REGULATION_OF_CELL_SUBSTRATE_JUNCTION_ORGANIZATION,1
REACTOME_CALCITONIN_LIKE_LIG...,SET,9,-0.6568,-0.014531,0.32803,0.97736,REACTOME_CALCITONIN_LIKE_LIGAND_RECEPTORS,1
GOBP_POSITIVE_REGULATION_OF_...693,SET,5,-0.78842,-0.013002,0.39374,0.97737,GOBP_POSITIVE_REGULATION_OF_SARCOMERE_ORGANIZATION,1
HP_ELEVATED_TISSUE_NON_SPECI...,SET,17,-0.42151,-0.012814,0.21046,0.9774,HP_ELEVATED_TISSUE_NON_SPECIFIC_ALKALINE_PHOSPHATASE,1
HP_STATUS_EPILEPTICUS_WITHOU...,SET,24,-0.34682,-0.012525,0.17302,0.97748,HP_STATUS_EPILEPTICUS_WITHOUT_PROMINENT_MOTOR_SYMPTOMS,1
GOCC_UNCONVENTIONAL_MYOSIN_C...,SET,9,-0.59898,-0.013252,0.2988,0.97749,GOCC_UNCONVENTIONAL_MYOSIN_COMPLEX,1
HP_ELEVATED_SERUM_ANION_GAP,SET,4,-0.8381,-0.012363,0.41782,0.97756,HP_ELEVATED_SERUM_ANION_GAP,1
TAKEDA_TARGETS_OF_NUP98_HOXA...9,SET,176,-0.13748,-0.013389,0.068533,0.97757,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_DN,1
HP_WIDE_ANTERIOR_FONTANEL,SET,80,-0.19035,-0.012531,0.094868,0.97759,HP_WIDE_ANTERIOR_FONTANEL,1
KIM_MYCN_AMPLIFICATION_TARGE...2,SET,79,-0.19373,-0.012674,0.096521,0.97763,KIM_MYCN_AMPLIFICATION_TARGETS_UP,1
HP_FREQUENT_TEMPER_TANTRUMS,SET,8,-0.57344,-0.011961,0.28563,0.97765,HP_FREQUENT_TEMPER_TANTRUMS,1
GOBP_RHO_PROTEIN_SIGNAL_TRAN...,SET,132,-0.15108,-0.012758,0.07524,0.97767,GOBP_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE360_DC_VS_MAC_UP,SET,178,-0.12687,-0.012425,0.063176,0.97768,GSE360_DC_VS_MAC_UP,1
GOBP_POSITIVE_REGULATION_OF_...163,SET,12,-0.43977,-0.011233,0.21895,0.9777,GOBP_POSITIVE_REGULATION_OF_CHROMATIN_ORGANIZATION,1
GOBP_TRIGLYCERIDE_CATABOLIC_...,SET,27,-0.34653,-0.013272,0.17252,0.9777,GOBP_TRIGLYCERIDE_CATABOLIC_PROCESS,1
GSE15659_CD45RA_NEG_CD4_TCEL...2,SET,164,-0.13126,-0.012344,0.065346,0.97771,GSE15659_CD45RA_NEG_CD4_TCELL_VS_ACTIVATED_TREG_UP,1
GOBP_ACID_SECRETION,SET,43,-0.26091,-0.012605,0.12986,0.97773,GOBP_ACID_SECRETION,1
PANAPASA_BLOOD_FLUENZ_AGE_03...1,SET,6,-0.60819,-0.010987,0.30265,0.97775,PANAPASA_BLOOD_FLUENZ_AGE_03_17YO_3DY_4DY_DN,1
GAO_SMALL_INTESTINE_24W_C9_E...,SET,42,-0.27394,-0.01308,0.13627,0.97779,GAO_SMALL_INTESTINE_24W_C9_ENTEROENDOCRINE_CELL,1
HP_POSTERIOR_PHARYNGEAL_CLEFT,SET,12,-0.54617,-0.013951,0.27168,0.9778,HP_POSTERIOR_PHARYNGEAL_CLEFT,1
GOBP_NEGATIVE_REGULATION_OF_...190,SET,22,-0.37141,-0.012842,0.18466,0.97785,GOBP_NEGATIVE_REGULATION_OF_DNA_REPLICATION,1
GOMF_FOLIC_ACID_TRANSMEMBRAN...,SET,5,-0.8839,-0.014577,0.43946,0.97785,GOMF_FOLIC_ACID_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
HP_DISTURBANCE_OF_FACIAL_EXP...,SET,40,-0.2662,-0.012405,0.13231,0.97788,HP_DISTURBANCE_OF_FACIAL_EXPRESSION,1
GSE3982_NEUTROPHIL_VS_BCELL_...2,SET,169,-0.1367,-0.013048,0.067908,0.97794,GSE3982_NEUTROPHIL_VS_BCELL_UP,1
GOBP_NEPHRIC_DUCT_MORPHOGENE...,SET,10,-0.63305,-0.014762,0.31437,0.97797,GOBP_NEPHRIC_DUCT_MORPHOGENESIS,1
WP_ACE_INHIBITOR_PATHWAY,SET,14,-0.54254,-0.014968,0.26936,0.978,WP_ACE_INHIBITOR_PATHWAY,1
YAMASHITA_LIVER_CANCER_STEM_...2,SET,46,-0.27105,-0.013543,0.13454,0.97802,YAMASHITA_LIVER_CANCER_STEM_CELL_UP,1
GOBP_POSITIVE_REGULATION_OF_...47,SET,18,-0.40095,-0.012541,0.199,0.97803,GOBP_POSITIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
HP_IRREGULAR_FEMORAL_EPIPHYS...,SET,8,-0.57233,-0.011938,0.284,0.97805,HP_IRREGULAR_FEMORAL_EPIPHYSIS,1
HOFT_CD4_POSITIVE_ALPHA_BETA...8,SET,25,-0.32961,-0.012148,0.16355,0.97806,HOFT_CD4_POSITIVE_ALPHA_BETA_MEMORY_T_CELL_BCG_VACCINE_AGE_18_45YO_ID_7DY_TOP_100_DEG_EX_VIVO_UP,1
GOBP_GLYCEROLIPID_CATABOLIC_...,SET,64,-0.22061,-0.012996,0.1094,0.97812,GOBP_GLYCEROLIPID_CATABOLIC_PROCESS,1
GOBP_GROOMING_BEHAVIOR,SET,18,-0.45296,-0.014168,0.22459,0.97814,GOBP_GROOMING_BEHAVIOR,1
GSE10273_HIGH_VS_LOW_IL7_TRE...1,SET,175,-0.12717,-0.01235,0.063037,0.97816,GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN,1
KEGG_MEDICUS_REFERENCE_CASR_...,SET,7,-0.66802,-0.013035,0.33109,0.97818,KEGG_MEDICUS_REFERENCE_CASR_PTH_SIGNALING_PATHWAY,1
GAVIN_IL2_RESPONSIVE_FOXP3_T...1,SET,5,-0.77089,-0.012713,0.38189,0.97823,GAVIN_IL2_RESPONSIVE_FOXP3_TARGETS_DN,1
REACTOME_CONDENSATION_OF_PRO...1,SET,11,-0.4207,-0.010289,0.2084,0.97823,REACTOME_CONDENSATION_OF_PROMETAPHASE_CHROMOSOMES,1
GOBP_NEGATIVE_REGULATION_OF_...610,SET,23,-0.38812,-0.013721,0.19227,0.97823,GOBP_NEGATIVE_REGULATION_OF_STEM_CELL_PROLIFERATION,1
GOMF_CYTOSKELETON_NUCLEAR_ME...,SET,5,-0.72844,-0.012013,0.3607,0.97828,GOMF_CYTOSKELETON_NUCLEAR_MEMBRANE_ANCHOR_ACTIVITY,1
HP_AGGRESSIVE_BEHAVIOR,SET,242,-0.10861,-0.012381,0.053767,0.9783,HP_AGGRESSIVE_BEHAVIOR,1
GSE17721_CTRL_VS_PAM3CSK4_6H...2,SET,178,-0.12799,-0.012535,0.063361,0.9783,GSE17721_CTRL_VS_PAM3CSK4_6H_BMDC_UP,1
GSE19401_UNSTIM_VS_PAM2CSK4_...2,SET,175,-0.12684,-0.012318,0.062791,0.9783,GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
MIR508_5P,SET,86,-0.18538,-0.012651,0.091755,0.97832,MIR508_5P,1
GSE27786_LSK_VS_MONO_MAC_DN,SET,188,-0.12333,-0.012409,0.061025,0.97835,GSE27786_LSK_VS_MONO_MAC_DN,1
GOBP_NEUTROPHIL_CLEARANCE,SET,6,-0.78841,-0.014243,0.39008,0.97836,GOBP_NEUTROPHIL_CLEARANCE,1
PLASARI_TGFB1_SIGNALING_VIA_...2,SET,51,-0.25254,-0.013284,0.12492,0.97838,PLASARI_TGFB1_SIGNALING_VIA_NFIC_10HR_UP,1
HP_ABNORMAL_CIRCULATING_CARB...2,SET,305,-0.097192,-0.012416,0.048075,0.97839,HP_ABNORMAL_CIRCULATING_CARBOXYLIC_ACID_CONCENTRATION,1
REACTOME_SIGNALING_BY_LRP5_M...,SET,6,-0.71085,-0.012842,0.35152,0.97842,REACTOME_SIGNALING_BY_LRP5_MUTANTS,1
GOBP_RECEPTOR_GUANYLYL_CYCLA...,SET,8,-0.60774,-0.012677,0.30052,0.97842,GOBP_RECEPTOR_GUANYLYL_CYCLASE_SIGNALING_PATHWAY,1
HP_RETINAL_ATROPHY,SET,92,-0.17655,-0.01246,0.087293,0.97843,HP_RETINAL_ATROPHY,1
HP_LENS_SUBLUXATION,SET,13,-0.49779,-0.013234,0.24582,0.97856,HP_LENS_SUBLUXATION,1
GOBP_G_PROTEIN_COUPLED_GLUTA...,SET,15,-0.4535,-0.01295,0.22385,0.9786,GOBP_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_FERROPTOSIS,SET,9,-0.61651,-0.013639,0.30417,0.97865,GOBP_FERROPTOSIS,1
GOMF_SIGNALING_RECEPTOR_COMP...,SET,51,-0.22718,-0.01195,0.11209,0.97865,GOMF_SIGNALING_RECEPTOR_COMPLEX_ADAPTOR_ACTIVITY,1
REACTOME_FASL_CD95L_SIGNALING,SET,5,-0.83049,-0.013696,0.40959,0.97869,REACTOME_FASL_CD95L_SIGNALING,1
SP1_Q4_01,SET,231,-0.11066,-0.012327,0.054568,0.97871,SP1_Q4_01,1
GOBP_ACTIVATION_INDUCED_CELL...,SET,8,-0.62051,-0.012943,0.30585,0.97875,GOBP_ACTIVATION_INDUCED_CELL_DEATH_OF_T_CELLS,1
GOBP_L_ASPARTATE_IMPORT_ACRO...,SET,6,-0.77963,-0.014084,0.3843,0.97875,GOBP_L_ASPARTATE_IMPORT_ACROSS_PLASMA_MEMBRANE,1
GOBP_POSITIVE_REGULATION_OF_...497,SET,4,-0.97114,-0.014325,0.4787,0.97875,GOBP_POSITIVE_REGULATION_OF_MUSCLE_ADAPTATION,1
KEGG_INOSITOL_PHOSPHATE_META...,SET,52,-0.22686,-0.01205,0.1118,0.97877,KEGG_INOSITOL_PHOSPHATE_METABOLISM,1
GOBP_PHOSPHATE_ION_HOMEOSTAS...,SET,19,-0.45882,-0.014744,0.22606,0.9788,GOBP_PHOSPHATE_ION_HOMEOSTASIS,1
DAVICIONI_MOLECULAR_ARMS_VS_...2,SET,301,-0.10008,-0.012702,0.049303,0.97881,DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP,1
HP_ABNORMAL_LYMPHOCYTE_APOPT...,SET,8,-0.59407,-0.012392,0.29265,0.97881,HP_ABNORMAL_LYMPHOCYTE_APOPTOSIS,1
GSE17721_PAM3CSK4_VS_CPG_8H_...1,SET,183,-0.12542,-0.012452,0.061784,0.97881,GSE17721_PAM3CSK4_VS_CPG_8H_BMDC_DN,1
REACTOME_RHOD_GTPASE_CYCLE,SET,48,-0.26369,-0.013458,0.12982,0.97887,REACTOME_RHOD_GTPASE_CYCLE,1
GOBP_SLEEP,SET,21,-0.40615,-0.013721,0.19988,0.97891,GOBP_SLEEP,1
HP_ABSENT_EPIPHYSES,SET,20,-0.4147,-0.013673,0.20406,0.97893,HP_ABSENT_EPIPHYSES,1
GSE21033_1H_VS_12H_POLYIC_ST...2,SET,166,-0.13301,-0.012583,0.065447,0.97893,GSE21033_1H_VS_12H_POLYIC_STIM_DC_UP,1
GSE1791_CTRL_VS_NEUROMEDINU_...7,SET,175,-0.12714,-0.012347,0.062556,0.97894,GSE1791_CTRL_VS_NEUROMEDINU_IN_T_CELL_LINE_6H_DN,1
GOBP_POSITIVE_REGULATION_OF_...791,SET,7,-0.64614,-0.012608,0.31787,0.97895,GOBP_POSITIVE_REGULATION_OF_TROPHOBLAST_CELL_MIGRATION,1
GOBP_REGULATION_OF_POSTSYNAP...9,SET,18,-0.38896,-0.012167,0.19135,0.97895,GOBP_REGULATION_OF_POSTSYNAPTIC_NEUROTRANSMITTER_RECEPTOR_INTERNALIZATION,1
HE_LIM_SUN_FETAL_LUNG_C1_MUC...,SET,48,-0.26945,-0.013752,0.13254,0.97896,HE_LIM_SUN_FETAL_LUNG_C1_MUC5AC_POS_ASCL1_POS_PROGENITOR_CELL,1
GSE9988_ANTI_TREM1_AND_LPS_V...1,SET,185,-0.12022,-0.012001,0.059123,0.97899,GSE9988_ANTI_TREM1_AND_LPS_VS_CTRL_TREATED_MONOCYTES_DN,1
GSE360_L_DONOVANI_VS_T_GONDI...3,SET,184,-0.12163,-0.012109,0.0598,0.97902,GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN,1
HP_CHORIORETINAL_HYPOPIGMENT...,SET,10,-0.58379,-0.013614,0.28696,0.97904,HP_CHORIORETINAL_HYPOPIGMENTATION,1
GOMF_LOW_DENSITY_LIPOPROTEIN...1,SET,16,-0.44423,-0.013101,0.21827,0.97908,GOMF_LOW_DENSITY_LIPOPROTEIN_PARTICLE_BINDING,1
SA_CASPASE_CASCADE,SET,18,-0.41767,-0.013065,0.20513,0.97913,SA_CASPASE_CASCADE,1
GOMF_THIAMINE_TRANSMEMBRANE_...,SET,7,-0.69779,-0.013615,0.34257,0.97916,GOMF_THIAMINE_TRANSMEMBRANE_TRANSPORTER_ACTIVITY,1
WP_HEDGEHOG_SIGNALING_WP47,SET,14,-0.42093,-0.011613,0.20659,0.9792,WP_HEDGEHOG_SIGNALING_WP47,1
GSE22886_CTRL_VS_LPS_24H_DC_...2,SET,178,-0.12058,-0.011809,0.059167,0.97922,GSE22886_CTRL_VS_LPS_24H_DC_UP,1
MIR515_5P,SET,282,-0.10365,-0.01274,0.050839,0.97925,MIR515_5P,1
GNF2_JAK1,SET,30,-0.2933,-0.01184,0.14384,0.97927,GNF2_JAK1,1
MCAATNNNNNGCG_UNKNOWN,SET,74,-0.21069,-0.013342,0.10332,0.97928,MCAATNNNNNGCG_UNKNOWN,1
GOBP_NEGATIVE_REGULATION_OF_...135,SET,5,-0.80315,-0.013245,0.39374,0.97931,GOBP_NEGATIVE_REGULATION_OF_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
KEGG_ARGININE_AND_PROLINE_ME...,SET,47,-0.23426,-0.011831,0.11481,0.97934,KEGG_ARGININE_AND_PROLINE_METABOLISM,1
MIR6503_3P,SET,28,-0.32458,-0.012659,0.15905,0.97935,MIR6503_3P,1
GOMF_SH2_DOMAIN_BINDING,SET,39,-0.29463,-0.013558,0.14433,0.97939,GOMF_SH2_DOMAIN_BINDING,1
GSE21927_EL4_VS_MCA203_TUMOR...1,SET,153,-0.13935,-0.012661,0.068236,0.97942,GSE21927_EL4_VS_MCA203_TUMOR_MONOCYTES_DN,1
GOMF_SULFATE_BINDING,SET,4,-0.9392,-0.013854,0.45983,0.97944,GOMF_SULFATE_BINDING,1
PID_ARF6_TRAFFICKING_PATHWAY,SET,47,-0.25694,-0.012976,0.12576,0.97947,PID_ARF6_TRAFFICKING_PATHWAY,1
HP_ABNORMAL_CEREBRAL_VENTRIC...,SET,816,-0.060222,-0.012404,0.029466,0.9795,HP_ABNORMAL_CEREBRAL_VENTRICLE_MORPHOLOGY,1
HE_LIM_SUN_FETAL_LUNG_C2_MYE...,SET,15,-0.50304,-0.014365,0.24611,0.97951,HE_LIM_SUN_FETAL_LUNG_C2_MYELOCYTE_LIKE_CELL,1
MIR4753_3P,SET,513,-0.078741,-0.01297,0.038512,0.97954,MIR4753_3P,1
GOBP_NEGATIVE_REGULATION_OF_...250,SET,10,-0.54658,-0.012746,0.26734,0.97954,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,1
HP_SUBCUTANEOUS_LIPOMA,SET,7,-0.65376,-0.012756,0.31968,0.97957,HP_SUBCUTANEOUS_LIPOMA,1
GOCC_CHLORIDE_CHANNEL_COMPLEX,SET,49,-0.27597,-0.01423,0.1349,0.9796,GOCC_CHLORIDE_CHANNEL_COMPLEX,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...2,SET,177,-0.12691,-0.012394,0.062033,0.97961,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_UP,1
KEGG_MEDICUS_REFERENCE_TNF_J...,SET,16,-0.44468,-0.013115,0.21734,0.97962,KEGG_MEDICUS_REFERENCE_TNF_JNK_SIGNALING_PATHWAY,1
GSE16386_IL4_VS_IL4_AND_ROSI...1,SET,173,-0.1308,-0.01263,0.063865,0.97971,GSE16386_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_6H_DN,1
GOBP_POSITIVE_REGULATION_OF_...589,SET,634,-0.07158,-0.013063,0.034948,0.97972,GOBP_POSITIVE_REGULATION_OF_PHOSPHORUS_METABOLIC_PROCESS,1
MODULE_122,SET,129,-0.16517,-0.013789,0.080594,0.97978,MODULE_122,1
BARX2_TARGET_GENES,SET,1491,-0.046291,-0.012639,0.022584,0.9798,BARX2_TARGET_GENES,1
ZNF491_TARGET_GENES,SET,6,-0.62379,-0.011269,0.30422,0.97983,ZNF491_TARGET_GENES,1
HP_CONGENITAL_NONBULLOUS_ICH...,SET,20,-0.39616,-0.013061,0.19321,0.97983,HP_CONGENITAL_NONBULLOUS_ICHTHYOSIFORM_ERYTHRODERMA,1
WARTERS_RESPONSE_TO_IR_SKIN,SET,70,-0.19788,-0.012189,0.09649,0.97985,WARTERS_RESPONSE_TO_IR_SKIN,1
HP_IMPOTENCE,SET,47,-0.25906,-0.013084,0.12629,0.97987,HP_IMPOTENCE,1
MIR1276,SET,163,-0.13714,-0.012857,0.06684,0.97989,MIR1276,1
GOCC_CORTICAL_CYTOSKELETON,SET,103,-0.1674,-0.012497,0.081584,0.9799,GOCC_CORTICAL_CYTOSKELETON,1
HP_BILIARY_ATRESIA,SET,11,-0.5046,-0.012341,0.2459,0.97991,HP_BILIARY_ATRESIA,1
WONG_ENDMETRIUM_CANCER_UP,SET,24,-0.35683,-0.012886,0.17384,0.97994,WONG_ENDMETRIUM_CANCER_UP,1
REACTOME_CONSTITUTIVE_SIGNAL...2,SET,25,-0.33131,-0.012211,0.16141,0.97994,REACTOME_CONSTITUTIVE_SIGNALING_BY_AKT1_E17K_IN_CANCER,1
GSE24634_TEFF_VS_TCONV_DAY3_...1,SET,169,-0.13755,-0.013129,0.067008,0.97994,GSE24634_TEFF_VS_TCONV_DAY3_IN_CULTURE_DN,1
GSE28783_ANTI_MIR33_VS_CTRL_...1,SET,166,-0.13835,-0.013089,0.067379,0.97997,GSE28783_ANTI_MIR33_VS_CTRL_ATHEROSCLEROSIS_MACROPHAGE_DN,1
REACTOME_FGFR3_LIGAND_BINDIN...,SET,12,-0.57377,-0.014656,0.27934,0.98,REACTOME_FGFR3_LIGAND_BINDING_AND_ACTIVATION,1
GSE4142_NAIVE_VS_MEMORY_BCEL...1,SET,189,-0.12392,-0.012502,0.06032,0.98003,GSE4142_NAIVE_VS_MEMORY_BCELL_DN,1
MIR219A_1_3P,SET,55,-0.22679,-0.012388,0.11034,0.98007,MIR219A_1_3P,1
MIR6128,SET,153,-0.14111,-0.012822,0.068659,0.98007,MIR6128,1
GOMF_G_RICH_STRAND_TELOMERIC...,SET,10,-0.51067,-0.011909,0.24846,0.98007,GOMF_G_RICH_STRAND_TELOMERIC_DNA_BINDING,1
GOBP_DESMOSOME_ORGANIZATION,SET,9,-0.68534,-0.015162,0.3333,0.98011,GOBP_DESMOSOME_ORGANIZATION,1
CCAWNWWNNNGGC_UNKNOWN,SET,75,-0.20318,-0.012953,0.098802,0.98012,CCAWNWWNNNGGC_UNKNOWN,1
GSE10240_IL22_VS_IL17_STIM_P...1,SET,174,-0.12621,-0.012222,0.06136,0.98014,GSE10240_IL22_VS_IL17_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN,1
GSE29618_LAIV_VS_TIV_FLU_VAC...7,SET,174,-0.13271,-0.012852,0.064516,0.98015,GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_DN,1
MIR4261,SET,387,-0.090438,-0.012984,0.043946,0.98019,MIR4261,1
HP_DUODENAL_ATRESIA,SET,39,-0.2833,-0.013036,0.13761,0.98023,HP_DUODENAL_ATRESIA,1
GOMF_CYTIDYLYLTRANSFERASE_AC...,SET,8,-0.64034,-0.013357,0.31099,0.98025,GOMF_CYTIDYLYLTRANSFERASE_ACTIVITY,1
MARTINEZ_RESPONSE_TO_TRABECT...3,SET,65,-0.21645,-0.012849,0.10503,0.98033,MARTINEZ_RESPONSE_TO_TRABECTEDIN_UP,1
HP_CONFETTI_LIKE_HYPOPIGMENT...,SET,8,-0.61756,-0.012882,0.29967,0.98033,HP_CONFETTI_LIKE_HYPOPIGMENTED_MACULES,1
GOBP_CAMP_METABOLIC_PROCESS,SET,23,-0.38579,-0.013639,0.18717,0.98035,GOBP_CAMP_METABOLIC_PROCESS,1
GOBP_POSITIVE_REGULATION_OF_...292,SET,7,-0.74327,-0.014503,0.36059,0.98035,GOBP_POSITIVE_REGULATION_OF_GAMMA_DELTA_T_CELL_DIFFERENTIATION,1
GNF2_HPX,SET,131,-0.15579,-0.013106,0.075572,0.98036,GNF2_HPX,1
GOBP_REGULATION_OF_SPINDLE_C...,SET,22,-0.32642,-0.011287,0.15833,0.98037,GOBP_REGULATION_OF_SPINDLE_CHECKPOINT,1
BIOCARTA_BBCELL_PATHWAY,SET,6,-0.79328,-0.014331,0.38477,0.98038,BIOCARTA_BBCELL_PATHWAY,1
GOBP_PROTEASOME_MEDIATED_UBI...,SET,369,-0.08866,-0.012436,0.04299,0.9804,GOBP_PROTEASOME_MEDIATED_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
GOBP_CYTOPLASMIC_TRANSLATION...1,SET,4,-0.74463,-0.010984,0.36099,0.98042,GOBP_CYTOPLASMIC_TRANSLATIONAL_ELONGATION,1
MODULE_27,SET,333,-0.10261,-0.013686,0.049731,0.98045,MODULE_27,1
ACTGCCT_MIR34B,SET,200,-0.12271,-0.012731,0.059467,0.98046,ACTGCCT_MIR34B,1
GOBP_REGULATION_OF_RESPONSE_...7,SET,29,-0.3346,-0.013281,0.16215,0.98046,GOBP_REGULATION_OF_RESPONSE_TO_NUTRIENT_LEVELS,1
GOCC_ENDOPLASMIC_RETICULUM_P...2,SET,9,-0.56213,-0.012436,0.2724,0.98047,GOCC_ENDOPLASMIC_RETICULUM_PLASMA_MEMBRANE_CONTACT_SITE,1
GSE21670_UNTREATED_VS_TGFB_T...2,SET,180,-0.13453,-0.013248,0.065189,0.98047,GSE21670_UNTREATED_VS_TGFB_TREATED_CD4_TCELL_UP,1
MODULE_396,SET,9,-0.64938,-0.014367,0.31463,0.98048,MODULE_396,1
GSE17721_CTRL_VS_LPS_2H_BMDC...1,SET,183,-0.13188,-0.013094,0.063889,0.9805,GSE17721_CTRL_VS_LPS_2H_BMDC_DN,1
TATCTGG_MIR488,SET,58,-0.23514,-0.013189,0.1139,0.98051,TATCTGG_MIR488,1
FARMER_BREAST_CANCER_CLUSTER...7,SET,19,-0.3971,-0.012761,0.19227,0.98055,FARMER_BREAST_CANCER_CLUSTER_7,1
KEGG_MEDICUS_REFERENCE_LEUCI...,SET,7,-0.6271,-0.012236,0.30359,0.98056,KEGG_MEDICUS_REFERENCE_LEUCINE_DEGRADATION,1
GOBP_REGULATION_OF_HEMATOPOI...3,SET,14,-0.46301,-0.012774,0.22413,0.98057,GOBP_REGULATION_OF_HEMATOPOIETIC_STEM_CELL_PROLIFERATION,1
HP_METAPHYSEAL_SPURS,SET,7,-0.64888,-0.012661,0.3141,0.98057,HP_METAPHYSEAL_SPURS,1
PKCA_DN.V1_DN,SET,141,-0.15289,-0.01334,0.073954,0.98064,PKCA_DN.V1_DN,1
GSE37301_HEMATOPOIETIC_STEM_...4,SET,174,-0.13226,-0.012808,0.063976,0.98064,GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_UP,1
GOBP_RESPONSE_TO_VITAMIN,SET,85,-0.20668,-0.014023,0.099921,0.98069,GOBP_RESPONSE_TO_VITAMIN,1
HP_FACIAL_HYPERTRICHOSIS,SET,174,-0.13056,-0.012643,0.063117,0.98069,HP_FACIAL_HYPERTRICHOSIS,1
GSE17186_NAIVE_VS_CD21HIGH_T...3,SET,179,-0.13168,-0.012932,0.06366,0.98069,GSE17186_NAIVE_VS_CD21HIGH_TRANSITIONAL_BCELL_DN,1
GSE27786_CD4_TCELL_VS_NKCELL...2,SET,183,-0.12329,-0.012241,0.0596,0.9807,GSE27786_CD4_TCELL_VS_NKCELL_UP,1
ROETH_TERT_TARGETS_DN,SET,9,-0.61853,-0.013684,0.29888,0.98074,ROETH_TERT_TARGETS_DN,1
GOBP_RESPONSE_TO_OXYGEN_GLUC...,SET,9,-0.55763,-0.012337,0.26943,0.98075,GOBP_RESPONSE_TO_OXYGEN_GLUCOSE_DEPRIVATION,1
GSE17721_POLYIC_VS_CPG_4H_BM...1,SET,184,-0.1294,-0.012882,0.062499,0.98078,GSE17721_POLYIC_VS_CPG_4H_BMDC_DN,1
GSE22886_NAIVE_BCELL_VS_BLOO...1,SET,175,-0.12868,-0.012497,0.062111,0.98085,GSE22886_NAIVE_BCELL_VS_BLOOD_PLASMA_CELL_DN,1
GSE32164_RESTING_DIFFERENTIA...1,SET,183,-0.13344,-0.013249,0.064389,0.98088,GSE32164_RESTING_DIFFERENTIATED_VS_ALTERNATIVELY_ACT_M2_MACROPHAGE_DN,1
MODULE_176,SET,209,-0.13328,-0.014132,0.064285,0.98092,MODULE_176,1
HP_PULMONARY_CYST,SET,26,-0.36593,-0.013754,0.1765,0.98092,HP_PULMONARY_CYST,1
GOBP_REGULATION_OF_TOLL_LIKE...5,SET,11,-0.56039,-0.013706,0.27004,0.98101,GOBP_REGULATION_OF_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,1
GSE37301_LYMPHOID_PRIMED_MPP...4,SET,187,-0.1247,-0.012514,0.06007,0.98104,GSE37301_LYMPHOID_PRIMED_MPP_VS_COMMON_LYMPHOID_PROGENITOR_UP,1
GSE9239_CTRL_VS_TNF_INHIBITO...2,SET,175,-0.13205,-0.012824,0.063609,0.98104,GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_UP,1
GOCC_MESSENGER_RIBONUCLEOPRO...,SET,6,-0.6258,-0.011305,0.30138,0.98107,GOCC_MESSENGER_RIBONUCLEOPROTEIN_COMPLEX,1
GOBP_EMBRYONIC_RETINA_MORPHO...,SET,6,-0.79496,-0.014361,0.38278,0.98108,GOBP_EMBRYONIC_RETINA_MORPHOGENESIS_IN_CAMERA_TYPE_EYE,1
REACTOME_RHOQ_GTPASE_CYCLE,SET,57,-0.23386,-0.013003,0.1126,0.98109,REACTOME_RHOQ_GTPASE_CYCLE,1
ZWANG_CLASS_1_TRANSIENTLY_IN...,SET,454,-0.085645,-0.013293,0.041219,0.98113,ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF,1
CTCAGGG_MIR125B_MIR125A,SET,303,-0.098804,-0.012581,0.047539,0.98115,CTCAGGG_MIR125B_MIR125A,1
GOBP_SPECIFICATION_OF_ANIMAL...,SET,35,-0.33739,-0.014709,0.1623,0.98118,GOBP_SPECIFICATION_OF_ANIMAL_ORGAN_IDENTITY,1
GSE5142_HTERT_TRANSDUCED_VS_...1,SET,178,-0.13156,-0.012884,0.06325,0.98123,GSE5142_HTERT_TRANSDUCED_VS_CTRL_CD8_TCELL_LATE_PASSAGE_CLONE_DN,1
GSE46606_UNSTIM_VS_CD40L_IL2...3,SET,171,-0.13206,-0.012679,0.063485,0.98124,GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4MID_SORTED_BCELL_DN,1
MIR218_5P,SET,384,-0.093593,-0.013386,0.044984,0.98126,MIR218_5P,1
PATEL_SKIN_OF_BODY_ZOSTAVAX_...1,SET,25,-0.37788,-0.013927,0.18161,0.98126,PATEL_SKIN_OF_BODY_ZOSTAVAX_AGE_70_93YO_VZV_CHALLENGED_POST_VACCINATION_VS_UNCHALLENGED_72HR_TOP_30_DEG_UP,1
CGGAARNGGCNG_UNKNOWN,SET,52,-0.22844,-0.012134,0.10978,0.98127,CGGAARNGGCNG_UNKNOWN,1
GSE7219_UNSTIM_VS_LPS_AND_AN...1,SET,162,-0.13901,-0.012993,0.066771,0.98131,GSE7219_UNSTIM_VS_LPS_AND_ANTI_CD40_STIM_DC_DN,1
PID_FAS_PATHWAY,SET,36,-0.30999,-0.013706,0.14875,0.98141,PID_FAS_PATHWAY,1
GOBP_METANEPHRIC_COLLECTING_...,SET,10,-0.63713,-0.014858,0.30556,0.98146,GOBP_METANEPHRIC_COLLECTING_DUCT_DEVELOPMENT,1
GOBP_LOCOMOTION,SET,1125,-0.056881,-0.013635,0.027278,0.98147,GOBP_LOCOMOTION,1
GSE40274_FOXP3_VS_FOXP3_AND_...12,SET,176,-0.133,-0.012952,0.063751,0.98151,GSE40274_FOXP3_VS_FOXP3_AND_PBX1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
HP_LARYNGEAL_CLEFT,SET,6,-0.91277,-0.016489,0.43751,0.98152,HP_LARYNGEAL_CLEFT,1
GOBP_ENERGY_DERIVATION_BY_OX...,SET,277,-0.10128,-0.012339,0.048523,0.98156,GOBP_ENERGY_DERIVATION_BY_OXIDATION_OF_ORGANIC_COMPOUNDS,1
GOCC_NEURON_SPINE,SET,167,-0.1408,-0.01336,0.067458,0.98156,GOCC_NEURON_SPINE,1
GOBP_REGULATION_OF_MACROPHAG...3,SET,27,-0.33155,-0.012699,0.15879,0.98159,GOBP_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,1
MIR338_5P,SET,428,-0.088474,-0.013343,0.042361,0.98162,MIR338_5P,1
MAHAJAN_RESPONSE_TO_IL1A_UP,SET,73,-0.22295,-0.014023,0.10673,0.98164,MAHAJAN_RESPONSE_TO_IL1A_UP,1
MIR634,SET,83,-0.18721,-0.012552,0.089585,0.98167,MIR634,1
DESCARTES_MAIN_FETAL_SYNCYTI...,SET,64,-0.23566,-0.013882,0.11277,0.98167,DESCARTES_MAIN_FETAL_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,1
GOCC_EXTRINSIC_COMPONENT_OF_...2,SET,167,-0.14161,-0.013437,0.067721,0.98173,GOCC_EXTRINSIC_COMPONENT_OF_MEMBRANE,1
KEGG_MEDICUS_REFERENCE_PKR_E...,SET,7,-0.60009,-0.011709,0.28692,0.98175,KEGG_MEDICUS_REFERENCE_PKR_EIF2ALPHA_SIGNALING_PATHWAY,1
GSE3565_CTRL_VS_LPS_INJECTED...2,SET,166,-0.14568,-0.013783,0.06964,0.98177,GSE3565_CTRL_VS_LPS_INJECTED_DUSP1_KO_SPLENOCYTES_UP,1
GOBP_RESPONSE_TO_CORTISOL,SET,6,-0.82983,-0.014991,0.39662,0.98178,GOBP_RESPONSE_TO_CORTISOL,1
HP_ABNORMALITY_OF_CRANIAL_SU...,SET,338,-0.094934,-0.012755,0.045374,0.98178,HP_ABNORMALITY_OF_CRANIAL_SUTURES,1
MIR4652_3P,SET,290,-0.10726,-0.013366,0.051221,0.98186,MIR4652_3P,1
GOCC_RISC_LOADING_COMPLEX,SET,8,-0.6772,-0.014126,0.32339,0.98187,GOCC_RISC_LOADING_COMPLEX,1
GSE13522_WT_VS_IFNAR_KO_SKIN...1,SET,178,-0.12929,-0.012662,0.061697,0.98194,GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN,1
GOMF_CYCLIC_NUCLEOTIDE_PHOSP...,SET,26,-0.35992,-0.013528,0.17173,0.98195,GOMF_CYCLIC_NUCLEOTIDE_PHOSPHODIESTERASE_ACTIVITY,1
GNF2_GSTM1,SET,105,-0.17356,-0.013081,0.082777,0.98198,GNF2_GSTM1,1
GOMF_MITOGEN_ACTIVATED_PROTE...1,SET,29,-0.32557,-0.012922,0.15528,0.98198,GOMF_MITOGEN_ACTIVATED_PROTEIN_KINASE_BINDING,1
HP_GASTRITIS,SET,18,-0.41567,-0.013002,0.19824,0.98199,HP_GASTRITIS,1
GOBP_NECROPTOTIC_PROCESS,SET,36,-0.30251,-0.013375,0.14422,0.98202,GOBP_NECROPTOTIC_PROCESS,1
DESCARTES_FETAL_LUNG_STROMAL...,SET,37,-0.31124,-0.013951,0.14834,0.98205,DESCARTES_FETAL_LUNG_STROMAL_CELLS,1
GOBP_SRP_DEPENDENT_COTRANSLA...3,SET,8,-0.61433,-0.012814,0.29261,0.98211,GOBP_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE_TRANSLOCATION,1
GSE40274_HELIOS_VS_FOXP3_AND...2,SET,182,-0.13458,-0.013326,0.064092,0.98212,GSE40274_HELIOS_VS_FOXP3_AND_HELIOS_TRANSDUCED_ACTIVATED_CD4_TCELL_UP,1
HP_INERTIA,SET,4,-0.95732,-0.014121,0.45584,0.98213,HP_INERTIA,1
GSE14308_TH2_VS_TH17_DN,SET,185,-0.12359,-0.012337,0.058847,0.98214,GSE14308_TH2_VS_TH17_DN,1
GSE25123_IL4_VS_IL4_AND_ROSI...1,SET,177,-0.12929,-0.012626,0.061552,0.98215,GSE25123_IL4_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_DN,1
chr7q36,SET,76,-0.40986,-0.026302,0.19508,0.98217,chr7q36,1
chr6q14,SET,36,-0.442,-0.019543,0.21033,0.98219,chr6q14,1
GOBP_TOLERANCE_INDUCTION_DEP...,SET,4,-0.98905,-0.014589,0.47053,0.98221,GOBP_TOLERANCE_INDUCTION_DEPENDENT_UPON_IMMUNE_RESPONSE,1
GSE20152_SPHK1_KO_VS_HTNFA_O...2,SET,171,-0.12868,-0.012354,0.061219,0.98221,GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP,1
WP_ACETYLCHOLINE_SYNTHESIS,SET,5,-0.75273,-0.012414,0.35809,0.98222,WP_ACETYLCHOLINE_SYNTHESIS,1
KOBAYASHI_EGFR_SIGNALING_6HR...2,SET,6,-0.69973,-0.012641,0.33279,0.98224,KOBAYASHI_EGFR_SIGNALING_6HR_UP,1
REACTOME_NON_INTEGRIN_MEMBRA...,SET,55,-0.25352,-0.013848,0.1205,0.9823,REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS,1
GOMF_FOLIC_ACID_BINDING,SET,12,-0.52746,-0.013473,0.25069,0.9823,GOMF_FOLIC_ACID_BINDING,1
GOBP_REGULATION_OF_CARDIAC_M...4,SET,16,-0.42516,-0.012539,0.20193,0.98237,GOBP_REGULATION_OF_CARDIAC_MUSCLE_CELL_DIFFERENTIATION,1
BIOCARTA_DEATH_PATHWAY,SET,28,-0.34588,-0.01349,0.1642,0.98241,BIOCARTA_DEATH_PATHWAY,1
GOMF_PHOSPHORIC_DIESTER_HYDR...,SET,86,-0.18724,-0.012778,0.088875,0.98243,GOMF_PHOSPHORIC_DIESTER_HYDROLASE_ACTIVITY,1
GSE45365_HEALTHY_VS_MCMV_INF...1,SET,167,-0.13677,-0.012978,0.064905,0.98244,GSE45365_HEALTHY_VS_MCMV_INFECTION_BCELL_IFNAR_KO_DN,1
AKL_HTLV1_INFECTION_DN,SET,61,-0.23378,-0.013446,0.11093,0.98245,AKL_HTLV1_INFECTION_DN,1
GOBP_GLIAL_CELL_APOPTOTIC_PR...,SET,17,-0.43769,-0.013305,0.20769,0.98245,GOBP_GLIAL_CELL_APOPTOTIC_PROCESS,1
BRIDEAU_IMPRINTED_GENES,SET,60,-0.27819,-0.015869,0.132,0.98246,BRIDEAU_IMPRINTED_GENES,1
GOBP_AMIDE_BIOSYNTHETIC_PROC...,SET,144,-0.15311,-0.013499,0.072649,0.98246,GOBP_AMIDE_BIOSYNTHETIC_PROCESS,1
HOSHIDA_LIVER_CANCER_SURVIVA...1,SET,99,-0.17499,-0.012808,0.083015,0.98247,HOSHIDA_LIVER_CANCER_SURVIVAL_DN,1
HP_ELEVATED_CIRCULATING_HEPA...,SET,325,-0.097327,-0.012827,0.046176,0.98247,HP_ELEVATED_CIRCULATING_HEPATIC_TRANSAMINASE_CONCENTRATION,1
MIR3692_5P,SET,128,-0.15629,-0.012997,0.074109,0.98252,MIR3692_5P,1
HP_CUPPED_RIBS,SET,23,-0.36174,-0.012789,0.17152,0.98252,HP_CUPPED_RIBS,1
REACTOME_CREATION_OF_C4_AND_...,SET,12,-0.62906,-0.016069,0.29825,0.98253,REACTOME_CREATION_OF_C4_AND_C2_ACTIVATORS,1
REACTOME_SYNAPTIC_ADHESION_L...,SET,19,-0.39175,-0.012589,0.18564,0.98257,REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES,1
HP_LARYNGEAL_HYPOPLASIA,SET,8,-0.56294,-0.011742,0.26678,0.98257,HP_LARYNGEAL_HYPOPLASIA,1
TRAVAGLINI_LUNG_VASCULAR_SMO...,SET,57,-0.2516,-0.01399,0.11919,0.98261,TRAVAGLINI_LUNG_VASCULAR_SMOOTH_MUSCLE_CELL,1
GOBP_AMINE_TRANSPORT,SET,90,-0.20367,-0.014217,0.096454,0.98263,GOBP_AMINE_TRANSPORT,1
REACTOME_FREE_FATTY_ACIDS_RE...,SET,10,-0.6261,-0.0146,0.29611,0.98275,REACTOME_FREE_FATTY_ACIDS_REGULATE_INSULIN_SECRETION,1
GOBP_CYTOPLASMIC_SEQUESTERIN...3,SET,7,-0.59937,-0.011695,0.28349,0.98275,GOBP_CYTOPLASMIC_SEQUESTERING_OF_TRANSCRIPTION_FACTOR,1
GOMF_NEUROPEPTIDE_ACTIVITY,SET,25,-0.38369,-0.014142,0.18148,0.98275,GOMF_NEUROPEPTIDE_ACTIVITY,1
GOBP_SALIVARY_GLAND_DEVELOPM...,SET,36,-0.31086,-0.013745,0.14701,0.98276,GOBP_SALIVARY_GLAND_DEVELOPMENT,1
REACTOME_AKT_PHOSPHORYLATES_...1,SET,14,-0.43416,-0.011978,0.20527,0.98278,REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL,1
GOBP_REGULATION_OF_MITOCHOND...1,SET,6,-0.66228,-0.011964,0.31313,0.98278,GOBP_REGULATION_OF_MITOCHONDRIAL_ATP_SYNTHESIS_COUPLED_ELECTRON_TRANSPORT,1
GOBP_NECROPTOTIC_SIGNALING_P...,SET,8,-0.66356,-0.013841,0.31368,0.9828,GOBP_NECROPTOTIC_SIGNALING_PATHWAY,1
ELK1_02,SET,236,-0.10926,-0.012302,0.051639,0.98282,ELK1_02,1
SHIN_B_CELL_LYMPHOMA_CLUSTER...1,SET,13,-0.48944,-0.013012,0.23107,0.98291,SHIN_B_CELL_LYMPHOMA_CLUSTER_1,1
GSE1925_CTRL_VS_24H_IFNG_STI...2,SET,184,-0.13494,-0.013434,0.063703,0.98292,GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_UP,1
REACTOME_NFE2L2_REGULATES_PE...,SET,7,-0.73762,-0.014392,0.34805,0.98296,REACTOME_NFE2L2_REGULATES_PENTOSE_PHOSPHATE_PATHWAY_GENES,1
GOBP_LONG_TERM_SYNAPTIC_DEPR...,SET,30,-0.3648,-0.014726,0.17213,0.98296,GOBP_LONG_TERM_SYNAPTIC_DEPRESSION,1
HP_ELEVATED_ALKALINE_PHOSPHA...,SET,13,-0.5167,-0.013737,0.2438,0.98296,HP_ELEVATED_ALKALINE_PHOSPHATASE_OF_BONE_ORIGIN,1
GOBP_ADP_BIOSYNTHETIC_PROCESS,SET,5,-0.91174,-0.015036,0.42997,0.98301,GOBP_ADP_BIOSYNTHETIC_PROCESS,1
MIR4440,SET,5,-0.96341,-0.015888,0.45424,0.98303,MIR4440,1
WP_PROSURVIVAL_SIGNALING_OF_...,SET,15,-0.45791,-0.013076,0.21586,0.98304,WP_PROSURVIVAL_SIGNALING_OF_NEUROPROTECTIN_D1,1
GSE42021_CD24INT_TREG_VS_CD2...1,SET,179,-0.12828,-0.012598,0.060466,0.98305,GSE42021_CD24INT_TREG_VS_CD24INT_TCONV_THYMUS_DN,1
HP_HYPOPIGMENTATION_OF_THE_F...,SET,22,-0.37292,-0.012895,0.17573,0.98308,HP_HYPOPIGMENTATION_OF_THE_FUNDUS,1
KEGG_MEDICUS_REFERENCE_ATR_P...,SET,8,-0.49897,-0.010408,0.23505,0.98311,KEGG_MEDICUS_REFERENCE_ATR_P21_CELL_CYCLE_G2_M,1
GOBP_DETERMINATION_OF_PANCRE...,SET,4,-0.85315,-0.012585,0.40186,0.98312,GOBP_DETERMINATION_OF_PANCREATIC_LEFT_RIGHT_ASYMMETRY,1
MIR3137,SET,47,-0.27877,-0.014079,0.13129,0.98313,MIR3137,1
HP_PARATHYROID_CARCINOMA,SET,7,-0.72912,-0.014227,0.3434,0.98313,HP_PARATHYROID_CARCINOMA,1
GOBP_BASEMENT_MEMBRANE_ORGAN...,SET,37,-0.29722,-0.013322,0.13991,0.98317,GOBP_BASEMENT_MEMBRANE_ORGANIZATION,1
GOBP_VENTRAL_MIDLINE_DEVELOP...,SET,6,-0.79414,-0.014346,0.37363,0.98322,GOBP_VENTRAL_MIDLINE_DEVELOPMENT,1
MIKKELSEN_ES_HCP_WITH_H3_UNM...,SET,55,-0.25898,-0.014146,0.12177,0.98327,MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED,1
BDP1_TARGET_GENES,SET,1011,-0.056572,-0.012898,0.026603,0.98327,BDP1_TARGET_GENES,1
HP_PANHYPOGAMMAGLOBULINEMIA,SET,16,-0.42895,-0.012651,0.20169,0.98327,HP_PANHYPOGAMMAGLOBULINEMIA,1
MIR4772_5P,SET,48,-0.26452,-0.013501,0.12434,0.9833,MIR4772_5P,1
GOCC_APICAL_DENDRITE,SET,16,-0.45377,-0.013383,0.21322,0.98333,GOCC_APICAL_DENDRITE,1
HP_ABNORMALITY_OF_ENDOCRINE_...,SET,28,-0.36899,-0.014391,0.17337,0.98334,HP_ABNORMALITY_OF_ENDOCRINE_PANCREAS_PHYSIOLOGY,1
MORF_SUPT3H,SET,288,-0.1092,-0.013563,0.051297,0.98336,MORF_SUPT3H,1
REACTOME_CD22_MEDIATED_BCR_R...,SET,4,-1.013,-0.014942,0.47569,0.98338,REACTOME_CD22_MEDIATED_BCR_REGULATION,1
GOBP_OSMOSENSORY_SIGNALING_P...,SET,6,-0.69526,-0.01256,0.32644,0.9834,GOBP_OSMOSENSORY_SIGNALING_PATHWAY,1
HP_INTELLECTUAL_DISABILITY_B...,SET,24,-0.39262,-0.014178,0.18433,0.98341,HP_INTELLECTUAL_DISABILITY_BORDERLINE,1
ACAWNRNSRCGG_UNKNOWN,SET,57,-0.24128,-0.013416,0.11326,0.98342,ACAWNRNSRCGG_UNKNOWN,1
MIR664A_5P,SET,65,-0.23637,-0.014032,0.11089,0.98347,MIR664A_5P,1
GOBP_PHOSPHOLIPID_CATABOLIC_...,SET,54,-0.24971,-0.013515,0.11707,0.98353,GOBP_PHOSPHOLIPID_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...510,SET,33,-0.28877,-0.012225,0.13536,0.98355,GOBP_NEGATIVE_REGULATION_OF_PROTEASOMAL_UBIQUITIN_DEPENDENT_PROTEIN_CATABOLIC_PROCESS,1
HP_AUTISTIC_BEHAVIOR,SET,499,-0.080913,-0.01315,0.037912,0.98358,HP_AUTISTIC_BEHAVIOR,1
GOBP_CELLULAR_RESPONSE_TO_NU...1,SET,45,-0.28173,-0.013923,0.1318,0.98372,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT,1
HP_GLUCAGONOMA,SET,6,-0.7473,-0.0135,0.34959,0.98372,HP_GLUCAGONOMA,1
HP_ABNORMAL_HEMIDIAPHRAGM_MO...,SET,7,-0.75138,-0.014661,0.35138,0.98375,HP_ABNORMAL_HEMIDIAPHRAGM_MORPHOLOGY,1
GSE37532_WT_VS_PPARG_KO_VISC...1,SET,180,-0.13173,-0.012972,0.061596,0.98376,GSE37532_WT_VS_PPARG_KO_VISCERAL_ADIPOSE_TISSUE_TCONV_DN,1
REACTOME_PTEN_REGULATION,SET,131,-0.14742,-0.012402,0.068907,0.98379,REACTOME_PTEN_REGULATION,1
EGR2_01,SET,179,-0.13662,-0.013417,0.063833,0.98382,EGR2_01,1
GOBP_PEPTIDYL_LYSINE_DIMETHY...,SET,4,-0.9464,-0.01396,0.44217,0.98383,GOBP_PEPTIDYL_LYSINE_DIMETHYLATION,1
MODULE_278,SET,32,-0.3105,-0.012945,0.14501,0.98386,MODULE_278,1
HP_VOMITING,SET,301,-0.10269,-0.013033,0.047925,0.98392,HP_VOMITING,1
REACTOME_VITAMINS,SET,6,-0.83554,-0.015094,0.38992,0.98393,REACTOME_VITAMINS,1
GOBP_PROTEIN_REFOLDING,SET,24,-0.36503,-0.013182,0.17034,0.98394,GOBP_PROTEIN_REFOLDING,1
MIR4524A_3P,SET,200,-0.12804,-0.013284,0.059714,0.98399,MIR4524A_3P,1
MIR2681_5P,SET,146,-0.15158,-0.013456,0.070668,0.98401,MIR2681_5P,1
GOBP_NEURAL_PLATE_PATTERN_SP...,SET,7,-0.71222,-0.013897,0.332,0.98403,GOBP_NEURAL_PLATE_PATTERN_SPECIFICATION,1
GSE37301_MULTIPOTENT_PROGENI...10,SET,178,-0.13622,-0.01334,0.063494,0.98403,GSE37301_MULTIPOTENT_PROGENITOR_VS_PRO_BCELL_UP,1
GNF2_ZAP70,SET,23,-0.37729,-0.013339,0.17575,0.98409,GNF2_ZAP70,1
GOBP_ARACHIDONIC_ACID_SECRET...,SET,31,-0.33599,-0.013787,0.15646,0.98411,GOBP_ARACHIDONIC_ACID_SECRETION,1
GAZDA_DIAMOND_BLACKFAN_ANEMI...6,SET,36,-0.32205,-0.014239,0.14996,0.98412,GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_UP,1
MIR3714,SET,404,-0.092165,-0.013514,0.042915,0.98412,MIR3714,1
DESCARTES_FETAL_SPLEEN_LYMPH...,SET,93,-0.1997,-0.01417,0.09298,0.98413,DESCARTES_FETAL_SPLEEN_LYMPHOID_CELLS,1
GAVISH_3CA_METAPROGRAM_B_CEL...1,SET,41,-0.26166,-0.012345,0.12181,0.98414,GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1,1
KIM_MYC_AMPLIFICATION_TARGET...1,SET,87,-0.20355,-0.013971,0.094745,0.98415,KIM_MYC_AMPLIFICATION_TARGETS_DN,1
GSE7460_CTRL_VS_TGFB_TREATED...9,SET,185,-0.13291,-0.013267,0.061835,0.98419,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_DN,1
MIR10398_5P,SET,70,-0.21534,-0.013264,0.10016,0.98421,MIR10398_5P,1
GOBP_RESPONSE_TO_INDOLE_3_ME...,SET,6,-0.78099,-0.014109,0.3633,0.98421,GOBP_RESPONSE_TO_INDOLE_3_METHANOL,1
PYEON_HPV_POSITIVE_TUMORS_UP,SET,81,-0.1935,-0.012818,0.089994,0.98422,PYEON_HPV_POSITIVE_TUMORS_UP,1
GSE17721_0.5H_VS_8H_GARDIQUI...2,SET,175,-0.12959,-0.012585,0.060244,0.98426,GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_UP,1
GOMF_MRNA_REGULATORY_ELEMENT...,SET,15,-0.39465,-0.01127,0.18338,0.9843,GOMF_MRNA_REGULATORY_ELEMENT_BINDING_TRANSLATION_REPRESSOR_ACTIVITY,1
GNF2_LCAT,SET,121,-0.16825,-0.013607,0.078143,0.98434,GNF2_LCAT,1
GOMF_CATALYTIC_ACTIVITY_ACTI...1,SET,22,-0.44608,-0.015424,0.20713,0.98436,GOMF_CATALYTIC_ACTIVITY_ACTING_ON_A_GLYCOPROTEIN,1
NAKAYAMA_SOFT_TISSUE_TUMORS_...1,SET,66,-0.24553,-0.014687,0.11398,0.98438,NAKAYAMA_SOFT_TISSUE_TUMORS_PCA1_DN,1
KEGG_MEDICUS_REFERENCE_IRE1A...,SET,7,-0.69399,-0.013541,0.32213,0.98439,KEGG_MEDICUS_REFERENCE_IRE1A_JNK_SIGNALING_PATHWAY,1
DESCARTES_FETAL_LUNG_VASCULA...,SET,43,-0.29914,-0.014453,0.13884,0.9844,DESCARTES_FETAL_LUNG_VASCULAR_ENDOTHELIAL_CELLS,1
WP_DRAVET_SYNDROME,SET,26,-0.39469,-0.014835,0.18303,0.98447,WP_DRAVET_SYNDROME,1
ATF2_S_UP.V1_UP,SET,174,-0.14808,-0.01434,0.068672,0.98447,ATF2_S_UP.V1_UP,1
GSE41978_WT_VS_BIM_KO_KLRG1_...1,SET,178,-0.1359,-0.013309,0.063021,0.98447,GSE41978_WT_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN,1
MODULE_143,SET,12,-0.56997,-0.014559,0.2642,0.9845,MODULE_143,1
GOBP_PROTEIN_PROCESSING_INVO...,SET,7,-0.70616,-0.013779,0.32732,0.9845,GOBP_PROTEIN_PROCESSING_INVOLVED_IN_PROTEIN_TARGETING_TO_MITOCHONDRION,1
GOCC_VESICLE_TETHERING_COMPL...,SET,62,-0.22112,-0.012821,0.10238,0.9846,GOCC_VESICLE_TETHERING_COMPLEX,1
chr6q27,SET,25,-0.5459,-0.02012,0.25271,0.98461,chr6q27,1
GOBP_REGULATION_OF_PLATELET_...3,SET,5,-0.84546,-0.013943,0.39142,0.98461,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_ALPHA_SIGNALING_PATHWAY,1
MORF_TPR,SET,131,-0.14628,-0.012306,0.067703,0.98463,MORF_TPR,1
GSE29618_PRE_VS_DAY7_POST_TI...1,SET,171,-0.1285,-0.012337,0.05946,0.98465,GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_BCELL_DN,1
REACTOME_KIDNEY_DEVELOPMENT,SET,42,-0.31703,-0.015138,0.14666,0.98467,REACTOME_KIDNEY_DEVELOPMENT,1
GOMF_CADHERIN_BINDING,SET,302,-0.10377,-0.013192,0.047994,0.98469,GOMF_CADHERIN_BINDING,1
GSE22601_IMMATURE_CD4_SINGLE...5,SET,181,-0.13536,-0.013366,0.062593,0.9847,GSE22601_IMMATURE_CD4_SINGLE_POSITIVE_VS_DOUBLE_POSITIVE_THYMOCYTE_DN,1
GSE7218_IGM_VS_IGG_SIGNAL_TH...2,SET,176,-0.13319,-0.012971,0.061589,0.9847,GSE7218_IGM_VS_IGG_SIGNAL_THGOUGH_ANTIGEN_BCELL_UP,1
GOMF_PEPTIDE_RECEPTOR_ACTIVI...,SET,119,-0.18508,-0.014844,0.085478,0.98481,GOMF_PEPTIDE_RECEPTOR_ACTIVITY,1
MIR3200_5P,SET,58,-0.24425,-0.013699,0.11271,0.98488,MIR3200_5P,1
GSE35685_CD34POS_CD38NEG_VS_...4,SET,181,-0.13611,-0.01344,0.062786,0.98491,GSE35685_CD34POS_CD38NEG_VS_CD34POS_CD10POS_BONE_MARROW_UP,1
GOBP_POLYOL_CATABOLIC_PROCESS,SET,8,-0.74723,-0.015586,0.34437,0.98498,GOBP_POLYOL_CATABOLIC_PROCESS,1
HP_DYSLEXIA,SET,29,-0.33667,-0.013363,0.15512,0.985,HP_DYSLEXIA,1
GOCC_GLUTAMATERGIC_SYNAPSE,SET,390,-0.094575,-0.01363,0.043566,0.98502,GOCC_GLUTAMATERGIC_SYNAPSE,1
GSE29615_CTRL_VS_LAIV_FLU_VA...2,SET,175,-0.14202,-0.013792,0.065395,0.98505,GSE29615_CTRL_VS_LAIV_FLU_VACCINE_PBMC_UP,1
MODULE_49,SET,249,-0.11418,-0.0132,0.052551,0.98509,MODULE_49,1
WP_RAS_AND_BRADYKININ_PATHWA...,SET,27,-0.39833,-0.015256,0.18325,0.98513,WP_RAS_AND_BRADYKININ_PATHWAYS_IN_COVID19,1
GOBP_ENDOPLASMIC_RETICULUM_O...,SET,84,-0.19089,-0.012876,0.087813,0.98513,GOBP_ENDOPLASMIC_RETICULUM_ORGANIZATION,1
DESCARTES_FETAL_INTESTINE_LY...1,SET,26,-0.37844,-0.014224,0.17396,0.98519,DESCARTES_FETAL_INTESTINE_LYMPHATIC_ENDOTHELIAL_CELLS,1
BOSCO_TH1_CYTOTOXIC_MODULE,SET,107,-0.19345,-0.014718,0.088886,0.98523,BOSCO_TH1_CYTOTOXIC_MODULE,1
KEGG_MEDICUS_REFERENCE_MLK_J...,SET,10,-0.60755,-0.014168,0.27914,0.98523,KEGG_MEDICUS_REFERENCE_MLK_JNK_SIGNALING_PATHWAY,1
GOBP_RESPONSE_TO_VITAMIN_E,SET,9,-0.62886,-0.013913,0.28895,0.98523,GOBP_RESPONSE_TO_VITAMIN_E,1
JECHLINGER_EPITHELIAL_TO_MES...1,SET,59,-0.24599,-0.013915,0.11301,0.98524,JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN,1
chr15q21,SET,78,-0.37026,-0.024069,0.17006,0.98526,chr15q21,1
GOBP_ENDOTHELIAL_CELL_MATRIX...,SET,6,-0.86137,-0.015561,0.39554,0.98528,GOBP_ENDOTHELIAL_CELL_MATRIX_ADHESION,1
CTIP_DN.V1_UP,SET,116,-0.17411,-0.013788,0.079938,0.98529,CTIP_DN.V1_UP,1
GOBP_PROTEIN_LOCALIZATION_TO...24,SET,25,-0.35451,-0.013066,0.16275,0.9853,GOBP_PROTEIN_LOCALIZATION_TO_ENDOSOME,1
MIR200A_3P,SET,366,-0.10031,-0.014014,0.046014,0.98536,MIR200A_3P,1
GOBP_ANATOMICAL_STRUCTURE_AR...,SET,16,-0.49901,-0.014717,0.22885,0.98538,GOBP_ANATOMICAL_STRUCTURE_ARRANGEMENT,1
HP_VISUAL_LOSS,SET,207,-0.12974,-0.013691,0.059504,0.98538,HP_VISUAL_LOSS,1
NFKB_Q6,SET,237,-0.12231,-0.013799,0.056088,0.98539,NFKB_Q6,1
GOBP_NEGATIVE_REGULATION_OF_...622,SET,52,-0.27439,-0.014574,0.12578,0.98542,GOBP_NEGATIVE_REGULATION_OF_SYNAPTIC_TRANSMISSION,1
GOBP_CELLULAR_RESPONSE_TO_LE...3,SET,10,-0.54089,-0.012613,0.24789,0.98544,GOBP_CELLULAR_RESPONSE_TO_LEUCINE_STARVATION,1
GSE24081_CONTROLLER_VS_PROGR...1,SET,173,-0.14217,-0.013728,0.06515,0.98545,GSE24081_CONTROLLER_VS_PROGRESSOR_HIV_SPECIFIC_CD8_TCELL_DN,1
GOLUB_ALL_VS_AML_UP,SET,24,-0.37994,-0.013721,0.17406,0.98547,GOLUB_ALL_VS_AML_UP,1
NIKOLSKY_BREAST_CANCER_17P11...,SET,9,-0.87629,-0.019387,0.40128,0.9855,NIKOLSKY_BREAST_CANCER_17P11_AMPLICON,1
GOBP_MUSCLE_ATROPHY,SET,11,-0.54662,-0.013369,0.25029,0.98551,GOBP_MUSCLE_ATROPHY,1
HP_SIMPLE_EAR,SET,19,-0.43284,-0.01391,0.19807,0.98556,HP_SIMPLE_EAR,1
GSE9988_LOW_LPS_VS_CTRL_TREA...1,SET,187,-0.12946,-0.012992,0.059242,0.98556,GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN,1
WU_APOPTOSIS_BY_CDKN1A_NOT_V...,SET,9,-0.59078,-0.01307,0.2703,0.98557,WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53,1
KUROZUMI_RESPONSE_TO_ONCOCYT...2,SET,20,-0.46014,-0.015171,0.21049,0.98559,KUROZUMI_RESPONSE_TO_ONCOCYTIC_VIRUS_AND_CYCLIC_RGD,1
GOBP_NEGATIVE_REGULATION_OF_...369,SET,7,-0.61091,-0.01192,0.2794,0.98561,GOBP_NEGATIVE_REGULATION_OF_MACROPHAGE_CHEMOTAXIS,1
GOBP_CELLULAR_RESPONSE_TO_VI...3,SET,19,-0.44465,-0.014289,0.20331,0.98563,GOBP_CELLULAR_RESPONSE_TO_VITAMIN_D,1
GOBP_NEGATIVE_REGULATION_OF_...573,SET,20,-0.39625,-0.013064,0.18115,0.98564,GOBP_NEGATIVE_REGULATION_OF_RHO_PROTEIN_SIGNAL_TRANSDUCTION,1
MIR141_3P,SET,369,-0.10033,-0.014073,0.045861,0.98565,MIR141_3P,1
HP_ABNORMAL_PROTEIN_GLYCOSYL...,SET,39,-0.26121,-0.01202,0.11938,0.98566,HP_ABNORMAL_PROTEIN_GLYCOSYLATION,1
HP_ABNORMAL_CIRCULATING_INTE...2,SET,8,-0.70618,-0.01473,0.32269,0.98567,HP_ABNORMAL_CIRCULATING_INTERLEUKIN_10_CONCENTRATION,1
GOCC_TRANSCRIPTION_EXPORT_CO...1,SET,10,-0.46865,-0.010929,0.2141,0.98569,GOCC_TRANSCRIPTION_EXPORT_COMPLEX,1
CUI_DEVELOPING_HEART_COMPACT...1,SET,15,-0.47616,-0.013598,0.21749,0.98571,CUI_DEVELOPING_HEART_COMPACT_ATRIAL_CARDIOMYOCYTE,1
HP_DIFFICULTY_STANDING,SET,28,-0.34034,-0.013274,0.15544,0.98572,HP_DIFFICULTY_STANDING,1
GOBP_HEMATOPOIETIC_STEM_CELL...1,SET,36,-0.30273,-0.013385,0.13816,0.98577,GOBP_HEMATOPOIETIC_STEM_CELL_DIFFERENTIATION,1
HP_FLARED_LOWER_LIMB_METAPHY...,SET,5,-0.75322,-0.012422,0.34377,0.98577,HP_FLARED_LOWER_LIMB_METAPHYSIS,1
BIOCARTA_CELL2CELL_PATHWAY,SET,12,-0.54209,-0.013847,0.2473,0.9858,BIOCARTA_CELL2CELL_PATHWAY,1
HP_HYPERGASTRINEMIA,SET,6,-0.76391,-0.0138,0.34849,0.98581,HP_HYPERGASTRINEMIA,1
GOBP_METANEPHRIC_S_SHAPED_BO...,SET,5,-1.004,-0.016558,0.45783,0.98584,GOBP_METANEPHRIC_S_SHAPED_BODY_MORPHOGENESIS,1
HP_THYMOMA,SET,5,-0.81937,-0.013513,0.37359,0.98585,HP_THYMOMA,1
GSE1925_3H_VS_24H_IFNG_STIM_...1,SET,187,-0.1327,-0.013317,0.060476,0.98589,GSE1925_3H_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN,1
GSE37301_RAG2_KO_VS_RAG2_AND...2,SET,181,-0.13549,-0.01338,0.061695,0.98595,GSE37301_RAG2_KO_VS_RAG2_AND_ETS1_KO_NK_CELL_UP,1
GOBP_EMBRYONIC_BODY_MORPHOGE...,SET,10,-0.50192,-0.011705,0.22853,0.98596,GOBP_EMBRYONIC_BODY_MORPHOGENESIS,1
MIR6514_3P,SET,67,-0.22648,-0.013649,0.10308,0.98599,MIR6514_3P,1
GSE4984_LPS_VS_VEHICLE_CTRL_...1,SET,177,-0.1398,-0.013653,0.063618,0.986,GSE4984_LPS_VS_VEHICLE_CTRL_TREATED_DC_DN,1
GSE2770_IL4_ACT_VS_ACT_CD4_T...3,SET,180,-0.14089,-0.013874,0.064105,0.98601,GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_48H_DN,1
WP_GLYCOSYLATION_AND_RELATED...,SET,20,-0.34739,-0.011453,0.15805,0.98602,WP_GLYCOSYLATION_AND_RELATED_CONGENITAL_DEFECTS,1
GOBP_POLYAMINE_TRANSPORT,SET,16,-0.47533,-0.014019,0.21626,0.98602,GOBP_POLYAMINE_TRANSPORT,1
HP_PERIPHERAL_CYANOSIS,SET,31,-0.33676,-0.013819,0.15319,0.98603,HP_PERIPHERAL_CYANOSIS,1
GOBP_INORGANIC_ANION_TRANSME...,SET,120,-0.17852,-0.014378,0.081196,0.98604,GOBP_INORGANIC_ANION_TRANSMEMBRANE_TRANSPORT,1
GOBP_REGULATION_OF_GLIAL_CEL...1,SET,12,-0.54349,-0.013883,0.24716,0.98605,GOBP_REGULATION_OF_GLIAL_CELL_APOPTOTIC_PROCESS,1
GOMF_GLUTAMATE_RECEPTOR_ACTI...,SET,25,-0.39743,-0.014648,0.18074,0.98605,GOMF_GLUTAMATE_RECEPTOR_ACTIVITY,1
BAE_BRCA1_TARGETS_UP,SET,60,-0.23805,-0.013579,0.10825,0.98606,BAE_BRCA1_TARGETS_UP,1
GSE36476_CTRL_VS_TSST_ACT_72...2,SET,174,-0.14289,-0.013837,0.064975,0.98606,GSE36476_CTRL_VS_TSST_ACT_72H_MEMORY_CD4_TCELL_OLD_UP,1
NUTT_GBM_VS_AO_GLIOMA_DN,SET,44,-0.25507,-0.012465,0.11594,0.98609,NUTT_GBM_VS_AO_GLIOMA_DN,1
HP_MULTIPLE_PULMONARY_CYSTS,SET,18,-0.44929,-0.014054,0.20419,0.9861,HP_MULTIPLE_PULMONARY_CYSTS,1
GOBP_MEMBRANE_LIPID_CATABOLI...,SET,44,-0.28398,-0.013878,0.12904,0.98612,GOBP_MEMBRANE_LIPID_CATABOLIC_PROCESS,1
MODULE_106,SET,14,-0.54311,-0.014984,0.24673,0.98613,MODULE_106,1
MORF_ERCC4,SET,286,-0.11188,-0.013847,0.050815,0.98615,MORF_ERCC4,1
GOCC_MPP7_DLG1_LIN7_COMPLEX,SET,5,-0.94467,-0.015579,0.42902,0.98616,GOCC_MPP7_DLG1_LIN7_COMPLEX,1
GOBP_PYRUVATE_TRANSPORT,SET,7,-0.76586,-0.014944,0.34777,0.98617,GOBP_PYRUVATE_TRANSPORT,1
HP_DEFORMED_RIB_CAGE,SET,7,-0.73136,-0.01427,0.33211,0.98617,HP_DEFORMED_RIB_CAGE,1
GSE21546_WT_VS_SAP1A_KO_ANTI...2,SET,183,-0.13583,-0.013486,0.06168,0.98617,GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP,1
SERVITJA_LIVER_HNF1A_TARGETS...1,SET,152,-0.159,-0.0144,0.072158,0.98621,SERVITJA_LIVER_HNF1A_TARGETS_DN,1
HOXB7_TARGET_GENES,SET,24,-0.37328,-0.01348,0.16942,0.98621,HOXB7_TARGET_GENES,1
GOBP_GLIAL_CELL_MIGRATION,SET,57,-0.27051,-0.015041,0.12277,0.98621,GOBP_GLIAL_CELL_MIGRATION,1
PID_FGF_PATHWAY,SET,54,-0.26126,-0.014141,0.11855,0.98622,PID_FGF_PATHWAY,1
GSE7460_CTRL_VS_TGFB_TREATED...10,SET,183,-0.12931,-0.012839,0.058676,0.98623,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TREG_UP,1
KEGG_MEDICUS_REFERENCE_CORE_...,SET,27,-0.28101,-0.010763,0.12749,0.98624,KEGG_MEDICUS_REFERENCE_CORE_NER_REACTION,1
PID_P38_ALPHA_BETA_PATHWAY,SET,29,-0.35022,-0.013901,0.15889,0.98624,PID_P38_ALPHA_BETA_PATHWAY,1
HP_CONTINUOUS_SPIKE_AND_WAVE...,SET,8,-0.70274,-0.014658,0.31854,0.98631,HP_CONTINUOUS_SPIKE_AND_WAVES_DURING_SLOW_SLEEP,1
HP_NON_CONVULSIVE_STATUS_EPI...,SET,18,-0.44331,-0.013867,0.20086,0.98634,HP_NON_CONVULSIVE_STATUS_EPILEPTICUS_WITHOUT_COMA,1
GCM_PTK2,SET,135,-0.15546,-0.013275,0.070413,0.98637,GCM_PTK2,1
GOMF_STEROID_BINDING,SET,102,-0.1934,-0.014368,0.087588,0.98637,GOMF_STEROID_BINDING,1
KRAS.600_UP.V1_DN,SET,254,-0.12333,-0.014399,0.055851,0.98638,KRAS.600_UP.V1_DN,1
GOBP_REGULATION_OF_SYNAPTIC_...6,SET,70,-0.2367,-0.01458,0.1071,0.98644,GOBP_REGULATION_OF_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
GOBP_SPERMIDINE_METABOLIC_PR...,SET,6,-0.69436,-0.012544,0.31414,0.98645,GOBP_SPERMIDINE_METABOLIC_PROCESS,1
GSE36078_WT_VS_IL1R_KO_LUNG_...2,SET,182,-0.14049,-0.013911,0.063532,0.98649,GSE36078_WT_VS_IL1R_KO_LUNG_DC_AFTER_AD5_INF_UP,1
REACTOME_DISEASES_OF_CARBOHY...,SET,30,-0.32627,-0.013171,0.14753,0.9865,REACTOME_DISEASES_OF_CARBOHYDRATE_METABOLISM,1
GSE17974_IL4_AND_ANTI_IL12_V...7,SET,163,-0.15389,-0.014428,0.069583,0.9865,GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_24H_ACT_CD4_TCELL_DN,1
GOBP_BRUSH_BORDER_ASSEMBLY,SET,8,-0.59854,-0.012485,0.27052,0.98653,GOBP_BRUSH_BORDER_ASSEMBLY,1
HP_APATHY,SET,82,-0.20766,-0.01384,0.093851,0.98653,HP_APATHY,1
GAVISH_3CA_METAPROGRAM_ENDOT...11,SET,50,-0.28672,-0.014935,0.12955,0.98655,GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_HEV_2,1
GOBP_RHYTHMIC_PROCESS,SET,281,-0.11649,-0.014293,0.052623,0.98657,GOBP_RHYTHMIC_PROCESS,1
GSE29618_PRE_VS_DAY7_FLU_VAC...8,SET,175,-0.1389,-0.013489,0.06274,0.98657,GSE29618_PRE_VS_DAY7_FLU_VACCINE_PDC_UP,1
GOBP_POSITIVE_REGULATION_OF_...570,SET,34,-0.32421,-0.013932,0.14643,0.98658,GOBP_POSITIVE_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
DCA_UP.V1_UP,SET,161,-0.15282,-0.014241,0.069029,0.98658,DCA_UP.V1_UP,1
REACTOME_SYNTHESIS_OF_ACTIVE...,SET,26,-0.36349,-0.013662,0.16399,0.98667,REACTOME_SYNTHESIS_OF_ACTIVE_UBIQUITIN_ROLES_OF_E1_AND_E2_ENZYMES,1
GOCC_DENDRITIC_SPINE_HEAD,SET,7,-0.75911,-0.014812,0.34247,0.98667,GOCC_DENDRITIC_SPINE_HEAD,1
HP_DEHYDRATION,SET,99,-0.19774,-0.014474,0.089202,0.98667,HP_DEHYDRATION,1
GSE5542_UNTREATED_VS_IFNA_TR...2,SET,186,-0.13574,-0.013587,0.061237,0.98667,GSE5542_UNTREATED_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP,1
REACTOME_SODIUM_COUPLED_SULP...,SET,5,-0.93954,-0.015495,0.42364,0.98671,REACTOME_SODIUM_COUPLED_SULPHATE_DI_AND_TRI_CARBOXYLATE_TRANSPORTERS,1
GOBP_CALMODULIN_DEPENDENT_KI...,SET,12,-0.54964,-0.01404,0.24778,0.98672,GOBP_CALMODULIN_DEPENDENT_KINASE_SIGNALING_PATHWAY,1
LI_ADIPOGENESIS_BY_ACTIVATED...,SET,18,-0.46107,-0.014422,0.20778,0.98675,LI_ADIPOGENESIS_BY_ACTIVATED_PPARG,1
HP_INCREASED_CIRCULATING_INT...2,SET,5,-0.85988,-0.014181,0.3873,0.98679,HP_INCREASED_CIRCULATING_INTERLEUKIN_18_CONCENTRATION,1
REACTOME_G2_M_DNA_REPLICATIO...,SET,5,-0.70703,-0.01166,0.31831,0.98682,REACTOME_G2_M_DNA_REPLICATION_CHECKPOINT,1
GOBP_TOLL_LIKE_RECEPTOR_9_SI...,SET,18,-0.44625,-0.013959,0.20081,0.98686,GOBP_TOLL_LIKE_RECEPTOR_9_SIGNALING_PATHWAY,1
KAECH_NAIVE_VS_DAY15_EFF_CD8...1,SET,183,-0.14139,-0.014039,0.063615,0.98687,KAECH_NAIVE_VS_DAY15_EFF_CD8_TCELL_DN,1
PID_AJDISS_2PATHWAY,SET,46,-0.29122,-0.014551,0.13101,0.98688,PID_AJDISS_2PATHWAY,1
ZNF677_TARGET_GENES,SET,128,-0.17009,-0.014145,0.076514,0.98689,ZNF677_TARGET_GENES,1
GOBP_REGULATION_OF_MONOCYTE_...1,SET,25,-0.38043,-0.014021,0.17111,0.9869,GOBP_REGULATION_OF_MONOCYTE_CHEMOTAXIS,1
MORF_CSNK1D,SET,65,-0.21796,-0.012939,0.098016,0.98691,MORF_CSNK1D,1
MIR31_5P,SET,129,-0.16759,-0.013991,0.07535,0.98693,MIR31_5P,1
GOBP_EPOXYGENASE_P450_PATHWAY,SET,18,-0.51702,-0.016172,0.23245,0.98693,GOBP_EPOXYGENASE_P450_PATHWAY,1
MIR6854_5P,SET,66,-0.22616,-0.013529,0.10161,0.98698,MIR6854_5P,1
GOBP_CRANIAL_SUTURE_MORPHOGE...,SET,9,-0.70961,-0.015699,0.31866,0.98701,GOBP_CRANIAL_SUTURE_MORPHOGENESIS,1
HP_ABNORMAL_FIBULA_MORPHOLOGY,SET,51,-0.26933,-0.014168,0.12095,0.98702,HP_ABNORMAL_FIBULA_MORPHOLOGY,1
GOBP_LYMPHATIC_ENDOTHELIAL_C...,SET,8,-0.67108,-0.013998,0.3012,0.98705,GOBP_LYMPHATIC_ENDOTHELIAL_CELL_DIFFERENTIATION,1
GOMF_LIPASE_ACTIVITY,SET,127,-0.16995,-0.014078,0.076236,0.98709,GOMF_LIPASE_ACTIVITY,1
REACTOME_REGULATION_OF_CDH11...1,SET,10,-0.63116,-0.014718,0.28301,0.98713,REACTOME_REGULATION_OF_CDH11_FUNCTION,1
GOBP_REGULATION_OF_OXIDOREDU...,SET,53,-0.2589,-0.013883,0.11608,0.98713,GOBP_REGULATION_OF_OXIDOREDUCTASE_ACTIVITY,1
GSE27859_DC_VS_CD11C_INT_F48...1,SET,143,-0.14882,-0.013076,0.06671,0.98715,GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_DN,1
GCACCTT_MIR18A_MIR18B,SET,112,-0.17724,-0.013794,0.079399,0.98719,GCACCTT_MIR18A_MIR18B,1
KEGG_MEDICUS_REFERENCE_FGF_F...1,SET,30,-0.37821,-0.015268,0.16939,0.98721,KEGG_MEDICUS_REFERENCE_FGF_FGFR_PI3K_SIGNALING_PATHWAY,1
MIR8086,SET,21,-0.43222,-0.014602,0.19352,0.98723,MIR8086,1
HP_PARTIAL_ABSENCE_OF_SPECIF...2,SET,6,-0.80684,-0.014576,0.3613,0.98723,HP_PARTIAL_ABSENCE_OF_SPECIFIC_ANTIBODY_RESPONSE_TO_UNCONJUGATED_PNEUMOCOCCUS_VACCINE,1
GOBP_NEGATIVE_REGULATION_OF_...212,SET,121,-0.18651,-0.015084,0.083493,0.98725,GOBP_NEGATIVE_REGULATION_OF_EPITHELIAL_CELL_PROLIFERATION,1
DURANTE_ADULT_OLFACTORY_NEUR...25,SET,25,-0.3711,-0.013677,0.16613,0.98725,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_UNSPECIFIED,1
GOBP_CELLULAR_MODIFIED_AMINO...1,SET,42,-0.28851,-0.013776,0.1291,0.98728,GOBP_CELLULAR_MODIFIED_AMINO_ACID_BIOSYNTHETIC_PROCESS,1
MIR518A_3P_MIR518B_MIR518C_3...,SET,8,-0.71332,-0.014879,0.31915,0.98729,MIR518A_3P_MIR518B_MIR518C_3P_MIR518D_3P_MIR518F_3P_MIR526A_3P,1
TERF1_TARGET_GENES,SET,214,-0.12903,-0.013842,0.05773,0.98729,TERF1_TARGET_GENES,1
HP_SLEEP_ABNORMALITY,SET,505,-0.085732,-0.014015,0.038357,0.98729,HP_SLEEP_ABNORMALITY,1
LIAN_LIPA_TARGETS_6M,SET,65,-0.25304,-0.015021,0.11318,0.98731,LIAN_LIPA_TARGETS_6M,1
REACTOME_MUCOPOLYSACCHARIDOS...,SET,10,-0.6081,-0.014181,0.27194,0.98732,REACTOME_MUCOPOLYSACCHARIDOSES,1
TGAATGT_MIR181A_MIR181B_MIR1...,SET,449,-0.09264,-0.014302,0.041428,0.98732,TGAATGT_MIR181A_MIR181B_MIR181C_MIR181D,1
DESCARTES_FETAL_PANCREAS_ENS...2,SET,125,-0.18255,-0.015003,0.081613,0.98734,DESCARTES_FETAL_PANCREAS_ENS_NEURONS,1
PID_ECADHERIN_STABILIZATION_...,SET,39,-0.28811,-0.013258,0.12879,0.98735,PID_ECADHERIN_STABILIZATION_PATHWAY,1
GSE17186_BLOOD_VS_CORD_BLOOD...1,SET,182,-0.13754,-0.013619,0.061484,0.98735,GSE17186_BLOOD_VS_CORD_BLOOD_CD21HIGH_TRANSITIONAL_BCELL_DN,1
GOMF_RNA_POLYMERASE_II_GENER...1,SET,35,-0.28483,-0.012418,0.12731,0.98736,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
HP_DIFFUSE_PALMOPLANTAR_HYPE...,SET,10,-0.61011,-0.014227,0.27269,0.98736,HP_DIFFUSE_PALMOPLANTAR_HYPERKERATOSIS,1
HP_HYPOPLASIA_OF_TEETH,SET,109,-0.17654,-0.013555,0.078855,0.98741,HP_HYPOPLASIA_OF_TEETH,1
REACTOME_VITAMIN_D_CALCIFERO...,SET,12,-0.57559,-0.014703,0.25705,0.98742,REACTOME_VITAMIN_D_CALCIFEROL_METABOLISM,1
HP_LARGE_CAFE_AU_LAIT_MACULE...,SET,6,-0.77539,-0.014008,0.34629,0.98742,HP_LARGE_CAFE_AU_LAIT_MACULES_WITH_IRREGULAR_MARGINS,1
HP_CEREBRAL_HYPOPLASIA,SET,53,-0.25146,-0.013484,0.11228,0.98743,HP_CEREBRAL_HYPOPLASIA,1
GSE1925_CTRL_VS_IFNG_PRIMED_...4,SET,156,-0.14193,-0.01302,0.063367,0.98744,GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_3H_IFNG_STIM_UP,1
GOBP_MAMMARY_GLAND_MORPHOGEN...,SET,44,-0.31338,-0.015315,0.13989,0.98746,GOBP_MAMMARY_GLAND_MORPHOGENESIS,1
REACTOME_RELAXIN_RECEPTORS,SET,7,-0.81234,-0.01585,0.36255,0.98747,REACTOME_RELAXIN_RECEPTORS,1
GOMF_ALDEHYDE_DEHYDROGENASE_...,SET,17,-0.4521,-0.013743,0.20178,0.98747,GOMF_ALDEHYDE_DEHYDROGENASE_NAD_P_PLUS_ACTIVITY,1
MIR18A_3P,SET,82,-0.20182,-0.01345,0.090026,0.9875,MIR18A_3P,1
WP_GPCRS_CLASS_C_METABOTROPI...,SET,15,-0.53682,-0.01533,0.2394,0.98752,WP_GPCRS_CLASS_C_METABOTROPIC_GLUTAMATE_PHEROMONE,1
HP_RED_EYE,SET,99,-0.18766,-0.013736,0.08364,0.98757,HP_RED_EYE,1
HP_MACULAR_ATROPHY,SET,39,-0.31527,-0.014507,0.1405,0.98758,HP_MACULAR_ATROPHY,1
GOBP_RAP_PROTEIN_SIGNAL_TRAN...,SET,12,-0.60255,-0.015392,0.26842,0.9876,GOBP_RAP_PROTEIN_SIGNAL_TRANSDUCTION,1
GSE1460_INTRATHYMIC_T_PROGEN...6,SET,178,-0.13707,-0.013424,0.06106,0.9876,GSE1460_INTRATHYMIC_T_PROGENITOR_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_UP,1
HP_DEFECTIVE_T_CELL_PROLIFER...,SET,7,-0.65464,-0.012773,0.29158,0.98761,HP_DEFECTIVE_T_CELL_PROLIFERATION,1
GSE17721_CTRL_VS_GARDIQUIMOD...4,SET,180,-0.13699,-0.013491,0.060971,0.98767,GSE17721_CTRL_VS_GARDIQUIMOD_12H_BMDC_UP,1
TRAVAGLINI_LUNG_ARTERY_CELL,SET,124,-0.18685,-0.015296,0.083164,0.98767,TRAVAGLINI_LUNG_ARTERY_CELL,1
GOBP_UV_PROTECTION,SET,11,-0.48546,-0.011873,0.21565,0.9878,GOBP_UV_PROTECTION,1
SU_LIVER,SET,55,-0.26998,-0.014747,0.11991,0.98782,SU_LIVER,1
GOBP_OVULATION_CYCLE,SET,71,-0.23906,-0.01483,0.10618,0.98782,GOBP_OVULATION_CYCLE,1
GSE16385_ROSIGLITAZONE_IL4_V...4,SET,178,-0.1412,-0.013828,0.062689,0.98784,GSE16385_ROSIGLITAZONE_IL4_VS_IL4_ALONE_STIM_MACROPHAGE_12H_UP,1
GOBP_ENDOPLASMIC_RETICULUM_T...4,SET,19,-0.42829,-0.013763,0.19012,0.98786,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_ORGANIZATION,1
MIR3166,SET,103,-0.19604,-0.014634,0.08701,0.98787,MIR3166,1
THRA_TARGET_GENES,SET,67,-0.22158,-0.013354,0.098344,0.98787,THRA_TARGET_GENES,1
GOBP_SPINAL_CORD_MOTOR_NEURO...2,SET,27,-0.37881,-0.014509,0.1681,0.98788,GOBP_SPINAL_CORD_MOTOR_NEURON_DIFFERENTIATION,1
BIOCARTA_FEEDER_PATHWAY,SET,8,-0.5515,-0.011504,0.2447,0.98789,BIOCARTA_FEEDER_PATHWAY,1
MIR944,SET,381,-0.098711,-0.014064,0.043795,0.98789,MIR944,1
GOBP_NEGATIVE_REGULATION_OF_...116,SET,151,-0.15769,-0.014234,0.069965,0.98789,GOBP_NEGATIVE_REGULATION_OF_CELL_GROWTH,1
GOBP_SKIN_EPIDERMIS_DEVELOPM...,SET,127,-0.18418,-0.015257,0.08169,0.98791,GOBP_SKIN_EPIDERMIS_DEVELOPMENT,1
CHIANG_LIVER_CANCER_SUBCLASS...6,SET,67,-0.24201,-0.014585,0.10733,0.98792,CHIANG_LIVER_CANCER_SUBCLASS_POLYSOMY7_UP,1
WP_TARGET_OF_RAPAMYCIN_SIGNA...,SET,35,-0.32683,-0.014249,0.14492,0.98793,WP_TARGET_OF_RAPAMYCIN_SIGNALING,1
NAKAMURA_LUNG_CANCER,SET,8,-0.77587,-0.016184,0.34398,0.98794,NAKAMURA_LUNG_CANCER,1
GOBP_REGULATION_OF_BROWN_FAT...,SET,22,-0.41309,-0.014284,0.1831,0.98796,GOBP_REGULATION_OF_BROWN_FAT_CELL_DIFFERENTIATION,1
KEGG_MEDICUS_REFERENCE_WEE1_...,SET,6,-0.60815,-0.010986,0.26945,0.98799,KEGG_MEDICUS_REFERENCE_WEE1_CELL_CYCLE_G2_M,1
GOMF_GLUCOSE_BINDING,SET,9,-0.68081,-0.015062,0.30165,0.98799,GOMF_GLUCOSE_BINDING,1
GOCC_AMINOACYL_TRNA_SYNTHETA...,SET,3,-0.87329,-0.011156,0.38679,0.98801,GOCC_AMINOACYL_TRNA_SYNTHETASE_MULTIENZYME_COMPLEX,1
GOBP_POSITIVE_REGULATION_OF_...56,SET,8,-0.76854,-0.016031,0.34031,0.98803,GOBP_POSITIVE_REGULATION_OF_BICELLULAR_TIGHT_JUNCTION_ASSEMBLY,1
HP_PERIVENTRICULAR_NODULAR_H...,SET,14,-0.46536,-0.012839,0.20606,0.98803,HP_PERIVENTRICULAR_NODULAR_HETEROTOPIA,1
MIR769_5P,SET,46,-0.28107,-0.014044,0.12445,0.98804,MIR769_5P,1
GNF2_CDKN1C,SET,25,-0.4181,-0.01541,0.18503,0.98807,GNF2_CDKN1C,1
GOCC_BASAL_DENDRITE,SET,6,-0.86694,-0.015662,0.38366,0.98807,GOCC_BASAL_DENDRITE,1
HP_LYMPHOPROLIFERATIVE_DISOR...,SET,13,-0.52783,-0.014033,0.23357,0.98808,HP_LYMPHOPROLIFERATIVE_DISORDER,1
GOBP_NEGATIVE_REGULATION_OF_...455,SET,61,-0.22969,-0.013211,0.10162,0.98809,GOBP_NEGATIVE_REGULATION_OF_NUCLEAR_DIVISION,1
WP_GLUCOCORTICOID_RECEPTOR_P...,SET,68,-0.24911,-0.015124,0.11018,0.98811,WP_GLUCOCORTICOID_RECEPTOR_PATHWAY,1
GOBP_REGULATION_OF_BONE_DEVE...,SET,8,-0.67705,-0.014122,0.29903,0.98821,GOBP_REGULATION_OF_BONE_DEVELOPMENT,1
WP_SILDENAFIL_TREATMENT,SET,19,-0.46283,-0.014874,0.20438,0.98823,WP_SILDENAFIL_TREATMENT,1
HU_FETAL_RETINA_BIPOLAR,SET,79,-0.22816,-0.014926,0.10072,0.98825,HU_FETAL_RETINA_BIPOLAR,1
GOBP_POLYOL_BIOSYNTHETIC_PRO...,SET,58,-0.24801,-0.01391,0.10926,0.98838,GOBP_POLYOL_BIOSYNTHETIC_PROCESS,1
HP_ECTOPIA_LENTIS,SET,39,-0.33478,-0.015405,0.14751,0.98838,HP_ECTOPIA_LENTIS,1
REACTOME_RHOH_GTPASE_CYCLE,SET,35,-0.32723,-0.014267,0.14415,0.9884,REACTOME_RHOH_GTPASE_CYCLE,1
GOMF_OXIDOREDUCTASE_ACTIVITY...34,SET,13,-0.46459,-0.012352,0.20462,0.98841,GOMF_OXIDOREDUCTASE_ACTIVITY_ACTING_ON_THE_CH_CH_GROUP_OF_DONORS_WITH_A_FLAVIN_AS_ACCEPTOR,1
GOBP_REGULATION_OF_NEUROTRAN...5,SET,17,-0.4598,-0.013978,0.20235,0.98846,GOBP_REGULATION_OF_NEUROTRANSMITTER_UPTAKE,1
GSE17721_CTRL_VS_POLYIC_24H_...1,SET,186,-0.14191,-0.014203,0.062401,0.98851,GSE17721_CTRL_VS_POLYIC_24H_BMDC_DN,1
CATTGTYY_SOX9_B1,SET,330,-0.10692,-0.014198,0.047015,0.98852,CATTGTYY_SOX9_B1,1
MIR3911,SET,81,-0.21173,-0.014025,0.093077,0.98853,MIR3911,1
GOBP_POSITIVE_REGULATION_OF_...320,SET,8,-0.80262,-0.016742,0.35268,0.98856,GOBP_POSITIVE_REGULATION_OF_GROWTH_HORMONE_SECRETION,1
ZHONG_PFC_C3_UNKNOWN_INP,SET,36,-0.2983,-0.013189,0.13106,0.98857,ZHONG_PFC_C3_UNKNOWN_INP,1
GOBP_REGULATION_OF_EMBRYONIC...,SET,81,-0.20488,-0.013572,0.089997,0.98859,GOBP_REGULATION_OF_EMBRYONIC_DEVELOPMENT,1
MIR4452,SET,148,-0.1571,-0.014041,0.069,0.9886,MIR4452,1
GOBP_RESPONSE_TO_NUTRIENT_LE...,SET,455,-0.093666,-0.014554,0.041122,0.98862,GOBP_RESPONSE_TO_NUTRIENT_LEVELS,1
HP_ABNORMALITY_OF_VISION,SET,1187,-0.057258,-0.014073,0.025139,0.98862,HP_ABNORMALITY_OF_VISION,1
GOBP_COMPLEMENT_ACTIVATION_L...,SET,10,-0.68305,-0.015928,0.2998,0.98864,GOBP_COMPLEMENT_ACTIVATION_LECTIN_PATHWAY,1
HP_NEOPLASM_OF_THE_THYMUS,SET,7,-0.72153,-0.014079,0.31658,0.98866,HP_NEOPLASM_OF_THE_THYMUS,1
GSE2770_UNTREATED_VS_IL12_TR...4,SET,179,-0.14147,-0.013893,0.06208,0.98866,GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_48H_UP,1
GNF2_CD97,SET,36,-0.34628,-0.015311,0.15185,0.9887,GNF2_CD97,1
BENPORATH_NANOG_TARGETS,SET,877,-0.066702,-0.014219,0.029233,0.98874,BENPORATH_NANOG_TARGETS,1
TERAO_AOX4_TARGETS_SKIN_DN,SET,17,-0.4845,-0.014728,0.21229,0.98876,TERAO_AOX4_TARGETS_SKIN_DN,1
GOBP_PHOSPHATIDYLINOSITOL_ME...1,SET,23,-0.41639,-0.014721,0.18245,0.98876,GOBP_PHOSPHATIDYLINOSITOL_MEDIATED_SIGNALING,1
HE_LIM_SUN_FETAL_LUNG_C0_MES...2,SET,265,-0.12034,-0.014345,0.0527,0.98879,HE_LIM_SUN_FETAL_LUNG_C0_MESENCHYMAL_2_CELL,1
GOBP_REGULATION_OF_SYSTEMIC_...1,SET,84,-0.21897,-0.01477,0.095886,0.9888,GOBP_REGULATION_OF_SYSTEMIC_ARTERIAL_BLOOD_PRESSURE,1
MIR24_1_5P_MIR24_2_5P,SET,42,-0.29087,-0.013889,0.1273,0.98883,MIR24_1_5P_MIR24_2_5P,1
REACTOME_PHENYLALANINE_AND_T...,SET,10,-0.66627,-0.015537,0.29148,0.98886,REACTOME_PHENYLALANINE_AND_TYROSINE_METABOLISM,1
AATGTGA_MIR23A_MIR23B,SET,381,-0.099646,-0.014198,0.043588,0.98887,AATGTGA_MIR23A_MIR23B,1
MIR6731_3P,SET,68,-0.23053,-0.013997,0.10083,0.98888,MIR6731_3P,1
GOBP_URETER_DEVELOPMENT,SET,17,-0.48061,-0.01461,0.21016,0.98889,GOBP_URETER_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...601,SET,22,-0.4573,-0.015812,0.19986,0.98893,GOBP_NEGATIVE_REGULATION_OF_SMOOTH_MUSCLE_CELL_MIGRATION,1
REACTOME_DEFECTIVE_RIPK1_MED...,SET,7,-0.70029,-0.013664,0.306,0.98894,REACTOME_DEFECTIVE_RIPK1_MEDIATED_REGULATED_NECROSIS,1
GSE21670_STAT3_KO_VS_WT_CD4_...8,SET,174,-0.14658,-0.014195,0.064013,0.98898,GSE21670_STAT3_KO_VS_WT_CD4_TCELL_UP,1
GSE34156_TLR1_TLR2_LIGAND_VS...4,SET,185,-0.14921,-0.014894,0.065164,0.98898,GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_UP,1
GSE3982_DC_VS_EFF_MEMORY_CD4...1,SET,163,-0.14392,-0.013494,0.062846,0.98899,GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN,1
GOBP_POSITIVE_REGULATION_OF_...541,SET,13,-0.52185,-0.013874,0.22781,0.989,GOBP_POSITIVE_REGULATION_OF_NITRIC_OXIDE_SYNTHASE_ACTIVITY,1
KANG_GLIS3_TARGETS,SET,34,-0.37305,-0.01603,0.16283,0.98901,KANG_GLIS3_TARGETS,1
LIM_MAMMARY_LUMINAL_MATURE_UP,SET,97,-0.20858,-0.015113,0.09102,0.98903,LIM_MAMMARY_LUMINAL_MATURE_UP,1
GOBP_NEGATIVE_REGULATION_OF_...507,SET,16,-0.47363,-0.013968,0.20651,0.98909,GOBP_NEGATIVE_REGULATION_OF_PROGRAMMED_NECROTIC_CELL_DEATH,1
HP_EEG_WITH_FRONTAL_EPILEPTI...,SET,5,-1.0029,-0.016539,0.43715,0.9891,HP_EEG_WITH_FRONTAL_EPILEPTIFORM_DISCHARGES,1
VERHAAK_GLIOBLASTOMA_PRONEUR...,SET,149,-0.16624,-0.014908,0.072458,0.98911,VERHAAK_GLIOBLASTOMA_PRONEURAL,1
BIOCARTA_SHH_PATHWAY,SET,16,-0.48829,-0.014401,0.21267,0.98916,BIOCARTA_SHH_PATHWAY,1
GSE7460_CTRL_VS_TGFB_TREATED...7,SET,183,-0.14488,-0.014385,0.063088,0.98917,GSE7460_CTRL_VS_TGFB_TREATED_ACT_TCONV_DN,1
GSE23502_BM_VS_COLON_TUMOR_H...2,SET,178,-0.15273,-0.014958,0.066484,0.98919,GSE23502_BM_VS_COLON_TUMOR_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_UP,1
REACTOME_NOTCH_HLH_TRANSCRIP...,SET,24,-0.37668,-0.013603,0.16391,0.98922,REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY,1
HP_ABNORMAL_CIRCULATING_FATT...1,SET,39,-0.29434,-0.013544,0.128,0.98926,HP_ABNORMAL_CIRCULATING_FATTY_ACID_ANION_CONCENTRATION,1
TGGNNNNNNKCCAR_UNKNOWN,SET,382,-0.1031,-0.014708,0.044781,0.98933,TGGNNNNNNKCCAR_UNKNOWN,1
HP_CRYPTOZOOSPERMIA,SET,6,-0.76548,-0.013829,0.33244,0.98934,HP_CRYPTOZOOSPERMIA,1
GSE10856_CTRL_VS_TNFRSF6B_IN...1,SET,164,-0.14551,-0.013684,0.063195,0.98934,GSE10856_CTRL_VS_TNFRSF6B_IN_MACROPHAGE_DN,1
KEGG_MEDICUS_REFERENCE_EXTRI...,SET,10,-0.60613,-0.014135,0.26321,0.98935,KEGG_MEDICUS_REFERENCE_EXTRINSIC_APOPTOTIC_PATHWAY,1
GOMF_CHLORIDE_CHANNEL_ACTIVI...,SET,72,-0.24928,-0.015572,0.10825,0.98935,GOMF_CHLORIDE_CHANNEL_ACTIVITY,1
DESCARTES_FETAL_PLACENTA_SMO...,SET,74,-0.25426,-0.016101,0.11036,0.98938,DESCARTES_FETAL_PLACENTA_SMOOTH_MUSCLE_CELLS,1
GOBP_NEGATIVE_REGULATION_OF_...159,SET,5,-0.79106,-0.013046,0.34305,0.98944,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_ACTIVATION_OF_PROTEIN_K...1,SET,75,-0.22985,-0.014653,0.099606,0.98948,GOBP_ACTIVATION_OF_PROTEIN_KINASE_ACTIVITY,1
NAKAYA_PBMC_FLUAD_MALE_AGE_1...2,SET,49,-0.30088,-0.015515,0.13035,0.9895,NAKAYA_PBMC_FLUAD_MALE_AGE_14_27YO_1D_POSTBOOST_VS_0D_PREIMM_MF59_ADJUVANTED_1DY_GENES_IN_BTM_M40_AND_M53_DN,1
GSE17721_CTRL_VS_PAM3CSK4_2H...2,SET,184,-0.13985,-0.013922,0.060581,0.98951,GSE17721_CTRL_VS_PAM3CSK4_2H_BMDC_UP,1
GOBP_TRANSFORMING_GROWTH_FAC...2,SET,8,-0.72267,-0.015074,0.31292,0.98953,GOBP_TRANSFORMING_GROWTH_FACTOR_BETA2_PRODUCTION,1
RSRFC4_Q2,SET,195,-0.1433,-0.014682,0.062038,0.98955,RSRFC4_Q2,1
IIZUKA_LIVER_CANCER_PROGRESS...8,SET,19,-0.48536,-0.015598,0.21005,0.98957,IIZUKA_LIVER_CANCER_PROGRESSION_L1_G1_UP,1
MIR4267,SET,203,-0.13561,-0.014173,0.058686,0.98957,MIR4267,1
GOBP_RESPONSE_TO_HEAT,SET,94,-0.19674,-0.014034,0.085125,0.98958,GOBP_RESPONSE_TO_HEAT,1
GOBP_MULTI_MULTICELLULAR_ORG...,SET,191,-0.14856,-0.015065,0.064244,0.98962,GOBP_MULTI_MULTICELLULAR_ORGANISM_PROCESS,1
REACTOME_VASOPRESSIN_LIKE_RE...,SET,5,-1.0244,-0.016894,0.44277,0.98965,REACTOME_VASOPRESSIN_LIKE_RECEPTORS,1
GOBP_NEGATIVE_REGULATION_OF_...543,SET,193,-0.14547,-0.014829,0.062865,0.98966,GOBP_NEGATIVE_REGULATION_OF_PROTEOLYSIS,1
HP_SMOOTH_PHILTRUM,SET,159,-0.14964,-0.013858,0.064665,0.98966,HP_SMOOTH_PHILTRUM,1
GOBP_NEGATIVE_REGULATION_OF_...252,SET,5,-0.90277,-0.014888,0.39006,0.98967,GOBP_NEGATIVE_REGULATION_OF_GLIAL_CELL_MIGRATION,1
GOBP_NEGATIVE_REGULATION_OF_...43,SET,11,-0.67285,-0.016456,0.29059,0.9897,GOBP_NEGATIVE_REGULATION_OF_BEHAVIOR,1
GOBP_ADHERENS_JUNCTION_ORGAN...,SET,56,-0.27823,-0.015335,0.12014,0.98971,GOBP_ADHERENS_JUNCTION_ORGANIZATION,1
GOBP_NEURON_DEVELOPMENT,SET,1054,-0.063871,-0.01485,0.027582,0.98971,GOBP_NEURON_DEVELOPMENT,1
GOBP_POSITIVE_REGULATION_OF_...23,SET,38,-0.34785,-0.015801,0.15017,0.98972,GOBP_POSITIVE_REGULATION_OF_AMINE_TRANSPORT,1
HP_ABNORMAL_PROPORTION_OF_DO...,SET,6,-0.84376,-0.015243,0.36421,0.98973,HP_ABNORMAL_PROPORTION_OF_DOUBLE_NEGATIVE_ALPHA_BETA_REGULATORY_T_CELL,1
HP_ABNORMAL_GLYCOSYLATION,SET,44,-0.26455,-0.012928,0.11416,0.98975,HP_ABNORMAL_GLYCOSYLATION,1
HP_ABNORMAL_MEAN_CORPUSCULAR...1,SET,16,-0.45785,-0.013503,0.1975,0.98978,HP_ABNORMAL_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,1
HP_DECREASED_LIBIDO,SET,11,-0.5599,-0.013693,0.24146,0.98979,HP_DECREASED_LIBIDO,1
HP_SHORT_STERNUM,SET,10,-0.64325,-0.015,0.27742,0.98979,HP_SHORT_STERNUM,1
GOBP_REGULATION_OF_ORGANIC_A...,SET,73,-0.24459,-0.015384,0.10545,0.98981,GOBP_REGULATION_OF_ORGANIC_ACID_TRANSPORT,1
GOBP_MITOCHONDRIAL_GENOME_MA...,SET,29,-0.34016,-0.013502,0.14658,0.98984,GOBP_MITOCHONDRIAL_GENOME_MAINTENANCE,1
GSE6092_UNSTIM_VS_IFNG_STIM_...1,SET,177,-0.15113,-0.01476,0.065099,0.98987,GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN,1
GOMF_PRIMARY_AMINE_OXIDASE_A...,SET,7,-0.96277,-0.018786,0.41457,0.98989,GOMF_PRIMARY_AMINE_OXIDASE_ACTIVITY,1
GOCC_DENDRITIC_TREE,SET,571,-0.085353,-0.014809,0.036737,0.98992,GOCC_DENDRITIC_TREE,1
HP_BURKITT_LYMPHOMA,SET,8,-0.74953,-0.015634,0.32246,0.98994,HP_BURKITT_LYMPHOMA,1
KEGG_MEDICUS_PATHOGEN_HIV_VP...3,SET,4,-0.79725,-0.01176,0.34277,0.98998,KEGG_MEDICUS_PATHOGEN_HIV_VPR_TO_WEE1_CELL_CYCLE_G2M,1
HP_FEMALE_PSEUDOHERMAPHRODIT...,SET,7,-0.84015,-0.016393,0.36122,0.98998,HP_FEMALE_PSEUDOHERMAPHRODITISM,1
DESCARTES_FETAL_ADRENAL_LYMP...,SET,131,-0.18495,-0.015559,0.079512,0.98999,DESCARTES_FETAL_ADRENAL_LYMPHOID_CELLS,1
GSE39820_TGFBETA1_VS_TGFBETA...2,SET,185,-0.14075,-0.01405,0.060465,0.99003,GSE39820_TGFBETA1_VS_TGFBETA3_IN_IL6_IL23A_TREATED_CD4_TCELL_UP,1
DESCARTES_MAIN_FETAL_MICROGL...,SET,121,-0.18758,-0.01517,0.080592,0.99003,DESCARTES_MAIN_FETAL_MICROGLIA,1
GSE3565_CTRL_VS_LPS_INJECTED...4,SET,160,-0.16367,-0.015205,0.070259,0.99008,GSE3565_CTRL_VS_LPS_INJECTED_SPLENOCYTES_UP,1
KEGG_MEDICUS_REFERENCE_GLYCO...2,SET,8,-0.71588,-0.014932,0.30717,0.99011,KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION,1
WP_PTDINS45P2_IN_CYTOKINESIS...,SET,9,-0.64465,-0.014262,0.27658,0.99011,WP_PTDINS45P2_IN_CYTOKINESIS_PATHWAY,1
HP_INTERMITTENT_DIARRHEA,SET,21,-0.41566,-0.014042,0.17824,0.99015,HP_INTERMITTENT_DIARRHEA,1
GOBP_VESICLE_MEDIATED_CHOLES...,SET,9,-0.64061,-0.014173,0.27455,0.99018,GOBP_VESICLE_MEDIATED_CHOLESTEROL_TRANSPORT,1
GOBP_RESPONSE_TO_ISCHEMIA,SET,62,-0.26003,-0.015077,0.11136,0.99022,GOBP_RESPONSE_TO_ISCHEMIA,1
MIR8076,SET,116,-0.17431,-0.013804,0.07459,0.99027,MIR8076,1
GSE8384_CTRL_VS_B_ABORTUS_4H...2,SET,174,-0.14837,-0.014368,0.063481,0.99028,GSE8384_CTRL_VS_B_ABORTUS_4H_MAC_CELL_LINE_UP,1
WP_NEURAL_CREST_CELL_MIGRATI...2,SET,40,-0.3387,-0.015784,0.14486,0.9903,WP_NEURAL_CREST_CELL_MIGRATION_IN_CANCER,1
MEF2_01,SET,137,-0.17872,-0.015373,0.076449,0.9903,MEF2_01,1
GOBP_NEUROTRANSMITTER_RECEPT...4,SET,9,-0.7045,-0.015586,0.30134,0.9903,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_ENDOSOME_TO_POSTSYNAPTIC_MEMBRANE,1
KRCTCNNNNMANAGC_UNKNOWN,SET,14,-0.54755,-0.015106,0.23403,0.99034,KRCTCNNNNMANAGC_UNKNOWN,1
GSE1460_DP_THYMOCYTE_VS_NAIV...4,SET,162,-0.15053,-0.01407,0.064311,0.99037,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_UP,1
GOMF_GLYCERALDEHYDE_3_PHOSPH...,SET,7,-0.67988,-0.013266,0.29027,0.99041,GOMF_GLYCERALDEHYDE_3_PHOSPHATE_DEHYDROGENASE_NADPLUS_NON_PHOSPHORYLATING_ACTIVITY,1
MIKKELSEN_ES_HCP_WITH_H3K27M...,SET,38,-0.33764,-0.015337,0.14412,0.99042,MIKKELSEN_ES_HCP_WITH_H3K27ME3,1
GOBP_NEGATIVE_REGULATION_OF_...84,SET,387,-0.10363,-0.014879,0.04424,0.99042,GOBP_NEGATIVE_REGULATION_OF_CATALYTIC_ACTIVITY,1
GNF2_IGFBP1,SET,30,-0.40336,-0.016283,0.17207,0.99046,GNF2_IGFBP1,1
GOBP_POSITIVE_REGULATION_OF_...620,SET,12,-0.53347,-0.013627,0.22757,0.99046,GOBP_POSITIVE_REGULATION_OF_PROTEIN_EXIT_FROM_ENDOPLASMIC_RETICULUM,1
GGGCATT_MIR365,SET,100,-0.19842,-0.014596,0.084623,0.99047,GGGCATT_MIR365,1
GOBP_GLAND_MORPHOGENESIS,SET,121,-0.19642,-0.015885,0.083769,0.99048,GOBP_GLAND_MORPHOGENESIS,1
GOMF_GLIAL_CELL_DERIVED_NEUR...,SET,5,-0.95762,-0.015793,0.40811,0.99052,GOMF_GLIAL_CELL_DERIVED_NEUROTROPHIC_FACTOR_RECEPTOR_ACTIVITY,1
GSE28237_EARLY_VS_LATE_GC_BC...1,SET,175,-0.14641,-0.014218,0.06239,0.99052,GSE28237_EARLY_VS_LATE_GC_BCELL_DN,1
HP_PATELLAR_APLASIA,SET,20,-0.43335,-0.014288,0.18458,0.99055,HP_PATELLAR_APLASIA,1
TBK1.DF_DN,SET,264,-0.12045,-0.014332,0.051305,0.99055,TBK1.DF_DN,1
MIR6889_3P,SET,100,-0.2037,-0.014985,0.086757,0.99056,MIR6889_3P,1
GSE9946_MATURE_STIMULATORY_V...2,SET,117,-0.1802,-0.014332,0.076692,0.9906,GSE9946_MATURE_STIMULATORY_VS_LISTERIA_INF_MATURE_DC_UP,1
REACTOME_ACROSOME_REACTION_A...,SET,6,-0.9199,-0.016618,0.39136,0.99062,REACTOME_ACROSOME_REACTION_AND_SPERM_OOCYTE_MEMBRANE_BINDING,1
WP_ALSTROM_SYNDROME,SET,30,-0.36909,-0.0149,0.15695,0.99065,WP_ALSTROM_SYNDROME,1
TTANTCA_UNKNOWN,SET,839,-0.073945,-0.015434,0.031442,0.99065,TTANTCA_UNKNOWN,1
GOBP_ENDOTHELIAL_CELL_MIGRAT...,SET,203,-0.14592,-0.01525,0.062,0.99069,GOBP_ENDOTHELIAL_CELL_MIGRATION,1
ZHAN_MULTIPLE_MYELOMA_PR_UP,SET,41,-0.30229,-0.014262,0.12841,0.99071,ZHAN_MULTIPLE_MYELOMA_PR_UP,1
GOCC_NEURON_TO_NEURON_SYNAPSE,SET,338,-0.10984,-0.014758,0.046659,0.99071,GOCC_NEURON_TO_NEURON_SYNAPSE,1
GOMF_STEROL_BINDING,SET,65,-0.25853,-0.015348,0.10982,0.99071,GOMF_STEROL_BINDING,1
HP_BROAD_COLUMELLA,SET,12,-0.54969,-0.014041,0.23341,0.99074,HP_BROAD_COLUMELLA,1
GSE17974_2H_VS_72H_UNTREATED...2,SET,174,-0.14351,-0.013897,0.06092,0.99075,GSE17974_2H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...587,SET,1301,-0.057467,-0.014738,0.024385,0.99078,GOBP_NEGATIVE_REGULATION_OF_SIGNALING,1
GCM_MLL,SET,157,-0.14632,-0.013466,0.062063,0.9908,GCM_MLL,1
KYNG_WERNER_SYNDROM_AND_NORM...1,SET,163,-0.14786,-0.013863,0.062691,0.99082,KYNG_WERNER_SYNDROM_AND_NORMAL_AGING_DN,1
WP_T_CELL_MODULATION_IN_PANC...,SET,43,-0.32217,-0.015565,0.13652,0.99086,WP_T_CELL_MODULATION_IN_PANCREATIC_CANCER,1
GOBP_MUSCLE_HYPERTROPHY,SET,84,-0.23086,-0.015571,0.097787,0.99088,GOBP_MUSCLE_HYPERTROPHY,1
HP_REPETITIVE_COMPULSIVE_BEH...,SET,12,-0.63161,-0.016134,0.26754,0.99088,HP_REPETITIVE_COMPULSIVE_BEHAVIOR,1
DURANTE_ADULT_OLFACTORY_NEUR...23,SET,28,-0.42937,-0.016746,0.18184,0.99089,DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_SECRETORY_CELLS,1
MIR507,SET,241,-0.12902,-0.014676,0.05462,0.99091,MIR507,1
GSE19401_PAM2CSK4_VS_RETINOI...2,SET,170,-0.15008,-0.014367,0.063537,0.99091,GSE19401_PAM2CSK4_VS_RETINOIC_ACID_AND_PAM2CSK4_STIM_FOLLICULAR_DC_UP,1
GOMF_CO_RECEPTOR_BINDING,SET,13,-0.57238,-0.015218,0.24209,0.99096,GOMF_CO_RECEPTOR_BINDING,1
GOBP_DNA_TEMPLATED_TRANSCRIP...3,SET,20,-0.48952,-0.016139,0.20702,0.99097,GOBP_DNA_TEMPLATED_TRANSCRIPTION_TERMINATION,1
GOMF_SODIUM_BICARBONATE_SYMP...,SET,6,-0.76611,-0.01384,0.32393,0.99098,GOMF_SODIUM_BICARBONATE_SYMPORTER_ACTIVITY,1
GOMF_ALPHA_ADRENERGIC_RECEPT...,SET,6,-0.91637,-0.016555,0.38738,0.99099,GOMF_ALPHA_ADRENERGIC_RECEPTOR_ACTIVITY,1
GOBP_ADENYLATE_CYCLASE_INHIB...3,SET,9,-0.69857,-0.015455,0.2953,0.991,GOBP_ADENYLATE_CYCLASE_INHIBITING_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_SIGNALING_PATHWAY,1
GOMF_G_PROTEIN_COUPLED_GLUTA...1,SET,9,-0.69857,-0.015455,0.2953,0.991,GOMF_G_PROTEIN_COUPLED_GLUTAMATE_RECEPTOR_ACTIVITY,1
GSE13762_CTRL_VS_125_VITAMIN...2,SET,131,-0.17279,-0.014536,0.072922,0.99109,GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_UP,1
MORF_RAD51L3,SET,343,-0.11101,-0.015023,0.046825,0.99112,MORF_RAD51L3,1
GSE32423_CTRL_VS_IL7_MEMORY_...1,SET,174,-0.15596,-0.015103,0.065783,0.99112,GSE32423_CTRL_VS_IL7_MEMORY_CD8_TCELL_DN,1
GOBP_REGULATION_OF_EPITHELIA...4,SET,213,-0.14255,-0.015257,0.060121,0.99113,GOBP_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,1
GSE26928_NAIVE_VS_CXCR5_POS_...2,SET,155,-0.15476,-0.014152,0.065207,0.99118,GSE26928_NAIVE_VS_CXCR5_POS_CD4_TCELL_UP,1
GOBP_NEGATIVE_REGULATION_OF_...265,SET,200,-0.14906,-0.015464,0.062754,0.99123,GOBP_NEGATIVE_REGULATION_OF_GROWTH,1
HP_DECREASED_CIRCULATING_CAR...,SET,22,-0.39114,-0.013525,0.16463,0.99124,HP_DECREASED_CIRCULATING_CARNITINE_CONCENTRATION,1
GOBP_REGULATION_OF_PLATELET_...5,SET,22,-0.42919,-0.01484,0.18062,0.99125,GOBP_REGULATION_OF_PLATELET_DERIVED_GROWTH_FACTOR_RECEPTOR_SIGNALING_PATHWAY,1
HP_ABNORMAL_URINE_CARBOXYLIC...,SET,117,-0.19004,-0.015114,0.07998,0.99125,HP_ABNORMAL_URINE_CARBOXYLIC_ACID_LEVEL,1
HP_ABNORMAL_PROTEIN_O_LINKED...,SET,5,-0.76257,-0.012576,0.32078,0.99127,HP_ABNORMAL_PROTEIN_O_LINKED_GLYCOSYLATION,1
HEBERT_MATRISOME_TNBC_LUNG_M...2,SET,6,-0.69794,-0.012608,0.29339,0.99131,HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED,1
GOBP_NEGATIVE_REGULATION_OF_...473,SET,25,-0.37088,-0.013669,0.15589,0.99132,GOBP_NEGATIVE_REGULATION_OF_OXIDATIVE_STRESS_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_SARCOMERE...,SET,8,-0.70852,-0.014779,0.29782,0.99132,GOBP_REGULATION_OF_SARCOMERE_ORGANIZATION,1
HP_ABNORMALITY_OF_THE_EXTRIN...,SET,20,-0.39189,-0.012921,0.16461,0.99136,HP_ABNORMALITY_OF_THE_EXTRINSIC_PATHWAY,1
MIR4802_5P,SET,57,-0.2699,-0.015007,0.11332,0.99138,MIR4802_5P,1
HP_MATURITY_ONSET_DIABETES_O...,SET,19,-0.51472,-0.016541,0.21612,0.99138,HP_MATURITY_ONSET_DIABETES_OF_THE_YOUNG,1
HP_ABNORMALITY_OF_THE_ANUS,SET,197,-0.14269,-0.014694,0.059903,0.99139,HP_ABNORMALITY_OF_THE_ANUS,1
HP_CAUDAL_APPENDAGE,SET,6,-0.96378,-0.017411,0.40443,0.99141,HP_CAUDAL_APPENDAGE,1
MIR3912_5P,SET,77,-0.23695,-0.015305,0.099407,0.99142,MIR3912_5P,1
GOBP_VAGINA_DEVELOPMENT,SET,10,-0.7275,-0.016965,0.30518,0.99143,GOBP_VAGINA_DEVELOPMENT,1
HP_ABNORMAL_SERUM_BILE_ACID_...,SET,25,-0.42473,-0.015654,0.17813,0.99144,HP_ABNORMAL_SERUM_BILE_ACID_CONCENTRATION,1
GOBP_INOSITOL_METABOLIC_PROC...,SET,8,-0.60704,-0.012662,0.25449,0.99146,GOBP_INOSITOL_METABOLIC_PROCESS,1
GSE6674_CPG_VS_CPG_AND_ANTI_...1,SET,172,-0.15861,-0.015272,0.066494,0.99146,GSE6674_CPG_VS_CPG_AND_ANTI_IGM_STIM_BCELL_DN,1
KIM_ALL_DISORDERS_DURATION_C...2,SET,8,-0.63628,-0.013272,0.26645,0.99152,KIM_ALL_DISORDERS_DURATION_CORR_UP,1
MIR1_5P,SET,82,-0.22391,-0.014923,0.09377,0.99152,MIR1_5P,1
KEGG_MEDICUS_ENV_FACTOR_META...1,SET,8,-0.78533,-0.016381,0.32885,0.99153,KEGG_MEDICUS_ENV_FACTOR_METALS_TO_JNK_SIGNALING_PATHWAY,1
GOBP_REGULATION_OF_MUSCLE_AD...,SET,73,-0.25311,-0.01592,0.10597,0.99154,GOBP_REGULATION_OF_MUSCLE_ADAPTATION,1
HP_VERRUCAE,SET,25,-0.41201,-0.015185,0.17249,0.99154,HP_VERRUCAE,1
GOBP_CELL_JUNCTION_ORGANIZAT...,SET,705,-0.080616,-0.015483,0.033737,0.99156,GOBP_CELL_JUNCTION_ORGANIZATION,1
MIR17_3P,SET,121,-0.18545,-0.014998,0.077599,0.99157,MIR17_3P,1
GSE40666_UNTREATED_VS_IFNA_S...2,SET,147,-0.17013,-0.015155,0.071171,0.99158,GSE40666_UNTREATED_VS_IFNA_STIM_CD8_TCELL_90MIN_UP,1
ZHENG_BOUND_BY_FOXP3,SET,456,-0.10065,-0.015656,0.042096,0.99159,ZHENG_BOUND_BY_FOXP3,1
GOMF_DYNEIN_COMPLEX_BINDING,SET,19,-0.45353,-0.014575,0.18965,0.9916,GOMF_DYNEIN_COMPLEX_BINDING,1
GOBP_SYNAPSE_ORGANIZATION,SET,449,-0.10121,-0.015624,0.042311,0.99162,GOBP_SYNAPSE_ORGANIZATION,1
GSE36476_CTRL_VS_TSST_ACT_16...2,SET,170,-0.15792,-0.015118,0.06602,0.99162,GSE36476_CTRL_VS_TSST_ACT_16H_MEMORY_CD4_TCELL_OLD_UP,1
GOBP_NEURAL_PLATE_REGIONALIZ...,SET,5,-0.96077,-0.015845,0.40132,0.99166,GOBP_NEURAL_PLATE_REGIONALIZATION,1
HP_HYPERPARATHYROIDISM,SET,28,-0.41168,-0.016056,0.17197,0.99166,HP_HYPERPARATHYROIDISM,1
GOCC_COPI_VESICLE_COAT,SET,12,-0.499,-0.012746,0.2083,0.9917,GOCC_COPI_VESICLE_COAT,1
ID1_TARGET_GENES,SET,1009,-0.064675,-0.014732,0.026986,0.99172,ID1_TARGET_GENES,1
TAKEDA_TARGETS_OF_NUP98_HOXA...8,SET,77,-0.23825,-0.015389,0.099368,0.99175,TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_6HR_UP,1
GSE8621_LPS_STIM_VS_LPS_PRIM...2,SET,185,-0.15086,-0.015059,0.062911,0.99175,GSE8621_LPS_STIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_UP,1
GOBP_REGULATION_OF_NEUTROPHI...1,SET,5,-0.99783,-0.016456,0.41597,0.99177,GOBP_REGULATION_OF_NEUTROPHIL_ACTIVATION,1
GCM_CRKL,SET,59,-0.24845,-0.014054,0.10347,0.99183,GCM_CRKL,1
WP_MAJOR_RECEPTORS_TARGETED_...,SET,16,-0.55306,-0.016311,0.23025,0.99184,WP_MAJOR_RECEPTORS_TARGETED_BY_EPINEPHRINE_AND_NOREPINEPHRINE,1
AAAYWAACM_HFH4_01,SET,224,-0.1417,-0.015548,0.058976,0.99186,AAAYWAACM_HFH4_01,1
GOBP_POSITIVE_REGULATION_OF_...88,SET,2,-1.5498,-0.016166,0.64503,0.99186,GOBP_POSITIVE_REGULATION_OF_CARDIAC_MUSCLE_ADAPTATION,1
MIR4794,SET,88,-0.22712,-0.015678,0.094448,0.9919,MIR4794,1
HE_LIM_SUN_FETAL_LUNG_C7_KCN...,SET,95,-0.23421,-0.016795,0.097365,0.99192,HE_LIM_SUN_FETAL_LUNG_C7_KCNIP4_POS_NEURON_CELL,1
MIR2117,SET,112,-0.18785,-0.01462,0.078047,0.99195,MIR2117,1
GOMF_GENERAL_TRANSCRIPTION_I...1,SET,46,-0.26472,-0.013227,0.10997,0.99195,GOMF_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_ACTIVITY,1
GSE15330_WT_VS_IKAROS_KO_HSC...1,SET,184,-0.14769,-0.014704,0.061327,0.99198,GSE15330_WT_VS_IKAROS_KO_HSC_DN,1
GSE41176_WT_VS_TAK1_KO_UNSTI...1,SET,175,-0.15533,-0.015084,0.064496,0.99198,GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN,1
MIR383_3P,SET,122,-0.18924,-0.015367,0.07855,0.992,MIR383_3P,1
GSE5099_UNSTIM_VS_MCSF_TREAT...1,SET,186,-0.14546,-0.014559,0.06037,0.99201,GSE5099_UNSTIM_VS_MCSF_TREATED_MONOCYTE_DAY3_DN,1
GSE37533_PPARG1_FOXP3_VS_PPA...3,SET,173,-0.15116,-0.014596,0.062704,0.99203,GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_UP,1
GOBP_NEGATIVE_REGULATION_OF_...690,SET,10,-0.75871,-0.017693,0.31448,0.99208,GOBP_NEGATIVE_REGULATION_OF_VASCULAR_ASSOCIATED_SMOOTH_MUSCLE_CELL_MIGRATION,1
GSE2770_TGFB_AND_IL4_VS_TGFB...3,SET,170,-0.15528,-0.014865,0.064352,0.99208,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_48H_DN,1
HP_SKIN_EROSION,SET,26,-0.3695,-0.013888,0.15305,0.99211,HP_SKIN_EROSION,1
GOCC_GARP_COMPLEX,SET,4,-0.8665,-0.012782,0.35886,0.99212,GOCC_GARP_COMPLEX,1
HP_ABNORMAL_FOURTH_VENTRICLE...,SET,132,-0.16631,-0.014043,0.068859,0.99213,HP_ABNORMAL_FOURTH_VENTRICLE_MORPHOLOGY,1
HP_ABNORMALITY_OF_THE_FONTAN...,SET,407,-0.099765,-0.014681,0.041291,0.99215,HP_ABNORMALITY_OF_THE_FONTANELLES_OR_CRANIAL_SUTURES,1
GSE26488_WT_VS_VP16_TRANSGEN...2,SET,181,-0.15494,-0.0153,0.064102,0.99217,GSE26488_WT_VS_VP16_TRANSGENIC_HDAC7_KO_DOUBLE_POSITIVE_THYMOCYTE_UP,1
PID_ECADHERIN_KERATINOCYTE_P...,SET,21,-0.42612,-0.014396,0.17628,0.99218,PID_ECADHERIN_KERATINOCYTE_PATHWAY,1
HP_NEURONAL_LOSS_IN_THE_CERE...,SET,12,-0.56409,-0.014409,0.23327,0.9922,HP_NEURONAL_LOSS_IN_THE_CEREBRAL_CORTEX,1
GOBP_CELLULAR_LIPID_CATABOLI...,SET,222,-0.13666,-0.014928,0.056482,0.99222,GOBP_CELLULAR_LIPID_CATABOLIC_PROCESS,1
MCBRYAN_PUBERTAL_TGFB1_TARGE...2,SET,156,-0.16561,-0.015193,0.068416,0.99225,MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP,1
MIR130A_5P,SET,307,-0.12351,-0.015829,0.051018,0.99225,MIR130A_5P,1
TGGTGCT_MIR29A_MIR29B_MIR29C,SET,470,-0.096191,-0.015184,0.039693,0.99231,TGGTGCT_MIR29A_MIR29B_MIR29C,1
HP_SEPTATE_VAGINA,SET,10,-0.67901,-0.015834,0.28019,0.99231,HP_SEPTATE_VAGINA,1
GSE17721_POLYIC_VS_PAM3CSK4_...17,SET,180,-0.14369,-0.014151,0.059226,0.99237,GSE17721_POLYIC_VS_PAM3CSK4_8H_BMDC_DN,1
GSE42021_TCONV_PLN_VS_TREG_P...2,SET,180,-0.15397,-0.015162,0.063451,0.99237,GSE42021_TCONV_PLN_VS_TREG_PRECURSORS_THYMUS_UP,1
GSE16385_ROSIGLITAZONE_IL4_V...6,SET,177,-0.15947,-0.015574,0.065709,0.99238,GSE16385_ROSIGLITAZONE_IL4_VS_ROSIGLITAZONE_ALONE_STIM_MACROPHAGE_UP,1
REACTOME_FATTY_ACIDS_BOUND_T...,SET,8,-0.7832,-0.016337,0.32265,0.99239,REACTOME_FATTY_ACIDS_BOUND_TO_GPR40_FFAR1_REGULATE_INSULIN_SECRETION,1
GOMF_CHOLESTEROL_BINDING,SET,51,-0.29213,-0.015367,0.12031,0.9924,GOMF_CHOLESTEROL_BINDING,1
MIR11399,SET,68,-0.2403,-0.01459,0.098935,0.99242,MIR11399,1
MIR4678,SET,100,-0.20434,-0.015031,0.084063,0.99246,MIR4678,1
GOBP_NEGATIVE_REGULATION_OF_...405,SET,5,-0.96388,-0.015896,0.39657,0.99246,GOBP_NEGATIVE_REGULATION_OF_MONOCYTE_CHEMOTAXIS,1
GSE11961_MARGINAL_ZONE_BCELL...1,SET,188,-0.15302,-0.015397,0.06295,0.99246,GSE11961_MARGINAL_ZONE_BCELL_VS_GERMINAL_CENTER_BCELL_DAY40_DN,1
MIR892C_5P,SET,252,-0.13334,-0.015506,0.054843,0.99247,MIR892C_5P,1
REACTOME_RUNX3_REGULATES_IMM...,SET,6,-0.93652,-0.016918,0.38511,0.99248,REACTOME_RUNX3_REGULATES_IMMUNE_RESPONSE_AND_CELL_MIGRATION,1
HP_CONCAVE_NAIL,SET,11,-0.57135,-0.013974,0.23484,0.99251,HP_CONCAVE_NAIL,1
GOBP_ENDOPLASMIC_RETICULUM_T...3,SET,5,-0.80617,-0.013295,0.33101,0.99256,GOBP_ENDOPLASMIC_RETICULUM_TUBULAR_NETWORK_FORMATION,1
GOBP_LUNG_SECRETORY_CELL_DIF...,SET,11,-0.65148,-0.015933,0.26699,0.99265,GOBP_LUNG_SECRETORY_CELL_DIFFERENTIATION,1
GSE7460_CTRL_VS_TGFB_TREATED...5,SET,186,-0.15459,-0.015473,0.063353,0.99266,GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN,1
GOBP_REGULATION_OF_HETEROCHR...,SET,18,-0.44036,-0.013774,0.18037,0.99268,GOBP_REGULATION_OF_HETEROCHROMATIN_FORMATION,1
GNF2_ITGAL,SET,51,-0.29593,-0.015567,0.12116,0.9927,GNF2_ITGAL,1
GOBP_CHONDROCYTE_DEVELOPMENT...,SET,8,-0.85682,-0.017872,0.35082,0.9927,GOBP_CHONDROCYTE_DEVELOPMENT_INVOLVED_IN_ENDOCHONDRAL_BONE_MORPHOGENESIS,1
GSE17974_CTRL_VS_ACT_IL4_AND...1,SET,167,-0.15323,-0.01454,0.062738,0.9927,GSE17974_CTRL_VS_ACT_IL4_AND_ANTI_IL12_0.5H_CD4_TCELL_DN,1
REACTOME_SURFACTANT_METABOLI...,SET,26,-0.44644,-0.01678,0.18274,0.99271,REACTOME_SURFACTANT_METABOLISM,1
WP_NEURAL_CREST_CELL_MIGRATI...1,SET,37,-0.36365,-0.0163,0.14885,0.99271,WP_NEURAL_CREST_CELL_MIGRATION_DURING_DEVELOPMENT,1
MIR96_3P,SET,65,-0.24494,-0.01454,0.10026,0.99271,MIR96_3P,1
GSE3982_CENT_MEMORY_CD4_TCEL...1,SET,175,-0.16023,-0.01556,0.065512,0.99277,GSE3982_CENT_MEMORY_CD4_TCELL_VS_NKCELL_DN,1
GOBP_PEPTIDYL_LYSINE_ACETYLA...,SET,22,-0.39065,-0.013508,0.15969,0.99278,GOBP_PEPTIDYL_LYSINE_ACETYLATION,1
GCM_UBE2N,SET,141,-0.16709,-0.014579,0.068275,0.9928,GCM_UBE2N,1
HP_ENLARGEMENT_OF_THE_WRISTS,SET,6,-0.93459,-0.016884,0.38132,0.99287,HP_ENLARGEMENT_OF_THE_WRISTS,1
GOBP_MUSCLE_ADAPTATION,SET,98,-0.22345,-0.016273,0.091109,0.9929,GOBP_MUSCLE_ADAPTATION,1
GOCC_SYNAPTIC_CLEFT,SET,22,-0.48299,-0.0167,0.19691,0.99291,GOCC_SYNAPTIC_CLEFT,1
MIR5683,SET,217,-0.14524,-0.015689,0.059202,0.99292,MIR5683,1
HP_ABNORMAL_INVOLUNTARY_EYE_...,SET,961,-0.067217,-0.014963,0.027372,0.99296,HP_ABNORMAL_INVOLUNTARY_EYE_MOVEMENTS,1
HP_ABNORMAL_CIRCULATING_OSTE...,SET,8,-0.77737,-0.016215,0.31652,0.99297,HP_ABNORMAL_CIRCULATING_OSTEOCALCIN_LEVEL,1
BIOCARTA_LEPTIN_PATHWAY,SET,11,-0.60803,-0.014871,0.24747,0.99299,BIOCARTA_LEPTIN_PATHWAY,1
MIR181C_3P,SET,10,-0.573,-0.013362,0.23297,0.99304,MIR181C_3P,1
GSE24972_WT_VS_IRF8_KO_MARGI...1,SET,181,-0.15558,-0.015363,0.063217,0.99307,GSE24972_WT_VS_IRF8_KO_MARGINAL_ZONE_SPLEEN_BCELL_DN,1
HP_DUMBBELL_SHAPED_LONG_BONE,SET,7,-0.75559,-0.014743,0.30638,0.99317,HP_DUMBBELL_SHAPED_LONG_BONE,1
NKX2_3_TARGET_GENES,SET,436,-0.098683,-0.015018,0.04,0.99318,NKX2_3_TARGET_GENES,1
HP_ENLARGEMENT_OF_THE_ANKLES,SET,5,-1.0105,-0.016665,0.40953,0.99319,HP_ENLARGEMENT_OF_THE_ANKLES,1
BIOCARTA_HSP27_PATHWAY,SET,14,-0.53968,-0.014889,0.21869,0.9932,BIOCARTA_HSP27_PATHWAY,1
MIR4492,SET,388,-0.10694,-0.015374,0.043329,0.99321,MIR4492,1
MIR502_5P,SET,68,-0.25283,-0.01535,0.10237,0.99324,MIR502_5P,1
WP_DEVELOPMENT_OF_URETERIC_C...,SET,57,-0.31104,-0.017295,0.12589,0.99325,WP_DEVELOPMENT_OF_URETERIC_COLLECTION_SYSTEM,1
PID_INTEGRIN4_PATHWAY,SET,11,-0.65623,-0.01605,0.26534,0.9933,PID_INTEGRIN4_PATHWAY,1
HP_ABNORMALITY_OF_VITAMIN_D_...,SET,45,-0.31216,-0.015427,0.12618,0.99331,HP_ABNORMALITY_OF_VITAMIN_D_METABOLISM,1
PEDERSEN_METASTASIS_BY_ERBB2...3,SET,99,-0.22571,-0.016521,0.091225,0.99332,PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_4,1
GSE21063_CTRL_VS_ANTI_IGM_ST...10,SET,185,-0.15524,-0.015496,0.06273,0.99333,GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_3H_UP,1
GSE6092_UNSTIM_VS_IFNG_STIM_...3,SET,173,-0.15711,-0.015171,0.063471,0.99334,GSE6092_UNSTIM_VS_IFNG_STIM_ENDOTHELIAL_CELL_DN,1
NADERI_BREAST_CANCER_PROGNOS...2,SET,47,-0.30839,-0.015575,0.12456,0.99335,NADERI_BREAST_CANCER_PROGNOSIS_UP,1
GOBP_INTESTINAL_EPITHELIAL_S...,SET,7,-0.89489,-0.017461,0.36143,0.99335,GOBP_INTESTINAL_EPITHELIAL_STRUCTURE_MAINTENANCE,1
GOBP_NEPHRIC_DUCT_DEVELOPMENT,SET,14,-0.60935,-0.016811,0.24598,0.99337,GOBP_NEPHRIC_DUCT_DEVELOPMENT,1
HP_ABNORMAL_TISSUE_ENZYME_CO...,SET,55,-0.26977,-0.014736,0.10878,0.99343,HP_ABNORMAL_TISSUE_ENZYME_CONCENTRATION_OR_ACTIVITY,1
WP_GPCRS_CLASS_A_RHODOPSINLI...,SET,230,-0.15754,-0.017513,0.063482,0.99346,WP_GPCRS_CLASS_A_RHODOPSINLIKE,1
MIR670_3P,SET,269,-0.12747,-0.015308,0.051326,0.99349,MIR670_3P,1
GSE17721_0.5H_VS_8H_LPS_BMDC...1,SET,180,-0.15334,-0.0151,0.061706,0.99352,GSE17721_0.5H_VS_8H_LPS_BMDC_DN,1
GSE23321_CD8_STEM_CELL_MEMOR...4,SET,178,-0.15254,-0.014939,0.061386,0.99352,GSE23321_CD8_STEM_CELL_MEMORY_VS_EFFECTOR_MEMORY_CD8_TCELL_UP,1
MIR3927_3P,SET,94,-0.21582,-0.015395,0.086829,0.99353,MIR3927_3P,1
PID_CD40_PATHWAY,SET,30,-0.40344,-0.016287,0.16221,0.99356,PID_CD40_PATHWAY,1
HP_FRAGILE_NAILS,SET,23,-0.42371,-0.01498,0.17029,0.99358,HP_FRAGILE_NAILS,1
GSE12003_MIR223_KO_VS_WT_BM_...2,SET,178,-0.15541,-0.01522,0.062433,0.99359,GSE12003_MIR223_KO_VS_WT_BM_PROGENITOR_4D_CULTURE_UP,1
HP_INFRA_ORBITAL_CREASE,SET,7,-0.79081,-0.01543,0.31749,0.99362,HP_INFRA_ORBITAL_CREASE,1
GOBP_POSITIVE_REGULATION_OF_...279,SET,6,-1.0016,-0.018094,0.40186,0.99365,GOBP_POSITIVE_REGULATION_OF_FEAR_RESPONSE,1
GOBP_CHEMICAL_HOMEOSTASIS,SET,937,-0.072513,-0.01595,0.029086,0.99366,GOBP_CHEMICAL_HOMEOSTASIS,1
ZHONG_PFC_C3_PROX1_CCK_POS_I...,SET,10,-0.80577,-0.01879,0.32314,0.99367,ZHONG_PFC_C3_PROX1_CCK_POS_INTERNEURON,1
GOBP_REGULATION_OF_LOCOMOTION,SET,961,-0.073288,-0.016314,0.029349,0.99373,GOBP_REGULATION_OF_LOCOMOTION,1
HP_DECREASED_MEAN_CORPUSCULA...2,SET,11,-0.56777,-0.013886,0.22714,0.99378,HP_DECREASED_MEAN_CORPUSCULAR_VOLUME,1
HE_LIM_SUN_FETAL_LUNG_C0_RES...,SET,98,-0.23291,-0.016962,0.093168,0.99378,HE_LIM_SUN_FETAL_LUNG_C0_RESTING_CHONDROCYTE,1
GSE36891_UNSTIM_VS_POLYIC_TL...1,SET,178,-0.15757,-0.015432,0.063017,0.99379,GSE36891_UNSTIM_VS_POLYIC_TLR3_STIM_PERITONEAL_MACROPHAGE_DN,1
GOBP_ASYMMETRIC_NEUROBLAST_D...,SET,5,-0.89349,-0.014735,0.35732,0.9938,GOBP_ASYMMETRIC_NEUROBLAST_DIVISION,1
GOBP_GENERATION_OF_NEURONS,SET,1372,-0.061521,-0.016169,0.0246,0.9938,GOBP_GENERATION_OF_NEURONS,1
chr1q24,SET,54,-0.50337,-0.027245,0.20114,0.99383,chr1q24,1
HP_BLOODY_DIARRHEA,SET,45,-0.32469,-0.016046,0.12959,0.99388,HP_BLOODY_DIARRHEA,1
HP_GRAY_MATTER_HETEROTOPIA,SET,111,-0.18558,-0.014379,0.07407,0.99388,HP_GRAY_MATTER_HETEROTOPIA,1
GOBP_REGULATION_OF_GLUTAMATE...3,SET,19,-0.53949,-0.017337,0.21513,0.99392,GOBP_REGULATION_OF_GLUTAMATE_SECRETION,1
HOLLERN_MICROACINAR_BREAST_T...1,SET,14,-0.58595,-0.016166,0.23361,0.99393,HOLLERN_MICROACINAR_BREAST_TUMOR_DN,1
MODULE_373,SET,20,-0.48121,-0.015866,0.19186,0.99393,MODULE_373,1
MIR4301,SET,34,-0.32957,-0.014162,0.13135,0.99394,MIR4301,1
HP_ERECTILE_DYSFUNCTION,SET,60,-0.2815,-0.016058,0.11216,0.99395,HP_ERECTILE_DYSFUNCTION,1
GSE1432_1H_VS_6H_IFNG_MICROG...2,SET,185,-0.15759,-0.015731,0.062798,0.99395,GSE1432_1H_VS_6H_IFNG_MICROGLIA_UP,1
HP_ERYTHRODERMA,SET,56,-0.27989,-0.015426,0.11144,0.99398,HP_ERYTHRODERMA,1
FREAC4_01,SET,134,-0.19819,-0.016861,0.078877,0.994,FREAC4_01,1
GOBP_NEGATIVE_REGULATION_OF_...28,SET,9,-0.73208,-0.016196,0.29132,0.99401,GOBP_NEGATIVE_REGULATION_OF_ANTIGEN_PROCESSING_AND_PRESENTATION,1
GOMF_SPHINGOMYELIN_PHOSPHODI...,SET,7,-0.81489,-0.0159,0.32424,0.99401,GOMF_SPHINGOMYELIN_PHOSPHODIESTERASE_ACTIVITY,1
GNF2_CASP8,SET,24,-0.46682,-0.016858,0.18573,0.99402,GNF2_CASP8,1
HP_ABNORMAL_CIRCULATING_INSU...,SET,144,-0.17927,-0.015806,0.071319,0.99402,HP_ABNORMAL_CIRCULATING_INSULIN_CONCENTRATION,1
GSE2826_WT_VS_BTK_KO_BCELL_DN,SET,193,-0.15621,-0.015923,0.062123,0.99404,GSE2826_WT_VS_BTK_KO_BCELL_DN,1
GOBP_NEGATIVE_REGULATION_OF_...240,SET,7,-0.67435,-0.013158,0.26774,0.99411,GOBP_NEGATIVE_REGULATION_OF_FIBROBLAST_APOPTOTIC_PROCESS,1
HP_ABNORMALITY_OF_CHORIORETI...,SET,12,-0.66925,-0.017095,0.26553,0.99414,HP_ABNORMALITY_OF_CHORIORETINAL_PIGMENTATION,1
GSE21546_UNSTIM_VS_ANTI_CD3_...5,SET,135,-0.19454,-0.016612,0.077161,0.99415,GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_DN,1
GOBP_NEGATIVE_REGULATION_OF_...36,SET,11,-0.60001,-0.014675,0.23784,0.99417,GOBP_NEGATIVE_REGULATION_OF_AUTOPHAGOSOME_ASSEMBLY,1
GSE3982_NEUTROPHIL_VS_BASOPH...2,SET,177,-0.15756,-0.015388,0.062378,0.99423,GSE3982_NEUTROPHIL_VS_BASOPHIL_UP,1
MIR1843,SET,58,-0.28436,-0.015949,0.11253,0.99424,MIR1843,1
GOBP_NEGATIVE_REGULATION_OF_...552,SET,5,-1.0229,-0.01687,0.40435,0.99429,GOBP_NEGATIVE_REGULATION_OF_RECEPTOR_RECYCLING,1
HP_NONKETOTIC_HYPOGLYCEMIA,SET,13,-0.55417,-0.014733,0.21888,0.99432,HP_NONKETOTIC_HYPOGLYCEMIA,1
GOBP_RESPONSE_TO_INTERFERON_...1,SET,17,-0.57898,-0.017601,0.22856,0.99434,GOBP_RESPONSE_TO_INTERFERON_ALPHA,1
GOBP_PHAGOSOME_ACIDIFICATION,SET,7,-0.90319,-0.017623,0.35647,0.99435,GOBP_PHAGOSOME_ACIDIFICATION,1
AGUIRRE_PANCREATIC_CANCER_CO...2,SET,271,-0.13506,-0.016279,0.053279,0.99437,AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP,1
GOBP_CELL_SURFACE_RECEPTOR_P...3,SET,6,-0.82142,-0.014839,0.32398,0.99438,GOBP_CELL_SURFACE_RECEPTOR_PROTEIN_TYROSINE_PHOSPHATASE_SIGNALING_PATHWAY,1
WP_DISORDERS_IN_KETONE_BODY_...,SET,5,-0.9826,-0.016205,0.38742,0.99439,WP_DISORDERS_IN_KETONE_BODY_SYNTHESIS,1
GOBP_CATECHOLAMINE_SECRETION,SET,46,-0.33642,-0.01681,0.13265,0.99439,GOBP_CATECHOLAMINE_SECRETION,1
HP_ABNORMAL_CIRCULATING_IGG_...,SET,107,-0.20769,-0.015801,0.081772,0.99445,HP_ABNORMAL_CIRCULATING_IGG_LEVEL,1
REACTOME_MET_ACTIVATES_PTK2_...,SET,30,-0.42693,-0.017235,0.16803,0.99447,REACTOME_MET_ACTIVATES_PTK2_SIGNALING,1
MIR6743_5P,SET,35,-0.3315,-0.014453,0.13047,0.99447,MIR6743_5P,1
GSE17721_CTRL_VS_CPG_8H_BMDC...1,SET,187,-0.15542,-0.015597,0.061147,0.99448,GSE17721_CTRL_VS_CPG_8H_BMDC_DN,1
GSE42021_CD24HI_VS_CD24INT_T...2,SET,182,-0.15726,-0.015572,0.061868,0.99448,GSE42021_CD24HI_VS_CD24INT_TCONV_THYMUS_UP,1
HP_ELEVATED_URINARY_CARBOXYL...,SET,94,-0.22686,-0.016182,0.089238,0.99449,HP_ELEVATED_URINARY_CARBOXYLIC_ACID,1
HP_RACHITIC_ROSARY,SET,6,-0.94897,-0.017143,0.37307,0.99451,HP_RACHITIC_ROSARY,1
FAN_EMBRYONIC_CTX_OLIG,SET,671,-0.086064,-0.016142,0.033828,0.99452,FAN_EMBRYONIC_CTX_OLIG,1
HNF1_01,SET,220,-0.15696,-0.01707,0.061513,0.99464,HNF1_01,1
GSE21546_WT_VS_ELK1_KO_DP_TH...1,SET,179,-0.15689,-0.015408,0.061464,0.99465,GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_DN,1
BERTUCCI_INVASIVE_CARCINOMA_...1,SET,41,-0.36187,-0.017073,0.14173,0.99466,BERTUCCI_INVASIVE_CARCINOMA_DUCTAL_VS_LOBULAR_DN,1
GSE5455_HEALTHY_VS_TUMOR_BEA...2,SET,176,-0.16406,-0.015978,0.064217,0.99468,GSE5455_HEALTHY_VS_TUMOR_BEARING_MOUSE_SPLEEN_MONOCYTE_24H_INCUBATION_UP,1
GOMF_ATPASE_ACTIVATOR_ACTIVI...,SET,24,-0.42095,-0.015202,0.16471,0.9947,GOMF_ATPASE_ACTIVATOR_ACTIVITY,1
GSE4590_PRE_BCELL_VS_LARGE_P...2,SET,142,-0.19319,-0.016915,0.075593,0.9947,GSE4590_PRE_BCELL_VS_LARGE_PRE_BCELL_UP,1
GSE9988_LPS_VS_VEHICLE_TREAT...1,SET,184,-0.15527,-0.015458,0.0607,0.99473,GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN,1
LIAN_LIPA_TARGETS_3M,SET,52,-0.32244,-0.017127,0.12595,0.99476,LIAN_LIPA_TARGETS_3M,1
KEGG_PHENYLALANINE_METABOLISM,SET,15,-0.62608,-0.017879,0.24457,0.99476,KEGG_PHENYLALANINE_METABOLISM,1
HP_LOSS_OF_PURKINJE_CELLS_IN...,SET,5,-0.97536,-0.016085,0.38091,0.99477,HP_LOSS_OF_PURKINJE_CELLS_IN_THE_CEREBELLAR_VERMIS,1
GSE34006_UNTREATED_VS_A2AR_A...2,SET,176,-0.15791,-0.015379,0.061599,0.99482,GSE34006_UNTREATED_VS_A2AR_AGONIST_TREATED_TREG_UP,1
HP_MALE_SEXUAL_DYSFUNCTION,SET,78,-0.25047,-0.016282,0.097666,0.99483,HP_MALE_SEXUAL_DYSFUNCTION,1
GOBP_CELLULAR_RESPONSE_TO_NU...2,SET,223,-0.14845,-0.016253,0.057865,0.99484,GOBP_CELLULAR_RESPONSE_TO_NUTRIENT_LEVELS,1
GOCC_POSTSYNAPTIC_SPECIALIZA...1,SET,324,-0.12318,-0.01621,0.047976,0.99487,GOCC_POSTSYNAPTIC_SPECIALIZATION,1
GSE43955_1H_VS_20H_ACT_CD4_T...2,SET,184,-0.16122,-0.01605,0.062799,0.99487,GSE43955_1H_VS_20H_ACT_CD4_TCELL_UP,1
GSE1460_DP_THYMOCYTE_VS_NAIV...1,SET,176,-0.16478,-0.016048,0.064129,0.9949,GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_ADULT_BLOOD_DN,1
REACTOME_POLB_DEPENDENT_LONG...,SET,7,-0.75311,-0.014695,0.29308,0.99491,REACTOME_POLB_DEPENDENT_LONG_PATCH_BASE_EXCISION_REPAIR,1
HP_FOLLICULAR_HYPERPLASIA,SET,14,-0.6027,-0.016628,0.23451,0.99491,HP_FOLLICULAR_HYPERPLASIA,1
GOMF_HEAT_SHOCK_PROTEIN_BIND...,SET,119,-0.19523,-0.015658,0.075944,0.99492,GOMF_HEAT_SHOCK_PROTEIN_BINDING,1
GOBP_PEPTIDYL_LYSINE_MONOMET...,SET,7,-0.74174,-0.014473,0.28834,0.99495,GOBP_PEPTIDYL_LYSINE_MONOMETHYLATION,1
WP_HEREDITARY_LEIOMYOMATOSIS...,SET,18,-0.48558,-0.015189,0.1887,0.99496,WP_HEREDITARY_LEIOMYOMATOSIS_AND_RENAL_CELL_CARCINOMA_PATHWAY,1
MIR5089_5P,SET,103,-0.21102,-0.015753,0.082,0.99496,MIR5089_5P,1
HP_ABNORMAL_VERTEBRAL_SEGMEN...,SET,8,-0.86073,-0.017954,0.33436,0.99497,HP_ABNORMAL_VERTEBRAL_SEGMENTATION_AND_FUSION,1
HP_ABNORMAL_MEAN_CORPUSCULAR...2,SET,55,-0.27037,-0.014768,0.10501,0.99498,HP_ABNORMAL_MEAN_CORPUSCULAR_VOLUME,1
GSE31622_WT_VS_KLF3_KO_BCELL...1,SET,178,-0.16686,-0.016342,0.064792,0.99499,GSE31622_WT_VS_KLF3_KO_BCELL_DN,1
MARTENS_TRETINOIN_RESPONSE_UP,SET,754,-0.08805,-0.017465,0.034177,0.995,MARTENS_TRETINOIN_RESPONSE_UP,1
MIKKELSEN_NPC_ICP_WITH_H3K4M...,SET,381,-0.11092,-0.015803,0.043056,0.995,MIKKELSEN_NPC_ICP_WITH_H3K4ME3,1
GSE3982_DC_VS_CENT_MEMORY_CD...2,SET,186,-0.15947,-0.015961,0.061906,0.995,GSE3982_DC_VS_CENT_MEMORY_CD4_TCELL_UP,1
GOBP_REGULATION_OF_MESODERM_...,SET,5,-1.0135,-0.016715,0.39332,0.99501,GOBP_REGULATION_OF_MESODERM_DEVELOPMENT,1
HP_DECREASED_CIRCULATING_PAR...,SET,10,-0.75743,-0.017663,0.29392,0.99501,HP_DECREASED_CIRCULATING_PARATHYROID_HORMONE_LEVEL,1
BMI1_DN_MEL18_DN.V1_DN,SET,130,-0.20459,-0.017145,0.079248,0.99508,BMI1_DN_MEL18_DN.V1_DN,1
LU_TUMOR_ENDOTHELIAL_MARKERS...2,SET,20,-0.54248,-0.017885,0.21009,0.99509,LU_TUMOR_ENDOTHELIAL_MARKERS_UP,1
MIR570_3P,SET,686,-0.084598,-0.016036,0.032758,0.99509,MIR570_3P,1
GOBP_CEREBRAL_CORTEX_DEVELOP...,SET,112,-0.21846,-0.017002,0.084591,0.99509,GOBP_CEREBRAL_CORTEX_DEVELOPMENT,1
GOCC_LAMININ_COMPLEX,SET,9,-0.75864,-0.016784,0.29378,0.99509,GOCC_LAMININ_COMPLEX,1
DESCARTES_FETAL_MUSCLE_VASCU...,SET,63,-0.29795,-0.017414,0.11536,0.99509,DESCARTES_FETAL_MUSCLE_VASCULAR_ENDOTHELIAL_CELLS,1
WP_LEPTIN_AND_ADIPONECTIN,SET,10,-0.66086,-0.015411,0.25584,0.9951,WP_LEPTIN_AND_ADIPONECTIN,1
GFI1_01,SET,241,-0.14313,-0.016282,0.055396,0.99511,GFI1_01,1
TOMIDA_METASTASIS_DN,SET,11,-0.63564,-0.015546,0.24597,0.99512,TOMIDA_METASTASIS_DN,1
ALPHACP1_01,SET,224,-0.1498,-0.016437,0.05793,0.99514,ALPHACP1_01,1
HP_DECREASED_SERUM_CREATININE,SET,4,-1.1329,-0.016712,0.43748,0.99519,HP_DECREASED_SERUM_CREATININE,1
HOEGERKORP_CD44_TARGETS_TEMP...2,SET,10,-0.71062,-0.016571,0.27438,0.9952,HOEGERKORP_CD44_TARGETS_TEMPORAL_UP,1
GOBP_HOMEOSTATIC_PROCESS,SET,1569,-0.059183,-0.016538,0.022847,0.9952,GOBP_HOMEOSTATIC_PROCESS,1
GOBP_INTRACELLULAR_STEROL_TR...,SET,32,-0.38735,-0.016149,0.14943,0.99523,GOBP_INTRACELLULAR_STEROL_TRANSPORT,1
GOBP_RISC_COMPLEX_ASSEMBLY,SET,10,-0.75817,-0.01768,0.29234,0.99525,GOBP_RISC_COMPLEX_ASSEMBLY,1
GOBP_LIPID_CATABOLIC_PROCESS,SET,325,-0.12393,-0.016334,0.047765,0.99526,GOBP_LIPID_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...92,SET,626,-0.088181,-0.015995,0.033952,0.9953,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_COMPONENT_ORGANIZATION,1
GSE16450_CTRL_VS_IFNA_12H_ST...4,SET,180,-0.1653,-0.016279,0.063641,0.9953,GSE16450_CTRL_VS_IFNA_12H_STIM_MATURE_NEURON_CELL_LINE_UP,1
ZIC3_01,SET,236,-0.14485,-0.016308,0.055744,0.99531,ZIC3_01,1
DESCARTES_FETAL_STOMACH_VASC...,SET,28,-0.46357,-0.01808,0.17839,0.99532,DESCARTES_FETAL_STOMACH_VASCULAR_ENDOTHELIAL_CELLS,1
COREBINDINGFACTOR_Q6,SET,247,-0.14307,-0.016474,0.055016,0.99534,COREBINDINGFACTOR_Q6,1
GOBP_SPINAL_CORD_MOTOR_NEURO...1,SET,9,-0.72688,-0.016081,0.27932,0.99537,GOBP_SPINAL_CORD_MOTOR_NEURON_CELL_FATE_SPECIFICATION,1
chr17q23,SET,51,-0.52909,-0.027832,0.2032,0.99539,chr17q23,1
GOBP_RETINAL_BLOOD_VESSEL_MO...,SET,5,-0.95824,-0.015803,0.36794,0.99539,GOBP_RETINAL_BLOOD_VESSEL_MORPHOGENESIS,1
PID_ECADHERIN_NASCENT_AJ_PAT...,SET,38,-0.36256,-0.016469,0.1392,0.9954,PID_ECADHERIN_NASCENT_AJ_PATHWAY,1
GOMF_HORMONE_BINDING,SET,88,-0.24644,-0.017012,0.094555,0.99542,GOMF_HORMONE_BINDING,1
MMEF2_Q6,SET,245,-0.14467,-0.016592,0.055407,0.99548,MMEF2_Q6,1
WTTGKCTG_UNKNOWN,SET,455,-0.10794,-0.016771,0.04132,0.9955,WTTGKCTG_UNKNOWN,1
HP_COOMBS_POSITIVE_HEMOLYTIC...,SET,9,-0.75149,-0.016626,0.28745,0.99553,HP_COOMBS_POSITIVE_HEMOLYTIC_ANEMIA,1
GOBP_POSITIVE_REGULATION_OF_...417,SET,547,-0.10095,-0.017154,0.038564,0.99557,GOBP_POSITIVE_REGULATION_OF_LOCOMOTION,1
GOCC_TRANSCRIPTION_FACTOR_TF...2,SET,30,-0.34105,-0.013768,0.1303,0.99557,GOCC_TRANSCRIPTION_FACTOR_TFIID_COMPLEX,1
HP_BROAD_BASED_GAIT,SET,99,-0.21541,-0.015767,0.082262,0.99558,HP_BROAD_BASED_GAIT,1
GOBP_NEUROGENESIS,SET,1595,-0.05968,-0.016801,0.022788,0.99559,GOBP_NEUROGENESIS,1
GOMF_ATPASE_REGULATOR_ACTIVI...,SET,45,-0.30859,-0.015251,0.11751,0.99568,GOMF_ATPASE_REGULATOR_ACTIVITY,1
chr4q26,SET,15,-1.0679,-0.030497,0.40654,0.99569,chr4q26,1
MIR6500_3P,SET,73,-0.25663,-0.016142,0.097702,0.99569,MIR6500_3P,1
GOBP_SPHINGOMYELIN_CATABOLIC...,SET,8,-0.80968,-0.016889,0.30825,0.99569,GOBP_SPHINGOMYELIN_CATABOLIC_PROCESS,1
GOBP_NEGATIVE_REGULATION_OF_...256,SET,15,-0.5867,-0.016754,0.22329,0.9957,GOBP_NEGATIVE_REGULATION_OF_GLUCONEOGENESIS,1
CHIBA_RESPONSE_TO_TSA_DN,SET,20,-0.49316,-0.016259,0.18751,0.99573,CHIBA_RESPONSE_TO_TSA_DN,1
WP_PI3KAKTMTOR_VITAMIN_D3_SI...,SET,20,-0.52211,-0.017214,0.19848,0.99573,WP_PI3KAKTMTOR_VITAMIN_D3_SIGNALING,1
MIR4259,SET,23,-0.44433,-0.015709,0.16895,0.99573,MIR4259,1
HP_ENAMEL_HYPOPLASIA,SET,90,-0.22895,-0.015982,0.087029,0.99574,HP_ENAMEL_HYPOPLASIA,1
WP_OXIDATIVE_DAMAGE_RESPONSE,SET,36,-0.37497,-0.016579,0.14216,0.99582,WP_OXIDATIVE_DAMAGE_RESPONSE,1
GOBP_STRIATED_MUSCLE_CELL_AP...,SET,42,-0.34205,-0.016332,0.12967,0.99582,GOBP_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
GOCC_COPI_COATED_VESICLE_MEM...,SET,17,-0.47519,-0.014445,0.1801,0.99583,GOCC_COPI_COATED_VESICLE_MEMBRANE,1
HP_ZOLLINGER_ELLISON_SYNDROME,SET,9,-0.75432,-0.016688,0.28585,0.99584,HP_ZOLLINGER_ELLISON_SYNDROME,1
HP_ROD_CONE_DYSTROPHY,SET,197,-0.15479,-0.015939,0.05864,0.99585,HP_ROD_CONE_DYSTROPHY,1
GOBP_AMINE_METABOLIC_PROCESS,SET,102,-0.23345,-0.017343,0.088403,0.99586,GOBP_AMINE_METABOLIC_PROCESS,1
HP_FRONTOTEMPORAL_CEREBRAL_A...,SET,14,-0.55647,-0.015352,0.21074,0.99586,HP_FRONTOTEMPORAL_CEREBRAL_ATROPHY,1
REACTOME_FORMATION_OF_INTERM...,SET,7,-0.96548,-0.018839,0.36459,0.99595,REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM,1
MODULE_135,SET,25,-0.48545,-0.017892,0.18333,0.99595,MODULE_135,1
GSE22886_TH1_VS_TH2_12H_ACT_...1,SET,178,-0.16768,-0.016422,0.063266,0.99598,GSE22886_TH1_VS_TH2_12H_ACT_DN,1
GSE3982_CTRL_VS_LPS_48H_DC_UP,SET,183,-0.1662,-0.016502,0.062672,0.996,GSE3982_CTRL_VS_LPS_48H_DC_UP,1
HP_RETINAL_DYSTROPHY,SET,310,-0.12577,-0.016195,0.047403,0.99601,HP_RETINAL_DYSTROPHY,1
GOMF_NUCLEAR_GLUCOCORTICOID_...,SET,12,-0.72312,-0.018471,0.27248,0.99602,GOMF_NUCLEAR_GLUCOCORTICOID_RECEPTOR_BINDING,1
DESCARTES_MAIN_FETAL_PDE1C_A...,SET,238,-0.13499,-0.015262,0.050866,0.99602,DESCARTES_MAIN_FETAL_PDE1C_ACSM3_POSITIVE_CELLS,1
OUELLET_CULTURED_OVARIAN_CAN...2,SET,60,-0.28063,-0.016008,0.10561,0.99606,OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP,1
GOBP_ANGIOTENSIN_ACTIVATED_S...,SET,17,-0.60035,-0.01825,0.2259,0.99606,GOBP_ANGIOTENSIN_ACTIVATED_SIGNALING_PATHWAY,1
GOBP_COTRANSLATIONAL_PROTEIN...,SET,21,-0.47057,-0.015897,0.17694,0.99608,GOBP_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE,1
MIR3663_5P,SET,49,-0.32281,-0.016646,0.12133,0.9961,MIR3663_5P,1
GSE29615_CTRL_VS_DAY7_LAIV_F...1,SET,131,-0.19386,-0.016308,0.072845,0.9961,GSE29615_CTRL_VS_DAY7_LAIV_FLU_VACCINE_PBMC_DN,1
GOBP_REGULATION_OF_APOPTOTIC...3,SET,11,-0.79402,-0.019419,0.29826,0.99611,GOBP_REGULATION_OF_APOPTOTIC_PROCESS_INVOLVED_IN_DEVELOPMENT,1
GOBP_NEGATIVE_REGULATION_OF_...20,SET,27,-0.47354,-0.018137,0.17771,0.99614,GOBP_NEGATIVE_REGULATION_OF_AMINE_TRANSPORT,1
GOBP_NEGATIVE_REGULATION_OF_...478,SET,112,-0.23232,-0.01808,0.087202,0.99614,GOBP_NEGATIVE_REGULATION_OF_PEPTIDASE_ACTIVITY,1
GCNP_SHH_UP_LATE.V1_DN,SET,159,-0.18047,-0.016713,0.067711,0.99615,GCNP_SHH_UP_LATE.V1_DN,1
GOBP_CYCLIC_NUCLEOTIDE_METAB...,SET,37,-0.38338,-0.017184,0.14375,0.99617,GOBP_CYCLIC_NUCLEOTIDE_METABOLIC_PROCESS,1
HOXA7_TARGET_GENES,SET,95,-0.22917,-0.016434,0.085902,0.99618,HOXA7_TARGET_GENES,1
GSE17721_POLYIC_VS_GARDIQUIM...1,SET,181,-0.16543,-0.016336,0.062003,0.99618,GSE17721_POLYIC_VS_GARDIQUIMOD_0.5H_BMDC_DN,1
MIR6762_3P,SET,115,-0.20523,-0.016184,0.076845,0.99621,MIR6762_3P,1
GSE17721_POLYIC_VS_PAM3CSK4_...16,SET,185,-0.16486,-0.016456,0.061701,0.99622,GSE17721_POLYIC_VS_PAM3CSK4_6H_BMDC_UP,1
GOBP_ACIDIC_AMINO_ACID_TRANS...,SET,65,-0.29808,-0.017695,0.11153,0.99623,GOBP_ACIDIC_AMINO_ACID_TRANSPORT,1
GSE43863_NAIVE_VS_LY6C_LOW_C...2,SET,140,-0.18681,-0.016242,0.069867,0.99625,GSE43863_NAIVE_VS_LY6C_LOW_CXCR5NEG_CD4_EFF_TCELL_D6_LCMV_UP,1
HP_CENTRAL_NERVOUS_SYSTEM_CY...,SET,180,-0.16301,-0.016053,0.06077,0.99634,HP_CENTRAL_NERVOUS_SYSTEM_CYST,1
GOBP_INTRACELLULAR_LIPID_TRA...,SET,44,-0.32649,-0.015956,0.12164,0.99636,GOBP_INTRACELLULAR_LIPID_TRANSPORT,1
GSE19923_E2A_KO_VS_E2A_AND_H...1,SET,182,-0.17276,-0.017107,0.064323,0.99638,GSE19923_E2A_KO_VS_E2A_AND_HEB_KO_DP_THYMOCYTE_DN,1
GOBP_GLUTAMATE_SECRETION_NEU...,SET,8,-0.8473,-0.017674,0.31531,0.99639,GOBP_GLUTAMATE_SECRETION_NEUROTRANSMISSION,1
GOBP_REGULATION_OF_BLOOD_PRE...,SET,170,-0.18606,-0.017811,0.069251,0.99639,GOBP_REGULATION_OF_BLOOD_PRESSURE,1
GOCC_EARP_COMPLEX,SET,3,-1.142,-0.014589,0.42493,0.9964,GOCC_EARP_COMPLEX,1
GSE17721_CTRL_VS_POLYIC_6H_B...1,SET,189,-0.16899,-0.017048,0.062867,0.9964,GSE17721_CTRL_VS_POLYIC_6H_BMDC_DN,1
GCM_MYCL1,SET,23,-0.43122,-0.015245,0.1604,0.99641,GCM_MYCL1,1
GOCC_CORTICAL_ACTIN_CYTOSKEL...,SET,72,-0.26159,-0.016341,0.097299,0.99641,GOCC_CORTICAL_ACTIN_CYTOSKELETON,1
HP_ABNORMAL_ENZYME_ACTIVITY_...1,SET,21,-0.5045,-0.017043,0.18763,0.99641,HP_ABNORMAL_ENZYME_ACTIVITY_IN_CULTURED_FIBROBLASTS,1
GOBP_PTERIDINE_CONTAINING_CO...1,SET,13,-0.59248,-0.015752,0.2202,0.99643,GOBP_PTERIDINE_CONTAINING_COMPOUND_BIOSYNTHETIC_PROCESS,1
WP_AMPACTIVATED_PROTEIN_KINA...,SET,67,-0.27853,-0.016786,0.10341,0.99646,WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING,1
HP_CEREBELLAR_CYST,SET,138,-0.18501,-0.015971,0.068661,0.99647,HP_CEREBELLAR_CYST,1
RSRFC4_01,SET,219,-0.15902,-0.017255,0.058994,0.99648,RSRFC4_01,1
GOBP_BILE_ACID_SECRETION,SET,10,-0.69941,-0.01631,0.25926,0.99651,GOBP_BILE_ACID_SECRETION,1
REACTOME_RHOJ_GTPASE_CYCLE,SET,50,-0.32609,-0.016985,0.12083,0.99652,REACTOME_RHOJ_GTPASE_CYCLE,1
ZIC1_01,SET,234,-0.14635,-0.016408,0.054228,0.99652,ZIC1_01,1
MIR556_3P,SET,129,-0.19623,-0.016382,0.072687,0.99653,MIR556_3P,1
GOCC_PHOTORECEPTOR_INNER_SEG...,SET,65,-0.29635,-0.017593,0.10967,0.99655,GOCC_PHOTORECEPTOR_INNER_SEGMENT,1
GOBP_NEGATIVE_REGULATION_OF_...286,SET,6,-0.83102,-0.015013,0.30727,0.99658,GOBP_NEGATIVE_REGULATION_OF_HYPOXIA_INDUCED_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY,1
GSE27859_MACROPHAGE_VS_DC_UP,SET,154,-0.18448,-0.016816,0.0682,0.99658,GSE27859_MACROPHAGE_VS_DC_UP,1
GSE36009_UNSTIM_VS_LPS_STIM_...4,SET,181,-0.16903,-0.016692,0.062414,0.99661,GSE36009_UNSTIM_VS_LPS_STIM_NLRP10_KO_DC_UP,1
MIR100_3P,SET,67,-0.28422,-0.017129,0.10489,0.99663,MIR100_3P,1
GOBP_NEGATIVE_REGULATION_OF_...285,SET,172,-0.1827,-0.017592,0.067406,0.99664,GOBP_NEGATIVE_REGULATION_OF_HYDROLASE_ACTIVITY,1
WP_PKCGAMMA_CALCIUM_SIGNALIN...,SET,21,-0.52939,-0.017884,0.19516,0.99666,WP_PKCGAMMA_CALCIUM_SIGNALING_IN_ATAXIA,1
HMEF2_Q6,SET,129,-0.2111,-0.017624,0.077728,0.99669,HMEF2_Q6,1
WTGAAAT_UNKNOWN,SET,529,-0.10555,-0.017648,0.038836,0.99671,WTGAAAT_UNKNOWN,1
GSE15930_STIM_VS_STIM_AND_TR...4,SET,186,-0.17729,-0.017745,0.065242,0.99671,GSE15930_STIM_VS_STIM_AND_TRICHOSTATINA_48H_CD8_T_CELL_UP,1
GOBP_NOREPINEPHRINE_TRANSPORT,SET,23,-0.54532,-0.019279,0.20032,0.99676,GOBP_NOREPINEPHRINE_TRANSPORT,1
HP_LOW_SET_NIPPLES,SET,6,-0.73567,-0.01329,0.27024,0.99676,HP_LOW_SET_NIPPLES,1
HP_THYROID_ADENOMA,SET,13,-0.65994,-0.017545,0.24194,0.99681,HP_THYROID_ADENOMA,1
PLASARI_TGFB1_SIGNALING_VIA_...3,SET,99,-0.23221,-0.016997,0.085075,0.99683,PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN,1
GOBP_CHOLINE_METABOLIC_PROCE...,SET,6,-1.0653,-0.019245,0.38951,0.99688,GOBP_CHOLINE_METABOLIC_PROCESS,1
MIR6831_5P,SET,106,-0.22535,-0.017065,0.082251,0.99692,MIR6831_5P,1
GOCC_THO_COMPLEX,SET,5,-0.97088,-0.016011,0.35411,0.99694,GOCC_THO_COMPLEX,1
GOBP_CHEMOKINE_C_C_MOTIF_LIG...,SET,10,-0.75681,-0.017648,0.27532,0.99701,GOBP_CHEMOKINE_C_C_MOTIF_LIGAND_5_PRODUCTION,1
PID_INTEGRIN1_PATHWAY,SET,63,-0.32022,-0.018716,0.11643,0.99702,PID_INTEGRIN1_PATHWAY,1
TRAVAGLINI_LUNG_CD8_MEMORY_E...,SET,26,-0.45399,-0.017063,0.16465,0.99708,TRAVAGLINI_LUNG_CD8_MEMORY_EFFECTOR_T_CELL,1
SP1_Q6,SET,235,-0.15074,-0.016936,0.054647,0.99709,SP1_Q6,1
GSE37532_WT_VS_PPARG_KO_LN_T...2,SET,181,-0.17211,-0.016996,0.062336,0.99712,GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP,1
GOMF_ADRENERGIC_RECEPTOR_ACT...,SET,10,-0.86719,-0.020223,0.31361,0.99715,GOMF_ADRENERGIC_RECEPTOR_ACTIVITY,1
chr5p13,SET,54,-0.63566,-0.034405,0.22962,0.99718,chr5p13,1
HP_ABNORMALITY_OF_VITAMIN_ME...,SET,94,-0.24355,-0.017373,0.087918,0.9972,HP_ABNORMALITY_OF_VITAMIN_METABOLISM,1
HP_INCREASED_MEAN_CORPUSCULA...,SET,11,-0.61229,-0.014975,0.22101,0.9972,HP_INCREASED_MEAN_CORPUSCULAR_HEMOGLOBIN_CONCENTRATION,1
HU_GENOTOXIN_ACTION_DIRECT_V...1,SET,45,-0.35222,-0.017407,0.12704,0.99722,HU_GENOTOXIN_ACTION_DIRECT_VS_INDIRECT_24HR,1
RELA_DN.V1_DN,SET,119,-0.22663,-0.018177,0.081595,0.99726,RELA_DN.V1_DN,1
GOBP_NEGATIVE_REGULATION_OF_...465,SET,312,-0.13001,-0.016795,0.046777,0.99727,GOBP_NEGATIVE_REGULATION_OF_ORGANELLE_ORGANIZATION,1
HP_RECURRENT_BRONCHOPULMONAR...,SET,10,-0.61806,-0.014413,0.2224,0.99727,HP_RECURRENT_BRONCHOPULMONARY_INFECTIONS,1
MOLENAAR_TARGETS_OF_CCND1_AN...1,SET,50,-0.32549,-0.016954,0.11708,0.99728,MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_DN,1
BIOCARTA_HIVNEF_PATHWAY,SET,54,-0.32366,-0.017518,0.11639,0.99729,BIOCARTA_HIVNEF_PATHWAY,1
HP_THORACIC_KYPHOSIS,SET,43,-0.32871,-0.015881,0.11813,0.9973,HP_THORACIC_KYPHOSIS,1
MIR9900,SET,40,-0.37423,-0.01744,0.13445,0.99731,MIR9900,1
GCM_BAG5,SET,34,-0.37276,-0.016018,0.13383,0.99732,GCM_BAG5,1
GOMF_RNA_POLYMERASE_II_GENER...2,SET,21,-0.47026,-0.015887,0.16886,0.99732,GOMF_RNA_POLYMERASE_II_GENERAL_TRANSCRIPTION_INITIATION_FACTOR_BINDING,1
GCM_PTPRD,SET,53,-0.32788,-0.017582,0.1177,0.99733,GCM_PTPRD,1
SAENZ_DETOX_PATHWAY_AND_CARC...,SET,14,-0.59915,-0.01653,0.21476,0.99736,SAENZ_DETOX_PATHWAY_AND_CARCINOGENESIS_DN,1
GOBP_ADENYLATE_CYCLASE_ACTIV...1,SET,23,-0.53725,-0.018994,0.19238,0.99738,GOBP_ADENYLATE_CYCLASE_ACTIVATING_ADRENERGIC_RECEPTOR_SIGNALING_PATHWAY,1
GOBP_PROTEIN_K11_LINKED_UBIQ...,SET,31,-0.39246,-0.016105,0.14052,0.99738,GOBP_PROTEIN_K11_LINKED_UBIQUITINATION,1
GOBP_POSITIVE_REGULATION_OF_...489,SET,23,-0.48374,-0.017102,0.17317,0.99739,GOBP_POSITIVE_REGULATION_OF_MONOOXYGENASE_ACTIVITY,1
GOBP_BASE_EXCISION_REPAIR_GA...,SET,13,-0.5011,-0.013322,0.17931,0.9974,GOBP_BASE_EXCISION_REPAIR_GAP_FILLING,1
MODULE_493,SET,58,-0.30545,-0.017132,0.1092,0.99742,MODULE_493,1
GSE11864_CSF1_PAM3CYS_VS_CSF...1,SET,173,-0.18315,-0.017686,0.065482,0.99742,GSE11864_CSF1_PAM3CYS_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
HOEK_MONOCYTE_2011_2012_TIV_...5,SET,9,-0.93345,-0.020651,0.33374,0.99742,HOEK_MONOCYTE_2011_2012_TIV_ADULT_7DY_DN,1
GOMF_THIOESTERASE_BINDING,SET,9,-0.67943,-0.015031,0.24272,0.99744,GOMF_THIOESTERASE_BINDING,1
GOBP_POLYOL_METABOLIC_PROCESS,SET,95,-0.24488,-0.01756,0.08733,0.99747,GOBP_POLYOL_METABOLIC_PROCESS,1
WP_CREATINE_PATHWAY,SET,4,-1.33,-0.019618,0.47415,0.99748,WP_CREATINE_PATHWAY,1
GOBP_CELLULAR_RESPONSE_TO_IN...6,SET,7,-0.91323,-0.017819,0.32496,0.99752,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_ALPHA,1
OSADA_ASCL1_TARGETS_DN,SET,23,-0.55038,-0.019458,0.19542,0.99757,OSADA_ASCL1_TARGETS_DN,1
GOCC_STEREOCILIUM_TIP,SET,18,-0.59611,-0.018646,0.21153,0.99758,GOCC_STEREOCILIUM_TIP,1
GOBP_PEPTIDYL_LYSINE_MODIFIC...,SET,127,-0.20146,-0.016688,0.071233,0.99766,GOBP_PEPTIDYL_LYSINE_MODIFICATION,1
GOBP_POSITIVE_REGULATION_OF_...247,SET,6,-1.1777,-0.021275,0.41599,0.99768,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_DIFFERENTIATION_INVOLVED_IN_KIDNEY_DEVELOPMENT,1
GOMF_PHOSPHATIDYLINOSITOL_TR...1,SET,10,-0.68543,-0.015984,0.24184,0.9977,GOMF_PHOSPHATIDYLINOSITOL_TRANSFER_ACTIVITY,1
REACTOME_LAMININ_INTERACTIONS,SET,28,-0.46944,-0.018309,0.1655,0.99772,REACTOME_LAMININ_INTERACTIONS,1
GOBP_ORGANOPHOSPHATE_METABOL...,SET,902,-0.080409,-0.017371,0.028284,0.99776,GOBP_ORGANOPHOSPHATE_METABOLIC_PROCESS,1
GSE7460_FOXP3_MUT_VS_WT_ACT_...3,SET,184,-0.17835,-0.017756,0.062718,0.99777,GSE7460_FOXP3_MUT_VS_WT_ACT_WITH_TGFB_TCONV_DN,1
GOBP_REGULATION_OF_ERBB_SIGN...,SET,66,-0.29677,-0.017752,0.10431,0.99778,GOBP_REGULATION_OF_ERBB_SIGNALING_PATHWAY,1
MIR338_3P,SET,132,-0.21605,-0.018244,0.075807,0.99781,MIR338_3P,1
GOBP_NEGATIVE_REGULATION_OF_...1,SET,27,-0.46509,-0.017813,0.1632,0.99781,GOBP_NEGATIVE_REGULATION_OF_ACTIN_FILAMENT_BUNDLE_ASSEMBLY,1
HP_DIFFUSE_CEREBELLAR_ATROPHY,SET,15,-0.54401,-0.015535,0.1909,0.99781,HP_DIFFUSE_CEREBELLAR_ATROPHY,1
GOBP_PROGRAMMED_NECROTIC_CEL...,SET,47,-0.34611,-0.01748,0.12132,0.99783,GOBP_PROGRAMMED_NECROTIC_CELL_DEATH,1
HP_ANOTIA,SET,12,-0.60525,-0.015461,0.21203,0.99784,HP_ANOTIA,1
HP_MACULAR_DEGENERATION,SET,88,-0.25732,-0.017763,0.090072,0.99786,HP_MACULAR_DEGENERATION,1
GOBP_ACTIVATION_OF_PROTEIN_K...2,SET,21,-0.57533,-0.019436,0.20123,0.99787,GOBP_ACTIVATION_OF_PROTEIN_KINASE_B_ACTIVITY,1
GOBP_RESPONSE_TO_INTERFERON_...2,SET,30,-0.48767,-0.019687,0.1706,0.99787,GOBP_RESPONSE_TO_INTERFERON_BETA,1
MIR3910,SET,365,-0.13183,-0.018393,0.045937,0.99794,MIR3910,1
HP_FIBULAR_BOWING,SET,9,-0.85428,-0.0189,0.29762,0.99795,HP_FIBULAR_BOWING,1
GSE17721_CTRL_VS_PAM3CSK4_8H...1,SET,180,-0.17233,-0.016971,0.059998,0.99796,GSE17721_CTRL_VS_PAM3CSK4_8H_BMDC_DN,1
GOBP_NEUROTRANSMITTER_RECEPT...6,SET,15,-0.65295,-0.018646,0.22654,0.99802,GOBP_NEUROTRANSMITTER_RECEPTOR_TRANSPORT_TO_PLASMA_MEMBRANE,1
GOCC_CELL_CORTEX,SET,288,-0.14427,-0.017918,0.050048,0.99803,GOCC_CELL_CORTEX,1
GOMF_HSP70_PROTEIN_BINDING,SET,48,-0.34403,-0.017559,0.11901,0.99808,GOMF_HSP70_PROTEIN_BINDING,1
GOBP_CELLULAR_RESPONSE_TO_IN...7,SET,24,-0.53533,-0.019332,0.185,0.99809,GOBP_CELLULAR_RESPONSE_TO_INTERFERON_BETA,1
HP_POOR_SUCK,SET,126,-0.229,-0.018896,0.079175,0.99809,HP_POOR_SUCK,1
GSE12366_NAIVE_VS_MEMORY_BCE...1,SET,174,-0.19717,-0.019094,0.068161,0.99809,GSE12366_NAIVE_VS_MEMORY_BCELL_DN,1
KUMAR_TARGETS_OF_MLL_AF9_FUS...,SET,367,-0.1322,-0.018494,0.045677,0.9981,KUMAR_TARGETS_OF_MLL_AF9_FUSION,1
GOBP_RESPONSE_TO_OXYGEN_LEVE...,SET,302,-0.14199,-0.018051,0.049065,0.9981,GOBP_RESPONSE_TO_OXYGEN_LEVELS,1
KEGG_MEDICUS_PATHOGEN_HCMV_U...2,SET,6,-1.0456,-0.01889,0.36091,0.99812,KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAQ_PLCB_G_CALCINEURIN_SIGNALING_PATHWAY,1
MIR619_5P,SET,130,-0.20837,-0.017463,0.07181,0.99814,MIR619_5P,1
GOBP_POSITIVE_REGULATION_OF_...529,SET,85,-0.29613,-0.020092,0.10207,0.99814,GOBP_POSITIVE_REGULATION_OF_NEURON_DIFFERENTIATION,1
HP_CLUBBING,SET,128,-0.20715,-0.017227,0.071203,0.99819,HP_CLUBBING,1
ZNF23_TARGET_GENES,SET,14,-0.64565,-0.017813,0.2218,0.9982,ZNF23_TARGET_GENES,1
MIR3185,SET,188,-0.17984,-0.018095,0.061665,0.99823,MIR3185,1
MIR4514,SET,162,-0.19411,-0.018144,0.066534,0.99823,MIR4514,1
BYSTROEM_CORRELATED_WITH_IL5...1,SET,55,-0.33575,-0.018339,0.1148,0.99827,BYSTROEM_CORRELATED_WITH_IL5_DN,1
GOCC_ADHERENS_JUNCTION,SET,170,-0.2008,-0.019222,0.068656,0.99827,GOCC_ADHERENS_JUNCTION,1
HE_LIM_SUN_FETAL_LUNG_C1_SMG...1,SET,347,-0.143,-0.019463,0.048716,0.99833,HE_LIM_SUN_FETAL_LUNG_C1_SMG_BASAL_CELL,1
FOXJ2_02,SET,214,-0.17646,-0.01893,0.060067,0.99834,FOXJ2_02,1
HP_ABNORMAL_ENZYME_CONCENTRA...,SET,638,-0.098829,-0.018091,0.033612,0.99836,HP_ABNORMAL_ENZYME_CONCENTRATION_OR_ACTIVITY,1
GSE25088_CTRL_VS_IL4_STIM_MA...2,SET,171,-0.19863,-0.01907,0.067482,0.99838,GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP,1
GOBP_POSITIVE_REGULATION_OF_...304,SET,3,-1.5507,-0.01981,0.52617,0.99839,GOBP_POSITIVE_REGULATION_OF_GLOMERULUS_DEVELOPMENT,1
GSE40666_UNTREATED_VS_IFNA_S...5,SET,181,-0.18648,-0.018414,0.063263,0.9984,GSE40666_UNTREATED_VS_IFNA_STIM_STAT1_KO_CD8_TCELL_90MIN_DN,1
MORF_DDB1,SET,224,-0.15204,-0.016683,0.051536,0.99841,MORF_DDB1,1
GSE5542_UNTREATED_VS_IFNG_TR...2,SET,184,-0.18677,-0.018594,0.063224,0.99843,GSE5542_UNTREATED_VS_IFNG_TREATED_EPITHELIAL_CELLS_24H_UP,1
CCTNTMAGA_UNKNOWN,SET,120,-0.2345,-0.018886,0.079321,0.99844,CCTNTMAGA_UNKNOWN,1
GSE32034_UNTREATED_VS_ROSIGL...4,SET,154,-0.1994,-0.018176,0.067437,0.99844,GSE32034_UNTREATED_VS_ROSIGLIZATONE_TREATED_LY6C_LOW_MONOCYTE_UP,1
GOBP_POSITIVE_REGULATION_OF_...822,SET,8,-0.93588,-0.019521,0.31615,0.99846,GOBP_POSITIVE_REGULATION_OF_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
SCHAEFFER_PROSTATE_DEVELOPME...2,SET,102,-0.25362,-0.018841,0.085648,0.99847,SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP,1
GOBP_NEGATIVE_REGULATION_OF_...96,SET,10,-0.76534,-0.017847,0.25842,0.99847,GOBP_NEGATIVE_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
MIR6882_3P,SET,106,-0.24312,-0.01841,0.081891,0.9985,MIR6882_3P,1
MIR302A_5P,SET,175,-0.18984,-0.018436,0.063913,0.99851,MIR302A_5P,1
GSE14908_ATOPIC_VS_NONATOPIC...4,SET,176,-0.18468,-0.017986,0.06213,0.99852,GSE14908_ATOPIC_VS_NONATOPIC_PATIENT_RESTING_CD4_TCELL_UP,1
NFKAPPAB_01,SET,234,-0.16787,-0.018821,0.056459,0.99853,NFKAPPAB_01,1
MORF_PTPRB,SET,222,-0.17247,-0.018841,0.057825,0.99857,MORF_PTPRB,1
GABRIELY_MIR21_TARGETS,SET,261,-0.15684,-0.018557,0.05256,0.99858,GABRIELY_MIR21_TARGETS,1
GOBP_REGULATION_OF_CELLULAR_...12,SET,17,-0.58058,-0.017649,0.19444,0.99858,GOBP_REGULATION_OF_CELLULAR_RESPONSE_TO_HYPOXIA,1
CHIN_BREAST_CANCER_COPY_NUMB...1,SET,12,-0.65497,-0.01673,0.21901,0.99861,CHIN_BREAST_CANCER_COPY_NUMBER_DN,1
KERLEY_RESPONSE_TO_CISPLATIN...1,SET,5,-1.21,-0.019955,0.40417,0.99862,KERLEY_RESPONSE_TO_CISPLATIN_DN,1
GOBP_POSITIVE_REGULATION_OF_...501,SET,25,-0.55942,-0.020618,0.18635,0.99866,GOBP_POSITIVE_REGULATION_OF_MUSCLE_HYPERTROPHY,1
GSE17721_CTRL_VS_POLYIC_2H_B...2,SET,177,-0.18342,-0.017914,0.061105,0.99866,GSE17721_CTRL_VS_POLYIC_2H_BMDC_UP,1
HP_ACTION_TREMOR,SET,167,-0.19055,-0.018081,0.063402,0.99867,HP_ACTION_TREMOR,1
DESCARTES_MAIN_FETAL_LENS_FI...,SET,137,-0.22076,-0.018989,0.073437,0.99868,DESCARTES_MAIN_FETAL_LENS_FIBRE_CELLS,1
GOBP_POSITIVE_REGULATION_OF_...575,SET,6,-1.0033,-0.018125,0.33303,0.9987,GOBP_POSITIVE_REGULATION_OF_PEPTIDYL_LYSINE_ACETYLATION,1
PID_HIV_NEF_PATHWAY,SET,35,-0.42366,-0.01847,0.14008,0.99875,PID_HIV_NEF_PATHWAY,1
GOBP_POSITIVE_REGULATION_OF_...248,SET,140,-0.22591,-0.019641,0.074374,0.99881,GOBP_POSITIVE_REGULATION_OF_EPITHELIAL_CELL_MIGRATION,1
GSE35543_IN_VIVO_NTREG_VS_IN...1,SET,144,-0.21556,-0.019006,0.070965,0.99881,GSE35543_IN_VIVO_NTREG_VS_IN_VITRO_ITREG_DN,1
FISCHER_G2_M_CELL_CYCLE,SET,221,-0.16909,-0.01843,0.05562,0.99882,FISCHER_G2_M_CELL_CYCLE,1
GOBP_DICARBOXYLIC_ACID_TRANS...,SET,99,-0.27108,-0.019842,0.089106,0.99882,GOBP_DICARBOXYLIC_ACID_TRANSPORT,1
HP_SPARSE_BONE_TRABECULAE,SET,4,-1.3703,-0.020213,0.45014,0.99883,HP_SPARSE_BONE_TRABECULAE,1
GOBP_SYNAPTIC_TRANSMISSION_G...2,SET,98,-0.2762,-0.020114,0.090562,0.99885,GOBP_SYNAPTIC_TRANSMISSION_GLUTAMATERGIC,1
HP_KINETIC_TREMOR,SET,90,-0.25754,-0.017978,0.084381,0.99886,HP_KINETIC_TREMOR,1
SCHAEFFER_SOX9_TARGETS_IN_PR...1,SET,44,-0.4167,-0.020364,0.13619,0.99889,SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN,1
GSE11864_UNTREATED_VS_CSF1_I...3,SET,164,-0.19423,-0.018265,0.063405,0.9989,GSE11864_UNTREATED_VS_CSF1_IFNG_PAM3CYS_IN_MAC_DN,1
GOBP_NEGATIVE_REGULATION_OF_...85,SET,13,-0.77563,-0.020621,0.25312,0.99891,GOBP_NEGATIVE_REGULATION_OF_CATECHOLAMINE_SECRETION,1
MIR20A_3P,SET,173,-0.19455,-0.018787,0.063424,0.99892,MIR20A_3P,1
GTF3C1_TARGET_GENES,SET,4,-1.3187,-0.019452,0.42955,0.99893,GTF3C1_TARGET_GENES,1
GOBP_BRAINSTEM_DEVELOPMENT,SET,7,-0.94308,-0.018402,0.30675,0.99894,GOBP_BRAINSTEM_DEVELOPMENT,1
GOCC_HISTONE_PRE_MRNA_3_END_...,SET,6,-0.90275,-0.016308,0.29288,0.99897,GOCC_HISTONE_PRE_MRNA_3_END_PROCESSING_COMPLEX,1
GOBP_RETINA_DEVELOPMENT_IN_C...,SET,155,-0.21964,-0.020085,0.071198,0.99898,GOBP_RETINA_DEVELOPMENT_IN_CAMERA_TYPE_EYE,1
MIR6124,SET,410,-0.12833,-0.018953,0.041531,0.999,MIR6124,1
GOCC_AUTOLYSOSOME,SET,12,-0.77016,-0.019673,0.24913,0.999,GOCC_AUTOLYSOSOME,1
GSE3720_LPS_VS_PMA_STIM_VD1_...2,SET,124,-0.23479,-0.01922,0.075214,0.9991,GSE3720_LPS_VS_PMA_STIM_VD1_GAMMADELTA_TCELL_UP,1
GOBP_GLUTAMATE_SECRETION,SET,28,-0.5544,-0.021623,0.17742,0.99911,GOBP_GLUTAMATE_SECRETION,1
SQSTM1_TARGET_GENES,SET,30,-0.45719,-0.018456,0.1461,0.99912,SQSTM1_TARGET_GENES,1
GOBP_ZYMOGEN_INHIBITION,SET,7,-0.90449,-0.017649,0.28849,0.99914,GOBP_ZYMOGEN_INHIBITION,1
AMEF2_Q6,SET,229,-0.18076,-0.020052,0.057617,0.99915,AMEF2_Q6,1
HP_EEG_WITH_FRONTAL_FOCAL_SP...,SET,4,-1.6384,-0.024168,0.52177,0.99915,HP_EEG_WITH_FRONTAL_FOCAL_SPIKES,1
GOBP_PEPTIDYL_LYSINE_METHYLA...,SET,14,-0.67946,-0.018746,0.21589,0.99917,GOBP_PEPTIDYL_LYSINE_METHYLATION,1
MIR497_3P,SET,217,-0.18269,-0.019734,0.058012,0.99918,MIR497_3P,1
MORF_PRKAG1,SET,203,-0.17291,-0.018071,0.054807,0.9992,MORF_PRKAG1,1
CTR9_TARGET_GENES,SET,46,-0.35865,-0.01792,0.11351,0.99921,CTR9_TARGET_GENES,1
NR1H4_TARGET_GENES,SET,328,-0.14965,-0.019813,0.04725,0.99923,NR1H4_TARGET_GENES,1
ZIC2_01,SET,228,-0.17974,-0.019895,0.056667,0.99924,ZIC2_01,1
DESCARTES_FETAL_PLACENTA_SYN...,SET,51,-0.39473,-0.020764,0.12401,0.99927,DESCARTES_FETAL_PLACENTA_SYNCYTIOTROPHOBLASTS_AND_VILLOUS_CYTOTROPHOBLASTS,1
REACTOME_ADRENOCEPTORS,SET,9,-1.055,-0.02334,0.32904,0.99933,REACTOME_ADRENOCEPTORS,1
MIR4774_3P,SET,75,-0.31375,-0.020002,0.097769,0.99933,MIR4774_3P,1
GCTNWTTGK_UNKNOWN,SET,279,-0.16859,-0.020613,0.052589,0.99933,GCTNWTTGK_UNKNOWN,1
GOMF_LIGASE_ACTIVITY_FORMING...5,SET,5,-1.0771,-0.017763,0.33271,0.9994,GOMF_LIGASE_ACTIVITY_FORMING_PHOSPHORIC_ESTER_BONDS,1
MIR8084,SET,213,-0.19535,-0.020908,0.060032,0.99943,MIR8084,1
MORF_PHB,SET,115,-0.23634,-0.018637,0.072644,0.99943,MORF_PHB,1
MODULE_134,SET,29,-0.58244,-0.023118,0.17891,0.99943,MODULE_134,1
GOBP_NEGATIVE_REGULATION_OF_...8,SET,10,-0.92974,-0.021681,0.28511,0.99944,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE,1
HP_PORTAL_FIBROSIS,SET,15,-0.67801,-0.019362,0.20778,0.99945,HP_PORTAL_FIBROSIS,1
GSE41978_ID2_KO_VS_ID2_KO_AN...2,SET,175,-0.21908,-0.021275,0.067074,0.99945,GSE41978_ID2_KO_VS_ID2_KO_AND_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_UP,1
MIR595,SET,57,-0.35708,-0.019855,0.10842,0.9995,MIR595,1
OVSYANNIKOVA_PBMC_FLUARIX_AG...6,SET,29,-0.47502,-0.018854,0.14426,0.9995,OVSYANNIKOVA_PBMC_FLUARIX_AGE_55_64YO_RESPONDERS_VS_NONRESPONDERS_0DY_UP,1
HP_NUMEROUS_PIGMENTED_FRECKL...,SET,7,-0.91842,-0.01792,0.27839,0.99951,HP_NUMEROUS_PIGMENTED_FRECKLES,1
GOBP_NOREPINEPHRINE_SECRETION,SET,14,-0.82292,-0.022704,0.24917,0.99952,GOBP_NOREPINEPHRINE_SECRETION,1
GOBP_POSITIVE_REGULATION_OF_...255,SET,29,-0.51922,-0.020608,0.15674,0.99954,GOBP_POSITIVE_REGULATION_OF_ERBB_SIGNALING_PATHWAY,1
GSE12366_GC_VS_NAIVE_BCELL_UP,SET,178,-0.20188,-0.019771,0.060453,0.99958,GSE12366_GC_VS_NAIVE_BCELL_UP,1
HP_PULP_CALCIFICATION,SET,7,-1.2479,-0.024349,0.37291,0.99959,HP_PULP_CALCIFICATION,1
GOMF_CATECHOLAMINE_BINDING,SET,12,-0.93938,-0.023995,0.28033,0.9996,GOMF_CATECHOLAMINE_BINDING,1
GOBP_NEGATIVE_REGULATION_OF_...158,SET,42,-0.42883,-0.020476,0.1275,0.99961,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY_INVOLVED_IN_APOPTOTIC_PROCESS,1
GOCC_COPI_COATED_VESICLE,SET,24,-0.51013,-0.018422,0.15168,0.99961,GOCC_COPI_COATED_VESICLE,1
GSE2770_TGFB_AND_IL4_VS_TGFB...6,SET,177,-0.21071,-0.020578,0.06257,0.99962,GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_UP,1
HP_ALOPECIA_OF_SCALP,SET,37,-0.45851,-0.020552,0.13575,0.99963,HP_ALOPECIA_OF_SCALP,1
MIR324_5P,SET,39,-0.44204,-0.020341,0.13064,0.99964,MIR324_5P,1
MIR329_5P,SET,124,-0.24827,-0.020324,0.073344,0.99964,MIR329_5P,1
MIR1237_3P,SET,120,-0.27136,-0.021855,0.079911,0.99966,MIR1237_3P,1
MIKKELSEN_MEF_ICP_WITH_H3K4M...,SET,37,-0.50631,-0.022694,0.1483,0.99968,MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3,1
GOBP_INTRINSIC_APOPTOTIC_SIG...7,SET,9,-0.83661,-0.018509,0.24443,0.99969,GOBP_INTRINSIC_APOPTOTIC_SIGNALING_PATHWAY_IN_RESPONSE_TO_HYPOXIA,1
YANAGIHARA_ESX1_TARGETS,SET,26,-0.59044,-0.022192,0.172,0.9997,YANAGIHARA_ESX1_TARGETS,1
GOBP_REGULATION_OF_GLOMERULU...,SET,4,-1.6162,-0.023841,0.4708,0.9997,GOBP_REGULATION_OF_GLOMERULUS_DEVELOPMENT,1
TATAAA_TATA_01,SET,1143,-0.093119,-0.022488,0.027057,0.99971,TATAAA_TATA_01,1
STARK_PREFRONTAL_CORTEX_22Q1...2,SET,180,-0.21907,-0.021573,0.063556,0.99972,STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP,1
MIR6499_3P,SET,111,-0.27534,-0.021333,0.079869,0.99972,MIR6499_3P,1
HP_ABNORMAL_CIRCULATING_MONO...,SET,66,-0.35589,-0.021289,0.10321,0.99972,HP_ABNORMAL_CIRCULATING_MONOCARBOXYLIC_ACID_CONCENTRATION,1
SPIELMAN_LYMPHOBLAST_EUROPEA...1,SET,17,-0.78821,-0.023961,0.22669,0.99975,SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_2FC_DN,1
HP_SPLIT_NAIL,SET,4,-1.1033,-0.016275,0.31633,0.99976,HP_SPLIT_NAIL,1
HP_TIGER_TAIL_BANDING,SET,4,-1.1033,-0.016275,0.31633,0.99976,HP_TIGER_TAIL_BANDING,1
HP_ABNORMAL_PERIOSTEUM_MORPH...,SET,8,-1.1848,-0.024714,0.33639,0.99979,HP_ABNORMAL_PERIOSTEUM_MORPHOLOGY,1
GOBP_POSITIVE_REGULATION_OF_...733,SET,12,-0.84502,-0.021585,0.23907,0.9998,GOBP_POSITIVE_REGULATION_OF_STRIATED_MUSCLE_CELL_APOPTOTIC_PROCESS,1
MIR10522_5P,SET,215,-0.20431,-0.021968,0.057543,0.99981,MIR10522_5P,1
HP_DIARRHEA,SET,362,-0.16684,-0.023183,0.045656,0.99987,HP_DIARRHEA,1
MCRS1_TARGET_GENES,SET,33,-0.54339,-0.023005,0.14677,0.99989,MCRS1_TARGET_GENES,1
GOBP_NEGATIVE_REGULATION_OF_...157,SET,55,-0.42629,-0.023285,0.11493,0.9999,GOBP_NEGATIVE_REGULATION_OF_CYSTEINE_TYPE_ENDOPEPTIDASE_ACTIVITY,1
GOBP_POSITIVE_REGULATION_OF_...61,SET,30,-0.59922,-0.02419,0.16059,0.9999,GOBP_POSITIVE_REGULATION_OF_BLOOD_PRESSURE,1
GOBP_UTERINE_SMOOTH_MUSCLE_C...,SET,10,-0.97919,-0.022834,0.26253,0.9999,GOBP_UTERINE_SMOOTH_MUSCLE_CONTRACTION,1
GOBP_NEGATIVE_REGULATION_OF_...9,SET,4,-1.8574,-0.027399,0.49505,0.99991,GOBP_NEGATIVE_REGULATION_OF_ACUTE_INFLAMMATORY_RESPONSE_TO_ANTIGENIC_STIMULUS,1
GOBP_CELLULAR_RESPONSE_TO_VI...2,SET,27,-0.67019,-0.025668,0.17684,0.99992,GOBP_CELLULAR_RESPONSE_TO_VITAMIN,1
RAF_UP.V1_DN,SET,171,-0.2714,-0.026056,0.071268,0.99993,RAF_UP.V1_DN,1
HP_ABNORMAL_METABOLISM,SET,146,-0.2595,-0.023036,0.067526,0.99994,HP_ABNORMAL_METABOLISM,1
GAVISH_3CA_MALIGNANT_METAPRO...31,SET,42,-0.53869,-0.025722,0.13893,0.99995,GAVISH_3CA_MALIGNANT_METAPROGRAM_39_METAL_RESPONSE,1
GOBP_TYPE_II_PNEUMOCYTE_DIFF...,SET,6,-1.3287,-0.024004,0.33995,0.99995,GOBP_TYPE_II_PNEUMOCYTE_DIFFERENTIATION,1
PID_REELIN_PATHWAY,SET,28,-0.7218,-0.028152,0.16538,0.99999,PID_REELIN_PATHWAY,1
MIR548AC,SET,545,-0.16022,-0.027179,0.036338,0.99999,MIR548AC,1
MIR548BB_3P,SET,541,-0.156,-0.026367,0.036486,0.99999,MIR548BB_3P,1
MIR548D_3P,SET,547,-0.15672,-0.026632,0.036315,0.99999,MIR548D_3P,1
GOBP_EPINEPHRINE_TRANSPORT,SET,11,-1.2784,-0.031266,0.29348,0.99999,GOBP_EPINEPHRINE_TRANSPORT,1
HP_HIGH_SERUM_CALCITRIOL,SET,5,-1.9528,-0.032206,0.45049,0.99999,HP_HIGH_SERUM_CALCITRIOL,1
MIR548H_3P_MIR548Z,SET,547,-0.16056,-0.027284,0.036284,1,MIR548H_3P_MIR548Z,1
GOBP_EPINEPHRINE_SECRETION,SET,7,-1.7322,-0.0338,0.3608,1,GOBP_EPINEPHRINE_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...208,SET,5,-2.0269,-0.033426,0.41078,1,GOBP_NEGATIVE_REGULATION_OF_EPINEPHRINE_SECRETION,1
GOBP_NEGATIVE_REGULATION_OF_...453,SET,6,-1.7621,-0.031833,0.38683,1,GOBP_NEGATIVE_REGULATION_OF_NOREPINEPHRINE_SECRETION,1
GOMF_EPINEPHRINE_BINDING,SET,6,-1.7703,-0.031981,0.38565,1,GOMF_EPINEPHRINE_BINDING,1
HP_ENLARGED_EPIPHYSES,SET,12,-1.0218,-0.0261,0.22752,1,HP_ENLARGED_EPIPHYSES,1
